,sentence,Mot,Label
0,1,With,O
1,1,severe,O
2,1,comorbidities,B-Condition
3,1,",",O
4,1,such,O
5,1,as,O
6,1,cardiovascular,B-Condition
7,1,disease,I-Condition
8,1,",",O
9,1,chronic,B-Condition
10,1,obstructive,I-Condition
11,1,pulmonary,I-Condition
12,1,disease,I-Condition
13,1,",",O
14,1,diabetes,B-Condition
15,1,mellitus,I-Condition
16,1,",",O
17,1,and,O
18,1,chronic,B-Condition
19,1,renal,I-Condition
20,1,dysfunction,I-Condition
21,1,.,O
22,2,With,O
23,2,bad,B-Condition
24,2,compliance,I-Condition
25,2,or,O
26,2,contraindication,B-Condition
27,2,to,I-Condition
28,2,enrollment,I-Condition
29,2,.,O
30,3,Pregnant,B-Condition
31,3,woman,B-Person
32,3,or,O
33,3,lactating,B-Condition
34,3,woman,B-Person
35,3,.,O
36,4,With,O
37,4,contraindication,B-Condition
38,4,to,O
39,4,receive,O
40,4,adjuvant,B-Procedure
41,4,chemotherapy,I-Procedure
42,4,.,O
43,5,The,O
44,5,informed,O
45,5,consent,O
46,5,has,O
47,5,been,O
48,5,obtained,O
49,5,from,O
50,5,the,O
51,5,patient,O
52,5,.,O
53,6,With,O
54,6,confirmed,O
55,6,diagnosis,O
56,6,of,O
57,6,stage,O
58,6,II,O
59,6,colon,B-Condition
60,6,cancer,I-Condition
61,6,.,O
62,7,With,O
63,7,moderate,O
64,7,/,O
65,7,good,O
66,7,ECOG,O
67,7,health,O
68,7,rating,O
69,7,(,O
70,7,PS,O
71,7,):,O
72,7,0,O
73,7,-,O
74,7,1,O
75,7,score,O
76,7,.,O
77,8,The,O
78,8,patient,O
79,8,receive,O
80,8,no,O
81,8,anti,B-Drug
82,8,-,I-Drug
83,8,cancer,I-Drug
84,8,treatment,I-Drug
85,8,before,O
86,8,primary,B-Procedure
87,8,surgery,I-Procedure
88,8,.,O
89,9,The,O
90,9,patient,O
91,9,receive,O
92,9,radical,B-Procedure
93,9,operation,I-Procedure
94,9,for,I-Procedure
95,9,colon,I-Procedure
96,9,cancer,I-Procedure
97,9,with,I-Procedure
98,9,negative,I-Procedure
99,9,margin,I-Procedure
100,9,.,O
101,10,Inability,O
102,10,to,O
103,10,give,O
104,10,informed,O
105,10,consent,O
106,11,Possible,B-Mood
107,11,pregnancy,B-Condition
108,11,(,O
109,11,confirmed,O
110,11,by,O
111,11,urine,B-Procedure
112,11,test,I-Procedure
113,11,),O
114,12,Women,B-Person
115,12,who,O
116,12,are,O
117,12,breastfeeding,B-Observation
118,13,Severe,O
119,13,claustrophobia,B-Condition
120,14,Inability,B-Condition
121,14,to,I-Condition
122,14,lie,I-Condition
123,14,flat,I-Condition
124,14,for,O
125,14,20,O
126,14,-,O
127,14,30,O
128,14,minutes,O
129,14,(,O
130,14,the,O
131,14,anticipated,O
132,14,amount,O
133,14,of,O
134,14,time,O
135,14,to,O
136,14,complete,O
137,14,the,O
138,14,MRI,O
139,14,procedure,O
140,14,),O
141,15,Individuals,O
142,15,with,O
143,15,cochlear,O
144,15,implants,O
145,16,Individuals,O
146,16,with,O
147,16,non,O
148,16,-,O
149,16,MRI,O
150,16,compatible,O
151,16,aneurysm,O
152,16,clips,O
153,17,Potential,O
154,17,contraindications,O
155,17,to,O
156,17,regadenoson,O
157,17,use,O
158,17,due,O
159,17,to,O
160,17,:,O
161,18,Contraindication,B-Condition
162,18,to,O
163,18,administration,O
164,18,of,O
165,18,Gadolinium,B-Drug
166,18,(,I-Drug
167,18,Gd,I-Drug
168,18,),I-Drug
169,18,based,I-Drug
170,18,contrast,I-Drug
171,18,agents,I-Drug
172,18,(,I-Drug
173,18,GBCA,I-Drug
174,18,):,I-Drug
175,19,Aged,B-Person
176,19,18,O
177,19,years,O
178,19,or,O
179,19,older,O
180,20,Scheduled,B-Mood
181,20,for,O
182,20,invasive,B-Procedure
183,20,coronary,I-Procedure
184,20,angiography,I-Procedure
185,21,allergic,B-Condition
186,21,history,B-Observation
187,21,to,O
188,21,dexmedetomidine,B-Drug
189,22,refractory,O
190,22,bradycardia,B-Condition
191,22,<,O
192,22,60,O
193,22,bpm,O
194,22,despite,O
195,22,treatment,B-Procedure
196,23,severe,O
197,23,atrioventricular,B-Condition
198,23,block,I-Condition
199,23,(,O
200,23,2nd,O
201,23,and,O
202,23,3rd,O
203,23,degree,O
204,23,),O
205,24,previous,O
206,24,operation,B-Procedure
207,24,of,I-Procedure
208,24,tongue,I-Procedure
209,25,kidney,B-Procedure
210,25,transplant,I-Procedure
211,25,recipient,O
212,26,Uncontrolled,O
213,26,diabetes,B-Condition
214,27,Ulcer,B-Condition
215,27,infection,I-Condition
216,28,Non,O
217,28,-,O
218,28,diabetic,O
219,28,ulcers,B-Condition
220,28,Orthopedic,B-Condition
221,28,or,I-Condition
222,28,neuromuscular,I-Condition
223,28,pathologic,I-Condition
224,28,conditions,I-Condition
225,29,Diagnosis,O
226,29,of,O
227,29,diabetes,B-Condition
228,29,mellitus,I-Condition
229,29,according,O
230,29,to,O
231,29,World,O
232,29,Health,O
233,29,Organization,O
234,29,criteria,O
235,29,(,O
236,29,treatment,B-Procedure
237,29,with,O
238,29,insulin,B-Drug
239,29,or,O
240,29,an,O
241,29,oral,B-Drug
242,29,hypoglycemic,I-Drug
243,29,agent,I-Drug
244,29,",",O
245,29,twice,O
246,29,random,O
247,29,glucose,O
248,29,measurements,O
249,29,major,O
250,29,than,O
251,29,200,O
252,29,mg,O
253,29,/,O
254,29,dl,O
255,29,",",O
256,29,or,O
257,29,a,O
258,29,fasting,O
259,29,glucose,O
260,29,major,O
261,29,than,O
262,29,140,O
263,29,mg,O
264,29,/,O
265,29,dl,O
266,29,),O
267,30,Ulcer,B-Condition
268,30,located,O
269,30,on,O
270,30,the,O
271,30,legs,O
272,30,or,O
273,30,feet,O
274,30,",",O
275,30,stage,O
276,30,III,O
277,30,or,O
278,30,IV,O
279,30,(,O
280,30,Wagner,O
281,30,Classification,O
282,30,System,O
283,30,),O
284,31,The,O
285,31,subject,O
286,31,agrees,O
287,31,to,O
288,31,comply,O
289,31,with,O
290,31,study,O
291,31,protocol,O
292,31,requirements,O
293,31,and,O
294,31,all,O
295,31,follow,O
296,31,up,O
297,31,visit,O
298,31,requirements,O
299,31,.,O
300,32,Hypersensitivity,B-Condition
301,32,to,O
302,32,B,B-Drug
303,32,-,I-Drug
304,32,lactams,I-Drug
305,33,concomitant,O
306,33,disease,B-Condition
307,33,which,O
308,33,must,O
309,33,be,O
310,33,treated,B-Procedure
311,33,with,O
312,33,antibiotics,B-Drug
313,34,chronic,O
314,34,disease,O
315,34,-,O
316,34,Immunocompromised,B-Condition
317,35,Antibiotics,B-Drug
318,35,within,O
319,35,72,O
320,35,h,O
321,36,history,B-Observation
322,36,of,O
323,36,ARF,B-Condition
324,36,",",O
325,36,scarlet,B-Condition
326,36,fever,I-Condition
327,36,",",O
328,36,impetigo,B-Condition
329,36,",",O
330,36,acute,B-Condition
331,36,glomerulonephritis,I-Condition
332,37,Family,B-Observation
333,37,history,I-Observation
334,37,of,O
335,37,ARF,B-Condition
336,38,Complicated,O
337,38,pharyngitis,B-Condition
338,39,3,O
339,39,-15,O
340,39,years,O
341,39,old,B-Person
342,40,Clinical,B-Mood
343,40,symptoms,I-Mood
344,40,suggestive,I-Mood
345,40,of,I-Mood
346,40,pharyngitis,B-Condition
347,40,with,O
348,40,MC,O
349,40,Isaac,O
350,40,score,O
351,40,=3,O
352,41,Rapid,O
353,41,-,O
354,41,antigen,O
355,41,detection,O
356,41,test,O
357,41,(,O
358,41,RADT,O
359,41,),O
360,41,positive,O
361,41,for,O
362,41,GAS-,O
363,42,Signed,O
364,42,informed,O
365,42,parental,O
366,42,/,O
367,42,patient,O
368,42,consent,O
369,42,form,O
370,43,aged,B-Person
371,43,less,O
372,43,than,O
373,43,20,O
374,43,years,O
375,44,history,O
376,44,of,O
377,44,gastric,B-Procedure
378,44,resection,I-Procedure
379,44,surgery,I-Procedure
380,45,history,O
381,45,of,O
382,45,allergy,B-Condition
383,45,to,O
384,45,study,B-Drug
385,45,drugs,I-Drug
386,46,pregnancy,B-Condition
387,46,or,O
388,46,lactating,B-Condition
389,46,women,B-Person
390,47,severe,B-Condition
391,47,underlying,I-Condition
392,47,illness,I-Condition
393,47,",",O
394,47,such,O
395,47,as,O
396,47,end,B-Condition
397,47,stage,I-Condition
398,47,renal,I-Condition
399,47,disease,I-Condition
400,47,",",O
401,47,decompensated,O
402,47,liver,B-Condition
403,47,cirrhosis,I-Condition
404,47,",",O
405,47,or,O
406,47,non,O
407,47,-,O
408,47,curative,O
409,47,malignancy,B-Condition
410,48,H,B-Condition
411,48,pylori,I-Condition
412,48,infection,I-Condition
413,48,failed,O
414,48,after,O
415,48,at,O
416,48,least,O
417,48,two,O
418,48,eradication,B-Procedure
419,48,therapies,I-Procedure
420,49,aged,B-Person
421,49,20,O
422,49,years,O
423,49,or,O
424,49,greater,O
425,50,willingness,B-Mood
426,50,to,O
427,50,receive,O
428,50,rescue,B-Procedure
429,50,therapy,I-Procedure
430,51,NA,O
431,52,Fluent,O
432,52,in,O
433,52,reading,O
434,52,and,O
435,52,writing,O
436,52,in,O
437,52,English,O
438,52,language,O
439,52,.,O
440,53,=,O
441,53,21,O
442,53,years,O
443,53,of,O
444,53,age,B-Person
445,53,at,O
446,53,the,O
447,53,time,O
448,53,of,O
449,53,participation,O
450,53,.,O
451,54,History,O
452,54,of,O
453,54,anti,B-Drug
454,54,-,I-Drug
455,54,vascular,I-Drug
456,54,endothelial,I-Drug
457,54,growth,I-Drug
458,54,factor,I-Drug
459,54,treatment,O
460,54,in,O
461,54,the,O
462,54,past,O
463,54,12,O
464,54,months,O
465,55,Any,O
466,55,diabetic,B-Condition
467,55,macular,I-Condition
468,55,edema,I-Condition
469,55,treatment,B-Procedure
470,55,in,O
471,55,the,O
472,55,past,O
473,55,4,O
474,55,months,O
475,56,Heart,B-Condition
476,56,attack,I-Condition
477,56,",",O
478,56,stroke,B-Condition
479,56,",",O
480,56,transient,B-Condition
481,56,ischemic,I-Condition
482,56,attack,I-Condition
483,56,or,O
484,56,acute,B-Condition
485,56,congestive,I-Condition
486,56,heart,I-Condition
487,56,failure,I-Condition
488,56,within,O
489,56,4,O
490,56,months,O
491,57,Diagnosis,O
492,57,of,O
493,57,diabetes,B-Condition
494,57,mellitus,I-Condition
495,58,Best,O
496,58,corrected,O
497,58,visual,O
498,58,acuity,O
499,58,20/32,O
500,58,-,O
501,58,20/320,O
502,59,Diabetic,B-Condition
503,59,macular,I-Condition
504,59,edema,I-Condition
505,59,involving,O
506,59,the,O
507,59,center,O
508,59,of,O
509,59,the,O
510,59,macula,O
511,60,Optical,O
512,60,coherence,O
513,60,tomography,O
514,60,central,O
515,60,subfield,O
516,60,thickness,O
517,60,of,O
518,60,at,O
519,60,least,O
520,60,250,O
521,60,microns,O
522,61,Nursing,O
523,61,homes,O
524,61,will,O
525,61,not,O
526,61,be,O
527,61,eligible,O
528,61,to,O
529,61,participate,O
530,61,if,O
531,61,they,O
532,61,meet,O
533,61,the,O
534,61,following,O
535,61,criteria,O
536,61,:,O
537,62,Facilities,O
538,62,routinely,O
539,62,using,O
540,62,decolonization,B-Procedure
541,63,Dedicated,O
542,63,psychiatric,O
543,63,nursing,O
544,63,homes,O
545,64,Facilities,O
546,64,with,O
547,64,a,O
548,64,resident,O
549,64,population,O
550,64,with,O
551,64,>,O
552,64,=,O
553,64,20,O
554,64,%,O
555,64,combative,B-Observation
556,64,patients,I-Observation
557,65,Pediatric,O
558,65,facilities,O
559,66,Nursing,O
560,66,homes,O
561,66,will,O
562,66,be,O
563,66,eligible,O
564,66,to,O
565,66,participate,O
566,66,if,O
567,66,they,O
568,66,meet,O
569,66,the,O
570,66,following,O
571,66,criteria,O
572,66,:,O
573,67,Licensed,O
574,67,nursing,O
575,67,home,O
576,67,in,O
577,67,Orange,O
578,67,County,O
579,67,or,O
580,67,Southern,O
581,67,Los,O
582,67,Angeles,O
583,67,County,O
584,67,serving,O
585,67,adults,O
586,68,Minimal,O
587,68,use,O
588,68,of,O
589,68,chlorhexidine,B-Procedure
590,68,bathing,I-Procedure
591,68,*,O
592,69,Minimal,O
593,69,use,O
594,69,of,O
595,69,nasal,B-Procedure
596,69,decolonization,I-Procedure
597,69,*,O
598,69,*,O
599,69,Minimal,O
600,69,use,O
601,69,defined,O
602,69,as,O
603,69,<,O
604,69,15,O
605,69,%,O
606,69,of,O
607,69,residents,O
608,69,receiving,O
609,69,at,O
610,69,least,O
611,69,one,O
612,69,chlorhexidine,B-Procedure
613,69,bath,I-Procedure
614,69,or,O
615,69,nasal,B-Procedure
616,69,decolonization,I-Procedure
617,69,treatment,I-Procedure
618,69,during,O
619,69,their,O
620,69,nursing,O
621,69,home,O
622,69,stay,O
623,69,.,O
624,70,1,O
625,70,.,O
626,70,Left,B-Condition
627,70,main,I-Condition
628,70,disease,I-Condition
629,70,(,O
630,70,angiographically,O
631,70,>,O
632,70,50,O
633,70,%,O
634,70,),O
635,71,2,O
636,71,.,O
637,71,Cardiogenic,B-Condition
638,71,shock,I-Condition
639,71,/,O
640,71,hemodynamic,B-Condition
641,71,instability,I-Condition
642,72,3,O
643,72,.,O
644,72,Previous,O
645,72,CABG,B-Condition
646,73,4,O
647,73,.,O
648,73,Increased,O
649,73,risk,O
650,73,of,O
651,73,bradycardia,B-Condition
652,73,on,O
653,73,investigator,O
654,73,clinical,O
655,73,judgment,O
656,74,5,O
657,74,.,O
658,74,Severe,O
659,74,chronic,B-Condition
660,74,obstructive,I-Condition
661,74,pulmonary,I-Condition
662,74,disease,I-Condition
663,75,6,O
664,75,.,O
665,75,Coronary,B-Condition
666,75,vessels,I-Condition
667,75,with,I-Condition
668,75,tortuosity,I-Condition
669,75,or,I-Condition
670,75,extremely,I-Condition
671,75,calcified,I-Condition
672,76,7,O
673,76,.,O
674,76,Severe,O
675,76,left,B-Condition
676,76,ventricular,I-Condition
677,76,hypertrophy,I-Condition
678,76,or,O
679,76,severe,O
680,76,valvular,B-Condition
681,76,disease,I-Condition
682,77,8,O
683,77,.,O
684,77,STEMI,B-Condition
685,77,or,O
686,77,non,B-Condition
687,77,-,I-Condition
688,77,STEMI,I-Condition
689,77,within,O
690,77,the,O
691,77,past,O
692,77,five,O
693,77,days,O
694,78,9,O
695,78,.,O
696,78,Previous,O
697,78,myocardial,B-Condition
698,78,infarction,I-Condition
699,78,in,O
700,78,the,O
701,78,distribution,O
702,78,of,O
703,78,the,O
704,78,target,O
705,78,vessel,O
706,78,for,O
707,78,the,O
708,78,FFR,O
709,79,10,O
710,79,.,O
711,79,Acute,B-Condition
712,79,decompensated,I-Condition
713,79,heart,I-Condition
714,79,failure,I-Condition
715,79,.,O
716,80,1,O
717,80,.,O
718,80,Age,B-Person
719,80,18,O
720,80,-,O
721,80,80,O
722,80,years,O
723,81,2,O
724,81,.,O
725,81,Patients,O
726,81,with,O
727,81,at,O
728,81,least,O
729,81,1,O
730,81,≥50,O
731,81,%,O
732,81,stenosis,O
733,81,in,O
734,81,a,O
735,81,coronary,O
736,81,vessel,O
737,81,",",O
738,81,subjected,O
739,81,to,O
740,81,FFR,B-Procedure
741,81,assessment,I-Procedure
742,81,",",O
743,81,who,O
744,81,exhibit,O
745,81,variation,B-Condition
746,81,in,I-Condition
747,81,Pd,I-Condition
748,81,/,I-Condition
749,81,Pa,I-Condition
750,81,ratio,I-Condition
751,81,≥,O
752,81,0.05,O
753,81,(,O
754,81,e.g.,O
755,81,difference,O
756,81,of,O
757,81,max,O
758,81,Pd,O
759,81,/,O
760,81,Pa,O
761,81,minus,O
762,81,min,O
763,81,Pd,O
764,81,/,O
765,81,Pa,O
766,81,),O
767,81,during,O
768,81,steady,O
769,81,state,O
770,81,hyperaemia,B-Condition
771,81,(,O
772,81,determined,O
773,81,by,O
774,81,visual,B-Procedure
775,81,assessment,I-Procedure
776,81,),O
777,81,.,O
778,82,3,O
779,82,.,O
780,82,Written,O
781,82,informed,O
782,82,consent,O
783,83,Age,B-Person
784,83,<,O
785,83,20,O
786,83,or,O
787,83,>,O
788,83,35,O
789,83,years,O
790,83,.,O
791,84,Congenital,B-Condition
792,84,uterine,I-Condition
793,84,malformation,I-Condition
794,84,.,O
795,85,Multifetal,B-Condition
796,85,pregnancy,I-Condition
797,85,.,O
798,86,Known,O
799,86,major,O
800,86,fetal,B-Condition
801,86,structural,I-Condition
802,86,or,O
803,86,chromosomal,B-Condition
804,86,abnormality,I-Condition
805,86,.,O
806,87,Known,O
807,87,allergy,B-Condition
808,87,or,O
809,87,contraindication,B-Condition
810,87,(,O
811,87,relative,O
812,87,or,O
813,87,absolute,O
814,87,),O
815,87,to,O
816,87,progesterone,B-Procedure
817,87,therapy,I-Procedure
818,87,.,O
819,88,Presence,O
820,88,of,O
821,88,contraindication,B-Condition
822,88,to,O
823,88,cervical,B-Procedure
824,88,cerclage,I-Procedure
825,88,.,O
826,89,Medical,B-Condition
827,89,conditions,I-Condition
828,89,complicating,O
829,89,pregnancy,O
830,89,.,O
831,90,Vaginal,B-Condition
832,90,bleeding,I-Condition
833,90,.,O
834,91,Women,B-Person
835,91,with,O
836,91,singleton,B-Condition
837,91,pregnancy,I-Condition
838,91,.,O
839,92,History,O
840,92,of,O
841,92,preterm,B-Condition
842,92,labor,I-Condition
843,92,and/or,O
844,92,midtrimester,B-Condition
845,92,miscarriage,I-Condition
846,92,in,O
847,92,a,O
848,92,previous,O
849,92,pregnancy,B-Condition
850,92,.,O
851,93,Cervical,O
852,93,length,O
853,93,of,O
854,93,15,O
855,93,-,O
856,93,25,O
857,93,mm,O
858,93,by,O
859,93,transvaginal,B-Procedure
860,93,sonography,I-Procedure
861,93,(,I-Procedure
862,93,TVS,I-Procedure
863,93,),I-Procedure
864,93,at,O
865,93,16,O
866,93,-,O
867,93,24,O
868,93,weeks,O
869,93,of,O
870,93,gestation,O
871,93,.,O
872,94,Contraindications,B-Condition
873,94,to,O
874,94,empagliflozin,B-Drug
875,94,",",O
876,94,Sitagliptin,B-Drug
877,95,DPP4,B-Drug
878,95,inhibitors,I-Drug
879,95,or,O
880,95,Sodium,B-Drug
881,95,-,I-Drug
882,95,glucose,I-Drug
883,95,cotransporter-2(SGLT2,I-Drug
884,95,),I-Drug
885,95,inhibitors,I-Drug
886,95,within,O
887,95,the,O
888,95,previous,O
889,95,4,O
890,95,weeks,O
891,96,Insulin,B-Drug
892,96,requiring,O
893,96,diabetes,B-Procedure
894,97,Poor,B-Condition
895,97,glucose,I-Condition
896,97,control,I-Condition
897,97,(,O
898,97,HbA1C>10,O
899,97,%,O
900,97,),O
901,98,Acute,B-Condition
902,98,coronary,I-Condition
903,98,syndrome,I-Condition
904,99,Stent,O
905,99,placement,B-Procedure
906,99,within,O
907,99,the,O
908,99,previous,O
909,99,6,O
910,99,months,O
911,100,Previous,O
912,100,coronary,B-Procedure
913,100,artery,I-Procedure
914,100,bypass,I-Procedure
915,100,graft,I-Procedure
916,100,surgery,I-Procedure
917,100,within,O
918,100,the,O
919,100,previous,O
920,100,6,O
921,100,months,O
922,101,Planned,B-Mood
923,101,revascularization,B-Procedure
924,101,within,O
925,101,6,O
926,101,months,O
927,102,Heart,B-Condition
928,102,failure,I-Condition
929,102,requiring,O
930,102,loop,B-Drug
931,102,diuretics,I-Drug
932,103,Severe,O
933,103,left,B-Condition
934,103,ventricular,I-Condition
935,103,hypertrophy,I-Condition
936,103,(,O
937,103,left,O
938,103,ventricular,O
939,103,septal,O
940,103,wall,O
941,103,thickness,O
942,103,>,O
943,103,13,O
944,103,mm,O
945,103,),O
946,104,Significant,O
947,104,renal,B-Condition
948,104,disease,I-Condition
949,104,manifested,O
950,104,by,O
951,104,creatinine,O
952,104,clearance,O
953,104,of,O
954,104,<,O
955,104,30,O
956,104,ml,O
957,104,/,O
958,104,min,O
959,104,),O
960,105,Hepatic,B-Condition
961,105,disease,I-Condition
962,105,or,O
963,105,biliary,B-Condition
964,105,tract,I-Condition
965,105,obstruction,I-Condition
966,105,",",O
967,105,or,O
968,105,significant,O
969,105,hepatic,B-Condition
970,105,enzyme,I-Condition
971,105,elevation,I-Condition
972,105,(,O
973,105,alanine,O
974,105,transaminase,O
975,105,or,O
976,105,Aspartate,O
977,105,Aminotransferase,O
978,105,>,O
979,105,3,O
980,105,times,O
981,105,upper,O
982,105,limit,O
983,105,of,O
984,105,normal,O
985,105,),O
986,106,Radiopaque,O
987,106,material,O
988,106,implanted,O
989,106,in,O
990,106,the,O
991,106,chest,O
992,106,wall,O
993,106,(,O
994,106,metal,O
995,106,",",O
996,106,silicone,O
997,106,",",O
998,106,etc,O
999,106,.,O
1000,106,),O
1001,107,Contraindication,B-Condition
1002,107,to,O
1003,107,adenosine,B-Procedure
1004,107,stress,I-Procedure
1005,107,test,I-Procedure
1006,108,Any,O
1007,108,clinically,O
1008,108,significant,O
1009,108,abnormality,O
1010,108,identified,O
1011,108,at,O
1012,108,the,O
1013,108,screening,O
1014,108,visit,O
1015,108,",",O
1016,108,physical,O
1017,108,examination,O
1018,108,",",O
1019,108,laboratory,O
1020,108,tests,O
1021,108,",",O
1022,108,or,O
1023,108,electrocardiogram,O
1024,108,which,O
1025,108,",",O
1026,108,in,O
1027,108,the,O
1028,108,judgment,O
1029,108,of,O
1030,108,the,O
1031,108,Investigator,O
1032,108,",",O
1033,108,would,O
1034,108,preclude,O
1035,108,safe,O
1036,108,completion,O
1037,108,of,O
1038,108,the,O
1039,108,study,O
1040,108,.,O
1041,109,Patient,O
1042,109,'s,O
1043,109,pregnant,B-Condition
1044,109,or,O
1045,109,breast,B-Condition
1046,109,-,I-Condition
1047,109,feeding,I-Condition
1048,109,or,O
1049,109,child,B-Condition
1050,109,-,I-Condition
1051,109,bearing,I-Condition
1052,109,potential,I-Condition
1053,110,Expected,B-Observation
1054,110,life,I-Observation
1055,110,expectancy,I-Observation
1056,110,<,O
1057,110,1,O
1058,110,year,O
1059,111,Unwillingness,O
1060,111,or,O
1061,111,inability,O
1062,111,to,O
1063,111,comply,O
1064,111,with,O
1065,111,the,O
1066,111,procedures,O
1067,111,described,O
1068,111,in,O
1069,111,this,O
1070,111,protocol,O
1071,112,Men,B-Person
1072,112,or,O
1073,112,women,B-Person
1074,112,at,O
1075,112,least,O
1076,112,19,O
1077,112,years,O
1078,112,of,O
1079,112,age,B-Person
1080,113,Type,B-Condition
1081,113,2,I-Condition
1082,113,diabetes,I-Condition
1083,113,mellitus,I-Condition
1084,114,Stable,O
1085,114,coronary,B-Condition
1086,114,artery,I-Condition
1087,114,disease,I-Condition
1088,115,Global,O
1089,115,myocardial,O
1090,115,perfusion,O
1091,115,reserve,O
1092,115,(,O
1093,115,MPR,O
1094,115,),O
1095,115,index,O
1096,115,<,O
1097,115,2.5,O
1098,116,The,O
1099,116,patient,O
1100,116,or,O
1101,116,guardian,O
1102,116,agrees,O
1103,116,to,O
1104,116,the,O
1105,116,study,O
1106,116,protocol,O
1107,116,and,O
1108,116,the,O
1109,116,schedule,O
1110,116,of,O
1111,116,clinical,O
1112,116,and,O
1113,116,dynamic,O
1114,116,SPECT,O
1115,116,follow,O
1116,116,-,O
1117,116,up,O
1118,116,",",O
1119,116,and,O
1120,116,provides,O
1121,116,informed,O
1122,116,",",O
1123,116,written,O
1124,116,consent,O
1125,116,",",O
1126,116,as,O
1127,116,approved,O
1128,116,by,O
1129,116,the,O
1130,116,appropriate,O
1131,116,Institutional,O
1132,116,Review,O
1133,116,Board,O
1134,116,/,O
1135,116,Ethical,O
1136,116,Committee,O
1137,116,of,O
1138,116,the,O
1139,116,respective,O
1140,116,clinical,O
1141,116,site,O
1142,116,.,O
1143,117,Patients,O
1144,117,with,O
1145,117,cardiac,B-Condition
1146,117,",",I-Condition
1147,117,pulmonary,I-Condition
1148,117,",",I-Condition
1149,117,hepatic,I-Condition
1150,117,",",I-Condition
1151,117,or,I-Condition
1152,117,renal,I-Condition
1153,117,dysfunction,I-Condition
1154,117,",",O
1155,117,epilepsy,B-Condition
1156,117,",",O
1157,117,or,O
1158,117,uncontrolled,O
1159,117,hypertension,B-Condition
1160,117,",",O
1161,117,or,O
1162,117,those,O
1163,117,taking,O
1164,117,medications,B-Drug
1165,117,that,I-Drug
1166,117,influence,I-Drug
1167,117,the,I-Drug
1168,117,central,I-Drug
1169,117,nervous,I-Drug
1170,117,system,I-Drug
1171,117,",",O
1172,117,are,O
1173,117,excluded,O
1174,117,from,O
1175,117,the,O
1176,117,study,O
1177,117,.,O
1178,117,Patients,O
1179,117,who,O
1180,117,show,O
1181,117,obvious,O
1182,117,alteration,B-Condition
1183,117,of,I-Condition
1184,117,mental,I-Condition
1185,117,status,I-Condition
1186,117,",",O
1187,117,or,O
1188,117,refuse,B-Observation
1189,117,to,I-Observation
1190,117,participate,I-Observation
1191,117,",",O
1192,117,are,O
1193,117,also,O
1194,117,excluded,O
1195,117,from,O
1196,117,the,O
1197,117,study,O
1198,117,.,O
1199,118,Patients,O
1200,118,scheduled,B-Mood
1201,118,for,O
1202,118,laser,B-Procedure
1203,118,laryngeal,I-Procedure
1204,118,surgery,I-Procedure
1205,118,under,O
1206,118,general,B-Procedure
1207,118,anesthesia,I-Procedure
1208,118,with,O
1209,118,either,O
1210,118,Propofol,B-Drug
1211,118,or,O
1212,118,desflurane,B-Drug
1213,118,based,O
1214,118,technique,O
1215,118,.,O
1216,119,History,B-Observation
1217,119,of,O
1218,119,cardiovascular,B-Condition
1219,119,disease,I-Condition
1220,119,;,O
1221,120,Current,O
1222,120,pregnancy,B-Condition
1223,120,;,O
1224,121,Uncontrolled,O
1225,121,hypertension,B-Condition
1226,121,;,O
1227,122,Uncontrolled,O
1228,122,hyperlipidemia,B-Condition
1229,122,;,O
1230,123,Current,O
1231,123,hormone,B-Procedure
1232,123,replacement,I-Procedure
1233,123,therapy,I-Procedure
1234,123,;,O
1235,124,Current,O
1236,124,use,B-Observation
1237,124,of,I-Observation
1238,124,tobacco,I-Observation
1239,124,products,I-Observation
1240,124,;,O
1241,125,Elevated,B-Condition
1242,125,liver,I-Condition
1243,125,enzymes,I-Condition
1244,125,;,O
1245,126,Current,O
1246,126,autoimmune,B-Condition
1247,126,disease,I-Condition
1248,126,;,O
1249,127,Daily,O
1250,127,use,O
1251,127,of,O
1252,127,of,O
1253,127,antioxidants,B-Drug
1254,127,>,O
1255,127,300,O
1256,127,mg,O
1257,128,Stage,O
1258,128,3,O
1259,128,-,O
1260,128,5,O
1261,128,Chronic,B-Condition
1262,128,Kidney,I-Condition
1263,128,Disease,I-Condition
1264,129,Left,B-Condition
1265,129,main,I-Condition
1266,129,disease,I-Condition
1267,130,Known,O
1268,130,hypersensitivity,B-Condition
1269,130,or,O
1270,130,contraindication,B-Condition
1271,130,to,O
1272,130,any,O
1273,130,of,O
1274,130,the,O
1275,130,following,O
1276,130,medications,O
1277,130,:,O
1278,130,Heparin,B-Drug
1279,130,",",O
1280,130,aspirin,B-Drug
1281,130,",",O
1282,130,clopidogrel,B-Drug
1283,130,",",O
1284,130,sirolimus,B-Drug
1285,130,",",O
1286,130,siptagliptin,B-Drug
1287,130,and,O
1288,130,statin,B-Drug
1289,131,Congestive,B-Condition
1290,131,heart,I-Condition
1291,131,failure,I-Condition
1292,131,(,O
1293,131,patients,O
1294,131,with,O
1295,131,LVEF,O
1296,131,<,O
1297,131,30,O
1298,131,%,O
1299,131,or,O
1300,131,cardiogenic,B-Condition
1301,131,shock,I-Condition
1302,131,),O
1303,132,Uncontrolled,O
1304,132,myocardial,B-Condition
1305,132,ischemia,I-Condition
1306,132,(,O
1307,132,repeated,O
1308,132,chest,B-Condition
1309,132,pain,I-Condition
1310,132,or,O
1311,132,dyspnea,B-Condition
1312,132,after,O
1313,132,revascularization,B-Procedure
1314,132,),O
1315,133,Uncontrolled,O
1316,133,ventricular,B-Condition
1317,133,arrhythmia,I-Condition
1318,134,History,O
1319,134,of,O
1320,134,malignancy,B-Condition
1321,134,with,O
1322,134,chemotherapy,B-Procedure
1323,135,Serious,O
1324,135,hematologic,B-Condition
1325,135,disease,I-Condition
1326,135,(,O
1327,135,e.g.,O
1328,135,CML,B-Condition
1329,135,",",O
1330,135,MDS,B-Condition
1331,135,),O
1332,136,Current,O
1333,136,infectious,B-Condition
1334,136,disease,I-Condition
1335,136,needs,O
1336,136,antibiotics,B-Drug
1337,136,therapy,O
1338,137,Creatinine,O
1339,137,level,O
1340,137,>,O
1341,137,1.5,O
1342,137,mg,O
1343,137,/,O
1344,137,dL,O
1345,137,or,O
1346,137,dependence,O
1347,137,on,O
1348,137,dialysis,B-Procedure
1349,138,Other,O
1350,138,severe,O
1351,138,concurrent,O
1352,138,illness,B-Condition
1353,138,(,O
1354,138,e.g.,O
1355,138,active,B-Condition
1356,138,infection,I-Condition
1357,138,",",O
1358,138,malignancy,B-Condition
1359,138,),O
1360,138,.,O
1361,139,Life,O
1362,139,expectancy,I-Observation
1363,139,of,O
1364,139,less,O
1365,139,than,O
1366,139,one,O
1367,139,year,O
1368,140,Pregnancy,O
1369,140,or,O
1370,140,women,O
1371,140,with,O
1372,140,potential,O
1373,140,childbearing,O
1374,141,Type,B-Condition
1375,141,I,I-Condition
1376,141,DM,I-Condition
1377,142,Treatment,O
1378,142,with,O
1379,142,insulin,B-Drug
1380,143,History,O
1381,143,of,O
1382,143,pancreatitis,B-Condition
1383,144,Who,O
1384,144,can,O
1385,144,not,O
1386,144,read,O
1387,144,the,O
1388,144,informed,O
1389,144,consent,O
1390,144,form,O
1391,144,(,O
1392,144,e.g.,O
1393,144,illiteracy,O
1394,144,",",O
1395,144,foreigner,O
1396,144,),O
1397,145,Non,B-Condition
1398,145,-,I-Condition
1399,145,ST,I-Condition
1400,145,segement,I-Condition
1401,145,elevation,I-Condition
1402,145,acute,B-Condition
1403,145,coronary,I-Condition
1404,145,syndrome,I-Condition
1405,146,Receipt,O
1406,146,of,O
1407,146,DTaP,B-Drug
1408,146,",",O
1409,146,IPV,B-Drug
1410,146,",",O
1411,146,PCV13,B-Drug
1412,146,",",O
1413,146,or,O
1414,146,Hib,B-Drug
1415,146,prior,O
1416,146,to,O
1417,146,enrollment,O
1418,146,.,O
1419,146,Previous,O
1420,146,administration,O
1421,146,of,O
1422,146,the,O
1423,146,first,O
1424,146,dose,O
1425,146,of,O
1426,146,HBV,O
1427,146,is,O
1428,146,permitted,O
1429,147,Anticipated,B-Mood
1430,147,receipt,I-Mood
1431,147,of,O
1432,147,any,O
1433,147,vaccine,O
1434,147,other,O
1435,147,than,O
1436,147,DTaP,B-Drug
1437,147,",",O
1438,147,IPV,B-Drug
1439,147,",",O
1440,147,HBV,B-Drug
1441,147,",",O
1442,147,PCV13,B-Drug
1443,147,",",O
1444,147,or,O
1445,147,Hib,B-Drug
1446,147,during,O
1447,147,the,O
1448,147,first,O
1449,147,60,O
1450,147,hours,O
1451,147,after,O
1452,147,randomization,O
1453,148,History,O
1454,148,of,O
1455,148,a,O
1456,148,severe,O
1457,148,allergic,B-Condition
1458,148,reaction,I-Condition
1459,148,(,O
1460,148,e.g.,O
1461,148,anaphylaxis,B-Condition
1462,148,),O
1463,148,to,O
1464,148,a,O
1465,148,previous,O
1466,148,dose,O
1467,148,of,O
1468,148,any,O
1469,148,hepatitis,B-Drug
1470,148,B,I-Drug
1471,148,vaccine,I-Drug
1472,149,History,O
1473,149,of,O
1474,149,a,O
1475,149,severe,O
1476,149,allergic,B-Condition
1477,149,reaction,I-Condition
1478,149,(,O
1479,149,e.g.,O
1480,149,anaphylaxis,B-Condition
1481,149,),O
1482,149,to,O
1483,149,any,O
1484,149,component,B-Drug
1485,149,of,I-Drug
1486,149,the,I-Drug
1487,149,vaccines,I-Drug
1488,149,used,I-Drug
1489,149,in,I-Drug
1490,149,the,I-Drug
1491,149,study,I-Drug
1492,149,including,O
1493,149,neomycin,B-Drug
1494,149,",",O
1495,149,yeast,B-Drug
1496,149,and,O
1497,149,polymyxin,B-Drug
1498,149,B,I-Drug
1499,150,History,B-Observation
1500,150,of,O
1501,150,latex,B-Drug
1502,150,allergy,B-Condition
1503,151,History,B-Observation
1504,151,of,O
1505,151,unstable,O
1506,151,progressive,B-Condition
1507,151,neurologic,I-Condition
1508,151,disorder,I-Condition
1509,151,of,O
1510,151,unknown,O
1511,151,cause,O
1512,152,Known,B-Condition
1513,152,cause,I-Condition
1514,152,of,I-Condition
1515,152,apnea,I-Condition
1516,152,other,O
1517,152,than,O
1518,152,apnea,B-Condition
1519,152,of,I-Condition
1520,152,prematurity,I-Condition
1521,153,Cyanotic,B-Condition
1522,153,heart,I-Condition
1523,153,disease,I-Condition
1524,153,(,O
1525,153,congenital,O
1526,153,or,O
1527,153,acquired,O
1528,153,),O
1529,154,Child,O
1530,154,or,O
1531,154,parent,O
1532,154,/,O
1533,154,LAR,O
1534,154,is,O
1535,154,an,O
1536,154,immediate,O
1537,154,relative,O
1538,154,of,O
1539,154,study,O
1540,154,staff,O
1541,154,or,O
1542,154,an,O
1543,154,employee,O
1544,154,who,O
1545,154,is,O
1546,154,supervised,O
1547,154,by,O
1548,154,study,O
1549,154,staff,O
1550,154,.,O
1551,155,Any,O
1552,155,condition,O
1553,155,that,O
1554,155,would,O
1555,155,",",O
1556,155,in,O
1557,155,the,O
1558,155,opinion,O
1559,155,of,O
1560,155,the,O
1561,155,site,O
1562,155,investigator,O
1563,155,",",O
1564,155,place,O
1565,155,the,O
1566,155,participant,O
1567,155,at,O
1568,155,an,O
1569,155,unacceptable,O
1570,155,risk,O
1571,155,of,O
1572,155,injury,O
1573,155,or,O
1574,155,render,O
1575,155,the,O
1576,155,participant,O
1577,155,unable,O
1578,155,to,O
1579,155,meet,O
1580,155,the,O
1581,155,requirements,O
1582,155,of,O
1583,155,the,O
1584,155,protocol,O
1585,156,=,O
1586,156,32,O
1587,156,weeks,O
1588,156,gestational,O
1589,156,age,O
1590,156,at,O
1591,156,birth,O
1592,157,=,O
1593,157,6,O
1594,157,weeks,O
1595,157,postnatal,O
1596,157,age,O
1597,157,at,O
1598,157,randomization,O
1599,158,Remains,O
1600,158,hospitalized,B-Observation
1601,158,after,O
1602,158,birth,O
1603,158,(,O
1604,158,has,O
1605,158,never,O
1606,158,been,O
1607,158,discharged,O
1608,158,home,O
1609,158,),O
1610,159,Treating,O
1611,159,clinician,O
1612,159,deems,O
1613,159,infant,O
1614,159,eligible,B-Mood
1615,159,to,O
1616,159,receive,O
1617,159,2,B-Drug
1618,159,-,I-Drug
1619,159,month,I-Drug
1620,159,vaccines,I-Drug
1621,160,English-,O
1622,160,or,O
1623,160,Spanish,O
1624,160,-,O
1625,160,speaking,O
1626,160,parent(s)/legally,O
1627,160,authorized,O
1628,160,representative(s,O
1629,160,),O
1630,160,(,O
1631,160,LAR(s,O
1632,160,),O
1633,160,),O
1634,161,Not,O
1635,161,planned,B-Mood
1636,161,for,O
1637,161,discharge,B-Procedure
1638,161,within,O
1639,161,60,O
1640,161,hours,O
1641,161,of,O
1642,161,study,O
1643,161,entry,O
1644,162,The,O
1645,162,parent,O
1646,162,/,O
1647,162,guardian,O
1648,162,must,O
1649,162,be,O
1650,162,willing,O
1651,162,and,O
1652,162,capable,O
1653,162,of,O
1654,162,providing,O
1655,162,permission,O
1656,162,for,O
1657,162,their,O
1658,162,child,O
1659,162,to,O
1660,162,participate,O
1661,162,through,O
1662,162,the,O
1663,162,written,O
1664,162,informed,O
1665,162,consent,O
1666,162,process,O
1667,163,Glaucoma,B-Condition
1668,163,",",O
1669,164,Ocular,B-Condition
1670,164,allergy,I-Condition
1671,165,Autoimmune,B-Condition
1672,165,disease,I-Condition
1673,166,Contact,B-Observation
1674,166,lens,I-Observation
1675,166,-,I-Observation
1676,166,wear,I-Observation
1677,166,during,O
1678,166,study,O
1679,167,Current,O
1680,167,punctal,B-Condition
1681,167,plugging,I-Condition
1682,168,Pregnant,B-Condition
1683,168,/,O
1684,168,lactating,B-Condition
1685,169,Candidate,B-Mood
1686,169,for,I-Mood
1687,169,topical,B-Drug
1688,169,anti,I-Drug
1689,169,-,I-Drug
1690,169,inflammatory,I-Drug
1691,170,Cicatricial,O
1692,170,meibomian,B-Condition
1693,170,gland,I-Condition
1694,170,dysfunction,I-Condition
1695,171,Meibomian,B-Condition
1696,171,Gland,I-Condition
1697,171,Dysfunction,I-Condition
1698,172,Eligible,B-Mood
1699,172,for,I-Mood
1700,172,heat,B-Procedure
1701,172,treatment,I-Procedure
1702,173,Ocular,O
1703,173,Surface,O
1704,173,Disease,O
1705,173,Index,O
1706,173,(,O
1707,173,OSDI,O
1708,173,),O
1709,173,>,O
1710,173,12,O
1711,174,Quality,O
1712,174,or,O
1713,174,expressibility,O
1714,174,score,O
1715,174,=,O
1716,174,20,O
1717,174,years,O
1718,174,old,O
1719,174,:,O
1720,174,>,O
1721,174,1,O
1722,174,or,O
1723,174,>,O
1724,174,20,O
1725,174,years,O
1726,174,old,O
1727,174,:,O
1728,174,=,O
1729,174,1,O
1730,175,Non,O
1731,175,-,O
1732,175,invasive,O
1733,175,tear,O
1734,175,film,O
1735,175,break,O
1736,175,-,O
1737,175,up,O
1738,175,time,O
1739,175,(,O
1740,175,NITBUT,O
1741,175,),O
1742,175,<,O
1743,175,10,O
1744,175,s,O
1745,175,in,O
1746,175,at,O
1747,175,least,O
1748,175,one,O
1749,175,eye,O
1750,176,Schirmer-1,O
1751,176,test,O
1752,176,>,O
1753,176,5,O
1754,176,mm,O
1755,176,after,O
1756,176,5,O
1757,176,min,O
1758,177,pregnancy,B-Condition
1759,178,menopause,B-Condition
1760,179,interstitial,B-Condition
1761,179,cystitis,I-Condition
1762,180,irritable,B-Condition
1763,180,bowel,I-Condition
1764,180,syndrome,I-Condition
1765,181,untreated,B-Condition
1766,181,vaginitis,I-Condition
1767,182,cervicitis,B-Condition
1768,183,pelvic,B-Condition
1769,183,inflammatory,I-Condition
1770,183,disease,I-Condition
1771,184,any,O
1772,184,other,O
1773,184,pelvic,B-Condition
1774,184,pathology,I-Condition
1775,184,causing,O
1776,184,pain,O
1777,185,concomitant,O
1778,185,physical,B-Procedure
1779,185,therapy,I-Procedure
1780,186,concomitant,O
1781,186,biofeedback,B-Procedure
1782,187,concomitant,O
1783,187,massage,B-Procedure
1784,188,additional,O
1785,188,acupuncture,B-Procedure
1786,189,women,B-Person
1787,189,previously,O
1788,189,diagnosed,O
1789,189,with,O
1790,189,generalized,B-Condition
1791,189,vulvodynia,I-Condition
1792,190,women,B-Person
1793,190,previously,O
1794,190,diagnosed,O
1795,190,with,O
1796,190,localized,B-Condition
1797,190,vestibulodynia,I-Condition
1798,190,",",O
1799,191,Patients,O
1800,191,with,O
1801,191,2,O
1802,191,or,O
1803,191,more,O
1804,191,doses,O
1805,191,of,O
1806,191,methylprednisolone,B-Drug
1807,191,/,O
1808,191,prednisone,B-Drug
1809,191,per,O
1810,191,day,O
1811,192,Steroids,B-Drug
1812,192,other,O
1813,192,than,O
1814,192,methylprednisolone,B-Drug
1815,192,or,O
1816,192,prednisone,B-Drug
1817,193,Pregnancy,B-Condition
1818,194,estimated,O
1819,194,glomerular,O
1820,194,filtration,O
1821,194,rate,O
1822,194,(,O
1823,194,eGFR,O
1824,194,),O
1825,194,<,O
1826,194,45,O
1827,194,ml,O
1828,194,/,O
1829,194,min/1.73m2,O
1830,195,Patients,O
1831,195,receiving,O
1832,195,once,O
1833,195,daily,O
1834,195,dosing,O
1835,195,of,O
1836,195,methylprednisolone,B-Drug
1837,195,or,O
1838,195,prednisone,B-Drug
1839,195,in,O
1840,195,a,O
1841,195,dose,O
1842,195,of,O
1843,195,10,O
1844,195,mg,O
1845,195,/,O
1846,195,day,O
1847,195,or,O
1848,195,greater,O
1849,196,Hyperglycemic,B-Condition
1850,196,(,O
1851,196,Glucose,O
1852,196,level,O
1853,196,>,O
1854,196,126,O
1855,196,mg,O
1856,196,/,O
1857,196,dL,O
1858,196,),O
1859,197,Diabetic,B-Condition
1860,197,and,O
1861,197,nondiabetic,B-Condition
1862,197,patients,O
1863,198,Expected,O
1864,198,duration,O
1865,198,of,O
1866,198,hospital,O
1867,198,stay,O
1868,198,and,O
1869,198,time,O
1870,198,on,O
1871,198,steroids,O
1872,198,>,O
1873,198,=,O
1874,198,3,O
1875,198,days,O
1876,199,Patient,O
1877,199,of,O
1878,199,appropriate,O
1879,199,caregiver,O
1880,199,able,O
1881,199,to,O
1882,199,give,O
1883,199,Informed,O
1884,199,Consent,O
1885,200,Unstable,B-Condition
1886,200,angina,I-Condition
1887,200,;,O
1888,201,Myocardial,B-Condition
1889,201,infarction,I-Condition
1890,201,and,O
1891,201,heart,B-Procedure
1892,201,surgery,I-Procedure
1893,201,up,O
1894,201,to,O
1895,201,three,O
1896,201,months,O
1897,201,before,O
1898,201,the,O
1899,201,survey,O
1900,201,;,O
1901,202,Chronic,B-Condition
1902,202,respiratory,I-Condition
1903,202,diseases,I-Condition
1904,202,;,O
1905,203,Hemodynamic,B-Condition
1906,203,instability,I-Condition
1907,203,;,O
1908,204,Trauma,B-Condition
1909,204,recent,O
1910,204,face,O
1911,204,",",O
1912,204,nausea,B-Condition
1913,204,and,O
1914,204,vomiting,B-Condition
1915,204,.,O
1916,205,Orthopedic,B-Condition
1917,205,and,O
1918,205,neurological,B-Condition
1919,205,diseases,I-Condition
1920,205,that,O
1921,205,may,O
1922,205,preclude,O
1923,205,the,O
1924,205,achievement,O
1925,205,of,O
1926,205,the,O
1927,205,cardiopulmonary,O
1928,205,test,O
1929,205,and,O
1930,205,Cardiac,O
1931,205,Rehabilitation,O
1932,205,exercises,O
1933,205,;,O
1934,206,Psychological,B-Condition
1935,206,and,I-Condition
1936,206,/,I-Condition
1937,206,or,I-Condition
1938,206,cognitive,I-Condition
1939,206,impairments,I-Condition
1940,206,that,O
1941,206,restrict,O
1942,206,them,O
1943,206,to,O
1944,206,respond,O
1945,206,to,O
1946,206,questionnaires,O
1947,206,;,O
1948,207,Diagnosis,O
1949,207,of,O
1950,207,Heart,B-Condition
1951,207,Failure,I-Condition
1952,207,;,O
1953,208,Lower,O
1954,208,left,O
1955,208,ventricular,O
1956,208,ejection,O
1957,208,fraction,O
1958,208,45,O
1959,208,%,O
1960,208,(,O
1961,208,LVEF,O
1962,208,<,O
1963,208,45,O
1964,208,%,O
1965,208,),O
1966,208,assessed,O
1967,208,by,O
1968,208,simple,O
1969,208,and,O
1970,208,recent,O
1971,208,echocardiogram,B-Procedure
1972,208,;,O
1973,209,Functional,O
1974,209,Class,O
1975,209,II,O
1976,209,and,O
1977,209,III,O
1978,209,by,O
1979,209,the,O
1980,209,New,O
1981,209,York,O
1982,209,Heart,O
1983,209,Association,O
1984,209,(,O
1985,209,NYHA,O
1986,209,),O
1987,210,Clinically,B-Condition
1988,210,stable,I-Condition
1989,210,;,O
1990,211,Ex,B-Condition
1991,211,-,I-Condition
1992,211,smokers,I-Condition
1993,211,over,O
1994,211,five,O
1995,211,years,O
1996,211,;,O
1997,212,Maximal,O
1998,212,inspiratory,O
1999,212,pressure,O
2000,212,(,O
2001,212,MIP,O
2002,212,),O
2003,212,<,O
2004,212,70,O
2005,212,%,O
2006,212,of,O
2007,212,predicted,O
2008,212,;,O
2009,213,Forced,O
2010,213,expiratory,O
2011,213,volume,O
2012,213,/,O
2013,213,Forced,O
2014,213,vital,O
2015,213,capacity,O
2016,213,(,O
2017,213,FEV1,O
2018,213,/,O
2019,213,FVC,O
2020,213,),O
2021,213,>,O
2022,213,70,O
2023,213,%,O
2024,213,of,O
2025,213,predicted,O
2026,213,;,O
2027,214,Contraindications,B-Condition
2028,214,for,O
2029,214,BB,B-Drug
2030,214,.,O
2031,215,Living,B-Observation
2032,215,in,O
2033,215,a,O
2034,215,nursing,O
2035,215,home,O
2036,215,.,O
2037,216,Life,B-Observation
2038,216,expectancy,I-Observation
2039,216,<,O
2040,216,6,O
2041,216,months,O
2042,216,.,O
2043,217,Unable,B-Condition
2044,217,to,I-Condition
2045,217,self,I-Condition
2046,217,-,I-Condition
2047,217,care,I-Condition
2048,217,or,O
2049,217,mental,B-Condition
2050,217,disease,I-Condition
2051,217,without,O
2052,217,caregiver,O
2053,217,.,O
2054,218,Unable,B-Condition
2055,218,to,O
2056,218,weight,B-Procedure
2057,219,Without,O
2058,219,phone,B-Observation
2059,220,Unable,B-Observation
2060,220,to,O
2061,220,go,B-Observation
2062,220,to,I-Observation
2063,220,clinic,I-Observation
2064,220,visit,I-Observation
2065,220,.,O
2066,221,Patient,O
2067,221,with,O
2068,221,"""",O
2069,221,de,O
2070,221,novo,O
2071,221,"""",O
2072,221,heart,B-Condition
2073,221,Failure,I-Condition
2074,221,and,O
2075,221,LVEF,O
2076,221,<,O
2077,221,=,O
2078,221,40,O
2079,221,%,O
2080,221,admitted,B-Procedure
2081,221,in,O
2082,221,hospital,O
2083,221,",",O
2084,221,without,O
2085,221,contraindications,B-Condition
2086,221,for,O
2087,221,BB,B-Drug
2088,221,prescription,O
2089,221,with,O
2090,221,cardiologist,O
2091,221,up,O
2092,221,-,O
2093,221,titration,O
2094,221,prescription,O
2095,221,and,O
2096,221,without,O
2097,221,having,O
2098,221,achieved,O
2099,221,BB,O
2100,221,target,O
2101,221,dose,O
2102,221,previous,O
2103,221,discharge,O
2104,221,and,O
2105,221,signing,O
2106,221,informed,O
2107,221,consent,O
2108,221,.,O
2109,222,Currently,O
2110,222,enrolled,O
2111,222,in,O
2112,222,",",O
2113,222,or,O
2114,222,discontinued,O
2115,222,within,O
2116,222,the,O
2117,222,last,O
2118,222,30,O
2119,222,days,O
2120,222,from,O
2121,222,",",O
2122,222,a,O
2123,222,clinical,O
2124,222,trial,O
2125,222,involving,O
2126,222,an,O
2127,222,off,O
2128,222,-,O
2129,222,label,O
2130,222,use,O
2131,222,of,O
2132,222,an,O
2133,222,investigational,O
2134,222,drug,O
2135,222,.,O
2136,223,Current,O
2137,223,Axis,O
2138,223,I,O
2139,223,primary,O
2140,223,psychiatric,B-Condition
2141,223,diagnosis,I-Condition
2142,223,other,O
2143,223,than,O
2144,223,major,B-Condition
2145,223,depressive,I-Condition
2146,223,disorder,I-Condition
2147,223,.,O
2148,224,Organic,B-Condition
2149,224,mental,I-Condition
2150,224,disease,I-Condition
2151,224,",",O
2152,224,including,O
2153,224,mental,B-Condition
2154,224,retardation,I-Condition
2155,224,.,O
2156,225,History,O
2157,225,of,O
2158,225,clinically,O
2159,225,significant,O
2160,225,disease,B-Condition
2161,225,",",O
2162,225,including,O
2163,225,any,O
2164,225,cardiovascular,B-Condition
2165,225,",",I-Condition
2166,225,hepatic,I-Condition
2167,225,",",I-Condition
2168,225,renal,I-Condition
2169,225,",",I-Condition
2170,225,respiratory,I-Condition
2171,225,",",I-Condition
2172,225,hematologic,I-Condition
2173,225,",",I-Condition
2174,225,endocrinologic,I-Condition
2175,225,",",I-Condition
2176,225,or,I-Condition
2177,225,neurologic,I-Condition
2178,225,disease,I-Condition
2179,225,",",O
2180,225,or,O
2181,225,clinically,O
2182,225,significant,O
2183,225,laboratory,B-Condition
2184,225,abnormality,I-Condition
2185,225,that,O
2186,225,is,O
2187,225,not,O
2188,225,stabilized,O
2189,225,or,O
2190,225,is,O
2191,225,anticipated,B-Mood
2192,225,to,I-Mood
2193,225,require,I-Mood
2194,225,treatment,B-Procedure
2195,225,during,O
2196,225,the,O
2197,225,study,O
2198,225,.,O
2199,226,Subjects,O
2200,226,receiving,O
2201,226,an,O
2202,226,investigational,O
2203,226,agent,O
2204,226,(,O
2205,226,including,O
2206,226,different,O
2207,226,formulation,O
2208,226,and,O
2209,226,generic,O
2210,226,agents,O
2211,226,of,O
2212,226,investigational,O
2213,226,drug,O
2214,226,),O
2215,226,in,O
2216,226,the,O
2217,226,previous,O
2218,226,3,O
2219,226,months,O
2220,226,prior,O
2221,226,to,O
2222,226,screening,O
2223,226,.,O
2224,227,Women,O
2225,227,in,O
2226,227,pregnancy,O
2227,227,or,O
2228,227,lactation,O
2229,227,",",O
2230,227,or,O
2231,227,female,O
2232,227,of,O
2233,227,child,O
2234,227,bearing,O
2235,227,potential,O
2236,227,without,O
2237,227,appropriate,O
2238,227,birth,O
2239,227,control,O
2240,227,measures,O
2241,227,.,O
2242,228,Use,O
2243,228,of,O
2244,228,antipsychotics,B-Drug
2245,228,or,O
2246,228,mood,B-Drug
2247,228,stabilizers,I-Drug
2248,228,within,O
2249,228,5,O
2250,228,days,O
2251,228,prior,O
2252,228,to,O
2253,228,screening,O
2254,228,.,O
2255,229,Has,O
2256,229,received,O
2257,229,depot,B-Drug
2258,229,antipsychotic,I-Drug
2259,229,medication,I-Drug
2260,229,within,O
2261,229,one,O
2262,229,cycle,O
2263,229,prior,O
2264,229,to,O
2265,229,screening,O
2266,229,.,O
2267,230,Known,O
2268,230,allergy,B-Condition
2269,230,or,O
2270,230,lack,B-Condition
2271,230,of,I-Condition
2272,230,response,I-Condition
2273,230,to,O
2274,230,mirtazapine,B-Drug
2275,230,.,O
2276,231,Has,O
2277,231,received,O
2278,231,ECT,B-Procedure
2279,231,or,O
2280,231,MECT,B-Procedure
2281,231,within,O
2282,231,3,O
2283,231,months,O
2284,231,prior,O
2285,231,to,O
2286,231,screening,O
2287,231,.,O
2288,232,History,O
2289,232,of,O
2290,232,anticholinergic,B-Drug
2291,232,drug,I-Drug
2292,232,allergy,B-Condition
2293,232,or,O
2294,232,complications,O
2295,232,(,O
2296,232,allergic,B-Condition
2297,232,reaction,I-Condition
2298,232,",",O
2299,232,skin,B-Condition
2300,232,rash,I-Condition
2301,232,",",O
2302,232,urticaria,B-Condition
2303,232,and,O
2304,232,other,O
2305,232,allergic,B-Condition
2306,232,reactions,I-Condition
2307,232,which,O
2308,232,caused,O
2309,232,by,O
2310,232,drugs,B-Drug
2311,232,),O
2312,232,.,O
2313,233,Smokers,B-Observation
2314,233,.,O
2315,234,Significant,O
2316,234,risk,B-Mood
2317,234,of,I-Mood
2318,234,suicidal,B-Observation
2319,234,and/or,I-Observation
2320,234,self,I-Observation
2321,234,-,I-Observation
2322,234,harm,I-Observation
2323,234,behaviors,I-Observation
2324,235,Has,O
2325,235,given,O
2326,235,written,O
2327,235,informed,O
2328,235,consent,O
2329,235,.,O
2330,236,Male,B-Person
2331,236,or,O
2332,236,female,B-Person
2333,236,outpatients,O
2334,236,aged,B-Person
2335,236,at,O
2336,236,least,O
2337,236,18,O
2338,236,years,O
2339,236,and,O
2340,236,not,O
2341,236,more,O
2342,236,than,O
2343,236,45,O
2344,236,years,O
2345,236,.,O
2346,237,Has,O
2347,237,a,O
2348,237,diagnosis,O
2349,237,of,O
2350,237,major,B-Condition
2351,237,depressive,I-Condition
2352,237,disorder,I-Condition
2353,237,by,O
2354,237,Diagnostic,O
2355,237,and,O
2356,237,Statistical,O
2357,237,Manual,O
2358,237,of,O
2359,237,Mental,O
2360,237,Disorders,O
2361,237,",",O
2362,237,Fourth,O
2363,237,Edition,O
2364,237,(,O
2365,237,DSM,O
2366,237,-,O
2367,237,IV,O
2368,237,),O
2369,237,criteria,O
2370,237,.,O
2371,238,Current,O
2372,238,HAMD-17,O
2373,238,score,O
2374,238,=,O
2375,238,20,O
2376,238,and,O
2377,238,the,O
2378,238,duration,O
2379,238,of,O
2380,238,the,O
2381,238,index,B-Condition
2382,238,episode,I-Condition
2383,238,is,O
2384,238,greater,O
2385,238,than,O
2386,238,or,O
2387,238,equal,O
2388,238,to,O
2389,238,four,O
2390,238,weeks,O
2391,238,.,O
2392,239,Emergency,B-Procedure
2393,239,surgery,I-Procedure
2394,240,Monitored,B-Procedure
2395,240,Anesthesia,I-Procedure
2396,240,Care,I-Procedure
2397,240,(,O
2398,240,i.e.,O
2399,240,",",O
2400,240,regional,B-Procedure
2401,240,anesthesia,I-Procedure
2402,240,alone,O
2403,240,without,O
2404,240,plans,B-Mood
2405,240,for,I-Mood
2406,240,general,B-Procedure
2407,240,anesthesia,I-Procedure
2408,240,),O
2409,241,Surgery,B-Procedure
2410,241,involving,O
2411,241,the,O
2412,241,eye,O
2413,241,",",O
2414,241,eyebrow,O
2415,241,",",O
2416,241,forehead,O
2417,241,",",O
2418,241,or,O
2419,241,frontal,O
2420,241,scalp,O
2421,241,near,O
2422,241,the,O
2423,241,sensor,O
2424,241,placement,O
2425,242,Poor,B-Observation
2426,242,health,I-Observation
2427,242,literacy,I-Observation
2428,243,Allergy,B-Condition
2429,243,",",O
2430,243,or,O
2431,243,have,O
2432,243,experienced,O
2433,243,any,O
2434,243,drug,B-Condition
2435,243,reaction,I-Condition
2436,243,to,O
2437,243,ketamine,B-Drug
2438,244,Pregnant,B-Condition
2439,244,or,O
2440,244,lactating,B-Condition
2441,245,Currently,O
2442,245,in,O
2443,245,active,O
2444,245,alcohol,B-Condition
2445,245,withdrawal,I-Condition
2446,246,Current,O
2447,246,diagnosis,O
2448,246,of,O
2449,246,otolaryngeal,B-Condition
2450,246,cancer,I-Condition
2451,246,and,O
2452,246,undergoing,O
2453,246,surgery,B-Procedure
2454,246,with,O
2455,246,general,B-Procedure
2456,246,anesthesia,I-Procedure
2457,247,Competent,O
2458,247,to,O
2459,247,provide,O
2460,247,informed,O
2461,247,consent,O
2462,248,Participants,O
2463,248,taking,O
2464,248,CPI,B-Procedure
2465,248,combination,I-Procedure
2466,248,therapies,I-Procedure
2467,248,with,O
2468,248,chemotherapy,B-Procedure
2469,248,are,O
2470,248,not,O
2471,248,permitted,O
2472,248,.,O
2473,249,Pregnant,B-Condition
2474,249,",",O
2475,249,lactating,B-Condition
2476,249,",",O
2477,249,or,O
2478,249,intending,B-Mood
2479,249,to,I-Mood
2480,249,become,I-Mood
2481,249,pregnant,B-Condition
2482,249,during,O
2483,249,the,O
2484,249,study,O
2485,249,.,O
2486,250,Response,O
2487,250,assessment,O
2488,250,of,O
2489,250,complete,O
2490,250,response,O
2491,250,(,O
2492,250,CR,O
2493,250,),O
2494,250,",",O
2495,250,partial,O
2496,250,response,O
2497,250,(,O
2498,250,PR,O
2499,250,),O
2500,250,",",O
2501,250,long,O
2502,250,stable,O
2503,250,disease,O
2504,250,(,O
2505,250,SD,O
2506,250,),O
2507,250,for,O
2508,250,>,O
2509,250,3,O
2510,250,months,O
2511,250,with,O
2512,250,a,O
2513,250,cancer,O
2514,250,immunotherapy,B-Procedure
2515,250,treatment,I-Procedure
2516,250,for,O
2517,250,metastatic,B-Condition
2518,250,cancer,I-Condition
2519,250,or,O
2520,250,hematologic,B-Condition
2521,250,malignancies,I-Condition
2522,250,either,O
2523,250,through,O
2524,250,a,O
2525,250,marketed,B-Procedure
2526,250,CPI,I-Procedure
2527,250,or,O
2528,250,through,O
2529,250,participation,B-Observation
2530,250,in,I-Observation
2531,250,a,I-Observation
2532,250,Roche,I-Observation
2533,250,/,I-Observation
2534,250,Genentech,I-Observation
2535,250,CPI,I-Observation
2536,250,clinical,I-Observation
2537,250,trial,I-Observation
2538,250,.,O
2539,251,Availability,O
2540,251,of,O
2541,251,tumor,O
2542,251,biopsy,O
2543,251,material,O
2544,251,extracted,O
2545,251,and,O
2546,251,preserved,O
2547,251,by,O
2548,251,the,O
2549,251,investigating,O
2550,251,site,O
2551,251,.,O
2552,252,type,B-Condition
2553,252,1,I-Condition
2554,252,diabetes,I-Condition
2555,252,",",O
2556,252,specific,O
2557,252,types,O
2558,252,of,O
2559,252,diabetes,B-Condition
2560,252,",",O
2561,252,gestational,B-Condition
2562,252,diabetes,I-Condition
2563,252,or,O
2564,252,pregestational,B-Condition
2565,252,diabetes,I-Condition
2566,252,;,O
2567,253,acute,O
2568,253,cardiovascular,O
2569,253,or,O
2570,253,cerebrovascular,B-Condition
2571,253,accidents,I-Condition
2572,253,within,O
2573,253,past,O
2574,253,3,O
2575,253,months,O
2576,253,;,O
2577,254,severe,O
2578,254,hepatic,B-Condition
2579,254,or,I-Condition
2580,254,renal,I-Condition
2581,254,dysfunction,I-Condition
2582,254,;,O
2583,255,malignant,B-Condition
2584,255,tumor,I-Condition
2585,255,;,O
2586,256,allergic,B-Condition
2587,256,history,O
2588,256,or,O
2589,256,contraindication,B-Condition
2590,256,for,O
2591,256,any,O
2592,256,drugs,B-Drug
2593,256,in,I-Drug
2594,256,trials,I-Drug
2595,256,;,O
2596,257,taking,O
2597,257,part,O
2598,257,in,O
2599,257,other,O
2600,257,clinical,O
2601,257,trials,O
2602,257,;,O
2603,258,obviously,O
2604,258,poor,B-Observation
2605,258,compliance,I-Observation
2606,258,.,O
2607,259,35,O
2608,259,-,O
2609,259,75,O
2610,259,years,O
2611,259,old,B-Person
2612,259,;,O
2613,260,diagnosed,O
2614,260,as,O
2615,260,type,B-Condition
2616,260,2,I-Condition
2617,260,diabetes,I-Condition
2618,260,according,O
2619,260,to,O
2620,260,the,O
2621,260,criteria,O
2622,260,of,O
2623,260,the,O
2624,260,World,O
2625,260,Health,O
2626,260,Organization,O
2627,260,in,O
2628,260,1999,O
2629,260,.,O
2630,261,1,O
2631,261,.,O
2632,261,Prior,O
2633,261,treatment,O
2634,261,with,O
2635,261,gemcitabine,B-Drug
2636,261,",",O
2637,261,carboplatin,B-Drug
2638,261,(,O
2639,261,except,O
2640,261,in,O
2641,261,the,O
2642,261,adjuvant,O
2643,261,setting,O
2644,261,),O
2645,261,",",O
2646,261,or,O
2647,261,Iniparib,B-Drug
2648,261,.,O
2649,262,2,O
2650,262,.,O
2651,262,Past,O
2652,262,or,O
2653,262,current,O
2654,262,history,B-Observation
2655,262,of,O
2656,262,neoplasm,B-Condition
2657,262,other,O
2658,262,than,O
2659,262,the,O
2660,262,entry,B-Condition
2661,262,diagnosis,I-Condition
2662,262,",",O
2663,262,with,O
2664,262,the,O
2665,262,exception,O
2666,262,of,O
2667,262,treated,B-Procedure
2668,262,non,B-Condition
2669,262,-,I-Condition
2670,262,melanoma,I-Condition
2671,262,skin,I-Condition
2672,262,cancer,I-Condition
2673,262,or,O
2674,262,carcinoma,B-Condition
2675,262,in,I-Condition
2676,262,-,I-Condition
2677,262,situ,I-Condition
2678,262,of,O
2679,262,any,O
2680,262,primary,O
2681,262,site,O
2682,262,",",O
2683,262,or,O
2684,262,invasive,O
2685,262,cancers,B-Condition
2686,262,treated,B-Procedure
2687,262,definitively,O
2688,262,",",O
2689,262,with,O
2690,262,treatment,O
2691,262,ending,O
2692,262,>,O
2693,262,5,O
2694,262,years,O
2695,262,previously,O
2696,262,and,O
2697,262,no,O
2698,262,evidence,B-Observation
2699,262,of,I-Observation
2700,262,recurrences,I-Observation
2701,262,.,O
2702,263,3,O
2703,263,.,O
2704,263,A,O
2705,263,history,B-Observation
2706,263,of,O
2707,263,cardiac,B-Condition
2708,263,disease,I-Condition
2709,263,",",O
2710,263,as,O
2711,263,defined,O
2712,263,by,O
2713,263,:,O
2714,264,Malignant,B-Condition
2715,264,hypertension,I-Condition
2716,265,Unstable,B-Condition
2717,265,angina,I-Condition
2718,266,Congestive,B-Condition
2719,266,heart,I-Condition
2720,266,failure,I-Condition
2721,267,Myocardial,B-Condition
2722,267,infarction,I-Condition
2723,267,within,O
2724,267,the,O
2725,267,previous,O
2726,267,6,O
2727,267,months,O
2728,268,Symptomatic,O
2729,268,",",O
2730,268,unstable,O
2731,268,or,O
2732,268,uncontrolled,O
2733,268,",",O
2734,268,cardiac,B-Condition
2735,268,arrhythmias,I-Condition
2736,268,.,O
2737,268,Patients,O
2738,268,who,O
2739,268,have,O
2740,268,stable,O
2741,268,",",O
2742,268,rate,O
2743,268,-,O
2744,268,controlled,O
2745,268,atrial,B-Condition
2746,268,fibrillation,I-Condition
2747,268,are,O
2748,268,eligible,O
2749,268,for,O
2750,268,study,O
2751,268,enrollment,O
2752,268,.,O
2753,269,4,O
2754,269,.,O
2755,269,Active,O
2756,269,brain,B-Condition
2757,269,metastases,I-Condition
2758,269,.,O
2759,269,Patients,O
2760,269,with,O
2761,269,treated,B-Procedure
2762,269,brain,B-Condition
2763,269,metastases,I-Condition
2764,269,are,O
2765,269,eligible,O
2766,269,",",O
2767,269,if,O
2768,269,(,O
2769,269,1,O
2770,269,),O
2771,269,radiation,B-Procedure
2772,269,therapy,I-Procedure
2773,269,was,O
2774,269,completed,O
2775,269,at,O
2776,269,least,O
2777,269,2,O
2778,269,weeks,O
2779,269,prior,O
2780,269,to,O
2781,269,study,O
2782,269,entry,O
2783,269,;,O
2784,269,(,O
2785,269,2,O
2786,269,),O
2787,269,follow,B-Procedure
2788,269,-,I-Procedure
2789,269,up,I-Procedure
2790,269,scan,I-Procedure
2791,269,shows,O
2792,269,no,O
2793,269,disease,B-Condition
2794,269,progression,I-Condition
2795,269,;,O
2796,269,and,O
2797,269,(,O
2798,269,3,O
2799,269,),O
2800,269,patient,O
2801,269,does,O
2802,269,not,O
2803,269,require,B-Mood
2804,269,steroids,B-Drug
2805,269,.,O
2806,270,5,O
2807,270,.,O
2808,270,Women,B-Person
2809,270,who,O
2810,270,are,O
2811,270,pregnant,B-Condition
2812,270,or,O
2813,270,lactating,B-Condition
2814,270,.,O
2815,271,6,O
2816,271,.,O
2817,271,Any,O
2818,271,serious,O
2819,271,",",O
2820,271,active,O
2821,271,infection,B-Condition
2822,271,(,O
2823,271,>,O
2824,271,Grade,O
2825,271,2,O
2826,271,),O
2827,271,at,O
2828,271,the,O
2829,271,time,O
2830,271,of,O
2831,271,treatment,O
2832,271,.,O
2833,272,7,O
2834,272,.,O
2835,272,A,O
2836,272,serious,O
2837,272,underlying,O
2838,272,medical,B-Condition
2839,272,condition,I-Condition
2840,272,that,O
2841,272,would,B-Mood
2842,272,impair,B-Condition
2843,272,the,I-Condition
2844,272,ability,I-Condition
2845,272,of,I-Condition
2846,272,the,I-Condition
2847,272,patient,I-Condition
2848,272,to,I-Condition
2849,272,receive,I-Condition
2850,272,protocol,I-Condition
2851,272,treatment,I-Condition
2852,272,.,O
2853,273,8,O
2854,273,.,O
2855,273,A,O
2856,273,major,O
2857,273,surgical,B-Procedure
2858,273,procedure,I-Procedure
2859,273,",",O
2860,273,or,O
2861,273,significant,O
2862,273,traumatic,B-Condition
2863,273,injury,I-Condition
2864,273,≤28,O
2865,273,days,O
2866,273,of,O
2867,273,beginning,O
2868,273,treatment,O
2869,273,",",O
2870,273,or,O
2871,273,anticipation,O
2872,273,of,O
2873,273,the,O
2874,273,need,B-Mood
2875,273,for,I-Mood
2876,273,major,B-Procedure
2877,273,surgery,I-Procedure
2878,273,during,O
2879,273,the,O
2880,273,course,O
2881,273,of,O
2882,273,the,O
2883,273,study,O
2884,273,.,O
2885,274,9,O
2886,274,.,O
2887,274,Uncontrolled,O
2888,274,or,O
2889,274,intercurrent,O
2890,274,illness,B-Condition
2891,274,including,O
2892,274,",",O
2893,274,that,O
2894,274,in,O
2895,274,the,O
2896,274,opinion,O
2897,274,of,O
2898,274,the,O
2899,274,investigator,O
2900,274,may,O
2901,274,increase,O
2902,274,the,O
2903,274,risks,O
2904,274,associated,O
2905,274,with,O
2906,274,study,O
2907,274,participation,O
2908,274,or,O
2909,274,administration,O
2910,274,of,O
2911,274,the,O
2912,274,investigational,O
2913,274,products,O
2914,274,",",O
2915,274,or,O
2916,274,that,O
2917,274,may,O
2918,274,interfere,O
2919,274,with,O
2920,274,the,O
2921,274,interpretation,O
2922,274,of,O
2923,274,the,O
2924,274,results,O
2925,274,.,O
2926,275,10,O
2927,275,.,O
2928,275,History,O
2929,275,of,O
2930,275,any,O
2931,275,medical,O
2932,275,or,O
2933,275,psychiatric,B-Condition
2934,275,condition,I-Condition
2935,275,or,O
2936,275,laboratory,B-Condition
2937,275,abnormality,I-Condition
2938,275,that,O
2939,275,",",O
2940,275,in,O
2941,275,the,O
2942,275,opinion,O
2943,275,of,O
2944,275,the,O
2945,275,investigator,O
2946,275,",",O
2947,275,may,O
2948,275,increase,O
2949,275,the,O
2950,275,risks,O
2951,275,associated,O
2952,275,with,O
2953,275,the,O
2954,275,study,O
2955,275,participation,O
2956,275,or,O
2957,275,administration,O
2958,275,of,O
2959,275,the,O
2960,275,investigational,O
2961,275,products,O
2962,275,",",O
2963,275,or,O
2964,275,that,O
2965,275,may,O
2966,275,interfere,O
2967,275,with,O
2968,275,the,O
2969,275,interpretation,O
2970,275,of,O
2971,275,the,O
2972,275,results,O
2973,275,.,O
2974,276,11,O
2975,276,.,O
2976,276,Known,B-Mood
2977,276,or,O
2978,276,suspected,B-Mood
2979,276,allergy,B-Condition
2980,276,/,O
2981,276,hypersensitivity,B-Condition
2982,276,to,O
2983,276,any,O
2984,276,agent,B-Drug
2985,276,given,I-Drug
2986,276,in,I-Drug
2987,276,the,I-Drug
2988,276,course,I-Drug
2989,276,of,I-Drug
2990,276,this,I-Drug
2991,276,trial,I-Drug
2992,276,.,O
2993,277,The,O
2994,277,above,O
2995,277,information,O
2996,277,is,O
2997,277,not,O
2998,277,intended,O
2999,277,to,O
3000,277,contain,O
3001,277,all,O
3002,277,considerations,O
3003,277,relevant,O
3004,277,to,O
3005,277,a,O
3006,277,patient,O
3007,277,'s,O
3008,277,potential,O
3009,277,participation,O
3010,277,in,O
3011,277,a,O
3012,277,clinical,O
3013,277,trial,O
3014,277,.,O
3015,278,Eligible,O
3016,278,patients,O
3017,278,must,O
3018,278,meet,O
3019,278,the,O
3020,278,following,O
3021,278,criteria,O
3022,278,to,O
3023,278,be,O
3024,278,enrolled,O
3025,278,in,O
3026,278,the,O
3027,278,study,O
3028,278,:,O
3029,279,1,O
3030,279,.,O
3031,279,Newly,B-Mood
3032,279,diagnosed,I-Mood
3033,279,",",O
3034,279,stage,O
3035,279,IV,O
3036,279,squamous,B-Condition
3037,279,cell,I-Condition
3038,279,lung,I-Condition
3039,279,cancer,I-Condition
3040,279,.,O
3041,279,This,O
3042,279,includes,O
3043,279,patients,O
3044,279,who,O
3045,279,present,O
3046,279,with,O
3047,279,disseminated,O
3048,279,metastases,B-Condition
3049,279,",",O
3050,279,and,O
3051,279,those,O
3052,279,with,O
3053,279,a,O
3054,279,malignant,O
3055,279,pleural,B-Condition
3056,279,or,I-Condition
3057,279,pericardial,I-Condition
3058,279,effusion,I-Condition
3059,279,(,O
3060,279,i.e.,O
3061,279,",",O
3062,279,formerly,O
3063,279,stage,O
3064,279,IIIB,O
3065,279,in,O
3066,279,the,O
3067,279,6th,O
3068,279,TNM,O
3069,279,staging,O
3070,279,system,O
3071,279,),O
3072,279,.,O
3073,280,2,O
3074,280,.,O
3075,280,Patients,O
3076,280,who,O
3077,280,have,O
3078,280,received,O
3079,280,prior,O
3080,280,adjuvant,B-Procedure
3081,280,therapy,I-Procedure
3082,280,for,O
3083,280,early,B-Condition
3084,280,-,I-Condition
3085,280,stage,I-Condition
3086,280,lung,I-Condition
3087,280,cancer,I-Condition
3088,280,are,O
3089,280,eligible,O
3090,280,if,O
3091,280,at,O
3092,280,least,O
3093,280,12,O
3094,280,months,O
3095,280,have,O
3096,280,elapsed,O
3097,280,from,O
3098,280,that,O
3099,280,treatment,B-Procedure
3100,280,.,O
3101,281,3,O
3102,281,.,O
3103,281,Histologically,B-Procedure
3104,281,confirmed,O
3105,281,squamous,B-Condition
3106,281,cell,I-Condition
3107,281,bronchogenic,I-Condition
3108,281,carcinoma,I-Condition
3109,281,.,O
3110,281,Patients,O
3111,281,whose,O
3112,281,tumors,O
3113,281,contain,O
3114,281,mixed,B-Condition
3115,281,non,I-Condition
3116,281,-,I-Condition
3117,281,small,I-Condition
3118,281,cell,I-Condition
3119,281,histologies,I-Condition
3120,281,are,O
3121,281,eligible,O
3122,281,",",O
3123,281,as,O
3124,281,long,O
3125,281,as,O
3126,281,squamous,B-Condition
3127,281,carcinoma,I-Condition
3128,281,is,O
3129,281,the,O
3130,281,predominant,O
3131,281,histology,O
3132,281,.,O
3133,281,Mixed,B-Condition
3134,281,tumors,I-Condition
3135,281,with,O
3136,281,small,B-Observation
3137,281,cell,I-Observation
3138,281,anaplastic,I-Observation
3139,281,elements,I-Observation
3140,281,are,O
3141,281,not,O
3142,281,eligible,O
3143,281,.,O
3144,281,Cytologic,O
3145,281,specimens,O
3146,281,obtained,O
3147,281,by,O
3148,281,brushings,O
3149,281,",",O
3150,281,washings,O
3151,281,",",O
3152,281,or,O
3153,281,needle,O
3154,281,aspiration,O
3155,281,of,O
3156,281,the,O
3157,281,defined,O
3158,281,lesion,O
3159,281,are,O
3160,281,acceptable,O
3161,281,.,O
3162,282,4,O
3163,282,.,O
3164,282,Patients,O
3165,282,with,O
3166,282,previous,O
3167,282,radiotherapy,B-Procedure
3168,282,as,O
3169,282,definitive,O
3170,282,therapy,O
3171,282,for,O
3172,282,locally,O
3173,282,advanced,O
3174,282,non,B-Condition
3175,282,-,I-Condition
3176,282,small,I-Condition
3177,282,cell,I-Condition
3178,282,lung,I-Condition
3179,282,cancer,I-Condition
3180,282,are,O
3181,282,eligible,O
3182,282,",",O
3183,282,as,O
3184,282,long,O
3185,282,as,O
3186,282,the,O
3187,282,recurrence,O
3188,282,is,O
3189,282,outside,O
3190,282,the,O
3191,282,original,O
3192,282,radiation,O
3193,282,therapy,O
3194,282,port,O
3195,282,.,O
3196,282,Radiation,B-Procedure
3197,282,therapy,I-Procedure
3198,282,must,O
3199,282,have,O
3200,282,been,O
3201,282,completed,O
3202,282,>,O
3203,282,4,O
3204,282,weeks,O
3205,282,prior,O
3206,282,to,O
3207,282,the,O
3208,282,initiation,O
3209,282,of,O
3210,282,study,O
3211,282,treatment,O
3212,282,.,O
3213,282,Patients,O
3214,282,who,O
3215,282,have,O
3216,282,received,O
3217,282,chemo,B-Procedure
3218,282,/,O
3219,282,radiation,B-Procedure
3220,282,for,O
3221,282,locally,O
3222,282,advanced,O
3223,282,NSCLC,B-Condition
3224,282,are,O
3225,282,not,O
3226,282,eligible,O
3227,282,.,O
3228,282,Patients,O
3229,282,who,O
3230,282,have,O
3231,282,received,O
3232,282,palliative,B-Procedure
3233,282,radiation,I-Procedure
3234,282,therapy,I-Procedure
3235,282,for,O
3236,282,symptomatic,B-Condition
3237,282,metastases,I-Condition
3238,282,must,O
3239,282,have,O
3240,282,completed,O
3241,282,treatment,O
3242,282,>,O
3243,282,14,O
3244,282,days,O
3245,282,prior,O
3246,282,the,O
3247,282,initiation,O
3248,282,of,O
3249,282,the,O
3250,282,study,O
3251,282,treatment,O
3252,282,.,O
3253,283,5,O
3254,283,.,O
3255,283,Presence,O
3256,283,of,O
3257,283,evaluable,O
3258,283,(,O
3259,283,measureable,O
3260,283,or,O
3261,283,non,O
3262,283,-,O
3263,283,measurable,O
3264,283,),O
3265,283,disease,O
3266,283,.,O
3267,284,6,O
3268,284,.,O
3269,284,ECOG,O
3270,284,Performance,O
3271,284,Status,O
3272,284,of,O
3273,284,0,O
3274,284,or,O
3275,284,1,O
3276,284,.,O
3277,285,7,O
3278,285,.,O
3279,285,Laboratory,O
3280,285,values,O
3281,285,as,O
3282,285,follows,O
3283,285,:,O
3284,286,Absolute,O
3285,286,neutrophil,O
3286,286,count,O
3287,286,(,O
3288,286,ANC,O
3289,286,),O
3290,286,>,O
3291,286,"1,500",O
3292,286,/,O
3293,286,microL,O
3294,286,and,O
3295,286,platelets,O
3296,286,>,O
3297,286,"100,000",O
3298,286,/,O
3299,286,microL,O
3300,286,(,O
3301,286,≤72,O
3302,286,hours,O
3303,286,prior,O
3304,286,to,O
3305,286,initial,O
3306,286,treatment,O
3307,286,),O
3308,286,.,O
3309,287,Hemoglobin,O
3310,287,>,O
3311,287,9,O
3312,287,g,O
3313,287,/,O
3314,287,dL,O
3315,287,(,O
3316,287,Note,O
3317,287,:,O
3318,287,Patients,O
3319,287,may,O
3320,287,be,O
3321,287,transfused,O
3322,287,or,O
3323,287,receive,O
3324,287,erythropoietin,O
3325,287,to,O
3326,287,maintain,O
3327,287,or,O
3328,287,exceed,O
3329,287,this,O
3330,287,level,O
3331,287,),O
3332,287,.,O
3333,288,Bilirubin,O
3334,288,<,O
3335,288,ULN,O
3336,288,.,O
3337,289,Alanine,O
3338,289,aminotransferase,O
3339,289,(,O
3340,289,ALT,O
3341,289,),O
3342,289,and,O
3343,289,aspartate,O
3344,289,aminotransferase,O
3345,289,(,O
3346,289,AST,O
3347,289,),O
3348,289,≤2.5,O
3349,289,times,O
3350,289,the,O
3351,289,upper,O
3352,289,limit,O
3353,289,of,O
3354,289,normal,O
3355,289,if,O
3356,289,no,O
3357,289,liver,B-Condition
3358,289,involvement,I-Condition
3359,289,or,O
3360,289,≤5,O
3361,289,times,O
3362,289,the,O
3363,289,upper,O
3364,289,limit,O
3365,289,of,O
3366,289,normal,O
3367,289,with,O
3368,289,liver,B-Condition
3369,289,involvement,I-Condition
3370,289,.,I-Condition
3371,290,Creatinine,O
3372,290,<,O
3373,290,2.0,O
3374,290,mg,O
3375,290,/,O
3376,290,dL,O
3377,290,",",O
3378,290,or,O
3379,290,creatinine,O
3380,290,clearance,O
3381,290,>,O
3382,290,40,O
3383,290,mL,O
3384,290,/,O
3385,290,min,O
3386,290,(,O
3387,290,as,O
3388,290,calculated,O
3389,290,by,O
3390,290,the,O
3391,290,Cockcroft,O
3392,290,-,O
3393,290,Gault,O
3394,290,method,O
3395,290,.,O
3396,291,8,O
3397,291,.,O
3398,291,Women,O
3399,291,of,O
3400,291,childbearing,O
3401,291,potential,O
3402,291,must,O
3403,291,have,O
3404,291,a,O
3405,291,negative,O
3406,291,serum,O
3407,291,pregnancy,O
3408,291,test,O
3409,291,performed,O
3410,291,within,O
3411,291,7,O
3412,291,days,O
3413,291,prior,O
3414,291,to,O
3415,291,start,O
3416,291,of,O
3417,291,treatment,O
3418,291,.,O
3419,291,Women,O
3420,291,of,O
3421,291,childbearing,O
3422,291,potential,O
3423,291,or,O
3424,291,men,O
3425,291,with,O
3426,291,partners,O
3427,291,of,O
3428,291,childbearing,O
3429,291,potential,O
3430,291,must,O
3431,291,use,O
3432,291,effective,O
3433,291,birth,O
3434,291,control,O
3435,291,measures,O
3436,291,during,O
3437,291,treatment,O
3438,291,and,O
3439,291,at,O
3440,291,least,O
3441,291,6,O
3442,291,months,O
3443,291,after,O
3444,291,the,O
3445,291,last,O
3446,291,dose,O
3447,291,of,O
3448,291,the,O
3449,291,study,O
3450,291,treatment,O
3451,291,.,O
3452,291,If,O
3453,291,a,O
3454,291,woman,O
3455,291,becomes,O
3456,291,pregnant,O
3457,291,or,O
3458,291,suspects,O
3459,291,she,O
3460,291,is,O
3461,291,pregnant,O
3462,291,while,O
3463,291,participating,O
3464,291,in,O
3465,291,this,O
3466,291,study,O
3467,291,",",O
3468,291,she,O
3469,291,must,O
3470,291,agree,O
3471,291,to,O
3472,291,inform,O
3473,291,her,O
3474,291,treating,O
3475,291,physician,O
3476,291,immediately,O
3477,291,.,O
3478,291,Sexually,O
3479,291,active,O
3480,291,men,O
3481,291,must,O
3482,291,agree,O
3483,291,to,O
3484,291,use,O
3485,291,a,O
3486,291,medically,O
3487,291,acceptable,O
3488,291,form,O
3489,291,of,O
3490,291,birth,O
3491,291,control,O
3492,291,during,O
3493,291,treatment,O
3494,291,and,O
3495,291,at,O
3496,291,least,O
3497,291,6,O
3498,291,months,O
3499,291,after,O
3500,291,the,O
3501,291,last,O
3502,291,dose,O
3503,291,.,O
3504,291,If,O
3505,291,a,O
3506,291,female,O
3507,291,partner,O
3508,291,becomes,O
3509,291,pregnant,O
3510,291,during,O
3511,291,the,O
3512,291,course,O
3513,291,of,O
3514,291,the,O
3515,291,study,O
3516,291,the,O
3517,291,treating,O
3518,291,physician,O
3519,291,should,O
3520,291,be,O
3521,291,informed,O
3522,291,immediately,O
3523,291,.,O
3524,292,9,O
3525,292,.,O
3526,292,>,O
3527,292,18,O
3528,292,years,O
3529,292,of,O
3530,292,age,B-Person
3531,292,.,O
3532,293,10,O
3533,293,.,O
3534,293,Ability,O
3535,293,to,O
3536,293,understand,O
3537,293,the,O
3538,293,nature,O
3539,293,of,O
3540,293,this,O
3541,293,study,O
3542,293,",",O
3543,293,give,O
3544,293,written,O
3545,293,informed,O
3546,293,consent,O
3547,293,",",O
3548,293,and,O
3549,293,comply,O
3550,293,with,O
3551,293,study,O
3552,293,requirements,O
3553,293,.,O
3554,294,11,O
3555,294,.,O
3556,294,Patients,O
3557,294,entering,O
3558,294,this,O
3559,294,study,O
3560,294,must,O
3561,294,be,O
3562,294,willing,O
3563,294,to,O
3564,294,provide,O
3565,294,tissue,O
3566,294,from,O
3567,294,a,O
3568,294,previous,O
3569,294,tumor,O
3570,294,biopsy,O
3571,294,(,O
3572,294,if,O
3573,294,available,O
3574,294,),O
3575,294,for,O
3576,294,correlative,O
3577,294,testing,O
3578,294,.,O
3579,294,An,O
3580,294,exception,O
3581,294,to,O
3582,294,this,O
3583,294,is,O
3584,294,when,O
3585,294,the,O
3586,294,national,O
3587,294,/,O
3588,294,local,O
3589,294,regulations,O
3590,294,prohibits,O
3591,294,some,O
3592,294,of,O
3593,294,the,O
3594,294,key,O
3595,294,activities,O
3596,294,of,O
3597,294,this,O
3598,294,research,O
3599,294,like,O
3600,294,the,O
3601,294,export,O
3602,294,of,O
3603,294,samples,O
3604,294,to,O
3605,294,third,O
3606,294,countries,O
3607,294,",",O
3608,294,storage,O
3609,294,of,O
3610,294,coded,O
3611,294,samples,O
3612,294,or,O
3613,294,global,O
3614,294,gene,O
3615,294,expression,O
3616,294,profiling,O
3617,294,without,O
3618,294,a,O
3619,294,pre,O
3620,294,-,O
3621,294,specified,O
3622,294,list,O
3623,294,of,O
3624,294,target,O
3625,294,genes,O
3626,294,.,O
3627,294,If,O
3628,294,tissue,O
3629,294,is,O
3630,294,not,O
3631,294,available,O
3632,294,",",O
3633,294,a,O
3634,294,patient,O
3635,294,will,O
3636,294,still,O
3637,294,be,O
3638,294,eligible,O
3639,294,for,O
3640,294,enrollment,O
3641,294,into,O
3642,294,the,O
3643,294,study,O
3644,294,.,O
3645,295,Women,B-Person
3646,295,who,O
3647,295,are,O
3648,295,pregnant,B-Observation
3649,295,or,O
3650,295,breastfeeding,B-Observation
3651,296,Known,B-Mood
3652,296,or,O
3653,296,suspected,B-Mood
3654,296,",",O
3655,296,acquired,B-Condition
3656,296,or,I-Condition
3657,296,bleeding,I-Condition
3658,296,or,I-Condition
3659,296,coagulation,I-Condition
3660,296,disorder,I-Condition
3661,296,in,B-Person
3662,296,the,I-Person
3663,296,subject,I-Person
3664,296,or,O
3665,296,a,O
3666,296,first,B-Person
3667,296,degree,I-Person
3668,296,relative,I-Person
3669,297,Active,O
3670,297,bleeding,B-Condition
3671,297,or,O
3672,297,at,B-Mood
3673,297,high,I-Mood
3674,297,risk,I-Mood
3675,297,for,I-Mood
3676,297,bleeding,B-Condition
3677,297,.,O
3678,298,Brain,O
3679,298,",",O
3680,298,spinal,O
3681,298,",",O
3682,298,ophthalmologic,O
3683,298,",",O
3684,298,or,O
3685,298,major,O
3686,298,surgery,B-Procedure
3687,298,or,O
3688,298,trauma,B-Condition
3689,298,within,O
3690,298,the,O
3691,298,past,O
3692,298,90,O
3693,298,days,O
3694,298,other,O
3695,298,than,O
3696,298,the,O
3697,298,elective,B-Procedure
3698,298,knee,I-Procedure
3699,298,/,I-Procedure
3700,298,hip,I-Procedure
3701,298,surgery,I-Procedure
3702,299,Active,O
3703,299,hepatobiliary,B-Condition
3704,299,disease,I-Condition
3705,300,Hemoglobin,O
3706,300,<,O
3707,300,9,O
3708,300,g,O
3709,300,/,O
3710,300,dL,O
3711,301,Platelet,O
3712,301,count,O
3713,301,<,O
3714,301,"100,000",O
3715,301,/,O
3716,301,mm3,O
3717,302,Creatinine,O
3718,302,clearance,O
3719,302,<,O
3720,302,30,O
3721,302,mL,O
3722,302,/,O
3723,302,min,O
3724,303,Age,B-Person
3725,303,=,O
3726,303,18,O
3727,303,years,O
3728,304,Subjects,O
3729,304,undergoing,O
3730,304,elective,O
3731,304,total,B-Procedure
3732,304,knee,I-Procedure
3733,304,or,I-Procedure
3734,304,hip,I-Procedure
3735,304,replacement,I-Procedure
3736,304,or,O
3737,304,a,O
3738,304,revision,O
3739,304,of,O
3740,304,at,O
3741,304,least,O
3742,304,one,O
3743,304,component,O
3744,304,of,O
3745,304,a,O
3746,304,total,O
3747,304,knee,O
3748,304,or,O
3749,304,hip,O
3750,304,replacement,O
3751,305,1,O
3752,305,),O
3753,305,preoperative,O
3754,305,diagnosis,O
3755,305,of,O
3756,305,delirium,B-Condition
3757,305,or,O
3758,305,dementia,B-Condition
3759,305,;,O
3760,305,2,O
3761,305,),O
3762,305,MMSE,O
3763,305,score,O
3764,305,of,O
3765,305,=,O
3766,305,20,O
3767,305,out,O
3768,305,of,O
3769,305,30,O
3770,305,on,O
3771,305,preoperative,O
3772,305,testing,O
3773,305,(,O
3774,305,more,O
3775,305,than,O
3776,305,mild,O
3777,305,cognitive,B-Condition
3778,305,impairment,I-Condition
3779,305,),O
3780,305,or,O
3781,305,delirium,B-Condition
3782,305,on,O
3783,305,preoperative,O
3784,305,CAM,B-Procedure
3785,305,testing,I-Procedure
3786,305,;,O
3787,305,3,O
3788,305,),O
3789,305,language,B-Observation
3790,305,barriers,I-Observation
3791,305,that,O
3792,305,would,O
3793,305,preclude,O
3794,305,testing,O
3795,305,;,O
3796,305,4,O
3797,305,),O
3798,305,preoperative,O
3799,305,steroid,B-Drug
3800,305,use,O
3801,305,within,O
3802,305,3,O
3803,305,days,O
3804,305,of,O
3805,305,surgery,B-Procedure
3806,305,;,O
3807,305,or,O
3808,305,5,O
3809,305,),O
3810,305,anticipation,B-Mood
3811,305,of,O
3812,305,postoperative,O
3813,305,intubation,B-Procedure
3814,305,.,O
3815,306,patients,O
3816,306,=,O
3817,306,70,O
3818,306,years,O
3819,306,of,O
3820,306,age,B-Person
3821,306,",",O
3822,306,undergoing,O
3823,306,a,O
3824,306,noncardiac,B-Procedure
3825,306,surgical,I-Procedure
3826,306,procedure,I-Procedure
3827,306,under,O
3828,306,general,B-Procedure
3829,306,anesthesia,I-Procedure
3830,306,",",O
3831,306,with,O
3832,306,an,O
3833,306,anticipated,B-Mood
3834,306,duration,O
3835,306,of,O
3836,306,postoperative,O
3837,306,admission,B-Procedure
3838,306,of,O
3839,306,at,O
3840,306,least,O
3841,306,2,O
3842,306,days,O
3843,306,.,O
3844,307,Patients,O
3845,307,will,O
3846,307,be,O
3847,307,excluded,O
3848,307,if,O
3849,307,they,O
3850,307,have,O
3851,307,known,O
3852,307,middle,B-Condition
3853,307,ear,I-Condition
3854,307,disease,I-Condition
3855,307,",",O
3856,307,chronic,B-Condition
3857,307,lung,I-Condition
3858,307,disease,I-Condition
3859,307,or,O
3860,307,claustrophobia,B-Condition
3861,308,The,O
3862,308,study,O
3863,308,will,O
3864,308,include,O
3865,308,40,O
3866,308,post,O
3867,308,-,O
3868,308,deep,B-Condition
3869,308,peel,I-Condition
3870,308,women,B-Person
3871,308,(,O
3872,308,exoderm,B-Condition
3873,308,),O
3874,308,",",O
3875,308,older,O
3876,308,than,O
3877,308,18,O
3878,308,years,O
3879,308,old,B-Person
3880,308,",",O
3881,308,treated,O
3882,308,by,O
3883,308,the,O
3884,308,same,O
3885,308,dermatologist,O
3886,308,(,O
3887,308,dr,O
3888,308,.,O
3889,308,Landau,O
3890,308,),O
3891,308,.,O
3892,309,The,O
3893,309,treatment,O
3894,309,group,O
3895,309,will,O
3896,309,receive,O
3897,309,5,O
3898,309,consecutive,O
3899,309,daily,O
3900,309,hyperbaric,O
3901,309,treatments,O
3902,309,",",O
3903,309,1,O
3904,309,hours,O
3905,309,long,O
3906,309,each,O
3907,309,",",O
3908,309,at,O
3909,309,2,O
3910,309,ATF,O
3911,309,",",O
3912,309,starting,O
3913,309,from,O
3914,309,day,O
3915,309,7,O
3916,309,to,O
3917,309,peel,O
3918,309,.,O
3919,309,Prior,O
3920,309,to,O
3921,309,treatment,O
3922,309,",",O
3923,309,each,O
3924,309,patient,O
3925,309,will,O
3926,309,be,O
3927,309,signed,O
3928,309,on,O
3929,309,informed,O
3930,309,consent,O
3931,309,and,O
3932,309,will,O
3933,309,have,O
3934,309,complete,O
3935,309,physical,O
3936,309,examination,O
3937,309,.,O
3938,310,The,O
3939,310,control,B-Observation
3940,310,group,I-Observation
3941,310,will,O
3942,310,be,O
3943,310,matched,O
3944,310,by,O
3945,310,the,O
3946,310,following,O
3947,310,parameters,O
3948,310,:,O
3949,310,age,B-Person
3950,310,",",O
3951,310,skin,B-Person
3952,310,color,I-Person
3953,310,and,O
3954,310,type,B-Person
3955,310,",",O
3956,310,and,O
3957,310,indication,O
3958,310,for,O
3959,310,peeling,O
3960,310,",",O
3961,310,and,O
3962,310,will,O
3963,310,be,O
3964,310,picked,O
3965,310,up,O
3966,310,by,O
3967,310,the,O
3968,310,dermatologist,O
3969,310,.,O
3970,311,previous,O
3971,311,treated,O
3972,311,dupuytrens,B-Condition
3973,311,contracture,I-Condition
3974,311,same,O
3975,311,hand,O
3976,312,more,O
3977,312,than,O
3978,312,tree,O
3979,312,fingers,B-Condition
3980,312,involvement,I-Condition
3981,313,we,O
3982,313,will,O
3983,313,not,O
3984,313,include,O
3985,313,thumbs,O
3986,314,other,B-Condition
3987,314,things,I-Condition
3988,314,affecting,O
3989,314,hand,O
3990,314,function,O
3991,315,ASA>3,O
3992,316,expected,B-Observation
3993,316,to,I-Observation
3994,316,live,I-Observation
3995,316,under,O
3996,316,five,O
3997,316,years,O
3998,317,Tetracycline,B-Drug
3999,317,treatment,O
4000,317,within,O
4001,317,two,O
4002,317,weeks,O
4003,318,pregnancy,B-Condition
4004,319,nursing,B-Condition
4005,320,allergy,B-Condition
4006,320,to,O
4007,320,clostridium,B-Observation
4008,320,histolyticum,I-Observation
4009,321,participant,O
4010,321,in,O
4011,321,other,O
4012,321,trial,O
4013,322,symptomatic,O
4014,322,Dupuytrens,B-Condition
4015,322,contracture,I-Condition
4016,322,with,O
4017,322,palpable,B-Condition
4018,322,cord,I-Condition
4019,322,",",O
4020,322,involving,O
4021,322,MCP,O
4022,322,",",O
4023,322,total,O
4024,322,contracture,O
4025,322,size,O
4026,322,over,O
4027,322,30,O
4028,322,degrees,O
4029,323,a,O
4030,323,history,B-Observation
4031,323,of,O
4032,323,non,B-Procedure
4033,323,-,I-Procedure
4034,323,standard,I-Procedure
4035,323,treatment(chemotherapy,I-Procedure
4036,323,or,O
4037,323,surgery,B-Procedure
4038,323,),O
4039,324,secondary,B-Condition
4040,324,osteosarcoma,I-Condition
4041,324,or,O
4042,324,well,O
4043,324,-,O
4044,324,differentiated,O
4045,324,parosteal,B-Condition
4046,324,osteosarcoma,I-Condition
4047,325,evident,O
4048,325,dysfunction,B-Condition
4049,325,of,I-Condition
4050,325,cardia,I-Condition
4051,325,",",I-Condition
4052,325,liver,I-Condition
4053,325,and,I-Condition
4054,325,kidney,I-Condition
4055,325,",",O
4056,325,or,O
4057,325,pregnant,B-Condition
4058,325,women,O
4059,325,or,O
4060,325,women,O
4061,325,during,O
4062,325,lactation,B-Condition
4063,326,histologically,B-Procedure
4064,326,diagnosed,O
4065,326,primary,O
4066,326,classical,B-Condition
4067,326,osteosarcoma,I-Condition
4068,326,in,O
4069,326,extremities,O
4070,327,staging,O
4071,327,IIB,O
4072,328,MRI,B-Procedure
4073,328,showing,O
4074,328,no,O
4075,328,skip,B-Observation
4076,328,lesion,I-Observation
4077,329,receive,O
4078,329,standard,B-Procedure
4079,329,neo,I-Procedure
4080,329,-,I-Procedure
4081,329,adjuvant,I-Procedure
4082,329,chemotherapy,I-Procedure
4083,329,",",O
4084,329,adjuvant,B-Procedure
4085,329,chemotherapy,I-Procedure
4086,329,",",O
4087,329,and,O
4088,329,standard,B-Procedure
4089,329,surgical,I-Procedure
4090,329,treatment,I-Procedure
4091,330,Known,O
4092,330,or,O
4093,330,suspected,O
4094,330,allergy,B-Condition
4095,330,to,I-Condition
4096,330,trial,I-Condition
4097,330,product(s,I-Condition
4098,330,),I-Condition
4099,330,or,I-Condition
4100,330,related,I-Condition
4101,330,products,I-Condition
4102,331,Subjects,O
4103,331,who,O
4104,331,are,O
4105,331,unlikely,O
4106,331,to,O
4107,331,comply,O
4108,331,with,O
4109,331,protocol,O
4110,331,requirements,O
4111,331,",",O
4112,331,e.g.,O
4113,331,uncooperative,O
4114,331,attitude,O
4115,331,",",O
4116,331,inability,O
4117,331,to,O
4118,331,return,O
4119,331,for,O
4120,331,the,O
4121,331,final,O
4122,331,visit,O
4123,332,Subjects,O
4124,332,who,O
4125,332,previously,O
4126,332,enrolled,O
4127,332,in,O
4128,332,this,O
4129,332,study,O
4130,333,Females,B-Person
4131,333,of,O
4132,333,childbearing,B-Condition
4133,333,potential,I-Condition
4134,333,who,O
4135,333,are,O
4136,333,pregnant,B-Condition
4137,333,",",O
4138,333,breast,B-Condition
4139,333,-,I-Condition
4140,333,feeding,I-Condition
4141,333,or,O
4142,333,intend,B-Mood
4143,333,to,I-Mood
4144,333,become,I-Mood
4145,333,pregnant,B-Condition
4146,333,or,O
4147,333,are,O
4148,333,not,O
4149,333,using,O
4150,333,adequate,O
4151,333,contraceptive,B-Procedure
4152,333,methods,I-Procedure
4153,334,The,O
4154,334,receipt,O
4155,334,of,O
4156,334,any,O
4157,334,investigational,B-Drug
4158,334,product,I-Drug
4159,334,within,O
4160,334,3,O
4161,334,months,O
4162,334,prior,O
4163,334,to,O
4164,334,this,O
4165,334,trial,O
4166,335,After,O
4167,335,the,O
4168,335,investigator,O
4169,335,has,O
4170,335,taken,O
4171,335,the,O
4172,335,decision,O
4173,335,to,O
4174,335,use,O
4175,335,human,O
4176,335,insulin,O
4177,335,or,O
4178,335,insulin,O
4179,335,analogues,O
4180,335,to,O
4181,335,treat,O
4182,335,the,O
4183,335,subject,O
4184,335,",",O
4185,335,any,O
4186,335,type,B-Condition
4187,335,2,I-Condition
4188,335,diabetic,I-Condition
4189,335,previously,O
4190,335,inadequately,O
4191,335,controlled,O
4192,335,with,O
4193,335,two,O
4194,335,or,O
4195,335,more,O
4196,335,OADs,B-Condition
4197,335,is,O
4198,335,eligible,O
4199,335,for,O
4200,335,the,O
4201,335,study,O
4202,336,The,O
4203,336,selection,O
4204,336,of,O
4205,336,the,O
4206,336,subjects,O
4207,336,will,O
4208,336,be,O
4209,336,at,O
4210,336,the,O
4211,336,discretion,O
4212,336,of,O
4213,336,the,O
4214,336,individual,O
4215,336,investigator,O
4216,337,Patient,O
4217,337,has,O
4218,337,previously,O
4219,337,received,O
4220,337,or,O
4221,337,is,O
4222,337,receiving,O
4223,337,an,O
4224,337,organ,B-Procedure
4225,337,transplant,I-Procedure
4226,337,other,O
4227,337,than,O
4228,337,a,O
4229,337,liver,O
4230,337,.,O
4231,338,Patient,O
4232,338,currently,O
4233,338,requires,O
4234,338,dialysis,B-Procedure
4235,339,Recipient,B-Person
4236,339,or,O
4237,339,donor,B-Person
4238,339,is,O
4239,339,known,O
4240,339,to,O
4241,339,be,O
4242,339,seropositive,O
4243,339,for,O
4244,339,human,O
4245,339,immunodeficiency,O
4246,339,virus,O
4247,339,(,O
4248,339,HIV,O
4249,339,),O
4250,340,Patient,O
4251,340,has,O
4252,340,received,O
4253,340,a,O
4254,340,liver,B-Procedure
4255,340,transplant,I-Procedure
4256,340,from,O
4257,340,a,O
4258,340,non,O
4259,340,-,O
4260,340,heart,O
4261,340,beating,O
4262,340,donor,B-Person
4263,341,Patient,O
4264,341,who,O
4265,341,is,O
4266,341,HCV,O
4267,341,negative,O
4268,341,has,O
4269,341,received,O
4270,341,an,O
4271,341,HCV,O
4272,341,positive,O
4273,341,(,O
4274,341,HCV,O
4275,341,RNA,O
4276,341,by,O
4277,341,PCR,O
4278,341,or,O
4279,341,HCV,O
4280,341,antibody,O
4281,341,),O
4282,341,donor,B-Person
4283,341,liver,O
4284,342,Patient,O
4285,342,who,O
4286,342,is,O
4287,342,HbsAg,O
4288,342,negative,O
4289,342,has,O
4290,342,received,O
4291,342,an,O
4292,342,HbsAg,O
4293,342,positive,O
4294,342,(,O
4295,342,HBV,O
4296,342,DNA,O
4297,342,by,O
4298,342,PCR,O
4299,342,or,O
4300,342,HBV,O
4301,342,antibody,O
4302,342,),O
4303,342,donor,B-Person
4304,342,liver,O
4305,343,Patient,O
4306,343,has,O
4307,343,received,O
4308,343,a,O
4309,343,liver,B-Procedure
4310,343,transplant,I-Procedure
4311,343,from,O
4312,343,a,O
4313,343,decrease,O
4314,343,donor,B-Person
4315,343,>,O
4316,343,70,O
4317,343,years,O
4318,343,of,O
4319,343,age,B-Person
4320,344,Patient,O
4321,344,has,O
4322,344,a,O
4323,344,current,O
4324,344,malignancy,B-Condition
4325,344,or,O
4326,344,a,O
4327,344,history,B-Condition
4328,344,of,I-Condition
4329,344,malignancy,I-Condition
4330,344,(,O
4331,344,within,O
4332,344,the,O
4333,344,past,O
4334,344,5,O
4335,344,years,O
4336,344,),O
4337,344,",",O
4338,344,except,O
4339,344,hepatocellular,B-Condition
4340,344,carcinoma,I-Condition
4341,344,within,O
4342,344,UCSF,O
4343,344,Criteria,O
4344,344,and,O
4345,344,basal,B-Condition
4346,344,or,I-Condition
4347,344,non,I-Condition
4348,344,-,I-Condition
4349,344,metastatic,I-Condition
4350,344,squamous,I-Condition
4351,344,cell,I-Condition
4352,344,carcinoma,I-Condition
4353,344,of,I-Condition
4354,344,skin,I-Condition
4355,344,that,O
4356,344,has,O
4357,344,been,O
4358,344,treated,B-Mood
4359,344,successfully,I-Mood
4360,344,.,O
4361,345,Patient,O
4362,345,is,O
4363,345,hemodynamically,B-Condition
4364,345,unstable,I-Condition
4365,345,on,O
4366,345,POD,O
4367,345,15,O
4368,346,Patient,O
4369,346,has,O
4370,346,been,O
4371,346,fully,O
4372,346,informed,O
4373,346,and,O
4374,346,has,O
4375,346,signed,O
4376,346,an,O
4377,346,IRB,O
4378,346,approved,O
4379,346,informed,O
4380,346,consent,O
4381,346,form,O
4382,346,within,O
4383,346,7,O
4384,346,days,O
4385,346,(,O
4386,346,Day,O
4387,346,7,O
4388,346,-,O
4389,346,13,O
4390,346,),O
4391,346,prior,O
4392,346,to,O
4393,346,POD,O
4394,346,15,O
4395,346,and,O
4396,346,is,O
4397,346,willing,O
4398,346,and,O
4399,346,able,O
4400,346,to,O
4401,346,follow,O
4402,346,study,O
4403,346,procedure,O
4404,347,Patient,O
4405,347,is,O
4406,347,a,O
4407,347,primary,B-Condition
4408,347,liver,I-Condition
4409,347,transplant,I-Condition
4410,347,recipient,B-Person
4411,348,Patient,O
4412,348,is,O
4413,348,20,O
4414,348,to,O
4415,348,70,O
4416,348,years,O
4417,348,of,O
4418,348,age,B-Person
4419,349,Patient,O
4420,349,should,O
4421,349,be,O
4422,349,clearly,O
4423,349,conscious,O
4424,349,",",O
4425,349,fully,O
4426,349,understand,O
4427,349,and,O
4428,349,able,O
4429,349,to,O
4430,349,answer,O
4431,349,questionnaire,O
4432,350,Women,B-Person
4433,350,with,O
4434,350,confirmed,O
4435,350,or,O
4436,350,suspected,O
4437,350,pregnancy,B-Condition
4438,351,Women,B-Person
4439,351,under,O
4440,351,lactation,B-Condition
4441,351,and/or,O
4442,351,puerperium,B-Condition
4443,352,Hypersensibility,B-Condition
4444,352,to,O
4445,352,ingredients,B-Drug
4446,352,of,I-Drug
4447,352,intervention,I-Drug
4448,353,Physical,O
4449,353,impossibility,O
4450,353,for,O
4451,353,apply,O
4452,353,the,O
4453,353,drug,O
4454,354,Known,O
4455,354,pancreatic,B-Condition
4456,354,",",I-Condition
4457,354,renal,I-Condition
4458,354,",",I-Condition
4459,354,hepatic,I-Condition
4460,354,",",I-Condition
4461,354,heart,I-Condition
4462,354,or,I-Condition
4463,354,thyroid,I-Condition
4464,354,diseased,I-Condition
4465,355,Hypertension,B-Condition
4466,355,diagnosis,O
4467,356,Previous,O
4468,356,treatment,B-Procedure
4469,356,for,I-Procedure
4470,356,glucose,I-Procedure
4471,357,Body,O
4472,357,Mass,O
4473,357,Index,O
4474,357,=,O
4475,357,39.9,O
4476,357,kg,O
4477,357,/,O
4478,357,m2,O
4479,358,Triglycerides,O
4480,358,=,O
4481,358,500,O
4482,358,mg,O
4483,358,/,O
4484,358,dL,O
4485,359,Total,O
4486,359,cholesterol,O
4487,359,=,O
4488,359,300,O
4489,359,mg,O
4490,359,/,O
4491,359,dL,O
4492,360,Night,B-Person
4493,360,or,I-Person
4494,360,rotating,I-Person
4495,360,shift,I-Person
4496,360,workers,I-Person
4497,361,Blood,O
4498,361,Pressure,O
4499,361,=,O
4500,361,140/90,O
4501,361,mmHg,O
4502,362,Patients,O
4503,362,both,B-Person
4504,362,sexes,I-Person
4505,363,Age,B-Person
4506,363,between,O
4507,363,31,O
4508,363,and,O
4509,363,60,O
4510,363,years,O
4511,364,Diagnosis,O
4512,364,of,O
4513,364,diabetes,B-Condition
4514,364,according,O
4515,364,ADA,O
4516,364,criteria,O
4517,364,:,O
4518,365,Patients,O
4519,365,who,O
4520,365,have,O
4521,365,had,O
4522,365,a,O
4523,365,prior,O
4524,365,abdominal,B-Procedure
4525,365,myomectomy,I-Procedure
4526,366,Post,B-Observation
4527,366,-,I-Observation
4528,366,menopausal,I-Observation
4529,366,women,B-Person
4530,367,Patients,O
4531,367,with,O
4532,367,known,O
4533,367,bleeding,O
4534,367,/,O
4535,367,clotting,B-Condition
4536,367,disorders,I-Condition
4537,368,Patients,O
4538,368,with,O
4539,368,a,O
4540,368,history,B-Observation
4541,368,of,O
4542,368,gynecologic,B-Condition
4543,368,malignancy,I-Condition
4544,369,History,B-Observation
4545,369,of,O
4546,369,allergic,B-Condition
4547,369,reactions,I-Condition
4548,369,attributed,O
4549,369,to,O
4550,369,compounds,B-Drug
4551,369,of,I-Drug
4552,369,similar,I-Drug
4553,369,chemical,I-Drug
4554,369,or,I-Drug
4555,369,biologic,I-Drug
4556,369,composition,I-Drug
4557,369,to,I-Drug
4558,369,misoprostol,I-Drug
4559,370,Any,O
4560,370,cases,O
4561,370,converted,B-Mood
4562,370,to,I-Mood
4563,370,abdominal,B-Procedure
4564,370,hysterectomy,I-Procedure
4565,370,or,O
4566,370,other,O
4567,370,additional,O
4568,370,elective,O
4569,370,surgical,B-Procedure
4570,370,procedures,I-Procedure
4571,370,performed,O
4572,370,at,O
4573,370,time,O
4574,370,of,O
4575,370,abdominal,B-Procedure
4576,370,myomectomy,I-Procedure
4577,370,will,O
4578,370,be,O
4579,370,excluded,O
4580,370,from,O
4581,370,data,O
4582,370,analysis,O
4583,371,Uncontrolled,O
4584,371,intercurrent,B-Condition
4585,371,illness,I-Condition
4586,371,including,O
4587,371,",",O
4588,371,but,O
4589,371,not,O
4590,371,limited,O
4591,371,to,O
4592,371,",",O
4593,371,ongoing,O
4594,371,or,O
4595,371,active,O
4596,371,infection,B-Condition
4597,371,",",O
4598,371,symptomatic,O
4599,371,congestive,B-Condition
4600,371,heart,I-Condition
4601,371,failure,I-Condition
4602,371,",",O
4603,371,unstable,B-Condition
4604,371,angina,I-Condition
4605,371,pectoris,I-Condition
4606,371,",",O
4607,371,cardiac,B-Condition
4608,371,arrhythmia,I-Condition
4609,371,",",O
4610,371,or,O
4611,371,psychiatric,B-Condition
4612,371,illness,I-Condition
4613,371,/,O
4614,371,social,B-Observation
4615,371,situations,I-Observation
4616,371,that,I-Observation
4617,371,would,I-Observation
4618,371,limit,I-Observation
4619,371,compliance,I-Observation
4620,371,with,I-Observation
4621,371,study,I-Observation
4622,371,requirements,I-Observation
4623,371,.,O
4624,372,Patients,O
4625,372,presenting,O
4626,372,for,O
4627,372,abdominal,B-Procedure
4628,372,myomectomy,I-Procedure
4629,372,with,O
4630,372,documented,O
4631,372,uterine,B-Condition
4632,372,fibroids,I-Condition
4633,372,on,O
4634,372,pelvic,B-Procedure
4635,372,imaging,I-Procedure
4636,372,(,O
4637,372,pelvic,B-Procedure
4638,372,ultrasound,I-Procedure
4639,372,or,O
4640,372,MRI,O
4641,372,),O
4642,372,within,O
4643,372,in,O
4644,372,last,O
4645,372,12,O
4646,372,months,O
4647,373,Age,B-Person
4648,373,=,O
4649,373,18,O
4650,373,years,O
4651,373,and,O
4652,373,=,O
4653,373,50,O
4654,373,years,O
4655,374,Pre,O
4656,374,-,O
4657,374,operative,B-Procedure
4658,374,hemoglobin,O
4659,374,>,O
4660,374,8,O
4661,374,g,O
4662,374,/,O
4663,374,dl,O
4664,375,Willing,B-Mood
4665,375,to,I-Mood
4666,375,have,I-Mood
4667,375,buccal,B-Procedure
4668,375,administration,I-Procedure
4669,375,of,O
4670,375,misoprostol,B-Drug
4671,375,or,O
4672,375,a,O
4673,375,placebo,B-Drug
4674,375,at,O
4675,375,least,O
4676,375,one,O
4677,375,hour,O
4678,375,pre,O
4679,375,-,O
4680,375,procedure,O
4681,375,.,O
4682,376,Ability,B-Observation
4683,376,to,I-Observation
4684,376,understand,I-Observation
4685,376,and,I-Observation
4686,376,the,I-Observation
4687,376,willingness,I-Observation
4688,376,to,I-Observation
4689,376,sign,I-Observation
4690,376,a,I-Observation
4691,376,written,I-Observation
4692,376,informed,I-Observation
4693,376,consent,I-Observation
4694,376,.,O
4695,377,Admissible,O
4696,377,medical,B-Observation
4697,377,/,I-Observation
4698,377,surgical,I-Observation
4699,377,history,I-Observation
4700,378,Can,O
4701,378,be,O
4702,378,previously,O
4703,378,treated,B-Procedure
4704,378,with,O
4705,378,Depo,B-Drug
4706,378,-,I-Drug
4707,378,Lupron,I-Drug
4708,378,",",O
4709,378,Depo,B-Drug
4710,378,-,I-Drug
4711,378,Provera,I-Drug
4712,378,",",O
4713,378,or,O
4714,378,Oral,B-Drug
4715,378,Contraceptive,I-Drug
4716,378,pills,I-Drug
4717,379,Intraoperative,O
4718,379,use,O
4719,379,of,O
4720,379,vasopressin,O
4721,379,and,O
4722,379,uterine,O
4723,379,tourniquet,O
4724,379,is,O
4725,379,permissible,O
4726,380,Can,O
4727,380,have,O
4728,380,had,O
4729,380,prior,O
4730,380,Cesarean,O
4731,380,delivery,O
4732,381,NA,O
4733,382,Adult,B-Person
4734,382,patients,O
4735,382,(,O
4736,382,age,B-Person
4737,382,=,O
4738,382,18,O
4739,382,),O
4740,383,Diagnosed,O
4741,383,by,O
4742,383,preoperative,O
4743,383,imaging,B-Procedure
4744,383,modalities,I-Procedure
4745,383,to,O
4746,383,have,O
4747,383,a,O
4748,383,brain,B-Condition
4749,383,tumor,I-Condition
4750,383,(,O
4751,383,including,O
4752,383,metastatic,B-Condition
4753,383,brain,I-Condition
4754,383,tumors,I-Condition
4755,383,),O
4756,383,or,O
4757,383,vascular,B-Condition
4758,383,lesions,I-Condition
4759,383,(,O
4760,383,aneurysm,B-Condition
4761,383,",",O
4762,383,arteriovenous,B-Condition
4763,383,malformation,I-Condition
4764,383,or,O
4765,383,arteriovenous,B-Condition
4766,383,fistula,I-Condition
4767,383,),O
4768,383,requiring,O
4769,383,surgical,B-Procedure
4770,383,intervention,I-Procedure
4771,383,.,O
4772,384,The,O
4773,384,patient,O
4774,384,is,O
4775,384,determined,O
4776,384,by,O
4777,384,a,O
4778,384,board,O
4779,384,certified,O
4780,384,neurosurgeon,O
4781,384,to,O
4782,384,have,O
4783,384,a,O
4784,384,tumor,B-Condition
4785,384,or,O
4786,384,vascular,B-Condition
4787,384,lesion,I-Condition
4788,384,that,O
4789,384,would,O
4790,384,take,O
4791,384,up,O
4792,384,fluorescein,B-Drug
4793,385,Patient,O
4794,385,or,O
4795,385,legally,O
4796,385,authorized,O
4797,385,representative,O
4798,385,provides,O
4799,385,written,O
4800,385,informed,O
4801,385,consent,O
4802,385,to,O
4803,385,enroll,O
4804,385,in,O
4805,385,this,O
4806,385,study,O
4807,386,Kidney,O
4808,386,",",O
4809,386,parathyroid,O
4810,386,",",O
4811,386,congenital,O
4812,386,bone,O
4813,386,metabolic,O
4814,386,disease,B-Condition
4815,387,Osteoporosis,B-Condition
4816,388,Failure,O
4817,388,to,O
4818,388,provide,O
4819,388,informed,O
4820,388,consent,O
4821,389,Inability,B-Condition
4822,389,to,I-Condition
4823,389,complete,I-Condition
4824,389,400,I-Condition
4825,389,m,I-Condition
4826,389,walk,I-Condition
4827,389,within,I-Condition
4828,389,15,I-Condition
4829,389,minutes,I-Condition
4830,389,without,I-Condition
4831,389,sitting,I-Condition
4832,389,or,O
4833,389,interpersonal,O
4834,389,assistance,O
4835,389,",",O
4836,389,as,O
4837,389,an,O
4838,389,indicator,O
4839,389,of,O
4840,389,disablement,O
4841,389,and,O
4842,389,likely,O
4843,389,inability,O
4844,389,to,O
4845,389,fully,O
4846,389,engage,O
4847,389,in,O
4848,389,the,O
4849,389,exercise,O
4850,389,intervention,O
4851,390,Primary,B-Condition
4852,390,indication,I-Condition
4853,390,for,I-Condition
4854,390,ACE,I-Condition
4855,390,inhibitor,I-Condition
4856,390,use,I-Condition
4857,390,",",O
4858,390,i.e.,O
4859,390,Congestive,B-Condition
4860,390,Heart,I-Condition
4861,390,Failure,I-Condition
4862,390,",",O
4863,390,CAD,B-Condition
4864,390,",",O
4865,390,diabetes,B-Condition
4866,391,Known,O
4867,391,hypersensitivity,B-Condition
4868,391,to,I-Condition
4869,391,ACE,I-Condition
4870,391,inhibitors,I-Condition
4871,392,Resistant,O
4872,392,hypertension,B-Condition
4873,392,",",O
4874,392,defined,O
4875,392,as,O
4876,392,BP,O
4877,392,>,O
4878,392,140/90,O
4879,392,",",O
4880,392,despite,O
4881,392,the,O
4882,392,use,O
4883,392,of,O
4884,392,three,O
4885,392,or,O
4886,392,more,O
4887,392,anti,B-Drug
4888,392,-,I-Drug
4889,392,hypertensive,I-Drug
4890,392,drugs,I-Drug
4891,393,Office,O
4892,393,or,O
4893,393,average,O
4894,393,home,O
4895,393,SBP,O
4896,393,>,O
4897,393,180,O
4898,393,mm,O
4899,393,Hg,O
4900,393,or,O
4901,393,DBP,O
4902,393,>,O
4903,393,110,O
4904,393,mm,O
4905,393,Hg,O
4906,393,(,O
4907,393,Average,O
4908,393,home,O
4909,393,BP,O
4910,393,in,O
4911,393,any,O
4912,393,seven,O
4913,393,day,O
4914,393,period,O
4915,393,during,O
4916,393,trial,O
4917,393,),O
4918,394,Primary,B-Condition
4919,394,renal,I-Condition
4920,394,disease,I-Condition
4921,395,Serum,O
4922,395,creatinine,O
4923,395,>,O
4924,395,2.5,O
4925,395,mg,O
4926,395,/,O
4927,395,dL,O
4928,395,in,O
4929,395,men,B-Person
4930,395,",",O
4931,395,or,O
4932,395,>,O
4933,395,2.0,O
4934,395,mg,O
4935,395,/,O
4936,395,dL,O
4937,395,in,O
4938,395,women,B-Person
4939,396,Serum,O
4940,396,potassium,O
4941,396,>,O
4942,396,5.0,O
4943,396,molar,O
4944,396,equivalent,O
4945,396,/,O
4946,396,L,O
4947,397,Urinary,O
4948,397,protein,O
4949,397,>,O
4950,397,1,O
4951,397,on,O
4952,397,dipstick,O
4953,398,Abnormal,O
4954,398,liver,O
4955,398,enzymes,O
4956,398,(,O
4957,398,Aspartate,O
4958,398,transaminase,O
4959,398,(,O
4960,398,AST,O
4961,398,),O
4962,398,",",O
4963,398,Alanine,O
4964,398,transaminase,O
4965,398,(,O
4966,398,ALT,O
4967,398,),O
4968,398,",",O
4969,398,or,O
4970,398,alkaline,O
4971,398,phosphatase,O
4972,398,>,O
4973,398,2.5,O
4974,398,times,O
4975,398,the,O
4976,398,upper,O
4977,398,limit,O
4978,398,of,O
4979,398,normal,O
4980,398,),O
4981,399,Severe,O
4982,399,cardiac,B-Condition
4983,399,disease,I-Condition
4984,399,",",O
4985,399,including,O
4986,399,New,O
4987,399,York,O
4988,399,Heart,O
4989,399,Association,O
4990,399,Class,O
4991,399,III,O
4992,399,or,O
4993,399,IV,O
4994,399,congestive,B-Condition
4995,399,heart,I-Condition
4996,399,failure,I-Condition
4997,399,",",O
4998,399,clinically,O
4999,399,significant,O
5000,399,aortic,B-Condition
5001,399,stenosis,I-Condition
5002,399,",",O
5003,399,history,B-Observation
5004,399,of,O
5005,399,cardiac,B-Condition
5006,399,arrest,I-Condition
5007,399,",",O
5008,399,use,O
5009,399,of,O
5010,399,a,O
5011,399,cardiac,O
5012,399,defibrillator,O
5013,399,",",O
5014,399,or,O
5015,399,uncontrolled,B-Condition
5016,399,angina,I-Condition
5017,400,Acute,B-Condition
5018,400,myocardial,I-Condition
5019,400,infarction,I-Condition
5020,400,identified,O
5021,400,by,O
5022,400,ECG,B-Procedure
5023,401,Lives,B-Observation
5024,401,in,I-Observation
5025,401,a,I-Observation
5026,401,nursing,I-Observation
5027,401,home,I-Observation
5028,401,(,O
5029,401,persons,O
5030,401,living,O
5031,401,in,O
5032,401,assisted,O
5033,401,or,O
5034,401,independent,O
5035,401,housing,O
5036,401,will,O
5037,401,not,O
5038,401,be,O
5039,401,excluded,O
5040,401,),O
5041,402,Significant,O
5042,402,cognitive,B-Condition
5043,402,impairment,I-Condition
5044,402,",",O
5045,402,defined,O
5046,402,as,O
5047,402,a,O
5048,402,known,O
5049,402,diagnosis,O
5050,402,of,O
5051,402,dementia,B-Condition
5052,402,or,O
5053,402,a,O
5054,402,Mini,O
5055,402,-,O
5056,402,Mental,O
5057,402,State,O
5058,402,Examination,O
5059,402,exam,O
5060,402,score,O
5061,402,<,O
5062,402,24,O
5063,403,Unable,B-Condition
5064,403,to,I-Condition
5065,403,communicate,I-Condition
5066,403,because,O
5067,403,of,O
5068,403,severe,B-Condition
5069,403,hearing,I-Condition
5070,403,loss,I-Condition
5071,403,or,O
5072,403,speech,B-Condition
5073,403,disorder,I-Condition
5074,404,Severe,O
5075,404,visual,B-Condition
5076,404,impairment,I-Condition
5077,404,",",O
5078,404,which,O
5079,404,would,O
5080,404,preclude,O
5081,404,completion,O
5082,404,of,O
5083,404,the,O
5084,404,assessments,O
5085,404,and/or,O
5086,404,intervention,O
5087,405,Other,O
5088,405,significant,O
5089,405,co,B-Condition
5090,405,-,I-Condition
5091,405,morbid,I-Condition
5092,405,disease,I-Condition
5093,405,that,O
5094,405,would,O
5095,405,prevent,O
5096,405,participation,O
5097,405,in,O
5098,405,exercise,O
5099,406,Planning,O
5100,406,to,O
5101,406,move,O
5102,406,out,O
5103,406,of,O
5104,406,the,O
5105,406,area,O
5106,406,during,O
5107,406,the,O
5108,406,study,O
5109,406,time,O
5110,406,frame,O
5111,407,Simultaneous,O
5112,407,participation,O
5113,407,in,O
5114,407,another,O
5115,407,intervention,O
5116,407,trial,O
5117,408,Age,B-Person
5118,408,65,O
5119,408,years,O
5120,408,and,O
5121,408,older,O
5122,409,Hypertension,B-Condition
5123,409,-,O
5124,409,untreated,O
5125,409,(,O
5126,409,Systolic,O
5127,409,Blood,O
5128,409,Pressure,O
5129,409,(,O
5130,409,SBP,O
5131,409,),O
5132,409,≥,O
5133,409,140,O
5134,409,mm,O
5135,409,Hg,O
5136,409,or,O
5137,409,Diastolic,O
5138,409,Blood,O
5139,409,Pressure,O
5140,409,(,O
5141,409,DBP,O
5142,409,),O
5143,409,≥,O
5144,409,90,O
5145,409,mm,O
5146,409,Hg,O
5147,409,),O
5148,409,or,O
5149,409,treated,O
5150,410,Physical,O
5151,410,limitations,O
5152,410,evidenced,O
5153,410,by,O
5154,410,either,O
5155,410,:,O
5156,411,Score,O
5157,411,≤,O
5158,411,10,O
5159,411,on,O
5160,411,the,O
5161,411,Short,O
5162,411,Physical,O
5163,411,Performance,O
5164,411,Battery,O
5165,411,OR,O
5166,411,Walking,O
5167,411,speed,O
5168,411,<,O
5169,411,1.2,O
5170,411,m,O
5171,411,/,O
5172,411,sec,O
5173,411,during,O
5174,411,400,B-Procedure
5175,411,m,I-Procedure
5176,411,usual,I-Procedure
5177,411,-,I-Procedure
5178,411,paced,I-Procedure
5179,411,test,I-Procedure
5180,412,Sedentary,B-Condition
5181,412,lifestyle,I-Condition
5182,412,",",O
5183,412,defined,O
5184,412,as,O
5185,412,<,O
5186,412,150,O
5187,412,min,O
5188,412,/,O
5189,412,wk,O
5190,412,of,O
5191,412,moderate,O
5192,412,physical,O
5193,412,activity,O
5194,412,as,O
5195,412,assessed,O
5196,412,by,O
5197,412,CHAMPS,B-Procedure
5198,412,questionnaire,I-Procedure
5199,413,Willingness,O
5200,413,to,O
5201,413,participate,O
5202,413,in,O
5203,413,all,O
5204,413,study,O
5205,413,procedures,O
5206,414,pregnant,B-Condition
5207,414,or,O
5208,414,breastfeeding,B-Observation
5209,414,patients,O
5210,415,patient,O
5211,415,with,O
5212,415,a,O
5213,415,history,B-Observation
5214,415,of,I-Observation
5215,415,hypersensitivity,B-Condition
5216,415,to,O
5217,415,colistin,B-Drug
5218,416,patient,O
5219,416,hospitalized,B-Procedure
5220,416,in,O
5221,416,critical,O
5222,416,care,O
5223,416,units,O
5224,417,patient,O
5225,417,infected,O
5226,417,by,O
5227,417,multi,O
5228,417,drug,O
5229,417,resistant,O
5230,417,Gram,B-Condition
5231,417,negative,I-Condition
5232,417,bacteria,I-Condition
5233,417,susceptibly,B-Observation
5234,417,only,O
5235,417,to,O
5236,417,colistin,B-Drug
5237,418,source,O
5238,418,of,O
5239,418,infection,O
5240,418,:,O
5241,418,blood,O
5242,418,",",O
5243,418,respiratory,O
5244,418,",",O
5245,418,intra,O
5246,418,abdominal,O
5247,418,or,O
5248,418,urinary,O
5249,419,Plan,O
5250,419,for,O
5251,419,diagnostic,O
5252,419,-,O
5253,419,only,O
5254,419,coronary,B-Procedure
5255,419,angiography,I-Procedure
5256,420,On,O
5257,420,colchicine,B-Drug
5258,420,chronically,O
5259,421,History,O
5260,421,of,O
5261,421,intolerance,B-Condition
5262,421,to,O
5263,421,colchicine,B-Drug
5264,422,Glomerular,O
5265,422,filtration,O
5266,422,rate,O
5267,422,<,O
5268,422,30mL,O
5269,422,/,O
5270,422,minute,O
5271,422,or,O
5272,422,on,O
5273,422,dialysis,B-Procedure
5274,423,Active,O
5275,423,malignancy,B-Condition
5276,423,or,O
5277,423,infection,B-Condition
5278,424,History,O
5279,424,of,O
5280,424,myelodysplasia,B-Condition
5281,425,High,B-Drug
5282,425,-,I-Drug
5283,425,dose,I-Drug
5284,425,statin,I-Drug
5285,425,load,O
5286,425,<,O
5287,425,24,O
5288,425,hours,O
5289,425,prior,O
5290,425,to,O
5291,425,procedure,O
5292,426,Use,O
5293,426,of,O
5294,426,oral,B-Drug
5295,426,steroids,I-Drug
5296,426,or,O
5297,426,non,B-Drug
5298,426,-,I-Drug
5299,426,steroidal,I-Drug
5300,426,anti,I-Drug
5301,426,-,I-Drug
5302,426,inflammatory,I-Drug
5303,426,agents,I-Drug
5304,426,other,O
5305,426,than,O
5306,426,aspirin,B-Drug
5307,426,within,O
5308,426,72,O
5309,426,hours,O
5310,426,or,O
5311,426,3,O
5312,426,times,O
5313,426,the,O
5314,426,agent,O
5315,426,'s,O
5316,426,half,O
5317,426,-,O
5318,426,life,O
5319,426,(,O
5320,426,whichever,O
5321,426,is,O
5322,426,longer,O
5323,426,),O
5324,427,Use,O
5325,427,of,O
5326,427,strong,B-Drug
5327,427,CYP3A4,I-Drug
5328,427,/,I-Drug
5329,427,P,I-Drug
5330,427,-,I-Drug
5331,427,glycoprotein,I-Drug
5332,427,inhibitors,I-Drug
5333,427,(,O
5334,427,specifically,O
5335,427,ritonavir,B-Drug
5336,427,",",O
5337,427,ketoconazole,B-Drug
5338,427,",",O
5339,427,clarithromycin,B-Drug
5340,427,",",O
5341,427,cyclosporine,B-Drug
5342,427,",",O
5343,427,diltiazem,B-Drug
5344,427,and,O
5345,427,verapamil,B-Drug
5346,427,),O
5347,428,Unable,O
5348,428,to,O
5349,428,consent,O
5350,429,Participating,O
5351,429,in,O
5352,429,a,O
5353,429,competing,O
5354,429,study,O
5355,430,Patients,O
5356,430,must,O
5357,430,be,O
5358,430,more,O
5359,430,than,O
5360,430,18,O
5361,430,years,O
5362,430,of,O
5363,430,age,B-Person
5364,430,and,O
5365,430,referred,B-Mood
5366,430,for,I-Mood
5367,430,coronary,B-Procedure
5368,430,angiography,I-Procedure
5369,431,Renal,B-Condition
5370,431,disease,I-Condition
5371,431,unrelated,O
5372,431,to,O
5373,431,SLE,B-Condition
5374,431,(,O
5375,431,e.g.,O
5376,431,diabetes,B-Condition
5377,431,mellitus,I-Condition
5378,431,",",O
5379,431,other,O
5380,431,glomerular,B-Condition
5381,431,or,I-Condition
5382,431,tubulointerstitial,I-Condition
5383,431,disease,I-Condition
5384,431,",",O
5385,431,renovascular,B-Condition
5386,431,disease,I-Condition
5387,431,),O
5388,431,",",O
5389,431,or,O
5390,431,transplanted,B-Procedure
5391,431,kidney,I-Procedure
5392,431,.,O
5393,432,Estimated,O
5394,432,glomerular,O
5395,432,filtration,O
5396,432,rate,O
5397,432,(,O
5398,432,eGFR,O
5399,432,by,O
5400,432,MDRD,O
5401,432,),O
5402,432,=,O
5403,432,20,O
5404,432,mL,O
5405,432,/,O
5406,432,min,O
5407,432,per,O
5408,432,1.73,O
5409,432,m2,O
5410,432,or,O
5411,432,serum,O
5412,432,creatinine,O
5413,432,>,O
5414,432,300,O
5415,432,micromol,O
5416,432,/,O
5417,432,L,O
5418,432,(,O
5419,432,3.39,O
5420,432,mg,O
5421,432,/,O
5422,432,dL,O
5423,432,),O
5424,432,at,O
5425,432,screening,O
5426,432,.,O
5427,433,Renal,B-Procedure
5428,433,biopsy,I-Procedure
5429,433,showing,O
5430,433,cellular,B-Condition
5431,433,or,I-Condition
5432,433,fibrocellular,I-Condition
5433,433,crescent,I-Condition
5434,433,in,O
5435,433,more,O
5436,433,than,O
5437,433,25,O
5438,433,%,O
5439,433,of,O
5440,433,glomeruli,O
5441,433,.,O
5442,434,CNS,O
5443,434,or,O
5444,434,other,O
5445,434,severe,O
5446,434,organ,O
5447,434,manifestation,O
5448,434,of,O
5449,434,lupus,B-Condition
5450,434,that,O
5451,434,necessitate,O
5452,434,aggressive,O
5453,434,immunosuppressive,B-Procedure
5454,434,therapy,I-Procedure
5455,434,on,O
5456,434,its,O
5457,434,own,O
5458,434,.,O
5459,435,Co,B-Condition
5460,435,-,I-Condition
5461,435,morbidities,I-Condition
5462,435,that,O
5463,435,require,O
5464,435,corticosteroid,B-Drug
5465,435,therapy,I-Drug
5466,435,(,O
5467,435,e.g.,O
5468,435,asthma,B-Condition
5469,435,",",O
5470,435,inflammatory,B-Condition
5471,435,bowel,I-Condition
5472,435,disease,I-Condition
5473,435,),O
5474,435,.,O
5475,436,Treatment,O
5476,436,with,O
5477,436,prednisolone,B-Drug
5478,436,(,O
5479,436,or,O
5480,436,prednisone,B-Drug
5481,436,",",I-Drug
5482,436,or,I-Drug
5483,436,equivalent,I-Drug
5484,436,),O
5485,436,at,O
5486,436,>,O
5487,436,20,O
5488,436,mg,O
5489,436,/,O
5490,436,D,O
5491,436,for,O
5492,436,over,O
5493,436,4,O
5494,436,weeks,O
5495,436,within,O
5496,436,the,O
5497,436,past,O
5498,436,3,O
5499,436,months,O
5500,436,.,O
5501,437,Treatment,O
5502,437,with,O
5503,437,MMF,B-Drug
5504,437,at,O
5505,437,>,O
5506,437,1.5,O
5507,437,g,O
5508,437,/,O
5509,437,D,O
5510,437,for,O
5511,437,over,O
5512,437,4,O
5513,437,weeks,O
5514,437,within,O
5515,437,the,O
5516,437,past,O
5517,437,3,O
5518,437,months,O
5519,437,.,O
5520,438,Known,O
5521,438,hypersensitivity,B-Condition
5522,438,or,O
5523,438,intolerability,B-Condition
5524,438,to,O
5525,438,prednisolone,B-Drug
5526,438,(,O
5527,438,or,O
5528,438,prednisone,B-Drug
5529,438,",",I-Drug
5530,438,or,I-Drug
5531,438,equivalent,I-Drug
5532,438,),O
5533,438,",",O
5534,438,TAC,B-Drug
5535,438,",",O
5536,438,or,O
5537,438,MMF,B-Drug
5538,438,at,O
5539,438,a,O
5540,438,dose,O
5541,438,of,O
5542,438,1.25,O
5543,438,g,O
5544,438,or,O
5545,438,below,O
5546,438,per,O
5547,438,day,O
5548,438,.,O
5549,439,Subjects,O
5550,439,who,O
5551,439,are,O
5552,439,already,O
5553,439,on,O
5554,439,treatment,O
5555,439,with,O
5556,439,TAC,B-Drug
5557,439,",",O
5558,439,cyclosporine,B-Drug
5559,439,or,O
5560,439,any,O
5561,439,other,O
5562,439,calcineurin,B-Drug
5563,439,inhibitor,I-Drug
5564,439,for,O
5565,439,over,O
5566,439,4,O
5567,439,weeks,O
5568,439,within,O
5569,439,the,O
5570,439,past,O
5571,439,12,O
5572,439,months,O
5573,439,.,O
5574,440,Treatment,O
5575,440,with,O
5576,440,cyclophosphamide,B-Drug
5577,440,",",O
5578,440,leflunomide,B-Drug
5579,440,",",O
5580,440,or,O
5581,440,methotrexate,B-Drug
5582,440,for,O
5583,440,over,O
5584,440,2,O
5585,440,weeks,O
5586,440,",",O
5587,440,or,O
5588,440,use,O
5589,440,of,O
5590,440,biological,B-Procedure
5591,440,agent(s,I-Procedure
5592,440,),O
5593,440,regardless,O
5594,440,of,O
5595,440,duration,O
5596,440,",",O
5597,440,within,O
5598,440,the,O
5599,440,past,O
5600,440,6,O
5601,440,months,O
5602,440,(,O
5603,440,Note,O
5604,440,:,O
5605,440,prior,O
5606,440,use,O
5607,440,of,O
5608,440,azathioprine,B-Drug
5609,440,",",O
5610,440,mizoribine,B-Drug
5611,440,",",O
5612,440,intravenous,O
5613,440,immunoglobulins,B-Drug
5614,440,and,O
5615,440,anti,B-Drug
5616,440,-,I-Drug
5617,440,malarials,I-Drug
5618,440,is,O
5619,440,allowed,O
5620,440,),O
5621,440,.,O
5622,441,Uncontrolled,O
5623,441,hypertension,B-Condition
5624,441,with,O
5625,441,systolic,O
5626,441,BP,O
5627,441,>,O
5628,441,160,O
5629,441,mmHg,O
5630,441,or,O
5631,441,diastolic,O
5632,441,BP,O
5633,441,>,O
5634,441,95,O
5635,441,mmHg,O
5636,441,.,O
5637,442,Women,O
5638,442,who,O
5639,442,are,O
5640,442,pregnant,O
5641,442,or,O
5642,442,breastfeeding,O
5643,442,.,O
5644,443,Women,O
5645,443,with,O
5646,443,childbearing,O
5647,443,potential,O
5648,443,or,O
5649,443,their,O
5650,443,male,O
5651,443,partners,O
5652,443,",",O
5653,443,who,O
5654,443,refuse,O
5655,443,to,O
5656,443,use,O
5657,443,an,O
5658,443,effective,O
5659,443,birth,O
5660,443,control,O
5661,443,method,O
5662,444,Biopsy,O
5663,444,-,O
5664,444,proven,O
5665,444,LN,B-Condition
5666,444,Class,O
5667,444,III,O
5668,444,/,O
5669,444,IV±V,O
5670,444,(,O
5671,444,ISN,O
5672,444,/,O
5673,444,RPS,O
5674,444,2003,O
5675,444,),O
5676,444,",",O
5677,444,with,O
5678,444,biopsy,B-Procedure
5679,444,performed,O
5680,444,within,O
5681,444,12,O
5682,444,weeks,O
5683,444,of,O
5684,444,randomization,O
5685,444,.,O
5686,445,Positive,O
5687,445,anti,O
5688,445,-,O
5689,445,dsDNA,O
5690,445,.,O
5691,446,Active,O
5692,446,LN,B-Condition
5693,446,with,O
5694,446,proteinuria,B-Condition
5695,446,(,O
5696,446,urine,O
5697,446,protein,O
5698,446,/,O
5699,446,creatinine,O
5700,446,ratio,O
5701,446,>,O
5702,446,1.0,O
5703,446,or,O
5704,446,24,O
5705,446,-,O
5706,446,hr,O
5707,446,urine,O
5708,446,protein,O
5709,446,>,O
5710,446,1.0,O
5711,446,g,O
5712,446,at,O
5713,446,baseline,O
5714,446,),O
5715,446,",",O
5716,446,with,O
5717,446,or,O
5718,446,without,O
5719,446,hematuria,B-Condition
5720,446,.,O
5721,447,Both,O
5722,447,',O
5723,447,incident,O
5724,447,',O
5725,447,(,O
5726,447,i.e.,O
5727,447,new,O
5728,447,),O
5729,447,patients,O
5730,447,and,O
5731,447,',O
5732,447,flare,O
5733,447,',O
5734,447,patients,O
5735,447,can,O
5736,447,be,O
5737,447,included,O
5738,447,.,O
5739,448,NA,O
5740,449,At,O
5741,449,least,O
5742,449,18,O
5743,449,years,O
5744,449,of,O
5745,449,age,B-Person
5746,450,Signed,O
5747,450,informed,O
5748,450,consent,O
5749,451,African,O
5750,451,American,O
5751,451,race,B-Person
5752,452,History,O
5753,452,of,O
5754,452,a,O
5755,452,solitary,O
5756,452,renal,B-Procedure
5757,452,transplant,I-Procedure
5758,453,Stable,O
5759,453,tacrolimus,B-Drug
5760,453,dose,O
5761,453,for,O
5762,453,at,O
5763,453,least,O
5764,453,2,O
5765,453,weeks,O
5766,453,prior,O
5767,453,to,O
5768,453,randomization,O
5769,454,underlying,O
5770,454,lung,B-Condition
5771,454,or,I-Condition
5772,454,heart,I-Condition
5773,454,disase,I-Condition
5774,455,contra,B-Condition
5775,455,indication,I-Condition
5776,455,to,O
5777,455,dexamethasone,B-Drug
5778,456,immune,B-Condition
5779,456,deficient,I-Condition
5780,456,state,I-Condition
5781,457,preterm,B-Condition
5782,457,birth,I-Condition
5783,458,previous,O
5784,458,intubation,B-Procedure
5785,458,or,O
5786,458,apnea,B-Condition
5787,458,history,B-Observation
5788,459,croup,O
5789,459,children,B-Person
5790,459,between,O
5791,459,6,O
5792,459,month,O
5793,459,and,O
5794,459,5,O
5795,459,years,O
5796,459,old,B-Person
5797,460,Westley,O
5798,460,croup,O
5799,460,score,O
5800,460,between,O
5801,460,3,O
5802,460,and,O
5803,460,11,O
5804,461,Is,O
5805,461,currently,O
5806,461,participating,O
5807,461,or,O
5808,461,has,O
5809,461,participated,O
5810,461,in,O
5811,461,a,O
5812,461,study,O
5813,461,with,O
5814,461,an,O
5815,461,investigational,O
5816,461,agent,O
5817,461,or,O
5818,461,using,O
5819,461,an,O
5820,461,investigational,O
5821,461,device,O
5822,461,within,O
5823,461,4,O
5824,461,weeks,O
5825,461,of,O
5826,461,the,O
5827,461,first,O
5828,461,dose,O
5829,461,of,O
5830,461,study,O
5831,461,medication,O
5832,462,Has,O
5833,462,received,O
5834,462,sorafenib,B-Drug
5835,462,or,O
5836,462,oxaliplatin,B-Drug
5837,462,-,O
5838,462,based,O
5839,462,chemotherapy,B-Procedure
5840,462,within,O
5841,462,14,O
5842,462,days,O
5843,462,of,O
5844,462,first,O
5845,462,dose,O
5846,462,of,O
5847,462,study,O
5848,462,medication,O
5849,463,Has,O
5850,463,had,O
5851,463,esophageal,B-Condition
5852,463,or,I-Condition
5853,463,gastric,I-Condition
5854,463,variceal,I-Condition
5855,463,bleeding,I-Condition
5856,463,within,O
5857,463,the,O
5858,463,last,O
5859,463,6,O
5860,463,months,O
5861,464,Has,O
5862,464,clinically,O
5863,464,apparent,O
5864,464,ascites,B-Condition
5865,464,on,O
5866,464,physical,O
5867,464,examination,O
5868,465,Has,O
5869,465,portal,B-Condition
5870,465,vein,I-Condition
5871,465,invasion,I-Condition
5872,465,at,O
5873,465,the,O
5874,465,main,O
5875,465,portal,O
5876,465,branch,O
5877,465,(,O
5878,465,Vp4,O
5879,465,),O
5880,465,",",O
5881,465,inferior,O
5882,465,vena,O
5883,465,cava,O
5884,465,",",O
5885,465,or,O
5886,465,cardiac,B-Condition
5887,465,involvement,I-Condition
5888,465,of,O
5889,465,HCC,B-Condition
5890,465,based,O
5891,465,on,O
5892,465,imaging,B-Procedure
5893,466,Has,O
5894,466,had,O
5895,466,clinically,O
5896,466,diagnosed,O
5897,466,hepatic,B-Condition
5898,466,encephalopathy,I-Condition
5899,466,in,O
5900,466,the,O
5901,466,last,O
5902,466,6,O
5903,466,months,O
5904,467,Has,O
5905,467,had,O
5906,467,a,O
5907,467,solid,B-Procedure
5908,467,organ,I-Procedure
5909,467,or,I-Procedure
5910,467,hematologic,I-Procedure
5911,467,transplant,I-Procedure
5912,468,Has,O
5913,468,had,O
5914,468,prior,O
5915,468,systemic,B-Procedure
5916,468,therapy,I-Procedure
5917,468,for,O
5918,468,HCC,B-Condition
5919,468,in,O
5920,468,the,O
5921,468,advanced,O
5922,468,(,O
5923,468,incurable,O
5924,468,),O
5925,468,setting,O
5926,468,other,O
5927,468,than,O
5928,468,sorafenib,B-Drug
5929,468,or,O
5930,468,oxaliplatin,B-Drug
5931,468,-,O
5932,468,based,O
5933,468,chemotherapy,B-Procedure
5934,468,",",O
5935,468,prior,O
5936,468,to,O
5937,468,start,O
5938,468,of,O
5939,468,study,O
5940,468,medication,O
5941,469,Has,O
5942,469,an,O
5943,469,active,O
5944,469,autoimmune,B-Condition
5945,469,disease,I-Condition
5946,469,that,O
5947,469,has,O
5948,469,required,O
5949,469,systemic,B-Procedure
5950,469,treatment,I-Procedure
5951,469,in,O
5952,469,the,O
5953,469,past,O
5954,469,2,O
5955,469,years,O
5956,469,.,O
5957,469,Replacement,O
5958,469,therapy,O
5959,469,is,O
5960,469,not,O
5961,469,considered,O
5962,469,a,O
5963,469,form,O
5964,469,of,O
5965,469,systemic,O
5966,469,treatment,O
5967,469,.,O
5968,470,Has,O
5969,470,a,O
5970,470,diagnosis,O
5971,470,of,O
5972,470,immunodeficiency,B-Condition
5973,470,or,O
5974,470,is,O
5975,470,receiving,O
5976,470,systemic,B-Procedure
5977,470,steroid,I-Procedure
5978,470,therapy,I-Procedure
5979,470,or,O
5980,470,any,O
5981,470,other,O
5982,470,form,O
5983,470,of,O
5984,470,immunosuppressive,B-Procedure
5985,470,therapy,I-Procedure
5986,470,within,O
5987,470,7,O
5988,470,days,O
5989,470,prior,O
5990,470,to,O
5991,470,the,O
5992,470,first,O
5993,470,dose,O
5994,470,of,O
5995,470,study,O
5996,470,medication,O
5997,471,Has,O
5998,471,received,O
5999,471,locoregional,B-Procedure
6000,471,therapy,I-Procedure
6001,471,to,O
6002,471,liver,O
6003,471,(,O
6004,471,transcatheter,B-Procedure
6005,471,chemoembolization,I-Procedure
6006,471,[,I-Procedure
6007,471,TACE,I-Procedure
6008,471,],I-Procedure
6009,471,",",O
6010,471,transcatheter,B-Procedure
6011,471,embolization,I-Procedure
6012,471,[,I-Procedure
6013,471,TAE,I-Procedure
6014,471,],I-Procedure
6015,471,",",O
6016,471,hepatic,B-Procedure
6017,471,arterial,I-Procedure
6018,471,infusion,I-Procedure
6019,471,[,I-Procedure
6020,471,HAI,I-Procedure
6021,471,],I-Procedure
6022,471,",",O
6023,471,radiation,B-Procedure
6024,471,",",O
6025,471,radioembolization,B-Procedure
6026,471,",",O
6027,471,or,O
6028,471,ablation,B-Procedure
6029,471,),O
6030,471,or,O
6031,471,other,O
6032,471,site,O
6033,471,within,O
6034,471,4,O
6035,471,weeks,O
6036,471,prior,O
6037,471,to,O
6038,471,the,O
6039,471,first,O
6040,471,dose,O
6041,471,of,O
6042,471,study,O
6043,471,medication,O
6044,472,Has,O
6045,472,had,O
6046,472,major,B-Procedure
6047,472,surgery,I-Procedure
6048,472,to,O
6049,472,liver,O
6050,472,or,O
6051,472,other,O
6052,472,site,O
6053,472,within,O
6054,472,4,O
6055,472,weeks,O
6056,472,prior,O
6057,472,to,O
6058,472,the,O
6059,472,first,O
6060,472,dose,O
6061,472,of,O
6062,472,study,O
6063,472,medication,O
6064,473,Has,O
6065,473,had,O
6066,473,a,O
6067,473,minor,B-Procedure
6068,473,surgery,I-Procedure
6069,473,≤7,O
6070,473,days,O
6071,473,prior,O
6072,473,to,O
6073,473,the,O
6074,473,first,O
6075,473,dose,O
6076,473,of,O
6077,473,study,O
6078,473,medication,O
6079,474,Has,O
6080,474,not,O
6081,474,recovered,O
6082,474,adequately,O
6083,474,(,O
6084,474,i.e.,O
6085,474,",",O
6086,474,Grade,O
6087,474,≤1,O
6088,474,or,O
6089,474,baseline,O
6090,474,),O
6091,474,from,O
6092,474,the,O
6093,474,toxicity,O
6094,474,and/or,O
6095,474,complications,O
6096,474,from,O
6097,474,any,O
6098,474,intervention,O
6099,474,prior,O
6100,474,to,O
6101,474,study,O
6102,474,start,O
6103,475,Has,O
6104,475,a,O
6105,475,diagnosed,O
6106,475,additional,O
6107,475,malignancy,B-Condition
6108,475,within,O
6109,475,3,O
6110,475,years,O
6111,475,prior,O
6112,475,to,O
6113,475,first,O
6114,475,dose,O
6115,475,of,O
6116,475,study,O
6117,475,medication,O
6118,475,with,O
6119,475,the,O
6120,475,exception,O
6121,475,of,O
6122,475,curatively,O
6123,475,treated,B-Procedure
6124,475,basal,B-Condition
6125,475,cell,I-Condition
6126,475,carcinoma,I-Condition
6127,475,of,I-Condition
6128,475,the,I-Condition
6129,475,skin,I-Condition
6130,475,",",O
6131,475,squamous,B-Condition
6132,475,cell,I-Condition
6133,475,carcinoma,I-Condition
6134,475,of,I-Condition
6135,475,the,I-Condition
6136,475,skin,I-Condition
6137,475,and/or,O
6138,475,curatively,O
6139,475,resected,B-Procedure
6140,475,in,B-Condition
6141,475,situ,I-Condition
6142,475,cancers,I-Condition
6143,476,Has,O
6144,476,a,O
6145,476,known,O
6146,476,history,B-Observation
6147,476,of,O
6148,476,",",O
6149,476,or,O
6150,476,any,O
6151,476,evidence,B-Observation
6152,476,of,O
6153,476,",",O
6154,476,central,B-Condition
6155,476,nervous,I-Condition
6156,476,system,I-Condition
6157,476,(,I-Condition
6158,476,CNS,I-Condition
6159,476,),I-Condition
6160,476,metastases,I-Condition
6161,476,and/or,O
6162,476,carcinomatous,B-Condition
6163,476,meningitis,I-Condition
6164,477,Has,O
6165,477,a,O
6166,477,history,B-Observation
6167,477,of,O
6168,477,(,O
6169,477,non,B-Condition
6170,477,-,I-Condition
6171,477,infectious,I-Condition
6172,477,),I-Condition
6173,477,pneumonitis,I-Condition
6174,477,that,O
6175,477,required,O
6176,477,steroids,B-Drug
6177,477,or,O
6178,477,current,O
6179,477,pneumonitis,B-Drug
6180,478,Has,O
6181,478,an,O
6182,478,active,O
6183,478,infection,B-Condition
6184,478,requiring,O
6185,478,systemic,B-Procedure
6186,478,therapy,I-Procedure
6187,479,Is,O
6188,479,pregnant,B-Condition
6189,479,or,O
6190,479,breast,B-Observation
6191,479,feeding,I-Observation
6192,479,or,O
6193,479,expecting,B-Observation
6194,479,to,I-Observation
6195,479,conceive,I-Observation
6196,479,or,I-Observation
6197,479,father,I-Observation
6198,479,starting,O
6199,479,from,O
6200,479,the,O
6201,479,first,O
6202,479,dose,O
6203,479,of,O
6204,479,study,O
6205,479,medication,O
6206,479,",",O
6207,479,throughout,O
6208,479,the,O
6209,479,study,O
6210,479,period,O
6211,479,",",O
6212,479,and,O
6213,479,for,O
6214,479,up,O
6215,479,to,O
6216,479,120,O
6217,479,days,O
6218,479,after,O
6219,479,the,O
6220,479,last,O
6221,479,dose,O
6222,479,of,O
6223,479,study,O
6224,479,medication,O
6225,480,Has,O
6226,480,received,O
6227,480,prior,O
6228,480,immunotherapy,B-Procedure
6229,480,with,O
6230,480,an,O
6231,480,anti,B-Drug
6232,480,-,I-Drug
6233,480,Programmed,I-Drug
6234,480,Cell,I-Drug
6235,480,Death,I-Drug
6236,480,Receptor,I-Drug
6237,480,1,I-Drug
6238,480,(,I-Drug
6239,480,PD-1,I-Drug
6240,480,),I-Drug
6241,480,",",O
6242,480,Programmed,B-Drug
6243,480,Cell,I-Drug
6244,480,Death,I-Drug
6245,480,Receptor,I-Drug
6246,480,Ligand,I-Drug
6247,480,1,I-Drug
6248,480,(,I-Drug
6249,480,anti,I-Drug
6250,480,-,I-Drug
6251,480,PD,I-Drug
6252,480,-,I-Drug
6253,480,L1,I-Drug
6254,480,),I-Drug
6255,480,",",O
6256,480,or,O
6257,480,anti-,B-Drug
6258,480,Programmed,I-Drug
6259,480,Cell,I-Drug
6260,480,Death,I-Drug
6261,480,Receptor,I-Drug
6262,480,Ligand,I-Drug
6263,480,2,I-Drug
6264,480,(,I-Drug
6265,480,PD,I-Drug
6266,480,-,I-Drug
6267,480,L2,I-Drug
6268,480,),I-Drug
6269,480,or,O
6270,480,has,O
6271,480,previously,O
6272,480,participated,B-Observation
6273,480,in,I-Observation
6274,480,clinical,I-Observation
6275,480,studies,I-Observation
6276,480,with,I-Observation
6277,480,pembrolizumab,I-Observation
6278,481,Has,O
6279,481,a,O
6280,481,known,O
6281,481,history,B-Observation
6282,481,of,O
6283,481,human,B-Condition
6284,481,immunodeficiency,I-Condition
6285,481,virus,I-Condition
6286,481,(,I-Condition
6287,481,HIV,I-Condition
6288,481,),I-Condition
6289,482,Has,O
6290,482,untreated,O
6291,482,active,O
6292,482,Hepatitis,B-Condition
6293,482,B,I-Condition
6294,483,Has,O
6295,483,hepatitis,B-Condition
6296,483,C,I-Condition
6297,483,in,O
6298,483,which,O
6299,483,participants,O
6300,483,received,O
6301,483,therapy,B-Procedure
6302,483,for,I-Procedure
6303,483,HCV,I-Procedure
6304,483,<,O
6305,483,4,O
6306,483,weeks,O
6307,483,prior,O
6308,483,to,O
6309,483,receiving,O
6310,483,pembrolizumab,B-Drug
6311,484,Has,O
6312,484,received,O
6313,484,a,O
6314,484,live,B-Condition
6315,484,vaccine,I-Condition
6316,484,within,O
6317,484,30,O
6318,484,days,O
6319,484,prior,O
6320,484,to,O
6321,484,the,O
6322,484,first,O
6323,484,dose,O
6324,484,of,O
6325,484,study,O
6326,484,therapy,O
6327,485,Has,O
6328,485,a,O
6329,485,HCC,B-Condition
6330,485,diagnosis,O
6331,485,confirmed,O
6332,485,by,O
6333,485,radiology,B-Procedure
6334,485,",",O
6335,485,histology,B-Procedure
6336,485,",",O
6337,485,or,O
6338,485,cytology,B-Procedure
6339,485,(,O
6340,485,fibrolamellar,O
6341,485,",",O
6342,485,and,O
6343,485,mixed,B-Condition
6344,485,hepatocellular,I-Condition
6345,485,/,I-Condition
6346,485,cholangiocarcinoma,I-Condition
6347,485,subtypes,I-Condition
6348,485,are,O
6349,485,not,O
6350,485,eligible,O
6351,485,),O
6352,486,Has,O
6353,486,Barcelona,O
6354,486,Clinic,O
6355,486,Liver,O
6356,486,Cancer,O
6357,486,(,O
6358,486,BCLC,O
6359,486,),O
6360,486,Stage,O
6361,486,C,O
6362,486,disease,B-Condition
6363,486,or,O
6364,486,BCLC,O
6365,486,Stage,O
6366,486,B,O
6367,486,disease,B-Condition
6368,486,not,O
6369,486,amenable,O
6370,486,to,O
6371,486,locoregional,O
6372,486,therapy,O
6373,486,or,O
6374,486,refractory,O
6375,486,to,O
6376,486,locoregional,O
6377,486,therapy,O
6378,486,and,O
6379,486,not,O
6380,486,amenable,O
6381,486,to,O
6382,486,a,O
6383,486,curative,O
6384,486,treatment,O
6385,486,approach,O
6386,487,Has,O
6387,487,a,O
6388,487,Child,O
6389,487,-,O
6390,487,Pugh,O
6391,487,A,O
6392,487,liver,O
6393,487,score,O
6394,487,within,O
6395,487,7,O
6396,487,days,O
6397,487,prior,O
6398,487,to,O
6399,487,first,O
6400,487,dose,O
6401,487,of,O
6402,487,study,O
6403,487,medication,O
6404,488,Has,O
6405,488,a,O
6406,488,life,B-Observation
6407,488,expectancy,I-Observation
6408,488,of,O
6409,488,>,O
6410,488,3,O
6411,488,months,O
6412,489,Has,O
6413,489,at,O
6414,489,least,O
6415,489,one,O
6416,489,measurable,O
6417,489,lesion,B-Condition
6418,489,based,O
6419,489,on,O
6420,489,RECIST,O
6421,489,version,O
6422,489,1.1,O
6423,489,as,O
6424,489,determined,O
6425,489,by,O
6426,489,investigator,O
6427,490,Has,O
6428,490,Eastern,O
6429,490,Cooperative,O
6430,490,Oncology,O
6431,490,Group,O
6432,490,(,O
6433,490,ECOG,O
6434,490,),O
6435,490,performance,O
6436,490,status,O
6437,490,of,O
6438,490,0,O
6439,490,or,O
6440,490,1,O
6441,490,performed,O
6442,490,within,O
6443,490,7,O
6444,490,days,O
6445,490,prior,O
6446,490,to,O
6447,490,receiving,O
6448,490,the,O
6449,490,first,O
6450,490,dose,O
6451,490,of,O
6452,490,study,O
6453,490,medication,O
6454,491,Has,O
6455,491,documented,O
6456,491,objective,B-Observation
6457,491,radiographic,I-Observation
6458,491,progression,I-Observation
6459,491,during,O
6460,491,or,O
6461,491,after,O
6462,491,treatment,O
6463,491,with,O
6464,491,sorafenib,B-Drug
6465,491,or,O
6466,491,oxaliplatin,B-Drug
6467,491,-,O
6468,491,based,O
6469,491,chemotherapy,B-Procedure
6470,491,",",O
6471,491,or,O
6472,491,else,O
6473,491,intolerance,B-Condition
6474,491,to,O
6475,491,sorafenib,B-Drug
6476,491,or,O
6477,491,oxaliplatin,B-Drug
6478,491,-,O
6479,491,based,O
6480,491,chemotherapy,B-Procedure
6481,492,Female,B-Person
6482,492,participants,O
6483,492,of,O
6484,492,childbearing,B-Condition
6485,492,potential,I-Condition
6486,492,must,O
6487,492,have,O
6488,492,a,O
6489,492,negative,O
6490,492,urine,O
6491,492,or,O
6492,492,serum,O
6493,492,pregnancy,O
6494,492,test,O
6495,492,within,O
6496,492,72,O
6497,492,hours,O
6498,492,prior,O
6499,492,to,O
6500,492,receiving,O
6501,492,the,O
6502,492,first,O
6503,492,dose,O
6504,492,of,O
6505,492,study,O
6506,492,therapy,O
6507,493,Female,B-Person
6508,493,and,O
6509,493,male,B-Person
6510,493,participants,O
6511,493,of,O
6512,493,reproductive,B-Condition
6513,493,potential,I-Condition
6514,493,must,O
6515,493,agree,O
6516,493,to,O
6517,493,use,O
6518,493,adequate,B-Procedure
6519,493,contraception,I-Procedure
6520,493,starting,O
6521,493,from,O
6522,493,the,O
6523,493,first,O
6524,493,dose,O
6525,493,of,O
6526,493,study,O
6527,493,medication,O
6528,493,",",O
6529,493,throughout,O
6530,493,the,O
6531,493,study,O
6532,493,period,O
6533,493,",",O
6534,493,and,O
6535,493,for,O
6536,493,up,O
6537,493,to,O
6538,493,120,O
6539,493,days,O
6540,493,after,O
6541,493,the,O
6542,493,last,O
6543,493,dose,O
6544,493,of,O
6545,493,study,O
6546,493,medication,O
6547,494,age,B-Person
6548,494,>,O
6549,494,80,O
6550,494,years,O
6551,494,;,O
6552,495,Kellgren,O
6553,495,-,O
6554,495,Lawrence,O
6555,495,score,O
6556,495,at,O
6557,495,X,B-Procedure
6558,495,-,I-Procedure
6559,495,ray,I-Procedure
6560,495,evaluation,I-Procedure
6561,495,>,O
6562,495,3,O
6563,495,;,O
6564,496,major,B-Condition
6565,496,axial,I-Condition
6566,496,deviation,I-Condition
6567,496,(,O
6568,496,varus,O
6569,496,>,O
6570,496,5,O
6571,496,°,O
6572,496,",",O
6573,496,valgus,O
6574,496,>,O
6575,496,5,O
6576,496,°,O
6577,496,),O
6578,496,",",O
6579,497,systemic,B-Condition
6580,497,disorders,I-Condition
6581,497,such,O
6582,497,as,O
6583,497,diabetes,B-Condition
6584,497,",",O
6585,497,rheumatoid,B-Condition
6586,497,arthritis,I-Condition
6587,497,",",O
6588,497,haematological,B-Condition
6589,497,diseases,I-Condition
6590,497,(,O
6591,497,coagulopathy,B-Condition
6592,497,),O
6593,497,",",O
6594,497,severe,O
6595,497,cardiovascular,B-Condition
6596,497,diseases,I-Condition
6597,497,",",O
6598,497,infections,B-Condition
6599,497,",",O
6600,497,immunodepression,B-Condition
6601,497,;,O
6602,498,patients,O
6603,498,in,O
6604,498,therapy,B-Procedure
6605,498,with,O
6606,498,anticoagulants,B-Drug
6607,498,or,O
6608,498,antiaggregants,B-Drug
6609,498,;,O
6610,499,use,O
6611,499,of,O
6612,499,NSAIDs,B-Drug
6613,499,in,O
6614,499,the,O
6615,499,5,O
6616,499,days,O
6617,499,before,O
6618,499,blood,O
6619,499,donation,O
6620,499,;,O
6621,500,patients,O
6622,500,with,O
6623,500,Hb,O
6624,500,values,O
6625,500,<,O
6626,500,11,O
6627,500,g,O
6628,500,/,O
6629,500,dl,O
6630,500,and,O
6631,500,platelet,O
6632,500,values,O
6633,500,<,O
6634,500,"150,000",O
6635,500,/,O
6636,500,mmc,O
6637,500,.,O
6638,501,patients,O
6639,501,affected,O
6640,501,by,O
6641,501,mono,O
6642,501,-,O
6643,501,lateral,O
6644,501,symptomatic,O
6645,501,knee,B-Condition
6646,501,articular,I-Condition
6647,501,degenerative,I-Condition
6648,501,pathology,I-Condition
6649,501,with,O
6650,501,history,O
6651,501,of,O
6652,501,chronic,O
6653,501,(,O
6654,501,for,O
6655,501,at,O
6656,501,least,O
6657,501,4,O
6658,501,months,O
6659,501,),O
6660,501,pain,B-Condition
6661,501,or,O
6662,501,swelling,B-Condition
6663,501,;,O
6664,502,imaging,B-Procedure
6665,502,findings,O
6666,502,of,O
6667,502,degenerative,B-Condition
6668,502,changes,I-Condition
6669,502,of,O
6670,502,the,O
6671,502,joint,O
6672,502,(,O
6673,502,osteoarthritis,B-Condition
6674,502,or,O
6675,502,chondropathy,B-Condition
6676,502,with,O
6677,502,Kellgren,O
6678,502,Lawrence,O
6679,502,Score,O
6680,502,from,O
6681,502,0,O
6682,502,to,O
6683,502,3,O
6684,502,at,O
6685,502,X,B-Procedure
6686,502,-,I-Procedure
6687,502,ray,I-Procedure
6688,502,evaluation,O
6689,502,),O
6690,502,.,O
6691,503,Patients,O
6692,503,with,O
6693,503,any,O
6694,503,contraindications,B-Condition
6695,503,or,O
6696,503,hypersensitivity,B-Condition
6697,503,related,O
6698,503,to,O
6699,503,antiplatelet,B-Procedure
6700,503,therapy,I-Procedure
6701,504,Patients,O
6702,504,with,O
6703,504,Acute,B-Condition
6704,504,Myocardial,I-Condition
6705,504,Infarction,I-Condition
6706,504,(,O
6707,504,ST,B-Condition
6708,504,elevation,I-Condition
6709,504,myocardial,I-Condition
6710,504,infarction,I-Condition
6711,504,",",O
6712,504,Non,B-Condition
6713,504,ST,I-Condition
6714,504,elevation,I-Condition
6715,504,myocardial,I-Condition
6716,504,infarction,I-Condition
6717,504,),O
6718,505,Patients,O
6719,505,who,O
6720,505,are,O
6721,505,anticipated,B-Mood
6722,505,to,I-Mood
6723,505,receive,O
6724,505,treatment,B-Procedure
6725,505,or,O
6726,505,surgery,B-Procedure
6727,505,that,O
6728,505,may,O
6729,505,require,O
6730,505,desisting,O
6731,505,the,O
6732,505,administration,O
6733,505,of,O
6734,505,antiplatelet,B-Procedure
6735,505,therapy,I-Procedure
6736,505,for,O
6737,505,2,O
6738,505,weeks,O
6739,505,or,O
6740,505,longer,O
6741,505,during,O
6742,505,the,O
6743,505,period,O
6744,505,of,O
6745,505,the,O
6746,505,clinical,O
6747,505,trial,O
6748,506,Chronic,B-Condition
6749,506,total,I-Condition
6750,506,occlusion,I-Condition
6751,506,(,O
6752,506,CTO,B-Condition
6753,506,),O
6754,506,lesions,O
6755,506,",",O
6756,506,in,B-Condition
6757,506,-,I-Condition
6758,506,stent,I-Condition
6759,506,restenosis,I-Condition
6760,506,(,O
6761,506,ISR,B-Condition
6762,506,),O
6763,507,Patients,O
6764,507,experiencing,O
6765,507,cardiogenic,B-Condition
6766,507,shock,I-Condition
6767,508,Women,O
6768,508,who,O
6769,508,are,O
6770,508,breastfeeding,O
6771,508,",",O
6772,508,pregnant,O
6773,508,",",O
6774,508,or,O
6775,508,desiring,O
6776,508,pregnancy,O
6777,509,Patients,O
6778,509,with,O
6779,509,findings,O
6780,509,of,O
6781,509,hemorrhage,B-Condition
6782,510,Patients,O
6783,510,with,O
6784,510,a,O
6785,510,life,B-Observation
6786,510,expectancy,I-Observation
6787,510,of,O
6788,510,less,O
6789,510,than,O
6790,510,1,O
6791,510,year,O
6792,511,Patients,O
6793,511,who,O
6794,511,have,O
6795,511,received,O
6796,511,a,O
6797,511,drug,B-Procedure
6798,511,-,I-Procedure
6799,511,eluting,I-Procedure
6800,511,stent,I-Procedure
6801,511,(,I-Procedure
6802,511,DES,I-Procedure
6803,511,),I-Procedure
6804,511,procedure,I-Procedure
6805,511,within,O
6806,511,the,O
6807,511,past,O
6808,511,6,O
6809,511,months,O
6810,512,Any,O
6811,512,other,O
6812,512,patients,O
6813,512,judged,O
6814,512,by,O
6815,512,the,O
6816,512,investigator,O
6817,512,to,O
6818,512,be,O
6819,512,unsuitable,O
6820,512,for,O
6821,512,the,O
6822,512,trial,O
6823,513,Patients,O
6824,513,aged,B-Person
6825,513,19,O
6826,513,or,O
6827,513,older,O
6828,514,Patients,O
6829,514,who,O
6830,514,have,O
6831,514,submitted,O
6832,514,a,O
6833,514,written,O
6834,514,consent,O
6835,514,to,O
6836,514,participate,O
6837,514,in,O
6838,514,the,O
6839,514,clinical,O
6840,514,trial,O
6841,515,De,B-Condition
6842,515,novo,I-Condition
6843,515,lesion,I-Condition
6844,516,Patients,O
6845,516,scheduled,O
6846,516,for,O
6847,516,elective,O
6848,516,intervention,O
6849,516,to,O
6850,516,treat,O
6851,516,ischemic,O
6852,516,cardiovascular,O
6853,516,disease,O
6854,517,Allergy,B-Condition
6855,517,to,O
6856,517,LA,B-Drug
6857,518,Infection,O
6858,518,in,O
6859,518,or,O
6860,518,near,O
6861,518,insertion,O
6862,518,site,O
6863,518,of,O
6864,518,the,O
6865,518,peripheral,O
6866,518,nerve,O
6867,518,catheter,O
6868,519,Anatomical,B-Condition
6869,519,abnormalities,I-Condition
6870,519,preventing,B-Mood
6871,519,successful,O
6872,519,peripheral,O
6873,519,catheter,O
6874,519,insertion,B-Procedure
6875,520,Habitual,O
6876,520,use,O
6877,520,of,O
6878,520,opioids,B-Drug
6879,521,Pregnancy,B-Condition
6880,521,or,O
6881,521,breastfeeding,B-Observation
6882,521,(,O
6883,521,disproved,O
6884,521,by,O
6885,521,a,O
6886,521,negative,O
6887,521,pregnancy,B-Procedure
6888,521,test,I-Procedure
6889,521,before,O
6890,521,trial,O
6891,521,inclusion,O
6892,521,),O
6893,522,Age,B-Person
6894,522,=,O
6895,522,18,O
6896,522,years,O
6897,523,American,B-Observation
6898,523,Society,I-Observation
6899,523,of,I-Observation
6900,523,Anesthesiologists,I-Observation
6901,523,Classification,I-Observation
6902,523,I,O
6903,523,-,O
6904,523,III,O
6905,524,Normal,O
6906,524,cognitive,O
6907,524,function,O
6908,524,in,O
6909,524,order,O
6910,524,to,O
6911,524,sign,O
6912,524,written,O
6913,524,",",O
6914,524,informed,O
6915,524,consent,O
6916,524,and,O
6917,524,to,O
6918,524,understand,O
6919,524,trial,O
6920,524,protocol,O
6921,525,Agreement,B-Observation
6922,525,to,I-Observation
6923,525,the,I-Observation
6924,525,trial,I-Observation
6925,525,protocol,I-Observation
6926,525,",",I-Observation
6927,525,including,I-Observation
6928,525,the,I-Observation
6929,525,randomized,I-Observation
6930,525,manner,I-Observation
6931,526,History,O
6932,526,of,O
6933,526,intolerance,B-Condition
6934,526,to,O
6935,526,LMWHs,B-Drug
6936,526,during,O
6937,526,HD,B-Procedure
6938,527,Receiving,O
6939,527,warfarin,B-Drug
6940,527,or,O
6941,527,other,O
6942,527,oral,B-Condition
6943,527,anticoagulant,I-Condition
6944,528,Pregnant,B-Condition
6945,528,patients,O
6946,529,Prevalent,O
6947,529,NHHD,B-Condition
6948,529,patients,O
6949,529,who,O
6950,529,have,O
6951,529,received,O
6952,529,>,O
6953,529,1,O
6954,529,year,O
6955,529,dialysis,B-Procedure
6956,529,with,O
6957,529,unfractionated,B-Drug
6958,529,heparin,I-Drug
6959,529,as,O
6960,529,anticoagulant,B-Drug
6961,530,Age,B-Person
6962,530,>,O
6963,530,=,O
6964,530,18,O
6965,531,Informed,O
6966,531,consent,O
6967,531,available,O
6968,532,do,O
6969,532,n't,O
6970,532,have,O
6971,532,Diabetes,B-Condition
6972,532,and,O
6973,532,abnormal,B-Condition
6974,532,metabolism,I-Condition
6975,532,of,I-Condition
6976,532,sugar,I-Condition
6977,533,not,O
6978,533,noticed,B-Mood
6979,533,as,O
6980,533,bipolar,B-Condition
6981,533,disorder,I-Condition
6982,534,have,O
6983,534,an,O
6984,534,organic,B-Condition
6985,534,brain,I-Condition
6986,534,disease,I-Condition
6987,535,pregnant,B-Condition
6988,535,or,O
6989,535,breastfeeding,B-Observation
6990,535,women,B-Person
6991,536,do,O
6992,536,n't,O
6993,536,have,O
6994,536,heart,B-Condition
6995,536,disease,I-Condition
6996,537,have,O
6997,537,actively,B-Condition
6998,537,suicidal,I-Condition
6999,537,thought(Suicidal,I-Condition
7000,537,ideation,O
7001,537,score,O
7002,537,of,O
7003,537,MADRS,O
7004,537,is,O
7005,537,6,O
7006,537,),O
7007,538,who,O
7008,538,are,O
7009,538,judged,B-Observation
7010,538,by,I-Observation
7011,538,the,I-Observation
7012,538,investigator,I-Observation
7013,538,to,I-Observation
7014,538,should,I-Observation
7015,538,be,I-Observation
7016,538,excluded,I-Observation
7017,538,from,I-Observation
7018,538,the,I-Observation
7019,538,study,I-Observation
7020,539,major,B-Condition
7021,539,depressive,I-Condition
7022,539,episode,I-Condition
7023,539,in,O
7024,539,type2,B-Condition
7025,539,bipolar,I-Condition
7026,539,disorder,I-Condition
7027,539,or,O
7028,539,bipolar,B-Condition
7029,539,disorder,I-Condition
7030,539,NOS.(MADRS,O
7031,539,more,O
7032,539,than,O
7033,539,20,O
7034,539,point,O
7035,539,),O
7036,540,18years,O
7037,540,to,O
7038,540,65years,O
7039,541,subjects,O
7040,541,who,O
7041,541,sign,B-Observation
7042,541,the,I-Observation
7043,541,informed,I-Observation
7044,541,consent,I-Observation
7045,541,document,O
7046,542,Ongoing,O
7047,542,serious,O
7048,542,bacterial,B-Condition
7049,542,infections,I-Condition
7050,542,at,O
7051,542,the,O
7052,542,time,O
7053,542,of,O
7054,542,screening,O
7055,542,.,O
7056,543,Other,O
7057,543,significant,O
7058,543,medical,O
7059,543,conditions,O
7060,543,that,O
7061,543,could,O
7062,543,increase,O
7063,543,the,O
7064,543,risk,O
7065,543,to,O
7066,543,the,O
7067,543,subject,O
7068,543,.,O
7069,544,Females,O
7070,544,who,O
7071,544,are,O
7072,544,pregnant,O
7073,544,",",O
7074,544,breast,O
7075,544,feeding,O
7076,544,",",O
7077,544,or,O
7078,544,planning,O
7079,544,a,O
7080,544,pregnancy,O
7081,544,during,O
7082,544,the,O
7083,544,course,O
7084,544,study,O
7085,544,.,O
7086,545,Participation,O
7087,545,in,O
7088,545,a,O
7089,545,study,O
7090,545,with,O
7091,545,an,O
7092,545,Investigational,O
7093,545,Medicinal,O
7094,545,Product,O
7095,545,(,O
7096,545,IMP,O
7097,545,),O
7098,545,other,O
7099,545,than,O
7100,545,IgPro20,O
7101,545,within,O
7102,545,three,O
7103,545,months,O
7104,545,prior,O
7105,545,to,O
7106,545,enrollment,O
7107,545,.,O
7108,546,Male,B-Person
7109,546,or,O
7110,546,female,B-Person
7111,546,on,O
7112,546,stable,O
7113,546,dose,O
7114,546,of,O
7115,546,IgPro20,B-Drug
7116,546,(,O
7117,546,Hizentra,B-Drug
7118,546,),O
7119,546,therapy,O
7120,546,.,O
7121,547,Women,O
7122,547,of,O
7123,547,childbearing,O
7124,547,potential,O
7125,547,must,O
7126,547,be,O
7127,547,using,O
7128,547,and,O
7129,547,agree,O
7130,547,to,O
7131,547,continue,O
7132,547,using,O
7133,547,medically,O
7134,547,approved,O
7135,547,contraception,O
7136,547,(,O
7137,547,which,O
7138,547,must,O
7139,547,be,O
7140,547,discussed,O
7141,547,with,O
7142,547,the,O
7143,547,study,O
7144,547,doctor,O
7145,547,),O
7146,547,and,O
7147,547,must,O
7148,547,have,O
7149,547,a,O
7150,547,negative,O
7151,547,pregnancy,O
7152,547,test,O
7153,547,at,O
7154,547,screening,O
7155,547,.,O
7156,548,Subjects,O
7157,548,with,O
7158,548,PID,B-Condition
7159,548,",",O
7160,548,eg,O
7161,548,",",O
7162,548,with,O
7163,548,a,O
7164,548,diagnosis,O
7165,548,of,O
7166,548,common,B-Condition
7167,548,variable,I-Condition
7168,548,immunodeficiency,I-Condition
7169,548,or,O
7170,548,X,B-Condition
7171,548,-,I-Condition
7172,548,linked,I-Condition
7173,548,agammaglobulinemia,I-Condition
7174,548,",",O
7175,548,as,O
7176,548,defined,O
7177,548,by,O
7178,548,the,O
7179,548,Pan,O
7180,548,American,O
7181,548,Group,O
7182,548,for,O
7183,548,Immune,O
7184,548,Deficiency,O
7185,548,and,O
7186,548,the,O
7187,548,European,O
7188,548,Society,O
7189,548,of,O
7190,548,Immune,O
7191,548,Deficiencies,O
7192,548,.,O
7193,549,With,O
7194,549,infusion,O
7195,549,parameters,O
7196,549,as,O
7197,549,specified,O
7198,549,below,O
7199,549,:,O
7200,550,Experience,O
7201,550,with,O
7202,550,pump,O
7203,550,-,O
7204,550,assisted,O
7205,550,infusions,O
7206,550,of,O
7207,550,IgPro20,B-Drug
7208,550,at,O
7209,550,the,O
7210,550,tolerated,O
7211,550,flow,O
7212,550,rate,O
7213,550,of,O
7214,550,25,O
7215,550,mL,O
7216,550,/,O
7217,550,h,O
7218,550,per,O
7219,550,injection,O
7220,550,site,O
7221,550,for,O
7222,550,at,O
7223,550,least,O
7224,550,1,O
7225,550,month,O
7226,550,prior,O
7227,550,to,O
7228,550,Day,O
7229,550,1,O
7230,550,.,O
7231,551,Total,O
7232,551,weekly,O
7233,551,IgPro20,B-Drug
7234,551,dose,O
7235,551,of,O
7236,551,=,O
7237,551,50,O
7238,551,mL,O
7239,551,(=,O
7240,551,10,O
7241,551,g,O
7242,551,),O
7243,551,.,O
7244,552,Experience,O
7245,552,with,O
7246,552,pump,O
7247,552,-,O
7248,552,assisted,O
7249,552,infusions,O
7250,552,of,O
7251,552,IgPro20,B-Drug
7252,552,at,O
7253,552,tolerated,O
7254,552,volumes,O
7255,552,of,O
7256,552,25,O
7257,552,mL,O
7258,552,/,O
7259,552,injection,O
7260,552,site,O
7261,552,for,O
7262,552,at,O
7263,552,least,O
7264,552,1,O
7265,552,month,O
7266,552,prior,O
7267,552,to,O
7268,552,Day,O
7269,552,1,O
7270,552,.,O
7271,553,Experience,O
7272,553,with,O
7273,553,frequent,O
7274,553,(,O
7275,553,2,O
7276,553,-,O
7277,553,7,O
7278,553,times,O
7279,553,per,O
7280,553,week,O
7281,553,),O
7282,553,infusions,O
7283,553,of,O
7284,553,IgPro20,B-Drug
7285,553,at,O
7286,553,the,O
7287,553,tolerated,O
7288,553,flow,O
7289,553,rate,O
7290,553,of,O
7291,553,approximately,O
7292,553,0.5,O
7293,553,mL,O
7294,553,/,O
7295,553,min,O
7296,553,(,O
7297,553,equivalent,O
7298,553,of,O
7299,553,25,O
7300,553,-,O
7301,553,30,O
7302,553,mL,O
7303,553,/,O
7304,553,h,O
7305,553,),O
7306,553,per,O
7307,553,injection,O
7308,553,site,O
7309,553,for,O
7310,553,at,O
7311,553,least,O
7312,553,1,O
7313,553,month,O
7314,553,prior,O
7315,553,to,O
7316,553,Day,O
7317,553,1,O
7318,553,.,O
7319,553,The,O
7320,553,dose,O
7321,553,(,O
7322,553,volume,O
7323,553,),O
7324,553,per,O
7325,553,injection,O
7326,553,site,O
7327,553,should,O
7328,553,not,O
7329,553,exceed,O
7330,553,25,O
7331,553,mL.,O
7332,554,Inability,B-Observation
7333,554,to,I-Observation
7334,554,consent,I-Observation
7335,554,/,O
7336,554,refusal,B-Observation
7337,554,Allergy,B-Condition
7338,554,to,O
7339,554,any,O
7340,554,of,O
7341,554,the,O
7342,554,study,B-Drug
7343,554,medications,I-Drug
7344,554,Multiple,B-Condition
7345,554,traumatic,I-Condition
7346,554,injuries,I-Condition
7347,554,Contraindication,B-Condition
7348,554,to,O
7349,554,neuraxial,B-Procedure
7350,554,or,I-Procedure
7351,554,general,I-Procedure
7352,554,anesthesia,I-Procedure
7353,554,Pregnancy,B-Condition
7354,555,ASA,O
7355,555,I,O
7356,555,-,O
7357,555,IV,O
7358,555,Age,B-Person
7359,555,55,O
7360,555,or,O
7361,555,older,O
7362,555,Scheduled,B-Mood
7363,555,for,I-Mood
7364,555,operative,B-Procedure
7365,555,repair,I-Procedure
7366,555,of,O
7367,555,isolated,O
7368,555,intertrochanteric,B-Condition
7369,555,hip,I-Condition
7370,555,fracture,I-Condition
7371,556,The,O
7372,556,use,O
7373,556,of,O
7374,556,weight,O
7375,556,-,O
7376,556,lowering,O
7377,556,drugs,B-Drug
7378,556,",",O
7379,556,any,O
7380,556,investigational,O
7381,556,blood,O
7382,556,-,O
7383,556,glucose,O
7384,556,or,O
7385,556,lipid,O
7386,556,-,O
7387,556,lowering,O
7388,556,agent,B-Drug
7389,556,(,O
7390,556,other,O
7391,556,than,O
7392,556,statins,B-Drug
7393,556,or,O
7394,556,ezetimibe,B-Drug
7395,556,),O
7396,556,within,O
7397,556,the,O
7398,556,past,O
7399,556,3,O
7400,556,months,O
7401,557,Previous,O
7402,557,treatment,O
7403,557,with,O
7404,557,systemic,B-Drug
7405,557,corticosteroids,I-Drug
7406,557,or,O
7407,557,a,O
7408,557,change,O
7409,557,in,O
7410,557,dosage,O
7411,557,of,O
7412,557,thyroid,B-Drug
7413,557,hormones,I-Drug
7414,557,in,O
7415,557,the,O
7416,557,previous,O
7417,557,6,O
7418,557,weeks,O
7419,558,The,O
7420,558,use,O
7421,558,of,O
7422,558,insulin,B-Drug
7423,558,within,O
7424,558,the,O
7425,558,3,O
7426,558,months,O
7427,558,prior,O
7428,558,to,O
7429,558,screening,O
7430,559,Others,O
7431,560,Type,B-Condition
7432,560,2,I-Condition
7433,560,Diabetes,I-Condition
7434,560,Mellitus,I-Condition
7435,560,patients,O
7436,561,Patient,O
7437,561,who,O
7438,561,had,O
7439,561,been,O
7440,561,diagnosed,O
7441,561,within,O
7442,561,the,O
7443,561,previous,O
7444,561,12,O
7445,561,months,O
7446,561,with,O
7447,561,HbA1c,O
7448,561,levels,O
7449,561,of,O
7450,561,8.0,O
7451,561,-,O
7452,561,12.0,O
7453,561,%,O
7454,561,",",O
7455,561,did,O
7456,561,not,O
7457,561,have,O
7458,561,a,O
7459,561,medical,B-Observation
7460,561,history,I-Observation
7461,561,related,I-Observation
7462,561,to,I-Observation
7463,561,diabetes,I-Observation
7464,561,",",O
7465,561,and,O
7466,561,did,O
7467,561,not,O
7468,561,display,O
7469,561,proliferative,B-Condition
7470,561,retinopathy,I-Condition
7471,562,History,O
7472,562,of,O
7473,562,seizures,B-Condition
7474,562,within,O
7475,562,last,O
7476,562,10,O
7477,562,years,O
7478,563,History,O
7479,563,of,O
7480,563,epilepsy,B-Condition
7481,564,History,O
7482,564,of,O
7483,564,prior,O
7484,564,stroke,B-Condition
7485,565,Currently,O
7486,565,prescribed,O
7487,565,medication,B-Drug
7488,565,with,O
7489,565,anti,O
7490,565,-,O
7491,565,epileptic,O
7492,565,activity,O
7493,565,(,O
7494,565,keppra,B-Drug
7495,565,",",O
7496,565,dilantin,B-Drug
7497,565,",",O
7498,565,tegretol,B-Drug
7499,565,",",O
7500,565,lamictal,B-Drug
7501,565,",",O
7502,565,topamax,B-Drug
7503,565,",",O
7504,565,etc,O
7505,565,.,O
7506,565,),O
7507,566,Brain,B-Condition
7508,566,tumor,I-Condition
7509,567,Pregnant,B-Condition
7510,567,or,O
7511,567,nursing,B-Condition
7512,567,woman,B-Person
7513,568,Known,O
7514,568,levetiracetam,B-Drug
7515,568,allergy,B-Condition
7516,569,Adult,B-Person
7517,569,(=,O
7518,569,18,O
7519,569,years,B-Person
7520,569,),O
7521,570,Presence,O
7522,570,of,O
7523,570,intracranial,B-Condition
7524,570,aneurysm,I-Condition
7525,570,(,O
7526,570,with,O
7527,570,or,O
7528,570,without,O
7529,570,rupture,O
7530,570,),O
7531,571,Treating,O
7532,571,surgeon,O
7533,571,has,O
7534,571,recommended,B-Mood
7535,571,surgical,B-Procedure
7536,571,repair,I-Procedure
7537,571,of,O
7538,571,the,O
7539,571,aneurysm,B-Condition
7540,572,micturition,B-Condition
7541,572,problems,O
7542,572,",",O
7543,573,neurological,B-Observation
7544,573,history,I-Observation
7545,573,or,O
7546,574,previous,O
7547,574,lower,B-Procedure
7548,574,abdominal,I-Procedure
7549,574,surgery,I-Procedure
7550,574,with,O
7551,574,an,O
7552,574,abnormal,O
7553,574,micturition,B-Condition
7554,575,ASA,O
7555,575,(,O
7556,575,American,O
7557,575,Society,O
7558,575,of,O
7559,575,Anesthesiologists,O
7560,575,),O
7561,575,class,O
7562,575,1,O
7563,575,&,O
7564,575,2,O
7565,575,",",O
7566,576,undergoing,O
7567,576,day,O
7568,576,-,O
7569,576,case,O
7570,576,knee,B-Procedure
7571,576,arthroscopy,I-Procedure
7572,577,1,O
7573,577,.,O
7574,577,Unable,B-Condition
7575,577,to,I-Condition
7576,577,ambulate,I-Condition
7577,577,at,I-Condition
7578,577,least,I-Condition
7579,577,150,I-Condition
7580,577,feet,I-Condition
7581,577,prior,O
7582,577,to,O
7583,577,stroke,B-Condition
7584,577,",",O
7585,577,or,O
7586,577,experienced,O
7587,577,intermittent,B-Condition
7588,577,claudication,I-Condition
7589,577,while,O
7590,577,walking,O
7591,577,;,O
7592,578,2,O
7593,578,.,O
7594,578,history,B-Observation
7595,578,of,O
7596,578,congestive,B-Condition
7597,578,heart,I-Condition
7598,578,failure,I-Condition
7599,578,",",O
7600,578,unstable,B-Condition
7601,578,cardiac,I-Condition
7602,578,arrhythmias,I-Condition
7603,578,",",O
7604,578,hypertrophic,B-Condition
7605,578,cardiomyopathy,I-Condition
7606,578,",",O
7607,578,severe,B-Condition
7608,578,aortic,I-Condition
7609,578,stenosis,I-Condition
7610,578,",",O
7611,578,angina,B-Condition
7612,578,or,O
7613,578,dyspnea,B-Condition
7614,578,at,I-Condition
7615,578,rest,I-Condition
7616,578,or,I-Condition
7617,578,during,I-Condition
7618,578,ADL,I-Condition
7619,578,'s,I-Condition
7620,578,;,O
7621,579,3,O
7622,579,.,O
7623,579,History,B-Observation
7624,579,of,O
7625,579,oxygen,B-Condition
7626,579,dependence,I-Condition
7627,579,;,O
7628,580,4,O
7629,580,.,O
7630,580,Preexisting,O
7631,580,neurological,B-Condition
7632,580,disorders,I-Condition
7633,580,",",O
7634,580,dementia,B-Condition
7635,580,or,O
7636,580,previous,O
7637,580,stroke,B-Condition
7638,580,;,O
7639,581,5,O
7640,581,.,O
7641,581,History,B-Observation
7642,581,of,O
7643,581,major,B-Condition
7644,581,head,I-Condition
7645,581,trauma,I-Condition
7646,581,;,O
7647,582,6,O
7648,582,.,O
7649,582,Legal,B-Condition
7650,582,blindness,I-Condition
7651,582,or,O
7652,582,severe,B-Condition
7653,582,visual,I-Condition
7654,582,impairment,I-Condition
7655,582,;,O
7656,583,7,O
7657,583,.,O
7658,583,history,B-Observation
7659,583,of,O
7660,583,psychosis,B-Condition
7661,583,or,O
7662,583,other,O
7663,583,Axis,B-Condition
7664,583,I,I-Condition
7665,583,disorder,I-Condition
7666,583,that,O
7667,583,is,O
7668,583,primary,O
7669,583,;,O
7670,584,8,O
7671,584,.,O
7672,584,Life,B-Observation
7673,584,expectancy,I-Observation
7674,584,<,O
7675,584,1,O
7676,584,yr,O
7677,584,.,O
7678,584,;,O
7679,585,9,O
7680,585,.,O
7681,585,Severe,B-Condition
7682,585,arthritis,I-Condition
7683,585,or,O
7684,585,other,O
7685,585,problems,B-Condition
7686,585,that,I-Condition
7687,585,limit,I-Condition
7688,585,passive,I-Condition
7689,585,range,I-Condition
7690,585,of,I-Condition
7691,585,motion,I-Condition
7692,585,;,O
7693,586,10,O
7694,586,.,O
7695,586,History,B-Observation
7696,586,of,O
7697,586,DVT,B-Condition
7698,586,or,O
7699,586,pulmonary,B-Condition
7700,586,embolism,I-Condition
7701,586,within,O
7702,586,6,O
7703,586,months,O
7704,586,;,O
7705,587,11,O
7706,587,.,O
7707,587,Uncontrolled,O
7708,587,diabetes,B-Condition
7709,587,with,O
7710,587,recent,O
7711,587,weight,B-Condition
7712,587,loss,I-Condition
7713,587,",",O
7714,587,diabetic,B-Condition
7715,587,coma,I-Condition
7716,587,",",O
7717,587,or,O
7718,587,frequent,O
7719,587,insulin,B-Condition
7720,587,reactions,I-Condition
7721,587,;,O
7722,588,12,O
7723,588,.,O
7724,588,Severe,B-Condition
7725,588,hypertension,I-Condition
7726,588,with,O
7727,588,systolic,O
7728,588,>,O
7729,588,200,O
7730,588,mmHg,O
7731,588,and,O
7732,588,diastolic,O
7733,588,>,O
7734,588,110,O
7735,588,mmHg,O
7736,588,at,O
7737,588,rest,O
7738,588,;,O
7739,589,13,O
7740,589,.,O
7741,589,attempt,B-Condition
7742,589,of,I-Condition
7743,589,suicide,I-Condition
7744,589,in,O
7745,589,the,O
7746,589,last,O
7747,589,2,O
7748,589,years,O
7749,589,or,O
7750,589,at,B-Condition
7751,589,suicidal,I-Condition
7752,589,risk,I-Condition
7753,589,assessed,O
7754,589,by,O
7755,589,SCID,B-Procedure
7756,589,interview,I-Procedure
7757,589,;,O
7758,590,14,O
7759,590,.,O
7760,590,Previous,O
7761,590,or,O
7762,590,current,O
7763,590,enrollment,O
7764,590,in,O
7765,590,a,O
7766,590,clinical,O
7767,590,trial,O
7768,590,to,O
7769,590,enhance,O
7770,590,motor,O
7771,590,recovery,O
7772,590,;,O
7773,590,15,O
7774,590,),O
7775,590,currently,O
7776,590,exercising,O
7777,590,≥,O
7778,590,2,O
7779,590,times,O
7780,590,per,O
7781,590,week,O
7782,590,(,O
7783,590,≥20,O
7784,590,minutes,O
7785,590,),O
7786,590,;,O
7787,591,16,O
7788,591,),O
7789,591,Presence,O
7790,591,of,O
7791,591,non,O
7792,591,-,O
7793,591,MR,O
7794,591,compatible,O
7795,591,implants,O
7796,591,",",O
7797,591,pregnancy,B-Condition
7798,591,or,O
7799,591,severe,O
7800,591,claustrophobia,B-Condition
7801,591,.,O
7802,592,1,O
7803,592,),O
7804,592,age,B-Person
7805,592,50,O
7806,592,-,O
7807,592,70,O
7808,593,2,O
7809,593,),O
7810,593,stroke,B-Condition
7811,593,within,O
7812,593,the,O
7813,593,past,O
7814,593,6,O
7815,593,to,O
7816,593,60,O
7817,593,months,O
7818,593,",",O
7819,594,3,O
7820,594,),O
7821,594,major,B-Condition
7822,594,depressive,I-Condition
7823,594,disorder,I-Condition
7824,594,(,O
7825,594,PHQ-9,O
7826,594,>,O
7827,594,10,O
7828,594,),O
7829,594,and,O
7830,594,diagnosed,O
7831,594,using,O
7832,594,the,O
7833,594,Structured,B-Procedure
7834,594,Clinical,I-Procedure
7835,594,Interview,I-Procedure
7836,594,for,I-Procedure
7837,594,Depression,I-Procedure
7838,594,(,I-Procedure
7839,594,SCID,I-Procedure
7840,594,),I-Procedure
7841,594,according,I-Procedure
7842,594,to,I-Procedure
7843,594,the,I-Procedure
7844,594,Diagnostic,I-Procedure
7845,594,and,I-Procedure
7846,594,Statistical,I-Procedure
7847,594,Manual,I-Procedure
7848,594,of,I-Procedure
7849,594,Mental,I-Procedure
7850,594,Disorders,I-Procedure
7851,594,",",I-Procedure
7852,594,Fourth,I-Procedure
7853,594,Edition,I-Procedure
7854,594,(,I-Procedure
7855,594,DSM,I-Procedure
7856,594,-,I-Procedure
7857,594,IV,I-Procedure
7858,594,),I-Procedure
7859,594,",",O
7860,595,4,O
7861,595,),O
7862,595,residual,B-Condition
7863,595,paresis,I-Condition
7864,595,in,O
7865,595,the,O
7866,595,lower,O
7867,595,extremity,O
7868,595,(,O
7869,595,Fugl,O
7870,595,-,O
7871,595,Meyer,O
7872,595,LE,O
7873,595,motor,O
7874,595,score,O
7875,595,<,O
7876,595,34,O
7877,595,),O
7878,595,",",O
7879,596,5,O
7880,596,),O
7881,596,ability,B-Condition
7882,596,to,I-Condition
7883,596,walk,I-Condition
7884,596,without,I-Condition
7885,596,assistance,I-Condition
7886,596,and,O
7887,596,without,O
7888,596,an,O
7889,596,AFO,O
7890,596,on,O
7891,596,the,O
7892,596,treadmill,O
7893,596,≥,O
7894,596,30,O
7895,596,seconds,O
7896,596,at,O
7897,596,speeds,O
7898,596,ranging,O
7899,596,from,O
7900,596,0.2,O
7901,596,-,O
7902,596,0.8,O
7903,596,m,O
7904,596,/,O
7905,596,s,O
7906,596,",",O
7907,597,6,O
7908,597,),O
7909,597,no,O
7910,597,antidepressant,B-Drug
7911,597,medications,O
7912,597,or,O
7913,597,clinically,B-Condition
7914,597,able,I-Condition
7915,597,to,I-Condition
7916,597,discontinue,I-Condition
7917,597,medications,I-Condition
7918,597,",",O
7919,598,7,O
7920,598,),O
7921,598,HRSD,O
7922,598,question,O
7923,598,#,O
7924,598,9,O
7925,598,regarding,O
7926,598,suicide,O
7927,598,<,O
7928,598,2,O
7929,598,",",O
7930,599,8),O
7931,599,provision,O
7932,599,of,O
7933,599,informed,O
7934,599,consent,O
7935,599,.,O
7936,599,In,O
7937,599,addition,O
7938,599,",",O
7939,599,all,O
7940,599,subjects,O
7941,599,who,O
7942,599,meet,O
7943,599,criteria,O
7944,599,for,O
7945,599,the,O
7946,599,training,O
7947,599,portion,O
7948,599,must,O
7949,599,complete,O
7950,599,an,O
7951,599,exercise,O
7952,599,tolerance,O
7953,599,test,O
7954,599,and,O
7955,599,be,O
7956,599,cleared,O
7957,599,for,O
7958,599,participation,O
7959,599,by,O
7960,599,the,O
7961,599,study,O
7962,599,cardiologist,O
7963,599,.,O
7964,600,Age,B-Person
7965,600,less,O
7966,600,than,O
7967,600,10,O
7968,600,years,O
7969,600,or,O
7970,600,greater,O
7971,600,than,O
7972,600,55,O
7973,600,years,O
7974,600,",",O
7975,600,at,O
7976,600,time,O
7977,600,of,O
7978,600,consent,B-Observation
7979,601,Estimated,O
7980,601,IQ,O
7981,601,<,O
7982,601,70,O
7983,602,Uncontrolled,B-Condition
7984,602,epilepsy,I-Condition
7985,602,(,O
7986,602,seizure,B-Condition
7987,602,within,O
7988,602,6,O
7989,602,months,O
7990,602,prior,O
7991,602,to,O
7992,602,consent,O
7993,602,),O
7994,603,4,O
7995,603,.,O
7996,603,Presence,O
7997,603,of,O
7998,603,medical,O
7999,603,conditions,O
8000,603,that,O
8001,603,might,O
8002,603,interfere,O
8003,603,with,O
8004,603,participation,O
8005,603,",",O
8006,603,or,O
8007,603,where,O
8008,603,participation,O
8009,603,would,O
8010,603,be,O
8011,603,contraindicated,O
8012,604,History,B-Observation
8013,604,of,O
8014,604,neurological,B-Condition
8015,604,injury,I-Condition
8016,604,:,O
8017,604,head,B-Condition
8018,604,trauma,I-Condition
8019,604,",",O
8020,604,poorly,O
8021,604,-,O
8022,604,controlled,O
8023,604,seizure,B-Condition
8024,604,disorder,I-Condition
8025,604,(,O
8026,604,seizure,B-Condition
8027,604,within,O
8028,604,the,O
8029,604,preceding,O
8030,604,six,O
8031,604,months,O
8032,604,),O
8033,604,",",O
8034,604,stroke,B-Condition
8035,604,",",O
8036,604,prior,O
8037,604,neurosurgery,B-Condition
8038,604,",",O
8039,604,or,O
8040,604,under,B-Observation
8041,604,the,I-Observation
8042,604,care,I-Observation
8043,604,of,I-Observation
8044,604,a,I-Observation
8045,604,neurologist,I-Observation
8046,604,or,I-Observation
8047,604,neurosurgeon,I-Observation
8048,604,as,O
8049,604,determined,O
8050,604,by,O
8051,604,interview,O
8052,605,History,B-Observation
8053,605,of,O
8054,605,claustrophobia,B-Condition
8055,606,Implanted,O
8056,606,or,O
8057,606,irremovable,O
8058,606,metal,O
8059,606,in,O
8060,606,the,O
8061,606,body,O
8062,606,(,O
8063,606,including,O
8064,606,certain,O
8065,606,tattoos,O
8066,606,and,O
8067,606,permanent,O
8068,606,make,O
8069,606,-,O
8070,606,up,O
8071,606,),O
8072,607,Current,O
8073,607,pregnancy,B-Condition
8074,607,(,O
8075,607,as,O
8076,607,verified,O
8077,607,by,O
8078,607,testing,O
8079,607,prior,O
8080,607,to,O
8081,607,both,O
8082,607,initial,O
8083,607,dose,O
8084,607,administration,O
8085,607,of,O
8086,607,citalopram,O
8087,607,or,O
8088,607,placebo,O
8089,607,and,O
8090,607,prior,O
8091,607,to,O
8092,607,magnetic,O
8093,607,resonance,O
8094,607,imaging,O
8095,607,),O
8096,607,due,O
8097,607,to,O
8098,607,the,O
8099,607,risk,O
8100,607,that,O
8101,607,may,O
8102,607,be,O
8103,607,associated,O
8104,607,with,O
8105,607,SSRI,O
8106,607,treatment,O
8107,607,and,O
8108,607,magnetic,O
8109,607,resonance,O
8110,607,imaging,O
8111,607,on,O
8112,607,fetal,O
8113,607,health,O
8114,608,Medical,O
8115,608,contraindications,B-Condition
8116,608,to,I-Condition
8117,608,SSRI,I-Condition
8118,608,therapy,I-Condition
8119,608,as,O
8120,608,determined,O
8121,608,by,O
8122,608,history,B-Observation
8123,608,(,O
8124,608,including,O
8125,608,induction,O
8126,608,of,O
8127,608,mania,B-Condition
8128,608,or,O
8129,608,hypomania,B-Condition
8130,608,during,O
8131,608,SSRI,O
8132,608,therapy,O
8133,608,",",O
8134,608,or,O
8135,608,known,O
8136,608,drug,B-Condition
8137,608,allergy,I-Condition
8138,608,),O
8139,609,Concomitant,O
8140,609,medication,O
8141,609,that,O
8142,609,would,O
8143,609,interfere,O
8144,609,with,O
8145,609,study,O
8146,609,participation,O
8147,610,Prior,O
8148,610,history,B-Observation
8149,610,of,O
8150,610,citalopram,B-Drug
8151,610,treatment,B-Procedure
8152,610,failure,O
8153,610,at,O
8154,610,appropriate,O
8155,610,doses,O
8156,610,and,O
8157,610,duration,O
8158,611,Prior,O
8159,611,history,O
8160,611,of,O
8161,611,treatment,O
8162,611,failure,O
8163,611,to,O
8164,611,two,O
8165,611,previous,O
8166,611,SSRI,O
8167,611,trials,O
8168,611,at,O
8169,611,appropriate,O
8170,611,doses,O
8171,611,and,O
8172,611,duration,O
8173,612,Ongoing,O
8174,612,need,O
8175,612,for,O
8176,612,psychoactive,B-Drug
8177,612,medication,I-Drug
8178,612,other,O
8179,612,than,O
8180,612,study,B-Drug
8181,612,medication,I-Drug
8182,612,[,O
8183,612,excepting,O
8184,612,stable,O
8185,612,doses,O
8186,612,(,O
8187,612,greater,O
8188,612,than,O
8189,612,three,O
8190,612,months,O
8191,612,duration,O
8192,612,),O
8193,612,of,O
8194,612,anticonvulsant,B-Drug
8195,612,medication,I-Drug
8196,612,for,O
8197,612,seizure,B-Condition
8198,612,disorder,I-Condition
8199,612,",",O
8200,612,or,O
8201,612,diphenhydramine,B-Drug
8202,612,(,O
8203,612,Benadryl,O
8204,612,®,O
8205,612,)for,O
8206,612,sleep,O
8207,612,],O
8208,613,Ambulatory,O
8209,613,status,O
8210,613,(,O
8211,613,outpatient,O
8212,613,),O
8213,613,at,O
8214,613,time,O
8215,613,of,O
8216,613,consent,O
8217,614,Age,B-Person
8218,614,10,O
8219,614,-,O
8220,614,55,O
8221,614,years,O
8222,615,Clinical,O
8223,615,diagnosis,O
8224,615,of,O
8225,615,Autism,B-Condition
8226,615,Spectrum,I-Condition
8227,615,Disorder,I-Condition
8228,616,IQ,O
8229,616,greater,O
8230,616,than,O
8231,616,or,O
8232,616,equal,O
8233,616,to,O
8234,616,70,O
8235,617,Score,O
8236,617,greater,O
8237,617,than,O
8238,617,8,O
8239,617,on,O
8240,617,Children,O
8241,617,'s,O
8242,617,Yale,O
8243,617,-,O
8244,617,Brown,O
8245,617,Obsessive,O
8246,617,Compulsive,O
8247,617,Scale,O
8248,618,Free,O
8249,618,of,O
8250,618,psychoactive,B-Drug
8251,618,medication,I-Drug
8252,618,for,O
8253,618,at,O
8254,618,least,O
8255,618,:,O
8256,618,one,O
8257,618,month,O
8258,618,for,O
8259,618,fluoxetine,B-Drug
8260,618,;,O
8261,618,two,O
8262,618,weeks,O
8263,618,for,O
8264,618,other,O
8265,618,SSRIs,B-Drug
8266,618,and,O
8267,618,neuroleptics,B-Drug
8268,618,;,O
8269,618,and,O
8270,618,five,O
8271,618,days,O
8272,618,for,O
8273,618,stimulants,B-Drug
8274,618,prior,O
8275,618,to,O
8276,618,MRI,O
8277,618,scanning,O
8278,618,[,O
8279,618,excepting,O
8280,618,stable,O
8281,618,doses,O
8282,618,(,O
8283,618,greater,O
8284,618,than,O
8285,618,three,O
8286,618,months,O
8287,618,duration,O
8288,618,),O
8289,618,of,O
8290,618,anticonvulsant,B-Drug
8291,618,medication,I-Drug
8292,618,for,O
8293,618,seizure,B-Condition
8294,618,disorder,I-Condition
8295,618,],O
8296,619,Presence,O
8297,619,of,O
8298,619,organic,B-Condition
8299,619,pathology,I-Condition
8300,619,identified,O
8301,619,by,O
8302,619,upper,B-Procedure
8303,619,endoscopy,I-Procedure
8304,619,or,O
8305,619,other,O
8306,619,investigations,B-Procedure
8307,620,Presence,O
8308,620,of,O
8309,620,sliding,O
8310,620,hiatus,B-Condition
8311,620,hernia,I-Condition
8312,620,as,O
8313,620,defined,O
8314,620,by,O
8315,620,flap,O
8316,620,valve,O
8317,620,grade,O
8318,620,IV,O
8319,620,disruption,O
8320,620,of,O
8321,620,morphology,O
8322,620,at,O
8323,620,gastro,O
8324,620,-,O
8325,620,esophageal,O
8326,620,junction,O
8327,621,Concurrent,O
8328,621,medications,B-Drug
8329,621,that,O
8330,621,affect,O
8331,621,gastrointestinal,B-Condition
8332,621,motility,I-Condition
8333,622,Presence,O
8334,622,of,O
8335,622,acid,B-Condition
8336,622,reflux,I-Condition
8337,622,or,O
8338,622,heartburn,B-Condition
8339,622,symptoms,I-Condition
8340,622,of,O
8341,622,more,O
8342,622,than,O
8343,622,twice,O
8344,622,a,O
8345,622,month,O
8346,623,History,O
8347,623,of,O
8348,623,gastric,B-Procedure
8349,623,surgery,I-Procedure
8350,624,H.,B-Condition
8351,624,pylori,I-Condition
8352,624,infection,I-Condition
8353,625,Use,O
8354,625,of,O
8355,625,PPI,B-Drug
8356,625,or,O
8357,625,NSAID,B-Drug
8358,625,in,O
8359,625,the,O
8360,625,past,O
8361,625,4,O
8362,625,weeks,O
8363,626,Pregnancy,B-Condition
8364,627,Known,O
8365,627,hypersensitivity,B-Condition
8366,627,to,O
8367,627,PPI,B-Drug
8368,628,Patients,O
8369,628,with,O
8370,628,functional,B-Condition
8371,628,dyspepsia,I-Condition
8372,628,that,O
8373,628,fulfill,O
8374,628,Rome,O
8375,628,III,O
8376,628,criteria,O
8377,628,with,O
8378,628,inadequate,O
8379,628,relief,O
8380,628,of,O
8381,628,dyspeptic,B-Condition
8382,628,symptoms,I-Condition
8383,629,Age,B-Person
8384,629,>,O
8385,629,18,O
8386,630,Provision,O
8387,630,of,O
8388,630,written,O
8389,630,consent,O
8390,631,Subject,O
8391,631,who,O
8392,631,showed,O
8393,631,medically,O
8394,631,significant,O
8395,631,adverse,B-Condition
8396,631,events,I-Condition
8397,631,or,O
8398,631,intolerance,B-Condition
8399,631,with,O
8400,631,aripiprazole,B-Drug
8401,631,during,O
8402,631,screening,O
8403,631,period,O
8404,631,or,O
8405,631,as,O
8406,631,prior,O
8407,631,experiences,O
8408,631,.,O
8409,632,Subjects,O
8410,632,with,O
8411,632,a,O
8412,632,current,O
8413,632,DSM-<U+2163>-TR,O
8414,632,or,O
8415,632,5,O
8416,632,diagnosis,O
8417,632,other,O
8418,632,than,O
8419,632,schizophrenia,B-Condition
8420,632,",",O
8421,632,including,O
8422,632,schizoaffective,B-Condition
8423,632,disorder,I-Condition
8424,632,",",O
8425,632,major,B-Condition
8426,632,depressive,I-Condition
8427,632,disorder,I-Condition
8428,632,",",O
8429,632,bipolar,B-Condition
8430,632,disorder,I-Condition
8431,632,",",O
8432,632,delirium,B-Condition
8433,632,",",O
8434,632,dementia,B-Condition
8435,632,",",O
8436,632,amnesia,B-Condition
8437,632,",",O
8438,632,Borderline,B-Condition
8439,632,",",I-Condition
8440,632,Paranoid,I-Condition
8441,632,",",I-Condition
8442,632,Histrionic,I-Condition
8443,632,",",I-Condition
8444,632,Schizotypal,I-Condition
8445,632,",",I-Condition
8446,632,Schizoid,I-Condition
8447,632,",",I-Condition
8448,632,Antisocial,I-Condition
8449,632,or,I-Condition
8450,632,other,I-Condition
8451,632,cognitive,I-Condition
8452,632,or,I-Condition
8453,632,personality,I-Condition
8454,632,disorders,I-Condition
8455,632,.,O
8456,633,Subjects,O
8457,633,with,O
8458,633,diseases,O
8459,633,of,O
8460,633,the,O
8461,633,central,O
8462,633,nervous,O
8463,633,system,O
8464,633,that,O
8465,633,may,O
8466,633,impact,O
8467,633,the,O
8468,633,assessment,O
8469,633,of,O
8470,633,the,O
8471,633,psychotic,O
8472,633,symptoms,O
8473,633,as,O
8474,633,per,O
8475,633,investigator,O
8476,633,'s,O
8477,633,opinion,O
8478,633,.,O
8479,634,Subjects,O
8480,634,who,O
8481,634,have,O
8482,634,been,O
8483,634,treated,O
8484,634,with,O
8485,634,clozapine,B-Drug
8486,634,or,O
8487,634,long,B-Drug
8488,634,-,I-Drug
8489,634,acting,I-Drug
8490,634,injectable,I-Drug
8491,634,antipsychotic,I-Drug
8492,634,drugs,I-Drug
8493,634,within,O
8494,634,3,O
8495,634,months,O
8496,634,prior,O
8497,634,to,O
8498,634,the,O
8499,634,screening,O
8500,634,.,O
8501,635,Subjects,O
8502,635,who,O
8503,635,have,O
8504,635,been,O
8505,635,treated,O
8506,635,over,O
8507,635,maximum,O
8508,635,maintenance,O
8509,635,dose,O
8510,635,(,O
8511,635,as,O
8512,635,specified,O
8513,635,in,O
8514,635,each,O
8515,635,label,O
8516,635,),O
8517,635,of,O
8518,635,oral,B-Drug
8519,635,antipsychotics,I-Drug
8520,635,at,O
8521,635,screening,O
8522,635,.,O
8523,635,(,O
8524,635,e.g.,O
8525,635,Aripiprazole>30mg,B-Drug
8526,635,/,O
8527,635,day,O
8528,635,",",O
8529,635,Olanzapine>20mg,B-Drug
8530,635,/,O
8531,635,day,O
8532,635,",",O
8533,635,Risperidone,B-Drug
8534,635,>,O
8535,635,6mg,O
8536,635,/,O
8537,635,day,O
8538,635,",",O
8539,635,Quetiapine,B-Drug
8540,635,>,O
8541,635,750mg,O
8542,635,/,O
8543,635,day,O
8544,635,),O
8545,636,Subjects,O
8546,636,with,O
8547,636,a,O
8548,636,significant,B-Mood
8549,636,risk,I-Mood
8550,636,of,O
8551,636,violent,B-Observation
8552,636,behaviour,I-Observation
8553,636,or,O
8554,636,a,O
8555,636,significant,B-Mood
8556,636,risk,I-Mood
8557,636,of,O
8558,636,committing,B-Condition
8559,636,suicide,I-Condition
8560,636,based,O
8561,636,on,O
8562,636,history,O
8563,636,or,O
8564,636,investigator,O
8565,636,'s,O
8566,636,judgment,O
8567,636,.,O
8568,637,Subjects,O
8569,637,had,O
8570,637,a,O
8571,637,history,B-Observation
8572,637,of,O
8573,637,seizures,B-Condition
8574,637,",",O
8575,637,neuroleptic,B-Condition
8576,637,malignant,I-Condition
8577,637,syndrome,I-Condition
8578,637,",",O
8579,637,clinically,O
8580,637,significant,O
8581,637,tardive,B-Condition
8582,637,dyskinesia,I-Condition
8583,637,",",O
8584,637,or,O
8585,637,other,O
8586,637,medical,O
8587,637,condition,O
8588,637,that,O
8589,637,would,O
8590,637,expose,O
8591,637,them,O
8592,637,to,O
8593,637,undue,O
8594,637,risk,O
8595,637,or,O
8596,637,interfere,O
8597,637,with,O
8598,637,study,O
8599,637,assessments,O
8600,637,.,O
8601,638,Significant,O
8602,638,history,O
8603,638,of,O
8604,638,drug,O
8605,638,abuse,O
8606,638,disorder,O
8607,638,(,O
8608,638,including,O
8609,638,alcohol,O
8610,638,",",O
8611,638,as,O
8612,638,defined,O
8613,638,in,O
8614,638,DSM-5,O
8615,638,substance,O
8616,638,use,O
8617,638,disorder,O
8618,638,or,O
8619,638,in,O
8620,638,the,O
8621,638,opinion,O
8622,638,of,O
8623,638,the,O
8624,638,investigator,O
8625,638,),O
8626,638,within,O
8627,638,the,O
8628,638,last,O
8629,638,6,O
8630,638,months,O
8631,638,prior,O
8632,638,to,O
8633,638,screening,O
8634,638,.,O
8635,639,Subjects,O
8636,639,participating,O
8637,639,another,O
8638,639,interventional,O
8639,639,clinical,O
8640,639,trial,O
8641,639,within,O
8642,639,30,O
8643,639,days,O
8644,639,prior,O
8645,639,to,O
8646,639,screening,O
8647,639,.,O
8648,640,Women,O
8649,640,who,O
8650,640,are,O
8651,640,pregnant,O
8652,640,",",O
8653,640,nursing,O
8654,640,",",O
8655,640,or,O
8656,640,who,O
8657,640,plan,O
8658,640,to,O
8659,640,become,O
8660,640,pregnant,O
8661,640,while,O
8662,640,in,O
8663,640,the,O
8664,640,trial,O
8665,640,.,O
8666,641,Subjects,O
8667,641,having,O
8668,641,any,O
8669,641,other,O
8670,641,clinically,O
8671,641,significant,O
8672,641,finding,O
8673,641,of,O
8674,641,the,O
8675,641,physical,O
8676,641,examination,O
8677,641,or,O
8678,641,laboratory,O
8679,641,value,O
8680,641,that,O
8681,641,make,O
8682,641,investigator,O
8683,641,consider,O
8684,641,that,O
8685,641,it,O
8686,641,would,O
8687,641,be,O
8688,641,inappropriate,O
8689,641,to,O
8690,641,participate,O
8691,641,in,O
8692,641,this,O
8693,641,study,O
8694,641,.,O
8695,642,Subjects,O
8696,642,must,O
8697,642,be,O
8698,642,capable,O
8699,642,of,O
8700,642,providing,O
8701,642,signed,O
8702,642,and,O
8703,642,dated,O
8704,642,written,O
8705,642,informed,O
8706,642,consent,O
8707,642,by,O
8708,642,date,O
8709,642,of,O
8710,642,Visit,O
8711,642,0,O
8712,642,(,O
8713,642,-2,O
8714,642,week,O
8715,642,),O
8716,642,.,O
8717,643,Male,B-Person
8718,643,and,O
8719,643,female,B-Person
8720,643,aged,B-Person
8721,643,=,O
8722,643,19,O
8723,643,and,O
8724,643,<,O
8725,643,65,O
8726,643,years,O
8727,643,.,O
8728,644,Subjects,O
8729,644,diagnosed,O
8730,644,of,O
8731,644,schizophrenia,B-Condition
8732,644,as,O
8733,644,defined,O
8734,644,by,O
8735,644,Diagnostic,O
8736,644,and,O
8737,644,Statistical,O
8738,644,Manual,O
8739,644,of,O
8740,644,Mental,O
8741,644,Disorders,O
8742,644,",",O
8743,644,4th,O
8744,644,edition,O
8745,644,text,O
8746,644,revision,O
8747,644,or,O
8748,644,5th,O
8749,644,edition,O
8750,644,(,O
8751,644,DSM-<U+2163>-TR,O
8752,644,or,O
8753,644,5,O
8754,644,),O
8755,644,criteria,O
8756,644,",",O
8757,644,and,O
8758,644,a,O
8759,644,history,B-Observation
8760,644,of,I-Observation
8761,644,illness,I-Observation
8762,644,for,O
8763,644,at,O
8764,644,least,O
8765,644,for,O
8766,644,3,O
8767,644,years,O
8768,644,prior,O
8769,644,to,O
8770,644,screening,O
8771,644,.,O
8772,645,Subjects,O
8773,645,who,O
8774,645,take,O
8775,645,atypical,B-Drug
8776,645,antipsychotic,I-Drug
8777,645,drugs,I-Drug
8778,645,",",O
8779,645,and,O
8780,645,should,O
8781,645,be,O
8782,645,maintained,O
8783,645,on,O
8784,645,current,O
8785,645,antipsychotic,O
8786,645,drugs,O
8787,645,(,O
8788,645,including,O
8789,645,atypical,O
8790,645,antipsychotic,O
8791,645,drugs,O
8792,645,),O
8793,645,and,O
8794,645,dose,O
8795,645,for,O
8796,645,at,O
8797,645,least,O
8798,645,4,O
8799,645,weeks,O
8800,645,prior,O
8801,645,to,O
8802,645,the,O
8803,645,screening,O
8804,645,.,O
8805,646,Subjects,O
8806,646,who,O
8807,646,need,O
8808,646,antipsychotic,O
8809,646,treatment,O
8810,646,(,O
8811,646,other,O
8812,646,than,O
8813,646,clozapine,O
8814,646,),O
8815,646,",",O
8816,646,and,O
8817,646,would,O
8818,646,be,O
8819,646,stable,O
8820,646,when,O
8821,646,switching,O
8822,646,to,O
8823,646,long,O
8824,646,-,O
8825,646,acting,O
8826,646,injectable,O
8827,646,aripiprazole,O
8828,646,in,O
8829,646,the,O
8830,646,investigator,O
8831,646,'s,O
8832,646,judgement,O
8833,646,.,O
8834,647,Subjects,O
8835,647,must,O
8836,647,exhibit,O
8837,647,willingness,O
8838,647,",",O
8839,647,physiologic,O
8840,647,capability,O
8841,647,",",O
8842,647,and,O
8843,647,an,O
8844,647,educational,O
8845,647,level,O
8846,647,sufficient,O
8847,647,to,O
8848,647,comply,O
8849,647,with,O
8850,647,all,O
8851,647,protocol,O
8852,647,procedures,O
8853,647,.,O
8854,648,Progressive,O
8855,648,",",O
8856,648,unstable,O
8857,648,or,O
8858,648,uncontrolled,O
8859,648,clinical,B-Condition
8860,648,conditions,I-Condition
8861,648,.,O
8862,649,Hypersensitivity,B-Condition
8863,649,",",O
8864,649,including,O
8865,649,allergy,B-Condition
8866,649,",",O
8867,649,to,O
8868,649,any,O
8869,649,component,B-Drug
8870,649,of,I-Drug
8871,649,vaccines,I-Drug
8872,649,",",O
8873,649,medicinal,B-Drug
8874,649,products,I-Drug
8875,649,or,O
8876,649,medical,O
8877,649,equipment,O
8878,649,whose,O
8879,649,use,O
8880,649,is,O
8881,649,foreseen,O
8882,649,in,O
8883,649,this,O
8884,649,study,O
8885,649,.,O
8886,650,Clinical,O
8887,650,conditions,O
8888,650,representing,O
8889,650,a,O
8890,650,contraindication,B-Condition
8891,650,to,O
8892,650,intramuscular,B-Procedure
8893,650,vaccination,I-Procedure
8894,650,and,O
8895,650,blood,B-Procedure
8896,650,draws,I-Procedure
8897,650,.,O
8898,651,Clinical,O
8899,651,conditions,O
8900,651,.,O
8901,652,Systemic,O
8902,652,administration,O
8903,652,of,O
8904,652,corticosteroids,B-Drug
8905,652,(,O
8906,652,PO,O
8907,652,/,O
8908,652,IV,O
8909,652,/,O
8910,652,IM,O
8911,652,),O
8912,652,within,O
8913,652,90,O
8914,652,days,O
8915,652,prior,O
8916,652,to,O
8917,652,informed,O
8918,652,consent,O
8919,652,.,O
8920,653,Administration,O
8921,653,of,O
8922,653,antineoplastic,B-Drug
8923,653,and,I-Drug
8924,653,immunomodulating,I-Drug
8925,653,agents,I-Drug
8926,653,or,O
8927,653,radiotherapy,B-Procedure
8928,653,within,O
8929,653,90,O
8930,653,days,O
8931,653,prior,O
8932,653,to,O
8933,653,informed,O
8934,653,consent,O
8935,653,.,O
8936,654,Received,O
8937,654,immunoglobulins,B-Drug
8938,654,or,O
8939,654,any,O
8940,654,blood,B-Drug
8941,654,products,I-Drug
8942,654,within,O
8943,654,180,O
8944,654,days,O
8945,654,prior,O
8946,654,to,O
8947,654,informed,O
8948,654,consent,O
8949,654,.,O
8950,655,Received,O
8951,655,an,O
8952,655,investigational,O
8953,655,or,O
8954,655,non,O
8955,655,-,O
8956,655,registered,O
8957,655,medicinal,B-Drug
8958,655,product,I-Drug
8959,655,within,O
8960,655,30,O
8961,655,days,O
8962,655,prior,O
8963,655,to,O
8964,655,informed,O
8965,655,consent,O
8966,655,.,O
8967,656,Any,O
8968,656,other,O
8969,656,clinical,O
8970,656,condition,O
8971,656,that,O
8972,656,",",O
8973,656,in,O
8974,656,the,O
8975,656,opinion,O
8976,656,of,O
8977,656,the,O
8978,656,investigator,O
8979,656,",",O
8980,656,might,O
8981,656,pose,O
8982,656,additional,O
8983,656,risk,O
8984,656,to,O
8985,656,the,O
8986,656,subject,O
8987,656,due,O
8988,656,to,O
8989,656,participation,O
8990,656,in,O
8991,656,the,O
8992,656,study,O
8993,656,.,O
8994,657,Any,O
8995,657,history,B-Observation
8996,657,of,O
8997,657,meningococcal,B-Drug
8998,657,vaccination,I-Drug
8999,657,or,O
9000,657,meningococcal,B-Condition
9001,657,and,I-Condition
9002,657,gonorrhoea,I-Condition
9003,657,diseases,I-Condition
9004,657,.,O
9005,658,Enrolment,O
9006,658,in,O
9007,658,any,O
9008,658,activity,O
9009,658,requiring,O
9010,658,a,O
9011,658,blood,B-Procedure
9012,658,donation,I-Procedure
9013,658,greater,O
9014,658,than,O
9015,658,50,O
9016,658,mL,O
9017,658,during,O
9018,658,the,O
9019,658,period,O
9020,658,starting,O
9021,658,30,O
9022,658,days,O
9023,658,before,O
9024,658,the,O
9025,658,first,O
9026,658,study,O
9027,658,visit,O
9028,658,(,O
9029,658,Day,O
9030,658,-83,O
9031,658,",",O
9032,658,Day,O
9033,658,-60,O
9034,658,or,O
9035,658,Day,O
9036,658,-30,O
9037,658,),O
9038,658,or,O
9039,658,for,O
9040,658,the,O
9041,658,duration,O
9042,658,of,O
9043,658,the,O
9044,658,study,O
9045,658,period,O
9046,658,.,O
9047,659,Administration,O
9048,659,of,O
9049,659,long,O
9050,659,-,O
9051,659,acting,O
9052,659,immune,B-Drug
9053,659,-,I-Drug
9054,659,modifying,I-Drug
9055,659,drugs,I-Drug
9056,659,at,O
9057,659,any,O
9058,659,time,O
9059,659,during,O
9060,659,the,O
9061,659,study,O
9062,659,period,O
9063,660,Subjects,O
9064,660,with,O
9065,660,blood,B-Condition
9066,660,disorders,I-Condition
9067,660,.,O
9068,661,Subjects,O
9069,661,with,O
9070,661,a,O
9071,661,history,B-Observation
9072,661,of,O
9073,661,difficulty,B-Observation
9074,661,in,I-Observation
9075,661,providing,I-Observation
9076,661,blood,I-Observation
9077,661,samples,I-Observation
9078,662,Any,O
9079,662,antibiotic,B-Drug
9080,662,intake,O
9081,662,7,O
9082,662,days,O
9083,662,prior,O
9084,662,to,O
9085,662,blood,O
9086,662,collection,O
9087,662,.,O
9088,663,Subjects,O
9089,663,who,O
9090,663,donated,B-Procedure
9091,663,>,I-Procedure
9092,663,450,I-Procedure
9093,663,mL,I-Procedure
9094,663,of,I-Procedure
9095,663,blood,I-Procedure
9096,663,within,O
9097,663,60,O
9098,663,days,O
9099,663,prior,O
9100,663,to,O
9101,663,any,O
9102,663,blood,O
9103,663,collection,O
9104,663,visits,O
9105,663,.,O
9106,664,Subjects,O
9107,664,who,O
9108,664,lost,O
9109,664,>,O
9110,664,200,O
9111,664,mL,O
9112,664,during,O
9113,664,a,O
9114,664,single,O
9115,664,apheresis,B-Procedure
9116,664,or,O
9117,664,who,O
9118,664,lost,O
9119,664,red,O
9120,664,blood,O
9121,664,cells,O
9122,664,on,O
9123,664,more,O
9124,664,than,O
9125,664,one,O
9126,664,occasion,O
9127,664,during,O
9128,664,apheresis,B-Procedure
9129,664,within,O
9130,664,the,O
9131,664,previous,O
9132,664,60,O
9133,664,days,O
9134,664,.,O
9135,665,Concurrently,O
9136,665,participating,B-Observation
9137,665,in,I-Observation
9138,665,another,I-Observation
9139,665,clinical,I-Observation
9140,665,study,I-Observation
9141,665,",",O
9142,665,at,O
9143,665,any,O
9144,665,time,O
9145,665,during,O
9146,665,the,O
9147,665,study,O
9148,665,period,O
9149,665,",",O
9150,665,in,O
9151,665,which,O
9152,665,the,O
9153,665,subject,O
9154,665,has,O
9155,665,been,O
9156,665,or,O
9157,665,will,O
9158,665,be,O
9159,665,exposed,O
9160,665,to,O
9161,665,an,O
9162,665,investigational,O
9163,665,or,O
9164,665,a,O
9165,665,non,O
9166,665,-,O
9167,665,investigational,O
9168,665,vaccine,B-Drug
9169,665,/,O
9170,665,product,B-Drug
9171,666,Ongoing,O
9172,666,anaemia,B-Condition
9173,666,as,O
9174,666,indicated,O
9175,666,by,O
9176,666,haemoglobin,O
9177,666,values,O
9178,666,below,O
9179,666,the,O
9180,666,lower,O
9181,666,limit,O
9182,666,of,O
9183,666,the,O
9184,666,laboratory,O
9185,666,-,O
9186,666,specified,O
9187,666,reference,O
9188,666,range,O
9189,666,.,O
9190,666,If,O
9191,666,the,O
9192,666,finger,B-Procedure
9193,666,prick,I-Procedure
9194,666,method,I-Procedure
9195,666,demonstrates,O
9196,666,an,O
9197,666,anaemia,B-Condition
9198,666,",",O
9199,666,no,O
9200,666,further,O
9201,666,protocol,O
9202,666,procedures,O
9203,666,will,O
9204,666,be,O
9205,666,performed,O
9206,666,",",O
9207,666,and,O
9208,666,the,O
9209,666,subject,O
9210,666,will,O
9211,666,be,O
9212,666,referred,O
9213,666,for,O
9214,666,appropriate,O
9215,666,medical,O
9216,666,management,O
9217,666,.,O
9218,666,The,O
9219,666,subject,O
9220,666,may,O
9221,666,participate,O
9222,666,in,O
9223,666,this,O
9224,666,study,O
9225,666,following,O
9226,666,therapy,O
9227,666,and,O
9228,666,evidence,O
9229,666,that,O
9230,666,the,O
9231,666,anaemia,O
9232,666,has,O
9233,666,been,O
9234,666,resolved,O
9235,666,.,O
9236,667,History,O
9237,667,of,O
9238,667,any,O
9239,667,reaction,B-Condition
9240,667,or,O
9241,667,hypersensitivity,B-Condition
9242,667,likely,O
9243,667,to,O
9244,667,be,O
9245,667,exacerbated,O
9246,667,by,O
9247,667,any,O
9248,667,component,B-Drug
9249,667,of,I-Drug
9250,667,the,I-Drug
9251,667,vaccines,I-Drug
9252,667,.,O
9253,668,Pregnant,B-Condition
9254,668,or,O
9255,668,lactating,B-Observation
9256,668,female,B-Person
9257,668,.,O
9258,669,Female,B-Person
9259,669,planning,B-Observation
9260,669,to,I-Observation
9261,669,become,I-Observation
9262,669,pregnant,I-Observation
9263,669,or,O
9264,669,planning,B-Mood
9265,669,to,I-Mood
9266,669,discontinue,I-Mood
9267,669,contraceptive,B-Observation
9268,669,precautions,I-Observation
9269,669,.,O
9270,670,Any,O
9271,670,confirmed,O
9272,670,or,O
9273,670,suspected,B-Mood
9274,670,immunosuppressive,B-Condition
9275,670,or,I-Condition
9276,670,immunodeficiency,I-Condition
9277,670,condition,I-Condition
9278,670,based,O
9279,670,on,O
9280,670,medical,B-Observation
9281,670,history,I-Observation
9282,670,and,O
9283,670,physical,B-Procedure
9284,670,examination,I-Procedure
9285,671,Family,B-Observation
9286,671,history,I-Observation
9287,671,of,O
9288,671,congenital,B-Condition
9289,671,or,I-Condition
9290,671,hereditary,I-Condition
9291,671,immunodeficiency,I-Condition
9292,671,.,O
9293,672,Serious,O
9294,672,chronic,B-Condition
9295,672,illness,I-Condition
9296,672,.,O
9297,673,History,B-Observation
9298,673,of,O
9299,673,chronic,B-Condition
9300,673,alcohol,I-Condition
9301,673,consumption,I-Condition
9302,673,and/or,O
9303,673,drug,B-Condition
9304,673,abuse,I-Condition
9305,673,.,O
9306,674,Subjects,O
9307,674,who,O
9308,674,",",O
9309,674,in,O
9310,674,the,O
9311,674,opinion,O
9312,674,of,O
9313,674,the,O
9314,674,investigator,O
9315,674,",",O
9316,674,can,O
9317,674,and,O
9318,674,will,O
9319,674,comply,B-Observation
9320,674,with,I-Observation
9321,674,the,I-Observation
9322,674,requirements,I-Observation
9323,674,of,I-Observation
9324,674,the,I-Observation
9325,674,protocol,I-Observation
9326,674,.,O
9327,675,Written,B-Observation
9328,675,informed,I-Observation
9329,675,consent,I-Observation
9330,675,obtained,O
9331,675,from,O
9332,675,the,O
9333,675,subject,O
9334,675,prior,O
9335,675,to,O
9336,675,performing,O
9337,675,any,O
9338,675,study,B-Procedure
9339,675,specific,I-Procedure
9340,675,procedure,I-Procedure
9341,675,.,O
9342,676,A,O
9343,676,male,B-Person
9344,676,or,O
9345,676,female,B-Person
9346,676,between,O
9347,676,",",O
9348,676,and,O
9349,676,including,O
9350,676,",",O
9351,676,18,O
9352,676,and,O
9353,676,50,O
9354,676,years,O
9355,676,of,O
9356,676,age,B-Person
9357,676,at,O
9358,676,the,O
9359,676,time,O
9360,676,of,O
9361,676,the,O
9362,676,first,O
9363,676,study,O
9364,676,visit,O
9365,676,.,O
9366,677,Healthy,B-Condition
9367,677,subjects,O
9368,677,as,O
9369,677,established,O
9370,677,by,O
9371,677,medical,B-Observation
9372,677,history,I-Observation
9373,677,and,O
9374,677,clinical,B-Procedure
9375,677,examination,I-Procedure
9376,677,before,O
9377,677,entering,O
9378,677,into,O
9379,677,the,O
9380,677,study,O
9381,677,.,O
9382,677,Healthy,O
9383,677,subjects,O
9384,677,with,O
9385,677,no,O
9386,677,medical,O
9387,677,conditions,O
9388,677,that,O
9389,677,",",O
9390,677,in,O
9391,677,the,O
9392,677,opinion,O
9393,677,of,O
9394,677,the,O
9395,677,investigator,O
9396,677,",",O
9397,677,prevents,O
9398,677,the,O
9399,677,subject,O
9400,677,from,O
9401,677,participating,O
9402,677,in,O
9403,677,the,O
9404,677,study,O
9405,677,.,O
9406,678,Subjects,O
9407,678,must,O
9408,678,weigh,O
9409,678,at,O
9410,678,least,O
9411,678,110,O
9412,678,pounds,O
9413,678,(,O
9414,678,50,O
9415,678,kg,O
9416,678,),O
9417,678,",",O
9418,678,but,O
9419,678,not,O
9420,678,to,O
9421,678,present,O
9422,678,obesity,B-Condition
9423,678,(,O
9424,678,BMI,O
9425,678,<,O
9426,678,32kg,O
9427,678,/,O
9428,678,m2,O
9429,678,),O
9430,678,.,O
9431,679,Female,B-Person
9432,679,subjects,O
9433,679,of,O
9434,679,non,O
9435,679,-,O
9436,679,childbearing,B-Observation
9437,679,potential,I-Observation
9438,679,may,O
9439,679,be,O
9440,679,enrolled,O
9441,679,in,O
9442,679,the,O
9443,679,study,O
9444,679,.,O
9445,679,Non,O
9446,679,-,O
9447,679,childbearing,O
9448,679,potential,O
9449,679,is,O
9450,679,defined,O
9451,679,as,O
9452,679,pre,B-Observation
9453,679,-,I-Observation
9454,679,menarche,I-Observation
9455,679,",",O
9456,679,current,O
9457,679,bilateral,B-Condition
9458,679,tubal,I-Condition
9459,679,ligation,I-Condition
9460,679,or,I-Condition
9461,679,occlusion,I-Condition
9462,679,",",O
9463,679,hysterectomy,B-Condition
9464,679,",",O
9465,679,bilateral,B-Condition
9466,679,ovariectomy,I-Condition
9467,679,or,O
9468,679,post,B-Observation
9469,679,-,I-Observation
9470,679,menopause,I-Observation
9471,679,.,O
9472,680,has,O
9473,680,practiced,O
9474,680,adequate,O
9475,680,contraception,B-Observation
9476,680,for,O
9477,680,30,O
9478,680,days,O
9479,680,prior,O
9480,680,to,O
9481,680,vaccination,O
9482,680,",",O
9483,680,and,O
9484,681,has,O
9485,681,a,O
9486,681,negative,O
9487,681,pregnancy,O
9488,681,test,O
9489,681,on,O
9490,681,the,O
9491,681,day,O
9492,681,of,O
9493,681,vaccination,O
9494,681,and,O
9495,682,has,O
9496,682,agreed,O
9497,682,to,O
9498,682,continue,O
9499,682,adequate,B-Observation
9500,682,contraception,I-Observation
9501,682,during,O
9502,682,the,O
9503,682,entire,O
9504,682,treatment,O
9505,682,period,O
9506,682,and,O
9507,682,for,O
9508,682,1,O
9509,682,month,O
9510,682,",",O
9511,682,after,O
9512,682,completion,O
9513,682,of,O
9514,682,the,O
9515,682,vaccination,O
9516,682,series,O
9517,682,.,O
9518,683,allergy,B-Condition
9519,683,to,O
9520,683,morphine,B-Drug
9521,683,or,O
9522,683,ketamine,B-Drug
9523,684,contraindicate,B-Condition
9524,684,to,O
9525,684,ketamine,B-Drug
9526,685,remain,O
9527,685,intubated,B-Condition
9528,685,in,O
9529,685,the,O
9530,685,postoperative,O
9531,685,period,O
9532,686,ASA,O
9533,686,physical,O
9534,686,status,O
9535,686,1,O
9536,686,-,O
9537,686,3,O
9538,687,elective,O
9539,687,thoracotomy,B-Procedure
9540,688,can,O
9541,688,operate,O
9542,688,patient,O
9543,688,-,O
9544,688,controlled,O
9545,688,analgesia,O
9546,688,(,O
9547,688,PCA,O
9548,688,),O
9549,688,machine,O
9550,689,patients,O
9551,689,with,O
9552,689,cancer,B-Condition
9553,690,patients,O
9554,690,with,O
9555,690,chronic,B-Condition
9556,690,inflammation,I-Condition
9557,690,diseases,I-Condition
9558,691,non,O
9559,691,-,O
9560,691,valvular,O
9561,691,atrial,B-Condition
9562,691,fibrillation,I-Condition
9563,692,nondiabetic,O
9564,692,patients,O
9565,693,type,O
9566,693,1,O
9567,693,and,O
9568,693,2,O
9569,693,diabetic,B-Condition
9570,693,patients,O
9571,694,Received,O
9572,694,any,O
9573,694,vaccine,B-Procedure
9574,694,within,O
9575,694,a,O
9576,694,month,O
9577,694,prior,O
9578,694,to,O
9579,694,study,O
9580,694,vaccine,O
9581,695,Positive,O
9582,695,serum,O
9583,695,antibody,O
9584,695,against,O
9585,695,Hep,O
9586,695,B,O
9587,695,surface,O
9588,695,antigen,O
9589,695,and/or,O
9590,695,core,O
9591,695,Hep,O
9592,695,B,O
9593,695,core,O
9594,695,antigen,O
9595,696,HIV,O
9596,696,positive,O
9597,697,For,O
9598,697,HCV,O
9599,697,-,O
9600,697,negative,O
9601,697,",",O
9602,697,healthy,O
9603,697,volunteers,O
9604,697,:,O
9605,697,History,B-Observation
9606,697,of,I-Observation
9607,697,HCV,I-Observation
9608,697,infection,I-Observation
9609,697,or,O
9610,697,positive,O
9611,697,HCV,O
9612,697,antibody,O
9613,697,test,O
9614,698,Participation,O
9615,698,in,O
9616,698,another,O
9617,698,clinical,O
9618,698,study,O
9619,698,of,O
9620,698,an,O
9621,698,investigational,O
9622,698,product,O
9623,698,currently,O
9624,698,or,O
9625,698,within,O
9626,698,the,O
9627,698,past,O
9628,698,90,O
9629,698,days,O
9630,698,",",O
9631,698,or,O
9632,698,expected,O
9633,698,participation,O
9634,698,during,O
9635,698,this,O
9636,698,study,O
9637,699,In,O
9638,699,the,O
9639,699,opinion,O
9640,699,of,O
9641,699,the,O
9642,699,investigator,O
9643,699,",",O
9644,699,the,O
9645,699,volunteer,O
9646,699,is,O
9647,699,unlikely,O
9648,699,to,O
9649,699,comply,O
9650,699,with,O
9651,699,the,O
9652,699,study,O
9653,699,protocol,O
9654,700,Any,O
9655,700,clinically,O
9656,700,significant,O
9657,700,abnormality,O
9658,700,or,O
9659,700,medical,O
9660,700,history,O
9661,700,or,O
9662,700,physical,O
9663,700,examination,O
9664,700,including,O
9665,700,history,O
9666,700,of,O
9667,700,immunodeficiency,B-Condition
9668,700,or,O
9669,700,autoimmune,B-Condition
9670,700,disease,I-Condition
9671,700,(,O
9672,700,in,O
9673,700,addition,O
9674,700,to,O
9675,700,HCV,B-Condition
9676,700,infection,I-Condition
9677,700,",",O
9678,700,for,O
9679,700,HCV,O
9680,700,group,O
9681,700,),O
9682,701,Currently,O
9683,701,taking,O
9684,701,systemic,B-Drug
9685,701,steroids,I-Drug
9686,701,or,O
9687,701,other,O
9688,701,immunomodulatory,B-Procedure
9689,701,medications,I-Procedure
9690,701,including,O
9691,701,anticancer,B-Procedure
9692,701,medications,I-Procedure
9693,701,and,O
9694,701,antiviral,B-Procedure
9695,701,medications,I-Procedure
9696,702,Any,O
9697,702,clinically,O
9698,702,significant,O
9699,702,acute,O
9700,702,or,O
9701,702,chronic,O
9702,702,medical,O
9703,702,condition,O
9704,702,requiring,O
9705,702,care,O
9706,702,by,O
9707,702,a,O
9708,702,primary,O
9709,702,care,O
9710,702,provider,O
9711,702,(,O
9712,702,e.g.,O
9713,702,",",O
9714,702,diabetes,B-Condition
9715,702,",",O
9716,702,coronary,B-Condition
9717,702,artery,I-Condition
9718,702,disease,I-Condition
9719,702,",",O
9720,702,rheumatologic,B-Condition
9721,702,illness,I-Condition
9722,702,",",O
9723,702,malignancy,B-Condition
9724,702,",",O
9725,702,substance,B-Condition
9726,702,abuse,I-Condition
9727,702,),O
9728,702,that,O
9729,702,",",O
9730,702,in,O
9731,702,the,O
9732,702,opinion,O
9733,702,of,O
9734,702,the,O
9735,702,investigator,O
9736,702,",",O
9737,702,would,O
9738,702,preclude,O
9739,702,participation,O
9740,703,Unable,O
9741,703,to,O
9742,703,continue,O
9743,703,participation,O
9744,703,for,O
9745,703,156,O
9746,703,weeks,O
9747,704,History,O
9748,704,of,O
9749,704,previous,O
9750,704,Hepatitis,B-Procedure
9751,704,B,I-Procedure
9752,704,vaccination(s,I-Procedure
9753,704,),O
9754,705,Male,B-Person
9755,705,or,O
9756,705,female,B-Person
9757,705,<,O
9758,705,18,O
9759,705,and,O
9760,705,>,O
9761,705,62,O
9762,705,years,O
9763,705,of,O
9764,705,age,B-Person
9765,706,Is,O
9766,706,pregnant,O
9767,706,or,O
9768,706,lactating,O
9769,707,History,O
9770,707,of,O
9771,707,Hepatitis,B-Condition
9772,707,B,I-Condition
9773,707,infection,I-Condition
9774,708,Clinical,O
9775,708,",",O
9776,708,laboratory,O
9777,708,",",O
9778,708,or,O
9779,708,biopsy,O
9780,708,evidence,O
9781,708,of,O
9782,708,cirrhosis,B-Condition
9783,709,Willing,O
9784,709,to,O
9785,709,receive,O
9786,709,three,O
9787,709,doses,O
9788,709,of,O
9789,709,an,O
9790,709,FDA,O
9791,709,-,O
9792,709,approved,O
9793,709,Hepatitis,O
9794,709,B,O
9795,709,vaccine,O
9796,710,Volunteer,O
9797,710,chronically,O
9798,710,infected,O
9799,710,with,O
9800,710,HCV,O
9801,710,(,O
9802,710,as,O
9803,710,demonstrated,O
9804,710,by,O
9805,710,serology,O
9806,710,and/or,O
9807,710,viral,O
9808,710,load,O
9809,710,laboratory,O
9810,710,studies,O
9811,710,),O
9812,711,Healthy,O
9813,711,volunteer,B-Person
9814,711,without,O
9815,711,significant,O
9816,711,medical,O
9817,711,problems,O
9818,712,Preoperative,O
9819,712,renal,B-Condition
9820,712,failure,I-Condition
9821,712,(,O
9822,712,defined,O
9823,712,as,O
9824,712,a,O
9825,712,serum,O
9826,712,creatinine,O
9827,712,>,O
9828,712,2.0,O
9829,712,mg,O
9830,712,/,O
9831,712,dL.,O
9832,712,),O
9833,713,American,O
9834,713,Society,O
9835,713,of,O
9836,713,Anesthesiologists,O
9837,713,Physical,O
9838,713,Status,O
9839,713,IV,O
9840,713,or,O
9841,713,V,O
9842,714,Pulmonary,B-Condition
9843,714,disease,I-Condition
9844,714,necessitating,O
9845,714,home,B-Procedure
9846,714,oxygen,I-Procedure
9847,714,therapy,I-Procedure
9848,715,Allergy,O
9849,715,to,O
9850,715,methadone,B-Drug
9851,715,",",O
9852,715,hydromorphone,B-Drug
9853,715,",",O
9854,715,or,O
9855,715,ketamine,B-Drug
9856,716,Preoperative,O
9857,716,recent,O
9858,716,history,B-Observation
9859,716,of,O
9860,716,opioid,B-Condition
9861,716,or,I-Condition
9862,716,alcohol,I-Condition
9863,716,abuse,I-Condition
9864,717,Significant,O
9865,717,liver,B-Condition
9866,717,disease,I-Condition
9867,718,Inability,B-Observation
9868,718,to,I-Observation
9869,718,use,I-Observation
9870,718,a,I-Observation
9871,718,PCA,I-Observation
9872,718,device,I-Observation
9873,718,or,I-Observation
9874,718,speak,I-Observation
9875,718,the,I-Observation
9876,718,English,I-Observation
9877,718,language,I-Observation
9878,719,Patients,O
9879,719,presenting,O
9880,719,for,O
9881,719,elective,O
9882,719,posterior,B-Procedure
9883,719,spinal,I-Procedure
9884,719,fusion,I-Procedure
9885,719,surgery,I-Procedure
9886,719,(,O
9887,719,lower,O
9888,719,thoracic,O
9889,719,",",O
9890,719,lumbar,O
9891,719,",",O
9892,719,sacral,O
9893,719,),O
9894,720,Ages,B-Person
9895,720,18,O
9896,720,-,O
9897,720,80,O
9898,721,Women,B-Person
9899,721,of,O
9900,721,child,B-Condition
9901,721,-,I-Condition
9902,721,bearing,I-Condition
9903,721,potential,I-Condition
9904,721,that,O
9905,721,do,O
9906,721,not,O
9907,721,practice,O
9908,721,adequate,B-Procedure
9909,721,contraception,I-Procedure
9910,721,.,O
9911,722,Pregnant,B-Condition
9912,722,or,O
9913,722,lactating,B-Condition
9914,722,.,O
9915,723,Received,O
9916,723,more,O
9917,723,than,O
9918,723,one,O
9919,723,primary,B-Drug
9920,723,chemotherapy,I-Drug
9921,723,regimen,I-Drug
9922,723,.,O
9923,724,Concomitant,O
9924,724,or,O
9925,724,previous,O
9926,724,malignancies,B-Condition
9927,724,with,O
9928,724,the,O
9929,724,exception,O
9930,724,of,O
9931,724,adequately,O
9932,724,treated,O
9933,724,basal,B-Condition
9934,724,cell,I-Condition
9935,724,or,I-Condition
9936,724,squamous,I-Condition
9937,724,cell,I-Condition
9938,724,skin,I-Condition
9939,724,cancer,I-Condition
9940,724,",",O
9941,724,in,B-Condition
9942,724,situ,I-Condition
9943,724,cervical,I-Condition
9944,724,cancer,I-Condition
9945,724,",",O
9946,724,incidental,B-Condition
9947,724,carcinoid,I-Condition
9948,724,",",O
9949,724,or,O
9950,724,other,B-Condition
9951,724,cancer,I-Condition
9952,724,from,O
9953,724,which,O
9954,724,the,O
9955,724,patient,O
9956,724,has,O
9957,724,been,O
9958,724,disease,O
9959,724,free,O
9960,724,for,O
9961,724,5,O
9962,724,years,O
9963,724,.,O
9964,725,Active,O
9965,725,uncontrolled,O
9966,725,infection,B-Condition
9967,725,requiring,O
9968,725,antibiotics,B-Drug
9969,725,.,O
9970,726,Concurrent,O
9971,726,severe,O
9972,726,medical,B-Condition
9973,726,problems,I-Condition
9974,726,unrelated,O
9975,726,to,O
9976,726,the,O
9977,726,malignancy,B-Condition
9978,726,which,O
9979,726,would,O
9980,726,limit,O
9981,726,full,O
9982,726,compliance,O
9983,726,with,O
9984,726,the,O
9985,726,study,O
9986,726,.,O
9987,727,Received,O
9988,727,radiation,B-Procedure
9989,727,to,O
9990,727,more,O
9991,727,than,O
9992,727,10,O
9993,727,%,O
9994,727,of,O
9995,727,bone,O
9996,727,.,O
9997,728,Prior,O
9998,728,treatment,B-Observation
9999,728,with,O
10000,728,topotecan,B-Drug
10001,728,or,O
10002,728,gemcitabine,B-Drug
10003,728,.,O
10004,729,Hypersensitivity,B-Condition
10005,729,to,O
10006,729,camptothecin,B-Drug
10007,729,or,O
10008,729,nucleoside,B-Drug
10009,729,analogues,I-Drug
10010,729,.,O
10011,730,Use,O
10012,730,of,O
10013,730,an,O
10014,730,investigational,B-Drug
10015,730,agent,I-Drug
10016,730,within,O
10017,730,30,O
10018,730,days,O
10019,730,.,O
10020,731,Have,O
10021,731,had,O
10022,731,one,O
10023,731,prior,O
10024,731,platinum,B-Drug
10025,731,-,I-Drug
10026,731,based,I-Drug
10027,731,chemotherapy,I-Drug
10028,731,regimen,I-Drug
10029,731,for,O
10030,731,the,O
10031,731,treatment,O
10032,731,of,O
10033,731,primary,B-Condition
10034,731,disease,I-Condition
10035,731,.,O
10036,732,At,O
10037,732,least,O
10038,732,4,O
10039,732,weeks,O
10040,732,since,O
10041,732,last,O
10042,732,surgery,O
10043,732,or,O
10044,732,radiation,O
10045,732,therapy,O
10046,732,.,O
10047,733,Must,O
10048,733,have,O
10049,733,had,O
10050,733,a,B-Condition
10051,733,treatment,I-Condition
10052,733,-,I-Condition
10053,733,free,I-Condition
10054,733,interval,I-Condition
10055,733,of,O
10056,733,greater,O
10057,733,than,O
10058,733,6,O
10059,733,months,O
10060,733,following,O
10061,733,response,O
10062,733,to,O
10063,733,platinum,B-Drug
10064,733,.,O
10065,734,ECOG,O
10066,734,performance,O
10067,734,status,O
10068,734,of,O
10069,734,"0,1",O
10070,734,",",O
10071,734,or,O
10072,734,2,O
10073,734,.,O
10074,735,Known,B-Observation
10075,735,or,O
10076,735,suspected,B-Observation
10077,735,sensitivity,B-Condition
10078,735,to,I-Condition
10079,735,Dexamethasone,I-Condition
10080,735,Acetate,I-Condition
10081,735,(,I-Condition
10082,735,DXA,I-Condition
10083,735,),I-Condition
10084,736,Mechanical,O
10085,736,tricuspid,O
10086,736,heart,O
10087,736,valve,O
10088,737,Subject,O
10089,737,is,O
10090,737,enrolled,O
10091,737,in,O
10092,737,any,O
10093,737,other,O
10094,737,concurrent,O
10095,737,study,O
10096,737,without,O
10097,737,prior,O
10098,737,written,O
10099,737,approval,O
10100,737,from,O
10101,737,Boston,O
10102,737,Scientific,O
10103,737,(,O
10104,737,BSC,O
10105,737,),O
10106,737,",",O
10107,737,with,O
10108,737,the,O
10109,737,exception,O
10110,737,of,O
10111,737,local,O
10112,737,mandatory,O
10113,737,governmental,O
10114,737,registries,O
10115,737,and,O
10116,737,observational,O
10117,737,studies,O
10118,737,/,O
10119,737,registries,O
10120,737,that,O
10121,737,are,O
10122,737,not,O
10123,737,in,O
10124,737,conflict,O
10125,737,and,O
10126,737,do,O
10127,737,not,O
10128,737,affect,O
10129,737,the,O
10130,737,following,O
10131,737,:,O
10132,738,Schedule,O
10133,738,of,O
10134,738,procedures,O
10135,738,for,O
10136,738,the,O
10137,738,RELIANCE,O
10138,738,4,O
10139,738,-,O
10140,738,Front,O
10141,738,Study,O
10142,738,(,O
10143,738,i.e.,O
10144,738,should,O
10145,738,not,O
10146,738,cause,O
10147,738,additional,O
10148,738,or,O
10149,738,missed,O
10150,738,visits,O
10151,738,),O
10152,738,;,O
10153,739,RELIANCE,O
10154,739,4,O
10155,739,-,O
10156,739,Front,O
10157,739,Study,O
10158,739,outcome,O
10159,739,(,O
10160,739,i.e.,O
10161,739,involve,O
10162,739,medications,O
10163,739,that,O
10164,739,could,O
10165,739,affect,O
10166,739,the,O
10167,739,heart,O
10168,739,rate,O
10169,739,of,O
10170,739,the,O
10171,739,subject,O
10172,739,),O
10173,739,;,O
10174,740,Conduct,O
10175,740,of,O
10176,740,the,O
10177,740,RELIANCE,O
10178,740,4,O
10179,740,-,O
10180,740,Front,O
10181,740,Study,O
10182,740,per,O
10183,740,Good,O
10184,740,Clinical,O
10185,740,Practice,O
10186,740,(,O
10187,740,GCP)/,O
10188,740,International,O
10189,740,Organization,O
10190,740,for,O
10191,740,Standardization,O
10192,740,(,O
10193,740,ISO,O
10194,740,),O
10195,740,14155:2011/,O
10196,740,21,O
10197,740,CFR,O
10198,740,812/,O
10199,740,local,O
10200,740,regulations,O
10201,741,Currently,O
10202,741,on,O
10203,741,the,O
10204,741,active,B-Observation
10205,741,heart,I-Observation
10206,741,transplant,I-Observation
10207,741,list,I-Observation
10208,742,Documented,O
10209,742,life,B-Observation
10210,742,expectancy,I-Observation
10211,742,of,O
10212,742,less,O
10213,742,than,O
10214,742,12,O
10215,742,months,O
10216,743,Women,B-Person
10217,743,of,O
10218,743,childbearing,B-Condition
10219,743,potential,I-Condition
10220,743,who,O
10221,743,are,B-Observation
10222,743,or,I-Observation
10223,743,might,I-Observation
10224,743,be,I-Observation
10225,743,pregnant,B-Condition
10226,743,at,O
10227,743,the,O
10228,743,time,O
10229,743,of,O
10230,743,study,O
10231,743,enrollment,O
10232,743,(,O
10233,743,method,O
10234,743,of,O
10235,743,assessment,O
10236,743,upon,O
10237,743,physician,O
10238,743,discretion,O
10239,743,),O
10240,744,Currently,O
10241,744,requiring,B-Condition
10242,744,chronic,I-Condition
10243,744,dialysis,I-Condition
10244,745,Willing,O
10245,745,and,O
10246,745,capable,O
10247,745,of,O
10248,745,providing,O
10249,745,informed,O
10250,745,consent,O
10251,746,Has,O
10252,746,an,O
10253,746,indication,B-Observation
10254,746,for,O
10255,746,implantation,O
10256,746,of,O
10257,746,a,O
10258,746,single,O
10259,746,or,O
10260,746,dual,O
10261,746,chamber,O
10262,746,ICD,O
10263,746,or,O
10264,746,CRT,O
10265,746,-,O
10266,746,D,O
10267,746,system,O
10268,746,in,O
10269,746,their,O
10270,746,respective,O
10271,746,geography,O
10272,747,Subjects,O
10273,747,planned,B-Observation
10274,747,to,O
10275,747,be,O
10276,747,implanted,B-Procedure
10277,747,with,I-Procedure
10278,747,the,I-Procedure
10279,747,RELIANCE,I-Procedure
10280,747,4,I-Procedure
10281,747,-,I-Procedure
10282,747,FRONT,I-Procedure
10283,747,Passive,I-Procedure
10284,747,Fixation,I-Procedure
10285,747,Lead,I-Procedure
10286,748,Willing,O
10287,748,and,O
10288,748,capable,O
10289,748,of,O
10290,748,participating,O
10291,748,in,O
10292,748,all,O
10293,748,testing/,O
10294,748,visits,O
10295,748,associated,O
10296,748,with,O
10297,748,this,O
10298,748,clinical,O
10299,748,study,O
10300,748,at,O
10301,748,an,O
10302,748,approved,O
10303,748,clinical,O
10304,748,study,O
10305,748,center,O
10306,748,and,O
10307,748,at,O
10308,748,the,O
10309,748,intervals,O
10310,748,defined,O
10311,748,by,O
10312,748,this,O
10313,748,protocol,O
10314,749,Age,B-Person
10315,749,18,O
10316,749,or,O
10317,749,above,O
10318,749,",",O
10319,749,or,O
10320,749,of,O
10321,749,legal,O
10322,749,age,O
10323,749,to,O
10324,749,give,O
10325,749,informed,O
10326,749,consent,O
10327,749,specific,O
10328,749,to,O
10329,749,state,O
10330,749,and,O
10331,749,national,O
10332,749,law,O
10333,750,Allergy,B-Condition
10334,750,to,O
10335,750,any,O
10336,750,of,O
10337,750,proposed,B-Drug
10338,750,medications,I-Drug
10339,751,Patients,O
10340,751,with,O
10341,751,any,O
10342,751,active,B-Condition
10343,751,infection,I-Condition
10344,751,including,O
10345,751,HBV,B-Condition
10346,751,",",O
10347,751,HCV,B-Condition
10348,751,and,O
10349,751,HIV,B-Condition
10350,751,.,O
10351,752,All,O
10352,752,renal,O
10353,752,(,O
10354,752,only,O
10355,752,),O
10356,752,male,B-Person
10357,752,and,O
10358,752,female,B-Person
10359,752,recipients,O
10360,752,aged,O
10361,752,=,O
10362,752,60,O
10363,752,",",O
10364,752,years,O
10365,752,undergoing,O
10366,752,kidney,B-Procedure
10367,752,transplantation,I-Procedure
10368,752,from,O
10369,752,a,O
10370,752,living,O
10371,752,or,O
10372,752,deceased,O
10373,752,donor,O
10374,752,",",O
10375,752,including,O
10376,752,Expanded,O
10377,752,Criteria,O
10378,752,Donors,O
10379,752,(,O
10380,752,ECD,O
10381,752,),O
10382,752,.,O
10383,753,Panel,O
10384,753,Reactive,O
10385,753,Antibody,O
10386,753,(,O
10387,753,PRA,O
10388,753,),O
10389,753,<,O
10390,753,30,O
10391,753,%,O
10392,753,.,O
10393,754,Patients,O
10394,754,who,O
10395,754,consented,O
10396,754,to,O
10397,754,participate,O
10398,754,in,O
10399,754,the,O
10400,754,study,O
10401,754,by,O
10402,754,signing,O
10403,754,the,O
10404,754,informed,O
10405,754,consent,O
10406,754,form,O
10407,754,before,O
10408,754,the,O
10409,754,transplant,O
10410,754,surgery,O
10411,754,to,O
10412,754,the,O
10413,754,1st,O
10414,754,post,O
10415,754,-,O
10416,754,operative,O
10417,754,day,O
10418,754,),O
10419,754,.,O
10420,755,Use,O
10421,755,of,O
10422,755,any,O
10423,755,investigational,O
10424,755,or,O
10425,755,non,B-Drug
10426,755,-,I-Drug
10427,755,registered,I-Drug
10428,755,product,I-Drug
10429,755,(,I-Drug
10430,755,drug,I-Drug
10431,755,or,I-Drug
10432,755,vaccine,I-Drug
10433,755,),I-Drug
10434,755,other,I-Drug
10435,755,than,I-Drug
10436,755,the,I-Drug
10437,755,study,I-Drug
10438,755,vaccine(s,I-Drug
10439,755,),I-Drug
10440,755,within,O
10441,755,30,O
10442,755,days,O
10443,755,preceding,O
10444,755,the,O
10445,755,first,O
10446,755,dose,O
10447,755,of,O
10448,755,study,O
10449,755,vaccine,O
10450,755,",",O
10451,755,or,O
10452,755,planned,B-Observation
10453,755,use,I-Observation
10454,755,during,O
10455,755,the,O
10456,755,study,O
10457,755,period,O
10458,756,Chronic,O
10459,756,administration,O
10460,756,(,O
10461,756,defined,O
10462,756,as,O
10463,756,more,O
10464,756,than,O
10465,756,14,O
10466,756,days,O
10467,756,),O
10468,756,of,O
10469,756,immunosuppressants,B-Drug
10470,756,or,O
10471,756,other,B-Drug
10472,756,immune,I-Drug
10473,756,-,I-Drug
10474,756,modifying,I-Drug
10475,756,drugs,I-Drug
10476,756,within,O
10477,756,six,O
10478,756,months,O
10479,756,prior,O
10480,756,to,O
10481,756,the,O
10482,756,first,O
10483,756,vaccine,O
10484,756,dose,O
10485,756,.,O
10486,757,Planned,B-Observation
10487,757,administration/,O
10488,757,administration,O
10489,757,of,O
10490,757,a,O
10491,757,vaccine,B-Drug
10492,757,not,O
10493,757,foreseen,O
10494,757,by,O
10495,757,the,O
10496,757,study,O
10497,757,protocol,O
10498,757,during,O
10499,757,the,O
10500,757,period,O
10501,757,starting,O
10502,757,one,O
10503,757,month,O
10504,757,before,O
10505,757,each,O
10506,757,dose,O
10507,757,of,O
10508,757,vaccine(s,O
10509,757,),O
10510,757,and,O
10511,757,ending,O
10512,757,7,O
10513,757,days,O
10514,757,after,O
10515,757,dose,B-Drug
10516,757,1,I-Drug
10517,757,and,O
10518,757,dose,B-Drug
10519,757,2,I-Drug
10520,757,or,O
10521,757,1,O
10522,757,month,O
10523,757,after,O
10524,757,dose,B-Drug
10525,757,3,I-Drug
10526,757,.,O
10527,758,Previous,O
10528,758,vaccination,B-Drug
10529,758,against,O
10530,758,diphtheria,B-Condition
10531,758,",",O
10532,758,tetanus,B-Condition
10533,758,",",O
10534,758,pertussis,B-Condition
10535,758,",",O
10536,758,polio,B-Condition
10537,758,",",O
10538,758,hepatitis,B-Condition
10539,758,B,I-Condition
10540,758,",",O
10541,758,Haemophilus,B-Condition
10542,758,influenzae,I-Condition
10543,758,type,I-Condition
10544,758,b,I-Condition
10545,758,",",O
10546,758,and/or,O
10547,758,S.,B-Condition
10548,758,pneumoniae,I-Condition
10549,758,with,O
10550,758,the,O
10551,758,exception,O
10552,758,of,O
10553,758,vaccines,B-Drug
10554,758,where,O
10555,758,the,O
10556,758,first,O
10557,758,dose,O
10558,758,can,O
10559,758,be,O
10560,758,given,O
10561,758,within,O
10562,758,the,O
10563,758,first,O
10564,758,two,O
10565,758,weeks,O
10566,758,of,O
10567,758,life,O
10568,758,according,O
10569,758,to,O
10570,758,the,O
10571,758,national,O
10572,758,recommendations,O
10573,759,History,B-Observation
10574,759,of,O
10575,759,or,O
10576,759,intercurrent,O
10577,759,diphtheria,B-Condition
10578,759,",",O
10579,759,tetanus,B-Condition
10580,759,",",O
10581,759,pertussis,B-Condition
10582,759,",",O
10583,759,hepatitis,B-Condition
10584,759,B,I-Condition
10585,759,",",O
10586,759,polio,B-Condition
10587,759,",",O
10588,759,and,O
10589,759,Haemophilus,B-Condition
10590,759,influenzae,I-Condition
10591,759,type,I-Condition
10592,759,b,I-Condition
10593,759,diseases,O
10594,759,.,O
10595,760,History,B-Observation
10596,760,of,O
10597,760,allergic,B-Condition
10598,760,disease,I-Condition
10599,760,or,O
10600,760,reactions,O
10601,760,likely,O
10602,760,to,O
10603,760,be,O
10604,760,exacerbated,O
10605,760,by,O
10606,760,any,O
10607,760,component,O
10608,760,of,O
10609,760,the,O
10610,760,vaccines,O
10611,760,.,O
10612,761,History,B-Observation
10613,761,of,O
10614,761,seizures,B-Condition
10615,761,(,O
10616,761,this,O
10617,761,criterion,O
10618,761,does,O
10619,761,not,O
10620,761,apply,O
10621,761,to,O
10622,761,subjects,O
10623,761,who,O
10624,761,have,O
10625,761,had,O
10626,761,a,O
10627,761,single,O
10628,761,",",O
10629,761,uncomplicated,O
10630,761,febrile,B-Condition
10631,761,convulsion,I-Condition
10632,761,in,O
10633,761,the,O
10634,761,past,O
10635,761,),O
10636,761,or,O
10637,761,neurological,B-Condition
10638,761,disease,I-Condition
10639,761,.,O
10640,762,Acute,B-Condition
10641,762,disease,I-Condition
10642,762,at,O
10643,762,the,O
10644,762,time,O
10645,762,of,O
10646,762,enrolment,O
10647,763,Any,O
10648,763,confirmed,O
10649,763,or,O
10650,763,suspected,O
10651,763,immunosuppressive,B-Condition
10652,763,or,I-Condition
10653,763,immunodeficient,I-Condition
10654,763,condition,I-Condition
10655,763,based,O
10656,763,on,O
10657,763,medical,O
10658,763,history,O
10659,763,and,O
10660,763,physical,O
10661,764,A,O
10662,764,family,B-Observation
10663,764,history,I-Observation
10664,764,of,O
10665,764,congenital,B-Condition
10666,764,or,I-Condition
10667,764,hereditary,I-Condition
10668,764,immunodeficiency,I-Condition
10669,764,.,O
10670,765,Major,B-Condition
10671,765,congenital,I-Condition
10672,765,defects,I-Condition
10673,765,or,O
10674,765,serious,B-Condition
10675,765,chronic,I-Condition
10676,765,illness,I-Condition
10677,765,.,O
10678,766,Administration,O
10679,766,of,O
10680,766,immunoglobulins,B-Drug
10681,766,and/or,O
10682,766,any,B-Drug
10683,766,blood,I-Drug
10684,766,products,I-Drug
10685,766,since,O
10686,766,birth,O
10687,766,or,O
10688,766,planned,B-Observation
10689,766,administration,O
10690,766,during,O
10691,766,the,O
10692,766,active,O
10693,766,phase,O
10694,766,of,O
10695,766,the,O
10696,766,study,O
10697,766,.,O
10698,767,Male,O
10699,767,or,O
10700,767,female,O
10701,767,between,O
10702,767,",",O
10703,767,and,O
10704,767,including,O
10705,767,",",O
10706,767,6,O
10707,767,-,O
10708,767,12,O
10709,767,weeks,O
10710,767,(,O
10711,767,42,O
10712,767,to,O
10713,767,90,O
10714,767,days,O
10715,767,),O
10716,767,of,B-Person
10717,767,age,I-Person
10718,767,at,O
10719,767,the,O
10720,767,time,O
10721,767,of,O
10722,767,the,O
10723,767,first,O
10724,767,vaccination,O
10725,767,.,O
10726,768,Subjects,O
10727,768,for,O
10728,768,whom,O
10729,768,the,O
10730,768,investigator,O
10731,768,believes,O
10732,768,that,O
10733,768,their,O
10734,768,parents,O
10735,768,/,O
10736,768,guardians,O
10737,768,can,O
10738,768,and,O
10739,768,will,O
10740,768,comply,O
10741,768,with,O
10742,768,the,O
10743,768,requirements,O
10744,768,of,O
10745,768,the,O
10746,768,protocol,O
10747,769,Written,B-Observation
10748,769,informed,I-Observation
10749,769,consent,I-Observation
10750,769,obtained,O
10751,769,from,O
10752,769,the,O
10753,769,parent,O
10754,769,or,O
10755,769,guardian,O
10756,769,of,O
10757,769,the,O
10758,769,subject,O
10759,769,.,O
10760,770,Free,O
10761,770,of,O
10762,770,obvious,O
10763,770,health,B-Condition
10764,770,problems,I-Condition
10765,770,as,O
10766,770,established,O
10767,770,by,O
10768,770,medical,O
10769,770,history,O
10770,770,and,O
10771,770,clinical,O
10772,770,examination,O
10773,770,before,O
10774,770,entering,O
10775,770,into,O
10776,770,the,O
10777,770,study,O
10778,770,.,O
10779,771,Born,B-Condition
10780,771,after,O
10781,771,a,O
10782,771,gestation,O
10783,771,period,O
10784,771,between,O
10785,771,36,O
10786,771,and,O
10787,771,42,O
10788,771,weeks,O
10789,771,.,O
10790,772,Pregnancy,O
10791,772,:,O
10792,772,Women,O
10793,772,who,O
10794,772,are,O
10795,772,pregnant,O
10796,772,or,O
10797,772,lactating,O
10798,772,.,O
10799,773,Asthma,B-Condition
10800,773,:,O
10801,773,Subjects,O
10802,773,with,O
10803,773,a,O
10804,773,current,O
10805,773,diagnosis,O
10806,773,of,O
10807,773,asthma,B-Condition
10808,773,.,O
10809,773,(,O
10810,773,Subjects,O
10811,773,with,O
10812,773,a,O
10813,773,prior,O
10814,773,history,B-Observation
10815,773,of,O
10816,773,asthma,B-Condition
10817,773,are,O
10818,773,eligible,O
10819,773,if,O
10820,773,they,O
10821,773,also,O
10822,773,have,O
10823,773,a,O
10824,773,current,O
10825,773,diagnosis,O
10826,773,of,O
10827,773,COPD,B-Condition
10828,773,),O
10829,773,.,O
10830,774,alpha,B-Condition
10831,774,1,I-Condition
10832,774,-,I-Condition
10833,774,antitrypsin,I-Condition
10834,774,deficiency,I-Condition
10835,774,:,O
10836,774,Subjects,O
10837,774,with,O
10838,774,known,O
10839,774,alpha-1,B-Condition
10840,774,antitrypsin,I-Condition
10841,774,deficiency,I-Condition
10842,774,as,O
10843,774,the,O
10844,774,underlying,O
10845,774,cause,O
10846,774,of,O
10847,774,COPD,B-Condition
10848,774,.,O
10849,775,Other,B-Condition
10850,775,respiratory,I-Condition
10851,775,disorders,I-Condition
10852,775,:,O
10853,775,Subjects,O
10854,775,with,O
10855,775,active,O
10856,775,tuberculosis,B-Condition
10857,775,",",O
10858,775,lung,B-Condition
10859,775,cancer,I-Condition
10860,775,",",O
10861,775,bronchiectasis,B-Condition
10862,775,",",O
10863,775,sarcoidosis,B-Condition
10864,775,",",O
10865,775,pulmonary,B-Condition
10866,775,fibrosis,I-Condition
10867,775,",",O
10868,775,pulmonary,B-Condition
10869,775,hypertension,I-Condition
10870,775,",",O
10871,775,interstitial,B-Condition
10872,775,lung,I-Condition
10873,775,diseases,I-Condition
10874,775,or,O
10875,775,other,O
10876,775,active,B-Condition
10877,775,pulmonary,I-Condition
10878,775,diseases,I-Condition
10879,775,.,O
10880,776,Lung,B-Procedure
10881,776,resection,I-Procedure
10882,776,or,O
10883,776,transplantation,B-Procedure
10884,776,:,O
10885,776,Subjects,O
10886,776,with,B-Condition
10887,776,lung,I-Condition
10888,776,volume,I-Condition
10889,776,reduction,I-Condition
10890,776,surgery,I-Condition
10891,776,within,O
10892,776,the,O
10893,776,12,O
10894,776,months,O
10895,776,prior,O
10896,776,to,O
10897,776,Screening,O
10898,776,or,O
10899,776,having,B-Condition
10900,776,had,I-Condition
10901,776,a,I-Condition
10902,776,lung,I-Condition
10903,776,transplant,I-Condition
10904,776,.,O
10905,777,A,O
10906,777,moderate,O
10907,777,/,O
10908,777,severe,O
10909,777,COPD,B-Condition
10910,777,exacerbation,I-Condition
10911,777,that,O
10912,777,has,O
10913,777,not,O
10914,777,resolved,B-Observation
10915,777,at,O
10916,777,least,O
10917,777,14,O
10918,777,days,O
10919,777,prior,O
10920,777,to,O
10921,777,Visit,O
10922,777,1,O
10923,777,and,O
10924,777,at,O
10925,777,least,O
10926,777,30,O
10927,777,days,O
10928,777,following,O
10929,777,the,O
10930,777,last,O
10931,777,dose,O
10932,777,of,O
10933,777,oral,O
10934,777,corticosteroids,O
10935,777,(,O
10936,777,if,O
10937,777,applicable,O
10938,777,),O
10939,777,.,O
10940,778,Current,O
10941,778,severe,O
10942,778,heart,B-Condition
10943,778,failure,I-Condition
10944,778,(,O
10945,778,New,O
10946,778,York,O
10947,778,Heart,O
10948,778,Association,O
10949,778,class,O
10950,778,IV,O
10951,778,),O
10952,778,.,O
10953,778,Subjects,O
10954,778,will,O
10955,778,also,O
10956,778,be,O
10957,778,excluded,O
10958,778,if,O
10959,778,they,O
10960,778,have,O
10961,778,a,O
10962,778,known,O
10963,778,ejection,O
10964,778,fraction,O
10965,778,of,O
10966,778,<,O
10967,778,30,O
10968,778,%,O
10969,778,or,O
10970,778,if,O
10971,778,they,O
10972,778,have,O
10973,778,an,O
10974,778,implantable,O
10975,778,cardioverter,O
10976,778,defibrillator,O
10977,778,(,O
10978,778,ICD,O
10979,778,),O
10980,778,.,O
10981,779,Other,O
10982,779,diseases,O
10983,779,/,O
10984,779,abnormalities,O
10985,779,:,O
10986,779,Any,O
10987,779,life,B-Condition
10988,779,-,I-Condition
10989,779,threatening,I-Condition
10990,779,condition,I-Condition
10991,779,with,O
10992,779,life,B-Observation
10993,779,expectancy,I-Observation
10994,779,<3,O
10995,779,years,O
10996,779,",",O
10997,779,other,O
10998,779,than,O
10999,779,vascular,B-Condition
11000,779,disease,I-Condition
11001,779,or,O
11002,779,COPD,B-Condition
11003,779,",",O
11004,779,that,O
11005,779,might,O
11006,779,prevent,O
11007,779,the,O
11008,779,subject,O
11009,779,from,O
11010,779,completing,O
11011,779,the,O
11012,779,study,O
11013,779,.,O
11014,780,End,B-Condition
11015,780,stage,I-Condition
11016,780,chronic,I-Condition
11017,780,renal,I-Condition
11018,780,disease,I-Condition
11019,780,:,O
11020,780,Subjects,O
11021,780,will,O
11022,780,be,O
11023,780,excluded,O
11024,780,if,O
11025,780,on,O
11026,780,renal,B-Procedure
11027,780,replacement,I-Procedure
11028,780,therapy,I-Procedure
11029,780,(,O
11030,780,hemodialysis,B-Procedure
11031,780,or,O
11032,780,peritoneal,O
11033,780,),O
11034,780,.,O
11035,781,Drug,B-Condition
11036,781,/,I-Condition
11037,781,food,I-Condition
11038,781,allergy,I-Condition
11039,781,:,O
11040,781,Subjects,O
11041,781,with,O
11042,781,a,O
11043,781,history,O
11044,781,of,O
11045,781,hypersensitivity,B-Condition
11046,781,to,O
11047,781,any,O
11048,781,of,O
11049,781,the,O
11050,781,study,B-Drug
11051,781,medications,I-Drug
11052,781,(,O
11053,781,e.g.,O
11054,781,beta,B-Drug
11055,781,-,I-Drug
11056,781,agonists,I-Drug
11057,781,",",O
11058,781,corticosteroid,B-Drug
11059,781,),O
11060,781,or,O
11061,781,components,B-Drug
11062,781,of,I-Drug
11063,781,the,I-Drug
11064,781,inhalation,I-Drug
11065,781,powder,I-Drug
11066,781,(,O
11067,781,e.g.,O
11068,781,lactose,B-Drug
11069,781,",",O
11070,781,magnesium,B-Drug
11071,781,stearate,I-Drug
11072,781,),O
11073,781,.,O
11074,781,In,O
11075,781,addition,O
11076,781,",",O
11077,781,patients,O
11078,781,with,O
11079,781,a,O
11080,781,history,B-Observation
11081,781,of,O
11082,781,severe,O
11083,781,milk,B-Condition
11084,781,protein,I-Condition
11085,781,allergy,I-Condition
11086,781,that,O
11087,781,",",O
11088,781,in,O
11089,781,the,O
11090,781,opinion,O
11091,781,of,O
11092,781,the,O
11093,781,study,O
11094,781,physician,O
11095,781,",",O
11096,781,contraindicates,O
11097,781,the,O
11098,781,subject,O
11099,781,'s,O
11100,781,participation,O
11101,781,will,O
11102,781,also,O
11103,781,be,O
11104,781,excluded,O
11105,781,.,O
11106,782,Drug,B-Drug
11107,782,/,I-Drug
11108,782,alcohol,I-Drug
11109,782,abuse,I-Drug
11110,782,:,O
11111,782,Subjects,O
11112,782,with,O
11113,782,a,O
11114,782,known,O
11115,782,or,O
11116,782,suspected,O
11117,782,history,B-Observation
11118,782,of,O
11119,782,alcohol,B-Drug
11120,782,or,I-Drug
11121,782,drug,I-Drug
11122,782,abuse,I-Drug
11123,782,within,O
11124,782,the,O
11125,782,last,O
11126,782,2,O
11127,782,years,O
11128,782,.,O
11129,783,Oxygen,O
11130,783,therapy,O
11131,783,:,O
11132,783,Subjects,O
11133,783,receiving,O
11134,783,treatment,O
11135,783,with,O
11136,783,long,B-Procedure
11137,783,-,I-Procedure
11138,783,term,I-Procedure
11139,783,oxygen,I-Procedure
11140,783,therapy,I-Procedure
11141,783,(,I-Procedure
11142,783,LTOT,I-Procedure
11143,783,),I-Procedure
11144,783,or,O
11145,783,nocturnal,B-Procedure
11146,783,oxygen,I-Procedure
11147,783,therapy,I-Procedure
11148,783,required,O
11149,783,for,O
11150,783,greater,O
11151,783,than,O
11152,783,12,O
11153,783,hours,O
11154,783,a,O
11155,783,day,O
11156,783,.,O
11157,783,Oxygen,O
11158,783,prn,O
11159,783,use,O
11160,783,(,O
11161,783,i.e.,O
11162,783,<,O
11163,783,=,O
11164,783,12,O
11165,783,hours,O
11166,783,per,O
11167,783,day,O
11168,783,),O
11169,783,is,O
11170,783,not,O
11171,783,exclusionary,O
11172,783,.,O
11173,784,Questionable,O
11174,784,validity,O
11175,784,of,O
11176,784,consent,O
11177,784,:,O
11178,784,Subjects,O
11179,784,with,O
11180,784,a,O
11181,784,history,O
11182,784,of,O
11183,784,psychiatric,O
11184,784,disease,O
11185,784,",",O
11186,784,intellectual,O
11187,784,deficiency,O
11188,784,",",O
11189,784,poor,O
11190,784,motivation,O
11191,784,or,O
11192,784,other,O
11193,784,conditions,O
11194,784,that,O
11195,784,will,O
11196,784,limit,O
11197,784,the,O
11198,784,validity,O
11199,784,of,O
11200,784,informed,O
11201,784,consent,O
11202,784,to,O
11203,784,participate,O
11204,784,in,O
11205,784,the,O
11206,784,study,O
11207,784,or,O
11208,784,the,O
11209,784,potential,O
11210,784,compliance,O
11211,784,to,O
11212,784,study,O
11213,784,procedures,O
11214,784,.,O
11215,785,Affiliation,O
11216,785,with,O
11217,785,investigator,O
11218,785,site,O
11219,785,:,O
11220,785,Study,O
11221,785,investigators,O
11222,785,",",O
11223,785,sub,O
11224,785,-,O
11225,785,investigators,O
11226,785,",",O
11227,785,study,O
11228,785,coordinators,O
11229,785,",",O
11230,785,employees,O
11231,785,of,O
11232,785,a,O
11233,785,participating,O
11234,785,investigator,O
11235,785,or,O
11236,785,immediate,O
11237,785,family,O
11238,785,members,O
11239,785,of,O
11240,785,the,O
11241,785,aforementioned,O
11242,785,are,O
11243,785,excluded,O
11244,785,from,O
11245,785,participating,O
11246,785,in,O
11247,785,this,O
11248,785,study,O
11249,785,.,O
11250,786,Additional,O
11251,786,medication,O
11252,786,:,O
11253,786,Use,O
11254,786,of,O
11255,786,the,O
11256,786,following,O
11257,786,medications,O
11258,786,within,O
11259,786,the,O
11260,786,following,O
11261,786,time,O
11262,786,intervals,O
11263,786,prior,O
11264,786,to,O
11265,786,Visit,O
11266,786,1,O
11267,786,or,O
11268,786,during,O
11269,786,the,O
11270,786,study,O
11271,786,(,O
11272,786,unless,O
11273,786,otherwise,O
11274,786,specified,O
11275,786,):,O
11276,787,Medication,O
11277,787,No,O
11278,787,use,O
11279,787,within,O
11280,787,the,O
11281,787,following,O
11282,787,time,O
11283,787,intervals,O
11284,787,prior,O
11285,787,to,O
11286,787,Screening,O
11287,787,or,O
11288,787,thereafter,O
11289,787,at,O
11290,787,any,O
11291,787,time,O
11292,787,during,O
11293,787,the,O
11294,787,study,O
11295,787,(,O
11296,787,unless,O
11297,787,otherwise,O
11298,787,specified,O
11299,787,),O
11300,787,Inhaled,B-Drug
11301,787,Long,I-Drug
11302,787,acting,I-Drug
11303,787,beta,I-Drug
11304,787,-,I-Drug
11305,787,agonists,I-Drug
11306,787,(,I-Drug
11307,787,LABA,I-Drug
11308,787,),I-Drug
11309,787,48,O
11310,787,hours,O
11311,787,ICS,B-Drug
11312,787,/,I-Drug
11313,787,LABA,I-Drug
11314,787,combination,I-Drug
11315,787,products,I-Drug
11316,787,48,O
11317,787,hours,O
11318,787,Inhaled,B-Drug
11319,787,corticosteroids,I-Drug
11320,787,48,O
11321,787,hours,O
11322,787,Tiotropium,B-Drug
11323,787,1,O
11324,787,week,O
11325,787,Systemic,O
11326,787,",",O
11327,787,Oral,O
11328,787,",",O
11329,787,parenteral,O
11330,787,",",O
11331,787,intra,O
11332,787,-,O
11333,787,articular,O
11334,787,corticosteroids,B-Drug
11335,787,30,O
11336,787,days,O
11337,787,(,O
11338,787,oral,O
11339,787,and,O
11340,787,systemic,O
11341,787,corticosteroids,B-Drug
11342,787,may,O
11343,787,be,O
11344,787,used,O
11345,787,to,O
11346,787,treat,B-Procedure
11347,787,COPD,I-Procedure
11348,787,exacerbations,I-Procedure
11349,787,during,O
11350,787,the,O
11351,787,study,O
11352,787,),O
11353,787,Cytochrome,B-Drug
11354,787,P450,I-Drug
11355,787,3A4,I-Drug
11356,787,strong,I-Drug
11357,787,inhibitors,I-Drug
11358,787,including,O
11359,787,but,O
11360,787,not,O
11361,787,limited,O
11362,787,to,O
11363,787,antiretrovirals,B-Drug
11364,787,(,O
11365,787,protease,B-Drug
11366,787,inhibitors,I-Drug
11367,787,),O
11368,787,(,O
11369,787,e.g.,O
11370,787,Indinavir,B-Drug
11371,787,",",O
11372,787,Nelfinavir,B-Drug
11373,787,",",O
11374,787,Ritonavir,B-Drug
11375,787,",",O
11376,787,Saquinavir,B-Drug
11377,787,),O
11378,787,;,O
11379,787,Imidazole,B-Drug
11380,787,and,I-Drug
11381,787,Triazole,I-Drug
11382,787,anti,I-Drug
11383,787,-,I-Drug
11384,787,fungals,I-Drug
11385,787,(,O
11386,787,e.g.,O
11387,787,Ketaconazole,B-Drug
11388,787,",",O
11389,787,Itraconazole,B-Drug
11390,787,),O
11391,787,;,O
11392,787,Clarithromycin,B-Drug
11393,787,",",O
11394,787,Telithromycin,B-Drug
11395,787,",",O
11396,787,Amiodarone,B-Drug
11397,787,",",O
11398,787,and,O
11399,787,Nefazodone,B-Drug
11400,787,6,O
11401,787,weeks,O
11402,787,Grapefruit,B-Drug
11403,787,is,O
11404,787,allowed,O
11405,787,up,O
11406,787,to,O
11407,787,Visit,O
11408,787,1,O
11409,787,",",O
11410,787,then,O
11411,787,limited,O
11412,787,to,O
11413,787,no,O
11414,787,more,O
11415,787,than,O
11416,787,one,O
11417,787,glass,O
11418,787,of,O
11419,787,grapefruit,O
11420,787,juice,O
11421,787,(,O
11422,787,250,O
11423,787,mL/,O
11424,787,8,O
11425,787,ounces,O
11426,787,),O
11427,787,or,O
11428,787,one,O
11429,787,grapefruit,O
11430,787,per,O
11431,787,day,O
11432,787,Any,O
11433,787,other,O
11434,787,investigational,B-Drug
11435,787,drug,I-Drug
11436,787,30,O
11437,787,days,O
11438,787,or,O
11439,787,5,O
11440,787,half,O
11441,787,lives,O
11442,787,whichever,O
11443,787,is,O
11444,787,longer,O
11445,787,.,O
11446,788,Type,O
11447,788,of,O
11448,788,subject,O
11449,788,:,O
11450,788,outpatient,O
11451,788,.,O
11452,789,Informed,O
11453,789,consent,O
11454,789,:,O
11455,789,Subjects,O
11456,789,must,O
11457,789,give,O
11458,789,their,O
11459,789,signed,O
11460,789,and,O
11461,789,dated,O
11462,789,written,O
11463,789,informed,O
11464,789,consent,O
11465,789,to,O
11466,789,participate,O
11467,789,.,O
11468,790,Gender,O
11469,790,:,O
11470,790,Male,B-Person
11471,790,or,O
11472,790,female,B-Person
11473,790,.,O
11474,790,Female,O
11475,790,subjects,O
11476,790,must,O
11477,790,be,O
11478,790,post,O
11479,790,-,O
11480,790,menopausal,O
11481,790,or,O
11482,790,using,O
11483,790,a,O
11484,790,highly,O
11485,790,effective,O
11486,790,method,O
11487,790,for,O
11488,790,avoidance,O
11489,790,of,O
11490,790,pregnancy,O
11491,790,.,O
11492,790,The,O
11493,790,decision,O
11494,790,to,O
11495,790,include,O
11496,790,or,O
11497,790,exclude,O
11498,790,women,O
11499,790,of,O
11500,790,childbearing,O
11501,790,potential,O
11502,790,may,O
11503,790,be,O
11504,790,made,O
11505,790,at,O
11506,790,the,O
11507,790,discretion,O
11508,790,of,O
11509,790,the,O
11510,790,investigator,O
11511,790,in,O
11512,790,accordance,O
11513,790,with,O
11514,790,local,O
11515,790,practice,O
11516,790,in,O
11517,790,relation,O
11518,790,to,O
11519,790,adequate,O
11520,790,contraception,O
11521,790,.,O
11522,791,Age,B-Person
11523,791,:,O
11524,791,>,O
11525,791,=,O
11526,791,40,O
11527,791,and,O
11528,791,<,O
11529,791,=,O
11530,791,80,O
11531,791,years,O
11532,791,of,O
11533,791,age,B-Person
11534,791,at,O
11535,791,Screening,O
11536,791,(,O
11537,791,Visit,O
11538,791,1,O
11539,791,),O
11540,791,.,O
11541,792,Tobacco,O
11542,792,use,O
11543,792,:,O
11544,792,Subjects,O
11545,792,with,O
11546,792,a,O
11547,792,current,O
11548,792,or,O
11549,792,prior,O
11550,792,history,B-Observation
11551,792,of,O
11552,792,>,O
11553,792,=,O
11554,792,10,O
11555,792,pack,O
11556,792,-,O
11557,792,years,O
11558,792,of,O
11559,792,cigarette,B-Observation
11560,792,smoking,I-Observation
11561,792,at,O
11562,792,screening,O
11563,792,(,O
11564,792,Visit,O
11565,792,1,O
11566,792,),O
11567,792,.,O
11568,792,Previous,B-Condition
11569,792,smokers,I-Condition
11570,792,are,O
11571,792,defined,O
11572,792,as,O
11573,792,those,O
11574,792,who,O
11575,792,have,O
11576,792,stopped,B-Observation
11577,792,smoking,I-Observation
11578,792,for,O
11579,792,at,O
11580,792,least,O
11581,792,6,O
11582,792,months,O
11583,792,prior,O
11584,792,to,O
11585,792,Visit,O
11586,792,1,O
11587,792,.,O
11588,793,Airflow,O
11589,793,Obstruction,O
11590,793,:,O
11591,794,Subjects,O
11592,794,with,O
11593,794,a,O
11594,794,measured,O
11595,794,post,O
11596,794,-,O
11597,794,albuterol,B-Drug
11598,794,/,O
11599,794,salbutamol,B-Drug
11600,794,forced,O
11601,794,expiratory,O
11602,794,volume,O
11603,794,in,O
11604,794,1,O
11605,794,second,O
11606,794,(,O
11607,794,FEV1)/(forced,O
11608,794,vital,O
11609,794,capacity)FVC,O
11610,794,ratio,O
11611,794,of,O
11612,794,<,O
11613,794,=,O
11614,794,0.70,O
11615,794,at,O
11616,794,Screening,O
11617,794,(,O
11618,794,Visit,O
11619,794,1,O
11620,794,),O
11621,794,.,O
11622,795,Subjects,O
11623,795,with,O
11624,795,a,O
11625,795,measured,O
11626,795,post,O
11627,795,-,O
11628,795,albuterol,B-Drug
11629,795,/,O
11630,795,salbutamol,B-Drug
11631,795,FEV1,O
11632,795,>,O
11633,795,=,O
11634,795,50,O
11635,795,and,O
11636,795,<,O
11637,795,=,O
11638,795,70,O
11639,795,%,O
11640,795,of,O
11641,795,predicted,O
11642,795,normal,O
11643,795,values,O
11644,795,calculated,O
11645,795,using,O
11646,795,NHANES,O
11647,795,III,O
11648,795,reference,O
11649,795,equations,O
11650,795,[,O
11651,795,Hankinson,O
11652,795,",",O
11653,795,1999,O
11654,795,;,O
11655,795,Hankinson,O
11656,795,",",O
11657,795,2010,O
11658,795,],O
11659,795,at,O
11660,795,Screening,O
11661,795,(,O
11662,795,Visit,O
11663,795,1,O
11664,795,),O
11665,795,.,O
11666,796,Post,O
11667,796,-,O
11668,796,bronchodilator,B-Drug
11669,796,spirometry,B-Procedure
11670,796,will,O
11671,796,be,O
11672,796,performed,O
11673,796,approximately,O
11674,796,15,O
11675,796,minutes,O
11676,796,after,O
11677,796,the,O
11678,796,subject,O
11679,796,has,O
11680,796,self,O
11681,796,-,O
11682,796,administered,O
11683,796,4,O
11684,796,inhalations,B-Procedure
11685,796,(,O
11686,796,i.e.,O
11687,796,",",O
11688,796,total,O
11689,796,400mcg,O
11690,796,),O
11691,796,of,O
11692,796,albuterol,B-Drug
11693,796,/,O
11694,796,salbutamol,B-Drug
11695,796,via,O
11696,796,a,O
11697,796,metered,B-Procedure
11698,796,dose,I-Procedure
11699,796,inhaler,I-Procedure
11700,796,(,I-Procedure
11701,796,MDI,I-Procedure
11702,796,),I-Procedure
11703,796,with,O
11704,796,a,O
11705,796,valved,O
11706,796,-,O
11707,796,holding,O
11708,796,chamber,O
11709,796,.,O
11710,796,The,O
11711,796,FEV1,O
11712,796,/,O
11713,796,FVC,O
11714,796,ratio,O
11715,796,and,O
11716,796,FEV1,O
11717,796,percent,O
11718,796,predicted,O
11719,796,values,O
11720,796,will,O
11721,796,be,O
11722,796,calculated,O
11723,796,.,O
11724,797,Symptoms,B-Condition
11725,797,of,I-Condition
11726,797,COPD,I-Condition
11727,797,:,O
11728,797,Subjects,O
11729,797,must,O
11730,797,score,O
11731,797,2,O
11732,797,or,O
11733,797,higher,O
11734,797,on,O
11735,797,the,O
11736,797,modified,O
11737,797,Medical,O
11738,797,Research,O
11739,797,Council,O
11740,797,Dyspnea,O
11741,797,scale,O
11742,797,(,O
11743,797,Visit,O
11744,797,1,O
11745,797,),O
11746,798,Cardiovascular,O
11747,798,disease,O
11748,798,:,O
11749,799,For,O
11750,799,patients,O
11751,799,>,O
11752,799,=,O
11753,799,40,O
11754,799,years,O
11755,799,of,O
11756,799,age,B-Person
11757,799,:,O
11758,799,any,O
11759,799,one,O
11760,799,of,O
11761,799,the,O
11762,799,following,O
11763,799,:,O
11764,800,Established,B-Observation
11765,800,(,O
11766,800,i.e.,O
11767,800,by,O
11768,800,clinical,B-Observation
11769,800,signs,I-Observation
11770,800,or,O
11771,800,imaging,B-Procedure
11772,800,studies,I-Procedure
11773,800,),O
11774,800,coronary,B-Condition
11775,800,artery,I-Condition
11776,800,disease,I-Condition
11777,800,(,I-Condition
11778,800,CAD,I-Condition
11779,800,),I-Condition
11780,800,Established,B-Observation
11781,800,(,O
11782,800,i.e.,O
11783,800,by,O
11784,800,clinical,B-Observation
11785,800,signs,I-Observation
11786,800,or,O
11787,800,imaging,B-Procedure
11788,800,studies,I-Procedure
11789,800,),O
11790,800,peripheral,B-Condition
11791,800,vascular,I-Condition
11792,800,disease,I-Condition
11793,800,(,I-Condition
11794,800,PVD,I-Condition
11795,800,),I-Condition
11796,800,Previous,O
11797,800,stroke,B-Condition
11798,800,Previous,O
11799,800,MI,B-Condition
11800,800,Diabetes,B-Condition
11801,800,mellitus,I-Condition
11802,800,with,O
11803,800,target,B-Condition
11804,800,organ,I-Condition
11805,800,disease,I-Condition
11806,800,OR,O
11807,801,For,O
11808,801,patients,O
11809,801,>,O
11810,801,=,O
11811,801,60,O
11812,801,years,O
11813,801,of,O
11814,801,age,B-Person
11815,801,:,O
11816,801,any,O
11817,801,2,O
11818,801,of,O
11819,801,the,O
11820,801,following,O
11821,801,:,O
11822,802,Being,O
11823,802,treated,B-Procedure
11824,802,for,I-Procedure
11825,802,hypercholesterolemia,I-Procedure
11826,802,Being,O
11827,802,treated,B-Procedure
11828,802,for,I-Procedure
11829,802,hypertension,I-Procedure
11830,802,Being,O
11831,802,treated,B-Procedure
11832,802,for,I-Procedure
11833,802,diabetes,I-Procedure
11834,802,mellitus,I-Procedure
11835,802,Being,O
11836,802,treated,B-Procedure
11837,802,for,I-Procedure
11838,802,peripheral,I-Procedure
11839,802,vascular,I-Procedure
11840,802,disease,I-Procedure
11841,803,1,O
11842,803,.,O
11843,803,Are,O
11844,803,unable,O
11845,803,to,O
11846,803,understand,O
11847,803,and,O
11848,803,sign,O
11849,803,the,O
11850,803,consent,O
11851,803,form,O
11852,804,2,O
11853,804,.,O
11854,804,Are,O
11855,804,pregnant,B-Condition
11856,804,or,O
11857,804,lactating,B-Condition
11858,805,3,O
11859,805,.,O
11860,805,Are,O
11861,805,physically,B-Condition
11862,805,unable,I-Condition
11863,805,to,I-Condition
11864,805,sit,I-Condition
11865,805,upright,I-Condition
11866,805,and,I-Condition
11867,805,still,I-Condition
11868,805,for,O
11869,805,40,O
11870,805,minutes,O
11871,806,4,O
11872,806,.,O
11873,806,Have,O
11874,806,undergone,O
11875,806,bilateral,B-Procedure
11876,806,mastectomy,I-Procedure
11877,807,5,O
11878,807,.,O
11879,807,Are,O
11880,807,not,O
11881,807,scheduled,B-Observation
11882,807,to,O
11883,807,undergo,O
11884,807,conventional,B-Procedure
11885,807,ultrasound,I-Procedure
11886,808,1,O
11887,808,.,O
11888,808,Have,O
11889,808,a,O
11890,808,finding,O
11891,808,of,O
11892,808,a,O
11893,808,mass,B-Condition
11894,808,lesion,I-Condition
11895,808,on,O
11896,808,mammography,B-Procedure
11897,808,or,O
11898,808,breast,B-Procedure
11899,808,MRI,I-Procedure
11900,808,(,O
11901,808,BIRADS,O
11902,808,0,O
11903,808,",",O
11904,808,4,O
11905,808,or,O
11906,808,5,O
11907,808,),O
11908,808,that,O
11909,808,is,O
11910,808,>,O
11911,808,0.5,O
11912,808,cm,O
11913,808,and,O
11914,808,<,O
11915,808,2,O
11916,808,cm,O
11917,808,in,O
11918,808,size,O
11919,808,and,O
11920,808,has,O
11921,808,had,O
11922,808,or,O
11923,808,will,O
11924,808,have,O
11925,808,additional,O
11926,808,workup,O
11927,808,with,O
11928,808,focused,O
11929,808,ultrasound,O
11930,808,.,O
11931,809,2,O
11932,809,.,O
11933,809,Have,O
11934,809,a,O
11935,809,finding,O
11936,809,of,O
11937,809,a,O
11938,809,mass,B-Condition
11939,809,lesion,I-Condition
11940,809,on,O
11941,809,ultrasound,B-Procedure
11942,809,(,O
11943,809,BIRADS,O
11944,809,0,O
11945,809,",",O
11946,809,4,O
11947,809,or,O
11948,809,5,O
11949,809,),O
11950,809,that,O
11951,809,is,O
11952,809,>,O
11953,809,0.5,O
11954,809,cm,O
11955,809,and,O
11956,809,<,O
11957,809,2,O
11958,809,cm,O
11959,809,in,O
11960,809,size,O
11961,809,.,O
11962,810,3,O
11963,810,.,O
11964,810,Have,O
11965,810,a,O
11966,810,positive,B-Condition
11967,810,finding,I-Condition
11968,810,on,O
11969,810,MBI,B-Procedure
11970,810,that,O
11971,810,is,O
11972,810,<,O
11973,810,2,O
11974,810,cm,O
11975,810,in,O
11976,810,size,O
11977,810,and,O
11978,810,requires,O
11979,810,additional,O
11980,810,diagnostic,O
11981,810,workup,O
11982,810,with,O
11983,810,focused,O
11984,810,ultrasound,O
11985,810,.,O
11986,811,Congestive,B-Condition
11987,811,heart,I-Condition
11988,811,failure,I-Condition
11989,811,",",O
11990,811,history,B-Observation
11991,811,of,I-Observation
11992,811,ventricular,B-Condition
11993,811,tachycardia,I-Condition
11994,811,",",O
11995,811,ventricular,B-Condition
11996,811,fibrillation,I-Condition
11997,811,or,O
11998,811,multifocal,B-Condition
11999,811,ventricular,I-Condition
12000,811,extrasystoles,I-Condition
12001,811,or,O
12002,811,QTc,B-Condition
12003,811,prolongation,I-Condition
12004,811,.,O
12005,812,Patients,O
12006,812,with,O
12007,812,atrial,B-Condition
12008,812,fibrillation,I-Condition
12009,812,taking,O
12010,812,any,O
12011,812,anticoagulant,B-Procedure
12012,812,therapy,I-Procedure
12013,812,or,O
12014,812,patients,O
12015,812,with,O
12016,812,a,O
12017,812,history,B-Observation
12018,812,of,I-Observation
12019,812,cardioembolic,O
12020,812,ischemic,B-Condition
12021,812,stroke,I-Condition
12022,812,or,O
12023,812,hemorrhagic,B-Condition
12024,812,stroke,I-Condition
12025,812,.,O
12026,813,Patients,O
12027,813,with,O
12028,813,a,O
12029,813,history,B-Observation
12030,813,(=,O
12031,813,12,O
12032,813,months,O
12033,813,),O
12034,813,of,O
12035,813,acute,B-Condition
12036,813,coronary,I-Condition
12037,813,syndrome,I-Condition
12038,813,receiving,O
12039,813,dual,B-Procedure
12040,813,antiplatelet,I-Procedure
12041,813,therapy,I-Procedure
12042,813,",",O
12043,813,or,O
12044,813,patients,O
12045,813,receiving,O
12046,813,monotherapy,B-Procedure
12047,813,with,O
12048,813,aspirin,B-Drug
12049,813,.,O
12050,814,Patients,O
12051,814,with,O
12052,814,hepatic,B-Condition
12053,814,impairment,I-Condition
12054,814,(,O
12055,814,child,O
12056,814,-,O
12057,814,Pugh,O
12058,814,staging,O
12059,814,",",O
12060,814,calibration,O
12061,814,=,O
12062,814,5,O
12063,814,),O
12064,814,or,O
12065,814,renal,B-Condition
12066,814,impairment,I-Condition
12067,814,(,O
12068,814,creatinine,O
12069,814,clearance,O
12070,814,=,O
12071,814,30ml,O
12072,814,/,O
12073,814,min,O
12074,814,),O
12075,814,",",O
12076,814,recent,O
12077,814,peptic,B-Condition
12078,814,ulcer,I-Condition
12079,814,",",O
12080,814,a,O
12081,814,history,B-Observation
12082,814,of,I-Observation
12083,814,hypersensitivity,B-Condition
12084,814,to,O
12085,814,cilostazol,B-Drug
12086,814,",",O
12087,814,cancer,B-Condition
12088,814,patients,O
12089,814,undergoing,O
12090,814,treatment,B-Procedure
12091,814,.,O
12092,815,Patients,O
12093,815,aged,B-Person
12094,815,=,O
12095,815,50,O
12096,815,years,O
12097,815,with,O
12098,815,DM2,B-Condition
12099,815,and,O
12100,815,symptomatic,O
12101,815,PAD,B-Condition
12102,815,diagnosed,O
12103,815,clinically,O
12104,815,(,O
12105,815,according,O
12106,815,to,O
12107,815,Fontaine,O
12108,815,criteria,O
12109,815,",",O
12110,815,stage,O
12111,815,IIa,O
12112,815,or,O
12113,815,IIb,O
12114,815,and,O
12115,815,III,O
12116,815,),O
12117,815,and,O
12118,815,by,O
12119,815,measuring,O
12120,815,the,O
12121,815,<,O
12122,815,U+0391><U+0392><U+0399,O
12123,815,>,O
12124,815,.,O
12125,816,On,O
12126,816,systemic,B-Drug
12127,816,antibiotics,I-Drug
12128,816,or,O
12129,816,with,O
12130,816,an,O
12131,816,active,O
12132,816,bacterial,B-Condition
12133,816,infection,I-Condition
12134,816,at,O
12135,816,the,O
12136,816,time,O
12137,816,of,O
12138,816,surgery,B-Procedure
12139,817,Patients,O
12140,817,previously,B-Observation
12141,817,enrolled,I-Observation
12142,817,in,I-Observation
12143,817,this,I-Observation
12144,817,trial,I-Observation
12145,818,Patients,O
12146,818,known,O
12147,818,to,O
12148,818,be,O
12149,818,colonized,B-Condition
12150,818,with,O
12151,818,Methicillin,O
12152,818,-,O
12153,818,resistant,O
12154,818,S.,O
12155,818,aureus,O
12156,818,(,O
12157,818,MRSA)(unethical,O
12158,818,not,O
12159,818,to,O
12160,818,administer,O
12161,818,glycopeptides,O
12162,818,),O
12163,818,",",O
12164,818,beta,B-Drug
12165,818,-,I-Drug
12166,818,lactam,I-Drug
12167,818,or,O
12168,818,vancomycin,B-Drug
12169,818,allergy,B-Condition
12170,818,precluding,O
12171,818,the,O
12172,818,use,O
12173,818,of,O
12174,818,cefazolin,B-Drug
12175,818,or,O
12176,818,vancomycin,B-Drug
12177,818,",",O
12178,818,respectively,O
12179,818,",",O
12180,818,or,O
12181,818,to,O
12182,818,silver,B-Drug
12183,818,precluding,O
12184,818,the,O
12185,818,use,O
12186,818,of,O
12187,818,Prevena,O
12188,819,Participation,O
12189,819,in,O
12190,819,other,O
12191,819,studies,O
12192,819,that,O
12193,819,may,O
12194,819,interfere,O
12195,819,with,O
12196,819,this,O
12197,819,trial,O
12198,820,≥18,O
12199,820,years,O
12200,820,of,O
12201,820,age,B-Person
12202,820,undergoing,O
12203,820,open,B-Procedure
12204,820,-,I-Procedure
12205,820,heart,I-Procedure
12206,820,surgery,I-Procedure
12207,820,(,O
12208,820,sternotomy,B-Procedure
12209,820,",",O
12210,820,including,O
12211,820,minimally,B-Procedure
12212,820,-,I-Procedure
12213,820,invasive,I-Procedure
12214,820,sternotomies,I-Procedure
12215,820,),O
12216,821,1,O
12217,821,.,O
12218,821,Presence,O
12219,821,of,O
12220,821,other,O
12221,821,neoplasia,B-Condition
12222,822,2,O
12223,822,.,O
12224,822,Man,B-Person
12225,823,1,O
12226,823,.,O
12227,823,Age,B-Person
12228,823,≥,O
12229,823,18,O
12230,823,years,O
12231,824,2,O
12232,824,.,O
12233,824,Patient,O
12234,824,with,O
12235,824,breast,B-Condition
12236,824,cancer,I-Condition
12237,824,",",O
12238,824,histologically,B-Procedure
12239,824,proven,O
12240,824,",",O
12241,824,metastatic,O
12242,824,or,O
12243,824,locally,O
12244,824,advanced,O
12245,825,3,O
12246,825,.,O
12247,825,Patient,O
12248,825,treated,O
12249,825,by,O
12250,825,Eribulin,B-Drug
12251,825,between,O
12252,825,January,O
12253,825,and,O
12254,825,October,O
12255,825,2014,O
12256,825,(,O
12257,825,for,O
12258,825,the,O
12259,825,retrospective,O
12260,825,part,O
12261,825,),O
12262,825,or,O
12263,825,between,O
12264,825,November,O
12265,825,2014,O
12266,825,and,O
12267,825,September,O
12268,825,2015,O
12269,825,(,O
12270,825,for,O
12271,825,the,O
12272,825,prospective,O
12273,825,part,O
12274,825,),O
12275,825,.,O
12276,826,4,O
12277,826,.,O
12278,826,Patient,O
12279,826,with,O
12280,826,at,O
12281,826,least,O
12282,826,an,O
12283,826,assessment,B-Procedure
12284,826,of,I-Procedure
12285,826,the,I-Procedure
12286,826,response,I-Procedure
12287,826,to,O
12288,826,Eribulin,B-Drug
12289,827,Participants,O
12290,827,with,O
12291,827,congenital,B-Condition
12292,827,or,I-Condition
12293,827,acquired,I-Condition
12294,827,hypogonadism,I-Condition
12295,827,for,O
12296,827,whom,O
12297,827,long,O
12298,827,-,O
12299,827,term,O
12300,827,therapy,O
12301,827,with,O
12302,827,placebo,O
12303,827,would,O
12304,827,not,O
12305,827,be,O
12306,827,medically,O
12307,827,appropriate,O
12308,828,Participants,O
12309,828,with,O
12310,828,prostate,O
12311,828,specific,O
12312,828,antigen,O
12313,828,(,O
12314,828,PSA,O
12315,828,),O
12316,828,>,O
12317,828,3.0,O
12318,828,ng,O
12319,828,/,O
12320,828,mL,O
12321,828,(,O
12322,828,or,O
12323,828,1.5,O
12324,828,if,O
12325,828,on,O
12326,828,5,B-Drug
12327,828,-,I-Drug
12328,828,alpha,I-Drug
12329,828,reductase,I-Drug
12330,828,inhibitors,I-Drug
12331,828,),O
12332,829,Participants,O
12333,829,who,O
12334,829,have,O
12335,829,been,O
12336,829,treated,O
12337,829,with,O
12338,829,testosterone,B-Drug
12339,829,in,O
12340,829,the,O
12341,829,past,O
12342,829,6,O
12343,829,months,O
12344,829,and,O
12345,829,for,O
12346,829,whom,O
12347,829,testosterone,B-Procedure
12348,829,therapy,I-Procedure
12349,829,is,O
12350,829,contraindicated,B-Condition
12351,830,Confirmed,O
12352,830,testosterone,O
12353,830,<,O
12354,830,100,O
12355,830,ng,O
12356,830,/,O
12357,830,dL,O
12358,831,Body,O
12359,831,Mass,O
12360,831,Index,O
12361,831,(,O
12362,831,BMI,O
12363,831,),O
12364,831,>,O
12365,831,50,O
12366,832,Hemoglobin,O
12367,832,A1c,O
12368,832,(,O
12369,832,HbA1C,O
12370,832,),O
12371,832,>,O
12372,832,11,O
12373,832,%,O
12374,833,Hematocrit,O
12375,833,(,O
12376,833,Hct,O
12377,833,),O
12378,833,>,O
12379,833,50,O
12380,833,%,O
12381,834,Estimated,O
12382,834,Glomerular,O
12383,834,Filtration,O
12384,834,Rate,O
12385,834,(,O
12386,834,eGFR,O
12387,834,),O
12388,834,<,O
12389,834,30,O
12390,834,ml,O
12391,834,/,O
12392,834,min,O
12393,835,History,O
12394,835,of,O
12395,835,deep,B-Condition
12396,835,vein,I-Condition
12397,835,thrombosis,I-Condition
12398,835,or,O
12399,835,pulmonary,B-Condition
12400,835,embolism,I-Condition
12401,835,or,O
12402,835,prostate,B-Condition
12403,835,cancer,I-Condition
12404,835,or,O
12405,835,heart,B-Condition
12406,835,failure,I-Condition
12407,835,(,O
12408,835,Class,O
12409,835,III,O
12410,835,and,O
12411,835,IV,O
12412,835,),O
12413,835,.,O
12414,836,Men,B-Person
12415,836,between,O
12416,836,45,O
12417,836,and,O
12418,836,80,O
12419,836,years,O
12420,836,age,B-Person
12421,837,Participants,O
12422,837,with,O
12423,837,low,O
12424,837,serum,O
12425,837,testosterone,O
12426,837,concentrations,O
12427,837,(,O
12428,837,<,O
12429,837,300,O
12430,837,ng,O
12431,837,/,O
12432,837,dL,O
12433,837,),O
12434,837,who,O
12435,837,exhibit,O
12436,837,at,O
12437,837,least,O
12438,837,one,O
12439,837,sign,B-Condition
12440,837,or,O
12441,837,symptom,B-Condition
12442,837,of,O
12443,837,hypogonadism,B-Condition
12444,837,and,O
12445,837,have,O
12446,837,evidence,B-Mood
12447,837,of,I-Mood
12448,837,cardiovascular,B-Condition
12449,837,(,I-Condition
12450,837,CV,I-Condition
12451,837,),I-Condition
12452,837,disease,I-Condition
12453,837,or,O
12454,837,are,O
12455,837,at,O
12456,837,an,O
12457,837,increased,B-Mood
12458,837,risk,I-Mood
12459,837,for,O
12460,837,CV,B-Condition
12461,837,disease,I-Condition
12462,837,.,O
12463,838,Subjects,O
12464,838,with,O
12465,838,topical,B-Drug
12466,838,and/or,I-Drug
12467,838,systemic,I-Drug
12468,838,medication,I-Drug
12469,838,or,O
12470,838,mechanical,O
12471,838,devices,O
12472,838,that,O
12473,838,interfere,O
12474,838,determinedly,O
12475,838,on,O
12476,838,the,O
12477,838,results,O
12478,838,of,O
12479,838,the,O
12480,838,study,O
12481,838,(,O
12482,838,such,O
12483,838,as,O
12484,838,topical,B-Drug
12485,838,immunomodulators,I-Drug
12486,838,",",O
12487,838,punctal,O
12488,838,plugs,O
12489,838,",",O
12490,838,corticosteroids,B-Drug
12491,838,",",O
12492,838,preservative,B-Drug
12493,838,artificial,I-Drug
12494,838,tears,I-Drug
12495,838,",",O
12496,838,contact,O
12497,838,lenses,O
12498,838,),O
12499,838,.,O
12500,839,Subjects,O
12501,839,(,O
12502,839,females,B-Person
12503,839,),O
12504,839,with,O
12505,839,active,B-Observation
12506,839,sexual,I-Observation
12507,839,life,I-Observation
12508,839,that,O
12509,839,do,O
12510,839,not,O
12511,839,use,O
12512,839,a,O
12513,839,contraceptive,B-Procedure
12514,839,method,I-Procedure
12515,839,.,O
12516,840,Female,B-Person
12517,840,subjects,O
12518,840,who,O
12519,840,are,O
12520,840,pregnant,B-Condition
12521,840,or,O
12522,840,lactating,B-Condition
12523,841,Female,B-Person
12524,841,subjects,O
12525,841,with,O
12526,841,a,O
12527,841,positive,O
12528,841,urine,O
12529,841,pregnancy,O
12530,841,test,O
12531,842,Positive,B-Condition
12532,842,drug,I-Condition
12533,842,addictions,I-Condition
12534,842,*,O
12535,842,(,O
12536,842,verbal,B-Procedure
12537,842,interrogatory,I-Procedure
12538,842,),O
12539,843,Subjects,O
12540,843,who,O
12541,843,have,O
12542,843,participated,O
12543,843,on,O
12544,843,any,O
12545,843,other,O
12546,843,research,O
12547,843,clinical,O
12548,843,trials,O
12549,843,on,O
12550,843,the,O
12551,843,last,O
12552,843,40,O
12553,843,days,O
12554,844,Subjects,O
12555,844,legal,B-Condition
12556,844,or,I-Condition
12557,844,mentally,I-Condition
12558,844,disabled,I-Condition
12559,844,to,O
12560,844,give,O
12561,844,an,O
12562,844,informed,O
12563,844,consent,O
12564,844,for,O
12565,844,participating,O
12566,844,on,O
12567,844,this,O
12568,844,study,O
12569,845,Subjects,O
12570,845,who,O
12571,845,ca,O
12572,845,n't,O
12573,845,comply,O
12574,845,with,O
12575,845,the,O
12576,845,appointments,O
12577,845,or,O
12578,845,with,O
12579,845,every,O
12580,845,protocol,O
12581,845,requirement,O
12582,845,.,O
12583,846,Serious,B-Condition
12584,846,tear,I-Condition
12585,846,film,I-Condition
12586,846,dysfunction,I-Condition
12587,846,syndrome,I-Condition
12588,846,TBUT,O
12589,846,<,O
12590,846,5,O
12591,846,s,O
12592,846,Schirmer,O
12593,846,:,O
12594,846,<,O
12595,846,4,O
12596,846,mm,O
12597,846,OSDI,O
12598,846,>,O
12599,846,30,O
12600,846,pints,O
12601,846,Corneal,O
12602,846,staining,O
12603,846,>,O
12604,846,grade,O
12605,846,III,O
12606,846,on,O
12607,846,the,O
12608,846,Oxford,O
12609,846,scale,O
12610,847,Non,O
12611,847,perforated,O
12612,847,corneal,B-Condition
12613,847,ulcer,I-Condition
12614,848,Perforated,O
12615,848,corneal,B-Condition
12616,848,ulcer,I-Condition
12617,849,Autoimmune,O
12618,849,corneal,B-Condition
12619,849,ulcer,I-Condition
12620,850,Ocular,B-Condition
12621,850,surface,I-Condition
12622,850,scarring,I-Condition
12623,850,diseases,I-Condition
12624,851,Ocular,O
12625,851,surface,O
12626,851,or,O
12627,851,annexes,O
12628,851,metaplastic,O
12629,851,lesions,O
12630,852,Fibro,B-Condition
12631,852,vascular,I-Condition
12632,852,proliferation,I-Condition
12633,852,lesions,I-Condition
12634,852,on,O
12635,852,the,O
12636,852,conjunctival,O
12637,852,and/or,O
12638,852,corneal,O
12639,852,surface,O
12640,852,(,O
12641,852,i.e.,O
12642,852,:,O
12643,852,pterygium,O
12644,852,),O
12645,853,Concomitant,O
12646,853,chronic,B-Condition
12647,853,inflammatory,I-Condition
12648,853,diseases,I-Condition
12649,853,on,O
12650,853,any,O
12651,853,ocular,O
12652,853,structure,O
12653,854,Acute,O
12654,854,or,O
12655,854,infectious,O
12656,854,inflammatory,B-Condition
12657,854,disease,I-Condition
12658,855,Corneal,B-Condition
12659,855,disease,I-Condition
12660,855,potentially,B-Mood
12661,855,requiring,I-Mood
12662,855,a,O
12663,855,treatment,B-Procedure
12664,855,during,O
12665,855,the,O
12666,855,following,O
12667,855,3,O
12668,855,months,O
12669,856,Use,O
12670,856,of,O
12671,856,topical,O
12672,856,or,O
12673,856,systemic,O
12674,856,drug,O
12675,856,products,O
12676,856,classified,O
12677,856,as,O
12678,856,forbidden,O
12679,857,Ocular,B-Procedure
12680,857,surgical,I-Procedure
12681,857,procedures,I-Procedure
12682,857,3,O
12683,857,months,O
12684,857,before,O
12685,857,the,O
12686,857,protocol,O
12687,857,inclusion,O
12688,858,Treatments,B-Procedure
12689,858,or,O
12690,858,procedures,B-Procedure
12691,858,indicated,O
12692,858,on,O
12693,858,the,O
12694,858,tear,B-Procedure
12695,858,film,I-Procedure
12696,858,dysfunction,I-Procedure
12697,858,treatment,I-Procedure
12698,858,",",O
12699,858,as,O
12700,858,punctal,O
12701,858,silicone,O
12702,858,plugs,O
12703,858,.,O
12704,859,Posterior,B-Condition
12705,859,segment,I-Condition
12706,859,diseases,I-Condition
12707,859,requiring,B-Mood
12708,859,a,O
12709,859,treatment,B-Procedure
12710,859,or,O
12711,859,threatening,B-Condition
12712,859,the,I-Condition
12713,859,visual,I-Condition
12714,859,prognosis,I-Condition
12715,860,Retinal,B-Condition
12716,860,diseases,I-Condition
12717,860,potentially,O
12718,860,requiring,B-Mood
12719,860,treatment,B-Procedure
12720,860,during,O
12721,860,the,O
12722,860,following,O
12723,860,3,O
12724,860,months,O
12725,861,History,B-Observation
12726,861,of,O
12727,861,penetrating,B-Procedure
12728,861,keratoplasty,I-Procedure
12729,861,.,O
12730,862,Soft,O
12731,862,or,O
12732,862,hard,O
12733,862,contact,O
12734,862,lenses,O
12735,862,use,O
12736,862,during,O
12737,862,the,O
12738,862,last,O
12739,862,month,O
12740,862,from,O
12741,862,inclusion,O
12742,862,day,O
12743,863,>,O
12744,863,18,O
12745,863,to,O
12746,863,<,O
12747,863,90,O
12748,863,years,O
12749,863,old,B-Person
12750,864,Both,B-Person
12751,864,sexes,I-Person
12752,865,Mild,O
12753,865,to,O
12754,865,moderate,O
12755,865,tear,B-Condition
12756,865,film,I-Condition
12757,865,dysfunction,I-Condition
12758,865,clinical,O
12759,865,diagnose,O
12760,866,TBUT,O
12761,866,>,O
12762,866,5,O
12763,866,sec,O
12764,866,.,O
12765,866,and,O
12766,866,<,O
12767,866,10,O
12768,866,sec,O
12769,866,.,O
12770,867,Schirmer,O
12771,867,:,O
12772,867,>,O
12773,867,4,O
12774,867,mm,O
12775,867,and,O
12776,867,<,O
12777,867,14,O
12778,867,mm,O
12779,868,OSDI,O
12780,868,<,O
12781,868,30,O
12782,868,points,O
12783,869,Corneal,B-Condition
12784,869,staining,I-Condition
12785,869,<,O
12786,869,grade,O
12787,869,III,O
12788,869,on,O
12789,869,the,O
12790,869,Oxford,O
12791,869,scale,O
12792,870,Availability,O
12793,870,to,O
12794,870,go,O
12795,870,to,O
12796,870,each,O
12797,870,revision,O
12798,870,when,O
12799,870,indicated,O
12800,870,.,O
12801,871,Allergy,B-Condition
12802,871,known,O
12803,871,to,O
12804,871,fish,B-Drug
12805,872,Pregnant,B-Condition
12806,872,women,B-Person
12807,872,who,O
12808,872,breast,B-Condition
12809,872,-,I-Condition
12810,872,feed,I-Condition
12811,872,or,O
12812,872,test,O
12813,872,positive,O
12814,872,for,O
12815,872,pregnancy,O
12816,873,Participant,O
12817,873,aged,B-Person
12818,873,19,O
12819,873,or,O
12820,873,over,O
12821,874,Available,O
12822,874,for,O
12823,874,the,O
12824,874,entire,O
12825,874,duration,O
12826,874,of,O
12827,874,the,O
12828,874,study,O
12829,874,and,O
12830,874,willing,O
12831,874,to,O
12832,874,participate,O
12833,874,on,O
12834,874,the,O
12835,874,basis,O
12836,874,of,O
12837,874,the,O
12838,874,information,O
12839,874,provided,O
12840,874,in,O
12841,874,the,O
12842,874,FIU,O
12843,874,duly,O
12844,874,read,O
12845,874,and,O
12846,874,signed,O
12847,874,.,O
12848,875,Surgery,B-Procedure
12849,875,and/or,O
12850,875,previous,O
12851,875,ocular,B-Condition
12852,875,pathology,I-Condition
12853,875,(,O
12854,875,presence,O
12855,875,of,O
12856,875,scar,B-Condition
12857,875,/,O
12858,875,change,B-Observation
12859,875,in,I-Observation
12860,875,the,I-Observation
12861,875,cornea,I-Observation
12862,875,",",O
12863,875,glaucoma,B-Condition
12864,875,",",O
12865,875,retinopathies,B-Condition
12866,875,",",O
12867,875,etc,O
12868,875,.,O
12869,875,),O
12870,875,.,O
12871,876,Patient,O
12872,876,has,O
12873,876,diabetes,B-Condition
12874,876,or,O
12875,876,is,O
12876,876,immunodepressed,B-Condition
12877,876,.,O
12878,877,Any,O
12879,877,systemic,O
12880,877,infection,B-Condition
12881,877,during,O
12882,877,the,O
12883,877,study,O
12884,877,.,O
12885,878,Signs,O
12886,878,and/or,O
12887,878,symptoms,O
12888,878,of,O
12889,878,ocular,B-Condition
12890,878,inflammation,I-Condition
12891,878,/,I-Condition
12892,878,infection,I-Condition
12893,878,(,O
12894,878,bacterial,O
12895,878,",",O
12896,878,viral,O
12897,878,",",O
12898,878,fungal,O
12899,878,",",O
12900,878,caused,O
12901,878,by,O
12902,878,Chlamydia,B-Observation
12903,878,",",O
12904,878,by,O
12905,878,Mycobacterium,B-Observation
12906,878,",",O
12907,878,Acanthamoeba,B-Observation
12908,878,or,O
12909,878,of,O
12910,878,allergic,B-Condition
12911,878,etiology,I-Condition
12912,878,),O
12913,878,.,O
12914,879,Have,O
12915,879,used,O
12916,879,any,O
12917,879,systemic,B-Drug
12918,879,or,I-Drug
12919,879,topical,I-Drug
12920,879,antibiotics,I-Drug
12921,879,for,O
12922,879,ocular,B-Condition
12923,879,infection,I-Condition
12924,879,in,O
12925,879,the,O
12926,879,previous,O
12927,879,14,O
12928,879,days,O
12929,879,.,O
12930,880,Patient,O
12931,880,has,O
12932,880,known,O
12933,880,hypersensitivity,B-Condition
12934,880,to,O
12935,880,any,O
12936,880,of,O
12937,880,the,O
12938,880,components,O
12939,880,of,O
12940,880,the,O
12941,880,formulations,O
12942,880,used,O
12943,880,in,O
12944,880,the,O
12945,880,study,O
12946,880,.,O
12947,881,Patient,O
12948,881,is,O
12949,881,indicated,B-Condition
12950,881,to,I-Condition
12951,881,have,I-Condition
12952,881,an,I-Condition
12953,881,ocular,I-Condition
12954,881,refractive,I-Condition
12955,881,surgery,I-Condition
12956,881,performed,I-Condition
12957,881,(,O
12958,881,myopia,B-Condition
12959,881,",",O
12960,881,astigmatism,B-Condition
12961,881,",",O
12962,881,hypermetropy,B-Condition
12963,881,),O
12964,881,by,O
12965,881,the,O
12966,881,Lasik,O
12967,881,method,O
12968,881,.,O
12969,882,Patient,O
12970,882,presents,O
12971,882,a,O
12972,882,normal,B-Condition
12973,882,eye,I-Condition
12974,882,fundus,I-Condition
12975,882,.,O
12976,883,Patient,O
12977,883,has,O
12978,883,intraocular,O
12979,883,pressure,O
12980,883,(,O
12981,883,IOP,O
12982,883,),O
12983,883,≤,O
12984,883,20,O
12985,883,mmHg,O
12986,883,.,O
12987,884,1,O
12988,884,.,O
12989,884,Expected,O
12990,884,performance,O
12991,884,of,O
12992,884,PCI,O
12993,884,<,O
12994,884,60,O
12995,884,minutes,O
12996,884,from,O
12997,884,diagnosis,O
12998,884,(,O
12999,884,qualifying,O
13000,884,ECG,O
13001,884,),O
13002,884,or,O
13003,884,inability,O
13004,884,to,O
13005,884,arrive,O
13006,884,at,O
13007,884,the,O
13008,884,catheterisation,O
13009,884,laboratory,O
13010,884,within,O
13011,884,3,O
13012,884,hours,O
13013,885,Previous,O
13014,885,CABG,B-Procedure
13015,886,Left,B-Condition
13016,886,bundle,I-Condition
13017,886,branch,I-Condition
13018,886,block,I-Condition
13019,886,or,O
13020,886,ventricular,B-Condition
13021,886,pacing,I-Condition
13022,887,Patients,O
13023,887,with,O
13024,887,cardiogenic,B-Condition
13025,887,shock,I-Condition
13026,887,-,O
13027,887,Killip,O
13028,887,Class,O
13029,887,4,O
13030,888,Patients,O
13031,888,with,O
13032,888,a,O
13033,888,body,O
13034,888,weight,O
13035,888,<,O
13036,888,55,O
13037,888,kg,O
13038,888,(,O
13039,888,known,O
13040,888,or,O
13041,888,estimated,O
13042,888,),O
13043,889,Uncontrolled,O
13044,889,hypertension,B-Condition
13045,889,",",O
13046,889,defined,O
13047,889,as,O
13048,889,sustained,O
13049,889,blood,O
13050,889,pressure,O
13051,889,=,O
13052,889,180/110,O
13053,889,mm,O
13054,889,Hg,O
13055,889,(,O
13056,889,systolic,O
13057,889,BP,O
13058,889,=,O
13059,889,180,O
13060,889,mm,O
13061,889,Hg,O
13062,889,and/or,O
13063,889,diastolic,O
13064,889,BP,O
13065,889,=,O
13066,889,110,O
13067,889,mm,O
13068,889,Hg,O
13069,889,),O
13070,889,prior,O
13071,889,to,O
13072,889,randomisation,O
13073,890,Known,O
13074,890,prior,O
13075,890,stroke,B-Condition
13076,890,or,O
13077,890,TIA,B-Condition
13078,891,Recent,O
13079,891,administration,O
13080,891,of,O
13081,891,any,O
13082,891,i.v,O
13083,891,.,O
13084,891,or,O
13085,891,s.c,O
13086,891,.,O
13087,891,anticoagulation,B-Drug
13088,891,within,O
13089,891,12,O
13090,891,hours,O
13091,891,",",O
13092,891,including,O
13093,891,unfractionated,B-Drug
13094,891,heparin,I-Drug
13095,891,",",O
13096,891,enoxaparin,B-Drug
13097,891,",",O
13098,891,and/or,O
13099,891,bivalirudin,B-Drug
13100,891,or,O
13101,891,current,O
13102,891,use,O
13103,891,of,O
13104,891,oral,B-Drug
13105,891,anticoagulation,I-Drug
13106,891,(,O
13107,891,i.e.,O
13108,891,warfarin,B-Drug
13109,891,or,O
13110,891,a,O
13111,891,NOACs,B-Drug
13112,891,),O
13113,892,Active,B-Condition
13114,892,bleeding,I-Condition
13115,892,or,O
13116,892,known,O
13117,892,bleeding,B-Condition
13118,892,disorder,I-Condition
13119,892,/,O
13120,892,diathesis,B-Condition
13121,893,Known,O
13122,893,history,O
13123,893,of,O
13124,893,central,B-Condition
13125,893,nervous,I-Condition
13126,893,system,I-Condition
13127,893,damage,I-Condition
13128,893,(,O
13129,893,i.e.,O
13130,893,neoplasm,B-Condition
13131,893,",",O
13132,893,aneurysm,B-Condition
13133,893,",",O
13134,893,intracranial,B-Procedure
13135,893,or,I-Procedure
13136,893,spinal,I-Procedure
13137,893,surgery,I-Procedure
13138,893,),O
13139,893,or,O
13140,893,recent,O
13141,893,trauma,B-Condition
13142,893,to,O
13143,893,the,O
13144,893,head,O
13145,893,or,O
13146,893,cranium,O
13147,893,(,O
13148,893,i.e.,O
13149,893,<,O
13150,893,3,O
13151,893,months,O
13152,893,),O
13153,894,Major,B-Procedure
13154,894,surgery,I-Procedure
13155,894,",",O
13156,894,biopsy,B-Procedure
13157,894,of,O
13158,894,a,O
13159,894,parenchymal,O
13160,894,organ,O
13161,894,",",O
13162,894,or,O
13163,894,significant,O
13164,894,trauma,B-Condition
13165,894,within,O
13166,894,the,O
13167,894,past,O
13168,894,2,O
13169,894,months,O
13170,894,(,O
13171,894,this,O
13172,894,includes,O
13173,894,any,O
13174,894,trauma,O
13175,894,associated,O
13176,894,with,O
13177,894,the,O
13178,894,current,O
13179,894,myocardial,B-Condition
13180,894,infarction,I-Condition
13181,894,),O
13182,895,Clinical,O
13183,895,diagnosis,O
13184,895,associated,O
13185,895,with,O
13186,895,increased,O
13187,895,risk,B-Observation
13188,895,of,I-Observation
13189,895,bleeding,I-Observation
13190,895,including,O
13191,895,known,O
13192,895,active,O
13193,895,peptic,B-Condition
13194,895,ulceration,I-Condition
13195,895,and/or,O
13196,895,neoplasm,B-Condition
13197,895,with,O
13198,895,increased,O
13199,895,bleeding,O
13200,895,risk,O
13201,896,Prolonged,O
13202,896,cardiopulmonary,B-Condition
13203,896,resuscitation,I-Condition
13204,896,(,O
13205,896,>,O
13206,896,2,O
13207,896,minutes,O
13208,896,),O
13209,896,within,O
13210,896,the,O
13211,896,past,O
13212,896,2,O
13213,896,weeks,O
13214,897,Known,O
13215,897,acute,B-Condition
13216,897,pericarditis,I-Condition
13217,897,and/or,O
13218,897,subacute,B-Condition
13219,897,bacterial,I-Condition
13220,897,endocarditis,I-Condition
13221,898,Known,O
13222,898,acute,B-Condition
13223,898,pancreatitis,I-Condition
13224,898,or,O
13225,898,known,O
13226,898,severe,O
13227,898,hepatic,B-Condition
13228,898,dysfunction,I-Condition
13229,898,",",O
13230,898,including,O
13231,898,hepatic,B-Condition
13232,898,failure,I-Condition
13233,898,",",O
13234,898,cirrhosis,B-Condition
13235,898,",",O
13236,898,portal,B-Condition
13237,898,hypertension,I-Condition
13238,898,(,O
13239,898,oesophageal,B-Condition
13240,898,varices,I-Condition
13241,898,),O
13242,898,and,O
13243,898,active,B-Condition
13244,898,hepatitis,I-Condition
13245,899,Dementia,B-Condition
13246,900,Known,O
13247,900,severe,O
13248,900,renal,B-Condition
13249,900,insufficiency,I-Condition
13250,901,Previous,O
13251,901,enrolment,O
13252,901,in,O
13253,901,this,O
13254,901,study,O
13255,901,or,O
13256,901,treatment,O
13257,901,with,O
13258,901,an,O
13259,901,investigational,O
13260,901,drug,O
13261,901,or,O
13262,901,device,O
13263,901,under,O
13264,901,another,O
13265,901,study,O
13266,901,protocol,O
13267,901,in,O
13268,901,the,O
13269,901,past,O
13270,901,7,O
13271,901,days,O
13272,902,Known,O
13273,902,allergic,B-Condition
13274,902,reactions,I-Condition
13275,902,to,O
13276,902,tenecteplase,B-Drug
13277,902,",",O
13278,902,clopidogrel,B-Drug
13279,902,",",O
13280,902,enoxaparin,B-Drug
13281,902,and,O
13282,902,aspirin,B-Drug
13283,903,Inability,O
13284,903,to,O
13285,903,follow,O
13286,903,the,O
13287,903,protocol,O
13288,903,and,O
13289,903,comply,O
13290,903,with,O
13291,903,follow,O
13292,903,-,O
13293,903,up,O
13294,903,requirements,O
13295,903,or,O
13296,903,any,O
13297,903,other,O
13298,903,reason,O
13299,903,that,O
13300,903,the,O
13301,903,investigator,O
13302,903,feels,O
13303,903,would,O
13304,903,place,O
13305,903,the,O
13306,903,patient,O
13307,903,at,O
13308,903,increased,O
13309,903,risk,O
13310,903,if,O
13311,903,the,O
13312,903,investigational,O
13313,903,therapy,O
13314,903,is,O
13315,903,initiated,O
13316,903,.,O
13317,904,Age,B-Person
13318,904,equal,O
13319,904,or,O
13320,904,greater,O
13321,904,than,O
13322,904,70,O
13323,904,years,O
13324,905,Onset,B-Observation
13325,905,of,I-Observation
13326,905,symptoms,I-Observation
13327,905,<,O
13328,905,3,O
13329,905,hours,O
13330,905,prior,O
13331,905,to,O
13332,905,randomisation,O
13333,906,=,O
13334,906,2,O
13335,906,mm,O
13336,906,ST,O
13337,906,-,O
13338,906,elevation,O
13339,906,across,O
13340,906,2,O
13341,906,contiguous,O
13342,906,precordial,O
13343,906,leads,O
13344,906,(,O
13345,906,V1,O
13346,906,-,O
13347,906,V6,O
13348,906,),O
13349,906,or,O
13350,906,leads,O
13351,906,I,O
13352,906,and,O
13353,906,aVL,O
13354,906,for,O
13355,906,a,O
13356,906,minimum,O
13357,906,combined,O
13358,906,total,O
13359,906,of,O
13360,906,=,O
13361,906,4,O
13362,906,mm,O
13363,906,ST,O
13364,906,-,O
13365,906,elevation,O
13366,906,or,O
13367,907,=,O
13368,907,2,O
13369,907,mm,O
13370,907,ST,O
13371,907,-,O
13372,907,elevation,O
13373,907,in,O
13374,907,2,O
13375,907,contiguous,O
13376,907,inferior,O
13377,907,leads,O
13378,907,(,O
13379,907,II,O
13380,907,",",O
13381,907,III,O
13382,907,",",O
13383,907,aVF,O
13384,907,),O
13385,907,for,O
13386,907,a,O
13387,907,minimum,O
13388,907,combined,O
13389,907,total,O
13390,907,of,O
13391,907,=,O
13392,907,4,O
13393,907,mm,O
13394,907,ST,O
13395,907,-,O
13396,907,elevation,O
13397,908,Informed,O
13398,908,consent,O
13399,908,received,O
13400,909,prior,O
13401,909,allergic,B-Condition
13402,909,reaction,I-Condition
13403,909,to,O
13404,909,interferon,B-Drug
13405,909,products,I-Drug
13406,909,",",O
13407,909,congestive,B-Condition
13408,909,heart,I-Condition
13409,909,failure,I-Condition
13410,909,",",O
13411,909,elevated,B-Condition
13412,909,liver,I-Condition
13413,909,enzymes,I-Condition
13414,910,diagnosed,O
13415,910,any,O
13416,910,form,O
13417,910,of,O
13418,910,MS,B-Condition
13419,910,(,O
13420,910,relapsing,O
13421,910,remitting,O
13422,910,",",O
13423,910,primary,O
13424,910,progressive,O
13425,910,",",O
13426,910,secondary,O
13427,910,progressive,O
13428,910,),O
13429,910,",",O
13430,910,any,O
13431,910,EDSS,O
13432,910,(,O
13433,910,expanded,O
13434,910,stability,O
13435,910,status,O
13436,910,scale,O
13437,910,),O
13438,910,score,O
13439,911,Previous,O
13440,911,thoracic,B-Procedure
13441,911,operation,I-Procedure
13442,911,in,O
13443,911,the,O
13444,911,same,O
13445,911,side,O
13446,911,.,O
13447,912,Thoracoscopic,B-Procedure
13448,912,surgery,I-Procedure
13449,912,candidate,B-Mood
13450,912,.,O
13451,913,Over,O
13452,913,18,O
13453,913,years,O
13454,913,old,B-Person
13455,913,.,O
13456,914,No,O
13457,914,known,O
13458,914,allergy,B-Condition
13459,914,to,O
13460,914,Bupivacaine,B-Drug
13461,914,.,O
13462,915,Patient,O
13463,915,is,O
13464,915,able,B-Observation
13465,915,to,I-Observation
13466,915,read,I-Observation
13467,915,understand,B-Observation
13468,915,and,O
13469,915,singe,B-Observation
13470,915,an,O
13471,915,inform,O
13472,915,consent,O
13473,915,.,O
13474,916,Diabetes,B-Condition
13475,916,mellitus,I-Condition
13476,916,type,I-Condition
13477,916,1,I-Condition
13478,917,renal,B-Condition
13479,917,insufficiency,I-Condition
13480,917,III,O
13481,917,-,O
13482,917,V,O
13483,917,°,O
13484,918,Cirrhosis,B-Condition
13485,918,hepatis,I-Condition
13486,918,(,O
13487,918,Child,O
13488,918,B,O
13489,918,or,O
13490,918,higher,O
13491,918,),O
13492,919,Chronic,O
13493,919,alcohol,B-Condition
13494,919,abuse,I-Condition
13495,920,rheumatic,B-Condition
13496,920,disease,I-Condition
13497,920,(,O
13498,920,RA,B-Condition
13499,920,",",O
13500,920,SpA,B-Condition
13501,920,",",O
13502,920,SLE,B-Condition
13503,920,),O
13504,921,Malignancies,B-Condition
13505,921,(,O
13506,921,<,O
13507,921,5,O
13508,921,years,O
13509,921,),O
13510,922,Eating,B-Condition
13511,922,Disorder,I-Condition
13512,922,(,O
13513,922,anorexia,B-Condition
13514,922,nervosa,I-Condition
13515,922,",",O
13516,922,bulimia,B-Condition
13517,922,),O
13518,923,bone,B-Procedure
13519,923,-,I-Procedure
13520,923,specific,I-Procedure
13521,923,pretreatment,I-Procedure
13522,923,(,O
13523,923,DMAB,B-Drug
13524,923,",",O
13525,923,TPTD,B-Drug
13526,923,",",O
13527,923,strontium,B-Drug
13528,923,ranelate,I-Drug
13529,923,",",O
13530,923,SERMs,B-Drug
13531,923,),O
13532,923,Bisphosphonate,O
13533,923,treatment,O
13534,923,is,O
13535,923,allowed,O
13536,924,Postmenopausal,B-Condition
13537,924,women,B-Person
13538,925,Age,B-Person
13539,925,60,O
13540,925,-,O
13541,925,80,O
13542,925,years,O
13543,926,T,O
13544,926,-,O
13545,926,score,O
13546,926,according,O
13547,926,to,O
13548,926,DXA,B-Procedure
13549,926,:,O
13550,926,<,O
13551,926,-2.5,O
13552,927,indication,B-Mood
13553,927,for,I-Mood
13554,927,osteoporosis,B-Procedure
13555,927,therapy,I-Procedure
13556,927,according,O
13557,927,to,O
13558,927,international,O
13559,927,guidelines,O
13560,928,Subjects,O
13561,928,with,O
13562,928,cognitive,O
13563,928,",",O
13564,928,psychiatric,O
13565,928,",",O
13566,928,or,O
13567,928,other,B-Condition
13568,928,problems,I-Condition
13569,928,that,I-Condition
13570,928,preclude,I-Condition
13571,928,informed,I-Condition
13572,928,consent,I-Condition
13573,928,.,O
13574,929,Patients,O
13575,929,with,O
13576,929,history,B-Observation
13577,929,of,O
13578,929,glucose,B-Condition
13579,929,intolerance,I-Condition
13580,929,or,O
13581,929,diabetes,B-Condition
13582,929,.,O
13583,930,Patient,O
13584,930,on,O
13585,930,chemotherapy,B-Procedure
13586,931,People,O
13587,931,with,O
13588,931,any,O
13589,931,open,B-Condition
13590,931,or,I-Condition
13591,931,bleeding,I-Condition
13592,931,wounds,I-Condition
13593,931,at,O
13594,931,any,O
13595,931,sensor,O
13596,931,plate,O
13597,931,contact,O
13598,931,surface,O
13599,931,location,O
13600,932,People,O
13601,932,with,O
13602,932,any,O
13603,932,type,O
13604,932,of,O
13605,932,implantable,O
13606,932,device,O
13607,933,People,O
13608,933,with,O
13609,933,missing,B-Condition
13610,933,hand(s,I-Condition
13611,933,),I-Condition
13612,933,and/or,I-Condition
13613,933,leg(s,I-Condition
13614,933,),O
13615,934,Pregnant,B-Condition
13616,934,women,O
13617,934,or,O
13618,934,women,O
13619,934,who,O
13620,934,are,O
13621,934,uncertain,O
13622,934,about,O
13623,934,a,O
13624,934,possible,B-Observation
13625,934,pregnancy,I-Observation
13626,935,Patients,O
13627,935,sensitive,B-Condition
13628,935,to,I-Condition
13629,935,chemicals,I-Condition
13630,935,used,I-Condition
13631,935,to,I-Condition
13632,935,induce,I-Condition
13633,935,sweating,I-Condition
13634,936,Patients,O
13635,936,with,O
13636,936,heat,B-Condition
13637,936,intolerance,I-Condition
13638,937,Patients,O
13639,937,with,O
13640,937,bleeding,B-Condition
13641,937,disorders,I-Condition
13642,938,Patients,O
13643,938,on,O
13644,938,current,O
13645,938,anticoagulant,B-Procedure
13646,938,therapy,I-Procedure
13647,939,Patients,O
13648,939,with,O
13649,939,keloids,B-Condition
13650,939,on,O
13651,939,the,O
13652,939,intended,O
13653,939,biopsy,O
13654,939,site,O
13655,940,People,O
13656,940,with,O
13657,940,hypersensitivity,B-Condition
13658,940,to,O
13659,940,local,B-Drug
13660,940,amide,I-Drug
13661,940,-,I-Drug
13662,940,type,I-Drug
13663,940,anesthetics,I-Drug
13664,941,Males,B-Person
13665,941,and,O
13666,941,females,B-Person
13667,941,with,O
13668,941,confirmed,B-Condition
13669,941,disease,I-Condition
13670,941,:,O
13671,941,Fabry,O
13672,941,(,O
13673,941,by,O
13674,941,GLA,B-Procedure
13675,941,enzymes,I-Procedure
13676,941,and/or,O
13677,941,DNA,B-Procedure
13678,941,testing,I-Procedure
13679,941,),O
13680,941,naïve,O
13681,941,and,O
13682,941,on,O
13683,941,ERT,B-Procedure
13684,941,",",O
13685,941,Mitochondrial,B-Condition
13686,941,diseases,I-Condition
13687,941,(,O
13688,941,electron,B-Procedure
13689,941,transport,I-Procedure
13690,941,chain,I-Procedure
13691,941,and/or,O
13692,941,DNA,B-Procedure
13693,941,testing,I-Procedure
13694,941,),O
13695,941,or,O
13696,941,connective,B-Condition
13697,941,tissue,I-Condition
13698,941,diseases,I-Condition
13699,941,(,O
13700,941,clinical,B-Observation
13701,941,criteria,I-Observation
13702,941,and/or,O
13703,941,DNA,B-Procedure
13704,941,testing,I-Procedure
13705,941,when,O
13706,941,available,O
13707,941,),O
13708,942,Consenting,O
13709,942,adults,O
13710,942,(,O
13711,942,18,O
13712,942,years,O
13713,942,and,O
13714,942,older,O
13715,942,),O
13716,942,who,O
13717,942,agrees,O
13718,942,and,O
13719,942,consents,O
13720,942,to,O
13721,942,skin,O
13722,942,biopsy,O
13723,942,and,O
13724,942,QSART,O
13725,942,procedure,O
13726,943,Patients,O
13727,943,who,O
13728,943,have,O
13729,943,Tacrolimus,O
13730,943,trough,O
13731,943,level,O
13732,943,resulted,O
13733,943,as,O
13734,943,2,O
13735,943,ng,O
13736,943,/,O
13737,943,mg,O
13738,943,at,O
13739,943,the,O
13740,943,baseline,O
13741,943,.,O
13742,944,Patients,O
13743,944,who,O
13744,944,are,O
13745,944,on,O
13746,944,steroid,B-Drug
13747,944,therapy,O
13748,944,due,O
13749,944,to,O
13750,944,positive,O
13751,944,result,O
13752,944,of,O
13753,944,acute,O
13754,944,rejection,O
13755,944,test,O
13756,944,before,O
13757,944,the,O
13758,944,baseline,O
13759,944,.,O
13760,945,Patients,O
13761,945,who,O
13762,945,have,O
13763,945,received,O
13764,945,a,O
13765,945,transplant,B-Procedure
13766,945,besides,O
13767,945,liver,O
13768,945,.,O
13769,946,Patients,O
13770,946,who,O
13771,946,are,O
13772,946,allergic,B-Condition
13773,946,to,O
13774,946,IP,B-Drug
13775,946,or,O
13776,946,macrolide,B-Drug
13777,946,compounds,O
13778,946,.,O
13779,947,Patients,O
13780,947,who,O
13781,947,are,O
13782,947,on,O
13783,947,cyclosporine,B-Drug
13784,947,",",O
13785,947,bosentan,B-Drug
13786,947,",",O
13787,947,or,O
13788,947,potassium,B-Drug
13789,947,sparing,I-Drug
13790,947,diuretic,I-Drug
13791,947,.,O
13792,948,Patients,O
13793,948,with,O
13794,948,genetic,B-Condition
13795,948,diseases,I-Condition
13796,948,such,O
13797,948,as,O
13798,948,galactose,B-Condition
13799,948,intolerance,I-Condition
13800,948,",",O
13801,948,Lapp,B-Condition
13802,948,lactase,I-Condition
13803,948,deficiency,I-Condition
13804,948,",",O
13805,948,or,O
13806,948,glucose,B-Condition
13807,948,-,I-Condition
13808,948,galactose,I-Condition
13809,948,malabsorption,I-Condition
13810,948,.,O
13811,949,Pregnant,O
13812,949,or,O
13813,949,lactating,O
13814,949,women,O
13815,949,.,O
13816,950,Patients,O
13817,950,not,O
13818,950,willing,O
13819,950,to,O
13820,950,adhere,O
13821,950,to,O
13822,950,study,O
13823,950,procedures,O
13824,950,/,O
13825,950,treatments,O
13826,950,.,O
13827,951,19,O
13828,951,years,O
13829,951,old,B-Person
13830,951,and,O
13831,951,above,O
13832,951,.,O
13833,952,Patients,O
13834,952,who,O
13835,952,previously,O
13836,952,have,O
13837,952,received,O
13838,952,a,O
13839,952,liver,B-Procedure
13840,952,transplant,I-Procedure
13841,952,over,O
13842,952,the,O
13843,952,last,O
13844,952,six,O
13845,952,months,O
13846,952,and,O
13847,952,within,O
13848,952,last,O
13849,952,three,O
13850,952,years,O
13851,952,.,O
13852,953,Patients,O
13853,953,who,O
13854,953,are,O
13855,953,on,O
13856,953,Tacrolimus,B-Drug
13857,953,immunosuppressive,O
13858,953,therapy,O
13859,953,twice,O
13860,953,a,O
13861,953,day,O
13862,953,for,O
13863,953,at,O
13864,953,least,O
13865,953,two,O
13866,953,weeks,O
13867,953,.,O
13868,954,Patients,O
13869,954,who,O
13870,954,have,O
13871,954,normal,O
13872,954,liver,B-Condition
13873,954,function,I-Condition
13874,954,and,O
13875,954,renal,B-Condition
13876,954,function,I-Condition
13877,954,.,O
13878,955,Patients,O
13879,955,who,O
13880,955,have,O
13881,955,been,O
13882,955,monitored,O
13883,955,without,O
13884,955,complication,B-Condition
13885,955,such,O
13886,955,as,O
13887,955,acute,B-Condition
13888,955,rejection,I-Condition
13889,955,.,O
13890,956,Patients,O
13891,956,willing,O
13892,956,to,O
13893,956,sign,O
13894,956,his,O
13895,956,/,O
13896,956,her,O
13897,956,consent,O
13898,956,.,O
13899,957,Atrial,B-Condition
13900,957,fibrillation,I-Condition
13901,957,of,O
13902,957,new,O
13903,957,onset,O
13904,957,or,O
13905,957,when,O
13906,957,rate,B-Condition
13907,957,control,I-Condition
13908,957,has,I-Condition
13909,957,been,I-Condition
13910,957,difficult,I-Condition
13911,958,Known,O
13912,958,bigemini,B-Condition
13913,958,/,O
13914,958,trigeminy,B-Condition
13915,959,Prior,O
13916,959,CABG,B-Procedure
13917,959,surgery,I-Procedure
13918,960,Allergic,B-Condition
13919,960,to,O
13920,960,contrast,B-Drug
13921,961,Advanced,B-Condition
13922,961,renal,I-Condition
13923,961,impairment,I-Condition
13924,962,Significant,O
13925,962,valve,B-Condition
13926,962,disease,I-Condition
13927,962,(,O
13928,962,severe,O
13929,962,aortic,B-Condition
13930,962,stenosis,I-Condition
13931,962,or,O
13932,962,regurgitation,B-Condition
13933,962,;,O
13934,962,severe,O
13935,962,mitral,B-Condition
13936,962,regurgitation,I-Condition
13937,962,),O
13938,963,Life,B-Observation
13939,963,expectancy,I-Observation
13940,963,<,O
13941,963,12,O
13942,963,months,O
13943,964,Inclusion,O
13944,964,in,O
13945,964,another,O
13946,964,trial,O
13947,964,without,O
13948,964,prior,O
13949,964,agreement,O
13950,964,with,O
13951,964,CI,O
13952,965,Aged,B-Person
13953,965,over,O
13954,965,18,O
13955,966,Primary,O
13956,966,symptom,O
13957,966,of,O
13958,966,chest,B-Condition
13959,966,pain,I-Condition
13960,967,No,O
13961,967,contraindication,B-Condition
13962,967,to,O
13963,967,CTA,B-Procedure
13964,968,Willing,O
13965,968,and,O
13966,968,able,O
13967,968,to,O
13968,968,provide,O
13969,968,written,O
13970,968,informed,O
13971,968,consent,O
13972,969,More,O
13973,969,than,O
13974,969,three,O
13975,969,doses,O
13976,969,of,O
13977,969,any,O
13978,969,opioid,B-Drug
13979,969,within,O
13980,969,one,O
13981,969,week,O
13982,969,of,O
13983,969,surgery,O
13984,970,Pregnancy,B-Condition
13985,971,Prisoners,B-Person
13986,972,Unable,O
13987,972,to,O
13988,972,provide,O
13989,972,consent,O
13990,973,Emergency,B-Procedure
13991,973,surgery,I-Procedure
13992,974,Chronic,B-Condition
13993,974,kidney,I-Condition
13994,974,disease,I-Condition
13995,974,stage,O
13996,974,5,O
13997,974,(,O
13998,974,GFR,O
13999,974,<,O
14000,974,15,O
14001,974,ml,O
14002,974,/,O
14003,974,min,O
14004,974,),O
14005,975,Severe,O
14006,975,hepatic,B-Condition
14007,975,impairment,I-Condition
14008,976,Recent,O
14009,976,myocardial,B-Condition
14010,976,infarction,I-Condition
14011,976,(,O
14012,976,within,O
14013,976,the,O
14014,976,last,O
14015,976,3,O
14016,976,months,O
14017,976,),O
14018,977,Major,B-Procedure
14019,977,spine,I-Procedure
14020,977,surgery,I-Procedure
14021,977,scheduled,O
14022,977,as,O
14023,977,part,O
14024,977,of,O
14025,977,clinical,O
14026,977,care,O
14027,978,18,O
14028,978,-,O
14029,978,80,O
14030,978,years,B-Person
14031,979,none,O
14032,979,",",O
14033,979,all,O
14034,979,patients,O
14035,979,meeting,O
14036,979,the,O
14037,979,inclusion,O
14038,979,criteria,O
14039,979,will,O
14040,979,be,O
14041,979,eligible,O
14042,979,.,O
14043,980,acute,B-Condition
14044,980,myocardial,I-Condition
14045,980,infarction,I-Condition
14046,980,or,O
14047,981,ischemic,B-Condition
14048,981,cardiomyopathy,I-Condition
14049,981,with,O
14050,981,or,O
14051,981,without,O
14052,981,previous,O
14053,981,myocardial,B-Condition
14054,981,infarction,I-Condition
14055,981,or,O
14056,982,dilated,B-Condition
14057,982,cardiomyopathy,I-Condition
14058,982,due,O
14059,982,to,O
14060,982,valvular,B-Condition
14061,982,heart,I-Condition
14062,982,disease,I-Condition
14063,982,",",O
14064,982,hypertensive,B-Condition
14065,982,heart,I-Condition
14066,982,disease,I-Condition
14067,982,",",O
14068,982,history,B-Observation
14069,982,of,O
14070,982,myocarditis,B-Condition
14071,982,(,O
14072,982,no,O
14073,982,active,O
14074,982,myocardial,B-Condition
14075,982,infection,I-Condition
14076,982,present,O
14077,982,),O
14078,983,History,O
14079,983,of,O
14080,983,a,O
14081,983,primary,B-Condition
14082,983,sleep,I-Condition
14083,983,disorder,I-Condition
14084,983,other,O
14085,983,than,O
14086,983,RLS,B-Condition
14087,983,that,O
14088,983,may,O
14089,983,significantly,O
14090,983,affect,O
14091,983,the,O
14092,983,symptoms,O
14093,983,of,O
14094,983,RLS,O
14095,983,.,O
14096,984,Serum,O
14097,984,ferritin,O
14098,984,level,O
14099,984,<,O
14100,984,20,O
14101,984,ng,O
14102,984,/,O
14103,984,mL,O
14104,984,at,O
14105,984,screening,O
14106,984,.,O
14107,985,History,O
14108,985,of,O
14109,985,allergy,B-Condition
14110,985,",",O
14111,985,hypersensitivity,B-Condition
14112,985,",",O
14113,985,or,O
14114,985,intolerance,B-Condition
14115,985,to,O
14116,985,HORIZANT,B-Drug
14117,985,or,O
14118,985,any,O
14119,985,other,O
14120,985,gabapentin,B-Drug
14121,985,products,O
14122,985,(,O
14123,985,eg,O
14124,985,",",O
14125,985,Neurontin,B-Drug
14126,985,®,O
14127,985,",",O
14128,985,Gralise,B-Drug
14129,985,®,O
14130,985,),O
14131,985,.,O
14132,986,Suffering,O
14133,986,from,O
14134,986,a,O
14135,986,movement,B-Condition
14136,986,disorder,I-Condition
14137,986,that,O
14138,986,could,O
14139,986,mimic,O
14140,986,or,O
14141,986,confound,O
14142,986,the,O
14143,986,accurate,O
14144,986,diagnosis,O
14145,986,of,O
14146,986,RLS,O
14147,986,(,O
14148,986,eg,O
14149,986,",",O
14150,986,Tourette,B-Condition
14151,986,'s,I-Condition
14152,986,syndrome,I-Condition
14153,986,",",O
14154,986,tic,B-Condition
14155,986,disorder,I-Condition
14156,986,",",O
14157,986,periodic,B-Condition
14158,986,limb,I-Condition
14159,986,movement,I-Condition
14160,986,disorder,I-Condition
14161,986,[,O
14162,986,PLMD,B-Condition
14163,986,],O
14164,986,",",O
14165,986,sleep,B-Condition
14166,986,disorders,I-Condition
14167,986,),O
14168,986,.,O
14169,987,Currently,O
14170,987,meet,O
14171,987,Diagnostic,O
14172,987,and,O
14173,987,Statistical,O
14174,987,Manual,O
14175,987,of,O
14176,987,Mental,O
14177,987,Disorders,O
14178,987,-,O
14179,987,Fifth,O
14180,987,Edition,O
14181,987,(,O
14182,987,DSM-5,O
14183,987,),O
14184,987,criteria,O
14185,987,for,O
14186,987,substance,B-Condition
14187,987,use,I-Condition
14188,987,disorder,I-Condition
14189,987,",",O
14190,987,or,O
14191,987,history,O
14192,987,thereof,O
14193,987,",",O
14194,987,within,O
14195,987,12,O
14196,987,months,O
14197,987,before,O
14198,987,dosing,O
14199,987,.,O
14200,988,Current,O
14201,988,or,O
14202,988,past,O
14203,988,history,O
14204,988,of,O
14205,988,any,O
14206,988,significant,O
14207,988,psychiatric,B-Condition
14208,988,disorder,I-Condition
14209,988,including,O
14210,988,",",O
14211,988,but,O
14212,988,not,O
14213,988,limited,O
14214,988,to,O
14215,988,",",O
14216,988,depression,B-Condition
14217,988,(,O
14218,988,treatment,O
14219,988,with,O
14220,988,antidepressants,B-Drug
14221,988,),O
14222,988,",",O
14223,988,bipolar,B-Condition
14224,988,disorder,I-Condition
14225,988,",",O
14226,988,or,O
14227,988,schizophrenia,B-Condition
14228,988,.,O
14229,989,Diagnosis,O
14230,989,of,O
14231,989,attention,B-Condition
14232,989,-,I-Condition
14233,989,deficit,I-Condition
14234,989,hyperactivity,I-Condition
14235,989,disorder,I-Condition
14236,989,(,O
14237,989,ADHD,B-Condition
14238,989,),O
14239,989,is,O
14240,989,allowed,O
14241,989,",",O
14242,989,provided,O
14243,989,the,O
14244,989,patient,O
14245,989,is,O
14246,989,not,O
14247,989,receiving,O
14248,989,medication(s,O
14249,989,),O
14250,989,known,O
14251,989,to,O
14252,989,affect,O
14253,989,the,O
14254,989,assessment,O
14255,989,of,O
14256,989,RLS,O
14257,989,.,O
14258,990,History,O
14259,990,of,O
14260,990,suicidal,B-Observation
14261,990,behavior,I-Observation
14262,990,or,O
14263,990,suicidal,B-Condition
14264,990,ideation,I-Condition
14265,990,as,O
14266,990,indicated,O
14267,990,by,O
14268,990,the,O
14269,990,C,O
14270,990,-,O
14271,990,SSRS,O
14272,990,",",O
14273,990,administered,O
14274,990,at,O
14275,990,screening,O
14276,990,(,O
14277,990,the,O
14278,990,questionnaire,O
14279,990,is,O
14280,990,provided,O
14281,990,in,O
14282,990,Appendix,O
14283,990,4,O
14284,990,),O
14285,990,",",O
14286,990,and,O
14287,990,as,O
14288,990,per,O
14289,990,investigator,O
14290,990,'s,O
14291,990,judgment,O
14292,990,.,O
14293,991,History,O
14294,991,of,O
14295,991,seizure,B-Condition
14296,991,disorder,I-Condition
14297,991,or,O
14298,991,at,O
14299,991,increased,O
14300,991,risk,O
14301,991,for,O
14302,991,development,O
14303,991,of,O
14304,991,a,O
14305,991,seizure,O
14306,991,disorder,O
14307,991,including,O
14308,991,",",O
14309,991,but,O
14310,991,not,O
14311,991,limited,O
14312,991,to,O
14313,991,",",O
14314,991,complicated,B-Condition
14315,991,febrile,I-Condition
14316,991,seizure,I-Condition
14317,991,and,O
14318,991,history,O
14319,991,of,O
14320,991,significant,O
14321,991,head,B-Condition
14322,991,injury,I-Condition
14323,991,.,O
14324,992,Medical,O
14325,992,condition,O
14326,992,or,O
14327,992,disorder,O
14328,992,that,O
14329,992,would,O
14330,992,interfere,O
14331,992,with,O
14332,992,the,O
14333,992,action,O
14334,992,",",O
14335,992,absorption,O
14336,992,",",O
14337,992,distribution,O
14338,992,",",O
14339,992,metabolism,O
14340,992,",",O
14341,992,or,O
14342,992,excretion,O
14343,992,of,O
14344,992,gabapentin,O
14345,992,enacarbil,O
14346,992,",",O
14347,992,or,O
14348,992,",",O
14349,992,in,O
14350,992,the,O
14351,992,investigator,O
14352,992,'s,O
14353,992,judgment,O
14354,992,is,O
14355,992,considered,O
14356,992,to,O
14357,992,be,O
14358,992,clinically,O
14359,992,significant,O
14360,992,and,O
14361,992,may,O
14362,992,pose,O
14363,992,a,O
14364,992,safety,O
14365,992,concern,O
14366,992,",",O
14367,992,or,O
14368,992,",",O
14369,992,could,O
14370,992,interfere,O
14371,992,with,O
14372,992,the,O
14373,992,accurate,O
14374,992,assessment,O
14375,992,of,O
14376,992,safety,O
14377,992,or,O
14378,992,efficacy,O
14379,992,",",O
14380,992,or,O
14381,992,could,O
14382,992,potentially,O
14383,992,affect,O
14384,992,a,O
14385,992,patient,O
14386,992,'s,O
14387,992,safety,O
14388,992,or,O
14389,992,study,O
14390,992,outcome,O
14391,992,.,O
14392,993,Clinically,O
14393,993,significant,O
14394,993,abnormal,O
14395,993,laboratory,O
14396,993,result,O
14397,993,or,O
14398,993,physical,O
14399,993,examination,O
14400,993,finding,O
14401,993,not,O
14402,993,resolved,O
14403,993,by,O
14404,993,the,O
14405,993,time,O
14406,993,of,O
14407,993,baseline,O
14408,993,assessments,O
14409,993,.,O
14410,994,Male,B-Person
14411,994,and,O
14412,994,female,B-Person
14413,994,adolescent,B-Person
14414,994,patients,O
14415,994,",",O
14416,994,aged,B-Person
14417,994,13,O
14418,994,to,O
14419,994,17,O
14420,994,years,O
14421,994,",",O
14422,994,diagnosed,O
14423,994,with,O
14424,994,RLS,B-Condition
14425,994,based,O
14426,994,on,O
14427,994,the,O
14428,994,IRLSSG,O
14429,994,consensus,O
14430,994,criteria,O
14431,994,(,O
14432,994,Allen,O
14433,994,RP,O
14434,994,2014,O
14435,994,),O
14436,994,(,O
14437,994,Appendix,O
14438,994,2,O
14439,994,),O
14440,994,.,O
14441,995,Total,O
14442,995,RLS,O
14443,995,severity,O
14444,995,score,O
14445,995,of,O
14446,995,15,O
14447,995,or,O
14448,995,greater,O
14449,995,on,O
14450,995,the,O
14451,995,IRLS,O
14452,995,rating,O
14453,995,scale,O
14454,995,at,O
14455,995,Visit,O
14456,995,1,O
14457,995,(,O
14458,995,screening,O
14459,995,),O
14460,995,and,O
14461,995,at,O
14462,995,Visit,O
14463,995,2,O
14464,995,(,O
14465,995,baseline,O
14466,995,),O
14467,995,(,O
14468,995,Appendix,O
14469,995,8),O
14470,995,.,O
14471,996,RLS,B-Condition
14472,996,symptoms,I-Condition
14473,996,for,O
14474,996,at,O
14475,996,least,O
14476,996,4,O
14477,996,of,O
14478,996,7,O
14479,996,consecutive,O
14480,996,evenings,O
14481,996,/,O
14482,996,nights,O
14483,996,during,O
14484,996,the,O
14485,996,screening,O
14486,996,period,O
14487,996,.,O
14488,997,Body,O
14489,997,weight,O
14490,997,greater,O
14491,997,than,O
14492,997,33.4,O
14493,997,kg,O
14494,997,and,O
14495,997,a,O
14496,997,healthy,O
14497,997,weight,O
14498,997,using,O
14499,997,age,O
14500,997,-,O
14501,997,based,O
14502,997,body,O
14503,997,mass,O
14504,997,index,O
14505,997,(,O
14506,997,BMI,O
14507,997,),O
14508,997,range,O
14509,997,5th-85th,O
14510,997,percentile,O
14511,997,at,O
14512,997,screening,O
14513,997,and,O
14514,997,baseline,O
14515,997,.,O
14516,997,Appendix,O
14517,997,3,O
14518,997,contains,O
14519,997,BMI,O
14520,997,-,O
14521,997,for,O
14522,997,-,O
14523,997,age,O
14524,997,charts,O
14525,997,that,O
14526,997,can,O
14527,997,be,O
14528,997,consulted,O
14529,997,.,O
14530,998,Estimated,O
14531,998,creatinine,O
14532,998,clearance,O
14533,998,of,O
14534,998,at,O
14535,998,least,O
14536,998,60,O
14537,998,mL,O
14538,998,/,O
14539,998,min,O
14540,998,(,O
14541,998,using,O
14542,998,the,O
14543,998,Cockcroft,O
14544,998,-,O
14545,998,Gault,O
14546,998,equation,O
14547,998,),O
14548,998,at,O
14549,998,screening,O
14550,998,only,O
14551,998,.,O
14552,999,Signed,O
14553,999,patient,O
14554,999,and,O
14555,999,parent,O
14556,999,Institutional,O
14557,999,Review,O
14558,999,Board,O
14559,999,(,O
14560,999,IRB)-approved,O
14561,999,informed,O
14562,999,consent,O
14563,999,/,O
14564,999,assent,O
14565,999,form,O
14566,999,(,O
14567,999,as,O
14568,999,applicable,O
14569,999,),O
14570,999,before,O
14571,999,any,O
14572,999,study,O
14573,999,-,O
14574,999,related,O
14575,999,procedures,O
14576,999,are,O
14577,999,performed,O
14578,999,.,O
14579,1000,Thalassemia,B-Condition
14580,1000,syndromes,I-Condition
14581,1000,;,O
14582,1001,Myelodysplastic,B-Condition
14583,1001,syndrome,I-Condition
14584,1001,(,I-Condition
14585,1001,MDS,I-Condition
14586,1001,),I-Condition
14587,1001,or,O
14588,1001,myelofibrosis,B-Condition
14589,1001,;,O
14590,1002,Diamond,B-Condition
14591,1002,Blackfan,I-Condition
14592,1002,anemia,I-Condition
14593,1002,;,O
14594,1003,Primary,B-Condition
14595,1003,bone,I-Condition
14596,1003,marrow,I-Condition
14597,1003,failure,I-Condition
14598,1003,;,O
14599,1004,Baseline,O
14600,1004,LIC,O
14601,1004,>,O
14602,1004,30,O
14603,1004,mg,O
14604,1004,/,O
14605,1004,g,O
14606,1004,dw,O
14607,1004,(,O
14608,1004,measured,B-Mood
14609,1004,by,I-Mood
14610,1004,MRI,B-Procedure
14611,1004,),O
14612,1004,;,O
14613,1005,Unable,O
14614,1005,or,O
14615,1005,unwilling,O
14616,1005,to,O
14617,1005,undergo,O
14618,1005,a,O
14619,1005,7,O
14620,1005,day,O
14621,1005,washout,O
14622,1005,period,O
14623,1005,if,O
14624,1005,currently,O
14625,1005,being,O
14626,1005,treated,O
14627,1005,with,O
14628,1005,deferiprone,O
14629,1005,or,O
14630,1005,deferoxamine,O
14631,1005,or,O
14632,1005,deferasirox,O
14633,1005,;,O
14634,1006,Previous,O
14635,1006,discontinuation,B-Procedure
14636,1006,of,I-Procedure
14637,1006,treatment,I-Procedure
14638,1006,with,O
14639,1006,deferiprone,B-Condition
14640,1006,or,O
14641,1006,deferoxamine,B-Condition
14642,1006,due,O
14643,1006,to,O
14644,1006,adverse,O
14645,1006,events,O
14646,1006,;,O
14647,1007,History,O
14648,1007,or,O
14649,1007,presence,O
14650,1007,of,O
14651,1007,hypersensitivity,B-Condition
14652,1007,or,O
14653,1007,idiosyncratic,B-Condition
14654,1007,reaction,I-Condition
14655,1007,to,O
14656,1007,deferiprone,B-Drug
14657,1007,or,O
14658,1007,deferoxamine,B-Drug
14659,1007,;,O
14660,1008,Treated,O
14661,1008,with,O
14662,1008,hydroxyurea,B-Drug
14663,1008,within,O
14664,1008,30,O
14665,1008,days,O
14666,1008,;,O
14667,1009,History,O
14668,1009,of,O
14669,1009,malignancy,B-Condition
14670,1009,;,O
14671,1010,Evidence,O
14672,1010,of,O
14673,1010,abnormal,O
14674,1010,liver,O
14675,1010,function,O
14676,1010,(,O
14677,1010,serum,O
14678,1010,ALT,O
14679,1010,level(s,O
14680,1010,),O
14681,1010,>,O
14682,1010,5,O
14683,1010,times,O
14684,1010,upper,O
14685,1010,limit,O
14686,1010,of,O
14687,1010,normal,O
14688,1010,at,O
14689,1010,screening,O
14690,1010,or,O
14691,1010,creatinine,O
14692,1010,levels,O
14693,1010,>,O
14694,1010,2,O
14695,1010,times,O
14696,1010,upper,O
14697,1010,limit,O
14698,1010,of,O
14699,1010,normal,O
14700,1010,at,O
14701,1010,screening,O
14702,1010,),O
14703,1010,;,O
14704,1011,A,O
14705,1011,serious,O
14706,1011,",",O
14707,1011,unstable,B-Condition
14708,1011,illness,I-Condition
14709,1011,",",O
14710,1011,as,O
14711,1011,judged,O
14712,1011,by,O
14713,1011,the,O
14714,1011,Investigator,O
14715,1011,",",O
14716,1011,during,O
14717,1011,the,O
14718,1011,past,O
14719,1011,3,O
14720,1011,months,O
14721,1011,before,O
14722,1011,screening,O
14723,1011,/,O
14724,1011,baseline,O
14725,1011,visit,O
14726,1011,including,O
14727,1011,but,O
14728,1011,not,O
14729,1011,limited,O
14730,1011,to,O
14731,1011,:,O
14732,1011,hepatic,B-Condition
14733,1011,",",I-Condition
14734,1011,renal,I-Condition
14735,1011,",",I-Condition
14736,1011,gastro,I-Condition
14737,1011,-,I-Condition
14738,1011,enterologic,I-Condition
14739,1011,",",I-Condition
14740,1011,respiratory,I-Condition
14741,1011,",",I-Condition
14742,1011,cardiovascular,I-Condition
14743,1011,",",I-Condition
14744,1011,endocrinologic,I-Condition
14745,1011,",",I-Condition
14746,1011,neurologic,I-Condition
14747,1011,or,I-Condition
14748,1011,immunologic,I-Condition
14749,1011,disease,I-Condition
14750,1011,;,O
14751,1012,Clinically,O
14752,1012,significant,O
14753,1012,abnormal,O
14754,1012,12,B-Procedure
14755,1012,-,I-Procedure
14756,1012,lead,I-Procedure
14757,1012,ECG,I-Procedure
14758,1012,findings,B-Condition
14759,1012,;,O
14760,1013,Cardiac,O
14761,1013,MRI,O
14762,1013,T2,O
14763,1013,*,O
14764,1013,<,O
14765,1013,10ms,O
14766,1013,;,O
14767,1014,Myocardial,B-Condition
14768,1014,infarction,I-Condition
14769,1014,",",O
14770,1014,cardiac,B-Condition
14771,1014,arrest,I-Condition
14772,1014,or,O
14773,1014,cardiac,B-Condition
14774,1014,failure,I-Condition
14775,1014,within,O
14776,1014,1,O
14777,1014,year,O
14778,1014,before,O
14779,1014,screening,O
14780,1014,/,O
14781,1014,baseline,O
14782,1014,visit,O
14783,1014,;,O
14784,1015,Unable,B-Condition
14785,1015,to,I-Condition
14786,1015,undergo,I-Condition
14787,1015,MRI,B-Procedure
14788,1016,Presence,O
14789,1016,of,O
14790,1016,metallic,O
14791,1016,objects,O
14792,1016,such,O
14793,1016,as,O
14794,1016,artificial,O
14795,1016,joints,O
14796,1016,",",O
14797,1016,inner,O
14798,1016,ear,O
14799,1016,(,O
14800,1016,cochlear,O
14801,1016,),O
14802,1016,implants,O
14803,1016,",",O
14804,1016,brain,O
14805,1016,aneurysm,O
14806,1016,clips,O
14807,1016,",",O
14808,1016,pacemakers,O
14809,1016,",",O
14810,1016,and,O
14811,1016,metallic,O
14812,1016,foreign,O
14813,1016,bodies,O
14814,1016,in,O
14815,1016,the,O
14816,1016,eye,O
14817,1016,or,O
14818,1016,other,O
14819,1016,body,O
14820,1016,areas,O
14821,1016,that,O
14822,1016,would,O
14823,1016,prevent,O
14824,1016,use,O
14825,1016,of,O
14826,1016,MRI,O
14827,1016,imaging,O
14828,1017,Male,B-Person
14829,1017,or,O
14830,1017,female,B-Person
14831,1017,=,O
14832,1017,2,O
14833,1017,years,O
14834,1017,of,O
14835,1017,age,B-Person
14836,1017,;,O
14837,1018,Have,O
14838,1018,sickle,B-Condition
14839,1018,cell,I-Condition
14840,1018,disease,I-Condition
14841,1018,(,O
14842,1018,confirmed,O
14843,1018,by,O
14844,1018,Hb,B-Procedure
14845,1018,electrophoresis,I-Procedure
14846,1018,or,O
14847,1018,more,B-Procedure
14848,1018,specific,I-Procedure
14849,1018,tests,I-Procedure
14850,1018,),O
14851,1018,or,O
14852,1018,other,B-Condition
14853,1018,conditions,I-Condition
14854,1018,with,I-Condition
14855,1018,iron,I-Condition
14856,1018,overload,I-Condition
14857,1018,from,O
14858,1018,repeated,O
14859,1018,blood,B-Procedure
14860,1018,transfusions,I-Procedure
14861,1018,(,O
14862,1018,see,O
14863,1018,exclusion,O
14864,1018,criteria,O
14865,1018,for,O
14866,1018,exceptions,O
14867,1018,),O
14868,1018,;,O
14869,1019,Baseline,O
14870,1019,LIC,O
14871,1019,>,O
14872,1019,7,O
14873,1019,mg,O
14874,1019,/,O
14875,1019,g,O
14876,1019,dw,O
14877,1019,(,O
14878,1019,measured,O
14879,1019,by,O
14880,1019,MRI,B-Procedure
14881,1019,),O
14882,1019,;,O
14883,1020,Patients,O
14884,1020,who,O
14885,1020,have,O
14886,1020,received,O
14887,1020,no,O
14888,1020,less,O
14889,1020,than,O
14890,1020,20,O
14891,1020,transfusions,B-Procedure
14892,1020,of,I-Procedure
14893,1020,RBCs,I-Procedure
14894,1020,;,O
14895,1021,Patients,O
14896,1021,who,O
14897,1021,have,O
14898,1021,received,O
14899,1021,at,O
14900,1021,least,O
14901,1021,1,O
14902,1021,transfusion,B-Procedure
14903,1021,per,O
14904,1021,year,O
14905,1021,in,O
14906,1021,the,O
14907,1021,last,O
14908,1021,2,O
14909,1021,years,O
14910,1021,and,O
14911,1021,who,O
14912,1021,are,O
14913,1021,expected,B-Condition
14914,1021,to,I-Condition
14915,1021,have,I-Condition
14916,1021,a,I-Condition
14917,1021,continuing,I-Condition
14918,1021,requirement,I-Condition
14919,1021,(,O
14920,1021,based,O
14921,1021,on,O
14922,1021,Investigator,O
14923,1021,'s,O
14924,1021,judgement,O
14925,1021,),O
14926,1021,during,O
14927,1021,the,O
14928,1021,duration,O
14929,1021,of,O
14930,1021,the,O
14931,1021,trial,O
14932,1022,Diabetes,B-Condition
14933,1022,mellitus,I-Condition
14934,1022,or,O
14935,1022,plasma,O
14936,1022,glucose,O
14937,1022,>,O
14938,1022,"11,1",O
14939,1022,at,O
14940,1022,admission,O
14941,1022,.,O
14942,1023,Receiving,B-Procedure
14943,1023,steroids,B-Drug
14944,1023,at,O
14945,1023,the,O
14946,1023,time,O
14947,1023,of,O
14948,1023,transplantation,O
14949,1023,or,O
14950,1023,likely,B-Mood
14951,1023,to,I-Mood
14952,1023,need,I-Mood
14953,1023,steroids,B-Drug
14954,1023,after,O
14955,1023,transplantation,O
14956,1023,.,O
14957,1024,Multiorgan,B-Procedure
14958,1024,transplants,I-Procedure
14959,1024,and/or,O
14960,1024,previously,O
14961,1024,transplanted,B-Procedure
14962,1024,with,I-Procedure
14963,1024,any,I-Procedure
14964,1024,other,I-Procedure
14965,1024,organ,I-Procedure
14966,1024,than,I-Procedure
14967,1024,kidney,I-Procedure
14968,1024,.,O
14969,1025,Panel,O
14970,1025,reacting,O
14971,1025,antibodies(PRA,O
14972,1025,),O
14973,1025,>,O
14974,1025,25,O
14975,1025,%,O
14976,1025,in,O
14977,1025,most,O
14978,1025,recent,O
14979,1025,test,O
14980,1025,or,O
14981,1025,considered,B-Mood
14982,1025,to,I-Mood
14983,1025,be,I-Mood
14984,1025,of,I-Mood
14985,1025,high,I-Mood
14986,1025,risk,I-Mood
14987,1025,for,O
14988,1025,rejection,B-Condition
14989,1025,which,O
14990,1025,requires,O
14991,1025,an,O
14992,1025,enhanced,B-Procedure
14993,1025,immunosuppression,I-Procedure
14994,1025,.,O
14995,1026,Renal,B-Procedure
14996,1026,transplants,I-Procedure
14997,1026,from,O
14998,1026,HLA,O
14999,1026,-,O
15000,1026,identical,O
15001,1026,sibling,O
15002,1026,.,O
15003,1027,Hypersensitivity,B-Condition
15004,1027,to,O
15005,1027,",",O
15006,1027,or,O
15007,1027,disability,B-Condition
15008,1027,to,O
15009,1027,take,O
15010,1027,immunosuppressive,B-Drug
15011,1027,drugs,I-Drug
15012,1027,.,O
15013,1028,Blood,O
15014,1028,group(ABO)-incompatible,O
15015,1028,transplants,B-Procedure
15016,1028,.,O
15017,1029,Unlikely,O
15018,1029,to,O
15019,1029,comply,O
15020,1029,with,O
15021,1029,the,O
15022,1029,study,O
15023,1029,requirements,O
15024,1029,.,O
15025,1030,Transplant,B-Procedure
15026,1030,from,O
15027,1030,donor,O
15028,1030,positive,B-Condition
15029,1030,for,I-Condition
15030,1030,HIV,I-Condition
15031,1030,",",I-Condition
15032,1030,HBsAg,I-Condition
15033,1030,",",I-Condition
15034,1030,Hepatitis,I-Condition
15035,1030,C.,I-Condition
15036,1031,Female,O
15037,1031,of,O
15038,1031,childbearing,O
15039,1031,potential,O
15040,1031,planing,O
15041,1031,/,O
15042,1031,being,O
15043,1031,pregnant,O
15044,1031,or,O
15045,1031,unwilling,O
15046,1031,to,O
15047,1031,use,O
15048,1031,contraception,O
15049,1031,.,O
15050,1032,First,B-Procedure
15051,1032,or,I-Procedure
15052,1032,second,I-Procedure
15053,1032,single,I-Procedure
15054,1032,kidney,I-Procedure
15055,1032,(,I-Procedure
15056,1032,cadaveric,I-Procedure
15057,1032,or,I-Procedure
15058,1032,living,I-Procedure
15059,1032,donors,I-Procedure
15060,1032,),I-Procedure
15061,1032,transplant,I-Procedure
15062,1032,recipients,O
15063,1032,.,O
15064,1033,Considered,B-Mood
15065,1033,for,I-Mood
15066,1033,a,O
15067,1033,standard,B-Procedure
15068,1033,immunosuppressive,I-Procedure
15069,1033,protocol,I-Procedure
15070,1033,.,O
15071,1034,Must,O
15072,1034,be,O
15073,1034,capable,O
15074,1034,of,O
15075,1034,giving,O
15076,1034,written,O
15077,1034,informed,O
15078,1034,connect,O
15079,1034,for,O
15080,1034,participation,O
15081,1034,in,O
15082,1034,the,O
15083,1034,study,O
15084,1034,for,O
15085,1034,24,O
15086,1034,months,O
15087,1034,.,O
15088,1035,Chronic,O
15089,1035,opiate,B-Drug
15090,1035,use,O
15091,1036,Liver,B-Condition
15092,1036,disease,I-Condition
15093,1036,(,O
15094,1036,known,O
15095,1036,history,B-Observation
15096,1036,of,O
15097,1036,hepatitis,B-Condition
15098,1036,B,I-Condition
15099,1036,or,I-Condition
15100,1036,C,I-Condition
15101,1036,",",O
15102,1036,cirrhosis,B-Condition
15103,1036,",",O
15104,1036,nonalcoholic,B-Condition
15105,1036,steatohepatitis,I-Condition
15106,1036,",",O
15107,1036,history,B-Observation
15108,1036,of,O
15109,1036,alcoholism,B-Condition
15110,1036,",",O
15111,1036,ALT,O
15112,1036,/,O
15113,1036,AST,O
15114,1036,greater,O
15115,1036,than,O
15116,1036,3,O
15117,1036,times,O
15118,1036,upper,O
15119,1036,limit,O
15120,1036,of,O
15121,1036,normal,O
15122,1036,in,O
15123,1036,the,O
15124,1036,past,O
15125,1036,3,O
15126,1036,months,O
15127,1036,),O
15128,1037,Allergy,B-Condition
15129,1037,/,O
15130,1037,hypersensitivity,B-Condition
15131,1037,to,O
15132,1037,acetaminophen,B-Drug
15133,1038,Patients,O
15134,1038,with,O
15135,1038,baseline,O
15136,1038,dementia,B-Condition
15137,1039,Chronic,O
15138,1039,diathesis,B-Condition
15139,1040,Chronic,O
15140,1040,kidney,B-Condition
15141,1040,disease,I-Condition
15142,1041,Patients,O
15143,1041,undergoing,O
15144,1041,robotic,O
15145,1041,-,I-Procedure
15146,1041,assisted,I-Procedure
15147,1041,laparoscopic,I-Procedure
15148,1041,prostatectomy,I-Procedure
15149,1042,=,O
15150,1042,18,O
15151,1042,years,B-Person
15152,1042,old,O
15153,1042,males,B-Person
15154,1043,ASA,O
15155,1043,class,O
15156,1043,1,O
15157,1043,-,O
15158,1043,4,O
15159,1044,Psychiatric,B-Condition
15160,1044,disorders,I-Condition
15161,1044,other,O
15162,1044,than,O
15163,1044,insomnia,B-Condition
15164,1044,",",O
15165,1044,PTSD,B-Condition
15166,1044,and,O
15167,1044,specific,O
15168,1044,phobias,B-Condition
15169,1044,;,O
15170,1044,including,O
15171,1044,bipolar,B-Condition
15172,1044,and,O
15173,1044,psychotic,B-Condition
15174,1044,disorders,I-Condition
15175,1044,and,O
15176,1044,meeting,O
15177,1044,criteria,O
15178,1044,for,O
15179,1044,DSM-5,O
15180,1044,moderate,O
15181,1044,alcohol,B-Condition
15182,1044,or,I-Condition
15183,1044,drug,I-Condition
15184,1044,use,I-Condition
15185,1044,disorders,I-Condition
15186,1044,within,O
15187,1044,the,O
15188,1044,past,O
15189,1044,year,O
15190,1044,.,O
15191,1045,Diagnosis,O
15192,1045,of,O
15193,1045,a,O
15194,1045,sleep,B-Condition
15195,1045,disorder,I-Condition
15196,1045,other,O
15197,1045,than,O
15198,1045,insomnia,B-Condition
15199,1045,including,O
15200,1045,PSG,O
15201,1045,findings,O
15202,1045,of,O
15203,1045,apnea,B-Condition
15204,1045,/,O
15205,1045,hypopnea,B-Condition
15206,1045,or,O
15207,1045,periodic,O
15208,1045,limb,O
15209,1045,movement,O
15210,1045,indices,O
15211,1045,>,O
15212,1045,10,O
15213,1045,/,O
15214,1045,hour,O
15215,1045,;,O
15216,1046,Medical,O
15217,1046,conditions,O
15218,1046,that,O
15219,1046,require,O
15220,1046,consistent,O
15221,1046,use,O
15222,1046,of,O
15223,1046,medication,O
15224,1046,or,O
15225,1046,compromise,O
15226,1046,sleep,O
15227,1046,;,O
15228,1047,History,O
15229,1047,of,O
15230,1047,moderate,O
15231,1047,to,O
15232,1047,severe,O
15233,1047,traumatic,B-Condition
15234,1047,brain,I-Condition
15235,1047,injury,I-Condition
15236,1047,or,O
15237,1047,mild,O
15238,1047,traumatic,B-Condition
15239,1047,brain,I-Condition
15240,1047,injury,I-Condition
15241,1047,with,O
15242,1047,ongoing,O
15243,1047,post,B-Condition
15244,1047,-,I-Condition
15245,1047,concussive,I-Condition
15246,1047,symptoms,I-Condition
15247,1047,;,O
15248,1048,Suicidal,B-Condition
15249,1048,ideation,I-Condition
15250,1048,with,O
15251,1048,intent,O
15252,1048,to,O
15253,1048,act,O
15254,1048,or,O
15255,1048,with,O
15256,1048,specific,O
15257,1048,plan,O
15258,1048,and,O
15259,1048,intent,O
15260,1048,in,O
15261,1048,the,O
15262,1048,past,O
15263,1048,6,O
15264,1048,months,O
15265,1048,(,O
15266,1048,Type,O
15267,1048,4,O
15268,1048,-,O
15269,1048,5,O
15270,1048,ideation,O
15271,1048,on,O
15272,1048,the,O
15273,1048,Columbia,O
15274,1048,Suicide,O
15275,1048,Severity,O
15276,1048,Rating,O
15277,1048,Scale,O
15278,1048,),O
15279,1048,or,O
15280,1048,a,O
15281,1048,concerning,O
15282,1048,history,O
15283,1048,of,O
15284,1048,prior,O
15285,1048,suicidal,B-Condition
15286,1048,behavior,I-Condition
15287,1048,.,I-Condition
15288,1049,Caffeine,B-Drug
15289,1049,use,O
15290,1049,exceeding,O
15291,1049,5,O
15292,1049,cups,O
15293,1049,of,O
15294,1049,coffee,O
15295,1049,per,O
15296,1049,day,O
15297,1049,or,O
15298,1049,its,O
15299,1049,equivalent,O
15300,1049,;,O
15301,1050,Habitual,O
15302,1050,bedtimes,O
15303,1050,after,O
15304,1050,3,O
15305,1050,AM,O
15306,1050,",",O
15307,1050,habitual,O
15308,1050,rise,O
15309,1050,times,O
15310,1050,after,O
15311,1050,10,O
15312,1050,AM,O
15313,1050,",",O
15314,1050,or,O
15315,1050,habitual,O
15316,1050,napping,O
15317,1050,>,O
15318,1050,1hour,O
15319,1050,/,O
15320,1050,day,O
15321,1050,;,O
15322,1051,Pregnancy,O
15323,1051,or,O
15324,1051,breastfeeding,O
15325,1051,",",O
15326,1051,or,O
15327,1051,expecting,O
15328,1051,to,O
15329,1051,conceive,O
15330,1051,while,O
15331,1051,in,O
15332,1051,study,O
15333,1051,;,O
15334,1052,Positive,O
15335,1052,urine,O
15336,1052,toxicology,O
15337,1052,.,O
15338,1053,Physically,O
15339,1053,healthy,O
15340,1053,adults,B-Person
15341,1053,age,B-Person
15342,1053,18,O
15343,1053,-,O
15344,1053,55,O
15345,1053,who,O
15346,1053,meet,O
15347,1053,DSM-5,O
15348,1053,criteria,O
15349,1053,for,O
15350,1053,insomnia,B-Condition
15351,1053,and,O
15352,1053,Criterion,O
15353,1053,A,O
15354,1053,(,O
15355,1053,exposure,O
15356,1053,to,O
15357,1053,a,O
15358,1053,traumatic,O
15359,1053,event,O
15360,1053,),O
15361,1053,for,O
15362,1053,PTSD,B-Condition
15363,1053,.,O
15364,1053,The,O
15365,1053,index,O
15366,1053,trauma,B-Condition
15367,1053,must,O
15368,1053,have,O
15369,1053,occurred,O
15370,1053,within,O
15371,1053,the,O
15372,1053,past,O
15373,1053,5,O
15374,1053,years,O
15375,1053,and,O
15376,1053,at,O
15377,1053,least,O
15378,1053,3,O
15379,1053,months,O
15380,1053,before,O
15381,1053,enrolling,O
15382,1053,",",O
15383,1053,and,O
15384,1053,insomnia,O
15385,1053,symptoms,O
15386,1053,must,O
15387,1053,have,O
15388,1053,started,O
15389,1053,or,O
15390,1053,worsened,O
15391,1053,after,O
15392,1053,the,O
15393,1053,exposure,O
15394,1053,to,O
15395,1053,the,O
15396,1053,index,O
15397,1053,trauma,O
15398,1054,impaired,B-Condition
15399,1054,decision,I-Condition
15400,1054,making,I-Condition
15401,1055,neurofibromatosis,B-Condition
15402,1056,signs,B-Mood
15403,1056,for,O
15404,1056,central,B-Condition
15405,1056,dysfunction,I-Condition
15406,1057,remaining,B-Condition
15407,1057,vestibular,I-Condition
15408,1057,function,I-Condition
15409,1058,Patients,O
15410,1058,are,O
15411,1058,advised,O
15412,1058,not,O
15413,1058,to,O
15414,1058,participate,O
15415,1058,in,O
15416,1058,the,O
15417,1058,gentamicin,O
15418,1058,arm,O
15419,1058,if,O
15420,1059,hearing,O
15421,1059,is,O
15422,1059,better,O
15423,1059,than,O
15424,1059,30,O
15425,1059,deciBel,O
15426,1059,(,O
15427,1059,dB,O
15428,1059,),O
15429,1059,in,O
15430,1059,pure,O
15431,1059,tone,O
15432,1059,average,O
15433,1059,(,O
15434,1059,500,O
15435,1059,",",O
15436,1059,1000,O
15437,1059,",",O
15438,1059,2000,O
15439,1059,",",O
15440,1059,3,O
15441,1059,-,O
15442,1059,4000,O
15443,1059,Hz,O
15444,1059,),O
15445,1059,and,O
15446,1059,speech,O
15447,1059,discrimination,O
15448,1059,better,O
15449,1059,than,O
15450,1059,70,O
15451,1059,%,O
15452,1060,the,O
15453,1060,neurosurgeon,O
15454,1060,aim,O
15455,1060,at,O
15456,1060,hearing,O
15457,1060,preservation,O
15458,1060,surgery,O
15459,1060,and,O
15460,1060,do,O
15461,1060,not,O
15462,1060,want,O
15463,1060,to,O
15464,1060,risk,O
15465,1060,gentamicin,O
15466,1060,associated,O
15467,1060,hearing,O
15468,1060,loss,O
15469,1061,Vestibular,B-Condition
15470,1061,schwannoma,I-Condition
15471,1061,advised,B-Mood
15472,1061,to,O
15473,1061,surgical,B-Procedure
15474,1061,treatment,I-Procedure
15475,1062,No,O
15476,1062,measurable,O
15477,1062,remaining,O
15478,1062,vestibular,O
15479,1062,function,O
15480,1063,ca,O
15481,1063,n't,O
15482,1063,understand,O
15483,1063,patient,O
15484,1063,controlled,O
15485,1063,analgesia,O
15486,1063,device,O
15487,1063,refuse,O
15488,1063,trial,O
15489,1064,elective,O
15490,1064,Laparoscopic,O
15491,1064,myomectomy,B-Procedure
15492,1064,patients,O
15493,1064,24hr,O
15494,1064,post,O
15495,1064,-,O
15496,1064,operative,O
15497,1064,patient,B-Procedure
15498,1064,controlled,I-Procedure
15499,1064,analgesia,I-Procedure
15500,1064,analgesia,O
15501,1064,no,O
15502,1064,mild,O
15503,1064,or,O
15504,1064,severe,O
15505,1064,liver,B-Condition
15506,1064,or,I-Condition
15507,1064,renal,I-Condition
15508,1064,disfunction,I-Condition
15509,1065,Known,O
15510,1065,fetal,B-Condition
15511,1065,anomaly,I-Condition
15512,1066,Other,O
15513,1066,indication,B-Condition
15514,1066,for,O
15515,1066,intrapartum,B-Drug
15516,1066,antibiotics,I-Drug
15517,1066,(,O
15518,1066,endocarditis,B-Condition
15519,1066,prophylaxis,I-Condition
15520,1066,",",O
15521,1066,other,O
15522,1066,known,O
15523,1066,maternal,B-Condition
15524,1066,infection,I-Condition
15525,1066,),O
15526,1067,Pregnant,B-Condition
15527,1067,women,B-Person
15528,1067,between,O
15529,1067,34,O
15530,1067,-,O
15531,1067,42,O
15532,1067,weeks,O
15533,1067,gestation,O
15534,1068,Singleton,B-Condition
15535,1068,fetus,I-Condition
15536,1069,Admitted,B-Mood
15537,1069,for,I-Mood
15538,1069,labor,B-Procedure
15539,1069,management,I-Procedure
15540,1069,&,O
15541,1069,develops,O
15542,1069,a,O
15543,1069,fever,O
15544,1069,of,O
15545,1069,100.4,O
15546,1069,F,O
15547,1069,or,O
15548,1069,greater,O
15549,1070,Bismuth,B-Drug
15550,1070,compounds,I-Drug
15551,1070,",",O
15552,1070,acid,B-Drug
15553,1070,inhibitor,I-Drug
15554,1070,",",O
15555,1070,or,O
15556,1070,antibiotics,B-Drug
15557,1070,during,O
15558,1070,4,O
15559,1070,weeks,O
15560,1070,before,O
15561,1070,the,O
15562,1070,patient,O
15563,1070,is,O
15564,1070,enrolled,O
15565,1071,Allergic,B-Condition
15566,1071,to,O
15567,1071,the,O
15568,1071,medications,B-Drug
15569,1072,Upper,B-Procedure
15570,1072,gastrointestinal,I-Procedure
15571,1072,surgery,I-Procedure
15572,1072,history,B-Observation
15573,1073,Serious,O
15574,1073,heart,B-Condition
15575,1073,insufficiency,I-Condition
15576,1073,",",O
15577,1073,liver,B-Condition
15578,1073,insufficiency,I-Condition
15579,1073,",",O
15580,1073,renal,B-Condition
15581,1073,insufficiency,I-Condition
15582,1073,and,O
15583,1073,other,O
15584,1073,serious,B-Condition
15585,1073,medical,I-Condition
15586,1073,problems,I-Condition
15587,1074,Evidence,B-Mood
15588,1074,of,O
15589,1074,blood,B-Condition
15590,1074,dyscrasia,I-Condition
15591,1075,Pregnant,B-Condition
15592,1075,and,O
15593,1075,lactating,B-Condition
15594,1075,women,B-Person
15595,1076,Ca,O
15596,1076,n't,O
15597,1076,express,O
15598,1076,his,O
15599,1076,complain,O
15600,1076,correctly,O
15601,1076,and,O
15602,1076,ca,O
15603,1076,n't,O
15604,1076,cooperate,O
15605,1076,with,O
15606,1076,the,O
15607,1076,researcher,O
15608,1077,A,O
15609,1077,positive,O
15610,1077,13,O
15611,1077,C,O
15612,1077,-,O
15613,1077,urea,O
15614,1077,breath,O
15615,1077,test,O
15616,1078,Formal,O
15617,1078,H.pylori,B-Procedure
15618,1078,treatment,I-Procedure
15619,1078,more,O
15620,1078,than,O
15621,1078,two,O
15622,1078,times,O
15623,1079,Age,B-Person
15624,1079,>,O
15625,1079,18,O
15626,1079,years,O
15627,1080,Non,B-Condition
15628,1080,papillary,I-Condition
15629,1080,gross,I-Condition
15630,1080,features,I-Condition
15631,1080,of,O
15632,1080,the,O
15633,1080,tumor,B-Condition
15634,1081,Anteriorly,O
15635,1081,located,O
15636,1081,tumor,B-Condition
15637,1082,Patients,O
15638,1082,criteria,O
15639,1083,Poor,O
15640,1083,performance,B-Observation
15641,1083,status,I-Observation
15642,1084,History,B-Observation
15643,1084,of,O
15644,1084,BCG,B-Condition
15645,1084,sepsis,B-Condition
15646,1085,History,B-Observation
15647,1085,of,O
15648,1085,bladder,B-Condition
15649,1085,irradiation,I-Condition
15650,1086,Contracted,B-Condition
15651,1086,bladder,I-Condition
15652,1087,Patients,O
15653,1087,diagnosed,O
15654,1087,at,O
15655,1087,the,O
15656,1087,out,O
15657,1087,-,O
15658,1087,patient,O
15659,1087,cystoscopy,B-Procedure
15660,1087,with,O
15661,1087,papillary,B-Condition
15662,1087,bladder,I-Condition
15663,1087,tumour,I-Condition
15664,1087,will,O
15665,1087,be,O
15666,1087,legible,O
15667,1087,for,O
15668,1087,inclusion,O
15669,1088,Severe,O
15670,1088,deformity,B-Condition
15671,1088,(,O
15672,1088,varus,B-Condition
15673,1088,or,O
15674,1088,values,O
15675,1088,from,O
15676,1088,mechanical,O
15677,1088,axis,O
15678,1088,more,O
15679,1088,than,O
15680,1088,5,O
15681,1088,degrees,O
15682,1089,Allergy,B-Condition
15683,1089,to,O
15684,1089,hyaluronic,B-Drug
15685,1089,acid,I-Drug
15686,1090,Pain,B-Condition
15687,1090,on,O
15688,1090,hip,O
15689,1090,or,O
15690,1090,ankle,O
15691,1091,Post,O
15692,1091,-,O
15693,1091,traumatic,O
15694,1091,or,O
15695,1091,post,O
15696,1091,surgery,O
15697,1091,of,O
15698,1091,lower,O
15699,1091,extremity,O
15700,1092,Post,O
15701,1092,infection,B-Condition
15702,1092,of,I-Condition
15703,1092,knee,I-Condition
15704,1093,Previous,O
15705,1093,hyaluronic,B-Procedure
15706,1093,acid,I-Procedure
15707,1093,injection,I-Procedure
15708,1093,within,O
15709,1093,6,O
15710,1093,months,O
15711,1094,Pregnancy,B-Condition
15712,1094,or,O
15713,1094,lactation,B-Condition
15714,1095,Underlying,O
15715,1095,Rheumatoid,B-Condition
15716,1095,arthritis,I-Condition
15717,1095,",",O
15718,1095,stroke,B-Condition
15719,1095,",",O
15720,1095,malignancy,B-Condition
15721,1095,",",O
15722,1095,venous,B-Condition
15723,1095,occlusion,I-Condition
15724,1096,Symptomatic,O
15725,1096,primary,O
15726,1096,knee,O
15727,1096,osteoarthritis,B-Condition
15728,1096,with,O
15729,1096,failed,O
15730,1096,conservative,B-Procedure
15731,1096,treatment,I-Procedure
15732,1096,at,O
15733,1096,least,O
15734,1096,3,O
15735,1096,months,O
15736,1097,Kellgren,O
15737,1097,-,O
15738,1097,Lawrence,O
15739,1097,grade,O
15740,1097,I,O
15741,1097,-,O
15742,1097,III,O
15743,1098,Gave,O
15744,1098,informed,O
15745,1098,consent,O
15746,1099,Can,B-Observation
15747,1099,do,I-Observation
15748,1099,questionnaires,I-Observation
15749,1100,Epilepsy,B-Condition
15750,1101,Hydrocephalus,B-Condition
15751,1101,with,O
15752,1101,ventricular,O
15753,1101,drain,O
15754,1102,Coagulation,B-Condition
15755,1102,disorders,I-Condition
15756,1103,Allergy,B-Condition
15757,1103,to,O
15758,1103,anesthetic,B-Drug
15759,1103,agents,I-Drug
15760,1104,Severe,B-Condition
15761,1104,health,I-Condition
15762,1104,conditions,I-Condition
15763,1104,such,O
15764,1104,as,O
15765,1104,cancer,B-Condition
15766,1104,",",O
15767,1104,failure,B-Condition
15768,1104,of,I-Condition
15769,1104,heart,I-Condition
15770,1104,",",I-Condition
15771,1104,lung,I-Condition
15772,1104,",",I-Condition
15773,1104,liver,I-Condition
15774,1104,or,I-Condition
15775,1104,kidney,I-Condition
15776,1105,Active,O
15777,1105,infections,B-Condition
15778,1106,Cerebral,B-Condition
15779,1106,palsy,I-Condition
15780,1106,of,O
15781,1106,any,O
15782,1106,types,O
15783,1106,caused,O
15784,1106,by,O
15785,1106,Neonatal,B-Condition
15786,1106,Jaundice,I-Condition
15787,1107,Clinically,O
15788,1107,significant,O
15789,1107,new,O
15790,1107,illness,B-Condition
15791,1107,within,O
15792,1107,1,O
15793,1107,month,O
15794,1107,before,O
15795,1107,randomization,O
15796,1107,that,O
15797,1107,may,B-Observation
15798,1107,affect,I-Observation
15799,1107,the,I-Observation
15800,1107,participant,I-Observation
15801,1107,'s,I-Observation
15802,1107,ability,I-Observation
15803,1107,to,I-Observation
15804,1107,fulfill,I-Observation
15805,1107,the,I-Observation
15806,1107,study,I-Observation
15807,1107,requirements,I-Observation
15808,1107,or,O
15809,1107,significantly,O
15810,1107,confound,O
15811,1107,the,O
15812,1107,assessments,O
15813,1108,Participants,O
15814,1108,who,O
15815,1108,can,B-Observation
15816,1108,not,I-Observation
15817,1108,swallow,I-Observation
15818,1108,investigational,B-Drug
15819,1108,products,I-Drug
15820,1109,Participants,O
15821,1109,with,O
15822,1109,T2DM,B-Condition
15823,1109,who,O
15824,1109,have,O
15825,1109,hypoglycemia,B-Condition
15826,1109,unawareness,I-Condition
15827,1110,Aortic,B-Condition
15828,1110,regurgitation,I-Condition
15829,1110,mild,O
15830,1110,or,O
15831,1110,greater,O
15832,1111,Mitral,B-Condition
15833,1111,regurgitation,I-Condition
15834,1111,moderate,O
15835,1111,or,O
15836,1111,greater,O
15837,1112,Mitral,B-Condition
15838,1112,or,I-Condition
15839,1112,aortic,I-Condition
15840,1112,valve,I-Condition
15841,1112,stenosis,I-Condition
15842,1112,greater,O
15843,1112,than,O
15844,1112,mild,O
15845,1112,(,O
15846,1112,ie,O
15847,1112,",",O
15848,1112,aortic,B-Condition
15849,1112,stenosis,I-Condition
15850,1112,:,O
15851,1112,jet,O
15852,1112,>,O
15853,1112,3.0,O
15854,1112,meters,O
15855,1112,per,O
15856,1112,second,O
15857,1112,[,O
15858,1112,m,O
15859,1112,/,O
15860,1112,s,O
15861,1112,],O
15862,1112,",",O
15863,1112,mean,O
15864,1112,gradient,O
15865,1112,>,O
15866,1112,25,O
15867,1112,millimeters,O
15868,1112,of,O
15869,1112,mercury,O
15870,1112,[,O
15871,1112,mmHg,O
15872,1112,],O
15873,1112,",",O
15874,1112,and,O
15875,1112,aortic,O
15876,1112,valve,O
15877,1112,area,O
15878,1112,<,O
15879,1112,1.5,O
15880,1112,centimeters,O
15881,1112,squared,O
15882,1112,[,O
15883,1112,cm^2,O
15884,1112,],O
15885,1112,;,O
15886,1112,mitral,B-Condition
15887,1112,stenosis,I-Condition
15888,1112,:,O
15889,1112,mean,O
15890,1112,gradient,O
15891,1112,>,O
15892,1112,5,O
15893,1112,mmHg,O
15894,1112,and,O
15895,1112,mitral,O
15896,1112,valve,O
15897,1112,area,O
15898,1112,<,O
15899,1112,1.5,O
15900,1112,cm^2,O
15901,1112,),O
15902,1113,Systolic,O
15903,1113,pulmonary,O
15904,1113,artery,O
15905,1113,pressure,O
15906,1113,(,O
15907,1113,SPAP,O
15908,1113,),O
15909,1113,>,O
15910,1113,40,O
15911,1113,mmHg,O
15912,1113,(,O
15913,1113,and/or,O
15914,1113,tricuspid,O
15915,1113,regurgitation,O
15916,1113,[,O
15917,1113,TR,O
15918,1113,],O
15919,1113,jet,O
15920,1113,velocity,O
15921,1113,>,O
15922,1113,2.9,O
15923,1113,m,O
15924,1113,/,O
15925,1113,s,O
15926,1113,),O
15927,1113,In,O
15928,1113,cases,O
15929,1113,where,O
15930,1113,an,O
15931,1113,actual,O
15932,1113,SPAP,O
15933,1113,value,O
15934,1113,is,O
15935,1113,not,O
15936,1113,measurable,O
15937,1113,due,O
15938,1113,to,O
15939,1113,lack,O
15940,1113,of,O
15941,1113,adequate,O
15942,1113,TR,O
15943,1113,jet,O
15944,1113,",",O
15945,1113,the,O
15946,1113,pulmonary,O
15947,1113,flow,O
15948,1113,acceleration,O
15949,1113,time,O
15950,1113,measured,O
15951,1113,at,O
15952,1113,the,O
15953,1113,right,O
15954,1113,ventricular,O
15955,1113,outflow,O
15956,1113,tract,O
15957,1113,(,O
15958,1113,RVOTAT,O
15959,1113,),O
15960,1113,will,O
15961,1113,be,O
15962,1113,used,O
15963,1113,to,O
15964,1113,assess,O
15965,1113,eligibility,O
15966,1113,.,O
15967,1113,Participants,O
15968,1113,with,O
15969,1113,a,O
15970,1113,RVOTAT,O
15971,1113,=,O
15972,1113,100,O
15973,1113,milliseconds,O
15974,1113,(,O
15975,1113,msec,O
15976,1113,),O
15977,1113,will,O
15978,1113,be,O
15979,1113,excluded,O
15980,1113,",",O
15981,1113,suggesting,O
15982,1113,an,O
15983,1113,elevated,O
15984,1113,mean,O
15985,1113,SPAP,O
15986,1113,;,O
15987,1113,eligibility,O
15988,1113,for,O
15989,1113,the,O
15990,1113,those,O
15991,1113,participants,O
15992,1113,with,O
15993,1113,RVOTAT,O
15994,1113,between,O
15995,1113,100,O
15996,1113,and,O
15997,1113,120,O
15998,1113,msec,O
15999,1113,will,O
16000,1113,be,O
16001,1113,determined,O
16002,1113,based,O
16003,1113,on,O
16004,1113,combined,O
16005,1113,assessment,O
16006,1113,of,O
16007,1113,the,O
16008,1113,TR,O
16009,1113,jet,O
16010,1113,",",O
16011,1113,septal,O
16012,1113,motion,O
16013,1113,",",O
16014,1113,and,O
16015,1113,right,O
16016,1113,ventricular,O
16017,1113,size,O
16018,1113,.,O
16019,1114,Left,O
16020,1114,ventricular,O
16021,1114,ejection,O
16022,1114,fraction,O
16023,1114,<,O
16024,1114,45,O
16025,1114,%,O
16026,1115,Intracardiac,B-Condition
16027,1115,mass,I-Condition
16028,1115,",",O
16029,1115,tumor,B-Condition
16030,1115,",",O
16031,1115,or,O
16032,1115,thrombus,B-Condition
16033,1116,Evidence,B-Mood
16034,1116,of,I-Mood
16035,1116,congenital,B-Condition
16036,1116,heart,I-Condition
16037,1116,disease,I-Condition
16038,1117,Clinically,O
16039,1117,significant,O
16040,1117,pericardial,B-Condition
16041,1117,effusion,I-Condition
16042,1117,(,O
16043,1117,eg,O
16044,1117,",",O
16045,1117,moderate,O
16046,1117,or,O
16047,1117,larger,O
16048,1117,or,O
16049,1117,with,O
16050,1117,hemodynamic,B-Condition
16051,1117,compromise,I-Condition
16052,1117,),O
16053,1118,Significant,O
16054,1118,renal,B-Condition
16055,1118,or,I-Condition
16056,1118,hepatic,I-Condition
16057,1118,disease,I-Condition
16058,1118,as,O
16059,1118,evidenced,O
16060,1118,by,O
16061,1118,a,O
16062,1118,serum,O
16063,1118,creatinine,O
16064,1118,greater,O
16065,1118,than,O
16066,1118,1.5×,O
16067,1118,upper,O
16068,1118,limit,O
16069,1118,of,O
16070,1118,normal,O
16071,1118,(,O
16072,1118,ULN,O
16073,1118,),O
16074,1118,",",O
16075,1118,serum,O
16076,1118,transaminases,O
16077,1118,greater,O
16078,1118,than,O
16079,1118,3×,O
16080,1118,ULN,O
16081,1118,",",O
16082,1118,or,O
16083,1118,total,O
16084,1118,bilirubin,O
16085,1118,greater,O
16086,1118,than,O
16087,1118,1.5×,O
16088,1118,ULN,O
16089,1118,in,O
16090,1118,absence,O
16091,1118,of,O
16092,1118,Gilbert,B-Condition
16093,1118,'s,I-Condition
16094,1118,syndrome,I-Condition
16095,1119,Any,O
16096,1119,suicidal,B-Condition
16097,1119,ideation,I-Condition
16098,1119,with,O
16099,1119,intent,O
16100,1119,with,O
16101,1119,or,O
16102,1119,without,O
16103,1119,a,O
16104,1119,plan,O
16105,1119,",",O
16106,1119,at,O
16107,1119,the,O
16108,1119,time,O
16109,1119,of,O
16110,1119,or,O
16111,1119,within,O
16112,1119,6,O
16113,1119,months,O
16114,1119,of,O
16115,1119,Screening,O
16116,1119,",",O
16117,1119,as,O
16118,1119,indicated,O
16119,1119,by,O
16120,1119,answering,O
16121,1119,"""",O
16122,1119,Yes,O
16123,1119,"""",O
16124,1119,to,O
16125,1119,questions,O
16126,1119,4,O
16127,1119,or,O
16128,1119,5,O
16129,1119,on,O
16130,1119,the,O
16131,1119,Suicidal,B-Procedure
16132,1119,Ideation,I-Procedure
16133,1119,section,I-Procedure
16134,1119,of,I-Procedure
16135,1119,the,I-Procedure
16136,1119,Columbia,I-Procedure
16137,1119,-,I-Procedure
16138,1119,Suicide,I-Procedure
16139,1119,Severity,I-Procedure
16140,1119,Rating,I-Procedure
16141,1119,Scale,I-Procedure
16142,1119,(,I-Procedure
16143,1119,C,I-Procedure
16144,1119,-,I-Procedure
16145,1119,SSRS,I-Procedure
16146,1119,),I-Procedure
16147,1120,Any,O
16148,1120,suicidal,B-Condition
16149,1120,behavior,I-Condition
16150,1120,in,O
16151,1120,the,O
16152,1120,past,O
16153,1120,based,O
16154,1120,on,O
16155,1120,the,O
16156,1120,C,B-Procedure
16157,1120,-,I-Procedure
16158,1120,SSRS,I-Procedure
16159,1121,Any,O
16160,1121,history,B-Observation
16161,1121,of,O
16162,1121,anorexia,B-Condition
16163,1121,or,O
16164,1121,bulimia,B-Condition
16165,1121,within,O
16166,1121,2,O
16167,1121,years,O
16168,1121,before,O
16169,1121,Screening,O
16170,1121,",",O
16171,1121,Attention,B-Condition
16172,1121,Deficit,I-Condition
16173,1121,Hyperactivity,I-Condition
16174,1121,Disorder,I-Condition
16175,1121,",",O
16176,1121,any,O
16177,1121,Diagnostic,O
16178,1121,and,O
16179,1121,Statistical,O
16180,1121,Manual,O
16181,1121,of,O
16182,1121,Mental,O
16183,1121,Disorders,O
16184,1121,",",O
16185,1121,5th,O
16186,1121,Edition,O
16187,1121,depressive,B-Condition
16188,1121,disorder,I-Condition
16189,1121,",",O
16190,1121,bipolar,B-Condition
16191,1121,disorder,I-Condition
16192,1121,",",O
16193,1121,or,O
16194,1121,schizophrenia,B-Condition
16195,1122,Known,O
16196,1122,secondary,B-Condition
16197,1122,causes,I-Condition
16198,1122,(,I-Condition
16199,1122,genetic,I-Condition
16200,1122,",",I-Condition
16201,1122,endocrine,I-Condition
16202,1122,",",I-Condition
16203,1122,or,I-Condition
16204,1122,metabolic,I-Condition
16205,1122,),I-Condition
16206,1122,for,I-Condition
16207,1122,obesity,I-Condition
16208,1122,(,O
16209,1122,eg,O
16210,1122,",",O
16211,1122,Prader,B-Condition
16212,1122,-,I-Condition
16213,1122,Willi,I-Condition
16214,1122,syndrome,I-Condition
16215,1122,",",O
16216,1122,Bardet,B-Condition
16217,1122,Biedl,I-Condition
16218,1122,syndrome,I-Condition
16219,1122,",",O
16220,1122,Down,B-Condition
16221,1122,'s,I-Condition
16222,1122,Syndrome,I-Condition
16223,1122,",",O
16224,1122,untreated,B-Condition
16225,1122,hypothyroidism,I-Condition
16226,1122,",",O
16227,1122,Cushing,B-Condition
16228,1122,'s,I-Condition
16229,1122,syndrome,I-Condition
16230,1122,",",O
16231,1122,daily,O
16232,1122,systemic,B-Drug
16233,1122,corticosteroid,I-Drug
16234,1122,exposure,O
16235,1122,for,O
16236,1122,longer,O
16237,1122,than,O
16238,1122,30,O
16239,1122,days,O
16240,1122,",",O
16241,1122,history,B-Observation
16242,1122,of,O
16243,1122,significant,O
16244,1122,exposure,O
16245,1122,to,O
16246,1122,corticosteroids,B-Drug
16247,1122,for,O
16248,1122,chronic,B-Condition
16249,1122,illness,I-Condition
16250,1122,during,O
16251,1122,the,O
16252,1122,past,O
16253,1122,year,O
16254,1122,;,O
16255,1122,inhaled,O
16256,1122,steroids,O
16257,1122,will,O
16258,1122,be,O
16259,1122,allowed,O
16260,1122,),O
16261,1123,Use,O
16262,1123,of,O
16263,1123,other,O
16264,1123,products,B-Drug
16265,1123,intended,I-Drug
16266,1123,for,I-Drug
16267,1123,weight,I-Drug
16268,1123,loss,I-Drug
16269,1123,including,O
16270,1123,prescription,O
16271,1123,drugs,O
16272,1123,",",O
16273,1123,over,O
16274,1123,-,O
16275,1123,the,O
16276,1123,-,O
16277,1123,counter,O
16278,1123,(,O
16279,1123,OTC,O
16280,1123,),O
16281,1123,drugs,O
16282,1123,",",O
16283,1123,and,O
16284,1123,herbal,O
16285,1123,preparations,O
16286,1123,within,O
16287,1123,1,O
16288,1123,month,O
16289,1123,before,O
16290,1123,Screening,O
16291,1124,selective,B-Drug
16292,1124,serotonin,I-Drug
16293,1124,reuptake,I-Drug
16294,1124,inhibitors,I-Drug
16295,1125,serotonin,B-Drug
16296,1125,norepinephrine,I-Drug
16297,1125,reuptake,I-Drug
16298,1125,inhibitors,I-Drug
16299,1126,tricyclic,B-Drug
16300,1126,antidepressants,I-Drug
16301,1127,bupropion,B-Drug
16302,1128,triptans,B-Drug
16303,1129,St.,B-Drug
16304,1129,John,I-Drug
16305,1129,'s,I-Drug
16306,1129,Wort,I-Drug
16307,1130,tryptophan,B-Drug
16308,1131,linezolid,B-Drug
16309,1132,dextromethorphan,B-Drug
16310,1132,in,O
16311,1132,any,O
16312,1132,form,O
16313,1132,(,O
16314,1132,eg,O
16315,1132,",",O
16316,1132,OTC,O
16317,1132,cold,O
16318,1132,medicines,O
16319,1132,),O
16320,1133,lithium,B-Drug
16321,1134,tramadol,B-Drug
16322,1135,antipsychotics,B-Drug
16323,1135,or,O
16324,1135,other,O
16325,1135,dopamine,B-Drug
16326,1135,antagonists,I-Drug
16327,1136,antiseizure,O
16328,1136,medications,I-Drug
16329,1136,including,O
16330,1136,valproic,O
16331,1136,acid,I-Drug
16332,1136,",",I-Drug
16333,1136,zonisamide,O
16334,1136,",",I-Drug
16335,1136,topiramate,O
16336,1136,",",I-Drug
16337,1136,and,O
16338,1136,lamotrigine,O
16339,1137,oral,O
16340,1137,steroids,I-Drug
16341,1137,(,O
16342,1137,topical,O
16343,1137,and,I-Drug
16344,1137,inhaled,I-Drug
16345,1137,steroids,I-Drug
16346,1137,are,O
16347,1137,acceptable,O
16348,1137,),O
16349,1138,stimulant,O
16350,1138,medications,I-Drug
16351,1138,(,O
16352,1138,eg,O
16353,1138,",",O
16354,1138,Ritalin,O
16355,1138,",",I-Drug
16356,1138,Concerta,O
16357,1138,",",I-Drug
16358,1138,Biphetamine,O
16359,1138,",",I-Drug
16360,1138,and,O
16361,1138,Dexedrine,O
16362,1138,),I-Drug
16363,1139,benzodiazepines,O
16364,1140,Use,O
16365,1140,of,O
16366,1140,drugs,O
16367,1140,known,O
16368,1140,to,O
16369,1140,increase,O
16370,1140,the,O
16371,1140,risk,O
16372,1140,for,O
16373,1140,cardiac,O
16374,1140,valvulopathy,I-Condition
16375,1140,within,O
16376,1140,6,O
16377,1140,months,O
16378,1140,before,O
16379,1140,Screening,O
16380,1140,",",O
16381,1140,including,O
16382,1140,but,O
16383,1140,not,O
16384,1140,limited,O
16385,1140,to,O
16386,1140,pergolide,O
16387,1140,",",I-Drug
16388,1140,ergotamine,O
16389,1140,",",I-Drug
16390,1140,methysergide,O
16391,1140,",",I-Drug
16392,1140,and,O
16393,1140,cabergoline,O
16394,1141,History,O
16395,1141,or,O
16396,1141,evidence,O
16397,1141,of,O
16398,1141,clinically,O
16399,1141,significant,O
16400,1141,disease,O
16401,1141,(,O
16402,1141,eg,O
16403,1141,",",O
16404,1141,malignancy,O
16405,1141,;,I-Condition
16406,1141,cardiac,O
16407,1141,",",O
16408,1141,respiratory,O
16409,1141,",",O
16410,1141,gastrointestinal,O
16411,1141,",",O
16412,1141,renal,O
16413,1141,",",O
16414,1141,or,O
16415,1141,psychiatric,O
16416,1141,disease,O
16417,1141,),I-Condition
16418,1141,other,O
16419,1141,than,O
16420,1141,prediabetes,O
16421,1141,(,O
16422,1141,impaired,O
16423,1141,fasting,I-Condition
16424,1141,glucose,I-Condition
16425,1141,or,O
16426,1141,impaired,O
16427,1141,glucose,I-Condition
16428,1141,tolerance,I-Condition
16429,1141,),I-Condition
16430,1141,",",O
16431,1141,type,O
16432,1141,2,I-Condition
16433,1141,diabetes,I-Condition
16434,1141,treated,O
16435,1141,with,O
16436,1141,oral,O
16437,1141,anti,I-Drug
16438,1141,-,I-Drug
16439,1141,diabetic,I-Drug
16440,1141,agents,I-Drug
16441,1141,(,O
16442,1141,excluding,O
16443,1141,sulfonylurea,O
16444,1141,),I-Drug
16445,1141,or,O
16446,1141,non,O
16447,1141,-,O
16448,1141,insulin,O
16449,1141,injectable,O
16450,1141,antidiabetic,O
16451,1141,agents,I-Drug
16452,1141,",",I-Drug
16453,1141,obstructive,O
16454,1141,sleep,I-Condition
16455,1141,apnea,I-Condition
16456,1141,",",I-Condition
16457,1141,dyslipidemia,O
16458,1141,",",I-Condition
16459,1141,and,O
16460,1141,nonalcoholic,O
16461,1141,fatty,I-Condition
16462,1141,liver,I-Condition
16463,1141,disease,I-Condition
16464,1142,Use,O
16465,1142,of,O
16466,1142,Belviq,O
16467,1142,XR,I-Drug
16468,1142,within,O
16469,1142,6,O
16470,1142,months,O
16471,1142,before,O
16472,1142,Screening,O
16473,1142,or,O
16474,1142,hypersensitivity,O
16475,1142,to,O
16476,1142,Belviq,O
16477,1142,XR,I-Drug
16478,1142,or,O
16479,1142,any,O
16480,1142,of,O
16481,1142,the,O
16482,1142,excipients,O
16483,1143,Significant,O
16484,1143,change,O
16485,1143,in,I-Observation
16486,1143,diet,I-Observation
16487,1143,or,I-Observation
16488,1143,level,I-Observation
16489,1143,of,I-Observation
16490,1143,physical,I-Observation
16491,1143,activity,I-Observation
16492,1143,within,O
16493,1143,1,O
16494,1143,month,O
16495,1143,before,O
16496,1143,dosing,O
16497,1143,or,O
16498,1143,change,O
16499,1143,in,I-Observation
16500,1143,weight,I-Observation
16501,1143,of,O
16502,1143,more,O
16503,1143,than,O
16504,1143,5,O
16505,1143,kg,O
16506,1143,within,O
16507,1143,3,O
16508,1143,months,O
16509,1143,before,O
16510,1143,Screening,O
16511,1144,Any,O
16512,1144,use,O
16513,1144,of,O
16514,1144,a,O
16515,1144,very,O
16516,1144,-,I-Observation
16517,1144,low,I-Observation
16518,1144,-,I-Observation
16519,1144,calorie,I-Observation
16520,1144,(,I-Observation
16521,1144,<,I-Observation
16522,1144,1000,I-Observation
16523,1144,calories,I-Observation
16524,1144,/,I-Observation
16525,1144,day,I-Observation
16526,1144,),I-Observation
16527,1144,weight,I-Observation
16528,1144,loss,I-Observation
16529,1144,diet,I-Observation
16530,1144,within,O
16531,1144,6,O
16532,1144,months,O
16533,1144,before,O
16534,1144,Screening,O
16535,1145,History,O
16536,1145,of,O
16537,1145,alcohol,O
16538,1145,or,I-Condition
16539,1145,drug,I-Condition
16540,1145,dependence,I-Condition
16541,1145,or,I-Condition
16542,1145,abuse,I-Condition
16543,1146,Recreational,O
16544,1146,drug,I-Observation
16545,1146,use,I-Observation
16546,1146,within,O
16547,1146,2,O
16548,1146,years,O
16549,1146,before,O
16550,1146,Screening,O
16551,1147,Known,O
16552,1147,to,O
16553,1147,be,O
16554,1147,human,O
16555,1147,immunodeficiency,I-Condition
16556,1147,virus,I-Condition
16557,1147,positive,I-Condition
16558,1148,Known,O
16559,1148,to,O
16560,1148,have,O
16561,1148,active,O
16562,1148,viral,O
16563,1148,hepatitis,I-Condition
16564,1148,(,O
16565,1148,B,O
16566,1148,or,O
16567,1148,C,O
16568,1148,),O
16569,1149,Malignancy,O
16570,1149,within,O
16571,1149,5,O
16572,1149,years,O
16573,1149,before,O
16574,1149,Screening,O
16575,1150,Unable,O
16576,1150,to,I-Observation
16577,1150,attend,I-Observation
16578,1150,scheduled,I-Observation
16579,1150,visits,I-Observation
16580,1150,(,O
16581,1150,eg,O
16582,1150,",",O
16583,1150,lack,O
16584,1150,of,I-Observation
16585,1150,transportation,I-Observation
16586,1150,),I-Observation
16587,1150,or,O
16588,1150,lack,O
16589,1150,of,I-Observation
16590,1150,a,I-Observation
16591,1150,caregiver,I-Observation
16592,1150,or,I-Observation
16593,1150,guardian,I-Observation
16594,1150,to,O
16595,1150,supervise,O
16596,1150,study,O
16597,1150,participation,O
16598,1151,Special,O
16599,1151,needs,I-Observation
16600,1151,participants,O
16601,1151,who,O
16602,1151,are,O
16603,1151,unable,O
16604,1151,to,I-Observation
16605,1151,comprehend,I-Observation
16606,1151,study,I-Observation
16607,1151,-,I-Observation
16608,1151,related,I-Observation
16609,1151,instructions,I-Observation
16610,1151,(,O
16611,1151,eg,O
16612,1151,",",O
16613,1151,mild,O
16614,1151,to,O
16615,1151,profound,O
16616,1151,mental,O
16617,1151,retardation,I-Condition
16618,1151,[,O
16619,1151,intelligence,O
16620,1151,quotient,O
16621,1151,<,O
16622,1151,70,O
16623,1151,],O
16624,1151,",",O
16625,1151,moderate,O
16626,1151,to,O
16627,1151,severe,O
16628,1151,cognitive,O
16629,1151,developmental,I-Condition
16630,1151,delay,I-Condition
16631,1151,",",I-Condition
16632,1151,pervasive,O
16633,1151,development,I-Condition
16634,1151,disorders,I-Condition
16635,1151,",",I-Condition
16636,1151,autism,O
16637,1151,),I-Condition
16638,1152,Ongoing,O
16639,1152,epilepsy,O
16640,1152,or,O
16641,1152,other,O
16642,1152,seizure,O
16643,1152,disorder,I-Condition
16644,1152,",",I-Condition
16645,1152,or,O
16646,1152,use,O
16647,1152,of,O
16648,1152,medications,O
16649,1152,for,O
16650,1152,a,O
16651,1152,seizure,O
16652,1152,disorder,I-Condition
16653,1152,within,O
16654,1152,6,O
16655,1152,months,O
16656,1152,of,O
16657,1152,screening,O
16658,1152,or,O
16659,1152,any,O
16660,1152,time,O
16661,1152,between,O
16662,1152,screening,O
16663,1152,and,O
16664,1152,randomization,O
16665,1153,Participants,O
16666,1153,with,O
16667,1153,a,O
16668,1153,blood,O
16669,1153,pressure,O
16670,1153,in,O
16671,1153,the,O
16672,1153,95th,O
16673,1153,percentile,O
16674,1153,or,O
16675,1153,greater,O
16676,1153,for,O
16677,1153,age,O
16678,1153,",",O
16679,1153,sex,O
16680,1153,",",O
16681,1153,and,O
16682,1153,height,O
16683,1153,on,O
16684,1153,2,O
16685,1153,separate,O
16686,1153,readings,O
16687,1153,recorded,O
16688,1153,on,O
16689,1153,2,O
16690,1153,separate,O
16691,1153,days,O
16692,1153,.,O
16693,1153,Those,O
16694,1153,participants,O
16695,1153,who,O
16696,1153,had,O
16697,1153,uncontrolled,O
16698,1153,hypertension,O
16699,1153,at,O
16700,1153,Screening,O
16701,1153,can,O
16702,1153,be,O
16703,1153,rescreened,O
16704,1153,more,O
16705,1153,than,O
16706,1153,1,O
16707,1153,month,O
16708,1153,after,O
16709,1153,initiation,O
16710,1153,or,O
16711,1153,adjustment,O
16712,1153,of,O
16713,1153,antihypertensive,O
16714,1153,therapy,O
16715,1153,1,O
16716,1153,time,O
16717,1153,.,O
16718,1154,Currently,O
16719,1154,enrolled,O
16720,1154,in,I-Observation
16721,1154,another,I-Observation
16722,1154,clinical,I-Observation
16723,1154,study,I-Observation
16724,1154,or,O
16725,1154,has,O
16726,1154,used,O
16727,1154,any,O
16728,1154,investigational,O
16729,1154,drug,I-Drug
16730,1154,or,O
16731,1154,device,O
16732,1154,within,O
16733,1154,30,O
16734,1154,days,O
16735,1154,before,O
16736,1154,providing,O
16737,1154,informed,O
16738,1154,consent,O
16739,1155,Planned,O
16740,1155,bariatric,O
16741,1155,surgery,I-Procedure
16742,1155,during,O
16743,1155,the,O
16744,1155,study,O
16745,1155,or,O
16746,1155,prior,O
16747,1155,bariatric,O
16748,1155,surgical,I-Procedure
16749,1155,procedures,I-Procedure
16750,1156,Not,O
16751,1156,suitable,O
16752,1156,to,O
16753,1156,participate,O
16754,1156,in,O
16755,1156,the,O
16756,1156,study,O
16757,1156,in,O
16758,1156,the,O
16759,1156,opinion,O
16760,1156,of,O
16761,1156,the,O
16762,1156,investigator,O
16763,1156,",",O
16764,1156,including,O
16765,1156,consideration,O
16766,1156,of,O
16767,1156,any,O
16768,1156,existing,O
16769,1156,physical,O
16770,1156,",",O
16771,1156,medical,O
16772,1156,",",O
16773,1156,or,O
16774,1156,mental,O
16775,1156,condition,O
16776,1156,that,O
16777,1156,prevents,O
16778,1156,compliance,O
16779,1156,with,O
16780,1156,the,O
16781,1156,protocol,O
16782,1157,Female,O
16783,1157,participants,O
16784,1157,who,O
16785,1157,are,O
16786,1157,breastfeeding,O
16787,1157,or,O
16788,1157,pregnant,O
16789,1157,at,O
16790,1157,Screening,O
16791,1157,or,O
16792,1157,Baseline,O
16793,1157,(,O
16794,1157,as,O
16795,1157,documented,O
16796,1157,by,O
16797,1157,a,O
16798,1157,positive,O
16799,1157,beta,O
16800,1157,-,O
16801,1157,human,O
16802,1157,chorionic,O
16803,1157,gonadotropin,O
16804,1157,test,O
16805,1157,),O
16806,1157,.,O
16807,1157,A,O
16808,1157,separate,O
16809,1157,Baseline,O
16810,1157,assessment,I-Procedure
16811,1157,is,O
16812,1157,required,O
16813,1157,if,O
16814,1157,a,O
16815,1157,negative,O
16816,1157,screening,O
16817,1157,pregnancy,O
16818,1157,test,O
16819,1157,was,O
16820,1157,obtained,O
16821,1157,more,O
16822,1157,than,O
16823,1157,72,O
16824,1157,hours,O
16825,1157,before,O
16826,1157,the,O
16827,1157,first,O
16828,1157,dose,O
16829,1157,of,O
16830,1157,study,O
16831,1157,drug,O
16832,1157,.,O
16833,1158,Had,O
16834,1158,unprotected,O
16835,1158,sexual,I-Condition
16836,1158,intercourse,I-Condition
16837,1158,within,O
16838,1158,30,O
16839,1158,days,O
16840,1158,before,O
16841,1158,study,O
16842,1158,entry,O
16843,1158,and,O
16844,1158,who,O
16845,1158,do,O
16846,1158,not,I-Observation
16847,1158,agree,I-Observation
16848,1158,to,O
16849,1158,use,O
16850,1158,a,O
16851,1158,highly,O
16852,1158,effective,O
16853,1158,method,O
16854,1158,of,I-Observation
16855,1158,contraception,I-Observation
16856,1158,(,O
16857,1158,eg,O
16858,1158,",",O
16859,1158,total,O
16860,1158,abstinence,O
16861,1158,",",O
16862,1158,an,O
16863,1158,intrauterine,O
16864,1158,device,O
16865,1158,",",O
16866,1158,a,O
16867,1158,double,O
16868,1158,-,I-Observation
16869,1158,barrier,I-Observation
16870,1158,method,I-Observation
16871,1158,[,O
16872,1158,such,O
16873,1158,as,O
16874,1158,condom,O
16875,1158,plus,O
16876,1158,diaphragm,O
16877,1158,with,O
16878,1158,spermicide,O
16879,1158,],O
16880,1158,",",O
16881,1158,a,O
16882,1158,contraceptive,O
16883,1158,implant,O
16884,1158,",",O
16885,1158,an,O
16886,1158,oral,O
16887,1158,contraceptive,I-Drug
16888,1158,",",I-Drug
16889,1158,or,O
16890,1158,have,O
16891,1158,a,O
16892,1158,vasectomized,O
16893,1158,partner,O
16894,1158,with,O
16895,1158,confirmed,O
16896,1158,azoospermia,O
16897,1158,),I-Condition
16898,1158,throughout,O
16899,1158,the,O
16900,1158,entire,O
16901,1158,study,O
16902,1158,period,O
16903,1158,and,O
16904,1158,for,O
16905,1158,28,O
16906,1158,days,O
16907,1158,after,O
16908,1158,study,O
16909,1158,drug,I-Drug
16910,1158,discontinuation,O
16911,1159,Are,O
16912,1159,currently,O
16913,1159,abstinent,O
16914,1159,and,O
16915,1159,do,O
16916,1159,not,I-Observation
16917,1159,agree,I-Observation
16918,1159,to,O
16919,1159,use,O
16920,1159,a,O
16921,1159,double,O
16922,1159,-,I-Observation
16923,1159,barrier,I-Observation
16924,1159,method,I-Observation
16925,1159,(,O
16926,1159,as,O
16927,1159,described,O
16928,1159,above,O
16929,1159,),O
16930,1159,or,O
16931,1159,refrain,O
16932,1159,from,O
16933,1159,sexual,O
16934,1159,activity,I-Observation
16935,1159,during,O
16936,1159,the,O
16937,1159,study,O
16938,1159,period,O
16939,1159,and,O
16940,1159,for,O
16941,1159,28,O
16942,1159,days,O
16943,1159,after,O
16944,1159,study,O
16945,1159,drug,I-Drug
16946,1159,discontinuation,O
16947,1160,Are,O
16948,1160,using,O
16949,1160,hormonal,O
16950,1160,contraceptives,I-Drug
16951,1160,",",I-Drug
16952,1160,but,O
16953,1160,are,O
16954,1160,not,O
16955,1160,on,O
16956,1160,a,O
16957,1160,stable,O
16958,1160,dose,O
16959,1160,of,O
16960,1160,the,O
16961,1160,same,O
16962,1160,hormonal,O
16963,1160,contraceptive,I-Drug
16964,1160,product,O
16965,1160,for,O
16966,1160,at,O
16967,1160,least,O
16968,1160,4,O
16969,1160,weeks,O
16970,1160,before,O
16971,1160,dosing,O
16972,1160,and,O
16973,1160,who,O
16974,1160,do,O
16975,1160,not,I-Observation
16976,1160,agree,I-Observation
16977,1160,to,O
16978,1160,use,O
16979,1160,the,O
16980,1160,same,O
16981,1160,contraceptive,O
16982,1160,during,O
16983,1160,the,O
16984,1160,study,O
16985,1160,and,O
16986,1160,for,O
16987,1160,28,O
16988,1160,days,O
16989,1160,after,O
16990,1160,study,O
16991,1160,drug,O
16992,1160,discontinuation,O
16993,1160,(,O
16994,1160,Note,O
16995,1160,:,O
16996,1160,All,O
16997,1160,female,O
16998,1160,participants,O
16999,1160,will,O
17000,1160,be,O
17001,1160,considered,O
17002,1160,to,O
17003,1160,be,O
17004,1160,of,O
17005,1160,childbearing,O
17006,1160,potential,O
17007,1160,unless,O
17008,1160,they,O
17009,1160,have,O
17010,1160,been,O
17011,1160,sterilized,O
17012,1160,surgically,O
17013,1160,[,O
17014,1160,ie,O
17015,1160,",",O
17016,1160,bilateral,O
17017,1160,tubal,O
17018,1160,ligation,O
17019,1160,",",O
17020,1160,total,O
17021,1160,hysterectomy,O
17022,1160,",",O
17023,1160,or,O
17024,1160,bilateral,O
17025,1160,oophorectomy,O
17026,1160,",",O
17027,1160,all,O
17028,1160,with,O
17029,1160,surgery,O
17030,1160,at,O
17031,1160,least,O
17032,1160,1,O
17033,1160,month,O
17034,1160,before,O
17035,1160,dosing,O
17036,1160,],O
17037,1160,),O
17038,1160,.,O
17039,1161,Healthy,B-Condition
17040,1161,male,B-Person
17041,1161,or,O
17042,1161,female,B-Person
17043,1161,adolescents,B-Person
17044,1161,",",O
17045,1161,age,B-Person
17046,1161,12,O
17047,1161,to,O
17048,1161,17,O
17049,1161,years,O
17050,1161,(,O
17051,1161,inclusive,O
17052,1161,),O
17053,1161,at,O
17054,1161,Screening,O
17055,1161,",",O
17056,1161,with,O
17057,1161,a,O
17058,1161,body,O
17059,1161,mass,O
17060,1161,index,O
17061,1161,(,O
17062,1161,BMI,O
17063,1161,),O
17064,1161,that,O
17065,1161,is,O
17066,1161,greater,O
17067,1161,than,O
17068,1161,or,O
17069,1161,equal,O
17070,1161,to,O
17071,1161,the,O
17072,1161,United,O
17073,1161,States,O
17074,1161,-,O
17075,1161,weighted,O
17076,1161,mean,O
17077,1161,of,O
17078,1161,the,O
17079,1161,95th,O
17080,1161,percentile,O
17081,1161,based,O
17082,1161,on,O
17083,1161,age,O
17084,1161,and,O
17085,1161,sex,O
17086,1161,with,O
17087,1161,a,O
17088,1161,body,O
17089,1161,weight,O
17090,1161,greater,O
17091,1161,than,O
17092,1161,60,O
17093,1161,kilograms,O
17094,1161,(,O
17095,1161,kg,O
17096,1161,),O
17097,1161,.,O
17098,1161,Participants,O
17099,1161,with,O
17100,1161,Type,O
17101,1161,2,O
17102,1161,diabetes,O
17103,1161,mellitus,O
17104,1161,(,O
17105,1161,T2DM,O
17106,1161,),O
17107,1161,may,O
17108,1161,have,O
17109,1161,a,O
17110,1161,pre,O
17111,1161,-,O
17112,1161,existing,O
17113,1161,or,O
17114,1161,new,O
17115,1161,diagnosis,O
17116,1161,of,O
17117,1161,T2DM,O
17118,1161,.,O
17119,1162,HbA1c,O
17120,1162,=,O
17121,1162,6.5,O
17122,1162,%,O
17123,1163,fasting,O
17124,1163,plasma,O
17125,1163,glucose,O
17126,1163,(,O
17127,1163,FPG,O
17128,1163,),O
17129,1163,=,O
17130,1163,126,O
17131,1163,mg,O
17132,1163,/,O
17133,1163,dL,O
17134,1163,(,O
17135,1163,7.0,O
17136,1163,mmol,O
17137,1163,/,O
17138,1163,L,O
17139,1163,),O
17140,1164,Participants,O
17141,1164,and,O
17142,1164,their,O
17143,1164,families,O
17144,1164,not,O
17145,1164,planning,B-Observation
17146,1164,to,I-Observation
17147,1164,move,I-Observation
17148,1164,away,I-Observation
17149,1164,from,O
17150,1164,the,O
17151,1164,area,O
17152,1164,for,O
17153,1164,the,O
17154,1164,duration,O
17155,1164,of,O
17156,1164,the,O
17157,1164,study,O
17158,1165,Participants,O
17159,1165,able,B-Observation
17160,1165,and,I-Observation
17161,1165,willing,I-Observation
17162,1165,to,I-Observation
17163,1165,comply,I-Observation
17164,1165,with,O
17165,1165,all,O
17166,1165,aspects,O
17167,1165,of,O
17168,1165,the,O
17169,1165,study,O
17170,1165,",",O
17171,1165,including,O
17172,1165,a,O
17173,1165,standardized,O
17174,1165,",",O
17175,1165,reduced,B-Observation
17176,1165,calorie,I-Observation
17177,1165,diet,I-Observation
17178,1165,and,O
17179,1165,an,O
17180,1165,age,O
17181,1165,appropriate,O
17182,1165,",",O
17183,1165,increased,B-Observation
17184,1165,physical,I-Observation
17185,1165,activity,I-Observation
17186,1165,program,I-Observation
17187,1166,Participants,O
17188,1166,considered,O
17189,1166,in,O
17190,1166,stable,B-Observation
17191,1166,health,I-Observation
17192,1166,in,O
17193,1166,the,O
17194,1166,opinion,O
17195,1166,of,O
17196,1166,the,O
17197,1166,investigator,O
17198,1167,Able,O
17199,1167,and,O
17200,1167,willing,O
17201,1167,to,O
17202,1167,support,O
17203,1167,and,O
17204,1167,supervise,O
17205,1167,study,O
17206,1167,participation,O
17207,1167,in,O
17208,1167,the,O
17209,1167,opinion,O
17210,1167,of,O
17211,1167,the,O
17212,1167,investigator,O
17213,1167,",",O
17214,1167,including,O
17215,1167,consideration,O
17216,1167,of,O
17217,1167,any,O
17218,1167,existing,O
17219,1167,physical,O
17220,1167,",",O
17221,1167,medical,O
17222,1167,",",O
17223,1167,or,O
17224,1167,mental,O
17225,1167,condition,O
17226,1167,that,O
17227,1167,prevents,O
17228,1167,compliance,O
17229,1167,with,O
17230,1167,the,O
17231,1167,protocol,O
17232,1168,Able,B-Observation
17233,1168,and,I-Observation
17234,1168,willing,I-Observation
17235,1168,to,I-Observation
17236,1168,personally,I-Observation
17237,1168,comply,I-Observation
17238,1168,with,O
17239,1168,and,O
17240,1168,execute,O
17241,1168,all,O
17242,1168,aspects,O
17243,1168,of,O
17244,1168,the,O
17245,1168,study,O
17246,1168,requirements,O
17247,1168,for,O
17248,1168,the,O
17249,1168,caregivers,B-Person
17250,1168,or,O
17251,1168,guardians,B-Person
17252,1169,Patients,O
17253,1169,who,O
17254,1169,will,O
17255,1169,not,O
17256,1169,get,O
17257,1169,surgical,B-Procedure
17258,1169,treatment,I-Procedure
17259,1169,for,O
17260,1169,their,O
17261,1169,endometrial,B-Condition
17262,1169,cancer,I-Condition
17263,1170,Patients,O
17264,1170,not,O
17265,1170,suffering,O
17266,1170,from,O
17267,1170,endometrial,B-Condition
17268,1170,or,I-Condition
17269,1170,epithelial,I-Condition
17270,1170,ovarian,I-Condition
17271,1170,cancer,I-Condition
17272,1171,Patients,O
17273,1171,who,O
17274,1171,do,O
17275,1171,not,O
17276,1171,agree,B-Observation
17277,1171,to,I-Observation
17278,1171,the,I-Observation
17279,1171,proposed,I-Observation
17280,1171,treatment,I-Observation
17281,1171,or,O
17282,1171,will,O
17283,1171,receive,O
17284,1171,(,O
17285,1171,part,O
17286,1171,of,O
17287,1171,),O
17288,1171,the,O
17289,1171,treatment,B-Procedure
17290,1171,in,O
17291,1171,a,O
17292,1171,non,O
17293,1171,-,O
17294,1171,participating,O
17295,1171,centre,O
17296,1172,Patients,O
17297,1172,who,O
17298,1172,can,O
17299,1172,not,O
17300,1172,or,O
17301,1172,do,O
17302,1172,not,O
17303,1172,want,O
17304,1172,to,O
17305,1172,give,B-Observation
17306,1172,informed,I-Observation
17307,1172,consent,I-Observation
17308,1172,(,O
17309,1172,including,O
17310,1172,language,B-Observation
17311,1172,barriers,I-Observation
17312,1172,),O
17313,1173,All,O
17314,1173,patients,O
17315,1173,referred,O
17316,1173,to,O
17317,1173,a,O
17318,1173,participating,O
17319,1173,research,O
17320,1173,centre,O
17321,1173,with,O
17322,1173,suspicion,B-Mood
17323,1173,of,I-Mood
17324,1173,or,O
17325,1173,confirmed,O
17326,1173,endometrial,B-Condition
17327,1173,cancer,I-Condition
17328,1173,.,O
17329,1174,Patients,O
17330,1174,with,O
17331,1174,endometrial,B-Condition
17332,1174,or,I-Condition
17333,1174,epithelial,I-Condition
17334,1174,ovarian,I-Condition
17335,1174,cancer,I-Condition
17336,1174,who,O
17337,1174,following,O
17338,1174,routine,O
17339,1174,clinical,O
17340,1174,guidelines,O
17341,1174,are,O
17342,1174,offered,O
17343,1174,weekly,O
17344,1174,taxane,B-Drug
17345,1174,(,O
17346,1174,paclitaxel,B-Drug
17347,1174,),O
17348,1174,treatment,B-Procedure
17349,1174,.,O
17350,1174,This,O
17351,1174,will,O
17352,1174,often,O
17353,1174,be,O
17354,1174,a,O
17355,1174,third,O
17356,1174,or,O
17357,1174,fourth,O
17358,1174,line,O
17359,1174,treatment,O
17360,1174,",",O
17361,1174,i.e.,O
17362,1174,patients,O
17363,1174,with,O
17364,1174,advanced,O
17365,1174,disease,O
17366,1174,.,O
17367,1175,Technical,B-Mood
17368,1175,possibility,I-Mood
17369,1175,to,I-Mood
17370,1175,obtain,I-Mood
17371,1175,a,O
17372,1175,new,O
17373,1175,tissue,B-Procedure
17374,1175,biopsy,I-Procedure
17375,1175,to,O
17376,1175,determine,O
17377,1175,stathmin,O
17378,1175,level,O
17379,1175,in,O
17380,1175,the,O
17381,1175,tumour,B-Condition
17382,1175,recurrence,I-Condition
17383,1175,.,O
17384,1176,previous,O
17385,1176,retinal,B-Condition
17386,1176,vein,I-Condition
17387,1176,occlusion,I-Condition
17388,1176,.,O
17389,1177,any,O
17390,1177,intraocular,B-Procedure
17391,1177,surgery,I-Procedure
17392,1177,within,O
17393,1177,the,O
17394,1177,previous,O
17395,1177,12,O
17396,1177,months,O
17397,1177,.,O
17398,1178,myopia,B-Condition
17399,1178,of,O
17400,1178,>,O
17401,1178,or,O
17402,1178,=,O
17403,1178,to,O
17404,1178,8,O
17405,1178,diopters,O
17406,1178,.,O
17407,1179,active,O
17408,1179,ocular,B-Condition
17409,1179,or,I-Condition
17410,1179,periocular,I-Condition
17411,1179,infection,I-Condition
17412,1180,treatment,O
17413,1180,with,O
17414,1180,an,O
17415,1180,investigational,O
17416,1180,agent,O
17417,1180,for,O
17418,1180,any,O
17419,1180,condition,O
17420,1180,60,O
17421,1180,days,O
17422,1180,prior,O
17423,1180,to,O
17424,1180,enrollment,O
17425,1180,.,O
17426,1181,evidence,B-Mood
17427,1181,of,I-Mood
17428,1181,severe,O
17429,1181,cardiac,B-Condition
17430,1181,disease,I-Condition
17431,1181,.,O
17432,1182,clinically,O
17433,1182,significant,O
17434,1182,peripheral,B-Condition
17435,1182,vascular,I-Condition
17436,1182,disease,I-Condition
17437,1182,(,O
17438,1182,previous,B-Procedure
17439,1182,surgery,I-Procedure
17440,1182,",",O
17441,1182,amputation,B-Procedure
17442,1182,",",O
17443,1182,or,O
17444,1182,symptoms,B-Condition
17445,1182,of,I-Condition
17446,1182,claudication,I-Condition
17447,1182,),O
17448,1183,uncontrolled,O
17449,1183,hypertension,B-Condition
17450,1183,(,O
17451,1183,treated,O
17452,1183,systolic,O
17453,1183,blood,O
17454,1183,pressure,O
17455,1183,>,O
17456,1183,155,O
17457,1183,mmHg,O
17458,1183,or,O
17459,1183,diastolic,O
17460,1183,blood,O
17461,1183,pressure,O
17462,1183,>,O
17463,1183,95,O
17464,1183,mmHg,O
17465,1183,),O
17466,1184,stroke,B-Condition
17467,1184,within,O
17468,1184,the,O
17469,1184,preceding,O
17470,1184,12,O
17471,1184,months,O
17472,1184,.,O
17473,1185,18,O
17474,1185,years,O
17475,1185,or,O
17476,1185,older,B-Person
17477,1186,Type,B-Condition
17478,1186,1,I-Condition
17479,1186,or,I-Condition
17480,1186,2,I-Condition
17481,1186,diabetes,I-Condition
17482,1187,PDR,B-Condition
17483,1187,patients,O
17484,1187,requiring,B-Mood
17485,1187,surgical,B-Procedure
17486,1187,intervention,I-Procedure
17487,1187,for,O
17488,1187,complications,O
17489,1187,of,O
17490,1187,vitreous,B-Condition
17491,1187,hemorrhage,I-Condition
17492,1187,or,O
17493,1187,traction,B-Condition
17494,1187,retinal,I-Condition
17495,1187,detachment,I-Condition
17496,1187,and,O
17497,1187,pre,O
17498,1187,-,O
17499,1187,operative,O
17500,1187,IVC,B-Procedure
17501,1187,treatment,I-Procedure
17502,1187,.,O
17503,1188,women,O
17504,1188,postmenopausal,O
17505,1188,for,O
17506,1188,12,O
17507,1188,months,O
17508,1188,before,O
17509,1188,the,O
17510,1188,study,O
17511,1188,",",O
17512,1188,surgically,O
17513,1188,sterile,O
17514,1188,",",O
17515,1188,or,O
17516,1188,not,O
17517,1188,pregnant,O
17518,1188,and,O
17519,1188,on,O
17520,1188,effective,O
17521,1188,contraception,O
17522,1188,.,O
17523,1189,Meets,O
17524,1189,criteria,O
17525,1189,for,O
17526,1189,Major,B-Condition
17527,1189,Depressive,I-Condition
17528,1189,Episode,I-Condition
17529,1189,",",O
17530,1189,by,O
17531,1189,Diagnostic,O
17532,1189,Statistical,O
17533,1189,Manual,O
17534,1189,of,O
17535,1189,Mental,O
17536,1189,Disorder,O
17537,1189,-,O
17538,1189,IV,O
17539,1189,(,O
17540,1189,TR,O
17541,1189,),O
17542,1189,criteria,O
17543,1190,Clinically,O
17544,1190,significant,O
17545,1190,agitation,B-Condition
17546,1190,/aggression,I-Condition
17547,1190,for,O
17548,1190,which,O
17549,1190,either,O
17550,1190,1,O
17551,1190,),O
17552,1190,the,O
17553,1190,frequency,O
17554,1190,of,O
17555,1190,agitation,B-Condition
17556,1190,/aggression,I-Condition
17557,1190,as,O
17558,1190,assessed,O
17559,1190,by,O
17560,1190,the,O
17561,1190,NPI,O
17562,1190,is,O
17563,1190,',O
17564,1190,Very,O
17565,1190,frequently,O
17566,1190,',O
17567,1190,",",O
17568,1190,or,O
17569,1190,2,O
17570,1190,),O
17571,1190,the,O
17572,1190,frequency,O
17573,1190,of,O
17574,1190,agitation,B-Condition
17575,1190,/aggression,I-Condition
17576,1190,as,O
17577,1190,assessed,O
17578,1190,by,O
17579,1190,the,O
17580,1190,NPI,O
17581,1190,is,O
17582,1190,',O
17583,1190,Frequently,O
17584,1190,',O
17585,1190,AND,O
17586,1190,the,O
17587,1190,severity,O
17588,1190,of,O
17589,1190,the,O
17590,1190,agitation,B-Condition
17591,1190,as,O
17592,1190,assessed,O
17593,1190,by,O
17594,1190,the,O
17595,1190,NPI,O
17596,1190,is,O
17597,1190,',O
17598,1190,Moderate,O
17599,1190,',O
17600,1190,",",O
17601,1190,or,O
17602,1190,',O
17603,1190,Marked,O
17604,1190,',O
17605,1191,Clinically,O
17606,1191,significant,O
17607,1191,delusions,B-Condition
17608,1191,for,O
17609,1191,which,O
17610,1191,either,O
17611,1191,1,O
17612,1191,),O
17613,1191,the,O
17614,1191,frequency,O
17615,1191,of,O
17616,1191,delusions,B-Condition
17617,1191,as,O
17618,1191,assessed,O
17619,1191,by,O
17620,1191,the,O
17621,1191,NPI,O
17622,1191,is,O
17623,1191,',O
17624,1191,Very,O
17625,1191,frequently,O
17626,1191,',O
17627,1191,",",O
17628,1191,or,O
17629,1191,2,O
17630,1191,),O
17631,1191,the,O
17632,1191,frequency,O
17633,1191,of,O
17634,1191,delusions,B-Condition
17635,1191,as,O
17636,1191,assessed,O
17637,1191,by,O
17638,1191,the,O
17639,1191,NPI,O
17640,1191,is,O
17641,1191,',O
17642,1191,Frequently,O
17643,1191,',O
17644,1191,AND,O
17645,1191,the,O
17646,1191,severity,O
17647,1191,of,O
17648,1191,the,O
17649,1191,delusions,B-Condition
17650,1191,as,O
17651,1191,assessed,O
17652,1191,by,O
17653,1191,the,O
17654,1191,NPI,O
17655,1191,is,O
17656,1191,',O
17657,1191,Moderate,O
17658,1191,',O
17659,1191,",",O
17660,1191,or,O
17661,1191,',O
17662,1191,Marked,O
17663,1191,',O
17664,1192,Clinically,O
17665,1192,significant,O
17666,1192,hallucinations,B-Condition
17667,1192,for,O
17668,1192,which,O
17669,1192,either,O
17670,1192,1,O
17671,1192,),O
17672,1192,the,O
17673,1192,frequency,O
17674,1192,of,O
17675,1192,hallucinations,B-Condition
17676,1192,as,O
17677,1192,assessed,O
17678,1192,by,O
17679,1192,the,O
17680,1192,NPI,O
17681,1192,is,O
17682,1192,',O
17683,1192,Very,O
17684,1192,frequently,O
17685,1192,',O
17686,1192,",",O
17687,1192,or,O
17688,1192,2,O
17689,1192,),O
17690,1192,the,O
17691,1192,frequency,O
17692,1192,of,O
17693,1192,hallucinations,B-Condition
17694,1192,as,O
17695,1192,assessed,O
17696,1192,by,O
17697,1192,the,O
17698,1192,NPI,O
17699,1192,is,O
17700,1192,',O
17701,1192,Frequently,O
17702,1192,',O
17703,1192,AND,O
17704,1192,the,O
17705,1192,severity,O
17706,1192,of,O
17707,1192,the,O
17708,1192,hallucinations,B-Condition
17709,1192,as,O
17710,1192,assessed,O
17711,1192,by,O
17712,1192,the,O
17713,1192,NPI,O
17714,1192,is,O
17715,1192,',O
17716,1192,Moderate,O
17717,1192,',O
17718,1192,",",O
17719,1192,or,O
17720,1192,',O
17721,1192,Marked,O
17722,1192,',O
17723,1193,Treatment,O
17724,1193,with,O
17725,1193,psychotropic,B-Drug
17726,1193,medications,I-Drug
17727,1193,in,O
17728,1193,the,O
17729,1193,2,O
17730,1193,weeks,O
17731,1193,prior,O
17732,1193,to,O
17733,1193,randomization,O
17734,1193,with,O
17735,1193,the,O
17736,1193,exception,O
17737,1193,of,O
17738,1193,approved,O
17739,1193,treatments,B-Procedure
17740,1193,for,I-Procedure
17741,1193,dementia,I-Procedure
17742,1193,(,O
17743,1193,ChEIs,B-Drug
17744,1193,and,O
17745,1193,memantine,B-Drug
17746,1193,),O
17747,1193,",",O
17748,1193,selective,B-Drug
17749,1193,serotonin,I-Drug
17750,1193,reuptake,I-Drug
17751,1193,inhibitor,I-Drug
17752,1193,antidepressants,I-Drug
17753,1193,",",O
17754,1193,and,O
17755,1193,trazodone,B-Drug
17756,1193,(,O
17757,1193,if,O
17758,1193,used,O
17759,1193,as,O
17760,1193,an,O
17761,1193,aid,O
17762,1193,to,O
17763,1193,facilitate,O
17764,1193,sleep,O
17765,1193,and,O
17766,1193,not,O
17767,1193,as,O
17768,1193,an,O
17769,1193,antidepressant,O
17770,1193,),O
17771,1193,;,O
17772,1193,other,B-Drug
17773,1193,psychotropics,I-Drug
17774,1193,(,O
17775,1193,with,O
17776,1193,the,O
17777,1193,exclusion,O
17778,1193,of,O
17779,1193,antipsychotics,B-Drug
17780,1193,),O
17781,1193,",",O
17782,1193,if,O
17783,1193,stable,O
17784,1193,for,O
17785,1193,3,O
17786,1193,months,O
17787,1193,",",O
17788,1193,may,O
17789,1193,be,O
17790,1193,allowed,O
17791,1193,only,O
17792,1193,with,O
17793,1193,Steering,O
17794,1193,Committee,O
17795,1193,approval,O
17796,1193,on,O
17797,1193,a,O
17798,1193,case,O
17799,1193,by,O
17800,1193,case,O
17801,1193,basis,O
17802,1193,.,O
17803,1193,Note,O
17804,1193,that,O
17805,1193,antipsychotics,O
17806,1193,are,O
17807,1193,expressly,O
17808,1193,prohibited,O
17809,1193,.,O
17810,1194,Treatment,O
17811,1194,with,O
17812,1194,methylphenidate,B-Drug
17813,1194,is,O
17814,1194,contraindicated,O
17815,1194,in,O
17816,1194,the,O
17817,1194,opinion,O
17818,1194,of,O
17819,1194,the,O
17820,1194,study,O
17821,1194,physician,O
17822,1195,Failure,O
17823,1195,of,O
17824,1195,treatment,O
17825,1195,with,O
17826,1195,methylphenidate,B-Drug
17827,1195,in,O
17828,1195,the,O
17829,1195,past,O
17830,1195,for,O
17831,1195,apathy,O
17832,1195,after,O
17833,1195,convincing,O
17834,1195,evidence,O
17835,1195,of,O
17836,1195,an,O
17837,1195,adequate,O
17838,1195,trial,O
17839,1195,as,O
17840,1195,judged,O
17841,1195,by,O
17842,1195,study,O
17843,1195,physician,O
17844,1196,Treatment,O
17845,1196,with,O
17846,1196,a,O
17847,1196,medication,B-Drug
17848,1196,that,I-Drug
17849,1196,would,I-Drug
17850,1196,prohibit,I-Drug
17851,1196,the,I-Drug
17852,1196,safe,I-Drug
17853,1196,concurrent,I-Drug
17854,1196,use,I-Drug
17855,1196,of,I-Drug
17856,1196,methylphenidate,I-Drug
17857,1196,such,O
17858,1196,as,O
17859,1196,monoamine,B-Drug
17860,1196,oxidase,I-Drug
17861,1196,inhibitors,I-Drug
17862,1196,and,O
17863,1196,tricyclic,B-Drug
17864,1196,antidepressants,I-Drug
17865,1197,Need,B-Observation
17866,1197,for,I-Observation
17867,1197,acute,O
17868,1197,psychiatric,B-Procedure
17869,1197,hospitalization,I-Procedure
17870,1197,or,O
17871,1197,is,O
17872,1197,suicidal,B-Condition
17873,1198,Uncontrolled,B-Condition
17874,1198,hypertension,I-Condition
17875,1198,(,O
17876,1198,medication,B-Condition
17877,1198,non,I-Condition
17878,1198,-,I-Condition
17879,1198,compliance,I-Condition
17880,1198,or,O
17881,1198,past,O
17882,1198,3,O
17883,1198,months,O
17884,1198,with,O
17885,1198,a,O
17886,1198,diastolic,O
17887,1198,reading,O
17888,1198,of,O
17889,1198,105,O
17890,1198,as,O
17891,1198,verified,O
17892,1198,by,O
17893,1198,compartment,O
17894,1198,pressure,O
17895,1198,of,O
17896,1198,the,O
17897,1198,rectus,O
17898,1198,sheath,O
17899,1198,(,O
17900,1198,CPRS,O
17901,1198,),O
17902,1198,),O
17903,1199,Symptomatic,O
17904,1199,coronary,B-Condition
17905,1199,artery,I-Condition
17906,1199,disease,I-Condition
17907,1199,deemed,O
17908,1199,to,O
17909,1199,be,O
17910,1199,significant,O
17911,1199,by,O
17912,1199,study,O
17913,1199,physician,O
17914,1199,at,O
17915,1199,the,O
17916,1199,time,O
17917,1199,of,O
17918,1199,screening,O
17919,1200,Lack,B-Condition
17920,1200,of,I-Condition
17921,1200,appetite,I-Condition
17922,1200,that,O
17923,1200,results,O
17924,1200,in,O
17925,1200,significant,O
17926,1200,unintentional,B-Condition
17927,1200,weight,I-Condition
17928,1200,loss,I-Condition
17929,1200,as,O
17930,1200,determined,O
17931,1200,by,O
17932,1200,the,O
17933,1200,study,O
17934,1200,physician,O
17935,1200,in,O
17936,1200,the,O
17937,1200,last,O
17938,1200,three,O
17939,1200,months,O
17940,1201,Significant,O
17941,1201,communicative,B-Condition
17942,1201,impairments,I-Condition
17943,1202,Current,O
17944,1202,participation,O
17945,1202,in,O
17946,1202,a,O
17947,1202,clinical,O
17948,1202,trial,O
17949,1202,or,O
17950,1202,in,O
17951,1202,any,O
17952,1202,study,O
17953,1202,that,O
17954,1202,may,O
17955,1202,add,O
17956,1202,significant,O
17957,1202,burden,O
17958,1202,or,O
17959,1202,affect,O
17960,1202,study,O
17961,1202,outcomes,O
17962,1203,Hyperthyroidism,B-Condition
17963,1203,",",O
17964,1203,advanced,O
17965,1203,arteriosclerosis,B-Condition
17966,1203,",",O
17967,1203,symptomatic,O
17968,1203,cardiovascular,B-Condition
17969,1203,disease,I-Condition
17970,1203,",",O
17971,1203,serious,O
17972,1203,structural,B-Condition
17973,1203,cardiac,I-Condition
17974,1203,abnormalities,I-Condition
17975,1203,",",O
17976,1203,cardiomyopathy,B-Condition
17977,1203,",",O
17978,1203,serious,O
17979,1203,heart,B-Condition
17980,1203,rhythm,I-Condition
17981,1203,abnormalities,I-Condition
17982,1203,",",O
17983,1203,or,O
17984,1203,a,O
17985,1203,family,B-Observation
17986,1203,history,I-Observation
17987,1203,of,O
17988,1203,sudden,B-Condition
17989,1203,death,I-Condition
17990,1203,or,O
17991,1203,death,B-Condition
17992,1203,related,I-Condition
17993,1203,to,I-Condition
17994,1203,heart,I-Condition
17995,1203,problems,I-Condition
17996,1204,Glaucoma,B-Condition
17997,1204,",",O
17998,1204,pheochromocytoma,B-Condition
17999,1204,",",O
18000,1204,or,O
18001,1204,known,B-Observation
18002,1204,or,O
18003,1204,suspected,B-Observation
18004,1204,hypersensitivity,B-Condition
18005,1204,to,O
18006,1204,methylphenidate,B-Drug
18007,1204,or,I-Drug
18008,1204,its,I-Drug
18009,1204,excipients,I-Drug
18010,1205,Central,B-Condition
18011,1205,Nervous,I-Condition
18012,1205,System,I-Condition
18013,1205,(,I-Condition
18014,1205,CNS,I-Condition
18015,1205,),I-Condition
18016,1205,abnormalities,I-Condition
18017,1205,(,O
18018,1205,e.g.,O
18019,1205,",",O
18020,1205,cerebral,B-Condition
18021,1205,aneurysm,I-Condition
18022,1205,),O
18023,1205,and/or,O
18024,1205,other,O
18025,1205,vascular,B-Condition
18026,1205,abnormalities,I-Condition
18027,1205,such,O
18028,1205,as,O
18029,1205,vasculitis,B-Condition
18030,1205,or,O
18031,1205,pre,O
18032,1205,-,O
18033,1205,existing,O
18034,1205,stroke,B-Condition
18035,1205,",",O
18036,1205,motor,B-Condition
18037,1205,tics,I-Condition
18038,1205,or,O
18039,1205,a,O
18040,1205,family,B-Observation
18041,1205,history,I-Observation
18042,1205,or,O
18043,1205,diagnosis,B-Observation
18044,1205,of,O
18045,1205,Tourette,B-Condition
18046,1205,'s,I-Condition
18047,1205,syndrome,I-Condition
18048,1205,",",O
18049,1205,seizures,B-Condition
18050,1205,(,O
18051,1205,convulsions,B-Condition
18052,1205,",",O
18053,1205,epilepsy,B-Condition
18054,1205,),O
18055,1205,",",O
18056,1205,or,O
18057,1205,abnormal,O
18058,1205,EEGs,B-Condition
18059,1206,Any,O
18060,1206,condition,O
18061,1206,that,O
18062,1206,",",O
18063,1206,in,O
18064,1206,the,O
18065,1206,opinion,O
18066,1206,of,O
18067,1206,the,O
18068,1206,study,O
18069,1206,physician,O
18070,1206,",",O
18071,1206,makes,O
18072,1206,it,O
18073,1206,medically,O
18074,1206,inappropriate,O
18075,1206,or,O
18076,1206,risky,O
18077,1206,for,O
18078,1206,the,O
18079,1206,patient,O
18080,1206,to,O
18081,1206,enroll,O
18082,1206,in,O
18083,1206,the,O
18084,1206,trial,O
18085,1207,Possible,O
18086,1207,or,O
18087,1207,probable,O
18088,1207,Alzheimer,B-Condition
18089,1207,'s,I-Condition
18090,1207,disease,I-Condition
18091,1207,(,O
18092,1207,National,O
18093,1207,Institute,O
18094,1207,of,O
18095,1207,Neurological,O
18096,1207,and,O
18097,1207,Communicative,O
18098,1207,Disorders,O
18099,1207,and,O
18100,1207,Stroke,O
18101,1207,-,O
18102,1207,Alzheimer,O
18103,1207,'s,O
18104,1207,Disease,O
18105,1207,and,O
18106,1207,Related,O
18107,1207,Disorders,O
18108,1207,Association,O
18109,1207,(,O
18110,1207,NINCDS,O
18111,1207,-,O
18112,1207,ADRDA,O
18113,1207,),O
18114,1207,criteria,O
18115,1207,),O
18116,1207,",",O
18117,1207,with,O
18118,1207,Mini,O
18119,1207,-,O
18120,1207,Mental,O
18121,1207,State,O
18122,1207,Exam,O
18123,1207,(,O
18124,1207,MMSE,O
18125,1207,),O
18126,1207,score,O
18127,1207,of,O
18128,1207,10,O
18129,1207,-,O
18130,1207,26,O
18131,1207,inclusive,O
18132,1207,;,O
18133,1207,MMSE,O
18134,1207,scores,O
18135,1207,above,O
18136,1207,26,O
18137,1207,in,O
18138,1207,those,O
18139,1207,who,O
18140,1207,nevertheless,O
18141,1207,meet,O
18142,1207,criteria,O
18143,1207,for,O
18144,1207,AD,B-Condition
18145,1207,may,O
18146,1207,be,O
18147,1207,allowed,O
18148,1207,with,O
18149,1207,Steering,O
18150,1207,Committee,O
18151,1207,approval,O
18152,1207,on,O
18153,1207,a,O
18154,1207,case,O
18155,1207,by,O
18156,1207,case,O
18157,1207,basis,O
18158,1208,Clinically,O
18159,1208,significant,O
18160,1208,apathy,B-Condition
18161,1208,for,O
18162,1208,at,B-Person
18163,1208,least,I-Person
18164,1208,four,I-Person
18165,1208,weeks,I-Person
18166,1208,for,O
18167,1208,which,O
18168,1208,either,O
18169,1208,1,O
18170,1208,),O
18171,1208,the,O
18172,1208,frequency,B-Observation
18173,1208,of,I-Observation
18174,1208,apathy,I-Observation
18175,1208,as,O
18176,1208,assessed,O
18177,1208,by,O
18178,1208,the,O
18179,1208,Neuropsychiatric,O
18180,1208,Inventory,O
18181,1208,(,O
18182,1208,NPI,O
18183,1208,),O
18184,1208,is,O
18185,1208,',O
18186,1208,Very,O
18187,1208,frequently,O
18188,1208,',O
18189,1208,",",O
18190,1208,or,O
18191,1208,2,O
18192,1208,),O
18193,1208,the,O
18194,1208,frequency,B-Observation
18195,1208,of,I-Observation
18196,1208,apathy,I-Observation
18197,1208,as,O
18198,1208,assessed,O
18199,1208,by,O
18200,1208,the,O
18201,1208,NPI,O
18202,1208,is,O
18203,1208,',O
18204,1208,Frequently,O
18205,1208,',O
18206,1208,or,O
18207,1208,',O
18208,1208,Often,O
18209,1208,',O
18210,1208,AND,O
18211,1208,the,O
18212,1208,severity,B-Observation
18213,1208,of,I-Observation
18214,1208,apathy,I-Observation
18215,1208,as,O
18216,1208,assessed,O
18217,1208,by,O
18218,1208,the,O
18219,1208,NPI,O
18220,1208,is,O
18221,1208,',O
18222,1208,Moderate,O
18223,1208,',O
18224,1208,or,O
18225,1208,',O
18226,1208,Marked,O
18227,1208,',O
18228,1209,A,O
18229,1209,medication,B-Drug
18230,1209,for,I-Drug
18231,1209,apathy,I-Drug
18232,1209,is,O
18233,1209,appropriate,O
18234,1209,",",O
18235,1209,in,O
18236,1209,the,O
18237,1209,opinion,O
18238,1209,of,O
18239,1209,the,O
18240,1209,study,O
18241,1209,physician,O
18242,1210,Provision,O
18243,1210,of,O
18244,1210,informed,O
18245,1210,consent,O
18246,1210,for,O
18247,1210,participation,O
18248,1210,in,O
18249,1210,the,O
18250,1210,study,O
18251,1210,by,O
18252,1210,patient,O
18253,1210,or,O
18254,1210,surrogate,O
18255,1210,(,O
18256,1210,if,O
18257,1210,the,O
18258,1210,patient,O
18259,1210,is,O
18260,1210,unable,O
18261,1210,to,O
18262,1210,provide,O
18263,1210,informed,O
18264,1210,consent,O
18265,1210,),O
18266,1210,and,O
18267,1210,caregiver,O
18268,1211,Availability,O
18269,1211,of,O
18270,1211,primary,O
18271,1211,caregiver,O
18272,1211,",",O
18273,1211,who,O
18274,1211,spends,O
18275,1211,greater,O
18276,1211,than,O
18277,1211,ten,O
18278,1211,hours,O
18279,1211,a,O
18280,1211,week,O
18281,1211,with,O
18282,1211,the,O
18283,1211,patient,O
18284,1211,and,O
18285,1211,supervises,O
18286,1211,his,O
18287,1211,/,O
18288,1211,her,O
18289,1211,care,O
18290,1211,",",O
18291,1211,to,O
18292,1211,accompany,O
18293,1211,the,O
18294,1211,patient,O
18295,1211,to,O
18296,1211,study,O
18297,1211,visits,O
18298,1211,and,O
18299,1211,to,O
18300,1211,participate,O
18301,1211,in,O
18302,1211,the,O
18303,1211,study,O
18304,1212,Sufficient,O
18305,1212,fluency,O
18306,1212,",",O
18307,1212,of,O
18308,1212,both,O
18309,1212,the,O
18310,1212,patient,O
18311,1212,and,O
18312,1212,caregiver,O
18313,1212,",",O
18314,1212,in,O
18315,1212,written,O
18316,1212,and,O
18317,1212,spoken,O
18318,1212,English,O
18319,1212,to,O
18320,1212,participate,O
18321,1212,in,O
18322,1212,study,O
18323,1212,visits,O
18324,1212,",",O
18325,1212,physical,O
18326,1212,exams,O
18327,1212,",",O
18328,1212,and,O
18329,1212,outcome,O
18330,1212,assessments,O
18331,1213,No,O
18332,1213,change,B-Observation
18333,1213,to,I-Observation
18334,1213,AD,I-Observation
18335,1213,medications,I-Observation
18336,1213,within,O
18337,1213,the,O
18338,1213,month,O
18339,1213,preceding,O
18340,1213,randomization,O
18341,1213,",",O
18342,1213,including,O
18343,1213,starting,O
18344,1213,",",O
18345,1213,stopping,O
18346,1213,",",O
18347,1213,or,O
18348,1213,dosage,O
18349,1213,modifications,O
18350,1214,Treatment,B-Procedure
18351,1214,with,O
18352,1214,stable,O
18353,1214,doses,O
18354,1214,of,O
18355,1214,selective,B-Drug
18356,1214,serotonin,I-Drug
18357,1214,reuptake,I-Drug
18358,1214,inhibitor,I-Drug
18359,1214,antidepressants(SSRIs,I-Drug
18360,1214,),I-Drug
18361,1214,is,O
18362,1214,appropriate,O
18363,1214,if,O
18364,1214,stable,O
18365,1214,for,O
18366,1214,3,O
18367,1214,months,O
18368,1214,prior,O
18369,1214,to,O
18370,1214,randomization,O
18371,1214,.,O
18372,1214,Other,O
18373,1214,psychotropics(with,O
18374,1214,the,O
18375,1214,exclusion,O
18376,1214,of,O
18377,1214,antipsychotics,O
18378,1214,),O
18379,1214,",",O
18380,1214,if,O
18381,1214,stable,O
18382,1214,for,O
18383,1214,3,O
18384,1214,months,O
18385,1214,",",O
18386,1214,may,O
18387,1214,be,O
18388,1214,allowed,O
18389,1214,only,O
18390,1214,with,O
18391,1214,Steering,O
18392,1214,Committee,O
18393,1214,approval,O
18394,1214,on,O
18395,1214,a,O
18396,1214,case,O
18397,1214,by,O
18398,1214,case,O
18399,1214,basis,O
18400,1214,.,O
18401,1215,Exclusions,O
18402,1215,Related,O
18403,1215,to,O
18404,1215,Cardiovascular,O
18405,1215,Disease,O
18406,1216,1,O
18407,1216,.,O
18408,1216,History,B-Observation
18409,1216,of,O
18410,1216,uncontrolled,O
18411,1216,hypertension,B-Condition
18412,1217,2,O
18413,1217,.,O
18414,1217,Persistent,B-Condition
18415,1217,hypotension,I-Condition
18416,1217,at,O
18417,1217,Screening,O
18418,1217,.,O
18419,1218,3,O
18420,1218,.,O
18421,1218,Evidence,O
18422,1218,or,O
18423,1218,history,B-Observation
18424,1218,of,O
18425,1218,left,B-Condition
18426,1218,-,I-Condition
18427,1218,sided,I-Condition
18428,1218,heart,I-Condition
18429,1218,disease,I-Condition
18430,1218,and/or,O
18431,1218,clinically,O
18432,1218,significant,O
18433,1218,cardiac,B-Condition
18434,1218,disease,I-Condition
18435,1218,in,O
18436,1218,which,O
18437,1218,pulmonary,B-Condition
18438,1218,hypertension,I-Condition
18439,1218,is,O
18440,1218,more,O
18441,1218,likely,O
18442,1218,WHO,O
18443,1218,Group,O
18444,1218,2,O
18445,1218,.,O
18446,1219,4,O
18447,1219,.,O
18448,1219,Acute,O
18449,1219,decompensated,O
18450,1219,heart,B-Condition
18451,1219,failure,I-Condition
18452,1219,within,O
18453,1219,1,O
18454,1219,month,O
18455,1219,of,O
18456,1219,Screening,O
18457,1219,.,O
18458,1220,5,O
18459,1220,.,O
18460,1220,Recent,O
18461,1220,initiation,O
18462,1220,(,O
18463,1220,<,O
18464,1220,8,O
18465,1220,weeks,O
18466,1220,from,O
18467,1220,Screening,O
18468,1220,),O
18469,1220,or,O
18470,1220,planned,O
18471,1220,initiation,O
18472,1220,of,O
18473,1220,cardiopulmonary,B-Procedure
18474,1220,rehabilitation,I-Procedure
18475,1220,exercise,I-Procedure
18476,1220,program,I-Procedure
18477,1220,.,O
18478,1221,Exclusions,O
18479,1221,Related,O
18480,1221,to,O
18481,1221,Pulmonary,O
18482,1221,Disease,O
18483,1222,6,O
18484,1222,.,O
18485,1222,Newly,O
18486,1222,diagnosed,O
18487,1222,with,O
18488,1222,PAH,B-Condition
18489,1222,and,O
18490,1222,not,O
18491,1222,on,O
18492,1222,PAH,B-Procedure
18493,1222,-,I-Procedure
18494,1222,specific,I-Procedure
18495,1222,therapy,I-Procedure
18496,1222,.,O
18497,1223,7,O
18498,1223,.,O
18499,1223,Pulmonary,O
18500,1223,hypertension,O
18501,1223,due,O
18502,1223,to,O
18503,1223,:,O
18504,1224,1,O
18505,1224,.,O
18506,1224,Uncorrected,O
18507,1224,congenital,B-Condition
18508,1224,systemic,I-Condition
18509,1224,-,I-Condition
18510,1224,to,I-Condition
18511,1224,-,I-Condition
18512,1224,pulmonary,I-Condition
18513,1224,shunt,I-Condition
18514,1224,.,O
18515,1225,2,O
18516,1225,.,O
18517,1225,Pulmonary,B-Condition
18518,1225,veno,I-Condition
18519,1225,-,I-Condition
18520,1225,occlusive,I-Condition
18521,1225,disease,I-Condition
18522,1225,and/or,O
18523,1225,pulmonary,B-Condition
18524,1225,capillary,I-Condition
18525,1225,hemangiomatosis,I-Condition
18526,1226,3,O
18527,1226,.,O
18528,1226,Persistent,O
18529,1226,pulmonary,B-Condition
18530,1226,hypertension,I-Condition
18531,1226,of,I-Condition
18532,1226,the,I-Condition
18533,1226,newborn,I-Condition
18534,1227,4,O
18535,1227,.,O
18536,1227,WHO,O
18537,1227,clinical,O
18538,1227,classification,O
18539,1227,Groups,O
18540,1227,2,O
18541,1227,-,O
18542,1227,5,O
18543,1228,8,O
18544,1228,.,O
18545,1228,Evidence,O
18546,1228,of,O
18547,1228,significant,O
18548,1228,airway,B-Condition
18549,1228,and/or,I-Condition
18550,1228,parenchymal,I-Condition
18551,1228,lung,I-Condition
18552,1228,disease,I-Condition
18553,1228,.,O
18554,1229,9,O
18555,1229,.,O
18556,1229,Chronic,O
18557,1229,infection,B-Condition
18558,1229,related,B-Observation
18559,1229,to,I-Observation
18560,1229,tuberculosis,B-Condition
18561,1229,or,O
18562,1229,fungal,B-Condition
18563,1229,or,I-Condition
18564,1229,mycobacterial,I-Condition
18565,1229,disease,I-Condition
18566,1229,.,O
18567,1230,Exclusions,O
18568,1230,Based,O
18569,1230,on,O
18570,1230,Other,O
18571,1230,Medical,O
18572,1230,Conditions,O
18573,1231,10,O
18574,1231,.,O
18575,1231,Chronic,O
18576,1231,infections,B-Condition
18577,1231,including,O
18578,1231,",",O
18579,1231,but,O
18580,1231,not,O
18581,1231,limited,O
18582,1231,to,O
18583,1231,tuberculosis,B-Condition
18584,1231,(,I-Condition
18585,1231,TB,I-Condition
18586,1231,),I-Condition
18587,1231,",",O
18588,1231,hepatitis,B-Condition
18589,1231,B,I-Condition
18590,1231,virus,I-Condition
18591,1231,(,I-Condition
18592,1231,HBV,I-Condition
18593,1231,),I-Condition
18594,1231,or,O
18595,1231,hepatitis,B-Condition
18596,1231,C,I-Condition
18597,1231,virus,I-Condition
18598,1231,(,I-Condition
18599,1231,HCV,I-Condition
18600,1231,),I-Condition
18601,1231,.,O
18602,1232,11,O
18603,1232,.,O
18604,1232,History,O
18605,1232,of,O
18606,1232,portal,B-Condition
18607,1232,hypertension,I-Condition
18608,1232,or,O
18609,1232,chronic,B-Condition
18610,1232,liver,I-Condition
18611,1232,disease,I-Condition
18612,1232,",",O
18613,1232,including,O
18614,1232,positive,O
18615,1232,serology,O
18616,1232,for,O
18617,1232,infection,O
18618,1232,with,O
18619,1232,HCV,O
18620,1232,and/or,O
18621,1232,HBV,O
18622,1232,.,O
18623,1233,12,O
18624,1233,.,O
18625,1233,Evidence,O
18626,1233,of,O
18627,1233,active,O
18628,1233,infection,B-Condition
18629,1233,requiring,I-Condition
18630,1233,intravenous,I-Condition
18631,1233,or,I-Condition
18632,1233,oral,I-Condition
18633,1233,antibiotics,I-Condition
18634,1233,within,O
18635,1233,4,O
18636,1233,weeks,O
18637,1233,of,O
18638,1233,Screening,O
18639,1233,.,O
18640,1234,13,O
18641,1234,.,O
18642,1234,Body,O
18643,1234,mass,O
18644,1234,index,O
18645,1234,≥35.0,O
18646,1234,at,O
18647,1234,Screening,O
18648,1234,.,O
18649,1235,14,O
18650,1235,.,O
18651,1235,History,B-Observation
18652,1235,of,O
18653,1235,obstructive,B-Condition
18654,1235,sleep,I-Condition
18655,1235,apnea,I-Condition
18656,1235,.,O
18657,1236,15,O
18658,1236,.,O
18659,1236,History,B-Observation
18660,1236,of,O
18661,1236,malignancy,B-Condition
18662,1236,within,O
18663,1236,the,O
18664,1236,last,O
18665,1236,5,O
18666,1236,years,O
18667,1236,",",O
18668,1236,except,O
18669,1236,nonmelanoma,B-Condition
18670,1236,skin,I-Condition
18671,1236,cancer,I-Condition
18672,1236,and,O
18673,1236,cervical,B-Condition
18674,1236,carcinoma,I-Condition
18675,1236,in,I-Condition
18676,1236,situ,I-Condition
18677,1236,treated,B-Procedure
18678,1236,with,O
18679,1236,curative,O
18680,1236,intent,O
18681,1236,.,O
18682,1237,16,O
18683,1237,.,O
18684,1237,Neuropsychiatric,B-Condition
18685,1237,disorders,I-Condition
18686,1237,/,I-Condition
18687,1237,symptoms,I-Condition
18688,1237,or,O
18689,1237,psychological,B-Condition
18690,1237,conditions,I-Condition
18691,1237,.,O
18692,1238,17,O
18693,1238,.,O
18694,1238,Pregnancy,B-Condition
18695,1238,or,O
18696,1238,breast,B-Condition
18697,1238,-,I-Condition
18698,1238,feeding,I-Condition
18699,1239,18,O
18700,1239,.,O
18701,1239,Prior,O
18702,1239,treatment,O
18703,1239,with,O
18704,1239,B,B-Drug
18705,1239,cell,I-Drug
18706,1239,or,I-Drug
18707,1239,lymphocyte,I-Drug
18708,1239,-,I-Drug
18709,1239,depleting,I-Drug
18710,1239,agents,I-Drug
18711,1239,(,O
18712,1239,eg,O
18713,1239,",",O
18714,1239,rituximab,B-Drug
18715,1239,",",O
18716,1239,Campath,B-Drug
18717,1239,),O
18718,1240,Exclusions,O
18719,1240,Based,O
18720,1240,on,O
18721,1240,Concomitant,O
18722,1240,Medication,O
18723,1240,Use,O
18724,1241,19,O
18725,1241,.,O
18726,1241,Concurrent,O
18727,1241,regular,O
18728,1241,use,O
18729,1241,of,O
18730,1241,another,O
18731,1241,leukotriene,B-Drug
18732,1241,pathway,I-Drug
18733,1241,inhibitor,I-Drug
18734,1241,",",O
18735,1241,including,O
18736,1241,over,O
18737,1241,-,O
18738,1241,the,O
18739,1241,-,O
18740,1241,counter,O
18741,1241,medications,O
18742,1241,or,O
18743,1241,herbal,O
18744,1241,remedies,O
18745,1241,.,O
18746,1242,Exclusions,O
18747,1242,Based,O
18748,1242,on,O
18749,1242,Laboratory,O
18750,1242,Values,O
18751,1243,20,O
18752,1243,.,O
18753,1243,Significant,O
18754,1243,/,O
18755,1243,chronic,B-Condition
18756,1243,renal,I-Condition
18757,1243,insufficiency,I-Condition
18758,1243,.,O
18759,1244,21,O
18760,1244,.,O
18761,1244,Transaminases,O
18762,1244,(,O
18763,1244,alanine,O
18764,1244,transaminase,O
18765,1244,",",O
18766,1244,aspartate,O
18767,1244,transaminase,O
18768,1244,),O
18769,1244,levels,O
18770,1244,>,O
18771,1244,3,O
18772,1244,×,O
18773,1244,upper,O
18774,1244,limit,O
18775,1244,of,O
18776,1244,normal,O
18777,1244,(,O
18778,1244,ULN,O
18779,1244,),O
18780,1244,and/or,O
18781,1244,bilirubin,O
18782,1244,level,O
18783,1244,>,O
18784,1244,2,O
18785,1244,×,O
18786,1244,ULN,O
18787,1244,.,O
18788,1245,22,O
18789,1245,.,O
18790,1245,Absolute,O
18791,1245,neutrophil,O
18792,1245,count,O
18793,1245,<,O
18794,1245,1500,O
18795,1245,mm3,O
18796,1245,.,O
18797,1246,23,O
18798,1246,.,O
18799,1246,Hemoglobin,O
18800,1246,concentration,O
18801,1246,<,O
18802,1246,9,O
18803,1246,g,O
18804,1246,/,O
18805,1246,dL,O
18806,1246,at,O
18807,1246,Screening,O
18808,1246,.,O
18809,1247,24,O
18810,1247,.,O
18811,1247,Hepatic,B-Condition
18812,1247,dysfunction,I-Condition
18813,1247,as,O
18814,1247,defined,O
18815,1247,by,O
18816,1247,Child,O
18817,1247,-,O
18818,1247,Pugh,O
18819,1247,Class,O
18820,1247,B,O
18821,1247,or,O
18822,1247,C,O
18823,1248,1,O
18824,1248,.,O
18825,1248,Male,B-Person
18826,1248,or,O
18827,1248,female,B-Person
18828,1248,",",O
18829,1248,18,O
18830,1248,-,O
18831,1248,75,O
18832,1248,years,B-Person
18833,1248,old,I-Person
18834,1248,.,O
18835,1249,2,O
18836,1249,.,O
18837,1249,Has,O
18838,1249,a,O
18839,1249,diagnosis,O
18840,1249,of,O
18841,1249,WHO,O
18842,1249,Group,O
18843,1249,1,O
18844,1249,PAH,B-Condition
18845,1249,.,O
18846,1250,3,O
18847,1250,.,O
18848,1250,Right,B-Procedure
18849,1250,heart,I-Procedure
18850,1250,catheterization,I-Procedure
18851,1250,performed,O
18852,1250,at,O
18853,1250,Screening,O
18854,1250,with,O
18855,1250,results,O
18856,1250,that,O
18857,1250,are,O
18858,1250,:,O
18859,1251,1,O
18860,1251,.,O
18861,1251,Mean,O
18862,1251,pulmonary,O
18863,1251,arterial,O
18864,1251,pressure,O
18865,1251,≥25,O
18866,1251,mmHg,O
18867,1251,(,O
18868,1251,at,O
18869,1251,rest,O
18870,1251,),O
18871,1251,and,O
18872,1252,2,O
18873,1252,.,O
18874,1252,Pulmonary,B-Condition
18875,1252,venous,I-Condition
18876,1252,hypertension,I-Condition
18877,1252,(,O
18878,1252,measured,O
18879,1252,as,O
18880,1252,pulmonary,O
18881,1252,capillary,O
18882,1252,wedge,O
18883,1252,pressure,O
18884,1252,(,O
18885,1252,PCWP,O
18886,1252,),O
18887,1252,≤15,O
18888,1252,mmHg,O
18889,1252,.,O
18890,1252,If,O
18891,1252,PCWP,O
18892,1252,is,O
18893,1252,not,O
18894,1252,available,O
18895,1252,",",O
18896,1252,then,O
18897,1252,mean,B-Condition
18898,1252,left,I-Condition
18899,1252,atrial,I-Condition
18900,1252,pressure,I-Condition
18901,1252,or,O
18902,1252,left,B-Condition
18903,1252,ventricular,I-Condition
18904,1252,end,I-Condition
18905,1252,-,I-Condition
18906,1252,diastolic,I-Condition
18907,1252,pressure,I-Condition
18908,1252,≤15,O
18909,1252,mmHg,O
18910,1252,in,O
18911,1252,the,O
18912,1252,absence,O
18913,1252,of,O
18914,1252,left,B-Condition
18915,1252,atrial,I-Condition
18916,1252,obstruction,I-Condition
18917,1252,.,O
18918,1252,and,O
18919,1253,3,O
18920,1253,.,O
18921,1253,Pulmonary,B-Condition
18922,1253,vascular,I-Condition
18923,1253,resistance,I-Condition
18924,1253,(,I-Condition
18925,1253,PVR,I-Condition
18926,1253,),I-Condition
18927,1253,≥300,O
18928,1253,dyn•s,O
18929,1253,/,O
18930,1253,cm5,O
18931,1253,(,O
18932,1253,3.75,O
18933,1253,Wood,O
18934,1253,units,O
18935,1253,),O
18936,1254,4,O
18937,1254,.,O
18938,1254,Has,O
18939,1254,WHO,O
18940,1254,/,O
18941,1254,NYHA,O
18942,1254,-,O
18943,1254,FC,O
18944,1254,of,O
18945,1254,II,O
18946,1254,or,O
18947,1254,III,O
18948,1254,.,O
18949,1255,5,O
18950,1255,.,O
18951,1255,Be,O
18952,1255,on,O
18953,1255,stable,O
18954,1255,dose,O
18955,1255,of,O
18956,1255,at,O
18957,1255,least,O
18958,1255,one,O
18959,1255,of,O
18960,1255,the,O
18961,1255,following,O
18962,1255,PAH,B-Procedure
18963,1255,-,I-Procedure
18964,1255,specific,I-Procedure
18965,1255,therapies,I-Procedure
18966,1255,:,O
18967,1255,endothelin,B-Drug
18968,1255,receptor,I-Drug
18969,1255,antagonist,I-Drug
18970,1255,",",O
18971,1255,an,O
18972,1255,agent,B-Drug
18973,1255,acting,I-Drug
18974,1255,on,I-Drug
18975,1255,the,I-Drug
18976,1255,nitric,I-Drug
18977,1255,oxide,I-Drug
18978,1255,pathway,I-Drug
18979,1255,(,O
18980,1255,phosphodiesterase,B-Drug
18981,1255,type,I-Drug
18982,1255,5,I-Drug
18983,1255,inhibitor,I-Drug
18984,1255,or,O
18985,1255,soluble,B-Drug
18986,1255,guanylate,I-Drug
18987,1255,cyclase,I-Drug
18988,1255,stimulator,I-Drug
18989,1255,),O
18990,1255,",",O
18991,1255,and/or,O
18992,1255,a,O
18993,1255,prostacyclin,B-Drug
18994,1255,or,I-Drug
18995,1255,prostacyclin,I-Drug
18996,1255,analog,I-Drug
18997,1255,.,O
18998,1256,6,O
18999,1256,.,O
19000,1256,Has,O
19001,1256,a,O
19002,1256,6,O
19003,1256,-,O
19004,1256,minute,O
19005,1256,walk,O
19006,1256,distance,O
19007,1256,that,O
19008,1256,is,O
19009,1256,≥150,O
19010,1256,and,O
19011,1256,≤500,O
19012,1256,meters,O
19013,1256,.,O
19014,1257,7,O
19015,1257,.,O
19016,1257,Have,O
19017,1257,a,O
19018,1257,ventilation,B-Procedure
19019,1257,-,I-Procedure
19020,1257,perfusion,I-Procedure
19021,1257,scan,I-Procedure
19022,1257,that,O
19023,1257,rules,O
19024,1257,out,O
19025,1257,thromboembolic,B-Condition
19026,1257,disease,I-Condition
19027,1257,.,O
19028,1258,1,O
19029,1258,.,O
19030,1258,History,B-Observation
19031,1258,of,O
19032,1258,colorectal,B-Procedure
19033,1258,surgery,I-Procedure
19034,1259,2,O
19035,1259,.,O
19036,1259,Suspected,O
19037,1259,or,O
19038,1259,known,O
19039,1259,digestive,B-Condition
19040,1259,tract,I-Condition
19041,1259,obstruction,I-Condition
19042,1259,",",I-Condition
19043,1259,stricture,I-Condition
19044,1259,",",I-Condition
19045,1259,or,I-Condition
19046,1259,perforation,I-Condition
19047,1260,3,O
19048,1260,.,O
19049,1260,Serious,B-Condition
19050,1260,status,I-Condition
19051,1260,of,I-Condition
19052,1260,illness,I-Condition
19053,1260,",",O
19054,1260,such,O
19055,1260,as,O
19056,1260,severe,O
19057,1260,renal,B-Condition
19058,1260,failure,I-Condition
19059,1260,whose,O
19060,1260,creatinine,O
19061,1260,clearance<30,O
19062,1260,ml,O
19063,1260,/,O
19064,1260,min,O
19065,1260,",",O
19066,1260,New,O
19067,1260,York,O
19068,1260,Heart,O
19069,1260,Association,O
19070,1260,grade,O
19071,1260,III,O
19072,1260,or,O
19073,1260,grade,O
19074,1260,IV,O
19075,1260,congestive,B-Condition
19076,1260,heart,I-Condition
19077,1260,failure,I-Condition
19078,1260,",",O
19079,1260,or,O
19080,1260,hemodynamic,B-Condition
19081,1260,instability,I-Condition
19082,1260,",",O
19083,1260,etc,O
19084,1260,.,O
19085,1261,4,O
19086,1261,.,O
19087,1261,Incapable,B-Condition
19088,1261,of,I-Condition
19089,1261,completing,I-Condition
19090,1261,bowel,I-Condition
19091,1261,preparation，such,I-Condition
19092,1261,as,O
19093,1261,dysphagia,B-Condition
19094,1261,",",O
19095,1261,allergy,B-Condition
19096,1261,to,O
19097,1261,purgatives,B-Drug
19098,1261,",",O
19099,1261,or,O
19100,1261,impaired,B-Condition
19101,1261,mental,I-Condition
19102,1261,status,I-Condition
19103,1261,",",O
19104,1261,etc,O
19105,1261,.,O
19106,1262,5,O
19107,1262,.,O
19108,1262,Pregnancy,B-Condition
19109,1262,or,O
19110,1262,breastfeeding,B-Observation
19111,1263,6,O
19112,1263,.,O
19113,1263,Incomplete,O
19114,1263,colonoscopy,B-Procedure
19115,1263,due,O
19116,1263,to,O
19117,1263,causes,O
19118,1263,except,O
19119,1263,poor,B-Condition
19120,1263,bowel,I-Condition
19121,1263,preparation,I-Condition
19122,1264,7,O
19123,1264,.,O
19124,1264,Unable,O
19125,1264,to,O
19126,1264,give,O
19127,1264,informed,B-Observation
19128,1264,consent,I-Observation
19129,1265,8,O
19130,1265,.,O
19131,1265,Have,O
19132,1265,participated,O
19133,1265,in,O
19134,1265,the,O
19135,1265,study,O
19136,1265,before,O
19137,1265,.,O
19138,1266,1,O
19139,1266,.,O
19140,1266,Individuals,O
19141,1266,scheduled,O
19142,1266,for,O
19143,1266,undergoing,O
19144,1266,colonoscopy,B-Procedure
19145,1266,at,O
19146,1266,the,O
19147,1266,Endoscopy,O
19148,1266,Center,O
19149,1266,of,O
19150,1266,Wuxi,O
19151,1266,people,O
19152,1266,'s,O
19153,1266,Hospital,O
19154,1266,in,O
19155,1266,China,O
19156,1267,2,O
19157,1267,.,O
19158,1267,Greater,O
19159,1267,than,O
19160,1267,the,O
19161,1267,age,B-Person
19162,1267,of,O
19163,1267,18,O
19164,1268,3,O
19165,1268,.,O
19166,1268,Individuals,O
19167,1268,living,O
19168,1268,with,O
19169,1268,other,O
19170,1268,family,O
19171,1268,members,O
19172,1269,4,O
19173,1269,.,O
19174,1269,Outpatients,O
19175,1270,Form,O
19176,1270,of,O
19177,1270,diagnosed,O
19178,1270,psoriasis,B-Condition
19179,1270,other,O
19180,1270,than,O
19181,1270,chronic,B-Condition
19182,1270,plaque,I-Condition
19183,1270,psoriasis,I-Condition
19184,1270,(,O
19185,1270,i.e.,O
19186,1270,guttate,O
19187,1270,",",O
19188,1270,erythrodermic,O
19189,1270,",",O
19190,1270,pustular,O
19191,1270,),O
19192,1271,Diagnosis,O
19193,1271,of,O
19194,1271,other,O
19195,1271,active,O
19196,1271,",",O
19197,1271,ongoing,O
19198,1271,skin,B-Condition
19199,1271,diseases,I-Condition
19200,1271,or,O
19201,1271,skin,B-Condition
19202,1271,infections,I-Condition
19203,1271,that,O
19204,1271,may,O
19205,1271,interfere,O
19206,1271,with,O
19207,1271,examination,O
19208,1271,of,O
19209,1271,psoriasis,O
19210,1271,lesions,O
19211,1272,Ongoing,O
19212,1272,use,O
19213,1272,of,O
19214,1272,other,O
19215,1272,psoriasis,B-Condition
19216,1272,treatment,B-Procedure
19217,1272,including,O
19218,1272,but,O
19219,1272,not,O
19220,1272,limited,O
19221,1272,to,O
19222,1272,topical,B-Drug
19223,1272,or,I-Drug
19224,1272,systemic,I-Drug
19225,1272,corticosteroids,I-Drug
19226,1272,",",O
19227,1272,other,O
19228,1272,topical,B-Drug
19229,1272,medications,I-Drug
19230,1272,(,O
19231,1272,i.e.,O
19232,1272,coal,B-Drug
19233,1272,tar,I-Drug
19234,1272,),O
19235,1272,",",O
19236,1272,oral,B-Drug
19237,1272,or,I-Drug
19238,1272,biologic,I-Drug
19239,1272,medications,I-Drug
19240,1272,for,O
19241,1272,the,O
19242,1272,treatment,O
19243,1272,of,O
19244,1272,psoriasis,O
19245,1272,",",O
19246,1272,and,O
19247,1272,UV,B-Procedure
19248,1272,therapy,I-Procedure
19249,1272,.,O
19250,1272,The,O
19251,1272,following,O
19252,1272,washout,O
19253,1272,periods,O
19254,1272,will,O
19255,1272,be,O
19256,1272,required,O
19257,1272,:,O
19258,1272,2,O
19259,1272,weeks,O
19260,1272,for,O
19261,1272,topical,O
19262,1272,therapy,O
19263,1272,;,O
19264,1272,2,O
19265,1272,weeks,O
19266,1272,for,O
19267,1272,phototherapy,O
19268,1272,;,O
19269,1272,12,O
19270,1272,weeks,O
19271,1272,for,O
19272,1272,biologic,O
19273,1272,or,O
19274,1272,targeted,O
19275,1272,therapies,O
19276,1272,;,O
19277,1272,4,O
19278,1272,weeks,O
19279,1272,for,O
19280,1272,other,O
19281,1272,systemic,O
19282,1272,therapies,O
19283,1273,Use,O
19284,1273,of,O
19285,1273,oral,B-Procedure
19286,1273,estrogen,I-Procedure
19287,1273,therapy,I-Procedure
19288,1273,",",O
19289,1273,excluding,O
19290,1273,oral,B-Drug
19291,1273,contraceptive,I-Drug
19292,1273,pills,I-Drug
19293,1274,Women,O
19294,1274,who,O
19295,1274,are,O
19296,1274,pregnant,O
19297,1274,",",O
19298,1274,nursing,O
19299,1274,",",O
19300,1274,or,O
19301,1274,of,O
19302,1274,child,O
19303,1274,-,O
19304,1274,bearing,O
19305,1274,potential,O
19306,1274,who,O
19307,1274,are,O
19308,1274,unwilling,O
19309,1274,to,O
19310,1274,use,O
19311,1274,appropriate,O
19312,1274,method(s,O
19313,1274,),O
19314,1274,of,O
19315,1274,contraception,O
19316,1274,.,O
19317,1275,Patients,O
19318,1275,unwilling,B-Mood
19319,1275,to,O
19320,1275,limit,B-Procedure
19321,1275,exposure,I-Procedure
19322,1275,to,I-Procedure
19323,1275,UV,I-Procedure
19324,1275,light,I-Procedure
19325,1276,Current,O
19326,1276,significant,O
19327,1276,medical,O
19328,1276,problems,O
19329,1276,that,O
19330,1276,",",O
19331,1276,in,O
19332,1276,the,O
19333,1276,discretion,O
19334,1276,of,O
19335,1276,the,O
19336,1276,investigator,O
19337,1276,",",O
19338,1276,would,O
19339,1276,put,O
19340,1276,the,O
19341,1276,patient,O
19342,1276,at,O
19343,1276,significant,O
19344,1276,risk,O
19345,1277,Patients,O
19346,1277,with,O
19347,1277,disorders,B-Condition
19348,1277,of,I-Condition
19349,1277,calcium,I-Condition
19350,1277,metabolism,I-Condition
19351,1277,and/or,O
19352,1277,hypercalcemia,B-Condition
19353,1278,Use,O
19354,1278,of,O
19355,1278,any,O
19356,1278,investigational,O
19357,1278,drug,O
19358,1278,within,O
19359,1278,4,O
19360,1278,weeks,O
19361,1278,prior,O
19362,1278,to,O
19363,1278,randomization,O
19364,1278,",",O
19365,1278,or,O
19366,1278,5,O
19367,1278,pharmacokinetic,O
19368,1278,/,O
19369,1278,pharmacodynamics,O
19370,1278,half,O
19371,1278,-,O
19372,1278,lives,O
19373,1278,",",O
19374,1278,if,O
19375,1278,known,O
19376,1278,(,O
19377,1278,whichever,O
19378,1278,is,O
19379,1278,longer,O
19380,1278,),O
19381,1279,History,O
19382,1279,of,O
19383,1279,allergy,B-Condition
19384,1279,to,O
19385,1279,any,B-Drug
19386,1279,component,I-Drug
19387,1279,of,I-Drug
19388,1279,the,I-Drug
19389,1279,IP,I-Drug
19390,1280,Provide,O
19391,1280,written,O
19392,1280,",",O
19393,1280,signed,O
19394,1280,and,O
19395,1280,dated,O
19396,1280,informed,O
19397,1280,consent,O
19398,1280,prior,O
19399,1280,to,O
19400,1280,initiating,O
19401,1280,any,O
19402,1280,study,O
19403,1280,-,O
19404,1280,related,O
19405,1280,activities,O
19406,1280,.,O
19407,1281,Male,B-Person
19408,1281,or,O
19409,1281,female,B-Person
19410,1281,>,O
19411,1281,18,O
19412,1281,years,O
19413,1281,of,O
19414,1281,age,B-Person
19415,1281,at,O
19416,1281,the,O
19417,1281,time,O
19418,1281,of,O
19419,1281,screening,O
19420,1282,Fitzpatrick,O
19421,1282,Skin,O
19422,1282,phototype,O
19423,1282,IV,O
19424,1282,-,O
19425,1282,VI,O
19426,1282,",",O
19427,1282,non,B-Person
19428,1282,-,I-Person
19429,1282,white,I-Person
19430,1282,race,I-Person
19431,1282,/,I-Person
19432,1282,ethnicity,I-Person
19433,1282,",",O
19434,1282,including,O
19435,1282,but,O
19436,1282,not,O
19437,1282,limited,O
19438,1282,to,O
19439,1282,-,O
19440,1282,--African,O
19441,1282,Americans,I-Person
19442,1282,",",O
19443,1282,Asians,B-Person
19444,1282,",",O
19445,1282,Pacific,B-Person
19446,1282,Islanders,I-Person
19447,1282,and,O
19448,1282,Hispanics,B-Person
19449,1282,.,O
19450,1283,Clinical,O
19451,1283,diagnosis,O
19452,1283,of,O
19453,1283,chronic,O
19454,1283,plaque,O
19455,1283,-,O
19456,1283,type,O
19457,1283,psoriasis,B-Condition
19458,1283,of,I-Condition
19459,1283,the,I-Condition
19460,1283,body,I-Condition
19461,1284,Plaque,B-Condition
19462,1284,psoriasis,I-Condition
19463,1284,with,O
19464,1284,=,O
19465,1284,2,O
19466,1284,%,O
19467,1284,Body,O
19468,1284,Surface,O
19469,1284,Area,O
19470,1284,(,O
19471,1284,BSA,O
19472,1284,),O
19473,1284,involvement,O
19474,1284,(,O
19475,1284,may,O
19476,1284,include,O
19477,1284,scalp,O
19478,1284,involvement,O
19479,1284,),O
19480,1284,",",O
19481,1284,PASI,O
19482,1284,Score,O
19483,1284,=,O
19484,1284,2,O
19485,1284,",",O
19486,1284,IGA,O
19487,1284,mod,O
19488,1284,2011,O
19489,1284,score,O
19490,1284,of,O
19491,1284,2,O
19492,1284,or,O
19493,1284,greater,O
19494,1284,(,O
19495,1284,based,O
19496,1284,on,O
19497,1284,scale,O
19498,1284,of,O
19499,1284,0,O
19500,1284,-,O
19501,1284,4,O
19502,1284,),O
19503,1285,Females,O
19504,1285,of,O
19505,1285,childbearing,O
19506,1285,potential,O
19507,1285,(,O
19508,1285,FCBP,O
19509,1285,),O
19510,1285,must,O
19511,1285,have,O
19512,1285,a,O
19513,1285,negative,O
19514,1285,pregnancy,O
19515,1285,test,O
19516,1285,at,O
19517,1285,Screening,O
19518,1285,and,O
19519,1285,Baseline,O
19520,1285,.,O
19521,1285,While,O
19522,1285,using,O
19523,1285,investigational,O
19524,1285,product,O
19525,1285,and,O
19526,1285,for,O
19527,1285,at,O
19528,1285,least,O
19529,1285,28,O
19530,1285,days,O
19531,1285,after,O
19532,1285,last,O
19533,1285,application,O
19534,1285,of,O
19535,1285,investigational,O
19536,1285,product,O
19537,1285,",",O
19538,1285,FCBP,O
19539,1285,who,O
19540,1285,engage,O
19541,1285,in,O
19542,1285,activity,O
19543,1285,in,O
19544,1285,which,O
19545,1285,conception,O
19546,1285,is,O
19547,1285,possible,O
19548,1285,must,O
19549,1285,use,O
19550,1285,one,O
19551,1285,of,O
19552,1285,the,O
19553,1285,approved,O
19554,1285,contraceptive,O
19555,1285,options,O
19556,1285,d,O
19557,1286,Must,O
19558,1286,be,O
19559,1286,in,O
19560,1286,general,O
19561,1286,good,O
19562,1286,health,O
19563,1286,as,O
19564,1286,judged,O
19565,1286,by,O
19566,1286,the,O
19567,1286,Investigator,O
19568,1286,",",O
19569,1286,based,O
19570,1286,on,O
19571,1286,medical,O
19572,1286,history,O
19573,1286,and,O
19574,1286,physical,O
19575,1286,examination,O
19576,1286,.,O
19577,1287,Subjects,O
19578,1287,with,O
19579,1287,known,O
19580,1287,intolerance,B-Condition
19581,1287,to,O
19582,1287,blood,B-Procedure
19583,1287,products,I-Procedure
19584,1287,or,O
19585,1287,to,O
19586,1287,one,O
19587,1287,of,O
19588,1287,the,O
19589,1287,components,O
19590,1287,of,O
19591,1287,the,O
19592,1287,study,O
19593,1287,product,O
19594,1287,or,O
19595,1287,is,O
19596,1287,unwilling,O
19597,1287,to,O
19598,1287,receive,O
19599,1287,blood,O
19600,1287,products,O
19601,1287,;,O
19602,1288,Female,O
19603,1288,subjects,O
19604,1288,",",O
19605,1288,who,O
19606,1288,are,O
19607,1288,of,O
19608,1288,childbearing,O
19609,1288,age,O
19610,1288,(,O
19611,1288,i.e.,O
19612,1288,adolescent,O
19613,1288,),O
19614,1288,",",O
19615,1288,who,O
19616,1288,are,O
19617,1288,pregnant,O
19618,1288,or,O
19619,1288,nursing,O
19620,1288,;,O
19621,1289,Subject,O
19622,1289,is,O
19623,1289,currently,O
19624,1289,participating,O
19625,1289,or,O
19626,1289,plans,O
19627,1289,to,O
19628,1289,participate,O
19629,1289,in,O
19630,1289,any,O
19631,1289,other,O
19632,1289,investigational,O
19633,1289,device,O
19634,1289,or,O
19635,1289,drug,O
19636,1289,without,O
19637,1289,prior,O
19638,1289,approval,O
19639,1289,from,O
19640,1289,the,O
19641,1289,Sponsor,O
19642,1289,;,O
19643,1290,Subjects,O
19644,1290,who,O
19645,1290,are,O
19646,1290,known,O
19647,1290,",",O
19648,1290,current,O
19649,1290,alcohol,B-Person
19650,1290,and/or,I-Person
19651,1290,drug,I-Person
19652,1290,abusers,I-Person
19653,1291,Subjects,O
19654,1291,admitted,O
19655,1291,for,O
19656,1291,trauma,B-Procedure
19657,1291,surgery,I-Procedure
19658,1292,Subjects,O
19659,1292,with,O
19660,1292,any,O
19661,1292,pre,O
19662,1292,or,O
19663,1292,intra,O
19664,1292,-,O
19665,1292,operative,O
19666,1292,findings,O
19667,1292,identified,O
19668,1292,by,O
19669,1292,the,O
19670,1292,surgeon,O
19671,1292,that,O
19672,1292,may,O
19673,1292,preclude,O
19674,1292,conduct,O
19675,1292,of,O
19676,1292,the,O
19677,1292,study,O
19678,1292,procedure,O
19679,1292,.,O
19680,1293,Subject,O
19681,1293,with,O
19682,1293,TBS,B-Condition
19683,1293,in,O
19684,1293,an,O
19685,1293,actively,O
19686,1293,infected,O
19687,1293,field,O
19688,1293,(,O
19689,1293,Class,O
19690,1293,III,O
19691,1293,Contaminated,O
19692,1293,or,O
19693,1293,Class,O
19694,1293,IV,O
19695,1293,Dirty,O
19696,1293,or,O
19697,1293,Infected,O
19698,1293,),O
19699,1294,TBS,O
19700,1294,is,O
19701,1294,from,O
19702,1294,large,O
19703,1294,defects,O
19704,1294,in,O
19705,1294,arteries,O
19706,1294,or,O
19707,1294,veins,O
19708,1294,where,O
19709,1294,the,O
19710,1294,injured,O
19711,1294,vascular,O
19712,1294,wall,O
19713,1294,requires,O
19714,1294,repair,O
19715,1294,with,O
19716,1294,maintenance,O
19717,1294,of,O
19718,1294,vessel,O
19719,1294,patency,O
19720,1294,and,O
19721,1294,which,O
19722,1294,would,O
19723,1294,result,O
19724,1294,in,O
19725,1294,persistent,O
19726,1294,exposure,O
19727,1294,of,O
19728,1294,the,O
19729,1294,EVARREST,O
19730,1294,™,O
19731,1294,or,O
19732,1294,SURGICEL,O
19733,1294,®,O
19734,1294,to,O
19735,1294,blood,O
19736,1294,flow,O
19737,1294,and,O
19738,1294,pressure,O
19739,1294,during,O
19740,1294,healing,O
19741,1294,and,O
19742,1294,absorption,O
19743,1294,of,O
19744,1294,the,O
19745,1294,product,O
19746,1294,;,O
19747,1295,TBS,B-Condition
19748,1295,with,O
19749,1295,major,B-Condition
19750,1295,arterial,I-Condition
19751,1295,bleeding,I-Condition
19752,1295,requiring,O
19753,1295,suture,B-Procedure
19754,1295,or,O
19755,1295,mechanical,B-Procedure
19756,1295,ligation,I-Procedure
19757,1295,;,O
19758,1296,Bleeding,O
19759,1296,site,O
19760,1296,is,O
19761,1296,in,O
19762,1296,",",O
19763,1296,around,O
19764,1296,",",O
19765,1296,or,O
19766,1296,in,O
19767,1296,proximity,O
19768,1296,to,O
19769,1296,foramina,O
19770,1296,in,O
19771,1296,bone,O
19772,1296,",",O
19773,1296,or,O
19774,1296,areas,O
19775,1296,of,O
19776,1296,bony,O
19777,1296,confine,O
19778,1296,.,O
19779,1297,Paediatric,O
19780,1297,subjects,O
19781,1297,aged,B-Person
19782,1297,=,O
19783,1297,28,O
19784,1297,days,O
19785,1297,(=,O
19786,1297,1,O
19787,1297,month,O
19788,1297,),O
19789,1297,to,O
19790,1297,<,O
19791,1297,18,O
19792,1297,years,O
19793,1297,",",O
19794,1297,requiring,O
19795,1297,non,O
19796,1297,-,O
19797,1297,emergent,O
19798,1297,open,O
19799,1297,hepatic,O
19800,1297,",",O
19801,1297,abdominal,O
19802,1297,",",O
19803,1297,retroperitoneal,O
19804,1297,",",O
19805,1297,pelvic,O
19806,1297,or,O
19807,1297,thoracic,O
19808,1297,(,O
19809,1297,non,O
19810,1297,-,O
19811,1297,cardiac,O
19812,1297,),O
19813,1297,surgical,B-Procedure
19814,1297,procedures,I-Procedure
19815,1297,.,O
19816,1297,i,O
19817,1297,),O
19818,1297,The,O
19819,1297,first,O
19820,1297,36,O
19821,1297,subjects,O
19822,1297,to,O
19823,1297,be,O
19824,1297,enrolled,O
19825,1297,will,O
19826,1297,be,O
19827,1297,subjects,O
19828,1297,aged,O
19829,1297,=,O
19830,1297,1,O
19831,1297,years,O
19832,1297,to,O
19833,1297,<,O
19834,1297,18,O
19835,1297,years,O
19836,1297,.,O
19837,1297,ii,O
19838,1297,),O
19839,1297,The,O
19840,1297,next,O
19841,1297,4,O
19842,1297,subjects,O
19843,1297,to,O
19844,1297,be,O
19845,1297,enrolled,O
19846,1297,will,O
19847,1297,be,O
19848,1297,subjects,O
19849,1297,aged,O
19850,1297,=,O
19851,1297,28,O
19852,1297,days,O
19853,1297,to,O
19854,1297,<,O
19855,1297,1,O
19856,1297,year,O
19857,1297,.,O
19858,1298,The,O
19859,1298,subject,O
19860,1298,'s,O
19861,1298,parent,O
19862,1298,/,O
19863,1298,legal,O
19864,1298,guardian,O
19865,1298,must,O
19866,1298,be,O
19867,1298,willing,O
19868,1298,to,O
19869,1298,give,O
19870,1298,permission,O
19871,1298,for,O
19872,1298,the,O
19873,1298,subject,O
19874,1298,to,O
19875,1298,participate,O
19876,1298,in,O
19877,1298,the,O
19878,1298,trial,O
19879,1298,",",O
19880,1298,and,O
19881,1298,provide,O
19882,1298,written,O
19883,1298,informed,O
19884,1298,consent,O
19885,1298,for,O
19886,1298,the,O
19887,1298,subject,O
19888,1298,.,O
19889,1298,In,O
19890,1298,addition,O
19891,1298,",",O
19892,1298,assent,O
19893,1298,must,O
19894,1298,be,O
19895,1298,obtained,O
19896,1298,from,O
19897,1298,paediatric,O
19898,1298,subjects,O
19899,1298,who,O
19900,1298,possess,O
19901,1298,the,O
19902,1298,intellectual,O
19903,1298,and,O
19904,1298,emotional,O
19905,1298,ability,O
19906,1298,to,O
19907,1298,comprehend,O
19908,1298,the,O
19909,1298,concepts,O
19910,1298,involved,O
19911,1298,in,O
19912,1298,the,O
19913,1298,trial,O
19914,1298,.,O
19915,1298,If,O
19916,1298,the,O
19917,1298,paediatric,O
19918,1298,subject,O
19919,1298,is,O
19920,1298,not,O
19921,1298,able,O
19922,1298,to,O
19923,1298,provide,O
19924,1298,assent,O
19925,1298,(,O
19926,1298,due,O
19927,1298,to,O
19928,1298,age,O
19929,1298,",",O
19930,1298,maturity,O
19931,1298,and/or,O
19932,1298,inability,O
19933,1298,to,O
19934,1298,intellectually,O
19935,1298,and/or,O
19936,1298,emotionally,O
19937,1298,comprehend,O
19938,1298,the,O
19939,1298,trial,O
19940,1298,),O
19941,1298,",",O
19942,1298,the,O
19943,1298,parent,O
19944,1298,/,O
19945,1298,legal,O
19946,1298,guardian,O
19947,1298,'s,O
19948,1298,written,O
19949,1298,Informed,O
19950,1298,Consent,O
19951,1298,for,O
19952,1298,the,O
19953,1298,subject,O
19954,1298,will,O
19955,1298,be,O
19956,1298,acceptable,O
19957,1298,for,O
19958,1298,the,O
19959,1298,subject,O
19960,1298,to,O
19961,1298,be,O
19962,1298,included,O
19963,1298,in,O
19964,1298,the,O
19965,1298,study,O
19966,1298,.,O
19967,1299,Presence,O
19968,1299,of,O
19969,1299,an,O
19970,1299,appropriate,O
19971,1299,mild,O
19972,1299,or,O
19973,1299,moderate,O
19974,1299,bleeding,O
19975,1299,soft,O
19976,1299,tissue,O
19977,1299,or,O
19978,1299,hepatic,O
19979,1299,parenchyma,O
19980,1299,Target,O
19981,1299,Bleeding,O
19982,1299,Site,O
19983,1299,(,O
19984,1299,TBS,O
19985,1299,),O
19986,1299,identified,O
19987,1299,intra,O
19988,1299,-,O
19989,1299,operatively,O
19990,1299,by,O
19991,1299,the,O
19992,1299,surgeon,O
19993,1299,;,O
19994,1300,Ability,O
19995,1300,to,O
19996,1300,firmly,O
19997,1300,press,O
19998,1300,trial,O
19999,1300,treatment,O
20000,1300,at,O
20001,1300,TBS,O
20002,1300,until,O
20003,1300,4,O
20004,1300,minutes,O
20005,1300,after,O
20006,1300,randomisation,O
20007,1301,Previous,O
20008,1301,anaphylaxis,B-Condition
20009,1301,following,O
20010,1301,any,O
20011,1301,component,O
20012,1301,of,O
20013,1301,Bexsero,B-Drug
20014,1301,vaccine,I-Drug
20015,1302,Previous,O
20016,1302,receipt,O
20017,1302,of,O
20018,1302,meningococcal,B-Drug
20019,1302,B,I-Drug
20020,1302,vaccine,I-Drug
20021,1302,(,O
20022,1302,Bexsero,B-Drug
20023,1302,),O
20024,1303,Known,O
20025,1303,pregnancy,B-Condition
20026,1304,South,O
20027,1304,Australian,O
20028,1304,secondary,B-Observation
20029,1304,school,I-Observation
20030,1304,students,I-Observation
20031,1304,in,O
20032,1304,years,O
20033,1304,10,O
20034,1304,",",O
20035,1304,11,O
20036,1304,",",O
20037,1304,and,O
20038,1304,12,O
20039,1304,in,O
20040,1304,2017,O
20041,1305,Written,O
20042,1305,parental,O
20043,1305,consent,O
20044,1305,for,O
20045,1305,those,O
20046,1305,under,O
20047,1305,the,O
20048,1305,age,O
20049,1305,of,O
20050,1305,18,O
20051,1306,Written,O
20052,1306,student,O
20053,1306,consent,O
20054,1306,assent,O
20055,1306,for,O
20056,1306,those,O
20057,1306,under,O
20058,1306,the,O
20059,1306,age,O
20060,1306,of,O
20061,1306,18,O
20062,1306,(,O
20063,1306,or,O
20064,1306,if,O
20065,1306,18,O
20066,1306,years,O
20067,1306,old,O
20068,1306,and,O
20069,1306,older,O
20070,1306,consent,O
20071,1306,for,O
20072,1306,themselves,O
20073,1306,),O
20074,1307,Available,O
20075,1307,at,O
20076,1307,school,O
20077,1307,for,O
20078,1307,at,O
20079,1307,least,O
20080,1307,the,O
20081,1307,first,O
20082,1307,pharyngeal,B-Procedure
20083,1307,swab,I-Procedure
20084,1307,and,O
20085,1307,willing,B-Mood
20086,1307,to,I-Mood
20087,1307,comply,B-Observation
20088,1307,with,I-Observation
20089,1307,study,I-Observation
20090,1307,procedures,I-Observation
20091,1308,Patients,O
20092,1308,who,O
20093,1308,may,B-Condition
20094,1308,receive,I-Condition
20095,1308,therapeutically,I-Condition
20096,1308,effective,I-Condition
20097,1308,doses,I-Condition
20098,1308,via,I-Condition
20099,1308,an,I-Condition
20100,1308,external,I-Condition
20101,1308,beam,I-Condition
20102,1308,approach,I-Condition
20103,1308,to,I-Condition
20104,1308,the,I-Condition
20105,1308,lesion,I-Condition
20106,1308,of,I-Condition
20107,1308,interest,I-Condition
20108,1308,as,O
20109,1308,specified,O
20110,1308,by,O
20111,1308,MSKCC,O
20112,1308,Radiation,O
20113,1308,Oncology,O
20114,1308,Department,O
20115,1308,dose,O
20116,1308,constraint,O
20117,1308,criteria,O
20118,1308,.,O
20119,1309,Patients,O
20120,1309,with,O
20121,1309,kyphoplasty,O
20122,1309,cement,O
20123,1309,or,O
20124,1309,hardware,O
20125,1309,that,O
20126,1309,would,O
20127,1309,preclude,O
20128,1309,effective,O
20129,1309,catheter,O
20130,1309,placement,O
20131,1309,.,O
20132,1310,Patients,O
20133,1310,with,O
20134,1310,paraspinal,B-Condition
20135,1310,extension,I-Condition
20136,1310,of,I-Condition
20137,1310,disease,I-Condition
20138,1310,with,O
20139,1310,visceral,B-Condition
20140,1310,involvement,I-Condition
20141,1310,.,O
20142,1311,Abnormal,B-Condition
20143,1311,complete,I-Condition
20144,1311,blood,I-Condition
20145,1311,count,I-Condition
20146,1311,.,O
20147,1311,Any,O
20148,1311,of,O
20149,1311,the,O
20150,1311,following,O
20151,1311,:,O
20152,1312,Platelet,O
20153,1312,count,O
20154,1312,<,O
20155,1312,"75,000",O
20156,1312,/,O
20157,1312,ml,O
20158,1313,Hb,O
20159,1313,level,O
20160,1313,<,O
20161,1313,9gm,O
20162,1313,/,O
20163,1313,dl,O
20164,1314,WBC,O
20165,1314,<,O
20166,1314,3.5,O
20167,1314,/,O
20168,1314,ml,O
20169,1315,Abnormal,B-Condition
20170,1315,coagulation,I-Condition
20171,1315,profile,I-Condition
20172,1315,:,O
20173,1315,INR,O
20174,1315,>,O
20175,1315,2.5,O
20176,1315,and/or,O
20177,1315,PTT,O
20178,1315,>,O
20179,1315,80,O
20180,1316,Patients,O
20181,1316,who,O
20182,1316,are,O
20183,1316,on,O
20184,1316,anticoagulation,B-Drug
20185,1316,medication,I-Drug
20186,1316,that,O
20187,1316,may,O
20188,1316,not,O
20189,1316,be,O
20190,1316,safely,O
20191,1316,held,O
20192,1316,for,O
20193,1316,the,O
20194,1316,procedure,O
20195,1316,(,O
20196,1316,≥,O
20197,1316,5,O
20198,1316,days,O
20199,1316,for,O
20200,1316,antiplatelet,B-Drug
20201,1316,agents,I-Drug
20202,1316,and,O
20203,1316,warfarin,B-Drug
20204,1316,;,O
20205,1316,≥,O
20206,1316,24,O
20207,1316,hours,O
20208,1316,for,O
20209,1316,low,B-Drug
20210,1316,-,I-Drug
20211,1316,molecular,I-Drug
20212,1316,weight,I-Drug
20213,1316,heparin,I-Drug
20214,1316,formulations,O
20215,1316,),O
20216,1316,will,O
20217,1316,be,O
20218,1316,excluded,O
20219,1316,.,O
20220,1317,Contraindications,B-Condition
20221,1317,to,I-Condition
20222,1317,general,I-Condition
20223,1317,anesthesia,I-Condition
20224,1318,Patients,O
20225,1318,must,O
20226,1318,have,O
20227,1318,histologic,B-Procedure
20228,1318,proof,O
20229,1318,of,O
20230,1318,a,O
20231,1318,malignancy,B-Condition
20232,1318,suitable,O
20233,1318,for,O
20234,1318,radiation,B-Procedure
20235,1318,therapy,I-Procedure
20236,1318,.,O
20237,1319,Patients,O
20238,1319,must,O
20239,1319,have,O
20240,1319,received,O
20241,1319,prior,O
20242,1319,external,B-Procedure
20243,1319,beam,I-Procedure
20244,1319,radiation,I-Procedure
20245,1319,therapy,I-Procedure
20246,1319,to,O
20247,1319,the,O
20248,1319,region,O
20249,1319,proposed,O
20250,1319,for,O
20251,1319,HDR,B-Procedure
20252,1319,brachytherapy,I-Procedure
20253,1319,treatment,O
20254,1319,;,O
20255,1319,evaluation,O
20256,1319,of,O
20257,1319,doses,O
20258,1319,previously,O
20259,1319,delivered,O
20260,1319,to,O
20261,1319,spinal,O
20262,1319,cord,O
20263,1319,/,O
20264,1319,cauda,O
20265,1319,equine,O
20266,1319,",",O
20267,1319,pelvis,O
20268,1319,",",O
20269,1319,and,O
20270,1319,other,O
20271,1319,critical,O
20272,1319,structures,O
20273,1319,(,O
20274,1319,bowel,O
20275,1319,",",O
20276,1319,kidneys,O
20277,1319,",",O
20278,1319,rectum,O
20279,1319,),O
20280,1319,will,O
20281,1319,be,O
20282,1319,taken,O
20283,1319,into,O
20284,1319,consideration,O
20285,1319,.,O
20286,1320,If,O
20287,1320,repeat,B-Procedure
20288,1320,irradiation,I-Procedure
20289,1320,would,O
20290,1320,exceed,O
20291,1320,any,O
20292,1320,normal,O
20293,1320,tissue,O
20294,1320,constraint,O
20295,1320,set,O
20296,1320,by,O
20297,1320,MSKCC,O
20298,1320,Radiation,O
20299,1320,Oncology,O
20300,1320,Department,O
20301,1320,dose,O
20302,1320,constraint,O
20303,1320,criteria,O
20304,1320,",",O
20305,1320,the,O
20306,1320,patient,O
20307,1320,will,O
20308,1320,potentially,O
20309,1320,be,O
20310,1320,eligible,O
20311,1320,.,O
20312,1321,If,O
20313,1321,the,O
20314,1321,total,O
20315,1321,prior,O
20316,1321,radiation,O
20317,1321,dose,O
20318,1321,to,O
20319,1321,the,O
20320,1321,cord,O
20321,1321,or,O
20322,1321,pelvis,O
20323,1321,exceeds,O
20324,1321,100,O
20325,1321,Gy,O
20326,1321,BED,O
20327,1321,equivalent,O
20328,1321,",",O
20329,1321,the,O
20330,1321,patient,O
20331,1321,will,O
20332,1321,be,O
20333,1321,potentially,O
20334,1321,eligible,O
20335,1321,",",O
20336,1321,where,O
20337,1321,a,O
20338,1321,total,O
20339,1321,of,O
20340,1321,100,O
20341,1321,BED,O
20342,1321,Gy,O
20343,1321,equivalent,O
20344,1321,is,O
20345,1321,determined,O
20346,1321,by,O
20347,1321,the,O
20348,1321,biological,O
20349,1321,equivalent,O
20350,1321,dose,O
20351,1321,(,O
20352,1321,BED,O
20353,1321,),O
20354,1321,calculation,O
20355,1321,;,O
20356,1321,BED,O
20357,1321,=,O
20358,1321,nd(1,O
20359,1321,+,O
20360,1321,d,O
20361,1321,/,O
20362,1321,α,O
20363,1321,/,O
20364,1321,β,O
20365,1321,),O
20366,1321,",",O
20367,1321,where,O
20368,1321,n,O
20369,1321,=,O
20370,1321,number,O
20371,1321,of,O
20372,1321,fractions,O
20373,1321,and,O
20374,1321,d,O
20375,1321,=,O
20376,1321,dose,O
20377,1321,per,O
20378,1321,fraction,O
20379,1321,;,O
20380,1321,α,O
20381,1321,/,O
20382,1321,β,O
20383,1321,is,O
20384,1321,the,O
20385,1321,constant,O
20386,1321,for,O
20387,1321,spinal,O
20388,1321,cord,O
20389,1321,late,O
20390,1321,effect,O
20391,1321,and,O
20392,1321,equals,O
20393,1321,2,O
20394,1321,.,O
20395,1321,[,O
20396,1321,Rades,O
20397,1321,2005,O
20398,1321,",",O
20399,1321,Nieder,O
20400,1321,2005,O
20401,1321,",",O
20402,1321,Sahgal,O
20403,1321,2012,O
20404,1321,],O
20405,1322,KPS,O
20406,1322,≥,O
20407,1322,60,O
20408,1323,Age,B-Person
20409,1323,≥,O
20410,1323,18,O
20411,1323,years,O
20412,1323,old,O
20413,1324,Patients,O
20414,1324,with,O
20415,1324,a,O
20416,1324,personal,B-Observation
20417,1324,or,I-Observation
20418,1324,family,I-Observation
20419,1324,history,I-Observation
20420,1324,of,O
20421,1324,medullary,B-Condition
20422,1324,thyroid,I-Condition
20423,1324,carcinoma,I-Condition
20424,1324,or,O
20425,1324,patients,O
20426,1324,with,O
20427,1324,Multiple,B-Condition
20428,1324,Endocrine,I-Condition
20429,1324,Neoplasia,I-Condition
20430,1324,syndrome,I-Condition
20431,1324,type,I-Condition
20432,1324,2,I-Condition
20433,1325,Patients,O
20434,1325,with,O
20435,1325,a,O
20436,1325,prior,O
20437,1325,serious,O
20438,1325,hypersensitivity,B-Condition
20439,1325,reaction,I-Condition
20440,1325,to,O
20441,1325,liraglutide,B-Drug
20442,1326,Other,O
20443,1326,contra,B-Condition
20444,1326,-,I-Condition
20445,1326,indications,I-Condition
20446,1326,to,O
20447,1326,liraglutide,B-Drug
20448,1326,in,O
20449,1326,accordance,O
20450,1326,with,O
20451,1326,risks,O
20452,1326,and,O
20453,1326,safety,O
20454,1326,information,O
20455,1326,included,O
20456,1326,in,O
20457,1326,the,O
20458,1326,latest,O
20459,1326,updated,O
20460,1326,prescribing,O
20461,1326,information,O
20462,1327,Type,B-Condition
20463,1327,1,I-Condition
20464,1327,diabetes,I-Condition
20465,1327,",",O
20466,1327,as,O
20467,1327,defined,O
20468,1327,by,O
20469,1327,ADA,O
20470,1327,criteria,O
20471,1328,Current,O
20472,1328,use,O
20473,1328,of,O
20474,1328,other,O
20475,1328,GLP-1A,B-Drug
20476,1328,",",O
20477,1328,dipeptidyl,B-Drug
20478,1328,peptidase,I-Drug
20479,1328,4,I-Drug
20480,1328,(,I-Drug
20481,1328,DPP4,I-Drug
20482,1328,),I-Drug
20483,1328,or,I-Drug
20484,1328,Sodium,I-Drug
20485,1328,Glucose,I-Drug
20486,1328,transporters,I-Drug
20487,1328,2,I-Drug
20488,1328,(,I-Drug
20489,1328,SGLT2,I-Drug
20490,1328,),I-Drug
20491,1328,inhibitors,I-Drug
20492,1328,",",O
20493,1328,thiazolidinediones,B-Drug
20494,1328,(,I-Drug
20495,1328,TZDs,I-Drug
20496,1328,),I-Drug
20497,1328,",",O
20498,1328,pramlintide,B-Drug
20499,1328,and,O
20500,1328,fixed,O
20501,1328,prandial,B-Drug
20502,1328,insulin,I-Drug
20503,1328,.,O
20504,1329,Patients,O
20505,1329,with,O
20506,1329,unstable,B-Condition
20507,1329,CAD,I-Condition
20508,1329,",",O
20509,1329,assessed,O
20510,1329,by,O
20511,1329,the,O
20512,1329,Cardiology,O
20513,1329,team,O
20514,1329,and,O
20515,1329,defined,O
20516,1329,as,O
20517,1329,new,B-Condition
20518,1329,onset,I-Condition
20519,1329,angina,I-Condition
20520,1329,",",O
20521,1329,rest,B-Condition
20522,1329,angina,I-Condition
20523,1329,",",O
20524,1329,rapidly,B-Condition
20525,1329,increasing,I-Condition
20526,1329,or,I-Condition
20527,1329,crescendo,I-Condition
20528,1329,angina,I-Condition
20529,1330,History,B-Observation
20530,1330,of,O
20531,1330,diabetic,B-Condition
20532,1330,ketoacidosis,I-Condition
20533,1330,",",O
20534,1330,pancreas,B-Procedure
20535,1330,or,I-Procedure
20536,1330,beta,I-Procedure
20537,1330,-,I-Procedure
20538,1330,cell,I-Procedure
20539,1330,transplantation,I-Procedure
20540,1330,",",O
20541,1330,or,O
20542,1330,diabetes,B-Condition
20543,1330,secondary,O
20544,1330,to,O
20545,1330,pancreatitis,B-Procedure
20546,1330,or,O
20547,1330,pancreatectomy,B-Procedure
20548,1330,;,O
20549,1330,acute,O
20550,1330,or,O
20551,1330,chronic,O
20552,1330,infective,B-Condition
20553,1330,diseases,I-Condition
20554,1330,",",O
20555,1330,cancer,B-Condition
20556,1330,or,O
20557,1330,chemotherapy,B-Procedure
20558,1330,",",O
20559,1330,history,O
20560,1330,of,O
20561,1330,pulmonary,B-Condition
20562,1330,",",I-Condition
20563,1330,renal,I-Condition
20564,1330,or,I-Condition
20565,1330,liver,I-Condition
20566,1330,diseases,I-Condition
20567,1330,",",O
20568,1330,and,O
20569,1330,drug,B-Condition
20570,1330,abuse,I-Condition
20571,1331,Patients,O
20572,1331,with,O
20573,1331,chronic,O
20574,1331,and,O
20575,1331,acute,O
20576,1331,inflammatory,B-Condition
20577,1331,conditions,I-Condition
20578,1331,such,O
20579,1331,as,O
20580,1331,sepsis,B-Condition
20581,1331,",",O
20582,1331,rheumatoid,B-Condition
20583,1331,arthritis,I-Condition
20584,1331,",",O
20585,1331,ectopic,B-Condition
20586,1331,dermatitis,I-Condition
20587,1331,",",O
20588,1331,asthma,B-Condition
20589,1331,",",O
20590,1331,ulcerative,B-Condition
20591,1331,colitis,I-Condition
20592,1331,.,O
20593,1332,Current,O
20594,1332,use,O
20595,1332,of,O
20596,1332,systemic,B-Drug
20597,1332,corticosteroids,I-Drug
20598,1332,in,O
20599,1332,the,O
20600,1332,3,O
20601,1332,months,O
20602,1332,prior,O
20603,1332,this,O
20604,1332,study,O
20605,1332,.,O
20606,1333,Pregnant,B-Condition
20607,1333,or,O
20608,1333,breast,B-Condition
20609,1333,-,I-Condition
20610,1333,feeding,I-Condition
20611,1333,women,I-Condition
20612,1334,Females,O
20613,1334,of,O
20614,1334,childbearing,O
20615,1334,potential,O
20616,1334,who,O
20617,1334,are,O
20618,1334,not,O
20619,1334,using,O
20620,1334,adequate,O
20621,1334,contraceptive,O
20622,1334,methods,O
20623,1334,(,O
20624,1334,as,O
20625,1334,required,O
20626,1334,by,O
20627,1334,local,O
20628,1334,law,O
20629,1334,or,O
20630,1334,practice,O
20631,1334,),O
20632,1335,T2DM,B-Condition
20633,1335,as,O
20634,1335,defined,O
20635,1335,by,O
20636,1335,American,O
20637,1335,Diabetes,O
20638,1335,Association,O
20639,1335,(,O
20640,1335,ADA,O
20641,1335,),O
20642,1335,criteria,O
20643,1336,Adult,B-Person
20644,1336,patients,O
20645,1336,with,O
20646,1336,T2DM,B-Condition
20647,1336,who,O
20648,1336,are,O
20649,1336,indicated,B-Mood
20650,1336,to,I-Mood
20651,1336,receive,I-Mood
20652,1336,liraglutide,B-Drug
20653,1336,",",O
20654,1336,not,O
20655,1336,as,O
20656,1336,first,O
20657,1336,-,O
20658,1336,line,O
20659,1336,therapy,O
20660,1336,",",O
20661,1336,in,O
20662,1336,addition,O
20663,1336,to,O
20664,1336,diet,O
20665,1336,and,O
20666,1336,exercise,O
20667,1336,to,O
20668,1336,improve,O
20669,1336,glycemic,O
20670,1336,control,O
20671,1337,Hemoglobin,O
20672,1337,A1c,O
20673,1337,(,O
20674,1337,HbA1c,O
20675,1337,),O
20676,1337,=,O
20677,1337,9,O
20678,1337,%,O
20679,1338,Age,B-Person
20680,1338,=,O
20681,1338,18,O
20682,1338,years,O
20683,1338,old,O
20684,1339,Body,O
20685,1339,mass,O
20686,1339,index,O
20687,1339,(,O
20688,1339,BMI,O
20689,1339,),O
20690,1339,=,O
20691,1339,27,O
20692,1339,Kg,O
20693,1339,/,O
20694,1339,m2,O
20695,1339,and/or,O
20696,1339,waist,O
20697,1339,circumference,O
20698,1339,=,O
20699,1339,102,O
20700,1339,cm,O
20701,1339,(,O
20702,1339,40,O
20703,1339,inches,O
20704,1339,),O
20705,1339,in,O
20706,1339,men,B-Person
20707,1339,and,O
20708,1339,88,O
20709,1339,cm,O
20710,1339,(,O
20711,1339,35,O
20712,1339,inches,O
20713,1339,),O
20714,1339,in,O
20715,1339,women,B-Person
20716,1339,",",O
20717,1339,respectively,O
20718,1339,.,O
20719,1340,Clinically,O
20720,1340,and,O
20721,1340,angiographically,O
20722,1340,stable,O
20723,1340,CAD,B-Condition
20724,1340,who,O
20725,1340,requires,B-Mood
20726,1340,CABG,B-Procedure
20727,1340,as,O
20728,1340,part,O
20729,1340,of,O
20730,1340,the,O
20731,1340,standard,O
20732,1340,medical,O
20733,1340,care,O
20734,1340,",",O
20735,1340,as,O
20736,1340,CAD,O
20737,1340,does,O
20738,1340,not,O
20739,1340,represent,O
20740,1340,a,O
20741,1340,contraindication,O
20742,1340,for,O
20743,1340,using,O
20744,1340,liraglutide,O
20745,1340,.,O
20746,1340,The,O
20747,1340,stability,O
20748,1340,of,O
20749,1340,the,O
20750,1340,CAD,O
20751,1340,further,O
20752,1340,warranties,O
20753,1340,that,O
20754,1340,study,O
20755,1340,patients,O
20756,1340,will,O
20757,1340,not,O
20758,1340,be,O
20759,1340,exposed,O
20760,1340,to,O
20761,1340,higher,O
20762,1340,risk,O
20763,1340,by,O
20764,1340,using,O
20765,1340,liraglutide,O
20766,1341,Major,B-Condition
20767,1341,depressive,I-Condition
20768,1341,disorder,I-Condition
20769,1341,with,O
20770,1341,psychotic,O
20771,1341,features,O
20772,1342,Traumatic,B-Condition
20773,1342,Brain,I-Condition
20774,1342,Injury,I-Condition
20775,1342,(,I-Condition
20776,1342,TBI,I-Condition
20777,1342,),I-Condition
20778,1342,with,O
20779,1342,a,O
20780,1342,clear,O
20781,1342,impact,B-Condition
20782,1342,on,I-Condition
20783,1342,activities,I-Condition
20784,1342,of,I-Condition
20785,1342,daily,I-Condition
20786,1342,living,I-Condition
20787,1343,Developmental,B-Condition
20788,1343,delay,I-Condition
20789,1343,",",O
20790,1343,intellectual,B-Condition
20791,1343,deficit,I-Condition
20792,1343,",",O
20793,1343,and/or,O
20794,1343,severe,O
20795,1343,educational,I-Condition
20796,1343,disability,I-Condition
20797,1343,resulting,O
20798,1343,in,O
20799,1343,some,O
20800,1343,dependence,B-Condition
20801,1343,for,I-Condition
20802,1343,activities,I-Condition
20803,1343,of,I-Condition
20804,1343,daily,I-Condition
20805,1343,living,I-Condition
20806,1344,Ongoing,O
20807,1344,substance,B-Condition
20808,1344,use,I-Condition
20809,1344,disorder,I-Condition
20810,1344,with,O
20811,1344,significant,O
20812,1344,impact,B-Condition
20813,1344,on,I-Condition
20814,1344,activities,I-Condition
20815,1344,of,I-Condition
20816,1344,daily,I-Condition
20817,1344,living,I-Condition
20818,1344,.,O
20819,1344,Difficult,O
20820,1344,or,O
20821,1344,impossible,O
20822,1344,to,O
20823,1344,determine,O
20824,1344,whether,O
20825,1344,cognitive,O
20826,1344,or,O
20827,1344,functional,O
20828,1344,decline,O
20829,1344,is,O
20830,1344,due,O
20831,1344,to,O
20832,1344,substance,O
20833,1344,use,O
20834,1344,or,O
20835,1344,HIV,O
20836,1344,",",O
20837,1344,or,O
20838,1344,both,O
20839,1345,Evidence,O
20840,1345,of,O
20841,1345,intoxication,B-Condition
20842,1345,or,O
20843,1345,withdrawal,B-Condition
20844,1345,during,O
20845,1345,the,O
20846,1345,screening,O
20847,1345,evaluation,O
20848,1346,Central,B-Condition
20849,1346,nervous,I-Condition
20850,1346,system,I-Condition
20851,1346,(,I-Condition
20852,1346,CNS,I-Condition
20853,1346,),I-Condition
20854,1346,infections,I-Condition
20855,1346,or,I-Condition
20856,1346,opportunistic,I-Condition
20857,1346,conditions,I-Condition
20858,1346,:,O
20859,1346,brain,B-Condition
20860,1346,abscess,I-Condition
20861,1346,(,O
20862,1346,bacterial,O
20863,1346,",",O
20864,1346,mycobacterial,O
20865,1346,",",O
20866,1346,fungal,O
20867,1346,or,O
20868,1346,Toxoplasma,O
20869,1346,),O
20870,1346,",",O
20871,1346,meningitis,B-Condition
20872,1346,with,O
20873,1346,persistent,O
20874,1346,neurologic,B-Condition
20875,1346,impairment,I-Condition
20876,1346,",",O
20877,1346,primary,O
20878,1346,CNS,B-Condition
20879,1346,lymphoma,I-Condition
20880,1346,",",O
20881,1346,progressive,B-Condition
20882,1346,multifocal,I-Condition
20883,1346,leukoencephalopathy,I-Condition
20884,1346,(,I-Condition
20885,1346,PML,I-Condition
20886,1346,),I-Condition
20887,1346,",",O
20888,1346,or,O
20889,1346,another,O
20890,1346,structural,B-Condition
20891,1346,brain,I-Condition
20892,1346,lesion,I-Condition
20893,1346,with,O
20894,1346,neurological,B-Condition
20895,1346,sequelae,I-Condition
20896,1347,Other,O
20897,1347,CNS,B-Condition
20898,1347,conditions,I-Condition
20899,1347,:,O
20900,1347,non,O
20901,1347,-,O
20902,1347,opportunistic,O
20903,1347,primary,O
20904,1347,or,O
20905,1347,metastatic,O
20906,1347,brain,B-Condition
20907,1347,tumors,I-Condition
20908,1347,",",O
20909,1347,uncontrolled,O
20910,1347,seizure,B-Condition
20911,1347,disorder,I-Condition
20912,1347,",",O
20913,1347,progressive,B-Condition
20914,1347,multiple,I-Condition
20915,1347,sclerosis,I-Condition
20916,1347,",",O
20917,1347,stroke,B-Condition
20918,1347,with,O
20919,1347,neurological,B-Condition
20920,1347,sequelae,I-Condition
20921,1347,",",O
20922,1347,or,O
20923,1347,dementia,B-Condition
20924,1347,due,O
20925,1347,to,O
20926,1347,causes,O
20927,1347,other,O
20928,1347,than,O
20929,1347,HIV,B-Condition
20930,1347,(,O
20931,1347,eg,O
20932,1347,",",O
20933,1347,Alzheimer,B-Condition
20934,1347,'s,I-Condition
20935,1347,disease,I-Condition
20936,1347,),O
20937,1348,Constitutional,B-Condition
20938,1348,illness,I-Condition
20939,1348,(,O
20940,1348,eg,O
20941,1348,",",O
20942,1348,persistent,O
20943,1348,unexplained,B-Condition
20944,1348,fever,I-Condition
20945,1348,",",O
20946,1348,diarrhea,B-Condition
20947,1348,",",O
20948,1348,significant,O
20949,1348,weight,B-Condition
20950,1348,loss,I-Condition
20951,1348,",",O
20952,1348,disabling,B-Condition
20953,1348,weakness,I-Condition
20954,1348,),O
20955,1348,within,O
20956,1348,30,O
20957,1348,days,O
20958,1348,of,O
20959,1348,screening,O
20960,1349,Known,O
20961,1349,untreated,O
20962,1349,B12,B-Condition
20963,1349,deficiency,I-Condition
20964,1349,or,O
20965,1349,malnutrition,B-Condition
20966,1349,(,O
20967,1349,body,O
20968,1349,mass,O
20969,1349,index,O
20970,1349,[,O
20971,1349,BMI,O
20972,1349,],O
20973,1349,less,O
20974,1349,than,O
20975,1349,18,O
20976,1349,),O
20977,1349,at,O
20978,1349,screening,O
20979,1350,Evidence,B-Mood
20980,1350,of,O
20981,1350,current,O
20982,1350,hepatitis,B-Condition
20983,1350,C,I-Condition
20984,1350,virus,I-Condition
20985,1350,infection,I-Condition
20986,1350,(,I-Condition
20987,1350,HCV,I-Condition
20988,1350,),I-Condition
20989,1350,(,O
20990,1350,ie,O
20991,1350,",",O
20992,1350,HCV,O
20993,1350,antibody,O
20994,1350,[,O
20995,1350,Ab,O
20996,1350,],O
20997,1350,positive,O
20998,1350,within,O
20999,1350,90,O
21000,1350,days,O
21001,1350,prior,O
21002,1350,to,O
21003,1350,study,O
21004,1350,entry,O
21005,1350,unless,O
21006,1350,also,O
21007,1350,shown,O
21008,1350,to,O
21009,1350,be,O
21010,1350,plasma,O
21011,1350,HCV,O
21012,1350,RNA,O
21013,1350,negative,O
21014,1350,within,O
21015,1350,the,O
21016,1350,same,O
21017,1350,time,O
21018,1350,period,O
21019,1350,),O
21020,1351,Unstable,O
21021,1351,and,O
21022,1351,advanced,O
21023,1351,liver,B-Condition
21024,1351,disease,I-Condition
21025,1351,(,O
21026,1351,as,O
21027,1351,defined,O
21028,1351,by,O
21029,1351,the,O
21030,1351,presence,O
21031,1351,of,O
21032,1351,at,O
21033,1351,least,O
21034,1351,one,O
21035,1351,of,O
21036,1351,the,O
21037,1351,following,O
21038,1351,:,O
21039,1351,ascites,B-Condition
21040,1351,",",O
21041,1351,encephalopathy,B-Condition
21042,1351,",",O
21043,1351,coagulopathy,B-Condition
21044,1351,",",O
21045,1351,hypoalbuminemia,B-Condition
21046,1351,",",O
21047,1351,esophageal,B-Condition
21048,1351,or,I-Condition
21049,1351,gastric,I-Condition
21050,1351,varices,I-Condition
21051,1351,",",O
21052,1351,or,O
21053,1351,persistent,O
21054,1351,jaundice,B-Condition
21055,1351,),O
21056,1352,Prior,O
21057,1352,or,O
21058,1352,current,O
21059,1352,use,O
21060,1352,of,O
21061,1352,any,O
21062,1352,CCR5,B-Drug
21063,1352,antagonist,I-Drug
21064,1352,(,O
21065,1352,such,O
21066,1352,as,O
21067,1352,MVC,B-Drug
21068,1352,and,O
21069,1352,cenicriviroc,B-Drug
21070,1352,[,I-Drug
21071,1352,CVC,I-Drug
21072,1352,],I-Drug
21073,1352,),O
21074,1352,and,O
21075,1352,integrase,B-Drug
21076,1352,inhibitor,I-Drug
21077,1352,(,O
21078,1352,such,O
21079,1352,as,O
21080,1352,RAL,B-Drug
21081,1352,",",O
21082,1352,DTG,B-Drug
21083,1352,",",O
21084,1352,and,O
21085,1352,elvitegravir,B-Drug
21086,1352,[,I-Drug
21087,1352,EVG,I-Drug
21088,1352,],I-Drug
21089,1352,),O
21090,1353,Current,O
21091,1353,use,O
21092,1353,of,O
21093,1353,any,O
21094,1353,medication,B-Drug
21095,1353,",",O
21096,1353,including,O
21097,1353,antiretrovirals,B-Drug
21098,1353,",",O
21099,1353,prohibited,O
21100,1353,in,O
21101,1353,the,O
21102,1353,study,O
21103,1353,(,O
21104,1353,refer,O
21105,1353,to,O
21106,1353,the,O
21107,1353,A5324,O
21108,1353,protocol,O
21109,1353,-,O
21110,1353,specific,O
21111,1353,web,O
21112,1353,page,O
21113,1353,[,O
21114,1353,PSWP,O
21115,1353,],O
21116,1353,for,O
21117,1353,the,O
21118,1353,prohibited,O
21119,1353,medications,O
21120,1353,),O
21121,1354,Breastfeeding,B-Observation
21122,1355,Presence,O
21123,1355,of,O
21124,1355,an,O
21125,1355,AIDS,B-Condition
21126,1355,-,I-Condition
21127,1355,defining,I-Condition
21128,1355,opportunistic,I-Condition
21129,1355,infection,I-Condition
21130,1355,within,O
21131,1355,6,O
21132,1355,months,O
21133,1355,prior,O
21134,1355,to,O
21135,1355,entry,O
21136,1355,.,O
21137,1355,Note,O
21138,1355,:,O
21139,1355,Refer,O
21140,1355,to,O
21141,1355,the,O
21142,1355,A5324,O
21143,1355,Manual,O
21144,1355,of,O
21145,1355,Operations,O
21146,1355,(,O
21147,1355,MOPS,O
21148,1355,),O
21149,1355,for,O
21150,1355,the,O
21151,1355,list,O
21152,1355,of,O
21153,1355,AIDS,O
21154,1355,-,O
21155,1355,defining,O
21156,1355,opportunistic,O
21157,1355,infections,O
21158,1355,.,O
21159,1356,Active,O
21160,1356,syphilis,B-Condition
21161,1356,or,O
21162,1356,treatment,B-Procedure
21163,1356,for,O
21164,1356,syphilis,B-Condition
21165,1356,within,O
21166,1356,90,O
21167,1356,days,O
21168,1356,prior,O
21169,1356,to,O
21170,1356,study,O
21171,1356,entry,O
21172,1356,.,O
21173,1356,NOTE,O
21174,1356,:,O
21175,1356,Active,O
21176,1356,syphilis,B-Condition
21177,1356,is,O
21178,1356,defined,O
21179,1356,as,O
21180,1356,four,O
21181,1356,-,O
21182,1356,fold,O
21183,1356,increase,O
21184,1356,in,O
21185,1356,serum,O
21186,1356,rapid,O
21187,1356,plasma,O
21188,1356,reagin,O
21189,1356,(,O
21190,1356,RPR,O
21191,1356,),O
21192,1356,or,O
21193,1356,venereal,O
21194,1356,disease,O
21195,1356,research,O
21196,1356,laboratory,O
21197,1356,(,O
21198,1356,VDRL,O
21199,1356,),O
21200,1356,tests,O
21201,1356,in,O
21202,1356,an,O
21203,1356,individual,O
21204,1356,with,O
21205,1356,past,O
21206,1356,syphilis,B-Condition
21207,1356,",",O
21208,1356,or,O
21209,1356,newly,O
21210,1356,reactive,O
21211,1356,serum,O
21212,1356,RPR,O
21213,1356,or,O
21214,1356,VDRL,O
21215,1356,with,O
21216,1356,a,O
21217,1356,reactive,B-Procedure
21218,1356,confirmatory,I-Procedure
21219,1356,test,I-Procedure
21220,1356,(,O
21221,1356,enzyme,B-Procedure
21222,1356,immunoassays,I-Procedure
21223,1356,[,I-Procedure
21224,1356,EIA,I-Procedure
21225,1356,],I-Procedure
21226,1356,or,O
21227,1356,chemiluminescent,B-Procedure
21228,1356,assay,I-Procedure
21229,1356,[,I-Procedure
21230,1356,CIA,I-Procedure
21231,1356,],I-Procedure
21232,1356,",",O
21233,1356,T.,B-Procedure
21234,1356,pallidum,I-Procedure
21235,1356,particle,I-Procedure
21236,1356,agglutination,I-Procedure
21237,1356,[,I-Procedure
21238,1356,TP,I-Procedure
21239,1356,-,I-Procedure
21240,1356,PA,I-Procedure
21241,1356,],I-Procedure
21242,1356,",",O
21243,1356,or,O
21244,1356,fluorescent,B-Procedure
21245,1356,treponemal,I-Procedure
21246,1356,antibody,I-Procedure
21247,1356,absorbed,I-Procedure
21248,1356,[,I-Procedure
21249,1356,FTA,I-Procedure
21250,1356,-,I-Procedure
21251,1356,ABS,I-Procedure
21252,1356,],I-Procedure
21253,1356,),O
21254,1356,.,O
21255,1357,Known,O
21256,1357,allergy,B-Condition
21257,1357,/,O
21258,1357,sensitivity,B-Condition
21259,1357,or,O
21260,1357,any,O
21261,1357,hypersensitivity,B-Condition
21262,1357,to,O
21263,1357,components,B-Drug
21264,1357,of,I-Drug
21265,1357,study,I-Drug
21266,1357,drugs,I-Drug
21267,1357,or,O
21268,1357,their,O
21269,1357,formulation,O
21270,1358,a,O
21271,1358,licensed,O
21272,1358,rapid,O
21273,1358,HIV,O
21274,1358,test,O
21275,1358,or,O
21276,1358,HIV,O
21277,1358,enzyme,O
21278,1358,or,O
21279,1358,chemiluminescence,O
21280,1358,immunoassay,O
21281,1358,(,O
21282,1358,E,O
21283,1358,/,O
21284,1358,CIA,O
21285,1358,),O
21286,1358,test,O
21287,1358,kit,O
21288,1358,at,O
21289,1358,any,O
21290,1358,time,O
21291,1358,prior,O
21292,1358,to,O
21293,1358,study,O
21294,1358,entry,O
21295,1358,and,O
21296,1358,confirmed,O
21297,1358,by,O
21298,1358,a,O
21299,1358,licensed,O
21300,1358,Western,O
21301,1358,blot,O
21302,1358,or,O
21303,1358,a,O
21304,1358,second,O
21305,1358,antibody,O
21306,1358,test,O
21307,1358,by,O
21308,1358,a,O
21309,1358,method,O
21310,1358,other,O
21311,1358,than,O
21312,1358,the,O
21313,1358,initial,O
21314,1358,rapid,O
21315,1358,HIV,O
21316,1358,and/or,O
21317,1358,E,O
21318,1358,/,O
21319,1358,CIA,O
21320,1358,",",O
21321,1358,or,O
21322,1358,by,O
21323,1358,HIV-1,O
21324,1358,antigen,O
21325,1358,or,O
21326,1358,plasma,O
21327,1358,HIV-1,O
21328,1358,RNA,O
21329,1358,viral,O
21330,1358,load,O
21331,1358,.,O
21332,1358,NOTE,O
21333,1358,:,O
21334,1358,The,O
21335,1358,term,O
21336,1358,"""",O
21337,1358,licensed,O
21338,1358,"""",O
21339,1358,refers,O
21340,1358,to,O
21341,1358,a,O
21342,1358,United,O
21343,1358,States,O
21344,1358,Food,O
21345,1358,and,O
21346,1358,Drug,O
21347,1358,Administration,O
21348,1358,(,O
21349,1358,FDA)-approved,O
21350,1358,kit,O
21351,1358,",",O
21352,1358,which,O
21353,1358,is,O
21354,1358,required,O
21355,1358,for,O
21356,1358,all,O
21357,1358,IND,O
21358,1358,studies,O
21359,1358,",",O
21360,1358,or,O
21361,1358,for,O
21362,1358,sites,O
21363,1358,located,O
21364,1358,in,O
21365,1358,countries,O
21366,1358,other,O
21367,1358,than,O
21368,1358,the,O
21369,1358,United,O
21370,1358,States,O
21371,1358,",",O
21372,1358,a,O
21373,1358,kit,O
21374,1358,that,O
21375,1358,has,O
21376,1358,been,O
21377,1358,certified,O
21378,1358,or,O
21379,1358,licensed,O
21380,1358,by,O
21381,1358,an,O
21382,1358,oversight,O
21383,1358,body,O
21384,1358,within,O
21385,1358,that,O
21386,1358,country,O
21387,1358,and,O
21388,1358,validated,O
21389,1358,internally,O
21390,1358,.,O
21391,1358,Non,O
21392,1358,-,O
21393,1358,US,O
21394,1358,sites,O
21395,1358,are,O
21396,1358,encouraged,O
21397,1358,to,O
21398,1358,use,O
21399,1358,US,O
21400,1358,FDA,O
21401,1358,-,O
21402,1358,approved,O
21403,1358,methods,O
21404,1358,for,O
21405,1358,IND,O
21406,1358,studies,O
21407,1358,.,O
21408,1358,WHO,O
21409,1358,(,O
21410,1358,World,O
21411,1358,Health,O
21412,1358,Organization,O
21413,1358,),O
21414,1358,and,O
21415,1358,CDC,O
21416,1358,(,O
21417,1358,Centers,O
21418,1358,for,O
21419,1358,Disease,O
21420,1358,Control,O
21421,1358,and,O
21422,1358,Prevention,O
21423,1358,),O
21424,1358,guidelines,O
21425,1358,mandate,O
21426,1358,that,O
21427,1358,confirmation,O
21428,1358,of,O
21429,1358,the,O
21430,1358,initial,O
21431,1358,test,O
21432,1358,result,O
21433,1358,must,O
21434,1358,use,O
21435,1358,a,O
21436,1358,test,O
21437,1358,that,O
21438,1358,is,O
21439,1358,different,O
21440,1358,from,O
21441,1358,the,O
21442,1358,one,O
21443,1358,used,O
21444,1358,for,O
21445,1358,the,O
21446,1358,initial,O
21447,1358,assessment,O
21448,1358,.,O
21449,1358,A,O
21450,1358,reactive,O
21451,1358,initial,O
21452,1358,rapid,O
21453,1358,test,O
21454,1358,should,O
21455,1358,be,O
21456,1358,confirmed,O
21457,1358,by,O
21458,1358,either,O
21459,1358,another,O
21460,1358,type,O
21461,1358,of,O
21462,1358,rapid,O
21463,1358,assay,O
21464,1358,or,O
21465,1358,an,O
21466,1358,E,O
21467,1358,/,O
21468,1358,CIA,O
21469,1358,that,O
21470,1358,is,O
21471,1358,based,O
21472,1358,on,O
21473,1358,a,O
21474,1358,different,O
21475,1358,antigen,O
21476,1358,preparation,O
21477,1358,and/or,O
21478,1358,different,O
21479,1358,test,O
21480,1358,principle,O
21481,1358,(,O
21482,1358,eg,O
21483,1358,",",O
21484,1358,indirect,O
21485,1358,versus,O
21486,1358,competitive,O
21487,1358,),O
21488,1358,",",O
21489,1358,or,O
21490,1358,a,O
21491,1358,Western,O
21492,1358,blot,O
21493,1358,or,O
21494,1358,a,O
21495,1358,plasma,O
21496,1358,HIV-1,O
21497,1358,RNA,O
21498,1358,.,O
21499,1358,OR,O
21500,1359,Documentation,O
21501,1359,of,O
21502,1359,HIV,B-Condition
21503,1359,diagnosis,I-Condition
21504,1359,in,O
21505,1359,the,O
21506,1359,medical,O
21507,1359,record,O
21508,1359,by,O
21509,1359,a,O
21510,1359,healthcare,O
21511,1359,provider,O
21512,1359,.,O
21513,1360,Tenofovir,B-Drug
21514,1360,disoproxil,I-Drug
21515,1360,fumarate,I-Drug
21516,1360,(,I-Drug
21517,1360,TDF,I-Drug
21518,1360,),I-Drug
21519,1360,to,O
21520,1360,tenofovir,B-Drug
21521,1360,alafenamide,I-Drug
21522,1360,fumarate,I-Drug
21523,1360,(,I-Drug
21524,1360,TAF)/TAF,I-Drug
21525,1360,-,I-Procedure
21526,1360,containing,I-Procedure
21527,1360,fixed,I-Procedure
21528,1360,-,I-Procedure
21529,1360,dose,I-Procedure
21530,1360,combination,I-Procedure
21531,1360,regimens,I-Procedure
21532,1361,Ritonavir,B-Drug
21533,1361,(,I-Drug
21534,1361,RTV,I-Drug
21535,1361,),I-Drug
21536,1361,to,O
21537,1361,cobicistat,B-Drug
21538,1361,(,I-Drug
21539,1361,COBI)/COBI,I-Drug
21540,1361,-,I-Procedure
21541,1361,containing,I-Procedure
21542,1361,fixed,I-Procedure
21543,1361,-,I-Procedure
21544,1361,dose,I-Procedure
21545,1361,combination,I-Procedure
21546,1361,regimens,I-Procedure
21547,1362,TDF,B-Drug
21548,1362,to,O
21549,1362,TAF,B-Drug
21550,1362,/,O
21551,1362,TAF,B-Procedure
21552,1362,-,I-Procedure
21553,1362,containing,I-Procedure
21554,1362,fixed,I-Procedure
21555,1362,-,I-Procedure
21556,1362,dose,I-Procedure
21557,1362,combination,I-Procedure
21558,1362,regimens,I-Procedure
21559,1363,RTV,B-Drug
21560,1363,to,O
21561,1363,COBI,B-Drug
21562,1363,/,O
21563,1363,COBI,B-Procedure
21564,1363,-,I-Procedure
21565,1363,containing,I-Procedure
21566,1363,fixed,I-Procedure
21567,1363,-,I-Procedure
21568,1363,dose,I-Procedure
21569,1363,combination,I-Procedure
21570,1363,regimens,I-Procedure
21571,1364,HIV-1,O
21572,1364,plasma,O
21573,1364,RNA,O
21574,1364,less,O
21575,1364,than,O
21576,1364,50,O
21577,1364,copies,O
21578,1364,/,O
21579,1364,mL,O
21580,1364,obtained,O
21581,1364,within,O
21582,1364,90,O
21583,1364,days,O
21584,1364,prior,O
21585,1364,to,O
21586,1364,study,O
21587,1364,entry,O
21588,1364,by,O
21589,1364,any,O
21590,1364,FDA,O
21591,1364,-,O
21592,1364,approved,O
21593,1364,assay,O
21594,1364,at,O
21595,1364,any,O
21596,1364,United,O
21597,1364,States,O
21598,1364,laboratory,O
21599,1364,that,O
21600,1364,has,O
21601,1364,a,O
21602,1364,Clinical,O
21603,1364,Laboratory,O
21604,1364,Improvement,O
21605,1364,Amendments,O
21606,1364,(,O
21607,1364,CLIA,O
21608,1364,),O
21609,1364,certification,O
21610,1364,or,O
21611,1364,its,O
21612,1364,equivalent,O
21613,1364,",",O
21614,1364,or,O
21615,1364,at,O
21616,1364,any,O
21617,1364,network,O
21618,1364,-,O
21619,1364,approved,O
21620,1364,non,O
21621,1364,-,O
21622,1364,US,O
21623,1364,laboratory,O
21624,1364,that,O
21625,1364,operates,O
21626,1364,in,O
21627,1364,accordance,O
21628,1364,with,O
21629,1364,Good,O
21630,1364,Clinical,O
21631,1364,Laboratory,O
21632,1364,Practices,O
21633,1364,(,O
21634,1364,GCLP,O
21635,1364,),O
21636,1364,and,O
21637,1364,participates,O
21638,1364,in,O
21639,1364,appropriate,O
21640,1364,external,O
21641,1364,quality,O
21642,1364,assurance,O
21643,1364,programs,O
21644,1364,.,O
21645,1365,No,O
21646,1365,more,O
21647,1365,than,O
21648,1365,one,O
21649,1365,HIV-1,O
21650,1365,plasma,O
21651,1365,RNA,O
21652,1365,greater,O
21653,1365,than,O
21654,1365,or,O
21655,1365,equal,O
21656,1365,to,O
21657,1365,50,O
21658,1365,and,O
21659,1365,less,O
21660,1365,than,O
21661,1365,200,O
21662,1365,copies,O
21663,1365,/,O
21664,1365,mL,O
21665,1365,(,O
21666,1365,only,O
21667,1365,one,O
21668,1365,"""",O
21669,1365,blip,O
21670,1365,"""",O
21671,1365,),O
21672,1365,in,O
21673,1365,the,O
21674,1365,past,O
21675,1365,6,O
21676,1365,months,O
21677,1365,with,O
21678,1365,a,O
21679,1365,subsequent,O
21680,1365,HIV-1,O
21681,1365,plasma,O
21682,1365,RNA,O
21683,1365,less,O
21684,1365,than,O
21685,1365,50,O
21686,1365,copies,O
21687,1365,/,O
21688,1365,mL.,O
21689,1365,NOTE,O
21690,1365,:,O
21691,1365,There,O
21692,1365,should,O
21693,1365,be,O
21694,1365,no,O
21695,1365,plasma,O
21696,1365,HIV-1,O
21697,1365,RNA,O
21698,1365,greater,O
21699,1365,than,O
21700,1365,200,O
21701,1365,copies,O
21702,1365,/,O
21703,1365,mL,O
21704,1365,within,O
21705,1365,the,O
21706,1365,6,O
21707,1365,months,O
21708,1365,prior,O
21709,1365,to,O
21710,1365,study,O
21711,1365,entry,O
21712,1365,.,O
21713,1366,HAND,B-Condition
21714,1366,diagnosis,O
21715,1366,(,O
21716,1366,ANI,B-Condition
21717,1366,",",O
21718,1366,MND,B-Condition
21719,1366,",",O
21720,1366,or,O
21721,1366,HAD,B-Condition
21722,1366,),O
21723,1366,within,O
21724,1366,60,O
21725,1366,days,O
21726,1366,prior,O
21727,1366,to,O
21728,1366,study,O
21729,1366,entry,O
21730,1366,.,O
21731,1366,HAND,O
21732,1366,is,O
21733,1366,defined,O
21734,1366,as,O
21735,1366,at,O
21736,1366,least,O
21737,1366,mild,O
21738,1366,impairment,O
21739,1366,on,O
21740,1366,neurocognitive,O
21741,1366,testing,O
21742,1366,(,O
21743,1366,more,O
21744,1366,than,O
21745,1366,one,O
21746,1366,standard,O
21747,1366,deviation,O
21748,1366,below,O
21749,1366,appropriate,O
21750,1366,normative,O
21751,1366,data,O
21752,1366,in,O
21753,1366,two,O
21754,1366,domains,O
21755,1366,of,O
21756,1366,functioning,O
21757,1366,),O
21758,1366,and,O
21759,1366,no,O
21760,1366,severely,B-Condition
21761,1366,confounding,I-Condition
21762,1366,factors,I-Condition
21763,1366,.,O
21764,1367,Absolute,O
21765,1367,neutrophil,O
21766,1367,count,O
21767,1367,(,O
21768,1367,ANC,O
21769,1367,),O
21770,1367,greater,O
21771,1367,than,O
21772,1367,or,O
21773,1367,equal,O
21774,1367,to,O
21775,1367,500,O
21776,1367,/,O
21777,1367,mm^3,O
21778,1368,Hemoglobin,O
21779,1368,greater,O
21780,1368,than,O
21781,1368,or,O
21782,1368,equal,O
21783,1368,to,O
21784,1368,7.5,O
21785,1368,g,O
21786,1368,/,O
21787,1368,dL,O
21788,1369,Platelet,O
21789,1369,count,O
21790,1369,greater,O
21791,1369,than,O
21792,1369,or,O
21793,1369,equal,O
21794,1369,to,O
21795,1369,"40,000",O
21796,1369,/,O
21797,1369,mm^3,O
21798,1370,Creatinine,O
21799,1370,less,O
21800,1370,than,O
21801,1370,or,O
21802,1370,equal,O
21803,1370,to,O
21804,1370,2.0,O
21805,1370,x,O
21806,1370,upper,O
21807,1370,limit,O
21808,1370,of,O
21809,1370,normal,O
21810,1370,(,O
21811,1370,ULN,O
21812,1370,),O
21813,1371,Aspartate,O
21814,1371,transaminase,O
21815,1371,(,O
21816,1371,AST,O
21817,1371,),O
21818,1371,less,O
21819,1371,than,O
21820,1371,or,O
21821,1371,equal,O
21822,1371,to,O
21823,1371,5,O
21824,1371,x,O
21825,1371,ULN,O
21826,1372,Alanine,O
21827,1372,transaminase,O
21828,1372,(,O
21829,1372,ALT,O
21830,1372,),O
21831,1372,less,O
21832,1372,than,O
21833,1372,3,O
21834,1372,x,O
21835,1372,ULN,O
21836,1373,Alkaline,O
21837,1373,phosphatase,O
21838,1373,less,O
21839,1373,than,O
21840,1373,or,O
21841,1373,equal,O
21842,1373,to,O
21843,1373,5,O
21844,1373,x,O
21845,1373,ULN,O
21846,1374,Total,O
21847,1374,bilirubin,O
21848,1374,less,O
21849,1374,than,O
21850,1374,1.5,O
21851,1374,x,O
21852,1374,ULN,O
21853,1374,.,O
21854,1374,NOTE,O
21855,1374,:,O
21856,1374,If,O
21857,1374,the,O
21858,1374,potential,O
21859,1374,participant,O
21860,1374,is,O
21861,1374,taking,O
21862,1374,an,O
21863,1374,indinavir,B-Drug
21864,1374,(,I-Drug
21865,1374,IDV)-,I-Drug
21866,1374,or,O
21867,1374,atazanavir,B-Drug
21868,1374,(,I-Drug
21869,1374,ATV)-containing,I-Drug
21870,1374,regimen,B-Procedure
21871,1374,at,O
21872,1374,the,O
21873,1374,time,O
21874,1374,of,O
21875,1374,screening,O
21876,1374,",",O
21877,1374,total,O
21878,1374,bilirubin,O
21879,1374,less,O
21880,1374,than,O
21881,1374,or,O
21882,1374,equal,O
21883,1374,to,O
21884,1374,5,O
21885,1374,x,O
21886,1374,ULN,O
21887,1374,is,O
21888,1374,acceptable,O
21889,1374,.,O
21890,1375,Creatinine,O
21891,1375,clearance,O
21892,1375,(,O
21893,1375,CrCl,O
21894,1375,),O
21895,1375,greater,O
21896,1375,than,O
21897,1375,or,O
21898,1375,equal,O
21899,1375,to,O
21900,1375,60,O
21901,1375,mL,O
21902,1375,/,O
21903,1375,min,O
21904,1375,",",O
21905,1375,either,O
21906,1375,measured,O
21907,1375,or,O
21908,1375,estimated,O
21909,1375,by,O
21910,1375,Cockcroft,B-Procedure
21911,1375,-,I-Procedure
21912,1375,Gault,I-Procedure
21913,1375,equation,I-Procedure
21914,1375,.,O
21915,1375,NOTE,O
21916,1375,:,O
21917,1375,A,O
21918,1375,calculator,O
21919,1375,for,O
21920,1375,estimating,O
21921,1375,the,O
21922,1375,CrCl,O
21923,1375,can,O
21924,1375,be,O
21925,1375,found,O
21926,1375,at,O
21927,1375,www.fstrf.org/ACTG/ccc.html,O
21928,1376,Females,O
21929,1376,of,O
21930,1376,reproductive,O
21931,1376,potential,O
21932,1376,(,O
21933,1376,women,O
21934,1376,who,O
21935,1376,have,O
21936,1376,not,O
21937,1376,been,O
21938,1376,post,O
21939,1376,-,O
21940,1376,menopausal,O
21941,1376,for,O
21942,1376,at,O
21943,1376,least,O
21944,1376,24,O
21945,1376,consecutive,O
21946,1376,months,O
21947,1376,",",O
21948,1376,ie,O
21949,1376,",",O
21950,1376,who,O
21951,1376,have,O
21952,1376,had,O
21953,1376,menses,O
21954,1376,within,O
21955,1376,the,O
21956,1376,preceding,O
21957,1376,24,O
21958,1376,months,O
21959,1376,",",O
21960,1376,or,O
21961,1376,women,O
21962,1376,who,O
21963,1376,have,O
21964,1376,not,O
21965,1376,undergone,O
21966,1376,surgical,O
21967,1376,sterilization,O
21968,1376,",",O
21969,1376,hysterectomy,O
21970,1376,or,O
21971,1376,bilateral,O
21972,1376,salpingectomy,O
21973,1376,or,O
21974,1376,bilateral,O
21975,1376,oophorectomy,O
21976,1376,or,O
21977,1376,tubal,O
21978,1376,ligation,O
21979,1376,),O
21980,1376,must,O
21981,1376,have,O
21982,1376,a,O
21983,1376,negative,O
21984,1376,serum,O
21985,1376,or,O
21986,1376,urine,O
21987,1376,pregnancy,O
21988,1376,test,O
21989,1376,by,O
21990,1376,any,O
21991,1376,US,O
21992,1376,clinic,O
21993,1376,or,O
21994,1376,laboratory,O
21995,1376,that,O
21996,1376,has,O
21997,1376,a,O
21998,1376,CLIA,O
21999,1376,certification,O
22000,1376,or,O
22001,1376,its,O
22002,1376,equivalent,O
22003,1376,",",O
22004,1376,or,O
22005,1376,is,O
22006,1376,using,O
22007,1376,a,O
22008,1376,point,O
22009,1376,of,O
22010,1376,care,O
22011,1376,(,O
22012,1376,POC,O
22013,1376,),O
22014,1376,/,O
22015,1376,CLIA,O
22016,1376,-,O
22017,1376,waived,O
22018,1376,test,O
22019,1376,",",O
22020,1376,or,O
22021,1376,at,O
22022,1376,any,O
22023,1376,network,O
22024,1376,-,O
22025,1376,approved,O
22026,1376,non,O
22027,1376,-,O
22028,1376,US,O
22029,1376,laboratory,O
22030,1376,or,O
22031,1376,clinic,O
22032,1376,that,O
22033,1376,operates,O
22034,1376,in,O
22035,1376,accordance,O
22036,1376,with,O
22037,1376,GCLP,O
22038,1376,and,O
22039,1376,participates,O
22040,1376,in,O
22041,1376,appropriate,O
22042,1376,external,O
22043,1376,quality,O
22044,1376,assurance,O
22045,1376,programs,O
22046,1376,within,O
22047,1376,48,O
22048,1376,hours,O
22049,1376,prior,O
22050,1376,to,O
22051,1376,study,O
22052,1376,entry,O
22053,1377,Females,O
22054,1377,of,O
22055,1377,reproductive,O
22056,1377,potential,O
22057,1377,must,O
22058,1377,agree,O
22059,1377,not,O
22060,1377,to,O
22061,1377,participate,O
22062,1377,in,O
22063,1377,the,O
22064,1377,conception,O
22065,1377,process,O
22066,1377,(,O
22067,1377,ie,O
22068,1377,",",O
22069,1377,active,O
22070,1377,attempt,O
22071,1377,to,O
22072,1377,become,O
22073,1377,pregnant,O
22074,1377,",",O
22075,1377,in,O
22076,1377,vitro,O
22077,1377,fertilization,O
22078,1377,),O
22079,1377,",",O
22080,1377,and,O
22081,1377,if,O
22082,1377,participating,O
22083,1377,in,O
22084,1377,sexual,O
22085,1377,activity,O
22086,1377,that,O
22087,1377,could,O
22088,1377,lead,O
22089,1377,to,O
22090,1377,pregnancy,O
22091,1377,",",O
22092,1377,must,O
22093,1377,use,O
22094,1377,at,O
22095,1377,least,O
22096,1377,one,O
22097,1377,reliable,O
22098,1377,form,O
22099,1377,of,O
22100,1377,contraception,O
22101,1377,.,O
22102,1377,Female,O
22103,1377,participants,O
22104,1377,must,O
22105,1377,use,O
22106,1377,contraceptives,O
22107,1377,while,O
22108,1377,receiving,O
22109,1377,study,O
22110,1377,treatment,O
22111,1377,and,O
22112,1377,for,O
22113,1377,6,O
22114,1377,weeks,O
22115,1377,after,O
22116,1377,stopping,O
22117,1377,study,O
22118,1377,treatment,O
22119,1377,.,O
22120,1377,More,O
22121,1377,information,O
22122,1377,on,O
22123,1377,this,O
22124,1377,criterion,O
22125,1377,is,O
22126,1377,available,O
22127,1377,in,O
22128,1377,the,O
22129,1377,protocol,O
22130,1377,.,O
22131,1378,Men,B-Person
22132,1378,and,O
22133,1378,women,B-Person
22134,1378,18,O
22135,1378,years,O
22136,1378,of,O
22137,1378,age,B-Person
22138,1378,and,O
22139,1378,older,O
22140,1378,who,O
22141,1378,are,O
22142,1378,able,B-Observation
22143,1378,to,I-Observation
22144,1378,complete,I-Observation
22145,1378,the,O
22146,1378,neuropsychological,B-Procedure
22147,1378,tests,I-Procedure
22148,1379,Ability,O
22149,1379,and,O
22150,1379,willingness,O
22151,1379,of,O
22152,1379,participant,O
22153,1379,or,O
22154,1379,a,O
22155,1379,legally,O
22156,1379,authorized,O
22157,1379,representative,O
22158,1379,(,O
22159,1379,see,O
22160,1379,protocol,O
22161,1379,for,O
22162,1379,more,O
22163,1379,information,O
22164,1379,),O
22165,1379,to,O
22166,1379,provide,O
22167,1379,informed,O
22168,1379,consent,O
22169,1380,Ability,O
22170,1380,and,O
22171,1380,willingness,O
22172,1380,to,O
22173,1380,take,O
22174,1380,oral,O
22175,1380,study,O
22176,1380,medications,O
22177,1381,Intracranial,B-Condition
22178,1381,infection,I-Condition
22179,1381,.,O
22180,1382,Severe,O
22181,1382,respiratory,B-Condition
22182,1382,and,I-Condition
22183,1382,circulatory,I-Condition
22184,1382,system,I-Condition
22185,1382,diseases,I-Condition
22186,1382,.,O
22187,1383,Hematologic,B-Condition
22188,1383,malignancies,I-Condition
22189,1383,.,O
22190,1384,Positive,O
22191,1384,serological,O
22192,1384,tests,O
22193,1384,such,O
22194,1384,as,O
22195,1384,AIDS,B-Condition
22196,1384,",",O
22197,1384,hepatitis,B-Condition
22198,1384,B,I-Condition
22199,1384,virus,I-Condition
22200,1384,",",O
22201,1384,hepatitis,B-Condition
22202,1384,C,I-Condition
22203,1384,virus,I-Condition
22204,1384,and,O
22205,1384,syphilis,B-Condition
22206,1384,（,O
22207,1384,antigen,O
22208,1384,or,O
22209,1384,antibody,O
22210,1384,）,O
22211,1384,.,O
22212,1385,Tumors,B-Condition
22213,1385,.,O
22214,1386,Genetic,B-Condition
22215,1386,and,I-Condition
22216,1386,metabolic,I-Condition
22217,1386,diseases,I-Condition
22218,1386,.,O
22219,1387,Patients,O
22220,1387,with,O
22221,1387,diagnosis,O
22222,1387,of,O
22223,1387,cerebral,B-Condition
22224,1387,palsy,I-Condition
22225,1387,.,O
22226,1388,Patients,O
22227,1388,',O
22228,1388,curator,O
22229,1388,must,O
22230,1388,be,O
22231,1388,able,O
22232,1388,to,O
22233,1388,give,O
22234,1388,voluntary,O
22235,1388,consent,O
22236,1388,.,O
22237,1389,Patients,O
22238,1389,unable,O
22239,1389,to,O
22240,1389,give,O
22241,1389,informed,O
22242,1389,consent,O
22243,1389,.,O
22244,1390,Any,O
22245,1390,patient,O
22246,1390,whose,O
22247,1390,condition,B-Condition
22248,1390,will,O
22249,1390,not,O
22250,1390,allow,B-Mood
22251,1390,for,O
22252,1390,placement,B-Procedure
22253,1390,of,O
22254,1390,the,O
22255,1390,electrode,O
22256,1390,PadSet,O
22257,1390,.,O
22258,1391,Patients,O
22259,1391,whose,O
22260,1391,tracheas,O
22261,1391,were,O
22262,1391,not,O
22263,1391,extubated,B-Procedure
22264,1391,in,O
22265,1391,OR,O
22266,1391,or,O
22267,1391,PACU,O
22268,1391,.,O
22269,1392,Patients,O
22270,1392,with,O
22271,1392,Impaired,B-Condition
22272,1392,Renal,I-Condition
22273,1392,Function,I-Condition
22274,1392,with,O
22275,1392,a,O
22276,1392,have,O
22277,1392,a,O
22278,1392,known,O
22279,1392,estimated,O
22280,1392,CrCl<30,O
22281,1392,ml,O
22282,1392,/,O
22283,1392,min,O
22284,1393,Patients,O
22285,1393,using,O
22286,1393,oral,B-Procedure
22287,1393,contraception,I-Procedure
22288,1393,.,O
22289,1394,Patients,O
22290,1394,undergoing,O
22291,1394,surgery,B-Procedure
22292,1394,with,O
22293,1394,general,B-Procedure
22294,1394,anesthesia,I-Procedure
22295,1394,",",O
22296,1395,Patients,O
22297,1395,weighing,O
22298,1395,=,O
22299,1395,80,O
22300,1395,pounds,O
22301,1395,who,O
22302,1395,are,O
22303,1395,not,O
22304,1395,-intubated,O
22305,1395,prior,O
22306,1395,to,O
22307,1395,surgery,B-Procedure
22308,1395,",",O
22309,1396,Patients,O
22310,1396,who,O
22311,1396,are,O
22312,1396,able,O
22313,1396,to,O
22314,1396,give,O
22315,1396,informed,O
22316,1396,consent,O
22317,1396,.,O
22318,1397,Existing,O
22319,1397,sacral,B-Condition
22320,1397,pressure,I-Condition
22321,1397,ulcer,I-Condition
22322,1397,",",O
22323,1397,undergoing,O
22324,1397,a,O
22325,1397,cardiac,B-Procedure
22326,1397,procedure,I-Procedure
22327,1397,",",O
22328,1397,or,O
22329,1397,inability,B-Condition
22330,1397,to,I-Condition
22331,1397,provide,I-Condition
22332,1397,informed,I-Condition
22333,1397,consent,I-Condition
22334,1397,.,O
22335,1398,Patients,O
22336,1398,undergoing,O
22337,1398,an,O
22338,1398,operation,B-Procedure
22339,1398,that,O
22340,1398,is,O
22341,1398,scheduled,O
22342,1398,to,O
22343,1398,last,O
22344,1398,more,O
22345,1398,than,O
22346,1398,2,O
22347,1398,hours,O
22348,1399,severe,O
22349,1399,coronary,B-Condition
22350,1399,artery,I-Condition
22351,1399,disease,I-Condition
22352,1399,",",O
22353,1399,heart,B-Condition
22354,1399,failure,I-Condition
22355,1399,",",O
22356,1399,kidney,B-Condition
22357,1399,failure,I-Condition
22358,1400,insulin,B-Condition
22359,1400,-,I-Condition
22360,1400,dependent,I-Condition
22361,1400,DM,I-Condition
22362,1400,(,O
22363,1400,diabetes,B-Condition
22364,1400,mellitus,I-Condition
22365,1400,),O
22366,1400,",",O
22367,1400,poorly,O
22368,1400,controlled,O
22369,1400,type,B-Condition
22370,1400,II,I-Condition
22371,1400,DM,I-Condition
22372,1401,gastric,B-Condition
22373,1401,/,I-Condition
22374,1401,duodenal,I-Condition
22375,1401,ulcer,I-Condition
22376,1402,allergy,B-Condition
22377,1402,/,O
22378,1402,contra,B-Condition
22379,1402,-,I-Condition
22380,1402,indication,I-Condition
22381,1402,for,O
22382,1402,any,O
22383,1402,drug,B-Drug
22384,1402,used,I-Drug
22385,1402,in,I-Drug
22386,1402,the,I-Drug
22387,1402,study,I-Drug
22388,1403,corticosteroid,B-Drug
22389,1403,use,O
22390,1403,during,O
22391,1403,last,O
22392,1403,3,O
22393,1403,months,O
22394,1404,preoperative,O
22395,1404,use,O
22396,1404,of,O
22397,1404,opioid,B-Drug
22398,1404,drugs,I-Drug
22399,1404,(,O
22400,1404,excl,O
22401,1404,.,O
22402,1404,codeine,B-Drug
22403,1404,",",O
22404,1404,tramadol,B-Drug
22405,1404,),O
22406,1405,neuropathy,B-Condition
22407,1405,/,O
22408,1405,sensory,B-Condition
22409,1405,impairment,I-Condition
22410,1405,of,O
22411,1405,lower,O
22412,1405,limbs,O
22413,1406,lack,B-Observation
22414,1406,of,I-Observation
22415,1406,co,I-Observation
22416,1406,-,I-Observation
22417,1406,operation,I-Observation
22418,1406,",",O
22419,1406,e.g.,O
22420,1406,inability,B-Condition
22421,1406,to,I-Condition
22422,1406,use,I-Condition
22423,1406,a,O
22424,1406,PCA,O
22425,1406,(,O
22426,1406,patient,O
22427,1406,controlled,O
22428,1406,analgesia)-device,O
22429,1407,primary,O
22430,1407,total,B-Procedure
22431,1407,knee,I-Procedure
22432,1407,replacement,I-Procedure
22433,1407,surgery,I-Procedure
22434,1408,ASA,O
22435,1408,(,O
22436,1408,american,O
22437,1408,society,O
22438,1408,of,O
22439,1408,anesthesiologists,O
22440,1408,),O
22441,1408,class,O
22442,1408,1,O
22443,1408,-,O
22444,1408,3,O
22445,1409,Unstable,O
22446,1409,vital,B-Condition
22447,1409,sign,I-Condition
22448,1409,before,O
22449,1409,surgery,B-Procedure
22450,1410,Severe,O
22451,1410,pulmonary,B-Condition
22452,1410,disease,I-Condition
22453,1410,requiring,B-Mood
22454,1410,consistent,B-Procedure
22455,1410,treatment,I-Procedure
22456,1411,Illiterate,B-Observation
22457,1412,Pregnancy,B-Condition
22458,1413,Patients,O
22459,1413,undergoing,O
22460,1413,thoracic,O
22461,1413,aorta,O
22462,1413,surgery,B-Procedure
22463,1413,with,O
22464,1413,hypothermic,B-Condition
22465,1413,circulatory,I-Condition
22466,1413,arrest,I-Condition
22467,1413,",",O
22468,1413,over,O
22469,1413,20,O
22470,1413,-,O
22471,1413,of,O
22472,1413,age,B-Person
22473,1414,Current,O
22474,1414,or,O
22475,1414,past,O
22476,1414,diagnoses,O
22477,1414,of,O
22478,1414,other,O
22479,1414,Axis,B-Condition
22480,1414,I,I-Condition
22481,1414,psychiatric,I-Condition
22482,1414,disorders,I-Condition
22483,1414,",",O
22484,1414,except,O
22485,1414,for,O
22486,1414,generalized,B-Condition
22487,1414,anxiety,I-Condition
22488,1414,disorder,I-Condition
22489,1414,(,I-Condition
22490,1414,GAD,I-Condition
22491,1414,),I-Condition
22492,1414,symptoms,O
22493,1414,occurring,O
22494,1414,during,O
22495,1414,a,O
22496,1414,depressive,B-Condition
22497,1414,episode,I-Condition
22498,1415,History,O
22499,1415,of,O
22500,1415,alcohol,B-Condition
22501,1415,or,I-Condition
22502,1415,drug,I-Condition
22503,1415,dependence,I-Condition
22504,1415,or,I-Condition
22505,1415,abuse,I-Condition
22506,1415,in,O
22507,1415,the,O
22508,1415,last,O
22509,1415,three,O
22510,1415,years,O
22511,1416,History,O
22512,1416,of,O
22513,1416,developmental,B-Condition
22514,1416,disorder,I-Condition
22515,1416,or,O
22516,1416,IQ,O
22517,1416,score,O
22518,1416,<,O
22519,1416,70,O
22520,1417,Presence,O
22521,1417,of,O
22522,1417,acute,B-Condition
22523,1417,suicidality,I-Condition
22524,1418,Acute,B-Condition
22525,1418,grief,I-Condition
22526,1418,(,O
22527,1418,<,O
22528,1418,1,O
22529,1418,month,O
22530,1418,),O
22531,1419,Current,O
22532,1419,or,O
22533,1419,past,O
22534,1419,psychosis,B-Condition
22535,1420,Primary,B-Condition
22536,1420,neurological,I-Condition
22537,1420,disorder,I-Condition
22538,1420,",",O
22539,1420,including,O
22540,1420,but,O
22541,1420,not,O
22542,1420,limited,O
22543,1420,to,O
22544,1420,dementia,B-Condition
22545,1420,",",O
22546,1420,stroke,B-Condition
22547,1420,",",O
22548,1420,brain,B-Condition
22549,1420,tumors,I-Condition
22550,1420,",",O
22551,1420,epilepsy,B-Condition
22552,1420,",",O
22553,1420,Parkinson,B-Condition
22554,1420,'s,I-Condition
22555,1420,disease,I-Condition
22556,1420,",",O
22557,1420,or,O
22558,1420,demyelinating,B-Condition
22559,1420,diseases,I-Condition
22560,1421,MRI,B-Procedure
22561,1421,contraindications,B-Condition
22562,1422,Any,O
22563,1422,physical,B-Condition
22564,1422,or,I-Condition
22565,1422,intellectual,I-Condition
22566,1422,disability,I-Condition
22567,1422,adversely,O
22568,1422,affecting,O
22569,1422,ability,O
22570,1422,to,O
22571,1422,complete,O
22572,1422,assessments,O
22573,1423,Electroconvulsive,B-Procedure
22574,1423,therapy,I-Procedure
22575,1423,in,O
22576,1423,last,O
22577,1423,6,O
22578,1423,months,O
22579,1424,Use,O
22580,1424,of,O
22581,1424,antidepressant,B-Drug
22582,1424,medications,I-Drug
22583,1424,or,O
22584,1424,other,O
22585,1424,psychotropic,B-Drug
22586,1424,medications,I-Drug
22587,1424,in,O
22588,1424,the,O
22589,1424,last,O
22590,1424,4,O
22591,1424,weeks,O
22592,1424,(,O
22593,1424,or,O
22594,1424,the,O
22595,1424,last,O
22596,1424,6,O
22597,1424,weeks,O
22598,1424,for,O
22599,1424,fluoxetine,B-Drug
22600,1424,),O
22601,1424,.,O
22602,1424,Occasional,O
22603,1424,use,O
22604,1424,of,O
22605,1424,benzodiazepines,B-Drug
22606,1424,or,I-Drug
22607,1424,non,I-Drug
22608,1424,-,I-Drug
22609,1424,benzodiazepine,I-Drug
22610,1424,sedatives,I-Drug
22611,1424,(,O
22612,1424,such,O
22613,1424,as,O
22614,1424,zolpidem,B-Drug
22615,1424,",",O
22616,1424,eszopiclone,B-Drug
22617,1424,",",O
22618,1424,or,O
22619,1424,zaleplon,B-Drug
22620,1424,),O
22621,1424,during,O
22622,1424,this,O
22623,1424,period,O
22624,1424,is,O
22625,1424,allowable,O
22626,1424,.,O
22627,1425,A,O
22628,1425,failed,O
22629,1425,therapeutic,B-Procedure
22630,1425,trial,I-Procedure
22631,1425,of,O
22632,1425,escitalopram,B-Drug
22633,1425,in,O
22634,1425,the,O
22635,1425,current,O
22636,1425,depressive,B-Condition
22637,1425,episode,I-Condition
22638,1425,(,O
22639,1425,defined,O
22640,1425,as,O
22641,1425,at,O
22642,1425,least,O
22643,1425,6,O
22644,1425,weeks,O
22645,1425,of,O
22646,1425,treatment,O
22647,1425,at,O
22648,1425,a,O
22649,1425,daily,O
22650,1425,dose,O
22651,1425,of,O
22652,1425,10,O
22653,1425,mg,O
22654,1425,or,O
22655,1425,higher,O
22656,1425,),O
22657,1426,Known,O
22658,1426,allergy,B-Condition
22659,1426,or,O
22660,1426,hypersensitivity,B-Condition
22661,1426,to,O
22662,1426,escitalopram,B-Drug
22663,1426,or,O
22664,1426,bupropion,B-Drug
22665,1427,Current,O
22666,1427,or,O
22667,1427,planned,B-Mood
22668,1427,psychotherapy,B-Procedure
22669,1428,Age,B-Person
22670,1428,60,O
22671,1428,years,O
22672,1428,or,O
22673,1428,older,O
22674,1428,.,O
22675,1429,Current,O
22676,1429,diagnosis,O
22677,1429,of,O
22678,1429,major,B-Condition
22679,1429,depressive,I-Condition
22680,1429,disorder,I-Condition
22681,1429,(,O
22682,1429,DSM,B-Procedure
22683,1429,-,I-Procedure
22684,1429,IV,I-Procedure
22685,1429,-,I-Procedure
22686,1429,TR,I-Procedure
22687,1429,),O
22688,1429,",",O
22689,1429,single,O
22690,1429,episode,O
22691,1429,",",O
22692,1429,recurrent,O
22693,1429,or,O
22694,1429,chronic,O
22695,1429,",",O
22696,1429,without,O
22697,1429,psychotic,B-Condition
22698,1429,features,I-Condition
22699,1429,",",O
22700,1429,as,O
22701,1429,detected,O
22702,1429,by,O
22703,1429,MINI,B-Procedure
22704,1429,and,O
22705,1429,clinical,B-Procedure
22706,1429,exam,I-Procedure
22707,1429,.,O
22708,1430,Minimum,O
22709,1430,MADRS,O
22710,1430,score,O
22711,1430,=,O
22712,1430,15,O
22713,1430,.,O
22714,1431,Mini,O
22715,1431,-,O
22716,1431,Mental,O
22717,1431,State,O
22718,1431,Exam,O
22719,1431,=,O
22720,1431,24,O
22721,1431,.,O
22722,1432,Fluent,O
22723,1432,in,O
22724,1432,English,O
22725,1432,.,O
22726,1433,History,B-Observation
22727,1433,of,O
22728,1433,spinal,B-Condition
22729,1433,cord,I-Condition
22730,1433,stenosis,I-Condition
22731,1433,or,O
22732,1433,clinical,B-Condition
22733,1433,symptoms,I-Condition
22734,1433,of,O
22735,1433,lumbar,B-Condition
22736,1433,radiculopathy,I-Condition
22737,1433,;,O
22738,1434,History,B-Observation
22739,1434,or,O
22740,1434,onset,O
22741,1434,neurological,B-Condition
22742,1434,diseases,I-Condition
22743,1434,;,O
22744,1435,Generalized,B-Condition
22745,1435,pain,I-Condition
22746,1435,or,O
22747,1435,fibromyalgia,B-Condition
22748,1435,;,O
22749,1436,Inability,B-Condition
22750,1436,to,I-Condition
22751,1436,walk,I-Condition
22752,1436,;,O
22753,1437,History,B-Observation
22754,1437,of,O
22755,1437,knee,B-Procedure
22756,1437,surgery,I-Procedure
22757,1437,in,O
22758,1437,the,O
22759,1437,target,O
22760,1437,knee,O
22761,1437,;,O
22762,1438,Secondary,B-Condition
22763,1438,causes,I-Condition
22764,1438,of,O
22765,1438,osteoarthritis,B-Condition
22766,1438,;,O
22767,1439,Use,O
22768,1439,of,O
22769,1439,statins,B-Drug
22770,1439,and,O
22771,1439,quinolones,B-Drug
22772,1439,in,O
22773,1439,the,O
22774,1439,previous,O
22775,1439,year,O
22776,1439,;,O
22777,1440,Uncontrolled,O
22778,1440,and,O
22779,1440,ongoing,O
22780,1440,psychiatric,B-Condition
22781,1440,diseases,I-Condition
22782,1440,;,O
22783,1441,Invasive,B-Procedure
22784,1441,knee,I-Procedure
22785,1441,treatments,I-Procedure
22786,1441,with,O
22787,1441,hyaluronic,B-Procedure
22788,1441,acid,I-Procedure
22789,1441,infusion,I-Procedure
22790,1441,",",O
22791,1441,corticosteroids,B-Drug
22792,1441,and,O
22793,1441,anaesthetics,B-Drug
22794,1441,",",O
22795,1441,in,O
22796,1441,the,O
22797,1441,target,O
22798,1441,knee,O
22799,1441,",",O
22800,1441,up,O
22801,1441,to,O
22802,1441,6,O
22803,1441,months,O
22804,1441,previous,O
22805,1441,to,O
22806,1441,study,O
22807,1441,inclusion,O
22808,1441,.,O
22809,1442,Clinical,O
22810,1442,and,O
22811,1442,radiologic,O
22812,1442,diagnosis,O
22813,1442,of,O
22814,1442,primary,B-Condition
22815,1442,knee,I-Condition
22816,1442,osteoarthritis,I-Condition
22817,1442,(,O
22818,1442,Kellgren,O
22819,1442,&,O
22820,1442,Lawrence,O
22821,1442,I,O
22822,1442,",",O
22823,1442,II,O
22824,1442,or,O
22825,1442,III,O
22826,1442,),O
22827,1442,;,O
22828,1443,Capability,O
22829,1443,to,O
22830,1443,understand,O
22831,1443,the,O
22832,1443,Informed,O
22833,1443,Consent,O
22834,1443,Form,O
22835,1443,;,O
22836,1444,Chronic,B-Condition
22837,1444,pain,I-Condition
22838,1444,for,O
22839,1444,at,O
22840,1444,least,O
22841,1444,3,O
22842,1444,months,O
22843,1444,prior,O
22844,1444,to,O
22845,1444,inclusion,O
22846,1444,",",O
22847,1444,measured,O
22848,1444,by,O
22849,1444,VAS,B-Procedure
22850,1444,.,O
22851,1444,(,O
22852,1444,VAS,O
22853,1444,4,O
22854,1444,or,O
22855,1444,above,O
22856,1444,),O
22857,1444,;,O
22858,1445,Absence,O
22859,1445,of,O
22860,1445,skin,B-Condition
22861,1445,injures,I-Condition
22862,1445,",",O
22863,1445,infections,B-Condition
22864,1445,or,O
22865,1445,tumor,B-Condition
22866,1445,in,O
22867,1445,the,O
22868,1445,target,O
22869,1445,knee,O
22870,1445,;,O
22871,1446,Availability,O
22872,1446,to,O
22873,1446,comply,O
22874,1446,with,O
22875,1446,the,O
22876,1446,visits,O
22877,1446,.,O
22878,1447,With,O
22879,1447,severe,O
22880,1447,systemic,B-Condition
22881,1447,alteration,I-Condition
22882,1447,;,O
22883,1448,In,O
22884,1448,the,O
22885,1448,use,O
22886,1448,of,O
22887,1448,antibiotics,B-Drug
22888,1448,and,O
22889,1448,anti,B-Drug
22890,1448,-,I-Drug
22891,1448,inflammatories,I-Drug
22892,1448,in,O
22893,1448,the,O
22894,1448,last,O
22895,1448,three,O
22896,1448,months,O
22897,1448,;,O
22898,1449,With,O
22899,1449,periodontium,O
22900,1449,with,O
22901,1449,periodontal,O
22902,1449,parameters,O
22903,1449,different,O
22904,1449,from,O
22905,1449,those,O
22906,1449,established,O
22907,1449,in,O
22908,1449,the,O
22909,1449,inclusion,O
22910,1449,criteria,O
22911,1449,.,O
22912,1450,Individuals,O
22913,1450,with,O
22914,1450,clinical,B-Condition
22915,1450,signs,I-Condition
22916,1450,of,I-Condition
22917,1450,parafunctional,I-Condition
22918,1450,habits,I-Condition
22919,1450,;,O
22920,1451,Smoking,B-Observation
22921,1451,;,O
22922,1452,Individuals,O
22923,1452,who,O
22924,1452,have,O
22925,1452,performed,O
22926,1452,other,B-Procedure
22927,1452,restorations,I-Procedure
22928,1452,in,O
22929,1452,the,O
22930,1452,last,O
22931,1452,12,O
22932,1452,months,O
22933,1452,;,O
22934,1453,Pregnant,B-Condition
22935,1453,women,B-Person
22936,1453,and,O
22937,1453,infants,B-Person
22938,1453,;,O
22939,1454,Periodontal,O
22940,1454,sites,O
22941,1454,that,O
22942,1454,presented,O
22943,1454,bleeding,O
22944,1454,during,O
22945,1454,crevicular,O
22946,1454,fluid,O
22947,1454,collection,O
22948,1454,or,O
22949,1454,sites,O
22950,1454,that,O
22951,1454,prevent,O
22952,1454,proper,O
22953,1454,collection,O
22954,1454,of,O
22955,1454,clinical,O
22956,1454,parameters,O
22957,1454,.,O
22958,1455,Over,O
22959,1455,18,O
22960,1455,years,O
22961,1455,of,O
22962,1455,age,B-Person
22963,1455,;,O
22964,1455,Systemically,B-Condition
22965,1455,healthy,I-Condition
22966,1455,;,O
22967,1455,Non,B-Condition
22968,1455,-,I-Condition
22969,1455,smoking,I-Condition
22970,1455,;,O
22971,1456,With,O
22972,1456,good,B-Observation
22973,1456,oral,I-Observation
22974,1456,hygiene,I-Observation
22975,1456,;,O
22976,1457,Absent,O
22977,1457,irreversible,B-Condition
22978,1457,pulpal,I-Condition
22979,1457,alteration,I-Condition
22980,1457,;,O
22981,1458,With,O
22982,1458,the,O
22983,1458,presence,O
22984,1458,of,O
22985,1458,a,O
22986,1458,non,B-Condition
22987,1458,-,I-Condition
22988,1458,carious,I-Condition
22989,1458,cervical,I-Condition
22990,1458,lesion,I-Condition
22991,1458,(,I-Condition
22992,1458,LCNCs,I-Condition
22993,1458,),I-Condition
22994,1458,that,O
22995,1458,needs,B-Mood
22996,1458,to,I-Mood
22997,1458,be,I-Mood
22998,1458,restored,B-Procedure
22999,1458,.,O
23000,1458,This,O
23001,1458,lesion,B-Condition
23002,1458,should,O
23003,1458,be,O
23004,1458,non,O
23005,1458,-,O
23006,1458,carious,O
23007,1458,",",O
23008,1458,non,O
23009,1458,-,O
23010,1458,retentive,O
23011,1458,",",O
23012,1458,with,O
23013,1458,at,O
23014,1458,least,O
23015,1458,1,O
23016,1458,mm,O
23017,1458,and,O
23018,1458,up,O
23019,1458,to,O
23020,1458,3,O
23021,1458,mm,O
23022,1458,depth,O
23023,1458,",",O
23024,1458,should,O
23025,1458,involve,O
23026,1458,both,O
23027,1458,enamel,O
23028,1458,and,O
23029,1458,dentin,O
23030,1458,of,O
23031,1458,vital,O
23032,1458,teeth,O
23033,1458,without,O
23034,1458,mobility,O
23035,1458,",",O
23036,1458,and,O
23037,1458,present,O
23038,1458,hypersensitivity,B-Condition
23039,1458,;,O
23040,1459,Presence,O
23041,1459,a,O
23042,1459,natural,O
23043,1459,tooth,O
23044,1459,of,O
23045,1459,the,O
23046,1459,same,O
23047,1459,position,O
23048,1459,of,O
23049,1459,the,O
23050,1459,restored,O
23051,1459,tooth,O
23052,1459,",",O
23053,1459,but,O
23054,1459,in,O
23055,1459,the,O
23056,1459,opposite,O
23057,1459,arch,O
23058,1459,of,O
23059,1459,the,O
23060,1459,same,O
23061,1459,jaw,O
23062,1459,to,O
23063,1459,be,O
23064,1459,considered,O
23065,1459,for,O
23066,1459,the,O
23067,1459,positive,O
23068,1459,control,O
23069,1459,;,O
23070,1460,Periodontal,O
23071,1460,parameters,O
23072,1460,:,O
23073,1460,Depth,O
23074,1460,Probing,O
23075,1460,(,O
23076,1460,PS,O
23077,1460,),O
23078,1460,",",O
23079,1460,Visible,O
23080,1460,Plaque,O
23081,1460,Index,O
23082,1460,(,O
23083,1460,IPV,O
23084,1460,),O
23085,1460,",",O
23086,1460,Gingival,O
23087,1460,Index,O
23088,1460,(,O
23089,1460,GI,O
23090,1460,),O
23091,1460,and,O
23092,1460,Probing,O
23093,1460,Bleed,O
23094,1460,Index,O
23095,1460,(,O
23096,1460,SS,O
23097,1460,),O
23098,1460,.,O
23099,1460,The,O
23100,1460,normal,O
23101,1460,included,O
23102,1460,were,O
23103,1460,:,O
23104,1460,PS,O
23105,1460,=,O
23106,1460,1,O
23107,1460,to,O
23108,1460,3,O
23109,1460,mm,O
23110,1460,",",O
23111,1460,GI,O
23112,1460,=,O
23113,1460,0,O
23114,1460,",",O
23115,1460,IPV,O
23116,1460,=,O
23117,1460,score,O
23118,1460,0,O
23119,1460,e,O
23120,1460,SS,O
23121,1460,=,O
23122,1460,score,O
23123,1460,0,O
23124,1460,.,O
23125,1461,use,O
23126,1461,of,O
23127,1461,any,O
23128,1461,sedative,B-Drug
23129,1461,hypnotics,I-Drug
23130,1461,",",O
23131,1461,tranquilizers,B-Drug
23132,1461,",",O
23133,1461,anticonvulsants,B-Drug
23134,1461,",",O
23135,1461,antihistamines,B-Drug
23136,1461,(,O
23137,1461,except,O
23138,1461,non,O
23139,1461,-,O
23140,1461,sedating,O
23141,1461,),O
23142,1461,",",O
23143,1461,benzodiazepines,B-Drug
23144,1461,",",O
23145,1461,clonidine,B-Drug
23146,1461,or,O
23147,1461,any,O
23148,1461,medication,B-Drug
23149,1461,known,I-Drug
23150,1461,to,I-Drug
23151,1461,affect,I-Drug
23152,1461,dopamine,I-Drug
23153,1461,at,O
23154,1461,start,O
23155,1461,of,O
23156,1461,baseline,O
23157,1461,period,O
23158,1462,significant,O
23159,1462,unstable,O
23160,1462,or,O
23161,1462,uncontrolled,O
23162,1462,medical,B-Condition
23163,1462,/,I-Condition
23164,1462,psychiatric,I-Condition
23165,1462,disease,I-Condition
23166,1463,significant,O
23167,1463,history,B-Observation
23168,1463,of,O
23169,1463,head,B-Procedure
23170,1463,trauma,I-Procedure
23171,1463,/,I-Procedure
23172,1463,surgery,I-Procedure
23173,1463,or,O
23174,1463,seizure,B-Condition
23175,1463,disorder,I-Condition
23176,1464,radiation,B-Condition
23177,1464,exposure,I-Condition
23178,1464,exceeding,O
23179,1464,20mSv,O
23180,1464,in,O
23181,1464,last,O
23182,1464,12,O
23183,1464,months,O
23184,1465,pregnancy,B-Condition
23185,1466,substance,B-Condition
23186,1466,abuse,I-Condition
23187,1466,/,I-Condition
23188,1466,dependence,I-Condition
23189,1466,(,O
23190,1466,including,O
23191,1466,alcohol,B-Drug
23192,1466,),O
23193,1467,have,O
23194,1467,sleep,B-Condition
23195,1467,apnea,I-Condition
23196,1467,",",O
23197,1467,or,O
23198,1467,are,O
23199,1467,shift,B-Person
23200,1467,workers,I-Person
23201,1468,on,O
23202,1468,a,O
23203,1468,sodium,B-Procedure
23204,1468,-,I-Procedure
23205,1468,restricted,I-Procedure
23206,1468,diet,I-Procedure
23207,1469,has,O
23208,1469,ever,O
23209,1469,taken,O
23210,1469,Xyrem,B-Drug
23211,1469,/,O
23212,1469,sodium,B-Drug
23213,1469,oxybate,I-Drug
23214,1469,/,O
23215,1469,GHB,B-Drug
23216,1469,at,O
23217,1469,any,O
23218,1469,time,O
23219,1470,claustrophobia,B-Condition
23220,1471,metal,O
23221,1471,implants,O
23222,1471,/,O
23223,1471,objects,O
23224,1471,in,O
23225,1471,the,O
23226,1471,body,O
23227,1471,that,O
23228,1471,may,B-Mood
23229,1471,interfere,I-Mood
23230,1471,with,I-Mood
23231,1471,MRI,B-Procedure
23232,1472,succinic,B-Condition
23233,1472,semialdehyde,I-Condition
23234,1472,dehydrogenase,I-Condition
23235,1472,deficiency,I-Condition
23236,1473,current,O
23237,1473,diagnosis,O
23238,1473,of,O
23239,1473,narcolepsy,B-Condition
23240,1473,with,O
23241,1473,cataplexy,B-Condition
23242,1473,OR,O
23243,1473,healthy,B-Condition
23244,1473,control,O
23245,1474,Patients,O
23246,1474,who,O
23247,1474,do,O
23248,1474,not,O
23249,1474,meet,B-Observation
23250,1474,the,I-Observation
23251,1474,inclusion,I-Observation
23252,1474,criteria,I-Observation
23253,1474,and,O
23254,1474,those,O
23255,1474,who,O
23256,1474,have,O
23257,1474,a,O
23258,1474,history,B-Observation
23259,1474,of,O
23260,1474,allergic,B-Condition
23261,1474,reactions,O
23262,1474,to,O
23263,1474,human,B-Drug
23264,1474,albumin,I-Drug
23265,1474,",",O
23266,1474,as,O
23267,1474,well,O
23268,1474,as,O
23269,1474,those,O
23270,1474,who,O
23271,1474,have,O
23272,1474,received,O
23273,1474,iodinated,B-Drug
23274,1474,contrast,I-Drug
23275,1474,during,O
23276,1474,the,O
23277,1474,7,O
23278,1474,days,O
23279,1474,prior,O
23280,1474,to,O
23281,1474,surgery,B-Procedure
23282,1474,and,O
23283,1474,pregnant,B-Condition
23284,1474,women,B-Person
23285,1474,",",O
23286,1474,will,O
23287,1474,be,O
23288,1474,excluded,O
23289,1474,from,O
23290,1474,the,O
23291,1474,study,O
23292,1474,.,O
23293,1475,Adult,B-Person
23294,1475,patients,O
23295,1475,(,O
23296,1475,>,O
23297,1475,18,O
23298,1475,years,B-Person
23299,1475,),O
23300,1475,scheduled,B-Mood
23301,1475,for,I-Mood
23302,1475,cardiopulmonary,B-Procedure
23303,1475,bypass,I-Procedure
23304,1475,surgery,I-Procedure
23305,1475,with,O
23306,1475,Glomerular,O
23307,1475,Filtration,O
23308,1475,Rate,O
23309,1475,(,O
23310,1475,GFR,O
23311,1475,),O
23312,1475,greater,O
23313,1475,than,O
23314,1475,or,O
23315,1475,equal,O
23316,1475,to,O
23317,1475,60,O
23318,1475,and,O
23319,1475,left,O
23320,1475,ventricular,O
23321,1475,ejection,O
23322,1475,fraction,O
23323,1475,greater,O
23324,1475,than,O
23325,1475,or,O
23326,1475,equal,O
23327,1475,to,O
23328,1475,40,O
23329,1475,%,O
23330,1476,Patients,O
23331,1476,with,O
23332,1476,a,O
23333,1476,history,B-Observation
23334,1476,of,O
23335,1476,any,O
23336,1476,other,O
23337,1476,malignancy,B-Condition
23338,1476,.,O
23339,1477,Concomitant,O
23340,1477,treatment,B-Procedure
23341,1477,with,O
23342,1477,any,O
23343,1477,other,O
23344,1477,anticancer,B-Procedure
23345,1477,therapy,I-Procedure
23346,1477,.,O
23347,1478,Patient,O
23348,1478,have,O
23349,1478,contraindication,B-Condition
23350,1478,to,O
23351,1478,chemotherapy(eg.uncontrolled,B-Procedure
23352,1478,coronarism,B-Condition
23353,1478,and,O
23354,1478,heart,B-Condition
23355,1478,failure,I-Condition
23356,1478,;,O
23357,1478,History,B-Observation
23358,1478,of,O
23359,1478,myocardial,B-Condition
23360,1478,infarction,I-Condition
23361,1478,within,O
23362,1478,the,O
23363,1478,past,O
23364,1478,6,O
23365,1478,months,O
23366,1478,",",O
23367,1478,Chronic,B-Condition
23368,1478,obstructive,I-Condition
23369,1478,pulmonary,I-Condition
23370,1478,",",O
23371,1478,uncontrolled,O
23372,1478,epileptic,B-Condition
23373,1478,attack,I-Condition
23374,1478,and,O
23375,1478,other,O
23376,1478,disease,B-Condition
23377,1478,that,O
23378,1478,investigator,O
23379,1478,consider,O
23380,1478,it,O
23381,1478,unsuitable,B-Condition
23382,1478,for,I-Condition
23383,1478,the,I-Condition
23384,1478,chemotherapy,I-Condition
23385,1478,),O
23386,1479,Before,O
23387,1479,participate,O
23388,1479,in,O
23389,1479,the,O
23390,1479,study,O
23391,1479,",",O
23392,1479,patients,O
23393,1479,must,O
23394,1479,understand,O
23395,1479,the,O
23396,1479,treatment,O
23397,1479,plan,O
23398,1479,and,O
23399,1479,willing,O
23400,1479,to,O
23401,1479,participate,O
23402,1479,in,O
23403,1479,the,O
23404,1479,study,O
23405,1479,.,O
23406,1479,Patients,O
23407,1479,must,O
23408,1479,have,O
23409,1479,signed,O
23410,1479,an,O
23411,1479,approved,O
23412,1479,informed,O
23413,1479,consent,O
23414,1479,.,O
23415,1480,Histopathologic,B-Procedure
23416,1480,confirmed,O
23417,1480,squamous,B-Condition
23418,1480,cell,I-Condition
23419,1480,carcinoma,I-Condition
23420,1480,of,O
23421,1480,head,O
23422,1480,and,O
23423,1480,neck,O
23424,1480,",",O
23425,1480,including,O
23426,1480,oral,O
23427,1480,cavity,O
23428,1480,",",O
23429,1480,oropharynx,O
23430,1480,",",O
23431,1480,larynx,O
23432,1480,",",O
23433,1480,or,O
23434,1480,hypopharynx,O
23435,1480,.,O
23436,1481,Ages=65,B-Person
23437,1481,years,O
23438,1481,",",O
23439,1481,Not,O
23440,1481,limited,O
23441,1481,to,O
23442,1481,gender,O
23443,1481,.,O
23444,1482,ECOG,O
23445,1482,performance,O
23446,1482,status,O
23447,1482,=,O
23448,1482,2,O
23449,1482,.,O
23450,1483,Patients,O
23451,1483,with,O
23452,1483,surgical,B-Procedure
23453,1483,contraindication,B-Condition
23454,1483,or,O
23455,1483,reject,B-Observation
23456,1483,to,O
23457,1483,surgery,B-Procedure
23458,1483,.,O
23459,1484,Postoperative,O
23460,1484,TNM(primary,O
23461,1484,tumor,O
23462,1484,",",O
23463,1484,regional,O
23464,1484,nodes,O
23465,1484,",",O
23466,1484,metastasis,O
23467,1484,),O
23468,1484,staging,O
23469,1484,III,O
23470,1484,~,O
23471,1484,IV,O
23472,1484,",",O
23473,1484,positive,O
23474,1484,surgical,O
23475,1484,margin,O
23476,1484,.,O
23477,1485,without,O
23478,1485,evidence,B-Mood
23479,1485,of,O
23480,1485,distant,B-Condition
23481,1485,metastases,I-Condition
23482,1485,.,O
23483,1486,No,O
23484,1486,contraindication,B-Condition
23485,1486,to,O
23486,1486,chemoradiotherapy,B-Procedure
23487,1486,.,O
23488,1487,Life,B-Observation
23489,1487,expectancy,I-Observation
23490,1487,>,O
23491,1487,3,O
23492,1487,months,O
23493,1487,.,O
23494,1488,Available,O
23495,1488,Organ,O
23496,1488,function,O
23497,1488,:,O
23498,1488,white,O
23499,1488,blood,O
23500,1488,cell=3.5×109,O
23501,1488,/,O
23502,1488,L,O
23503,1488,",",O
23504,1488,Neutrophils,O
23505,1488,=,O
23506,1488,1.5×109,O
23507,1488,/,O
23508,1488,L,O
23509,1488,",",O
23510,1488,Hemoglobin,O
23511,1488,=,O
23512,1488,80g,O
23513,1488,/,O
23514,1488,L,O
23515,1488,",",O
23516,1488,Blood,O
23517,1488,platelet>100×109,O
23518,1488,/,O
23519,1488,L,O
23520,1488,;,O
23521,1488,Alanine,O
23522,1488,aminotransferase,O
23523,1488,(,O
23524,1488,ALT,O
23525,1488,),O
23526,1488,and,O
23527,1488,Aspartate,O
23528,1488,aminotransferase,O
23529,1488,(,O
23530,1488,AST)=,O
23531,1488,2.5,O
23532,1488,upper,O
23533,1488,limit,O
23534,1488,of,O
23535,1488,normal(ULN,O
23536,1488,),O
23537,1488,;,O
23538,1488,Total,O
23539,1488,bilirubin,O
23540,1488,(,O
23541,1488,TBIL,O
23542,1488,),O
23543,1488,<,O
23544,1488,1.5,O
23545,1488,ULN;serum,O
23546,1488,creatinine=1.5,O
23547,1488,ULN,O
23548,1488,;,O
23549,1488,creatinine,O
23550,1488,clearance,O
23551,1488,of,O
23552,1488,=,O
23553,1488,50ml,O
23554,1488,/,O
23555,1488,min,O
23556,1489,age,B-Person
23557,1489,<,O
23558,1489,18,O
23559,1489,years,O
23560,1489,;,O
23561,1490,Pregnancy,B-Condition
23562,1491,inability,O
23563,1491,to,O
23564,1491,give,O
23565,1491,informed,O
23566,1491,written,O
23567,1491,consent,O
23568,1491,;,O
23569,1492,previous,O
23570,1492,thoracic,B-Procedure
23571,1492,surgery,I-Procedure
23572,1492,or,O
23573,1492,thrombolytic,B-Procedure
23574,1492,therapy,I-Procedure
23575,1492,for,O
23576,1492,pleural,B-Condition
23577,1492,infection,I-Condition
23578,1492,;,O
23579,1493,medical,B-Procedure
23580,1493,thoracoscopy,I-Procedure
23581,1493,can,B-Mood
23582,1493,not,I-Mood
23583,1493,be,I-Mood
23584,1493,performed,I-Mood
23585,1493,within,O
23586,1493,48,O
23587,1493,hours,O
23588,1493,;,O
23589,1494,inability,B-Condition
23590,1494,to,I-Condition
23591,1494,tolerate,I-Condition
23592,1494,procedure,B-Procedure
23593,1494,due,O
23594,1494,to,O
23595,1494,hemodynamic,B-Condition
23596,1494,instability,I-Condition
23597,1494,or,O
23598,1494,severe,O
23599,1494,hypoxemia,B-Condition
23600,1494,;,O
23601,1495,inability,B-Mood
23602,1495,to,I-Mood
23603,1495,correct,B-Procedure
23604,1495,coagulopathy,B-Condition
23605,1495,;,O
23606,1496,presence,O
23607,1496,of,O
23608,1496,a,O
23609,1496,homogeneously,B-Condition
23610,1496,echogenic,I-Condition
23611,1496,effusion,I-Condition
23612,1496,on,O
23613,1496,pleural,B-Procedure
23614,1496,US27,I-Procedure
23615,1496,-,O
23616,1497,CPPE,B-Condition
23617,1497,along,O
23618,1497,with,O
23619,1497,evidence,B-Mood
23620,1497,of,I-Mood
23621,1497,septated,B-Condition
23622,1497,pleural,I-Condition
23623,1497,effusion,I-Condition
23624,1497,on,O
23625,1497,pleural,B-Procedure
23626,1497,ultrasonography,I-Procedure
23627,1497,and/or,O
23628,1497,chest,B-Procedure
23629,1497,CT,I-Procedure
23630,1497,scan,I-Procedure
23631,1498,empyema,B-Condition
23632,1498,.,O
23633,1499,HIV,B-Condition
23634,1499,infection,I-Condition
23635,1499,at,O
23636,1499,screening,O
23637,1500,participation,O
23638,1500,in,O
23639,1500,previous,O
23640,1500,or,O
23641,1500,concurrent,O
23642,1500,HIV,O
23643,1500,vaccine,O
23644,1500,trials,O
23645,1501,lactating,O
23646,1501,",",O
23647,1501,pregnant,O
23648,1501,or,O
23649,1501,planning,O
23650,1501,pregnancy,O
23651,1502,renal,B-Condition
23652,1502,function,I-Condition
23653,1502,impairment,I-Condition
23654,1502,(,O
23655,1502,serum,O
23656,1502,creatinine,O
23657,1502,>,O
23658,1502,1.5,O
23659,1502,mg,O
23660,1502,/,O
23661,1502,dl,O
23662,1502,),O
23663,1502,",",O
23664,1502,Fanconi,B-Condition
23665,1502,syndrome,I-Condition
23666,1503,abnormal,O
23667,1503,liver,O
23668,1503,function,O
23669,1503,tests,O
23670,1503,(,O
23671,1503,AST,O
23672,1503,/,O
23673,1503,ALT,O
23674,1503,>,O
23675,1503,43,O
23676,1503,U,O
23677,1503,/,O
23678,1503,L,O
23679,1503,),O
23680,1503,",",O
23681,1503,liver,B-Condition
23682,1503,disease,I-Condition
23683,1503,",",O
23684,1503,viral,B-Condition
23685,1503,hepatitis,I-Condition
23686,1503,",",O
23687,1503,hepatitis,B-Condition
23688,1503,B,I-Condition
23689,1503,virus,I-Condition
23690,1503,(,I-Condition
23691,1503,HBV,I-Condition
23692,1503,),I-Condition
23693,1503,infection,I-Condition
23694,1504,serum,O
23695,1504,phosphorus,O
23696,1504,<,O
23697,1504,2.2mg,O
23698,1504,/,O
23699,1504,dl,O
23700,1504,",",O
23701,1504,osteoporosis,B-Condition
23702,1505,known,O
23703,1505,sensitivity,B-Condition
23704,1505,to,O
23705,1505,components,O
23706,1505,of,O
23707,1505,the,O
23708,1505,Truvada,B-Drug
23709,1505,®,O
23710,1505,formulation,O
23711,1506,any,O
23712,1506,immunosuppressive,B-Procedure
23713,1506,treatment,I-Procedure
23714,1506,",",O
23715,1506,such,O
23716,1506,as,O
23717,1506,systemic,B-Drug
23718,1506,corticosteroids,I-Drug
23719,1507,assumption,O
23720,1507,of,O
23721,1507,medication,O
23722,1507,that,O
23723,1507,interacts,O
23724,1507,with,O
23725,1507,Truvada,O
23726,1507,®,O
23727,1508,high,O
23728,1508,likelihood,O
23729,1508,of,O
23730,1508,poor,O
23731,1508,adherence,O
23732,1508,to,O
23733,1508,PREP,O
23734,1508,and,O
23735,1508,clinic,O
23736,1508,attendance,O
23737,1509,any,O
23738,1509,condition,O
23739,1509,that,O
23740,1509,in,O
23741,1509,the,O
23742,1509,opinion,O
23743,1509,of,O
23744,1509,the,O
23745,1509,attending,O
23746,1509,physician,O
23747,1509,could,O
23748,1509,endanger,O
23749,1509,the,O
23750,1509,health,O
23751,1509,of,O
23752,1509,the,O
23753,1509,participant,O
23754,1509,or,O
23755,1509,render,O
23756,1509,her,O
23757,1509,unsuitable,O
23758,1509,to,O
23759,1509,participate,O
23760,1509,in,O
23761,1509,the,O
23762,1509,trial,O
23763,1510,age,B-Person
23764,1510,=,O
23765,1510,18,O
23766,1510,at,O
23767,1510,screening,O
23768,1511,not,O
23769,1511,intending,O
23770,1511,to,O
23771,1511,move,O
23772,1511,away,O
23773,1511,from,O
23774,1511,the,O
23775,1511,clinic,O
23776,1511,'s,O
23777,1511,catchment,O
23778,1511,area,O
23779,1511,for,O
23780,1511,the,O
23781,1511,next,O
23782,1511,2,O
23783,1511,years,O
23784,1512,HIV-1,O
23785,1512,antibody,O
23786,1512,negative,O
23787,1513,reports,O
23788,1513,commercial,B-Observation
23789,1513,sex,I-Observation
23790,1513,work,I-Observation
23791,1514,contact,O
23792,1514,information,O
23793,1514,is,O
23794,1514,provided,O
23795,1515,written,O
23796,1515,informed,O
23797,1515,consent,O
23798,1516,NA,O
23799,1517,ASA,O
23800,1517,physical,O
23801,1517,status,O
23802,1517,1,O
23803,1517,or,O
23804,1517,2,O
23805,1518,Written,O
23806,1518,informed,O
23807,1518,consent,O
23808,1519,Cardiovascular,B-Condition
23809,1519,disease,I-Condition
23810,1520,Pulmonary,B-Condition
23811,1520,disease,I-Condition
23812,1521,Liver,B-Condition
23813,1521,disease,I-Condition
23814,1522,CNS,B-Condition
23815,1522,disease,I-Condition
23816,1523,Alcohol,B-Condition
23817,1523,or,I-Condition
23818,1523,drug,I-Condition
23819,1523,abuse,I-Condition
23820,1524,Chronic,O
23821,1524,intake,O
23822,1524,of,O
23823,1524,CNS,B-Drug
23824,1524,active,I-Drug
23825,1524,drugs,I-Drug
23826,1525,Body,O
23827,1525,mass,O
23828,1525,index,O
23829,1525,>,O
23830,1525,35,O
23831,1526,Diabetes,B-Condition
23832,1526,mellitus,I-Condition
23833,1527,Hypersensitivity,B-Condition
23834,1527,or,O
23835,1527,allergy,B-Condition
23836,1527,to,O
23837,1527,one,O
23838,1527,of,O
23839,1527,the,O
23840,1527,study,B-Drug
23841,1527,drugs,I-Drug
23842,1528,Current,O
23843,1528,pregnancy,B-Condition
23844,1529,Desire,B-Observation
23845,1529,/,I-Observation
23846,1529,intent,I-Observation
23847,1529,to,I-Observation
23848,1529,become,I-Observation
23849,1529,pregnant,I-Observation
23850,1529,over,O
23851,1529,the,O
23852,1529,course,O
23853,1529,of,O
23854,1529,the,O
23855,1529,study,O
23856,1530,Women,B-Person
23857,1530,who,O
23858,1530,are,O
23859,1530,less,O
23860,1530,than,O
23861,1530,6,O
23862,1530,weeks,O
23863,1530,postpartum,O
23864,1531,Contraindications,B-Observation
23865,1531,to,I-Observation
23866,1531,hormonal,I-Observation
23867,1531,contraceptive,I-Observation
23868,1531,use,O
23869,1531,per,O
23870,1531,package,O
23871,1531,insert,O
23872,1531,",",O
23873,1531,including,O
23874,1531,history,O
23875,1531,of,O
23876,1531,deep,B-Condition
23877,1531,vein,I-Condition
23878,1531,thrombosis,I-Condition
23879,1531,",",O
23880,1531,smoking,B-Observation
23881,1531,in,O
23882,1531,women,B-Person
23883,1531,older,O
23884,1531,than,O
23885,1531,35,O
23886,1531,years,O
23887,1532,Current,O
23888,1532,IUD,B-Procedure
23889,1533,Unable,O
23890,1533,to,O
23891,1533,comprehend,O
23892,1533,consent,O
23893,1533,material,O
23894,1533,because,O
23895,1533,of,O
23896,1533,language,O
23897,1533,barrier,O
23898,1533,or,O
23899,1533,psychological,O
23900,1533,difficulty,O
23901,1534,=,O
23902,1534,18,O
23903,1534,-,O
23904,1534,40,O
23905,1534,year,O
23906,1534,old,B-Person
23907,1534,women,B-Person
23908,1535,BV+,B-Condition
23909,1535,by,O
23910,1535,Amsel,O
23911,1535,criteria,O
23912,1535,and,O
23913,1535,Nugent,O
23914,1535,score,O
23915,1535,OR,O
23916,1535,history,O
23917,1535,of,O
23918,1535,BV,B-Condition
23919,1535,in,O
23920,1535,the,O
23921,1535,prior,O
23922,1535,6,O
23923,1535,months,O
23924,1536,Willing,B-Observation
23925,1536,to,I-Observation
23926,1536,use,I-Observation
23927,1536,the,O
23928,1536,NuvaRing,B-Drug
23929,1536,as,O
23930,1536,directed,O
23931,1537,Not,O
23932,1537,intending,O
23933,1537,or,O
23934,1537,wishing,O
23935,1537,to,O
23936,1537,become,O
23937,1537,pregnant,O
23938,1537,over,O
23939,1537,the,O
23940,1537,course,O
23941,1537,of,O
23942,1537,the,O
23943,1537,study,O
23944,1538,Capable,B-Observation
23945,1538,of,I-Observation
23946,1538,providing,I-Observation
23947,1538,written,I-Observation
23948,1538,informed,I-Observation
23949,1538,consent,I-Observation
23950,1539,Central,B-Condition
23951,1539,+,I-Condition
23952,1539,mixed,I-Condition
23953,1539,apneas,I-Condition
23954,1539,>,O
23955,1539,25,O
23956,1539,%,O
23957,1539,of,O
23958,1539,the,O
23959,1539,total,O
23960,1539,apnea,O
23961,1539,-,O
23962,1539,hypopnea,O
23963,1539,index,O
23964,1539,(,O
23965,1539,AHI,O
23966,1539,),O
23967,1540,Any,O
23968,1540,anatomical,O
23969,1540,finding,O
23970,1540,that,O
23971,1540,would,O
23972,1540,compromise,O
23973,1540,the,O
23974,1540,performance,O
23975,1540,of,O
23976,1540,upper,O
23977,1540,airway,O
23978,1540,stimulation,O
23979,1540,",",O
23980,1540,such,O
23981,1540,as,O
23982,1540,the,O
23983,1540,presence,O
23984,1540,of,O
23985,1540,complete,O
23986,1540,concentric,O
23987,1540,collapse,O
23988,1540,of,O
23989,1540,the,O
23990,1540,soft,O
23991,1540,palate,O
23992,1541,Any,O
23993,1541,condition,O
23994,1541,or,O
23995,1541,procedure,O
23996,1541,that,O
23997,1541,has,O
23998,1541,compromised,O
23999,1541,neurological,O
24000,1541,control,O
24001,1541,of,O
24002,1541,the,O
24003,1541,upper,O
24004,1541,airway,O
24005,1542,Patients,O
24006,1542,who,O
24007,1542,are,O
24008,1542,unable,O
24009,1542,or,O
24010,1542,do,O
24011,1542,not,O
24012,1542,have,O
24013,1542,the,O
24014,1542,necessary,O
24015,1542,assistance,O
24016,1542,to,O
24017,1542,operate,O
24018,1542,the,O
24019,1542,patient,O
24020,1542,remote,O
24021,1543,Patients,O
24022,1543,who,O
24023,1543,are,O
24024,1543,pregnant,O
24025,1543,or,O
24026,1543,plan,O
24027,1543,to,O
24028,1543,become,O
24029,1543,pregnant,O
24030,1544,Patients,O
24031,1544,who,O
24032,1544,will,O
24033,1544,require,O
24034,1544,magnetic,B-Procedure
24035,1544,resonance,I-Procedure
24036,1544,imaging,I-Procedure
24037,1544,(,O
24038,1544,MRI,B-Procedure
24039,1544,),O
24040,1545,Patients,O
24041,1545,with,O
24042,1545,an,O
24043,1545,implantable,O
24044,1545,device,O
24045,1545,that,O
24046,1545,may,O
24047,1545,be,O
24048,1545,susceptible,O
24049,1545,to,O
24050,1545,unintended,O
24051,1545,interaction,O
24052,1545,with,O
24053,1545,the,O
24054,1545,Inspire,O
24055,1545,system,O
24056,1545,.,O
24057,1546,Body,O
24058,1546,Mass,O
24059,1546,Index,O
24060,1546,(,O
24061,1546,BMI,O
24062,1546,),O
24063,1546,of,O
24064,1546,>,O
24065,1546,32,O
24066,1547,Any,O
24067,1547,chronic,O
24068,1547,medical,O
24069,1547,illness,O
24070,1547,or,O
24071,1547,condition,O
24072,1547,that,O
24073,1547,contraindicates,B-Condition
24074,1547,a,O
24075,1547,surgical,B-Procedure
24076,1547,procedure,I-Procedure
24077,1547,under,O
24078,1547,general,B-Procedure
24079,1547,anesthesia,I-Procedure
24080,1547,",",O
24081,1547,as,O
24082,1547,judged,O
24083,1547,by,O
24084,1547,the,O
24085,1547,clinical,O
24086,1547,study,O
24087,1547,Investigator,O
24088,1548,Has,O
24089,1548,a,O
24090,1548,terminal,O
24091,1548,illness,O
24092,1548,with,O
24093,1548,life,B-Observation
24094,1548,expectancy,I-Observation
24095,1548,<,O
24096,1548,12,O
24097,1548,months,O
24098,1549,Active,O
24099,1549,psychiatric,B-Condition
24100,1549,disease,I-Condition
24101,1549,(,O
24102,1549,psychotic,B-Condition
24103,1549,illness,I-Condition
24104,1549,",",O
24105,1549,major,B-Condition
24106,1549,depression,I-Condition
24107,1549,",",O
24108,1549,or,O
24109,1549,acute,B-Condition
24110,1549,anxiety,I-Condition
24111,1549,attacks,I-Condition
24112,1549,),O
24113,1549,which,O
24114,1549,prevents,O
24115,1549,subject,O
24116,1549,compliance,O
24117,1549,with,O
24118,1549,the,O
24119,1549,requirements,O
24120,1549,of,O
24121,1549,the,O
24122,1549,investigational,O
24123,1549,study,O
24124,1549,testing,O
24125,1550,Any,O
24126,1550,other,O
24127,1550,reason,O
24128,1550,the,O
24129,1550,investigator,O
24130,1550,deems,O
24131,1550,subject,O
24132,1550,is,O
24133,1550,unfit,O
24134,1550,for,O
24135,1550,participation,O
24136,1550,in,O
24137,1550,the,O
24138,1550,study,O
24139,1551,Likely,O
24140,1551,suffer,O
24141,1551,moderate,O
24142,1551,-,O
24143,1551,to,O
24144,1551,-,O
24145,1551,severe,O
24146,1551,OSA,B-Condition
24147,1551,based,O
24148,1551,on,O
24149,1551,history,O
24150,1551,and,O
24151,1551,physical,O
24152,1551,or,O
24153,1551,have,O
24154,1551,an,O
24155,1551,established,O
24156,1551,diagnosis,O
24157,1551,of,O
24158,1551,OSA,B-Condition
24159,1551,(,O
24160,1551,20,O
24161,1551,=,O
24162,1551,AHI=65,O
24163,1551,),O
24164,1551,based,O
24165,1551,on,O
24166,1551,a,O
24167,1551,prior,O
24168,1551,in,O
24169,1551,-,O
24170,1551,lab,O
24171,1551,Polysomnography,O
24172,1552,Documentation,O
24173,1552,the,O
24174,1552,subject,O
24175,1552,not,O
24176,1552,effectively,O
24177,1552,treated,O
24178,1552,with,O
24179,1552,CPAP,B-Procedure
24180,1552,therapy,I-Procedure
24181,1552,.,O
24182,1552,(,O
24183,1552,Examples,O
24184,1552,include,O
24185,1552,non,O
24186,1552,-,O
24187,1552,compliance,O
24188,1552,",",O
24189,1552,discomfort,O
24190,1552,",",O
24191,1552,undesirable,O
24192,1552,side,O
24193,1552,effects,O
24194,1552,",",O
24195,1552,symptoms,O
24196,1552,persist,O
24197,1552,despite,O
24198,1552,use,O
24199,1552,),O
24200,1552,.,O
24201,1552,Subjects,O
24202,1552,who,O
24203,1552,have,O
24204,1552,been,O
24205,1552,prescribed,O
24206,1552,",",O
24207,1552,but,O
24208,1552,refuse,O
24209,1552,to,O
24210,1552,try,O
24211,1552,CPAP,O
24212,1552,would,O
24213,1552,be,O
24214,1552,considered,O
24215,1552,intolerant,O
24216,1552,.,O
24217,1553,Age,B-Person
24218,1553,22,O
24219,1553,or,O
24220,1553,above,O
24221,1554,Willing,O
24222,1554,and,O
24223,1554,capable,O
24224,1554,to,O
24225,1554,have,O
24226,1554,stimulation,O
24227,1554,hardware,O
24228,1554,permanently,O
24229,1554,implanted,O
24230,1554,",",O
24231,1554,and,O
24232,1554,to,O
24233,1554,use,O
24234,1554,the,O
24235,1554,patient,O
24236,1554,remote,O
24237,1554,to,O
24238,1554,activate,O
24239,1554,the,O
24240,1554,stimulation,O
24241,1555,Willing,O
24242,1555,and,O
24243,1555,capable,O
24244,1555,to,O
24245,1555,return,O
24246,1555,for,O
24247,1555,all,O
24248,1555,follow,O
24249,1555,-,O
24250,1555,up,O
24251,1555,visits,O
24252,1555,and,O
24253,1555,conduct,O
24254,1555,sleep,O
24255,1555,studies,O
24256,1555,at,O
24257,1555,home,O
24258,1555,",",O
24259,1555,including,O
24260,1555,the,O
24261,1555,evaluation,O
24262,1555,procedures,O
24263,1555,and,O
24264,1555,filling,O
24265,1555,out,O
24266,1555,questionnaires,O
24267,1556,Willing,O
24268,1556,and,O
24269,1556,capable,O
24270,1556,of,O
24271,1556,providing,O
24272,1556,informed,O
24273,1556,consent,O
24274,1557,NA,O
24275,1558,Aged,B-Person
24276,1558,between,O
24277,1558,18,O
24278,1558,-,O
24279,1558,70,O
24280,1558,years,O
24281,1559,Meets,O
24282,1559,the,O
24283,1559,Diagnostic,O
24284,1559,and,O
24285,1559,Statistical,O
24286,1559,Manual,O
24287,1559,(,O
24288,1559,DSM,O
24289,1559,),O
24290,1559,IV,O
24291,1559,and,O
24292,1559,DSM,O
24293,1559,-,O
24294,1559,V,O
24295,1559,diagnostic,O
24296,1559,criteria,O
24297,1559,for,O
24298,1559,generalised,B-Condition
24299,1559,anxiety,I-Condition
24300,1559,disorder,I-Condition
24301,1559,(,O
24302,1559,GAD,B-Condition
24303,1559,),O
24304,1559,based,O
24305,1559,on,O
24306,1559,structured,B-Procedure
24307,1559,interview,I-Procedure
24308,1559,(,O
24309,1559,Mini,B-Procedure
24310,1559,International,I-Procedure
24311,1559,Neuropsychiatric,I-Procedure
24312,1559,Interview,I-Procedure
24313,1559,-,I-Procedure
24314,1559,Plus,I-Procedure
24315,1559,6,I-Procedure
24316,1559,[,I-Procedure
24317,1559,MINI,I-Procedure
24318,1559,-,I-Procedure
24319,1559,Plus,I-Procedure
24320,1559,6,I-Procedure
24321,1559,],I-Procedure
24322,1559,.,O
24323,1559,Note,O
24324,1559,that,O
24325,1559,while,O
24326,1559,the,O
24327,1559,MINI,O
24328,1559,-,O
24329,1559,Plus,O
24330,1559,6,O
24331,1559,uses,O
24332,1559,the,O
24333,1559,DSM,O
24334,1559,-,O
24335,1559,IV,O
24336,1559,criteria,O
24337,1559,",",O
24338,1559,the,O
24339,1559,same,O
24340,1559,criteria,O
24341,1559,are,O
24342,1559,used,O
24343,1559,in,O
24344,1559,the,O
24345,1559,DSM,O
24346,1559,-,O
24347,1559,V,O
24348,1559,),O
24349,1559,.,O
24350,1560,Presents,O
24351,1560,with,O
24352,1560,anxiety,B-Condition
24353,1560,(,O
24354,1560,Hamilton,O
24355,1560,Anxiety,O
24356,1560,Rating,O
24357,1560,Scale,O
24358,1560,=,O
24359,1560,18,O
24360,1560,),O
24361,1560,at,O
24362,1560,the,O
24363,1560,time,O
24364,1560,of,O
24365,1560,study,O
24366,1560,entry,O
24367,1561,Fluent,O
24368,1561,in,O
24369,1561,written,O
24370,1561,and,O
24371,1561,spoken,O
24372,1561,English,O
24373,1562,Provides,O
24374,1562,a,O
24375,1562,signed,O
24376,1562,copy,O
24377,1562,of,O
24378,1562,the,O
24379,1562,consent,O
24380,1562,form,O
24381,1563,Primary,B-Condition
24382,1563,diagnosis,I-Condition
24383,1563,other,O
24384,1563,than,O
24385,1563,GAD,B-Condition
24386,1564,Presentation,O
24387,1564,of,O
24388,1564,moderate,O
24389,1564,to,O
24390,1564,severe,O
24391,1564,depressive,B-Condition
24392,1564,symptoms,I-Condition
24393,1564,(,O
24394,1564,Montgomery,O
24395,1564,-,O
24396,1564,Asberg,O
24397,1564,Rating,O
24398,1564,Scale,O
24399,1564,:,O
24400,1564,MADRS,O
24401,1564,=,O
24402,1564,18,O
24403,1564,at,O
24404,1564,time,O
24405,1564,of,O
24406,1564,study,O
24407,1564,entry,O
24408,1564,or,O
24409,1564,=,O
24410,1564,24,O
24411,1564,at,O
24412,1564,any,O
24413,1564,time,O
24414,1564,during,O
24415,1564,study,O
24416,1564,),O
24417,1565,Presentation,O
24418,1565,of,O
24419,1565,suicidal,B-Condition
24420,1565,ideation,I-Condition
24421,1565,(=,O
24422,1565,3,O
24423,1565,on,O
24424,1565,MADRS,O
24425,1565,suicidal,O
24426,1565,thoughts,O
24427,1565,domain,O
24428,1565,at,O
24429,1565,time,O
24430,1565,of,O
24431,1565,study,O
24432,1565,entry,O
24433,1565,or,O
24434,1565,at,O
24435,1565,any,O
24436,1565,time,O
24437,1565,during,O
24438,1565,study,O
24439,1565,),O
24440,1566,Current,O
24441,1566,diagnosis,O
24442,1566,of,O
24443,1566,bipolar,B-Condition
24444,1566,disorder,I-Condition
24445,1566,or,O
24446,1566,schizophrenia,B-Condition
24447,1566,on,O
24448,1566,structured,O
24449,1566,interview,O
24450,1566,(,O
24451,1566,MINI,O
24452,1566,Plus,O
24453,1566,),O
24454,1567,Current,O
24455,1567,substance,B-Condition
24456,1567,/,I-Condition
24457,1567,alcohol,I-Condition
24458,1567,use,I-Condition
24459,1567,disorder,I-Condition
24460,1567,on,O
24461,1567,structured,O
24462,1567,interview,O
24463,1567,(,O
24464,1567,MINI,O
24465,1567,Plus,O
24466,1567,),O
24467,1567,Page,O
24468,1567,21,O
24469,1567,of,O
24470,1567,39,O
24471,1567,Commercial,O
24472,1567,-,O
24473,1567,in,O
24474,1567,-,O
24475,1567,Confidence,O
24476,1568,Currently,O
24477,1568,taking,B-Condition
24478,1568,an,O
24479,1568,antidepressant,B-Drug
24480,1568,",",O
24481,1568,mood,B-Drug
24482,1568,stabiliser,I-Drug
24483,1568,",",O
24484,1568,antipsychotic,B-Drug
24485,1568,",",O
24486,1568,anticonvulsant,B-Drug
24487,1568,",",O
24488,1568,warfarin,B-Drug
24489,1568,or,O
24490,1568,thyroxin,B-Drug
24491,1568,",",O
24492,1568,or,O
24493,1568,current,O
24494,1568,regular,O
24495,1568,use,B-Procedure
24496,1568,(,O
24497,1568,more,O
24498,1568,than,O
24499,1568,2,O
24500,1568,days,O
24501,1568,per,O
24502,1568,week,O
24503,1568,),O
24504,1568,of,O
24505,1568,a,O
24506,1568,benzodiazepine,B-Drug
24507,1568,or,O
24508,1568,opioid,B-Drug
24509,1568,-,I-Drug
24510,1568,based,I-Drug
24511,1568,analgesic,I-Drug
24512,1569,Current,O
24513,1569,use,B-Procedure
24514,1569,of,O
24515,1569,a,O
24516,1569,psychotropic,B-Drug
24517,1569,nutraceutical,I-Drug
24518,1569,(,O
24519,1569,e.g.,O
24520,1569,St,B-Condition
24521,1569,John,I-Condition
24522,1569,'s,I-Condition
24523,1569,wort,I-Condition
24524,1569,),O
24525,1570,Previous,O
24526,1570,intolerance,B-Condition
24527,1570,to,O
24528,1570,kava,B-Drug
24529,1571,Three,O
24530,1571,or,O
24531,1571,more,O
24532,1571,failed,O
24533,1571,trials,B-Procedure
24534,1571,of,I-Procedure
24535,1571,pharmacotherapy,I-Procedure
24536,1571,for,O
24537,1571,the,O
24538,1571,current,O
24539,1571,GAD,B-Condition
24540,1571,episode,I-Condition
24541,1572,Recently,O
24542,1572,commenced,O
24543,1572,psychotherapy,B-Procedure
24544,1572,(,O
24545,1572,within,O
24546,1572,four,O
24547,1572,weeks,O
24548,1572,of,O
24549,1572,study,O
24550,1572,entry,O
24551,1572,),O
24552,1573,Known,B-Mood
24553,1573,or,O
24554,1573,suspected,B-Mood
24555,1573,clinically,O
24556,1573,unstable,O
24557,1573,systemic,O
24558,1573,medical,B-Condition
24559,1573,disorder,I-Condition
24560,1574,Diagnosed,O
24561,1574,hepato,B-Condition
24562,1574,-,I-Condition
24563,1574,biliary,I-Condition
24564,1574,disease,I-Condition
24565,1574,/,I-Condition
24566,1574,inflammation,I-Condition
24567,1575,Elevated,O
24568,1575,liver,O
24569,1575,enzymes,O
24570,1575,at,O
24571,1575,baseline,O
24572,1575,blood,B-Procedure
24573,1575,test,I-Procedure
24574,1576,Pregnancy,B-Condition
24575,1576,or,O
24576,1576,breastfeeding,B-Observation
24577,1576,",",O
24578,1576,or,O
24579,1576,trying,B-Condition
24580,1576,to,I-Condition
24581,1576,conceive,I-Condition
24582,1577,Not,O
24583,1577,using,O
24584,1577,medically,O
24585,1577,approved,O
24586,1577,contraception,B-Procedure
24587,1577,(,O
24588,1577,including,O
24589,1577,abstinence,B-Procedure
24590,1577,),O
24591,1577,if,O
24592,1577,female,B-Person
24593,1577,and,O
24594,1577,of,O
24595,1577,childbearing,B-Person
24596,1577,age,I-Person
24597,1578,Unable,B-Observation
24598,1578,to,I-Observation
24599,1578,participate,I-Observation
24600,1578,in,O
24601,1578,all,O
24602,1578,scheduled,O
24603,1578,visits,O
24604,1578,",",O
24605,1578,treatment,B-Observation
24606,1578,plan,I-Observation
24607,1578,",",O
24608,1578,or,O
24609,1578,other,O
24610,1578,trial,B-Procedure
24611,1578,procedures,I-Procedure
24612,1578,according,O
24613,1578,to,O
24614,1578,the,O
24615,1578,protocol,O
24616,1578,(,O
24617,1578,except,O
24618,1578,for,O
24619,1578,the,O
24620,1578,optional,O
24621,1578,genetic,B-Observation
24622,1578,component,I-Observation
24623,1578,),O
24624,1579,Body,O
24625,1579,mass,O
24626,1579,index,O
24627,1579,less,O
24628,1579,than,O
24629,1579,18,O
24630,1579,kg,O
24631,1579,/,O
24632,1579,m2,O
24633,1579,or,O
24634,1579,greater,O
24635,1579,than,O
24636,1579,30,O
24637,1579,kg,O
24638,1579,/,O
24639,1579,m2,O
24640,1579,.,O
24641,1580,History,B-Observation
24642,1580,of,O
24643,1580,previous,O
24644,1580,open,B-Procedure
24645,1580,-,I-Procedure
24646,1580,laparotomy,I-Procedure
24647,1580,.,O
24648,1581,Surgery,B-Procedure
24649,1581,with,O
24650,1581,major,B-Condition
24651,1581,complication,I-Condition
24652,1581,",",O
24653,1581,or,O
24654,1581,need,B-Mood
24655,1581,blood,B-Condition
24656,1581,transfusion,I-Condition
24657,1581,.,O
24658,1582,History,O
24659,1582,of,O
24660,1582,hypersensitivity,B-Condition
24661,1582,or,O
24662,1582,adverse,B-Condition
24663,1582,reaction,I-Condition
24664,1582,to,O
24665,1582,local,B-Drug
24666,1582,anesthetics,I-Drug
24667,1582,",",O
24668,1582,opioid,B-Drug
24669,1582,",",O
24670,1582,or,O
24671,1582,any,O
24672,1582,ingredient,B-Drug
24673,1582,of,I-Drug
24674,1582,the,I-Drug
24675,1582,medications,I-Drug
24676,1582,administered,I-Drug
24677,1582,in,I-Drug
24678,1582,this,I-Drug
24679,1582,study,I-Drug
24680,1582,.,O
24681,1583,Severe,O
24682,1583,comorbidity,B-Condition
24683,1583,.,O
24684,1584,Chronic,O
24685,1584,preoperative,O
24686,1584,opioid,B-Drug
24687,1584,consumption,O
24688,1584,.,O
24689,1585,Pregnant,B-Condition
24690,1585,or,O
24691,1585,breastfeeding,B-Observation
24692,1585,.,O
24693,1586,Inability,B-Condition
24694,1586,to,O
24695,1586,use,B-Procedure
24696,1586,the,I-Procedure
24697,1586,PCA,I-Procedure
24698,1586,device,O
24699,1586,.,O
24700,1587,Male,B-Person
24701,1587,or,O
24702,1587,female,B-Person
24703,1587,who,O
24704,1587,is,O
24705,1587,among,O
24706,1587,20,O
24707,1587,to,O
24708,1587,80,O
24709,1587,years,O
24710,1587,of,O
24711,1587,age,B-Person
24712,1587,at,O
24713,1587,screening,O
24714,1587,.,O
24715,1588,Scheduled,B-Mood
24716,1588,to,O
24717,1588,electively,B-Mood
24718,1588,undergo,O
24719,1588,open,B-Procedure
24720,1588,-,I-Procedure
24721,1588,laparotomy,I-Procedure
24722,1588,.,O
24723,1589,American,O
24724,1589,Society,O
24725,1589,of,O
24726,1589,Anesthesiology,O
24727,1589,Physical,O
24728,1589,Class,O
24729,1589,1,O
24730,1589,-,O
24731,1589,3,O
24732,1589,.,O
24733,1590,Ability,O
24734,1590,and,O
24735,1590,willingness,O
24736,1590,to,O
24737,1590,provide,O
24738,1590,informed,O
24739,1590,consent,O
24740,1591,Teeth,O
24741,1591,with,O
24742,1591,clinical,O
24743,1591,symptoms,O
24744,1591,of,O
24745,1591,irriversible,B-Condition
24746,1591,pulpitis,I-Condition
24747,1591,or,O
24748,1591,pulp,B-Condition
24749,1591,necrosis,I-Condition
24750,1591,or,O
24751,1591,acute,B-Condition
24752,1591,dental,I-Condition
24753,1591,infection,I-Condition
24754,1592,Children,O
24755,1592,with,O
24756,1592,systemic,B-Condition
24757,1592,illness,I-Condition
24758,1592,that,O
24759,1592,contraindicated,B-Condition
24760,1592,vital,B-Procedure
24761,1592,pulp,I-Procedure
24762,1592,treatment,I-Procedure
24763,1592,such,O
24764,1592,a,O
24765,1592,sickle,B-Condition
24766,1592,cell,I-Condition
24767,1592,disease,I-Condition
24768,1593,Teeth,B-Observation
24769,1593,that,I-Observation
24770,1593,are,I-Observation
24771,1593,not,I-Observation
24772,1593,restorable,I-Observation
24773,1594,Pediatric,B-Person
24774,1594,patients,O
24775,1594,with,O
24776,1594,deep,B-Condition
24777,1594,dental,I-Condition
24778,1594,decay,I-Condition
24779,1594,in,O
24780,1594,primary,O
24781,1594,molars,O
24782,1595,Teeth,O
24783,1595,with,O
24784,1595,signs,O
24785,1595,and,O
24786,1595,symptoms,O
24787,1595,of,O
24788,1595,reversible,B-Condition
24789,1595,pulpitis,I-Condition
24790,1596,Chronic,B-Condition
24791,1596,pain,I-Condition
24792,1596,more,O
24793,1596,than,O
24794,1596,3,O
24795,1596,months,O
24796,1597,Drug,B-Condition
24797,1597,abuse,I-Condition
24798,1598,Chronic,O
24799,1598,use,O
24800,1598,of,O
24801,1598,analgesic,B-Drug
24802,1598,drugs,I-Drug
24803,1598,(,O
24804,1598,more,O
24805,1598,than,O
24806,1598,3,O
24807,1598,months,O
24808,1598,),O
24809,1599,Psychiatric,B-Condition
24810,1599,illness,I-Condition
24811,1600,Peripheral,B-Condition
24812,1600,neuropathy,I-Condition
24813,1601,Drug,B-Drug
24814,1601,allergy,B-Condition
24815,1602,Severe,O
24816,1602,gastroesophageal,B-Condition
24817,1602,reflux,I-Condition
24818,1602,disease,I-Condition
24819,1603,Male,B-Person
24820,1603,sex,O
24821,1604,ASA,O
24822,1604,status,O
24823,1604,I,O
24824,1604,or,O
24825,1604,II,O
24826,1605,BMI,O
24827,1605,between,O
24828,1605,20,O
24829,1605,and,O
24830,1605,34,O
24831,1605,kg,O
24832,1605,/,O
24833,1605,m2,O
24834,1606,Cruciate,O
24835,1606,ligament,O
24836,1606,of,O
24837,1606,the,O
24838,1606,knee,O
24839,1606,reconstructive,B-Procedure
24840,1606,surgery,I-Procedure
24841,1607,No,O
24842,1607,contraindications,B-Condition
24843,1607,to,O
24844,1607,general,B-Procedure
24845,1607,and,I-Procedure
24846,1607,regional,I-Procedure
24847,1607,anesthesia,I-Procedure
24848,1608,major,B-Condition
24849,1608,systemic,I-Condition
24850,1608,disease,I-Condition
24851,1609,Pregnant,B-Condition
24852,1609,woman,B-Person
24853,1609,with,O
24854,1609,infection,O
24855,1609,of,O
24856,1609,human,B-Condition
24857,1609,immunodeficiency,I-Condition
24858,1609,virus,I-Condition
24859,1609,or,O
24860,1609,hepatitis,B-Condition
24861,1609,C,I-Condition
24862,1609,virus,I-Condition
24863,1610,Pregnant,B-Condition
24864,1610,woman,B-Person
24865,1610,is,O
24866,1610,receiving,O
24867,1610,any,O
24868,1610,drug,B-Drug
24869,1610,with,I-Drug
24870,1610,antiviral,I-Drug
24871,1610,activity,I-Drug
24872,1610,or,O
24873,1610,any,O
24874,1610,form,O
24875,1610,of,O
24876,1610,drug,B-Procedure
24877,1610,therapy,I-Procedure
24878,1610,for,O
24879,1610,hepatitis,B-Condition
24880,1610,B,I-Condition
24881,1610,virus,I-Condition
24882,1611,Pregnant,B-Condition
24883,1611,woman,B-Person
24884,1611,whose,O
24885,1611,ultrasonographic,B-Procedure
24886,1611,examination,I-Procedure
24887,1611,reveals,O
24888,1611,congenital,O
24889,1611,anomaly,O
24890,1611,of,O
24891,1611,the,O
24892,1611,fetus,O
24893,1612,Pregnant,B-Condition
24894,1612,woman,B-Person
24895,1612,whose,O
24896,1612,amniocentesis,B-Procedure
24897,1612,reveals,O
24898,1612,any,O
24899,1612,genetic,O
24900,1612,abnormality,O
24901,1613,pregnant,B-Condition
24902,1613,women,B-Person
24903,1613,in,O
24904,1613,30,O
24905,1613,to,O
24906,1613,32,O
24907,1613,weeks,O
24908,1613,of,O
24909,1613,gestation,O
24910,1613,",",O
24911,1613,with,O
24912,1613,positive,O
24913,1613,HBsAg,O
24914,1613,and,O
24915,1613,HBeAg,O
24916,1613,",",O
24917,1613,serum,O
24918,1613,viral,O
24919,1613,load,O
24920,1613,above,O
24921,1613,8log10,O
24922,1613,copies,O
24923,1613,per,O
24924,1613,mL,O
24925,1614,PCOS,B-Condition
24926,1614,or,O
24927,1614,polycystic,B-Condition
24928,1614,ovary,I-Condition
24929,1614,on,O
24930,1614,ultrasound,B-Procedure
24931,1614,scan,I-Procedure
24932,1614,.,O
24933,1615,Moderate,O
24934,1615,or,O
24935,1615,severe,O
24936,1615,endometriosis,B-Condition
24937,1615,.,O
24938,1616,Hydrosalpinx,B-Condition
24939,1616,.,O
24940,1617,Uterine,B-Condition
24941,1617,abnormalities,I-Condition
24942,1617,or,O
24943,1617,myoma,B-Condition
24944,1617,.,O
24945,1618,Previous,O
24946,1618,uterine,B-Procedure
24947,1618,surgery,I-Procedure
24948,1618,.,O
24949,1619,Women,O
24950,1619,without,O
24951,1619,PCOS,B-Condition
24952,1619,as,O
24953,1619,defined,O
24954,1619,by,O
24955,1619,the,O
24956,1619,Rotterdam,O
24957,1619,criteria,O
24958,1619,.,O
24959,1620,Presence,O
24960,1620,of,O
24961,1620,at,O
24962,1620,least,O
24963,1620,2,O
24964,1620,cryopreserved,O
24965,1620,good,O
24966,1620,quality,O
24967,1620,cleavage,B-Observation
24968,1620,-,I-Observation
24969,1620,stage,I-Observation
24970,1620,embryo,I-Observation
24971,1620,(,O
24972,1620,good,O
24973,1620,quality,O
24974,1620,cleavage,B-Observation
24975,1620,-,I-Observation
24976,1620,stage,I-Observation
24977,1620,embryos,I-Observation
24978,1620,display,O
24979,1620,stage,O
24980,1620,-,O
24981,1620,specific,O
24982,1620,cell,O
24983,1620,division,O
24984,1620,",",O
24985,1620,have,O
24986,1620,blastomeres,O
24987,1620,of,O
24988,1620,fairly,O
24989,1620,equal,O
24990,1620,size,O
24991,1620,with,O
24992,1620,few,O
24993,1620,to,O
24994,1620,no,O
24995,1620,cytoplasmic,O
24996,1620,fragments,O
24997,1620,),O
24998,1620,.,O
24999,1621,Pregnancy,B-Condition
25000,1621,or,O
25001,1621,breastfeeding,B-Observation
25002,1622,Allergy,B-Condition
25003,1622,against,O
25004,1622,to,O
25005,1622,penicillin,B-Drug
25006,1622,or,O
25007,1622,cephalosporins,B-Drug
25008,1623,Renal,B-Condition
25009,1623,impairment,I-Condition
25010,1624,Active,O
25011,1624,hepatic,B-Condition
25012,1624,disease,I-Condition
25013,1625,Antibiotic,B-Drug
25014,1625,use,O
25015,1625,except,O
25016,1625,study,B-Drug
25017,1625,drugs,I-Drug
25018,1626,Immunosuppressive,B-Procedure
25019,1626,therapy,I-Procedure
25020,1626,before,O
25021,1626,6,O
25022,1626,months,O
25023,1626,of,O
25024,1626,study,O
25025,1626,initiation,O
25026,1627,Use,O
25027,1627,of,O
25028,1627,probenecid,B-Drug
25029,1627,like,I-Drug
25030,1627,drugs,I-Drug
25031,1628,The,O
25032,1628,diagnosis,O
25033,1628,of,O
25034,1628,chronic,B-Condition
25035,1628,bronchitis,I-Condition
25036,1629,The,O
25037,1629,diagnosis,O
25038,1629,of,O
25039,1629,community,B-Condition
25040,1629,-,I-Condition
25041,1629,acquired,I-Condition
25042,1629,pneumoniae,I-Condition
25043,1630,FEV1,O
25044,1630,value,O
25045,1630,=,O
25046,1630,30,O
25047,1630,-,O
25048,1630,80,O
25049,1630,%,O
25050,1631,The,O
25051,1631,diagnosis,O
25052,1631,of,O
25053,1631,mild,O
25054,1631,-,O
25055,1631,severe,O
25056,1631,acute,O
25057,1631,exacerbation,B-Condition
25058,1631,of,I-Condition
25059,1631,chronic,I-Condition
25060,1631,bronchitis,I-Condition
25061,1631,(,O
25062,1631,AECB,B-Condition
25063,1631,),O
25064,1632,Oxygen,O
25065,1632,saturation,O
25066,1632,<,O
25067,1632,90,O
25068,1632,%,O
25069,1633,Babies,B-Person
25070,1633,who,O
25071,1633,have,O
25072,1633,been,O
25073,1633,close,B-Observation
25074,1633,to,I-Observation
25075,1633,death,I-Observation
25076,1634,Seizure,B-Condition
25077,1634,occurred,O
25078,1634,by,O
25079,1634,metabolic,O
25080,1634,factors,O
25081,1634,(,O
25082,1634,hypoglycemia,B-Condition
25083,1634,",",O
25084,1634,hypocalcemia,B-Condition
25085,1634,",",O
25086,1634,electrolyte,B-Condition
25087,1634,disorder,I-Condition
25088,1634,),O
25089,1635,Babies,B-Person
25090,1635,who,O
25091,1635,have,O
25092,1635,received,O
25093,1635,phenobarbitone,B-Drug
25094,1635,or,O
25095,1635,any,O
25096,1635,other,O
25097,1635,anticonvulsive,B-Drug
25098,1635,medication,I-Drug
25099,1635,before,O
25100,1635,hospitalization,B-Procedure
25101,1636,Abnormal,B-Condition
25102,1636,renal,I-Condition
25103,1636,function,I-Condition
25104,1637,Male,B-Person
25105,1637,or,O
25106,1637,female,B-Person
25107,1637,term,B-Condition
25108,1637,baby,B-Person
25109,1637,with,O
25110,1637,gestational,O
25111,1637,>,O
25112,1637,37,O
25113,1637,weeks,O
25114,1637,and,O
25115,1637,postnatal,O
25116,1637,age,O
25117,1637,<,O
25118,1637,or=,O
25119,1637,28,O
25120,1637,days,O
25121,1638,Birthweight,O
25122,1638,>,O
25123,1638,2500,O
25124,1638,g,O
25125,1639,Written,O
25126,1639,informed,O
25127,1639,consent,O
25128,1639,of,O
25129,1639,parent,O
25130,1639,or,O
25131,1639,guardian,O
25132,1640,a,O
25133,1640,disease,B-Condition
25134,1640,that,O
25135,1640,might,O
25136,1640,affect,O
25137,1640,hepatic,O
25138,1640,or,O
25139,1640,renal,O
25140,1640,function,O
25141,1640,",",O
25142,1640,contraindications,B-Condition
25143,1640,to,O
25144,1640,opioid,B-Drug
25145,1640,analgesics,I-Drug
25146,1640,",",O
25147,1640,fetal,B-Condition
25148,1640,growth,I-Condition
25149,1640,retardation,I-Condition
25150,1640,",",O
25151,1640,signs,B-Mood
25152,1640,of,I-Mood
25153,1640,fetal,B-Condition
25154,1640,asphyxia,I-Condition
25155,1640,by,O
25156,1640,cardiotocography,B-Procedure
25157,1640,",",O
25158,1640,meconium,B-Condition
25159,1640,stained,I-Condition
25160,1640,amniotic,I-Condition
25161,1640,fluid,I-Condition
25162,1640,or,O
25163,1640,placental,B-Condition
25164,1640,insufficiency,I-Condition
25165,1640,.,O
25166,1640,The,O
25167,1640,subjects,O
25168,1640,should,O
25169,1640,not,O
25170,1640,have,O
25171,1640,received,O
25172,1640,fentanyl,B-Drug
25173,1640,during,O
25174,1640,the,O
25175,1640,previous,O
25176,1640,14,O
25177,1640,days,O
25178,1640,.,O
25179,1641,healthy,B-Condition
25180,1641,parturients,B-Person
25181,1641,with,O
25182,1641,uncomplicated,O
25183,1641,",",O
25184,1641,single,O
25185,1641,gestation,O
25186,1641,pregnancies,B-Condition
25187,1641,",",O
25188,1641,full,O
25189,1641,term,O
25190,1641,(,O
25191,1641,38,O
25192,1641,-,O
25193,1641,42,O
25194,1641,weeks,O
25195,1641,of,O
25196,1641,gestation,O
25197,1641,),O
25198,1641,pregnancy,B-Condition
25199,1641,",",O
25200,1641,agreed,O
25201,1641,to,O
25202,1641,participate,O
25203,1642,recent,O
25204,1642,surgery,B-Procedure
25205,1642,(,O
25206,1642,<,O
25207,1642,3,O
25208,1642,months,O
25209,1642,),O
25210,1643,previous,O
25211,1643,chemotherapy,B-Procedure
25212,1644,previous,O
25213,1644,transfusion,B-Procedure
25214,1644,of,I-Procedure
25215,1644,blood,I-Procedure
25216,1644,products,I-Procedure
25217,1645,neurodevelopmental,B-Condition
25218,1645,disorders,I-Condition
25219,1645,(,O
25220,1645,including,O
25221,1645,Trisomy,B-Condition
25222,1645,21,I-Condition
25223,1645,),O
25224,1646,supplemental,B-Procedure
25225,1646,oxygen,I-Procedure
25226,1646,requirement,B-Mood
25227,1646,(,O
25228,1646,<,O
25229,1646,3,O
25230,1646,months,O
25231,1646,),O
25232,1647,asthma,B-Condition
25233,1647,requiring,O
25234,1647,regular,B-Procedure
25235,1647,therapy,I-Procedure
25236,1648,obstructive,B-Condition
25237,1648,sleep,I-Condition
25238,1648,apnea,I-Condition
25239,1649,the,O
25240,1649,presence,O
25241,1649,of,O
25242,1649,concurrent,O
25243,1649,infection,B-Condition
25244,1649,or,O
25245,1649,inflammation,B-Condition
25246,1650,a,O
25247,1650,known,O
25248,1650,allergy,B-Condition
25249,1650,to,O
25250,1650,dexmedetomidine,B-Drug
25251,1650,hydrochloride,I-Drug
25252,1651,aged,B-Person
25253,1651,between,O
25254,1651,3,O
25255,1651,-,O
25256,1651,36,O
25257,1651,months,O
25258,1652,having,O
25259,1652,primary,O
25260,1652,corrective,B-Procedure
25261,1652,heart,I-Procedure
25262,1652,surgery,I-Procedure
25263,1653,Estimated,O
25264,1653,GFR,O
25265,1653,(,O
25266,1653,eGFR,O
25267,1653,),O
25268,1653,<,O
25269,1653,60,O
25270,1653,mL,O
25271,1653,/,O
25272,1653,min/1.73,O
25273,1653,m2,O
25274,1653,and,O
25275,1653,blood,O
25276,1653,glucose,O
25277,1653,>,O
25278,1653,135,O
25279,1653,mg,O
25280,1653,/,O
25281,1653,dl,O
25282,1653,;,O
25283,1653,Past,O
25284,1653,or,O
25285,1653,present,O
25286,1653,history,O
25287,1653,of,O
25288,1653,acute,B-Condition
25289,1653,renal,I-Condition
25290,1653,failure,I-Condition
25291,1653,",",O
25292,1653,renal,B-Procedure
25293,1653,dialysis,I-Procedure
25294,1653,",",O
25295,1653,diabetes,B-Condition
25296,1653,mellitus,I-Condition
25297,1653,.,O
25298,1654,Women,B-Person
25299,1654,who,O
25300,1654,received,O
25301,1654,metallic,B-Procedure
25302,1654,fixation,I-Procedure
25303,1654,",",O
25304,1654,coronary,O
25305,1654,artery,O
25306,1654,stent,O
25307,1654,in,O
25308,1654,recent,O
25309,1654,3,O
25310,1654,months,O
25311,1654,;,O
25312,1654,or,O
25313,1654,women,B-Person
25314,1654,who,O
25315,1654,received,O
25316,1654,mechanical,O
25317,1654,valve,O
25318,1654,replacement,O
25319,1654,that,O
25320,1654,is,O
25321,1654,not,O
25322,1654,compatible,O
25323,1654,with,O
25324,1654,MR,O
25325,1654,magnet,O
25326,1654,;,O
25327,1654,or,O
25328,1654,women,B-Person
25329,1654,with,O
25330,1654,aneurysmal,O
25331,1654,clips,O
25332,1654,",",O
25333,1654,pacemakers,O
25334,1654,.,O
25335,1655,Past,O
25336,1655,history,O
25337,1655,of,O
25338,1655,claustrophobia,B-Condition
25339,1655,.,O
25340,1656,Women,O
25341,1656,who,O
25342,1656,are,O
25343,1656,pregnant,O
25344,1656,or,O
25345,1656,who,O
25346,1656,are,O
25347,1656,planning,O
25348,1656,to,O
25349,1656,be,O
25350,1656,pregnant,O
25351,1656,",",O
25352,1656,or,O
25353,1656,who,O
25354,1656,are,O
25355,1656,lactating,O
25356,1656,(,O
25357,1656,though,O
25358,1656,the,O
25359,1656,possibility,O
25360,1656,in,O
25361,1656,our,O
25362,1656,target,O
25363,1656,population,O
25364,1656,should,O
25365,1656,be,O
25366,1656,very,O
25367,1656,low,O
25368,1656,),O
25369,1657,Past,O
25370,1657,history,O
25371,1657,of,O
25372,1657,breast,B-Condition
25373,1657,cancer,I-Condition
25374,1657,within,O
25375,1657,recent,O
25376,1657,5,O
25377,1657,years,O
25378,1657,before,O
25379,1657,the,O
25380,1657,currently,O
25381,1657,diagnosed,O
25382,1657,breast,O
25383,1657,cancer,O
25384,1657,.,O
25385,1658,Women,O
25386,1658,who,O
25387,1658,received,O
25388,1658,chemotherapy,B-Procedure
25389,1658,for,O
25390,1658,other,O
25391,1658,disease,O
25392,1658,entity,O
25393,1658,in,O
25394,1658,recent,O
25395,1658,1,O
25396,1658,year,O
25397,1658,.,O
25398,1659,Women,O
25399,1659,who,O
25400,1659,can,O
25401,1659,not,O
25402,1659,cooperate,O
25403,1659,with,O
25404,1659,the,O
25405,1659,examinations,O
25406,1659,.,O
25407,1660,Women,B-Person
25408,1660,aged,B-Person
25409,1660,25,O
25410,1660,-,O
25411,1660,75,O
25412,1660,years,O
25413,1660,old,O
25414,1660,.,O
25415,1661,Women,B-Person
25416,1661,with,O
25417,1661,recently,O
25418,1661,diagnosed,O
25419,1661,breast,B-Condition
25420,1661,cancer,I-Condition
25421,1661,and,O
25422,1661,who,O
25423,1661,will,O
25424,1661,receive,O
25425,1661,NAC,B-Procedure
25426,1661,to,O
25427,1661,reduce,O
25428,1661,tumor,O
25429,1661,burden,O
25430,1661,before,O
25431,1661,surgery,O
25432,1661,.,O
25433,1661,(,O
25434,1661,including,O
25435,1661,locally,O
25436,1661,advanced,O
25437,1661,breast,O
25438,1661,cancer,O
25439,1661,(,O
25440,1661,LABC,O
25441,1661,),O
25442,1661,according,O
25443,1661,to,O
25444,1661,clinical,O
25445,1661,assessment,O
25446,1661,;,O
25447,1661,or,O
25448,1661,tumor,O
25449,1661,size,O
25450,1661,>,O
25451,1661,2,O
25452,1661,cm,O
25453,1661,",",O
25454,1661,that,O
25455,1661,is,O
25456,1661,",",O
25457,1661,at,O
25458,1661,least,O
25459,1661,T2,O
25460,1661,in,O
25461,1661,TNM,O
25462,1661,staging,O
25463,1661,),O
25464,1661,.,O
25465,1662,Known,O
25466,1662,or,O
25467,1662,suspected,O
25468,1662,gram,O
25469,1662,-,O
25470,1662,negative,O
25471,1662,infections,B-Condition
25472,1662,",",O
25473,1662,anaerobic,O
25474,1662,infections,B-Condition
25475,1662,",",O
25476,1662,or,O
25477,1662,fungemia,B-Condition
25478,1663,Known,O
25479,1663,or,O
25480,1663,suspected,O
25481,1663,infections,B-Condition
25482,1663,that,O
25483,1663,are,O
25484,1663,severe,O
25485,1663,",",O
25486,1663,life,O
25487,1663,threatening,O
25488,1663,or,O
25489,1663,are,O
25490,1663,not,O
25491,1663,included,O
25492,1663,in,O
25493,1663,the,O
25494,1663,ABSSSI,O
25495,1663,Food,O
25496,1663,and,O
25497,1663,Drug,O
25498,1663,Administration,O
25499,1663,(,O
25500,1663,FDA,O
25501,1663,),O
25502,1663,guidance,O
25503,1664,Injection,O
25504,1664,drug,B-Person
25505,1664,users,I-Person
25506,1664,with,O
25507,1664,a,O
25508,1664,fever,B-Condition
25509,1665,Severe,O
25510,1665,neurological,B-Condition
25511,1665,disorder,I-Condition
25512,1665,leading,O
25513,1665,to,O
25514,1665,immobility,B-Observation
25515,1665,or,O
25516,1665,confined,O
25517,1665,to,O
25518,1665,a,O
25519,1665,wheelchair,O
25520,1666,Bilateral,O
25521,1666,Lower,O
25522,1666,extremity,O
25523,1666,involvement,O
25524,1666,of,O
25525,1666,the,O
25526,1666,suspected,O
25527,1666,infection,B-Condition
25528,1666,.,O
25529,1667,Presents,O
25530,1667,to,O
25531,1667,the,O
25532,1667,Emergency,O
25533,1667,Department,O
25534,1667,(,O
25535,1667,ED,O
25536,1667,),O
25537,1667,and,O
25538,1667,meets,O
25539,1667,the,O
25540,1667,clinical,O
25541,1667,definition,O
25542,1667,for,O
25543,1667,Acute,O
25544,1667,Bacterial,O
25545,1667,Skin,O
25546,1667,and,O
25547,1667,Skin,O
25548,1667,Structure,O
25549,1667,Infections,O
25550,1667,(,O
25551,1667,ABSSSI,O
25552,1667,),O
25553,1668,Known,O
25554,1668,or,O
25555,1668,suspected,O
25556,1668,gram,O
25557,1668,-,O
25558,1668,positive,O
25559,1668,infection,B-Condition
25560,1668,.,O
25561,1669,Weight,O
25562,1669,<,O
25563,1669,800,O
25564,1669,g,O
25565,1669,;,O
25566,1670,Airway,B-Condition
25567,1670,anomalies,I-Condition
25568,1670,;,O
25569,1671,Pulmonary,B-Condition
25570,1671,air,I-Condition
25571,1671,leaks,I-Condition
25572,1671,;,O
25573,1672,Craniofacial,B-Condition
25574,1672,or,I-Condition
25575,1672,cardiothoracic,I-Condition
25576,1672,malformations,I-Condition
25577,1673,Mild,O
25578,1673,-,O
25579,1673,to,O
25580,1673,-,O
25581,1673,moderate,O
25582,1673,RDS,O
25583,1673,;,O
25584,1674,Postnatal,O
25585,1674,age,O
25586,1674,2,O
25587,1674,to,O
25588,1674,48,O
25589,1674,hours,O
25590,1674,;,O
25591,1675,Gestational,O
25592,1675,age,O
25593,1675,27,O
25594,1675,0/7,O
25595,1675,to,O
25596,1675,36,O
25597,1675,6/7,O
25598,1675,weeks,O
25599,1675,;,O
25600,1676,Treated,O
25601,1676,with,O
25602,1676,nasal,O
25603,1676,CPAP,O
25604,1676,modalities,O
25605,1676,=,O
25606,1676,5,O
25607,1676,cm,O
25608,1676,H2O,O
25609,1676,and,O
25610,1676,FiO2,O
25611,1676,between,O
25612,1676,0.30,O
25613,1676,and,O
25614,1676,0.60,O
25615,1676,for,O
25616,1676,at,O
25617,1676,least,O
25618,1676,2,O
25619,1676,hours,O
25620,1676,to,O
25621,1676,maintain,O
25622,1676,SpO2,O
25623,1676,90,O
25624,1676,-,O
25625,1676,95,O
25626,1676,%,O
25627,1676,;,O
25628,1677,Informed,O
25629,1677,consent,O
25630,1678,Heart,B-Procedure
25631,1678,Team,I-Procedure
25632,1678,assessment,I-Procedure
25633,1678,of,I-Procedure
25634,1678,operability,I-Procedure
25635,1678,(,O
25636,1678,the,O
25637,1678,heart,B-Condition
25638,1678,team,I-Condition
25639,1678,considers,I-Condition
25640,1678,the,I-Condition
25641,1678,patient,I-Condition
25642,1678,to,I-Condition
25643,1678,be,I-Condition
25644,1678,a,I-Condition
25645,1678,good,I-Condition
25646,1678,surgical,I-Condition
25647,1678,candidate,I-Condition
25648,1678,),O
25649,1678,.,O
25650,1679,Evidence,O
25651,1679,of,O
25652,1679,an,O
25653,1679,acute,B-Condition
25654,1679,myocardial,I-Condition
25655,1679,infarction,I-Condition
25656,1679,=,O
25657,1679,1,O
25658,1679,month,O
25659,1679,(,O
25660,1679,30,O
25661,1679,days,O
25662,1679,),O
25663,1679,before,O
25664,1679,the,O
25665,1679,intended,O
25666,1679,treatment,O
25667,1679,[,O
25668,1679,defined,O
25669,1679,as,O
25670,1679,:,O
25671,1679,Q,O
25672,1679,wave,O
25673,1679,MI,O
25674,1679,",",O
25675,1679,or,O
25676,1679,non,O
25677,1679,-,O
25678,1679,Q,O
25679,1679,wave,O
25680,1679,MI,O
25681,1679,with,O
25682,1679,total,O
25683,1679,CK,O
25684,1679,elevation,O
25685,1679,of,O
25686,1679,CK,O
25687,1679,-,O
25688,1679,MB,O
25689,1679,=,O
25690,1679,twice,O
25691,1679,normal,O
25692,1679,in,O
25693,1679,the,O
25694,1679,presence,O
25695,1679,of,O
25696,1679,MB,O
25697,1679,elevation,O
25698,1679,and/or,O
25699,1679,troponin,O
25700,1679,level,O
25701,1679,elevation,O
25702,1679,(,O
25703,1679,WHO,O
25704,1679,definition,O
25705,1679,),O
25706,1679,],O
25707,1679,.,O
25708,1680,Untreated,O
25709,1680,",",O
25710,1680,severe,O
25711,1680,",",O
25712,1680,left,O
25713,1680,sided,O
25714,1680,valvular,B-Condition
25715,1680,heart,I-Condition
25716,1680,disease,I-Condition
25717,1680,including,O
25718,1680,mitral,B-Condition
25719,1680,regurgitation,I-Condition
25720,1680,or,I-Condition
25721,1680,stenosis,I-Condition
25722,1680,",",O
25723,1680,and,O
25724,1680,aortic,B-Condition
25725,1680,regurgitation,I-Condition
25726,1680,or,I-Condition
25727,1680,stenosis,I-Condition
25728,1680,.,O
25729,1681,Mean,O
25730,1681,pulmonary,O
25731,1681,artery,O
25732,1681,pressures,O
25733,1681,=,O
25734,1681,40mmHG,O
25735,1681,and,O
25736,1681,PVR,O
25737,1681,>,O
25738,1681,4,O
25739,1681,woods,O
25740,1681,units,O
25741,1681,as,O
25742,1681,assessed,O
25743,1681,by,O
25744,1681,right,B-Condition
25745,1681,heart,I-Condition
25746,1681,catheterization,I-Condition
25747,1681,.,O
25748,1682,Any,O
25749,1682,therapeutic,O
25750,1682,invasive,O
25751,1682,cardiac,B-Procedure
25752,1682,procedure,I-Procedure
25753,1682,resulting,O
25754,1682,in,O
25755,1682,a,O
25756,1682,permanent,O
25757,1682,implant,O
25758,1682,that,O
25759,1682,is,O
25760,1682,performed,O
25761,1682,within,O
25762,1682,30,O
25763,1682,days,O
25764,1682,of,O
25765,1682,the,O
25766,1682,index,O
25767,1682,procedure,O
25768,1682,.,O
25769,1682,Examples,O
25770,1682,of,O
25771,1682,permanent,O
25772,1682,implant,O
25773,1682,would,O
25774,1682,include,O
25775,1682,any,O
25776,1682,new,O
25777,1682,heart,O
25778,1682,valve,O
25779,1682,.,O
25780,1682,Implantation,O
25781,1682,of,O
25782,1682,a,O
25783,1682,permanent,O
25784,1682,pacemaker,O
25785,1682,is,O
25786,1682,excluded,O
25787,1682,.,O
25788,1683,Patients,O
25789,1683,with,O
25790,1683,planned,B-Mood
25791,1683,concomitant,O
25792,1683,surgical,B-Procedure
25793,1683,or,I-Procedure
25794,1683,transcatheter,I-Procedure
25795,1683,ablation,I-Procedure
25796,1683,for,O
25797,1683,Atrial,B-Condition
25798,1683,Fibrillation,I-Condition
25799,1683,.,O
25800,1684,Leukopenia,B-Condition
25801,1684,(,O
25802,1684,WBC,O
25803,1684,<,O
25804,1684,3000,O
25805,1684,cell,O
25806,1684,/,O
25807,1684,mL,O
25808,1684,),O
25809,1684,",",O
25810,1684,acute,B-Condition
25811,1684,anemia,I-Condition
25812,1684,(,O
25813,1684,Hgb,O
25814,1684,<,O
25815,1684,9,O
25816,1684,g,O
25817,1684,/,O
25818,1684,dL,O
25819,1684,),O
25820,1684,",",O
25821,1684,Thrombocytopenia,B-Condition
25822,1684,(,O
25823,1684,Plt,O
25824,1684,<,O
25825,1684,"50,000",O
25826,1684,cell,O
25827,1684,/,O
25828,1684,mL,O
25829,1684,),O
25830,1684,.,O
25831,1685,Hemodynamic,B-Condition
25832,1685,or,I-Condition
25833,1685,respiratory,I-Condition
25834,1685,instability,I-Condition
25835,1685,requiring,O
25836,1685,inotropic,B-Procedure
25837,1685,support,I-Procedure
25838,1685,",",O
25839,1685,mechanical,B-Procedure
25840,1685,ventilation,I-Procedure
25841,1685,or,O
25842,1685,mechanical,B-Procedure
25843,1685,heart,I-Procedure
25844,1685,assistance,I-Procedure
25845,1685,within,O
25846,1685,30,O
25847,1685,days,O
25848,1685,of,O
25849,1685,screening,O
25850,1685,evaluation,O
25851,1685,.,O
25852,1686,Need,B-Mood
25853,1686,for,I-Mood
25854,1686,emergency,B-Procedure
25855,1686,surgery,I-Procedure
25856,1686,for,O
25857,1686,any,O
25858,1686,reason,O
25859,1686,.,O
25860,1687,Left,O
25861,1687,ventricular,O
25862,1687,ejection,O
25863,1687,fraction,O
25864,1687,<,O
25865,1687,40,O
25866,1687,%,O
25867,1687,.,O
25868,1688,Echocardiographic,B-Procedure
25869,1688,evidence,O
25870,1688,of,O
25871,1688,intracardiac,B-Condition
25872,1688,mass,I-Condition
25873,1688,",",I-Condition
25874,1688,thrombus,I-Condition
25875,1688,or,I-Condition
25876,1688,vegetation,I-Condition
25877,1688,.,O
25878,1689,Active,O
25879,1689,upper,B-Condition
25880,1689,GI,I-Condition
25881,1689,bleeding,I-Condition
25882,1689,within,O
25883,1689,3,O
25884,1689,months,O
25885,1689,(,O
25886,1689,90,O
25887,1689,days,O
25888,1689,),O
25889,1689,prior,O
25890,1689,to,O
25891,1689,procedure,O
25892,1689,.,O
25893,1690,A,O
25894,1690,known,O
25895,1690,contraindication,B-Condition
25896,1690,or,O
25897,1690,hypersensitivity,B-Condition
25898,1690,to,O
25899,1690,all,O
25900,1690,anticoagulation,B-Procedure
25901,1690,regimens,I-Procedure
25902,1690,",",O
25903,1690,or,O
25904,1690,inability,B-Condition
25905,1690,to,O
25906,1690,be,O
25907,1690,anticoagulated,B-Procedure
25908,1690,for,O
25909,1690,the,O
25910,1690,study,O
25911,1690,procedure,O
25912,1690,.,O
25913,1691,Recent,O
25914,1691,CVA,B-Condition
25915,1691,clinically,O
25916,1691,confirmed,O
25917,1691,(,O
25918,1691,by,O
25919,1691,neurologist,O
25920,1691,),O
25921,1691,or,O
25922,1691,neuroimaging,B-Procedure
25923,1691,confirmed,O
25924,1691,stroke,B-Condition
25925,1691,or,O
25926,1691,transient,B-Condition
25927,1691,ischemic,I-Condition
25928,1691,attack,I-Condition
25929,1691,(,I-Condition
25930,1691,TIA,I-Condition
25931,1691,),I-Condition
25932,1691,within,O
25933,1691,6,O
25934,1691,months,O
25935,1691,(,O
25936,1691,180,O
25937,1691,days,O
25938,1691,),O
25939,1691,of,O
25940,1691,the,O
25941,1691,procedure,O
25942,1691,.,O
25943,1692,Estimated,B-Observation
25944,1692,life,I-Observation
25945,1692,expectancy,I-Observation
25946,1692,<,O
25947,1692,1,O
25948,1692,year,O
25949,1692,from,O
25950,1692,conditions,O
25951,1692,other,O
25952,1692,than,O
25953,1692,TR,O
25954,1692,.,O
25955,1693,Expectation,O
25956,1693,that,O
25957,1693,patient,O
25958,1693,will,O
25959,1693,not,O
25960,1693,improve,O
25961,1693,despite,O
25962,1693,treatment,O
25963,1693,of,O
25964,1693,tricuspid,O
25965,1693,regurgitation,O
25966,1694,Currently,O
25967,1694,participating,O
25968,1694,in,O
25969,1694,another,O
25970,1694,investigational,O
25971,1694,cardiac,O
25972,1694,device,O
25973,1694,study,O
25974,1694,or,O
25975,1694,any,O
25976,1694,other,O
25977,1694,clinical,O
25978,1694,trial,O
25979,1694,",",O
25980,1694,including,O
25981,1694,drugs,O
25982,1694,or,O
25983,1694,biologics,O
25984,1694,.,O
25985,1694,Note,O
25986,1694,:,O
25987,1694,Trials,O
25988,1694,requiring,O
25989,1694,extended,O
25990,1694,follow,O
25991,1694,-,O
25992,1694,up,O
25993,1694,for,O
25994,1694,products,O
25995,1694,that,O
25996,1694,were,O
25997,1694,investigational,O
25998,1694,",",O
25999,1694,but,O
26000,1694,have,O
26001,1694,since,O
26002,1694,become,O
26003,1694,commercially,O
26004,1694,available,O
26005,1694,",",O
26006,1694,are,O
26007,1694,not,O
26008,1694,considered,O
26009,1694,investigational,O
26010,1694,trials,O
26011,1694,.,O
26012,1695,Active,O
26013,1695,bacterial,B-Condition
26014,1695,endocarditis,I-Condition
26015,1695,within,O
26016,1695,6,O
26017,1695,months,O
26018,1695,(,O
26019,1695,180,O
26020,1695,days,O
26021,1695,),O
26022,1695,of,O
26023,1695,procedure,O
26024,1695,.,O
26025,1696,Patients,O
26026,1696,with,O
26027,1696,signs,O
26028,1696,or,O
26029,1696,symptoms,O
26030,1696,of,O
26031,1696,SVC,B-Condition
26032,1696,syndrome,I-Condition
26033,1696,",",O
26034,1696,or,O
26035,1696,hepatic,B-Condition
26036,1696,cirrhosis,I-Condition
26037,1696,not,O
26038,1696,felt,O
26039,1696,due,O
26040,1696,to,O
26041,1696,passive,B-Condition
26042,1696,congestion,I-Condition
26043,1696,from,I-Condition
26044,1696,TR,I-Condition
26045,1696,.,O
26046,1697,Patients,O
26047,1697,must,O
26048,1697,be,O
26049,1697,at,O
26050,1697,least,O
26051,1697,21,O
26052,1697,years,O
26053,1697,old,B-Person
26054,1697,.,O
26055,1698,The,O
26056,1698,patient,O
26057,1698,must,O
26058,1698,have,O
26059,1698,severe,O
26060,1698,",",O
26061,1698,symptomatic,O
26062,1698,(,O
26063,1698,ACC,O
26064,1698,/,O
26065,1698,AHA,O
26066,1698,Stage,O
26067,1698,D,O
26068,1698,symptoms,O
26069,1698,),O
26070,1698,tricuspid,B-Condition
26071,1698,regurgitation,I-Condition
26072,1698,(,O
26073,1698,TR,B-Condition
26074,1698,),O
26075,1698,as,O
26076,1698,assessed,O
26077,1698,by,O
26078,1698,2D,B-Procedure
26079,1698,echocardiogram,I-Procedure
26080,1698,with,O
26081,1698,evidence,O
26082,1698,of,O
26083,1698,peripheral,B-Condition
26084,1698,and,I-Condition
26085,1698,central,I-Condition
26086,1698,venous,I-Condition
26087,1698,congestion,I-Condition
26088,1698,(,O
26089,1698,specifically,O
26090,1698,lower,B-Condition
26091,1698,extremity,I-Condition
26092,1698,edema,I-Condition
26093,1698,and,O
26094,1698,abdominal,B-Condition
26095,1698,ascites,I-Condition
26096,1698,requiring,O
26097,1698,diuretics,B-Drug
26098,1698,.,O
26099,1698,),O
26100,1699,The,O
26101,1699,patient,O
26102,1699,must,O
26103,1699,be,O
26104,1699,evaluated,O
26105,1699,by,O
26106,1699,a,O
26107,1699,"""",O
26108,1699,heart,O
26109,1699,team,O
26110,1699,"""",O
26111,1699,of,O
26112,1699,physicians,O
26113,1699,including,O
26114,1699,an,O
26115,1699,interventional,O
26116,1699,cardiologist,O
26117,1699,",",O
26118,1699,cardiothoracic,O
26119,1699,surgeon,O
26120,1699,",",O
26121,1699,heart,O
26122,1699,failure,O
26123,1699,specialist,O
26124,1699,",",O
26125,1699,and,O
26126,1699,imaging,O
26127,1699,specialist,O
26128,1699,",",O
26129,1699,and,O
26130,1699,presented,O
26131,1699,for,O
26132,1699,review,O
26133,1699,at,O
26134,1699,a,O
26135,1699,local,O
26136,1699,multi,O
26137,1699,-,O
26138,1699,disciplinary,O
26139,1699,conference,O
26140,1699,.,O
26141,1699,By,O
26142,1699,consensus,O
26143,1699,",",O
26144,1699,the,O
26145,1699,heart,O
26146,1699,team,O
26147,1699,must,O
26148,1699,agree,O
26149,1699,(,O
26150,1699,and,O
26151,1699,verify,O
26152,1699,in,O
26153,1699,the,O
26154,1699,case,O
26155,1699,review,O
26156,1699,process,O
26157,1699,),O
26158,1699,that,O
26159,1699,valve,O
26160,1699,implantation,O
26161,1699,will,O
26162,1699,likely,O
26163,1699,benefit,O
26164,1699,the,O
26165,1699,patient,O
26166,1699,.,O
26167,1700,The,O
26168,1700,heart,O
26169,1700,team,O
26170,1700,must,O
26171,1700,agree,O
26172,1700,that,O
26173,1700,medical,O
26174,1700,factors,O
26175,1700,preclude,O
26176,1700,operation,O
26177,1700,",",O
26178,1700,based,O
26179,1700,on,O
26180,1700,a,O
26181,1700,conclusion,O
26182,1700,that,O
26183,1700,the,O
26184,1700,probability,O
26185,1700,of,O
26186,1700,death,O
26187,1700,or,O
26188,1700,serious,O
26189,1700,",",O
26190,1700,irreversible,O
26191,1700,morbidity,O
26192,1700,exceeds,O
26193,1700,the,O
26194,1700,probability,O
26195,1700,of,O
26196,1700,meaningful,O
26197,1700,improvement,O
26198,1700,.,O
26199,1700,Also,O
26200,1700,",",O
26201,1700,other,O
26202,1700,factors,O
26203,1700,which,O
26204,1700,may,O
26205,1700,increase,O
26206,1700,the,O
26207,1700,patients,O
26208,1700,perceived,O
26209,1700,surgical,O
26210,1700,risk,O
26211,1700,for,O
26212,1700,inclusion,O
26213,1700,in,O
26214,1700,the,O
26215,1700,trial,O
26216,1700,will,O
26217,1700,be,O
26218,1700,clearly,O
26219,1700,delineated,O
26220,1700,if,O
26221,1700,they,O
26222,1700,are,O
26223,1700,present,O
26224,1700,.,O
26225,1700,These,O
26226,1700,include,O
26227,1700,",",O
26228,1700,but,O
26229,1700,are,O
26230,1700,not,O
26231,1700,limited,O
26232,1700,to,O
26233,1700,the,O
26234,1700,following,O
26235,1700,as,O
26236,1700,defined,O
26237,1700,by,O
26238,1700,VARC,O
26239,1700,2,O
26240,1700,:,O
26241,1700,Frailty,O
26242,1700,",",O
26243,1700,Hostile,O
26244,1700,chest,O
26245,1700,",",O
26246,1700,porcelain,O
26247,1700,aorta,O
26248,1700,",",O
26249,1700,IMA,O
26250,1700,or,O
26251,1700,other,O
26252,1700,critical,O
26253,1700,conduit,O
26254,1700,crossing,O
26255,1700,the,O
26256,1700,midline,O
26257,1700,or,O
26258,1700,adherent,O
26259,1700,to,O
26260,1700,the,O
26261,1700,posterior,O
26262,1700,table,O
26263,1700,of,O
26264,1700,sternum,O
26265,1700,",",O
26266,1700,severe,O
26267,1700,right,O
26268,1700,ventricular,O
26269,1700,(,O
26270,1700,RV,O
26271,1700,),O
26272,1700,dysfunction,O
26273,1700,.,O
26274,1700,The,O
26275,1700,surgeons,O
26276,1700,',O
26277,1700,consultation,O
26278,1700,notes,O
26279,1700,shall,O
26280,1700,specify,O
26281,1700,the,O
26282,1700,medical,O
26283,1700,or,O
26284,1700,anatomic,O
26285,1700,factors,O
26286,1700,leading,O
26287,1700,to,O
26288,1700,that,O
26289,1700,conclusion,O
26290,1700,.,O
26291,1700,At,O
26292,1700,least,O
26293,1700,one,O
26294,1700,of,O
26295,1700,the,O
26296,1700,cardiac,O
26297,1700,surgeon,O
26298,1700,assessors,O
26299,1700,must,O
26300,1700,have,O
26301,1700,interviewed,O
26302,1700,and,O
26303,1700,examined,O
26304,1700,the,O
26305,1700,patient,O
26306,1700,.,O
26307,1701,The,O
26308,1701,study,O
26309,1701,patient,O
26310,1701,provides,O
26311,1701,informed,O
26312,1701,consent,O
26313,1701,and,O
26314,1701,agrees,O
26315,1701,to,O
26316,1701,comply,O
26317,1701,with,O
26318,1701,all,O
26319,1701,required,O
26320,1701,post,O
26321,1701,-,O
26322,1701,procedure,O
26323,1701,follow,O
26324,1701,-,O
26325,1701,up,O
26326,1701,visits,O
26327,1701,",",O
26328,1701,including,O
26329,1701,annual,O
26330,1701,visits,O
26331,1701,up,O
26332,1701,to,O
26333,1701,5,O
26334,1701,years,O
26335,1701,.,O
26336,1702,The,O
26337,1702,patient,O
26338,1702,is,O
26339,1702,unwilling,O
26340,1702,to,O
26341,1702,provide,O
26342,1702,informed,O
26343,1702,consent,O
26344,1703,acutely,B-Condition
26345,1703,sick,I-Condition
26346,1703,(,O
26347,1703,for,O
26348,1703,example,O
26349,1703,",",O
26350,1703,crying,B-Condition
26351,1703,",",O
26352,1703,wheezing,B-Condition
26353,1703,",",O
26354,1703,bleeding,B-Condition
26355,1703,",",O
26356,1703,screaming,B-Condition
26357,1703,or,O
26358,1703,shaken,B-Condition
26359,1703,),O
26360,1704,unable,O
26361,1704,to,O
26362,1704,participate,O
26363,1704,in,O
26364,1704,a,O
26365,1704,discussion,O
26366,1704,about,O
26367,1704,the,O
26368,1704,study,O
26369,1705,between,O
26370,1705,7,O
26371,1705,to,O
26372,1705,70,O
26373,1705,years,O
26374,1705,of,O
26375,1705,age,B-Person
26376,1706,fluent,B-Observation
26377,1706,in,I-Observation
26378,1706,English,I-Observation
26379,1706,or,I-Observation
26380,1706,Spanish,I-Observation
26381,1707,plans,B-Mood
26382,1707,to,I-Mood
26383,1707,receive,B-Procedure
26384,1707,care,I-Procedure
26385,1707,in,O
26386,1707,the,O
26387,1707,Community,O
26388,1707,Health,O
26389,1707,Center,O
26390,1707,during,O
26391,1707,the,O
26392,1707,next,O
26393,1707,year,O
26394,1708,presents,O
26395,1708,with,O
26396,1708,signs,B-Condition
26397,1708,and,O
26398,1708,symptoms,B-Condition
26399,1708,of,O
26400,1708,a,O
26401,1708,SSTI,B-Condition
26402,1709,willing,O
26403,1709,/,O
26404,1709,able,O
26405,1709,to,O
26406,1709,provide,O
26407,1709,informed,O
26408,1709,consent,O
26409,1710,Not,O
26410,1710,available,O
26411,1710,for,O
26412,1710,follow,O
26413,1710,-,O
26414,1710,up,O
26415,1711,Pregnant,B-Condition
26416,1711,or,O
26417,1711,breast,B-Condition
26418,1711,-,I-Condition
26419,1711,feeding,I-Condition
26420,1712,Chronic,B-Condition
26421,1712,pain,I-Condition
26422,1712,syndrome,I-Condition
26423,1712,defined,O
26424,1712,as,O
26425,1712,use,O
26426,1712,of,O
26427,1712,any,O
26428,1712,analgesic,B-Drug
26429,1712,medication,I-Drug
26430,1712,on,O
26431,1712,a,O
26432,1712,daily,O
26433,1712,or,O
26434,1712,near,O
26435,1712,-,O
26436,1712,daily,O
26437,1712,basis,O
26438,1713,Allergic,B-Condition
26439,1713,to,O
26440,1713,or,O
26441,1713,intolerant,B-Condition
26442,1713,of,O
26443,1713,investigational,B-Drug
26444,1713,medications,I-Drug
26445,1714,Contra,B-Condition
26446,1714,-,I-Condition
26447,1714,indications,I-Condition
26448,1714,to,O
26449,1714,non,B-Drug
26450,1714,-,I-Drug
26451,1714,steroidal,I-Drug
26452,1714,anti,I-Drug
26453,1714,-,I-Drug
26454,1714,inflammatory,I-Drug
26455,1714,drugs,I-Drug
26456,1714,:,O
26457,1714,1,O
26458,1714,),O
26459,1714,history,B-Observation
26460,1714,of,O
26461,1714,hypersensitivity,B-Condition
26462,1714,to,O
26463,1714,NSAIDs,B-Drug
26464,1714,or,O
26465,1714,aspirin,B-Drug
26466,1714,2,O
26467,1714,),O
26468,1714,active,O
26469,1714,or,O
26470,1714,history,B-Observation
26471,1714,of,O
26472,1714,peptic,B-Condition
26473,1714,ulcer,I-Condition
26474,1714,disease,I-Condition
26475,1714,",",O
26476,1714,chronic,B-Condition
26477,1714,dyspepsia,I-Condition
26478,1714,",",O
26479,1714,or,O
26480,1714,active,O
26481,1714,or,O
26482,1714,history,B-Observation
26483,1714,of,O
26484,1714,gastrointestinal,B-Condition
26485,1714,bleed,I-Condition
26486,1714,3,O
26487,1714,),O
26488,1714,Severe,O
26489,1714,heart,B-Condition
26490,1714,failure,I-Condition
26491,1714,(,O
26492,1714,NYHA,O
26493,1714,2,O
26494,1714,or,O
26495,1714,worse,O
26496,1714,),O
26497,1714,4,O
26498,1714,),O
26499,1714,hypertension,B-Condition
26500,1714,(,O
26501,1714,JNC7,O
26502,1714,stage,O
26503,1714,2,O
26504,1714,or,O
26505,1714,worse,O
26506,1714,),O
26507,1714,5,O
26508,1714,),O
26509,1714,Chronic,B-Condition
26510,1714,kidney,I-Condition
26511,1714,disease,I-Condition
26512,1714,3,O
26513,1714,or,O
26514,1714,worse,O
26515,1714,6,O
26516,1714,),O
26517,1714,Current,O
26518,1714,use,O
26519,1714,of,O
26520,1714,anti,B-Drug
26521,1714,-,I-Drug
26522,1714,coagulants,I-Drug
26523,1714,7,O
26524,1714,),O
26525,1714,Hepatitis,B-Condition
26526,1714,8),O
26527,1714,Alcoholism,B-Condition
26528,1715,Contra,B-Condition
26529,1715,-,I-Condition
26530,1715,indications,I-Condition
26531,1715,to,O
26532,1715,muscle,B-Drug
26533,1715,relaxants,I-Drug
26534,1715,:,O
26535,1715,1,O
26536,1715,),O
26537,1715,Concurrent,O
26538,1715,use,O
26539,1715,of,O
26540,1715,centrally,B-Drug
26541,1715,acting,I-Drug
26542,1715,opioids,I-Drug
26543,1715,;,O
26544,1715,2,O
26545,1715,),O
26546,1715,Renal,B-Condition
26547,1715,impairment,I-Condition
26548,1715,;,O
26549,1715,3,O
26550,1715,),O
26551,1715,Liver,B-Condition
26552,1715,abnormality,I-Condition
26553,1715,including,O
26554,1715,cirrhosis,B-Condition
26555,1715,or,O
26556,1715,elevated,B-Condition
26557,1715,enzymes,I-Condition
26558,1715,4,O
26559,1715,),O
26560,1715,Use,O
26561,1715,of,O
26562,1715,any,O
26563,1715,of,O
26564,1715,the,O
26565,1715,following,O
26566,1715,medications,O
26567,1715,:,O
26568,1715,fluvoxamine,B-Drug
26569,1715,",",O
26570,1715,fluoroquinolones,B-Drug
26571,1715,",",O
26572,1715,amiodarone,B-Drug
26573,1715,",",O
26574,1715,mexiletine,B-Drug
26575,1715,",",O
26576,1715,propafenone,B-Drug
26577,1715,",",O
26578,1715,verapamil,B-Drug
26579,1715,",",O
26580,1715,cimetidine,B-Drug
26581,1715,",",O
26582,1715,famotidine,B-Drug
26583,1715,",",O
26584,1715,acyclovir,B-Drug
26585,1715,",",O
26586,1715,ticlopidine,B-Drug
26587,1715,",",O
26588,1715,oral,B-Drug
26589,1715,contraceptive,I-Drug
26590,1715,pills,I-Drug
26591,1716,Present,B-Observation
26592,1716,to,O
26593,1716,ED,O
26594,1716,primary,O
26595,1716,for,O
26596,1716,management,O
26597,1716,of,O
26598,1716,LBP,B-Condition
26599,1716,",",O
26600,1716,defined,O
26601,1716,as,O
26602,1716,pain,B-Condition
26603,1716,originating,O
26604,1716,between,O
26605,1716,the,O
26606,1716,lower,O
26607,1716,border,O
26608,1716,of,O
26609,1716,the,O
26610,1716,scapulae,O
26611,1716,and,O
26612,1716,the,O
26613,1716,upper,O
26614,1716,gluteal,O
26615,1716,folds,O
26616,1716,.,O
26617,1716,Flank,B-Condition
26618,1716,pain,I-Condition
26619,1716,",",O
26620,1716,that,O
26621,1716,is,O
26622,1716,pain,B-Condition
26623,1716,originating,O
26624,1716,from,O
26625,1716,tissues,O
26626,1716,lateral,O
26627,1716,to,O
26628,1716,the,O
26629,1716,paraspinal,O
26630,1716,muscles,O
26631,1716,",",O
26632,1716,will,O
26633,1716,not,O
26634,1716,be,O
26635,1716,included,O
26636,1716,.,O
26637,1717,Musculoskeletal,O
26638,1717,etiology,B-Condition
26639,1717,of,O
26640,1717,low,O
26641,1717,back,O
26642,1717,.,O
26643,1717,Patients,O
26644,1717,with,O
26645,1717,non,O
26646,1717,-,O
26647,1717,musculoskeletal,O
26648,1717,etiologies,B-Condition
26649,1717,such,O
26650,1717,as,O
26651,1717,urinary,B-Condition
26652,1717,tract,I-Condition
26653,1717,infection,I-Condition
26654,1717,",",O
26655,1717,ovarian,B-Condition
26656,1717,cysts,I-Condition
26657,1717,",",O
26658,1717,or,O
26659,1717,influenza,B-Condition
26660,1717,like,I-Condition
26661,1717,illness,I-Condition
26662,1717,will,O
26663,1717,be,O
26664,1717,excluded,O
26665,1717,.,O
26666,1717,The,O
26667,1717,primary,O
26668,1717,clinical,O
26669,1717,diagnosis,O
26670,1717,",",O
26671,1717,at,O
26672,1717,the,O
26673,1717,conclusion,O
26674,1717,of,O
26675,1717,the,O
26676,1717,ED,O
26677,1717,visit,O
26678,1717,",",O
26679,1717,must,O
26680,1717,be,O
26681,1717,a,O
26682,1717,diagnosis,O
26683,1717,consistent,O
26684,1717,with,O
26685,1717,non,O
26686,1717,-,O
26687,1717,traumatic,O
26688,1717,",",O
26689,1717,non,O
26690,1717,-,O
26691,1717,radicular,O
26692,1717,",",O
26693,1717,musculoskeletal,O
26694,1717,LBP,B-Condition
26695,1717,.,O
26696,1718,Patient,O
26697,1718,is,O
26698,1718,to,O
26699,1718,be,O
26700,1718,discharged,O
26701,1718,home,O
26702,1718,.,O
26703,1718,Patients,O
26704,1718,admitted,O
26705,1718,to,O
26706,1718,the,O
26707,1718,hospital,O
26708,1718,are,O
26709,1718,more,O
26710,1718,likely,O
26711,1718,to,O
26712,1718,be,O
26713,1718,treated,O
26714,1718,with,O
26715,1718,parenteral,O
26716,1718,medication,O
26717,1718,and,O
26718,1718,therefore,O
26719,1718,are,O
26720,1718,not,O
26721,1718,appropriate,O
26722,1718,for,O
26723,1718,this,O
26724,1718,study,O
26725,1718,.,O
26726,1719,Age,B-Person
26727,1719,18,O
26728,1719,-,O
26729,1719,64,O
26730,1719,Enrollment,O
26731,1719,will,O
26732,1719,be,O
26733,1719,limited,O
26734,1719,to,O
26735,1719,adults,B-Person
26736,1719,younger,O
26737,1719,than,O
26738,1719,65,O
26739,1719,years,O
26740,1719,because,O
26741,1719,of,O
26742,1719,the,O
26743,1719,increased,B-Mood
26744,1719,risk,I-Mood
26745,1719,of,O
26746,1719,adverse,B-Condition
26747,1719,medication,I-Condition
26748,1719,effects,I-Condition
26749,1719,in,O
26750,1719,the,O
26751,1719,elderly,B-Person
26752,1719,.,O
26753,1720,Non,O
26754,1720,-,O
26755,1720,radicular,O
26756,1720,pain,B-Condition
26757,1720,.,O
26758,1720,Patients,O
26759,1720,will,O
26760,1720,be,O
26761,1720,excluded,O
26762,1720,if,O
26763,1720,the,O
26764,1720,pain,B-Condition
26765,1720,radiates,O
26766,1720,below,O
26767,1720,the,O
26768,1720,gluteal,O
26769,1720,folds,O
26770,1720,in,O
26771,1720,a,O
26772,1720,radicular,O
26773,1720,pattern,O
26774,1720,.,O
26775,1721,Pain,B-Condition
26776,1721,duration,O
26777,1721,<,O
26778,1721,2,O
26779,1721,weeks,O
26780,1721,(,O
26781,1721,336,O
26782,1721,hours,O
26783,1721,),O
26784,1721,.,O
26785,1721,Patients,O
26786,1721,with,O
26787,1721,more,O
26788,1721,than,O
26789,1721,two,O
26790,1721,weeks,O
26791,1721,of,O
26792,1721,pain,O
26793,1721,are,O
26794,1721,at,O
26795,1721,increased,O
26796,1721,risk,O
26797,1721,of,O
26798,1721,poor,O
26799,1721,pain,O
26800,1721,and,O
26801,1721,functional,O
26802,1721,outcomes.(9,O
26803,1721,),O
26804,1722,Prior,O
26805,1722,to,O
26806,1722,the,O
26807,1722,acute,O
26808,1722,attack,B-Condition
26809,1722,of,I-Condition
26810,1722,LBP,I-Condition
26811,1722,",",O
26812,1722,back,B-Condition
26813,1722,pain,I-Condition
26814,1722,can,O
26815,1722,not,O
26816,1722,occur,O
26817,1722,more,O
26818,1722,frequently,O
26819,1722,than,O
26820,1722,once,O
26821,1722,per,O
26822,1722,month,O
26823,1722,.,O
26824,1722,Patients,O
26825,1722,with,O
26826,1722,more,O
26827,1722,frequent,O
26828,1722,back,O
26829,1722,pain,O
26830,1722,are,O
26831,1722,at,O
26832,1722,increased,O
26833,1722,risk,O
26834,1722,of,O
26835,1722,poor,O
26836,1722,pain,O
26837,1722,and,O
26838,1722,functional,O
26839,1722,outcomes.(9,O
26840,1722,),O
26841,1723,Non,O
26842,1723,-,O
26843,1723,traumatic,O
26844,1723,LBP,B-Condition
26845,1723,:,O
26846,1723,no,O
26847,1723,substantial,O
26848,1723,and,O
26849,1723,direct,O
26850,1723,trauma,B-Condition
26851,1723,to,O
26852,1723,the,O
26853,1723,back,O
26854,1723,within,O
26855,1723,the,O
26856,1723,previous,O
26857,1723,month,O
26858,1724,Functionally,O
26859,1724,impairing,O
26860,1724,back,B-Condition
26861,1724,pain,I-Condition
26862,1724,:,O
26863,1724,A,O
26864,1724,baseline,O
26865,1724,score,O
26866,1724,of,O
26867,1724,>,O
26868,1724,5,O
26869,1724,on,O
26870,1724,the,O
26871,1724,Roland,O
26872,1724,-,O
26873,1724,Morris,O
26874,1724,Disability,O
26875,1724,Questionnaire,O
26876,1725,Known,O
26877,1725,asthmatic,B-Condition
26878,1725,or,O
26879,1725,history,B-Observation
26880,1725,of,O
26881,1725,allergy,B-Condition
26882,1725,towards,O
26883,1725,peanut,B-Drug
26884,1725,or,O
26885,1725,milk,B-Drug
26886,1725,products,I-Drug
26887,1726,Concurrent,O
26888,1726,participation,B-Observation
26889,1726,in,I-Observation
26890,1726,another,I-Observation
26891,1726,clinical,I-Observation
26892,1726,trial,I-Observation
26893,1727,Severe,O
26894,1727,illness,B-Condition
26895,1727,warranting,B-Mood
26896,1727,hospital,B-Procedure
26897,1727,referral,I-Procedure
26898,1728,At,O
26899,1728,least,O
26900,1728,18,O
26901,1728,years,O
26902,1728,of,O
26903,1728,age,B-Person
26904,1729,No,O
26905,1729,more,O
26906,1729,than,O
26907,1729,20,O
26908,1729,wk,O
26909,1729,of,O
26910,1729,gestation,B-Condition
26911,1730,Given,O
26912,1730,Ante,O
26913,1730,-,O
26914,1730,natal,O
26915,1730,Cards,O
26916,1730,of,O
26917,1730,the,O
26918,1730,Ghana,O
26919,1730,Health,O
26920,1730,Service,O
26921,1731,Completed,O
26922,1731,the,O
26923,1731,initial,O
26924,1731,routine,B-Condition
26925,1731,ante,I-Condition
26926,1731,-,I-Condition
26927,1731,natal,I-Condition
26928,1731,examination,I-Condition
26929,1731,at,O
26930,1731,the,O
26931,1731,clinics,O
26932,1732,HIV,B-Condition
26933,1732,negative,O
26934,1732,or,O
26935,1732,status,O
26936,1732,unknown,O
26937,1732,(,O
26938,1732,as,O
26939,1732,from,O
26940,1732,the,O
26941,1732,Ante,O
26942,1732,-,O
26943,1732,natal,O
26944,1732,card,O
26945,1732,),O
26946,1733,Free,O
26947,1733,from,O
26948,1733,chronic,B-Condition
26949,1733,disease,I-Condition
26950,1733,e.g.,O
26951,1733,malignancy,B-Condition
26952,1733,requiring,O
26953,1733,frequent,O
26954,1733,medical,O
26955,1733,attention,O
26956,1733,(,O
26957,1733,as,O
26958,1733,from,O
26959,1733,the,O
26960,1733,Ante,O
26961,1733,-,O
26962,1733,natal,O
26963,1733,card,O
26964,1733,),O
26965,1734,Residing,B-Observation
26966,1734,in,O
26967,1734,the,O
26968,1734,Manya,O
26969,1734,Krobo,O
26970,1734,or,O
26971,1734,Yilo,O
26972,1734,Krobo,O
26973,1734,district,O
26974,1735,Prepared,O
26975,1735,to,O
26976,1735,sign,O
26977,1735,an,O
26978,1735,informed,O
26979,1735,consent,O
26980,1736,Living,B-Observation
26981,1736,in,I-Observation
26982,1736,the,I-Observation
26983,1736,area,I-Observation
26984,1736,throughout,O
26985,1736,the,O
26986,1736,duration,O
26987,1736,of,O
26988,1736,the,O
26989,1736,study,O
26990,1737,Acceptance,O
26991,1737,of,O
26992,1737,home,O
26993,1737,visitors,O
26994,1738,small,B-Procedure
26995,1738,bowel,I-Procedure
26996,1738,resection,I-Procedure
26997,1739,right,B-Procedure
26998,1739,sided,I-Procedure
26999,1739,hemicolectomy,I-Procedure
27000,1740,known,O
27001,1740,chronic,B-Condition
27002,1740,diarrheal,I-Condition
27003,1740,disease,I-Condition
27004,1740,(,O
27005,1740,celiac,B-Condition
27006,1740,disease,I-Condition
27007,1740,",",O
27008,1740,lactose,B-Condition
27009,1740,malabsorption,I-Condition
27010,1740,",",O
27011,1740,Inflammatory,B-Condition
27012,1740,bowel,I-Condition
27013,1740,diseases,I-Condition
27014,1740,",",O
27015,1740,incl,O
27016,1740,microscopic,B-Condition
27017,1740,colitis,I-Condition
27018,1740,),O
27019,1741,pregnancy,B-Condition
27020,1742,wish,B-Mood
27021,1742,for,I-Mood
27022,1742,pregnancy,B-Condition
27023,1742,within,O
27024,1742,next,O
27025,1742,three,O
27026,1742,months,O
27027,1743,allergy,B-Condition
27028,1743,to,O
27029,1743,eggs,B-Drug
27030,1744,allergy,B-Condition
27031,1744,to,O
27032,1744,constituents,B-Drug
27033,1744,in,I-Drug
27034,1744,Xenbilox,I-Drug
27035,1744,(,O
27036,1744,capsules,O
27037,1744,with,O
27038,1744,chenodeoxycholic,B-Drug
27039,1744,acid,I-Drug
27040,1744,),O
27041,1745,acute,B-Condition
27042,1745,cholecystitis,I-Condition
27043,1745,within,O
27044,1745,two,O
27045,1745,months,O
27046,1746,chronic,B-Condition
27047,1746,cholecystitis,I-Condition
27048,1747,cirrhosis,B-Condition
27049,1747,of,I-Condition
27050,1747,the,I-Condition
27051,1747,liver,I-Condition
27052,1748,suspected,B-Mood
27053,1748,obstructive,B-Condition
27054,1748,choledocholithiasis,I-Condition
27055,1749,icterus,B-Condition
27056,1750,planned,B-Mood
27057,1750,elective,O
27058,1750,cholecystectomy,B-Condition
27059,1751,Patients,O
27060,1751,who,O
27061,1751,had,O
27062,1751,history,B-Observation
27063,1751,of,O
27064,1751,systemic,B-Drug
27065,1751,antibiotic,I-Drug
27066,1751,usage,O
27067,1751,over,O
27068,1751,the,O
27069,1751,previous,O
27070,1751,4,O
27071,1751,months,O
27072,1752,Patients,O
27073,1752,who,O
27074,1752,were,O
27075,1752,pregnant,B-Condition
27076,1753,Patients,O
27077,1753,who,O
27078,1753,had,O
27079,1753,received,O
27080,1753,non,B-Procedure
27081,1753,-,I-Procedure
27082,1753,surgical,I-Procedure
27083,1753,periodontal,I-Procedure
27084,1753,treatment,I-Procedure
27085,1753,within,O
27086,1753,the,O
27087,1753,past,O
27088,1753,6,O
27089,1753,months,O
27090,1754,Patients,O
27091,1754,who,O
27092,1754,had,O
27093,1754,received,O
27094,1754,surgical,B-Procedure
27095,1754,periodontal,I-Procedure
27096,1754,treatment,I-Procedure
27097,1754,within,O
27098,1754,the,O
27099,1754,past,O
27100,1754,12,O
27101,1754,months,O
27102,1755,Patients,O
27103,1755,who,O
27104,1755,were,O
27105,1755,smokers,B-Condition
27106,1756,Patients,O
27107,1756,with,O
27108,1756,a,O
27109,1756,history,O
27110,1756,of,O
27111,1756,stroke,B-Condition
27112,1756,or,O
27113,1756,an,O
27114,1756,acute,B-Procedure
27115,1756,cardiovascular,I-Procedure
27116,1756,event,I-Procedure
27117,1756,over,O
27118,1756,the,O
27119,1756,previous,O
27120,1756,12,O
27121,1756,months,O
27122,1756,.,O
27123,1757,Patients,O
27124,1757,should,O
27125,1757,have,O
27126,1757,at,O
27127,1757,least,O
27128,1757,12,O
27129,1757,teeth,B-Condition
27130,1757,present,I-Condition
27131,1758,Patients,O
27132,1758,with,O
27133,1758,Moderate,O
27134,1758,to,O
27135,1758,Advanced,O
27136,1758,Chronic,B-Condition
27137,1758,periodontitis,I-Condition
27138,1759,Patients,O
27139,1759,with,O
27140,1759,2,O
27141,1759,or,O
27142,1759,more,O
27143,1759,interproximal,B-Condition
27144,1759,sites,I-Condition
27145,1759,(,I-Condition
27146,1759,not,I-Condition
27147,1759,on,I-Condition
27148,1759,same,I-Condition
27149,1759,tooth,I-Condition
27150,1759,),I-Condition
27151,1759,with,I-Condition
27152,1759,probing,I-Condition
27153,1759,pocket,I-Condition
27154,1759,depths,I-Condition
27155,1759,of,I-Condition
27156,1759,5,I-Condition
27157,1759,mm,I-Condition
27158,1759,or,I-Condition
27159,1759,more,I-Condition
27160,1759,and,O
27161,1759,2,O
27162,1759,or,O
27163,1759,more,O
27164,1759,interproximal,B-Condition
27165,1759,sites,I-Condition
27166,1759,(,I-Condition
27167,1759,not,I-Condition
27168,1759,on,I-Condition
27169,1759,same,I-Condition
27170,1759,tooth)of,I-Condition
27171,1759,probing,I-Condition
27172,1759,attachment,I-Condition
27173,1759,loss,I-Condition
27174,1759,of,I-Condition
27175,1759,4,I-Condition
27176,1759,mm,I-Condition
27177,1759,or,I-Condition
27178,1759,more,I-Condition
27179,1759,which,O
27180,1759,bled,O
27181,1759,on,O
27182,1759,probing,B-Procedure
27183,1759,.,O
27184,1760,History,O
27185,1760,of,O
27186,1760,documented,O
27187,1760,clotting,B-Condition
27188,1760,/,I-Condition
27189,1760,coagulation,I-Condition
27190,1760,disorder,I-Condition
27191,1761,History,O
27192,1761,of,O
27193,1761,cancer,B-Condition
27194,1761,(,O
27195,1761,within,O
27196,1761,the,O
27197,1761,last,O
27198,1761,year,O
27199,1761,),O
27200,1762,Any,O
27201,1762,diagnosis,O
27202,1762,requiring,O
27203,1762,anti,B-Drug
27204,1762,-,I-Drug
27205,1762,coagulation,I-Drug
27206,1763,History,O
27207,1763,of,O
27208,1763,hypersensitivity,B-Condition
27209,1763,reaction,O
27210,1763,to,O
27211,1763,apixaban,B-Drug
27212,1764,Active,O
27213,1764,clinically,O
27214,1764,significant,O
27215,1764,bleeding,B-Condition
27216,1765,Creatinine,O
27217,1765,>,O
27218,1765,1.5,O
27219,1765,mg,O
27220,1765,/,O
27221,1765,dL,O
27222,1766,Participants,O
27223,1766,currently,O
27224,1766,receiving,O
27225,1766,any,O
27226,1766,type,O
27227,1766,of,O
27228,1766,anticoagulation,B-Drug
27229,1766,or,O
27230,1766,blood,B-Drug
27231,1766,thinning,I-Drug
27232,1766,medications,I-Drug
27233,1766,",",O
27234,1766,including,O
27235,1766,heparin,B-Drug
27236,1766,",",O
27237,1766,low,B-Drug
27238,1766,molecular,I-Drug
27239,1766,weight,I-Drug
27240,1766,heparins,I-Drug
27241,1766,",",O
27242,1766,Plavix,B-Drug
27243,1766,",",O
27244,1766,aspirin,B-Drug
27245,1766,",",O
27246,1766,NSAIDS,B-Drug
27247,1767,Combined,O
27248,1767,P,B-Drug
27249,1767,-,I-Drug
27250,1767,glycoprotein,I-Drug
27251,1767,and,I-Drug
27252,1767,strong,I-Drug
27253,1767,cytochrome,I-Drug
27254,1767,P450,I-Drug
27255,1767,(,I-Drug
27256,1767,CYP,I-Drug
27257,1767,),I-Drug
27258,1767,3A4,I-Drug
27259,1767,inhibitor,I-Drug
27260,1768,Combined,O
27261,1768,P,B-Drug
27262,1768,-,I-Drug
27263,1768,glycoprotein,I-Drug
27264,1768,and,I-Drug
27265,1768,moderate,I-Drug
27266,1768,CYP,I-Drug
27267,1768,3A4,I-Drug
27268,1768,inhibitor,I-Drug
27269,1769,Combined,O
27270,1769,P,B-Drug
27271,1769,-,I-Drug
27272,1769,glycoprotein,I-Drug
27273,1769,inducer,I-Drug
27274,1769,and,O
27275,1769,strong,O
27276,1769,CYP,B-Drug
27277,1769,3A4,I-Drug
27278,1769,inducer,I-Drug
27279,1770,Inducers,B-Drug
27280,1770,of,I-Drug
27281,1770,p,I-Drug
27282,1770,-,I-Drug
27283,1770,glycoprotein,I-Drug
27284,1771,Strong,O
27285,1771,inducers,B-Drug
27286,1771,of,I-Drug
27287,1771,CYP,I-Drug
27288,1771,3A4,I-Drug
27289,1772,Men,B-Person
27290,1772,or,O
27291,1772,women,B-Person
27292,1772,",",O
27293,1772,18,O
27294,1772,to,O
27295,1772,65,O
27296,1772,years,O
27297,1772,old,B-Person
27298,1772,with,O
27299,1772,a,O
27300,1772,BMI,O
27301,1772,of,O
27302,1772,35,O
27303,1772,kg,O
27304,1772,/,O
27305,1772,m2,O
27306,1772,or,O
27307,1772,greater,O
27308,1772,who,O
27309,1772,will,O
27310,1772,be,O
27311,1772,undergoing,O
27312,1772,bariatric,B-Procedure
27313,1772,surgery,I-Procedure
27314,1772,(,O
27315,1772,VSG,B-Procedure
27316,1772,and,O
27317,1772,RYGB,B-Procedure
27318,1772,),O
27319,1773,Signed,O
27320,1773,written,O
27321,1773,informed,O
27322,1773,consent,O
27323,1774,Women,O
27324,1774,of,O
27325,1774,childbearing,O
27326,1774,potential,O
27327,1774,(,O
27328,1774,WOCBP,O
27329,1774,),O
27330,1774,must,O
27331,1774,have,O
27332,1774,a,O
27333,1774,negative,O
27334,1774,serum,O
27335,1774,or,O
27336,1774,urine,O
27337,1774,pregnancy,O
27338,1774,test,O
27339,1774,(,O
27340,1774,minimum,O
27341,1774,sensitivity,O
27342,1774,25,O
27343,1774,IU,O
27344,1774,/,O
27345,1774,L,O
27346,1774,or,O
27347,1774,equivalent,O
27348,1774,units,O
27349,1774,of,O
27350,1774,HCG,O
27351,1774,),O
27352,1774,within,O
27353,1774,24,O
27354,1774,hours,O
27355,1774,prior,O
27356,1774,to,O
27357,1774,the,O
27358,1774,start,O
27359,1774,of,O
27360,1774,study,O
27361,1774,drug,O
27362,1775,Women,O
27363,1775,must,O
27364,1775,not,O
27365,1775,be,O
27366,1775,breastfeeding,O
27367,1776,Newborns,B-Person
27368,1776,with,O
27369,1776,severe,B-Condition
27370,1776,congenital,I-Condition
27371,1776,anomalies,I-Condition
27372,1777,Newborns,B-Person
27373,1777,with,O
27374,1777,infection,B-Condition
27375,1777,of,I-Condition
27376,1777,the,I-Condition
27377,1777,umbilical,I-Condition
27378,1777,cord,I-Condition
27379,1777,at,O
27380,1777,birth,O
27381,1778,Newborns,B-Person
27382,1778,weighing,O
27383,1778,1.5,O
27384,1778,kg,O
27385,1778,or,O
27386,1778,more,O
27387,1778,at,O
27388,1778,birth,O
27389,1779,Revision,B-Procedure
27390,1779,total,I-Procedure
27391,1779,knee,I-Procedure
27392,1779,arthroplasty,I-Procedure
27393,1780,Bilateral,B-Procedure
27394,1780,total,I-Procedure
27395,1780,knee,I-Procedure
27396,1780,arthroplasty,I-Procedure
27397,1781,Patients,O
27398,1781,with,O
27399,1781,inflammatory,B-Condition
27400,1781,arthritis,I-Condition
27401,1782,Patients,O
27402,1782,with,O
27403,1782,a,O
27404,1782,body,O
27405,1782,mass,O
27406,1782,index,O
27407,1782,(,O
27408,1782,BMI,O
27409,1782,),O
27410,1782,>,O
27411,1782,40,O
27412,1783,Allergy,B-Condition
27413,1783,to,O
27414,1783,ropivacaine,B-Drug
27415,1783,",",O
27416,1783,bupivacaine,B-Drug
27417,1783,",",O
27418,1783,or,O
27419,1783,other,O
27420,1783,local,B-Drug
27421,1783,anesthetic,I-Drug
27422,1783,agents,I-Drug
27423,1784,Current,O
27424,1784,use,O
27425,1784,of,O
27426,1784,opioid,B-Drug
27427,1784,drugs,O
27428,1785,Patients,O
27429,1785,with,O
27430,1785,a,O
27431,1785,history,O
27432,1785,of,O
27433,1785,total,O
27434,1785,or,O
27435,1785,unicompartmental,O
27436,1785,reconstruction,B-Procedure
27437,1785,of,O
27438,1785,the,O
27439,1785,affected,O
27440,1785,joint,O
27441,1786,Patients,O
27442,1786,that,O
27443,1786,have,O
27444,1786,had,O
27445,1786,a,O
27446,1786,high,B-Procedure
27447,1786,tibial,I-Procedure
27448,1786,osteotomy,I-Procedure
27449,1786,or,O
27450,1786,femoral,B-Procedure
27451,1786,osteotomy,I-Procedure
27452,1787,Patients,O
27453,1787,with,O
27454,1787,neuromuscular,B-Condition
27455,1787,or,I-Condition
27456,1787,neurosensory,I-Condition
27457,1787,deficiency,I-Condition
27458,1787,",",O
27459,1787,which,O
27460,1787,would,O
27461,1787,limit,O
27462,1787,the,O
27463,1787,ability,O
27464,1787,to,O
27465,1787,assess,O
27466,1787,pain,O
27467,1787,levels,O
27468,1788,Patients,O
27469,1788,with,O
27470,1788,a,O
27471,1788,systemic,B-Condition
27472,1788,or,I-Condition
27473,1788,metabolic,I-Condition
27474,1788,disorder,I-Condition
27475,1788,leading,O
27476,1788,to,O
27477,1788,progressive,O
27478,1788,bone,B-Condition
27479,1788,deterioration,I-Condition
27480,1789,Patients,O
27481,1789,that,O
27482,1789,are,O
27483,1789,immunologically,B-Condition
27484,1789,compromised,I-Condition
27485,1789,",",O
27486,1789,or,O
27487,1789,receiving,O
27488,1789,chronic,O
27489,1789,steroids,B-Drug
27490,1789,(,O
27491,1789,>,O
27492,1789,30,O
27493,1789,days,O
27494,1789,),O
27495,1789,",",O
27496,1789,excluding,O
27497,1789,inhalers,B-Drug
27498,1790,Patients,O
27499,1790,',O
27500,1790,bone,O
27501,1790,stock,O
27502,1790,is,O
27503,1790,compromised,O
27504,1790,by,O
27505,1790,disease,O
27506,1790,or,O
27507,1790,infection,O
27508,1790,",",O
27509,1790,which,O
27510,1790,can,O
27511,1790,not,O
27512,1790,provide,O
27513,1790,adequate,O
27514,1790,support,O
27515,1790,and/or,O
27516,1790,fixation,O
27517,1790,to,O
27518,1790,the,O
27519,1790,prosthesis,O
27520,1791,Patients,O
27521,1791,with,O
27522,1791,knee,B-Procedure
27523,1791,fusion,I-Procedure
27524,1791,to,O
27525,1791,the,O
27526,1791,affected,O
27527,1791,joint,O
27528,1792,Patients,O
27529,1792,with,O
27530,1792,an,O
27531,1792,active,O
27532,1792,or,O
27533,1792,suspected,O
27534,1792,latent,O
27535,1792,infection,B-Condition
27536,1792,in,O
27537,1792,or,O
27538,1792,about,O
27539,1792,the,O
27540,1792,knee,O
27541,1792,joint,O
27542,1793,Patients,O
27543,1793,that,O
27544,1793,are,O
27545,1793,prisoners,B-Person
27546,1794,Male,B-Person
27547,1794,or,O
27548,1794,non,O
27549,1794,-,O
27550,1794,pregnant,O
27551,1794,female,B-Person
27552,1794,between,O
27553,1794,the,O
27554,1794,ages,B-Person
27555,1794,of,O
27556,1794,18,O
27557,1794,-,O
27558,1794,65,O
27559,1795,Patients,O
27560,1795,willing,O
27561,1795,and,O
27562,1795,able,O
27563,1795,to,O
27564,1795,sign,O
27565,1795,the,O
27566,1795,informed,O
27567,1795,consent,O
27568,1796,Patients,O
27569,1796,able,O
27570,1796,to,O
27571,1796,comply,O
27572,1796,with,O
27573,1796,follow,O
27574,1796,-,O
27575,1796,up,O
27576,1796,requirements,O
27577,1796,including,O
27578,1796,self,O
27579,1796,-,O
27580,1796,evaluations,O
27581,1797,Patients,O
27582,1797,requiring,O
27583,1797,a,O
27584,1797,primary,B-Procedure
27585,1797,total,I-Procedure
27586,1797,knee,I-Procedure
27587,1797,replacement,I-Procedure
27588,1798,Patients,O
27589,1798,with,O
27590,1798,a,O
27591,1798,diagnosis,O
27592,1798,of,O
27593,1798,osteoarthritis,B-Condition
27594,1798,",",O
27595,1798,traumatic,B-Condition
27596,1798,arthritis,I-Condition
27597,1798,",",O
27598,1798,or,O
27599,1798,avascular,B-Condition
27600,1798,necrosis,I-Condition
27601,1799,current,O
27602,1799,or,O
27603,1799,recent,O
27604,1799,(,O
27605,1799,within,O
27606,1799,one,O
27607,1799,week,O
27608,1799,of,O
27609,1799,surgery,O
27610,1799,),O
27611,1799,systemic,O
27612,1799,antibiotic,B-Drug
27613,1799,use,O
27614,1799,",",O
27615,1799,intolerance,B-Condition
27616,1799,to,O
27617,1799,both,O
27618,1799,clindamycin,B-Drug
27619,1799,and,O
27620,1799,cephalexin,B-Drug
27621,1799,",",O
27622,1799,discovery,O
27623,1799,of,O
27624,1799,a,O
27625,1799,persistent,B-Condition
27626,1799,cutaneous,I-Condition
27627,1799,malignancy,I-Condition
27628,1799,at,O
27629,1799,the,O
27630,1799,site,O
27631,1799,of,O
27632,1799,the,O
27633,1799,defect,O
27634,1799,following,O
27635,1799,the,O
27636,1799,reconstructive,B-Procedure
27637,1799,procedure,I-Procedure
27638,1799,and,O
27639,1799,previous,O
27640,1799,reconstruction,O
27641,1799,at,O
27642,1799,the,O
27643,1799,site,O
27644,1799,of,O
27645,1799,the,O
27646,1799,skin,O
27647,1799,/,O
27648,1799,soft,O
27649,1799,-,O
27650,1799,tissue,O
27651,1799,defect,O
27652,1799,.,O
27653,1800,all,O
27654,1800,adult,O
27655,1800,patients,O
27656,1800,with,O
27657,1800,a,O
27658,1800,nasal,B-Condition
27659,1800,or,I-Condition
27660,1800,facial,I-Condition
27661,1800,skin,I-Condition
27662,1800,/,I-Condition
27663,1800,soft,I-Condition
27664,1800,tissue,I-Condition
27665,1800,defect,I-Condition
27666,1800,requiring,B-Mood
27667,1800,reconstruction,B-Procedure
27668,1800,limited,O
27669,1800,to,O
27670,1800,or,O
27671,1800,including,O
27672,1800,a,O
27673,1800,full,O
27674,1800,-,O
27675,1800,thickness,O
27676,1800,skin,O
27677,1800,graft,O
27678,1801,Pregnancy,B-Condition
27679,1801,and,O
27680,1801,breast,B-Observation
27681,1801,feeding,I-Observation
27682,1801,mother,O
27683,1801,;,O
27684,1802,Estimated,B-Observation
27685,1802,life,I-Observation
27686,1802,expectancy,I-Observation
27687,1802,<,O
27688,1802,12,O
27689,1802,months,O
27690,1802,;,O
27691,1803,Scheduled,B-Mood
27692,1803,major,B-Procedure
27693,1803,surgery,I-Procedure
27694,1803,in,O
27695,1803,the,O
27696,1803,next,O
27697,1803,6,O
27698,1803,months,O
27699,1803,;,O
27700,1804,Inability,B-Observation
27701,1804,to,I-Observation
27702,1804,follow,I-Observation
27703,1804,the,I-Observation
27704,1804,protocol,I-Observation
27705,1804,and,I-Observation
27706,1804,comply,I-Observation
27707,1804,with,I-Observation
27708,1804,follow,I-Observation
27709,1804,-,I-Observation
27710,1804,up,I-Observation
27711,1804,requirements,I-Observation
27712,1804,or,O
27713,1804,any,O
27714,1804,other,O
27715,1804,reason,O
27716,1804,that,O
27717,1804,the,O
27718,1804,investigator,O
27719,1804,feels,O
27720,1804,would,O
27721,1804,place,O
27722,1804,the,O
27723,1804,patient,O
27724,1804,at,O
27725,1804,increased,O
27726,1804,risk,O
27727,1804,;,O
27728,1805,Previous,O
27729,1805,enrolment,B-Observation
27730,1805,in,I-Observation
27731,1805,this,I-Observation
27732,1805,study,I-Observation
27733,1805,or,O
27734,1805,treatment,B-Procedure
27735,1805,with,I-Procedure
27736,1805,an,I-Procedure
27737,1805,investigational,I-Procedure
27738,1805,drug,I-Procedure
27739,1805,or,O
27740,1805,device,O
27741,1805,under,O
27742,1805,another,O
27743,1805,study,O
27744,1805,protocol,O
27745,1805,in,O
27746,1805,the,O
27747,1805,past,O
27748,1805,30,O
27749,1805,days,O
27750,1805,.,O
27751,1806,WHO,O
27752,1806,group,O
27753,1806,II,O
27754,1806,",",O
27755,1806,III,O
27756,1806,",",O
27757,1806,IV,O
27758,1806,",",O
27759,1806,V,O
27760,1806,PH,B-Condition
27761,1807,Severe,O
27762,1807,Renal,B-Condition
27763,1807,dysfunction,I-Condition
27764,1807,(,O
27765,1807,Ccr<30,O
27766,1807,ml,O
27767,1807,/,O
27768,1807,min,O
27769,1807,),O
27770,1808,Blood,O
27771,1808,platelet,O
27772,1808,"count<100,000",O
27773,1808,/,O
27774,1808,L,O
27775,1809,Expected,B-Observation
27776,1809,life,I-Observation
27777,1809,span<6,I-Observation
27778,1809,-,O
27779,1809,month,O
27780,1810,Systematical,B-Condition
27781,1810,inflammation,I-Condition
27782,1811,Malignant,B-Condition
27783,1811,cancer(s,I-Condition
27784,1811,),O
27785,1812,Tricuspid,B-Condition
27786,1812,valve,I-Condition
27787,1812,stenosis,I-Condition
27788,1812,",",O
27789,1812,Supra,B-Condition
27790,1812,-,I-Condition
27791,1812,pulmonary,I-Condition
27792,1812,valve,I-Condition
27793,1812,stenosis,I-Condition
27794,1813,Allergic,B-Condition
27795,1813,to,O
27796,1813,studied,B-Drug
27797,1813,drugs,I-Drug
27798,1813,or,I-Drug
27799,1813,metal,I-Drug
27800,1813,materials,I-Drug
27801,1813,.,O
27802,1814,Provision,O
27803,1814,of,O
27804,1814,informed,O
27805,1814,consent,O
27806,1814,prior,O
27807,1814,to,O
27808,1814,any,O
27809,1814,study,O
27810,1814,specific,O
27811,1814,procedures,O
27812,1814,;,O
27813,1815,Men,B-Person
27814,1815,and,O
27815,1815,women,B-Person
27816,1815,18,O
27817,1815,years,B-Person
27818,1815,and,O
27819,1815,older,O
27820,1815,;,O
27821,1816,Group,O
27822,1816,I,O
27823,1816,PAH,B-Condition
27824,1816,",",O
27825,1816,defined,O
27826,1816,as,O
27827,1816,a,O
27828,1816,mPAP=25mmHg,O
27829,1816,",",O
27830,1816,PCWP<15mmHg,O
27831,1816,and,O
27832,1816,PVR[The,O
27833,1816,PVR,O
27834,1816,=(,O
27835,1816,mPAP,O
27836,1816,-,O
27837,1816,PCWP)/CO]>3.0,O
27838,1816,Woods,O
27839,1816,unit,O
27840,1816,.,O
27841,1817,The,O
27842,1817,patient,O
27843,1817,'s,O
27844,1817,data,O
27845,1817,will,O
27846,1817,be,O
27847,1817,excluded,O
27848,1817,if,O
27849,1817,they,O
27850,1817,die,B-Observation
27851,1817,within,O
27852,1817,3,O
27853,1817,days,O
27854,1817,of,O
27855,1817,hospital,O
27856,1817,admission,O
27857,1817,.,O
27858,1818,All,O
27859,1818,adult,B-Person
27860,1818,patients,O
27861,1818,18,O
27862,1818,years,O
27863,1818,of,O
27864,1818,age,B-Person
27865,1818,or,O
27866,1818,older,O
27867,1818,admitted,B-Procedure
27868,1818,to,O
27869,1818,the,O
27870,1818,intensive,O
27871,1818,care,O
27872,1818,units,O
27873,1818,of,O
27874,1818,St.,O
27875,1818,Boniface,O
27876,1818,General,O
27877,1818,Hospital,O
27878,1818,with,O
27879,1818,a,O
27880,1818,diagnosis,O
27881,1818,of,O
27882,1818,acute,B-Condition
27883,1818,pulmonary,I-Condition
27884,1818,blastomycosis,I-Condition
27885,1818,requiring,O
27886,1818,mechanical,B-Procedure
27887,1818,ventilation,I-Procedure
27888,1818,.,O
27889,1819,no,O
27890,1819,confirmation,O
27891,1819,of,O
27892,1819,the,O
27893,1819,gestational,O
27894,1819,age,O
27895,1820,ruptured,B-Condition
27896,1820,membranes,I-Condition
27897,1821,painful,B-Condition
27898,1821,regular,I-Condition
27899,1821,uterine,I-Condition
27900,1821,contractions,I-Condition
27901,1822,major,O
27902,1822,fetal,B-Condition
27903,1822,abnormalities,I-Condition
27904,1823,gestational,O
27905,1823,age,O
27906,1823,between,O
27907,1823,20,O
27908,1823,weeks,O
27909,1823,and,O
27910,1823,23,O
27911,1823,weeks,O
27912,1823,and,O
27913,1823,6,O
27914,1823,days,O
27915,1824,singleton,B-Condition
27916,1824,pregnancies,I-Condition
27917,1825,Patient,O
27918,1825,has,O
27919,1825,been,O
27920,1825,permanently,O
27921,1825,discontinued,O
27922,1825,from,O
27923,1825,nilotinib,B-Drug
27924,1825,treatment,B-Procedure
27925,1825,in,O
27926,1825,the,O
27927,1825,parent,O
27928,1825,study,O
27929,1825,due,O
27930,1825,to,O
27931,1825,unacceptable,B-Condition
27932,1825,toxicity,I-Condition
27933,1825,",",O
27934,1825,non,B-Observation
27935,1825,-,I-Observation
27936,1825,compliance,I-Observation
27937,1825,to,O
27938,1825,study,B-Procedure
27939,1825,procedures,I-Procedure
27940,1825,",",O
27941,1825,withdrawal,O
27942,1825,of,O
27943,1825,consent,B-Observation
27944,1825,or,O
27945,1825,any,B-Observation
27946,1825,other,I-Observation
27947,1825,reason,I-Observation
27948,1826,Patient,O
27949,1826,has,O
27950,1826,participated,B-Observation
27951,1826,in,I-Observation
27952,1826,a,I-Observation
27953,1826,Novartis,I-Observation
27954,1826,sponsored,I-Observation
27955,1826,combination,I-Observation
27956,1826,trial,I-Observation
27957,1826,where,O
27958,1826,nilotinib,O
27959,1826,was,O
27960,1826,dispensed,O
27961,1826,in,O
27962,1826,combination,O
27963,1826,with,O
27964,1826,another,O
27965,1826,study,O
27966,1826,medication,O
27967,1826,and,O
27968,1826,patient,O
27969,1826,is,O
27970,1826,still,O
27971,1826,receiving,O
27972,1826,combination,O
27973,1826,therapy,O
27974,1827,Patients,O
27975,1827,who,O
27976,1827,are,O
27977,1827,currently,O
27978,1827,receiving,O
27979,1827,treatment,B-Procedure
27980,1827,with,O
27981,1827,any,B-Drug
27982,1827,medications,I-Drug
27983,1827,that,O
27984,1827,have,O
27985,1827,the,O
27986,1827,potential,O
27987,1827,to,O
27988,1827,prolong,O
27989,1827,the,O
27990,1827,QT,O
27991,1827,interval,O
27992,1827,or,O
27993,1827,inducing,O
27994,1827,Torsade,O
27995,1827,de,O
27996,1827,Pointes,O
27997,1827,and,O
27998,1827,the,O
27999,1827,treatment,O
28000,1827,can,O
28001,1827,not,O
28002,1827,be,O
28003,1827,either,O
28004,1827,safely,O
28005,1827,discontinued,O
28006,1827,at,O
28007,1827,least,O
28008,1827,one,O
28009,1827,week,O
28010,1827,prior,O
28011,1827,to,O
28012,1827,nilotinib,O
28013,1827,treatment,O
28014,1827,or,O
28015,1827,switched,O
28016,1827,to,O
28017,1827,a,O
28018,1827,different,O
28019,1827,medication,O
28020,1827,prior,O
28021,1827,to,O
28022,1827,start,O
28023,1827,of,O
28024,1827,nilotinib,O
28025,1827,treatment,O
28026,1827,and,O
28027,1827,for,O
28028,1827,the,O
28029,1827,duration,O
28030,1827,of,O
28031,1827,the,O
28032,1827,study,O
28033,1828,Pregnant,B-Observation
28034,1828,or,O
28035,1828,nursing,B-Observation
28036,1828,(,O
28037,1828,lactating,B-Observation
28038,1828,),O
28039,1828,women,B-Person
28040,1828,",",O
28041,1828,where,O
28042,1828,pregnancy,O
28043,1828,is,O
28044,1828,defined,O
28045,1828,as,O
28046,1828,the,O
28047,1828,state,O
28048,1828,of,O
28049,1828,a,O
28050,1828,female,O
28051,1828,after,O
28052,1828,conception,O
28053,1828,and,O
28054,1828,until,O
28055,1828,the,O
28056,1828,termination,O
28057,1828,of,O
28058,1828,gestation,O
28059,1828,",",O
28060,1828,confirmed,O
28061,1828,by,O
28062,1828,a,O
28063,1828,positive,O
28064,1828,hcG,B-Observation
28065,1828,laboratory,I-Observation
28066,1828,test,I-Observation
28067,1828,.,O
28068,1829,Women,B-Person
28069,1829,of,O
28070,1829,child,B-Observation
28071,1829,-,I-Observation
28072,1829,bearing,I-Observation
28073,1829,potential,I-Observation
28074,1829,",",O
28075,1829,defined,O
28076,1829,as,O
28077,1829,all,O
28078,1829,women,B-Person
28079,1829,physiologically,B-Observation
28080,1829,capable,I-Observation
28081,1829,of,I-Observation
28082,1829,becoming,I-Observation
28083,1829,pregnant,I-Observation
28084,1829,",",O
28085,1829,unless,O
28086,1829,they,O
28087,1829,are,O
28088,1829,using,O
28089,1829,highly,O
28090,1829,effective,O
28091,1829,methods,O
28092,1829,of,O
28093,1829,contraception,B-Observation
28094,1829,during,O
28095,1829,the,O
28096,1829,study,O
28097,1829,and,O
28098,1829,for,O
28099,1829,30,O
28100,1829,days,O
28101,1829,after,O
28102,1829,the,O
28103,1829,final,O
28104,1829,dose,O
28105,1829,of,O
28106,1829,nilotinib,O
28107,1829,.,O
28108,1830,Patient,O
28109,1830,is,O
28110,1830,currently,O
28111,1830,enrolled,B-Observation
28112,1830,in,I-Observation
28113,1830,a,I-Observation
28114,1830,Novartis,I-Observation
28115,1830,-,I-Observation
28116,1830,sponsored,I-Observation
28117,1830,",",I-Observation
28118,1830,Oncology,I-Observation
28119,1830,Clinical,I-Observation
28120,1830,Development,I-Observation
28121,1830,&,I-Observation
28122,1830,Medical,I-Observation
28123,1830,Affairs,I-Observation
28124,1830,study,I-Observation
28125,1830,receiving,O
28126,1830,nilotinib,B-Drug
28127,1830,and,O
28128,1830,has,O
28129,1830,fulfilled,O
28130,1830,all,O
28131,1830,their,O
28132,1830,requirements,O
28133,1830,in,O
28134,1830,the,O
28135,1830,parent,O
28136,1830,study,O
28137,1831,Patient,O
28138,1831,is,O
28139,1831,currently,O
28140,1831,benefiting,O
28141,1831,from,O
28142,1831,the,O
28143,1831,treatment,B-Procedure
28144,1831,with,O
28145,1831,nilotinib,B-Drug
28146,1831,",",O
28147,1831,as,O
28148,1831,determined,O
28149,1831,by,O
28150,1831,the,O
28151,1831,investigator,O
28152,1832,Patient,O
28153,1832,has,O
28154,1832,demonstrated,O
28155,1832,compliance,B-Observation
28156,1832,",",I-Observation
28157,1832,as,I-Observation
28158,1832,assessed,I-Observation
28159,1832,by,I-Observation
28160,1832,the,I-Observation
28161,1832,investigator,I-Observation
28162,1832,",",I-Observation
28163,1832,with,I-Observation
28164,1832,the,I-Observation
28165,1832,parent,I-Observation
28166,1832,study,I-Observation
28167,1832,protocol,I-Observation
28168,1832,requirements,I-Observation
28169,1833,Willingness,B-Observation
28170,1833,and,I-Observation
28171,1833,ability,I-Observation
28172,1833,to,I-Observation
28173,1833,comply,I-Observation
28174,1833,with,I-Observation
28175,1833,scheduled,I-Observation
28176,1833,visits,I-Observation
28177,1833,",",I-Observation
28178,1833,treatment,I-Observation
28179,1833,plans,I-Observation
28180,1833,and,O
28181,1833,any,O
28182,1833,other,O
28183,1833,study,O
28184,1833,procedures,O
28185,1834,Written,B-Observation
28186,1834,informed,I-Observation
28187,1834,consent,I-Observation
28188,1834,obtained,O
28189,1834,prior,O
28190,1834,to,O
28191,1834,enrolling,O
28192,1834,in,O
28193,1834,roll,O
28194,1834,-,O
28195,1834,over,O
28196,1834,study,O
28197,1835,contra,B-Condition
28198,1835,-,I-Condition
28199,1835,indication,I-Condition
28200,1835,to,O
28201,1835,inhalational,B-Procedure
28202,1835,induction,I-Procedure
28203,1835,(,O
28204,1835,full,O
28205,1835,stomach,O
28206,1835,),O
28207,1836,contra,B-Condition
28208,1836,-,I-Condition
28209,1836,indication,I-Condition
28210,1836,to,O
28211,1836,the,O
28212,1836,use,O
28213,1836,of,O
28214,1836,rocuronium,B-Drug
28215,1837,American,O
28216,1837,Society,O
28217,1837,of,O
28218,1837,Anesthesiologists,O
28219,1837,score,O
28220,1837,(,O
28221,1837,ASA,O
28222,1837,),O
28223,1837,III,O
28224,1837,or,O
28225,1837,IV,O
28226,1838,intracranial,B-Procedure
28227,1838,surgery,I-Procedure
28228,1839,parental,O
28229,1839,refusal,O
28230,1840,absence,O
28231,1840,of,O
28232,1840,affiliation,B-Observation
28233,1840,to,I-Observation
28234,1840,social,I-Observation
28235,1840,security,I-Observation
28236,1841,age,B-Person
28237,1841,<,O
28238,1841,2,O
28239,1841,years,O
28240,1842,indication,B-Mood
28241,1842,of,O
28242,1842,general,B-Procedure
28243,1842,anesthesia,I-Procedure
28244,1842,with,O
28245,1842,tracheal,B-Procedure
28246,1842,intubation,I-Procedure
28247,1843,inhalational,B-Procedure
28248,1843,induction,I-Procedure
28249,1843,scheduled,B-Mood
28250,1844,written,O
28251,1844,informed,O
28252,1844,consent,O
28253,1844,of,O
28254,1844,both,O
28255,1844,parents,O
28256,1845,Hypersensibility,B-Condition
28257,1845,to,O
28258,1845,toxin,B-Drug
28259,1845,or,O
28260,1845,excipients,B-Drug
28261,1846,Myastheny,B-Condition
28262,1847,Deglutition,B-Condition
28263,1847,'s,I-Condition
28264,1847,problems,I-Condition
28265,1848,Past,B-Observation
28266,1848,medical,I-Observation
28267,1848,history,I-Observation
28268,1848,of,O
28269,1848,dysphagia,B-Condition
28270,1848,or,O
28271,1848,aspiration,B-Condition
28272,1848,pneumonia,I-Condition
28273,1849,Pregnancy,B-Condition
28274,1849,(,O
28275,1849,positive,O
28276,1849,B,O
28277,1849,-,O
28278,1849,HCG,O
28279,1849,test,O
28280,1849,performed,O
28281,1849,a,O
28282,1849,maxima,O
28283,1849,72h,O
28284,1849,before,O
28285,1849,),O
28286,1849,or,O
28287,1849,breastfeeding,B-Observation
28288,1850,Mental,B-Condition
28289,1850,",",I-Condition
28290,1850,physical,I-Condition
28291,1850,incapacity,I-Condition
28292,1850,to,O
28293,1850,fill,B-Procedure
28294,1850,in,I-Procedure
28295,1850,the,I-Procedure
28296,1850,questionnaires,I-Procedure
28297,1851,Guardianship,O
28298,1851,patients,O
28299,1852,Skin,B-Condition
28300,1852,infections,I-Condition
28301,1852,at,O
28302,1852,the,O
28303,1852,inclusion,O
28304,1852,visit,O
28305,1853,Application,B-Procedure
28306,1853,in,I-Procedure
28307,1853,the,I-Procedure
28308,1853,last,I-Procedure
28309,1853,7,I-Procedure
28310,1853,days,I-Procedure
28311,1853,at,I-Procedure
28312,1853,the,I-Procedure
28313,1853,site,I-Procedure
28314,1853,of,I-Procedure
28315,1853,injection,I-Procedure
28316,1853,of,I-Procedure
28317,1853,local,I-Procedure
28318,1853,treatments,I-Procedure
28319,1853,(,O
28320,1853,apart,O
28321,1853,emollients,B-Drug
28322,1853,or,O
28323,1853,antiseptics,B-Drug
28324,1853,),O
28325,1853,or,O
28326,1853,injections,B-Procedure
28327,1853,of,O
28328,1853,botulism,B-Drug
28329,1853,toxin,I-Drug
28330,1853,or,O
28331,1853,dynamic,B-Procedure
28332,1853,phototherapy,I-Procedure
28333,1853,or,O
28334,1853,laser,B-Procedure
28335,1853,in,O
28336,1853,the,O
28337,1853,last,O
28338,1853,6,O
28339,1853,months,O
28340,1853,.,O
28341,1854,Systemic,B-Procedure
28342,1854,treatment,I-Procedure
28343,1854,with,O
28344,1854,aminosides,B-Drug
28345,1854,in,O
28346,1854,the,O
28347,1854,last,O
28348,1854,15,O
28349,1854,days,O
28350,1855,Inclusion,B-Procedure
28351,1855,in,I-Procedure
28352,1855,another,I-Procedure
28353,1855,study,I-Procedure
28354,1855,in,O
28355,1855,the,O
28356,1855,last,O
28357,1855,2,O
28358,1855,months,O
28359,1855,.,O
28360,1856,Confirmed,O
28361,1856,diagnosis,O
28362,1856,(,O
28363,1856,clinical,O
28364,1856,and,O
28365,1856,histological,B-Procedure
28366,1856,features,O
28367,1856,),O
28368,1856,of,O
28369,1856,Hailey,B-Condition
28370,1856,Hailey,I-Condition
28371,1856,or,I-Condition
28372,1856,Darier,I-Condition
28373,1856,diseases,I-Condition
28374,1856,.,O
28375,1857,Moderate,O
28376,1857,to,O
28377,1857,very,O
28378,1857,severe,O
28379,1857,lesions,B-Condition
28380,1857,located,O
28381,1857,in,O
28382,1857,large,O
28383,1857,folds,O
28384,1858,Patient,O
28385,1858,aged,B-Person
28386,1858,18,O
28387,1858,ans,O
28388,1858,or,O
28389,1858,more,O
28390,1859,Patient,O
28391,1859,with,O
28392,1859,health,B-Observation
28393,1859,coverage,I-Observation
28394,1860,Patient,O
28395,1860,who,O
28396,1860,have,O
28397,1860,signed,O
28398,1860,the,O
28399,1860,consent,O
28400,1860,form,O
28401,1861,Patient,O
28402,1861,proficient,O
28403,1861,into,O
28404,1861,filling,O
28405,1861,out,O
28406,1861,the,O
28407,1861,questionnaires,O
28408,1861,.,O
28409,1862,Known,O
28410,1862,allergy,B-Condition
28411,1862,or,O
28412,1862,hypersensitivity,B-Condition
28413,1862,reaction,O
28414,1862,to,O
28415,1862,dexmedetomidine,B-Drug
28416,1863,Organ,B-Condition
28417,1863,dysfunction,I-Condition
28418,1863,(,O
28419,1863,renal,B-Condition
28420,1863,/,I-Condition
28421,1863,hepatic,I-Condition
28422,1863,failure,I-Condition
28423,1863,or,O
28424,1863,leukemia,B-Condition
28425,1863,),O
28426,1864,Cardiac,B-Condition
28427,1864,disease,I-Condition
28428,1864,(,O
28429,1864,congenital,O
28430,1864,or,O
28431,1864,acquired,O
28432,1864,),O
28433,1865,Airway,B-Condition
28434,1865,or,I-Condition
28435,1865,thoracic,I-Condition
28436,1865,malformation,I-Condition
28437,1866,Cerebral,B-Condition
28438,1866,palsy,I-Condition
28439,1867,Hypotonia,B-Condition
28440,1868,Need,B-Mood
28441,1868,for,I-Mood
28442,1868,premedication,B-Drug
28443,1869,Current,O
28444,1869,/,O
28445,1869,recent,O
28446,1869,upper,B-Condition
28447,1869,respiratory,I-Condition
28448,1869,infection,I-Condition
28449,1869,(,O
28450,1869,within,O
28451,1869,four,O
28452,1869,weeks,O
28453,1869,prior,O
28454,1869,to,O
28455,1869,the,O
28456,1869,surgery,B-Procedure
28457,1869,),O
28458,1870,Asthma,B-Condition
28459,1871,Allergy,B-Condition
28460,1871,or,O
28461,1871,intolerance,B-Condition
28462,1871,to,O
28463,1871,clonidine,B-Drug
28464,1872,Non,B-Observation
28465,1872,-,I-Observation
28466,1872,English,I-Observation
28467,1872,speaking,I-Observation
28468,1872,parents,I-Observation
28469,1872,/,I-Observation
28470,1872,patients,I-Observation
28471,1872,.,O
28472,1873,Patients,O
28473,1873,between,O
28474,1873,3,O
28475,1873,to,O
28476,1873,16,O
28477,1873,years,O
28478,1873,of,O
28479,1873,age,B-Person
28480,1873,undergoing,O
28481,1873,adenotonsillectomy,B-Procedure
28482,1873,",",O
28483,1873,with,O
28484,1873,or,O
28485,1873,without,O
28486,1873,myringotomy,B-Procedure
28487,1873,or,O
28488,1873,myringoplasty,B-Procedure
28489,1874,ASA,O
28490,1874,1,O
28491,1874,&,O
28492,1874,2,O
28493,1875,Presence,O
28494,1875,of,O
28495,1875,systemic,B-Condition
28496,1875,diseases,I-Condition
28497,1875,;,O
28498,1876,Presence,O
28499,1876,of,O
28500,1876,local,B-Condition
28501,1876,inflammation,I-Condition
28502,1876,and/or,I-Condition
28503,1876,infection,I-Condition
28504,1876,;,O
28505,1877,Any,O
28506,1877,history,B-Observation
28507,1877,of,O
28508,1877,allergic,B-Condition
28509,1877,reaction,I-Condition
28510,1877,to,O
28511,1877,local,B-Drug
28512,1877,anesthetics,I-Drug
28513,1877,",",O
28514,1877,gastrointestinal,B-Condition
28515,1877,bleeding,I-Condition
28516,1877,or,I-Condition
28517,1877,ulceration,I-Condition
28518,1877,;,O
28519,1878,Cardiovascular,B-Condition
28520,1878,",",I-Condition
28521,1878,kidney,I-Condition
28522,1878,or,I-Condition
28523,1878,hepatic,I-Condition
28524,1878,diseases,I-Condition
28525,1878,;,O
28526,1879,Patients,O
28527,1879,who,O
28528,1879,are,O
28529,1879,making,O
28530,1879,use,O
28531,1879,of,O
28532,1879,antidepressants,B-Drug
28533,1879,",",O
28534,1879,diuretics,B-Drug
28535,1879,or,O
28536,1879,anticoagulants,B-Drug
28537,1879,;,O
28538,1880,Asthma,B-Condition
28539,1880,and,O
28540,1880,allergy,B-Condition
28541,1880,to,O
28542,1880,aspirin,B-Drug
28543,1880,",",O
28544,1880,ibuprofen,B-Drug
28545,1880,or,O
28546,1880,any,O
28547,1880,other,O
28548,1880,nonsteroidal,B-Drug
28549,1880,antiinflammatory,I-Drug
28550,1880,drug,I-Drug
28551,1880,;,O
28552,1881,Regular,O
28553,1881,use,O
28554,1881,of,O
28555,1881,any,O
28556,1881,nonsteroidal,B-Condition
28557,1881,antiinflammatory,I-Condition
28558,1881,drug,I-Condition
28559,1881,",",O
28560,1882,Pregnancy,B-Condition
28561,1882,or,O
28562,1882,breast,B-Observation
28563,1882,feeding,I-Observation
28564,1882,.,O
28565,1883,Need,O
28566,1883,of,O
28567,1883,lower,O
28568,1883,third,O
28569,1883,molar,O
28570,1883,surgeries,B-Procedure
28571,1884,Clinically,O
28572,1884,significant,O
28573,1884,cardiac,B-Condition
28574,1884,disease,I-Condition
28575,1884,(,O
28576,1884,New,O
28577,1884,York,O
28578,1884,Heart,O
28579,1884,Association,O
28580,1884,Class,O
28581,1884,III,O
28582,1884,/,O
28583,1884,"IV),or",O
28584,1884,severe,O
28585,1884,debilitating,B-Condition
28586,1884,puhnonary,I-Condition
28587,1884,disease,I-Condition
28588,1884,.,O
28589,1885,Uncontrolled,O
28590,1885,serious,O
28591,1885,active,O
28592,1885,infection,B-Condition
28593,1885,.,O
28594,1886,Anticipated,B-Observation
28595,1886,survival,I-Observation
28596,1886,of,O
28597,1886,less,O
28598,1886,than,O
28599,1886,3,O
28600,1886,months,O
28601,1886,.,O
28602,1887,Active,O
28603,1887,CNS,B-Condition
28604,1887,or,I-Condition
28605,1887,epiduraltumor,I-Condition
28606,1888,Inability,B-Condition
28607,1888,or,O
28608,1888,unwillingness,B-Observation
28609,1888,to,O
28610,1888,comply,O
28611,1888,with,O
28612,1888,the,O
28613,1888,treatment,O
28614,1888,protocol,O
28615,1888,",",O
28616,1888,follow,B-Procedure
28617,1888,-,I-Procedure
28618,1888,up,I-Procedure
28619,1888,",",O
28620,1888,or,O
28621,1888,research,O
28622,1888,tests,O
28623,1888,.,O
28624,1889,-Patients,O
28625,1889,residing,O
28626,1889,in,O
28627,1889,the,O
28628,1889,following,O
28629,1889,clinical,O
28630,1889,states,O
28631,1889,wit,O
28632,1889,!,O
28633,1889,be,O
28634,1889,considered,O
28635,1889,:,O
28636,1889,A.,O
28637,1889,Rising,O
28638,1889,PSA,O
28639,1889,:,O
28640,1889,Patients,O
28641,1889,with,O
28642,1889,a,O
28643,1889,history,B-Observation
28644,1889,of,I-Observation
28645,1889,localized,B-Condition
28646,1889,disease,I-Condition
28647,1889,who,O
28648,1889,have,O
28649,1889,undergone,O
28650,1889,definitive,O
28651,1889,radiation,B-Procedure
28652,1889,or,O
28653,1889,surgery,B-Procedure
28654,1889,.,O
28655,1889,These,O
28656,1889,patients,O
28657,1889,must,O
28658,1889,demonstrate,O
28659,1889,progression,B-Observation
28660,1889,of,I-Observation
28661,1889,disease,I-Observation
28662,1889,biochemically,O
28663,1889,as,O
28664,1889,outlined,O
28665,1889,below,O
28666,1889,.,O
28667,1889,Patients,O
28668,1889,in,O
28669,1889,this,O
28670,1889,group,O
28671,1889,may,O
28672,1889,not,O
28673,1889,have,O
28674,1889,radiographically,O
28675,1889,evident,O
28676,1889,disease,B-Condition
28677,1889,.,O
28678,1890,B.,O
28679,1890,Non,O
28680,1890,-,O
28681,1890,castrate,O
28682,1890,metastatic,O
28683,1890,:,O
28684,1890,Patients,O
28685,1890,must,O
28686,1890,present,O
28687,1890,with,O
28688,1890,radiographic,B-Observation
28689,1890,evidence,I-Observation
28690,1890,of,O
28691,1890,metastatic,B-Condition
28692,1890,disease,I-Condition
28693,1890,at,O
28694,1890,the,O
28695,1890,time,O
28696,1890,of,O
28697,1890,diagnosis,O
28698,1890,or,O
28699,1890,after,O
28700,1890,treatment,B-Procedure
28701,1890,for,O
28702,1890,localized,B-Condition
28703,1890,disease,I-Condition
28704,1890,.,O
28705,1890,These,O
28706,1890,patients,O
28707,1890,must,O
28708,1890,show,O
28709,1890,newly,O
28710,1890,detected,O
28711,1890,disease,B-Condition
28712,1890,or,I-Condition
28713,1890,progressing,I-Condition
28714,1890,disease,I-Condition
28715,1890,in,I-Condition
28716,1890,bone,I-Condition
28717,1890,or,I-Condition
28718,1890,in,I-Condition
28719,1890,soft,I-Condition
28720,1890,tissue,I-Condition
28721,1890,.,O
28722,1890,Biochemical,B-Observation
28723,1890,progression,I-Observation
28724,1890,is,O
28725,1890,defined,O
28726,1890,as,O
28727,1890,:,O
28728,1890,minimum,O
28729,1890,no,O
28730,1890,.,O
28731,1890,of,O
28732,1890,determinations,O
28733,1890,:,O
28734,1890,3,O
28735,1890,Interval,O
28736,1890,:,O
28737,1890,>,O
28738,1890,2,O
28739,1890,weeks,O
28740,1890,Minimal,O
28741,1890,Baseline,O
28742,1890,PSA,O
28743,1890,value,O
28744,1890,(,O
28745,1890,ng,O
28746,1890,/,O
28747,1890,ml,O
28748,1890,):,O
28749,1890,2,O
28750,1890,Minimal,O
28751,1890,%,O
28752,1890,increase,O
28753,1890,in,O
28754,1890,range,O
28755,1890,of,O
28756,1890,values,O
28757,1890,:,O
28758,1890,50,O
28759,1890,%,O
28760,1891,Diagnosis,O
28761,1891,of,O
28762,1891,prostate,B-Condition
28763,1891,adenocarcinoma,I-Condition
28764,1891,histologically,B-Procedure
28765,1891,confirmed,O
28766,1891,at,O
28767,1891,MSKCC,O
28768,1891,.,O
28769,1892,Patient,O
28770,1892,must,O
28771,1892,have,O
28772,1892,level,O
28773,1892,of,O
28774,1892,serum,O
28775,1892,testosterone,O
28776,1892,above,O
28777,1892,the,O
28778,1892,lower,O
28779,1892,limit,O
28780,1892,of,O
28781,1892,normal,O
28782,1892,.,O
28783,1893,Karnofskcy,O
28784,1893,performance,O
28785,1893,status,O
28786,1893,(,O
28787,1893,KPS,O
28788,1893,),O
28789,1893,>,O
28790,1893,_,O
28791,1893,70,O
28792,1893,%,O
28793,1893,.,O
28794,1894,Patients,O
28795,1894,must,O
28796,1894,have,O
28797,1894,adequate,B-Observation
28798,1894,organ,I-Observation
28799,1894,function,I-Observation
28800,1894,as,O
28801,1894,defined,O
28802,1894,by,O
28803,1894,the,O
28804,1894,following,O
28805,1894,laboratory,O
28806,1894,criteria,O
28807,1894,:,O
28808,1895,WBC,O
28809,1895,>,O
28810,1895,_,O
28811,1895,3500,O
28812,1895,/,O
28813,1895,mm3,O
28814,1895,",",O
28815,1895,platelet,O
28816,1895,count,O
28817,1895,>,O
28818,1895,_,O
28819,1895,"100,000",O
28820,1895,/,O
28821,1895,mm3,O
28822,1895,.,O
28823,1896,Bilirubin,O
28824,1896,<,O
28825,1896,2.0,O
28826,1896,mg,O
28827,1896,/,O
28828,1896,dl,O
28829,1896,or,O
28830,1896,SGOT,O
28831,1896,<,O
28832,1896,3.0,O
28833,1896,X,O
28834,1896,the,O
28835,1896,upper,O
28836,1896,limit,O
28837,1896,of,O
28838,1896,normal,O
28839,1896,.,O
28840,1897,Creatinine,O
28841,1897,<,O
28842,1897,_,O
28843,1897,1.6,O
28844,1897,mg,O
28845,1897,/,O
28846,1897,dl,O
28847,1897,or,O
28848,1897,creatinine,O
28849,1897,clearance,O
28850,1897,>,O
28851,1897,_,O
28852,1897,60,O
28853,1897,cc,O
28854,1897,/,O
28855,1897,min,O
28856,1897,.,O
28857,1898,Prior,O
28858,1898,hormonal,B-Procedure
28859,1898,therapy,I-Procedure
28860,1898,is,B-Mood
28861,1898,allowed,I-Mood
28862,1898,as,O
28863,1898,:,O
28864,1899,1,O
28865,1899,.,O
28866,1899,Neoadjuvant,B-Procedure
28867,1899,treatment,I-Procedure
28868,1899,prior,O
28869,1899,to,O
28870,1899,radiation,B-Procedure
28871,1899,therapy,I-Procedure
28872,1899,or,O
28873,1899,radical,B-Procedure
28874,1899,prostatectomy,I-Procedure
28875,1899,",",O
28876,1899,provided,O
28877,1899,that,O
28878,1899,the,O
28879,1899,total,O
28880,1899,duration,O
28881,1899,of,O
28882,1899,exposure,O
28883,1899,does,O
28884,1899,not,O
28885,1899,exceed,O
28886,1899,10,O
28887,1899,months,O
28888,1899,.,O
28889,1900,2,O
28890,1900,.,O
28891,1900,One,O
28892,1900,cycle,O
28893,1900,of,O
28894,1900,intermittent,B-Procedure
28895,1900,therapy,I-Procedure
28896,1900,up,O
28897,1900,to,O
28898,1900,a,O
28899,1900,maximum,O
28900,1900,exposure,O
28901,1900,of,O
28902,1900,10,O
28903,1900,months,O
28904,1900,.,O
28905,1901,Patients,O
28906,1901,must,O
28907,1901,be,O
28908,1901,at,O
28909,1901,least,O
28910,1901,18,O
28911,1901,years,O
28912,1901,of,O
28913,1901,age,B-Person
28914,1901,.,O
28915,1902,Patients,O
28916,1902,must,O
28917,1902,have,O
28918,1902,signed,O
28919,1902,an,O
28920,1902,informed,O
28921,1902,consent,O
28922,1902,document,O
28923,1902,stating,O
28924,1902,that,O
28925,1902,they,O
28926,1902,understand,O
28927,1902,the,O
28928,1902,investigational,O
28929,1902,nature,O
28930,1902,of,O
28931,1902,the,O
28932,1902,proposed,O
28933,1902,treatment,O
28934,1903,Pregnancy,B-Condition
28935,1903,",",O
28936,1903,age,B-Person
28937,1903,<,O
28938,1903,18,O
28939,1903,",",O
28940,1903,nursing,B-Condition
28941,1903,",",O
28942,1903,or,O
28943,1903,documented,O
28944,1903,allergy,B-Condition
28945,1903,to,O
28946,1903,naloxone,B-Drug
28947,1904,Patients,O
28948,1904,will,O
28949,1904,be,O
28950,1904,included,O
28951,1904,if,O
28952,1904,they,O
28953,1904,are,O
28954,1904,having,O
28955,1904,an,O
28956,1904,in,O
28957,1904,-,O
28958,1904,patient,O
28959,1904,spinal,B-Procedure
28960,1904,fusion,I-Procedure
28961,1904,procedure,I-Procedure
28962,1904,",",O
28963,1904,are,O
28964,1904,18,O
28965,1904,years,B-Person
28966,1904,or,O
28967,1904,older,O
28968,1904,",",O
28969,1904,post,O
28970,1904,and,O
28971,1904,post,O
28972,1904,-,O
28973,1904,operative,O
28974,1904,pain,B-Procedure
28975,1904,control,I-Procedure
28976,1904,plan,I-Procedure
28977,1904,includes,O
28978,1904,opioid,B-Drug
28979,1904,medications,O
28980,1904,.,O
28981,1905,Body,O
28982,1905,mass,O
28983,1905,index,O
28984,1905,(,O
28985,1905,BMI,O
28986,1905,),O
28987,1905,of,O
28988,1905,35,O
28989,1905,kg,O
28990,1905,/,O
28991,1905,m2,O
28992,1905,or,O
28993,1905,more,O
28994,1905,.,O
28995,1906,Significant,O
28996,1906,metabolic,B-Condition
28997,1906,and,I-Condition
28998,1906,endocrine,I-Condition
28999,1906,diseases,I-Condition
29000,1906,.,O
29001,1907,Diagnosis,O
29002,1907,of,O
29003,1907,cancer,B-Condition
29004,1907,.,O
29005,1908,Use,O
29006,1908,of,O
29007,1908,steroids,B-Drug
29008,1908,or,O
29009,1908,drugs,B-Drug
29010,1908,that,I-Drug
29011,1908,interfere,I-Drug
29012,1908,with,I-Drug
29013,1908,the,I-Drug
29014,1908,metabolism,I-Drug
29015,1908,of,I-Drug
29016,1908,estrogen,I-Drug
29017,1908,.,O
29018,1909,Use,O
29019,1909,of,O
29020,1909,any,O
29021,1909,systemic,B-Drug
29022,1909,estrogen,I-Drug
29023,1909,",",I-Drug
29024,1909,progestin,I-Drug
29025,1909,",",O
29026,1909,or,O
29027,1909,DHEA,B-Drug
29028,1909,in,O
29029,1909,the,O
29030,1909,eight,O
29031,1909,weeks,O
29032,1909,prior,O
29033,1909,to,O
29034,1909,randomization,O
29035,1909,.,O
29036,1910,Use,O
29037,1910,of,O
29038,1910,alternative,B-Procedure
29039,1910,therapies,I-Procedure
29040,1910,or,O
29041,1910,natural,B-Drug
29042,1910,products,I-Drug
29043,1910,to,O
29044,1910,treat,O
29045,1910,postmenopausal,B-Condition
29046,1910,symptoms,I-Condition
29047,1910,in,O
29048,1910,the,O
29049,1910,four,O
29050,1910,weeks,O
29051,1910,prior,O
29052,1910,to,O
29053,1910,randomization,O
29054,1910,.,O
29055,1911,Palpable,B-Condition
29056,1911,fibroids,I-Condition
29057,1911,or,O
29058,1911,uterine,B-Condition
29059,1911,prolapse,I-Condition
29060,1911,:,O
29061,1911,Grade,O
29062,1911,2,O
29063,1911,or,O
29064,1911,3,O
29065,1911,.,O
29066,1912,Cigarette,B-Condition
29067,1912,smoking,I-Condition
29068,1913,Healthy,B-Condition
29069,1913,postmenopausal,B-Condition
29070,1913,women,B-Person
29071,1913,with,O
29072,1913,50,O
29073,1913,or,O
29074,1913,more,O
29075,1913,moderate,B-Condition
29076,1913,to,I-Condition
29077,1913,severe,I-Condition
29078,1913,hot,I-Condition
29079,1913,flushes,I-Condition
29080,1913,.,O
29081,1914,Women,B-Person
29082,1914,between,O
29083,1914,40,O
29084,1914,to,O
29085,1914,70,O
29086,1914,years,O
29087,1914,of,O
29088,1914,age,B-Person
29089,1914,.,O
29090,1915,Subjects,O
29091,1915,with,O
29092,1915,evidence,B-Mood
29093,1915,of,O
29094,1915,liver,B-Condition
29095,1915,cirrhosis,I-Condition
29096,1916,Evidence,B-Mood
29097,1916,of,O
29098,1916,HCC,B-Condition
29099,1917,Co,O
29100,1917,-,O
29101,1917,infection,O
29102,1917,with,O
29103,1917,hepatitis,B-Condition
29104,1917,B,I-Condition
29105,1917,virus,I-Condition
29106,1917,",",O
29107,1917,HIV,B-Condition
29108,1918,Subjects,O
29109,1918,chronically,O
29110,1918,infected,O
29111,1918,with,O
29112,1918,HCV,B-Condition
29113,1918,Genotype,O
29114,1918,1,O
29115,1919,HCV,O
29116,1919,RNA,O
29117,1919,viral,O
29118,1919,load,O
29119,1919,of,O
29120,1919,≥,O
29121,1919,10,O
29122,1919,*,O
29123,1919,5,O
29124,1919,*,O
29125,1919,IU,O
29126,1919,/,O
29127,1919,mL,O
29128,1919,(,O
29129,1919,"100,000",O
29130,1919,IU,O
29131,1919,/,O
29132,1919,mL,O
29133,1919,),O
29134,1919,at,O
29135,1919,screening,O
29136,1920,Patients,O
29137,1920,with,O
29138,1920,head,B-Condition
29139,1920,trauma,I-Condition
29140,1920,or,O
29141,1920,Neurosurgical,B-Procedure
29142,1920,intervention,I-Procedure
29143,1921,Patients,O
29144,1921,<,O
29145,1921,65,O
29146,1921,years,O
29147,1921,of,O
29148,1921,age,B-Person
29149,1922,Patients,O
29150,1922,with,O
29151,1922,an,O
29152,1922,expected,B-Observation
29153,1922,life,I-Observation
29154,1922,expectancy,I-Observation
29155,1922,<,O
29156,1922,48,O
29157,1922,hours,O
29158,1923,Blind,B-Condition
29159,1923,patients,O
29160,1924,Patients,O
29161,1924,with,O
29162,1924,a,O
29163,1924,seizure,B-Condition
29164,1924,history,B-Observation
29165,1925,Patients,O
29166,1925,with,O
29167,1925,uncontrolled,B-Condition
29168,1925,hypertension,I-Condition
29169,1926,Patients,O
29170,1926,with,O
29171,1926,a,O
29172,1926,supratheraputic,O
29173,1926,(,O
29174,1926,>,O
29175,1926,3.0,O
29176,1926,),O
29177,1926,INR,O
29178,1927,Patients,O
29179,1927,on,O
29180,1927,strong,B-Drug
29181,1927,CYP1A2,I-Drug
29182,1927,inhibitors,I-Drug
29183,1927,:,O
29184,1927,ciprofloxacin,B-Drug
29185,1927,",",O
29186,1927,fluvoxamine,B-Drug
29187,1927,",",O
29188,1927,methoxsalen,B-Drug
29189,1927,",",O
29190,1927,ofloxacin,B-Drug
29191,1927,",",O
29192,1927,primaquine,B-Drug
29193,1928,Patients,O
29194,1928,who,O
29195,1928,do,O
29196,1928,not,O
29197,1928,speak,B-Observation
29198,1928,English,I-Observation
29199,1928,or,I-Observation
29200,1928,Spanish,I-Observation
29201,1929,Non,O
29202,1929,-,O
29203,1929,ventilated,B-Procedure
29204,1929,Patients,O
29205,1929,over,O
29206,1929,the,O
29207,1929,age,B-Person
29208,1929,of,O
29209,1929,65,O
29210,1930,Any,O
29211,1930,condition,O
29212,1930,that,O
29213,1930,prevents,O
29214,1930,participation,O
29215,1930,in,O
29216,1930,the,O
29217,1930,study,O
29218,1930,",",O
29219,1930,including,O
29220,1930,pregnancy,B-Condition
29221,1930,and,O
29222,1930,other,O
29223,1930,contraindications,B-Condition
29224,1930,for,O
29225,1930,Ventavis,B-Procedure
29226,1930,treatment,I-Procedure
29227,1930,(,O
29228,1930,as,O
29229,1930,listed,O
29230,1930,in,O
29231,1930,the,O
29232,1930,current,O
29233,1930,Ventavis,O
29234,1930,Summary,O
29235,1930,of,O
29236,1930,Product,O
29237,1930,Characteristics,O
29238,1930,and,O
29239,1930,patient,O
29240,1930,package,O
29241,1930,insert,O
29242,1930,),O
29243,1931,The,O
29244,1931,treating,O
29245,1931,physician,O
29246,1931,has,O
29247,1931,chosen,O
29248,1931,Ventavis,B-Drug
29249,1931,as,O
29250,1931,a,O
29251,1931,suitable,O
29252,1931,long,O
29253,1931,-,O
29254,1931,term,O
29255,1931,treatment,O
29256,1931,for,O
29257,1931,the,O
29258,1931,patient,O
29259,1932,Patient,O
29260,1932,with,O
29261,1932,primary,B-Condition
29262,1932,pulmonary,I-Condition
29263,1932,hypertension,I-Condition
29264,1932,(,O
29265,1932,i.e.,O
29266,1932,Idiopathic,B-Condition
29267,1932,Pulmonary,I-Condition
29268,1932,Arterial,I-Condition
29269,1932,Hypertension,I-Condition
29270,1932,or,O
29271,1932,Familial,B-Condition
29272,1932,Pulmonary,I-Condition
29273,1932,Arterial,I-Condition
29274,1932,Hypertension,I-Condition
29275,1932,),O
29276,1932,and,O
29277,1932,classified,O
29278,1932,as,O
29279,1932,NYHA,O
29280,1932,functional,O
29281,1932,class,O
29282,1932,III,O
29283,1932,(,O
29284,1932,NYHA,O
29285,1932,=,O
29286,1932,New,O
29287,1932,York,O
29288,1932,Heart,O
29289,1932,Association,O
29290,1932,),O
29291,1933,No,O
29292,1933,prior,O
29293,1933,treatment,B-Procedure
29294,1933,with,I-Procedure
29295,1933,Ventavis,I-Procedure
29296,1933,or,O
29297,1933,other,O
29298,1933,active,O
29299,1933,treatments,B-Procedure
29300,1933,for,O
29301,1933,primary,B-Condition
29302,1933,pulmonary,I-Condition
29303,1933,hypertension,I-Condition
29304,1933,within,O
29305,1933,6,O
29306,1933,weeks,O
29307,1933,of,O
29308,1933,date,O
29309,1933,of,O
29310,1933,study,O
29311,1933,inclusion,O
29312,1933,(,O
29313,1933,unless,O
29314,1933,otherwise,O
29315,1933,advised,O
29316,1933,by,O
29317,1933,Bayer,O
29318,1933,Schering,O
29319,1933,Pharma,O
29320,1933,),O
29321,1934,Patients,O
29322,1934,will,O
29323,1934,be,O
29324,1934,excluded,O
29325,1934,if,O
29326,1934,they,O
29327,1934,have,O
29328,1934,had,O
29329,1934,exposure,O
29330,1934,to,O
29331,1934,a,O
29332,1934,total,O
29333,1934,daily,O
29334,1934,dose,O
29335,1934,of,O
29336,1934,MET,B-Drug
29337,1934,1000,O
29338,1934,mg,O
29339,1934,bid,O
29340,1934,for,O
29341,1934,at,O
29342,1934,least,O
29343,1934,2,O
29344,1934,weeks,O
29345,1934,in,O
29346,1934,the,O
29347,1934,past,O
29348,1934,3,O
29349,1934,months,O
29350,1934,;,O
29351,1935,Patients,O
29352,1935,will,O
29353,1935,be,O
29354,1935,excluded,O
29355,1935,if,O
29356,1935,they,O
29357,1935,could,O
29358,1935,not,B-Condition
29359,1935,tolerate,I-Condition
29360,1935,MET,B-Drug
29361,1935,during,O
29362,1935,the,O
29363,1935,recommended,O
29364,1935,titration,O
29365,1935,schedule,O
29366,1935,outlined,O
29367,1935,in,O
29368,1935,the,O
29369,1935,protocol,O
29370,1935,;,O
29371,1936,Major,O
29372,1936,neurological,O
29373,1936,or,O
29374,1936,medical,O
29375,1936,illnesses,O
29376,1936,that,O
29377,1936,affect,O
29378,1936,weight,O
29379,1936,gain,O
29380,1936,(,O
29381,1936,e.g.,O
29382,1936,",",O
29383,1936,unstable,O
29384,1936,thyroid,B-Condition
29385,1936,disease,I-Condition
29386,1936,),O
29387,1936,or,O
29388,1936,require,O
29389,1936,a,O
29390,1936,systemic,O
29391,1936,medication,O
29392,1936,that,O
29393,1936,might,O
29394,1936,impact,O
29395,1936,weight,O
29396,1936,or,O
29397,1936,glucose,O
29398,1936,regulation,O
29399,1936,(,O
29400,1936,e.g.,O
29401,1936,",",O
29402,1936,diabetes,B-Condition
29403,1936,mellitus,I-Condition
29404,1936,[,O
29405,1936,insulin,B-Drug
29406,1936,],O
29407,1936,",",O
29408,1936,chronic,B-Condition
29409,1936,renal,I-Condition
29410,1936,failure,I-Condition
29411,1936,[,O
29412,1936,steroids,B-Drug
29413,1936,],O
29414,1936,),O
29415,1936,;,O
29416,1937,Fasting,O
29417,1937,glucose,O
29418,1937,=,O
29419,1937,126,O
29420,1937,mg,O
29421,1937,/,O
29422,1937,dL,O
29423,1937,on,O
29424,1937,2,O
29425,1937,occasions,O
29426,1937,during,O
29427,1937,screening,O
29428,1937,indicating,O
29429,1937,need,O
29430,1937,for,O
29431,1937,prompt,O
29432,1937,treatment,O
29433,1937,;,O
29434,1938,If,O
29435,1938,lab,O
29436,1938,results,O
29437,1938,are,O
29438,1938,available,O
29439,1938,in,O
29440,1938,the,O
29441,1938,last,O
29442,1938,6,O
29443,1938,months,O
29444,1938,",",O
29445,1938,then,O
29446,1938,a,O
29447,1938,serum,O
29448,1938,creatinine,O
29449,1938,=,O
29450,1938,1.3,O
29451,1938,mg,O
29452,1938,/,O
29453,1938,dL,O
29454,1938,on,O
29455,1938,2,O
29456,1938,occasions,O
29457,1938,during,O
29458,1938,screening,O
29459,1938,and/or,O
29460,1938,follow,O
29461,1938,-,O
29462,1938,up,O
29463,1938,",",O
29464,1938,indicating,O
29465,1938,potential,O
29466,1938,impairment,O
29467,1938,of,O
29468,1938,renal,O
29469,1938,functioning,O
29470,1938,;,O
29471,1939,Pregnant,O
29472,1939,or,O
29473,1939,breast,O
29474,1939,feeding,O
29475,1939,;,O
29476,1940,Children,O
29477,1940,and,O
29478,1940,caregivers,O
29479,1940,who,O
29480,1940,are,O
29481,1940,unable,O
29482,1940,to,O
29483,1940,complete,O
29484,1940,assessments,O
29485,1940,for,O
29486,1940,any,O
29487,1940,reason,O
29488,1940,;,O
29489,1941,Inpatient,B-Person
29490,1941,or,O
29491,1941,outpatient,B-Person
29492,1941,age,B-Person
29493,1941,8,O
29494,1941,-,O
29495,1941,19,O
29496,1941,years,O
29497,1941,inclusive,O
29498,1941,;,O
29499,1941,participants,O
29500,1941,must,O
29501,1941,live,O
29502,1941,with,O
29503,1941,a,O
29504,1941,parent,O
29505,1941,",",O
29506,1941,guardian,O
29507,1941,",",O
29508,1941,or,O
29509,1941,caregiver,O
29510,1941,;,O
29511,1942,Fluent,O
29512,1942,in,O
29513,1942,English,O
29514,1942,;,O
29515,1943,Diagnosed,O
29516,1943,or,O
29517,1943,told,O
29518,1943,by,O
29519,1943,a,O
29520,1943,clinician,O
29521,1943,that,O
29522,1943,they,O
29523,1943,have,O
29524,1943,any,O
29525,1943,of,O
29526,1943,the,O
29527,1943,following,O
29528,1943,bipolar,B-Condition
29529,1943,spectrum,I-Condition
29530,1943,disorders,I-Condition
29531,1943,(,O
29532,1943,BSD,B-Condition
29533,1943,):,O
29534,1943,bipolar,B-Condition
29535,1943,I,I-Condition
29536,1943,",",O
29537,1943,bipolar,B-Condition
29538,1943,II,I-Condition
29539,1943,",",O
29540,1943,unspecified,B-Condition
29541,1943,bipolar,I-Condition
29542,1943,and,I-Condition
29543,1943,related,I-Condition
29544,1943,disorders,I-Condition
29545,1943,",",O
29546,1943,Disruptive,B-Condition
29547,1943,Mood,I-Condition
29548,1943,Dysregulation,I-Condition
29549,1943,Disorder,I-Condition
29550,1943,(,O
29551,1943,DMDD,B-Condition
29552,1943,),O
29553,1943,",",O
29554,1943,cyclothymic,B-Condition
29555,1943,disorder,I-Condition
29556,1943,",",O
29557,1943,other,B-Condition
29558,1943,specified,I-Condition
29559,1943,bipolar,I-Condition
29560,1943,and,I-Condition
29561,1943,related,I-Condition
29562,1943,disorders,I-Condition
29563,1943,",",O
29564,1943,as,O
29565,1943,well,O
29566,1943,as,O
29567,1943,mood,B-Condition
29568,1943,disorder,I-Condition
29569,1943,not,I-Condition
29570,1943,otherwise,I-Condition
29571,1943,specified,I-Condition
29572,1943,(,O
29573,1943,if,O
29574,1943,diagnosed,O
29575,1943,in,O
29576,1943,the,O
29577,1943,past,O
29578,1943,as,O
29579,1943,per,O
29580,1943,DSM,O
29581,1943,-,O
29582,1943,IV,O
29583,1943,),O
29584,1943,;,O
29585,1944,Body,O
29586,1944,mass,O
29587,1944,index,O
29588,1944,>,O
29589,1944,85%ile,O
29590,1944,for,O
29591,1944,age,O
29592,1944,and,O
29593,1944,sex,O
29594,1944,by,O
29595,1944,standard,O
29596,1944,growth,O
29597,1944,charts,O
29598,1944,;,O
29599,1945,Received,O
29600,1945,a,O
29601,1945,new,O
29602,1945,or,O
29603,1945,ongoing,O
29604,1945,prescription,O
29605,1945,for,O
29606,1945,at,O
29607,1945,least,O
29608,1945,one,O
29609,1945,SGA,B-Drug
29610,1945,(,O
29611,1945,i.e.,O
29612,1945,",",O
29613,1945,olanzapine,B-Drug
29614,1945,",",O
29615,1945,clozapine,B-Drug
29616,1945,",",O
29617,1945,risperidone,B-Drug
29618,1945,",",O
29619,1945,quetiapine,B-Drug
29620,1945,",",O
29621,1945,aripiprazole,B-Drug
29622,1945,",",O
29623,1945,ziprasidone,B-Drug
29624,1945,",",O
29625,1945,iloperidone,B-Drug
29626,1945,",",O
29627,1945,lurasidone,B-Drug
29628,1945,",",O
29629,1945,paliperidone,B-Drug
29630,1945,",",O
29631,1945,brexpiprazole,B-Drug
29632,1945,or,O
29633,1945,cariprazine,B-Drug
29634,1945,),O
29635,1945,that,O
29636,1945,is,O
29637,1945,not,O
29638,1945,prescribed,O
29639,1945,as,O
29640,1945,a,O
29641,1945,PRN,O
29642,1945,medication,O
29643,1945,;,O
29644,1946,Prior,O
29645,1946,endobronchial,B-Procedure
29646,1946,treatment,I-Procedure
29647,1946,for,O
29648,1946,emphysema,B-Condition
29649,1947,Pleural,B-Condition
29650,1947,or,I-Condition
29651,1947,interstitial,I-Condition
29652,1947,disease,I-Condition
29653,1947,that,O
29654,1947,precludes,O
29655,1947,surgery,B-Procedure
29656,1947,.,O
29657,1948,Prior,O
29658,1948,lung,B-Procedure
29659,1948,transplant,I-Procedure
29660,1948,",",O
29661,1948,LVRS,B-Procedure
29662,1948,",",O
29663,1948,median,B-Procedure
29664,1948,sternotomy,I-Procedure
29665,1948,",",O
29666,1948,bullectomy,B-Procedure
29667,1948,or,O
29668,1948,lobectomy,B-Procedure
29669,1948,.,O
29670,1949,Clinically,O
29671,1949,significant,O
29672,1949,bronchiectasis,B-Condition
29673,1950,Pulmonary,B-Condition
29674,1950,nodule,I-Condition
29675,1950,requiring,O
29676,1950,surgery,B-Procedure
29677,1951,History,B-Observation
29678,1951,of,O
29679,1951,recurrent,O
29680,1951,respiratory,B-Condition
29681,1951,infections,I-Condition
29682,1951,(,O
29683,1951,>,O
29684,1951,3,O
29685,1951,hospitalization,B-Procedure
29686,1951,in,O
29687,1951,the,O
29688,1951,last,O
29689,1951,year,O
29690,1951,),O
29691,1952,Clinically,O
29692,1952,significant,O
29693,1952,(,O
29694,1952,>,O
29695,1952,4,O
29696,1952,Tablespoons,O
29697,1952,per,O
29698,1952,day,O
29699,1952,),O
29700,1952,sputum,B-Observation
29701,1952,production,I-Observation
29702,1953,Fever,B-Condition
29703,1953,",",O
29704,1953,elevated,O
29705,1953,white,O
29706,1953,cell,O
29707,1953,count,O
29708,1953,",",O
29709,1953,or,O
29710,1953,other,O
29711,1953,evidence,B-Mood
29712,1953,of,O
29713,1953,active,B-Condition
29714,1953,infection,I-Condition
29715,1954,Dysrhythmia,B-Condition
29716,1954,that,O
29717,1954,might,O
29718,1954,pose,B-Condition
29719,1954,a,I-Condition
29720,1954,risk,I-Condition
29721,1954,during,O
29722,1954,exercise,O
29723,1954,or,O
29724,1954,training,O
29725,1955,Congestive,B-Condition
29726,1955,heart,I-Condition
29727,1955,failure,I-Condition
29728,1955,within,O
29729,1955,6,O
29730,1955,mo,O
29731,1955,and,O
29732,1955,LVEF,O
29733,1955,<,O
29734,1955,45,O
29735,1955,%,O
29736,1956,Evidence,B-Mood
29737,1956,or,O
29738,1956,history,B-Observation
29739,1956,of,O
29740,1956,Cor,B-Condition
29741,1956,Pulmonale,I-Condition
29742,1957,Resting,B-Condition
29743,1957,bradycardia,I-Condition
29744,1957,(,O
29745,1957,<,O
29746,1957,50,O
29747,1957,beats,O
29748,1957,/,O
29749,1957,min,O
29750,1957,),O
29751,1957,",",O
29752,1957,frequent,O
29753,1957,multifocal,B-Condition
29754,1957,PVCs,I-Condition
29755,1957,",",O
29756,1957,complex,B-Condition
29757,1957,ventricular,I-Condition
29758,1957,arrhythmia,I-Condition
29759,1957,",",O
29760,1957,sustained,B-Condition
29761,1957,SVT,I-Condition
29762,1958,History,B-Observation
29763,1958,of,O
29764,1958,exercise,O
29765,1958,-,O
29766,1958,related,O
29767,1958,syncope,B-Condition
29768,1959,MI,B-Condition
29769,1959,within,O
29770,1959,6,O
29771,1959,mo,O
29772,1959,and,O
29773,1959,LVEF,O
29774,1959,<,O
29775,1959,45,O
29776,1959,%,O
29777,1960,Evidence,O
29778,1960,of,O
29779,1960,systemic,B-Condition
29780,1960,disease,I-Condition
29781,1960,or,O
29782,1960,neoplasia,B-Condition
29783,1960,expected,O
29784,1960,to,O
29785,1960,compromise,O
29786,1960,survival,O
29787,1960,during,O
29788,1960,5,O
29789,1960,-,O
29790,1960,yr,O
29791,1960,period,O
29792,1961,Any,O
29793,1961,disease,B-Condition
29794,1961,or,O
29795,1961,condition,B-Condition
29796,1961,that,O
29797,1961,interferes,O
29798,1961,with,O
29799,1961,completion,O
29800,1961,of,O
29801,1961,initial,O
29802,1961,or,O
29803,1961,follow,O
29804,1961,-,O
29805,1961,up,O
29806,1961,assessments,O
29807,1962,Patient,O
29808,1962,is,O
29809,1962,currently,O
29810,1962,enrolled,B-Observation
29811,1962,in,I-Observation
29812,1962,another,I-Observation
29813,1962,clinical,I-Observation
29814,1962,trial,I-Observation
29815,1963,Patient,O
29816,1963,is,O
29817,1963,unable,B-Observation
29818,1963,to,I-Observation
29819,1963,complete,I-Observation
29820,1963,3,O
29821,1963,minutes,O
29822,1963,of,O
29823,1963,unloaded,O
29824,1963,peddling,O
29825,1963,on,O
29826,1963,cycle,O
29827,1963,ergometer,O
29828,1964,Alpha-1,B-Condition
29829,1964,-,I-Condition
29830,1964,Antitrypsin,I-Condition
29831,1964,Deficiency,I-Condition
29832,1965,Patient,O
29833,1965,diagnosed,O
29834,1965,by,O
29835,1965,HRCT,B-Procedure
29836,1965,Core,I-Procedure
29837,1965,Lab,I-Procedure
29838,1965,with,O
29839,1965,eligible,O
29840,1965,heterogeneous,B-Condition
29841,1965,disease,I-Condition
29842,1965,distribution,I-Condition
29843,1965,and,O
29844,1965,at,O
29845,1965,least,O
29846,1965,one,O
29847,1965,complete,B-Condition
29848,1965,oblique,I-Condition
29849,1965,fissure,I-Condition
29850,1965,.,O
29851,1966,Age,B-Person
29852,1966,from,O
29853,1966,40,O
29854,1966,to,O
29855,1966,75,O
29856,1966,years,O
29857,1967,BMI,O
29858,1967,<,O
29859,1967,32,O
29860,1967,kg,O
29861,1967,/,O
29862,1967,m2,O
29863,1968,FEV1,O
29864,1968,<,O
29865,1968,40,O
29866,1968,%,O
29867,1968,of,O
29868,1968,predicted,O
29869,1968,value,O
29870,1968,",",O
29871,1968,FEV1,O
29872,1968,/,O
29873,1968,FVC,O
29874,1968,<,O
29875,1968,70,O
29876,1968,%,O
29877,1969,TLC,O
29878,1969,>,O
29879,1969,120,O
29880,1969,%,O
29881,1969,predicted,O
29882,1969,",",O
29883,1969,RV,O
29884,1969,>,O
29885,1969,150,O
29886,1969,%,O
29887,1969,predicted,O
29888,1969,.,O
29889,1970,Stable,B-Condition
29890,1970,with,O
29891,1970,<,O
29892,1970,20,O
29893,1970,mg,O
29894,1970,prednisone,B-Drug
29895,1970,(,O
29896,1970,or,O
29897,1970,equivalent,O
29898,1970,),O
29899,1970,qd,O
29900,1971,PaCO2,O
29901,1971,<,O
29902,1971,50,O
29903,1971,mm,O
29904,1971,Hg,O
29905,1972,PaO2,O
29906,1972,>,O
29907,1972,45,O
29908,1972,mm,O
29909,1972,Hg,O
29910,1972,on,O
29911,1972,room,O
29912,1972,air,O
29913,1973,6,O
29914,1973,-,O
29915,1973,min,O
29916,1973,walk,O
29917,1973,of,O
29918,1973,>,O
29919,1973,50,O
29920,1973,m,O
29921,1973,(,O
29922,1973,without,O
29923,1973,rehabilitation,O
29924,1973,),O
29925,1973,or,O
29926,1973,>,O
29927,1973,100,O
29928,1973,m,O
29929,1973,(,O
29930,1973,with,O
29931,1973,rehabilitation,O
29932,1973,),O
29933,1974,Nonsmoking,B-Condition
29934,1974,for,O
29935,1974,4,O
29936,1974,months,O
29937,1974,prior,O
29938,1974,to,O
29939,1974,initial,O
29940,1974,interview,O
29941,1974,and,O
29942,1974,throughout,O
29943,1974,screening,O
29944,1975,The,O
29945,1975,patient,O
29946,1975,agrees,B-Observation
29947,1975,to,I-Observation
29948,1975,all,I-Observation
29949,1975,protocol,I-Observation
29950,1975,required,I-Observation
29951,1975,follow,I-Observation
29952,1975,-,I-Observation
29953,1975,up,I-Observation
29954,1975,intervals,I-Observation
29955,1975,.,O
29956,1976,The,O
29957,1976,patient,O
29958,1976,has,O
29959,1976,no,O
29960,1976,child,B-Condition
29961,1976,bearing,I-Condition
29962,1976,potential,I-Condition
29963,1977,The,O
29964,1977,patient,O
29965,1977,is,O
29966,1977,willing,B-Observation
29967,1977,and,I-Observation
29968,1977,able,I-Observation
29969,1977,to,I-Observation
29970,1977,complete,I-Observation
29971,1977,protocol,I-Observation
29972,1977,required,O
29973,1977,baseline,B-Procedure
29974,1977,assessments,I-Procedure
29975,1977,and,I-Procedure
29976,1977,procedures,I-Procedure
29977,1978,NA,O
29978,1979,Children,O
29979,1979,born,O
29980,1979,outside,O
29981,1979,the,O
29982,1979,cluster,O
29983,1979,",",O
29984,1979,and,O
29985,1979,returning,O
29986,1979,more,O
29987,1979,than,O
29988,1979,72,O
29989,1979,hours,O
29990,1979,after,O
29991,1979,the,O
29992,1979,delivery,O
29993,1980,Children,O
29994,1980,that,O
29995,1980,the,O
29996,1980,nurse,O
29997,1980,evaluates,O
29998,1980,to,O
29999,1980,die,O
30000,1980,within,O
30001,1980,the,O
30002,1980,next,O
30003,1980,24,O
30004,1980,hours,O
30005,1980,.,O
30006,1981,Unable,O
30007,1981,to,O
30008,1981,speak,O
30009,1981,Spanish,O
30010,1981,or,O
30011,1981,English,O
30012,1982,Active,O
30013,1982,smoking,B-Observation
30014,1982,(,O
30015,1982,within,O
30016,1982,the,O
30017,1982,past,O
30018,1982,year,O
30019,1982,),O
30020,1983,Autoimmune,O
30021,1983,",",O
30022,1983,rheumatologic,O
30023,1983,or,O
30024,1983,inflammatory,B-Condition
30025,1983,disease,I-Condition
30026,1983,which,O
30027,1983,are,O
30028,1983,not,O
30029,1983,psoriasis,B-Condition
30030,1983,or,O
30031,1983,psoriatic,B-Condition
30032,1983,arthritis,I-Condition
30033,1984,Known,O
30034,1984,active,O
30035,1984,cancer,B-Condition
30036,1984,receiving,O
30037,1984,treatment,B-Procedure
30038,1985,Pregnancy,B-Condition
30039,1986,Anemia,B-Condition
30040,1986,(,O
30041,1986,hemoglobin,O
30042,1986,<,O
30043,1986,9,O
30044,1986,mg,O
30045,1986,/,O
30046,1986,dl,O
30047,1986,),O
30048,1986,or,O
30049,1986,thrombocytopenia,B-Condition
30050,1986,(,O
30051,1986,Platelet,O
30052,1986,count,O
30053,1986,<,O
30054,1986,75,O
30055,1986,),O
30056,1986,",",O
30057,1986,or,O
30058,1986,thrombocytosis,B-Condition
30059,1986,(,O
30060,1986,Platelet,O
30061,1986,count,O
30062,1986,>,O
30063,1986,600,O
30064,1986,),O
30065,1987,A,O
30066,1987,history,B-Observation
30067,1987,of,O
30068,1987,severe,O
30069,1987,bleeding,B-Condition
30070,1987,or,O
30071,1987,bleeding,B-Condition
30072,1987,disorders,I-Condition
30073,1988,Current,O
30074,1988,medication,B-Drug
30075,1988,use,O
30076,1988,which,O
30077,1988,interact,B-Condition
30078,1988,with,O
30079,1988,either,O
30080,1988,aspirin,B-Drug
30081,1988,or,O
30082,1988,atorvastatin,B-Drug
30083,1989,Chronic,B-Condition
30084,1989,kidney,I-Condition
30085,1989,disease,I-Condition
30086,1989,(,O
30087,1989,CrCl,O
30088,1989,<,O
30089,1989,30ml,O
30090,1989,/,O
30091,1989,min,O
30092,1989,),O
30093,1990,Congestive,B-Condition
30094,1990,heart,I-Condition
30095,1990,failure,I-Condition
30096,1991,Currently,O
30097,1991,taking,O
30098,1991,aspirin,B-Drug
30099,1991,or,O
30100,1991,a,O
30101,1991,statin,B-Drug
30102,1991,.,O
30103,1992,NSAID,B-Drug
30104,1992,use,O
30105,1992,within,O
30106,1992,the,O
30107,1992,past,O
30108,1992,48,O
30109,1992,hours,O
30110,1993,Subjects,O
30111,1993,with,O
30112,1993,a,O
30113,1993,history,B-Observation
30114,1993,of,O
30115,1993,moderate,O
30116,1993,to,O
30117,1993,severe,O
30118,1993,psoriatic,B-Condition
30119,1993,disease,I-Condition
30120,1994,Group,O
30121,1994,2,O
30122,1994,:,O
30123,1994,Healthy,B-Condition
30124,1994,subjects,O
30125,1994,without,O
30126,1994,known,O
30127,1994,psoriatic,B-Condition
30128,1994,disease,I-Condition
30129,1994,or,O
30130,1994,cardiovascular,B-Condition
30131,1994,disease,I-Condition
30132,1995,Metastatic,B-Condition
30133,1995,disease,I-Condition
30134,1995,(,I-Condition
30135,1995,M1)/stage,I-Condition
30136,1995,4,I-Condition
30137,1995,NSCLC,I-Condition
30138,1996,Pleural,B-Condition
30139,1996,or,I-Condition
30140,1996,pericardial,I-Condition
30141,1996,effusion,I-Condition
30142,1996,greater,O
30143,1996,than,O
30144,1996,100,O
30145,1996,ml,O
30146,1996,in,O
30147,1996,volume,O
30148,1996,as,O
30149,1996,documented,O
30150,1996,by,O
30151,1996,appropriate,O
30152,1996,imaging,O
30153,1996,(,O
30154,1996,positron,O
30155,1996,emission,O
30156,1996,tomography,O
30157,1996,[,O
30158,1996,PET,O
30159,1996,],O
30160,1996,",",O
30161,1996,computed,O
30162,1996,tomography,O
30163,1996,[,O
30164,1996,CT,O
30165,1996,],O
30166,1996,scan,O
30167,1996,or,O
30168,1996,ultrasound,O
30169,1996,),O
30170,1996,.,O
30171,1996,If,O
30172,1996,an,O
30173,1996,effusion,O
30174,1996,greater,O
30175,1996,than,O
30176,1996,100,O
30177,1996,ml,O
30178,1996,is,O
30179,1996,documented,O
30180,1996,by,O
30181,1996,cytology,O
30182,1996,to,O
30183,1996,be,O
30184,1996,free,O
30185,1996,from,O
30186,1996,malignancy,O
30187,1996,and,O
30188,1996,the,O
30189,1996,investigator,O
30190,1996,feels,O
30191,1996,the,O
30192,1996,patient,O
30193,1996,is,O
30194,1996,capable,O
30195,1996,of,O
30196,1996,receiving,O
30197,1996,chemo,O
30198,1996,/,O
30199,1996,radiotherapy,O
30200,1996,for,O
30201,1996,their,O
30202,1996,primary,O
30203,1996,disease/,O
30204,1996,NSCLC,O
30205,1996,",",O
30206,1996,the,O
30207,1996,investigator,O
30208,1996,should,O
30209,1996,discuss,O
30210,1996,the,O
30211,1996,patient,O
30212,1996,with,O
30213,1996,the,O
30214,1996,study,O
30215,1996,physician,O
30216,1996,at,O
30217,1996,Amgen,O
30218,1996,.,O
30219,1996,Effusions,O
30220,1996,smaller,O
30221,1996,than,O
30222,1996,100,O
30223,1996,ml,O
30224,1996,would,O
30225,1996,be,O
30226,1996,acceptable,O
30227,1996,",",O
30228,1996,unless,O
30229,1996,the,O
30230,1996,investigator,O
30231,1996,suspects,O
30232,1996,that,O
30233,1996,the,O
30234,1996,effusion,O
30235,1996,is,O
30236,1996,malignant,O
30237,1996,",",O
30238,1996,in,O
30239,1996,which,O
30240,1996,case,O
30241,1996,the,O
30242,1996,effusions,O
30243,1996,should,O
30244,1996,be,O
30245,1996,evaluated,O
30246,1996,by,O
30247,1996,cytology,O
30248,1996,.,O
30249,1996,Sponsor,O
30250,1996,approval,O
30251,1996,must,O
30252,1996,be,O
30253,1996,obtained,O
30254,1996,before,O
30255,1996,patient,O
30256,1996,is,O
30257,1996,randomized,O
30258,1996,.,O
30259,1997,Plan,B-Observation
30260,1997,to,I-Observation
30261,1997,remove,I-Observation
30262,1997,the,I-Observation
30263,1997,tumor,I-Observation
30264,1997,surgically,I-Observation
30265,1997,before,O
30266,1997,completing,O
30267,1997,the,O
30268,1997,protocol,O
30269,1997,chemo,O
30270,1997,/,O
30271,1997,radiotherapy,O
30272,1997,course,O
30273,1998,Shielding,B-Procedure
30274,1998,of,O
30275,1998,any,O
30276,1998,part,O
30277,1998,of,O
30278,1998,the,O
30279,1998,esophagus,O
30280,1998,during,O
30281,1998,radiotherapy,B-Procedure
30282,1998,(,O
30283,1998,including,O
30284,1998,posterior,B-Procedure
30285,1998,spinal,I-Procedure
30286,1998,cord,I-Procedure
30287,1998,shielding,I-Procedure
30288,1998,),O
30289,1999,Prior,O
30290,1999,chemotherapy,B-Drug
30291,1999,",",O
30292,1999,radiotherapy,B-Procedure
30293,1999,",",O
30294,1999,or,O
30295,1999,surgery,B-Procedure
30296,1999,for,O
30297,1999,NSCLC,B-Condition
30298,2000,Prior,O
30299,2000,invasive,O
30300,2000,malignancy,B-Condition
30301,2000,during,O
30302,2000,the,O
30303,2000,past,O
30304,2000,3,O
30305,2000,years,O
30306,2000,other,O
30307,2000,than,O
30308,2000,non,B-Condition
30309,2000,-,I-Condition
30310,2000,melanomatous,I-Condition
30311,2000,skin,I-Condition
30312,2000,cancer,I-Condition
30313,2000,.,O
30314,2000,Note,O
30315,2000,:,O
30316,2000,Patients,O
30317,2000,with,O
30318,2000,prior,O
30319,2000,surgically,B-Condition
30320,2000,-,I-Condition
30321,2000,cured,I-Condition
30322,2000,malignancies,I-Condition
30323,2000,[,O
30324,2000,eg,O
30325,2000,",",O
30326,2000,stage,O
30327,2000,I,O
30328,2000,breast,O
30329,2000,cancer,O
30330,2000,or,O
30331,2000,prostate,O
30332,2000,cancer,O
30333,2000,",",O
30334,2000,in,O
30335,2000,-,O
30336,2000,situ,O
30337,2000,carcinoma,O
30338,2000,of,O
30339,2000,the,O
30340,2000,cervix,O
30341,2000,",",O
30342,2000,etc,O
30343,2000,],O
30344,2000,are,O
30345,2000,not,O
30346,2000,excluded,O
30347,2000,;,O
30348,2000,however,O
30349,2000,",",O
30350,2000,sponsor,O
30351,2000,approval,O
30352,2000,must,O
30353,2000,be,O
30354,2000,obtained,O
30355,2000,before,O
30356,2000,patient,O
30357,2000,is,O
30358,2000,randomized,O
30359,2000,.,O
30360,2001,Presence,O
30361,2001,or,O
30362,2001,history,B-Observation
30363,2001,of,I-Observation
30364,2001,dysphagia,B-Condition
30365,2001,or,O
30366,2001,conditions,B-Condition
30367,2001,predisposing,I-Condition
30368,2001,to,I-Condition
30369,2001,dysphagia,I-Condition
30370,2001,(,O
30371,2001,eg,O
30372,2001,",",O
30373,2001,uncontrolled,O
30374,2001,gastroesophageal,B-Condition
30375,2001,reflux,I-Condition
30376,2001,disease,I-Condition
30377,2001,[,O
30378,2001,GERD,B-Condition
30379,2001,],O
30380,2001,",",O
30381,2001,dyspepsia,B-Condition
30382,2001,",",O
30383,2001,etc,O
30384,2001,),O
30385,2002,History,B-Observation
30386,2002,of,I-Observation
30387,2002,pancreatitis,B-Condition
30388,2003,Four,O
30389,2003,weeks,O
30390,2003,or,O
30391,2003,less,O
30392,2003,since,O
30393,2003,completion,O
30394,2003,of,O
30395,2003,treatment,B-Procedure
30396,2003,using,O
30397,2003,an,O
30398,2003,investigational,B-Drug
30399,2003,product,I-Drug
30400,2003,/,O
30401,2003,device,O
30402,2003,in,O
30403,2003,another,O
30404,2003,clinical,O
30405,2003,study,O
30406,2003,or,O
30407,2003,presence,O
30408,2003,of,O
30409,2003,any,O
30410,2003,unresolved,O
30411,2003,toxicity,B-Condition
30412,2003,from,O
30413,2003,previous,O
30414,2003,treatment,B-Procedure
30415,2004,Previous,O
30416,2004,treatment,B-Procedure
30417,2004,on,O
30418,2004,this,O
30419,2004,study,O
30420,2004,or,O
30421,2004,with,O
30422,2004,a,O
30423,2004,fibroblast,B-Drug
30424,2004,growth,I-Drug
30425,2004,factor,I-Drug
30426,2005,Known,O
30427,2005,to,O
30428,2005,be,O
30429,2005,sero,B-Condition
30430,2005,-,I-Condition
30431,2005,positive,I-Condition
30432,2005,for,I-Condition
30433,2005,human,I-Condition
30434,2005,immunodeficiency,I-Condition
30435,2005,virus,I-Condition
30436,2005,(,I-Condition
30437,2005,HIV,I-Condition
30438,2005,),I-Condition
30439,2005,",",I-Condition
30440,2005,hepatitis,I-Condition
30441,2005,C,I-Condition
30442,2005,virus,I-Condition
30443,2005,(,I-Condition
30444,2005,HCV,I-Condition
30445,2005,),I-Condition
30446,2005,",",I-Condition
30447,2005,or,I-Condition
30448,2005,hepatitis,I-Condition
30449,2005,B,I-Condition
30450,2005,virus,I-Condition
30451,2005,(,I-Condition
30452,2005,HBV,I-Condition
30453,2005,),I-Condition
30454,2006,Pregnant,B-Condition
30455,2006,or,O
30456,2006,breastfeeding,B-Condition
30457,2006,women,B-Person
30458,2007,Known,O
30459,2007,sensitivity,B-Condition
30460,2007,to,O
30461,2007,E.,O
30462,2007,coli,O
30463,2007,derived,O
30464,2007,products,B-Drug
30465,2008,Compromised,B-Condition
30466,2008,ability,I-Condition
30467,2008,of,O
30468,2008,the,O
30469,2008,patient,O
30470,2008,to,O
30471,2008,give,O
30472,2008,written,O
30473,2008,informed,O
30474,2008,consent,O
30475,2008,and/or,O
30476,2008,to,O
30477,2008,comply,O
30478,2008,with,O
30479,2008,study,O
30480,2008,procedures,O
30481,2009,Refusal,B-Observation
30482,2009,to,I-Observation
30483,2009,sign,O
30484,2009,an,O
30485,2009,informed,O
30486,2009,consent,O
30487,2009,form,O
30488,2009,to,O
30489,2009,participate,O
30490,2009,in,O
30491,2009,this,O
30492,2009,study,O
30493,2009,",",O
30494,2009,and,O
30495,2009,sign,O
30496,2009,the,O
30497,2009,hospital,O
30498,2009,information,O
30499,2009,release,O
30500,2009,form,O
30501,2009,",",O
30502,2009,if,O
30503,2009,applicable,O
30504,2010,Unwilling,O
30505,2010,or,O
30506,2010,unable,O
30507,2010,to,O
30508,2010,complete,O
30509,2010,the,O
30510,2010,patient,O
30511,2010,reported,O
30512,2010,outcome,O
30513,2010,(,O
30514,2010,PRO,O
30515,2010,),O
30516,2010,questionnaires,O
30517,2011,Psychological,O
30518,2011,",",O
30519,2011,social,O
30520,2011,",",O
30521,2011,familial,O
30522,2011,",",O
30523,2011,or,O
30524,2011,geographical,O
30525,2011,reasons,O
30526,2011,that,O
30527,2011,would,O
30528,2011,prevent,O
30529,2011,regular,O
30530,2011,follow,O
30531,2011,-,O
30532,2011,up,O
30533,2012,Patients,O
30534,2012,with,O
30535,2012,a,O
30536,2012,histologically,O
30537,2012,or,O
30538,2012,cytologically,O
30539,2012,proven,O
30540,2012,diagnosis,O
30541,2012,of,O
30542,2012,NSCLC,B-Condition
30543,2013,Unresectable,O
30544,2013,(,O
30545,2013,locally,O
30546,2013,advanced,O
30547,2013,),O
30548,2013,stage,B-Condition
30549,2013,IIIa,I-Condition
30550,2013,or,I-Condition
30551,2013,IIIb,I-Condition
30552,2013,disease,I-Condition
30553,2014,Initial,O
30554,2014,radiotherapy,O
30555,2014,field,O
30556,2014,of,O
30557,2014,treatment,O
30558,2014,to,O
30559,2014,encompass,O
30560,2014,greater,O
30561,2014,than,O
30562,2014,or,O
30563,2014,equal,O
30564,2014,to,O
30565,2014,30,O
30566,2014,%,O
30567,2014,of,O
30568,2014,the,O
30569,2014,esophagus,O
30570,2015,Life,B-Observation
30571,2015,expectancy,I-Observation
30572,2015,greater,O
30573,2015,than,O
30574,2015,or,O
30575,2015,equal,O
30576,2015,to,O
30577,2015,6,O
30578,2015,months,O
30579,2016,Estimated,O
30580,2016,weight,O
30581,2016,loss,O
30582,2016,less,O
30583,2016,than,O
30584,2016,or,O
30585,2016,equal,O
30586,2016,to,O
30587,2016,10,O
30588,2016,%,O
30589,2016,in,O
30590,2016,the,O
30591,2016,3,O
30592,2016,months,O
30593,2016,before,O
30594,2016,study,O
30595,2016,randomization,O
30596,2017,Measurable,B-Condition
30597,2017,disease,I-Condition
30598,2018,18,O
30599,2018,years,O
30600,2018,of,O
30601,2018,age,B-Person
30602,2018,or,O
30603,2018,older,O
30604,2019,Eastern,O
30605,2019,Cooperative,O
30606,2019,Oncology,O
30607,2019,Group,O
30608,2019,(,O
30609,2019,ECOG,O
30610,2019,),O
30611,2019,performance,O
30612,2019,status,O
30613,2019,of,O
30614,2019,0,O
30615,2019,-,O
30616,2019,2,O
30617,2020,Hemoglobin,O
30618,2020,(,O
30619,2020,hgb,O
30620,2020,),O
30621,2020,greater,O
30622,2020,than,O
30623,2020,or,O
30624,2020,equal,O
30625,2020,to,O
30626,2020,10,O
30627,2020,g,O
30628,2020,/,O
30629,2020,dL,O
30630,2020,without,O
30631,2020,transfusional,B-Observation
30632,2020,support,I-Observation
30633,2020,or,O
30634,2020,growth,B-Observation
30635,2020,factor,I-Observation
30636,2020,use,I-Observation
30637,2020,in,O
30638,2020,the,O
30639,2020,4,O
30640,2020,weeks,O
30641,2020,before,O
30642,2020,study,O
30643,2020,randomization,O
30644,2021,Absolute,O
30645,2021,neutrophil,O
30646,2021,count,O
30647,2021,(,O
30648,2021,ANC,O
30649,2021,),O
30650,2021,greater,O
30651,2021,than,O
30652,2021,or,O
30653,2021,equal,O
30654,2021,to,O
30655,2021,1.5,O
30656,2021,x,O
30657,2021,10,O
30658,2021,^,O
30659,2021,9,O
30660,2021,/,O
30661,2021,L,O
30662,2021,without,O
30663,2021,growth,B-Observation
30664,2021,factor,I-Observation
30665,2021,use,I-Observation
30666,2021,in,O
30667,2021,the,O
30668,2021,2,O
30669,2021,weeks,O
30670,2021,before,O
30671,2021,study,O
30672,2021,randomization,O
30673,2022,Platelet,O
30674,2022,count,O
30675,2022,greater,O
30676,2022,than,O
30677,2022,or,O
30678,2022,equal,O
30679,2022,to,O
30680,2022,100,O
30681,2022,x,O
30682,2022,10,O
30683,2022,^,O
30684,2022,9,O
30685,2022,/,O
30686,2022,L,O
30687,2023,Serum,O
30688,2023,bilirubin,O
30689,2023,less,O
30690,2023,than,O
30691,2023,or,O
30692,2023,equal,O
30693,2023,to,O
30694,2023,1.5,O
30695,2023,x,O
30696,2023,institutional,O
30697,2023,upper,O
30698,2023,limit,O
30699,2023,of,O
30700,2023,normal,O
30701,2023,(,O
30702,2023,ULN,O
30703,2023,),O
30704,2024,Serum,O
30705,2024,creatinine,O
30706,2024,less,O
30707,2024,than,O
30708,2024,or,O
30709,2024,equal,O
30710,2024,to,O
30711,2024,2.0,O
30712,2024,mg,O
30713,2024,/,O
30714,2024,dL,O
30715,2024,(,O
30716,2024,Note,O
30717,2024,:,O
30718,2024,Patients,O
30719,2024,with,O
30720,2024,a,O
30721,2024,serum,O
30722,2024,creatinine,O
30723,2024,greater,O
30724,2024,than,O
30725,2024,or,O
30726,2024,equal,O
30727,2024,to,O
30728,2024,1.4,O
30729,2024,and,O
30730,2024,less,O
30731,2024,than,O
30732,2024,or,O
30733,2024,equal,O
30734,2024,to,O
30735,2024,2.0,O
30736,2024,mg,O
30737,2024,/,O
30738,2024,dL,O
30739,2024,must,O
30740,2024,demonstrate,O
30741,2024,a,O
30742,2024,24,O
30743,2024,-,O
30744,2024,hour,O
30745,2024,urinary,O
30746,2024,creatinine,O
30747,2024,clearance,O
30748,2024,greater,O
30749,2024,than,O
30750,2024,or,O
30751,2024,equal,O
30752,2024,to,O
30753,2024,50,O
30754,2024,mL,O
30755,2024,/,O
30756,2024,min,O
30757,2024,),O
30758,2025,Females,B-Person
30759,2025,of,O
30760,2025,childbearing,B-Condition
30761,2025,potential,I-Condition
30762,2025,:,O
30763,2025,negative,O
30764,2025,serum,O
30765,2025,or,O
30766,2025,urine,O
30767,2025,pregnancy,O
30768,2025,test,O
30769,2026,Patient,O
30770,2026,must,O
30771,2026,give,O
30772,2026,written,O
30773,2026,informed,B-Observation
30774,2026,consent,I-Observation
30775,2026,before,O
30776,2026,participating,O
30777,2026,in,O
30778,2026,any,O
30779,2026,study,O
30780,2026,-,O
30781,2026,specific,O
30782,2026,procedure,B-Procedure
30783,2026,",",O
30784,2026,randomization,B-Procedure
30785,2026,",",O
30786,2026,or,O
30787,2026,receiving,O
30788,2026,investigational,B-Drug
30789,2026,product,I-Drug
30790,2026,.,O
30791,2027,Patients,O
30792,2027,with,O
30793,2027,reproductive,B-Condition
30794,2027,capability,I-Condition
30795,2027,must,O
30796,2027,agree,O
30797,2027,to,O
30798,2027,practice,O
30799,2027,adequate,O
30800,2027,contraception,B-Procedure
30801,2027,methods,I-Procedure
30802,2027,.,O
30803,2028,HCV,B-Condition
30804,2028,",",I-Condition
30805,2028,HIV,I-Condition
30806,2028,",",I-Condition
30807,2028,or,I-Condition
30808,2028,HDV,I-Condition
30809,2028,coinfection,I-Condition
30810,2028,.,O
30811,2029,HCC,B-Condition
30812,2029,or,O
30813,2029,other,O
30814,2029,malignancy,B-Condition
30815,2029,within,O
30816,2029,3,O
30817,2029,years,O
30818,2029,.,O
30819,2030,Decompensated,B-Condition
30820,2030,liver,I-Condition
30821,2030,cirrhosis,I-Condition
30822,2030,(,O
30823,2030,CTP,O
30824,2030,score,O
30825,2030,=,O
30826,2030,7,O
30827,2030,),O
30828,2030,.,O
30829,2031,Uremia,B-Condition
30830,2031,patients,O
30831,2031,under,O
30832,2031,hemodialysis,B-Procedure
30833,2031,or,O
30834,2031,continuous,B-Condition
30835,2031,ambulatory,I-Condition
30836,2031,peritoneal,I-Condition
30837,2031,dialysis,I-Condition
30838,2031,or,O
30839,2031,patients,O
30840,2031,with,O
30841,2031,Ccr,O
30842,2031,<,O
30843,2031,50,O
30844,2031,mL,O
30845,2031,/,O
30846,2031,min,O
30847,2032,Pregnant,O
30848,2032,or,O
30849,2032,breastfeeding,O
30850,2032,women,O
30851,2032,.,O
30852,2033,Women,O
30853,2033,of,O
30854,2033,child,O
30855,2033,-,O
30856,2033,bearing,O
30857,2033,potential,O
30858,2033,(,O
30859,2033,WOCBP,O
30860,2033,),O
30861,2033,who,O
30862,2033,are,O
30863,2033,unwilling,O
30864,2033,or,O
30865,2033,unable,O
30866,2033,to,O
30867,2033,use,O
30868,2033,an,O
30869,2033,acceptable,O
30870,2033,method,O
30871,2033,of,O
30872,2033,contraception,O
30873,2033,to,O
30874,2033,avoid,O
30875,2033,pregnancy,O
30876,2033,throughout,O
30877,2033,the,O
30878,2033,study,O
30879,2033,and,O
30880,2033,for,O
30881,2033,up,O
30882,2033,to,O
30883,2033,4,O
30884,2033,weeks,O
30885,2033,after,O
30886,2033,the,O
30887,2033,last,O
30888,2033,dose,O
30889,2033,of,O
30890,2033,study,O
30891,2033,drug,O
30892,2033,.,O
30893,2034,Age,B-Person
30894,2034,:,O
30895,2034,from,O
30896,2034,20,O
30897,2034,to,O
30898,2034,90,O
30899,2034,y,O
30900,2034,/,O
30901,2034,o.,O
30902,2035,HBsAg,O
30903,2035,-,O
30904,2035,positive,O
30905,2035,for,O
30906,2035,more,O
30907,2035,than,O
30908,2035,6,O
30909,2035,months,O
30910,2035,and,O
30911,2035,HBV,O
30912,2035,DNA,O
30913,2035,<,O
30914,2035,2000,O
30915,2035,IU,O
30916,2035,/,O
30917,2035,ml,O
30918,2035,(,O
30919,2035,Subgroup,O
30920,2035,1)or,O
30921,2035,HBsAg,O
30922,2035,-,O
30923,2035,negative,O
30924,2035,but,O
30925,2035,anti,O
30926,2035,-,O
30927,2035,HBc,O
30928,2035,positive,O
30929,2035,with,O
30930,2035,HBV,O
30931,2035,DNA,O
30932,2035,<,O
30933,2035,2000,O
30934,2035,IU,O
30935,2035,/,O
30936,2035,ml,O
30937,2035,(,O
30938,2035,Subgroup,O
30939,2035,2,O
30940,2035,),O
30941,2035,.,O
30942,2036,Inflammatory,B-Condition
30943,2036,arthritis,I-Condition
30944,2036,patients,O
30945,2036,who,O
30946,2036,plan,O
30947,2036,to,O
30948,2036,treat,O
30949,2036,with,O
30950,2036,biological,B-Procedure
30951,2036,agents,I-Procedure
30952,2036,",",O
30953,2036,including,O
30954,2036,Humira,B-Drug
30955,2036,or,O
30956,2036,Enbrel,B-Drug
30957,2036,or,O
30958,2036,Simponi,B-Drug
30959,2036,or,O
30960,2036,Orencia,B-Drug
30961,2036,or,O
30962,2036,Mabthera,B-Drug
30963,2036,or,O
30964,2036,Actemra,B-Drug
30965,2036,;,O
30966,2036,as,O
30967,2036,first,O
30968,2036,line,O
30969,2036,biologic,O
30970,2036,treatment,O
30971,2036,is,O
30972,2036,indicated,O
30973,2036,.,O
30974,2037,Use,O
30975,2037,of,O
30976,2037,any,O
30977,2037,investigational,O
30978,2037,or,O
30979,2037,non,O
30980,2037,-,O
30981,2037,registered,O
30982,2037,drug,B-Drug
30983,2037,or,O
30984,2037,vaccine,B-Drug
30985,2037,product,I-Drug
30986,2037,within,O
30987,2037,30,O
30988,2037,days,O
30989,2037,preceding,O
30990,2037,the,O
30991,2037,administration,O
30992,2037,of,O
30993,2037,the,O
30994,2037,study,O
30995,2037,vaccine,O
30996,2037,or,O
30997,2037,planned,B-Observation
30998,2037,use,I-Observation
30999,2037,within,O
31000,2037,the,O
31001,2037,first,O
31002,2037,six,O
31003,2037,weeks,O
31004,2037,of,O
31005,2037,the,O
31006,2037,study,O
31007,2037,period,O
31008,2038,Has,O
31009,2038,received,O
31010,2038,any,O
31011,2038,licensed,O
31012,2038,or,O
31013,2038,other,O
31014,2038,investigational,O
31015,2038,influenza,B-Drug
31016,2038,vaccine,I-Drug
31017,2038,within,O
31018,2038,3,O
31019,2038,months,O
31020,2038,prior,O
31021,2038,to,O
31022,2038,enrollment,O
31023,2038,in,O
31024,2038,this,O
31025,2038,study,O
31026,2038,or,O
31027,2038,expected,B-Observation
31028,2038,receipt,I-Observation
31029,2038,of,O
31030,2038,any,B-Drug
31031,2038,influenza,I-Drug
31032,2038,vaccination,I-Drug
31033,2038,before,O
31034,2038,the,O
31035,2038,Day,O
31036,2038,21,O
31037,2038,blood,O
31038,2038,collection,O
31039,2039,History,B-Observation
31040,2039,of,O
31041,2039,excessive,B-Condition
31042,2039,alcohol,I-Condition
31043,2039,use,I-Condition
31044,2039,",",O
31045,2039,drug,B-Condition
31046,2039,abuse,I-Condition
31047,2039,or,O
31048,2039,significant,O
31049,2039,psychiatric,B-Condition
31050,2039,illness,I-Condition
31051,2040,Tobacco,B-Condition
31052,2040,use,I-Condition
31053,2040,within,O
31054,2040,3,O
31055,2040,months,O
31056,2040,of,O
31057,2040,enrollment,O
31058,2040,and,O
31059,2040,throughout,O
31060,2040,first,O
31061,2040,6,O
31062,2040,months,O
31063,2040,of,O
31064,2040,the,O
31065,2040,study,O
31066,2041,Has,O
31067,2041,a,O
31068,2041,chronic,B-Condition
31069,2041,illness,I-Condition
31070,2041,(,O
31071,2041,e.g.,O
31072,2041,",",O
31073,2041,liver,B-Condition
31074,2041,or,I-Condition
31075,2041,kidney,I-Condition
31076,2041,disease,I-Condition
31077,2041,),O
31078,2041,",",O
31079,2041,receiving,O
31080,2041,a,O
31081,2041,concomitant,O
31082,2041,therapy,B-Procedure
31083,2041,or,O
31084,2041,have,O
31085,2041,any,B-Condition
31086,2041,other,I-Condition
31087,2041,condition,I-Condition
31088,2041,that,O
31089,2041,could,O
31090,2041,interfere,O
31091,2041,with,O
31092,2041,the,O
31093,2041,subject,O
31094,2041,'s,O
31095,2041,participation,O
31096,2041,in,O
31097,2041,the,O
31098,2041,study,O
31099,2041,or,O
31100,2041,in,O
31101,2041,the,O
31102,2041,interpretation,O
31103,2041,of,O
31104,2041,the,O
31105,2041,study,O
31106,2041,results,O
31107,2042,Clinically,O
31108,2042,significant,O
31109,2042,abnormal,O
31110,2042,liver,O
31111,2042,function,O
31112,2042,tests,O
31113,2042,at,O
31114,2042,screening,O
31115,2043,Positive,O
31116,2043,serology,O
31117,2043,for,O
31118,2043,HBsAg,O
31119,2043,",",O
31120,2043,HCV,O
31121,2043,or,O
31122,2043,HIV,O
31123,2043,antibodies,O
31124,2044,Pregnant,B-Condition
31125,2044,or,O
31126,2044,lactating,B-Condition
31127,2044,female,B-Person
31128,2045,Having,O
31129,2045,cancer,B-Condition
31130,2045,or,O
31131,2045,have,O
31132,2045,received,O
31133,2045,treatment,B-Procedure
31134,2045,for,I-Procedure
31135,2045,cancer,I-Procedure
31136,2045,within,O
31137,2045,three,O
31138,2045,years,O
31139,2045,(,O
31140,2045,persons,O
31141,2045,with,O
31142,2045,a,O
31143,2045,history,B-Observation
31144,2045,of,O
31145,2045,cancer,B-Condition
31146,2045,who,O
31147,2045,are,O
31148,2045,disease,B-Condition
31149,2045,-,I-Condition
31150,2045,free,I-Condition
31151,2045,without,O
31152,2045,treatment,B-Procedure
31153,2045,for,O
31154,2045,three,O
31155,2045,years,O
31156,2045,or,O
31157,2045,more,O
31158,2045,are,O
31159,2045,eligible,O
31160,2045,),O
31161,2045,",",O
31162,2045,excluding,O
31163,2045,minor,O
31164,2045,skin,O
31165,2045,cancers,O
31166,2045,",",O
31167,2045,which,O
31168,2045,are,O
31169,2045,allowed,O
31170,2045,unless,O
31171,2045,located,O
31172,2045,at,O
31173,2045,the,O
31174,2045,vaccination,O
31175,2045,site,O
31176,2046,Persons,O
31177,2046,with,O
31178,2046,impaired,B-Condition
31179,2046,immune,I-Condition
31180,2046,responsiveness,I-Condition
31181,2046,(,O
31182,2046,of,O
31183,2046,any,O
31184,2046,cause,O
31185,2046,),O
31186,2046,",",O
31187,2046,including,O
31188,2046,diabetes,B-Condition
31189,2046,mellitus,I-Condition
31190,2046,and,O
31191,2046,autoimmune,B-Condition
31192,2046,disorders,I-Condition
31193,2047,Persons,O
31194,2047,presently,O
31195,2047,receiving,O
31196,2047,or,O
31197,2047,having,O
31198,2047,a,O
31199,2047,recent,O
31200,2047,history,O
31201,2047,of,O
31202,2047,receiving,O
31203,2047,(,O
31204,2047,within,O
31205,2047,the,O
31206,2047,past,O
31207,2047,six,O
31208,2047,months,O
31209,2047,),O
31210,2047,any,B-Drug
31211,2047,medication,I-Drug
31212,2047,or,O
31213,2047,therapeutic,B-Procedure
31214,2047,modality,I-Procedure
31215,2047,that,O
31216,2047,affects,O
31217,2047,the,O
31218,2047,immune,O
31219,2047,system,O
31220,2047,such,O
31221,2047,as,O
31222,2047,allergy,B-Drug
31223,2047,shots,I-Drug
31224,2047,",",O
31225,2047,immune,B-Drug
31226,2047,globulin,I-Drug
31227,2047,",",O
31228,2047,interferon,B-Drug
31229,2047,",",O
31230,2047,immunomodulators,B-Drug
31231,2047,",",O
31232,2047,radiation,B-Procedure
31233,2047,therapy,I-Procedure
31234,2047,",",O
31235,2047,cytotoxic,B-Drug
31236,2047,drugs,I-Drug
31237,2047,or,O
31238,2047,drugs,B-Drug
31239,2047,known,I-Drug
31240,2047,to,I-Drug
31241,2047,be,I-Drug
31242,2047,frequently,I-Drug
31243,2047,associated,I-Drug
31244,2047,with,I-Drug
31245,2047,significant,I-Drug
31246,2047,major,I-Drug
31247,2047,organ,I-Drug
31248,2047,toxicity,I-Drug
31249,2047,",",O
31250,2047,or,O
31251,2047,systemic,B-Drug
31252,2047,corticosteroids,I-Drug
31253,2047,(,O
31254,2047,oral,O
31255,2047,or,O
31256,2047,injectable,O
31257,2047,),O
31258,2047,.,O
31259,2047,Inhaled,O
31260,2047,and,O
31261,2047,topical,O
31262,2047,corticosteroids,O
31263,2047,are,O
31264,2047,allowed,O
31265,2047,.,O
31266,2048,Persons,O
31267,2048,with,O
31268,2048,a,O
31269,2048,history,B-Observation
31270,2048,of,O
31271,2048,severe,O
31272,2048,allergic,B-Condition
31273,2048,reaction,I-Condition
31274,2048,after,O
31275,2048,previous,O
31276,2048,vaccinations,O
31277,2048,or,O
31278,2048,hypersensitivity,B-Condition
31279,2048,to,I-Condition
31280,2048,any,I-Condition
31281,2048,seasonal,I-Condition
31282,2048,influenza,I-Condition
31283,2048,vaccine,I-Condition
31284,2048,component,I-Condition
31285,2049,Persons,O
31286,2049,with,O
31287,2049,a,O
31288,2049,history,O
31289,2049,of,O
31290,2049,Guillain,B-Condition
31291,2049,-,I-Condition
31292,2049,Barré,I-Condition
31293,2049,Syndrome,I-Condition
31294,2050,Receipt,B-Procedure
31295,2050,of,I-Procedure
31296,2050,blood,I-Procedure
31297,2050,or,I-Procedure
31298,2050,blood,I-Procedure
31299,2050,products,I-Procedure
31300,2050,8,O
31301,2050,weeks,O
31302,2050,prior,O
31303,2050,to,O
31304,2050,vaccination,O
31305,2050,or,O
31306,2050,planned,B-Observation
31307,2050,administration,I-Observation
31308,2050,during,O
31309,2050,the,O
31310,2050,three,O
31311,2050,week,O
31312,2050,study,O
31313,2050,period,O
31314,2050,following,O
31315,2050,vaccination,O
31316,2051,Donation,B-Procedure
31317,2051,of,I-Procedure
31318,2051,blood,I-Procedure
31319,2051,or,I-Procedure
31320,2051,blood,I-Procedure
31321,2051,products,I-Procedure
31322,2051,within,O
31323,2051,8,O
31324,2051,weeks,O
31325,2051,prior,O
31326,2051,to,O
31327,2051,vaccination,O
31328,2051,or,O
31329,2051,during,O
31330,2051,the,O
31331,2051,three,O
31332,2051,week,O
31333,2051,study,O
31334,2051,period,O
31335,2051,following,O
31336,2052,An,O
31337,2052,oral,O
31338,2052,temperature,O
31339,2052,>,O
31340,2052,100.4,O
31341,2052,°,O
31342,2052,or,O
31343,2052,acute,B-Condition
31344,2052,disease,I-Condition
31345,2052,within,O
31346,2052,72,O
31347,2052,hours,O
31348,2052,prior,O
31349,2052,to,O
31350,2052,vaccination,O
31351,2052,",",O
31352,2052,defined,O
31353,2052,as,O
31354,2052,the,O
31355,2052,presence,O
31356,2052,of,O
31357,2052,a,O
31358,2052,moderate,B-Condition
31359,2052,or,I-Condition
31360,2052,severe,I-Condition
31361,2052,illness,I-Condition
31362,2052,(,O
31363,2052,as,O
31364,2052,determined,O
31365,2052,by,O
31366,2052,the,O
31367,2052,investigator,O
31368,2052,through,O
31369,2052,medical,O
31370,2052,history,O
31371,2052,and,O
31372,2052,physical,O
31373,2052,examination,O
31374,2052,;,O
31375,2052,for,O
31376,2052,example,O
31377,2052,",",O
31378,2052,those,O
31379,2052,requiring,O
31380,2052,an,O
31381,2052,absence,O
31382,2052,from,O
31383,2052,work,O
31384,2052,),O
31385,2052,with,O
31386,2052,or,O
31387,2052,without,O
31388,2052,fever,O
31389,2052,.,O
31390,2053,Body,O
31391,2053,Mass,O
31392,2053,Index,O
31393,2053,>,O
31394,2053,29.9,O
31395,2054,Any,O
31396,2054,disorder,B-Condition
31397,2054,of,I-Condition
31398,2054,coagulation,I-Condition
31399,2055,A,O
31400,2055,clinical,O
31401,2055,diagnosis,O
31402,2055,of,O
31403,2055,influenza,B-Condition
31404,2055,within,O
31405,2055,the,O
31406,2055,previous,O
31407,2055,12,O
31408,2055,months,O
31409,2056,Any,O
31410,2056,other,O
31411,2056,condition,O
31412,2056,or,O
31413,2056,circumstance,O
31414,2056,which,O
31415,2056,",",O
31416,2056,in,O
31417,2056,the,O
31418,2056,opinion,O
31419,2056,of,O
31420,2056,the,O
31421,2056,Principal,O
31422,2056,Investigator,O
31423,2056,",",O
31424,2056,poses,O
31425,2056,an,O
31426,2056,unacceptable,O
31427,2056,risk,O
31428,2056,for,O
31429,2056,participation,O
31430,2056,in,O
31431,2056,the,O
31432,2056,study,O
31433,2057,Males,B-Person
31434,2057,and,O
31435,2057,females,B-Person
31436,2057,aged,B-Person
31437,2057,18,O
31438,2057,-,O
31439,2057,40,O
31440,2057,years,O
31441,2057,of,O
31442,2057,age,B-Person
31443,2057,at,O
31444,2057,the,O
31445,2057,time,O
31446,2057,of,O
31447,2057,vaccination,O
31448,2057,in,O
31449,2057,good,B-Condition
31450,2057,health,I-Condition
31451,2057,as,O
31452,2057,determined,O
31453,2057,by,O
31454,2057,medical,B-Observation
31455,2057,history,I-Observation
31456,2057,",",O
31457,2057,physical,B-Procedure
31458,2057,exam,I-Procedure
31459,2057,",",O
31460,2057,laboratory,B-Procedure
31461,2057,assessments,I-Procedure
31462,2057,and,O
31463,2057,the,O
31464,2057,clinical,O
31465,2057,judgment,O
31466,2057,of,O
31467,2057,the,O
31468,2057,Principal,O
31469,2057,Investigator,O
31470,2058,Able,O
31471,2058,to,O
31472,2058,provide,O
31473,2058,informed,O
31474,2058,consent,O
31475,2058,indicating,O
31476,2058,that,O
31477,2058,they,O
31478,2058,understand,O
31479,2058,the,O
31480,2058,purpose,O
31481,2058,of,O
31482,2058,this,O
31483,2058,study,O
31484,2058,and,O
31485,2058,are,O
31486,2058,willing,O
31487,2058,to,O
31488,2058,adhere,O
31489,2058,to,O
31490,2058,the,O
31491,2058,procedures,O
31492,2058,described,O
31493,2058,in,O
31494,2058,this,O
31495,2058,protocol,O
31496,2059,If,O
31497,2059,the,O
31498,2059,subject,O
31499,2059,is,O
31500,2059,a,O
31501,2059,female,O
31502,2059,of,O
31503,2059,childbearing,O
31504,2059,potential,O
31505,2059,",",O
31506,2059,she,O
31507,2059,must,O
31508,2059,use,O
31509,2059,adequate,O
31510,2059,contraceptive,O
31511,2059,precautions,O
31512,2059,(,O
31513,2059,e.g.,O
31514,2059,",",O
31515,2059,intrauterine,O
31516,2059,contraceptive,O
31517,2059,device,O
31518,2059,",",O
31519,2059,oral,O
31520,2059,contraceptives,O
31521,2059,or,O
31522,2059,other,O
31523,2059,equivalent,O
31524,2059,hormonal,O
31525,2059,contraception,O
31526,2059,),O
31527,2059,for,O
31528,2059,2,O
31529,2059,months,O
31530,2059,prior,O
31531,2059,to,O
31532,2059,vaccination,O
31533,2059,and,O
31534,2059,continue,O
31535,2059,to,O
31536,2059,use,O
31537,2059,such,O
31538,2059,precautions,O
31539,2059,for,O
31540,2059,a,O
31541,2059,minimum,O
31542,2059,of,O
31543,2059,three,O
31544,2059,months,O
31545,2059,after,O
31546,2059,vaccination,O
31547,2059,.,O
31548,2059,She,O
31549,2059,must,O
31550,2059,also,O
31551,2059,have,O
31552,2059,a,O
31553,2059,negative,O
31554,2059,urine,O
31555,2059,pregnancy,O
31556,2059,test,O
31557,2059,within,O
31558,2059,24,O
31559,2059,hours,O
31560,2059,prior,O
31561,2059,to,O
31562,2059,receiving,O
31563,2059,study,O
31564,2059,vaccine,O
31565,2059,.,O
31566,2059,Women,O
31567,2059,at,O
31568,2059,least,O
31569,2059,one,O
31570,2059,year,O
31571,2059,post,O
31572,2059,-,O
31573,2059,menopausal,O
31574,2059,or,O
31575,2059,surgically,O
31576,2059,sterile,O
31577,2059,will,O
31578,2059,not,O
31579,2059,be,O
31580,2059,considered,O
31581,2059,of,O
31582,2059,childbearing,O
31583,2059,potential,O
31584,2059,.,O
31585,2060,Willing,O
31586,2060,to,O
31587,2060,receive,O
31588,2060,the,O
31589,2060,unlicensed,O
31590,2060,vaccine,B-Drug
31591,2060,given,O
31592,2060,as,O
31593,2060,an,O
31594,2060,IM,B-Procedure
31595,2060,injection,I-Procedure
31596,2061,Willing,O
31597,2061,to,O
31598,2061,provide,O
31599,2061,multiple,O
31600,2061,blood,O
31601,2061,specimens,O
31602,2061,collected,O
31603,2061,by,O
31604,2061,venipuncture,O
31605,2062,Newborns,B-Person
31606,2062,of,O
31607,2062,substance,B-Condition
31608,2062,abusing,I-Condition
31609,2062,mothers,B-Person
31610,2062,.,O
31611,2063,Newborns,B-Person
31612,2063,with,O
31613,2063,any,O
31614,2063,contraindications,B-Condition
31615,2063,to,O
31616,2063,routine,O
31617,2063,circumcision,B-Procedure
31618,2063,",",O
31619,2063,anatomical,O
31620,2063,or,O
31621,2063,hematologic,O
31622,2063,.,O
31623,2064,Apgar,O
31624,2064,score,O
31625,2064,at,O
31626,2064,5,O
31627,2064,minutes,O
31628,2064,>,O
31629,2064,7,O
31630,2065,birthweight,O
31631,2065,greater,O
31632,2065,than,O
31633,2065,2.4,O
31634,2065,kg,O
31635,2066,Age,B-Person
31636,2066,of,O
31637,2066,at,O
31638,2066,least,O
31639,2066,10,O
31640,2066,hours,O
31641,2067,At,O
31642,2067,least,O
31643,2067,one,O
31644,2067,void,B-Observation
31645,2067,.,O
31646,2068,pathological,B-Condition
31647,2068,obesity,I-Condition
31648,2069,chronic,B-Condition
31649,2069,diseases,I-Condition
31650,2069,e.g.,O
31651,2069,cerebral,B-Condition
31652,2069,palsy,I-Condition
31653,2069,",",O
31654,2069,metabolic,B-Condition
31655,2069,disease,I-Condition
31656,2069,",",O
31657,2069,etc,O
31658,2069,.,O
31659,2070,diseases,B-Condition
31660,2070,of,I-Condition
31661,2070,red,I-Condition
31662,2070,blood,I-Condition
31663,2070,cells,I-Condition
31664,2071,on,O
31665,2071,medication,O
31666,2071,e.g.,O
31667,2071,steroid,B-Drug
31668,2071,",",O
31669,2071,multivitamins,B-Drug
31670,2071,",",O
31671,2071,thiamine,B-Drug
31672,2071,-,I-Drug
31673,2071,containing,I-Drug
31674,2071,vitamins,I-Drug
31675,2071,",",O
31676,2071,diuretic,B-Drug
31677,2071,drugs,I-Drug
31678,2072,hemodialysis,B-Procedure
31679,2072,or,O
31680,2072,peritoneal,B-Procedure
31681,2072,dialysis,I-Procedure
31682,2073,bariatric,B-Procedure
31683,2073,surgery,I-Procedure
31684,2074,obese,B-Condition
31685,2074,:,O
31686,2074,weight,O
31687,2074,for,O
31688,2074,height,O
31689,2074,>,O
31690,2074,median,O
31691,2074,+,O
31692,2074,3,O
31693,2074,standard,O
31694,2074,deviations,O
31695,2075,simple,B-Condition
31696,2075,obesity,I-Condition
31697,2076,Subjects,O
31698,2076,not,O
31699,2076,able,B-Mood
31700,2076,to,I-Mood
31701,2076,give,O
31702,2076,informed,O
31703,2076,consent,O
31704,2077,Left,B-Condition
31705,2077,Bundle,I-Condition
31706,2077,Branch,I-Condition
31707,2077,Block,I-Condition
31708,2078,Thrombolytic,B-Procedure
31709,2078,therapy,I-Procedure
31710,2078,within,O
31711,2078,24,O
31712,2078,hours,O
31713,2078,before,O
31714,2078,randomization,O
31715,2079,Oral,B-Procedure
31716,2079,anticoagulation,I-Procedure
31717,2079,with,O
31718,2079,International,O
31719,2079,Normalized,O
31720,2079,Ratio,O
31721,2079,(,O
31722,2079,INR,O
31723,2079,),O
31724,2079,>,O
31725,2079,2,O
31726,2080,Known,O
31727,2080,platelets,O
31728,2080,<,O
31729,2080,100.000/µl,O
31730,2080,or,O
31731,2080,known,O
31732,2080,hemorrhagic,B-Condition
31733,2080,diathesis,I-Condition
31734,2081,Stroke,B-Condition
31735,2081,or,O
31736,2081,Transient,B-Condition
31737,2081,Ischemic,I-Condition
31738,2081,Attack,I-Condition
31739,2081,(,I-Condition
31740,2081,TIA,I-Condition
31741,2081,),I-Condition
31742,2081,within,O
31743,2081,the,O
31744,2081,past,O
31745,2081,6,O
31746,2081,months,O
31747,2081,or,O
31748,2081,any,O
31749,2081,permanent,O
31750,2081,residual,B-Condition
31751,2081,neurological,I-Condition
31752,2081,defect,I-Condition
31753,2082,Evidence,O
31754,2082,of,O
31755,2082,an,O
31756,2082,active,O
31757,2082,gastrointestinal,B-Condition
31758,2082,or,I-Condition
31759,2082,urogenital,I-Condition
31760,2082,bleeding,I-Condition
31761,2083,Major,B-Procedure
31762,2083,surgery,I-Procedure
31763,2083,within,O
31764,2083,6,O
31765,2083,weeks,O
31766,2084,History,B-Observation
31767,2084,of,O
31768,2084,allergic,B-Condition
31769,2084,reaction,I-Condition
31770,2084,to,O
31771,2084,abciximab,B-Drug
31772,2084,or,O
31773,2084,eptifibatide,B-Drug
31774,2084,or,O
31775,2084,any,O
31776,2084,component,B-Drug
31777,2084,used,I-Drug
31778,2084,in,I-Drug
31779,2084,the,I-Drug
31780,2084,study,I-Drug
31781,2084,(,O
31782,2084,including,O
31783,2084,contrast,B-Drug
31784,2084,media,I-Drug
31785,2084,),O
31786,2085,Known,O
31787,2085,severe,O
31788,2085,renal,B-Condition
31789,2085,(,I-Condition
31790,2085,creatinine,I-Condition
31791,2085,clearance,I-Condition
31792,2085,<,I-Condition
31793,2085,30ml,I-Condition
31794,2085,/,I-Condition
31795,2085,min,I-Condition
31796,2085,),I-Condition
31797,2085,or,I-Condition
31798,2085,hepatic,I-Condition
31799,2085,insufficiency,I-Condition
31800,2085,as,O
31801,2085,well,O
31802,2085,as,O
31803,2085,Alanine,O
31804,2085,transaminase,O
31805,2085,(,O
31806,2085,ALT)/aspartate,O
31807,2085,transaminase,O
31808,2085,(,O
31809,2085,AST,O
31810,2085,),O
31811,2085,elevations,O
31812,2085,=,O
31813,2085,3xUpper,O
31814,2085,limit,O
31815,2085,normal,O
31816,2085,(,O
31817,2085,ULN,O
31818,2085,),O
31819,2085,;,O
31820,2085,isolated,O
31821,2085,AST,O
31822,2085,-,O
31823,2085,elevation,O
31824,2085,is,O
31825,2085,not,O
31826,2085,considered,O
31827,2085,an,O
31828,2085,exclusion,O
31829,2085,criteria,O
31830,2085,from,O
31831,2085,study,O
31832,2085,participation,O
31833,2086,Severe,B-Condition
31834,2086,concomitant,I-Condition
31835,2086,disease,I-Condition
31836,2086,with,O
31837,2086,life,O
31838,2086,expectation,O
31839,2086,<,O
31840,2086,1,O
31841,2086,year,O
31842,2087,Subject,O
31843,2087,has,O
31844,2087,participated,B-Observation
31845,2087,in,I-Observation
31846,2087,any,I-Observation
31847,2087,study,I-Observation
31848,2087,using,O
31849,2087,an,O
31850,2087,investigational,B-Drug
31851,2087,drug,I-Drug
31852,2087,or,O
31853,2087,device,O
31854,2087,within,O
31855,2087,30,O
31856,2087,days,O
31857,2087,or,O
31858,2087,within,O
31859,2087,5,O
31860,2087,half,O
31861,2087,-,O
31862,2087,lives,O
31863,2087,of,O
31864,2087,the,O
31865,2087,investigational,O
31866,2087,drug,O
31867,2087,(,O
31868,2087,whichever,O
31869,2087,is,O
31870,2087,longer,O
31871,2087,),O
31872,2087,of,O
31873,2087,entry,O
31874,2087,into,O
31875,2087,this,O
31876,2087,study,O
31877,2087,.,O
31878,2088,Subjects,O
31879,2088,who,O
31880,2088,will,O
31881,2088,be,O
31882,2088,inaccessible,B-Observation
31883,2088,due,O
31884,2088,to,O
31885,2088,geographic,O
31886,2088,or,O
31887,2088,social,O
31888,2088,factors,O
31889,2088,during,O
31890,2088,treatment,O
31891,2088,or,O
31892,2088,follow,O
31893,2088,-,O
31894,2088,up,O
31895,2089,In,O
31896,2089,France,O
31897,2089,",",O
31898,2089,a,O
31899,2089,subject,O
31900,2089,is,O
31901,2089,neither,O
31902,2089,affiliated,O
31903,2089,with,O
31904,2089,nor,O
31905,2089,a,O
31906,2089,beneficiary,O
31907,2089,of,O
31908,2089,a,O
31909,2089,social,O
31910,2089,security,O
31911,2089,category,O
31912,2089,.,O
31913,2090,Women,B-Person
31914,2090,must,O
31915,2090,be,O
31916,2090,postmenopausal,B-Condition
31917,2090,(,O
31918,2090,i.e.12,O
31919,2090,months,O
31920,2090,without,O
31921,2090,menstrual,B-Condition
31922,2090,period,I-Condition
31923,2090,),O
31924,2090,",",O
31925,2090,or,O
31926,2090,surgically,B-Condition
31927,2090,sterile,I-Condition
31928,2090,",",O
31929,2090,i.e.,O
31930,2090,women,B-Person
31931,2090,of,O
31932,2090,child,B-Condition
31933,2090,bearing,I-Condition
31934,2090,potential,I-Condition
31935,2090,are,O
31936,2090,not,O
31937,2090,allowed,O
31938,2090,to,O
31939,2090,be,O
31940,2090,included,O
31941,2090,into,O
31942,2090,the,O
31943,2090,study,O
31944,2090,.,O
31945,2090,In,O
31946,2090,cases,O
31947,2090,of,O
31948,2090,doubt,O
31949,2090,a,O
31950,2090,pregnancy,B-Condition
31951,2090,test,I-Condition
31952,2090,should,O
31953,2090,be,O
31954,2090,performed,O
31955,2090,.,O
31956,2090,(,O
31957,2090,NB,O
31958,2090,-post,O
31959,2090,menopausal,O
31960,2090,women,O
31961,2090,currently,O
31962,2090,receiving,O
31963,2090,hormone,O
31964,2090,replacement,O
31965,2090,are,O
31966,2090,permissible,O
31967,2090,),O
31968,2091,Acute,B-Condition
31969,2091,myocardial,I-Condition
31970,2091,infarction,I-Condition
31971,2091,<,O
31972,2091,12,O
31973,2091,h,O
31974,2091,defined,O
31975,2091,as,O
31976,2091,:,O
31977,2092,1,O
31978,2092,.,O
31979,2092,Angina,B-Condition
31980,2092,or,I-Condition
31981,2092,equivalent,I-Condition
31982,2092,symptoms,I-Condition
31983,2092,>,O
31984,2092,20,O
31985,2092,min,O
31986,2092,and,O
31987,2093,2,O
31988,2093,.,O
31989,2093,ST,B-Condition
31990,2093,elevation,I-Condition
31991,2093,in,O
31992,2093,2,O
31993,2093,contiguous,O
31994,2093,ECG,O
31995,2093,leads,O
31996,2093,(=,O
31997,2093,2,O
31998,2093,mm,O
31999,2093,precordial,O
32000,2093,lead,O
32001,2093,",",O
32002,2093,=,O
32003,2093,1,O
32004,2093,mm,O
32005,2093,limb,O
32006,2093,lead,O
32007,2093,),O
32008,2093,.,O
32009,2093,This,O
32010,2093,ECG,O
32011,2093,recording,O
32012,2093,serves,O
32013,2093,as,O
32014,2093,baseline,O
32015,2093,ECG,O
32016,2093,",",O
32017,2093,i.e.,O
32018,2093,ECG,O
32019,2093,I.,O
32020,2094,Planned,B-Observation
32021,2094,primary,B-Procedure
32022,2094,percutaneous,I-Procedure
32023,2094,coronary,I-Procedure
32024,2094,intervention,I-Procedure
32025,2095,The,O
32026,2095,subject,O
32027,2095,has,O
32028,2095,given,B-Observation
32029,2095,written,I-Observation
32030,2095,informed,I-Observation
32031,2095,",",I-Observation
32032,2095,dated,I-Observation
32033,2095,consent,I-Observation
32034,2095,to,O
32035,2095,participate,O
32036,2095,in,O
32037,2095,the,O
32038,2095,study,O
32039,2096,Exclusion,O
32040,2096,criteria,O
32041,2096,include,O
32042,2096,patients,O
32043,2096,following,O
32044,2096,resuscitation,B-Procedure
32045,2096,from,I-Procedure
32046,2096,cardiac,I-Procedure
32047,2096,arrest,I-Procedure
32048,2096,who,O
32049,2096,are,O
32050,2096,treated,O
32051,2096,on,O
32052,2096,the,O
32053,2096,cooling,O
32054,2096,protocol,O
32055,2097,patients,O
32056,2097,who,O
32057,2097,have,O
32058,2097,suffered,O
32059,2097,a,O
32060,2097,neurologic,B-Condition
32061,2097,event,I-Condition
32062,2097,(,O
32063,2097,seizure,B-Condition
32064,2097,",",O
32065,2097,stroke,B-Condition
32066,2097,),O
32067,2097,or,O
32068,2097,who,O
32069,2097,have,O
32070,2097,baseline,B-Condition
32071,2097,dementia,I-Condition
32072,2097,",",O
32073,2097,both,O
32074,2097,of,O
32075,2097,which,O
32076,2097,could,O
32077,2097,limit,O
32078,2097,delirium,O
32079,2097,assessment,O
32080,2098,patients,O
32081,2098,with,O
32082,2098,child,O
32083,2098,class,O
32084,2098,B,O
32085,2098,and,O
32086,2098,C,O
32087,2098,liver,B-Condition
32088,2098,disease,I-Condition
32089,2099,patients,O
32090,2099,with,O
32091,2099,known,O
32092,2099,allergy,B-Condition
32093,2099,to,O
32094,2099,study,B-Drug
32095,2099,medications,I-Drug
32096,2099,.,O
32097,2100,All,O
32098,2100,patients,O
32099,2100,admitted,B-Procedure
32100,2100,to,O
32101,2100,the,O
32102,2100,Duke,O
32103,2100,CICU,O
32104,2100,",",O
32105,2100,who,O
32106,2100,require,O
32107,2100,intubation,B-Procedure
32108,2100,and,O
32109,2100,sedation,B-Procedure
32110,2100,for,O
32111,2100,mechanical,B-Procedure
32112,2100,ventilation,I-Procedure
32113,2100,that,O
32114,2100,is,O
32115,2100,expected,B-Mood
32116,2100,to,I-Mood
32117,2100,be,I-Mood
32118,2100,>,O
32119,2100,24,O
32120,2100,hours,O
32121,2100,in,O
32122,2100,duration,O
32123,2100,will,O
32124,2100,be,O
32125,2100,included,O
32126,2100,",",O
32127,2100,unless,O
32128,2100,they,O
32129,2100,meet,O
32130,2100,the,O
32131,2100,specified,O
32132,2100,exclusion,O
32133,2100,criteria,O
32134,2100,.,O
32135,2101,Patients,O
32136,2101,intubated,B-Procedure
32137,2101,within,O
32138,2101,one,O
32139,2101,hour,O
32140,2101,prior,O
32141,2101,to,O
32142,2101,care,B-Procedure
32143,2101,transition,I-Procedure
32144,2101,to,O
32145,2101,the,O
32146,2101,CICU,O
32147,2101,will,O
32148,2101,also,O
32149,2101,be,O
32150,2101,screened,O
32151,2101,for,O
32152,2101,inclusion,O
32153,2101,.,O
32154,2102,eGFR,O
32155,2102,<,O
32156,2102,60,O
32157,2102,T2DM,B-Condition
32158,2102,patients,O
32159,2102,on,O
32160,2102,insulin,B-Drug
32161,2102,",",O
32162,2102,GLP-1,B-Drug
32163,2102,RA,B-Drug
32164,2102,or,O
32165,2102,SGLT2,B-Drug
32166,2102,treatment,O
32167,2102,Major,B-Condition
32168,2102,organ,I-Condition
32169,2102,disease,I-Condition
32170,2102,type,B-Condition
32171,2102,1,I-Condition
32172,2102,diabetes,I-Condition
32173,2103,eGFR>60,O
32174,2103,ml,O
32175,2103,/,O
32176,2103,min,O
32177,2103,healthy,B-Condition
32178,2103,volunteers,O
32179,2103,type,B-Condition
32180,2103,2,I-Condition
32181,2103,diabetes,I-Condition
32182,2103,patients,O
32183,2103,who,O
32184,2103,otherwise,O
32185,2103,healthy,O
32186,2104,Women,B-Person
32187,2104,under,O
32188,2104,the,O
32189,2104,age,B-Person
32190,2104,of,O
32191,2104,18,O
32192,2104,",",O
32193,2105,Clinically,O
32194,2105,positive,O
32195,2105,axillary,B-Condition
32196,2105,nodes,I-Condition
32197,2106,Neoadjuvant,B-Procedure
32198,2106,therapy,I-Procedure
32199,2106,for,O
32200,2106,current,O
32201,2106,breast,B-Condition
32202,2106,cancer,I-Condition
32203,2106,diagnosis,O
32204,2107,Women,B-Person
32205,2107,with,O
32206,2107,previous,O
32207,2107,SLNBx,B-Procedure
32208,2107,or,O
32209,2107,axillary,B-Procedure
32210,2107,node,I-Procedure
32211,2107,dissection,I-Procedure
32212,2108,Pregnant,O
32213,2108,women,O
32214,2109,Women,B-Person
32215,2109,with,O
32216,2109,previous,O
32217,2109,radiation,B-Procedure
32218,2109,above,O
32219,2109,the,O
32220,2109,diaphragm,O
32221,2109,",",O
32222,2109,and,O
32223,2109,below,O
32224,2109,the,O
32225,2109,neck,O
32226,2110,Women,B-Person
32227,2110,above,O
32228,2110,18,O
32229,2110,years,O
32230,2110,of,O
32231,2110,age,B-Person
32232,2110,with,O
32233,2110,biopsy,B-Procedure
32234,2110,proven,O
32235,2110,",",O
32236,2110,clinically,O
32237,2110,stage,O
32238,2110,1,O
32239,2110,or,O
32240,2110,2,O
32241,2110,breast,B-Condition
32242,2110,cancer,I-Condition
32243,2110,who,O
32244,2110,will,B-Mood
32245,2110,be,I-Mood
32246,2110,undergoing,I-Mood
32247,2110,partial,B-Procedure
32248,2110,mastectomy,I-Procedure
32249,2110,with,O
32250,2110,SLNBx,B-Procedure
32251,2110,at,O
32252,2110,Memorial,O
32253,2110,Health,O
32254,2111,Known,O
32255,2111,hypersensitivity,B-Condition
32256,2111,to,O
32257,2111,egg,B-Drug
32258,2111,",",O
32259,2111,soybean,B-Drug
32260,2111,proteins,I-Drug
32261,2111,",",O
32262,2111,peanut,B-Drug
32263,2111,proteins,I-Drug
32264,2111,",",O
32265,2111,corn,B-Drug
32266,2111,or,O
32267,2111,corn,B-Drug
32268,2111,products,I-Drug
32269,2111,",",O
32270,2111,or,O
32271,2111,to,O
32272,2111,any,O
32273,2111,of,O
32274,2111,the,O
32275,2111,active,B-Drug
32276,2111,substances,I-Drug
32277,2111,or,O
32278,2111,excipients,B-Drug
32279,2112,Severe,O
32280,2112,hyperlipidemia,B-Condition
32281,2112,or,O
32282,2112,severe,O
32283,2112,disorders,B-Condition
32284,2112,of,I-Condition
32285,2112,lipid,I-Condition
32286,2112,metabolism,I-Condition
32287,2112,characterized,O
32288,2112,by,O
32289,2112,hypertriglyceridemia,B-Condition
32290,2112,(,O
32291,2112,serum,O
32292,2112,triglyceride,O
32293,2112,concentration,O
32294,2112,>,O
32295,2112,"1,000",O
32296,2112,g,O
32297,2112,/,O
32298,2112,dL,O
32299,2112,),O
32300,2112,.,O
32301,2113,Inborn,B-Condition
32302,2113,errors,I-Condition
32303,2113,of,I-Condition
32304,2113,amino,I-Condition
32305,2113,acid,I-Condition
32306,2113,metabolism,I-Condition
32307,2114,Cardiopulmonary,B-Condition
32308,2114,instability,I-Condition
32309,2114,(,O
32310,2114,including,O
32311,2114,pulmonary,B-Condition
32312,2114,edema,I-Condition
32313,2114,",",O
32314,2114,cardiac,B-Condition
32315,2114,insufficiency,I-Condition
32316,2114,",",O
32317,2114,myocardial,B-Condition
32318,2114,infarction,I-Condition
32319,2114,",",O
32320,2114,acidosis,B-Condition
32321,2114,and,O
32322,2114,hemodynamic,B-Condition
32323,2114,instability,I-Condition
32324,2114,requiring,O
32325,2114,significant,O
32326,2114,vasopressor,B-Drug
32327,2114,support,O
32328,2114,),O
32329,2115,Hemophagocytic,B-Condition
32330,2115,syndrome,I-Condition
32331,2115,.,O
32332,2116,PN,B-Procedure
32333,2116,in,O
32334,2116,the,O
32335,2116,last,O
32336,2116,7,O
32337,2116,days,O
32338,2116,prior,O
32339,2116,to,O
32340,2116,study,O
32341,2116,enrollment,O
32342,2116,.,O
32343,2117,Need,O
32344,2117,for,O
32345,2117,chronic,B-Procedure
32346,2117,PN,I-Procedure
32347,2117,before,O
32348,2117,study,O
32349,2117,start,O
32350,2118,Liver,O
32351,2118,enzymes,O
32352,2118,(,O
32353,2118,either,O
32354,2118,AST,O
32355,2118,",",O
32356,2118,ALT,O
32357,2118,",",O
32358,2118,GGPT,O
32359,2118,),O
32360,2118,",",O
32361,2118,or,O
32362,2118,direct,O
32363,2118,bilirubin,O
32364,2118,exceeding,O
32365,2118,2,O
32366,2118,x,O
32367,2118,upper,O
32368,2118,limit,O
32369,2118,of,O
32370,2118,normal,O
32371,2118,range,O
32372,2119,Pathologically,O
32373,2119,altered,O
32374,2119,level,O
32375,2119,of,O
32376,2119,any,O
32377,2119,serum,O
32378,2119,electrolyte,O
32379,2119,(,O
32380,2119,sodium,O
32381,2119,",",O
32382,2119,potassium,O
32383,2119,",",O
32384,2119,magnesium,O
32385,2119,",",O
32386,2119,calcium,O
32387,2119,",",O
32388,2119,chloride,O
32389,2119,",",O
32390,2119,phosphate,O
32391,2119,),O
32392,2119,unless,O
32393,2119,corrected,O
32394,2119,prior,O
32395,2119,to,O
32396,2119,the,O
32397,2119,start,O
32398,2119,of,O
32399,2119,study,O
32400,2119,treatment,O
32401,2120,Pathologically,O
32402,2120,altered,O
32403,2120,blood,O
32404,2120,pH,O
32405,2120,",",O
32406,2120,or,O
32407,2120,oxygen,O
32408,2120,saturation,O
32409,2120,",",O
32410,2120,or,O
32411,2120,carbon,O
32412,2120,dioxide,O
32413,2120,unless,O
32414,2120,corrected,O
32415,2120,prior,O
32416,2120,to,O
32417,2120,the,O
32418,2120,start,O
32419,2120,of,O
32420,2120,study,O
32421,2120,treatment,O
32422,2121,Pregnancy,B-Condition
32423,2121,or,O
32424,2121,lactation,B-Condition
32425,2122,Participation,O
32426,2122,in,O
32427,2122,another,O
32428,2122,clinical,O
32429,2122,study,O
32430,2123,Male,B-Person
32431,2123,or,O
32432,2123,female,B-Person
32433,2123,patients,O
32434,2123,2,O
32435,2123,to,O
32436,2123,16,O
32437,2123,years,O
32438,2123,of,O
32439,2123,age,B-Person
32440,2124,Patients,O
32441,2124,who,O
32442,2124,require,O
32443,2124,at,O
32444,2124,least,O
32445,2124,80,O
32446,2124,%,O
32447,2124,of,O
32448,2124,their,O
32449,2124,caloric,O
32450,2124,intake,O
32451,2124,as,O
32452,2124,PN,B-Procedure
32453,2124,at,O
32454,2124,study,O
32455,2124,start,O
32456,2124,",",O
32457,2124,and,O
32458,2124,in,O
32459,2124,whom,O
32460,2124,an,O
32461,2124,indication,B-Condition
32462,2124,for,O
32463,2124,PN,B-Procedure
32464,2124,is,O
32465,2124,expected,B-Mood
32466,2124,for,O
32467,2124,at,O
32468,2124,least,O
32469,2124,5,O
32470,2124,days,O
32471,2125,Patients,O
32472,2125,who,O
32473,2125,require,O
32474,2125,a,O
32475,2125,central,O
32476,2125,venous,O
32477,2125,line,O
32478,2125,to,O
32479,2125,receive,O
32480,2125,PN,B-Procedure
32481,2125,or,O
32482,2125,already,O
32483,2125,have,O
32484,2125,a,O
32485,2125,central,O
32486,2125,venous,O
32487,2125,line,O
32488,2125,in,O
32489,2125,place,O
32490,2125,for,O
32491,2125,other,B-Observation
32492,2125,reasons,I-Observation
32493,2126,Written,O
32494,2126,informed,O
32495,2126,consent,O
32496,2126,from,O
32497,2126,legal,O
32498,2126,representative(s,O
32499,2126,),O
32500,2127,1,O
32501,2127,.,O
32502,2127,For,O
32503,2127,subjects,O
32504,2127,in,O
32505,2127,Cohort,B-Observation
32506,2127,A,I-Observation
32507,2127,:,O
32508,2127,previous,O
32509,2127,therapy,B-Procedure
32510,2127,for,O
32511,2127,more,O
32512,2127,than,O
32513,2127,48,O
32514,2127,hours,O
32515,2127,with,O
32516,2127,any,O
32517,2127,parenteral,B-Drug
32518,2127,antibiotic,I-Drug
32519,2127,with,I-Drug
32520,2127,activity,I-Drug
32521,2127,against,I-Drug
32522,2127,S.,I-Drug
32523,2127,aureus,I-Drug
32524,2127,within,O
32525,2127,72,O
32526,2127,hours,O
32527,2127,of,O
32528,2127,positive,O
32529,2127,blood,B-Procedure
32530,2127,culture,I-Procedure
32531,2127,results,O
32532,2127,.,O
32533,2128,2,O
32534,2128,.,O
32535,2128,For,O
32536,2128,subjects,O
32537,2128,in,O
32538,2128,Cohort,B-Observation
32539,2128,B,I-Observation
32540,2128,:,O
32541,2128,previous,O
32542,2128,therapy,B-Procedure
32543,2128,for,O
32544,2128,more,O
32545,2128,than,O
32546,2128,48,O
32547,2128,hours,O
32548,2128,with,O
32549,2128,any,O
32550,2128,parenteral,B-Drug
32551,2128,antibiotic,I-Drug
32552,2128,with,I-Drug
32553,2128,activity,I-Drug
32554,2128,against,I-Drug
32555,2128,MRSA,I-Drug
32556,2128,",",O
32557,2128,except,O
32558,2128,vancomycin,B-Drug
32559,2128,and/or,O
32560,2128,daptomycin,B-Drug
32561,2128,",",O
32562,2128,within,O
32563,2128,72,O
32564,2128,hours,O
32565,2128,of,O
32566,2128,positive,O
32567,2128,blood,B-Procedure
32568,2128,culture,I-Procedure
32569,2128,results,O
32570,2128,confirming,O
32571,2128,persistence,O
32572,2128,.,O
32573,2129,3,O
32574,2129,.,O
32575,2129,Previous,O
32576,2129,episode,O
32577,2129,of,O
32578,2129,S.,B-Condition
32579,2129,aureus,I-Condition
32580,2129,bacteremia,I-Condition
32581,2129,within,O
32582,2129,3,O
32583,2129,months,O
32584,2129,.,O
32585,2130,4,O
32586,2130,.,O
32587,2130,Known,O
32588,2130,left,B-Condition
32589,2130,-,I-Condition
32590,2130,sided,I-Condition
32591,2130,endocarditis,I-Condition
32592,2130,or,O
32593,2130,prosthetic,O
32594,2130,heart,O
32595,2130,valve,O
32596,2130,.,O
32597,2131,5,O
32598,2131,.,O
32599,2131,Osteomyelitis,B-Condition
32600,2131,or,O
32601,2131,prosthetic,B-Condition
32602,2131,joint,I-Condition
32603,2131,infection,I-Condition
32604,2131,except,O
32605,2131,new,O
32606,2131,onset,O
32607,2131,nonhardware,O
32608,2131,-,O
32609,2131,associated,O
32610,2131,vertebral,B-Condition
32611,2131,osteomyelitis,I-Condition
32612,2131,.,O
32613,2132,6,O
32614,2132,.,O
32615,2132,History,B-Observation
32616,2132,of,O
32617,2132,any,O
32618,2132,hypersensitivity,B-Condition
32619,2132,or,O
32620,2132,allergic,B-Condition
32621,2132,reaction,I-Condition
32622,2132,to,O
32623,2132,any,O
32624,2132,β,B-Drug
32625,2132,-,I-Drug
32626,2132,lactam,I-Drug
32627,2132,antibacterial,I-Drug
32628,2132,agent,I-Drug
32629,2132,.,O
32630,2133,7,O
32631,2133,.,O
32632,2133,Evidence,O
32633,2133,of,O
32634,2133,significant,O
32635,2133,hepatic,B-Condition
32636,2133,",",I-Condition
32637,2133,hematologic,I-Condition
32638,2133,",",I-Condition
32639,2133,or,I-Condition
32640,2133,immunologic,I-Condition
32641,2133,impairment,I-Condition
32642,2133,.,O
32643,2134,8,O
32644,2134,.,O
32645,2134,Pregnant,B-Condition
32646,2134,or,O
32647,2134,nursing,B-Condition
32648,2134,females,B-Person
32649,2134,.,O
32650,2135,1,O
32651,2135,.,O
32652,2135,Presence,O
32653,2135,of,O
32654,2135,bacteremia,B-Condition
32655,2135,due,O
32656,2135,solely,O
32657,2135,to,O
32658,2135,:,O
32659,2136,S.,B-Observation
32660,2136,aureus,I-Observation
32661,2136,on,O
32662,2136,at,O
32663,2136,least,O
32664,2136,1,O
32665,2136,blood,B-Procedure
32666,2136,culture,I-Procedure
32667,2136,within,O
32668,2136,72,O
32669,2136,hours,O
32670,2136,of,O
32671,2136,beginning,O
32672,2136,study,O
32673,2136,drug,O
32674,2136,(,O
32675,2136,Cohort,O
32676,2136,A,O
32677,2136,),O
32678,2136,OR,O
32679,2137,MRSA,B-Observation
32680,2137,on,O
32681,2137,a,O
32682,2137,baseline,O
32683,2137,blood,B-Procedure
32684,2137,culture,I-Procedure
32685,2137,and,O
32686,2137,on,O
32687,2137,at,O
32688,2137,least,O
32689,2137,1,O
32690,2137,additional,O
32691,2137,blood,B-Procedure
32692,2137,culture,I-Procedure
32693,2137,after,O
32694,2137,at,O
32695,2137,least,O
32696,2137,72,O
32697,2137,hours,O
32698,2137,of,O
32699,2137,vancomycin,B-Procedure
32700,2137,and/or,I-Procedure
32701,2137,daptomycin,I-Procedure
32702,2137,treatment,I-Procedure
32703,2137,(,O
32704,2137,Cohort,O
32705,2137,B,O
32706,2137,),O
32707,2137,.,O
32708,2138,2,O
32709,2138,.,O
32710,2138,Male,B-Person
32711,2138,or,O
32712,2138,female,B-Person
32713,2138,≥,O
32714,2138,18,O
32715,2138,years,O
32716,2138,of,O
32717,2138,age,B-Person
32718,2138,.,O
32719,2139,3,O
32720,2139,.,O
32721,2139,If,O
32722,2139,female,B-Person
32723,2139,of,O
32724,2139,childbearing,B-Condition
32725,2139,potential,I-Condition
32726,2139,must,O
32727,2139,be,O
32728,2139,willing,B-Observation
32729,2139,to,O
32730,2139,practice,B-Procedure
32731,2139,sexual,I-Procedure
32732,2139,abstinence,I-Procedure
32733,2139,or,O
32734,2139,dual,O
32735,2139,methods,B-Procedure
32736,2139,of,I-Procedure
32737,2139,contraception,I-Procedure
32738,2139,during,O
32739,2139,treatment,O
32740,2139,and,O
32741,2139,for,O
32742,2139,at,O
32743,2139,least,O
32744,2139,30,O
32745,2139,days,O
32746,2139,after,O
32747,2139,the,O
32748,2139,last,O
32749,2139,dose,O
32750,2139,of,O
32751,2139,study,O
32752,2139,drug,O
32753,2139,.,O
32754,2140,4,O
32755,2140,.,O
32756,2140,Expectation,B-Observation
32757,2140,of,O
32758,2140,survival,B-Condition
32759,2140,for,O
32760,2140,at,O
32761,2140,least,O
32762,2140,2,O
32763,2140,months,O
32764,2140,.,O
32765,2141,Presence,O
32766,2141,of,O
32767,2141,VTE,B-Condition
32768,2141,upon,O
32769,2141,admission,O
32770,2142,Pregnant,B-Condition
32771,2142,or,O
32772,2142,nursing,B-Condition
32773,2143,Inability,B-Observation
32774,2143,to,I-Observation
32775,2143,give,I-Observation
32776,2143,informed,I-Observation
32777,2143,consent,I-Observation
32778,2143,by,O
32779,2143,patient,O
32780,2143,or,O
32781,2143,healthcare,O
32782,2143,proxy,O
32783,2144,Contraindication,B-Condition
32784,2144,to,O
32785,2144,enoxaparin,B-Drug
32786,2145,Contraindication,B-Condition
32787,2145,to,O
32788,2145,aspirin,B-Drug
32789,2146,Epidural,B-Condition
32790,2146,or,I-Condition
32791,2146,subdural,I-Condition
32792,2146,hematoma,I-Condition
32793,2147,Presence,B-Condition
32794,2147,",",I-Condition
32795,2147,or,I-Condition
32796,2147,removal,I-Condition
32797,2147,within,I-Condition
32798,2147,the,I-Condition
32799,2147,last,I-Condition
32800,2147,12,I-Condition
32801,2147,hours,I-Condition
32802,2147,",",I-Condition
32803,2147,of,I-Condition
32804,2147,an,I-Condition
32805,2147,epidural,I-Condition
32806,2147,or,I-Condition
32807,2147,spinal,I-Condition
32808,2147,catheter,I-Condition
32809,2147,",",O
32810,2147,or,O
32811,2147,recent,O
32812,2147,(,O
32813,2147,within,O
32814,2147,the,O
32815,2147,last,O
32816,2147,12,O
32817,2147,hours,O
32818,2147,),O
32819,2147,epidural,B-Procedure
32820,2147,or,I-Procedure
32821,2147,spinal,I-Procedure
32822,2147,anesthesia,I-Procedure
32823,2147,/,O
32824,2147,procedures,O
32825,2148,Age,B-Person
32826,2148,18,O
32827,2148,years,O
32828,2148,or,O
32829,2148,older,O
32830,2149,Blunt,B-Condition
32831,2149,or,I-Condition
32832,2149,penetrating,I-Condition
32833,2149,trauma,I-Condition
32834,2150,Requires,O
32835,2150,VTE,B-Condition
32836,2150,thromboprophylaxis,B-Procedure
32837,2151,High,B-Mood
32838,2151,-,I-Mood
32839,2151,risk,I-Mood
32840,2151,for,O
32841,2151,VTE,B-Condition
32842,2152,Patients,O
32843,2152,with,O
32844,2152,a,O
32845,2152,history,O
32846,2152,of,O
32847,2152,allergy,B-Condition
32848,2152,or,O
32849,2152,hypersensitivity,B-Condition
32850,2152,to,O
32851,2152,tramadol,B-Drug
32852,2152,.,O
32853,2153,History,O
32854,2153,of,O
32855,2153,epilepsy,B-Condition
32856,2153,or,O
32857,2153,convulsions,B-Condition
32858,2153,due,O
32859,2153,to,O
32860,2153,any,O
32861,2153,reason,O
32862,2153,.,O
32863,2154,Chronic,O
32864,2154,usage,O
32865,2154,of,O
32866,2154,analgesic,B-Drug
32867,2154,drugs,I-Drug
32868,2154,.,O
32869,2155,Patients,O
32870,2155,using,O
32871,2155,monoamine,B-Drug
32872,2155,oxidase,I-Drug
32873,2155,inhibitors,I-Drug
32874,2155,.,O
32875,2156,Patients,O
32876,2156,with,O
32877,2156,clinical,O
32878,2156,signs,O
32879,2156,of,O
32880,2156,raised,O
32881,2156,ICP,O
32882,2156,.,O
32883,2157,Obesity,B-Condition
32884,2157,(,O
32885,2157,women,B-Person
32886,2157,with,O
32887,2157,a,O
32888,2157,body,O
32889,2157,mass,O
32890,2157,index,O
32891,2157,>,O
32892,2157,35,O
32893,2157,kg,O
32894,2157,/,O
32895,2157,m2,O
32896,2157,or,O
32897,2157,men,B-Person
32898,2157,with,O
32899,2157,a,O
32900,2157,body,O
32901,2157,mass,O
32902,2157,index,O
32903,2157,>,O
32904,2157,42,O
32905,2157,kg,O
32906,2157,/,O
32907,2157,m2,O
32908,2157,),O
32909,2158,Language,O
32910,2158,barrier,O
32911,2158,.,O
32912,2159,Patients,O
32913,2159,taking,O
32914,2159,B,B-Drug
32915,2159,-,I-Drug
32916,2159,blockers,I-Drug
32917,2159,or,O
32918,2159,Ca,B-Drug
32919,2159,channel,I-Drug
32920,2159,blockers,I-Drug
32921,2159,.,O
32922,2160,Patients,O
32923,2160,above,O
32924,2160,65,O
32925,2160,years,O
32926,2160,of,O
32927,2160,age,B-Person
32928,2160,(,O
32929,2160,Physiology,O
32930,2160,difference,O
32931,2160,),O
32932,2161,Patients,O
32933,2161,with,O
32934,2161,craniotomy,B-Procedure
32935,2161,for,O
32936,2161,supratentorial,B-Condition
32937,2161,tumors,I-Condition
32938,2161,under,O
32939,2161,general,B-Procedure
32940,2161,anesthesia,I-Procedure
32941,2162,American,O
32942,2162,Society,O
32943,2162,of,O
32944,2162,Anaesthesiologists,O
32945,2162,(,O
32946,2162,ASA,O
32947,2162,),O
32948,2162,2,O
32949,2162,and,O
32950,2162,stable,O
32951,2162,ASA,O
32952,2162,3,O
32953,2162,patients,O
32954,2163,Elective,B-Procedure
32955,2163,surgery,I-Procedure
32956,2164,Patients,O
32957,2164,with,O
32958,2164,Glasgow,O
32959,2164,Coma,O
32960,2164,Scale,O
32961,2164,(,O
32962,2164,GCS,O
32963,2164,),O
32964,2164,15/15,O
32965,2165,HbA1c,O
32966,2165,greater,O
32967,2165,than,O
32968,2165,75,O
32969,2165,mmol,O
32970,2165,/,O
32971,2165,mol,O
32972,2165,(,O
32973,2165,9.0,O
32974,2165,%,O
32975,2165,),O
32976,2166,Child,O
32977,2166,unwilling,O
32978,2166,to,O
32979,2166,agree,O
32980,2166,to,O
32981,2166,second,O
32982,2166,insulin,O
32983,2166,injection,O
32984,2166,at,O
32985,2166,a,O
32986,2166,meal,O
32987,2166,-,O
32988,2166,time,O
32989,2167,Untreated,O
32990,2167,coeliac,B-Condition
32991,2167,disease,I-Condition
32992,2167,or,O
32993,2167,other,O
32994,2167,concomitant,O
32995,2167,condition,O
32996,2167,likely,O
32997,2167,to,O
32998,2167,affect,O
32999,2167,BG,O
33000,2167,control,O
33001,2168,Food,B-Condition
33002,2168,allergies,I-Condition
33003,2168,(,O
33004,2168,other,O
33005,2168,than,O
33006,2168,controlled,O
33007,2168,Coeliac,B-Condition
33008,2168,Disease,I-Condition
33009,2168,),O
33010,2169,Vegetarians,B-Person
33011,2169,",",O
33012,2169,vegans,O
33013,2169,or,O
33014,2169,patients,O
33015,2169,with,O
33016,2169,religious,O
33017,2169,dietary,O
33018,2169,restrictions,O
33019,2169,(,O
33020,2169,as,O
33021,2169,the,O
33022,2169,standard,O
33023,2169,meal,O
33024,2169,contains,O
33025,2169,meat,O
33026,2169,),O
33027,2170,Participant,O
33028,2170,taking,O
33029,2170,any,O
33030,2170,glucose,B-Procedure
33031,2170,-,I-Procedure
33032,2170,containing,I-Procedure
33033,2170,medication,I-Procedure
33034,2170,concurrently,O
33035,2171,Diagnosis,O
33036,2171,of,O
33037,2171,Type,B-Condition
33038,2171,1,I-Condition
33039,2171,diabetes,I-Condition
33040,2171,(,O
33041,2171,for,O
33042,2171,at,O
33043,2171,least,O
33044,2171,a,O
33045,2171,year,O
33046,2171,),O
33047,2172,On,O
33048,2172,multiple,O
33049,2172,daily,O
33050,2172,insulin,B-Drug
33051,2172,injections,O
33052,2172,",",O
33053,2172,including,O
33054,2172,basal,O
33055,2172,long,O
33056,2172,-,O
33057,2172,acting,O
33058,2172,insulin,B-Drug
33059,2172,and,O
33060,2172,rapid,O
33061,2172,-,O
33062,2172,acting,O
33063,2172,insulin,B-Drug
33064,2172,before,O
33065,2172,each,O
33066,2172,meal,O
33067,2172,.,O
33068,2173,HbA1c,O
33069,2173,<,O
33070,2173,75,O
33071,2173,mmol,O
33072,2173,/,O
33073,2173,mol,O
33074,2173,(,O
33075,2173,9.0,O
33076,2173,%,O
33077,2173,),O
33078,2174,Participant,O
33079,2174,and/or,O
33080,2174,parent,O
33081,2174,/,O
33082,2174,legal,O
33083,2174,guardian,O
33084,2174,willing,O
33085,2174,and,O
33086,2174,able,O
33087,2174,to,O
33088,2174,give,O
33089,2174,informed,O
33090,2174,consent,O
33091,2174,for,O
33092,2174,participation,O
33093,2174,in,O
33094,2174,the,O
33095,2174,study,O
33096,2174,.,O
33097,2175,Family,O
33098,2175,have,O
33099,2175,a,O
33100,2175,freezer,O
33101,2175,in,O
33102,2175,which,O
33103,2175,to,O
33104,2175,safely,O
33105,2175,store,O
33106,2175,the,O
33107,2175,test,O
33108,2175,meals,O
33109,2175,.,O
33110,2176,In,O
33111,2176,the,O
33112,2176,Investigator,O
33113,2176,'s,O
33114,2176,opinion,O
33115,2176,",",O
33116,2176,is,O
33117,2176,able,O
33118,2176,and,O
33119,2176,willing,O
33120,2176,to,O
33121,2176,comply,O
33122,2176,with,O
33123,2176,all,O
33124,2176,trial,O
33125,2176,requirements,O
33126,2176,.,O
33127,2177,Subject,O
33128,2177,has,O
33129,2177,indeterminate,B-Observation
33130,2177,",",O
33131,2177,ulcerative,B-Observation
33132,2177,",",O
33133,2177,antibiotic,B-Observation
33134,2177,-,I-Observation
33135,2177,associated,I-Observation
33136,2177,colitis,B-Condition
33137,2177,.,O
33138,2178,Subject,O
33139,2178,has,O
33140,2178,stool,O
33141,2178,positive,O
33142,2178,for,O
33143,2178,ova,O
33144,2178,and,O
33145,2178,parasite,O
33146,2178,and,O
33147,2178,for,O
33148,2178,Clostridium,O
33149,2178,difficule,O
33150,2178,toxins,O
33151,2178,within,O
33152,2178,3,O
33153,2178,months,O
33154,2178,prior,O
33155,2178,to,O
33156,2178,enrollment,O
33157,2178,.,O
33158,2179,Subject,O
33159,2179,with,O
33160,2179,other,O
33161,2179,known,O
33162,2179,infectious,O
33163,2179,cause,O
33164,2179,of,O
33165,2179,abdominal,O
33166,2179,symptoms,O
33167,2179,.,O
33168,2180,Subject,O
33169,2180,with,O
33170,2180,clinical,O
33171,2180,evidence,O
33172,2180,of,O
33173,2180,renal,B-Condition
33174,2180,disease,I-Condition
33175,2180,with,O
33176,2180,the,O
33177,2180,past,O
33178,2180,6,O
33179,2180,months,O
33180,2180,",",O
33181,2180,defined,O
33182,2180,as,O
33183,2180,estimated,O
33184,2180,glomerular,O
33185,2180,filtration,O
33186,2180,rate,O
33187,2180,(,O
33188,2180,GFR,O
33189,2180,),O
33190,2180,outside,O
33191,2180,the,O
33192,2180,normal,O
33193,2180,reference,O
33194,2180,range,O
33195,2180,.,O
33196,2181,Subject,O
33197,2181,with,O
33198,2181,known,O
33199,2181,history,B-Observation
33200,2181,of,O
33201,2181,intestinal,B-Condition
33202,2181,obstruction,I-Condition
33203,2181,or,O
33204,2181,current,O
33205,2181,obstructive,B-Condition
33206,2181,symptoms,I-Condition
33207,2181,",",O
33208,2181,such,O
33209,2181,as,O
33210,2181,severe,B-Condition
33211,2181,abdominal,I-Condition
33212,2181,pain,I-Condition
33213,2181,with,O
33214,2181,accompanying,O
33215,2181,nausea,B-Condition
33216,2181,or,O
33217,2181,vomiting,B-Condition
33218,2181,",",O
33219,2181,based,O
33220,2181,on,O
33221,2181,investigator,O
33222,2181,judgment,O
33223,2181,.,O
33224,2182,Subject,O
33225,2182,with,O
33226,2182,a,O
33227,2182,diagnosis,O
33228,2182,of,O
33229,2182,gastroparesis,B-Condition
33230,2182,or,O
33231,2182,small,B-Condition
33232,2182,bowel,I-Condition
33233,2182,or,O
33234,2182,large,B-Condition
33235,2182,bowel,I-Condition
33236,2182,dysmotility,I-Condition
33237,2182,.,O
33238,2183,Subjects,O
33239,2183,with,O
33240,2183,a,O
33241,2183,history,B-Observation
33242,2183,of,O
33243,2183,small,B-Condition
33244,2183,bowel,I-Condition
33245,2183,or,I-Condition
33246,2183,colonic,I-Condition
33247,2183,resection,I-Condition
33248,2183,.,O
33249,2184,Subject,O
33250,2184,with,O
33251,2184,any,O
33252,2184,current,O
33253,2184,condition,O
33254,2184,believed,O
33255,2184,to,O
33256,2184,have,O
33257,2184,an,O
33258,2184,increased,O
33259,2184,risk,O
33260,2184,of,O
33261,2184,capsule,O
33262,2184,retention,O
33263,2184,such,O
33264,2184,as,O
33265,2184,suspected,O
33266,2184,or,O
33267,2184,known,O
33268,2184,bowel,O
33269,2184,obstruction,O
33270,2184,",",O
33271,2184,stricture,O
33272,2184,",",O
33273,2184,or,O
33274,2184,fistula,O
33275,2184,.,O
33276,2185,Subject,O
33277,2185,has,O
33278,2185,used,O
33279,2185,non,B-Drug
33280,2185,-,I-Drug
33281,2185,steroidal,I-Drug
33282,2185,anti,I-Drug
33283,2185,-,I-Drug
33284,2185,inflammatory,I-Drug
33285,2185,drugs,I-Drug
33286,2185,including,O
33287,2185,aspirin,B-Drug
33288,2185,",",O
33289,2185,two,O
33290,2185,times,O
33291,2185,per,O
33292,2185,week,O
33293,2185,",",O
33294,2185,during,O
33295,2185,the,O
33296,2185,4,O
33297,2185,weeks,O
33298,2185,preceding,O
33299,2185,enrollment,O
33300,2185,.,O
33301,2185,Low,O
33302,2185,dose,O
33303,2185,aspirin,B-Drug
33304,2185,regimens,O
33305,2185,(,O
33306,2185,<,O
33307,2185,100,O
33308,2185,mg,O
33309,2185,daily,O
33310,2185,),O
33311,2185,are,O
33312,2185,acceptable,O
33313,2185,and,O
33314,2185,not,O
33315,2185,exclusionary,O
33316,2185,.,O
33317,2186,Subject,O
33318,2186,suffers,O
33319,2186,from,O
33320,2186,any,O
33321,2186,condition,B-Condition
33322,2186,",",O
33323,2186,such,O
33324,2186,as,O
33325,2186,swallowing,B-Condition
33326,2186,problems,I-Condition
33327,2186,",",O
33328,2186,that,O
33329,2186,precludes,O
33330,2186,compliance,O
33331,2186,with,O
33332,2186,study,O
33333,2186,and/or,O
33334,2186,device,O
33335,2186,instructions,O
33336,2186,.,O
33337,2187,Subject,O
33338,2187,with,O
33339,2187,cardiac,O
33340,2187,pacemaker,O
33341,2187,or,O
33342,2187,other,O
33343,2187,implanted,O
33344,2187,electromedical,O
33345,2187,device,O
33346,2187,.,O
33347,2188,Subject,O
33348,2188,has,O
33349,2188,an,O
33350,2188,allergy,B-Condition
33351,2188,or,O
33352,2188,other,O
33353,2188,known,O
33354,2188,contraindication,B-Condition
33355,2188,to,O
33356,2188,the,O
33357,2188,medications,B-Drug
33358,2188,used,I-Drug
33359,2188,in,I-Drug
33360,2188,the,I-Drug
33361,2188,study,I-Drug
33362,2188,.,O
33363,2189,Subject,O
33364,2189,is,O
33365,2189,pregnant,B-Condition
33366,2189,(,O
33367,2189,documented,O
33368,2189,by,O
33369,2189,a,O
33370,2189,positive,O
33371,2189,pregnancy,O
33372,2189,test,O
33373,2189,),O
33374,2189,or,O
33375,2189,is,O
33376,2189,actively,O
33377,2189,breast,B-Observation
33378,2189,-,I-Observation
33379,2189,feeding,I-Observation
33380,2189,.,O
33381,2190,Subject,O
33382,2190,is,O
33383,2190,considered,O
33384,2190,to,O
33385,2190,be,O
33386,2190,a,O
33387,2190,part,B-Person
33388,2190,of,I-Person
33389,2190,a,I-Person
33390,2190,vulnerable,I-Person
33391,2190,population,I-Person
33392,2190,(,O
33393,2190,eg,O
33394,2190,.,O
33395,2190,prisoners,B-Person
33396,2190,or,O
33397,2190,those,O
33398,2190,without,B-Condition
33399,2190,sufficient,I-Condition
33400,2190,mental,I-Condition
33401,2190,capacity,I-Condition
33402,2190,),O
33403,2190,.,O
33404,2191,Subject,O
33405,2191,has,O
33406,2191,a,O
33407,2191,known,O
33408,2191,contraindication,B-Condition
33409,2191,to,O
33410,2191,MRE,B-Procedure
33411,2191,or,O
33412,2191,IC,B-Procedure
33413,2191,.,O
33414,2192,Subject,O
33415,2192,has,O
33416,2192,participated,O
33417,2192,in,O
33418,2192,a,O
33419,2192,drug,O
33420,2192,or,O
33421,2192,device,O
33422,2192,research,O
33423,2192,study,O
33424,2192,within,O
33425,2192,30,O
33426,2192,days,O
33427,2192,of,O
33428,2192,enrollment,O
33429,2192,that,O
33430,2192,may,O
33431,2192,interfere,O
33432,2192,with,O
33433,2192,the,O
33434,2192,subject,O
33435,2192,'s,O
33436,2192,safety,O
33437,2192,or,O
33438,2192,ability,O
33439,2192,to,O
33440,2192,participate,O
33441,2192,in,O
33442,2192,the,O
33443,2192,study,O
33444,2192,.,O
33445,2193,Subject,O
33446,2193,has,O
33447,2193,any,O
33448,2193,medical,O
33449,2193,condition,O
33450,2193,that,O
33451,2193,would,O
33452,2193,make,O
33453,2193,it,O
33454,2193,unsafe,O
33455,2193,for,O
33456,2193,them,O
33457,2193,to,O
33458,2193,participate,O
33459,2193,",",O
33460,2193,per,O
33461,2193,Investigator,O
33462,2193,'s,O
33463,2193,descretion,O
33464,2194,Subject,O
33465,2194,has,O
33466,2194,provided,O
33467,2194,informed,O
33468,2194,consent,O
33469,2194,.,O
33470,2195,Subject,O
33471,2195,is,O
33472,2195,≥,O
33473,2195,18,O
33474,2195,years,O
33475,2195,of,O
33476,2195,age,B-Person
33477,2196,Subject,O
33478,2196,is,O
33479,2196,willing,O
33480,2196,and,O
33481,2196,able,O
33482,2196,to,O
33483,2196,comply,O
33484,2196,with,O
33485,2196,all,O
33486,2196,aspects,O
33487,2196,of,O
33488,2196,treatment,O
33489,2196,and,O
33490,2196,evaluation,O
33491,2196,schedule,O
33492,2196,.,O
33493,2197,Subject,O
33494,2197,has,O
33495,2197,known,O
33496,2197,CD,O
33497,2197,and,O
33498,2197,a,O
33499,2197,recent,O
33500,2197,history,O
33501,2197,(,O
33502,2197,within,O
33503,2197,last,O
33504,2197,2,O
33505,2197,years,O
33506,2197,),O
33507,2197,of,O
33508,2197,mucosal,B-Condition
33509,2197,disease,I-Condition
33510,2197,(,O
33511,2197,diagnosis,O
33512,2197,based,O
33513,2197,on,O
33514,2197,radiologic,B-Observation
33515,2197,",",I-Observation
33516,2197,endoscopic,I-Observation
33517,2197,",",I-Observation
33518,2197,or,I-Observation
33519,2197,histological,I-Observation
33520,2197,evidence,I-Observation
33521,2197,),O
33522,2197,.,O
33523,2198,allergy,B-Condition
33524,2198,to,O
33525,2198,Doxycycline,B-Drug
33526,2198,or,O
33527,2198,Methylprednisolone,B-Drug
33528,2198,",",O
33529,2199,pregnancy,B-Condition
33530,2199,",",O
33531,2200,diagnosis,B-Condition
33532,2200,",",O
33533,2201,Inflammatory,B-Condition
33534,2201,arthritis,I-Condition
33535,2201,or,O
33536,2201,diabetes,B-Condition
33537,2201,",",O
33538,2202,secondary,O
33539,2202,adhesive,B-Condition
33540,2202,capsulitis,I-Condition
33541,2202,(,O
33542,2202,history,B-Observation
33543,2202,of,O
33544,2202,significant,O
33545,2202,trauma,B-Condition
33546,2202,",",O
33547,2202,rotator,B-Condition
33548,2202,cuff,I-Condition
33549,2202,tear,I-Condition
33550,2202,injury,I-Condition
33551,2202,",",O
33552,2202,stroke,B-Condition
33553,2202,),O
33554,2203,evidence,B-Mood
33555,2203,of,I-Mood
33556,2203,arthritis,B-Condition
33557,2203,on,O
33558,2203,x,B-Procedure
33559,2203,-,I-Procedure
33560,2203,ray,I-Procedure
33561,2203,",",O
33562,2204,current,O
33563,2204,infectious,B-Condition
33564,2204,disease,I-Condition
33565,2204,",",O
33566,2204,and,O
33567,2205,any,O
33568,2205,previous,O
33569,2205,treatment,B-Procedure
33570,2205,for,O
33571,2205,the,O
33572,2205,for,O
33573,2205,adhesive,B-Condition
33574,2205,capsulitis,I-Condition
33575,2205,of,O
33576,2205,the,O
33577,2205,affected,O
33578,2205,shoulder,O
33579,2205,.,O
33580,2206,18,O
33581,2206,years,O
33582,2206,of,O
33583,2206,age,B-Person
33584,2206,and,O
33585,2206,older,O
33586,2206,",",O
33587,2207,diagnosis,O
33588,2207,of,O
33589,2207,stage,O
33590,2207,II,O
33591,2207,adhesive,B-Condition
33592,2207,capsulitis,I-Condition
33593,2207,as,O
33594,2207,determined,O
33595,2207,by,O
33596,2207,clinical,B-Procedure
33597,2207,examination,I-Procedure
33598,2207,of,O
33599,2207,the,O
33600,2207,treating,O
33601,2207,physician,O
33602,2207,",",O
33603,2207,and,O
33604,2208,absence,O
33605,2208,of,O
33606,2208,abnormal,B-Condition
33607,2208,findings,I-Condition
33608,2208,on,O
33609,2208,X,B-Procedure
33610,2208,-,I-Procedure
33611,2208,ray,I-Procedure
33612,2208,.,O
33613,2209,Patient,O
33614,2209,refusal,O
33615,2209,.,O
33616,2210,Emergency,B-Procedure
33617,2210,surgeries,I-Procedure
33618,2211,Redo,B-Procedure
33619,2211,surgeries,I-Procedure
33620,2212,Pregnancy,B-Condition
33621,2213,Vasculitis,B-Condition
33622,2214,Inflammation,B-Condition
33623,2214,or,O
33624,2214,infection,B-Condition
33625,2214,at,O
33626,2214,the,O
33627,2214,study,O
33628,2214,site,O
33629,2215,History,O
33630,2215,of,O
33631,2215,allergic,B-Condition
33632,2215,reaction,O
33633,2215,to,O
33634,2215,study,O
33635,2215,medications,O
33636,2216,Adult,O
33637,2216,patients,O
33638,2216,aged,B-Person
33639,2216,(,O
33640,2216,>,O
33641,2216,18,O
33642,2216,),O
33643,2216,",",O
33644,2216,males,B-Person
33645,2216,and,O
33646,2216,females,B-Person
33647,2216,",",O
33648,2216,undergoing,O
33649,2216,elective,O
33650,2216,coronary,O
33651,2216,artery,O
33652,2216,bypass,O
33653,2216,graft,O
33654,2216,(,O
33655,2216,CABG,B-Procedure
33656,2216,),O
33657,2216,surgery,O
33658,2216,with,O
33659,2216,cardiopulmonary,B-Procedure
33660,2216,bypass,I-Procedure
33661,2216,(,O
33662,2216,CPB,B-Procedure
33663,2216,),O
33664,2216,.,O
33665,2217,1,O
33666,2217,.,O
33667,2217,History,O
33668,2217,or,O
33669,2217,presence,O
33670,2217,of,O
33671,2217,allergy,B-Condition
33672,2217,to,O
33673,2217,the,O
33674,2217,study,B-Drug
33675,2217,drugs,I-Drug
33676,2217,or,O
33677,2217,their,O
33678,2217,components,O
33679,2217,or,O
33680,2217,drugs,O
33681,2217,of,O
33682,2217,their,O
33683,2217,class,O
33684,2217,",",O
33685,2217,or,O
33686,2217,a,O
33687,2217,history,O
33688,2217,of,O
33689,2217,drug,O
33690,2217,or,O
33691,2217,other,O
33692,2217,allergy,O
33693,2217,that,O
33694,2217,",",O
33695,2217,in,O
33696,2217,the,O
33697,2217,opinion,O
33698,2217,of,O
33699,2217,the,O
33700,2217,physician,O
33701,2217,responsible,O
33702,2217,",",O
33703,2217,contraindicates,O
33704,2217,their,O
33705,2217,participation,O
33706,2218,2,O
33707,2218,.,O
33708,2218,Any,O
33709,2218,finding,O
33710,2218,of,O
33711,2218,the,O
33712,2218,medical,O
33713,2218,examination,O
33714,2218,(,O
33715,2218,including,O
33716,2218,blood,O
33717,2218,pressure,O
33718,2218,",",O
33719,2218,pulse,O
33720,2218,rate,O
33721,2218,and,O
33722,2218,electrocardiogram,O
33723,2218,),O
33724,2218,deviating,O
33725,2218,from,O
33726,2218,normal,O
33727,2218,and,O
33728,2218,of,O
33729,2218,clinical,O
33730,2218,relevance,O
33731,2219,3,O
33732,2219,.,O
33733,2219,History,O
33734,2219,or,O
33735,2219,diagnosis,O
33736,2219,of,O
33737,2219,any,O
33738,2219,significant,O
33739,2219,medical,B-Condition
33740,2219,conditions,I-Condition
33741,2219,:,O
33742,2219,Including,O
33743,2219,but,O
33744,2219,not,O
33745,2219,limited,O
33746,2219,to,O
33747,2219,gastrointestinal,B-Condition
33748,2219,",",I-Condition
33749,2219,hepatic,I-Condition
33750,2219,",",I-Condition
33751,2219,renal,I-Condition
33752,2219,",",I-Condition
33753,2219,respiratory,I-Condition
33754,2219,",",I-Condition
33755,2219,cardiovascular,I-Condition
33756,2219,",",I-Condition
33757,2219,metabolic,I-Condition
33758,2219,",",I-Condition
33759,2219,immunologic,I-Condition
33760,2219,",",I-Condition
33761,2219,hematological,I-Condition
33762,2219,",",I-Condition
33763,2219,psychiatric,I-Condition
33764,2219,",",I-Condition
33765,2219,neurological,I-Condition
33766,2219,",",I-Condition
33767,2219,oncological,I-Condition
33768,2219,or,I-Condition
33769,2219,hormonal,I-Condition
33770,2219,disorders,I-Condition
33771,2220,4,O
33772,2220,.,O
33773,2220,Known,O
33774,2220,elevated,O
33775,2220,liver,O
33776,2220,enzymes,O
33777,2220,in,O
33778,2220,past,O
33779,2220,clinical,O
33780,2220,trials,O
33781,2220,with,O
33782,2220,any,O
33783,2220,compound,O
33784,2220,(,O
33785,2220,experimental,O
33786,2220,or,O
33787,2220,marketed,O
33788,2220,),O
33789,2221,5,O
33790,2221,.,O
33791,2221,Clinically,O
33792,2221,relevant,O
33793,2221,laboratory,B-Condition
33794,2221,abnormalities,I-Condition
33795,2221,(,O
33796,2221,e.g.,O
33797,2221,Hgb<11g,O
33798,2221,/,O
33799,2221,dL,O
33800,2221,",",O
33801,2221,Hct<30g,O
33802,2221,/,O
33803,2221,dL,O
33804,2221,",",O
33805,2221,total,O
33806,2221,cholesterol,O
33807,2221,>,O
33808,2221,240mg,O
33809,2221,/,O
33810,2221,dL,O
33811,2221,",",O
33812,2221,triglycerides,O
33813,2221,>,O
33814,2221,500mg,O
33815,2221,/,O
33816,2221,dL,O
33817,2221,",",O
33818,2221,fasting,O
33819,2221,glucose,O
33820,2221,>,O
33821,2221,130mg,O
33822,2221,/,O
33823,2221,dL,O
33824,2221,",",O
33825,2221,liver,O
33826,2221,function,O
33827,2221,tests,O
33828,2221,>,O
33829,2221,2.5x,O
33830,2221,upper,O
33831,2221,limit,O
33832,2221,of,O
33833,2221,normal,O
33834,2221,",",O
33835,2221,baseline,O
33836,2221,international,O
33837,2221,normalized,O
33838,2221,ratio,O
33839,2221,>,O
33840,2221,1.2,O
33841,2221,),O
33842,2222,6,O
33843,2222,.,O
33844,2222,History,B-Observation
33845,2222,of,O
33846,2222,evidence,O
33847,2222,of,O
33848,2222,clinically,O
33849,2222,significant,O
33850,2222,hepatic,B-Condition
33851,2222,",",I-Condition
33852,2222,cardiac,I-Condition
33853,2222,",",I-Condition
33854,2222,pulmonary,I-Condition
33855,2222,",",I-Condition
33856,2222,endocrine,I-Condition
33857,2222,",",I-Condition
33858,2222,immunological,I-Condition
33859,2222,",",I-Condition
33860,2222,gastrointestinal,I-Condition
33861,2222,",",I-Condition
33862,2222,hematological,I-Condition
33863,2222,",",I-Condition
33864,2222,vascular,I-Condition
33865,2222,or,I-Condition
33866,2222,collagen,I-Condition
33867,2222,disease,I-Condition
33868,2223,7,O
33869,2223,.,O
33870,2223,History,O
33871,2223,of,O
33872,2223,alcohol,B-Condition
33873,2223,abuse,I-Condition
33874,2223,or,O
33875,2223,use,B-Condition
33876,2223,of,I-Condition
33877,2223,any,I-Condition
33878,2223,illicit,I-Condition
33879,2223,drugs,I-Condition
33880,2224,8,O
33881,2224,.,O
33882,2224,Unable,O
33883,2224,to,O
33884,2224,abstain,O
33885,2224,from,O
33886,2224,more,O
33887,2224,than,O
33888,2224,one,O
33889,2224,beer,O
33890,2224,or,O
33891,2224,alcohol,O
33892,2224,equivalent,O
33893,2224,per,O
33894,2224,day,O
33895,2224,for,O
33896,2224,the,O
33897,2224,duration,O
33898,2224,of,O
33899,2224,the,O
33900,2224,study,O
33901,2225,9,O
33902,2225,.,O
33903,2225,Use,O
33904,2225,of,O
33905,2225,tobacco,B-Drug
33906,2225,products,I-Drug
33907,2225,and/or,O
33908,2225,history,B-Observation
33909,2225,of,O
33910,2225,smoking,B-Observation
33911,2225,within,O
33912,2225,the,O
33913,2225,past,O
33914,2225,2,O
33915,2225,months,O
33916,2226,10,O
33917,2226,.,O
33918,2226,Pregnant,B-Condition
33919,2226,or,O
33920,2226,breast,B-Observation
33921,2226,feeding,I-Observation
33922,2227,11,O
33923,2227,.,O
33924,2227,Sexually,B-Condition
33925,2227,active,I-Condition
33926,2227,women,B-Person
33927,2227,of,O
33928,2227,childbearing,O
33929,2227,age,B-Person
33930,2227,who,O
33931,2227,do,O
33932,2227,not,O
33933,2227,use,O
33934,2227,an,O
33935,2227,acceptable,O
33936,2227,barrier,O
33937,2227,method,O
33938,2227,of,O
33939,2227,birth,O
33940,2227,control,O
33941,2228,12,O
33942,2228,.,O
33943,2228,Hypersensitivity,B-Condition
33944,2228,to,O
33945,2228,caffeine,B-Drug
33946,2228,",",O
33947,2228,warfarin,B-Drug
33948,2228,",",O
33949,2228,vitamin,B-Drug
33950,2228,K,I-Drug
33951,2228,",",O
33952,2228,omeprazole,B-Drug
33953,2228,",",O
33954,2228,dextromethorphan,B-Drug
33955,2228,",",O
33956,2228,midazolam,B-Drug
33957,2228,",",O
33958,2228,tipranavir,B-Drug
33959,2228,",",O
33960,2228,ritonavir,B-Drug
33961,2228,or,O
33962,2228,their,O
33963,2228,excipients,O
33964,2229,13,O
33965,2229,.,O
33966,2229,Concomitant,O
33967,2229,treatment,O
33968,2229,with,O
33969,2229,other,O
33970,2229,experimental,B-Drug
33971,2229,compounds,I-Drug
33972,2230,14,O
33973,2230,.,O
33974,2230,Concomitant,O
33975,2230,administration,O
33976,2230,of,O
33977,2230,any,O
33978,2230,prescription,O
33979,2230,or,O
33980,2230,over,O
33981,2230,the,O
33982,2230,counter,O
33983,2230,medications,B-Drug
33984,2230,known,I-Drug
33985,2230,to,I-Drug
33986,2230,alter,I-Drug
33987,2230,P450,I-Drug
33988,2230,enzyme,I-Drug
33989,2230,or,I-Drug
33990,2230,P,I-Drug
33991,2230,-,I-Drug
33992,2230,gp,I-Drug
33993,2230,activity,I-Drug
33994,2231,15,O
33995,2231,.,O
33996,2231,Concomitant,O
33997,2231,administration,O
33998,2231,of,O
33999,2231,any,O
34000,2231,prescription,O
34001,2231,or,O
34002,2231,over,O
34003,2231,the,O
34004,2231,counter,O
34005,2231,medications,B-Drug
34006,2231,known,I-Drug
34007,2231,to,I-Drug
34008,2231,be,I-Drug
34009,2231,highly,I-Drug
34010,2231,dependent,I-Drug
34011,2231,on,I-Drug
34012,2231,P450,I-Drug
34013,2231,or,I-Drug
34014,2231,P,I-Drug
34015,2231,-,I-Drug
34016,2231,gp,I-Drug
34017,2231,for,I-Drug
34018,2231,clearance,I-Drug
34019,2231,for,O
34020,2231,which,O
34021,2231,elevated,O
34022,2231,plasma,O
34023,2231,concentrations,O
34024,2231,are,O
34025,2231,known,O
34026,2231,to,O
34027,2231,be,O
34028,2231,associated,O
34029,2231,with,O
34030,2231,serious,O
34031,2231,toxicity,B-Condition
34032,2232,16,O
34033,2232,.,O
34034,2232,Concomitant,O
34035,2232,administration,O
34036,2232,of,O
34037,2232,any,O
34038,2232,food,B-Drug
34039,2232,product,I-Drug
34040,2232,known,I-Drug
34041,2232,to,I-Drug
34042,2232,alter,I-Drug
34043,2232,P450,I-Drug
34044,2232,enzyme,I-Drug
34045,2232,or,I-Drug
34046,2232,P,I-Drug
34047,2232,-,I-Drug
34048,2232,gp,I-Drug
34049,2232,activity,I-Drug
34050,2232,such,O
34051,2232,as,O
34052,2232,grapefruit,B-Drug
34053,2232,juice,I-Drug
34054,2232,",",O
34055,2232,Seville,B-Drug
34056,2232,oranges,I-Drug
34057,2233,17,O
34058,2233,.,O
34059,2233,Concomitant,O
34060,2233,administration,O
34061,2233,of,O
34062,2233,any,O
34063,2233,drug,B-Drug
34064,2233,that,I-Drug
34065,2233,could,I-Drug
34066,2233,affect,I-Drug
34067,2233,bleeding,I-Drug
34068,2233,(,O
34069,2233,e.g.,O
34070,2233,",",O
34071,2233,aspirin,B-Drug
34072,2233,",",O
34073,2233,clopidogrel,B-Drug
34074,2233,",",O
34075,2233,ticlopidine,B-Drug
34076,2233,",",O
34077,2233,warfarin,B-Drug
34078,2233,",",O
34079,2233,heparin,B-Drug
34080,2233,",",O
34081,2233,low,B-Drug
34082,2233,-,I-Drug
34083,2233,molecular,I-Drug
34084,2233,weight,I-Drug
34085,2233,heparin,I-Drug
34086,2233,),O
34087,2234,18,O
34088,2234,.,O
34089,2234,Concomitant,O
34090,2234,administration,O
34091,2234,of,O
34092,2234,oral,B-Drug
34093,2234,contraceptives,I-Drug
34094,2234,(,O
34095,2234,may,O
34096,2234,be,O
34097,2234,included,O
34098,2234,with,O
34099,2234,7,O
34100,2234,-,O
34101,2234,day,O
34102,2234,washout,O
34103,2234,period,O
34104,2234,),O
34105,2235,19,O
34106,2235,.,O
34107,2235,Concomitant,O
34108,2235,administration,O
34109,2235,of,O
34110,2235,any,O
34111,2235,herbal,B-Drug
34112,2235,medications,I-Drug
34113,2236,20,O
34114,2236,.,O
34115,2236,Inadequate,O
34116,2236,venous,O
34117,2236,access,O
34118,2237,21,O
34119,2237,.,O
34120,2237,Renal,B-Condition
34121,2237,or,I-Condition
34122,2237,hepatic,I-Condition
34123,2237,insufficiency,I-Condition
34124,2238,22,O
34125,2238,.,O
34126,2238,Clinically,B-Condition
34127,2238,unacceptable,I-Condition
34128,2238,result,I-Condition
34129,2238,at,O
34130,2238,the,O
34131,2238,screening,O
34132,2238,physical,B-Procedure
34133,2238,examination,I-Procedure
34134,2239,23,O
34135,2239,.,O
34136,2239,Use,O
34137,2239,of,O
34138,2239,investigational,B-Drug
34139,2239,medications,I-Drug
34140,2239,within,O
34141,2239,30,O
34142,2239,days,O
34143,2239,before,O
34144,2239,study,O
34145,2239,entry,O
34146,2240,24,O
34147,2240,.,O
34148,2240,HIV,O
34149,2240,-,O
34150,2240,positive,O
34151,2241,25,O
34152,2241,.,O
34153,2241,Body,O
34154,2241,Mass,O
34155,2241,Index,O
34156,2241,(,O
34157,2241,BMI,O
34158,2241,),O
34159,2241,>,O
34160,2241,30,O
34161,2241,kg,O
34162,2241,/,O
34163,2241,m²,O
34164,2242,1,O
34165,2242,.,O
34166,2242,Signed,O
34167,2242,informed,O
34168,2242,consent,O
34169,2243,2,O
34170,2243,.,O
34171,2243,Healthy,B-Condition
34172,2243,subjects,O
34173,2243,aged,B-Person
34174,2243,between,O
34175,2243,18,O
34176,2243,years,O
34177,2243,and,O
34178,2243,45,O
34179,2243,years,O
34180,2243,inclusive,O
34181,2244,3,O
34182,2244,.,O
34183,2244,Weighing,O
34184,2244,at,O
34185,2244,least,O
34186,2244,50,O
34187,2244,kg,O
34188,2245,4,O
34189,2245,.,O
34190,2245,Volunteers,O
34191,2245,must,O
34192,2245,be,O
34193,2245,hospitalized,O
34194,2245,on,O
34195,2245,Days,O
34196,2245,1,O
34197,2245,-,O
34198,2245,4,O
34199,2245,",",O
34200,2245,7,O
34201,2245,-,O
34202,2245,9,O
34203,2245,",",O
34204,2245,and,O
34205,2245,17,O
34206,2245,-,O
34207,2245,20,O
34208,2245,for,O
34209,2245,pharmacokinetic,O
34210,2245,assessments,O
34211,2245,for,O
34212,2245,each,O
34213,2245,biomarker,O
34214,2245,and,O
34215,2245,TPV,O
34216,2245,/,O
34217,2245,r,O
34218,2245,(,O
34219,2245,Days,O
34220,2245,7,O
34221,2245,-,O
34222,2245,9,O
34223,2245,and,O
34224,2245,17,O
34225,2245,-,O
34226,2245,20,O
34227,2245,),O
34228,2246,5,O
34229,2246,.,O
34230,2246,Volunteers,O
34231,2246,must,O
34232,2246,be,O
34233,2246,willing,O
34234,2246,to,O
34235,2246,complete,O
34236,2246,all,O
34237,2246,study,O
34238,2246,-,O
34239,2246,related,O
34240,2246,activities,O
34241,2247,6,O
34242,2247,.,O
34243,2247,Each,O
34244,2247,volunteer,O
34245,2247,must,O
34246,2247,have,O
34247,2247,a,O
34248,2247,valid,O
34249,2247,social,O
34250,2247,security,O
34251,2247,number,O
34252,2248,7,O
34253,2248,.,O
34254,2248,Each,O
34255,2248,volunteer,O
34256,2248,must,O
34257,2248,have,O
34258,2248,acceptable,O
34259,2248,medical,B-Observation
34260,2248,history,I-Observation
34261,2248,",",O
34262,2248,physical,B-Procedure
34263,2248,examination,I-Procedure
34264,2248,and,O
34265,2248,laboratory,O
34266,2248,test,O
34267,2249,Known,O
34268,2249,pregnancy,B-Condition
34269,2249,or,O
34270,2249,breast,B-Condition
34271,2249,-,I-Condition
34272,2249,feeding,I-Condition
34273,2249,.,O
34274,2250,Medical,B-Condition
34275,2250,illness,I-Condition
34276,2250,unrelated,I-Condition
34277,2250,to,I-Condition
34278,2250,the,I-Condition
34279,2250,tumor,I-Condition
34280,2250,which,O
34281,2250,in,O
34282,2250,the,O
34283,2250,opinion,O
34284,2250,of,O
34285,2250,the,O
34286,2250,attending,O
34287,2250,physician,O
34288,2250,and,O
34289,2250,principal,O
34290,2250,investigator,O
34291,2250,will,O
34292,2250,preclude,O
34293,2250,administration,O
34294,2250,of,O
34295,2250,the,O
34296,2250,agent,O
34297,2250,.,O
34298,2250,This,O
34299,2250,includes,O
34300,2250,patients,O
34301,2250,with,O
34302,2250,uncontrolled,B-Condition
34303,2250,infection,I-Condition
34304,2250,",",O
34305,2250,chronic,B-Condition
34306,2250,renal,I-Condition
34307,2250,insufficiency,I-Condition
34308,2250,",",O
34309,2250,myocardial,B-Condition
34310,2250,infarction,I-Condition
34311,2250,within,O
34312,2250,the,O
34313,2250,past,O
34314,2250,6,O
34315,2250,months,O
34316,2250,",",O
34317,2250,unstable,B-Condition
34318,2250,angina,I-Condition
34319,2250,",",O
34320,2250,cardiac,B-Condition
34321,2250,arrhythmias,I-Condition
34322,2250,other,O
34323,2250,than,O
34324,2250,chronic,B-Condition
34325,2250,atrial,I-Condition
34326,2250,fibrillation,I-Condition
34327,2250,and,O
34328,2250,chronic,B-Condition
34329,2250,active,I-Condition
34330,2250,or,I-Condition
34331,2250,persistent,I-Condition
34332,2250,hepatitis,I-Condition
34333,2250,",",O
34334,2250,or,O
34335,2250,New,O
34336,2250,York,O
34337,2250,Heart,O
34338,2250,Association,O
34339,2250,Classification,O
34340,2250,III,O
34341,2250,or,O
34342,2250,IV,O
34343,2250,heart,B-Condition
34344,2250,disease,I-Condition
34345,2250,.,O
34346,2251,18,O
34347,2251,years,O
34348,2251,of,O
34349,2251,age,B-Person
34350,2251,or,O
34351,2251,older,O
34352,2252,Histologically,B-Procedure
34353,2252,confirmed,O
34354,2252,diagnosis,O
34355,2252,of,O
34356,2252,melanoma,B-Condition
34357,2252,",",O
34358,2252,breast,B-Condition
34359,2252,cancer,I-Condition
34360,2252,or,O
34361,2252,gynecologic,B-Condition
34362,2252,cancer,I-Condition
34363,2252,at,O
34364,2252,MSKCC,O
34365,2253,Have,O
34366,2253,one,O
34367,2253,of,O
34368,2253,the,O
34369,2253,following,O
34370,2253,disease,O
34371,2253,histories,O
34372,2253,:,O
34373,2254,Newly,O
34374,2254,-,O
34375,2254,diagnosed,O
34376,2254,or,O
34377,2254,recurrent,O
34378,2254,(,O
34379,2254,local,O
34380,2254,",",O
34381,2254,regional,O
34382,2254,",",O
34383,2254,metastatic,O
34384,2254,),O
34385,2254,malignant,B-Condition
34386,2254,melanoma,I-Condition
34387,2254,or,O
34388,2254,breast,B-Condition
34389,2254,cancer,I-Condition
34390,2254,patients,O
34391,2254,in,O
34392,2254,whom,O
34393,2254,SLN,O
34394,2254,mapping,O
34395,2254,is,O
34396,2254,indicated,O
34397,2255,Residual,O
34398,2255,clinically,B-Procedure
34399,2255,or,O
34400,2255,radiographically,B-Procedure
34401,2255,evident,O
34402,2255,tumor,B-Condition
34403,2255,",",O
34404,2255,including,O
34405,2255,primary,B-Condition
34406,2255,cutaneous,I-Condition
34407,2255,and,O
34408,2255,mucosal,B-Condition
34409,2255,melanomas,I-Condition
34410,2256,Prior,O
34411,2256,radiation,B-Procedure
34412,2256,therapy,I-Procedure
34413,2256,",",O
34414,2256,chemotherapy,B-Procedure
34415,2256,",",O
34416,2256,or,O
34417,2256,surgery,B-Procedure
34418,2256,in,O
34419,2256,patients,O
34420,2256,requiring,B-Condition
34421,2256,flap,I-Condition
34422,2256,reconstruction,I-Condition
34423,2256,in,O
34424,2256,the,O
34425,2256,head,O
34426,2256,and,O
34427,2256,neck,O
34428,2256,region,O
34429,2256,.,O
34430,2257,Newly,O
34431,2257,diagnosed,O
34432,2257,patients,O
34433,2257,with,O
34434,2257,previous,O
34435,2257,excisional,B-Procedure
34436,2257,biopsy,I-Procedure
34437,2257,.,O
34438,2257,OR,O
34439,2258,Newly,O
34440,2258,-,O
34441,2258,diagnosed,O
34442,2258,gynecologic,B-Condition
34443,2258,cancer,I-Condition
34444,2258,patients,O
34445,2258,in,O
34446,2258,whom,O
34447,2258,SLN,B-Condition
34448,2258,mapping,I-Condition
34449,2258,and,I-Condition
34450,2258,surgical,I-Condition
34451,2258,excision,I-Condition
34452,2258,is,I-Condition
34453,2258,indicated,I-Condition
34454,2258,OR,O
34455,2259,Normal,O
34456,2259,baseline,O
34457,2259,cardiac,O
34458,2259,function,O
34459,2259,based,O
34460,2259,upon,O
34461,2259,pre,B-Procedure
34462,2259,-,I-Procedure
34463,2259,operative,I-Procedure
34464,2259,evaluation,I-Procedure
34465,2260,At,O
34466,2260,the,O
34467,2260,discretion,O
34468,2260,of,O
34469,2260,the,O
34470,2260,operating,O
34471,2260,surgeon,O
34472,2260,",",O
34473,2260,ANC>1000,O
34474,2260,/,O
34475,2260,mcl,O
34476,2260,and,O
34477,2260,"platelets>100,000",O
34478,2260,/,O
34479,2260,mcl,O
34480,2260,.,O
34481,2261,At,O
34482,2261,the,O
34483,2261,discretion,O
34484,2261,of,O
34485,2261,the,O
34486,2261,operating,O
34487,2261,surgeon,O
34488,2261,",",O
34489,2261,Bilirubin,O
34490,2261,level,O
34491,2261,of,O
34492,2261,<,O
34493,2261,2.0,O
34494,2261,mg,O
34495,2261,/,O
34496,2261,dl,O
34497,2261,in,O
34498,2261,the,O
34499,2261,absence,O
34500,2261,of,O
34501,2261,a,O
34502,2261,history,B-Observation
34503,2261,of,O
34504,2261,Gilbert,B-Condition
34505,2261,'s,I-Condition
34506,2261,disease,I-Condition
34507,2261,(,O
34508,2261,or,O
34509,2261,pattern,O
34510,2261,consistent,O
34511,2261,with,O
34512,2261,Gilbert,O
34513,2261,'s,O
34514,2261,),O
34515,2261,.,O
34516,2262,For,O
34517,2262,melanoma,B-Condition
34518,2262,patients,O
34519,2262,",",O
34520,2262,If,O
34521,2262,patients,O
34522,2262,have,O
34523,2262,a,O
34524,2262,history,B-Observation
34525,2262,of,O
34526,2262,malignancy,B-Condition
34527,2262,other,O
34528,2262,than,O
34529,2262,melanoma,B-Condition
34530,2262,",",O
34531,2262,and,O
34532,2262,other,O
34533,2262,skin,B-Condition
34534,2262,cancers,I-Condition
34535,2262,in,O
34536,2262,the,O
34537,2262,past,O
34538,2262,five,O
34539,2262,years,O
34540,2262,",",O
34541,2262,their,O
34542,2262,inclusion,O
34543,2262,is,O
34544,2262,up,O
34545,2262,to,O
34546,2262,the,O
34547,2262,discretion,O
34548,2262,of,O
34549,2262,the,O
34550,2262,physician,O
34551,2262,.,O
34552,2263,All,O
34553,2263,patients,O
34554,2263,of,O
34555,2263,childbearing,O
34556,2263,and,O
34557,2263,child,O
34558,2263,-,O
34559,2263,creating,O
34560,2263,age,O
34561,2263,must,O
34562,2263,be,O
34563,2263,using,O
34564,2263,an,O
34565,2263,acceptable,O
34566,2263,form,O
34567,2263,of,O
34568,2263,birth,O
34569,2263,control,O
34570,2264,Women,B-Person
34571,2264,who,O
34572,2264,are,O
34573,2264,pre,B-Condition
34574,2264,-,I-Condition
34575,2264,menopausal,I-Condition
34576,2264,must,O
34577,2264,have,O
34578,2264,a,O
34579,2264,negative,O
34580,2264,serum,O
34581,2264,pregnancy,O
34582,2264,test,O
34583,2265,1,O
34584,2265,.,O
34585,2265,Prior,O
34586,2265,Therapy,O
34587,2265,Exposure,O
34588,2265,to,O
34589,2265,chemotherapy,B-Procedure
34590,2265,or,O
34591,2265,radiotherapy,B-Procedure
34592,2265,within,O
34593,2265,2,O
34594,2265,weeks,O
34595,2265,prior,O
34596,2265,to,O
34597,2265,entering,O
34598,2265,the,O
34599,2265,study,O
34600,2265,or,O
34601,2265,those,O
34602,2265,who,O
34603,2265,have,O
34604,2265,not,O
34605,2265,recovered,B-Condition
34606,2265,from,O
34607,2265,adverse,B-Condition
34608,2265,events,I-Condition
34609,2265,due,O
34610,2265,to,O
34611,2265,agents,B-Drug
34612,2265,administered,O
34613,2265,more,O
34614,2265,than,O
34615,2265,2,O
34616,2265,weeks,O
34617,2265,earlier,O
34618,2265,.,O
34619,2265,Systemic,B-Drug
34620,2265,steroids,I-Drug
34621,2265,that,O
34622,2265,have,O
34623,2265,not,O
34624,2265,been,O
34625,2265,stabilized,O
34626,2265,(,O
34627,2265,≥,O
34628,2265,5,O
34629,2265,days,O
34630,2265,),O
34631,2265,to,O
34632,2265,the,O
34633,2265,equivalent,O
34634,2265,of,O
34635,2265,≤10,O
34636,2265,mg,O
34637,2265,/,O
34638,2265,day,O
34639,2265,prednisone,B-Drug
34640,2265,prior,O
34641,2265,to,O
34642,2265,the,O
34643,2265,start,O
34644,2265,of,O
34645,2265,the,O
34646,2265,study,O
34647,2265,drugs,O
34648,2265,.,O
34649,2265,No,O
34650,2265,other,B-Drug
34651,2265,investigational,I-Drug
34652,2265,agents,I-Drug
34653,2265,are,O
34654,2265,allowed,O
34655,2265,.,O
34656,2266,2,O
34657,2266,.,O
34658,2266,History,B-Observation
34659,2266,of,O
34660,2266,allergic,B-Condition
34661,2266,reactions,I-Condition
34662,2266,to,O
34663,2266,TGR-1202,B-Drug
34664,2266,or,O
34665,2266,carfilzomib,B-Drug
34666,2267,3,O
34667,2267,.,O
34668,2267,Uncontrolled,O
34669,2267,inter,B-Condition
34670,2267,-,I-Condition
34671,2267,current,I-Condition
34672,2267,illness,I-Condition
34673,2268,4,O
34674,2268,.,O
34675,2268,Pregnant,B-Condition
34676,2268,women,B-Person
34677,2269,5,O
34678,2269,.,O
34679,2269,Nursing,B-Condition
34680,2269,women,B-Person
34681,2270,6,O
34682,2270,.,O
34683,2270,Current,O
34684,2270,malignancy,B-Condition
34685,2270,or,O
34686,2270,history,B-Observation
34687,2270,of,I-Observation
34688,2270,a,I-Observation
34689,2270,prior,I-Observation
34690,2270,malignancy,B-Condition
34691,2271,7,O
34692,2271,.,O
34693,2271,Patient,O
34694,2271,known,O
34695,2271,to,O
34696,2271,be,O
34697,2271,Human,O
34698,2271,Immunodeficiency,O
34699,2271,Virus,O
34700,2271,(,O
34701,2271,HIV)-positive,O
34702,2272,8,O
34703,2272,.,O
34704,2272,Active,O
34705,2272,Hepatitis,B-Condition
34706,2272,A,I-Condition
34707,2272,",",O
34708,2272,Hepatitis,B-Condition
34709,2272,B,I-Condition
34710,2272,",",O
34711,2272,or,O
34712,2272,Hepatitis,B-Condition
34713,2272,C,I-Condition
34714,2272,infection,O
34715,2273,Phase,O
34716,2273,I,O
34717,2273,:,O
34718,2273,Patients,O
34719,2273,must,O
34720,2273,have,O
34721,2273,histologically,B-Procedure
34722,2273,confirmed,O
34723,2273,R,O
34724,2273,/,O
34725,2273,R,O
34726,2273,NHL,B-Condition
34727,2273,or,O
34728,2273,HL,B-Condition
34729,2273,(,O
34730,2273,defined,O
34731,2273,by,O
34732,2273,WHO,O
34733,2273,criteria,O
34734,2273,),O
34735,2273,.,O
34736,2273,Patients,O
34737,2273,with,O
34738,2273,chronic,B-Procedure
34739,2273,lymphocytic,I-Procedure
34740,2273,leukemia,I-Procedure
34741,2273,(,I-Procedure
34742,2273,CLL,I-Procedure
34743,2273,),I-Procedure
34744,2273,and,O
34745,2273,small,B-Procedure
34746,2273,lymphocytic,I-Procedure
34747,2273,lymphoma,I-Procedure
34748,2273,(,I-Procedure
34749,2273,SLL,I-Procedure
34750,2273,),I-Procedure
34751,2273,are,O
34752,2273,eligible,O
34753,2273,.,O
34754,2273,In,O
34755,2273,addition,O
34756,2273,",",O
34757,2273,patients,O
34758,2273,with,O
34759,2273,NHL,B-Condition
34760,2273,other,O
34761,2273,than,O
34762,2273,diffuse,B-Condition
34763,2273,large,I-Condition
34764,2273,B,I-Condition
34765,2273,cell,I-Condition
34766,2273,lymphomas,I-Condition
34767,2273,(,I-Condition
34768,2273,DLBCL,I-Condition
34769,2273,),I-Condition
34770,2273,must,O
34771,2273,have,O
34772,2273,received,O
34773,2273,at,O
34774,2273,least,O
34775,2273,2,O
34776,2273,prior,O
34777,2273,therapies,B-Procedure
34778,2273,.,O
34779,2273,Patients,O
34780,2273,with,O
34781,2273,DLBCL,B-Condition
34782,2273,and,O
34783,2273,HL,B-Condition
34784,2273,will,O
34785,2273,be,O
34786,2273,eligible,O
34787,2273,if,O
34788,2273,there,O
34789,2273,is,O
34790,2273,no,O
34791,2273,available,O
34792,2273,standard,B-Procedure
34793,2273,therapy,I-Procedure
34794,2273,.,O
34795,2274,Phase,O
34796,2274,II,O
34797,2274,:,O
34798,2274,Patients,O
34799,2274,must,O
34800,2274,have,O
34801,2274,histologically,O
34802,2274,confirmed,O
34803,2274,R,O
34804,2274,/,O
34805,2274,R,O
34806,2274,NHL,B-Condition
34807,2274,(,O
34808,2274,as,O
34809,2274,defined,O
34810,2274,by,O
34811,2274,WHO,O
34812,2274,criteria,O
34813,2274,),O
34814,2274,.,O
34815,2274,Patients,O
34816,2274,with,O
34817,2274,NHL,B-Condition
34818,2274,other,O
34819,2274,than,O
34820,2274,diffuse,B-Condition
34821,2274,large,I-Condition
34822,2274,B,I-Condition
34823,2274,cell,I-Condition
34824,2274,lymphomas,I-Condition
34825,2274,(,I-Condition
34826,2274,DLBCL,I-Condition
34827,2274,),I-Condition
34828,2274,must,O
34829,2274,have,O
34830,2274,received,O
34831,2274,at,O
34832,2274,least,O
34833,2274,2,O
34834,2274,prior,O
34835,2274,therapies,B-Procedure
34836,2274,.,O
34837,2274,Patients,O
34838,2274,with,O
34839,2274,DLBCL,B-Condition
34840,2274,will,O
34841,2274,be,O
34842,2274,eligible,O
34843,2274,if,O
34844,2274,there,O
34845,2274,is,O
34846,2274,no,O
34847,2274,available,O
34848,2274,standard,B-Procedure
34849,2274,therapy,I-Procedure
34850,2274,.,O
34851,2275,Must,O
34852,2275,have,O
34853,2275,received,O
34854,2275,front,O
34855,2275,line,O
34856,2275,chemotherapy,B-Procedure
34857,2275,.,O
34858,2275,No,O
34859,2275,upper,O
34860,2275,limit,O
34861,2275,for,O
34862,2275,the,O
34863,2275,number,O
34864,2275,of,O
34865,2275,prior,O
34866,2275,therapies,O
34867,2276,Evaluable,O
34868,2276,Disease,B-Condition
34869,2276,in,O
34870,2276,the,O
34871,2276,Phase,O
34872,2276,I,O
34873,2276,",",O
34874,2276,and,O
34875,2276,measurable,O
34876,2276,disease,O
34877,2276,in,O
34878,2276,the,O
34879,2276,Phase,O
34880,2276,II,O
34881,2277,Age,B-Person
34882,2277,>,O
34883,2277,18,O
34884,2277,years,O
34885,2278,ECOG,O
34886,2278,performance,O
34887,2278,status,O
34888,2278,<,O
34889,2278,2,O
34890,2279,Patients,O
34891,2279,must,O
34892,2279,have,O
34893,2279,adequate,O
34894,2279,organ,O
34895,2279,and,O
34896,2279,marrow,O
34897,2279,function,O
34898,2280,Adequate,O
34899,2280,Contraception,B-Procedure
34900,2281,Ability,O
34901,2281,to,O
34902,2281,understand,O
34903,2281,and,O
34904,2281,the,O
34905,2281,willingness,O
34906,2281,to,O
34907,2281,sign,O
34908,2281,a,O
34909,2281,written,O
34910,2281,informed,O
34911,2281,consent,O
34912,2281,document,O
34913,2282,History,O
34914,2282,of,O
34915,2282,prostate,B-Condition
34916,2282,",",I-Condition
34917,2282,bladder,I-Condition
34918,2282,",",I-Condition
34919,2282,or,I-Condition
34920,2282,rectal,I-Condition
34921,2282,cancer,I-Condition
34922,2283,History,O
34923,2283,of,O
34924,2283,transurethral,B-Procedure
34925,2283,resection,I-Procedure
34926,2283,of,I-Procedure
34927,2283,the,I-Procedure
34928,2283,prostate,I-Procedure
34929,2283,(,I-Procedure
34930,2283,TURP,I-Procedure
34931,2283,),I-Procedure
34932,2283,",",O
34933,2283,open,B-Procedure
34934,2283,prostate,I-Procedure
34935,2283,surgery,I-Procedure
34936,2283,",",O
34937,2283,or,O
34938,2283,radiofrequency,B-Procedure
34939,2283,or,O
34940,2283,microwave,B-Procedure
34941,2283,therapies,I-Procedure
34942,2284,History,O
34943,2284,of,O
34944,2284,open,B-Procedure
34945,2284,bladder,I-Procedure
34946,2284,",",I-Procedure
34947,2284,rectosigmoid,I-Procedure
34948,2284,colon,I-Procedure
34949,2284,",",I-Procedure
34950,2284,or,I-Procedure
34951,2284,other,I-Procedure
34952,2284,pelvic,I-Procedure
34953,2284,surgery,I-Procedure
34954,2285,Patient,O
34955,2285,is,O
34956,2285,unwilling,O
34957,2285,to,O
34958,2285,discontinue,O
34959,2285,alpha,B-Drug
34960,2285,blockers,I-Drug
34961,2285,1,O
34962,2285,month,O
34963,2285,after,O
34964,2285,study,O
34965,2285,treatment,O
34966,2286,Patient,O
34967,2286,is,O
34968,2286,unwilling,O
34969,2286,to,O
34970,2286,discontinue,O
34971,2286,5,B-Drug
34972,2286,-,I-Drug
34973,2286,alph,I-Drug
34974,2286,reductase,I-Drug
34975,2286,inhibitors,I-Drug
34976,2286,1,O
34977,2286,month,O
34978,2286,after,O
34979,2286,study,O
34980,2286,treatment,O
34981,2287,Neurogenic,B-Condition
34982,2287,bladder,I-Condition
34983,2287,or,O
34984,2287,other,O
34985,2287,neurologic,B-Condition
34986,2287,disorder,I-Condition
34987,2287,impacting,I-Condition
34988,2287,bladder,I-Condition
34989,2287,function,I-Condition
34990,2287,such,O
34991,2287,as,O
34992,2287,Parkinson,B-Condition
34993,2287,'s,I-Condition
34994,2287,disease,I-Condition
34995,2287,",",O
34996,2287,multiple,B-Condition
34997,2287,sclerosis,I-Condition
34998,2287,",",O
34999,2287,cerebral,B-Condition
35000,2287,vascular,I-Condition
35001,2287,accident,I-Condition
35002,2287,or,O
35003,2287,diabetes,B-Condition
35004,2288,Any,O
35005,2288,other,O
35006,2288,confounding,O
35007,2288,bladder,B-Condition
35008,2288,or,I-Condition
35009,2288,urethral,I-Condition
35010,2288,pathology,I-Condition
35011,2288,",",O
35012,2288,including,O
35013,2288,urethral,B-Condition
35014,2288,stricture,I-Condition
35015,2288,",",O
35016,2288,bladder,B-Condition
35017,2288,neck,I-Condition
35018,2288,contracture,I-Condition
35019,2288,",",O
35020,2288,or,O
35021,2288,bladder,B-Condition
35022,2288,atonia,I-Condition
35023,2289,Active,O
35024,2289,prostatitis,B-Condition
35025,2289,or,O
35026,2289,urinary,B-Condition
35027,2289,tract,I-Condition
35028,2289,infection,I-Condition
35029,2290,Cystolithiasis,B-Condition
35030,2290,within,O
35031,2290,the,O
35032,2290,past,O
35033,2290,3,O
35034,2290,months,O
35035,2291,Serum,O
35036,2291,creatinine,O
35037,2291,>,O
35038,2291,1.7mg,O
35039,2291,/,O
35040,2291,dL,O
35041,2292,Inability,O
35042,2292,to,O
35043,2292,discontinue,O
35044,2292,oral,B-Drug
35045,2292,anticoagulant,I-Drug
35046,2292,2,O
35047,2292,-,O
35048,2292,5,O
35049,2292,days,O
35050,2292,prior,O
35051,2292,to,O
35052,2292,study,O
35053,2292,treatment,O
35054,2293,Coagulation,B-Condition
35055,2293,disturbances,I-Condition
35056,2293,not,O
35057,2293,normalized,O
35058,2293,by,O
35059,2293,medical,B-Procedure
35060,2293,treatment,I-Procedure
35061,2294,Iodinated,B-Drug
35062,2294,contrast,I-Drug
35063,2294,allergy,B-Condition
35064,2294,that,O
35065,2294,",",O
35066,2294,in,O
35067,2294,the,O
35068,2294,opinion,O
35069,2294,of,O
35070,2294,the,O
35071,2294,Investigator,O
35072,2294,",",O
35073,2294,can,O
35074,2294,not,O
35075,2294,be,O
35076,2294,adequately,O
35077,2294,premedicated,O
35078,2295,Gelatin,B-Drug
35079,2295,allergy,B-Condition
35080,2296,Known,O
35081,2296,severe,O
35082,2296,peripheral,B-Condition
35083,2296,vascular,I-Condition
35084,2296,disease,I-Condition
35085,2296,or,O
35086,2296,major,O
35087,2296,iliac,B-Condition
35088,2296,arterial,I-Condition
35089,2296,occlusive,I-Condition
35090,2296,disease,I-Condition
35091,2297,Interest,O
35092,2297,in,O
35093,2297,future,O
35094,2297,fertility,O
35095,2298,Clinically,O
35096,2298,significant,O
35097,2298,cardiac,B-Condition
35098,2298,arrhythmia,I-Condition
35099,2298,or,O
35100,2298,other,O
35101,2298,cardiac,B-Condition
35102,2298,disease,I-Condition
35103,2298,(,O
35104,2298,including,O
35105,2298,congestive,B-Condition
35106,2298,heart,I-Condition
35107,2298,failure,I-Condition
35108,2298,),O
35109,2298,",",O
35110,2298,uncontrolled,O
35111,2298,diabetes,B-Condition
35112,2298,mellitus,I-Condition
35113,2298,",",O
35114,2298,clinically,O
35115,2298,significant,O
35116,2298,respiratory,B-Condition
35117,2298,disease,I-Condition
35118,2298,",",O
35119,2298,or,O
35120,2298,known,O
35121,2298,immunosuppression,B-Condition
35122,2299,Other,O
35123,2299,condition,O
35124,2299,that,O
35125,2299,the,O
35126,2299,Investigator,O
35127,2299,believes,O
35128,2299,puts,O
35129,2299,the,O
35130,2299,patient,O
35131,2299,at,O
35132,2299,risk,O
35133,2299,for,O
35134,2299,a,O
35135,2299,complication,O
35136,2299,during,O
35137,2299,the,O
35138,2299,procedure,O
35139,2300,Patient,O
35140,2300,has,O
35141,2300,provided,O
35142,2300,signed,B-Observation
35143,2300,informed,I-Observation
35144,2300,consent,I-Observation
35145,2301,Patient,O
35146,2301,is,O
35147,2301,aged,B-Person
35148,2301,greater,O
35149,2301,than,O
35150,2301,or,O
35151,2301,equal,O
35152,2301,to,O
35153,2301,40,O
35154,2301,and,O
35155,2301,less,O
35156,2301,than,O
35157,2301,or,O
35158,2301,equal,O
35159,2301,to,O
35160,2301,89,O
35161,2301,years,O
35162,2301,of,O
35163,2301,age,O
35164,2302,Patient,O
35165,2302,has,O
35166,2302,a,O
35167,2302,prostate,O
35168,2302,size,O
35169,2302,between,O
35170,2302,90,O
35171,2302,g,O
35172,2302,and,O
35173,2302,200,O
35174,2302,g,O
35175,2302,",",O
35176,2302,as,O
35177,2302,determined,O
35178,2302,by,O
35179,2302,MRI,B-Procedure
35180,2303,Patient,O
35181,2303,has,O
35182,2303,experienced,O
35183,2303,lower,B-Condition
35184,2303,urinary,I-Condition
35185,2303,tract,I-Condition
35186,2303,symptoms,I-Condition
35187,2303,(,I-Condition
35188,2303,LUTS,I-Condition
35189,2303,),I-Condition
35190,2303,for,O
35191,2303,at,O
35192,2303,least,O
35193,2303,6,O
35194,2303,months,O
35195,2303,prior,O
35196,2303,to,O
35197,2303,study,O
35198,2303,enrollment,O
35199,2304,Patient,O
35200,2304,has,O
35201,2304,an,O
35202,2304,IPSS,O
35203,2304,score,O
35204,2304,of,O
35205,2304,at,O
35206,2304,least,O
35207,2304,13,O
35208,2304,at,O
35209,2304,baseline,O
35210,2305,Patient,O
35211,2305,is,O
35212,2305,either,O
35213,2305,:,O
35214,2305,refractory,B-Condition
35215,2305,to,I-Condition
35216,2305,medical,I-Condition
35217,2305,treatment,I-Condition
35218,2305,",",O
35219,2305,contraindicated,B-Condition
35220,2305,to,I-Condition
35221,2305,medical,I-Condition
35222,2305,treatment,I-Condition
35223,2305,",",O
35224,2305,OR,O
35225,2305,refuses,B-Condition
35226,2305,medical,I-Condition
35227,2305,treatment,I-Condition
35228,2306,Patient,O
35229,2306,either,O
35230,2306,:,O
35231,2306,refuses,B-Condition
35232,2306,surgical,I-Condition
35233,2306,treatment,I-Condition
35234,2306,OR,O
35235,2306,is,O
35236,2306,contraindicated,B-Condition
35237,2306,for,I-Condition
35238,2306,surgical,I-Condition
35239,2306,treatment,I-Condition
35240,2307,Patient,O
35241,2307,meets,O
35242,2307,ONE,O
35243,2307,of,O
35244,2307,the,O
35245,2307,following,O
35246,2307,criteria,O
35247,2307,:,O
35248,2307,baseline,O
35249,2307,PSA,O
35250,2307,<,O
35251,2307,4.0ng,O
35252,2307,/,O
35253,2307,mL,O
35254,2307,(,O
35255,2307,no,O
35256,2307,prostate,O
35257,2307,biopsy,O
35258,2307,required,O
35259,2307,),O
35260,2307,OR,O
35261,2307,baseline,O
35262,2307,PSA,O
35263,2307,>,O
35264,2307,/=,O
35265,2307,4,O
35266,2307,ng,O
35267,2307,/,O
35268,2307,mL,O
35269,2307,AND,O
35270,2307,a,O
35271,2307,negative,O
35272,2307,prostate,O
35273,2307,biopsy,O
35274,2307,(,O
35275,2307,minimum,O
35276,2307,12,O
35277,2307,core,B-Procedure
35278,2307,biopsy,I-Procedure
35279,2307,),O
35280,2307,within,O
35281,2307,the,O
35282,2307,prior,O
35283,2307,12,O
35284,2307,months,O
35285,2308,Patients,O
35286,2308,with,O
35287,2308,documented,O
35288,2308,allergies,B-Condition
35289,2308,to,O
35290,2308,propofol,B-Drug
35291,2308,",",O
35292,2308,dexmedetomidine,B-Drug
35293,2308,",",O
35294,2308,fentanyl,B-Drug
35295,2308,",",O
35296,2308,eggs,B-Observation
35297,2308,or,O
35298,2308,egg,B-Observation
35299,2308,products,I-Observation
35300,2308,",",O
35301,2308,or,O
35302,2308,soy,B-Observation
35303,2308,or,O
35304,2308,soy,B-Observation
35305,2308,products,I-Observation
35306,2308,.,O
35307,2309,A,O
35308,2309,heart,O
35309,2309,rate,O
35310,2309,less,O
35311,2309,than,O
35312,2309,50,O
35313,2309,beats,O
35314,2309,/,O
35315,2309,minute,O
35316,2309,or,O
35317,2309,grade,O
35318,2309,2,O
35319,2309,or,O
35320,2309,3,O
35321,2309,AV,B-Condition
35322,2309,heart,I-Condition
35323,2309,block,I-Condition
35324,2310,Mean,O
35325,2310,arterial,O
35326,2310,pressure,O
35327,2310,less,O
35328,2310,than,O
35329,2310,55,O
35330,2310,mmHg,O
35331,2310,despite,O
35332,2310,appropriate,O
35333,2310,fluid,B-Procedure
35334,2310,resuscitation,I-Procedure
35335,2310,and,O
35336,2310,vasopressor,B-Procedure
35337,2310,support,O
35338,2310,.,O
35339,2311,Current,O
35340,2311,triglyceride,O
35341,2311,level,O
35342,2311,>,O
35343,2311,400,O
35344,2311,mg,O
35345,2311,/,O
35346,2311,dl,O
35347,2312,Men,B-Person
35348,2312,and,O
35349,2312,women,B-Person
35350,2312,18,O
35351,2312,-,O
35352,2312,89,O
35353,2312,years,O
35354,2312,old,B-Person
35355,2313,with,O
35356,2313,the,O
35357,2313,diagnosis,O
35358,2313,of,O
35359,2313,sepsis,B-Condition
35360,2313,(,O
35361,2313,as,O
35362,2313,specified,O
35363,2313,below,O
35364,2313,),O
35365,2313,within,O
35366,2313,the,O
35367,2313,previous,O
35368,2313,24,O
35369,2313,hours,O
35370,2314,who,O
35371,2314,require,O
35372,2314,mechanical,B-Procedure
35373,2314,ventilation,I-Procedure
35374,2314,",",O
35375,2314,and,O
35376,2315,provide,O
35377,2315,informed,O
35378,2315,consent,O
35379,2315,either,O
35380,2315,personally,O
35381,2315,or,O
35382,2315,by,O
35383,2315,an,O
35384,2315,authorized,O
35385,2315,representative,O
35386,2315,.,O
35387,2316,multiple,B-Condition
35388,2316,injuries,I-Condition
35389,2316,(,O
35390,2316,polytrauma,B-Condition
35391,2316,patients,O
35392,2316,),O
35393,2317,previous,O
35394,2317,adverse,B-Condition
35395,2317,reaction,I-Condition
35396,2317,or,O
35397,2317,known,O
35398,2317,allergy,B-Condition
35399,2317,to,O
35400,2317,local,B-Procedure
35401,2317,anaesthetics,I-Procedure
35402,2317,or,O
35403,2317,opioids,B-Drug
35404,2317,or,O
35405,2317,paracetamol,B-Drug
35406,2318,skin,B-Condition
35407,2318,infection,I-Condition
35408,2318,in,O
35409,2318,proximity,O
35410,2318,of,O
35411,2318,injection,O
35412,2318,site,O
35413,2319,delirious,B-Condition
35414,2319,state,O
35415,2319,at,O
35416,2319,presentation,O
35417,2319,in,O
35418,2319,the,O
35419,2319,ED,O
35420,2320,adult,B-Person
35421,2320,patients,O
35422,2320,aged,B-Person
35423,2320,=,O
35424,2320,55,O
35425,2320,years,O
35426,2320,with,O
35427,2321,a,O
35428,2321,radiographically,B-Procedure
35429,2321,confirmed,O
35430,2321,hip,B-Condition
35431,2321,fracture,I-Condition
35432,2322,Lack,B-Observation
35433,2322,of,I-Observation
35434,2322,understanding,I-Observation
35435,2322,of,I-Observation
35436,2322,the,I-Observation
35437,2322,study,I-Observation
35438,2323,contra,B-Condition
35439,2323,-,I-Condition
35440,2323,indication,I-Condition
35441,2323,to,O
35442,2323,nicotine,B-Procedure
35443,2323,replacement,I-Procedure
35444,2323,therapy,I-Procedure
35445,2324,health,O
35446,2324,status,O
35447,2324,incompatible,B-Observation
35448,2324,with,I-Observation
35449,2324,detention,I-Observation
35450,2324,in,I-Observation
35451,2324,police,I-Observation
35452,2324,cells,I-Observation
35453,2325,serious,B-Condition
35454,2325,mental,I-Condition
35455,2325,disorder,I-Condition
35456,2326,usual,O
35457,2326,place,B-Observation
35458,2326,of,I-Observation
35459,2326,residence,I-Observation
35460,2326,outside,O
35461,2326,Seine,O
35462,2326,-,O
35463,2326,Saint,O
35464,2326,-,O
35465,2326,Denis,O
35466,2327,Arrestees,B-Person
35467,2327,examined,B-Procedure
35468,2327,by,I-Procedure
35469,2327,a,I-Procedure
35470,2327,physician,I-Procedure
35471,2327,during,O
35472,2327,detention,O
35473,2327,in,O
35474,2327,police,O
35475,2327,cells,O
35476,2328,aged,B-Person
35477,2328,18,O
35478,2328,or,O
35479,2328,older,O
35480,2329,smoking,B-Observation
35481,2329,at,O
35482,2329,least,O
35483,2329,10,O
35484,2329,cigarettes,O
35485,2329,per,O
35486,2329,day,O
35487,2330,giving,O
35488,2330,written,O
35489,2330,consent,O
35490,2330,to,O
35491,2330,participate,O
35492,2330,in,O
35493,2330,the,O
35494,2330,study,O
35495,2331,health,O
35496,2331,status,O
35497,2331,compatible,O
35498,2331,with,O
35499,2331,detention,O
35500,2331,in,O
35501,2331,police,O
35502,2331,cells,O
35503,2332,not,O
35504,2332,a,O
35505,2332,regular,B-Person
35506,2332,user,I-Person
35507,2332,of,O
35508,2332,e,B-Procedure
35509,2332,-,I-Procedure
35510,2332,cigarettes,I-Procedure
35511,2333,pregnant,O
35512,2333,or,O
35513,2333,lactating,O
35514,2333,(,O
35515,2333,only,O
35516,2333,excluded,O
35517,2333,from,O
35518,2333,imaging,O
35519,2333,study,O
35520,2333,),O
35521,2334,prisoner,B-Person
35522,2335,incapable,O
35523,2335,of,O
35524,2335,giving,O
35525,2335,informed,O
35526,2335,consent,O
35527,2336,unable,O
35528,2336,to,O
35529,2336,lie,O
35530,2336,flat,O
35531,2336,on,O
35532,2336,the,O
35533,2336,scanner,O
35534,2336,for,O
35535,2336,extended,O
35536,2336,periods,O
35537,2336,of,O
35538,2336,time,O
35539,2337,unstable,O
35540,2337,medical,B-Condition
35541,2337,condition,I-Condition
35542,2337,like,O
35543,2337,heart,B-Condition
35544,2337,disease,I-Condition
35545,2337,",",O
35546,2337,uncontrolled,O
35547,2337,hypertension,B-Condition
35548,2337,",",O
35549,2337,thyroid,B-Condition
35550,2337,disease,I-Condition
35551,2337,",",O
35552,2337,diabetes,B-Condition
35553,2337,",",O
35554,2337,renal,B-Condition
35555,2337,or,I-Condition
35556,2337,liver,I-Condition
35557,2337,impairment,I-Condition
35558,2337,",",O
35559,2337,or,O
35560,2337,glaucoma,B-Condition
35561,2338,prostatic,B-Condition
35562,2338,hypertrophy,I-Condition
35563,2338,",",O
35564,2338,stroke,B-Condition
35565,2338,",",O
35566,2338,or,O
35567,2338,ulcer,B-Condition
35568,2338,in,O
35569,2338,past,O
35570,2338,year,O
35571,2339,psychiatric,B-Condition
35572,2339,conditions,I-Condition
35573,2339,such,O
35574,2339,as,O
35575,2339,schizophrenia,B-Condition
35576,2339,",",O
35577,2339,adult,B-Condition
35578,2339,ADHD,I-Condition
35579,2339,",",O
35580,2339,or,O
35581,2339,bipolar,B-Condition
35582,2339,disorder,I-Condition
35583,2340,current,O
35584,2340,or,O
35585,2340,regular,O
35586,2340,use,O
35587,2340,of,O
35588,2340,psychiatric,B-Drug
35589,2340,medications,I-Drug
35590,2340,such,O
35591,2340,as,O
35592,2340,tranquilizers,B-Drug
35593,2340,",",O
35594,2340,antipsychotics,B-Drug
35595,2340,",",O
35596,2340,and/or,O
35597,2340,antidepressants,B-Drug
35598,2341,use,O
35599,2341,of,O
35600,2341,medications,B-Drug
35601,2341,that,O
35602,2341,are,O
35603,2341,inducers,O
35604,2341,of,O
35605,2341,CYP2A6,O
35606,2341,(,O
35607,2341,a,O
35608,2341,nicotine,B-Drug
35609,2341,metabolizing,I-Drug
35610,2341,enzyme,I-Drug
35611,2341,),O
35612,2341,such,O
35613,2341,as,O
35614,2341,rifampicin,B-Drug
35615,2341,",",O
35616,2341,dexamethasone,B-Drug
35617,2341,",",O
35618,2341,phenobarbital,B-Drug
35619,2341,",",O
35620,2341,and,O
35621,2341,other,O
35622,2341,anti,B-Drug
35623,2341,-,I-Drug
35624,2341,convulsant,I-Drug
35625,2341,drugs,I-Drug
35626,2342,unable,O
35627,2342,to,O
35628,2342,communicate,O
35629,2342,in,O
35630,2342,English,O
35631,2343,current,O
35632,2343,use,O
35633,2343,of,O
35634,2343,smokeless,B-Procedure
35635,2343,tobacco,I-Procedure
35636,2343,",",O
35637,2343,tobacco,B-Procedure
35638,2343,cigarettes,I-Procedure
35639,2343,(,O
35640,2343,5,O
35641,2343,and,O
35642,2343,fewer,O
35643,2343,a,O
35644,2343,day,O
35645,2343,),O
35646,2344,occasional,O
35647,2344,use,O
35648,2344,of,O
35649,2344,pipes,O
35650,2344,is,O
35651,2344,permitted,O
35652,2344,if,O
35653,2344,subject,O
35654,2344,abstains,O
35655,2344,for,O
35656,2344,the,O
35657,2344,week,O
35658,2344,prior,O
35659,2344,to,O
35660,2344,the,O
35661,2344,study,O
35662,2345,older,O
35663,2345,than,O
35664,2345,80,O
35665,2345,years,B-Person
35666,2346,males,B-Person
35667,2346,and,O
35668,2346,females,B-Person
35669,2346,greater,O
35670,2346,than,O
35671,2346,or,O
35672,2346,equal,O
35673,2346,to,O
35674,2346,18,O
35675,2346,years,O
35676,2346,of,O
35677,2346,age,B-Person
35678,2347,current,O
35679,2347,regular,O
35680,2347,user,B-Person
35681,2347,of,O
35682,2347,e,O
35683,2347,-,O
35684,2347,cigarettes,O
35685,2347,(,O
35686,2347,use,O
35687,2347,at,O
35688,2347,least,O
35689,2347,once,O
35690,2347,daily,O
35691,2347,for,O
35692,2347,the,O
35693,2347,past,O
35694,2347,30,O
35695,2347,days,O
35696,2347,),O
35697,2347,with,O
35698,2347,nicotine,O
35699,2347,strength,O
35700,2347,>,O
35701,2347,6mg,O
35702,2347,/,O
35703,2347,ml,O
35704,2348,health,O
35705,2348,medical,B-Observation
35706,2348,history,I-Observation
35707,2349,abstinent,B-Condition
35708,2349,from,O
35709,2349,any,O
35710,2349,tobacco,B-Drug
35711,2349,/,O
35712,2349,nicotine,B-Drug
35713,2349,use,O
35714,2349,for,O
35715,2349,4,O
35716,2349,hours,O
35717,2349,prior,O
35718,2349,to,O
35719,2349,imaging,O
35720,2350,Re,B-Procedure
35721,2350,-,I-Procedure
35722,2350,transplant,I-Procedure
35723,2350,;,O
35724,2351,Patients,O
35725,2351,with,O
35726,2351,any,O
35727,2351,panel,O
35728,2351,reactive,O
35729,2351,antibody,O
35730,2351,(,O
35731,2351,PRA,O
35732,2351,),O
35733,2351,equal,O
35734,2351,to,O
35735,2351,or,O
35736,2351,above,O
35737,2351,50,O
35738,2351,%,O
35739,2351,",",O
35740,2351,class,O
35741,2351,I,O
35742,2351,or,O
35743,2351,class,O
35744,2351,II,O
35745,2351,;,O
35746,2352,Acute,B-Condition
35747,2352,rejection,I-Condition
35748,2352,episode,I-Condition
35749,2352,in,O
35750,2352,the,O
35751,2352,last,O
35752,2352,30,O
35753,2352,days,O
35754,2352,",",O
35755,2352,or,O
35756,2352,episode,O
35757,2352,>,O
35758,2352,2A,O
35759,2352,in,O
35760,2352,the,O
35761,2352,Banff,O
35762,2352,criteria,O
35763,2352,;,O
35764,2353,GFR,O
35765,2353,(,O
35766,2353,MDRD,O
35767,2353,),O
35768,2353,<,O
35769,2353,40,O
35770,2353,ml,O
35771,2353,/,O
35772,2353,min,O
35773,2353,;,O
35774,2354,Proteinuria,B-Condition
35775,2354,>,O
35776,2354,"0,5",O
35777,2354,g,O
35778,2354,/,O
35779,2354,l,O
35780,2354,;,O
35781,2355,Hemoglobin,O
35782,2355,<,O
35783,2355,10,O
35784,2355,g,O
35785,2355,/,O
35786,2355,l,O
35787,2355,and/or,O
35788,2355,leucocytes,O
35789,2355,<,O
35790,2355,4000,O
35791,2355,cels,O
35792,2355,/,O
35793,2355,mm3,O
35794,2355,and/or,O
35795,2355,platelets,O
35796,2355,<,O
35797,2355,150.000,O
35798,2355,cels,O
35799,2355,/,O
35800,2355,mm3,O
35801,2355,;,O
35802,2356,Triglycerides,O
35803,2356,>,O
35804,2356,500,O
35805,2356,mg,O
35806,2356,/,O
35807,2356,dl,O
35808,2356,with,O
35809,2356,or,O
35810,2356,without,O
35811,2356,use,O
35812,2356,of,O
35813,2356,fibrate,B-Drug
35814,2356,;,O
35815,2357,Cholesterol,O
35816,2357,total,O
35817,2357,>,O
35818,2357,300,O
35819,2357,mg,O
35820,2357,/,O
35821,2357,dl,O
35822,2357,with,O
35823,2357,or,O
35824,2357,without,O
35825,2357,use,O
35826,2357,of,O
35827,2357,statin,B-Drug
35828,2357,;,O
35829,2358,Hepatic,B-Condition
35830,2358,abnormalities,I-Condition
35831,2358,;,O
35832,2359,Significant,O
35833,2359,periphery,B-Condition
35834,2359,edema,I-Condition
35835,2359,;,O
35836,2360,Pulmonary,B-Condition
35837,2360,abnormalities,I-Condition
35838,2360,or,O
35839,2360,breast,B-Procedure
35840,2360,x,I-Procedure
35841,2360,-,I-Procedure
35842,2360,ray,I-Procedure
35843,2360,abnormalities,O
35844,2360,;,O
35845,2361,Hyper,B-Condition
35846,2361,sensibility,I-Condition
35847,2361,to,O
35848,2361,sirolimus,B-Drug
35849,2361,formula,O
35850,2361,;,O
35851,2362,Adult,B-Person
35852,2362,kidney,B-Procedure
35853,2362,transplant,I-Procedure
35854,2362,recipients,O
35855,2362,>,O
35856,2362,18,O
35857,2362,y.o,B-Person
35858,2362,.,I-Person
35859,2363,Kidney,O
35860,2363,Transplant,O
35861,2363,recipients,O
35862,2363,",",O
35863,2363,after,O
35864,2363,the,O
35865,2363,first,O
35866,2363,episode,O
35867,2363,of,O
35868,2363,cytomegalovirus,B-Condition
35869,2363,infection,I-Condition
35870,2363,",",O
35871,2363,using,O
35872,2363,the,O
35873,2363,current,O
35874,2363,immunosuppressive,B-Drug
35875,2363,regimen,I-Drug
35876,2363,:,O
35877,2363,azathioprine,B-Drug
35878,2363,or,O
35879,2363,mycophenolate,B-Drug
35880,2363,",",O
35881,2363,tacrolimus,B-Drug
35882,2363,and,O
35883,2363,prednisone,B-Drug
35884,2363,.,O
35885,2364,Is,O
35886,2364,not,O
35887,2364,a,O
35888,2364,habitual,O
35889,2364,wearer,O
35890,2364,of,O
35891,2364,Avaira,O
35892,2364,sphere,O
35893,2364,lenses,O
35894,2365,Has,O
35895,2365,a,O
35896,2365,CL,O
35897,2365,prescription,O
35898,2365,outside,O
35899,2365,the,O
35900,2365,range,O
35901,2365,of,O
35902,2365,the,O
35903,2365,available,O
35904,2365,parameters,O
35905,2365,of,O
35906,2365,the,O
35907,2365,study,O
35908,2365,lenses,O
35909,2365,.,O
35910,2366,Has,O
35911,2366,a,O
35912,2366,spectacle,O
35913,2366,cylinder,O
35914,2366,≥1.00D,O
35915,2366,of,O
35916,2366,cylinder,O
35917,2366,in,O
35918,2366,either,O
35919,2366,eye,O
35920,2366,.,O
35921,2367,Has,O
35922,2367,a,O
35923,2367,history,B-Observation
35924,2367,of,O
35925,2367,not,O
35926,2367,achieving,O
35927,2367,comfortable,B-Condition
35928,2367,CL,I-Condition
35929,2367,wear,I-Condition
35930,2367,(,O
35931,2367,5,O
35932,2367,days,O
35933,2367,per,O
35934,2367,week,O
35935,2367,;,O
35936,2367,>,O
35937,2367,8,O
35938,2367,hours,O
35939,2367,/,O
35940,2367,day,O
35941,2367,),O
35942,2368,Has,O
35943,2368,contact,O
35944,2368,lens,O
35945,2368,best,O
35946,2368,corrected,O
35947,2368,distance,O
35948,2368,vision,O
35949,2368,worse,O
35950,2368,than,O
35951,2368,20/25,O
35952,2368,(,O
35953,2368,0.10,O
35954,2368,logMAR,O
35955,2368,),O
35956,2368,in,O
35957,2368,either,O
35958,2368,eye,O
35959,2368,.,O
35960,2369,Presence,O
35961,2369,of,O
35962,2369,clinically,O
35963,2369,significant,O
35964,2369,(,O
35965,2369,grade,O
35966,2369,2,O
35967,2369,-,O
35968,2369,4,O
35969,2369,),O
35970,2369,anterior,B-Condition
35971,2369,segment,I-Condition
35972,2369,abnormalities,I-Condition
35973,2370,Presence,O
35974,2370,of,O
35975,2370,ocular,B-Condition
35976,2370,or,I-Condition
35977,2370,systemic,I-Condition
35978,2370,disease,I-Condition
35979,2370,or,O
35980,2370,need,B-Condition
35981,2370,of,I-Condition
35982,2370,medications,I-Condition
35983,2370,which,O
35984,2370,might,O
35985,2370,interfere,O
35986,2370,with,O
35987,2370,contact,O
35988,2370,lens,O
35989,2370,wear,O
35990,2370,.,O
35991,2371,Slit,B-Procedure
35992,2371,lamp,I-Procedure
35993,2371,findings,O
35994,2371,that,O
35995,2371,would,O
35996,2371,contraindicate,B-Condition
35997,2371,contact,I-Condition
35998,2371,lens,I-Condition
35999,2371,wear,O
36000,2371,such,O
36001,2371,as,O
36002,2371,:,O
36003,2372,Pathological,B-Condition
36004,2372,dry,I-Condition
36005,2372,eye,I-Condition
36006,2372,or,O
36007,2372,associated,B-Condition
36008,2372,findings,I-Condition
36009,2373,Pterygium,B-Condition
36010,2373,",",O
36011,2373,pinguecula,B-Condition
36012,2373,",",O
36013,2373,or,O
36014,2373,corneal,B-Condition
36015,2373,scars,I-Condition
36016,2373,within,O
36017,2373,the,O
36018,2373,visual,O
36019,2373,axis,O
36020,2374,Neovascularization,B-Condition
36021,2374,>,O
36022,2374,0.75,O
36023,2374,mm,O
36024,2374,in,O
36025,2374,from,O
36026,2374,of,O
36027,2374,the,O
36028,2374,limbus,O
36029,2375,Giant,B-Condition
36030,2375,papillary,I-Condition
36031,2375,conjunctivitis,I-Condition
36032,2375,(,I-Condition
36033,2375,GCP,I-Condition
36034,2375,),I-Condition
36035,2375,worse,O
36036,2375,than,O
36037,2375,grade,O
36038,2375,1,O
36039,2376,Anterior,B-Condition
36040,2376,uveitis,I-Condition
36041,2376,or,O
36042,2376,iritis,B-Condition
36043,2376,(,O
36044,2376,past,O
36045,2376,or,O
36046,2376,present,O
36047,2376,),O
36048,2377,Seborrheic,B-Condition
36049,2377,eczema,I-Condition
36050,2377,",",O
36051,2377,Seborrheic,B-Condition
36052,2377,conjunctivitis,I-Condition
36053,2378,History,B-Observation
36054,2378,of,O
36055,2378,corneal,B-Condition
36056,2378,ulcers,I-Condition
36057,2378,or,O
36058,2378,fungal,B-Condition
36059,2378,infections,I-Condition
36060,2379,Poor,B-Condition
36061,2379,personal,I-Condition
36062,2379,hygiene,I-Condition
36063,2380,Has,O
36064,2380,a,O
36065,2380,known,O
36066,2380,history,B-Observation
36067,2380,of,O
36068,2380,corneal,B-Condition
36069,2380,hypoesthesia,I-Condition
36070,2380,(,O
36071,2380,reduced,B-Condition
36072,2380,corneal,I-Condition
36073,2380,sensitivity,I-Condition
36074,2380,),O
36075,2381,Has,O
36076,2381,aphakia,B-Condition
36077,2381,",",O
36078,2381,keratoconus,B-Condition
36079,2381,or,O
36080,2381,a,O
36081,2381,highly,B-Condition
36082,2381,irregular,I-Condition
36083,2381,cornea,I-Condition
36084,2381,.,O
36085,2382,Has,O
36086,2382,Presbyopia,B-Condition
36087,2382,or,O
36088,2382,has,O
36089,2382,dependence,B-Condition
36090,2382,on,I-Condition
36091,2382,spectacles,I-Condition
36092,2382,for,I-Condition
36093,2382,near,I-Condition
36094,2382,work,I-Condition
36095,2382,over,O
36096,2382,the,O
36097,2382,contact,O
36098,2382,lenses,O
36099,2382,.,O
36100,2383,Has,O
36101,2383,undergone,O
36102,2383,corneal,B-Procedure
36103,2383,refractive,I-Procedure
36104,2383,surgery,I-Procedure
36105,2383,.,O
36106,2384,Is,O
36107,2384,participating,O
36108,2384,in,O
36109,2384,any,O
36110,2384,other,O
36111,2384,type,O
36112,2384,of,O
36113,2384,eye,O
36114,2384,related,O
36115,2384,clinical,O
36116,2384,or,O
36117,2384,research,O
36118,2384,study,O
36119,2385,Is,O
36120,2385,between,O
36121,2385,18,O
36122,2385,and,O
36123,2385,40,O
36124,2385,years,O
36125,2385,of,O
36126,2385,age,B-Person
36127,2385,(,O
36128,2385,inclusive,O
36129,2385,),O
36130,2386,Has,O
36131,2386,had,O
36132,2386,a,O
36133,2386,self,B-Procedure
36134,2386,-,I-Procedure
36135,2386,reported,I-Procedure
36136,2386,visual,I-Procedure
36137,2386,exam,I-Procedure
36138,2386,in,O
36139,2386,the,O
36140,2386,last,O
36141,2386,two,O
36142,2386,years,O
36143,2387,Is,O
36144,2387,an,O
36145,2387,adapted,O
36146,2387,Avaira,O
36147,2387,sphere,O
36148,2387,contact,O
36149,2387,lens,O
36150,2387,wearer,O
36151,2387,(,O
36152,2387,at,O
36153,2387,least,O
36154,2387,1,O
36155,2387,week,O
36156,2387,in,O
36157,2387,Avaira,O
36158,2387,sphere,O
36159,2387,),O
36160,2388,Has,O
36161,2388,a,O
36162,2388,contact,O
36163,2388,lens,O
36164,2388,spherical,O
36165,2388,prescription,O
36166,2388,between,O
36167,2388,+,O
36168,2388,2.25,O
36169,2388,to,O
36170,2388,-,O
36171,2388,8.00,O
36172,2388,(,O
36173,2388,inclusive,O
36174,2388,),O
36175,2389,Has,O
36176,2389,a,O
36177,2389,spectacle,O
36178,2389,cylinder,O
36179,2389,up,O
36180,2389,to,O
36181,2389,0.75D,O
36182,2389,in,O
36183,2389,each,O
36184,2389,eye,O
36185,2389,.,O
36186,2390,Can,O
36187,2390,achieve,O
36188,2390,best,O
36189,2390,corrected,O
36190,2390,spectacle,O
36191,2390,distance,O
36192,2390,visual,O
36193,2390,acuity,O
36194,2390,of,O
36195,2390,20/25,O
36196,2390,(,O
36197,2390,0.10,O
36198,2390,logMAR,O
36199,2390,),O
36200,2390,or,O
36201,2390,better,O
36202,2390,in,O
36203,2390,each,O
36204,2390,eye,O
36205,2390,.,O
36206,2391,Can,O
36207,2391,achieve,O
36208,2391,a,O
36209,2391,distance,O
36210,2391,visual,O
36211,2391,acuity,O
36212,2391,of,O
36213,2391,20/30,O
36214,2391,(,O
36215,2391,0.18,O
36216,2391,logMAR,O
36217,2391,),O
36218,2391,or,O
36219,2391,better,O
36220,2391,in,O
36221,2391,each,O
36222,2391,eye,O
36223,2391,with,O
36224,2391,the,O
36225,2391,study,O
36226,2391,contact,O
36227,2391,lenses,O
36228,2391,.,O
36229,2392,Has,O
36230,2392,clear,B-Condition
36231,2392,corneas,I-Condition
36232,2392,and,O
36233,2392,no,O
36234,2392,active,O
36235,2392,ocular,B-Condition
36236,2392,disease,I-Condition
36237,2393,Has,O
36238,2393,read,O
36239,2393,",",O
36240,2393,understood,O
36241,2393,and,O
36242,2393,signed,O
36243,2393,the,O
36244,2393,information,O
36245,2393,consent,O
36246,2393,letter,O
36247,2393,.,O
36248,2394,Patient,O
36249,2394,contact,O
36250,2394,lens,O
36251,2394,refraction,O
36252,2394,should,O
36253,2394,fit,O
36254,2394,within,O
36255,2394,the,O
36256,2394,available,O
36257,2394,parameters,O
36258,2394,of,O
36259,2394,the,O
36260,2394,study,O
36261,2394,lenses,O
36262,2394,.,O
36263,2395,Is,O
36264,2395,willing,O
36265,2395,to,O
36266,2395,comply,O
36267,2395,with,O
36268,2395,the,O
36269,2395,wear,O
36270,2395,schedule,O
36271,2395,(,O
36272,2395,at,O
36273,2395,least,O
36274,2395,5,O
36275,2395,days,O
36276,2395,per,O
36277,2395,week,O
36278,2395,",",O
36279,2395,>,O
36280,2395,8,O
36281,2395,hours,O
36282,2395,/,O
36283,2395,day,O
36284,2395,assuming,O
36285,2395,there,O
36286,2395,are,O
36287,2395,no,O
36288,2395,contraindications,O
36289,2395,for,O
36290,2395,doing,O
36291,2395,so,O
36292,2395,),O
36293,2395,.,O
36294,2396,Is,O
36295,2396,willing,O
36296,2396,to,O
36297,2396,comply,O
36298,2396,with,O
36299,2396,the,O
36300,2396,visit,O
36301,2396,schedule,O
36302,2397,with,O
36303,2397,centre,B-Condition
36304,2397,neural,I-Condition
36305,2397,system,I-Condition
36306,2397,involvement,I-Condition
36307,2398,serious,O
36308,2398,complications,B-Condition
36309,2398,such,O
36310,2398,as,O
36311,2398,uncontrolled,O
36312,2398,diabetes,B-Condition
36313,2398,",",O
36314,2398,gastric,B-Condition
36315,2398,ulcer,I-Condition
36316,2398,or,O
36317,2398,other,O
36318,2398,serious,O
36319,2398,angiocardiopathy,B-Condition
36320,2398,determined,O
36321,2398,by,O
36322,2398,the,O
36323,2398,physician,O
36324,2399,HIV,B-Condition
36325,2399,positive,I-Condition
36326,2399,or,O
36327,2399,active,B-Condition
36328,2399,HBV,I-Condition
36329,2399,infection,I-Condition
36330,2399,or,O
36331,2399,other,O
36332,2399,uncontrolled,O
36333,2399,systematic,B-Condition
36334,2399,infection,I-Condition
36335,2400,clinical,O
36336,2400,central,B-Condition
36337,2400,nervous,I-Condition
36338,2400,dysfunction,I-Condition
36339,2401,serious,O
36340,2401,surgery,B-Procedure
36341,2401,within,O
36342,2401,30,O
36343,2401,days,O
36344,2402,pregnancy,B-Observation
36345,2402,or,O
36346,2402,baby,B-Observation
36347,2402,nursing,I-Observation
36348,2402,period,I-Observation
36349,2402,or,O
36350,2402,un,O
36351,2402,-,O
36352,2402,contracepted,B-Procedure
36353,2402,child,B-Observation
36354,2402,bearing,I-Observation
36355,2402,period,I-Observation
36356,2402,woman,B-Person
36357,2402,.,O
36358,2403,age=65,B-Person
36359,2403,years,O
36360,2404,diagnosis,O
36361,2404,with,O
36362,2404,mantle,B-Condition
36363,2404,cell,I-Condition
36364,2404,lymphoma,I-Condition
36365,2405,Ann,O
36366,2405,Arbor,O
36367,2405,stage,O
36368,2405,II,O
36369,2405,",",O
36370,2405,III,O
36371,2405,or,O
36372,2405,IV,O
36373,2406,ECOG=1,O
36374,2406,or,O
36375,2406,if,O
36376,2406,ECOG=2,O
36377,2406,but,O
36378,2406,recover,B-Condition
36379,2406,after,O
36380,2406,pretreatment,B-Procedure
36381,2406,.,O
36382,2407,no,O
36383,2407,consent,O
36384,2408,periprocedural,B-Condition
36385,2408,complications,I-Condition
36386,2408,requiring,B-Mood
36387,2408,continuation,O
36388,2408,of,O
36389,2408,heparin,B-Drug
36390,2408,or,O
36391,2408,administration,O
36392,2408,of,O
36393,2408,protamine,B-Drug
36394,2408,sulfate,I-Drug
36395,2409,alergy,B-Condition
36396,2409,to,O
36397,2409,fish,B-Drug
36398,2409,",",O
36399,2409,protamine,B-Drug
36400,2409,",",O
36401,2409,protamine,B-Drug
36402,2409,derivates,I-Drug
36403,2409,",",O
36404,2409,history,B-Observation
36405,2409,of,O
36406,2409,Humulin,B-Drug
36407,2409,N,I-Drug
36408,2409,",",O
36409,2409,Novolin,B-Drug
36410,2409,N,I-Drug
36411,2409,",",O
36412,2409,Novolin,B-Drug
36413,2409,NPH,I-Drug
36414,2409,",",O
36415,2409,Gensulin,B-Drug
36416,2409,N,I-Drug
36417,2409,",",O
36418,2409,SciLin,B-Drug
36419,2409,N,I-Drug
36420,2409,",",O
36421,2409,NPH,B-Drug
36422,2409,Iletin,I-Drug
36423,2409,II,I-Drug
36424,2409,and,O
36425,2409,isophane,B-Drug
36426,2409,insulin,I-Drug
36427,2409,intake,O
36428,2410,patients,O
36429,2410,who,O
36430,2410,underwent,O
36431,2410,successful,O
36432,2410,TAVI,B-Procedure
36433,2411,with,O
36434,2411,any,O
36435,2411,approved,O
36436,2411,TAVI,O
36437,2411,device,O
36438,2412,via,O
36439,2412,transfemoral,B-Procedure
36440,2412,access,I-Procedure
36441,2413,with,O
36442,2413,use,O
36443,2413,of,O
36444,2413,any,O
36445,2413,of,O
36446,2413,the,O
36447,2413,approved,O
36448,2413,vascular,O
36449,2413,closure,O
36450,2413,devices,O
36451,2414,provided,O
36452,2414,written,O
36453,2414,informed,O
36454,2414,consent,O
36455,2415,An,O
36456,2415,initial,O
36457,2415,plasma,O
36458,2415,sodium,O
36459,2415,concentration,O
36460,2415,of,O
36461,2415,lower,O
36462,2415,than,O
36463,2415,130,O
36464,2415,mmol,O
36465,2415,/,O
36466,2415,L,O
36467,2416,An,O
36468,2416,initial,O
36469,2416,plasma,O
36470,2416,sodium,O
36471,2416,concentration,O
36472,2416,of,O
36473,2416,higher,O
36474,2416,than,O
36475,2416,150,O
36476,2416,mmol,O
36477,2416,/,O
36478,2416,L,O
36479,2417,An,O
36480,2417,initial,O
36481,2417,plasma,O
36482,2417,potassium,O
36483,2417,concentration,O
36484,2417,of,O
36485,2417,lower,O
36486,2417,than,O
36487,2417,3.0,O
36488,2417,mmol,O
36489,2417,/,O
36490,2417,L,O
36491,2418,Need,B-Mood
36492,2418,for,I-Mood
36493,2418,10,B-Drug
36494,2418,%,I-Drug
36495,2418,glucose,I-Drug
36496,2418,solution,I-Drug
36497,2419,Diabetes,B-Condition
36498,2420,Diabetes,B-Condition
36499,2420,insipidus,I-Condition
36500,2421,Diabetic,B-Condition
36501,2421,ketoacidosis,I-Condition
36502,2422,Renal,B-Condition
36503,2422,disease,I-Condition
36504,2422,that,O
36505,2422,needs,B-Mood
36506,2422,dialysis,B-Procedure
36507,2423,Protocol,O
36508,2423,-,O
36509,2423,determined,O
36510,2423,chemotherapy,B-Procedure
36511,2423,hydration,I-Procedure
36512,2424,Severe,O
36513,2424,liver,B-Condition
36514,2424,disease,I-Condition
36515,2425,Inborn,B-Condition
36516,2425,errors,I-Condition
36517,2425,of,I-Condition
36518,2425,metabolism,I-Condition
36519,2425,that,O
36520,2425,need,B-Mood
36521,2425,protocol,O
36522,2425,-,O
36523,2425,determined,O
36524,2425,fluid,B-Procedure
36525,2425,therapy,I-Procedure
36526,2426,Acutely,B-Condition
36527,2426,ill,I-Condition
36528,2426,hospitalised,B-Observation
36529,2426,children,B-Person
36530,2427,Need,B-Mood
36531,2427,for,I-Mood
36532,2427,intravenous,B-Procedure
36533,2427,fluid,I-Procedure
36534,2427,therapy,I-Procedure
36535,2428,•,O
36536,2428,Diabetes,B-Condition
36537,2428,duration,O
36538,2428,>,O
36539,2428,12,O
36540,2428,years,O
36541,2429,Currently,O
36542,2429,taking,O
36543,2429,more,O
36544,2429,than,O
36545,2429,three,O
36546,2429,glucose,B-Procedure
36547,2429,lowering,I-Procedure
36548,2429,therapies,I-Procedure
36549,2430,Weight,B-Observation
36550,2430,-,I-Observation
36551,2430,loss,I-Observation
36552,2430,of,O
36553,2430,>,O
36554,2430,5,O
36555,2430,kg,O
36556,2430,in,O
36557,2430,the,O
36558,2430,preceding,O
36559,2430,6,O
36560,2430,months,O
36561,2431,Stage,O
36562,2431,4,O
36563,2431,or,O
36564,2431,5,O
36565,2431,chronic,B-Condition
36566,2431,kidney,I-Condition
36567,2431,disease,I-Condition
36568,2431,(,O
36569,2431,eGFR,O
36570,2431,<,O
36571,2431,30ml,O
36572,2431,/,O
36573,2431,min/1.73m2,O
36574,2431,),O
36575,2431,",",O
36576,2432,Current,O
36577,2432,therapy,O
36578,2432,with,O
36579,2432,Insulin,B-Drug
36580,2432,",",O
36581,2432,thiazolidinediones,B-Drug
36582,2432,",",O
36583,2432,steroids,B-Drug
36584,2432,or,O
36585,2432,atypical,B-Drug
36586,2432,antipsychotic,I-Drug
36587,2432,medication,I-Drug
36588,2433,Untreated,O
36589,2433,thyroid,B-Condition
36590,2433,disease,I-Condition
36591,2434,Known,O
36592,2434,macrovascular,B-Condition
36593,2434,disease,I-Condition
36594,2434,including,O
36595,2434,coronary,B-Condition
36596,2434,artery,I-Condition
36597,2434,disease,I-Condition
36598,2434,",",O
36599,2434,stroke,B-Condition
36600,2434,/,O
36601,2434,TIA,B-Condition
36602,2434,or,O
36603,2434,peripheral,B-Condition
36604,2434,vascular,I-Condition
36605,2434,disease,I-Condition
36606,2435,Presence,O
36607,2435,of,O
36608,2435,arrhythmia,B-Condition
36609,2435,(,O
36610,2435,including,O
36611,2435,atrial,B-Condition
36612,2435,fibrillation,I-Condition
36613,2435,",",O
36614,2435,atrial,B-Condition
36615,2435,flutter,I-Condition
36616,2435,",",O
36617,2435,or,O
36618,2435,2nd,B-Condition
36619,2435,or,I-Condition
36620,2435,3rd,I-Condition
36621,2435,degree,I-Condition
36622,2435,atrioventricular,I-Condition
36623,2435,block,I-Condition
36624,2435,),O
36625,2436,Known,O
36626,2436,heart,B-Condition
36627,2436,failure,I-Condition
36628,2437,Other,O
36629,2437,clinically,O
36630,2437,relevant,O
36631,2437,heart,B-Condition
36632,2437,disease,I-Condition
36633,2438,Inability,O
36634,2438,to,O
36635,2438,exercise,B-Observation
36636,2438,or,O
36637,2438,undertake,O
36638,2438,a,O
36639,2438,MRP,B-Procedure
36640,2439,Absolute,O
36641,2439,contraindication,B-Condition
36642,2439,to,O
36643,2439,CMR,B-Procedure
36644,2440,Cardiovascular,B-Condition
36645,2440,symptoms,I-Condition
36646,2440,(,O
36647,2440,angina,B-Condition
36648,2440,",",O
36649,2440,limiting,O
36650,2440,dyspnoea,B-Condition
36651,2440,during,O
36652,2440,normal,O
36653,2440,physical,O
36654,2440,activity,O
36655,2440,),O
36656,2441,Inflammatory,B-Condition
36657,2441,condition,O
36658,2441,e.g.,O
36659,2441,Connective,B-Condition
36660,2441,tissue,I-Condition
36661,2441,disorder,I-Condition
36662,2441,",",I-Condition
36663,2441,Rheumatoid,B-Condition
36664,2441,arthritis,I-Condition
36665,2442,Capacity,O
36666,2442,to,O
36667,2442,provide,O
36668,2442,informed,O
36669,2442,consent,O
36670,2442,before,O
36671,2442,any,O
36672,2442,trial,O
36673,2442,-,O
36674,2442,related,O
36675,2442,activities,O
36676,2443,Established,O
36677,2443,T2DM,B-Condition
36678,2443,(=,O
36679,2443,3months,O
36680,2443,),O
36681,2444,HbA1c,O
36682,2444,=,O
36683,2444,9,O
36684,2444,%,O
36685,2444,if,O
36686,2444,on,O
36687,2444,triple,O
36688,2444,therapy,O
36689,2444,or,O
36690,2444,=,O
36691,2444,10,O
36692,2444,%,O
36693,2444,on,O
36694,2444,diet,O
36695,2444,&,O
36696,2444,exercise,O
36697,2444,or,O
36698,2444,monotherapy,O
36699,2444,or,O
36700,2444,dual,O
36701,2444,therapy,O
36702,2445,Current,O
36703,2445,glucose,B-Procedure
36704,2445,lowering,I-Procedure
36705,2445,therapy,I-Procedure
36706,2445,either,O
36707,2445,mono,O
36708,2445,",",O
36709,2445,dual,O
36710,2445,or,O
36711,2445,triple,O
36712,2445,of,O
36713,2445,any,O
36714,2445,combination,O
36715,2445,of,O
36716,2445,metformin,B-Drug
36717,2445,",",O
36718,2445,sulphonylurea,B-Drug
36719,2445,",",O
36720,2445,DPP,B-Drug
36721,2445,-,I-Drug
36722,2445,IV,I-Drug
36723,2445,inhibitor,I-Drug
36724,2445,",",I-Drug
36725,2445,GLP-1,B-Drug
36726,2445,therapy,I-Drug
36727,2445,or,O
36728,2445,an,O
36729,2445,SGLT2,B-Drug
36730,2445,+,O
36731,2445,/-,O
36732,2445,diet,B-Observation
36733,2445,and,O
36734,2445,exercise,B-Observation
36735,2446,Poorly,O
36736,2446,managed,O
36737,2446,diet,O
36738,2446,controlled,O
36739,2446,diabetes,B-Condition
36740,2446,(,O
36741,2446,with,O
36742,2446,HbA1c,O
36743,2446,>,O
36744,2446,6.5,O
36745,2446,%,O
36746,2446,",",O
36747,2446,not,O
36748,2446,currently,O
36749,2446,taking,O
36750,2446,any,O
36751,2446,glucose,B-Procedure
36752,2446,lowering,I-Procedure
36753,2446,therapy,I-Procedure
36754,2446,",",O
36755,2446,meeting,O
36756,2446,BMI,O
36757,2446,inclusion,O
36758,2446,range,O
36759,2446,),O
36760,2447,Body,O
36761,2447,mass,O
36762,2447,index,O
36763,2447,>,O
36764,2447,30Kg,O
36765,2447,/,O
36766,2447,m2,O
36767,2447,or,O
36768,2447,>,O
36769,2447,27.5,O
36770,2447,Kg,O
36771,2447,/,O
36772,2447,m2,O
36773,2447,(,O
36774,2447,South,O
36775,2447,Asian,O
36776,2447,),O
36777,2447,",",O
36778,2448,Diagnosis,O
36779,2448,of,O
36780,2448,T2DM,B-Condition
36781,2448,before,O
36782,2448,the,O
36783,2448,age,B-Person
36784,2448,of,O
36785,2448,60,O
36786,2448,years,O
36787,2448,of,O
36788,2448,age,O
36789,2449,Age,B-Person
36790,2449,=,O
36791,2449,18,O
36792,2449,and,O
36793,2449,=,O
36794,2449,65,O
36795,2449,years,O
36796,2450,Patient,O
36797,2450,with,O
36798,2450,history,B-Observation
36799,2450,of,O
36800,2450,allergy,B-Condition
36801,2450,in,O
36802,2450,any,O
36803,2450,kind,O
36804,2450,anesthetic,B-Drug
36805,2450,drug,I-Drug
36806,2451,Patient,O
36807,2451,who,O
36808,2451,pregnant,B-Condition
36809,2452,Patient,O
36810,2452,who,O
36811,2452,sign,O
36812,2452,for,O
36813,2452,single,O
36814,2452,port,O
36815,2452,gynecologic,B-Procedure
36816,2452,laparoscopic,I-Procedure
36817,2452,surgery,I-Procedure
36818,2452,or,O
36819,2452,NOTE,B-Procedure
36820,2452,surgery,I-Procedure
36821,2453,Patient,O
36822,2453,whom,O
36823,2453,the,O
36824,2453,surgery,B-Procedure
36825,2453,is,O
36826,2453,withhold,B-Observation
36827,2453,or,O
36828,2453,canceled,B-Observation
36829,2454,Patient,O
36830,2454,whom,O
36831,2454,the,O
36832,2454,surgery,B-Procedure
36833,2454,is,O
36834,2454,converted,B-Observation
36835,2454,to,I-Observation
36836,2454,laparotomy,B-Procedure
36837,2455,Patient,O
36838,2455,who,O
36839,2455,undergoing,O
36840,2455,gynecologic,B-Procedure
36841,2455,laparoscopic,I-Procedure
36842,2455,surgery,I-Procedure
36843,2456,Patient,O
36844,2456,who,O
36845,2456,agrees,B-Observation
36846,2456,to,I-Observation
36847,2456,participate,I-Observation
36848,2456,in,I-Observation
36849,2456,this,I-Observation
36850,2456,study,I-Observation
36851,2457,Patient,O
36852,2457,able,B-Observation
36853,2457,to,I-Observation
36854,2457,speak,I-Observation
36855,2457,and,I-Observation
36856,2457,understand,I-Observation
36857,2457,Thai,I-Observation
36858,2458,Patient,O
36859,2458,able,B-Observation
36860,2458,to,I-Observation
36861,2458,complete,I-Observation
36862,2458,the,I-Observation
36863,2458,questionnaire,I-Observation
36864,2459,Subjects,O
36865,2459,who,O
36866,2459,have,O
36867,2459,systemic,B-Condition
36868,2459,infection,I-Condition
36869,2460,Subjects,O
36870,2460,who,O
36871,2460,have,O
36872,2460,human,B-Condition
36873,2460,Immunodeficiency,I-Condition
36874,2460,virus,I-Condition
36875,2460,(,I-Condition
36876,2460,HIV,I-Condition
36877,2460,),I-Condition
36878,2460,",",O
36879,2460,hepatitis,B-Condition
36880,2460,B,I-Condition
36881,2460,virus,I-Condition
36882,2460,(,I-Condition
36883,2460,HBV,I-Condition
36884,2460,),I-Condition
36885,2460,",",O
36886,2460,and,O
36887,2460,hepatitis,B-Condition
36888,2460,C,I-Condition
36889,2460,virus,I-Condition
36890,2460,(,I-Condition
36891,2460,HCV,I-Condition
36892,2460,),I-Condition
36893,2461,Subjects,O
36894,2461,who,O
36895,2461,need,O
36896,2461,to,O
36897,2461,take,O
36898,2461,the,O
36899,2461,medicine,O
36900,2461,which,O
36901,2461,is,O
36902,2461,prohibited,O
36903,2461,during,O
36904,2461,this,O
36905,2461,study,O
36906,2462,Subjects,O
36907,2462,who,O
36908,2462,have,O
36909,2462,asthma,B-Condition
36910,2463,Subjects,O
36911,2463,who,O
36912,2463,can,O
36913,2463,not,O
36914,2463,stop,O
36915,2463,treatment,O
36916,2463,with,O
36917,2463,topical,B-Drug
36918,2463,steroids,I-Drug
36919,2463,(,O
36920,2463,group,O
36921,2463,1~5,O
36922,2463,),O
36923,2463,",",O
36924,2463,oral,B-Drug
36925,2463,antibiotics,I-Drug
36926,2463,",",O
36927,2463,whole,B-Procedure
36928,2463,body,I-Procedure
36929,2463,photochemotherapy,I-Procedure
36930,2463,",",O
36931,2463,immunosuppressive,B-Drug
36932,2463,drug,I-Drug
36933,2463,within,O
36934,2463,4,O
36935,2463,weeks,O
36936,2463,before,O
36937,2463,the,O
36938,2463,treatment,O
36939,2463,visit,O
36940,2464,Pregnant,B-Condition
36941,2464,",",O
36942,2464,breast,B-Condition
36943,2464,-,I-Condition
36944,2464,feeding,I-Condition
36945,2464,women,B-Person
36946,2464,or,O
36947,2464,women,B-Person
36948,2464,who,O
36949,2464,plan,O
36950,2464,to,O
36951,2464,become,O
36952,2464,pregnant,B-Condition
36953,2464,during,O
36954,2464,this,O
36955,2464,study,O
36956,2464,(,O
36957,2464,Females,B-Person
36958,2464,of,O
36959,2464,childbearing,B-Condition
36960,2464,potential,I-Condition
36961,2464,must,O
36962,2464,have,O
36963,2464,a,O
36964,2464,negative,O
36965,2464,urine,O
36966,2464,pregnancy,O
36967,2464,test,O
36968,2464,),O
36969,2465,Subjects,O
36970,2465,who,O
36971,2465,currently,O
36972,2465,participate,O
36973,2465,in,O
36974,2465,other,O
36975,2465,clinical,O
36976,2465,trial,O
36977,2465,or,O
36978,2465,participated,O
36979,2465,in,O
36980,2465,other,O
36981,2465,clinical,O
36982,2465,trial,O
36983,2465,within,O
36984,2465,30,O
36985,2465,days,O
36986,2466,Subjects,O
36987,2466,who,O
36988,2466,had,O
36989,2466,a,O
36990,2466,serious,B-Condition
36991,2466,adverse,I-Condition
36992,2466,events,I-Condition
36993,2466,during,O
36994,2466,stem,B-Procedure
36995,2466,cell,I-Procedure
36996,2466,therapy,I-Procedure
36997,2467,Subjects,O
36998,2467,who,O
36999,2467,had,O
37000,2467,a,O
37001,2467,hypersensitivity,B-Condition
37002,2467,to,O
37003,2467,antibiotics,B-Drug
37004,2467,or,O
37005,2467,antimycotics,B-Drug
37006,2468,Subjects,O
37007,2468,who,O
37008,2468,creatinine,O
37009,2468,value,O
37010,2468,is,O
37011,2468,more,O
37012,2468,than,O
37013,2468,two,O
37014,2468,times,O
37015,2468,of,O
37016,2468,the,O
37017,2468,upper,O
37018,2468,limit,O
37019,2468,of,O
37020,2468,the,O
37021,2468,normal,O
37022,2468,range,O
37023,2468,at,O
37024,2468,screening,O
37025,2468,test,O
37026,2469,Subjects,O
37027,2469,who,O
37028,2469,aspartate,O
37029,2469,transaminase,O
37030,2469,/,O
37031,2469,alkaline,O
37032,2469,transaminase,O
37033,2469,(,O
37034,2469,AST,O
37035,2469,/,O
37036,2469,ALT,O
37037,2469,),O
37038,2469,value,O
37039,2469,is,O
37040,2469,more,O
37041,2469,than,O
37042,2469,three,O
37043,2469,times,O
37044,2469,of,O
37045,2469,the,O
37046,2469,upper,O
37047,2469,limit,O
37048,2469,of,O
37049,2469,the,O
37050,2469,normal,O
37051,2469,range,O
37052,2469,at,O
37053,2469,screening,O
37054,2469,test,O
37055,2470,Subjects,O
37056,2470,who,O
37057,2470,have,O
37058,2470,any,B-Condition
37059,2470,other,I-Condition
37060,2470,condition,I-Condition
37061,2470,which,O
37062,2470,the,O
37063,2470,investigator,O
37064,2470,judges,O
37065,2470,would,O
37066,2470,make,O
37067,2470,patients,O
37068,2470,unsuitable,O
37069,2470,for,O
37070,2470,study,O
37071,2470,participation,O
37072,2471,Of,O
37073,2471,either,O
37074,2471,gender,O
37075,2471,",",O
37076,2471,aged,B-Person
37077,2471,≥19,O
37078,2471,and,O
37079,2471,≤70,O
37080,2471,years,O
37081,2472,Atopic,B-Condition
37082,2472,dermatitis,I-Condition
37083,2472,subjects,O
37084,2472,who,O
37085,2472,are,O
37086,2472,coincident,O
37087,2472,with,O
37088,2472,Hanifin,O
37089,2472,and,O
37090,2472,Rajka,O
37091,2472,diagnosis,O
37092,2472,criteria,O
37093,2473,Subacute,O
37094,2473,and,O
37095,2473,chronic,O
37096,2473,atopic,O
37097,2473,subjects,O
37098,2473,who,O
37099,2473,have,O
37100,2473,atopic,O
37101,2473,dermatitis,B-Condition
37102,2473,symptoms,I-Condition
37103,2473,continually,O
37104,2473,at,O
37105,2473,least,O
37106,2473,6,O
37107,2473,months,O
37108,2474,Subjects,O
37109,2474,with,O
37110,2474,over,O
37111,2474,moderate,O
37112,2474,atopic,B-Condition
37113,2474,dermatitis,I-Condition
37114,2474,(,O
37115,2474,SCORAD,O
37116,2474,score,O
37117,2474,>,O
37118,2474,20,O
37119,2474,),O
37120,2475,Subjects,O
37121,2475,who,O
37122,2475,understand,O
37123,2475,and,O
37124,2475,voluntarily,O
37125,2475,sign,O
37126,2475,an,O
37127,2475,informed,O
37128,2475,consent,O
37129,2475,form,O
37130,2476,Past,O
37131,2476,history,O
37132,2476,of,O
37133,2476,hypersensitivity,B-Condition
37134,2476,to,O
37135,2476,aripiprazole,B-Drug
37136,2477,Primary,O
37137,2477,diagnosis,O
37138,2477,of,O
37139,2477,MDD,B-Condition
37140,2477,with,O
37141,2477,psychotic,B-Condition
37142,2477,feature,I-Condition
37143,2477,",",O
37144,2477,bipolar,B-Condition
37145,2477,disorder,I-Condition
37146,2477,",",O
37147,2477,schizophrenia,B-Condition
37148,2477,",",O
37149,2477,schizoaffective,B-Condition
37150,2477,disorder,I-Condition
37151,2477,",",O
37152,2477,other,O
37153,2477,psychotic,B-Condition
37154,2477,disorder,I-Condition
37155,2477,or,O
37156,2477,anxiety,B-Condition
37157,2477,disorder,I-Condition
37158,2477,",",I-Condition
37159,2477,a,O
37160,2477,history,O
37161,2477,of,O
37162,2477,alcohol/,B-Condition
37163,2477,drug,I-Condition
37164,2477,abuse,I-Condition
37165,2477,within,O
37166,2477,the,O
37167,2477,past,O
37168,2477,12,O
37169,2477,months,O
37170,2477,",",O
37171,2477,or,O
37172,2477,a,O
37173,2477,diagnosis,O
37174,2477,of,O
37175,2477,dementia,B-Condition
37176,2478,Clinically,O
37177,2478,significant,O
37178,2478,current,O
37179,2478,Axis,O
37180,2478,II,O
37181,2478,(,O
37182,2478,DSM,O
37183,2478,-,O
37184,2478,IV,O
37185,2478,-,O
37186,2478,TR,O
37187,2478,),O
37188,2478,diagnosis,B-Condition
37189,2479,A,O
37190,2479,significant,O
37191,2479,risk,B-Observation
37192,2479,of,I-Observation
37193,2479,suicide,I-Observation
37194,2479,corroborated,O
37195,2479,by,O
37196,2479,a,O
37197,2479,score,O
37198,2479,of,O
37199,2479,=,O
37200,2479,5,O
37201,2479,on,O
37202,2479,item,O
37203,2479,10(suicidal,O
37204,2479,thoughts,O
37205,2479,),O
37206,2479,on,O
37207,2479,the,O
37208,2479,MADRS,O
37209,2479,scale,O
37210,2479,or,O
37211,2479,by,O
37212,2479,clinical,O
37213,2479,judgment,O
37214,2479,of,O
37215,2479,the,O
37216,2479,investigator,O
37217,2480,Pregnancy,O
37218,2480,or,O
37219,2480,in,O
37220,2480,breast,O
37221,2480,-,O
37222,2480,feeding,O
37223,2481,Presence,O
37224,2481,of,O
37225,2481,a,O
37226,2481,serious,O
37227,2481,medical,B-Condition
37228,2481,illness,I-Condition
37229,2481,including,O
37230,2481,cardiac,B-Condition
37231,2481,",",O
37232,2481,hepatic,B-Condition
37233,2481,",",O
37234,2481,renal,B-Condition
37235,2481,",",O
37236,2481,respiratory,B-Condition
37237,2481,",",O
37238,2481,endocrinologic,B-Condition
37239,2481,",",O
37240,2481,neurologic,B-Condition
37241,2481,",",O
37242,2481,or,O
37243,2481,hematologic,B-Condition
37244,2481,disease,I-Condition
37245,2481,or,O
37246,2481,physical,B-Condition
37247,2481,disorder,I-Condition
37248,2481,judged,O
37249,2481,to,O
37250,2481,significantly,O
37251,2481,affect,O
37252,2481,central,O
37253,2481,nervous,O
37254,2481,system,O
37255,2481,function,O
37256,2482,Patients,O
37257,2482,taking,O
37258,2482,antipsychotics,B-Drug
37259,2482,",",O
37260,2482,mood,B-Drug
37261,2482,stabilizer,I-Drug
37262,2482,or,O
37263,2482,any,O
37264,2482,psychotropic,B-Drug
37265,2482,medications,I-Drug
37266,2482,besides,O
37267,2482,antidepressants,B-Drug
37268,2482,",",O
37269,2482,except,O
37270,2482,benzodiazepines,B-Drug
37271,2482,or,O
37272,2482,beta,B-Drug
37273,2482,blockers,I-Drug
37274,2482,or,O
37275,2482,hypnotics,B-Drug
37276,2483,Patients,O
37277,2483,with,O
37278,2483,past,O
37279,2483,treatment,B-Observation
37280,2483,failures,I-Observation
37281,2483,of,O
37282,2483,aripiprazole,B-Drug
37283,2484,Age,B-Person
37284,2484,:,O
37285,2484,18,O
37286,2484,-,O
37287,2484,65,O
37288,2485,Patients,O
37289,2485,with,O
37290,2485,major,B-Condition
37291,2485,depressive,I-Condition
37292,2485,disorder,I-Condition
37293,2485,according,O
37294,2485,to,O
37295,2485,DSM,O
37296,2485,-,O
37297,2485,IV,O
37298,2485,criteria,O
37299,2485,that,O
37300,2485,have,O
37301,2485,lasted,O
37302,2485,>,O
37303,2485,8,O
37304,2485,weeks,O
37305,2486,MADRS,O
37306,2486,total,O
37307,2486,score,O
37308,2486,of,O
37309,2486,18,O
37310,2486,or,O
37311,2486,higher,O
37312,2487,Patients,O
37313,2487,who,O
37314,2487,responded,B-Observation
37315,2487,inadequately,I-Observation
37316,2487,(,O
37317,2487,a,O
37318,2487,score,O
37319,2487,of,O
37320,2487,>,O
37321,2487,18,O
37322,2487,on,O
37323,2487,the,O
37324,2487,MADRS,O
37325,2487,),O
37326,2487,to,O
37327,2487,first,O
37328,2487,-,O
37329,2487,line,O
37330,2487,antidepressant,B-Drug
37331,2487,treatment,O
37332,2487,of,O
37333,2487,4,O
37334,2487,week,O
37335,2487,duration,O
37336,2488,Current,O
37337,2488,use,O
37338,2488,of,O
37339,2488,standard,O
37340,2488,antidepressant,B-Drug
37341,2488,treatment,O
37342,2488,in,O
37343,2488,monotherapy,O
37344,2488,or,O
37345,2488,combination,O
37346,2488,of,O
37347,2488,2,O
37348,2488,antidepressants,B-Drug
37349,2488,:,O
37350,2488,escitalopram,B-Drug
37351,2488,(,O
37352,2488,10,O
37353,2488,-,O
37354,2488,20mg,O
37355,2488,/,O
37356,2488,d,O
37357,2488,),O
37358,2488,",",O
37359,2488,fluoxetine(20,B-Drug
37360,2488,-,O
37361,2488,40mg,O
37362,2488,/,O
37363,2488,d,O
37364,2488,),O
37365,2488,",",O
37366,2488,paroxetine,B-Drug
37367,2488,CR(25,I-Drug
37368,2488,-,O
37369,2488,50mg,O
37370,2488,/,O
37371,2488,d,O
37372,2488,),O
37373,2488,",",O
37374,2488,sertraline(100,B-Drug
37375,2488,-,O
37376,2488,150mg,O
37377,2488,/,O
37378,2488,d,O
37379,2488,),O
37380,2488,",",O
37381,2488,mirtazapine,B-Drug
37382,2488,(,O
37383,2488,15,O
37384,2488,-,O
37385,2488,45mg,O
37386,2488,/,O
37387,2488,d,O
37388,2488,),O
37389,2488,",",O
37390,2488,duloxetine,B-Drug
37391,2488,(,O
37392,2488,30,O
37393,2488,-,O
37394,2488,60mg,O
37395,2488,/,O
37396,2488,d,O
37397,2488,),O
37398,2488,or,O
37399,2488,venlafaxine,B-Drug
37400,2488,ER(150,I-Drug
37401,2488,-,O
37402,2488,225mg,O
37403,2488,/,O
37404,2488,d,O
37405,2488,),O
37406,2489,Any,O
37407,2489,MS,B-Condition
37408,2489,relapse,B-Condition
37409,2489,in,O
37410,2489,the,O
37411,2489,last,O
37412,2489,five,O
37413,2489,years,O
37414,2489,",",O
37415,2489,as,O
37416,2489,determined,O
37417,2489,at,O
37418,2489,the,O
37419,2489,screen,O
37420,2489,visit,O
37421,2489,by,O
37422,2489,the,O
37423,2489,PI,O
37424,2490,Any,O
37425,2490,new,O
37426,2490,or,O
37427,2490,definitely,O
37428,2490,enlarging,O
37429,2490,T2,B-Condition
37430,2490,/,I-Condition
37431,2490,FLAIR,I-Condition
37432,2490,lesion,I-Condition
37433,2490,or,O
37434,2490,new,O
37435,2490,gadolinium,B-Drug
37436,2490,-,O
37437,2490,enhancing,O
37438,2490,lesion,B-Condition
37439,2490,within,O
37440,2490,the,O
37441,2490,past,O
37442,2490,three,O
37443,2490,years,O
37444,2490,(,O
37445,2490,at,O
37446,2490,least,O
37447,2490,two,O
37448,2490,scans,B-Procedure
37449,2490,separated,O
37450,2490,by,O
37451,2490,at,O
37452,2490,least,O
37453,2490,three,O
37454,2490,years,O
37455,2490,must,O
37456,2490,be,O
37457,2490,reviewed,O
37458,2490,),O
37459,2490,on,O
37460,2490,brain,B-Procedure
37461,2490,or,I-Procedure
37462,2490,spine,I-Procedure
37463,2490,MRI,I-Procedure
37464,2490,scan,I-Procedure
37465,2490,.,O
37466,2490,Lesions,B-Condition
37467,2490,must,O
37468,2490,be,O
37469,2490,3,O
37470,2490,mm,O
37471,2490,or,O
37472,2490,larger,O
37473,2490,to,O
37474,2490,be,O
37475,2490,exclusionary,O
37476,2490,.,O
37477,2491,Significant,O
37478,2491,(,O
37479,2491,as,O
37480,2491,defined,O
37481,2491,by,O
37482,2491,the,O
37483,2491,PI,O
37484,2491,),O
37485,2491,intolerance,B-Condition
37486,2491,of,O
37487,2491,presently,O
37488,2491,-,O
37489,2491,used,O
37490,2491,DMT,B-Drug
37491,2492,Use,O
37492,2492,of,O
37493,2492,inhaled,B-Drug
37494,2492,or,I-Drug
37495,2492,topical,I-Drug
37496,2492,steroids,I-Drug
37497,2492,are,O
37498,2492,not,O
37499,2492,an,O
37500,2492,exclusion,O
37501,2492,criteria,O
37502,2492,.,O
37503,2493,Use,O
37504,2493,of,O
37505,2493,oral,B-Drug
37506,2493,steroids,I-Drug
37507,2493,for,O
37508,2493,no,O
37509,2493,greater,O
37510,2493,than,O
37511,2493,14,O
37512,2493,days,O
37513,2493,given,O
37514,2493,for,O
37515,2493,a,O
37516,2493,non,B-Condition
37517,2493,-,I-Condition
37518,2493,MS,I-Condition
37519,2493,condition,I-Condition
37520,2493,is,O
37521,2493,not,O
37522,2493,exclusionary,O
37523,2493,.,O
37524,2494,alemtuzumab,B-Drug
37525,2494,",",O
37526,2495,mitoxantrone,B-Drug
37527,2495,",",O
37528,2496,cyclophosphamide,B-Drug
37529,2496,",",O
37530,2497,methotrexate,B-Drug
37531,2497,",",O
37532,2498,cyclosporine,B-Drug
37533,2498,",",O
37534,2498,or,O
37535,2499,rituximab,B-Drug
37536,2500,Prior,O
37537,2500,use,O
37538,2500,of,O
37539,2500,any,O
37540,2500,experimental,O
37541,2500,agent,O
37542,2500,used,O
37543,2500,as,O
37544,2500,a,O
37545,2500,DMT,O
37546,2500,for,O
37547,2500,MS,O
37548,2500,in,O
37549,2500,the,O
37550,2500,last,O
37551,2500,five,O
37552,2500,years,O
37553,2501,uncontrolled,O
37554,2501,hypertension,B-Condition
37555,2501,",",O
37556,2502,uncontrolled,O
37557,2502,diabetes,B-Condition
37558,2502,",",O
37559,2503,uncontrolled,O
37560,2503,asthma,B-Condition
37561,2503,",",O
37562,2503,or,O
37563,2504,uncontrolled,O
37564,2504,depression,B-Condition
37565,2505,Cancers,B-Condition
37566,2505,other,O
37567,2505,than,O
37568,2505,basal,B-Condition
37569,2505,cell,I-Condition
37570,2505,skin,I-Condition
37571,2505,cancers,I-Condition
37572,2505,within,O
37573,2505,the,O
37574,2505,last,O
37575,2505,5,O
37576,2505,years,O
37577,2506,Unable,O
37578,2506,to,O
37579,2506,give,O
37580,2506,informed,O
37581,2506,consent,O
37582,2506,or,O
37583,2506,follow,O
37584,2506,the,O
37585,2506,protocol,O
37586,2507,Unable,B-Mood
37587,2507,to,I-Mood
37588,2507,undergo,I-Mood
37589,2507,brain,B-Procedure
37590,2507,MRI,I-Procedure
37591,2508,Unwilling,O
37592,2508,to,O
37593,2508,be,O
37594,2508,randomized,O
37595,2508,per,O
37596,2508,this,O
37597,2508,protocol,O
37598,2509,History,B-Observation
37599,2509,of,I-Observation
37600,2509,other,O
37601,2509,chronic,B-Condition
37602,2509,neurological,I-Condition
37603,2509,illnesses,I-Condition
37604,2509,that,O
37605,2509,might,O
37606,2509,mimic,O
37607,2509,MS,O
37608,2509,with,O
37609,2509,chronic,O
37610,2509,or,O
37611,2509,intermittent,O
37612,2509,symptoms,O
37613,2509,(,O
37614,2509,i.e.,O
37615,2509,ALS,B-Condition
37616,2509,",",O
37617,2509,myasthenia,B-Condition
37618,2509,gravis,I-Condition
37619,2509,",",O
37620,2509,chronic,B-Condition
37621,2509,neuropathy,I-Condition
37622,2509,",",O
37623,2509,etc,O
37624,2509,.,O
37625,2509,),O
37626,2510,Patients,O
37627,2510,with,O
37628,2510,either,O
37629,2510,Relapsing,B-Condition
37630,2510,-,I-Condition
37631,2510,remitting,I-Condition
37632,2510,MS,I-Condition
37633,2510,(,I-Condition
37634,2510,RRMS,I-Condition
37635,2510,),I-Condition
37636,2510,",",O
37637,2510,Secondary,B-Condition
37638,2510,progressive,I-Condition
37639,2510,MS,I-Condition
37640,2510,(,I-Condition
37641,2510,SPMS,I-Condition
37642,2510,),I-Condition
37643,2510,",",O
37644,2510,or,O
37645,2510,Primary,B-Condition
37646,2510,progressive,I-Condition
37647,2510,MS,I-Condition
37648,2510,(,I-Condition
37649,2510,PPMS,I-Condition
37650,2510,),I-Condition
37651,2510,by,O
37652,2510,McDonald,O
37653,2510,2010,O
37654,2510,criteria,O
37655,2510,.,O
37656,2511,Patients,O
37657,2511,defined,O
37658,2511,by,O
37659,2511,subtype,O
37660,2511,based,O
37661,2511,on,O
37662,2511,2013,O
37663,2511,updated,O
37664,2511,phenotypic,O
37665,2511,criteria,O
37666,2511,.,O
37667,2512,prospectively,O
37668,2512,with,O
37669,2512,an,O
37670,2512,EDSS,B-Condition
37671,2512,change,I-Condition
37672,2512,of,O
37673,2512,at,O
37674,2512,least,O
37675,2512,1.0,O
37676,2512,points,O
37677,2512,over,O
37678,2512,the,O
37679,2512,last,O
37680,2512,two,O
37681,2512,years,O
37682,2512,",",O
37683,2512,or,O
37684,2513,retrospectively,O
37685,2513,",",O
37686,2513,with,O
37687,2513,any,O
37688,2513,significant,O
37689,2513,change,B-Condition
37690,2513,in,I-Condition
37691,2513,motor,I-Condition
37692,2513,function,I-Condition
37693,2513,over,O
37694,2513,at,O
37695,2513,least,O
37696,2513,one,O
37697,2513,year,O
37698,2513,",",O
37699,2513,unrelated,O
37700,2513,to,O
37701,2513,relapse,O
37702,2513,.,O
37703,2514,55,O
37704,2514,years,O
37705,2514,of,O
37706,2514,age,B-Person
37707,2514,or,O
37708,2514,older,O
37709,2514,at,O
37710,2514,time,O
37711,2514,of,O
37712,2514,randomization,O
37713,2514,;,O
37714,2515,No,O
37715,2515,evidence,O
37716,2515,of,O
37717,2515,recent,O
37718,2515,new,O
37719,2515,inflammatory,B-Condition
37720,2515,disease,I-Condition
37721,2515,activity,O
37722,2515,(,O
37723,2515,inactive,O
37724,2515,by,O
37725,2515,the,O
37726,2515,Lublin,O
37727,2515,criteria16,O
37728,2515,),O
37729,2515,with,O
37730,2515,no,O
37731,2515,new,O
37732,2515,relapse,B-Condition
37733,2515,for,O
37734,2515,at,O
37735,2515,least,O
37736,2515,five,O
37737,2515,years,O
37738,2515,and,O
37739,2515,no,O
37740,2515,new,O
37741,2515,MRI,B-Procedure
37742,2515,lesion,B-Condition
37743,2515,for,O
37744,2515,at,O
37745,2515,least,O
37746,2515,three,O
37747,2515,years,O
37748,2516,interferon,B-Drug
37749,2516,ß-1a,I-Drug
37750,2516,",",O
37751,2517,interferon,B-Drug
37752,2517,ß-1b,I-Drug
37753,2517,",",O
37754,2518,glatiramer,B-Drug
37755,2518,acetate,I-Drug
37756,2518,",",O
37757,2519,natalizumab,B-Drug
37758,2519,",",O
37759,2520,fingolimod,B-Drug
37760,2520,",",O
37761,2521,dimethyl,B-Drug
37762,2521,fumarate,I-Drug
37763,2521,",",O
37764,2521,or,O
37765,2522,teriflunomide,B-Drug
37766,2522,;,O
37767,2522,continuously,O
37768,2522,for,O
37769,2522,no,O
37770,2522,less,O
37771,2522,than,O
37772,2522,5,O
37773,2522,years,O
37774,2522,.,O
37775,2523,Taking,O
37776,2523,most,O
37777,2523,recent,O
37778,2523,DMT,B-Drug
37779,2523,continuously,O
37780,2523,*,O
37781,2523,for,O
37782,2523,no,O
37783,2523,less,O
37784,2523,than,O
37785,2523,two,O
37786,2523,years,O
37787,2523,.,O
37788,2524,Willing,O
37789,2524,to,O
37790,2524,be,O
37791,2524,randomized,O
37792,2524,per,O
37793,2524,this,O
37794,2524,protocol,O
37795,2524,;,O
37796,2524,each,O
37797,2524,patient,O
37798,2524,will,O
37799,2524,be,O
37800,2524,questioned,O
37801,2524,as,O
37802,2524,to,O
37803,2524,their,O
37804,2524,willingness,O
37805,2524,to,O
37806,2524,stay,O
37807,2524,in,O
37808,2524,the,O
37809,2524,trial,O
37810,2524,regardless,O
37811,2524,of,O
37812,2524,the,O
37813,2524,group,O
37814,2524,to,O
37815,2524,which,O
37816,2524,group,O
37817,2524,they,O
37818,2524,are,O
37819,2524,randomized,O
37820,2524,.,O
37821,2525,Willing,O
37822,2525,to,O
37823,2525,follow,O
37824,2525,the,O
37825,2525,protocol,O
37826,2526,Continuously,O
37827,2526,will,O
37828,2526,be,O
37829,2526,defined,O
37830,2526,as,O
37831,2526,no,O
37832,2526,less,O
37833,2526,than,O
37834,2526,75,O
37835,2526,%,O
37836,2526,of,O
37837,2526,all,O
37838,2526,prescribed,O
37839,2526,doses,O
37840,2526,",",O
37841,2526,with,O
37842,2526,no,O
37843,2526,time,O
37844,2526,of,O
37845,2526,greater,O
37846,2526,than,O
37847,2526,four,O
37848,2526,weeks,O
37849,2526,from,O
37850,2526,last,O
37851,2526,intended,O
37852,2526,dose,O
37853,2526,to,O
37854,2526,have,O
37855,2526,missed,O
37856,2526,a,O
37857,2526,dose,O
37858,2526,(,O
37859,2526,8,O
37860,2526,weeks,O
37861,2526,for,O
37862,2526,natalizumab,O
37863,2526,",",O
37864,2526,i.e.,O
37865,2526,one,O
37866,2526,missed,O
37867,2526,dose,O
37868,2526,),O
37869,2526,.,O
37870,2527,History,O
37871,2527,of,O
37872,2527,severe,O
37873,2527,related,O
37874,2527,adverse,B-Condition
37875,2527,event(s,I-Condition
37876,2527,),O
37877,2527,from,O
37878,2527,previous,O
37879,2527,participation,O
37880,2527,in,O
37881,2527,VA-001,O
37882,2527,or,O
37883,2527,VA-006,O
37884,2527,trials,O
37885,2527,or,O
37886,2527,to,O
37887,2527,any,O
37888,2527,smallpox,B-Procedure
37889,2527,vaccination,I-Procedure
37890,2527,.,O
37891,2528,Eczema,B-Condition
37892,2528,",",O
37893,2528,history,B-Observation
37894,2528,of,I-Observation
37895,2528,eczema,I-Observation
37896,2528,",",O
37897,2528,exfoliative,B-Condition
37898,2528,skin,I-Condition
37899,2528,conditions,I-Condition
37900,2528,",",O
37901,2528,wounds,B-Condition
37902,2528,",",O
37903,2528,burns,B-Condition
37904,2528,",",O
37905,2528,or,O
37906,2528,other,B-Condition
37907,2528,skin,I-Condition
37908,2528,conditions,I-Condition
37909,2528,at,O
37910,2528,the,O
37911,2528,investigator,O
37912,2528,'s,O
37913,2528,discretion,O
37914,2528,.,O
37915,2529,A,O
37916,2529,history,B-Condition
37917,2529,of,I-Condition
37918,2529,immunodeficiency,I-Condition
37919,2529,.,O
37920,2530,Currently,O
37921,2530,or,O
37922,2530,has,O
37923,2530,recently,O
37924,2530,received,O
37925,2530,radiotherapy,B-Procedure
37926,2530,or,O
37927,2530,chemotherapy,B-Procedure
37928,2530,",",O
37929,2530,adrenocorticotropic,B-Drug
37930,2530,hormone,I-Drug
37931,2530,(,O
37932,2530,ACTH,B-Drug
37933,2530,),O
37934,2530,",",O
37935,2530,corticosteroids,B-Drug
37936,2530,",",O
37937,2530,or,O
37938,2530,immunosuppressive,B-Procedure
37939,2530,drugs,I-Procedure
37940,2530,.,O
37941,2531,Eye,B-Condition
37942,2531,disease,I-Condition
37943,2531,treated,O
37944,2531,with,O
37945,2531,topical,B-Procedure
37946,2531,steroids,I-Procedure
37947,2531,.,O
37948,2532,Known,O
37949,2532,or,O
37950,2532,suspected,O
37951,2532,disorders,B-Condition
37952,2532,of,I-Condition
37953,2532,immunoglobulin,I-Condition
37954,2532,synthesis,I-Condition
37955,2532,.,O
37956,2533,Leukemia,B-Condition
37957,2533,",",O
37958,2533,lymphomas,B-Condition
37959,2533,of,O
37960,2533,any,O
37961,2533,type,O
37962,2533,",",O
37963,2533,melanoma,B-Condition
37964,2533,",",O
37965,2533,or,O
37966,2533,other,O
37967,2533,malignant,B-Condition
37968,2533,neoplasms,I-Condition
37969,2533,affecting,O
37970,2533,the,O
37971,2533,bone,B-Condition
37972,2533,marrow,I-Condition
37973,2533,or,O
37974,2533,lymphatic,B-Condition
37975,2533,systems,I-Condition
37976,2533,.,O
37977,2534,Has,O
37978,2534,been,O
37979,2534,diagnosed,B-Condition
37980,2534,with,I-Condition
37981,2534,cancer,I-Condition
37982,2534,and,O
37983,2534,who,O
37984,2534,will,O
37985,2534,be,O
37986,2534,undergoing,O
37987,2534,chemotherapy,B-Procedure
37988,2534,or,O
37989,2534,radiation,B-Procedure
37990,2534,therapy,I-Procedure
37991,2534,during,O
37992,2534,the,O
37993,2534,vaccination,O
37994,2534,healing,O
37995,2534,time,O
37996,2534,.,O
37997,2535,Is,O
37998,2535,a,O
37999,2535,transplant,B-Person
38000,2535,recipient,I-Person
38001,2535,(,O
38002,2535,except,O
38003,2535,for,O
38004,2535,corneal,B-Condition
38005,2535,transplant,I-Condition
38006,2535,),O
38007,2535,.,O
38008,2536,Is,O
38009,2536,pregnant,B-Condition
38010,2536,",",O
38011,2536,planning,B-Observation
38012,2536,pregnancy,I-Observation
38013,2536,or,O
38014,2536,breast,B-Observation
38015,2536,feeding,I-Observation
38016,2536,(,O
38017,2536,female,B-Person
38018,2536,subjects,O
38019,2536,of,O
38020,2536,childbearing,B-Observation
38021,2536,potential,I-Observation
38022,2536,must,O
38023,2536,have,O
38024,2536,negative,O
38025,2536,pregnancy,O
38026,2536,test,O
38027,2536,prior,O
38028,2536,to,O
38029,2536,vaccination,B-Procedure
38030,2536,),O
38031,2536,.,O
38032,2537,Household,B-Person
38033,2537,or,O
38034,2537,other,O
38035,2537,close,B-Person
38036,2537,/,I-Person
38037,2537,intimate,I-Person
38038,2537,contact(s,I-Person
38039,2537,),I-Person
38040,2537,under,O
38041,2537,the,O
38042,2537,age,B-Person
38043,2537,of,O
38044,2537,12,O
38045,2537,months,O
38046,2537,.,O
38047,2538,History,O
38048,2538,of,O
38049,2538,allergies,B-Condition
38050,2538,to,O
38051,2538,phenol,B-Drug
38052,2538,",",O
38053,2538,any,O
38054,2538,of,O
38055,2538,the,O
38056,2538,antibiotics,B-Procedure
38057,2538,listed,O
38058,2538,in,O
38059,2538,the,O
38060,2538,vaccine,B-Procedure
38061,2538,content,O
38062,2538,",",O
38063,2538,or,O
38064,2538,any,O
38065,2538,other,O
38066,2538,component,O
38067,2538,of,O
38068,2538,ACAM2000,B-Drug
38069,2538,or,I-Drug
38070,2538,its,I-Drug
38071,2538,diluents,I-Drug
38072,2538,.,O
38073,2539,Subjects,O
38074,2539,with,O
38075,2539,kidney,B-Condition
38076,2539,disease,I-Condition
38077,2539,(,O
38078,2539,except,O
38079,2539,kidney,B-Condition
38080,2539,stones,I-Condition
38081,2539,),O
38082,2539,.,O
38083,2540,Subjects,O
38084,2540,with,O
38085,2540,abnormal,O
38086,2540,EKG,B-Procedure
38087,2540,at,O
38088,2540,screening,O
38089,2540,(,O
38090,2540,if,O
38091,2540,applicable,O
38092,2540,),O
38093,2540,.,O
38094,2540,To,O
38095,2540,mitigate,O
38096,2540,the,O
38097,2540,risk,O
38098,2540,of,O
38099,2540,enrolling,O
38100,2540,at,O
38101,2540,risk,O
38102,2540,subjects,O
38103,2540,and,O
38104,2540,potentially,O
38105,2540,jeopardizing,O
38106,2540,subject,O
38107,2540,safety,O
38108,2540,an,O
38109,2540,EKG,O
38110,2540,will,O
38111,2540,be,O
38112,2540,performed,O
38113,2540,prior,O
38114,2540,to,O
38115,2540,vaccination,O
38116,2540,with,O
38117,2540,ACAM2000,O
38118,2540,smallpox,O
38119,2540,vaccine,O
38120,2540,in,O
38121,2540,all,O
38122,2540,potential,O
38123,2540,subjects,O
38124,2540,=,O
38125,2540,50,O
38126,2540,years,O
38127,2540,old,O
38128,2540,and,O
38129,2540,for,O
38130,2540,all,O
38131,2540,potential,O
38132,2540,subjects,O
38133,2540,<,O
38134,2540,50,O
38135,2540,with,O
38136,2540,two,O
38137,2540,cardiac,O
38138,2540,risk,O
38139,2540,factors,O
38140,2540,as,O
38141,2540,listed,O
38142,2540,immediately,O
38143,2540,below,O
38144,2540,including,O
38145,2540,;,O
38146,2540,severely,O
38147,2540,or,O
38148,2540,morbidly,O
38149,2540,obese,O
38150,2540,or,O
38151,2540,higher,O
38152,2540,obesity,O
38153,2540,classification,O
38154,2540,(,O
38155,2540,BMI,O
38156,2540,=,O
38157,2540,36,O
38158,2540,),O
38159,2540,;,O
38160,2540,high,O
38161,2540,blood,O
38162,2540,pressure,O
38163,2540,;,O
38164,2540,high,O
38165,2540,blood,O
38166,2540,cholesterol,O
38167,2540,;,O
38168,2540,diabetes,O
38169,2540,or,O
38170,2540,high,O
38171,2540,blood,O
38172,2540,sugar,O
38173,2540,;,O
38174,2540,a,O
38175,2540,first,O
38176,2540,degree,O
38177,2540,relative,O
38178,2540,who,O
38179,2540,had,O
38180,2540,a,O
38181,2540,heart,O
38182,2540,condition,O
38183,2540,before,O
38184,2540,the,O
38185,2540,age,O
38186,2540,of,O
38187,2540,50,O
38188,2540,;,O
38189,2540,and,O
38190,2540,current,O
38191,2540,tobacco,O
38192,2540,smokers,O
38193,2540,.,O
38194,2541,Severely,O
38195,2541,or,O
38196,2541,morbidly,O
38197,2541,obese,B-Condition
38198,2541,or,O
38199,2541,higher,B-Observation
38200,2541,obesity,I-Observation
38201,2541,classification,I-Observation
38202,2541,(,O
38203,2541,BMI,O
38204,2541,=,O
38205,2541,36,O
38206,2541,),O
38207,2542,High,B-Condition
38208,2542,blood,I-Condition
38209,2542,pressure,I-Condition
38210,2542,diagnosed,O
38211,2542,by,O
38212,2542,a,O
38213,2542,doctor,O
38214,2543,High,B-Condition
38215,2543,blood,I-Condition
38216,2543,cholesterol,I-Condition
38217,2543,diagnosed,O
38218,2543,by,O
38219,2543,a,O
38220,2543,doctor,O
38221,2544,Diabetes,B-Condition
38222,2544,or,O
38223,2544,high,B-Condition
38224,2544,blood,I-Condition
38225,2544,sugar,I-Condition
38226,2544,diagnosed,O
38227,2544,by,O
38228,2544,a,O
38229,2544,doctor,O
38230,2545,A,B-Person
38231,2545,first,I-Person
38232,2545,degree,I-Person
38233,2545,relative,I-Person
38234,2545,(,O
38235,2545,for,O
38236,2545,example,O
38237,2545,",",O
38238,2545,mother,B-Person
38239,2545,",",O
38240,2545,father,B-Person
38241,2545,",",O
38242,2545,brother,B-Person
38243,2545,",",O
38244,2545,sister,B-Person
38245,2545,),O
38246,2545,who,O
38247,2545,had,O
38248,2545,a,O
38249,2545,heart,B-Condition
38250,2545,condition,I-Condition
38251,2545,before,O
38252,2545,the,O
38253,2545,age,B-Person
38254,2545,of,O
38255,2545,50,O
38256,2546,Currently,O
38257,2546,smokes,B-Observation
38258,2546,tobacco,I-Observation
38259,2546,(,I-Observation
38260,2546,cigarettes,I-Observation
38261,2546,),O
38262,2547,Arrhythmia,B-Condition
38263,2548,Syncope,B-Condition
38264,2548,related,O
38265,2548,to,O
38266,2548,cardiac,B-Condition
38267,2548,disease,I-Condition
38268,2549,Previous,B-Condition
38269,2549,myocardial,I-Condition
38270,2549,infarction,I-Condition
38271,2550,Angina,B-Condition
38272,2551,Coronary,B-Condition
38273,2551,artery,I-Condition
38274,2551,disease,I-Condition
38275,2552,Congestive,B-Condition
38276,2552,heart,I-Condition
38277,2552,failure,I-Condition
38278,2553,Cardiomyopathy,B-Condition
38279,2554,Stroke,B-Condition
38280,2554,or,O
38281,2554,transient,B-Condition
38282,2554,ischemic,I-Condition
38283,2554,attack,I-Condition
38284,2555,Myocarditis,B-Condition
38285,2556,Pericarditis,B-Condition
38286,2557,Chest,B-Condition
38287,2557,pain,I-Condition
38288,2557,or,O
38289,2557,shortness,B-Condition
38290,2557,of,I-Condition
38291,2557,breath,I-Condition
38292,2557,with,I-Condition
38293,2557,activity,I-Condition
38294,2557,(,O
38295,2557,such,O
38296,2557,as,O
38297,2557,climbing,O
38298,2557,stairs,O
38299,2557,),O
38300,2557,",",O
38301,2557,peripheral,B-Condition
38302,2557,edema,I-Condition
38303,2557,",",O
38304,2557,heart,B-Condition
38305,2557,palpitations,I-Condition
38306,2557,",",O
38307,2557,dry,B-Condition
38308,2557,cough,I-Condition
38309,2557,",",O
38310,2557,irregular,B-Condition
38311,2557,heartbeat,I-Condition
38312,2557,",",O
38313,2557,excessive,B-Condition
38314,2557,fatigue,I-Condition
38315,2557,",",O
38316,2557,unexplained,O
38317,2557,syncope,B-Condition
38318,2558,Other,B-Condition
38319,2558,heart,I-Condition
38320,2558,conditions,I-Condition
38321,2558,being,O
38322,2558,treated,O
38323,2558,by,O
38324,2558,a,O
38325,2558,physician,O
38326,2559,Signed,O
38327,2559,written,O
38328,2559,informed,O
38329,2559,consent,O
38330,2559,.,O
38331,2560,Age,B-Person
38332,2560,18,O
38333,2560,to,O
38334,2560,65,O
38335,2560,.,O
38336,2561,Normal,O
38337,2561,and,O
38338,2561,healthy,O
38339,2561,(,O
38340,2561,immune,O
38341,2561,competent,O
38342,2561,),O
38343,2561,as,O
38344,2561,determined,O
38345,2561,by,O
38346,2561,medical,B-Observation
38347,2561,history,I-Observation
38348,2561,",",O
38349,2561,physical,B-Procedure
38350,2561,exam,I-Procedure
38351,2561,",",O
38352,2561,vital,O
38353,2561,signs,O
38354,2561,and,O
38355,2561,clinical,O
38356,2561,laboratory,O
38357,2561,tests,O
38358,2561,during,O
38359,2561,the,O
38360,2561,screening,O
38361,2561,period,O
38362,2561,.,O
38363,2562,If,O
38364,2562,all,O
38365,2562,lab,O
38366,2562,results,O
38367,2562,for,O
38368,2562,quantitative,O
38369,2562,IgA,O
38370,2562,immunoglobulin,O
38371,2562,level,O
38372,2562,are,O
38373,2562,lower,O
38374,2562,than,O
38375,2562,15,O
38376,2562,%,O
38377,2562,below,O
38378,2562,normal,O
38379,2562,range,O
38380,2562,",",O
38381,2562,the,O
38382,2562,subject,O
38383,2562,may,O
38384,2562,not,O
38385,2562,proceed,O
38386,2562,further,O
38387,2562,in,O
38388,2562,the,O
38389,2562,screening,O
38390,2562,process,O
38391,2562,.,O
38392,2563,Subject,O
38393,2563,must,O
38394,2563,meet,O
38395,2563,all,O
38396,2563,required,O
38397,2563,subject,O
38398,2563,suitability,O
38399,2563,criteria,O
38400,2563,that,O
38401,2563,pertain,O
38402,2563,to,O
38403,2563,normal,O
38404,2563,source,O
38405,2563,plasma,O
38406,2563,donors,O
38407,2563,.,O
38408,2564,Negative,O
38409,2564,HIV,O
38410,2564,serology,O
38411,2564,during,O
38412,2564,screening,O
38413,2564,period,O
38414,2564,.,O
38415,2565,Subject,O
38416,2565,must,O
38417,2565,have,O
38418,2565,been,O
38419,2565,previously,O
38420,2565,immunized,B-Procedure
38421,2565,for,O
38422,2565,smallpox,B-Condition
38423,2565,",",O
38424,2565,at,O
38425,2565,=3,O
38426,2565,years,O
38427,2565,prior,O
38428,2565,to,O
38429,2565,commencement,O
38430,2565,of,O
38431,2565,screening,O
38432,2565,assessments,O
38433,2565,",",O
38434,2565,and,O
38435,2565,vaccination,O
38436,2565,history,O
38437,2565,must,O
38438,2565,be,O
38439,2565,confirmed,O
38440,2565,by,O
38441,2565,oral,O
38442,2565,or,O
38443,2565,written,O
38444,2565,history,O
38445,2565,and,O
38446,2565,the,O
38447,2565,presence,O
38448,2565,of,O
38449,2565,a,O
38450,2565,visible,O
38451,2565,pathognomonic,O
38452,2565,smallpox,O
38453,2565,vaccination,O
38454,2565,scar,O
38455,2565,.,O
38456,2566,Female,B-Person
38457,2566,subjects,O
38458,2566,of,O
38459,2566,childbearing,B-Condition
38460,2566,potential,I-Condition
38461,2566,must,O
38462,2566,agree,O
38463,2566,to,O
38464,2566,use,O
38465,2566,highly,O
38466,2566,effective,O
38467,2566,birth,B-Procedure
38468,2566,control,I-Procedure
38469,2566,methods,I-Procedure
38470,2566,.,O
38471,2567,The,O
38472,2567,use,O
38473,2567,of,O
38474,2567,beta,B-Drug
38475,2567,blockers,I-Drug
38476,2567,within,O
38477,2567,2,O
38478,2567,months,O
38479,2567,of,O
38480,2567,randomization,O
38481,2568,Patients,O
38482,2568,actively,O
38483,2568,listed,B-Observation
38484,2568,for,I-Observation
38485,2568,transplantation,I-Observation
38486,2568,at,O
38487,2568,time,O
38488,2568,of,O
38489,2568,entry,O
38490,2568,into,O
38491,2568,the,O
38492,2568,study,O
38493,2568,or,O
38494,2568,anticipated,B-Mood
38495,2568,to,I-Mood
38496,2568,undergo,I-Mood
38497,2568,heart,B-Procedure
38498,2568,transplantation,I-Procedure
38499,2568,",",O
38500,2568,interventional,B-Procedure
38501,2568,catheterization,I-Procedure
38502,2568,",",O
38503,2568,or,O
38504,2568,corrective,B-Procedure
38505,2568,cardiac,I-Procedure
38506,2568,surgery,I-Procedure
38507,2568,during,O
38508,2568,the,O
38509,2568,7,O
38510,2568,months,O
38511,2568,following,O
38512,2568,entry,O
38513,2568,into,O
38514,2568,the,O
38515,2568,study,O
38516,2569,Sustained,O
38517,2569,or,O
38518,2569,symptomatic,O
38519,2569,ventricular,B-Condition
38520,2569,dysrhythmias,I-Condition
38521,2569,uncontrolled,O
38522,2569,by,O
38523,2569,drug,B-Procedure
38524,2569,therapy,I-Procedure
38525,2569,or,O
38526,2569,the,O
38527,2569,use,O
38528,2569,of,O
38529,2569,an,O
38530,2569,implantable,O
38531,2569,defibrillator,O
38532,2569,",",O
38533,2569,and/or,O
38534,2569,significant,O
38535,2569,cardiac,B-Condition
38536,2569,conduction,I-Condition
38537,2569,defects,I-Condition
38538,2569,",",O
38539,2569,e.g.,O
38540,2569,",",O
38541,2569,2nd,B-Condition
38542,2569,degree,I-Condition
38543,2569,or,I-Condition
38544,2569,3rd,I-Condition
38545,2569,degree,I-Condition
38546,2569,AV,I-Condition
38547,2569,block,I-Condition
38548,2569,",",O
38549,2569,or,O
38550,2569,sick,B-Condition
38551,2569,sinus,I-Condition
38552,2569,syndrome,I-Condition
38553,2569,",",O
38554,2569,unless,O
38555,2569,a,O
38556,2569,functioning,O
38557,2569,pacemaker,O
38558,2569,is,O
38559,2569,in,O
38560,2569,place,O
38561,2570,Uncorrected,O
38562,2570,obstructive,B-Condition
38563,2570,or,I-Condition
38564,2570,severe,I-Condition
38565,2570,regurgitant,I-Condition
38566,2570,valve,I-Condition
38567,2570,disease,I-Condition
38568,2570,",",O
38569,2570,nondilated,B-Condition
38570,2570,cardiomyopathy,I-Condition
38571,2570,",",O
38572,2570,or,O
38573,2570,significant,O
38574,2570,systemic,B-Condition
38575,2570,ventricular,I-Condition
38576,2570,outflow,I-Condition
38577,2570,obstruction,I-Condition
38578,2571,Known,O
38579,2571,renovascular,B-Condition
38580,2571,hypertension,I-Condition
38581,2571,or,O
38582,2571,evidence,B-Mood
38583,2571,of,I-Mood
38584,2571,pulmonary,B-Condition
38585,2571,hypertension,I-Condition
38586,2571,(,O
38587,2571,pulmonary,O
38588,2571,vascular,O
38589,2571,resistance,O
38590,2571,>,O
38591,2571,6,O
38592,2571,Wood,O
38593,2571,units,O
38594,2571,),O
38595,2571,unresponsive,O
38596,2571,to,O
38597,2571,vasodilator,B-Drug
38598,2571,agents,I-Drug
38599,2571,such,O
38600,2571,as,O
38601,2571,oxygen,B-Drug
38602,2571,",",O
38603,2571,nitroprusside,B-Drug
38604,2571,",",O
38605,2571,or,O
38606,2571,nitric,B-Drug
38607,2571,oxide,I-Drug
38608,2572,History,B-Observation
38609,2572,or,O
38610,2572,current,O
38611,2572,clinical,B-Mood
38612,2572,evidence,I-Mood
38613,2572,of,I-Mood
38614,2572,moderate,O
38615,2572,-,O
38616,2572,to,O
38617,2572,-,O
38618,2572,severe,O
38619,2572,fixed,O
38620,2572,obstructive,B-Condition
38621,2572,pulmonary,I-Condition
38622,2572,disease,I-Condition
38623,2572,or,O
38624,2572,severe,O
38625,2572,reactive,B-Condition
38626,2572,airway,I-Condition
38627,2572,diseases,I-Condition
38628,2572,(,O
38629,2572,e.g.,O
38630,2572,",",O
38631,2572,asthma,B-Condition
38632,2572,),O
38633,2572,requiring,B-Mood
38634,2572,hospitalization,B-Procedure
38635,2572,within,O
38636,2572,the,O
38637,2572,past,O
38638,2572,2,O
38639,2572,years,O
38640,2572,or,O
38641,2572,patient,O
38642,2572,currently,O
38643,2572,using,O
38644,2572,long,B-Drug
38645,2572,-,I-Drug
38646,2572,term,I-Drug
38647,2572,inhaled,I-Drug
38648,2572,bronchodilators,I-Drug
38649,2573,Renal,O
38650,2573,",",O
38651,2573,hepatic,O
38652,2573,",",O
38653,2573,gastrointestinal,O
38654,2573,",",O
38655,2573,or,O
38656,2573,biliary,O
38657,2573,disorder,B-Condition
38658,2573,that,O
38659,2573,could,O
38660,2573,impair,B-Condition
38661,2573,absorption,I-Condition
38662,2573,",",I-Condition
38663,2573,metabolism,I-Condition
38664,2573,or,I-Condition
38665,2573,excretion,I-Condition
38666,2573,of,O
38667,2573,orally,B-Drug
38668,2573,administered,I-Drug
38669,2573,medication,I-Drug
38670,2574,Concurrent,O
38671,2574,terminal,B-Condition
38672,2574,illness,I-Condition
38673,2574,or,O
38674,2574,other,O
38675,2574,severe,B-Condition
38676,2574,disease,I-Condition
38677,2574,(,O
38678,2574,e.g.,O
38679,2574,",",O
38680,2574,active,O
38681,2574,neoplasm,B-Condition
38682,2574,),O
38683,2574,or,O
38684,2574,other,O
38685,2574,significant,B-Condition
38686,2574,laboratory,I-Condition
38687,2574,value(s,I-Condition
38688,2574,),I-Condition
38689,2574,which,O
38690,2574,",",O
38691,2574,in,O
38692,2574,the,O
38693,2574,opinion,O
38694,2574,of,O
38695,2574,the,O
38696,2574,investigator,O
38697,2574,",",O
38698,2574,could,O
38699,2574,preclude,O
38700,2574,participation,O
38701,2574,or,O
38702,2574,survival,O
38703,2575,Endocrine,B-Condition
38704,2575,disorders,I-Condition
38705,2575,such,O
38706,2575,as,O
38707,2575,primary,B-Condition
38708,2575,aldosteronism,I-Condition
38709,2575,",",O
38710,2575,pheochromocytoma,B-Condition
38711,2575,",",O
38712,2575,hyper-,B-Condition
38713,2575,or,I-Condition
38714,2575,hypothyroidism,I-Condition
38715,2575,",",O
38716,2575,insulin,O
38717,2575,-,O
38718,2575,dependent,O
38719,2575,diabetes,B-Condition
38720,2575,mellitus,I-Condition
38721,2576,Unwillingness,B-Observation
38722,2576,or,I-Observation
38723,2576,inability,I-Observation
38724,2576,to,I-Observation
38725,2576,cooperate,I-Observation
38726,2576,",",I-Observation
38727,2576,or,I-Observation
38728,2576,for,I-Observation
38729,2576,the,I-Observation
38730,2576,parents,I-Observation
38731,2576,or,I-Observation
38732,2576,guardians,I-Observation
38733,2576,to,I-Observation
38734,2576,give,I-Observation
38735,2576,consent,I-Observation
38736,2576,",",O
38737,2576,or,O
38738,2576,for,O
38739,2576,the,O
38740,2576,child,O
38741,2576,to,O
38742,2576,give,O
38743,2576,assent,O
38744,2576,",",O
38745,2576,or,O
38746,2576,any,O
38747,2576,condition,O
38748,2576,of,O
38749,2576,sufficient,O
38750,2576,severity,O
38751,2576,to,O
38752,2576,impair,O
38753,2576,cooperation,O
38754,2576,in,O
38755,2576,the,O
38756,2576,study,O
38757,2577,Pregnancy,B-Condition
38758,2577,or,O
38759,2577,possible,B-Mood
38760,2577,pregnancy,B-Condition
38761,2577,at,O
38762,2577,time,O
38763,2577,of,O
38764,2577,randomization,O
38765,2577,",",O
38766,2577,or,O
38767,2577,female,B-Person
38768,2577,of,O
38769,2577,child,B-Observation
38770,2577,bearing,I-Observation
38771,2577,potential,I-Observation
38772,2577,who,O
38773,2577,are,O
38774,2577,lactating,B-Observation
38775,2577,",",O
38776,2577,or,O
38777,2577,sexually,B-Observation
38778,2577,active,I-Observation
38779,2577,and,O
38780,2577,not,O
38781,2577,taking,O
38782,2577,adequate,O
38783,2577,contraceptive,B-Observation
38784,2577,precautions,I-Observation
38785,2577,(,O
38786,2577,e.g.,O
38787,2577,",",O
38788,2577,intrauterine,O
38789,2577,device,O
38790,2577,or,O
38791,2577,oral,B-Drug
38792,2577,contraceptives,I-Drug
38793,2577,for,O
38794,2577,3,O
38795,2577,months,O
38796,2577,prior,O
38797,2577,to,O
38798,2577,entry,O
38799,2577,into,O
38800,2577,the,O
38801,2577,study,O
38802,2577,),O
38803,2578,Use,O
38804,2578,of,O
38805,2578,an,O
38806,2578,investigational,B-Drug
38807,2578,drug,I-Drug
38808,2578,within,O
38809,2578,30,O
38810,2578,days,O
38811,2578,of,O
38812,2578,randomization,O
38813,2578,",",O
38814,2578,or,O
38815,2578,within,O
38816,2578,5,O
38817,2578,half,O
38818,2578,-,O
38819,2578,lives,O
38820,2578,of,O
38821,2578,the,O
38822,2578,investigational,B-Drug
38823,2578,drug,I-Drug
38824,2578,(,O
38825,2578,the,O
38826,2578,longer,O
38827,2578,period,O
38828,2578,will,O
38829,2578,apply,O
38830,2578,),O
38831,2579,History,B-Observation
38832,2579,of,O
38833,2579,drug,B-Condition
38834,2579,sensitivity,I-Condition
38835,2579,or,O
38836,2579,allergic,B-Condition
38837,2579,reaction,I-Condition
38838,2579,to,O
38839,2579,alpha,B-Drug
38840,2579,-,I-Drug
38841,2579,blockers,I-Drug
38842,2579,or,O
38843,2579,beta,B-Drug
38844,2579,-,I-Drug
38845,2579,blockers,I-Drug
38846,2580,Use,O
38847,2580,of,O
38848,2580,any,O
38849,2580,of,O
38850,2580,the,O
38851,2580,following,O
38852,2580,medications,O
38853,2580,within,O
38854,2580,two,O
38855,2580,weeks,O
38856,2580,of,O
38857,2580,randomization,O
38858,2580,:,O
38859,2580,MAO,B-Drug
38860,2580,inhibitors,I-Drug
38861,2580,",",O
38862,2580,Calcium,B-Drug
38863,2580,channel,I-Drug
38864,2580,blockers,I-Drug
38865,2580,",",O
38866,2580,alpha,B-Drug
38867,2580,blockers,I-Drug
38868,2580,",",O
38869,2580,beta,B-Drug
38870,2580,blockers,I-Drug
38871,2580,",",O
38872,2580,disopyramide,B-Drug
38873,2580,",",O
38874,2580,flecainide,B-Drug
38875,2580,",",O
38876,2580,encainide,B-Drug
38877,2580,",",O
38878,2580,moricizine,B-Drug
38879,2580,",",O
38880,2580,propafenone,B-Drug
38881,2580,",",O
38882,2580,sotalol,B-Drug
38883,2580,",",O
38884,2580,or,O
38885,2580,beta,B-Drug
38886,2580,adrenergic,I-Drug
38887,2580,agonists,I-Drug
38888,2581,Hospital,B-Procedure
38889,2581,admission,I-Procedure
38890,2581,for,O
38891,2581,protein,B-Condition
38892,2581,losing,I-Condition
38893,2581,enteropathy,I-Condition
38894,2581,or,O
38895,2581,plastic,B-Condition
38896,2581,bronchitis,I-Condition
38897,2581,within,O
38898,2581,3,O
38899,2581,months,O
38900,2581,of,O
38901,2581,randomization,O
38902,2582,Active,O
38903,2582,and/or,O
38904,2582,chronic,O
38905,2582,protein,B-Condition
38906,2582,losing,I-Condition
38907,2582,enteropathy,I-Condition
38908,2582,or,O
38909,2582,plastic,B-Condition
38910,2582,bronchitis,I-Condition
38911,2582,(,O
38912,2582,on,O
38913,2582,inhaled,B-Drug
38914,2582,medication,I-Drug
38915,2582,to,O
38916,2582,control,O
38917,2582,the,O
38918,2582,plastic,O
38919,2582,bronchitis,O
38920,2582,),O
38921,2582,.,O
38922,2583,Hypoalbuminemia,B-Condition
38923,2583,defined,O
38924,2583,as,O
38925,2583,serum,O
38926,2583,albumin,O
38927,2583,<,O
38928,2583,2.0g,O
38929,2583,/,O
38930,2583,dL,O
38931,2584,Renal,B-Condition
38932,2584,dysfunction,I-Condition
38933,2584,defined,O
38934,2584,as,O
38935,2584,serum,O
38936,2584,creatinine,O
38937,2584,>,O
38938,2584,2.0mg,O
38939,2584,/,O
38940,2584,dL,O
38941,2585,Hepatic,B-Condition
38942,2585,dysfunction,I-Condition
38943,2585,defined,O
38944,2585,as,O
38945,2585,serum,O
38946,2585,AST,O
38947,2585,and/or,O
38948,2585,ALT,O
38949,2585,>,O
38950,2585,3,O
38951,2585,times,O
38952,2585,upper,O
38953,2585,limit,O
38954,2585,of,O
38955,2585,normal,O
38956,2585,(,O
38957,2585,approximately,O
38958,2585,120,O
38959,2585,IU,O
38960,2585,/,O
38961,2585,L,O
38962,2585,however,O
38963,2585,",",O
38964,2585,will,O
38965,2585,vary,O
38966,2585,depending,O
38967,2585,on,O
38968,2585,age,O
38969,2585,),O
38970,2585,",",O
38971,2586,Significant,O
38972,2586,anemia,B-Condition
38973,2586,or,O
38974,2586,polycythemia,B-Condition
38975,2586,defined,O
38976,2586,as,O
38977,2586,hemoglobin,O
38978,2586,>,O
38979,2586,18gm,O
38980,2586,/,O
38981,2586,dL,O
38982,2586,or,O
38983,2586,hemoglobin,O
38984,2586,<,O
38985,2586,7gm,O
38986,2586,/,O
38987,2586,dL,O
38988,2587,Severely,O
38989,2587,elevated,O
38990,2587,serum,O
38991,2587,BNP,O
38992,2587,defined,O
38993,2587,as,O
38994,2587,BNP>300pg,O
38995,2587,/,O
38996,2587,ml,O
38997,2588,Informed,B-Observation
38998,2588,consent,I-Observation
38999,2588,of,I-Observation
39000,2588,parent(s,I-Observation
39001,2588,),I-Observation
39002,2588,or,I-Observation
39003,2588,legal,I-Observation
39004,2588,guardian,I-Observation
39005,2588,;,O
39006,2588,informed,B-Observation
39007,2588,consent,I-Observation
39008,2588,or,I-Observation
39009,2588,assent,I-Observation
39010,2588,of,I-Observation
39011,2588,subject,I-Observation
39012,2588,as,O
39013,2588,applicable,O
39014,2588,.,O
39015,2589,Male,B-Person
39016,2589,or,O
39017,2589,female,B-Person
39018,2589,children,B-Person
39019,2589,between,O
39020,2589,the,O
39021,2589,ages,B-Person
39022,2589,of,O
39023,2589,10,O
39024,2589,and,O
39025,2589,35,O
39026,2589,years,O
39027,2589,with,O
39028,2589,congenital,B-Condition
39029,2589,heart,I-Condition
39030,2589,disease,I-Condition
39031,2589,that,O
39032,2589,has,O
39033,2589,been,O
39034,2589,palliated,O
39035,2589,with,O
39036,2589,a,O
39037,2589,Fontan,B-Procedure
39038,2589,circulation,I-Procedure
39039,2589,.,O
39040,2590,Ability,B-Observation
39041,2590,of,I-Observation
39042,2590,perform,I-Observation
39043,2590,a,O
39044,2590,maximal,B-Procedure
39045,2590,exercise,I-Procedure
39046,2590,test,I-Procedure
39047,2590,as,O
39048,2590,defined,O
39049,2590,by,O
39050,2590,a,O
39051,2590,respiratory,O
39052,2590,exchange,O
39053,2590,ratio,O
39054,2590,(,O
39055,2590,RER,O
39056,2590,),O
39057,2590,greater,O
39058,2590,than,O
39059,2590,1.0,O
39060,2590,at,O
39061,2590,the,O
39062,2590,time,O
39063,2590,of,O
39064,2590,maximal,O
39065,2590,exercise,O
39066,2591,Allergy,B-Condition
39067,2591,to,O
39068,2591,Glitazones,B-Drug
39069,2592,Myocardial,B-Condition
39070,2592,infarction,I-Condition
39071,2593,Heart,B-Condition
39072,2593,failure,I-Condition
39073,2594,Angina,B-Condition
39074,2595,History,B-Observation
39075,2595,of,O
39076,2595,kidney,B-Condition
39077,2595,stones,I-Condition
39078,2596,Liver,B-Condition
39079,2596,disease,I-Condition
39080,2596,(,O
39081,2596,abnormal,O
39082,2596,liver,O
39083,2596,enzymes,O
39084,2596,),O
39085,2597,Anemia,B-Condition
39086,2597,(,O
39087,2597,hemoglobin,O
39088,2597,<,O
39089,2597,8,O
39090,2597,g,O
39091,2597,/,O
39092,2597,dl,O
39093,2597,),O
39094,2598,Cancer,B-Condition
39095,2598,with,O
39096,2598,current,O
39097,2598,treatment,B-Procedure
39098,2599,Previous,O
39099,2599,organ,B-Procedure
39100,2599,transplantation,I-Procedure
39101,2600,Immunosuppressant,B-Procedure
39102,2600,therapy,I-Procedure
39103,2601,Human,B-Condition
39104,2601,immunodeficiency,I-Condition
39105,2601,virus,I-Condition
39106,2601,infection,I-Condition
39107,2602,Pregnancy,B-Condition
39108,2602,or,O
39109,2602,lactating,B-Condition
39110,2603,Current,O
39111,2603,tobacco,B-Observation
39112,2603,use,I-Observation
39113,2604,Dilantin,B-Drug
39114,2604,and,O
39115,2604,oral,B-Drug
39116,2604,contraceptive,I-Drug
39117,2604,usage,O
39118,2604,due,O
39119,2604,to,O
39120,2604,potential,B-Mood
39121,2604,drug,B-Condition
39122,2604,interaction,I-Condition
39123,2604,with,O
39124,2604,glitazones,B-Drug
39125,2605,Self,O
39126,2605,-,O
39127,2605,identified,O
39128,2605,history,B-Observation
39129,2605,of,O
39130,2605,hypoglycemia,B-Condition
39131,2606,CKD,B-Condition
39132,2606,patients,O
39133,2606,classified,O
39134,2606,as,O
39135,2606,Stage,O
39136,2606,3,O
39137,2606,and,O
39138,2606,4,O
39139,2606,of,O
39140,2606,National,O
39141,2606,Kidney,O
39142,2606,Foundation,O
39143,2606,Classification,O
39144,2606,with,O
39145,2606,estimated,O
39146,2606,glomerular,O
39147,2606,filtration,O
39148,2606,rate,O
39149,2606,(,O
39150,2606,GFR,O
39151,2606,),O
39152,2606,between,O
39153,2606,15,O
39154,2606,and,O
39155,2606,59,O
39156,2606,mL,O
39157,2606,/,O
39158,2606,min/1.73,O
39159,2606,m2,O
39160,2606,according,O
39161,2606,to,O
39162,2606,the,O
39163,2606,Modification,O
39164,2606,of,O
39165,2606,Diet,O
39166,2606,in,O
39167,2606,Renal,O
39168,2606,Disease,O
39169,2606,(,O
39170,2606,MDRD,O
39171,2606,),O
39172,2606,formula,O
39173,2606,based,O
39174,2606,on,O
39175,2606,serum,O
39176,2606,creatinine,O
39177,2606,",",O
39178,2606,age,O
39179,2606,",",O
39180,2606,gender,O
39181,2606,",",O
39182,2606,and,O
39183,2606,race,O
39184,2606,.,O
39185,2607,Men,B-Person
39186,2607,and,O
39187,2607,women,B-Person
39188,2607,35,O
39189,2607,to,O
39190,2607,70,O
39191,2607,years,O
39192,2607,of,O
39193,2607,age,B-Person
39194,2608,Untreated,O
39195,2608,symptomatic,B-Condition
39196,2608,brain,I-Condition
39197,2608,or,I-Condition
39198,2608,leptomeningeal,I-Condition
39199,2608,metastatic,I-Condition
39200,2608,disease,I-Condition
39201,2608,.,O
39202,2609,Medical,B-Condition
39203,2609,or,I-Condition
39204,2609,psychiatric,I-Condition
39205,2609,conditions,I-Condition
39206,2609,comprising,O
39207,2609,informed,O
39208,2609,consent,O
39209,2609,.,O
39210,2610,Any,O
39211,2610,medical,O
39212,2610,condition,O
39213,2610,which,O
39214,2610,in,O
39215,2610,the,O
39216,2610,opinion,O
39217,2610,of,O
39218,2610,the,O
39219,2610,investigator,O
39220,2610,would,O
39221,2610,compromise,O
39222,2610,the,O
39223,2610,ability,O
39224,2610,of,O
39225,2610,the,O
39226,2610,patient,O
39227,2610,to,O
39228,2610,participate,O
39229,2610,in,O
39230,2610,the,O
39231,2610,trial,O
39232,2610,or,O
39233,2610,which,O
39234,2610,would,O
39235,2610,jeopardise,O
39236,2610,compliance,O
39237,2610,with,O
39238,2610,the,O
39239,2610,protocol,O
39240,2610,.,O
39241,2611,Radiotherapy,B-Procedure
39242,2611,within,O
39243,2611,4,O
39244,2611,weeks,O
39245,2611,of,O
39246,2611,trial,O
39247,2611,entry,O
39248,2611,.,O
39249,2612,Active,O
39250,2612,autoimmune,B-Condition
39251,2612,disease,I-Condition
39252,2612,that,O
39253,2612,has,O
39254,2612,required,O
39255,2612,systemic,B-Procedure
39256,2612,treatment,I-Procedure
39257,2612,in,O
39258,2612,past,O
39259,2612,2,O
39260,2612,years,O
39261,2613,Chronic,O
39262,2613,usage,O
39263,2613,of,O
39264,2613,steroids,B-Drug
39265,2613,or,O
39266,2613,other,O
39267,2613,immunosuppressant,B-Drug
39268,2613,medication,I-Drug
39269,2613,.,O
39270,2614,Previous,O
39271,2614,history,B-Observation
39272,2614,of,O
39273,2614,pneumonitis,B-Condition
39274,2614,.,O
39275,2615,Any,B-Condition
39276,2615,evidence,I-Condition
39277,2615,of,I-Condition
39278,2615,clinical,I-Condition
39279,2615,autoimmunity,I-Condition
39280,2615,.,O
39281,2616,Histologically,O
39282,2616,confirmed,O
39283,2616,PD,O
39284,2616,-,O
39285,2616,L1,O
39286,2616,status,O
39287,2616,defined,O
39288,2616,NSCLC,B-Condition
39289,2616,.,O
39290,2616,Biopsy,B-Procedure
39291,2616,must,O
39292,2616,be,O
39293,2616,within,O
39294,2616,70,O
39295,2616,days,O
39296,2616,of,O
39297,2616,first,O
39298,2616,treatment,O
39299,2616,with,O
39300,2616,pembrolizumab,B-Drug
39301,2616,.,O
39302,2617,ECOG,O
39303,2617,performance,O
39304,2617,status,O
39305,2617,2,O
39306,2617,.,O
39307,2618,Life,B-Observation
39308,2618,expectancy,I-Observation
39309,2618,>,O
39310,2618,12,O
39311,2618,weeks,O
39312,2618,.,O
39313,2619,Uni,O
39314,2619,-,O
39315,2619,dimensionally,O
39316,2619,measurable,O
39317,2619,disease,B-Condition
39318,2619,according,O
39319,2619,to,O
39320,2619,Response,O
39321,2619,Evaluation,O
39322,2619,Criteria,O
39323,2619,in,O
39324,2619,Solid,O
39325,2619,Tumours,O
39326,2619,(,O
39327,2619,RECIST,O
39328,2619,),O
39329,2619,v1.1,O
39330,2620,Computerised,B-Procedure
39331,2620,Tomography,I-Procedure
39332,2620,(,I-Procedure
39333,2620,CT,I-Procedure
39334,2620,),I-Procedure
39335,2620,scan,I-Procedure
39336,2620,of,I-Procedure
39337,2620,chest,I-Procedure
39338,2620,and,I-Procedure
39339,2620,abdomen,I-Procedure
39340,2620,within,O
39341,2620,28,O
39342,2620,days,O
39343,2620,of,O
39344,2620,starting,O
39345,2620,pembrolizumab,B-Drug
39346,2620,.,O
39347,2621,Adequate,O
39348,2621,haematological,O
39349,2621,function,O
39350,2621,:,O
39351,2622,Platelet,O
39352,2622,count,O
39353,2622,≥100,O
39354,2622,x,O
39355,2622,109,O
39356,2622,/L.,O
39357,2623,Neutrophils,O
39358,2623,≥1.5,O
39359,2623,x,O
39360,2623,109,O
39361,2623,/,O
39362,2623,L.,O
39363,2624,Haemoglobin,O
39364,2624,≥,O
39365,2624,9g,O
39366,2624,/,O
39367,2624,dL.,O
39368,2625,Adequate,O
39369,2625,hepatic,O
39370,2625,function,O
39371,2625,:,O
39372,2626,Serum,O
39373,2626,bilirubin,O
39374,2626,≤1.5,O
39375,2626,x,O
39376,2626,upper,O
39377,2626,limit,O
39378,2626,of,O
39379,2626,normal,O
39380,2626,(,O
39381,2626,ULN,O
39382,2626,),O
39383,2626,.,O
39384,2627,Serum,O
39385,2627,transaminases,O
39386,2627,≤2.5,O
39387,2627,x,O
39388,2627,ULN,O
39389,2627,.,O
39390,2628,Adequate,O
39391,2628,renal,O
39392,2628,function,O
39393,2628,:,O
39394,2628,Creatinine,O
39395,2628,clearance,O
39396,2628,<,O
39397,2628,1.5,O
39398,2628,times,O
39399,2628,ULN,O
39400,2628,concurrent,O
39401,2628,with,O
39402,2628,creatinine,O
39403,2628,clearance,O
39404,2628,>,O
39405,2628,50,O
39406,2628,ml,O
39407,2628,/,O
39408,2628,min,O
39409,2628,.,O
39410,2629,Provision,O
39411,2629,of,O
39412,2629,signed,O
39413,2629,and,O
39414,2629,dated,O
39415,2629,",",O
39416,2629,written,O
39417,2629,informed,O
39418,2629,consent,O
39419,2629,prior,O
39420,2629,to,O
39421,2629,any,O
39422,2629,study,O
39423,2629,specific,O
39424,2629,procedures,O
39425,2629,",",O
39426,2629,sampling,O
39427,2629,and,O
39428,2629,analyses,O
39429,2629,.,O
39430,2630,NA,O
39431,2631,Healthy,B-Condition
39432,2632,Male,B-Person
39433,2633,>,O
39434,2633,7,O
39435,2633,Metabolic,O
39436,2633,Equivalents,O
39437,2634,Written,O
39438,2634,informed,O
39439,2634,consent,O
39440,2635,Chronic,B-Condition
39441,2635,pain,I-Condition
39442,2635,syndrome,I-Condition
39443,2636,Drug,B-Condition
39444,2636,abuse,I-Condition
39445,2637,Alcohol,B-Condition
39446,2637,abuse,I-Condition
39447,2638,Suspicion,B-Mood
39448,2638,of,O
39449,2638,neurologic,B-Condition
39450,2638,dysfunction,I-Condition
39451,2638,at,O
39452,2638,tested,O
39453,2638,sites,O
39454,2639,Ongoing,O
39455,2639,treatment,B-Procedure
39456,2639,with,O
39457,2639,antidepressants,B-Drug
39458,2640,Ongoing,O
39459,2640,treatment,B-Procedure
39460,2640,with,O
39461,2640,analgesics,B-Drug
39462,2641,Pretreatment,B-Procedure
39463,2641,with,O
39464,2641,any,O
39465,2641,CYP3A,B-Drug
39466,2641,inducers,I-Drug
39467,2641,or,I-Drug
39468,2641,inhibitors,I-Drug
39469,2642,Known,O
39470,2642,allergy,B-Condition
39471,2642,to,O
39472,2642,tested,B-Drug
39473,2642,drugs,I-Drug
39474,2643,Elevated,B-Condition
39475,2643,eye,I-Condition
39476,2643,pressure,I-Condition
39477,2644,Obstructive,B-Condition
39478,2644,uropathy,I-Condition
39479,2645,Heart,B-Condition
39480,2645,disease,I-Condition
39481,2646,Pulmonary,B-Condition
39482,2646,disease,I-Condition
39483,2647,Neurological,B-Condition
39484,2647,disease,I-Condition
39485,2648,Psychiatric,B-Condition
39486,2648,illness,I-Condition
39487,2649,polycystic,B-Condition
39488,2649,ovaries,I-Condition
39489,2650,untreated,O
39490,2650,thyroid,B-Condition
39491,2650,pathology,I-Condition
39492,2651,hypogonadotropic,B-Condition
39493,2651,hypogonadism,I-Condition
39494,2652,untreaed,O
39495,2652,hyperprolactinemia,B-Condition
39496,2653,study,B-Drug
39497,2653,drug,I-Drug
39498,2653,hypersensitivity,B-Condition
39499,2654,previous,O
39500,2654,OHSS,B-Condition
39501,2655,unilateral,O
39502,2655,ovariectomy,B-Procedure
39503,2656,genital,B-Condition
39504,2656,malformation,I-Condition
39505,2657,BMI>40,O
39506,2658,female,B-Person
39507,2658,infertile,B-Condition
39508,2658,patients,O
39509,2658,eligible,B-Mood
39510,2658,for,O
39511,2658,IVF,B-Procedure
39512,2658,treatment,I-Procedure
39513,2659,The,O
39514,2659,patient,O
39515,2659,is,O
39516,2659,participating,O
39517,2659,in,O
39518,2659,another,O
39519,2659,clinical,O
39520,2659,study,O
39521,2659,using,O
39522,2659,an,O
39523,2659,investigational,O
39524,2659,product,O
39525,2659,.,O
39526,2660,The,O
39527,2660,patient,O
39528,2660,",",O
39529,2660,in,O
39530,2660,the,O
39531,2660,opinion,O
39532,2660,of,O
39533,2660,the,O
39534,2660,Investigator,O
39535,2660,",",O
39536,2660,is,O
39537,2660,unable,O
39538,2660,to,O
39539,2660,adhere,O
39540,2660,to,O
39541,2660,the,O
39542,2660,requirements,O
39543,2660,of,O
39544,2660,the,O
39545,2660,study,O
39546,2660,.,O
39547,2661,The,O
39548,2661,patient,O
39549,2661,and/or,O
39550,2661,the,O
39551,2661,patient,O
39552,2661,'s,O
39553,2661,parent,O
39554,2661,/,O
39555,2661,legal,O
39556,2661,guardian,O
39557,2661,is,O
39558,2661,willing,O
39559,2661,and,O
39560,2661,able,O
39561,2661,to,O
39562,2661,provide,O
39563,2661,signed,O
39564,2661,informed,O
39565,2661,consent,O
39566,2661,.,O
39567,2662,The,O
39568,2662,patient,O
39569,2662,has,O
39570,2662,a,O
39571,2662,confirmed,O
39572,2662,GAA,B-Condition
39573,2662,enzyme,I-Condition
39574,2662,deficiency,I-Condition
39575,2662,from,O
39576,2662,skin,O
39577,2662,",",O
39578,2662,blood,O
39579,2662,",",O
39580,2662,or,O
39581,2662,muscle,O
39582,2662,tissue,O
39583,2662,and/or,O
39584,2662,2,O
39585,2662,confirmed,O
39586,2662,GAA,B-Observation
39587,2662,gene,I-Observation
39588,2662,mutations,I-Observation
39589,2662,.,O
39590,2663,Infant,B-Person
39591,2663,and,O
39592,2663,toddler,B-Person
39593,2663,Pompe,B-Condition
39594,2663,disease,I-Condition
39595,2663,patients,O
39596,2663,can,O
39597,2663,be,O
39598,2663,included,O
39599,2663,in,O
39600,2663,the,O
39601,2663,study,O
39602,2663,only,O
39603,2663,under,O
39604,2663,condition,O
39605,2663,(,O
39606,2663,minimal,O
39607,2663,body,O
39608,2663,weight,O
39609,2663,),O
39610,2663,that,O
39611,2663,the,O
39612,2663,trial,O
39613,2663,-,O
39614,2663,related,O
39615,2663,blood,O
39616,2663,loss,O
39617,2663,(,O
39618,2663,including,O
39619,2663,any,O
39620,2663,losses,O
39621,2663,in,O
39622,2663,the,O
39623,2663,maneuver,O
39624,2663,),O
39625,2663,will,O
39626,2663,not,O
39627,2663,exceed,O
39628,2663,3,O
39629,2663,percent,O
39630,2663,of,O
39631,2663,the,O
39632,2663,total,O
39633,2663,blood,O
39634,2663,volume,O
39635,2663,during,O
39636,2663,a,O
39637,2663,period,O
39638,2663,of,O
39639,2663,4,O
39640,2663,weeks,O
39641,2663,and,O
39642,2663,will,O
39643,2663,not,O
39644,2663,exceed,O
39645,2663,1,O
39646,2663,percent,O
39647,2663,at,O
39648,2663,any,O
39649,2663,single,O
39650,2663,time,O
39651,2663,.,O
39652,2664,The,O
39653,2664,patient,O
39654,2664,",",O
39655,2664,if,O
39656,2664,female,O
39657,2664,and,O
39658,2664,of,O
39659,2664,childbearing,O
39660,2664,potential,O
39661,2664,",",O
39662,2664,must,O
39663,2664,have,O
39664,2664,a,O
39665,2664,negative,O
39666,2664,pregnancy,O
39667,2664,test,O
39668,2664,(,O
39669,2664,urine,O
39670,2664,beta,O
39671,2664,-,O
39672,2664,human,O
39673,2664,chorionic,O
39674,2664,gonadotropin,O
39675,2664,),O
39676,2664,at,O
39677,2664,screening,O
39678,2664,.,O
39679,2664,Note,O
39680,2664,:,O
39681,2664,All,O
39682,2664,female,O
39683,2664,patients,O
39684,2664,of,O
39685,2664,childbearing,O
39686,2664,potential,O
39687,2664,and,O
39688,2664,sexually,O
39689,2664,mature,O
39690,2664,males,O
39691,2664,must,O
39692,2664,agree,O
39693,2664,to,O
39694,2664,use,O
39695,2664,a,O
39696,2664,medically,O
39697,2664,accepted,O
39698,2664,method,O
39699,2664,of,O
39700,2664,contraception,O
39701,2664,throughout,O
39702,2664,the,O
39703,2664,study,O
39704,2664,.,O
39705,2665,For,O
39706,2665,patients,O
39707,2665,previously,O
39708,2665,treated,O
39709,2665,with,O
39710,2665,alglucosidase,O
39711,2665,alfa,O
39712,2665,the,O
39713,2665,patient,O
39714,2665,has,O
39715,2665,received,O
39716,2665,alglucosidase,B-Drug
39717,2665,alfa,I-Drug
39718,2665,for,O
39719,2665,at,O
39720,2665,least,O
39721,2665,6,O
39722,2665,months,O
39723,2665,.,O
39724,2666,Do,B-Observation
39725,2666,not,I-Observation
39726,2666,sign,I-Observation
39727,2666,informed,I-Observation
39728,2666,consent,I-Observation
39729,2667,Pregnant,B-Condition
39730,2667,patients,O
39731,2668,Liver,B-Condition
39732,2668,cirrhosis,I-Condition
39733,2669,Undifferentiated,O
39734,2669,adenocarcinoma,B-Condition
39735,2669,.,O
39736,2670,cT4,B-Condition
39737,2671,Metastatic,B-Condition
39738,2671,disease,I-Condition
39739,2671,(,I-Condition
39740,2671,M1,I-Condition
39741,2671,),I-Condition
39742,2672,chronic,B-Condition
39743,2672,renal,I-Condition
39744,2672,failure,I-Condition
39745,2672,on,O
39746,2672,dialysis,B-Procedure
39747,2673,ASA,O
39748,2673,IV,O
39749,2674,BMI,O
39750,2674,<,O
39751,2674,18,O
39752,2674,and,O
39753,2674,>,O
39754,2674,35,O
39755,2674,kg,O
39756,2674,/,O
39757,2674,m2,O
39758,2675,Age,B-Person
39759,2675,over,O
39760,2675,18,O
39761,2675,years,O
39762,2676,Patients,O
39763,2676,with,O
39764,2676,rectal,B-Condition
39765,2676,cancer,I-Condition
39766,2676,stage,O
39767,2676,:,O
39768,2676,cT1,O
39769,2676,-,O
39770,2676,2,O
39771,2676,-,O
39772,2676,3,O
39773,2676,",",O
39774,2676,cN0,O
39775,2676,-,O
39776,2676,1,O
39777,2676,",",O
39778,2676,cM0,O
39779,2676,.,O
39780,2677,Tumor,B-Condition
39781,2677,equal,O
39782,2677,or,O
39783,2677,below,O
39784,2677,10,O
39785,2677,cm,O
39786,2677,from,O
39787,2677,the,O
39788,2677,anal,O
39789,2677,verge,O
39790,2677,",",O
39791,2677,candidates,B-Mood
39792,2677,to,O
39793,2677,(,O
39794,2677,ETM,O
39795,2677,),O
39796,2677,low,B-Procedure
39797,2677,anterior,I-Procedure
39798,2677,resection,I-Procedure
39799,2677,and,I-Procedure
39800,2677,anastomosis,I-Procedure
39801,2677,",",O
39802,2677,with,O
39803,2677,or,O
39804,2677,without,O
39805,2677,preoperative,O
39806,2677,chemo,B-Procedure
39807,2677,-,I-Procedure
39808,2677,radiotherapy,I-Procedure
39809,2677,.,O
39810,2678,Adenocarcinoma,B-Condition
39811,2678,of,O
39812,2678,low,O
39813,2678,or,O
39814,2678,moderate,O
39815,2678,differentiation,O
39816,2679,ASA,O
39817,2679,I,O
39818,2679,",",O
39819,2679,II,O
39820,2679,",",O
39821,2679,III,O
39822,2679,.,O
39823,2680,Except,O
39824,2680,for,O
39825,2680,serious,B-Condition
39826,2680,complications,I-Condition
39827,2680,(,O
39828,2680,cardiovascular,B-Condition
39829,2680,events,I-Condition
39830,2680,and,O
39831,2680,recent,O
39832,2680,significant,O
39833,2680,liver,O
39834,2680,",",O
39835,2680,kidney,O
39836,2680,or,O
39837,2680,lung,B-Condition
39838,2680,disease,I-Condition
39839,2680,within,O
39840,2680,3,O
39841,2680,months,O
39842,2680,),O
39843,2681,high,B-Condition
39844,2681,blood,I-Condition
39845,2681,pressure,I-Condition
39846,2681,(,O
39847,2681,>,O
39848,2681,160/100mmHg,O
39849,2681,),O
39850,2682,active,B-Condition
39851,2682,infection,I-Condition
39852,2683,secondary,O
39853,2683,diabetes,B-Condition
39854,2684,pregnancy,B-Condition
39855,2685,alcohol,B-Condition
39856,2685,abuse,I-Condition
39857,2686,allergic,B-Condition
39858,2686,to,O
39859,2686,GLP-1,B-Drug
39860,2686,receptor,I-Drug
39861,2686,agonist,I-Drug
39862,2687,Overweight,B-Condition
39863,2687,and,O
39864,2687,obese,B-Condition
39865,2687,PCOS,B-Condition
39866,2687,patients,O
39867,2687,with,O
39868,2687,newly,O
39869,2687,diagnosed,O
39870,2687,IGR,B-Condition
39871,2687,;,O
39872,2688,PCOS,B-Condition
39873,2688,diagnosis,O
39874,2688,based,O
39875,2688,on,O
39876,2688,2003,O
39877,2688,Rotterdam,O
39878,2688,criteria,O
39879,2689,Overweight,B-Condition
39880,2689,/,O
39881,2689,obesity,B-Condition
39882,2689,diagnostic,O
39883,2689,criteria,O
39884,2689,according,O
39885,2689,to,O
39886,2689,WHO,O
39887,2689,-,O
39888,2689,WPR,O
39889,2690,Impaired,B-Condition
39890,2690,glucose,I-Condition
39891,2690,regulation,I-Condition
39892,2690,diagnostic,O
39893,2690,criteria,O
39894,2690,according,O
39895,2690,to,O
39896,2690,1998,O
39897,2690,WHO,O
39898,2690,diagnostic,O
39899,2690,criteria,O
39900,2690,.,O
39901,2691,unstable,O
39902,2691,condition,B-Condition
39903,2691,",",O
39904,2691,COPD,B-Condition
39905,2691,exacerbation,I-Condition
39906,2692,mild,O
39907,2692,(,O
39908,2692,GOLD,O
39909,2692,1,O
39910,2692,),O
39911,2692,or,O
39912,2692,very,O
39913,2692,severe,O
39914,2692,COPD,B-Condition
39915,2692,(,O
39916,2692,GOLD,O
39917,2692,4,O
39918,2692,),O
39919,2693,requirement,O
39920,2693,for,O
39921,2693,oxygen,B-Procedure
39922,2693,therapy,I-Procedure
39923,2693,at,O
39924,2693,low,O
39925,2693,altitude,O
39926,2693,residence,O
39927,2694,hypoventilation,B-Condition
39928,2695,pulmonary,B-Condition
39929,2695,hypertension,I-Condition
39930,2696,more,O
39931,2696,than,O
39932,2696,mild,O
39933,2696,or,O
39934,2696,unstable,O
39935,2696,cardiovascular,B-Condition
39936,2696,disease,I-Condition
39937,2697,use,O
39938,2697,of,O
39939,2697,drugs,O
39940,2697,that,O
39941,2697,affect,O
39942,2697,respiratory,O
39943,2697,center,O
39944,2697,drive,O
39945,2698,internal,B-Condition
39946,2698,",",I-Condition
39947,2698,neurologic,I-Condition
39948,2698,or,I-Condition
39949,2698,psychiatric,I-Condition
39950,2698,disease,I-Condition
39951,2698,that,O
39952,2698,interfere,O
39953,2698,with,O
39954,2698,protocol,O
39955,2698,compliance,O
39956,2698,including,O
39957,2698,current,O
39958,2698,heavy,O
39959,2698,smoking,B-Observation
39960,2698,(,O
39961,2698,>,O
39962,2698,20,O
39963,2698,cigarettes,O
39964,2698,per,O
39965,2698,day,O
39966,2698,),O
39967,2698,",",O
39968,2698,inability,O
39969,2698,to,O
39970,2698,perform,O
39971,2698,6,B-Procedure
39972,2698,min,I-Procedure
39973,2698,walk,I-Procedure
39974,2698,test,I-Procedure
39975,2698,.,O
39976,2699,previous,O
39977,2699,intolerance,B-Condition
39978,2699,to,O
39979,2699,moderate,O
39980,2699,altitude,B-Observation
39981,2699,(,O
39982,2699,<,O
39983,2699,2600,O
39984,2699,m,O
39985,2699,),O
39986,2699,.,O
39987,2700,exposure,O
39988,2700,to,O
39989,2700,altitudes,O
39990,2700,>,O
39991,2700,1500,O
39992,2700,m,O
39993,2700,for,O
39994,2700,>,O
39995,2700,2,O
39996,2700,days,O
39997,2700,within,O
39998,2700,the,O
39999,2700,last,O
40000,2700,4,O
40001,2700,weeks,O
40002,2700,before,O
40003,2700,the,O
40004,2700,study,O
40005,2700,.,O
40006,2701,pregnant,O
40007,2701,or,O
40008,2701,nursing,O
40009,2701,patients,O
40010,2702,chronic,B-Condition
40011,2702,obstructive,I-Condition
40012,2702,pulmonary,I-Condition
40013,2702,disease,I-Condition
40014,2702,(,O
40015,2702,COPD,B-Condition
40016,2702,),O
40017,2702,",",O
40018,2702,GOLD,O
40019,2702,grade,O
40020,2702,2,O
40021,2702,-,O
40022,2702,3,O
40023,2703,residents,O
40024,2703,at,O
40025,2703,low,O
40026,2703,altitude,O
40027,2703,(,O
40028,2703,<,O
40029,2703,800,O
40030,2703,m,O
40031,2703,),O
40032,2704,pregnancy,B-Condition
40033,2704,",",O
40034,2705,patients,O
40035,2705,under,O
40036,2705,legal,B-Person
40037,2705,custody,I-Person
40038,2705,",",O
40039,2706,patients,O
40040,2706,without,O
40041,2706,health,B-Person
40042,2706,insurance,I-Person
40043,2706,",",O
40044,2707,patients,O
40045,2707,included,O
40046,2707,in,O
40047,2707,another,O
40048,2707,interventional,O
40049,2707,clinical,O
40050,2707,study,O
40051,2707,involving,O
40052,2707,infections,O
40053,2707,or,O
40054,2707,antibiotics,O
40055,2707,and,O
40056,2707,having,O
40057,2707,the,O
40058,2707,same,O
40059,2707,primary,O
40060,2707,parameter,O
40061,2707,",",O
40062,2708,moribund,B-Condition
40063,2708,patients,O
40064,2708,",",O
40065,2709,situation,O
40066,2709,in,O
40067,2709,which,O
40068,2709,the,O
40069,2709,procalcitonin,O
40070,2709,concentration,O
40071,2709,could,O
40072,2709,be,O
40073,2709,increased,O
40074,2709,without,O
40075,2709,correlation,O
40076,2709,to,O
40077,2709,an,O
40078,2709,infectious,O
40079,2709,process,O
40080,2709,(,O
40081,2709,poly,B-Condition
40082,2709,-,I-Condition
40083,2709,traumatised,I-Condition
40084,2709,patients,O
40085,2709,",",O
40086,2710,surgical,B-Procedure
40087,2710,interventions,I-Procedure
40088,2710,within,O
40089,2710,the,O
40090,2710,last,O
40091,2710,4,O
40092,2710,days,O
40093,2710,",",O
40094,2711,cardiorespiratory,B-Condition
40095,2711,arrest,I-Condition
40096,2711,",",O
40097,2712,administration,O
40098,2712,of,O
40099,2712,anti,B-Drug
40100,2712,-,I-Drug
40101,2712,thymocyte,I-Drug
40102,2712,globulin,I-Drug
40103,2712,",",O
40104,2713,immunodepressed,B-Condition
40105,2713,patients,O
40106,2713,(,O
40107,2713,bone,B-Procedure
40108,2713,marrow,I-Procedure
40109,2713,transplant,I-Procedure
40110,2713,patients,O
40111,2713,",",O
40112,2713,patients,O
40113,2713,with,O
40114,2713,severe,B-Condition
40115,2713,neutropenia,I-Condition
40116,2713,),O
40117,2713,",",O
40118,2714,patients,O
40119,2714,with,O
40120,2714,an,O
40121,2714,absolute,O
40122,2714,indication,B-Condition
40123,2714,for,O
40124,2714,administration,O
40125,2714,of,O
40126,2714,antibiotics,B-Drug
40127,2714,at,O
40128,2714,the,O
40129,2714,moment,O
40130,2714,of,O
40131,2714,ICU,O
40132,2714,admission,O
40133,2714,(,O
40134,2714,meningitis,B-Condition
40135,2714,",",O
40136,2714,pneumonia,B-Condition
40137,2714,),O
40138,2714,or,O
40139,2714,a,O
40140,2714,chronic,B-Condition
40141,2714,infection,I-Condition
40142,2714,for,O
40143,2714,which,O
40144,2714,long,O
40145,2714,-,O
40146,2714,term,O
40147,2714,antibiotic,B-Procedure
40148,2714,treatment,I-Procedure
40149,2714,is,O
40150,2714,necessary,O
40151,2714,(,O
40152,2714,endocarditis,B-Condition
40153,2714,",",O
40154,2714,osteo,B-Condition
40155,2714,-,I-Condition
40156,2714,articular,I-Condition
40157,2714,infections,I-Condition
40158,2714,",",O
40159,2714,mediastinitis,B-Condition
40160,2714,",",O
40161,2714,deep,B-Condition
40162,2714,abscesses,I-Condition
40163,2714,",",O
40164,2714,pneumocystis,B-Condition
40165,2714,infection,I-Condition
40166,2714,",",O
40167,2714,toxoplasmosis,B-Condition
40168,2714,",",O
40169,2714,tuberculosis,B-Condition
40170,2714,),O
40171,2715,patients,O
40172,2715,with,O
40173,2715,haemodynamic,B-Condition
40174,2715,instability,I-Condition
40175,2715,of,O
40176,2715,septic,B-Condition
40177,2715,origin,O
40178,2715,or,O
40179,2715,a,O
40180,2715,respiratory,O
40181,2715,insufficiency,I-Condition
40182,2715,(,O
40183,2715,defined,O
40184,2715,by,O
40185,2715,a,O
40186,2715,ratio,O
40187,2715,Pa02,O
40188,2715,/,O
40189,2715,Fi02,O
40190,2715,=,O
40191,2715,200,O
40192,2715,mmHg,O
40193,2715,and,O
40194,2715,PEP,O
40195,2715,=,O
40196,2715,5,O
40197,2715,cmH2O,O
40198,2715,),O
40199,2716,aged,B-Person
40200,2716,18,O
40201,2716,or,O
40202,2716,older,O
40203,2716,",",O
40204,2717,have,O
40205,2717,undergone,O
40206,2717,oro,B-Procedure
40207,2717,-,I-Procedure
40208,2717,tracheal,I-Procedure
40209,2717,intubation,I-Procedure
40210,2717,for,O
40211,2717,a,O
40212,2717,coma,B-Condition
40213,2717,(,O
40214,2717,Glasgow,O
40215,2717,Coma,O
40216,2717,Score,O
40217,2717,below,O
40218,2717,or,O
40219,2717,equal,O
40220,2717,to,O
40221,2717,8),O
40222,2717,",",O
40223,2718,with,O
40224,2718,mechanical,B-Procedure
40225,2718,ventilation,I-Procedure
40226,2718,initiated,O
40227,2718,in,O
40228,2718,the,O
40229,2718,first,O
40230,2718,48,O
40231,2718,hours,O
40232,2718,following,O
40233,2718,hospital,O
40234,2718,admission,O
40235,2719,Ongoing,O
40236,2719,treatment,B-Procedure
40237,2719,with,O
40238,2719,inotropic,B-Drug
40239,2719,drugs,I-Drug
40240,2719,(,O
40241,2719,not,O
40242,2719,norepinephrine,B-Drug
40243,2719,),O
40244,2720,Central,O
40245,2720,venous,O
40246,2720,oxygen,O
40247,2720,saturation,O
40248,2720,(,O
40249,2720,ScvO2,O
40250,2720,),O
40251,2720,<,O
40252,2720,60,O
40253,2720,%,O
40254,2720,despite,B-Observation
40255,2720,optimization,B-Procedure
40256,2720,of,I-Procedure
40257,2720,hematocrit,I-Procedure
40258,2720,and,O
40259,2720,volume,B-Observation
40260,2720,status,I-Observation
40261,2721,Need,B-Mood
40262,2721,of,O
40263,2721,renal,B-Procedure
40264,2721,replacement,I-Procedure
40265,2721,therapy,I-Procedure
40266,2722,Ongoing,O
40267,2722,bleeding,B-Condition
40268,2723,Patient,O
40269,2723,or,O
40270,2723,next,O
40271,2723,of,O
40272,2723,kin,O
40273,2723,does,O
40274,2723,not,O
40275,2723,consent,O
40276,2723,with,O
40277,2723,study,O
40278,2723,participation,O
40279,2724,Patients,O
40280,2724,in,O
40281,2724,the,O
40282,2724,cardiothoracic,O
40283,2724,intensive,O
40284,2724,care,O
40285,2724,after,O
40286,2724,cardiac,B-Procedure
40287,2724,surgery,I-Procedure
40288,2724,with,O
40289,2724,cardiopulmonary,B-Procedure
40290,2724,bypass,I-Procedure
40291,2725,Acute,B-Condition
40292,2725,kidney,I-Condition
40293,2725,injury,I-Condition
40294,2725,",",O
40295,2725,defined,O
40296,2725,as,O
40297,2725,increase,O
40298,2725,in,O
40299,2725,S,O
40300,2725,-,O
40301,2725,creatinine,O
40302,2725,50,O
40303,2725,%,O
40304,2725,or,O
40305,2725,27,O
40306,2725,mol,O
40307,2725,/,O
40308,2725,L,O
40309,2726,Normal,O
40310,2726,S,O
40311,2726,-,O
40312,2726,creatinine,O
40313,2726,before,O
40314,2726,surgery,B-Procedure
40315,2727,Heavy,B-Condition
40316,2727,tobacco,I-Condition
40317,2727,smokers,I-Condition
40318,2728,Drug,B-Condition
40319,2728,and,I-Condition
40320,2728,/,I-Condition
40321,2728,or,I-Condition
40322,2728,alcohol,I-Condition
40323,2728,abusers,I-Condition
40324,2729,Healthy,B-Condition
40325,2729,patients,I-Condition
40326,2729,(,O
40327,2729,ASA,O
40328,2729,I,O
40329,2729,),O
40330,2730,Bilateral,O
40331,2730,symmetrically,O
40332,2730,impacted,O
40333,2730,lower,O
40334,2730,third,O
40335,2730,molars,O
40336,2730,according,O
40337,2730,to,O
40338,2730,Pel,O
40339,2730,-,O
40340,2730,Gregory,O
40341,2730,'s,O
40342,2730,and,O
40343,2730,Winter,O
40344,2730,'s,O
40345,2730,classification,O
40346,2731,diagnosed,O
40347,2731,advanced,B-Condition
40348,2731,heart,I-Condition
40349,2731,",",I-Condition
40350,2731,kidney,I-Condition
40351,2731,or,I-Condition
40352,2731,liver,I-Condition
40353,2731,failure,I-Condition
40354,2732,benign,B-Condition
40355,2732,prostatic,I-Condition
40356,2732,hyperplasia,I-Condition
40357,2733,prostatic,B-Condition
40358,2733,carcinoma,I-Condition
40359,2734,frequent,O
40360,2734,urinary,B-Condition
40361,2734,tract,I-Condition
40362,2734,infections,I-Condition
40363,2735,non,B-Condition
40364,2735,-,I-Condition
40365,2735,type,I-Condition
40366,2735,1,I-Condition
40367,2735,diabetes,I-Condition
40368,2735,mellitus,I-Condition
40369,2736,diabetes,B-Condition
40370,2736,mellitus,I-Condition
40371,2736,type,I-Condition
40372,2736,1,I-Condition
40373,2737,1,O
40374,2737,.,O
40375,2737,Orthopedic,B-Condition
40376,2737,injuries,I-Condition
40377,2737,that,O
40378,2737,are,O
40379,2737,unstable,O
40380,2738,2,O
40381,2738,.,O
40382,2738,Osteoporosis,B-Condition
40383,2738,with,O
40384,2738,high,O
40385,2738,risk,O
40386,2738,of,O
40387,2738,pathological,O
40388,2738,fracture,O
40389,2739,3,O
40390,2739,.,O
40391,2739,Cutaneous,B-Condition
40392,2739,lesions,I-Condition
40393,2739,and/or,O
40394,2739,pressure,B-Condition
40395,2739,ulcers,I-Condition
40396,2740,4,O
40397,2740,.,O
40398,2740,Joint,B-Condition
40399,2740,contractures,I-Condition
40400,2741,5,O
40401,2741,.,O
40402,2741,Cardiopulmonary,B-Condition
40403,2741,diseases,I-Condition
40404,2742,6,O
40405,2742,.,O
40406,2742,Body,O
40407,2742,weight,O
40408,2742,exceeding,O
40409,2742,150,O
40410,2742,Kg,O
40411,2743,1,O
40412,2743,.,O
40413,2743,Patients,O
40414,2743,≥,O
40415,2743,18,O
40416,2743,years,B-Person
40417,2743,-,I-Person
40418,2743,old,I-Person
40419,2743,from,O
40420,2743,"""",O
40421,2743,Instituto,O
40422,2743,Teletón,O
40423,2743,Santiago,O
40424,2743,"""",O
40425,2743,and,O
40426,2743,"""",O
40427,2743,Hospital,O
40428,2743,Clínico,O
40429,2743,Mutual,O
40430,2743,de,O
40431,2743,seguridad,O
40432,2743,"""",O
40433,2743,.,O
40434,2744,2,O
40435,2744,.,O
40436,2744,C5,O
40437,2744,to,O
40438,2744,T12,O
40439,2744,spinal,B-Condition
40440,2744,cord,I-Condition
40441,2744,injury,I-Condition
40442,2744,",",O
40443,2744,classified,O
40444,2744,as,O
40445,2744,ISNCSCI,O
40446,2744,grades,O
40447,2744,C,O
40448,2744,and,O
40449,2744,D,O
40450,2745,3,O
40451,2745,.,O
40452,2745,Traumatic,O
40453,2745,and,O
40454,2745,non,O
40455,2745,-,O
40456,2745,traumatic,O
40457,2745,",",O
40458,2745,non,O
40459,2745,-,O
40460,2745,progressive,O
40461,2745,lesions,B-Condition
40462,2746,4,O
40463,2746,.,O
40464,2746,Onset,O
40465,2746,>,O
40466,2746,6,O
40467,2746,months,O
40468,2747,5,O
40469,2747,.,O
40470,2747,Ability,B-Condition
40471,2747,to,I-Condition
40472,2747,ambulate,I-Condition
40473,2747,with,I-Condition
40474,2747,or,I-Condition
40475,2747,without,I-Condition
40476,2747,assistive,I-Condition
40477,2747,devices,I-Condition
40478,2748,6,O
40479,2748,.,O
40480,2748,Ability,B-Condition
40481,2748,to,I-Condition
40482,2748,follow,I-Condition
40483,2748,verbal,I-Condition
40484,2748,or,I-Condition
40485,2748,visual,I-Condition
40486,2748,commands,I-Condition
40487,2749,7,O
40488,2749,.,O
40489,2749,Signed,O
40490,2749,informed,O
40491,2749,consent,O
40492,2750,History,B-Observation
40493,2750,of,O
40494,2750,morphine,B-Drug
40495,2750,allergy,B-Condition
40496,2751,History,B-Observation
40497,2751,of,O
40498,2751,bupivacaine,B-Drug
40499,2751,allergy,B-Condition
40500,2752,Contraindication,B-Condition
40501,2752,for,O
40502,2752,ketamine,B-Procedure
40503,2752,infusion,I-Procedure
40504,2753,Contraindication,B-Condition
40505,2753,for,O
40506,2753,thoracic,O
40507,2753,paravertebral,B-Procedure
40508,2753,block,I-Procedure
40509,2754,Anticipated,B-Mood
40510,2754,postoperative,O
40511,2754,positive,B-Procedure
40512,2754,pressure,I-Procedure
40513,2754,ventilation,I-Procedure
40514,2755,Body,O
40515,2755,mass,O
40516,2755,index,O
40517,2755,more,O
40518,2755,than,O
40519,2755,35,O
40520,2756,Any,O
40521,2756,known,O
40522,2756,psychiatric,B-Condition
40523,2756,disorder,I-Condition
40524,2757,American,O
40525,2757,Society,O
40526,2757,of,O
40527,2757,Anesthesiologist,O
40528,2757,physical,O
40529,2757,status,O
40530,2757,1,O
40531,2757,-,O
40532,2757,3,O
40533,2758,Scheduled,B-Mood
40534,2758,for,I-Mood
40535,2758,elective,O
40536,2758,video,B-Procedure
40537,2758,-,I-Procedure
40538,2758,assisted,I-Procedure
40539,2758,thoracic,I-Procedure
40540,2758,surgery,I-Procedure
40541,2759,Able,O
40542,2759,to,O
40543,2759,operate,O
40544,2759,a,O
40545,2759,patient,O
40546,2759,-,O
40547,2759,controlled,O
40548,2759,analgesia,O
40549,2759,device,O
40550,2759,(,O
40551,2759,PCA,O
40552,2759,),O
40553,2760,NA,O
40554,2761,the,O
40555,2761,patients,O
40556,2761,undergoing,O
40557,2761,ascending,B-Procedure
40558,2761,",",I-Procedure
40559,2761,arch,I-Procedure
40560,2761,and/or,I-Procedure
40561,2761,proximal,I-Procedure
40562,2761,descending,I-Procedure
40563,2761,aorta,I-Procedure
40564,2761,surgery,I-Procedure
40565,2761,with,O
40566,2761,cardiopulmonary,B-Procedure
40567,2761,bypass,I-Procedure
40568,2762,20,O
40569,2762,-,O
40570,2762,100,O
40571,2762,yrs,O
40572,2762,old,B-Person
40573,2763,Has,O
40574,2763,previously,O
40575,2763,received,O
40576,2763,Dapsone,B-Drug
40577,2763,therapy,O
40578,2763,.,O
40579,2764,The,O
40580,2764,subject,O
40581,2764,or,O
40582,2764,any,O
40583,2764,of,O
40584,2764,their,O
40585,2764,healthcare,O
40586,2764,providers,O
40587,2764,is,O
40588,2764,aware,O
40589,2764,of,O
40590,2764,the,O
40591,2764,subjects,O
40592,2764,HLA,O
40593,2764,type,O
40594,2764,.,O
40595,2765,Has,O
40596,2765,been,O
40597,2765,diagnosed,O
40598,2765,with,O
40599,2765,Glucose-6,B-Condition
40600,2765,-,I-Condition
40601,2765,phosphate,I-Condition
40602,2765,dehydrogenase,I-Condition
40603,2765,deficiency,I-Condition
40604,2765,or,O
40605,2765,methemoglobin,B-Condition
40606,2765,reductase,I-Condition
40607,2765,deficiency,I-Condition
40608,2766,Satisfies,O
40609,2766,any,O
40610,2766,contraindications,B-Condition
40611,2766,or,O
40612,2766,restrictions,O
40613,2766,to,O
40614,2766,Dapsone,B-Drug
40615,2766,therapy,O
40616,2766,as,O
40617,2766,listed,O
40618,2766,in,O
40619,2766,the,O
40620,2766,product,O
40621,2766,labels,O
40622,2766,.,O
40623,2767,Current,O
40624,2767,severe,O
40625,2767,illness,O
40626,2767,",",O
40627,2767,including,O
40628,2767,heart,B-Condition
40629,2767,",",I-Condition
40630,2767,liver,I-Condition
40631,2767,and,I-Condition
40632,2767,renal,I-Condition
40633,2767,failure,I-Condition
40634,2767,",",O
40635,2767,major,B-Condition
40636,2767,organ,I-Condition
40637,2767,allograft,I-Condition
40638,2767,",",O
40639,2767,malignancy,B-Condition
40640,2767,requiring,O
40641,2767,parenteral,O
40642,2767,chemotherapy,B-Procedure
40643,2767,that,O
40644,2767,can,O
40645,2767,not,O
40646,2767,be,O
40647,2767,discontinued,O
40648,2767,for,O
40649,2767,the,O
40650,2767,duration,O
40651,2767,of,O
40652,2767,the,O
40653,2767,trial,O
40654,2767,",",O
40655,2767,or,O
40656,2767,any,O
40657,2767,other,O
40658,2767,conditions,O
40659,2767,which,O
40660,2767,",",O
40661,2767,in,O
40662,2767,the,O
40663,2767,opinion,O
40664,2767,of,O
40665,2767,the,O
40666,2767,Investigator,O
40667,2767,",",O
40668,2767,would,O
40669,2767,make,O
40670,2767,the,O
40671,2767,patient,O
40672,2767,unsuitable,O
40673,2767,for,O
40674,2767,the,O
40675,2767,study,O
40676,2767,.,O
40677,2768,Any,O
40678,2768,laboratory,O
40679,2768,abnormality,O
40680,2768,at,O
40681,2768,Screening,O
40682,2768,which,O
40683,2768,",",O
40684,2768,in,O
40685,2768,the,O
40686,2768,opinion,O
40687,2768,of,O
40688,2768,the,O
40689,2768,Investigator,O
40690,2768,",",O
40691,2768,should,O
40692,2768,preclude,O
40693,2768,the,O
40694,2768,subject,O
40695,2768,'s,O
40696,2768,participation,O
40697,2768,in,O
40698,2768,the,O
40699,2768,study,O
40700,2768,[,O
40701,2768,alanine,O
40702,2768,aminotransferase,O
40703,2768,(,O
40704,2768,ALT,O
40705,2768,),O
40706,2768,",",O
40707,2768,glutamic,O
40708,2768,oxaloacetic,O
40709,2768,transaminase(ALT,O
40710,2768,),O
40711,2768,",",O
40712,2768,et,O
40713,2768,al,O
40714,2768,),O
40715,2768,.,O
40716,2769,Pregnant,O
40717,2769,women,O
40718,2769,or,O
40719,2769,women,O
40720,2769,who,O
40721,2769,are,O
40722,2769,breastfeeding,O
40723,2769,.,O
40724,2770,Subject,O
40725,2770,is,O
40726,2770,",",O
40727,2770,in,O
40728,2770,the,O
40729,2770,opinion,O
40730,2770,of,O
40731,2770,the,O
40732,2770,Investigator,O
40733,2770,",",O
40734,2770,unable,O
40735,2770,to,O
40736,2770,complete,O
40737,2770,the,O
40738,2770,6,O
40739,2770,week,O
40740,2770,Observation,O
40741,2770,period,O
40742,2770,and,O
40743,2770,the,O
40744,2770,EPT,O
40745,2770,assessments,O
40746,2770,as,O
40747,2770,required,O
40748,2770,.,O
40749,2771,A,O
40750,2771,positive,O
40751,2771,result,O
40752,2771,for,O
40753,2771,HLA,O
40754,2771,-,O
40755,2771,B*1301,O
40756,2771,in,O
40757,2771,those,O
40758,2771,subjects,O
40759,2771,randomised,O
40760,2771,to,O
40761,2771,the,O
40762,2771,genetic,O
40763,2771,screening,O
40764,2771,arm,O
40765,2771,.,O
40766,2772,Diagnosed,O
40767,2772,with,O
40768,2772,cutaneous,B-Condition
40769,2772,vasculitis,I-Condition
40770,2772,",",O
40771,2772,urticaria,B-Condition
40772,2772,",",O
40773,2772,psoriasis,B-Condition
40774,2772,",",O
40775,2772,acne,B-Condition
40776,2772,",",O
40777,2772,bullous,B-Condition
40778,2772,skin,I-Condition
40779,2772,diseases,I-Condition
40780,2772,",",O
40781,2772,sterile,B-Condition
40782,2772,pustulosis,I-Condition
40783,2772,",",O
40784,2772,leprosy,B-Condition
40785,2772,",",O
40786,2772,pneumocystis,B-Condition
40787,2772,pneumonia,I-Condition
40788,2772,and,O
40789,2772,any,O
40790,2772,other,O
40791,2772,patients,O
40792,2772,who,O
40793,2772,need,O
40794,2772,dapsone,B-Drug
40795,2772,administration,O
40796,2772,.,O
40797,2773,Subjects,O
40798,2773,are,O
40799,2773,dapsone,B-Drug
40800,2773,-,O
40801,2773,naive,O
40802,2773,.,O
40803,2774,All,O
40804,2774,subjects,O
40805,2774,must,O
40806,2774,have,O
40807,2774,a,O
40808,2774,clinical,O
40809,2774,need,O
40810,2774,for,O
40811,2774,treatment,O
40812,2774,with,O
40813,2774,dapsone,O
40814,2774,that,O
40815,2774,precedes,O
40816,2774,the,O
40817,2774,decision,O
40818,2774,to,O
40819,2774,participate,O
40820,2774,in,O
40821,2774,the,O
40822,2774,study,O
40823,2774,.,O
40824,2775,All,O
40825,2775,subjects,O
40826,2775,are,O
40827,2775,willing,O
40828,2775,to,O
40829,2775,complete,O
40830,2775,the,O
40831,2775,6,O
40832,2775,-,O
40833,2775,weeks,O
40834,2775,period,O
40835,2775,clinical,O
40836,2775,trial,O
40837,2775,.,O
40838,2776,All,O
40839,2776,subjects,O
40840,2776,are,O
40841,2776,written,O
40842,2776,informed,O
40843,2776,consent,O
40844,2776,.,O
40845,2777,thrombus,B-Condition
40846,2777,in,O
40847,2777,the,O
40848,2777,LA,O
40849,2777,or,O
40850,2777,LAA,O
40851,2777,;,O
40852,2778,mechanical,O
40853,2778,valve,O
40854,2778,prosthesis,O
40855,2778,;,O
40856,2779,mitral,B-Condition
40857,2779,stenosis,I-Condition
40858,2779,;,O
40859,2780,previous,O
40860,2780,LAA,B-Procedure
40861,2780,ligation,I-Procedure
40862,2780,during,O
40863,2780,cardiac,B-Procedure
40864,2780,surgery,I-Procedure
40865,2780,;,O
40866,2781,life,B-Observation
40867,2781,expectancy,I-Observation
40868,2781,less,O
40869,2781,than,O
40870,2781,2,O
40871,2781,years,O
40872,2781,;,O
40873,2782,comorbidities,B-Condition
40874,2782,other,O
40875,2782,than,O
40876,2782,AF,B-Condition
40877,2782,",",O
40878,2782,which,O
40879,2782,present,O
40880,2782,an,O
40881,2782,indication,B-Condition
40882,2782,for,O
40883,2782,anticoagulation,B-Procedure
40884,2782,;,O
40885,2783,patent,B-Condition
40886,2783,foramen,I-Condition
40887,2783,ovale,I-Condition
40888,2783,with,O
40889,2783,atrial,B-Condition
40890,2783,septal,I-Condition
40891,2783,aneurysm,I-Condition
40892,2784,mobile,B-Condition
40893,2784,plaque,I-Condition
40894,2784,in,I-Condition
40895,2784,the,I-Condition
40896,2784,aorta,I-Condition
40897,2784,;,O
40898,2785,symptomatic,O
40899,2785,atherosclerosis,B-Condition
40900,2785,of,O
40901,2785,the,O
40902,2785,carotid,O
40903,2785,artery,O
40904,2785,;,O
40905,2786,pericardial,B-Condition
40906,2786,effusion,I-Condition
40907,2786,greater,O
40908,2786,than,O
40909,2786,10,O
40910,2786,mm,O
40911,2786,;,O
40912,2787,clinically,O
40913,2787,significant,O
40914,2787,bleeding,B-Condition
40915,2787,within,O
40916,2787,the,O
40917,2787,30,O
40918,2787,days,O
40919,2787,prior,O
40920,2787,to,O
40921,2787,the,O
40922,2787,scheduled,O
40923,2787,procedure,O
40924,2787,;,O
40925,2788,stroke,B-Condition
40926,2788,or,O
40927,2788,other,O
40928,2788,cardioembolic,B-Condition
40929,2788,event,I-Condition
40930,2788,within,O
40931,2788,the,O
40932,2788,30,O
40933,2788,days,O
40934,2788,prior,O
40935,2788,to,O
40936,2788,the,O
40937,2788,scheduled,O
40938,2788,procedure,O
40939,2788,;,O
40940,2789,acute,B-Condition
40941,2789,coronary,I-Condition
40942,2789,syndrome,I-Condition
40943,2789,within,O
40944,2789,the,O
40945,2789,90,O
40946,2789,days,O
40947,2789,prior,O
40948,2789,to,O
40949,2789,the,O
40950,2789,scheduled,O
40951,2789,procedure,O
40952,2789,",",O
40953,2790,gravidity,B-Condition
40954,2790,",",O
40955,2791,significant,O
40956,2791,valvular,B-Condition
40957,2791,disease,I-Condition
40958,2791,",",O
40959,2792,creatinine,O
40960,2792,clearance,O
40961,2792,less,O
40962,2792,than,O
40963,2792,30,O
40964,2792,ml,O
40965,2792,/,O
40966,2792,min,O
40967,2793,history,O
40968,2793,of,O
40969,2793,significant,O
40970,2793,bleeding,B-Condition
40971,2793,(,O
40972,2793,i.e.,O
40973,2793,bleeding,B-Condition
40974,2793,which,O
40975,2793,required,O
40976,2793,intervention,B-Procedure
40977,2793,or,O
40978,2793,hospitalization,B-Procedure
40979,2793,),O
40980,2793,",",O
40981,2793,even,O
40982,2793,in,O
40983,2793,the,O
40984,2793,absence,O
40985,2793,of,O
40986,2793,anticoagulation,O
40987,2793,treatment,O
40988,2793,at,O
40989,2793,the,O
40990,2793,time,O
40991,2793,of,O
40992,2793,the,O
40993,2793,bleeding,O
40994,2793,event,O
40995,2793,",",O
40996,2793,or,O
40997,2794,a,O
40998,2794,cardioembolic,B-Condition
40999,2794,event,I-Condition
41000,2794,",",O
41001,2794,which,O
41002,2794,occurred,O
41003,2794,on,O
41004,2794,anticoagulation,B-Drug
41005,2794,",",O
41006,2794,or,O
41007,2795,a,O
41008,2795,high,B-Condition
41009,2795,risk,I-Condition
41010,2795,profile,I-Condition
41011,2795,of,O
41012,2795,the,O
41013,2795,patient,O
41014,2795,",",O
41015,2795,defined,O
41016,2795,as,O
41017,2795,a,O
41018,2795,CHA2DS2,O
41019,2795,-,O
41020,2795,VASc,O
41021,2795,score,O
41022,2795,=,O
41023,2795,3,O
41024,2795,and,O
41025,2795,a,O
41026,2795,HAS,O
41027,2795,-,O
41028,2795,BLED,O
41029,2795,score,O
41030,2795,=,O
41031,2795,2,O
41032,2796,Established,O
41033,2796,pre,O
41034,2796,-,O
41035,2796,existing,O
41036,2796,diabetes,B-Condition
41037,2796,(,O
41038,2796,including,O
41039,2796,unrecognised,O
41040,2796,diabetes,O
41041,2796,defined,O
41042,2796,as,O
41043,2796,a,O
41044,2796,fasting,O
41045,2796,plasma,O
41046,2796,glucose,O
41047,2796,=,O
41048,2796,7.0mmol,O
41049,2796,/,O
41050,2796,L,O
41051,2796,and/,O
41052,2796,or,O
41053,2796,HbA1c,O
41054,2796,=,O
41055,2796,48mmol,O
41056,2796,/,O
41057,2796,mol,O
41058,2796,),O
41059,2796,;,O
41060,2796,Contraindications,B-Condition
41061,2796,to,O
41062,2796,metformin,B-Drug
41063,2796,therapy,O
41064,2796,(,O
41065,2796,creatinine,O
41066,2796,=,O
41067,2796,130µmol,O
41068,2796,/,O
41069,2796,L/,O
41070,2796,alanine,O
41071,2796,transaminase,O
41072,2796,=,O
41073,2796,2.0,O
41074,2796,x,O
41075,2796,upper,O
41076,2796,limit,O
41077,2796,normal/,O
41078,2796,previous,O
41079,2796,intolerance,B-Condition
41080,2796,to,O
41081,2796,metformin,B-Drug
41082,2796,),O
41083,2797,Planned,O
41084,2797,continued,O
41085,2797,antenatal,O
41086,2797,care/,O
41087,2797,delivery,O
41088,2797,at,O
41089,2797,centre,O
41090,2797,not,O
41091,2797,included,O
41092,2797,in,O
41093,2797,trial,O
41094,2798,Planned,O
41095,2798,fast,O
41096,2798,for,O
41097,2798,cultural/,O
41098,2798,religious,O
41099,2798,reasons,O
41100,2798,e.g.,O
41101,2798,Ramadan,O
41102,2799,Singleton,B-Condition
41103,2799,pregnancy,I-Condition
41104,2799,;,O
41105,2800,8,O
41106,2800,-,O
41107,2800,22,O
41108,2800,weeks,O
41109,2800,gestation,B-Condition
41110,2801,Previous,O
41111,2801,pregnancy,B-Condition
41112,2801,complicated,O
41113,2801,by,O
41114,2801,gestational,B-Condition
41115,2801,diabetes,I-Condition
41116,2802,Claustrophobia,B-Condition
41117,2802,",",O
41118,2802,or,O
41119,2802,the,O
41120,2802,inability,B-Observation
41121,2802,to,I-Observation
41122,2802,lie,I-Observation
41123,2802,still,I-Observation
41124,2802,in,I-Observation
41125,2802,a,I-Observation
41126,2802,confined,I-Observation
41127,2802,space,I-Observation
41128,2803,Major,O
41129,2803,medical,B-Condition
41130,2803,disorders,I-Condition
41131,2803,(,O
41132,2803,e.g.,O
41133,2803,",",O
41134,2803,HIV,B-Condition
41135,2803,",",O
41136,2803,cancer,B-Condition
41137,2803,),O
41138,2804,Magnetic,O
41139,2804,metallic,O
41140,2804,implants,O
41141,2804,(,O
41142,2804,such,O
41143,2804,as,O
41144,2804,screws,O
41145,2804,",",O
41146,2804,pins,O
41147,2804,",",O
41148,2804,shrapnel,O
41149,2804,remnants,O
41150,2804,",",O
41151,2804,aneurysm,O
41152,2804,clips,O
41153,2804,",",O
41154,2804,artificial,O
41155,2804,heart,O
41156,2804,valves,O
41157,2804,",",O
41158,2804,inner,O
41159,2804,ear,O
41160,2804,(,O
41161,2804,cochlear,O
41162,2804,),O
41163,2804,implants,O
41164,2804,",",O
41165,2804,artificial,O
41166,2804,joints,O
41167,2804,",",O
41168,2804,and,O
41169,2804,vascular,O
41170,2804,stents,O
41171,2804,),O
41172,2805,Electronic,O
41173,2805,or,O
41174,2805,magnetic,O
41175,2805,implants,O
41176,2805,",",O
41177,2805,such,O
41178,2805,as,O
41179,2805,pacemakers,O
41180,2806,Permanent,B-Observation
41181,2806,makeup,I-Observation
41182,2806,or,O
41183,2806,tattoos,B-Observation
41184,2806,with,O
41185,2806,metallic,O
41186,2806,dyes,O
41187,2807,Currently,O
41188,2807,pregnant,B-Condition
41189,2808,A,O
41190,2808,self,O
41191,2808,-,O
41192,2808,reported,O
41193,2808,history,B-Observation
41194,2808,of,I-Observation
41195,2808,loss,I-Observation
41196,2808,of,I-Observation
41197,2808,consciousness,I-Observation
41198,2808,(,O
41199,2808,greater,O
41200,2808,than,O
41201,2808,10,O
41202,2808,minutes,O
41203,2808,),O
41204,2809,Physical,O
41205,2809,disabilities,O
41206,2809,that,O
41207,2809,prohibit,O
41208,2809,task,O
41209,2809,performance,O
41210,2809,(,O
41211,2809,such,O
41212,2809,as,O
41213,2809,blindness,B-Condition
41214,2809,or,O
41215,2809,deafness,B-Condition
41216,2809,),O
41217,2810,Psychotic,B-Condition
41218,2810,disorders,I-Condition
41219,2810,(,O
41220,2810,e.g.,O
41221,2810,",",O
41222,2810,schizophrenia,B-Condition
41223,2810,),O
41224,2811,Any,O
41225,2811,other,O
41226,2811,condition,O
41227,2811,that,O
41228,2811,the,O
41229,2811,investigator,O
41230,2811,believes,O
41231,2811,might,O
41232,2811,put,O
41233,2811,the,O
41234,2811,participant,O
41235,2811,at,O
41236,2811,risk,O
41237,2812,25,O
41238,2812,-,O
41239,2812,50,O
41240,2812,years,O
41241,2812,of,O
41242,2812,age,B-Person
41243,2813,PTSD,B-Condition
41244,2813,related,O
41245,2813,to,O
41246,2813,physical,B-Observation
41247,2813,or,I-Observation
41248,2813,sexual,I-Observation
41249,2813,assault,I-Observation
41250,2814,Medically,B-Observation
41251,2814,healthy,I-Observation
41252,2815,English,B-Observation
41253,2815,speaking,I-Observation
41254,2816,pregnancy,B-Condition
41255,2817,past,O
41256,2817,esophageal,B-Procedure
41257,2817,",",I-Procedure
41258,2817,gastric,I-Procedure
41259,2817,or,I-Procedure
41260,2817,bariatric,I-Procedure
41261,2817,surgery,I-Procedure
41262,2818,irritable,B-Condition
41263,2818,bowel,I-Condition
41264,2818,",",O
41265,2818,unexplained,O
41266,2818,intermittent,O
41267,2818,vomiting,B-Condition
41268,2818,",",O
41269,2818,severe,O
41270,2818,abdominal,B-Condition
41271,2818,pain,I-Condition
41272,2818,",",O
41273,2818,chronic,O
41274,2818,diarrhea,B-Condition
41275,2818,or,O
41276,2818,constipation,B-Condition
41277,2819,history,O
41278,2819,of,O
41279,2819,gastric,B-Condition
41280,2819,or,I-Condition
41281,2819,duodenal,I-Condition
41282,2819,ulcers,I-Condition
41283,2820,pre,O
41284,2820,-,O
41285,2820,operatory,O
41286,2820,hypoalbuminemy,B-Condition
41287,2821,history,O
41288,2821,of,O
41289,2821,renal,B-Condition
41290,2821,",",I-Condition
41291,2821,hepatic,I-Condition
41292,2821,",",I-Condition
41293,2821,cardiac,I-Condition
41294,2821,or,I-Condition
41295,2821,pulmonary,I-Condition
41296,2821,severe,I-Condition
41297,2821,disease,I-Condition
41298,2822,taken,O
41299,2822,of,O
41300,2822,corticosteroid,B-Drug
41301,2822,in,O
41302,2822,the,O
41303,2822,last,O
41304,2822,month,O
41305,2823,evidence,O
41306,2823,of,O
41307,2823,psycological,O
41308,2823,problem,O
41309,2823,that,O
41310,2823,may,O
41311,2823,affect,O
41312,2823,the,O
41313,2823,capacity,O
41314,2823,to,O
41315,2823,understand,O
41316,2823,the,O
41317,2823,project,O
41318,2823,and,O
41319,2823,to,O
41320,2823,comply,O
41321,2823,with,O
41322,2823,the,O
41323,2823,medical,O
41324,2823,recommandations,O
41325,2824,history,O
41326,2824,of,O
41327,2824,drug,B-Condition
41328,2824,use,I-Condition
41329,2824,or,O
41330,2824,alcool,B-Condition
41331,2824,abuse,I-Condition
41332,2824,in,O
41333,2824,the,O
41334,2824,last,O
41335,2824,12,O
41336,2824,months,O
41337,2825,history,O
41338,2825,of,O
41339,2825,gastro,B-Condition
41340,2825,-,I-Condition
41341,2825,intestinal,I-Condition
41342,2825,inflammatory,I-Condition
41343,2825,diseases,I-Condition
41344,2826,BMI,O
41345,2826,=,O
41346,2826,35,O
41347,2827,type,B-Condition
41348,2827,2,I-Condition
41349,2827,diabetes,I-Condition
41350,2828,HbA1c,O
41351,2828,=,O
41352,2828,"6,5",O
41353,2828,%,O
41354,2828,or,O
41355,2828,fasting,O
41356,2828,glycemia,O
41357,2828,=,O
41358,2828,7mmol,O
41359,2828,/,O
41360,2828,l,O
41361,2828,or,O
41362,2828,non,O
41363,2828,-,O
41364,2828,fasting,O
41365,2828,glycemia,O
41366,2828,=,O
41367,2828,11mmol,O
41368,2828,/,O
41369,2828,l,O
41370,2829,able,O
41371,2829,to,O
41372,2829,consent,O
41373,2830,1,O
41374,2830,.,O
41375,2830,Personal,O
41376,2830,history,B-Observation
41377,2830,of,I-Observation
41378,2830,stroke,B-Condition
41379,2830,",",O
41380,2830,brain,B-Condition
41381,2830,lesions,I-Condition
41382,2830,",",O
41383,2830,previous,O
41384,2830,neurosurgery,B-Condition
41385,2830,",",O
41386,2830,any,O
41387,2830,personal,B-Observation
41388,2830,history,I-Observation
41389,2830,of,I-Observation
41390,2830,seizure,B-Condition
41391,2830,or,O
41392,2830,fainting,B-Condition
41393,2830,episode,I-Condition
41394,2830,of,O
41395,2830,unknown,O
41396,2830,cause,O
41397,2830,",",O
41398,2830,or,O
41399,2830,head,B-Condition
41400,2830,trauma,I-Condition
41401,2830,resulting,I-Condition
41402,2830,in,I-Condition
41403,2830,loss,I-Condition
41404,2830,of,I-Condition
41405,2830,consciousness,I-Condition
41406,2830,",",O
41407,2830,lasting,O
41408,2830,over,O
41409,2830,30,O
41410,2830,minutes,O
41411,2830,or,O
41412,2830,with,O
41413,2830,sequela,B-Condition
41414,2830,lasting,O
41415,2830,longer,O
41416,2830,than,O
41417,2830,two,O
41418,2830,days,O
41419,2830,.,O
41420,2831,Justification,O
41421,2831,:,O
41422,2831,Stroke,O
41423,2831,or,O
41424,2831,head,O
41425,2831,trauma,O
41426,2831,can,O
41427,2831,lower,O
41428,2831,the,O
41429,2831,seizure,O
41430,2831,threshold,O
41431,2831,",",O
41432,2831,and,O
41433,2831,are,O
41434,2831,therefore,O
41435,2831,contra,O
41436,2831,-,O
41437,2831,indications,O
41438,2831,for,O
41439,2831,TMS,O
41440,2831,.,O
41441,2831,Fainting,O
41442,2831,episodes,O
41443,2831,or,O
41444,2831,syncope,O
41445,2831,of,O
41446,2831,unknown,O
41447,2831,cause,O
41448,2831,could,O
41449,2831,indicate,O
41450,2831,an,O
41451,2831,undiagnosed,O
41452,2831,condition,O
41453,2831,associated,O
41454,2831,with,O
41455,2831,seizures,O
41456,2831,.,O
41457,2832,Screening,B-Procedure
41458,2832,tool,O
41459,2832,:,O
41460,2832,TMS,B-Procedure
41461,2832,adult,I-Procedure
41462,2832,safety,I-Procedure
41463,2832,questionnaire,I-Procedure
41464,2832,",",O
41465,2832,Medical,B-Observation
41466,2832,History,I-Observation
41467,2832,.,O
41468,2833,2,O
41469,2833,.,O
41470,2833,First,O
41471,2833,-,O
41472,2833,degree,O
41473,2833,family,B-Observation
41474,2833,history,I-Observation
41475,2833,of,I-Observation
41476,2833,any,O
41477,2833,neurological,B-Condition
41478,2833,disorder,I-Condition
41479,2833,with,O
41480,2833,a,O
41481,2833,potentially,O
41482,2833,hereditary,O
41483,2833,basis,O
41484,2833,",",O
41485,2833,including,O
41486,2833,migraines,B-Condition
41487,2833,",",O
41488,2833,epilepsy,B-Condition
41489,2833,",",O
41490,2833,or,O
41491,2833,multiple,B-Condition
41492,2833,sclerosis,I-Condition
41493,2833,.,O
41494,2834,1,O
41495,2834,.,O
41496,2834,Justification,O
41497,2834,:,O
41498,2834,Neurological,O
41499,2834,disorders,O
41500,2834,can,O
41501,2834,lower,O
41502,2834,the,O
41503,2834,seizure,O
41504,2834,threshold,O
41505,2834,",",O
41506,2834,and,O
41507,2834,are,O
41508,2834,therefore,O
41509,2834,contra,O
41510,2834,-,O
41511,2834,indications,O
41512,2834,for,O
41513,2834,TMS,O
41514,2834,.,O
41515,2834,First,O
41516,2834,-,O
41517,2834,degree,O
41518,2834,family,O
41519,2834,history,O
41520,2834,of,O
41521,2834,certain,O
41522,2834,neurological,O
41523,2834,disorders,O
41524,2834,with,O
41525,2834,a,O
41526,2834,hereditary,O
41527,2834,component,O
41528,2834,increases,O
41529,2834,the,O
41530,2834,risk,O
41531,2834,of,O
41532,2834,the,O
41533,2834,subject,O
41534,2834,having,O
41535,2834,an,O
41536,2834,undiagnosed,O
41537,2834,condition,O
41538,2834,that,O
41539,2834,is,O
41540,2834,associated,O
41541,2834,with,O
41542,2834,lowered,O
41543,2834,seizure,O
41544,2834,threshold,O
41545,2834,.,O
41546,2835,2,O
41547,2835,.,O
41548,2835,Screening,B-Procedure
41549,2835,tool,O
41550,2835,:,O
41551,2835,TMS,B-Procedure
41552,2835,adult,I-Procedure
41553,2835,safety,I-Procedure
41554,2835,screening,I-Procedure
41555,2835,",",O
41556,2835,Medical,B-Observation
41557,2835,History,I-Observation
41558,2835,.,O
41559,2836,3,O
41560,2836,.,O
41561,2836,Cardiac,O
41562,2836,pacemakers,O
41563,2836,",",O
41564,2836,neural,O
41565,2836,stimulators,O
41566,2836,",",O
41567,2836,implantable,O
41568,2836,defibrillator,O
41569,2836,",",O
41570,2836,implanted,O
41571,2836,medication,O
41572,2836,pumps,O
41573,2836,",",O
41574,2836,intracardiac,O
41575,2836,lines,O
41576,2836,",",O
41577,2836,or,O
41578,2836,acute,O
41579,2836,",",O
41580,2836,unstable,O
41581,2836,cardiac,B-Condition
41582,2836,disease,I-Condition
41583,2836,",",O
41584,2836,with,O
41585,2836,intracranial,O
41586,2836,implants,O
41587,2836,(,O
41588,2836,e.g.,O
41589,2836,aneurysm,O
41590,2836,clips,O
41591,2836,",",O
41592,2836,shunts,O
41593,2836,",",O
41594,2836,stimulators,O
41595,2836,",",O
41596,2836,cochlear,O
41597,2836,implants,O
41598,2836,",",O
41599,2836,or,O
41600,2836,electrodes,O
41601,2836,),O
41602,2836,or,O
41603,2836,any,O
41604,2836,other,O
41605,2836,metal,O
41606,2836,object,O
41607,2836,within,O
41608,2836,or,O
41609,2836,near,O
41610,2836,the,O
41611,2836,head,O
41612,2836,that,O
41613,2836,precludes,O
41614,2836,MRI,B-Procedure
41615,2836,scanning,I-Procedure
41616,2836,.,O
41617,2837,1,O
41618,2837,.,O
41619,2837,Justification,O
41620,2837,:,O
41621,2837,Any,O
41622,2837,metal,O
41623,2837,around,O
41624,2837,the,O
41625,2837,head,O
41626,2837,is,O
41627,2837,a,O
41628,2837,contraindication,O
41629,2837,for,O
41630,2837,both,O
41631,2837,MRI,O
41632,2837,and,O
41633,2837,TMS,O
41634,2837,",",O
41635,2837,as,O
41636,2837,both,O
41637,2837,methods,O
41638,2837,involve,O
41639,2837,exposure,O
41640,2837,to,O
41641,2837,a,O
41642,2837,relatively,O
41643,2837,strong,O
41644,2837,magnetic,O
41645,2837,field,O
41646,2837,.,O
41647,2838,2,O
41648,2838,.,O
41649,2838,Screening,B-Procedure
41650,2838,tool,O
41651,2838,:,O
41652,2838,TMS,B-Procedure
41653,2838,adult,I-Procedure
41654,2838,safety,I-Procedure
41655,2838,screening,I-Procedure
41656,2838,",",O
41657,2838,MRI,B-Procedure
41658,2838,safety,I-Procedure
41659,2838,screening,I-Procedure
41660,2838,",",O
41661,2838,Medical,B-Observation
41662,2838,History,I-Observation
41663,2838,.,O
41664,2839,4,O
41665,2839,.,O
41666,2839,Noise,B-Condition
41667,2839,-,I-Condition
41668,2839,induced,I-Condition
41669,2839,hearing,I-Condition
41670,2839,loss,I-Condition
41671,2839,or,O
41672,2839,tinnitus,B-Condition
41673,2839,.,O
41674,2840,1,O
41675,2840,.,O
41676,2840,Justification,O
41677,2840,:,O
41678,2840,individuals,O
41679,2840,with,O
41680,2840,noise,O
41681,2840,-,O
41682,2840,induced,O
41683,2840,hearing,O
41684,2840,problems,O
41685,2840,may,O
41686,2840,be,O
41687,2840,particularly,O
41688,2840,vulnerable,O
41689,2840,to,O
41690,2840,the,O
41691,2840,acoustic,O
41692,2840,noise,O
41693,2840,generated,O
41694,2840,by,O
41695,2840,TMS,O
41696,2840,and,O
41697,2840,MRI,O
41698,2840,equipment,O
41699,2840,.,O
41700,2841,2,O
41701,2841,.,O
41702,2841,Screening,B-Procedure
41703,2841,tools,O
41704,2841,:,O
41705,2841,TMS,B-Procedure
41706,2841,adult,I-Procedure
41707,2841,safety,I-Procedure
41708,2841,screening,I-Procedure
41709,2841,.,O
41710,2842,5,O
41711,2842,.,O
41712,2842,Current,O
41713,2842,use,O
41714,2842,(,O
41715,2842,any,O
41716,2842,use,O
41717,2842,in,O
41718,2842,the,O
41719,2842,past,O
41720,2842,4,O
41721,2842,weeks,O
41722,2842,",",O
41723,2842,chronic,O
41724,2842,use,O
41725,2842,within,O
41726,2842,6,O
41727,2842,past,O
41728,2842,six,O
41729,2842,months,O
41730,2842,),O
41731,2842,of,O
41732,2842,any,O
41733,2842,investigational,B-Drug
41734,2842,drug,I-Drug
41735,2842,or,O
41736,2842,of,O
41737,2842,any,O
41738,2842,medications,B-Drug
41739,2842,with,O
41740,2842,psychotropic,O
41741,2842,",",O
41742,2842,anti,O
41743,2842,or,O
41744,2842,pro,O
41745,2842,-,O
41746,2842,convulsive,O
41747,2842,action,O
41748,2842,.,O
41749,2843,1,O
41750,2843,.,O
41751,2843,Justification,O
41752,2843,:,O
41753,2843,The,O
41754,2843,use,O
41755,2843,of,O
41756,2843,certain,O
41757,2843,medications,O
41758,2843,or,O
41759,2843,drugs,O
41760,2843,can,O
41761,2843,lower,O
41762,2843,seizure,O
41763,2843,threshold,O
41764,2843,and,O
41765,2843,is,O
41766,2843,therefore,O
41767,2843,contra,O
41768,2843,-,O
41769,2843,indicated,O
41770,2843,for,O
41771,2843,TMS,O
41772,2843,.,O
41773,2844,2,O
41774,2844,.,O
41775,2844,Screening,B-Procedure
41776,2844,tools,O
41777,2844,:,O
41778,2844,MRI,B-Procedure
41779,2844,safety,I-Procedure
41780,2844,screening,I-Procedure
41781,2844,questionnaire,I-Procedure
41782,2844,",",O
41783,2844,Medical,B-Procedure
41784,2844,history,I-Procedure
41785,2844,",",O
41786,2844,Medical,O
41787,2844,Assessments,O
41788,2844,:,O
41789,2844,Urine,B-Procedure
41790,2844,toxicology,I-Procedure
41791,2844,analyzes,I-Procedure
41792,2844,for,O
41793,2844,presence,O
41794,2844,of,O
41795,2844,a,O
41796,2844,broad,O
41797,2844,range,O
41798,2844,of,O
41799,2844,prescription,O
41800,2844,and,O
41801,2844,nonprescription,O
41802,2844,drugs,B-Drug
41803,2844,.,O
41804,2845,6,O
41805,2845,.,O
41806,2845,Lifetime,B-Observation
41807,2845,history,I-Observation
41808,2845,of,I-Observation
41809,2845,major,B-Condition
41810,2845,depressive,I-Condition
41811,2845,disorder,I-Condition
41812,2845,",",O
41813,2845,schizophrenia,B-Condition
41814,2845,",",O
41815,2845,bipolar,B-Condition
41816,2845,disorder,I-Condition
41817,2845,",",O
41818,2845,mania,B-Condition
41819,2845,",",O
41820,2845,or,O
41821,2845,hypomania,B-Condition
41822,2845,.,O
41823,2846,1,O
41824,2846,.,O
41825,2846,Justification,O
41826,2846,:,O
41827,2846,The,O
41828,2846,population,O
41829,2846,of,O
41830,2846,interest,O
41831,2846,here,O
41832,2846,is,O
41833,2846,a,O
41834,2846,healthy,O
41835,2846,control,O
41836,2846,population,O
41837,2846,with,O
41838,2846,no,O
41839,2846,psychiatric,O
41840,2846,disorders,O
41841,2846,.,O
41842,2846,In,O
41843,2846,subjects,O
41844,2846,with,O
41845,2846,depression,O
41846,2846,",",O
41847,2846,bipolar,O
41848,2846,disorder,O
41849,2846,",",O
41850,2846,mania,O
41851,2846,or,O
41852,2846,hypomania,O
41853,2846,",",O
41854,2846,there,O
41855,2846,is,O
41856,2846,a,O
41857,2846,small,O
41858,2846,chance,O
41859,2846,that,O
41860,2846,TMS,O
41861,2846,can,O
41862,2846,trigger,O
41863,2846,(,O
41864,2846,hypo)manic,O
41865,2846,symptoms,O
41866,2846,.,O
41867,2847,2,O
41868,2847,.,O
41869,2847,Screening,O
41870,2847,tools,O
41871,2847,:,O
41872,2847,SCID,O
41873,2847,Screen,O
41874,2847,Patient,O
41875,2847,Questionnaire,O
41876,2847,.,O
41877,2847,Potential,O
41878,2847,diagnoses,O
41879,2847,will,O
41880,2847,be,O
41881,2847,further,O
41882,2847,evaluated,O
41883,2847,by,O
41884,2847,a,O
41885,2847,counsellor,O
41886,2847,.,O
41887,2848,7,O
41888,2848,.,O
41889,2848,Meet,O
41890,2848,current,O
41891,2848,DSM,O
41892,2848,V,O
41893,2848,criteria,O
41894,2848,for,O
41895,2848,moderate,O
41896,2848,to,O
41897,2848,severe,O
41898,2848,substance,B-Condition
41899,2848,use,I-Condition
41900,2848,disorder,I-Condition
41901,2848,(,O
41902,2848,excluding,O
41903,2848,nicotine,B-Drug
41904,2848,),O
41905,2848,",",O
41906,2848,smoke,B-Observation
41907,2848,daily,I-Observation
41908,2848,",",O
41909,2848,or,O
41910,2848,urine,O
41911,2848,toxicology,O
41912,2848,positive,O
41913,2848,for,O
41914,2848,any,O
41915,2848,illicit,B-Drug
41916,2848,substance,I-Drug
41917,2848,inconsistent,O
41918,2848,with,O
41919,2848,history,O
41920,2848,given,O
41921,2848,.,O
41922,2849,1,O
41923,2849,.,O
41924,2849,Justification,O
41925,2849,:,O
41926,2849,The,O
41927,2849,population,O
41928,2849,of,O
41929,2849,interest,O
41930,2849,here,O
41931,2849,is,O
41932,2849,a,O
41933,2849,healthy,O
41934,2849,control,O
41935,2849,population,O
41936,2849,with,O
41937,2849,no,O
41938,2849,substance,O
41939,2849,use,O
41940,2849,disorder,O
41941,2849,.,O
41942,2849,Current,O
41943,2849,use,O
41944,2849,of,O
41945,2849,illicit,O
41946,2849,substances,O
41947,2849,could,O
41948,2849,impact,O
41949,2849,on,O
41950,2849,seizure,O
41951,2849,threshold,O
41952,2849,and,O
41953,2849,is,O
41954,2849,therefore,O
41955,2849,contra,O
41956,2849,-,O
41957,2849,indicated,O
41958,2849,for,O
41959,2849,TMS,O
41960,2849,.,O
41961,2850,2,O
41962,2850,.,O
41963,2850,Screening,O
41964,2850,tools,O
41965,2850,:,O
41966,2850,SCID,B-Procedure
41967,2850,Screen,I-Procedure
41968,2850,Patient,I-Procedure
41969,2850,Questionnaire,I-Procedure
41970,2850,.,O
41971,2850,Potential,O
41972,2850,diagnoses,O
41973,2850,will,O
41974,2850,be,O
41975,2850,further,O
41976,2850,evaluated,O
41977,2850,by,O
41978,2850,a,O
41979,2850,counsellor,O
41980,2850,",",O
41981,2850,Drug,O
41982,2850,Use,O
41983,2850,Survey,O
41984,2850,(,O
41985,2850,DUS,O
41986,2850,),O
41987,2850,",",O
41988,2850,Substance,O
41989,2850,Use,O
41990,2850,Disorder,O
41991,2850,Evaluation,O
41992,2850,",",O
41993,2850,Medical,O
41994,2850,Assessments,O
41995,2850,:,O
41996,2850,urine,O
41997,2850,qualitative,O
41998,2850,drug,O
41999,2850,screen,O
42000,2850,is,O
42001,2850,performed,O
42002,2850,for,O
42003,2850,methadone,O
42004,2850,",",O
42005,2850,benzodiazepines,O
42006,2850,",",O
42007,2850,cocaine,O
42008,2850,",",O
42009,2850,amphetamine,O
42010,2850,/,O
42011,2850,methamphetamine,O
42012,2850,",",O
42013,2850,opiates,O
42014,2850,",",O
42015,2850,barbiturates,O
42016,2850,",",O
42017,2850,and,O
42018,2850,tetrahydrocannabinol,O
42019,2850,.,O
42020,2851,8,O
42021,2851,.,O
42022,2851,Have,O
42023,2851,met,O
42024,2851,DSM,O
42025,2851,V,O
42026,2851,criteria,O
42027,2851,for,O
42028,2851,moderate,O
42029,2851,to,O
42030,2851,severe,O
42031,2851,substance,B-Condition
42032,2851,use,I-Condition
42033,2851,disorder,I-Condition
42034,2851,(,O
42035,2851,excluding,O
42036,2851,nicotine,B-Drug
42037,2851,",",O
42038,2851,alcohol,B-Drug
42039,2851,and,O
42040,2851,cannabis,B-Drug
42041,2851,),O
42042,2851,in,O
42043,2851,the,O
42044,2851,past,O
42045,2851,",",O
42046,2851,or,O
42047,2851,have,O
42048,2851,met,O
42049,2851,DSM,O
42050,2851,V,O
42051,2851,criteria,O
42052,2851,for,O
42053,2851,moderate,O
42054,2851,to,O
42055,2851,severe,O
42056,2851,substance,B-Condition
42057,2851,use,I-Condition
42058,2851,disorder,I-Condition
42059,2851,for,O
42060,2851,cannabis,B-Drug
42061,2851,or,O
42062,2851,alcohol,B-Drug
42063,2851,in,O
42064,2851,the,O
42065,2851,past,O
42066,2851,5,O
42067,2851,years,O
42068,2851,.,O
42069,2852,1,O
42070,2852,.,O
42071,2852,Justification,O
42072,2852,:,O
42073,2852,the,O
42074,2852,population,O
42075,2852,of,O
42076,2852,interest,O
42077,2852,here,O
42078,2852,is,O
42079,2852,a,O
42080,2852,healthy,O
42081,2852,control,O
42082,2852,population,O
42083,2852,with,O
42084,2852,no,O
42085,2852,present,O
42086,2852,or,O
42087,2852,past,O
42088,2852,substance,O
42089,2852,use,O
42090,2852,disorder,O
42091,2852,.,O
42092,2853,2,O
42093,2853,.,O
42094,2853,Screening,O
42095,2853,tools,O
42096,2853,:,O
42097,2853,SCID,B-Procedure
42098,2853,Screen,I-Procedure
42099,2853,Patient,I-Procedure
42100,2853,Questionnaire,I-Procedure
42101,2853,.,O
42102,2853,Potential,O
42103,2853,diagnoses,O
42104,2853,will,O
42105,2853,be,O
42106,2853,further,O
42107,2853,evaluated,O
42108,2853,by,O
42109,2853,a,O
42110,2853,counselor,O
42111,2853,.,O
42112,2853,Drug,B-Procedure
42113,2853,Use,I-Procedure
42114,2853,Survey,I-Procedure
42115,2853,(,I-Procedure
42116,2853,DUS,I-Procedure
42117,2853,),I-Procedure
42118,2853,",",O
42119,2853,Substance,B-Procedure
42120,2853,Use,I-Procedure
42121,2853,Disorder,I-Procedure
42122,2853,Evaluation,I-Procedure
42123,2853,.,O
42124,2854,9,O
42125,2854,.,O
42126,2854,History,B-Observation
42127,2854,of,O
42128,2854,myocardial,B-Condition
42129,2854,infarction,I-Condition
42130,2854,",",O
42131,2854,angina,B-Condition
42132,2854,",",O
42133,2854,congestive,B-Condition
42134,2854,heart,I-Condition
42135,2854,failure,I-Condition
42136,2854,",",O
42137,2854,cardiomyopathy,B-Condition
42138,2854,",",O
42139,2854,stroke,B-Condition
42140,2854,or,O
42141,2854,transient,B-Condition
42142,2854,ischemic,I-Condition
42143,2854,attack,I-Condition
42144,2854,",",O
42145,2854,or,O
42146,2854,any,O
42147,2854,heart,B-Condition
42148,2854,condition,I-Condition
42149,2854,currently,O
42150,2854,under,O
42151,2854,medical,O
42152,2854,care,O
42153,2854,.,O
42154,2855,1,O
42155,2855,.,O
42156,2855,Justifications,O
42157,2855,:,O
42158,2855,the,O
42159,2855,risk,O
42160,2855,of,O
42161,2855,TMS,O
42162,2855,for,O
42163,2855,individuals,O
42164,2855,with,O
42165,2855,a,O
42166,2855,heart,O
42167,2855,condition,O
42168,2855,is,O
42169,2855,unknown,O
42170,2855,.,O
42171,2856,2,O
42172,2856,.,O
42173,2856,Screening,O
42174,2856,tool,O
42175,2856,:,O
42176,2856,physical,O
42177,2856,assessment,O
42178,2856,(,O
42179,2856,EKG,O
42180,2856,),O
42181,2856,",",O
42182,2856,medical,O
42183,2856,history,O
42184,2856,.,O
42185,2857,10,O
42186,2857,.,O
42187,2857,Pregnant,B-Condition
42188,2857,women,B-Person
42189,2857,or,O
42190,2857,women,B-Person
42191,2857,with,O
42192,2857,reproductive,B-Condition
42193,2857,potential,I-Condition
42194,2857,who,O
42195,2857,are,O
42196,2857,sexually,B-Condition
42197,2857,active,I-Condition
42198,2857,and,O
42199,2857,not,O
42200,2857,using,O
42201,2857,an,O
42202,2857,acceptable,O
42203,2857,form,O
42204,2857,of,O
42205,2857,contraception,B-Condition
42206,2857,.,O
42207,2858,1,O
42208,2858,.,O
42209,2858,Justification,O
42210,2858,:,O
42211,2858,it,O
42212,2858,is,O
42213,2858,unknown,O
42214,2858,whether,O
42215,2858,TMS,O
42216,2858,poses,O
42217,2858,a,O
42218,2858,risk,O
42219,2858,to,O
42220,2858,fetuses,O
42221,2858,.,O
42222,2859,2,O
42223,2859,.,O
42224,2859,Screening,O
42225,2859,tool,O
42226,2859,:,O
42227,2859,Medical,B-Procedure
42228,2859,assessments,I-Procedure
42229,2859,(,O
42230,2859,urine,O
42231,2859,pregnancy,O
42232,2859,test,O
42233,2859,),O
42234,2859,at,O
42235,2859,the,O
42236,2859,beginning,O
42237,2859,of,O
42238,2859,each,O
42239,2859,visit,O
42240,2859,that,O
42241,2859,involves,O
42242,2859,TMS,B-Procedure
42243,2859,or,O
42244,2859,MRI,B-Procedure
42245,2859,.,O
42246,2860,11,O
42247,2860,.,O
42248,2860,History,B-Observation
42249,2860,of,O
42250,2860,learning,B-Condition
42251,2860,disability,I-Condition
42252,2860,or,O
42253,2860,current,O
42254,2860,ADHD,B-Condition
42255,2861,1,O
42256,2861,.,O
42257,2861,Justification,O
42258,2861,:,O
42259,2861,Subjects,O
42260,2861,should,O
42261,2861,be,O
42262,2861,able,O
42263,2861,to,O
42264,2861,perform,O
42265,2861,cognitive,O
42266,2861,tasks,O
42267,2861,to,O
42268,2861,a,O
42269,2861,high,O
42270,2861,degree,O
42271,2861,of,O
42272,2861,accuracy,O
42273,2861,",",O
42274,2861,both,O
42275,2861,in,O
42276,2861,the,O
42277,2861,MRI,O
42278,2861,scanner,O
42279,2861,and,O
42280,2861,outside,O
42281,2861,the,O
42282,2861,scanner,O
42283,2861,.,O
42284,2861,Subjects,O
42285,2861,with,O
42286,2861,ADHD,B-Condition
42287,2861,/,O
42288,2861,LD,B-Condition
42289,2861,may,O
42290,2861,engage,O
42291,2861,different,O
42292,2861,neural,O
42293,2861,circuitry,O
42294,2861,even,O
42295,2861,if,O
42296,2861,they,O
42297,2861,can,O
42298,2861,perform,O
42299,2861,the,O
42300,2861,tasks,O
42301,2861,.,O
42302,2862,2,O
42303,2862,.,O
42304,2862,Screening,O
42305,2862,tool,O
42306,2862,:,O
42307,2862,Wechsler,B-Procedure
42308,2862,Abbreviated,I-Procedure
42309,2862,Scale,I-Procedure
42310,2862,of,I-Procedure
42311,2862,Intelligence,I-Procedure
42312,2862,",",O
42313,2862,Medical,B-Observation
42314,2862,history,I-Observation
42315,2862,",",O
42316,2862,Adult,B-Procedure
42317,2862,ADHD,I-Procedure
42318,2862,Self,I-Procedure
42319,2862,-,I-Procedure
42320,2862,Report,I-Procedure
42321,2862,Scale,I-Procedure
42322,2862,.,O
42323,2863,12,O
42324,2863,.,O
42325,2863,Participation,O
42326,2863,in,O
42327,2863,an,O
42328,2863,rTMS,B-Procedure
42329,2863,session,I-Procedure
42330,2863,less,O
42331,2863,than,O
42332,2863,two,O
42333,2863,weeks,O
42334,2863,ago,O
42335,2863,.,O
42336,2864,1,O
42337,2864,.,O
42338,2864,Justification,O
42339,2864,:,O
42340,2864,in,O
42341,2864,order,O
42342,2864,to,O
42343,2864,limit,O
42344,2864,exposure,O
42345,2864,to,O
42346,2864,TMS,O
42347,2864,",",O
42348,2864,we,O
42349,2864,will,O
42350,2864,not,O
42351,2864,enroll,O
42352,2864,subjects,O
42353,2864,who,O
42354,2864,have,O
42355,2864,received,O
42356,2864,TMS,O
42357,2864,less,O
42358,2864,than,O
42359,2864,two,O
42360,2864,weeks,O
42361,2864,ago,O
42362,2864,.,O
42363,2865,2,O
42364,2865,.,O
42365,2865,Screening,O
42366,2865,tool,O
42367,2865,:,O
42368,2865,TMS,B-Procedure
42369,2865,safety,I-Procedure
42370,2865,screening,I-Procedure
42371,2865,questionnaire,I-Procedure
42372,2865,.,O
42373,2866,Subjects,O
42374,2866,must,O
42375,2866,:,O
42376,2867,1,O
42377,2867,.,O
42378,2867,Be,O
42379,2867,able,O
42380,2867,to,O
42381,2867,give,O
42382,2867,valid,O
42383,2867,informed,O
42384,2867,consent,O
42385,2868,2,O
42386,2868,.,O
42387,2868,Be,O
42388,2868,18,O
42389,2868,55,O
42390,2868,years,O
42391,2868,of,O
42392,2868,age,B-Person
42393,2868,.,O
42394,2869,1,O
42395,2869,.,O
42396,2869,Justification,O
42397,2869,:,O
42398,2869,Many,O
42399,2869,neural,O
42400,2869,processes,O
42401,2869,change,O
42402,2869,with,O
42403,2869,age,O
42404,2869,",",O
42405,2869,and,O
42406,2869,these,O
42407,2869,changes,O
42408,2869,could,O
42409,2869,introduce,O
42410,2869,unwanted,O
42411,2869,variability,O
42412,2869,in,O
42413,2869,both,O
42414,2869,behavioral,O
42415,2869,and,O
42416,2869,MRI,O
42417,2869,signals,O
42418,2869,.,O
42419,2869,In,O
42420,2869,addition,O
42421,2869,",",O
42422,2869,the,O
42423,2869,risk,O
42424,2869,of,O
42425,2869,difficult,O
42426,2869,-,O
42427,2869,to,O
42428,2869,-,O
42429,2869,detect,O
42430,2869,medical,O
42431,2869,abnormalities,O
42432,2869,such,O
42433,2869,as,O
42434,2869,silent,O
42435,2869,cerebral,O
42436,2869,infarcts,O
42437,2869,increases,O
42438,2869,with,O
42439,2869,age,O
42440,2869,.,O
42441,2870,2,O
42442,2870,.,O
42443,2870,Screening,O
42444,2870,tool,O
42445,2870,:,O
42446,2870,History,B-Observation
42447,2870,.,O
42448,2870,Government,O
42449,2870,-,O
42450,2870,issued,O
42451,2870,forms,O
42452,2870,of,O
42453,2870,identification,O
42454,2870,(,O
42455,2870,e.g.,O
42456,2870,driver,O
42457,2870,s,O
42458,2870,license,O
42459,2870,",",O
42460,2870,birth,O
42461,2870,certificate,O
42462,2870,),O
42463,2870,will,O
42464,2870,be,O
42465,2870,required,O
42466,2870,when,O
42467,2870,participant,O
42468,2870,appears,O
42469,2870,to,O
42470,2870,be,O
42471,2870,out,O
42472,2870,of,O
42473,2870,age,O
42474,2870,range,O
42475,2870,.,O
42476,2871,3,O
42477,2871,.,O
42478,2871,Be,O
42479,2871,in,O
42480,2871,good,B-Condition
42481,2871,health,I-Condition
42482,2871,.,O
42483,2872,1,O
42484,2872,.,O
42485,2872,Justification,O
42486,2872,:,O
42487,2872,Many,O
42488,2872,illnesses,O
42489,2872,may,O
42490,2872,alter,O
42491,2872,neural,O
42492,2872,functioning,O
42493,2872,as,O
42494,2872,well,O
42495,2872,as,O
42496,2872,fMRI,O
42497,2872,signals,O
42498,2872,.,O
42499,2873,2,O
42500,2873,.,O
42501,2873,Screening,O
42502,2873,tools,O
42503,2873,:,O
42504,2873,Medical,B-Procedure
42505,2873,Assessment,I-Procedure
42506,2873,",",O
42507,2873,Medical,B-Observation
42508,2873,History,I-Observation
42509,2873,and,O
42510,2873,Physical,B-Procedure
42511,2873,Examination,I-Procedure
42512,2873,.,O
42513,2873,Medical,O
42514,2873,assessments,O
42515,2873,include,O
42516,2873,:,O
42517,2873,Vital,O
42518,2873,Signs,O
42519,2873,",",O
42520,2873,EKG,B-Procedure
42521,2873,",",O
42522,2873,oral,B-Procedure
42523,2873,HIV,I-Procedure
42524,2873,test,I-Procedure
42525,2873,",",O
42526,2873,height,O
42527,2873,/,O
42528,2873,weight,O
42529,2873,measurements,O
42530,2873,",",O
42531,2873,urinalysis,B-Procedure
42532,2873,and,O
42533,2873,blood,B-Procedure
42534,2873,sample,I-Procedure
42535,2873,.,O
42536,2873,Tests,O
42537,2873,on,O
42538,2873,the,O
42539,2873,blood,O
42540,2873,sample,O
42541,2873,include,O
42542,2873,CBC,B-Procedure
42543,2873,",",O
42544,2873,complete,B-Procedure
42545,2873,metabolic,I-Procedure
42546,2873,profile,I-Procedure
42547,2873,",",O
42548,2873,TSH,B-Procedure
42549,2873,",",O
42550,2873,ESR,B-Procedure
42551,2873,",",O
42552,2873,STS,B-Procedure
42553,2873,and,O
42554,2873,HIV,B-Procedure
42555,2873,(,O
42556,2873,if,O
42557,2873,needed,O
42558,2873,to,O
42559,2873,confirm,O
42560,2873,a,O
42561,2873,positive,O
42562,2873,salivary,O
42563,2873,test,O
42564,2873,for,O
42565,2873,HIV,O
42566,2873,),O
42567,2873,.,O
42568,2873,The,O
42569,2873,following,O
42570,2873,individual,O
42571,2873,laboratory,O
42572,2873,results,O
42573,2873,will,O
42574,2873,independently,O
42575,2873,disqualify,O
42576,2873,individuals,O
42577,2873,:,O
42578,2873,Cholesterol,O
42579,2873,>,O
42580,2873,250,O
42581,2873,mg,O
42582,2873,/,O
42583,2873,dl,O
42584,2873,",",O
42585,2873,Hemoglobin,O
42586,2873,<,O
42587,2873,10.5,O
42588,2873,g,O
42589,2873,/,O
42590,2873,dl,O
42591,2873,",",O
42592,2873,WBC,O
42593,2873,<,O
42594,2873,2400,O
42595,2873,/,O
42596,2873,microl,O
42597,2873,",",O
42598,2873,LFTs,O
42599,2873,>,O
42600,2873,3Xnormal,O
42601,2873,",",O
42602,2873,HCG,O
42603,2873,positive,O
42604,2873,",",O
42605,2873,Casual,O
42606,2873,serum,O
42607,2873,glucose,O
42608,2873,>,O
42609,2873,200,O
42610,2873,mg,O
42611,2873,/,O
42612,2873,dl,O
42613,2873,",",O
42614,2873,Urine,O
42615,2873,protein,O
42616,2873,>,O
42617,2873,1,O
42618,2873,+,O
42619,2873,.,O
42620,2873,The,O
42621,2873,MAI,O
42622,2873,will,O
42623,2873,retain,O
42624,2873,discretion,O
42625,2873,to,O
42626,2873,exclude,O
42627,2873,at,O
42628,2873,less,O
42629,2873,extreme,O
42630,2873,values,O
42631,2873,",",O
42632,2873,depending,O
42633,2873,on,O
42634,2873,the,O
42635,2873,clinical,O
42636,2873,presentation,O
42637,2873,.,O
42638,2873,(,O
42639,2873,Serum,O
42640,2873,glucose,O
42641,2873,over,O
42642,2873,140,O
42643,2873,mg,O
42644,2873,/,O
42645,2873,dl,O
42646,2873,will,O
42647,2873,be,O
42648,2873,followed,O
42649,2873,up,O
42650,2873,with,O
42651,2873,a,O
42652,2873,fasting,B-Procedure
42653,2873,serum,I-Procedure
42654,2873,glucose,I-Procedure
42655,2873,assessment,I-Procedure
42656,2873,.,O
42657,2873,Those,O
42658,2873,with,O
42659,2873,fasting,O
42660,2873,glucose,O
42661,2873,below,O
42662,2873,100,O
42663,2873,mg,O
42664,2873,/,O
42665,2873,dl,O
42666,2873,may,O
42667,2873,be,O
42668,2873,considered,O
42669,2873,for,O
42670,2873,the,O
42671,2873,protocol,O
42672,2873,.,O
42673,2873,Others,O
42674,2873,will,O
42675,2873,be,O
42676,2873,rejected,O
42677,2873,and,O
42678,2873,referred,O
42679,2873,for,O
42680,2873,work,O
42681,2873,-,O
42682,2873,up,O
42683,2873,.,O
42684,2873,),O
42685,2873,MAI,O
42686,2873,will,O
42687,2873,make,O
42688,2873,the,O
42689,2873,final,O
42690,2873,judgment,O
42691,2873,on,O
42692,2873,any,O
42693,2873,questionable,O
42694,2873,lab,O
42695,2873,results,O
42696,2873,.,O
42697,2874,4,O
42698,2874,.,O
42699,2874,Right,B-Condition
42700,2874,-,I-Condition
42701,2874,handed,I-Condition
42702,2874,.,O
42703,2875,1,O
42704,2875,.,O
42705,2875,Justification,O
42706,2875,:,O
42707,2875,Using,O
42708,2875,right,O
42709,2875,-,O
42710,2875,handed,O
42711,2875,individuals,O
42712,2875,will,O
42713,2875,reduce,O
42714,2875,variability,O
42715,2875,in,O
42716,2875,BOLD,O
42717,2875,MRI,O
42718,2875,data,O
42719,2875,.,O
42720,2876,2,O
42721,2876,.,O
42722,2876,Screening,O
42723,2876,tool,O
42724,2876,:,O
42725,2876,Edinburgh,B-Procedure
42726,2876,Handedness,I-Procedure
42727,2876,Inventory,I-Procedure
42728,2876,.,O
42729,2877,5,O
42730,2877,.,O
42731,2877,Estimated,O
42732,2877,IQ,O
42733,2877,greater,O
42734,2877,than,O
42735,2877,or,O
42736,2877,equal,O
42737,2877,to,O
42738,2877,85,O
42739,2878,1,O
42740,2878,.,O
42741,2878,Justification,O
42742,2878,:,O
42743,2878,Subjects,O
42744,2878,must,O
42745,2878,be,O
42746,2878,able,O
42747,2878,to,O
42748,2878,perform,O
42749,2878,a,O
42750,2878,cognitively,O
42751,2878,challenging,O
42752,2878,task,O
42753,2878,to,O
42754,2878,a,O
42755,2878,high,O
42756,2878,standard,O
42757,2878,.,O
42758,2879,2,O
42759,2879,.,O
42760,2879,Screening,O
42761,2879,tool,O
42762,2879,:,O
42763,2879,Wechsler,B-Procedure
42764,2879,Abbreviated,I-Procedure
42765,2879,Scale,I-Procedure
42766,2879,of,I-Procedure
42767,2879,Intelligence,I-Procedure
42768,2879,.,O
42769,2880,NA,O
42770,2881,Intrauterine,B-Condition
42771,2881,fetal,I-Condition
42772,2881,death,I-Condition
42773,2881,as,O
42774,2881,confirmed,O
42775,2881,by,O
42776,2881,absence,B-Condition
42777,2881,of,I-Condition
42778,2881,cardiac,I-Condition
42779,2881,motion,I-Condition
42780,2881,on,O
42781,2881,ultrasound,B-Procedure
42782,2881,by,O
42783,2881,Attending,O
42784,2881,physician,O
42785,2881,at,O
42786,2881,the,O
42787,2881,time,O
42788,2881,of,O
42789,2881,admission,O
42790,2881,to,O
42791,2881,the,O
42792,2881,hospital,O
42793,2881,.,O
42794,2882,Estimated,O
42795,2882,gestational,O
42796,2882,age,O
42797,2882,greater,O
42798,2882,than,O
42799,2882,20,O
42800,2882,weeks,O
42801,2883,Hemodynamically,B-Condition
42802,2883,stable,I-Condition
42803,2883,and,O
42804,2883,appropriate,O
42805,2883,for,O
42806,2883,induction,B-Procedure
42807,2883,of,I-Procedure
42808,2883,labor,I-Procedure
42809,2883,as,O
42810,2883,per,O
42811,2883,primary,O
42812,2883,clinical,O
42813,2883,health,O
42814,2883,team,O
42815,2883,in,O
42816,2883,house,O
42817,2884,Women,B-Person
42818,2884,with,O
42819,2884,one,O
42820,2884,prior,O
42821,2884,low,B-Procedure
42822,2884,transverse,I-Procedure
42823,2884,cesarean,I-Procedure
42824,2884,delivery,I-Procedure
42825,2885,Serious,O
42826,2885,suicidal,B-Condition
42827,2885,tendency,I-Condition
42828,2886,The,O
42829,2886,score,O
42830,2886,of,O
42831,2886,the,O
42832,2886,sixth,O
42833,2886,item,O
42834,2886,of,O
42835,2886,HAMA,O
42836,2886,=3,O
42837,2887,The,O
42838,2887,score,O
42839,2887,of,O
42840,2887,HAMD,O
42841,2887,=,O
42842,2887,21,O
42843,2888,Pregnant,B-Condition
42844,2888,or,O
42845,2888,lactating,B-Condition
42846,2888,women,B-Person
42847,2889,History,O
42848,2889,of,O
42849,2889,allergic,B-Condition
42850,2889,or,O
42851,2889,hypersensitivity,B-Condition
42852,2889,to,O
42853,2889,tandospirone,B-Drug
42854,2890,Serious,O
42855,2890,or,O
42856,2890,unstable,O
42857,2890,cardiac,B-Condition
42858,2890,",",I-Condition
42859,2890,renal,I-Condition
42860,2890,",",I-Condition
42861,2890,neurologic,I-Condition
42862,2890,",",I-Condition
42863,2890,cerebrovascular,I-Condition
42864,2890,",",I-Condition
42865,2890,metabolic,I-Condition
42866,2890,",",I-Condition
42867,2890,or,I-Condition
42868,2890,pulmonary,I-Condition
42869,2890,disease,I-Condition
42870,2891,Secondary,B-Condition
42871,2891,anxiety,I-Condition
42872,2891,disorders,I-Condition
42873,2892,Drug,B-Condition
42874,2892,or,I-Condition
42875,2892,alcohol,I-Condition
42876,2892,dependence,I-Condition
42877,2892,within,O
42878,2892,1,O
42879,2892,year,O
42880,2893,Patients,O
42881,2893,currently,O
42882,2893,taking,O
42883,2893,benzodiazepine,B-Procedure
42884,2893,drugs,I-Procedure
42885,2894,Drivers,B-Person
42886,2894,and,O
42887,2894,dangerous,B-Person
42888,2894,machine,I-Person
42889,2894,operators,I-Person
42890,2895,Participated,B-Observation
42891,2895,in,I-Observation
42892,2895,other,I-Observation
42893,2895,clinical,I-Observation
42894,2895,studies,I-Observation
42895,2895,in,O
42896,2895,the,O
42897,2895,last,O
42898,2895,30,O
42899,2895,days,O
42900,2896,Patients,O
42901,2896,with,O
42902,2896,clinically,O
42903,2896,significant,O
42904,2896,ECG,B-Condition
42905,2896,or,I-Condition
42906,2896,laboratory,I-Condition
42907,2896,abnormalities,I-Condition
42908,2897,Patients,O
42909,2897,with,O
42910,2897,a,O
42911,2897,history,O
42912,2897,of,O
42913,2897,epilepsy,B-Condition
42914,2898,Patients,O
42915,2898,with,O
42916,2898,abnormal,O
42917,2898,TSH,O
42918,2898,concentration,O
42919,2899,18,O
42920,2899,-,O
42921,2899,65,O
42922,2899,years,B-Person
42923,2899,old,I-Person
42924,2900,Male,B-Person
42925,2900,or,O
42926,2900,female,B-Person
42927,2901,Diagnosed,O
42928,2901,with,O
42929,2901,GAD,B-Condition
42930,2901,according,O
42931,2901,to,O
42932,2901,DSM,O
42933,2901,-,O
42934,2901,IV,O
42935,2902,HAMA,O
42936,2902,score=17,O
42937,2903,Provide,O
42938,2903,with,O
42939,2903,written,O
42940,2903,informed,O
42941,2903,consent,O
42942,2904,Agree,O
42943,2904,to,O
42944,2904,be,O
42945,2904,washed,B-Procedure
42946,2904,-,I-Procedure
42947,2904,out,I-Procedure
42948,2904,for,O
42949,2904,two,O
42950,2904,weeks,O
42951,2904,if,O
42952,2904,receiving,O
42953,2904,SSRI,B-Procedure
42954,2904,",",O
42955,2904,SNRI,B-Procedure
42956,2904,or,O
42957,2904,NASA,B-Procedure
42958,2904,.,O
42959,2905,Known,O
42960,2905,intolerance,B-Condition
42961,2905,to,I-Condition
42962,2905,the,I-Condition
42963,2905,doxycycline,I-Condition
42964,2905,Body,O
42965,2905,weight,O
42966,2905,<,O
42967,2905,40,O
42968,2905,kg,O
42969,2905,Pregnancy,B-Condition
42970,2905,or,O
42971,2905,breastfeeding,B-Observation
42972,2905,History,B-Observation
42973,2905,of,I-Observation
42974,2905,severe,O
42975,2905,allergic,B-Condition
42976,2905,reaction,I-Condition
42977,2905,or,O
42978,2905,anaphylaxis,B-Condition
42979,2905,Alcohol,B-Condition
42980,2905,or,I-Condition
42981,2905,drug,I-Condition
42982,2905,abuse,I-Condition
42983,2906,M.,O
42984,2906,perstans,O
42985,2906,mg,O
42986,2906,-,O
42987,2906,positive,O
42988,2906,status,O
42989,2906,Good,B-Condition
42990,2906,general,I-Condition
42991,2906,health,I-Condition
42992,2906,without,O
42993,2906,any,O
42994,2906,clinical,B-Condition
42995,2906,condition,I-Condition
42996,2906,requiring,I-Condition
42997,2906,long,I-Condition
42998,2906,-,I-Condition
42999,2906,term,I-Condition
43000,2906,medication,I-Condition
43001,2906,.,O
43002,2907,Normal,O
43003,2907,renal,O
43004,2907,and,O
43005,2907,hepatic,O
43006,2907,laboratory,O
43007,2907,profiles,O
43008,2908,History,O
43009,2908,of,O
43010,2908,constipation,B-Condition
43011,2909,Pre,O
43012,2909,-,O
43013,2909,existing,O
43014,2909,use,O
43015,2909,of,O
43016,2909,narcotics,B-Drug
43017,2909,or,O
43018,2909,opioids,B-Drug
43019,2910,Pre,O
43020,2910,-,O
43021,2910,existing,O
43022,2910,renal,B-Condition
43023,2910,or,I-Condition
43024,2910,hepatic,I-Condition
43025,2910,failure,I-Condition
43026,2911,Mental,B-Condition
43027,2911,illness,I-Condition
43028,2911,",",O
43029,2911,mental,B-Condition
43030,2911,retardation,I-Condition
43031,2911,",",O
43032,2911,or,O
43033,2911,inability,B-Condition
43034,2911,to,I-Condition
43035,2911,participate,I-Condition
43036,2911,in,I-Condition
43037,2911,informed,I-Condition
43038,2911,consent,I-Condition
43039,2911,due,O
43040,2911,to,O
43041,2911,mental,B-Condition
43042,2911,status,I-Condition
43043,2912,Pre,O
43044,2912,-,O
43045,2912,existing,O
43046,2912,dementia,B-Condition
43047,2913,Allergy,B-Condition
43048,2913,to,O
43049,2913,any,O
43050,2913,protocol,O
43051,2913,medication,O
43052,2914,Emergency,O
43053,2914,operation,B-Procedure
43054,2915,Subjects,O
43055,2915,who,O
43056,2915,are,O
43057,2915,incarcerated,O
43058,2915,or,O
43059,2915,wards,O
43060,2915,of,O
43061,2915,the,O
43062,2915,state,O
43063,2916,Minors,B-Person
43064,2917,Subjects,O
43065,2917,with,O
43066,2917,inflammatory,B-Condition
43067,2917,bowel,I-Condition
43068,2917,disease,I-Condition
43069,2917,",",O
43070,2917,active,O
43071,2917,colitis,B-Condition
43072,2917,",",O
43073,2917,or,O
43074,2917,pre,O
43075,2917,-,O
43076,2917,existing,O
43077,2917,intra,B-Condition
43078,2917,-,I-Condition
43079,2917,abdominal,I-Condition
43080,2917,inflammation,I-Condition
43081,2917,.,O
43082,2917,Diverticulitis,B-Condition
43083,2917,without,O
43084,2917,active,O
43085,2917,infection,B-Condition
43086,2917,/,O
43087,2917,inflammation,B-Condition
43088,2917,will,O
43089,2917,not,O
43090,2917,be,O
43091,2917,excluded,O
43092,2917,.,O
43093,2918,Males,B-Person
43094,2918,or,O
43095,2918,females,B-Person
43096,2918,above,O
43097,2918,the,O
43098,2918,age,B-Person
43099,2918,of,O
43100,2918,18,O
43101,2919,Patients,O
43102,2919,undergoing,O
43103,2919,laparoscopic,O
43104,2919,or,O
43105,2919,robotic,O
43106,2919,colorectal,B-Procedure
43107,2919,resections,I-Procedure
43108,2920,Patients,O
43109,2920,with,O
43110,2920,liver,B-Condition
43111,2920,disease,I-Condition
43112,2920,(,O
43113,2920,documented,O
43114,2920,liver,O
43115,2920,function,O
43116,2920,test,O
43117,2920,abnormality,O
43118,2920,),O
43119,2921,Patients,O
43120,2921,with,O
43121,2921,renal,B-Condition
43122,2921,disease,I-Condition
43123,2921,(,O
43124,2921,documented,O
43125,2921,glomerular,O
43126,2921,filtration,O
43127,2921,rate,O
43128,2921,<,O
43129,2921,60mL,O
43130,2921,/,O
43131,2921,min/1.73m2,O
43132,2921,),O
43133,2922,Patients,O
43134,2922,with,O
43135,2922,a,O
43136,2922,baseline,O
43137,2922,(,O
43138,2922,pre,O
43139,2922,-,O
43140,2922,operative,O
43141,2922,),O
43142,2922,opioid,B-Drug
43143,2922,use,O
43144,2922,greater,O
43145,2922,than,O
43146,2922,30,O
43147,2922,mg,O
43148,2922,of,O
43149,2922,morphine,O
43150,2922,equivalents,O
43151,2922,/,O
43152,2922,day,O
43153,2922,.,O
43154,2923,Patients,O
43155,2923,with,O
43156,2923,active,O
43157,2923,alcohol,B-Condition
43158,2923,dependence,I-Condition
43159,2924,Patients,O
43160,2924,with,O
43161,2924,active,O
43162,2924,illicit,B-Condition
43163,2924,drug,I-Condition
43164,2924,dependence,I-Condition
43165,2925,Patients,O
43166,2925,<,O
43167,2925,18,O
43168,2925,years,O
43169,2925,of,O
43170,2925,age,B-Person
43171,2925,and,O
43172,2925,>,O
43173,2925,70,O
43174,2925,years,O
43175,2925,of,O
43176,2925,age,B-Person
43177,2926,Patients,O
43178,2926,allergic,B-Condition
43179,2926,to,O
43180,2926,any,O
43181,2926,medication,B-Drug
43182,2926,given,O
43183,2926,in,O
43184,2926,either,O
43185,2926,arm,O
43186,2926,(,O
43187,2926,list,O
43188,2926,medications,O
43189,2926,),O
43190,2927,Patients,O
43191,2927,who,O
43192,2927,have,O
43193,2927,a,O
43194,2927,seizure,B-Condition
43195,2927,disorder,I-Condition
43196,2928,Subjects,O
43197,2928,undergoing,O
43198,2928,a,O
43199,2928,single,O
43200,2928,level,O
43201,2928,lumbar,B-Procedure
43202,2928,decompression,I-Procedure
43203,2928,and,I-Procedure
43204,2928,fusion,I-Procedure
43205,2929,>,O
43206,2929,18,O
43207,2929,years,O
43208,2929,of,O
43209,2929,age,O
43210,2929,and,O
43211,2929,<,O
43212,2929,70,O
43213,2929,years,O
43214,2929,of,O
43215,2929,age,B-Person
43216,2930,The,O
43217,2930,subject,O
43218,2930,is,O
43219,2930,willing,O
43220,2930,and,O
43221,2930,able,O
43222,2930,to,O
43223,2930,understand,O
43224,2930,",",O
43225,2930,sign,O
43226,2930,and,O
43227,2930,date,O
43228,2930,the,O
43229,2930,study,O
43230,2930,specific,O
43231,2930,patient,O
43232,2930,informed,O
43233,2930,consent,O
43234,2930,and,O
43235,2930,HIPAA,O
43236,2930,authorization,O
43237,2930,to,O
43238,2930,volunteer,O
43239,2930,participation,O
43240,2930,in,O
43241,2930,the,O
43242,2930,study,O
43243,2931,pregnant,B-Condition
43244,2931,or,O
43245,2931,nursing,B-Condition
43246,2931,woman,B-Person
43247,2932,serious,O
43248,2932,concomitant,O
43249,2932,illness,B-Condition
43250,2932,and,O
43251,2932,malignant,B-Condition
43252,2932,tumor,I-Condition
43253,2932,of,O
43254,2932,any,O
43255,2932,kind,O
43256,2933,history,B-Observation
43257,2933,of,I-Observation
43258,2933,hypersensitivity,B-Condition
43259,2933,to,O
43260,2933,test,B-Drug
43261,2933,drugs,I-Drug
43262,2934,serious,O
43263,2934,bleeding,B-Condition
43264,2934,during,O
43265,2934,the,O
43266,2934,course,O
43267,2934,of,O
43268,2934,the,O
43269,2934,ulcer,O
43270,2935,previous,O
43271,2935,gastric,B-Procedure
43272,2935,surgery,I-Procedure
43273,2936,receiving,O
43274,2936,bismuth,B-Drug
43275,2936,salts,I-Drug
43276,2936,",",O
43277,2936,PPIs,B-Drug
43278,2936,",",O
43279,2936,or,O
43280,2936,antibiotics,B-Drug
43281,2936,in,O
43282,2936,the,O
43283,2936,previous,O
43284,2936,month,O
43285,2936,.,O
43286,2937,Participants,O
43287,2937,having,O
43288,2937,H.,O
43289,2937,pylori,O
43290,2937,related,O
43291,2937,chronic,B-Condition
43292,2937,gastritis,I-Condition
43293,2937,with,O
43294,2937,/,O
43295,2937,without,O
43296,2937,peptic,B-Condition
43297,2937,ulcers,I-Condition
43298,2937,who,O
43299,2937,are,O
43300,2937,aged,B-Person
43301,2937,greater,O
43302,2937,than,O
43303,2937,20,O
43304,2937,years,O
43305,2937,old,O
43306,2937,and,O
43307,2937,are,O
43308,2937,willing,B-Mood
43309,2937,to,I-Mood
43310,2937,received,I-Mood
43311,2937,eradication,B-Procedure
43312,2937,therapy,I-Procedure
43313,2937,.,O
43314,2938,Acute,O
43315,2938,pain,B-Condition
43316,2938,(,O
43317,2938,less,O
43318,2938,than,O
43319,2938,3,O
43320,2938,months,O
43321,2938,in,O
43322,2938,duration,O
43323,2938,),O
43324,2939,Previous,O
43325,2939,serious,O
43326,2939,adverse,B-Condition
43327,2939,event,I-Condition
43328,2939,or,O
43329,2939,hypersensitivity,B-Condition
43330,2939,to,O
43331,2939,cannabis,B-Drug
43332,2939,or,O
43333,2939,cannabinoids,B-Drug
43334,2940,Inability,O
43335,2940,to,O
43336,2940,understand,O
43337,2940,and,O
43338,2940,comply,O
43339,2940,with,O
43340,2940,the,O
43341,2940,instructions,O
43342,2940,of,O
43343,2940,the,O
43344,2940,study,O
43345,2941,Presence,O
43346,2941,of,O
43347,2941,significant,O
43348,2941,cardiac,B-Condition
43349,2941,disease,I-Condition
43350,2941,(,O
43351,2941,history,B-Observation
43352,2941,of,O
43353,2941,unstable,B-Condition
43354,2941,ischemic,I-Condition
43355,2941,heart,I-Condition
43356,2941,disease,I-Condition
43357,2941,",",O
43358,2941,heart,B-Condition
43359,2941,failure,I-Condition
43360,2941,",",O
43361,2941,severe,O
43362,2941,and,O
43363,2941,uncontrolled,O
43364,2941,hypertension,B-Condition
43365,2941,),O
43366,2941,that,O
43367,2941,",",O
43368,2941,in,O
43369,2941,the,O
43370,2941,opinion,O
43371,2941,of,O
43372,2941,the,O
43373,2941,investigator,O
43374,2941,",",O
43375,2941,would,O
43376,2941,put,O
43377,2941,the,O
43378,2941,patient,O
43379,2941,at,B-Mood
43380,2941,risk,I-Mood
43381,2941,of,I-Mood
43382,2941,a,O
43383,2941,clinically,O
43384,2941,significant,O
43385,2941,arrhythmia,B-Condition
43386,2941,or,O
43387,2941,myocardial,B-Condition
43388,2941,infarction,I-Condition
43389,2942,Current,O
43390,2942,substance,B-Condition
43391,2942,use,I-Condition
43392,2942,disorder,I-Condition
43393,2942,according,O
43394,2942,to,O
43395,2942,the,O
43396,2942,Diagnostic,O
43397,2942,and,O
43398,2942,Statistical,O
43399,2942,Manual,O
43400,2942,of,O
43401,2942,Mental,O
43402,2942,Disorders,O
43403,2942,Fifth,O
43404,2942,Edition,O
43405,2942,(,O
43406,2942,DSM,O
43407,2942,5,O
43408,2942,),O
43409,2943,Life,O
43410,2943,-,O
43411,2943,time,O
43412,2943,history,O
43413,2943,of,O
43414,2943,dependence,B-Condition
43415,2943,on,I-Condition
43416,2943,cannabis,I-Condition
43417,2943,or,O
43418,2943,diagnosis,O
43419,2943,of,O
43420,2943,cannabis,B-Condition
43421,2943,use,I-Condition
43422,2943,disorder,I-Condition
43423,2943,(,I-Condition
43424,2943,CUD,I-Condition
43425,2943,),I-Condition
43426,2943,according,O
43427,2943,to,O
43428,2943,the,O
43429,2943,DSM,O
43430,2943,5,O
43431,2944,Life,O
43432,2944,-,O
43433,2944,time,O
43434,2944,history,O
43435,2944,of,O
43436,2944,DSM,O
43437,2944,5,O
43438,2944,schizophrenia,B-Condition
43439,2944,",",O
43440,2944,bipolar,B-Condition
43441,2944,disorder,I-Condition
43442,2944,",",O
43443,2944,or,O
43444,2944,previous,O
43445,2944,psychosis,B-Condition
43446,2944,with,O
43447,2944,or,O
43448,2944,intolerance,B-Condition
43449,2944,to,O
43450,2944,cannabinoids,B-Drug
43451,2945,Current,O
43452,2945,or,O
43453,2945,history,B-Observation
43454,2945,of,O
43455,2945,suicidal,B-Condition
43456,2945,ideation,I-Condition
43457,2946,Pregnant,O
43458,2946,",",O
43459,2946,breast,O
43460,2946,-,O
43461,2946,feeding,O
43462,2946,or,O
43463,2946,female,O
43464,2946,patients,O
43465,2946,of,O
43466,2946,child,O
43467,2946,-,O
43468,2946,bearing,O
43469,2946,potential,O
43470,2946,and,O
43471,2946,male,O
43472,2946,patients,O
43473,2946,whose,O
43474,2946,partner,O
43475,2946,is,O
43476,2946,of,O
43477,2946,child,O
43478,2946,-,O
43479,2946,bearing,O
43480,2946,potential,O
43481,2946,",",O
43482,2946,unless,O
43483,2946,willing,O
43484,2946,to,O
43485,2946,ensure,O
43486,2946,that,O
43487,2946,they,O
43488,2946,or,O
43489,2946,their,O
43490,2946,partner,O
43491,2946,use,O
43492,2946,effective,O
43493,2946,contraception,O
43494,2947,Hepatic,B-Condition
43495,2947,impairment,I-Condition
43496,2947,(,O
43497,2947,aspartate,O
43498,2947,aminotransferase,O
43499,2947,more,O
43500,2947,than,O
43501,2947,three,O
43502,2947,times,O
43503,2947,normal,O
43504,2947,),O
43505,2947,or,O
43506,2947,renal,B-Condition
43507,2947,function,I-Condition
43508,2947,impairment,I-Condition
43509,2947,(,O
43510,2947,serum,O
43511,2947,creatinine,O
43512,2947,level,O
43513,2947,>,O
43514,2947,133,O
43515,2947,µmol,O
43516,2947,/,O
43517,2947,L,O
43518,2947,",",O
43519,2947,Estimated,O
43520,2947,Glomerular,O
43521,2947,Filtration,O
43522,2947,Rate,O
43523,2947,(,O
43524,2947,eGFR,O
43525,2947,),O
43526,2947,<,O
43527,2947,60,O
43528,2947,),O
43529,2948,Cognitive,B-Condition
43530,2948,impairment,I-Condition
43531,2948,according,O
43532,2948,to,O
43533,2948,MiniCog,B-Procedure
43534,2949,The,O
43535,2949,patient,O
43536,2949,is,O
43537,2949,currently,O
43538,2949,using,O
43539,2949,or,O
43540,2949,has,O
43541,2949,used,O
43542,2949,cannabinoid,B-Drug
43543,2949,based,I-Drug
43544,2949,medications,I-Drug
43545,2949,within,O
43546,2949,90,O
43547,2949,days,O
43548,2949,of,O
43549,2949,study,O
43550,2949,entry,O
43551,2949,and,O
43552,2949,is,O
43553,2949,unwilling,O
43554,2949,to,O
43555,2949,abstain,O
43556,2949,for,O
43557,2949,the,O
43558,2949,duration,O
43559,2949,of,O
43560,2949,the,O
43561,2949,study,O
43562,2950,Positive,O
43563,2950,urine,O
43564,2950,drug,O
43565,2950,screen,O
43566,2950,for,O
43567,2950,cannabinoids,B-Drug
43568,2950,and,O
43569,2950,other,O
43570,2950,potential,O
43571,2950,abuse,O
43572,2950,substances,O
43573,2950,(,O
43574,2950,e.g.,O
43575,2950,alcohol,B-Drug
43576,2950,",",O
43577,2950,cocaine,B-Drug
43578,2950,",",O
43579,2950,amphetamines,B-Drug
43580,2950,and,O
43581,2950,methamphetamines,B-Drug
43582,2950,",",O
43583,2950,unprescribed,O
43584,2950,opioids,B-Drug
43585,2950,),O
43586,2951,Participation,O
43587,2951,in,O
43588,2951,another,O
43589,2951,clinical,O
43590,2951,trial,O
43591,2951,within,O
43592,2951,30,O
43593,2951,days,O
43594,2951,of,O
43595,2951,enrolment,O
43596,2951,in,O
43597,2951,our,O
43598,2951,trial,O
43599,2952,Written,O
43600,2952,informed,O
43601,2952,consent,O
43602,2953,Adult,B-Person
43603,2953,patients,O
43604,2953,(,O
43605,2953,older,O
43606,2953,than,O
43607,2953,18,O
43608,2953,years,O
43609,2953,of,O
43610,2953,age,B-Person
43611,2953,),O
43612,2953,",",O
43613,2953,male,B-Person
43614,2953,and,O
43615,2953,female,B-Person
43616,2953,",",O
43617,2953,with,O
43618,2953,chronic,O
43619,2953,non,O
43620,2953,-,O
43621,2953,cancer,O
43622,2953,and,O
43623,2953,cancer,O
43624,2953,pain,B-Condition
43625,2953,(,O
43626,2953,at,O
43627,2953,least,O
43628,2953,3,O
43629,2953,months,O
43630,2953,in,O
43631,2953,duration,O
43632,2953,),O
43633,2954,Patients,O
43634,2954,experiencing,O
43635,2954,an,O
43636,2954,average,O
43637,2954,weekly,O
43638,2954,pain,O
43639,2954,intensity,O
43640,2954,score,O
43641,2954,greater,O
43642,2954,than,O
43643,2954,4,O
43644,2954,on,O
43645,2954,a,O
43646,2954,11,O
43647,2954,points,O
43648,2954,NRS,O
43649,2955,Subject,O
43650,2955,agreed,O
43651,2955,to,O
43652,2955,follow,O
43653,2955,the,O
43654,2955,protocol,O
43655,2956,Naïve,B-Condition
43656,2956,cannabis,I-Condition
43657,2956,patients,O
43658,2956,with,O
43659,2956,chronic,O
43660,2956,non,O
43661,2956,-,O
43662,2956,cancer,O
43663,2956,and,O
43664,2956,cancer,O
43665,2956,pain,B-Condition
43666,2956,(,O
43667,2956,not,O
43668,2956,used,O
43669,2956,cannabis,B-Drug
43670,2956,in,O
43671,2956,any,O
43672,2956,presentation,O
43673,2956,in,O
43674,2956,the,O
43675,2956,last,O
43676,2956,12,O
43677,2956,weeks,O
43678,2956,),O
43679,2957,Patients,O
43680,2957,receiving,O
43681,2957,opioids,B-Drug
43682,2957,and,O
43683,2957,other,O
43684,2957,concomitant,O
43685,2957,pain,B-Drug
43686,2957,medications,I-Drug
43687,2957,should,O
43688,2957,have,O
43689,2957,a,O
43690,2957,stable,O
43691,2957,dose,O
43692,2957,for,O
43693,2957,the,O
43694,2957,last,O
43695,2957,15,O
43696,2957,days,O
43697,2957,.,O
43698,2958,Normal,B-Condition
43699,2958,cognitive,I-Condition
43700,2958,status,I-Condition
43701,2958,according,O
43702,2958,to,O
43703,2958,MiniCog,B-Procedure
43704,2959,Normal,B-Condition
43705,2959,liver,I-Condition
43706,2959,function,I-Condition
43707,2959,(,O
43708,2959,defined,O
43709,2959,as,O
43710,2959,aspartate,O
43711,2959,aminotransferase,O
43712,2959,10,O
43713,2959,-,O
43714,2959,40,O
43715,2959,U,O
43716,2959,/,O
43717,2959,L,O
43718,2959,and,O
43719,2959,alanine,O
43720,2959,aminotransferase,O
43721,2959,7,O
43722,2959,-,O
43723,2959,56,O
43724,2959,U,O
43725,2959,/,O
43726,2959,L,O
43727,2959,),O
43728,2960,Normal,B-Condition
43729,2960,renal,I-Condition
43730,2960,function,I-Condition
43731,2960,(,O
43732,2960,defined,O
43733,2960,as,O
43734,2960,serum,O
43735,2960,creatinine,O
43736,2960,level,O
43737,2960,<,O
43738,2960,133,O
43739,2960,µmol,O
43740,2960,/,O
43741,2960,L,O
43742,2960,and,O
43743,2960,Estimated,O
43744,2960,Glomerular,O
43745,2960,Filtration,O
43746,2960,Rate,O
43747,2960,(,O
43748,2960,eGFR,O
43749,2960,),O
43750,2960,greater,O
43751,2960,than,O
43752,2960,or,O
43753,2960,equal,O
43754,2960,to,O
43755,2960,60,O
43756,2960,),O
43757,2961,Negative,O
43758,2961,result,O
43759,2961,on,O
43760,2961,ßhuman,O
43761,2961,chorionic,O
43762,2961,gonadotropin,O
43763,2961,pregnancy,O
43764,2961,test,O
43765,2961,(,O
43766,2961,if,O
43767,2961,applicable,O
43768,2961,),O
43769,2962,Ability,O
43770,2962,to,O
43771,2962,read,O
43772,2962,and,O
43773,2962,respond,O
43774,2962,to,O
43775,2962,questions,O
43776,2962,in,O
43777,2962,French,O
43778,2962,or,O
43779,2962,English,O
43780,2962,.,O
43781,2963,A,O
43782,2963,male,O
43783,2963,volunteer,O
43784,2963,with,O
43785,2963,sexual,O
43786,2963,partners,O
43787,2963,who,O
43788,2963,are,O
43789,2963,pregnant,O
43790,2963,",",O
43791,2963,possibly,O
43792,2963,pregnant,O
43793,2963,",",O
43794,2963,or,O
43795,2963,who,O
43796,2963,could,O
43797,2963,become,O
43798,2963,pregnant,O
43799,2963,must,O
43800,2963,be,O
43801,2963,surgically,O
43802,2963,sterile,O
43803,2963,or,O
43804,2963,agrees,O
43805,2963,to,O
43806,2963,use,O
43807,2963,one,O
43808,2963,of,O
43809,2963,the,O
43810,2963,accepted,O
43811,2963,contraceptive,O
43812,2963,regimens,O
43813,2963,from,O
43814,2963,first,O
43815,2963,drug,O
43816,2963,administration,O
43817,2963,until,O
43818,2963,3,O
43819,2963,months,O
43820,2963,after,O
43821,2963,the,O
43822,2963,last,O
43823,2963,drug,O
43824,2963,administration,O
43825,2963,.,O
43826,2964,pregnant,B-Condition
43827,2964,or,O
43828,2964,nursing,B-Condition
43829,2964,woman,B-Person
43830,2965,serious,O
43831,2965,concomitant,O
43832,2965,illness,B-Condition
43833,2965,and,O
43834,2965,malignant,B-Condition
43835,2965,tumor,I-Condition
43836,2965,of,O
43837,2965,any,O
43838,2965,kind,O
43839,2966,history,B-Observation
43840,2966,of,O
43841,2966,hypersensitivity,B-Condition
43842,2966,to,O
43843,2966,test,B-Drug
43844,2966,drugs,I-Drug
43845,2967,serious,O
43846,2967,bleeding,B-Condition
43847,2967,during,O
43848,2967,the,O
43849,2967,course,O
43850,2967,of,O
43851,2967,the,O
43852,2967,ulcer,B-Condition
43853,2968,previous,O
43854,2968,gastric,B-Procedure
43855,2968,surgery,I-Procedure
43856,2969,receiving,O
43857,2969,bismuth,B-Drug
43858,2969,salts,I-Drug
43859,2969,",",O
43860,2969,PPIs,B-Drug
43861,2969,",",O
43862,2969,or,O
43863,2969,antibiotics,B-Drug
43864,2969,in,O
43865,2969,the,O
43866,2969,previous,O
43867,2969,month,O
43868,2969,.,O
43869,2970,Participants,O
43870,2970,having,O
43871,2970,H.,O
43872,2970,pylori,O
43873,2970,related,O
43874,2970,chronic,B-Condition
43875,2970,gastritis,I-Condition
43876,2970,with,O
43877,2970,/,O
43878,2970,without,O
43879,2970,peptic,B-Condition
43880,2970,ulcers,I-Condition
43881,2970,who,O
43882,2970,are,O
43883,2970,aged,B-Person
43884,2970,greater,O
43885,2970,than,O
43886,2970,20,O
43887,2970,years,O
43888,2970,old,O
43889,2970,and,O
43890,2970,are,O
43891,2970,willing,B-Mood
43892,2970,to,I-Mood
43893,2970,received,I-Mood
43894,2970,eradication,B-Procedure
43895,2970,therapy,I-Procedure
43896,2970,.,O
43897,2971,Upper,B-Condition
43898,2971,urinary,I-Condition
43899,2971,tract,I-Condition
43900,2971,deterioration,I-Condition
43901,2972,Uncontrolled,O
43902,2972,diabetes,B-Condition
43903,2972,mellitus,I-Condition
43904,2973,Evident,O
43905,2973,local,B-Condition
43906,2973,or,I-Condition
43907,2973,pelvic,I-Condition
43908,2973,recurrence,I-Condition
43909,2974,Adjuvant,B-Procedure
43910,2974,chemotherapy,I-Procedure
43911,2975,Chronic,B-Condition
43912,2975,retention,I-Condition
43913,2976,Pouch,B-Condition
43914,2976,stones,I-Condition
43915,2977,Urethral,B-Condition
43916,2977,stricture,I-Condition
43917,2977,or,O
43918,2977,urethro,B-Condition
43919,2977,-,I-Condition
43920,2977,ileal,I-Condition
43921,2977,maldirection,I-Condition
43922,2978,Sensitivity,B-Condition
43923,2978,to,O
43924,2978,Mebeverine,B-Drug
43925,2979,Untreated,O
43926,2979,chronic,B-Condition
43927,2979,constipation,I-Condition
43928,2980,Active,O
43929,2980,symptomatic,O
43930,2980,urinary,B-Condition
43931,2980,infection,I-Condition
43932,2981,Men,B-Person
43933,2981,18,B-Person
43934,2981,years,I-Person
43935,2981,or,I-Person
43936,2981,older,I-Person
43937,2982,ONB,B-Condition
43938,2982,within,O
43939,2982,1,O
43940,2982,year,O
43941,2982,post,O
43942,2982,-,O
43943,2982,surgery,B-Procedure
43944,2982,.,O
43945,2983,A,O
43946,2983,history,B-Observation
43947,2983,of,O
43948,2983,life,O
43949,2983,-,O
43950,2983,threatening,O
43951,2983,asthma,B-Condition
43952,2983,defined,O
43953,2983,for,O
43954,2983,this,O
43955,2983,protocol,O
43956,2983,as,O
43957,2983,an,O
43958,2983,asthma,B-Condition
43959,2983,episode,I-Condition
43960,2983,that,O
43961,2983,required,O
43962,2983,intubation,B-Procedure
43963,2983,",",O
43964,2983,hypercapnea,B-Condition
43965,2983,requiring,O
43966,2983,non,O
43967,2983,-,O
43968,2983,invasive,O
43969,2983,ventilatory,O
43970,2983,support,O
43971,2983,",",O
43972,2983,respiratory,B-Condition
43973,2983,arrest,I-Condition
43974,2983,",",O
43975,2983,hypoxic,B-Condition
43976,2983,seizures,I-Condition
43977,2983,or,O
43978,2983,asthma,B-Condition
43979,2983,-,I-Condition
43980,2983,related,I-Condition
43981,2983,syncopal,I-Condition
43982,2983,episode(s,I-Condition
43983,2983,),O
43984,2983,.,O
43985,2984,Subjects,O
43986,2984,with,O
43987,2984,a,O
43988,2984,history,B-Observation
43989,2984,of,O
43990,2984,asthma,B-Condition
43991,2984,exacerbation,I-Condition
43992,2984,requiring,O
43993,2984,the,O
43994,2984,use,O
43995,2984,of,O
43996,2984,systemic,B-Drug
43997,2984,corticosteroids,I-Drug
43998,2984,(,O
43999,2984,tablets,O
44000,2984,",",O
44001,2984,suspension,O
44002,2984,",",O
44003,2984,or,O
44004,2984,injection,O
44005,2984,),O
44006,2984,for,O
44007,2984,at,O
44008,2984,least,O
44009,2984,3,O
44010,2984,days,O
44011,2984,or,O
44012,2984,a,O
44013,2984,depot,B-Drug
44014,2984,corticosteroid,I-Drug
44015,2984,injection,I-Drug
44016,2984,or,O
44017,2984,emergency,B-Procedure
44018,2984,room,I-Procedure
44019,2984,attendance,I-Procedure
44020,2984,(,O
44021,2984,within,O
44022,2984,3,O
44023,2984,months,O
44024,2984,),O
44025,2984,or,O
44026,2984,requiring,O
44027,2984,hospitalization,B-Procedure
44028,2984,for,O
44029,2984,asthma,B-Condition
44030,2984,(,O
44031,2984,within,O
44032,2984,6,O
44033,2984,months,O
44034,2984,),O
44035,2984,prior,O
44036,2984,to,O
44037,2984,screening,O
44038,2984,.,O
44039,2985,Significant,O
44040,2985,",",O
44041,2985,non,O
44042,2985,-,O
44043,2985,reversible,O
44044,2985,active,O
44045,2985,pulmonary,B-Condition
44046,2985,disease,I-Condition
44047,2985,(,O
44048,2985,e.g.,O
44049,2985,cystic,B-Condition
44050,2985,fibrosis,I-Condition
44051,2985,",",O
44052,2985,bronchiectasis,B-Condition
44053,2985,",",O
44054,2985,tuberculosis,B-Condition
44055,2985,),O
44056,2985,.,O
44057,2986,Culture,B-Procedure
44058,2986,-,O
44059,2986,documented,O
44060,2986,or,O
44061,2986,suspected,B-Observation
44062,2986,bacterial,B-Condition
44063,2986,or,I-Condition
44064,2986,viral,I-Condition
44065,2986,infection,I-Condition
44066,2986,of,I-Condition
44067,2986,the,I-Condition
44068,2986,upper,I-Condition
44069,2986,or,I-Condition
44070,2986,lower,I-Condition
44071,2986,respiratory,I-Condition
44072,2986,tract,I-Condition
44073,2986,",",I-Condition
44074,2986,sinus,I-Condition
44075,2986,or,I-Condition
44076,2986,middle,I-Condition
44077,2986,ear,I-Condition
44078,2986,that,O
44079,2986,is,O
44080,2986,not,O
44081,2986,resolved,O
44082,2986,within,O
44083,2986,4,O
44084,2986,weeks,O
44085,2986,of,O
44086,2986,Visit,O
44087,2986,1,O
44088,2986,and,O
44089,2986,led,O
44090,2986,to,O
44091,2986,a,O
44092,2986,change,B-Observation
44093,2986,in,I-Observation
44094,2986,asthma,I-Observation
44095,2986,management,I-Observation
44096,2986,or,O
44097,2986,",",O
44098,2986,in,O
44099,2986,the,O
44100,2986,opinion,O
44101,2986,of,O
44102,2986,the,O
44103,2986,Investigator,O
44104,2986,",",O
44105,2986,is,O
44106,2986,expected,O
44107,2986,to,O
44108,2986,affect,O
44109,2986,the,O
44110,2986,subject,O
44111,2986,'s,O
44112,2986,asthma,O
44113,2986,status,O
44114,2986,or,O
44115,2986,the,O
44116,2986,subject,O
44117,2986,'s,O
44118,2986,ability,O
44119,2986,to,O
44120,2986,participate,O
44121,2986,in,O
44122,2986,the,O
44123,2986,study,O
44124,2986,.,O
44125,2987,Any,O
44126,2987,fracture,B-Condition
44127,2987,in,I-Condition
44128,2987,the,I-Condition
44129,2987,leg,I-Condition
44130,2987,to,O
44131,2987,be,O
44132,2987,measured,O
44133,2987,within,O
44134,2987,6,O
44135,2987,months,O
44136,2987,prior,O
44137,2987,to,O
44138,2987,the,O
44139,2987,screening,O
44140,2987,visit,O
44141,2987,.,O
44142,2988,Any,O
44143,2988,metabolic,B-Condition
44144,2988,disorders,I-Condition
44145,2988,or,O
44146,2988,other,B-Condition
44147,2988,diseases,I-Condition
44148,2988,that,O
44149,2988,may,O
44150,2988,impact,O
44151,2988,on,O
44152,2988,normal,O
44153,2988,growth,O
44154,2988,patterns,O
44155,2988,.,O
44156,2989,No,O
44157,2989,major,B-Condition
44158,2989,surgery,I-Condition
44159,2989,requiring,O
44160,2989,general,B-Procedure
44161,2989,anaesthesia,I-Procedure
44162,2989,for,O
44163,2989,at,O
44164,2989,least,O
44165,2989,3,O
44166,2989,months,O
44167,2989,prior,O
44168,2989,to,O
44169,2989,the,O
44170,2989,screening,O
44171,2989,visit,O
44172,2989,.,O
44173,2990,No,O
44174,2990,febrile,B-Condition
44175,2990,illnesses,I-Condition
44176,2990,with,O
44177,2990,temperature,O
44178,2990,>,O
44179,2990,39,O
44180,2990,degree,O
44181,2990,celsius,O
44182,2990,for,O
44183,2990,more,O
44184,2990,than,O
44185,2990,five,O
44186,2990,consecutive,O
44187,2990,days,O
44188,2990,within,O
44189,2990,the,O
44190,2990,week,O
44191,2990,preceding,O
44192,2990,the,O
44193,2990,Screening,O
44194,2990,Visit,O
44195,2990,.,O
44196,2991,Any,O
44197,2991,significant,O
44198,2991,abnormality,B-Condition
44199,2991,or,O
44200,2991,medical,B-Condition
44201,2991,condition,I-Condition
44202,2991,identified,O
44203,2991,at,O
44204,2991,the,O
44205,2991,screening,O
44206,2991,medical,O
44207,2991,assessment,O
44208,2991,(,O
44209,2991,including,O
44210,2991,serious,O
44211,2991,psychological,O
44212,2991,disorder,O
44213,2991,),O
44214,2991,that,O
44215,2991,in,O
44216,2991,the,O
44217,2991,Investigator,O
44218,2991,'s,O
44219,2991,opinion,O
44220,2991,",",O
44221,2991,preclude,O
44222,2991,entry,O
44223,2991,into,O
44224,2991,the,O
44225,2991,study,O
44226,2991,due,O
44227,2991,to,O
44228,2991,risk,O
44229,2991,to,O
44230,2991,the,O
44231,2991,subject,O
44232,2991,or,O
44233,2991,that,O
44234,2991,may,O
44235,2991,interfere,O
44236,2991,with,O
44237,2991,the,O
44238,2991,outcome,O
44239,2991,of,O
44240,2991,the,O
44241,2991,study,O
44242,2991,.,O
44243,2992,Clinical,O
44244,2992,visual,B-Condition
44245,2992,evidence,I-Condition
44246,2992,of,O
44247,2992,candidiasis,B-Condition
44248,2992,at,O
44249,2992,Visit,O
44250,2992,1,O
44251,2992,(,O
44252,2992,Screening,O
44253,2992,),O
44254,2992,.,O
44255,2993,Use,O
44256,2993,of,O
44257,2993,any,O
44258,2993,of,O
44259,2993,the,O
44260,2993,prohibited,B-Drug
44261,2993,medications,I-Drug
44262,2993,listed,I-Drug
44263,2993,in,I-Drug
44264,2993,protocol,I-Drug
44265,2993,.,O
44266,2994,Strenuous,B-Condition
44267,2994,physical,I-Condition
44268,2994,exercise,I-Condition
44269,2994,within,O
44270,2994,3,O
44271,2994,hours,O
44272,2994,of,O
44273,2994,Visit,O
44274,2994,1,O
44275,2994,(,O
44276,2994,Screening,O
44277,2994,),O
44278,2995,Drug,B-Condition
44279,2995,allergies,I-Condition
44280,2995,:,O
44281,2995,Any,O
44282,2995,adverse,B-Condition
44283,2995,reaction,I-Condition
44284,2995,including,O
44285,2995,immediate,B-Condition
44286,2995,or,I-Condition
44287,2995,delayed,I-Condition
44288,2995,hypersensitivity,I-Condition
44289,2995,to,O
44290,2995,any,O
44291,2995,intranasal,B-Drug
44292,2995,",",I-Drug
44293,2995,inhaled,I-Drug
44294,2995,",",I-Drug
44295,2995,or,I-Drug
44296,2995,systemic,I-Drug
44297,2995,corticosteroid,I-Drug
44298,2995,therapy,O
44299,2995,.,O
44300,2995,Known,O
44301,2995,or,O
44302,2995,suspected,O
44303,2995,sensitivity,B-Condition
44304,2995,to,O
44305,2995,the,O
44306,2995,constituents,B-Drug
44307,2995,of,I-Drug
44308,2995,the,I-Drug
44309,2995,ELLIPTA,I-Drug
44310,2995,Inhaler,I-Drug
44311,2995,(,O
44312,2995,i.e.,O
44313,2995,",",O
44314,2995,lactose,B-Drug
44315,2995,",",O
44316,2995,FF,B-Drug
44317,2995,),O
44318,2995,.,O
44319,2996,Milk,B-Condition
44320,2996,Protein,I-Condition
44321,2996,Allergy,I-Condition
44322,2996,:,O
44323,2996,History,O
44324,2996,of,O
44325,2996,severe,O
44326,2996,milk,B-Condition
44327,2996,protein,I-Condition
44328,2996,allergy,I-Condition
44329,2996,.,O
44330,2997,The,O
44331,2997,subject,O
44332,2997,has,O
44333,2997,participated,O
44334,2997,in,O
44335,2997,a,O
44336,2997,clinical,O
44337,2997,trial,O
44338,2997,and,O
44339,2997,has,O
44340,2997,received,O
44341,2997,an,O
44342,2997,investigational,O
44343,2997,product,O
44344,2997,within,O
44345,2997,the,O
44346,2997,following,O
44347,2997,time,O
44348,2997,period,O
44349,2997,prior,O
44350,2997,to,O
44351,2997,the,O
44352,2997,first,O
44353,2997,dosing,O
44354,2997,day,O
44355,2997,in,O
44356,2997,the,O
44357,2997,current,O
44358,2997,study,O
44359,2997,:,O
44360,2997,30,O
44361,2997,days,O
44362,2997,",",O
44363,2997,5,O
44364,2997,half,O
44365,2997,-,O
44366,2997,lives,O
44367,2997,or,O
44368,2997,twice,O
44369,2997,the,O
44370,2997,duration,O
44371,2997,of,O
44372,2997,the,O
44373,2997,biological,O
44374,2997,effect,O
44375,2997,of,O
44376,2997,the,O
44377,2997,investigational,O
44378,2997,product,O
44379,2997,(,O
44380,2997,whichever,O
44381,2997,is,O
44382,2997,longer,O
44383,2997,),O
44384,2997,.,O
44385,2998,Exposure,O
44386,2998,to,O
44387,2998,more,O
44388,2998,than,O
44389,2998,4,O
44390,2998,investigational,B-Drug
44391,2998,medicinal,I-Drug
44392,2998,products,I-Drug
44393,2998,within,O
44394,2998,12,O
44395,2998,months,O
44396,2998,prior,O
44397,2998,to,O
44398,2998,the,O
44399,2998,first,O
44400,2998,dosing,O
44401,2998,day,O
44402,2998,.,O
44403,2999,Unable,B-Condition
44404,2999,to,I-Condition
44405,2999,use,I-Condition
44406,2999,the,I-Condition
44407,2999,ELLIPTA,I-Condition
44408,2999,inhaler,I-Condition
44409,2999,and,I-Condition
44410,2999,peak,I-Condition
44411,2999,flow,I-Condition
44412,2999,meter,I-Condition
44413,2999,correctly,I-Condition
44414,2999,.,I-Condition
44415,3000,An,O
44416,3000,affiliation,O
44417,3000,with,O
44418,3000,the,O
44419,3000,Investigator,O
44420,3000,site,O
44421,3000,:,O
44422,3000,the,O
44423,3000,parents,O
44424,3000,/,O
44425,3000,guardians,O
44426,3000,or,O
44427,3000,child,O
44428,3000,is,O
44429,3000,an,O
44430,3000,immediate,O
44431,3000,family,O
44432,3000,member,O
44433,3000,of,O
44434,3000,the,O
44435,3000,participating,O
44436,3000,Investigator,O
44437,3000,",",O
44438,3000,sub,O
44439,3000,-,O
44440,3000,Investigator,O
44441,3000,",",O
44442,3000,study,O
44443,3000,coordinator,O
44444,3000,",",O
44445,3000,or,O
44446,3000,employee,O
44447,3000,of,O
44448,3000,the,O
44449,3000,participating,O
44450,3000,Investigator,O
44451,3000,.,O
44452,3001,The,O
44453,3001,Parent,O
44454,3001,or,O
44455,3001,Guardian,O
44456,3001,has,O
44457,3001,a,O
44458,3001,history,O
44459,3001,of,O
44460,3001,psychiatric,O
44461,3001,disease,O
44462,3001,",",O
44463,3001,intellectual,O
44464,3001,deficiency,O
44465,3001,",",O
44466,3001,substance,O
44467,3001,abuse,O
44468,3001,or,O
44469,3001,other,O
44470,3001,condition,O
44471,3001,(,O
44472,3001,e.g.,O
44473,3001,inability,O
44474,3001,to,O
44475,3001,read,O
44476,3001,",",O
44477,3001,comprehend,O
44478,3001,or,O
44479,3001,write,O
44480,3001,),O
44481,3001,which,O
44482,3001,may,O
44483,3001,affect,O
44484,3001,:,O
44485,3001,validity,O
44486,3001,of,O
44487,3001,consent,O
44488,3001,to,O
44489,3001,participate,O
44490,3001,in,O
44491,3001,the,O
44492,3001,study,O
44493,3001,;,O
44494,3001,adequate,O
44495,3001,supervision,O
44496,3001,of,O
44497,3001,the,O
44498,3001,subject,O
44499,3001,during,O
44500,3001,the,O
44501,3001,study,O
44502,3001,;,O
44503,3001,compliance,O
44504,3001,of,O
44505,3001,subject,O
44506,3001,with,O
44507,3001,study,O
44508,3001,medication,O
44509,3001,and,O
44510,3001,study,O
44511,3001,procedures,O
44512,3001,(,O
44513,3001,e.g.,O
44514,3001,completion,O
44515,3001,of,O
44516,3001,daily,O
44517,3001,diary,O
44518,3001,",",O
44519,3001,attending,O
44520,3001,scheduled,O
44521,3001,clinic,O
44522,3001,visits,O
44523,3001,),O
44524,3001,;,O
44525,3001,subject,O
44526,3001,safety,O
44527,3001,and,O
44528,3001,well,O
44529,3001,-,O
44530,3001,being,O
44531,3001,.,O
44532,3002,Children,O
44533,3002,in,O
44534,3002,care,O
44535,3002,:,O
44536,3002,Children,O
44537,3002,who,O
44538,3002,are,O
44539,3002,wards,O
44540,3002,of,O
44541,3002,the,O
44542,3002,government,O
44543,3002,or,O
44544,3002,state,O
44545,3002,are,O
44546,3002,not,O
44547,3002,eligible,O
44548,3002,for,O
44549,3002,participation,O
44550,3002,in,O
44551,3002,this,O
44552,3002,study,O
44553,3002,.,O
44554,3003,Aged,B-Person
44555,3003,5,O
44556,3003,years,O
44557,3003,to,O
44558,3003,less,O
44559,3003,than,O
44560,3003,12,O
44561,3003,years,O
44562,3003,at,O
44563,3003,Visit,O
44564,3003,1,O
44565,3003,.,O
44566,3003,At,O
44567,3003,least,O
44568,3003,15,O
44569,3003,(,O
44570,3003,25,O
44571,3003,%,O
44572,3003,),O
44573,3003,children,O
44574,3003,of,O
44575,3003,the,O
44576,3003,total,O
44577,3003,study,O
44578,3003,population,O
44579,3003,must,O
44580,3003,be,O
44581,3003,aged,O
44582,3003,5,O
44583,3003,to,O
44584,3003,less,O
44585,3003,than,O
44586,3003,8,O
44587,3003,years,O
44588,3003,.,O
44589,3004,Male,B-Person
44590,3004,or,O
44591,3004,pre,B-Person
44592,3004,-,I-Person
44593,3004,menarchial,I-Person
44594,3004,female,B-Person
44595,3004,subjects,O
44596,3004,.,O
44597,3005,Subjects,O
44598,3005,must,O
44599,3005,be,O
44600,3005,pre,B-Person
44601,3005,-,I-Person
44602,3005,adolescent,I-Person
44603,3005,without,O
44604,3005,any,O
44605,3005,signs,B-Condition
44606,3005,of,I-Condition
44607,3005,puberty,I-Condition
44608,3005,(,O
44609,3005,Tanner,O
44610,3005,Stage,O
44611,3005,1,O
44612,3005,),O
44613,3005,.,O
44614,3006,Normal,O
44615,3006,range,O
44616,3006,for,O
44617,3006,their,O
44618,3006,height,O
44619,3006,and,O
44620,3006,weight,O
44621,3006,.,O
44622,3006,Weight,O
44623,3006,and,O
44624,3006,height,O
44625,3006,measurements,O
44626,3006,should,O
44627,3006,fall,O
44628,3006,within,O
44629,3006,the,O
44630,3006,percentile,O
44631,3006,range,O
44632,3006,3,O
44633,3006,-,O
44634,3006,97,O
44635,3006,%,O
44636,3006,of,O
44637,3006,normal,O
44638,3006,values,O
44639,3006,for,O
44640,3006,age,O
44641,3006,according,O
44642,3006,to,O
44643,3006,Danish,O
44644,3006,growth,O
44645,3006,charts,O
44646,3006,.,O
44647,3007,Have,O
44648,3007,a,O
44649,3007,documented,O
44650,3007,diagnosis,O
44651,3007,of,O
44652,3007,persistent,B-Condition
44653,3007,asthma,I-Condition
44654,3007,",",O
44655,3007,as,O
44656,3007,defined,O
44657,3007,by,O
44658,3007,the,O
44659,3007,National,O
44660,3007,Institutes,O
44661,3007,of,O
44662,3007,Health,O
44663,3007,for,O
44664,3007,at,O
44665,3007,least,O
44666,3007,3,O
44667,3007,months,O
44668,3007,prior,O
44669,3007,to,O
44670,3007,the,O
44671,3007,Screening,O
44672,3007,Visit,O
44673,3007,.,O
44674,3008,A,O
44675,3008,pre,O
44676,3008,-,O
44677,3008,bronchodilatory,O
44678,3008,forced,O
44679,3008,expiratory,O
44680,3008,flow,O
44681,3008,in,O
44682,3008,1,O
44683,3008,second,O
44684,3008,(,O
44685,3008,FEV1,O
44686,3008,),O
44687,3008,at,O
44688,3008,Visit,O
44689,3008,1,O
44690,3008,(,O
44691,3008,Screening,O
44692,3008,),O
44693,3008,>,O
44694,3008,=,O
44695,3008,80,O
44696,3008,%,O
44697,3008,predicted,O
44698,3008,.,O
44699,3008,There,O
44700,3008,should,O
44701,3008,be,O
44702,3008,no,O
44703,3008,Short,B-Drug
44704,3008,acting,I-Drug
44705,3008,beta,I-Drug
44706,3008,-,I-Drug
44707,3008,agonist,I-Drug
44708,3008,(,I-Drug
44709,3008,SABA,I-Drug
44710,3008,),I-Drug
44711,3008,use,O
44712,3008,within,O
44713,3008,4,O
44714,3008,hours,O
44715,3008,of,O
44716,3008,this,O
44717,3008,measurement,O
44718,3008,.,O
44719,3009,Using,O
44720,3009,one,O
44721,3009,of,O
44722,3009,the,O
44723,3009,following,O
44724,3009,asthma,B-Procedure
44725,3009,therapies,I-Procedure
44726,3009,prior,O
44727,3009,to,O
44728,3009,entry,O
44729,3009,into,O
44730,3009,the,O
44731,3009,study,O
44732,3009,:,O
44733,3009,SABA,B-Drug
44734,3009,inhaler,I-Drug
44735,3009,alone,O
44736,3009,(,O
44737,3009,e.g.,O
44738,3009,salbutamol,B-Drug
44739,3009,),O
44740,3009,on,O
44741,3009,an,O
44742,3009,as,O
44743,3009,required,O
44744,3009,basis,O
44745,3009,and/or,O
44746,3009,Regular,O
44747,3009,non,O
44748,3009,-,O
44749,3009,inhaled,O
44750,3009,corticosteroid,O
44751,3009,(,O
44752,3009,ICS,O
44753,3009,),O
44754,3009,controller,O
44755,3009,medications,O
44756,3009,for,O
44757,3009,asthma,O
44758,3009,(,O
44759,3009,e.g.,O
44760,3009,cromones,B-Drug
44761,3009,or,O
44762,3009,leukotriene,B-Drug
44763,3009,receptor,I-Drug
44764,3009,antagonists,I-Drug
44765,3009,),O
44766,3009,and/or,O
44767,3009,Previously,O
44768,3009,treated,O
44769,3009,with,O
44770,3009,ICS,B-Drug
44771,3009,(,O
44772,3009,equipotent,O
44773,3009,to,O
44774,3009,inhaled,O
44775,3009,budesonide,B-Drug
44776,3009,<,O
44777,3009,=,O
44778,3009,400,O
44779,3009,micrograms,O
44780,3009,(,O
44781,3009,mcg,O
44782,3009,),O
44783,3009,total,O
44784,3009,daily,O
44785,3009,dose,O
44786,3009,),O
44787,3009,.,O
44788,3009,There,O
44789,3009,must,O
44790,3009,be,O
44791,3009,no,O
44792,3009,ICS,B-Procedure
44793,3009,use,O
44794,3009,within,O
44795,3009,2,O
44796,3009,weeks,O
44797,3009,of,O
44798,3009,Visit,O
44799,3009,1,O
44800,3009,(,O
44801,3009,Screening,O
44802,3009,),O
44803,3009,.,O
44804,3010,Able,O
44805,3010,to,O
44806,3010,replace,O
44807,3010,their,O
44808,3010,current,O
44809,3010,SABA,B-Drug
44810,3010,treatment,O
44811,3010,with,O
44812,3010,study,O
44813,3010,supplied,O
44814,3010,rescue,B-Drug
44815,3010,SABA,I-Drug
44816,3010,provided,O
44817,3010,at,O
44818,3010,Visit,O
44819,3010,1,O
44820,3010,for,O
44821,3010,use,O
44822,3010,as,O
44823,3010,needed,O
44824,3010,for,O
44825,3010,the,O
44826,3010,duration,O
44827,3010,of,O
44828,3010,the,O
44829,3010,study,O
44830,3010,.,O
44831,3011,Written,O
44832,3011,informed,O
44833,3011,consent,O
44834,3011,from,O
44835,3011,at,O
44836,3011,least,O
44837,3011,one,O
44838,3011,parent,O
44839,3011,/,O
44840,3011,care,O
44841,3011,giver,O
44842,3011,(,O
44843,3011,legal,O
44844,3011,guardian,O
44845,3011,),O
44846,3011,and,O
44847,3011,accompanying,O
44848,3011,informed,O
44849,3011,assent,O
44850,3011,from,O
44851,3011,the,O
44852,3011,subject,O
44853,3011,(,O
44854,3011,where,O
44855,3011,the,O
44856,3011,subject,O
44857,3011,is,O
44858,3011,able,O
44859,3011,to,O
44860,3011,provide,O
44861,3011,assent,O
44862,3011,),O
44863,3011,prior,O
44864,3011,to,O
44865,3011,admission,O
44866,3011,to,O
44867,3011,the,O
44868,3011,study,O
44869,3011,:,O
44870,3011,(,O
44871,3011,1,O
44872,3011,),O
44873,3011,If,O
44874,3011,applicable,O
44875,3011,",",O
44876,3011,subject,O
44877,3011,must,O
44878,3011,be,O
44879,3011,able,O
44880,3011,and,O
44881,3011,willing,O
44882,3011,to,O
44883,3011,give,O
44884,3011,assent,O
44885,3011,to,O
44886,3011,take,O
44887,3011,part,O
44888,3011,in,O
44889,3011,the,O
44890,3011,study,O
44891,3011,according,O
44892,3011,to,O
44893,3011,the,O
44894,3011,local,O
44895,3011,requirement,O
44896,3011,.,O
44897,3011,The,O
44898,3011,study,O
44899,3011,investigator,O
44900,3011,is,O
44901,3011,accountable,O
44902,3011,for,O
44903,3011,determining,O
44904,3011,a,O
44905,3011,child,O
44906,3011,'s,O
44907,3011,capacity,O
44908,3011,to,O
44909,3011,assent,O
44910,3011,to,O
44911,3011,participation,O
44912,3011,in,O
44913,3011,a,O
44914,3011,research,O
44915,3011,study,O
44916,3011,",",O
44917,3011,taking,O
44918,3011,into,O
44919,3011,consideration,O
44920,3011,any,O
44921,3011,standards,O
44922,3011,set,O
44923,3011,by,O
44924,3011,the,O
44925,3011,responsible,O
44926,3011,independent,O
44927,3011,ethics,O
44928,3011,committee,O
44929,3011,(,O
44930,3011,IEC,O
44931,3011,),O
44932,3011,.,O
44933,3011,(,O
44934,3011,2,O
44935,3011,),O
44936,3011,Subject,O
44937,3011,and,O
44938,3011,their,O
44939,3011,legal,O
44940,3011,guardian(s,O
44941,3011,),O
44942,3011,understand,O
44943,3011,that,O
44944,3011,the,O
44945,3011,study,O
44946,3011,requires,O
44947,3011,them,O
44948,3011,to,O
44949,3011,be,O
44950,3011,treated,O
44951,3011,on,O
44952,3011,an,O
44953,3011,outpatient,O
44954,3011,basis,O
44955,3011,.,O
44956,3011,(,O
44957,3011,3,O
44958,3011,),O
44959,3011,Subject,O
44960,3011,and,O
44961,3011,their,O
44962,3011,legal,O
44963,3011,guardian(s,O
44964,3011,),O
44965,3011,understand,O
44966,3011,that,O
44967,3011,they,O
44968,3011,must,O
44969,3011,comply,O
44970,3011,with,O
44971,3011,study,O
44972,3011,medication,O
44973,3011,and,O
44974,3011,study,O
44975,3011,assessments,O
44976,3011,including,O
44977,3011,recording,O
44978,3011,of,O
44979,3011,peak,O
44980,3011,expiratory,O
44981,3011,flow,O
44982,3011,and,O
44983,3011,rescue,O
44984,3011,SABA,O
44985,3011,use,O
44986,3011,",",O
44987,3011,attending,O
44988,3011,scheduled,O
44989,3011,study,O
44990,3011,visits,O
44991,3011,",",O
44992,3011,and,O
44993,3011,being,O
44994,3011,accessible,O
44995,3011,by,O
44996,3011,a,O
44997,3011,telephone,O
44998,3011,call,O
44999,3011,.,O
45000,3012,Conversion,B-Observation
45001,3012,to,I-Observation
45002,3012,laparotomy,B-Procedure
45003,3013,Emergent,O
45004,3013,re,B-Procedure
45005,3013,intervention,I-Procedure
45006,3014,Immunosuppression,B-Condition
45007,3015,Umbilical,B-Condition
45008,3015,hernia,I-Condition
45009,3016,Age,B-Person
45010,3016,=,O
45011,3016,18,O
45012,3016,years,O
45013,3017,Laparoscopic,O
45014,3017,cholecystectomy,B-Procedure
45015,3018,Emergent,O
45016,3018,/,O
45017,3018,elective,O
45018,3019,=,O
45019,3019,2,O
45020,3019,risk,B-Condition
45021,3019,factors,I-Condition
45022,3019,:,O
45023,3019,diabetes,B-Condition
45024,3019,mellitus,I-Condition
45025,3019,",",O
45026,3019,age,B-Person
45027,3019,=,O
45028,3019,70,O
45029,3019,years,O
45030,3019,",",O
45031,3019,BMI,O
45032,3019,=,O
45033,3019,30,O
45034,3019,",",O
45035,3019,fascial,B-Condition
45036,3019,enlargement,I-Condition
45037,3020,Other,O
45038,3020,tumor,B-Condition
45039,3020,type,O
45040,3020,than,O
45041,3020,adenocarcinoma,B-Condition
45042,3021,Central,B-Condition
45043,3021,nervous,I-Condition
45044,3021,system,I-Condition
45045,3021,(,I-Condition
45046,3021,CNS,I-Condition
45047,3021,),I-Condition
45048,3021,metastases,I-Condition
45049,3021,or,O
45050,3021,prior,O
45051,3021,radiation,B-Procedure
45052,3021,for,O
45053,3021,CNS,B-Condition
45054,3021,metastases,I-Condition
45055,3022,Gastric,B-Condition
45056,3022,outlet,I-Condition
45057,3022,obstruction,I-Condition
45058,3022,or,O
45059,3022,intestinal,B-Condition
45060,3022,obstruction,I-Condition
45061,3023,Evidence,B-Observation
45062,3023,of,I-Observation
45063,3023,gastrointestinal,B-Condition
45064,3023,bleeding,I-Condition
45065,3024,The,O
45066,3024,patient,O
45067,3024,has,O
45068,3024,bony,B-Condition
45069,3024,lesions,I-Condition
45070,3024,as,O
45071,3024,the,O
45072,3024,sole,O
45073,3024,evaluable,O
45074,3024,disease,O
45075,3024,.,O
45076,3025,Past,O
45077,3025,or,O
45078,3025,concurrent,O
45079,3025,history,B-Observation
45080,3025,of,I-Observation
45081,3025,neoplasm,B-Condition
45082,3025,other,O
45083,3025,than,O
45084,3025,stomach,B-Condition
45085,3025,cancer,I-Condition
45086,3025,",",O
45087,3025,except,O
45088,3025,for,O
45089,3025,curatively,O
45090,3025,treated,B-Procedure
45091,3025,non,B-Condition
45092,3025,-,I-Condition
45093,3025,melanoma,I-Condition
45094,3025,skin,I-Condition
45095,3025,cancer,I-Condition
45096,3025,or,O
45097,3025,in,B-Condition
45098,3025,situ,I-Condition
45099,3025,carcinoma,I-Condition
45100,3025,of,I-Condition
45101,3025,the,I-Condition
45102,3025,cervix,I-Condition
45103,3025,uteri,I-Condition
45104,3026,Pregnant,B-Condition
45105,3026,or,O
45106,3026,lactating,B-Condition
45107,3026,women,B-Person
45108,3026,",",O
45109,3026,women,B-Person
45110,3026,of,O
45111,3026,childbearing,B-Condition
45112,3026,potential,I-Condition
45113,3026,not,O
45114,3026,employing,O
45115,3026,adequate,O
45116,3026,contraception,B-Procedure
45117,3027,Other,O
45118,3027,serious,B-Condition
45119,3027,illness,I-Condition
45120,3027,or,O
45121,3027,medical,B-Condition
45122,3027,conditions,I-Condition
45123,3028,Unstable,B-Condition
45124,3028,cardiac,I-Condition
45125,3028,disease,I-Condition
45126,3028,despite,O
45127,3028,treatment,B-Procedure
45128,3028,",",O
45129,3028,myocardial,B-Condition
45130,3028,infarction,I-Condition
45131,3028,within,O
45132,3028,6,O
45133,3028,months,O
45134,3028,prior,O
45135,3028,to,O
45136,3028,study,O
45137,3028,entry,O
45138,3029,History,B-Observation
45139,3029,of,O
45140,3029,significant,O
45141,3029,neurologic,B-Condition
45142,3029,or,I-Condition
45143,3029,psychiatric,I-Condition
45144,3029,disorders,I-Condition
45145,3029,including,O
45146,3029,dementia,B-Condition
45147,3029,or,O
45148,3029,seizures,B-Condition
45149,3030,Active,O
45150,3030,uncontrolled,O
45151,3030,infection,B-Condition
45152,3031,Other,O
45153,3031,serious,B-Condition
45154,3031,underlying,I-Condition
45155,3031,medical,I-Condition
45156,3031,conditions,I-Condition
45157,3031,which,O
45158,3031,could,O
45159,3031,impair,O
45160,3031,the,O
45161,3031,ability,B-Observation
45162,3031,of,I-Observation
45163,3031,the,I-Observation
45164,3031,patient,I-Observation
45165,3031,to,I-Observation
45166,3031,participate,I-Observation
45167,3031,in,O
45168,3031,the,O
45169,3031,study,O
45170,3032,Concomitant,O
45171,3032,administration,O
45172,3032,of,O
45173,3032,any,O
45174,3032,other,O
45175,3032,experimental,B-Drug
45176,3032,drug,I-Drug
45177,3032,under,O
45178,3032,investigation,O
45179,3032,",",O
45180,3032,or,O
45181,3032,concomitant,O
45182,3032,chemotherapy,B-Procedure
45183,3032,",",O
45184,3032,hormonal,B-Procedure
45185,3032,therapy,I-Procedure
45186,3032,",",O
45187,3032,or,O
45188,3032,immunotherapy,B-Procedure
45189,3033,concomitant,O
45190,3033,drug,B-Drug
45191,3033,medication,B-Drug
45192,3033,;,O
45193,3033,The,O
45194,3033,following,O
45195,3033,drugs,O
45196,3033,cause,O
45197,3033,drug,O
45198,3033,interaction,O
45199,3033,with,O
45200,3033,S-1,O
45201,3033,.,O
45202,3034,i.,O
45203,3034,Warfarin,B-Drug
45204,3034,",",O
45205,3034,phenprocoumon,B-Drug
45206,3034,:,O
45207,3034,increase,O
45208,3034,bleeding,O
45209,3034,tendency,O
45210,3034,ii,O
45211,3034,.,O
45212,3034,Increase,O
45213,3034,blood,O
45214,3034,concentration,O
45215,3034,of,O
45216,3034,phenytoin,O
45217,3034,iii,O
45218,3034,.,O
45219,3034,sorivudine,B-Drug
45220,3034,:,O
45221,3034,inhibit,O
45222,3034,DPD,O
45223,3034,-,O
45224,3034,>,O
45225,3034,increase,O
45226,3034,toxicity,O
45227,3034,according,O
45228,3034,to,O
45229,3034,fluoropyrimidine,B-Drug
45230,3034,iv,O
45231,3034,.,O
45232,3034,allopurinol,B-Drug
45233,3034,:,O
45234,3034,decrease,O
45235,3034,activity,O
45236,3034,of,O
45237,3034,S-1,O
45238,3035,Pathologically,O
45239,3035,proven,O
45240,3035,unresectable,O
45241,3035,adenocarcinoma,B-Condition
45242,3035,of,I-Condition
45243,3035,stomach,I-Condition
45244,3036,With,O
45245,3036,uni,O
45246,3036,-,O
45247,3036,dimensionally,O
45248,3036,measurable,O
45249,3036,disease,B-Condition
45250,3036,(,O
45251,3036,at,O
45252,3036,least,O
45253,3036,longest,O
45254,3036,diameter,O
45255,3036,2,O
45256,3036,cm,O
45257,3036,on,O
45258,3036,conventional,B-Procedure
45259,3036,CT,I-Procedure
45260,3036,scan,I-Procedure
45261,3036,",",O
45262,3036,x,B-Procedure
45263,3036,-,I-Procedure
45264,3036,ray,I-Procedure
45265,3036,or,O
45266,3036,physical,B-Procedure
45267,3036,examination,I-Procedure
45268,3036,",",O
45269,3036,or,O
45270,3036,1,O
45271,3036,cm,O
45272,3036,on,O
45273,3036,spiral,B-Procedure
45274,3036,CT,I-Procedure
45275,3036,scan,I-Procedure
45276,3036,),O
45277,3037,Age,B-Person
45278,3037,18,O
45279,3037,to,O
45280,3037,70,O
45281,3037,years,O
45282,3037,old,O
45283,3038,Estimated,O
45284,3038,life,O
45285,3038,expectancy,O
45286,3038,of,O
45287,3038,more,O
45288,3038,than,O
45289,3038,3,O
45290,3038,months,O
45291,3039,ECOG,O
45292,3039,performance,O
45293,3039,status,O
45294,3039,of,O
45295,3039,2,O
45296,3039,or,O
45297,3039,lower,O
45298,3040,Adequate,O
45299,3040,bone,O
45300,3040,marrow,O
45301,3040,function(absolute,O
45302,3040,neutrophil,O
45303,3040,count,O
45304,3040,[,O
45305,3040,ANC,O
45306,3040,],O
45307,3040,"≥1,500/µL",O
45308,3040,",",O
45309,3040,hemoglobin,O
45310,3040,≥9.0,O
45311,3040,g,O
45312,3040,/,O
45313,3040,dL,O
45314,3040,",",O
45315,3040,and,O
45316,3040,platelets,O
45317,3040,"≥100,000/µL",O
45318,3040,),O
45319,3041,Adequate,O
45320,3041,kidney,O
45321,3041,function,O
45322,3041,(,O
45323,3041,serum,O
45324,3041,creatinine,O
45325,3041,<,O
45326,3041,1.5,O
45327,3041,mg,O
45328,3041,/,O
45329,3041,dL,O
45330,3041,),O
45331,3042,Adequate,O
45332,3042,liver,O
45333,3042,function,O
45334,3042,(,O
45335,3042,serum,O
45336,3042,total,O
45337,3042,bilirubin,O
45338,3042,<,O
45339,3042,2,O
45340,3042,times,O
45341,3042,the,O
45342,3042,upper,O
45343,3042,normal,O
45344,3042,limit,O
45345,3042,(,O
45346,3042,UNL,O
45347,3042,),O
45348,3042,;,O
45349,3042,serum,O
45350,3042,transaminases,O
45351,3042,levels,O
45352,3042,<3,O
45353,3042,times,O
45354,3042,[,O
45355,3042,<,O
45356,3042,5,O
45357,3042,times,O
45358,3042,for,O
45359,3042,patients,O
45360,3042,with,O
45361,3042,liver,B-Condition
45362,3042,metastasis,I-Condition
45363,3042,],O
45364,3042,UNL,O
45365,3042,),O
45366,3043,No,O
45367,3043,prior,O
45368,3043,chemotherapy,B-Procedure
45369,3043,but,O
45370,3043,prior,O
45371,3043,adjuvant,B-Procedure
45372,3043,chemotherapy,I-Procedure
45373,3043,finished,O
45374,3043,at,O
45375,3043,least,O
45376,3043,6,O
45377,3043,months,O
45378,3043,before,O
45379,3043,enrollment,O
45380,3043,was,O
45381,3043,allowed,O
45382,3043,.,O
45383,3043,(,O
45384,3043,but,O
45385,3043,",",O
45386,3043,prior,O
45387,3043,adjuvant,B-Procedure
45388,3043,chemotherapy,I-Procedure
45389,3043,with,O
45390,3043,capecitabine,B-Drug
45391,3043,or,O
45392,3043,S-1,B-Drug
45393,3043,or,O
45394,3043,camptothecin,B-Drug
45395,3043,analogues,I-Drug
45396,3043,was,O
45397,3043,excluded,O
45398,3043,),O
45399,3044,No,O
45400,3044,prior,O
45401,3044,radiation,B-Procedure
45402,3044,therapy,I-Procedure
45403,3044,for,O
45404,3044,at,O
45405,3044,least,O
45406,3044,4,O
45407,3044,weeks,O
45408,3044,before,O
45409,3044,enrollment,O
45410,3044,in,O
45411,3044,the,O
45412,3044,study,O
45413,3045,PRA,O
45414,3045,>,O
45415,3045,50,O
45416,3045,%,O
45417,3046,DSA,O
45418,3046,>,O
45419,3046,1500,O
45420,3046,MFI,O
45421,3047,Retransplantation,B-Condition
45422,3048,Patients,O
45423,3048,who,O
45424,3048,are,O
45425,3048,planning,B-Mood
45426,3048,to,I-Mood
45427,3048,receive,O
45428,3048,mycophenolate,B-Drug
45429,3048,instead,O
45430,3048,of,O
45431,3048,everolimus,B-Drug
45432,3049,Patients,O
45433,3049,who,O
45434,3049,have,O
45435,3049,planning,B-Mood
45436,3049,for,I-Mood
45437,3049,follow,B-Procedure
45438,3049,-,I-Procedure
45439,3049,up,I-Procedure
45440,3049,in,O
45441,3049,another,O
45442,3049,center,O
45443,3050,Primary,O
45444,3050,kidney,B-Procedure
45445,3050,transplant,I-Procedure
45446,3050,recipients,O
45447,3050,",",O
45448,3050,adults,B-Person
45449,3051,using,O
45450,3051,daily,O
45451,3051,medication,B-Drug
45452,3051,for,O
45453,3051,chronic,B-Condition
45454,3051,condition,I-Condition
45455,3052,acute,O
45456,3052,narrow,B-Condition
45457,3052,angle,I-Condition
45458,3052,glaucoma,I-Condition
45459,3053,previous,O
45460,3053,adverse,B-Condition
45461,3053,experience,I-Condition
45462,3053,with,O
45463,3053,study,B-Drug
45464,3053,drugs,I-Drug
45465,3054,experiences,O
45466,3054,motion,B-Condition
45467,3054,sickness,I-Condition
45468,3054,in,O
45469,3054,response,O
45470,3054,to,O
45471,3054,driving,O
45472,3054,simulator,O
45473,3055,BMI,O
45474,3055,>,O
45475,3055,30,O
45476,3056,women,B-Person
45477,3056,who,O
45478,3056,are,O
45479,3056,pregnant,B-Condition
45480,3056,",",O
45481,3056,lactating,B-Condition
45482,3056,",",O
45483,3056,or,O
45484,3056,planning,B-Mood
45485,3056,on,I-Mood
45486,3056,becoming,I-Mood
45487,3056,pregnant,B-Condition
45488,3057,regular,O
45489,3057,use,B-Observation
45490,3057,of,I-Observation
45491,3057,tobacco,I-Observation
45492,3057,products,I-Observation
45493,3058,current,O
45494,3058,substance,B-Condition
45495,3058,use,I-Condition
45496,3058,disorder,I-Condition
45497,3059,clinically,O
45498,3059,significant,O
45499,3059,ECG,B-Procedure
45500,3060,current,O
45501,3060,ongoing,O
45502,3060,psychiatric,B-Condition
45503,3060,disorder,I-Condition
45504,3061,valid,B-Observation
45505,3061,driver,I-Observation
45506,3061,'s,I-Observation
45507,3061,license,I-Observation
45508,3062,english,B-Observation
45509,3062,-,I-Observation
45510,3062,speaking,I-Observation
45511,3062,and,O
45512,3062,literate,B-Observation
45513,3063,Pregnant,B-Condition
45514,3063,or,O
45515,3063,lactating,B-Condition
45516,3063,women,B-Person
45517,3064,Women,B-Person
45518,3064,with,O
45519,3064,breast,O
45520,3064,implants,O
45521,3064,on,O
45522,3064,the,O
45523,3064,same,O
45524,3064,side,O
45525,3064,as,O
45526,3064,the,O
45527,3064,lesion,O
45528,3065,Women,B-Person
45529,3065,that,O
45530,3065,underwent,O
45531,3065,local,B-Procedure
45532,3065,radiation,I-Procedure
45533,3065,or,O
45534,3065,chemotherapy,B-Procedure
45535,3065,within,O
45536,3065,the,O
45537,3065,last,O
45538,3065,12,O
45539,3065,months,O
45540,3066,Women,B-Person
45541,3066,with,O
45542,3066,history,O
45543,3066,of,O
45544,3066,breast,B-Condition
45545,3066,cancer,I-Condition
45546,3066,or,O
45547,3066,breast,B-Condition
45548,3066,surgery,I-Condition
45549,3066,in,O
45550,3066,the,O
45551,3066,same,O
45552,3066,quadrant,O
45553,3067,Lesions,B-Condition
45554,3067,in,O
45555,3067,or,O
45556,3067,close,O
45557,3067,to,O
45558,3067,scar,O
45559,3067,tissue,O
45560,3067,(,O
45561,3067,<,O
45562,3067,1,O
45563,3067,cm,O
45564,3067,),O
45565,3068,Skin,B-Condition
45566,3068,lesions,I-Condition
45567,3068,or,O
45568,3068,lesions,B-Condition
45569,3068,that,O
45570,3068,have,O
45571,3068,been,O
45572,3068,biopsied,B-Procedure
45573,3068,previously,O
45574,3069,Lesion,B-Condition
45575,3069,larger,O
45576,3069,than,O
45577,3069,4,O
45578,3069,cm,O
45579,3069,in,O
45580,3069,the,O
45581,3069,longest,O
45582,3069,dimension,O
45583,3070,No,O
45584,3070,lesion,B-Condition
45585,3070,should,O
45586,3070,be,O
45587,3070,included,O
45588,3070,when,O
45589,3070,more,O
45590,3070,than,O
45591,3070,50,O
45592,3070,%,O
45593,3070,of,O
45594,3070,the,O
45595,3070,lesion,O
45596,3070,is,O
45597,3070,further,O
45598,3070,down,O
45599,3070,than,O
45600,3070,4,O
45601,3070,cm,O
45602,3070,beneath,O
45603,3070,the,O
45604,3070,skin,O
45605,3070,level,O
45606,3070,.,O
45607,3071,Female,B-Person
45608,3072,Age,B-Person
45609,3072,≥18,O
45610,3072,years,O
45611,3073,Patients,O
45612,3073,with,O
45613,3073,a,O
45614,3073,lesion,B-Condition
45615,3073,>,O
45616,3073,0.5,O
45617,3073,cm,O
45618,3073,in,O
45619,3073,largest,O
45620,3073,diameter,O
45621,3073,size,O
45622,3073,",",O
45623,3073,initially,O
45624,3073,scored,O
45625,3073,BI,O
45626,3073,-,O
45627,3073,RADS,O
45628,3073,®,O
45629,3073,3,O
45630,3073,",",O
45631,3073,4a,O
45632,3073,",",O
45633,3073,4b,O
45634,3073,or,O
45635,3073,4c,O
45636,3073,in,O
45637,3073,B,B-Procedure
45638,3073,-,I-Procedure
45639,3073,mode,I-Procedure
45640,3073,ultrasound,I-Procedure
45641,3074,Informed,O
45642,3074,consent,O
45643,3074,about,O
45644,3074,histological,B-Procedure
45645,3074,examination,I-Procedure
45646,3074,(,O
45647,3074,core,B-Procedure
45648,3074,cut,I-Procedure
45649,3074,biopsy,I-Procedure
45650,3074,(,I-Procedure
45651,3074,CCB,I-Procedure
45652,3074,),I-Procedure
45653,3074,",",O
45654,3074,vacuum,B-Procedure
45655,3074,-,I-Procedure
45656,3074,assisted,I-Procedure
45657,3074,biopsy,I-Procedure
45658,3074,(,I-Procedure
45659,3074,VAB,I-Procedure
45660,3074,),I-Procedure
45661,3074,",",O
45662,3074,fine,B-Procedure
45663,3074,needle,I-Procedure
45664,3074,aspiration,I-Procedure
45665,3074,(,I-Procedure
45666,3074,FNA,I-Procedure
45667,3074,),I-Procedure
45668,3074,or,O
45669,3074,surgery,B-Procedure
45670,3074,),O
45671,3074,has,O
45672,3074,already,O
45673,3074,been,O
45674,3074,given,O
45675,3074,in,O
45676,3074,the,O
45677,3074,course,O
45678,3074,of,O
45679,3074,clinical,O
45680,3074,routine,O
45681,3075,Signed,O
45682,3075,informed,O
45683,3075,consent,O
45684,3075,of,O
45685,3075,study,O
45686,3075,participation,O
45687,3076,1,O
45688,3076,.,O
45689,3076,Deny,O
45690,3076,to,O
45691,3076,sign,O
45692,3076,the,O
45693,3076,informed,O
45694,3076,consent,O
45695,3076,;,O
45696,3077,2,O
45697,3077,.,O
45698,3077,type,B-Condition
45699,3077,1,I-Condition
45700,3077,diabetes,I-Condition
45701,3077,;,O
45702,3078,3,O
45703,3078,.,O
45704,3078,Family,B-Observation
45705,3078,history,I-Observation
45706,3078,of,O
45707,3078,hypertriglyceridemia,B-Condition
45708,3078,or,O
45709,3078,fasting,O
45710,3078,triglyceride>4.56,O
45711,3078,mmol,O
45712,3078,/,O
45713,3078,L,O
45714,3078,;,O
45715,3079,4,O
45716,3079,.,O
45717,3079,Have,O
45718,3079,severe,O
45719,3079,liver,B-Condition
45720,3079,disease,I-Condition
45721,3079,",",O
45722,3079,kidney,B-Condition
45723,3079,disease,I-Condition
45724,3079,or,O
45725,3079,cancer,B-Condition
45726,3079,;,O
45727,3080,5,O
45728,3080,.,O
45729,3080,Participating,O
45730,3080,in,O
45731,3080,the,O
45732,3080,other,O
45733,3080,clinical,O
45734,3080,trial,O
45735,3080,within,O
45736,3080,30,O
45737,3080,days,O
45738,3080,;,O
45739,3081,6,O
45740,3081,.,O
45741,3081,Other,B-Condition
45742,3081,diseases,I-Condition
45743,3081,or,I-Condition
45744,3081,conditions,I-Condition
45745,3081,",",O
45746,3081,for,O
45747,3081,which,O
45748,3081,the,O
45749,3081,doctor,O
45750,3081,of,O
45751,3081,the,O
45752,3081,patients,O
45753,3081,do,O
45754,3081,not,O
45755,3081,agree,O
45756,3081,his,O
45757,3081,or,O
45758,3081,her,O
45759,3081,participating,O
45760,3081,.,O
45761,3082,1,O
45762,3082,.,O
45763,3082,Fasting,O
45764,3082,glucose,O
45765,3082,>,O
45766,3082,7.0,O
45767,3082,or,O
45768,3082,have,O
45769,3082,diabetes,B-Drug
45770,3082,medication,I-Drug
45771,3082,;,O
45772,3083,2,O
45773,3083,.,O
45774,3083,Male,B-Person
45775,3083,",",O
45776,3083,35,B-Person
45777,3083,-,I-Person
45778,3083,80,I-Person
45779,3083,years,I-Person
45780,3083,;,O
45781,3083,female,B-Person
45782,3083,",",O
45783,3083,postmenopausal,B-Condition
45784,3083,to,B-Person
45785,3083,80,I-Person
45786,3083,years,I-Person
45787,3083,;,O
45788,3084,3,O
45789,3084,.,O
45790,3084,Agree,O
45791,3084,to,O
45792,3084,participant,O
45793,3084,in,O
45794,3084,the,O
45795,3084,trial,O
45796,3084,.,O
45797,3085,Hemoglobin,O
45798,3085,concentration,O
45799,3085,under,O
45800,3085,6.5,O
45801,3085,mmol,O
45802,3085,/,O
45803,3085,l,O
45804,3085,screening,O
45805,3086,HBA1c,O
45806,3086,more,O
45807,3086,than,O
45808,3086,108,O
45809,3086,mmol,O
45810,3086,/,O
45811,3086,l,O
45812,3087,Non,B-Condition
45813,3087,-,I-Condition
45814,3087,compliant,I-Condition
45815,3087,with,O
45816,3087,blood,B-Procedure
45817,3087,-,I-Procedure
45818,3087,letting,I-Procedure
45819,3088,Clinically,O
45820,3088,infected,B-Condition
45821,3088,ulcer,I-Condition
45822,3089,Patient,O
45823,3089,planned,B-Observation
45824,3089,for,O
45825,3089,or,O
45826,3089,has,B-Observation
45827,3089,had,I-Observation
45828,3089,a,O
45829,3089,revascularization,B-Procedure
45830,3089,procedure,I-Procedure
45831,3089,in,O
45832,3089,the,O
45833,3089,affected,O
45834,3089,leg,O
45835,3089,within,O
45836,3089,the,O
45837,3089,last,O
45838,3089,8,O
45839,3089,weeks,O
45840,3090,The,O
45841,3090,ulcer,B-Condition
45842,3090,have,O
45843,3090,been,O
45844,3090,treated,B-Procedure
45845,3090,with,O
45846,3090,growth,B-Drug
45847,3090,factors,I-Drug
45848,3090,in,O
45849,3090,the,O
45850,3090,last,O
45851,3090,8,O
45852,3090,weeks,O
45853,3091,History,B-Observation
45854,3091,of,O
45855,3091,deep,B-Condition
45856,3091,venous,I-Condition
45857,3091,insufficiency,I-Condition
45858,3091,",",O
45859,3091,chronic,B-Condition
45860,3091,venous,I-Condition
45861,3091,leg,I-Condition
45862,3091,ulcer,I-Condition
45863,3091,or,O
45864,3091,stasis,B-Condition
45865,3091,dermatitis,I-Condition
45866,3092,Breast,B-Condition
45867,3092,-,I-Condition
45868,3092,feeding,I-Condition
45869,3092,women,B-Person
45870,3092,or,O
45871,3092,fertile,B-Condition
45872,3092,women,B-Person
45873,3092,not,O
45874,3092,agreeing,B-Observation
45875,3092,to,I-Observation
45876,3092,use,I-Observation
45877,3092,an,I-Observation
45878,3092,effective,I-Observation
45879,3092,method,I-Observation
45880,3092,of,I-Observation
45881,3092,contraception,I-Observation
45882,3093,Participation,O
45883,3093,in,O
45884,3093,another,O
45885,3093,clinical,O
45886,3093,ulcer,O
45887,3093,-,O
45888,3093,healing,O
45889,3093,study,O
45890,3093,within,O
45891,3093,the,O
45892,3093,last,O
45893,3093,4,O
45894,3093,weeks,O
45895,3094,Patient,O
45896,3094,has,O
45897,3094,previously,O
45898,3094,been,O
45899,3094,randomized,O
45900,3094,in,O
45901,3094,this,O
45902,3094,study,O
45903,3095,Judgement,O
45904,3095,by,O
45905,3095,the,O
45906,3095,investigator,O
45907,3095,that,O
45908,3095,the,O
45909,3095,patient,O
45910,3095,is,O
45911,3095,not,O
45912,3095,able,O
45913,3095,to,O
45914,3095,participate,O
45915,3095,in,O
45916,3095,the,O
45917,3095,study,O
45918,3096,Diabetes,B-Condition
45919,3096,mellitus,I-Condition
45920,3097,Foot,B-Condition
45921,3097,ulcer,I-Condition
45922,3097,at,O
45923,3097,the,O
45924,3097,malleoli,O
45925,3097,area,O
45926,3097,between,O
45927,3097,"0,25",O
45928,3097,cm²,O
45929,3097,and,O
45930,3097,"5,0",O
45931,3097,cm²,O
45932,3098,Foot,B-Condition
45933,3098,ulcer,I-Condition
45934,3098,duration,O
45935,3098,more,O
45936,3098,than,O
45937,3098,6,O
45938,3098,weeks,O
45939,3099,Ankle,O
45940,3099,-,O
45941,3099,brachial,O
45942,3099,index,O
45943,3099,above,O
45944,3099,"0,40",O
45945,3099,or,O
45946,3099,presence,O
45947,3099,of,O
45948,3099,palpable,B-Condition
45949,3099,pulses,I-Condition
45950,3099,in,O
45951,3099,arteria,O
45952,3099,dorsalis,O
45953,3099,pedes,O
45954,3099,and/or,O
45955,3099,arteria,O
45956,3099,tibialis,O
45957,3099,posterior,O
45958,3100,informed,O
45959,3100,consent,O
45960,3101,Tuberculosis,B-Condition
45961,3101,resistant,O
45962,3101,to,O
45963,3101,any,O
45964,3101,of,O
45965,3101,the,O
45966,3101,study,B-Drug
45967,3101,drugs,I-Drug
45968,3101,(,O
45969,3101,isoniazid,B-Drug
45970,3101,",",O
45971,3101,rifampin,B-Drug
45972,3101,",",O
45973,3101,EMB,B-Drug
45974,3101,",",O
45975,3101,PZA,B-Drug
45976,3101,",",O
45977,3101,CFZ,B-Drug
45978,3101,",",O
45979,3101,Pto,B-Drug
45980,3101,),O
45981,3102,Unable,B-Observation
45982,3102,to,I-Observation
45983,3102,take,I-Observation
45984,3102,oral,I-Observation
45985,3102,medications,I-Observation
45986,3102,.,O
45987,3103,History,B-Observation
45988,3103,of,O
45989,3103,allergy,B-Condition
45990,3103,or,O
45991,3103,intolerance,B-Condition
45992,3103,to,O
45993,3103,any,O
45994,3103,of,O
45995,3103,the,O
45996,3103,study,B-Drug
45997,3103,drugs,I-Drug
45998,3104,Serum,O
45999,3104,aminotransferase,O
46000,3104,(,O
46001,3104,AST,O
46002,3104,or,O
46003,3104,ALT,O
46004,3104,),O
46005,3104,3x,O
46006,3104,upper,O
46007,3104,limit,O
46008,3104,of,O
46009,3104,normal,O
46010,3104,or,O
46011,3104,higher,O
46012,3105,Pregnant,B-Condition
46013,3105,or,O
46014,3105,nursing,B-Observation
46015,3105,females,B-Person
46016,3105,",",O
46017,3105,or,O
46018,3105,plan,B-Mood
46019,3105,to,I-Mood
46020,3105,become,B-Observation
46021,3105,pregnant,I-Observation
46022,3105,or,O
46023,3105,nurse,B-Observation
46024,3105,during,O
46025,3105,the,O
46026,3105,study,O
46027,3105,period,O
46028,3106,Males,B-Person
46029,3106,planning,B-Mood
46030,3106,to,I-Mood
46031,3106,conceive,B-Observation
46032,3106,a,I-Observation
46033,3106,child,I-Observation
46034,3106,during,O
46035,3106,the,O
46036,3106,study,O
46037,3106,or,O
46038,3106,within,O
46039,3106,6,O
46040,3106,months,O
46041,3106,of,O
46042,3106,cessation,O
46043,3106,of,O
46044,3106,treatment,O
46045,3106,.,O
46046,3107,Any,O
46047,3107,treatment,B-Procedure
46048,3107,directed,O
46049,3107,against,O
46050,3107,active,O
46051,3107,tuberculosis,B-Condition
46052,3107,within,O
46053,3107,6,O
46054,3107,months,O
46055,3107,preceding,O
46056,3107,initiation,O
46057,3107,of,O
46058,3107,study,O
46059,3107,drugs,O
46060,3107,.,O
46061,3108,Suspected,B-Mood
46062,3108,or,O
46063,3108,documented,B-Mood
46064,3108,tuberculosis,B-Condition
46065,3108,involving,O
46066,3108,the,O
46067,3108,central,O
46068,3108,nervous,O
46069,3108,system,O
46070,3108,and/or,O
46071,3108,bones,O
46072,3108,and/or,O
46073,3108,joints,O
46074,3108,",",O
46075,3108,and/or,O
46076,3108,miliary,O
46077,3108,tuberculosis,O
46078,3108,and/or,O
46079,3108,pericardial,O
46080,3108,tuberculosis,O
46081,3108,.,O
46082,3109,HIV,B-Condition
46083,3109,infected,I-Condition
46084,3110,HBV,B-Condition
46085,3110,infected,I-Condition
46086,3110,or,O
46087,3110,HCV,B-Condition
46088,3110,infected,I-Condition
46089,3110,(,O
46090,3110,these,O
46091,3110,increase,O
46092,3110,the,O
46093,3110,risk,O
46094,3110,of,O
46095,3110,TB,O
46096,3110,-,O
46097,3110,drug,O
46098,3110,induced,O
46099,3110,hepatotoxicity,O
46100,3110,),O
46101,3111,Weight,O
46102,3111,less,O
46103,3111,than,O
46104,3111,40.0,O
46105,3111,kg,O
46106,3111,.,O
46107,3112,Known,O
46108,3112,allergy,B-Condition
46109,3112,or,O
46110,3112,intolerance,B-Condition
46111,3112,to,O
46112,3112,any,O
46113,3112,of,O
46114,3112,the,O
46115,3112,study,B-Drug
46116,3112,medications,I-Drug
46117,3112,.,O
46118,3113,Individuals,O
46119,3113,will,O
46120,3113,be,O
46121,3113,excluded,O
46122,3113,from,O
46123,3113,enrollment,O
46124,3113,if,O
46125,3113,",",O
46126,3113,at,O
46127,3113,the,O
46128,3113,time,O
46129,3113,of,O
46130,3113,enrollment,O
46131,3113,",",O
46132,3113,their,O
46133,3113,M.,B-Condition
46134,3113,tuberculosis,I-Condition
46135,3113,isolate,I-Condition
46136,3113,is,O
46137,3113,already,O
46138,3113,known,O
46139,3113,to,O
46140,3113,be,O
46141,3113,resistant,O
46142,3113,to,O
46143,3113,any,O
46144,3113,of,O
46145,3113,the,O
46146,3113,study,B-Drug
46147,3113,drugs,I-Drug
46148,3113,.,O
46149,3114,QTcF,O
46150,3114,>,O
46151,3114,500,O
46152,3114,msec,O
46153,3115,Other,O
46154,3115,medical,O
46155,3115,conditions,O
46156,3115,",",O
46157,3115,that,O
46158,3115,",",O
46159,3115,in,O
46160,3115,the,O
46161,3115,investigator,O
46162,3115,'s,O
46163,3115,judgment,O
46164,3115,",",O
46165,3115,make,O
46166,3115,study,O
46167,3115,participation,O
46168,3115,not,O
46169,3115,in,O
46170,3115,the,O
46171,3115,individual,O
46172,3115,'s,O
46173,3115,best,O
46174,3115,interest,O
46175,3115,.,O
46176,3116,Current,O
46177,3116,or,O
46178,3116,planned,B-Mood
46179,3116,incarceration,B-Observation
46180,3116,or,O
46181,3116,other,O
46182,3116,involuntary,B-Observation
46183,3116,detention,I-Observation
46184,3117,Having,O
46185,3117,participated,B-Observation
46186,3117,in,I-Observation
46187,3117,other,I-Observation
46188,3117,clinical,I-Observation
46189,3117,studies,I-Observation
46190,3117,with,O
46191,3117,dosing,O
46192,3117,of,O
46193,3117,investigational,B-Drug
46194,3117,agents,I-Drug
46195,3117,within,O
46196,3117,8,O
46197,3117,weeks,O
46198,3117,prior,O
46199,3117,to,O
46200,3117,trial,O
46201,3117,start,O
46202,3117,or,O
46203,3117,currently,O
46204,3117,enrolled,B-Observation
46205,3117,in,I-Observation
46206,3117,an,I-Observation
46207,3117,investigational,I-Observation
46208,3117,study,I-Observation
46209,3117,that,O
46210,3117,includes,O
46211,3117,treatment,O
46212,3117,with,O
46213,3117,medicinal,B-Drug
46214,3117,agents,I-Drug
46215,3117,.,O
46216,3117,Subjects,O
46217,3117,who,O
46218,3117,are,O
46219,3117,participating,O
46220,3117,in,O
46221,3117,observational,O
46222,3117,studies,O
46223,3117,or,O
46224,3117,who,O
46225,3117,are,O
46226,3117,in,O
46227,3117,a,O
46228,3117,follow,O
46229,3117,up,O
46230,3117,period,O
46231,3117,of,O
46232,3117,a,O
46233,3117,trial,O
46234,3117,that,O
46235,3117,included,O
46236,3117,drug,O
46237,3117,therapy,O
46238,3117,may,O
46239,3117,be,O
46240,3117,considered,O
46241,3117,for,O
46242,3117,inclusion,O
46243,3117,.,O
46244,3118,Newly,O
46245,3118,diagnosed,O
46246,3118,and,O
46247,3118,untreated,O
46248,3118,sputum,O
46249,3118,smear,O
46250,3118,positive,O
46251,3118,tuberculosis,B-Condition
46252,3118,patient,O
46253,3119,Pulmonary,B-Condition
46254,3119,lesion,I-Condition
46255,3119,consistent,O
46256,3119,with,O
46257,3119,TB,B-Condition
46258,3119,by,O
46259,3119,radiological,B-Procedure
46260,3119,examination,I-Procedure
46261,3120,Positive,O
46262,3120,sputum,O
46263,3120,culture,O
46264,3120,",",O
46265,3120,identification,O
46266,3120,of,O
46267,3120,bacterial,O
46268,3120,type,O
46269,3120,confirmed,O
46270,3120,Mycobacterium,B-Condition
46271,3120,tuberculosis,I-Condition
46272,3120,.,O
46273,3120,MGIT,O
46274,3120,drug,O
46275,3120,sensitivity,O
46276,3120,test,O
46277,3120,(,O
46278,3120,DST,O
46279,3120,),O
46280,3120,results,O
46281,3120,are,O
46282,3120,sensitive,O
46283,3120,of,O
46284,3120,the,O
46285,3120,first,B-Drug
46286,3120,-,I-Drug
46287,3120,line,I-Drug
46288,3120,drugs,I-Drug
46289,3120,(,O
46290,3120,isoniazid,B-Drug
46291,3120,",",O
46292,3120,streptomycin,B-Drug
46293,3120,",",O
46294,3120,rifampicin,B-Drug
46295,3120,and,O
46296,3120,ethambutol,B-Drug
46297,3120,),O
46298,3120,.,O
46299,3121,Age,B-Person
46300,3121,18,O
46301,3121,years-65,O
46302,3121,years,O
46303,3121,old,O
46304,3122,Males,B-Person
46305,3122,or,O
46306,3122,non,O
46307,3122,-,O
46308,3122,pregnant,B-Condition
46309,3122,",",O
46310,3122,non,O
46311,3122,-,O
46312,3122,nursing,B-Observation
46313,3122,females,B-Person
46314,3123,Serum,O
46315,3123,or,O
46316,3123,plasma,O
46317,3123,aminotransferases,O
46318,3123,(,O
46319,3123,AST,O
46320,3123,",",O
46321,3123,ALT,O
46322,3123,),O
46323,3123,less,O
46324,3123,than,O
46325,3123,3,O
46326,3123,times,O
46327,3123,the,O
46328,3123,upper,O
46329,3123,limit,O
46330,3123,of,O
46331,3123,normal,O
46332,3124,Serum,O
46333,3124,or,O
46334,3124,plasma,O
46335,3124,total,O
46336,3124,bilirubin,O
46337,3124,less,O
46338,3124,than,O
46339,3124,or,O
46340,3124,equal,O
46341,3124,to,O
46342,3124,2.5,O
46343,3124,times,O
46344,3124,the,O
46345,3124,upper,O
46346,3124,limit,O
46347,3124,of,O
46348,3124,normal,O
46349,3125,Serum,O
46350,3125,or,O
46351,3125,plasma,O
46352,3125,creatinine,O
46353,3125,level,O
46354,3125,less,O
46355,3125,than,O
46356,3125,or,O
46357,3125,equal,O
46358,3125,to,O
46359,3125,2,O
46360,3125,times,O
46361,3125,the,O
46362,3125,upper,O
46363,3125,limit,O
46364,3125,of,O
46365,3125,normal,O
46366,3126,Serum,O
46367,3126,or,O
46368,3126,plasma,O
46369,3126,potassium,O
46370,3126,level,O
46371,3126,greater,O
46372,3126,than,O
46373,3126,or,O
46374,3126,equal,O
46375,3126,to,O
46376,3126,3.5,O
46377,3126,meq,O
46378,3126,/,O
46379,3126,L,O
46380,3127,Hemoglobin,O
46381,3127,level,O
46382,3127,of,O
46383,3127,7.0,O
46384,3127,g,O
46385,3127,/,O
46386,3127,dL,O
46387,3127,or,O
46388,3127,greater,O
46389,3128,Platelet,O
46390,3128,count,O
46391,3128,of,O
46392,3128,"100,000",O
46393,3128,/,O
46394,3128,mm3,O
46395,3128,or,O
46396,3128,greater,O
46397,3129,For,O
46398,3129,women,B-Person
46399,3129,of,O
46400,3129,childbearing,B-Observation
46401,3129,potential,I-Observation
46402,3129,",",O
46403,3129,a,O
46404,3129,negative,O
46405,3129,pregnancy,O
46406,3129,test,O
46407,3129,is,O
46408,3129,required,O
46409,3129,during,O
46410,3129,screening,O
46411,3130,Provides,O
46412,3130,written,B-Observation
46413,3130,informed,I-Observation
46414,3130,consent,I-Observation
46415,3131,Willingness,O
46416,3131,and,O
46417,3131,ability,B-Observation
46418,3131,to,I-Observation
46419,3131,attend,I-Observation
46420,3131,scheduled,I-Observation
46421,3131,follow,I-Observation
46422,3131,-,I-Observation
46423,3131,up,I-Observation
46424,3131,visits,I-Observation
46425,3131,and,I-Observation
46426,3131,undergo,I-Observation
46427,3131,study,I-Observation
46428,3131,assessments,I-Observation
46429,3131,.,O
46430,3132,eGFR(Epidermal,O
46431,3132,growth,O
46432,3132,factor,O
46433,3132,receptor,O
46434,3132,),O
46435,3132,<,O
46436,3132,50mL,O
46437,3132,/,O
46438,3132,min,O
46439,3133,AST(aspartate,O
46440,3133,aminotransferase)/ALT(alanine,O
46441,3133,aminotransaminase,O
46442,3133,),O
46443,3133,>,O
46444,3133,2.5,O
46445,3133,upper,O
46446,3133,limit,O
46447,3133,of,O
46448,3133,normal,O
46449,3134,Pregnant,O
46450,3134,or,O
46451,3134,lactating,O
46452,3134,women,O
46453,3135,Subject,O
46454,3135,who,O
46455,3135,the,O
46456,3135,investigator,O
46457,3135,deems,O
46458,3135,inappropriate,O
46459,3135,to,O
46460,3135,participate,O
46461,3135,in,O
46462,3135,this,O
46463,3135,study,O
46464,3136,Patients,O
46465,3136,with,O
46466,3136,a,O
46467,3136,history,O
46468,3136,of,O
46469,3136,bladder,B-Condition
46470,3136,cancer,I-Condition
46471,3136,or,O
46472,3136,patients,O
46473,3136,with,O
46474,3136,active,O
46475,3136,bladder,B-Condition
46476,3136,cancer,I-Condition
46477,3137,Patients,O
46478,3137,with,O
46479,3137,uninvestigated,O
46480,3137,macroscopic,B-Condition
46481,3137,hematuria,I-Condition
46482,3138,Patients,O
46483,3138,with,O
46484,3138,cardiac,B-Condition
46485,3138,failure,I-Condition
46486,3138,or,O
46487,3138,a,O
46488,3138,history,B-Observation
46489,3138,of,I-Observation
46490,3138,cardiac,I-Observation
46491,3138,failure,I-Observation
46492,3138,(,O
46493,3138,New,O
46494,3138,York,O
46495,3138,Heart,O
46496,3138,Association,O
46497,3138,[,O
46498,3138,NYHA,O
46499,3138,],O
46500,3138,Stages,O
46501,3138,3,O
46502,3138,to,O
46503,3138,4,O
46504,3138,),O
46505,3139,Patients,O
46506,3139,with,O
46507,3139,genetic,B-Condition
46508,3139,problems,I-Condition
46509,3139,such,O
46510,3139,as,O
46511,3139,galactose,B-Condition
46512,3139,intolerance,I-Condition
46513,3139,",",O
46514,3139,Lapp,B-Condition
46515,3139,lactase,I-Condition
46516,3139,deficiency,I-Condition
46517,3139,or,O
46518,3139,glucose,B-Condition
46519,3139,-,I-Condition
46520,3139,galactose,I-Condition
46521,3139,malabsorption,I-Condition
46522,3139,",",O
46523,3139,since,O
46524,3139,this,O
46525,3139,study,O
46526,3139,drug,O
46527,3139,contains,O
46528,3139,lactose,O
46529,3140,Completed,O
46530,3140,"""",O
46531,3140,ALO,O
46532,3140,-,O
46533,3140,IIT-012(PEAK,O
46534,3140,study,O
46535,3140,),O
46536,3140,"""",O
46537,3140,",",O
46538,3140,without,O
46539,3140,major,O
46540,3140,protocol,O
46541,3140,deviations,O
46542,3140,.,O
46543,3141,Male,B-Person
46544,3141,",",O
46545,3141,or,O
46546,3141,female,B-Person
46547,3141,",",O
46548,3141,19,O
46549,3141,years,O
46550,3141,to,O
46551,3141,75,O
46552,3141,years,B-Person
46553,3141,.,O
46554,3142,Female,O
46555,3142,with,O
46556,3142,childbearing,O
46557,3142,potential,O
46558,3142,who,O
46559,3142,has,O
46560,3142,a,O
46561,3142,negative,O
46562,3142,urine,O
46563,3142,pregnancy,O
46564,3142,test,O
46565,3142,result,O
46566,3142,at,O
46567,3142,study,O
46568,3142,start,O
46569,3142,and,O
46570,3142,willing,O
46571,3142,to,O
46572,3142,continue,O
46573,3142,practice,O
46574,3142,appropriate,O
46575,3142,birth,O
46576,3142,control,O
46577,3142,during,O
46578,3142,the,O
46579,3142,entire,O
46580,3142,duration,O
46581,3142,of,O
46582,3142,study,O
46583,3143,Subjects,O
46584,3143,completed,O
46585,3143,PEAK,O
46586,3143,can,O
46587,3143,be,O
46588,3143,included,O
46589,3143,within,O
46590,3143,30,O
46591,3143,days,O
46592,3143,after,O
46593,3143,End,O
46594,3143,Of,O
46595,3143,the,O
46596,3143,Study,O
46597,3144,Subjects,O
46598,3144,completed,O
46599,3144,PEAK,O
46600,3144,can,O
46601,3144,be,O
46602,3144,included,O
46603,3144,if,O
46604,3144,their,O
46605,3144,treatment,O
46606,3144,is,O
46607,3144,the,O
46608,3144,same,O
46609,3144,as,O
46610,3144,randomized,O
46611,3144,even,O
46612,3144,after,O
46613,3144,30,O
46614,3144,days,O
46615,3144,of,O
46616,3144,End,O
46617,3144,Of,O
46618,3144,the,O
46619,3144,Study,O
46620,3144,.,O
46621,3145,1,O
46622,3145,.,O
46623,3145,Decrease,O
46624,3145,in,O
46625,3145,size,O
46626,3145,of,O
46627,3145,the,O
46628,3145,designated,O
46629,3145,target,B-Condition
46630,3145,ulcer(s,I-Condition
46631,3145,),O
46632,3145,by,O
46633,3145,≥,O
46634,3145,30,O
46635,3145,%,O
46636,3145,during,O
46637,3145,the,O
46638,3145,7,O
46639,3145,-,O
46640,3145,day,O
46641,3145,screening,O
46642,3145,period,O
46643,3146,2,O
46644,3146,.,O
46645,3146,Can,O
46646,3146,not,O
46647,3146,tolerate,O
46648,3146,or,O
46649,3146,comply,O
46650,3146,with,O
46651,3146,compression,B-Procedure
46652,3146,therapy,I-Procedure
46653,3146,.,O
46654,3147,3,O
46655,3147,.,O
46656,3147,An,O
46657,3147,ulcer,B-Condition
46658,3147,which,O
46659,3147,shows,O
46660,3147,signs,O
46661,3147,of,O
46662,3147,severe,B-Condition
46663,3147,clinical,I-Condition
46664,3147,infection,I-Condition
46665,3147,",",O
46666,3147,defined,O
46667,3147,as,O
46668,3147,pus,B-Condition
46669,3147,oozing,O
46670,3147,from,O
46671,3147,the,O
46672,3147,ulcer,O
46673,3147,site,O
46674,3148,4,O
46675,3148,.,O
46676,3148,An,O
46677,3148,ulcer,B-Condition
46678,3148,positive,O
46679,3148,for,O
46680,3148,β,O
46681,3148,-,O
46682,3148,hemolytic,O
46683,3148,streptococci,O
46684,3148,upon,O
46685,3148,culture,O
46686,3149,5,O
46687,3149,.,O
46688,3149,The,O
46689,3149,ulcer,B-Condition
46690,3149,has,O
46691,3149,>,O
46692,3149,50,O
46693,3149,%,O
46694,3149,slough,O
46695,3149,",",O
46696,3149,significant,O
46697,3149,necrotic,B-Observation
46698,3149,tissue,I-Observation
46699,3149,",",O
46700,3149,bone,B-Observation
46701,3149,",",I-Observation
46702,3149,tendon,I-Observation
46703,3149,",",I-Observation
46704,3149,or,I-Observation
46705,3149,capsule,I-Observation
46706,3149,exposure,I-Observation
46707,3149,or,O
46708,3149,avascular,B-Observation
46709,3149,ulcer,I-Observation
46710,3149,beds,I-Observation
46711,3150,6,O
46712,3150,.,O
46713,3150,Is,O
46714,3150,highly,O
46715,3150,exuding,O
46716,3150,(,O
46717,3150,i.e.,O
46718,3150,requires,O
46719,3150,daily,O
46720,3150,change,B-Procedure
46721,3150,of,I-Procedure
46722,3150,dressing,I-Procedure
46723,3150,),O
46724,3151,7,O
46725,3151,.,O
46726,3151,Ankle,O
46727,3151,brachial,O
46728,3151,pressure,O
46729,3151,index,O
46730,3151,<,O
46731,3151,0.65,O
46732,3152,8,O
46733,3152,.,O
46734,3152,Patients,O
46735,3152,with,O
46736,3152,active,O
46737,3152,systemic,B-Condition
46738,3152,infections,I-Condition
46739,3153,9,O
46740,3153,.,O
46741,3153,Patients,O
46742,3153,with,O
46743,3153,clinically,O
46744,3153,significant,O
46745,3153,medical,B-Condition
46746,3153,conditions,I-Condition
46747,3153,as,B-Observation
46748,3153,determined,I-Observation
46749,3153,by,I-Observation
46750,3153,the,I-Observation
46751,3153,investigator,I-Observation
46752,3153,including,O
46753,3153,renal,B-Condition
46754,3153,",",I-Condition
46755,3153,hepatic,I-Condition
46756,3153,",",I-Condition
46757,3153,hematologic,I-Condition
46758,3153,",",I-Condition
46759,3153,neurologic,I-Condition
46760,3153,or,I-Condition
46761,3153,immune,I-Condition
46762,3153,disease,I-Condition
46763,3153,.,O
46764,3153,Examples,O
46765,3153,include,O
46766,3153,but,O
46767,3153,are,O
46768,3153,not,O
46769,3153,limited,O
46770,3153,to,O
46771,3153,:,O
46772,3154,1,O
46773,3154,.,O
46774,3154,Renal,B-Condition
46775,3154,insufficiency,I-Condition
46776,3154,as,O
46777,3154,an,O
46778,3154,estimated,O
46779,3154,GFR,O
46780,3154,which,O
46781,3154,is,O
46782,3154,<,O
46783,3154,30,O
46784,3154,mL,O
46785,3154,/,O
46786,3154,min/1.7m2,O
46787,3155,2,O
46788,3155,.,O
46789,3155,Abnormal,O
46790,3155,blood,O
46791,3155,biochemistry,O
46792,3155,defined,O
46793,3155,as,O
46794,3155,3,O
46795,3155,times,O
46796,3155,that,O
46797,3155,of,O
46798,3155,the,O
46799,3155,upper,O
46800,3155,limit,O
46801,3155,of,O
46802,3155,the,O
46803,3155,normal,O
46804,3155,range,O
46805,3155,.,O
46806,3156,3,O
46807,3156,.,O
46808,3156,Hepatic,B-Condition
46809,3156,insufficiency,I-Condition
46810,3156,defined,O
46811,3156,as,O
46812,3156,total,O
46813,3156,bilirubin,O
46814,3156,>,O
46815,3156,2,O
46816,3156,mg,O
46817,3156,/,O
46818,3156,dL,O
46819,3156,or,O
46820,3156,serum,O
46821,3156,albumin,O
46822,3156,<,O
46823,3156,25,O
46824,3156,g,O
46825,3156,/,O
46826,3156,L,O
46827,3157,4,O
46828,3157,.,O
46829,3157,HbA1c,O
46830,3157,>,O
46831,3157,9,O
46832,3157,%,O
46833,3158,5,O
46834,3158,.,O
46835,3158,Hemoglobin,O
46836,3158,<,O
46837,3158,10,O
46838,3158,g,O
46839,3158,/,O
46840,3158,dL,O
46841,3159,6,O
46842,3159,.,O
46843,3159,Hematocrit,O
46844,3159,<,O
46845,3159,0.30,O
46846,3160,7,O
46847,3160,.,O
46848,3160,Platelet,O
46849,3160,count,O
46850,3160,<,O
46851,3160,"100,000",O
46852,3161,10,O
46853,3161,.,O
46854,3161,Presence,O
46855,3161,of,O
46856,3161,an,O
46857,3161,active,O
46858,3161,systemic,B-Condition
46859,3161,or,I-Condition
46860,3161,local,I-Condition
46861,3161,cancer,I-Condition
46862,3161,or,O
46863,3161,tumor,B-Condition
46864,3161,of,I-Condition
46865,3161,any,I-Condition
46866,3161,kind,I-Condition
46867,3161,(,O
46868,3161,with,O
46869,3161,the,O
46870,3161,exception,O
46871,3161,of,O
46872,3161,non,B-Condition
46873,3161,-,I-Condition
46874,3161,melanoma,I-Condition
46875,3161,skin,I-Condition
46876,3161,cancer,I-Condition
46877,3161,),O
46878,3162,11,O
46879,3162,.,O
46880,3162,Patients,O
46881,3162,with,O
46882,3162,severe,O
46883,3162,rheumatoid,B-Condition
46884,3162,arthritis,I-Condition
46885,3162,(,O
46886,3162,with,O
46887,3162,more,O
46888,3162,than,O
46889,3162,20,O
46890,3162,persistently,O
46891,3162,inflamed,B-Condition
46892,3162,joints,I-Condition
46893,3162,",",O
46894,3162,or,O
46895,3162,below,O
46896,3162,lower,O
46897,3162,normal,O
46898,3162,limit,O
46899,3162,blood,O
46900,3162,albumin,O
46901,3162,level,O
46902,3162,",",O
46903,3162,or,O
46904,3162,evidence,O
46905,3162,of,O
46906,3162,bone,B-Condition
46907,3162,and,I-Condition
46908,3162,cartilage,I-Condition
46909,3162,damage,I-Condition
46910,3162,on,O
46911,3162,x,B-Procedure
46912,3162,-,I-Procedure
46913,3162,ray,I-Procedure
46914,3162,",",O
46915,3162,or,O
46916,3162,inflammation,B-Condition
46917,3162,in,I-Condition
46918,3162,tissues,I-Condition
46919,3162,other,I-Condition
46920,3162,than,I-Condition
46921,3162,joints,I-Condition
46922,3162,),O
46923,3162,and,O
46924,3162,other,O
46925,3162,collagen,B-Condition
46926,3162,vascular,I-Condition
46927,3162,diseases,I-Condition
46928,3162,.,O
46929,3163,12,O
46930,3163,.,O
46931,3163,Patients,O
46932,3163,with,O
46933,3163,active,O
46934,3163,connective,B-Condition
46935,3163,tissue,I-Condition
46936,3163,disease,I-Condition
46937,3164,13,O
46938,3164,.,O
46939,3164,Treatment,B-Procedure
46940,3164,with,O
46941,3164,systemic,B-Drug
46942,3164,corticosteroids,I-Drug
46943,3164,(,O
46944,3164,>,O
46945,3164,15,O
46946,3164,mg,O
46947,3164,/,O
46948,3164,day,O
46949,3164,),O
46950,3164,",",O
46951,3164,or,O
46952,3164,current,O
46953,3164,immunosuppressive,B-Drug
46954,3164,agents,I-Drug
46955,3165,14,O
46956,3165,.,O
46957,3165,Previous,O
46958,3165,or,O
46959,3165,current,O
46960,3165,radiation,B-Procedure
46961,3165,therapy,I-Procedure
46962,3165,or,O
46963,3165,likelihood,O
46964,3165,to,O
46965,3165,receive,O
46966,3165,this,O
46967,3165,therapy,O
46968,3165,during,O
46969,3165,study,O
46970,3165,participation,O
46971,3166,15,O
46972,3166,.,O
46973,3166,Pregnant,B-Condition
46974,3166,or,O
46975,3166,nursing,B-Condition
46976,3166,patients,O
46977,3167,16,O
46978,3167,.,O
46979,3167,Known,O
46980,3167,prior,O
46981,3167,inability,O
46982,3167,or,O
46983,3167,unavailability,O
46984,3167,to,O
46985,3167,complete,O
46986,3167,required,O
46987,3167,study,O
46988,3167,visits,O
46989,3167,during,O
46990,3167,study,O
46991,3167,participation,O
46992,3168,17,O
46993,3168,.,O
46994,3168,Significant,O
46995,3168,peripheral,B-Condition
46996,3168,edema,I-Condition
46997,3168,as,O
46998,3168,per,O
46999,3168,investigator,O
47000,3168,'s,O
47001,3168,discretion,O
47002,3169,18,O
47003,3169,.,O
47004,3169,A,O
47005,3169,psychiatric,B-Condition
47006,3169,condition,I-Condition
47007,3169,(,O
47008,3169,e.g.,O
47009,3169,",",O
47010,3169,suicidal,B-Condition
47011,3169,ideation,I-Condition
47012,3169,),O
47013,3169,or,O
47014,3169,chronic,O
47015,3169,alcohol,B-Condition
47016,3169,or,I-Condition
47017,3169,drug,I-Condition
47018,3169,abuse,I-Condition
47019,3169,problem,I-Condition
47020,3169,",",O
47021,3169,determined,O
47022,3169,from,O
47023,3169,the,O
47024,3169,patient,O
47025,3169,'s,O
47026,3169,medical,O
47027,3169,history,O
47028,3169,",",O
47029,3169,which,O
47030,3169,",",O
47031,3169,in,O
47032,3169,the,O
47033,3169,opinion,O
47034,3169,of,O
47035,3169,the,O
47036,3169,investigator,O
47037,3169,",",O
47038,3169,may,O
47039,3169,pose,O
47040,3169,a,O
47041,3169,threat,O
47042,3169,to,O
47043,3169,patient,O
47044,3169,compliance,O
47045,3170,19,O
47046,3170,.,O
47047,3170,Use,O
47048,3170,of,O
47049,3170,a,O
47050,3170,platelet,B-Drug
47051,3170,-,I-Drug
47052,3170,derived,I-Drug
47053,3170,growth,I-Drug
47054,3170,factor,I-Drug
47055,3170,within,O
47056,3170,28,O
47057,3170,days,O
47058,3170,before,O
47059,3170,screening,O
47060,3171,20,O
47061,3171,.,O
47062,3171,Use,O
47063,3171,of,O
47064,3171,any,O
47065,3171,investigational,B-Procedure
47066,3171,drug,I-Procedure
47067,3171,or,I-Procedure
47068,3171,therapy,I-Procedure
47069,3171,within,O
47070,3171,28,O
47071,3171,days,O
47072,3171,before,O
47073,3171,screening,O
47074,3172,21,O
47075,3172,.,O
47076,3172,Has,O
47077,3172,any,O
47078,3172,other,O
47079,3172,factor,O
47080,3172,which,O
47081,3172,may,O
47082,3172,",",O
47083,3172,in,O
47084,3172,the,O
47085,3172,opinion,O
47086,3172,of,O
47087,3172,the,O
47088,3172,investigator,O
47089,3172,",",O
47090,3172,compromise,O
47091,3172,participation,O
47092,3172,and/or,O
47093,3172,follow,O
47094,3172,-,O
47095,3172,up,O
47096,3172,in,O
47097,3172,the,O
47098,3172,study,O
47099,3173,1,O
47100,3173,.,O
47101,3173,Age,B-Person
47102,3173,18,O
47103,3173,years,O
47104,3173,or,O
47105,3173,older,O
47106,3174,2,O
47107,3174,.,O
47108,3174,Diagnosis,O
47109,3174,of,O
47110,3174,venous,B-Condition
47111,3174,leg,I-Condition
47112,3174,ulcer(s,I-Condition
47113,3174,),I-Condition
47114,3174,",",O
47115,3174,as,O
47116,3174,clinically,O
47117,3174,determined,O
47118,3174,by,O
47119,3174,the,O
47120,3174,investigator,O
47121,3174,by,O
47122,3174,a,O
47123,3174,positive,O
47124,3174,venous,O
47125,3174,reflux,O
47126,3174,test,O
47127,3174,(,O
47128,3174,venous,O
47129,3174,refilling,O
47130,3174,<,O
47131,3174,20,O
47132,3174,seconds,O
47133,3174,),O
47134,3174,using,O
47135,3174,Doppler,B-Procedure
47136,3174,ultrasound,I-Procedure
47137,3174,for,O
47138,3174,at,O
47139,3174,least,O
47140,3174,4,O
47141,3174,weeks,O
47142,3174,prior,O
47143,3174,to,O
47144,3174,screening,O
47145,3174,day,O
47146,3174,",",O
47147,3174,which,O
47148,3174,have,O
47149,3174,not,O
47150,3174,adequately,O
47151,3174,responded,B-Observation
47152,3174,to,O
47153,3174,conventional,B-Procedure
47154,3174,ulcer,I-Procedure
47155,3174,therapy,I-Procedure
47156,3174,.,O
47157,3175,3,O
47158,3175,.,O
47159,3175,Designated,O
47160,3175,venous,B-Condition
47161,3175,leg,I-Condition
47162,3175,ulcer,I-Condition
47163,3175,meets,O
47164,3175,the,O
47165,3175,following,O
47166,3175,criteria,O
47167,3175,at,O
47168,3175,both,O
47169,3175,the,O
47170,3175,screening,O
47171,3175,and,O
47172,3175,baseline,O
47173,3175,visits,O
47174,3175,.,O
47175,3175,If,O
47176,3175,the,O
47177,3175,patient,O
47178,3175,has,O
47179,3175,multiple,O
47180,3175,ulcers,B-Condition
47181,3175,",",O
47182,3175,at,O
47183,3175,least,O
47184,3175,one,O
47185,3175,ulcer,B-Condition
47186,3175,must,O
47187,3175,meet,O
47188,3175,the,O
47189,3175,following,O
47190,3175,criteria,O
47191,3175,at,O
47192,3175,both,O
47193,3175,the,O
47194,3175,screening,O
47195,3175,and,O
47196,3175,baseline,O
47197,3175,visits,O
47198,3175,:,O
47199,3176,1,O
47200,3176,.,O
47201,3176,Present,O
47202,3176,for,O
47203,3176,at,O
47204,3176,least,O
47205,3176,4,O
47206,3176,weeks,O
47207,3177,2,O
47208,3177,.,O
47209,3177,CEAP,O
47210,3177,Classification,O
47211,3177,Stage,O
47212,3177,6,O
47213,3178,3,O
47214,3178,.,O
47215,3178,Surface,B-Condition
47216,3178,ulcer,I-Condition
47217,3178,with,O
47218,3178,an,O
47219,3178,area,O
47220,3178,>,O
47221,3178,15cm2,O
47222,3178,post,O
47223,3178,debridement,O
47224,3179,4,O
47225,3179,.,O
47226,3179,Viable,O
47227,3179,",",O
47228,3179,granulating,O
47229,3179,wound,B-Condition
47230,3179,(,O
47231,3179,investigator,O
47232,3179,discretion,O
47233,3179,),O
47234,3180,4,O
47235,3180,.,O
47236,3180,Ulcers,B-Condition
47237,3180,that,O
47238,3180,extend,O
47239,3180,through,O
47240,3180,the,O
47241,3180,epidermis,O
47242,3180,but,O
47243,3180,not,O
47244,3180,through,O
47245,3180,the,O
47246,3180,muscle,O
47247,3180,",",O
47248,3180,tendon,O
47249,3180,",",O
47250,3180,or,O
47251,3180,bone,O
47252,3180,(,O
47253,3180,Stage,O
47254,3180,II,O
47255,3180,or,O
47256,3180,III,O
47257,3180,ulcers,B-Condition
47258,3180,as,O
47259,3180,defined,O
47260,3180,by,O
47261,3180,the,O
47262,3180,IAET,O
47263,3180,),O
47264,3180,.,O
47265,3181,5,O
47266,3181,.,O
47267,3181,Female,B-Person
47268,3181,patients,O
47269,3181,of,O
47270,3181,childbearing,B-Condition
47271,3181,potential,I-Condition
47272,3181,must,O
47273,3181,have,O
47274,3181,a,O
47275,3181,negative,O
47276,3181,pregnancy,O
47277,3181,test,O
47278,3181,at,O
47279,3181,screening,O
47280,3181,and,O
47281,3181,must,O
47282,3181,agree,O
47283,3181,to,O
47284,3181,use,O
47285,3181,hormonal,B-Drug
47286,3181,contraceptive,I-Drug
47287,3181,",",O
47288,3181,intrauterine,O
47289,3181,device,O
47290,3181,",",O
47291,3181,diaphragm,O
47292,3181,with,O
47293,3181,spermicide,O
47294,3181,",",O
47295,3181,condom,O
47296,3181,with,O
47297,3181,spermicide,O
47298,3181,",",O
47299,3181,or,O
47300,3181,abstinence,B-Observation
47301,3181,throughout,O
47302,3181,until,O
47303,3181,2,O
47304,3181,weeks,O
47305,3181,after,O
47306,3181,the,O
47307,3181,last,O
47308,3181,administration,O
47309,3181,of,O
47310,3181,study,O
47311,3181,drug,O
47312,3182,6,O
47313,3182,.,O
47314,3182,Signed,O
47315,3182,informed,O
47316,3182,consent,O
47317,3183,fetal,B-Condition
47318,3183,anomalies,I-Condition
47319,3184,contra,B-Condition
47320,3184,-,I-Condition
47321,3184,indications,I-Condition
47322,3184,for,O
47323,3184,medical,B-Procedure
47324,3184,induction,I-Procedure
47325,3184,of,I-Procedure
47326,3184,labor,I-Procedure
47327,3185,placental,B-Condition
47328,3185,pathologies,I-Condition
47329,3186,St.p,B-Condition
47330,3186,.,I-Condition
47331,3186,surgery,B-Procedure
47332,3186,with,I-Procedure
47333,3186,opening,I-Procedure
47334,3186,the,I-Procedure
47335,3186,uterine,I-Procedure
47336,3186,cavity,I-Procedure
47337,3186,(,O
47338,3186,incl,O
47339,3186,.,O
47340,3186,caesarean,B-Procedure
47341,3186,section,I-Procedure
47342,3186,),O
47343,3187,PROM,B-Condition
47344,3188,multiple,B-Condition
47345,3188,gestations,I-Condition
47346,3189,<,O
47347,3189,37,O
47348,3189,-,O
47349,3189,0,O
47350,3189,weeks,O
47351,3189,of,O
47352,3189,gestation,O
47353,3190,St.p,B-Condition
47354,3190,.,I-Condition
47355,3190,cervical,B-Procedure
47356,3190,tear,I-Procedure
47357,3191,medical,B-Condition
47358,3191,indication,I-Condition
47359,3191,for,O
47360,3191,induction,B-Procedure
47361,3191,of,I-Procedure
47362,3191,labor,I-Procedure
47363,3192,18,O
47364,3192,years,O
47365,3192,of,O
47366,3192,age,B-Person
47367,3193,signed,O
47368,3193,informed,O
47369,3193,consent,O
47370,3194,cephalic,B-Condition
47371,3194,presentation,I-Condition
47372,3195,no,O
47373,3195,PROM,B-Condition
47374,3196,37,O
47375,3196,+,O
47376,3196,0,O
47377,3196,-,O
47378,3196,42,O
47379,3196,+,O
47380,3196,0,O
47381,3196,weeks,O
47382,3196,of,O
47383,3196,gestation,O
47384,3197,Bishop,O
47385,3197,-,O
47386,3197,Score,O
47387,3197,=,O
47388,3197,6,O
47389,3198,no,O
47390,3198,contra,B-Condition
47391,3198,-,I-Condition
47392,3198,indication,I-Condition
47393,3198,for,O
47394,3198,medical,B-Procedure
47395,3198,induction,I-Procedure
47396,3198,of,I-Procedure
47397,3198,labor,I-Procedure
47398,3199,no,O
47399,3199,clinical,B-Mood
47400,3199,signs,I-Mood
47401,3199,of,I-Mood
47402,3199,infection,B-Condition
47403,3200,NA,O
47404,3201,Age>18,B-Person
47405,3201,years,O
47406,3202,Scheduled,O
47407,3202,1,O
47408,3202,or,O
47409,3202,2,O
47410,3202,-,O
47411,3202,level,O
47412,3202,ACDF,B-Procedure
47413,3202,spine,I-Procedure
47414,3202,surgery,I-Procedure
47415,3203,The,O
47416,3203,capacity,O
47417,3203,to,O
47418,3203,provide,O
47419,3203,informed,O
47420,3203,consent,O
47421,3203,.,O
47422,3204,Degenerative,B-Condition
47423,3204,Disc,I-Condition
47424,3204,Disease,I-Condition
47425,3204,(,O
47426,3204,as,O
47427,3204,defined,O
47428,3204,by,O
47429,3204,neck,B-Condition
47430,3204,pain,I-Condition
47431,3204,of,O
47432,3204,discogenic,O
47433,3204,origin,O
47434,3204,with,O
47435,3204,degeneration,B-Condition
47436,3204,of,I-Condition
47437,3204,the,I-Condition
47438,3204,disc,I-Condition
47439,3204,confirmed,O
47440,3204,by,O
47441,3204,patient,B-Observation
47442,3204,history,I-Observation
47443,3204,and,O
47444,3204,radiographic,B-Procedure
47445,3204,studies,I-Procedure
47446,3204,),O
47447,3205,Trauma,B-Condition
47448,3205,(,O
47449,3205,including,O
47450,3205,fractures,B-Condition
47451,3205,),O
47452,3206,Tumors,B-Condition
47453,3207,Deformities,B-Condition
47454,3207,or,O
47455,3207,curvatures,B-Condition
47456,3207,(,O
47457,3207,including,O
47458,3207,kyphosis,B-Condition
47459,3207,",",O
47460,3207,lordosis,B-Condition
47461,3207,",",O
47462,3207,or,O
47463,3207,scoliosis,B-Condition
47464,3207,),O
47465,3208,Pseudoarthrosis,B-Condition
47466,3209,Failed,O
47467,3209,previous,O
47468,3209,fusion,B-Procedure
47469,3210,Decompression,B-Procedure
47470,3210,of,I-Procedure
47471,3210,the,I-Procedure
47472,3210,spinal,I-Procedure
47473,3210,cord,I-Procedure
47474,3210,following,O
47475,3210,total,B-Procedure
47476,3210,or,I-Procedure
47477,3210,partial,I-Procedure
47478,3210,cervical,I-Procedure
47479,3210,vertebrectomy,I-Procedure
47480,3211,Spondylolisthesis,B-Condition
47481,3212,Spinal,B-Condition
47482,3212,stenosis,I-Condition
47483,3213,Patients,O
47484,3213,with,O
47485,3213,current,O
47486,3213,or,O
47487,3213,recent,O
47488,3213,history,B-Observation
47489,3213,of,O
47490,3213,malignancy,B-Condition
47491,3213,or,O
47492,3213,infectious,B-Condition
47493,3213,disease,I-Condition
47494,3213,.,O
47495,3214,The,O
47496,3214,inability,O
47497,3214,to,O
47498,3214,provide,O
47499,3214,informed,O
47500,3214,consent,O
47501,3214,.,O
47502,3215,Subject,O
47503,3215,has,O
47504,3215,marked,O
47505,3215,local,B-Condition
47506,3215,inflammation,I-Condition
47507,3216,Subject,O
47508,3216,has,O
47509,3216,any,O
47510,3216,mental,B-Condition
47511,3216,or,I-Condition
47512,3216,neuromuscular,I-Condition
47513,3216,disorder,I-Condition
47514,3216,which,O
47515,3216,would,O
47516,3216,create,O
47517,3216,an,O
47518,3216,unacceptable,O
47519,3216,risk,B-Mood
47520,3216,of,I-Mood
47521,3216,fixation,B-Condition
47522,3216,failure,I-Condition
47523,3216,or,O
47524,3216,complications,B-Condition
47525,3216,in,O
47526,3216,postoperative,O
47527,3216,care,O
47528,3216,.,O
47529,3217,Subject,O
47530,3217,has,O
47531,3217,a,O
47532,3217,bone,B-Condition
47533,3217,stock,I-Condition
47534,3217,compromised,I-Condition
47535,3217,by,O
47536,3217,disease,B-Condition
47537,3217,",",O
47538,3217,infection,B-Condition
47539,3217,or,O
47540,3217,prior,O
47541,3217,implantation,B-Procedure
47542,3217,which,O
47543,3217,can,O
47544,3217,not,O
47545,3217,provide,O
47546,3217,adequate,B-Observation
47547,3217,support,I-Observation
47548,3217,and/or,O
47549,3217,fixation,B-Procedure
47550,3217,to,I-Procedure
47551,3217,the,I-Procedure
47552,3217,devices,I-Procedure
47553,3217,.,O
47554,3218,Subject,O
47555,3218,has,O
47556,3218,bone,B-Condition
47557,3218,abnormalities,I-Condition
47558,3218,preventing,O
47559,3218,safe,O
47560,3218,screw,B-Procedure
47561,3218,fixation,I-Procedure
47562,3218,.,O
47563,3219,Subject,O
47564,3219,has,O
47565,3219,any,O
47566,3219,open,B-Condition
47567,3219,wounds,I-Condition
47568,3219,.,O
47569,3220,Subject,O
47570,3220,has,O
47571,3220,rapid,B-Condition
47572,3220,joint,I-Condition
47573,3220,disease,I-Condition
47574,3220,",",O
47575,3220,bone,B-Condition
47576,3220,absorption,I-Condition
47577,3220,",",O
47578,3220,osteopenia,B-Condition
47579,3220,",",O
47580,3220,osteomalacia,B-Condition
47581,3220,",",O
47582,3220,and/or,O
47583,3220,osteoporosis,B-Condition
47584,3220,.,O
47585,3220,Osteoporosis,B-Condition
47586,3220,or,O
47587,3220,osteopenia,B-Condition
47588,3220,are,O
47589,3220,relative,O
47590,3220,contraindications,B-Condition
47591,3220,",",O
47592,3220,since,O
47593,3220,this,O
47594,3220,condition,O
47595,3220,may,O
47596,3220,limit,O
47597,3220,the,O
47598,3220,degree,O
47599,3220,of,O
47600,3220,obtainable,O
47601,3220,correction,O
47602,3220,and/or,O
47603,3220,the,O
47604,3220,amount,O
47605,3220,of,O
47606,3220,mechanical,O
47607,3220,fixation,O
47608,3220,.,O
47609,3221,Subject,O
47610,3221,has,O
47611,3221,a,O
47612,3221,documented,B-Mood
47613,3221,or,O
47614,3221,suspected,B-Mood
47615,3221,metal,O
47616,3221,sensitivity,B-Condition
47617,3221,.,O
47618,3222,Subject,O
47619,3222,is,O
47620,3222,pregnant,B-Condition
47621,3222,.,O
47622,3223,Subject,O
47623,3223,has,O
47624,3223,anatomical,B-Observation
47625,3223,structures,I-Observation
47626,3223,or,O
47627,3223,physiological,B-Observation
47628,3223,performance,I-Observation
47629,3223,that,O
47630,3223,would,O
47631,3223,interfere,B-Observation
47632,3223,with,I-Observation
47633,3223,implant,I-Observation
47634,3223,utilization,I-Observation
47635,3223,.,O
47636,3224,Subject,O
47637,3224,has,O
47638,3224,inadequate,B-Condition
47639,3224,tissue,I-Condition
47640,3224,coverage,I-Condition
47641,3224,over,O
47642,3224,the,O
47643,3224,operative,O
47644,3224,site,O
47645,3224,.,O
47646,3225,Subject,O
47647,3225,has,O
47648,3225,other,O
47649,3225,medical,B-Condition
47650,3225,or,I-Condition
47651,3225,surgical,I-Condition
47652,3225,conditions,I-Condition
47653,3225,which,O
47654,3225,would,O
47655,3225,preclude,O
47656,3225,the,O
47657,3225,potential,O
47658,3225,benefit,O
47659,3225,of,O
47660,3225,surgery,B-Procedure
47661,3225,",",O
47662,3225,such,O
47663,3225,as,O
47664,3225,congenital,B-Condition
47665,3225,abnormalities,I-Condition
47666,3225,",",O
47667,3225,immunosuppressive,B-Condition
47668,3225,disease,I-Condition
47669,3225,",",O
47670,3225,elevation,O
47671,3225,of,O
47672,3225,sedimentation,O
47673,3225,rate,O
47674,3225,unexplained,O
47675,3225,by,O
47676,3225,other,O
47677,3225,diseases,O
47678,3225,",",O
47679,3225,elevation,O
47680,3225,of,O
47681,3225,white,O
47682,3225,blood,O
47683,3225,count,O
47684,3225,(,O
47685,3225,WBC,O
47686,3225,),O
47687,3225,",",O
47688,3225,or,O
47689,3225,marked,O
47690,3225,left,O
47691,3225,shift,O
47692,3225,in,O
47693,3225,the,O
47694,3225,WBC,O
47695,3225,differential,O
47696,3225,count,O
47697,3225,.,O
47698,3226,Note,O
47699,3226,:,O
47700,3226,The,O
47701,3226,Aviator,O
47702,3226,Anterior,O
47703,3226,Cervical,O
47704,3226,Plating,O
47705,3226,System,O
47706,3226,is,O
47707,3226,not,O
47708,3226,approved,O
47709,3226,or,O
47710,3226,intended,O
47711,3226,for,O
47712,3226,screw,O
47713,3226,attachment,O
47714,3226,to,O
47715,3226,the,O
47716,3226,posterior,O
47717,3226,elements,O
47718,3226,(,O
47719,3226,pedicles,O
47720,3226,),O
47721,3226,of,O
47722,3226,the,O
47723,3226,cervical,O
47724,3226,",",O
47725,3226,thoracic,O
47726,3226,",",O
47727,3226,or,O
47728,3226,lumbar,O
47729,3226,spine,O
47730,3226,.,O
47731,3226,The,O
47732,3226,surgeon,O
47733,3226,must,O
47734,3226,consider,O
47735,3226,the,O
47736,3226,levels,O
47737,3226,of,O
47738,3226,implantation,O
47739,3226,",",O
47740,3226,patient,O
47741,3226,weight,O
47742,3226,",",O
47743,3226,patient,O
47744,3226,activity,O
47745,3226,level,O
47746,3226,",",O
47747,3226,and,O
47748,3226,other,O
47749,3226,patient,O
47750,3226,conditions,O
47751,3226,which,O
47752,3226,may,O
47753,3226,impact,O
47754,3226,on,O
47755,3226,the,O
47756,3226,performance,O
47757,3226,of,O
47758,3226,the,O
47759,3226,system,O
47760,3226,.,O
47761,3227,Subject,O
47762,3227,has,O
47763,3227,documented,O
47764,3227,typical,O
47765,3227,atrial,B-Condition
47766,3227,flutter,I-Condition
47767,3227,.,O
47768,3228,Subject,O
47769,3228,has,O
47770,3228,any,O
47771,3228,history,O
47772,3228,of,O
47773,3228,successful,O
47774,3228,or,O
47775,3228,unsuccessful,O
47776,3228,treatment,O
47777,3228,of,O
47778,3228,AF,B-Condition
47779,3228,with,O
47780,3228,class,O
47781,3228,I,O
47782,3228,or,O
47783,3228,III,O
47784,3228,antiarrhythmic,B-Drug
47785,3228,or,O
47786,3228,sotalol,B-Drug
47787,3228,with,O
47788,3228,the,O
47789,3228,intention,O
47790,3228,to,O
47791,3228,prevent,O
47792,3228,an,O
47793,3228,AF,O
47794,3228,recurrence,O
47795,3228,.,O
47796,3228,Patients,O
47797,3228,pretreated,O
47798,3228,with,O
47799,3228,above,O
47800,3228,AAD,O
47801,3228,at,O
47802,3228,maximum,O
47803,3228,48,O
47804,3228,hours,O
47805,3228,with,O
47806,3228,the,O
47807,3228,intention,O
47808,3228,to,O
47809,3228,convert,O
47810,3228,an,O
47811,3228,AF,O
47812,3228,episode,O
47813,3228,are,O
47814,3228,allowed,O
47815,3228,.,O
47816,3229,Subject,O
47817,3229,had,O
47818,3229,any,O
47819,3229,previous,O
47820,3229,left,O
47821,3229,atrial,B-Procedure
47822,3229,ablation,I-Procedure
47823,3229,.,O
47824,3230,Subject,O
47825,3230,had,O
47826,3230,any,O
47827,3230,previous,O
47828,3230,cardiac,B-Procedure
47829,3230,surgery,I-Procedure
47830,3230,",",O
47831,3230,e.g.,O
47832,3230,prosthetic,O
47833,3230,valves,O
47834,3230,.,O
47835,3231,Subject,O
47836,3231,has,O
47837,3231,permanent,O
47838,3231,pacemaker,O
47839,3231,or,O
47840,3231,defibrillator,O
47841,3231,implant,O
47842,3231,.,O
47843,3232,Subject,O
47844,3232,has,O
47845,3232,2,B-Condition
47846,3232,°,I-Condition
47847,3232,type,I-Condition
47848,3232,II,I-Condition
47849,3232,",",I-Condition
47850,3232,3,I-Condition
47851,3232,°,I-Condition
47852,3232,degree,I-Condition
47853,3232,AV,I-Condition
47854,3232,-,I-Condition
47855,3232,block,I-Condition
47856,3232,or,O
47857,3232,left,B-Condition
47858,3232,/,I-Condition
47859,3232,right,I-Condition
47860,3232,bundle,I-Condition
47861,3232,branch,I-Condition
47862,3232,block,I-Condition
47863,3232,pattern,O
47864,3232,.,O
47865,3233,Subject,O
47866,3233,has,O
47867,3233,unstable,B-Condition
47868,3233,angina,I-Condition
47869,3233,pectoris,I-Condition
47870,3233,.,O
47871,3234,Subject,O
47872,3234,has,O
47873,3234,history,O
47874,3234,of,O
47875,3234,previous,O
47876,3234,myocardial,B-Condition
47877,3234,infarction,I-Condition
47878,3234,or,O
47879,3234,percutaneous,B-Procedure
47880,3234,intervention,I-Procedure
47881,3234,during,O
47882,3234,the,O
47883,3234,last,O
47884,3234,three,O
47885,3234,months,O
47886,3234,.,O
47887,3235,Subject,O
47888,3235,has,O
47889,3235,symptomatic,O
47890,3235,carotid,B-Condition
47891,3235,stenosis,I-Condition
47892,3235,.,O
47893,3236,Subject,O
47894,3236,has,O
47895,3236,chronic,B-Condition
47896,3236,obstructive,I-Condition
47897,3236,pulmonary,I-Condition
47898,3236,disease,I-Condition
47899,3236,with,O
47900,3236,detected,O
47901,3236,pulmonary,B-Condition
47902,3236,hypertension,I-Condition
47903,3236,or,O
47904,3236,any,O
47905,3236,other,O
47906,3236,evidence,O
47907,3236,of,O
47908,3236,significant,O
47909,3236,lung,B-Condition
47910,3236,disease,I-Condition
47911,3236,.,O
47912,3237,Subject,O
47913,3237,has,O
47914,3237,any,O
47915,3237,contraindication,B-Condition
47916,3237,for,O
47917,3237,oral,B-Drug
47918,3237,anticoagulation,I-Drug
47919,3237,.,O
47920,3238,Subject,O
47921,3238,has,O
47922,3238,any,O
47923,3238,history,O
47924,3238,of,O
47925,3238,previous,O
47926,3238,transient,B-Condition
47927,3238,ischemic,I-Condition
47928,3238,attack,I-Condition
47929,3238,or,O
47930,3238,stroke,B-Condition
47931,3238,.,O
47932,3239,Subject,O
47933,3239,has,O
47934,3239,known,O
47935,3239,intra,B-Condition
47936,3239,-,I-Condition
47937,3239,cardiac,I-Condition
47938,3239,thrombus,I-Condition
47939,3239,formation,O
47940,3239,.,O
47941,3240,Subject,O
47942,3240,has,O
47943,3240,any,O
47944,3240,significant,O
47945,3240,congenital,B-Condition
47946,3240,heart,I-Condition
47947,3240,defect,I-Condition
47948,3240,corrected,O
47949,3240,or,O
47950,3240,not,O
47951,3240,(,O
47952,3240,except,O
47953,3240,for,O
47954,3240,patent,B-Condition
47955,3240,foramen,I-Condition
47956,3240,ovale,I-Condition
47957,3240,that,O
47958,3240,is,O
47959,3240,allowed,O
47960,3240,),O
47961,3240,.,O
47962,3241,Subject,O
47963,3241,has,O
47964,3241,evidence,O
47965,3241,of,O
47966,3241,congestive,B-Condition
47967,3241,heart,I-Condition
47968,3241,failure,I-Condition
47969,3241,(,O
47970,3241,NYHA,O
47971,3241,class,O
47972,3241,II,O
47973,3241,",",O
47974,3241,III,O
47975,3241,or,O
47976,3241,IV,O
47977,3241,),O
47978,3241,in,O
47979,3241,sinus,B-Condition
47980,3241,rhythm,I-Condition
47981,3241,.,O
47982,3242,Subject,O
47983,3242,has,O
47984,3242,hypertrophic,B-Condition
47985,3242,cardiomyopathy,I-Condition
47986,3242,.,O
47987,3243,Subject,O
47988,3243,has,O
47989,3243,abnormal,O
47990,3243,long,O
47991,3243,or,O
47992,3243,short,O
47993,3243,QT,O
47994,3243,interval,O
47995,3243,",",O
47996,3243,signs,O
47997,3243,of,O
47998,3243,Brugada,B-Condition
47999,3243,syndrome,I-Condition
48000,3243,",",O
48001,3243,known,O
48002,3243,inheriting,B-Observation
48003,3243,ion,I-Observation
48004,3243,channel,I-Observation
48005,3243,disease,I-Observation
48006,3243,on,I-Observation
48007,3243,the,I-Observation
48008,3243,family,I-Observation
48009,3243,",",O
48010,3243,arrhythmogenic,O
48011,3243,right,B-Condition
48012,3243,ventricular,I-Condition
48013,3243,dysplasia,I-Condition
48014,3243,.,O
48015,3244,Subject,O
48016,3244,has,O
48017,3244,sarcoidosis,B-Condition
48018,3244,.,O
48019,3245,Subject,O
48020,3245,has,O
48021,3245,pulmonary,O
48022,3245,vein,O
48023,3245,stent,O
48024,3245,.,O
48025,3246,Subject,O
48026,3246,has,O
48027,3246,myxoma,B-Condition
48028,3246,.,O
48029,3246,Exclusion,O
48030,3246,criteria,O
48031,3246,based,O
48032,3246,on,O
48033,3246,laboratory,O
48034,3246,abnormalities,O
48035,3247,Subject,O
48036,3247,has,O
48037,3247,thrombocytosis,B-Condition
48038,3247,(,O
48039,3247,platelet,O
48040,3247,count,O
48041,3247,>,O
48042,3247,"600,000",O
48043,3247,/,O
48044,3247,µl,O
48045,3247,),O
48046,3247,or,O
48047,3247,thrombocytopenia,B-Condition
48048,3247,(,O
48049,3247,platelet,O
48050,3247,count,O
48051,3247,<,O
48052,3247,"100,000",O
48053,3247,/,O
48054,3247,µl,O
48055,3247,),O
48056,3247,.,O
48057,3248,Subject,O
48058,3248,has,O
48059,3248,any,O
48060,3248,untreated,O
48061,3248,or,O
48062,3248,uncontrolled,O
48063,3248,hyperthyroidism,B-Condition
48064,3248,or,O
48065,3248,hypothyroidism,B-Condition
48066,3248,.,O
48067,3249,Subject,O
48068,3249,has,O
48069,3249,renal,B-Condition
48070,3249,dysfunction,I-Condition
48071,3249,with,O
48072,3249,glomerular,O
48073,3249,filtration,O
48074,3249,rate,O
48075,3249,<,O
48076,3249,60,O
48077,3249,ml,O
48078,3249,/,O
48079,3249,min,O
48080,3249,.,O
48081,3250,Subject,O
48082,3250,has,O
48083,3250,known,O
48084,3250,cryoglobulinaemia,B-Condition
48085,3250,.,O
48086,3250,General,O
48087,3250,exclusion,O
48088,3250,criteria,O
48089,3251,Subject,O
48090,3251,has,O
48091,3251,a,O
48092,3251,reversible,O
48093,3251,causes,O
48094,3251,for,O
48095,3251,AF,O
48096,3251,like,O
48097,3251,hyperthyroidism,B-Condition
48098,3251,and,O
48099,3251,alcoholism,B-Condition
48100,3251,.,O
48101,3252,Subject,O
48102,3252,is,O
48103,3252,a,O
48104,3252,pregnant,O
48105,3252,woman,O
48106,3252,or,O
48107,3252,woman,O
48108,3252,of,O
48109,3252,childbearing,O
48110,3252,potential,O
48111,3252,not,O
48112,3252,on,O
48113,3252,adequate,O
48114,3252,birth,O
48115,3252,control,O
48116,3252,:,O
48117,3252,only,O
48118,3252,woman,O
48119,3252,with,O
48120,3252,a,O
48121,3252,highly,O
48122,3252,effective,O
48123,3252,method,O
48124,3252,of,O
48125,3252,contraception,O
48126,3252,[,O
48127,3252,oral,O
48128,3252,contraception,O
48129,3252,or,O
48130,3252,intra,O
48131,3252,-,O
48132,3252,uterine,O
48133,3252,device,O
48134,3252,],O
48135,3252,(,O
48136,3252,who,O
48137,3252,must,O
48138,3252,have,O
48139,3252,a,O
48140,3252,negative,O
48141,3252,pregnancy,O
48142,3252,test,O
48143,3252,within,O
48144,3252,1,O
48145,3252,week,O
48146,3252,of,O
48147,3252,the,O
48148,3252,start,O
48149,3252,of,O
48150,3252,the,O
48151,3252,therapy,O
48152,3252,),O
48153,3252,or,O
48154,3252,sterile,O
48155,3252,woman,O
48156,3252,can,O
48157,3252,be,O
48158,3252,enrolled,O
48159,3252,.,O
48160,3253,Subject,O
48161,3253,is,O
48162,3253,a,O
48163,3253,breastfeeding,O
48164,3253,woman,O
48165,3253,.,O
48166,3254,Subject,O
48167,3254,has,O
48168,3254,an,O
48169,3254,active,O
48170,3254,systemic,B-Condition
48171,3254,infection,I-Condition
48172,3254,.,O
48173,3255,Subject,O
48174,3255,is,O
48175,3255,employed,O
48176,3255,by,O
48177,3255,Medtronic,O
48178,3255,or,O
48179,3255,by,O
48180,3255,the,O
48181,3255,department,O
48182,3255,of,O
48183,3255,any,O
48184,3255,of,O
48185,3255,the,O
48186,3255,investigators,O
48187,3255,or,O
48188,3255,is,O
48189,3255,a,O
48190,3255,close,O
48191,3255,relative,O
48192,3255,of,O
48193,3255,any,O
48194,3255,of,O
48195,3255,the,O
48196,3255,investigators,O
48197,3255,.,O
48198,3256,Subject,O
48199,3256,is,O
48200,3256,unwilling,O
48201,3256,or,O
48202,3256,unable,O
48203,3256,to,O
48204,3256,comply,O
48205,3256,fully,O
48206,3256,with,O
48207,3256,study,O
48208,3256,procedures,O
48209,3256,and,O
48210,3256,follow,O
48211,3256,-,O
48212,3256,up,O
48213,3256,due,O
48214,3256,to,O
48215,3256,any,O
48216,3256,disease,O
48217,3256,condition,O
48218,3256,",",O
48219,3256,which,O
48220,3256,can,O
48221,3256,raise,O
48222,3256,doubt,O
48223,3256,about,O
48224,3256,compliance,O
48225,3256,and,O
48226,3256,influencing,O
48227,3256,the,O
48228,3256,study,O
48229,3256,outcome,O
48230,3256,especially,O
48231,3256,any,O
48232,3256,kind,O
48233,3256,of,O
48234,3256,cancer,O
48235,3256,",",O
48236,3256,severe,O
48237,3256,bleeding,O
48238,3256,in,O
48239,3256,history,O
48240,3256,or,O
48241,3256,a,O
48242,3256,suspected,O
48243,3256,pro,O
48244,3256,-,O
48245,3256,coagulant,O
48246,3256,state,O
48247,3256,.,O
48248,3257,Legal,O
48249,3257,incapacity,O
48250,3257,or,O
48251,3257,evidence,O
48252,3257,that,O
48253,3257,a,O
48254,3257,subject,O
48255,3257,can,O
48256,3257,not,O
48257,3257,understand,O
48258,3257,the,O
48259,3257,purpose,O
48260,3257,and,O
48261,3257,risks,O
48262,3257,of,O
48263,3257,the,O
48264,3257,study,O
48265,3257,or,O
48266,3257,inability,O
48267,3257,to,O
48268,3257,comply,O
48269,3257,fully,O
48270,3257,with,O
48271,3257,study,O
48272,3257,procedures,O
48273,3257,and,O
48274,3257,follow,O
48275,3257,up,O
48276,3257,.,O
48277,3258,Subject,O
48278,3258,has,O
48279,3258,a,O
48280,3258,life,B-Observation
48281,3258,expectancy,I-Observation
48282,3258,of,O
48283,3258,=,O
48284,3258,1,O
48285,3258,year,O
48286,3258,.,O
48287,3259,Subject,O
48288,3259,is,O
48289,3259,currently,O
48290,3259,enrolled,O
48291,3259,or,O
48292,3259,planning,O
48293,3259,to,O
48294,3259,participate,O
48295,3259,in,O
48296,3259,a,O
48297,3259,potentially,O
48298,3259,confounding,O
48299,3259,drug,O
48300,3259,or,O
48301,3259,device,O
48302,3259,trial,O
48303,3259,during,O
48304,3259,the,O
48305,3259,course,O
48306,3259,of,O
48307,3259,this,O
48308,3259,study,O
48309,3259,.,O
48310,3259,Co,O
48311,3259,-,O
48312,3259,enrollment,O
48313,3259,in,O
48314,3259,concurrent,O
48315,3259,trials,O
48316,3259,is,O
48317,3259,only,O
48318,3259,allowed,O
48319,3259,when,O
48320,3259,documented,O
48321,3259,pre,O
48322,3259,-,O
48323,3259,approval,O
48324,3259,is,O
48325,3259,obtained,O
48326,3259,from,O
48327,3259,the,O
48328,3259,Medtronic,O
48329,3259,study,O
48330,3259,manager,O
48331,3259,.,O
48332,3260,Subject,O
48333,3260,has,O
48334,3260,been,O
48335,3260,diagnosed,O
48336,3260,with,O
48337,3260,symptomatic,O
48338,3260,paroxysmal,B-Condition
48339,3260,atrial,I-Condition
48340,3260,fibrillation,I-Condition
48341,3260,as,O
48342,3260,defined,O
48343,3260,above,O
48344,3260,and,O
48345,3260,at,O
48346,3260,least,O
48347,3260,two,O
48348,3260,symptomatic,O
48349,3260,episodes,B-Condition
48350,3260,in,O
48351,3260,the,O
48352,3260,last,O
48353,3260,six,O
48354,3260,months,O
48355,3260,prior,O
48356,3260,to,O
48357,3260,inclusion,O
48358,3260,.,O
48359,3261,At,O
48360,3261,least,O
48361,3261,one,O
48362,3261,episode,B-Condition
48363,3261,of,O
48364,3261,AF,B-Condition
48365,3261,must,O
48366,3261,be,O
48367,3261,documented,O
48368,3261,during,O
48369,3261,the,O
48370,3261,prior,O
48371,3261,year,O
48372,3261,by,O
48373,3261,any,O
48374,3261,kind,O
48375,3261,of,O
48376,3261,ECG,O
48377,3261,recording,O
48378,3261,.,O
48379,3262,Subject,O
48380,3262,has,O
48381,3262,structural,O
48382,3262,normal,O
48383,3262,heart,B-Condition
48384,3262,with,O
48385,3262,an,O
48386,3262,LVEF,O
48387,3262,=,O
48388,3262,50,O
48389,3262,%,O
48390,3262,",",O
48391,3262,thickness,O
48392,3262,of,O
48393,3262,the,O
48394,3262,inter,O
48395,3262,-,O
48396,3262,ventricular,O
48397,3262,septum,O
48398,3262,=,O
48399,3262,12,O
48400,3262,mm,O
48401,3262,and,O
48402,3262,left,O
48403,3262,atrium,O
48404,3262,diameters,O
48405,3262,(,O
48406,3262,short,O
48407,3262,axis,O
48408,3262,),O
48409,3262,<,O
48410,3262,46,O
48411,3262,mm,O
48412,3262,obtained,O
48413,3262,by,O
48414,3262,transthoracic,B-Procedure
48415,3262,echocardiography,I-Procedure
48416,3262,.,O
48417,3263,Subject,O
48418,3263,has,O
48419,3263,normal,O
48420,3263,ECG,B-Procedure
48421,3263,parameters,O
48422,3263,(,O
48423,3263,QRS,O
48424,3263,width,O
48425,3263,in,O
48426,3263,the,O
48427,3263,12,O
48428,3263,channel,O
48429,3263,surface,O
48430,3263,ECG,O
48431,3263,=,O
48432,3263,120,O
48433,3263,ms,O
48434,3263,",",O
48435,3263,QTc,O
48436,3263,-,O
48437,3263,interval,O
48438,3263,<,O
48439,3263,440,O
48440,3263,ms,O
48441,3263,",",O
48442,3263,PQ,O
48443,3263,-,O
48444,3263,interval,O
48445,3263,=,O
48446,3263,210,O
48447,3263,ms,O
48448,3263,;,O
48449,3263,all,O
48450,3263,parameters,O
48451,3263,should,O
48452,3263,be,O
48453,3263,measured,O
48454,3263,at,O
48455,3263,sinus,B-Condition
48456,3263,rhythm,I-Condition
48457,3263,),O
48458,3263,.,O
48459,3264,Subject,O
48460,3264,is,O
48461,3264,at,O
48462,3264,least,O
48463,3264,18,O
48464,3264,and,O
48465,3264,not,O
48466,3264,older,O
48467,3264,than,O
48468,3264,75years,O
48469,3264,old,B-Person
48470,3264,.,O
48471,3265,Subject,O
48472,3265,is,O
48473,3265,able,O
48474,3265,and,O
48475,3265,willing,O
48476,3265,to,O
48477,3265,give,O
48478,3265,informed,O
48479,3265,consent,O
48480,3265,.,O
48481,3266,NA,O
48482,3267,Informed,O
48483,3267,consent,O
48484,3267,must,O
48485,3267,be,O
48486,3267,obtained,O
48487,3267,prior,O
48488,3267,to,O
48489,3267,any,O
48490,3267,study,O
48491,3267,procedure,O
48492,3267,.,O
48493,3268,Age>18,B-Person
48494,3268,years,O
48495,3268,.,O
48496,3269,Subjects,O
48497,3269,of,O
48498,3269,STEMI,B-Condition
48499,3269,who,O
48500,3269,underwent,O
48501,3269,primary,B-Procedure
48502,3269,PCI,I-Procedure
48503,3269,within,O
48504,3269,the,O
48505,3269,first,O
48506,3269,12,O
48507,3269,hours,O
48508,3269,.,O
48509,3270,Cholesterol,B-Drug
48510,3270,-,I-Drug
48511,3270,lowering,I-Drug
48512,3270,drugs,I-Drug
48513,3271,Diabetes,B-Condition
48514,3271,Mellitus,I-Condition
48515,3272,Cardiovascular,B-Condition
48516,3272,disease,I-Condition
48517,3272,such,O
48518,3272,as,O
48519,3272,arrythmia,B-Condition
48520,3272,",",O
48521,3272,ischaemic,B-Condition
48522,3272,heart,I-Condition
48523,3272,disease,I-Condition
48524,3272,.,O
48525,3273,Musculoskeletal,B-Condition
48526,3273,disorders,I-Condition
48527,3273,preventing,O
48528,3273,the,O
48529,3273,subject,O
48530,3273,to,O
48531,3273,perform,O
48532,3273,physical,O
48533,3273,training,O
48534,3274,Mental,B-Condition
48535,3274,disorders,I-Condition
48536,3274,preventing,O
48537,3274,the,O
48538,3274,subject,O
48539,3274,to,O
48540,3274,understand,O
48541,3274,the,O
48542,3274,project,O
48543,3274,description,O
48544,3274,.,O
48545,3275,Elevated,O
48546,3275,blood,O
48547,3275,-,O
48548,3275,cholesterol,O
48549,3276,Type,B-Condition
48550,3276,1,I-Condition
48551,3276,diabetes,I-Condition
48552,3276,mellitus,I-Condition
48553,3276,",",O
48554,3276,presence,O
48555,3276,of,O
48556,3276,autoimmune,B-Condition
48557,3276,diabetes,I-Condition
48558,3276,indicated,O
48559,3276,by,O
48560,3276,antibodies,B-Condition
48561,3276,to,O
48562,3276,insulin,O
48563,3276,",",O
48564,3276,islet,O
48565,3276,cells,O
48566,3276,",",O
48567,3276,and,O
48568,3276,GAD,O
48569,3276,;,O
48570,3277,Gestational,B-Condition
48571,3277,diabetes,I-Condition
48572,3277,;,O
48573,3278,patients,O
48574,3278,with,O
48575,3278,heart,B-Condition
48576,3278,",",I-Condition
48577,3278,liver,I-Condition
48578,3278,",",I-Condition
48579,3278,or,I-Condition
48580,3278,renal,I-Condition
48581,3278,function,I-Condition
48582,3278,impairment;presence,I-Condition
48583,3278,of,O
48584,3278,severe,O
48585,3278,infections,B-Condition
48586,3278,or,O
48587,3278,cerebrovascular,B-Condition
48588,3278,disease,I-Condition
48589,3278,;,O
48590,3279,Newly,O
48591,3279,dignosised,O
48592,3279,type,B-Condition
48593,3279,2,I-Condition
48594,3279,diabetes,I-Condition
48595,3279,according,O
48596,3279,to,O
48597,3279,WHO,O
48598,3279,criteria.glycated,O
48599,3279,hemoglobin,O
48600,3279,(,O
48601,3279,HbA1c,O
48602,3279,),O
48603,3279,was,O
48604,3279,more,O
48605,3279,than,O
48606,3279,10,O
48607,3279,%,O
48608,3279,;,O
48609,3280,Seronegative,O
48610,3280,for,O
48611,3280,antibodies,B-Condition
48612,3280,against,O
48613,3280,insulin,O
48614,3280,",",O
48615,3280,islet,O
48616,3280,cells,O
48617,3280,and,O
48618,3280,glutamic,O
48619,3280,acid,O
48620,3280,decarboxylase,O
48621,3280,(,O
48622,3280,GAD,O
48623,3280,),O
48624,3280,;,O
48625,3281,Regular,B-Observation
48626,3281,cigarette,I-Observation
48627,3281,smoker,I-Observation
48628,3282,Alcohol,B-Observation
48629,3282,abuse,I-Observation
48630,3283,Drug,B-Observation
48631,3283,abuse,I-Observation
48632,3284,History,O
48633,3284,of,O
48634,3284,falls,B-Condition
48635,3284,or,O
48636,3284,dizziness,B-Condition
48637,3284,at,O
48638,3284,exit,O
48639,3284,from,O
48640,3284,bed,O
48641,3284,in,O
48642,3284,the,O
48643,3284,morning,O
48644,3284,(,O
48645,3284,at,O
48646,3284,least,O
48647,3284,two,O
48648,3284,incidents,B-Condition
48649,3284,in,O
48650,3284,the,O
48651,3284,past,O
48652,3284,year,O
48653,3284,),O
48654,3285,At,O
48655,3285,least,O
48656,3285,20/200,O
48657,3285,corrected,O
48658,3285,visual,O
48659,3285,acuity,O
48660,3286,Stable,B-Condition
48661,3286,health,I-Condition
48662,3287,Normal,B-Condition
48663,3287,hearing,I-Condition
48664,3288,Chronic,B-Condition
48665,3288,HCV,I-Condition
48666,3288,Infection,I-Condition
48667,3288,with,O
48668,3288,Genotype,O
48669,3288,2,O
48670,3288,or,O
48671,3288,3,O
48672,3289,Amiodarone,B-Drug
48673,3289,.,O
48674,3289,Subjects,O
48675,3289,previously,O
48676,3289,treated,O
48677,3289,with,O
48678,3289,amiodarone,O
48679,3289,must,O
48680,3289,have,O
48681,3289,stopped,O
48682,3289,the,O
48683,3289,amiodarone,O
48684,3289,at,O
48685,3289,least,O
48686,3289,60,O
48687,3289,days,O
48688,3289,prior,O
48689,3289,to,O
48690,3289,day,O
48691,3289,1,O
48692,3289,of,O
48693,3289,SOF,O
48694,3289,/,O
48695,3289,LDV,O
48696,3289,FDC,O
48697,3290,Carbamazepine,B-Drug
48698,3290,",",O
48699,3290,phenytoin,B-Drug
48700,3290,",",O
48701,3290,phenobarbital,B-Drug
48702,3290,",",O
48703,3290,oxcarbazepine,B-Drug
48704,3291,Rifabutin,B-Drug
48705,3291,",",O
48706,3291,rifampin,B-Drug
48707,3291,or,O
48708,3291,rifapentine,B-Drug
48709,3292,HIV,O
48710,3292,regimens,O
48711,3292,containing,O
48712,3292,tenofovir,B-Drug
48713,3292,or,O
48714,3292,tipranavir,B-Drug
48715,3292,/,I-Drug
48716,3292,ritonavir,I-Drug
48717,3293,St.,B-Condition
48718,3293,John,I-Condition
48719,3293,'s,I-Condition
48720,3293,wort,I-Condition
48721,3294,Rosuvastatin,B-Drug
48722,3295,Have,O
48723,3295,any,O
48724,3295,serious,O
48725,3295,or,O
48726,3295,active,O
48727,3295,medical,O
48728,3295,or,O
48729,3295,psychiatric,O
48730,3295,illness,O
48731,3295,which,O
48732,3295,",",O
48733,3295,in,O
48734,3295,the,O
48735,3295,opinion,O
48736,3295,of,O
48737,3295,the,O
48738,3295,investigator,O
48739,3295,",",O
48740,3295,would,O
48741,3295,interfere,O
48742,3295,with,O
48743,3295,subject,O
48744,3295,treatment,O
48745,3295,",",O
48746,3295,assessment,O
48747,3295,",",O
48748,3295,or,O
48749,3295,compliance,O
48750,3296,History,O
48751,3296,of,O
48752,3296,hepatic,B-Condition
48753,3296,encephalopathy,I-Condition
48754,3296,or,O
48755,3296,variceal,B-Condition
48756,3296,hemorrhage,I-Condition
48757,3297,Hepatitis,O
48758,3297,B,O
48759,3297,surface,O
48760,3297,antigen,O
48761,3297,positive,O
48762,3298,Hemoglobin,O
48763,3298,(,O
48764,3298,Hb,O
48765,3298,),O
48766,3298,<,O
48767,3298,8,O
48768,3298,g,O
48769,3298,/,O
48770,3298,dL,O
48771,3299,Platelets,O
48772,3299,=,O
48773,3299,"50,000",O
48774,3299,/,O
48775,3299,mm3,O
48776,3300,alanine,O
48777,3300,aminotransferase,O
48778,3300,(,O
48779,3300,ALT,O
48780,3300,),O
48781,3300,",",O
48782,3300,aspartase,O
48783,3300,aminotransferase,O
48784,3300,(,O
48785,3300,AST,O
48786,3300,),O
48787,3300,",",O
48788,3300,or,O
48789,3300,alkaline,O
48790,3300,phosphatase,O
48791,3300,=,O
48792,3300,10,O
48793,3300,times,O
48794,3300,upper,O
48795,3300,limit,O
48796,3300,of,O
48797,3300,normal(ULN,O
48798,3300,),O
48799,3301,Total,O
48800,3301,bilirubin,O
48801,3301,>,O
48802,3301,3,O
48803,3301,mg,O
48804,3301,/,O
48805,3301,dl,O
48806,3302,Severe,O
48807,3302,renal,B-Condition
48808,3302,impairment,I-Condition
48809,3302,creatinine,O
48810,3302,clearance,O
48811,3302,(,O
48812,3302,CrCl,O
48813,3302,),O
48814,3302,",",O
48815,3302,i.e.,O
48816,3302,<,O
48817,3302,30,O
48818,3302,mL,O
48819,3302,/,O
48820,3302,min,O
48821,3302,.,O
48822,3303,History,O
48823,3303,of,O
48824,3303,major,B-Condition
48825,3303,organ,I-Condition
48826,3303,transplantation,I-Condition
48827,3303,with,O
48828,3303,an,O
48829,3303,existing,O
48830,3303,functional,O
48831,3303,graft,O
48832,3303,.,O
48833,3304,History,O
48834,3304,of,O
48835,3304,clinically,O
48836,3304,-,O
48837,3304,significant,O
48838,3304,drug,B-Condition
48839,3304,allergy,I-Condition
48840,3304,to,O
48841,3304,nucleoside,B-Drug
48842,3304,/,O
48843,3304,nucleotide,B-Drug
48844,3304,analogs,I-Drug
48845,3304,.,O
48846,3305,Pregnant,O
48847,3305,women,O
48848,3305,or,O
48849,3305,women,O
48850,3305,planning,O
48851,3305,to,O
48852,3305,become,O
48853,3305,pregnant,O
48854,3306,Women,O
48855,3306,who,O
48856,3306,are,O
48857,3306,breastfeeding,O
48858,3307,Active,O
48859,3307,or,O
48860,3307,recent,O
48861,3307,history,O
48862,3307,(=,O
48863,3307,1,O
48864,3307,year,O
48865,3307,),O
48866,3307,of,O
48867,3307,drug,B-Observation
48868,3307,or,I-Observation
48869,3307,alcohol,I-Observation
48870,3307,abuse,I-Observation
48871,3308,Chronic,B-Condition
48872,3308,HCV,I-Condition
48873,3308,Infection,I-Condition
48874,3308,of,O
48875,3308,Genotype,O
48876,3308,1,O
48877,3308,",",O
48878,3308,4,O
48879,3308,",",O
48880,3308,5,O
48881,3308,",",O
48882,3308,or,O
48883,3308,6,O
48884,3309,HCV,O
48885,3309,RNA,O
48886,3309,>,O
48887,3309,103,O
48888,3309,IU,O
48889,3309,/,O
48890,3309,mL,O
48891,3309,at,O
48892,3309,screening,O
48893,3310,18,O
48894,3310,years,O
48895,3310,of,O
48896,3310,age,B-Person
48897,3310,or,O
48898,3310,older,O
48899,3311,Diagnosis,O
48900,3311,of,O
48901,3311,chronic,B-Condition
48902,3311,HCV,I-Condition
48903,3311,infection,I-Condition
48904,3311,",",O
48905,3311,defined,O
48906,3311,as,O
48907,3311,positive,O
48908,3311,HCV,O
48909,3311,antibody,O
48910,3311,or,O
48911,3311,HCV,O
48912,3311,RNA,O
48913,3311,more,O
48914,3311,than,O
48915,3311,6,O
48916,3311,months,O
48917,3311,prior,O
48918,3311,to,O
48919,3311,screening,O
48920,3311,OR,O
48921,3311,an,O
48922,3311,assessment,O
48923,3311,of,O
48924,3311,fibrosis,O
48925,3311,F2,O
48926,3311,or,O
48927,3311,greater,O
48928,3311,prior,O
48929,3311,to,O
48930,3311,screening,O
48931,3311,.,O
48932,3312,NYHA,O
48933,3312,Class,O
48934,3312,III,O
48935,3312,:,O
48936,3312,Subjects,O
48937,3312,with,O
48938,3312,cardiac,O
48939,3312,disease,O
48940,3312,resulting,O
48941,3312,in,O
48942,3312,marked,O
48943,3312,limitation,O
48944,3312,of,O
48945,3312,physical,O
48946,3312,activity,O
48947,3312,.,O
48948,3312,They,O
48949,3312,are,O
48950,3312,comfortable,O
48951,3312,at,O
48952,3312,rest,O
48953,3312,.,O
48954,3312,Less,O
48955,3312,than,O
48956,3312,ordinary,O
48957,3312,physical,O
48958,3312,activity,O
48959,3312,causes,O
48960,3312,fatigue,O
48961,3312,",",O
48962,3312,palpitation,O
48963,3312,",",O
48964,3312,dyspnea,O
48965,3312,",",O
48966,3312,or,O
48967,3312,anginal,O
48968,3312,pain,O
48969,3312,.,O
48970,3313,NYHA,O
48971,3313,Class,O
48972,3313,IV,O
48973,3313,:,O
48974,3313,Patient,O
48975,3313,with,O
48976,3313,cardiac,O
48977,3313,disease,O
48978,3313,resulting,O
48979,3313,in,O
48980,3313,inability,O
48981,3313,to,O
48982,3313,carry,O
48983,3313,on,O
48984,3313,any,O
48985,3313,physical,O
48986,3313,activity,O
48987,3313,without,O
48988,3313,discomfort,O
48989,3313,.,O
48990,3313,Symptoms,O
48991,3313,of,O
48992,3313,cardiac,O
48993,3313,insufficiency,O
48994,3313,or,O
48995,3313,of,O
48996,3313,the,O
48997,3313,anginal,O
48998,3313,syndrome,O
48999,3313,may,O
49000,3313,be,O
49001,3313,present,O
49002,3313,even,O
49003,3313,at,O
49004,3313,rest,O
49005,3313,.,O
49006,3313,If,O
49007,3313,any,O
49008,3313,physical,O
49009,3313,activity,O
49010,3313,is,O
49011,3313,undertaken,O
49012,3313,",",O
49013,3313,discomfort,O
49014,3313,is,O
49015,3313,increased,O
49016,3313,.,O
49017,3314,ejection,O
49018,3314,fraction,O
49019,3314,=,O
49020,3314,30,O
49021,3314,%,O
49022,3315,hospitalized,B-Observation
49023,3315,for,O
49024,3315,heart,B-Condition
49025,3315,failure,I-Condition
49026,3315,in,O
49027,3315,last,O
49028,3315,12,O
49029,3315,months,O
49030,3316,ILD,O
49031,3316,criteria,O
49032,3316,:,O
49033,3316,diagnosis,O
49034,3316,of,O
49035,3316,interstitial,B-Condition
49036,3316,lung,I-Condition
49037,3316,disease,I-Condition
49038,3316,with,O
49039,3316,chronic,B-Observation
49040,3316,supplemental,I-Observation
49041,3316,oxygen,I-Observation
49042,3316,requirement,I-Observation
49043,3316,at,O
49044,3316,rest,O
49045,3316,and/or,O
49046,3316,with,O
49047,3316,exertion,O
49048,3316,.,O
49049,3317,Forced,O
49050,3317,expiratory,O
49051,3317,volume,O
49052,3317,(,O
49053,3317,FEV1,O
49054,3317,),O
49055,3317,<,O
49056,3317,30,O
49057,3317,%,O
49058,3317,predicted,O
49059,3318,OR,O
49060,3318,any,O
49061,3318,FEV1,O
49062,3318,with,O
49063,3318,chronic,B-Observation
49064,3318,supplemental,I-Observation
49065,3318,oxygen,I-Observation
49066,3318,requirement,I-Observation
49067,3318,at,O
49068,3318,rest,O
49069,3318,and/or,O
49070,3318,with,O
49071,3318,exertion,O
49072,3319,OR,O
49073,3319,any,O
49074,3319,FEV1,O
49075,3319,with,O
49076,3319,chronic,B-Condition
49077,3319,hypercapnia,I-Condition
49078,3319,(,O
49079,3319,baseline,O
49080,3319,partial,O
49081,3319,pressure,O
49082,3319,of,O
49083,3319,arterial,O
49084,3319,carbon,O
49085,3319,dioxide,O
49086,3319,[,O
49087,3319,PaCO2,O
49088,3319,],O
49089,3319,>,O
49090,3319,45,O
49091,3319,),O
49092,3320,Women,B-Person
49093,3320,of,O
49094,3320,child,B-Condition
49095,3320,-,I-Condition
49096,3320,bearing,I-Condition
49097,3320,potential,I-Condition
49098,3320,",",O
49099,3320,who,O
49100,3320,are,O
49101,3320,biologically,B-Condition
49102,3320,able,I-Condition
49103,3320,to,I-Condition
49104,3320,conceive,I-Condition
49105,3320,",",O
49106,3320,not,O
49107,3320,employing,O
49108,3320,two,O
49109,3320,forms,O
49110,3320,of,O
49111,3320,highly,O
49112,3320,effective,O
49113,3320,contraception,O
49114,3320,or,O
49115,3320,who,O
49116,3320,are,O
49117,3320,pregnant,B-Condition
49118,3320,.,O
49119,3321,Women,B-Person
49120,3321,who,O
49121,3321,are,O
49122,3321,breast,B-Condition
49123,3321,-,I-Condition
49124,3321,feeding,I-Condition
49125,3322,Fertile,B-Condition
49126,3322,males,B-Person
49127,3322,unwilling,B-Observation
49128,3322,to,I-Observation
49129,3322,use,I-Observation
49130,3322,contraception,I-Observation
49131,3323,Patients,O
49132,3323,with,O
49133,3323,brain,B-Condition
49134,3323,metastases,I-Condition
49135,3323,or,O
49136,3323,any,O
49137,3323,history,B-Observation
49138,3323,of,O
49139,3323,brain,B-Condition
49140,3323,metastases,I-Condition
49141,3324,Patients,O
49142,3324,who,O
49143,3324,have,O
49144,3324,undergone,O
49145,3324,major,B-Procedure
49146,3324,surgery,I-Procedure
49147,3324,(,O
49148,3324,e.g.,O
49149,3324,",",O
49150,3324,intra,B-Procedure
49151,3324,-,I-Procedure
49152,3324,thoracic,I-Procedure
49153,3324,",",I-Procedure
49154,3324,-abdominal,I-Procedure
49155,3324,",",I-Procedure
49156,3324,or,I-Procedure
49157,3324,-pelvic,I-Procedure
49158,3324,),O
49159,3324,<,O
49160,3324,/=,O
49161,3324,4,O
49162,3324,weeks,O
49163,3324,prior,O
49164,3324,to,O
49165,3324,starting,O
49166,3324,study,O
49167,3324,treatment,O
49168,3324,or,O
49169,3324,who,O
49170,3324,have,O
49171,3324,not,O
49172,3324,recovered,B-Condition
49173,3324,from,I-Condition
49174,3324,such,I-Condition
49175,3324,therapy,I-Condition
49176,3325,Patients,O
49177,3325,with,O
49178,3325,a,O
49179,3325,history,B-Observation
49180,3325,of,O
49181,3325,pulmonary,B-Condition
49182,3325,embolism,I-Condition
49183,3325,",",O
49184,3325,or,O
49185,3325,untreated,O
49186,3325,deep,B-Condition
49187,3325,vein,I-Condition
49188,3325,thrombosis,I-Condition
49189,3325,within,O
49190,3325,the,O
49191,3325,past,O
49192,3325,6,O
49193,3325,months,O
49194,3326,Impairment,B-Condition
49195,3326,of,I-Condition
49196,3326,gastrointestinal,I-Condition
49197,3326,(,I-Condition
49198,3326,GI,I-Condition
49199,3326,),I-Condition
49200,3326,function,I-Condition
49201,3326,or,O
49202,3326,GI,B-Condition
49203,3326,disease,I-Condition
49204,3326,that,O
49205,3326,may,O
49206,3326,significantly,O
49207,3326,alter,O
49208,3326,the,O
49209,3326,absorption,O
49210,3326,of,O
49211,3326,dovitinib,O
49212,3327,The,O
49213,3327,subject,O
49214,3327,has,O
49215,3327,had,O
49216,3327,another,O
49217,3327,active,B-Condition
49218,3327,malignancy,I-Condition
49219,3327,within,O
49220,3327,the,O
49221,3327,past,O
49222,3327,5,O
49223,3327,years,O
49224,3327,except,O
49225,3327,for,O
49226,3327,cervical,B-Condition
49227,3327,cancer,I-Condition
49228,3327,in,I-Condition
49229,3327,situ,I-Condition
49230,3327,",",O
49231,3327,in,B-Condition
49232,3327,situ,I-Condition
49233,3327,carcinoma,I-Condition
49234,3327,of,I-Condition
49235,3327,the,I-Condition
49236,3327,bladder,I-Condition
49237,3327,or,O
49238,3327,non,B-Condition
49239,3327,-,I-Condition
49240,3327,melanoma,I-Condition
49241,3327,carcinoma,I-Condition
49242,3327,of,I-Condition
49243,3327,the,I-Condition
49244,3327,skin,I-Condition
49245,3327,.,O
49246,3328,Patients,O
49247,3328,who,O
49248,3328,have,O
49249,3328,received,O
49250,3328,the,O
49251,3328,last,O
49252,3328,administration,O
49253,3328,of,O
49254,3328,an,O
49255,3328,anticancer,B-Procedure
49256,3328,therapy,I-Procedure
49257,3328,including,O
49258,3328,chemotherapy,B-Procedure
49259,3328,",",O
49260,3328,immunotherapy,B-Procedure
49261,3328,",",O
49262,3328,hormonal,B-Procedure
49263,3328,therapy,I-Procedure
49264,3328,and,O
49265,3328,monoclonal,B-Drug
49266,3328,antibodies,I-Drug
49267,3328,<,O
49268,3328,/=,O
49269,3328,2,O
49270,3328,weeks,O
49271,3328,prior,O
49272,3328,to,O
49273,3328,starting,O
49274,3328,the,O
49275,3328,study,O
49276,3328,drug,O
49277,3328,",",O
49278,3328,or,O
49279,3328,who,O
49280,3328,have,O
49281,3328,not,O
49282,3328,recovered,B-Condition
49283,3328,from,I-Condition
49284,3328,the,I-Condition
49285,3328,side,I-Condition
49286,3328,effects,I-Condition
49287,3328,of,I-Condition
49288,3328,such,I-Condition
49289,3328,therapy,I-Condition
49290,3329,Cirrhosis,B-Condition
49291,3329,",",O
49292,3329,chronic,B-Condition
49293,3329,active,I-Condition
49294,3329,hepatitis,I-Condition
49295,3329,or,O
49296,3329,chronic,B-Condition
49297,3329,persistent,I-Condition
49298,3329,hepatitis,I-Condition
49299,3330,Patients,O
49300,3330,who,O
49301,3330,are,O
49302,3330,currently,O
49303,3330,receiving,O
49304,3330,prasugrel,B-Drug
49305,3331,No,O
49306,3331,concurrent,O
49307,3331,use,O
49308,3331,of,O
49309,3331,isoniazid,B-Drug
49310,3331,",",O
49311,3331,labetolol,B-Drug
49312,3331,",",O
49313,3331,trovafloxacin,B-Drug
49314,3331,",",O
49315,3331,tolcapone,B-Drug
49316,3331,",",O
49317,3331,and,O
49318,3331,felbamate,B-Drug
49319,3332,No,O
49320,3332,concurrent,O
49321,3332,use,O
49322,3332,of,O
49323,3332,other,B-Drug
49324,3332,investigational,I-Drug
49325,3332,drugs,I-Drug
49326,3332,or,O
49327,3332,antineoplastic,B-Procedure
49328,3332,therapies,I-Procedure
49329,3332,.,O
49330,3333,Patients,O
49331,3333,with,O
49332,3333,impaired,B-Condition
49333,3333,cardiac,I-Condition
49334,3333,function,I-Condition
49335,3333,or,O
49336,3333,clinically,O
49337,3333,significant,O
49338,3333,cardiac,B-Condition
49339,3333,diseases,I-Condition
49340,3333,.,O
49341,3334,Patients,O
49342,3334,with,O
49343,3334,a,O
49344,3334,confirmed,O
49345,3334,diagnosis,O
49346,3334,of,O
49347,3334,:,O
49348,3335,1,O
49349,3335,.,O
49350,3335,Stage,O
49351,3335,4,O
49352,3335,colon,B-Condition
49353,3335,cancer,I-Condition
49354,3335,either,O
49355,3335,s,B-Condition
49356,3335,/,I-Condition
49357,3335,p,I-Condition
49358,3335,metastasectomy,I-Condition
49359,3335,or,O
49360,3335,post,B-Condition
49361,3335,-,I-Condition
49362,3335,initial,I-Condition
49363,3335,chemotherapy,I-Condition
49364,3335,or,O
49365,3335,maintenance,B-Procedure
49366,3335,"""",I-Procedure
49367,3335,standard,I-Procedure
49368,3335,of,I-Procedure
49369,3335,care,I-Procedure
49370,3335,"""",I-Procedure
49371,3335,",",O
49372,3335,either,O
49373,3335,involving,O
49374,3335,5,B-Drug
49375,3335,-,I-Drug
49376,3335,fluorouracil,I-Drug
49377,3335,/,I-Drug
49378,3335,leucovorin,I-Drug
49379,3335,(,I-Drug
49380,3335,5,I-Drug
49381,3335,-,I-Drug
49382,3335,FU,I-Drug
49383,3335,/,I-Drug
49384,3335,LV,I-Drug
49385,3335,),I-Drug
49386,3335,alone,O
49387,3335,or,O
49388,3335,continual,O
49389,3335,bevacizumab,B-Drug
49390,3335,alone,O
49391,3335,.,O
49392,3335,Patients,O
49393,3335,in,O
49394,3335,maintenance,O
49395,3335,cohort,O
49396,3335,must,O
49397,3335,have,O
49398,3335,had,O
49399,3335,2,O
49400,3335,consecutive,O
49401,3335,CT,B-Procedure
49402,3335,scans,I-Procedure
49403,3335,showing,O
49404,3335,stable,O
49405,3335,disease,B-Condition
49406,3335,and,O
49407,3335,not,O
49408,3335,be,O
49409,3335,experiencing,O
49410,3335,significant,O
49411,3335,prior,O
49412,3335,treatment,B-Condition
49413,3335,-,I-Condition
49414,3335,related,I-Condition
49415,3335,toxicity,I-Condition
49416,3335,above,O
49417,3335,Grade,O
49418,3335,1,O
49419,3335,.,O
49420,3336,2,O
49421,3336,.,O
49422,3336,Pancreas,B-Condition
49423,3336,cancer,I-Condition
49424,3336,",",O
49425,3336,either,O
49426,3336,s,B-Condition
49427,3336,/,I-Condition
49428,3336,p,I-Condition
49429,3336,resection,I-Condition
49430,3336,and,I-Condition
49431,3336,adjuvant,I-Condition
49432,3336,chemotherapy,I-Condition
49433,3336,or,O
49434,3336,locally,O
49435,3336,advanced,O
49436,3336,pancreas,B-Condition
49437,3336,cancer,I-Condition
49438,3336,s,B-Condition
49439,3336,/,I-Condition
49440,3336,p,I-Condition
49441,3336,chemotherapy,I-Condition
49442,3336,and,I-Condition
49443,3336,radiation,I-Condition
49444,3336,.,O
49445,3336,Initial,O
49446,3336,chemotherapy,B-Procedure
49447,3336,or,O
49448,3336,radiation,B-Procedure
49449,3336,therapy,I-Procedure
49450,3336,may,B-Observation
49451,3336,have,I-Observation
49452,3336,been,I-Observation
49453,3336,stopped,I-Observation
49454,3336,between,O
49455,3336,2,O
49456,3336,weeks,O
49457,3336,and,O
49458,3336,2,O
49459,3336,months,O
49460,3336,prior,O
49461,3336,to,O
49462,3336,study,O
49463,3336,start,O
49464,3336,",",O
49465,3336,and,O
49466,3336,patients,O
49467,3336,must,O
49468,3336,have,O
49469,3336,recovered,B-Condition
49470,3336,from,I-Condition
49471,3336,prior,I-Condition
49472,3336,treatment,I-Condition
49473,3336,related,O
49474,3336,toxicity,O
49475,3336,to,O
49476,3336,grade,O
49477,3336,1,O
49478,3336,or,O
49479,3336,less,O
49480,3336,.,O
49481,3337,Prior,O
49482,3337,surgery,B-Procedure
49483,3337,",",O
49484,3337,including,O
49485,3337,tumor,B-Procedure
49486,3337,resection,I-Procedure
49487,3337,or,O
49488,3337,metastasectomy,B-Procedure
49489,3337,must,O
49490,3337,have,O
49491,3337,been,O
49492,3337,performed,O
49493,3337,at,O
49494,3337,least,O
49495,3337,4,O
49496,3337,weeks,O
49497,3337,prior,O
49498,3337,to,O
49499,3337,study,O
49500,3337,enrollment,O
49501,3337,.,O
49502,3338,No,O
49503,3338,concomitant,O
49504,3338,anti,O
49505,3338,-,O
49506,3338,cancer,O
49507,3338,treatment,O
49508,3338,is,O
49509,3338,allowed,O
49510,3339,Age,B-Person
49511,3339,>,O
49512,3339,/=,O
49513,3339,18,O
49514,3339,years,O
49515,3340,Performance,O
49516,3340,status,O
49517,3340,of,O
49518,3340,0,O
49519,3340,-,O
49520,3340,1,O
49521,3341,Adequate,O
49522,3341,hepatic,O
49523,3341,",",O
49524,3341,bone,O
49525,3341,marrow,O
49526,3341,",",O
49527,3341,and,O
49528,3341,renal,O
49529,3341,function,O
49530,3342,Partial,O
49531,3342,thromboplastin,O
49532,3342,time,O
49533,3342,(,O
49534,3342,PTT,O
49535,3342,),O
49536,3342,must,O
49537,3342,be,O
49538,3342,<,O
49539,3342,/=,O
49540,3342,1.5,O
49541,3342,x,O
49542,3342,upper,O
49543,3342,normal,O
49544,3342,limit,O
49545,3342,of,O
49546,3342,institution,O
49547,3342,'s,O
49548,3342,normal,O
49549,3342,range,O
49550,3342,and,O
49551,3342,INR,O
49552,3342,(,O
49553,3342,International,O
49554,3342,Normalized,O
49555,3342,Ratio,O
49556,3342,),O
49557,3342,<,O
49558,3342,1.5,O
49559,3342,.,O
49560,3343,Life,B-Observation
49561,3343,expectancy,I-Observation
49562,3343,>,O
49563,3343,/=,O
49564,3343,4,O
49565,3343,months,O
49566,3343,for,O
49567,3343,maintenance,B-Observation
49568,3343,cohorts,I-Observation
49569,3343,and,O
49570,3343,>,O
49571,3343,/=,O
49572,3343,6,O
49573,3343,months,O
49574,3343,for,O
49575,3343,adjuvant,B-Observation
49576,3343,cohorts,I-Observation
49577,3344,Women,B-Person
49578,3344,of,O
49579,3344,childbearing,B-Condition
49580,3344,potential,I-Condition
49581,3344,must,O
49582,3344,have,O
49583,3344,a,O
49584,3344,negative,O
49585,3344,serum,O
49586,3344,pregnancy,O
49587,3344,test,O
49588,3344,within,O
49589,3344,14,O
49590,3344,days,O
49591,3344,prior,O
49592,3344,to,O
49593,3344,initiation,O
49594,3344,of,O
49595,3344,treatment,O
49596,3344,and,O
49597,3344,must,O
49598,3344,not,O
49599,3344,be,O
49600,3344,lactating,B-Condition
49601,3344,.,O
49602,3345,Subject,O
49603,3345,is,O
49604,3345,capable,O
49605,3345,of,O
49606,3345,understanding,O
49607,3345,and,O
49608,3345,complying,O
49609,3345,with,O
49610,3345,protocol,O
49611,3345,demands,O
49612,3345,and,O
49613,3345,able,O
49614,3345,to,O
49615,3345,sign,O
49616,3345,and,O
49617,3345,date,O
49618,3345,the,O
49619,3345,informed,O
49620,3345,consent,O
49621,3346,advanced,O
49622,3346,chronic,O
49623,3346,disease,O
49624,3346,that,O
49625,3346,would,O
49626,3346,not,O
49627,3346,allow,O
49628,3346,the,O
49629,3346,patient,O
49630,3346,to,O
49631,3346,complete,O
49632,3346,the,O
49633,3346,treatment,O
49634,3346,or,O
49635,3346,follow,O
49636,3346,-,O
49637,3346,up,O
49638,3346,or,O
49639,3346,attend,O
49640,3346,visits,O
49641,3347,allergy,O
49642,3347,to,O
49643,3347,any,O
49644,3347,of,O
49645,3347,the,O
49646,3347,drugs,O
49647,3347,used,O
49648,3347,in,O
49649,3347,this,O
49650,3347,study,O
49651,3348,previous,O
49652,3348,Helicobacter,B-Procedure
49653,3348,Pylori,I-Procedure
49654,3348,eradication,I-Procedure
49655,3348,treatment,I-Procedure
49656,3349,pregnancy,O
49657,3349,or,O
49658,3349,breastfeeding,O
49659,3349,(,O
49660,3349,female,O
49661,3349,participants,O
49662,3349,with,O
49663,3349,childbearing,O
49664,3349,potential,O
49665,3349,were,O
49666,3349,required,O
49667,3349,to,O
49668,3349,use,O
49669,3349,medically,O
49670,3349,accepted,O
49671,3349,contraception,O
49672,3349,for,O
49673,3349,the,O
49674,3349,duration,O
49675,3349,of,O
49676,3349,the,O
49677,3349,study,O
49678,3349,),O
49679,3350,taking,O
49680,3350,antibiotics,B-Drug
49681,3350,or,O
49682,3350,PPIs,B-Drug
49683,3350,or,O
49684,3350,bismuth,B-Drug
49685,3350,salts,I-Drug
49686,3350,within,O
49687,3350,four,O
49688,3350,weeks,O
49689,3351,previous,O
49690,3351,gastrointestinal,B-Procedure
49691,3351,surgery,I-Procedure
49692,3352,outpatients,O
49693,3352,aged,B-Person
49694,3352,18,O
49695,3352,-,O
49696,3352,70,O
49697,3352,years,O
49698,3353,confirmed,O
49699,3353,diagnosis,O
49700,3353,of,O
49701,3353,H.,B-Condition
49702,3353,pylori,I-Condition
49703,3353,infection,I-Condition
49704,3353,by,O
49705,3353,at,O
49706,3353,least,O
49707,3353,one,O
49708,3353,of,O
49709,3353,the,O
49710,3353,following,O
49711,3353,methods,O
49712,3353,:,O
49713,3353,13C,O
49714,3353,-,O
49715,3353,urea,O
49716,3353,breath,O
49717,3353,test,O
49718,3353,",",O
49719,3353,histology,O
49720,3353,",",O
49721,3353,rapid,O
49722,3353,urease,O
49723,3353,test,O
49724,3353,or,O
49725,3353,bacterial,O
49726,3353,culture,O
49727,3354,an,O
49728,3354,intention,O
49729,3354,of,O
49730,3354,H.,O
49731,3354,pylori,O
49732,3354,eradication,O
49733,3354,treatment,O
49734,3354,and,O
49735,3354,have,O
49736,3354,written,O
49737,3354,inform,O
49738,3354,consent,O
49739,3355,ability,O
49740,3355,to,O
49741,3355,read,O
49742,3355,short,O
49743,3355,messages,O
49744,3355,on,O
49745,3355,the,O
49746,3355,mobile,O
49747,3355,phone,O
49748,3356,Person,O
49749,3356,is,O
49750,3356,under,O
49751,3356,18,O
49752,3356,years,O
49753,3356,of,O
49754,3356,age,B-Person
49755,3356,.,O
49756,3357,Person,O
49757,3357,who,O
49758,3357,weighs,B-Person
49759,3357,more,O
49760,3357,than,O
49761,3357,136,O
49762,3357,kg,O
49763,3357,.,O
49764,3358,Person,O
49765,3358,who,O
49766,3358,weighs,B-Person
49767,3358,less,O
49768,3358,than,O
49769,3358,50,O
49770,3358,kg,O
49771,3358,.,O
49772,3359,Person,O
49773,3359,who,O
49774,3359,is,O
49775,3359,pregnant,B-Condition
49776,3359,.,O
49777,3360,Person,O
49778,3360,has,O
49779,3360,a,O
49780,3360,history,O
49781,3360,of,O
49782,3360,chronic,O
49783,3360,skin,B-Condition
49784,3360,breakdown,I-Condition
49785,3360,on,O
49786,3360,the,O
49787,3360,residual,O
49788,3360,limb,O
49789,3360,.,O
49790,3361,Person,O
49791,3361,has,O
49792,3361,conditions,O
49793,3361,that,O
49794,3361,would,O
49795,3361,prevent,O
49796,3361,participation,O
49797,3361,and,O
49798,3361,pose,O
49799,3361,increased,O
49800,3361,risk,O
49801,3361,(,O
49802,3361,e.g.,O
49803,3361,unstable,O
49804,3361,cardiovascular,O
49805,3361,conditions,O
49806,3361,that,O
49807,3361,preclude,O
49808,3361,physical,O
49809,3361,activity,O
49810,3361,such,O
49811,3361,as,O
49812,3361,walking,O
49813,3361,),O
49814,3361,.,O
49815,3362,Person,O
49816,3362,falls,B-Observation
49817,3362,=,O
49818,3362,once,O
49819,3362,a,O
49820,3362,week,O
49821,3362,due,O
49822,3362,to,O
49823,3362,the,O
49824,3362,reasons,O
49825,3362,that,O
49826,3362,could,O
49827,3362,not,O
49828,3362,be,O
49829,3362,corrected,O
49830,3362,by,O
49831,3362,the,O
49832,3362,new,O
49833,3362,prosthesis,O
49834,3362,(,O
49835,3362,for,O
49836,3362,ex,O
49837,3362,.,O
49838,3362,problems,O
49839,3362,with,O
49840,3362,vestibular,O
49841,3362,system,O
49842,3362,),O
49843,3362,.,O
49844,3363,Person,O
49845,3363,is,O
49846,3363,using,O
49847,3363,under,O
49848,3363,arm,O
49849,3363,axillary,O
49850,3363,crutches,O
49851,3363,or,O
49852,3363,walker,O
49853,3363,.,O
49854,3364,Person,O
49855,3364,in,O
49856,3364,an,O
49857,3364,emergency,B-Observation
49858,3364,",",I-Observation
49859,3364,life,I-Observation
49860,3364,threatening,I-Observation
49861,3364,situation,I-Observation
49862,3364,.,O
49863,3365,Person,O
49864,3365,is,O
49865,3365,unwilling,O
49866,3365,/,O
49867,3365,unable,O
49868,3365,to,O
49869,3365,follow,O
49870,3365,instructions,O
49871,3365,.,O
49872,3366,Person,O
49873,3366,who,O
49874,3366,is,O
49875,3366,not,O
49876,3366,available,O
49877,3366,to,O
49878,3366,follow,O
49879,3366,the,O
49880,3366,entire,O
49881,3366,study,O
49882,3366,protocol,O
49883,3366,.,O
49884,3367,Person,O
49885,3367,who,O
49886,3367,is,O
49887,3367,participating,O
49888,3367,in,O
49889,3367,another,O
49890,3367,study,O
49891,3367,or,O
49892,3367,intends,O
49893,3367,to,O
49894,3367,participate,O
49895,3367,in,O
49896,3367,another,O
49897,3367,study,O
49898,3367,during,O
49899,3367,this,O
49900,3367,study,O
49901,3367,duration,O
49902,3367,.,O
49903,3368,Person,O
49904,3368,who,O
49905,3368,can,O
49906,3368,not,O
49907,3368,personally,O
49908,3368,provide,O
49909,3368,their,O
49910,3368,consent,O
49911,3368,.,O
49912,3369,Person,O
49913,3369,who,O
49914,3369,is,O
49915,3369,not,O
49916,3369,wearing,O
49917,3369,prosthesis,O
49918,3369,8hours,O
49919,3369,/,O
49920,3369,day,O
49921,3369,on,O
49922,3369,average,O
49923,3369,.,O
49924,3370,Person,O
49925,3370,who,O
49926,3370,has,O
49927,3370,a,O
49928,3370,score,O
49929,3370,on,O
49930,3370,10,O
49931,3370,m,O
49932,3370,walk,O
49933,3370,test,O
49934,3370,less,O
49935,3370,than,O
49936,3370,3,O
49937,3370,km/h,O
49938,3370,(,O
49939,3370,~0.8,O
49940,3370,m/s,O
49941,3370,),O
49942,3370,(,O
49943,3370,based,O
49944,3370,on,O
49945,3370,10,O
49946,3370,m,O
49947,3370,walk,O
49948,3370,test,O
49949,3370,conducted,O
49950,3370,during,O
49951,3370,recruiting,O
49952,3370,),O
49953,3370,.,O
49954,3371,Person,O
49955,3371,who,O
49956,3371,walks,B-Observation
49957,3371,on,O
49958,3371,average,O
49959,3371,less,O
49960,3371,than,O
49961,3371,1,O
49962,3371,km,O
49963,3371,per,O
49964,3371,day,O
49965,3371,.,O
49966,3372,Person,O
49967,3372,who,O
49968,3372,is,O
49969,3372,not,O
49970,3372,able,O
49971,3372,to,O
49972,3372,walk,O
49973,3372,on,O
49974,3372,level,O
49975,3372,ground,O
49976,3372,in,O
49977,3372,a,O
49978,3372,step,O
49979,3372,over,O
49980,3372,step,O
49981,3372,manner,O
49982,3372,.,O
49983,3373,Person,O
49984,3373,is,O
49985,3373,>,O
49986,3373,18,O
49987,3373,years,O
49988,3373,old,B-Person
49989,3373,.,O
49990,3374,Person,O
49991,3374,is,O
49992,3374,a,O
49993,3374,unilateral,O
49994,3374,transfemoral,O
49995,3374,or,O
49996,3374,knee,O
49997,3374,-,O
49998,3374,disarticulation,O
49999,3374,amputee,O
50000,3374,with,O
50001,3374,stabilized,O
50002,3374,residual,O
50003,3374,limb,O
50004,3374,.,O
50005,3375,Person,O
50006,3375,is,O
50007,3375,a,O
50008,3375,K2,O
50009,3375,",",O
50010,3375,K3,O
50011,3375,or,O
50012,3375,K4,O
50013,3375,ambulator,O
50014,3375,based,O
50015,3375,on,O
50016,3375,Medicare,O
50017,3375,Functional,O
50018,3375,Classification,O
50019,3375,Level,O
50020,3375,(,O
50021,3375,MFCL,O
50022,3375,),O
50023,3375,.,O
50024,3376,Person,O
50025,3376,is,O
50026,3376,currently,O
50027,3376,fitted,O
50028,3376,with,O
50029,3376,a,O
50030,3376,prosthesis,O
50031,3376,using,O
50032,3376,a,O
50033,3376,non,O
50034,3376,-,O
50035,3376,microprocessor,O
50036,3376,controlled,O
50037,3376,prosthetic,O
50038,3376,knee,O
50039,3376,for,O
50040,3376,at,O
50041,3376,least,O
50042,3376,6,O
50043,3376,months,O
50044,3376,.,O
50045,3377,Person,O
50046,3377,was,O
50047,3377,never,O
50048,3377,fitted,O
50049,3377,with,O
50050,3377,microprocessor,O
50051,3377,controlled,O
50052,3377,prosthetic,O
50053,3377,knee,O
50054,3377,joint,O
50055,3377,.,O
50056,3378,Person,O
50057,3378,is,O
50058,3378,willing,O
50059,3378,and,O
50060,3378,able,O
50061,3378,to,O
50062,3378,independently,O
50063,3378,provide,O
50064,3378,informed,O
50065,3378,consent,O
50066,3378,.,O
50067,3379,Person,O
50068,3379,is,O
50069,3379,willing,O
50070,3379,to,O
50071,3379,comply,O
50072,3379,with,O
50073,3379,study,O
50074,3379,procedures,O
50075,3379,.,O
50076,3380,Person,O
50077,3380,wears,O
50078,3380,prosthesis,O
50079,3380,daily,O
50080,3380,and,O
50081,3380,=,O
50082,3380,8,O
50083,3380,hours,O
50084,3380,/,O
50085,3380,day,O
50086,3380,.,O
50087,3381,Person,O
50088,3381,is,O
50089,3381,walking,B-Observation
50090,3381,on,O
50091,3381,average,O
50092,3381,1km,O
50093,3381,/,O
50094,3381,day,O
50095,3381,.,O
50096,3382,Person,O
50097,3382,is,O
50098,3382,walking,B-Observation
50099,3382,not,O
50100,3382,slower,O
50101,3382,than,O
50102,3382,3,O
50103,3382,km/h,O
50104,3382,(,O
50105,3382,~0.8,O
50106,3382,m/s,O
50107,3382,),O
50108,3382,(,O
50109,3382,based,O
50110,3382,on,O
50111,3382,10,O
50112,3382,m,O
50113,3382,walk,O
50114,3382,test,O
50115,3382,conducted,O
50116,3382,during,O
50117,3382,recruiting,O
50118,3382,),O
50119,3382,.,O
50120,3383,Person,O
50121,3383,is,O
50122,3383,walking,B-Observation
50123,3383,on,O
50124,3383,level,O
50125,3383,ground,O
50126,3383,in,O
50127,3383,a,O
50128,3383,step,O
50129,3383,over,O
50130,3383,step,O
50131,3383,manner,O
50132,3383,.,O
50133,3384,myocardial,B-Condition
50134,3384,infarction,I-Condition
50135,3384,within,O
50136,3384,the,O
50137,3384,preceding,O
50138,3384,4,O
50139,3384,weeks,O
50140,3385,severe,O
50141,3385,valve,B-Condition
50142,3385,disease,I-Condition
50143,3385,requiring,O
50144,3385,valve,B-Procedure
50145,3385,replacement,I-Procedure
50146,3386,cardiac,B-Procedure
50147,3386,reoperations,I-Procedure
50148,3387,patients,O
50149,3387,with,O
50150,3387,severe,O
50151,3387,left,B-Condition
50152,3387,ventricle,I-Condition
50153,3387,dysfunction,I-Condition
50154,3387,with,O
50155,3387,an,O
50156,3387,ejection,O
50157,3387,fraction,O
50158,3387,(,O
50159,3387,EF)=40,O
50160,3387,%,O
50161,3387,",",O
50162,3387,being,B-Observation
50163,3387,scheduled,I-Observation
50164,3387,for,I-Observation
50165,3387,revascularization,B-Procedure
50166,3387,.,O
50167,3388,1,O
50168,3388,.,O
50169,3388,Have,O
50170,3388,dementia,B-Condition
50171,3388,or,O
50172,3388,delirium,B-Condition
50173,3388,(,O
50174,3388,as,O
50175,3388,determined,O
50176,3388,by,O
50177,3388,the,O
50178,3388,palliative,O
50179,3388,care,O
50180,3388,specialist,O
50181,3388,),O
50182,3388,at,O
50183,3388,study,O
50184,3388,entry,O
50185,3388,.,O
50186,3389,2,O
50187,3389,.,O
50188,3389,Are,O
50189,3389,pregnant,B-Condition
50190,3390,3,O
50191,3390,.,O
50192,3390,Have,O
50193,3390,been,O
50194,3390,taking,O
50195,3390,corticosteroids,B-Drug
50196,3390,for,O
50197,3390,longer,O
50198,3390,than,O
50199,3390,48,O
50200,3390,hours,O
50201,3390,.,O
50202,3391,4,O
50203,3391,.,O
50204,3391,Have,O
50205,3391,pulmonary,B-Condition
50206,3391,edema,I-Condition
50207,3391,",",O
50208,3391,ascites,B-Condition
50209,3391,or,O
50210,3391,pitting,B-Condition
50211,3391,edema,I-Condition
50212,3391,on,O
50213,3391,clinical,O
50214,3391,examination,O
50215,3391,.,O
50216,3392,5,O
50217,3392,.,O
50218,3392,Are,O
50219,3392,unable,B-Condition
50220,3392,to,I-Condition
50221,3392,walk,I-Condition
50222,3392,.,O
50223,3393,6,O
50224,3393,.,O
50225,3393,Have,O
50226,3393,a,O
50227,3393,history,B-Observation
50228,3393,of,O
50229,3393,serious,O
50230,3393,adverse,B-Condition
50231,3393,gastrointestinal,I-Condition
50232,3393,events,I-Condition
50233,3393,(,O
50234,3393,i.e.,O
50235,3393,",",O
50236,3393,bleeding,B-Condition
50237,3393,or,O
50238,3393,"perforation),history",B-Condition
50239,3393,of,O
50240,3393,a,O
50241,3393,coagulopathy,B-Condition
50242,3393,or,O
50243,3393,current,O
50244,3393,anti,B-Drug
50245,3393,-,I-Drug
50246,3393,coagulant,I-Drug
50247,3393,use,O
50248,3393,.,O
50249,3394,7,O
50250,3394,.,O
50251,3394,Have,O
50252,3394,an,O
50253,3394,ALT,O
50254,3394,/,O
50255,3394,AST>3x,O
50256,3394,upper,O
50257,3394,limit,O
50258,3394,of,O
50259,3394,normal,O
50260,3394,.,O
50261,3395,8,O
50262,3395,.,O
50263,3395,Patients,O
50264,3395,on,O
50265,3395,methotrexate,B-Drug
50266,3395,.,O
50267,3396,9,O
50268,3396,.,O
50269,3396,Patients,O
50270,3396,taking,O
50271,3396,melatonin,B-Drug
50272,3396,receptor,I-Drug
50273,3396,agonists,I-Drug
50274,3396,(,O
50275,3396,such,O
50276,3396,as,O
50277,3396,Rozerem,B-Drug
50278,3396,®,O
50279,3396,[,O
50280,3396,ramelteon,B-Drug
50281,3396,],O
50282,3396,),O
50283,3396,.,O
50284,3397,1,O
50285,3397,.,O
50286,3397,Are,O
50287,3397,referred,O
50288,3397,to,O
50289,3397,the,O
50290,3397,Cachexia,O
50291,3397,Clinic,O
50292,3397,with,O
50293,3397,involuntary,B-Condition
50294,3397,weight,I-Condition
50295,3397,loss,I-Condition
50296,3397,of,O
50297,3397,>,O
50298,3397,5,O
50299,3397,%,O
50300,3397,of,O
50301,3397,their,O
50302,3397,premorbid,O
50303,3397,weight,O
50304,3397,within,O
50305,3397,the,O
50306,3397,previous,O
50307,3397,6,O
50308,3397,months,O
50309,3397,.,O
50310,3398,2,O
50311,3398,.,O
50312,3398,Are,O
50313,3398,18,O
50314,3398,years,O
50315,3398,of,B-Person
50316,3398,age,I-Person
50317,3398,or,O
50318,3398,older,O
50319,3399,3,O
50320,3399,.,O
50321,3399,Have,O
50322,3399,a,O
50323,3399,Karnofsky,O
50324,3399,performance,O
50325,3399,score,O
50326,3399,of,O
50327,3399,60,O
50328,3399,or,O
50329,3399,higher,O
50330,3399,.,O
50331,3400,4,O
50332,3400,.,O
50333,3400,Can,O
50334,3400,maintain,O
50335,3400,oral,O
50336,3400,food,O
50337,3400,intake,O
50338,3400,during,O
50339,3400,the,O
50340,3400,study,O
50341,3401,5,O
50342,3401,.,O
50343,3401,Can,O
50344,3401,understand,O
50345,3401,the,O
50346,3401,study,O
50347,3401,procedures,O
50348,3401,and,O
50349,3401,can,O
50350,3401,sign,O
50351,3401,an,O
50352,3401,informed,O
50353,3401,consent,O
50354,3401,form,O
50355,3401,.,O
50356,3402,6,O
50357,3402,.,O
50358,3402,Are,O
50359,3402,not,O
50360,3402,currently,O
50361,3402,taking,O
50362,3402,melatonin,B-Drug
50363,3402,.,O
50364,3403,7,O
50365,3403,.,O
50366,3403,Are,O
50367,3403,taking,O
50368,3403,megestrol,B-Drug
50369,3403,acetate,I-Drug
50370,3403,and,O
50371,3403,continue,O
50372,3403,to,O
50373,3403,lose,B-Observation
50374,3403,weight,I-Observation
50375,3403,despite,O
50376,3403,at,O
50377,3403,least,O
50378,3403,2,O
50379,3403,weeks,O
50380,3403,of,O
50381,3403,therapy,B-Procedure
50382,3403,.,O
50383,3404,8,O
50384,3404,.,O
50385,3404,Have,O
50386,3404,a,O
50387,3404,calculated,O
50388,3404,creatinine,O
50389,3404,clearance,O
50390,3404,of,O
50391,3404,>,O
50392,3404,/=,O
50393,3404,60,O
50394,3404,cc,O
50395,3404,/,O
50396,3404,min,O
50397,3404,.,O
50398,3405,day,O
50399,3405,3,O
50400,3405,transfers,O
50401,3406,women,B-Person
50402,3406,undergoing,O
50403,3406,IVF,B-Procedure
50404,3406,/,O
50405,3406,ICSI,B-Procedure
50406,3406,or,O
50407,3406,frozen,B-Procedure
50408,3406,embryo,I-Procedure
50409,3406,transfers,I-Procedure
50410,3406,(,I-Procedure
50411,3406,FET,I-Procedure
50412,3406,),I-Procedure
50413,3406,that,O
50414,3406,less,O
50415,3406,than,O
50416,3406,40,O
50417,3406,years,O
50418,3406,old,B-Person
50419,3406,.,O
50420,3407,AJCC,O
50421,3407,Stage,O
50422,3407,III,O
50423,3407,or,O
50424,3407,greater,O
50425,3408,Undifferentiated,B-Condition
50426,3408,",",I-Condition
50427,3408,Anaplastic,I-Condition
50428,3408,or,I-Condition
50429,3408,Medullary,I-Condition
50430,3408,Thyroid,I-Condition
50431,3408,Cancer,I-Condition
50432,3409,Planned,O
50433,3409,postoperative,O
50434,3409,TSH,O
50435,3409,goal,O
50436,3409,other,O
50437,3409,than,O
50438,3409,0.1,O
50439,3409,-,O
50440,3409,0.5,O
50441,3409,mU,O
50442,3409,/,O
50443,3409,L,O
50444,3410,History,O
50445,3410,of,O
50446,3410,gastrointestinal,B-Condition
50447,3410,malabsorption,I-Condition
50448,3410,or,O
50449,3410,gastric,B-Procedure
50450,3410,bypass,I-Procedure
50451,3410,surgery,I-Procedure
50452,3411,Pregnancy,O
50453,3412,Use,O
50454,3412,of,O
50455,3412,medications,B-Drug
50456,3412,that,O
50457,3412,alter,O
50458,3412,the,O
50459,3412,absorption,B-Observation
50460,3412,or,I-Observation
50461,3412,metabolism,I-Observation
50462,3412,of,I-Observation
50463,3412,levothyroxine,I-Observation
50464,3413,Prior,O
50465,3413,use,O
50466,3413,of,O
50467,3413,levothyroxine,B-Drug
50468,3414,Age,B-Person
50469,3414,>,O
50470,3414,18,O
50471,3414,years,O
50472,3415,Presumed,O
50473,3415,AJCC,O
50474,3415,(,O
50475,3415,American,O
50476,3415,Joint,O
50477,3415,Committee,O
50478,3415,on,O
50479,3415,Cancer,O
50480,3415,),O
50481,3415,tumor,O
50482,3415,Stage,O
50483,3415,I,O
50484,3415,or,O
50485,3415,II,O
50486,3416,Planned,O
50487,3416,total,O
50488,3416,or,O
50489,3416,near,O
50490,3416,-,O
50491,3416,total,O
50492,3416,thyroidectomy,B-Procedure
50493,3417,Planned,O
50494,3417,goal,O
50495,3417,TSH,B-Condition
50496,3417,suppression,I-Condition
50497,3417,0.1,O
50498,3417,-,O
50499,3417,0.5,O
50500,3417,mU,O
50501,3417,/,O
50502,3417,L,O
50503,3417,for,O
50504,3417,at,O
50505,3417,least,O
50506,3417,18,O
50507,3417,weeks,O
50508,3417,postoperatively,O
50509,3418,Normal,O
50510,3418,serum,O
50511,3418,TSH,O
50512,3418,within,O
50513,3418,12,O
50514,3418,months,O
50515,3418,preceding,O
50516,3418,surgery,O
50517,3419,NA,O
50518,3420,Meets,O
50519,3420,Diagnostic,O
50520,3420,and,O
50521,3420,Statistical,O
50522,3420,Manual,O
50523,3420,of,O
50524,3420,Mental,O
50525,3420,Disorders,O
50526,3420,(,O
50527,3420,Versions,O
50528,3420,4,O
50529,3420,and,O
50530,3420,5,O
50531,3420,),O
50532,3420,criteria,O
50533,3420,for,O
50534,3420,and,O
50535,3420,Major,B-Condition
50536,3420,Depressive,I-Condition
50537,3420,Disorder,I-Condition
50538,3420,.,O
50539,3421,Hamilton,O
50540,3421,Depression,O
50541,3421,Rating,O
50542,3421,Scale-17,O
50543,3421,score,O
50544,3421,greater,O
50545,3421,than,O
50546,3421,18,O
50547,3421,.,O
50548,3422,Men,B-Person
50549,3422,and,O
50550,3422,women,B-Person
50551,3422,between,O
50552,3422,ages,B-Person
50553,3422,>,O
50554,3422,=,O
50555,3422,18,O
50556,3422,and,O
50557,3422,65,O
50558,3422,.,O
50559,3423,The,O
50560,3423,patient,O
50561,3423,has,O
50562,3423,a,O
50563,3423,known,O
50564,3423,hypersensitivity,B-Condition
50565,3423,or,O
50566,3423,contraindication,B-Condition
50567,3423,to,O
50568,3423,any,O
50569,3423,of,O
50570,3423,the,O
50571,3423,following,O
50572,3423,medications,O
50573,3423,:,O
50574,3423,Heparin,B-Drug
50575,3423,",",O
50576,3423,Aspirin,B-Drug
50577,3423,",",O
50578,3423,Clopidogrel,B-Drug
50579,3423,",",O
50580,3423,Cilostazol,B-Drug
50581,3424,Uncontrolled,O
50582,3424,hypertension,B-Condition
50583,3425,History,B-Observation
50584,3425,of,O
50585,3425,bleeding,B-Condition
50586,3425,diathesis,I-Condition
50587,3425,or,O
50588,3425,known,O
50589,3425,coagulopathy,B-Condition
50590,3425,(,O
50591,3425,including,O
50592,3425,heparin,B-Condition
50593,3425,-,I-Condition
50594,3425,induced,I-Condition
50595,3425,thrombocytopenia,I-Condition
50596,3425,),O
50597,3425,",",O
50598,3425,or,O
50599,3425,refuses,B-Observation
50600,3425,blood,I-Observation
50601,3425,transfusions,I-Observation
50602,3425,.,O
50603,3426,Baseline,O
50604,3426,hemogram,B-Procedure
50605,3426,with,O
50606,3426,Hb<10g,O
50607,3426,/,O
50608,3426,dL,O
50609,3426,or,O
50610,3426,PLT,O
50611,3426,"count<100,000",O
50612,3426,/,O
50613,3426,μL,O
50614,3427,Patients,O
50615,3427,already,O
50616,3427,taking,O
50617,3427,warfarin,B-Drug
50618,3427,",",O
50619,3427,cilostazol,B-Drug
50620,3427,or,O
50621,3427,any,O
50622,3427,other,O
50623,3427,type,O
50624,3427,of,O
50625,3427,anti,B-Drug
50626,3427,-,I-Drug
50627,3427,platelet,I-Drug
50628,3427,agents,I-Drug
50629,3427,except,O
50630,3427,aspirin,B-Drug
50631,3427,and,O
50632,3427,clopidogrel,B-Drug
50633,3428,Gastrointestinal,B-Condition
50634,3428,or,I-Condition
50635,3428,genitourinary,I-Condition
50636,3428,bleeding,I-Condition
50637,3428,within,O
50638,3428,the,O
50639,3428,prior,O
50640,3428,3,O
50641,3428,months,O
50642,3428,",",O
50643,3428,or,O
50644,3428,major,B-Procedure
50645,3428,surgery,I-Procedure
50646,3428,within,O
50647,3428,2,O
50648,3428,months,O
50649,3428,.,O
50650,3429,Pregnancy,B-Condition
50651,3430,Acute,B-Condition
50652,3430,Myocardial,I-Condition
50653,3430,Infarction,I-Condition
50654,3430,Undergoing,O
50655,3430,Primary,B-Procedure
50656,3430,percutaneous,I-Procedure
50657,3430,coronary,I-Procedure
50658,3430,intervention,I-Procedure
50659,3430,.,O
50660,3431,Age,B-Person
50661,3431,less,O
50662,3431,than,O
50663,3431,18,O
50664,3431,years,O
50665,3432,Significant,O
50666,3432,arterial,B-Condition
50667,3432,disease,I-Condition
50668,3432,(,O
50669,3432,Ankle,O
50670,3432,Brachial,O
50671,3432,Pressure,O
50672,3432,Index,O
50673,3432,<,O
50674,3432,0•9,O
50675,3432,or,O
50676,3432,evidence,O
50677,3432,on,O
50678,3432,Arterial,B-Procedure
50679,3432,Duplex,I-Procedure
50680,3432,),O
50681,3433,Acute,B-Condition
50682,3433,Deep,I-Condition
50683,3433,Vein,I-Condition
50684,3433,Thrombosis,I-Condition
50685,3434,Patient,O
50686,3434,unable,O
50687,3434,or,O
50688,3434,unwilling,O
50689,3434,to,O
50690,3434,have,O
50691,3434,high,O
50692,3434,compression,O
50693,3434,(,O
50694,3434,30mmHg,O
50695,3434,minimum,O
50696,3434,),O
50697,3435,Patients,O
50698,3435,with,O
50699,3435,dexterity,B-Condition
50700,3435,insufficiency,I-Condition
50701,3435,of,I-Condition
50702,3435,hands,I-Condition
50703,3436,Patients,O
50704,3436,with,O
50705,3436,peripheral,B-Condition
50706,3436,neuropathy,I-Condition
50707,3437,Leg,B-Condition
50708,3437,ulcers,I-Condition
50709,3437,of,O
50710,3437,another,O
50711,3437,underlying,B-Condition
50712,3437,cause,I-Condition
50713,3438,Leg,B-Condition
50714,3438,ulcers,I-Condition
50715,3438,of,O
50716,3438,greater,O
50717,3438,than,O
50718,3438,1,O
50719,3438,year,O
50720,3438,duration,O
50721,3439,Patients,O
50722,3439,unable,O
50723,3439,or,O
50724,3439,unwilling,O
50725,3439,to,O
50726,3439,provide,O
50727,3439,written,O
50728,3439,",",O
50729,3439,informed,O
50730,3439,consent,O
50731,3440,Age,B-Person
50732,3440,>,O
50733,3440,18,O
50734,3440,years,O
50735,3440,old,O
50736,3441,1,O
50737,3441,cm,O
50738,3441,squared,O
50739,3441,surface,O
50740,3441,area,O
50741,3442,Venous,B-Condition
50742,3442,incompetence,I-Condition
50743,3442,confirmed,O
50744,3442,by,O
50745,3442,clinical,B-Procedure
50746,3442,assessment,I-Procedure
50747,3442,and,O
50748,3442,duplex,B-Procedure
50749,3442,ultrasound,I-Procedure
50750,3442,scan,I-Procedure
50751,3443,No,O
50752,3443,evidence,O
50753,3443,of,O
50754,3443,arterial,B-Condition
50755,3443,disease,I-Condition
50756,3443,(,O
50757,3443,Arterial,B-Procedure
50758,3443,Duplex,I-Procedure
50759,3443,or,O
50760,3443,Ankle,O
50761,3443,Brachial,O
50762,3443,Pressure,O
50763,3443,Index,O
50764,3443,>,O
50765,3443,0.9,O
50766,3443,),O
50767,3444,Patients,O
50768,3444,able,O
50769,3444,to,O
50770,3444,complete,O
50771,3444,trial,O
50772,3444,procedures,O
50773,3445,Patients,O
50774,3445,with,O
50775,3445,a,O
50776,3445,life,B-Observation
50777,3445,expectancy,I-Observation
50778,3445,of,O
50779,3445,greater,O
50780,3445,than,O
50781,3445,1,O
50782,3445,year,O
50783,3446,Exposure,O
50784,3446,/,O
50785,3446,treatment,O
50786,3446,to,O
50787,3446,an,O
50788,3446,investigational,O
50789,3446,(,O
50790,3446,new,O
50791,3446,chemical,O
50792,3446,entity,O
50793,3446,),O
50794,3446,or,O
50795,3446,marketed,O
50796,3446,drug,O
50797,3446,or,O
50798,3446,biologic,O
50799,3446,within,O
50800,3446,30,O
50801,3446,days,O
50802,3446,preceding,O
50803,3446,the,O
50804,3446,first,O
50805,3446,dose,O
50806,3446,administration,O
50807,3446,",",O
50808,3446,or,O
50809,3446,five,O
50810,3446,half,O
50811,3446,-,O
50812,3446,lives,O
50813,3446,of,O
50814,3446,that,O
50815,3446,investigational,O
50816,3446,drug,O
50817,3446,or,O
50818,3446,biologic,O
50819,3446,",",O
50820,3446,if,O
50821,3446,known,O
50822,3446,(,O
50823,3446,whichever,O
50824,3446,is,O
50825,3446,longer,O
50826,3446,),O
50827,3446,.,O
50828,3447,Donation,B-Procedure
50829,3447,blood,I-Procedure
50830,3447,or,I-Procedure
50831,3447,serum,I-Procedure
50832,3447,within,O
50833,3447,8,O
50834,3447,weeks,O
50835,3447,before,O
50836,3447,the,O
50837,3447,first,O
50838,3447,dose,O
50839,3447,administration,O
50840,3447,to,O
50841,3447,a,O
50842,3447,blood,O
50843,3447,bank,O
50844,3447,or,O
50845,3447,blood,O
50846,3447,donation,O
50847,3447,center,O
50848,3447,.,O
50849,3448,History,B-Observation
50850,3448,of,O
50851,3448,alcohol,B-Condition
50852,3448,or,I-Condition
50853,3448,drug,I-Condition
50854,3448,abuse,I-Condition
50855,3448,(,O
50856,3448,as,O
50857,3448,defined,O
50858,3448,by,O
50859,3448,the,O
50860,3448,current,B-Procedure
50861,3448,version,I-Procedure
50862,3448,of,I-Procedure
50863,3448,the,I-Procedure
50864,3448,DSM,I-Procedure
50865,3448,),O
50866,3448,within,O
50867,3448,2,O
50868,3448,years,O
50869,3448,before,O
50870,3448,the,O
50871,3448,first,O
50872,3448,dose,O
50873,3448,administration,O
50874,3448,",",O
50875,3448,or,O
50876,3448,positive,O
50877,3448,alcohol,O
50878,3448,or,O
50879,3448,drug,O
50880,3448,screen,O
50881,3448,.,O
50882,3449,Vaccination,B-Procedure
50883,3449,within,O
50884,3449,30,O
50885,3449,days,O
50886,3449,prior,O
50887,3449,to,O
50888,3449,the,O
50889,3449,first,O
50890,3449,dose,O
50891,3449,administration,O
50892,3449,or,O
50893,3449,has,O
50894,3449,plans,B-Observation
50895,3449,to,O
50896,3449,receive,O
50897,3449,a,O
50898,3449,vaccination,B-Procedure
50899,3449,during,O
50900,3449,the,O
50901,3449,course,O
50902,3449,of,O
50903,3449,the,O
50904,3449,study,O
50905,3449,(,O
50906,3449,including,O
50907,3449,the,O
50908,3449,follow,O
50909,3449,phone,O
50910,3449,call,O
50911,3449,on,O
50912,3449,Day,O
50913,3449,105,O
50914,3449,),O
50915,3449,.,O
50916,3450,Healthy,B-Condition
50917,3450,male,B-Person
50918,3450,and/or,O
50919,3450,female,B-Person
50920,3450,subjects,O
50921,3450,between,O
50922,3450,the,O
50923,3450,ages,B-Person
50924,3450,of,O
50925,3450,18,O
50926,3450,and,O
50927,3450,55,O
50928,3450,years,O
50929,3450,",",O
50930,3450,and,O
50931,3450,a,O
50932,3450,body,O
50933,3450,mass,O
50934,3450,index,O
50935,3450,(,O
50936,3450,BMI,O
50937,3450,),O
50938,3450,of,O
50939,3450,≥,O
50940,3450,18,O
50941,3450,and,O
50942,3450,≤,O
50943,3450,33,O
50944,3450,kg,O
50945,3450,/,O
50946,3450,m2,O
50947,3450,with,O
50948,3450,body,O
50949,3450,weight,O
50950,3450,≥,O
50951,3450,50,O
50952,3450,and,O
50953,3450,≤,O
50954,3450,90,O
50955,3450,kg,O
50956,3450,at,O
50957,3450,screening,O
50958,3450,.,O
50959,3451,Females,B-Person
50960,3451,must,O
50961,3451,have,O
50962,3451,been,O
50963,3451,surgically,B-Condition
50964,3451,sterilized,I-Condition
50965,3451,(,O
50966,3451,hysterectomy,B-Procedure
50967,3451,",",O
50968,3451,bilateral,B-Procedure
50969,3451,oophorectomy,I-Procedure
50970,3451,",",O
50971,3451,or,O
50972,3451,bilateral,B-Procedure
50973,3451,salpingo,I-Procedure
50974,3451,-,I-Procedure
50975,3451,oophorectomy,I-Procedure
50976,3451,;,O
50977,3451,proper,O
50978,3451,documentation,O
50979,3451,required,O
50980,3451,),O
50981,3451,at,O
50982,3451,least,O
50983,3451,6,O
50984,3451,months,O
50985,3451,before,O
50986,3451,screening,O
50987,3451,",",O
50988,3451,or,O
50989,3451,be,O
50990,3451,postmenopausal,B-Condition
50991,3451,(,O
50992,3451,defined,O
50993,3451,as,O
50994,3451,24,O
50995,3451,consecutive,O
50996,3451,months,O
50997,3451,without,O
50998,3451,menses,B-Condition
50999,3451,before,O
51000,3451,screening,O
51001,3451,",",O
51002,3451,with,O
51003,3451,a,O
51004,3451,follicle,O
51005,3451,-,O
51006,3451,stimulating,O
51007,3451,hormone,O
51008,3451,[,O
51009,3451,FSH,O
51010,3451,],O
51011,3451,level,O
51012,3451,of,O
51013,3451,>,O
51014,3451,40,O
51015,3451,IU,O
51016,3451,/,O
51017,3451,L,O
51018,3451,at,O
51019,3451,screening,O
51020,3451,),O
51021,3451,.,O
51022,3452,Patient,O
51023,3452,with,O
51024,3452,fever,B-Condition
51025,3452,(,O
51026,3452,38C,O
51027,3452,or,O
51028,3452,100.4F,O
51029,3452,),O
51030,3453,Patient,O
51031,3453,less,O
51032,3453,than,O
51033,3453,age,B-Person
51034,3453,4,O
51035,3453,years,O
51036,3454,Patient,O
51037,3454,greater,O
51038,3454,than,O
51039,3454,age,B-Person
51040,3454,16,O
51041,3454,years,O
51042,3455,Patient,O
51043,3455,with,O
51044,3455,hypersensitivity,B-Condition
51045,3455,/,O
51046,3455,allergy,B-Condition
51047,3455,to,O
51048,3455,either,O
51049,3455,morphine,B-Drug
51050,3455,",",O
51051,3455,NSAIDs,B-Drug
51052,3455,",",O
51053,3455,or,O
51054,3455,acetaminophen,B-Drug
51055,3456,Patient,O
51056,3456,received,O
51057,3456,acetaminophen,B-Drug
51058,3456,within,O
51059,3456,the,O
51060,3456,past,O
51061,3456,4,O
51062,3456,hours,O
51063,3457,Patient,O
51064,3457,with,O
51065,3457,known,O
51066,3457,liver,B-Condition
51067,3457,disease,I-Condition
51068,3457,or,O
51069,3457,renal,B-Condition
51070,3457,disease,I-Condition
51071,3458,Patient,O
51072,3458,not,O
51073,3458,requiring,B-Mood
51074,3458,IV,B-Drug
51075,3458,morphine,I-Drug
51076,3458,(,O
51077,3458,pain,O
51078,3458,score,O
51079,3458,5/10,O
51080,3458,or,O
51081,3458,less,O
51082,3458,),O
51083,3459,Patient,O
51084,3459,enrolled,B-Observation
51085,3459,in,I-Observation
51086,3459,the,I-Observation
51087,3459,study,I-Observation
51088,3459,within,O
51089,3459,the,O
51090,3459,past,O
51091,3459,72,O
51092,3459,hours,O
51093,3460,Any,O
51094,3460,patient,O
51095,3460,age,B-Person
51096,3460,4,O
51097,3460,-,O
51098,3460,16,O
51099,3460,years,O
51100,3460,with,O
51101,3460,sickle,B-Condition
51102,3460,cell,I-Condition
51103,3460,disease,I-Condition
51104,3460,who,O
51105,3460,presents,O
51106,3460,the,O
51107,3460,Pediatric,O
51108,3460,ER,O
51109,3460,with,O
51110,3460,acute,B-Condition
51111,3460,sickle,I-Condition
51112,3460,cell,I-Condition
51113,3460,pain,I-Condition
51114,3460,crisis,I-Condition
51115,3460,with,O
51116,3460,a,O
51117,3460,pain,O
51118,3460,of,O
51119,3460,6/10,O
51120,3460,or,O
51121,3460,higher,O
51122,3461,Open,B-Procedure
51123,3461,surgery,I-Procedure
51124,3461,;,O
51125,3462,Patients,O
51126,3462,allergic,B-Condition
51127,3462,to,O
51128,3462,lidocaine,B-Drug
51129,3462,or,O
51130,3462,other,O
51131,3462,local,B-Drug
51132,3462,anesthetics,I-Drug
51133,3462,;,O
51134,3463,Drug,B-Condition
51135,3463,abuser,I-Condition
51136,3463,.,O
51137,3464,American,O
51138,3464,Society,O
51139,3464,of,O
51140,3464,Anesthesiologist,O
51141,3464,(,O
51142,3464,ASA,O
51143,3464,),O
51144,3464,status,O
51145,3464,I,O
51146,3464,-,O
51147,3464,II,O
51148,3464,adult,B-Person
51149,3464,patients,O
51150,3464,undergoing,O
51151,3464,elective,O
51152,3464,laparoscopic,B-Procedure
51153,3464,cholecystectomy,I-Procedure
51154,3464,.,O
51155,3465,Clear,B-Condition
51156,3465,indication,I-Condition
51157,3465,for,I-Condition
51158,3465,specific,I-Condition
51159,3465,duration,I-Condition
51160,3465,of,O
51161,3465,dual,B-Procedure
51162,3465,anti,I-Procedure
51163,3465,-,I-Procedure
51164,3465,platelet,I-Procedure
51165,3465,therapy,I-Procedure
51166,3466,Type,B-Condition
51167,3466,2,I-Condition
51168,3466,myocardial,I-Condition
51169,3466,infarction,I-Condition
51170,3467,Contraindication,B-Condition
51171,3467,to,O
51172,3467,aspirin,B-Condition
51173,3467,or,O
51174,3467,P2Y12,B-Condition
51175,3467,receptor,I-Condition
51176,3467,antagonist,I-Condition
51177,3468,Non,B-Person
51178,3468,-,I-Person
51179,3468,resident,I-Person
51180,3468,of,O
51181,3468,Scotland,O
51182,3469,Previous,O
51183,3469,recruitment,O
51184,3469,into,O
51185,3469,the,O
51186,3469,trial,O
51187,3470,Inability,O
51188,3470,or,O
51189,3470,unwilling,O
51190,3470,to,O
51191,3470,give,O
51192,3470,informed,O
51193,3470,consent,O
51194,3471,Aged,B-Person
51195,3471,=,O
51196,3471,18,O
51197,3471,years,O
51198,3472,Clinical,O
51199,3472,diagnosis,O
51200,3472,of,O
51201,3472,acute,B-Condition
51202,3472,coronary,I-Condition
51203,3472,syndrome,I-Condition
51204,3473,In,O
51205,3473,the,O
51206,3473,opinion,O
51207,3473,of,O
51208,3473,the,O
51209,3473,attending,O
51210,3473,clinician,O
51211,3473,requires,B-Mood
51212,3473,dual,B-Procedure
51213,3473,anti,I-Procedure
51214,3473,-,I-Procedure
51215,3473,platelet,I-Procedure
51216,3473,therapy,I-Procedure
51217,3473,with,O
51218,3473,aspirin,B-Drug
51219,3473,and,O
51220,3473,a,O
51221,3473,P2Y12,B-Drug
51222,3473,receptor,I-Drug
51223,3473,antagonist,I-Drug
51224,3474,Resident,B-Person
51225,3474,in,O
51226,3474,Scotland,O
51227,3474,with,O
51228,3474,a,O
51229,3474,Community,O
51230,3474,Health,O
51231,3474,Index,O
51232,3474,(,O
51233,3474,CHI,O
51234,3474,),O
51235,3474,number,O
51236,3475,The,O
51237,3475,attending,O
51238,3475,clinician,O
51239,3475,has,O
51240,3475,equipoise,O
51241,3475,regarding,O
51242,3475,the,O
51243,3475,duration,O
51244,3475,of,O
51245,3475,therapy,O
51246,3476,Provision,O
51247,3476,of,O
51248,3476,informed,O
51249,3476,consent,O
51250,3477,Contraindication,B-Condition
51251,3477,to,O
51252,3477,antiplatelet,B-Drug
51253,3477,therapy,I-Drug
51254,3478,Need,B-Mood
51255,3478,to,I-Mood
51256,3478,continue,O
51257,3478,clopidogrel,B-Drug
51258,3478,due,O
51259,3478,to,O
51260,3478,stroke,B-Condition
51261,3478,",",O
51262,3478,peripheral,B-Condition
51263,3478,disease,I-Condition
51264,3478,",",O
51265,3478,significant,O
51266,3478,carotid,B-Condition
51267,3478,disease,I-Condition
51268,3478,or,O
51269,3478,recent,O
51270,3478,acute,B-Condition
51271,3478,coronary,I-Condition
51272,3478,syndrome,I-Condition
51273,3479,Major,O
51274,3479,bleeding,B-Condition
51275,3479,history,B-Observation
51276,3479,or,O
51277,3479,bleeding,B-Condition
51278,3479,diathesis,I-Condition
51279,3480,Pregnancy,B-Condition
51280,3481,Age,B-Person
51281,3481,19,O
51282,3481,and,O
51283,3481,more,O
51284,3482,On,O
51285,3482,dual,B-Procedure
51286,3482,or,I-Procedure
51287,3482,triple,I-Procedure
51288,3482,antiplatelet,I-Procedure
51289,3482,therapy,I-Procedure
51290,3482,and,O
51291,3482,between,O
51292,3482,12months,O
51293,3482,and,O
51294,3482,14months,O
51295,3482,from,O
51296,3482,Bioresorbable,O
51297,3482,Vascular,O
51298,3482,Scaffold,O
51299,3482,implantation,B-Procedure
51300,3483,No,O
51301,3483,history,B-Observation
51302,3483,of,O
51303,3483,death,B-Condition
51304,3483,",",O
51305,3483,serious,O
51306,3483,myocardial,B-Condition
51307,3483,infarction,I-Condition
51308,3483,",",O
51309,3483,stroke,B-Condition
51310,3483,",",O
51311,3483,repeat,O
51312,3483,revascularization,B-Procedure
51313,3483,",",O
51314,3483,or,O
51315,3483,major,O
51316,3483,bleeding,B-Condition
51317,3484,Planned,B-Mood
51318,3484,surgery,B-Procedure
51319,3484,under,O
51320,3484,regional,B-Procedure
51321,3484,anesthesia,I-Procedure
51322,3485,contraindication,B-Condition
51323,3485,to,O
51324,3485,the,O
51325,3485,study,B-Drug
51326,3485,drug,I-Drug
51327,3486,contraindication,B-Condition
51328,3486,to,O
51329,3486,the,O
51330,3486,lumbar,B-Procedure
51331,3486,puncture,I-Procedure
51332,3487,Contraindication,B-Condition
51333,3487,to,O
51334,3487,oxycodone,B-Drug
51335,3488,Pregnancy,B-Condition
51336,3488,or,O
51337,3488,lactation,B-Condition
51338,3489,no,O
51339,3489,informed,O
51340,3489,consent,O
51341,3490,Planned,B-Mood
51342,3490,gynecological,B-Procedure
51343,3490,lower,I-Procedure
51344,3490,abdomen,I-Procedure
51345,3490,surgery,I-Procedure
51346,3490,with,O
51347,3490,epidural,B-Procedure
51348,3490,pain,I-Procedure
51349,3490,treatment,I-Procedure
51350,3491,Informed,O
51351,3491,consent,O
51352,3491,obtained,O
51353,3492,endometrial,B-Condition
51354,3492,hyperplasia,I-Condition
51355,3492,with,O
51356,3492,atypia,B-Condition
51357,3492,",",O
51358,3493,estrogen,B-Procedure
51359,3493,-,I-Procedure
51360,3493,progestin,I-Procedure
51361,3493,therapy,I-Procedure
51362,3493,in,O
51363,3493,the,O
51364,3493,2,O
51365,3493,months,O
51366,3493,before,O
51367,3493,enrollment,O
51368,3493,",",O
51369,3494,autoimmune,B-Condition
51370,3494,diseases,I-Condition
51371,3494,",",O
51372,3495,chronic,B-Condition
51373,3495,",",I-Condition
51374,3495,metabolic,I-Condition
51375,3495,",",I-Condition
51376,3495,systemic,I-Condition
51377,3495,and,I-Condition
51378,3495,endocrine,I-Condition
51379,3495,disorders,I-Condition
51380,3495,",",O
51381,3495,including,O
51382,3495,hyperandrogenism,B-Condition
51383,3495,",",O
51384,3495,hyperprolactinemia,B-Condition
51385,3495,",",O
51386,3495,diabetes,B-Condition
51387,3495,mellitus,I-Condition
51388,3495,and,O
51389,3495,thyroid,B-Condition
51390,3495,disease,I-Condition
51391,3495,",",O
51392,3496,hypogonadotropic,B-Condition
51393,3496,hypogonadism,I-Condition
51394,3496,",",O
51395,3497,majors,B-Condition
51396,3497,clinical,I-Condition
51397,3497,conditions,I-Condition
51398,3498,submucosal,B-Condition
51399,3498,",",O
51400,3499,intramural,B-Condition
51401,3499,or,I-Condition
51402,3499,subserosal,I-Condition
51403,3499,leiomyomas,I-Condition
51404,3499,",",O
51405,3500,symptoms,B-Mood
51406,3500,of,O
51407,3500,menometrorrhagia,B-Condition
51408,3500,",",O
51409,3501,menstrual,B-Condition
51410,3501,disorder,I-Condition
51411,3501,",",O
51412,3502,infertility,B-Condition
51413,3502,",",O
51414,3503,pelvic,B-Condition
51415,3503,pain,I-Condition
51416,3504,NA,O
51417,3505,NA,O
51418,3506,Age,B-Person
51419,3506,<,O
51420,3506,18,O
51421,3506,years,O
51422,3507,Creatinine,O
51423,3507,>,O
51424,3507,1.5,O
51425,3507,mg,O
51426,3507,/,O
51427,3507,dL,O
51428,3508,History,O
51429,3508,of,O
51430,3508,severe,O
51431,3508,allergy,B-Condition
51432,3508,to,O
51433,3508,Iodine,B-Procedure
51434,3508,contrast,I-Procedure
51435,3508,agents,I-Procedure
51436,3509,Pregnancy,B-Condition
51437,3510,Active,O
51438,3510,atrial,B-Condition
51439,3510,fibrillation,I-Condition
51440,3511,Multiple,B-Condition
51441,3511,premature,I-Condition
51442,3511,ventricular,I-Condition
51443,3511,or,I-Condition
51444,3511,atrial,I-Condition
51445,3511,contractions,I-Condition
51446,3512,Ejection,O
51447,3512,fraction,O
51448,3512,<,O
51449,3512,35,O
51450,3512,%,O
51451,3513,Class,O
51452,3513,III,O
51453,3513,congestive,B-Condition
51454,3513,heart,I-Condition
51455,3513,failure,I-Condition
51456,3514,Acute,B-Condition
51457,3514,Coronary,I-Condition
51458,3514,Syndrome,I-Condition
51459,3514,group,O
51460,3514,:,O
51461,3514,40,O
51462,3514,patients,O
51463,3514,with,O
51464,3514,type,O
51465,3514,1,O
51466,3514,myocardial,O
51467,3514,infarction,O
51468,3514,within,O
51469,3514,21,O
51470,3514,days,O
51471,3514,prior,O
51472,3514,to,O
51473,3514,the,O
51474,3514,imaging,O
51475,3514,visit,O
51476,3514,and,O
51477,3514,invasive,O
51478,3514,coronary,O
51479,3514,angiography,O
51480,3514,with,O
51481,3514,angiographic,O
51482,3514,evidence,O
51483,3514,of,O
51484,3514,at,O
51485,3514,least,O
51486,3514,a,O
51487,3514,50,O
51488,3514,%,O
51489,3514,stenosis,O
51490,3514,in,O
51491,3514,one,O
51492,3514,or,O
51493,3514,more,O
51494,3514,coronary,O
51495,3514,arteries,O
51496,3514,.,O
51497,3514,Only,O
51498,3514,patients,O
51499,3514,undergoing,O
51500,3514,PCI,O
51501,3514,will,O
51502,3514,be,O
51503,3514,included,O
51504,3514,in,O
51505,3514,the,O
51506,3514,study,O
51507,3514,.,O
51508,3515,Stable,O
51509,3515,Ischemic,O
51510,3515,Heart,O
51511,3515,Disease,O
51512,3515,group,O
51513,3515,:,O
51514,3515,40,O
51515,3515,patients,O
51516,3515,who,O
51517,3515,have,O
51518,3515,undergone,O
51519,3515,invasive,O
51520,3515,coronary,O
51521,3515,angiography,O
51522,3515,within,O
51523,3515,21,O
51524,3515,days,O
51525,3515,prior,O
51526,3515,to,O
51527,3515,the,O
51528,3515,imaging,O
51529,3515,visit,O
51530,3515,",",O
51531,3515,with,O
51532,3515,history,O
51533,3515,of,O
51534,3515,typical,O
51535,3515,angina,O
51536,3515,prior,O
51537,3515,to,O
51538,3515,the,O
51539,3515,angiogram,O
51540,3515,",",O
51541,3515,but,O
51542,3515,no,O
51543,3515,prior,O
51544,3515,myocardial,O
51545,3515,infarction,O
51546,3515,or,O
51547,3515,coronary,O
51548,3515,revascularization,O
51549,3515,.,O
51550,3516,have,O
51551,3516,no,O
51552,3516,prior,O
51553,3516,CAD,B-Condition
51554,3516,associated,O
51555,3516,event,O
51556,3516,(,O
51557,3516,no,O
51558,3516,prior,O
51559,3516,myocardial,B-Condition
51560,3516,infarction,I-Condition
51561,3516,",",O
51562,3516,acute,B-Condition
51563,3516,coronary,I-Condition
51564,3516,syndrome,I-Condition
51565,3516,",",O
51566,3516,coronary,B-Procedure
51567,3516,angiogram,I-Procedure
51568,3516,",",O
51569,3516,or,O
51570,3516,PCI,B-Procedure
51571,3516,),O
51572,3516,",",O
51573,3517,have,O
51574,3517,CAC,O
51575,3517,between,O
51576,3517,10,O
51577,3517,to,O
51578,3517,<,O
51579,3517,1000,O
51580,3517,",",O
51581,3517,and,O
51582,3518,match,O
51583,3518,to,O
51584,3518,patients,O
51585,3518,in,O
51586,3518,the,O
51587,3518,ACS,O
51588,3518,group,O
51589,3518,by,O
51590,3518,gender,O
51591,3518,",",O
51592,3518,age,O
51593,3518,by,O
51594,3518,decile,O
51595,3518,",",O
51596,3518,and,O
51597,3518,CAC,O
51598,3518,category,O
51599,3518,(,O
51600,3518,using,O
51601,3518,CAC,O
51602,3518,categories,O
51603,3518,of,O
51604,3518,10,O
51605,3518,to,O
51606,3518,<,O
51607,3518,100,O
51608,3518,",",O
51609,3518,100,O
51610,3518,to,O
51611,3518,<,O
51612,3518,400,O
51613,3518,",",O
51614,3518,400,O
51615,3518,to,O
51616,3518,<,O
51617,3518,1000,O
51618,3518,),O
51619,3518,.,O
51620,3519,Bone,O
51621,3519,age,O
51622,3519,reading,O
51623,3519,more,O
51624,3519,than,O
51625,3519,14.0,O
51626,3519,years,O
51627,3520,Follicle,O
51628,3520,stimulating,O
51629,3520,hormone,O
51630,3520,>,O
51631,3520,20,O
51632,3520,IU,O
51633,3520,/,O
51634,3520,L,O
51635,3521,Current,O
51636,3521,height,O
51637,3521,less,O
51638,3521,than,O
51639,3521,5th,O
51640,3521,percentile,O
51641,3521,AND,O
51642,3521,/,O
51643,3521,OR,O
51644,3522,Predicted,O
51645,3522,adult,O
51646,3522,height,O
51647,3522,(,O
51648,3522,based,O
51649,3522,on,O
51650,3522,bone,O
51651,3522,age,O
51652,3522,),O
51653,3522,more,O
51654,3522,than,O
51655,3522,10,O
51656,3522,cm,O
51657,3522,below,O
51658,3522,target,O
51659,3522,height,O
51660,3522,(,O
51661,3522,mid,O
51662,3522,parental,O
51663,3522,height,O
51664,3522,),O
51665,3523,Evidence,B-Observation
51666,3523,of,I-Observation
51667,3523,puberty,I-Observation
51668,3523,:,O
51669,3523,physical,B-Condition
51670,3523,signs,I-Condition
51671,3523,and,O
51672,3523,serum,O
51673,3523,luteinizing,O
51674,3523,hormone,O
51675,3523,>,O
51676,3523,0.3,O
51677,3523,IU,O
51678,3523,/,O
51679,3523,L,O
51680,3523,and,O
51681,3523,testosterone,O
51682,3523,>,O
51683,3523,15,O
51684,3523,ng,O
51685,3523,/,O
51686,3523,dl,O
51687,3524,Any,O
51688,3524,concomitant,O
51689,3524,cardiovascular,B-Procedure
51690,3524,procedure,I-Procedure
51691,3524,to,O
51692,3524,CABG,B-Procedure
51693,3524,(,O
51694,3524,i.e.,O
51695,3524,valve,B-Procedure
51696,3524,",",I-Procedure
51697,3524,aortic,I-Procedure
51698,3524,or,I-Procedure
51699,3524,carotid,I-Procedure
51700,3524,surgery,I-Procedure
51701,3524,),O
51702,3525,Acute,B-Condition
51703,3525,ST,I-Condition
51704,3525,-,I-Condition
51705,3525,segment,I-Condition
51706,3525,-,I-Condition
51707,3525,elevation,I-Condition
51708,3525,myocardial,I-Condition
51709,3525,infarction,I-Condition
51710,3525,(,O
51711,3525,STEMI,B-Condition
51712,3525,),O
51713,3526,NSTE,B-Condition
51714,3526,-,I-Condition
51715,3526,ACS,I-Condition
51716,3526,with,O
51717,3526,cardiogenic,B-Condition
51718,3526,shock,I-Condition
51719,3526,warranting,B-Mood
51720,3526,emergent,O
51721,3526,salvage,B-Procedure
51722,3526,surgery,I-Procedure
51723,3526,within,O
51724,3526,12,O
51725,3526,hrs,O
51726,3526,from,O
51727,3526,hospital,O
51728,3526,admission,O
51729,3527,History,O
51730,3527,of,O
51731,3527,atrial,B-Condition
51732,3527,fibrillation,I-Condition
51733,3527,or,O
51734,3527,muscle,B-Condition
51735,3527,disease,I-Condition
51736,3527,(,O
51737,3527,myopathy,B-Condition
51738,3527,),O
51739,3528,Current,O
51740,3528,renal,B-Condition
51741,3528,(,I-Condition
51742,3528,creatinine>2x,I-Condition
51743,3528,upper,I-Condition
51744,3528,limit,I-Condition
51745,3528,of,I-Condition
51746,3528,normal,I-Condition
51747,3528,(,I-Condition
51748,3528,ULN,I-Condition
51749,3528,),I-Condition
51750,3528,",",I-Condition
51751,3528,dialysis,I-Condition
51752,3528,",",I-Condition
51753,3528,kidney,I-Condition
51754,3528,transplant,I-Condition
51755,3528,),I-Condition
51756,3528,or,I-Condition
51757,3528,hepatic,I-Condition
51758,3528,dysfunction,I-Condition
51759,3528,(,O
51760,3528,AST,O
51761,3528,/,O
51762,3528,ALT>2x,O
51763,3528,ULN,O
51764,3528,",",O
51765,3528,liver,B-Procedure
51766,3528,transplant,I-Procedure
51767,3528,or,O
51768,3528,neoplasm,B-Condition
51769,3528,),O
51770,3529,Inability,B-Mood
51771,3529,of,I-Mood
51772,3529,oral,B-Observation
51773,3529,drug,I-Observation
51774,3529,intake,I-Observation
51775,3530,Patients,O
51776,3530,on,O
51777,3530,chronic,O
51778,3530,statin,B-Drug
51779,3530,treatment,B-Procedure
51780,3530,(,O
51781,3530,>,O
51782,3530,30,O
51783,3530,days,O
51784,3530,),O
51785,3530,scheduled,B-Mood
51786,3530,for,O
51787,3530,isolated,O
51788,3530,CABG,B-Procedure
51789,3530,",",O
51790,3530,including,O
51791,3530,on-,O
51792,3530,or,O
51793,3530,off,O
51794,3530,-,O
51795,3530,pump,O
51796,3530,or,O
51797,3530,repeat,O
51798,3530,(,O
51799,3530,redo,O
51800,3530,'s,O
51801,3530,),O
51802,3530,revascularisation,B-Procedure
51803,3530,procedures,I-Procedure
51804,3531,Stable,B-Condition
51805,3531,or,I-Condition
51806,3531,unstable,I-Condition
51807,3531,angina,I-Condition
51808,3531,",",O
51809,3531,including,O
51810,3531,non,B-Condition
51811,3531,ST,I-Condition
51812,3531,-,I-Condition
51813,3531,segment,I-Condition
51814,3531,-,I-Condition
51815,3531,elevation,I-Condition
51816,3531,acute,I-Condition
51817,3531,coronary,I-Condition
51818,3531,syndrome,I-Condition
51819,3531,(,O
51820,3531,NSTE,B-Condition
51821,3531,-,I-Condition
51822,3531,ACS,I-Condition
51823,3531,),O
51824,3532,Age,B-Person
51825,3532,=,O
51826,3532,18,O
51827,3532,years,O
51828,3533,Written,O
51829,3533,informed,O
51830,3533,consent,O
51831,3534,Prior,O
51832,3534,treatment,O
51833,3534,with,O
51834,3534,cisplatin,B-Drug
51835,3534,before,O
51836,3534,randomization,O
51837,3535,Uncontrolled,O
51838,3535,concurrent,B-Condition
51839,3535,disease,I-Condition
51840,3536,Pregnancy,B-Condition
51841,3537,Age,B-Person
51842,3537,>,O
51843,3537,18,O
51844,3537,years,O
51845,3538,Eastern,O
51846,3538,Cooperative,O
51847,3538,Oncology,O
51848,3538,Group,O
51849,3538,score,O
51850,3538,0,O
51851,3538,-,O
51852,3538,2,O
51853,3539,First,O
51854,3539,Diagnosed,O
51855,3539,Head,B-Condition
51856,3539,and,I-Condition
51857,3539,neck,I-Condition
51858,3539,cancer,I-Condition
51859,3539,and,O
51860,3539,plan,B-Mood
51861,3539,for,O
51862,3539,treatment,O
51863,3539,with,O
51864,3539,cisplatin,B-Drug
51865,3540,Serum,O
51866,3540,creatinine,O
51867,3540,=,O
51868,3540,1.5,O
51869,3540,mg,O
51870,3540,/,O
51871,3540,dl,O
51872,3540,or,O
51873,3540,eGFR=60(ml,O
51874,3540,/,O
51875,3540,min/1.73,O
51876,3540,m2,O
51877,3540,),O
51878,3541,Diabetes,B-Condition
51879,3541,Mellitus,I-Condition
51880,3542,Acute,B-Condition
51881,3542,coronary,I-Condition
51882,3542,syndrome,I-Condition
51883,3542,in,O
51884,3542,the,O
51885,3542,past,O
51886,3542,6,O
51887,3542,months,O
51888,3543,Cardiac,B-Condition
51889,3543,arrhythmias,I-Condition
51890,3543,(,O
51891,3543,2nd,B-Condition
51892,3543,and,I-Condition
51893,3543,3rd,I-Condition
51894,3543,degree,I-Condition
51895,3543,heart,I-Condition
51896,3543,block,I-Condition
51897,3543,or,O
51898,3543,premature,B-Condition
51899,3543,ventricular,I-Condition
51900,3543,complexes,I-Condition
51901,3543,in,O
51902,3543,Lown,O
51903,3543,classes,O
51904,3543,4,O
51905,3543,or,O
51906,3543,5,O
51907,3543,),O
51908,3544,Symptoms,O
51909,3544,suggestive,O
51910,3544,of,O
51911,3544,obstructive,B-Condition
51912,3544,or,I-Condition
51913,3544,central,I-Condition
51914,3544,sleep,I-Condition
51915,3544,apnea,I-Condition
51916,3544,(,O
51917,3544,with,O
51918,3544,a,O
51919,3544,score,O
51920,3544,of,O
51921,3544,>,O
51922,3544,10,O
51923,3544,on,O
51924,3544,Epworth,O
51925,3544,sleepiness,O
51926,3544,scale,O
51927,3544,),O
51928,3545,Patients,O
51929,3545,taking,O
51930,3545,Clonidine,B-Drug
51931,3546,Body,O
51932,3546,mass,O
51933,3546,index,O
51934,3546,(,O
51935,3546,BMI,O
51936,3546,),O
51937,3546,>,O
51938,3546,34,O
51939,3547,Patients,O
51940,3547,unable,O
51941,3547,to,O
51942,3547,give,O
51943,3547,consent,O
51944,3548,Pregnant,O
51945,3548,women,O
51946,3549,Patients,O
51947,3549,with,O
51948,3549,leg,B-Condition
51949,3549,injury,I-Condition
51950,3549,involving,O
51951,3549,nerve,B-Condition
51952,3549,damage,I-Condition
51953,3550,Patients,O
51954,3550,taking,O
51955,3550,anticoagulant,B-Drug
51956,3550,medication,O
51957,3551,Patients,O
51958,3551,with,O
51959,3551,significant,O
51960,3551,bleeding,B-Condition
51961,3551,disorder,I-Condition
51962,3551,or,O
51963,3551,liver,B-Condition
51964,3551,disorder,I-Condition
51965,3552,Hemoglobin,O
51966,3552,<,O
51967,3552,1.05,O
51968,3552,g,O
51969,3552,/,O
51970,3552,dl,O
51971,3552,at,O
51972,3552,the,O
51973,3552,time,O
51974,3552,of,O
51975,3552,initiation,O
51976,3552,of,O
51977,3552,therapy,O
51978,3553,patients,O
51979,3553,with,O
51980,3553,unilateral,O
51981,3553,or,O
51982,3553,bilateral,O
51983,3553,nephrectomy,B-Procedure
51984,3554,Planned,O
51985,3554,kidney,B-Condition
51986,3554,transplant,I-Condition
51987,3554,in,O
51988,3554,the,O
51989,3554,next,O
51990,3554,4,O
51991,3554,months,O
51992,3555,Life,B-Observation
51993,3555,expectancy,I-Observation
51994,3555,under,O
51995,3555,6,O
51996,3555,months,O
51997,3556,Oliguria,B-Condition
51998,3556,(,O
51999,3556,urine,O
52000,3556,output,O
52001,3556,less,O
52002,3556,than,O
52003,3556,400,O
52004,3556,ml,O
52005,3556,per,O
52006,3556,day,O
52007,3556,),O
52008,3557,Adult,B-Person
52009,3557,(,O
52010,3557,age,B-Person
52011,3557,18,O
52012,3557,years,O
52013,3557,and,O
52014,3557,older,O
52015,3557,),O
52016,3558,Patients,O
52017,3558,with,O
52018,3558,end,B-Condition
52019,3558,-,I-Condition
52020,3558,stage,I-Condition
52021,3558,renal,I-Condition
52022,3558,disease(ESRD)/chronic,I-Condition
52023,3558,kidney,I-Condition
52024,3558,disease(CKD)stage,I-Condition
52025,3558,5,O
52026,3559,Decompensated,O
52027,3559,heart,B-Condition
52028,3559,failure,I-Condition
52029,3559,or,O
52030,3559,hemodynamic,B-Condition
52031,3559,instability,I-Condition
52032,3560,Prior,O
52033,3560,coronary,B-Condition
52034,3560,revascularization,I-Condition
52035,3560,(,O
52036,3560,PCI,B-Procedure
52037,3560,or,O
52038,3560,CABG,B-Procedure
52039,3560,),O
52040,3560,or,O
52041,3560,myocardial,B-Condition
52042,3560,infarction,I-Condition
52043,3560,(,O
52044,3560,as,O
52045,3560,evidenced,O
52046,3560,by,O
52047,3560,previously,O
52048,3560,elevated,O
52049,3560,CPK,O
52050,3560,-,O
52051,3560,MB,O
52052,3560,or,O
52053,3560,troponin,O
52054,3560,levels,O
52055,3560,),O
52056,3561,Accelerating,B-Condition
52057,3561,angina,I-Condition
52058,3561,or,O
52059,3561,unstable,B-Condition
52060,3561,angina,I-Condition
52061,3562,Inability,B-Condition
52062,3562,to,I-Condition
52063,3562,physically,I-Condition
52064,3562,tolerate,I-Condition
52065,3562,MRI,B-Procedure
52066,3562,or,O
52067,3562,implanted,O
52068,3562,objects,O
52069,3562,that,O
52070,3562,are,O
52071,3562,MRI,O
52072,3562,incompatible,O
52073,3563,Inability,O
52074,3563,to,O
52075,3563,provide,O
52076,3563,written,O
52077,3563,informed,O
52078,3563,consent,O
52079,3563,obtained,O
52080,3563,at,O
52081,3563,time,O
52082,3563,of,O
52083,3563,study,O
52084,3563,enrollment,O
52085,3563,.,O
52086,3564,Severe,O
52087,3564,claustrophobia,B-Condition
52088,3565,Advanced,O
52089,3565,heart,B-Condition
52090,3565,block,I-Condition
52091,3565,or,O
52092,3565,sinus,B-Condition
52093,3565,node,I-Condition
52094,3565,dysfunction,I-Condition
52095,3566,Hypersensitivity,B-Condition
52096,3566,or,O
52097,3566,allergic,B-Condition
52098,3566,reaction,O
52099,3566,to,O
52100,3566,regadenoson,B-Drug
52101,3566,or,O
52102,3566,adenosine,B-Drug
52103,3567,Hypotension,B-Condition
52104,3568,Active,O
52105,3568,bronchospasm,B-Condition
52106,3568,or,O
52107,3568,history,B-Observation
52108,3568,of,O
52109,3568,hospitalization,B-Procedure
52110,3568,due,O
52111,3568,to,O
52112,3568,bronchospasm,B-Condition
52113,3569,History,B-Observation
52114,3569,of,O
52115,3569,seizures,B-Condition
52116,3570,Recent,O
52117,3570,cerebrovascular,B-Condition
52118,3570,accident,I-Condition
52119,3571,Use,O
52120,3571,of,O
52121,3571,dipyridamole,B-Drug
52122,3571,within,O
52123,3571,the,O
52124,3571,last,O
52125,3571,5,O
52126,3571,days,O
52127,3572,Contraindication,B-Condition
52128,3572,to,O
52129,3572,aminophylline,B-Drug
52130,3573,Severe,O
52131,3573,renal,B-Condition
52132,3573,insufficiency,I-Condition
52133,3573,with,O
52134,3573,estimated,O
52135,3573,glomerular,O
52136,3573,filtration,O
52137,3573,rate,O
52138,3573,<,O
52139,3573,30,O
52140,3573,ml,O
52141,3573,/,O
52142,3573,min/,O
52143,3573,1.73,O
52144,3573,m2,O
52145,3574,Pregnant,B-Condition
52146,3574,or,O
52147,3574,nursing,B-Condition
52148,3575,Men,B-Person
52149,3575,or,O
52150,3575,women,B-Person
52151,3575,aged,B-Person
52152,3575,18,O
52153,3575,years,O
52154,3575,or,O
52155,3575,older,O
52156,3576,Patients,O
52157,3576,presenting,O
52158,3576,for,O
52159,3576,CMR,O
52160,3576,with,O
52161,3576,the,O
52162,3576,clinical,O
52163,3576,diagnosis,O
52164,3576,of,O
52165,3576,hypertrophic,B-Condition
52166,3576,cardiomyopathy,I-Condition
52167,3576,based,O
52168,3576,on,O
52169,3576,left,O
52170,3576,ventricular,O
52171,3576,wall,O
52172,3576,thickness,O
52173,3576,of,O
52174,3576,at,O
52175,3576,least,O
52176,3576,=,O
52177,3576,15,O
52178,3576,mm,O
52179,3576,in,O
52180,3576,the,O
52181,3576,absence,O
52182,3576,of,O
52183,3576,any,O
52184,3576,other,O
52185,3576,cardiac,B-Condition
52186,3576,or,I-Condition
52187,3576,systemic,I-Condition
52188,3576,cause,I-Condition
52189,3576,of,I-Condition
52190,3576,hypertrophy,I-Condition
52191,3577,Patients,O
52192,3577,presenting,O
52193,3577,for,O
52194,3577,CMR,O
52195,3577,with,O
52196,3577,the,O
52197,3577,clinical,O
52198,3577,diagnosis,O
52199,3577,of,O
52200,3577,idiopathic,B-Condition
52201,3577,dilated,I-Condition
52202,3577,cardiomyopathy,I-Condition
52203,3577,based,O
52204,3577,upon,O
52205,3577,left,O
52206,3577,ventricular,O
52207,3577,ejection,O
52208,3577,fraction,O
52209,3577,=,O
52210,3577,40,O
52211,3577,%,O
52212,3577,",",O
52213,3577,LV,O
52214,3577,end,O
52215,3577,-,O
52216,3577,diastolic,O
52217,3577,diameter,O
52218,3577,=,O
52219,3577,55,O
52220,3577,mm,O
52221,3577,or,O
52222,3577,left,O
52223,3577,ventricular,O
52224,3577,end,O
52225,3577,-,O
52226,3577,systolic,O
52227,3577,diameter,O
52228,3577,=,O
52229,3577,45,O
52230,3577,mm,O
52231,3577,",",O
52232,3577,and,O
52233,3577,the,O
52234,3577,absence,O
52235,3577,of,O
52236,3577,coronary,B-Condition
52237,3577,stenoses,I-Condition
52238,3577,on,O
52239,3577,angiography,B-Procedure
52240,3577,.,O
52241,3578,Patients,O
52242,3578,presenting,O
52243,3578,for,O
52244,3578,CMR,O
52245,3578,evaluation,O
52246,3578,of,O
52247,3578,chest,B-Condition
52248,3578,pain,I-Condition
52249,3578,but,O
52250,3578,without,O
52251,3578,evidence,O
52252,3578,of,O
52253,3578,obstructive,B-Condition
52254,3578,coronary,I-Condition
52255,3578,artery,I-Condition
52256,3578,disease,I-Condition
52257,3578,either,O
52258,3578,by,O
52259,3578,coronary,B-Procedure
52260,3578,angiography,I-Procedure
52261,3578,or,O
52262,3578,stress,B-Procedure
52263,3578,testing,I-Procedure
52264,3578,.,O
52265,3579,Children,O
52266,3579,who,O
52267,3579,are,O
52268,3579,uncooperative,B-Condition
52269,3579,and,O
52270,3579,difficult,B-Observation
52271,3579,to,I-Observation
52272,3579,manage,I-Observation
52273,3579,",",O
52274,3579,have,O
52275,3579,major,O
52276,3579,systemic,B-Condition
52277,3579,diseases,I-Condition
52278,3579,",",O
52279,3579,or,O
52280,3579,are,O
52281,3579,on,O
52282,3579,long,O
52283,3579,-,O
52284,3579,term,O
52285,3579,medication,B-Drug
52286,3579,will,O
52287,3579,be,O
52288,3579,excluded,O
52289,3579,.,O
52290,3580,Kindergarteners,B-Person
52291,3580,who,O
52292,3580,have,O
52293,3580,joined,O
52294,3580,our,O
52295,3580,outreach,O
52296,3580,dental,O
52297,3580,service,O
52298,3580,will,O
52299,3580,be,O
52300,3580,invited,O
52301,3580,to,O
52302,3580,join,O
52303,3580,this,O
52304,3580,study,O
52305,3580,.,O
52306,3580,Preschool,B-Person
52307,3580,children,I-Person
52308,3580,aged,B-Person
52309,3580,3,O
52310,3580,-,O
52311,3580,4,O
52312,3580,years,O
52313,3580,who,O
52314,3580,have,O
52315,3580,tooth,B-Condition
52316,3580,decay,I-Condition
52317,3580,and,O
52318,3580,are,O
52319,3580,attending,O
52320,3580,the,O
52321,3580,first,O
52322,3580,year,O
52323,3580,of,O
52324,3580,kindergarten,O
52325,3580,will,O
52326,3580,be,O
52327,3580,invited,O
52328,3580,to,O
52329,3580,join,O
52330,3580,this,O
52331,3580,study,O
52332,3580,.,O
52333,3581,1,O
52334,3581,.,O
52335,3581,Prior,O
52336,3581,exposure,O
52337,3581,to,O
52338,3581,doxorubicin,B-Drug
52339,3581,",",O
52340,3581,PLD,B-Drug
52341,3581,or,O
52342,3581,any,O
52343,3581,other,O
52344,3581,anthracycline,B-Drug
52345,3581,",",O
52346,3581,motolimod,B-Drug
52347,3581,and,O
52348,3581,other,O
52349,3581,TLR,B-Drug
52350,3581,agonists,I-Drug
52351,3581,",",O
52352,3581,MEDI4736,B-Drug
52353,3581,or,O
52354,3581,checkpoint,B-Drug
52355,3581,inhibitors,I-Drug
52356,3581,",",O
52357,3581,such,O
52358,3581,as,O
52359,3581,anti,B-Drug
52360,3581,-,I-Drug
52361,3581,CTLA4,I-Drug
52362,3581,and,O
52363,3581,anti,B-Drug
52364,3581,-,I-Drug
52365,3581,PD1,I-Drug
52366,3581,/,I-Drug
52367,3581,anti,I-Drug
52368,3581,-,I-Drug
52369,3581,PD,I-Drug
52370,3581,-,I-Drug
52371,3581,L1,I-Drug
52372,3581,antibodies,I-Drug
52373,3581,.,O
52374,3582,2,O
52375,3582,.,O
52376,3582,Subjects,O
52377,3582,with,O
52378,3582,platinum,B-Condition
52379,3582,-,I-Condition
52380,3582,refractory,I-Condition
52381,3582,disease,I-Condition
52382,3582,",",O
52383,3582,defined,O
52384,3582,as,O
52385,3582,disease,B-Condition
52386,3582,progression,I-Condition
52387,3582,while,O
52388,3582,receiving,O
52389,3582,first,O
52390,3582,line,O
52391,3582,platinum,O
52392,3582,-,O
52393,3582,based,O
52394,3582,therapy,O
52395,3582,.,O
52396,3583,3,O
52397,3583,.,O
52398,3583,Clinically,O
52399,3583,significant,O
52400,3583,persistent,O
52401,3583,immune,B-Condition
52402,3583,-,I-Condition
52403,3583,related,I-Condition
52404,3583,adverse,I-Condition
52405,3583,events,I-Condition
52406,3583,following,O
52407,3583,prior,O
52408,3583,therapy,O
52409,3583,.,O
52410,3584,4,O
52411,3584,.,O
52412,3584,Subjects,O
52413,3584,with,O
52414,3584,history,O
52415,3584,or,O
52416,3584,evidence,O
52417,3584,upon,O
52418,3584,physical,O
52419,3584,examination,O
52420,3584,of,O
52421,3584,CNS,B-Condition
52422,3584,disease,I-Condition
52423,3584,",",O
52424,3584,including,O
52425,3584,primary,B-Condition
52426,3584,brain,I-Condition
52427,3584,tumor,I-Condition
52428,3584,",",O
52429,3584,seizures,B-Condition
52430,3584,not,O
52431,3584,controlled,O
52432,3584,with,O
52433,3584,standard,B-Drug
52434,3584,medical,I-Drug
52435,3584,therapy,I-Drug
52436,3584,",",O
52437,3584,any,O
52438,3584,brain,B-Condition
52439,3584,metastases,I-Condition
52440,3584,",",O
52441,3584,or,O
52442,3584,",",O
52443,3584,within,O
52444,3584,six,O
52445,3584,months,O
52446,3584,prior,O
52447,3584,to,O
52448,3584,Day,O
52449,3584,1,O
52450,3584,of,O
52451,3584,this,O
52452,3584,study,O
52453,3584,",",O
52454,3584,history,O
52455,3584,of,O
52456,3584,cerebrovascular,B-Condition
52457,3584,accident,I-Condition
52458,3584,(,O
52459,3584,CVA,B-Condition
52460,3584,",",O
52461,3584,stroke,B-Condition
52462,3584,),O
52463,3584,",",O
52464,3584,transient,B-Condition
52465,3584,ischemic,I-Condition
52466,3584,attack,I-Condition
52467,3584,(,I-Condition
52468,3584,TIA,I-Condition
52469,3584,),I-Condition
52470,3584,or,O
52471,3584,subarachnoid,B-Condition
52472,3584,hemorrhage,I-Condition
52473,3584,.,O
52474,3585,5,O
52475,3585,.,O
52476,3585,Subjects,O
52477,3585,with,O
52478,3585,clinically,O
52479,3585,significant,O
52480,3585,cardiovascular,B-Condition
52481,3585,disease,I-Condition
52482,3585,.,O
52483,3585,This,O
52484,3585,includes,O
52485,3585,:,O
52486,3586,1,O
52487,3586,.,O
52488,3586,Resisted,B-Condition
52489,3586,hypertension,I-Condition
52490,3587,2,O
52491,3587,.,O
52492,3587,Myocardial,B-Condition
52493,3587,infarction,I-Condition
52494,3587,or,O
52495,3587,unstable,B-Condition
52496,3587,angina,I-Condition
52497,3587,within,O
52498,3587,6,O
52499,3587,months,O
52500,3587,prior,O
52501,3587,to,O
52502,3587,Day,O
52503,3587,1,O
52504,3587,of,O
52505,3587,the,O
52506,3587,study,O
52507,3587,.,O
52508,3588,3,O
52509,3588,.,O
52510,3588,History,B-Observation
52511,3588,of,O
52512,3588,serious,O
52513,3588,ventricular,B-Condition
52514,3588,arrhythmia,I-Condition
52515,3588,(,O
52516,3588,i.e.,O
52517,3588,",",O
52518,3588,ventricular,B-Condition
52519,3588,tachycardia,I-Condition
52520,3588,or,O
52521,3588,ventricular,B-Condition
52522,3588,fibrillation,I-Condition
52523,3588,),O
52524,3588,or,O
52525,3588,cardiac,B-Condition
52526,3588,arrhythmias,I-Condition
52527,3588,requiring,O
52528,3588,anti,B-Drug
52529,3588,-,I-Drug
52530,3588,arrhythmic,I-Drug
52531,3588,medications,I-Drug
52532,3588,",",O
52533,3588,except,O
52534,3588,for,O
52535,3588,atrial,B-Condition
52536,3588,fibrillation,I-Condition
52537,3588,that,O
52538,3588,is,O
52539,3588,well,O
52540,3588,controlled,O
52541,3588,with,O
52542,3588,anti,B-Drug
52543,3588,-,I-Drug
52544,3588,arrhythmic,I-Drug
52545,3588,medication,I-Drug
52546,3588,.,O
52547,3589,4,O
52548,3589,.,O
52549,3589,Baseline,O
52550,3589,ejection,O
52551,3589,fraction,O
52552,3589,≤,O
52553,3589,50,O
52554,3589,%,O
52555,3589,as,O
52556,3589,assessed,O
52557,3589,by,O
52558,3589,echocardiogram,B-Procedure
52559,3589,or,O
52560,3589,MUGA,B-Procedure
52561,3589,.,O
52562,3590,5,O
52563,3590,.,O
52564,3590,New,O
52565,3590,York,O
52566,3590,Heart,O
52567,3590,Association,O
52568,3590,(,O
52569,3590,NYHA,O
52570,3590,),O
52571,3590,Class,O
52572,3590,II,O
52573,3590,or,O
52574,3590,higher,O
52575,3590,congestive,B-Condition
52576,3590,heart,I-Condition
52577,3590,failure,I-Condition
52578,3590,.,O
52579,3591,6,O
52580,3591,.,O
52581,3591,Grade,O
52582,3591,2,O
52583,3591,or,O
52584,3591,higher,O
52585,3591,peripheral,B-Condition
52586,3591,ischemia,I-Condition
52587,3591,",",O
52588,3591,except,O
52589,3591,for,O
52590,3591,brief,O
52591,3591,(,O
52592,3591,<,O
52593,3591,24,O
52594,3591,hrs,O
52595,3591,),O
52596,3591,episodes,O
52597,3591,of,O
52598,3591,ischemia,B-Condition
52599,3591,managed,O
52600,3591,non,O
52601,3591,-,O
52602,3591,surgically,B-Procedure
52603,3591,and,O
52604,3591,without,O
52605,3591,permanent,B-Condition
52606,3591,deficit,I-Condition
52607,3591,.,O
52608,3592,6,O
52609,3592,.,O
52610,3592,History,B-Observation
52611,3592,of,O
52612,3592,pneumonitis,B-Condition
52613,3592,or,O
52614,3592,interstitial,B-Condition
52615,3592,lung,I-Condition
52616,3592,disease,I-Condition
52617,3592,.,O
52618,3593,7,O
52619,3593,.,O
52620,3593,Active,O
52621,3593,",",O
52622,3593,suspected,O
52623,3593,or,O
52624,3593,prior,O
52625,3593,documented,O
52626,3593,autoimmune,B-Condition
52627,3593,disease,I-Condition
52628,3593,(,O
52629,3593,including,O
52630,3593,inflammatory,B-Condition
52631,3593,bowel,I-Condition
52632,3593,disease,I-Condition
52633,3593,",",O
52634,3593,celiac,B-Condition
52635,3593,disease,I-Condition
52636,3593,",",O
52637,3593,Wegner,B-Condition
52638,3593,'s,I-Condition
52639,3593,granulomatosis,I-Condition
52640,3593,",",O
52641,3593,active,O
52642,3593,Hashimoto,B-Condition
52643,3593,'s,I-Condition
52644,3593,thyroiditis,I-Condition
52645,3593,",",O
52646,3593,rheumatoid,B-Condition
52647,3593,arthritis,I-Condition
52648,3593,",",O
52649,3593,lupus,B-Condition
52650,3593,",",O
52651,3593,scleroderma,B-Condition
52652,3593,and,I-Condition
52653,3593,its,I-Condition
52654,3593,variants,I-Condition
52655,3593,",",O
52656,3593,multiple,B-Condition
52657,3593,sclerosis,I-Condition
52658,3593,",",O
52659,3593,myasthenia,B-Condition
52660,3593,gravis,I-Condition
52661,3593,),O
52662,3593,.,O
52663,3593,Vitiligo,B-Condition
52664,3593,",",O
52665,3593,type,B-Condition
52666,3593,I,I-Condition
52667,3593,diabetes,I-Condition
52668,3593,mellitus,I-Condition
52669,3593,",",O
52670,3593,residual,B-Condition
52671,3593,hypothyroidism,I-Condition
52672,3593,due,O
52673,3593,to,O
52674,3593,autoimmune,B-Condition
52675,3593,condition,I-Condition
52676,3593,only,O
52677,3593,requiring,O
52678,3593,hormone,B-Drug
52679,3593,replacement,I-Drug
52680,3593,",",O
52681,3593,psoriasis,B-Condition
52682,3593,not,O
52683,3593,requiring,O
52684,3593,systemic,B-Procedure
52685,3593,treatment,I-Procedure
52686,3593,",",O
52687,3593,or,O
52688,3593,conditions,B-Condition
52689,3593,not,O
52690,3593,expected,O
52691,3593,to,O
52692,3593,recur,O
52693,3593,in,O
52694,3593,the,O
52695,3593,absence,O
52696,3593,of,O
52697,3593,an,O
52698,3593,external,O
52699,3593,trigger,O
52700,3593,are,O
52701,3593,permitted,O
52702,3593,.,O
52703,3594,8,O
52704,3594,.,O
52705,3594,Other,O
52706,3594,malignancy,B-Condition
52707,3594,within,O
52708,3594,2,O
52709,3594,years,O
52710,3594,prior,O
52711,3594,to,O
52712,3594,Day,O
52713,3594,1,O
52714,3594,of,O
52715,3594,the,O
52716,3594,study,O
52717,3594,",",O
52718,3594,except,O
52719,3594,for,O
52720,3594,those,B-Condition
52721,3594,treated,O
52722,3594,with,O
52723,3594,surgical,B-Procedure
52724,3594,intervention,I-Procedure
52725,3594,only,O
52726,3594,.,O
52727,3595,9,O
52728,3595,.,O
52729,3595,Subjects,O
52730,3595,with,O
52731,3595,clinical,B-Condition
52732,3595,symptoms,I-Condition
52733,3595,or,I-Condition
52734,3595,signs,I-Condition
52735,3595,of,I-Condition
52736,3595,gastrointestinal,I-Condition
52737,3595,obstruction,I-Condition
52738,3595,and/or,O
52739,3595,who,O
52740,3595,require,O
52741,3595,drainage,O
52742,3595,gastrostomy,O
52743,3595,tube,O
52744,3595,and/or,O
52745,3595,parenteral,B-Procedure
52746,3595,hydration,I-Procedure
52747,3595,or,I-Procedure
52748,3595,nutrition,I-Procedure
52749,3595,.,O
52750,3596,10,O
52751,3596,.,O
52752,3596,Known,O
52753,3596,immunodeficiency,B-Condition
52754,3596,or,O
52755,3596,HIV,B-Condition
52756,3596,",",O
52757,3596,Hepatitis,B-Condition
52758,3596,B,I-Condition
52759,3596,or,O
52760,3596,Hepatitis,B-Condition
52761,3596,C,I-Condition
52762,3596,positivity,O
52763,3596,.,O
52764,3597,11,O
52765,3597,.,O
52766,3597,History,B-Observation
52767,3597,of,O
52768,3597,severe,O
52769,3597,allergic,B-Condition
52770,3597,reactions,I-Condition
52771,3597,to,B-Drug
52772,3597,any,I-Drug
52773,3597,unknown,I-Drug
52774,3597,allergens,I-Drug
52775,3597,or,I-Drug
52776,3597,components,I-Drug
52777,3597,of,I-Drug
52778,3597,the,I-Drug
52779,3597,study,I-Drug
52780,3597,drugs,I-Drug
52781,3597,.,O
52782,3598,12,O
52783,3598,.,O
52784,3598,Other,O
52785,3598,serious,O
52786,3598,illnesses,B-Condition
52787,3598,(,O
52788,3598,e.g.,O
52789,3598,",",O
52790,3598,serious,O
52791,3598,infections,B-Condition
52792,3598,requiring,I-Condition
52793,3598,antibiotics,I-Condition
52794,3598,",",O
52795,3598,bleeding,B-Condition
52796,3598,disorders,I-Condition
52797,3598,),O
52798,3598,.,O
52799,3599,13,O
52800,3599,.,O
52801,3599,Prior,O
52802,3599,treatment,B-Procedure
52803,3599,in,O
52804,3599,any,O
52805,3599,other,O
52806,3599,interventional,O
52807,3599,clinical,O
52808,3599,trial,O
52809,3599,within,O
52810,3599,4,O
52811,3599,weeks,O
52812,3599,prior,O
52813,3599,to,O
52814,3599,Day,O
52815,3599,1,O
52816,3599,of,O
52817,3599,the,O
52818,3599,study,O
52819,3599,.,O
52820,3600,14,O
52821,3600,.,O
52822,3600,Mental,B-Condition
52823,3600,impairment,I-Condition
52824,3600,that,O
52825,3600,may,O
52826,3600,compromise,B-Observation
52827,3600,compliance,I-Observation
52828,3600,with,O
52829,3600,the,O
52830,3600,requirements,O
52831,3600,of,O
52832,3600,the,O
52833,3600,study,O
52834,3600,.,O
52835,3601,15,O
52836,3601,.,O
52837,3601,Lack,O
52838,3601,of,O
52839,3601,availability,B-Mood
52840,3601,for,I-Mood
52841,3601,immunological,B-Procedure
52842,3601,and,I-Procedure
52843,3601,clinical,I-Procedure
52844,3601,follow,I-Procedure
52845,3601,-,I-Procedure
52846,3601,up,I-Procedure
52847,3601,assessment,I-Procedure
52848,3601,.,O
52849,3602,16,O
52850,3602,.,O
52851,3602,Women,B-Person
52852,3602,who,O
52853,3602,are,O
52854,3602,breastfeeding,B-Observation
52855,3602,or,O
52856,3602,pregnant,B-Condition
52857,3602,as,O
52858,3602,evidenced,O
52859,3602,by,O
52860,3602,positive,O
52861,3602,serum,O
52862,3602,pregnancy,O
52863,3602,test,O
52864,3603,17,O
52865,3603,.,O
52866,3603,Subjects,O
52867,3603,unwilling,B-Condition
52868,3603,to,O
52869,3603,use,O
52870,3603,acceptable,O
52871,3603,methods,O
52872,3603,of,O
52873,3603,contraception,B-Procedure
52874,3603,.,O
52875,3604,-Female,O
52876,3604,subjects,O
52877,3604,should,O
52878,3604,refrain,O
52879,3604,from,O
52880,3604,breastfeeding,B-Observation
52881,3604,throughout,O
52882,3604,this,O
52883,3604,period,O
52884,3604,.,O
52885,3605,18,O
52886,3605,.,O
52887,3605,Any,O
52888,3605,condition,O
52889,3605,that,O
52890,3605,",",O
52891,3605,in,O
52892,3605,the,O
52893,3605,clinical,O
52894,3605,judgment,O
52895,3605,of,O
52896,3605,the,O
52897,3605,treating,O
52898,3605,physician,O
52899,3605,",",O
52900,3605,is,O
52901,3605,likely,O
52902,3605,to,O
52903,3605,prevent,O
52904,3605,the,O
52905,3605,subject,O
52906,3605,from,O
52907,3605,complying,O
52908,3605,with,O
52909,3605,any,O
52910,3605,aspect,O
52911,3605,of,O
52912,3605,the,O
52913,3605,protocol,O
52914,3605,or,O
52915,3605,that,O
52916,3605,may,O
52917,3605,put,O
52918,3605,the,O
52919,3605,subject,O
52920,3605,at,O
52921,3605,unacceptable,O
52922,3605,risk,O
52923,3605,.,O
52924,3606,19,O
52925,3606,.,O
52926,3606,Subjects,O
52927,3606,must,O
52928,3606,not,O
52929,3606,donate,B-Procedure
52930,3606,blood,I-Procedure
52931,3606,while,O
52932,3606,on,O
52933,3606,study,O
52934,3606,and,O
52935,3606,for,O
52936,3606,at,O
52937,3606,least,O
52938,3606,90,O
52939,3606,days,O
52940,3606,following,O
52941,3606,the,O
52942,3606,last,O
52943,3606,MEDI4736,O
52944,3606,treatment,O
52945,3606,.,O
52946,3607,20,O
52947,3607,.,O
52948,3607,History,B-Observation
52949,3607,of,O
52950,3607,allogeneic,B-Procedure
52951,3607,organ,I-Procedure
52952,3607,transplant,I-Procedure
52953,3608,1,O
52954,3608,.,O
52955,3608,Subjects,O
52956,3608,must,O
52957,3608,have,O
52958,3608,recurrent,O
52959,3608,or,O
52960,3608,persistent,O
52961,3608,platinum,O
52962,3608,-,O
52963,3608,resistant,O
52964,3608,epithelial,O
52965,3608,ovarian,O
52966,3608,",",O
52967,3608,fallopian,O
52968,3608,tube,O
52969,3608,",",O
52970,3608,or,O
52971,3608,primary,B-Condition
52972,3608,peritoneal,I-Condition
52973,3608,carcinoma,I-Condition
52974,3608,with,O
52975,3608,measureable,B-Condition
52976,3608,disease,I-Condition
52977,3608,(,O
52978,3608,as,O
52979,3608,defined,O
52980,3608,by,O
52981,3608,RECIST,O
52982,3608,1.1,O
52983,3608,.,O
52984,3608,),O
52985,3608,after,O
52986,3608,first,O
52987,3608,or,O
52988,3608,second,O
52989,3608,line,O
52990,3608,platinum,O
52991,3608,-,O
52992,3608,based,O
52993,3608,chemotherapy,O
52994,3608,",",O
52995,3608,for,O
52996,3608,which,O
52997,3608,treatment,B-Procedure
52998,3608,with,I-Procedure
52999,3608,PLD,I-Procedure
53000,3608,is,O
53001,3608,indicated,O
53002,3608,.,O
53003,3608,Platinum,B-Procedure
53004,3608,-,I-Procedure
53005,3608,based,I-Procedure
53006,3608,therapy,I-Procedure
53007,3608,is,O
53008,3608,defined,O
53009,3608,as,O
53010,3608,treatment,O
53011,3608,with,O
53012,3608,carboplatin,B-Drug
53013,3608,",",O
53014,3608,cisplatin,B-Drug
53015,3608,or,O
53016,3608,another,B-Drug
53017,3608,organoplatinum,I-Drug
53018,3608,compound,I-Drug
53019,3608,.,O
53020,3608,Platinum,B-Condition
53021,3608,-,I-Condition
53022,3608,resistant,I-Condition
53023,3608,is,O
53024,3608,defined,O
53025,3608,as,O
53026,3608,having,O
53027,3608,a,O
53028,3608,platinum,O
53029,3608,-,O
53030,3608,free,O
53031,3608,interval,O
53032,3608,(,O
53033,3608,PFI,O
53034,3608,),O
53035,3608,of,O
53036,3608,<,O
53037,3608,12,O
53038,3608,months,O
53039,3608,after,O
53040,3608,first-,O
53041,3608,or,O
53042,3608,second,O
53043,3608,-,O
53044,3608,line,O
53045,3608,platinum,O
53046,3608,-,O
53047,3608,based,O
53048,3608,chemotherapy,O
53049,3608,",",O
53050,3608,or,O
53051,3608,having,O
53052,3608,disease,B-Condition
53053,3608,progression,I-Condition
53054,3608,while,O
53055,3608,receiving,O
53056,3608,second,B-Procedure
53057,3608,-,I-Procedure
53058,3608,line,I-Procedure
53059,3608,platinum,I-Procedure
53060,3608,-,I-Procedure
53061,3608,based,I-Procedure
53062,3608,chemotherapy,I-Procedure
53063,3608,.,O
53064,3609,Subjects,O
53065,3609,are,O
53066,3609,allowed,O
53067,3609,to,O
53068,3609,have,O
53069,3609,received,O
53070,3609,",",O
53071,3609,but,O
53072,3609,are,O
53073,3609,not,O
53074,3609,required,O
53075,3609,to,O
53076,3609,have,O
53077,3609,received,O
53078,3609,:,O
53079,3610,one,O
53080,3610,additional,O
53081,3610,cytotoxic,B-Drug
53082,3610,regimen,I-Drug
53083,3610,and/or,O
53084,3610,PARP,B-Drug
53085,3610,inhibitor,I-Drug
53086,3610,for,O
53087,3610,management,O
53088,3610,of,O
53089,3610,recurrent,O
53090,3610,or,O
53091,3610,persistent,O
53092,3610,disease,B-Condition
53093,3610,.,O
53094,3611,biologic,B-Procedure
53095,3611,therapy,I-Procedure
53096,3611,(,O
53097,3611,e.g.,O
53098,3611,",",O
53099,3611,bevacizumab,B-Drug
53100,3611,),O
53101,3611,as,O
53102,3611,part,O
53103,3611,of,O
53104,3611,their,O
53105,3611,primary,B-Procedure
53106,3611,treatment,I-Procedure
53107,3611,regimen,I-Procedure
53108,3611,or,O
53109,3611,part,O
53110,3611,of,O
53111,3611,their,O
53112,3611,treatment,B-Procedure
53113,3611,for,O
53114,3611,management,O
53115,3611,of,O
53116,3611,recurrent,O
53117,3611,or,O
53118,3611,persistent,O
53119,3611,disease,B-Condition
53120,3611,.,O
53121,3612,2,O
53122,3612,.,O
53123,3612,Histologic,B-Procedure
53124,3612,documentation,O
53125,3612,of,O
53126,3612,the,O
53127,3612,original,B-Condition
53128,3612,primary,I-Condition
53129,3612,tumor,I-Condition
53130,3612,.,O
53131,3613,3,O
53132,3613,.,O
53133,3613,Documented,O
53134,3613,radiographic,B-Procedure
53135,3613,disease,B-Condition
53136,3613,progression,I-Condition
53137,3613,<,O
53138,3613,12,O
53139,3613,months,O
53140,3613,after,O
53141,3613,the,O
53142,3613,last,O
53143,3613,dose,O
53144,3613,of,O
53145,3613,first-,O
53146,3613,or,O
53147,3613,second,O
53148,3613,-,O
53149,3613,line,O
53150,3613,platinum,O
53151,3613,-,O
53152,3613,based,O
53153,3613,chemotherapy,O
53154,3613,.,O
53155,3614,4,O
53156,3614,.,O
53157,3614,Subjects,O
53158,3614,in,O
53159,3614,Phase,O
53160,3614,2,O
53161,3614,must,O
53162,3614,have,O
53163,3614,disease,B-Condition
53164,3614,amenable,I-Condition
53165,3614,to,I-Condition
53166,3614,biopsy,I-Condition
53167,3614,and,O
53168,3614,must,O
53169,3614,be,O
53170,3614,willing,O
53171,3614,to,O
53172,3614,undergo,O
53173,3614,pre-,O
53174,3614,and,O
53175,3614,post,O
53176,3614,-,O
53177,3614,treatment,O
53178,3614,tumor,O
53179,3614,biopsies,O
53180,3614,.,O
53181,3614,Optional,O
53182,3614,for,O
53183,3614,Phase,O
53184,3614,1,O
53185,3614,.,O
53186,3615,Note,O
53187,3615,:,O
53188,3615,archival,O
53189,3615,tissue,O
53190,3615,will,O
53191,3615,be,O
53192,3615,requested,O
53193,3615,for,O
53194,3615,all,O
53195,3615,subjects,O
53196,3615,preferably,O
53197,3615,from,O
53198,3615,primary,O
53199,3615,tumor,O
53200,3615,site,O
53201,3615,prior,O
53202,3615,to,O
53203,3615,cancer,O
53204,3615,treatment,O
53205,3615,;,O
53206,3615,however,O
53207,3615,",",O
53208,3615,archival,O
53209,3615,tissue,O
53210,3615,is,O
53211,3615,not,O
53212,3615,a,O
53213,3615,requirement,O
53214,3615,for,O
53215,3615,study,O
53216,3615,entry,O
53217,3615,.,O
53218,3616,5,O
53219,3616,.,O
53220,3616,ECOG,O
53221,3616,performance,O
53222,3616,status,O
53223,3616,of,O
53224,3616,0,O
53225,3616,or,O
53226,3616,1,O
53227,3616,.,O
53228,3617,6,O
53229,3617,.,O
53230,3617,Laboratory,O
53231,3617,parameters,O
53232,3617,for,O
53233,3617,vital,O
53234,3617,functions,O
53235,3617,should,O
53236,3617,be,O
53237,3617,in,O
53238,3617,the,O
53239,3617,normal,O
53240,3617,range,O
53241,3617,.,O
53242,3617,Laboratory,O
53243,3617,abnormalities,O
53244,3617,that,O
53245,3617,are,O
53246,3617,not,O
53247,3617,clinically,O
53248,3617,significant,O
53249,3617,are,O
53250,3617,generally,O
53251,3617,permitted,O
53252,3617,",",O
53253,3617,except,O
53254,3617,for,O
53255,3617,the,O
53256,3617,following,O
53257,3617,laboratory,O
53258,3617,parameters,O
53259,3617,",",O
53260,3617,which,O
53261,3617,must,O
53262,3617,be,O
53263,3617,within,O
53264,3617,the,O
53265,3617,ranges,O
53266,3617,specified,O
53267,3617,",",O
53268,3617,regardless,O
53269,3617,of,O
53270,3617,clinical,O
53271,3617,significance,O
53272,3617,:,O
53273,3618,Hemoglobin,O
53274,3618,:,O
53275,3618,≥,O
53276,3618,9,O
53277,3618,g,O
53278,3618,/,O
53279,3618,dL,O
53280,3619,Neutrophil,O
53281,3619,count,O
53282,3619,:,O
53283,3619,≥,O
53284,3619,1.5,O
53285,3619,x,O
53286,3619,109,O
53287,3619,/,O
53288,3619,L,O
53289,3620,Platelet,O
53290,3620,count,O
53291,3620,:,O
53292,3620,≥,O
53293,3620,"100,000",O
53294,3620,/,O
53295,3620,mm3,O
53296,3621,Serum,O
53297,3621,creatinine,O
53298,3621,",",O
53299,3621,≤,O
53300,3621,1.5x,O
53301,3621,Institutional,O
53302,3621,Upper,O
53303,3621,Limit,O
53304,3621,of,O
53305,3621,Normal,O
53306,3621,(,O
53307,3621,ULN,O
53308,3621,),O
53309,3621,",",O
53310,3621,or,O
53311,3621,Creatinine,O
53312,3621,Clearance,O
53313,3621,≥,O
53314,3621,50,O
53315,3621,mL,O
53316,3621,/,O
53317,3621,min,O
53318,3621,(,O
53319,3621,by,O
53320,3621,Cockcroft,O
53321,3621,-,O
53322,3621,Gault,O
53323,3621,formula,O
53324,3621,),O
53325,3622,Serum,O
53326,3622,bilirubin,O
53327,3622,:,O
53328,3622,≤,O
53329,3622,1.2,O
53330,3622,mg,O
53331,3622,/,O
53332,3622,dL,O
53333,3623,AST,O
53334,3623,/,O
53335,3623,ALT,O
53336,3623,:,O
53337,3623,≤,O
53338,3623,2.5,O
53339,3623,x,O
53340,3623,ULN,O
53341,3624,Alkaline,O
53342,3624,phosphatase,O
53343,3624,:,O
53344,3624,≤,O
53345,3624,2.5,O
53346,3624,x,O
53347,3624,ULN,O
53348,3625,7,O
53349,3625,.,O
53350,3625,Age,B-Person
53351,3625,≥18,O
53352,3625,years,O
53353,3625,.,O
53354,3626,8,O
53355,3626,.,O
53356,3626,Able,O
53357,3626,and,O
53358,3626,willing,O
53359,3626,to,O
53360,3626,give,O
53361,3626,valid,O
53362,3626,written,O
53363,3626,informed,O
53364,3626,consent,O
53365,3626,.,O
53366,3627,9,O
53367,3627,.,O
53368,3627,Body,O
53369,3627,weight,O
53370,3627,>,O
53371,3627,30,O
53372,3627,kg,O
53373,3628,Allergy,B-Condition
53374,3628,",",O
53375,3628,sensitivity,B-Condition
53376,3628,",",O
53377,3628,or,O
53378,3628,absolute,O
53379,3628,contraindications,B-Condition
53380,3628,to,O
53381,3628,any,O
53382,3628,of,O
53383,3628,the,O
53384,3628,medications,B-Drug
53385,3628,involved,O
53386,3628,in,O
53387,3628,the,O
53388,3628,study,O
53389,3629,preexisting,O
53390,3629,CNS,B-Condition
53391,3629,depression,I-Condition
53392,3629,",",O
53393,3629,or,O
53394,3629,taking,O
53395,3629,regularly,O
53396,3629,medication,B-Drug
53397,3629,that,O
53398,3629,cause,O
53399,3629,CNS,B-Condition
53400,3629,depression,I-Condition
53401,3630,preexisting,O
53402,3630,cognitive,B-Condition
53403,3630,deficits,I-Condition
53404,3630,",",O
53405,3630,dementia,B-Condition
53406,3630,",",O
53407,3630,or,O
53408,3630,delirium,B-Condition
53409,3631,severe,O
53410,3631,respiratory,B-Condition
53411,3631,comorbidities,I-Condition
53412,3631,(,O
53413,3631,e.g.,O
53414,3631,chronic,B-Condition
53415,3631,obstructive,I-Condition
53416,3631,pulmonary,I-Condition
53417,3631,disease,I-Condition
53418,3631,",",O
53419,3631,pneumonia,B-Condition
53420,3631,",",O
53421,3631,respiratory,B-Condition
53422,3631,failure,I-Condition
53423,3631,),O
53424,3632,sleep,B-Condition
53425,3632,disordered,I-Condition
53426,3632,breathing,I-Condition
53427,3632,(,O
53428,3632,diagnosed,O
53429,3632,OSA,B-Condition
53430,3632,",",O
53431,3632,obesity,B-Condition
53432,3632,hypoventilation,I-Condition
53433,3632,syndrome,I-Condition
53434,3632,),O
53435,3633,pregnancy,O
53436,3633,and,O
53437,3633,breast,O
53438,3633,feeding,O
53439,3634,history,O
53440,3634,of,O
53441,3634,chronic,B-Condition
53442,3634,pain,I-Condition
53443,3634,or,O
53444,3634,regular,O
53445,3634,(,O
53446,3634,at,O
53447,3634,least,O
53448,3634,once,O
53449,3634,daily,O
53450,3634,),O
53451,3634,opioid,B-Drug
53452,3634,use,O
53453,3634,preoperatively,O
53454,3635,renal,B-Condition
53455,3635,impairment,I-Condition
53456,3635,-,O
53457,3635,CrCl,O
53458,3635,=,O
53459,3635,60,O
53460,3635,mL,O
53461,3635,/,O
53462,3635,minute,O
53463,3636,not,O
53464,3636,fluent,O
53465,3636,in,O
53466,3636,English,O
53467,3636,to,O
53468,3636,be,O
53469,3636,able,O
53470,3636,to,O
53471,3636,participate,O
53472,3636,in,O
53473,3636,the,O
53474,3636,study,O
53475,3636,process,O
53476,3636,",",O
53477,3636,including,O
53478,3636,consent,O
53479,3636,and,O
53480,3636,phone,O
53481,3636,interview,O
53482,3637,Body,O
53483,3637,Mass,O
53484,3637,Index,O
53485,3637,>,O
53486,3637,35,O
53487,3638,inability,B-Mood
53488,3638,to,O
53489,3638,take,O
53490,3638,oral,B-Drug
53491,3638,medication,I-Drug
53492,3638,.,O
53493,3639,Age,B-Person
53494,3639,18,O
53495,3639,-,O
53496,3639,65,O
53497,3640,scheduled,O
53498,3640,to,O
53499,3640,receive,O
53500,3640,ISB,B-Procedure
53501,3640,and,O
53502,3640,general,B-Procedure
53503,3640,anesthesia,I-Procedure
53504,3640,as,O
53505,3640,a,O
53506,3640,day,O
53507,3640,surgery,O
53508,3640,patient,O
53509,3640,for,O
53510,3640,rotator,B-Procedure
53511,3640,cuff,I-Procedure
53512,3640,repair,I-Procedure
53513,3640,and,O
53514,3640,acromioplasty,B-Procedure
53515,3640,",",O
53516,3640,as,O
53517,3640,a,O
53518,3640,part,O
53519,3640,of,O
53520,3640,planned,O
53521,3640,routine,O
53522,3640,care,O
53523,3641,Patients,O
53524,3641,with,O
53525,3641,azathioprine,B-Drug
53526,3641,or,O
53527,3641,biologics,B-Drug
53528,3641,therapy,B-Procedure
53529,3642,Ulcerative,B-Condition
53530,3642,colitis,I-Condition
53531,3642,patients,O
53532,3642,with,O
53533,3642,moderate,O
53534,3642,to,O
53535,3642,severe,O
53536,3642,activity,O
53537,3642,who,O
53538,3642,achieved,O
53539,3642,a,O
53540,3642,clinical,B-Condition
53541,3642,remission,I-Condition
53542,3642,by,O
53543,3642,the,O
53544,3642,first,O
53545,3642,course,O
53546,3642,of,O
53547,3642,corticosteroids,B-Drug
53548,3643,Newly,O
53549,3643,diagnosed,O
53550,3643,or,O
53551,3643,without,O
53552,3643,steroid,B-Drug
53553,3643,use,O
53554,3643,during,O
53555,3643,last,O
53556,3643,1,O
53557,3643,year,O
53558,3644,Endoscopic,O
53559,3644,Mayo,O
53560,3644,subscore,O
53561,3644,>,O
53562,3644,0,O
53563,3645,Patients,O
53564,3645,requiring,O
53565,3645,surgery,B-Procedure
53566,3645,for,O
53567,3645,neoplastic,B-Condition
53568,3645,processes,I-Condition
53569,3646,Allergy,B-Condition
53570,3646,to,O
53571,3646,acetaminophen,B-Drug
53572,3647,Liver,B-Condition
53573,3647,dysfunction,I-Condition
53574,3647,and,O
53575,3647,elevated,O
53576,3647,Liver,O
53577,3647,Function,O
53578,3647,Tests,O
53579,3647,(,O
53580,3647,LFTs,O
53581,3647,),O
53582,3648,Alcohol,B-Condition
53583,3648,or,I-Condition
53584,3648,drug,I-Condition
53585,3648,dependency,I-Condition
53586,3649,Mental,B-Condition
53587,3649,retardation,I-Condition
53588,3650,Less,O
53589,3650,than,O
53590,3650,50,O
53591,3650,kg,O
53592,3650,of,O
53593,3650,weight,O
53594,3651,regnant,B-Condition
53595,3651,women,B-Person
53596,3652,Patients,O
53597,3652,requiring,B-Mood
53598,3652,long,B-Drug
53599,3652,-,I-Drug
53600,3652,acting,I-Drug
53601,3652,opioid,I-Drug
53602,3652,pain,O
53603,3652,management,O
53604,3652,(,O
53605,3652,including,O
53606,3652,fentanyl,B-Drug
53607,3652,patch,I-Drug
53608,3652,",",O
53609,3652,oxycontin,B-Drug
53610,3652,",",O
53611,3652,etc,O
53612,3652,),O
53613,3652,for,O
53614,3652,over,O
53615,3652,3,O
53616,3652,weeks,O
53617,3652,immediately,O
53618,3652,prior,O
53619,3652,to,O
53620,3652,surgery,O
53621,3653,ASA,O
53622,3653,I,O
53623,3653,-,O
53624,3653,III,O
53625,3653,patients,O
53626,3653,scheduled,B-Mood
53627,3653,for,O
53628,3653,elective,O
53629,3653,one,O
53630,3653,or,O
53631,3653,two,O
53632,3653,level,O
53633,3653,minimally,B-Procedure
53634,3653,invasive,I-Procedure
53635,3653,lumbar,I-Procedure
53636,3653,fusions,I-Procedure
53637,3654,Lifetime,O
53638,3654,personal,O
53639,3654,history,O
53640,3654,of,O
53641,3654,diagnosis,O
53642,3654,of,O
53643,3654,major,B-Condition
53644,3654,depressive,I-Condition
53645,3654,disorder,I-Condition
53646,3654,according,O
53647,3654,to,O
53648,3654,the,O
53649,3654,DSM,O
53650,3654,-,O
53651,3654,V,O
53652,3654,(,O
53653,3654,American,O
53654,3654,Psychiatric,O
53655,3654,Association,O
53656,3654,",",O
53657,3654,2013,O
53658,3654,),O
53659,3654,using,O
53660,3654,the,O
53661,3654,Structured,B-Procedure
53662,3654,Clinical,I-Procedure
53663,3654,Interview,I-Procedure
53664,3654,for,I-Procedure
53665,3654,DSM,I-Procedure
53666,3654,-,I-Procedure
53667,3654,V,I-Procedure
53668,3654,Axis,I-Procedure
53669,3654,I,I-Procedure
53670,3654,Disorders,I-Procedure
53671,3654,",",I-Procedure
53672,3654,Research,I-Procedure
53673,3654,Version,I-Procedure
53674,3654,",",I-Procedure
53675,3654,Non,I-Procedure
53676,3654,-,I-Procedure
53677,3654,patient,I-Procedure
53678,3654,Edition,I-Procedure
53679,3654,(,O
53680,3654,SCID-5,O
53681,3654,-,O
53682,3654,RV,O
53683,3654,for,O
53684,3654,DSM,O
53685,3654,-,O
53686,3654,V,O
53687,3654,;,O
53688,3654,First,O
53689,3654,et,O
53690,3654,al,O
53691,3654,.,O
53692,3654,",",O
53693,3654,2015,O
53694,3654,),O
53695,3655,A,O
53696,3655,history,O
53697,3655,of,O
53698,3655,suicidal,B-Condition
53699,3655,ideation,I-Condition
53700,3655,and,I-Condition
53701,3655,behaviour,I-Condition
53702,3655,",",O
53703,3655,including,O
53704,3655,self,B-Condition
53705,3655,-,I-Condition
53706,3655,harm,I-Condition
53707,3655,and/or,O
53708,3655,harm,B-Condition
53709,3655,to,I-Condition
53710,3655,others,I-Condition
53711,3655,.,O
53712,3656,A,O
53713,3656,history,O
53714,3656,of,O
53715,3656,substance,B-Condition
53716,3656,abuse,I-Condition
53717,3656,and/or,I-Condition
53718,3656,dependence,I-Condition
53719,3656,.,O
53720,3657,A,O
53721,3657,positive,O
53722,3657,drug,B-Procedure
53723,3657,screen,I-Procedure
53724,3657,for,I-Procedure
53725,3657,illicit,I-Procedure
53726,3657,drugs,I-Procedure
53727,3658,Substantial,B-Condition
53728,3658,alcohol,I-Condition
53729,3658,use,I-Condition
53730,3659,Current,O
53731,3659,use,O
53732,3659,of,O
53733,3659,Monoamine,B-Drug
53734,3659,Oxidase,I-Drug
53735,3659,Inhibitors,I-Drug
53736,3659,(,I-Drug
53737,3659,MAOIs,I-Drug
53738,3659,),I-Drug
53739,3659,",",O
53740,3659,including,O
53741,3659,the,O
53742,3659,antibiotic,B-Drug
53743,3659,linezolid,I-Drug
53744,3659,and,O
53745,3659,the,O
53746,3659,thiazine,B-Drug
53747,3659,dye,I-Drug
53748,3659,methylthioninium,B-Drug
53749,3659,chloride,I-Drug
53750,3659,(,O
53751,3659,methylene,B-Drug
53752,3659,blue,I-Drug
53753,3659,),O
53754,3660,Current,O
53755,3660,use,O
53756,3660,of,O
53757,3660,serotonin,B-Drug
53758,3660,-,I-Drug
53759,3660,precursors,I-Drug
53760,3660,(,O
53761,3660,such,O
53762,3660,as,O
53763,3660,L,B-Drug
53764,3660,-,I-Drug
53765,3660,tryptophan,I-Drug
53766,3660,",",O
53767,3660,oxitriptan,B-Drug
53768,3660,),O
53769,3661,Current,O
53770,3661,use,O
53771,3661,of,O
53772,3661,serotonergic,B-Drug
53773,3661,drugs,I-Drug
53774,3661,(,O
53775,3661,triptans,B-Drug
53776,3661,",",O
53777,3661,certain,O
53778,3661,tricyclic,B-Drug
53779,3661,antidepressants,I-Drug
53780,3661,",",O
53781,3661,lithium,B-Drug
53782,3661,",",O
53783,3661,tramadol,B-Drug
53784,3661,",",O
53785,3661,St.,B-Drug
53786,3661,John,I-Drug
53787,3661,'s,I-Drug
53788,3661,Wort,I-Drug
53789,3661,),O
53790,3662,Concomitant,O
53791,3662,use,O
53792,3662,of,O
53793,3662,NSAIDS,B-Drug
53794,3662,",",O
53795,3662,ASA,B-Drug
53796,3662,",",O
53797,3662,and,O
53798,3662,other,O
53799,3662,anticoagulants,B-Drug
53800,3662,.,O
53801,3663,Current,O
53802,3663,use,O
53803,3663,of,O
53804,3663,Thioridazine,B-Drug
53805,3664,Current,O
53806,3664,use,O
53807,3664,of,O
53808,3664,CYP1A2,B-Drug
53809,3664,Inhibitors,I-Drug
53810,3665,Current,O
53811,3665,use,O
53812,3665,of,O
53813,3665,Triptans,B-Drug
53814,3665,(,O
53815,3665,5HT1,B-Drug
53816,3665,Agonists,I-Drug
53817,3665,),O
53818,3666,Blood,O
53819,3666,pressure,O
53820,3666,greater,O
53821,3666,than,O
53822,3666,140/90,O
53823,3666,and/or,O
53824,3666,a,O
53825,3666,pulse,O
53826,3666,rate,O
53827,3666,greater,O
53828,3666,than,O
53829,3666,90,O
53830,3666,bpm,O
53831,3667,Recent,O
53832,3667,history,B-Observation
53833,3667,of,O
53834,3667,myocardial,B-Condition
53835,3667,infarction,I-Condition
53836,3667,",",O
53837,3667,cerebrovascular,B-Condition
53838,3667,accident,I-Condition
53839,3667,",",O
53840,3667,cardiac,B-Condition
53841,3667,arrhythmias,I-Condition
53842,3667,",",O
53843,3667,or,O
53844,3667,unstable,B-Condition
53845,3667,heart,I-Condition
53846,3667,disease,I-Condition
53847,3667,.,O
53848,3668,Evidence,O
53849,3668,of,O
53850,3668,significant,O
53851,3668,physical,B-Condition
53852,3668,illness,I-Condition
53853,3668,contraindicating,B-Condition
53854,3668,the,O
53855,3668,use,O
53856,3668,of,O
53857,3668,levomilnacipran,B-Drug
53858,3668,and,O
53859,3668,duloxetine,B-Drug
53860,3668,found,O
53861,3668,on,O
53862,3668,the,O
53863,3668,physical,B-Procedure
53864,3668,exam,I-Procedure
53865,3668,or,O
53866,3668,in,O
53867,3668,the,O
53868,3668,laboratory,B-Procedure
53869,3668,data,O
53870,3668,obtained,O
53871,3668,during,O
53872,3668,the,O
53873,3668,first,O
53874,3668,week,O
53875,3668,of,O
53876,3668,the,O
53877,3668,study,O
53878,3669,Current,O
53879,3669,use,O
53880,3669,of,O
53881,3669,medication,B-Drug
53882,3669,that,O
53883,3669,may,O
53884,3669,affect,B-Condition
53885,3669,voiding,I-Condition
53886,3669,(,O
53887,3669,ie-,O
53888,3669,anticholinergics,B-Drug
53889,3669,),O
53890,3670,History,B-Observation
53891,3670,of,O
53892,3670,obstructive,B-Condition
53893,3670,urinary,I-Condition
53894,3670,disorders,I-Condition
53895,3670,and,O
53896,3670,dysuria,B-Condition
53897,3670,",",O
53898,3670,prostatic,B-Condition
53899,3670,hypertrophy,I-Condition
53900,3670,",",O
53901,3670,prostatitis,B-Condition
53902,3670,",",O
53903,3670,and,O
53904,3670,other,O
53905,3670,lower,B-Condition
53906,3670,urinary,I-Condition
53907,3670,tract,I-Condition
53908,3670,obstructive,I-Condition
53909,3670,disorders,I-Condition
53910,3670,.,O
53911,3671,History,O
53912,3671,of,O
53913,3671,Stevens,B-Condition
53914,3671,-,I-Condition
53915,3671,Johnson,I-Condition
53916,3671,Syndrome,I-Condition
53917,3671,and,O
53918,3671,Erythema,B-Condition
53919,3671,multiforme,I-Condition
53920,3671,.,O
53921,3672,Diabetes,B-Condition
53922,3672,Type,I-Condition
53923,3672,I,I-Condition
53924,3672,and,I-Condition
53925,3672,II,I-Condition
53926,3673,Fructose,B-Condition
53927,3673,intolerance,I-Condition
53928,3673,",",O
53929,3673,glucose,B-Condition
53930,3673,-,I-Condition
53931,3673,galactose,I-Condition
53932,3673,malabsorption,I-Condition
53933,3673,or,O
53934,3673,sucrose,B-Condition
53935,3673,-,I-Condition
53936,3673,isomaltase,I-Condition
53937,3673,insufficiency,I-Condition
53938,3673,.,O
53939,3674,Hepatic,B-Condition
53940,3674,Impairment,I-Condition
53941,3675,Uncontrolled,O
53942,3675,narrow,B-Condition
53943,3675,-,I-Condition
53944,3675,angle,I-Condition
53945,3675,glaucoma,I-Condition
53946,3676,Severe,O
53947,3676,renal,B-Condition
53948,3676,impairment,I-Condition
53949,3677,History,B-Observation
53950,3677,of,O
53951,3677,seizure,B-Condition
53952,3677,disorder,I-Condition
53953,3678,Anatomically,B-Condition
53954,3678,narrow,I-Condition
53955,3678,ocular,I-Condition
53956,3678,angles,I-Condition
53957,3678,.,O
53958,3679,Osteoporosis,B-Condition
53959,3679,or,O
53960,3679,major,B-Mood
53961,3679,risk,I-Mood
53962,3679,for,O
53963,3679,bone,B-Condition
53964,3679,fractures,I-Condition
53965,3679,.,O
53966,3680,Male,B-Person
53967,3680,participants,O
53968,3680,between,O
53969,3680,18,O
53970,3680,and,O
53971,3680,40,O
53972,3680,years,O
53973,3680,-,O
53974,3680,old,B-Person
53975,3681,Written,O
53976,3681,informed,O
53977,3681,consent,O
53978,3681,signed,O
53979,3681,by,O
53980,3681,the,O
53981,3681,participant,O
53982,3682,indications,B-Condition
53983,3682,to,O
53984,3682,dual,B-Procedure
53985,3682,antiplatelet,I-Procedure
53986,3682,therapy,I-Procedure
53987,3682,other,O
53988,3682,than,O
53989,3682,atrial,B-Condition
53990,3682,fibrillation,I-Condition
53991,3682,or,O
53992,3682,left,B-Condition
53993,3682,atrial,I-Condition
53994,3682,appendage,I-Condition
53995,3682,occlusion,I-Condition
53996,3682,at,O
53997,3682,the,O
53998,3682,time,O
53999,3682,of,O
54000,3682,enrollment,O
54001,3682,or,O
54002,3682,predicted,B-Mood
54003,3682,appearance,I-Mood
54004,3682,of,O
54005,3682,such,O
54006,3682,indications,O
54007,3682,within,O
54008,3682,the,O
54009,3682,duration,O
54010,3682,of,O
54011,3682,the,O
54012,3682,trial,O
54013,3682,(,O
54014,3682,eg,O
54015,3682,.,O
54016,3682,coronary,B-Condition
54017,3682,artery,I-Condition
54018,3682,disease,I-Condition
54019,3682,),O
54020,3683,indications,B-Condition
54021,3683,to,O
54022,3683,anticoagulation,B-Procedure
54023,3683,at,O
54024,3683,the,O
54025,3683,time,O
54026,3683,of,O
54027,3683,enrollment,O
54028,3683,or,O
54029,3683,predicted,B-Mood
54030,3683,appearance,I-Mood
54031,3683,of,O
54032,3683,such,O
54033,3683,indications,O
54034,3683,within,O
54035,3683,the,O
54036,3683,duration,O
54037,3683,of,O
54038,3683,the,O
54039,3683,trial,O
54040,3683,(,O
54041,3683,eg,O
54042,3683,.,O
54043,3683,pulmonary,B-Condition
54044,3683,embolism,I-Condition
54045,3683,),O
54046,3684,known,O
54047,3684,allergy,B-Condition
54048,3684,to,O
54049,3684,clopidogrel,B-Drug
54050,3684,or,O
54051,3684,acetylsalicylic,B-Drug
54052,3684,acid,I-Drug
54053,3684,precluding,O
54054,3684,its,O
54055,3684,administration,O
54056,3684,as,O
54057,3684,specified,O
54058,3684,by,O
54059,3684,the,O
54060,3684,protocol,O
54061,3685,any,O
54062,3685,known,O
54063,3685,inborn,O
54064,3685,or,O
54065,3685,acquired,O
54066,3685,coagulation,B-Condition
54067,3685,disorders,I-Condition
54068,3686,poor,B-Condition
54069,3686,tolerance,I-Condition
54070,3686,of,O
54071,3686,or,O
54072,3686,technical,B-Observation
54073,3686,difficulties,I-Observation
54074,3686,with,O
54075,3686,performing,O
54076,3686,transesophageal,B-Procedure
54077,3686,echocardiography,I-Procedure
54078,3687,peridevice,O
54079,3687,leak,O
54080,3687,>,O
54081,3687,5,O
54082,3687,mm,O
54083,3687,on,O
54084,3687,transesophageal,B-Procedure
54085,3687,echocardiography,I-Procedure
54086,3687,study,I-Procedure
54087,3687,preceding,O
54088,3687,enrollment,O
54089,3688,left,B-Condition
54090,3688,atrial,I-Condition
54091,3688,thrombus,I-Condition
54092,3688,on,O
54093,3688,transesophageal,B-Procedure
54094,3688,echocardiography,I-Procedure
54095,3688,study,O
54096,3688,performed,O
54097,3688,after,O
54098,3688,successful,O
54099,3688,left,B-Procedure
54100,3688,atrial,I-Procedure
54101,3688,appendage,I-Procedure
54102,3688,closure,I-Procedure
54103,3688,but,O
54104,3688,before,O
54105,3688,enrollment,O
54106,3689,life,B-Observation
54107,3689,expectancy,I-Observation
54108,3689,of,O
54109,3689,less,O
54110,3689,than,O
54111,3689,18months,O
54112,3690,participation,O
54113,3690,in,O
54114,3690,other,O
54115,3690,clinical,O
54116,3690,studies,O
54117,3690,with,O
54118,3690,experimental,O
54119,3690,therapies,O
54120,3690,at,O
54121,3690,the,O
54122,3690,time,O
54123,3690,of,O
54124,3690,enrollment,O
54125,3690,and,O
54126,3690,preceding,O
54127,3690,3,O
54128,3690,months,O
54129,3691,chronic,B-Condition
54130,3691,kidney,I-Condition
54131,3691,disease,I-Condition
54132,3691,stage,O
54133,3691,IV,O
54134,3691,and,O
54135,3691,V,O
54136,3692,women,B-Person
54137,3692,who,O
54138,3692,are,O
54139,3692,pregnant,B-Condition
54140,3692,or,O
54141,3692,breast,B-Observation
54142,3692,feeding,I-Observation
54143,3692,;,O
54144,3692,women,O
54145,3692,of,O
54146,3692,childbearing,O
54147,3692,potential,O
54148,3692,who,O
54149,3692,do,O
54150,3692,not,O
54151,3692,consent,O
54152,3692,to,O
54153,3692,apply,O
54154,3692,at,O
54155,3692,least,O
54156,3692,to,O
54157,3692,methods,O
54158,3692,of,O
54159,3692,contraception,O
54160,3692,.,O
54161,3692,This,O
54162,3692,criterion,O
54163,3692,does,O
54164,3692,not,O
54165,3692,apply,O
54166,3692,to,O
54167,3692,postmenopausal,O
54168,3692,women,O
54169,3693,successful,O
54170,3693,left,B-Procedure
54171,3693,atrial,I-Procedure
54172,3693,appendage,I-Procedure
54173,3693,occlusion,I-Procedure
54174,3693,with,O
54175,3693,Amulet,O
54176,3693,device,O
54177,3693,within,O
54178,3693,37,O
54179,3693,days,O
54180,3693,prior,O
54181,3693,to,O
54182,3693,randomization,O
54183,3693,.,O
54184,3694,treatment,O
54185,3694,with,O
54186,3694,dual,B-Procedure
54187,3694,antiplatelet,I-Procedure
54188,3694,therapy,I-Procedure
54189,3694,(,O
54190,3694,clopidogrel,B-Drug
54191,3694,and,O
54192,3694,acetylsalicylic,B-Drug
54193,3694,acid,I-Drug
54194,3694,),O
54195,3694,between,O
54196,3694,left,B-Procedure
54197,3694,atrial,I-Procedure
54198,3694,appendage,I-Procedure
54199,3694,closure,I-Procedure
54200,3694,and,O
54201,3694,randomization,O
54202,3695,participant,O
54203,3695,'s,O
54204,3695,age,B-Person
54205,3695,18,O
54206,3695,years,O
54207,3695,or,O
54208,3695,older,O
54209,3695,at,O
54210,3695,the,O
54211,3695,time,O
54212,3695,of,O
54213,3695,signing,O
54214,3695,the,O
54215,3695,informed,O
54216,3695,consent,O
54217,3695,form,O
54218,3696,participant,O
54219,3696,is,O
54220,3696,willing,O
54221,3696,to,O
54222,3696,follow,O
54223,3696,all,O
54224,3696,study,O
54225,3696,procedures,O
54226,3696,;,O
54227,3696,especially,O
54228,3696,randomized,O
54229,3696,antiplatelet,O
54230,3696,treatment,O
54231,3696,regimen,O
54232,3696,and,O
54233,3696,follow,O
54234,3696,-,O
54235,3696,up,O
54236,3696,visits,O
54237,3696,with,O
54238,3696,transesophageal,O
54239,3696,echocardiography,O
54240,3696,when,O
54241,3696,applicable,O
54242,3697,participant,O
54243,3697,is,O
54244,3697,willing,O
54245,3697,to,O
54246,3697,sign,O
54247,3697,the,O
54248,3697,study,O
54249,3697,informed,O
54250,3697,consent,O
54251,3697,form,O
54252,3698,1,O
54253,3698,.,O
54254,3698,Taking,O
54255,3698,a,O
54256,3698,tetracycline,B-Drug
54257,3698,within,O
54258,3698,6,O
54259,3698,months,O
54260,3698,or,O
54261,3698,history,B-Observation
54262,3698,of,O
54263,3698,adverse,B-Condition
54264,3698,reaction,I-Condition
54265,3698,to,O
54266,3698,minocycline,B-Drug
54267,3698,or,O
54268,3698,another,O
54269,3698,tetracycline,B-Drug
54270,3698,.,O
54271,3699,2,O
54272,3699,.,O
54273,3699,Enhanced,B-Mood
54274,3699,risk,I-Mood
54275,3699,from,O
54276,3699,lumbar,B-Procedure
54277,3699,puncture,I-Procedure
54278,3699,",",O
54279,3699,including,O
54280,3699,documented,B-Mood
54281,3699,or,O
54282,3699,suspected,B-Mood
54283,3699,cerebral,B-Condition
54284,3699,mass,I-Condition
54285,3699,lesion,I-Condition
54286,3699,predisposing,B-Mood
54287,3699,to,I-Mood
54288,3699,brain,B-Condition
54289,3699,herniation,I-Condition
54290,3699,or,O
54291,3699,bleeding,B-Condition
54292,3699,diathesis,I-Condition
54293,3699,.,O
54294,3700,3,O
54295,3700,.,O
54296,3700,Pregnancy,B-Condition
54297,3700,or,O
54298,3700,expectation,B-Mood
54299,3700,of,O
54300,3700,pregnancy,B-Condition
54301,3700,during,O
54302,3700,the,O
54303,3700,study,O
54304,3700,.,O
54305,3701,4,O
54306,3701,.,O
54307,3701,Active,O
54308,3701,opportunistic,B-Condition
54309,3701,infection,I-Condition
54310,3701,or,O
54311,3701,active,O
54312,3701,neurological,B-Condition
54313,3701,disease,I-Condition
54314,3701,that,O
54315,3701,might,O
54316,3701,confound,O
54317,3701,evaluation,O
54318,3701,.,O
54319,3702,5,O
54320,3702,.,O
54321,3702,ADC,O
54322,3702,Stage,O
54323,3702,>,O
54324,3702,1,O
54325,3702,.,O
54326,3703,6,O
54327,3703,.,O
54328,3703,Hemoglobin,O
54329,3703,<,O
54330,3703,10,O
54331,3703,Gms,O
54332,3703,/,O
54333,3703,dL.,O
54334,3704,7,O
54335,3704,.,O
54336,3704,BUN,O
54337,3704,or,O
54338,3704,creatine,O
54339,3704,above,O
54340,3704,the,O
54341,3704,normal,O
54342,3704,limits,O
54343,3704,.,O
54344,3705,8,O
54345,3705,.,O
54346,3705,Taking,O
54347,3705,other,O
54348,3705,drugs,O
54349,3705,known,O
54350,3705,to,O
54351,3705,reduce,O
54352,3705,the,O
54353,3705,metabolism,O
54354,3705,of,O
54355,3705,minocycline,B-Drug
54356,3705,and,O
54357,3705,thus,O
54358,3705,increase,O
54359,3705,the,O
54360,3705,probability,O
54361,3705,of,O
54362,3705,toxicity,O
54363,3705,.,O
54364,3706,1,O
54365,3706,.,O
54366,3706,HIV,B-Condition
54367,3706,infection,I-Condition
54368,3706,with,O
54369,3706,plasma,O
54370,3706,and,O
54371,3706,CSF,O
54372,3706,HIV,O
54373,3706,RNA,O
54374,3706,concentrations,O
54375,3706,(,O
54376,3706,using,O
54377,3706,Roche,B-Procedure
54378,3706,Amplicor,I-Procedure
54379,3706,assay,I-Procedure
54380,3706,),O
54381,3706,>,O
54382,3706,"1,000",O
54383,3706,copies/,O
54384,3706,mL,O
54385,3706,(,O
54386,3706,available,O
54387,3706,after,O
54388,3706,baseline,O
54389,3706,LP,O
54390,3706,),O
54391,3706,.,O
54392,3707,2,O
54393,3707,.,O
54394,3707,Off,B-Condition
54395,3707,antiretroviral,I-Condition
54396,3707,therapy,I-Condition
54397,3707,(,I-Condition
54398,3707,ART,I-Condition
54399,3707,),I-Condition
54400,3707,for,O
54401,3707,>,O
54402,3707,6,O
54403,3707,weeks,O
54404,3707,before,O
54405,3707,the,O
54406,3707,study,O
54407,3707,and,O
54408,3707,no,O
54409,3707,plans,B-Mood
54410,3707,to,I-Mood
54411,3707,begin,I-Mood
54412,3707,treatment,B-Procedure
54413,3707,for,O
54414,3707,the,O
54415,3707,study,O
54416,3707,duration,O
54417,3707,.,O
54418,3707,(,O
54419,3707,The,O
54420,3707,decision,O
54421,3707,of,O
54422,3707,whether,O
54423,3707,or,O
54424,3707,not,O
54425,3707,a,O
54426,3707,subject,O
54427,3707,takes,O
54428,3707,antiretroviral,O
54429,3707,therapy,O
54430,3707,will,O
54431,3707,be,O
54432,3707,made,O
54433,3707,by,O
54434,3707,the,O
54435,3707,subject,O
54436,3707,in,O
54437,3707,consultation,O
54438,3707,with,O
54439,3707,his,O
54440,3707,/,O
54441,3707,her,O
54442,3707,primary,O
54443,3707,care,O
54444,3707,provider,O
54445,3707,prior,O
54446,3707,to,O
54447,3707,screening,O
54448,3707,for,O
54449,3707,this,O
54450,3707,study,O
54451,3707,.,O
54452,3707,),O
54453,3708,3,O
54454,3708,.,O
54455,3708,Predicted,O
54456,3708,adherence,O
54457,3708,to,O
54458,3708,the,O
54459,3708,medication,O
54460,3708,.,O
54461,3709,4,O
54462,3709,.,O
54463,3709,Capable,O
54464,3709,of,O
54465,3709,providing,O
54466,3709,informed,O
54467,3709,consent,O
54468,3709,.,O
54469,3710,5,O
54470,3710,.,O
54471,3710,>,O
54472,3710,18,O
54473,3710,years,O
54474,3710,old,B-Person
54475,3711,6,O
54476,3711,.,O
54477,3711,CD4,O
54478,3711,cell,O
54479,3711,counts,O
54480,3711,>,O
54481,3711,150,O
54482,3711,cells,O
54483,3711,/,O
54484,3711,μL,O
54485,3711,(,O
54486,3711,though,O
54487,3711,likely,O
54488,3711,most,O
54489,3711,",",O
54490,3711,if,O
54491,3711,not,O
54492,3711,all,O
54493,3711,",",O
54494,3711,will,O
54495,3711,be,O
54496,3711,>,O
54497,3711,250,O
54498,3711,cells,O
54499,3711,/,O
54500,3711,μL,O
54501,3711,),O
54502,3711,.,O
54503,3712,7,O
54504,3712,.,O
54505,3712,When,O
54506,3712,available,O
54507,3712,",",O
54508,3712,subjects,O
54509,3712,will,O
54510,3712,be,O
54511,3712,screened,O
54512,3712,for,O
54513,3712,stability,O
54514,3712,of,O
54515,3712,blood,O
54516,3712,CD4,O
54517,3712,and,O
54518,3712,HIV,O
54519,3712,RNA,O
54520,3712,levels,O
54521,3712,.,O
54522,3713,1,O
54523,3713,),O
54524,3713,pregnancy,O
54525,3713,",",O
54526,3713,breast,O
54527,3713,-,O
54528,3713,feeding,O
54529,3713,women,O
54530,3713,",",O
54531,3713,or,O
54532,3713,female,O
54533,3713,patients,O
54534,3713,of,O
54535,3713,childbearing,O
54536,3713,potential,O
54537,3713,but,O
54538,3713,did,O
54539,3713,not,O
54540,3713,take,O
54541,3713,contraceptive,O
54542,3713,measures;2,O
54543,3713,),O
54544,3713,existing,O
54545,3713,severe,O
54546,3713,acute,O
54547,3713,infection,B-Condition
54548,3713,and,O
54549,3713,is,O
54550,3713,not,O
54551,3713,controlled,O
54552,3713,;,O
54553,3713,or,O
54554,3713,purulent,O
54555,3713,and,O
54556,3713,chronic,O
54557,3713,infection,B-Condition
54558,3713,",",O
54559,3713,delayed,B-Condition
54560,3713,healing,I-Condition
54561,3713,wounds,I-Condition
54562,3713,;,O
54563,3713,3,O
54564,3713,),O
54565,3713,the,O
54566,3713,original,O
54567,3713,severe,O
54568,3713,heart,B-Condition
54569,3713,disease,I-Condition
54570,3713,",",O
54571,3713,including,O
54572,3713,congestive,B-Condition
54573,3713,heart,I-Condition
54574,3713,failure,I-Condition
54575,3713,",",O
54576,3713,uncontrolled,O
54577,3713,high,O
54578,3713,-,O
54579,3713,risk,O
54580,3713,arrhythmias,B-Condition
54581,3713,",",O
54582,3713,unstable,B-Condition
54583,3713,angina,I-Condition
54584,3713,",",O
54585,3713,myocardial,B-Condition
54586,3713,infarction,I-Condition
54587,3713,",",O
54588,3713,severe,O
54589,3713,heart,B-Condition
54590,3713,valve,I-Condition
54591,3713,disease,I-Condition
54592,3713,and,O
54593,3713,resistant,O
54594,3713,hypertension,B-Condition
54595,3713,;,O
54596,3713,4,O
54597,3713,),O
54598,3713,suffering,O
54599,3713,from,O
54600,3713,neurological,B-Condition
54601,3713,and,I-Condition
54602,3713,psychiatric,I-Condition
54603,3713,diseases,I-Condition
54604,3713,or,O
54605,3713,mental,B-Condition
54606,3713,disorders,I-Condition
54607,3713,is,O
54608,3713,not,O
54609,3713,easy,O
54610,3713,to,O
54611,3713,control,O
54612,3713,",",O
54613,3713,poor,B-Condition
54614,3713,compliance,I-Condition
54615,3713,",",O
54616,3713,and,O
54617,3713,can,O
54618,3713,not,O
54619,3713,be,O
54620,3713,described,O
54621,3713,with,O
54622,3713,treatment,O
54623,3713,responders,O
54624,3713,;,O
54625,3713,primary,B-Condition
54626,3713,brain,I-Condition
54627,3713,or,I-Condition
54628,3713,central,I-Condition
54629,3713,nervous,I-Condition
54630,3713,metastasis,I-Condition
54631,3713,disease,I-Condition
54632,3713,has,O
54633,3713,not,O
54634,3713,been,O
54635,3713,controlled,O
54636,3713,",",O
54637,3713,with,O
54638,3713,significant,O
54639,3713,cranial,B-Condition
54640,3713,hypertension,I-Condition
54641,3713,or,O
54642,3713,neuropsychiatric,B-Condition
54643,3713,symptoms,I-Condition
54644,3713,;,O
54645,3713,5,O
54646,3713,),O
54647,3713,have,O
54648,3713,bleeding,B-Condition
54649,3713,tendencies,I-Condition
54650,3713,;,O
54651,3713,6,O
54652,3713,),O
54653,3713,other,O
54654,3713,researchers,O
54655,3713,believe,O
54656,3713,that,O
54657,3713,patients,O
54658,3713,should,O
54659,3713,not,O
54660,3713,participate,O
54661,3713,in,O
54662,3713,the,O
54663,3713,present,O
54664,3713,trial,O
54665,3713,.,O
54666,3714,1,O
54667,3714,),O
54668,3714,histologically,O
54669,3714,confirmed,O
54670,3714,(,O
54671,3714,patients,O
54672,3714,not,O
54673,3714,receiving,O
54674,3714,a,O
54675,3714,single,O
54676,3714,sputum,O
54677,3714,cytology,O
54678,3714,diagnosis,O
54679,3714,),O
54680,3714,non,B-Condition
54681,3714,-,I-Condition
54682,3714,small,I-Condition
54683,3714,cell,I-Condition
54684,3714,lung,I-Condition
54685,3714,cancer,I-Condition
54686,3714,patients,O
54687,3714,",",O
54688,3714,with,O
54689,3714,wild,O
54690,3714,-,O
54691,3714,type,O
54692,3714,EGFR,O
54693,3714,and,O
54694,3714,ALK,O
54695,3714,-,O
54696,3714,negative,O
54697,3714,;,O
54698,3714,2,O
54699,3714,),O
54700,3714,According,O
54701,3714,to,O
54702,3714,IASLC2009,O
54703,3714,new,O
54704,3714,TNM,O
54705,3714,staging,O
54706,3714,of,O
54707,3714,lung,B-Condition
54708,3714,cancer,I-Condition
54709,3714,stage,O
54710,3714,<,O
54711,3714,U+2162,O
54712,3714,>,O
54713,3714,B,O
54714,3714,or,O
54715,3714,<,O
54716,3714,U+2163,O
54717,3714,>,O
54718,3714,",",O
54719,3714,previously,O
54720,3714,untreated,O
54721,3714,or,O
54722,3714,relapsed,O
54723,3714,after,O
54724,3714,1,O
54725,3714,year,O
54726,3714,of,O
54727,3714,lung,O
54728,3714,cancer,O
54729,3714,resection,O
54730,3714,;,O
54731,3714,3,O
54732,3714,),O
54733,3714,have,O
54734,3714,at,O
54735,3714,least,O
54736,3714,one,O
54737,3714,evaluable,B-Condition
54738,3714,lesions,I-Condition
54739,3714,",",O
54740,3714,according,O
54741,3714,to,O
54742,3714,version,O
54743,3714,1.1,O
54744,3714,of,O
54745,3714,the,O
54746,3714,standard,O
54747,3714,in,O
54748,3714,accordance,O
54749,3714,with,O
54750,3714,a,O
54751,3714,judgment,O
54752,3714,RECIST(longest,O
54753,3714,diameter,O
54754,3714,on,O
54755,3714,a,O
54756,3714,spiral,B-Procedure
54757,3714,CT,I-Procedure
54758,3714,at,O
54759,3714,least,O
54760,3714,10mm,O
54761,3714,",",O
54762,3714,on,O
54763,3714,a,O
54764,3714,regular,B-Procedure
54765,3714,CT,I-Procedure
54766,3714,longest,O
54767,3714,diameter,O
54768,3714,at,O
54769,3714,least,O
54770,3714,20,O
54771,3714,mm,O
54772,3714,),O
54773,3714,;,O
54774,3714,4,O
54775,3714,),O
54776,3714,Male,B-Person
54777,3714,or,O
54778,3714,female,B-Person
54779,3714,",",O
54780,3714,aged,B-Person
54781,3714,18,O
54782,3714,to,O
54783,3714,75,O
54784,3714,years,O
54785,3714,;,O
54786,3714,5,O
54787,3714,),O
54788,3714,ECOG,O
54789,3714,PS,O
54790,3714,0,O
54791,3714,or,O
54792,3714,1,O
54793,3714,;,O
54794,3714,6,O
54795,3714,),O
54796,3714,expected,B-Observation
54797,3714,survival,I-Observation
54798,3714,at,O
54799,3714,least,O
54800,3714,3,O
54801,3714,months,O
54802,3714,;,O
54803,3714,7,O
54804,3714,),O
54805,3714,adequate,B-Condition
54806,3714,hematological,I-Condition
54807,3714,function,I-Condition
54808,3714,:,O
54809,3714,absolute,O
54810,3714,neutrophil,O
54811,3714,count,O
54812,3714,(,O
54813,3714,ANC,O
54814,3714,),O
54815,3714,at,O
54816,3714,least,O
54817,3714,2×10,O
54818,3714,^,O
54819,3714,9,O
54820,3714,/,O
54821,3714,L,O
54822,3714,and,O
54823,3714,platelet,O
54824,3714,count,O
54825,3714,at,O
54826,3714,least,O
54827,3714,100×10,O
54828,3714,^,O
54829,3714,9,O
54830,3714,/,O
54831,3714,L,O
54832,3714,and,O
54833,3714,hemoglobin,O
54834,3714,at,O
54835,3714,least,O
54836,3714,9,O
54837,3714,g,O
54838,3714,/,O
54839,3714,dL,O
54840,3714,;,O
54841,3714,8),O
54842,3714,adequate,B-Condition
54843,3714,liver,I-Condition
54844,3714,function,I-Condition
54845,3714,:,O
54846,3714,total,O
54847,3714,bilirubin,O
54848,3714,less,O
54849,3714,than,O
54850,3714,upper,O
54851,3714,limit,O
54852,3714,of,O
54853,3714,normal,O
54854,3714,(,O
54855,3714,ULN,O
54856,3714,),O
54857,3714,;,O
54858,3714,AST,O
54859,3714,and,O
54860,3714,ALT,O
54861,3714,less,O
54862,3714,than,O
54863,3714,2.5,O
54864,3714,times,O
54865,3714,upper,O
54866,3714,limit,O
54867,3714,of,O
54868,3714,normal,O
54869,3714,(,O
54870,3714,ULN,O
54871,3714,),O
54872,3714,;,O
54873,3714,alkaline,O
54874,3714,phosphatase,O
54875,3714,less,O
54876,3714,than,O
54877,3714,5,O
54878,3714,times,O
54879,3714,the,O
54880,3714,upper,O
54881,3714,limit,O
54882,3714,of,O
54883,3714,normal,O
54884,3714,(,O
54885,3714,ULN,O
54886,3714,),O
54887,3714,;,O
54888,3714,9,O
54889,3714,),O
54890,3714,adequate,B-Condition
54891,3714,renal,I-Condition
54892,3714,function,I-Condition
54893,3714,:,O
54894,3714,serum,O
54895,3714,creatinine,O
54896,3714,less,O
54897,3714,than,O
54898,3714,upper,O
54899,3714,limit,O
54900,3714,of,O
54901,3714,normal,O
54902,3714,(,O
54903,3714,ULN,O
54904,3714,),O
54905,3714,or,O
54906,3714,calculated,O
54907,3714,creatinine,O
54908,3714,clearance,O
54909,3714,at,O
54910,3714,least,O
54911,3714,60,O
54912,3714,mL,O
54913,3714,/,O
54914,3714,min,O
54915,3714,;,O
54916,3714,10,O
54917,3714,),O
54918,3714,ECG,O
54919,3714,is,O
54920,3714,normal,O
54921,3714,",",O
54922,3714,there,O
54923,3714,is,O
54924,3714,no,O
54925,3714,non,B-Condition
54926,3714,-,I-Condition
54927,3714,healing,I-Condition
54928,3714,wounds,I-Condition
54929,3714,on,I-Condition
54930,3714,the,I-Condition
54931,3714,body,I-Condition
54932,3714,;,O
54933,3714,11,O
54934,3714,),O
54935,3714,had,O
54936,3714,not,O
54937,3714,received,O
54938,3714,previous,O
54939,3714,treatment,O
54940,3714,anticancer,B-Drug
54941,3714,drugs,I-Drug
54942,3714,",",O
54943,3714,or,O
54944,3714,had,O
54945,3714,only,O
54946,3714,received,O
54947,3714,for,O
54948,3714,previous,O
54949,3714,non,B-Condition
54950,3714,-,I-Condition
54951,3714,metastatic,I-Condition
54952,3714,tumors,I-Condition
54953,3714,adjuvant,O
54954,3714,or,O
54955,3714,neoadjuvant,O
54956,3714,chemotherapy,B-Procedure
54957,3714,",",O
54958,3714,but,O
54959,3714,when,O
54960,3714,you,O
54961,3714,start,O
54962,3714,to,O
54963,3714,study,O
54964,3714,treatment,O
54965,3714,has,O
54966,3714,ended,O
54967,3714,more,O
54968,3714,than,O
54969,3714,6,O
54970,3714,months,O
54971,3714,;,O
54972,3714,12,O
54973,3714,),O
54974,3714,have,O
54975,3714,conducted,O
54976,3714,previous,O
54977,3714,surgery,O
54978,3714,patients,O
54979,3714,required,O
54980,3714,to,O
54981,3714,study,O
54982,3714,treatment,O
54983,3714,was,O
54984,3714,started,O
54985,3714,more,O
54986,3714,than,O
54987,3714,four,O
54988,3714,weeks,O
54989,3714,",",O
54990,3714,and,O
54991,3714,the,O
54992,3714,patient,O
54993,3714,had,O
54994,3714,recovered,O
54995,3714,;,O
54996,3714,13,O
54997,3714,),O
54998,3714,have,O
54999,3714,an,O
55000,3714,intact,O
55001,3714,uterus,O
55002,3714,in,O
55003,3714,women,O
55004,3714,prior,O
55005,3714,to,O
55006,3714,enrollment,O
55007,3714,in,O
55008,3714,the,O
55009,3714,study,O
55010,3714,must,O
55011,3714,have,O
55012,3714,a,O
55013,3714,negative,O
55014,3714,pregnancy,O
55015,3714,test,O
55016,3714,result,O
55017,3714,(,O
55018,3714,unless,O
55019,3714,it,O
55020,3714,is,O
55021,3714,already,O
55022,3714,24,O
55023,3714,months,O
55024,3714,of,O
55025,3714,amenorrhea,O
55026,3714,),O
55027,3714,within,O
55028,3714,28,O
55029,3714,days,O
55030,3714,.,O
55031,3714,If,O
55032,3714,the,O
55033,3714,pregnancy,O
55034,3714,test,O
55035,3714,from,O
55036,3714,the,O
55037,3714,first,O
55038,3714,administration,O
55039,3714,more,O
55040,3714,than,O
55041,3714,seven,O
55042,3714,days,O
55043,3714,",",O
55044,3714,urine,O
55045,3714,pregnancy,O
55046,3714,test,O
55047,3714,is,O
55048,3714,required,O
55049,3714,for,O
55050,3714,authentication,O
55051,3714,(,O
55052,3714,less,O
55053,3714,than,O
55054,3714,7,O
55055,3714,days,O
55056,3714,before,O
55057,3714,the,O
55058,3714,first,O
55059,3714,dose,O
55060,3714,),O
55061,3714,;,O
55062,3714,14,O
55063,3714,),O
55064,3714,previous,O
55065,3714,to,O
55066,3714,biological,O
55067,3714,agents,O
55068,3714,",",O
55069,3714,particularly,O
55070,3714,E.coli,O
55071,3714,genetically,O
55072,3714,engineered,O
55073,3714,products,O
55074,3714,without,O
55075,3714,serious,O
55076,3714,allergic,O
55077,3714,reactions,O
55078,3714,;,O
55079,3714,15,O
55080,3714,),O
55081,3714,signed,O
55082,3714,informed,O
55083,3714,consent,O
55084,3714,.,O
55085,3715,Nonfluency,O
55086,3715,or,O
55087,3715,inability,O
55088,3715,to,O
55089,3715,communicate,O
55090,3715,in,O
55091,3715,English,O
55092,3715,spoken,O
55093,3715,language,O
55094,3716,Inability,O
55095,3716,to,O
55096,3716,participate,O
55097,3716,or,O
55098,3716,attend,O
55099,3716,biweekly,O
55100,3716,30,O
55101,3716,minute,O
55102,3716,session,O
55103,3716,over,O
55104,3716,14,O
55105,3716,weeks,O
55106,3717,Frank,O
55107,3717,psychosis,B-Condition
55108,3718,Active,O
55109,3718,self,B-Condition
55110,3718,harm,I-Condition
55111,3718,urges,I-Condition
55112,3719,Serious,O
55113,3719,medical,B-Condition
55114,3719,illness,I-Condition
55115,3720,Active,O
55116,3720,substance,B-Condition
55117,3720,or,I-Condition
55118,3720,alcohol,I-Condition
55119,3720,use,I-Condition
55120,3720,or,I-Condition
55121,3720,dependence,I-Condition
55122,3720,that,O
55123,3720,could,O
55124,3720,interfere,O
55125,3720,with,O
55126,3720,participation,O
55127,3721,Diagnoses,O
55128,3721,of,O
55129,3721,mental,B-Condition
55130,3721,retardation,I-Condition
55131,3721,",",O
55132,3721,dementia,B-Condition
55133,3721,or,O
55134,3721,delirium,B-Condition
55135,3722,Pregnant,B-Condition
55136,3722,women,B-Person
55137,3723,Adults,B-Person
55138,3723,18,B-Person
55139,3723,-,I-Person
55140,3723,65,I-Person
55141,3723,years,I-Person
55142,3723,",",O
55143,3723,who,O
55144,3723,are,O
55145,3723,diagnosed,O
55146,3723,with,O
55147,3723,functional,B-Condition
55148,3723,neurologic,I-Condition
55149,3723,symptom,I-Condition
55150,3723,or,O
55151,3723,conversion,B-Condition
55152,3723,disorder,I-Condition
55153,3723,.,O
55154,3723,If,O
55155,3723,diagnosis,O
55156,3723,of,O
55157,3723,seizure,B-Condition
55158,3723,type,I-Condition
55159,3723,then,O
55160,3723,video,B-Procedure
55161,3723,EEG,I-Procedure
55162,3723,with,O
55163,3723,diagnosis,O
55164,3723,confirmed,O
55165,3723,by,O
55166,3723,board,O
55167,3723,-,O
55168,3723,certified,O
55169,3723,neurologist,O
55170,3723,with,O
55171,3723,subspecialty,O
55172,3723,training,O
55173,3723,in,O
55174,3723,epilepsy,O
55175,3723,and,O
55176,3723,clinical,O
55177,3723,neurophysiology,O
55178,3723,using,O
55179,3723,the,O
55180,3723,criteria,O
55181,3723,of,O
55182,3723,the,O
55183,3723,International,O
55184,3723,Classification,O
55185,3723,of,O
55186,3723,the,O
55187,3723,Epilepsies,O
55188,3723,is,O
55189,3723,required,O
55190,3723,.,O
55191,3723,If,O
55192,3723,diagnosis,O
55193,3723,of,O
55194,3723,motor,B-Condition
55195,3723,type,I-Condition
55196,3723,",",O
55197,3723,documented,O
55198,3723,and,O
55199,3723,clinically,O
55200,3723,established,O
55201,3723,levels,O
55202,3723,of,O
55203,3723,diagnostic,O
55204,3723,certainty,O
55205,3723,(,O
55206,3723,"Williams,1995",O
55207,3723,),O
55208,3723,confirmed,O
55209,3723,by,O
55210,3723,2,O
55211,3723,neurologists,O
55212,3723,is,O
55213,3723,required,O
55214,3723,.,O
55215,3724,Participants,O
55216,3724,must,O
55217,3724,have,O
55218,3724,at,O
55219,3724,least,O
55220,3724,one,O
55221,3724,symptom,B-Condition
55222,3724,per,O
55223,3724,month,O
55224,3724,in,O
55225,3724,the,O
55226,3724,month,O
55227,3724,prior,O
55228,3724,to,O
55229,3724,enrollment,O
55230,3725,Fluency,O
55231,3725,in,O
55232,3725,English,O
55233,3725,spoken,O
55234,3725,language,O
55235,3726,Obstructed,B-Condition
55236,3726,outlet,I-Condition
55237,3726,syndrome,I-Condition
55238,3726,(,O
55239,3726,objectified,O
55240,3726,by,O
55241,3726,defeacography,B-Procedure
55242,3726,),O
55243,3727,Irritable,B-Condition
55244,3727,bowel,I-Condition
55245,3727,syndrome,I-Condition
55246,3727,(,O
55247,3727,Rome,O
55248,3727,-,O
55249,3727,IV,O
55250,3727,criteria,O
55251,3727,for,O
55252,3727,irritable,B-Condition
55253,3727,bowel,I-Condition
55254,3727,syndrome,I-Condition
55255,3727,),O
55256,3728,Congenital,B-Condition
55257,3728,or,I-Condition
55258,3728,organic,I-Condition
55259,3728,bowel,I-Condition
55260,3728,pathology,I-Condition
55261,3729,Rectal,B-Condition
55262,3729,prolapse,I-Condition
55263,3730,Anatomical,B-Observation
55264,3730,limitations,I-Observation
55265,3730,preventing,O
55266,3730,placement,B-Procedure
55267,3730,of,I-Procedure
55268,3730,an,I-Procedure
55269,3730,electrode,I-Procedure
55270,3731,Skin,B-Condition
55271,3731,and,I-Condition
55272,3731,perineal,I-Condition
55273,3731,disease,I-Condition
55274,3731,with,O
55275,3731,risk,B-Observation
55276,3731,of,I-Observation
55277,3731,infection,I-Observation
55278,3732,Previous,O
55279,3732,large,B-Procedure
55280,3732,bowel,I-Procedure
55281,3732,/,I-Procedure
55282,3732,rectal,I-Procedure
55283,3732,surgery,I-Procedure
55284,3733,Stoma,B-Condition
55285,3734,Coexisting,O
55286,3734,neurological,B-Condition
55287,3734,disease,I-Condition
55288,3735,Significant,O
55289,3735,psychological,B-Condition
55290,3735,co,I-Condition
55291,3735,-,I-Condition
55292,3735,morbidity,I-Condition
55293,3735,as,O
55294,3735,assessed,O
55295,3735,subjectively,O
55296,3735,by,O
55297,3735,the,O
55298,3735,investigator,O
55299,3736,Being,O
55300,3736,or,O
55301,3736,attempting,O
55302,3736,to,O
55303,3736,become,O
55304,3736,pregnant,O
55305,3736,during,O
55306,3736,study,O
55307,3736,follow,O
55308,3736,-,O
55309,3736,up,O
55310,3737,An,O
55311,3737,average,O
55312,3737,defecation,O
55313,3737,frequency,O
55314,3737,(,O
55315,3737,DF,O
55316,3737,),O
55317,3737,of,O
55318,3737,<3,O
55319,3737,per,O
55320,3737,week,O
55321,3737,based,O
55322,3737,on,O
55323,3737,a,O
55324,3737,3,B-Procedure
55325,3737,-,I-Procedure
55326,3737,week,I-Procedure
55327,3737,defecation,I-Procedure
55328,3737,diary,I-Procedure
55329,3737,(,O
55330,3737,patient,O
55331,3737,-,O
55332,3737,reported,O
55333,3737,),O
55334,3738,Meet,O
55335,3738,at,O
55336,3738,least,O
55337,3738,one,O
55338,3738,other,O
55339,3738,criterion,B-Condition
55340,3738,of,O
55341,3738,the,O
55342,3738,Rome,O
55343,3738,-,O
55344,3738,IV,O
55345,3738,criteria,O
55346,3738,for,O
55347,3738,idiopathic,B-Condition
55348,3738,constipation,I-Condition
55349,3738,based,O
55350,3738,on,O
55351,3738,the,O
55352,3738,3,B-Procedure
55353,3738,-,I-Procedure
55354,3738,week,I-Procedure
55355,3738,defecation,I-Procedure
55356,3738,diary,I-Procedure
55357,3738,(,O
55358,3738,1,O
55359,3738,),O
55360,3739,Refractory,O
55361,3739,to,O
55362,3739,conservative,B-Procedure
55363,3739,treatment,I-Procedure
55364,3740,Age,B-Person
55365,3740,:,O
55366,3740,14,O
55367,3740,-,O
55368,3740,80,O
55369,3740,years,O
55370,3741,Straining,B-Condition
55371,3741,during,O
55372,3741,=,O
55373,3741,25,O
55374,3741,%,O
55375,3741,of,O
55376,3741,defecations,B-Condition
55377,3742,Lumpy,B-Observation
55378,3742,or,I-Observation
55379,3742,hard,I-Observation
55380,3742,stools,I-Observation
55381,3742,in,O
55382,3742,=,O
55383,3742,25,O
55384,3742,%,O
55385,3742,of,O
55386,3742,defecations,B-Condition
55387,3743,Sensation,B-Condition
55388,3743,of,I-Condition
55389,3743,incomplete,I-Condition
55390,3743,evacuation,I-Condition
55391,3743,for,O
55392,3743,=,O
55393,3743,25,O
55394,3743,%,O
55395,3743,of,O
55396,3743,defecations,B-Condition
55397,3744,Sensation,B-Condition
55398,3744,of,I-Condition
55399,3744,anorectal,I-Condition
55400,3744,obstruction,I-Condition
55401,3744,/,I-Condition
55402,3744,blockage,I-Condition
55403,3744,for,O
55404,3744,=,O
55405,3744,25,O
55406,3744,%,O
55407,3744,of,O
55408,3744,defecations,B-Condition
55409,3745,Manual,B-Procedure
55410,3745,manoeuvres,I-Procedure
55411,3745,to,O
55412,3745,facilitate,O
55413,3745,=,O
55414,3745,25,O
55415,3745,%,O
55416,3745,of,O
55417,3745,defecations,B-Condition
55418,3746,Preoperative,O
55419,3746,renal,B-Condition
55420,3746,failure,I-Condition
55421,3746,requiring,B-Mood
55422,3746,dialysis,B-Procedure
55423,3747,Poorly,O
55424,3747,controlled,O
55425,3747,pulmonary,B-Condition
55426,3747,disease,I-Condition
55427,3747,(,O
55428,3747,severe,O
55429,3747,asthma,B-Condition
55430,3747,or,O
55431,3747,COPD,B-Condition
55432,3747,),O
55433,3747,-Contraindication,O
55434,3747,to,O
55435,3747,regional,B-Procedure
55436,3747,anesthesia,I-Procedure
55437,3747,(,O
55438,3747,recent,O
55439,3747,anticoagulant,B-Drug
55440,3747,use,O
55441,3747,),O
55442,3748,Sleep,B-Condition
55443,3748,apnea,I-Condition
55444,3748,or,O
55445,3748,morbid,B-Condition
55446,3748,obesity,I-Condition
55447,3748,with,O
55448,3748,possible,B-Mood
55449,3748,sleep,B-Condition
55450,3748,apnea,I-Condition
55451,3749,Allergy,B-Condition
55452,3749,to,O
55453,3749,methadone,B-Drug
55454,3750,Significant,O
55455,3750,preoperative,B-Condition
55456,3750,pain,I-Condition
55457,3750,requiring,B-Mood
55458,3750,treatment,O
55459,3750,with,O
55460,3750,high,O
55461,3750,doses,O
55462,3750,of,O
55463,3750,opioids,B-Drug
55464,3750,(,O
55465,3750,more,O
55466,3750,than,O
55467,3750,6,O
55468,3750,-,O
55469,3750,8,O
55470,3750,Norco,B-Drug
55471,3750,tablets,I-Drug
55472,3750,or,O
55473,3750,equivalence,B-Drug
55474,3750,per,O
55475,3750,day,O
55476,3750,),O
55477,3750,or,O
55478,3750,recent,O
55479,3750,history,B-Observation
55480,3750,of,O
55481,3750,opioid,B-Condition
55482,3750,abuse,I-Condition
55483,3751,All,O
55484,3751,patients,O
55485,3751,presenting,O
55486,3751,for,O
55487,3751,elective,O
55488,3751,shoulder,B-Procedure
55489,3751,arthroscopic,I-Procedure
55490,3751,procedures,I-Procedure
55491,3751,will,O
55492,3751,be,O
55493,3751,eligible,O
55494,3751,for,O
55495,3751,enrollment,O
55496,3751,.,O
55497,3752,Weight,O
55498,3752,stable,O
55499,3752,(,O
55500,3752,<3,O
55501,3752,kg,O
55502,3752,weight,O
55503,3752,change,O
55504,3752,within,O
55505,3752,last,O
55506,3752,3,O
55507,3752,months,O
55508,3752,),O
55509,3753,Constant,B-Condition
55510,3753,habitual,I-Condition
55511,3753,activity,I-Condition
55512,3753,patterns,I-Condition
55513,3753,(,O
55514,3753,no,B-Observation
55515,3753,deviation,I-Observation
55516,3753,>,I-Observation
55517,3753,1x,I-Observation
55518,3753,/,I-Observation
55519,3753,wk,I-Observation
55520,3753,at,I-Observation
55521,3753,30,I-Observation
55522,3753,min,I-Observation
55523,3753,/,I-Observation
55524,3753,session,I-Observation
55525,3753,within,I-Observation
55526,3753,last,I-Observation
55527,3753,3,I-Observation
55528,3753,months,I-Observation
55529,3753,),O
55530,3754,Constant,B-Condition
55531,3754,habitual,I-Condition
55532,3754,diet,I-Condition
55533,3754,patterns,I-Condition
55534,3754,within,O
55535,3754,last,O
55536,3754,3,O
55537,3754,months,O
55538,3755,Willingness,B-Observation
55539,3755,to,I-Observation
55540,3755,eat,I-Observation
55541,3755,a,I-Observation
55542,3755,chocolate,I-Observation
55543,3755,-,I-Observation
55544,3755,flavored,I-Observation
55545,3755,snack,I-Observation
55546,3755,at,O
55547,3755,test,O
55548,3755,sessions,O
55549,3755,and,O
55550,3755,two,O
55551,3755,week,O
55552,3755,training,O
55553,3755,period,O
55554,3756,No,O
55555,3756,allergies,B-Condition
55556,3756,to,O
55557,3756,any,O
55558,3756,test,B-Observation
55559,3756,foods,I-Observation
55560,3757,Not,O
55561,3757,planning,B-Observation
55562,3757,to,I-Observation
55563,3757,change,I-Observation
55564,3757,use,O
55565,3757,of,O
55566,3757,medications,B-Drug
55567,3757,known,I-Drug
55568,3757,to,I-Drug
55569,3757,influence,I-Drug
55570,3757,appetite,I-Drug
55571,3757,or,I-Drug
55572,3757,metabolism,I-Drug
55573,3758,Not,O
55574,3758,diabetic,B-Condition
55575,3759,No,O
55576,3759,history,B-Observation
55577,3759,of,O
55578,3759,GI,B-Condition
55579,3759,pathology,I-Condition
55580,3760,Non,O
55581,3760,-,O
55582,3760,smoker,B-Condition
55583,3760,for,O
55584,3760,one,O
55585,3760,year,O
55586,3760,or,O
55587,3760,more,O
55588,3761,Patient,O
55589,3761,does,O
55590,3761,not,O
55591,3761,meet,O
55592,3761,inclusion,O
55593,3761,criteria,O
55594,3761,",",O
55595,3761,discovered,O
55596,3761,after,O
55597,3761,randomization,O
55598,3762,Inability,O
55599,3762,to,O
55600,3762,give,O
55601,3762,informed,O
55602,3762,consent,O
55603,3763,Known,O
55604,3763,clotting,B-Condition
55605,3763,disorder,I-Condition
55606,3763,or,O
55607,3763,use,O
55608,3763,of,O
55609,3763,anticoagulants,B-Drug
55610,3764,Known,O
55611,3764,risk,B-Observation
55612,3764,factors,I-Observation
55613,3764,for,I-Observation
55614,3764,",",I-Observation
55615,3764,or,I-Observation
55616,3764,presence,I-Observation
55617,3764,of,I-Observation
55618,3764,",",I-Observation
55619,3764,a,I-Observation
55620,3764,cardiovascular,I-Observation
55621,3764,disease,I-Observation
55622,3765,Language,O
55623,3765,barrier,O
55624,3766,a,O
55625,3766,crown,O
55626,3766,-,O
55627,3766,rump,O
55628,3766,length,O
55629,3766,=,O
55630,3766,6,O
55631,3766,mm,O
55632,3766,and,O
55633,3766,no,O
55634,3766,cardiac,B-Observation
55635,3766,activity,I-Observation
55636,3766,OR,O
55637,3767,a,O
55638,3767,crown,O
55639,3767,-,O
55640,3767,rump,O
55641,3767,length,O
55642,3767,<,O
55643,3767,6,O
55644,3767,mm,O
55645,3767,and,O
55646,3767,no,O
55647,3767,fetal,B-Observation
55648,3767,growth,I-Observation
55649,3767,at,O
55650,3767,least,O
55651,3767,one,O
55652,3767,week,O
55653,3767,later,O
55654,3767,OR,O
55655,3768,At,O
55656,3768,least,O
55657,3768,one,O
55658,3768,week,O
55659,3768,after,O
55660,3768,diagnosis,O
55661,3768,OR,O
55662,3768,a,O
55663,3768,discrepancy,B-Condition
55664,3768,of,O
55665,3768,at,O
55666,3768,least,O
55667,3768,one,O
55668,3768,week,O
55669,3768,between,O
55670,3768,crown,O
55671,3768,-,O
55672,3768,rump,O
55673,3768,length,O
55674,3768,and,O
55675,3768,calendar,O
55676,3768,gestational,O
55677,3768,age,O
55678,3769,Intra,B-Condition
55679,3769,-,I-Condition
55680,3769,uterine,I-Condition
55681,3769,pregnancy,I-Condition
55682,3770,Women,B-Person
55683,3770,aged,B-Person
55684,3770,above,O
55685,3770,16,O
55686,3770,years,O
55687,3771,Hemodynamic,B-Condition
55688,3771,stable,I-Condition
55689,3771,patient,O
55690,3772,No,O
55691,3772,signs,B-Condition
55692,3772,of,I-Condition
55693,3772,infection,I-Condition
55694,3773,No,O
55695,3773,signs,B-Condition
55696,3773,of,I-Condition
55697,3773,incomplete,I-Condition
55698,3773,abortion,I-Condition
55699,3774,No,O
55700,3774,contraindications,B-Mood
55701,3774,for,I-Mood
55702,3774,mifepristone,B-Drug
55703,3774,or,O
55704,3774,misoprostol,B-Drug
55705,3775,Less,O
55706,3775,than,O
55707,3775,30,O
55708,3775,yrs,O
55709,3775,of,O
55710,3775,age,B-Person
55711,3775,or,O
55712,3775,>,O
55713,3775,65,O
55714,3775,yrs,O
55715,3775,of,O
55716,3775,age,B-Person
55717,3776,Any,O
55718,3776,significant,O
55719,3776,co,B-Condition
55720,3776,-,I-Condition
55721,3776,morbidities,I-Condition
55722,3776,",",O
55723,3776,such,O
55724,3776,as,O
55725,3776,active,O
55726,3776,heart,O
55727,3776,",",O
55728,3776,kidney,O
55729,3776,",",O
55730,3776,or,O
55731,3776,liver,B-Condition
55732,3776,diseases,I-Condition
55733,3776,",",O
55734,3776,accelerated,O
55735,3776,or,O
55736,3776,malignant,O
55737,3776,hypertension,B-Condition
55738,3776,",",O
55739,3776,heart,B-Condition
55740,3776,failure,I-Condition
55741,3776,",",O
55742,3776,severe,B-Condition
55743,3776,anemia,I-Condition
55744,3776,.,O
55745,3777,Healthy,B-Condition
55746,3777,adults,B-Person
55747,3777,30-,O
55748,3777,65,O
55749,3777,years,O
55750,3777,old,B-Person
55751,3777,",",O
55752,3778,BMI,O
55753,3778,25,O
55754,3778,-,O
55755,3778,35,O
55756,3778,kg,O
55757,3778,/,O
55758,3778,m2,O
55759,3778,",",O
55760,3779,nondiabetic,B-Condition
55761,3779,as,O
55762,3779,defined,O
55763,3779,by,O
55764,3779,fasting,O
55765,3779,plasma,O
55766,3779,glucose,O
55767,3779,<,O
55768,3779,126,O
55769,3779,mg,O
55770,3779,/,O
55771,3779,dL,O
55772,3780,Lipids,O
55773,3780,:,O
55774,3780,one,O
55775,3780,group,O
55776,3780,with,O
55777,3780,an,O
55778,3780,LDL,O
55779,3780,=,O
55780,3780,/>130,O
55781,3780,and,O
55782,3780,Triglycerides,O
55783,3780,<,O
55784,3780,150,O
55785,3780,mg,O
55786,3780,/,O
55787,3780,dL,O
55788,3780,The,O
55789,3780,2nd,O
55790,3780,group,O
55791,3780,will,O
55792,3780,have,O
55793,3780,and,O
55794,3780,LDL=/>130,O
55795,3780,mg,O
55796,3780,/,O
55797,3780,dL,O
55798,3780,and,O
55799,3780,Triglycerides,O
55800,3780,=,O
55801,3780,/>150,O
55802,3780,mg,O
55803,3780,/,O
55804,3780,dL,O
55805,3780,but,O
55806,3780,less,O
55807,3780,than,O
55808,3780,400,O
55809,3780,mg,O
55810,3780,/,O
55811,3780,dL.,O
55812,3781,osteoarticular,B-Observation
55813,3781,",",I-Observation
55814,3781,neuromuscular,I-Observation
55815,3781,or,I-Observation
55816,3781,cognitive,I-Observation
55817,3781,limitation,I-Observation
55818,3781,that,O
55819,3781,prevents,O
55820,3781,ambulation,B-Observation
55821,3782,previous,O
55822,3782,diagnosis,O
55823,3782,of,O
55824,3782,active,O
55825,3782,neoplastic,B-Condition
55826,3782,disease,I-Condition
55827,3783,institutionalized,B-Person
55828,3783,patients,O
55829,3783,;,O
55830,3783,alcohol,B-Observation
55831,3783,consumption,I-Observation
55832,3783,>,O
55833,3783,60,O
55834,3783,g,O
55835,3783,/,O
55836,3783,day,O
55837,3784,patient,O
55838,3784,belonging,O
55839,3784,to,O
55840,3784,another,O
55841,3784,health,O
55842,3784,sector,O
55843,3784,in,O
55844,3784,the,O
55845,3784,Community,O
55846,3784,of,O
55847,3784,Madrid,O
55848,3784,or,O
55849,3784,other,O
55850,3784,community,O
55851,3785,participation,O
55852,3785,in,O
55853,3785,another,O
55854,3785,study,O
55855,3785,within,O
55856,3785,6,O
55857,3785,months,O
55858,3785,prior,O
55859,3785,.,O
55860,3786,subjects,O
55861,3786,older,O
55862,3786,than,O
55863,3786,35,O
55864,3786,years,B-Person
55865,3787,diagnosis,O
55866,3787,of,O
55867,3787,moderate,O
55868,3787,to,O
55869,3787,very,O
55870,3787,severe,O
55871,3787,COPD,B-Condition
55872,3787,(,O
55873,3787,FEV1,O
55874,3787,<,O
55875,3787,80,O
55876,3787,%,O
55877,3787,predicted,O
55878,3787,),O
55879,3787,",",O
55880,3787,according,O
55881,3787,to,O
55882,3787,the,O
55883,3787,GesEPOC,O
55884,3787,criteria,O
55885,3787,",",O
55886,3787,established,O
55887,3787,at,O
55888,3787,least,O
55889,3787,3,O
55890,3787,months,O
55891,3788,current,O
55892,3788,or,O
55893,3788,former,O
55894,3788,smoker,B-Person
55895,3788,with,O
55896,3788,an,O
55897,3788,accumulated,O
55898,3788,consumption,B-Observation
55899,3788,>,O
55900,3788,10,O
55901,3788,packs,O
55902,3788,x,O
55903,3788,year,O
55904,3789,hospital,O
55905,3789,admission,O
55906,3789,for,O
55907,3789,COPD,B-Condition
55908,3789,exacerbation,I-Condition
55909,3790,Age,B-Person
55910,3790,less,O
55911,3790,than,O
55912,3790,one,O
55913,3790,year,O
55914,3790,or,O
55915,3790,over,O
55916,3790,18,O
55917,3790,years,O
55918,3791,Patients,O
55919,3791,with,O
55920,3791,renal,B-Condition
55921,3791,impairment,I-Condition
55922,3792,Colistin,B-Drug
55923,3792,use,O
55924,3792,less,O
55925,3792,than,O
55926,3792,72,O
55927,3792,hours,O
55928,3793,Age,B-Person
55929,3793,between,O
55930,3793,one,O
55931,3793,year,O
55932,3793,and,O
55933,3793,18,O
55934,3793,years,O
55935,3794,Sepsis,B-Condition
55936,3794,due,O
55937,3794,to,O
55938,3794,MDR,O
55939,3794,or,O
55940,3794,minimally,B-Condition
55941,3794,susceptible,I-Condition
55942,3794,gram,I-Condition
55943,3794,-,I-Condition
55944,3794,negative,I-Condition
55945,3794,bacteria,I-Condition
55946,3795,History,O
55947,3795,of,O
55948,3795,MDR,O
55949,3795,gram,B-Condition
55950,3795,-,I-Condition
55951,3795,negative,I-Condition
55952,3795,infection,I-Condition
55953,3795,or,O
55954,3795,sepsis,B-Condition
55955,3795,due,O
55956,3795,to,O
55957,3795,organisms,B-Observation
55958,3795,sensitive,O
55959,3795,to,O
55960,3795,colistin,O
55961,3795,.,O
55962,3796,Culture,O
55963,3796,result,O
55964,3796,consistent,O
55965,3796,with,O
55966,3796,MDR,O
55967,3796,gram,B-Condition
55968,3796,negative,I-Condition
55969,3796,for,O
55970,3796,this,O
55971,3796,febrile,O
55972,3796,neutropenic,O
55973,3796,episode,O
55974,3796,.,O
55975,3797,Patient,O
55976,3797,in,O
55977,3797,sepsis,B-Condition
55978,3797,and,O
55979,3797,colistin,B-Drug
55980,3797,was,O
55981,3797,administered,B-Procedure
55982,3797,empirically,I-Procedure
55983,3797,to,O
55984,3797,increase,O
55985,3797,antibiotic,O
55986,3797,coverage,O
55987,3797,.,O
55988,3798,indication,B-Mood
55989,3798,for,O
55990,3798,catheter,B-Procedure
55991,3798,insertion,I-Procedure
55992,3798,;,O
55993,3799,contraindications,B-Condition
55994,3799,to,O
55995,3799,brachial,B-Procedure
55996,3799,plexus,I-Procedure
55997,3799,block,I-Procedure
55998,3799,(,O
55999,3799,e.g.,O
56000,3799,",",O
56001,3799,allergy,B-Condition
56002,3799,to,O
56003,3799,local,B-Drug
56004,3799,anaesthetics,I-Drug
56005,3799,",",O
56006,3799,malignancy,B-Condition
56007,3799,or,O
56008,3799,infection,B-Condition
56009,3799,in,O
56010,3799,the,O
56011,3799,area,O
56012,3799,),O
56013,3799,;,O
56014,3800,existing,O
56015,3800,neurological,B-Condition
56016,3800,deficit,I-Condition
56017,3800,in,O
56018,3800,the,O
56019,3800,area,O
56020,3800,to,O
56021,3800,be,O
56022,3800,blocked,O
56023,3800,;,O
56024,3801,pregnancy,B-Condition
56025,3801,;,O
56026,3802,history,O
56027,3802,of,O
56028,3802,neck,B-Procedure
56029,3802,surgery,I-Procedure
56030,3802,or,O
56031,3802,radiotherapy,B-Procedure
56032,3802,;,O
56033,3803,severe,O
56034,3803,respiratory,B-Condition
56035,3803,disease,I-Condition
56036,3803,;,O
56037,3804,chest,B-Condition
56038,3804,deformity,I-Condition
56039,3804,;,O
56040,3805,inability,O
56041,3805,to,O
56042,3805,understand,O
56043,3805,the,O
56044,3805,informed,O
56045,3805,consent,O
56046,3805,and,O
56047,3805,demands,O
56048,3805,of,O
56049,3805,the,O
56050,3805,study,O
56051,3805,;,O
56052,3806,patient,O
56053,3806,refusal,O
56054,3806,.,O
56055,3807,ASA,O
56056,3807,physical,O
56057,3807,status,O
56058,3807,I,O
56059,3807,-,O
56060,3807,III,O
56061,3807,;,O
56062,3808,18,O
56063,3808,-,O
56064,3808,85,O
56065,3808,years,O
56066,3808,of,O
56067,3808,age,B-Person
56068,3808,",",O
56069,3808,inclusive,O
56070,3808,;,O
56071,3809,surgery,O
56072,3809,less,O
56073,3809,than,O
56074,3809,3,O
56075,3809,hours,O
56076,3809,.,O
56077,3810,Any,O
56078,3810,other,O
56079,3810,variety,O
56080,3810,of,O
56081,3810,LAL,B-Condition
56082,3811,Patients,O
56083,3811,with,O
56084,3811,a,O
56085,3811,history,B-Observation
56086,3811,of,O
56087,3811,coronary,B-Condition
56088,3811,artery,I-Condition
56089,3811,disease,I-Condition
56090,3811,",",O
56091,3811,valvular,O
56092,3811,or,O
56093,3811,hypertensive,B-Condition
56094,3811,heart,I-Condition
56095,3811,disease,I-Condition
56096,3812,Patients,O
56097,3812,with,O
56098,3812,chronic,B-Condition
56099,3812,liver,I-Condition
56100,3812,disease,I-Condition
56101,3813,Patients,O
56102,3813,with,O
56103,3813,chronic,B-Condition
56104,3813,respiratory,I-Condition
56105,3813,failure,I-Condition
56106,3814,Renal,B-Condition
56107,3814,failure,I-Condition
56108,3814,not,O
56109,3814,due,B-Mood
56110,3814,to,I-Mood
56111,3814,LAL,B-Condition
56112,3815,Patients,O
56113,3815,with,O
56114,3815,positive,O
56115,3815,HIV,O
56116,3815,status,O
56117,3816,No,O
56118,3816,serious,O
56119,3816,neurological,B-Condition
56120,3816,abnormalities,I-Condition
56121,3816,due,B-Mood
56122,3816,to,I-Mood
56123,3816,LAL,B-Condition
56124,3817,Impact,O
56125,3817,on,O
56126,3817,overall,O
56127,3817,severe,O
56128,3817,(,O
56129,3817,grade,O
56130,3817,3,O
56131,3817,or,O
56132,3817,4,O
56133,3817,of,O
56134,3817,the,O
56135,3817,WHO,O
56136,3817,scale,O
56137,3817,),O
56138,3817,not,O
56139,3817,attributable,O
56140,3817,to,O
56141,3817,the,O
56142,3817,LAL,O
56143,3818,Pregnant,B-Observation
56144,3818,or,O
56145,3818,breastfeeding,B-Observation
56146,3819,initial,O
56147,3819,blast,O
56148,3819,crisis,O
56149,3819,CML,B-Condition
56150,3820,Patients,O
56151,3820,with,O
56152,3820,Ph,O
56153,3820,(,O
56154,3820,BCR,O
56155,3820,/,O
56156,3820,ABL,O
56157,3820,),O
56158,3820,positive,O
56159,3820,de,O
56160,3820,novo,O
56161,3820,<,O
56162,3820,55,O
56163,3820,years,O
56164,3820,old,B-Person
56165,3820,(,O
56166,3820,it,O
56167,3820,is,O
56168,3820,advisable,O
56169,3820,to,O
56170,3820,include,O
56171,3820,patients,O
56172,3820,over,O
56173,3820,55,O
56174,3820,years,O
56175,3820,LAL07OPH,O
56176,3820,protocol,O
56177,3820,),O
56178,3820,.,O
56179,3821,Performance,O
56180,3821,status,O
56181,3821,0,O
56182,3821,-,O
56183,3821,2,O
56184,3821,(,O
56185,3821,Appendix,O
56186,3821,B,O
56187,3821,),O
56188,3821,may,O
56189,3821,include,O
56190,3821,patients,O
56191,3821,with,O
56192,3821,performance,O
56193,3821,status,O
56194,3821,>,O
56195,3821,2,O
56196,3821,attributable,O
56197,3821,to,O
56198,3821,LAL,O
56199,3821,.,O
56200,3822,Patients,O
56201,3822,without,O
56202,3822,functional,B-Condition
56203,3822,impairment,I-Condition
56204,3822,of,I-Condition
56205,3822,organs,I-Condition
56206,3822,:,O
56207,3822,liver,O
56208,3822,function,O
56209,3822,:,O
56210,3822,total,O
56211,3822,bilirubin,O
56212,3822,",",O
56213,3822,AST,O
56214,3822,",",O
56215,3822,ALT,O
56216,3822,",",O
56217,3822,alfa,O
56218,3822,-,O
56219,3822,GT,O
56220,3822,and,O
56221,3822,alkaline,O
56222,3822,phosphatase,O
56223,3822,less,O
56224,3822,than,O
56225,3822,3,O
56226,3822,times,O
56227,3822,the,O
56228,3822,upper,O
56229,3822,limit,O
56230,3822,of,O
56231,3822,normal,O
56232,3822,laboratory,O
56233,3822,renal,O
56234,3822,function,O
56235,3822,:,O
56236,3822,serum,O
56237,3822,creatinine,O
56238,3822,<,O
56239,3822,2,O
56240,3822,mg,O
56241,3822,/,O
56242,3822,dL,O
56243,3822,or,O
56244,3822,clearance,O
56245,3822,creatinine,O
56246,3822,>,O
56247,3822,30,O
56248,3822,ml,O
56249,3822,/,O
56250,3822,min,O
56251,3822,(,O
56252,3822,except,O
56253,3822,renal,O
56254,3822,function,O
56255,3822,attributable,O
56256,3822,to,O
56257,3822,LAL,O
56258,3822,),O
56259,3822,cardiac,O
56260,3822,function,O
56261,3822,(,O
56262,3822,Appendix,O
56263,3822,B,O
56264,3822,),O
56265,3822,normal,O
56266,3822,:,O
56267,3822,ventricular,O
56268,3822,EF,O
56269,3822,>,O
56270,3822,50,O
56271,3822,%,O
56272,3822,",",O
56273,3822,absence,O
56274,3822,of,O
56275,3822,severe,B-Condition
56276,3822,chronic,I-Condition
56277,3822,respiratory,I-Condition
56278,3822,disease,I-Condition
56279,3822,.,O
56280,3822,In,O
56281,3822,the,O
56282,3822,event,O
56283,3822,that,O
56284,3822,alterations,O
56285,3822,are,O
56286,3822,secondary,O
56287,3822,to,O
56288,3822,the,O
56289,3822,disease,O
56290,3822,is,O
56291,3822,at,O
56292,3822,the,O
56293,3822,discretion,O
56294,3822,of,O
56295,3822,the,O
56296,3822,investigator,O
56297,3822,to,O
56298,3822,determine,O
56299,3822,if,O
56300,3822,the,O
56301,3822,patient,O
56302,3822,can,O
56303,3822,be,O
56304,3822,included,O
56305,3822,in,O
56306,3822,the,O
56307,3822,trial,O
56308,3822,.,O
56309,3823,Cardiac,B-Condition
56310,3823,morbidities,I-Condition
56311,3824,hypertensive,B-Condition
56312,3824,disorders,I-Condition
56313,3824,of,I-Condition
56314,3824,pregnancy,I-Condition
56315,3825,peripartum,B-Condition
56316,3825,bleeding,I-Condition
56317,3826,baseline,O
56318,3826,systolic,O
56319,3826,blood,O
56320,3826,pressure,O
56321,3826,(,O
56322,3826,SBP,O
56323,3826,),O
56324,3826,<,O
56325,3826,100,O
56326,3826,mmHg,O
56327,3827,body,O
56328,3827,mass,O
56329,3827,index,O
56330,3827,>,O
56331,3827,35,O
56332,3828,full,B-Condition
56333,3828,term,I-Condition
56334,3829,singleton,O
56335,3829,pregnant,B-Condition
56336,3829,women,B-Person
56337,3830,scheduled,B-Mood
56338,3830,for,I-Mood
56339,3830,elective,O
56340,3830,cesarean,B-Procedure
56341,3830,delivery,I-Procedure
56342,3831,No,O
56343,3831,informed,O
56344,3831,consent,O
56345,3831,for,O
56346,3831,participation,O
56347,3831,in,O
56348,3831,the,O
56349,3831,study,O
56350,3831,",",O
56351,3831,mental,O
56352,3831,illness,O
56353,3831,",",O
56354,3831,which,O
56355,3831,do,O
56356,3831,n't,O
56357,3831,allow,O
56358,3831,to,O
56359,3831,obtain,O
56360,3831,informed,O
56361,3831,consent,O
56362,3831,and,O
56363,3831,conduct,O
56364,3831,the,O
56365,3831,treatment,O
56366,3831,according,O
56367,3831,to,O
56368,3831,the,O
56369,3831,protocol,O
56370,3832,Pregnancy,B-Condition
56371,3833,HIV,B-Condition
56372,3833,infection,I-Condition
56373,3834,Active,O
56374,3834,cancer,B-Condition
56375,3835,Active,O
56376,3835,hepatitis,B-Condition
56377,3835,virus,I-Condition
56378,3835,infection,I-Condition
56379,3836,Adult,B-Condition
56380,3836,acute,I-Condition
56381,3836,myeloid,I-Condition
56382,3836,leukemia,I-Condition
56383,3837,Age,B-Person
56384,3837,:,O
56385,3837,≥18,O
56386,3837,and,O
56387,3837,≤,O
56388,3837,60,O
56389,3838,Clinical,O
56390,3838,condition,O
56391,3838,of,O
56392,3838,the,O
56393,3838,patient,O
56394,3838,allows,O
56395,3838,to,O
56396,3838,carry,O
56397,3838,out,O
56398,3838,induction,O
56399,3838,therapy,O
56400,3838,:,O
56401,3838,ECOG,O
56402,3838,performance,O
56403,3838,status,O
56404,3838,:,O
56405,3838,≤,O
56406,3838,2,O
56407,3838,and,O
56408,3838,the,O
56409,3838,Hematopoietic,O
56410,3838,Cell,O
56411,3838,Transplant,O
56412,3838,-,O
56413,3838,Co,O
56414,3838,-,O
56415,3838,morbidity,O
56416,3838,Index,O
56417,3838,(,O
56418,3838,HCT,O
56419,3838,-,O
56420,3838,I,O
56421,3838,):,O
56422,3838,≤3,O
56423,3839,Informed,O
56424,3839,consent,O
56425,3839,to,O
56426,3839,participate,O
56427,3839,in,O
56428,3839,the,O
56429,3839,study,O
56430,3839,(,O
56431,3839,ICF,O
56432,3839,signed,O
56433,3839,),O
56434,3840,The,O
56435,3840,second,O
56436,3840,early,O
56437,3840,induction,O
56438,3840,start,O
56439,3840,criteria,O
56440,3840,is,O
56441,3840,in,O
56442,3840,addition,O
56443,3840,to,O
56444,3840,the,O
56445,3840,listed,O
56446,3840,above,O
56447,3840,",",O
56448,3840,the,O
56449,3840,percentage,O
56450,3840,of,O
56451,3840,the,O
56452,3840,blasts,O
56453,3840,on,O
56454,3840,the,O
56455,3840,level,O
56456,3840,>,O
56457,3840,10,O
56458,3840,%,O
56459,3840,on,O
56460,3840,7th,O
56461,3840,day,O
56462,3840,.,O
56463,3841,hypoglycemia,B-Condition
56464,3841,SE;psychogenic,I-Condition
56465,3841,SE;any,I-Condition
56466,3841,other,O
56467,3841,pseudo,B-Condition
56468,3841,-,I-Condition
56469,3841,SE,I-Condition
56470,3842,30,O
56471,3842,min,O
56472,3842,or,O
56473,3842,more,O
56474,3842,of,O
56475,3842,(,O
56476,3842,1,O
56477,3842,),O
56478,3842,continuous,O
56479,3842,clinical,O
56480,3842,seizure,B-Condition
56481,3842,activities,O
56482,3842,or,O
56483,3842,(,O
56484,3842,2,O
56485,3842,),O
56486,3842,recurrent,O
56487,3842,seizure,B-Condition
56488,3842,activities,O
56489,3842,without,O
56490,3842,recovery(returning,O
56491,3842,to,O
56492,3842,baseline)between,O
56493,3842,seizures,O
56494,3842,;,O
56495,3843,clinical,O
56496,3843,data,O
56497,3843,is,O
56498,3843,complete,O
56499,3843,.,O
56500,3844,use,O
56501,3844,illicit,B-Drug
56502,3844,drugs,I-Drug
56503,3844,or,O
56504,3844,relapse,B-Condition
56505,3844,during,O
56506,3844,the,O
56507,3844,last,O
56508,3844,trimester,O
56509,3844,of,O
56510,3844,pregnancy,B-Condition
56511,3845,positive,O
56512,3845,drug,O
56513,3845,screen,O
56514,3845,at,O
56515,3845,the,O
56516,3845,time,O
56517,3845,of,O
56518,3845,delivery,B-Procedure
56519,3846,allergies,B-Condition
56520,3846,to,O
56521,3846,any,O
56522,3846,medications,B-Drug
56523,3846,used,I-Drug
56524,3846,in,I-Drug
56525,3846,the,I-Drug
56526,3846,study,I-Drug
56527,3847,taking,O
56528,3847,prescribed,O
56529,3847,gabapentin,B-Drug
56530,3847,at,O
56531,3847,the,O
56532,3847,time,O
56533,3847,of,O
56534,3847,admission,B-Procedure
56535,3847,for,O
56536,3847,CD,B-Procedure
56537,3848,contraindications,B-Condition
56538,3848,to,O
56539,3848,neuraxial,B-Procedure
56540,3848,anesthesia,I-Procedure
56541,3848,or,O
56542,3848,require,B-Mood
56543,3848,general,B-Procedure
56544,3848,anesthesia,I-Procedure
56545,3848,for,O
56546,3848,CD,B-Procedure
56547,3849,designated,O
56548,3849,ASA,O
56549,3849,physical,O
56550,3849,status,O
56551,3849,4,O
56552,3849,or,O
56553,3849,above,O
56554,3850,singleton,O
56555,3850,",",O
56556,3850,term,O
56557,3850,pregnancy,B-Condition
56558,3851,currently,O
56559,3851,on,O
56560,3851,buprenorphine,B-Procedure
56561,3851,maintenance,I-Procedure
56562,3851,therapy,I-Procedure
56563,3852,scheduled,B-Mood
56564,3852,for,I-Mood
56565,3852,elective,O
56566,3852,CD,B-Procedure
56567,3852,under,O
56568,3852,spinal,B-Procedure
56569,3852,anesthesia,I-Procedure
56570,3853,Cases,O
56571,3853,(,O
56572,3853,with,O
56573,3853,a,O
56574,3853,history,O
56575,3853,of,O
56576,3853,TBI,O
56577,3853,):,O
56578,3854,1,O
56579,3854,.,O
56580,3854,History,B-Observation
56581,3854,of,O
56582,3854,penetrating,B-Condition
56583,3854,brain,I-Condition
56584,3854,injury,I-Condition
56585,3855,2,O
56586,3855,.,O
56587,3855,History,B-Observation
56588,3855,of,O
56589,3855,disabling,O
56590,3855,neurological,O
56591,3855,or,O
56592,3855,psychiatric,O
56593,3855,condition,O
56594,3855,such,O
56595,3855,as,O
56596,3855,epilepsy,B-Condition
56597,3855,(,O
56598,3855,besides,O
56599,3855,posttraumatic,B-Condition
56600,3855,epilepsy,I-Condition
56601,3855,),O
56602,3855,",",O
56603,3855,multiple,B-Condition
56604,3855,sclerosis,I-Condition
56605,3855,",",O
56606,3855,cortical,B-Condition
56607,3855,stroke,I-Condition
56608,3855,",",O
56609,3855,hypoxic,B-Condition
56610,3855,-,I-Condition
56611,3855,ischemic,I-Condition
56612,3855,encephalopathy,I-Condition
56613,3855,",",O
56614,3855,encephalitis,B-Condition
56615,3855,",",O
56616,3855,or,O
56617,3855,schizophrenia,B-Condition
56618,3856,Controls,O
56619,3856,(,O
56620,3856,without,O
56621,3856,a,O
56622,3856,history,O
56623,3856,of,O
56624,3856,TBI,O
56625,3856,):,O
56626,3857,History,B-Observation
56627,3857,of,O
56628,3857,disabling,B-Condition
56629,3857,neurological,I-Condition
56630,3857,or,I-Condition
56631,3857,psychiatric,I-Condition
56632,3857,condition,I-Condition
56633,3857,such,O
56634,3857,as,O
56635,3857,epilepsy,B-Condition
56636,3857,",",O
56637,3857,multiple,B-Condition
56638,3857,sclerosis,I-Condition
56639,3857,",",O
56640,3857,cortical,B-Condition
56641,3857,stroke,I-Condition
56642,3857,",",O
56643,3857,hypoxic,B-Condition
56644,3857,-,I-Condition
56645,3857,ischemic,I-Condition
56646,3857,encephalopathy,I-Condition
56647,3857,",",O
56648,3857,encephalitis,B-Condition
56649,3857,",",O
56650,3857,or,O
56651,3857,schizophrenia,B-Condition
56652,3858,Cases,O
56653,3858,(,O
56654,3858,with,O
56655,3858,a,O
56656,3858,history,O
56657,3858,of,O
56658,3858,TBI,O
56659,3858,):,O
56660,3859,1,O
56661,3859,.,O
56662,3859,Ages,B-Person
56663,3859,50,O
56664,3859,-,O
56665,3859,95,O
56666,3859,years,O
56667,3860,2,O
56668,3860,.,O
56669,3860,History,B-Observation
56670,3860,of,O
56671,3860,traumatic,B-Condition
56672,3860,brain,I-Condition
56673,3860,injury,I-Condition
56674,3860,of,O
56675,3860,sufficient,O
56676,3860,severity,O
56677,3860,to,O
56678,3860,have,O
56679,3860,resulted,O
56680,3860,in,O
56681,3860,medical,O
56682,3860,attention,O
56683,3860,(,O
56684,3860,ascertained,O
56685,3860,via,O
56686,3860,the,O
56687,3860,Ohio,O
56688,3860,State,O
56689,3860,University,O
56690,3860,TBI,O
56691,3860,Identification,O
56692,3860,Questionnaire,O
56693,3860,—,O
56694,3860,OSU,O
56695,3860,TBI,O
56696,3860,-,O
56697,3860,ID,O
56698,3860,",",O
56699,3860,and,O
56700,3860,based,O
56701,3860,on,O
56702,3860,DoD,O
56703,3860,/,O
56704,3860,VA,O
56705,3860,criteria,O
56706,3860,),O
56707,3861,3,O
56708,3861,.,O
56709,3861,Residence,B-Observation
56710,3861,in,O
56711,3861,AFRH,O
56712,3861,-,O
56713,3861,Washington,O
56714,3861,D.C.,O
56715,3861,or,O
56716,3861,the,O
56717,3861,Veterans,O
56718,3861,Home,O
56719,3861,of,O
56720,3861,California,O
56721,3861,-,O
56722,3861,Yountville,O
56723,3862,4,O
56724,3862,.,O
56725,3862,MMSE,O
56726,3862,score,O
56727,3862,≥,O
56728,3862,20,O
56729,3863,5,O
56730,3863,.,O
56731,3863,Capacity,O
56732,3863,to,O
56733,3863,provide,O
56734,3863,consent,O
56735,3863,to,O
56736,3863,participate,O
56737,3863,in,O
56738,3863,research,O
56739,3863,(,O
56740,3863,assessment,O
56741,3863,made,O
56742,3863,by,O
56743,3863,study,O
56744,3863,physician,O
56745,3863,),O
56746,3864,6,O
56747,3864,.,O
56748,3864,Ability,O
56749,3864,to,O
56750,3864,read,O
56751,3864,and,O
56752,3864,write,O
56753,3864,English,O
56754,3865,Controls,O
56755,3865,(,O
56756,3865,without,O
56757,3865,a,O
56758,3865,history,O
56759,3865,of,O
56760,3865,TBI,O
56761,3865,):,O
56762,3866,1,O
56763,3866,.,O
56764,3866,Ages,B-Person
56765,3866,50,O
56766,3866,-,O
56767,3866,95,O
56768,3866,years,O
56769,3867,2,O
56770,3867,.,O
56771,3867,No,O
56772,3867,history,B-Observation
56773,3867,of,O
56774,3867,traumatic,B-Condition
56775,3867,brain,I-Condition
56776,3867,injury,I-Condition
56777,3867,of,O
56778,3867,sufficient,O
56779,3867,severity,O
56780,3867,to,O
56781,3867,have,O
56782,3867,resulted,O
56783,3867,in,O
56784,3867,medical,O
56785,3867,attention,O
56786,3867,(,O
56787,3867,ascertained,O
56788,3867,via,O
56789,3867,the,O
56790,3867,Ohio,O
56791,3867,State,O
56792,3867,University,O
56793,3867,TBI,O
56794,3867,Identification,O
56795,3867,Questionnaire,O
56796,3867,—,O
56797,3867,OSU,O
56798,3867,TBI,O
56799,3867,-,O
56800,3867,ID,O
56801,3867,),O
56802,3868,3,O
56803,3868,.,O
56804,3868,Residence,B-Observation
56805,3868,in,O
56806,3868,AFRH,O
56807,3868,-,O
56808,3868,Washington,O
56809,3868,or,O
56810,3868,the,O
56811,3868,Veterans,O
56812,3868,Home,O
56813,3868,of,O
56814,3868,California,O
56815,3868,-,O
56816,3868,Yountville,O
56817,3869,4,O
56818,3869,.,O
56819,3869,MMSE,O
56820,3869,score,O
56821,3869,≥,O
56822,3869,20,O
56823,3870,5,O
56824,3870,.,O
56825,3870,Capacity,O
56826,3870,to,O
56827,3870,provide,O
56828,3870,consent,O
56829,3870,or,O
56830,3870,assent,O
56831,3870,to,O
56832,3870,participate,O
56833,3870,in,O
56834,3870,research,O
56835,3871,6,O
56836,3871,.,O
56837,3871,Ability,O
56838,3871,to,O
56839,3871,read,O
56840,3871,and,O
56841,3871,write,O
56842,3871,English,O
56843,3871,-,O
56844,3872,1,O
56845,3872,.,O
56846,3872,The,O
56847,3872,patient,O
56848,3872,is,O
56849,3872,pregnant,B-Condition
56850,3872,or,O
56851,3872,breastfeeding,B-Observation
56852,3872,.,O
56853,3873,2,O
56854,3873,.,O
56855,3873,Evidence,O
56856,3873,of,O
56857,3873,STEMI,B-Condition
56858,3873,within,O
56859,3873,72,O
56860,3873,hours,O
56861,3873,of,O
56862,3873,the,O
56863,3873,intended,O
56864,3873,treatment,B-Procedure
56865,3873,on,O
56866,3873,infarct,O
56867,3873,related,O
56868,3873,or,O
56869,3873,non,O
56870,3873,-,O
56871,3873,infarct,O
56872,3873,related,O
56873,3873,artery,O
56874,3873,.,O
56875,3874,3,O
56876,3874,.,O
56877,3874,Cardiogenic,B-Condition
56878,3874,shock,I-Condition
56879,3874,on,O
56880,3874,presentation,O
56881,3874,or,O
56882,3874,during,O
56883,3874,current,O
56884,3874,hospitalization,B-Procedure
56885,3874,.,O
56886,3875,4,O
56887,3875,.,O
56888,3875,Left,O
56889,3875,ventricular,O
56890,3875,ejection,O
56891,3875,fraction,O
56892,3875,less,O
56893,3875,than,O
56894,3875,20,O
56895,3875,%,O
56896,3875,.,O
56897,3876,5,O
56898,3876,.,O
56899,3876,Known,O
56900,3876,allergies,B-Condition
56901,3876,to,O
56902,3876,:,O
56903,3876,aspirin,B-Drug
56904,3876,",",O
56905,3876,clopidogrel,B-Drug
56906,3876,(,O
56907,3876,Plavix,B-Drug
56908,3876,),O
56909,3876,and,O
56910,3876,ticlopidine,B-Drug
56911,3876,(,O
56912,3876,Ticlid,B-Drug
56913,3876,),O
56914,3876,",",O
56915,3876,heparin,B-Drug
56916,3876,",",O
56917,3876,bivalirudin,B-Drug
56918,3876,",",O
56919,3876,stainless,B-Observation
56920,3876,steel,I-Observation
56921,3876,",",O
56922,3876,or,O
56923,3876,contrast,B-Drug
56924,3876,agent,I-Drug
56925,3876,(,O
56926,3876,which,O
56927,3876,can,O
56928,3876,not,O
56929,3876,be,O
56930,3876,adequately,O
56931,3876,premedicated,O
56932,3876,),O
56933,3876,.,O
56934,3877,6,O
56935,3877,.,O
56936,3877,A,O
56937,3877,platelet,O
56938,3877,count,O
56939,3877,less,O
56940,3877,than,O
56941,3877,"75,000",O
56942,3877,cells,O
56943,3877,/,O
56944,3877,mm3,O
56945,3877,or,O
56946,3877,greater,O
56947,3877,than,O
56948,3877,"700,000",O
56949,3877,cells,O
56950,3877,/,O
56951,3877,mm3,O
56952,3877,or,O
56953,3877,a,O
56954,3877,WBC,O
56955,3877,less,O
56956,3877,than,O
56957,3877,"3,000",O
56958,3877,cells,O
56959,3877,/,O
56960,3877,mm3,O
56961,3877,.,O
56962,3878,7,O
56963,3878,.,O
56964,3878,Acute,B-Condition
56965,3878,or,I-Condition
56966,3878,chronic,I-Condition
56967,3878,renal,I-Condition
56968,3878,dysfunction,I-Condition
56969,3878,(,O
56970,3878,creatinine,O
56971,3878,greater,O
56972,3878,than,O
56973,3878,2.5,O
56974,3878,mg,O
56975,3878,/,O
56976,3878,dl,O
56977,3878,or,O
56978,3878,less,O
56979,3878,than,O
56980,3878,150µmol,O
56981,3878,/,O
56982,3878,L,O
56983,3878,),O
56984,3878,.,O
56985,3879,8,O
56986,3879,.,O
56987,3879,Subject,O
56988,3879,is,O
56989,3879,currently,O
56990,3879,participating,O
56991,3879,in,O
56992,3879,an,O
56993,3879,investigational,O
56994,3879,drug,O
56995,3879,or,O
56996,3879,device,O
56997,3879,study,O
56998,3879,that,O
56999,3879,has,O
57000,3879,not,O
57001,3879,completed,O
57002,3879,the,O
57003,3879,primary,O
57004,3879,endpoint,O
57005,3879,or,O
57006,3879,that,O
57007,3879,clinically,O
57008,3879,interferes,O
57009,3879,with,O
57010,3879,the,O
57011,3879,current,O
57012,3879,study,O
57013,3879,endpoints,O
57014,3879,.,O
57015,3879,(,O
57016,3879,Note,O
57017,3879,:,O
57018,3879,Trials,O
57019,3879,requiring,O
57020,3879,extended,O
57021,3879,follow,O
57022,3879,-,O
57023,3879,up,O
57024,3879,for,O
57025,3879,products,O
57026,3879,that,O
57027,3879,were,O
57028,3879,investigational,O
57029,3879,",",O
57030,3879,but,O
57031,3879,have,O
57032,3879,since,O
57033,3879,become,O
57034,3879,commercially,O
57035,3879,available,O
57036,3879,",",O
57037,3879,are,O
57038,3879,not,O
57039,3879,considered,O
57040,3879,investigational,O
57041,3879,trials,O
57042,3879,),O
57043,3879,.,O
57044,3880,9,O
57045,3880,.,O
57046,3880,Prior,O
57047,3880,participation,O
57048,3880,in,O
57049,3880,this,O
57050,3880,study,O
57051,3880,.,O
57052,3881,10,O
57053,3881,.,O
57054,3881,Within,O
57055,3881,30,O
57056,3881,days,O
57057,3881,prior,O
57058,3881,to,O
57059,3881,the,O
57060,3881,index,O
57061,3881,study,O
57062,3881,procedure,O
57063,3881,",",O
57064,3881,the,O
57065,3881,subject,O
57066,3881,has,O
57067,3881,undergone,O
57068,3881,a,O
57069,3881,previous,O
57070,3881,coronary,B-Procedure
57071,3881,interventional,I-Procedure
57072,3881,procedure,I-Procedure
57073,3881,of,O
57074,3881,any,O
57075,3881,kind,O
57076,3881,.,O
57077,3881,Note,O
57078,3881,:,O
57079,3881,This,O
57080,3881,exclusion,O
57081,3881,criterion,O
57082,3881,does,O
57083,3881,not,O
57084,3881,apply,O
57085,3881,to,O
57086,3881,post,O
57087,3881,-,O
57088,3881,STEMI,B-Condition
57089,3881,patients,O
57090,3881,.,O
57091,3882,11,O
57092,3882,.,O
57093,3882,Stroke,B-Condition
57094,3882,or,O
57095,3882,transient,B-Condition
57096,3882,ischemic,I-Condition
57097,3882,attack,I-Condition
57098,3882,within,O
57099,3882,the,O
57100,3882,prior,O
57101,3882,3,O
57102,3882,months,O
57103,3882,.,O
57104,3883,12,O
57105,3883,.,O
57106,3883,Active,O
57107,3883,peptic,B-Condition
57108,3883,ulcer,I-Condition
57109,3883,or,O
57110,3883,upper,B-Condition
57111,3883,gastrointestinal,I-Condition
57112,3883,bleeding,I-Condition
57113,3883,within,O
57114,3883,the,O
57115,3883,prior,O
57116,3883,3,O
57117,3883,months,O
57118,3883,.,O
57119,3884,13,O
57120,3884,.,O
57121,3884,Subject,O
57122,3884,has,O
57123,3884,active,O
57124,3884,sepsis,B-Condition
57125,3884,.,O
57126,3885,14,O
57127,3885,.,O
57128,3885,Unprotected,O
57129,3885,left,B-Condition
57130,3885,main,I-Condition
57131,3885,coronary,I-Condition
57132,3885,artery,I-Condition
57133,3885,disease,I-Condition
57134,3885,(,O
57135,3885,stenosis,B-Condition
57136,3885,greater,O
57137,3885,than,O
57138,3885,50,O
57139,3885,%,O
57140,3885,),O
57141,3885,.,O
57142,3886,15,O
57143,3886,.,O
57144,3886,In,O
57145,3886,the,O
57146,3886,investigator,O
57147,3886,'s,O
57148,3886,opinion,O
57149,3886,",",O
57150,3886,subject,O
57151,3886,has,O
57152,3886,a,O
57153,3886,co,O
57154,3886,-,O
57155,3886,morbid,O
57156,3886,condition(s,O
57157,3886,),O
57158,3886,that,O
57159,3886,could,O
57160,3886,limit,O
57161,3886,the,O
57162,3886,life,B-Observation
57163,3886,expectancy,I-Observation
57164,3886,to,O
57165,3886,less,O
57166,3886,than,O
57167,3886,one,O
57168,3886,year,O
57169,3886,",",O
57170,3886,or,O
57171,3886,limit,O
57172,3886,the,O
57173,3886,subject,O
57174,3886,'s,O
57175,3886,ability,O
57176,3886,to,O
57177,3886,participate,O
57178,3886,in,O
57179,3886,the,O
57180,3886,study,O
57181,3886,or,O
57182,3886,comply,O
57183,3886,with,O
57184,3886,follow,O
57185,3886,-,O
57186,3886,up,O
57187,3886,requirements,O
57188,3886,or,O
57189,3886,impact,O
57190,3886,the,O
57191,3886,scientific,O
57192,3886,integrity,O
57193,3886,of,O
57194,3886,the,O
57195,3886,study,O
57196,3886,.,O
57197,3887,16,O
57198,3887,.,O
57199,3887,Subject,O
57200,3887,has,O
57201,3887,normal,O
57202,3887,or,O
57203,3887,insignificant,O
57204,3887,coronaries,O
57205,3887,(,O
57206,3887,i.e.,O
57207,3887,coronary,B-Condition
57208,3887,lesion(s,I-Condition
57209,3887,),O
57210,3887,less,O
57211,3887,than,O
57212,3887,50,O
57213,3887,%,O
57214,3887,stenosis,B-Condition
57215,3887,),O
57216,3887,.,O
57217,3888,17,O
57218,3888,.,O
57219,3888,Any,O
57220,3888,target,O
57221,3888,vessel,O
57222,3888,has,O
57223,3888,evidence,O
57224,3888,of,O
57225,3888,:,O
57226,3889,excessive,O
57227,3889,thrombus,B-Condition
57228,3889,(,O
57229,3889,e.g.,O
57230,3889,requires,O
57231,3889,target,B-Procedure
57232,3889,vessel,I-Procedure
57233,3889,thrombectomy,I-Procedure
57234,3889,),O
57235,3890,tortuousity,B-Condition
57236,3890,(,O
57237,3890,greater,O
57238,3890,than,O
57239,3890,60,O
57240,3890,degree,O
57241,3890,angle,O
57242,3890,),O
57243,3890,that,O
57244,3890,makes,O
57245,3890,it,O
57246,3890,unsuitable,O
57247,3890,for,O
57248,3890,proper,O
57249,3890,stent,B-Procedure
57250,3890,delivery,I-Procedure
57251,3890,and,I-Procedure
57252,3890,deployment,I-Procedure
57253,3890,",",O
57254,3891,heavy,O
57255,3891,calcification,B-Condition
57256,3891,.,O
57257,3892,18,O
57258,3892,.,O
57259,3892,Any,O
57260,3892,target,B-Condition
57261,3892,lesion,I-Condition
57262,3892,requires,B-Mood
57263,3892,treatment,B-Procedure
57264,3892,with,O
57265,3892,a,O
57266,3892,device,O
57267,3892,other,O
57268,3892,than,O
57269,3892,percutaneous,B-Procedure
57270,3892,transluminal,I-Procedure
57271,3892,coronary,I-Procedure
57272,3892,angioplasty,I-Procedure
57273,3892,(,I-Procedure
57274,3892,PTCA,I-Procedure
57275,3892,),I-Procedure
57276,3892,prior,O
57277,3892,to,O
57278,3892,stent,B-Procedure
57279,3892,placement,I-Procedure
57280,3892,(,O
57281,3892,e.g.,O
57282,3892,but,O
57283,3892,not,O
57284,3892,limited,O
57285,3892,to,O
57286,3892,",",O
57287,3892,directional,B-Procedure
57288,3892,coronary,I-Procedure
57289,3892,atherectomy,I-Procedure
57290,3892,",",O
57291,3892,excimer,B-Procedure
57292,3892,laser,I-Procedure
57293,3892,",",O
57294,3892,rotational,B-Procedure
57295,3892,atherectomy,I-Procedure
57296,3892,",",O
57297,3892,etc,O
57298,3892,.,O
57299,3892,),O
57300,3892,.,O
57301,3893,19,O
57302,3893,.,O
57303,3893,Any,O
57304,3893,lesion,B-Condition
57305,3893,that,O
57306,3893,is,O
57307,3893,located,O
57308,3893,in,O
57309,3893,a,O
57310,3893,saphenous,O
57311,3893,vein,O
57312,3893,graft,O
57313,3893,",",O
57314,3893,however,O
57315,3893,",",O
57316,3893,lesions,O
57317,3893,located,O
57318,3893,within,O
57319,3893,the,O
57320,3893,native,O
57321,3893,vessel,O
57322,3893,but,O
57323,3893,accessed,O
57324,3893,through,O
57325,3893,the,O
57326,3893,graft,O
57327,3893,are,O
57328,3893,eligible,O
57329,3893,.,O
57330,3894,20,O
57331,3894,.,O
57332,3894,The,O
57333,3894,target,O
57334,3894,vessel,O
57335,3894,is,O
57336,3894,in,O
57337,3894,a,O
57338,3894,"""",O
57339,3894,last,O
57340,3894,remaining,O
57341,3894,"""",O
57342,3894,epicardial,O
57343,3894,vessel,O
57344,3894,(,O
57345,3894,e.g.,O
57346,3894,greater,O
57347,3894,than,O
57348,3894,2,O
57349,3894,non,O
57350,3894,-,O
57351,3894,target,O
57352,3894,epicardial,O
57353,3894,vessels,O
57354,3894,and,O
57355,3894,the,O
57356,3894,bypass,O
57357,3894,grafts,O
57358,3894,to,O
57359,3894,these,O
57360,3894,territories,O
57361,3894,[,O
57362,3894,if,O
57363,3894,present,O
57364,3894,],O
57365,3894,are,O
57366,3894,totally,O
57367,3894,occluded,O
57368,3894,),O
57369,3894,.,O
57370,3895,1,O
57371,3895,.,O
57372,3895,Subject,O
57373,3895,is,O
57374,3895,at,O
57375,3895,least,O
57376,3895,18,O
57377,3895,years,O
57378,3895,old,B-Person
57379,3895,.,O
57380,3896,2,O
57381,3896,.,O
57382,3896,Subject,O
57383,3896,requires,O
57384,3896,single-,O
57385,3896,or,O
57386,3896,multi,O
57387,3896,-,O
57388,3896,vessel,O
57389,3896,percutaneous,B-Procedure
57390,3896,coronary,I-Procedure
57391,3896,intervention,I-Procedure
57392,3896,(,I-Procedure
57393,3896,PCI,I-Procedure
57394,3896,),I-Procedure
57395,3896,of,O
57396,3896,de,O
57397,3896,novo,O
57398,3896,or,O
57399,3896,restenotic,O
57400,3896,target,B-Condition
57401,3896,lesion,I-Condition
57402,3896,(,O
57403,3896,including,O
57404,3896,in,B-Condition
57405,3896,-,I-Condition
57406,3896,stent,I-Condition
57407,3896,restenotic,I-Condition
57408,3896,lesions,I-Condition
57409,3896,),O
57410,3896,.,O
57411,3897,3,O
57412,3897,.,O
57413,3897,Subject,O
57414,3897,'s,O
57415,3897,lesion(s,O
57416,3897,),O
57417,3897,is,O
57418,3897,(,O
57419,3897,are,O
57420,3897,),O
57421,3897,amenable,B-Condition
57422,3897,to,I-Condition
57423,3897,stent,I-Condition
57424,3897,treatment,I-Condition
57425,3897,with,O
57426,3897,currently,O
57427,3897,available,O
57428,3897,FDA,O
57429,3897,-,O
57430,3897,approved,O
57431,3897,bare,O
57432,3897,metal,O
57433,3897,or,O
57434,3897,drug,O
57435,3897,eluting,O
57436,3897,stents,O
57437,3897,.,O
57438,3898,4,O
57439,3898,.,O
57440,3898,Subject,O
57441,3898,is,O
57442,3898,an,O
57443,3898,acceptable,O
57444,3898,candidate,O
57445,3898,for,O
57446,3898,elective,O
57447,3898,",",O
57448,3898,urgent,O
57449,3898,or,O
57450,3898,emergency,O
57451,3898,coronary,B-Condition
57452,3898,artery,I-Condition
57453,3898,bypass,I-Condition
57454,3898,graft,I-Condition
57455,3898,(,I-Condition
57456,3898,CABG,I-Condition
57457,3898,),I-Condition
57458,3898,.,O
57459,3899,5,O
57460,3899,.,O
57461,3899,Subject,O
57462,3899,has,O
57463,3899,clinical,B-Observation
57464,3899,evidence,I-Observation
57465,3899,of,O
57466,3899,ischemic,B-Condition
57467,3899,heart,I-Condition
57468,3899,disease,I-Condition
57469,3899,in,O
57470,3899,terms,O
57471,3899,of,O
57472,3899,a,O
57473,3899,positive,O
57474,3899,functional,B-Procedure
57475,3899,study,I-Procedure
57476,3899,",",O
57477,3899,or,O
57478,3899,documented,O
57479,3899,symptoms,O
57480,3899,.,O
57481,3900,6,O
57482,3900,.,O
57483,3900,Documented,O
57484,3900,stable,B-Condition
57485,3900,angina,I-Condition
57486,3900,pectoris,I-Condition
57487,3900,[,O
57488,3900,Canadian,O
57489,3900,Cardiovascular,O
57490,3900,Society,O
57491,3900,Classification,O
57492,3900,(,O
57493,3900,CCS,O
57494,3900,),O
57495,3900,1,O
57496,3900,",",O
57497,3900,2,O
57498,3900,",",O
57499,3900,3,O
57500,3900,",",O
57501,3900,or,O
57502,3900,4,O
57503,3900,],O
57504,3900,",",O
57505,3900,unstable,B-Condition
57506,3900,angina,I-Condition
57507,3900,pectoris,I-Condition
57508,3900,with,O
57509,3900,documented,B-Observation
57510,3900,ischemia,B-Condition
57511,3900,(,O
57512,3900,Braunwald,O
57513,3900,Class,O
57514,3900,IB,O
57515,3900,-,O
57516,3900,C,O
57517,3900,",",O
57518,3900,IIB,O
57519,3900,-,O
57520,3900,C,O
57521,3900,",",O
57522,3900,or,O
57523,3900,IIIB,O
57524,3900,-,O
57525,3900,C,O
57526,3900,),O
57527,3900,",",O
57528,3900,non,B-Condition
57529,3900,-,I-Condition
57530,3900,ST,I-Condition
57531,3900,segment,I-Condition
57532,3900,elevation,I-Condition
57533,3900,myocardial,I-Condition
57534,3900,infarction,I-Condition
57535,3900,",",O
57536,3900,or,O
57537,3900,documented,B-Observation
57538,3900,silent,B-Condition
57539,3900,ischemia,I-Condition
57540,3900,.,O
57541,3901,7,O
57542,3901,.,O
57543,3901,Subject,O
57544,3901,is,O
57545,3901,willing,B-Observation
57546,3901,and,O
57547,3901,able,B-Observation
57548,3901,to,O
57549,3901,undergo,O
57550,3901,percutaneous,B-Procedure
57551,3901,intervention,I-Procedure
57552,3901,at,O
57553,3901,SOS,O
57554,3901,hospital,O
57555,3901,",",O
57556,3901,if,O
57557,3901,randomized,O
57558,3901,to,O
57559,3901,SOS,O
57560,3901,study,O
57561,3901,arm,O
57562,3901,.,O
57563,3902,8,O
57564,3902,.,O
57565,3902,Subject,O
57566,3902,and,O
57567,3902,the,O
57568,3902,treating,O
57569,3902,physician,O
57570,3902,agree,O
57571,3902,that,O
57572,3902,the,O
57573,3902,subject,O
57574,3902,will,O
57575,3902,comply,O
57576,3902,with,O
57577,3902,all,O
57578,3902,follow,O
57579,3902,-,O
57580,3902,up,O
57581,3902,evaluations,O
57582,3902,.,O
57583,3903,9,O
57584,3903,.,O
57585,3903,Subject,O
57586,3903,has,O
57587,3903,been,O
57588,3903,informed,O
57589,3903,of,O
57590,3903,the,O
57591,3903,nature,O
57592,3903,of,O
57593,3903,the,O
57594,3903,study,O
57595,3903,and,O
57596,3903,agrees,O
57597,3903,to,O
57598,3903,its,O
57599,3903,provisions,O
57600,3903,and,O
57601,3903,has,O
57602,3903,provided,O
57603,3903,written,O
57604,3903,informed,O
57605,3903,consent,O
57606,3903,as,O
57607,3903,approved,O
57608,3903,by,O
57609,3903,the,O
57610,3903,Institutional,O
57611,3903,Review,O
57612,3903,Board,O
57613,3903,/,O
57614,3903,Ethics,O
57615,3903,Committee,O
57616,3903,of,O
57617,3903,the,O
57618,3903,respective,O
57619,3903,clinical,O
57620,3903,site,O
57621,3903,.,O
57622,3904,10,O
57623,3904,.,O
57624,3904,The,O
57625,3904,target,B-Condition
57626,3904,lesion(s,I-Condition
57627,3904,),O
57628,3904,is,O
57629,3904,(,O
57630,3904,are,O
57631,3904,),O
57632,3904,de,O
57633,3904,novo,O
57634,3904,or,O
57635,3904,restenotic,O
57636,3904,(,O
57637,3904,including,O
57638,3904,in,O
57639,3904,-,O
57640,3904,stent,O
57641,3904,restenotic,O
57642,3904,),O
57643,3904,native,O
57644,3904,coronary,B-Condition
57645,3904,artery,I-Condition
57646,3904,lesion(s,I-Condition
57647,3904,),O
57648,3904,with,O
57649,3904,greater,O
57650,3904,than,O
57651,3904,50,O
57652,3904,and,O
57653,3904,less,O
57654,3904,than,O
57655,3904,100,O
57656,3904,%,O
57657,3904,stenosis,B-Condition
57658,3904,(,O
57659,3904,visual,O
57660,3904,estimate,O
57661,3904,),O
57662,3904,",",O
57663,3904,or,O
57664,3904,the,O
57665,3904,target,B-Condition
57666,3904,lesion,I-Condition
57667,3904,is,O
57668,3904,an,O
57669,3904,acute,O
57670,3904,(,O
57671,3904,less,O
57672,3904,than,O
57673,3904,1,O
57674,3904,month,O
57675,3904,),O
57676,3904,total,B-Condition
57677,3904,occlusion,I-Condition
57678,3904,as,O
57679,3904,evidenced,O
57680,3904,by,O
57681,3904,clinical,B-Observation
57682,3904,symptoms,I-Observation
57683,3904,.,O
57684,3905,11,O
57685,3905,.,O
57686,3905,Target,B-Condition
57687,3905,lesions(s,I-Condition
57688,3905,),O
57689,3905,is,O
57690,3905,(,O
57691,3905,are,O
57692,3905,),O
57693,3905,located,O
57694,3905,in,O
57695,3905,an,O
57696,3905,infarct,B-Condition
57697,3905,(,O
57698,3905,if,O
57699,3905,not,O
57700,3905,treated,O
57701,3905,with,O
57702,3905,primary,B-Procedure
57703,3905,PCI,I-Procedure
57704,3905,),O
57705,3905,or,O
57706,3905,non,O
57707,3905,-,O
57708,3905,infarct,O
57709,3905,-,O
57710,3905,related,O
57711,3905,artery,O
57712,3905,with,O
57713,3905,a,O
57714,3905,70,O
57715,3905,%,O
57716,3905,or,O
57717,3905,greater,O
57718,3905,stenosis,B-Condition
57719,3905,(,O
57720,3905,by,O
57721,3905,visual,O
57722,3905,estimate,O
57723,3905,),O
57724,3905,more,O
57725,3905,than,O
57726,3905,72,O
57727,3905,hours,O
57728,3905,following,O
57729,3905,the,O
57730,3905,ST,B-Condition
57731,3905,segment,I-Condition
57732,3905,elevation,I-Condition
57733,3905,myocardial,I-Condition
57734,3905,infarction,I-Condition
57735,3905,(,I-Condition
57736,3905,STEMI,I-Condition
57737,3905,),I-Condition
57738,3905,.,O
57739,3906,Lesions,O
57740,3906,treated,O
57741,3906,with,O
57742,3906,PCI,O
57743,3906,more,O
57744,3906,than,O
57745,3906,72,O
57746,3906,hours,O
57747,3906,following,O
57748,3906,STEMI,O
57749,3906,would,O
57750,3906,be,O
57751,3906,subject,O
57752,3906,to,O
57753,3906,the,O
57754,3906,same,O
57755,3906,protocol,O
57756,3906,inclusion,O
57757,3906,/,O
57758,3906,exclusion,O
57759,3906,criteria,O
57760,3906,listed,O
57761,3906,above,O
57762,3906,and,O
57763,3906,below,O
57764,3906,with,O
57765,3906,the,O
57766,3906,exception,O
57767,3906,that,O
57768,3906,a,O
57769,3906,target,O
57770,3906,lesion,O
57771,3906,of,O
57772,3906,70,O
57773,3906,%,O
57774,3906,or,O
57775,3906,greater,O
57776,3906,stenosis,O
57777,3906,may,O
57778,3906,be,O
57779,3906,treated,O
57780,3906,with,O
57781,3906,or,O
57782,3906,without,O
57783,3906,symptoms,O
57784,3906,or,O
57785,3906,abnormal,O
57786,3906,stress,O
57787,3906,test,O
57788,3906,),O
57789,3906,.,O
57790,3907,Enrollment,O
57791,3907,in,O
57792,3907,another,O
57793,3907,trial,O
57794,3908,Lack,O
57795,3908,of,O
57796,3908,consent,O
57797,3909,Infants,B-Person
57798,3909,in,O
57799,3909,the,O
57800,3909,newborn,O
57801,3909,intensive,O
57802,3909,care,O
57803,3909,unit,O
57804,3910,TPN,B-Condition
57805,3910,cholestasis,I-Condition
57806,3910,of,O
57807,3910,at,O
57808,3910,least,O
57809,3910,2.5,O
57810,3910,mg,O
57811,3910,/,O
57812,3910,dl,O
57813,3911,Anticipated,O
57814,3911,TPN,B-Procedure
57815,3911,treatment,I-Procedure
57816,3911,for,O
57817,3911,at,O
57818,3911,least,O
57819,3911,one,O
57820,3911,month,O
57821,3912,signed,O
57822,3912,informed,O
57823,3912,consent,O
57824,3913,Co,O
57825,3913,-,O
57826,3913,infected,O
57827,3913,with,O
57828,3913,HCV,B-Condition
57829,3913,",",O
57830,3913,HIV,B-Condition
57831,3913,or,O
57832,3913,other,O
57833,3913,viral,B-Condition
57834,3913,hepatitis,I-Condition
57835,3913,",",O
57836,3914,Diagnosis,O
57837,3914,of,O
57838,3914,HCC,B-Condition
57839,3915,Chronic,B-Condition
57840,3915,hepatitis,I-Condition
57841,3915,B,I-Condition
57842,3915,",",O
57843,3916,Antiviral,B-Drug
57844,3916,experienced,B-Mood
57845,3916,",",O
57846,3917,Currently,O
57847,3917,on,O
57848,3917,long,O
57849,3917,term,O
57850,3917,TDF,B-Procedure
57851,3917,anti,I-Procedure
57852,3917,-,I-Procedure
57853,3917,HBV,I-Procedure
57854,3917,treatment,I-Procedure
57855,3917,",",O
57856,3918,HBV,O
57857,3918,DNA,O
57858,3918,<,O
57859,3918,6,O
57860,3918,log,O
57861,3918,IU,O
57862,3918,/,O
57863,3918,ml,O
57864,3918,(,O
57865,3918,LLOD,O
57866,3918,),O
57867,3919,Able,O
57868,3919,to,O
57869,3919,sign,O
57870,3919,the,O
57871,3919,consent,O
57872,3919,form,O
57873,3919,of,O
57874,3919,anticipating,O
57875,3919,in,O
57876,3919,the,O
57877,3919,study,O
57878,3920,The,O
57879,3920,patients,O
57880,3920,have,O
57881,3920,other,B-Condition
57882,3920,cancers,I-Condition
57883,3920,at,O
57884,3920,the,O
57885,3920,same,O
57886,3920,time,O
57887,3920,or,O
57888,3920,have,O
57889,3920,the,O
57890,3920,history,O
57891,3920,of,O
57892,3920,other,B-Condition
57893,3920,cancers,I-Condition
57894,3920,except,O
57895,3920,controlled,B-Condition
57896,3920,skin,I-Condition
57897,3920,basal,I-Condition
57898,3920,cell,I-Condition
57899,3920,carcinoma,I-Condition
57900,3920,or,O
57901,3920,skin,B-Condition
57902,3920,squamous,I-Condition
57903,3920,cell,I-Condition
57904,3920,carcinoma,I-Condition
57905,3920,or,O
57906,3920,carcinoma,B-Condition
57907,3920,in,I-Condition
57908,3920,situ,I-Condition
57909,3920,of,I-Condition
57910,3920,cervix,I-Condition
57911,3920,uterus,I-Condition
57912,3920,;,O
57913,3921,The,O
57914,3921,patients,O
57915,3921,have,O
57916,3921,active,O
57917,3921,infections,B-Condition
57918,3921,that,O
57919,3921,were,O
57920,3921,not,O
57921,3921,suitable,O
57922,3921,for,O
57923,3921,chemotherapy,O
57924,3921,;,O
57925,3922,The,O
57926,3922,patients,O
57927,3922,have,O
57928,3922,severe,O
57929,3922,non,B-Condition
57930,3922,-,I-Condition
57931,3922,cancerous,I-Condition
57932,3922,diseases,I-Condition
57933,3922,.,O
57934,3923,The,O
57935,3923,patients,O
57936,3923,have,O
57937,3923,history,O
57938,3923,of,O
57939,3923,neoadjuvant,B-Procedure
57940,3923,hormone,I-Procedure
57941,3923,therapy,I-Procedure
57942,3923,.,O
57943,3924,The,O
57944,3924,patients,O
57945,3924,have,O
57946,3924,bilateral,B-Condition
57947,3924,breast,I-Condition
57948,3924,cancers,I-Condition
57949,3924,or,O
57950,3924,DCIS,B-Condition
57951,3924,or,O
57952,3924,metastatic,B-Condition
57953,3924,breast,I-Condition
57954,3924,cancers,I-Condition
57955,3924,.,O
57956,3925,The,O
57957,3925,patients,O
57958,3925,are,O
57959,3925,undergoing,O
57960,3925,current,O
57961,3925,administration,O
57962,3925,of,O
57963,3925,anti,B-Procedure
57964,3925,-,I-Procedure
57965,3925,cancer,I-Procedure
57966,3925,therapies,I-Procedure
57967,3925,",",O
57968,3925,or,O
57969,3925,are,O
57970,3925,attending,B-Observation
57971,3925,other,I-Observation
57972,3925,clinical,I-Observation
57973,3925,trials,I-Observation
57974,3925,.,O
57975,3926,The,O
57976,3926,patients,O
57977,3926,are,O
57978,3926,pregnant,B-Condition
57979,3926,or,O
57980,3926,lactational,B-Condition
57981,3926,",",O
57982,3926,or,O
57983,3926,they,O
57984,3926,refuse,O
57985,3926,to,O
57986,3926,practice,O
57987,3926,contraception,B-Procedure
57988,3926,during,O
57989,3926,the,O
57990,3926,whole,O
57991,3926,trial,O
57992,3926,.,O
57993,3927,The,O
57994,3927,patients,O
57995,3927,are,O
57996,3927,in,O
57997,3927,some,O
57998,3927,special,O
57999,3927,conditions,O
58000,3927,that,O
58001,3927,they,O
58002,3927,ca,O
58003,3927,n't,O
58004,3927,understand,O
58005,3927,the,O
58006,3927,written,O
58007,3927,informed,O
58008,3927,consent,O
58009,3927,",",O
58010,3927,such,O
58011,3927,as,O
58012,3927,they,O
58013,3927,are,O
58014,3927,demented,O
58015,3927,or,O
58016,3927,hawkish,O
58017,3927,.,O
58018,3928,The,O
58019,3928,patients,O
58020,3928,have,O
58021,3928,allergic,B-Condition
58022,3928,history,O
58023,3928,or,O
58024,3928,contraindication,B-Condition
58025,3928,of,O
58026,3928,tamoxifen,B-Drug
58027,3928,.,O
58028,3929,The,O
58029,3929,patients,O
58030,3929,signed,O
58031,3929,the,O
58032,3929,written,O
58033,3929,informed,O
58034,3929,consent,O
58035,3930,The,O
58036,3930,patients,O
58037,3930,present,O
58038,3930,with,O
58039,3930,operable,O
58040,3930,unilateral,O
58041,3930,invasive,O
58042,3930,breast,B-Condition
58043,3930,cancers,I-Condition
58044,3930,without,O
58045,3930,distant,B-Condition
58046,3930,metastasis(stage,I-Condition
58047,3930,I,O
58048,3930,",",O
58049,3930,II,O
58050,3930,",",O
58051,3930,and,O
58052,3930,III,O
58053,3930,),O
58054,3931,The,O
58055,3931,breast,B-Condition
58056,3931,tumor,I-Condition
58057,3931,'s,O
58058,3931,positive,O
58059,3931,ER,O
58060,3931,/,O
58061,3931,PR,O
58062,3931,rate,O
58063,3931,is,O
58064,3931,<,O
58065,3931,1,O
58066,3931,%,O
58067,3931,",",O
58068,3931,and,O
58069,3931,positive,O
58070,3931,ER,O
58071,3931,-,O
58072,3931,beta1,O
58073,3931,rate,O
58074,3931,is,O
58075,3931,=,O
58076,3931,10,O
58077,3931,%,O
58078,3931,by,O
58079,3931,IHC,B-Procedure
58080,3931,.,O
58081,3932,The,O
58082,3932,patients,O
58083,3932,have,O
58084,3932,no,O
58085,3932,history,O
58086,3932,of,O
58087,3932,neoadjuvant,B-Procedure
58088,3932,hormone,I-Procedure
58089,3932,therapy,I-Procedure
58090,3932,.,O
58091,3933,The,O
58092,3933,patients,O
58093,3933,have,O
58094,3933,normal,B-Condition
58095,3933,cardiac,I-Condition
58096,3933,functions,I-Condition
58097,3933,by,O
58098,3933,echocardiography,B-Procedure
58099,3933,.,O
58100,3934,The,O
58101,3934,patients,O
58102,3934,',O
58103,3934,ECOG,O
58104,3934,scores,O
58105,3934,are,O
58106,3934,=,O
58107,3934,0,O
58108,3934,-,O
58109,3934,2,O
58110,3934,.,O
58111,3935,Female,B-Person
58112,3935,patient,O
58113,3935,who,O
58114,3935,is,O
58115,3935,=,O
58116,3935,18yrs,O
58117,3935,",",O
58118,3935,and,O
58119,3935,=,O
58120,3935,65yrs,O
58121,3935,.,O
58122,3936,The,O
58123,3936,patients,O
58124,3936,are,O
58125,3936,non,O
58126,3936,-,O
58127,3936,pregnant,O
58128,3936,",",O
58129,3936,and,O
58130,3936,disposed,O
58131,3936,to,O
58132,3936,practice,O
58133,3936,contraception,O
58134,3936,during,O
58135,3936,the,O
58136,3936,whole,O
58137,3936,trial,O
58138,3936,.,O
58139,3937,The,O
58140,3937,patients,O
58141,3937,underwent,O
58142,3937,neoadjuvant,B-Procedure
58143,3937,chemotherapy,I-Procedure
58144,3937,plus,O
58145,3937,surgery,B-Procedure
58146,3937,or,O
58147,3937,directly,O
58148,3937,modified,O
58149,3937,radical,B-Procedure
58150,3937,mastectomy,I-Procedure
58151,3937,or,O
58152,3937,breast,B-Procedure
58153,3937,-,I-Procedure
58154,3937,conserving,I-Procedure
58155,3937,surgery,I-Procedure
58156,3937,(,O
58157,3937,plus,O
58158,3937,sentinel,B-Procedure
58159,3937,lymph,I-Procedure
58160,3937,node,I-Procedure
58161,3937,biopsy,I-Procedure
58162,3937,or,O
58163,3937,axillary,B-Procedure
58164,3937,lymph,I-Procedure
58165,3937,node,I-Procedure
58166,3937,dissection,I-Procedure
58167,3937,),O
58168,3937,after,O
58169,3937,diagnosis,O
58170,3937,of,O
58171,3937,breast,O
58172,3937,cancer,O
58173,3937,.,O
58174,3938,The,O
58175,3938,patients,O
58176,3938,underwent,O
58177,3938,chemotherapy,B-Procedure
58178,3938,",",O
58179,3938,radiation,B-Procedure
58180,3938,therapy,I-Procedure
58181,3938,or,O
58182,3938,targeted,B-Procedure
58183,3938,therapy(herceptin,I-Procedure
58184,3938,),O
58185,3938,after,O
58186,3938,surgery,B-Procedure
58187,3938,according,O
58188,3938,to,O
58189,3938,the,O
58190,3938,2013,O
58191,3938,NCCN,O
58192,3938,guideline,O
58193,3938,.,O
58194,3939,The,O
58195,3939,results,O
58196,3939,of,O
58197,3939,patients,O
58198,3939,',O
58199,3939,blood,O
58200,3939,tests,O
58201,3939,are,O
58202,3939,as,O
58203,3939,follows,O
58204,3939,:,O
58205,3940,Pregnant,O
58206,3940,women,B-Person
58207,3940,and,O
58208,3940,young,B-Person
58209,3940,children,I-Person
58210,3940,aged,B-Person
58211,3940,<,O
58212,3940,18,O
58213,3940,years,O
58214,3940,;,O
58215,3941,Patients,O
58216,3941,with,O
58217,3941,underlying,B-Condition
58218,3941,disease,I-Condition
58219,3941,cases,O
58220,3941,without,O
58221,3941,the,O
58222,3941,possibility,O
58223,3941,of,O
58224,3941,resuscitation,O
58225,3941,(,O
58226,3941,e.g.,O
58227,3941,",",O
58228,3941,terminal,B-Condition
58229,3941,cancer,I-Condition
58230,3941,),O
58231,3941,;,O
58232,3942,Patients,O
58233,3942,with,O
58234,3942,do,B-Observation
58235,3942,-,I-Observation
58236,3942,not,I-Observation
58237,3942,-,I-Observation
58238,3942,resuscitate,I-Observation
58239,3942,(,I-Observation
58240,3942,DNR,I-Observation
58241,3942,),I-Observation
58242,3942,status,I-Observation
58243,3942,;,O
58244,3943,Death,B-Condition
58245,3943,by,I-Condition
58246,3943,excessive,I-Condition
58247,3943,bleeding,I-Condition
58248,3943,(,O
58249,3943,e.g.,O
58250,3943,",",O
58251,3943,abdominal,O
58252,3943,main,B-Condition
58253,3943,artery,I-Condition
58254,3943,rupture,I-Condition
58255,3943,),O
58256,3943,;,O
58257,3944,Patients,O
58258,3944,who,O
58259,3944,have,O
58260,3944,experienced,O
58261,3944,in,O
58262,3944,-,O
58263,3944,hospital,O
58264,3944,CA,B-Condition
58265,3944,;,O
58266,3945,Patients,O
58267,3945,previously,O
58268,3945,treated,B-Procedure
58269,3945,with,O
58270,3945,steroid,B-Drug
58271,3945,",",O
58272,3945,anti,B-Drug
58273,3945,-,I-Drug
58274,3945,cancer,I-Drug
58275,3945,medicine,I-Drug
58276,3945,",",O
58277,3945,or,O
58278,3945,immunosuppression,B-Procedure
58279,3945,treatment,I-Procedure
58280,3945,before,O
58281,3945,CA,B-Condition
58282,3945,;,O
58283,3946,Patients,O
58284,3946,already,O
58285,3946,been,O
58286,3946,registered,O
58287,3946,with,O
58288,3946,other,O
58289,3946,studies,O
58290,3946,;,O
58291,3946,or,O
58292,3947,Patients,O
58293,3947,from,O
58294,3947,whom,O
58295,3947,informed,O
58296,3947,consent,O
58297,3947,can,O
58298,3947,not,O
58299,3947,be,O
58300,3947,obtained,O
58301,3948,The,O
58302,3948,group,O
58303,3948,of,O
58304,3948,patients,O
58305,3948,who,O
58306,3948,participated,O
58307,3948,in,O
58308,3948,the,O
58309,3948,study,O
58310,3948,included,O
58311,3948,adults,B-Person
58312,3948,aged,B-Person
58313,3948,at,O
58314,3948,least,O
58315,3948,19,O
58316,3948,years,O
58317,3948,among,O
58318,3948,the,O
58319,3948,atraumatic,B-Condition
58320,3948,CA,I-Condition
58321,3948,outpatients,O
58322,3948,who,O
58323,3948,came,O
58324,3948,to,O
58325,3948,the,O
58326,3948,ER,O
58327,3948,and,O
58328,3948,received,O
58329,3948,CPR,B-Procedure
58330,3948,.,O
58331,3949,UTIs,B-Condition
58332,3949,=,O
58333,3949,12,O
58334,3949,within,O
58335,3949,1,O
58336,3949,year,O
58337,3950,Pregnancy,B-Condition
58338,3950,or,O
58339,3950,Lactation,B-Condition
58340,3951,Immune,B-Condition
58341,3951,disease,I-Condition
58342,3952,Lactose,B-Condition
58343,3952,intolerance,I-Condition
58344,3953,Urinary,B-Condition
58345,3953,tract,I-Condition
58346,3953,anomaly,I-Condition
58347,3954,Systemic,B-Condition
58348,3954,infection,I-Condition
58349,3955,Newly,O
58350,3955,started,O
58351,3955,hormone,B-Procedure
58352,3955,therapy,I-Procedure
58353,3955,within,O
58354,3955,the,O
58355,3955,last,O
58356,3955,6,O
58357,3955,months,O
58358,3956,Antibiotic,B-Procedure
58359,3956,prophylaxis,I-Procedure
58360,3956,within,O
58361,3956,the,O
58362,3956,last,O
58363,3956,6,O
58364,3956,months,O
58365,3957,a,B-Drug
58366,3957,-,I-Drug
58367,3957,D,I-Drug
58368,3957,-,I-Drug
58369,3957,mannose,I-Drug
58370,3957,intake,O
58371,3957,within,O
58372,3957,the,O
58373,3957,last,O
58374,3957,month,O
58375,3958,Use,O
58376,3958,of,O
58377,3958,catheters,O
58378,3959,Diabetes,B-Condition
58379,3959,mellitus,I-Condition
58380,3960,Participation,O
58381,3960,to,O
58382,3960,other,O
58383,3960,studies,O
58384,3961,Women,B-Person
58385,3962,=,O
58386,3962,3,O
58387,3962,UTIs,B-Condition
58388,3962,within,O
58389,3962,the,O
58390,3962,last,O
58391,3962,12,O
58392,3962,months,O
58393,3962,or,O
58394,3962,=,O
58395,3962,2,O
58396,3962,UTIs,B-Condition
58397,3962,within,O
58398,3962,the,O
58399,3962,last,O
58400,3962,6,O
58401,3962,months,O
58402,3962,;,O
58403,3963,Laboratory,O
58404,3963,urine,O
58405,3963,culture,O
58406,3963,:,O
58407,3963,<,O
58408,3963,103,O
58409,3963,CFUs,O
58410,3964,Age,B-Person
58411,3964,>,O
58412,3964,18,O
58413,3964,years,O
58414,3965,Has,O
58415,3965,chronic,B-Condition
58416,3965,hepatitis,I-Condition
58417,3965,B,I-Condition
58418,3965,(,O
58419,3965,measured,O
58420,3965,by,O
58421,3965,hepatitis,O
58422,3965,B,O
58423,3965,surface,O
58424,3965,antigen,O
58425,3965,test,O
58426,3965,),O
58427,3965,or,O
58428,3965,active,B-Condition
58429,3965,hepatitis,I-Condition
58430,3965,C,I-Condition
58431,3965,(,O
58432,3965,measured,O
58433,3965,by,O
58434,3965,hepatitis,O
58435,3965,C,O
58436,3965,virus,O
58437,3965,[,O
58438,3965,HCV,O
58439,3965,],O
58440,3965,Ab,O
58441,3965,test,O
58442,3965,;,O
58443,3965,if,O
58444,3965,positive,O
58445,3965,",",O
58446,3965,HCV,O
58447,3965,ribonucleic,O
58448,3965,acid,O
58449,3965,[,O
58450,3965,RNA,O
58451,3965,],O
58452,3965,PCR,O
58453,3965,test,O
58454,3965,will,O
58455,3965,be,O
58456,3965,used,O
58457,3965,to,O
58458,3965,confirm,O
58459,3965,active,O
58460,3965,versus,O
58461,3965,past,O
58462,3965,HCV,O
58463,3965,infection,O
58464,3965,),O
58465,3965,",",O
58466,3965,active,O
58467,3965,syphilis,B-Condition
58468,3965,infection,I-Condition
58469,3965,",",O
58470,3965,chlamydia,B-Condition
58471,3965,",",O
58472,3965,gonorrhea,B-Condition
58473,3965,",",O
58474,3965,or,O
58475,3965,trichomonas,B-Condition
58476,3965,.,O
58477,3965,Active,O
58478,3965,syphilis,B-Condition
58479,3965,documented,O
58480,3965,by,O
58481,3965,serology,O
58482,3965,unless,O
58483,3965,positive,O
58484,3965,serology,O
58485,3965,is,O
58486,3965,due,O
58487,3965,to,O
58488,3965,past,O
58489,3965,treated,B-Condition
58490,3965,infection,I-Condition
58491,3966,Has,O
58492,3966,had,O
58493,3966,a,O
58494,3966,thyroidectomy,B-Procedure
58495,3966,or,O
58496,3966,active,O
58497,3966,thyroid,B-Condition
58498,3966,disease,I-Condition
58499,3966,requiring,O
58500,3966,medication,B-Drug
58501,3966,during,O
58502,3966,the,O
58503,3966,last,O
58504,3966,12,O
58505,3966,months,O
58506,3966,(,O
58507,3966,not,O
58508,3966,excluded,O
58509,3966,:,O
58510,3966,a,O
58511,3966,stable,O
58512,3966,thyroid,B-Drug
58513,3966,supplementation,I-Drug
58514,3966,),O
58515,3967,Has,O
58516,3967,had,O
58517,3967,major,O
58518,3967,psychiatric,B-Condition
58519,3967,illness,I-Condition
58520,3967,and/or,O
58521,3967,substance,B-Condition
58522,3967,abuse,I-Condition
58523,3967,problems,O
58524,3967,during,O
58525,3967,the,O
58526,3967,past,O
58527,3967,12,O
58528,3967,months,O
58529,3967,(,O
58530,3967,including,O
58531,3967,hospitalization,B-Procedure
58532,3967,or,O
58533,3967,periods,O
58534,3967,of,O
58535,3967,work,B-Condition
58536,3967,disability,I-Condition
58537,3967,),O
58538,3967,that,O
58539,3967,in,O
58540,3967,the,O
58541,3967,opinion,O
58542,3967,of,O
58543,3967,the,O
58544,3967,investigator,O
58545,3967,would,O
58546,3967,preclude,O
58547,3967,participation,O
58548,3968,Has,O
58549,3968,been,O
58550,3968,in,O
58551,3968,receipt,O
58552,3968,of,O
58553,3968,any,O
58554,3968,licensed,B-Drug
58555,3968,vaccine,I-Drug
58556,3968,within,O
58557,3968,14,O
58558,3968,days,O
58559,3968,prior,O
58560,3968,to,O
58561,3968,the,O
58562,3968,first,O
58563,3968,dose,O
58564,3968,of,O
58565,3968,study,B-Drug
58566,3968,vaccine,I-Drug
58567,3968,/,O
58568,3968,placebo,B-Drug
58569,3968,",",O
58570,3968,plans,O
58571,3968,to,O
58572,3968,receive,O
58573,3968,within,O
58574,3968,14,O
58575,3968,days,O
58576,3968,after,O
58577,3968,the,O
58578,3968,first,O
58579,3968,study,B-Procedure
58580,3968,vaccination,I-Procedure
58581,3968,",",O
58582,3968,or,O
58583,3968,plans,O
58584,3968,to,O
58585,3968,receive,O
58586,3968,within,O
58587,3968,14,O
58588,3968,days,O
58589,3968,before,O
58590,3968,or,O
58591,3968,after,O
58592,3968,the,O
58593,3968,second,O
58594,3968,",",O
58595,3968,third,O
58596,3968,or,O
58597,3968,fourth,O
58598,3968,vaccination,B-Drug
58599,3969,Is,O
58600,3969,a,O
58601,3969,recipient,O
58602,3969,of,O
58603,3969,a,O
58604,3969,prophylactic,O
58605,3969,or,O
58606,3969,therapeutic,O
58607,3969,HIV,B-Drug
58608,3969,vaccine,I-Drug
58609,3969,candidate,I-Drug
58610,3969,at,O
58611,3969,any,O
58612,3969,time,O
58613,3969,",",O
58614,3969,or,O
58615,3969,a,O
58616,3969,recipient,O
58617,3969,of,O
58618,3969,other,B-Drug
58619,3969,experimental,I-Drug
58620,3969,vaccine(s,I-Drug
58621,3969,),I-Drug
58622,3969,within,O
58623,3969,the,O
58624,3969,last,O
58625,3969,12,O
58626,3969,months,O
58627,3969,.,O
58628,3969,For,O
58629,3969,participants,O
58630,3969,who,O
58631,3969,received,O
58632,3969,an,O
58633,3969,experimental,B-Drug
58634,3969,vaccine,I-Drug
58635,3969,(,O
58636,3969,except,O
58637,3969,HIV,B-Drug
58638,3969,vaccine,I-Drug
58639,3969,),O
58640,3969,more,O
58641,3969,than,O
58642,3969,12,O
58643,3969,months,O
58644,3969,ago,O
58645,3969,",",O
58646,3969,documentation,O
58647,3969,of,O
58648,3969,the,O
58649,3969,identity,O
58650,3969,of,O
58651,3969,the,O
58652,3969,experimental,O
58653,3969,vaccine,O
58654,3969,must,O
58655,3969,be,O
58656,3969,provided,O
58657,3969,to,O
58658,3969,the,O
58659,3969,sponsor,O
58660,3969,",",O
58661,3969,who,O
58662,3969,will,O
58663,3969,determine,O
58664,3969,eligibility,O
58665,3969,on,O
58666,3969,a,O
58667,3969,case,O
58668,3969,-,O
58669,3969,by,O
58670,3969,-,O
58671,3969,case,O
58672,3969,basis,O
58673,3970,Are,O
58674,3970,negative,O
58675,3970,for,O
58676,3970,human,B-Condition
58677,3970,immunodeficiency,I-Condition
58678,3970,virus,I-Condition
58679,3970,(,I-Condition
58680,3970,HIV,I-Condition
58681,3970,),I-Condition
58682,3970,infection,O
58683,3970,at,O
58684,3970,screening,O
58685,3971,Is,O
58686,3971,healthy,B-Condition
58687,3971,on,O
58688,3971,the,O
58689,3971,basis,O
58690,3971,of,O
58691,3971,physical,B-Procedure
58692,3971,examination,I-Procedure
58693,3971,",",O
58694,3971,medical,B-Observation
58695,3971,history,I-Observation
58696,3971,",",O
58697,3971,electrocardiogram,B-Procedure
58698,3971,(,I-Procedure
58699,3971,ECG,I-Procedure
58700,3971,),I-Procedure
58701,3971,",",O
58702,3971,and,O
58703,3971,vital,B-Procedure
58704,3971,signs,I-Procedure
58705,3971,measurement,I-Procedure
58706,3971,performed,O
58707,3971,at,O
58708,3971,screening,O
58709,3972,Are,O
58710,3972,willing,O
58711,3972,/,O
58712,3972,able,O
58713,3972,to,O
58714,3972,adhere,O
58715,3972,to,O
58716,3972,the,O
58717,3972,prohibitions,O
58718,3972,and,O
58719,3972,restrictions,O
58720,3972,specified,O
58721,3972,in,O
58722,3972,the,O
58723,3972,protocol,O
58724,3972,and,O
58725,3972,study,O
58726,3972,procedures,O
58727,3973,Female,B-Person
58728,3973,participants,O
58729,3973,of,O
58730,3973,childbearing,B-Condition
58731,3973,potential,I-Condition
58732,3973,must,O
58733,3973,have,O
58734,3973,a,O
58735,3973,negative,O
58736,3973,serum,O
58737,3973,pregnancy,O
58738,3973,test,O
58739,3973,(,O
58740,3973,beta,O
58741,3973,human,O
58742,3973,chorionic,O
58743,3973,gonadotropin,O
58744,3973,[,O
58745,3973,beta,O
58746,3973,hCG,O
58747,3973,],O
58748,3973,),O
58749,3973,at,O
58750,3973,the,O
58751,3973,Screening,O
58752,3973,visit,O
58753,3973,",",O
58754,3973,and,O
58755,3973,a,O
58756,3973,negative,O
58757,3973,urine,O
58758,3973,pregnancy,O
58759,3973,test,O
58760,3973,pre,O
58761,3973,-,O
58762,3973,dose,O
58763,3973,on,O
58764,3973,Day,O
58765,3973,1,O
58766,3974,Are,O
58767,3974,assessed,O
58768,3974,by,O
58769,3974,the,O
58770,3974,clinic,O
58771,3974,staff,O
58772,3974,as,O
58773,3974,being,O
58774,3974,at,O
58775,3974,low,B-Condition
58776,3974,risk,I-Condition
58777,3974,for,O
58778,3974,HIV,B-Condition
58779,3974,infection,I-Condition
58780,3975,Overlap,B-Condition
58781,3975,syndrome,I-Condition
58782,3975,with,O
58783,3975,Primary,B-Condition
58784,3975,Sclerosing,I-Condition
58785,3975,Cholangitis,I-Condition
58786,3975,(,O
58787,3975,PSC,B-Condition
58788,3975,),O
58789,3975,or,O
58790,3975,Primary,B-Condition
58791,3975,Biliary,I-Condition
58792,3975,Cholangitis,I-Condition
58793,3975,(,O
58794,3975,PBC,B-Condition
58795,3975,),O
58796,3975,(,O
58797,3975,Paris,O
58798,3975,criteria,O
58799,3975,",",O
58800,3975,strong,O
58801,3975,positive,O
58802,3975,Anti,O
58803,3975,-,O
58804,3975,Mitochondrial,O
58805,3975,Antibodies,O
58806,3975,(,O
58807,3975,AMA,O
58808,3975,),O
58809,3975,",",O
58810,3975,past,O
58811,3975,liver,B-Procedure
58812,3975,biopsy,I-Procedure
58813,3975,or,O
58814,3975,cholangiographic,B-Procedure
58815,3975,findings,I-Procedure
58816,3975,compatible,O
58817,3975,with,O
58818,3975,PBC,B-Condition
58819,3975,or,O
58820,3975,PSC,B-Condition
58821,3975,),O
58822,3975,.,O
58823,3976,Presentation,O
58824,3976,with,O
58825,3976,acute,B-Condition
58826,3976,liver,I-Condition
58827,3976,failure,I-Condition
58828,3976,",",O
58829,3976,defined,O
58830,3976,as,O
58831,3976,presence,O
58832,3976,of,O
58833,3976,hepatic,B-Condition
58834,3976,encephalopathy,I-Condition
58835,3976,and,O
58836,3976,coagulopathy,B-Condition
58837,3976,(,O
58838,3976,INR,O
58839,3976,>,O
58840,3976,1.5,O
58841,3976,),O
58842,3977,Current,O
58843,3977,treatment,O
58844,3977,with,O
58845,3977,prednisone,B-Drug
58846,3977,/,O
58847,3977,prednisolone,B-Drug
58848,3977,and/or,O
58849,3977,immunosuppressive,B-Drug
58850,3977,medication,I-Drug
58851,3977,for,O
58852,3977,an,O
58853,3977,indication,B-Condition
58854,3977,other,O
58855,3977,than,O
58856,3977,autoimmune,B-Condition
58857,3977,hepatitis,I-Condition
58858,3978,Current,O
58859,3978,systemic,B-Condition
58860,3978,infection,I-Condition
58861,3979,Other,O
58862,3979,clinically,O
58863,3979,significant,O
58864,3979,medical,O
58865,3979,conditions,O
58866,3979,that,O
58867,3979,could,O
58868,3979,interfere,O
58869,3979,with,O
58870,3979,the,O
58871,3979,trial,O
58872,3980,If,O
58873,3980,female,O
58874,3980,of,O
58875,3980,childbearing,O
58876,3980,potential,O
58877,3980,:,O
58878,3980,known,O
58879,3980,pregnancy,O
58880,3980,",",O
58881,3980,or,O
58882,3980,unwilling,O
58883,3980,to,O
58884,3980,practice,O
58885,3980,anticontraceptive,O
58886,3980,measures,O
58887,3980,.,O
58888,3981,History,O
58889,3981,of,O
58890,3981,noncompliance,O
58891,3981,with,O
58892,3981,medical,O
58893,3981,regimens,O
58894,3981,",",O
58895,3981,or,O
58896,3981,patients,O
58897,3981,who,O
58898,3981,are,O
58899,3981,considered,O
58900,3981,to,O
58901,3981,be,O
58902,3981,potentially,O
58903,3981,unreliable,O
58904,3981,or,O
58905,3981,unable,O
58906,3981,to,O
58907,3981,participate,O
58908,3982,Mental,O
58909,3982,instability,O
58910,3982,or,O
58911,3982,incompetence,O
58912,3982,",",O
58913,3982,such,O
58914,3982,that,O
58915,3982,the,O
58916,3982,validity,O
58917,3982,of,O
58918,3982,informed,O
58919,3982,consent,O
58920,3982,or,O
58921,3982,compliance,O
58922,3982,with,O
58923,3982,the,O
58924,3982,trial,O
58925,3982,is,O
58926,3982,uncertain,O
58927,3983,Probable,O
58928,3983,or,O
58929,3983,definite,O
58930,3983,diagnosis,O
58931,3983,of,O
58932,3983,autoimmune,B-Condition
58933,3983,hepatitis,I-Condition
58934,3983,according,O
58935,3983,to,O
58936,3983,the,O
58937,3983,International,O
58938,3983,Autoimmune,O
58939,3983,Hepatitis,O
58940,3983,Study,O
58941,3983,Group,O
58942,3983,criteria,O
58943,3984,First,O
58944,3984,presentation,O
58945,3984,of,O
58946,3984,AIH,B-Condition
58947,3984,requiring,O
58948,3984,treatment,B-Procedure
58949,3984,according,O
58950,3984,to,O
58951,3984,the,O
58952,3984,current,O
58953,3984,EASL,O
58954,3984,guidelines,O
58955,3985,Age,B-Person
58956,3985,=,O
58957,3985,18,O
58958,3985,years,O
58959,3986,Must,O
58960,3986,provide,O
58961,3986,informed,O
58962,3986,consent,O
58963,3986,and,O
58964,3986,agree,O
58965,3986,to,O
58966,3986,comply,O
58967,3986,with,O
58968,3986,the,O
58969,3986,trial,O
58970,3986,protocol,O
58971,3987,Risk,B-Mood
58972,3987,of,I-Mood
58973,3987,severe,O
58974,3987,alcohol,B-Condition
58975,3987,withdrawal,I-Condition
58976,3987,(,O
58977,3987,e.g.,O
58978,3987,history,B-Observation
58979,3987,of,O
58980,3987,seizures,B-Condition
58981,3987,or,O
58982,3987,delirium,B-Condition
58983,3987,tremens,I-Condition
58984,3987,),O
58985,3988,Current,O
58986,3988,Moderate,O
58987,3988,or,O
58988,3988,Severe,O
58989,3988,Substance,B-Condition
58990,3988,Use,I-Condition
58991,3988,Disorder,I-Condition
58992,3988,",",O
58993,3988,other,O
58994,3988,than,O
58995,3988,Alcohol,B-Condition
58996,3988,",",I-Condition
58997,3988,Nicotine,I-Condition
58998,3988,or,I-Condition
58999,3988,Caffeine,I-Condition
59000,3988,Use,I-Condition
59001,3988,Disorders,I-Condition
59002,3989,Lifetime,B-Observation
59003,3989,history,I-Observation
59004,3989,of,O
59005,3989,Bipolar,B-Condition
59006,3989,Disorder,I-Condition
59007,3989,",",O
59008,3989,Schizophrenia,B-Condition
59009,3989,or,O
59010,3989,Schizoaffective,B-Condition
59011,3989,Disorder,I-Condition
59012,3990,Any,O
59013,3990,current,O
59014,3990,psychiatric,B-Condition
59015,3990,disorder,I-Condition
59016,3990,",",O
59017,3990,other,O
59018,3990,than,O
59019,3990,Alcohol,B-Condition
59020,3990,Use,I-Condition
59021,3990,Disorder,I-Condition
59022,3990,",",O
59023,3990,that,O
59024,3990,",",O
59025,3990,in,O
59026,3990,the,O
59027,3990,judgment,O
59028,3990,of,O
59029,3990,the,O
59030,3990,investigator,O
59031,3990,",",O
59032,3990,will,O
59033,3990,require,O
59034,3990,treatment,O
59035,3990,that,O
59036,3990,will,O
59037,3990,interfere,O
59038,3990,with,O
59039,3990,study,O
59040,3990,participation,O
59041,3990,.,O
59042,3991,Current,O
59043,3991,severe,O
59044,3991,depression,B-Condition
59045,3991,(,O
59046,3991,HAM,O
59047,3991,-,O
59048,3991,D,O
59049,3991,>,O
59050,3991,24,O
59051,3991,),O
59052,3991,or,O
59053,3991,anxiety,B-Condition
59054,3991,(,O
59055,3991,HAM,O
59056,3991,-,O
59057,3991,A,O
59058,3991,>,O
59059,3991,24,O
59060,3991,),O
59061,3992,Significant,O
59062,3992,suicide,B-Condition
59063,3992,or,I-Condition
59064,3992,violence,I-Condition
59065,3992,risk,I-Condition
59066,3993,Currently,O
59067,3993,taking,O
59068,3993,any,O
59069,3993,psychotropic,B-Drug
59070,3993,medications,I-Drug
59071,3994,Legally,O
59072,3994,mandated,O
59073,3994,to,O
59074,3994,participate,O
59075,3994,in,O
59076,3994,treatment,O
59077,3995,History,B-Observation
59078,3995,of,I-Observation
59079,3995,prior,I-Observation
59080,3995,treatment,I-Observation
59081,3995,with,O
59082,3995,disulfiram,B-Drug
59083,3996,Sufficiently,O
59084,3996,socially,B-Condition
59085,3996,unstable,I-Condition
59086,3996,as,O
59087,3996,to,O
59088,3996,preclude,O
59089,3996,participation,O
59090,3996,(,O
59091,3996,e.g.,O
59092,3996,homeless,O
59093,3996,),O
59094,3997,Contraindications,B-Condition
59095,3997,to,O
59096,3997,disulfiram,B-Drug
59097,3997,treatment,O
59098,3997,(,O
59099,3997,liver,B-Condition
59100,3997,disease,I-Condition
59101,3997,",",O
59102,3997,kidney,B-Condition
59103,3997,disease,I-Condition
59104,3997,",",O
59105,3997,cardiac,B-Condition
59106,3997,disease,I-Condition
59107,3997,",",O
59108,3997,seizure,B-Condition
59109,3997,disorder,I-Condition
59110,3997,",",O
59111,3997,hypothyroidism,B-Condition
59112,3997,",",O
59113,3997,diabetes,B-Condition
59114,3997,mellitus,I-Condition
59115,3997,",",O
59116,3997,pregnancy,B-Condition
59117,3997,or,O
59118,3997,lactation,B-Condition
59119,3997,",",O
59120,3997,allergy,B-Condition
59121,3997,to,O
59122,3997,disulfiram,B-Drug
59123,3997,or,O
59124,3997,thiuran,B-Drug
59125,3997,derivatives,I-Drug
59126,3997,),O
59127,3998,Neurological,O
59128,3998,or,O
59129,3998,medical,B-Condition
59130,3998,conditions,I-Condition
59131,3998,that,O
59132,3998,would,O
59133,3998,interfere,B-Condition
59134,3998,with,O
59135,3998,MRI,B-Procedure
59136,3998,scanning,I-Procedure
59137,3998,(,O
59138,3998,e.g.,O
59139,3998,history,O
59140,3998,of,O
59141,3998,stroke,B-Condition
59142,3998,",",O
59143,3998,seizure,B-Condition
59144,3998,",",O
59145,3998,brain,B-Condition
59146,3998,tumor,I-Condition
59147,3998,",",O
59148,3998,brain,B-Condition
59149,3998,infection,I-Condition
59150,3998,",",O
59151,3998,traumatic,B-Condition
59152,3998,brain,I-Condition
59153,3998,injury,I-Condition
59154,3998,",",O
59155,3998,multiple,B-Condition
59156,3998,sclerosis,I-Condition
59157,3998,",",O
59158,3998,dementia,B-Condition
59159,3998,",",O
59160,3998,metal,O
59161,3998,device,O
59162,3998,in,O
59163,3998,body,O
59164,3998,",",O
59165,3998,pregnancy,B-Condition
59166,3998,",",O
59167,3998,claustrophobia,B-Condition
59168,3998,",",O
59169,3998,color,B-Condition
59170,3998,blindness,I-Condition
59171,3998,",",O
59172,3998,severe,O
59173,3998,hearing,B-Condition
59174,3998,impairment,I-Condition
59175,3998,",",O
59176,3998,weight>300,O
59177,3998,lbs,O
59178,3998,.,O
59179,3998,",",O
59180,3998,wheelchair,B-Condition
59181,3998,-,I-Condition
59182,3998,bound,I-Condition
59183,3998,),O
59184,3999,Currently,O
59185,3999,taking,O
59186,3999,medications,O
59187,3999,containing,O
59188,3999,alcohol,B-Drug
59189,3999,",",O
59190,3999,metronidazole,B-Drug
59191,3999,",",O
59192,3999,isoniazid,B-Drug
59193,3999,",",O
59194,3999,paraldehyde,B-Drug
59195,3999,",",O
59196,3999,phenytoin,B-Drug
59197,3999,",",O
59198,3999,warfarin,B-Drug
59199,3999,",",O
59200,3999,or,O
59201,3999,theophylline,B-Drug
59202,3999,.,O
59203,4000,Significant,O
59204,4000,alcohol,B-Condition
59205,4000,withdrawal,I-Condition
59206,4000,(,O
59207,4000,CIWA>8,O
59208,4000,),O
59209,4000,at,O
59210,4000,screening,O
59211,4000,",",O
59212,4000,after,O
59213,4000,confirming,O
59214,4000,a,O
59215,4000,blood,O
59216,4000,alcohol,O
59217,4000,level,O
59218,4000,of,O
59219,4000,zero,O
59220,4000,.,O
59221,4001,Between,O
59222,4001,the,O
59223,4001,ages,B-Person
59224,4001,of,O
59225,4001,21,O
59226,4001,-,O
59227,4001,60,O
59228,4002,Right,B-Condition
59229,4002,-,I-Condition
59230,4002,handed,I-Condition
59231,4003,Capable,O
59232,4003,of,O
59233,4003,giving,O
59234,4003,informed,O
59235,4003,consent,O
59236,4003,and,O
59237,4003,complying,O
59238,4003,with,O
59239,4003,study,O
59240,4003,procedures,O
59241,4004,Reports,O
59242,4004,drinking,O
59243,4004,a,O
59244,4004,minimum,O
59245,4004,of,O
59246,4004,5,O
59247,4004,standard,O
59248,4004,drinks,O
59249,4004,for,O
59250,4004,men,B-Person
59251,4004,or,O
59252,4004,4,O
59253,4004,standard,O
59254,4004,drinks,O
59255,4004,for,O
59256,4004,women,B-Person
59257,4004,on,O
59258,4004,at,O
59259,4004,least,O
59260,4004,4,O
59261,4004,days,O
59262,4004,per,O
59263,4004,week,O
59264,4004,on,O
59265,4004,average,O
59266,4004,over,O
59267,4004,the,O
59268,4004,past,O
59269,4004,28,O
59270,4004,days,O
59271,4005,Meets,O
59272,4005,DSM,O
59273,4005,-,O
59274,4005,V,O
59275,4005,criteria,O
59276,4005,for,O
59277,4005,current,O
59278,4005,Alcohol,B-Condition
59279,4005,Use,I-Condition
59280,4005,Disorder,I-Condition
59281,4006,Seeking,B-Mood
59282,4006,treatment,B-Procedure
59283,4006,for,O
59284,4006,Alcohol,B-Condition
59285,4006,Use,I-Condition
59286,4006,Disorder,I-Condition
59287,4007,Agree,O
59288,4007,to,O
59289,4007,not,O
59290,4007,seek,O
59291,4007,additional,O
59292,4007,treatment,O
59293,4007,",",O
59294,4007,apart,O
59295,4007,from,O
59296,4007,Alcoholics,O
59297,4007,Anonymous,O
59298,4008,Willing,B-Mood
59299,4008,to,O
59300,4008,attempt,O
59301,4008,to,O
59302,4008,abstain,B-Condition
59303,4008,from,I-Condition
59304,4008,alcohol,I-Condition
59305,4008,completely,O
59306,4008,for,O
59307,4008,the,O
59308,4008,duration,O
59309,4008,of,O
59310,4008,the,O
59311,4008,study,O
59312,4009,Willing,O
59313,4009,to,O
59314,4009,be,O
59315,4009,hospitalized,O
59316,4009,on,O
59317,4009,a,O
59318,4009,research,O
59319,4009,unit,O
59320,4009,for,O
59321,4009,24,O
59322,4009,hours,O
59323,4009,",",O
59324,4009,longer,O
59325,4009,if,O
59326,4009,detoxification,O
59327,4009,is,O
59328,4009,needed,O
59329,4009,.,O
59330,4010,any,O
59331,4010,neurological,B-Condition
59332,4010,conditions,I-Condition
59333,4010,other,O
59334,4010,than,O
59335,4010,PD,B-Condition
59336,4010,;,O
59337,4011,significant,O
59338,4011,musculoskeletal,B-Condition
59339,4011,or,I-Condition
59340,4011,cardiopulmonary,I-Condition
59341,4011,diseases,I-Condition
59342,4011,;,O
59343,4012,other,O
59344,4012,disorders,B-Condition
59345,4012,that,I-Condition
59346,4012,may,I-Condition
59347,4012,affect,I-Condition
59348,4012,balance,I-Condition
59349,4012,or,I-Condition
59350,4012,locomotion,I-Condition
59351,4012,;,O
59352,4013,taken,O
59353,4013,any,O
59354,4013,structured,B-Procedure
59355,4013,behavioral,I-Procedure
59356,4013,or,I-Procedure
59357,4013,exercise,I-Procedure
59358,4013,programs,I-Procedure
59359,4013,in,O
59360,4013,the,O
59361,4013,past,O
59362,4013,3,O
59363,4013,months,O
59364,4014,or,O
59365,4014,they,O
59366,4014,are,O
59367,4014,receiving,O
59368,4014,regular,B-Procedure
59369,4014,physical,I-Procedure
59370,4014,rehabilitation,I-Procedure
59371,4014,at,O
59372,4014,present,O
59373,4014,;,O
59374,4015,unstable,B-Condition
59375,4015,condition,I-Condition
59376,4015,on,O
59377,4015,anti,B-Drug
59378,4015,-,I-Drug
59379,4015,parkinsonian,I-Drug
59380,4015,medications,I-Drug
59381,4015,;,O
59382,4016,surgical,B-Procedure
59383,4016,interventions,I-Procedure
59384,4016,for,I-Procedure
59385,4016,PD,I-Procedure
59386,4016,;,O
59387,4017,communication,B-Condition
59388,4017,or,I-Condition
59389,4017,cognitive,I-Condition
59390,4017,deficits,I-Condition
59391,4017,with,O
59392,4017,mini,O
59393,4017,-,O
59394,4017,mental,O
59395,4017,state,O
59396,4017,examination,O
59397,4017,",",O
59398,4017,(,O
59399,4017,MMSE,O
59400,4017,),O
59401,4017,<,O
59402,4017,24/30,O
59403,4017,(,O
59404,4017,Folstein,O
59405,4017,et,O
59406,4017,al,O
59407,4017,.,O
59408,4017,",",O
59409,4017,1975,O
59410,4017,),O
59411,4017,;,O
59412,4018,a,O
59413,4018,history,B-Observation
59414,4018,of,O
59415,4018,more,O
59416,4018,than,O
59417,4018,two,O
59418,4018,falls,B-Condition
59419,4018,in,O
59420,4018,the,O
59421,4018,previous,O
59422,4018,12,O
59423,4018,months,O
59424,4018,.,O
59425,4019,diagnosed,O
59426,4019,with,O
59427,4019,PD,B-Condition
59428,4019,by,O
59429,4019,a,O
59430,4019,neurologist,O
59431,4019,(,O
59432,4019,Fahn,O
59433,4019,and,O
59434,4019,Elton,O
59435,4019,",",O
59436,4019,1987,O
59437,4019,),O
59438,4019,;,O
59439,4020,aged,B-Person
59440,4020,30,O
59441,4020,to,O
59442,4020,85,O
59443,4020,years,O
59444,4020,;,O
59445,4021,at,O
59446,4021,modified,O
59447,4021,Hoehn,O
59448,4021,and,O
59449,4021,Yahr,O
59450,4021,(,O
59451,4021,H&Y,O
59452,4021,),O
59453,4021,stage,O
59454,4021,1.5,O
59455,4021,to,O
59456,4021,3,O
59457,4021,(,O
59458,4021,Hoehn,O
59459,4021,and,O
59460,4021,Yahr,O
59461,4021,",",O
59462,4021,1967,O
59463,4021,;,O
59464,4021,Goetz,O
59465,4021,et,O
59466,4021,al,O
59467,4021,.,O
59468,4021,",",O
59469,4021,2004,O
59470,4021,),O
59471,4021,;,O
59472,4022,able,O
59473,4022,and,O
59474,4022,willing,O
59475,4022,to,O
59476,4022,give,O
59477,4022,written,O
59478,4022,consent,O
59479,4022,for,O
59480,4022,participation,O
59481,4022,in,O
59482,4022,the,O
59483,4022,study,O
59484,4022,;,O
59485,4023,living,B-Observation
59486,4023,at,I-Observation
59487,4023,home,I-Observation
59488,4023,in,I-Observation
59489,4023,the,I-Observation
59490,4023,community,I-Observation
59491,4023,;,O
59492,4024,able,B-Condition
59493,4024,to,I-Condition
59494,4024,walk,I-Condition
59495,4024,independently,I-Condition
59496,4024,for,I-Condition
59497,4024,30,I-Condition
59498,4024,metres,I-Condition
59499,4024,with,I-Condition
59500,4024,or,I-Condition
59501,4024,without,I-Condition
59502,4024,an,I-Condition
59503,4024,assistive,I-Condition
59504,4024,device,I-Condition
59505,4024,.,O
59506,4025,Subject,O
59507,4025,are,O
59508,4025,pregnant,B-Condition
59509,4026,Subject,O
59510,4026,is,O
59511,4026,unable,O
59512,4026,to,O
59513,4026,perform,O
59514,4026,tasks,O
59515,4026,associated,O
59516,4026,with,O
59517,4026,study,O
59518,4027,Subject,O
59519,4027,are,O
59520,4027,at,O
59521,4027,least,O
59522,4027,18,O
59523,4027,years,O
59524,4027,of,O
59525,4027,age,B-Person
59526,4028,Subject,O
59527,4028,has,O
59528,4028,confirmed,B-Mood
59529,4028,Pulmonary,B-Condition
59530,4028,Hypertension,I-Condition
59531,4028,and,O
59532,4028,Interstitial,B-Condition
59533,4028,Lung,I-Condition
59534,4028,Disease,I-Condition
59535,4029,Subject,O
59536,4029,are,O
59537,4029,able,O
59538,4029,to,O
59539,4029,complete,O
59540,4029,study,B-Procedure
59541,4029,procedures,I-Procedure
59542,4029,",",O
59543,4029,such,O
59544,4029,as,O
59545,4029,spirometry,B-Procedure
59546,4029,",",O
59547,4029,and,O
59548,4029,Pulmonary,B-Procedure
59549,4029,Exercise,I-Procedure
59550,4029,test,I-Procedure
59551,4029,.,O
59552,4030,Any,O
59553,4030,anti,B-Procedure
59554,4030,-,I-Procedure
59555,4030,coagulation,I-Procedure
59556,4030,therapy,I-Procedure
59557,4030,(,O
59558,4030,apart,O
59559,4030,from,O
59560,4030,rivaroxaban,B-Drug
59561,4030,for,O
59562,4030,second,O
59563,4030,objective,O
59564,4030,),O
59565,4031,Hypersensitivity,B-Condition
59566,4031,or,O
59567,4031,allergy,B-Condition
59568,4031,to,O
59569,4031,factor,B-Drug
59570,4031,Xa,I-Drug
59571,4031,inhibitors,I-Drug
59572,4032,Acute,B-Condition
59573,4032,bacterial,I-Condition
59574,4032,endocarditis,I-Condition
59575,4033,Bleeding,B-Condition
59576,4033,disorder,I-Condition
59577,4034,Clinically,O
59578,4034,relevant,O
59579,4034,active,B-Condition
59580,4034,bleeding,I-Condition
59581,4035,Gastrointestinal,B-Condition
59582,4035,ulcer,I-Condition
59583,4035,or,I-Condition
59584,4035,tumor,I-Condition
59585,4036,Hepatic,B-Condition
59586,4036,dysfunction,I-Condition
59587,4036,with,O
59588,4036,increased,O
59589,4036,bleeding,B-Observation
59590,4036,risk,I-Observation
59591,4037,Renal,B-Condition
59592,4037,failure,I-Condition
59593,4037,/,O
59594,4037,patients,O
59595,4037,undergoing,O
59596,4037,dialysis,B-Procedure
59597,4038,Pregnancy,O
59598,4038,and,O
59599,4038,breast,O
59600,4038,feeding,O
59601,4039,Gastrectomy,B-Procedure
59602,4039,",",O
59603,4039,biliopancreatic,B-Procedure
59604,4039,diversion,I-Procedure
59605,4039,",",O
59606,4039,resection,B-Procedure
59607,4039,or,O
59608,4039,re,B-Procedure
59609,4039,-,I-Procedure
59610,4039,routing,I-Procedure
59611,4039,of,O
59612,4039,small,O
59613,4039,intestines,O
59614,4040,Feeding,O
59615,4040,tube,O
59616,4041,Recent,O
59617,4041,blood,B-Observation
59618,4041,donation,I-Observation
59619,4042,Abnormalities,O
59620,4042,of,O
59621,4042,laboratory,O
59622,4042,values,O
59623,4042,:,O
59624,4042,alanine,O
59625,4042,-,O
59626,4042,aminotransferase,O
59627,4042,(,O
59628,4042,ALAT,O
59629,4042,),O
59630,4042,",",O
59631,4042,aspartate,O
59632,4042,-,O
59633,4042,aminotransferase,O
59634,4042,(,O
59635,4042,ASAT,O
59636,4042,),O
59637,4042,",",O
59638,4042,gamma,O
59639,4042,-,O
59640,4042,glutamyl,O
59641,4042,transferase,O
59642,4042,(,O
59643,4042,gammaGT,O
59644,4042,),O
59645,4042,",",O
59646,4042,alkalic,O
59647,4042,phosphatase,O
59648,4042,(,O
59649,4042,AP,O
59650,4042,),O
59651,4042,",",O
59652,4042,bilirubin,O
59653,4042,",",O
59654,4042,amylase,O
59655,4042,",",O
59656,4042,lipase,O
59657,4042,",",O
59658,4042,cystatin,O
59659,4042,C,O
59660,4042,",",O
59661,4042,creatinine,O
59662,4042,",",O
59663,4042,white,O
59664,4042,blood,O
59665,4042,cell,O
59666,4042,count,O
59667,4042,",",O
59668,4042,haemoglobin,O
59669,4042,",",O
59670,4042,platelet,O
59671,4042,count,O
59672,4042,",",O
59673,4042,prothrombin,O
59674,4042,time,O
59675,4042,",",O
59676,4042,aPTT,O
59677,4042,",",O
59678,4042,fibrinogen,O
59679,4042,",",O
59680,4042,thrombin,O
59681,4042,time,O
59682,4042,",",O
59683,4042,factors,O
59684,4042,II,O
59685,4042,",",O
59686,4042,V,O
59687,4042,",",O
59688,4042,VII,O
59689,4042,and,O
59690,4042,X,O
59691,4043,Use,O
59692,4043,of,O
59693,4043,therapeutic,O
59694,4043,or,O
59695,4043,recreational,O
59696,4043,drugs,O
59697,4043,influencing,O
59698,4043,plasmatic,O
59699,4043,coagulation,O
59700,4044,Motor,O
59701,4044,complete,O
59702,4044,tetraplegia,B-Condition
59703,4044,for,O
59704,4044,at,O
59705,4044,least,O
59706,4044,3,O
59707,4044,months,O
59708,4045,Age,B-Person
59709,4045,from,O
59710,4045,18,O
59711,4045,to,O
59712,4045,74,O
59713,4045,years,O
59714,4046,Body,O
59715,4046,mass,O
59716,4046,index,O
59717,4046,(,O
59718,4046,BMI,O
59719,4046,),O
59720,4046,from,O
59721,4046,18,O
59722,4046,to,O
59723,4046,35kg,O
59724,4046,/,O
59725,4046,m2,O
59726,4047,Informed,O
59727,4047,consent,O
59728,4047,as,O
59729,4047,documented,O
59730,4047,by,O
59731,4047,signature,O
59732,4048,Emergency,B-Procedure
59733,4048,surgery,I-Procedure
59734,4049,Pregnancy,B-Condition
59735,4049,or,O
59736,4049,lactation,B-Condition
59737,4050,Immune,B-Condition
59738,4050,disorders,I-Condition
59739,4051,Kidney,B-Condition
59740,4051,or,I-Condition
59741,4051,liver,I-Condition
59742,4051,disease,I-Condition
59743,4051,or,O
59744,4051,advanced,B-Condition
59745,4051,-,I-Condition
59746,4051,stage,I-Condition
59747,4051,cardiopulmonary,I-Condition
59748,4052,Patient,O
59749,4052,refusal,O
59750,4052,to,O
59751,4052,participate,O
59752,4052,in,O
59753,4052,the,O
59754,4052,study,O
59755,4053,Patients,O
59756,4053,under,O
59757,4053,18,O
59758,4053,years,B-Person
59759,4053,or,O
59760,4053,inability,B-Condition
59761,4053,to,I-Condition
59762,4053,consent,I-Condition
59763,4054,Associated,O
59764,4054,neuromuscular,B-Condition
59765,4054,disorders,I-Condition
59766,4054,",",O
59767,4054,contraindication,B-Condition
59768,4054,for,O
59769,4054,the,O
59770,4054,use,O
59771,4054,of,O
59772,4054,rocuronium/,B-Drug
59773,4054,sugammadex,B-Drug
59774,4054,",",O
59775,4054,allergy,B-Condition
59776,4054,or,O
59777,4054,hypersensitivity,B-Condition
59778,4054,to,O
59779,4054,rocuronium,B-Drug
59780,4054,/,O
59781,4054,sugammadex,B-Drug
59782,4055,Patients,O
59783,4055,older,O
59784,4055,than,O
59785,4055,18,O
59786,4055,years,B-Person
59787,4056,Classification,O
59788,4056,of,O
59789,4056,the,O
59790,4056,American,O
59791,4056,Society,O
59792,4056,of,O
59793,4056,Anesthesiologists,O
59794,4056,(,O
59795,4056,ASA,O
59796,4056,I,O
59797,4056,-,O
59798,4056,III,O
59799,4056,),O
59800,4057,No,O
59801,4057,cognitive,B-Condition
59802,4057,deficits,I-Condition
59803,4058,Signed,O
59804,4058,informed,O
59805,4058,consent,O
59806,4058,prior,O
59807,4058,to,O
59808,4058,surgery,O
59809,4059,The,O
59810,4059,other,O
59811,4059,types,O
59812,4059,of,O
59813,4059,pulmonary,B-Condition
59814,4059,hypertension,I-Condition
59815,4059,.,O
59816,4060,Subjects,O
59817,4060,who,O
59818,4060,refuse,B-Observation
59819,4060,to,I-Observation
59820,4060,subscribe,I-Observation
59821,4060,written,I-Observation
59822,4060,informed,I-Observation
59823,4060,consents,I-Observation
59824,4060,or,O
59825,4060,ca,B-Observation
59826,4060,n't,I-Observation
59827,4060,cooperate,I-Observation
59828,4060,with,I-Observation
59829,4060,the,I-Observation
59830,4060,trial,I-Observation
59831,4060,well,O
59832,4060,.,O
59833,4061,Subjects,O
59834,4061,with,O
59835,4061,serious,O
59836,4061,acute,O
59837,4061,or,O
59838,4061,chronic,B-Condition
59839,4061,disease,I-Condition
59840,4061,involved,I-Condition
59841,4061,liver,I-Condition
59842,4061,",",I-Condition
59843,4061,kidney,I-Condition
59844,4061,",",I-Condition
59845,4061,and,I-Condition
59846,4061,brain,I-Condition
59847,4061,or,O
59848,4061,have,O
59849,4061,to,O
59850,4061,use,O
59851,4061,potent,O
59852,4061,CYP3A4,B-Drug
59853,4061,-,I-Drug
59854,4061,inhibitor,I-Drug
59855,4061,or,O
59856,4061,nitrate,B-Drug
59857,4061,to,O
59858,4061,treat,O
59859,4061,the,O
59860,4061,underlying,B-Condition
59861,4061,diseases,I-Condition
59862,4061,.,O
59863,4062,Subjects,O
59864,4062,who,O
59865,4062,are,O
59866,4062,currently,O
59867,4062,treated,O
59868,4062,with,O
59869,4062,sildenafil,B-Drug
59870,4062,for,O
59871,4062,PAH,B-Condition
59872,4062,or,O
59873,4062,taking,O
59874,4062,sildenafil,B-Drug
59875,4062,or,O
59876,4062,tadalafil,B-Drug
59877,4062,.,O
59878,4063,Other,O
59879,4063,contraindications,B-Observation
59880,4063,in,I-Observation
59881,4063,package,I-Observation
59882,4063,insert,I-Observation
59883,4063,.,O
59884,4064,Subjects,O
59885,4064,aged,B-Person
59886,4064,12,O
59887,4064,-,O
59888,4064,65,O
59889,4064,.,O
59890,4065,Confirmed,O
59891,4065,idiopathic,B-Condition
59892,4065,pulmonary,I-Condition
59893,4065,hypertension,I-Condition
59894,4065,",",O
59895,4065,connective,O
59896,4065,tissue,O
59897,4065,disease,O
59898,4065,associated,O
59899,4065,pulmonary,B-Condition
59900,4065,hypertension,I-Condition
59901,4065,",",O
59902,4065,congenital,O
59903,4065,heart,O
59904,4065,disease(with,O
59905,4065,Eisenmenger,B-Condition
59906,4065,syndrome,I-Condition
59907,4065,),O
59908,4065,associated,O
59909,4065,pulmonary,B-Condition
59910,4065,hypertension,I-Condition
59911,4065,.,O
59912,4066,Baseline,O
59913,4066,6,O
59914,4066,-,O
59915,4066,minutes,O
59916,4066,walking,O
59917,4066,distance,O
59918,4066,150m-550,O
59919,4066,m.,O
59920,4067,WHO,O
59921,4067,pulmonary,O
59922,4067,hypertension,O
59923,4067,function,O
59924,4067,II,O
59925,4067,-,O
59926,4067,III,O
59927,4067,with,O
59928,4067,non,B-Condition
59929,4067,-,I-Condition
59930,4067,responder,I-Condition
59931,4067,to,I-Condition
59932,4067,calcium,I-Condition
59933,4067,channel,I-Condition
59934,4067,blockers,I-Condition
59935,4067,.,O
59936,4068,Documented,O
59937,4068,written,B-Observation
59938,4068,informed,I-Observation
59939,4068,consent,I-Observation
59940,4068,.,O
59941,4069,Evidence,O
59942,4069,of,O
59943,4069,low,B-Condition
59944,4069,ovarian,I-Condition
59945,4069,reserve,I-Condition
59946,4069,by,O
59947,4069,at,O
59948,4069,least,O
59949,4069,one,O
59950,4069,of,O
59951,4069,the,O
59952,4069,following,O
59953,4069,:,O
59954,4069,AMH,O
59955,4069,=,O
59956,4069,"1,5",O
59957,4069,ng,O
59958,4069,/,O
59959,4069,mL,O
59960,4069,and/or,O
59961,4069,basal,O
59962,4069,CD,O
59963,4069,3,O
59964,4069,FSH,O
59965,4069,=,O
59966,4069,10,O
59967,4069,mIU,O
59968,4069,/,O
59969,4069,mL,O
59970,4069,and/or,O
59971,4069,basal,O
59972,4069,CD,O
59973,4069,3,O
59974,4069,Estradiol,O
59975,4069,=,O
59976,4069,60,O
59977,4069,ng,O
59978,4069,/,O
59979,4069,mL,O
59980,4069,and/or,O
59981,4069,previous,O
59982,4069,egg,O
59983,4069,collection,O
59984,4069,yield,O
59985,4069,=,O
59986,4069,3,O
59987,4069,oocytes,O
59988,4069,.,O
59989,4070,Preexisting,O
59990,4070,medical,O
59991,4070,condition,O
59992,4070,(,O
59993,4070,thyroid,B-Condition
59994,4070,disease,I-Condition
59995,4070,",",O
59996,4070,diabetes,B-Condition
59997,4070,mellitus,I-Condition
59998,4070,",",O
59999,4070,hypertension,B-Condition
60000,4070,",",O
60001,4070,pulmonary,B-Condition
60002,4070,conditions,I-Condition
60003,4070,",",O
60004,4070,cardiac,B-Condition
60005,4070,condition,I-Condition
60006,4070,…,O
60007,4070,),O
60008,4070,.,O
60009,4071,Severe,O
60010,4071,male,B-Condition
60011,4071,factor,I-Condition
60012,4071,infertility,I-Condition
60013,4071,(,O
60014,4071,Total,O
60015,4071,motile,O
60016,4071,sperm,O
60017,4071,count,O
60018,4071,<,O
60019,4071,5,O
60020,4071,million,O
60021,4071,/,O
60022,4071,ml,O
60023,4071,and/or,O
60024,4071,normal,O
60025,4071,WHO,O
60026,4071,morphology,O
60027,4071,<,O
60028,4071,20,O
60029,4071,%,O
60030,4071,),O
60031,4071,.,O
60032,4072,Hypersensitivity,B-Condition
60033,4072,to,O
60034,4072,Heparin,B-Drug
60035,4072,or,O
60036,4072,its,O
60037,4072,derivatives,O
60038,4072,.,O
60039,4073,Acquired,O
60040,4073,thrombophilia,B-Condition
60041,4073,.,O
60042,4074,Active,B-Condition
60043,4074,hemorrhage,I-Condition
60044,4074,or,O
60045,4074,increased,O
60046,4074,risk,B-Observation
60047,4074,of,I-Observation
60048,4074,bleeding,I-Observation
60049,4074,due,O
60050,4074,to,O
60051,4074,impairment,B-Condition
60052,4074,of,I-Condition
60053,4074,homeostasis,I-Condition
60054,4074,.,O
60055,4075,Severe,O
60056,4075,impairment,B-Condition
60057,4075,of,I-Condition
60058,4075,liver,I-Condition
60059,4075,or,I-Condition
60060,4075,pancreatic,I-Condition
60061,4075,function,I-Condition
60062,4075,.,O
60063,4076,Severe,O
60064,4076,renal,B-Condition
60065,4076,insufficiency,I-Condition
60066,4076,(,O
60067,4076,Creatinine,O
60068,4076,Clearance,O
60069,4076,<,O
60070,4076,30,O
60071,4076,ml,O
60072,4076,/,O
60073,4076,min,O
60074,4076,),O
60075,4076,.,O
60076,4077,Injuries,B-Condition
60077,4077,to,O
60078,4077,or,O
60079,4077,operations,B-Procedure
60080,4077,on,O
60081,4077,the,O
60082,4077,central,O
60083,4077,nervous,O
60084,4077,system,O
60085,4077,",",O
60086,4077,eyes,O
60087,4077,and,O
60088,4077,ears,O
60089,4077,within,O
60090,4077,the,O
60091,4077,last,O
60092,4077,2,O
60093,4077,months,O
60094,4077,.,O
60095,4078,Disseminated,B-Condition
60096,4078,Intravascular,I-Condition
60097,4078,Coagulation,I-Condition
60098,4078,(,O
60099,4078,DIC,B-Condition
60100,4078,),O
60101,4078,attributable,O
60102,4078,to,O
60103,4078,heparin,B-Condition
60104,4078,-,I-Condition
60105,4078,induced,I-Condition
60106,4078,thrombocytopenia,I-Condition
60107,4078,.,O
60108,4079,Acute,B-Condition
60109,4079,bacterial,I-Condition
60110,4079,endocarditis,I-Condition
60111,4079,and,O
60112,4079,endocarditis,B-Condition
60113,4079,lenta,I-Condition
60114,4079,.,O
60115,4080,Any,O
60116,4080,organic,B-Condition
60117,4080,lesion,I-Condition
60118,4080,with,O
60119,4080,high,O
60120,4080,risk,B-Observation
60121,4080,of,I-Observation
60122,4080,bleeding,I-Observation
60123,4080,(,O
60124,4080,e.g.,O
60125,4080,:,O
60126,4080,active,B-Condition
60127,4080,peptic,I-Condition
60128,4080,ulcer,I-Condition
60129,4080,",",O
60130,4080,hemorrhagic,B-Condition
60131,4080,stroke,I-Condition
60132,4080,",",O
60133,4080,cerebral,B-Condition
60134,4080,aneurysm,I-Condition
60135,4080,or,O
60136,4080,cerebral,B-Condition
60137,4080,neoplasms,I-Condition
60138,4080,),O
60139,4080,.,O
60140,4081,History,O
60141,4081,of,O
60142,4081,three,O
60143,4081,or,O
60144,4081,more,O
60145,4081,consecutively,O
60146,4081,failed,O
60147,4081,In,B-Procedure
60148,4081,Vitro,I-Procedure
60149,4081,Fertilization,I-Procedure
60150,4081,(,O
60151,4081,IVF,B-Procedure
60152,4081,),O
60153,4081,cycles,O
60154,4081,after,O
60155,4081,embryo,O
60156,4081,transfer,O
60157,4081,.,O
60158,4082,Normal,O
60159,4082,uterine,B-Observation
60160,4082,cavity,I-Observation
60161,4082,(,O
60162,4082,as,O
60163,4082,assessed,O
60164,4082,by,O
60165,4082,hysteroscopy,B-Procedure
60166,4082,or,O
60167,4082,HSG,B-Procedure
60168,4082,),O
60169,4082,.,O
60170,4083,Normal,O
60171,4083,hormonal,B-Procedure
60172,4083,investigation,I-Procedure
60173,4083,:,I-Procedure
60174,4083,TSH,O
60175,4083,",",O
60176,4083,PRL,O
60177,4083,",",O
60178,4083,FBS,O
60179,4083,.,O
60180,4084,Normal,O
60181,4084,acquired,O
60182,4084,/,O
60183,4084,inherited,O
60184,4084,thrombophilia,O
60185,4084,profile,O
60186,4084,:,O
60187,4084,LAC,O
60188,4084,",",O
60189,4084,ACA,O
60190,4084,IgG,O
60191,4084,/,O
60192,4084,IgM,O
60193,4084,",",O
60194,4084,Prot,O
60195,4084,S,O
60196,4084,",",O
60197,4084,Antithrombin,O
60198,4084,III,O
60199,4084,",",O
60200,4084,beta-2,O
60201,4084,glycoprotein,O
60202,4084,",",O
60203,4084,Factors,O
60204,4084,V,O
60205,4084,",",O
60206,4084,II,O
60207,4084,",",O
60208,4084,MTHFR,O
60209,4084,.,O
60210,4085,Normal,O
60211,4085,semen,O
60212,4085,analysis,O
60213,4085,and,O
60214,4085,mild,O
60215,4085,/,O
60216,4085,moderate,O
60217,4085,male,B-Condition
60218,4085,factor,I-Condition
60219,4085,(,O
60220,4085,Total,O
60221,4085,motile,O
60222,4085,sperm,O
60223,4085,count,O
60224,4085,>,O
60225,4085,5,O
60226,4085,million,O
60227,4085,/,O
60228,4085,ml,O
60229,4085,and/or,O
60230,4085,normal,O
60231,4085,WHO,O
60232,4085,morphology,O
60233,4085,>,O
60234,4085,20,O
60235,4085,%,O
60236,4085,.,O
60237,4086,Patient,O
60238,4086,provides,O
60239,4086,written,O
60240,4086,informed,O
60241,4086,consent,O
60242,4086,.,O
60243,4087,A,O
60244,4087,medical,O
60245,4087,condition,O
60246,4087,that,O
60247,4087,could,O
60248,4087,interfere,O
60249,4087,with,O
60250,4087,study,O
60251,4087,participation,O
60252,4088,Body,O
60253,4088,weight,O
60254,4088,less,O
60255,4088,than,O
60256,4088,50,O
60257,4088,kg,O
60258,4089,Participating,O
60259,4089,in,O
60260,4089,another,O
60261,4089,study,O
60262,4089,involving,O
60263,4089,an,O
60264,4089,investigational,O
60265,4089,medication,O
60266,4090,Undergoing,O
60267,4090,abdominoplasty,B-Procedure
60268,4090,or,O
60269,4090,TRAM,B-Procedure
60270,4090,flap,I-Procedure
60271,4090,breast,I-Procedure
60272,4090,reconstruction,I-Procedure
60273,4091,Patients,O
60274,4091,with,O
60275,4091,allergies,B-Condition
60276,4091,or,O
60277,4091,contraindications,B-Condition
60278,4091,to,O
60279,4091,study,B-Drug
60280,4091,medications,I-Drug
60281,4092,ASA,O
60282,4092,I,O
60283,4092,",",O
60284,4092,II,O
60285,4092,",",O
60286,4092,III,O
60287,4092,presenting,O
60288,4092,for,O
60289,4092,ambulatory,B-Procedure
60290,4092,surgery,I-Procedure
60291,4092,to,O
60292,4092,be,O
60293,4092,performed,O
60294,4092,under,O
60295,4092,general,B-Procedure
60296,4092,anesthesia,I-Procedure
60297,4093,Unable,O
60298,4093,to,O
60299,4093,give,O
60300,4093,informed,O
60301,4093,consent,O
60302,4093,in,O
60303,4093,English,O
60304,4094,Unable,O
60305,4094,to,O
60306,4094,complete,O
60307,4094,surveys,O
60308,4094,in,O
60309,4094,English,O
60310,4095,Unable,O
60311,4095,to,O
60312,4095,understand,O
60313,4095,instructions,O
60314,4095,for,O
60315,4095,using,O
60316,4095,pump,O
60317,4095,in,O
60318,4095,English,O
60319,4096,Unavailable,O
60320,4096,for,O
60321,4096,followup,O
60322,4097,Polytrauma,B-Condition
60323,4097,;,O
60324,4097,undergoing,O
60325,4097,other,B-Procedure
60326,4097,surgeries,I-Procedure
60327,4097,or,O
60328,4097,having,O
60329,4097,other,B-Condition
60330,4097,orthopedic,I-Condition
60331,4097,injuries,I-Condition
60332,4097,related,O
60333,4097,to,O
60334,4097,the,O
60335,4097,precipitating,O
60336,4097,cause,O
60337,4097,of,O
60338,4097,the,O
60339,4097,ankle,B-Condition
60340,4097,fracture,I-Condition
60341,4098,Infection,B-Condition
60342,4099,Peripheral,B-Condition
60343,4099,vascular,I-Condition
60344,4099,disease,I-Condition
60345,4100,Diabetes,B-Condition
60346,4101,Currently,O
60347,4101,undergoing,O
60348,4101,chemotherapy,B-Procedure
60349,4102,Pregnancy,B-Condition
60350,4103,Currently,O
60351,4103,lactating,O
60352,4104,Heart,B-Condition
60353,4104,disease,I-Condition
60354,4104,or,O
60355,4104,heart,B-Condition
60356,4104,rhythm,I-Condition
60357,4104,disorder,I-Condition
60358,4104,or,O
60359,4104,taking,O
60360,4104,anti,B-Drug
60361,4104,-,I-Drug
60362,4104,arrhythmic,I-Drug
60363,4104,drugs,I-Drug
60364,4105,Severe,B-Condition
60365,4105,renal,I-Condition
60366,4105,impairment,I-Condition
60367,4105,(,O
60368,4105,Class,O
60369,4105,3,O
60370,4105,or,O
60371,4105,worse,O
60372,4105,kidney,O
60373,4105,disease,O
60374,4105,),O
60375,4106,Liver,B-Condition
60376,4106,disease,I-Condition
60377,4106,(,O
60378,4106,cirrhosis,B-Condition
60379,4106,or,O
60380,4106,liver,B-Condition
60381,4106,failure,I-Condition
60382,4106,),O
60383,4107,Prior,O
60384,4107,allergic,B-Condition
60385,4107,reaction,I-Condition
60386,4107,to,O
60387,4107,any,O
60388,4107,type,O
60389,4107,of,O
60390,4107,local,B-Drug
60391,4107,anesthetic,I-Drug
60392,4108,Taking,O
60393,4108,therapeutic,O
60394,4108,doses,O
60395,4108,of,O
60396,4108,anti,B-Drug
60397,4108,-,I-Drug
60398,4108,coagulants,I-Drug
60399,4108,or,O
60400,4108,anti,B-Drug
60401,4108,-,I-Drug
60402,4108,platelet,I-Drug
60403,4108,therapy,I-Drug
60404,4108,(,O
60405,4108,prophylactic,O
60406,4108,doses,O
60407,4108,started,O
60408,4108,because,O
60409,4108,of,O
60410,4108,hospital,O
60411,4108,admission,O
60412,4108,are,O
60413,4108,not,O
60414,4108,an,O
60415,4108,exclusion,O
60416,4108,),O
60417,4109,Currently,O
60418,4109,taking,O
60419,4109,antidepressants,B-Drug
60420,4109,or,O
60421,4109,other,O
60422,4109,psychiatric,B-Drug
60423,4109,medications,I-Drug
60424,4110,Single,O
60425,4110,shot,O
60426,4110,local,B-Procedure
60427,4110,nerve,I-Procedure
60428,4110,block,I-Procedure
60429,4110,prior,O
60430,4110,to,O
60431,4110,surgery,O
60432,4110,was,O
60433,4110,ineffective,O
60434,4111,Selected,O
60435,4111,for,O
60436,4111,neuraxial,B-Procedure
60437,4111,anesthesia,I-Procedure
60438,4111,rather,O
60439,4111,than,O
60440,4111,general,B-Procedure
60441,4111,anesthesia,I-Procedure
60442,4111,for,O
60443,4111,the,O
60444,4111,open,B-Procedure
60445,4111,reduction,I-Procedure
60446,4111,surgery,I-Procedure
60447,4112,Already,O
60448,4112,receiving,O
60449,4112,chronic,O
60450,4112,analgesic,B-Procedure
60451,4112,therapy,I-Procedure
60452,4112,for,O
60453,4112,a,O
60454,4112,separate,O
60455,4112,chronic,B-Condition
60456,4112,pain,I-Condition
60457,4112,condition,O
60458,4113,Referred,O
60459,4113,for,O
60460,4113,surgery,B-Procedure
60461,4113,for,O
60462,4113,open,B-Procedure
60463,4113,reduction,I-Procedure
60464,4113,and,I-Procedure
60465,4113,internal,I-Procedure
60466,4113,fixation,I-Procedure
60467,4113,for,O
60468,4113,ankle,B-Condition
60469,4113,fracture,I-Condition
60470,4114,adults,B-Person
60471,4114,61,O
60472,4114,years,O
60473,4114,old,B-Person
60474,4114,and,O
60475,4114,above,O
60476,4115,smokers,B-Observation
60477,4116,pregnant,B-Condition
60478,4116,women,B-Person
60479,4117,taking,O
60480,4117,any,O
60481,4117,prescription,B-Drug
60482,4117,pain/,I-Drug
60483,4117,insulin,I-Drug
60484,4117,medication,I-Drug
60485,4118,has,O
60486,4118,a,O
60487,4118,history,B-Observation
60488,4118,of,O
60489,4118,taste,B-Condition
60490,4118,or,I-Condition
60491,4118,smell,I-Condition
60492,4118,loss,I-Condition
60493,4118,or,O
60494,4118,other,O
60495,4118,oral,B-Condition
60496,4118,disorders,I-Condition
60497,4118,(,O
60498,4118,e.g.,O
60499,4118,",",O
60500,4118,burning,B-Condition
60501,4118,mouth,I-Condition
60502,4118,syndrome,I-Condition
60503,4118,),O
60504,4119,has,O
60505,4119,current,O
60506,4119,oral,B-Condition
60507,4119,lesions,I-Condition
60508,4119,",",O
60509,4119,canker,B-Condition
60510,4119,sores,I-Condition
60511,4119,",",O
60512,4119,or,O
60513,4119,piercings,O
60514,4120,has,O
60515,4120,a,O
60516,4120,history,B-Observation
60517,4120,of,O
60518,4120,food,B-Condition
60519,4120,allergy,I-Condition
60520,4121,self,O
60521,4121,-,O
60522,4121,reported,O
60523,4121,healthy,B-Condition
60524,4121,adults,B-Person
60525,4121,between,O
60526,4121,the,O
60527,4121,ages,B-Person
60528,4121,of,O
60529,4121,18,O
60530,4121,-,O
60531,4121,60,O
60532,4121,who,O
60533,4121,are,O
60534,4121,fluent,B-Observation
60535,4121,in,I-Observation
60536,4121,English,I-Observation
60537,4121,.,O
60538,4122,Undergoing,O
60539,4122,Interleukin-2,B-Procedure
60540,4122,(,I-Procedure
60541,4122,IL-2,I-Procedure
60542,4122,),I-Procedure
60543,4122,therapy,I-Procedure
60544,4122,within,O
60545,4122,8,O
60546,4122,weeks,O
60547,4122,of,O
60548,4122,study,O
60549,4122,entry,O
60550,4123,Diagnosed,O
60551,4123,with,O
60552,4123,a,O
60553,4123,medical,O
60554,4123,or,O
60555,4123,psychiatric,B-Condition
60556,4123,illness,I-Condition
60557,4123,that,I-Condition
60558,4123,may,I-Condition
60559,4123,interfere,I-Condition
60560,4123,with,I-Condition
60561,4123,study,I-Condition
60562,4123,participation,I-Condition
60563,4124,Pregnant,B-Condition
60564,4125,Diagnosis,O
60565,4125,reviewed,O
60566,4125,at,O
60567,4125,transplant,O
60568,4125,center,O
60569,4125,and,O
60570,4125,confirmed,O
60571,4125,to,O
60572,4125,fit,O
60573,4125,the,O
60574,4125,criterion,O
60575,4125,for,O
60576,4125,high,B-Condition
60577,4125,risk,I-Condition
60578,4125,blood,I-Condition
60579,4125,disease,I-Condition
60580,4125,or,O
60581,4125,cancer,B-Condition
60582,4125,",",O
60583,4125,as,O
60584,4125,defined,O
60585,4125,for,O
60586,4125,the,O
60587,4125,study,O
60588,4126,Estimated,O
60589,4126,life,O
60590,4126,expectancy,O
60591,4126,of,O
60592,4126,at,O
60593,4126,least,O
60594,4126,6,O
60595,4126,weeks,O
60596,4126,following,O
60597,4126,study,O
60598,4126,entry,O
60599,4127,Cancer,O
60600,4127,and,O
60601,4127,Leukemia,O
60602,4127,Group,O
60603,4127,B,O
60604,4127,(,O
60605,4127,CALGB,O
60606,4127,),O
60607,4127,performance,O
60608,4127,status,O
60609,4127,less,O
60610,4127,than,O
60611,4127,or,O
60612,4127,equal,O
60613,4127,to,O
60614,4127,2,O
60615,4128,White,O
60616,4128,blood,O
60617,4128,cell,O
60618,4128,count,O
60619,4128,",",O
60620,4128,platelet,O
60621,4128,",",O
60622,4128,hematocrit,O
60623,4128,",",O
60624,4128,tuberculosis,O
60625,4128,",",O
60626,4128,aspartate,O
60627,4128,aminotransferase,O
60628,4128,(,O
60629,4128,AST,O
60630,4128,),O
60631,4128,",",O
60632,4128,alanine,O
60633,4128,aminotransferase,O
60634,4128,(,O
60635,4128,ALT,O
60636,4128,),O
60637,4128,",",O
60638,4128,alkaline,O
60639,4128,phosphatase,O
60640,4128,",",O
60641,4128,creatinine,O
60642,4128,",",O
60643,4128,and,O
60644,4128,HIV,O
60645,4128,test,O
60646,4128,results,O
60647,4128,reviewed,O
60648,4128,by,O
60649,4128,transplant,O
60650,4128,center,O
60651,4129,Multiple,B-Procedure
60652,4129,gated,I-Procedure
60653,4129,acquisition,I-Procedure
60654,4129,(,I-Procedure
60655,4129,MUGA,I-Procedure
60656,4129,),I-Procedure
60657,4129,",",O
60658,4129,echocardiogram,B-Procedure
60659,4129,",",O
60660,4129,cardiac,B-Procedure
60661,4129,MRI,I-Procedure
60662,4129,",",O
60663,4129,and/or,O
60664,4129,pulmonary,B-Procedure
60665,4129,function,I-Procedure
60666,4129,tests,I-Procedure
60667,4129,(,I-Procedure
60668,4129,PFT,I-Procedure
60669,4129,),I-Procedure
60670,4129,performed,O
60671,4129,and,O
60672,4129,reviewed,O
60673,4129,by,O
60674,4129,transplant,O
60675,4129,center,O
60676,4129,(,O
60677,4129,for,O
60678,4129,individuals,O
60679,4129,with,O
60680,4129,an,O
60681,4129,ejection,O
60682,4129,fraction,O
60683,4129,and,O
60684,4129,diffusing,O
60685,4129,capacity,O
60686,4129,[,O
60687,4129,DLCO,O
60688,4129,],O
60689,4129,of,O
60690,4129,40,O
60691,4129,-,O
60692,4129,50,O
60693,4129,%,O
60694,4129,",",O
60695,4129,the,O
60696,4129,appropriate,O
60697,4129,cardiology,O
60698,4129,or,O
60699,4129,pulmonary,O
60700,4129,consultations,O
60701,4129,should,O
60702,4129,be,O
60703,4129,considered,O
60704,4129,if,O
60705,4129,the,O
60706,4129,individual,O
60707,4129,has,O
60708,4129,severe,O
60709,4129,heart,O
60710,4129,or,O
60711,4129,lung,O
60712,4129,disease,O
60713,4129,at,O
60714,4129,the,O
60715,4129,initiation,O
60716,4129,of,O
60717,4129,therapy,O
60718,4129,),O
60719,4130,Sufficient,O
60720,4130,number,O
60721,4130,of,O
60722,4130,umbilical,O
60723,4130,cord,O
60724,4130,blood,O
60725,4130,units,O
60726,4130,available,O
60727,4130,for,O
60728,4130,transplantation,B-Procedure
60729,4131,If,O
60730,4131,female,B-Person
60731,4131,",",O
60732,4131,willing,O
60733,4131,to,O
60734,4131,use,O
60735,4131,contraception,B-Procedure
60736,4131,throughout,O
60737,4131,the,O
60738,4131,study,O
60739,4132,Other,O
60740,4132,causes,O
60741,4132,of,O
60742,4132,heart,B-Condition
60743,4132,failure,I-Condition
60744,4132,other,O
60745,4132,than,O
60746,4132,diastolic,B-Condition
60747,4132,dysfunction,I-Condition
60748,4132,",",O
60749,4132,such,O
60750,4132,as,O
60751,4132,restrictive,B-Condition
60752,4132,cardiomyopathy,I-Condition
60753,4132,or,O
60754,4132,infiltrative,B-Condition
60755,4132,cardiomyopathy,I-Condition
60756,4133,Women,B-Person
60757,4133,who,O
60758,4133,are,O
60759,4133,pregnant,B-Condition
60760,4133,or,O
60761,4133,nursing,B-Condition
60762,4134,Liver,B-Condition
60763,4134,cirrhosis,I-Condition
60764,4134,",",O
60765,4135,Primary,B-Condition
60766,4135,valvular,I-Condition
60767,4135,disease,I-Condition
60768,4136,Acute,B-Condition
60769,4136,coronary,I-Condition
60770,4136,syndrome,I-Condition
60771,4137,Causes,B-Condition
60772,4137,of,I-Condition
60773,4137,PH,I-Condition
60774,4137,other,O
60775,4137,than,O
60776,4137,that,O
60777,4137,of,O
60778,4137,heart,B-Condition
60779,4137,failure,I-Condition
60780,4137,",",O
60781,4137,such,O
60782,4137,as,O
60783,4137,:,O
60784,4137,chronic,B-Condition
60785,4137,thromboembolic,I-Condition
60786,4137,PH,I-Condition
60787,4137,",",O
60788,4137,sickle,B-Condition
60789,4137,-,I-Condition
60790,4137,cell,I-Condition
60791,4137,disease,I-Condition
60792,4137,",",O
60793,4137,or,O
60794,4137,sarcoidosis,B-Condition
60795,4138,Severe,O
60796,4138,bradycardia,B-Condition
60797,4138,or,O
60798,4138,greater,O
60799,4138,than,O
60800,4138,1st,O
60801,4138,degree,O
60802,4138,heart,B-Condition
60803,4138,block,I-Condition
60804,4139,Decompensated,O
60805,4139,heart,B-Condition
60806,4139,failure,I-Condition
60807,4140,Current,O
60808,4140,use,O
60809,4140,of,O
60810,4140,a,O
60811,4140,third,B-Drug
60812,4140,generation,I-Drug
60813,4140,beta,I-Drug
60814,4140,-,I-Drug
60815,4140,blocker,I-Drug
60816,4140,(,O
60817,4140,nebivolol,B-Drug
60818,4140,",",O
60819,4140,carvedilol,B-Drug
60820,4140,",",O
60821,4140,or,O
60822,4140,labetalol,B-Drug
60823,4140,),O
60824,4140,or,O
60825,4140,high,O
60826,4140,dose,O
60827,4140,of,O
60828,4140,any,B-Drug
60829,4140,beta,I-Drug
60830,4140,-,I-Drug
60831,4140,blockers,I-Drug
60832,4140,(,O
60833,4140,greater,O
60834,4140,than,O
60835,4140,100,O
60836,4140,mg,O
60837,4140,daily,O
60838,4140,of,O
60839,4140,metoprolol,B-Drug
60840,4140,",",O
60841,4140,or,O
60842,4140,equivalent,O
60843,4140,),O
60844,4141,Adults,B-Person
60845,4141,(=,O
60846,4141,18,O
60847,4141,years,O
60848,4141,of,O
60849,4141,age,B-Person
60850,4141,),O
60851,4141,with,O
60852,4141,World,O
60853,4141,Health,O
60854,4141,Organization,O
60855,4141,Group,O
60856,4141,2,O
60857,4141,Pulmonary,B-Condition
60858,4141,Hypertension,I-Condition
60859,4141,(,O
60860,4141,Mean,O
60861,4141,pulmonary,O
60862,4141,artery,O
60863,4141,pressure,O
60864,4141,=,O
60865,4141,25,O
60866,4141,mmHg,O
60867,4141,and,O
60868,4141,pulmonary,O
60869,4141,capillary,O
60870,4141,wedge,O
60871,4141,pressure,O
60872,4141,=,O
60873,4141,15,O
60874,4141,mmHg,O
60875,4141,),O
60876,4142,New,O
60877,4142,York,O
60878,4142,Heart,O
60879,4142,Association,O
60880,4142,class,O
60881,4142,II,O
60882,4142,-,O
60883,4142,IV,O
60884,4142,symptoms,B-Condition
60885,4143,Left,O
60886,4143,ventricular,O
60887,4143,ejection,O
60888,4143,fraction,O
60889,4143,(,O
60890,4143,LVEF,O
60891,4143,),O
60892,4143,=,O
60893,4143,45,O
60894,4143,%,O
60895,4144,Newborn,B-Person
60896,4144,infants,I-Person
60897,4144,<,O
60898,4144,28,O
60899,4144,weeks,O
60900,4144,and,O
60901,4144,>,O
60902,4144,34,O
60903,4144,weeks,O
60904,4144,gestation,O
60905,4144,",",O
60906,4144,those,O
60907,4144,with,O
60908,4144,life,B-Condition
60909,4144,threatening,I-Condition
60910,4144,illness,I-Condition
60911,4144,",",O
60912,4144,congenital,O
60913,4144,and,O
60914,4144,chromosomal,B-Condition
60915,4144,anomalies,I-Condition
60916,4144,",",O
60917,4144,gastrointestinal,B-Condition
60918,4144,anomalies,I-Condition
60919,4144,or,O
60920,4144,necrotizing,B-Condition
60921,4144,enterocolitis,I-Condition
60922,4144,and,O
60923,4144,fed,B-Observation
60924,4144,premature,I-Observation
60925,4144,formula,I-Observation
60926,4145,Inborn,B-Condition
60927,4145,preterm,B-Condition
60928,4145,infants,B-Person
60929,4145,born,O
60930,4145,between,O
60931,4145,28,O
60932,4145,0/7,O
60933,4145,and,O
60934,4145,34,O
60935,4145,0/7,O
60936,4145,weeks,O
60937,4145,gestation,O
60938,4145,and,O
60939,4145,fed,B-Observation
60940,4145,either,I-Observation
60941,4145,mother,I-Observation
60942,4145,'s,I-Observation
60943,4145,own,I-Observation
60944,4145,milk,I-Observation
60945,4145,or,O
60946,4145,donor,O
60947,4145,human,O
60948,4145,milk,O
60949,4146,Age,B-Person
60950,4146,younger,O
60951,4146,than,O
60952,4146,18,O
60953,4146,yrs,O
60954,4146,.,O
60955,4146,or,O
60956,4146,older,O
60957,4146,than,O
60958,4146,75,O
60959,4146,yrs,O
60960,4146,.,O
60961,4147,Pregnancy,B-Condition
60962,4147,or,O
60963,4147,nursing,B-Condition
60964,4147,(,O
60965,4147,negative,O
60966,4147,pregnancy,O
60967,4147,blood,O
60968,4147,test,O
60969,4147,),O
60970,4148,History,B-Observation
60971,4148,of,O
60972,4148,allergic,B-Condition
60973,4148,reactions,I-Condition
60974,4148,to,O
60975,4148,phenylephrine,B-Drug
60976,4148,or,O
60977,4148,ephedrine,B-Drug
60978,4149,eGFR,O
60979,4149,<,O
60980,4149,60ml,O
60981,4149,/,O
60982,4149,min/1.73m2,O
60983,4150,Patients,O
60984,4150,scheduled,B-Mood
60985,4150,for,O
60986,4150,supine,B-Procedure
60987,4150,-,I-Procedure
60988,4150,positioned,I-Procedure
60989,4150,elective,I-Procedure
60990,4150,craniotomy,I-Procedure
60991,4150,for,O
60992,4150,supratentorial,O
60993,4150,malignant,O
60994,4150,and,O
60995,4150,non,O
60996,4150,-,O
60997,4150,malignant,O
60998,4150,brain,B-Condition
60999,4150,tumors,I-Condition
61000,4150,3,O
61001,4150,cm,O
61002,4150,or,O
61003,4150,larger,O
61004,4150,(,O
61005,4150,measured,O
61006,4150,as,O
61007,4150,the,O
61008,4150,largest,O
61009,4150,diameter,O
61010,4150,in,O
61011,4150,any,O
61012,4150,plane,O
61013,4150,on,O
61014,4150,MR,B-Procedure
61015,4150,images,O
61016,4150,),O
61017,4151,ASA,O
61018,4151,(,O
61019,4151,American,O
61020,4151,Society,O
61021,4151,of,O
61022,4151,Anesthesiologist,O
61023,4151,),O
61024,4151,status,O
61025,4151,1,O
61026,4151,-,O
61027,4151,3,O
61028,4151,(,O
61029,4151,27,O
61030,4151,),O
61031,4152,Written,O
61032,4152,informed,O
61033,4152,consent,O
61034,4152,from,O
61035,4152,participating,O
61036,4152,patients,O
61037,4153,endometrial,O
61038,4153,thickness,O
61039,4153,<,O
61040,4153,7,O
61041,4153,mm,O
61042,4153,or,O
61043,4153,no,O
61044,4153,triple,B-Observation
61045,4153,layer,I-Observation
61046,4153,endometrium,I-Observation
61047,4153,and/or,O
61048,4153,functional,B-Observation
61049,4153,follicles,I-Observation
61050,4154,Uterine,B-Condition
61051,4154,abnormality,I-Condition
61052,4155,Chronic,B-Condition
61053,4155,medical,I-Condition
61054,4155,disease,I-Condition
61055,4156,oocyte,B-Procedure
61056,4156,donation,I-Procedure
61057,4156,cycles,I-Procedure
61058,4157,Endometrial,O
61059,4157,thickness,O
61060,4157,=,O
61061,4157,7,O
61062,4157,mm,O
61063,4157,after,O
61064,4157,stimulation,B-Procedure
61065,4158,18,O
61066,4158,-,O
61067,4158,45,O
61068,4158,years,B-Person
61069,4159,IVF,B-Procedure
61070,4159,/,I-Procedure
61071,4159,ICSI,I-Procedure
61072,4159,fertilisation,I-Procedure
61073,4160,BMI,O
61074,4160,>,O
61075,4160,"18,5",O
61076,4160,<,O
61077,4160,30,O
61078,4160,kg,O
61079,4160,/,O
61080,4160,m2,O
61081,4161,cycle,O
61082,4161,length,O
61083,4161,25,O
61084,4161,-,O
61085,4161,34,O
61086,4161,days,O
61087,4162,Non,O
61088,4162,-,O
61089,4162,English,O
61090,4162,speaking,O
61091,4162,/,O
61092,4162,illiterate,O
61093,4163,Painful,B-Condition
61094,4163,active,O
61095,4163,",",O
61096,4163,concurrent,O
61097,4163,cervical,B-Condition
61098,4163,spine,I-Condition
61099,4163,conditions,I-Condition
61100,4164,Current,O
61101,4164,non,B-Drug
61102,4164,-,I-Drug
61103,4164,steroidal,I-Drug
61104,4164,anti,I-Drug
61105,4164,-,I-Drug
61106,4164,inflammatory,I-Drug
61107,4164,drug,I-Drug
61108,4164,(,O
61109,4164,NSAID,B-Drug
61110,4164,),O
61111,4164,use,O
61112,4165,History,O
61113,4165,of,O
61114,4165,taking,O
61115,4165,coumadin,B-Drug
61116,4165,or,O
61117,4165,similar,O
61118,4165,anticoagulant,B-Drug
61119,4165,",",O
61120,4165,have,O
61121,4165,a,O
61122,4165,known,O
61123,4165,coagulopathy,B-Condition
61124,4165,",",O
61125,4165,bleeding,B-Condition
61126,4165,dyscrasia,I-Condition
61127,4165,",",O
61128,4165,or,O
61129,4165,platelet,O
61130,4165,count,O
61131,4165,<,O
61132,4165,"150,000",O
61133,4165,/,O
61134,4165,cubic,O
61135,4165,mm,O
61136,4166,Allergic,B-Condition
61137,4166,reaction,I-Condition
61138,4166,to,O
61139,4166,poultry,B-Observation
61140,4166,or,O
61141,4166,previous,O
61142,4166,viscosupplementation,B-Observation
61143,4167,Involved,O
61144,4167,in,O
61145,4167,workers,O
61146,4167,',O
61147,4167,compensation,O
61148,4167,or,O
61149,4167,active,O
61150,4167,litigation,O
61151,4167,involving,O
61152,4167,affected,O
61153,4167,shoulder,O
61154,4168,Inability,B-Mood
61155,4168,to,I-Mood
61156,4168,refrain,I-Mood
61157,4168,from,I-Mood
61158,4168,NSAID,B-Drug
61159,4168,use,O
61160,4168,for,O
61161,4168,5,O
61162,4168,days,O
61163,4168,prior,O
61164,4168,to,O
61165,4168,and,O
61166,4168,6,O
61167,4168,weeks,O
61168,4168,after,O
61169,4168,injection,O
61170,4169,History,B-Observation
61171,4169,of,I-Observation
61172,4169,corticosteroid,B-Procedure
61173,4169,injection,I-Procedure
61174,4169,to,O
61175,4169,affected,O
61176,4169,shoulder,O
61177,4169,within,O
61178,4169,the,O
61179,4169,last,O
61180,4169,3,O
61181,4169,months,O
61182,4170,History,B-Observation
61183,4170,of,I-Observation
61184,4170,viscosupplementation,B-Procedure
61185,4170,or,O
61186,4170,platelet,B-Drug
61187,4170,-,I-Drug
61188,4170,rich,I-Drug
61189,4170,plasma,I-Drug
61190,4170,to,O
61191,4170,affected,O
61192,4170,shoulder,O
61193,4170,within,O
61194,4170,the,O
61195,4170,last,O
61196,4170,6,O
61197,4170,months,O
61198,4171,Presence,O
61199,4171,of,O
61200,4171,acute,O
61201,4171,fracture,B-Condition
61202,4172,History,B-Observation
61203,4172,of,I-Observation
61204,4172,shoulder,B-Condition
61205,4172,tumor,I-Condition
61206,4173,Known,O
61207,4173,uncontrolled,O
61208,4173,systemic,B-Condition
61209,4173,illness,I-Condition
61210,4173,(,O
61211,4173,uncontrolled,O
61212,4173,diabetes,B-Condition
61213,4173,",",O
61214,4173,human,B-Condition
61215,4173,immunodeficiency,I-Condition
61216,4173,virus,I-Condition
61217,4173,",",O
61218,4173,vasculitis,B-Condition
61219,4173,",",O
61220,4173,autoimmune,B-Condition
61221,4173,/,O
61222,4173,inflammatory,B-Condition
61223,4173,disease,I-Condition
61224,4173,),O
61225,4174,Psychiatric,B-Condition
61226,4174,and,I-Condition
61227,4174,somatoform,I-Condition
61228,4174,disorders,I-Condition
61229,4175,English,O
61230,4175,speaking,O
61231,4175,/,O
61232,4175,literate,O
61233,4176,Age,B-Person
61234,4176,18,O
61235,4176,-,O
61236,4176,100,O
61237,4176,years,O
61238,4177,Visual,O
61239,4177,analog,O
61240,4177,score,O
61241,4177,pain,O
61242,4177,>,O
61243,4177,=,O
61244,4177,5,O
61245,4178,Greater,O
61246,4178,than,O
61247,4178,or,O
61248,4178,equal,O
61249,4178,to,O
61250,4178,3,O
61251,4178,months,O
61252,4178,of,O
61253,4178,pain,B-Condition
61254,4178,after,O
61255,4178,onset,O
61256,4178,of,O
61257,4178,symptoms,O
61258,4178,that,O
61259,4178,has,O
61260,4178,failed,B-Mood
61261,4178,conservative,B-Procedure
61262,4178,treatments,I-Procedure
61263,4179,Confirmation,O
61264,4179,of,O
61265,4179,glenohumeral,B-Condition
61266,4179,OA,I-Condition
61267,4179,via,O
61268,4179,imaging,B-Procedure
61269,4180,Transient,O
61270,4180,relief,B-Condition
61271,4180,of,I-Condition
61272,4180,symptoms,I-Condition
61273,4180,after,O
61274,4180,diagnostic,O
61275,4180,intra,B-Procedure
61276,4180,-,I-Procedure
61277,4180,articular,I-Procedure
61278,4180,injection,I-Procedure
61279,4180,into,O
61280,4180,the,O
61281,4180,glenohumeral,O
61282,4180,joint,O
61283,4181,Intolerability,B-Condition
61284,4181,of,O
61285,4181,tamsulosin,B-Drug
61286,4181,or,O
61287,4181,related,B-Drug
61288,4181,drugs,I-Drug
61289,4182,Investigator,O
61290,4182,discretion,O
61291,4183,Unwillingness,O
61292,4183,or,O
61293,4183,inability,O
61294,4183,to,O
61295,4183,comply,O
61296,4183,with,O
61297,4183,protocol,O
61298,4183,procedures,O
61299,4183,and,O
61300,4183,assessments,O
61301,4184,Male,B-Person
61302,4185,18,O
61303,4185,years,O
61304,4185,of,O
61305,4185,age,B-Person
61306,4186,Presenting,O
61307,4186,with,O
61308,4186,hernia,B-Condition
61309,4186,requiring,B-Mood
61310,4186,surgical,B-Procedure
61311,4186,intervention,I-Procedure
61312,4187,cognitive,B-Condition
61313,4187,impairment,I-Condition
61314,4187,(,O
61315,4187,Mini,O
61316,4187,-,O
61317,4187,Mental,O
61318,4187,Status,O
61319,4187,Examination,O
61320,4187,score,O
61321,4187,:,O
61322,4187,illiterate,B-Observation
61323,4187,13,O
61324,4187,points,O
61325,4187,;,O
61326,4187,elementary,B-Observation
61327,4187,and,O
61328,4187,middle,B-Observation
61329,4187,school,I-Observation
61330,4187,18,O
61331,4187,points,O
61332,4187,;,O
61333,4187,and,O
61334,4187,high,B-Observation
61335,4187,-,I-Observation
61336,4187,school,I-Observation
61337,4187,26,O
61338,4187,points,O
61339,4187,;,O
61340,4187,or,O
61341,4187,inability,B-Condition
61342,4187,to,I-Condition
61343,4187,respond,I-Condition
61344,4187,to,I-Condition
61345,4187,verbal,I-Condition
61346,4187,command,I-Condition
61347,4187,),O
61348,4187,;,O
61349,4188,inability,B-Condition
61350,4188,to,I-Condition
61351,4188,walk,I-Condition
61352,4188,independently,I-Condition
61353,4188,for,O
61354,4188,at,O
61355,4188,least,O
61356,4188,10,O
61357,4188,minutes,O
61358,4188,",",O
61359,4188,with,O
61360,4188,or,O
61361,4188,without,O
61362,4188,walking,O
61363,4188,devices,O
61364,4188,;,O
61365,4189,pain,B-Condition
61366,4189,or,O
61367,4189,other,B-Condition
61368,4189,disorders,I-Condition
61369,4189,precluding,O
61370,4189,their,O
61371,4189,participation,O
61372,4189,.,O
61373,4190,=,O
61374,4190,20years,O
61375,4190,of,O
61376,4190,age,B-Person
61377,4190,;,O
61378,4191,diagnosis,O
61379,4191,of,O
61380,4191,stroke,B-Condition
61381,4191,(,O
61382,4191,>,O
61383,4191,6months,O
61384,4191,),O
61385,4191,;,O
61386,4192,sedentary,B-Observation
61387,4192,or,O
61388,4192,insufficiently,B-Observation
61389,4192,active,I-Observation
61390,4192,;,O
61391,4193,have,O
61392,4193,a,O
61393,4193,writing,O
61394,4193,medical,O
61395,4193,permission,O
61396,4193,to,O
61397,4193,participate,O
61398,4193,in,O
61399,4193,the,O
61400,4193,training,O
61401,4193,program,O
61402,4193,.,O
61403,4194,Patients,O
61404,4194,under,B-Person
61405,4194,18,I-Person
61406,4195,Pregnancy,B-Condition
61407,4195,and,O
61408,4195,Lactation,B-Condition
61409,4196,Patients,O
61410,4196,allergic,B-Condition
61411,4196,to,O
61412,4196,polyglycolic,B-Drug
61413,4196,/,I-Drug
61414,4196,trimethylene,I-Drug
61415,4196,carbonate,I-Drug
61416,4197,Carrier,O
61417,4197,of,O
61418,4197,prosthetic,O
61419,4197,mesh,O
61420,4197,in,O
61421,4197,the,O
61422,4197,ostomy,B-Procedure
61423,4198,Patients,O
61424,4198,presenting,O
61425,4198,midline,B-Condition
61426,4198,hernia,I-Condition
61427,4198,.,O
61428,4199,Patients,O
61429,4199,affected,O
61430,4199,by,O
61431,4199,inflammatory,B-Condition
61432,4199,bowel,I-Condition
61433,4199,disease,I-Condition
61434,4200,Patients,O
61435,4200,undergoing,O
61436,4200,a,O
61437,4200,loop,B-Procedure
61438,4200,ileostomy,I-Procedure
61439,4200,closure,I-Procedure
61440,4201,Previous,O
61441,4201,antispastic,B-Drug
61442,4201,drugs,I-Drug
61443,4202,Contraindication,B-Condition
61444,4202,for,O
61445,4202,baclofen,B-Drug
61446,4202,or,O
61447,4202,toxin,B-Drug
61448,4203,Antecedent,O
61449,4203,of,O
61450,4203,epileptic,B-Condition
61451,4203,seizure,I-Condition
61452,4204,Psychiatric,B-Condition
61453,4204,antecedent,O
61454,4205,First,O
61455,4205,single,O
61456,4205,stroke,B-Condition
61457,4205,ischaemic,O
61458,4205,or,O
61459,4205,haemorrhagic,O
61460,4205,responsible,O
61461,4205,of,O
61462,4205,an,O
61463,4205,hemiplegia,B-Condition
61464,4206,Stoke,B-Condition
61465,4206,since,O
61466,4206,less,O
61467,4206,than,O
61468,4206,2,O
61469,4206,month,O
61470,4207,A,O
61471,4207,sufficient,O
61472,4207,understood,O
61473,4208,A,O
61474,4208,spasticity,B-Condition
61475,4208,:,O
61476,4208,a,O
61477,4208,Tardieu,O
61478,4208,score,O
61479,4208,upper,O
61480,4208,or,O
61481,4208,equal,O
61482,4208,to,O
61483,4208,2,O
61484,4208,on,O
61485,4208,at,O
61486,4208,least,O
61487,4208,one,O
61488,4208,of,O
61489,4208,the,O
61490,4208,following,O
61491,4208,muscle,O
61492,4208,-,O
61493,4208,triceps,O
61494,4208,surae,O
61495,4208,",",O
61496,4208,flexors,O
61497,4208,of,O
61498,4208,fingers,O
61499,4208,",",O
61500,4208,of,O
61501,4208,wrist,O
61502,4208,and,O
61503,4208,of,O
61504,4208,elbow,O
61505,4209,A,O
61506,4209,free,O
61507,4209,consent,O
61508,4210,<,O
61509,4210,18,O
61510,4210,years,O
61511,4210,old,B-Person
61512,4211,Evidence,O
61513,4211,of,O
61514,4211,decompensated,O
61515,4211,liver,B-Condition
61516,4211,disease,I-Condition
61517,4212,HOMA,O
61518,4212,IR,O
61519,4212,<,O
61520,4212,2.0,O
61521,4213,HIV,O
61522,4213,seropositivity,O
61523,4214,Chronic,O
61524,4214,HBV,O
61525,4214,/,O
61526,4214,HIV,O
61527,4214,infection,O
61528,4215,Use,O
61529,4215,of,O
61530,4215,immune,B-Drug
61531,4215,suppressing,I-Drug
61532,4215,medications,I-Drug
61533,4216,Active,O
61534,4216,malignancy,B-Condition
61535,4217,HCV,O
61536,4217,RNA,O
61537,4217,evidence,O
61538,4217,of,O
61539,4217,HCV,B-Condition
61540,4217,infection,I-Condition
61541,4218,Documented,O
61542,4218,history,O
61543,4218,of,O
61544,4218,chronic,B-Condition
61545,4218,HCV,I-Condition
61546,4218,RNA,I-Condition
61547,4218,infection,I-Condition
61548,4218,with,O
61549,4218,Genotype,O
61550,4218,1,O
61551,4219,Able,O
61552,4219,to,O
61553,4219,provide,O
61554,4219,informed,O
61555,4219,consent,O
61556,4220,Available,O
61557,4220,for,O
61558,4220,ongoing,O
61559,4220,follow,O
61560,4220,-,O
61561,4220,up,O
61562,4220,if,O
61563,4220,required,O
61564,4221,Limited,B-Observation
61565,4221,English,I-Observation
61566,4221,proficiency,I-Observation
61567,4221,(,O
61568,4221,LEP,B-Observation
61569,4221,),O
61570,4222,Pregnant,B-Condition
61571,4223,Prisoners,B-Person
61572,4224,Wolff,B-Condition
61573,4224,Parkinson,I-Condition
61574,4224,White,I-Condition
61575,4224,syndrome,I-Condition
61576,4225,Administration,O
61577,4225,of,O
61578,4225,electrical,B-Procedure
61579,4225,or,I-Procedure
61580,4225,chemical,I-Procedure
61581,4225,cardioversion,I-Procedure
61582,4225,before,O
61583,4225,screening,O
61584,4226,Administration,O
61585,4226,of,O
61586,4226,other,O
61587,4226,antiarrhythmics,B-Drug
61588,4226,for,O
61589,4226,acute,O
61590,4226,heart,B-Procedure
61591,4226,rate,I-Procedure
61592,4226,control,I-Procedure
61593,4226,(,O
61594,4226,excluding,O
61595,4226,adenosine,B-Drug
61596,4226,),O
61597,4227,History,O
61598,4227,of,O
61599,4227,allergy,B-Condition
61600,4227,or,O
61601,4227,idiosyncratic,B-Condition
61602,4227,reaction,I-Condition
61603,4227,to,O
61604,4227,diltiazem,B-Drug
61605,4228,Unable,B-Condition
61606,4228,to,I-Condition
61607,4228,take,I-Condition
61608,4228,oral,B-Drug
61609,4228,medications,I-Drug
61610,4229,Heart,O
61611,4229,rate,O
61612,4229,<,O
61613,4229,60,O
61614,4229,beats,O
61615,4229,/,O
61616,4229,min,O
61617,4230,>,O
61618,4230,/=,O
61619,4230,18,O
61620,4230,years,O
61621,4230,old,B-Person
61622,4231,Atrial,B-Condition
61623,4231,fibrillation,I-Condition
61624,4231,or,I-Condition
61625,4231,flutter,I-Condition
61626,4231,on,O
61627,4231,electrocardiogram,B-Procedure
61628,4232,Heart,O
61629,4232,rate,O
61630,4232,>,O
61631,4232,110,O
61632,4232,beats,O
61633,4232,/,O
61634,4232,min,O
61635,4233,Systolic,O
61636,4233,blood,O
61637,4233,pressure,O
61638,4233,>,O
61639,4233,/=,O
61640,4233,90,O
61641,4233,mmHg,O
61642,4234,Participation,O
61643,4234,in,O
61644,4234,another,O
61645,4234,clinical,O
61646,4234,trial,O
61647,4234,.,O
61648,4235,Known,B-Mood
61649,4235,or,O
61650,4235,suspected,B-Mood
61651,4235,(,O
61652,4235,or,O
61653,4235,history,B-Observation
61654,4235,of,I-Observation
61655,4235,),O
61656,4235,malignancy,B-Condition
61657,4235,or,O
61658,4235,chronic,B-Condition
61659,4235,illness,I-Condition
61660,4235,.,O
61661,4236,Serious,O
61662,4236,organic,B-Condition
61663,4236,or,I-Condition
61664,4236,mental,I-Condition
61665,4236,disease,I-Condition
61666,4236,diagnosed,O
61667,4236,by,O
61668,4236,a,O
61669,4236,psychiatrist,O
61670,4236,(,O
61671,4236,e.g.,O
61672,4236,",",O
61673,4236,major,B-Condition
61674,4236,depression,I-Condition
61675,4236,currently,O
61676,4236,treated,B-Procedure
61677,4236,with,O
61678,4236,antidepressant,B-Drug
61679,4236,medication,I-Drug
61680,4236,),O
61681,4236,suspected,B-Mood
61682,4236,on,O
61683,4236,the,O
61684,4236,basis,O
61685,4236,of,O
61686,4236,the,O
61687,4236,medical,B-Observation
61688,4236,history,I-Observation
61689,4236,and/or,O
61690,4236,clinical,B-Procedure
61691,4236,examination,I-Procedure
61692,4236,.,O
61693,4237,Conditions,O
61694,4237,that,O
61695,4237,may,O
61696,4237,affect,O
61697,4237,the,O
61698,4237,compliance,O
61699,4237,to,O
61700,4237,the,O
61701,4237,study,O
61702,4237,.,O
61703,4238,Contraindications,O
61704,4238,to,O
61705,4238,therapy,O
61706,4238,with,O
61707,4238,the,O
61708,4238,study,O
61709,4238,drug,O
61710,4238,or,O
61711,4238,hypersensitivity,O
61712,4238,to,O
61713,4238,the,O
61714,4238,study,O
61715,4238,drug,O
61716,4238,(,O
61717,4238,active,O
61718,4238,ingredient,O
61719,4238,or,O
61720,4238,excipients,O
61721,4238,of,O
61722,4238,the,O
61723,4238,formulation,O
61724,4238,),O
61725,4238,.,O
61726,4239,Female,B-Person
61727,4239,subjects,O
61728,4239,aged,B-Person
61729,4239,=/,O
61730,4239,>,O
61731,4239,18,O
61732,4239,years,O
61733,4239,and,O
61734,4239,of,O
61735,4239,reproductive,B-Condition
61736,4239,age,I-Condition
61737,4239,.,O
61738,4240,Capacity,O
61739,4240,to,O
61740,4240,give,O
61741,4240,consent,O
61742,4240,for,O
61743,4240,study,O
61744,4240,participation,O
61745,4240,",",O
61746,4240,after,O
61747,4240,being,O
61748,4240,adequately,O
61749,4240,informed,O
61750,4240,of,O
61751,4240,the,O
61752,4240,aims,O
61753,4240,",",O
61754,4240,benefits,O
61755,4240,",",O
61756,4240,risks,O
61757,4240,",",O
61758,4240,time,O
61759,4240,and,O
61760,4240,motion,O
61761,4240,of,O
61762,4240,the,O
61763,4240,study,O
61764,4240,.,O
61765,4241,Inability,O
61766,4241,to,O
61767,4241,provide,O
61768,4241,an,O
61769,4241,informed,O
61770,4241,consent,O
61771,4242,Evidence,O
61772,4242,of,O
61773,4242,oral,O
61774,4242,distant,O
61775,4242,metastasis,B-Condition
61776,4242,or,O
61777,4242,other,O
61778,4242,malignancies,B-Condition
61779,4243,The,O
61780,4243,patient,O
61781,4243,has,O
61782,4243,received,O
61783,4243,prior,O
61784,4243,surgery,B-Procedure
61785,4243,for,O
61786,4243,primary,O
61787,4243,tumor,B-Condition
61788,4243,or,O
61789,4243,lymph,B-Condition
61790,4243,node,I-Condition
61791,4243,(,O
61792,4243,except,O
61793,4243,for,O
61794,4243,biopsy,B-Procedure
61795,4243,),O
61796,4244,Prior,O
61797,4244,radiotherapy,B-Procedure
61798,4244,for,O
61799,4244,primary,O
61800,4244,tumor,B-Condition
61801,4245,The,O
61802,4245,patient,O
61803,4245,has,O
61804,4245,previously,O
61805,4245,received,O
61806,4245,anti,B-Procedure
61807,4245,-,I-Procedure
61808,4245,tumor,I-Procedure
61809,4245,biological,I-Procedure
61810,4245,targeted,I-Procedure
61811,4245,therapy,I-Procedure
61812,4246,The,O
61813,4246,patient,O
61814,4246,has,O
61815,4246,received,O
61816,4246,chemotherapy,B-Procedure
61817,4246,or,O
61818,4246,immunotherapy,B-Procedure
61819,4246,for,O
61820,4246,primary,B-Condition
61821,4246,tumors,I-Condition
61822,4247,Prior,O
61823,4247,malignancy,B-Condition
61824,4247,within,O
61825,4247,the,O
61826,4247,previous,O
61827,4247,5,O
61828,4247,years,O
61829,4247,(,O
61830,4247,except,O
61831,4247,for,O
61832,4247,cured,B-Condition
61833,4247,skin,I-Condition
61834,4247,basal,I-Condition
61835,4247,cell,I-Condition
61836,4247,carcinoma,I-Condition
61837,4247,or,O
61838,4247,cervical,B-Condition
61839,4247,carcinoma,I-Condition
61840,4247,in,I-Condition
61841,4247,situ,I-Condition
61842,4247,),O
61843,4248,With,O
61844,4248,3,O
61845,4248,-,O
61846,4248,4,O
61847,4248,grad,O
61848,4248,Allergy,B-Condition
61849,4248,to,O
61850,4248,any,O
61851,4248,drug,B-Drug
61852,4248,in,O
61853,4248,the,O
61854,4248,treatment,O
61855,4249,Peripheral,B-Condition
61856,4249,neuropathy,I-Condition
61857,4249,>,O
61858,4249,1,O
61859,4249,grade,O
61860,4250,Any,O
61861,4250,unstable,O
61862,4250,systematic,B-Condition
61863,4250,disease,I-Condition
61864,4250,(,O
61865,4250,including,O
61866,4250,active,O
61867,4250,infection,B-Condition
61868,4250,",",O
61869,4250,uncontrolled,O
61870,4250,high,B-Condition
61871,4250,blood,I-Condition
61872,4250,pressure,I-Condition
61873,4250,",",O
61874,4250,unstable,B-Condition
61875,4250,angina,I-Condition
61876,4250,",",O
61877,4250,onset,O
61878,4250,of,O
61879,4250,angina,B-Condition
61880,4250,within,O
61881,4250,the,O
61882,4250,last,O
61883,4250,3,O
61884,4250,months,O
61885,4250,",",O
61886,4250,congestive,B-Condition
61887,4250,heart,I-Condition
61888,4250,failure,I-Condition
61889,4250,",",O
61890,4250,myocardial,B-Condition
61891,4250,infarction,I-Condition
61892,4250,within,O
61893,4250,the,O
61894,4250,previous,O
61895,4250,12,O
61896,4250,months,O
61897,4250,",",O
61898,4250,severe,O
61899,4250,arrhythmia,B-Condition
61900,4250,needing,O
61901,4250,drug,B-Drug
61902,4250,treatment,B-Procedure
61903,4250,",",O
61904,4250,liver,B-Condition
61905,4250,",",I-Condition
61906,4250,kidney,I-Condition
61907,4250,or,I-Condition
61908,4250,metabolic,I-Condition
61909,4250,disease,I-Condition
61910,4250,),O
61911,4251,HIV,B-Condition
61912,4251,positive,I-Condition
61913,4252,Chronic,B-Condition
61914,4252,diseases,I-Condition
61915,4252,requiring,O
61916,4252,immune,B-Drug
61917,4252,agents,I-Drug
61918,4252,or,O
61919,4252,hormone,B-Procedure
61920,4252,therapy,I-Procedure
61921,4253,Pregnant,B-Condition
61922,4253,or,O
61923,4253,lactating,B-Condition
61924,4253,women,B-Person
61925,4254,Drug,O
61926,4254,/,O
61927,4254,alcohol,O
61928,4254,abuse,O
61929,4254,",",O
61930,4254,psychological,O
61931,4254,or,O
61932,4254,spiritual,O
61933,4254,illness,O
61934,4254,that,O
61935,4254,may,O
61936,4254,interfere,O
61937,4254,compliance,O
61938,4254,to,O
61939,4254,the,O
61940,4254,study,O
61941,4255,Patients,O
61942,4255,with,O
61943,4255,epilepsy,B-Condition
61944,4255,requiring,O
61945,4255,medications,B-Drug
61946,4255,(,O
61947,4255,such,O
61948,4255,as,O
61949,4255,steroids,B-Drug
61950,4255,or,O
61951,4255,antiepileptic,B-Drug
61952,4255,drugs,I-Drug
61953,4255,),O
61954,4256,The,O
61955,4256,patient,O
61956,4256,has,O
61957,4256,participated,O
61958,4256,in,O
61959,4256,other,O
61960,4256,experimental,O
61961,4256,therapy,O
61962,4256,studies,O
61963,4256,within,O
61964,4256,30,O
61965,4256,days,O
61966,4257,Researchers,O
61967,4257,believe,O
61968,4257,that,O
61969,4257,the,O
61970,4257,situation,O
61971,4257,is,O
61972,4257,unsuitable,O
61973,4257,for,O
61974,4257,participation,O
61975,4257,in,O
61976,4257,the,O
61977,4257,group,O
61978,4258,Ability,O
61979,4258,to,O
61980,4258,understand,O
61981,4258,and,O
61982,4258,the,O
61983,4258,willingness,O
61984,4258,to,O
61985,4258,sign,O
61986,4258,a,O
61987,4258,written,O
61988,4258,informed,O
61989,4258,consent,O
61990,4258,document,O
61991,4259,Age=,B-Person
61992,4259,18,O
61993,4259,and=,O
61994,4259,75,O
61995,4259,years,O
61996,4260,Clinical/,B-Procedure
61997,4260,Histological/,I-Procedure
61998,4260,cytological/,I-Procedure
61999,4260,Imaging,I-Procedure
62000,4260,examination,I-Procedure
62001,4260,proven,O
62002,4260,Oral,O
62003,4260,/,O
62004,4260,Oropharynx,O
62005,4260,Squamous,B-Condition
62006,4260,-,I-Condition
62007,4260,cell,I-Condition
62008,4260,carcinoma,I-Condition
62009,4260,(,O
62010,4260,Tongue,O
62011,4260,",",O
62012,4260,buccal,O
62013,4260,mucosa,O
62014,4260,",",O
62015,4260,mouth,O
62016,4260,floor,O
62017,4260,",",O
62018,4260,hard,O
62019,4260,palate,O
62020,4260,",",O
62021,4260,Molar,O
62022,4260,area,O
62023,4260,),O
62024,4260,",",O
62025,4260,the,O
62026,4260,depth,O
62027,4260,of,O
62028,4260,invasion,O
62029,4260,>,O
62030,4260,4,O
62031,4260,mm,O
62032,4260,in,O
62033,4260,preoperative,B-Procedure
62034,4260,assessment,I-Procedure
62035,4261,In,O
62036,4261,line,O
62037,4261,with,O
62038,4261,clinical,B-Condition
62039,4261,stage,I-Condition
62040,4261,I,I-Condition
62041,4261,/,I-Condition
62042,4261,II,I-Condition
62043,4261,stage,O
62044,4261,(,O
62045,4261,T1,O
62046,4261,-,O
62047,4261,2,O
62048,4261,N0,O
62049,4261,M0,O
62050,4261,;,O
62051,4261,AJCC,O
62052,4261,2010,O
62053,4261,),O
62054,4261,and,O
62055,4261,receiving,O
62056,4261,surgical,B-Procedure
62057,4261,resection,I-Procedure
62058,4262,KPS=,O
62059,4262,70,O
62060,4263,Normal,O
62061,4263,bone,O
62062,4263,marrow,O
62063,4263,reserve,O
62064,4263,function,O
62065,4263,and,O
62066,4263,normal,O
62067,4263,liver,O
62068,4263,",",O
62069,4263,kidney,O
62070,4263,function,O
62071,4264,Expected,B-Observation
62072,4264,survival,I-Observation
62073,4264,period=,I-Observation
62074,4264,6,O
62075,4264,months,O
62076,4265,Acute,B-Condition
62077,4265,heart,I-Condition
62078,4265,failure,I-Condition
62079,4265,or,O
62080,4265,acute,O
62081,4265,exacerbation,B-Condition
62082,4265,of,O
62083,4265,chronic,B-Condition
62084,4265,heart,I-Condition
62085,4265,failure,I-Condition
62086,4265,within,O
62087,4265,the,O
62088,4265,past,O
62089,4265,2,O
62090,4265,weeks,O
62091,4265,.,O
62092,4266,Scheduled,O
62093,4266,cardiac,B-Procedure
62094,4266,resynchronization,I-Procedure
62095,4266,therapy,I-Procedure
62096,4266,or,O
62097,4266,heart,B-Procedure
62098,4266,transplantation,I-Procedure
62099,4266,.,O
62100,4267,History,O
62101,4267,of,O
62102,4267,malignant,B-Condition
62103,4267,tumor,I-Condition
62104,4267,or,O
62105,4267,life,B-Person
62106,4267,expectancy,I-Person
62107,4267,under,O
62108,4267,12,O
62109,4267,months,O
62110,4267,.,O
62111,4268,Already,O
62112,4268,on,O
62113,4268,medications,B-Drug
62114,4268,that,O
62115,4268,may,O
62116,4268,affect,O
62117,4268,thyroid,O
62118,4268,function,O
62119,4268,(,O
62120,4268,L,B-Drug
62121,4268,-,I-Drug
62122,4268,T4,I-Drug
62123,4268,",",O
62124,4268,carbimazole,B-Drug
62125,4268,",",O
62126,4268,propylthiouracil,B-Drug
62127,4268,",",O
62128,4268,amiodarone,B-Drug
62129,4268,",",O
62130,4268,lithium,B-Drug
62131,4268,),O
62132,4268,.,O
62133,4269,Pregnancy,B-Condition
62134,4269,and,O
62135,4269,lactation,B-Condition
62136,4269,period,I-Condition
62137,4269,.,O
62138,4270,Participation,O
62139,4270,in,O
62140,4270,another,O
62141,4270,clinical,O
62142,4270,trial,O
62143,4270,within,O
62144,4270,the,O
62145,4270,past,O
62146,4270,30,O
62147,4270,days,O
62148,4270,.,O
62149,4271,Contraindication,B-Condition
62150,4271,or,O
62151,4271,intolerance,B-Condition
62152,4271,to,O
62153,4271,evidence,B-Procedure
62154,4271,-,I-Procedure
62155,4271,based,I-Procedure
62156,4271,therapy,I-Procedure
62157,4271,for,O
62158,4271,CHF,B-Condition
62159,4271,",",O
62160,4271,such,O
62161,4271,as,O
62162,4271,beta,B-Drug
62163,4271,-,I-Drug
62164,4271,blocker,I-Drug
62165,4271,",",O
62166,4271,angiotensin,B-Drug
62167,4271,-,I-Drug
62168,4271,converting,I-Drug
62169,4271,enzyme,I-Drug
62170,4271,inhibitor,I-Drug
62171,4271,or,O
62172,4271,angiotensin,B-Drug
62173,4271,receptor,I-Drug
62174,4271,blocker,I-Drug
62175,4271,.,O
62176,4272,Known,O
62177,4272,hypersensitivity,B-Condition
62178,4272,to,O
62179,4272,the,O
62180,4272,trial,B-Drug
62181,4272,treatment(s,I-Drug
62182,4272,),I-Drug
62183,4272,or,I-Drug
62184,4272,diluents,I-Drug
62185,4272,(,O
62186,4272,when,O
62187,4272,applicable,O
62188,4272,),O
62189,4272,",",O
62190,4272,including,O
62191,4272,placebo,B-Drug
62192,4272,or,O
62193,4272,other,O
62194,4272,comparator,B-Drug
62195,4272,drug(s,I-Drug
62196,4272,),I-Drug
62197,4272,.,O
62198,4273,Untreated,O
62199,4273,adrenal,B-Condition
62200,4273,insufficiency,I-Condition
62201,4273,.,O
62202,4274,Untreated,O
62203,4274,pituitary,B-Condition
62204,4274,insufficiency,I-Condition
62205,4274,.,O
62206,4275,Untreated,O
62207,4275,thyrotoxicosis,B-Condition
62208,4275,.,O
62209,4276,Treatment,B-Procedure
62210,4276,with,O
62211,4276,levothyroxine,B-Drug
62212,4276,must,O
62213,4276,not,O
62214,4276,be,O
62215,4276,initiated,O
62216,4276,in,O
62217,4276,patients,O
62218,4276,with,O
62219,4276,acute,B-Condition
62220,4276,myocardial,I-Condition
62221,4276,infarction,I-Condition
62222,4276,",",O
62223,4276,acute,B-Condition
62224,4276,myocarditis,I-Condition
62225,4276,",",O
62226,4276,or,O
62227,4276,acute,B-Condition
62228,4276,pancarditis,I-Condition
62229,4276,.,O
62230,4277,Severe,O
62231,4277,renal,B-Condition
62232,4277,dysfunction,I-Condition
62233,4277,(,O
62234,4277,eGFR=30,O
62235,4277,ml,O
62236,4277,/,O
62237,4277,min/1.73m2,O
62238,4277,),O
62239,4277,.,O
62240,4278,Significant,O
62241,4278,hepatic,B-Condition
62242,4278,impairment,I-Condition
62243,4278,(,O
62244,4278,Serum,O
62245,4278,GPT,O
62246,4278,>,O
62247,4278,120,O
62248,4278,U,O
62249,4278,/,O
62250,4278,L,O
62251,4278,),O
62252,4278,.,O
62253,4279,Any,O
62254,4279,disorder,O
62255,4279,which,O
62256,4279,",",O
62257,4279,in,O
62258,4279,the,O
62259,4279,opinion,O
62260,4279,of,O
62261,4279,the,O
62262,4279,investigator,O
62263,4279,",",O
62264,4279,might,O
62265,4279,jeopardise,O
62266,4279,subject,O
62267,4279,'s,O
62268,4279,safety,O
62269,4279,or,O
62270,4279,compliance,O
62271,4279,with,O
62272,4279,the,O
62273,4279,protocol,O
62274,4279,.,O
62275,4280,Aged,B-Person
62276,4280,18,O
62277,4280,years,O
62278,4280,or,O
62279,4280,older,O
62280,4280,",",O
62281,4280,male,B-Person
62282,4280,or,O
62283,4280,female,B-Person
62284,4280,.,O
62285,4281,Systolic,B-Condition
62286,4281,heart,I-Condition
62287,4281,failure,I-Condition
62288,4281,with,O
62289,4281,New,O
62290,4281,York,O
62291,4281,Heart,O
62292,4281,Association,O
62293,4281,(,O
62294,4281,NYHA,O
62295,4281,),O
62296,4281,class,O
62297,4281,II,O
62298,4281,-,O
62299,4281,III,O
62300,4281,.,O
62301,4282,Left,O
62302,4282,ventricular,O
62303,4282,ejection,O
62304,4282,fraction,O
62305,4282,(,O
62306,4282,LVEF,O
62307,4282,),O
62308,4282,less,O
62309,4282,than,O
62310,4282,40,O
62311,4282,%,O
62312,4282,by,O
62313,4282,echocardiography,B-Procedure
62314,4282,during,O
62315,4282,screening,O
62316,4282,and,O
62317,4282,randomization,O
62318,4282,.,O
62319,4283,SCH,B-Condition
62320,4283,(,O
62321,4283,TSH,O
62322,4283,:,O
62323,4283,upper,O
62324,4283,limits,O
62325,4283,of,O
62326,4283,normal,O
62327,4283,(,O
62328,4283,ULN,O
62329,4283,),O
62330,4283,-10mIU,O
62331,4283,/,O
62332,4283,L,O
62333,4283,",",O
62334,4283,and,O
62335,4283,FT4,O
62336,4283,level,O
62337,4283,within,O
62338,4283,reference,O
62339,4283,range,O
62340,4283,),O
62341,4283,.,O
62342,4284,Having,O
62343,4284,received,O
62344,4284,standard,B-Procedure
62345,4284,HF,I-Procedure
62346,4284,therapy,I-Procedure
62347,4284,for,O
62348,4284,at,O
62349,4284,least,O
62350,4284,2,O
62351,4284,weeks,O
62352,4284,",",O
62353,4284,having,O
62354,4284,reached,O
62355,4284,target,O
62356,4284,dose,O
62357,4284,or,O
62358,4284,max,O
62359,4284,tolerable,O
62360,4284,dose,O
62361,4284,.,O
62362,4285,Provided,O
62363,4285,informed,O
62364,4285,consent,O
62365,4285,.,O
62366,4286,Current,O
62367,4286,use,O
62368,4286,of,O
62369,4286,gabapentin,B-Drug
62370,4286,or,O
62371,4286,pregabalin,B-Drug
62372,4287,Allergy,B-Condition
62373,4287,to,O
62374,4287,gabapentin,B-Drug
62375,4287,",",O
62376,4287,acetaminophen,B-Drug
62377,4287,",",O
62378,4287,codeine,B-Drug
62379,4287,",",O
62380,4287,or,O
62381,4287,ibuprofen,B-Drug
62382,4288,Self,O
62383,4288,reported,O
62384,4288,renal,B-Condition
62385,4288,disease,I-Condition
62386,4288,(,O
62387,4288,severe,O
62388,4288,impaired,B-Condition
62389,4288,renal,I-Condition
62390,4288,function,I-Condition
62391,4288,),O
62392,4289,Self,O
62393,4289,reported,O
62394,4289,current,O
62395,4289,or,O
62396,4289,chronic,O
62397,4289,narcotic,B-Condition
62398,4289,use,I-Condition
62399,4289,(,O
62400,4289,typical,O
62401,4289,daily,O
62402,4289,use,O
62403,4289,),O
62404,4290,Women,O
62405,4290,with,O
62406,4290,any,O
62407,4290,issue,O
62408,4290,that,O
62409,4290,",",O
62410,4290,in,O
62411,4290,the,O
62412,4290,opinion,O
62413,4290,of,O
62414,4290,the,O
62415,4290,investigator,O
62416,4290,",",O
62417,4290,would,O
62418,4290,interfere,O
62419,4290,with,O
62420,4290,study,O
62421,4290,participation,O
62422,4290,or,O
62423,4290,generating,O
62424,4290,accurate,O
62425,4290,study,O
62426,4290,data,O
62427,4291,15,O
62428,4291,weeks,O
62429,4291,0,O
62430,4291,days,O
62431,4291,gestational,O
62432,4291,age,O
62433,4291,-,O
62434,4291,23,O
62435,4291,weeks,O
62436,4291,5,O
62437,4291,days,O
62438,4291,gestational,O
62439,4291,age,O
62440,4291,at,O
62441,4291,time,O
62442,4291,of,O
62443,4291,dilator,O
62444,4291,insertion,O
62445,4292,Able,B-Observation
62446,4292,to,I-Observation
62447,4292,read,I-Observation
62448,4292,and,I-Observation
62449,4292,write,I-Observation
62450,4292,in,I-Observation
62451,4292,English,I-Observation
62452,4293,Active,B-Observation
62453,4293,cell,I-Observation
62454,4293,phone,I-Observation
62455,4293,with,I-Observation
62456,4293,text,I-Observation
62457,4293,messaging,I-Observation
62458,4293,capability,I-Observation
62459,4294,Ride,B-Observation
62460,4294,home,I-Observation
62461,4294,from,O
62462,4294,dilator,B-Procedure
62463,4294,insertion,I-Procedure
62464,4294,clinic,O
62465,4294,appointment,O
62466,4295,Endoscopically,B-Procedure
62467,4295,confirmed,O
62468,4295,gastric,B-Condition
62469,4295,and/or,O
62470,4295,duodenal,B-Condition
62471,4295,ulcers,I-Condition
62472,4295,on,O
62473,4295,Day,O
62474,4295,1,O
62475,4295,.,O
62476,4296,Endoscopically,B-Procedure
62477,4296,confirmed,O
62478,4296,active,O
62479,4296,upper,B-Condition
62480,4296,gastrointestinal,I-Condition
62481,4296,hemorrhage,I-Condition
62482,4296,on,O
62483,4296,Day,O
62484,4296,1,O
62485,4296,.,O
62486,4297,Current,O
62487,4297,or,O
62488,4297,past,B-Observation
62489,4297,history,I-Observation
62490,4297,of,O
62491,4297,aspirin,B-Drug
62492,4297,-,O
62493,4297,induced,O
62494,4297,asthma,B-Condition
62495,4297,or,O
62496,4297,hypersensitivity,B-Condition
62497,4297,to,I-Condition
62498,4297,NSAIDs,I-Condition
62499,4297,.,O
62500,4298,Past,O
62501,4298,or,O
62502,4298,planned,B-Mood
62503,4298,surgery,B-Procedure
62504,4298,affecting,O
62505,4298,gastric,O
62506,4298,acid,O
62507,4298,secretion,O
62508,4298,.,O
62509,4299,Clinically,O
62510,4299,significant,O
62511,4299,hepatic,B-Condition
62512,4299,or,I-Condition
62513,4299,renal,I-Condition
62514,4299,disorder,I-Condition
62515,4299,.,O
62516,4300,Serious,O
62517,4300,cardiac,B-Condition
62518,4300,dysfunction,I-Condition
62519,4300,",",O
62520,4300,hypertension,B-Condition
62521,4300,",",O
62522,4300,or,O
62523,4300,hematological,B-Condition
62524,4300,disorder,I-Condition
62525,4300,.,O
62526,4301,The,O
62527,4301,patient,O
62528,4301,was,O
62529,4301,on,O
62530,4301,nonsteroid,B-Drug
62531,4301,anti,I-Drug
62532,4301,-,I-Drug
62533,4301,inflammatory,I-Drug
62534,4301,drug,I-Drug
62535,4301,(,I-Drug
62536,4301,NSAID,I-Drug
62537,4301,),I-Drug
62538,4301,treatment,O
62539,4301,on,O
62540,4301,the,O
62541,4301,day,O
62542,4301,when,O
62543,4301,consent,B-Observation
62544,4301,was,O
62545,4301,obtained,O
62546,4301,",",O
62547,4301,and,O
62548,4301,requires,O
62549,4301,the,O
62550,4301,long,O
62551,4301,-,O
62552,4301,term,O
62553,4301,continuous,O
62554,4301,treatment,O
62555,4301,even,O
62556,4301,after,O
62557,4301,treatment,O
62558,4301,with,O
62559,4301,the,O
62560,4301,investigational,O
62561,4301,drug,O
62562,4301,is,O
62563,4301,started,O
62564,4301,.,O
62565,4302,The,O
62566,4302,patient,O
62567,4302,was,O
62568,4302,confirmed,O
62569,4302,to,O
62570,4302,have,O
62571,4302,a,O
62572,4302,history,B-Observation
62573,4302,of,O
62574,4302,gastric,B-Condition
62575,4302,ulcer,I-Condition
62576,4302,or,O
62577,4302,duodenal,B-Condition
62578,4302,ulcer,I-Condition
62579,4302,.,O
62580,4303,Other,O
62581,4303,spinal,B-Condition
62582,4303,pathology,I-Condition
62583,4303,or,O
62584,4303,other,O
62585,4303,associated,B-Condition
62586,4303,medical,I-Condition
62587,4303,condition,I-Condition
62588,4304,Major,B-Condition
62589,4304,neurologic,I-Condition
62590,4304,developmental,I-Condition
62591,4304,delay,I-Condition
62592,4305,Need,B-Mood
62593,4305,for,I-Mood
62594,4305,anterior,B-Procedure
62595,4305,surgery,I-Procedure
62596,4305,or,O
62597,4305,for,O
62598,4305,vertebral,B-Procedure
62599,4305,column,I-Procedure
62600,4305,resection,I-Procedure
62601,4305,.,O
62602,4306,Preoperative,O
62603,4306,opioid,B-Drug
62604,4306,use,O
62605,4307,Inability,B-Condition
62606,4307,to,I-Condition
62607,4307,use,I-Condition
62608,4307,PCA,B-Procedure
62609,4308,Adolescent,B-Person
62610,4308,(,O
62611,4308,10,O
62612,4308,-,O
62613,4308,21,O
62614,4308,years,B-Person
62615,4308,),O
62616,4308,undergoing,O
62617,4308,spinal,B-Procedure
62618,4308,fusion,I-Procedure
62619,4308,for,O
62620,4308,idiopathic,B-Condition
62621,4308,scoliosis,I-Condition
62622,4308,",",O
62623,4308,spondylolisthesis,B-Condition
62624,4308,or,O
62625,4308,Scheuermann,B-Condition
62626,4308,kyphosis,I-Condition
62627,4308,.,O
62628,4309,Posterior,B-Procedure
62629,4309,spinal,I-Procedure
62630,4309,fusion,I-Procedure
62631,4310,No,O
62632,4310,contraindication,B-Condition
62633,4310,for,O
62634,4310,Pregabalin,B-Drug
62635,4310,use,O
62636,4311,ASA,O
62637,4311,I,O
62638,4311,-,O
62639,4311,III,O
62640,4312,Written,O
62641,4312,informed,O
62642,4312,consent,O
62643,4313,Patients,O
62644,4313,with,O
62645,4313,severe,O
62646,4313,-,O
62647,4313,complicated,O
62648,4313,disease,O
62649,4313,that,O
62650,4313,would,O
62651,4313,compromise,O
62652,4313,oral,O
62653,4313,therapy,O
62654,4313,(,O
62655,4313,hypotenstion,B-Condition
62656,4313,or,O
62657,4313,shock,B-Condition
62658,4313,",",O
62659,4313,ileus,B-Condition
62660,4313,or,O
62661,4313,bowel,B-Condition
62662,4313,obstruction,I-Condition
62663,4313,",",O
62664,4313,megacolon,B-Condition
62665,4313,),O
62666,4313,.,O
62667,4314,Patients,O
62668,4314,with,O
62669,4314,an,O
62670,4314,allergy,B-Condition
62671,4314,to,O
62672,4314,oral,O
62673,4314,vancomycin,B-Drug
62674,4314,or,O
62675,4314,fidaxomicin,B-Drug
62676,4314,.,O
62677,4315,Patients,O
62678,4315,anticipated,B-Mood
62679,4315,to,O
62680,4315,receive,O
62681,4315,metronidazole,B-Drug
62682,4315,after,O
62683,4315,enrollment,O
62684,4315,.,O
62685,4316,Patients,O
62686,4316,who,O
62687,4316,already,O
62688,4316,received,O
62689,4316,oral,O
62690,4316,vancomycin,B-Drug
62691,4316,or,O
62692,4316,metronidazole,B-Drug
62693,4316,(,O
62694,4316,either,O
62695,4316,oral,O
62696,4316,or,O
62697,4316,intravenous,O
62698,4316,),O
62699,4316,for,O
62700,4316,>,O
62701,4316,24,O
62702,4316,hours,O
62703,4316,within,O
62704,4316,the,O
62705,4316,preceding,O
62706,4316,72,O
62707,4316,hours,O
62708,4316,at,O
62709,4316,the,O
62710,4316,time,O
62711,4316,of,O
62712,4316,enrollment,O
62713,4316,.,O
62714,4317,Patients,O
62715,4317,anticipated,B-Mood
62716,4317,to,O
62717,4317,receive,O
62718,4317,adjunctive,O
62719,4317,C.,B-Procedure
62720,4317,difficile,I-Procedure
62721,4317,therapy,I-Procedure
62722,4317,(,O
62723,4317,rifaxamin,B-Drug
62724,4317,",",O
62725,4317,nitazoxanide,B-Drug
62726,4317,",",O
62727,4317,tigecycline,B-Drug
62728,4317,),O
62729,4317,after,O
62730,4317,enrollment,O
62731,4317,.,O
62732,4318,Patients,O
62733,4318,18,O
62734,4318,years,O
62735,4318,of,O
62736,4318,age,B-Person
62737,4318,or,O
62738,4318,older,O
62739,4318,with,O
62740,4318,>,O
62741,4318,3,O
62742,4318,unformed,B-Observation
62743,4318,stools/24,I-Observation
62744,4318,hours,O
62745,4318,with,O
62746,4318,positive,O
62747,4318,stool,O
62748,4318,test,O
62749,4318,for,O
62750,4318,C.,O
62751,4318,difficile,O
62752,4318,.,O
62753,4319,Patients,O
62754,4319,receiving,O
62755,4319,=,O
62756,4319,1,O
62757,4319,high,O
62758,4319,or,O
62759,4319,medium,O
62760,4319,risk,O
62761,4319,antibiotic,O
62762,4319,for,O
62763,4319,treatment,O
62764,4319,of,O
62765,4319,an,O
62766,4319,infection,O
62767,4319,other,O
62768,4319,than,O
62769,4319,CDI,O
62770,4319,",",O
62771,4319,for,O
62772,4319,an,O
62773,4319,anticipated,O
62774,4319,duration,O
62775,4319,of,O
62776,4319,=,O
62777,4319,5,O
62778,4319,days,O
62779,4319,from,O
62780,4319,the,O
62781,4319,time,O
62782,4319,of,O
62783,4319,enrollment,O
62784,4319,.,O
62785,4320,clinically,O
62786,4320,significant,O
62787,4320,medical,B-Condition
62788,4320,or,I-Condition
62789,4320,neurologic,I-Condition
62790,4320,condition,I-Condition
62791,4320,or,O
62792,4320,neurocognitive,B-Condition
62793,4320,dysfunction,I-Condition
62794,4320,that,O
62795,4320,would,O
62796,4320,affect,O
62797,4320,function,O
62798,4320,and/or,O
62799,4320,task,O
62800,4320,performance,O
62801,4320,and/or,O
62802,4320,interfere,O
62803,4320,with,O
62804,4320,the,O
62805,4320,study,O
62806,4320,protocol,O
62807,4321,any,O
62808,4321,current,O
62809,4321,(,O
62810,4321,or,O
62811,4321,within,O
62812,4321,past,O
62813,4321,2,O
62814,4321,months,O
62815,4321,),O
62816,4321,medical,B-Condition
62817,4321,condition,I-Condition
62818,4321,requiring,O
62819,4321,medication,B-Drug
62820,4321,that,O
62821,4321,would,B-Mood
62822,4321,interact,I-Mood
62823,4321,with,I-Mood
62824,4321,dronabinol,B-Drug
62825,4321,or,O
62826,4321,interfere,B-Mood
62827,4321,with,I-Mood
62828,4321,the,I-Mood
62829,4321,study,I-Mood
62830,4321,protocol,I-Mood
62831,4322,risk,O
62832,4322,of,O
62833,4322,harm,O
62834,4322,to,O
62835,4322,self,O
62836,4322,or,O
62837,4322,others,O
62838,4322,that,O
62839,4322,requires,O
62840,4322,immediate,O
62841,4322,intervention,O
62842,4323,presence,O
62843,4323,of,O
62844,4323,contraindications,B-Condition
62845,4323,",",O
62846,4323,current,O
62847,4323,or,O
62848,4323,past,O
62849,4323,allergic,B-Condition
62850,4323,or,I-Condition
62851,4323,adverse,I-Condition
62852,4323,reaction,I-Condition
62853,4323,",",O
62854,4323,or,O
62855,4323,known,O
62856,4323,sensitivity,B-Condition
62857,4323,to,O
62858,4323,cannabinoid,B-Drug
62859,4323,-,I-Drug
62860,4323,like,I-Drug
62861,4323,substances,I-Drug
62862,4323,(,O
62863,4323,dronabinol,B-Drug
62864,4323,/,O
62865,4323,marijuana,B-Drug
62866,4323,/,O
62867,4323,cannabis,B-Drug
62868,4323,/,O
62869,4323,THC,B-Drug
62870,4323,",",O
62871,4323,cannabinoid,B-Drug
62872,4323,oil,I-Drug
62873,4323,",",O
62874,4323,sesame,B-Drug
62875,4323,oil,I-Drug
62876,4323,",",O
62877,4323,gelatin,B-Drug
62878,4323,",",O
62879,4323,glycerin,B-Drug
62880,4323,",",O
62881,4323,and,O
62882,4323,titanium,B-Drug
62883,4323,dioxide,I-Drug
62884,4323,),O
62885,4324,lack,O
62886,4324,of,O
62887,4324,fluency,O
62888,4324,in,O
62889,4324,English,O
62890,4325,positive,O
62891,4325,drug,O
62892,4325,screen,O
62893,4325,or,O
62894,4325,alcohol,O
62895,4325,breathalyzer,O
62896,4326,unwilling,O
62897,4326,/,O
62898,4326,unable,O
62899,4326,to,O
62900,4326,sign,O
62901,4326,informed,O
62902,4326,consent,O
62903,4326,document,O
62904,4327,currently,O
62905,4327,pregnant,B-Condition
62906,4327,(,O
62907,4327,positive,O
62908,4327,pregnancy,O
62909,4327,test,O
62910,4327,),O
62911,4327,",",O
62912,4327,planning,B-Mood
62913,4327,pregnancy,B-Condition
62914,4327,",",O
62915,4327,or,O
62916,4327,lactating,B-Condition
62917,4327,(,O
62918,4327,women,O
62919,4327,),O
62920,4328,under,O
62921,4328,18,O
62922,4328,or,O
62923,4328,over,O
62924,4328,50,O
62925,4328,years,O
62926,4328,of,O
62927,4328,age,B-Person
62928,4329,traumatic,B-Condition
62929,4329,brain,I-Condition
62930,4329,injury,I-Condition
62931,4329,(,O
62932,4329,as,O
62933,4329,defined,O
62934,4329,by,O
62935,4329,The,O
62936,4329,American,O
62937,4329,Congress,O
62938,4329,of,O
62939,4329,Rehabilitation,O
62940,4329,as,O
62941,4329,a,O
62942,4329,person,O
62943,4329,who,O
62944,4329,has,O
62945,4329,had,O
62946,4329,a,O
62947,4329,traumatically,O
62948,4329,induced,O
62949,4329,physiological,O
62950,4329,disruption,O
62951,4329,of,O
62952,4329,brain,O
62953,4329,function,O
62954,4329,(,O
62955,4329,i.e.,O
62956,4329,",",O
62957,4329,the,O
62958,4329,head,O
62959,4329,being,O
62960,4329,struck,O
62961,4329,",",O
62962,4329,the,O
62963,4329,head,O
62964,4329,striking,O
62965,4329,an,O
62966,4329,object,O
62967,4329,",",O
62968,4329,and/or,O
62969,4329,the,O
62970,4329,brain,O
62971,4329,undergoing,O
62972,4329,an,O
62973,4329,acceleration,O
62974,4329,/,O
62975,4329,deceleration,O
62976,4329,movement,O
62977,4329,(,O
62978,4329,i.e.,O
62979,4329,",",O
62980,4329,whiplash,O
62981,4329,),O
62982,4329,without,O
62983,4329,direct,O
62984,4329,external,O
62985,4329,trauma,O
62986,4329,to,O
62987,4329,the,O
62988,4329,head,O
62989,4329,),O
62990,4329,",",O
62991,4329,as,O
62992,4329,manifested,O
62993,4329,by,O
62994,4329,at,O
62995,4329,least,O
62996,4329,one,O
62997,4329,of,O
62998,4329,the,O
62999,4329,following,O
63000,4329,:,O
63001,4329,any,O
63002,4329,loss,O
63003,4329,of,O
63004,4329,consciousness,O
63005,4329,;,O
63006,4329,any,O
63007,4329,loss,O
63008,4329,of,O
63009,4329,memory,O
63010,4329,for,O
63011,4329,events,O
63012,4329,immediately,O
63013,4329,before,O
63014,4329,or,O
63015,4329,after,O
63016,4329,the,O
63017,4329,injury,O
63018,4329,;,O
63019,4329,any,O
63020,4329,alteration,O
63021,4329,in,O
63022,4329,mental,O
63023,4329,status,O
63024,4329,at,O
63025,4329,the,O
63026,4329,time,O
63027,4329,of,O
63028,4329,the,O
63029,4329,incident,O
63030,4329,;,O
63031,4329,or,O
63032,4329,focal,O
63033,4329,neurological,O
63034,4329,deficits,O
63035,4329,that,O
63036,4329,may,O
63037,4329,or,O
63038,4329,may,O
63039,4329,not,O
63040,4329,be,O
63041,4329,transient,O
63042,4329,),O
63043,4330,inability,B-Mood
63044,4330,to,O
63045,4330,tolerate,B-Condition
63046,4330,small,I-Condition
63047,4330,",",I-Condition
63048,4330,enclosed,I-Condition
63049,4330,spaces,I-Condition
63050,4330,without,I-Condition
63051,4330,anxiety,I-Condition
63052,4330,(,O
63053,4330,e.g.,O
63054,4330,claustrophobia,B-Condition
63055,4330,),O
63056,4330,",",O
63057,4330,as,O
63058,4330,determined,O
63059,4330,by,O
63060,4330,self,B-Procedure
63061,4330,-,I-Procedure
63062,4330,report,I-Procedure
63063,4330,and/or,O
63064,4330,a,O
63065,4330,preliminary,O
63066,4330,session,O
63067,4330,in,O
63068,4330,a,O
63069,4330,mock,O
63070,4330,scanner,O
63071,4331,left,B-Condition
63072,4331,-,I-Condition
63073,4331,handed,I-Condition
63074,4331,;,O
63075,4332,presence,O
63076,4332,of,O
63077,4332,ferrous,O
63078,4332,-,O
63079,4332,containing,O
63080,4332,metals,O
63081,4332,within,O
63082,4332,the,O
63083,4332,body,O
63084,4332,(,O
63085,4332,e.g.,O
63086,4332,",",O
63087,4332,aneurysm,O
63088,4332,clips,O
63089,4332,",",O
63090,4332,shrapnel,O
63091,4332,/,O
63092,4332,retained,O
63093,4332,particles,O
63094,4332,),O
63095,4333,anticipation,B-Mood
63096,4333,of,I-Mood
63097,4333,a,O
63098,4333,required,O
63099,4333,drug,B-Procedure
63100,4333,test,I-Procedure
63101,4333,in,O
63102,4333,the,O
63103,4333,4,O
63104,4333,weeks,O
63105,4333,following,O
63106,4333,the,O
63107,4333,study,O
63108,4333,.,O
63109,4334,current,O
63110,4334,diagnosis,O
63111,4334,of,O
63112,4334,a,O
63113,4334,mood,B-Condition
63114,4334,",",I-Condition
63115,4334,anxiety,I-Condition
63116,4334,",",I-Condition
63117,4334,or,I-Condition
63118,4334,other,I-Condition
63119,4334,disorder,I-Condition
63120,4334,that,O
63121,4334,is,O
63122,4334,more,O
63123,4334,clinically,O
63124,4334,salient,O
63125,4334,than,O
63126,4334,PTSD,B-Condition
63127,4335,current,O
63128,4335,moderate,O
63129,4335,or,O
63130,4335,severe,O
63131,4335,alcohol,B-Condition
63132,4335,/,I-Condition
63133,4335,drug,I-Condition
63134,4335,use,I-Condition
63135,4335,disorder,I-Condition
63136,4335,or,O
63137,4335,in,O
63138,4335,the,O
63139,4335,past,O
63140,4335,8,O
63141,4335,weeks,O
63142,4336,current,O
63143,4336,or,O
63144,4336,past,O
63145,4336,diagnosis,O
63146,4336,of,O
63147,4336,bipolar,B-Condition
63148,4336,and,O
63149,4336,other,O
63150,4336,related,B-Condition
63151,4336,disorders,I-Condition
63152,4336,",",O
63153,4336,schizophrenia,B-Condition
63154,4336,spectrum,I-Condition
63155,4336,",",O
63156,4336,or,O
63157,4336,other,O
63158,4336,psychotic,B-Condition
63159,4336,disorders,I-Condition
63160,4337,concomitant,O
63161,4337,treatments,B-Procedure
63162,4337,with,O
63163,4337,medication,B-Drug
63164,4337,known,O
63165,4337,to,O
63166,4337,have,O
63167,4337,drug,B-Condition
63168,4337,interactions,I-Condition
63169,4337,with,O
63170,4337,dronabinol,B-Drug
63171,4337,",",O
63172,4337,such,O
63173,4337,as,O
63174,4337,",",O
63175,4337,central,B-Drug
63176,4337,nervous,I-Drug
63177,4337,system,I-Drug
63178,4337,depressants,I-Drug
63179,4337,(,O
63180,4337,barbiturates,B-Drug
63181,4337,",",O
63182,4337,benzodiazepines,B-Drug
63183,4337,",",O
63184,4337,buspirone,B-Drug
63185,4337,",",O
63186,4337,lithium,B-Drug
63187,4337,",",O
63188,4337,etc,O
63189,4337,),O
63190,4337,and,O
63191,4337,anticholinergic,B-Drug
63192,4337,agents,I-Drug
63193,4337,(,O
63194,4337,atropine,B-Drug
63195,4337,",",O
63196,4337,scopolamine,B-Drug
63197,4337,",",O
63198,4337,antihistamines,B-Drug
63199,4337,",",O
63200,4337,etc,O
63201,4337,),O
63202,4337,.,O
63203,4338,Able,O
63204,4338,to,O
63205,4338,give,O
63206,4338,informed,O
63207,4338,consent,O
63208,4339,Right,B-Condition
63209,4339,-,I-Condition
63210,4339,handed,I-Condition
63211,4340,Age,B-Person
63212,4340,between,O
63213,4340,18,O
63214,4340,-,O
63215,4340,50,O
63216,4340,years,O
63217,4340,old,O
63218,4340,",",O
63219,4341,Physically,O
63220,4341,and,O
63221,4341,neurologically,B-Condition
63222,4341,healthy,I-Condition
63223,4341,[,O
63224,4341,confirmed,O
63225,4341,by,O
63226,4341,a,O
63227,4341,comprehensive,B-Procedure
63228,4341,medical,I-Procedure
63229,4341,history,I-Procedure
63230,4341,],O
63231,4342,Current,O
63232,4342,PTSD,B-Condition
63233,4342,diagnosis,O
63234,4343,Hypersensitivity,B-Condition
63235,4343,on,O
63236,4343,Colchicine,B-Drug
63237,4344,The,O
63238,4344,existence,O
63239,4344,of,O
63240,4344,intra,B-Condition
63241,4344,-,I-Condition
63242,4344,cardiac,I-Condition
63243,4344,thrombus,I-Condition
63244,4344,on,O
63245,4344,trans,B-Procedure
63246,4344,-,I-Procedure
63247,4344,esophageal,I-Procedure
63248,4344,echocardiography,I-Procedure
63249,4345,Pregnancy,B-Condition
63250,4346,Patients,O
63251,4346,needed,O
63252,4346,to,O
63253,4346,pericardiocentesis,B-Procedure
63254,4346,during,O
63255,4346,RFCA,B-Procedure
63256,4346,for,O
63257,4346,paroxysmal,O
63258,4346,or,O
63259,4346,persistent,O
63260,4346,atrial,B-Condition
63261,4346,fibrillation,I-Condition
63262,4346,.,O
63263,4347,Not,O
63264,4347,applicable,O
63265,4347,to,O
63266,4347,this,O
63267,4347,follow,O
63268,4347,up,O
63269,4347,study,O
63270,4348,Subject,O
63271,4348,was,O
63272,4348,previously,O
63273,4348,enrolled,O
63274,4348,in,O
63275,4348,a,O
63276,4348,selected,O
63277,4348,company,O
63278,4348,sponsored,O
63279,4348,feeder,O
63280,4348,trial,O
63281,4348,",",O
63282,4348,and,O
63283,4348,has,O
63284,4348,received,O
63285,4348,at,O
63286,4348,least,O
63287,4348,1,O
63288,4348,dose,O
63289,4348,of,O
63290,4348,radium,O
63291,4348,223,O
63292,4348,dichloride,O
63293,4348,or,O
63294,4348,placebo,O
63295,4348,in,O
63296,4348,the,O
63297,4348,feeder,O
63298,4348,trial,O
63299,4349,COPD,B-Condition
63300,4349,exacerbation,I-Condition
63301,4349,",",O
63302,4349,very,O
63303,4349,severe,O
63304,4349,COPD,B-Condition
63305,4349,with,O
63306,4349,hypoxemia,B-Condition
63307,4349,at,O
63308,4349,low,O
63309,4349,altitude,O
63310,4349,(,O
63311,4349,FEV1,O
63312,4349,/,O
63313,4349,FVC,O
63314,4349,<,O
63315,4349,0.7,O
63316,4349,",",O
63317,4349,FEV1,O
63318,4349,<,O
63319,4349,40,O
63320,4349,%,O
63321,4349,predicted,O
63322,4349,",",O
63323,4349,oxygen,O
63324,4349,saturation,O
63325,4349,on,O
63326,4349,room,O
63327,4349,air,O
63328,4349,<,O
63329,4349,92,O
63330,4349,%,O
63331,4349,at,O
63332,4349,750,O
63333,4349,m,O
63334,4349,),O
63335,4349,.,O
63336,4350,Comorbidities,B-Condition
63337,4350,such,O
63338,4350,as,O
63339,4350,uncontrolled,O
63340,4350,cardiovascular,B-Condition
63341,4350,disease,I-Condition
63342,4350,",",O
63343,4350,i.e.,O
63344,4350,",",O
63345,4350,unstable,O
63346,4350,systemic,B-Condition
63347,4350,arterial,I-Condition
63348,4350,hypertension,I-Condition
63349,4350,",",O
63350,4350,coronary,B-Condition
63351,4350,artery,I-Condition
63352,4350,disease,I-Condition
63353,4350,;,O
63354,4350,previous,O
63355,4350,stroke,B-Condition
63356,4350,;,O
63357,4350,OSA,B-Condition
63358,4350,;,O
63359,4350,pneumothorax,B-Condition
63360,4350,in,O
63361,4350,the,O
63362,4350,last,O
63363,4350,2,O
63364,4350,months,O
63365,4350,.,O
63366,4351,Internal,O
63367,4351,",",O
63368,4351,neurologic,O
63369,4351,",",O
63370,4351,rheumatologic,O
63371,4351,or,O
63372,4351,psychiatric,O
63373,4351,disease,B-Condition
63374,4351,including,O
63375,4351,current,O
63376,4351,heavy,O
63377,4351,smoking,B-Observation
63378,4351,(,O
63379,4351,>,O
63380,4351,20,O
63381,4351,cigarettes,O
63382,4351,per,O
63383,4351,day,O
63384,4351,),O
63385,4352,Known,O
63386,4352,renal,B-Condition
63387,4352,failure,I-Condition
63388,4352,or,O
63389,4352,allergy,B-Condition
63390,4352,to,O
63391,4352,acetazolamide,B-Drug
63392,4352,and,O
63393,4352,other,O
63394,4352,sulfonamides,B-Drug
63395,4353,Male,B-Person
63396,4353,and,O
63397,4353,female,B-Person
63398,4353,patients,O
63399,4353,",",O
63400,4353,age,B-Person
63401,4353,18,O
63402,4353,-,O
63403,4353,75,O
63404,4353,yrs,O
63405,4353,.,O
63406,4354,COPD,B-Condition
63407,4354,diagnosed,O
63408,4354,according,O
63409,4354,to,O
63410,4354,GOLD,O
63411,4354,",",O
63412,4354,FEV1,O
63413,4354,40,O
63414,4354,-,O
63415,4354,80,O
63416,4354,%,O
63417,4354,predicted,O
63418,4354,",",O
63419,4354,SpO2,O
63420,4354,=,O
63421,4354,92,O
63422,4354,%,O
63423,4354,at,O
63424,4354,750,O
63425,4354,m.,O
63426,4355,Born,O
63427,4355,",",O
63428,4355,raised,O
63429,4355,and,O
63430,4355,currently,O
63431,4355,living,B-Observation
63432,4355,at,I-Observation
63433,4355,low,I-Observation
63434,4355,altitude,I-Observation
63435,4355,(,O
63436,4355,<,O
63437,4355,800,O
63438,4355,m,O
63439,4355,),O
63440,4355,.,O
63441,4356,Written,O
63442,4356,informed,O
63443,4356,consent,O
63444,4356,.,O
63445,4357,Patients,O
63446,4357,posing,O
63447,4357,a,O
63448,4357,serious,O
63449,4357,suicidal,B-Observation
63450,4357,risk,I-Observation
63451,4357,and/or,O
63452,4357,violence,B-Observation
63453,4357,as,O
63454,4357,judged,O
63455,4357,by,O
63456,4357,the,O
63457,4357,investigator,O
63458,4357,;,O
63459,4358,Delirium,B-Condition
63460,4359,Dementia,B-Condition
63461,4360,Amnestic,B-Condition
63462,4360,and,I-Condition
63463,4360,other,I-Condition
63464,4360,cognitive,I-Condition
63465,4360,disorder,I-Condition
63466,4360,;,O
63467,4361,Patients,O
63468,4361,with,O
63469,4361,a,O
63470,4361,history,O
63471,4361,of,O
63472,4361,hypothyroidism,B-Condition
63473,4361,unless,O
63474,4361,taking,O
63475,4361,a,O
63476,4361,stable,O
63477,4361,dose,O
63478,4361,of,O
63479,4361,thyroid,B-Drug
63480,4361,medication,I-Drug
63481,4361,and,O
63482,4361,asymptomatic,O
63483,4361,or,O
63484,4361,euthyroid,O
63485,4361,for,O
63486,4361,6,O
63487,4361,months,O
63488,4361,;,O
63489,4362,Patients,O
63490,4362,who,O
63491,4362,meet,O
63492,4362,DSM,O
63493,4362,-,O
63494,4362,IV,O
63495,4362,-,O
63496,4362,TR,O
63497,4362,criteria,O
63498,4362,for,O
63499,4362,any,O
63500,4362,significant,O
63501,4362,current,O
63502,4362,substance,B-Condition
63503,4362,abuse,I-Condition
63504,4362,;,O
63505,4363,hepatic,B-Condition
63506,4363,insufficiency,I-Condition
63507,4363,(,O
63508,4363,three,O
63509,4363,times,O
63510,4363,the,O
63511,4363,upper,O
63512,4363,limit,O
63513,4363,of,O
63514,4363,normal,O
63515,4363,(,O
63516,4363,ULN,O
63517,4363,),O
63518,4363,for,O
63519,4363,aspartate,O
63520,4363,aminotransferase,O
63521,4363,(,O
63522,4363,AST,O
63523,4363,),O
63524,4363,and/or,O
63525,4363,alanine,O
63526,4363,aminotransferase,O
63527,4363,(,O
63528,4363,ALT,O
63529,4363,),O
63530,4363,),O
63531,4363,;,O
63532,4363,liver,B-Procedure
63533,4363,transplant,I-Procedure
63534,4363,recipient,O
63535,4363,;,O
63536,4363,cirrhosis,B-Condition
63537,4363,of,I-Condition
63538,4363,the,I-Condition
63539,4363,liver,I-Condition
63540,4363,;,O
63541,4364,malignancy,B-Condition
63542,4364,(,O
63543,4364,except,O
63544,4364,basal,B-Condition
63545,4364,cell,I-Condition
63546,4364,carcinoma,I-Condition
63547,4364,),O
63548,4364,and/or,O
63549,4364,chemotherapy,B-Procedure
63550,4364,within,O
63551,4364,1,O
63552,4364,year,O
63553,4364,prior,O
63554,4364,to,O
63555,4364,screening,O
63556,4364,;,O
63557,4364,malignancy,B-Condition
63558,4364,more,O
63559,4364,than,O
63560,4364,1,O
63561,4364,year,O
63562,4364,prior,O
63563,4364,to,O
63564,4364,screening,O
63565,4364,must,O
63566,4364,have,O
63567,4364,been,O
63568,4364,local,O
63569,4364,and,O
63570,4364,without,O
63571,4364,metastasis,B-Condition
63572,4364,and/or,O
63573,4364,recurrence,B-Condition
63574,4364,",",O
63575,4364,and,O
63576,4364,if,O
63577,4364,treated,O
63578,4364,with,O
63579,4364,chemotherapy,O
63580,4364,",",O
63581,4364,without,O
63582,4364,nervous,O
63583,4364,system,O
63584,4364,complications,O
63585,4364,;,O
63586,4365,significant,O
63587,4365,unstable,O
63588,4365,medical,B-Condition
63589,4365,condition,I-Condition
63590,4365,or,O
63591,4365,life,B-Condition
63592,4365,threatening,I-Condition
63593,4365,disease,I-Condition
63594,4365,with,O
63595,4365,anticipated,B-Observation
63596,4365,survival,I-Observation
63597,4365,of,O
63598,4365,less,O
63599,4365,than,O
63600,4365,6,O
63601,4365,months,O
63602,4365,;,O
63603,4366,need,O
63604,4366,for,O
63605,4366,therapies,O
63606,4366,that,O
63607,4366,may,O
63608,4366,obscure,O
63609,4366,the,O
63610,4366,results,O
63611,4366,of,O
63612,4366,treatment,O
63613,4366,and/or,O
63614,4366,of,O
63615,4366,the,O
63616,4366,study,O
63617,4367,Participation,O
63618,4367,in,O
63619,4367,another,O
63620,4367,clinical,O
63621,4367,trial,O
63622,4367,within,O
63623,4367,30,O
63624,4367,days,O
63625,4367,of,O
63626,4367,the,O
63627,4367,screening,O
63628,4367,visit,O
63629,4367,;,O
63630,4368,Anticipated,O
63631,4368,inability,O
63632,4368,to,O
63633,4368,attend,O
63634,4368,scheduled,O
63635,4368,study,O
63636,4368,visits,O
63637,4368,;,O
63638,4369,Patients,O
63639,4369,who,O
63640,4369,in,O
63641,4369,the,O
63642,4369,judgment,O
63643,4369,of,O
63644,4369,the,O
63645,4369,Investigator,O
63646,4369,may,O
63647,4369,be,O
63648,4369,unreliable,O
63649,4369,or,O
63650,4369,uncooperative,O
63651,4369,with,O
63652,4369,the,O
63653,4369,evaluation,O
63654,4369,procedure,O
63655,4369,outlined,O
63656,4369,in,O
63657,4369,this,O
63658,4369,protocol,O
63659,4369,;,O
63660,4370,Patients,O
63661,4370,with,O
63662,4370,a,O
63663,4370,history,O
63664,4370,of,O
63665,4370,prior,O
63666,4370,pharmacogenomic,O
63667,4370,testing,O
63668,4370,;,O
63669,4371,Any,O
63670,4371,change,O
63671,4371,in,O
63672,4371,psychotropic,B-Procedure
63673,4371,medication,I-Procedure
63674,4371,(,O
63675,4371,including,O
63676,4371,change,O
63677,4371,in,O
63678,4371,dosage,O
63679,4371,),O
63680,4371,between,O
63681,4371,screening,O
63682,4371,and,O
63683,4371,baseline,O
63684,4371,;,O
63685,4372,Patients,O
63686,4372,who,O
63687,4372,are,O
63688,4372,known,O
63689,4372,to,O
63690,4372,be,O
63691,4372,pregnant,O
63692,4372,or,O
63693,4372,lactating,O
63694,4372,;,O
63695,4373,Patients,O
63696,4373,with,O
63697,4373,a,O
63698,4373,history,O
63699,4373,of,O
63700,4373,gastric,B-Procedure
63701,4373,bypass,I-Procedure
63702,4373,surgery,I-Procedure
63703,4373,.,O
63704,4374,18,O
63705,4374,years,O
63706,4374,of,O
63707,4374,age,B-Person
63708,4374,or,O
63709,4374,older,O
63710,4374,;,O
63711,4375,Suffer,O
63712,4375,from,O
63713,4375,schizophrenia,B-Condition
63714,4375,/,O
63715,4375,schizoaffective,B-Condition
63716,4375,disorder,I-Condition
63717,4375,meeting,O
63718,4375,Diagnostic,O
63719,4375,and,O
63720,4375,Statistical,O
63721,4375,Manual,O
63722,4375,of,O
63723,4375,Mental,O
63724,4375,Disorders,O
63725,4375,",",O
63726,4375,Fourth,O
63727,4375,Edition,O
63728,4375,",",O
63729,4375,Text,O
63730,4375,Revision,O
63731,4375,(,O
63732,4375,DSM,O
63733,4375,-,O
63734,4375,IV,O
63735,4375,-,O
63736,4375,TR,O
63737,4375,),O
63738,4375,criteria,O
63739,4375,;,O
63740,4376,Have,O
63741,4376,a,O
63742,4376,total,O
63743,4376,baseline,O
63744,4376,score,O
63745,4376,on,O
63746,4376,the,O
63747,4376,Brief,O
63748,4376,Psychiatric,O
63749,4376,Rating,O
63750,4376,Scale,O
63751,4376,(,O
63752,4376,BPRS,O
63753,4376,),O
63754,4376,=,O
63755,4376,45,O
63756,4376,;,O
63757,4377,Be,O
63758,4377,capable,O
63759,4377,and,O
63760,4377,willing,O
63761,4377,to,O
63762,4377,provide,O
63763,4377,written,O
63764,4377,informed,O
63765,4377,consent,O
63766,4377,to,O
63767,4377,participate,O
63768,4377,in,O
63769,4377,this,O
63770,4377,study,O
63771,4377,;,O
63772,4378,Agree,O
63773,4378,to,O
63774,4378,abide,O
63775,4378,by,O
63776,4378,the,O
63777,4378,study,O
63778,4378,protocol,O
63779,4378,and,O
63780,4378,its,O
63781,4378,restrictions,O
63782,4378,and,O
63783,4378,be,O
63784,4378,able,O
63785,4378,to,O
63786,4378,complete,O
63787,4378,all,O
63788,4378,aspects,O
63789,4378,of,O
63790,4378,the,O
63791,4378,study,O
63792,4378,",",O
63793,4378,including,O
63794,4378,all,O
63795,4378,visits,O
63796,4378,and,O
63797,4378,tests,O
63798,4379,Have,O
63799,4379,history,O
63800,4379,of,O
63801,4379,female,B-Procedure
63802,4379,sterilization,I-Procedure
63803,4379,procedure,I-Procedure
63804,4380,Desire,B-Mood
63805,4380,for,O
63806,4380,conception,B-Observation
63807,4380,in,O
63808,4380,the,O
63809,4380,next,O
63810,4380,12,O
63811,4380,months,O
63812,4381,Not,O
63813,4381,sexually,B-Observation
63814,4381,active,I-Observation
63815,4381,with,O
63816,4381,a,O
63817,4381,male,O
63818,4381,partner,O
63819,4382,Women,B-Person
63820,4382,age,B-Person
63821,4382,18,O
63822,4382,-,O
63823,4382,45,O
63824,4383,Within,O
63825,4383,6,O
63826,4383,months,O
63827,4383,of,O
63828,4383,expiration,O
63829,4383,or,O
63830,4383,beyond,O
63831,4383,the,O
63832,4383,end,O
63833,4383,of,O
63834,4383,the,O
63835,4383,FDA,O
63836,4383,-,O
63837,4383,approved,O
63838,4383,duration,O
63839,4383,of,O
63840,4383,use,O
63841,4383,of,O
63842,4383,the,O
63843,4383,levonorgestrel,O
63844,4383,intrauterine,O
63845,4383,device,O
63846,4383,(,O
63847,4383,LNG,O
63848,4383,-,O
63849,4383,IUD,O
63850,4383,=,O
63851,4383,5,O
63852,4383,years,O
63853,4383,),O
63854,4383,OR,O
63855,4383,the,O
63856,4383,etonogestrel,O
63857,4383,-,O
63858,4383,releasing,O
63859,4383,subdermal,O
63860,4383,implant,O
63861,4383,(,O
63862,4383,ENG,O
63863,4383,implant,O
63864,4383,=,O
63865,4383,3,O
63866,4383,years,O
63867,4383,),O
63868,4384,Able,O
63869,4384,to,O
63870,4384,consent,O
63871,4384,in,O
63872,4384,English,O
63873,4384,or,O
63874,4384,Spanish,O
63875,4384,.,O
63876,4385,Not,O
63877,4385,pregnant,B-Condition
63878,4385,at,O
63879,4385,the,O
63880,4385,time,O
63881,4385,of,O
63882,4385,enrollment,O
63883,4386,Can,O
63884,4386,not,O
63885,4386,cooperate,B-Observation
63886,4386,with,I-Observation
63887,4386,the,I-Observation
63888,4386,treatment,I-Observation
63889,4387,Can,O
63890,4387,not,O
63891,4387,obtain,O
63892,4387,the,O
63893,4387,child,B-Observation
63894,4387,'s,I-Observation
63895,4387,parental,I-Observation
63896,4387,consent,I-Observation
63897,4388,generally,B-Condition
63898,4388,healthy,I-Condition
63899,4388,grade,B-Observation
63900,4388,1,I-Observation
63901,4388,-,I-Observation
63902,4388,2,I-Observation
63903,4388,school,I-Observation
63904,4388,children,B-Person
63905,4389,with,O
63906,4389,written,O
63907,4389,parental,O
63908,4389,consent,O
63909,4390,with,O
63910,4390,at,O
63911,4390,least,O
63912,4390,1,O
63913,4390,sound,O
63914,4390,and,O
63915,4390,fully,O
63916,4390,erupted,O
63917,4390,permanent,B-Condition
63918,4390,first,I-Condition
63919,4390,molar,I-Condition
63920,4391,latex,B-Drug
63921,4391,allergy,B-Condition
63922,4392,non,O
63923,4392,-,O
63924,4392,reassuring,O
63925,4392,fetal,B-Condition
63926,4392,status,I-Condition
63927,4393,HIV,B-Condition
63928,4394,active,O
63929,4394,herpes,B-Condition
63930,4394,outbreak,O
63931,4395,Prior,O
63932,4395,uterine,B-Condition
63933,4395,scar,I-Condition
63934,4396,Contraindication,B-Condition
63935,4396,to,O
63936,4396,prostaglandins,B-Drug
63937,4396,according,O
63938,4396,to,O
63939,4396,current,O
63940,4396,Parkland,B-Procedure
63941,4396,protocol,I-Procedure
63942,4397,Contraindication,B-Condition
63943,4397,to,O
63944,4397,vaginal,B-Procedure
63945,4397,delivery,I-Procedure
63946,4398,37,O
63947,4398,weeks,O
63948,4398,gestation,B-Condition
63949,4398,or,O
63950,4398,greater,O
63951,4399,Living,O
63952,4399,",",O
63953,4399,singleton,B-Condition
63954,4399,fetus,I-Condition
63955,4400,No,O
63956,4400,major,B-Condition
63957,4400,fetal,I-Condition
63958,4400,malformations,I-Condition
63959,4401,Cephalic,B-Condition
63960,4401,presentation,I-Condition
63961,4402,No,O
63962,4402,prior,O
63963,4402,uterine,B-Condition
63964,4402,scar,I-Condition
63965,4403,Intact,O
63966,4403,fetal,B-Condition
63967,4403,membranes,I-Condition
63968,4404,Qualifies,O
63969,4404,for,O
63970,4404,prostaglandin,B-Procedure
63971,4404,administration,I-Procedure
63972,4404,according,O
63973,4404,to,O
63974,4404,current,O
63975,4404,Parkland,B-Procedure
63976,4404,protocol,I-Procedure
63977,4405,Have,O
63978,4405,a,O
63979,4405,cervical,B-Condition
63980,4405,dilation,I-Condition
63981,4405,of,O
63982,4405,2,O
63983,4405,centimeters,O
63984,4405,or,O
63985,4405,less,O
63986,4405,",",O
63987,4405,measured,O
63988,4405,at,O
63989,4405,the,O
63990,4405,level,O
63991,4405,of,O
63992,4405,the,O
63993,4405,internal,O
63994,4405,os,O
63995,4406,Have,O
63996,4406,an,O
63997,4406,indication,B-Condition
63998,4406,for,O
63999,4406,induction,B-Procedure
64000,4406,or,I-Procedure
64001,4406,attempted,I-Procedure
64002,4406,induction,I-Procedure
64003,4406,of,I-Procedure
64004,4406,labor,I-Procedure
64005,4406,according,O
64006,4406,to,O
64007,4406,Parkland,B-Procedure
64008,4406,protocol,I-Procedure
64009,4407,Organic,B-Condition
64010,4407,diseases,I-Condition
64011,4407,of,O
64012,4407,the,O
64013,4407,digestive,O
64014,4407,system,O
64015,4407,(,O
64016,4407,gastro,B-Condition
64017,4407,-,I-Condition
64018,4407,oesophageal,I-Condition
64019,4407,reflux,I-Condition
64020,4407,disease,I-Condition
64021,4407,(,I-Condition
64022,4407,GERD,I-Condition
64023,4407,),I-Condition
64024,4407,",",O
64025,4407,ulcer,B-Condition
64026,4407,",",O
64027,4407,chronic,B-Condition
64028,4407,pancreatitis,I-Condition
64029,4407,",",O
64030,4407,cholelithiasis,B-Condition
64031,4407,",",O
64032,4407,fatty,B-Condition
64033,4407,liver,I-Condition
64034,4407,disease,I-Condition
64035,4407,",",O
64036,4407,hepatitis,B-Condition
64037,4407,",",O
64038,4407,cirrhosis,B-Condition
64039,4407,of,I-Condition
64040,4407,liver,I-Condition
64041,4407,",",O
64042,4407,etc,O
64043,4407,.,O
64044,4407,),O
64045,4407,.,O
64046,4408,Diagnosis,O
64047,4408,of,O
64048,4408,other,O
64049,4408,functional,B-Condition
64050,4408,diseases,I-Condition
64051,4408,of,O
64052,4408,the,O
64053,4408,digestive,O
64054,4408,system,O
64055,4408,",",O
64056,4408,such,O
64057,4408,as,O
64058,4408,dyskinesia,B-Condition
64059,4408,of,I-Condition
64060,4408,cystic,I-Condition
64061,4408,duct,I-Condition
64062,4408,or,I-Condition
64063,4408,gallbladder,I-Condition
64064,4408,",",O
64065,4408,irritable,B-Condition
64066,4408,bowel,I-Condition
64067,4408,syndrome,I-Condition
64068,4408,",",O
64069,4408,etc,O
64070,4408,.,O
64071,4409,Discontinuation,B-Observation
64072,4409,of,O
64073,4409,proton,B-Drug
64074,4409,pump,I-Drug
64075,4409,inhibitors,I-Drug
64076,4409,",",O
64077,4409,propulsives,B-Drug
64078,4409,",",O
64079,4409,antispasmodics,B-Drug
64080,4409,",",O
64081,4409,antacids,B-Drug
64082,4409,",",O
64083,4409,or,O
64084,4409,bismuth,B-Drug
64085,4409,preparations,I-Drug
64086,4409,less,O
64087,4409,than,O
64088,4409,7,O
64089,4409,days,O
64090,4409,prior,O
64091,4409,to,O
64092,4409,randomization,O
64093,4409,.,O
64094,4410,H.,B-Procedure
64095,4410,Pylori,I-Procedure
64096,4410,eradication,I-Procedure
64097,4410,within,O
64098,4410,2,O
64099,4410,months,O
64100,4410,before,O
64101,4410,study,O
64102,4410,entry,O
64103,4410,.,O
64104,4411,Intestinal,B-Condition
64105,4411,infection,I-Condition
64106,4411,within,O
64107,4411,2,O
64108,4411,months,O
64109,4411,before,O
64110,4411,study,O
64111,4411,entry,O
64112,4411,.,O
64113,4412,Known,O
64114,4412,history,B-Observation
64115,4412,of,I-Observation
64116,4412,/,O
64117,4412,suspected,B-Mood
64118,4412,malignant,B-Condition
64119,4412,neoplasm,I-Condition
64120,4412,of,O
64121,4412,various,O
64122,4412,sites,O
64123,4412,.,O
64124,4413,Prior,O
64125,4413,diagnosis,O
64126,4413,of,O
64127,4413,a,O
64128,4413,class,O
64129,4413,IV,O
64130,4413,cardiovascular,B-Condition
64131,4413,disease,I-Condition
64132,4413,(,O
64133,4413,according,O
64134,4413,to,O
64135,4413,the,O
64136,4413,New,O
64137,4413,York,O
64138,4413,Heart,O
64139,4413,Association,O
64140,4413,",",O
64141,4413,1964,O
64142,4413,),O
64143,4413,",",O
64144,4413,hypothyroidism,B-Condition
64145,4413,",",O
64146,4413,diabetes,B-Condition
64147,4413,mellitus,I-Condition
64148,4413,",",O
64149,4413,chronic,B-Condition
64150,4413,kidney,I-Condition
64151,4413,disease,I-Condition
64152,4413,(,O
64153,4413,С3,O
64154,4413,-,O
64155,4413,5,O
64156,4413,),O
64157,4413,",",O
64158,4413,or,O
64159,4413,disease,B-Condition
64160,4413,of,I-Condition
64161,4413,liver,I-Condition
64162,4413,with,O
64163,4413,portal,B-Condition
64164,4413,hypertension,I-Condition
64165,4413,and/or,O
64166,4413,severe,B-Condition
64167,4413,decompensation,I-Condition
64168,4413,(,O
64169,4413,Child,O
64170,4413,-,O
64171,4413,Pugh,O
64172,4413,score,O
64173,4413,>,O
64174,4413,6,O
64175,4413,),O
64176,4413,.,O
64177,4414,Other,O
64178,4414,severe,O
64179,4414,coexisting,O
64180,4414,morbidity,B-Condition
64181,4414,which,O
64182,4414,",",O
64183,4414,in,O
64184,4414,the,O
64185,4414,investigator,O
64186,4414,'s,O
64187,4414,opinion,O
64188,4414,",",O
64189,4414,can,O
64190,4414,prevent,O
64191,4414,the,O
64192,4414,patient,O
64193,4414,from,O
64194,4414,participating,O
64195,4414,in,O
64196,4414,the,O
64197,4414,study,O
64198,4414,.,O
64199,4415,Allergy,B-Condition
64200,4415,/,O
64201,4415,intolerance,B-Condition
64202,4415,to,O
64203,4415,any,O
64204,4415,of,O
64205,4415,the,O
64206,4415,components,B-Drug
64207,4415,of,I-Drug
64208,4415,medications,I-Drug
64209,4415,used,I-Drug
64210,4415,in,I-Drug
64211,4415,the,I-Drug
64212,4415,treatment,I-Drug
64213,4415,.,O
64214,4416,Pregnancy,B-Condition
64215,4416,",",O
64216,4416,breast,B-Observation
64217,4416,-,I-Observation
64218,4416,feeding,I-Observation
64219,4416,.,O
64220,4417,Patients,O
64221,4417,who,O
64222,4417,",",O
64223,4417,from,O
64224,4417,investigator,O
64225,4417,'s,O
64226,4417,point,O
64227,4417,of,O
64228,4417,view,O
64229,4417,",",O
64230,4417,will,O
64231,4417,fail,O
64232,4417,to,O
64233,4417,comply,O
64234,4417,with,O
64235,4417,the,O
64236,4417,observation,O
64237,4417,requirements,O
64238,4417,of,O
64239,4417,the,O
64240,4417,trial,O
64241,4417,or,O
64242,4417,with,O
64243,4417,the,O
64244,4417,dosing,O
64245,4417,regimen,O
64246,4417,of,O
64247,4417,the,O
64248,4417,investigational,O
64249,4417,drugs,O
64250,4417,.,O
64251,4418,Planned,B-Mood
64252,4418,hospitalization,B-Procedure
64253,4418,during,O
64254,4418,the,O
64255,4418,study,O
64256,4418,period,O
64257,4418,",",O
64258,4418,for,O
64259,4418,any,O
64260,4418,diagnostic,B-Procedure
64261,4418,or,I-Procedure
64262,4418,treatment,I-Procedure
64263,4418,procedures,I-Procedure
64264,4418,.,O
64265,4419,Drug,B-Condition
64266,4419,addiction,I-Condition
64267,4419,",",O
64268,4419,alcohol,O
64269,4419,use,O
64270,4419,in,O
64271,4419,the,O
64272,4419,amount,O
64273,4419,over,O
64274,4419,2,O
64275,4419,units,O
64276,4419,of,O
64277,4419,alcohol,O
64278,4419,a,O
64279,4419,day,O
64280,4419,",",O
64281,4419,mental,B-Condition
64282,4419,diseases,I-Condition
64283,4419,.,O
64284,4420,Intake,O
64285,4420,of,O
64286,4420,medicines,B-Drug
64287,4420,listed,O
64288,4420,in,O
64289,4420,the,O
64290,4420,section,O
64291,4420,',O
64292,4420,Prohibited,O
64293,4420,concomitant,O
64294,4420,treatment,O
64295,4420,',O
64296,4420,for,O
64297,4420,1,O
64298,4420,month,O
64299,4420,prior,O
64300,4420,to,O
64301,4420,the,O
64302,4420,enrollment,O
64303,4420,in,O
64304,4420,the,O
64305,4420,trial,O
64306,4420,.,O
64307,4421,Participation,O
64308,4421,in,O
64309,4421,other,O
64310,4421,clinical,O
64311,4421,trials,O
64312,4421,within,O
64313,4421,3,O
64314,4421,months,O
64315,4421,to,O
64316,4421,the,O
64317,4421,enrollment,O
64318,4421,in,O
64319,4421,this,O
64320,4421,study,O
64321,4421,.,O
64322,4422,Patient,O
64323,4422,is,O
64324,4422,related,O
64325,4422,to,O
64326,4422,the,O
64327,4422,research,O
64328,4422,staff,O
64329,4422,of,O
64330,4422,the,O
64331,4422,clinical,O
64332,4422,investigative,O
64333,4422,site,O
64334,4422,who,O
64335,4422,are,O
64336,4422,directly,O
64337,4422,involved,O
64338,4422,in,O
64339,4422,the,O
64340,4422,trial,O
64341,4422,or,O
64342,4422,is,O
64343,4422,the,O
64344,4422,immediate,O
64345,4422,family,O
64346,4422,member,O
64347,4422,of,O
64348,4422,the,O
64349,4422,investigator,O
64350,4422,.,O
64351,4422,The,O
64352,4422,immediate,O
64353,4422,family,O
64354,4422,members,O
64355,4422,include,O
64356,4422,husband,O
64357,4422,/,O
64358,4422,wife,O
64359,4422,",",O
64360,4422,parents,O
64361,4422,",",O
64362,4422,children,O
64363,4422,or,O
64364,4422,brothers,O
64365,4422,(,O
64366,4422,or,O
64367,4422,sisters,O
64368,4422,),O
64369,4422,",",O
64370,4422,regardless,O
64371,4422,of,O
64372,4422,whether,O
64373,4422,they,O
64374,4422,are,O
64375,4422,natural,O
64376,4422,or,O
64377,4422,adopted,O
64378,4422,.,O
64379,4423,Patient,O
64380,4423,works,B-Person
64381,4423,for,I-Person
64382,4423,OOO,I-Person
64383,4423,"""",I-Person
64384,4423,NPF,I-Person
64385,4423,"""",I-Person
64386,4423,MATERIA,I-Person
64387,4423,MEDICA,I-Person
64388,4423,HOLDING,I-Person
64389,4423,"""",I-Person
64390,4423,(,O
64391,4423,i.e.,O
64392,4423,",",O
64393,4423,is,O
64394,4423,the,O
64395,4423,company,B-Person
64396,4423,'s,I-Person
64397,4423,employee,I-Person
64398,4423,",",O
64399,4423,temporary,B-Person
64400,4423,contract,I-Person
64401,4423,worker,I-Person
64402,4423,or,O
64403,4423,appointed,B-Person
64404,4423,official,I-Person
64405,4423,responsible,B-Observation
64406,4423,for,I-Observation
64407,4423,carrying,I-Observation
64408,4423,out,I-Observation
64409,4423,the,I-Observation
64410,4423,research,I-Observation
64411,4423,or,I-Observation
64412,4423,their,I-Observation
64413,4423,immediate,I-Observation
64414,4423,family,I-Observation
64415,4423,),O
64416,4423,.,O
64417,4424,Men,B-Person
64418,4424,and,O
64419,4424,women,B-Person
64420,4424,aged,B-Person
64421,4424,18,O
64422,4424,-,O
64423,4424,45,O
64424,4424,years,O
64425,4424,.,O
64426,4425,Diagnosis,O
64427,4425,of,O
64428,4425,functional,B-Condition
64429,4425,dyspepsia,I-Condition
64430,4425,",",O
64431,4425,based,O
64432,4425,on,O
64433,4425,the,O
64434,4425,Rome,O
64435,4425,IV,O
64436,4425,criteria,O
64437,4425,(,O
64438,4425,2016,O
64439,4425,),O
64440,4425,.,O
64441,4426,GIS,O
64442,4426,score,O
64443,4426,of,O
64444,4426,at,O
64445,4426,least,O
64446,4426,6,O
64447,4426,.,O
64448,4427,Negative,O
64449,4427,H.,O
64450,4427,pylori,O
64451,4427,test,O
64452,4427,.,O
64453,4428,Availability,O
64454,4428,of,O
64455,4428,a,O
64456,4428,signed,O
64457,4428,patient,O
64458,4428,information,O
64459,4428,sheet,O
64460,4428,(,O
64461,4428,Informed,O
64462,4428,Consent,O
64463,4428,form,O
64464,4428,),O
64465,4428,for,O
64466,4428,participation,O
64467,4428,in,O
64468,4428,the,O
64469,4428,clinical,O
64470,4428,trial,O
64471,4428,.,O
64472,4429,Patients,O
64473,4429,who,O
64474,4429,agree,O
64475,4429,to,O
64476,4429,use,O
64477,4429,an,O
64478,4429,effective,O
64479,4429,method,O
64480,4429,of,O
64481,4429,contraception,O
64482,4429,throughout,O
64483,4429,the,O
64484,4429,clinical,O
64485,4429,trial,O
64486,4429,.,O
64487,4430,Preexisting,O
64488,4430,untreated,O
64489,4430,medical,B-Condition
64490,4430,condition,I-Condition
64491,4430,(,O
64492,4430,thyroid,B-Condition
64493,4430,disease,I-Condition
64494,4430,",",O
64495,4430,diabetes,B-Condition
64496,4430,mellitus,I-Condition
64497,4430,",",O
64498,4430,hypertension,B-Condition
64499,4430,",",O
64500,4430,pulmonary,B-Condition
64501,4430,conditions,I-Condition
64502,4430,",",O
64503,4430,cardiac,B-Condition
64504,4430,condition,I-Condition
64505,4430,…,O
64506,4430,),O
64507,4431,History,O
64508,4431,of,O
64509,4431,three,O
64510,4431,or,O
64511,4431,more,O
64512,4431,consecutively,O
64513,4431,failed,O
64514,4431,In,B-Procedure
64515,4431,Vitro,I-Procedure
64516,4431,Fertilization,I-Procedure
64517,4431,(,O
64518,4431,IVF,B-Procedure
64519,4431,),O
64520,4431,cycles,O
64521,4431,after,O
64522,4431,embryo,B-Procedure
64523,4431,transfer,I-Procedure
64524,4432,History,O
64525,4432,of,O
64526,4432,three,O
64527,4432,or,O
64528,4432,more,O
64529,4432,miscarriages,B-Condition
64530,4433,Previous,O
64531,4433,allergy,B-Condition
64532,4433,reactions,O
64533,4433,to,O
64534,4433,progesterone,B-Drug
64535,4433,products,I-Drug
64536,4434,Normal,O
64537,4434,uterine,B-Condition
64538,4434,cavity,I-Condition
64539,4435,Normal,O
64540,4435,Hormonal,O
64541,4435,investigation,O
64542,4435,:,O
64543,4435,TSH,O
64544,4435,",",O
64545,4435,PRL,O
64546,4435,",",O
64547,4435,FBS,O
64548,4436,Frozen,B-Procedure
64549,4436,embryo,I-Procedure
64550,4436,transfer,I-Procedure
64551,4436,cycles,I-Procedure
64552,4436,:,O
64553,4436,at,O
64554,4436,least,O
64555,4436,2,O
64556,4436,embryos,B-Condition
64557,4437,Primary,B-Condition
64558,4437,or,I-Condition
64559,4437,secondary,I-Condition
64560,4437,infertility,I-Condition
64561,4437,:,O
64562,4437,tubal,B-Condition
64563,4437,occlusion,I-Condition
64564,4437,",",O
64565,4437,male,B-Observation
64566,4437,factor,I-Observation
64567,4437,",",O
64568,4437,unexplained,B-Observation
64569,4437,",",I-Observation
64570,4437,endometriosis,I-Observation
64571,4437,",",I-Observation
64572,4437,ovarian,I-Observation
64573,4437,factors,I-Observation
64574,4437,…,O
64575,4438,Body,O
64576,4438,mass,O
64577,4438,index,O
64578,4438,(,O
64579,4438,BMI,O
64580,4438,),O
64581,4438,=,O
64582,4438,18,O
64583,4438,to,O
64584,4438,=,O
64585,4438,30,O
64586,4438,kg,O
64587,4438,/,O
64588,4438,m2,O
64589,4439,recent,O
64590,4439,thrombotic,B-Condition
64591,4439,event,I-Condition
64592,4440,LVAD,B-Condition
64593,4440,on,O
64594,4440,warfarin,B-Drug
64595,4440,requiring,O
64596,4440,temporary,O
64597,4440,interruption,O
64598,4440,of,O
64599,4440,anticoagulation,O
64600,4440,for,O
64601,4440,procedures,O
64602,4441,rearthroplasty,B-Procedure
64603,4442,ASA,O
64604,4442,IV,O
64605,4442,-,O
64606,4442,V,O
64607,4443,inadequate,B-Observation
64608,4443,spoken,I-Observation
64609,4443,finnish,I-Observation
64610,4443,for,O
64611,4443,reliable,B-Procedure
64612,4443,pain,I-Procedure
64613,4443,assessment,I-Procedure
64614,4444,Dementia,B-Condition
64615,4444,or,O
64616,4444,otherwise,O
64617,4444,impaired,B-Condition
64618,4444,cognition,I-Condition
64619,4445,contraindication,B-Condition
64620,4445,for,O
64621,4445,any,O
64622,4445,medication,B-Drug
64623,4445,or,I-Drug
64624,4445,substance,I-Drug
64625,4445,used,I-Drug
64626,4445,in,I-Drug
64627,4445,survey,I-Drug
64628,4445,protocol,I-Drug
64629,4446,weight,O
64630,4446,<,O
64631,4446,50,O
64632,4446,kg,O
64633,4446,or,O
64634,4446,BMI,O
64635,4446,=,O
64636,4446,35,O
64637,4446,kg,O
64638,4446,/,O
64639,4446,m2,O
64640,4447,preoperative,O
64641,4447,SpO2,O
64642,4447,less,O
64643,4447,than,O
64644,4447,93,O
64645,4447,%,O
64646,4448,clinical,B-Mood
64647,4448,suspicion,I-Mood
64648,4448,that,O
64649,4448,subject,B-Observation
64650,4448,can,I-Observation
64651,4448,not,I-Observation
64652,4448,use,I-Observation
64653,4448,PCA,I-Observation
64654,4448,adequately,I-Observation
64655,4449,history,B-Observation
64656,4449,of,O
64657,4449,substance,B-Condition
64658,4449,abuse,I-Condition
64659,4449,or,O
64660,4449,current,O
64661,4449,excessive,B-Condition
64662,4449,use,I-Condition
64663,4449,of,I-Condition
64664,4449,alcohol,I-Condition
64665,4450,preoperative,O
64666,4450,use,O
64667,4450,of,O
64668,4450,either,O
64669,4450,pregabalin,B-Drug
64670,4450,",",O
64671,4450,gabapentin,B-Drug
64672,4450,or,O
64673,4450,strong,B-Drug
64674,4450,opiates,I-Drug
64675,4451,elective,O
64676,4451,primary,O
64677,4451,total,B-Procedure
64678,4451,knee,I-Procedure
64679,4451,arthroplasty,I-Procedure
64680,4452,ASA,O
64681,4452,I,O
64682,4452,-,O
64683,4452,III,O
64684,4453,written,O
64685,4453,consent,O
64686,4454,1,O
64687,4454,.,O
64688,4454,Congestive,B-Condition
64689,4454,heart,I-Condition
64690,4454,failure,I-Condition
64691,4454,;,O
64692,4455,2,O
64693,4455,.,O
64694,4455,CABG,B-Procedure
64695,4455,or,O
64696,4455,Percutaneous,B-Procedure
64697,4455,Coronary,I-Procedure
64698,4455,Intervention,I-Procedure
64699,4455,(,I-Procedure
64700,4455,PCI,I-Procedure
64701,4455,),I-Procedure
64702,4455,procedure,O
64703,4455,;,O
64704,4456,3,O
64705,4456,.,O
64706,4456,Planned,O
64707,4456,need,O
64708,4456,for,O
64709,4456,major,B-Procedure
64710,4456,surgery,I-Procedure
64711,4456,(,O
64712,4456,e.g.,O
64713,4456,valve,B-Procedure
64714,4456,surgery,I-Procedure
64715,4456,or,O
64716,4456,resection,B-Procedure
64717,4456,of,I-Procedure
64718,4456,aortic,I-Procedure
64719,4456,or,I-Procedure
64720,4456,left,I-Procedure
64721,4456,ventricular,I-Procedure
64722,4456,aneurysm,I-Procedure
64723,4456,",",O
64724,4456,carotid,B-Procedure
64725,4456,end,I-Procedure
64726,4456,-,I-Procedure
64727,4456,arterectomy,I-Procedure
64728,4456,",",O
64729,4456,abdominal,B-Procedure
64730,4456,aortic,I-Procedure
64731,4456,aneurysm,I-Procedure
64732,4456,surgery,I-Procedure
64733,4456,etc,O
64734,4456,.,O
64735,4456,),O
64736,4456,;,O
64737,4457,4,O
64738,4457,.,O
64739,4457,Congenital,B-Procedure
64740,4457,heart,I-Procedure
64741,4457,disease,I-Procedure
64742,4457,;,O
64743,4458,5,O
64744,4458,.,O
64745,4458,Transmural,B-Procedure
64746,4458,myocardial,I-Procedure
64747,4458,infarction,I-Procedure
64748,4458,within,O
64749,4458,the,O
64750,4458,previous,O
64751,4458,seven,O
64752,4458,days,O
64753,4458,and,O
64754,4458,CK,O
64755,4458,has,O
64756,4458,not,O
64757,4458,returned,O
64758,4458,to,O
64759,4458,normal,O
64760,4458,;,O
64761,4459,6,O
64762,4459,.,O
64763,4459,Chest,B-Condition
64764,4459,pain,I-Condition
64765,4459,lasting,O
64766,4459,longer,O
64767,4459,than,O
64768,4459,30,O
64769,4459,minutes,O
64770,4459,within,O
64771,4459,12,O
64772,4459,hours,O
64773,4459,pre,O
64774,4459,-,O
64775,4459,procedure,O
64776,4459,",",O
64777,4459,if,O
64778,4459,CK,O
64779,4459,enzymes,O
64780,4459,positive,O
64781,4459,(,O
64782,4459,≥,O
64783,4459,2x,O
64784,4459,the,O
64785,4459,normal,O
64786,4459,upper,O
64787,4459,limit,O
64788,4459,),O
64789,4459,.,O
64790,4460,7,O
64791,4460,.,O
64792,4460,History,B-Observation
64793,4460,of,I-Observation
64794,4460,any,B-Condition
64795,4460,cerebrovascular,I-Condition
64796,4460,accident,I-Condition
64797,4460,;,O
64798,4461,8,O
64799,4461,.,O
64800,4461,Left,B-Condition
64801,4461,main,I-Condition
64802,4461,stenosis,I-Condition
64803,4461,of,O
64804,4461,50,O
64805,4461,%,O
64806,4461,or,O
64807,4461,more,O
64808,4461,;,O
64809,4462,9,O
64810,4462,.,O
64811,4462,Intention,B-Mood
64812,4462,to,I-Mood
64813,4462,treat,B-Procedure
64814,4462,more,O
64815,4462,than,O
64816,4462,1,O
64817,4462,totally,O
64818,4462,occluded,O
64819,4462,major,O
64820,4462,epicardial,O
64821,4462,vessel,O
64822,4462,;,O
64823,4463,10,O
64824,4463,.,O
64825,4463,Single,B-Condition
64826,4463,vessel,I-Condition
64827,4463,(,I-Condition
64828,4463,single,I-Condition
64829,4463,territory,I-Condition
64830,4463,),I-Condition
64831,4463,disease,I-Condition
64832,4463,.,O
64833,4464,1,O
64834,4464,.,O
64835,4464,Patients,O
64836,4464,with,O
64837,4464,stable,O
64838,4464,(,O
64839,4464,Canadian,O
64840,4464,Cardiovascular,O
64841,4464,Society,O
64842,4464,1,O
64843,4464,",",O
64844,4464,2,O
64845,4464,",",O
64846,4464,3,O
64847,4464,or,O
64848,4464,4,O
64849,4464,),O
64850,4464,or,O
64851,4464,unstable,O
64852,4464,(,O
64853,4464,Braunwald,O
64854,4464,class,O
64855,4464,IB,O
64856,4464,",",O
64857,4464,IC,O
64858,4464,",",O
64859,4464,IIB,O
64860,4464,",",O
64861,4464,IIC,O
64862,4464,",",O
64863,4464,IIIB,O
64864,4464,",",O
64865,4464,IIIC,O
64866,4464,),O
64867,4464,angina,B-Condition
64868,4464,pectoris,I-Condition
64869,4464,and,O
64870,4464,ischemia,B-Condition
64871,4464,",",O
64872,4464,or,O
64873,4464,patients,O
64874,4464,with,O
64875,4464,atypical,B-Condition
64876,4464,chest,I-Condition
64877,4464,pain,I-Condition
64878,4464,or,O
64879,4464,even,O
64880,4464,those,O
64881,4464,who,O
64882,4464,are,O
64883,4464,asymptomatic,B-Condition
64884,4464,provided,O
64885,4464,they,O
64886,4464,have,O
64887,4464,documented,B-Observation
64888,4464,myocardial,B-Condition
64889,4464,ischaemia,I-Condition
64890,4464,(,O
64891,4464,e.g.,O
64892,4464,treadmill,B-Procedure
64893,4464,exercise,I-Procedure
64894,4464,test,I-Procedure
64895,4464,",",O
64896,4464,radionuclide,B-Procedure
64897,4464,scintigraphy,I-Procedure
64898,4464,",",O
64899,4464,stress,B-Procedure
64900,4464,echocardiography,I-Procedure
64901,4464,",",O
64902,4464,Holter,B-Procedure
64903,4464,tape,I-Procedure
64904,4464,),O
64905,4464,;,O
64906,4465,2,O
64907,4465,.,O
64908,4465,Patients,O
64909,4465,who,O
64910,4465,are,O
64911,4465,eligible,B-Mood
64912,4465,for,I-Mood
64913,4465,coronary,B-Procedure
64914,4465,revascularization,I-Procedure
64915,4465,(,O
64916,4465,angioplasty,B-Procedure
64917,4465,or,O
64918,4465,CABG,B-Procedure
64919,4465,),O
64920,4465,;,O
64921,4466,3,O
64922,4466,.,O
64923,4466,At,O
64924,4466,least,O
64925,4466,2,O
64926,4466,lesions,B-Condition
64927,4466,(,O
64928,4466,located,O
64929,4466,in,O
64930,4466,different,O
64931,4466,vessels,O
64932,4466,and,O
64933,4466,in,O
64934,4466,different,O
64935,4466,territories,O
64936,4466,),O
64937,4466,potentially,B-Observation
64938,4466,amenable,I-Observation
64939,4466,to,O
64940,4466,stent,B-Procedure
64941,4466,implantation,I-Procedure
64942,4466,;,O
64943,4467,4,O
64944,4467,.,O
64945,4467,de,O
64946,4467,novo,O
64947,4467,native,B-Condition
64948,4467,vessels,I-Condition
64949,4467,;,O
64950,4468,5,O
64951,4468,.,O
64952,4468,Multivessel,B-Condition
64953,4468,disease,I-Condition
64954,4468,with,O
64955,4468,at,O
64956,4468,least,O
64957,4468,one,O
64958,4468,significant,B-Condition
64959,4468,stenosis,I-Condition
64960,4468,in,I-Condition
64961,4468,LAD,I-Condition
64962,4468,and,O
64963,4468,with,O
64964,4468,treatment,B-Procedure
64965,4468,of,I-Procedure
64966,4468,the,I-Procedure
64967,4468,lesion,I-Procedure
64968,4468,in,O
64969,4468,another,O
64970,4468,major,O
64971,4468,epicardial,O
64972,4468,coronary,O
64973,4468,artery,O
64974,4468,.,O
64975,4468,A,O
64976,4468,two,O
64977,4468,-,O
64978,4468,vessel,O
64979,4468,disease,O
64980,4468,or,O
64981,4468,a,O
64982,4468,three,O
64983,4468,-,O
64984,4468,vessel,O
64985,4468,disease,O
64986,4468,may,O
64987,4468,be,O
64988,4468,viewed,O
64989,4468,as,O
64990,4468,a,O
64991,4468,combination,O
64992,4468,of,O
64993,4468,a,O
64994,4468,side,O
64995,4468,branch,O
64996,4468,and,O
64997,4468,a,O
64998,4468,main,O
64999,4468,epicardial,O
65000,4468,vessel,O
65001,4468,provided,O
65002,4468,they,O
65003,4468,supply,O
65004,4468,different,O
65005,4468,territories,O
65006,4468,;,O
65007,4468,left,O
65008,4468,anterior,O
65009,4468,descending,O
65010,4468,",",O
65011,4468,left,O
65012,4468,circumflex,O
65013,4468,and,O
65014,4468,right,O
65015,4468,coronary,O
65016,4468,artery,O
65017,4468,),O
65018,4468,;,O
65019,4469,6,O
65020,4469,.,O
65021,4469,Total,B-Condition
65022,4469,occluded,I-Condition
65023,4469,vessels,I-Condition
65024,4469,.,O
65025,4469,One,O
65026,4469,total,B-Condition
65027,4469,occluded,I-Condition
65028,4469,major,I-Condition
65029,4469,epicardial,I-Condition
65030,4469,vessel,I-Condition
65031,4469,or,I-Condition
65032,4469,side,I-Condition
65033,4469,branch,I-Condition
65034,4469,can,O
65035,4469,be,O
65036,4469,included,O
65037,4469,and,O
65038,4469,targeted,O
65039,4469,as,O
65040,4469,long,O
65041,4469,as,O
65042,4469,one,O
65043,4469,other,O
65044,4469,major,O
65045,4469,vessel,O
65046,4469,has,O
65047,4469,a,O
65048,4469,significant,O
65049,4469,stenosis,O
65050,4469,amenable,O
65051,4469,for,O
65052,4469,SA,O
65053,4469,",",O
65054,4469,provided,O
65055,4469,the,O
65056,4469,age,O
65057,4469,of,O
65058,4469,occlusion,O
65059,4469,is,O
65060,4469,less,O
65061,4469,than,O
65062,4469,one,O
65063,4469,month,O
65064,4469,e.g.,O
65065,4469,recent,O
65066,4469,instability,O
65067,4469,",",O
65068,4469,infarction,O
65069,4469,with,O
65070,4469,ECG,O
65071,4469,changes,O
65072,4469,in,O
65073,4469,the,O
65074,4469,area,O
65075,4469,subtended,O
65076,4469,by,O
65077,4469,the,O
65078,4469,occluded,O
65079,4469,vessel,O
65080,4469,.,O
65081,4469,Patients,O
65082,4469,with,O
65083,4469,total,B-Condition
65084,4469,occluded,I-Condition
65085,4469,vessels,I-Condition
65086,4469,of,O
65087,4469,unknown,O
65088,4469,duration,O
65089,4469,or,O
65090,4469,existing,O
65091,4469,longer,O
65092,4469,than,O
65093,4469,one,O
65094,4469,month,O
65095,4469,and,O
65096,4469,a,O
65097,4469,reference,O
65098,4469,over,O
65099,4469,1.50,O
65100,4469,mm,O
65101,4469,should,O
65102,4469,not,O
65103,4469,be,O
65104,4469,included,O
65105,4469,",",O
65106,4469,not,O
65107,4469,even,O
65108,4469,as,O
65109,4469,a,O
65110,4469,third,O
65111,4469,or,O
65112,4469,fourth,O
65113,4469,vessel,O
65114,4469,to,O
65115,4469,be,O
65116,4469,dilated,O
65117,4469,;,O
65118,4470,7,O
65119,4470,.,O
65120,4470,Significant,B-Condition
65121,4470,stenosis,I-Condition
65122,4470,has,O
65123,4470,been,O
65124,4470,defined,O
65125,4470,as,O
65126,4470,a,O
65127,4470,stenosis,O
65128,4470,of,O
65129,4470,more,O
65130,4470,than,O
65131,4470,50,O
65132,4470,%,O
65133,4470,in,O
65134,4470,luminal,O
65135,4470,diameter,O
65136,4470,(,O
65137,4470,in,O
65138,4470,at,O
65139,4470,least,O
65140,4470,one,O
65141,4470,view,O
65142,4470,",",O
65143,4470,on,O
65144,4470,visual,O
65145,4470,interpretation,O
65146,4470,or,O
65147,4470,preferably,O
65148,4470,by,O
65149,4470,QCA,O
65150,4470,),O
65151,4470,;,O
65152,4471,8,O
65153,4471,.,O
65154,4471,Left,O
65155,4471,ventricular,O
65156,4471,ejection,O
65157,4471,fraction,O
65158,4471,should,O
65159,4471,be,O
65160,4471,at,O
65161,4471,least,O
65162,4471,30,O
65163,4471,%,O
65164,4471,.,O
65165,4472,Patients,O
65166,4472,with,O
65167,4472,symptomatic,O
65168,4472,CNS,B-Condition
65169,4472,metastases,I-Condition
65170,4472,or,O
65171,4472,leptomeningeal,B-Condition
65172,4472,involvement,I-Condition
65173,4473,Patients,O
65174,4473,with,O
65175,4473,known,O
65176,4473,brain,B-Condition
65177,4473,metastases,I-Condition
65178,4473,",",O
65179,4473,unless,O
65180,4473,these,O
65181,4473,metastases,O
65182,4473,have,O
65183,4473,been,O
65184,4473,treated,B-Procedure
65185,4473,and/or,O
65186,4473,have,O
65187,4473,been,O
65188,4473,stable,O
65189,4473,for,O
65190,4473,at,O
65191,4473,least,O
65192,4473,six,O
65193,4473,months,O
65194,4473,prior,O
65195,4473,to,O
65196,4473,study,O
65197,4473,start,O
65198,4473,.,O
65199,4473,Subjects,O
65200,4473,with,O
65201,4473,a,O
65202,4473,history,B-Observation
65203,4473,of,I-Observation
65204,4473,brain,B-Condition
65205,4473,metastases,I-Condition
65206,4473,must,O
65207,4473,have,O
65208,4473,a,O
65209,4473,head,B-Procedure
65210,4473,CT,I-Procedure
65211,4473,with,I-Procedure
65212,4473,contrast,I-Procedure
65213,4473,to,O
65214,4473,document,O
65215,4473,either,O
65216,4473,response,O
65217,4473,or,O
65218,4473,progression,O
65219,4473,.,O
65220,4474,Patients,O
65221,4474,with,O
65222,4474,bone,B-Condition
65223,4474,metastases,I-Condition
65224,4474,as,O
65225,4474,the,O
65226,4474,only,O
65227,4474,site(s,O
65228,4474,),O
65229,4474,of,O
65230,4474,measurable,O
65231,4474,disease,O
65232,4475,Patients,O
65233,4475,with,O
65234,4475,hepatic,B-Procedure
65235,4475,artery,I-Procedure
65236,4475,chemoembolization,I-Procedure
65237,4475,within,O
65238,4475,the,O
65239,4475,last,O
65240,4475,6,O
65241,4475,months,O
65242,4475,(,O
65243,4475,one,O
65244,4475,month,O
65245,4475,if,O
65246,4475,there,O
65247,4475,are,O
65248,4475,other,B-Observation
65249,4475,sites,I-Observation
65250,4475,of,I-Observation
65251,4475,measurable,I-Observation
65252,4475,disease,I-Observation
65253,4475,),O
65254,4476,Patients,O
65255,4476,who,O
65256,4476,have,O
65257,4476,been,O
65258,4476,previously,O
65259,4476,treated,O
65260,4476,with,O
65261,4476,radioactive,B-Procedure
65262,4476,directed,I-Procedure
65263,4476,therapies,I-Procedure
65264,4477,Patients,O
65265,4477,who,O
65266,4477,have,O
65267,4477,been,O
65268,4477,previously,O
65269,4477,treated,O
65270,4477,with,O
65271,4477,epothilone,B-Drug
65272,4478,Patients,O
65273,4478,with,O
65274,4478,any,O
65275,4478,peripheral,B-Condition
65276,4478,neuropathy,I-Condition
65277,4478,or,O
65278,4478,unresolved,B-Condition
65279,4478,diarrhea,I-Condition
65280,4478,greater,O
65281,4478,than,O
65282,4478,Grade,O
65283,4478,1,O
65284,4479,Patients,O
65285,4479,with,O
65286,4479,severe,B-Condition
65287,4479,cardiac,I-Condition
65288,4479,insufficiency,I-Condition
65289,4479,patients,O
65290,4479,taking,O
65291,4479,Coumadin,B-Drug
65292,4479,or,O
65293,4479,other,O
65294,4479,warfarin,B-Drug
65295,4479,-,I-Drug
65296,4479,containing,I-Drug
65297,4479,agents,I-Drug
65298,4479,with,O
65299,4479,the,O
65300,4479,exception,O
65301,4479,of,O
65302,4479,low,O
65303,4479,dose,O
65304,4479,warfarin,B-Drug
65305,4479,(,O
65306,4479,1,O
65307,4479,mg,O
65308,4479,or,O
65309,4479,less,O
65310,4479,),O
65311,4479,for,O
65312,4479,the,O
65313,4479,maintenance,O
65314,4479,of,O
65315,4479,in,O
65316,4479,-,O
65317,4479,dwelling,O
65318,4479,lines,O
65319,4479,or,O
65320,4479,ports,O
65321,4480,Patients,O
65322,4480,taking,O
65323,4480,any,O
65324,4480,experimental,O
65325,4480,therapies,O
65326,4480,history,B-Observation
65327,4480,of,I-Observation
65328,4480,another,B-Condition
65329,4480,malignancy,I-Condition
65330,4480,within,O
65331,4480,5,O
65332,4480,years,O
65333,4480,prior,O
65334,4480,to,O
65335,4480,study,O
65336,4480,entry,O
65337,4480,except,O
65338,4480,curatively,O
65339,4480,treated,O
65340,4480,non,B-Condition
65341,4480,-,I-Condition
65342,4480,melanoma,I-Condition
65343,4480,skin,I-Condition
65344,4480,cancer,I-Condition
65345,4480,",",O
65346,4480,prostate,B-Condition
65347,4480,cancer,I-Condition
65348,4480,",",O
65349,4480,or,O
65350,4480,cervical,B-Condition
65351,4480,cancer,I-Condition
65352,4480,in,I-Condition
65353,4480,situ,I-Condition
65354,4481,Patients,O
65355,4481,with,O
65356,4481,active,O
65357,4481,or,O
65358,4481,suspected,O
65359,4481,acute,O
65360,4481,or,O
65361,4481,chronic,O
65362,4481,uncontrolled,B-Condition
65363,4481,infection,I-Condition
65364,4481,including,O
65365,4481,abcesses,B-Condition
65366,4481,or,O
65367,4481,fistulae,B-Condition
65368,4482,Patients,O
65369,4482,with,O
65370,4482,a,O
65371,4482,medical,B-Condition
65372,4482,or,I-Condition
65373,4482,psychiatric,I-Condition
65374,4482,illness,I-Condition
65375,4482,that,O
65376,4482,would,O
65377,4482,preclude,B-Observation
65378,4482,study,I-Observation
65379,4482,or,O
65380,4482,informed,B-Observation
65381,4482,consent,I-Observation
65382,4482,and/or,O
65383,4482,history,O
65384,4482,of,O
65385,4482,noncompliance,B-Observation
65386,4482,to,I-Observation
65387,4482,medical,I-Observation
65388,4482,regimens,I-Observation
65389,4482,or,O
65390,4482,inability,B-Observation
65391,4482,or,I-Observation
65392,4482,unwillingness,I-Observation
65393,4482,to,I-Observation
65394,4482,return,I-Observation
65395,4482,for,I-Observation
65396,4482,all,I-Observation
65397,4482,scheduled,I-Observation
65398,4482,visits,I-Observation
65399,4483,HIV+,B-Condition
65400,4483,patients,O
65401,4484,Pregnant,B-Condition
65402,4484,or,O
65403,4484,lactating,B-Condition
65404,4484,females,O
65405,4484,.,O
65406,4485,Patients,O
65407,4485,with,O
65408,4485,biopsy,B-Procedure
65409,4485,-,O
65410,4485,proven,O
65411,4485,metastatic,B-Condition
65412,4485,carcinoid,I-Condition
65413,4485,tumors,I-Condition
65414,4485,or,O
65415,4485,other,B-Condition
65416,4485,neuroendocrine,I-Condition
65417,4485,tumors,I-Condition
65418,4485,(,O
65419,4485,Islet,B-Condition
65420,4485,cell,I-Condition
65421,4485,",",O
65422,4485,Gastrinomas,B-Condition
65423,4485,and,O
65424,4485,VIPomas,B-Condition
65425,4485,),O
65426,4485,with,O
65427,4485,at,O
65428,4485,least,O
65429,4485,one,O
65430,4485,measurable,B-Condition
65431,4485,lesion,I-Condition
65432,4485,(,O
65433,4485,other,O
65434,4485,than,O
65435,4485,bone,O
65436,4485,),O
65437,4485,that,O
65438,4485,has,O
65439,4485,either,O
65440,4485,not,O
65441,4485,been,O
65442,4485,previously,O
65443,4485,irradiated,B-Procedure
65444,4485,or,O
65445,4485,if,O
65446,4485,previously,O
65447,4485,irradiated,B-Procedure
65448,4485,has,O
65449,4485,demonstrated,O
65450,4485,progression,B-Observation
65451,4485,since,O
65452,4485,the,O
65453,4485,radiation,B-Procedure
65454,4485,therapy,I-Procedure
65455,4486,The,O
65456,4486,patient,O
65457,4486,has,O
65458,4486,no,O
65459,4486,major,B-Condition
65460,4486,impairment,I-Condition
65461,4486,of,I-Condition
65462,4486,renal,I-Condition
65463,4486,or,I-Condition
65464,4486,hepatic,I-Condition
65465,4486,function,I-Condition
65466,4486,",",O
65467,4486,as,O
65468,4486,defined,O
65469,4486,by,O
65470,4486,the,O
65471,4486,following,O
65472,4486,laboratory,O
65473,4486,parameters,O
65474,4486,:,O
65475,4486,total,O
65476,4486,bilirubin,O
65477,4486,<,O
65478,4486,1.5,O
65479,4486,X,O
65480,4486,ULN,O
65481,4486,;,O
65482,4486,AST,O
65483,4486,",",O
65484,4486,ALT<2.5X,O
65485,4486,ULN,O
65486,4486,(,O
65487,4486,<,O
65488,4486,5,O
65489,4486,X,O
65490,4486,ULN,O
65491,4486,if,O
65492,4486,liver,B-Condition
65493,4486,metastases,I-Condition
65494,4486,are,O
65495,4486,present,O
65496,4486,),O
65497,4487,Patients,O
65498,4487,on,O
65499,4487,Sandostatin,B-Drug
65500,4487,Lar,I-Drug
65501,4487,(,O
65502,4487,long,B-Drug
65503,4487,acting,I-Drug
65504,4487,somatostatin,I-Drug
65505,4487,analogue,I-Drug
65506,4487,),O
65507,4487,must,O
65508,4487,be,O
65509,4487,on,O
65510,4487,a,O
65511,4487,stable,O
65512,4487,dose,O
65513,4487,for,O
65514,4487,30,O
65515,4487,days,O
65516,4487,prior,O
65517,4487,to,O
65518,4487,study,O
65519,4487,entry,O
65520,4487,and,O
65521,4487,short,B-Drug
65522,4487,acting,I-Drug
65523,4487,somatostatin,I-Drug
65524,4487,analogues,I-Drug
65525,4487,must,O
65526,4487,be,O
65527,4487,judged,O
65528,4487,to,O
65529,4487,be,O
65530,4487,on,O
65531,4487,a,O
65532,4487,clinically,O
65533,4487,stable,O
65534,4487,dose,O
65535,4487,by,O
65536,4487,the,O
65537,4487,investigator,O
65538,4487,prior,O
65539,4487,to,O
65540,4487,study,O
65541,4487,entry,O
65542,4488,Must,O
65543,4488,have,O
65544,4488,a,O
65545,4488,life,B-Observation
65546,4488,expectancy,I-Observation
65547,4488,of,O
65548,4488,greater,O
65549,4488,than,O
65550,4488,three,O
65551,4488,(,O
65552,4488,3,O
65553,4488,),O
65554,4488,months,O
65555,4489,Karnofsky,O
65556,4489,Performance,O
65557,4489,Status,O
65558,4489,>,O
65559,4489,60,O
65560,4490,Female,B-Person
65561,4490,patients,O
65562,4490,must,O
65563,4490,have,O
65564,4490,a,O
65565,4490,negative,O
65566,4490,serum,O
65567,4490,pregnancy,O
65568,4490,test,O
65569,4490,at,O
65570,4490,screening,O
65571,4490,.,O
65572,4490,(,O
65573,4490,Not,O
65574,4490,applicable,O
65575,4490,to,O
65576,4490,patients,O
65577,4490,with,O
65578,4490,bilateral,B-Procedure
65579,4490,oophorectomy,I-Procedure
65580,4490,and/or,O
65581,4490,hysterectomy,B-Procedure
65582,4490,or,O
65583,4490,to,O
65584,4490,those,O
65585,4490,patients,O
65586,4490,who,O
65587,4490,are,O
65588,4490,postmenopausal,B-Condition
65589,4490,.,O
65590,4490,),O
65591,4491,Females,B-Person
65592,4491,who,O
65593,4491,have,O
65594,4491,high,B-Condition
65595,4491,response,I-Condition
65596,4491,(,O
65597,4491,estradiol,O
65598,4491,at,O
65599,4491,time,O
65600,4491,of,O
65601,4491,ovulation,O
65602,4491,trigger,O
65603,4491,is,O
65604,4491,>,O
65605,4491,5000,O
65606,4491,pg,O
65607,4491,/,O
65608,4491,ml,O
65609,4491,or,O
65610,4491,more,O
65611,4491,than,O
65612,4491,15,O
65613,4491,oocytes,O
65614,4491,are,O
65615,4491,retrieved,O
65616,4491,),O
65617,4492,Females,B-Person
65618,4492,undergoing,O
65619,4492,Intra,B-Procedure
65620,4492,-,I-Procedure
65621,4492,Cytoplasmic,I-Procedure
65622,4492,Sperm,I-Procedure
65623,4492,Injection,I-Procedure
65624,4492,(,I-Procedure
65625,4492,ICSI,I-Procedure
65626,4492,),I-Procedure
65627,4492,cycles,I-Procedure
65628,4493,Age,B-Person
65629,4493,between,O
65630,4493,20,O
65631,4493,and,O
65632,4493,40,O
65633,4493,years,O
65634,4494,Patients,O
65635,4494,under,O
65636,4494,the,O
65637,4494,age,B-Person
65638,4494,of,O
65639,4494,18,O
65640,4494,(,O
65641,4494,Subjects,O
65642,4494,under,O
65643,4494,the,O
65644,4494,age,O
65645,4494,of,O
65646,4494,18,O
65647,4494,will,O
65648,4494,not,O
65649,4494,be,O
65650,4494,included,O
65651,4494,in,O
65652,4494,this,O
65653,4494,study,O
65654,4494,due,O
65655,4494,to,O
65656,4494,the,O
65657,4494,continued,O
65658,4494,growth,O
65659,4494,and,O
65660,4494,development,O
65661,4494,of,O
65662,4494,their,O
65663,4494,joints,O
65664,4494,and,O
65665,4494,unstudied,O
65666,4494,effects,O
65667,4494,on,O
65668,4494,children,O
65669,4494,.,O
65670,4494,),O
65671,4495,Over,O
65672,4495,the,O
65673,4495,age,B-Person
65674,4495,of,O
65675,4495,80,O
65676,4496,Multiple,B-Condition
65677,4496,pain,I-Condition
65678,4496,sources,I-Condition
65679,4496,and,O
65680,4496,multifactorial,B-Condition
65681,4496,pain,I-Condition
65682,4496,sources,I-Condition
65683,4496,that,O
65684,4496,complicated,O
65685,4496,or,O
65686,4496,confound,O
65687,4496,diagnosing,O
65688,4496,the,O
65689,4496,SI,O
65690,4496,joint,O
65691,4496,as,O
65692,4496,the,O
65693,4496,primary,O
65694,4496,and,O
65695,4496,predominant,O
65696,4496,pain,O
65697,4496,generator,O
65698,4496,that,O
65699,4496,may,O
65700,4496,contribute,O
65701,4496,to,O
65702,4496,low,O
65703,4496,back,O
65704,4496,pain,O
65705,4496,(,O
65706,4496,including,O
65707,4496,but,O
65708,4496,not,O
65709,4496,limited,O
65710,4496,to,O
65711,4496,:,O
65712,4496,lumbar,B-Condition
65713,4496,diagnosis,I-Condition
65714,4496,",",O
65715,4496,lumbar,B-Condition
65716,4496,radiculopathy,I-Condition
65717,4496,",",O
65718,4496,intra,B-Condition
65719,4496,or,I-Condition
65720,4496,extra,I-Condition
65721,4496,-,I-Condition
65722,4496,articular,I-Condition
65723,4496,hip,I-Condition
65724,4496,pathology,I-Condition
65725,4496,to,O
65726,4496,include,O
65727,4496,acetabulum,B-Condition
65728,4496,and,I-Condition
65729,4496,femoral,I-Condition
65730,4496,head,I-Condition
65731,4496,",",I-Condition
65732,4496,lumbo,I-Condition
65733,4496,-,I-Condition
65734,4496,sacral,I-Condition
65735,4496,joint,I-Condition
65736,4496,pathology,I-Condition
65737,4496,",",O
65738,4496,intervertebral,B-Condition
65739,4496,disk,I-Condition
65740,4496,disease,I-Condition
65741,4496,",",O
65742,4496,spondylolisthesis,B-Condition
65743,4496,/,O
65744,4496,spondylosis,B-Condition
65745,4496,/,O
65746,4496,spondylolysis,B-Condition
65747,4496,of,I-Condition
65748,4496,lumbar,I-Condition
65749,4496,vertebra,I-Condition
65750,4496,),O
65751,4497,Immunosuppressed,B-Condition
65752,4497,/,O
65753,4497,immune,B-Condition
65754,4497,compromised,I-Condition
65755,4498,Underlying,B-Condition
65756,4498,comorbidities,I-Condition
65757,4498,that,O
65758,4498,contraindicate,B-Condition
65759,4498,the,O
65760,4498,procedure,B-Procedure
65761,4498,(,O
65762,4498,including,O
65763,4498,but,O
65764,4498,not,O
65765,4498,limited,O
65766,4498,to,O
65767,4498,polycythemia,B-Condition
65768,4498,",",O
65769,4498,coagulation,B-Condition
65770,4498,disorder,I-Condition
65771,4498,",",O
65772,4498,or,O
65773,4498,malignancy,B-Condition
65774,4498,),O
65775,4498,.,O
65776,4499,Diagnosis,O
65777,4499,of,O
65778,4499,sacroiliitis,B-Condition
65779,4500,Age,B-Person
65780,4500,18,O
65781,4500,to,O
65782,4500,80,O
65783,4500,years,O
65784,4500,old,O
65785,4501,Chronic,B-Condition
65786,4501,low,I-Condition
65787,4501,back,I-Condition
65788,4501,pain,I-Condition
65789,4502,SI,B-Condition
65790,4502,joint,I-Condition
65791,4502,pathology,I-Condition
65792,4502,is,O
65793,4502,the,O
65794,4502,predominant,O
65795,4502,source,O
65796,4502,of,O
65797,4502,pain,O
65798,4503,Positive,O
65799,4503,Fortin,O
65800,4503,Finger,O
65801,4503,Test,O
65802,4503,(,O
65803,4503,PMT,O
65804,4503,),O
65805,4504,Joint,O
65806,4504,anatomy,O
65807,4504,is,O
65808,4504,identifiable,O
65809,4504,using,O
65810,4504,ultrasonography,O
65811,4505,Patient,O
65812,4505,has,O
65813,4505,no,O
65814,4505,other,O
65815,4505,comorbidities,B-Condition
65816,4505,that,I-Condition
65817,4505,contraindicate,I-Condition
65818,4505,the,I-Condition
65819,4505,procedure,I-Condition
65820,4506,Patient,O
65821,4506,has,O
65822,4506,attempted,O
65823,4506,physical,B-Procedure
65824,4506,therapy,I-Procedure
65825,4506,and,O
65826,4506,corticosteroid,B-Procedure
65827,4506,injections,I-Procedure
65828,4506,with,O
65829,4506,local,O
65830,4506,anesthetic,I-Drug
65831,4506,-Previous,O
65832,4506,injections,O
65833,4506,of,O
65834,4506,lidocaine,O
65835,4506,and,O
65836,4506,corticosteroid,O
65837,4506,provided,O
65838,4506,at,O
65839,4506,least,O
65840,4506,minor,O
65841,4506,immediate,O
65842,4506,relief,O
65843,4507,Patient,O
65844,4507,must,O
65845,4507,not,O
65846,4507,have,O
65847,4507,had,O
65848,4507,a,O
65849,4507,corticosteroid,B-Procedure
65850,4507,injection,I-Procedure
65851,4507,in,O
65852,4507,the,O
65853,4507,SI,O
65854,4507,joint,O
65855,4507,within,O
65856,4507,the,O
65857,4507,last,O
65858,4507,three,O
65859,4507,months,O
65860,4508,Patient,O
65861,4508,must,O
65862,4508,consent,B-Observation
65863,4508,to,I-Observation
65864,4508,the,I-Observation
65865,4508,procedure,I-Observation
65866,4509,Other,O
65867,4509,neuromuscular,B-Condition
65868,4509,disease,I-Condition
65869,4510,Contraindication,B-Condition
65870,4510,to,O
65871,4510,weight,B-Observation
65872,4510,bearing,I-Observation
65873,4510,on,I-Observation
65874,4510,lower,I-Observation
65875,4510,extremities,I-Observation
65876,4511,Pressure,B-Condition
65877,4511,sores,I-Condition
65878,4511,where,O
65879,4511,harness,O
65880,4511,would,O
65881,4511,be,O
65882,4511,applied,O
65883,4512,Uncontrollable,O
65884,4512,hypotension,B-Condition
65885,4512,when,O
65886,4512,upright,O
65887,4513,Lower,B-Condition
65888,4513,limb,I-Condition
65889,4513,contractures,I-Condition
65890,4513,impeding,B-Mood
65891,4513,range,B-Observation
65892,4513,of,I-Observation
65893,4513,motion,I-Observation
65894,4513,necessary,I-Observation
65895,4513,for,I-Observation
65896,4513,ambulation,I-Observation
65897,4514,Prior,O
65898,4514,enrolment,O
65899,4514,in,O
65900,4514,a,O
65901,4514,BWATT,O
65902,4514,program,O
65903,4515,Unable,O
65904,4515,to,O
65905,4515,commit,O
65906,4515,to,O
65907,4515,intervention,O
65908,4515,for,O
65909,4515,duration,O
65910,4515,of,O
65911,4515,protocol,O
65912,4516,Children,B-Person
65913,4516,between,O
65914,4516,the,O
65915,4516,ages,B-Person
65916,4516,of,O
65917,4516,4,O
65918,4516,-,O
65919,4516,18,O
65920,4516,with,O
65921,4516,incomplete,O
65922,4516,ASIA,O
65923,4516,C,O
65924,4516,or,O
65925,4516,D,O
65926,4516,spinal,B-Condition
65927,4516,cord,I-Condition
65928,4516,injuries,I-Condition
65929,4516,at,O
65930,4516,least,O
65931,4516,12,O
65932,4516,months,O
65933,4516,before,O
65934,4516,study,O
65935,4516,enrolment,O
65936,4517,Non,B-Observation
65937,4517,-,I-Observation
65938,4517,ambulatory,I-Observation
65939,4517,or,O
65940,4517,',B-Observation
65941,4517,exercise,I-Observation
65942,4517,only,I-Observation
65943,4517,',I-Observation
65944,4517,ambulators,I-Observation
65945,4517,with,O
65946,4517,or,O
65947,4517,without,O
65948,4517,assistive,O
65949,4517,devices,O
65950,4518,Normal,O
65951,4518,motor,O
65952,4518,and,O
65953,4518,cognitive,O
65954,4518,development,O
65955,4518,up,O
65956,4518,to,O
65957,4518,time,O
65958,4518,of,O
65959,4518,injury,O
65960,4519,Medical,B-Condition
65961,4519,Stability,I-Condition
65962,4520,acute,O
65963,4520,or,O
65964,4520,unstable,O
65965,4520,medical,B-Condition
65966,4520,disease,I-Condition
65967,4520,",",O
65968,4521,current,O
65969,4521,or,O
65970,4521,past,O
65971,4521,history,O
65972,4521,of,O
65973,4521,psychiatric,B-Condition
65974,4521,disease,I-Condition
65975,4521,",",O
65976,4521,alcoholism,B-Condition
65977,4521,or,O
65978,4521,drug,B-Condition
65979,4521,abuse,I-Condition
65980,4521,",",O
65981,4521,and,O
65982,4521,other,O
65983,4521,primary,B-Condition
65984,4521,sleep,I-Condition
65985,4521,disorders,I-Condition
65986,4522,DSM-5,O
65987,4522,diagnosis,O
65988,4522,of,O
65989,4522,insomnia,B-Condition
65990,4523,Diagnosis,O
65991,4523,of,O
65992,4523,ankle,B-Condition
65993,4523,fracture,I-Condition
65994,4523,or,O
65995,4523,ligament,B-Condition
65996,4523,rupture,I-Condition
65997,4524,Has,O
65998,4524,planned,O
65999,4524,release,B-Observation
66000,4524,from,I-Observation
66001,4524,the,I-Observation
66002,4524,Canadian,I-Observation
66003,4524,Armed,I-Observation
66004,4524,Forces,I-Observation
66005,4524,within,O
66006,4524,one,O
66007,4524,year,O
66008,4524,;,O
66009,4525,Documented,O
66010,4525,restrictions,B-Observation
66011,4525,on,I-Observation
66012,4525,military,I-Observation
66013,4525,duties,I-Observation
66014,4526,Has,O
66015,4526,known,O
66016,4526,intolerance,B-Condition
66017,4526,or,O
66018,4526,documented,O
66019,4526,adverse,B-Condition
66020,4526,reaction,I-Condition
66021,4526,to,O
66022,4526,acetaminophen,B-Drug
66023,4526,or,O
66024,4526,naproxen,B-Drug
66025,4526,or,O
66026,4526,celecoxib,B-Drug
66027,4527,Documented,O
66028,4527,history,B-Observation
66029,4527,of,O
66030,4527,liver,B-Condition
66031,4527,or,I-Condition
66032,4527,kidney,I-Condition
66033,4527,problems,I-Condition
66034,4528,pregnant,B-Condition
66035,4528,or,O
66036,4528,breastfeeding,B-Observation
66037,4529,Acquired,O
66038,4529,acute,B-Condition
66039,4529,ankle,I-Condition
66040,4529,injury,I-Condition
66041,4529,(,O
66042,4529,injured,O
66043,4529,less,O
66044,4529,than,O
66045,4529,48,O
66046,4529,hours,O
66047,4529,ago,O
66048,4529,),O
66049,4529,;,O
66050,4530,Clinical,O
66051,4530,diagnosis,O
66052,4530,of,O
66053,4530,a,O
66054,4530,Grade,O
66055,4530,I,O
66056,4530,or,O
66057,4530,II,O
66058,4530,ankle,B-Condition
66059,4530,sprain,I-Condition
66060,4531,Is,O
66061,4531,eligible,O
66062,4531,to,O
66063,4531,receive,O
66064,4531,comprehensive,O
66065,4531,medical,O
66066,4531,care,O
66067,4531,from,O
66068,4531,Garrison,O
66069,4531,Petawawa,O
66070,4532,Contraindication,B-Condition
66071,4532,for,O
66072,4532,IR,B-Drug
66073,4532,-,I-Drug
66074,4532,MPH,I-Drug
66075,4532,use,O
66076,4533,Current,O
66077,4533,stimulant,B-Procedure
66078,4533,treatment,I-Procedure
66079,4534,Evidence,B-Mood
66080,4534,of,O
66081,4534,a,O
66082,4534,clinically,O
66083,4534,significant,O
66084,4534,neurological,B-Condition
66085,4534,disease,I-Condition
66086,4534,that,O
66087,4534,might,O
66088,4534,affect,O
66089,4534,cognition,O
66090,4534,(,O
66091,4534,e.g.,O
66092,4534,",",O
66093,4534,delirium,B-Condition
66094,4534,",",O
66095,4534,dementia,B-Condition
66096,4534,",",O
66097,4534,epilepsy,B-Condition
66098,4534,",",O
66099,4534,head,B-Condition
66100,4534,trauma,I-Condition
66101,4534,",",O
66102,4534,and,O
66103,4534,multiple,B-Condition
66104,4534,sclerosis,I-Condition
66105,4534,),O
66106,4535,Current,O
66107,4535,or,O
66108,4535,past,O
66109,4535,history,B-Observation
66110,4535,of,O
66111,4535,psychosis,B-Condition
66112,4536,Estimated,O
66113,4536,intelligence,O
66114,4536,quotient,O
66115,4536,score,O
66116,4536,lower,O
66117,4536,than,O
66118,4536,70,O
66119,4537,White,B-Person
66120,4537,Brazilian,B-Person
66121,4537,of,O
66122,4537,European,B-Person
66123,4537,descent,I-Person
66124,4538,Fulfillment,O
66125,4538,of,O
66126,4538,the,O
66127,4538,Diagnostic,O
66128,4538,and,O
66129,4538,Statistical,O
66130,4538,Manual,O
66131,4538,of,O
66132,4538,Mental,O
66133,4538,Disorders,O
66134,4538,",",O
66135,4538,Fourth,O
66136,4538,Edition,O
66137,4538,",",O
66138,4538,(,O
66139,4538,DSM,O
66140,4538,-,O
66141,4538,IV,O
66142,4538,),O
66143,4538,diagnostic,O
66144,4538,criteria,O
66145,4538,for,O
66146,4538,ADHD,B-Condition
66147,4539,Eligibility,B-Mood
66148,4539,to,O
66149,4539,immediate,B-Drug
66150,4539,-,I-Drug
66151,4539,release,I-Drug
66152,4539,MPH,I-Drug
66153,4539,(,I-Drug
66154,4539,IR,I-Drug
66155,4539,-,I-Drug
66156,4539,MPH,I-Drug
66157,4539,),I-Drug
66158,4539,treatment,O
66159,4540,Multiple,B-Condition
66160,4540,pregnancy,I-Condition
66161,4540,(,O
66162,4540,more,O
66163,4540,than,O
66164,4540,3,O
66165,4540,fetuses,O
66166,4540,),O
66167,4541,Maternal,B-Observation
66168,4541,history,I-Observation
66169,4541,of,I-Observation
66170,4541,placental,B-Condition
66171,4541,abruptio,I-Condition
66172,4542,Fetus,B-Condition
66173,4542,with,O
66174,4542,IUGR,B-Condition
66175,4543,Pregnancy,B-Condition
66176,4543,complicated,O
66177,4543,with,O
66178,4543,pre,B-Condition
66179,4543,-,I-Condition
66180,4543,eclampsia,I-Condition
66181,4544,Unability,O
66182,4544,to,O
66183,4544,give,B-Observation
66184,4544,informed,I-Observation
66185,4544,consent,I-Observation
66186,4545,Pregnant,B-Condition
66187,4545,women,B-Person
66188,4545,with,O
66189,4545,abdomen,B-Condition
66190,4545,discumfort,I-Condition
66191,4545,and,O
66192,4545,ultrasound,B-Procedure
66193,4545,diagnosis,O
66194,4545,of,O
66195,4545,polyhydramnios,B-Condition
66196,4545,(,O
66197,4545,AFI>25,O
66198,4545,cm,O
66199,4545,),O
66200,4546,Single,O
66201,4546,or,O
66202,4546,twin,O
66203,4546,pregnancies,B-Condition
66204,4547,Sensitization,B-Condition
66205,4547,(,O
66206,4547,i.e.,O
66207,4547,PRA,O
66208,4547,>,O
66209,4547,20,O
66210,4547,%,O
66211,4547,),O
66212,4548,Any,O
66213,4548,liver,B-Condition
66214,4548,disease,I-Condition
66215,4548,in,O
66216,4548,recipient,O
66217,4549,Albumin,O
66218,4549,<,O
66219,4549,3g,O
66220,4549,/,O
66221,4549,dl,O
66222,4549,or,O
66223,4549,platelet,O
66224,4549,count,O
66225,4549,<,O
66226,4549,75,O
66227,4549,x,O
66228,4549,103,O
66229,4549,/,O
66230,4549,mL,O
66231,4550,Need,B-Mood
66232,4550,for,I-Mood
66233,4550,dual,O
66234,4550,organ,O
66235,4550,transplant,O
66236,4551,Recipient,O
66237,4551,is,O
66238,4551,Age,B-Person
66239,4551,=,O
66240,4551,18,O
66241,4551,years,O
66242,4552,Serum,O
66243,4552,ALT,O
66244,4552,within,O
66245,4552,normal,O
66246,4552,limits,O
66247,4552,with,O
66248,4552,no,O
66249,4552,history,B-Observation
66250,4552,of,O
66251,4552,liver,B-Condition
66252,4552,disease,I-Condition
66253,4553,Lack,O
66254,4553,of,O
66255,4553,sensitization,B-Condition
66256,4553,(,O
66257,4553,i.e.,O
66258,4553,PRA,O
66259,4553,<,O
66260,4553,20,O
66261,4553,%,O
66262,4553,),O
66263,4553,that,O
66264,4553,would,O
66265,4553,be,O
66266,4553,expected,O
66267,4553,to,O
66268,4553,result,O
66269,4553,in,O
66270,4553,a,O
66271,4553,high,O
66272,4553,likelihood,O
66273,4553,of,O
66274,4553,needing,O
66275,4553,aggressive,O
66276,4553,immunosuppression,O
66277,4553,to,O
66278,4553,treat,O
66279,4553,rejection,O
66280,4554,Patients,O
66281,4554,who,O
66282,4554,are,O
66283,4554,unwilling,O
66284,4554,to,O
66285,4554,participate,O
66286,4554,in,O
66287,4554,the,O
66288,4554,study,O
66289,4554,.,O
66290,4554,For,O
66291,4554,the,O
66292,4554,one,O
66293,4554,under,O
66294,4554,guardianship,O
66295,4554,",",O
66296,4554,the,O
66297,4554,refusal,O
66298,4554,of,O
66299,4554,the,O
66300,4554,patient,O
66301,4554,will,O
66302,4554,be,O
66303,4554,the,O
66304,4554,final,O
66305,4554,decision,O
66306,4554,even,O
66307,4554,if,O
66308,4554,the,O
66309,4554,guardian,O
66310,4554,is,O
66311,4554,willing,O
66312,4554,to,O
66313,4554,participate,O
66314,4554,.,O
66315,4555,Subjects,O
66316,4555,who,O
66317,4555,are,O
66318,4555,unlikely,O
66319,4555,to,O
66320,4555,adhere,O
66321,4555,to,O
66322,4555,the,O
66323,4555,study,O
66324,4555,an,O
66325,4555,/,O
66326,4555,or,O
66327,4555,poor,O
66328,4555,adherence,O
66329,4555,anticipated,O
66330,4555,by,O
66331,4555,the,O
66332,4555,investigator,O
66333,4555,.,O
66334,4556,Un,O
66335,4556,-,O
66336,4556,controlled,O
66337,4556,progressive,O
66338,4556,pathology,O
66339,4556,.,O
66340,4557,Osteoarticular,B-Condition
66341,4557,lesion,I-Condition
66342,4557,which,O
66343,4557,contraindicates,O
66344,4557,part,O
66345,4557,of,O
66346,4557,the,O
66347,4557,rehabilitation,O
66348,4557,involved,O
66349,4557,in,O
66350,4557,the,O
66351,4557,study,O
66352,4557,.,O
66353,4558,Patients,O
66354,4558,with,O
66355,4558,other,O
66356,4558,interventions,O
66357,4558,planned,O
66358,4558,prior,O
66359,4558,to,O
66360,4558,the,O
66361,4558,end,O
66362,4558,of,O
66363,4558,the,O
66364,4558,study,O
66365,4558,period,O
66366,4558,(,O
66367,4558,orthosis,O
66368,4558,",",O
66369,4558,surgery,O
66370,4558,etc,O
66371,4558,.,O
66372,4558,),O
66373,4558,.,O
66374,4559,Surgery,B-Procedure
66375,4559,to,O
66376,4559,the,O
66377,4559,treated,O
66378,4559,limb,O
66379,4559,less,O
66380,4559,than,O
66381,4559,6,O
66382,4559,months,O
66383,4559,previously,O
66384,4559,.,O
66385,4560,Pregnant,O
66386,4560,woman,O
66387,4560,.,O
66388,4561,Males,B-Person
66389,4561,and,O
66390,4561,females,B-Person
66391,4561,aged,B-Person
66392,4561,between,O
66393,4561,18,O
66394,4561,to,O
66395,4561,75,O
66396,4561,years,O
66397,4561,.,O
66398,4562,Adult,O
66399,4562,patient,O
66400,4562,under,O
66401,4562,guardianship,O
66402,4562,with,O
66403,4562,consent,O
66404,4562,obtained,O
66405,4562,and,O
66406,4562,the,O
66407,4562,legal,O
66408,4562,guardian,O
66409,4562,'s,O
66410,4562,authorisation,O
66411,4562,obtained,O
66412,4562,.,O
66413,4563,Single,O
66414,4563,stroke,B-Condition
66415,4563,having,O
66416,4563,occurred,O
66417,4563,more,O
66418,4563,than,O
66419,4563,6,O
66420,4563,months,O
66421,4563,before,O
66422,4563,(,O
66423,4563,previous,O
66424,4563,TIA,B-Condition
66425,4563,is,O
66426,4563,accepted,O
66427,4563,),O
66428,4563,.,O
66429,4564,Capable,O
66430,4564,of,O
66431,4564,understanding,O
66432,4564,instructions,O
66433,4564,and,O
66434,4564,participating,O
66435,4564,in,O
66436,4564,the,O
66437,4564,definition,O
66438,4564,of,O
66439,4564,a,O
66440,4564,therapeutic,O
66441,4564,goal,O
66442,4564,(,O
66443,4564,Boston,O
66444,4564,Diagnostic,O
66445,4564,Aphasia,O
66446,4564,Examination,O
66447,4564,(,O
66448,4564,BDAE,O
66449,4564,),O
66450,4564,<,O
66451,4564,3,O
66452,4564,),O
66453,4564,.,O
66454,4565,Having,O
66455,4565,previously,O
66456,4565,undergone,O
66457,4565,BTI,B-Procedure
66458,4565,.,O
66459,4565,The,O
66460,4565,last,O
66461,4565,injection,B-Procedure
66462,4565,must,O
66463,4565,have,O
66464,4565,been,O
66465,4565,performed,O
66466,4565,at,O
66467,4565,least,O
66468,4565,4,O
66469,4565,months,O
66470,4565,prior,O
66471,4565,to,O
66472,4565,inclusion,O
66473,4565,.,O
66474,4566,Affiliation,O
66475,4566,to,O
66476,4566,the,O
66477,4566,French,O
66478,4566,social,O
66479,4566,security,O
66480,4566,regime,O
66481,4566,or,O
66482,4566,a,O
66483,4566,similar,O
66484,4566,regime,O
66485,4566,.,O
66486,4567,Patient,O
66487,4567,(,O
66488,4567,or,O
66489,4567,the,O
66490,4567,legal,O
66491,4567,guardian,O
66492,4567,if,O
66493,4567,under,O
66494,4567,guardian,O
66495,4567,adult,O
66496,4567,patient,O
66497,4567,),O
66498,4567,has,O
66499,4567,signed,O
66500,4567,the,O
66501,4567,informed,O
66502,4567,consent,O
66503,4567,form,O
66504,4567,.,O
66505,4568,Smoker,B-Condition
66506,4568,or,O
66507,4568,former,B-Condition
66508,4568,smoker,I-Condition
66509,4568,.,O
66510,4569,Presence,O
66511,4569,of,O
66512,4569,dental,O
66513,4569,prostheses,O
66514,4569,.,O
66515,4570,Presence,O
66516,4570,of,O
66517,4570,orthodontic,O
66518,4570,devices,O
66519,4570,.,O
66520,4571,Antibiotic,B-Drug
66521,4571,treatment,O
66522,4571,or,O
66523,4571,routine,O
66524,4571,use,O
66525,4571,of,O
66526,4571,oral,B-Drug
66527,4571,antiseptics,I-Drug
66528,4571,in,O
66529,4571,the,O
66530,4571,previous,O
66531,4571,3,O
66532,4571,months,O
66533,4571,.,O
66534,4572,Presence,O
66535,4572,of,O
66536,4572,any,O
66537,4572,systemic,B-Condition
66538,4572,disease,I-Condition
66539,4572,that,O
66540,4572,could,O
66541,4572,alter,O
66542,4572,the,O
66543,4572,production,O
66544,4572,or,O
66545,4572,composition,O
66546,4572,of,O
66547,4572,saliva,O
66548,4572,.,O
66549,4573,Systemically,O
66550,4573,healthy,B-Condition
66551,4573,adults,B-Person
66552,4573,.,O
66553,4574,Minimum,O
66554,4574,of,O
66555,4574,24,O
66556,4574,permanent,B-Observation
66557,4574,teeth,I-Observation
66558,4574,.,O
66559,4575,No,O
66560,4575,gingivitis,B-Condition
66561,4575,(,O
66562,4575,Community,O
66563,4575,Periodontal,O
66564,4575,Index,O
66565,4575,score,O
66566,4575,=,O
66567,4575,0,O
66568,4575,),O
66569,4575,.,O
66570,4576,No,O
66571,4576,periodontitis,B-Condition
66572,4576,(,O
66573,4576,Community,O
66574,4576,Periodontal,O
66575,4576,Index,O
66576,4576,score,O
66577,4576,=,O
66578,4576,0,O
66579,4576,),O
66580,4576,.,O
66581,4577,Absence,O
66582,4577,of,O
66583,4577,untreated,O
66584,4577,caries,B-Condition
66585,4577,.,O
66586,4578,No,O
66587,4578,known,O
66588,4578,history,B-Observation
66589,4578,of,O
66590,4578,seizure,B-Condition
66591,4578,activity,I-Condition
66592,4578,.,O
66593,4579,Pregnant,B-Condition
66594,4579,or,O
66595,4579,breastfeeding,B-Observation
66596,4579,.,O
66597,4580,Renal,B-Condition
66598,4580,dysfunction,I-Condition
66599,4580,(,O
66600,4580,CrCl,O
66601,4580,<,O
66602,4580,30ml,O
66603,4580,/,O
66604,4580,min,O
66605,4580,),O
66606,4580,.,O
66607,4581,Beck,O
66608,4581,'s,O
66609,4581,Depression,O
66610,4581,Inventory,O
66611,4581,(,O
66612,4581,BDI,O
66613,4581,),O
66614,4581,=,O
66615,4581,14,O
66616,4582,Allergy,B-Condition
66617,4582,to,O
66618,4582,levetiracetam,B-Drug
66619,4582,.,O
66620,4583,Adult,B-Person
66621,4583,(,O
66622,4583,>,O
66623,4583,18,O
66624,4583,years,O
66625,4583,of,O
66626,4583,age,B-Person
66627,4583,and,O
66628,4583,older,O
66629,4583,),O
66630,4583,patients,O
66631,4583,who,O
66632,4583,have,O
66633,4583,or,O
66634,4583,will,B-Mood
66635,4583,have,I-Mood
66636,4583,undergone,I-Mood
66637,4583,surgical,B-Procedure
66638,4583,resection,I-Procedure
66639,4583,or,O
66640,4583,biopsy,B-Procedure
66641,4583,of,O
66642,4583,a,O
66643,4583,supratentorial,B-Condition
66644,4583,brain,I-Condition
66645,4583,tumor,I-Condition
66646,4583,and,O
66647,4583,are,O
66648,4583,able,O
66649,4583,to,O
66650,4583,consent,O
66651,4583,for,O
66652,4583,themselves,O
66653,4583,.,O
66654,4584,Able,O
66655,4584,to,O
66656,4584,be,O
66657,4584,randomized,O
66658,4584,prior,O
66659,4584,to,O
66660,4584,or,O
66661,4584,up,O
66662,4584,to,O
66663,4584,48,O
66664,4584,hours,O
66665,4584,after,O
66666,4584,surgery,O
66667,4584,.,O
66668,4585,Pregnant,B-Condition
66669,4586,Meningeal,B-Condition
66670,4586,signs,I-Condition
66671,4586,are,O
66672,4586,present,O
66673,4587,Acute,B-Condition
66674,4587,angle,I-Condition
66675,4587,closure,I-Condition
66676,4587,glaucoma,I-Condition
66677,4587,is,O
66678,4587,suspected,B-Mood
66679,4588,Head,B-Condition
66680,4588,trauma,I-Condition
66681,4588,within,O
66682,4588,the,O
66683,4588,previous,O
66684,4588,two,O
66685,4588,weeks,O
66686,4589,Lumbar,B-Procedure
66687,4589,puncture,I-Procedure
66688,4589,within,O
66689,4589,the,O
66690,4589,previous,O
66691,4589,two,O
66692,4589,weeks,O
66693,4590,Thunderclap,B-Condition
66694,4590,onset,I-Condition
66695,4590,of,O
66696,4590,the,O
66697,4590,headache,B-Condition
66698,4591,Known,O
66699,4591,allergy,B-Condition
66700,4591,to,O
66701,4591,one,O
66702,4591,of,O
66703,4591,the,O
66704,4591,study,B-Drug
66705,4591,drugs,I-Drug
66706,4592,History,B-Observation
66707,4592,of,O
66708,4592,intracranial,B-Condition
66709,4592,hypertension,I-Condition
66710,4593,Is,O
66711,4593,a,O
66712,4593,prisoner,B-Person
66713,4594,Patient,O
66714,4594,declined,O
66715,4594,informed,O
66716,4594,consent,O
66717,4595,Non,O
66718,4595,-,O
66719,4595,English,O
66720,4595,speaking,O
66721,4595,patient,O
66722,4595,or,O
66723,4595,parent,O
66724,4595,/,O
66725,4595,guardian,O
66726,4595,for,O
66727,4595,pediatric,O
66728,4595,patients,O
66729,4596,Attending,O
66730,4596,provider,O
66731,4596,excludes,O
66732,4596,patient,O
66733,4597,Severe,O
66734,4597,Dehydration,B-Condition
66735,4598,Age,B-Person
66736,4598,10,O
66737,4598,to,O
66738,4598,65,O
66739,4598,years,O
66740,4599,Temperature,O
66741,4599,less,O
66742,4599,than,O
66743,4599,100.4,O
66744,4599,F,O
66745,4600,Normal,O
66746,4600,neurologic,B-Procedure
66747,4600,exam,I-Procedure
66748,4600,and,O
66749,4600,normal,O
66750,4600,mental,O
66751,4600,status,O
66752,4601,dual,O
66753,4601,organ,B-Procedure
66754,4601,transplant,I-Procedure
66755,4602,liver,B-Procedure
66756,4602,transplant,I-Procedure
66757,4603,younger,O
66758,4603,than,O
66759,4603,18,O
66760,4603,years,O
66761,4603,old,B-Person
66762,4604,HBsAg,B-Condition
66763,4604,positive,I-Condition
66764,4604,or,O
66765,4604,HBcAb,B-Condition
66766,4604,negative,I-Condition
66767,4604,or,O
66768,4604,hepatitis,B-Condition
66769,4604,B,I-Condition
66770,4604,virus,I-Condition
66771,4604,DNA,I-Condition
66772,4604,positive,I-Condition
66773,4604,at,O
66774,4604,baseline,O
66775,4605,pregnant,B-Condition
66776,4605,or,O
66777,4605,lactating,B-Condition
66778,4605,women,B-Person
66779,4606,treatment,B-Observation
66780,4606,-,I-Observation
66781,4606,naive,I-Observation
66782,4606,patients,O
66783,4606,with,O
66784,4606,lymphoma,B-Condition
66785,4607,HBsAg,O
66786,4607,negative,O
66787,4607,/,O
66788,4607,HBcAb,O
66789,4607,positive,O
66790,4607,/,O
66791,4607,hepatitis,O
66792,4607,B,O
66793,4607,virus,O
66794,4607,DNA,O
66795,4607,negative,O
66796,4607,at,O
66797,4607,baseline,O
66798,4608,treated,O
66799,4608,with,O
66800,4608,chemotherapy,B-Procedure
66801,4608,and/or,O
66802,4608,immunosuppressive,B-Procedure
66803,4608,therapy,I-Procedure
66804,4609,life,B-Observation
66805,4609,expectancy,I-Observation
66806,4609,of,O
66807,4609,more,O
66808,4609,than,O
66809,4609,3,O
66810,4609,months,O
66811,4610,Subjects,O
66812,4610,with,O
66813,4610,hypersensitivity,B-Condition
66814,4610,reaction,O
66815,4610,to,O
66816,4610,Statin,B-Drug
66817,4610,and,O
66818,4610,Ezetimibe,B-Drug
66819,4611,Subjects,O
66820,4611,with,O
66821,4611,severe,O
66822,4611,kidney,B-Condition
66823,4611,disease,I-Condition
66824,4612,Subjects,O
66825,4612,with,O
66826,4612,HIV,B-Condition
66827,4612,positive,I-Condition
66828,4612,result,O
66829,4612,at,O
66830,4612,the,O
66831,4612,screening,O
66832,4613,Pregnant,B-Condition
66833,4613,or,O
66834,4613,breast,B-Condition
66835,4613,-,I-Condition
66836,4613,feeding,I-Condition
66837,4613,subjects,O
66838,4614,Subjects,O
66839,4614,with,O
66840,4614,taking,O
66841,4614,any,O
66842,4614,medication,B-Drug
66843,4614,affecting,B-Condition
66844,4614,level,O
66845,4614,of,O
66846,4614,LDL,B-Procedure
66847,4614,(,O
66848,4614,Fenofibrate,B-Drug
66849,4614,",",O
66850,4614,Omega,B-Drug
66851,4614,3,I-Drug
66852,4614,fatty,I-Drug
66853,4614,aicd,I-Drug
66854,4614,etc,O
66855,4614,.,O
66856,4614,),O
66857,4615,Insulin,B-Drug
66858,4615,-,O
66859,4615,treated,O
66860,4615,Subjects,O
66861,4616,Other,O
66862,4616,exclusions,O
66863,4616,applied,O
66864,4617,Subjects,O
66865,4617,=,O
66866,4617,19,O
66867,4617,or,O
66868,4617,=,O
66869,4617,75,O
66870,4617,years,O
66871,4617,of,O
66872,4617,age,B-Person
66873,4618,Subjects,O
66874,4618,undergoing,O
66875,4618,treatment,B-Procedure
66876,4618,for,O
66877,4618,type,B-Condition
66878,4618,2,I-Condition
66879,4618,diabetes,I-Condition
66880,4619,Subjects,O
66881,4619,undergoing,O
66882,4619,treatment,B-Procedure
66883,4619,of,O
66884,4619,statin,B-Drug
66885,4619,for,O
66886,4619,hypercholesterolemia,B-Condition
66887,4620,Fasting,O
66888,4620,LDL,O
66889,4620,-,O
66890,4620,C,O
66891,4620,=,O
66892,4620,250mg,O
66893,4620,/,O
66894,4620,dL,O
66895,4620,at,O
66896,4620,the,O
66897,4620,screening,O
66898,4620,visit,O
66899,4621,Fasting,O
66900,4621,LDL,O
66901,4621,-,O
66902,4621,C,O
66903,4621,=,O
66904,4621,70mg,O
66905,4621,/,O
66906,4621,dL,O
66907,4621,or,O
66908,4621,=,O
66909,4621,160mg,O
66910,4621,/,O
66911,4621,dL,O
66912,4621,at,O
66913,4621,the,O
66914,4621,randomization,O
66915,4621,visit,O
66916,4622,Fasting,O
66917,4622,TG<500mg,O
66918,4622,/,O
66919,4622,dL,O
66920,4623,Ulcers,B-Condition
66921,4623,due,O
66922,4623,to,O
66923,4623,non,O
66924,4623,-,O
66925,4623,diabetic,O
66926,4623,etiology,O
66927,4623,.,O
66928,4624,Uncontrolled,B-Condition
66929,4624,diabetes,I-Condition
66930,4624,defined,O
66931,4624,as,O
66932,4624,HbA1c,O
66933,4624,above,O
66934,4624,70,O
66935,4624,mmol,O
66936,4624,/,O
66937,4624,mol,O
66938,4624,and,O
66939,4624,insufficient,B-Condition
66940,4624,nutritional,I-Condition
66941,4624,status,I-Condition
66942,4624,.,O
66943,4625,Ulcers,B-Condition
66944,4625,older,O
66945,4625,than,O
66946,4625,1,O
66947,4625,year,O
66948,4625,.,O
66949,4626,Any,O
66950,4626,of,O
66951,4626,gangrene,B-Condition
66952,4626,",",O
66953,4626,osteomyelitis,B-Condition
66954,4626,",",O
66955,4626,cellulitis,B-Condition
66956,4626,",",O
66957,4626,or,O
66958,4626,Charcot,B-Condition
66959,4626,osteoarthropathy,I-Condition
66960,4626,.,O
66961,4627,Type,B-Condition
66962,4627,I,I-Condition
66963,4627,or,I-Condition
66964,4627,II,I-Condition
66965,4627,diabetes,I-Condition
66966,4627,mellitus,I-Condition
66967,4627,.,O
66968,4628,Target,O
66969,4628,ulcer,O
66970,4628,area,O
66971,4628,between,O
66972,4628,0.5,O
66973,4628,and,O
66974,4628,5,O
66975,4628,sqcm,O
66976,4628,",",O
66977,4628,and,O
66978,4628,more,O
66979,4628,than,O
66980,4628,4,O
66981,4628,weeks,O
66982,4628,old,O
66983,4628,.,O
66984,4629,Ankle,O
66985,4629,-,O
66986,4629,brachial,O
66987,4629,pressure,O
66988,4629,index,O
66989,4629,above,O
66990,4629,0.7,O
66991,4629,.,O
66992,4630,Lack,O
66993,4630,of,O
66994,4630,consent,O
66995,4631,Age,B-Person
66996,4631,from,O
66997,4631,birth,O
66998,4631,to,O
66999,4631,21,O
67000,4631,years,O
67001,4632,All,O
67002,4632,solid,B-Procedure
67003,4632,organ,I-Procedure
67004,4632,transplant,I-Procedure
67005,4632,recipients,O
67006,4632,receiving,O
67007,4632,their,O
67008,4632,care,O
67009,4632,at,O
67010,4632,Seattle,O
67011,4632,Children,O
67012,4632,'s,O
67013,4632,Hospital,O
67014,4633,Signed,O
67015,4633,consent,O
67016,4633,",",O
67017,4633,and,O
67018,4633,when,O
67019,4633,age,O
67020,4633,appropriate,O
67021,4633,",",O
67022,4633,signed,O
67023,4633,assent,O
67024,4634,Active,O
67025,4634,consumption,B-Condition
67026,4634,of,I-Condition
67027,4634,alcohol,I-Condition
67028,4634,and/or,O
67029,4634,drugs,O
67030,4635,Co,O
67031,4635,-,O
67032,4635,infection,O
67033,4635,with,O
67034,4635,human,B-Condition
67035,4635,immunodeficiency,I-Condition
67036,4635,virus,I-Condition
67037,4635,",",O
67038,4635,hepatitis,B-Condition
67039,4635,C,I-Condition
67040,4635,virus,I-Condition
67041,4635,",",O
67042,4635,or,O
67043,4635,hepatitis,B-Condition
67044,4635,D,I-Condition
67045,4635,virus,I-Condition
67046,4636,History,O
67047,4636,of,O
67048,4636,autoimmune,B-Condition
67049,4636,hepatitis,I-Condition
67050,4637,Psychiatric,B-Condition
67051,4637,disease,I-Condition
67052,4638,Evidence,O
67053,4638,of,O
67054,4638,neoplastic,B-Condition
67055,4638,diseases,I-Condition
67056,4638,of,O
67057,4638,the,O
67058,4638,liver,O
67059,4639,HBsAg,B-Condition
67060,4639,and,I-Condition
67061,4639,HBeAg,I-Condition
67062,4639,positive,I-Condition
67063,4639,for,O
67064,4639,more,O
67065,4639,than,O
67066,4639,6,O
67067,4639,months,O
67068,4639,",",O
67069,4639,HBV,B-Condition
67070,4639,DNA,I-Condition
67071,4639,detectable,I-Condition
67072,4639,with,O
67073,4639,ALT,O
67074,4639,level,O
67075,4639,abnormal,O
67076,4639,lasted,O
67077,4639,for,O
67078,4639,three,O
67079,4639,months,O
67080,4639,and,O
67081,4639,at,O
67082,4639,least,O
67083,4639,time190,O
67084,4639,IU,O
67085,4639,/,O
67086,4639,L,O
67087,4639,or,O
67088,4639,liver,B-Procedure
67089,4639,puncture,I-Procedure
67090,4639,biopsy,I-Procedure
67091,4639,demonstrated,O
67092,4639,apparent,O
67093,4639,inflammation,B-Condition
67094,4639,",",O
67095,4639,never,O
67096,4639,treated,B-Procedure
67097,4639,before,O
67098,4639,enrolled,B-Procedure
67099,4639,.,O
67100,4640,Active,B-Condition
67101,4640,proliferative,I-Condition
67102,4640,diabetic,I-Condition
67103,4640,retinopathy,I-Condition
67104,4640,(,I-Condition
67105,4640,PDR,I-Condition
67106,4640,),I-Condition
67107,4640,in,O
67108,4640,the,O
67109,4640,study,O
67110,4640,eye,O
67111,4640,such,O
67112,4640,as,O
67113,4640,NVE,B-Condition
67114,4640,",",O
67115,4640,NVD,B-Condition
67116,4640,",",O
67117,4640,vitreous,B-Condition
67118,4640,hemorrhage,I-Condition
67119,4640,",",O
67120,4640,or,O
67121,4640,neovascular,B-Condition
67122,4640,glaucoma,I-Condition
67123,4640,.,O
67124,4641,Uncontrolled,B-Condition
67125,4641,hypertension,I-Condition
67126,4641,defined,O
67127,4641,as,O
67128,4641,systolic,O
67129,4641,>,O
67130,4641,180,O
67131,4641,mmHg,O
67132,4641,or,O
67133,4641,>,O
67134,4641,160,O
67135,4641,mmHg,O
67136,4641,on,O
67137,4641,2,O
67138,4641,consecutive,O
67139,4641,measurements,O
67140,4641,or,O
67141,4641,diastolic,O
67142,4641,>,O
67143,4641,100,O
67144,4641,mmHg,O
67145,4641,on,O
67146,4641,optimal,B-Procedure
67147,4641,medical,I-Procedure
67148,4641,regimen,I-Procedure
67149,4642,Screening,O
67150,4642,HgA1c,O
67151,4642,blood,O
67152,4642,test,O
67153,4642,>,O
67154,4642,10.0,O
67155,4643,Focal,B-Procedure
67156,4643,laser,I-Procedure
67157,4643,photocoagulation,I-Procedure
67158,4643,or,O
67159,4643,intravitreal,B-Drug
67160,4643,/,I-Drug
67161,4643,periocular,I-Drug
67162,4643,steroids,I-Drug
67163,4643,of,O
67164,4643,any,O
67165,4643,type,O
67166,4643,in,O
67167,4643,the,O
67168,4643,study,O
67169,4643,eye,O
67170,4643,within,O
67171,4643,the,O
67172,4643,last,O
67173,4643,90,O
67174,4643,days,O
67175,4643,prior,O
67176,4643,to,O
67177,4643,study,O
67178,4643,enrollment,O
67179,4643,.,O
67180,4644,A,O
67181,4644,history,B-Observation
67182,4644,of,I-Observation
67183,4644,intravitreal,O
67184,4644,anti,B-Procedure
67185,4644,-,I-Procedure
67186,4644,VEGF,I-Procedure
67187,4644,injection,I-Procedure
67188,4644,of,O
67189,4644,any,O
67190,4644,type,O
67191,4644,in,O
67192,4644,the,O
67193,4644,study,O
67194,4644,eye,O
67195,4644,within,O
67196,4644,the,O
67197,4644,last,O
67198,4644,45,O
67199,4644,days,O
67200,4644,prior,O
67201,4644,to,O
67202,4644,study,O
67203,4644,enrollment,O
67204,4644,.,O
67205,4645,History,B-Observation
67206,4645,of,I-Observation
67207,4645,rhegmatogenous,B-Condition
67208,4645,retinal,I-Condition
67209,4645,detachment,I-Condition
67210,4645,",",O
67211,4645,retinal,B-Condition
67212,4645,tear(s,I-Condition
67213,4645,),I-Condition
67214,4645,",",O
67215,4645,or,O
67216,4645,traction,B-Condition
67217,4645,retinal,I-Condition
67218,4645,detachments,I-Condition
67219,4645,in,O
67220,4645,the,O
67221,4645,study,O
67222,4645,eye,O
67223,4645,.,O
67224,4646,Epiretinal,B-Condition
67225,4646,membrane,I-Condition
67226,4646,and/or,I-Condition
67227,4646,vitreomacular,I-Condition
67228,4646,traction,I-Condition
67229,4646,in,O
67230,4646,the,O
67231,4646,study,O
67232,4646,eye,O
67233,4646,as,O
67234,4646,determined,O
67235,4646,by,O
67236,4646,the,O
67237,4646,central,O
67238,4646,reading,O
67239,4646,center,O
67240,4646,.,O
67241,4647,Previous,O
67242,4647,pars,B-Procedure
67243,4647,plana,I-Procedure
67244,4647,vitrectomy,I-Procedure
67245,4647,in,O
67246,4647,the,O
67247,4647,study,O
67248,4647,eye,O
67249,4648,Any,O
67250,4648,intraocular,B-Procedure
67251,4648,surgery,I-Procedure
67252,4648,in,O
67253,4648,the,O
67254,4648,study,O
67255,4648,eye,O
67256,4648,within,O
67257,4648,the,O
67258,4648,last,O
67259,4648,90,O
67260,4648,days,O
67261,4648,prior,O
67262,4648,to,O
67263,4648,study,O
67264,4648,enrollment,O
67265,4648,.,O
67266,4649,YAG,B-Procedure
67267,4649,laser,I-Procedure
67268,4649,treatment,I-Procedure
67269,4649,in,O
67270,4649,the,O
67271,4649,study,O
67272,4649,eye,O
67273,4649,in,O
67274,4649,last,O
67275,4649,30,O
67276,4649,days,O
67277,4649,prior,O
67278,4649,to,O
67279,4649,study,O
67280,4649,enrollment,O
67281,4649,.,O
67282,4650,High,B-Condition
67283,4650,myopia,I-Condition
67284,4650,in,O
67285,4650,the,O
67286,4650,study,O
67287,4650,eye,O
67288,4650,",",O
67289,4650,with,O
67290,4650,a,O
67291,4650,spherical,O
67292,4650,equivalent,O
67293,4650,of,O
67294,4650,>,O
67295,4650,8.00D,O
67296,4650,at,O
67297,4650,screening,O
67298,4651,Other,O
67299,4651,ocular,B-Condition
67300,4651,pathologies,I-Condition
67301,4651,that,O
67302,4651,in,O
67303,4651,the,O
67304,4651,investigator,O
67305,4651,'s,O
67306,4651,opinion,O
67307,4651,would,B-Observation
67308,4651,interfere,I-Observation
67309,4651,with,I-Observation
67310,4651,the,I-Observation
67311,4651,subject,I-Observation
67312,4651,'s,I-Observation
67313,4651,vision,I-Observation
67314,4651,in,I-Observation
67315,4651,the,I-Observation
67316,4651,study,I-Observation
67317,4651,eye,I-Observation
67318,4651,.,O
67319,4652,Chronic,O
67320,4652,or,O
67321,4652,recurrent,O
67322,4652,uveitis,B-Condition
67323,4652,.,O
67324,4653,Ongoing,O
67325,4653,ocular,B-Condition
67326,4653,infection,I-Condition
67327,4653,or,I-Condition
67328,4653,inflammation,I-Condition
67329,4653,in,O
67330,4653,either,O
67331,4653,eye,O
67332,4653,.,O
67333,4654,A,O
67334,4654,history,B-Observation
67335,4654,of,I-Observation
67336,4654,cataract,B-Condition
67337,4654,surgery,I-Condition
67338,4654,complications,I-Condition
67339,4654,/,O
67340,4654,vitreous,B-Condition
67341,4654,loss,I-Condition
67342,4654,in,O
67343,4654,the,O
67344,4654,study,O
67345,4654,eye,O
67346,4654,.,O
67347,4655,Congenital,B-Condition
67348,4655,eye,I-Condition
67349,4655,malformations,I-Condition
67350,4655,in,O
67351,4655,the,O
67352,4655,study,O
67353,4655,eye,O
67354,4655,.,O
67355,4656,A,O
67356,4656,history,B-Observation
67357,4656,of,I-Observation
67358,4656,penetrating,B-Condition
67359,4656,ocular,I-Condition
67360,4656,trauma,I-Condition
67361,4656,in,O
67362,4656,the,O
67363,4656,study,O
67364,4656,eye,O
67365,4656,.,O
67366,4657,Mentally,B-Condition
67367,4657,handicapped,I-Condition
67368,4657,.,O
67369,4658,Pregnant,B-Condition
67370,4658,female,B-Person
67371,4658,",",O
67372,4658,as,O
67373,4658,determined,O
67374,4658,for,O
67375,4658,women,B-Person
67376,4658,less,O
67377,4658,than,O
67378,4658,60,O
67379,4658,years,O
67380,4658,old,B-Person
67381,4658,by,O
67382,4658,a,O
67383,4658,positive,O
67384,4658,urine,O
67385,4658,pregnancy,O
67386,4658,test,O
67387,4658,during,O
67388,4658,the,O
67389,4658,screening,O
67390,4658,window,O
67391,4658,.,O
67392,4659,Nursing,B-Observation
67393,4659,female,B-Person
67394,4659,.,O
67395,4660,Currently,O
67396,4660,participating,O
67397,4660,in,O
67398,4660,any,O
67399,4660,other,O
67400,4660,clinical,O
67401,4660,research,O
67402,4660,study,O
67403,4660,.,O
67404,4661,Contraindication,B-Condition
67405,4661,to,O
67406,4661,the,O
67407,4661,study,B-Drug
67408,4661,medication,I-Drug
67409,4661,.,O
67410,4662,Male,B-Person
67411,4662,or,O
67412,4662,female,B-Person
67413,4662,",",O
67414,4662,18,O
67415,4662,years,O
67416,4662,of,O
67417,4662,age,B-Person
67418,4662,or,O
67419,4662,older,O
67420,4662,.,O
67421,4663,Study,O
67422,4663,eye,O
67423,4663,with,O
67424,4663,clinically,O
67425,4663,significant,O
67426,4663,diabetic,B-Condition
67427,4663,macular,I-Condition
67428,4663,edema,I-Condition
67429,4663,(,I-Condition
67430,4663,DME,I-Condition
67431,4663,),I-Condition
67432,4663,with,O
67433,4663,central,O
67434,4663,subfield,O
67435,4663,thickness,O
67436,4663,≥,O
67437,4663,350,O
67438,4663,µm,O
67439,4663,on,O
67440,4663,spectral,B-Procedure
67441,4663,domain,I-Procedure
67442,4663,OCT,I-Procedure
67443,4664,Best,O
67444,4664,corrected,O
67445,4664,visual,O
67446,4664,acuity,O
67447,4664,(,O
67448,4664,BCVA,O
67449,4664,),O
67450,4664,of,O
67451,4664,20/50,O
67452,4664,to,O
67453,4664,20/320,O
67454,4664,ETDRS,O
67455,4664,equivalent,O
67456,4664,(,O
67457,4664,65,O
67458,4664,letters,O
67459,4664,to,O
67460,4664,23,O
67461,4664,letters,O
67462,4664,),O
67463,4664,in,O
67464,4664,the,O
67465,4664,study,O
67466,4664,eye,O
67467,4664,",",O
67468,4664,with,O
67469,4664,BCVA,O
67470,4664,decrement,O
67471,4664,primarily,O
67472,4664,attributable,O
67473,4664,to,O
67474,4664,DME,O
67475,4664,.,O
67476,4665,Treatment,B-Observation
67477,4665,naïve,I-Observation
67478,4665,",",O
67479,4665,i.e.,O
67480,4665,",",O
67481,4665,no,O
67482,4665,previous,O
67483,4665,anti,B-Procedure
67484,4665,-,I-Procedure
67485,4665,VEGF,I-Procedure
67486,4665,treatment,I-Procedure
67487,4665,in,O
67488,4665,the,O
67489,4665,study,O
67490,4665,eye,O
67491,4665,or,O
67492,4665,no,O
67493,4665,anti,B-Procedure
67494,4665,-,I-Procedure
67495,4665,VEGF,I-Procedure
67496,4665,treatment,I-Procedure
67497,4665,in,O
67498,4665,the,O
67499,4665,45,O
67500,4665,days,O
67501,4665,prior,O
67502,4665,to,O
67503,4665,study,O
67504,4665,enrollment,O
67505,4665,.,O
67506,4666,In,O
67507,4666,the,O
67508,4666,investigator,O
67509,4666,'s,O
67510,4666,opinion,O
67511,4666,",",O
67512,4666,the,O
67513,4666,subject,O
67514,4666,still,O
67515,4666,has,O
67516,4666,significant,O
67517,4666,intraretinal,B-Condition
67518,4666,fluid,I-Condition
67519,4666,with,O
67520,4666,room,O
67521,4666,for,O
67522,4666,improvement,O
67523,4666,in,O
67524,4666,both,O
67525,4666,macular,B-Condition
67526,4666,edema,I-Condition
67527,4666,and,O
67528,4666,BCVA,B-Condition
67529,4666,.,O
67530,4667,Intra,O
67531,4667,-,O
67532,4667,Ocular,O
67533,4667,Pressure,O
67534,4667,(,O
67535,4667,IOP,O
67536,4667,),O
67537,4667,is,O
67538,4667,under,O
67539,4667,control,O
67540,4667,(,O
67541,4667,i.e.,O
67542,4667,",",O
67543,4667,IOP,O
67544,4667,≤,O
67545,4667,25,O
67546,4667,mm,O
67547,4667,in,O
67548,4667,the,O
67549,4667,study,O
67550,4667,eye,O
67551,4667,),O
67552,4667,and,O
67553,4667,study,O
67554,4667,eye,O
67555,4667,is,O
67556,4667,not,O
67557,4667,receiving,O
67558,4667,any,O
67559,4667,IOP,B-Drug
67560,4667,lowering,I-Drug
67561,4667,drops,I-Drug
67562,4667,.,O
67563,4668,Willing,O
67564,4668,and,O
67565,4668,able,O
67566,4668,to,O
67567,4668,return,O
67568,4668,for,O
67569,4668,all,O
67570,4668,study,O
67571,4668,visits,O
67572,4668,.,O
67573,4669,Able,O
67574,4669,to,O
67575,4669,meet,O
67576,4669,the,O
67577,4669,extensive,O
67578,4669,post,O
67579,4669,-,O
67580,4669,op,O
67581,4669,evaluation,O
67582,4669,regimen,O
67583,4669,.,O
67584,4670,Understands,O
67585,4670,and,O
67586,4670,signs,O
67587,4670,the,O
67588,4670,informed,O
67589,4670,consent,O
67590,4670,form,O
67591,4670,.,O
67592,4671,1,O
67593,4671,.,O
67594,4671,Had,O
67595,4671,a,O
67596,4671,neurological,B-Condition
67597,4671,condition,I-Condition
67598,4671,other,O
67599,4671,than,O
67600,4671,that,O
67601,4671,associated,O
67602,4671,with,O
67603,4671,their,O
67604,4671,pain,B-Condition
67605,4671,diagnosis,I-Condition
67606,4671,which,O
67607,4671,",",O
67608,4671,in,O
67609,4671,the,O
67610,4671,opinion,O
67611,4671,of,O
67612,4671,the,O
67613,4671,investigator,O
67614,4671,",",O
67615,4671,would,O
67616,4671,interfere,O
67617,4671,with,O
67618,4671,their,O
67619,4671,ability,O
67620,4671,to,O
67621,4671,participate,O
67622,4671,in,O
67623,4671,the,O
67624,4671,study,O
67625,4672,2,O
67626,4672,.,O
67627,4672,Were,O
67628,4672,taking,O
67629,4672,a,O
67630,4672,lidocaine,B-Drug
67631,4672,-,I-Drug
67632,4672,containing,I-Drug
67633,4672,product,I-Drug
67634,4672,that,O
67635,4672,could,O
67636,4672,not,O
67637,4672,be,O
67638,4672,discontinued,O
67639,4672,while,O
67640,4672,receiving,O
67641,4672,lidocaine,B-Drug
67642,4673,3,O
67643,4673,.,O
67644,4673,Were,O
67645,4673,taking,O
67646,4673,class,B-Drug
67647,4673,1,I-Drug
67648,4673,anti,I-Drug
67649,4673,-,I-Drug
67650,4673,arrhythmic,I-Drug
67651,4673,drugs,I-Drug
67652,4673,(,O
67653,4673,e.g.,O
67654,4673,",",O
67655,4673,mexiletine,B-Drug
67656,4673,",",O
67657,4673,tocainide,B-Drug
67658,4673,),O
67659,4674,1,O
67660,4674,.,O
67661,4674,Had,O
67662,4674,a,O
67663,4674,diagnosis,O
67664,4674,of,O
67665,4674,PHN,B-Condition
67666,4674,",",O
67667,4674,DN,B-Condition
67668,4674,",",O
67669,4674,CRPS,B-Condition
67670,4674,",",O
67671,4674,carpal,B-Condition
67672,4674,tunnel,I-Condition
67673,4674,syndrome,I-Condition
67674,4674,",",O
67675,4674,HIV,B-Condition
67676,4674,neuropathy,I-Condition
67677,4674,",",O
67678,4674,idiopathic,O
67679,4674,sensory,B-Condition
67680,4674,neuropathy,I-Condition
67681,4674,",",O
67682,4674,or,O
67683,4674,other,O
67684,4674,peripheral,B-Condition
67685,4674,neuropathy,I-Condition
67686,4674,(,O
67687,4674,upon,O
67688,4674,mutual,O
67689,4674,agreement,O
67690,4674,of,O
67691,4674,the,O
67692,4674,sponsor,O
67693,4674,and,O
67694,4674,investigator,O
67695,4674,),O
67696,4675,2,O
67697,4675,.,O
67698,4675,Patients,O
67699,4675,with,O
67700,4675,PHN,B-Condition
67701,4675,must,O
67702,4675,have,O
67703,4675,had,O
67704,4675,pain,B-Condition
67705,4675,>,O
67706,4675,3,O
67707,4675,months,O
67708,4675,after,O
67709,4675,rash,B-Condition
67710,4675,healing,I-Condition
67711,4676,3,O
67712,4676,.,O
67713,4676,Patients,O
67714,4676,with,O
67715,4676,DN,B-Condition
67716,4676,must,O
67717,4676,have,O
67718,4676,had,O
67719,4676,Type,B-Condition
67720,4676,I,I-Condition
67721,4676,or,I-Condition
67722,4676,II,I-Condition
67723,4676,diabetes,I-Condition
67724,4676,and,O
67725,4676,painful,O
67726,4676,distal,O
67727,4676,symmetric,O
67728,4676,sensorimotor,B-Condition
67729,4676,polyneuropathy,I-Condition
67730,4676,with,O
67731,4676,or,O
67732,4676,without,O
67733,4676,dynamic,B-Condition
67734,4676,allodynia,I-Condition
67735,4676,of,O
67736,4676,the,O
67737,4676,lower,O
67738,4676,extremities,O
67739,4677,4,O
67740,4677,.,O
67741,4677,Patients,O
67742,4677,with,O
67743,4677,CRPS,B-Condition
67744,4677,must,O
67745,4677,have,O
67746,4677,met,O
67747,4677,current,O
67748,4677,IASP,O
67749,4677,(,O
67750,4677,International,O
67751,4677,Association,O
67752,4677,for,O
67753,4677,the,O
67754,4677,Study,O
67755,4677,of,O
67756,4677,Pain,O
67757,4677,),O
67758,4677,diagnostic,O
67759,4677,criteria,O
67760,4678,5,O
67761,4678,.,O
67762,4678,Patients,O
67763,4678,with,O
67764,4678,carpal,B-Condition
67765,4678,tunnel,I-Condition
67766,4678,syndrome,I-Condition
67767,4678,must,O
67768,4678,have,O
67769,4678,had,O
67770,4678,a,O
67771,4678,diagnosis,O
67772,4678,by,O
67773,4678,combination,O
67774,4678,clinical,B-Procedure
67775,4678,neurological,I-Procedure
67776,4678,examination,I-Procedure
67777,4678,(,O
67778,4678,e.g.,O
67779,4678,",",O
67780,4678,Phalen,B-Condition
67781,4678,'s,I-Condition
67782,4678,and,I-Condition
67783,4678,Tinel,I-Condition
67784,4678,'s,I-Condition
67785,4678,signs,I-Condition
67786,4678,),O
67787,4678,",",O
67788,4678,electrodiagnostic,B-Procedure
67789,4678,testing,O
67790,4678,",",O
67791,4678,and,O
67792,4678,daily,O
67793,4678,painful,B-Condition
67794,4678,symptoms,I-Condition
67795,4678,of,O
67796,4678,at,O
67797,4678,least,O
67798,4678,3,O
67799,4678,months,O
67800,4678,',O
67801,4678,duration,O
67802,4679,6,O
67803,4679,.,O
67804,4679,Patients,O
67805,4679,with,O
67806,4679,HIV,B-Condition
67807,4679,neuropathy,I-Condition
67808,4679,must,O
67809,4679,have,O
67810,4679,had,O
67811,4679,HIV,B-Condition
67812,4679,",",O
67813,4679,subjective,B-Condition
67814,4679,symptoms,I-Condition
67815,4679,of,O
67816,4679,painful,O
67817,4679,peripheral,B-Condition
67818,4679,neuropathy,I-Condition
67819,4679,",",O
67820,4679,and,O
67821,4679,daily,O
67822,4679,painful,B-Condition
67823,4679,symptoms,I-Condition
67824,4679,of,O
67825,4679,at,O
67826,4679,least,O
67827,4679,3,O
67828,4679,months,O
67829,4679,',O
67830,4679,duration,O
67831,4680,7,O
67832,4680,.,O
67833,4680,Patients,O
67834,4680,with,O
67835,4680,idiopathic,B-Condition
67836,4680,sensory,I-Condition
67837,4680,neuropathy,I-Condition
67838,4680,must,O
67839,4680,have,O
67840,4680,had,O
67841,4680,pain,B-Condition
67842,4680,of,O
67843,4680,at,O
67844,4680,least,O
67845,4680,3,O
67846,4680,months,O
67847,4680,',O
67848,4680,duration,O
67849,4681,8,O
67850,4681,.,O
67851,4681,Reached,O
67852,4681,an,O
67853,4681,average,O
67854,4681,daily,O
67855,4681,pain,O
67856,4681,rating,O
67857,4681,during,O
67858,4681,the,O
67859,4681,baseline,O
67860,4681,week,O
67861,4681,of,O
67862,4681,pain,O
67863,4681,ratings,O
67864,4681,greater,O
67865,4681,than,O
67866,4681,4,O
67867,4681,on,O
67868,4681,the,O
67869,4681,0,B-Procedure
67870,4681,-,I-Procedure
67871,4681,to-10,I-Procedure
67872,4681,numerical,I-Procedure
67873,4681,pain,I-Procedure
67874,4681,rating,I-Procedure
67875,4681,scale,I-Procedure
67876,4681,(,O
67877,4681,Question,O
67878,4681,5,O
67879,4681,of,O
67880,4681,the,O
67881,4681,BPI,O
67882,4681,),O
67883,4682,9,O
67884,4682,.,O
67885,4682,Had,O
67886,4682,never,O
67887,4682,received,O
67888,4682,an,O
67889,4682,analgesic,B-Drug
67890,4682,regimen,I-Drug
67891,4682,that,O
67892,4682,contained,O
67893,4682,lidocaine,B-Drug
67894,4682,or,O
67895,4682,gabapentin,B-Drug
67896,4683,BMI,O
67897,4683,>,O
67898,4683,30,O
67899,4683,kg.m-2,O
67900,4683,",",O
67901,4684,ASA,O
67902,4684,physical,O
67903,4684,state,O
67904,4684,>,O
67905,4684,II,O
67906,4685,Allergy,B-Condition
67907,4685,to,O
67908,4685,the,O
67909,4685,used,O
67910,4685,local,B-Drug
67911,4685,anesthetics,I-Drug
67912,4686,Infection,B-Condition
67913,4686,at,O
67914,4686,the,O
67915,4686,injection,O
67916,4686,site,O
67917,4687,age,B-Person
67918,4687,<,O
67919,4687,18y,O
67920,4688,Adult,B-Person
67921,4688,patients,O
67922,4688,scheduled,B-Mood
67923,4688,for,O
67924,4688,arthroscopic,B-Procedure
67925,4688,knee,I-Procedure
67926,4688,ligament,I-Procedure
67927,4688,reconstruction,I-Procedure
67928,4689,NA,O
67929,4690,NA,O
67930,4691,Allergy,B-Condition
67931,4691,to,O
67932,4691,ceftriaxone,B-Drug
67933,4691,or,O
67934,4691,macrolides,B-Drug
67935,4692,Major,O
67936,4692,typhoid,B-Condition
67937,4692,fever,I-Condition
67938,4692,-,O
67939,4692,associated,O
67940,4692,complications,B-Condition
67941,4693,Inability,B-Condition
67942,4693,to,I-Condition
67943,4693,swallow,I-Condition
67944,4693,oral,I-Condition
67945,4693,medication,I-Condition
67946,4694,Underlying,B-Condition
67947,4694,illness,I-Condition
67948,4695,Pregnancy,B-Condition
67949,4696,Lactation,B-Condition
67950,4697,Treatment,O
67951,4697,within,O
67952,4697,the,O
67953,4697,past,O
67954,4697,4,O
67955,4697,days,O
67956,4697,with,O
67957,4697,an,O
67958,4697,antibiotic,B-Drug
67959,4697,that,O
67960,4697,may,O
67961,4697,be,O
67962,4697,effective,O
67963,4697,against,O
67964,4697,typhoid,B-Condition
67965,4697,fever,I-Condition
67966,4698,Blood,O
67967,4698,culture,O
67968,4698,-,O
67969,4698,proven,O
67970,4698,typhoid,B-Condition
67971,4698,fever,I-Condition
67972,4698,(,O
67973,4698,S.,B-Condition
67974,4698,typhi,I-Condition
67975,4698,or,O
67976,4698,S.,B-Condition
67977,4698,paratyphi,I-Condition
67978,4698,),O
67979,4699,Signed,O
67980,4699,informed,O
67981,4699,consent,O
67982,4699,to,O
67983,4699,participate,O
67984,4699,in,O
67985,4699,the,O
67986,4699,study,O
67987,4699,.,O
67988,4700,Infants,B-Person
67989,4700,who,O
67990,4700,have,O
67991,4700,already,O
67992,4700,received,O
67993,4700,postnatal,B-Procedure
67994,4700,vitamin,I-Procedure
67995,4700,D,I-Procedure
67996,4700,supplementation,I-Procedure
67997,4701,prematurity,B-Condition
67998,4701,(,O
67999,4701,<,O
68000,4701,37,O
68001,4701,weeks)/low,O
68002,4701,birthweight,I-Condition
68003,4701,<,O
68004,4701,2500,O
68005,4701,g,O
68006,4702,poor,B-Condition
68007,4702,health,I-Condition
68008,4702,due,O
68009,4702,to,O
68010,4702,a,O
68011,4702,current,O
68012,4702,or,O
68013,4702,past,O
68014,4702,significant,B-Condition
68015,4702,disease,I-Condition
68016,4702,state,I-Condition
68017,4702,or,O
68018,4702,congenital,B-Condition
68019,4702,abnormality,I-Condition
68020,4702,.,O
68021,4703,Healthy,B-Condition
68022,4703,",",O
68023,4703,term,B-Condition
68024,4703,",",O
68025,4703,breastfeeding,B-Observation
68026,4703,infants,B-Person
68027,4703,who,O
68028,4703,will,O
68029,4703,be,O
68030,4703,predominately,B-Observation
68031,4703,breastfed,I-Observation
68032,4703,for,O
68033,4703,at,O
68034,4703,least,O
68035,4703,6,O
68036,4703,-,O
68037,4703,months,O
68038,4703,.,O
68039,4703,This,O
68040,4703,will,O
68041,4703,be,O
68042,4703,determined,O
68043,4703,by,O
68044,4703,answering,O
68045,4703,yes,O
68046,4703,/,O
68047,4703,no,O
68048,4703,to,O
68049,4703,question,O
68050,4703,',O
68051,4703,do,O
68052,4703,you,O
68053,4703,intend,O
68054,4703,to,O
68055,4703,breastfeed,O
68056,4703,until,O
68057,4703,your,O
68058,4703,infant,O
68059,4703,is,O
68060,4703,at,O
68061,4703,least,O
68062,4703,6,O
68063,4703,months,O
68064,4703,of,O
68065,4703,age,O
68066,4703,.,O
68067,4703,',O
68068,4704,Uncontrolled,O
68069,4704,medical,B-Condition
68070,4704,problems,I-Condition
68071,4704,including,O
68072,4704,pulmonary,B-Condition
68073,4704,",",I-Condition
68074,4704,cardiovascular,I-Condition
68075,4704,or,I-Condition
68076,4704,orthopedic,I-Condition
68077,4704,disease,I-Condition
68078,4704,",",O
68079,4705,Any,O
68080,4705,debilitating,B-Condition
68081,4705,disease,I-Condition
68082,4705,prior,O
68083,4705,to,O
68084,4705,the,O
68085,4705,SCI,O
68086,4705,that,O
68087,4705,caused,O
68088,4705,exercise,B-Condition
68089,4705,intolerance,I-Condition
68090,4706,Premorbid,O
68091,4706,",",O
68092,4706,ongoing,O
68093,4706,major,B-Condition
68094,4706,depression,I-Condition
68095,4706,or,O
68096,4706,psychosis,B-Condition
68097,4706,",",O
68098,4706,altered,B-Condition
68099,4706,cognitive,I-Condition
68100,4706,status,I-Condition
68101,4707,History,B-Observation
68102,4707,of,I-Observation
68103,4707,head,B-Condition
68104,4707,injury,I-Condition
68105,4707,or,O
68106,4707,stroke,B-Condition
68107,4707,",",O
68108,4708,Metal,O
68109,4708,plate,O
68110,4708,in,O
68111,4708,skull,O
68112,4709,History,O
68113,4709,of,O
68114,4709,seizures,B-Condition
68115,4710,Receiving,O
68116,4710,drugs,B-Drug
68117,4710,acting,I-Drug
68118,4710,primarily,I-Drug
68119,4710,on,I-Drug
68120,4710,the,I-Drug
68121,4710,central,I-Drug
68122,4710,nervous,I-Drug
68123,4710,system,I-Drug
68124,4710,",",O
68125,4710,which,O
68126,4710,lower,O
68127,4710,the,O
68128,4710,seizure,O
68129,4710,threshold,O
68130,4710,such,O
68131,4710,as,O
68132,4710,antipsychotic,B-Drug
68133,4710,drugs,I-Drug
68134,4710,(,O
68135,4710,chlorpromazine,B-Drug
68136,4710,",",O
68137,4710,clozapine,B-Drug
68138,4710,),O
68139,4710,or,O
68140,4710,tricyclic,B-Drug
68141,4710,antidepressants,I-Drug
68142,4710,.,O
68143,4711,Pregnant,B-Condition
68144,4711,females,B-Person
68145,4711,",",O
68146,4711,and,O
68147,4712,Ongoing,O
68148,4712,cord,B-Condition
68149,4712,compression,I-Condition
68150,4712,or,O
68151,4712,a,O
68152,4712,syrinx,B-Condition
68153,4712,in,O
68154,4712,the,O
68155,4712,spinal,O
68156,4712,cord,O
68157,4712,or,O
68158,4712,who,O
68159,4712,suffer,O
68160,4712,from,O
68161,4712,a,O
68162,4712,spinal,B-Condition
68163,4712,cord,I-Condition
68164,4712,disease,I-Condition
68165,4712,such,O
68166,4712,as,O
68167,4712,spinal,B-Condition
68168,4712,stenosis,I-Condition
68169,4712,",",O
68170,4712,spina,B-Condition
68171,4712,bifida,I-Condition
68172,4712,or,O
68173,4712,herniated,B-Condition
68174,4712,cervical,I-Condition
68175,4712,disk,I-Condition
68176,4712,.,O
68177,4713,Uncontrolled,O
68178,4713,medical,B-Condition
68179,4713,problems,I-Condition
68180,4713,including,O
68181,4713,pulmonary,B-Condition
68182,4713,",",I-Condition
68183,4713,cardiovascular,I-Condition
68184,4713,or,I-Condition
68185,4713,orthopedic,I-Condition
68186,4713,disease,I-Condition
68187,4713,",",O
68188,4714,Any,O
68189,4714,debilitating,B-Condition
68190,4714,disease,I-Condition
68191,4714,that,O
68192,4714,causes,O
68193,4714,exercise,B-Condition
68194,4714,intolerance,I-Condition
68195,4715,Premorbid,O
68196,4715,",",O
68197,4715,ongoing,O
68198,4715,major,B-Condition
68199,4715,depression,I-Condition
68200,4715,or,O
68201,4715,psychosis,B-Condition
68202,4715,",",O
68203,4715,altered,B-Condition
68204,4715,cognitive,I-Condition
68205,4715,status,I-Condition
68206,4716,History,B-Observation
68207,4716,of,O
68208,4716,head,B-Condition
68209,4716,injury,I-Condition
68210,4716,or,O
68211,4716,stroke,B-Condition
68212,4716,",",O
68213,4717,Metal,O
68214,4717,plate,O
68215,4717,in,O
68216,4717,skull,O
68217,4718,History,B-Observation
68218,4718,of,I-Observation
68219,4718,seizures,B-Condition
68220,4719,Receiving,O
68221,4719,drugs,B-Drug
68222,4719,acting,I-Drug
68223,4719,primarily,I-Drug
68224,4719,on,I-Drug
68225,4719,the,I-Drug
68226,4719,central,I-Drug
68227,4719,nervous,I-Drug
68228,4719,system,I-Drug
68229,4719,",",O
68230,4719,which,O
68231,4719,lower,O
68232,4719,the,O
68233,4719,seizure,O
68234,4719,threshold,O
68235,4719,such,O
68236,4719,as,O
68237,4719,antipsychotic,B-Drug
68238,4719,drugs,I-Drug
68239,4719,(,O
68240,4719,chlorpromazine,B-Drug
68241,4719,",",O
68242,4719,clozapine,B-Drug
68243,4719,),O
68244,4719,or,O
68245,4719,tricyclic,B-Drug
68246,4719,antidepressants,I-Drug
68247,4719,.,O
68248,4720,Pregnant,B-Condition
68249,4720,females,B-Person
68250,4720,",",O
68251,4720,and,O
68252,4721,Ongoing,O
68253,4721,cord,B-Condition
68254,4721,compression,I-Condition
68255,4721,or,O
68256,4721,a,O
68257,4721,syrinx,B-Condition
68258,4721,in,O
68259,4721,the,O
68260,4721,spinal,O
68261,4721,cord,O
68262,4721,or,O
68263,4721,who,O
68264,4721,suffer,O
68265,4721,from,O
68266,4721,a,O
68267,4721,spinal,B-Condition
68268,4721,cord,I-Condition
68269,4721,disease,I-Condition
68270,4721,such,O
68271,4721,as,O
68272,4721,spinal,B-Condition
68273,4721,stenosis,I-Condition
68274,4721,",",O
68275,4721,spina,B-Condition
68276,4721,bifida,I-Condition
68277,4721,or,O
68278,4721,herniated,B-Condition
68279,4721,cervical,I-Condition
68280,4721,disk,I-Condition
68281,4721,.,O
68282,4722,Male,B-Person
68283,4722,and,O
68284,4722,females,B-Person
68285,4722,between,O
68286,4722,ages,B-Person
68287,4722,18,O
68288,4722,-,O
68289,4722,85,O
68290,4722,years,O
68291,4722,of,O
68292,4722,age,O
68293,4723,SCI,B-Condition
68294,4723,(,O
68295,4723,=,O
68296,4723,1,O
68297,4723,month,O
68298,4723,of,O
68299,4723,injury,O
68300,4723,),O
68301,4724,ASIA,O
68302,4724,A,O
68303,4724,",",O
68304,4724,B,O
68305,4724,",",O
68306,4724,C,O
68307,4724,and,O
68308,4724,D,O
68309,4725,SCI,O
68310,4725,above,O
68311,4725,L5,O
68312,4726,Able,O
68313,4726,to,O
68314,4726,perform,O
68315,4726,a,O
68316,4726,visible,O
68317,4726,contraction,O
68318,4726,with,O
68319,4726,dorsiflexor,O
68320,4726,and,O
68321,4726,hip,O
68322,4726,flexor,O
68323,4726,muscles,O
68324,4726,(,O
68325,4726,allowing,O
68326,4726,testing,O
68327,4726,of,O
68328,4726,largely,O
68329,4726,impaired,O
68330,4726,patients,O
68331,4726,),O
68332,4727,Able,B-Condition
68333,4727,to,I-Condition
68334,4727,ambulate,I-Condition
68335,4727,a,I-Condition
68336,4727,few,I-Condition
68337,4727,steps,I-Condition
68338,4727,with,O
68339,4727,or,O
68340,4727,without,O
68341,4727,an,O
68342,4727,assistive,O
68343,4727,device,O
68344,4728,Male,O
68345,4728,and,O
68346,4728,females,B-Person
68347,4728,between,O
68348,4728,ages,B-Person
68349,4728,18,O
68350,4728,-,O
68351,4728,85,O
68352,4728,years,O
68353,4728,of,O
68354,4728,age,O
68355,4729,Able,B-Condition
68356,4729,to,I-Condition
68357,4729,walk,I-Condition
68358,4729,and,I-Condition
68359,4729,complete,I-Condition
68360,4729,lower,I-Condition
68361,4729,-,I-Condition
68362,4729,limb,I-Condition
68363,4729,tests,I-Condition
68364,4729,with,O
68365,4729,both,O
68366,4729,legs,O
68367,4730,History,O
68368,4730,of,O
68369,4730,ischaemic,B-Condition
68370,4730,heart,I-Condition
68371,4730,disease,I-Condition
68372,4730,",",O
68373,4730,cardiac,B-Condition
68374,4730,failure,I-Condition
68375,4730,",",O
68376,4730,cerebrovascular,B-Condition
68377,4730,disease,I-Condition
68378,4730,",",O
68379,4730,liver,B-Condition
68380,4730,impairment,I-Condition
68381,4730,(,O
68382,4730,ALT,O
68383,4730,/,O
68384,4730,AST>50IU,O
68385,4730,/,O
68386,4730,L,O
68387,4730,),O
68388,4730,or,O
68389,4730,stage,O
68390,4730,3,O
68391,4730,-,O
68392,4730,5,O
68393,4730,chronic,B-Condition
68394,4730,kidney,I-Condition
68395,4730,disease,I-Condition
68396,4730,.,O
68397,4731,History,O
68398,4731,of,O
68399,4731,overdose,B-Condition
68400,4731,or,O
68401,4731,suicidal,B-Condition
68402,4731,ideation,I-Condition
68403,4732,Patients,O
68404,4732,weighing,O
68405,4732,<,O
68406,4732,55kgs,O
68407,4732,.,O
68408,4733,Patients,O
68409,4733,with,O
68410,4733,chronic,B-Condition
68411,4733,pain,I-Condition
68412,4733,requiring,O
68413,4733,treatment,O
68414,4733,",",O
68415,4733,with,O
68416,4733,a,O
68417,4733,known,B-Condition
68418,4733,allergy,I-Condition
68419,4733,to,O
68420,4733,paracetamol,B-Drug
68421,4733,",",O
68422,4733,or,O
68423,4733,concomitant,O
68424,4733,use,O
68425,4733,of,O
68426,4733,non,B-Drug
68427,4733,-,I-Drug
68428,4733,steroidal,I-Drug
68429,4733,anti,I-Drug
68430,4733,-,I-Drug
68431,4733,inflammatories,I-Drug
68432,4733,",",O
68433,4733,oral,B-Drug
68434,4733,anticoagulants,I-Drug
68435,4733,or,O
68436,4733,corticosteroids,B-Drug
68437,4733,.,O
68438,4734,=,O
68439,4734,18,O
68440,4734,years,B-Person
68441,4734,old,I-Person
68442,4734,",",O
68443,4734,men,B-Person
68444,4734,or,O
68445,4734,post,B-Condition
68446,4734,-,I-Condition
68447,4734,menopausal,I-Condition
68448,4734,women,B-Person
68449,4734,(,O
68450,4734,women,O
68451,4734,with,O
68452,4734,no,B-Condition
68453,4734,periods,I-Condition
68454,4734,for,O
68455,4734,12,O
68456,4734,months,O
68457,4734,or,O
68458,4734,more,O
68459,4734,",",O
68460,4734,or,O
68461,4734,those,O
68462,4734,who,O
68463,4734,have,O
68464,4734,had,O
68465,4734,a,O
68466,4734,surgical,B-Procedure
68467,4734,menopause,B-Condition
68468,4734,),O
68469,4735,Treated,O
68470,4735,hypertensive,B-Condition
68471,4735,patients,O
68472,4735,with,O
68473,4735,an,O
68474,4735,average,O
68475,4735,daytime,O
68476,4735,ambulatory,O
68477,4735,blood,O
68478,4735,pressure,O
68479,4735,measurement,O
68480,4735,(,O
68481,4735,ABPM,O
68482,4735,),O
68483,4735,<,O
68484,4735,150/95mmHg,O
68485,4735,on,O
68486,4735,stable,O
68487,4735,doses,O
68488,4735,of,O
68489,4735,one,O
68490,4735,or,O
68491,4735,more,O
68492,4735,antihypertensive,B-Drug
68493,4735,medication,I-Drug
68494,4735,(,O
68495,4735,at,O
68496,4735,least,O
68497,4735,one,O
68498,4735,of,O
68499,4735,which,O
68500,4735,should,O
68501,4735,be,O
68502,4735,;,O
68503,4735,an,O
68504,4735,ACE,B-Drug
68505,4735,inhibitor,I-Drug
68506,4735,",",O
68507,4735,angiotensin,B-Drug
68508,4735,receptor,I-Drug
68509,4735,blocker,I-Drug
68510,4735,or,O
68511,4735,diuretic,B-Drug
68512,4735,),O
68513,4735,for,O
68514,4735,3,O
68515,4735,months,O
68516,4735,",",O
68517,4735,or,O
68518,4735,untreated,O
68519,4735,hypertensive,B-Condition
68520,4735,patients,I-Condition
68521,4735,with,O
68522,4735,an,O
68523,4735,average,O
68524,4735,daytime,O
68525,4735,ABPM,O
68526,4735,=,O
68527,4735,135/85,O
68528,4735,but,O
68529,4735,<,O
68530,4735,150/95,O
68531,4735,.,O
68532,4736,Evidence,O
68533,4736,of,O
68534,4736,sympathetic,B-Observation
68535,4736,integrity,I-Observation
68536,4736,below,O
68537,4736,the,O
68538,4736,lesion,O
68539,4736,level,O
68540,4736,by,O
68541,4736,the,O
68542,4736,skin,O
68543,4736,axon,O
68544,4736,-,O
68545,4736,reflex,O
68546,4736,vasodilatation,O
68547,4736,(,O
68548,4736,SkARV,O
68549,4736,),O
68550,4736,test,O
68551,4736,;,O
68552,4737,Known,O
68553,4737,allergies,B-Condition
68554,4737,to,O
68555,4737,midodrine,B-Drug
68556,4737,hydrochloride,I-Drug
68557,4737,;,O
68558,4738,PMH,O
68559,4738,of,O
68560,4738,diagnosed,O
68561,4738,heart,B-Condition
68562,4738,",",I-Condition
68563,4738,kidney,I-Condition
68564,4738,",",I-Condition
68565,4738,peripheral,I-Condition
68566,4738,vascular,I-Condition
68567,4738,",",I-Condition
68568,4738,or,I-Condition
68569,4738,cerebral,I-Condition
68570,4738,vascular,I-Condition
68571,4738,disease,I-Condition
68572,4738,",",O
68573,4738,or,O
68574,4738,diabetes,B-Condition
68575,4738,mellitus,I-Condition
68576,4738,;,O
68577,4739,Hypertension,B-Condition
68578,4739,(,O
68579,4739,BP>140/90,O
68580,4739,mmHg,O
68581,4739,),O
68582,4739,;,O
68583,4740,Untreated,O
68584,4740,thyroid,B-Condition
68585,4740,disease,I-Condition
68586,4740,;,O
68587,4741,Acute,O
68588,4741,illness,B-Condition
68589,4741,or,O
68590,4741,infection,B-Condition
68591,4741,;,O
68592,4742,Current,O
68593,4742,smoker,B-Person
68594,4742,;,O
68595,4743,Pregnancy,B-Condition
68596,4743,.,O
68597,4744,Duration,O
68598,4744,of,O
68599,4744,SCI,B-Condition
68600,4744,=,O
68601,4744,1,O
68602,4744,year,O
68603,4744,;,O
68604,4745,Level,O
68605,4745,of,O
68606,4745,SCI,O
68607,4745,C3,O
68608,4745,-,O
68609,4745,T1,O
68610,4745,",",O
68611,4745,AIS,O
68612,4745,A,O
68613,4745,&,O
68614,4745,B,O
68615,4745,;,O
68616,4746,Age,B-Person
68617,4746,between,O
68618,4746,18,O
68619,4746,and,O
68620,4746,65,O
68621,4746,years,O
68622,4746,.,O
68623,4747,History,O
68624,4747,or,O
68625,4747,known,O
68626,4747,presence,O
68627,4747,of,O
68628,4747,central,B-Condition
68629,4747,nervous,I-Condition
68630,4747,system,I-Condition
68631,4747,metastases,I-Condition
68632,4747,.,O
68633,4748,History,O
68634,4748,of,O
68635,4748,another,O
68636,4748,malignancy,B-Condition
68637,4748,except,O
68638,4748,:,O
68639,4748,Malignancy,B-Condition
68640,4748,treated,B-Procedure
68641,4748,with,I-Procedure
68642,4748,curative,I-Procedure
68643,4748,intent,I-Procedure
68644,4748,and,O
68645,4748,with,O
68646,4748,no,O
68647,4748,known,O
68648,4748,active,B-Condition
68649,4748,disease,I-Condition
68650,4748,present,O
68651,4748,for,O
68652,4748,>,O
68653,4748,=,O
68654,4748,5,O
68655,4748,years,O
68656,4748,prior,O
68657,4748,to,O
68658,4748,enrolment,O
68659,4748,and,O
68660,4748,felt,B-Mood
68661,4748,to,I-Mood
68662,4748,be,I-Mood
68663,4748,at,I-Mood
68664,4748,low,I-Mood
68665,4748,risk,I-Mood
68666,4748,for,O
68667,4748,recurrence,B-Condition
68668,4748,by,O
68669,4748,the,O
68670,4748,treating,O
68671,4748,physician,O
68672,4748,;,O
68673,4748,Adequately,O
68674,4748,treated,B-Procedure
68675,4748,non,B-Condition
68676,4748,-,I-Condition
68677,4748,melanomatous,I-Condition
68678,4748,skin,I-Condition
68679,4748,cancer,I-Condition
68680,4748,or,O
68681,4748,lentigo,B-Condition
68682,4748,maligna,I-Condition
68683,4748,without,O
68684,4748,evidence,B-Condition
68685,4748,of,I-Condition
68686,4748,disease,I-Condition
68687,4748,;,O
68688,4748,Adequately,O
68689,4748,treated,B-Procedure
68690,4748,cervical,B-Condition
68691,4748,carcinoma,I-Condition
68692,4748,in,I-Condition
68693,4748,situ,I-Condition
68694,4748,without,O
68695,4748,evidence,B-Mood
68696,4748,of,I-Mood
68697,4748,disease,B-Condition
68698,4748,;,O
68699,4748,Prostatic,B-Condition
68700,4748,intraepithelial,I-Condition
68701,4748,neoplasia,I-Condition
68702,4748,without,O
68703,4748,evidence,B-Mood
68704,4748,of,I-Mood
68705,4748,prostate,B-Condition
68706,4748,cancer,I-Condition
68707,4748,.,O
68708,4749,Known,O
68709,4749,immediate,B-Condition
68710,4749,or,I-Condition
68711,4749,delayed,I-Condition
68712,4749,hypersensitivity,I-Condition
68713,4749,reaction,I-Condition
68714,4749,or,O
68715,4749,idiosyncrasy,B-Condition
68716,4749,to,O
68717,4749,drugs,B-Drug
68718,4749,chemically,I-Drug
68719,4749,related,I-Drug
68720,4749,to,I-Drug
68721,4749,panitumumab,I-Drug
68722,4749,or,I-Drug
68723,4749,excipients,I-Drug
68724,4749,that,O
68725,4749,contraindicates,O
68726,4749,their,O
68727,4749,participation,O
68728,4749,.,O
68729,4750,Prior,O
68730,4750,anti,B-Procedure
68731,4750,-,I-Procedure
68732,4750,epidermal,I-Procedure
68733,4750,growth,I-Procedure
68734,4750,factor,I-Procedure
68735,4750,receptor,I-Procedure
68736,4750,(,I-Procedure
68737,4750,EGFr,I-Procedure
68738,4750,),I-Procedure
68739,4750,antibody,I-Procedure
68740,4750,therapy,I-Procedure
68741,4750,(,O
68742,4750,e.g.,O
68743,4750,",",O
68744,4750,panitumumab,B-Drug
68745,4750,or,O
68746,4750,cetuximab,B-Drug
68747,4750,),O
68748,4750,or,O
68749,4750,treatment,B-Procedure
68750,4750,with,I-Procedure
68751,4750,small,I-Procedure
68752,4750,molecule,I-Procedure
68753,4750,EGFr,I-Procedure
68754,4750,inhibitors,I-Procedure
68755,4750,(,O
68756,4750,e.g.,O
68757,4750,",",O
68758,4750,gefitinib,B-Drug
68759,4750,",",O
68760,4750,erlotinib,B-Drug
68761,4750,",",O
68762,4750,lapatinib,B-Drug
68763,4750,),O
68764,4750,.,O
68765,4751,Antitumor,B-Procedure
68766,4751,therapy,I-Procedure
68767,4751,(,O
68768,4751,e.g.,O
68769,4751,",",O
68770,4751,chemotherapy,B-Procedure
68771,4751,",",O
68772,4751,hormonal,B-Procedure
68773,4751,therapy,I-Procedure
68774,4751,",",O
68775,4751,immunotherapy,B-Procedure
68776,4751,",",O
68777,4751,antibody,B-Procedure
68778,4751,therapy,I-Procedure
68779,4751,",",O
68780,4751,radiotherapy,B-Procedure
68781,4751,),O
68782,4751,",",O
68783,4751,or,O
68784,4751,investigational,B-Drug
68785,4751,agent,I-Drug
68786,4751,or,O
68787,4751,therapy,B-Procedure
68788,4751,<,O
68789,4751,=,O
68790,4751,30,O
68791,4751,days,O
68792,4751,before,O
68793,4751,first,O
68794,4751,dose,O
68795,4751,of,O
68796,4751,study,O
68797,4751,treatment,O
68798,4751,or,O
68799,4751,not,B-Condition
68800,4751,recovered,I-Condition
68801,4751,from,I-Condition
68802,4751,any,I-Condition
68803,4751,acute,I-Condition
68804,4751,toxicity,I-Condition
68805,4751,.,O
68806,4752,Other,O
68807,4752,investigational,B-Procedure
68808,4752,procedure,I-Procedure
68809,4752,<,O
68810,4752,=,O
68811,4752,30,O
68812,4752,days,O
68813,4752,before,O
68814,4752,study,O
68815,4752,entry,O
68816,4752,.,O
68817,4753,History,O
68818,4753,of,O
68819,4753,interstitial,B-Condition
68820,4753,lung,I-Condition
68821,4753,disease,I-Condition
68822,4753,(,O
68823,4753,ILD,B-Condition
68824,4753,),O
68825,4753,e.g.,O
68826,4753,",",O
68827,4753,interstitial,B-Condition
68828,4753,pneumonitis,I-Condition
68829,4753,",",O
68830,4753,pulmonary,B-Condition
68831,4753,fibrosis,I-Condition
68832,4753,or,O
68833,4753,evidence,B-Mood
68834,4753,of,I-Mood
68835,4753,ILD,B-Condition
68836,4753,on,O
68837,4753,baseline,O
68838,4753,chest,B-Procedure
68839,4753,computer,I-Procedure
68840,4753,tomography,I-Procedure
68841,4753,.,O
68842,4754,Subject,O
68843,4754,previously,O
68844,4754,enrolled,O
68845,4754,to,O
68846,4754,this,O
68847,4754,study,O
68848,4754,.,O
68849,4755,History,O
68850,4755,of,O
68851,4755,keratitis,B-Condition
68852,4755,",",O
68853,4755,ulcerative,B-Condition
68854,4755,keratitis,I-Condition
68855,4755,or,O
68856,4755,severe,O
68857,4755,dry,B-Condition
68858,4755,eye,I-Condition
68859,4755,.,O
68860,4756,Major,B-Procedure
68861,4756,surgery,I-Procedure
68862,4756,(,O
68863,4756,e.g.,O
68864,4756,",",O
68865,4756,requiring,O
68866,4756,general,B-Procedure
68867,4756,anesthesia,I-Procedure
68868,4756,),O
68869,4756,<,O
68870,4756,=,O
68871,4756,30,O
68872,4756,days,O
68873,4756,before,O
68874,4756,first,O
68875,4756,dose,O
68876,4756,of,O
68877,4756,study,O
68878,4756,treatment,O
68879,4756,.,O
68880,4756,Subjects,O
68881,4756,must,O
68882,4756,have,O
68883,4756,recovered,O
68884,4756,from,O
68885,4756,any,O
68886,4756,surgery,O
68887,4756,related,O
68888,4756,toxicities,O
68889,4756,.,O
68890,4757,Minor,B-Procedure
68891,4757,surgical,I-Procedure
68892,4757,procedure,I-Procedure
68893,4757,(,O
68894,4757,e.g.,O
68895,4757,",",O
68896,4757,open,B-Procedure
68897,4757,biopsy,I-Procedure
68898,4757,),O
68899,4757,<,O
68900,4757,=,O
68901,4757,7,O
68902,4757,days,O
68903,4757,before,O
68904,4757,first,O
68905,4757,dose,O
68906,4757,of,O
68907,4757,study,O
68908,4757,treatment,O
68909,4757,",",O
68910,4757,or,O
68911,4757,not,O
68912,4757,yet,O
68913,4757,recovered,B-Condition
68914,4757,from,O
68915,4757,prior,O
68916,4757,minor,B-Procedure
68917,4757,surgery,I-Procedure
68918,4757,Note,O
68919,4757,:,O
68920,4757,uncomplicated,O
68921,4757,placement,O
68922,4757,of,O
68923,4757,vascular,O
68924,4757,access,O
68925,4757,device,O
68926,4757,",",O
68927,4757,fine,O
68928,4757,needle,O
68929,4757,aspiration,O
68930,4757,",",O
68931,4757,thoracocentesis,O
68932,4757,or,O
68933,4757,paracentesis,O
68934,4757,>,O
68935,4757,=3,O
68936,4757,days,O
68937,4757,prior,O
68938,4757,to,O
68939,4757,first,O
68940,4757,dose,O
68941,4757,of,O
68942,4757,study,O
68943,4757,treatment,O
68944,4757,is,O
68945,4757,acceptable,O
68946,4757,.,O
68947,4758,Clinically,O
68948,4758,significant,O
68949,4758,cardiovascular,B-Condition
68950,4758,disease,I-Condition
68951,4758,(,O
68952,4758,including,O
68953,4758,myocardial,B-Condition
68954,4758,infarction,I-Condition
68955,4758,",",O
68956,4758,unstable,B-Condition
68957,4758,angina,I-Condition
68958,4758,",",O
68959,4758,symptomatic,O
68960,4758,congestive,B-Condition
68961,4758,heart,I-Condition
68962,4758,failure,I-Condition
68963,4758,",",O
68964,4758,serious,O
68965,4758,uncontrolled,O
68966,4758,cardiac,B-Condition
68967,4758,arrhythmia,I-Condition
68968,4758,),O
68969,4758,<,O
68970,4758,=,O
68971,4758,6,O
68972,4758,months,O
68973,4758,prior,O
68974,4758,to,O
68975,4758,enrolment,O
68976,4758,.,O
68977,4759,History,O
68978,4759,of,O
68979,4759,any,O
68980,4759,medical,O
68981,4759,or,O
68982,4759,psychiatric,O
68983,4759,condition,O
68984,4759,or,O
68985,4759,laboratory,O
68986,4759,abnormality,O
68987,4759,that,O
68988,4759,in,O
68989,4759,the,O
68990,4759,opinion,O
68991,4759,of,O
68992,4759,the,O
68993,4759,investigator,O
68994,4759,may,O
68995,4759,increase,O
68996,4759,the,O
68997,4759,risk,O
68998,4759,associated,O
68999,4759,with,O
69000,4759,the,O
69001,4759,study,O
69002,4759,participation,O
69003,4759,or,O
69004,4759,investigational,O
69005,4759,product,O
69006,4759,administration,O
69007,4759,",",O
69008,4759,compliance,O
69009,4759,with,O
69010,4759,the,O
69011,4759,study,O
69012,4759,procedures,O
69013,4759,or,O
69014,4759,may,O
69015,4759,interfere,O
69016,4759,with,O
69017,4759,the,O
69018,4759,interpretation,O
69019,4759,of,O
69020,4759,the,O
69021,4759,results,O
69022,4759,.,O
69023,4760,Unstable,O
69024,4760,pulmonary,B-Condition
69025,4760,embolism,I-Condition
69026,4760,",",O
69027,4760,deep,B-Condition
69028,4760,vein,I-Condition
69029,4760,thrombosis,I-Condition
69030,4760,",",O
69031,4760,or,O
69032,4760,other,O
69033,4760,significant,O
69034,4760,arterial,B-Condition
69035,4760,/,I-Condition
69036,4760,venous,I-Condition
69037,4760,thromboembolic,I-Condition
69038,4760,event,I-Condition
69039,4760,<,O
69040,4760,=,O
69041,4760,30,O
69042,4760,days,O
69043,4760,before,O
69044,4760,first,O
69045,4760,dose,O
69046,4760,of,O
69047,4760,study,O
69048,4760,treatment,O
69049,4760,.,O
69050,4760,If,O
69051,4760,on,O
69052,4760,anticoagulation,B-Procedure
69053,4760,",",O
69054,4760,subject,O
69055,4760,must,O
69056,4760,be,O
69057,4760,on,O
69058,4760,stable,O
69059,4760,therapeutic,O
69060,4760,dose,O
69061,4760,prior,O
69062,4760,to,O
69063,4760,first,O
69064,4760,dose,O
69065,4760,of,O
69066,4760,study,O
69067,4760,treatment,O
69068,4760,.,O
69069,4761,Subject,O
69070,4761,who,O
69071,4761,is,O
69072,4761,pregnant,B-Condition
69073,4761,or,O
69074,4761,breast,B-Observation
69075,4761,feeding,I-Observation
69076,4761,",",O
69077,4761,or,O
69078,4761,planning,B-Mood
69079,4761,to,I-Mood
69080,4761,become,B-Observation
69081,4761,pregnant,I-Observation
69082,4761,during,O
69083,4761,treatment,O
69084,4761,and,O
69085,4761,within,O
69086,4761,2,O
69087,4761,months,O
69088,4761,after,O
69089,4761,the,O
69090,4761,discontinuation,O
69091,4761,of,O
69092,4761,study,O
69093,4761,treatment,O
69094,4761,.,O
69095,4762,Known,O
69096,4762,positive,O
69097,4762,test(s,O
69098,4762,),O
69099,4762,for,O
69100,4762,human,O
69101,4762,immunodeficiency,O
69102,4762,virus,O
69103,4762,infection,O
69104,4762,(,O
69105,4762,testing,O
69106,4762,is,O
69107,4762,not,O
69108,4762,required,O
69109,4762,in,O
69110,4762,the,O
69111,4762,absence,O
69112,4762,of,O
69113,4762,clinical,O
69114,4762,suspicion,O
69115,4762,),O
69116,4762,.,O
69117,4763,Active,O
69118,4763,infection,B-Condition
69119,4763,requiring,O
69120,4763,systemic,B-Procedure
69121,4763,treatment,I-Procedure
69122,4763,or,O
69123,4763,any,O
69124,4763,uncontrolled,B-Condition
69125,4763,infection,I-Condition
69126,4763,<,O
69127,4763,=,O
69128,4763,14,O
69129,4763,days,O
69130,4763,prior,O
69131,4763,to,O
69132,4763,first,O
69133,4763,dose,O
69134,4763,of,O
69135,4763,study,O
69136,4763,treatment,O
69137,4763,(,O
69138,4763,with,O
69139,4763,the,O
69140,4763,exception,O
69141,4763,of,O
69142,4763,uncomplicated,O
69143,4763,urinary,B-Condition
69144,4763,tract,I-Condition
69145,4763,infection,I-Condition
69146,4763,or,O
69147,4763,upper,B-Condition
69148,4763,respiratory,I-Condition
69149,4763,tract,I-Condition
69150,4763,infection,I-Condition
69151,4763,),O
69152,4763,.,O
69153,4764,Subject,O
69154,4764,has,O
69155,4764,any,O
69156,4764,kind,O
69157,4764,of,O
69158,4764,disorder,O
69159,4764,that,O
69160,4764,compromises,O
69161,4764,the,O
69162,4764,ability,O
69163,4764,of,O
69164,4764,the,O
69165,4764,subject,O
69166,4764,to,O
69167,4764,give,O
69168,4764,written,O
69169,4764,informed,O
69170,4764,consent,O
69171,4764,and/or,O
69172,4764,to,O
69173,4764,comply,O
69174,4764,with,O
69175,4764,study,O
69176,4764,procedures,O
69177,4764,or,O
69178,4764,is,O
69179,4764,unwilling,O
69180,4764,or,O
69181,4764,unable,O
69182,4764,to,O
69183,4764,comply,O
69184,4764,with,O
69185,4764,study,O
69186,4764,requirements,O
69187,4764,.,O
69188,4765,Subject,O
69189,4765,or,O
69190,4765,subject,O
69191,4765,'s,O
69192,4765,legally,O
69193,4765,acceptable,O
69194,4765,representative,O
69195,4765,has,O
69196,4765,provided,O
69197,4765,informed,O
69198,4765,consent,O
69199,4765,.,O
69200,4766,Male,B-Person
69201,4766,or,O
69202,4766,female,B-Person
69203,4766,>,O
69204,4766,=,O
69205,4766,18,O
69206,4766,years,O
69207,4766,of,O
69208,4766,age,B-Person
69209,4766,.,O
69210,4767,Histologically,B-Procedure
69211,4767,or,O
69212,4767,cytologically,B-Procedure
69213,4767,confirmed,O
69214,4767,diagnosis,O
69215,4767,of,O
69216,4767,adenocarcinoma,B-Condition
69217,4767,of,O
69218,4767,the,O
69219,4767,colon,O
69220,4767,or,O
69221,4767,rectum,O
69222,4767,.,O
69223,4768,Wild,O
69224,4768,-,O
69225,4768,type,O
69226,4768,KRAS,O
69227,4768,(,O
69228,4768,without,O
69229,4768,mutation,O
69230,4768,in,O
69231,4768,exon,O
69232,4768,2,O
69233,4768,[,O
69234,4768,codons,O
69235,4768,12,O
69236,4768,and,O
69237,4768,13,O
69238,4768,],O
69239,4768,",",O
69240,4768,exon,O
69241,4768,3,O
69242,4768,[,O
69243,4768,codons,O
69244,4768,59,O
69245,4768,and,O
69246,4768,61,O
69247,4768,],O
69248,4768,",",O
69249,4768,and,O
69250,4768,exon,O
69251,4768,4,O
69252,4768,[,O
69253,4768,codons,O
69254,4768,117,O
69255,4768,and,O
69256,4768,146,O
69257,4768,],O
69258,4768,),O
69259,4768,and,O
69260,4768,wild,O
69261,4768,-,O
69262,4768,type,O
69263,4768,NRAS,O
69264,4768,(,O
69265,4768,without,O
69266,4768,mutation,O
69267,4768,in,O
69268,4768,exon,O
69269,4768,2,O
69270,4768,[,O
69271,4768,codons,O
69272,4768,12,O
69273,4768,and,O
69274,4768,13,O
69275,4768,],O
69276,4768,",",O
69277,4768,exon,O
69278,4768,3,O
69279,4768,[,O
69280,4768,codons,O
69281,4768,59,O
69282,4768,and,O
69283,4768,61,O
69284,4768,],O
69285,4768,",",O
69286,4768,and,O
69287,4768,exon,O
69288,4768,4,O
69289,4768,[,O
69290,4768,codons,O
69291,4768,117,O
69292,4768,and,O
69293,4768,146,O
69294,4768,],O
69295,4768,),O
69296,4768,tumor,O
69297,4768,status,O
69298,4768,.,O
69299,4769,Eastern,O
69300,4769,Cooperative,O
69301,4769,Oncology,O
69302,4769,Group,O
69303,4769,(,O
69304,4769,ECOG,O
69305,4769,),O
69306,4769,performance,O
69307,4769,status,O
69308,4769,of,O
69309,4769,0,O
69310,4769,",",O
69311,4769,1,O
69312,4769,or,O
69313,4769,2,O
69314,4769,.,O
69315,4770,Measurable,B-Condition
69316,4770,or,I-Condition
69317,4770,non,I-Condition
69318,4770,-,I-Condition
69319,4770,measurable,I-Condition
69320,4770,disease,I-Condition
69321,4770,per,O
69322,4770,RECIST,B-Procedure
69323,4770,Version,I-Procedure
69324,4770,1.1,I-Procedure
69325,4770,.,O
69326,4771,Must,O
69327,4771,have,O
69328,4771,failed,O
69329,4771,after,O
69330,4771,fluoropyrimidine-,B-Procedure
69331,4771,",",I-Procedure
69332,4771,oxaliplatin-,I-Procedure
69333,4771,",",I-Procedure
69334,4771,and,I-Procedure
69335,4771,irinotecan,I-Procedure
69336,4771,-,I-Procedure
69337,4771,containing,I-Procedure
69338,4771,chemotherapy,I-Procedure
69339,4771,regimens,O
69340,4771,for,O
69341,4771,metastatic,B-Condition
69342,4771,disease,I-Condition
69343,4771,.,O
69344,4771,Failure,O
69345,4771,is,O
69346,4771,defined,O
69347,4771,as,O
69348,4771,either,O
69349,4771,disease,B-Condition
69350,4771,progression,I-Condition
69351,4771,(,O
69352,4771,clinical,O
69353,4771,or,O
69354,4771,radiological,O
69355,4771,),O
69356,4771,or,O
69357,4771,intolerance,B-Condition
69358,4771,to,O
69359,4771,the,B-Procedure
69360,4771,regimen,I-Procedure
69361,4771,.,O
69362,4771,Metastatic,B-Condition
69363,4771,relapse,I-Condition
69364,4771,within,O
69365,4771,6,O
69366,4771,months,O
69367,4771,after,O
69368,4771,completing,O
69369,4771,adjuvant,O
69370,4771,chemotherapy,O
69371,4771,(,O
69372,4771,with,O
69373,4771,either,O
69374,4771,an,O
69375,4771,irinotecan,B-Procedure
69376,4771,or,I-Procedure
69377,4771,oxaliplatin,I-Procedure
69378,4771,containing,I-Procedure
69379,4771,regimen,I-Procedure
69380,4771,),O
69381,4771,will,O
69382,4771,also,O
69383,4771,be,O
69384,4771,considered,O
69385,4771,as,O
69386,4771,treatment,O
69387,4771,failure,O
69388,4771,of,O
69389,4771,a,O
69390,4771,prior,O
69391,4771,regimen,O
69392,4771,for,O
69393,4771,metastatic,O
69394,4771,disease,O
69395,4771,.,O
69396,4771,Laboratory,O
69397,4771,:,O
69398,4771,Adequate,B-Condition
69399,4771,baseline,I-Condition
69400,4771,organ,I-Condition
69401,4771,function,I-Condition
69402,4771,defined,O
69403,4771,by,O
69404,4771,(,O
69405,4771,<,O
69406,4771,=,O
69407,4771,7,O
69408,4771,days,O
69409,4771,prior,O
69410,4771,to,O
69411,4771,first,O
69412,4771,dose,O
69413,4771,of,O
69414,4771,study,O
69415,4771,treatment,O
69416,4771,),O
69417,4771,.,O
69418,4772,Hematologic,O
69419,4772,function,O
69420,4772,",",O
69421,4772,as,O
69422,4772,follows,O
69423,4772,:,O
69424,4772,Absolute,O
69425,4772,neutrophil,O
69426,4772,count,O
69427,4772,(,O
69428,4772,ANC,O
69429,4772,),O
69430,4772,>,O
69431,4772,=,O
69432,4772,1.5,O
69433,4772,x,O
69434,4772,10,O
69435,4772,^,O
69436,4772,9,O
69437,4772,/,O
69438,4772,Liter,O
69439,4772,(,O
69440,4772,L,O
69441,4772,),O
69442,4772,",",O
69443,4772,Platelet,O
69444,4772,count,O
69445,4772,>,O
69446,4772,=,O
69447,4772,75,O
69448,4772,x,O
69449,4772,10,O
69450,4772,^,O
69451,4772,9,O
69452,4772,/,O
69453,4772,L,O
69454,4772,",",O
69455,4772,Hemoglobin,O
69456,4772,>,O
69457,4772,=,O
69458,4772,8.0,O
69459,4772,gram,O
69460,4772,/,O
69461,4772,deciliter,O
69462,4772,(,O
69463,4772,g,O
69464,4772,/,O
69465,4772,dL,O
69466,4772,),O
69467,4772,.,O
69468,4773,Renal,O
69469,4773,function,O
69470,4773,",",O
69471,4773,as,O
69472,4773,follows,O
69473,4773,:,O
69474,4773,Creatinine,O
69475,4773,<,O
69476,4773,=,O
69477,4773,1.5,O
69478,4773,x,O
69479,4773,upper,O
69480,4773,limit,O
69481,4773,of,O
69482,4773,normal,O
69483,4773,(,O
69484,4773,ULN,O
69485,4773,),O
69486,4773,.,O
69487,4774,Hepatic,O
69488,4774,function,O
69489,4774,",",O
69490,4774,as,O
69491,4774,follows,O
69492,4774,:,O
69493,4774,Aspartate,O
69494,4774,aminotransferase,O
69495,4774,(,O
69496,4774,AST,O
69497,4774,),O
69498,4774,<,O
69499,4774,=3,O
69500,4774,x,O
69501,4774,ULN,O
69502,4774,",",O
69503,4774,Alanine,O
69504,4774,aminotransferase,O
69505,4774,(,O
69506,4774,ALT,O
69507,4774,),O
69508,4774,<,O
69509,4774,=3,O
69510,4774,x,O
69511,4774,ULN,O
69512,4774,",",O
69513,4774,Total,O
69514,4774,Bilirubin,O
69515,4774,<,O
69516,4774,=,O
69517,4774,1.5,O
69518,4774,x,O
69519,4774,ULN,O
69520,4774,.,O
69521,4775,Metabolic,O
69522,4775,function,O
69523,4775,",",O
69524,4775,as,O
69525,4775,follows,O
69526,4775,:,O
69527,4775,Serum,O
69528,4775,Magnesium,O
69529,4775,within,O
69530,4775,normal,O
69531,4775,limits,O
69532,4775,.,O
69533,4775,Serum,O
69534,4775,Calcium,O
69535,4775,within,O
69536,4775,normal,O
69537,4775,limits,O
69538,4775,.,O
69539,4775,Serum,O
69540,4775,Potassium,O
69541,4775,within,O
69542,4775,normal,O
69543,4775,limits,O
69544,4775,.,O
69545,4776,All,O
69546,4776,prior,O
69547,4776,treatment,O
69548,4776,related,O
69549,4776,toxicities,O
69550,4776,common,O
69551,4776,terminology,O
69552,4776,criteria,O
69553,4776,for,O
69554,4776,adverse,O
69555,4776,events,O
69556,4776,(,O
69557,4776,CTCAE,O
69558,4776,),O
69559,4776,version,O
69560,4776,4.03,O
69561,4776,<,O
69562,4776,=,O
69563,4776,Grade,O
69564,4776,1,O
69565,4776,at,O
69566,4776,the,O
69567,4776,time,O
69568,4776,of,O
69569,4776,enrollment,O
69570,4776,.,O
69571,4777,Women,O
69572,4777,of,O
69573,4777,childbearing,O
69574,4777,potential,O
69575,4777,must,O
69576,4777,have,O
69577,4777,a,O
69578,4777,negative,O
69579,4777,serum,O
69580,4777,pregnancy,O
69581,4777,test,O
69582,4777,within,O
69583,4777,7,O
69584,4777,days,O
69585,4777,of,O
69586,4777,first,O
69587,4777,dose,O
69588,4777,of,O
69589,4777,study,O
69590,4777,treatment,O
69591,4777,and,O
69592,4777,agree,O
69593,4777,to,O
69594,4777,use,O
69595,4777,adequate,O
69596,4777,contraception,O
69597,4777,",",O
69598,4777,during,O
69599,4777,the,O
69600,4777,study,O
69601,4777,and,O
69602,4777,for,O
69603,4777,2,O
69604,4777,months,O
69605,4777,following,O
69606,4777,the,O
69607,4777,last,O
69608,4777,dose,O
69609,4777,of,O
69610,4777,study,O
69611,4777,treatment,O
69612,4777,.,O
69613,4777,Men,O
69614,4777,with,O
69615,4777,a,O
69616,4777,female,O
69617,4777,partner,O
69618,4777,of,O
69619,4777,childbearing,O
69620,4777,potential,O
69621,4777,must,O
69622,4777,have,O
69623,4777,either,O
69624,4777,had,O
69625,4777,a,O
69626,4777,prior,O
69627,4777,vasectomy,O
69628,4777,or,O
69629,4777,agree,O
69630,4777,to,O
69631,4777,use,O
69632,4777,adequate,O
69633,4777,contraception,O
69634,4777,",",O
69635,4777,from,O
69636,4777,time,O
69637,4777,of,O
69638,4777,signing,O
69639,4777,informed,O
69640,4777,consent,O
69641,4777,until,O
69642,4777,5,O
69643,4777,months,O
69644,4777,after,O
69645,4777,the,O
69646,4777,last,O
69647,4777,dose,O
69648,4777,of,O
69649,4777,study,O
69650,4777,treatment,O
69651,4777,.,O
69652,4778,No,O
69653,4778,consent,B-Observation
69654,4779,Spinal,B-Procedure
69655,4779,anesthesia,I-Procedure
69656,4779,or,O
69657,4779,sciatic,B-Procedure
69658,4779,nerve,I-Procedure
69659,4779,block,I-Procedure
69660,4779,contraindicated,B-Condition
69661,4780,Known,O
69662,4780,intolerance,B-Condition
69663,4780,to,O
69664,4780,tramadol,B-Drug
69665,4780,or,O
69666,4780,other,O
69667,4780,contraindications,B-Condition
69668,4780,for,O
69669,4780,the,B-Drug
69670,4780,drug,I-Drug
69671,4781,Patients,O
69672,4781,with,O
69673,4781,foot,B-Condition
69674,4781,fracture,I-Condition
69675,4781,scheduled,B-Mood
69676,4781,for,I-Mood
69677,4781,surgical,B-Procedure
69678,4781,repair,I-Procedure
69679,4781,in,O
69680,4781,spinal,B-Procedure
69681,4781,anesthesia,I-Procedure
69682,4782,Informed,O
69683,4782,consent,O
69684,4783,Currently,O
69685,4783,dependent,B-Condition
69686,4783,on,O
69687,4783,any,O
69688,4783,substance,B-Drug
69689,4783,other,O
69690,4783,than,O
69691,4783,cannabis,B-Drug
69692,4783,",",O
69693,4783,alcohol,B-Drug
69694,4783,or,O
69695,4783,nicotine,B-Drug
69696,4783,;,O
69697,4784,History,O
69698,4784,of,O
69699,4784,any,O
69700,4784,major,B-Condition
69701,4784,internal,I-Condition
69702,4784,disease,I-Condition
69703,4784,(,O
69704,4784,including,O
69705,4784,diabetes,B-Condition
69706,4784,",",O
69707,4784,cardiovascular,B-Condition
69708,4784,disease,I-Condition
69709,4784,",",O
69710,4784,lung,B-Condition
69711,4784,disease,I-Condition
69712,4784,",",O
69713,4784,liver,B-Condition
69714,4784,or,I-Condition
69715,4784,kidney,I-Condition
69716,4784,disease,I-Condition
69717,4784,),O
69718,4784,;,O
69719,4785,An,O
69720,4785,active,O
69721,4785,or,O
69722,4785,any,O
69723,4785,history,B-Observation
69724,4785,of,O
69725,4785,neurological,B-Condition
69726,4785,disorder,I-Condition
69727,4785,",",O
69728,4785,including,O
69729,4785,but,O
69730,4785,not,O
69731,4785,limited,O
69732,4785,to,O
69733,4785,seizure,B-Condition
69734,4785,disorder,I-Condition
69735,4785,",",O
69736,4785,epilepsy,B-Condition
69737,4785,",",O
69738,4785,stroke,B-Condition
69739,4785,",",O
69740,4785,neurological,B-Condition
69741,4785,disease,I-Condition
69742,4785,",",O
69743,4785,cognitive,B-Condition
69744,4785,impairment,I-Condition
69745,4785,",",O
69746,4785,head,B-Condition
69747,4785,trauma,I-Condition
69748,4785,with,O
69749,4785,prolonged,B-Condition
69750,4785,loss,I-Condition
69751,4785,of,I-Condition
69752,4785,consciousness,I-Condition
69753,4785,(,O
69754,4785,>,O
69755,4785,10,O
69756,4785,minutes,O
69757,4785,),O
69758,4785,",",O
69759,4785,or,O
69760,4785,migraine,B-Condition
69761,4785,headaches,I-Condition
69762,4785,;,O
69763,4786,An,O
69764,4786,active,O
69765,4786,or,O
69766,4786,a,O
69767,4786,history,B-Observation
69768,4786,of,O
69769,4786,a,O
69770,4786,psychiatric,B-Condition
69771,4786,disorder,I-Condition
69772,4786,including,O
69773,4786,",",O
69774,4786,but,O
69775,4786,not,O
69776,4786,limited,O
69777,4786,to,O
69778,4786,",",O
69779,4786,depression,B-Condition
69780,4786,",",O
69781,4786,schizophrenia,B-Condition
69782,4786,",",O
69783,4786,bipolar,B-Condition
69784,4786,disorder,I-Condition
69785,4786,",",O
69786,4786,anxiety,B-Condition
69787,4786,",",O
69788,4786,or,O
69789,4786,other,O
69790,4786,psychiatric,B-Condition
69791,4786,disorders,I-Condition
69792,4786,;,O
69793,4787,Asthma,B-Condition
69794,4787,;,O
69795,4788,Known,O
69796,4788,hypersensitivity,B-Condition
69797,4788,or,O
69798,4788,allergy,B-Condition
69799,4788,to,O
69800,4788,n,B-Drug
69801,4788,-,I-Drug
69802,4788,acetylcysteine,I-Drug
69803,4788,",",O
69804,4788,or,O
69805,4788,receiving,O
69806,4788,chronic,B-Procedure
69807,4788,therapy,I-Procedure
69808,4788,with,O
69809,4788,medication,O
69810,4788,that,O
69811,4788,could,O
69812,4788,interact,O
69813,4788,adversely,O
69814,4788,with,O
69815,4788,n,B-Drug
69816,4788,-,I-Drug
69817,4788,acetylcysteine,I-Drug
69818,4788,within,O
69819,4788,30,O
69820,4788,days,O
69821,4788,prior,O
69822,4788,to,O
69823,4788,randomization,O
69824,4788,(,O
69825,4788,i.e.,O
69826,4788,",",O
69827,4788,nitroglycerin,B-Drug
69828,4788,",",O
69829,4788,ACE,B-Drug
69830,4788,inhibitors,I-Drug
69831,4788,or,O
69832,4788,antihypertensive,B-Drug
69833,4788,drugs,I-Drug
69834,4788,",",O
69835,4788,anti,B-Drug
69836,4788,-,I-Drug
69837,4788,coagulants,I-Drug
69838,4788,),O
69839,4788,;,O
69840,4789,Exclusion,B-Condition
69841,4789,criteria,I-Condition
69842,4789,for,I-Condition
69843,4789,MRI,I-Condition
69844,4789,:,O
69845,4789,having,O
69846,4789,metal,O
69847,4789,in,O
69848,4789,the,O
69849,4789,body,O
69850,4789,and/or,O
69851,4789,having,O
69852,4789,claustrophobia,B-Condition
69853,4790,Current,O
69854,4790,DSM,O
69855,4790,-,O
69856,4790,IV,O
69857,4790,diagnosis,O
69858,4790,of,O
69859,4790,cannabis,B-Condition
69860,4790,dependence,I-Condition
69861,4790,",",O
69862,4790,>,O
69863,4790,1,O
69864,4790,week,O
69865,4790,detoxified,B-Condition
69866,4790,and,O
69867,4790,abstinent,B-Condition
69868,4790,;,O
69869,4791,Able,O
69870,4791,to,O
69871,4791,provide,O
69872,4791,written,O
69873,4791,informed,O
69874,4791,consent,O
69875,4791,and,O
69876,4791,to,O
69877,4791,comply,O
69878,4791,with,O
69879,4791,study,O
69880,4791,procedures,O
69881,4791,.,O
69882,4792,Dutch,O
69883,4792,speaking,O
69884,4792,(,O
69885,4792,Dutch,O
69886,4792,as,O
69887,4792,primary,O
69888,4792,language,O
69889,4792,),O
69890,4792,.,O
69891,4793,Non,O
69892,4793,-,O
69893,4793,reassuring,O
69894,4793,fetal,O
69895,4793,assessment,O
69896,4793,at,O
69897,4793,the,O
69898,4793,time,O
69899,4793,of,O
69900,4793,recruitment,O
69901,4794,Previous,O
69902,4794,cervical,B-Drug
69903,4794,ripening,I-Drug
69904,4794,agents,I-Drug
69905,4794,(,O
69906,4794,cytotec,B-Drug
69907,4794,",",O
69908,4794,cervidil,B-Drug
69909,4794,",",O
69910,4794,cervical,O
69911,4794,Foley,O
69912,4794,Balloon,O
69913,4794,),O
69914,4795,<,O
69915,4795,18,O
69916,4795,years,O
69917,4795,of,O
69918,4795,age,B-Person
69919,4796,Prisoners,B-Person
69920,4797,Any,O
69921,4797,patients,O
69922,4797,contraindicated,B-Condition
69923,4797,for,O
69924,4797,vaginal,B-Procedure
69925,4797,delivery,I-Procedure
69926,4798,Multiple,B-Observation
69927,4798,gestations,I-Observation
69928,4799,History,B-Observation
69929,4799,of,O
69930,4799,previous,O
69931,4799,cesarean,B-Procedure
69932,4799,delivery,I-Procedure
69933,4800,Patients,O
69934,4800,with,O
69935,4800,history,B-Observation
69936,4800,of,O
69937,4800,significant,O
69938,4800,cardiac,B-Condition
69939,4800,disease,I-Condition
69940,4801,Fetal,B-Condition
69941,4801,demise,I-Condition
69942,4802,Estimated,O
69943,4802,fetal,O
69944,4802,weight,O
69945,4802,greater,O
69946,4802,than,O
69947,4802,4500,O
69948,4802,grams,O
69949,4802,in,O
69950,4802,diabetic,B-Condition
69951,4802,and,O
69952,4802,5000,O
69953,4802,grams,O
69954,4802,in,O
69955,4802,non,O
69956,4802,-,O
69957,4802,diabetic,B-Condition
69958,4802,mother,O
69959,4803,Ruptured,B-Condition
69960,4803,membranes,I-Condition
69961,4804,Spontaneous,B-Condition
69962,4804,labor,I-Condition
69963,4804,(,O
69964,4804,latent,O
69965,4804,or,O
69966,4804,active,O
69967,4804,phase,O
69968,4804,),O
69969,4805,Augmentation,B-Condition
69970,4805,of,I-Condition
69971,4805,labor,I-Condition
69972,4805,(,O
69973,4805,latent,O
69974,4805,or,O
69975,4805,active,O
69976,4805,phase,O
69977,4805,),O
69978,4806,Singleton,B-Condition
69979,4806,pregnancy,I-Condition
69980,4806,=,O
69981,4806,37,O
69982,4806,weeks,O
69983,4806,gestation,O
69984,4807,Patient,O
69985,4807,presented,B-Mood
69986,4807,for,I-Mood
69987,4807,induction,B-Procedure
69988,4807,of,I-Procedure
69989,4807,labor,I-Procedure
69990,4807,who,O
69991,4807,is,O
69992,4807,determined,O
69993,4807,to,O
69994,4807,be,O
69995,4807,a,O
69996,4807,candidate,B-Condition
69997,4807,for,I-Condition
69998,4807,oxytocin,I-Condition
69999,4808,Cephalic,B-Observation
70000,4808,presentation,I-Observation
70001,4809,Reassuring,O
70002,4809,fetal,O
70003,4809,health,O
70004,4809,assessment,O
70005,4809,(,O
70006,4809,no,O
70007,4809,abnormal,B-Condition
70008,4809,findings,I-Condition
70009,4809,in,O
70010,4809,fetal,B-Procedure
70011,4809,assessment,I-Procedure
70012,4809,",",O
70013,4809,see,O
70014,4809,below,O
70015,4809,),O
70016,4810,Meeting,O
70017,4810,one,O
70018,4810,of,O
70019,4810,the,O
70020,4810,following,O
70021,4810,BMI,O
70022,4810,category,O
70023,4810,:,O
70024,4811,NA,O
70025,4812,Understand,O
70026,4812,and,O
70027,4812,communicate,O
70028,4812,with,O
70029,4812,the,O
70030,4812,investigator,O
70031,4812,",",O
70032,4812,comply,O
70033,4812,with,O
70034,4812,the,O
70035,4812,requirements,O
70036,4812,of,O
70037,4812,the,O
70038,4812,study,O
70039,4812,and,O
70040,4812,give,O
70041,4812,a,O
70042,4812,written,O
70043,4812,",",O
70044,4812,signed,O
70045,4812,and,O
70046,4812,dated,O
70047,4812,informed,O
70048,4812,consent,O
70049,4813,Male,O
70050,4813,or,O
70051,4813,non,O
70052,4813,-,O
70053,4813,pregnant,O
70054,4813,",",O
70055,4813,non,O
70056,4813,-,O
70057,4813,lactating,O
70058,4813,female,O
70059,4813,patients,O
70060,4813,at,O
70061,4813,least,O
70062,4813,18,O
70063,4813,years,O
70064,4813,of,O
70065,4813,age,O
70066,4814,Diagnosis,O
70067,4814,of,O
70068,4814,moderate,O
70069,4814,to,O
70070,4814,severe,O
70071,4814,Ankylosing,B-Condition
70072,4814,Spondylitis,I-Condition
70073,4814,(,I-Condition
70074,4814,AS,I-Condition
70075,4814,),I-Condition
70076,4814,with,O
70077,4814,prior,O
70078,4814,documented,O
70079,4814,radiologic,B-Condition
70080,4814,evidence,I-Condition
70081,4814,fulfilling,O
70082,4814,the,O
70083,4814,Modified,O
70084,4814,New,O
70085,4814,York,O
70086,4814,criteria,O
70087,4814,for,O
70088,4814,AS,O
70089,4815,Active,O
70090,4815,AS,B-Condition
70091,4815,assessed,O
70092,4815,by,O
70093,4815,total,O
70094,4815,Bath,O
70095,4815,Ankylosing,O
70096,4815,Spondylitis,O
70097,4815,Disease,O
70098,4815,Activity,O
70099,4815,index,O
70100,4815,(,O
70101,4815,BASDAI,O
70102,4815,),O
70103,4815,=,O
70104,4815,4,O
70105,4815,(,O
70106,4815,0,O
70107,4815,-,O
70108,4815,10,O
70109,4815,),O
70110,4815,at,O
70111,4815,baseline,O
70112,4816,Spinal,B-Condition
70113,4816,pain,I-Condition
70114,4816,as,O
70115,4816,measured,O
70116,4816,by,O
70117,4816,BASDAI,O
70118,4816,question,O
70119,4816,#,O
70120,4816,2,O
70121,4816,=,O
70122,4816,4,O
70123,4816,cm,O
70124,4816,(,O
70125,4816,0,O
70126,4816,-,O
70127,4816,10,O
70128,4816,cm,O
70129,4816,),O
70130,4816,at,O
70131,4816,baseline,O
70132,4817,Total,B-Condition
70133,4817,back,I-Condition
70134,4817,pain,I-Condition
70135,4817,as,O
70136,4817,measured,O
70137,4817,by,O
70138,4817,visual,O
70139,4817,analog,O
70140,4817,scale,O
70141,4817,(,O
70142,4817,VAS,O
70143,4817,),O
70144,4817,=,O
70145,4817,40,O
70146,4817,mm,O
70147,4817,(,O
70148,4817,0,O
70149,4817,-,O
70150,4817,100,O
70151,4817,mm,O
70152,4817,),O
70153,4817,at,O
70154,4817,baseline,O
70155,4818,Patients,O
70156,4818,should,O
70157,4818,have,O
70158,4818,been,O
70159,4818,on,O
70160,4818,non,B-Drug
70161,4818,-,I-Drug
70162,4818,steroidal,I-Drug
70163,4818,anti,I-Drug
70164,4818,-,I-Drug
70165,4818,inflammatory,I-Drug
70166,4818,drugs,I-Drug
70167,4818,(,I-Drug
70168,4818,NSAIDs,I-Drug
70169,4818,),I-Drug
70170,4818,at,O
70171,4818,the,O
70172,4818,maximum,O
70173,4818,tolerated,O
70174,4818,dose,O
70175,4818,for,O
70176,4818,at,O
70177,4818,least,O
70178,4818,4,O
70179,4818,weeks,O
70180,4818,prior,O
70181,4818,to,O
70182,4818,their,O
70183,4818,Baseline,O
70184,4818,Visit,O
70185,4818,",",O
70186,4818,with,O
70187,4818,an,O
70188,4818,inadequate,B-Condition
70189,4818,response,I-Condition
70190,4818,or,O
70191,4818,for,O
70192,4818,less,O
70193,4818,than,O
70194,4818,4,O
70195,4818,weeks,O
70196,4818,if,O
70197,4818,withdrawn,B-Condition
70198,4818,for,I-Condition
70199,4818,intolerance,I-Condition
70200,4818,",",I-Condition
70201,4818,toxicity,I-Condition
70202,4818,or,O
70203,4818,contraindications,B-Condition
70204,4819,Stable,O
70205,4819,dose,O
70206,4819,of,O
70207,4819,NSAIDs,B-Drug
70208,4819,including,O
70209,4819,Cyclooxygenase-1,O
70210,4819,(,O
70211,4819,COX-1,O
70212,4819,),O
70213,4819,or,O
70214,4819,Cyclooxygenase-2,B-Drug
70215,4819,(,I-Drug
70216,4819,COX-2,I-Drug
70217,4819,),I-Drug
70218,4819,inhibitors,I-Drug
70219,4819,for,O
70220,4819,at,O
70221,4819,least,O
70222,4819,2,O
70223,4819,weeks,O
70224,4819,before,O
70225,4819,their,O
70226,4819,Baseline,O
70227,4819,Visit,O
70228,4820,Patients,O
70229,4820,who,O
70230,4820,have,O
70231,4820,been,O
70232,4820,on,O
70233,4820,a,O
70234,4820,tumor,B-Drug
70235,4820,necrosis,I-Drug
70236,4820,factor,I-Drug
70237,4820,alpha,I-Drug
70238,4820,(,I-Drug
70239,4820,TNFa,I-Drug
70240,4820,),I-Drug
70241,4820,inhibitor,I-Drug
70242,4820,(,O
70243,4820,not,O
70244,4820,more,O
70245,4820,than,O
70246,4820,one,O
70247,4820,),O
70248,4820,must,O
70249,4820,have,O
70250,4820,experienced,O
70251,4820,an,O
70252,4820,inadequate,B-Condition
70253,4820,response,I-Condition
70254,4820,to,O
70255,4820,previous,O
70256,4820,or,O
70257,4820,current,O
70258,4820,treatment,B-Procedure
70259,4820,given,O
70260,4820,at,O
70261,4820,an,O
70262,4820,approved,O
70263,4820,dose,O
70264,4820,for,O
70265,4820,at,O
70266,4820,least,O
70267,4820,3,O
70268,4820,months,O
70269,4820,prior,O
70270,4820,to,O
70271,4820,baseline,O
70272,4820,or,O
70273,4820,had,O
70274,4820,been,O
70275,4820,intolerant,B-Condition
70276,4820,upon,O
70277,4820,administration,O
70278,4820,of,O
70279,4820,an,O
70280,4820,anti,B-Drug
70281,4820,-,I-Drug
70282,4820,TNFa,I-Drug
70283,4820,agent,I-Drug
70284,4821,Total,B-Condition
70285,4821,ankylosis,I-Condition
70286,4821,of,I-Condition
70287,4821,the,I-Condition
70288,4821,spine,I-Condition
70289,4822,Use,O
70290,4822,of,O
70291,4822,other,O
70292,4822,investigational,O
70293,4822,drugs,O
70294,4822,within,O
70295,4822,5,O
70296,4822,half,O
70297,4822,-,O
70298,4822,lives,O
70299,4822,of,O
70300,4822,enrollment,O
70301,4822,",",O
70302,4822,or,O
70303,4822,within,O
70304,4822,4,O
70305,4822,weeks,O
70306,4822,before,O
70307,4822,the,O
70308,4822,Baseline,O
70309,4822,Visit,O
70310,4822,",",O
70311,4822,whichever,O
70312,4822,is,O
70313,4822,longer,O
70314,4822,.,O
70315,4823,History,O
70316,4823,of,O
70317,4823,hypersensitivity,B-Condition
70318,4823,to,O
70319,4823,any,O
70320,4823,of,O
70321,4823,the,O
70322,4823,study,B-Drug
70323,4823,drugs,I-Drug
70324,4823,or,O
70325,4823,its,O
70326,4823,excipients,B-Drug
70327,4823,or,O
70328,4823,to,O
70329,4823,drugs,B-Drug
70330,4823,of,I-Drug
70331,4823,similar,I-Drug
70332,4823,chemical,I-Drug
70333,4823,classes,I-Drug
70334,4823,.,O
70335,4824,Chest,B-Procedure
70336,4824,x,I-Procedure
70337,4824,-,I-Procedure
70338,4824,ray,I-Procedure
70339,4824,",",O
70340,4824,computerized,B-Procedure
70341,4824,tomography,I-Procedure
70342,4824,(,I-Procedure
70343,4824,CT,I-Procedure
70344,4824,),I-Procedure
70345,4824,scan,I-Procedure
70346,4824,",",O
70347,4824,or,O
70348,4824,chest,B-Procedure
70349,4824,magnetic,I-Procedure
70350,4824,resonance,I-Procedure
70351,4824,imaging,I-Procedure
70352,4824,(,I-Procedure
70353,4824,MRI,I-Procedure
70354,4824,),I-Procedure
70355,4824,with,O
70356,4824,evidence,O
70357,4824,of,O
70358,4824,ongoing,O
70359,4824,infectious,B-Condition
70360,4824,or,O
70361,4824,malignant,B-Condition
70362,4824,process,I-Condition
70363,4824,",",O
70364,4824,obtained,O
70365,4824,within,O
70366,4824,3,O
70367,4824,months,O
70368,4824,prior,O
70369,4824,to,O
70370,4824,screening,O
70371,4824,and,O
70372,4824,evaluated,O
70373,4824,by,O
70374,4824,a,O
70375,4824,qualified,O
70376,4824,physician,O
70377,4824,.,O
70378,4825,Previous,O
70379,4825,exposure,O
70380,4825,to,O
70381,4825,secukinumab,B-Drug
70382,4825,or,O
70383,4825,any,O
70384,4825,other,O
70385,4825,biologic,B-Drug
70386,4825,drug,I-Drug
70387,4825,directly,O
70388,4825,targeting,B-Condition
70389,4825,Interleukin-17,B-Drug
70390,4825,(,I-Drug
70391,4825,IL-17,I-Drug
70392,4825,),I-Drug
70393,4825,",",O
70394,4825,Interleukin-12/23,B-Drug
70395,4825,(,I-Drug
70396,4825,IL-12/23,I-Drug
70397,4825,),I-Drug
70398,4825,",",O
70399,4825,or,O
70400,4825,the,O
70401,4825,IL-17,B-Drug
70402,4825,receptor,I-Drug
70403,4825,",",O
70404,4825,or,O
70405,4825,any,O
70406,4825,other,O
70407,4825,biologic,B-Drug
70408,4825,immunomodulating,I-Drug
70409,4825,agent,I-Drug
70410,4825,",",O
70411,4825,except,O
70412,4825,those,O
70413,4825,targeting,O
70414,4825,TNFa,B-Drug
70415,4826,Patients,O
70416,4826,who,O
70417,4826,have,O
70418,4826,taken,O
70419,4826,more,O
70420,4826,than,O
70421,4826,one,O
70422,4826,anti,B-Drug
70423,4826,-,I-Drug
70424,4826,TNFa,I-Drug
70425,4826,agent,I-Drug
70426,4827,Any,O
70427,4827,intramuscular,O
70428,4827,or,O
70429,4827,intravenous,O
70430,4827,corticosteroid,B-Procedure
70431,4827,injection,I-Procedure
70432,4827,within,O
70433,4827,2,O
70434,4827,weeks,O
70435,4827,before,O
70436,4827,baseline,O
70437,4828,Any,O
70438,4828,therapy,O
70439,4828,by,O
70440,4828,intra,B-Procedure
70441,4828,-,I-Procedure
70442,4828,articular,I-Procedure
70443,4828,injections,I-Procedure
70444,4828,(,O
70445,4828,e.g.,O
70446,4828,corticosteroid,B-Drug
70447,4828,),O
70448,4828,within,O
70449,4828,4,O
70450,4828,weeks,O
70451,4828,before,O
70452,4828,baseline,O
70453,4829,Previous,O
70454,4829,treatment,O
70455,4829,with,O
70456,4829,any,O
70457,4829,cell,B-Procedure
70458,4829,-,I-Procedure
70459,4829,depleting,I-Procedure
70460,4829,therapies,I-Procedure
70461,4830,Patients,O
70462,4830,taking,O
70463,4830,high,B-Drug
70464,4830,potency,I-Drug
70465,4830,opioid,I-Drug
70466,4830,analgesics,I-Drug
70467,4830,(,O
70468,4830,e.g.,O
70469,4830,",",O
70470,4830,methadone,B-Drug
70471,4830,",",O
70472,4830,hydromorphone,B-Drug
70473,4830,",",O
70474,4830,morphine,B-Drug
70475,4830,),O
70476,4831,Invasive,O
70477,4831,hepatocellular,B-Condition
70478,4831,carcinoma,I-Condition
70479,4831,without,O
70480,4831,any,O
70481,4831,isolated,B-Condition
70482,4831,tumor,I-Condition
70483,4832,Disease,O
70484,4832,needing,O
70485,4832,2,O
70486,4832,injections,O
70487,4832,of,O
70488,4832,Therasphere,O
70489,4833,Thrombosis,B-Condition
70490,4833,extending,O
70491,4833,into,O
70492,4833,the,O
70493,4833,porta(thrombosis,O
70494,4833,of,O
70495,4833,one,O
70496,4833,of,O
70497,4833,left,O
70498,4833,or,O
70499,4833,right,O
70500,4833,branch,O
70501,4833,authorized,O
70502,4833,),O
70503,4833,",",O
70504,4833,extra,B-Condition
70505,4833,hepatic,I-Condition
70506,4833,metastasis,I-Condition
70507,4834,Previous,O
70508,4834,treatment,O
70509,4834,by,O
70510,4834,chemoembolization,B-Procedure
70511,4834,",",O
70512,4834,radiofrequency,B-Procedure
70513,4834,less,O
70514,4834,than,O
70515,4834,3,O
70516,4834,months,O
70517,4834,before,O
70518,4834,radioembolization,O
70519,4835,No,O
70520,4835,antiangiogenic,B-Procedure
70521,4835,concomitant,I-Procedure
70522,4835,treatment,I-Procedure
70523,4835,",",O
70524,4835,15,O
70525,4835,days,O
70526,4835,before,O
70527,4835,and,O
70528,4835,15,O
70529,4835,days,O
70530,4835,after,O
70531,4835,radioembolization,O
70532,4835,",",O
70533,4835,including,O
70534,4835,Sorafenib,B-Drug
70535,4836,Associated,B-Condition
70536,4836,disease,I-Condition
70537,4836,which,O
70538,4836,could,O
70539,4836,prevent,O
70540,4836,patient,O
70541,4836,from,O
70542,4836,receiving,O
70543,4836,treatment,O
70544,4837,RMI,B-Condition
70545,4837,contre,I-Condition
70546,4837,-,I-Condition
70547,4837,indication(particle,I-Condition
70548,4837,or,O
70549,4837,metal,O
70550,4837,prosthesis,O
70551,4837,",",O
70552,4837,pacemaker,O
70553,4837,",",O
70554,4837,claustrophobia,O
70555,4837,),O
70556,4837,or,O
70557,4837,contrast,O
70558,4837,product,O
70559,4837,contre,O
70560,4837,-,O
70561,4837,indication,O
70562,4837,(,O
70563,4837,allergy,O
70564,4837,),O
70565,4838,Patient,O
70566,4838,already,O
70567,4838,participating,O
70568,4838,in,O
70569,4838,an,O
70570,4838,other,O
70571,4838,therapeutic,O
70572,4838,trial,O
70573,4838,with,O
70574,4838,an,O
70575,4838,experimental,O
70576,4838,drug,O
70577,4839,Pregnant,B-Condition
70578,4839,or,O
70579,4839,childbearing,B-Condition
70580,4839,potential,I-Condition
70581,4839,women,B-Person
70582,4839,or,O
70583,4839,breastfeeding,B-Observation
70584,4839,women,B-Person
70585,4840,minors,B-Person
70586,4840,",",O
70587,4840,persons,O
70588,4840,deprived,O
70589,4840,of,O
70590,4840,liberty,O
70591,4840,or,O
70592,4840,protected,O
70593,4840,adults,O
70594,4840,(,O
70595,4840,maintenance,O
70596,4840,of,O
70597,4840,justice,O
70598,4840,",",O
70599,4840,guardianship,O
70600,4840,or,O
70601,4840,supervision,O
70602,4840,),O
70603,4840,Unable,O
70604,4840,to,O
70605,4840,comply,O
70606,4840,with,O
70607,4840,trial,O
70608,4840,medical,O
70609,4840,follow,O
70610,4840,-,O
70611,4840,up,O
70612,4840,for,O
70613,4840,geographical,O
70614,4840,",",O
70615,4840,social,O
70616,4840,or,O
70617,4840,psychological,O
70618,4840,reasons,O
70619,4841,Unable,O
70620,4841,to,O
70621,4841,sign,O
70622,4841,an,O
70623,4841,informed,O
70624,4841,consent,O
70625,4842,Early,O
70626,4842,",",O
70627,4842,intermediate,O
70628,4842,",",O
70629,4842,advanced,O
70630,4842,",",O
70631,4842,non,O
70632,4842,metastatic,O
70633,4842,Hepatocellular,B-Condition
70634,4842,Carcinoma,I-Condition
70635,4842,.,O
70636,4842,Indication,B-Observation
70637,4842,for,O
70638,4842,radioembolization,B-Procedure
70639,4842,validated,O
70640,4842,after,O
70641,4842,pluridisciplinary,O
70642,4842,committee,O
70643,4842,meeting,O
70644,4842,.,O
70645,4843,Isolated,O
70646,4843,target,O
70647,4843,on,O
70648,4843,initial,O
70649,4843,imagery,O
70650,4843,(,O
70651,4843,invasive,O
70652,4843,hepatocellular,O
70653,4843,carcinoma,O
70654,4843,excluded,O
70655,4843,),O
70656,4844,WHO,O
70657,4844,(,O
70658,4844,World,O
70659,4844,Health,O
70660,4844,organization,O
70661,4844,),O
70662,4844,Performance,O
70663,4844,status,O
70664,4844,:,O
70665,4844,0,O
70666,4844,",",O
70667,4844,1,O
70668,4844,or,O
70669,4844,2,O
70670,4845,If,O
70671,4845,cirrhosis,B-Condition
70672,4845,",",O
70673,4845,Child,O
70674,4845,A,O
70675,4845,score,O
70676,4845,with,O
70677,4845,total,O
70678,4845,bilirubin,O
70679,4845,less,O
70680,4845,than,O
70681,4845,30,O
70682,4845,micromoles,O
70683,4845,per,O
70684,4845,liter,O
70685,4846,Creatinine,O
70686,4846,clearance,O
70687,4846,more,O
70688,4846,or,O
70689,4846,equal,O
70690,4846,to,O
70691,4846,30,O
70692,4846,mL,O
70693,4846,/,O
70694,4846,min,O
70695,4847,Patient,O
70696,4847,informed,O
70697,4847,and,O
70698,4847,consent,O
70699,4847,signature,O
70700,4847,obtained,O
70701,4848,Total,O
70702,4848,lesion,O
70703,4848,area,O
70704,4848,of,O
70705,4848,>,O
70706,4848,12,O
70707,4848,DA,O
70708,4848,or,O
70709,4848,>,O
70710,4848,30.5,O
70711,4848,mm2,O
70712,4849,The,O
70713,4849,existence,O
70714,4849,of,O
70715,4849,subretinal,O
70716,4849,hemorrhage,O
70717,4849,area,O
70718,4849,constituting,O
70719,4849,=,O
70720,4849,50,O
70721,4849,%,O
70722,4849,of,O
70723,4849,total,O
70724,4849,lesion,O
70725,4849,area,O
70726,4850,The,O
70727,4850,existence,O
70728,4850,of,O
70729,4850,scar,O
70730,4850,or,O
70731,4850,fibrosis,O
70732,4850,area,O
70733,4850,constituting,O
70734,4850,=,O
70735,4850,50,O
70736,4850,%,O
70737,4850,of,O
70738,4850,total,O
70739,4850,lesion,O
70740,4850,area,O
70741,4851,The,O
70742,4851,existence,O
70743,4851,of,O
70744,4851,RPE,B-Condition
70745,4851,tear,I-Condition
70746,4852,Prior,O
70747,4852,treatment,B-Procedure
70748,4852,for,O
70749,4852,wet,O
70750,4852,AMD,O
70751,4853,History,O
70752,4853,of,O
70753,4853,vitrectomy,B-Procedure
70754,4853,surgery,I-Procedure
70755,4853,",",O
70756,4853,submacular,B-Procedure
70757,4853,surgery,I-Procedure
70758,4853,",",O
70759,4853,or,O
70760,4853,other,O
70761,4853,surgical,B-Procedure
70762,4853,intervention,I-Procedure
70763,4853,for,O
70764,4853,AMD,B-Condition
70765,4854,The,O
70766,4854,pregnant,B-Condition
70767,4854,or,O
70768,4854,lactating,B-Condition
70769,4854,woman,B-Person
70770,4855,Signed,O
70771,4855,informed,O
70772,4855,consent,O
70773,4855,form,O
70774,4856,Male,B-Person
70775,4856,or,O
70776,4856,female,B-Person
70777,4856,of,O
70778,4856,aged,B-Person
70779,4856,50,O
70780,4856,years,O
70781,4856,or,O
70782,4856,older,O
70783,4857,Typical,O
70784,4857,AMD,B-Condition
70785,4857,and,O
70786,4857,PCV,B-Condition
70787,4857,patients,I-Condition
70788,4858,BCVA,B-Condition
70789,4858,of,O
70790,4858,24,O
70791,4858,letters,O
70792,4858,or,O
70793,4858,over,O
70794,4859,hypersensitivity,B-Condition
70795,4859,to,O
70796,4859,perindopril,B-Drug
70797,4859,or,O
70798,4859,to,O
70799,4859,other,O
70800,4859,ACE,B-Drug
70801,4859,inhibitors,I-Drug
70802,4859,",",O
70803,4859,amlodipine,B-Drug
70804,4859,",",O
70805,4859,atorvastatin,B-Drug
70806,4859,",",O
70807,4859,dihydropyridines,B-Drug
70808,4859,or,O
70809,4859,to,O
70810,4859,or,O
70811,4859,statins,B-Drug
70812,4860,angioneurotic,B-Condition
70813,4860,edema,I-Condition
70814,4860,in,O
70815,4860,medical,O
70816,4860,history,O
70817,4860,(,O
70818,4860,hereditary,O
70819,4860,/,O
70820,4860,idiopathic,O
70821,4860,or,O
70822,4860,associated,O
70823,4860,with,O
70824,4860,prior,O
70825,4860,treatment,B-Procedure
70826,4860,with,O
70827,4860,ACE,B-Drug
70828,4860,inhibitors,I-Drug
70829,4860,),O
70830,4861,severe,O
70831,4861,hypotension,B-Condition
70832,4861,",",O
70833,4861,shock,B-Condition
70834,4861,",",O
70835,4861,including,O
70836,4861,cardiogenic,B-Condition
70837,4861,shock,I-Condition
70838,4862,hemodynamically,O
70839,4862,unstable,O
70840,4862,heart,B-Condition
70841,4862,failure,I-Condition
70842,4863,Active,O
70843,4863,liver,B-Condition
70844,4863,disease,I-Condition
70845,4863,or,O
70846,4863,unexplained,O
70847,4863,persistent,O
70848,4863,elevations,O
70849,4863,of,O
70850,4863,serum,O
70851,4863,transaminases,O
70852,4863,more,O
70853,4863,than,O
70854,4863,three,O
70855,4863,times,O
70856,4863,normal,O
70857,4864,Women,B-Person
70858,4864,of,O
70859,4864,childbearing,B-Person
70860,4864,age,I-Person
70861,4864,without,O
70862,4864,reliable,O
70863,4864,contraception,B-Procedure
70864,4865,pregnancy,B-Condition
70865,4866,breastfeeding,B-Observation
70866,4867,Patients,O
70867,4867,with,O
70868,4867,contraindications,B-Condition
70869,4867,listed,O
70870,4867,in,O
70871,4867,the,O
70872,4867,currently,O
70873,4867,valid,O
70874,4867,SP,O
70875,4868,a,O
70876,4868,very,O
70877,4868,high,O
70878,4868,cardiovascular,B-Condition
70879,4868,risk,I-Condition
70880,4868,and,O
70881,4868,LDL,O
70882,4868,-,O
70883,4868,cholesterol,O
70884,4868,>,O
70885,4868,1.8,O
70886,4868,mmol,O
70887,4868,/,O
70888,4868,l,O
70889,4869,a,O
70890,4869,high,O
70891,4869,cardiovascular,B-Condition
70892,4869,risk,I-Condition
70893,4869,and,O
70894,4869,LDL,O
70895,4869,-,O
70896,4869,cholesterol,O
70897,4869,>,O
70898,4869,2.5,O
70899,4869,mmol,O
70900,4869,/,O
70901,4869,l,O
70902,4870,Patient,O
70903,4870,with,O
70904,4870,a,O
70905,4870,high,O
70906,4870,or,O
70907,4870,very,O
70908,4870,high,O
70909,4870,cardiovascular,B-Condition
70910,4870,risk,I-Condition
70911,4870,treated,O
70912,4870,by,O
70913,4870,lipidlowering,B-Procedure
70914,4870,therapy,I-Procedure
70915,4870,with,O
70916,4870,statin,B-Drug
70917,4871,Genotype,O
70918,4871,2,O
70919,4871,",",O
70920,4871,3,O
70921,4871,",",O
70922,4871,5,O
70923,4871,or,O
70924,4871,6,O
70925,4871,infection,B-Condition
70926,4871,.,O
70927,4872,Decompensated,O
70928,4872,cirrhosis,B-Condition
70929,4872,defined,O
70930,4872,by,O
70931,4872,the,O
70932,4872,presence,O
70933,4872,of,O
70934,4872,actual,O
70935,4872,or,O
70936,4872,previous,O
70937,4872,history,O
70938,4872,of,O
70939,4872,clinical,B-Condition
70940,4872,decompensation,I-Condition
70941,4872,including,O
70942,4872,ascites,B-Condition
70943,4872,",",O
70944,4872,hepatic,B-Condition
70945,4872,encephalopathy,I-Condition
70946,4872,",",O
70947,4872,variceal,B-Condition
70948,4872,bleeding,I-Condition
70949,4872,or,O
70950,4872,spontaneous,B-Condition
70951,4872,bacterial,I-Condition
70952,4872,peritonitis,I-Condition
70953,4872,",",O
70954,4872,or,O
70955,4872,a,O
70956,4872,Child,O
70957,4872,-,O
70958,4872,Pugh,O
70959,4872,B,O
70960,4872,or,O
70961,4872,C.,O
70962,4873,Hepatocellular,B-Condition
70963,4873,carcinoma,I-Condition
70964,4873,after,O
70965,4873,liver,B-Procedure
70966,4873,transplantation,I-Procedure
70967,4873,.,O
70968,4874,Total,O
70969,4874,bilirubin,O
70970,4874,>,O
70971,4874,3,O
70972,4874,mg,O
70973,4874,/,O
70974,4874,dL.,O
70975,4875,Immunosuppression,B-Procedure
70976,4875,with,O
70977,4875,cyclosporine,B-Drug
70978,4875,or,O
70979,4875,an,O
70980,4875,mTOR,B-Drug
70981,4875,inhibitor,I-Drug
70982,4875,(,O
70983,4875,everolimus,B-Drug
70984,4875,or,O
70985,4875,sirolimus,B-Drug
70986,4875,),O
70987,4875,.,O
70988,4876,Severe,O
70989,4876,extrahepatic,B-Condition
70990,4876,diseases,I-Condition
70991,4876,:,O
70992,4876,cardiovascular,B-Condition
70993,4876,",",O
70994,4876,respiratory,B-Condition
70995,4876,",",O
70996,4876,cerebrovascular,B-Condition
70997,4876,and,O
70998,4876,poorly,O
70999,4876,controlled,O
71000,4876,diabetes,B-Condition
71001,4876,.,O
71002,4877,Platelets,O
71003,4877,<,O
71004,4877,75,O
71005,4877,x,O
71006,4877,109,O
71007,4877,cells,O
71008,4877,/,O
71009,4877,L.,O
71010,4878,Neutrophil,O
71011,4878,count,O
71012,4878,<,O
71013,4878,0.5,O
71014,4878,x,O
71015,4878,109,O
71016,4878,cells,O
71017,4878,/,O
71018,4878,L.,O
71019,4879,Hemoglobin,O
71020,4879,<,O
71021,4879,9,O
71022,4879,g,O
71023,4879,/,O
71024,4879,dL.,O
71025,4880,Albumin,O
71026,4880,<,O
71027,4880,3g,O
71028,4880,/,O
71029,4880,dL.,O
71030,4881,HIV,B-Condition
71031,4881,infection,I-Condition
71032,4881,.,O
71033,4882,Hepatitis,B-Condition
71034,4882,B,I-Condition
71035,4882,infection,I-Condition
71036,4882,.,O
71037,4883,Active,O
71038,4883,intake,O
71039,4883,of,O
71040,4883,toxic,O
71041,4883,amounts,O
71042,4883,of,O
71043,4883,alcohol,B-Condition
71044,4883,or,O
71045,4883,recreational,B-Condition
71046,4883,drugs,I-Condition
71047,4883,.,O
71048,4884,Females,B-Person
71049,4884,who,O
71050,4884,are,O
71051,4884,pregnant,B-Condition
71052,4884,",",O
71053,4884,become,B-Observation
71054,4884,to,O
71055,4884,be,O
71056,4884,pregnant,B-Condition
71057,4884,or,O
71058,4884,breastfeeding,B-Observation
71059,4884,or,O
71060,4884,males,B-Person
71061,4884,whose,O
71062,4884,partners,O
71063,4884,are,O
71064,4884,pregnant,O
71065,4884,",",O
71066,4884,become,O
71067,4884,to,O
71068,4884,be,O
71069,4884,pregnant,O
71070,4884,or,O
71071,4884,breastfeeding,O
71072,4884,.,O
71073,4885,Intake,O
71074,4885,of,O
71075,4885,disallowed,B-Drug
71076,4885,medications,I-Drug
71077,4885,including(but,O
71078,4885,not,O
71079,4885,limited,O
71080,4885,to,O
71081,4885,):,O
71082,4886,1,O
71083,4886,.,O
71084,4886,Antibiotics,O
71085,4886,:,O
71086,4886,clarithromycin,B-Drug
71087,4886,",",O
71088,4886,erythromycin,B-Drug
71089,4886,",",O
71090,4886,telithromycin,B-Drug
71091,4886,",",O
71092,4886,nafcillin,B-Drug
71093,4886,",",O
71094,4886,rifampin,B-Drug
71095,4887,2,O
71096,4887,.,O
71097,4887,Antifungals,O
71098,4887,:,O
71099,4887,itraconazole,B-Drug
71100,4887,",",O
71101,4887,ketoconazole,B-Drug
71102,4887,",",O
71103,4887,voriconazole,B-Drug
71104,4888,3,O
71105,4888,.,O
71106,4888,Antihypertensives,O
71107,4888,:,O
71108,4888,nifedipine,B-Drug
71109,4889,4,O
71110,4889,.,O
71111,4889,Anticonvulsants,O
71112,4889,:,O
71113,4889,carbamazepine,B-Drug
71114,4889,",",O
71115,4889,phenytoin,B-Drug
71116,4889,",",O
71117,4889,phenobarbital,B-Drug
71118,4890,5,O
71119,4890,.,O
71120,4890,Bosentan,B-Drug
71121,4891,6,O
71122,4891,.,O
71123,4891,Modafinil,B-Drug
71124,4892,7,O
71125,4892,.,O
71126,4892,St.,B-Drug
71127,4892,Jonh,I-Drug
71128,4892,'s,I-Drug
71129,4892,Wort,I-Drug
71130,4893,8,O
71131,4893,.,O
71132,4893,Immunosuppressants,O
71133,4893,:,O
71134,4893,cyclosporin,B-Drug
71135,4893,",",O
71136,4893,everolimus,B-Drug
71137,4893,",",O
71138,4893,sirolimus,B-Drug
71139,4894,9,O
71140,4894,.,O
71141,4894,Diabetes,O
71142,4894,agents,O
71143,4894,:,O
71144,4894,glibenclamide,B-Drug
71145,4894,",",O
71146,4894,glyburide,B-Drug
71147,4895,10,O
71148,4895,.,O
71149,4895,Lipid,O
71150,4895,lowering,O
71151,4895,agents,O
71152,4895,:,O
71153,4895,gemfibrozil,B-Drug
71154,4896,11,O
71155,4896,.,O
71156,4896,Eltrombopag,B-Drug
71157,4897,12,O
71158,4897,.,O
71159,4897,Lapatinib,B-Drug
71160,4898,13,O
71161,4898,.,O
71162,4898,HIV,O
71163,4898,medications,O
71164,4898,:,O
71165,4898,efavirenz,B-Drug
71166,4898,",",O
71167,4898,etravirine,B-Drug
71168,4898,",",O
71169,4898,all,O
71170,4898,ritonavir,B-Drug
71171,4898,boosted,O
71172,4898,and,O
71173,4898,unboosted,O
71174,4898,HIV,B-Drug
71175,4898,protease,I-Drug
71176,4898,inhibitors,I-Drug
71177,4899,14,O
71178,4899,.,O
71179,4899,Statins,O
71180,4899,:,O
71181,4899,simvastatin,B-Drug
71182,4899,",",O
71183,4899,fluvastatin,B-Drug
71184,4899,",",O
71185,4899,rosuvastatin,B-Drug
71186,4899,at,O
71187,4899,doses,O
71188,4899,greater,O
71189,4899,than,O
71190,4899,10,O
71191,4899,mg,O
71192,4899,/,O
71193,4899,d,O
71194,4899,",",O
71195,4899,atorvastatin,B-Drug
71196,4899,at,O
71197,4899,doses,O
71198,4899,greater,O
71199,4899,than,O
71200,4899,10,O
71201,4899,mg,O
71202,4899,/,O
71203,4899,d.,O
71204,4900,Age,B-Person
71205,4900,between,O
71206,4900,18,O
71207,4900,and,O
71208,4900,78,O
71209,4900,year,O
71210,4900,-,O
71211,4900,old,O
71212,4900,.,O
71213,4901,Previous,O
71214,4901,liver,B-Procedure
71215,4901,transplantation(more,I-Procedure
71216,4901,than,O
71217,4901,6,O
71218,4901,month,O
71219,4901,),O
71220,4901,.,O
71221,4902,Genotype,O
71222,4902,1,O
71223,4902,and,O
71224,4902,4,O
71225,4902,infection,B-Condition
71226,4902,.,O
71227,4903,Hepatitis,B-Condition
71228,4903,C,I-Condition
71229,4903,recurrence,O
71230,4903,defined,O
71231,4903,by,O
71232,4903,the,O
71233,4903,presence,O
71234,4903,of,O
71235,4903,abnormal,O
71236,4903,liver,O
71237,4903,function,O
71238,4903,test,O
71239,4903,",",O
71240,4903,positive,O
71241,4903,HCV,O
71242,4903,-,O
71243,4903,RNA,O
71244,4903,",",O
71245,4903,histological,B-Condition
71246,4903,signs,I-Condition
71247,4903,of,I-Condition
71248,4903,hepatitis,I-Condition
71249,4903,C,I-Condition
71250,4903,recurrence,I-Condition
71251,4903,.,O
71252,4904,Viral,O
71253,4904,load,O
71254,4904,≥10000UI,O
71255,4904,/,O
71256,4904,mL.,O
71257,4905,Immunosuppression,B-Procedure
71258,4905,with,O
71259,4905,tacrolimus,B-Drug
71260,4905,and/or,O
71261,4905,mycophenolate,B-Drug
71262,4905,(,O
71263,4905,Prednisone,B-Drug
71264,4905,use,O
71265,4905,is,O
71266,4905,allowed,O
71267,4905,at,O
71268,4905,low,O
71269,4905,dose,O
71270,4905,",",O
71271,4905,≤10,O
71272,4905,mg,O
71273,4905,/,O
71274,4905,d,O
71275,4905,),O
71276,4905,.,O
71277,4906,Treatment,B-Condition
71278,4906,naïve,I-Condition
71279,4906,or,O
71280,4906,treatment,B-Condition
71281,4906,experienced,I-Condition
71282,4906,(,O
71283,4906,Peg,B-Procedure
71284,4906,-,I-Procedure
71285,4906,RBV,I-Procedure
71286,4906,or,O
71287,4906,triple,B-Procedure
71288,4906,therapy,I-Procedure
71289,4906,),O
71290,4906,.,O
71291,4907,Morbidly,B-Condition
71292,4907,obese,I-Condition
71293,4907,patients,O
71294,4907,(,O
71295,4907,BMI,O
71296,4907,>,O
71297,4907,47,O
71298,4907,kg,O
71299,4907,/,O
71300,4907,m2,O
71301,4907,),O
71302,4907,and,O
71303,4907,overweight,B-Condition
71304,4907,/,O
71305,4907,lean,B-Condition
71306,4907,patients,O
71307,4907,(,O
71308,4907,BMI,O
71309,4907,<,O
71310,4907,27,O
71311,4907,kg,O
71312,4907,/,O
71313,4907,m2,O
71314,4907,),O
71315,4908,Evidence,O
71316,4908,of,O
71317,4908,type,B-Condition
71318,4908,1,I-Condition
71319,4908,diabetes,I-Condition
71320,4908,and,O
71321,4908,diabetics,B-Condition
71322,4908,requiring,O
71323,4908,insulin,B-Procedure
71324,4908,therapy,I-Procedure
71325,4908,.,O
71326,4909,Subjects,O
71327,4909,who,O
71328,4909,have,O
71329,4909,not,O
71330,4909,been,O
71331,4909,weight,B-Observation
71332,4909,stable,I-Observation
71333,4909,(,O
71334,4909,>,O
71335,4909,2,O
71336,4909,kg,O
71337,4909,weight,O
71338,4909,change,O
71339,4909,in,O
71340,4909,past,O
71341,4909,3,O
71342,4909,months,O
71343,4909,),O
71344,4910,Subjects,O
71345,4910,who,O
71346,4910,have,O
71347,4910,been,O
71348,4910,recently,O
71349,4910,active,B-Condition
71350,4910,(,O
71351,4910,>,O
71352,4910,30,O
71353,4910,min,O
71354,4910,of,O
71355,4910,moderate,O
71356,4910,/,O
71357,4910,high,O
71358,4910,intensity,O
71359,4910,exercise,O
71360,4910,",",O
71361,4910,2,O
71362,4910,times,O
71363,4910,/,O
71364,4910,week,O
71365,4910,),O
71366,4910,.,O
71367,4911,Subjects,O
71368,4911,who,O
71369,4911,are,O
71370,4911,smokers,B-Observation
71371,4911,or,O
71372,4911,who,O
71373,4911,have,O
71374,4911,quit,B-Observation
71375,4911,smoking,I-Observation
71376,4911,<,O
71377,4911,5,O
71378,4911,years,O
71379,4911,ago,O
71380,4912,Subjects,O
71381,4912,prescribed,O
71382,4912,metformin,B-Drug
71383,4912,or,O
71384,4912,have,O
71385,4912,taken,O
71386,4912,metformin,B-Drug
71387,4912,within,O
71388,4912,1,O
71389,4912,year,O
71390,4912,.,O
71391,4913,Subjects,O
71392,4913,with,O
71393,4913,abnormal,O
71394,4913,estimated,O
71395,4913,glomerular,O
71396,4913,filtration,O
71397,4913,rate,O
71398,4913,(,O
71399,4913,eGFR,O
71400,4913,),O
71401,4913,.,O
71402,4914,Hypertriglyceridemic,B-Condition
71403,4914,(,O
71404,4914,>,O
71405,4914,400,O
71406,4914,mg,O
71407,4914,/,O
71408,4914,dl,O
71409,4914,),O
71410,4914,and,O
71411,4914,hypercholesterolemic,B-Condition
71412,4914,(,O
71413,4914,>,O
71414,4914,260,O
71415,4914,mg,O
71416,4914,/,O
71417,4914,dl,O
71418,4914,),O
71419,4914,subjects,O
71420,4915,Hypertensive,B-Condition
71421,4915,(,O
71422,4915,>,O
71423,4915,160/100,O
71424,4915,mmHg,O
71425,4915,),O
71426,4916,Subjects,O
71427,4916,currently,O
71428,4916,taking,O
71429,4916,medications,B-Drug
71430,4916,that,O
71431,4916,affect,O
71432,4916,heart,O
71433,4916,rate,O
71434,4916,and,O
71435,4916,rhythm,O
71436,4916,(,O
71437,4916,i.e.,O
71438,4916,Ca++,B-Drug
71439,4916,channel,I-Drug
71440,4916,blockers,I-Drug
71441,4916,",",O
71442,4916,nitrates,B-Drug
71443,4916,",",O
71444,4916,alpha-,B-Drug
71445,4916,or,I-Drug
71446,4916,beta,I-Drug
71447,4916,-,I-Drug
71448,4916,blockers,I-Drug
71449,4916,),O
71450,4916,.,O
71451,4917,Subjects,O
71452,4917,with,O
71453,4917,a,O
71454,4917,history,B-Observation
71455,4917,of,O
71456,4917,significant,O
71457,4917,metabolic,O
71458,4917,",",O
71459,4917,cardiac,O
71460,4917,",",O
71461,4917,congestive,B-Condition
71462,4917,heart,I-Condition
71463,4917,failure,I-Condition
71464,4917,",",O
71465,4917,cerebrovascular,O
71466,4917,",",O
71467,4917,hematological,O
71468,4917,",",O
71469,4917,pulmonary,O
71470,4917,",",O
71471,4917,gastrointestinal,O
71472,4917,",",O
71473,4917,liver,O
71474,4917,",",O
71475,4917,renal,O
71476,4917,",",O
71477,4917,or,O
71478,4917,endocrine,O
71479,4917,disease,B-Condition
71480,4917,or,O
71481,4917,cancer,B-Condition
71482,4917,that,O
71483,4917,in,O
71484,4917,the,O
71485,4917,investigator,O
71486,4917,'s,O
71487,4917,opinion,O
71488,4917,would,O
71489,4917,interfere,O
71490,4917,with,O
71491,4917,or,O
71492,4917,alter,O
71493,4917,the,O
71494,4917,outcome,O
71495,4917,measures,O
71496,4917,",",O
71497,4917,or,O
71498,4917,impact,O
71499,4917,subject,O
71500,4917,safety,O
71501,4917,.,O
71502,4918,Pregnant,B-Condition
71503,4918,(,O
71504,4918,as,O
71505,4918,evidenced,O
71506,4918,by,O
71507,4918,positive,O
71508,4918,pregnancy,O
71509,4918,test,O
71510,4918,),O
71511,4918,or,O
71512,4918,nursing,B-Observation
71513,4918,women,B-Person
71514,4919,Subjects,O
71515,4919,with,O
71516,4919,contraindications,B-Condition
71517,4919,to,O
71518,4919,participation,B-Observation
71519,4919,in,I-Observation
71520,4919,an,I-Observation
71521,4919,exercise,I-Observation
71522,4919,training,I-Observation
71523,4919,program,I-Observation
71524,4920,Currently,O
71525,4920,taking,O
71526,4920,active,B-Drug
71527,4920,weight,I-Drug
71528,4920,suppression,I-Drug
71529,4920,medication,I-Drug
71530,4920,(,O
71531,4920,e.g.,O
71532,4920,phentermine,B-Drug
71533,4920,",",O
71534,4920,orlistat,B-Drug
71535,4920,",",O
71536,4920,lorcaserin,B-Drug
71537,4920,",",O
71538,4920,naltrexone,B-Drug
71539,4920,-,I-Drug
71540,4920,bupropion,I-Drug
71541,4920,in,I-Drug
71542,4920,combination,I-Drug
71543,4920,",",O
71544,4920,liraglutide,B-Drug
71545,4920,",",O
71546,4920,benzephetamine,B-Drug
71547,4920,",",O
71548,4920,diethylpropion,B-Drug
71549,4920,",",O
71550,4920,phendimetrazine,B-Drug
71551,4920,),O
71552,4921,Known,O
71553,4921,hypersensitivity,B-Condition
71554,4921,to,O
71555,4921,perflutren,B-Drug
71556,4921,(,O
71557,4921,contained,O
71558,4921,in,O
71559,4921,Definity,B-Drug
71560,4921,),O
71561,4922,Male,B-Person
71562,4922,or,O
71563,4922,female,B-Person
71564,4922,>,O
71565,4922,40,O
71566,4922,and,O
71567,4922,<,O
71568,4922,70,O
71569,4922,years,O
71570,4922,old,B-Person
71571,4922,.,O
71572,4923,Has,O
71573,4923,a,O
71574,4923,body,O
71575,4923,mass,O
71576,4923,index,O
71577,4923,>,O
71578,4923,27,O
71579,4923,and,O
71580,4923,<,O
71581,4923,47,O
71582,4923,kg,O
71583,4923,/,O
71584,4923,m2,O
71585,4923,.,O
71586,4924,Not,O
71587,4924,diagnosed,O
71588,4924,with,O
71589,4924,Type,B-Condition
71590,4924,2,I-Condition
71591,4924,diabetes,I-Condition
71592,4924,.,O
71593,4925,Not,O
71594,4925,currently,O
71595,4925,engaged,B-Observation
71596,4925,in,I-Observation
71597,4925,>,I-Observation
71598,4925,60,I-Observation
71599,4925,min,I-Observation
71600,4925,/,I-Observation
71601,4925,wk,I-Observation
71602,4925,of,I-Observation
71603,4925,exercise,I-Observation
71604,4926,Meet,O
71605,4926,at,O
71606,4926,least,O
71607,4926,3,O
71608,4926,of,O
71609,4926,5,O
71610,4926,National,O
71611,4926,Cholesterol,O
71612,4926,Education,O
71613,4926,Adult,O
71614,4926,Treatment,O
71615,4926,Panel,O
71616,4926,III,O
71617,4927,Increased,O
71618,4927,waist,O
71619,4927,circumference,O
71620,4927,(=,O
71621,4927,102,O
71622,4927,cm,O
71623,4927,in,O
71624,4927,men,B-Person
71625,4927,;,O
71626,4927,=,O
71627,4927,88,O
71628,4927,cm,O
71629,4927,in,O
71630,4927,women,B-Person
71631,4927,),O
71632,4928,Elevated,O
71633,4928,triglycerides,O
71634,4928,(=,O
71635,4928,150,O
71636,4928,mg,O
71637,4928,/,O
71638,4928,dl,O
71639,4928,),O
71640,4928,",",O
71641,4928,or,O
71642,4928,on,O
71643,4928,medication,B-Drug
71644,4928,for,I-Drug
71645,4928,treating,I-Drug
71646,4928,the,O
71647,4928,condition,O
71648,4929,Reduced,O
71649,4929,HDL,O
71650,4929,-,O
71651,4929,cholesterol,O
71652,4929,(,O
71653,4929,<,O
71654,4929,40mg,O
71655,4929,/,O
71656,4929,dl,O
71657,4929,in,O
71658,4929,men,B-Person
71659,4929,",",O
71660,4929,<,O
71661,4929,50,O
71662,4929,mg,O
71663,4929,/,O
71664,4929,dl,O
71665,4929,in,O
71666,4929,women,B-Person
71667,4929,),O
71668,4929,",",O
71669,4929,or,O
71670,4929,on,O
71671,4929,medication,B-Drug
71672,4929,for,I-Drug
71673,4929,treating,I-Drug
71674,4929,the,O
71675,4929,condition,O
71676,4930,High,B-Condition
71677,4930,blood,I-Condition
71678,4930,pressure,I-Condition
71679,4930,(=,O
71680,4930,130,O
71681,4930,mmHg,O
71682,4930,systolic,O
71683,4930,or,O
71684,4930,=,O
71685,4930,85mmHg,O
71686,4930,diastolic,O
71687,4930,),O
71688,4930,",",O
71689,4930,or,O
71690,4930,on,O
71691,4930,medication,B-Drug
71692,4930,for,I-Drug
71693,4930,treating,I-Drug
71694,4930,the,O
71695,4930,condition,O
71696,4931,Elevated,B-Condition
71697,4931,fasting,I-Condition
71698,4931,glucose,I-Condition
71699,4931,(=,O
71700,4931,100,O
71701,4931,mg,O
71702,4931,/,O
71703,4931,dl,O
71704,4931,),O
71705,4931,",",O
71706,4931,or,O
71707,4931,on,O
71708,4931,medication,B-Drug
71709,4931,for,I-Drug
71710,4931,treating,I-Drug
71711,4931,the,O
71712,4931,condition,O
71713,4932,NA,O
71714,4933,Male,B-Person
71715,4933,or,O
71716,4933,female,B-Person
71717,4933,=,O
71718,4933,18,O
71719,4933,years,O
71720,4933,of,O
71721,4933,age,B-Person
71722,4933,at,O
71723,4933,Visit,O
71724,4933,1,O
71725,4933,.,O
71726,4934,Sweat,O
71727,4934,chloride,O
71728,4934,equal,O
71729,4934,or,O
71730,4934,greater,O
71731,4934,than,O
71732,4934,60,O
71733,4934,mEq,O
71734,4934,/,O
71735,4934,L,O
71736,4934,by,O
71737,4934,quantitative,O
71738,4934,pilocarpine,O
71739,4934,iontophoresis,O
71740,4934,test,O
71741,4934,.,O
71742,4935,Two,O
71743,4935,well,O
71744,4935,-,O
71745,4935,characterized,O
71746,4935,mutations,B-Condition
71747,4935,in,O
71748,4935,the,O
71749,4935,cystic,B-Condition
71750,4935,fibrosis,I-Condition
71751,4935,transmembrane,I-Condition
71752,4935,conductance,I-Condition
71753,4935,regulator,I-Condition
71754,4935,(,I-Condition
71755,4935,CFTR,I-Condition
71756,4935,),I-Condition
71757,4935,gene,I-Condition
71758,4936,Abnormal,O
71759,4936,nasal,O
71760,4936,potential,O
71761,4936,difference,O
71762,4936,(,O
71763,4936,NPD,O
71764,4936,),O
71765,4936,as,O
71766,4936,measured,O
71767,4936,by,O
71768,4936,a,O
71769,4936,change,O
71770,4936,in,O
71771,4936,NPD,O
71772,4936,in,O
71773,4936,response,O
71774,4936,to,O
71775,4936,a,O
71776,4936,low,O
71777,4936,chloride,O
71778,4936,solution,O
71779,4936,and,O
71780,4936,isoproterenol,O
71781,4936,of,O
71782,4936,less,O
71783,4936,than,O
71784,4936,-5,O
71785,4936,mV.,O
71786,4937,Documentation,O
71787,4937,of,O
71788,4937,the,O
71789,4937,presence,O
71790,4937,of,O
71791,4937,an,O
71792,4937,acute,B-Condition
71793,4937,pulmonary,I-Condition
71794,4937,exacerbation,I-Condition
71795,4937,",",O
71796,4937,based,O
71797,4937,on,O
71798,4937,CF,O
71799,4937,Foundation,O
71800,4937,guidelines,O
71801,4937,",",O
71802,4937,as,O
71803,4937,diagnosed,O
71804,4937,by,O
71805,4937,a,O
71806,4937,faculty,O
71807,4937,member,O
71808,4937,of,O
71809,4937,the,O
71810,4937,Denver,O
71811,4937,Adult,O
71812,4937,CF,O
71813,4937,Program,O
71814,4937,.,O
71815,4938,Respiratory,O
71816,4938,culture(s,O
71817,4938,),O
71818,4938,demonstrating,O
71819,4938,evidence,O
71820,4938,of,O
71821,4938,Pseudomonas,O
71822,4938,aeruginosa,O
71823,4938,or,O
71824,4938,Achromobacter,O
71825,4938,species,O
71826,4938,airway,B-Condition
71827,4938,infection,I-Condition
71828,4938,.,O
71829,4939,Subject,O
71830,4939,is,O
71831,4939,able,O
71832,4939,to,O
71833,4939,produce,O
71834,4939,sputum,O
71835,4939,",",O
71836,4939,undergo,O
71837,4939,phlebotomy,O
71838,4939,",",O
71839,4939,and,O
71840,4939,provide,O
71841,4939,written,O
71842,4939,consent,O
71843,4939,.,O
71844,4940,The,O
71845,4940,subject,O
71846,4940,'s,O
71847,4940,treating,O
71848,4940,physician,O
71849,4940,has,O
71850,4940,determined,O
71851,4940,that,O
71852,4940,they,O
71853,4940,should,O
71854,4940,receive,O
71855,4940,either,O
71856,4940,tobramycin,O
71857,4940,or,O
71858,4940,colistin,O
71859,4940,intravenously,O
71860,4940,as,O
71861,4940,one,O
71862,4940,of,O
71863,4940,the,O
71864,4940,designated,O
71865,4940,agents,O
71866,4940,for,O
71867,4940,their,O
71868,4940,APE,O
71869,4940,treatment,O
71870,4940,.,O
71871,4940,Subjects,O
71872,4940,who,O
71873,4940,are,O
71874,4940,able,O
71875,4940,to,O
71876,4940,receive,O
71877,4940,either,O
71878,4940,tobramycin,O
71879,4940,or,O
71880,4940,colistin,O
71881,4940,as,O
71882,4940,part,O
71883,4940,of,O
71884,4940,their,O
71885,4940,antibiotic,O
71886,4940,regimen,O
71887,4940,will,O
71888,4940,be,O
71889,4940,randomized,O
71890,4940,into,O
71891,4940,one,O
71892,4940,of,O
71893,4940,three,O
71894,4940,arms,O
71895,4940,.,O
71896,4940,If,O
71897,4940,a,O
71898,4940,treating,O
71899,4940,physician,O
71900,4940,deems,O
71901,4940,that,O
71902,4940,a,O
71903,4940,subject,O
71904,4940,can,O
71905,4940,not,O
71906,4940,receive,O
71907,4940,tobramycin,O
71908,4940,due,O
71909,4940,to,O
71910,4940,vestibular,O
71911,4940,toxicity,O
71912,4940,",",O
71913,4940,ototoxicity,O
71914,4940,or,O
71915,4940,bacterial,O
71916,4940,resistance,O
71917,4940,",",O
71918,4940,the,O
71919,4940,subject,O
71920,4940,will,O
71921,4940,be,O
71922,4940,randomized,O
71923,4940,to,O
71924,4940,either,O
71925,4940,standard,O
71926,4940,or,O
71927,4940,PK,O
71928,4940,-,O
71929,4940,adjusted,O
71930,4940,colistin,O
71931,4940,.,O
71932,4941,Women,O
71933,4941,refusing,O
71934,4941,HBs,O
71935,4941,Ag,O
71936,4941,test,O
71937,4942,HIV,O
71938,4942,co,B-Condition
71939,4942,-,I-Condition
71940,4942,infection,I-Condition
71941,4943,HCV,O
71942,4943,co,B-Condition
71943,4943,-,I-Condition
71944,4943,infection,I-Condition
71945,4944,HBV,B-Procedure
71946,4944,treatment,I-Procedure
71947,4944,ongoing,O
71948,4944,at,O
71949,4944,the,O
71950,4944,day,O
71951,4944,of,O
71952,4944,inclusion,O
71953,4945,Creatinine,O
71954,4945,clearance,O
71955,4945,<,O
71956,4945,30,O
71957,4945,mL,O
71958,4945,/,O
71959,4945,min,O
71960,4946,Severe,O
71961,4946,gravidic,B-Condition
71962,4946,disease,I-Condition
71963,4946,present,O
71964,4946,at,O
71965,4946,inclusion,O
71966,4946,involving,O
71967,4946,life,O
71968,4946,threatening,O
71969,4946,to,O
71970,4946,the,O
71971,4946,mother,O
71972,4946,and/or,O
71973,4946,the,O
71974,4946,child,O
71975,4947,Evidence,O
71976,4947,of,O
71977,4947,pre,O
71978,4947,-,O
71979,4947,existing,O
71980,4947,fetal,B-Condition
71981,4947,anomalies,I-Condition
71982,4947,incompatible,O
71983,4947,with,O
71984,4947,the,O
71985,4947,child,O
71986,4947,'s,O
71987,4947,life,O
71988,4948,Imminent,B-Condition
71989,4948,child,I-Condition
71990,4948,'s,I-Condition
71991,4948,birth,I-Condition
71992,4948,defined,O
71993,4948,as,O
71994,4948,cervix,O
71995,4948,dilatation,O
71996,4948,up,O
71997,4948,to,O
71998,4948,7,O
71999,4948,centimeters,O
72000,4949,Intention,O
72001,4949,to,O
72002,4949,deliver,O
72003,4949,in,O
72004,4949,a,O
72005,4949,maternity,O
72006,4949,not,O
72007,4949,linked,O
72008,4949,to,O
72009,4949,the,O
72010,4949,study,O
72011,4950,Any,O
72012,4950,concomitant,O
72013,4950,medical,O
72014,4950,condition,O
72015,4950,that,O
72016,4950,",",O
72017,4950,according,O
72018,4950,to,O
72019,4950,the,O
72020,4950,clinical,O
72021,4950,site,O
72022,4950,investigator,O
72023,4950,would,O
72024,4950,contraindicate,O
72025,4950,participation,O
72026,4950,in,O
72027,4950,the,O
72028,4950,study,O
72029,4950,.,O
72030,4951,Concurrent,O
72031,4951,participation,O
72032,4951,in,O
72033,4951,any,O
72034,4951,other,O
72035,4951,clinical,O
72036,4951,trial,O
72037,4951,without,O
72038,4951,written,O
72039,4951,agreement,O
72040,4951,of,O
72041,4951,the,O
72042,4951,two,O
72043,4951,study,O
72044,4951,teams,O
72045,4952,>,O
72046,4952,=,O
72047,4952,18,O
72048,4952,years,O
72049,4952,old,B-Person
72050,4952,the,O
72051,4952,day,O
72052,4952,of,O
72053,4952,inclusion,O
72054,4953,Pregnancy,B-Condition
72055,4954,Positive,O
72056,4954,HBs,O
72057,4954,Ag,O
72058,4955,Informed,O
72059,4955,consent,O
72060,4955,obtained,O
72061,4955,with,O
72062,4955,information,O
72063,4955,sheet,O
72064,4955,given,O
72065,4955,and,O
72066,4955,explained,O
72067,4955,and,O
72068,4955,the,O
72069,4955,consent,O
72070,4955,form,O
72071,4955,signed,O
72072,4955,by,O
72073,4955,the,O
72074,4955,participant,O
72075,4955,of,O
72076,4955,the,O
72077,4955,project,O
72078,4955,investigator,O
72079,4955,at,O
72080,4955,the,O
72081,4955,latest,O
72082,4955,the,O
72083,4955,day,O
72084,4955,of,O
72085,4955,the,O
72086,4955,inclusion,O
72087,4956,Psychotic,B-Condition
72088,4956,depression,I-Condition
72089,4956,by,O
72090,4956,DSM,O
72091,4956,-,O
72092,4956,IV,O
72093,4956,",",O
72094,4956,i.e.,O
72095,4956,",",O
72096,4956,presence,O
72097,4956,of,O
72098,4956,delusions,B-Condition
72099,4956,with,O
72100,4956,a,O
72101,4956,SCID,O
72102,4956,-,O
72103,4956,R,O
72104,4956,score,O
72105,4956,higher,O
72106,4956,than,O
72107,4956,2,O
72108,4956,;,O
72109,4957,High,O
72110,4957,suicide,B-Observation
72111,4957,risk,I-Observation
72112,4957,",",O
72113,4957,i.e.,O
72114,4957,intent,B-Mood
72115,4957,or,O
72116,4957,plan,B-Mood
72117,4957,to,I-Mood
72118,4957,attempt,B-Observation
72119,4957,suicide,I-Observation
72120,4957,in,O
72121,4957,near,O
72122,4957,future,O
72123,4957,;,O
72124,4958,Presence,O
72125,4958,of,O
72126,4958,any,O
72127,4958,Axis,O
72128,4958,I,O
72129,4958,psychiatric,B-Condition
72130,4958,disorder,I-Condition
72131,4958,(,O
72132,4958,other,O
72133,4958,than,O
72134,4958,unipolar,B-Condition
72135,4958,major,I-Condition
72136,4958,depression,I-Condition
72137,4958,),O
72138,4958,or,O
72139,4958,substance,B-Condition
72140,4958,abuse,I-Condition
72141,4958,;,O
72142,4959,History,O
72143,4959,of,O
72144,4959,psychiatric,B-Condition
72145,4959,disorders,I-Condition
72146,4959,other,O
72147,4959,than,O
72148,4959,unipolar,B-Condition
72149,4959,major,I-Condition
72150,4959,depression,I-Condition
72151,4959,or,O
72152,4959,generalized,B-Condition
72153,4959,anxiety,I-Condition
72154,4959,disorder,I-Condition
72155,4959,(,O
72156,4959,bipolar,B-Condition
72157,4959,disorder,I-Condition
72158,4959,",",O
72159,4959,hypomania,B-Condition
72160,4959,",",O
72161,4959,and,O
72162,4959,dysthymia,B-Condition
72163,4959,are,O
72164,4959,exclusion,O
72165,4959,criteria,O
72166,4959,),O
72167,4959,;,O
72168,4960,Dementia,B-Condition
72169,4960,:,O
72170,4960,Diagnosis,O
72171,4960,of,O
72172,4960,dementia,O
72173,4960,by,O
72174,4960,DSM,O
72175,4960,-,O
72176,4960,IV,O
72177,4960,;,O
72178,4961,Mild,B-Condition
72179,4961,Cognitive,I-Condition
72180,4961,Impairment,I-Condition
72181,4961,(,O
72182,4961,MCI,B-Condition
72183,4961,),O
72184,4961,;,O
72185,4962,Acute,O
72186,4962,or,O
72187,4962,severe,O
72188,4962,medical,B-Condition
72189,4962,illness,I-Condition
72190,4962,",",O
72191,4962,i.e.,O
72192,4962,",",O
72193,4962,delirium,B-Condition
72194,4962,",",O
72195,4962,metastatic,B-Condition
72196,4962,cancer,I-Condition
72197,4962,",",O
72198,4962,decompensated,O
72199,4962,cardiac,B-Condition
72200,4962,",",I-Condition
72201,4962,liver,I-Condition
72202,4962,or,I-Condition
72203,4962,kidney,I-Condition
72204,4962,failure,I-Condition
72205,4962,",",O
72206,4962,major,B-Procedure
72207,4962,surgery,I-Procedure
72208,4962,",",O
72209,4962,stroke,B-Condition
72210,4962,or,O
72211,4962,myocardial,B-Condition
72212,4962,infarction,I-Condition
72213,4962,during,O
72214,4962,the,O
72215,4962,three,O
72216,4962,months,O
72217,4962,prior,O
72218,4962,to,O
72219,4962,entry,O
72220,4962,;,O
72221,4962,or,O
72222,4962,use,O
72223,4962,of,O
72224,4962,drugs,B-Drug
72225,4962,known,O
72226,4962,to,O
72227,4962,cause,O
72228,4962,depression,B-Condition
72229,4962,",",O
72230,4962,e.g.,O
72231,4962,",",O
72232,4962,reserpine,B-Drug
72233,4962,",",O
72234,4962,alpha,B-Drug
72235,4962,-,I-Drug
72236,4962,methyl,I-Drug
72237,4962,-,I-Drug
72238,4962,dopa,I-Drug
72239,4962,",",O
72240,4962,steroids,B-Drug
72241,4962,",",O
72242,4962,sympathomimetics,B-Condition
72243,4962,withdrawal,I-Condition
72244,4962,;,O
72245,4963,Neurological,O
72246,4963,brain,B-Condition
72247,4963,disease,I-Condition
72248,4963,and/or,O
72249,4963,history,O
72250,4963,of,O
72251,4963,electroconvulsive,B-Procedure
72252,4963,therapy,I-Procedure
72253,4963,;,O
72254,4964,History,O
72255,4964,of,O
72256,4964,any,O
72257,4964,use,O
72258,4964,of,O
72259,4964,citalopram,B-Drug
72260,4964,or,O
72261,4964,escitalopram,B-Drug
72262,4964,during,O
72263,4964,the,O
72264,4964,current,O
72265,4964,episode,B-Condition
72266,4964,or,O
72267,4964,need,O
72268,4964,for,O
72269,4964,drugs,B-Drug
72270,4964,that,O
72271,4964,may,O
72272,4964,interact,O
72273,4964,with,O
72274,4964,these,O
72275,4964,agents,B-Drug
72276,4964,",",O
72277,4964,i.e.,O
72278,4964,drug,O
72279,4964,metabolized,O
72280,4964,by,O
72281,4964,the,O
72282,4964,2D6,O
72283,4964,P450,O
72284,4964,isoenzyme,O
72285,4964,system,O
72286,4964,;,O
72287,4965,Current,O
72288,4965,involvement,O
72289,4965,in,O
72290,4965,psychotherapy,B-Procedure
72291,4965,;,O
72292,4966,Contraindications,B-Condition
72293,4966,to,O
72294,4966,MRI,B-Procedure
72295,4966,scanning,O
72296,4966,including,O
72297,4966,cardiac,O
72298,4966,pacemaker,O
72299,4966,",",O
72300,4966,metallic,O
72301,4966,objects,O
72302,4966,and,O
72303,4966,metallic,O
72304,4966,implants,O
72305,4966,contraindicating,O
72306,4966,MRI,O
72307,4966,",",O
72308,4966,cardiac,O
72309,4966,stent,O
72310,4966,",",O
72311,4966,claustrophobia,B-Condition
72312,4966,;,O
72313,4967,Inability,O
72314,4967,to,O
72315,4967,speak,O
72316,4967,English,O
72317,4967,;,O
72318,4968,Corrected,O
72319,4968,visual,O
72320,4968,acuity,O
72321,4968,<,O
72322,4968,20/70,O
72323,4968,;,O
72324,4968,Color,B-Condition
72325,4968,blindness,I-Condition
72326,4968,.,O
72327,4969,Age,B-Person
72328,4969,:,O
72329,4969,60,O
72330,4969,-,O
72331,4969,85,O
72332,4969,years,O
72333,4969,",",O
72334,4969,right,B-Observation
72335,4969,-,I-Observation
72336,4969,handed,I-Observation
72337,4969,;,O
72338,4970,Diagnosis,O
72339,4970,:,O
72340,4970,Major,B-Condition
72341,4970,depression,I-Condition
72342,4970,",",O
72343,4970,unipolar,O
72344,4970,(,O
72345,4970,by,O
72346,4970,Structured,O
72347,4970,Clinical,O
72348,4970,Interview,O
72349,4970,for,O
72350,4970,Diagnostic,O
72351,4970,and,O
72352,4970,Statistical,O
72353,4970,Manual,O
72354,4970,(,O
72355,4970,DSM)IV,O
72356,4970,(,O
72357,4970,SCID,O
72358,4970,-,O
72359,4970,R,O
72360,4970,),O
72361,4970,and,O
72362,4970,DSM,O
72363,4970,-,O
72364,4970,IV,O
72365,4970,criteria,O
72366,4970,),O
72367,4970,;,O
72368,4971,Age,B-Person
72369,4971,of,O
72370,4971,onset,B-Condition
72371,4971,of,I-Condition
72372,4971,first,I-Condition
72373,4971,episode,I-Condition
72374,4971,=,O
72375,4971,50,O
72376,4971,years,O
72377,4971,with,O
72378,4971,up,O
72379,4971,to,O
72380,4971,three,O
72381,4971,depressive,B-Condition
72382,4971,episodes,I-Condition
72383,4971,;,O
72384,4972,Severity,O
72385,4972,of,O
72386,4972,depression,B-Condition
72387,4972,:,O
72388,4972,A,O
72389,4972,24,O
72390,4972,-,O
72391,4972,Item,O
72392,4972,Hamilton,O
72393,4972,Depression,O
72394,4972,Rating,O
72395,4972,Scale,O
72396,4972,(,O
72397,4972,HDRS,O
72398,4972,),O
72399,4972,=,O
72400,4972,20,O
72401,4972,.,O
72402,4973,Known,O
72403,4973,coagulation,B-Condition
72404,4973,defect,I-Condition
72405,4974,Patients,O
72406,4974,on,O
72407,4974,longstanding,O
72408,4974,NSAID,B-Procedure
72409,4974,therapy,I-Procedure
72410,4975,Known,O
72411,4975,renal,B-Condition
72412,4975,impairment,I-Condition
72413,4976,Patients,O
72414,4976,may,O
72415,4976,also,O
72416,4976,be,O
72417,4976,excluded,O
72418,4976,at,O
72419,4976,the,O
72420,4976,discretion,O
72421,4976,of,O
72422,4976,the,O
72423,4976,investigator,O
72424,4977,Diagnosis,O
72425,4977,of,O
72426,4977,sleep,B-Condition
72427,4977,disordered,I-Condition
72428,4977,breathing,I-Condition
72429,4977,or,O
72430,4977,obstructive,B-Condition
72431,4977,sleep,I-Condition
72432,4977,apnea,I-Condition
72433,4978,Children,B-Person
72434,4978,undergoing,O
72435,4978,elective,O
72436,4978,tonsillectomy,B-Procedure
72437,4978,or,O
72438,4978,adenotonsillectomy,B-Procedure
72439,4978,at,O
72440,4978,Children,O
72441,4978,'s,O
72442,4978,Healthcare,O
72443,4978,of,O
72444,4978,Atlanta,O
72445,4978,Egleston,O
72446,4978,location,O
72447,4979,Parent,O
72448,4979,or,O
72449,4979,legal,O
72450,4979,guardian,O
72451,4979,willing,O
72452,4979,to,O
72453,4979,participate,O
72454,4979,",",O
72455,4979,and,O
72456,4979,able,O
72457,4979,to,O
72458,4979,understand,O
72459,4979,and,O
72460,4979,sign,O
72461,4979,the,O
72462,4979,provided,O
72463,4979,informed,O
72464,4979,consent,O
72465,4980,NA,O
72466,4981,presence,O
72467,4981,of,O
72468,4981,typical,O
72469,4981,HF,B-Condition
72470,4981,symptoms,I-Condition
72471,4981,and,I-Condition
72472,4981,signs,I-Condition
72473,4982,LV,O
72474,4982,ejection,O
72475,4982,fraction,O
72476,4982,=,O
72477,4982,50,O
72478,4983,elevated,O
72479,4983,levels,O
72480,4983,of,O
72481,4983,NT,O
72482,4983,-,O
72483,4983,proBNP,O
72484,4983,(,O
72485,4983,at,O
72486,4983,least,O
72487,4983,>,O
72488,4983,125,O
72489,4983,pg,O
72490,4983,/,O
72491,4983,ml,O
72492,4983,),O
72493,4984,echocardiographic,O
72494,4984,structural,O
72495,4984,(,O
72496,4984,a,O
72497,4984,left,O
72498,4984,atrial,O
72499,4984,volume,O
72500,4984,index,O
72501,4984,>,O
72502,4984,34,O
72503,4984,mL,O
72504,4984,/,O
72505,4984,m2,O
72506,4984,or,O
72507,4984,a,O
72508,4984,left,O
72509,4984,ventricular,O
72510,4984,mass,O
72511,4984,index,O
72512,4984,=,O
72513,4984,115,O
72514,4984,g,O
72515,4984,/,O
72516,4984,m2,O
72517,4984,for,O
72518,4984,males,B-Person
72519,4984,and,O
72520,4984,=,O
72521,4984,95,O
72522,4984,g,O
72523,4984,/,O
72524,4984,m2,O
72525,4984,for,O
72526,4984,females,B-Person
72527,4984,),O
72528,4984,or,O
72529,4984,functional,O
72530,4984,alterations,O
72531,4984,(,O
72532,4984,E,O
72533,4984,/,O
72534,4984,e'=13,O
72535,4984,and,O
72536,4984,a,O
72537,4984,mean,O
72538,4984,e,O
72539,4984,',O
72540,4984,septal,O
72541,4984,and,O
72542,4984,lateral,O
72543,4984,wall,O
72544,4984,<,O
72545,4984,9,O
72546,4984,cm,O
72547,4984,/,O
72548,4984,s,O
72549,4984,),O
72550,4984,.,O
72551,4985,Anaphylactic,B-Condition
72552,4985,reaction,I-Condition
72553,4985,to,O
72554,4985,a,O
72555,4985,previous,O
72556,4985,dose,O
72557,4985,of,O
72558,4985,TIV(trivalent,B-Drug
72559,4985,influenza,I-Drug
72560,4985,vaccine,I-Drug
72561,4985,),O
72562,4986,Known,O
72563,4986,IgE,B-Condition
72564,4986,(,I-Condition
72565,4986,Immunoglobulin,I-Condition
72566,4986,E)-mediated,I-Condition
72567,4986,hypersensitivity,I-Condition
72568,4986,to,O
72569,4986,eggs,B-Drug
72570,4986,manifested,O
72571,4986,as,O
72572,4986,hives,B-Condition
72573,4986,",",O
72574,4986,swelling,B-Condition
72575,4986,of,I-Condition
72576,4986,the,I-Condition
72577,4986,mouth,I-Condition
72578,4986,and,I-Condition
72579,4986,throat,I-Condition
72580,4986,",",O
72581,4986,difficulty,B-Condition
72582,4986,in,I-Condition
72583,4986,breathing,I-Condition
72584,4986,",",O
72585,4986,hypotension,B-Condition
72586,4986,",",O
72587,4986,or,O
72588,4986,shock,B-Condition
72589,4987,Guillain,B-Condition
72590,4987,-,I-Condition
72591,4987,Barré,I-Condition
72592,4987,syndrome,I-Condition
72593,4987,within,O
72594,4987,eight,O
72595,4987,weeks,O
72596,4987,of,O
72597,4987,a,O
72598,4987,previous,O
72599,4987,influenza,B-Drug
72600,4987,vaccine,I-Drug
72601,4988,Anaphylactic,B-Condition
72602,4988,reaction,I-Condition
72603,4988,to,O
72604,4988,neomycin,B-Drug
72605,4989,Patients,O
72606,4989,who,O
72607,4989,have,O
72608,4989,had,O
72609,4989,influenza,B-Drug
72610,4989,vaccine,I-Drug
72611,4989,in,O
72612,4989,two,O
72613,4989,of,O
72614,4989,the,O
72615,4989,three,O
72616,4989,previous,O
72617,4989,years,O
72618,4990,Age,B-Person
72619,4990,=,O
72620,4990,18,O
72621,4990,years,O
72622,4990,and,O
72623,4990,NYHA,O
72624,4990,(,O
72625,4990,New,O
72626,4990,York,O
72627,4990,Heart,O
72628,4990,Association,O
72629,4990,),O
72630,4990,functional,O
72631,4990,class,O
72632,4990,II,O
72633,4990,",",O
72634,4990,III,O
72635,4990,and,O
72636,4990,IV,O
72637,4991,tinnitus,B-Condition
72638,4991,or,O
72639,4991,hearing,B-Condition
72640,4991,loss,I-Condition
72641,4991,with,O
72642,4991,same,O
72643,4991,debut,O
72644,4991,as,O
72645,4991,vertigo,B-Condition
72646,4992,history,O
72647,4992,of,O
72648,4992,bleeding,B-Condition
72649,4992,peptic,B-Condition
72650,4992,ulcer,I-Condition
72651,4993,glaucoma,B-Condition
72652,4994,pregnancy,O
72653,4994,or,O
72654,4994,non,O
72655,4994,-,O
72656,4994,acceptance,O
72657,4994,to,O
72658,4994,use,O
72659,4994,anticonception,O
72660,4994,measures,O
72661,4994,during,O
72662,4994,13,O
72663,4994,days,O
72664,4994,after,O
72665,4994,debut,O
72666,4995,high,O
72667,4995,blood,O
72668,4995,pressure,O
72669,4995,>,O
72670,4995,180,O
72671,4995,systolic,O
72672,4995,",",O
72673,4995,105,O
72674,4995,",",O
72675,4995,diastolic,O
72676,4996,ketoacidosis,B-Condition
72677,4996,with,O
72678,4996,a,O
72679,4996,Base,O
72680,4996,Excess,O
72681,4996,>,O
72682,4996,=,O
72683,4996,2,O
72684,4997,psychic,B-Condition
72685,4997,disorder,I-Condition
72686,4997,(,O
72687,4997,not,O
72688,4997,including,O
72689,4997,mild,B-Condition
72690,4997,depression,I-Condition
72691,4997,),O
72692,4998,serious,O
72693,4998,infection,B-Condition
72694,4998,(,O
72695,4998,neutropenia,B-Condition
72696,4998,",",O
72697,4998,tuberculosis,B-Condition
72698,4998,),O
72699,4999,chronic,B-Condition
72700,4999,otitis,I-Condition
72701,5000,history,O
72702,5000,of,O
72703,5000,vertiginous,B-Condition
72704,5000,disease,I-Condition
72705,5000,;,O
72706,5000,Ménière,B-Condition
72707,5000,",",O
72708,5000,Vertiginous,B-Condition
72709,5000,migraine,I-Condition
72710,5000,",",O
72711,5000,atypical,B-Condition
72712,5000,BPPV,I-Condition
72713,5001,definite,O
72714,5001,unilateral,O
72715,5001,vestibulopathy,B-Condition
72716,5002,no,O
72717,5002,pathological,O
72718,5002,HINTS,B-Condition
72719,5002,(,O
72720,5002,examination,O
72721,5002,criteria,O
72722,5002,in,O
72723,5002,acute,B-Condition
72724,5002,vestibular,I-Condition
72725,5002,syndrome,I-Condition
72726,5002,),O
72727,5003,capable,O
72728,5003,of,O
72729,5003,making,O
72730,5003,their,O
72731,5003,own,O
72732,5003,decisions,O
72733,5004,Involvement,O
72734,5004,in,O
72735,5004,the,O
72736,5004,planning,O
72737,5004,and,O
72738,5004,conduct,O
72739,5004,of,O
72740,5004,the,O
72741,5004,study,O
72742,5004,(,O
72743,5004,applies,O
72744,5004,to,O
72745,5004,both,O
72746,5004,AstraZeneca,O
72747,5004,staff,O
72748,5004,and,O
72749,5004,staff,O
72750,5004,at,O
72751,5004,third,O
72752,5004,party,O
72753,5004,vendor,O
72754,5004,or,O
72755,5004,at,O
72756,5004,the,O
72757,5004,investigational,O
72758,5004,sites,O
72759,5004,),O
72760,5004,.,O
72761,5005,Previous,O
72762,5005,enrolment,O
72763,5005,in,O
72764,5005,the,O
72765,5005,present,O
72766,5005,study,O
72767,5005,or,O
72768,5005,participation,O
72769,5005,in,O
72770,5005,another,O
72771,5005,clinical,O
72772,5005,study,O
72773,5005,with,O
72774,5005,an,O
72775,5005,investigational,O
72776,5005,product,O
72777,5005,during,O
72778,5005,the,O
72779,5005,last,O
72780,5005,3,O
72781,5005,months,O
72782,5005,or,O
72783,5005,as,O
72784,5005,judged,O
72785,5005,by,O
72786,5005,the,O
72787,5005,Investigator,O
72788,5005,.,O
72789,5006,History,O
72790,5006,of,O
72791,5006,or,O
72792,5006,presence,O
72793,5006,of,O
72794,5006,any,O
72795,5006,clinically,O
72796,5006,significant,O
72797,5006,disease,B-Condition
72798,5006,or,O
72799,5006,disorder,B-Condition
72800,5006,including,O
72801,5006,a,O
72802,5006,recent,O
72803,5006,(,O
72804,5006,<,O
72805,5006,3,O
72806,5006,months,O
72807,5006,),O
72808,5006,cardiovascular,B-Condition
72809,5006,event,I-Condition
72810,5006,which,O
72811,5006,",",O
72812,5006,in,O
72813,5006,the,O
72814,5006,opinion,O
72815,5006,of,O
72816,5006,the,O
72817,5006,Investigator,O
72818,5006,",",O
72819,5006,may,O
72820,5006,either,O
72821,5006,put,O
72822,5006,the,O
72823,5006,patient,O
72824,5006,at,O
72825,5006,risk,O
72826,5006,because,O
72827,5006,of,O
72828,5006,participation,O
72829,5006,in,O
72830,5006,the,O
72831,5006,study,O
72832,5006,or,O
72833,5006,influence,O
72834,5006,the,O
72835,5006,results,O
72836,5006,or,O
72837,5006,the,O
72838,5006,patient,O
72839,5006,'s,O
72840,5006,ability,O
72841,5006,to,O
72842,5006,participate,O
72843,5006,in,O
72844,5006,the,O
72845,5006,study,O
72846,5006,.,O
72847,5007,Clinical,O
72848,5007,diagnosis,O
72849,5007,of,O
72850,5007,Type,B-Condition
72851,5007,1,I-Condition
72852,5007,diabetes,I-Condition
72853,5007,",",O
72854,5007,maturity,B-Condition
72855,5007,onset,I-Condition
72856,5007,diabetes,I-Condition
72857,5007,of,I-Condition
72858,5007,the,I-Condition
72859,5007,young,I-Condition
72860,5007,",",O
72861,5007,secondary,B-Condition
72862,5007,diabetes,I-Condition
72863,5007,or,O
72864,5007,diabetes,B-Condition
72865,5007,insipidus,I-Condition
72866,5007,.,O
72867,5008,Unstable,O
72868,5008,/,O
72869,5008,rapidly,O
72870,5008,progressing,O
72871,5008,renal,B-Condition
72872,5008,disease,I-Condition
72873,5008,or,O
72874,5008,estimated,O
72875,5008,Glomerular,O
72876,5008,Filtration,O
72877,5008,Rate,O
72878,5008,<,O
72879,5008,60,O
72880,5008,mL,O
72881,5008,/,O
72882,5008,min,O
72883,5008,(,O
72884,5008,Cockcroft,O
72885,5008,-,O
72886,5008,Gault,O
72887,5008,formula,O
72888,5008,),O
72889,5008,.,O
72890,5009,Clinically,O
72891,5009,significant,O
72892,5009,out,O
72893,5009,of,O
72894,5009,range,O
72895,5009,values,O
72896,5009,of,O
72897,5009,serum,O
72898,5009,levels,O
72899,5009,of,O
72900,5009,either,O
72901,5009,alanine,O
72902,5009,aminotransferase,O
72903,5009,(,O
72904,5009,ALT,O
72905,5009,),O
72906,5009,",",O
72907,5009,aspartate,O
72908,5009,aminotransferase,O
72909,5009,(,O
72910,5009,AST,O
72911,5009,),O
72912,5009,or,O
72913,5009,alkaline,O
72914,5009,phosphatase,O
72915,5009,(,O
72916,5009,ALP,O
72917,5009,),O
72918,5009,in,O
72919,5009,the,O
72920,5009,Investigator,O
72921,5009,'s,O
72922,5009,opinion,O
72923,5009,.,O
72924,5010,Contraindications,B-Condition
72925,5010,to,O
72926,5010,dapagliflozin,B-Drug
72927,5010,according,O
72928,5010,to,O
72929,5010,the,O
72930,5010,local,O
72931,5010,label,O
72932,5010,.,O
72933,5011,Use,O
72934,5011,of,O
72935,5011,antidiabetic,B-Drug
72936,5011,drugs,I-Drug
72937,5011,other,O
72938,5011,than,O
72939,5011,metformin,B-Drug
72940,5011,within,O
72941,5011,3,O
72942,5011,months,O
72943,5011,prior,O
72944,5011,to,O
72945,5011,screening,O
72946,5011,.,O
72947,5012,Weight,O
72948,5012,gain,O
72949,5012,or,O
72950,5012,loss,O
72951,5012,>,O
72952,5012,5,O
72953,5012,kg,O
72954,5012,in,O
72955,5012,the,O
72956,5012,last,O
72957,5012,3,O
72958,5012,months,O
72959,5012,",",O
72960,5012,ongoing,O
72961,5012,weight,B-Observation
72962,5012,-,I-Observation
72963,5012,loss,I-Observation
72964,5012,diet,I-Observation
72965,5012,(,O
72966,5012,hypocaloric,B-Observation
72967,5012,diet,I-Observation
72968,5012,),O
72969,5012,or,O
72970,5012,use,O
72971,5012,of,O
72972,5012,weight,B-Drug
72973,5012,loss,I-Drug
72974,5012,agents,I-Drug
72975,5012,.,O
72976,5013,History,B-Observation
72977,5013,of,O
72978,5013,drug,B-Observation
72979,5013,abuse,I-Observation
72980,5013,or,O
72981,5013,alcohol,B-Observation
72982,5013,abuse,I-Observation
72983,5013,in,O
72984,5013,the,O
72985,5013,past,O
72986,5013,12,O
72987,5013,months,O
72988,5013,.,O
72989,5014,Any,O
72990,5014,clinically,O
72991,5014,significant,O
72992,5014,abnormalities,O
72993,5014,in,O
72994,5014,clinical,O
72995,5014,chemistry,O
72996,5014,",",O
72997,5014,hematology,O
72998,5014,or,O
72999,5014,urinalysis,O
73000,5014,or,O
73001,5014,other,O
73002,5014,condition,O
73003,5014,the,O
73004,5014,Investigator,O
73005,5014,believes,O
73006,5014,would,O
73007,5014,interfere,O
73008,5014,with,O
73009,5014,the,O
73010,5014,patient,O
73011,5014,'s,O
73012,5014,ability,O
73013,5014,to,O
73014,5014,provide,O
73015,5014,informed,O
73016,5014,consent,O
73017,5014,",",O
73018,5014,comply,O
73019,5014,with,O
73020,5014,study,O
73021,5014,instructions,O
73022,5014,",",O
73023,5014,or,O
73024,5014,which,O
73025,5014,might,O
73026,5014,confound,O
73027,5014,the,O
73028,5014,interpretation,O
73029,5014,of,O
73030,5014,the,O
73031,5014,study,O
73032,5014,results,O
73033,5014,or,O
73034,5014,put,O
73035,5014,the,O
73036,5014,patient,O
73037,5014,at,O
73038,5014,undue,O
73039,5014,risk,O
73040,5014,.,O
73041,5015,Plasma,B-Procedure
73042,5015,donation,I-Procedure
73043,5015,within,O
73044,5015,one,O
73045,5015,month,O
73046,5015,of,O
73047,5015,screening,O
73048,5015,or,O
73049,5015,any,O
73050,5015,blood,B-Procedure
73051,5015,donation,I-Procedure
73052,5015,/,O
73053,5015,blood,O
73054,5015,loss,O
73055,5015,>,O
73056,5015,500,O
73057,5015,mL,O
73058,5015,within,O
73059,5015,3,O
73060,5015,months,O
73061,5015,prior,O
73062,5015,to,O
73063,5015,screening,O
73064,5015,or,O
73065,5015,during,O
73066,5015,the,O
73067,5015,study,O
73068,5015,.,O
73069,5016,Anemia,B-Condition
73070,5016,defined,O
73071,5016,as,O
73072,5016,Hemoglobin,O
73073,5016,(,O
73074,5016,Hb,O
73075,5016,),O
73076,5016,<,O
73077,5016,115,O
73078,5016,g,O
73079,5016,/,O
73080,5016,L,O
73081,5016,(,O
73082,5016,7.1,O
73083,5016,mM,O
73084,5016,),O
73085,5016,in,O
73086,5016,women,B-Person
73087,5016,and,O
73088,5016,<,O
73089,5016,120,O
73090,5016,g,O
73091,5016,/,O
73092,5016,L,O
73093,5016,(,O
73094,5016,7.5,O
73095,5016,mM,O
73096,5016,),O
73097,5016,in,O
73098,5016,men,B-Person
73099,5016,.,O
73100,5017,Use,O
73101,5017,of,O
73102,5017,anti,B-Procedure
73103,5017,-,I-Procedure
73104,5017,coagulant,I-Procedure
73105,5017,treatment,I-Procedure
73106,5017,such,O
73107,5017,as,O
73108,5017,heparin,B-Drug
73109,5017,",",O
73110,5017,warfarin,B-Drug
73111,5017,",",O
73112,5017,platelet,B-Drug
73113,5017,inhibitors,I-Drug
73114,5017,",",O
73115,5017,thrombin,B-Drug
73116,5017,and,O
73117,5017,factor,B-Drug
73118,5017,X,I-Drug
73119,5017,inhibitors,I-Drug
73120,5017,.,O
73121,5018,Use,O
73122,5018,of,O
73123,5018,medication,O
73124,5018,such,O
73125,5018,as,O
73126,5018,oral,B-Drug
73127,5018,glucocorticoids,I-Drug
73128,5018,",",O
73129,5018,anti,B-Drug
73130,5018,-,I-Drug
73131,5018,estrogens,I-Drug
73132,5018,or,O
73133,5018,other,O
73134,5018,medications,B-Drug
73135,5018,that,O
73136,5018,are,O
73137,5018,known,O
73138,5018,to,O
73139,5018,markedly,O
73140,5018,influence,O
73141,5018,insulin,O
73142,5018,sensitivity,O
73143,5018,.,O
73144,5019,Use,O
73145,5019,of,O
73146,5019,loop,B-Drug
73147,5019,diuretics,I-Drug
73148,5019,.,O
73149,5020,Regular,O
73150,5020,smoking,B-Observation
73151,5020,and,O
73152,5020,other,O
73153,5020,regular,O
73154,5020,nicotine,B-Drug
73155,5020,use,O
73156,5020,.,O
73157,5021,Central,O
73158,5021,nervous,O
73159,5021,system,O
73160,5021,aneurysm,O
73161,5021,clip,O
73162,5022,Implanted,O
73163,5022,neural,O
73164,5022,stimulator,O
73165,5023,Implanted,O
73166,5023,cardiac,O
73167,5023,pacemaker,O
73168,5023,of,O
73169,5023,defibrillator,O
73170,5024,Cochlear,O
73171,5024,implant,O
73172,5025,Metal,O
73173,5025,containing,O
73174,5025,corpora,O
73175,5025,aliena,O
73176,5025,in,O
73177,5025,the,O
73178,5025,eye,O
73179,5025,or,O
73180,5025,brain,O
73181,5025,.,O
73182,5026,Patients,O
73183,5026,",",O
73184,5026,who,O
73185,5026,do,O
73186,5026,not,O
73187,5026,want,O
73188,5026,to,O
73189,5026,be,O
73190,5026,informed,O
73191,5026,about,O
73192,5026,unexpected,O
73193,5026,medical,O
73194,5026,findings,O
73195,5026,",",O
73196,5026,or,O
73197,5026,do,O
73198,5026,not,O
73199,5026,wish,O
73200,5026,that,O
73201,5026,their,O
73202,5026,physician,O
73203,5026,be,O
73204,5026,informed,O
73205,5026,about,O
73206,5026,coincidental,O
73207,5026,findings,O
73208,5026,",",O
73209,5026,can,O
73210,5026,not,O
73211,5026,participate,O
73212,5026,in,O
73213,5026,the,O
73214,5026,study,O
73215,5026,.,O
73216,5027,Patients,O
73217,5027,are,O
73218,5027,able,O
73219,5027,to,O
73220,5027,provide,O
73221,5027,signed,O
73222,5027,and,O
73223,5027,dated,O
73224,5027,written,O
73225,5027,informed,O
73226,5027,consent,O
73227,5027,prior,O
73228,5027,to,O
73229,5027,any,O
73230,5027,study,O
73231,5027,specific,O
73232,5027,procedures,O
73233,5027,.,O
73234,5028,Women,B-Person
73235,5028,are,O
73236,5028,post,B-Condition
73237,5028,-,I-Condition
73238,5028,menopausal,I-Condition
73239,5028,(,O
73240,5028,defined,O
73241,5028,as,O
73242,5028,at,O
73243,5028,least,O
73244,5028,1,O
73245,5028,year,O
73246,5028,post,O
73247,5028,cessation,O
73248,5028,of,O
73249,5028,menses,O
73250,5028,),O
73251,5028,and,O
73252,5028,aged,B-Person
73253,5028,=,O
73254,5028,45,O
73255,5028,and,O
73256,5028,=,O
73257,5028,70,O
73258,5028,years,O
73259,5028,.,O
73260,5028,Males,B-Person
73261,5028,are,O
73262,5028,aged,B-Person
73263,5028,=,O
73264,5028,40,O
73265,5028,years,O
73266,5028,and,O
73267,5028,=,O
73268,5028,70,O
73269,5028,years,O
73270,5028,.,O
73271,5028,Patients,O
73272,5028,should,O
73273,5028,have,O
73274,5028,suitable,O
73275,5028,veins,O
73276,5028,for,O
73277,5028,cannulation,O
73278,5028,or,O
73279,5028,repeated,O
73280,5028,venipuncture,O
73281,5028,.,O
73282,5029,Patients,O
73283,5029,are,O
73284,5029,diagnosed,O
73285,5029,with,O
73286,5029,T2DM,B-Condition
73287,5029,for,O
73288,5029,at,O
73289,5029,least,O
73290,5029,the,O
73291,5029,last,O
73292,5029,6,O
73293,5029,months,O
73294,5029,.,O
73295,5030,Patients,O
73296,5030,are,O
73297,5030,on,O
73298,5030,no,O
73299,5030,other,O
73300,5030,anti,B-Procedure
73301,5030,-,I-Procedure
73302,5030,diabetic,I-Procedure
73303,5030,drug,I-Procedure
73304,5030,treatment,I-Procedure
73305,5030,",",O
73306,5030,or,O
73307,5030,on,O
73308,5030,stable,O
73309,5030,maximum,O
73310,5030,3000,O
73311,5030,mg,O
73312,5030,daily,O
73313,5030,dose,O
73314,5030,metformin,B-Drug
73315,5030,treatment,O
73316,5030,and/or,O
73317,5030,on,O
73318,5030,stable,O
73319,5030,dose,O
73320,5030,of,O
73321,5030,a,O
73322,5030,DPPIV,B-Drug
73323,5030,inhibitor,I-Drug
73324,5030,treatment,O
73325,5030,for,O
73326,5030,at,O
73327,5030,least,O
73328,5030,the,O
73329,5030,last,O
73330,5030,3,O
73331,5030,months5,O
73332,5030,.,O
73333,5030,HbA1c,O
73334,5030,levels,O
73335,5030,=,O
73336,5030,6.0,O
73337,5030,%,O
73338,5030,(=,O
73339,5030,42,O
73340,5030,mmol,O
73341,5030,/,O
73342,5030,mol,O
73343,5030,),O
73344,5030,and,O
73345,5030,=,O
73346,5030,9.0,O
73347,5030,%,O
73348,5030,(,O
73349,5030,75,O
73350,5030,mmol,O
73351,5030,/,O
73352,5030,mol,O
73353,5030,),O
73354,5030,.,O
73355,5031,Have,O
73356,5031,a,O
73357,5031,body,O
73358,5031,mass,O
73359,5031,index,O
73360,5031,(,O
73361,5031,BMI,O
73362,5031,),O
73363,5031,=,O
73364,5031,35,O
73365,5031,kg,O
73366,5031,/,O
73367,5031,m2,O
73368,5031,.,O
73369,5032,Participation,O
73370,5032,in,O
73371,5032,the,O
73372,5032,4,O
73373,5032,weeks,O
73374,5032,preceding,O
73375,5032,inclusion,O
73376,5032,or,O
73377,5032,planned,B-Observation
73378,5032,participation,I-Observation
73379,5032,during,O
73380,5032,the,O
73381,5032,present,O
73382,5032,trial,O
73383,5032,period,O
73384,5032,in,O
73385,5032,another,O
73386,5032,clinical,O
73387,5032,trial,O
73388,5032,investigating,O
73389,5032,a,O
73390,5032,vaccine,O
73391,5032,",",O
73392,5032,drug,O
73393,5032,",",O
73394,5032,medical,O
73395,5032,device,O
73396,5032,",",O
73397,5032,or,O
73398,5032,medical,O
73399,5032,procedure,O
73400,5032,.,O
73401,5033,Receipt,O
73402,5033,of,O
73403,5033,any,O
73404,5033,vaccine,B-Drug
73405,5033,in,O
73406,5033,the,O
73407,5033,4,O
73408,5033,weeks,O
73409,5033,preceding,O
73410,5033,each,O
73411,5033,trial,O
73412,5033,vaccination,O
73413,5033,or,O
73414,5033,planned,B-Observation
73415,5033,receipt,I-Observation
73416,5033,of,O
73417,5033,any,O
73418,5033,vaccine,B-Drug
73419,5033,in,O
73420,5033,the,O
73421,5033,4,O
73422,5033,weeks,O
73423,5033,following,O
73424,5033,each,O
73425,5033,trial,O
73426,5033,vaccination,O
73427,5033,",",O
73428,5033,except,O
73429,5033,for,O
73430,5033,:,O
73431,5034,(,O
73432,5034,i,O
73433,5034,),O
73434,5034,influenza,B-Drug
73435,5034,vaccination,I-Drug
73436,5034,",",O
73437,5034,which,O
73438,5034,may,O
73439,5034,be,O
73440,5034,received,O
73441,5034,at,O
73442,5034,least,O
73443,5034,2,O
73444,5034,weeks,O
73445,5034,before,O
73446,5034,study,O
73447,5034,vaccines,O
73448,5034,.,O
73449,5035,(,O
73450,5035,ii,O
73451,5035,),O
73452,5035,measles,B-Procedure
73453,5035,(,I-Procedure
73454,5035,M,I-Procedure
73455,5035,),I-Procedure
73456,5035,or,I-Procedure
73457,5035,measles,I-Procedure
73458,5035,",",I-Procedure
73459,5035,mumps,I-Procedure
73460,5035,",",I-Procedure
73461,5035,rubella,I-Procedure
73462,5035,(,I-Procedure
73463,5035,MMR,I-Procedure
73464,5035,),I-Procedure
73465,5035,routine,I-Procedure
73466,5035,vaccination,I-Procedure
73467,5035,",",O
73468,5035,which,O
73469,5035,can,O
73470,5035,be,O
73471,5035,administered,O
73472,5035,concomitantly,O
73473,5035,with,O
73474,5035,the,O
73475,5035,first,O
73476,5035,dose,O
73477,5035,of,O
73478,5035,study,O
73479,5035,vaccine,O
73480,5035,as,O
73481,5035,per,O
73482,5035,routine,O
73483,5035,immunization,O
73484,5035,schedule,O
73485,5036,(,O
73486,5036,iii,O
73487,5036,),O
73488,5036,for,O
73489,5036,subjects,O
73490,5036,enrolled,O
73491,5036,at,O
73492,5036,Indian,O
73493,5036,sites,O
73494,5036,:,O
73495,5036,oral,B-Drug
73496,5036,poliomyelitis,I-Drug
73497,5036,vaccine,I-Drug
73498,5036,(,I-Drug
73499,5036,OPV,I-Drug
73500,5036,),I-Drug
73501,5036,received,O
73502,5036,during,O
73503,5036,National,O
73504,5036,Immunization,O
73505,5036,Days,O
73506,5036,(,O
73507,5036,NIDs,O
73508,5036,),O
73509,5036,and,O
73510,5036,supplementary,O
73511,5036,immunization,O
73512,5036,activity,O
73513,5036,days,O
73514,5036,(,O
73515,5036,SIADs,O
73516,5036,),O
73517,5037,Previous,O
73518,5037,vaccination,B-Procedure
73519,5037,against,I-Procedure
73520,5037,meningococcal,I-Procedure
73521,5037,disease,I-Procedure
73522,5037,with,O
73523,5037,either,O
73524,5037,the,O
73525,5037,study,B-Drug
73526,5037,vaccine,I-Drug
73527,5037,or,O
73528,5037,another,B-Drug
73529,5037,meningococcal,I-Drug
73530,5037,vaccine,I-Drug
73531,5038,Receipt,O
73532,5038,of,O
73533,5038,immune,B-Drug
73534,5038,globulins,I-Drug
73535,5038,",",O
73536,5038,blood,B-Drug
73537,5038,or,O
73538,5038,blood,B-Drug
73539,5038,-,I-Drug
73540,5038,derived,I-Drug
73541,5038,products,I-Drug
73542,5038,in,O
73543,5038,the,O
73544,5038,past,O
73545,5038,3,O
73546,5038,months,O
73547,5039,Known,B-Observation
73548,5039,or,O
73549,5039,suspected,B-Observation
73550,5039,congenital,B-Condition
73551,5039,or,I-Condition
73552,5039,acquired,I-Condition
73553,5039,immunodeficiency,I-Condition
73554,5039,;,O
73555,5039,or,O
73556,5039,receipt,O
73557,5039,of,O
73558,5039,immunosuppressive,B-Procedure
73559,5039,therapy,I-Procedure
73560,5039,",",O
73561,5039,such,O
73562,5039,as,O
73563,5039,anti,B-Procedure
73564,5039,-,I-Procedure
73565,5039,cancer,I-Procedure
73566,5039,chemotherapy,I-Procedure
73567,5039,or,O
73568,5039,radiation,B-Procedure
73569,5039,therapy,I-Procedure
73570,5039,",",O
73571,5039,within,O
73572,5039,the,O
73573,5039,preceding,O
73574,5039,6,O
73575,5039,months,O
73576,5039,;,O
73577,5039,or,O
73578,5039,long,O
73579,5039,-,O
73580,5039,term,O
73581,5039,systemic,B-Procedure
73582,5039,corticosteroid,I-Procedure
73583,5039,therapy,I-Procedure
73584,5039,(,O
73585,5039,prednisone,B-Drug
73586,5039,or,O
73587,5039,equivalent,O
73588,5039,for,O
73589,5039,more,O
73590,5039,than,O
73591,5039,2,O
73592,5039,consecutive,O
73593,5039,weeks,O
73594,5039,within,O
73595,5039,the,O
73596,5039,past,O
73597,5039,3,O
73598,5039,months,O
73599,5039,),O
73600,5040,History,O
73601,5040,of,O
73602,5040,meningococcal,B-Condition
73603,5040,diseases,I-Condition
73604,5040,",",O
73605,5040,confirmed,O
73606,5040,either,O
73607,5040,clinically,O
73608,5040,",",O
73609,5040,serologically,B-Procedure
73610,5040,",",O
73611,5040,or,O
73612,5040,microbiologically,B-Procedure
73613,5041,At,O
73614,5041,high,O
73615,5041,risk,O
73616,5041,",",O
73617,5041,in,O
73618,5041,the,O
73619,5041,opinion,O
73620,5041,of,O
73621,5041,the,O
73622,5041,Investigator,O
73623,5041,",",O
73624,5041,for,O
73625,5041,meningococcal,O
73626,5041,disease,O
73627,5041,during,O
73628,5041,the,O
73629,5041,trial,O
73630,5042,Known,O
73631,5042,or,O
73632,5042,suspected,O
73633,5042,systemic,B-Condition
73634,5042,hypersensitivity,I-Condition
73635,5042,to,O
73636,5042,any,O
73637,5042,of,O
73638,5042,the,O
73639,5042,vaccine,B-Drug
73640,5042,components,I-Drug
73641,5042,",",O
73642,5042,or,O
73643,5042,history,B-Observation
73644,5042,of,O
73645,5042,a,O
73646,5042,life,B-Condition
73647,5042,-,I-Condition
73648,5042,threatening,I-Condition
73649,5042,reaction,I-Condition
73650,5042,to,O
73651,5042,the,O
73652,5042,vaccine,B-Drug
73653,5042,used,O
73654,5042,in,O
73655,5042,the,O
73656,5042,trial,O
73657,5042,or,O
73658,5042,to,O
73659,5042,a,O
73660,5042,vaccine,B-Drug
73661,5042,containing,O
73662,5042,any,O
73663,5042,of,O
73664,5042,the,O
73665,5042,same,O
73666,5042,substances,O
73667,5043,Known,O
73668,5043,thrombocytopenia,B-Condition
73669,5043,",",O
73670,5043,contraindicating,B-Condition
73671,5043,intramuscular,B-Procedure
73672,5043,vaccination,I-Procedure
73673,5044,Bleeding,B-Condition
73674,5044,disorder,I-Condition
73675,5044,",",O
73676,5044,or,O
73677,5044,receipt,O
73678,5044,of,O
73679,5044,anticoagulants,B-Drug
73680,5044,in,O
73681,5044,the,O
73682,5044,3,O
73683,5044,weeks,O
73684,5044,preceding,O
73685,5044,inclusion,O
73686,5044,",",O
73687,5044,contraindicating,B-Condition
73688,5044,intramuscular,B-Procedure
73689,5044,vaccination,I-Procedure
73690,5045,In,O
73691,5045,an,O
73692,5045,emergency,O
73693,5045,setting,O
73694,5045,",",O
73695,5045,or,O
73696,5045,hospitalized,B-Condition
73697,5045,involuntarily,I-Condition
73698,5046,Chronic,O
73699,5046,illness,O
73700,5046,that,O
73701,5046,",",O
73702,5046,in,O
73703,5046,the,O
73704,5046,opinion,O
73705,5046,of,O
73706,5046,the,O
73707,5046,investigator,O
73708,5046,",",O
73709,5046,is,O
73710,5046,at,O
73711,5046,a,O
73712,5046,stage,O
73713,5046,where,O
73714,5046,it,O
73715,5046,might,O
73716,5046,interfere,O
73717,5046,with,O
73718,5046,trial,O
73719,5046,conduct,O
73720,5046,or,O
73721,5046,completion,O
73722,5047,For,O
73723,5047,subjects,O
73724,5047,enrolled,O
73725,5047,at,O
73726,5047,Indian,O
73727,5047,sites,O
73728,5047,:,O
73729,5047,Moderate,O
73730,5047,or,O
73731,5047,severe,O
73732,5047,acute,B-Condition
73733,5047,illness,I-Condition
73734,5047,/,I-Condition
73735,5047,infection,I-Condition
73736,5047,(,O
73737,5047,according,O
73738,5047,to,O
73739,5047,investigator,O
73740,5047,judgment,O
73741,5047,),O
73742,5047,on,O
73743,5047,the,O
73744,5047,day,O
73745,5047,of,O
73746,5047,vaccination,O
73747,5047,or,O
73748,5047,febrile,B-Condition
73749,5047,illness,I-Condition
73750,5047,(,O
73751,5047,temperature,O
73752,5047,≥,O
73753,5047,38.0,O
73754,5047,°,O
73755,5047,C,O
73756,5047,),O
73757,5047,.,O
73758,5048,For,O
73759,5048,subjects,O
73760,5048,enrolled,O
73761,5048,at,O
73762,5048,Russian,O
73763,5048,sites,O
73764,5048,:,O
73765,5048,Acute,B-Condition
73766,5048,disease,I-Condition
73767,5048,of,O
73768,5048,any,O
73769,5048,severity,O
73770,5048,on,O
73771,5048,the,O
73772,5048,day,O
73773,5048,of,O
73774,5048,vaccination,O
73775,5048,or,O
73776,5048,febrile,B-Condition
73777,5048,illness,I-Condition
73778,5048,(,O
73779,5048,axillary,O
73780,5048,temperature,O
73781,5048,≥,O
73782,5048,37.0,O
73783,5048,°,O
73784,5048,C,O
73785,5048,),O
73786,5048,.,O
73787,5049,A,O
73788,5049,prospective,O
73789,5049,subject,O
73790,5049,should,O
73791,5049,not,O
73792,5049,be,O
73793,5049,included,O
73794,5049,in,O
73795,5049,the,O
73796,5049,study,O
73797,5049,until,O
73798,5049,the,O
73799,5049,condition,O
73800,5049,has,O
73801,5049,resolved,O
73802,5049,or,O
73803,5049,the,O
73804,5049,febrile,O
73805,5049,event,O
73806,5049,has,O
73807,5049,subsided,O
73808,5049,.,O
73809,5050,Receipt,O
73810,5050,of,O
73811,5050,oral,O
73812,5050,or,O
73813,5050,injectable,O
73814,5050,antibiotic,B-Drug
73815,5050,therapy,I-Drug
73816,5050,within,O
73817,5050,72,O
73818,5050,hours,O
73819,5050,prior,O
73820,5050,to,O
73821,5050,the,O
73822,5050,first,O
73823,5050,blood,O
73824,5050,draw,O
73825,5051,Identified,O
73826,5051,as,O
73827,5051,a,O
73828,5051,natural,O
73829,5051,or,O
73830,5051,adopted,O
73831,5051,child,O
73832,5051,of,O
73833,5051,the,O
73834,5051,Investigator,O
73835,5051,or,O
73836,5051,employee,O
73837,5051,with,O
73838,5051,direct,O
73839,5051,involvement,O
73840,5051,in,O
73841,5051,the,O
73842,5051,proposed,O
73843,5051,study,O
73844,5052,Personal,O
73845,5052,history,B-Observation
73846,5052,of,O
73847,5052,Guillain,B-Condition
73848,5052,-,I-Condition
73849,5052,Barré,I-Condition
73850,5052,Syndrome,I-Condition
73851,5052,.,O
73852,5053,Male,B-Person
73853,5053,and,O
73854,5053,female,B-Person
73855,5053,subjects,O
73856,5053,aged,B-Person
73857,5053,9,O
73858,5053,to,O
73859,5053,17,O
73860,5053,months,O
73861,5053,on,O
73862,5053,the,O
73863,5053,day,O
73864,5053,of,O
73865,5053,inclusion,O
73866,5054,Informed,O
73867,5054,consent,O
73868,5054,form,O
73869,5054,has,O
73870,5054,been,O
73871,5054,signed,O
73872,5054,and,O
73873,5054,dated,O
73874,5054,by,O
73875,5054,the,O
73876,5054,parent(s,O
73877,5054,),O
73878,5054,or,O
73879,5054,other,O
73880,5054,legally,O
73881,5054,acceptable,O
73882,5054,representative(s,O
73883,5054,),O
73884,5054,(,O
73885,5054,if,O
73886,5054,applicable,O
73887,5054,),O
73888,5055,Subject,O
73889,5055,and,O
73890,5055,parent,O
73891,5055,/,O
73892,5055,legally,O
73893,5055,acceptable,O
73894,5055,representative,O
73895,5055,(,O
73896,5055,if,O
73897,5055,applicable,O
73898,5055,),O
73899,5055,able,O
73900,5055,to,O
73901,5055,attend,O
73902,5055,all,O
73903,5055,scheduled,O
73904,5055,visits,O
73905,5055,and,O
73906,5055,to,O
73907,5055,comply,O
73908,5055,with,O
73909,5055,all,O
73910,5055,trial,O
73911,5055,procedures,O
73912,5055,.,O
73913,5056,Known,O
73914,5056,hypersensitivity,B-Condition
73915,5056,to,O
73916,5056,paracetamol,B-Drug
73917,5056,or,O
73918,5056,mannitol,B-Drug
73919,5056,(,O
73920,5056,excipient,O
73921,5056,with,O
73922,5056,known,O
73923,5056,effect,O
73924,5056,),O
73925,5057,Severe,O
73926,5057,hepatocellular,B-Condition
73927,5057,insufficiency,I-Condition
73928,5057,(,O
73929,5057,ASAT,O
73930,5057,or,O
73931,5057,ALAT,O
73932,5057,>,O
73933,5057,5N,O
73934,5057,",",O
73935,5057,or,O
73936,5057,bilirubin,O
73937,5057,>,O
73938,5057,2N,O
73939,5057,),O
73940,5058,Pharmacological,B-Procedure
73941,5058,intervention,I-Procedure
73942,5058,(,O
73943,5058,administration,O
73944,5058,of,O
73945,5058,corticosteroids,B-Drug
73946,5058,",",O
73947,5058,NSAIDs,B-Drug
73948,5058,or,O
73949,5058,paracetamol,B-Drug
73950,5058,),O
73951,5058,or,O
73952,5058,physical,B-Procedure
73953,5058,intervention,I-Procedure
73954,5058,(,O
73955,5058,external,B-Procedure
73956,5058,cooling,I-Procedure
73957,5058,technique,I-Procedure
73958,5058,),O
73959,5058,that,O
73960,5058,may,O
73961,5058,influence,O
73962,5058,temperature,O
73963,5058,in,O
73964,5058,the,O
73965,5058,last,O
73966,5058,6,O
73967,5058,hours,O
73968,5058,.,O
73969,5059,Pregnant,B-Condition
73970,5059,or,O
73971,5059,breastfeeding,B-Observation
73972,5059,women,B-Person
73973,5060,Previous,O
73974,5060,participation,O
73975,5060,in,O
73976,5060,this,O
73977,5060,study,O
73978,5061,18,O
73979,5061,-,O
73980,5061,year,O
73981,5061,or,O
73982,5061,older,B-Person
73983,5061,patients,O
73984,5062,Patient,O
73985,5062,hospitalized,O
73986,5062,in,O
73987,5062,neuro,O
73988,5062,-,O
73989,5062,critical,O
73990,5062,care,O
73991,5062,for,O
73992,5062,:,O
73993,5063,Arachnoid,B-Condition
73994,5063,hemorrhage,I-Condition
73995,5064,Intra,O
73996,5064,parenchymatous,O
73997,5064,hematoma,B-Condition
73998,5065,stroke,B-Condition
73999,5066,Acute,B-Condition
74000,5066,brain,I-Condition
74001,5066,Severe,I-Condition
74002,5066,injury,I-Condition
74003,5067,Post,B-Condition
74004,5067,-,I-Condition
74005,5067,operative,I-Condition
74006,5067,complication,I-Condition
74007,5067,of,O
74008,5067,an,O
74009,5067,act,O
74010,5067,of,O
74011,5067,neurosurgery,B-Procedure
74012,5067,or,O
74013,5067,programmed,O
74014,5067,neuroradiology,B-Procedure
74015,5068,Sedation,B-Procedure
74016,5068,and,O
74017,5068,mechanical,B-Procedure
74018,5068,ventilation,I-Procedure
74019,5068,planned,B-Mood
74020,5068,>,O
74021,5068,2,O
74022,5068,days,O
74023,5069,Monitoring,O
74024,5069,of,O
74025,5069,intracranial,O
74026,5069,temperature,O
74027,5069,and,O
74028,5069,pressure,O
74029,5069,by,O
74030,5069,intraparenchymal,O
74031,5069,sensor,O
74032,5069,(,O
74033,5069,Sophysa,O
74034,5069,®,O
74035,5069,),O
74036,5070,Brain,O
74037,5070,temperature,O
74038,5070,>,O
74039,5070,38.5,O
74040,5070,°,O
74041,5070,C,O
74042,5070,for,O
74043,5070,more,O
74044,5070,than,O
74045,5070,30,O
74046,5070,minutes,O
74047,5071,Indication,B-Condition
74048,5071,for,O
74049,5071,emergent,B-Procedure
74050,5071,cesarean,I-Procedure
74051,5071,or,O
74052,5071,known,O
74053,5071,fetal,B-Condition
74054,5071,anomaly,I-Condition
74055,5072,Anti,B-Procedure
74056,5072,-,I-Procedure
74057,5072,hypertensive,I-Procedure
74058,5072,therapy,I-Procedure
74059,5072,received,O
74060,5072,in,O
74061,5072,the,O
74062,5072,past,O
74063,5072,12,O
74064,5072,hours,O
74065,5073,History,O
74066,5073,of,O
74067,5073,eclampsia,B-Condition
74068,5073,or,O
74069,5073,other,O
74070,5073,adverse,O
74071,5073,CNS,B-Condition
74072,5073,complication,I-Condition
74073,5073,(,O
74074,5073,e.g.,O
74075,5073,",",O
74076,5073,stroke,B-Condition
74077,5073,or,O
74078,5073,PRES,B-Condition
74079,5073,),O
74080,5073,in,O
74081,5073,this,O
74082,5073,pregnancy,O
74083,5074,Actively,O
74084,5074,wheezing,B-Condition
74085,5074,at,O
74086,5074,time,O
74087,5074,of,O
74088,5074,enrollment,O
74089,5074,or,O
74090,5074,history,O
74091,5074,of,O
74092,5074,asthma,B-Condition
74093,5074,complications,I-Condition
74094,5075,Known,O
74095,5075,coronary,B-Condition
74096,5075,artery,I-Condition
74097,5075,disease,I-Condition
74098,5075,or,O
74099,5075,type,B-Condition
74100,5075,I,I-Condition
74101,5075,DM,I-Condition
74102,5075,with,O
74103,5075,microvascular,B-Condition
74104,5075,complications,I-Condition
74105,5075,or,O
74106,5075,signs,O
74107,5075,of,O
74108,5075,heart,B-Condition
74109,5075,failure,I-Condition
74110,5075,or,O
74111,5075,clinical,O
74112,5075,dissection,B-Condition
74113,5075,of,I-Condition
74114,5075,the,I-Condition
74115,5075,aorta,I-Condition
74116,5076,Pregnant,O
74117,5076,gestational,O
74118,5076,age,O
74119,5076,>,O
74120,5076,=,O
74121,5076,28,O
74122,5076,weeks,O
74123,5077,Systolic,O
74124,5077,blood,O
74125,5077,pressure,O
74126,5077,>,O
74127,5077,=,O
74128,5077,160,O
74129,5077,mm,O
74130,5077,Hg,O
74131,5077,OR,O
74132,5077,a,O
74133,5077,diastolic,O
74134,5077,blood,O
74135,5077,pressure,O
74136,5077,of,O
74137,5077,>,O
74138,5077,=,O
74139,5077,110,O
74140,5077,mm,O
74141,5077,Hg,O
74142,5077,measured,O
74143,5077,twice,O
74144,5077,more,O
74145,5077,than,O
74146,5077,15,O
74147,5077,minutes,O
74148,5077,apart,O
74149,5078,Able,O
74150,5078,to,O
74151,5078,swallow,O
74152,5078,pills,O
74153,5079,>,O
74154,5079,=,O
74155,5079,18,O
74156,5079,years,B-Person
74157,5080,history,B-Observation
74158,5080,of,O
74159,5080,hypertension,B-Condition
74160,5081,known,O
74161,5081,impaired,B-Condition
74162,5081,renal,I-Condition
74163,5081,function,I-Condition
74164,5082,liver,B-Condition
74165,5082,disease,I-Condition
74166,5083,heart,B-Condition
74167,5083,failure,I-Condition
74168,5084,myocardial,B-Condition
74169,5084,infarction,I-Condition
74170,5085,coronary,B-Condition
74171,5085,artery,I-Condition
74172,5085,disease,I-Condition
74173,5086,smoked,B-Observation
74174,5086,within,O
74175,5086,the,O
74176,5086,past,O
74177,5086,year,O
74178,5087,apnea,O
74179,5087,hypopnea,O
74180,5087,index,O
74181,5087,>,O
74182,5087,5,O
74183,5087,events,O
74184,5087,per,O
74185,5087,hour,O
74186,5088,normotensive,B-Condition
74187,5089,forced,O
74188,5089,expiratory,O
74189,5089,volume,O
74190,5089,in,O
74191,5089,1s,O
74192,5089,:,O
74193,5089,forced,O
74194,5089,vital,O
74195,5089,capacity,O
74196,5089,ratio,O
74197,5089,>,O
74198,5089,0.75,O
74199,5090,no,O
74200,5090,medical,B-Observation
74201,5090,history,I-Observation
74202,5090,of,O
74203,5090,cardiovascular,B-Condition
74204,5090,and,I-Condition
74205,5090,respiratory,I-Condition
74206,5090,disease,I-Condition
74207,5091,not,O
74208,5091,taking,O
74209,5091,medications,B-Drug
74210,5091,other,O
74211,5091,than,O
74212,5091,oral,B-Drug
74213,5091,contraceptives,I-Drug
74214,5092,free,O
74215,5092,from,O
74216,5092,sleep,B-Condition
74217,5092,apnea,I-Condition
74218,5093,body,O
74219,5093,mass,O
74220,5093,index,O
74221,5093,less,O
74222,5093,than,O
74223,5093,30,O
74224,5093,kg,O
74225,5093,/,O
74226,5093,m2,O
74227,5094,Subject,O
74228,5094,unwilling,O
74229,5094,to,O
74230,5094,cease,B-Mood
74231,5094,use,I-Mood
74232,5094,of,I-Mood
74233,5094,any,O
74234,5094,treatment,B-Procedure
74235,5094,for,O
74236,5094,erectile,B-Condition
74237,5094,dysfunction,I-Condition
74238,5094,during,O
74239,5094,the,O
74240,5094,study,O
74241,5094,",",O
74242,5094,including,O
74243,5094,oral,B-Procedure
74244,5094,medication,I-Procedure
74245,5094,",",O
74246,5094,vacuum,O
74247,5094,devices,O
74248,5094,",",O
74249,5094,constrictive,O
74250,5094,devices,O
74251,5094,",",O
74252,5094,injections,B-Procedure
74253,5094,",",O
74254,5094,urethral,O
74255,5094,suppositories,O
74256,5094,",",O
74257,5094,gels,B-Procedure
74258,5094,",",O
74259,5094,any,O
74260,5094,over,O
74261,5094,-,O
74262,5094,the,O
74263,5094,-,O
74264,5094,counter,O
74265,5094,or,O
74266,5094,nonprescription,O
74267,5094,medications,B-Procedure
74268,5094,",",O
74269,5094,and,O
74270,5094,products,O
74271,5094,purchased,O
74272,5094,via,O
74273,5094,the,O
74274,5094,internet,O
74275,5095,Subject,O
74276,5095,receiving,O
74277,5095,dopamine,B-Drug
74278,5095,agonists,I-Drug
74279,5095,",",O
74280,5095,nitrates,B-Drug
74281,5095,",",O
74282,5095,alpha,B-Drug
74283,5095,-,I-Drug
74284,5095,receptor,I-Drug
74285,5095,blocking,I-Drug
74286,5095,agents,I-Drug
74287,5095,",",O
74288,5095,or,O
74289,5095,antihypertensive,B-Drug
74290,5095,medication,I-Drug
74291,5095,(,O
74292,5095,see,O
74293,5095,other,O
74294,5095,exclusionary,O
74295,5095,medications,O
74296,5095,listed,O
74297,5095,below,O
74298,5095,),O
74299,5096,Subject,O
74300,5096,with,O
74301,5096,a,O
74302,5096,history,O
74303,5096,of,O
74304,5096,syncope,B-Condition
74305,5096,within,O
74306,5096,the,O
74307,5096,last,O
74308,5096,6,O
74309,5096,months,O
74310,5096,prior,O
74311,5096,to,O
74312,5096,screening,O
74313,5097,Subject,O
74314,5097,with,O
74315,5097,symptomatic,O
74316,5097,postural,B-Condition
74317,5097,hypotension,I-Condition
74318,5097,(,O
74319,5097,severe,O
74320,5097,dizziness,B-Condition
74321,5097,or,O
74322,5097,fainting,B-Condition
74323,5098,Subject,O
74324,5098,with,O
74325,5098,hypotension,B-Condition
74326,5098,and,O
74327,5098,a,O
74328,5098,resting,O
74329,5098,systolic,O
74330,5098,blood,O
74331,5098,pressure,O
74332,5098,of,O
74333,5098,<,O
74334,5098,90,O
74335,5098,mmHG,O
74336,5098,or,O
74337,5098,hypertension,B-Condition
74338,5098,with,O
74339,5098,a,O
74340,5098,resting,O
74341,5098,systolic,O
74342,5098,blood,O
74343,5098,pressure,O
74344,5098,>,O
74345,5098,170,O
74346,5098,mmHG,O
74347,5098,or,O
74348,5098,a,O
74349,5098,resting,O
74350,5098,diastolic,O
74351,5098,blood,O
74352,5098,pressure,O
74353,5098,>,O
74354,5098,110,O
74355,5098,mmHG,O
74356,5099,Subject,O
74357,5099,with,O
74358,5099,any,O
74359,5099,underlying,O
74360,5099,cardiovascular,B-Condition
74361,5099,condition,I-Condition
74362,5099,",",O
74363,5099,including,O
74364,5099,unstable,B-Condition
74365,5099,angina,I-Condition
74366,5099,pectoris,I-Condition
74367,5099,",",O
74368,5099,which,O
74369,5099,preclude,O
74370,5099,sexual,B-Observation
74371,5099,activity,I-Observation
74372,5100,Subject,O
74373,5100,with,O
74374,5100,a,O
74375,5100,history,O
74376,5100,of,O
74377,5100,myocardial,B-Condition
74378,5100,infarction,I-Condition
74379,5100,",",O
74380,5100,stroke,B-Condition
74381,5100,or,O
74382,5100,life,O
74383,5100,-,O
74384,5100,threatening,O
74385,5100,arrhythmia,B-Condition
74386,5100,within,O
74387,5100,6,O
74388,5100,months,O
74389,5100,prior,O
74390,5100,to,O
74391,5100,screening,O
74392,5101,Subject,O
74393,5101,with,O
74394,5101,uncontrolled,O
74395,5101,atrial,B-Condition
74396,5101,fibrillation,I-Condition
74397,5101,/,I-Condition
74398,5101,flutter,I-Condition
74399,5101,at,O
74400,5101,screening,O
74401,5101,(,O
74402,5101,defined,O
74403,5101,as,O
74404,5101,ventricular,O
74405,5101,response,O
74406,5101,rate,O
74407,5101,=,O
74408,5101,100,O
74409,5101,bpm,O
74410,5101,),O
74411,5102,Subject,O
74412,5102,with,O
74413,5102,a,O
74414,5102,bleeding,B-Condition
74415,5102,disorder,I-Condition
74416,5103,Subject,O
74417,5103,with,O
74418,5103,a,O
74419,5103,history,O
74420,5103,of,O
74421,5103,prostatectomy,B-Procedure
74422,5103,because,O
74423,5103,of,O
74424,5103,prostate,B-Condition
74425,5103,cancer,I-Condition
74426,5103,",",O
74427,5103,including,O
74428,5103,nerve,B-Procedure
74429,5103,sparing,I-Procedure
74430,5103,techniques,I-Procedure
74431,5103,.,O
74432,5103,Subjects,O
74433,5103,with,O
74434,5103,a,O
74435,5103,history,B-Observation
74436,5103,of,I-Observation
74437,5103,surgical,B-Procedure
74438,5103,procedures,I-Procedure
74439,5103,for,O
74440,5103,the,O
74441,5103,treatment,O
74442,5103,of,O
74443,5103,benign,B-Condition
74444,5103,prostate,I-Condition
74445,5103,hypertrophy,I-Condition
74446,5103,are,O
74447,5103,permitted,O
74448,5103,",",O
74449,5103,with,O
74450,5103,the,O
74451,5103,exception,O
74452,5103,of,O
74453,5103,cryosurgery,B-Procedure
74454,5103,",",O
74455,5103,cryotherapy,B-Procedure
74456,5103,or,O
74457,5103,cryoablation,B-Procedure
74458,5104,Subject,O
74459,5104,with,O
74460,5104,hereditary,B-Condition
74461,5104,degenerative,I-Condition
74462,5104,retinal,I-Condition
74463,5104,disorders,I-Condition
74464,5104,such,O
74465,5104,as,O
74466,5104,retinitis,B-Condition
74467,5104,pigmentosa,I-Condition
74468,5105,Subject,O
74469,5105,with,O
74470,5105,a,O
74471,5105,history,B-Observation
74472,5105,of,I-Observation
74473,5105,loss,B-Condition
74474,5105,of,I-Condition
74475,5105,vision,I-Condition
74476,5105,because,O
74477,5105,of,O
74478,5105,non,B-Condition
74479,5105,-,I-Condition
74480,5105,arteritic,I-Condition
74481,5105,anterior,I-Condition
74482,5105,ischemic,I-Condition
74483,5105,optic,I-Condition
74484,5105,neuropathy,I-Condition
74485,5105,(,O
74486,5105,NAION,B-Condition
74487,5105,),O
74488,5105,",",O
74489,5105,history,O
74490,5105,of,O
74491,5105,temporary,O
74492,5105,or,O
74493,5105,permanent,O
74494,5105,loss,B-Condition
74495,5105,of,I-Condition
74496,5105,vision,I-Condition
74497,5105,",",O
74498,5105,including,O
74499,5105,unilateral,O
74500,5105,loss,B-Condition
74501,5105,of,I-Condition
74502,5105,vision,I-Condition
74503,5106,Subject,O
74504,5106,with,O
74505,5106,a,O
74506,5106,history,B-Observation
74507,5106,of,I-Observation
74508,5106,congenital,B-Condition
74509,5106,QT,I-Condition
74510,5106,prolongation,I-Condition
74511,5107,Subject,O
74512,5107,with,O
74513,5107,a,O
74514,5107,penile,B-Condition
74515,5107,anatomical,I-Condition
74516,5107,abnormality,I-Condition
74517,5107,(,O
74518,5107,e.g.,O
74519,5107,",",O
74520,5107,penile,B-Condition
74521,5107,fibrosis,I-Condition
74522,5107,",",I-Condition
74523,5107,fractures,I-Condition
74524,5107,",",O
74525,5107,or,O
74526,5107,Peyronie,B-Condition
74527,5107,'s,I-Condition
74528,5107,disease,I-Condition
74529,5107,),I-Condition
74530,5107,which,O
74531,5107,",",O
74532,5107,in,O
74533,5107,the,O
74534,5107,investigator,O
74535,5107,'s,O
74536,5107,opinion,O
74537,5107,",",O
74538,5107,could,O
74539,5107,significantly,O
74540,5107,impair,B-Condition
74541,5107,sexual,I-Condition
74542,5107,performance,I-Condition
74543,5107,.,O
74544,5107,This,O
74545,5107,will,O
74546,5107,be,O
74547,5107,based,O
74548,5107,on,O
74549,5107,subject,O
74550,5107,'s,O
74551,5107,reported,O
74552,5107,medical,O
74553,5107,history,O
74554,5107,(,O
74555,5107,penile,B-Procedure
74556,5107,exam,I-Procedure
74557,5107,not,O
74558,5107,required,O
74559,5107,),O
74560,5108,Subject,O
74561,5108,with,O
74562,5108,primary,B-Observation
74563,5108,hypoactive,I-Observation
74564,5108,sexual,I-Observation
74565,5108,desire,I-Observation
74566,5108,.,O
74567,5109,Subject,O
74568,5109,with,O
74569,5109,a,O
74570,5109,spinal,B-Condition
74571,5109,cord,I-Condition
74572,5109,injury,I-Condition
74573,5110,Subject,O
74574,5110,with,O
74575,5110,a,O
74576,5110,severe,O
74577,5110,chronic,B-Condition
74578,5110,or,I-Condition
74579,5110,acute,I-Condition
74580,5110,liver,I-Condition
74581,5110,disease,I-Condition
74582,5110,",",O
74583,5110,history,O
74584,5110,of,O
74585,5110,moderate,O
74586,5110,(,O
74587,5110,Child,O
74588,5110,-,O
74589,5110,Pugh,O
74590,5110,B,O
74591,5110,),O
74592,5110,",",O
74593,5110,or,O
74594,5110,severe,O
74595,5110,(,O
74596,5110,Child,O
74597,5110,-,O
74598,5110,Pugh,O
74599,5110,C,O
74600,5110,),O
74601,5110,hepatic,B-Condition
74602,5110,impairment,I-Condition
74603,5111,Subject,O
74604,5111,with,O
74605,5111,clinically,O
74606,5111,significant,O
74607,5111,chronic,O
74608,5111,hematological,B-Condition
74609,5111,disease,I-Condition
74610,5111,which,O
74611,5111,could,O
74612,5111,lead,O
74613,5111,to,O
74614,5111,priapism,B-Condition
74615,5111,such,O
74616,5111,as,O
74617,5111,sickle,B-Condition
74618,5111,cell,I-Condition
74619,5111,anemia,I-Condition
74620,5111,",",O
74621,5111,multiple,B-Condition
74622,5111,myeloma,I-Condition
74623,5111,",",O
74624,5111,and,O
74625,5111,leukemia,B-Condition
74626,5112,Subject,O
74627,5112,with,O
74628,5112,active,O
74629,5112,peptic,B-Condition
74630,5112,ulceration,I-Condition
74631,5113,Subject,O
74632,5113,with,O
74633,5113,a,O
74634,5113,history,B-Observation
74635,5113,of,I-Observation
74636,5113,malignancy,B-Condition
74637,5113,within,O
74638,5113,the,O
74639,5113,past,O
74640,5113,5,O
74641,5113,years,O
74642,5113,(,O
74643,5113,other,O
74644,5113,than,O
74645,5113,squamous,B-Condition
74646,5113,or,I-Condition
74647,5113,basal,I-Condition
74648,5113,cell,I-Condition
74649,5113,skin,I-Condition
74650,5113,cancer,I-Condition
74651,5113,),O
74652,5114,Subject,O
74653,5114,with,O
74654,5114,a,O
74655,5114,history,B-Observation
74656,5114,of,I-Observation
74657,5114,a,O
74658,5114,positive,O
74659,5114,test,O
74660,5114,for,O
74661,5114,Hepatitis,O
74662,5114,B,O
74663,5114,surface,O
74664,5114,antigen,O
74665,5114,(,O
74666,5114,HbsAg,O
74667,5114,),O
74668,5114,or,O
74669,5114,Hepatitis,O
74670,5114,C,O
74671,5115,Subject,O
74672,5115,with,O
74673,5115,a,O
74674,5115,known,O
74675,5115,hypersensitivity,B-Condition
74676,5115,to,O
74677,5115,any,O
74678,5115,component,O
74679,5115,of,O
74680,5115,the,O
74681,5115,investigational,O
74682,5115,medications,B-Drug
74683,5115,",",O
74684,5115,monoamine,B-Drug
74685,5115,oxidase,I-Drug
74686,5115,inhibitors,I-Drug
74687,5115,",",O
74688,5115,phosphodiesterase,B-Drug
74689,5115,type,I-Drug
74690,5115,5,I-Drug
74691,5115,inhibitors,I-Drug
74692,5115,or,O
74693,5115,phenylethylamines,B-Drug
74694,5116,Subjects,O
74695,5116,with,O
74696,5116,a,O
74697,5116,history,B-Observation
74698,5116,of,I-Observation
74699,5116,drug,B-Condition
74700,5116,or,I-Condition
74701,5116,alcohol,I-Condition
74702,5116,abuse,I-Condition
74703,5116,within,O
74704,5116,the,O
74705,5116,past,O
74706,5116,6,O
74707,5116,months,O
74708,5117,Subjects,O
74709,5117,currently,O
74710,5117,consuming,B-Observation
74711,5117,=,I-Observation
74712,5117,5,I-Observation
74713,5117,units,I-Observation
74714,5117,of,I-Observation
74715,5117,alcohol,I-Observation
74716,5117,per,I-Observation
74717,5117,day,I-Observation
74718,5118,Subject,O
74719,5118,who,O
74720,5118,is,O
74721,5118,illiterate,B-Observation
74722,5118,or,O
74723,5118,unable,O
74724,5118,to,O
74725,5118,understand,O
74726,5118,the,O
74727,5118,Informed,O
74728,5118,Consent,O
74729,5118,Form,O
74730,5118,",",O
74731,5118,questionnaires,O
74732,5118,or,O
74733,5118,subject,O
74734,5118,diary,O
74735,5119,Subject,O
74736,5119,who,O
74737,5119,",",O
74738,5119,in,O
74739,5119,the,O
74740,5119,opinion,O
74741,5119,of,O
74742,5119,the,O
74743,5119,investigator,O
74744,5119,",",O
74745,5119,will,O
74746,5119,be,O
74747,5119,noncompliant,O
74748,5119,with,O
74749,5119,the,O
74750,5119,visit,O
74751,5119,schedule,O
74752,5119,or,O
74753,5119,study,O
74754,5119,procedures,O
74755,5120,Subject,O
74756,5120,with,O
74757,5120,any,O
74758,5120,unstable,O
74759,5120,medical,B-Condition
74760,5120,",",I-Condition
74761,5120,psychiatric,I-Condition
74762,5120,",",I-Condition
74763,5120,or,I-Condition
74764,5120,substance,I-Condition
74765,5120,abuse,I-Condition
74766,5120,disorder,I-Condition
74767,5120,that,O
74768,5120,in,O
74769,5120,the,O
74770,5120,opinion,O
74771,5120,of,O
74772,5120,the,O
74773,5120,investigator,O
74774,5120,is,O
74775,5120,likely,O
74776,5120,to,O
74777,5120,affect,O
74778,5120,the,O
74779,5120,subject,O
74780,5120,'s,O
74781,5120,ability,O
74782,5120,to,O
74783,5120,complete,O
74784,5120,the,O
74785,5120,study,O
74786,5120,or,O
74787,5120,preclude,O
74788,5120,the,O
74789,5120,subject,O
74790,5120,'s,O
74791,5120,participation,O
74792,5120,in,O
74793,5120,the,O
74794,5120,study,O
74795,5121,Diagnosis,O
74796,5121,of,O
74797,5121,any,O
74798,5121,other,O
74799,5121,neurologic,B-Condition
74800,5121,disease,I-Condition
74801,5122,Uncontrolled,O
74802,5122,Diabetes,B-Condition
74803,5122,(,O
74804,5122,Hemoglobin,O
74805,5122,A1C,O
74806,5122,>,O
74807,5122,7.5,O
74808,5122,),O
74809,5123,Diagnosis,O
74810,5123,of,O
74811,5123,idiopathic,B-Condition
74812,5123,Parkinson,I-Condition
74813,5123,'s,I-Condition
74814,5123,disease,I-Condition
74815,5123,that,O
74816,5123,is,O
74817,5123,optimally,O
74818,5123,treated,O
74819,5123,(,O
74820,5123,motor,O
74821,5123,fluctuations,O
74822,5123,<,O
74823,5123,20,O
74824,5123,%,O
74825,5123,of,O
74826,5123,subject,O
74827,5123,'s,O
74828,5123,awake,O
74829,5123,time,O
74830,5123,),O
74831,5123,.,O
74832,5123,Subjects,O
74833,5123,may,O
74834,5123,be,O
74835,5123,on,O
74836,5123,levodopa,O
74837,5123,therapy,O
74838,5123,but,O
74839,5123,must,O
74840,5123,be,O
74841,5123,stable,O
74842,5123,at,O
74843,5123,the,O
74844,5123,time,O
74845,5123,of,O
74846,5123,entry,O
74847,5123,into,O
74848,5123,the,O
74849,5123,study,O
74850,5124,Sexually,B-Observation
74851,5124,active,I-Observation
74852,5124,(,O
74853,5124,i.e.,O
74854,5124,=,O
74855,5124,1,O
74856,5124,attempt,O
74857,5124,/,O
74858,5124,week,O
74859,5124,),O
74860,5124,males,B-Person
74861,5124,",",O
74862,5124,40,O
74863,5124,-,O
74864,5124,64,O
74865,5124,years,O
74866,5124,of,O
74867,5124,age,B-Person
74868,5124,(,O
74869,5124,inclusive,O
74870,5124,),O
74871,5124,at,O
74872,5124,time,O
74873,5124,of,O
74874,5124,screening,O
74875,5125,Diagnosis,O
74876,5125,of,O
74877,5125,moderate,O
74878,5125,erectile,B-Condition
74879,5125,dysfunction,I-Condition
74880,5125,(,O
74881,5125,defined,O
74882,5125,according,O
74883,5125,to,O
74884,5125,the,O
74885,5125,NIH,O
74886,5125,Consensus,O
74887,5125,Development,O
74888,5125,Panel,O
74889,5125,on,O
74890,5125,Impotence,O
74891,5125,),O
74892,5125,for,O
74893,5125,more,O
74894,5125,than,O
74895,5125,6,O
74896,5125,months,O
74897,5125,and,O
74898,5125,demonstrating,O
74899,5125,and,O
74900,5125,incomplete,O
74901,5125,response,B-Condition
74902,5125,to,O
74903,5125,tadalafil,B-Drug
74904,5125,alone,O
74905,5126,Subject,O
74906,5126,demonstrating,O
74907,5126,an,O
74908,5126,IIEF-5,O
74909,5126,drug,O
74910,5126,-,O
74911,5126,free,O
74912,5126,baseline,O
74913,5126,score,O
74914,5126,that,O
74915,5126,is,O
74916,5126,=,O
74917,5126,10,O
74918,5126,but,O
74919,5126,=,O
74920,5126,16,O
74921,5126,",",O
74922,5126,and,O
74923,5126,an,O
74924,5126,IIEF-5,O
74925,5126,tadalafil,O
74926,5126,-,O
74927,5126,alone,O
74928,5126,baseline,O
74929,5126,score,O
74930,5126,that,O
74931,5126,is,O
74932,5126,=,O
74933,5126,18,O
74934,5127,Subject,O
74935,5127,in,O
74936,5127,a,O
74937,5127,stable,O
74938,5127,heterosexual,B-Observation
74939,5127,relationship,I-Observation
74940,5127,for,O
74941,5127,at,O
74942,5127,least,O
74943,5127,6,O
74944,5127,months,O
74945,5127,.,O
74946,5127,(,O
74947,5127,2,O
74948,5127,),O
74949,5128,Subject,O
74950,5128,motivated,O
74951,5128,to,O
74952,5128,seek,O
74953,5128,treatment,B-Procedure
74954,5128,for,O
74955,5128,erectile,B-Condition
74956,5128,dysfunction,I-Condition
74957,5128,.,O
74958,5129,Subject,O
74959,5129,with,O
74960,5129,a,O
74961,5129,total,O
74962,5129,serum,O
74963,5129,testosterone,O
74964,5129,level,O
74965,5129,=,O
74966,5129,300,O
74967,5129,ng,O
74968,5129,/,O
74969,5129,dL,O
74970,5129,",",O
74971,5129,with,O
74972,5129,or,O
74973,5129,without,O
74974,5129,supplementation,O
74975,5130,Hoehn,O
74976,5130,and,O
74977,5130,Yahr,O
74978,5130,Scale,O
74979,5130,score,O
74980,5130,of,O
74981,5130,1,O
74982,5130,-,O
74983,5130,3,O
74984,5131,Patient,O
74985,5131,able,O
74986,5131,to,O
74987,5131,consent,O
74988,5131,and,O
74989,5131,comply,O
74990,5131,with,O
74991,5131,protocol,O
74992,5131,requirements,O
74993,5132,Allergic,B-Condition
74994,5132,to,O
74995,5132,sirolimus,B-Drug
74996,5132,or,O
74997,5132,serious,O
74998,5132,side,B-Condition
74999,5132,effects,I-Condition
75000,5133,Need,B-Mood
75001,5133,emergency,B-Procedure
75002,5133,surgery,I-Procedure
75003,5134,Accompanied,O
75004,5134,with,O
75005,5134,other,O
75006,5134,severe,B-Condition
75007,5134,disease,I-Condition
75008,5134,(,O
75009,5134,involve,O
75010,5134,C.diff,B-Condition
75011,5134,infection,I-Condition
75012,5134,),O
75013,5135,Follow,O
75014,5135,-,O
75015,5135,up,O
75016,5135,less,O
75017,5135,than,O
75018,5135,1,O
75019,5135,year,O
75020,5136,moderate,O
75021,5136,to,O
75022,5136,severe,O
75023,5136,Crohn,B-Condition
75024,5136,'s,I-Condition
75025,5136,Disease,I-Condition
75026,5136,(,O
75027,5136,basic,O
75028,5136,HBI,O
75029,5136,=,O
75030,5136,7,O
75031,5136,),O
75032,5136,with,O
75033,5136,stenosis,B-Condition
75034,5137,Serum,O
75035,5137,phosphate,O
75036,5137,<,O
75037,5137,3.0,O
75038,5137,mg,O
75039,5137,/,O
75040,5137,dL,O
75041,5138,Intravenous,O
75042,5138,(,O
75043,5138,IV,O
75044,5138,),O
75045,5138,iron,B-Drug
75046,5138,administered,O
75047,5138,within,O
75048,5138,4,O
75049,5138,weeks,O
75050,5138,prior,O
75051,5138,to,O
75052,5138,Screening,O
75053,5139,Erythropoiesis,B-Drug
75054,5139,-,I-Drug
75055,5139,stimulating,I-Drug
75056,5139,agents,I-Drug
75057,5139,(,O
75058,5139,ESA,B-Drug
75059,5139,),O
75060,5139,administered,O
75061,5139,within,O
75062,5139,4,O
75063,5139,weeks,O
75064,5139,prior,O
75065,5139,to,O
75066,5139,Screening,O
75067,5140,Blood,B-Procedure
75068,5140,transfusion,I-Procedure
75069,5140,within,O
75070,5140,4,O
75071,5140,weeks,O
75072,5140,prior,O
75073,5140,to,O
75074,5140,Screening,O
75075,5141,Estimated,O
75076,5141,glomerular,O
75077,5141,filtration,O
75078,5141,rate,O
75079,5141,=,O
75080,5141,20,O
75081,5141,mL,O
75082,5141,/,O
75083,5141,min,O
75084,5141,and,O
75085,5141,<,O
75086,5141,60,O
75087,5141,mL,O
75088,5141,/,O
75089,5141,min,O
75090,5142,Hgb,O
75091,5142,=,O
75092,5142,8.5,O
75093,5142,g,O
75094,5142,/,O
75095,5142,dL,O
75096,5142,and,O
75097,5142,=,O
75098,5142,11.5,O
75099,5142,g,O
75100,5142,/,O
75101,5142,dL,O
75102,5143,Serum,O
75103,5143,ferritin,O
75104,5143,=,O
75105,5143,500,O
75106,5143,ng,O
75107,5143,/,O
75108,5143,mL,O
75109,5143,and,O
75110,5143,transferrin,O
75111,5143,saturation,O
75112,5143,(,O
75113,5143,TSAT,O
75114,5143,),O
75115,5143,=,O
75116,5143,25,O
75117,5143,%,O
75118,5144,Serum,O
75119,5144,intact,O
75120,5144,parathyroid,O
75121,5144,hormone,O
75122,5144,=,O
75123,5144,600,O
75124,5144,pg,O
75125,5144,/,O
75126,5144,mL,O
75127,5145,Suicidal,B-Condition
75128,5145,patients,O
75129,5145,and/or,O
75130,5145,severe,O
75131,5145,automutilation,B-Condition
75132,5145,behavior,I-Condition
75133,5145,and/or,O
75134,5145,psychotic,B-Condition
75135,5145,symptoms,I-Condition
75136,5145,and/or,O
75137,5145,lack,B-Condition
75138,5145,of,I-Condition
75139,5145,event,I-Condition
75140,5145,memory,I-Condition
75141,5145,.,O
75142,5146,Clinical,O
75143,5146,Administered,O
75144,5146,PTSD,O
75145,5146,Scale,O
75146,5146,5,O
75147,5146,Monthly,O
75148,5146,version,O
75149,5146,Criteria,O
75150,5146,A,O
75151,5146,and,O
75152,5146,>,O
75153,5146,30,O
75154,5146,points,O
75155,5147,Treatment,O
75156,5147,with,O
75157,5147,any,O
75158,5147,investigational,O
75159,5147,drug,O
75160,5147,within,O
75161,5147,30,O
75162,5147,days,O
75163,5147,of,O
75164,5147,entry,O
75165,5147,to,O
75166,5147,this,O
75167,5147,protocol,O
75168,5148,Current,O
75169,5148,treatment,O
75170,5148,with,O
75171,5148,Telbivudine,B-Drug
75172,5149,Severe,O
75173,5149,hepatitis,B-Condition
75174,5149,activity,O
75175,5149,as,O
75176,5149,documented,O
75177,5149,by,O
75178,5149,ALT>10,O
75179,5149,x,O
75180,5149,ULN,O
75181,5150,History,O
75182,5150,of,O
75183,5150,decompensated,O
75184,5150,cirrhosis,B-Condition
75185,5150,(,O
75186,5150,defined,O
75187,5150,as,O
75188,5150,jaundice,B-Condition
75189,5150,in,O
75190,5150,the,O
75191,5150,presence,O
75192,5150,of,O
75193,5150,cirrhosis,B-Condition
75194,5150,",",O
75195,5150,ascites,B-Condition
75196,5150,",",O
75197,5150,bleeding,B-Condition
75198,5150,gastric,I-Condition
75199,5150,or,O
75200,5150,esophageal,B-Condition
75201,5150,varices,I-Condition
75202,5150,or,O
75203,5150,encephalopathy,B-Condition
75204,5150,),O
75205,5151,Pre,O
75206,5151,-,O
75207,5151,existent,O
75208,5151,neutropenia,B-Condition
75209,5151,(,O
75210,5151,neutrophils,O
75211,5151,<,O
75212,5151,"1,500",O
75213,5151,/,O
75214,5151,mm3,O
75215,5151,),O
75216,5151,or,O
75217,5151,thrombocytopenia,B-Condition
75218,5151,(,O
75219,5151,platelets,O
75220,5151,<,O
75221,5151,"90,000",O
75222,5151,/,O
75223,5151,mm3,O
75224,5151,),O
75225,5152,Co,B-Condition
75226,5152,-,I-Condition
75227,5152,infection,I-Condition
75228,5152,with,O
75229,5152,hepatitis,O
75230,5152,C,O
75231,5152,virus,O
75232,5152,",",O
75233,5152,hepatitis,O
75234,5152,D,O
75235,5152,virus,O
75236,5152,or,O
75237,5152,human,O
75238,5152,immunodeficiency,O
75239,5152,virus,O
75240,5152,(,O
75241,5152,HIV,O
75242,5152,),O
75243,5153,Other,O
75244,5153,acquired,O
75245,5153,or,O
75246,5153,inherited,O
75247,5153,causes,O
75248,5153,of,O
75249,5153,liver,B-Condition
75250,5153,disease,I-Condition
75251,5153,:,O
75252,5153,alcoholic,B-Condition
75253,5153,liver,I-Condition
75254,5153,disease,I-Condition
75255,5153,",",O
75256,5153,obesity,B-Condition
75257,5153,induced,I-Condition
75258,5153,liver,I-Condition
75259,5153,disease,I-Condition
75260,5153,",",O
75261,5153,drug,B-Condition
75262,5153,related,I-Condition
75263,5153,liver,I-Condition
75264,5153,disease,I-Condition
75265,5153,",",O
75266,5153,auto,B-Condition
75267,5153,-,I-Condition
75268,5153,immune,I-Condition
75269,5153,hepatitis,I-Condition
75270,5153,",",O
75271,5153,hemochromatosis,B-Condition
75272,5153,",",O
75273,5153,Wilson,B-Condition
75274,5153,'s,I-Condition
75275,5153,disease,I-Condition
75276,5153,or,O
75277,5153,alpha-1,B-Condition
75278,5153,antitrypsin,I-Condition
75279,5153,deficiency,I-Condition
75280,5154,Alpha,O
75281,5154,fetoprotein,O
75282,5154,>,O
75283,5154,50,O
75284,5154,ng,O
75285,5154,/,O
75286,5154,ml,O
75287,5155,Hyper-,B-Condition
75288,5155,or,I-Condition
75289,5155,hypothyroidism,I-Condition
75290,5155,(,O
75291,5155,subjects,O
75292,5155,requiring,O
75293,5155,medication,B-Drug
75294,5155,to,O
75295,5155,maintain,O
75296,5155,TSH,O
75297,5155,levels,O
75298,5155,in,O
75299,5155,the,O
75300,5155,normal,O
75301,5155,range,O
75302,5155,are,O
75303,5155,eligible,O
75304,5155,if,O
75305,5155,all,O
75306,5155,other,O
75307,5155,inclusion,O
75308,5155,/,O
75309,5155,exclusion,O
75310,5155,criteria,O
75311,5155,are,O
75312,5155,met,O
75313,5155,),O
75314,5156,Immune,B-Procedure
75315,5156,suppressive,I-Procedure
75316,5156,treatment,I-Procedure
75317,5156,within,O
75318,5156,the,O
75319,5156,previous,O
75320,5156,6,O
75321,5156,months,O
75322,5157,Contra,B-Condition
75323,5157,-,I-Condition
75324,5157,indications,I-Condition
75325,5157,for,O
75326,5157,alfa,B-Drug
75327,5157,-,I-Drug
75328,5157,interferon,I-Drug
75329,5157,therapy,I-Drug
75330,5157,like,O
75331,5157,suspected,O
75332,5157,hypersensitivity,B-Condition
75333,5157,to,O
75334,5157,interferon,B-Drug
75335,5157,or,O
75336,5157,Peginterferon,B-Drug
75337,5157,or,O
75338,5157,any,O
75339,5157,known,O
75340,5157,pre,O
75341,5157,-,O
75342,5157,existing,O
75343,5157,medical,O
75344,5157,condition,O
75345,5157,that,O
75346,5157,could,O
75347,5157,interfere,O
75348,5157,with,O
75349,5157,the,O
75350,5157,patient,O
75351,5157,'s,O
75352,5157,participation,O
75353,5157,in,O
75354,5157,and,O
75355,5157,completion,O
75356,5157,of,O
75357,5157,the,O
75358,5157,study,O
75359,5157,.,O
75360,5158,Pregnancy,O
75361,5158,",",O
75362,5158,breast,O
75363,5158,-,O
75364,5158,feeding,O
75365,5159,Other,O
75366,5159,significant,O
75367,5159,medical,B-Condition
75368,5159,illness,I-Condition
75369,5159,that,O
75370,5159,might,O
75371,5159,interfere,O
75372,5159,with,O
75373,5159,this,O
75374,5159,study,O
75375,5159,:,O
75376,5159,significant,O
75377,5159,pulmonary,B-Condition
75378,5159,dysfunction,I-Condition
75379,5159,in,O
75380,5159,the,O
75381,5159,previous,O
75382,5159,6,O
75383,5159,months,O
75384,5159,",",O
75385,5159,malignancy,B-Condition
75386,5159,other,O
75387,5159,than,O
75388,5159,skin,B-Condition
75389,5159,basocellular,I-Condition
75390,5159,carcinoma,I-Condition
75391,5159,in,O
75392,5159,previous,O
75393,5159,5,O
75394,5159,years,O
75395,5159,",",O
75396,5159,immunodeficiency,B-Condition
75397,5159,syndromes,I-Condition
75398,5159,(,O
75399,5159,e.g.,O
75400,5159,HIV,B-Condition
75401,5159,positivity,I-Condition
75402,5159,",",O
75403,5159,auto,B-Condition
75404,5159,-,I-Condition
75405,5159,immune,I-Condition
75406,5159,diseases,I-Condition
75407,5159,",",O
75408,5159,organ,B-Procedure
75409,5159,transplants,I-Procedure
75410,5159,other,O
75411,5159,than,O
75412,5159,cornea,B-Procedure
75413,5159,and,I-Procedure
75414,5159,hair,I-Procedure
75415,5159,transplant,I-Procedure
75416,5159,),O
75417,5160,Any,O
75418,5160,medical,O
75419,5160,condition,O
75420,5160,requiring,O
75421,5160,",",O
75422,5160,or,O
75423,5160,likely,O
75424,5160,to,O
75425,5160,require,O
75426,5160,chronic,O
75427,5160,systemic,B-Drug
75428,5160,administration,I-Drug
75429,5160,of,I-Drug
75430,5160,steroids,I-Drug
75431,5160,",",O
75432,5160,during,O
75433,5160,the,O
75434,5160,course,O
75435,5160,of,O
75436,5160,the,O
75437,5160,study,O
75438,5161,Substance,B-Condition
75439,5161,abuse,I-Condition
75440,5161,",",O
75441,5161,such,O
75442,5161,as,O
75443,5161,alcohol,O
75444,5161,(,O
75445,5161,>,O
75446,5161,80,O
75447,5161,g,O
75448,5161,/,O
75449,5161,day,O
75450,5161,),O
75451,5161,",",O
75452,5161,I.V.,O
75453,5161,drugs,O
75454,5161,and,O
75455,5161,inhaled,O
75456,5161,drugs,O
75457,5161,in,O
75458,5161,the,O
75459,5161,past,O
75460,5161,2,O
75461,5161,years,O
75462,5161,.,O
75463,5162,Any,O
75464,5162,other,O
75465,5162,condition,O
75466,5162,which,O
75467,5162,in,O
75468,5162,the,O
75469,5162,opinion,O
75470,5162,of,O
75471,5162,the,O
75472,5162,investigator,O
75473,5162,would,O
75474,5162,make,O
75475,5162,the,O
75476,5162,patient,O
75477,5162,unsuitable,O
75478,5162,for,O
75479,5162,enrollment,O
75480,5162,",",O
75481,5162,or,O
75482,5162,could,O
75483,5162,interfere,O
75484,5162,with,O
75485,5162,the,O
75486,5162,patient,O
75487,5162,participating,O
75488,5162,in,O
75489,5162,and,O
75490,5162,completing,O
75491,5162,the,O
75492,5162,study,O
75493,5163,Chronic,B-Condition
75494,5163,hepatitis,I-Condition
75495,5163,B,I-Condition
75496,5163,(,O
75497,5163,HBsAg,O
75498,5163,positive,O
75499,5163,>,O
75500,5163,6,O
75501,5163,months,O
75502,5163,),O
75503,5164,HBeAg,O
75504,5164,negative,O
75505,5164,within,O
75506,5164,six,O
75507,5164,months,O
75508,5164,prior,O
75509,5164,to,O
75510,5164,initiation,O
75511,5164,of,O
75512,5164,peginterferon,B-Drug
75513,5164,alfa-2a,I-Drug
75514,5165,HBV,O
75515,5165,DNA,O
75516,5165,<,O
75517,5165,200,O
75518,5165,IU,O
75519,5165,/,O
75520,5165,ml,O
75521,5165,during,O
75522,5165,nucleos(t)ide,B-Drug
75523,5165,analogue,I-Drug
75524,5165,(,O
75525,5165,except,O
75526,5165,Telbivudine,B-Drug
75527,5165,),O
75528,5165,treatment,O
75529,5165,within,O
75530,5165,one,O
75531,5165,month,O
75532,5165,prior,O
75533,5165,to,O
75534,5165,initiation,O
75535,5165,of,O
75536,5165,peginterferon,B-Drug
75537,5165,alfa-2a,I-Drug
75538,5166,Compensated,O
75539,5166,liver,B-Condition
75540,5166,disease,I-Condition
75541,5167,Age,B-Person
75542,5167,>,O
75543,5167,18,O
75544,5167,years,O
75545,5168,Written,O
75546,5168,informed,O
75547,5168,consent,O
75548,5169,Recanalized,B-Procedure
75549,5169,(,O
75550,5169,TIMI,O
75551,5169,I,O
75552,5169,-,O
75553,5169,III,O
75554,5169,flow,O
75555,5169,),O
75556,5169,IRA,B-Condition
75557,5169,at,O
75558,5169,coronary,B-Procedure
75559,5169,angiography,I-Procedure
75560,5169,.,O
75561,5170,Patients,O
75562,5170,in,O
75563,5170,whom,O
75564,5170,TIMI-3,O
75565,5170,flow,O
75566,5170,was,O
75567,5170,not,O
75568,5170,able,O
75569,5170,to,O
75570,5170,be,O
75571,5170,established,O
75572,5170,after,O
75573,5170,wire,O
75574,5170,crossing,O
75575,5170,",",O
75576,5170,balloon,O
75577,5170,angioplasty,O
75578,5170,or,O
75579,5170,thrombectomy,O
75580,5170,.,O
75581,5171,STEMI,B-Condition
75582,5171,due,O
75583,5171,to,O
75584,5171,bypass,O
75585,5171,-,O
75586,5171,graft,O
75587,5171,occlusion,B-Condition
75588,5172,Severe,O
75589,5172,heart,B-Condition
75590,5172,failure,I-Condition
75591,5172,or,O
75592,5172,cardiogenic,B-Condition
75593,5172,shock,I-Condition
75594,5173,Patients,O
75595,5173,presenting,O
75596,5173,with,O
75597,5173,ST,B-Condition
75598,5173,-,I-Condition
75599,5173,elevation,I-Condition
75600,5173,acute,I-Condition
75601,5173,myocardial,I-Condition
75602,5173,infarction,I-Condition
75603,5173,(,I-Condition
75604,5173,STEMI,I-Condition
75605,5173,),I-Condition
75606,5173,within,O
75607,5173,12,O
75608,5173,hours,O
75609,5173,of,O
75610,5173,their,O
75611,5173,symptom,O
75612,5173,onset,O
75613,5173,in,O
75614,5173,whom,O
75615,5173,TIMI-3,B-Observation
75616,5173,flow,I-Observation
75617,5173,was,I-Observation
75618,5173,established,I-Observation
75619,5173,in,O
75620,5173,infarct,O
75621,5173,related,O
75622,5173,artery,O
75623,5173,(,O
75624,5173,IRA,O
75625,5173,),O
75626,5173,after,O
75627,5173,balloon,B-Procedure
75628,5173,angioplasty,I-Procedure
75629,5173,or,O
75630,5173,thrombectomy,B-Procedure
75631,5173,.,O
75632,5174,Allergy,B-Condition
75633,5174,to,O
75634,5174,narcotic,B-Drug
75635,5174,medications,I-Drug
75636,5175,Intake,O
75637,5175,of,O
75638,5175,any,O
75639,5175,chronic,O
75640,5175,opioids,B-Drug
75641,5175,or,O
75642,5175,pain,B-Drug
75643,5175,medications,I-Drug
75644,5175,preoperatively,O
75645,5176,Subjects,O
75646,5176,must,O
75647,5176,be,O
75648,5176,female,B-Person
75649,5177,Subjects,O
75650,5177,must,O
75651,5177,be,O
75652,5177,18,O
75653,5177,years,O
75654,5177,or,O
75655,5177,older,B-Person
75656,5178,Subjects,O
75657,5178,must,O
75658,5178,be,O
75659,5178,undergoing,O
75660,5178,unilateral,O
75661,5178,or,O
75662,5178,bilateral,O
75663,5178,mastectomy,B-Procedure
75664,5178,with,O
75665,5178,tissue,B-Procedure
75666,5178,expander,I-Procedure
75667,5178,reconstruction,I-Procedure
75668,5179,History,B-Observation
75669,5179,of,O
75670,5179,other,O
75671,5179,significant,O
75672,5179,skin,B-Condition
75673,5179,disease,I-Condition
75674,5179,",",O
75675,5179,or,O
75676,5179,skin,B-Condition
75677,5179,manifestations,I-Condition
75678,5179,of,O
75679,5179,allergic,B-Condition
75680,5179,illness,I-Condition
75681,5179,or,O
75682,5179,other,O
75683,5179,dermatologic,B-Condition
75684,5179,condition,I-Condition
75685,5179,",",O
75686,5179,except,O
75687,5179,chronic,O
75688,5179,moderate,O
75689,5179,or,O
75690,5179,severe,O
75691,5179,atopic,B-Condition
75692,5179,dermatitis,I-Condition
75693,5179,",",O
75694,5179,that,O
75695,5179,would,O
75696,5179,interfere,O
75697,5179,with,O
75698,5179,the,O
75699,5179,trial,O
75700,5179,assessments,O
75701,5179,or,O
75702,5179,compromise,O
75703,5179,the,O
75704,5179,patient,O
75705,5179,'s,O
75706,5179,safety,O
75707,5179,according,O
75708,5179,to,O
75709,5179,the,O
75710,5179,opinion,O
75711,5179,of,O
75712,5179,the,O
75713,5179,Investigator,O
75714,5180,Present,O
75715,5180,symptoms,O
75716,5180,of,O
75717,5180,other,O
75718,5180,skin,B-Condition
75719,5180,diseases,I-Condition
75720,5180,",",O
75721,5180,except,O
75722,5180,chronic,B-Condition
75723,5180,atopic,I-Condition
75724,5180,dermatitis,I-Condition
75725,5180,",",O
75726,5180,that,O
75727,5180,could,O
75728,5180,disturb,O
75729,5180,the,O
75730,5180,study,O
75731,5180,assessment,O
75732,5180,and,O
75733,5180,evaluation,O
75734,5180,of,O
75735,5180,the,O
75736,5180,skin,O
75737,5181,Current,O
75738,5181,use,O
75739,5181,of,O
75740,5181,any,O
75741,5181,active,O
75742,5181,systemic,B-Drug
75743,5181,medication,I-Drug
75744,5181,for,O
75745,5181,chronic,B-Condition
75746,5181,atopic,I-Condition
75747,5181,dermatitis,I-Condition
75748,5181,within,O
75749,5181,one,O
75750,5181,month,O
75751,5182,Current,O
75752,5182,use,O
75753,5182,of,O
75754,5182,active,O
75755,5182,topical,B-Drug
75756,5182,medication,I-Drug
75757,5182,in,O
75758,5182,the,O
75759,5182,planned,O
75760,5182,investigational,O
75761,5182,area,O
75762,5182,for,O
75763,5182,chronic,B-Condition
75764,5182,atopic,I-Condition
75765,5182,dermatitis,I-Condition
75766,5182,within,O
75767,5182,two,O
75768,5182,weeks,O
75769,5183,History,O
75770,5183,of,O
75771,5183,a,O
75772,5183,sunny,B-Observation
75773,5183,holiday,I-Observation
75774,5183,",",O
75775,5183,UV,B-Procedure
75776,5183,-,I-Procedure
75777,5183,light,I-Procedure
75778,5183,therapy,I-Procedure
75779,5183,or,O
75780,5183,solarium,B-Observation
75781,5183,use,I-Observation
75782,5183,within,O
75783,5183,one,O
75784,5183,month,O
75785,5183,before,O
75786,5183,beginning,O
75787,5183,of,O
75788,5183,study,O
75789,5183,treatments,O
75790,5183,",",O
75791,5183,or,O
75792,5183,planning,B-Observation
75793,5183,such,O
75794,5183,during,O
75795,5183,the,O
75796,5183,study,O
75797,5183,or,O
75798,5183,within,O
75799,5183,7,O
75800,5183,days,O
75801,5183,after,O
75802,5183,the,O
75803,5183,study,O
75804,5184,Allergy,B-Condition
75805,5184,to,O
75806,5184,cis,B-Drug
75807,5184,-,I-Drug
75808,5184,UCA,I-Drug
75809,5184,",",O
75810,5184,or,O
75811,5184,any,O
75812,5184,constituents,O
75813,5184,of,O
75814,5184,the,O
75815,5184,placebo,B-Drug
75816,5184,emulsion,I-Drug
75817,5184,cream,I-Drug
75818,5184,or,O
75819,5184,any,O
75820,5184,constituents,O
75821,5184,of,O
75822,5184,Protopic,B-Drug
75823,5184,®,I-Drug
75824,5184,ointment,I-Drug
75825,5185,History,B-Observation
75826,5185,of,O
75827,5185,any,O
75828,5185,skin,B-Condition
75829,5185,-,I-Condition
75830,5185,related,I-Condition
75831,5185,cancer,I-Condition
75832,5186,Congenital,O
75833,5186,or,O
75834,5186,acquired,B-Condition
75835,5186,immunodeficiency,I-Condition
75836,5186,or,O
75837,5186,ongoing,O
75838,5186,therapy,B-Procedure
75839,5186,that,I-Procedure
75840,5186,cause,I-Procedure
75841,5186,immunosuppression,I-Procedure
75842,5187,Earlier,O
75843,5187,participation,O
75844,5187,in,O
75845,5187,a,O
75846,5187,clinical,O
75847,5187,study,O
75848,5187,performed,O
75849,5187,with,O
75850,5187,cis,O
75851,5187,-,O
75852,5187,UCA,O
75853,5188,Any,O
75854,5188,clinically,O
75855,5188,significant,O
75856,5188,laboratory,B-Procedure
75857,5188,test,I-Procedure
75858,5188,result,O
75859,5189,Suspected,B-Observation
75860,5189,current,O
75861,5189,drug,B-Condition
75862,5189,or,I-Condition
75863,5189,alcohol,I-Condition
75864,5189,abuse,I-Condition
75865,5190,Clinically,O
75866,5190,significant,O
75867,5190,illness,B-Condition
75868,5190,during,O
75869,5190,the,O
75870,5190,4,O
75871,5190,weeks,O
75872,5190,prior,O
75873,5190,to,O
75874,5190,the,O
75875,5190,first,O
75876,5190,dose,O
75877,5190,administration,O
75878,5191,Any,O
75879,5191,other,O
75880,5191,condition,O
75881,5191,that,O
75882,5191,in,O
75883,5191,the,O
75884,5191,opinion,O
75885,5191,of,O
75886,5191,the,O
75887,5191,Investigator,O
75888,5191,would,O
75889,5191,interfere,O
75890,5191,with,O
75891,5191,the,O
75892,5191,evaluation,O
75893,5191,of,O
75894,5191,the,O
75895,5191,study,O
75896,5191,results,O
75897,5191,or,O
75898,5191,constitute,O
75899,5191,a,O
75900,5191,health,O
75901,5191,hazard,O
75902,5191,for,O
75903,5191,the,O
75904,5191,patient,O
75905,5192,Unwillingness,O
75906,5192,or,O
75907,5192,doubtful,O
75908,5192,capacity,O
75909,5192,to,O
75910,5192,comply,O
75911,5192,with,O
75912,5192,the,O
75913,5192,protocol,O
75914,5193,Doubtful,O
75915,5193,availability,O
75916,5193,to,O
75917,5193,complete,O
75918,5193,the,O
75919,5193,study,O
75920,5194,Informed,O
75921,5194,consent,O
75922,5194,obtained,O
75923,5194,prior,O
75924,5194,to,O
75925,5194,any,O
75926,5194,screening,O
75927,5194,procedure,O
75928,5195,Caucasian,B-Person
75929,5195,male,B-Person
75930,5195,or,O
75931,5195,female,B-Person
75932,5195,patient,O
75933,5196,At,O
75934,5196,least,O
75935,5196,18,O
75936,5196,years,O
75937,5196,of,O
75938,5196,age,B-Person
75939,5197,Weight,O
75940,5197,at,O
75941,5197,least,O
75942,5197,45,O
75943,5197,kg,O
75944,5198,Patient,O
75945,5198,with,O
75946,5198,moderate,O
75947,5198,or,O
75948,5198,severe,O
75949,5198,chronic,B-Condition
75950,5198,atopic,I-Condition
75951,5198,dermatitis,I-Condition
75952,5199,Good,B-Condition
75953,5199,general,I-Condition
75954,5199,health,I-Condition
75955,5199,ascertained,O
75956,5199,by,O
75957,5199,medical,B-Observation
75958,5199,history,I-Observation
75959,5199,",",O
75960,5199,physical,B-Procedure
75961,5199,examination,I-Procedure
75962,5199,and,O
75963,5199,laboratory,B-Procedure
75964,5199,determinations,I-Procedure
75965,5199,",",O
75966,5199,showing,O
75967,5199,no,O
75968,5199,signs,B-Observation
75969,5199,of,I-Observation
75970,5199,clinically,I-Observation
75971,5199,significant,I-Observation
75972,5199,findings,I-Observation
75973,5199,",",O
75974,5199,except,O
75975,5199,chronic,B-Condition
75976,5199,atopic,I-Condition
75977,5199,dermatitis,I-Condition
75978,5200,Negative,O
75979,5200,pregnancy,O
75980,5200,test,O
75981,5200,(,O
75982,5200,premenopausal,B-Condition
75983,5200,female,B-Person
75984,5200,patient,O
75985,5200,),O
75986,5200,at,O
75987,5200,screening,O
75988,5200,and,O
75989,5200,use,O
75990,5200,of,O
75991,5200,adequate,O
75992,5200,contraceptive,O
75993,5200,measures,O
75994,5200,(,O
75995,5200,both,O
75996,5200,male,O
75997,5200,and,O
75998,5200,female,O
75999,5200,patients,O
76000,5200,),O
76001,5200,throughout,O
76002,5200,the,O
76003,5200,study,O
76004,5200,and,O
76005,5200,30,O
76006,5200,days,O
76007,5200,after,O
76008,5200,the,O
76009,5200,last,O
76010,5200,cis,O
76011,5200,-,O
76012,5200,UCA,O
76013,5200,dose,O
76014,5201,NA,O
76015,5202,Patient,B-Person
76016,5202,age,I-Person
76017,5202,>,O
76018,5202,=,O
76019,5202,18,O
76020,5202,years,O
76021,5203,Zubrod,O
76022,5203,performance,O
76023,5203,status,O
76024,5203,of,O
76025,5203,0,O
76026,5203,-,O
76027,5203,3,O
76028,5204,T1,O
76029,5204,-,O
76030,5204,3,O
76031,5204,N0,O
76032,5204,M0,O
76033,5204,adenocarcinoma,B-Condition
76034,5204,of,O
76035,5204,the,O
76036,5204,prostate,O
76037,5205,Prostate,O
76038,5205,volume,O
76039,5205,=,O
76040,5205,100,O
76041,5205,cc,O
76042,5206,Signed,O
76043,5206,study,O
76044,5206,-,O
76045,5206,specific,O
76046,5206,consent,O
76047,5206,form,O
76048,5207,Extension,B-Condition
76049,5207,of,I-Condition
76050,5207,local,I-Condition
76051,5207,tumor,I-Condition
76052,5207,to,O
76053,5207,involve,O
76054,5207,adjacent,O
76055,5207,organs,O
76056,5207,other,O
76057,5207,than,O
76058,5207,seminal,O
76059,5207,vesicles,O
76060,5207,(,O
76061,5207,T4,O
76062,5207,),O
76063,5208,Prostate,O
76064,5208,volume,O
76065,5208,>,O
76066,5208,100,O
76067,5208,cc,O
76068,5209,Nodal,B-Condition
76069,5209,involvement,I-Condition
76070,5210,Metastatic,B-Condition
76071,5210,disease,I-Condition
76072,5211,Prior,O
76073,5211,pelvic,O
76074,5211,radiotherapy,B-Procedure
76075,5211,except,O
76076,5211,as,O
76077,5211,part,O
76078,5211,of,O
76079,5211,combination,B-Procedure
76080,5211,therapy,I-Procedure
76081,5211,for,O
76082,5211,prostate,B-Condition
76083,5211,cancer,I-Condition
76084,5212,History,B-Observation
76085,5212,of,O
76086,5212,scleroderma,B-Condition
76087,5213,Patients,O
76088,5213,with,O
76089,5213,psychiatric,B-Condition
76090,5213,or,I-Condition
76091,5213,addictive,I-Condition
76092,5213,disorder,I-Condition
76093,5213,that,O
76094,5213,would,O
76095,5213,preclude,O
76096,5213,obtaining,O
76097,5213,informed,O
76098,5213,consent,O
76099,5214,Any,O
76100,5214,patient,O
76101,5214,with,O
76102,5214,esophageal,B-Condition
76103,5214,cancer,I-Condition
76104,5214,who,O
76105,5214,is,O
76106,5214,not,O
76107,5214,deemed,O
76108,5214,a,O
76109,5214,surgical,B-Procedure
76110,5214,candidate,B-Observation
76111,5214,or,O
76112,5214,who,O
76113,5214,is,O
76114,5214,not,O
76115,5214,deemed,O
76116,5214,a,O
76117,5214,candidate,B-Observation
76118,5214,for,O
76119,5214,the,O
76120,5214,Ivor,O
76121,5214,Lewis,O
76122,5214,technique,O
76123,5214,of,O
76124,5214,esophagectomy,B-Procedure
76125,5214,(,O
76126,5214,with,O
76127,5214,intrathoracic,B-Condition
76128,5214,anastomosis,I-Condition
76129,5214,),O
76130,5214,.,O
76131,5215,Any,O
76132,5215,patient,O
76133,5215,less,O
76134,5215,than,O
76135,5215,18,O
76136,5215,years,O
76137,5215,of,O
76138,5215,age,B-Person
76139,5216,All,O
76140,5216,patients,O
76141,5216,with,O
76142,5216,esophageal,B-Condition
76143,5216,cancer,I-Condition
76144,5216,who,O
76145,5216,are,O
76146,5216,deemed,O
76147,5216,candidates,B-Observation
76148,5216,for,O
76149,5216,minimally,O
76150,5216,invasive,O
76151,5216,robot,O
76152,5216,assisted,O
76153,5216,Ivor,O
76154,5216,Lewis,O
76155,5216,esophagogastrectomy,B-Procedure
76156,5216,.,O
76157,5217,Patients,O
76158,5217,who,O
76159,5217,provide,O
76160,5217,written,O
76161,5217,informed,O
76162,5217,consent,O
76163,5217,for,O
76164,5217,the,O
76165,5217,study,O
76166,5217,.,O
76167,5218,Inability,O
76168,5218,to,O
76169,5218,provide,O
76170,5218,informed,O
76171,5218,consent,O
76172,5218,or,O
76173,5218,to,O
76174,5218,comply,O
76175,5218,with,O
76176,5218,study,O
76177,5218,assessments,O
76178,5218,(,O
76179,5218,e.g.,O
76180,5218,due,O
76181,5218,to,O
76182,5218,cognitive,O
76183,5218,impairment,O
76184,5218,or,O
76185,5218,geographic,O
76186,5218,distance,O
76187,5218,),O
76188,5218,.,O
76189,5219,Age,B-Person
76190,5219,=,O
76191,5219,17,O
76192,5219,.,O
76193,5220,Allergy,B-Condition
76194,5220,to,O
76195,5220,povidone,B-Drug
76196,5220,iodine,I-Drug
76197,5220,.,O
76198,5221,Any,O
76199,5221,condition,O
76200,5221,requiring,O
76201,5221,antibiotics,B-Procedure
76202,5221,14,O
76203,5221,days,O
76204,5221,prior,O
76205,5221,to,O
76206,5221,arriving,O
76207,5221,for,O
76208,5221,surgery,B-Procedure
76209,5221,.,O
76210,5222,Patients,O
76211,5222,with,O
76212,5222,chronic,O
76213,5222,immunosuppression,B-Condition
76214,5222,(,O
76215,5222,such,O
76216,5222,as,O
76217,5222,HIV,B-Condition
76218,5222,/,I-Condition
76219,5222,AIDS,I-Condition
76220,5222,),O
76221,5222,.,O
76222,5223,Unable,O
76223,5223,to,O
76224,5223,adhere,O
76225,5223,to,O
76226,5223,follow,O
76227,5223,up,O
76228,5223,schedule,O
76229,5223,and,O
76230,5223,treatment,O
76231,5223,.,O
76232,5224,Patients,O
76233,5224,scheduled,O
76234,5224,to,O
76235,5224,undergo,O
76236,5224,revision,B-Procedure
76237,5224,total,I-Procedure
76238,5224,knee,I-Procedure
76239,5224,arthroplasty,I-Procedure
76240,5224,for,O
76241,5224,infectious,B-Condition
76242,5224,reasons,I-Condition
76243,5224,.,O
76244,5225,Scheduled,O
76245,5225,to,O
76246,5225,undergo,O
76247,5225,revision,B-Procedure
76248,5225,total,I-Procedure
76249,5225,knee,I-Procedure
76250,5225,arthroplasty,I-Procedure
76251,5226,dysphagia,B-Condition
76252,5227,severe,O
76253,5227,gastroparesis,B-Condition
76254,5227,requiring,B-Mood
76255,5227,endoscopic,B-Procedure
76256,5227,placement,I-Procedure
76257,5227,of,O
76258,5227,capsule,O
76259,5228,small,B-Condition
76260,5228,bowel,I-Condition
76261,5228,obstruction,I-Condition
76262,5229,pregnancy,B-Condition
76263,5230,Adult,B-Person
76264,5230,outpatients,O
76265,5230,(,O
76266,5230,18,O
76267,5230,years,O
76268,5230,or,O
76269,5230,older,O
76270,5230,),O
76271,5231,routinely,O
76272,5231,referred,O
76273,5231,for,O
76274,5231,small,B-Procedure
76275,5231,bowel,I-Procedure
76276,5231,video,I-Procedure
76277,5231,capsule,I-Procedure
76278,5231,endoscopy,I-Procedure
76279,5231,(,O
76280,5231,CE,O
76281,5231,),O
76282,5232,History,B-Observation
76283,5232,of,O
76284,5232,a,O
76285,5232,seizure,B-Condition
76286,5232,disorder,I-Condition
76287,5232,other,O
76288,5232,than,O
76289,5232,a,O
76290,5232,single,O
76291,5232,childhood,B-Condition
76292,5232,febrile,I-Condition
76293,5232,seizure,I-Condition
76294,5232,.,O
76295,5233,History,B-Observation
76296,5233,or,O
76297,5233,presence,O
76298,5233,of,O
76299,5233,clinically,B-Condition
76300,5233,important,I-Condition
76301,5233,hepatic,I-Condition
76302,5233,or,I-Condition
76303,5233,renal,I-Condition
76304,5233,disease,I-Condition
76305,5233,or,I-Condition
76306,5233,other,I-Condition
76307,5233,medical,I-Condition
76308,5233,disease,I-Condition
76309,5233,.,O
76310,5234,Presence,O
76311,5234,or,O
76312,5234,recent,O
76313,5234,history,B-Observation
76314,5234,of,O
76315,5234,major,B-Condition
76316,5234,depressive,I-Condition
76317,5234,disorder,I-Condition
76318,5234,",",O
76319,5234,bipolar,B-Condition
76320,5234,disorder,I-Condition
76321,5234,",",O
76322,5234,psychotic,B-Condition
76323,5234,disorder,I-Condition
76324,5234,",",O
76325,5234,or,O
76326,5234,generalized,B-Condition
76327,5234,anxiety,I-Condition
76328,5234,disorder,I-Condition
76329,5234,requiring,O
76330,5234,therapy,O
76331,5234,.,O
76332,5235,Generally,O
76333,5235,healthy,B-Condition
76334,5235,",",O
76335,5235,postmenopausal,B-Condition
76336,5235,woman,B-Person
76337,5235,who,O
76338,5235,seeks,O
76339,5235,treatment,O
76340,5235,for,O
76341,5235,hot,B-Condition
76342,5235,flushes,I-Condition
76343,5235,.,O
76344,5236,Meets,O
76345,5236,1,O
76346,5236,of,O
76347,5236,the,O
76348,5236,following,O
76349,5236,:,O
76350,5236,At,O
76351,5236,least,O
76352,5236,12,O
76353,5236,months,O
76354,5236,of,O
76355,5236,spontaneous,B-Condition
76356,5236,amenorrhea,I-Condition
76357,5236,;,O
76358,5236,At,O
76359,5236,least,O
76360,5236,6,O
76361,5236,months,O
76362,5236,of,O
76363,5236,spontaneous,B-Condition
76364,5236,amenorrhea,I-Condition
76365,5236,with,O
76366,5236,serum,O
76367,5236,follicle,O
76368,5236,-,O
76369,5236,stimulating,O
76370,5236,hormone,O
76371,5236,(,O
76372,5236,FSH,O
76373,5236,),O
76374,5236,levels,O
76375,5236,>,O
76376,5236,40,O
76377,5236,mIU,O
76378,5236,/,O
76379,5236,mL,O
76380,5236,;,O
76381,5236,At,O
76382,5236,least,O
76383,5236,6,O
76384,5236,weeks,O
76385,5236,postsurgical,O
76386,5236,bilateral,B-Procedure
76387,5236,oophorectomy,I-Procedure
76388,5236,(,I-Procedure
76389,5236,with,I-Procedure
76390,5236,or,I-Procedure
76391,5236,without,I-Procedure
76392,5236,hysterectomy,I-Procedure
76393,5236,),O
76394,5236,.,O
76395,5236,Hysterectomized,B-Condition
76396,5236,without,O
76397,5236,bilateral,B-Procedure
76398,5236,oophorectomy,I-Procedure
76399,5236,and,O
76400,5236,with,O
76401,5236,serum,O
76402,5236,FSH,O
76403,5236,levels,O
76404,5236,>,O
76405,5236,40,O
76406,5236,mIU,O
76407,5236,/,O
76408,5236,mL.,O
76409,5237,Pulseless,B-Condition
76410,5237,extremity,I-Condition
76411,5238,Compromised,B-Condition
76412,5238,neurologic,I-Condition
76413,5238,status,I-Condition
76414,5238,on,O
76415,5238,exam,O
76416,5238,(,O
76417,5238,specifically,O
76418,5238,assessment,O
76419,5238,of,O
76420,5238,radial,O
76421,5238,",",O
76422,5238,ulnar,O
76423,5238,",",O
76424,5238,and,O
76425,5238,median,O
76426,5238,nerve,O
76427,5238,),O
76428,5239,Known,O
76429,5239,allergy,B-Condition
76430,5239,to,O
76431,5239,local,B-Drug
76432,5239,anesthetics,I-Drug
76433,5239,(,O
76434,5239,7,O
76435,5239,),O
76436,5239,Not,O
76437,5239,scheduled,B-Mood
76438,5239,for,I-Mood
76439,5239,closed,B-Procedure
76440,5239,reduction,I-Procedure
76441,5239,with,I-Procedure
76442,5239,percutaneous,I-Procedure
76443,5239,pinning,I-Procedure
76444,5239,under,O
76445,5239,general,B-Procedure
76446,5239,anesthesia,I-Procedure
76447,5240,Bleeding,B-Condition
76448,5240,diathesis,I-Condition
76449,5241,American,O
76450,5241,Society,O
76451,5241,of,O
76452,5241,Anesthesiologist,O
76453,5241,(,O
76454,5241,ASA,O
76455,5241,),O
76456,5241,status,O
76457,5241,4,O
76458,5241,or,O
76459,5241,higher,O
76460,5241,.,O
76461,5242,Sleep,B-Condition
76462,5242,apnea,I-Condition
76463,5242,by,O
76464,5242,polysomnography,B-Procedure
76465,5243,Supracondylar,B-Condition
76466,5243,fracture,I-Condition
76467,5244,Age,B-Person
76468,5244,2,O
76469,5244,-,O
76470,5244,17,O
76471,5244,years,O
76472,5245,American,O
76473,5245,Society,O
76474,5245,of,O
76475,5245,Anesthesiologists,O
76476,5245,Status,O
76477,5245,1,O
76478,5245,-3,O
76479,5246,Scheduled,B-Mood
76480,5246,for,I-Mood
76481,5246,closed,B-Procedure
76482,5246,reduction,I-Procedure
76483,5246,with,I-Procedure
76484,5246,percutaneous,I-Procedure
76485,5246,pinning,I-Procedure
76486,5246,under,O
76487,5246,general,B-Procedure
76488,5246,anesthesia,I-Procedure
76489,5247,1,O
76490,5247,.,O
76491,5247,The,O
76492,5247,subject,O
76493,5247,is,O
76494,5247,a,O
76495,5247,pregnant,B-Condition
76496,5247,or,O
76497,5247,lactating,B-Condition
76498,5247,female,B-Person
76499,5247,.,O
76500,5248,2,O
76501,5248,.,O
76502,5248,The,O
76503,5248,subject,O
76504,5248,has,O
76505,5248,pre,O
76506,5248,-,O
76507,5248,existing,O
76508,5248,sustained,O
76509,5248,supine,B-Condition
76510,5248,hypertension,I-Condition
76511,5248,greater,O
76512,5248,than,O
76513,5248,180mmHg,O
76514,5248,systolic,O
76515,5248,and,O
76516,5248,110mmHg,O
76517,5248,diastolic,O
76518,5248,BP,O
76519,5248,or,O
76520,5248,had,O
76521,5248,these,O
76522,5248,measurements,O
76523,5248,at,O
76524,5248,the,O
76525,5248,Screening,O
76526,5248,Visit,O
76527,5248,.,O
76528,5248,Sustained,O
76529,5248,is,O
76530,5248,defined,O
76531,5248,as,O
76532,5248,persistently,O
76533,5248,greater,O
76534,5248,at,O
76535,5248,2,O
76536,5248,separate,O
76537,5248,measurements,O
76538,5248,at,O
76539,5248,least,O
76540,5248,5,O
76541,5248,minutes,O
76542,5248,apart,O
76543,5248,with,O
76544,5248,the,O
76545,5248,subject,O
76546,5248,supine,O
76547,5248,and,O
76548,5248,at,O
76549,5248,rest,O
76550,5248,for,O
76551,5248,the,O
76552,5248,5,O
76553,5248,minutes,O
76554,5248,.,O
76555,5249,3,O
76556,5249,.,O
76557,5249,Subjects,O
76558,5249,taking,O
76559,5249,concomitant,O
76560,5249,medications,B-Drug
76561,5249,of,I-Drug
76562,5249,interest,I-Drug
76563,5249,are,O
76564,5249,excluded,O
76565,5249,unless,O
76566,5249,those,O
76567,5249,medications,O
76568,5249,are,O
76569,5249,reviewed,O
76570,5249,and,O
76571,5249,discussed,O
76572,5249,with,O
76573,5249,the,O
76574,5249,Medical,O
76575,5249,Monitor,O
76576,5249,or,O
76577,5249,Study,O
76578,5249,Physician,O
76579,5249,and,O
76580,5249,documented,O
76581,5249,prior,O
76582,5249,to,O
76583,5249,enrolling,O
76584,5249,the,O
76585,5249,subject,O
76586,5249,.,O
76587,5249,If,O
76588,5249,agreement,O
76589,5249,is,O
76590,5249,reached,O
76591,5249,between,O
76592,5249,the,O
76593,5249,Investigator,O
76594,5249,and,O
76595,5249,Sponsor,O
76596,5249,for,O
76597,5249,the,O
76598,5249,subject,O
76599,5249,to,O
76600,5249,continue,O
76601,5249,in,O
76602,5249,the,O
76603,5249,study,O
76604,5249,",",O
76605,5249,all,O
76606,5249,allowed,O
76607,5249,medications,O
76608,5249,should,O
76609,5249,be,O
76610,5249,maintained,O
76611,5249,at,O
76612,5249,a,O
76613,5249,constant,O
76614,5249,dose,O
76615,5249,throughout,O
76616,5249,the,O
76617,5249,study,O
76618,5249,.,O
76619,5250,4,O
76620,5250,.,O
76621,5250,The,O
76622,5250,Principal,O
76623,5250,Investigator,O
76624,5250,deems,O
76625,5250,any,O
76626,5250,clinical,O
76627,5250,laboratory,O
76628,5250,test,O
76629,5250,(,O
76630,5250,at,O
76631,5250,the,O
76632,5250,Screening,O
76633,5250,Visit,O
76634,5250,),O
76635,5250,abnormality,O
76636,5250,to,O
76637,5250,be,O
76638,5250,clinically,O
76639,5250,significant,O
76640,5251,5,O
76641,5251,.,O
76642,5251,The,O
76643,5251,subject,O
76644,5251,has,O
76645,5251,participated,O
76646,5251,in,O
76647,5251,other,O
76648,5251,studies,O
76649,5251,of,O
76650,5251,investigational,O
76651,5251,drugs,O
76652,5251,or,O
76653,5251,devices,O
76654,5251,within,O
76655,5251,30,O
76656,5251,days,O
76657,5251,prior,O
76658,5251,to,O
76659,5251,enrollment,O
76660,5251,in,O
76661,5251,this,O
76662,5251,study,O
76663,5251,(,O
76664,5251,other,O
76665,5251,than,O
76666,5251,Study,O
76667,5251,SPD426,O
76668,5251,-,O
76669,5251,406,O
76670,5251,),O
76671,5251,.,O
76672,5252,6,O
76673,5252,.,O
76674,5252,Current,O
76675,5252,or,O
76676,5252,relevant,O
76677,5252,history,O
76678,5252,of,O
76679,5252,physical,O
76680,5252,or,O
76681,5252,psychiatric,O
76682,5252,illness,O
76683,5252,",",O
76684,5252,any,O
76685,5252,medical,O
76686,5252,disorder,O
76687,5252,that,O
76688,5252,may,O
76689,5252,require,O
76690,5252,treatment,O
76691,5252,or,O
76692,5252,make,O
76693,5252,the,O
76694,5252,subject,O
76695,5252,unlikely,O
76696,5252,to,O
76697,5252,fully,O
76698,5252,comply,O
76699,5252,with,O
76700,5252,the,O
76701,5252,requirements,O
76702,5252,of,O
76703,5252,the,O
76704,5252,study,O
76705,5252,or,O
76706,5252,complete,O
76707,5252,the,O
76708,5252,study,O
76709,5252,",",O
76710,5252,or,O
76711,5252,any,O
76712,5252,condition,O
76713,5252,that,O
76714,5252,presents,O
76715,5252,undue,O
76716,5252,risk,O
76717,5252,from,O
76718,5252,the,O
76719,5252,investigational,O
76720,5252,product,O
76721,5252,or,O
76722,5252,study,O
76723,5252,procedures,O
76724,5252,.,O
76725,5253,7,O
76726,5253,.,O
76727,5253,The,O
76728,5253,subject,O
76729,5253,has,O
76730,5253,a,O
76731,5253,concurrent,O
76732,5253,chronic,B-Condition
76733,5253,or,I-Condition
76734,5253,acute,I-Condition
76735,5253,illness,I-Condition
76736,5253,",",O
76737,5253,disability,B-Condition
76738,5253,",",O
76739,5253,or,O
76740,5253,other,B-Condition
76741,5253,condition,I-Condition
76742,5253,(,O
76743,5253,including,O
76744,5253,significant,O
76745,5253,unexpected,O
76746,5253,laboratory,B-Condition
76747,5253,or,I-Condition
76748,5253,electrocardiogram,I-Condition
76749,5253,[,I-Condition
76750,5253,ECG,I-Condition
76751,5253,],I-Condition
76752,5253,findings,I-Condition
76753,5253,),O
76754,5253,that,O
76755,5253,might,O
76756,5253,confound,O
76757,5253,the,O
76758,5253,results,O
76759,5253,of,O
76760,5253,the,O
76761,5253,tests,O
76762,5253,and/or,O
76763,5253,measurements,O
76764,5253,administered,O
76765,5253,in,O
76766,5253,this,O
76767,5253,study,O
76768,5253,",",O
76769,5253,or,O
76770,5253,that,O
76771,5253,might,O
76772,5253,have,O
76773,5253,increased,O
76774,5253,the,O
76775,5253,risk,O
76776,5253,to,O
76777,5253,the,O
76778,5253,subject,O
76779,5253,.,O
76780,5254,8,O
76781,5254,.,O
76782,5254,Known,O
76783,5254,or,O
76784,5254,suspected,O
76785,5254,intolerance,O
76786,5254,or,O
76787,5254,hypersensitivity,O
76788,5254,to,O
76789,5254,the,O
76790,5254,investigational,O
76791,5254,product(s,O
76792,5254,),O
76793,5254,",",O
76794,5254,closely,O
76795,5254,-,O
76796,5254,related,O
76797,5254,compounds,O
76798,5254,",",O
76799,5254,or,O
76800,5254,any,O
76801,5254,of,O
76802,5254,the,O
76803,5254,stated,O
76804,5254,ingredients,O
76805,5254,.,O
76806,5255,9,O
76807,5255,.,O
76808,5255,Prior,O
76809,5255,enrollment,B-Condition
76810,5255,failure,I-Condition
76811,5255,or,O
76812,5255,randomization,O
76813,5255,in,O
76814,5255,this,O
76815,5255,study,O
76816,5255,.,O
76817,5256,10,O
76818,5256,.,O
76819,5256,History,O
76820,5256,of,O
76821,5256,alcohol,B-Condition
76822,5256,abuse,I-Condition
76823,5256,or,O
76824,5256,other,O
76825,5256,substance,B-Condition
76826,5256,abuse,I-Condition
76827,5256,within,O
76828,5256,the,O
76829,5256,last,O
76830,5256,year,O
76831,5256,.,O
76832,5257,1,O
76833,5257,.,O
76834,5257,Male,B-Person
76835,5257,and,O
76836,5257,female,B-Person
76837,5257,subjects,O
76838,5257,must,O
76839,5257,be,O
76840,5257,18,O
76841,5257,years,O
76842,5257,of,O
76843,5257,age,B-Person
76844,5257,or,O
76845,5257,older,O
76846,5257,and,O
76847,5257,ambulatory,O
76848,5257,.,O
76849,5258,2,O
76850,5258,.,O
76851,5258,Females,B-Person
76852,5258,of,O
76853,5258,child,B-Condition
76854,5258,-,I-Condition
76855,5258,bearing,I-Condition
76856,5258,potential,I-Condition
76857,5258,(,O
76858,5258,FOCP,O
76859,5258,),O
76860,5258,must,O
76861,5258,have,O
76862,5258,a,O
76863,5258,negative,O
76864,5258,serum,O
76865,5258,beta,O
76866,5258,human,O
76867,5258,chorionic,O
76868,5258,gonadotropin,O
76869,5258,(,O
76870,5258,HCG,O
76871,5258,),O
76872,5258,pregnancy,O
76873,5258,test,O
76874,5258,.,O
76875,5259,3,O
76876,5259,.,O
76877,5259,A,O
76878,5259,documented,O
76879,5259,history,O
76880,5259,of,O
76881,5259,severe,O
76882,5259,Symptomatic,B-Condition
76883,5259,Orthostatic,I-Condition
76884,5259,Hypotension,I-Condition
76885,5259,(,I-Condition
76886,5259,SOH,I-Condition
76887,5259,),I-Condition
76888,5259,that,O
76889,5259,",",O
76890,5259,in,O
76891,5259,the,O
76892,5259,judgment,O
76893,5259,of,O
76894,5259,the,O
76895,5259,treating,O
76896,5259,physician,O
76897,5259,",",O
76898,5259,has,O
76899,5259,required,O
76900,5259,treatment,O
76901,5259,with,O
76902,5259,midodrine,B-Drug
76903,5259,HCl,I-Drug
76904,5259,",",O
76905,5259,and,O
76906,5259,has,O
76907,5259,been,O
76908,5259,at,O
76909,5259,a,O
76910,5259,stable,O
76911,5259,dose,O
76912,5259,for,O
76913,5259,at,O
76914,5259,least,O
76915,5259,3,O
76916,5259,months,O
76917,5259,.,O
76918,5260,4,O
76919,5260,.,O
76920,5260,The,O
76921,5260,subject,O
76922,5260,has,O
76923,5260,manifested,O
76924,5260,at,O
76925,5260,least,O
76926,5260,1,O
76927,5260,of,O
76928,5260,the,O
76929,5260,following,O
76930,5260,symptoms,O
76931,5260,while,O
76932,5260,standing,O
76933,5260,or,O
76934,5260,had,O
76935,5260,a,O
76936,5260,medical,O
76937,5260,history,O
76938,5260,of,O
76939,5260,1,O
76940,5260,of,O
76941,5260,the,O
76942,5260,following,O
76943,5260,when,O
76944,5260,not,O
76945,5260,treated,B-Procedure
76946,5260,for,O
76947,5260,orthostatic,B-Condition
76948,5260,hypotension,I-Condition
76949,5260,(,I-Condition
76950,5260,OH,I-Condition
76951,5260,):,I-Condition
76952,5260,dizziness,B-Condition
76953,5260,",",O
76954,5260,lightheadedness,B-Condition
76955,5260,",",O
76956,5260,feeling,B-Condition
76957,5260,faint,I-Condition
76958,5260,",",O
76959,5260,or,O
76960,5260,feeling,B-Condition
76961,5260,like,I-Condition
76962,5260,they,I-Condition
76963,5260,might,I-Condition
76964,5260,black,I-Condition
76965,5260,out,I-Condition
76966,5260,.,O
76967,5261,Severe,O
76968,5261,intercurrent,O
76969,5261,infection,B-Condition
76970,5262,Known,O
76971,5262,HIV,B-Condition
76972,5262,positivity,I-Condition
76973,5263,Pregnant,B-Condition
76974,5263,or,O
76975,5263,lactating,B-Condition
76976,5264,History,O
76977,5264,of,O
76978,5264,hypersensitivity,B-Condition
76979,5264,reactions,I-Condition
76980,5264,to,O
76981,5264,murine,B-Drug
76982,5264,protein,I-Drug
76983,5264,-,I-Drug
76984,5264,containing,I-Drug
76985,5264,products,I-Drug
76986,5264,.,O
76987,5265,Histopathological,B-Observation
76988,5265,verification,I-Observation
76989,5265,of,O
76990,5265,glioblastoma,B-Condition
76991,5265,multiforme,I-Condition
76992,5265,(,O
76993,5265,GBM,B-Condition
76994,5265,:,O
76995,5265,WHO,O
76996,5265,grade,O
76997,5265,IV,O
76998,5265,),O
76999,5265,in,O
77000,5265,remission,O
77001,5265,(,O
77002,5265,Group,O
77003,5265,A,O
77004,5265,),O
77005,5265,or,O
77006,5265,with,O
77007,5265,active,O
77008,5265,disease,O
77009,5265,(,O
77010,5265,Group,O
77011,5265,B,O
77012,5265,),O
77013,5265,.,O
77014,5266,CMV,B-Condition
77015,5266,-,O
77016,5266,positive,O
77017,5266,GBM,B-Condition
77018,5267,CMV,B-Condition
77019,5267,seropositive,I-Condition
77020,5268,Life,B-Observation
77021,5268,expectancy,I-Observation
77022,5268,6,O
77023,5268,weeks,O
77024,5268,or,O
77025,5268,greater,O
77026,5269,Karnofsky,O
77027,5269,/,O
77028,5269,Lansky,O
77029,5269,score,O
77030,5269,50,O
77031,5269,or,O
77032,5269,greater,O
77033,5270,Patient,O
77034,5270,or,O
77035,5270,parent,O
77036,5270,/,O
77037,5270,guardian,O
77038,5270,capable,O
77039,5270,of,O
77040,5270,providing,O
77041,5270,informed,O
77042,5270,consent,O
77043,5271,Bilirubin,O
77044,5271,less,O
77045,5271,than,O
77046,5271,1.5x,O
77047,5271,upper,O
77048,5271,limit,O
77049,5271,of,O
77050,5271,normal,O
77051,5271,",",O
77052,5271,AST,O
77053,5271,less,O
77054,5271,than,O
77055,5271,3x,O
77056,5271,upper,O
77057,5271,limit,O
77058,5271,of,O
77059,5271,normal,O
77060,5271,",",O
77061,5271,serum,O
77062,5271,creatinine,O
77063,5271,less,O
77064,5271,than,O
77065,5271,1.5x,O
77066,5271,normal,O
77067,5271,and,O
77068,5271,Hgb,O
77069,5271,8.0,O
77070,5271,g,O
77071,5271,/,O
77072,5271,dL,O
77073,5271,or,O
77074,5271,greater,O
77075,5272,Pulse,O
77076,5272,oximetry,O
77077,5272,of,O
77078,5272,90,O
77079,5272,%,O
77080,5272,or,O
77081,5272,greater,O
77082,5272,on,O
77083,5272,room,O
77084,5272,air,O
77085,5273,Sexually,O
77086,5273,active,O
77087,5273,patients,O
77088,5273,must,O
77089,5273,be,O
77090,5273,willing,O
77091,5273,to,O
77092,5273,utilize,O
77093,5273,one,O
77094,5273,of,O
77095,5273,the,O
77096,5273,more,O
77097,5273,effective,O
77098,5273,birth,O
77099,5273,control,O
77100,5273,methods,O
77101,5273,for,O
77102,5273,6,O
77103,5273,months,O
77104,5273,after,O
77105,5273,the,O
77106,5273,CTL,O
77107,5273,infusion,O
77108,5273,.,O
77109,5273,The,O
77110,5273,male,O
77111,5273,partner,O
77112,5273,should,O
77113,5273,use,O
77114,5273,a,O
77115,5273,condom,O
77116,5273,.,O
77117,5274,Patients,O
77118,5274,should,O
77119,5274,have,O
77120,5274,been,O
77121,5274,off,O
77122,5274,other,O
77123,5274,investigational,O
77124,5274,antineoplastic,B-Procedure
77125,5274,therapy,I-Procedure
77126,5274,for,O
77127,5274,one,O
77128,5274,month,O
77129,5274,prior,O
77130,5274,to,O
77131,5274,entry,O
77132,5274,in,O
77133,5274,this,O
77134,5274,study,O
77135,5274,.,O
77136,5275,Informed,O
77137,5275,consent,O
77138,5275,explained,O
77139,5275,to,O
77140,5275,",",O
77141,5275,understood,O
77142,5275,by,O
77143,5275,and,O
77144,5275,signed,O
77145,5275,by,O
77146,5275,patient,O
77147,5275,/,O
77148,5275,guardian,O
77149,5275,.,O
77150,5275,Patient,O
77151,5275,/,O
77152,5275,guardian,O
77153,5275,given,O
77154,5275,copy,O
77155,5275,of,O
77156,5275,informed,O
77157,5275,consent,O
77158,5275,.,O
77159,5276,Pregnancy,B-Condition
77160,5276,at,O
77161,5276,enrollment,O
77162,5276,.,O
77163,5277,Any,O
77164,5277,condition,O
77165,5277,",",O
77166,5277,which,O
77167,5277,in,O
77168,5277,the,O
77169,5277,opinion,O
77170,5277,of,O
77171,5277,the,O
77172,5277,provider,O
77173,5277,",",O
77174,5277,will,O
77175,5277,seriously,O
77176,5277,compromise,O
77177,5277,the,O
77178,5277,participant,O
77179,5277,'s,O
77180,5277,ability,O
77181,5277,to,O
77182,5277,comply,O
77183,5277,with,O
77184,5277,the,O
77185,5277,protocol,O
77186,5277,",",O
77187,5277,including,O
77188,5277,adherence,O
77189,5277,to,O
77190,5277,PrEP,O
77191,5277,medication,O
77192,5277,dosing,O
77193,5277,",",O
77194,5277,such,O
77195,5277,as,O
77196,5277,active,O
77197,5277,",",O
77198,5277,untreated,O
77199,5277,or,O
77200,5277,unstable,O
77201,5277,major,O
77202,5277,mental,O
77203,5277,illness,O
77204,5277,(,O
77205,5277,i.e.,O
77206,5277,untreated,O
77207,5277,psychotic,O
77208,5277,disorder,O
77209,5277,),O
77210,5277,.,O
77211,5278,Use,O
77212,5278,of,O
77213,5278,prohibited,O
77214,5278,medications,O
77215,5278,",",O
77216,5278,in,O
77217,5278,particular,O
77218,5278,",",O
77219,5278,agents,B-Procedure
77220,5278,known,O
77221,5278,to,O
77222,5278,be,O
77223,5278,nephrotoxic,O
77224,5278,or,O
77225,5278,drugs,B-Procedure
77226,5278,slow,O
77227,5278,in,O
77228,5278,renal,O
77229,5278,excretion,O
77230,5278,.,O
77231,5279,Previous,O
77232,5279,participation,B-Person
77233,5279,in,O
77234,5279,an,O
77235,5279,HIV,B-Observation
77236,5279,vaccine,I-Observation
77237,5279,trial,I-Observation
77238,5279,.,O
77239,5279,Participants,B-Person
77240,5279,that,O
77241,5279,were,O
77242,5279,documented,O
77243,5279,to,O
77244,5279,have,O
77245,5279,received,O
77246,5279,only,O
77247,5279,placebo,B-Procedure
77248,5279,are,O
77249,5279,not,B-Mood
77250,5279,excluded,O
77251,5279,.,O
77252,5280,Signs,B-Condition
77253,5280,or,O
77254,5280,symptoms,B-Condition
77255,5280,suspicious,O
77256,5280,for,O
77257,5280,Primary,B-Condition
77258,5280,HIV,I-Condition
77259,5280,Infection,I-Condition
77260,5280,(,O
77261,5280,PHI,B-Condition
77262,5280,),O
77263,5280,.,O
77264,5281,Female,B-Person
77265,5281,at,O
77266,5281,birth,O
77267,5281,and,O
77268,5281,identifies,O
77269,5281,as,O
77270,5281,female,O
77271,5281,gender,B-Person
77272,5282,Age,B-Person
77273,5282,18,O
77274,5282,years,O
77275,5282,or,O
77276,5282,older,O
77277,5283,Able,O
77278,5283,to,O
77279,5283,understand,O
77280,5283,and,O
77281,5283,provide,O
77282,5283,consent,O
77283,5283,in,O
77284,5283,English,O
77285,5283,or,O
77286,5283,Spanish,O
77287,5284,HIV,O
77288,5284,negative,O
77289,5284,by,O
77290,5284,4th,O
77291,5284,generation,O
77292,5284,test,O
77293,5284,(,O
77294,5284,Ag,O
77295,5284,/,O
77296,5284,Ab,O
77297,5284,test,O
77298,5284,),O
77299,5284,or,O
77300,5284,combination,O
77301,5284,of,O
77302,5284,enzymeimmunoassay,O
77303,5284,(,O
77304,5284,EIA,O
77305,5284,),O
77306,5284,and,O
77307,5284,HIV,O
77308,5284,RNA,O
77309,5285,Creatinine,O
77310,5285,clearance,O
77311,5285,=,O
77312,5285,60,O
77313,5285,ml,O
77314,5285,/,O
77315,5285,min,O
77316,5285,(,O
77317,5285,via,O
77318,5285,Cockcroft,O
77319,5285,-,O
77320,5285,Gault,O
77321,5285,formula,O
77322,5285,),O
77323,5286,Condomless,B-Observation
77324,5286,sex,I-Observation
77325,5286,in,O
77326,5286,the,O
77327,5286,last,O
77328,5286,3,O
77329,5286,months,O
77330,5286,with,O
77331,5286,one,O
77332,5286,or,O
77333,5286,more,O
77334,5286,male,B-Person
77335,5286,partners,I-Person
77336,5286,of,O
77337,5286,unknown,B-Condition
77338,5286,HIV,I-Condition
77339,5286,status,I-Condition
77340,5286,known,O
77341,5286,to,O
77342,5286,be,O
77343,5286,at,O
77344,5286,substantial,B-Observation
77345,5286,risk,I-Observation
77346,5286,of,I-Observation
77347,5286,HIV,I-Observation
77348,5286,infection,I-Observation
77349,5286,(,O
77350,5286,IDU,B-Observation
77351,5286,",",O
77352,5286,bisexual,B-Observation
77353,5286,",",O
77354,5286,sex,B-Observation
77355,5286,for,I-Observation
77356,5286,goods,I-Observation
77357,5286,",",O
77358,5286,recently,B-Observation
77359,5286,incarcerated,I-Observation
77360,5286,",",O
77361,5286,from,B-Observation
77362,5286,a,I-Observation
77363,5286,country,I-Observation
77364,5286,with,I-Observation
77365,5286,HIV,I-Observation
77366,5286,prevalence,I-Observation
77367,5286,>,I-Observation
77368,5286,1,I-Observation
77369,5286,%,I-Observation
77370,5286,",",O
77371,5286,interpersonal,B-Observation
77372,5286,Partner,I-Observation
77373,5286,Violence,I-Observation
77374,5286,),O
77375,5286,;,O
77376,5287,STI,B-Condition
77377,5287,(,O
77378,5287,rectal,B-Condition
77379,5287,or,I-Condition
77380,5287,vaginal,I-Condition
77381,5287,gonorrhea,I-Condition
77382,5287,or,O
77383,5287,syphilis,B-Condition
77384,5287,),O
77385,5287,diagnosis,O
77386,5287,during,O
77387,5287,the,O
77388,5287,last,O
77389,5287,6,O
77390,5287,months,O
77391,5287,.,O
77392,5288,Previous,O
77393,5288,post,B-Procedure
77394,5288,-,I-Procedure
77395,5288,exposure,I-Procedure
77396,5288,prophylaxis,I-Procedure
77397,5288,(,I-Procedure
77398,5288,PEP,I-Procedure
77399,5288,),I-Procedure
77400,5288,use,I-Procedure
77401,5288,during,O
77402,5288,the,O
77403,5288,last,O
77404,5288,12,O
77405,5288,months,O
77406,5288,.,O
77407,5289,Has,O
77408,5289,at,O
77409,5289,least,O
77410,5289,one,O
77411,5289,HIV,B-Condition
77412,5289,-,I-Condition
77413,5289,infected,I-Condition
77414,5289,sexual,B-Observation
77415,5289,partner,I-Observation
77416,5289,for,O
77417,5289,=,O
77418,5289,4,O
77419,5289,weeks,O
77420,5289,.,O
77421,5290,Sex,B-Observation
77422,5290,for,I-Observation
77423,5290,exchange,I-Observation
77424,5290,of,I-Observation
77425,5290,money,I-Observation
77426,5290,",",I-Observation
77427,5290,goods,I-Observation
77428,5290,or,I-Observation
77429,5290,services,I-Observation
77430,5291,pregnant,O
77431,5291,or,O
77432,5291,breastfeeding,O
77433,5291,woman,O
77434,5292,patient,O
77435,5292,with,O
77436,5292,a,O
77437,5292,measure,O
77438,5292,of,O
77439,5292,legal,O
77440,5292,protection,O
77441,5293,subject,O
77442,5293,unaffiliated,O
77443,5293,insurance,O
77444,5294,patient,O
77445,5294,18,O
77446,5294,years,O
77447,5294,old,B-Person
77448,5294,and,O
77449,5294,more,O
77450,5295,with,O
77451,5295,multiple,B-Condition
77452,5295,sclerosis,I-Condition
77453,5295,according,O
77454,5295,to,O
77455,5295,the,O
77456,5295,criteria,O
77457,5295,of,O
77458,5295,Mac,O
77459,5295,Donald,O
77460,5295,2010,O
77461,5295,:,O
77462,5295,relapsing,O
77463,5295,-,O
77464,5295,remitting,O
77465,5295,(,O
77466,5295,RR,O
77467,5295,),O
77468,5295,",",O
77469,5295,secondary,O
77470,5295,-,O
77471,5295,progressive,O
77472,5295,(,O
77473,5295,SP,O
77474,5295,),O
77475,5295,or,O
77476,5295,primary,O
77477,5295,-,O
77478,5295,progressive,O
77479,5295,(,O
77480,5295,PP,O
77481,5295,),O
77482,5296,for,O
77483,5296,which,O
77484,5296,treatment,O
77485,5296,with,O
77486,5296,dimethyl,B-Drug
77487,5296,-,I-Drug
77488,5296,fumarate,I-Drug
77489,5296,has,O
77490,5296,been,O
77491,5296,prescribed,O
77492,5297,followed,O
77493,5297,at,O
77494,5297,the,O
77495,5297,Rothschild,O
77496,5297,Foundation,O
77497,5297,in,O
77498,5297,the,O
77499,5297,Neurology,O
77500,5297,Department,O
77501,5298,having,O
77502,5298,given,O
77503,5298,written,O
77504,5298,consent,O
77505,5298,to,O
77506,5298,participation,O
77507,5298,in,O
77508,5298,the,O
77509,5298,study,O
77510,5299,mRS=2,O
77511,5299,;,O
77512,5300,History,O
77513,5300,of,O
77514,5300,stroke,B-Condition
77515,5300,within,O
77516,5300,3,O
77517,5300,months,O
77518,5300,;,O
77519,5301,History,O
77520,5301,of,O
77521,5301,intracranial,B-Condition
77522,5301,hemorrhage,I-Condition
77523,5301,;,O
77524,5302,Suspected,O
77525,5302,subarachnoid,B-Condition
77526,5302,hemorrhage,I-Condition
77527,5302,;,O
77528,5303,Intracranial,B-Condition
77529,5303,tumour,I-Condition
77530,5303,",",O
77531,5303,vascular,B-Condition
77532,5303,malformation,I-Condition
77533,5303,or,O
77534,5303,arterial,B-Condition
77535,5303,aneurysm,I-Condition
77536,5303,;,O
77537,5304,Major,B-Procedure
77538,5304,surgery,I-Procedure
77539,5304,within,O
77540,5304,1,O
77541,5304,month,O
77542,5304,;,O
77543,5305,Systolic,O
77544,5305,pressure,O
77545,5305,=,O
77546,5305,180,O
77547,5305,mmHg,O
77548,5305,or,O
77549,5305,diastolic,O
77550,5305,pressure,O
77551,5305,=,O
77552,5305,110,O
77553,5305,mmHg,O
77554,5305,;,O
77555,5306,Platelet,O
77556,5306,count,O
77557,5306,<,O
77558,5306,105,O
77559,5306,/,O
77560,5306,mm3,O
77561,5306,;,O
77562,5307,Heparin,B-Drug
77563,5307,therapy,B-Procedure
77564,5307,or,O
77565,5307,oral,B-Procedure
77566,5307,anticoagulation,I-Procedure
77567,5307,therapy,I-Procedure
77568,5307,within,O
77569,5307,48,O
77570,5307,hours,O
77571,5307,;,O
77572,5308,Abnormal,O
77573,5308,APTT,O
77574,5308,;,O
77575,5309,Thrombin,B-Drug
77576,5309,or,O
77577,5309,Xa,B-Drug
77578,5309,factor,I-Drug
77579,5309,inhibitor,I-Drug
77580,5309,;,O
77581,5310,Severe,O
77582,5310,disease,B-Condition
77583,5310,with,O
77584,5310,a,O
77585,5310,life,B-Observation
77586,5310,expectancy,I-Observation
77587,5310,of,O
77588,5310,less,O
77589,5310,than,O
77590,5310,3,O
77591,5310,months,O
77592,5310,;,O
77593,5311,Blood,O
77594,5311,glucose,O
77595,5311,<,O
77596,5311,50,O
77597,5311,mg,O
77598,5311,/,O
77599,5311,dL,O
77600,5311,(,O
77601,5311,2.7mmol,O
77602,5311,/,O
77603,5311,L,O
77604,5311,),O
77605,5311,;,O
77606,5312,Patients,O
77607,5312,who,O
77608,5312,have,O
77609,5312,received,O
77610,5312,any,O
77611,5312,other,O
77612,5312,investigational,O
77613,5312,drug,O
77614,5312,or,O
77615,5312,device,O
77616,5312,within,O
77617,5312,3,O
77618,5312,months,O
77619,5312,;,O
77620,5313,Pregnancy,B-Condition
77621,5313,;,O
77622,5314,Researchers,O
77623,5314,consider,O
77624,5314,patients,O
77625,5314,inappropriate,O
77626,5314,to,O
77627,5314,participate,O
77628,5314,in,O
77629,5314,the,O
77630,5314,registry,O
77631,5314,.,O
77632,5315,18,O
77633,5315,-,O
77634,5315,80,O
77635,5315,years,O
77636,5315,old,B-Person
77637,5315,;,O
77638,5316,Diagnosis,O
77639,5316,of,O
77640,5316,posterior,B-Condition
77641,5316,circulation,I-Condition
77642,5316,ischemic,I-Condition
77643,5316,stroke,I-Condition
77644,5316,;,O
77645,5317,Time,B-Observation
77646,5317,from,I-Observation
77647,5317,onset,I-Observation
77648,5317,to,I-Observation
77649,5317,treatment,I-Observation
77650,5317,=,O
77651,5317,6,O
77652,5317,hours,O
77653,5317,;,O
77654,5318,NIHSS,O
77655,5318,:,O
77656,5318,4,O
77657,5318,-,O
77658,5318,25,O
77659,5318,;,O
77660,5319,Signed,O
77661,5319,informed,O
77662,5319,consent,O
77663,5319,by,O
77664,5319,patient,O
77665,5319,self,O
77666,5319,or,O
77667,5319,legally,O
77668,5319,authorized,O
77669,5319,representatives,O
77670,5319,.,O
77671,5320,Diagnosis,O
77672,5320,of,O
77673,5320,a,O
77674,5320,psychotic,B-Condition
77675,5320,disorder,I-Condition
77676,5320,.,O
77677,5321,History,B-Observation
77678,5321,of,O
77679,5321,",",O
77680,5321,or,O
77681,5321,current,O
77682,5321,",",O
77683,5321,open,B-Condition
77684,5321,head,I-Condition
77685,5321,brain,I-Condition
77686,5321,trauma,I-Condition
77687,5321,.,O
77688,5321,Candidates,O
77689,5321,with,O
77690,5321,any,O
77691,5321,metal,O
77692,5321,",",O
77693,5321,shrapnel,O
77694,5321,or,O
77695,5321,other,O
77696,5321,similar,O
77697,5321,objects,O
77698,5321,in,O
77699,5321,the,O
77700,5321,head,O
77701,5321,that,O
77702,5321,could,O
77703,5321,affect,B-Condition
77704,5321,the,O
77705,5321,QEEG,B-Procedure
77706,5322,History,B-Observation
77707,5322,of,O
77708,5322,:,O
77709,5322,craniotomy,B-Procedure
77710,5322,",",O
77711,5322,cerebral,B-Condition
77712,5322,metastases,I-Condition
77713,5322,",",O
77714,5322,cerebrovascular,B-Condition
77715,5322,accident,I-Condition
77716,5322,;,O
77717,5322,current,O
77718,5322,diagnosis,O
77719,5322,of,O
77720,5322,seizure,B-Condition
77721,5322,disorder,I-Condition
77722,5322,",",O
77723,5322,schizophrenia,B-Condition
77724,5322,",",O
77725,5322,schizo,B-Condition
77726,5322,-,I-Condition
77727,5322,affective,I-Condition
77728,5322,disorder,I-Condition
77729,5322,",",O
77730,5322,dementia,B-Condition
77731,5322,",",O
77732,5322,mental,B-Condition
77733,5322,retardation,I-Condition
77734,5322,",",O
77735,5322,or,O
77736,5322,major,B-Condition
77737,5322,depression,I-Condition
77738,5322,with,O
77739,5322,psychotic,B-Condition
77740,5322,features,I-Condition
77741,5322,;,O
77742,5322,or,O
77743,5322,use,O
77744,5322,of,O
77745,5322,depot,B-Drug
77746,5322,neuroleptics,I-Drug
77747,5322,in,O
77748,5322,last,O
77749,5322,12,O
77750,5322,months,O
77751,5322,.,O
77752,5323,Uncontrolled,O
77753,5323,thyroid,B-Condition
77754,5323,disorders,I-Condition
77755,5323,.,O
77756,5324,Known,O
77757,5324,pregnancy,O
77758,5324,and/or,O
77759,5324,lactation,O
77760,5324,",",O
77761,5324,or,O
77762,5324,intent,O
77763,5324,to,O
77764,5324,become,O
77765,5324,pregnant,O
77766,5324,during,O
77767,5324,this,O
77768,5324,study,O
77769,5324,.,O
77770,5325,Chronic,O
77771,5325,or,O
77772,5325,acute,O
77773,5325,pain,B-Condition
77774,5325,requiring,O
77775,5325,prescription,B-Drug
77776,5325,pain,I-Drug
77777,5325,medication(s,I-Drug
77778,5325,),O
77779,5325,(,O
77780,5325,narcotic,B-Drug
77781,5325,or,O
77782,5325,synthetic,B-Drug
77783,5325,narcotic,I-Drug
77784,5325,),O
77785,5326,Participation,O
77786,5326,in,O
77787,5326,any,O
77788,5326,other,O
77789,5326,therapeutic,O
77790,5326,drug,O
77791,5326,study,O
77792,5326,within,O
77793,5326,60,O
77794,5326,days,O
77795,5326,preceding,O
77796,5326,inclusion,O
77797,5326,.,O
77798,5327,Patients,O
77799,5327,with,O
77800,5327,a,O
77801,5327,clinical,O
77802,5327,diagnosis,O
77803,5327,of,O
77804,5327,depression,B-Condition
77805,5327,who,O
77806,5327,in,O
77807,5327,the,O
77808,5327,judgement,O
77809,5327,of,O
77810,5327,their,O
77811,5327,physician,O
77812,5327,require,O
77813,5327,medication,B-Drug
77814,5327,management,O
77815,5327,may,O
77816,5327,be,O
77817,5327,eligible,O
77818,5327,for,O
77819,5327,enrollment,O
77820,5327,.,O
77821,5327,A,O
77822,5327,score,O
77823,5327,of,O
77824,5327,10,O
77825,5327,or,O
77826,5327,more,O
77827,5327,on,O
77828,5327,the,O
77829,5327,PHQ-9,O
77830,5327,instrument,O
77831,5327,will,O
77832,5327,be,O
77833,5327,required,O
77834,5327,for,O
77835,5327,enrollment,O
77836,5327,.,O
77837,5328,Some,O
77838,5328,practices,O
77839,5328,utilize,O
77840,5328,the,O
77841,5328,PHQ-2,O
77842,5328,and,O
77843,5328,PHQ-9,O
77844,5328,are,O
77845,5328,part,O
77846,5328,of,O
77847,5328,routine,O
77848,5328,screening,O
77849,5328,for,O
77850,5328,depression,O
77851,5328,.,O
77852,5328,If,O
77853,5328,the,O
77854,5328,tests,O
77855,5328,are,O
77856,5328,performed,O
77857,5328,routinely,O
77858,5328,",",O
77859,5328,they,O
77860,5328,do,O
77861,5328,not,O
77862,5328,need,O
77863,5328,to,O
77864,5328,be,O
77865,5328,repeated,O
77866,5328,for,O
77867,5328,study,O
77868,5328,eligibility,O
77869,5328,",",O
77870,5328,and,O
77871,5328,may,O
77872,5328,be,O
77873,5328,performed,O
77874,5328,prior,O
77875,5328,to,O
77876,5328,informed,O
77877,5328,consent,O
77878,5328,for,O
77879,5328,this,O
77880,5328,study,O
77881,5328,.,O
77882,5328,If,O
77883,5328,",",O
77884,5328,however,O
77885,5328,",",O
77886,5328,the,O
77887,5328,PHQ-9,O
77888,5328,is,O
77889,5328,not,O
77890,5328,routinely,O
77891,5328,performed,O
77892,5328,",",O
77893,5328,informed,O
77894,5328,consent,O
77895,5328,must,O
77896,5328,be,O
77897,5328,performed,O
77898,5328,prior,O
77899,5328,to,O
77900,5328,administration,O
77901,5328,.,O
77902,5328,Patients,O
77903,5328,with,O
77904,5328,a,O
77905,5328,score,O
77906,5328,below,O
77907,5328,10,O
77908,5328,will,O
77909,5328,be,O
77910,5328,considered,O
77911,5328,screen,O
77912,5328,failures,O
77913,5328,and,O
77914,5328,will,O
77915,5328,not,O
77916,5328,be,O
77917,5328,enrolled,O
77918,5328,or,O
77919,5328,offered,O
77920,5328,the,O
77921,5328,MYnd,O
77922,5328,testing,O
77923,5328,.,O
77924,5329,Patients,O
77925,5329,with,O
77926,5329,non,B-Condition
77927,5329,-,I-Condition
77928,5329,psychotic,I-Condition
77929,5329,comorbid,I-Condition
77930,5329,conditions,I-Condition
77931,5329,may,O
77932,5329,be,O
77933,5329,included,O
77934,5329,.,O
77935,5330,Patients,O
77936,5330,must,O
77937,5330,be,O
77938,5330,either,O
77939,5330,medication,B-Drug
77940,5330,treatment,O
77941,5330,naïve,O
77942,5330,for,O
77943,5330,behavioral,B-Condition
77944,5330,illnesses,I-Condition
77945,5330,or,O
77946,5330,have,O
77947,5330,no,O
77948,5330,active,O
77949,5330,medication,B-Drug
77950,5330,treatments,O
77951,5330,for,O
77952,5330,at,O
77953,5330,least,O
77954,5330,1,O
77955,5330,month,O
77956,5330,prior,O
77957,5330,to,O
77958,5330,enrollment,O
77959,5330,.,O
77960,5330,Prohibited,O
77961,5330,medications,O
77962,5330,at,O
77963,5330,the,O
77964,5330,time,O
77965,5330,of,O
77966,5330,enrollment,O
77967,5330,will,O
77968,5330,include,O
77969,5330,stimulants,B-Drug
77970,5330,",",O
77971,5330,benzodiazepines,B-Drug
77972,5330,and,O
77973,5330,THC,B-Drug
77974,5330,.,O
77975,5330,Prior,O
77976,5330,therapy,O
77977,5330,with,O
77978,5330,these,O
77979,5330,agents,O
77980,5330,is,O
77981,5330,permitted,O
77982,5330,with,O
77983,5330,a,O
77984,5330,washout,O
77985,5330,of,O
77986,5330,>,O
77987,5330,30,O
77988,5330,days,O
77989,5330,.,O
77990,5331,Patients,O
77991,5331,must,O
77992,5331,have,O
77993,5331,private,O
77994,5331,medical,O
77995,5331,insurance,O
77996,5331,coverage,O
77997,5331,through,O
77998,5331,Horizon,O
77999,5331,Blue,O
78000,5331,Cross,O
78001,5331,Blue,O
78002,5331,Shield,O
78003,5331,.,O
78004,5331,This,O
78005,5331,is,O
78006,5331,limited,O
78007,5331,to,O
78008,5331,insured,O
78009,5331,commercial,O
78010,5331,members,O
78011,5331,",",O
78012,5331,including,O
78013,5331,HMO,O
78014,5331,",",O
78015,5331,and,O
78016,5331,excluding,O
78017,5331,",",O
78018,5331,for,O
78019,5331,the,O
78020,5331,avoidance,O
78021,5331,of,O
78022,5331,doubt,O
78023,5331,",",O
78024,5331,members,O
78025,5331,of,O
78026,5331,self,O
78027,5331,-,O
78028,5331,insured,O
78029,5331,customers,O
78030,5331,or,O
78031,5331,Medicare,O
78032,5331,or,O
78033,5331,Medicaid,O
78034,5331,programs,O
78035,5331,.,O
78036,5332,Subjects,O
78037,5332,were,O
78038,5332,not,O
78039,5332,to,O
78040,5332,have,O
78041,5332,a,O
78042,5332,history,O
78043,5332,or,O
78044,5332,presence,O
78045,5332,of,O
78046,5332,significant,O
78047,5332,cardiovascular,O
78048,5332,",",O
78049,5332,pulmonary,O
78050,5332,",",O
78051,5332,hepatic,O
78052,5332,",",O
78053,5332,renal,O
78054,5332,",",O
78055,5332,haematologic,O
78056,5332,",",O
78057,5332,gastrointestinal,O
78058,5332,",",O
78059,5332,endocrine,O
78060,5332,",",O
78061,5332,immunologic,O
78062,5332,",",O
78063,5332,dermatologic,O
78064,5332,",",O
78065,5332,neurologic,O
78066,5332,",",O
78067,5332,or,O
78068,5332,psychiatric,O
78069,5332,disease,O
78070,5332,.,O
78071,5333,Subjects,O
78072,5333,were,O
78073,5333,not,O
78074,5333,to,O
78075,5333,have,O
78076,5333,any,O
78077,5333,history,B-Observation
78078,5333,or,O
78079,5333,presence,B-Observation
78080,5333,or,O
78081,5333,family,B-Observation
78082,5333,history,I-Observation
78083,5333,of,O
78084,5333,schizophrenia,B-Condition
78085,5333,",",O
78086,5333,other,O
78087,5333,psychotic,B-Condition
78088,5333,illness,I-Condition
78089,5333,",",O
78090,5333,severe,B-Condition
78091,5333,personality,I-Condition
78092,5333,disorder,I-Condition
78093,5333,",",O
78094,5333,depression,B-Condition
78095,5333,",",O
78096,5333,or,O
78097,5333,other,O
78098,5333,significant,O
78099,5333,psychiatric,B-Condition
78100,5333,disorder,I-Condition
78101,5333,.,O
78102,5334,Subjects,O
78103,5334,were,O
78104,5334,not,O
78105,5334,to,O
78106,5334,have,O
78107,5334,a,O
78108,5334,postural,O
78109,5334,drop,O
78110,5334,of,O
78111,5334,20,O
78112,5334,mmHg,O
78113,5334,or,O
78114,5334,more,O
78115,5334,in,O
78116,5334,systolic,O
78117,5334,blood,O
78118,5334,pressure,O
78119,5334,at,O
78120,5334,screening,O
78121,5334,.,O
78122,5335,Subjects,O
78123,5335,were,O
78124,5335,not,O
78125,5335,to,O
78126,5335,have,O
78127,5335,participated,B-Observation
78128,5335,in,I-Observation
78129,5335,a,I-Observation
78130,5335,previous,I-Observation
78131,5335,clinical,I-Observation
78132,5335,trial,I-Observation
78133,5335,within,O
78134,5335,90,O
78135,5335,days,O
78136,5335,prior,O
78137,5335,to,O
78138,5335,study,O
78139,5335,initiation,O
78140,5335,.,O
78141,5336,Subjects,O
78142,5336,were,O
78143,5336,not,O
78144,5336,to,O
78145,5336,have,O
78146,5336,donated,B-Procedure
78147,5336,plasma,I-Procedure
78148,5336,within,O
78149,5336,90,O
78150,5336,days,O
78151,5336,prior,O
78152,5336,to,O
78153,5336,study,O
78154,5336,initiation,O
78155,5336,.,O
78156,5337,Subjects,O
78157,5337,were,O
78158,5337,not,O
78159,5337,to,O
78160,5337,have,O
78161,5337,donated,B-Procedure
78162,5337,blood,I-Procedure
78163,5337,within,O
78164,5337,90,O
78165,5337,days,O
78166,5337,prior,O
78167,5337,to,O
78168,5337,study,O
78169,5337,initiation,O
78170,5337,.,O
78171,5338,Subjects,O
78172,5338,were,O
78173,5338,not,O
78174,5338,to,O
78175,5338,have,O
78176,5338,had,O
78177,5338,an,O
78178,5338,abnormal,B-Observation
78179,5338,diet,I-Observation
78180,5338,or,O
78181,5338,substantial,O
78182,5338,changes,B-Observation
78183,5338,in,I-Observation
78184,5338,eating,I-Observation
78185,5338,habits,I-Observation
78186,5338,within,O
78187,5338,30,O
78188,5338,days,O
78189,5338,prior,O
78190,5338,to,O
78191,5338,study,O
78192,5338,initiation,O
78193,5338,.,O
78194,5339,Subjects,O
78195,5339,were,O
78196,5339,not,O
78197,5339,to,O
78198,5339,have,O
78199,5339,had,O
78200,5339,treatment,O
78201,5339,with,O
78202,5339,any,O
78203,5339,known,O
78204,5339,enzyme,B-Drug
78205,5339,-,I-Drug
78206,5339,altering,I-Drug
78207,5339,agents,I-Drug
78208,5339,(,O
78209,5339,barbiturates,B-Drug
78210,5339,",",O
78211,5339,phenothiazines,B-Drug
78212,5339,",",O
78213,5339,cimetidine,B-Drug
78214,5339,etc,O
78215,5339,.,O
78216,5339,),O
78217,5339,within,O
78218,5339,30,O
78219,5339,days,O
78220,5339,prior,O
78221,5339,to,O
78222,5339,or,O
78223,5339,during,O
78224,5339,the,O
78225,5339,study,O
78226,5339,.,O
78227,5340,Subjects,O
78228,5340,were,O
78229,5340,to,O
78230,5340,have,O
78231,5340,no,O
78232,5340,history,O
78233,5340,of,O
78234,5340,known,O
78235,5340,hypersensitivity,B-Condition
78236,5340,or,O
78237,5340,idiosyncratic,B-Condition
78238,5340,reaction,I-Condition
78239,5340,to,O
78240,5340,the,O
78241,5340,study,B-Drug
78242,5340,drug,I-Drug
78243,5340,or,O
78244,5340,related,O
78245,5340,compounds,O
78246,5340,.,O
78247,5341,Subjects,O
78248,5341,were,O
78249,5341,not,O
78250,5341,to,O
78251,5341,use,O
78252,5341,any,O
78253,5341,prescription,B-Drug
78254,5341,medication,I-Drug
78255,5341,within,O
78256,5341,14,O
78257,5341,days,O
78258,5341,prior,O
78259,5341,to,O
78260,5341,or,O
78261,5341,during,O
78262,5341,the,O
78263,5341,study,O
78264,5341,.,O
78265,5342,Subjects,O
78266,5342,were,O
78267,5342,not,O
78268,5342,to,O
78269,5342,use,O
78270,5342,any,O
78271,5342,over,B-Drug
78272,5342,-,I-Drug
78273,5342,the,I-Drug
78274,5342,-,I-Drug
78275,5342,counter,I-Drug
78276,5342,medication,I-Drug
78277,5342,within,O
78278,5342,7,O
78279,5342,days,O
78280,5342,prior,O
78281,5342,to,O
78282,5342,or,O
78283,5342,during,O
78284,5342,the,O
78285,5342,study,O
78286,5342,.,O
78287,5343,Subjects,O
78288,5343,were,O
78289,5343,not,O
78290,5343,to,O
78291,5343,have,O
78292,5343,a,O
78293,5343,history,B-Observation
78294,5343,of,O
78295,5343,alcohol,B-Condition
78296,5343,or,I-Condition
78297,5343,drug,I-Condition
78298,5343,abuse,I-Condition
78299,5343,within,O
78300,5343,2,O
78301,5343,years,O
78302,5343,prior,O
78303,5343,to,O
78304,5343,the,O
78305,5343,study,O
78306,5343,(,O
78307,5343,subjects,O
78308,5343,with,O
78309,5343,a,O
78310,5343,history,O
78311,5343,of,O
78312,5343,previous,O
78313,5343,use,B-Condition
78314,5343,of,I-Condition
78315,5343,cannabis,I-Condition
78316,5343,were,O
78317,5343,not,O
78318,5343,excluded,O
78319,5343,unless,O
78320,5343,they,O
78321,5343,had,O
78322,5343,used,O
78323,5343,cannabis,O
78324,5343,or,O
78325,5343,cannabinoid,O
78326,5343,based,O
78327,5343,medicine,O
78328,5343,within,O
78329,5343,30,O
78330,5343,days,O
78331,5343,prior,O
78332,5343,to,O
78333,5343,study,O
78334,5343,drug,O
78335,5343,administration,O
78336,5343,or,O
78337,5343,were,O
78338,5343,unwilling,O
78339,5343,to,O
78340,5343,abstain,O
78341,5343,for,O
78342,5343,the,O
78343,5343,duration,O
78344,5343,of,O
78345,5343,the,O
78346,5343,study,O
78347,5343,),O
78348,5343,.,O
78349,5344,Healthy,B-Condition
78350,5344,males,O
78351,5344,between,O
78352,5344,18,O
78353,5344,and,O
78354,5344,45,O
78355,5344,years,O
78356,5344,of,O
78357,5344,age,B-Person
78358,5344,(,O
78359,5344,inclusive,O
78360,5344,),O
78361,5344,.,O
78362,5345,Body,O
78363,5345,mass,O
78364,5345,index,O
78365,5345,to,O
78366,5345,be,O
78367,5345,between,O
78368,5345,18,O
78369,5345,to,O
78370,5345,30,O
78371,5345,kg,O
78372,5345,/,O
78373,5345,m2,O
78374,5345,(,O
78375,5345,inclusive,O
78376,5345,),O
78377,5345,as,O
78378,5345,calculated,O
78379,5345,by,O
78380,5345,weight(Kg)/height(m2,O
78381,5345,),O
78382,5345,.,O
78383,5346,Subjects,O
78384,5346,were,O
78385,5346,to,O
78386,5346,have,O
78387,5346,no,O
78388,5346,clinically,O
78389,5346,significant,O
78390,5346,abnormal,B-Condition
78391,5346,findings,I-Condition
78392,5346,on,O
78393,5346,physical,B-Procedure
78394,5346,examination,I-Procedure
78395,5346,",",O
78396,5346,ECG,B-Procedure
78397,5346,",",O
78398,5346,medical,B-Observation
78399,5346,history,I-Observation
78400,5346,",",O
78401,5346,or,O
78402,5346,clinical,B-Procedure
78403,5346,laboratory,I-Procedure
78404,5346,results,O
78405,5346,during,O
78406,5346,screening,O
78407,5346,.,O
78408,5347,Subjects,O
78409,5347,were,O
78410,5347,to,O
78411,5347,",",O
78412,5347,in,O
78413,5347,the,O
78414,5347,opinion,O
78415,5347,of,O
78416,5347,the,O
78417,5347,investigator,O
78418,5347,",",O
78419,5347,have,O
78420,5347,no,O
78421,5347,clinically,O
78422,5347,significant,O
78423,5347,abnormal,B-Condition
78424,5347,findings,I-Condition
78425,5347,of,O
78426,5347,renal,O
78427,5347,and,O
78428,5347,hepatic,O
78429,5347,function,O
78430,5347,as,O
78431,5347,determined,O
78432,5347,by,O
78433,5347,serum,O
78434,5347,creatinine,O
78435,5347,",",O
78436,5347,total,O
78437,5347,bilirubin,O
78438,5347,",",O
78439,5347,and,O
78440,5347,transaminase,O
78441,5347,levels,O
78442,5347,.,O
78443,5348,Subjects,O
78444,5348,were,O
78445,5348,to,O
78446,5348,be,O
78447,5348,non,O
78448,5348,-,O
78449,5348,users,B-Condition
78450,5348,of,I-Condition
78451,5348,tobacco,I-Condition
78452,5348,products,I-Condition
78453,5348,(,O
78454,5348,minimum,O
78455,5348,of,O
78456,5348,6,O
78457,5348,months,O
78458,5348,prior,O
78459,5348,to,O
78460,5348,the,O
78461,5348,start,O
78462,5348,of,O
78463,5348,the,O
78464,5348,study,O
78465,5348,),O
78466,5348,.,O
78467,5349,Subjects,O
78468,5349,were,O
78469,5349,to,O
78470,5349,have,O
78471,5349,a,O
78472,5349,negative,O
78473,5349,screen,O
78474,5349,for,O
78475,5349,HIV,O
78476,5349,I,O
78477,5349,and,O
78478,5349,II,O
78479,5349,",",O
78480,5349,HBsAg,O
78481,5349,",",O
78482,5349,and,O
78483,5349,antibody,O
78484,5349,to,O
78485,5349,Hepatitis,O
78486,5349,C,O
78487,5349,virus,O
78488,5349,.,O
78489,5350,Subjects,O
78490,5350,were,O
78491,5350,to,O
78492,5350,have,O
78493,5350,a,O
78494,5350,negative,O
78495,5350,urine,O
78496,5350,screen,O
78497,5350,for,O
78498,5350,alcohol,O
78499,5350,",",O
78500,5350,drugs,O
78501,5350,of,O
78502,5350,abuse,O
78503,5350,(,O
78504,5350,screening,O
78505,5350,only,O
78506,5350,),O
78507,5350,",",O
78508,5350,and,O
78509,5350,cotinine,O
78510,5350,.,O
78511,5351,Subjects,O
78512,5351,were,O
78513,5351,to,O
78514,5351,use,O
78515,5351,an,O
78516,5351,appropriate,O
78517,5351,barrier,O
78518,5351,method,O
78519,5351,of,O
78520,5351,contraception,O
78521,5351,(,O
78522,5351,condom,O
78523,5351,and,O
78524,5351,spermicide,O
78525,5351,),O
78526,5351,in,O
78527,5351,addition,O
78528,5351,to,O
78529,5351,having,O
78530,5351,their,O
78531,5351,female,O
78532,5351,partner,O
78533,5351,use,O
78534,5351,another,O
78535,5351,form,O
78536,5351,of,O
78537,5351,barrier,O
78538,5351,contraception,O
78539,5351,(,O
78540,5351,e.g.female,O
78541,5351,condom,O
78542,5351,or,O
78543,5351,occlusive,O
78544,5351,cap,O
78545,5351,with,O
78546,5351,spermicide,O
78547,5351,),O
78548,5351,during,O
78549,5351,the,O
78550,5351,study,O
78551,5351,and,O
78552,5351,for,O
78553,5351,3,O
78554,5351,months,O
78555,5351,following,O
78556,5351,administration,O
78557,5351,of,O
78558,5351,the,O
78559,5351,study,O
78560,5351,drug,O
78561,5351,.,O
78562,5352,Subjects,O
78563,5352,were,O
78564,5352,able,O
78565,5352,to,O
78566,5352,comply,O
78567,5352,with,O
78568,5352,the,O
78569,5352,protocol,O
78570,5352,and,O
78571,5352,the,O
78572,5352,restrictions,O
78573,5352,and,O
78574,5352,assessments,O
78575,5352,therein,O
78576,5352,.,O
78577,5353,Subjects,O
78578,5353,were,O
78579,5353,to,O
78580,5353,give,O
78581,5353,voluntary,O
78582,5353,written,O
78583,5353,informed,O
78584,5353,consent,O
78585,5353,to,O
78586,5353,participate,O
78587,5353,in,O
78588,5353,the,O
78589,5353,trial,O
78590,5353,.,O
78591,5354,Clinical,O
78592,5354,diagnosis,O
78593,5354,of,O
78594,5354,hepatic,B-Condition
78595,5354,or,I-Condition
78596,5354,renal,I-Condition
78597,5354,disease,I-Condition
78598,5355,Clinical,O
78599,5355,diagnosis,O
78600,5355,of,O
78601,5355,chronic,O
78602,5355,or,O
78603,5355,acute,O
78604,5355,alcoholism,B-Condition
78605,5356,History,B-Observation
78606,5356,of,O
78607,5356,allergy,B-Condition
78608,5356,or,O
78609,5356,hypersensitivity,B-Condition
78610,5356,to,O
78611,5356,Sugammadex,B-Drug
78612,5356,and/or,O
78613,5356,atropine,B-Drug
78614,5356,or,O
78615,5356,Neostigmine,B-Drug
78616,5357,Current,O
78617,5357,medications,B-Drug
78618,5357,with,O
78619,5357,CNS,B-Condition
78620,5357,effects,I-Condition
78621,5358,History,B-Observation
78622,5358,of,O
78623,5358,neurologic,B-Condition
78624,5358,disease,I-Condition
78625,5359,Diaphragmatic,B-Condition
78626,5359,palsy,I-Condition
78627,5360,Pregnancy,B-Condition
78628,5360,or,O
78629,5360,nursing,B-Condition
78630,5361,History,B-Observation
78631,5361,of,O
78632,5361,malignant,B-Condition
78633,5361,arrhythmias,I-Condition
78634,5362,ASA,O
78635,5362,physical,O
78636,5362,status,O
78637,5362,I,O
78638,5362,-,O
78639,5362,II,O
78640,5363,age,B-Person
78641,5363,between,O
78642,5363,18,O
78643,5363,-,O
78644,5363,80,O
78645,5363,years,O
78646,5363,old,O
78647,5364,dNMB,B-Drug
78648,5364,with,I-Drug
78649,5364,rocuronium,I-Drug
78650,5364,during,O
78651,5364,ear,B-Procedure
78652,5364,nose,I-Procedure
78653,5364,and,I-Procedure
78654,5364,throat,I-Procedure
78655,5364,(,I-Procedure
78656,5364,ENT,I-Procedure
78657,5364,),I-Procedure
78658,5364,surgery,I-Procedure
78659,5365,Toxic,B-Condition
78660,5365,epidermal,I-Condition
78661,5365,necrolysis,I-Condition
78662,5365,with,O
78663,5365,SCORTEN,O
78664,5365,6,O
78665,5365,or,O
78666,5365,7,O
78667,5365,at,O
78668,5365,admission,O
78669,5366,Hypercoagulable,B-Condition
78670,5366,state,I-Condition
78671,5367,Cardiac,O
78672,5367,or,O
78673,5367,peripheral,B-Condition
78674,5367,arterial,I-Condition
78675,5367,disease,I-Condition
78676,5368,Active,O
78677,5368,malignancy,B-Condition
78678,5369,Myelodysplastic,B-Condition
78679,5369,syndrome,I-Condition
78680,5369,or,O
78681,5369,hematological,B-Condition
78682,5369,malignancy,I-Condition
78683,5370,Fructose,B-Condition
78684,5370,intolerance,I-Condition
78685,5371,Pregnancy,O
78686,5372,Patient,O
78687,5372,refusal,O
78688,5373,Toxic,B-Condition
78689,5373,epidermal,I-Condition
78690,5373,necrolysis,I-Condition
78691,5373,with,O
78692,5373,SCORTEN,O
78693,5373,1,O
78694,5373,to,O
78695,5373,5,O
78696,5373,at,O
78697,5373,admission,O
78698,5374,Sensitivity,B-Condition
78699,5374,to,O
78700,5374,pilocarpine,B-Drug
78701,5375,Secondary,O
78702,5375,Sjögren,B-Condition
78703,5375,'s,I-Condition
78704,5375,syndrome,I-Condition
78705,5375,;,O
78706,5376,Type,B-Condition
78707,5376,II,I-Condition
78708,5376,diabetes,I-Condition
78709,5376,mellitus,I-Condition
78710,5376,;,O
78711,5377,AIDS,B-Condition
78712,5377,;,O
78713,5378,pregnant,O
78714,5378,or,O
78715,5378,lactating,O
78716,5378,women,O
78717,5378,;,O
78718,5379,Glaucoma,B-Condition
78719,5379,;,O
78720,5380,Uncontrolled,O
78721,5380,asthma,B-Condition
78722,5380,;,O
78723,5381,Chronic,B-Condition
78724,5381,obstructive,I-Condition
78725,5381,pulmonary,I-Condition
78726,5381,disease,I-Condition
78727,5381,;,O
78728,5382,Renal,B-Condition
78729,5382,diseases,I-Condition
78730,5382,;,O
78731,5383,Severe,O
78732,5383,cardiovascular,B-Condition
78733,5383,diseases,I-Condition
78734,5383,;,O
78735,5384,Gastrointestinal,B-Condition
78736,5384,disorders,I-Condition
78737,5384,;,O
78738,5385,Hepatic,B-Condition
78739,5385,insufficiency,I-Condition
78740,5385,.,O
78741,5386,Age,B-Person
78742,5386,equal,O
78743,5386,or,O
78744,5386,superior,O
78745,5386,to,O
78746,5386,18,O
78747,5386,years,O
78748,5386,;,O
78749,5387,Both,O
78750,5387,genders,B-Person
78751,5387,;,O
78752,5388,Lucid,B-Condition
78753,5388,and,O
78754,5388,without,O
78755,5388,diagnosis,O
78756,5388,of,O
78757,5388,any,O
78758,5388,psychiatric,B-Condition
78759,5388,disorder,I-Condition
78760,5388,;,O
78761,5389,Diagnosed,O
78762,5389,with,O
78763,5389,head,B-Condition
78764,5389,and,I-Condition
78765,5389,neck,I-Condition
78766,5389,cancer,I-Condition
78767,5389,and,O
78768,5389,treated,O
78769,5389,for,O
78770,5389,a,O
78771,5389,period,O
78772,5389,of,O
78773,5389,up,O
78774,5389,to,O
78775,5389,5,O
78776,5389,years,O
78777,5389,with,O
78778,5389,radiotherapy,B-Procedure
78779,5389,where,O
78780,5389,the,O
78781,5389,major,O
78782,5389,salivary,O
78783,5389,glands,O
78784,5389,(,O
78785,5389,parotid,O
78786,5389,",",O
78787,5389,submandibular,O
78788,5389,and,O
78789,5389,sublingual,O
78790,5389,),O
78791,5389,were,O
78792,5389,included,O
78793,5389,in,O
78794,5389,the,O
78795,5389,radiation,O
78796,5389,field,O
78797,5389,;,O
78798,5390,Primary,B-Condition
78799,5390,Sjögren,I-Condition
78800,5390,'s,I-Condition
78801,5390,syndrome,I-Condition
78802,5390,with,O
78803,5390,the,O
78804,5390,diagnosis,O
78805,5390,made,O
78806,5390,by,O
78807,5390,the,O
78808,5390,American,O
78809,5390,-,O
78810,5390,European,O
78811,5390,criteria,O
78812,5390,.,O
78813,5391,Participant,O
78814,5391,has,O
78815,5391,a,O
78816,5391,clinically,O
78817,5391,significant,O
78818,5391,abnormal,B-Condition
78819,5391,physical,I-Condition
78820,5391,examination,I-Condition
78821,5391,",",I-Condition
78822,5391,vital,I-Condition
78823,5391,signs,I-Condition
78824,5391,or,I-Condition
78825,5391,12,I-Condition
78826,5391,lead,I-Condition
78827,5391,ECG,I-Condition
78828,5391,(,O
78829,5391,including,O
78830,5391,QTc,O
78831,5391,greater,O
78832,5391,than,O
78833,5391,(,O
78834,5391,>,O
78835,5391,),O
78836,5391,450msec,O
78837,5391,",",O
78838,5391,Left,B-Condition
78839,5391,Bundle,I-Condition
78840,5391,Branch,I-Condition
78841,5391,Block,I-Condition
78842,5391,",",O
78843,5391,permanent,O
78844,5391,pacemaker,O
78845,5391,or,O
78846,5391,implantable,B-Condition
78847,5391,cardioverter,I-Condition
78848,5391,defibrillator,I-Condition
78849,5391,),O
78850,5391,at,O
78851,5391,Screening,O
78852,5391,or,O
78853,5391,admission,O
78854,5392,Participant,O
78855,5392,has,O
78856,5392,a,O
78857,5392,history,B-Observation
78858,5392,of,O
78859,5392,or,O
78860,5392,current,O
78861,5392,liver,B-Condition
78862,5392,or,I-Condition
78863,5392,renal,I-Condition
78864,5392,insufficiency,I-Condition
78865,5392,;,O
78866,5392,significant,O
78867,5392,cardiac,B-Condition
78868,5392,",",I-Condition
78869,5392,vascular,I-Condition
78870,5392,",",I-Condition
78871,5392,pulmonary,I-Condition
78872,5392,",",I-Condition
78873,5392,gastrointestinal,I-Condition
78874,5392,",",I-Condition
78875,5392,endocrine,I-Condition
78876,5392,",",I-Condition
78877,5392,neurologic,I-Condition
78878,5392,",",I-Condition
78879,5392,hematologic,I-Condition
78880,5392,",",I-Condition
78881,5392,rheumatologic,I-Condition
78882,5392,",",I-Condition
78883,5392,psychiatric,I-Condition
78884,5392,",",I-Condition
78885,5392,or,I-Condition
78886,5392,metabolic,I-Condition
78887,5392,disturbances,I-Condition
78888,5393,Use,O
78889,5393,of,O
78890,5393,any,B-Drug
78891,5393,prescription,I-Drug
78892,5393,or,O
78893,5393,over,B-Drug
78894,5393,-,I-Drug
78895,5393,the,I-Drug
78896,5393,-,I-Drug
78897,5393,counter,I-Drug
78898,5393,medication,I-Drug
78899,5393,",",O
78900,5393,herbal,B-Drug
78901,5393,medication,I-Drug
78902,5393,",",O
78903,5393,vitamins,B-Drug
78904,5393,",",O
78905,5393,or,O
78906,5393,mineral,B-Drug
78907,5393,supplements,I-Drug
78908,5393,within,O
78909,5393,14,O
78910,5393,days,O
78911,5393,prior,O
78912,5393,to,O
78913,5393,study,O
78914,5393,drug,O
78915,5393,administration,O
78916,5393,(,O
78917,5393,not,O
78918,5393,including,O
78919,5393,paracetamol,B-Drug
78920,5393,),O
78921,5393,.,O
78922,5393,Medication,B-Drug
78923,5393,for,O
78924,5393,chronic,O
78925,5393,use,O
78926,5393,in,O
78927,5393,age,B-Condition
78928,5393,related,I-Condition
78929,5393,disease,I-Condition
78930,5393,will,O
78931,5393,be,O
78932,5393,allowed,O
78933,5393,after,O
78934,5393,approval,O
78935,5393,by,O
78936,5393,both,O
78937,5393,the,O
78938,5393,investigator,O
78939,5393,and,O
78940,5393,to,O
78941,5393,the,O
78942,5393,sponsor,O
78943,5393,.,O
78944,5393,No,O
78945,5393,change,O
78946,5393,in,O
78947,5393,dose,O
78948,5393,or,O
78949,5393,regimen,O
78950,5393,will,O
78951,5393,be,O
78952,5393,permitted,O
78953,5393,during,O
78954,5393,the,O
78955,5393,study,O
78956,5393,that,O
78957,5393,is,O
78958,5393,",",O
78959,5393,from,O
78960,5393,the,O
78961,5393,Screening,O
78962,5393,visit,O
78963,5393,until,O
78964,5393,the,O
78965,5393,follow,O
78966,5393,-,O
78967,5393,up,O
78968,5393,visit,O
78969,5394,Participant,O
78970,5394,has,O
78971,5394,a,O
78972,5394,history,B-Observation
78973,5394,of,O
78974,5394,spontaneous,O
78975,5394,",",O
78976,5394,prolonged,O
78977,5394,or,O
78978,5394,severe,O
78979,5394,bleeding,B-Condition
78980,5394,of,O
78981,5394,unclear,O
78982,5394,origin,O
78983,5395,Participant,O
78984,5395,has,O
78985,5395,a,O
78986,5395,history,B-Observation
78987,5395,of,O
78988,5395,epilepsy,B-Condition
78989,5395,or,O
78990,5395,fits,B-Condition
78991,5395,or,O
78992,5395,unexplained,O
78993,5395,black,B-Condition
78994,5395,-,I-Condition
78995,5395,outs,I-Condition
78996,5395,other,O
78997,5395,than,O
78998,5395,vasovagal,B-Condition
78999,5395,collapse,I-Condition
79000,5396,Body,O
79001,5396,mass,O
79002,5396,index,O
79003,5396,(,O
79004,5396,BMI,O
79005,5396,;,O
79006,5396,weight,O
79007,5396,[,O
79008,5396,kilogram(kg)]/height^2,O
79009,5396,[,O
79010,5396,meter,O
79011,5396,square,O
79012,5396,(,O
79013,5396,m^2,O
79014,5396,),O
79015,5396,],O
79016,5396,),O
79017,5396,between,O
79018,5396,18,O
79019,5396,and,O
79020,5396,30,O
79021,5396,kg,O
79022,5396,/,O
79023,5396,m^2,O
79024,5396,",",O
79025,5396,(,O
79026,5396,inclusive,O
79027,5396,),O
79028,5397,Be,O
79029,5397,healthy,O
79030,5397,for,O
79031,5397,their,O
79032,5397,age,O
79033,5397,group,O
79034,5397,with,O
79035,5397,or,O
79036,5397,without,O
79037,5397,medication,O
79038,5397,on,O
79039,5397,the,O
79040,5397,basis,O
79041,5397,of,O
79042,5397,physical,B-Procedure
79043,5397,examination,I-Procedure
79044,5397,",",O
79045,5397,medical,B-Observation
79046,5397,history,I-Observation
79047,5397,",",O
79048,5397,vital,O
79049,5397,signs,O
79050,5397,",",O
79051,5397,and,O
79052,5397,12,O
79053,5397,-,O
79054,5397,lead,O
79055,5397,electrocardiogram,O
79056,5397,(,O
79057,5397,ECG,O
79058,5397,),O
79059,5397,performed,O
79060,5397,at,O
79061,5397,Screening,O
79062,5397,or,O
79063,5397,admission,O
79064,5397,.,O
79065,5397,Minor,O
79066,5397,deviations,B-Condition
79067,5397,in,I-Condition
79068,5397,ECG,I-Condition
79069,5397,",",O
79070,5397,which,O
79071,5397,are,O
79072,5397,not,O
79073,5397,considered,O
79074,5397,to,O
79075,5397,be,O
79076,5397,of,O
79077,5397,clinical,O
79078,5397,significance,O
79079,5397,to,O
79080,5397,the,O
79081,5397,investigator,O
79082,5397,",",O
79083,5397,are,O
79084,5397,acceptable,O
79085,5398,Be,O
79086,5398,healthy,B-Condition
79087,5398,on,O
79088,5398,the,O
79089,5398,basis,O
79090,5398,of,O
79091,5398,clinical,B-Procedure
79092,5398,laboratory,I-Procedure
79093,5398,tests,I-Procedure
79094,5398,performed,O
79095,5398,at,O
79096,5398,Screening,O
79097,5398,.,O
79098,5398,If,O
79099,5398,the,O
79100,5398,results,O
79101,5398,of,O
79102,5398,the,O
79103,5398,serum,O
79104,5398,chemistry,O
79105,5398,panel,O
79106,5398,[,O
79107,5398,including,O
79108,5398,liver,O
79109,5398,enzymes,O
79110,5398,],O
79111,5398,",",O
79112,5398,hematology,O
79113,5398,",",O
79114,5398,or,O
79115,5398,urinalysis,B-Procedure
79116,5398,are,O
79117,5398,outside,O
79118,5398,the,O
79119,5398,normal,O
79120,5398,reference,O
79121,5398,ranges,O
79122,5398,",",O
79123,5398,the,O
79124,5398,participant,O
79125,5398,may,O
79126,5398,be,O
79127,5398,included,O
79128,5398,only,O
79129,5398,if,O
79130,5398,the,O
79131,5398,investigator,O
79132,5398,judges,O
79133,5398,the,O
79134,5398,abnormalities,O
79135,5398,or,O
79136,5398,deviations,O
79137,5398,from,O
79138,5398,normal,O
79139,5398,to,O
79140,5398,be,O
79141,5398,not,O
79142,5398,clinically,O
79143,5398,significant,O
79144,5398,.,O
79145,5398,This,O
79146,5398,determination,O
79147,5398,must,O
79148,5398,be,O
79149,5398,recorded,O
79150,5398,in,O
79151,5398,the,O
79152,5398,participants,O
79153,5398,',O
79154,5398,source,O
79155,5398,documents,O
79156,5398,and,O
79157,5398,initialed,O
79158,5398,by,O
79159,5398,the,O
79160,5398,investigator,O
79161,5399,Men,O
79162,5399,who,O
79163,5399,are,O
79164,5399,sexually,O
79165,5399,active,O
79166,5399,with,O
79167,5399,a,O
79168,5399,woman,O
79169,5399,of,O
79170,5399,childbearing,O
79171,5399,potential,O
79172,5399,and,O
79173,5399,have,O
79174,5399,not,O
79175,5399,had,O
79176,5399,a,O
79177,5399,vasectomy,O
79178,5399,must,O
79179,5399,agree,O
79180,5399,to,O
79181,5399,use,O
79182,5399,a,O
79183,5399,barrier,O
79184,5399,method,O
79185,5399,of,O
79186,5399,birth,O
79187,5399,control,O
79188,5399,for,O
79189,5399,example,O
79190,5399,",",O
79191,5399,either,O
79192,5399,condom,O
79193,5399,with,O
79194,5399,spermicidal,O
79195,5399,foam,O
79196,5399,/,O
79197,5399,gel,O
79198,5399,/,O
79199,5399,film,O
79200,5399,/,O
79201,5399,cream,O
79202,5399,/,O
79203,5399,suppository,O
79204,5399,or,O
79205,5399,partner,O
79206,5399,with,O
79207,5399,occlusive,O
79208,5399,cap,O
79209,5399,(,O
79210,5399,diaphragm,O
79211,5399,or,O
79212,5399,cervical,O
79213,5399,/,O
79214,5399,vault,O
79215,5399,caps,O
79216,5399,),O
79217,5399,with,O
79218,5399,spermicidal,O
79219,5399,foam,O
79220,5399,/,O
79221,5399,gel,O
79222,5399,/,O
79223,5399,film,O
79224,5399,/,O
79225,5399,cream,O
79226,5399,/,O
79227,5399,suppository,O
79228,5399,",",O
79229,5399,and,O
79230,5399,all,O
79231,5399,men,O
79232,5399,must,O
79233,5399,also,O
79234,5399,not,O
79235,5399,donate,O
79236,5399,sperm,O
79237,5399,during,O
79238,5399,the,O
79239,5399,study,O
79240,5399,and,O
79241,5399,for,O
79242,5399,3,O
79243,5399,months,O
79244,5399,after,O
79245,5399,receiving,O
79246,5399,the,O
79247,5399,last,O
79248,5399,dose,O
79249,5399,of,O
79250,5399,study,O
79251,5399,drug,O
79252,5399,.,O
79253,5399,In,O
79254,5399,addition,O
79255,5399,",",O
79256,5399,their,O
79257,5399,female,O
79258,5399,partners,O
79259,5399,should,O
79260,5399,also,O
79261,5399,use,O
79262,5399,an,O
79263,5399,appropriate,O
79264,5399,method,O
79265,5399,of,O
79266,5399,birth,O
79267,5399,control,O
79268,5399,for,O
79269,5399,at,O
79270,5399,least,O
79271,5399,the,O
79272,5399,same,O
79273,5399,duration,O
79274,5400,Participants,O
79275,5400,',O
79276,5400,must,O
79277,5400,have,O
79278,5400,signed,O
79279,5400,an,O
79280,5400,informed,O
79281,5400,consent,O
79282,5400,document,O
79283,5400,indicating,O
79284,5400,that,O
79285,5400,they,O
79286,5400,understand,O
79287,5400,the,O
79288,5400,purpose,O
79289,5400,of,O
79290,5400,and,O
79291,5400,procedures,O
79292,5400,required,O
79293,5400,for,O
79294,5400,the,O
79295,5400,study,O
79296,5400,and,O
79297,5400,are,O
79298,5400,willing,O
79299,5400,to,O
79300,5400,participate,O
79301,5400,in,O
79302,5400,the,O
79303,5400,study,O
79304,5401,Psoriasis,B-Condition
79305,5401,or,O
79306,5401,psoriasis,B-Condition
79307,5401,arthropathy,I-Condition
79308,5402,Inflammatory,B-Condition
79309,5402,bowel,I-Condition
79310,5402,disease,I-Condition
79311,5403,Unwillingness,O
79312,5403,to,O
79313,5403,participate,O
79314,5403,in,O
79315,5403,the,O
79316,5403,study,O
79317,5403,with,O
79318,5403,additional,O
79319,5403,imaging,O
79320,5403,protocols,O
79321,5404,Expected,B-Observation
79322,5404,life,I-Observation
79323,5404,-,I-Observation
79324,5404,span,I-Observation
79325,5404,less,O
79326,5404,than,O
79327,5404,<,O
79328,5404,1,O
79329,5404,year,O
79330,5405,Diabetes,B-Condition
79331,5405,(,O
79332,5405,to,O
79333,5405,improve,O
79334,5405,the,O
79335,5405,PET,B-Procedure
79336,5405,imaging,I-Procedure
79337,5405,quality,I-Procedure
79338,5405,),O
79339,5406,Probable,O
79340,5406,noncompliance,B-Condition
79341,5407,Pregnancy,B-Condition
79342,5408,Age,B-Person
79343,5408,<,O
79344,5408,18,O
79345,5408,years,O
79346,5408,or,O
79347,5408,>,O
79348,5408,75,O
79349,5408,years,O
79350,5409,Contraindication,B-Condition
79351,5409,for,O
79352,5409,adalimumab,B-Drug
79353,5410,Methotrexate,B-Drug
79354,5410,used,O
79355,5410,within,O
79356,5410,the,O
79357,5410,previous,O
79358,5410,6,O
79359,5410,months,O
79360,5411,A,O
79361,5411,biologic,B-Drug
79362,5411,medicine,I-Drug
79363,5411,used,O
79364,5411,within,O
79365,5411,the,O
79366,5411,previous,O
79367,5411,6,O
79368,5411,months,O
79369,5412,Axial,B-Condition
79370,5412,spondyloarthritis,I-Condition
79371,5412,(,O
79372,5412,ASAS,O
79373,5412,criteria,O
79374,5412,),O
79375,5412,and,O
79376,5412,radiologic,B-Procedure
79377,5412,sacroiliitis,B-Condition
79378,5412,as,O
79379,5412,detected,O
79380,5412,either,O
79381,5412,by,O
79382,5412,MRI,B-Procedure
79383,5412,or,O
79384,5412,X,B-Procedure
79385,5412,-,I-Procedure
79386,5412,ray,I-Procedure
79387,5412,.,O
79388,5413,NA,O
79389,5414,NA,O
79390,5415,Previous,O
79391,5415,treatment,O
79392,5415,with,O
79393,5415,anti,B-Drug
79394,5415,-,I-Drug
79395,5415,VEGF,I-Drug
79396,5415,drugs,I-Drug
79397,5415,or,O
79398,5415,corticosteroid,B-Drug
79399,5415,or,O
79400,5415,grid,B-Procedure
79401,5415,laser,I-Procedure
79402,5415,photocoagulation,I-Procedure
79403,5415,(,I-Procedure
79404,5415,study,O
79405,5415,eye,O
79406,5415,),O
79407,5416,History,O
79408,5416,of,O
79409,5416,vitrectomy,B-Procedure
79410,5416,surgery,I-Procedure
79411,5416,",",O
79412,5416,submacular,B-Procedure
79413,5416,surgery,I-Procedure
79414,5416,",",O
79415,5416,or,O
79416,5416,other,O
79417,5416,surgical,B-Procedure
79418,5416,intervention,I-Procedure
79419,5416,for,O
79420,5416,RVO,B-Condition
79421,5417,Ocular,O
79422,5417,disorders,O
79423,5417,in,O
79424,5417,the,O
79425,5417,study,O
79426,5417,eye,O
79427,5417,that,O
79428,5417,may,O
79429,5417,confound,O
79430,5417,interpretation,O
79431,5417,of,O
79432,5417,study,O
79433,5417,results,O
79434,5418,BCVA,O
79435,5418,over,O
79436,5418,77,O
79437,5418,letters,O
79438,5418,between,O
79439,5418,screening,O
79440,5418,and,O
79441,5418,Day,O
79442,5418,0,O
79443,5419,The,O
79444,5419,pregnant,O
79445,5419,or,O
79446,5419,lactating,O
79447,5419,woman,O
79448,5420,Signed,O
79449,5420,informed,O
79450,5420,consent,O
79451,5420,form,O
79452,5421,Macula,B-Condition
79453,5421,edema,I-Condition
79454,5421,secondary,O
79455,5421,to,O
79456,5421,BRVO,B-Condition
79457,5422,BCVA,O
79458,5422,of,O
79459,5422,77,O
79460,5422,to,O
79461,5422,20,O
79462,5422,letters,O
79463,5422,assessed,O
79464,5422,with,O
79465,5422,the,O
79466,5422,use,O
79467,5422,of,O
79468,5422,ETDRS,O
79469,5422,charts,O
79470,5423,CRT,O
79471,5423,<,O
79472,5423,U+2267>250,O
79473,5423,µm,O
79474,5424,Patients,O
79475,5424,undergoing,O
79476,5424,bilateral,O
79477,5424,hip,B-Procedure
79478,5424,or,I-Procedure
79479,5424,knee,I-Procedure
79480,5424,replacement,I-Procedure
79481,5424,;,O
79482,5425,Patients,O
79483,5425,undergoing,O
79484,5425,total,B-Procedure
79485,5425,hip,I-Procedure
79486,5425,or,I-Procedure
79487,5425,knee,I-Procedure
79488,5425,replacement,I-Procedure
79489,5425,who,O
79490,5425,have,O
79491,5425,been,O
79492,5425,enrolled,O
79493,5425,in,O
79494,5425,this,O
79495,5425,study,O
79496,5425,for,O
79497,5425,a,O
79498,5425,prior,O
79499,5425,hip,O
79500,5425,or,O
79501,5425,knee,O
79502,5425,replacement,O
79503,5425,;,O
79504,5426,Patients,O
79505,5426,who,O
79506,5426,are,O
79507,5426,concurrently,O
79508,5426,enrolled,O
79509,5426,in,O
79510,5426,another,O
79511,5426,active,O
79512,5426,interventional,O
79513,5426,clinical,O
79514,5426,trial,O
79515,5426,testing,O
79516,5426,a,O
79517,5426,drug,O
79518,5426,or,O
79519,5426,intervention,O
79520,5426,known,O
79521,5426,or,O
79522,5426,believed,O
79523,5426,to,O
79524,5426,interact,O
79525,5426,with,O
79526,5426,aspirin,O
79527,5426,",",O
79528,5426,warfarin,O
79529,5426,",",O
79530,5426,or,O
79531,5426,rivaroxaban,O
79532,5426,;,O
79533,5427,Patients,O
79534,5427,who,O
79535,5427,have,O
79536,5427,a,O
79537,5427,contraindication,B-Condition
79538,5427,to,O
79539,5427,two,O
79540,5427,or,O
79541,5427,more,O
79542,5427,of,O
79543,5427,the,O
79544,5427,three,O
79545,5427,study,O
79546,5427,prophylaxis,O
79547,5427,regimens,O
79548,5427,;,O
79549,5428,Women,O
79550,5428,who,O
79551,5428,are,O
79552,5428,pregnant,O
79553,5428,or,O
79554,5428,breastfeeding,O
79555,5428,",",O
79556,5428,as,O
79557,5428,well,O
79558,5428,as,O
79559,5428,those,O
79560,5428,of,O
79561,5428,reproductive,O
79562,5428,potential,O
79563,5428,unless,O
79564,5428,there,O
79565,5428,is,O
79566,5428,a,O
79567,5428,negative,O
79568,5428,urine,O
79569,5428,pregnancy,O
79570,5428,test,O
79571,5428,on,O
79572,5428,the,O
79573,5428,day,O
79574,5428,of,O
79575,5428,surgery,O
79576,5428,;,O
79577,5429,Patients,O
79578,5429,on,O
79579,5429,chronic,O
79580,5429,(,O
79581,5429,longer,O
79582,5429,than,O
79583,5429,the,O
79584,5429,prior,O
79585,5429,6,O
79586,5429,months,O
79587,5429,),O
79588,5429,anticoagulation,B-Drug
79589,5429,other,O
79590,5429,than,O
79591,5429,with,O
79592,5429,antiplatelet,B-Drug
79593,5429,medications,O
79594,5429,;,O
79595,5430,Patients,O
79596,5430,with,O
79597,5430,documented,O
79598,5430,gastrointestinal,B-Condition
79599,5430,",",I-Condition
79600,5430,cerebral,I-Condition
79601,5430,",",I-Condition
79602,5430,or,I-Condition
79603,5430,other,I-Condition
79604,5430,hemorrhage,I-Condition
79605,5430,within,O
79606,5430,3,O
79607,5430,months,O
79608,5430,of,O
79609,5430,the,O
79610,5430,operation,O
79611,5430,;,O
79612,5431,Patients,O
79613,5431,with,O
79614,5431,a,O
79615,5431,known,O
79616,5431,diagnosis,O
79617,5431,of,O
79618,5431,defective,O
79619,5431,hemostasis,B-Condition
79620,5431,and,O
79621,5431,past,O
79622,5431,history,O
79623,5431,of,O
79624,5431,clinical,O
79625,5431,bleeding,B-Condition
79626,5431,requiring,O
79627,5431,transfusion,B-Procedure
79628,5431,and,O
79629,5431,treatment,B-Procedure
79630,5431,;,O
79631,5432,Patients,O
79632,5432,who,O
79633,5432,have,O
79634,5432,had,O
79635,5432,an,O
79636,5432,operative,B-Procedure
79637,5432,procedure,I-Procedure
79638,5432,involving,O
79639,5432,the,O
79640,5432,eye,O
79641,5432,",",O
79642,5432,ear,O
79643,5432,",",O
79644,5432,or,O
79645,5432,central,O
79646,5432,nervous,O
79647,5432,system,O
79648,5432,within,O
79649,5432,one,O
79650,5432,month,O
79651,5432,;,O
79652,5433,Patients,O
79653,5433,with,O
79654,5433,severe,O
79655,5433,uncontrolled,O
79656,5433,hypertension,B-Condition
79657,5433,with,O
79658,5433,systolic,O
79659,5433,BP,O
79660,5433,>,O
79661,5433,220mmHg,O
79662,5433,or,O
79663,5433,diastolic,O
79664,5433,BP,O
79665,5433,>,O
79666,5433,120mmHg,O
79667,5433,;,O
79668,5434,Patients,O
79669,5434,with,O
79670,5434,an,O
79671,5434,absolute,O
79672,5434,body,O
79673,5434,weight,O
79674,5434,of,O
79675,5434,less,O
79676,5434,than,O
79677,5434,41,O
79678,5434,kilograms,O
79679,5434,(,O
79680,5434,90.4,O
79681,5434,lbs,O
79682,5434,),O
79683,5434,at,O
79684,5434,baseline,O
79685,5434,visit,O
79686,5434,;,O
79687,5435,Vulnerable,O
79688,5435,patient,O
79689,5435,populations,O
79690,5435,including,O
79691,5435,prisoners,B-Person
79692,5435,and,O
79693,5435,institutionalized,O
79694,5435,individuals,O
79695,5435,.,O
79696,5436,Males,B-Person
79697,5436,and,O
79698,5436,females,B-Person
79699,5436,21,O
79700,5436,years,O
79701,5436,of,O
79702,5436,age,B-Person
79703,5436,or,O
79704,5436,older,O
79705,5436,;,O
79706,5437,Undergoing,O
79707,5437,elective,O
79708,5437,primary,O
79709,5437,",",O
79710,5437,resurfacing,O
79711,5437,arthroplasty,O
79712,5437,",",O
79713,5437,revision,O
79714,5437,",",O
79715,5437,or,O
79716,5437,second,O
79717,5437,stage,O
79718,5437,re,O
79719,5437,-,O
79720,5437,implantation,O
79721,5437,total,B-Procedure
79722,5437,hip,I-Procedure
79723,5437,replacement,I-Procedure
79724,5437,;,O
79725,5438,Undergoing,O
79726,5438,elective,O
79727,5438,primary,O
79728,5438,",",O
79729,5438,revision,O
79730,5438,",",O
79731,5438,or,O
79732,5438,second,O
79733,5438,stage,O
79734,5438,re,O
79735,5438,-,O
79736,5438,implantation,O
79737,5438,total,O
79738,5438,or,O
79739,5438,uni,O
79740,5438,compartmental,O
79741,5438,knee,B-Procedure
79742,5438,replacement,I-Procedure
79743,5438,;,O
79744,5439,Patient,O
79745,5439,has,O
79746,5439,necessary,O
79747,5439,mental,O
79748,5439,capacity,O
79749,5439,to,O
79750,5439,participate,O
79751,5439,and,O
79752,5439,is,O
79753,5439,able,O
79754,5439,to,O
79755,5439,comply,O
79756,5439,with,O
79757,5439,study,O
79758,5439,protocol,O
79759,5439,requirements,O
79760,5439,;,O
79761,5440,Patient,O
79762,5440,is,O
79763,5440,willing,O
79764,5440,and,O
79765,5440,able,O
79766,5440,to,O
79767,5440,give,O
79768,5440,informed,O
79769,5440,consent,O
79770,5440,;,O
79771,5440,and,O
79772,5441,Patient,O
79773,5441,is,O
79774,5441,willing,O
79775,5441,to,O
79776,5441,be,O
79777,5441,randomized,O
79778,5441,and,O
79779,5441,participate,O
79780,5441,.,O
79781,5442,Inability,B-Observation
79782,5442,to,I-Observation
79783,5442,follow,I-Observation
79784,5442,directions,I-Observation
79785,5442,or,I-Observation
79786,5442,comprehend,I-Observation
79787,5442,the,I-Observation
79788,5442,English,I-Observation
79789,5442,language,I-Observation
79790,5443,Severe,O
79791,5443,uncorrected,O
79792,5443,visual,O
79793,5443,or,O
79794,5443,auditory,B-Condition
79795,5443,handicaps,I-Condition
79796,5444,Delirium,B-Condition
79797,5444,at,O
79798,5444,screening,O
79799,5444,or,O
79800,5444,baseline,O
79801,5445,Emergency,B-Procedure
79802,5445,surgery,I-Procedure
79803,5446,Subject,O
79804,5446,or,O
79805,5446,legal,O
79806,5446,representative,O
79807,5446,has,O
79808,5446,voluntarily,O
79809,5446,signed,O
79810,5446,the,O
79811,5446,informed,O
79812,5446,consent,O
79813,5446,approved,O
79814,5446,by,O
79815,5446,the,O
79816,5446,Institutional,O
79817,5446,Review,O
79818,5446,Board,O
79819,5446,",",O
79820,5447,Hip,B-Procedure
79821,5447,fracture,I-Procedure
79822,5447,surgery,I-Procedure
79823,5447,scheduled,O
79824,5447,under,O
79825,5447,general,B-Procedure
79826,5447,anesthesia,I-Procedure
79827,5448,Subject,O
79828,5448,is,O
79829,5448,65,O
79830,5448,years,O
79831,5448,or,O
79832,5448,older,B-Person
79833,5448,on,O
79834,5448,the,O
79835,5448,day,O
79836,5448,of,O
79837,5448,surgery,B-Procedure
79838,5449,Contraindication,B-Condition
79839,5449,for,O
79840,5449,the,O
79841,5449,use,O
79842,5449,of,O
79843,5449,corticosteroids,B-Drug
79844,5449,or,O
79845,5449,local,B-Drug
79846,5449,anesthetics,I-Drug
79847,5450,Presence,O
79848,5450,of,O
79849,5450,inflammatory,B-Condition
79850,5450,arthropathy,I-Condition
79851,5450,or,O
79852,5450,neuropathy,O
79853,5451,Skin,B-Condition
79854,5451,lesions,I-Condition
79855,5451,in,O
79856,5451,the,O
79857,5451,area,O
79858,5452,diabetes,B-Condition
79859,5452,mellitus,I-Condition
79860,5453,Infiltration,B-Condition
79861,5453,or,O
79862,5453,previous,B-Procedure
79863,5453,surgery,I-Procedure
79864,5453,in,O
79865,5453,the,O
79866,5453,area,O
79867,5454,Refusal,O
79868,5454,to,O
79869,5454,participate,O
79870,5454,in,O
79871,5454,the,O
79872,5454,study,O
79873,5455,Clinical,B-Mood
79874,5455,suspicion,I-Mood
79875,5455,of,O
79876,5455,Morton,B-Condition
79877,5455,neuroma,I-Condition
79878,5455,confirmed,O
79879,5455,in,O
79880,5455,ultrasound,B-Procedure
79881,5455,scan,I-Procedure
79882,5456,Symptoms,B-Condition
79883,5456,present,O
79884,5456,more,O
79885,5456,than,O
79886,5456,six,O
79887,5456,months,O
79888,5457,The,O
79889,5457,thickness,O
79890,5457,of,O
79891,5457,the,O
79892,5457,nerve,O
79893,5457,must,O
79894,5457,be,O
79895,5457,at,O
79896,5457,least,O
79897,5457,2,O
79898,5457,mm,O
79899,5457,in,O
79900,5457,short,O
79901,5457,axis,O
79902,5457,and,O
79903,5457,at,O
79904,5457,least,O
79905,5457,5,O
79906,5457,mm,O
79907,5457,in,O
79908,5457,the,O
79909,5457,longitudinal,O
79910,5457,axis,O
79911,5457,.,O
79912,5458,Presence,O
79913,5458,of,O
79914,5458,severe,O
79915,5458,systemic,B-Condition
79916,5458,disease,I-Condition
79917,5459,Presence,O
79918,5459,of,O
79919,5459,coagulation,B-Condition
79920,5459,disorders,I-Condition
79921,5460,Current,O
79922,5460,or,O
79923,5460,previous,O
79924,5460,history,B-Observation
79925,5460,of,O
79926,5460,analgesic,B-Condition
79927,5460,dependence,I-Condition
79928,5461,Allergy,B-Condition
79929,5461,to,O
79930,5461,any,O
79931,5461,of,O
79932,5461,the,O
79933,5461,drugs,B-Drug
79934,5461,used,I-Drug
79935,5461,in,I-Drug
79936,5461,the,I-Drug
79937,5461,study,I-Drug
79938,5462,Women,B-Person
79939,5462,pregnant,B-Condition
79940,5462,or,O
79941,5462,lactating,B-Condition
79942,5462,",",O
79943,5462,or,O
79944,5462,women,B-Person
79945,5462,planning,B-Mood
79946,5462,to,I-Mood
79947,5462,become,I-Mood
79948,5462,pregnant,B-Condition
79949,5463,Presence,O
79950,5463,of,O
79951,5463,hearing,B-Condition
79952,5463,loss,I-Condition
79953,5464,Presence,O
79954,5464,of,O
79955,5464,cardiovascular,B-Condition
79956,5464,comorbidities,I-Condition
79957,5465,Presence,O
79958,5465,of,O
79959,5465,hepatic,B-Condition
79960,5465,comorbidities,I-Condition
79961,5466,Presence,O
79962,5466,of,O
79963,5466,kidney,B-Condition
79964,5466,comorbidities,I-Condition
79965,5467,Presence,O
79966,5467,of,O
79967,5467,cognitive,B-Condition
79968,5467,disabilities,I-Condition
79969,5468,Scheduled,B-Mood
79970,5468,to,I-Mood
79971,5468,undergo,I-Mood
79972,5468,bilateral,O
79973,5468,palatine,B-Procedure
79974,5468,tonsillectomy,I-Procedure
79975,5468,as,O
79976,5468,the,O
79977,5468,only,O
79978,5468,procedure,B-Procedure
79979,5469,Known,O
79980,5469,upper,B-Condition
79981,5469,gastrointestinal,I-Condition
79982,5469,malignancy,I-Condition
79983,5470,Bleeding,B-Condition
79984,5470,from,O
79985,5470,gastric,B-Condition
79986,5470,varices,I-Condition
79987,5470,",",O
79988,5470,with,O
79989,5470,or,O
79990,5470,without,O
79991,5470,esophageal,B-Condition
79992,5470,varices,I-Condition
79993,5471,Use,O
79994,5471,of,O
79995,5471,any,O
79996,5471,other,O
79997,5471,endoscopic,B-Procedure
79998,5471,method,I-Procedure
79999,5471,to,O
80000,5471,stop,O
80001,5471,GI,B-Condition
80002,5471,bleeding,I-Condition
80003,5471,beyond,O
80004,5471,endoscopic,B-Procedure
80005,5471,band,I-Procedure
80006,5471,ligation,I-Procedure
80007,5472,Variceal,B-Condition
80008,5472,bleeding,I-Condition
80009,5472,in,O
80010,5472,the,O
80011,5472,last,O
80012,5472,90,O
80013,5472,days,O
80014,5473,History,B-Observation
80015,5473,of,O
80016,5473,transjugular,B-Procedure
80017,5473,",",I-Procedure
80018,5473,intrahepatic,I-Procedure
80019,5473,",",I-Procedure
80020,5473,portosystemic,I-Procedure
80021,5473,shunt,I-Procedure
80022,5473,(,I-Procedure
80023,5473,TIPS,I-Procedure
80024,5473,),I-Procedure
80025,5473,or,O
80026,5473,vascular,B-Procedure
80027,5473,decompression,I-Procedure
80028,5473,surgery,I-Procedure
80029,5474,Pregnant,B-Condition
80030,5474,females,B-Person
80031,5475,Incarcerated,B-Person
80032,5475,individuals,I-Person
80033,5476,Myocardial,B-Condition
80034,5476,infarct,I-Condition
80035,5476,",",O
80036,5476,cerebrovascular,B-Condition
80037,5476,accident,I-Condition
80038,5476,",",O
80039,5476,sepsis,B-Condition
80040,5476,",",O
80041,5476,respiratory,B-Condition
80042,5476,failure,I-Condition
80043,5476,",",O
80044,5476,or,O
80045,5476,severe,O
80046,5476,intercurrent,B-Condition
80047,5476,illness,I-Condition
80048,5476,within,O
80049,5476,the,O
80050,5476,previous,O
80051,5476,6,O
80052,5476,weeks,O
80053,5477,Non,B-Condition
80054,5477,-,I-Condition
80055,5477,cirrhotic,I-Condition
80056,5477,portal,I-Condition
80057,5477,hypertension,I-Condition
80058,5477,causing,O
80059,5477,esophageal,B-Condition
80060,5477,varices,I-Condition
80061,5478,Known,B-Mood
80062,5478,or,O
80063,5478,suspected,B-Mood
80064,5478,allergy,B-Condition
80065,5478,to,O
80066,5478,octreotide,B-Drug
80067,5479,Adult,B-Person
80068,5479,males,B-Person
80069,5479,and,O
80070,5479,females,B-Person
80071,5479,who,O
80072,5479,are,O
80073,5479,18,O
80074,5479,years,O
80075,5479,of,O
80076,5479,age,O
80077,5479,or,O
80078,5479,older,O
80079,5479,.,O
80080,5480,Evidence,B-Mood
80081,5480,or,O
80082,5480,suspicion,B-Mood
80083,5480,of,O
80084,5480,upper,B-Condition
80085,5480,gastrointestinal,I-Condition
80086,5480,bleed,I-Condition
80087,5480,(,I-Condition
80088,5480,GIB,I-Condition
80089,5480,),I-Condition
80090,5481,Patient,O
80091,5481,with,O
80092,5481,known,B-Mood
80093,5481,or,O
80094,5481,suspected,B-Mood
80095,5481,cirrhosis,B-Condition
80096,5482,Upper,B-Condition
80097,5482,GIB,I-Condition
80098,5482,secondary,O
80099,5482,to,O
80100,5482,bleeding,O
80101,5482,esophageal,B-Condition
80102,5482,varices,I-Condition
80103,5482,as,O
80104,5482,show,O
80105,5482,by,O
80106,5482,esophageal,B-Procedure
80107,5482,endoscopy,I-Procedure
80108,5482,",",O
80109,5482,requiring,B-Mood
80110,5482,endoscopic,B-Procedure
80111,5482,band,I-Procedure
80112,5482,ligation,I-Procedure
80113,5482,(,I-Procedure
80114,5482,EBL,I-Procedure
80115,5482,),I-Procedure
80116,5482,at,O
80117,5482,presentation,O
80118,5483,Willing,O
80119,5483,and,O
80120,5483,able,O
80121,5483,to,O
80122,5483,provide,O
80123,5483,informed,O
80124,5483,consent,O
80125,5483,for,O
80126,5483,study,O
80127,5483,",",O
80128,5483,or,O
80129,5483,have,O
80130,5483,a,O
80131,5483,Legally,O
80132,5483,authorized,O
80133,5483,representative,O
80134,5483,(,O
80135,5483,LAR,O
80136,5483,),O
80137,5483,provide,O
80138,5483,consent,O
80139,5483,if,O
80140,5483,the,O
80141,5483,patient,O
80142,5483,is,O
80143,5483,unable,O
80144,5483,to,O
80145,5483,do,O
80146,5483,so,O
80147,5484,Active,O
80148,5484,substance,B-Condition
80149,5484,dependency,I-Condition
80150,5485,History,B-Observation
80151,5485,of,O
80152,5485,severe,B-Condition
80153,5485,head,I-Condition
80154,5485,injury,I-Condition
80155,5486,Non,B-Condition
80156,5486,-,I-Condition
80157,5486,affective,I-Condition
80158,5486,psychosis,I-Condition
80159,5487,Premorbid,O
80160,5487,IQ,O
80161,5487,of,O
80162,5487,over,O
80163,5487,70,O
80164,5488,A,O
80165,5488,service,O
80166,5488,user,O
80167,5488,of,O
80168,5488,the,O
80169,5488,early,O
80170,5488,intervention,O
80171,5488,service,O
80172,5489,Aged,B-Person
80173,5489,18,O
80174,5489,or,O
80175,5489,over,O
80176,5489,(,O
80177,5489,up,O
80178,5489,to,O
80179,5489,the,O
80180,5489,age,O
80181,5489,of,O
80182,5489,35,O
80183,5489,which,O
80184,5489,is,O
80185,5489,the,O
80186,5489,limit,O
80187,5489,for,O
80188,5489,the,O
80189,5489,early,O
80190,5489,intervention,O
80191,5489,service,O
80192,5489,),O
80193,5490,Psychiatrically,B-Condition
80194,5490,stable,I-Condition
80195,5490,enough,O
80196,5490,to,O
80197,5490,attend,O
80198,5490,to,O
80199,5490,completion,O
80200,5490,(,O
80201,5490,no,O
80202,5490,hospitalisations,B-Procedure
80203,5490,or,O
80204,5490,medication,B-Observation
80205,5490,changes,I-Observation
80206,5490,in,O
80207,5490,last,O
80208,5490,4,O
80209,5490,weeks,O
80210,5490,),O
80211,5491,Pediatric,B-Person
80212,5491,patients,O
80213,5491,(,O
80214,5491,under,O
80215,5491,18,O
80216,5491,years,B-Person
80217,5491,),O
80218,5491,Pregnancy,B-Condition
80219,5491,Patients,O
80220,5491,who,O
80221,5491,are,O
80222,5491,unresponsive,B-Observation
80223,5491,at,O
80224,5491,baseline,O
80225,5491,",",O
80226,5491,who,O
80227,5491,have,O
80228,5491,neurologic,B-Condition
80229,5491,deficits,I-Condition
80230,5491,at,O
80231,5491,baseline,O
80232,5491,",",O
80233,5491,or,O
80234,5491,who,O
80235,5491,are,O
80236,5491,allergic,B-Condition
80237,5491,to,O
80238,5491,dexmedetomidine,B-Drug
80239,5492,Adult,B-Person
80240,5492,patients,O
80241,5492,(,O
80242,5492,18years,O
80243,5492,old,O
80244,5492,or,O
80245,5492,older,O
80246,5492,),O
80247,5492,undergoing,O
80248,5492,living,B-Procedure
80249,5492,-,I-Procedure
80250,5492,donor,I-Procedure
80251,5492,or,I-Procedure
80252,5492,deceased,I-Procedure
80253,5492,-,I-Procedure
80254,5492,donor,I-Procedure
80255,5492,liver,I-Procedure
80256,5492,transplantation,I-Procedure
80257,5493,Contraindication,B-Condition
80258,5493,for,O
80259,5493,propofol,B-Drug
80260,5493,administration,O
80261,5494,Contraindication,B-Condition
80262,5494,for,O
80263,5494,IAP,B-Procedure
80264,5494,measurement,I-Procedure
80265,5494,in,O
80266,5494,supine,O
80267,5494,position,O
80268,5494,with,O
80269,5494,head,O
80270,5494,-,O
80271,5494,of,O
80272,5494,-,O
80273,5494,bed,O
80274,5494,at,O
80275,5494,0,O
80276,5494,°,O
80277,5495,Other,O
80278,5495,intervention,B-Procedure
80279,5495,for,I-Procedure
80280,5495,reduction,I-Procedure
80281,5495,of,I-Procedure
80282,5495,IAP,I-Procedure
80283,5495,planned,B-Mood
80284,5496,Previous,O
80285,5496,propofol,O
80286,5496,infusion,O
80287,5496,rate,O
80288,5496,>,O
80289,5496,4,O
80290,5496,mg,O
80291,5496,/,O
80292,5496,kg,O
80293,5496,/,O
80294,5496,h,O
80295,5497,Age,B-Person
80296,5497,18,O
80297,5497,years,O
80298,5497,or,O
80299,5497,older,O
80300,5498,Mechanical,B-Procedure
80301,5498,ventilation,I-Procedure
80302,5499,IAP,O
80303,5499,between,O
80304,5499,12,O
80305,5499,and,O
80306,5499,20,O
80307,5499,mmHg,O
80308,5499,in,O
80309,5499,at,O
80310,5499,least,O
80311,5499,two,O
80312,5499,consecutive,O
80313,5499,measurements,O
80314,5499,within,O
80315,5499,1,O
80316,5499,-,O
80317,5499,12,O
80318,5499,h,O
80319,5500,Spontaneous,O
80320,5500,breathing,O
80321,5500,activity,O
80322,5500,of,O
80323,5500,at,O
80324,5500,least,O
80325,5500,6,O
80326,5500,breaths,O
80327,5500,/,O
80328,5500,minute,O
80329,5501,RASS,O
80330,5501,score,O
80331,5501,between,O
80332,5501,0,O
80333,5501,and,O
80334,5501,-4,O
80335,5502,Physician,O
80336,5502,-,O
80337,5502,led,O
80338,5502,sedation,B-Procedure
80339,5502,(,O
80340,5502,if,O
80341,5502,sedated,O
80342,5502,;,O
80343,5502,as,O
80344,5502,opposed,O
80345,5502,to,O
80346,5502,nurse,O
80347,5502,-,O
80348,5502,led,O
80349,5502,protocol,O
80350,5502,),O
80351,5503,Previous,O
80352,5503,exposure,O
80353,5503,to,O
80354,5503,drugs,B-Drug
80355,5503,such,O
80356,5503,as,O
80357,5503,fingolimod,B-Drug
80358,5503,",",O
80359,5503,natalizumab,B-Drug
80360,5503,",",O
80361,5503,alemtuzumab,B-Drug
80362,5503,",",O
80363,5503,mitoxantrone,B-Drug
80364,5503,and,O
80365,5503,ocrelizumab,B-Drug
80366,5503,.,O
80367,5504,Positive,O
80368,5504,hepatitis,O
80369,5504,C,O
80370,5504,or,O
80371,5504,hepatitis,O
80372,5504,B,O
80373,5504,surface,O
80374,5504,antigen,O
80375,5504,test,O
80376,5504,and/or,O
80377,5504,hepatits,O
80378,5504,B,O
80379,5504,core,O
80380,5504,antibody,O
80381,5504,test,O
80382,5504,for,O
80383,5504,immunoglobulin,O
80384,5504,G,O
80385,5504,(,O
80386,5504,IgG,O
80387,5504,),O
80388,5504,and/or,O
80389,5504,immunoglobulin,O
80390,5504,M,O
80391,5504,(,O
80392,5504,IgM,O
80393,5504,),O
80394,5504,.,O
80395,5505,Current,O
80396,5505,or,O
80397,5505,previous,O
80398,5505,history,O
80399,5505,of,O
80400,5505,immune,B-Condition
80401,5505,deficiency,I-Condition
80402,5505,disorders,I-Condition
80403,5505,including,O
80404,5505,a,O
80405,5505,positive,O
80406,5505,human,O
80407,5505,immunodeficiency,O
80408,5505,virus,O
80409,5505,(,O
80410,5505,HIV,O
80411,5505,),O
80412,5505,result,O
80413,5505,.,O
80414,5506,Currently,O
80415,5506,receiving,O
80416,5506,immunosuppressive,B-Procedure
80417,5506,or,I-Procedure
80418,5506,myelosuppressive,I-Procedure
80419,5506,therapy,I-Procedure
80420,5506,with,O
80421,5506,",",O
80422,5506,for,O
80423,5506,example,O
80424,5506,",",O
80425,5506,monoclonal,B-Drug
80426,5506,antibodies,I-Drug
80427,5506,",",O
80428,5506,methotrexate,B-Drug
80429,5506,",",O
80430,5506,cyclophosphamide,B-Drug
80431,5506,",",O
80432,5506,cyclosporine,B-Drug
80433,5506,or,O
80434,5506,azathioprine,B-Drug
80435,5506,",",O
80436,5506,or,O
80437,5506,chronic,O
80438,5506,use,O
80439,5506,of,O
80440,5506,corticosteroids,B-Drug
80441,5506,.,O
80442,5507,History,B-Observation
80443,5507,of,O
80444,5507,tuberculosis,B-Procedure
80445,5507,",",O
80446,5507,presence,O
80447,5507,of,O
80448,5507,active,O
80449,5507,tuberculosis,B-Procedure
80450,5507,",",O
80451,5507,or,O
80452,5507,latent,O
80453,5507,tuberculosis,B-Procedure
80454,5508,Evidence,B-Mood
80455,5508,or,O
80456,5508,suspect,B-Mood
80457,5508,of,O
80458,5508,Progressive,B-Condition
80459,5508,Multifocal,I-Condition
80460,5508,Leukoencephalopathy,I-Condition
80461,5508,(,I-Condition
80462,5508,PML,I-Condition
80463,5508,),I-Condition
80464,5508,in,O
80465,5508,Magnetic,B-Procedure
80466,5508,Resonance,I-Procedure
80467,5508,Imaging,I-Procedure
80468,5508,(,I-Procedure
80469,5508,MRI,I-Procedure
80470,5508,),I-Procedure
80471,5508,.,O
80472,5509,Active,O
80473,5509,malignancy,B-Condition
80474,5509,or,O
80475,5509,history,B-Observation
80476,5509,of,O
80477,5509,malignancy,B-Condition
80478,5509,.,O
80479,5510,Other,O
80480,5510,protocol,O
80481,5510,defined,O
80482,5510,exclusion,O
80483,5510,criteria,O
80484,5510,could,O
80485,5510,apply,O
80486,5510,.,O
80487,5511,Highly,O
80488,5511,active,O
80489,5511,RMS,B-Condition
80490,5511,as,O
80491,5511,defined,O
80492,5511,by,O
80493,5511,:,O
80494,5512,One,O
80495,5512,relapse,B-Condition
80496,5512,in,O
80497,5512,the,O
80498,5512,previous,O
80499,5512,year,O
80500,5512,and,O
80501,5512,at,O
80502,5512,least,O
80503,5512,1,O
80504,5512,T1,O
80505,5512,Gadolinium,O
80506,5512,(,O
80507,5512,Gd)+,O
80508,5512,lesion,B-Condition
80509,5512,or,O
80510,5512,9,O
80511,5512,or,O
80512,5512,more,O
80513,5512,T2,B-Condition
80514,5512,lesions,I-Condition
80515,5512,",",O
80516,5512,while,O
80517,5512,on,O
80518,5512,therapy,B-Procedure
80519,5512,with,O
80520,5512,other,O
80521,5512,disease,B-Drug
80522,5512,modifying,I-Drug
80523,5512,drugs,I-Drug
80524,5512,(,I-Drug
80525,5512,DMDs,I-Drug
80526,5512,),I-Drug
80527,5513,Two,O
80528,5513,or,O
80529,5513,more,O
80530,5513,relapses,B-Condition
80531,5513,in,O
80532,5513,the,O
80533,5513,previous,O
80534,5513,year,O
80535,5513,",",O
80536,5513,whether,O
80537,5513,on,O
80538,5513,DMD,O
80539,5513,treatment,O
80540,5513,or,O
80541,5513,not,O
80542,5513,.,O
80543,5514,Expanded,O
80544,5514,Disability,O
80545,5514,Status,O
80546,5514,Scale,O
80547,5514,(,O
80548,5514,EDSS,O
80549,5514,),O
80550,5514,score,O
80551,5514,less,O
80552,5514,than,O
80553,5514,equals,O
80554,5514,to,O
80555,5514,(,O
80556,5514,<,O
80557,5514,=),O
80558,5514,5.0,O
80559,5514,.,O
80560,5515,Other,O
80561,5515,protocol,O
80562,5515,defined,O
80563,5515,inclusion,O
80564,5515,criteria,O
80565,5515,could,O
80566,5515,apply,O
80567,5515,.,O
80568,5516,A,O
80569,5516,prescription,O
80570,5516,of,O
80571,5516,a,O
80572,5516,NOAC,B-Drug
80573,5516,within,O
80574,5516,90,O
80575,5516,days,O
80576,5516,prior,O
80577,5516,to,O
80578,5516,hospitalization,B-Procedure
80579,5516,or,O
80580,5516,outpatient,B-Procedure
80581,5516,clinic,I-Procedure
80582,5516,visit,I-Procedure
80583,5516,for,O
80584,5516,VTE,B-Condition
80585,5516,.,O
80586,5517,Patients,O
80587,5517,with,O
80588,5517,NOAC,B-Observation
80589,5517,preference,I-Observation
80590,5517,apart,O
80591,5517,from,O
80592,5517,preference,O
80593,5517,consistent,O
80594,5517,with,O
80595,5517,current,O
80596,5517,cluster,O
80597,5517,randomized,O
80598,5517,NOAC,O
80599,5517,.,O
80600,5518,Other,O
80601,5518,contraindications,B-Condition
80602,5518,mentioned,O
80603,5518,in,O
80604,5518,the,O
80605,5518,"""",O
80606,5518,Summary,O
80607,5518,of,O
80608,5518,Product,O
80609,5518,Characteristics,O
80610,5518,"""",O
80611,5518,for,O
80612,5518,the,O
80613,5518,respective,O
80614,5518,NOAC,B-Drug
80615,5518,.,O
80616,5519,A,O
80617,5519,diagnosis,O
80618,5519,of,O
80619,5519,VTE,B-Condition
80620,5519,in,O
80621,5519,outpatient,O
80622,5519,clinic,O
80623,5519,or,O
80624,5519,as,O
80625,5519,discharge,O
80626,5519,diagnosis,O
80627,5519,after,O
80628,5519,hospitalization,B-Procedure
80629,5519,.,O
80630,5520,A,O
80631,5520,claimed,O
80632,5520,prescription,B-Procedure
80633,5520,of,O
80634,5520,a,O
80635,5520,NOAC,B-Drug
80636,5520,from,O
80637,5520,a,O
80638,5520,Danish,O
80639,5520,pharmacy,O
80640,5520,within,O
80641,5520,14,O
80642,5520,days,O
80643,5520,of,O
80644,5520,discharge,B-Procedure
80645,5520,or,O
80646,5520,outpatient,B-Procedure
80647,5520,clinic,I-Procedure
80648,5520,visit,I-Procedure
80649,5520,.,O
80650,5521,NA,O
80651,5522,Provision,O
80652,5522,of,O
80653,5522,written,O
80654,5522,informed,O
80655,5522,consent,O
80656,5522,(,O
80657,5522,by,O
80658,5522,patient,O
80659,5522,or,O
80660,5522,appropriate,O
80661,5522,designee,O
80662,5522,according,O
80663,5522,to,O
80664,5522,local,O
80665,5522,regulations,O
80666,5522,),O
80667,5522,prior,O
80668,5522,to,O
80669,5522,any,O
80670,5522,study,O
80671,5522,specific,O
80672,5522,procedures,O
80673,5522,.,O
80674,5523,Aged,B-Person
80675,5523,18,O
80676,5523,years,O
80677,5523,or,O
80678,5523,older,O
80679,5523,",",O
80680,5523,male,B-Person
80681,5523,or,O
80682,5523,female,B-Person
80683,5523,.,O
80684,5524,History,O
80685,5524,of,O
80686,5524,stable,B-Condition
80687,5524,angina,I-Condition
80688,5524,pectoris,I-Condition
80689,5524,with,O
80690,5524,angiographic,O
80691,5524,evidence,O
80692,5524,of,O
80693,5524,CAD,B-Condition
80694,5524,(,O
80695,5524,diameter,B-Observation
80696,5524,stenosis,I-Observation
80697,5524,=,O
80698,5524,50,O
80699,5524,%,O
80700,5524,),O
80701,5524,in,O
80702,5524,major,O
80703,5524,",",O
80704,5524,i.e.,O
80705,5524,",",O
80706,5524,left,O
80707,5524,main,O
80708,5524,",",O
80709,5524,left,O
80710,5524,anterior,O
80711,5524,descending,O
80712,5524,",",O
80713,5524,left,O
80714,5524,circumflex,O
80715,5524,",",O
80716,5524,and,O
80717,5524,right,O
80718,5524,coronary,O
80719,5524,arteries,O
80720,5524,.,O
80721,5525,History,O
80722,5525,of,O
80723,5525,previous,O
80724,5525,myocardial,B-Condition
80725,5525,infarction,I-Condition
80726,5525,(,O
80727,5525,MI,B-Condition
80728,5525,),O
80729,5526,History,O
80730,5526,of,O
80731,5526,coronary,B-Procedure
80732,5526,revascularization,I-Procedure
80733,5526,",",O
80734,5526,i.e.,O
80735,5526,",",O
80736,5526,percutaneous,B-Procedure
80737,5526,coronary,I-Procedure
80738,5526,intervention,I-Procedure
80739,5526,(,O
80740,5526,PCI,B-Procedure
80741,5526,),O
80742,5526,or,O
80743,5526,coronary,B-Procedure
80744,5526,artery,I-Procedure
80745,5526,bypass,I-Procedure
80746,5526,graft,I-Procedure
80747,5526,(,O
80748,5526,CABG,B-Procedure
80749,5526,),O
80750,5526,",",O
80751,5526,not,O
80752,5526,including,O
80753,5526,the,O
80754,5526,elective,O
80755,5526,PCI,B-Procedure
80756,5526,during,O
80757,5526,the,O
80758,5526,index,O
80759,5526,hospitalization,O
80760,5527,Documented,O
80761,5527,history,O
80762,5527,of,O
80763,5527,type,B-Condition
80764,5527,2,I-Condition
80765,5527,diabetes,I-Condition
80766,5527,mellitus,I-Condition
80767,5527,.,O
80768,5528,Post,B-Observation
80769,5528,-,I-Observation
80770,5528,procedural,I-Observation
80771,5528,residual,I-Observation
80772,5528,diameter,I-Observation
80773,5528,stenosis,I-Observation
80774,5528,of,O
80775,5528,the,O
80776,5528,treated,O
80777,5528,lesions,B-Condition
80778,5528,<,O
80779,5528,20,O
80780,5528,%,O
80781,5528,in,O
80782,5528,patients,O
80783,5528,with,O
80784,5528,stent,B-Procedure
80785,5528,implantation,I-Procedure
80786,5528,or,O
80787,5528,<,O
80788,5528,50,O
80789,5528,%,O
80790,5528,in,O
80791,5528,those,O
80792,5528,with,O
80793,5528,balloon,B-Procedure
80794,5528,angioplasty,I-Procedure
80795,5529,Post,B-Condition
80796,5529,-,I-Condition
80797,5529,procedural,I-Condition
80798,5529,thrombolysis,I-Condition
80799,5529,in,O
80800,5529,myocardial,B-Condition
80801,5529,infarction,I-Condition
80802,5529,(,O
80803,5529,TIMI,O
80804,5529,),O
80805,5529,grade,O
80806,5529,3,O
80807,5529,flow,O
80808,5529,in,O
80809,5529,treated,O
80810,5529,vessels,O
80811,5530,Negative,O
80812,5530,cardiac,O
80813,5530,troponin,O
80814,5530,test,O
80815,5530,before,O
80816,5530,the,O
80817,5530,index,O
80818,5530,elective,O
80819,5530,PCI,B-Procedure
80820,5530,.,O
80821,5531,Taking,O
80822,5531,Clopidogrel,B-Drug
80823,5531,75,O
80824,5531,mg,O
80825,5531,daily,O
80826,5531,dose,O
80827,5531,for,O
80828,5531,at,O
80829,5531,least,O
80830,5531,7,O
80831,5531,days,O
80832,5531,or,O
80833,5531,taking,O
80834,5531,Clopidogrel,B-Drug
80835,5531,75,O
80836,5531,mg,O
80837,5531,daily,O
80838,5531,dose,O
80839,5531,for,O
80840,5531,less,O
80841,5531,than,O
80842,5531,7,O
80843,5531,days,O
80844,5531,but,O
80845,5531,with,O
80846,5531,300,O
80847,5531,to,O
80848,5531,600,O
80849,5531,mg,O
80850,5531,Clopidogrel,B-Drug
80851,5531,loading,O
80852,5531,dose,O
80853,5531,before,O
80854,5531,PCI,B-Procedure
80855,5531,.,O
80856,5532,Taking,O
80857,5532,acetylsalicylic,B-Drug
80858,5532,acid,I-Drug
80859,5532,(,O
80860,5532,ASA,B-Drug
80861,5532,),O
80862,5532,100,O
80863,5532,mg,O
80864,5532,daily,O
80865,5532,treatment,O
80866,5532,for,O
80867,5532,at,O
80868,5532,least,O
80869,5532,7,O
80870,5532,days,O
80871,5532,or,O
80872,5532,taking,O
80873,5532,ASA,B-Drug
80874,5532,100,O
80875,5532,mg,O
80876,5532,daily,O
80877,5532,dose,O
80878,5532,for,O
80879,5532,less,O
80880,5532,than,O
80881,5532,7,O
80882,5532,days,O
80883,5532,but,O
80884,5532,with,O
80885,5532,300,O
80886,5532,mg,O
80887,5532,ASA,B-Drug
80888,5532,loading,O
80889,5532,dose,O
80890,5532,before,O
80891,5532,PCI,B-Procedure
80892,5532,.,O
80893,5533,have,O
80894,5533,a,O
80895,5533,negative,O
80896,5533,urine,O
80897,5533,or,O
80898,5533,blood,O
80899,5533,pregnancy,O
80900,5533,test,O
80901,5533,at,O
80902,5533,enrolment,O
80903,5533,and,O
80904,5533,prior,O
80905,5533,to,O
80906,5533,randomization,O
80907,5533,;,O
80908,5534,currently,O
80909,5534,be,O
80910,5534,using,O
80911,5534,a,O
80912,5534,hormonal,O
80913,5534,contraceptive,O
80914,5534,and,O
80915,5534,agree,O
80916,5534,to,O
80917,5534,continue,O
80918,5534,its,O
80919,5534,use,O
80920,5534,in,O
80921,5534,addition,O
80922,5534,to,O
80923,5534,using,O
80924,5534,double,O
80925,5534,-,O
80926,5534,barrier,O
80927,5534,local,O
80928,5534,contraception,O
80929,5534,(,O
80930,5534,i.e.,O
80931,5534,",",O
80932,5534,intra,O
80933,5534,-,O
80934,5534,uterine,O
80935,5534,device,O
80936,5534,plus,O
80937,5534,spermicidal,O
80938,5534,and,O
80939,5534,condom,O
80940,5534,for,O
80941,5534,male,O
80942,5534,partner,O
80943,5534,),O
80944,5534,from,O
80945,5534,screening,O
80946,5534,through,O
80947,5534,study,O
80948,5534,completion,O
80949,5534,.,O
80950,5535,acute,B-Condition
80951,5535,myocardial,I-Condition
80952,5535,infarction,I-Condition
80953,5535,",",O
80954,5535,heart,B-Condition
80955,5535,failure,I-Condition
80956,5535,",",O
80957,5535,neoplastic,B-Condition
80958,5535,disease,I-Condition
80959,5535,",",O
80960,5535,chronic,B-Condition
80961,5535,diseases,I-Condition
80962,5535,that,O
80963,5535,may,O
80964,5535,affect,O
80965,5535,the,O
80966,5535,inflammatory,O
80967,5535,profile,O
80968,5535,both,O
80969,5535,systemic,O
80970,5535,and,O
80971,5535,epicardial,O
80972,5535,(,O
80973,5535,cancer,B-Condition
80974,5535,",",O
80975,5535,chronic,B-Condition
80976,5535,intestinal,I-Condition
80977,5535,inflammation,I-Condition
80978,5535,",",O
80979,5535,hepatitis,B-Condition
80980,5535,",",O
80981,5535,AIDS,B-Condition
80982,5535,),O
80983,5535,;,O
80984,5535,life,B-Observation
80985,5535,expectancy,I-Observation
80986,5535,<,O
80987,5535,6,O
80988,5535,months,O
80989,5535,",",O
80990,5535,previous,O
80991,5535,CABG,B-Procedure
80992,5535,and/or,O
80993,5535,other,O
80994,5535,open,B-Procedure
80995,5535,heart,I-Procedure
80996,5535,surgery,I-Procedure
80997,5535,intervention,I-Procedure
80998,5535,",",O
80999,5535,acute,B-Condition
81000,5535,coronary,I-Condition
81001,5535,syndrome,I-Condition
81002,5536,patients,O
81003,5536,aged,B-Person
81004,5536,>,O
81005,5536,18,O
81006,5536,",",O
81007,5536,<,O
81008,5536,75,O
81009,5536,",",O
81010,5536,left,O
81011,5536,ventricle,O
81012,5536,ejection,O
81013,5536,fraction,O
81014,5536,(,O
81015,5536,LVEF,O
81016,5536,),O
81017,5536,>,O
81018,5536,50,O
81019,5536,%,O
81020,5536,",",O
81021,5536,multivessel,B-Condition
81022,5536,coronary,I-Condition
81023,5536,disease,I-Condition
81024,5536,detected,O
81025,5536,by,O
81026,5536,coronarography,B-Procedure
81027,5536,",",O
81028,5536,indication,B-Mood
81029,5536,to,I-Mood
81030,5536,receive,I-Mood
81031,5536,a,O
81032,5536,CABG,B-Procedure
81033,5536,",",O
81034,5536,stable,O
81035,5536,CAD,B-Condition
81036,5536,.,O
81037,5536,All,O
81038,5536,diabetics,B-Condition
81039,5536,and,O
81040,5536,non,B-Condition
81041,5536,diabetics,I-Condition
81042,5536,.,O
81043,5537,Psychosis,B-Condition
81044,5538,Tourette,B-Condition
81045,5538,syndrome,I-Condition
81046,5539,Intelligence,O
81047,5539,quotient,O
81048,5539,(,O
81049,5539,IQ,O
81050,5539,),O
81051,5539,<,O
81052,5539,70,O
81053,5540,Pervasive,B-Condition
81054,5540,developmental,I-Condition
81055,5540,disorder,I-Condition
81056,5540,(,O
81057,5540,PDD,B-Condition
81058,5540,),O
81059,5541,ADHD,B-Condition
81060,5542,Previous,O
81061,5542,vaginal,B-Procedure
81062,5542,delivery,I-Procedure
81063,5542,.,O
81064,5543,Submucous,B-Condition
81065,5543,myoma,I-Condition
81066,5543,.,O
81067,5544,Uterine,B-Condition
81068,5544,anomalies,I-Condition
81069,5544,.,O
81070,5545,Undiagnosed,O
81071,5545,vaginal,B-Condition
81072,5545,bleeding,I-Condition
81073,5545,.,O
81074,5546,Pelvic,B-Condition
81075,5546,inflammatory,I-Condition
81076,5546,disease,I-Condition
81077,5546,.,O
81078,5547,Women,B-Person
81079,5547,with,O
81080,5547,expected,B-Mood
81081,5547,difficult,O
81082,5547,IUD,B-Procedure
81083,5547,insertion,I-Procedure
81084,5547,like,O
81085,5547,nulliparous,B-Observation
81086,5547,women,B-Person
81087,5547,and,O
81088,5547,women,B-Person
81089,5547,with,O
81090,5547,previous,O
81091,5547,cesarean,B-Procedure
81092,5547,section,I-Procedure
81093,5547,.,O
81094,5548,1,O
81095,5548,.,O
81096,5548,Currently,O
81097,5548,enrolled,O
81098,5548,in,O
81099,5548,another,O
81100,5548,research,O
81101,5548,trial,O
81102,5548,for,O
81103,5548,investigative,O
81104,5548,nutritional,O
81105,5548,or,O
81106,5548,other,O
81107,5548,therapies,O
81108,5548,thought,O
81109,5548,to,O
81110,5548,have,O
81111,5548,an,O
81112,5548,impact,O
81113,5548,on,O
81114,5548,immune,O
81115,5548,system,O
81116,5548,functioning,O
81117,5548,.,O
81118,5549,2,O
81119,5549,.,O
81120,5549,Unable,O
81121,5549,to,O
81122,5549,consent,O
81123,5549,to,O
81124,5549,the,O
81125,5549,study,O
81126,5549,.,O
81127,5550,3,O
81128,5550,.,O
81129,5550,Women,B-Person
81130,5550,who,O
81131,5550,are,O
81132,5550,pregnant,B-Condition
81133,5550,or,O
81134,5550,are,O
81135,5550,attempting,O
81136,5550,conception,O
81137,5550,",",O
81138,5550,especially,O
81139,5550,in,O
81140,5550,the,O
81141,5550,presence,O
81142,5550,of,O
81143,5550,a,O
81144,5550,history,O
81145,5550,of,O
81146,5550,recurrent,O
81147,5550,spontaneous,B-Condition
81148,5550,abortion,I-Condition
81149,5550,.,O
81150,5551,4,O
81151,5551,.,O
81152,5551,Other,O
81153,5551,medical,B-Condition
81154,5551,complications,I-Condition
81155,5551,that,O
81156,5551,might,O
81157,5551,preclude,O
81158,5551,one,O
81159,5551,from,O
81160,5551,participating,O
81161,5551,in,O
81162,5551,the,O
81163,5551,study,O
81164,5551,",",O
81165,5551,i.e.,O
81166,5551,",",O
81167,5551,recent,O
81168,5551,heart,B-Condition
81169,5551,attack,I-Condition
81170,5551,or,O
81171,5551,stroke,B-Condition
81172,5551,or,O
81173,5551,chronic,B-Condition
81174,5551,kidney,I-Condition
81175,5551,disease,I-Condition
81176,5551,.,O
81177,5552,5,O
81178,5552,.,O
81179,5552,Currently,O
81180,5552,taking,O
81181,5552,immunomodulatory,B-Drug
81182,5552,medication,I-Drug
81183,5552,",",O
81184,5552,i.e.,O
81185,5552,interferon,B-Drug
81186,5552,.,O
81187,5553,6,O
81188,5553,.,O
81189,5553,Currently,O
81190,5553,taking,O
81191,5553,other,O
81192,5553,medications,B-Drug
81193,5553,thought,O
81194,5553,to,O
81195,5553,have,O
81196,5553,an,O
81197,5553,impact,O
81198,5553,on,O
81199,5553,immune,O
81200,5553,system,O
81201,5553,functioning,O
81202,5553,",",O
81203,5553,i.e.,O
81204,5553,",",O
81205,5553,chemotherapeutic,B-Drug
81206,5553,agents,I-Drug
81207,5553,.,O
81208,5554,7,O
81209,5554,.,O
81210,5554,Known,O
81211,5554,allergy,B-Condition
81212,5554,to,I-Condition
81213,5554,rice,I-Condition
81214,5554,",",I-Condition
81215,5554,rice,I-Condition
81216,5554,bran,I-Condition
81217,5554,",",O
81218,5554,or,O
81219,5554,related,O
81220,5554,food,O
81221,5554,products,O
81222,5554,.,O
81223,5555,8,O
81224,5555,.,O
81225,5555,Known,O
81226,5555,allergy,B-Condition
81227,5555,to,I-Condition
81228,5555,mushrooms,I-Condition
81229,5555,or,I-Condition
81230,5555,related,I-Condition
81231,5555,food,I-Condition
81232,5555,products,I-Condition
81233,5555,.,O
81234,5556,9,O
81235,5556,.,O
81236,5556,History,B-Observation
81237,5556,of,O
81238,5556,malignancies,B-Condition
81239,5556,related,O
81240,5556,to,O
81241,5556,the,O
81242,5556,NK,O
81243,5556,cell,O
81244,5556,line,O
81245,5556,",",O
81246,5556,including,O
81247,5556,:,O
81248,5556,NK,B-Condition
81249,5556,cell,I-Condition
81250,5556,leukemias,I-Condition
81251,5556,and,O
81252,5556,T,B-Condition
81253,5556,-,I-Condition
81254,5556,cell,I-Condition
81255,5556,large,I-Condition
81256,5556,granular,I-Condition
81257,5556,lymphocyte,I-Condition
81258,5556,leukemias,I-Condition
81259,5556,",",O
81260,5556,NK,B-Condition
81261,5556,-,I-Condition
81262,5556,cell,I-Condition
81263,5556,lymphoproliferative,I-Condition
81264,5556,disease,I-Condition
81265,5556,of,I-Condition
81266,5556,granular,I-Condition
81267,5556,lymphocytes,I-Condition
81268,5556,",",O
81269,5556,and,O
81270,5556,NK,B-Condition
81271,5556,cell,I-Condition
81272,5556,lymphomas,I-Condition
81273,5556,",",O
81274,5556,e.g.,O
81275,5556,",",O
81276,5556,nasal,B-Condition
81277,5556,and,I-Condition
81278,5556,nasal,I-Condition
81279,5556,-,I-Condition
81280,5556,like,I-Condition
81281,5556,NK,I-Condition
81282,5556,/,I-Condition
81283,5556,T,I-Condition
81284,5556,-,I-Condition
81285,5556,cell,I-Condition
81286,5556,lymphomas,I-Condition
81287,5556,.,O
81288,5557,10,O
81289,5557,.,O
81290,5557,Current,O
81291,5557,smoker,B-Observation
81292,5557,.,O
81293,5558,1,O
81294,5558,.,O
81295,5558,Women,B-Person
81296,5558,and,O
81297,5558,men,B-Person
81298,5558,ages,B-Person
81299,5558,18,O
81300,5558,years,O
81301,5558,and,O
81302,5558,over,O
81303,5558,.,O
81304,5559,2,O
81305,5559,.,O
81306,5559,Interest,O
81307,5559,in,O
81308,5559,participating,O
81309,5559,in,O
81310,5559,a,O
81311,5559,novel,O
81312,5559,nutritional,O
81313,5559,supplement,O
81314,5559,program,O
81315,5559,.,O
81316,5560,3,O
81317,5560,.,O
81318,5560,Willingness,O
81319,5560,to,O
81320,5560,follow,O
81321,5560,recommendations,O
81322,5560,.,O
81323,5561,NA,O
81324,5562,Signed,O
81325,5562,Informed,O
81326,5562,Consent,O
81327,5562,Form,O
81328,5563,Patients,O
81329,5563,having,O
81330,5563,physical,O
81331,5563,and,O
81332,5563,mental,O
81333,5563,ability,O
81334,5563,to,O
81335,5563,participate,O
81336,5563,in,O
81337,5563,the,O
81338,5563,study,O
81339,5564,Patients,O
81340,5564,of,O
81341,5564,both,O
81342,5564,sexes,B-Person
81343,5564,aged,B-Person
81344,5564,35,O
81345,5564,to,O
81346,5564,65,O
81347,5564,years,O
81348,5565,Presence,O
81349,5565,of,O
81350,5565,documented,O
81351,5565,ST,B-Condition
81352,5565,-,I-Condition
81353,5565,elevation,I-Condition
81354,5565,myocardial,I-Condition
81355,5565,infarction,I-Condition
81356,5565,confirmed,O
81357,5565,by,O
81358,5565,ECG,B-Procedure
81359,5565,",",O
81360,5565,as,O
81361,5565,well,O
81362,5565,as,O
81363,5565,troponin,O
81364,5565,I,O
81365,5565,and,O
81366,5565,CK,O
81367,5565,-,O
81368,5565,MB,O
81369,5565,levels,O
81370,5565,.,O
81371,5566,Presence,O
81372,5566,of,O
81373,5566,hemodynamically,O
81374,5566,relevant,O
81375,5566,stenosis,B-Condition
81376,5566,of,I-Condition
81377,5566,one,I-Condition
81378,5566,artery,I-Condition
81379,5566,(,O
81380,5566,i.e.,O
81381,5566,",",O
81382,5566,the,O
81383,5566,infarct,B-Condition
81384,5566,-,I-Condition
81385,5566,related,I-Condition
81386,5566,artery,I-Condition
81387,5566,),O
81388,5566,confirmed,O
81389,5566,by,O
81390,5566,coronary,B-Procedure
81391,5566,angiography,I-Procedure
81392,5566,(,O
81393,5566,CAG,B-Procedure
81394,5566,),O
81395,5566,",",O
81396,5566,with,O
81397,5566,the,O
81398,5566,occlusion,B-Condition
81399,5566,of,I-Condition
81400,5566,other,I-Condition
81401,5566,arteries,I-Condition
81402,5566,not,O
81403,5566,exceeding,O
81404,5566,30,O
81405,5566,%,O
81406,5566,.,O
81407,5567,NA,O
81408,5568,Patients,O
81409,5568,with,O
81410,5568,SOF,B-Procedure
81411,5568,/,I-Procedure
81412,5568,VEL,I-Procedure
81413,5568,treatment,I-Procedure
81414,5568,for,O
81415,5568,the,O
81416,5568,treatment,O
81417,5568,of,O
81418,5568,chronic,O
81419,5568,HCV,O
81420,5568,genotype,O
81421,5568,1,O
81422,5568,through,O
81423,5568,6,O
81424,5568,.,O
81425,5569,Patient,O
81426,5569,is,O
81427,5569,at,O
81428,5569,least,O
81429,5569,18,O
81430,5569,at,O
81431,5569,the,O
81432,5569,day,O
81433,5569,of,O
81434,5569,screening,O
81435,5569,.,O
81436,5570,Patient,O
81437,5570,is,O
81438,5570,able,O
81439,5570,and,O
81440,5570,willing,O
81441,5570,to,O
81442,5570,sign,O
81443,5570,the,O
81444,5570,Informed,O
81445,5570,Consent,O
81446,5570,Form,O
81447,5570,.,O
81448,5571,Patient,O
81449,5571,is,O
81450,5571,able,O
81451,5571,and,O
81452,5571,willing,O
81453,5571,to,O
81454,5571,follow,O
81455,5571,protocol,O
81456,5571,requirements,O
81457,5571,.,O
81458,5572,Metastatic,O
81459,5572,tumor,B-Condition
81460,5573,Locally,O
81461,5573,unresectable,O
81462,5573,tumor,B-Condition
81463,5574,Previous,O
81464,5574,gastric,B-Procedure
81465,5574,resection,I-Procedure
81466,5575,ASA,O
81467,5575,IV,O
81468,5575,-,O
81469,5575,V,O
81470,5576,Age,B-Person
81471,5576,under,O
81472,5576,18,O
81473,5576,years,O
81474,5577,Preoperative,O
81475,5577,complete,B-Condition
81476,5577,parenteral,I-Condition
81477,5577,or,I-Condition
81478,5577,enteral,I-Condition
81479,5577,feeding,I-Condition
81480,5578,Immunosuppressive,B-Procedure
81481,5578,therapy,I-Procedure
81482,5578,before,O
81483,5578,operation,B-Procedure
81484,5579,Severe,O
81485,5579,malnutrition,B-Condition
81486,5580,Lack,O
81487,5580,of,O
81488,5580,the,O
81489,5580,patient,O
81490,5580,'s,O
81491,5580,consent,O
81492,5580,for,O
81493,5580,the,O
81494,5580,trial,O
81495,5580,participation,O
81496,5580,",",O
81497,5580,feeding,O
81498,5580,tube,O
81499,5580,insertion,O
81500,5580,or,O
81501,5580,epidural,O
81502,5580,analgesia,O
81503,5581,Primary,O
81504,5581,periampullary,B-Condition
81505,5581,tumor,I-Condition
81506,5582,R0,B-Procedure
81507,5582,",",I-Procedure
81508,5582,R1,I-Procedure
81509,5582,resection,I-Procedure
81510,5583,Chronic,B-Condition
81511,5583,pancreatitis,I-Condition
81512,5583,requiring,B-Observation
81513,5583,pancreatoduodenectomy,B-Procedure
81514,5584,History,O
81515,5584,of,O
81516,5584,sensitivity,B-Condition
81517,5584,to,O
81518,5584,study,B-Drug
81519,5584,medications,I-Drug
81520,5584,or,O
81521,5584,any,O
81522,5584,of,O
81523,5584,their,O
81524,5584,excipients,O
81525,5585,RA,B-Condition
81526,5585,cohort,O
81527,5585,:,O
81528,5585,Previous,O
81529,5585,intolerance,B-Condition
81530,5585,to,O
81531,5585,MTX,B-Drug
81532,5586,Current,O
81533,5586,treatment,O
81534,5586,with,O
81535,5586,antiplatelet,B-Procedure
81536,5586,therapy,I-Procedure
81537,5587,Absolute,B-Mood
81538,5587,indication,I-Mood
81539,5587,for,I-Mood
81540,5587,anti,B-Procedure
81541,5587,-,I-Procedure
81542,5587,platelet,I-Procedure
81543,5587,therapy,I-Procedure
81544,5588,Need,B-Mood
81545,5588,for,I-Mood
81546,5588,chronic,B-Procedure
81547,5588,oral,I-Procedure
81548,5588,anticoagulant,I-Procedure
81549,5588,therapy,I-Procedure
81550,5589,Severe,B-Condition
81551,5589,hepatic,I-Condition
81552,5589,impairment,I-Condition
81553,5589,(,O
81554,5589,eg,O
81555,5589,",",O
81556,5589,ascites,B-Condition
81557,5589,and/or,O
81558,5589,clinical,B-Mood
81559,5589,signs,I-Mood
81560,5589,of,I-Mood
81561,5589,coagulopathy,B-Condition
81562,5589,),O
81563,5590,Renal,B-Condition
81564,5590,failure,I-Condition
81565,5590,(,O
81566,5590,eGFR,O
81567,5590,<,O
81568,5590,30,O
81569,5590,or,O
81570,5590,requiring,B-Mood
81571,5590,dialysis,B-Procedure
81572,5590,),O
81573,5591,A,O
81574,5591,known,O
81575,5591,bleeding,B-Condition
81576,5591,diathesis,I-Condition
81577,5591,",",O
81578,5591,hemostatic,B-Condition
81579,5591,or,I-Condition
81580,5591,coagulation,I-Condition
81581,5591,disorder,I-Condition
81582,5591,",",O
81583,5591,or,O
81584,5591,prior,O
81585,5591,major,B-Condition
81586,5591,bleeding,I-Condition
81587,5592,Prior,O
81588,5592,stroke,B-Condition
81589,5593,Active,O
81590,5593,pathological,B-Condition
81591,5593,bleeding,I-Condition
81592,5594,History,B-Observation
81593,5594,of,O
81594,5594,intracranial,B-Condition
81595,5594,haemorrhage,I-Condition
81596,5595,Life,O
81597,5595,expectancy,O
81598,5595,<,O
81599,5595,12,O
81600,5595,months,O
81601,5595,based,O
81602,5595,on,O
81603,5595,investigator,O
81604,5595,'s,O
81605,5595,judgement,O
81606,5596,Patients,O
81607,5596,considered,O
81608,5596,to,O
81609,5596,be,O
81610,5596,at,B-Mood
81611,5596,risk,I-Mood
81612,5596,of,I-Mood
81613,5596,bradycardic,B-Condition
81614,5596,events,I-Condition
81615,5596,(,O
81616,5596,e.g.,O
81617,5596,",",O
81618,5596,known,O
81619,5596,sick,B-Condition
81620,5596,sinus,I-Condition
81621,5596,syndrome,I-Condition
81622,5596,or,O
81623,5596,second,B-Condition
81624,5596,or,I-Condition
81625,5596,third,I-Condition
81626,5596,degree,I-Condition
81627,5596,atrioventricular,I-Condition
81628,5596,[,I-Condition
81629,5596,AV,I-Condition
81630,5596,),I-Condition
81631,5596,],I-Condition
81632,5596,block,I-Condition
81633,5596,),O
81634,5596,unless,O
81635,5596,already,O
81636,5596,treated,O
81637,5596,with,O
81638,5596,a,O
81639,5596,permanent,O
81640,5596,pacemaker,O
81641,5597,Anemia,B-Condition
81642,5597,(,O
81643,5597,hematocrit,O
81644,5597,<,O
81645,5597,27,O
81646,5597,%,O
81647,5597,),O
81648,5598,Platelet,O
81649,5598,count,O
81650,5598,<,O
81651,5598,"100,000",O
81652,5598,/,O
81653,5598,ml,O
81654,5599,Concomitant,O
81655,5599,use,O
81656,5599,of,O
81657,5599,strong,B-Drug
81658,5599,CYP,I-Drug
81659,5599,3A,I-Drug
81660,5599,inhibitors,I-Drug
81661,5599,or,I-Drug
81662,5599,inducers,I-Drug
81663,5600,History,B-Observation
81664,5600,of,O
81665,5600,thrombocytopenia,B-Condition
81666,5600,or,O
81667,5600,neutropenia,B-Condition
81668,5601,Pregnant,B-Condition
81669,5601,or,O
81670,5601,nursing,B-Condition
81671,5601,women,B-Person
81672,5601,",",O
81673,5601,or,O
81674,5601,females,B-Person
81675,5601,with,O
81676,5601,a,O
81677,5601,positive,O
81678,5601,pregnancy,O
81679,5601,test,O
81680,5601,at,O
81681,5601,screening,O
81682,5602,Females,B-Person
81683,5602,of,O
81684,5602,child,B-Condition
81685,5602,bearing,I-Condition
81686,5602,potential,I-Condition
81687,5602,not,O
81688,5602,using,O
81689,5602,acceptable,O
81690,5602,method,B-Observation
81691,5602,of,I-Observation
81692,5602,birth,I-Observation
81693,5602,control,I-Observation
81694,5602,prior,O
81695,5602,to,O
81696,5602,or,O
81697,5602,during,O
81698,5602,study,O
81699,5603,Concern,B-Mood
81700,5603,for,I-Mood
81701,5603,inability,B-Observation
81702,5603,of,I-Observation
81703,5603,the,I-Observation
81704,5603,patient,I-Observation
81705,5603,to,I-Observation
81706,5603,comply,I-Observation
81707,5603,with,I-Observation
81708,5603,study,I-Observation
81709,5603,procedures,I-Observation
81710,5603,and/or,I-Observation
81711,5603,follow,I-Observation
81712,5603,up,I-Observation
81713,5603,(,O
81714,5603,eg,O
81715,5603,",",O
81716,5603,alcohol,B-Condition
81717,5603,or,I-Condition
81718,5603,drug,I-Condition
81719,5603,abuse,I-Condition
81720,5603,),O
81721,5604,RA,B-Condition
81722,5604,cohort,O
81723,5604,:,O
81724,5604,Receiving,O
81725,5604,MTX,B-Drug
81726,5604,at,O
81727,5604,stable,O
81728,5604,doses,O
81729,5604,of,O
81730,5604,10,O
81731,5604,to,O
81732,5604,25,O
81733,5604,mg,O
81734,5604,weekly,O
81735,5604,for,O
81736,5604,at,O
81737,5604,least,O
81738,5604,12,O
81739,5604,weeks,O
81740,5604,",",O
81741,5604,Have,O
81742,5604,a,O
81743,5604,DAS28,O
81744,5604,of,O
81745,5604,3.2,O
81746,5604,or,O
81747,5604,higher,O
81748,5604,(,O
81749,5604,The,O
81750,5604,level,O
81751,5604,of,O
81752,5604,disease,O
81753,5604,activity,O
81754,5604,is,O
81755,5604,considered,O
81756,5604,to,O
81757,5604,be,O
81758,5604,low,O
81759,5604,if,O
81760,5604,the,O
81761,5604,DAS28,O
81762,5604,is,O
81763,5604,3.2,O
81764,5604,or,O
81765,5604,less,O
81766,5604,),O
81767,5604,(,O
81768,5604,Prevoo,O
81769,5604,et,O
81770,5604,al,O
81771,5604,.,O
81772,5604,",",O
81773,5604,1995,O
81774,5604,),O
81775,5605,OA,B-Condition
81776,5605,cohort,O
81777,5605,:,O
81778,5605,Diagnosis,O
81779,5605,of,O
81780,5605,osteoarthritis,B-Condition
81781,5605,made,B-Observation
81782,5605,by,I-Observation
81783,5605,physician,I-Observation
81784,5605,.,O
81785,5606,are,O
81786,5606,allergic,B-Condition
81787,5606,to,O
81788,5606,influenza,B-Drug
81789,5606,vaccination,I-Drug
81790,5607,have,O
81791,5607,received,O
81792,5607,influenza,B-Drug
81793,5607,vaccination,I-Drug
81794,5607,within,O
81795,5607,the,O
81796,5607,past,O
81797,5607,6,O
81798,5607,months,O
81799,5608,require,O
81800,5608,prednisone,B-Drug
81801,5608,",",O
81802,5608,methotrexate,B-Drug
81803,5608,",",O
81804,5608,or,O
81805,5608,other,O
81806,5608,immunosuppressing,B-Drug
81807,5608,medications,I-Drug
81808,5609,have,O
81809,5609,HIV,B-Condition
81810,5609,infection,I-Condition
81811,5610,have,O
81812,5610,a,O
81813,5610,history,O
81814,5610,of,O
81815,5610,solid,B-Procedure
81816,5610,organ,I-Procedure
81817,5610,or,I-Procedure
81818,5610,bone,I-Procedure
81819,5610,marrow,I-Procedure
81820,5610,transplant,I-Procedure
81821,5611,require,B-Mood
81822,5611,combination,B-Procedure
81823,5611,immunotherapy,I-Procedure
81824,5612,are,O
81825,5612,on,O
81826,5612,other,O
81827,5612,studies,O
81828,5612,requiring,O
81829,5612,blood,O
81830,5612,draws,O
81831,5612,that,O
81832,5612,might,O
81833,5612,exceed,O
81834,5612,450,O
81835,5612,mL,O
81836,5612,total,O
81837,5612,during,O
81838,5612,the,O
81839,5612,period,O
81840,5612,of,O
81841,5612,the,O
81842,5612,influenza,O
81843,5612,vaccine,O
81844,5612,study,O
81845,5613,adults,B-Person
81846,5613,capable,O
81847,5613,of,O
81848,5613,providing,O
81849,5613,consent,O
81850,5614,have,O
81851,5614,a,O
81852,5614,diagnosis,O
81853,5614,of,O
81854,5614,locally,O
81855,5614,advanced,O
81856,5614,or,O
81857,5614,metastatic,O
81858,5614,melanoma,B-Condition
81859,5615,The,O
81860,5615,participant,O
81861,5615,has,O
81862,5615,Modified,O
81863,5615,Hoehn,O
81864,5615,&,O
81865,5615,Yahr,O
81866,5615,stage,O
81867,5615,5,O
81868,5615,(,O
81869,5615,or,O
81870,5615,stage,O
81871,5615,5,O
81872,5615,at,O
81873,5615,eather,O
81874,5615,on,O
81875,5615,-,O
81876,5615,time,O
81877,5615,or,O
81878,5615,off,O
81879,5615,-,O
81880,5615,time,O
81881,5615,for,O
81882,5615,the,O
81883,5615,participant,O
81884,5615,with,O
81885,5615,wearing,B-Condition
81886,5615,off,I-Condition
81887,5615,phenomenon,I-Condition
81888,5615,),O
81889,5615,.,O
81890,5616,The,O
81891,5616,participant,O
81892,5616,has,O
81893,5616,severe,O
81894,5616,dyskinesia,B-Condition
81895,5616,.,O
81896,5617,The,O
81897,5617,participant,O
81898,5617,has,O
81899,5617,unstable,O
81900,5617,systemic,B-Condition
81901,5617,disease,I-Condition
81902,5617,.,O
81903,5618,The,O
81904,5618,participant,O
81905,5618,has,O
81906,5618,a,O
81907,5618,Mini,O
81908,5618,-,O
81909,5618,Mental,O
81910,5618,State,O
81911,5618,Examinations,O
81912,5618,(,O
81913,5618,MMSE,O
81914,5618,),O
81915,5618,score,O
81916,5618,of,O
81917,5618,<,O
81918,5618,=,O
81919,5618,24,O
81920,5618,.,O
81921,5618,psychiatric,B-Condition
81922,5618,disease,I-Condition
81923,5618,.,O
81924,5619,The,O
81925,5619,participant,O
81926,5619,has,O
81927,5619,a,O
81928,5619,history,O
81929,5619,of,O
81930,5619,clinically,O
81931,5619,significant,O
81932,5619,hypertension,B-Condition
81933,5619,or,O
81934,5619,other,O
81935,5619,reactions,B-Condition
81936,5619,associated,I-Condition
81937,5619,with,I-Condition
81938,5619,ingestion,I-Condition
81939,5619,of,I-Condition
81940,5619,tyramine,I-Condition
81941,5619,-,I-Condition
81942,5619,rich,I-Condition
81943,5619,food,I-Condition
81944,5619,.,O
81945,5620,The,O
81946,5620,participant,O
81947,5620,has,O
81948,5620,received,O
81949,5620,neurosurgical,B-Procedure
81950,5620,intervention,I-Procedure
81951,5620,for,O
81952,5620,Parkinson,B-Condition
81953,5620,'s,I-Condition
81954,5620,disease,I-Condition
81955,5620,(,O
81956,5620,e.g.,O
81957,5620,",",O
81958,5620,pallidotomy,B-Condition
81959,5620,",",O
81960,5620,thalamotomy,B-Condition
81961,5620,",",O
81962,5620,deep,B-Condition
81963,5620,brain,I-Condition
81964,5620,stimulation,I-Condition
81965,5620,),O
81966,5620,.,O
81967,5621,The,O
81968,5621,participant,O
81969,5621,has,O
81970,5621,received,O
81971,5621,transcranial,B-Procedure
81972,5621,magnetic,I-Procedure
81973,5621,stimulation,I-Procedure
81974,5621,within,O
81975,5621,6,O
81976,5621,months,O
81977,5621,.,O
81978,5621,The,O
81979,5621,participant,O
81980,5621,has,O
81981,5621,received,O
81982,5621,selegiline,B-Drug
81983,5621,",",O
81984,5621,pethidine,B-Drug
81985,5621,",",O
81986,5621,tramadol,B-Drug
81987,5621,",",O
81988,5621,reserpine,B-Drug
81989,5621,or,O
81990,5621,methyldopa,B-Drug
81991,5621,within,O
81992,5621,90,O
81993,5621,days,O
81994,5621,.,O
81995,5622,The,O
81996,5622,participant,O
81997,5622,has,O
81998,5622,received,O
81999,5622,levodopa,B-Procedure
82000,5622,monotherapy,I-Procedure
82001,5622,",",O
82002,5622,any,O
82003,5622,psychoneurotic,B-Drug
82004,5622,agent,I-Drug
82005,5622,or,O
82006,5622,antiemetic,B-Drug
82007,5622,medication,I-Drug
82008,5622,of,I-Drug
82009,5622,dopamine,I-Drug
82010,5622,agonist,I-Drug
82011,5622,within,O
82012,5622,14,O
82013,5622,days,O
82014,5622,.,O
82015,5622,However,O
82016,5622,",",O
82017,5622,the,O
82018,5622,participant,O
82019,5622,has,O
82020,5622,been,O
82021,5622,receiving,O
82022,5622,quetiapine,B-Drug
82023,5622,or,O
82024,5622,domperidone,B-Drug
82025,5622,with,O
82026,5622,a,O
82027,5622,stable,O
82028,5622,dose,O
82029,5622,regimen,O
82030,5622,for,O
82031,5622,>,O
82032,5622,=,O
82033,5622,14,O
82034,5622,days,O
82035,5622,may,O
82036,5622,be,O
82037,5622,included,O
82038,5622,in,O
82039,5622,the,O
82040,5622,study,O
82041,5622,.,O
82042,5623,The,O
82043,5623,participant,O
82044,5623,is,O
82045,5623,required,O
82046,5623,to,O
82047,5623,take,O
82048,5623,any,O
82049,5623,of,O
82050,5623,the,O
82051,5623,excluded,O
82052,5623,medications,O
82053,5623,or,O
82054,5623,treatments,O
82055,5623,.,O
82056,5624,The,O
82057,5624,participant,O
82058,5624,with,O
82059,5624,laboratory,O
82060,5624,data,O
82061,5624,meeting,O
82062,5624,any,O
82063,5624,of,O
82064,5624,the,O
82065,5624,following,O
82066,5624,:,O
82067,5625,Creatinine,O
82068,5625,>,O
82069,5625,=,O
82070,5625,2,O
82071,5625,x,O
82072,5625,upper,O
82073,5625,limit,O
82074,5625,of,O
82075,5625,normal,O
82076,5625,(,O
82077,5625,ULN,O
82078,5625,),O
82079,5626,Total,O
82080,5626,bilirubin,O
82081,5626,>,O
82082,5626,=,O
82083,5626,2,O
82084,5626,x,O
82085,5626,ULN,O
82086,5627,ALT,O
82087,5627,or,O
82088,5627,AST,O
82089,5627,>,O
82090,5627,=,O
82091,5627,1.5,O
82092,5627,x,O
82093,5627,ULN,O
82094,5628,ALP,O
82095,5628,>,O
82096,5628,=,O
82097,5628,3,O
82098,5628,x,O
82099,5628,ULN,O
82100,5629,The,O
82101,5629,participant,O
82102,5629,has,O
82103,5629,received,O
82104,5629,any,O
82105,5629,of,O
82106,5629,the,O
82107,5629,excluded,O
82108,5629,medications,O
82109,5629,or,O
82110,5629,treatments,O
82111,5629,during,O
82112,5629,.,O
82113,5630,The,O
82114,5630,participant,O
82115,5630,has,O
82116,5630,a,O
82117,5630,diagnosis,O
82118,5630,of,O
82119,5630,Parkinson,B-Condition
82120,5630,'s,I-Condition
82121,5630,disease,I-Condition
82122,5630,according,O
82123,5630,to,O
82124,5630,the,O
82125,5630,diagnostic,O
82126,5630,criteria,O
82127,5630,of,O
82128,5630,the,O
82129,5630,UK,O
82130,5630,Parkinson,O
82131,5630,'s,O
82132,5630,Disease,O
82133,5630,Society,O
82134,5630,Brain,O
82135,5630,Bank,O
82136,5630,.,O
82137,5631,The,O
82138,5631,participant,O
82139,5631,has,O
82140,5631,received,O
82141,5631,a,O
82142,5631,levodopa,B-Drug
82143,5631,combination,I-Drug
82144,5631,drug,O
82145,5631,for,O
82146,5631,>,O
82147,5631,=,O
82148,5631,1,O
82149,5631,month,O
82150,5631,and,O
82151,5631,has,O
82152,5631,either,O
82153,5631,of,O
82154,5631,the,O
82155,5631,following,O
82156,5631,.,O
82157,5632,Wearing,B-Condition
82158,5632,off,I-Condition
82159,5632,phenomenon,I-Condition
82160,5633,Decreased,B-Condition
82161,5633,response,I-Condition
82162,5633,to,O
82163,5633,levodopa,O
82164,5633,combination,I-Drug
82165,5633,drugs,I-Drug
82166,5634,The,O
82167,5634,participant,O
82168,5634,has,O
82169,5634,received,O
82170,5634,a,O
82171,5634,levodopa,B-Drug
82172,5634,combination,I-Drug
82173,5634,drug,I-Drug
82174,5634,without,O
82175,5634,change,O
82176,5634,in,O
82177,5634,the,O
82178,5634,dose,O
82179,5634,regimen,O
82180,5634,.,O
82181,5635,The,O
82182,5635,participant,O
82183,5635,is,O
82184,5635,an,O
82185,5635,outpatient,O
82186,5635,of,O
82187,5635,either,O
82188,5635,sex,O
82189,5635,aged,B-Person
82190,5635,>,O
82191,5635,=,O
82192,5635,30,O
82193,5635,and,O
82194,5635,<,O
82195,5635,80,O
82196,5635,years,O
82197,5635,.,O
82198,5636,Atypical,O
82199,5636,Parkinsonian,B-Condition
82200,5636,Syndromes,I-Condition
82201,5637,Parkinson,B-Condition
82202,5637,'s,I-Condition
82203,5637,disease,I-Condition
82204,5637,with,O
82205,5637,hallucinations,B-Condition
82206,5638,Parkinson,B-Condition
82207,5638,'s,I-Condition
82208,5638,disease,I-Condition
82209,5638,with,O
82210,5638,impulse,B-Condition
82211,5638,Control,I-Condition
82212,5638,disorder,I-Condition
82213,5638,(,I-Condition
82214,5638,ICD,I-Condition
82215,5638,),I-Condition
82216,5639,Parkinson,B-Condition
82217,5639,'s,I-Condition
82218,5639,disease,I-Condition
82219,5639,already,O
82220,5639,treated,O
82221,5639,with,O
82222,5639,APOMORPHINE,B-Drug
82223,5639,pump,O
82224,5639,or,O
82225,5639,justifying,O
82226,5639,the,O
82227,5639,use,O
82228,5639,of,O
82229,5639,the,O
82230,5639,pump,O
82231,5639,continuously,O
82232,5639,day,O
82233,5639,and,O
82234,5639,night,O
82235,5640,Another,O
82236,5640,obvious,O
82237,5640,severe,B-Condition
82238,5640,disease,I-Condition
82239,5640,explaining,O
82240,5640,insomnia,B-Condition
82241,5641,Exclusion,O
82242,5641,for,O
82243,5641,monitoring,O
82244,5641,difficulties,O
82245,5641,(,O
82246,5641,mutation,O
82247,5641,",",O
82248,5641,insufficient,O
82249,5641,motivation,O
82250,5641,",",O
82251,5641,priority,O
82252,5641,associated,O
82253,5641,pathology,O
82254,5641,in,O
82255,5641,care,O
82256,5641,),O
82257,5642,Patient,O
82258,5642,unwilling,B-Mood
82259,5642,to,I-Mood
82260,5642,accept,I-Mood
82261,5642,a,O
82262,5642,pump,O
82263,5643,Patient,O
82264,5643,not,B-Mood
82265,5643,accepting,I-Mood
82266,5643,polysomnography,B-Procedure
82267,5643,and,O
82268,5643,multiple,B-Procedure
82269,5643,sleep,I-Procedure
82270,5643,latency,I-Procedure
82271,5643,test,I-Procedure
82272,5644,Patient,O
82273,5644,with,O
82274,5644,health,B-Condition
82275,5644,problems,I-Condition
82276,5644,or,O
82277,5644,a,O
82278,5644,skin,B-Condition
82279,5644,disease,I-Condition
82280,5644,precluding,O
82281,5644,continuous,B-Procedure
82282,5644,subcutaneous,I-Procedure
82283,5644,infusion,I-Procedure
82284,5645,Female,B-Person
82285,5645,parturient,B-Condition
82286,5645,or,O
82287,5645,nursing,B-Condition
82288,5646,Cardiac,B-Condition
82289,5646,dysrhythmia,I-Condition
82290,5646,precluding,O
82291,5646,treatment,O
82292,5646,with,O
82293,5646,domperidone,B-Drug
82294,5646,or,O
82295,5646,apomorphine,B-Drug
82296,5646,(,O
82297,5646,increased,O
82298,5646,QTc,O
82299,5646,=,O
82300,5646,440,O
82301,5646,ms,O
82302,5646,in,O
82303,5646,men,B-Person
82304,5646,",",O
82305,5646,QTc,O
82306,5646,=,O
82307,5646,450,O
82308,5646,ms,O
82309,5646,in,O
82310,5646,women,B-Person
82311,5646,),O
82312,5647,antiemetic,B-Drug
82313,5647,neuroleptics,I-Drug
82314,5648,Tetrabenazine,B-Drug
82315,5649,Excessive,B-Condition
82316,5649,alcohol,I-Condition
82317,5649,consumption,I-Condition
82318,5650,Hypersensitivity,B-Condition
82319,5650,to,O
82320,5650,apomorphine,B-Drug
82321,5650,or,O
82322,5650,one,O
82323,5650,of,O
82324,5650,the,O
82325,5650,excipients,B-Drug
82326,5651,Respiratory,B-Condition
82327,5651,Depression,I-Condition
82328,5652,Hepatic,B-Condition
82329,5652,impairment,I-Condition
82330,5653,Intellectual,B-Condition
82331,5653,Disability,I-Condition
82332,5654,Dementia,B-Condition
82333,5655,Idiopathic,O
82334,5655,Parkinson,B-Condition
82335,5655,'s,I-Condition
82336,5655,disease,I-Condition
82337,5655,(,O
82338,5655,Hughes,O
82339,5655,AJ,O
82340,5655,et,O
82341,5655,al,O
82342,5655,.,O
82343,5655,2001,O
82344,5655,),O
82345,5656,Patients,O
82346,5656,with,O
82347,5656,motor,B-Condition
82348,5656,fluctuations,I-Condition
82349,5657,Chronic,B-Condition
82350,5657,Insomnia,I-Condition
82351,5657,disorder,I-Condition
82352,5657,criteria,O
82353,5657,according,O
82354,5657,to,O
82355,5657,the,O
82356,5657,criteria,O
82357,5657,of,O
82358,5657,DMS-,O
82359,5657,V,O
82360,5657,(,O
82361,5657,American,O
82362,5657,Psychiatric,O
82363,5657,Association,O
82364,5657,",",O
82365,5657,2013,O
82366,5657,),O
82367,5657,and,O
82368,5657,insomnia,O
82369,5657,severity,O
82370,5657,index,O
82371,5657,>,O
82372,5657,15,O
82373,5658,Able,O
82374,5658,to,O
82375,5658,use,O
82376,5658,independently,O
82377,5658,the,O
82378,5658,device,O
82379,5658,required,O
82380,5658,for,O
82381,5658,treatment,O
82382,5658,by,O
82383,5658,apomorphine,B-Drug
82384,5659,Collection,O
82385,5659,of,O
82386,5659,written,O
82387,5659,informed,O
82388,5659,consent,O
82389,5659,(,O
82390,5659,legal,O
82391,5659,obligation,O
82392,5659,for,O
82393,5659,any,O
82394,5659,project,O
82395,5659,under,O
82396,5659,the,O
82397,5659,public,O
82398,5659,health,O
82399,5659,law,O
82400,5659,",",O
82401,5659,bioethics,O
82402,5659,laws,O
82403,5659,and,O
82404,5659,/,O
82405,5659,or,O
82406,5659,CNIL,O
82407,5659,),O
82408,5659,.,O
82409,5660,Affiliate,O
82410,5660,to,O
82411,5660,social,B-Person
82412,5660,security,I-Person
82413,5660,or,I-Person
82414,5660,beneficiary,I-Person
82415,5660,of,O
82416,5660,such,O
82417,5660,a,O
82418,5660,regime,O
82419,5661,Drug,O
82420,5661,-,O
82421,5661,induced,O
82422,5661,hypotension,B-Condition
82423,5661,",",O
82424,5661,if,O
82425,5661,necessary,O
82426,5661,",",O
82427,5661,evaluate,O
82428,5661,patient,O
82429,5661,after,O
82430,5661,discontinuing,O
82431,5661,the,O
82432,5661,causative,O
82433,5661,drug,O
82434,5661,for,O
82435,5661,one,O
82436,5661,month,O
82437,5662,Heart,B-Condition
82438,5662,failure,I-Condition
82439,5662,or,O
82440,5662,Chronic,B-Condition
82441,5662,renal,I-Condition
82442,5662,failure,I-Condition
82443,5663,Severe,O
82444,5663,supine,B-Condition
82445,5663,hypertension,I-Condition
82446,5663,(,O
82447,5663,Systolic,O
82448,5663,Blood,O
82449,5663,Pressure,O
82450,5663,>,O
82451,5663,180,O
82452,5663,or,O
82453,5663,Diastolic,O
82454,5663,Blood,O
82455,5663,Pressure>110mmHg,O
82456,5663,),O
82457,5664,Pregnant,B-Condition
82458,5664,women,B-Person
82459,5664,",",O
82460,5664,breast,B-Condition
82461,5664,-,I-Condition
82462,5664,feeding,I-Condition
82463,5665,Unable,B-Observation
82464,5665,to,I-Observation
82465,5665,perform,I-Observation
82466,5665,questionnaire,I-Observation
82467,5666,Age,B-Person
82468,5666,>,O
82469,5666,=,O
82470,5666,19,O
82471,5666,patients,O
82472,5666,who,O
82473,5666,complained,O
82474,5666,of,O
82475,5666,dizziness,B-Condition
82476,5667,Orthostatic,B-Condition
82477,5667,hypotension,I-Condition
82478,5667,after,O
82479,5667,3,O
82480,5667,-,O
82481,5667,minute,O
82482,5667,standing,O
82483,5667,(,O
82484,5667,systolic,O
82485,5667,blood,O
82486,5667,pressure,O
82487,5667,drop,O
82488,5667,>,O
82489,5667,=,O
82490,5667,20,O
82491,5667,or,O
82492,5667,diastolic,O
82493,5667,blood,O
82494,5667,pressure,O
82495,5667,drop,O
82496,5667,>,O
82497,5667,=,O
82498,5667,10,O
82499,5668,Patients,O
82500,5668,unable,O
82501,5668,to,O
82502,5668,understand,O
82503,5668,the,O
82504,5668,objectives,O
82505,5668,of,O
82506,5668,the,O
82507,5668,dietary,O
82508,5668,intervention,O
82509,5669,Patients,O
82510,5669,in,O
82511,5669,paliative,O
82512,5669,care,O
82513,5670,Patients,O
82514,5670,receiving,O
82515,5670,supplement,O
82516,5670,diets,O
82517,5671,Elderly,B-Person
82518,5671,patients,O
82519,5671,over,O
82520,5671,65,O
82521,5671,years,O
82522,5671,old,B-Person
82523,5671,exhibiting,O
82524,5671,clinical,O
82525,5671,indices,O
82526,5671,of,O
82527,5671,cardiovascular,O
82528,5671,disease,O
82529,5672,Male,B-Person
82530,5672,or,O
82531,5672,female,B-Person
82532,5673,Subjects,O
82533,5673,who,O
82534,5673,were,O
82535,5673,hospitalized,O
82536,5673,in,O
82537,5673,the,O
82538,5673,Geriatric,O
82539,5673,Unit,O
82540,5673,of,O
82541,5673,the,O
82542,5673,Emile,O
82543,5673,Roux,O
82544,5673,Hospital,O
82545,5673,(,O
82546,5673,AP,O
82547,5673,-,O
82548,5673,HP,O
82549,5673,),O
82550,5674,MMSE,O
82551,5674,(,O
82552,5674,Mini,O
82553,5674,Mental,O
82554,5674,State,O
82555,5674,Examination)score,O
82556,5674,>,O
82557,5674,or,O
82558,5674,=,O
82559,5674,15,O
82560,5675,Supervision,O
82561,5675,available,O
82562,5675,for,O
82563,5675,study,O
82564,5675,medication,O
82565,5676,Able,B-Condition
82566,5676,to,I-Condition
82567,5676,ingest,I-Condition
82568,5676,oral,I-Condition
82569,5676,diet,I-Condition
82570,5677,NA,O
82571,5678,Horner,B-Condition
82572,5678,'s,I-Condition
82573,5678,Syndrome,I-Condition
82574,5679,History,O
82575,5679,of,O
82576,5679,taking,O
82577,5679,an,O
82578,5679,alpha,B-Drug
82579,5679,blocker,I-Drug
82580,5679,(,O
82581,5679,tamsulosin/,B-Drug
82582,5679,terazosin,B-Drug
82583,5679,/,O
82584,5679,doxazosin,B-Drug
82585,5679,/,O
82586,5679,alfuzosin,B-Drug
82587,5679,/,O
82588,5679,silodosin,B-Drug
82589,5679,),O
82590,5679,medication,O
82591,5680,Abnormal,B-Condition
82592,5680,karyotype,I-Condition
82593,5681,Previous,O
82594,5681,pelvic,B-Procedure
82595,5681,or,I-Procedure
82596,5681,abdominal,I-Procedure
82597,5681,radiotherapy,I-Procedure
82598,5682,Previous,O
82599,5682,surgical,B-Procedure
82600,5682,management,I-Procedure
82601,5682,of,O
82602,5682,ovarian,B-Condition
82603,5682,pathology,I-Condition
82604,5683,Chronic,B-Condition
82605,5683,disease,I-Condition
82606,5683,:,O
82607,5683,renal,B-Condition
82608,5683,",",I-Condition
82609,5683,liver,I-Condition
82610,5683,",",I-Condition
82611,5683,cardiac,I-Condition
82612,5683,",",I-Condition
82613,5683,malignancy,I-Condition
82614,5684,Women,B-Person
82615,5684,with,O
82616,5684,POI,B-Condition
82617,5684,:,O
82618,5684,For,O
82619,5684,the,O
82620,5684,purpose,O
82621,5684,of,O
82622,5684,the,O
82623,5684,research,O
82624,5684,women,O
82625,5684,is,O
82626,5684,considered,O
82627,5684,to,O
82628,5684,have,O
82629,5684,POI,O
82630,5684,if,O
82631,5684,she,O
82632,5684,is,O
82633,5684,aged,B-Person
82634,5684,less,O
82635,5684,than,O
82636,5684,40,O
82637,5684,years,O
82638,5684,and,O
82639,5684,has,O
82640,5684,amenorrhea,B-Condition
82641,5684,of,O
82642,5684,at,O
82643,5684,least,O
82644,5684,4,O
82645,5684,month,O
82646,5684,with,O
82647,5684,FSH,O
82648,5684,level,O
82649,5684,above,O
82650,5684,25,O
82651,5684,IU,O
82652,5684,/,O
82653,5684,L,O
82654,5684,(,O
82655,5684,repeated,O
82656,5684,twice,O
82657,5684,>,O
82658,5684,4,O
82659,5684,weeks,O
82660,5684,apart,O
82661,5684,),O
82662,5684,.,O
82663,5685,current,O
82664,5685,suicidal,B-Condition
82665,5685,risk,I-Condition
82666,5686,current,O
82667,5686,psychosis,B-Condition
82668,5687,ongoing,O
82669,5687,trauma,B-Condition
82670,5687,(,O
82671,5687,e.g.,O
82672,5687,current,O
82673,5687,involvement,B-Condition
82674,5687,in,I-Condition
82675,5687,an,I-Condition
82676,5687,abusive,I-Condition
82677,5687,relationship,I-Condition
82678,5687,),O
82679,5687,.,O
82680,5688,satisfying,O
82681,5688,DSM,O
82682,5688,-,O
82683,5688,V,O
82684,5688,criteria,O
82685,5688,for,O
82686,5688,ED,B-Condition
82687,5688,and,O
82688,5688,for,O
82689,5688,half,O
82690,5688,of,O
82691,5688,the,O
82692,5688,patients,O
82693,5688,in,O
82694,5688,addition,O
82695,5689,have,O
82696,5689,a,O
82697,5689,history,B-Observation
82698,5689,of,O
82699,5689,childhood,B-Condition
82700,5689,trauma,I-Condition
82701,5689,.,O
82702,5690,Patients,O
82703,5690,with,O
82704,5690,high,O
82705,5690,intracranial,O
82706,5690,pressure,O
82707,5690,.,O
82708,5691,Patients,O
82709,5691,with,O
82710,5691,Multiple,B-Condition
82711,5691,Sclerosis,I-Condition
82712,5691,.,O
82713,5692,Patients,O
82714,5692,with,O
82715,5692,Guillain,B-Condition
82716,5692,-,I-Condition
82717,5692,Barré,I-Condition
82718,5692,syndrome,I-Condition
82719,5692,radiculopathy,I-Condition
82720,5692,of,O
82721,5692,vascular,O
82722,5692,origin,O
82723,5692,.,O
82724,5693,Patients,O
82725,5693,with,O
82726,5693,previous,O
82727,5693,lumbar,B-Procedure
82728,5693,surgery,I-Procedure
82729,5693,.,I-Procedure
82730,5694,Patients,O
82731,5694,pregnant,O
82732,5694,or,O
82733,5694,lactating,O
82734,5694,.,O
82735,5695,Patients,O
82736,5695,with,O
82737,5695,allergy,B-Condition
82738,5695,or,O
82739,5695,intolerance,B-Condition
82740,5695,to,O
82741,5695,any,O
82742,5695,of,O
82743,5695,the,O
82744,5695,drugs,B-Drug
82745,5695,used,O
82746,5695,.,O
82747,5696,Patients,O
82748,5696,with,O
82749,5696,severe,O
82750,5696,cognitive,B-Condition
82751,5696,impairment,I-Condition
82752,5696,.,O
82753,5697,Patients,O
82754,5697,with,O
82755,5697,intrathecal,B-Procedure
82756,5697,injectio,I-Procedure
82757,5697,radiculalgia,I-Procedure
82758,5697,.,O
82759,5698,Patients,O
82760,5698,with,O
82761,5698,poorly,O
82762,5698,controlled,O
82763,5698,major,O
82764,5698,psychiatric,B-Condition
82765,5698,pathology,I-Condition
82766,5698,.,O
82767,5699,Patients,O
82768,5699,with,O
82769,5699,type,B-Condition
82770,5699,I,I-Condition
82771,5699,diabetes,I-Condition
82772,5699,or,O
82773,5699,poorly,O
82774,5699,controlled,O
82775,5699,type,B-Condition
82776,5699,II,I-Condition
82777,5699,diabetes,I-Condition
82778,5699,(,O
82779,5699,Hb1Ac>8.5,O
82780,5699,),O
82781,5699,.,O
82782,5700,Patients,O
82783,5700,with,O
82784,5700,glaucoma,B-Condition
82785,5700,.,O
82786,5701,Patients,O
82787,5701,with,O
82788,5701,caudal,B-Condition
82789,5701,equine,I-Condition
82790,5701,syndrome,I-Condition
82791,5701,.,O
82792,5702,Patients,O
82793,5702,with,O
82794,5702,pre,O
82795,5702,-,O
82796,5702,treatment,O
82797,5702,with,O
82798,5702,steroid,B-Procedure
82799,5702,injections,I-Procedure
82800,5702,/,O
82801,5702,or,O
82802,5702,local,B-Procedure
82803,5702,anesthetics,I-Procedure
82804,5702,.,O
82805,5703,Patients,O
82806,5703,with,O
82807,5703,central,B-Condition
82808,5703,canal,I-Condition
82809,5703,stenosis,I-Condition
82810,5703,.,O
82811,5704,patients,O
82812,5704,with,O
82813,5704,chronic,O
82814,5704,treatment,O
82815,5704,with,O
82816,5704,oral,B-Drug
82817,5704,corticosteroids,I-Drug
82818,5704,without,O
82819,5704,stabilized,O
82820,5704,pattern,O
82821,5704,.,O
82822,5705,Unilateral,B-Condition
82823,5705,leg,I-Condition
82824,5705,pain,I-Condition
82825,5705,secondary,O
82826,5705,to,O
82827,5705,lateral,B-Condition
82828,5705,stenosis,I-Condition
82829,5705,",",O
82830,5705,disc,B-Condition
82831,5705,protrusion,I-Condition
82832,5705,or,O
82833,5705,herniated,B-Condition
82834,5705,disc,I-Condition
82835,5705,.,O
82836,5706,Age,B-Person
82837,5706,between,O
82838,5706,18,O
82839,5706,and,O
82840,5706,80,O
82841,5706,years,O
82842,5706,.,O
82843,5707,Moderate,O
82844,5707,to,O
82845,5707,severe,O
82846,5707,pain,B-Condition
82847,5707,(,O
82848,5707,NVS>4,O
82849,5707,),O
82850,5707,.,O
82851,5708,Right,O
82852,5708,proficient,O
82853,5708,oral,O
82854,5708,and,O
82855,5708,written,O
82856,5708,language,O
82857,5708,.,O
82858,5709,Females,B-Person
82859,5709,who,O
82860,5709,are,O
82861,5709,pregnant,B-Condition
82862,5709,or,O
82863,5709,nursing,B-Condition
82864,5709,.,O
82865,5710,Patients,O
82866,5710,not,O
82867,5710,scheduled,B-Mood
82868,5710,for,O
82869,5710,trans,B-Procedure
82870,5710,-,I-Procedure
82871,5710,jugular,I-Procedure
82872,5710,liver,I-Procedure
82873,5710,biopsy,I-Procedure
82874,5711,Patients,O
82875,5711,who,O
82876,5711,have,O
82877,5711,received,O
82878,5711,an,O
82879,5711,investigational,O
82880,5711,drug,O
82881,5711,in,O
82882,5711,the,O
82883,5711,30,O
82884,5711,days,O
82885,5711,before,O
82886,5711,study,O
82887,5711,drug,O
82888,5711,administration,O
82889,5711,",",O
82890,5711,or,O
82891,5711,will,O
82892,5711,receive,O
82893,5711,one,O
82894,5711,within,O
82895,5711,72,O
82896,5711,h,O
82897,5711,afterwards,O
82898,5711,",",O
82899,5711,.,O
82900,5712,Patients,O
82901,5712,with,O
82902,5712,known,B-Mood
82903,5712,or,O
82904,5712,suspected,B-Mood
82905,5712,right,B-Condition
82906,5712,-,I-Condition
82907,5712,to,I-Condition
82908,5712,-,I-Condition
82909,5712,left,I-Condition
82910,5712,",",I-Condition
82911,5712,bi,I-Condition
82912,5712,-,I-Condition
82913,5712,directional,I-Condition
82914,5712,",",I-Condition
82915,5712,or,I-Condition
82916,5712,transient,I-Condition
82917,5712,right,I-Condition
82918,5712,-,I-Condition
82919,5712,to,I-Condition
82920,5712,-,I-Condition
82921,5712,left,I-Condition
82922,5712,cardiac,I-Condition
82923,5712,shunts,I-Condition
82924,5713,Patients,O
82925,5713,with,O
82926,5713,pulmonary,B-Condition
82927,5713,hypertension,I-Condition
82928,5713,or,O
82929,5713,unstable,B-Condition
82930,5713,cardiopulmonary,I-Condition
82931,5713,conditions,I-Condition
82932,5714,Patients,O
82933,5714,currently,O
82934,5714,on,O
82935,5714,chemotherapy,B-Procedure
82936,5714,or,O
82937,5714,with,O
82938,5714,other,O
82939,5714,primary,B-Condition
82940,5714,cancers,I-Condition
82941,5714,requiring,O
82942,5714,systemic,B-Procedure
82943,5714,or,I-Procedure
82944,5714,hepatic,I-Procedure
82945,5714,loco,I-Procedure
82946,5714,-,I-Procedure
82947,5714,regional,I-Procedure
82948,5714,treatment,I-Procedure
82949,5714,.,O
82950,5715,Patients,O
82951,5715,who,O
82952,5715,are,O
82953,5715,medically,B-Condition
82954,5715,unstable,I-Condition
82955,5715,",",O
82956,5715,patients,O
82957,5715,who,O
82958,5715,are,O
82959,5715,seriously,B-Condition
82960,5715,or,I-Condition
82961,5715,terminally,I-Condition
82962,5715,ill,I-Condition
82963,5715,",",O
82964,5715,and,O
82965,5715,patients,O
82966,5715,whose,O
82967,5715,clinical,B-Condition
82968,5715,course,I-Condition
82969,5715,is,I-Condition
82970,5715,unpredictable,I-Condition
82971,5715,.,O
82972,5715,For,O
82973,5715,example,O
82974,5715,:,O
82975,5716,Patients,O
82976,5716,on,O
82977,5716,life,B-Procedure
82978,5716,support,I-Procedure
82979,5716,or,O
82980,5716,in,O
82981,5716,a,O
82982,5716,critical,O
82983,5716,care,O
82984,5716,unit,O
82985,5716,.,O
82986,5717,Patients,O
82987,5717,with,O
82988,5717,unstable,B-Condition
82989,5717,occlusive,I-Condition
82990,5717,disease,I-Condition
82991,5717,(,O
82992,5717,e.g.,O
82993,5717,",",O
82994,5717,crescendo,O
82995,5717,angina,O
82996,5717,),O
82997,5718,Patients,O
82998,5718,with,O
82999,5718,clinically,O
83000,5718,unstable,O
83001,5718,cardiac,B-Condition
83002,5718,arrhythmias,I-Condition
83003,5718,",",O
83004,5718,such,O
83005,5718,as,O
83006,5718,recurrent,O
83007,5718,ventricular,B-Condition
83008,5718,tachycardia,I-Condition
83009,5718,.,O
83010,5719,Patients,O
83011,5719,with,O
83012,5719,uncontrolled,O
83013,5719,congestive,B-Condition
83014,5719,heart,I-Condition
83015,5719,failure,I-Condition
83016,5719,(,O
83017,5719,NYHA,O
83018,5719,Class,O
83019,5719,IV,O
83020,5719,),O
83021,5720,Patients,O
83022,5720,with,O
83023,5720,recent,O
83024,5720,cerebral,B-Condition
83025,5720,hemorrhage,I-Condition
83026,5720,.,O
83027,5721,Patients,O
83028,5721,who,O
83029,5721,have,O
83030,5721,undergone,O
83031,5721,surgery,B-Procedure
83032,5721,within,O
83033,5721,24,O
83034,5721,hours,O
83035,5721,prior,O
83036,5721,to,O
83037,5721,the,O
83038,5721,study,O
83039,5721,sonographic,B-Procedure
83040,5721,examination,I-Procedure
83041,5721,.,O
83042,5722,Patients,O
83043,5722,with,O
83044,5722,a,O
83045,5722,history,O
83046,5722,of,O
83047,5722,anaphylactic,B-Condition
83048,5722,allergy,I-Condition
83049,5722,to,O
83050,5722,eggs,B-Drug
83051,5722,or,O
83052,5722,egg,B-Drug
83053,5722,products,I-Drug
83054,5722,",",O
83055,5722,manifested,O
83056,5722,by,O
83057,5722,one,O
83058,5722,or,O
83059,5722,more,O
83060,5722,of,O
83061,5722,the,O
83062,5722,following,O
83063,5722,symptoms,O
83064,5722,:,O
83065,5722,generalized,B-Condition
83066,5722,urticaria,I-Condition
83067,5722,",",O
83068,5722,difficulty,B-Condition
83069,5722,in,I-Condition
83070,5722,breathing,I-Condition
83071,5722,",",O
83072,5722,swelling,B-Condition
83073,5722,of,I-Condition
83074,5722,the,I-Condition
83075,5722,mouth,I-Condition
83076,5722,and,I-Condition
83077,5722,throat,I-Condition
83078,5722,",",O
83079,5722,hypotension,B-Condition
83080,5722,",",O
83081,5722,or,O
83082,5722,shock,B-Condition
83083,5722,.,O
83084,5722,(,O
83085,5722,Subjects,O
83086,5722,with,O
83087,5722,nonanaphylactic,O
83088,5722,allergies,O
83089,5722,to,O
83090,5722,eggs,O
83091,5722,or,O
83092,5722,egg,O
83093,5722,products,O
83094,5722,may,O
83095,5722,be,O
83096,5722,enrolled,O
83097,5722,in,O
83098,5722,the,O
83099,5722,study,O
83100,5722,",",O
83101,5722,but,O
83102,5722,must,O
83103,5722,be,O
83104,5722,watched,O
83105,5722,carefully,O
83106,5722,for,O
83107,5722,1,O
83108,5722,h,O
83109,5722,following,O
83110,5722,the,O
83111,5722,administration,O
83112,5722,of,O
83113,5722,SONAZOID,O
83114,5722,),O
83115,5722,.,O
83116,5723,Patients,O
83117,5723,with,O
83118,5723,congenital,B-Condition
83119,5723,heart,I-Condition
83120,5723,defects,I-Condition
83121,5723,.,O
83122,5724,Patients,O
83123,5724,with,O
83124,5724,severe,O
83125,5724,emphysema,B-Condition
83126,5724,",",O
83127,5724,pulmonary,B-Condition
83128,5724,vasculitis,I-Condition
83129,5724,",",O
83130,5724,or,O
83131,5724,a,O
83132,5724,history,O
83133,5724,of,O
83134,5724,pulmonary,B-Condition
83135,5724,emboli,I-Condition
83136,5724,.,O
83137,5725,Patients,O
83138,5725,with,O
83139,5725,respiratory,B-Condition
83140,5725,distress,I-Condition
83141,5725,syndrome,I-Condition
83142,5726,Patients,O
83143,5726,with,O
83144,5726,thrombosis,B-Condition
83145,5726,within,O
83146,5726,the,O
83147,5726,hepatic,O
83148,5726,",",O
83149,5726,portal,O
83150,5726,",",O
83151,5726,or,O
83152,5726,mesenteric,O
83153,5726,veins,O
83154,5726,.,O
83155,5727,Be,O
83156,5727,scheduled,O
83157,5727,for,O
83158,5727,trans,B-Procedure
83159,5727,-,I-Procedure
83160,5727,jugular,I-Procedure
83161,5727,liver,I-Procedure
83162,5727,biopsy,I-Procedure
83163,5727,the,O
83164,5727,day,O
83165,5727,of,O
83166,5727,the,O
83167,5727,ultrasound,B-Procedure
83168,5727,procedure,I-Procedure
83169,5727,.,O
83170,5728,Be,O
83171,5728,at,O
83172,5728,least,O
83173,5728,21,O
83174,5728,years,O
83175,5728,of,O
83176,5728,age,B-Person
83177,5728,.,O
83178,5729,Be,O
83179,5729,medically,B-Condition
83180,5729,stable,I-Condition
83181,5729,.,O
83182,5730,If,O
83183,5730,a,O
83184,5730,female,B-Person
83185,5730,of,O
83186,5730,child,B-Condition
83187,5730,-,I-Condition
83188,5730,bearing,I-Condition
83189,5730,potential,I-Condition
83190,5730,",",O
83191,5730,must,O
83192,5730,have,O
83193,5730,a,O
83194,5730,negative,B-Condition
83195,5730,pregnancy,O
83196,5730,test,O
83197,5730,.,O
83198,5731,Be,O
83199,5731,conscious,O
83200,5731,and,O
83201,5731,able,O
83202,5731,to,O
83203,5731,comply,O
83204,5731,with,O
83205,5731,study,O
83206,5731,procedures,O
83207,5731,.,O
83208,5732,Have,O
83209,5732,read,O
83210,5732,and,O
83211,5732,signed,O
83212,5732,the,O
83213,5732,IRB,O
83214,5732,-,O
83215,5732,approved,O
83216,5732,Informed,O
83217,5732,Consent,O
83218,5732,form,O
83219,5732,for,O
83220,5732,participating,O
83221,5732,in,O
83222,5732,the,O
83223,5732,study,O
83224,5732,.,O
83225,5733,Having,O
83226,5733,significant,O
83227,5733,medical,O
83228,5733,illnesses,O
83229,5733,that,O
83230,5733,would,O
83231,5733,interfere,O
83232,5733,with,O
83233,5733,the,O
83234,5733,conduct,O
83235,5733,of,O
83236,5733,the,O
83237,5733,study,O
83238,5734,Clinically,O
83239,5734,significant,O
83240,5734,abnormal,O
83241,5734,laboratory,O
83242,5734,finding,O
83243,5735,Having,O
83244,5735,comorbid,O
83245,5735,psychiatric,B-Condition
83246,5735,conditions,I-Condition
83247,5735,according,O
83248,5735,to,O
83249,5735,the,O
83250,5735,criteria,O
83251,5735,set,O
83252,5735,forth,O
83253,5735,in,O
83254,5735,the,O
83255,5735,DSM,O
83256,5735,-,O
83257,5735,IV(administered,O
83258,5735,by,O
83259,5735,the,O
83260,5735,Mini,O
83261,5735,-,O
83262,5735,International,O
83263,5735,Neuropsychiatric,O
83264,5735,Interview,O
83265,5735,(,O
83266,5735,MINI,O
83267,5735,),O
83268,5735,),O
83269,5736,The,O
83270,5736,current,O
83271,5736,OCD,B-Condition
83272,5736,symptoms,I-Condition
83273,5736,are,O
83274,5736,too,O
83275,5736,severe,O
83276,5736,that,O
83277,5736,the,O
83278,5736,patient,O
83279,5736,can,O
83280,5736,not,O
83281,5736,finish,O
83282,5736,the,O
83283,5736,evaluation,O
83284,5736,or,O
83285,5736,receive,O
83286,5736,the,O
83287,5736,ERP,O
83288,5737,Being,O
83289,5737,currently,O
83290,5737,at,O
83291,5737,risk,B-Observation
83292,5737,for,I-Observation
83293,5737,suicide,I-Observation
83294,5738,Being,O
83295,5738,pregnant,O
83296,5738,or,O
83297,5738,having,O
83298,5738,the,O
83299,5738,intention,O
83300,5738,to,O
83301,5738,be,O
83302,5738,pregnant,O
83303,5738,before,O
83304,5738,the,O
83305,5738,end,O
83306,5738,of,O
83307,5738,the,O
83308,5738,study,O
83309,5739,A,O
83310,5739,history,O
83311,5739,of,O
83312,5739,having,O
83313,5739,inadequate,O
83314,5739,response,B-Condition
83315,5739,to,O
83316,5739,adequate,O
83317,5739,SSRIs,B-Drug
83318,5739,or,O
83319,5739,CBT,B-Drug
83320,5739,treatment,O
83321,5740,Subjects,O
83322,5740,who,O
83323,5740,are,O
83324,5740,unable,B-Mood
83325,5740,to,I-Mood
83326,5740,undergo,O
83327,5740,the,O
83328,5740,MRI,B-Procedure
83329,5741,Having,O
83330,5741,been,O
83331,5741,diagnosed,O
83332,5741,with,O
83333,5741,primary,B-Condition
83334,5741,OCD,I-Condition
83335,5741,as,O
83336,5741,defined,O
83337,5741,by,O
83338,5741,the,O
83339,5741,Diagnostic,O
83340,5741,and,O
83341,5741,Statistical,O
83342,5741,Manual,O
83343,5741,of,O
83344,5741,Mental,O
83345,5741,Disorders,O
83346,5741,(,O
83347,5741,DSM,O
83348,5741,-,O
83349,5741,IV-,O
83350,5741,),O
83351,5741,criteria;Cleaning,O
83352,5741,or,O
83353,5741,checking,O
83354,5741,as,O
83355,5741,primary,O
83356,5741,OCD,O
83357,5741,symptoms,O
83358,5742,Yale,O
83359,5742,-,O
83360,5742,Brown,O
83361,5742,Obsessive,O
83362,5742,-,O
83363,5742,Compulsive,O
83364,5742,Scale,O
83365,5742,(,O
83366,5742,Y,O
83367,5742,-,O
83368,5742,BOCS,O
83369,5742,),O
83370,5742,score,O
83371,5742,of,O
83372,5742,=,O
83373,5742,16,O
83374,5743,Never,O
83375,5743,receiving,O
83376,5743,adequate,O
83377,5743,treatment,B-Procedure
83378,5743,or,O
83379,5743,stop,O
83380,5743,receiving,O
83381,5743,treatment,B-Procedure
83382,5743,for,O
83383,5743,at,O
83384,5743,least,O
83385,5743,8,O
83386,5743,weeks,O
83387,5744,Having,O
83388,5744,an,O
83389,5744,education,O
83390,5744,degree,B-Person
83391,5744,of,I-Person
83392,5744,high,I-Person
83393,5744,school,I-Person
83394,5744,or,O
83395,5744,above,O
83396,5745,Accepting,O
83397,5745,to,O
83398,5745,participate,O
83399,5745,in,O
83400,5745,the,O
83401,5745,study,O
83402,5746,Age,B-Person
83403,5746,<,O
83404,5746,1,O
83405,5746,m,O
83406,5746,or,O
83407,5746,>,O
83408,5746,24,O
83409,5746,months,O
83410,5746,of,O
83411,5746,age,O
83412,5747,No,O
83413,5747,secure,O
83414,5747,diagnosis,O
83415,5747,of,O
83416,5747,epilepsy,B-Condition
83417,5748,<,O
83418,5748,4,O
83419,5748,seizures,B-Condition
83420,5748,/,O
83421,5748,week,O
83422,5748,on,O
83423,5748,average,O
83424,5748,in,O
83425,5748,baseline,O
83426,5748,period,O
83427,5749,Trial,O
83428,5749,of,O
83429,5749,<,O
83430,5749,2,O
83431,5749,AEDs,B-Drug
83432,5750,Continues,O
83433,5750,on,O
83434,5750,corticosteroids,B-Drug
83435,5750,in,O
83436,5750,previous,O
83437,5750,3,O
83438,5750,months,O
83439,5750,prior,O
83440,5750,to,O
83441,5750,randomisation,O
83442,5751,Metabolic,B-Condition
83443,5751,disease,I-Condition
83444,5751,contraindicating,B-Condition
83445,5751,use,O
83446,5751,of,O
83447,5751,the,O
83448,5751,ketogenic,B-Procedure
83449,5751,diet,I-Procedure
83450,5751,e.g.,O
83451,5751,pyruvate,B-Condition
83452,5751,carboxylase,I-Condition
83453,5751,deficiency,I-Condition
83454,5751,",",I-Condition
83455,5751,MCAD,B-Condition
83456,5751,from,O
83457,5751,previous,O
83458,5751,medical,O
83459,5751,investigation,O
83460,5751,and,O
83461,5751,screening,O
83462,5751,at,O
83463,5751,baseline,O
83464,5751,.,O
83465,5752,Progressive,O
83466,5752,neurological,B-Condition
83467,5752,disease,I-Condition
83468,5753,Severe,O
83469,5753,gastroesophageal,B-Condition
83470,5753,reflux,I-Condition
83471,5754,Previous,O
83472,5754,treatment,O
83473,5754,with,O
83474,5754,the,O
83475,5754,ketogenic,B-Procedure
83476,5754,diet,I-Procedure
83477,5755,Concurrent,O
83478,5755,participation,O
83479,5755,in,O
83480,5755,another,O
83481,5755,clinical,O
83482,5755,trial,O
83483,5755,of,O
83484,5755,an,O
83485,5755,investigational,O
83486,5755,medicinal,O
83487,5755,product,O
83488,5755,.,O
83489,5756,Patients,O
83490,5756,who,O
83491,5756,are,O
83492,5756,prescribed,O
83493,5756,AEDs,O
83494,5756,not,O
83495,5756,listed,O
83496,5756,in,O
83497,5756,the,O
83498,5756,trial,O
83499,5756,IMPs,O
83500,5757,Age,B-Person
83501,5757,between,O
83502,5757,1,O
83503,5757,month,O
83504,5757,and,O
83505,5757,24,O
83506,5757,months,O
83507,5757,of,O
83508,5757,age,O
83509,5757,(,O
83510,5757,not,O
83511,5757,beyond,O
83512,5757,second,O
83513,5757,birthday,O
83514,5757,at,O
83515,5757,baseline,O
83516,5757,),O
83517,5757,.,O
83518,5758,Diagnosis,O
83519,5758,of,O
83520,5758,epilepsy,B-Condition
83521,5758,confirmed,O
83522,5758,.,O
83523,5759,At,O
83524,5759,least,O
83525,5759,an,O
83526,5759,average,O
83527,5759,of,O
83528,5759,4,O
83529,5759,seizures,B-Condition
83530,5759,/,O
83531,5759,week,O
83532,5759,in,O
83533,5759,baseline,O
83534,5759,period,O
83535,5759,.,O
83536,5760,Failed,O
83537,5760,response,B-Condition
83538,5760,to,O
83539,5760,previous,O
83540,5760,trial,O
83541,5760,of,O
83542,5760,two,O
83543,5760,anti,B-Drug
83544,5760,-,I-Drug
83545,5760,epileptic,I-Drug
83546,5760,drugs,I-Drug
83547,5760,.,O
83548,5760,In,O
83549,5760,the,O
83550,5760,case,O
83551,5760,of,O
83552,5760,infantile,O
83553,5760,spasms,O
83554,5760,this,O
83555,5760,could,O
83556,5760,include,O
83557,5760,a,O
83558,5760,trial,O
83559,5760,of,O
83560,5760,corticosteroids,B-Drug
83561,5760,.,O
83562,5761,Children,O
83563,5761,with,O
83564,5761,written,O
83565,5761,informed,O
83566,5761,consent,O
83567,5761,from,O
83568,5761,parent,O
83569,5761,/,O
83570,5761,guardian,O
83571,5761,.,O
83572,5762,age,B-Person
83573,5762,<,O
83574,5762,18,O
83575,5762,years,O
83576,5763,previous,O
83577,5763,history,B-Observation
83578,5763,of,O
83579,5763,roux,B-Procedure
83580,5763,-,I-Procedure
83581,5763,en,I-Procedure
83582,5763,-,I-Procedure
83583,5763,y,I-Procedure
83584,5763,gastric,I-Procedure
83585,5763,bypass,I-Procedure
83586,5764,patients,O
83587,5764,undergoing,O
83588,5764,other,O
83589,5764,bariatric,B-Procedure
83590,5764,procedures,I-Procedure
83591,5765,pre,O
83592,5765,-,O
83593,5765,operative,O
83594,5765,opioid,B-Drug
83595,5765,analgesics,I-Drug
83596,5766,bariatric,B-Procedure
83597,5766,surgery,I-Procedure
83598,5766,patients,O
83599,5767,laparoscopic,O
83600,5767,roux,B-Procedure
83601,5767,-,I-Procedure
83602,5767,en,I-Procedure
83603,5767,-,I-Procedure
83604,5767,y,I-Procedure
83605,5767,gastric,I-Procedure
83606,5767,bypass,I-Procedure
83607,5768,use,O
83608,5768,of,O
83609,5768,EEA,O
83610,5768,stapler,O
83611,5768,anastomosis,O
83612,5769,Dual,B-Condition
83613,5769,organ,I-Condition
83614,5769,or,I-Condition
83615,5769,kidney,I-Condition
83616,5769,after,O
83617,5769,another,O
83618,5769,solid,B-Procedure
83619,5769,organ,I-Procedure
83620,5769,transplant,I-Procedure
83621,5770,Presence,O
83622,5770,of,O
83623,5770,a,O
83624,5770,preexisting,O
83625,5770,significant,O
83626,5770,GI,B-Condition
83627,5770,condition,I-Condition
83628,5770,that,O
83629,5770,does,O
83630,5770,not,O
83631,5770,have,O
83632,5770,a,O
83633,5770,presumed,O
83634,5770,causal,O
83635,5770,relationship,O
83636,5770,with,O
83637,5770,MPA,O
83638,5771,Evidence,O
83639,5771,of,O
83640,5771,any,O
83641,5771,GI,B-Condition
83642,5771,disorder,I-Condition
83643,5771,induced,O
83644,5771,by,O
83645,5771,an,O
83646,5771,infection,B-Condition
83647,5771,",",O
83648,5771,underlying,B-Condition
83649,5771,medical,I-Condition
83650,5771,condition,I-Condition
83651,5771,",",O
83652,5771,or,O
83653,5771,concomitant,O
83654,5771,medication,B-Drug
83655,5771,other,O
83656,5771,than,O
83657,5771,MPA,B-Drug
83658,5772,eGFR<40,O
83659,5772,ml,O
83660,5772,/,O
83661,5772,min,O
83662,5772,at,O
83663,5772,time,O
83664,5772,of,O
83665,5772,possible,O
83666,5772,conversion,O
83667,5773,Proteinuria,O
83668,5773,>,O
83669,5773,1,O
83670,5773,gram,O
83671,5773,/,O
83672,5773,day,O
83673,5773,at,O
83674,5773,time,O
83675,5773,of,O
83676,5773,possible,O
83677,5773,conversion,O
83678,5774,Hemoglobin,O
83679,5774,<,O
83680,5774,10,O
83681,5774,g,O
83682,5774,/,O
83683,5774,dL,O
83684,5775,WBC,O
83685,5775,<3,O
83686,5775,K,O
83687,5775,/,O
83688,5775,cumm,O
83689,5776,Platelets,O
83690,5776,<,O
83691,5776,100,O
83692,5776,K,O
83693,5776,/,O
83694,5776,cumm,O
83695,5777,Wound,B-Condition
83696,5777,healing,I-Condition
83697,5777,issues,I-Condition
83698,5777,at,O
83699,5777,time,O
83700,5777,of,O
83701,5777,possible,O
83702,5777,conversion,O
83703,5777,(,O
83704,5777,eg,O
83705,5777,",",O
83706,5777,wound,B-Condition
83707,5777,dehiscence,I-Condition
83708,5777,",",O
83709,5777,wound,B-Condition
83710,5777,infection,I-Condition
83711,5777,",",O
83712,5777,incisional,B-Condition
83713,5777,hernia,I-Condition
83714,5777,",",O
83715,5777,lymphocele,B-Condition
83716,5777,",",O
83717,5777,seroma,B-Condition
83718,5777,),O
83719,5778,Elevated,O
83720,5778,total,O
83721,5778,cholesterol,O
83722,5778,(,O
83723,5778,>,O
83724,5778,350,O
83725,5778,mg,O
83726,5778,/,O
83727,5778,dL,O
83728,5778,),O
83729,5778,and/or,O
83730,5778,triglycerides,O
83731,5778,(,O
83732,5778,>,O
83733,5778,500,O
83734,5778,ng,O
83735,5778,/,O
83736,5778,dL,O
83737,5778,),O
83738,5778,at,O
83739,5778,time,O
83740,5778,of,O
83741,5778,possible,O
83742,5778,conversion,O
83743,5779,Hypersensitivity,B-Condition
83744,5779,to,O
83745,5779,everolimus,B-Drug
83746,5779,",",O
83747,5779,sirolimus,B-Drug
83748,5779,",",O
83749,5779,or,O
83750,5779,other,O
83751,5779,rapamycin,B-Drug
83752,5779,deriviatives,O
83753,5780,Kidney,B-Procedure
83754,5780,transplant,I-Procedure
83755,5780,recipients,O
83756,5780,at,O
83757,5780,Washington,O
83758,5780,University,O
83759,5780,/,O
83760,5780,Barnes,O
83761,5780,-,O
83762,5780,Jewish,O
83763,5780,Hospital,O
83764,5781,Experiencing,O
83765,5781,GI,B-Procedure
83766,5781,toxicity,I-Procedure
83767,5781,from,O
83768,5781,MPA,B-Drug
83769,5781,as,O
83770,5781,determined,O
83771,5781,by,O
83772,5781,the,O
83773,5781,treating,O
83774,5781,physician,O
83775,5781,within,O
83776,5781,12,O
83777,5781,months,O
83778,5781,post,O
83779,5781,-,O
83780,5781,renal,O
83781,5781,transplant,O
83782,5782,On,O
83783,5782,standard,B-Procedure
83784,5782,immunosuppression,I-Procedure
83785,5782,with,O
83786,5782,tacrolimus,B-Drug
83787,5782,and,O
83788,5782,prednisone,B-Drug
83789,5783,Exclusion,O
83790,5783,Criteria,O
83791,5783,patients,B-Observation
83792,5783,:,O
83793,5783,Substance,B-Condition
83794,5783,abuse,I-Condition
83795,5783,on,O
83796,5783,a,O
83797,5783,daily,O
83798,5783,basis,O
83799,5783,during,O
83800,5783,the,O
83801,5783,last,O
83802,5783,3,O
83803,5783,month,O
83804,5783,or,O
83805,5783,patients,O
83806,5783,fulfilling,O
83807,5783,the,O
83808,5783,criteria,O
83809,5783,of,O
83810,5783,ongoing,O
83811,5783,substance,B-Condition
83812,5783,abuse,I-Condition
83813,5783,due,O
83814,5783,to,O
83815,5783,ICD-10,O
83816,5783,/,O
83817,5783,DSM,O
83818,5783,-,O
83819,5783,IV,O
83820,5783,/,O
83821,5783,V,O
83822,5783,",",O
83823,5783,Treatment,O
83824,5783,with,O
83825,5783,antidepressant,B-Drug
83826,5783,during,O
83827,5783,the,O
83828,5783,last,O
83829,5783,30,O
83830,5783,days,O
83831,5783,",",O
83832,5783,Head,B-Condition
83833,5783,injury,I-Condition
83834,5783,with,O
83835,5783,more,O
83836,5783,than,O
83837,5783,5,O
83838,5783,minutes,O
83839,5783,of,O
83840,5783,unconsciousness,B-Condition
83841,5783,",",O
83842,5783,Patients,O
83843,5783,involuntarily,B-Observation
83844,5783,admitted,I-Observation
83845,5783,or,I-Observation
83846,5783,treated,I-Observation
83847,5783,",",O
83848,5783,Components,O
83849,5783,of,O
83850,5783,metal,O
83851,5783,implanted,O
83852,5783,by,O
83853,5783,operation,O
83854,5783,",",O
83855,5783,Pacemaker,O
83856,5783,",",O
83857,5783,Pregnancy,B-Condition
83858,5783,",",O
83859,5783,Severe,B-Condition
83860,5783,physical,I-Condition
83861,5783,illness,I-Condition
83862,5784,Exclusion,O
83863,5784,criteria,O
83864,5784,controls,B-Observation
83865,5784,:,O
83866,5784,First,B-Observation
83867,5784,degree,I-Observation
83868,5784,relatives,I-Observation
83869,5784,with,O
83870,5784,psychiatric,B-Condition
83871,5784,disease,I-Condition
83872,5784,",",O
83873,5784,Substance,B-Condition
83874,5784,abuse,I-Condition
83875,5784,during,O
83876,5784,the,O
83877,5784,last,O
83878,5784,3,O
83879,5784,month,O
83880,5784,or,O
83881,5784,positive,O
83882,5784,screening,B-Procedure
83883,5784,of,I-Procedure
83884,5784,drugs,I-Procedure
83885,5784,in,O
83886,5784,urine,O
83887,5784,-,O
83888,5784,sample,O
83889,5784,",",O
83890,5784,Head,B-Condition
83891,5784,injury,I-Condition
83892,5784,with,O
83893,5784,more,O
83894,5784,than,O
83895,5784,5,O
83896,5784,minutes,O
83897,5784,of,O
83898,5784,unconsciousness,B-Condition
83899,5784,",",O
83900,5784,Components,O
83901,5784,of,O
83902,5784,metal,O
83903,5784,implanted,O
83904,5784,by,O
83905,5784,operation,O
83906,5784,",",O
83907,5784,Pacemaker,O
83908,5784,",",O
83909,5784,Pregnancy,B-Condition
83910,5784,",",O
83911,5784,Severe,B-Condition
83912,5784,physical,I-Condition
83913,5784,illness,I-Condition
83914,5785,Inclusion,O
83915,5785,Criteria,O
83916,5785,Patients,B-Observation
83917,5785,:,O
83918,5785,Fulfilling,O
83919,5785,the,O
83920,5785,diagnostic,O
83921,5785,criteria,O
83922,5785,of,O
83923,5785,schizophrenia,B-Condition
83924,5785,or,O
83925,5785,schizoaffective,B-Condition
83926,5785,disorder,I-Condition
83927,5785,according,O
83928,5785,to,O
83929,5785,ICD-10,O
83930,5785,(,O
83931,5785,International,O
83932,5785,Classification,O
83933,5785,of,O
83934,5785,Diseases,O
83935,5785,version,O
83936,5785,10,O
83937,5785,),O
83938,5785,or,O
83939,5785,DSM,O
83940,5785,-,O
83941,5785,IV,O
83942,5785,/,O
83943,5785,V,O
83944,5785,(,O
83945,5785,Diagnostic,O
83946,5785,and,O
83947,5785,Statistical,O
83948,5785,Manual,O
83949,5785,version,O
83950,5785,4,O
83951,5785,/5,O
83952,5785,),O
83953,5785,",",O
83954,5785,Age,B-Person
83955,5785,18,O
83956,5785,-,O
83957,5785,45,O
83958,5785,years,O
83959,5785,",",O
83960,5785,Never,O
83961,5785,treated,O
83962,5785,with,O
83963,5785,antipsychotic,B-Drug
83964,5785,compounds,I-Drug
83965,5785,or,O
83966,5785,central,B-Drug
83967,5785,nervous,I-Drug
83968,5785,system,I-Drug
83969,5785,(,I-Drug
83970,5785,CNS,I-Drug
83971,5785,),I-Drug
83972,5785,stimulants,I-Drug
83973,5785,",",O
83974,5785,Legally,B-Observation
83975,5785,competent,I-Observation
83976,5786,Inclusion,O
83977,5786,criteria,O
83978,5786,controls,B-Observation
83979,5786,:,O
83980,5786,Matching,O
83981,5786,patients,O
83982,5786,on,O
83983,5786,age,O
83984,5786,(,O
83985,5786,+,O
83986,5786,/-,O
83987,5786,2,O
83988,5786,years,O
83989,5786,),O
83990,5786,",",O
83991,5786,sex,O
83992,5786,and,O
83993,5786,parental,O
83994,5786,socioeconomic,O
83995,5786,status,O
83996,5786,",",O
83997,5786,Age,B-Person
83998,5786,18,O
83999,5786,-,O
84000,5786,45,O
84001,5786,years,O
84002,5786,",",O
84003,5786,No,O
84004,5786,psychiatric,B-Condition
84005,5786,or,I-Condition
84006,5786,physical,I-Condition
84007,5786,disease,I-Condition
84008,5786,.,O
84009,5787,Established,O
84010,5787,Osteoarthritis,B-Condition
84011,5787,(,O
84012,5787,Kellgren,O
84013,5787,-,O
84014,5787,Lawrence,O
84015,5787,>,O
84016,5787,3,O
84017,5787,),O
84018,5788,Minimum,O
84019,5788,joint,O
84020,5788,space,O
84021,5788,>,O
84022,5788,2,O
84023,5788,mm,O
84024,5788,as,O
84025,5788,measured,O
84026,5788,on,O
84027,5788,AP,B-Procedure
84028,5788,radiograph,I-Procedure
84029,5789,Hip,B-Condition
84030,5789,dysplasia,I-Condition
84031,5789,(,O
84032,5789,center,O
84033,5789,edge,O
84034,5789,angle,O
84035,5789,<,O
84036,5789,20,O
84037,5789,°,O
84038,5789,on,O
84039,5789,AP,B-Procedure
84040,5789,radiograph,I-Procedure
84041,5789,),O
84042,5790,Patients,O
84043,5790,with,O
84044,5790,clinically,O
84045,5790,significant,O
84046,5790,cardiovascular,B-Condition
84047,5790,",",I-Condition
84048,5790,renal,I-Condition
84049,5790,",",I-Condition
84050,5790,hepatic,I-Condition
84051,5790,",",I-Condition
84052,5790,endocrine,I-Condition
84053,5790,disease,I-Condition
84054,5790,",",O
84055,5790,cancer,B-Condition
84056,5790,or,O
84057,5790,diabetes,B-Condition
84058,5791,Patients,O
84059,5791,with,O
84060,5791,ongoing,O
84061,5791,infection,B-Condition
84062,5791,including,O
84063,5791,HIV,B-Condition
84064,5791,and,O
84065,5791,Hepatitis,B-Condition
84066,5792,Patient,O
84067,5792,with,O
84068,5792,history,O
84069,5792,of,O
84070,5792,osteomyelitis,B-Condition
84071,5792,/,O
84072,5792,septic,B-Condition
84073,5792,arthritis,I-Condition
84074,5793,Anticoagulation,B-Procedure
84075,5793,therapy,I-Procedure
84076,5794,Patients,O
84077,5794,who,O
84078,5794,are,O
84079,5794,pregnant,O
84080,5794,or,O
84081,5794,breast,O
84082,5794,feeding,O
84083,5795,Patients,O
84084,5795,with,O
84085,5795,systemic,B-Condition
84086,5795,",",I-Condition
84087,5795,rheumatic,I-Condition
84088,5795,or,I-Condition
84089,5795,inflammatory,I-Condition
84090,5795,disease,I-Condition
84091,5795,of,O
84092,5795,the,O
84093,5795,knee,O
84094,5795,or,O
84095,5795,chondrocalcinosis,B-Condition
84096,5795,",",O
84097,5795,hemochromatosis,B-Condition
84098,5795,",",O
84099,5795,inflammatory,B-Condition
84100,5795,arthritis,I-Condition
84101,5795,",",O
84102,5795,arthropathy,B-Condition
84103,5795,of,I-Condition
84104,5795,the,I-Condition
84105,5795,knee,I-Condition
84106,5795,associated,O
84107,5795,with,O
84108,5795,juxta,O
84109,5795,-,O
84110,5795,articular,O
84111,5795,Paget,B-Condition
84112,5795,'s,I-Condition
84113,5795,disease,I-Condition
84114,5795,of,O
84115,5795,the,O
84116,5795,femur,O
84117,5795,or,O
84118,5795,tibia,O
84119,5795,",",O
84120,5795,hemophilic,B-Condition
84121,5795,arthropathy,I-Condition
84122,5795,",",O
84123,5795,infectious,B-Condition
84124,5795,arthritis,I-Condition
84125,5795,",",O
84126,5795,Charcot,B-Condition
84127,5795,'s,I-Condition
84128,5795,knee,I-Condition
84129,5795,joint,I-Condition
84130,5795,",",O
84131,5795,villonodular,B-Condition
84132,5795,synovitis,I-Condition
84133,5795,",",O
84134,5795,and,O
84135,5795,synovial,B-Condition
84136,5795,chondromatosis,I-Condition
84137,5796,Patients,O
84138,5796,taking,O
84139,5796,immunosuppressant,B-Procedure
84140,5796,medication,I-Procedure
84141,5797,Patients,O
84142,5797,with,O
84143,5797,abnormal,O
84144,5797,hematology,O
84145,5797,or,O
84146,5797,serum,O
84147,5797,chemistry,O
84148,5797,lab,O
84149,5797,results,O
84150,5798,Patients,O
84151,5798,receiving,O
84152,5798,injection,B-Procedure
84153,5798,to,O
84154,5798,treatment,O
84155,5798,knee,O
84156,5798,within,O
84157,5798,2,O
84158,5798,months,O
84159,5798,of,O
84160,5798,study,O
84161,5798,enrollment,O
84162,5799,BMI,O
84163,5799,greater,O
84164,5799,than,O
84165,5799,35,O
84166,5799,or,O
84167,5799,less,O
84168,5799,than,O
84169,5799,20,O
84170,5800,Patients,O
84171,5800,with,O
84172,5800,symptomatic,O
84173,5800,FAI,B-Condition
84174,5801,Clinical,O
84175,5801,and,O
84176,5801,radiographic,O
84177,5801,evidence,O
84178,5801,of,O
84179,5801,FAI,B-Condition
84180,5802,Patients,O
84181,5802,able,O
84182,5802,to,O
84183,5802,provide,O
84184,5802,consent,O
84185,5802,to,O
84186,5802,study,O
84187,5802,participation,O
84188,5803,Completion,O
84189,5803,of,O
84190,5803,6,O
84191,5803,weeks,O
84192,5803,of,O
84193,5803,physical,B-Procedure
84194,5803,therapy,I-Procedure
84195,5803,program,I-Procedure
84196,5804,Biliary,B-Condition
84197,5804,strictures,I-Condition
84198,5804,caused,O
84199,5804,by,O
84200,5804,confirmed,O
84201,5804,benign,B-Condition
84202,5804,tumors,I-Condition
84203,5805,Biliary,B-Condition
84204,5805,strictures,I-Condition
84205,5805,caused,O
84206,5805,by,O
84207,5805,malignancies,B-Condition
84208,5805,other,O
84209,5805,than,O
84210,5805,pancreatic,B-Condition
84211,5805,cancer,I-Condition
84212,5805,",",O
84213,5805,distal,B-Condition
84214,5805,CBD,I-Condition
84215,5805,cholangiocarcinoma,I-Condition
84216,5805,and,O
84217,5805,other,B-Condition
84218,5805,periampullary,I-Condition
84219,5805,cancers,I-Condition
84220,5806,Surgically,B-Condition
84221,5806,altered,I-Condition
84222,5806,biliary,I-Condition
84223,5806,tract,I-Condition
84224,5806,anatomy,I-Condition
84225,5806,",",O
84226,5806,not,O
84227,5806,including,O
84228,5806,prior,O
84229,5806,cholecystectomy,B-Procedure
84230,5807,Neoadjuvant,B-Procedure
84231,5807,chemotherapy,I-Procedure
84232,5807,for,O
84233,5807,current,O
84234,5807,malignancy,B-Condition
84235,5808,Palliative,O
84236,5808,indication,O
84237,5808,due,O
84238,5808,to,O
84239,5808,reasons,O
84240,5808,other,O
84241,5808,than,O
84242,5808,surgical,O
84243,5808,candidate,O
84244,5808,status,O
84245,5809,Previous,O
84246,5809,biliary,B-Procedure
84247,5809,drainage,I-Procedure
84248,5809,by,I-Procedure
84249,5809,ERCP,I-Procedure
84250,5809,/,I-Procedure
84251,5809,PTC,I-Procedure
84252,5810,Patients,O
84253,5810,for,O
84254,5810,whom,O
84255,5810,endoscopic,B-Procedure
84256,5810,techniques,I-Procedure
84257,5810,are,O
84258,5810,contraindicated,B-Condition
84259,5811,Participation,O
84260,5811,in,O
84261,5811,another,O
84262,5811,investigational,O
84263,5811,trial,O
84264,5811,within,O
84265,5811,90,O
84266,5811,days,O
84267,5812,Pregnancy,B-Condition
84268,5813,Age,B-Person
84269,5813,18,O
84270,5813,or,O
84271,5813,older,O
84272,5814,Willing,O
84273,5814,and,O
84274,5814,able,O
84275,5814,to,O
84276,5814,comply,O
84277,5814,with,O
84278,5814,the,O
84279,5814,study,O
84280,5814,procedures,O
84281,5814,and,O
84282,5814,provide,O
84283,5814,written,O
84284,5814,informed,O
84285,5814,consent,O
84286,5814,to,O
84287,5814,participate,O
84288,5814,in,O
84289,5814,the,O
84290,5814,study,O
84291,5815,Diagnosis,O
84292,5815,of,O
84293,5815,probable,B-Mood
84294,5815,pancreatic,B-Condition
84295,5815,cancer,I-Condition
84296,5815,",",O
84297,5815,distal,B-Condition
84298,5815,common,I-Condition
84299,5815,bile,I-Condition
84300,5815,duct,I-Condition
84301,5815,(,I-Condition
84302,5815,CBD,I-Condition
84303,5815,),I-Condition
84304,5815,cholangiocarcinoma,I-Condition
84305,5815,and,O
84306,5815,other,O
84307,5815,periampullary,B-Condition
84308,5815,cancers,I-Condition
84309,5815,(,O
84310,5815,histology,O
84311,5815,not,O
84312,5815,required,O
84313,5815,),O
84314,5816,Biliary,B-Condition
84315,5816,obstructive,I-Condition
84316,5816,symptoms,I-Condition
84317,5816,or,I-Condition
84318,5816,signs,I-Condition
84319,5817,Bilirubin,O
84320,5817,level,O
84321,5817,at,O
84322,5817,/,O
84323,5817,above,O
84324,5817,100,O
84325,5817,umol,O
84326,5817,per,O
84327,5817,liter,O
84328,5817,(,O
84329,5817,5.8,O
84330,5817,mg,O
84331,5817,/,O
84332,5817,dL,O
84333,5817,),O
84334,5818,Distal,B-Condition
84335,5818,biliary,I-Condition
84336,5818,obstruction,I-Condition
84337,5818,consistent,O
84338,5818,with,O
84339,5818,pancreatic,B-Condition
84340,5818,cancer,I-Condition
84341,5818,",",O
84342,5818,distal,B-Condition
84343,5818,CBD,I-Condition
84344,5818,cholangiocarcinoma,I-Condition
84345,5818,or,O
84346,5818,other,O
84347,5818,periampullary,B-Condition
84348,5818,malignancy,I-Condition
84349,5819,Location,O
84350,5819,of,O
84351,5819,distal,B-Condition
84352,5819,biliary,I-Condition
84353,5819,obstruction,I-Condition
84354,5819,is,O
84355,5819,such,O
84356,5819,that,O
84357,5819,it,O
84358,5819,would,B-Mood
84359,5819,allow,I-Mood
84360,5819,the,O
84361,5819,proximal,O
84362,5819,end,O
84363,5819,of,O
84364,5819,a,O
84365,5819,stent,B-Procedure
84366,5819,to,O
84367,5819,be,O
84368,5819,positioned,O
84369,5819,at,O
84370,5819,least,O
84371,5819,2,O
84372,5819,cm,O
84373,5819,from,O
84374,5819,the,O
84375,5819,hilum,O
84376,5820,Patients,O
84377,5820,deemed,B-Condition
84378,5820,as,I-Condition
84379,5820,resectable,I-Condition
84380,5820,by,O
84381,5820,pancreatic,B-Procedure
84382,5820,protocol,I-Procedure
84383,5820,CT,I-Procedure
84384,5820,or,I-Procedure
84385,5820,MRI,I-Procedure
84386,5821,Surgical,B-Condition
84387,5821,candidate,I-Condition
84388,5821,per,O
84389,5821,pancreatobiliary,O
84390,5821,surgeon,O
84391,5821,after,O
84392,5821,multi,O
84393,5821,-,O
84394,5821,disciplinary,O
84395,5821,discussion,O
84396,5822,Surgery,B-Procedure
84397,5822,intent,B-Mood
84398,5822,within,O
84399,5822,4,O
84400,5822,weeks,O
84401,5823,Endoscopic,B-Procedure
84402,5823,and,I-Procedure
84403,5823,surgical,I-Procedure
84404,5823,treatment,I-Procedure
84405,5823,to,O
84406,5823,be,O
84407,5823,provided,O
84408,5823,by,O
84409,5823,same,O
84410,5823,team,O
84411,5824,Pregnant,O
84412,5824,or,O
84413,5824,breast,O
84414,5824,feeding,O
84415,5825,History,O
84416,5825,of,O
84417,5825,Stomach,B-Procedure
84418,5825,or,I-Procedure
84419,5825,esophagus,I-Procedure
84420,5825,surgery,I-Procedure
84421,5826,Peptic,B-Condition
84422,5826,ulcer,I-Condition
84423,5826,or,O
84424,5826,reflux,B-Condition
84425,5826,esophagitis,I-Condition
84426,5827,Zollinger,B-Condition
84427,5827,-,I-Condition
84428,5827,Ellison,I-Condition
84429,5827,syndrome,I-Condition
84430,5827,or,O
84431,5827,primary,B-Condition
84432,5827,esophageal,I-Condition
84433,5827,motility,I-Condition
84434,5827,disorders,I-Condition
84435,5828,Malignant,B-Condition
84436,5828,tumor,I-Condition
84437,5829,Bleeding,B-Condition
84438,5829,tendency,I-Condition
84439,5829,or,O
84440,5829,coagulopathy,B-Condition
84441,5830,Contraindication,B-Condition
84442,5830,of,O
84443,5830,ALBIS,B-Drug
84444,5831,Long,O
84445,5831,term,O
84446,5831,use,O
84447,5831,of,O
84448,5831,aspirin,B-Drug
84449,5831,or,O
84450,5831,P2Y12,B-Drug
84451,5831,receptor,I-Drug
84452,5831,antagonist,I-Drug
84453,5831,within,O
84454,5831,1month,O
84455,5832,Patients,O
84456,5832,who,O
84457,5832,tool,O
84458,5832,medicine,O
84459,5832,such,O
84460,5832,as,O
84461,5832,PPI,B-Drug
84462,5832,",",O
84463,5832,APA,B-Drug
84464,5832,",",O
84465,5832,H2blocker,B-Drug
84466,5832,",",O
84467,5832,Muscarine,B-Drug
84468,5832,receptor,I-Drug
84469,5832,antagonist,I-Drug
84470,5832,",",O
84471,5832,anti,B-Drug
84472,5832,-,I-Drug
84473,5832,gastic,I-Drug
84474,5832,agent,I-Drug
84475,5832,",",O
84476,5832,antacid,B-Drug
84477,5832,",",O
84478,5832,anticaogulant,B-Drug
84479,5832,",",O
84480,5832,Bisphosphonate,B-Drug
84481,5832,agents,I-Drug
84482,5832,",",O
84483,5832,Cytotoxic,B-Drug
84484,5832,drug,I-Drug
84485,5832,",",O
84486,5832,NSAID,B-Drug
84487,5832,",",O
84488,5832,adrenal,B-Drug
84489,5832,cortex,I-Drug
84490,5832,hormone,I-Drug
84491,5832,agents,I-Drug
84492,5832,(,O
84493,5832,topical,B-Procedure
84494,5832,treatment,I-Procedure
84495,5832,is,O
84496,5832,allowed,O
84497,5832,),O
84498,5833,Terminal,O
84499,5833,patient,B-Person
84500,5834,Age,B-Person
84501,5834,between,O
84502,5834,20,O
84503,5834,and,O
84504,5834,80,O
84505,5834,years,O
84506,5835,Patients,O
84507,5835,undergoing,O
84508,5835,percutaneous,B-Procedure
84509,5835,coronary,I-Procedure
84510,5835,intervention,I-Procedure
84511,5835,and,O
84512,5835,need,O
84513,5835,to,O
84514,5835,take,O
84515,5835,dual,B-Procedure
84516,5835,antiplatelet,I-Procedure
84517,5835,therapy,I-Procedure
84518,5835,continuously,O
84519,5835,at,O
84520,5835,least,O
84521,5835,12weeks,O
84522,5836,Modified,O
84523,5836,Lanza,O
84524,5836,Score,O
84525,5836,grade,O
84526,5836,0,O
84527,5836,-,O
84528,5836,1,O
84529,5836,measured,O
84530,5836,by,O
84531,5836,upper,B-Procedure
84532,5836,gastrointestinal,I-Procedure
84533,5836,endoscopy,I-Procedure
84534,5837,mild,O
84535,5837,gastrointestinal,B-Condition
84536,5837,symptom,I-Condition
84537,5838,Creatinen,O
84538,5838,in,O
84539,5838,blood,O
84540,5838,=,O
84541,5838,3mg,O
84542,5838,/,O
84543,5838,dl,O
84544,5839,BUN,O
84545,5839,=,O
84546,5839,50mg,O
84547,5839,/,O
84548,5839,dl,O
84549,5840,Birilubin,O
84550,5840,=,O
84551,5840,3mg,O
84552,5840,/,O
84553,5840,dl,O
84554,5841,AST,O
84555,5841,and,O
84556,5841,ALT,O
84557,5841,=,O
84558,5841,80U,O
84559,5841,/,O
84560,5841,L,O
84561,5842,Intolerance,B-Condition
84562,5842,or,O
84563,5842,allergy,B-Condition
84564,5842,to,O
84565,5842,ASA,B-Drug
84566,5842,",",O
84567,5842,clopidogrel,B-Drug
84568,5842,or,O
84569,5842,ticlopidine,B-Drug
84570,5842,precluding,O
84571,5842,treatment,B-Procedure
84572,5842,for,O
84573,5842,12,O
84574,5842,months,O
84575,5843,Concurrent,O
84576,5843,participation,O
84577,5843,in,O
84578,5843,other,O
84579,5843,investigational,O
84580,5843,study,O
84581,5844,Femoral,B-Condition
84582,5844,sheath,I-Condition
84583,5844,(,I-Condition
84584,5844,artery,I-Condition
84585,5844,),I-Condition
84586,5845,At,O
84587,5845,least,O
84588,5845,two,O
84589,5845,of,O
84590,5845,the,O
84591,5845,following,O
84592,5845,additional,O
84593,5845,criteria,O
84594,5846,At,O
84595,5846,least,O
84596,5846,70,O
84597,5846,yrs,O
84598,5846,old,B-Person
84599,5847,Female,B-Person
84600,5847,gender,O
84601,5848,Diabetes,B-Condition
84602,5849,Creatinine,O
84603,5849,clearance,O
84604,5849,<,O
84605,5849,60mL,O
84606,5849,/,O
84607,5849,min,O
84608,5850,History,B-Observation
84609,5850,of,O
84610,5850,gastro,B-Condition
84611,5850,-,I-Condition
84612,5850,intestinal,I-Condition
84613,5850,or,I-Condition
84614,5850,other,I-Condition
84615,5850,organ,I-Condition
84616,5850,bleeding,I-Condition
84617,5851,Baseline,O
84618,5851,anemia,B-Condition
84619,5852,Current,O
84620,5852,treatment,B-Procedure
84621,5852,with,O
84622,5852,glycoproteins,B-Drug
84623,5852,IIb,I-Drug
84624,5852,-,I-Drug
84625,5852,IIIa,I-Drug
84626,5852,inhibitors,I-Drug
84627,5853,irreversible,O
84628,5853,status,O
84629,5853,of,O
84630,5853,primary,B-Condition
84631,5853,disease,I-Condition
84632,5854,any,O
84633,5854,history,O
84634,5854,of,O
84635,5854,malnutrition,B-Condition
84636,5854,before,O
84637,5854,enrollment,O
84638,5855,history,O
84639,5855,of,O
84640,5855,steroid,B-Drug
84641,5855,cortisol,I-Drug
84642,5855,administration,O
84643,5856,severe,O
84644,5856,liver,B-Condition
84645,5856,dysfunction,I-Condition
84646,5856,(,O
84647,5856,Child,O
84648,5856,-,O
84649,5856,Pugh,O
84650,5856,Score,O
84651,5856,C,O
84652,5856,),O
84653,5857,pregnancy,B-Condition
84654,5858,refuse,O
84655,5858,to,O
84656,5858,enrollment,O
84657,5859,re,B-Procedure
84658,5859,-,I-Procedure
84659,5859,admission,I-Procedure
84660,5859,to,O
84661,5859,ICU,O
84662,5859,and,O
84663,5859,has,O
84664,5859,been,O
84665,5859,enrolled,O
84666,5859,during,O
84667,5859,former,O
84668,5859,admission,O
84669,5859,to,O
84670,5859,ICU,O
84671,5860,need,B-Mood
84672,5860,mechanical,B-Procedure
84673,5860,ventilation,I-Procedure
84674,5860,for,O
84675,5860,more,O
84676,5860,than,O
84677,5860,2,O
84678,5860,days,O
84679,5861,mean,O
84680,5861,blood,O
84681,5861,pressure,O
84682,5861,more,O
84683,5861,than,O
84684,5861,60mmHg,O
84685,5862,predicted,B-Observation
84686,5862,ICU,I-Observation
84687,5862,stay,I-Observation
84688,5862,more,O
84689,5862,than,O
84690,5862,7,O
84691,5862,days,O
84692,5863,tolerance,B-Condition
84693,5863,of,O
84694,5863,parenteral,B-Procedure
84695,5863,or,I-Procedure
84696,5863,enteral,I-Procedure
84697,5863,nutrition,I-Procedure
84698,5864,NA,O
84699,5865,Subjects,O
84700,5865,admitted,B-Observation
84701,5865,to,I-Observation
84702,5865,the,I-Observation
84703,5865,hospital,I-Observation
84704,5865,with,O
84705,5865,acute,O
84706,5865,or,O
84707,5865,chronic,O
84708,5865,medical,B-Condition
84709,5865,illnesses,I-Condition
84710,5865,or,O
84711,5865,for,O
84712,5865,elective,O
84713,5865,and,O
84714,5865,emergency,O
84715,5865,surgical,B-Condition
84716,5865,illness,I-Condition
84717,5865,or,O
84718,5865,trauma,B-Condition
84719,5866,Known,O
84720,5866,history,O
84721,5866,of,O
84722,5866,Type,B-Condition
84723,5866,2,I-Condition
84724,5866,diabetes,I-Condition
84725,5866,mellitus,I-Condition
84726,5866,for,O
84727,5866,>,O
84728,5866,3,O
84729,5866,months,O
84730,5867,Treated,O
84731,5867,with,O
84732,5867,either,O
84733,5867,diet,B-Procedure
84734,5867,alone,O
84735,5867,",",O
84736,5867,any,O
84737,5867,combination,O
84738,5867,of,O
84739,5867,oral,B-Drug
84740,5867,antidiabetic,I-Drug
84741,5867,agents,I-Drug
84742,5867,",",O
84743,5867,non,B-Drug
84744,5867,-,I-Drug
84745,5867,insulin,I-Drug
84746,5867,injectables,I-Drug
84747,5867,or,I-Drug
84748,5867,insulin,I-Drug
84749,5867,therapy,I-Drug
84750,5868,Blood,O
84751,5868,glucose,O
84752,5868,levels,O
84753,5868,between,O
84754,5868,>,O
84755,5868,140,O
84756,5868,mg,O
84757,5868,and,O
84758,5868,<,O
84759,5868,400,O
84760,5868,mg,O
84761,5868,/,O
84762,5868,dL,O
84763,5868,without,O
84764,5868,laboratory,O
84765,5868,evidence,O
84766,5868,of,O
84767,5868,diabetic,B-Condition
84768,5868,ketoacidosis,I-Condition
84769,5869,Smokers,B-Condition
84770,5870,Patients,O
84771,5870,under,O
84772,5870,chronic,O
84773,5870,use,O
84774,5870,of,O
84775,5870,medications,B-Drug
84776,5871,Neurological,B-Condition
84777,5871,diseases,I-Condition
84778,5872,Coronary,B-Condition
84779,5872,artery,I-Condition
84780,5872,disease,I-Condition
84781,5873,Acute,B-Condition
84782,5873,heart,I-Condition
84783,5873,failure,I-Condition
84784,5874,Chronic,O
84785,5874,renal,B-Condition
84786,5874,failure,I-Condition
84787,5874,(,O
84788,5874,GFR,O
84789,5874,<,O
84790,5874,30,O
84791,5874,ml,O
84792,5874,/,O
84793,5874,min,O
84794,5874,),O
84795,5875,Chronic,O
84796,5875,obstructive,B-Condition
84797,5875,pulmonary,I-Condition
84798,5875,disease,I-Condition
84799,5876,Mild,B-Condition
84800,5876,OSA,I-Condition
84801,5876,and,O
84802,5876,patients,O
84803,5876,with,O
84804,5876,BMI,O
84805,5876,over,O
84806,5876,40,O
84807,5876,kg,O
84808,5876,/,O
84809,5876,m2,O
84810,5876,.,O
84811,5877,Metabolic,B-Condition
84812,5877,Syndrome,I-Condition
84813,5877,(,O
84814,5877,ATP,O
84815,5877,III,O
84816,5877,),O
84817,5878,Moderate,O
84818,5878,to,O
84819,5878,severe,O
84820,5878,OSA,B-Condition
84821,5879,Has,O
84822,5879,bilateral,O
84823,5879,sacroiliitis,B-Condition
84824,5879,Grade,O
84825,5879,2,O
84826,5879,or,O
84827,5879,unilateral,O
84828,5879,sacroiliitis,B-Condition
84829,5879,Grade,O
84830,5879,3,O
84831,5879,or,O
84832,5879,Grade,O
84833,5879,4,O
84834,5880,Is,O
84835,5880,a,O
84836,5880,nursing,B-Condition
84837,5880,or,O
84838,5880,pregnant,B-Condition
84839,5880,female,B-Person
84840,5880,",",O
84841,5880,or,O
84842,5880,intends,B-Mood
84843,5880,to,I-Mood
84844,5880,become,I-Mood
84845,5880,pregnant,B-Condition
84846,5880,within,O
84847,5880,6,O
84848,5880,months,O
84849,5880,after,O
84850,5880,receiving,O
84851,5880,trial,O
84852,5880,medication,O
84853,5881,Intends,O
84854,5881,to,O
84855,5881,donate,B-Procedure
84856,5881,eggs,I-Procedure
84857,5881,(,I-Procedure
84858,5881,female,I-Procedure
84859,5881,participants,I-Procedure
84860,5881,),I-Procedure
84861,5881,or,I-Procedure
84862,5881,sperm,I-Procedure
84863,5881,(,O
84864,5881,male,B-Person
84865,5881,participants,O
84866,5881,),O
84867,5881,while,O
84868,5881,receiving,O
84869,5881,trial,O
84870,5881,medication,O
84871,5881,or,O
84872,5881,within,O
84873,5881,6,O
84874,5881,months,O
84875,5881,after,O
84876,5881,trial,O
84877,5881,medication,O
84878,5882,Has,O
84879,5882,any,O
84880,5882,clinically,O
84881,5882,significant,O
84882,5882,condition,O
84883,5882,or,O
84884,5882,situation,O
84885,5882,that,O
84886,5882,would,O
84887,5882,interfere,O
84888,5882,with,O
84889,5882,the,O
84890,5882,trial,O
84891,5882,evaluations,O
84892,5882,or,O
84893,5882,participation,O
84894,5882,in,O
84895,5882,the,O
84896,5882,trial,O
84897,5883,Has,O
84898,5883,ever,O
84899,5883,received,O
84900,5883,any,O
84901,5883,cytotoxic,B-Drug
84902,5883,drugs,I-Drug
84903,5883,",",O
84904,5883,including,O
84905,5883,chlorambucil,B-Drug
84906,5883,",",O
84907,5883,cyclophosphamide,B-Drug
84908,5883,",",O
84909,5883,nitrogen,B-Drug
84910,5883,mustard,I-Drug
84911,5883,",",O
84912,5883,or,O
84913,5883,other,O
84914,5883,alkylating,B-Drug
84915,5883,agents,I-Drug
84916,5884,•,O
84917,5884,Disease,B-Drug
84918,5884,-,I-Drug
84919,5884,modifying,I-Drug
84920,5884,anti,I-Drug
84921,5884,-,I-Drug
84922,5884,rheumatic,I-Drug
84923,5884,drugs,I-Drug
84924,5884,(,O
84925,5884,30,O
84926,5884,days,O
84927,5884,off,O
84928,5884,drug,O
84929,5884,),O
84930,5885,•,O
84931,5885,Live,B-Drug
84932,5885,vaccinations,I-Drug
84933,5885,(,O
84934,5885,3,O
84935,5885,months,O
84936,5885,off,O
84937,5885,drug,O
84938,5885,),O
84939,5886,•,O
84940,5886,Investigational,B-Drug
84941,5886,medications,I-Drug
84942,5886,(,O
84943,5886,30,O
84944,5886,days,O
84945,5886,or,O
84946,5886,5,O
84947,5886,half,O
84948,5886,-,O
84949,5886,lives,O
84950,5886,off,O
84951,5886,drug,O
84952,5886,",",O
84953,5886,whichever,O
84954,5886,is,O
84955,5886,longer,O
84956,5886,),O
84957,5887,•,O
84958,5887,Bacille,B-Drug
84959,5887,Calmette,I-Drug
84960,5887,-,I-Drug
84961,5887,Guerin,I-Drug
84962,5887,(,I-Drug
84963,5887,BCG,I-Drug
84964,5887,),I-Drug
84965,5887,vaccination,I-Drug
84966,5887,(,O
84967,5887,12,O
84968,5887,months,O
84969,5887,off,O
84970,5887,drug,O
84971,5887,),O
84972,5888,Has,O
84973,5888,any,O
84974,5888,systemic,O
84975,5888,inflammatory,B-Condition
84976,5888,condition,I-Condition
84977,5888,",",O
84978,5888,including,O
84979,5888,psoriatic,B-Condition
84980,5888,arthritis,I-Condition
84981,5888,",",O
84982,5888,active,O
84983,5888,Lyme,B-Condition
84984,5888,disease,I-Condition
84985,5888,",",O
84986,5888,systemic,B-Condition
84987,5888,lupus,I-Condition
84988,5888,erythematosus,I-Condition
84989,5888,",",O
84990,5888,infectious,B-Condition
84991,5888,arthritis,I-Condition
84992,5888,",",O
84993,5888,vasculitis,B-Condition
84994,5888,",",O
84995,5888,parvovirus,B-Condition
84996,5888,infection,I-Condition
84997,5888,",",O
84998,5888,rheumatoid,B-Condition
84999,5888,arthritis,I-Condition
85000,5888,",",O
85001,5888,active,B-Condition
85002,5888,uveitis,I-Condition
85003,5888,",",O
85004,5888,or,O
85005,5888,active,B-Condition
85006,5888,IBD,I-Condition
85007,5889,Has,O
85008,5889,a,O
85009,5889,history,O
85010,5889,of,O
85011,5889,latent,O
85012,5889,or,O
85013,5889,active,O
85014,5889,granulomatous,B-Condition
85015,5889,infection,I-Condition
85016,5889,prior,O
85017,5889,to,O
85018,5889,Screening,O
85019,5890,Had,O
85020,5890,a,O
85021,5890,nontuberculous,B-Condition
85022,5890,mycobacterial,I-Condition
85023,5890,infection,I-Condition
85024,5890,or,O
85025,5890,opportunistic,B-Condition
85026,5890,infection,I-Condition
85027,5890,within,O
85028,5890,6,O
85029,5890,months,O
85030,5890,prior,O
85031,5890,to,O
85032,5890,Screening,O
85033,5891,Has,O
85034,5891,a,O
85035,5891,history,B-Observation
85036,5891,of,O
85037,5891,an,O
85038,5891,infected,B-Condition
85039,5891,joint,O
85040,5891,prosthesis,O
85041,5891,",",O
85042,5891,or,O
85043,5891,has,O
85044,5891,received,O
85045,5891,antibiotics,B-Drug
85046,5891,for,O
85047,5891,a,O
85048,5891,suspected,B-Mood
85049,5891,infection,B-Condition
85050,5891,of,O
85051,5891,a,O
85052,5891,joint,O
85053,5891,prosthesis,O
85054,5891,",",O
85055,5891,if,O
85056,5891,that,O
85057,5891,prosthesis,O
85058,5891,has,O
85059,5891,not,O
85060,5891,been,O
85061,5891,removed,O
85062,5891,or,O
85063,5891,replaced,O
85064,5892,Had,O
85065,5892,a,O
85066,5892,serious,B-Condition
85067,5892,infection,I-Condition
85068,5892,",",O
85069,5892,has,O
85070,5892,been,O
85071,5892,hospitalized,B-Procedure
85072,5892,for,O
85073,5892,an,O
85074,5892,infection,B-Condition
85075,5892,",",O
85076,5892,or,O
85077,5892,has,O
85078,5892,been,O
85079,5892,treated,O
85080,5892,with,O
85081,5892,IV,B-Drug
85082,5892,antibiotics,I-Drug
85083,5892,for,O
85084,5892,an,O
85085,5892,infection,B-Condition
85086,5892,within,O
85087,5892,2,O
85088,5892,months,O
85089,5892,prior,O
85090,5892,to,O
85091,5892,Baseline,O
85092,5893,Had,O
85093,5893,a,O
85094,5893,history,B-Observation
85095,5893,of,O
85096,5893,",",O
85097,5893,or,O
85098,5893,ongoing,O
85099,5893,",",O
85100,5893,chronic,O
85101,5893,or,O
85102,5893,recurrent,O
85103,5893,infectious,B-Condition
85104,5893,disease,I-Condition
85105,5894,Is,O
85106,5894,known,O
85107,5894,to,O
85108,5894,be,O
85109,5894,infected,O
85110,5894,with,O
85111,5894,human,B-Condition
85112,5894,immunodeficiency,I-Condition
85113,5894,virus,I-Condition
85114,5894,(,I-Condition
85115,5894,HIV,I-Condition
85116,5894,),I-Condition
85117,5894,or,O
85118,5894,seropositive,B-Condition
85119,5894,for,I-Condition
85120,5894,hepatitis,I-Condition
85121,5894,C,I-Condition
85122,5894,virus,I-Condition
85123,5894,(,I-Condition
85124,5894,HCV,I-Condition
85125,5894,),I-Condition
85126,5895,Has,O
85127,5895,had,O
85128,5895,a,O
85129,5895,chest,B-Procedure
85130,5895,x,I-Procedure
85131,5895,-,I-Procedure
85132,5895,ray,I-Procedure
85133,5895,within,O
85134,5895,2,O
85135,5895,months,O
85136,5895,prior,O
85137,5895,to,O
85138,5895,Screening,O
85139,5895,that,O
85140,5895,shows,O
85141,5895,an,O
85142,5895,abnormality,B-Condition
85143,5895,suggestive,B-Mood
85144,5895,of,O
85145,5895,a,O
85146,5895,current,O
85147,5895,active,O
85148,5895,infection,B-Condition
85149,5895,or,O
85150,5895,malignancy,B-Condition
85151,5896,Has,O
85152,5896,a,O
85153,5896,history,O
85154,5896,of,O
85155,5896,lymphoproliferative,B-Condition
85156,5896,disease,I-Condition
85157,5897,Has,O
85158,5897,had,O
85159,5897,a,O
85160,5897,malignancy,B-Condition
85161,5897,within,O
85162,5897,5,O
85163,5897,years,O
85164,5897,before,O
85165,5897,screening,O
85166,5897,(,O
85167,5897,exceptions,O
85168,5897,are,O
85169,5897,squamous,B-Condition
85170,5897,and,I-Condition
85171,5897,basal,I-Condition
85172,5897,cell,I-Condition
85173,5897,carcinomas,I-Condition
85174,5897,of,I-Condition
85175,5897,the,I-Condition
85176,5897,skin,I-Condition
85177,5897,and,O
85178,5897,carcinoma,B-Condition
85179,5897,in,I-Condition
85180,5897,situ,I-Condition
85181,5897,of,O
85182,5897,cervix,O
85183,5897,that,O
85184,5897,has,O
85185,5897,been,O
85186,5897,surgically,B-Procedure
85187,5897,cured,O
85188,5897,),O
85189,5898,Has,O
85190,5898,a,O
85191,5898,history,B-Observation
85192,5898,of,O
85193,5898,known,O
85194,5898,demyelinating,B-Condition
85195,5898,diseases,I-Condition
85196,5898,such,O
85197,5898,as,O
85198,5898,multiple,B-Condition
85199,5898,sclerosis,I-Condition
85200,5898,or,O
85201,5898,optic,B-Condition
85202,5898,neuritis,I-Condition
85203,5899,Has,O
85204,5899,a,O
85205,5899,history,B-Observation
85206,5899,of,O
85207,5899,or,O
85208,5899,concurrent,O
85209,5899,congestive,B-Condition
85210,5899,heart,I-Condition
85211,5899,failure,I-Condition
85212,5899,of,O
85213,5899,any,O
85214,5899,grade,O
85215,5900,Has,O
85216,5900,a,O
85217,5900,transplanted,B-Procedure
85218,5900,organ,I-Procedure
85219,5900,(,O
85220,5900,with,O
85221,5900,the,O
85222,5900,exception,O
85223,5900,of,O
85224,5900,a,O
85225,5900,corneal,B-Procedure
85226,5900,transplant,I-Procedure
85227,5900,performed,O
85228,5900,>,O
85229,5900,=,O
85230,5900,3,O
85231,5900,months,O
85232,5900,prior,O
85233,5900,to,O
85234,5900,baseline,O
85235,5900,),O
85236,5901,Has,O
85237,5901,current,O
85238,5901,signs,O
85239,5901,or,O
85240,5901,symptoms,O
85241,5901,of,O
85242,5901,significant,O
85243,5901,medical,B-Condition
85244,5901,illness,I-Condition
85245,5901,which,O
85246,5901,could,O
85247,5901,interfere,B-Observation
85248,5901,with,I-Observation
85249,5901,the,I-Observation
85250,5901,trial,I-Observation
85251,5901,",",O
85252,5901,or,O
85253,5901,require,B-Mood
85254,5901,treatment,B-Procedure
85255,5901,that,O
85256,5901,might,O
85257,5901,interfere,B-Observation
85258,5901,with,I-Observation
85259,5901,the,I-Observation
85260,5901,trial,I-Observation
85261,5902,Is,O
85262,5902,a,O
85263,5902,user,O
85264,5902,of,O
85265,5902,recreational,O
85266,5902,or,O
85267,5902,illicit,O
85268,5902,drugs,O
85269,5902,or,O
85270,5902,has,O
85271,5902,or,O
85272,5902,had,O
85273,5902,a,O
85274,5902,substance,O
85275,5902,abuse,O
85276,5902,(,O
85277,5902,drug,O
85278,5902,or,O
85279,5902,alcohol,O
85280,5902,),O
85281,5902,problem,O
85282,5902,within,O
85283,5902,the,O
85284,5902,previous,O
85285,5902,2,O
85286,5902,years,O
85287,5903,Is,O
85288,5903,not,O
85289,5903,of,O
85290,5903,reproductive,O
85291,5903,potential,O
85292,5903,",",O
85293,5903,or,O
85294,5903,is,O
85295,5903,of,O
85296,5903,reproductive,O
85297,5903,potential,O
85298,5903,and,O
85299,5903,agrees,O
85300,5903,to,O
85301,5903,avoid,O
85302,5903,becoming,O
85303,5903,pregnant,O
85304,5903,or,O
85305,5903,impregnating,O
85306,5903,a,O
85307,5903,partner,O
85308,5903,while,O
85309,5903,receiving,O
85310,5903,trial,O
85311,5903,medication,O
85312,5903,or,O
85313,5903,within,O
85314,5903,6,O
85315,5903,months,O
85316,5903,after,O
85317,5903,the,O
85318,5903,last,O
85319,5903,dose,O
85320,5903,of,O
85321,5903,trial,O
85322,5903,medication,O
85323,5904,Has,O
85324,5904,chronic,B-Condition
85325,5904,back,I-Condition
85326,5904,pain,I-Condition
85327,5904,of,O
85328,5904,=3,O
85329,5904,months,O
85330,5904,duration,O
85331,5904,by,O
85332,5904,history,B-Observation
85333,5905,Has,O
85334,5905,physician,O
85335,5905,-,O
85336,5905,diagnosed,O
85337,5905,active,O
85338,5905,nr,B-Condition
85339,5905,-,I-Condition
85340,5905,axSpA,I-Condition
85341,5905,with,O
85342,5905,disease,O
85343,5905,duration,O
85344,5905,<,O
85345,5905,=,O
85346,5905,5,O
85347,5905,years,O
85348,5906,•,O
85349,5906,Inflammatory,B-Condition
85350,5906,back,I-Condition
85351,5906,pain,I-Condition
85352,5907,•,O
85353,5907,Arthritis,B-Condition
85354,5907,(,O
85355,5907,physician,O
85356,5907,-,O
85357,5907,diagnosed,O
85358,5907,),O
85359,5908,•,O
85360,5908,Enthesitis,B-Condition
85361,5908,(,O
85362,5908,heel,O
85363,5908,),O
85364,5908,physician,O
85365,5908,-,O
85366,5908,diagnosed,O
85367,5908,(,O
85368,5908,spontaneous,O
85369,5908,pain,B-Condition
85370,5908,or,O
85371,5908,tenderness,B-Condition
85372,5908,at,O
85373,5908,examination,O
85374,5908,of,O
85375,5908,the,O
85376,5908,site,O
85377,5908,of,O
85378,5908,the,O
85379,5908,insertion,O
85380,5908,of,O
85381,5908,the,O
85382,5908,Achilles,O
85383,5908,tendon,O
85384,5908,or,O
85385,5908,plantar,O
85386,5908,fascia,O
85387,5908,),O
85388,5909,•,O
85389,5909,Dactylitis,B-Condition
85390,5909,(,O
85391,5909,physician,O
85392,5909,-,O
85393,5909,diagnosed,O
85394,5909,),O
85395,5910,•,O
85396,5910,Psoriasis,B-Condition
85397,5910,(,O
85398,5910,physician,O
85399,5910,-,O
85400,5910,diagnosed,O
85401,5910,),O
85402,5911,•,O
85403,5911,History,B-Observation
85404,5911,of,O
85405,5911,physician,O
85406,5911,-,O
85407,5911,diagnosed,O
85408,5911,inflammatory,B-Condition
85409,5911,bowel,I-Condition
85410,5911,disease,I-Condition
85411,5911,(,I-Condition
85412,5911,IBD,I-Condition
85413,5911,),I-Condition
85414,5912,•,O
85415,5912,History,B-Observation
85416,5912,of,O
85417,5912,uveitis,B-Condition
85418,5912,confirmed,O
85419,5912,by,O
85420,5912,an,O
85421,5912,ophthalmologist,O
85422,5913,•,O
85423,5913,Good,B-Observation
85424,5913,response,I-Observation
85425,5913,to,O
85426,5913,nonsteroidal,B-Drug
85427,5913,anti,I-Drug
85428,5913,-,I-Drug
85429,5913,inflammatory,I-Drug
85430,5913,drugs,I-Drug
85431,5913,(,I-Drug
85432,5913,NSAID,I-Drug
85433,5913,),I-Drug
85434,5914,•,O
85435,5914,Family,B-Observation
85436,5914,history,I-Observation
85437,5914,of,O
85438,5914,SpA,B-Condition
85439,5914,(,O
85440,5914,presence,O
85441,5914,of,O
85442,5914,ankylosing,B-Condition
85443,5914,spondylitis,I-Condition
85444,5914,",",O
85445,5914,psoriasis,B-Condition
85446,5914,",",O
85447,5914,acute,B-Condition
85448,5914,uveitis,I-Condition
85449,5914,",",O
85450,5914,reactive,B-Condition
85451,5914,arthritis,I-Condition
85452,5914,",",O
85453,5914,or,O
85454,5914,IBD,B-Condition
85455,5914,),O
85456,5915,•,O
85457,5915,Elevated,O
85458,5915,CRP,O
85459,5916,•,O
85460,5916,Human,O
85461,5916,leukocyte,O
85462,5916,antigen,O
85463,5916,B27,O
85464,5916,(,B-Condition
85465,5916,HLA,I-Condition
85466,5916,-,I-Condition
85467,5916,B27)+,I-Condition
85468,5916,gene,O
85469,5917,Has,O
85470,5917,a,O
85471,5917,HLA,B-Condition
85472,5917,-,I-Condition
85473,5917,B27,I-Condition
85474,5917,+,I-Condition
85475,5917,gene,O
85476,5917,and,O
85477,5917,2,O
85478,5917,or,O
85479,5917,more,O
85480,5917,of,O
85481,5917,the,O
85482,5917,SpA,B-Condition
85483,5917,characteristics,O
85484,5917,listed,O
85485,5917,above,O
85486,5918,Has,O
85487,5918,elevated,O
85488,5918,CRP,O
85489,5918,at,O
85490,5918,Screening,O
85491,5918,or,O
85492,5918,evidence,O
85493,5918,of,O
85494,5918,active,O
85495,5918,inflammation,B-Condition
85496,5918,in,O
85497,5918,the,O
85498,5918,sacroiliac,O
85499,5918,joints,O
85500,5918,on,O
85501,5918,MRI,B-Procedure
85502,5919,Has,O
85503,5919,an,O
85504,5919,ASDAS,O
85505,5919,>,O
85506,5919,=,O
85507,5919,2.1,O
85508,5919,at,O
85509,5919,Screening,O
85510,5920,Shows,O
85511,5920,high,B-Condition
85512,5920,disease,I-Condition
85513,5920,activity,I-Condition
85514,5920,at,O
85515,5920,Screening,O
85516,5920,and,O
85517,5920,Baseline,O
85518,5920,of,O
85519,5920,both,O
85520,5920,a,O
85521,5920,Total,O
85522,5920,Back,O
85523,5920,Pain,O
85524,5920,score,O
85525,5920,of,O
85526,5920,=,O
85527,5920,4,O
85528,5920,and,O
85529,5920,a,O
85530,5920,Bath,O
85531,5920,Ankylosing,O
85532,5920,Spondylitis,O
85533,5920,Disease,O
85534,5920,Activity,O
85535,5920,Index,O
85536,5920,(,O
85537,5920,BASDAI,O
85538,5920,),O
85539,5920,score,O
85540,5920,of,O
85541,5920,>,O
85542,5920,=,O
85543,5920,4,O
85544,5921,Has,O
85545,5921,an,O
85546,5921,acceptable,O
85547,5921,history,B-Observation
85548,5921,of,O
85549,5921,NSAID,B-Drug
85550,5921,use,O
85551,5922,Has,O
85552,5922,no,O
85553,5922,history,B-Observation
85554,5922,of,O
85555,5922,untreated,O
85556,5922,latent,O
85557,5922,or,O
85558,5922,active,O
85559,5922,tuberculosis,B-Condition
85560,5922,(,I-Condition
85561,5922,TB,I-Condition
85562,5922,),I-Condition
85563,5922,prior,O
85564,5922,to,O
85565,5922,Screening,O
85566,5923,Has,O
85567,5923,had,O
85568,5923,no,O
85569,5923,recent,O
85570,5923,close,B-Observation
85571,5923,contact,I-Observation
85572,5923,with,O
85573,5923,a,O
85574,5923,person,B-Observation
85575,5923,with,I-Observation
85576,5923,active,I-Observation
85577,5923,TB,I-Observation
85578,5923,or,O
85579,5923,",",O
85580,5923,if,O
85581,5923,there,O
85582,5923,has,O
85583,5923,been,O
85584,5923,such,O
85585,5923,contact,O
85586,5923,",",O
85587,5923,will,O
85588,5923,undergo,O
85589,5923,additional,O
85590,5923,evaluations,O
85591,5923,and,O
85592,5923,receive,O
85593,5923,appropriate,O
85594,5923,treatment,O
85595,5923,for,O
85596,5923,latent,O
85597,5923,TB,O
85598,5924,History,B-Observation
85599,5924,of,O
85600,5924,allergic,B-Condition
85601,5924,reaction,I-Condition
85602,5924,to,O
85603,5924,compounds,B-Drug
85604,5924,of,I-Drug
85605,5924,similar,I-Drug
85606,5924,chemical,I-Drug
85607,5924,or,I-Drug
85608,5924,biologic,I-Drug
85609,5924,composition,I-Drug
85610,5924,to,I-Drug
85611,5924,hCG,I-Drug
85612,5925,receiving,O
85613,5925,medication,B-Drug
85614,5925,that,O
85615,5925,could,O
85616,5925,interfere,O
85617,5925,with,O
85618,5925,the,O
85619,5925,study,O
85620,5925,protocol,O
85621,5925,objectives,O
85622,5925,(,O
85623,5925,hormonal,B-Drug
85624,5925,contraceptives,I-Drug
85625,5925,",",O
85626,5925,androgens,B-Drug
85627,5925,",",O
85628,5925,prednisone,B-Drug
85629,5925,",",O
85630,5925,thyroid,B-Drug
85631,5925,hormones,I-Drug
85632,5925,",",O
85633,5925,insulin,B-Drug
85634,5925,),O
85635,5926,previous,O
85636,5926,treatment,B-Procedure
85637,5926,with,O
85638,5926,follicle,B-Drug
85639,5926,stimulating,I-Drug
85640,5926,hormone,I-Drug
85641,5926,for,O
85642,5926,assisted,B-Procedure
85643,5926,reproduction,I-Procedure
85644,5927,uncontrolled,O
85645,5927,intercurrent,B-Condition
85646,5927,illness,I-Condition
85647,5928,Heart,B-Condition
85648,5928,disease,I-Condition
85649,5929,Severe,O
85650,5929,cognitive,B-Condition
85651,5929,decline,I-Condition
85652,5930,Psychiatric,B-Condition
85653,5930,desease,I-Condition
85654,5931,HIV,B-Condition
85655,5931,positive,I-Condition
85656,5932,Hepatitis,B-Condition
85657,5932,B,I-Condition
85658,5932,or,I-Condition
85659,5932,C,I-Condition
85660,5932,infection,I-Condition
85661,5933,premenopausal,B-Condition
85662,5933,women,B-Person
85663,5934,BRCA1,B-Condition
85664,5934,carrier,I-Condition
85665,5935,Patients,O
85666,5935,with,O
85667,5935,a,O
85668,5935,history,B-Observation
85669,5935,of,O
85670,5935,drug,B-Condition
85671,5935,abuse,I-Condition
85672,5935,;,O
85673,5936,preoperative,O
85674,5936,history,B-Observation
85675,5936,of,O
85676,5936,schizophrenia,B-Condition
85677,5936,",",O
85678,5936,epilepsy,B-Condition
85679,5936,",",O
85680,5936,parkinsonism,B-Condition
85681,5936,",",O
85682,5936,use,O
85683,5936,of,O
85684,5936,cholinesterase,B-Drug
85685,5936,inhibitor,I-Drug
85686,5936,",",O
85687,5936,inability,B-Condition
85688,5936,to,I-Condition
85689,5936,communicate,I-Condition
85690,5936,in,O
85691,5936,the,O
85692,5936,preoperative,O
85693,5936,period,O
85694,5936,(,O
85695,5936,coma,B-Condition
85696,5936,",",O
85697,5936,profound,B-Condition
85698,5936,dementia,I-Condition
85699,5936,",",O
85700,5936,or,O
85701,5936,language,B-Condition
85702,5936,barrier,I-Condition
85703,5936,),O
85704,5936,.,O
85705,5937,age,B-Person
85706,5937,>,O
85707,5937,17,O
85708,5937,and,O
85709,5937,<,O
85710,5937,60,O
85711,5937,years,O
85712,5937,;,O
85713,5938,American,O
85714,5938,Society,O
85715,5938,of,O
85716,5938,Anesthesiology,O
85717,5938,(,O
85718,5938,ASA,O
85719,5938,),O
85720,5938,I,O
85721,5938,-,O
85722,5938,III,O
85723,5938,;,O
85724,5939,admitted,B-Mood
85725,5939,for,I-Mood
85726,5939,living,B-Procedure
85727,5939,donor,I-Procedure
85728,5939,renal,I-Procedure
85729,5939,transplantation,I-Procedure
85730,5939,.,O
85731,5940,Has,O
85732,5940,any,O
85733,5940,clinically,O
85734,5940,significant,O
85735,5940,condition,B-Condition
85736,5940,or,O
85737,5940,situation,B-Observation
85738,5940,(,O
85739,5940,eg,O
85740,5940,",",O
85741,5940,anatomical,O
85742,5940,malformation,O
85743,5940,that,O
85744,5940,complicates,O
85745,5940,intubation,O
85746,5940,),O
85747,5940,other,O
85748,5940,than,O
85749,5940,the,B-Condition
85750,5940,condition,I-Condition
85751,5940,being,I-Condition
85752,5940,studied,I-Condition
85753,5940,that,O
85754,5940,",",O
85755,5940,in,O
85756,5940,the,O
85757,5940,opinion,O
85758,5940,of,O
85759,5940,the,O
85760,5940,investigator,O
85761,5940,",",O
85762,5940,would,O
85763,5940,interfere,B-Observation
85764,5940,with,I-Observation
85765,5940,the,I-Observation
85766,5940,trial,I-Observation
85767,5940,evaluations,I-Observation
85768,5940,or,I-Observation
85769,5940,optimal,I-Observation
85770,5940,participation,I-Observation
85771,5940,in,O
85772,5940,the,O
85773,5940,trial,O
85774,5940,.,O
85775,5941,Has,O
85776,5941,a,O
85777,5941,neuromuscular,B-Condition
85778,5941,disorder,I-Condition
85779,5941,that,O
85780,5941,may,O
85781,5941,affect,B-Observation
85782,5941,NMB,I-Observation
85783,5941,and/or,I-Observation
85784,5941,trial,I-Observation
85785,5941,assessments,I-Observation
85786,5941,.,O
85787,5942,Is,O
85788,5942,dialysis,B-Condition
85789,5942,-,I-Condition
85790,5942,dependent,I-Condition
85791,5942,or,O
85792,5942,has,O
85793,5942,(,O
85794,5942,or,O
85795,5942,is,O
85796,5942,suspected,O
85797,5942,of,O
85798,5942,having,O
85799,5942,),O
85800,5942,severe,B-Condition
85801,5942,renal,I-Condition
85802,5942,insufficiency,I-Condition
85803,5942,(,O
85804,5942,defined,O
85805,5942,as,O
85806,5942,estimated,O
85807,5942,glomerular,O
85808,5942,filtration,O
85809,5942,rate,O
85810,5942,(,O
85811,5942,eGFR,O
85812,5942,),O
85813,5942,<,O
85814,5942,30,O
85815,5942,ml,O
85816,5942,/,O
85817,5942,min,O
85818,5942,),O
85819,5942,.,O
85820,5943,Has,O
85821,5943,or,O
85822,5943,is,O
85823,5943,suspected,O
85824,5943,of,O
85825,5943,having,O
85826,5943,a,O
85827,5943,family,B-Observation
85828,5943,or,O
85829,5943,personal,B-Observation
85830,5943,history,I-Observation
85831,5943,of,O
85832,5943,malignant,B-Condition
85833,5943,hyperthermia,I-Condition
85834,5943,.,O
85835,5944,Has,O
85836,5944,or,O
85837,5944,is,O
85838,5944,suspected,O
85839,5944,of,O
85840,5944,having,O
85841,5944,an,O
85842,5944,allergy,B-Condition
85843,5944,to,O
85844,5944,study,B-Procedure
85845,5944,treatments,I-Procedure
85846,5944,or,O
85847,5944,its,O
85848,5944,/,O
85849,5944,their,O
85850,5944,excipients,B-Drug
85851,5944,",",O
85852,5944,to,O
85853,5944,opioids,B-Drug
85854,5944,/,O
85855,5944,opiates,B-Drug
85856,5944,",",O
85857,5944,muscle,B-Drug
85858,5944,relaxants,I-Drug
85859,5944,or,O
85860,5944,their,O
85861,5944,excipients,B-Drug
85862,5944,",",O
85863,5944,or,O
85864,5944,other,O
85865,5944,medication(s,B-Drug
85866,5944,),O
85867,5944,used,O
85868,5944,during,O
85869,5944,general,B-Procedure
85870,5944,anesthesia,I-Procedure
85871,5944,.,O
85872,5945,Has,O
85873,5945,received,O
85874,5945,or,O
85875,5945,is,O
85876,5945,planned,B-Mood
85877,5945,to,I-Mood
85878,5945,receive,O
85879,5945,toremifene,B-Drug
85880,5945,and/or,O
85881,5945,fusidic,B-Drug
85882,5945,acid,I-Drug
85883,5945,via,O
85884,5945,IV,O
85885,5945,administration,O
85886,5945,within,O
85887,5945,24,O
85888,5945,hours,O
85889,5945,before,O
85890,5945,or,O
85891,5945,within,O
85892,5945,24,O
85893,5945,hours,O
85894,5945,after,O
85895,5945,administration,O
85896,5945,of,O
85897,5945,study,O
85898,5945,treatment,O
85899,5945,.,O
85900,5946,Has,O
85901,5946,been,O
85902,5946,previously,O
85903,5946,treated,O
85904,5946,with,O
85905,5946,sugammadex,B-Drug
85906,5946,or,O
85907,5946,has,O
85908,5946,participated,B-Observation
85909,5946,in,I-Observation
85910,5946,a,I-Observation
85911,5946,sugammadex,I-Observation
85912,5946,clinical,I-Observation
85913,5946,trial,I-Observation
85914,5946,.,O
85915,5947,Is,O
85916,5947,currently,B-Observation
85917,5947,participating,I-Observation
85918,5947,in,I-Observation
85919,5947,or,I-Observation
85920,5947,has,I-Observation
85921,5947,participated,I-Observation
85922,5947,in,I-Observation
85923,5947,an,I-Observation
85924,5947,interventional,I-Observation
85925,5947,clinical,I-Observation
85926,5947,trial,I-Observation
85927,5947,with,O
85928,5947,an,O
85929,5947,investigational,B-Drug
85930,5947,compound,I-Drug
85931,5947,or,O
85932,5947,device,O
85933,5947,within,O
85934,5947,30,O
85935,5947,days,O
85936,5947,of,O
85937,5947,signing,O
85938,5947,the,O
85939,5947,informed,O
85940,5947,consent,O
85941,5947,/,O
85942,5947,assent,O
85943,5947,for,O
85944,5947,this,O
85945,5947,current,O
85946,5947,trial,O
85947,5947,.,O
85948,5948,Be,O
85949,5948,categorized,O
85950,5948,as,O
85951,5948,American,O
85952,5948,Society,O
85953,5948,of,O
85954,5948,Anesthesiologists,O
85955,5948,(,O
85956,5948,ASA,O
85957,5948,),O
85958,5948,Physical,O
85959,5948,Status,O
85960,5948,Class,O
85961,5948,1,O
85962,5948,",",O
85963,5948,2,O
85964,5948,",",O
85965,5948,or,O
85966,5948,3,O
85967,5948,.,O
85968,5949,Have,O
85969,5949,a,O
85970,5949,planned,B-Mood
85971,5949,non,O
85972,5949,-,O
85973,5949,emergent,O
85974,5949,surgical,B-Procedure
85975,5949,procedure,I-Procedure
85976,5949,or,O
85977,5949,clinical,B-Condition
85978,5949,situation,I-Condition
85979,5949,(,O
85980,5949,e.g.,O
85981,5949,",",O
85982,5949,intubation,B-Procedure
85983,5949,),O
85984,5949,that,O
85985,5949,requires,O
85986,5949,moderate,O
85987,5949,or,O
85988,5949,deep,O
85989,5949,NMB,B-Procedure
85990,5949,with,O
85991,5949,either,O
85992,5949,rocuronium,B-Drug
85993,5949,or,O
85994,5949,vecuronium,B-Drug
85995,5949,.,O
85996,5950,Have,O
85997,5950,a,O
85998,5950,planned,B-Mood
85999,5950,surgical,B-Procedure
86000,5950,procedure,I-Procedure
86001,5950,or,O
86002,5950,clinical,B-Condition
86003,5950,situation,I-Condition
86004,5950,that,O
86005,5950,would,O
86006,5950,allow,O
86007,5950,objective,B-Procedure
86008,5950,neuromuscular,I-Procedure
86009,5950,monitoring,I-Procedure
86010,5950,techniques,I-Procedure
86011,5950,to,O
86012,5950,be,O
86013,5950,applied,O
86014,5950,with,O
86015,5950,access,O
86016,5950,to,O
86017,5950,the,O
86018,5950,arm,O
86019,5950,for,O
86020,5950,neuromuscular,O
86021,5950,transmission,O
86022,5950,monitoring,O
86023,5950,.,O
86024,5951,Age,B-Person
86025,5951,between,O
86026,5951,2,O
86027,5951,to,O
86028,5951,<,O
86029,5951,17,O
86030,5951,years,O
86031,5951,at,O
86032,5951,Visit,O
86033,5951,2,O
86034,5951,.,O
86035,5952,If,O
86036,5952,female,B-Person
86037,5952,",",O
86038,5952,may,O
86039,5952,participate,O
86040,5952,if,O
86041,5952,she,O
86042,5952,is,O
86043,5952,not,O
86044,5952,pregnant,B-Condition
86045,5952,",",O
86046,5952,not,O
86047,5952,breastfeeding,B-Observation
86048,5952,",",O
86049,5952,and,O
86050,5952,at,O
86051,5952,least,O
86052,5952,one,O
86053,5952,of,O
86054,5952,the,O
86055,5952,following,O
86056,5952,:,O
86057,5952,1,O
86058,5952,),O
86059,5952,Not,O
86060,5952,a,O
86061,5952,woman,B-Condition
86062,5952,of,I-Condition
86063,5952,childbearing,I-Condition
86064,5952,potential,I-Condition
86065,5952,(,I-Condition
86066,5952,WOCBP,I-Condition
86067,5952,),I-Condition
86068,5952,;,O
86069,5952,or,O
86070,5952,2,O
86071,5952,),O
86072,5952,A,O
86073,5952,WOCBP,B-Condition
86074,5952,who,O
86075,5952,agrees,O
86076,5952,to,O
86077,5952,follow,O
86078,5952,the,O
86079,5952,study,O
86080,5952,contraceptive,B-Procedure
86081,5952,guidance,I-Procedure
86082,5952,during,O
86083,5952,the,O
86084,5952,treatment,O
86085,5952,period,O
86086,5952,and,O
86087,5952,for,O
86088,5952,at,O
86089,5952,least,O
86090,5952,7,O
86091,5952,days,O
86092,5952,after,O
86093,5952,the,O
86094,5952,last,O
86095,5952,dose,O
86096,5952,of,O
86097,5952,study,O
86098,5952,treatment,O
86099,5952,.,O
86100,5953,Patient,O
86101,5953,with,O
86102,5953,contraindication,B-Condition
86103,5953,to,O
86104,5953,misoprostol,B-Drug
86105,5953,or,O
86106,5953,vasopressin,B-Drug
86107,5953,",",O
86108,5953,personal,B-Observation
86109,5953,history,I-Observation
86110,5953,or,O
86111,5953,cardiac,O
86112,5953,or,O
86113,5953,pulmonary,B-Condition
86114,5953,disease,I-Condition
86115,5953,",",O
86116,5953,history,B-Observation
86117,5953,of,O
86118,5953,prior,O
86119,5953,myomectomy,B-Procedure
86120,5954,Female,B-Person
86121,5954,age,B-Person
86122,5954,20,O
86123,5954,-,O
86124,5954,50,O
86125,5954,y,O
86126,5954,/,O
86127,5954,o,O
86128,5954,who,O
86129,5954,plan,B-Mood
86130,5954,to,I-Mood
86131,5954,undergo,I-Mood
86132,5954,abdominal,B-Procedure
86133,5954,myomectomy,I-Procedure
86134,5954,for,O
86135,5954,symptomatic,O
86136,5954,myomatous,B-Condition
86137,5954,uterus,I-Condition
86138,5955,Have,O
86139,5955,osteoporosis,B-Condition
86140,5956,Have,O
86141,5956,a,O
86142,5956,10,O
86143,5956,yr,O
86144,5956,probability,O
86145,5956,of,O
86146,5956,hip,B-Condition
86147,5956,fracture,I-Condition
86148,5956,>,O
86149,5956,3,O
86150,5956,%,O
86151,5956,or,O
86152,5956,major,B-Condition
86153,5956,fracture,I-Condition
86154,5956,>,O
86155,5956,20,O
86156,5956,%,O
86157,5956,based,O
86158,5956,on,O
86159,5956,results,O
86160,5956,of,O
86161,5956,the,O
86162,5956,FRAX,O
86163,5956,tool,O
86164,5957,Currently,O
86165,5957,take,O
86166,5957,bisphosphonates,B-Drug
86167,5957,",",O
86168,5957,estrogen,B-Procedure
86169,5957,replacement,I-Procedure
86170,5957,therapy,I-Procedure
86171,5957,",",O
86172,5957,glucocorticosteroids,B-Drug
86173,5957,",",O
86174,5957,or,O
86175,5957,other,O
86176,5957,drugs,B-Drug
86177,5957,affecting,I-Drug
86178,5957,bone,I-Drug
86179,5958,Currently,O
86180,5958,participate,B-Condition
86181,5958,in,I-Condition
86182,5958,a,I-Condition
86183,5958,resistance,I-Condition
86184,5958,training,I-Condition
86185,5958,or,I-Condition
86186,5958,high,I-Condition
86187,5958,impact,I-Condition
86188,5958,weight,I-Condition
86189,5958,bearing,I-Condition
86190,5958,exercise,I-Condition
86191,5958,program,O
86192,5958,two,O
86193,5958,or,O
86194,5958,more,O
86195,5958,times,O
86196,5958,weekly,O
86197,5959,Weigh,O
86198,5959,>,O
86199,5959,300,O
86200,5959,lbs,O
86201,5960,Have,O
86202,5960,abnormal,O
86203,5960,results,O
86204,5960,for,O
86205,5960,the,O
86206,5960,following,O
86207,5960,laboratory,O
86208,5960,tests,O
86209,5960,:,O
86210,5960,serum,O
86211,5960,25(OH)D,O
86212,5960,;,O
86213,5960,serum,O
86214,5960,creatinine,O
86215,5960,;,O
86216,5960,serum,O
86217,5960,calcium,O
86218,5960,;,O
86219,5960,PTH,O
86220,5960,;,O
86221,5960,TSH,O
86222,5961,Have,O
86223,5961,Paget,B-Condition
86224,5961,'s,I-Condition
86225,5961,disease,I-Condition
86226,5961,",",O
86227,5961,heart,B-Condition
86228,5961,disease,I-Condition
86229,5961,",",O
86230,5961,uncontrolled,B-Condition
86231,5961,hypertension,I-Condition
86232,5961,",",O
86233,5961,renal,B-Condition
86234,5961,disease,I-Condition
86235,5961,",",O
86236,5961,or,O
86237,5961,other,B-Condition
86238,5961,concomitant,I-Condition
86239,5961,conditions,I-Condition
86240,5961,that,I-Condition
86241,5961,prohibit,I-Condition
86242,5961,participation,I-Condition
86243,5961,in,I-Condition
86244,5961,exercises,I-Condition
86245,5961,",",O
86246,5961,risedronate,B-Procedure
86247,5961,therapy,I-Procedure
86248,5961,",",O
86249,5961,or,O
86250,5961,use,O
86251,5961,of,O
86252,5961,CaD,B-Drug
86253,5961,supplements,I-Drug
86254,5961,.,O
86255,5962,Women,B-Person
86256,5962,who,O
86257,5962,are,O
86258,5962,in,O
86259,5962,their,O
86260,5962,first,O
86261,5962,5,O
86262,5962,years,O
86263,5962,of,O
86264,5962,menopause,B-Condition
86265,5963,Have,O
86266,5963,a,O
86267,5963,T,O
86268,5963,score,O
86269,5963,between,O
86270,5963,-1,O
86271,5963,and,O
86272,5963,-2.49,O
86273,5963,at,O
86274,5963,the,O
86275,5963,femoral,O
86276,5963,neck,O
86277,5963,",",O
86278,5963,total,O
86279,5963,hip,O
86280,5963,",",O
86281,5963,or,O
86282,5963,L1,O
86283,5963,-,O
86284,5963,L4,O
86285,5963,spine,O
86286,5964,Be,O
86287,5964,19,O
86288,5964,years,O
86289,5964,of,O
86290,5964,age,B-Person
86291,5964,or,O
86292,5964,older,O
86293,5965,Have,O
86294,5965,their,O
86295,5965,health,O
86296,5965,care,O
86297,5965,provider,O
86298,5965,'s,O
86299,5965,permission,O
86300,5965,to,O
86301,5965,enroll,O
86302,5965,in,O
86303,5965,the,O
86304,5965,study,O
86305,5965,.,O
86306,5966,Anaphylactic,B-Condition
86307,5966,reaction,I-Condition
86308,5966,to,O
86309,5966,a,O
86310,5966,previous,O
86311,5966,dose,O
86312,5966,of,O
86313,5966,influenza,B-Drug
86314,5966,vaccine,I-Drug
86315,5966,or,O
86316,5966,to,O
86317,5966,any,O
86318,5966,of,O
86319,5966,its,B-Drug
86320,5966,components,I-Drug
86321,5967,Known,O
86322,5967,Immunoglobulin,B-Condition
86323,5967,E,I-Condition
86324,5967,(,I-Condition
86325,5967,IgE)-mediated,I-Condition
86326,5967,hypersensitivity,I-Condition
86327,5967,to,O
86328,5967,eggs,B-Drug
86329,5967,manifested,O
86330,5967,as,O
86331,5967,hives,B-Condition
86332,5967,",",O
86333,5967,swelling,B-Condition
86334,5967,of,I-Condition
86335,5967,the,I-Condition
86336,5967,mouth,I-Condition
86337,5967,and,I-Condition
86338,5967,throat,I-Condition
86339,5967,",",O
86340,5967,difficulty,B-Condition
86341,5967,in,I-Condition
86342,5967,breathing,I-Condition
86343,5967,",",O
86344,5967,hypotension,B-Condition
86345,5967,",",O
86346,5967,or,O
86347,5967,shock,B-Condition
86348,5968,Guillain-,B-Condition
86349,5968,Barré,I-Condition
86350,5968,syndrome,I-Condition
86351,5968,within,O
86352,5968,eight,O
86353,5968,weeks,O
86354,5968,of,O
86355,5968,a,O
86356,5968,previous,O
86357,5968,influenza,B-Drug
86358,5968,vaccine,I-Drug
86359,5969,Use,O
86360,5969,of,O
86361,5969,aspirin,B-Drug
86362,5969,or,O
86363,5969,salicylate-,B-Drug
86364,5969,containing,I-Drug
86365,5969,products,I-Drug
86366,5969,within,O
86367,5969,30,O
86368,5969,days,O
86369,5969,before,O
86370,5969,enrollment,O
86371,5970,Household,B-Person
86372,5970,members,I-Person
86373,5970,of,O
86374,5970,children,B-Person
86375,5970,in,O
86376,5970,Group,B-Person
86377,5970,A,I-Person
86378,5971,Healthy,B-Condition
86379,5971,children,B-Person
86380,5971,aged,B-Person
86381,5971,6,O
86382,5971,months,O
86383,5971,to,O
86384,5971,72,O
86385,5971,months,O
86386,5972,Refusal,O
86387,5973,Contraindication,B-Condition
86388,5973,to,O
86389,5973,neuraxial,B-Procedure
86390,5973,(,O
86391,5973,coagulopathy,B-Condition
86392,5973,",",O
86393,5973,anticoagulant,B-Drug
86394,5973,use,O
86395,5973,",",O
86396,5973,local,B-Condition
86397,5973,infection,I-Condition
86398,5973,",",O
86399,5973,sepsis,B-Condition
86400,5973,etc,O
86401,5973,),O
86402,5973,.Rupture,O
86403,5973,of,I-Condition
86404,5973,membranes,I-Condition
86405,5973,.,O
86406,5974,Drop,O
86407,5974,-,O
86408,5974,out,O
86409,5974,:,O
86410,5974,Patients,O
86411,5974,may,O
86412,5974,choose,O
86413,5974,to,O
86414,5974,drop,O
86415,5974,-,O
86416,5974,out,O
86417,5974,of,O
86418,5974,the,O
86419,5974,study,O
86420,5974,at,O
86421,5974,any,O
86422,5974,time,O
86423,5974,.,O
86424,5974,The,O
86425,5974,physicians,O
86426,5974,involved,O
86427,5974,in,O
86428,5974,this,O
86429,5974,study,O
86430,5974,may,O
86431,5974,choose,O
86432,5974,to,O
86433,5974,end,O
86434,5974,a,O
86435,5974,patient,O
86436,5974,'s,O
86437,5974,involvement,O
86438,5974,in,O
86439,5974,the,O
86440,5974,study,O
86441,5974,at,O
86442,5974,their,O
86443,5974,discretion,O
86444,5974,.,O
86445,5975,Healthy,B-Condition
86446,5975,patients,O
86447,5975,age,B-Person
86448,5975,18,O
86449,5975,and,O
86450,5975,older,O
86451,5976,Breech,B-Observation
86452,5976,presentation,I-Observation
86453,5977,Singleton,B-Condition
86454,5977,gestation,I-Condition
86455,5977,.scheduled,O
86456,5977,for,I-Mood
86457,5977,ECV,B-Procedure
86458,5977,desiring,B-Mood
86459,5977,CSE,B-Procedure
86460,5977,.,O
86461,5978,known,O
86462,5978,hypersensitivity,B-Condition
86463,5978,or,O
86464,5978,contraindication,B-Condition
86465,5978,to,O
86466,5978,the,O
86467,5978,study,B-Drug
86468,5978,drugs,I-Drug
86469,5979,reversible,B-Condition
86470,5979,aetiology,I-Condition
86471,5979,for,O
86472,5979,agitation,B-Condition
86473,5979,(,O
86474,5979,e.g.,O
86475,5979,hypotension,B-Condition
86476,5979,",",O
86477,5979,hypoxia,B-Condition
86478,5979,",",O
86479,5979,hypoglycaemia,B-Condition
86480,5979,),O
86481,5980,known,O
86482,5980,pregnancy,B-Condition
86483,5981,acute,B-Condition
86484,5981,alcohol,I-Condition
86485,5981,withdrawal,I-Condition
86486,5982,patients,O
86487,5982,aged>75,B-Person
86488,5982,years,O
86489,5982,.,O
86490,5983,Accident,O
86491,5983,&,O
86492,5983,Emergency,O
86493,5983,Department,O
86494,5983,patients,O
86495,5983,",",O
86496,5983,requiring,B-Mood
86497,5983,parenteral,B-Procedure
86498,5983,drug,I-Procedure
86499,5983,sedation,I-Procedure
86500,5983,(,O
86501,5983,as,O
86502,5983,determined,O
86503,5983,by,O
86504,5983,an,O
86505,5983,emergency,O
86506,5983,clinician,O
86507,5983,),O
86508,5983,will,O
86509,5983,be,O
86510,5983,enrolled,O
86511,5983,.,O
86512,5984,long,O
86513,5984,-,O
86514,5984,term,O
86515,5984,use,O
86516,5984,of,O
86517,5984,analgesics,B-Drug
86518,5984,",",O
86519,5984,sedatives,B-Drug
86520,5984,or,O
86521,5984,non,B-Drug
86522,5984,steroidal,I-Drug
86523,5984,anti,I-Drug
86524,5984,-,I-Drug
86525,5984,inflammatory,I-Drug
86526,5984,drugs,I-Drug
86527,5984,history,B-Observation
86528,5984,.,O
86529,5985,known,O
86530,5985,for,O
86531,5985,dexmedetomidine,B-Drug
86532,5985,or,O
86533,5985,other,O
86534,5985,drugs,B-Drug
86535,5985,allergy,B-Condition
86536,5985,in,O
86537,5985,this,O
86538,5985,study,O
86539,5985,.,O
86540,5986,can,B-Observation
86541,5986,not,I-Observation
86542,5986,communicate,I-Observation
86543,5986,.,O
86544,5987,preoperative,O
86545,5987,systolic,O
86546,5987,blood,O
86547,5987,pressure,O
86548,5987,<,O
86549,5987,90,O
86550,5987,mmHg,O
86551,5987,",",O
86552,5987,or,O
86553,5987,the,O
86554,5987,heart,O
86555,5987,rate,O
86556,5987,<,O
86557,5987,50,O
86558,5987,/,O
86559,5987,min,O
86560,5987,.,O
86561,5988,patients,O
86562,5988,undergoing,O
86563,5988,venous,B-Procedure
86564,5988,malformation,I-Procedure
86565,5988,embolization,I-Procedure
86566,5988,operation,I-Procedure
86567,5988,through,O
86568,5988,general,B-Procedure
86569,5988,anesthesia,I-Procedure
86570,5988,.,O
86571,5989,aged,B-Person
86572,5989,18,O
86573,5989,-,O
86574,5989,65,O
86575,5989,years,O
86576,5989,old,O
86577,5989,.,O
86578,5990,operating,O
86579,5990,time,O
86580,5990,varies,O
86581,5990,1,O
86582,5990,-,O
86583,5990,4h,O
86584,5990,",",O
86585,5990,and,O
86586,5990,extubation,B-Procedure
86587,5990,after,O
86588,5990,the,O
86589,5990,operation,B-Procedure
86590,5990,.,O
86591,5991,Unstable,O
86592,5991,patient,B-Person
86593,5992,Joint,B-Condition
86594,5992,contracture,I-Condition
86595,5993,Spasticity,B-Condition
86596,5994,Loss,B-Observation
86597,5994,of,I-Observation
86598,5994,function,I-Observation
86599,5994,is,O
86600,5994,expected,O
86601,5994,to,O
86602,5994,be,O
86603,5994,improved,B-Mood
86604,5994,by,I-Mood
86605,5994,reliable,O
86606,5994,tendon,B-Procedure
86607,5994,transfer,I-Procedure
86608,5994,",",O
86609,5994,tenodesis,B-Procedure
86610,5994,or,O
86611,5994,arthrodesis,B-Procedure
86612,5994,that,O
86613,5994,is,O
86614,5994,available,O
86615,5995,Evidence,O
86616,5995,of,O
86617,5995,recovering,B-Observation
86618,5995,finger,I-Observation
86619,5995,/,I-Observation
86620,5995,thumb,I-Observation
86621,5995,extension,I-Observation
86622,5995,at,O
86623,5995,4,O
86624,5995,-,O
86625,5995,6,O
86626,5995,months,O
86627,5996,Greater,O
86628,5996,than,O
86629,5996,12,O
86630,5996,months,O
86631,5996,from,O
86632,5996,spinal,B-Condition
86633,5996,cord,I-Condition
86634,5996,injury,I-Condition
86635,5997,Subject,O
86636,5997,not,O
86637,5997,fluent,O
86638,5997,in,O
86639,5997,English,O
86640,5997,or,O
86641,5997,an,O
86642,5997,appropriate,O
86643,5997,translator,O
86644,5997,not,O
86645,5997,available,O
86646,5998,Cervical,B-Condition
86647,5998,spine,I-Condition
86648,5998,injury,I-Condition
86649,5998,with,O
86650,5998,functional,B-Observation
86651,5998,loss,I-Observation
86652,5998,in,O
86653,5998,the,O
86654,5998,upper,O
86655,5998,extremity,O
86656,5999,Greater,O
86657,5999,than,O
86658,5999,4,O
86659,5999,months,O
86660,5999,out,O
86661,5999,from,O
86662,5999,C,B-Condition
86663,5999,-,I-Condition
86664,5999,spine,I-Condition
86665,5999,injury,I-Condition
86666,6000,Stable,O
86667,6000,motor,B-Observation
86668,6000,recovery,I-Observation
86669,6001,Medically,O
86670,6001,stable,B-Condition
86671,6002,International,O
86672,6002,Classification,O
86673,6002,for,O
86674,6002,Surgery,O
86675,6002,of,O
86676,6002,the,O
86677,6002,Hand,O
86678,6002,in,O
86679,6002,Tetraplegia,O
86680,6002,of,O
86681,6002,0,O
86682,6002,-,O
86683,6002,5,O
86684,6002,at,O
86685,6002,6,O
86686,6002,months,O
86687,6003,Grade,O
86688,6003,0,O
86689,6003,finger,O
86690,6003,/,O
86691,6003,thumb,O
86692,6003,extension,O
86693,6003,at,O
86694,6003,6,O
86695,6003,months,O
86696,6004,Subjects,O
86697,6004,fluent,O
86698,6004,in,O
86699,6004,English,O
86700,6004,or,O
86701,6004,when,O
86702,6004,not,O
86703,6004,fluent,O
86704,6004,",",O
86705,6004,an,O
86706,6004,appropriate,O
86707,6004,translator,O
86708,6004,is,O
86709,6004,present,O
86710,6005,Patients,O
86711,6005,with,O
86712,6005,previous,O
86713,6005,periorbital,B-Procedure
86714,6005,/,I-Procedure
86715,6005,forehead,I-Procedure
86716,6005,surgery,I-Procedure
86717,6006,Patients,O
86718,6006,who,O
86719,6006,plucked,B-Condition
86720,6006,the,I-Condition
86721,6006,upper,I-Condition
86722,6006,eyebrow,I-Condition
86723,6006,margin,I-Condition
86724,6007,Patients,O
86725,6007,with,O
86726,6007,eyebrow,B-Observation
86727,6007,tatoos,I-Observation
86728,6008,Patients,O
86729,6008,with,O
86730,6008,upper,O
86731,6008,face,O
86732,6008,botulinum,B-Procedure
86733,6008,toxin,I-Procedure
86734,6008,injection,I-Procedure
86735,6008,in,O
86736,6008,the,O
86737,6008,past,O
86738,6008,12,O
86739,6008,months,O
86740,6009,Patients,O
86741,6009,with,O
86742,6009,resorbable,B-Procedure
86743,6009,upper,I-Procedure
86744,6009,face,I-Procedure
86745,6009,fillers,I-Procedure
86746,6009,injection,I-Procedure
86747,6009,in,O
86748,6009,the,O
86749,6009,past,O
86750,6009,12,O
86751,6009,months,O
86752,6010,Patients,O
86753,6010,with,O
86754,6010,previous,O
86755,6010,permanent,B-Procedure
86756,6010,upper,I-Procedure
86757,6010,face,I-Procedure
86758,6010,fillers,I-Procedure
86759,6010,injection,I-Procedure
86760,6011,Pregnant,B-Condition
86761,6011,patients,O
86762,6012,Lactating,B-Condition
86763,6012,patients,O
86764,6013,Patients,O
86765,6013,with,O
86766,6013,preexisting,O
86767,6013,neuromuscular,B-Condition
86768,6013,conditions,I-Condition
86769,6013,(,O
86770,6013,myasthenia,B-Condition
86771,6013,gravis,I-Condition
86772,6013,",",O
86773,6013,Eaton,B-Condition
86774,6013,Lambert,I-Condition
86775,6013,syndrome,I-Condition
86776,6013,),O
86777,6014,Patients,O
86778,6014,using,O
86779,6014,medication,B-Drug
86780,6014,that,O
86781,6014,could,O
86782,6014,potentiate,B-Condition
86783,6014,the,I-Condition
86784,6014,effect,I-Condition
86785,6014,of,O
86786,6014,botulinum,B-Drug
86787,6014,(,O
86788,6014,ex,O
86789,6014,:,O
86790,6014,aminoglycoside,B-Drug
86791,6014,antibiotics,I-Drug
86792,6014,),O
86793,6015,Patients,O
86794,6015,with,O
86795,6015,sensitivity,B-Condition
86796,6015,to,O
86797,6015,botulinum,B-Drug
86798,6015,toxin,I-Drug
86799,6015,or,O
86800,6015,human,B-Drug
86801,6015,albumin,I-Drug
86802,6016,Consecutive,O
86803,6016,30,O
86804,6016,female,B-Person
86805,6016,patients,O
86806,6016,presenting,O
86807,6016,to,O
86808,6016,our,O
86809,6016,clinic,O
86810,6016,for,O
86811,6016,brow,B-Procedure
86812,6016,lifting,I-Procedure
86813,6016,with,O
86814,6016,botulinum,B-Drug
86815,6016,toxin,I-Drug
86816,6016,will,O
86817,6016,be,O
86818,6016,randomized,O
86819,6016,to,O
86820,6016,receive,O
86821,6016,one,O
86822,6016,of,O
86823,6016,the,O
86824,6016,two,O
86825,6016,injection,O
86826,6016,techniques,O
86827,6017,Current,O
86828,6017,or,O
86829,6017,chronic,O
86830,6017,history,B-Observation
86831,6017,of,O
86832,6017,liver,B-Condition
86833,6017,disease,I-Condition
86834,6017,",",O
86835,6017,or,O
86836,6017,known,O
86837,6017,hepatic,B-Condition
86838,6017,or,I-Condition
86839,6017,biliary,I-Condition
86840,6017,abnormalities,I-Condition
86841,6017,(,O
86842,6017,with,O
86843,6017,the,O
86844,6017,exception,O
86845,6017,of,O
86846,6017,Gilbert,B-Condition
86847,6017,'s,I-Condition
86848,6017,syndrome,I-Condition
86849,6017,or,O
86850,6017,asymptomatic,O
86851,6017,gallstones,B-Condition
86852,6017,),O
86853,6017,.,O
86854,6018,History,B-Observation
86855,6018,of,O
86856,6018,regular,B-Condition
86857,6018,alcohol,I-Condition
86858,6018,consumption,I-Condition
86859,6018,within,O
86860,6018,6,O
86861,6018,months,O
86862,6018,of,O
86863,6018,the,O
86864,6018,study,O
86865,6018,defined,O
86866,6018,as,O
86867,6018,:,O
86868,6018,An,O
86869,6018,average,O
86870,6018,weekly,O
86871,6018,intake,O
86872,6018,of,O
86873,6018,>,O
86874,6018,21,O
86875,6018,units,O
86876,6018,for,O
86877,6018,males,B-Person
86878,6018,or,O
86879,6018,>,O
86880,6018,14,O
86881,6018,units,O
86882,6018,for,O
86883,6018,females,B-Person
86884,6018,.,O
86885,6018,One,O
86886,6018,unit,O
86887,6018,is,O
86888,6018,equivalent,O
86889,6018,to,O
86890,6018,8,O
86891,6018,gram,O
86892,6018,of,O
86893,6018,alcohol,O
86894,6018,:,O
86895,6018,a,O
86896,6018,half,O
86897,6018,-,O
86898,6018,pint,O
86899,6018,(,O
86900,6018,approximately,O
86901,6018,240,O
86902,6018,milliliter,O
86903,6018,[,O
86904,6018,mL,O
86905,6018,],O
86906,6018,),O
86907,6018,of,O
86908,6018,beer,O
86909,6018,",",O
86910,6018,1,O
86911,6018,glass,O
86912,6018,(,O
86913,6018,100,O
86914,6018,mL,O
86915,6018,),O
86916,6018,of,O
86917,6018,wine,O
86918,6018,or,O
86919,6018,1,O
86920,6018,(,O
86921,6018,25,O
86922,6018,mL,O
86923,6018,),O
86924,6018,measure,O
86925,6018,of,O
86926,6018,spirits,O
86927,6018,.,O
86928,6019,History,O
86929,6019,of,O
86930,6019,sensitivity,B-Condition
86931,6019,to,I-Condition
86932,6019,heparin,I-Condition
86933,6019,or,O
86934,6019,heparin,B-Condition
86935,6019,-,I-Condition
86936,6019,induced,I-Condition
86937,6019,thrombocytopenia,I-Condition
86938,6019,.,O
86939,6020,History,B-Observation
86940,6020,of,O
86941,6020,sensitivity,B-Condition
86942,6020,to,I-Condition
86943,6020,any,I-Condition
86944,6020,of,I-Condition
86945,6020,the,I-Condition
86946,6020,study,I-Condition
86947,6020,medications,I-Condition
86948,6020,",",O
86949,6020,or,O
86950,6020,components,O
86951,6020,thereof,O
86952,6020,or,O
86953,6020,a,O
86954,6020,history,O
86955,6020,of,O
86956,6020,drug,B-Condition
86957,6020,or,I-Condition
86958,6020,other,I-Condition
86959,6020,allergy,I-Condition
86960,6020,that,O
86961,6020,",",O
86962,6020,in,O
86963,6020,the,O
86964,6020,opinion,O
86965,6020,of,O
86966,6020,the,O
86967,6020,investigator,O
86968,6020,or,O
86969,6020,GSK,O
86970,6020,Medical,O
86971,6020,Monitor,O
86972,6020,",",O
86973,6020,contraindicates,O
86974,6020,their,O
86975,6020,participation,O
86976,6020,.,O
86977,6021,Gastrointestinal,B-Condition
86978,6021,disease,I-Condition
86979,6021,or,O
86980,6021,with,O
86981,6021,gastrointestinal,B-Observation
86982,6021,surgical,I-Observation
86983,6021,history,I-Observation
86984,6021,which,O
86985,6021,can,O
86986,6021,affect,O
86987,6021,the,O
86988,6021,absorption,O
86989,6021,of,O
86990,6021,the,O
86991,6021,investigational,O
86992,6021,product,O
86993,6021,.,O
86994,6022,A,O
86995,6022,positive,O
86996,6022,pre,O
86997,6022,-,O
86998,6022,study,O
86999,6022,Hepatitis,O
87000,6022,B,O
87001,6022,surface,O
87002,6022,antigen,O
87003,6022,or,O
87004,6022,positive,O
87005,6022,Hepatitis,O
87006,6022,C,O
87007,6022,antibody,O
87008,6022,result,O
87009,6022,within,O
87010,6022,3,O
87011,6022,months,O
87012,6022,of,O
87013,6022,screening,O
87014,6023,Urinary,O
87015,6023,cotinine,O
87016,6023,levels,O
87017,6023,indicative,O
87018,6023,of,O
87019,6023,smoking,B-Condition
87020,6023,or,O
87021,6023,history,B-Observation
87022,6023,or,O
87023,6023,regular,B-Condition
87024,6023,use,I-Condition
87025,6023,of,I-Condition
87026,6023,tobacco-,I-Condition
87027,6023,or,I-Condition
87028,6023,nicotine,I-Condition
87029,6023,-,I-Condition
87030,6023,containing,I-Condition
87031,6023,products,I-Condition
87032,6023,within,O
87033,6023,6,O
87034,6023,months,O
87035,6023,prior,O
87036,6023,to,O
87037,6023,screening,O
87038,6023,.,O
87039,6024,A,O
87040,6024,positive,O
87041,6024,pre,O
87042,6024,-,O
87043,6024,study,O
87044,6024,drug,O
87045,6024,/,O
87046,6024,alcohol,O
87047,6024,screen,O
87048,6024,.,O
87049,6025,A,O
87050,6025,positive,O
87051,6025,test,O
87052,6025,for,O
87053,6025,Human,O
87054,6025,Immunodeficiency,O
87055,6025,Virus,O
87056,6025,(,O
87057,6025,HIV,O
87058,6025,),O
87059,6025,antibody,O
87060,6025,.,O
87061,6026,Pregnant,B-Condition
87062,6026,females,B-Person
87063,6026,as,O
87064,6026,determined,O
87065,6026,by,O
87066,6026,positive,O
87067,6026,serum,O
87068,6026,hCG,O
87069,6026,test,O
87070,6026,at,O
87071,6026,screening,O
87072,6026,or,O
87073,6026,prior,O
87074,6026,to,O
87075,6026,dosing,O
87076,6026,.,O
87077,6027,Where,O
87078,6027,participation,O
87079,6027,in,O
87080,6027,the,O
87081,6027,study,O
87082,6027,would,O
87083,6027,result,O
87084,6027,in,O
87085,6027,donation,O
87086,6027,of,O
87087,6027,blood,O
87088,6027,or,O
87089,6027,blood,O
87090,6027,products,O
87091,6027,in,O
87092,6027,excess,O
87093,6027,of,O
87094,6027,500,O
87095,6027,mL,O
87096,6027,within,O
87097,6027,a,O
87098,6027,90,O
87099,6027,day,O
87100,6027,period,O
87101,6027,.,O
87102,6028,Lactating,B-Condition
87103,6028,females,B-Person
87104,6028,.,O
87105,6029,The,O
87106,6029,subject,O
87107,6029,has,O
87108,6029,participated,O
87109,6029,in,O
87110,6029,a,O
87111,6029,clinical,O
87112,6029,trial,O
87113,6029,and,O
87114,6029,has,O
87115,6029,received,O
87116,6029,an,O
87117,6029,investigational,O
87118,6029,product,O
87119,6029,within,O
87120,6029,the,O
87121,6029,following,O
87122,6029,time,O
87123,6029,period,O
87124,6029,prior,O
87125,6029,to,O
87126,6029,the,O
87127,6029,first,O
87128,6029,dosing,O
87129,6029,day,O
87130,6029,in,O
87131,6029,the,O
87132,6029,current,O
87133,6029,study,O
87134,6029,:,O
87135,6029,90,O
87136,6029,days,O
87137,6029,",",O
87138,6029,5,O
87139,6029,half,O
87140,6029,-,O
87141,6029,lives,O
87142,6029,or,O
87143,6029,twice,O
87144,6029,the,O
87145,6029,duration,O
87146,6029,of,O
87147,6029,the,O
87148,6029,biological,O
87149,6029,effect,O
87150,6029,of,O
87151,6029,the,O
87152,6029,investigational,O
87153,6029,product,O
87154,6029,(,O
87155,6029,whichever,O
87156,6029,is,O
87157,6029,longer,O
87158,6029,),O
87159,6029,.,O
87160,6030,Exposure,O
87161,6030,to,O
87162,6030,more,O
87163,6030,than,O
87164,6030,four,O
87165,6030,new,B-Drug
87166,6030,chemical,I-Drug
87167,6030,entities,I-Drug
87168,6030,within,O
87169,6030,12,O
87170,6030,months,O
87171,6030,prior,O
87172,6030,to,O
87173,6030,the,O
87174,6030,first,O
87175,6030,dosing,O
87176,6030,day,O
87177,6030,.,O
87178,6031,Male,B-Person
87179,6031,and,O
87180,6031,females,B-Person
87181,6031,aged,B-Person
87182,6031,between,O
87183,6031,18,O
87184,6031,and,O
87185,6031,65,O
87186,6031,years,O
87187,6031,of,O
87188,6031,age,B-Person
87189,6031,inclusive,O
87190,6031,",",O
87191,6031,at,O
87192,6031,the,O
87193,6031,time,O
87194,6031,of,O
87195,6031,signing,O
87196,6031,the,O
87197,6031,informed,O
87198,6031,consent,O
87199,6031,.,O
87200,6032,Healthy,B-Condition
87201,6032,as,O
87202,6032,determined,O
87203,6032,by,O
87204,6032,a,O
87205,6032,responsible,O
87206,6032,and,O
87207,6032,experienced,O
87208,6032,physician,O
87209,6032,",",O
87210,6032,based,O
87211,6032,on,O
87212,6032,a,O
87213,6032,medical,B-Procedure
87214,6032,evaluation,I-Procedure
87215,6032,including,O
87216,6032,medical,B-Observation
87217,6032,history,I-Observation
87218,6032,",",O
87219,6032,physical,B-Procedure
87220,6032,examination,I-Procedure
87221,6032,",",O
87222,6032,laboratory,B-Procedure
87223,6032,tests,I-Procedure
87224,6032,and,O
87225,6032,cardiac,B-Procedure
87226,6032,monitoring,I-Procedure
87227,6032,.,O
87228,6032,A,O
87229,6032,subject,O
87230,6032,with,O
87231,6032,a,O
87232,6032,clinical,B-Condition
87233,6032,abnormality,I-Condition
87234,6032,or,O
87235,6032,laboratory,O
87236,6032,parameter(s,O
87237,6032,),O
87238,6032,which,O
87239,6032,is,O
87240,6032,/,O
87241,6032,are,O
87242,6032,not,O
87243,6032,specifically,O
87244,6032,listed,O
87245,6032,in,O
87246,6032,the,O
87247,6032,inclusion,O
87248,6032,or,O
87249,6032,exclusion,O
87250,6032,criteria,O
87251,6032,",",O
87252,6032,outside,O
87253,6032,the,O
87254,6032,reference,O
87255,6032,range,O
87256,6032,for,O
87257,6032,the,O
87258,6032,population,O
87259,6032,being,O
87260,6032,studied,O
87261,6032,may,O
87262,6032,be,O
87263,6032,included,O
87264,6032,only,O
87265,6032,if,O
87266,6032,the,O
87267,6032,Investigator,O
87268,6032,in,O
87269,6032,consultation,O
87270,6032,with,O
87271,6032,the,O
87272,6032,GSK,O
87273,6032,Medical,O
87274,6032,Monitor,O
87275,6032,if,O
87276,6032,required,O
87277,6032,agree,O
87278,6032,and,O
87279,6032,document,O
87280,6032,that,O
87281,6032,the,O
87282,6032,finding,O
87283,6032,is,O
87284,6032,unlikely,O
87285,6032,to,O
87286,6032,introduce,O
87287,6032,additional,O
87288,6032,risk,O
87289,6032,factors,O
87290,6032,and,O
87291,6032,will,O
87292,6032,not,O
87293,6032,interfere,O
87294,6032,with,O
87295,6032,the,O
87296,6032,study,O
87297,6032,procedures,O
87298,6032,.,O
87299,6033,Body,O
87300,6033,weight,O
87301,6033,>,O
87302,6033,=,O
87303,6033,50,O
87304,6033,kilogram,O
87305,6033,(,O
87306,6033,kg,O
87307,6033,),O
87308,6033,and,O
87309,6033,body,O
87310,6033,mass,O
87311,6033,index,O
87312,6033,within,O
87313,6033,the,O
87314,6033,range,O
87315,6033,19,O
87316,6033,-,O
87317,6033,24.9,O
87318,6033,kg,O
87319,6033,/,O
87320,6033,m^2,O
87321,6033,(,O
87322,6033,inclusive,O
87323,6033,),O
87324,6033,.,O
87325,6034,A,O
87326,6034,female,B-Person
87327,6034,subject,O
87328,6034,is,O
87329,6034,eligible,O
87330,6034,to,O
87331,6034,participate,O
87332,6034,if,O
87333,6034,she,O
87334,6034,is,O
87335,6034,of,O
87336,6034,:,O
87337,6034,Non,O
87338,6034,-,O
87339,6034,childbearing,B-Condition
87340,6034,potential,I-Condition
87341,6034,defined,O
87342,6034,as,O
87343,6034,pre,B-Condition
87344,6034,-,I-Condition
87345,6034,menopausal,I-Condition
87346,6034,females,B-Person
87347,6034,with,O
87348,6034,a,O
87349,6034,documented,O
87350,6034,tubal,B-Procedure
87351,6034,ligation,I-Procedure
87352,6034,or,O
87353,6034,hysterectomy,B-Procedure
87354,6034,for,O
87355,6034,this,O
87356,6034,definition,O
87357,6034,",",O
87358,6034,"""",O
87359,6034,documented,O
87360,6034,"""",O
87361,6034,refers,O
87362,6034,to,O
87363,6034,the,O
87364,6034,outcome,O
87365,6034,of,O
87366,6034,the,O
87367,6034,investigator's,O
87368,6034,/,O
87369,6034,designee,O
87370,6034,'s,O
87371,6034,review,O
87372,6034,of,O
87373,6034,the,O
87374,6034,subject,O
87375,6034,'s,O
87376,6034,medical,O
87377,6034,history,O
87378,6034,for,O
87379,6034,study,O
87380,6034,eligibility,O
87381,6034,",",O
87382,6034,as,O
87383,6034,obtained,O
87384,6034,via,O
87385,6034,a,O
87386,6034,verbal,O
87387,6034,interview,O
87388,6034,with,O
87389,6034,the,O
87390,6034,subject,O
87391,6034,or,O
87392,6034,from,O
87393,6034,the,O
87394,6034,subject,O
87395,6034,'s,O
87396,6034,medical,O
87397,6034,records,O
87398,6034,;,O
87399,6034,or,O
87400,6034,postmenopausal,B-Condition
87401,6034,defined,O
87402,6034,as,O
87403,6034,12,O
87404,6034,months,O
87405,6034,of,O
87406,6034,spontaneous,B-Condition
87407,6034,amenorrhea,I-Condition
87408,6034,[,O
87409,6034,in,O
87410,6034,questionable,O
87411,6034,cases,O
87412,6034,a,O
87413,6034,blood,O
87414,6034,sample,O
87415,6034,with,O
87416,6034,simultaneous,O
87417,6034,follicle,O
87418,6034,stimulating,O
87419,6034,hormone,O
87420,6034,(,O
87421,6034,FSH,O
87422,6034,),O
87423,6034,>,O
87424,6034,40,O
87425,6034,milli,O
87426,6034,-,O
87427,6034,international,O
87428,6034,units,O
87429,6034,per,O
87430,6034,milliliter,O
87431,6034,(,O
87432,6034,MlU,O
87433,6034,/,O
87434,6034,mL,O
87435,6034,),O
87436,6034,and,O
87437,6034,estradiol,O
87438,6034,<,O
87439,6034,40,O
87440,6034,picograms,O
87441,6034,per,O
87442,6034,mililiter,O
87443,6034,(,O
87444,6034,pg,O
87445,6034,/,O
87446,6034,mL,O
87447,6034,),O
87448,6034,[,O
87449,6034,<,O
87450,6034,147,O
87451,6034,picomole,O
87452,6034,per,O
87453,6034,liter,O
87454,6034,],O
87455,6034,is,O
87456,6034,confirmatory,O
87457,6034,],O
87458,6034,.,O
87459,6034,Females,B-Person
87460,6034,on,O
87461,6034,hormone,B-Procedure
87462,6034,replacement,I-Procedure
87463,6034,therapy,I-Procedure
87464,6034,(,I-Procedure
87465,6034,HRT,I-Procedure
87466,6034,),I-Procedure
87467,6034,and,O
87468,6034,whose,O
87469,6034,menopausal,O
87470,6034,status,O
87471,6034,is,O
87472,6034,in,O
87473,6034,doubt,O
87474,6034,will,O
87475,6034,be,O
87476,6034,required,O
87477,6034,to,O
87478,6034,use,O
87479,6034,one,O
87480,6034,of,O
87481,6034,the,O
87482,6034,contraception,O
87483,6034,methods,O
87484,6034,if,O
87485,6034,they,O
87486,6034,wish,O
87487,6034,to,O
87488,6034,continue,O
87489,6034,their,O
87490,6034,HRT,O
87491,6034,during,O
87492,6034,the,O
87493,6034,study,O
87494,6034,.,O
87495,6034,Otherwise,O
87496,6034,",",O
87497,6034,they,O
87498,6034,must,O
87499,6034,discontinue,O
87500,6034,HRT,O
87501,6034,to,O
87502,6034,allow,O
87503,6034,confirmation,O
87504,6034,of,O
87505,6034,post,O
87506,6034,-,O
87507,6034,menopausal,O
87508,6034,status,O
87509,6034,prior,O
87510,6034,to,O
87511,6034,study,O
87512,6034,enrollment,O
87513,6034,.,O
87514,6034,For,O
87515,6034,most,O
87516,6034,forms,O
87517,6034,of,O
87518,6034,HRT,O
87519,6034,",",O
87520,6034,at,O
87521,6034,least,O
87522,6034,2,O
87523,6034,-,O
87524,6034,4,O
87525,6034,weeks,O
87526,6034,will,O
87527,6034,elapse,O
87528,6034,between,O
87529,6034,the,O
87530,6034,cessation,O
87531,6034,of,O
87532,6034,therapy,O
87533,6034,and,O
87534,6034,the,O
87535,6034,blood,O
87536,6034,draw,O
87537,6034,;,O
87538,6034,this,O
87539,6034,interval,O
87540,6034,depends,O
87541,6034,on,O
87542,6034,the,O
87543,6034,type,O
87544,6034,and,O
87545,6034,dosage,O
87546,6034,of,O
87547,6034,HRT,O
87548,6034,.,O
87549,6034,Following,O
87550,6034,confirmation,O
87551,6034,of,O
87552,6034,their,O
87553,6034,post,O
87554,6034,-,O
87555,6034,menopausal,O
87556,6034,status,O
87557,6034,",",O
87558,6034,they,O
87559,6034,can,O
87560,6034,resume,O
87561,6034,use,O
87562,6034,of,O
87563,6034,HRT,O
87564,6034,during,O
87565,6034,the,O
87566,6034,study,O
87567,6034,without,O
87568,6034,use,O
87569,6034,of,O
87570,6034,a,O
87571,6034,contraceptive,O
87572,6034,method,O
87573,6034,;,O
87574,6034,Child,O
87575,6034,-,O
87576,6034,bearing,O
87577,6034,potential,O
87578,6034,with,O
87579,6034,negative,O
87580,6034,pregnancy,O
87581,6034,test,O
87582,6034,as,O
87583,6034,determined,O
87584,6034,by,O
87585,6034,serum,O
87586,6034,human,O
87587,6034,chorionic,O
87588,6034,gonadotrophin,O
87589,6034,(,O
87590,6034,hCG,O
87591,6034,),O
87592,6034,test,O
87593,6034,at,O
87594,6034,screening,O
87595,6034,or,O
87596,6034,prior,O
87597,6034,to,O
87598,6034,dosing,O
87599,6034,AND,O
87600,6034,;,O
87601,6034,Agrees,O
87602,6034,to,O
87603,6034,use,O
87604,6034,one,O
87605,6034,of,O
87606,6034,the,O
87607,6034,contraception,O
87608,6034,methods,O
87609,6034,listed,O
87610,6034,in,O
87611,6034,protocol,O
87612,6034,for,O
87613,6034,an,O
87614,6034,appropriate,O
87615,6034,period,O
87616,6034,of,O
87617,6034,time,O
87618,6034,(,O
87619,6034,as,O
87620,6034,determined,O
87621,6034,by,O
87622,6034,the,O
87623,6034,product,O
87624,6034,label,O
87625,6034,or,O
87626,6034,investigator,O
87627,6034,),O
87628,6034,prior,O
87629,6034,to,O
87630,6034,the,O
87631,6034,start,O
87632,6034,of,O
87633,6034,dosing,O
87634,6034,to,O
87635,6034,sufficiently,O
87636,6034,minimize,O
87637,6034,the,O
87638,6034,risk,O
87639,6034,of,O
87640,6034,pregnancy,O
87641,6034,at,O
87642,6034,that,O
87643,6034,point,O
87644,6034,.,O
87645,6034,Female,O
87646,6034,subjects,O
87647,6034,must,O
87648,6034,agree,O
87649,6034,to,O
87650,6034,use,O
87651,6034,contraception,O
87652,6034,until,O
87653,6034,the,O
87654,6034,follow,O
87655,6034,-,O
87656,6034,up,O
87657,6034,contact,O
87658,6034,visit,O
87659,6034,;,O
87660,6034,OR,O
87661,6034,has,O
87662,6034,only,O
87663,6034,same,O
87664,6034,-,O
87665,6034,sex,O
87666,6034,partners,O
87667,6034,",",O
87668,6034,when,O
87669,6034,this,O
87670,6034,is,O
87671,6034,her,O
87672,6034,preferred,O
87673,6034,and,O
87674,6034,usual,O
87675,6034,lifestyle,O
87676,6034,.,O
87677,6035,Male,O
87678,6035,subjects,O
87679,6035,with,O
87680,6035,female,O
87681,6035,partners,O
87682,6035,of,O
87683,6035,child,O
87684,6035,-,O
87685,6035,bearing,O
87686,6035,potential,O
87687,6035,must,O
87688,6035,agree,O
87689,6035,to,O
87690,6035,use,O
87691,6035,one,O
87692,6035,of,O
87693,6035,the,O
87694,6035,contraception,O
87695,6035,methods,O
87696,6035,listed,O
87697,6035,in,O
87698,6035,Protocol,O
87699,6035,.,O
87700,6035,This,O
87701,6035,criterion,O
87702,6035,must,O
87703,6035,be,O
87704,6035,followed,O
87705,6035,from,O
87706,6035,the,O
87707,6035,time,O
87708,6035,of,O
87709,6035,the,O
87710,6035,first,O
87711,6035,dose,O
87712,6035,of,O
87713,6035,study,O
87714,6035,medication,O
87715,6035,until,O
87716,6035,the,O
87717,6035,follow,O
87718,6035,-,O
87719,6035,up,O
87720,6035,contact,O
87721,6035,visit,O
87722,6035,.,O
87723,6036,Capable,O
87724,6036,of,O
87725,6036,giving,O
87726,6036,written,O
87727,6036,informed,O
87728,6036,consent,O
87729,6036,",",O
87730,6036,which,O
87731,6036,includes,O
87732,6036,compliance,O
87733,6036,with,O
87734,6036,the,O
87735,6036,requirements,O
87736,6036,and,O
87737,6036,restrictions,O
87738,6036,listed,O
87739,6036,in,O
87740,6036,the,O
87741,6036,consent,O
87742,6036,form,O
87743,6037,Alanine,O
87744,6037,aminotransferase,O
87745,6037,",",O
87746,6037,alkaline,O
87747,6037,phosphatase,O
87748,6037,and,O
87749,6037,bilirubin,O
87750,6037,<,O
87751,6037,=,O
87752,6037,1.5x,O
87753,6037,upper,O
87754,6037,limit,O
87755,6037,of,O
87756,6037,normal,O
87757,6037,(,O
87758,6037,ULN,O
87759,6037,),O
87760,6037,(,O
87761,6037,isolated,O
87762,6037,bilirubin,O
87763,6037,>,O
87764,6037,1.5xULN,O
87765,6037,is,O
87766,6037,acceptable,O
87767,6037,if,O
87768,6037,bilirubin,O
87769,6037,is,O
87770,6037,fractionated,O
87771,6037,and,O
87772,6037,direct,O
87773,6037,bilirubin,O
87774,6037,<,O
87775,6037,35,O
87776,6037,%,O
87777,6037,),O
87778,6037,.,O
87779,6038,Based,O
87780,6038,on,O
87781,6038,single,O
87782,6038,or,O
87783,6038,averaged,O
87784,6038,corrected,O
87785,6038,QT,O
87786,6038,interval,O
87787,6038,(,O
87788,6038,QTc,O
87789,6038,),O
87790,6038,values,O
87791,6038,of,O
87792,6038,triplicate,O
87793,6038,electrocardiograms,B-Procedure
87794,6038,obtained,O
87795,6038,over,O
87796,6038,a,O
87797,6038,brief,O
87798,6038,recording,O
87799,6038,period,O
87800,6038,:,O
87801,6038,QTcF,O
87802,6038,<,O
87803,6038,450,O
87804,6038,msec,O
87805,6039,NA,O
87806,6040,Age,B-Person
87807,6040,:,O
87808,6040,20,O
87809,6040,-,O
87810,6040,70,O
87811,6040,years,O
87812,6040,old,O
87813,6040,;,O
87814,6041,Gender,B-Person
87815,6041,:,O
87816,6041,male,O
87817,6041,or,O
87818,6041,female,O
87819,6041,;,O
87820,6042,clinical,O
87821,6042,or,O
87822,6042,pathological,O
87823,6042,diagnosis,O
87824,6042,of,O
87825,6042,hepatocellular,B-Condition
87826,6042,carcinoma,I-Condition
87827,6042,(,O
87828,6042,HCC,B-Condition
87829,6042,),O
87830,6042,in,O
87831,6042,previously,O
87832,6042,untreated,O
87833,6042,patients,O
87834,6042,;,O
87835,6043,The,O
87836,6043,expected,B-Observation
87837,6043,survival,I-Observation
87838,6043,>,O
87839,6043,3,O
87840,6043,months,O
87841,6043,;,O
87842,6044,Child,O
87843,6044,-,O
87844,6044,Pugh,O
87845,6044,grade,O
87846,6044,in,O
87847,6044,A,O
87848,6044,-,O
87849,6044,level,O
87850,6044,;,O
87851,6045,KPS,O
87852,6045,score,O
87853,6045,with,O
87854,6045,50,O
87855,6045,-,O
87856,6045,100,O
87857,6045,points,O
87858,6045,;,O
87859,6046,BCLC,O
87860,6046,stage,O
87861,6046,of,O
87862,6046,0,O
87863,6046,-,O
87864,6046,B,O
87865,6046,;,O
87866,6047,conform,O
87867,6047,to,O
87868,6047,the,O
87869,6047,indications,B-Observation
87870,6047,of,I-Observation
87871,6047,hepatectomy,I-Observation
87872,6047,;,O
87873,6048,Viable,O
87874,6048,tumor,O
87875,6048,resection,O
87876,6048,confirmed,O
87877,6048,by,O
87878,6048,two,O
87879,6048,highly,O
87880,6048,qualified,O
87881,6048,surgical,O
87882,6048,doctors,O
87883,6048,;,O
87884,6049,No,O
87885,6049,other,B-Observation
87886,6049,surgical,I-Observation
87887,6049,contraindications,I-Observation
87888,6049,.,O
87889,6050,women,B-Person
87890,6050,in,O
87891,6050,the,O
87892,6050,reproductive,B-Observation
87893,6050,period,I-Observation
87894,6050,must,O
87895,6050,be,O
87896,6050,completely,O
87897,6050,contraception,B-Procedure
87898,6050,in,O
87899,6050,28,O
87900,6050,days,O
87901,6050,before,O
87902,6050,treatment,O
87903,6050,",",O
87904,6050,during,O
87905,6050,the,O
87906,6050,treatment,O
87907,6050,process,O
87908,6050,and,O
87909,6050,in,O
87910,6050,28,O
87911,6050,days,O
87912,6050,after,O
87913,6050,treatment,O
87914,6050,;,O
87915,6051,Men,B-Person
87916,6051,must,O
87917,6051,be,O
87918,6051,completely,O
87919,6051,contraception,B-Procedure
87920,6051,and,O
87921,6051,prohibited,O
87922,6051,donation,B-Procedure
87923,6051,and,O
87924,6051,sperm,B-Procedure
87925,6051,donation,I-Procedure
87926,6051,during,O
87927,6051,the,O
87928,6051,treatment,O
87929,6051,process,O
87930,6051,and,O
87931,6051,in,O
87932,6051,28,O
87933,6051,days,O
87934,6051,after,O
87935,6051,treatment,O
87936,6051,;,O
87937,6052,All,O
87938,6052,patients,O
87939,6052,must,O
87940,6052,be,O
87941,6052,prohibited,O
87942,6052,donation,B-Procedure
87943,6052,during,O
87944,6052,the,O
87945,6052,treatment,O
87946,6052,process,O
87947,6052,and,O
87948,6052,in,O
87949,6052,28,O
87950,6052,days,O
87951,6052,after,O
87952,6052,treatment,O
87953,6052,;,O
87954,6053,In,O
87955,6053,addition,O
87956,6053,to,O
87957,6053,the,O
87958,6053,subjects,O
87959,6053,",",O
87960,6053,prohibitting,O
87961,6053,other,O
87962,6053,people,O
87963,6053,taking,O
87964,6053,this,O
87965,6053,product,O
87966,6053,.,O
87967,6054,patients,O
87968,6054,have,O
87969,6054,a,O
87970,6054,good,O
87971,6054,understanding,O
87972,6054,and,O
87973,6054,could,O
87974,6054,coordinate,O
87975,6054,with,O
87976,6054,investigators,O
87977,6054,for,O
87978,6054,the,O
87979,6054,trial,O
87980,6054,.,O
87981,6055,Patients,O
87982,6055,enrolled,O
87983,6055,in,O
87984,6055,the,O
87985,6055,trial,O
87986,6055,should,O
87987,6055,sign,O
87988,6055,an,O
87989,6055,informed,O
87990,6055,consent,O
87991,6055,form,O
87992,6055,",",O
87993,6055,to,O
87994,6055,indicate,O
87995,6055,understanding,O
87996,6055,the,O
87997,6055,purpose,O
87998,6055,and,O
87999,6055,procedure,O
88000,6055,of,O
88001,6055,the,O
88002,6055,trial,O
88003,6055,",",O
88004,6055,and,O
88005,6055,patients,O
88006,6055,volunteering,O
88007,6055,to,O
88008,6055,participate,O
88009,6055,in,O
88010,6055,the,O
88011,6055,trial,O
88012,6055,.,O
88013,6056,preexisting,O
88014,6056,pectoral,B-Condition
88015,6056,",",I-Condition
88016,6056,axillar,I-Condition
88017,6056,",",I-Condition
88018,6056,thoracic,I-Condition
88019,6056,homolateral,I-Condition
88020,6056,pain,I-Condition
88021,6057,habitual,O
88022,6057,opioid,B-Observation
88023,6057,consumption,I-Observation
88024,6057,;,O
88025,6058,drug,O
88026,6058,-,O
88027,6058,alcoholics,B-Condition
88028,6058,addiction,I-Condition
88029,6058,;,O
88030,6059,ICU,B-Observation
88031,6059,postoperative,I-Observation
88032,6059,recovery,I-Observation
88033,6059,;,O
88034,6060,kidney,B-Condition
88035,6060,failure,I-Condition
88036,6060,(,O
88037,6060,creatinin,O
88038,6060,>,O
88039,6060,2,O
88040,6060,g,O
88041,6060,/,O
88042,6060,dl,O
88043,6060,",",O
88044,6060,creatinin,O
88045,6060,<,O
88046,6060,clearance,O
88047,6060,30,O
88048,6060,ml,O
88049,6060,/,O
88050,6060,h,O
88051,6060,),O
88052,6060,and/or,O
88053,6060,hepatic,B-Condition
88054,6060,failure,I-Condition
88055,6060,(,O
88056,6060,cholinesterase,O
88057,6060,<,O
88058,6060,2000,O
88059,6060,UI,O
88060,6060,),O
88061,6060,;,O
88062,6061,cardiac,B-Condition
88063,6061,arrhythmias,I-Condition
88064,6061,o,O
88065,6061,;,O
88066,6062,Epilepsy,B-Condition
88067,6062,;,O
88068,6063,Psychiatric,B-Condition
88069,6063,",",I-Condition
88070,6063,cognitive,I-Condition
88071,6063,disorders,I-Condition
88072,6063,",",O
88073,6063,mental,B-Condition
88074,6063,retardation,I-Condition
88075,6063,;,O
88076,6064,Coagulopathies,B-Condition
88077,6064,(,O
88078,6064,INR,O
88079,6064,>,O
88080,6064,2,O
88081,6064,",",O
88082,6064,activated,O
88083,6064,partial,O
88084,6064,thromboplastin,O
88085,6064,time,O
88086,6064,-,O
88087,6064,aPTT>44,O
88088,6064,sec,O
88089,6064,),O
88090,6064,;,O
88091,6065,platelet,O
88092,6065,count,O
88093,6065,less,O
88094,6065,than,O
88095,6065,100.000,O
88096,6065,/,O
88097,6065,mm3,O
88098,6065,;,O
88099,6066,BMI,O
88100,6066,>,O
88101,6066,30,O
88102,6066,;,O
88103,6067,Allergies,B-Condition
88104,6067,to,O
88105,6067,study,B-Drug
88106,6067,drugs,I-Drug
88107,6067,.,O
88108,6068,F,B-Person
88109,6068,;,O
88110,6068,age,B-Person
88111,6068,18,O
88112,6068,to,O
88113,6068,70,O
88114,6069,American,O
88115,6069,Society,O
88116,6069,of,O
88117,6069,Anesthesiologists,O
88118,6069,(,O
88119,6069,ASA,O
88120,6069,),O
88121,6069,I,O
88122,6069,e,O
88123,6069,II,O
88124,6069,;,O
88125,6070,breast,B-Condition
88126,6070,cancer,I-Condition
88127,6070,(,O
88128,6070,DIN,O
88129,6070,2,O
88130,6070,e,O
88131,6070,3,O
88132,6070,",",O
88133,6070,o,O
88134,6070,LIN,O
88135,6070,2,O
88136,6070,e,O
88137,6070,3,O
88138,6070,sec,O
88139,6070,.,O
88140,6070,Tavassoli,O
88141,6070,),O
88142,6070,scheduled,B-Mood
88143,6070,for,I-Mood
88144,6070,nipple,B-Condition
88145,6070,-,I-Condition
88146,6070,sparing,I-Condition
88147,6070,mastectomy,I-Condition
88148,6070,",",O
88149,6070,simple,B-Condition
88150,6070,mastectomy,I-Condition
88151,6070,",",O
88152,6070,skin,B-Condition
88153,6070,-,I-Condition
88154,6070,sparing,I-Condition
88155,6070,mastectomy,I-Condition
88156,6070,",",O
88157,6070,skin,B-Condition
88158,6070,-,I-Condition
88159,6070,reducing,I-Condition
88160,6070,mastectomy,I-Condition
88161,6070,c,O
88162,6070,",",O
88163,6070,lymphnode,B-Condition
88164,6070,biopsy,I-Condition
88165,6070,and,O
88166,6070,axillary,B-Condition
88167,6070,dissection,I-Condition
88168,6070,;,O
88169,6071,immediate,O
88170,6071,sub,B-Procedure
88171,6071,-,I-Procedure
88172,6071,pectoral,I-Procedure
88173,6071,prosthetic,I-Procedure
88174,6071,reconstruction,I-Procedure
88175,6071,;,O
88176,6072,signed,O
88177,6072,informed,O
88178,6072,consent,O
88179,6072,.,O
88180,6073,Age,B-Person
88181,6073,less,O
88182,6073,than,O
88183,6073,14,O
88184,6073,years,O
88185,6074,Pregnancy,B-Condition
88186,6075,Estimated,B-Person
88187,6075,life,I-Person
88188,6075,expectancy,I-Person
88189,6075,(,O
88190,6075,due,O
88191,6075,to,O
88192,6075,comorbidities,O
88193,6075,),O
88194,6075,less,O
88195,6075,than,O
88196,6075,90,O
88197,6075,days,O
88198,6076,Presence,O
88199,6076,of,O
88200,6076,relative,B-Condition
88201,6076,or,I-Condition
88202,6076,absolute,I-Condition
88203,6076,contraindications,I-Condition
88204,6076,to,O
88205,6076,CPFA,B-Procedure
88206,6077,Admission,B-Procedure
88207,6077,from,O
88208,6077,an,O
88209,6077,other,O
88210,6077,ICU,O
88211,6077,where,O
88212,6077,the,O
88213,6077,patient,B-Observation
88214,6077,remained,I-Observation
88215,6077,for,O
88216,6077,more,O
88217,6077,than,O
88218,6077,24,O
88219,6077,hours,O
88220,6078,Absence,O
88221,6078,of,O
88222,6078,informed,O
88223,6078,consent,O
88224,6079,All,O
88225,6079,patients,O
88226,6079,admitted,B-Procedure
88227,6079,to,O
88228,6079,the,O
88229,6079,ICU,O
88230,6079,in,O
88231,6079,septic,B-Condition
88232,6079,shock,I-Condition
88233,6080,All,O
88234,6080,patients,O
88235,6080,that,O
88236,6080,develop,O
88237,6080,septic,B-Condition
88238,6080,shock,I-Condition
88239,6080,while,O
88240,6080,in,O
88241,6080,the,O
88242,6080,ICU,O
88243,6081,Patients,O
88244,6081,with,O
88245,6081,placenta,B-Condition
88246,6081,pathology,I-Condition
88247,6081,such,O
88248,6081,as,O
88249,6081,praevia,B-Condition
88250,6081,",",O
88251,6081,acreta,B-Condition
88252,6081,",",O
88253,6081,pre,B-Condition
88254,6081,-,I-Condition
88255,6081,eclampsia,I-Condition
88256,6082,Patients,O
88257,6082,with,O
88258,6082,bleeding,B-Condition
88259,6082,disorders,I-Condition
88260,6082,including,O
88261,6082,vonWillebrand,B-Condition
88262,6082,disease,I-Condition
88263,6082,type,I-Condition
88264,6082,I.,I-Condition
88265,6083,Known,O
88266,6083,intolerance,B-Condition
88267,6083,to,O
88268,6083,one,O
88269,6083,of,O
88270,6083,the,O
88271,6083,two,O
88272,6083,drugs,B-Drug
88273,6083,.,O
88274,6084,Patients,O
88275,6084,with,O
88276,6084,prolonged,B-Condition
88277,6084,QT,I-Condition
88278,6084,-,I-Condition
88279,6084,time,I-Condition
88280,6084,or,O
88281,6084,other,O
88282,6084,serious,B-Condition
88283,6084,cardiac,I-Condition
88284,6084,diseases,I-Condition
88285,6084,.,O
88286,6085,Liver,B-Condition
88287,6085,or,I-Condition
88288,6085,kidney,I-Condition
88289,6085,failure,I-Condition
88290,6085,.,O
88291,6086,Epilepsy,B-Condition
88292,6086,.,O
88293,6087,Any,O
88294,6087,medical,O
88295,6087,reason,O
88296,6087,why,O
88297,6087,",",O
88298,6087,in,O
88299,6087,the,O
88300,6087,opinion,O
88301,6087,of,O
88302,6087,the,O
88303,6087,investigator,O
88304,6087,",",O
88305,6087,the,O
88306,6087,patient,O
88307,6087,should,O
88308,6087,not,O
88309,6087,participate,O
88310,6088,Healthy,B-Condition
88311,6088,pregnant,B-Condition
88312,6088,women,B-Person
88313,6088,age,B-Person
88314,6088,18,O
88315,6088,to,O
88316,6088,50,O
88317,6089,Singleton,B-Condition
88318,6089,pregnancy,I-Condition
88319,6089,at,O
88320,6089,gestational,O
88321,6089,age,O
88322,6089,36,O
88323,6089,weeks,O
88324,6089,or,O
88325,6089,more,O
88326,6090,Able,B-Observation
88327,6090,to,I-Observation
88328,6090,read,I-Observation
88329,6090,and,I-Observation
88330,6090,understand,I-Observation
88331,6090,Norwegian,I-Observation
88332,6090,.,O
88333,6091,Contraindication,B-Condition
88334,6091,to,O
88335,6091,bariatric,B-Procedure
88336,6091,surgery,I-Procedure
88337,6092,Pregnancy,B-Condition
88338,6093,Affiliation,B-Observation
88339,6093,of,I-Observation
88340,6093,health,I-Observation
88341,6093,care,I-Observation
88342,6093,assurance,I-Observation
88343,6094,Psychiatric,B-Condition
88344,6094,disorders,I-Condition
88345,6095,Type,B-Condition
88346,6095,2,I-Condition
88347,6095,diabetes,I-Condition
88348,6095,mellitus,I-Condition
88349,6095,with,O
88350,6095,HbA1c,O
88351,6095,>,O
88352,6095,7.5,O
88353,6095,%,O
88354,6096,Body,O
88355,6096,mass,O
88356,6096,index,O
88357,6096,>,O
88358,6096,35,O
88359,6096,and,O
88360,6096,<,O
88361,6096,50,O
88362,6096,kg,O
88363,6096,/,O
88364,6096,m2,O
88365,6097,Candidate,B-Mood
88366,6097,for,O
88367,6097,Gastric,B-Procedure
88368,6097,By,I-Procedure
88369,6097,-,I-Procedure
88370,6097,Pass,I-Procedure
88371,6098,Treatment,B-Procedure
88372,6098,with,O
88373,6098,GLP1,B-Drug
88374,6098,(,I-Drug
88375,6098,glucagon,I-Drug
88376,6098,-,I-Drug
88377,6098,like,I-Drug
88378,6098,peptide,I-Drug
88379,6098,),I-Drug
88380,6098,analogue,I-Drug
88381,6098,or,O
88382,6098,insulin,B-Drug
88383,6099,NA,O
88384,6100,NA,O
88385,6101,Previous,O
88386,6101,or,O
88387,6101,concurrent,O
88388,6101,malignancy,B-Condition
88389,6101,",",O
88390,6101,except,O
88391,6101,for,O
88392,6101,adequately,O
88393,6101,treated,O
88394,6101,basal,B-Condition
88395,6101,cell,I-Condition
88396,6101,or,I-Condition
88397,6101,squamous,I-Condition
88398,6101,cell,I-Condition
88399,6101,skin,I-Condition
88400,6101,cancer,I-Condition
88401,6101,",",O
88402,6101,in,O
88403,6101,situ,O
88404,6101,cervical,B-Condition
88405,6101,cancer,I-Condition
88406,6101,",",O
88407,6101,or,O
88408,6101,any,O
88409,6101,other,O
88410,6101,cancer,O
88411,6101,for,O
88412,6101,which,O
88413,6101,the,O
88414,6101,patient,O
88415,6101,has,O
88416,6101,been,O
88417,6101,previously,O
88418,6101,treated,O
88419,6101,and,O
88420,6101,the,O
88421,6101,lifetime,O
88422,6101,recurrence,O
88423,6101,risk,O
88424,6101,is,O
88425,6101,less,O
88426,6101,than,O
88427,6101,30,O
88428,6101,%,O
88429,6102,Inflammatory,B-Condition
88430,6102,bowel,I-Condition
88431,6102,disease,I-Condition
88432,6102,that,O
88433,6102,is,O
88434,6102,uncontrolled,O
88435,6102,or,O
88436,6102,on,O
88437,6102,active,O
88438,6102,treatment,B-Procedure
88439,6102,(,O
88440,6102,Crohn,B-Condition
88441,6102,'s,I-Condition
88442,6102,disease,I-Condition
88443,6102,",",O
88444,6102,ulcerative,B-Condition
88445,6102,colitis,I-Condition
88446,6102,),O
88447,6103,Diarrhea,B-Condition
88448,6103,",",O
88449,6103,grade,O
88450,6103,1,O
88451,6103,or,O
88452,6103,greater,O
88453,6103,by,O
88454,6103,the,O
88455,6103,National,O
88456,6103,Cancer,O
88457,6103,Institute,O
88458,6103,Common,O
88459,6103,Terminology,O
88460,6103,Criteria,O
88461,6103,for,O
88462,6103,Adverse,O
88463,6103,Events,O
88464,6103,(,O
88465,6103,NCI,O
88466,6103,-,O
88467,6103,CTCAE,O
88468,6103,",",O
88469,6103,version,O
88470,6103,[,O
88471,6103,v,O
88472,6103,],O
88473,6103,4.0,O
88474,6103,),O
88475,6104,Neuropathy,B-Condition
88476,6104,",",O
88477,6104,grade,O
88478,6104,2,O
88479,6104,or,O
88480,6104,greater,O
88481,6104,by,O
88482,6104,NCI,O
88483,6104,-,O
88484,6104,CTCAE,O
88485,6104,",",O
88486,6104,v,O
88487,6104,4.0,O
88488,6105,Serious,O
88489,6105,underlying,O
88490,6105,medical,O
88491,6105,or,O
88492,6105,psychiatric,O
88493,6105,illnesses,O
88494,6105,that,O
88495,6105,would,O
88496,6105,",",O
88497,6105,in,O
88498,6105,the,O
88499,6105,opinion,O
88500,6105,of,O
88501,6105,the,O
88502,6105,treating,O
88503,6105,physician,O
88504,6105,",",O
88505,6105,substantially,O
88506,6105,increase,O
88507,6105,the,O
88508,6105,risk,O
88509,6105,for,O
88510,6105,complications,O
88511,6105,related,O
88512,6105,to,O
88513,6105,treatment,O
88514,6106,Active,O
88515,6106,uncontrolled,O
88516,6106,bleeding,B-Condition
88517,6107,Pregnancy,O
88518,6107,or,O
88519,6107,breastfeeding,O
88520,6108,Major,B-Procedure
88521,6108,surgery,I-Procedure
88522,6108,within,O
88523,6108,4,O
88524,6108,weeks,O
88525,6109,Patients,O
88526,6109,with,O
88527,6109,any,O
88528,6109,polymorphism,O
88529,6109,in,O
88530,6109,UGT1A1,O
88531,6109,other,O
88532,6109,than,O
88533,6109,*,O
88534,6109,1,O
88535,6109,or,O
88536,6109,*,O
88537,6109,28,O
88538,6109,(,O
88539,6109,e.g,O
88540,6109,",",O
88541,6109,*,O
88542,6109,6,O
88543,6109,),O
88544,6109,will,O
88545,6109,be,O
88546,6109,allowed,O
88547,6109,and,O
88548,6109,treated,O
88549,6109,as,O
88550,6109,in,O
88551,6109,the,O
88552,6109,*,O
88553,6109,28/*28,O
88554,6109,dosing,O
88555,6109,group,O
88556,6110,Histologically,O
88557,6110,confirmed,O
88558,6110,locally,O
88559,6110,advanced,O
88560,6110,gastric,O
88561,6110,(,O
88562,6110,primary,O
88563,6110,endpoint,O
88564,6110,includes,O
88565,6110,proximal,O
88566,6110,and,O
88567,6110,mid,O
88568,6110,-,O
88569,6110,body,O
88570,6110,stomach,O
88571,6110,),O
88572,6110,or,O
88573,6110,esophagogastric,B-Condition
88574,6110,adenocarcinoma,I-Condition
88575,6110,;,O
88576,6110,distal,O
88577,6110,gastric,O
88578,6110,(,O
88579,6110,antral,O
88580,6110,),O
88581,6110,adenocarcinomas,B-Condition
88582,6110,are,O
88583,6110,eligible,O
88584,6110,for,O
88585,6110,enrolment,O
88586,6110,but,O
88587,6110,will,O
88588,6110,not,O
88589,6110,be,O
88590,6110,included,O
88591,6110,in,O
88592,6110,the,O
88593,6110,primary,O
88594,6110,analysis,O
88595,6111,Locally,O
88596,6111,advanced,O
88597,6111,disease,B-Condition
88598,6111,as,O
88599,6111,determined,O
88600,6111,by,O
88601,6111,endoscopic,B-Procedure
88602,6111,ultrasound,I-Procedure
88603,6111,(,O
88604,6111,EUS,B-Procedure
88605,6111,),O
88606,6111,stage,O
88607,6111,>,O
88608,6111,primary,O
88609,6111,tumor,O
88610,6111,(,O
88611,6111,T,O
88612,6111,),O
88613,6111,3,O
88614,6111,and/or,O
88615,6111,any,O
88616,6111,T,O
88617,6111,",",O
88618,6111,lymph,O
88619,6111,nodes,O
88620,6111,(,O
88621,6111,N)+,O
88622,6111,disease,O
88623,6111,without,O
88624,6111,metastatic,O
88625,6111,disease,O
88626,6111,(,O
88627,6111,Mx,O
88628,6111,),O
88629,6112,All,O
88630,6112,patients,O
88631,6112,must,O
88632,6112,have,O
88633,6112,diagnostic,O
88634,6112,laparoscopy,B-Procedure
88635,6112,with,O
88636,6112,diagnostic,O
88637,6112,washings,B-Procedure
88638,6112,for,I-Procedure
88639,6112,cytology,I-Procedure
88640,6112,;,O
88641,6112,both,O
88642,6112,cytology,O
88643,6112,positive,O
88644,6112,and,O
88645,6112,negative,O
88646,6112,patients,O
88647,6112,are,O
88648,6112,eligible,O
88649,6112,for,O
88650,6112,enrolment,O
88651,6112,",",O
88652,6112,but,O
88653,6112,only,O
88654,6112,cytology,O
88655,6112,negative,O
88656,6112,patients,O
88657,6112,will,O
88658,6112,be,O
88659,6112,included,O
88660,6112,in,O
88661,6112,the,O
88662,6112,primary,O
88663,6112,analyses,O
88664,6112,;,O
88665,6112,gross,O
88666,6112,peritoneal,O
88667,6112,disease,O
88668,6112,is,O
88669,6112,not,O
88670,6112,eligible,O
88671,6113,Eastern,O
88672,6113,Cooperative,O
88673,6113,Oncology,O
88674,6113,Group,O
88675,6113,(,O
88676,6113,ECOG,O
88677,6113,),O
88678,6113,performance,O
88679,6113,status,O
88680,6113,=,O
88681,6113,<,O
88682,6113,1,O
88683,6114,Eligible,O
88684,6114,for,O
88685,6114,surgery,B-Procedure
88686,6114,with,O
88687,6114,curative,O
88688,6114,intent,O
88689,6115,Absolute,O
88690,6115,neutrophil,O
88691,6115,count,O
88692,6115,(,O
88693,6115,ANC,O
88694,6115,),O
88695,6115,>,O
88696,6115,=,O
88697,6115,1250,O
88698,6115,/,O
88699,6115,ul,O
88700,6116,Hemoglobin,O
88701,6116,>,O
88702,6116,=,O
88703,6116,9,O
88704,6116,g,O
88705,6116,/,O
88706,6116,dL,O
88707,6117,Platelets,O
88708,6117,>,O
88709,6117,=,O
88710,6117,"100,000",O
88711,6117,/,O
88712,6117,ul,O
88713,6118,Total,O
88714,6118,bilirubin,O
88715,6118,<,O
88716,6118,1.5,O
88717,6118,x,O
88718,6118,upper,O
88719,6118,limit,O
88720,6118,of,O
88721,6118,normal,O
88722,6119,Serum,O
88723,6119,glutamic,O
88724,6119,oxaloacetic,O
88725,6119,transaminase,O
88726,6119,(,O
88727,6119,SGOT,O
88728,6119,),O
88729,6119,and,O
88730,6119,serum,O
88731,6119,glutamate,O
88732,6119,pyruvate,O
88733,6119,transaminase,O
88734,6119,(,O
88735,6119,SGPT,O
88736,6119,),O
88737,6119,<,O
88738,6119,2.5,O
88739,6119,x,O
88740,6119,upper,O
88741,6119,limit,O
88742,6119,of,O
88743,6119,normal,O
88744,6119,for,O
88745,6119,patients,O
88746,6119,without,O
88747,6119,liver,B-Condition
88748,6119,metastases,I-Condition
88749,6119,OR,O
88750,6119,SGOT,O
88751,6119,and,O
88752,6119,SGPT,O
88753,6119,<,O
88754,6119,5,O
88755,6119,x,O
88756,6119,upper,O
88757,6119,limit,O
88758,6119,of,O
88759,6119,normal,O
88760,6119,for,O
88761,6119,patients,O
88762,6119,with,O
88763,6119,liver,B-Condition
88764,6119,metastases,I-Condition
88765,6120,Creatinine,O
88766,6120,=,O
88767,6120,<,O
88768,6120,1.5,O
88769,6120,x,O
88770,6120,upper,O
88771,6120,limit,O
88772,6120,of,O
88773,6120,normal,O
88774,6121,Measurable,O
88775,6121,or,O
88776,6121,non,O
88777,6121,-,O
88778,6121,measurable,O
88779,6121,disease,O
88780,6121,by,O
88781,6121,Response,O
88782,6121,Evaluation,O
88783,6121,Criteria,O
88784,6121,in,O
88785,6121,Solid,O
88786,6121,Tumor,O
88787,6121,(,O
88788,6121,RECIST,O
88789,6121,),O
88790,6121,1.1,O
88791,6121,will,O
88792,6121,be,O
88793,6121,allowed,O
88794,6122,Women,O
88795,6122,of,O
88796,6122,child,O
88797,6122,-,O
88798,6122,bearing,O
88799,6122,potential,O
88800,6122,and,O
88801,6122,men,O
88802,6122,must,O
88803,6122,agree,O
88804,6122,to,O
88805,6122,use,O
88806,6122,adequate,O
88807,6122,contraception,O
88808,6122,(,O
88809,6122,hormonal,O
88810,6122,or,O
88811,6122,barrier,O
88812,6122,method,O
88813,6122,of,O
88814,6122,birth,O
88815,6122,control,O
88816,6122,;,O
88817,6122,abstinence,O
88818,6122,),O
88819,6122,prior,O
88820,6122,to,O
88821,6122,study,O
88822,6122,entry,O
88823,6122,and,O
88824,6122,for,O
88825,6122,the,O
88826,6122,duration,O
88827,6122,of,O
88828,6122,study,O
88829,6122,participation,O
88830,6122,",",O
88831,6122,up,O
88832,6122,until,O
88833,6122,30,O
88834,6122,days,O
88835,6122,after,O
88836,6122,final,O
88837,6122,study,O
88838,6122,treatment,O
88839,6122,;,O
88840,6122,should,O
88841,6122,a,O
88842,6122,woman,O
88843,6122,become,O
88844,6122,pregnant,O
88845,6122,or,O
88846,6122,suspect,O
88847,6122,that,O
88848,6122,she,O
88849,6122,is,O
88850,6122,pregnant,O
88851,6122,while,O
88852,6122,participating,O
88853,6122,in,O
88854,6122,this,O
88855,6122,study,O
88856,6122,",",O
88857,6122,she,O
88858,6122,should,O
88859,6122,inform,O
88860,6122,her,O
88861,6122,treating,O
88862,6122,physician,O
88863,6122,immediately,O
88864,6123,Patients,O
88865,6123,taking,O
88866,6123,substrates,O
88867,6123,",",O
88868,6123,inhibitors,O
88869,6123,",",O
88870,6123,or,O
88871,6123,inducers,O
88872,6123,of,O
88873,6123,cytochrome,O
88874,6123,P450,O
88875,6123,",",O
88876,6123,family,O
88877,6123,3,O
88878,6123,",",O
88879,6123,subfamily,O
88880,6123,A,O
88881,6123,",",O
88882,6123,polypeptide,O
88883,6123,4,O
88884,6123,(,O
88885,6123,CYP3A4,O
88886,6123,),O
88887,6123,should,O
88888,6123,be,O
88889,6123,encouraged,O
88890,6123,to,O
88891,6123,switch,O
88892,6123,to,O
88893,6123,alternative,O
88894,6123,drugs,O
88895,6123,whenever,O
88896,6123,possible,O
88897,6123,",",O
88898,6123,given,O
88899,6123,the,O
88900,6123,potential,O
88901,6123,for,O
88902,6123,drug,O
88903,6123,-,O
88904,6123,drug,O
88905,6123,interactions,O
88906,6123,with,O
88907,6123,irinotecan,O
88908,6124,Signed,O
88909,6124,informed,O
88910,6124,consent,O
88911,6125,COPD,B-Condition
88912,6125,exacerbation,I-Condition
88913,6125,",",O
88914,6125,very,O
88915,6125,severe,O
88916,6125,COPD,B-Condition
88917,6125,with,O
88918,6125,hypoxemia,B-Condition
88919,6125,at,O
88920,6125,low,O
88921,6125,altitude,O
88922,6125,(,O
88923,6125,FEV1,O
88924,6125,/,O
88925,6125,FVC,O
88926,6125,<,O
88927,6125,0.7,O
88928,6125,",",O
88929,6125,FEV1,O
88930,6125,<,O
88931,6125,40,O
88932,6125,%,O
88933,6125,predicted,O
88934,6125,",",O
88935,6125,oxygen,O
88936,6125,saturation,O
88937,6125,on,O
88938,6125,room,O
88939,6125,air,O
88940,6125,<,O
88941,6125,92,O
88942,6125,%,O
88943,6125,at,O
88944,6125,750,O
88945,6125,m,O
88946,6125,),O
88947,6125,.,O
88948,6126,Comorbidities,B-Condition
88949,6126,such,O
88950,6126,as,O
88951,6126,uncontrolled,O
88952,6126,cardiovascular,B-Condition
88953,6126,disease,I-Condition
88954,6126,",",O
88955,6126,i.e.,O
88956,6126,",",O
88957,6126,unstable,O
88958,6126,systemic,B-Condition
88959,6126,arterial,I-Condition
88960,6126,hypertension,I-Condition
88961,6126,",",O
88962,6126,coronary,B-Condition
88963,6126,artery,I-Condition
88964,6126,disease,I-Condition
88965,6126,;,O
88966,6126,previous,O
88967,6126,stroke,B-Condition
88968,6126,;,O
88969,6126,OSA,B-Condition
88970,6126,;,O
88971,6126,pneumothorax,B-Condition
88972,6126,in,O
88973,6126,the,O
88974,6126,last,O
88975,6126,2,O
88976,6126,months,O
88977,6126,.,O
88978,6127,Internal,B-Condition
88979,6127,",",I-Condition
88980,6127,neurologic,I-Condition
88981,6127,",",I-Condition
88982,6127,rheumatologic,I-Condition
88983,6127,or,I-Condition
88984,6127,psychiatric,I-Condition
88985,6127,disease,I-Condition
88986,6127,including,O
88987,6127,current,O
88988,6127,heavy,B-Observation
88989,6127,smoking,I-Observation
88990,6127,(,O
88991,6127,>,O
88992,6127,20,O
88993,6127,cigarettes,O
88994,6127,per,O
88995,6127,day,O
88996,6127,),O
88997,6128,Known,O
88998,6128,renal,B-Condition
88999,6128,failure,I-Condition
89000,6128,or,O
89001,6128,allergy,B-Condition
89002,6128,to,O
89003,6128,acetazolamide,B-Drug
89004,6128,and,O
89005,6128,other,O
89006,6128,sulfonamides,B-Drug
89007,6129,Male,B-Person
89008,6129,and,O
89009,6129,female,B-Person
89010,6129,patients,O
89011,6129,",",O
89012,6129,age,B-Person
89013,6129,18,O
89014,6129,-,O
89015,6129,75,O
89016,6129,yrs,O
89017,6129,.,O
89018,6130,COPD,B-Condition
89019,6130,diagnosed,O
89020,6130,according,O
89021,6130,to,O
89022,6130,GOLD,O
89023,6130,",",O
89024,6130,FEV1,O
89025,6130,40,O
89026,6130,-,O
89027,6130,80,O
89028,6130,%,O
89029,6130,predicted,O
89030,6130,",",O
89031,6130,SpO2,O
89032,6130,=,O
89033,6130,92,O
89034,6130,%,O
89035,6130,at,O
89036,6130,750,O
89037,6130,m.,O
89038,6131,Born,O
89039,6131,",",O
89040,6131,raised,O
89041,6131,and,O
89042,6131,currently,O
89043,6131,living,O
89044,6131,at,O
89045,6131,low,O
89046,6131,altitude,O
89047,6131,(,O
89048,6131,<,O
89049,6131,800,O
89050,6131,m,O
89051,6131,),O
89052,6131,.,O
89053,6132,Written,O
89054,6132,informed,O
89055,6132,consent,O
89056,6132,.,O
89057,6133,allergic,B-Condition
89058,6133,to,O
89059,6133,dexmedetomidine,B-Drug
89060,6133,",",O
89061,6133,similar,B-Drug
89062,6133,active,I-Drug
89063,6133,ingredients,I-Drug
89064,6133,or,O
89065,6133,excipients,B-Drug
89066,6134,G-6,B-Condition
89067,6134,-,I-Condition
89068,6134,PD,I-Condition
89069,6134,deficiency,I-Condition
89070,6135,a,O
89071,6135,history,B-Observation
89072,6135,of,O
89073,6135,arrhythmia,B-Condition
89074,6135,",",O
89075,6135,bronchial,B-Condition
89076,6135,and,I-Condition
89077,6135,cardiovascular,I-Condition
89078,6135,diseases,I-Condition
89079,6135,",",O
89080,6135,abnormal,B-Condition
89081,6135,liver,I-Condition
89082,6135,function,I-Condition
89083,6135,and,O
89084,6135,so,O
89085,6135,on,O
89086,6136,a,O
89087,6136,history,B-Observation
89088,6136,of,O
89089,6136,use,O
89090,6136,of,O
89091,6136,alpha,B-Drug
89092,6136,2,I-Drug
89093,6136,receptor,I-Drug
89094,6136,agonists,I-Drug
89095,6136,or,I-Drug
89096,6136,antagonists,I-Drug
89097,6136,.,O
89098,6137,selective,O
89099,6137,operation,O
89100,6137,of,O
89101,6137,inguinal,B-Procedure
89102,6137,hernia,I-Procedure
89103,6137,repair,I-Procedure
89104,6137,<,O
89105,6137,U+3001,O
89106,6137,>,O
89107,6137,orthopedics,B-Procedure
89108,6137,operation,I-Procedure
89109,6137,or,O
89110,6137,general,B-Procedure
89111,6137,surgery,I-Procedure
89112,6137,operation,I-Procedure
89113,6137,in,O
89114,6137,children,B-Person
89115,6138,aged,B-Person
89116,6138,3,O
89117,6138,-,O
89118,6138,9,O
89119,6138,years,O
89120,6139,ASA,O
89121,6139,I,O
89122,6139,-,O
89123,6139,II,O
89124,6140,enter,O
89125,6140,the,O
89126,6140,operating,O
89127,6140,room,O
89128,6140,by,O
89129,6140,himself,O
89130,6140,without,O
89131,6140,parents,O
89132,6141,normal,B-Condition
89133,6141,liver,I-Condition
89134,6141,and,I-Condition
89135,6141,kidney,I-Condition
89136,6141,function,I-Condition
89137,6142,no,O
89138,6142,history,B-Observation
89139,6142,of,O
89140,6142,anesthesia,B-Drug
89141,6142,medication,I-Drug
89142,6142,allergy,B-Condition
89143,6142,.,O
89144,6143,Medical,O
89145,6143,history,B-Observation
89146,6143,of,O
89147,6143,chronic,B-Condition
89148,6143,psychiatric,I-Condition
89149,6143,disease,I-Condition
89150,6144,Medical,B-Condition
89151,6144,conditions,I-Condition
89152,6144,associated,O
89153,6144,with,O
89154,6144,female,B-Condition
89155,6144,sexual,I-Condition
89156,6144,dysfunction,I-Condition
89157,6144,;,O
89158,6144,cardiovascular,B-Condition
89159,6144,disease,I-Condition
89160,6144,",",O
89161,6144,uncontrolled,O
89162,6144,chronic,O
89163,6144,HT,B-Condition
89164,6144,(,O
89165,6144,hypertension,B-Condition
89166,6144,),O
89167,6144,",",O
89168,6144,DM,B-Condition
89169,6144,(,O
89170,6144,diabetes,B-Condition
89171,6144,mellitus,I-Condition
89172,6144,),O
89173,6144,",",O
89174,6144,History,B-Observation
89175,6144,of,O
89176,6144,gynecologic,B-Procedure
89177,6144,surgery,I-Procedure
89178,6144,",",O
89179,6144,female,B-Condition
89180,6144,gynecological,I-Condition
89181,6144,cancer,I-Condition
89182,6144,(,O
89183,6144,breast,B-Condition
89184,6144,",",O
89185,6144,ovarian,B-Condition
89186,6144,",",O
89187,6144,uterine,B-Condition
89188,6144,",",O
89189,6144,cervical,B-Condition
89190,6144,),O
89191,6145,Medications,B-Drug
89192,6145,associated,O
89193,6145,with,O
89194,6145,female,B-Condition
89195,6145,sexual,I-Condition
89196,6145,dysfunction,I-Condition
89197,6145,;,O
89198,6145,Antidepressants,B-Drug
89199,6145,opiates,B-Drug
89200,6145,",",O
89201,6145,beta,B-Drug
89202,6145,blockers,I-Drug
89203,6145,",",O
89204,6145,Antiepileptics,B-Drug
89205,6145,(,O
89206,6145,gabapentin,B-Drug
89207,6145,",",O
89208,6145,topiramate,B-Drug
89209,6145,",",O
89210,6145,phenytoin,B-Drug
89211,6145,),O
89212,6145,benzodiazepines,B-Drug
89213,6146,Menopausal,B-Condition
89214,6146,status,O
89215,6147,Sexually,B-Observation
89216,6147,active,I-Observation
89217,6148,Contraindications,B-Condition
89218,6148,for,O
89219,6148,spinal,B-Procedure
89220,6148,anesthesia,I-Procedure
89221,6148,(,O
89222,6148,like,O
89223,6148,bleeding,B-Condition
89224,6148,diathesis,I-Condition
89225,6148,or,O
89226,6148,regional,B-Condition
89227,6148,infection,I-Condition
89228,6148,at,O
89229,6148,site,O
89230,6148,of,O
89231,6148,neuroaxial,O
89232,6148,block,O
89233,6148,),O
89234,6149,Known,O
89235,6149,allergy,B-Condition
89236,6149,to,O
89237,6149,Granisetron,B-Drug
89238,6149,or,O
89239,6149,local,B-Drug
89240,6149,anaesthetic,I-Drug
89241,6149,(,O
89242,6149,heavy,B-Drug
89243,6149,bupivacaine,I-Drug
89244,6149,",",O
89245,6149,Marcaine,B-Drug
89246,6149,Spinal,I-Drug
89247,6149,0.5,I-Drug
89248,6149,%,I-Drug
89249,6149,Heavy,I-Drug
89250,6149,",",O
89251,6149,5mg,O
89252,6149,/,O
89253,6149,ml,O
89254,6149,",",O
89255,6149,AstraZeneca,O
89256,6149,ampule,O
89257,6149,),O
89258,6150,Pregnancy,B-Condition
89259,6150,induced,O
89260,6150,hypertension,B-Condition
89261,6151,Congenital,O
89262,6151,or,O
89263,6151,rheumatic,O
89264,6151,heart,B-Condition
89265,6151,diseases,I-Condition
89266,6152,Antepartum,B-Condition
89267,6152,haemorrhage,I-Condition
89268,6153,Fetal,B-Condition
89269,6153,destress,I-Condition
89270,6153,or,O
89271,6153,gestational,O
89272,6153,age,O
89273,6153,<,O
89274,6153,36,O
89275,6153,week,O
89276,6154,Type,B-Condition
89277,6154,I,I-Condition
89278,6154,diabetic,I-Condition
89279,6154,patients,O
89280,6155,Parturients,B-Condition
89281,6155,presented,O
89282,6155,for,O
89283,6155,Cesarean,O
89284,6155,section,O
89285,6156,Secondary,O
89286,6156,knee,B-Condition
89287,6156,osteoarthritis,I-Condition
89288,6157,Other,O
89289,6157,inflammatory,B-Condition
89290,6157,Knee,I-Condition
89291,6157,Osteoarthritis,I-Condition
89292,6157,(,O
89293,6157,e.g.,O
89294,6157,gout,B-Condition
89295,6157,",",O
89296,6157,rheumatoid,B-Condition
89297,6157,arthritis,I-Condition
89298,6157,",",O
89299,6157,etc,O
89300,6157,.,O
89301,6157,),O
89302,6158,Patients,O
89303,6158,presenting,O
89304,6158,with,O
89305,6158,gastroesophageal,B-Condition
89306,6158,reflux,I-Condition
89307,6158,disease,I-Condition
89308,6158,",",O
89309,6158,peptic,B-Condition
89310,6158,ulcer,I-Condition
89311,6158,.,O
89312,6159,Helicobacter,B-Condition
89313,6159,infected,I-Condition
89314,6159,patients,O
89315,6159,who,O
89316,6159,have,O
89317,6159,not,O
89318,6159,been,O
89319,6159,treated,B-Procedure
89320,6159,for,I-Procedure
89321,6159,eradication,I-Procedure
89322,6159,(,O
89323,6159,recruitment,O
89324,6159,if,O
89325,6159,negative,O
89326,6159,in,O
89327,6159,re,O
89328,6159,-,O
89329,6159,examination,O
89330,6159,after,O
89331,6159,treatment,O
89332,6159,),O
89333,6159,.,O
89334,6160,Short,B-Condition
89335,6160,bowel,I-Condition
89336,6160,syndrome,I-Condition
89337,6160,that,O
89338,6160,can,B-Mood
89339,6160,cause,I-Mood
89340,6160,inflammatory,B-Condition
89341,6160,bowel,I-Condition
89342,6160,disease,I-Condition
89343,6160,(,O
89344,6160,ulcerative,B-Condition
89345,6160,colitis,I-Condition
89346,6160,",",O
89347,6160,Crohn,B-Condition
89348,6160,'s,I-Condition
89349,6160,disease,I-Condition
89350,6160,),O
89351,6160,and,O
89352,6160,drug,B-Condition
89353,6160,absorption,I-Condition
89354,6160,disorder,I-Condition
89355,6160,.,O
89356,6161,Intestinal,B-Condition
89357,6161,obstruction,I-Condition
89358,6161,syndrome,I-Condition
89359,6162,Unexplained,O
89360,6162,abdominal,B-Condition
89361,6162,pain,I-Condition
89362,6163,ALT(Alanine,O
89363,6163,aminotransferase,O
89364,6163,),O
89365,6163,level,O
89366,6163,of,O
89367,6163,liver,B-Procedure
89368,6163,function,I-Procedure
89369,6163,test,I-Procedure
89370,6163,exceeded,O
89371,6163,5,O
89372,6163,times,O
89373,6163,of,O
89374,6163,reference,O
89375,6163,range,O
89376,6164,Total,O
89377,6164,bilirubin,O
89378,6164,level,O
89379,6164,exceeded,O
89380,6164,2,O
89381,6164,mg,O
89382,6164,/,O
89383,6164,dL,O
89384,6165,Serum,O
89385,6165,albumin,O
89386,6165,level,O
89387,6165,less,O
89388,6165,than,O
89389,6165,2,O
89390,6165,g,O
89391,6165,/,O
89392,6165,dL,O
89393,6166,Ascites,B-Condition
89394,6167,Hepatic,B-Condition
89395,6167,encephalopathy,I-Condition
89396,6168,Hepatitis,B-Condition
89397,6168,B,I-Condition
89398,6168,",",O
89399,6168,hepatitis,B-Condition
89400,6168,C,I-Condition
89401,6168,(,O
89402,6168,excluding,O
89403,6168,healthy,B-Condition
89404,6168,carriers,I-Condition
89405,6168,),O
89406,6168,or,O
89407,6168,HIV,B-Condition
89408,6168,positive,I-Condition
89409,6169,MDRD(Modification,O
89410,6169,of,O
89411,6169,Diet,O
89412,6169,in,O
89413,6169,Renal,O
89414,6169,Disease,O
89415,6169,),O
89416,6169,Estimated,O
89417,6169,Glomerular,O
89418,6169,filtration,O
89419,6169,rate,O
89420,6169,less,O
89421,6169,than,O
89422,6169,60,O
89423,6169,mL,O
89424,6169,/,O
89425,6169,m2,O
89426,6170,Patients,O
89427,6170,with,O
89428,6170,hyperkalemia,B-Condition
89429,6170,(,O
89430,6170,over,O
89431,6170,5.5,O
89432,6170,meq,O
89433,6170,/,O
89434,6170,L,O
89435,6170,),O
89436,6171,history,O
89437,6171,of,O
89438,6171,asthma,B-Condition
89439,6171,",",O
89440,6171,acute,B-Condition
89441,6171,rhinitis,I-Condition
89442,6171,",",O
89443,6171,nasal,B-Condition
89444,6171,polyps,I-Condition
89445,6171,",",O
89446,6171,angioedema,B-Condition
89447,6171,",",O
89448,6171,urticaria,B-Condition
89449,6171,or,O
89450,6171,allergic,B-Condition
89451,6171,reactions,I-Condition
89452,6171,to,O
89453,6171,aspirin,B-Drug
89454,6171,or,O
89455,6171,other,O
89456,6171,non,B-Drug
89457,6171,-,I-Drug
89458,6171,steroidal,I-Drug
89459,6171,anti,I-Drug
89460,6171,-,I-Drug
89461,6171,inflammatory,I-Drug
89462,6171,drugs(including,I-Drug
89463,6171,COX-2,B-Drug
89464,6171,inhibitors,I-Drug
89465,6171,),O
89466,6171,.,O
89467,6172,Malignant,B-Condition
89468,6172,tumors,I-Condition
89469,6172,other,O
89470,6172,than,O
89471,6172,basal,B-Condition
89472,6172,cell,I-Condition
89473,6172,or,I-Condition
89474,6172,squamous,I-Condition
89475,6172,cell,I-Condition
89476,6172,carcinoma,I-Condition
89477,6172,of,I-Condition
89478,6172,the,I-Condition
89479,6172,skin,I-Condition
89480,6172,",",O
89481,6172,CIN(Cervical,B-Condition
89482,6172,Intraepitherial,I-Condition
89483,6172,Neoplasia,I-Condition
89484,6172,),I-Condition
89485,6172,and,O
89486,6172,CIS(Carcinoma,B-Condition
89487,6172,in,I-Condition
89488,6172,situ,I-Condition
89489,6172,),I-Condition
89490,6172,of,I-Condition
89491,6172,the,I-Condition
89492,6172,cervix,I-Condition
89493,6172,",",O
89494,6172,and,O
89495,6172,intraepithelial,B-Condition
89496,6172,carcinoma,I-Condition
89497,6172,of,O
89498,6172,other,O
89499,6172,areas,O
89500,6172,Within,O
89501,6172,5,O
89502,6172,years,O
89503,6172,of,O
89504,6172,consent,O
89505,6172,date,O
89506,6172,.,O
89507,6173,Medical,O
89508,6173,history,O
89509,6173,of,O
89510,6173,hypersensitivity,B-Condition
89511,6173,to,O
89512,6173,the,O
89513,6173,components,B-Drug
89514,6173,of,I-Drug
89515,6173,the,I-Drug
89516,6173,investigational,I-Drug
89517,6173,products,I-Drug
89518,6173,.,O
89519,6173,(,O
89520,6173,The,O
89521,6173,components,B-Drug
89522,6173,of,I-Drug
89523,6173,test,I-Drug
89524,6173,drug,I-Drug
89525,6173,1,I-Drug
89526,6173,and,I-Drug
89527,6173,2,I-Drug
89528,6173,",",O
89529,6173,including,O
89530,6173,the,O
89531,6173,Rhein,B-Drug
89532,6173,-,I-Drug
89533,6173,based,I-Drug
89534,6173,drug,I-Drug
89535,6173,),O
89536,6174,Patients,O
89537,6174,with,O
89538,6174,an,O
89539,6174,allergic,B-Condition
89540,6174,reaction,I-Condition
89541,6174,to,O
89542,6174,sulfonamide,B-Drug
89543,6174,.,O
89544,6175,Patients,O
89545,6175,with,O
89546,6175,galactose,B-Condition
89547,6175,intolerance,I-Condition
89548,6175,",",O
89549,6175,lapp,B-Condition
89550,6175,lactase,I-Condition
89551,6175,deficiency,I-Condition
89552,6175,or,O
89553,6175,glucose,B-Condition
89554,6175,-,I-Condition
89555,6175,galactose,I-Condition
89556,6175,malabsorption,I-Condition
89557,6175,.,O
89558,6176,Subjects,O
89559,6176,who,O
89560,6176,have,O
89561,6176,not,O
89562,6176,reached,O
89563,6176,the,O
89564,6176,prescribed,O
89565,6176,period,O
89566,6176,after,O
89567,6176,receiving,O
89568,6176,contraindicated,O
89569,6176,medication,O
89570,6176,or,O
89571,6176,treatment,O
89572,6176,before,O
89573,6176,participation,O
89574,6176,in,O
89575,6176,this,O
89576,6176,clinical,O
89577,6176,trial,O
89578,6176,.,O
89579,6177,Patients,O
89580,6177,receiving,O
89581,6177,contraindicated,B-Drug
89582,6177,medication,I-Drug
89583,6177,.,O
89584,6178,Alcohol,B-Condition
89585,6178,and,I-Condition
89586,6178,other,I-Condition
89587,6178,drug,I-Condition
89588,6178,abuse,I-Condition
89589,6178,cases,O
89590,6178,based,O
89591,6178,on,O
89592,6178,6,O
89593,6178,months,O
89594,6178,before,O
89595,6178,screening,O
89596,6178,.,O
89597,6179,Pregnant,O
89598,6179,women,O
89599,6179,or,O
89600,6179,nursing,O
89601,6179,mothers,O
89602,6179,who,O
89603,6179,are,O
89604,6179,not,O
89605,6179,willing,O
89606,6179,to,O
89607,6179,stop,O
89608,6179,breastfeeding,O
89609,6179,.,O
89610,6180,(,O
89611,6180,1,O
89612,6180,),O
89613,6180,Menopause,B-Condition
89614,6180,(,O
89615,6180,non,O
89616,6180,-,O
89617,6180,therapy,O
89618,6180,-,O
89619,6180,induced,O
89620,6180,amenorrhea,B-Condition
89621,6180,of,O
89622,6180,more,O
89623,6180,than,O
89624,6180,12,O
89625,6180,months,O
89626,6180,),O
89627,6180,Female,B-Person
89628,6181,(,O
89629,6181,2,O
89630,6181,),O
89631,6181,Female,B-Person
89632,6181,infertility,B-Condition
89633,6181,due,O
89634,6181,to,O
89635,6181,surgery,O
89636,6181,(,O
89637,6181,no,B-Condition
89638,6181,ovaries,I-Condition
89639,6181,and,I-Condition
89640,6181,/,I-Condition
89641,6181,or,I-Condition
89642,6181,uterus,I-Condition
89643,6181,),O
89644,6182,(,O
89645,6182,3,O
89646,6182,),O
89647,6182,If,O
89648,6182,you,O
89649,6182,have,O
89650,6182,sexual,O
89651,6182,intercourse,O
89652,6182,with,O
89653,6182,only,O
89654,6182,one,O
89655,6182,male,O
89656,6182,partner,O
89657,6182,who,O
89658,6182,has,O
89659,6182,been,O
89660,6182,confirmed,O
89661,6182,to,O
89662,6182,have,O
89663,6182,no,O
89664,6182,semen,O
89665,6182,after,O
89666,6182,fertilization,O
89667,6182,.,O
89668,6183,(,O
89669,6183,4,O
89670,6183,),O
89671,6183,Female,O
89672,6183,subjects,O
89673,6183,who,O
89674,6183,agreed,O
89675,6183,to,O
89676,6183,abstinence,O
89677,6183,during,O
89678,6183,the,O
89679,6183,clinical,O
89680,6183,trial,O
89681,6183,period,O
89682,6183,.,O
89683,6184,If,O
89684,6184,the,O
89685,6184,subject,O
89686,6184,is,O
89687,6184,assured,O
89688,6184,of,O
89689,6184,an,O
89690,6184,abstinence,O
89691,6184,throughout,O
89692,6184,the,O
89693,6184,trial,O
89694,6184,period.(e.g,O
89695,6184,.,O
89696,6184,clergy,O
89697,6184,),O
89698,6185,However,O
89699,6185,",",O
89700,6185,intermittent,O
89701,6185,abstinence,O
89702,6185,(,O
89703,6185,eg,O
89704,6185,",",O
89705,6185,contraception,O
89706,6185,using,O
89707,6185,ovulation,O
89708,6185,period,O
89709,6185,",",O
89710,6185,symptothermal,O
89711,6185,),O
89712,6185,or,O
89713,6185,coitus,O
89714,6185,interrupts,O
89715,6185,is,O
89716,6185,not,O
89717,6185,a,O
89718,6185,case,O
89719,6185,of,O
89720,6185,consent,O
89721,6185,for,O
89722,6185,abstinence,O
89723,6185,.,O
89724,6186,(,O
89725,6186,5,O
89726,6186,),O
89727,6186,For,O
89728,6186,women,O
89729,6186,of,O
89730,6186,childbearing,O
89731,6186,age,O
89732,6186,",",O
89733,6186,the,O
89734,6186,following,O
89735,6186,methods,O
89736,6186,or,O
89737,6186,methods,O
89738,6186,of,O
89739,6186,contraception,O
89740,6186,use,O
89741,6186,the,O
89742,6186,effective,O
89743,6186,method,O
89744,6186,of,O
89745,6186,contraception,O
89746,6186,to,O
89747,6186,be,O
89748,6186,used,O
89749,6186,during,O
89750,6186,the,O
89751,6186,period,O
89752,6186,of,O
89753,6186,this,O
89754,6186,clinical,O
89755,6186,trial,O
89756,6186,:,O
89757,6187,Oral,B-Drug
89758,6187,contraceptive,I-Drug
89759,6188,The,O
89760,6188,contraceptive,O
89761,6188,patch,O
89762,6189,Intra,O
89763,6189,uterine,O
89764,6189,device,O
89765,6189,(,O
89766,6189,IUD,O
89767,6189,),O
89768,6190,contraceptive,O
89769,6190,implant,O
89770,6191,contraceptive,O
89771,6191,injection,O
89772,6192,intrauterine,O
89773,6192,hormonal,O
89774,6192,apparatus,O
89775,6193,Tubal,B-Procedure
89776,6193,ligation,I-Procedure
89777,6193,and,O
89778,6193,infertility,B-Procedure
89779,6193,surgery,I-Procedure
89780,6194,If,O
89781,6194,30,O
89782,6194,days,O
89783,6194,have,O
89784,6194,not,O
89785,6194,elapsed,O
89786,6194,after,O
89787,6194,the,O
89788,6194,date,O
89789,6194,of,O
89790,6194,signing,O
89791,6194,of,O
89792,6194,the,O
89793,6194,previous,O
89794,6194,clinical,O
89795,6194,trial,O
89796,6194,or,O
89797,6194,currently,O
89798,6194,participating,O
89799,6194,in,O
89800,6194,other,O
89801,6194,clinical,O
89802,6194,trials,O
89803,6194,.,O
89804,6195,Patients,O
89805,6195,who,O
89806,6195,are,O
89807,6195,scheduled,O
89808,6195,for,O
89809,6195,surgery,O
89810,6195,during,O
89811,6195,the,O
89812,6195,clinical,O
89813,6195,trial,O
89814,6195,period,O
89815,6195,or,O
89816,6195,who,O
89817,6195,have,O
89818,6195,difficulties,O
89819,6195,in,O
89820,6195,completing,O
89821,6195,the,O
89822,6195,protocol,O
89823,6195,during,O
89824,6195,this,O
89825,6195,clinical,O
89826,6195,trial,O
89827,6195,due,O
89828,6195,to,O
89829,6195,other,O
89830,6195,reasons,O
89831,6195,.,O
89832,6196,In,O
89833,6196,addition,O
89834,6196,to,O
89835,6196,the,O
89836,6196,above,O
89837,6196,",",O
89838,6196,other,O
89839,6196,diseases,O
89840,6196,that,O
89841,6196,the,O
89842,6196,investigator,O
89843,6196,judges,O
89844,6196,to,O
89845,6196,be,O
89846,6196,inappropriate,O
89847,6196,.,O
89848,6197,Subjects,O
89849,6197,who,O
89850,6197,voluntarily,O
89851,6197,consented,O
89852,6197,",",O
89853,6197,after,O
89854,6197,listening,O
89855,6197,enough,O
89856,6197,explanation,O
89857,6197,for,O
89858,6197,this,O
89859,6197,study,O
89860,6197,and,O
89861,6197,investigational,O
89862,6197,product,O
89863,6197,.,O
89864,6198,Adult,B-Person
89865,6198,over,O
89866,6198,50,O
89867,6198,years,O
89868,6198,of,O
89869,6198,age,B-Person
89870,6198,.,O
89871,6199,At,O
89872,6199,least,O
89873,6199,one,O
89874,6199,of,O
89875,6199,the,O
89876,6199,knee,B-Condition
89877,6199,pain,I-Condition
89878,6199,VAS,O
89879,6199,score,O
89880,6199,is,O
89881,6199,40,O
89882,6199,mm,O
89883,6199,or,O
89884,6199,more,O
89885,6199,.,O
89886,6200,Patients,O
89887,6200,who,O
89888,6200,require,O
89889,6200,medication,B-Drug
89890,6200,for,O
89891,6200,more,O
89892,6200,than,O
89893,6200,12,O
89894,6200,weeks,O
89895,6200,due,O
89896,6200,to,O
89897,6200,osteoarthritis,B-Condition
89898,6200,symptoms,I-Condition
89899,6200,.,O
89900,6201,Those,O
89901,6201,who,O
89902,6201,are,O
89903,6201,able,O
89904,6201,to,O
89905,6201,follow,O
89906,6201,the,O
89907,6201,requirements,O
89908,6201,of,O
89909,6201,this,O
89910,6201,clinical,O
89911,6201,trial,O
89912,6201,",",O
89913,6201,such,O
89914,6201,as,O
89915,6201,being,O
89916,6201,able,O
89917,6201,to,O
89918,6201,trace,O
89919,6201,during,O
89920,6201,the,O
89921,6201,clinical,O
89922,6201,trial,O
89923,6201,period,O
89924,6201,and,O
89925,6201,to,O
89926,6201,read,O
89927,6201,and,O
89928,6201,write,O
89929,6201,the,O
89930,6201,VAS,O
89931,6201,questionnaire,O
89932,6201,.,O
89933,6202,Those,O
89934,6202,who,O
89935,6202,weigh,O
89936,6202,more,O
89937,6202,than,O
89938,6202,40,O
89939,6202,kg,O
89940,6203,beta,B-Drug
89941,6203,blocker,I-Drug
89942,6204,supraventricular,B-Condition
89943,6204,rhythm,I-Condition
89944,6204,disorder,I-Condition
89945,6205,previous,O
89946,6205,history,O
89947,6205,of,O
89948,6205,respiratory,B-Condition
89949,6205,disease,I-Condition
89950,6205,other,O
89951,6205,than,O
89952,6205,COPD,B-Condition
89953,6206,diabetes,B-Condition
89954,6207,autonomic,B-Condition
89955,6207,dysfunction,I-Condition
89956,6208,dysautonomia,B-Condition
89957,6209,renal,B-Condition
89958,6209,failure,I-Condition
89959,6210,long,B-Procedure
89960,6210,-,I-Procedure
89961,6210,term,I-Procedure
89962,6210,oxygen,I-Procedure
89963,6210,therapy,I-Procedure
89964,6211,history,B-Observation
89965,6211,of,O
89966,6211,psychiatric,B-Condition
89967,6211,illness,I-Condition
89968,6212,patients,O
89969,6212,with,O
89970,6212,FEV1,O
89971,6212,/,O
89972,6212,FVC,O
89973,6212,<,O
89974,6212,70,O
89975,6212,%,O
89976,6213,Diagnosis,O
89977,6213,of,O
89978,6213,primary,O
89979,6213,progressive,B-Condition
89980,6213,MS,I-Condition
89981,6214,Inability,B-Mood
89982,6214,to,I-Mood
89983,6214,complete,I-Mood
89984,6214,an,O
89985,6214,MRI,B-Procedure
89986,6214,(,O
89987,6214,contraindications,B-Condition
89988,6214,for,O
89989,6214,MRI,B-Procedure
89990,6214,include,O
89991,6214,but,O
89992,6214,are,O
89993,6214,not,O
89994,6214,restricted,O
89995,6214,to,O
89996,6214,weight,O
89997,6214,=,O
89998,6214,140,O
89999,6214,kg,O
90000,6214,",",O
90001,6214,pacemaker,O
90002,6214,",",O
90003,6214,cochlear,O
90004,6214,implants,O
90005,6214,",",O
90006,6214,presence,O
90007,6214,of,O
90008,6214,foreign,O
90009,6214,substances,O
90010,6214,in,O
90011,6214,the,O
90012,6214,eye,O
90013,6214,",",O
90014,6214,intracranial,O
90015,6214,vascular,O
90016,6214,clips,O
90017,6214,",",O
90018,6214,surgery,B-Procedure
90019,6214,within,O
90020,6214,6,O
90021,6214,weeks,O
90022,6214,of,O
90023,6214,entry,O
90024,6214,into,O
90025,6214,the,O
90026,6214,study,O
90027,6214,",",O
90028,6214,coronary,O
90029,6214,stent,O
90030,6214,implanted,B-Procedure
90031,6214,within,O
90032,6214,8,O
90033,6214,weeks,O
90034,6214,prior,O
90035,6214,to,O
90036,6214,the,O
90037,6214,time,O
90038,6214,of,O
90039,6214,the,O
90040,6214,intended,B-Mood
90041,6214,MRI,B-Procedure
90042,6214,",",O
90043,6214,etc,O
90044,6214,…,O
90045,6214,),O
90046,6215,Gadolinium,B-Drug
90047,6215,intolerance,B-Condition
90048,6216,History,O
90049,6216,of,O
90050,6216,ischemic,B-Condition
90051,6216,cerebrovascular,I-Condition
90052,6216,disorders,I-Condition
90053,6216,(,O
90054,6216,e.g.,O
90055,6216,",",O
90056,6216,stroke,B-Condition
90057,6216,",",O
90058,6216,transient,B-Condition
90059,6216,ischemic,I-Condition
90060,6216,attack,I-Condition
90061,6216,),O
90062,6216,or,O
90063,6216,ischemia,B-Condition
90064,6216,of,I-Condition
90065,6216,the,I-Condition
90066,6216,spinal,I-Condition
90067,6216,cord,I-Condition
90068,6217,History,O
90069,6217,or,O
90070,6217,known,O
90071,6217,presence,O
90072,6217,of,O
90073,6217,central,B-Condition
90074,6217,nervous,I-Condition
90075,6217,system,I-Condition
90076,6217,(,I-Condition
90077,6217,CNS,I-Condition
90078,6217,),I-Condition
90079,6217,or,I-Condition
90080,6217,spinal,I-Condition
90081,6217,cord,I-Condition
90082,6217,tumor,I-Condition
90083,6217,(,O
90084,6217,e.g.,O
90085,6217,",",O
90086,6217,meningioma,B-Condition
90087,6217,",",O
90088,6217,glioma,B-Condition
90089,6217,),O
90090,6218,History,O
90091,6218,or,O
90092,6218,known,O
90093,6218,presence,O
90094,6218,of,O
90095,6218,potential,O
90096,6218,metabolic,B-Condition
90097,6218,causes,I-Condition
90098,6218,of,O
90099,6218,myelopathy,B-Condition
90100,6218,(,O
90101,6218,e.g.,O
90102,6218,",",O
90103,6218,untreated,O
90104,6218,vitamin,B-Condition
90105,6218,B12,I-Condition
90106,6218,deficiency,I-Condition
90107,6218,),O
90108,6219,History,O
90109,6219,or,O
90110,6219,known,O
90111,6219,presence,O
90112,6219,of,O
90113,6219,infectious,B-Condition
90114,6219,causes,I-Condition
90115,6219,of,O
90116,6219,myelopathy,B-Condition
90117,6219,(,O
90118,6219,e.g.,O
90119,6219,",",O
90120,6219,syphilis,B-Condition
90121,6219,",",O
90122,6219,Lyme,B-Condition
90123,6219,disease,I-Condition
90124,6219,",",O
90125,6219,human,B-Condition
90126,6219,T,I-Condition
90127,6219,-,I-Condition
90128,6219,lymphotropic,I-Condition
90129,6219,virus,I-Condition
90130,6219,1,I-Condition
90131,6219,(,I-Condition
90132,6219,HTLV-1,I-Condition
90133,6219,),I-Condition
90134,6219,",",O
90135,6219,herpes,B-Condition
90136,6219,zoster,I-Condition
90137,6219,myelopathy,I-Condition
90138,6219,),O
90139,6220,History,O
90140,6220,of,O
90141,6220,genetically,O
90142,6220,inherited,O
90143,6220,progressive,B-Condition
90144,6220,CNS,I-Condition
90145,6220,degenerative,I-Condition
90146,6220,disorder,I-Condition
90147,6220,(,O
90148,6220,e.g.,O
90149,6220,",",O
90150,6220,hereditary,B-Condition
90151,6220,paraparesis,I-Condition
90152,6220,;,O
90153,6220,MELAS,B-Condition
90154,6220,[,I-Condition
90155,6220,mitochondrial,I-Condition
90156,6220,myopathy,I-Condition
90157,6220,",",I-Condition
90158,6220,encephalopathy,I-Condition
90159,6220,",",I-Condition
90160,6220,lactic,I-Condition
90161,6220,acidosis,I-Condition
90162,6220,",",I-Condition
90163,6220,stroke,I-Condition
90164,6220,],I-Condition
90165,6220,syndrome,I-Condition
90166,6220,),O
90167,6221,Neuromyelitis,B-Condition
90168,6221,optica,I-Condition
90169,6222,History,B-Observation
90170,6222,or,O
90171,6222,known,O
90172,6222,presence,O
90173,6222,of,O
90174,6222,systemic,B-Condition
90175,6222,autoimmune,I-Condition
90176,6222,disorders,I-Condition
90177,6222,potentially,B-Mood
90178,6222,causing,I-Mood
90179,6222,progressive,B-Condition
90180,6222,neurologic,I-Condition
90181,6222,disease,I-Condition
90182,6222,(,O
90183,6222,e.g.,O
90184,6222,",",O
90185,6222,lupus,B-Condition
90186,6222,",",O
90187,6222,anti,B-Condition
90188,6222,-,I-Condition
90189,6222,phospholipid,I-Condition
90190,6222,antibody,I-Condition
90191,6222,syndrome,I-Condition
90192,6222,",",O
90193,6222,Sjogren,B-Condition
90194,6222,'s,I-Condition
90195,6222,syndrome,I-Condition
90196,6222,",",O
90197,6222,Behçet,B-Condition
90198,6222,'s,I-Condition
90199,6222,disease,I-Condition
90200,6222,",",O
90201,6222,sarcoidosis,B-Condition
90202,6222,),O
90203,6223,History,O
90204,6223,of,O
90205,6223,severe,O
90206,6223,",",O
90207,6223,clinically,O
90208,6223,significant,O
90209,6223,brain,B-Condition
90210,6223,or,I-Condition
90211,6223,spinal,I-Condition
90212,6223,cord,I-Condition
90213,6223,trauma,I-Condition
90214,6223,(,O
90215,6223,e.g.,O
90216,6223,",",O
90217,6223,cerebral,B-Condition
90218,6223,contusion,I-Condition
90219,6223,",",O
90220,6223,spinal,B-Condition
90221,6223,cord,I-Condition
90222,6223,compression,I-Condition
90223,6223,),O
90224,6224,Vulnerable,B-Observation
90225,6224,patients,I-Observation
90226,6224,(,O
90227,6224,Patient,O
90228,6224,referred,O
90229,6224,to,O
90230,6224,in,O
90231,6224,Articles,O
90232,6224,L.,O
90233,6224,1121,O
90234,6224,-,O
90235,6224,5,O
90236,6224,to,O
90237,6224,L.,O
90238,6224,1121,O
90239,6224,-,O
90240,6224,8,O
90241,6224,and,O
90242,6224,L.,O
90243,6224,1122,O
90244,6224,-,O
90245,6224,1,O
90246,6224,-,O
90247,6224,2,O
90248,6224,of,O
90249,6224,the,O
90250,6224,French,O
90251,6224,Public,O
90252,6224,Health,O
90253,6224,Code,O
90254,6224,),O
90255,6225,Age,B-Person
90256,6225,>,O
90257,6225,/=18,O
90258,6225,years,O
90259,6225,at,O
90260,6225,screening,O
90261,6226,Patients,O
90262,6226,with,O
90263,6226,relapsing,O
90264,6226,forms,O
90265,6226,of,O
90266,6226,multiple,B-Condition
90267,6226,sclerosis,I-Condition
90268,6226,(,I-Condition
90269,6226,RMS,I-Condition
90270,6226,),I-Condition
90271,6226,with,O
90272,6226,active,O
90273,6226,disease,O
90274,6226,defined,O
90275,6226,by,O
90276,6226,clinical,B-Observation
90277,6226,or,I-Observation
90278,6226,imaging,I-Observation
90279,6226,features,I-Observation
90280,6226,:,O
90281,6226,(,O
90282,6226,i,O
90283,6226,),O
90284,6226,at,O
90285,6226,least,O
90286,6226,one,O
90287,6226,clinical,B-Condition
90288,6226,relapse,I-Condition
90289,6226,over,O
90290,6226,a,O
90291,6226,6,O
90292,6226,-,O
90293,6226,month,O
90294,6226,period,O
90295,6226,prior,O
90296,6226,to,O
90297,6226,screening,O
90298,6226,;,O
90299,6226,(,O
90300,6226,ii,O
90301,6226,),O
90302,6226,AND,O
90303,6226,/,O
90304,6226,OR,O
90305,6226,at,O
90306,6226,least,O
90307,6226,one,O
90308,6226,T1,B-Condition
90309,6226,gadolinium,I-Condition
90310,6226,-,I-Condition
90311,6226,enhancing,I-Condition
90312,6226,lesion,I-Condition
90313,6226,or,O
90314,6226,new,O
90315,6226,and/or,O
90316,6226,enlarging,O
90317,6226,T2,B-Condition
90318,6226,lesion,I-Condition
90319,6226,as,O
90320,6226,detected,O
90321,6226,by,O
90322,6226,brain,B-Procedure
90323,6226,Magnetic,I-Procedure
90324,6226,Resonance,I-Procedure
90325,6226,Imaging,I-Procedure
90326,6226,(,I-Procedure
90327,6226,MRI,I-Procedure
90328,6226,),I-Procedure
90329,6226,performed,O
90330,6226,over,O
90331,6226,a,O
90332,6226,3,O
90333,6226,months,O
90334,6226,period,O
90335,6226,prior,O
90336,6226,to,O
90337,6226,screening,O
90338,6226,with,O
90339,6226,no,O
90340,6226,change,O
90341,6226,of,O
90342,6226,Disease,B-Procedure
90343,6226,-,I-Procedure
90344,6226,Modifying,I-Procedure
90345,6226,Treatment(s,I-Procedure
90346,6226,),I-Procedure
90347,6226,(,I-Procedure
90348,6226,DMT,I-Procedure
90349,6226,),I-Procedure
90350,6226,compared,O
90351,6226,to,O
90352,6226,a,O
90353,6226,previous,O
90354,6226,MRI,O
90355,6226,performed,O
90356,6226,within,O
90357,6226,24,O
90358,6226,months,O
90359,6226,before,O
90360,6226,screening,O
90361,6227,For,O
90362,6227,women,O
90363,6227,of,O
90364,6227,childbearing,O
90365,6227,potential,O
90366,6227,:,O
90367,6227,agreement,O
90368,6227,to,O
90369,6227,use,O
90370,6227,an,O
90371,6227,acceptable,O
90372,6227,birth,O
90373,6227,control,O
90374,6227,method,O
90375,6227,during,O
90376,6227,the,O
90377,6227,treatment,O
90378,6227,period,O
90379,6227,and,O
90380,6227,for,O
90381,6227,at,O
90382,6227,least,O
90383,6227,12,O
90384,6227,months,O
90385,6227,after,O
90386,6227,the,O
90387,6227,last,O
90388,6227,dose,O
90389,6227,of,O
90390,6227,ocrelizumab,O
90391,6228,Participants,O
90392,6228,should,O
90393,6228,be,O
90394,6228,beneficiary,B-Observation
90395,6228,of,I-Observation
90396,6228,healthcare,I-Observation
90397,6228,coverage,I-Observation
90398,6228,under,O
90399,6228,the,O
90400,6228,social,O
90401,6228,security,O
90402,6228,system,O
90403,6229,NA,O
90404,6230,Subject,O
90405,6230,must,O
90406,6230,be,O
90407,6230,at,O
90408,6230,least,O
90409,6230,30,O
90410,6230,years,O
90411,6230,of,O
90412,6230,age,B-Person
90413,6230,.,O
90414,6231,Subject,O
90415,6231,is,O
90416,6231,able,O
90417,6231,to,O
90418,6231,verbally,O
90419,6231,confirm,O
90420,6231,understandings,O
90421,6231,of,O
90422,6231,risks,O
90423,6231,",",O
90424,6231,benefits,O
90425,6231,and,O
90426,6231,treatment,O
90427,6231,alternatives,O
90428,6231,of,O
90429,6231,receiving,O
90430,6231,the,O
90431,6231,Vitamin,O
90432,6231,C+E,O
90433,6231,or,O
90434,6231,Statin,O
90435,6231,or,O
90436,6231,Dual,O
90437,6231,",",O
90438,6231,and,O
90439,6231,he,O
90440,6231,/,O
90441,6231,she,O
90442,6231,or,O
90443,6231,his,O
90444,6231,/,O
90445,6231,her,O
90446,6231,legally,O
90447,6231,authorized,O
90448,6231,representative,O
90449,6231,provides,O
90450,6231,written,O
90451,6231,informed,O
90452,6231,consent,O
90453,6231,prior,O
90454,6231,to,O
90455,6231,any,O
90456,6231,study,O
90457,6231,related,O
90458,6231,procedure,O
90459,6231,.,O
90460,6232,Subject,O
90461,6232,must,O
90462,6232,have,O
90463,6232,symptoms,B-Condition
90464,6232,that,O
90465,6232,are,O
90466,6232,consistent,O
90467,6232,with,O
90468,6232,vasospastic,B-Condition
90469,6232,angina,I-Condition
90470,6232,with,O
90471,6232,planned,B-Mood
90472,6232,Coronary,B-Procedure
90473,6232,angiography,I-Procedure
90474,6232,and,O
90475,6232,Provocation,B-Procedure
90476,6232,test,I-Procedure
90477,6232,.,O
90478,6233,NA,O
90479,6234,Written,O
90480,6234,informed,O
90481,6234,consent,O
90482,6234,prior,O
90483,6234,to,O
90484,6234,beginning,O
90485,6234,specific,O
90486,6234,protocol,O
90487,6234,procedures,O
90488,6234,",",O
90489,6234,including,O
90490,6234,expected,O
90491,6234,cooperation,O
90492,6234,of,O
90493,6234,the,O
90494,6234,patients,O
90495,6234,for,O
90496,6234,the,O
90497,6234,treatment,O
90498,6234,and,O
90499,6234,follow,O
90500,6234,-,O
90501,6234,up,O
90502,6234,",",O
90503,6234,willingness,O
90504,6234,and,O
90505,6234,ability,O
90506,6234,to,O
90507,6234,complete,O
90508,6234,collection,O
90509,6234,of,O
90510,6234,data,O
90511,6234,via,O
90512,6234,wearable,O
90513,6234,device,O
90514,6234,and,O
90515,6234,study,O
90516,6234,mobile,O
90517,6234,must,O
90518,6234,be,O
90519,6234,obtained,O
90520,6234,and,O
90521,6234,documented,O
90522,6234,according,O
90523,6234,to,O
90524,6234,the,O
90525,6234,local,O
90526,6234,regulatory,O
90527,6234,requirements,O
90528,6234,.,O
90529,6235,Female,B-Person
90530,6235,or,O
90531,6235,male,B-Person
90532,6235,patients,O
90533,6235,.,O
90534,6236,Age,B-Person
90535,6236,=,O
90536,6236,18,O
90537,6236,years,O
90538,6236,old,O
90539,6236,.,O
90540,6237,Metastatic,O
90541,6237,invasive,O
90542,6237,hormone,O
90543,6237,receptor,O
90544,6237,positive,O
90545,6237,and,O
90546,6237,HER2,O
90547,6237,negative,O
90548,6237,breast,B-Condition
90549,6237,cancer,I-Condition
90550,6237,(,O
90551,6237,histologically,O
90552,6237,confirmed,O
90553,6237,),O
90554,6237,.,O
90555,6238,Patients,O
90556,6238,who,O
90557,6238,in,O
90558,6238,the,O
90559,6238,opinion,O
90560,6238,of,O
90561,6238,the,O
90562,6238,treating,O
90563,6238,physician,O
90564,6238,are,O
90565,6238,candidates,O
90566,6238,suitable,O
90567,6238,for,O
90568,6238,randomization,O
90569,6238,for,O
90570,6238,mono,O
90571,6238,-,O
90572,6238,chemotherapy,O
90573,6238,treatment,O
90574,6238,",",O
90575,6238,that,O
90576,6238,has,O
90577,6238,either,O
90578,6238,an,O
90579,6238,approved,O
90580,6238,label,O
90581,6238,in,O
90582,6238,Europe,O
90583,6238,and/or,O
90584,6238,is,O
90585,6238,supported,O
90586,6238,by,O
90587,6238,guidelines,O
90588,6238,for,O
90589,6238,the,O
90590,6238,treatment,O
90591,6238,of,O
90592,6238,first,O
90593,6238,-,O
90594,6238,line,O
90595,6238,advanced,O
90596,6238,BC,O
90597,6238,",",O
90598,6238,which,O
90599,6238,are,O
90600,6238,based,O
90601,6238,on,O
90602,6238,evidence,O
90603,6238,on,O
90604,6238,safety,O
90605,6238,and,O
90606,6238,efficacy,O
90607,6238,in,O
90608,6238,this,O
90609,6238,setting,O
90610,6238,.,O
90611,6239,Symptomatic,O
90612,6239,or,O
90613,6239,asymptomatic,O
90614,6239,metastatic,B-Condition
90615,6239,breast,I-Condition
90616,6239,cancer,I-Condition
90617,6239,.,O
90618,6240,Resolution,B-Observation
90619,6240,of,O
90620,6240,all,O
90621,6240,acute,B-Condition
90622,6240,toxic,I-Condition
90623,6240,effects,I-Condition
90624,6240,of,O
90625,6240,prior,O
90626,6240,anti,B-Procedure
90627,6240,-,I-Procedure
90628,6240,cancer,I-Procedure
90629,6240,therapy,I-Procedure
90630,6240,or,O
90631,6240,surgical,B-Procedure
90632,6240,procedures,I-Procedure
90633,6240,to,O
90634,6240,NCI,O
90635,6240,CTCAE,O
90636,6240,version,O
90637,6240,4.0,O
90638,6240,grade,O
90639,6240,=,O
90640,6240,1,O
90641,6240,(,O
90642,6240,except,O
90643,6240,alopecia,B-Condition
90644,6240,or,O
90645,6240,other,O
90646,6240,toxicities,O
90647,6240,not,O
90648,6240,considered,O
90649,6240,a,O
90650,6240,safety,O
90651,6240,risk,O
90652,6240,for,O
90653,6240,the,O
90654,6240,patient,O
90655,6240,at,O
90656,6240,investigator,O
90657,6240,'s,O
90658,6240,discretion,O
90659,6240,),O
90660,6240,.,O
90661,6241,Life,B-Observation
90662,6241,-,I-Observation
90663,6241,expectancy,I-Observation
90664,6241,>,O
90665,6241,6,O
90666,6241,months,O
90667,6241,.,O
90668,6242,For,O
90669,6242,female,O
90670,6242,patients,O
90671,6242,:,O
90672,6242,The,O
90673,6242,patients,O
90674,6242,need,O
90675,6242,to,O
90676,6242,be,O
90677,6242,either,O
90678,6242,A,O
90679,6242,),O
90680,6242,of,O
90681,6242,non,O
90682,6242,-,O
90683,6242,childbearing,O
90684,6242,potential,O
90685,6242,(,O
90686,6242,documented,O
90687,6242,postmenopausal,O
90688,6242,or,O
90689,6242,post,O
90690,6242,hysterectomy,O
90691,6242,),O
90692,6242,B,O
90693,6242,),O
90694,6242,childbearing,O
90695,6242,potential,O
90696,6242,with,O
90697,6242,negative,O
90698,6242,serum,O
90699,6242,or,O
90700,6242,urinary,O
90701,6242,pregnancy,O
90702,6242,test,O
90703,6242,(,O
90704,6242,in,O
90705,6242,this,O
90706,6242,case,O
90707,6242,patients,O
90708,6242,need,O
90709,6242,to,O
90710,6242,use,O
90711,6242,highly,O
90712,6242,effective,O
90713,6242,non,O
90714,6242,-,O
90715,6242,hormonal,O
90716,6242,contraceptive,O
90717,6242,methods,O
90718,6242,),O
90719,6242,.,O
90720,6243,NA,O
90721,6244,Subject,O
90722,6244,'s,O
90723,6244,age,B-Person
90724,6244,is,O
90725,6244,between,O
90726,6244,=,O
90727,6244,12,O
90728,6244,and,O
90729,6244,16,O
90730,6244,years,O
90731,6244,",",O
90732,6244,inclusive,O
90733,6245,Subject,O
90734,6245,is,O
90735,6245,scheduled,B-Observation
90736,6245,for,I-Observation
90737,6245,a,I-Observation
90738,6245,procedure,I-Observation
90739,6245,that,O
90740,6245,requires,O
90741,6245,general,B-Procedure
90742,6245,or,I-Procedure
90743,6245,neuraxial,I-Procedure
90744,6245,anesthesia,I-Procedure
90745,6246,Subjects,O
90746,6246,must,O
90747,6246,have,O
90748,6246,normal,O
90749,6246,or,O
90750,6246,clinically,O
90751,6246,acceptable,O
90752,6246,physical,B-Procedure
90753,6246,exam,I-Procedure
90754,6247,Subjects,O
90755,6247,with,O
90756,6247,controlled,O
90757,6247,diabetes,B-Condition
90758,6247,prior,O
90759,6247,to,O
90760,6247,entry,O
90761,6247,must,O
90762,6247,have,O
90763,6247,a,O
90764,6247,mean,B-Condition
90765,6247,systolic,I-Condition
90766,6247,/,I-Condition
90767,6247,diastolic,I-Condition
90768,6247,office,I-Condition
90769,6247,blood,I-Condition
90770,6247,pressure,I-Condition
90771,6247,=,O
90772,6247,128/78,O
90773,6247,mmHg,O
90774,6247,(,O
90775,6247,sitting,O
90776,6247,",",O
90777,6247,after,O
90778,6247,5,O
90779,6247,minutes,O
90780,6247,of,O
90781,6247,rest,O
90782,6247,),O
90783,6248,Females,O
90784,6248,must,O
90785,6248,have,O
90786,6248,a,O
90787,6248,urine,O
90788,6248,or,O
90789,6248,serum,O
90790,6248,pregnancy,O
90791,6248,test,O
90792,6248,(,O
90793,6248,Human,O
90794,6248,Chorionic,O
90795,6248,Gonadotropin,O
90796,6248,),O
90797,6248,that,O
90798,6248,is,O
90799,6248,negative,O
90800,6248,at,O
90801,6248,Screening,O
90802,6248,and,O
90803,6248,Day,O
90804,6248,1,O
90805,6249,Subject,O
90806,6249,'s,O
90807,6249,parent,O
90808,6249,or,O
90809,6249,legal,O
90810,6249,guardian,O
90811,6249,gives,O
90812,6249,informed,O
90813,6249,consent,O
90814,6249,and,O
90815,6249,subject,O
90816,6249,gives,O
90817,6249,assent,O
90818,6249,.,O
90819,6250,Patients,O
90820,6250,who,O
90821,6250,are,O
90822,6250,being,B-Mood
90823,6250,prepared,I-Mood
90824,6250,for,I-Mood
90825,6250,surgery,B-Procedure
90826,6250,",",O
90827,6250,or,O
90828,6250,during,O
90829,6250,or,O
90830,6250,after,O
90831,6250,surgery,O
90832,6250,.,O
90833,6251,Patients,O
90834,6251,with,O
90835,6251,congenital,B-Condition
90836,6251,anomalies,I-Condition
90837,6251,",",O
90838,6251,chromosomal,B-Condition
90839,6251,anomalies,I-Condition
90840,6251,",",O
90841,6251,or,O
90842,6251,heart,B-Condition
90843,6251,defects,I-Condition
90844,6251,.,O
90845,6252,Patients,O
90846,6252,whose,O
90847,6252,parents,O
90848,6252,refuse,O
90849,6252,to,O
90850,6252,consent,O
90851,6252,.,O
90852,6253,Nonsurgical,B-Condition
90853,6253,neonates,B-Person
90854,6253,and,O
90855,6253,babies,B-Person
90856,6253,up,O
90857,6253,to,O
90858,6253,age,B-Person
90859,6253,6,O
90860,6253,months,O
90861,6253,with,O
90862,6253,INR,O
90863,6253,1.5,O
90864,6253,or,O
90865,6253,more,O
90866,6253,who,O
90867,6253,are,O
90868,6253,deemed,O
90869,6253,clinically,O
90870,6253,to,O
90871,6253,need,B-Condition
90872,6253,plasma,B-Procedure
90873,6253,infusion,I-Procedure
90874,6253,.,O
90875,6254,General,O
90876,6254,danger,O
90877,6254,signs,O
90878,6254,or,O
90879,6254,symptoms,O
90880,6254,of,O
90881,6254,severe,O
90882,6254,malaria,B-Condition
90883,6255,Anaemia,B-Condition
90884,6255,",",O
90885,6255,defined,O
90886,6255,as,O
90887,6255,Hb,O
90888,6255,<,O
90889,6255,9g,O
90890,6255,/,O
90891,6255,dl,O
90892,6256,G6PD,B-Condition
90893,6256,deficiency,I-Condition
90894,6256,(,O
90895,6256,as,O
90896,6256,determined,O
90897,6256,by,O
90898,6256,FST,O
90899,6256,),O
90900,6257,Pregnant,O
90901,6257,women,O
90902,6257,as,O
90903,6257,determined,O
90904,6257,by,O
90905,6257,Urine,O
90906,6257,ß,O
90907,6257,-,O
90908,6257,HCG,O
90909,6257,pregnancy,O
90910,6257,test,O
90911,6258,Known,O
90912,6258,hypersensitivity,B-Condition
90913,6258,to,O
90914,6258,any,O
90915,6258,of,O
90916,6258,the,O
90917,6258,drugs,B-Drug
90918,6258,given,O
90919,6259,Infection,B-Condition
90920,6259,with,O
90921,6259,Plasmodium,O
90922,6259,falciparum,O
90923,6259,or,O
90924,6259,P.,O
90925,6259,vivax,O
90926,6259,either,O
90927,6259,alone,O
90928,6259,or,O
90929,6259,mixed,O
90930,6260,Age,B-Person
90931,6260,>,O
90932,6260,12,O
90933,6260,months,O
90934,6261,Weight,B-Person
90935,6261,>,O
90936,6261,5,O
90937,6261,kg,O
90938,6262,Living,O
90939,6262,in,O
90940,6262,the,O
90941,6262,study,O
90942,6262,clusters,O
90943,6263,signs,O
90944,6263,of,O
90945,6263,complicated,B-Condition
90946,6263,UTI,I-Condition
90947,6263,(,O
90948,6263,e.,O
90949,6263,g.,O
90950,6263,temperature,O
90951,6263,>,O
90952,6263,38,O
90953,6263,°,O
90954,6263,C,O
90955,6263,",",O
90956,6263,loin,B-Condition
90957,6263,tenderness,I-Condition
90958,6263,),O
90959,6264,conditions,B-Condition
90960,6264,that,O
90961,6264,may,O
90962,6264,lead,O
90963,6264,to,O
90964,6264,complicated,B-Condition
90965,6264,infections,I-Condition
90966,6264,(,O
90967,6264,i.e.,O
90968,6264,renal,B-Condition
90969,6264,diseases,I-Condition
90970,6264,",",O
90971,6264,patients,B-Person
90972,6264,with,O
90973,6264,urinary,O
90974,6264,catheter,O
90975,6264,),O
90976,6265,pregnancy/,O
90977,6265,breastfeeding,O
90978,6266,current,O
90979,6266,self,O
90980,6266,-,O
90981,6266,medication,O
90982,6266,with,O
90983,6266,UU,B-Drug
90984,6266,preparations,I-Drug
90985,6266,e.g.,O
90986,6266,z.,B-Drug
90987,6266,B.,I-Drug
90988,6266,Cystinol,I-Drug
90989,6266,®,I-Drug
90990,6266,",",O
90991,6266,Uvalysat,B-Drug
90992,6266,®,I-Drug
90993,6266,",",O
90994,6266,Arctuvan,B-Drug
90995,6266,®,I-Drug
90996,6267,antibiotic,B-Drug
90997,6267,use,O
90998,6267,in,O
90999,6267,the,O
91000,6267,last,O
91001,6267,7,O
91002,6267,days,O
91003,6268,previous,O
91004,6268,UTI,B-Condition
91005,6268,in,O
91006,6268,the,O
91007,6268,past,O
91008,6268,2,O
91009,6268,weeks,O
91010,6269,history,O
91011,6269,of,O
91012,6269,pyelonephritis,B-Condition
91013,6270,contraindications,B-Mood
91014,6270,for,I-Mood
91015,6270,trial,O
91016,6270,drugs,B-Drug
91017,6271,serious,O
91018,6271,diseases,B-Condition
91019,6272,inability,O
91020,6272,to,O
91021,6272,understand,O
91022,6272,trial,O
91023,6272,Information,O
91024,6273,current,O
91025,6273,participation,O
91026,6273,in,O
91027,6273,another,O
91028,6273,clinical,O
91029,6273,trial,O
91030,6273,or,O
91031,6273,participation,O
91032,6273,in,O
91033,6273,another,O
91034,6273,clinical,O
91035,6273,trial,O
91036,6273,within,O
91037,6273,the,O
91038,6273,last,O
91039,6273,4,O
91040,6273,weeks,O
91041,6274,Women,B-Person
91042,6274,(,O
91043,6274,18,O
91044,6274,-,O
91045,6274,75,O
91046,6274,years,B-Person
91047,6274,),O
91048,6274,with,O
91049,6274,suspected,O
91050,6274,UTI,B-Condition
91051,6275,at,O
91052,6275,least,O
91053,6275,two,O
91054,6275,symptoms,B-Condition
91055,6275,of,I-Condition
91056,6275,UTI,I-Condition
91057,6275,(,O
91058,6275,dysuria,B-Condition
91059,6275,",",O
91060,6275,urgency,B-Condition
91061,6275,of,I-Condition
91062,6275,micturition,I-Condition
91063,6275,",",O
91064,6275,frequency,B-Condition
91065,6275,",",O
91066,6275,lower,B-Condition
91067,6275,abdominal,I-Condition
91068,6275,pain,I-Condition
91069,6275,),O
91070,6276,Written,O
91071,6276,informed,O
91072,6276,consent,O
91073,6277,Adults,B-Person
91074,6277,older,O
91075,6277,than,O
91076,6277,45,O
91077,6277,and,O
91078,6277,children,B-Person
91079,6277,younger,O
91080,6277,than,O
91081,6277,18,O
91082,6277,years,O
91083,6278,Platelet,O
91084,6278,count,O
91085,6278,higher,O
91086,6278,than,O
91087,6278,30x109,O
91088,6278,/,O
91089,6278,l,O
91090,6278,at,O
91091,6278,time,O
91092,6278,of,O
91093,6278,screening,O
91094,6279,Suspicion,O
91095,6279,of,O
91096,6279,secondary,B-Condition
91097,6279,ITP,I-Condition
91098,6280,Positive,O
91099,6280,family,B-Observation
91100,6280,history,I-Observation
91101,6280,for,I-Observation
91102,6280,ITP,I-Observation
91103,6281,Presence,O
91104,6281,or,O
91105,6281,history,O
91106,6281,of,O
91107,6281,autoimmune,B-Condition
91108,6281,disease,I-Condition
91109,6281,as,O
91110,6281,judged,O
91111,6281,by,O
91112,6281,the,O
91113,6281,investigator,O
91114,6282,Hepatosplenomegaly,B-Condition
91115,6283,Presence,O
91116,6283,or,O
91117,6283,history,O
91118,6283,of,O
91119,6283,relevant,O
91120,6283,hepatic,B-Condition
91121,6283,disease,I-Condition
91122,6283,as,O
91123,6283,judged,O
91124,6283,by,O
91125,6283,the,O
91126,6283,investigator,O
91127,6284,Presence,O
91128,6284,or,O
91129,6284,history,O
91130,6284,of,O
91131,6284,thromboembolic,B-Condition
91132,6284,disease,I-Condition
91133,6284,as,O
91134,6284,judged,O
91135,6284,by,O
91136,6284,the,O
91137,6284,investigator,O
91138,6285,Patients,O
91139,6285,with,O
91140,6285,splenectomy,B-Procedure
91141,6286,Women,O
91142,6286,who,O
91143,6286,are,O
91144,6286,pregnant,O
91145,6286,or,O
91146,6286,breast,O
91147,6286,feeding,O
91148,6287,Intention,O
91149,6287,to,O
91150,6287,become,O
91151,6287,pregnant,O
91152,6287,during,O
91153,6287,the,O
91154,6287,course,O
91155,6287,of,O
91156,6287,the,O
91157,6287,study,O
91158,6288,Lack,O
91159,6288,of,O
91160,6288,safe,O
91161,6288,double,O
91162,6288,contraception,O
91163,6288,(,O
91164,6288,see,O
91165,6288,7.1,O
91166,6288,),O
91167,6289,Any,O
91168,6289,vaccination,B-Procedure
91169,6289,2,O
91170,6289,weeks,O
91171,6289,prior,O
91172,6289,start,O
91173,6289,of,O
91174,6289,the,O
91175,6289,study,O
91176,6290,Drugs,O
91177,6290,with,O
91178,6290,a,O
91179,6290,known,O
91180,6290,impact,O
91181,6290,on,O
91182,6290,the,O
91183,6290,immune,O
91184,6290,system,O
91185,6290,or,O
91186,6290,on,O
91187,6290,platelet,O
91188,6290,function,O
91189,6290,must,O
91190,6290,be,O
91191,6290,recorded,O
91192,6290,and,O
91193,6290,an,O
91194,6290,exclusion,O
91195,6290,of,O
91196,6290,the,O
91197,6290,study,O
91198,6290,should,O
91199,6290,be,O
91200,6290,discussed,O
91201,6290,with,O
91202,6290,the,O
91203,6290,study,O
91204,6290,center,O
91205,6291,Known,O
91206,6291,or,O
91207,6291,suspected,O
91208,6291,non,O
91209,6291,-,O
91210,6291,compliance,O
91211,6291,",",O
91212,6291,drug,B-Condition
91213,6291,or,I-Condition
91214,6291,alcohol,I-Condition
91215,6291,abuse,I-Condition
91216,6292,Inability,O
91217,6292,to,O
91218,6292,follow,O
91219,6292,the,O
91220,6292,procedures,O
91221,6292,of,O
91222,6292,the,O
91223,6292,study,O
91224,6292,",",O
91225,6292,e.g.,O
91226,6292,due,O
91227,6292,to,O
91228,6292,language,O
91229,6292,problems,O
91230,6292,",",O
91231,6292,psychological,O
91232,6292,disorders,O
91233,6292,",",O
91234,6292,dementia,O
91235,6292,of,O
91236,6292,the,O
91237,6292,study,O
91238,6292,subject,O
91239,6293,Participation,O
91240,6293,in,O
91241,6293,another,O
91242,6293,study,O
91243,6293,with,O
91244,6293,investigational,O
91245,6293,drug,O
91246,6293,within,O
91247,6293,the,O
91248,6293,30,O
91249,6293,days,O
91250,6293,preceding,O
91251,6293,and,O
91252,6293,during,O
91253,6293,the,O
91254,6293,present,O
91255,6293,study,O
91256,6294,Previous,O
91257,6294,enrolment,O
91258,6294,into,O
91259,6294,the,O
91260,6294,current,O
91261,6294,study,O
91262,6295,Previous,O
91263,6295,treatment,O
91264,6295,with,O
91265,6295,romiplostim,B-Drug
91266,6295,or,O
91267,6295,eltrombopag,B-Drug
91268,6296,Hypersensitivity,B-Condition
91269,6296,to,O
91270,6296,the,O
91271,6296,active,O
91272,6296,substance,O
91273,6296,or,O
91274,6296,to,O
91275,6296,any,O
91276,6296,of,O
91277,6296,the,O
91278,6296,excipients,O
91279,6296,or,O
91280,6296,to,O
91281,6296,E.,O
91282,6296,coli,O
91283,6296,derived,O
91284,6296,proteins,O
91285,6297,Enrolment,O
91286,6297,of,O
91287,6297,the,O
91288,6297,investigator,O
91289,6297,",",O
91290,6297,his,O
91291,6297,/,O
91292,6297,her,O
91293,6297,family,O
91294,6297,members,O
91295,6297,",",O
91296,6297,employees,O
91297,6297,and,O
91298,6297,other,O
91299,6297,dependent,O
91300,6297,persons,O
91301,6298,Informed,O
91302,6298,consent,O
91303,6298,as,O
91304,6298,documented,O
91305,6298,by,O
91306,6298,signature,O
91307,6298,(,O
91308,6298,see,O
91309,6298,informed,O
91310,6298,consent,O
91311,6298,form,O
91312,6298,),O
91313,6299,Primary,B-Condition
91314,6299,ITP,I-Condition
91315,6299,according,O
91316,6299,to,O
91317,6299,the,O
91318,6299,definition,O
91319,6299,of,O
91320,6299,Rodeghiero,O
91321,6299,et,O
91322,6299,al,O
91323,6299,.,O
91324,6299,(,O
91325,6299,52,O
91326,6299,),O
91327,6299,and,O
91328,6299,a,O
91329,6299,platelet,O
91330,6299,count,O
91331,6299,of,O
91332,6299,<,O
91333,6299,30x109,O
91334,6299,/,O
91335,6299,l,O
91336,6300,Age,B-Person
91337,6300,range,O
91338,6300,:,O
91339,6300,18,O
91340,6300,-,O
91341,6300,45,O
91342,6300,years,O
91343,6301,Previously,B-Observation
91344,6301,treated,I-Observation
91345,6301,patients,O
91346,6301,",",O
91347,6301,with,O
91348,6301,failure,O
91349,6301,or,O
91350,6301,intolerance,O
91351,6301,to,O
91352,6301,first,B-Procedure
91353,6301,-,I-Procedure
91354,6301,line,I-Procedure
91355,6301,therapy,I-Procedure
91356,6301,",",O
91357,6301,or,O
91358,6301,relapse,B-Condition
91359,6301,after,O
91360,6301,first,B-Procedure
91361,6301,-,I-Procedure
91362,6301,line,I-Procedure
91363,6301,therapy,I-Procedure
91364,6301,",",O
91365,6301,i.e.,O
91366,6301,corticosteroids,B-Drug
91367,6301,",",O
91368,6301,intravenous,B-Drug
91369,6301,immunoglobulin,I-Drug
91370,6301,(,O
91371,6301,IVIG,B-Drug
91372,6301,),O
91373,6301,",",O
91374,6301,or,O
91375,6301,anti,B-Drug
91376,6301,-,I-Drug
91377,6301,D,I-Drug
91378,6301,immunoglobulins,I-Drug
91379,6302,Patients,O
91380,6302,are,O
91381,6302,not,O
91382,6302,expected,B-Observation
91383,6302,to,I-Observation
91384,6302,be,I-Observation
91385,6302,alive,I-Observation
91386,6302,for,O
91387,6302,longer,O
91388,6302,than,O
91389,6302,3,O
91390,6302,months,O
91391,6302,.,O
91392,6303,Mini,O
91393,6303,-,O
91394,6303,mental,O
91395,6303,State,O
91396,6303,Examination,O
91397,6303,(,O
91398,6303,MMSE,O
91399,6303,),O
91400,6303,[,O
91401,6303,18,O
91402,6303,],O
91403,6303,score,O
91404,6303,=,O
91405,6303,23,O
91406,6303,.,O
91407,6304,history,O
91408,6304,of,O
91409,6304,dementia,B-Condition
91410,6304,",",O
91411,6304,psychiatric,B-Condition
91412,6304,illness,I-Condition
91413,6304,or,O
91414,6304,any,O
91415,6304,diseases,B-Condition
91416,6304,of,I-Condition
91417,6304,central,I-Condition
91418,6304,nervous,I-Condition
91419,6304,system,I-Condition
91420,6304,.,O
91421,6305,current,O
91422,6305,use,O
91423,6305,of,O
91424,6305,sedatives,B-Drug
91425,6305,or,O
91426,6305,antidepressant,B-Drug
91427,6305,.,O
91428,6306,alcoholism,B-Condition
91429,6306,and,O
91430,6306,drug,B-Condition
91431,6306,dependence,I-Condition
91432,6306,.,O
91433,6307,patients,O
91434,6307,previously,O
91435,6307,included,O
91436,6307,in,O
91437,6307,this,O
91438,6307,study,O
91439,6307,(,O
91440,6307,for,O
91441,6307,patients,O
91442,6307,who,O
91443,6307,have,O
91444,6307,second,O
91445,6307,intra,O
91446,6307,-,O
91447,6307,abdominal,O
91448,6307,surgery,O
91449,6307,during,O
91450,6307,the,O
91451,6307,study,O
91452,6307,period,O
91453,6307,),O
91454,6307,.,O
91455,6308,difficult,O
91456,6308,to,O
91457,6308,follow,O
91458,6308,up,O
91459,6308,or,O
91460,6308,patients,O
91461,6308,with,O
91462,6308,poor,O
91463,6308,compliance,O
91464,6308,.,O
91465,6309,uncontrolled,B-Condition
91466,6309,hypertension,I-Condition
91467,6309,(,O
91468,6309,>,O
91469,6309,180/100,O
91470,6309,mmHg,O
91471,6309,),O
91472,6310,major,O
91473,6310,elective,O
91474,6310,gastrointestinal,B-Procedure
91475,6310,",",I-Procedure
91476,6310,gynecological,I-Procedure
91477,6310,",",I-Procedure
91478,6310,prostate,I-Procedure
91479,6310,or,I-Procedure
91480,6310,bladder,I-Procedure
91481,6310,surgery,I-Procedure
91482,6310,patients,O
91483,6310,who,O
91484,6310,are,O
91485,6310,=,O
91486,6310,60,O
91487,6310,years,O
91488,6310,old,B-Person
91489,6310,.,O
91490,6311,the,O
91491,6311,surgery,O
91492,6311,is,O
91493,6311,laparoscopic,B-Procedure
91494,6311,surgery,I-Procedure
91495,6311,and,O
91496,6311,is,O
91497,6311,expected,B-Mood
91498,6311,to,O
91499,6311,last,O
91500,6311,for,O
91501,6311,=,O
91502,6311,2,O
91503,6311,hours,O
91504,6311,under,O
91505,6311,general,O
91506,6311,anesthesia,O
91507,6311,and,O
91508,6311,the,O
91509,6311,patient,O
91510,6311,will,B-Mood
91511,6311,stay,B-Procedure
91512,6311,in,I-Procedure
91513,6311,hospital,I-Procedure
91514,6311,for,O
91515,6311,at,O
91516,6311,least,O
91517,6311,7,O
91518,6311,days,O
91519,6311,after,O
91520,6311,surgery,O
91521,6311,.,O
91522,6312,lack,O
91523,6312,of,O
91524,6312,serious,O
91525,6312,hearing,B-Condition
91526,6312,and,I-Condition
91527,6312,vision,I-Condition
91528,6312,impairment,I-Condition
91529,6312,and,O
91530,6312,be,O
91531,6312,able,B-Condition
91532,6312,to,I-Condition
91533,6312,read,I-Condition
91534,6312,so,O
91535,6312,that,O
91536,6312,neurobehavioral,B-Procedure
91537,6312,tests,I-Procedure
91538,6312,can,B-Mood
91539,6312,be,I-Mood
91540,6312,performed,I-Mood
91541,6312,.,O
91542,6313,Congestive,B-Condition
91543,6313,heart,I-Condition
91544,6313,failure,I-Condition
91545,6314,Ischemic,B-Condition
91546,6314,heart,I-Condition
91547,6314,disease,I-Condition
91548,6315,Hypotension,B-Condition
91549,6315,(,O
91550,6315,Systolic,O
91551,6315,blood,O
91552,6315,pressure,O
91553,6315,<,O
91554,6315,100,O
91555,6315,mmHg,O
91556,6315,),O
91557,6316,Treatment,O
91558,6316,with,O
91559,6316,class,O
91560,6316,I,O
91561,6316,or,O
91562,6316,III,O
91563,6316,antiarrhythmic,B-Drug
91564,6316,drugs,I-Drug
91565,6317,Severe,O
91566,6317,hepatic,B-Condition
91567,6317,or,I-Condition
91568,6317,renal,I-Condition
91569,6317,failure,I-Condition
91570,6318,Pregnancy,B-Condition
91571,6318,or,O
91572,6318,lactation,B-Condition
91573,6319,Hypersensitivity,B-Condition
91574,6319,or,O
91575,6319,contradictions,B-Condition
91576,6319,to,O
91577,6319,study,B-Drug
91578,6319,drugs,I-Drug
91579,6320,Atrio,B-Condition
91580,6320,-,I-Condition
91581,6320,ventricular,I-Condition
91582,6320,conduction,I-Condition
91583,6320,disturbances,I-Condition
91584,6321,Thyrotoxicosis,B-Condition
91585,6322,Life,B-Condition
91586,6322,limiting,I-Condition
91587,6322,disease,I-Condition
91588,6322,or,O
91589,6322,substance,B-Condition
91590,6322,abuse,I-Condition
91591,6322,which,O
91592,6322,may,O
91593,6322,affect,O
91594,6322,participation,O
91595,6323,Above,O
91596,6323,18,O
91597,6323,years,O
91598,6323,of,O
91599,6323,age,B-Person
91600,6324,Symptomatic,O
91601,6324,",",O
91602,6324,permanent,O
91603,6324,AF,B-Condition
91604,6324,of,O
91605,6324,at,O
91606,6324,least,O
91607,6324,three,O
91608,6324,months,O
91609,6324,duration,O
91610,6325,Resting,O
91611,6325,heart,O
91612,6325,rate,O
91613,6325,=,O
91614,6325,80,O
91615,6325,bpm,O
91616,6326,Signed,O
91617,6326,informed,O
91618,6326,consent,O
91619,6327,A,O
91620,6327,known,O
91621,6327,allergy,B-Condition
91622,6327,to,O
91623,6327,Celecoxib,B-Drug
91624,6327,",",O
91625,6327,aspirin,B-Drug
91626,6327,or,O
91627,6327,another,O
91628,6327,NSAID,B-Drug
91629,6327,.,O
91630,6328,Active,O
91631,6328,peptic,B-Condition
91632,6328,ulceration,I-Condition
91633,6328,or,O
91634,6328,gastrointestinal,B-Condition
91635,6328,bleeding,I-Condition
91636,6328,.,O
91637,6329,Inflammatory,B-Condition
91638,6329,bowel,I-Condition
91639,6329,disease,I-Condition
91640,6329,.,O
91641,6330,Congestive,B-Condition
91642,6330,heart,I-Condition
91643,6330,failure,I-Condition
91644,6330,(,O
91645,6330,NYHA,O
91646,6330,II,O
91647,6330,-,O
91648,6330,IV,O
91649,6330,),O
91650,6330,.,O
91651,6331,Established,O
91652,6331,ischemic,B-Condition
91653,6331,heart,I-Condition
91654,6331,disease,I-Condition
91655,6331,",",O
91656,6331,peripheral,B-Condition
91657,6331,arterial,I-Condition
91658,6331,disease,I-Condition
91659,6331,and/or,O
91660,6331,cerebrovascular,B-Condition
91661,6331,disease,I-Condition
91662,6331,.,O
91663,6332,History,B-Observation
91664,6332,of,O
91665,6332,neurologic,B-Condition
91666,6332,deficit,I-Condition
91667,6332,.,O
91668,6333,Known,O
91669,6333,hepatic,B-Condition
91670,6333,or,I-Condition
91671,6333,renal,I-Condition
91672,6333,impairment,I-Condition
91673,6333,.,O
91674,6334,Pregnancy,B-Condition
91675,6334,.,O
91676,6335,Breast,B-Observation
91677,6335,-,I-Observation
91678,6335,feeding,I-Observation
91679,6335,.,O
91680,6336,Post,O
91681,6336,-,O
91682,6336,hysterectomy,B-Procedure
91683,6336,.,O
91684,6337,Bleeding,B-Condition
91685,6337,disorders,I-Condition
91686,6337,.,O
91687,6338,Drug,B-Condition
91688,6338,abuse,I-Condition
91689,6338,.,O
91690,6339,Cervical,B-Condition
91691,6339,and,I-Condition
91692,6339,vaginal,I-Condition
91693,6339,infection,I-Condition
91694,6339,.,O
91695,6340,Females,B-Person
91696,6340,18,O
91697,6340,-,O
91698,6340,65,O
91699,6340,years,O
91700,6340,old,B-Person
91701,6340,who,O
91702,6340,undergoing,O
91703,6340,colposcopic,B-Procedure
91704,6340,directed,I-Procedure
91705,6340,biopsy,I-Procedure
91706,6341,Patients,O
91707,6341,in,O
91708,6341,whom,O
91709,6341,the,O
91710,6341,preferred,O
91711,6341,treatment,O
91712,6341,is,O
91713,6341,CABG(Coronary,B-Procedure
91714,6341,artery,I-Procedure
91715,6341,bypass,I-Procedure
91716,6341,grafting,I-Procedure
91717,6341,),O
91718,6342,Stented,O
91719,6342,lesion,B-Condition
91720,6343,Bypass,O
91721,6343,graft,O
91722,6343,lesion,B-Condition
91723,6344,The,O
91724,6344,patients,O
91725,6344,who,O
91726,6344,have,O
91727,6344,more,O
91728,6344,than,O
91729,6344,or,O
91730,6344,equal,O
91731,6344,to,O
91732,6344,3,O
91733,6344,target,B-Condition
91734,6344,lesions,I-Condition
91735,6345,2,O
91736,6345,target,B-Condition
91737,6345,lesions,I-Condition
91738,6345,in,O
91739,6345,the,O
91740,6345,same,O
91741,6345,coronary,O
91742,6345,territory,O
91743,6346,Heavily,O
91744,6346,calcified,O
91745,6346,or,O
91746,6346,angulated,O
91747,6346,lesion,B-Condition
91748,6347,Bifurcation,B-Condition
91749,6347,lesion,I-Condition
91750,6347,requiring,O
91751,6347,2,O
91752,6347,stenting,B-Procedure
91753,6347,technique,I-Procedure
91754,6348,Contraindication,B-Condition
91755,6348,to,O
91756,6348,or,O
91757,6348,planned,B-Mood
91758,6348,discontinuation,I-Mood
91759,6348,of,O
91760,6348,dual,B-Procedure
91761,6348,antiplatelet,I-Procedure
91762,6348,therapy,I-Procedure
91763,6348,within,O
91764,6348,1,O
91765,6348,year,O
91766,6349,Life,B-Observation
91767,6349,expectancy,I-Observation
91768,6349,less,O
91769,6349,than,O
91770,6349,2,O
91771,6349,years,O
91772,6350,Planned,B-Mood
91773,6350,cardiac,B-Procedure
91774,6350,surgery,I-Procedure
91775,6350,or,O
91776,6350,planned,B-Mood
91777,6350,major,O
91778,6350,non,B-Procedure
91779,6350,cardiac,I-Procedure
91780,6350,surgery,I-Procedure
91781,6351,Woman,B-Person
91782,6351,who,O
91783,6351,are,O
91784,6351,breastfeeding,B-Observation
91785,6351,",",O
91786,6351,pregnant,B-Condition
91787,6351,or,O
91788,6351,planning,B-Mood
91789,6351,to,I-Mood
91790,6351,become,I-Mood
91791,6351,pregnant,B-Condition
91792,6351,during,O
91793,6351,the,O
91794,6351,course,O
91795,6351,of,O
91796,6351,the,O
91797,6351,study,O
91798,6352,Age,B-Person
91799,6352,18,O
91800,6352,years,O
91801,6352,or,O
91802,6352,older,O
91803,6353,Symptomatic,O
91804,6353,or,O
91805,6353,asymptomatic,O
91806,6353,coronary,B-Condition
91807,6353,artery,I-Condition
91808,6353,disease,I-Condition
91809,6353,patients,O
91810,6354,MLA(minimal,O
91811,6354,luminal,O
91812,6354,area)<4mm2,O
91813,6355,plaque,O
91814,6355,burden>70,O
91815,6355,%,O
91816,6356,Lipid,B-Condition
91817,6356,-,I-Condition
91818,6356,rich,I-Condition
91819,6356,plaque,I-Condition
91820,6356,on,O
91821,6356,NIRS(Intracoronary,B-Procedure
91822,6356,Near,I-Procedure
91823,6356,-,I-Procedure
91824,6356,Infrared,I-Procedure
91825,6356,Spectroscopy,I-Procedure
91826,6356,),O
91827,6356,(,O
91828,6356,defined,O
91829,6356,as,O
91830,6356,maxLCBI4mm>315,O
91831,6356,),O
91832,6357,2,O
91833,6357,target,B-Condition
91834,6357,vulnerable,I-Condition
91835,6357,lesions,I-Condition
91836,6358,Eligible,B-Mood
91837,6358,for,I-Mood
91838,6358,percutaneous,B-Procedure
91839,6358,coronary,I-Procedure
91840,6358,intervention,I-Procedure
91841,6358,with,O
91842,6358,Absorb,O
91843,6358,Bioresorbable,O
91844,6358,Vascular,O
91845,6358,Scaffold,O
91846,6358,or,O
91847,6358,Everolimus,O
91848,6358,Eluting,O
91849,6358,Stent,O
91850,6359,Willing,O
91851,6359,and,O
91852,6359,able,O
91853,6359,to,O
91854,6359,provide,O
91855,6359,informed,O
91856,6359,written,O
91857,6359,consent,O
91858,6360,Reference,O
91859,6360,vessel,O
91860,6360,diameter,O
91861,6360,2.75,O
91862,6360,-,O
91863,6360,4.0,O
91864,6361,Lesion,O
91865,6361,length,O
91866,6361,=,O
91867,6361,40,O
91868,6362,Female,O
91869,6362,subjects,O
91870,6362,who,O
91871,6362,are,O
91872,6362,pregnant,O
91873,6362,or,O
91874,6362,breast,O
91875,6362,-,O
91876,6362,feeding,O
91877,6362,or,O
91878,6362,considering,O
91879,6362,becoming,O
91880,6362,pregnant,O
91881,6362,during,O
91882,6362,the,O
91883,6362,study,O
91884,6363,Patients,O
91885,6363,aged,B-Person
91886,6363,<,O
91887,6363,18,O
91888,6363,years,O
91889,6363,of,O
91890,6363,age,O
91891,6364,Patients,O
91892,6364,who,O
91893,6364,can,O
91894,6364,not,O
91895,6364,give,O
91896,6364,informed,O
91897,6364,consent,O
91898,6364,",",O
91899,6365,Pregnant,O
91900,6365,patients,O
91901,6365,or,O
91902,6365,those,O
91903,6365,who,O
91904,6365,are,O
91905,6365,breastfeeding,O
91906,6365,will,O
91907,6365,be,O
91908,6365,deemed,O
91909,6365,ineligible,O
91910,6365,.,O
91911,6366,Prior,O
91912,6366,treatment,B-Procedure
91913,6366,with,O
91914,6366,any,O
91915,6366,anti,B-Drug
91916,6366,-,I-Drug
91917,6366,TNF,I-Drug
91918,6366,agent,I-Drug
91919,6367,Contra,B-Condition
91920,6367,-,I-Condition
91921,6367,indication,I-Condition
91922,6367,to,O
91923,6367,use,O
91924,6367,of,O
91925,6367,GLM,B-Drug
91926,6367,(,O
91927,6367,Hypersensitivity,B-Condition
91928,6367,to,O
91929,6367,the,O
91930,6367,active,B-Drug
91931,6367,substance,I-Drug
91932,6367,or,O
91933,6367,to,O
91934,6367,any,O
91935,6367,of,O
91936,6367,the,O
91937,6367,excipients,B-Drug
91938,6367,;,O
91939,6367,Active,O
91940,6367,tuberculosis,B-Condition
91941,6367,(,I-Condition
91942,6367,TB,I-Condition
91943,6367,),I-Condition
91944,6367,",",O
91945,6367,acute,O
91946,6367,or,O
91947,6367,chronic,O
91948,6367,Hepatitis,B-Condition
91949,6367,B,I-Condition
91950,6367,infection,I-Condition
91951,6367,or,O
91952,6367,other,O
91953,6367,severe,B-Condition
91954,6367,infections,I-Condition
91955,6367,such,O
91956,6367,as,O
91957,6367,sepsis,B-Condition
91958,6367,and/or,O
91959,6367,opportunistic,B-Condition
91960,6367,infections,I-Condition
91961,6367,including,O
91962,6367,HIV,B-Condition
91963,6367,infection,I-Condition
91964,6367,;,O
91965,6367,Moderate,O
91966,6367,or,O
91967,6367,severe,O
91968,6367,heart,B-Condition
91969,6367,failure,I-Condition
91970,6367,(,O
91971,6367,NYHA,O
91972,6367,class,O
91973,6367,III,O
91974,6367,/,O
91975,6367,IV,O
91976,6367,),O
91977,6368,Have,O
91978,6368,symptoms,O
91979,6368,or,O
91980,6368,signs,O
91981,6368,suggestive,O
91982,6368,of,O
91983,6368,current,O
91984,6368,active,O
91985,6368,or,O
91986,6368,latent,O
91987,6368,TB,B-Condition
91988,6368,upon,O
91989,6368,medical,B-Observation
91990,6368,history,I-Observation
91991,6368,",",O
91992,6368,physical,B-Procedure
91993,6368,examination,I-Procedure
91994,6368,and/or,O
91995,6368,chest,B-Procedure
91996,6368,radiograph,I-Procedure
91997,6368,",",O
91998,6368,or,O
91999,6368,positive,O
92000,6368,Mycobacterium,O
92001,6368,tuberculosis,O
92002,6368,antigen,O
92003,6368,-,O
92004,6368,specific,O
92005,6368,interferon,O
92006,6368,-,O
92007,6368,gamma,O
92008,6368,release,O
92009,6368,assay,O
92010,6368,(,O
92011,6368,IGRA,O
92012,6368,),O
92013,6369,Patients,O
92014,6369,with,O
92015,6369,a,O
92016,6369,history,B-Observation
92017,6369,of,I-Observation
92018,6369,",",O
92019,6369,or,O
92020,6369,at,O
92021,6369,imminent,B-Mood
92022,6369,risk,I-Mood
92023,6369,for,I-Mood
92024,6369,",",O
92025,6369,colectomy,B-Procedure
92026,6369,;,O
92027,6369,who,O
92028,6369,required,O
92029,6369,gastrointestinal,B-Procedure
92030,6369,surgery,I-Procedure
92031,6369,within,O
92032,6369,2,O
92033,6369,months,O
92034,6369,before,O
92035,6369,screening,O
92036,6369,;,O
92037,6370,History,O
92038,6370,of,O
92039,6370,colonic,B-Condition
92040,6370,mucosal,I-Condition
92041,6370,dysplasia,I-Condition
92042,6370,or,O
92043,6370,adenomatous,B-Condition
92044,6370,colonic,I-Condition
92045,6370,polyps,I-Condition
92046,6370,that,O
92047,6370,were,O
92048,6370,not,O
92049,6370,removed,B-Procedure
92050,6371,Screening,O
92051,6371,stool,B-Procedure
92052,6371,study,I-Procedure
92053,6371,positive,O
92054,6371,for,O
92055,6371,enteric,O
92056,6371,pathogens,O
92057,6371,or,O
92058,6371,Clostridium,O
92059,6371,difficile,O
92060,6371,toxin,O
92061,6371,.,O
92062,6372,Oral,B-Drug
92063,6372,corticosteroids,I-Drug
92064,6372,at,O
92065,6372,a,O
92066,6372,dose,O
92067,6372,>,O
92068,6372,40,O
92069,6372,mg,O
92070,6372,prednisone,O
92071,6372,or,O
92072,6372,its,O
92073,6372,equivalent,O
92074,6372,per,O
92075,6372,day,O
92076,6372,;,O
92077,6372,receipt,O
92078,6372,of,O
92079,6372,cyclosporine,B-Drug
92080,6372,",",O
92081,6372,tacrolimus,B-Drug
92082,6372,",",O
92083,6372,sirolimus,B-Drug
92084,6372,",",O
92085,6372,or,O
92086,6372,mycophenolate,B-Drug
92087,6372,mofetil,I-Drug
92088,6372,within,O
92089,6372,8,O
92090,6372,weeks,O
92091,6372,before,O
92092,6372,the,O
92093,6372,first,O
92094,6372,study,O
92095,6372,agent,O
92096,6372,injection,O
92097,6372,;,O
92098,6372,or,O
92099,6372,use,O
92100,6372,of,O
92101,6372,an,O
92102,6372,investigational,B-Drug
92103,6372,agent,I-Drug
92104,6372,within,O
92105,6372,5,O
92106,6372,half,O
92107,6372,-,O
92108,6372,lives,O
92109,6372,of,O
92110,6372,that,O
92111,6372,agent,O
92112,6372,before,O
92113,6372,the,O
92114,6372,first,O
92115,6372,study,O
92116,6372,agent,O
92117,6372,injection,O
92118,6372,.,O
92119,6373,Patients,O
92120,6373,in,O
92121,6373,recent,O
92122,6373,receipt,O
92123,6373,of,O
92124,6373,live,B-Drug
92125,6373,vaccinations,I-Drug
92126,6373,within,O
92127,6373,4,O
92128,6373,weeks,O
92129,6373,prior,O
92130,6373,to,O
92131,6373,enrolment,O
92132,6374,Patients,O
92133,6374,=,O
92134,6374,18,O
92135,6374,years,O
92136,6374,of,O
92137,6374,age,B-Person
92138,6375,Subjects,O
92139,6375,must,O
92140,6375,be,O
92141,6375,able,O
92142,6375,and,O
92143,6375,willing,O
92144,6375,to,O
92145,6375,give,O
92146,6375,written,O
92147,6375,informed,O
92148,6375,consent,O
92149,6375,and,O
92150,6375,to,O
92151,6375,comply,O
92152,6375,with,O
92153,6375,the,O
92154,6375,requirements,O
92155,6375,of,O
92156,6375,this,O
92157,6375,study,O
92158,6375,protocol,O
92159,6376,Established,O
92160,6376,diagnosis,O
92161,6376,of,O
92162,6376,UC,B-Condition
92163,6376,and,O
92164,6376,moderate,O
92165,6376,-,O
92166,6376,to,O
92167,6376,-,O
92168,6376,severe,O
92169,6376,disease,O
92170,6376,activity,O
92171,6376,",",O
92172,6376,defined,O
92173,6376,as,O
92174,6376,a,O
92175,6376,Mayo,O
92176,6376,score,O
92177,6376,of,O
92178,6376,6,O
92179,6376,-,O
92180,6376,12,O
92181,6376,",",O
92182,6376,with,O
92183,6376,an,O
92184,6376,endoscopic,O
92185,6376,subscore,O
92186,6376,=,O
92187,6376,2,O
92188,6376,.,O
92189,6377,Patients,O
92190,6377,had,O
92191,6377,an,O
92192,6377,inadequate,B-Condition
92193,6377,response,I-Condition
92194,6377,to,O
92195,6377,",",O
92196,6377,or,O
92197,6377,had,O
92198,6377,failed,B-Condition
92199,6377,to,I-Condition
92200,6377,tolerate,I-Condition
92201,6377,",",O
92202,6377,1,O
92203,6377,or,O
92204,6377,more,O
92205,6377,of,O
92206,6377,the,O
92207,6377,following,O
92208,6377,conventional,O
92209,6377,therapies,O
92210,6377,:,O
92211,6377,oral,B-Drug
92212,6377,5,I-Drug
92213,6377,-,I-Drug
92214,6377,aminosalicylates,I-Drug
92215,6377,",",O
92216,6377,oral,B-Drug
92217,6377,corticosteroids,I-Drug
92218,6377,",",O
92219,6377,azathioprine,B-Drug
92220,6377,(,I-Drug
92221,6377,AZA,I-Drug
92222,6377,),I-Drug
92223,6377,",",O
92224,6377,and/or,O
92225,6377,6,B-Drug
92226,6377,-,I-Drug
92227,6377,mercaptopurine,I-Drug
92228,6377,(,I-Drug
92229,6377,6MP,I-Drug
92230,6377,),I-Drug
92231,6377,;,O
92232,6377,or,O
92233,6377,corticosteroid,B-Drug
92234,6377,dependent,B-Condition
92235,6377,(,O
92236,6377,ie,O
92237,6377,",",O
92238,6377,an,O
92239,6377,inability,O
92240,6377,to,O
92241,6377,taper,O
92242,6377,corticosteroids,O
92243,6377,without,O
92244,6377,recurrence,O
92245,6377,of,O
92246,6377,UC,O
92247,6377,symptoms,O
92248,6377,),O
92249,6377,.,O
92250,6378,Patients,O
92251,6378,concurrently,O
92252,6378,treated,B-Procedure
92253,6378,with,O
92254,6378,oral,B-Drug
92255,6378,5,I-Drug
92256,6378,-,I-Drug
92257,6378,aminosalicylates,I-Drug
92258,6378,or,O
92259,6378,corticosteroids,B-Drug
92260,6378,were,O
92261,6378,to,O
92262,6378,receive,O
92263,6378,a,O
92264,6378,stable,O
92265,6378,dose,O
92266,6378,for,O
92267,6378,at,O
92268,6378,least,O
92269,6378,2,O
92270,6378,weeks,O
92271,6378,before,O
92272,6378,baseline,O
92273,6378,",",O
92274,6378,and,O
92275,6378,patients,O
92276,6378,receiving,O
92277,6378,AZA,B-Drug
92278,6378,and/or,O
92279,6378,6MP,B-Drug
92280,6378,were,O
92281,6378,to,O
92282,6378,receive,O
92283,6378,a,O
92284,6378,stable,O
92285,6378,dose,O
92286,6378,for,O
92287,6378,at,O
92288,6378,least,O
92289,6378,4,O
92290,6378,weeks,O
92291,6378,before,O
92292,6378,baseline,O
92293,6378,.,O
92294,6378,Patients,O
92295,6378,were,O
92296,6378,required,O
92297,6378,to,O
92298,6378,maintain,O
92299,6378,stable,O
92300,6378,doses,O
92301,6378,of,O
92302,6378,their,O
92303,6378,concomitant,O
92304,6378,UC,O
92305,6378,medications,O
92306,6378,during,O
92307,6378,the,O
92308,6378,study,O
92309,6378,.,O
92310,6379,Female,O
92311,6379,subjects,O
92312,6379,of,O
92313,6379,child,O
92314,6379,bearing,O
92315,6379,potential,O
92316,6379,must,O
92317,6379,be,O
92318,6379,willing,O
92319,6379,to,O
92320,6379,ensure,O
92321,6379,that,O
92322,6379,they,O
92323,6379,or,O
92324,6379,their,O
92325,6379,partner,O
92326,6379,use,O
92327,6379,effective,O
92328,6379,contraception,O
92329,6379,during,O
92330,6379,the,O
92331,6379,study,O
92332,6379,and,O
92333,6379,for,O
92334,6379,6,O
92335,6379,months,O
92336,6379,thereafter,O
92337,6379,OR,O
92338,6380,Surgical,O
92339,6380,sterilized,O
92340,6380,female,O
92341,6380,patients,O
92342,6380,with,O
92343,6380,documentation,O
92344,6380,of,O
92345,6380,prior,O
92346,6380,hysterectomy,O
92347,6380,",",O
92348,6380,tubal,O
92349,6380,ligation,O
92350,6380,or,O
92351,6380,complete,O
92352,6380,bilateral,O
92353,6380,oophorectomy,O
92354,6380,OR,O
92355,6381,Postmenopausal,O
92356,6381,women,O
92357,6381,with,O
92358,6381,postmenopausal,O
92359,6381,defined,O
92360,6381,as,O
92361,6381,permanent,O
92362,6381,cessation,O
92363,6381,>,O
92364,6381,1,O
92365,6381,year,O
92366,6381,of,O
92367,6381,previously,O
92368,6381,occurring,O
92369,6381,menses,O
92370,6381,.,O
92371,6382,Female,O
92372,6382,subjects,O
92373,6382,',O
92374,6382,serum,O
92375,6382,pregnancy,O
92376,6382,test,O
92377,6382,performed,O
92378,6382,at,O
92379,6382,the,O
92380,6382,screening,O
92381,6382,visit,O
92382,6382,and,O
92383,6382,urine,O
92384,6382,pregnancy,O
92385,6382,test,O
92386,6382,performed,O
92387,6382,at,O
92388,6382,the,O
92389,6382,baseline,O
92390,6382,visit,O
92391,6382,must,O
92392,6382,be,O
92393,6382,negative,O
92394,6382,.,O
92395,6383,Subjects,O
92396,6383,have,O
92397,6383,following,O
92398,6383,investigations,O
92399,6383,within,O
92400,6383,1,O
92401,6383,month,O
92402,6383,prior,O
92403,6383,to,O
92404,6383,enrolment,O
92405,6383,.,O
92406,6384,Routine,B-Procedure
92407,6384,bloods,I-Procedure
92408,6384,including,O
92409,6384,U&E,B-Procedure
92410,6384,",",O
92411,6384,FBC,B-Procedure
92412,6384,",",O
92413,6384,LFTs,B-Procedure
92414,6384,",",O
92415,6384,inflammatory,B-Procedure
92416,6384,markers,I-Procedure
92417,6384,(,I-Procedure
92418,6384,CRP,I-Procedure
92419,6384,),I-Procedure
92420,6384,and,O
92421,6384,albumin,B-Procedure
92422,6384,will,O
92423,6384,be,O
92424,6384,measured,O
92425,6384,.,O
92426,6385,Medical,O
92427,6385,history,O
92428,6385,",",O
92429,6385,concomitant,O
92430,6385,medications,O
92431,6386,Intradermal,B-Procedure
92432,6386,reaction,I-Procedure
92433,6386,to,I-Procedure
92434,6386,Tuberculin,I-Procedure
92435,6386,(,I-Procedure
92436,6386,PPD,I-Procedure
92437,6386,skin,I-Procedure
92438,6386,test,I-Procedure
92439,6386,),I-Procedure
92440,6386,or,O
92441,6386,Mycobacterium,B-Procedure
92442,6386,tuberculosis,I-Procedure
92443,6386,antigenspecific,I-Procedure
92444,6386,interferon,I-Procedure
92445,6386,-,I-Procedure
92446,6386,gamma,I-Procedure
92447,6386,release,I-Procedure
92448,6386,assay,I-Procedure
92449,6386,(,I-Procedure
92450,6386,IGRA,I-Procedure
92451,6386,),I-Procedure
92452,6387,TB,B-Procedure
92453,6387,screening,I-Procedure
92454,6387,:,O
92455,6387,chest,B-Procedure
92456,6387,X,I-Procedure
92457,6387,-,I-Procedure
92458,6387,Ray,I-Procedure
92459,6387,unless,O
92460,6387,performed,O
92461,6387,in,O
92462,6387,the,O
92463,6387,last,O
92464,6387,6,O
92465,6387,months,O
92466,6388,Stool,B-Procedure
92467,6388,examination,I-Procedure
92468,6388,for,O
92469,6388,enteric,O
92470,6388,pathogens,O
92471,6388,including,O
92472,6388,Clostridium,O
92473,6388,difficile,O
92474,6389,Inclusion,O
92475,6389,/,O
92476,6389,exclusion,O
92477,6389,criteria,O
92478,6390,Informed,O
92479,6390,consent,O
92480,6391,Mayo,B-Procedure
92481,6391,score,I-Procedure
92482,6391,(,O
92483,6391,including,O
92484,6391,sigmoidoscopy,B-Procedure
92485,6391,unless,O
92486,6391,performed,O
92487,6391,in,O
92488,6391,previous,O
92489,6391,3,O
92490,6391,months,O
92491,6391,),O
92492,6392,Patient,O
92493,6392,'s,O
92494,6392,weight,B-Procedure
92495,6392,and,O
92496,6392,height,B-Procedure
92497,6392,and,O
92498,6392,abdominal,B-Procedure
92499,6392,circumference,I-Procedure
92500,6393,Age,B-Person
92501,6393,>,O
92502,6393,18,O
92503,6393,Years,O
92504,6394,Physician,O
92505,6394,discretion,O
92506,6395,Septic,B-Condition
92507,6395,or,I-Condition
92508,6395,hypovolemic,I-Condition
92509,6395,shock,I-Condition
92510,6396,Signs,B-Mood
92511,6396,of,I-Mood
92512,6396,life,O
92513,6396,-,O
92514,6396,threatening,O
92515,6396,cerebral,B-Condition
92516,6396,edema,I-Condition
92517,6396,or,O
92518,6396,multi,B-Condition
92519,6396,-,I-Condition
92520,6396,organ,I-Condition
92521,6396,failure,I-Condition
92522,6396,upon,O
92523,6396,presentation,O
92524,6396,to,O
92525,6396,the,O
92526,6396,emergency,O
92527,6396,room,O
92528,6396,or,O
92529,6396,pediatric,O
92530,6396,intensive,O
92531,6396,care,O
92532,6396,unit,O
92533,6397,Enrollment,B-Observation
92534,6397,time,O
92535,6397,more,O
92536,6397,than,O
92537,6397,1,O
92538,6397,hr,O
92539,6397,since,O
92540,6397,arrival,O
92541,6397,to,O
92542,6397,emergency,O
92543,6397,room,O
92544,6397,or,O
92545,6397,PICU,O
92546,6398,Pregnancy,B-Condition
92547,6399,Age,B-Person
92548,6399,between,O
92549,6399,0,O
92550,6399,and,O
92551,6399,18,O
92552,6399,years,O
92553,6400,Venous,O
92554,6400,pH,O
92555,6400,less,O
92556,6400,than,O
92557,6400,7.25,O
92558,6401,Ketonuria,B-Condition
92559,6401,as,O
92560,6401,confirmed,O
92561,6401,on,O
92562,6401,urine,O
92563,6401,point,O
92564,6401,-,O
92565,6401,of,O
92566,6401,-,O
92567,6401,care,O
92568,6401,testing,O
92569,6401,or,O
92570,6401,urinalysis,O
92571,6402,Hyperglycemia,B-Condition
92572,6402,(,O
92573,6402,Serum,O
92574,6402,glucose,O
92575,6402,>,O
92576,6402,200,O
92577,6402,mg,O
92578,6402,/,O
92579,6402,dl,O
92580,6402,),O
92581,6403,Serum,O
92582,6403,bicarbonate,O
92583,6403,<,O
92584,6403,15,O
92585,6403,mmol,O
92586,6403,/,O
92587,6403,L,O
92588,6404,PICU,O
92589,6404,admission,B-Procedure
92590,6405,History,B-Observation
92591,6405,of,I-Observation
92592,6405,organic,B-Condition
92593,6405,brain,I-Condition
92594,6405,disease,I-Condition
92595,6406,DSM,O
92596,6406,-,O
92597,6406,IV,O
92598,6406,diagnosis,O
92599,6406,of,O
92600,6406,Alcohol,B-Condition
92601,6406,or,I-Condition
92602,6406,Substance,I-Condition
92603,6406,Dependence,I-Condition
92604,6406,within,O
92605,6406,the,O
92606,6406,last,O
92607,6406,six,O
92608,6406,months,O
92609,6406,(,O
92610,6406,except,O
92611,6406,nicotine,B-Drug
92612,6406,),O
92613,6406,or,O
92614,6406,DSM-5,O
92615,6406,diagnosis,O
92616,6406,of,O
92617,6406,Substance,B-Condition
92618,6406,Use,I-Condition
92619,6406,Disorder,I-Condition
92620,6406,in,O
92621,6406,the,O
92622,6406,last,O
92623,6406,six,O
92624,6406,months,O
92625,6406,(,O
92626,6406,except,O
92627,6406,nicotine,B-Drug
92628,6406,),O
92629,6407,DSM,O
92630,6407,-,O
92631,6407,IV,O
92632,6407,diagnosis,O
92633,6407,of,O
92634,6407,Alcohol,B-Condition
92635,6407,or,I-Condition
92636,6407,Substance,I-Condition
92637,6407,Abuse,I-Condition
92638,6407,within,O
92639,6407,the,O
92640,6407,last,O
92641,6407,one,O
92642,6407,month,O
92643,6407,(,O
92644,6407,except,O
92645,6407,nicotine,B-Drug
92646,6407,),O
92647,6407,or,O
92648,6407,DSM-5,O
92649,6407,diagnosis,O
92650,6407,of,O
92651,6407,Substance,B-Condition
92652,6407,Use,I-Condition
92653,6407,Disorder,I-Condition
92654,6407,in,O
92655,6407,the,O
92656,6407,last,O
92657,6407,six,O
92658,6407,months,O
92659,6407,(,O
92660,6407,except,O
92661,6407,nicotine,B-Drug
92662,6407,),O
92663,6408,Pregnancy,B-Condition
92664,6408,or,O
92665,6408,lactation,B-Condition
92666,6409,Severe,O
92667,6409,liver,B-Condition
92668,6409,dysfunction,I-Condition
92669,6409,(,O
92670,6409,LFT,O
92671,6409,3X,O
92672,6409,upper,O
92673,6409,limit,O
92674,6409,of,O
92675,6409,normal,O
92676,6409,),O
92677,6410,Previous,O
92678,6410,known,O
92679,6410,hypersensitivity,B-Condition
92680,6410,to,O
92681,6410,tetracyclines,B-Drug
92682,6411,Current,O
92683,6411,treatment,B-Procedure
92684,6411,with,O
92685,6411,tetracycline,B-Drug
92686,6411,or,I-Drug
92687,6411,derivative,I-Drug
92688,6412,Treatment,B-Procedure
92689,6412,with,O
92690,6412,oral,B-Drug
92691,6412,contraceptives,I-Drug
92692,6412,(,O
92693,6412,unless,O
92694,6412,a,O
92695,6412,second,O
92696,6412,form,O
92697,6412,of,O
92698,6412,birth,B-Observation
92699,6412,control,I-Observation
92700,6412,is,O
92701,6412,used,O
92702,6412,and,O
92703,6412,documented,O
92704,6412,),O
92705,6413,Treatment,B-Procedure
92706,6413,with,O
92707,6413,cholestyramine,B-Drug
92708,6413,or,O
92709,6413,colestipol,B-Drug
92710,6414,Treatment,B-Procedure
92711,6414,with,O
92712,6414,Urinary,B-Drug
92713,6414,alkalinizers,I-Drug
92714,6414,(,O
92715,6414,e.g.,O
92716,6414,",",O
92717,6414,sodium,B-Drug
92718,6414,lactate,I-Drug
92719,6414,",",O
92720,6414,potassium,B-Drug
92721,6414,citrate,I-Drug
92722,6414,),O
92723,6415,Treatment,B-Procedure
92724,6415,with,O
92725,6415,warfarin,B-Drug
92726,6416,Treatment,B-Procedure
92727,6416,with,O
92728,6416,bupropion,B-Drug
92729,6416,",",O
92730,6416,varenicline,B-Drug
92731,6416,",",O
92732,6416,or,O
92733,6416,nicotine,B-Drug
92734,6416,replacement,I-Drug
92735,6416,products,I-Drug
92736,6416,in,O
92737,6416,the,O
92738,6416,month,O
92739,6416,prior,O
92740,6416,to,O
92741,6416,study,O
92742,6416,inclusion,O
92743,6417,Less,O
92744,6417,than,O
92745,6417,two,O
92746,6417,months,O
92747,6417,treatment,B-Procedure
92748,6417,of,O
92749,6417,adjunctive,B-Drug
92750,6417,medications,I-Drug
92751,6417,AND,O
92752,6417,less,O
92753,6417,than,O
92754,6417,one,O
92755,6417,month,O
92756,6417,on,O
92757,6417,same,O
92758,6417,dose,O
92759,6417,:,O
92760,6417,beta,B-Drug
92761,6417,blockers,I-Drug
92762,6417,",",O
92763,6417,antidepressants,B-Drug
92764,6417,",",O
92765,6417,mood,B-Drug
92766,6417,stabilizers,I-Drug
92767,6417,",",O
92768,6417,antianxiety,B-Drug
92769,6417,medications,I-Drug
92770,6417,.,O
92771,6418,Medical,B-Condition
92772,6418,condition,I-Condition
92773,6418,whose,O
92774,6418,pathology,O
92775,6418,or,O
92776,6418,treatment,O
92777,6418,would,O
92778,6418,significantly,O
92779,6418,increase,O
92780,6418,the,O
92781,6418,risk,O
92782,6418,associated,O
92783,6418,with,O
92784,6418,the,O
92785,6418,proposed,O
92786,6418,protocol,O
92787,6418,.,O
92788,6419,History,B-Observation
92789,6419,of,O
92790,6419,head,B-Condition
92791,6419,injury,I-Condition
92792,6419,",",O
92793,6419,seizures,B-Condition
92794,6419,",",O
92795,6419,or,O
92796,6419,stroke,B-Condition
92797,6420,Positive,O
92798,6420,urine,O
92799,6420,toxicology,O
92800,6420,screen,O
92801,6420,for,O
92802,6420,substances,O
92803,6420,of,O
92804,6420,non,O
92805,6420,-,O
92806,6420,therapeutic,O
92807,6420,use,O
92808,6420,prior,O
92809,6420,to,O
92810,6420,craving,O
92811,6420,assessments,O
92812,6421,DSM,O
92813,6421,-,O
92814,6421,IV,O
92815,6421,or,O
92816,6421,DSM-5,O
92817,6421,diagnosis,O
92818,6421,of,O
92819,6421,schizophrenia,B-Condition
92820,6421,or,O
92821,6421,schizoaffective,B-Condition
92822,6421,disorder,I-Condition
92823,6422,Male,B-Person
92824,6422,or,O
92825,6422,Female,B-Person
92826,6423,Age,B-Person
92827,6423,:,O
92828,6423,18,O
92829,6423,to,O
92830,6423,65,O
92831,6423,years,O
92832,6424,Caucasian,B-Person
92833,6424,or,O
92834,6424,Non,B-Person
92835,6424,-,I-Person
92836,6424,Caucasian,I-Person
92837,6425,Smoke,B-Observation
92838,6425,at,O
92839,6425,least,O
92840,6425,10,O
92841,6425,cigarettes,O
92842,6425,daily,O
92843,6426,Urine,O
92844,6426,cotinine,O
92845,6426,level,O
92846,6426,?,O
92847,6426,100,O
92848,6426,ng,O
92849,6426,/,O
92850,6426,ml,O
92851,6426,(,O
92852,6426,NicAlert(r,O
92853,6426,),O
92854,6426,reading,O
92855,6426,?,O
92856,6426,3,O
92857,6426,),O
92858,6427,Agrees,B-Observation
92859,6427,to,I-Observation
92860,6427,wear,I-Observation
92861,6427,a,O
92862,6427,head,O
92863,6427,mounted,O
92864,6427,display,O
92865,6427,(,O
92866,6427,HMD,O
92867,6427,),O
92868,6427,for,O
92869,6427,up,O
92870,6427,to,O
92871,6427,45,O
92872,6427,minutes,O
92873,6428,Able,B-Observation
92874,6428,to,I-Observation
92875,6428,complete,I-Observation
92876,6428,the,O
92877,6428,Evaluation,B-Procedure
92878,6428,to,I-Procedure
92879,6428,Sign,I-Procedure
92880,6428,Consent,I-Procedure
92881,6428,(,I-Procedure
92882,6428,ESC,I-Procedure
92883,6428,),I-Procedure
92884,6428,with,O
92885,6428,minimum,O
92886,6428,score,O
92887,6428,of,O
92888,6428,80,O
92889,6428,%,O
92890,6429,(,O
92891,6429,1)Women,O
92892,6429,who,O
92893,6429,are,O
92894,6429,pregnant,B-Condition
92895,6429,and/or,O
92896,6429,lactating,B-Observation
92897,6429,;,O
92898,6429,or,O
92899,6429,women,B-Person
92900,6429,who,O
92901,6429,intend,B-Observation
92902,6429,to,I-Observation
92903,6429,conceive,I-Observation
92904,6429,within,O
92905,6429,a,O
92906,6429,year,O
92907,6429,;,O
92908,6430,(,O
92909,6430,2)History,O
92910,6430,of,O
92911,6430,allergies,B-Condition
92912,6430,to,O
92913,6430,enalapril,B-Drug
92914,6430,",",O
92915,6430,folic,B-Drug
92916,6430,acid,I-Drug
92917,6430,or,O
92918,6430,other,O
92919,6430,components,B-Drug
92920,6430,of,I-Drug
92921,6430,the,I-Drug
92922,6430,compound,I-Drug
92923,6430,drug,I-Drug
92924,6430,;,O
92925,6431,(,O
92926,6431,3)History,O
92927,6431,of,O
92928,6431,adverse,B-Condition
92929,6431,reactions,I-Condition
92930,6431,or,O
92931,6431,intolerance,B-Condition
92932,6431,to,O
92933,6431,enalapril,B-Drug
92934,6431,or,O
92935,6431,other,O
92936,6431,ACE,B-Drug
92937,6431,inhibitors,I-Drug
92938,6431,",",O
92939,6431,or,O
92940,6431,drugs,O
92941,6431,or,O
92942,6431,supplements,O
92943,6431,containing,O
92944,6431,folic,B-Drug
92945,6431,acid,I-Drug
92946,6431,;,O
92947,6432,(,O
92948,6432,4)Diagnosis,O
92949,6432,or,O
92950,6432,suspicion,B-Mood
92951,6432,of,O
92952,6432,secondary,B-Condition
92953,6432,hypertension,I-Condition
92954,6432,;,O
92955,6433,(,O
92956,6433,5)Known,O
92957,6433,serious,O
92958,6433,medical,B-Condition
92959,6433,conditions,I-Condition
92960,6433,",",O
92961,6433,including,O
92962,6433,:,O
92963,6433,Cardiovascular,O
92964,6433,:,O
92965,6433,patients,O
92966,6433,with,O
92967,6433,clinically,O
92968,6433,diagnosed,O
92969,6433,cardiac,B-Condition
92970,6433,dysfunction,I-Condition
92971,6433,(,O
92972,6433,NYHA,O
92973,6433,class,O
92974,6433,III,O
92975,6433,and,O
92976,6433,above,O
92977,6433,),O
92978,6433,",",O
92979,6433,hypertrophic,B-Condition
92980,6433,obstructive,I-Condition
92981,6433,cardiomyopathy,I-Condition
92982,6433,",",O
92983,6433,clinically,O
92984,6433,significant,O
92985,6433,valvular,B-Condition
92986,6433,heart,I-Condition
92987,6433,disease,I-Condition
92988,6433,",",O
92989,6433,acute,B-Condition
92990,6433,coronary,I-Condition
92991,6433,syndrome,I-Condition
92992,6433,within,O
92993,6433,the,O
92994,6433,last,O
92995,6433,3,O
92996,6433,months,O
92997,6433,",",O
92998,6433,or,O
92999,6433,percutaneous,B-Procedure
93000,6433,coronary,I-Procedure
93001,6433,intervention,I-Procedure
93002,6433,(,I-Procedure
93003,6433,PCI,I-Procedure
93004,6433,),I-Procedure
93005,6433,",",O
93006,6433,or,O
93007,6433,coronary,B-Procedure
93008,6433,artery,I-Procedure
93009,6433,bypass,I-Procedure
93010,6433,graft,I-Procedure
93011,6433,(,I-Procedure
93012,6433,CABG,I-Procedure
93013,6433,),I-Procedure
93014,6433,;,O
93015,6433,or,O
93016,6433,abnormal,O
93017,6433,pre,O
93018,6433,-,O
93019,6433,enrollment,O
93020,6433,ECG,O
93021,6433,test,O
93022,6433,results,O
93023,6433,with,O
93024,6433,clinically,O
93025,6433,significant,O
93026,6433,arrhythmias,B-Condition
93027,6433,(,O
93028,6433,atrial,B-Condition
93029,6433,flutter,I-Condition
93030,6433,",",O
93031,6433,atrial,B-Condition
93032,6433,fibrillation,I-Condition
93033,6433,",",O
93034,6433,grade,O
93035,6433,II,O
93036,6433,-,O
93037,6433,III,O
93038,6433,atrioventricular,B-Condition
93039,6433,block,I-Condition
93040,6433,",",O
93041,6433,etc,O
93042,6433,.,O
93043,6433,),O
93044,6433,;,O
93045,6433,Digestive,O
93046,6433,:,O
93047,6433,a,O
93048,6433,previous,O
93049,6433,diagnosis,O
93050,6433,of,O
93051,6433,various,O
93052,6433,types,O
93053,6433,of,O
93054,6433,viral,B-Condition
93055,6433,hepatitis,I-Condition
93056,6433,that,O
93057,6433,are,O
93058,6433,still,O
93059,6433,in,O
93060,6433,the,O
93061,6433,active,O
93062,6433,phase,O
93063,6433,;,O
93064,6433,abnormal,O
93065,6433,pre,O
93066,6433,-,O
93067,6433,enrollment,O
93068,6433,liver,O
93069,6433,function,O
93070,6433,test,O
93071,6433,results,O
93072,6433,(,O
93073,6433,ALT,O
93074,6433,",",O
93075,6433,AST,O
93076,6433,",",O
93077,6433,GGT,O
93078,6433,",",O
93079,6433,TBIL,O
93080,6433,",",O
93081,6433,or,O
93082,6433,DBIL,O
93083,6433,3,O
93084,6433,times,O
93085,6433,higher,O
93086,6433,than,O
93087,6433,normal,O
93088,6433,",",O
93089,6433,ALB,O
93090,6433,=,O
93091,6433,30g,O
93092,6433,/,O
93093,6433,L,O
93094,6433,),O
93095,6433,;,O
93096,6433,gastrectomy,B-Procedure
93097,6433,and/or,O
93098,6433,gastrojejunostomy,B-Procedure
93099,6433,;,O
93100,6433,gastrointestinal,B-Condition
93101,6433,dysfunction,I-Condition
93102,6433,;,O
93103,6433,Urinary,O
93104,6433,:,O
93105,6433,pre,O
93106,6433,-,O
93107,6433,enrollment,O
93108,6433,serum,O
93109,6433,creatinine,O
93110,6433,greater,O
93111,6433,than,O
93112,6433,200umol,O
93113,6433,/,O
93114,6433,L,O
93115,6433,;,O
93116,6433,clinical,O
93117,6433,diagnosis,O
93118,6433,of,O
93119,6433,renal,B-Condition
93120,6433,artery,I-Condition
93121,6433,stenosis,I-Condition
93122,6433,",",O
93123,6433,isolated,B-Condition
93124,6433,kidney,I-Condition
93125,6433,",",O
93126,6433,kidney,B-Procedure
93127,6433,transplantation,I-Procedure
93128,6433,and/or,O
93129,6433,other,O
93130,6433,diseases,O
93131,6433,;,O
93132,6433,Endocrine,O
93133,6433,:,O
93134,6433,type,B-Condition
93135,6433,1,I-Condition
93136,6433,diabetes,I-Condition
93137,6433,or,O
93138,6433,uncontrolled,O
93139,6433,type,B-Condition
93140,6433,2,I-Condition
93141,6433,diabetes,I-Condition
93142,6433,(,O
93143,6433,fasting,O
93144,6433,blood,O
93145,6433,glucose,O
93146,6433,above,O
93147,6433,11.1,O
93148,6433,mmol,O
93149,6433,/,O
93150,6433,L,O
93151,6433,at,O
93152,6433,pre,O
93153,6433,-,O
93154,6433,enrollment,O
93155,6433,),O
93156,6433,;,O
93157,6433,previous,O
93158,6433,diagnosis,O
93159,6433,of,O
93160,6433,hyperthyroidism,B-Condition
93161,6433,and,O
93162,6433,failure,B-Observation
93163,6433,to,I-Observation
93164,6433,correct,I-Observation
93165,6433,;,O
93166,6433,Respiratory,O
93167,6433,:,O
93168,6433,pulmonary,B-Condition
93169,6433,heart,I-Condition
93170,6433,disease,I-Condition
93171,6433,;,O
93172,6433,chronic,B-Condition
93173,6433,obstructive,I-Condition
93174,6433,pulmonary,I-Condition
93175,6433,disease,I-Condition
93176,6433,;,O
93177,6433,Neuropsychiatric,O
93178,6433,:,O
93179,6433,recent,O
93180,6433,transient,B-Condition
93181,6433,ischemic,I-Condition
93182,6433,attack,I-Condition
93183,6433,or,O
93184,6433,stroke,B-Condition
93185,6433,(,O
93186,6433,within,O
93187,6433,the,O
93188,6433,last,O
93189,6433,3,O
93190,6433,months,O
93191,6433,),O
93192,6433,;,O
93193,6433,peripheral,O
93194,6433,or,O
93195,6433,severe,O
93196,6433,autonomic,B-Condition
93197,6433,dysfunction,I-Condition
93198,6433,;,O
93199,6433,mental,B-Condition
93200,6433,or,I-Condition
93201,6433,nervous,I-Condition
93202,6433,system,I-Condition
93203,6433,dysfunction,I-Condition
93204,6433,",",O
93205,6433,inability,B-Observation
93206,6433,to,I-Observation
93207,6433,express,I-Observation
93208,6433,desire,I-Observation
93209,6433,;,O
93210,6433,known,O
93211,6433,drug,B-Condition
93212,6433,or,I-Condition
93213,6433,alcohol,I-Condition
93214,6433,dependence,I-Condition
93215,6433,;,O
93216,6433,Malignancy,B-Condition
93217,6433,",",O
93218,6433,malnutrition,B-Condition
93219,6433,",",O
93220,6433,hematopoietic,B-Condition
93221,6433,disorders,I-Condition
93222,6433,and,O
93223,6433,other,O
93224,6433,serious,O
93225,6433,diseases,O
93226,6433,.,O
93227,6434,(,O
93228,6434,6)Significant,O
93229,6434,signs,B-Condition
93230,6434,of,I-Condition
93231,6434,abnormalities,I-Condition
93232,6434,as,O
93233,6434,seen,O
93234,6434,in,O
93235,6434,laboratory,O
93236,6434,tests,O
93237,6434,or,O
93238,6434,physical,O
93239,6434,characteristics,O
93240,6434,",",O
93241,6434,which,O
93242,6434,",",O
93243,6434,at,O
93244,6434,the,O
93245,6434,discretion,O
93246,6434,of,O
93247,6434,the,O
93248,6434,investigators,O
93249,6434,",",O
93250,6434,indicates,O
93251,6434,that,O
93252,6434,the,O
93253,6434,patient,O
93254,6434,is,O
93255,6434,experiencing,O
93256,6434,a,O
93257,6434,serious,O
93258,6434,illness,O
93259,6434,or,O
93260,6434,",",O
93261,6434,may,O
93262,6434,affect,O
93263,6434,the,O
93264,6434,observation,O
93265,6434,and,O
93266,6434,evaluation,O
93267,6434,of,O
93268,6434,the,O
93269,6434,drug,O
93270,6434,'s,O
93271,6434,efficacy,O
93272,6434,or,O
93273,6434,adverse,O
93274,6434,events,O
93275,6434,",",O
93276,6434,or,O
93277,6434,renders,O
93278,6434,the,O
93279,6434,patient,O
93280,6434,unsuitable,O
93281,6434,for,O
93282,6434,participating,O
93283,6434,in,O
93284,6434,this,O
93285,6434,study,O
93286,6434,;,O
93287,6435,(,O
93288,6435,7)Patients,O
93289,6435,currently,O
93290,6435,taking,O
93291,6435,folate,B-Drug
93292,6435,",",O
93293,6435,B12,B-Drug
93294,6435,",",O
93295,6435,or,O
93296,6435,B6,B-Drug
93297,6435,",",O
93298,6435,or,O
93299,6435,any,O
93300,6435,compounds,O
93301,6435,containing,O
93302,6435,them,O
93303,6435,",",O
93304,6435,who,O
93305,6435,express,O
93306,6435,an,O
93307,6435,inability,B-Observation
93308,6435,or,O
93309,6435,a,O
93310,6435,refusal,B-Observation
93311,6435,to,I-Observation
93312,6435,stop,I-Observation
93313,6435,usage,I-Observation
93314,6435,;,O
93315,6436,(,O
93316,6436,8)Regular,O
93317,6436,usage,O
93318,6436,of,O
93319,6436,folic,B-Drug
93320,6436,acid,I-Drug
93321,6436,supplements,I-Drug
93322,6436,or,O
93323,6436,compounds,B-Drug
93324,6436,containing,I-Drug
93325,6436,folic,I-Drug
93326,6436,acid,I-Drug
93327,6436,in,O
93328,6436,the,O
93329,6436,past,O
93330,6436,3,O
93331,6436,months,O
93332,6436,;,O
93333,6437,(,O
93334,6437,9)Participation,O
93335,6437,in,I-Observation
93336,6437,a,I-Observation
93337,6437,clinical,I-Observation
93338,6437,trial,I-Observation
93339,6437,for,O
93340,6437,a,O
93341,6437,drug,B-Drug
93342,6437,that,I-Drug
93343,6437,has,I-Drug
93344,6437,not,I-Drug
93345,6437,yet,I-Drug
93346,6437,been,I-Drug
93347,6437,officially,I-Drug
93348,6437,approved,I-Drug
93349,6437,for,I-Drug
93350,6437,marketing,I-Drug
93351,6437,within,O
93352,6437,one,O
93353,6437,month,O
93354,6437,prior,O
93355,6437,to,O
93356,6437,the,O
93357,6437,first,O
93358,6437,visit,O
93359,6437,.,O
93360,6438,(,O
93361,6438,1)=,O
93362,6438,45,O
93363,6438,years,O
93364,6438,old,B-Person
93365,6438,;,O
93366,6439,(,O
93367,6439,2)A,O
93368,6439,diagnosis,B-Mood
93369,6439,or,O
93370,6439,previous,O
93371,6439,diagnosis,O
93372,6439,of,O
93373,6439,essential,B-Condition
93374,6439,hypertension,I-Condition
93375,6439,",",O
93376,6439,including,O
93377,6439,anyone,O
93378,6439,currently,O
93379,6439,taking,O
93380,6439,antihypertensive,B-Drug
93381,6439,drugs,I-Drug
93382,6439,;,O
93383,6439,or,O
93384,6439,for,O
93385,6439,those,O
93386,6439,who,O
93387,6439,have,O
93388,6439,not,O
93389,6439,taken,O
93390,6439,antihypertensive,B-Drug
93391,6439,drugs,I-Drug
93392,6439,within,O
93393,6439,the,O
93394,6439,last,O
93395,6439,2,O
93396,6439,weeks,O
93397,6439,",",O
93398,6439,two,O
93399,6439,consecutive,O
93400,6439,examinations,O
93401,6439,were,O
93402,6439,conducted,O
93403,6439,at,O
93404,6439,least,O
93405,6439,one,O
93406,6439,day,O
93407,6439,apart,O
93408,6439,",",O
93409,6439,and,O
93410,6439,both,O
93411,6439,sitting,B-Procedure
93412,6439,blood,I-Procedure
93413,6439,pressure,I-Procedure
93414,6439,(,O
93415,6439,mean,O
93416,6439,value,O
93417,6439,of,O
93418,6439,3,O
93419,6439,measurements,O
93420,6439,),O
93421,6439,met,O
93422,6439,the,O
93423,6439,following,O
93424,6439,criteria,O
93425,6439,:,O
93426,6439,diastolic,O
93427,6439,blood,O
93428,6439,pressure,O
93429,6439,(,O
93430,6439,DBP,O
93431,6439,),O
93432,6439,=,O
93433,6439,90,O
93434,6439,mmHg,O
93435,6439,or,O
93436,6439,systolic,O
93437,6439,blood,O
93438,6439,pressure,O
93439,6439,(,O
93440,6439,SBP,O
93441,6439,),O
93442,6439,=,O
93443,6439,140,O
93444,6439,mmHg,O
93445,6439,(,O
93446,6439,the,O
93447,6439,second,O
93448,6439,blood,O
93449,6439,pressure,O
93450,6439,was,O
93451,6439,measured,O
93452,6439,at,O
93453,6439,V1,O
93454,6439,),O
93455,6439,;,O
93456,6440,(,O
93457,6440,3)If,O
93458,6440,a,O
93459,6440,study,O
93460,6440,participant,O
93461,6440,is,O
93462,6440,a,O
93463,6440,woman,B-Person
93464,6440,of,O
93465,6440,childbearing,B-Observation
93466,6440,age,I-Observation
93467,6440,",",O
93468,6440,she,O
93469,6440,agrees,B-Mood
93470,6440,to,I-Mood
93471,6440,use,I-Mood
93472,6440,a,O
93473,6440,reliable,O
93474,6440,contraceptive,B-Observation
93475,6440,method,I-Observation
93476,6440,during,O
93477,6440,the,O
93478,6440,trial,O
93479,6440,;,O
93480,6441,(,O
93481,6441,4)Voluntarily,O
93482,6441,participates,I-Observation
93483,6441,and,O
93484,6441,has,O
93485,6441,signed,B-Observation
93486,6441,an,I-Observation
93487,6441,informed,I-Observation
93488,6441,consent,I-Observation
93489,6441,form,O
93490,6441,.,O
93491,6442,(,O
93492,6442,1)Completed,O
93493,6442,MTHFR,O
93494,6442,C677,O
93495,6442,T,O
93496,6442,gene,B-Procedure
93497,6442,polymorphism,I-Procedure
93498,6442,detection,I-Procedure
93499,6442,in,O
93500,6442,run,O
93501,6442,-,O
93502,6442,in,O
93503,6442,period,O
93504,6442,or,O
93505,6442,MTHFR,O
93506,6442,C677,O
93507,6442,T,O
93508,6442,genotype,B-Observation
93509,6442,already,I-Observation
93510,6442,known,I-Observation
93511,6442,in,O
93512,6442,advance,O
93513,6442,;,O
93514,6443,(,O
93515,6443,2)Exhibited,O
93516,6443,good,B-Condition
93517,6443,tolerance,I-Condition
93518,6443,to,I-Condition
93519,6443,enalapril,I-Condition
93520,6443,and,O
93521,6443,good,O
93522,6443,overall,O
93523,6443,medication,O
93524,6443,compliance,O
93525,6443,(,O
93526,6443,>,O
93527,6443,80,O
93528,6443,%,O
93529,6443,),O
93530,6443,in,O
93531,6443,run,O
93532,6443,-,O
93533,6443,in,O
93534,6443,period,O
93535,6443,or,O
93536,6443,previously,O
93537,6443,exhibited,O
93538,6443,good,B-Condition
93539,6443,tolerance,I-Condition
93540,6443,and,I-Condition
93541,6443,adherence,I-Condition
93542,6443,to,I-Condition
93543,6443,ACEI,I-Condition
93544,6443,drugs,I-Condition
93545,6443,in,O
93546,6443,previous,O
93547,6443,medication,B-Observation
93548,6443,history,I-Observation
93549,6443,.,O
93550,6444,(,O
93551,6444,3)Voluntarily,O
93552,6444,continues,B-Observation
93553,6444,to,I-Observation
93554,6444,participate,I-Observation
93555,6444,in,I-Observation
93556,6444,this,I-Observation
93557,6444,study,I-Observation
93558,6444,.,O
93559,6445,Patients,O
93560,6445,with,O
93561,6445,a,O
93562,6445,calculated,O
93563,6445,PRA,O
93564,6445,higher,O
93565,6445,than,O
93566,6445,0,O
93567,6445,%,O
93568,6445,per,O
93569,6445,solid,O
93570,6445,phase,O
93571,6445,and,O
93572,6445,/,O
93573,6445,or,O
93574,6445,anti,O
93575,6445,-,O
93576,6445,HLA,O
93577,6445,class,O
93578,6445,I,O
93579,6445,and,O
93580,6445,/,O
93581,6445,or,O
93582,6445,class,O
93583,6445,II,O
93584,6445,antibodies,O
93585,6445,detectable,O
93586,6445,by,O
93587,6445,single,B-Procedure
93588,6445,antigen,I-Procedure
93589,6445,test,I-Procedure
93590,6445,(,O
93591,6445,Luminex,B-Procedure
93592,6445,®,O
93593,6445,),O
93594,6445,.,O
93595,6446,Positive,O
93596,6446,result,O
93597,6446,of,O
93598,6446,Cross,B-Procedure
93599,6446,Match,I-Procedure
93600,6446,.,O
93601,6447,Patients,O
93602,6447,who,O
93603,6447,receive,O
93604,6447,a,O
93605,6447,graft,B-Procedure
93606,6447,from,I-Procedure
93607,6447,a,I-Procedure
93608,6447,cadaver,I-Procedure
93609,6447,donor,I-Procedure
93610,6447,.,O
93611,6448,Identical,B-Condition
93612,6448,HLA,I-Condition
93613,6448,patients,O
93614,6449,Patients,O
93615,6449,who,O
93616,6449,have,O
93617,6449,undergone,O
93618,6449,a,O
93619,6449,previous,O
93620,6449,solid,B-Procedure
93621,6449,organ,I-Procedure
93622,6449,transplant,I-Procedure
93623,6449,(,O
93624,6449,including,O
93625,6449,kidney,B-Procedure
93626,6449,transplant,I-Procedure
93627,6449,),O
93628,6449,or,O
93629,6449,who,O
93630,6449,are,O
93631,6449,going,O
93632,6449,to,O
93633,6449,receive,O
93634,6449,another,O
93635,6449,solid,B-Procedure
93636,6449,organ,I-Procedure
93637,6449,transplant,I-Procedure
93638,6449,concomitantly,O
93639,6449,.,O
93640,6450,Glomerular,B-Condition
93641,6450,primary,I-Condition
93642,6450,focal,I-Condition
93643,6450,and,I-Condition
93644,6450,segmental,I-Condition
93645,6450,sclerosis,I-Condition
93646,6451,Atypical,B-Condition
93647,6451,hemolytic,I-Condition
93648,6451,uremic,I-Condition
93649,6451,syndrome,I-Condition
93650,6451,(,I-Condition
93651,6451,aHUS,I-Condition
93652,6451,),I-Condition
93653,6451,/,O
93654,6451,thrombotic,B-Condition
93655,6451,thrombocytopenic,I-Condition
93656,6451,purpura,I-Condition
93657,6451,syndrome,I-Condition
93658,6451,.,O
93659,6452,Patients,O
93660,6452,with,O
93661,6452,chronic,O
93662,6452,infection,O
93663,6452,with,O
93664,6452,Hepatitis,B-Condition
93665,6452,B,I-Condition
93666,6452,virus,I-Condition
93667,6452,(,I-Condition
93668,6452,HBV,I-Condition
93669,6452,),I-Condition
93670,6452,and,O
93671,6452,/,O
93672,6452,or,O
93673,6452,active,O
93674,6452,infection,O
93675,6452,with,O
93676,6452,Hepatitis,B-Condition
93677,6452,C,I-Condition
93678,6452,virus,I-Condition
93679,6452,(,O
93680,6452,positive,O
93681,6452,PCR,B-Procedure
93682,6452,result,I-Procedure
93683,6452,),O
93684,6452,at,O
93685,6452,the,O
93686,6452,time,O
93687,6452,of,O
93688,6452,transplant,O
93689,6452,.,O
93690,6453,Patients,O
93691,6453,with,O
93692,6453,infection,O
93693,6453,with,O
93694,6453,the,O
93695,6453,known,O
93696,6453,Human,B-Condition
93697,6453,Immunodeficiency,I-Condition
93698,6453,Virus,I-Condition
93699,6453,(,I-Condition
93700,6453,HIV,I-Condition
93701,6453,),I-Condition
93702,6453,.,O
93703,6454,Patients,O
93704,6454,with,O
93705,6454,active,O
93706,6454,systemic,B-Condition
93707,6454,infection,I-Condition
93708,6454,that,O
93709,6454,requires,O
93710,6454,the,O
93711,6454,continued,O
93712,6454,administration,O
93713,6454,of,O
93714,6454,antibiotics,B-Drug
93715,6454,.,O
93716,6455,Patients,O
93717,6455,with,O
93718,6455,any,O
93719,6455,neoplasm,B-Condition
93720,6455,except,O
93721,6455,localized,B-Condition
93722,6455,skin,I-Condition
93723,6455,cancer,I-Condition
93724,6455,and,O
93725,6455,who,O
93726,6455,is,O
93727,6455,receiving,O
93728,6455,adequate,O
93729,6455,treatment,O
93730,6455,.,O
93731,6456,Patients,O
93732,6456,with,O
93733,6456,severe,O
93734,6456,anemia,B-Condition
93735,6456,(,O
93736,6456,hemoglobin,O
93737,6456,<,O
93738,6456,6,O
93739,6456,g,O
93740,6456,/,O
93741,6456,dl,O
93742,6456,),O
93743,6456,",",O
93744,6456,leukopenia,B-Condition
93745,6456,(,O
93746,6456,WBC,O
93747,6456,<,O
93748,6456,2500,O
93749,6456,/,O
93750,6456,mm3,O
93751,6456,),O
93752,6456,and,O
93753,6456,/,O
93754,6456,or,O
93755,6456,thrombocytopenia,B-Condition
93756,6456,(,O
93757,6456,platelets,O
93758,6456,<,O
93759,6456,"80,000",O
93760,6456,/,O
93761,6456,mm3,O
93762,6456,),O
93763,6456,.,O
93764,6457,Patients,O
93765,6457,who,O
93766,6457,are,O
93767,6457,hemodynamically,B-Condition
93768,6457,unstable,I-Condition
93769,6457,even,O
93770,6457,if,O
93771,6457,they,O
93772,6457,have,O
93773,6457,hemoglobin,O
93774,6457,levels,O
93775,6457,>,O
93776,6457,6,O
93777,6457,g,O
93778,6457,/,O
93779,6457,dL.,O
93780,6458,Patients,O
93781,6458,with,O
93782,6458,intestinal,B-Condition
93783,6458,pathology,I-Condition
93784,6458,or,O
93785,6458,severe,B-Condition
93786,6458,diarrhea,I-Condition
93787,6458,that,O
93788,6458,may,B-Observation
93789,6458,decrease,I-Observation
93790,6458,absorption,I-Observation
93791,6458,according,O
93792,6458,to,O
93793,6458,medical,O
93794,6458,criteria,O
93795,6458,.,O
93796,6459,Patients,O
93797,6459,with,O
93798,6459,known,O
93799,6459,hypersensitivity,B-Condition
93800,6459,to,O
93801,6459,any,O
93802,6459,of,O
93803,6459,the,O
93804,6459,drugs,B-Drug
93805,6459,used,I-Drug
93806,6459,in,I-Drug
93807,6459,this,I-Drug
93808,6459,study,I-Drug
93809,6459,.,O
93810,6460,Patients,O
93811,6460,who,O
93812,6460,have,O
93813,6460,received,O
93814,6460,any,O
93815,6460,investigational,O
93816,6460,drug,O
93817,6460,in,O
93818,6460,the,O
93819,6460,30,O
93820,6460,days,O
93821,6460,prior,O
93822,6460,to,O
93823,6460,their,O
93824,6460,inclusion,O
93825,6460,in,O
93826,6460,this,O
93827,6460,study,O
93828,6460,.,O
93829,6461,Potentially,O
93830,6461,fertile,O
93831,6461,women,O
93832,6461,who,O
93833,6461,do,O
93834,6461,not,O
93835,6461,agree,O
93836,6461,to,O
93837,6461,use,O
93838,6461,reliable,O
93839,6461,contraceptive,O
93840,6461,measures,O
93841,6461,during,O
93842,6461,the,O
93843,6461,trial,O
93844,6461,",",O
93845,6461,who,O
93846,6461,are,O
93847,6461,pregnant,O
93848,6461,",",O
93849,6461,breastfeeding,O
93850,6461,or,O
93851,6461,who,O
93852,6461,present,O
93853,6461,a,O
93854,6461,positive,O
93855,6461,pregnancy,O
93856,6461,test,O
93857,6461,at,O
93858,6461,the,O
93859,6461,time,O
93860,6461,of,O
93861,6461,their,O
93862,6461,inclusion,O
93863,6461,in,O
93864,6461,the,O
93865,6461,study,O
93866,6461,.,O
93867,6462,Patients,O
93868,6462,who,O
93869,6462,are,O
93870,6462,legally,B-Observation
93871,6462,detained,I-Observation
93872,6462,in,O
93873,6462,an,O
93874,6462,official,O
93875,6462,institution,O
93876,6462,.,O
93877,6463,Adult,B-Person
93878,6463,men,B-Person
93879,6463,and,O
93880,6463,women,B-Person
93881,6463,(=,O
93882,6463,18,O
93883,6463,years,B-Person
93884,6463,),O
93885,6463,.,O
93886,6464,Receptors,O
93887,6464,of,O
93888,6464,a,O
93889,6464,first,B-Procedure
93890,6464,kidney,I-Procedure
93891,6464,transplant,I-Procedure
93892,6464,from,O
93893,6464,an,O
93894,6464,incompatible,O
93895,6464,HLA,O
93896,6464,living,O
93897,6464,donor,O
93898,6464,(,O
93899,6464,at,O
93900,6464,least,O
93901,6464,1,O
93902,6464,mismatch,B-Observation
93903,6464,HLA,I-Observation
93904,6464,at,O
93905,6464,any,O
93906,6464,antigenic,O
93907,6464,level,O
93908,6464,),O
93909,6464,.,O
93910,6465,AB0,O
93911,6465,compatible,O
93912,6465,transplant,B-Procedure
93913,6465,.,O
93914,6466,Patients,O
93915,6466,with,O
93916,6466,a,O
93917,6466,calculated,O
93918,6466,PRA,O
93919,6466,of,O
93920,6466,0,O
93921,6466,%,O
93922,6466,by,O
93923,6466,solid,O
93924,6466,phase,O
93925,6466,technique,O
93926,6466,and,O
93927,6466,absence,B-Observation
93928,6466,of,I-Observation
93929,6466,anti,I-Observation
93930,6466,-,I-Observation
93931,6466,HLA,I-Observation
93932,6466,class,I-Observation
93933,6466,I,I-Observation
93934,6466,and,I-Observation
93935,6466,class,I-Observation
93936,6466,II,I-Observation
93937,6466,antibodies,O
93938,6466,by,O
93939,6466,single,B-Procedure
93940,6466,antigen,I-Procedure
93941,6466,test,I-Procedure
93942,6466,(,I-Procedure
93943,6466,Luminex,I-Procedure
93944,6466,®,I-Procedure
93945,6466,),I-Procedure
93946,6466,.,O
93947,6467,Patients,O
93948,6467,who,O
93949,6467,agree,O
93950,6467,to,O
93951,6467,participate,O
93952,6467,in,O
93953,6467,the,O
93954,6467,Trial,O
93955,6467,by,O
93956,6467,signing,O
93957,6467,the,O
93958,6467,Specific,O
93959,6467,Informed,O
93960,6467,Consent,O
93961,6467,of,O
93962,6467,this,O
93963,6467,study,O
93964,6467,.,O
93965,6468,Potentially,O
93966,6468,fertile,O
93967,6468,women,O
93968,6468,should,O
93969,6468,use,O
93970,6468,high,O
93971,6468,reliability,O
93972,6468,contraceptive,O
93973,6468,methods,O
93974,6468,(,O
93975,6468,Pearl,O
93976,6468,-,O
93977,6468,Index,O
93978,6468,<,O
93979,6468,1,O
93980,6468,),O
93981,6468,in,O
93982,6468,order,O
93983,6468,to,O
93984,6468,avoid,O
93985,6468,pregnancy,O
93986,6468,during,O
93987,6468,the,O
93988,6468,entire,O
93989,6468,duration,O
93990,6468,of,O
93991,6468,the,O
93992,6468,study,O
93993,6468,and,O
93994,6468,up,O
93995,6468,to,O
93996,6468,6,O
93997,6468,weeks,O
93998,6468,after,O
93999,6468,the,O
94000,6468,end,O
94001,6468,of,O
94002,6468,their,O
94003,6468,treatment,O
94004,6468,with,O
94005,6468,Mycophenolate,O
94006,6468,Mofetil,O
94007,6468,(,O
94008,6468,MMF,O
94009,6468,),O
94010,6468,.,O
94011,6468,Potentially,O
94012,6468,Fertile,O
94013,6468,Women,O
94014,6468,include,O
94015,6468,any,O
94016,6468,woman,O
94017,6468,who,O
94018,6468,has,O
94019,6468,experienced,O
94020,6468,menarche,O
94021,6468,and,O
94022,6468,who,O
94023,6468,has,O
94024,6468,not,O
94025,6468,undergone,O
94026,6468,successful,O
94027,6468,surgical,O
94028,6468,sterilization,O
94029,6468,(,O
94030,6468,hysterectomy,O
94031,6468,",",O
94032,6468,bilateral,O
94033,6468,tubal,O
94034,6468,ligation,O
94035,6468,or,O
94036,6468,bilateral,O
94037,6468,oophorectomy,O
94038,6468,),O
94039,6468,or,O
94040,6468,who,O
94041,6468,is,O
94042,6468,not,O
94043,6468,post,O
94044,6468,-,O
94045,6468,menopausal,O
94046,6468,(,O
94047,6468,defined,O
94048,6468,as,O
94049,6468,amenorrhea,O
94050,6468,=,O
94051,6468,12,O
94052,6468,consecutive,O
94053,6468,months,O
94054,6468,",",O
94055,6468,or,O
94056,6468,women,O
94057,6468,who,O
94058,6468,are,O
94059,6468,receiving,O
94060,6468,hormone,O
94061,6468,replacement,O
94062,6468,therapy,O
94063,6468,with,O
94064,6468,a,O
94065,6468,documented,O
94066,6468,level,O
94067,6468,of,O
94068,6468,follicle,O
94069,6468,stimulating,O
94070,6468,hormone,O
94071,6468,(,O
94072,6468,FSH,O
94073,6468,),O
94074,6468,>,O
94075,6468,35,O
94076,6468,mlU,O
94077,6468,/,O
94078,6468,ml,O
94079,6468,),O
94080,6468,.,O
94081,6468,Potentially,O
94082,6468,fertile,O
94083,6468,women,O
94084,6468,must,O
94085,6468,have,O
94086,6468,a,O
94087,6468,pregnancy,O
94088,6468,test,O
94089,6468,with,O
94090,6468,a,O
94091,6468,negative,O
94092,6468,result,O
94093,6468,in,O
94094,6468,the,O
94095,6468,72,O
94096,6468,hours,O
94097,6468,prior,O
94098,6468,to,O
94099,6468,the,O
94100,6468,start,O
94101,6468,of,O
94102,6468,the,O
94103,6468,trial,O
94104,6468,.,O
94105,6469,Sexually,O
94106,6469,active,O
94107,6469,males,O
94108,6469,(,O
94109,6469,including,O
94110,6469,vasectomized,O
94111,6469,males,O
94112,6469,),O
94113,6469,who,O
94114,6469,are,O
94115,6469,being,O
94116,6469,treated,O
94117,6469,with,O
94118,6469,MMF,O
94119,6469,must,O
94120,6469,accept,O
94121,6469,the,O
94122,6469,use,O
94123,6469,of,O
94124,6469,barrier,O
94125,6469,contraceptive,O
94126,6469,methods,O
94127,6469,during,O
94128,6469,MMF,O
94129,6469,treatment,O
94130,6469,and,O
94131,6469,for,O
94132,6469,90,O
94133,6469,days,O
94134,6469,thereafter,O
94135,6469,.,O
94136,6469,Potentially,O
94137,6469,fertile,O
94138,6469,partners,O
94139,6469,of,O
94140,6469,these,O
94141,6469,patients,O
94142,6469,should,O
94143,6469,use,O
94144,6469,a,O
94145,6469,reliable,O
94146,6469,contraceptive,O
94147,6469,method,O
94148,6469,during,O
94149,6469,the,O
94150,6469,same,O
94151,6469,period,O
94152,6469,",",O
94153,6469,in,O
94154,6469,order,O
94155,6469,to,O
94156,6469,minimize,O
94157,6469,the,O
94158,6469,risk,O
94159,6469,of,O
94160,6469,pregnancy,O
94161,6469,.,O
94162,6470,Patients,O
94163,6470,must,O
94164,6470,agree,O
94165,6470,not,O
94166,6470,to,O
94167,6470,donate,O
94168,6470,blood,O
94169,6470,during,O
94170,6470,treatment,O
94171,6470,with,O
94172,6470,MMF,O
94173,6470,and,O
94174,6470,during,O
94175,6470,the,O
94176,6470,6,O
94177,6470,subsequent,O
94178,6470,weeks,O
94179,6470,.,O
94180,6470,Males,O
94181,6470,should,O
94182,6470,not,O
94183,6470,make,O
94184,6470,a,O
94185,6470,sperm,O
94186,6470,donation,O
94187,6470,during,O
94188,6470,MMF,O
94189,6470,treatment,O
94190,6470,and,O
94191,6470,up,O
94192,6470,to,O
94193,6470,90,O
94194,6470,days,O
94195,6470,after,O
94196,6470,completion,O
94197,6470,.,O
94198,6471,History,O
94199,6471,of,O
94200,6471,any,O
94201,6471,malignancy,B-Condition
94202,6471,or,O
94203,6471,other,O
94204,6471,severe,B-Condition
94205,6471,diseases,I-Condition
94206,6472,Female,O
94207,6472,patients,O
94208,6472,who,O
94209,6472,are,O
94210,6472,pregnant,O
94211,6472,or,O
94212,6472,breastfeeding,O
94213,6472,before,O
94214,6472,or,O
94215,6472,during,O
94216,6472,the,O
94217,6472,three,O
94218,6472,-,O
94219,6472,year,O
94220,6472,follow,O
94221,6472,-,O
94222,6472,up,O
94223,6473,Poor,B-Observation
94224,6473,compliance,I-Observation
94225,6473,or,O
94226,6473,refusal,B-Observation
94227,6473,to,I-Observation
94228,6473,participate,I-Observation
94229,6473,.,O
94230,6474,Type,B-Condition
94231,6474,1,I-Condition
94232,6474,diabetes,I-Condition
94233,6474,according,O
94234,6474,to,O
94235,6474,ADA,O
94236,6474,criterias,O
94237,6474,<,O
94238,6474,5,O
94239,6474,years,O
94240,6474,.,O
94241,6475,Age=,B-Person
94242,6475,18,O
94243,6475,years,O
94244,6475,and,O
94245,6475,less,O
94246,6475,than,O
94247,6475,70,O
94248,6475,years,O
94249,6475,.,O
94250,6476,Non,O
94251,6476,-,O
94252,6476,obese,B-Condition
94253,6476,:,O
94254,6476,defined,O
94255,6476,as,O
94256,6476,BMI,O
94257,6476,less,O
94258,6476,than,O
94259,6476,28,O
94260,6476,kg,O
94261,6476,/,O
94262,6476,m2,O
94263,6477,Positive,O
94264,6477,for,O
94265,6477,at,O
94266,6477,least,O
94267,6477,one,O
94268,6477,of,O
94269,6477,the,O
94270,6477,anti,B-Condition
94271,6477,-,I-Condition
94272,6477,islet,I-Condition
94273,6477,autoantibodies,I-Condition
94274,6477,:,O
94275,6477,GADA,B-Condition
94276,6477,",",O
94277,6477,IA2A,B-Condition
94278,6477,",",O
94279,6477,ZnT8A,B-Condition
94280,6478,Fasting,O
94281,6478,or,O
94282,6478,postprandial,O
94283,6478,plasma,O
94284,6478,C,O
94285,6478,-,O
94286,6478,peptide,O
94287,6478,more,O
94288,6478,than,O
94289,6478,100,O
94290,6478,pmol,O
94291,6478,/,O
94292,6478,L,O
94293,6479,Written,O
94294,6479,informed,O
94295,6479,consent,O
94296,6479,from,O
94297,6479,the,O
94298,6479,patient,O
94299,6479,or,O
94300,6479,family,O
94301,6479,representative,O
94302,6479,.,O
94303,6480,Inability,O
94304,6480,to,O
94305,6480,give,O
94306,6480,informed,O
94307,6480,consent,O
94308,6481,Pregnancy,B-Condition
94309,6482,Concurrent,O
94310,6482,antibiotherapy,B-Drug
94311,6483,Certain,O
94312,6483,infectious,B-Condition
94313,6483,endocarditis,I-Condition
94314,6484,Concurrent,O
94315,6484,anti,B-Procedure
94316,6484,-,I-Procedure
94317,6484,inflammatory,I-Procedure
94318,6484,therapy,I-Procedure
94319,6484,",",O
94320,6484,including,O
94321,6484,corticosteroid,B-Procedure
94322,6484,therapy,I-Procedure
94323,6485,age,B-Person
94324,6485,>,O
94325,6485,18,O
94326,6486,written,O
94327,6486,informed,O
94328,6486,consent,O
94329,6487,SVD,B-Condition
94330,6487,defined,O
94331,6487,on,O
94332,6487,echocardiography,B-Procedure
94333,6487,by,O
94334,6487,an,O
94335,6487,alteration,B-Condition
94336,6487,of,I-Condition
94337,6487,bioprosthesis,I-Condition
94338,6487,leaflets,I-Condition
94339,6487,function,I-Condition
94340,6487,with,O
94341,6487,a,O
94342,6487,mean,O
94343,6487,transvalvular,O
94344,6487,gradient,O
94345,6487,>,O
94346,6487,20,O
94347,6487,mmHg,O
94348,6487,and,O
94349,6487,maximal,O
94350,6487,velocity,O
94351,6487,=,O
94352,6487,3,O
94353,6487,m,O
94354,6487,/,O
94355,6487,s,O
94356,6487,and,O
94357,6487,effective,O
94358,6487,orifice,O
94359,6487,area,O
94360,6487,=,O
94361,6487,1.2,O
94362,6487,cm²,O
94363,6487,",",O
94364,6487,and/or,O
94365,6487,an,O
94366,6487,aortic,B-Condition
94367,6487,regurgitation,I-Condition
94368,6487,more,O
94369,6487,or,O
94370,6487,equal,O
94371,6487,to,O
94372,6487,grade,O
94373,6487,2,O
94374,6487,on,O
94375,6487,4,O
94376,6487,.,O
94377,6488,Patient,O
94378,6488,with,O
94379,6488,a,O
94380,6488,chronic,B-Condition
94381,6488,pain,I-Condition
94382,6488,condition,I-Condition
94383,6488,",",O
94384,6488,major,O
94385,6488,unexpected,B-Condition
94386,6488,surgical,I-Condition
94387,6488,complication,I-Condition
94388,6488,",",O
94389,6488,unexpected,O
94390,6488,prolonged,O
94391,6488,intubation,B-Procedure
94392,6488,",",O
94393,6488,patient,B-Observation
94394,6488,refusal,I-Observation
94395,6488,",",O
94396,6488,local,B-Drug
94397,6488,anesthetic,I-Drug
94398,6488,allergy,B-Condition
94399,6488,",",O
94400,6488,any,O
94401,6488,contraindication,B-Condition
94402,6488,to,O
94403,6488,regional,B-Drug
94404,6488,anesthesia,I-Drug
94405,6488,",",O
94406,6488,greater,O
94407,6488,than,O
94408,6488,2,O
94409,6488,attempts,O
94410,6488,by,O
94411,6488,resident,B-Person
94412,6488,and,O
94413,6488,greater,O
94414,6488,than,O
94415,6488,1,O
94416,6488,attempt,O
94417,6488,by,O
94418,6488,staff,O
94419,6488,anesthesiologist,B-Person
94420,6488,for,O
94421,6488,TAP,B-Procedure
94422,6488,block,I-Procedure
94423,6488,.,O
94424,6489,Elective,O
94425,6489,open,B-Procedure
94426,6489,abdominal,I-Procedure
94427,6489,hysterectomy,I-Procedure
94428,6489,with,O
94429,6489,midline,O
94430,6489,incision,O
94431,6489,",",O
94432,6489,age,B-Person
94433,6489,>,O
94434,6489,18,O
94435,6489,years,O
94436,6489,",",O
94437,6489,American,O
94438,6489,Society,O
94439,6489,of,O
94440,6489,Anesthesiologist,O
94441,6489,classification,O
94442,6489,score,O
94443,6489,(,O
94444,6489,ASA,O
94445,6489,classification,O
94446,6489,),O
94447,6489,1,O
94448,6489,-,O
94449,6489,3,O
94450,6489,.,O
94451,6490,Need,B-Mood
94452,6490,for,I-Mood
94453,6490,long,B-Procedure
94454,6490,-,I-Procedure
94455,6490,term,I-Procedure
94456,6490,oral,I-Procedure
94457,6490,anticoagulation,I-Procedure
94458,6490,;,O
94459,6491,Drug,O
94460,6491,-,O
94461,6491,eluting,O
94462,6491,stent,O
94463,6491,implantation,B-Procedure
94464,6491,within,O
94465,6491,3,O
94466,6491,months,O
94467,6491,prior,O
94468,6491,to,O
94469,6491,TAVI,B-Procedure
94470,6491,procedure,I-Procedure
94471,6491,;,O
94472,6492,Bare,O
94473,6492,-,O
94474,6492,metal,O
94475,6492,stent,O
94476,6492,implantation,B-Procedure
94477,6492,within,O
94478,6492,1,O
94479,6492,month,O
94480,6492,prior,O
94481,6492,to,O
94482,6492,TAVI,B-Procedure
94483,6492,procedure,I-Procedure
94484,6492,;,O
94485,6493,Allergy,B-Condition
94486,6493,or,O
94487,6493,intolerance,B-Condition
94488,6493,to,O
94489,6493,aspirin,B-Drug
94490,6493,or,O
94491,6493,clopidogrel,B-Drug
94492,6493,.,O
94493,6494,Drug,O
94494,6494,-,O
94495,6494,eluting,O
94496,6494,stent,O
94497,6494,implantation,B-Procedure
94498,6494,within,O
94499,6494,3,O
94500,6494,months,O
94501,6494,prior,O
94502,6494,to,O
94503,6494,TAVI,B-Procedure
94504,6494,procedure,I-Procedure
94505,6494,;,O
94506,6495,Bare,O
94507,6495,-,O
94508,6495,metal,O
94509,6495,stent,O
94510,6495,implantation,B-Procedure
94511,6495,within,O
94512,6495,1,O
94513,6495,month,O
94514,6495,prior,O
94515,6495,to,O
94516,6495,TAVI,B-Procedure
94517,6495,procedure,I-Procedure
94518,6495,;,O
94519,6496,Allergy,B-Condition
94520,6496,or,O
94521,6496,intolerance,B-Condition
94522,6496,to,O
94523,6496,(,B-Drug
94524,6496,N)OAC,I-Drug
94525,6496,or,O
94526,6496,clopidogrel,B-Drug
94527,6496,.,O
94528,6497,Need,B-Mood
94529,6497,for,I-Mood
94530,6497,long,B-Procedure
94531,6497,-,I-Procedure
94532,6497,term,I-Procedure
94533,6497,oral,I-Procedure
94534,6497,anticoagulation,I-Procedure
94535,6497,;,O
94536,6498,Patient,O
94537,6498,has,O
94538,6498,provided,O
94539,6498,written,O
94540,6498,informed,O
94541,6498,consent,O
94542,6498,.,O
94543,6499,Patients,O
94544,6499,refuse,B-Observation
94545,6499,to,I-Observation
94546,6499,follow,I-Observation
94547,6499,the,I-Observation
94548,6499,research,I-Observation
94549,6500,Patient,O
94550,6500,has,O
94551,6500,had,O
94552,6500,previous,O
94553,6500,eradication,B-Procedure
94554,6500,therapy,I-Procedure
94555,6500,of,O
94556,6500,Helicobacter,B-Condition
94557,6500,pylori,I-Condition
94558,6500,infection,I-Condition
94559,6500,.,O
94560,6501,The,O
94561,6501,patient,O
94562,6501,is,O
94563,6501,pregnant,B-Condition
94564,6501,or,O
94565,6501,breastfeeding,B-Observation
94566,6502,Patients,O
94567,6502,have,O
94568,6502,a,O
94569,6502,history,B-Observation
94570,6502,of,O
94571,6502,allergy,B-Condition
94572,6502,to,O
94573,6502,one,O
94574,6502,component,B-Drug
94575,6502,of,I-Drug
94576,6502,triple,I-Drug
94577,6502,therapy,I-Drug
94578,6502,regimen,I-Drug
94579,6502,(,O
94580,6502,proton,B-Drug
94581,6502,pump,I-Drug
94582,6502,inhibitor,I-Drug
94583,6502,",",O
94584,6502,penicillin,B-Drug
94585,6502,",",O
94586,6502,and,O
94587,6502,/,O
94588,6502,or,O
94589,6502,macrolide,B-Drug
94590,6502,),O
94591,6502,before,O
94592,6502,.,O
94593,6503,Patients,O
94594,6503,are,O
94595,6503,known,O
94596,6503,to,O
94597,6503,have,O
94598,6503,impaired,O
94599,6503,liver,O
94600,6503,function,O
94601,6503,",",O
94602,6503,evidenced,O
94603,6503,by,O
94604,6503,ALT,O
94605,6503,values,O
94606,6503,within,O
94607,6503,normal,O
94608,6503,limits,O
94609,6503,",",O
94610,6503,and,O
94611,6503,no,O
94612,6503,previous,O
94613,6503,liver,B-Condition
94614,6503,disease,I-Condition
94615,6503,.,O
94616,6504,Patients,O
94617,6504,were,O
94618,6504,found,O
94619,6504,to,O
94620,6504,have,O
94621,6504,arrhythmias,B-Condition
94622,6504,or,O
94623,6504,obtained,O
94624,6504,QT,B-Condition
94625,6504,wave,I-Condition
94626,6504,elongation,I-Condition
94627,6504,on,O
94628,6504,electrocardiographic,B-Procedure
94629,6505,18,O
94630,6505,years,O
94631,6505,or,O
94632,6505,older,B-Person
94633,6505,patients,O
94634,6505,who,O
94635,6505,are,O
94636,6505,proven,O
94637,6505,to,O
94638,6505,be,O
94639,6505,infected,B-Condition
94640,6505,by,I-Condition
94641,6505,Helicobacter,I-Condition
94642,6505,pylori,I-Condition
94643,6505,based,O
94644,6505,on,O
94645,6505,positive,O
94646,6505,in,O
94647,6505,Urea,O
94648,6505,Breath,O
94649,6505,Test,O
94650,6505,or,O
94651,6505,positive,O
94652,6505,in,O
94653,6505,histopathologic,B-Procedure
94654,6505,examination,I-Procedure
94655,6505,of,I-Procedure
94656,6505,biopsy,I-Procedure
94657,6505,in,O
94658,6505,antrum,O
94659,6505,and,O
94660,6505,corpus,O
94661,6505,of,O
94662,6505,gaster,O
94663,6505,through,O
94664,6505,esophagoduodenoscopy,B-Procedure
94665,6505,.,O
94666,6506,With,O
94667,6506,the,O
94668,6506,history,O
94669,6506,of,O
94670,6506,cognitive,B-Condition
94671,6506,disorders,I-Condition
94672,6507,With,O
94673,6507,chronic,B-Condition
94674,6507,neurological,I-Condition
94675,6507,disorders,I-Condition
94676,6508,Can,B-Observation
94677,6508,not,I-Observation
94678,6508,communicate,I-Observation
94679,6508,with,O
94680,6508,investigators,O
94681,6509,Can,B-Observation
94682,6509,not,I-Observation
94683,6509,stand,I-Observation
94684,6509,general,B-Procedure
94685,6509,anesthesia,I-Procedure
94686,6510,Patients,O
94687,6510,with,O
94688,6510,informed,O
94689,6510,consents,O
94690,6511,Without,O
94691,6511,basal,B-Condition
94692,6511,disorders,I-Condition
94693,6511,of,I-Condition
94694,6511,neurology,I-Condition
94695,6511,and,I-Condition
94696,6511,psychiatrics,I-Condition
94697,6512,Pregnancy,B-Condition
94698,6512,or,O
94699,6512,lactating,B-Condition
94700,6513,Allergy,B-Condition
94701,6513,to,O
94702,6513,NAC,B-Drug
94703,6514,History,B-Observation
94704,6514,of,O
94705,6514,chronic,B-Condition
94706,6514,pain,I-Condition
94707,6515,Use,O
94708,6515,of,O
94709,6515,opioids,B-Drug
94710,6515,or,O
94711,6515,neuropathic,B-Drug
94712,6515,analgesics,I-Drug
94713,6516,Use,O
94714,6516,of,O
94715,6516,NAC,B-Drug
94716,6516,prior,O
94717,6516,to,O
94718,6516,trial,O
94719,6516,(,O
94720,6516,<,O
94721,6516,1,O
94722,6516,month,O
94723,6516,of,O
94724,6516,planned,B-Mood
94725,6516,surgery,B-Procedure
94726,6516,),O
94727,6517,Alcoholism,B-Condition
94728,6518,Diabetes,B-Condition
94729,6518,Mellitus,I-Condition
94730,6518,(,O
94731,6518,insulin,B-Drug
94732,6518,therapy,O
94733,6518,),O
94734,6519,Asthma,B-Condition
94735,6519,or,O
94736,6519,Chronic,B-Condition
94737,6519,Obstructive,I-Condition
94738,6519,pulmonary,I-Condition
94739,6519,Disease,I-Condition
94740,6520,Known,O
94741,6520,renal,B-Condition
94742,6520,function,I-Condition
94743,6520,disorders,I-Condition
94744,6520,(,O
94745,6520,MDRD,O
94746,6520,<,O
94747,6520,ô0,O
94748,6520,),O
94749,6521,Known,O
94750,6521,liver,B-Condition
94751,6521,failure,I-Condition
94752,6521,(,O
94753,6521,bilirubin,O
94754,6521,>,O
94755,6521,1.Sx,O
94756,6521,upper,O
94757,6521,limit,O
94758,6521,of,O
94759,6521,normal,O
94760,6521,),O
94761,6522,No,O
94762,6522,written,O
94763,6522,lC,O
94764,6522,by,O
94765,6522,patient,O
94766,6523,Subjects,O
94767,6523,scheduled,B-Mood
94768,6523,for,O
94769,6523,laparoscopic,O
94770,6523,unilateral,O
94771,6523,inguinal,B-Procedure
94772,6523,hernia,I-Procedure
94773,6523,repair,I-Procedure
94774,6524,ASA,O
94775,6524,1,O
94776,6524,or2,O
94777,6524,.,O
94778,6525,Age,B-Person
94779,6525,>,O
94780,6525,18,O
94781,6525,years,O
94782,6525,.,O
94783,6526,Contraindication,B-Condition
94784,6526,to,O
94785,6526,azithromycin,B-Drug
94786,6526,use,O
94787,6526,and,O
94788,6526,other,O
94789,6526,prophylactic,B-Drug
94790,6526,antibiotic,I-Drug
94791,6526,use,I-Drug
94792,6527,Age,B-Person
94793,6527,1,O
94794,6527,-,O
94795,6527,59,O
94796,6527,months,O
94797,6527,",",O
94798,6528,Plan,B-Mood
94799,6528,to,O
94800,6528,remain,B-Observation
94801,6528,in,I-Observation
94802,6528,study,I-Observation
94803,6528,area,I-Observation
94804,6528,greater,O
94805,6528,than,O
94806,6528,6,O
94807,6528,months,O
94808,6529,Discharged,B-Procedure
94809,6529,from,I-Procedure
94810,6529,hospital,I-Procedure
94811,6529,following,O
94812,6529,non,B-Procedure
94813,6529,-,I-Procedure
94814,6529,trauma,I-Procedure
94815,6529,related,I-Procedure
94816,6529,admission,I-Procedure
94817,6530,Current,O
94818,6530,or,O
94819,6530,recent,O
94820,6530,infection,B-Condition
94821,6531,Clinically,O
94822,6531,significant,O
94823,6531,laboratory,B-Condition
94824,6531,abnormalities,I-Condition
94825,6532,Pregnancy,B-Condition
94826,6533,Moderate,O
94827,6533,to,O
94828,6533,severe,O
94829,6533,rheumatoid,B-Condition
94830,6533,arthritis,I-Condition
94831,6534,Taking,O
94832,6534,methotrexate,B-Drug
94833,6534,without,O
94834,6534,adequate,B-Observation
94835,6534,control,I-Observation
94836,6534,of,I-Observation
94837,6534,symptoms,I-Observation
94838,6535,Have,O
94839,6535,at,O
94840,6535,least,O
94841,6535,one,O
94842,6535,cardiovascular,B-Condition
94843,6535,risk,I-Condition
94844,6535,factor,I-Condition
94845,6535,(,O
94846,6535,eg,O
94847,6535,",",O
94848,6535,current,O
94849,6535,smoker,B-Observation
94850,6535,",",O
94851,6535,high,B-Condition
94852,6535,blood,I-Condition
94853,6535,pressure,I-Condition
94854,6535,",",O
94855,6535,high,B-Condition
94856,6535,cholesterol,I-Condition
94857,6535,levels,I-Condition
94858,6535,",",O
94859,6535,diabetes,B-Condition
94860,6535,mellitus,I-Condition
94861,6535,",",O
94862,6535,history,B-Observation
94863,6535,of,O
94864,6535,heart,B-Condition
94865,6535,attack,I-Condition
94866,6535,",",O
94867,6535,family,B-Observation
94868,6535,history,I-Observation
94869,6535,of,O
94870,6535,coronary,B-Condition
94871,6535,heart,I-Condition
94872,6535,disease,I-Condition
94873,6535,",",O
94874,6535,extra,O
94875,6535,-,O
94876,6535,articular,O
94877,6535,RA,B-Condition
94878,6535,disease,I-Condition
94879,6535,),O
94880,6536,Preexisting,O
94881,6536,ocular,B-Condition
94882,6536,diseases,I-Condition
94883,6536,or,O
94884,6536,conditions,B-Condition
94885,6536,other,O
94886,6536,than,O
94887,6536,age,O
94888,6536,related,O
94889,6536,cataracts,B-Condition
94890,6536,",",O
94891,6536,have,O
94892,6536,contraindications,B-Condition
94893,6536,for,O
94894,6536,cataract,B-Procedure
94895,6536,surgery,I-Procedure
94896,6536,;,O
94897,6537,Preexisting,O
94898,6537,systemic,B-Condition
94899,6537,diseases,I-Condition
94900,6537,or,O
94901,6537,conditions,B-Condition
94902,6537,that,O
94903,6537,may,O
94904,6537,confound,O
94905,6537,the,O
94906,6537,results,O
94907,6537,of,O
94908,6537,the,O
94909,6537,study,O
94910,6537,;,O
94911,6538,Previous,O
94912,6538,ocular,B-Procedure
94913,6538,surgery,I-Procedure
94914,6538,history,O
94915,6538,or,O
94916,6538,ocular,B-Condition
94917,6538,trauma,I-Condition
94918,6538,that,O
94919,6538,may,O
94920,6538,confound,O
94921,6538,the,O
94922,6538,results,O
94923,6538,of,O
94924,6538,the,O
94925,6538,study,O
94926,6538,;,O
94927,6539,Require,B-Mood
94928,6539,combined,B-Procedure
94929,6539,surgery,I-Procedure
94930,6539,that,O
94931,6539,may,O
94932,6539,confound,O
94933,6539,the,O
94934,6539,results,O
94935,6539,of,O
94936,6539,the,O
94937,6539,study,O
94938,6539,;,O
94939,6540,Previous,O
94940,6540,participation,O
94941,6540,in,O
94942,6540,other,O
94943,6540,clinical,O
94944,6540,trial,O
94945,6540,within,O
94946,6540,30,O
94947,6540,days,O
94948,6540,of,O
94949,6540,this,O
94950,6540,study,O
94951,6540,start,O
94952,6540,;,O
94953,6541,Systemic,B-Drug
94954,6541,or,I-Drug
94955,6541,ocular,I-Drug
94956,6541,medications,I-Drug
94957,6541,that,O
94958,6541,may,O
94959,6541,confound,O
94960,6541,the,O
94961,6541,outcome,O
94962,6541,of,O
94963,6541,the,O
94964,6541,intervention,O
94965,6542,Pregnant,B-Condition
94966,6542,",",O
94967,6542,lactating,B-Condition
94968,6542,",",O
94969,6542,or,O
94970,6542,planning,B-Mood
94971,6542,to,I-Mood
94972,6542,become,I-Mood
94973,6542,pregnant,B-Condition
94974,6542,during,O
94975,6542,the,O
94976,6542,course,O
94977,6542,of,O
94978,6542,the,O
94979,6542,trial,O
94980,6542,;,O
94981,6543,Age,B-Person
94982,6543,from,O
94983,6543,40,O
94984,6543,to,O
94985,6543,80,O
94986,6543,years,O
94987,6543,old,O
94988,6543,",",O
94989,6543,either,O
94990,6543,gender,O
94991,6543,;,O
94992,6544,Patients,O
94993,6544,with,O
94994,6544,bilateral,O
94995,6544,age,O
94996,6544,related,O
94997,6544,cataracts,B-Condition
94998,6544,",",O
94999,6544,require,O
95000,6544,bilateral,O
95001,6544,cataract,B-Procedure
95002,6544,phacoemulsification,I-Procedure
95003,6544,combined,O
95004,6544,Intraocular,B-Procedure
95005,6544,Lens,I-Procedure
95006,6544,implantation,I-Procedure
95007,6544,;,O
95008,6545,Willing,O
95009,6545,to,O
95010,6545,undergo,O
95011,6545,second,O
95012,6545,eye,O
95013,6545,surgery,O
95014,6545,within,O
95015,6545,7,O
95016,6545,days,O
95017,6545,after,O
95018,6545,first,O
95019,6545,eye,O
95020,6545,surgery,O
95021,6545,;,O
95022,6546,The,O
95023,6546,potential,O
95024,6546,postoperative,O
95025,6546,visual,O
95026,6546,acuity,O
95027,6546,of,O
95028,6546,20/40,O
95029,6546,or,O
95030,6546,better,O
95031,6546,in,O
95032,6546,both,O
95033,6546,eyes,O
95034,6546,;,O
95035,6547,Preoperative,O
95036,6547,measurement,O
95037,6547,of,O
95038,6547,corneal,O
95039,6547,astigmatism,O
95040,6547,indicate,O
95041,6547,the,O
95042,6547,subjects,O
95043,6547,are,O
95044,6547,suitable,O
95045,6547,for,O
95046,6547,multifocal,B-Procedure
95047,6547,intraocular,I-Procedure
95048,6547,lenses,I-Procedure
95049,6547,implantation,I-Procedure
95050,6547,;,O
95051,6548,Capability,O
95052,6548,to,O
95053,6548,understand,O
95054,6548,the,O
95055,6548,informed,O
95056,6548,consent,O
95057,6548,and,O
95058,6548,willing,O
95059,6548,and,O
95060,6548,able,O
95061,6548,to,O
95062,6548,attend,O
95063,6548,study,O
95064,6549,Women,B-Person
95065,6549,with,O
95066,6549,Non,B-Condition
95067,6549,-,I-Condition
95068,6549,proteinuric,I-Condition
95069,6549,hypertension,I-Condition
95070,6550,severe,O
95071,6550,renal,B-Condition
95072,6550,impairment,I-Condition
95073,6551,Myasthenia,B-Condition
95074,6551,gravis,I-Condition
95075,6552,High,O
95076,6552,amount,O
95077,6552,of,O
95078,6552,magnesium,O
95079,6552,in,O
95080,6552,blood,O
95081,6553,Low,O
95082,6553,or,O
95083,6553,high,O
95084,6553,amount,O
95085,6553,of,O
95086,6553,calcium,O
95087,6553,in,O
95088,6553,blood,O
95089,6554,Myocardial,B-Condition
95090,6554,damage,I-Condition
95091,6554,",",O
95092,6554,diabetic,B-Condition
95093,6554,coma,I-Condition
95094,6554,",",O
95095,6554,heart,B-Condition
95096,6554,block,I-Condition
95097,6555,Pregnant,B-Condition
95098,6555,women,B-Person
95099,6555,admitted,B-Procedure
95100,6555,to,I-Procedure
95101,6555,Women,O
95102,6555,health,O
95103,6555,hospital,O
95104,6555,with,O
95105,6555,a,O
95106,6555,diagnosis,O
95107,6555,of,O
95108,6555,severe,O
95109,6555,pre,B-Condition
95110,6555,-,I-Condition
95111,6555,eclampsia,I-Condition
95112,6556,Those,O
95113,6556,subjects,O
95114,6556,with,O
95115,6556,previous,O
95116,6556,use,O
95117,6556,of,O
95118,6556,vitamin,B-Drug
95119,6556,D.,I-Drug
95120,6557,Known,O
95121,6557,subjects,O
95122,6557,with,O
95123,6557,renal,O
95124,6557,",",O
95125,6557,liver,O
95126,6557,",",O
95127,6557,calcium,B-Condition
95128,6557,metabolism,I-Condition
95129,6557,disorders,I-Condition
95130,6557,",",O
95131,6557,malabsorption,B-Condition
95132,6557,disorders,I-Condition
95133,6557,",",O
95134,6557,known,O
95135,6557,neoplasms,B-Condition
95136,6557,.,O
95137,6558,Subjects,O
95138,6558,with,O
95139,6558,serum,O
95140,6558,calcium,O
95141,6558,levels,O
95142,6558,equal,O
95143,6558,to,O
95144,6558,or,O
95145,6558,greater,O
95146,6558,than,O
95147,6558,10.2,O
95148,6558,mg,O
95149,6558,/,O
95150,6558,dl,O
95151,6558,.,O
95152,6559,Female,B-Person
95153,6559,patients,O
95154,6559,older,O
95155,6559,than,O
95156,6559,18,O
95157,6559,years,B-Person
95158,6559,.,O
95159,6560,Patients,O
95160,6560,who,O
95161,6560,agree,O
95162,6560,to,O
95163,6560,participate,O
95164,6560,in,O
95165,6560,the,O
95166,6560,study,O
95167,6560,.,O
95168,6561,Those,O
95169,6561,that,O
95170,6561,meet,O
95171,6561,the,O
95172,6561,ACR,O
95173,6561,1990,O
95174,6561,and,O
95175,6561,2010,O
95176,6561,criteria,O
95177,6561,for,O
95178,6561,Fibromyalgia,B-Condition
95179,6561,.,O
95180,6562,No,O
95181,6562,previous,O
95182,6562,use,O
95183,6562,of,O
95184,6562,vitamin,O
95185,6562,D.,O
95186,6563,Patients,O
95187,6563,diagnosed,O
95188,6563,with,O
95189,6563,primary,O
95190,6563,or,O
95191,6563,secondary,O
95192,6563,fibromyalgia,B-Condition
95193,6563,.,O
95194,6564,Current,O
95195,6564,or,O
95196,6564,planned,B-Mood
95197,6564,pregnancy,B-Condition
95198,6565,History,B-Observation
95199,6565,of,O
95200,6565,neuropathic,B-Condition
95201,6565,pain,I-Condition
95202,6565,",",O
95203,6565,chronic,B-Condition
95204,6565,pain,I-Condition
95205,6565,syndrome,I-Condition
95206,6565,",",O
95207,6565,or,O
95208,6565,preoperative,O
95209,6565,use,O
95210,6565,of,O
95211,6565,narcotic,B-Drug
95212,6565,or,I-Drug
95213,6565,neuropathic,I-Drug
95214,6565,pain,I-Drug
95215,6565,medicine,I-Drug
95216,6566,Radiographic,B-Mood
95217,6566,signs,I-Mood
95218,6566,of,O
95219,6566,osteoarthritis,B-Condition
95220,6566,(,O
95221,6566,>,O
95222,6566,Tonis,O
95223,6566,grade,O
95224,6566,1,O
95225,6566,),O
95226,6567,Inability,B-Condition
95227,6567,to,O
95228,6567,attend,B-Observation
95229,6567,follow,I-Observation
95230,6567,up,I-Observation
95231,6567,visits,I-Observation
95232,6568,Documented,O
95233,6568,allergy,B-Condition
95234,6568,to,O
95235,6568,local,B-Drug
95236,6568,anesthetic,I-Drug
95237,6569,Scheduled,B-Mood
95238,6569,for,O
95239,6569,arthroscopic,B-Procedure
95240,6569,labral,I-Procedure
95241,6569,repair,I-Procedure
95242,6569,with,O
95243,6569,or,O
95244,6569,without,O
95245,6569,osteoplasty,B-Procedure
95246,6569,of,O
95247,6569,the,O
95248,6569,hip,O
95249,6569,.,O
95250,6570,18,O
95251,6570,to,O
95252,6570,50,O
95253,6570,years,O
95254,6570,old,B-Person
95255,6571,American,O
95256,6571,Society,O
95257,6571,of,O
95258,6571,Anesthesiologists,O
95259,6571,Physical,O
95260,6571,Status,O
95261,6571,(,O
95262,6571,ASA,O
95263,6571,PS,O
95264,6571,),O
95265,6571,score,O
95266,6571,of,O
95267,6571,I,O
95268,6571,or,O
95269,6571,II,O
95270,6571,.,O
95271,6572,1,O
95272,6572,.,O
95273,6572,Active,O
95274,6572,thromboembolic,B-Condition
95275,6572,disease,I-Condition
95276,6572,",",O
95277,6572,history,B-Observation
95278,6572,of,O
95279,6572,thromboembolic,B-Condition
95280,6572,disease,I-Condition
95281,6572,(,O
95282,6572,including,O
95283,6572,retinal,B-Condition
95284,6572,vein,I-Condition
95285,6572,or,O
95286,6572,artery,B-Condition
95287,6572,occlusion,I-Condition
95288,6572,),O
95289,6572,",",O
95290,6572,known,O
95291,6572,inherited,B-Condition
95292,6572,thrombophilia,I-Condition
95293,6572,",",O
95294,6572,or,O
95295,6572,family,B-Observation
95296,6572,history,I-Observation
95297,6572,of,O
95298,6572,thrombosis,B-Condition
95299,6572,in,B-Observation
95300,6572,a,I-Observation
95301,6572,first,I-Observation
95302,6572,degree,I-Observation
95303,6572,relative,I-Observation
95304,6573,2,O
95305,6573,.,O
95306,6573,Subject,O
95307,6573,has,O
95308,6573,a,O
95309,6573,severe,O
95310,6573,medical,B-Condition
95311,6573,or,I-Condition
95312,6573,psychiatric,I-Condition
95313,6573,illness,I-Condition
95314,6573,that,O
95315,6573,",",O
95316,6573,in,O
95317,6573,the,O
95318,6573,opinion,O
95319,6573,of,O
95320,6573,the,O
95321,6573,Investigator,O
95322,6573,",",O
95323,6573,would,O
95324,6573,affect,O
95325,6573,subject,O
95326,6573,safety,O
95327,6573,or,O
95328,6573,compliance,O
95329,6574,3,O
95330,6574,.,O
95331,6574,Clinical,O
95332,6574,evidence,O
95333,6574,of,O
95334,6574,severe,O
95335,6574,bleeding,B-Condition
95336,6574,disorder,I-Condition
95337,6574,.,O
95338,6574,Patients,O
95339,6574,with,O
95340,6574,mild,O
95341,6574,bleeding,B-Condition
95342,6574,disorders,I-Condition
95343,6574,such,O
95344,6574,as,O
95345,6574,type,B-Condition
95346,6574,1,I-Condition
95347,6574,von,I-Condition
95348,6574,Willebrand,I-Condition
95349,6574,disease,I-Condition
95350,6574,",",O
95351,6574,mild,B-Condition
95352,6574,platelet,I-Condition
95353,6574,function,I-Condition
95354,6574,defects,I-Condition
95355,6574,such,O
95356,6574,as,O
95357,6574,platelet,B-Condition
95358,6574,storage,I-Condition
95359,6574,pool,I-Condition
95360,6574,or,I-Condition
95361,6574,release,I-Condition
95362,6574,defects,I-Condition
95363,6574,",",O
95364,6574,and,O
95365,6574,patients,O
95366,6574,with,O
95367,6574,bleeding,B-Condition
95368,6574,due,O
95369,6574,to,O
95370,6574,Ehlers,B-Condition
95371,6574,Danlos,I-Condition
95372,6574,syndrome,I-Condition
95373,6574,WILL,O
95374,6574,be,O
95375,6574,eligible,O
95376,6574,to,O
95377,6574,participate,O
95378,6574,in,O
95379,6574,the,O
95380,6574,study,O
95381,6574,.,O
95382,6575,4,O
95383,6575,.,O
95384,6575,Pregnancy,B-Condition
95385,6575,within,O
95386,6575,the,O
95387,6575,past,O
95388,6575,6,O
95389,6575,months,O
95390,6575,and/or,O
95391,6575,breast,B-Condition
95392,6575,-,I-Condition
95393,6575,feeding,I-Condition
95394,6576,5,O
95395,6576,.,O
95396,6576,Use,O
95397,6576,of,O
95398,6576,hormonal,B-Procedure
95399,6576,contraception,I-Procedure
95400,6576,(,O
95401,6576,estrogen,B-Drug
95402,6576,and,O
95403,6576,progestin,B-Drug
95404,6576,),O
95405,6576,within,O
95406,6576,3,O
95407,6576,months,O
95408,6576,of,O
95409,6576,study,O
95410,6576,entry,O
95411,6576,",",O
95412,6576,or,O
95413,6576,anticipated,B-Observation
95414,6576,need,I-Observation
95415,6576,to,O
95416,6576,initiate,O
95417,6576,estrogen,B-Procedure
95418,6576,-,I-Procedure
95419,6576,containing,I-Procedure
95420,6576,hormonal,I-Procedure
95421,6576,contraception,I-Procedure
95422,6576,during,O
95423,6576,the,O
95424,6576,study,O
95425,6576,period,O
95426,6577,6,O
95427,6577,.,O
95428,6577,Use,O
95429,6577,of,O
95430,6577,systemic,B-Drug
95431,6577,steroids,I-Drug
95432,6577,within,O
95433,6577,1,O
95434,6577,month,O
95435,6577,of,O
95436,6577,study,O
95437,6577,entry,O
95438,6578,7,O
95439,6578,.,O
95440,6578,History,B-Observation
95441,6578,of,O
95442,6578,subarachnoid,B-Condition
95443,6578,hemorrhage,I-Condition
95444,6579,8,O
95445,6579,.,O
95446,6579,History,B-Observation
95447,6579,of,O
95448,6579,Hepatitis,B-Condition
95449,6579,B,I-Condition
95450,6579,",",I-Condition
95451,6579,C,I-Condition
95452,6579,",",O
95453,6579,or,O
95454,6579,HIV,B-Condition
95455,6580,9,O
95456,6580,.,O
95457,6580,Baseline,O
95458,6580,creatinine,O
95459,6580,>,O
95460,6580,20,O
95461,6580,%,O
95462,6580,above,O
95463,6580,the,O
95464,6580,upper,O
95465,6580,limit,O
95466,6580,of,O
95467,6580,normal,O
95468,6580,for,O
95469,6580,age,B-Person
95470,6581,10,O
95471,6581,.,O
95472,6581,Severe,O
95473,6581,anemia,B-Condition
95474,6581,(,O
95475,6581,hemoglobin,O
95476,6581,<,O
95477,6581,8,O
95478,6581,g,O
95479,6581,/,O
95480,6581,dL,O
95481,6581,),O
95482,6582,11,O
95483,6582,.,O
95484,6582,Systolic,O
95485,6582,blood,O
95486,6582,pressure,O
95487,6582,<,O
95488,6582,85,O
95489,6582,or,O
95490,6582,diastolic,O
95491,6582,blood,O
95492,6582,pressure,O
95493,6582,<,O
95494,6582,55,O
95495,6583,12,O
95496,6583,.,O
95497,6583,Heart,O
95498,6583,rate,O
95499,6583,<,O
95500,6583,50,O
95501,6583,at,O
95502,6583,time,O
95503,6583,of,O
95504,6583,screening,O
95505,6584,13,O
95506,6584,.,O
95507,6584,Use,O
95508,6584,of,O
95509,6584,intranasal,O
95510,6584,DDAVP,O
95511,6584,during,O
95512,6584,menses,O
95513,6584,will,O
95514,6584,be,O
95515,6584,permitted,O
95516,6584,",",O
95517,6584,but,O
95518,6584,only,O
95519,6584,if,O
95520,6584,the,O
95521,6584,patient,O
95522,6584,has,O
95523,6584,a,O
95524,6584,history,O
95525,6584,of,O
95526,6584,using,O
95527,6584,DDAVP,O
95528,6584,consistently,O
95529,6584,for,O
95530,6584,≥3,O
95531,6584,menstrual,O
95532,6584,cycles,O
95533,6584,prior,O
95534,6584,to,O
95535,6584,study,O
95536,6584,enrollment,O
95537,6584,",",O
95538,6584,so,O
95539,6584,that,O
95540,6584,change,O
95541,6584,in,O
95542,6584,menstrual,O
95543,6584,blood,O
95544,6584,loss,O
95545,6584,due,O
95546,6584,to,O
95547,6584,addition,O
95548,6584,of,O
95549,6584,Lysteda,O
95550,6584,can,O
95551,6584,be,O
95552,6584,assessed,O
95553,6584,.,O
95554,6584,Use,O
95555,6584,of,O
95556,6584,one,O
95557,6584,-,O
95558,6584,time,O
95559,6584,DDAVP,O
95560,6584,during,O
95561,6584,a,O
95562,6584,DDAVP,O
95563,6584,/,O
95564,6584,Stimate,O
95565,6584,challenge,O
95566,6584,is,O
95567,6584,also,O
95568,6584,permitted,O
95569,6584,during,O
95570,6584,the,O
95571,6584,study,O
95572,6584,period,O
95573,6584,",",O
95574,6584,as,O
95575,6584,is,O
95576,6584,use,O
95577,6584,of,O
95578,6584,DDAVP,O
95579,6584,in,O
95580,6584,the,O
95581,6584,event,O
95582,6584,of,O
95583,6584,severe,O
95584,6584,epistaxis,O
95585,6584,",",O
95586,6584,trauma,O
95587,6584,",",O
95588,6584,or,O
95589,6584,surgical,O
95590,6584,procedures,O
95591,6584,during,O
95592,6584,the,O
95593,6584,study,O
95594,6584,period,O
95595,6584,.,O
95596,6585,1,O
95597,6585,.,O
95598,6585,Menstruating,B-Condition
95599,6585,females,B-Person
95600,6585,10,O
95601,6585,-,O
95602,6585,19,O
95603,6585,years,O
95604,6585,of,O
95605,6585,age,B-Person
95606,6586,2,O
95607,6586,.,O
95608,6586,Non,B-Condition
95609,6586,-,I-Condition
95610,6586,smoker,I-Condition
95611,6587,3,O
95612,6587,.,O
95613,6587,Physician,O
95614,6587,and,O
95615,6587,patient,O
95616,6587,have,O
95617,6587,agreed,O
95618,6587,to,O
95619,6587,initiate,O
95620,6587,Lysteda,B-Drug
95621,6588,4,O
95622,6588,.,O
95623,6588,Diagnosis,O
95624,6588,of,O
95625,6588,HMB,B-Condition
95626,6588,based,O
95627,6588,on,O
95628,6588,the,O
95629,6588,medical,O
95630,6588,judgment,O
95631,6588,of,O
95632,6588,the,O
95633,6588,principal,O
95634,6588,or,O
95635,6588,site,O
95636,6588,investigator,O
95637,6589,5,O
95638,6589,.,O
95639,6589,Subjects,O
95640,6589,must,O
95641,6589,report,O
95642,6589,menstrual,B-Condition
95643,6589,periods,I-Condition
95644,6589,occurring,O
95645,6589,within,O
95646,6589,21,O
95647,6589,-,O
95648,6589,60,O
95649,6589,days,O
95650,6589,from,O
95651,6589,the,O
95652,6589,start,O
95653,6589,of,O
95654,6589,one,O
95655,6589,period,O
95656,6589,to,O
95657,6589,the,O
95658,6589,start,O
95659,6589,of,O
95660,6589,the,O
95661,6589,next,O
95662,6589,menstrual,O
95663,6589,period,O
95664,6590,6,O
95665,6590,.,O
95666,6590,Negative,O
95667,6590,pregnancy,O
95668,6590,test,O
95669,6591,7,O
95670,6591,.,O
95671,6591,Informed,O
95672,6591,consent,O
95673,6591,obtained,O
95674,6591,and,O
95675,6591,signed,O
95676,6592,8,O
95677,6592,.,O
95678,6592,Informed,O
95679,6592,assent,O
95680,6592,obtained,O
95681,6592,and,O
95682,6592,signed,O
95683,6593,9,O
95684,6593,.,O
95685,6593,Understanding,O
95686,6593,of,O
95687,6593,study,O
95688,6593,procedures,O
95689,6594,10,O
95690,6594,.,O
95691,6594,Ability,O
95692,6594,to,O
95693,6594,comply,O
95694,6594,with,O
95695,6594,study,O
95696,6594,procedures,O
95697,6594,for,O
95698,6594,the,O
95699,6594,entire,O
95700,6594,length,O
95701,6594,of,O
95702,6594,the,O
95703,6594,study,O
95704,6595,11,O
95705,6595,.,O
95706,6595,Subjects,O
95707,6595,should,O
95708,6595,be,O
95709,6595,either,O
95710,6595,sexually,B-Condition
95711,6595,inactive,I-Condition
95712,6595,(,I-Condition
95713,6595,abstinent,I-Condition
95714,6595,),O
95715,6595,or,O
95716,6595,agree,B-Observation
95717,6595,to,I-Observation
95718,6595,use,I-Observation
95719,6595,a,O
95720,6595,barrier,O
95721,6595,method,O
95722,6595,with,O
95723,6595,spermicide,O
95724,6595,in,O
95725,6595,the,O
95726,6595,event,O
95727,6595,of,O
95728,6595,sexual,O
95729,6595,activity,O
95730,6595,throughout,O
95731,6595,the,O
95732,6595,study,O
95733,6595,period,O
95734,6596,History,O
95735,6596,of,O
95736,6596,recurrent,B-Condition
95737,6596,UTI,I-Condition
95738,6596,(,O
95739,6596,defined,O
95740,6596,as,O
95741,6596,three,O
95742,6596,culture,O
95743,6596,proven,O
95744,6596,UTIs,O
95745,6596,within,O
95746,6596,last,O
95747,6596,12,O
95748,6596,months,O
95749,6596,),O
95750,6597,Systemic,O
95751,6597,neuromuscular,B-Condition
95752,6597,disease,I-Condition
95753,6597,known,O
95754,6597,to,O
95755,6597,affect,O
95756,6597,the,O
95757,6597,lower,O
95758,6597,urinary,O
95759,6597,tract,O
95760,6598,Undergoing,O
95761,6598,concomitant,O
95762,6598,prolapse,B-Procedure
95763,6598,surgery,I-Procedure
95764,6599,Previous,O
95765,6599,incontinence,B-Procedure
95766,6599,surgery,I-Procedure
95767,6600,Treatment,O
95768,6600,with,O
95769,6600,anticholinergic,B-Drug
95770,6600,medication,I-Drug
95771,6600,in,O
95772,6600,the,O
95773,6600,last,O
95774,6600,2,O
95775,6600,months,O
95776,6601,Previous,O
95777,6601,bladder,O
95778,6601,injection,O
95779,6601,with,O
95780,6601,onabotulinumtoxinA,B-Drug
95781,6602,Prisoner,B-Person
95782,6602,Status,O
95783,6603,Pregnancy,B-Condition
95784,6604,Undergoing,O
95785,6604,mid,B-Procedure
95786,6604,-,I-Procedure
95787,6604,urethral,I-Procedure
95788,6604,sling,I-Procedure
95789,6604,surgery,I-Procedure
95790,6605,Have,O
95791,6605,symptoms,O
95792,6605,of,O
95793,6605,both,O
95794,6605,stress,B-Condition
95795,6605,and,I-Condition
95796,6605,urgency,I-Condition
95797,6605,urinary,I-Condition
95798,6605,incontinence,I-Condition
95799,6606,Able,O
95800,6606,to,O
95801,6606,consent,O
95802,6606,",",O
95803,6606,fill,O
95804,6606,out,O
95805,6606,study,O
95806,6606,documents,O
95807,6606,",",O
95808,6606,and,O
95809,6606,complete,O
95810,6606,all,O
95811,6606,study,O
95812,6606,procedures,O
95813,6606,and,O
95814,6606,follow,O
95815,6606,-,O
95816,6606,up,O
95817,6606,visits,O
95818,6607,At,O
95819,6607,least,O
95820,6607,18,O
95821,6607,years,O
95822,6607,of,O
95823,6607,age,B-Person
95824,6608,English,O
95825,6608,speaking,O
95826,6609,Be,O
95827,6609,able,O
95828,6609,and,O
95829,6609,willing,O
95830,6609,to,O
95831,6609,learn,O
95832,6609,clean,O
95833,6609,intermittent,O
95834,6609,self,O
95835,6609,catheterization,O
95836,6609,technique,O
95837,6610,Having,O
95838,6610,experienced,O
95839,6610,severe,B-Condition
95840,6610,allergies,I-Condition
95841,6610,",",O
95842,6610,trauma,B-Condition
95843,6610,history,O
95844,6610,and/or,O
95845,6610,operation,B-Procedure
95846,6610,history,O
95847,6610,within,O
95848,6610,3,O
95849,6610,months,O
95850,6610,;,O
95851,6611,With,O
95852,6611,a,O
95853,6611,history,B-Observation
95854,6611,of,O
95855,6611,mental,B-Condition
95856,6611,illness,I-Condition
95857,6611,and/or,O
95858,6611,family,B-Observation
95859,6611,history,I-Observation
95860,6611,of,O
95861,6611,mental,B-Condition
95862,6611,illness,I-Condition
95863,6611,;,O
95864,6612,Limb,B-Condition
95865,6612,disabled,I-Condition
95866,6612,;,O
95867,6613,Taking,O
95868,6613,medicine,B-Drug
95869,6613,within,O
95870,6613,one,O
95871,6613,month,O
95872,6613,;,O
95873,6614,Suffering,O
95874,6614,major,B-Condition
95875,6614,events,I-Condition
95876,6614,or,O
95877,6614,having,O
95878,6614,mood,B-Condition
95879,6614,swings,I-Condition
95880,6614,.,O
95881,6615,Women,B-Person
95882,6615,aged,B-Person
95883,6615,20,O
95884,6615,-,O
95885,6615,49,O
95886,6615,;,O
95887,6616,Having,O
95888,6616,a,O
95889,6616,regular,B-Condition
95890,6616,menstrual,I-Condition
95891,6616,cycle,I-Condition
95892,6616,of,O
95893,6616,which,O
95894,6616,the,O
95895,6616,menstrual,O
95896,6616,period,O
95897,6616,is,O
95898,6616,between,O
95899,6616,day,O
95900,6616,3,O
95901,6616,-,O
95902,6616,7,O
95903,6616,",",O
95904,6616,and,O
95905,6616,the,O
95906,6616,period,O
95907,6616,between,O
95908,6616,day,O
95909,6616,25,O
95910,6616,-,O
95911,6616,35,O
95912,6616,;,O
95913,6617,Excluding,O
95914,6617,internal,B-Condition
95915,6617,and,I-Condition
95916,6617,surgical,I-Condition
95917,6617,disease,I-Condition
95918,6617,(,O
95919,6617,after,O
95920,6617,having,O
95921,6617,variety,O
95922,6617,of,O
95923,6617,physical,O
95924,6617,examination,O
95925,6617,such,O
95926,6617,as,O
95927,6617,electrocardiogram,O
95928,6617,/,O
95929,6617,hepatic,O
95930,6617,and,O
95931,6617,renal,O
95932,6617,function,O
95933,6617,/,O
95934,6617,blood,O
95935,6617,routine,O
95936,6617,and,O
95937,6617,urine,O
95938,6617,routine,O
95939,6617,),O
95940,6617,.,O
95941,6618,Patients,O
95942,6618,with,O
95943,6618,>,O
95944,6618,14,O
95945,6618,follicles,O
95946,6618,on,O
95947,6618,day,O
95948,6618,of,O
95949,6618,trigger,O
95950,6619,Previous,O
95951,6619,hyperresponse,B-Condition
95952,6619,with,O
95953,6619,OHSS,B-Observation
95954,6619,development,I-Observation
95955,6620,Previous,O
95956,6620,low,B-Condition
95957,6620,response,I-Condition
95958,6620,(,O
95959,6620,less,O
95960,6620,than,O
95961,6620,3,O
95962,6620,oocytes,O
95963,6620,on,O
95964,6620,a,O
95965,6620,high,B-Procedure
95966,6620,dose,I-Procedure
95967,6620,of,I-Procedure
95968,6620,FSH,I-Procedure
95969,6620,stimulation,I-Procedure
95970,6620,),O
95971,6621,Endocrine,B-Condition
95972,6621,disorders,I-Condition
95973,6622,Age,B-Person
95974,6622,between,O
95975,6622,20,O
95976,6622,and,O
95977,6622,40,O
95978,6623,Normal,B-Condition
95979,6623,menstrual,I-Condition
95980,6623,cycles,I-Condition
95981,6623,:,O
95982,6623,25,O
95983,6623,-,O
95984,6623,34,O
95985,6623,days,O
95986,6624,Oligomenorrhea,B-Condition
95987,6624,/,O
95988,6624,amenorrhea,B-Condition
95989,6624,or,O
95990,6624,polycystic,B-Condition
95991,6624,syndrome,I-Condition
95992,6624,(,O
95993,6624,defined,O
95994,6624,according,O
95995,6624,to,O
95996,6624,the,O
95997,6624,Rotterdam,O
95998,6624,criteria,O
95999,6624,2004,O
96000,6624,),O
96001,6625,BMI,O
96002,6625,>,O
96003,6625,18,O
96004,6625,and,O
96005,6625,<,O
96006,6625,35,O
96007,6625,kg,O
96008,6625,/,O
96009,6625,m2,O
96010,6626,Non-,B-Observation
96011,6626,English,I-Observation
96012,6626,speakers,I-Observation
96013,6627,Height,O
96014,6627,<,O
96015,6627,4,O
96016,6627,',O
96017,6627,11,O
96018,6627,"""",O
96019,6628,BMI,B-Observation
96020,6628,>,O
96021,6628,40,O
96022,6628,Kg/,O
96023,6628,mm,O
96024,6629,Antiemetic,B-Drug
96025,6629,drug,I-Drug
96026,6629,use,O
96027,6629,in,O
96028,6629,the,O
96029,6629,24,O
96030,6629,hours,O
96031,6629,prior,O
96032,6629,to,O
96033,6629,cesarean,B-Procedure
96034,6629,delivery,I-Procedure
96035,6629,",",O
96036,6630,Hypertensive,B-Condition
96037,6630,diseases,I-Condition
96038,6630,of,I-Condition
96039,6630,pregnancy,I-Condition
96040,6631,Chronic,B-Condition
96041,6631,hypertension,I-Condition
96042,6631,receiving,O
96043,6631,antihypertensive,B-Procedure
96044,6631,treatment,I-Procedure
96045,6632,Any,O
96046,6632,other,O
96047,6632,physical,O
96048,6632,or,O
96049,6632,psychiatric,O
96050,6632,condition,O
96051,6632,that,O
96052,6632,may,O
96053,6632,impair,O
96054,6632,their,O
96055,6632,ability,O
96056,6632,to,O
96057,6632,cooperate,O
96058,6632,with,O
96059,6632,study,O
96060,6632,data,O
96061,6632,collection,O
96062,6632,.,O
96063,6633,Pregnant,B-Condition
96064,6634,American,O
96065,6634,Society,O
96066,6634,of,O
96067,6634,Anesthesiologists,O
96068,6634,risk,O
96069,6634,classification,O
96070,6634,I,O
96071,6634,and,O
96072,6634,II,O
96073,6635,Age,B-Person
96074,6635,>,O
96075,6635,18,O
96076,6635,years,O
96077,6636,Non,O
96078,6636,-,O
96079,6636,laboring,O
96080,6637,Patients,O
96081,6637,with,O
96082,6637,elective,O
96083,6637,cesarean,B-Procedure
96084,6637,sections,I-Procedure
96085,6638,NA,O
96086,6639,Severe,O
96087,6639,or,O
96088,6639,uncontrolled,O
96089,6639,infection,B-Condition
96090,6639,.,O
96091,6640,Sensitive,B-Condition
96092,6640,to,O
96093,6640,the,B-Drug
96094,6640,product,I-Drug
96095,6640,or,O
96096,6640,other,O
96097,6640,genetically,B-Drug
96098,6640,engineered,I-Drug
96099,6640,biological,I-Drug
96100,6640,products,I-Drug
96101,6640,from,O
96102,6640,Escherichia,O
96103,6640,coli,O
96104,6640,strains,O
96105,6640,.,O
96106,6641,Mental,B-Condition
96107,6641,or,I-Condition
96108,6641,nervous,I-Condition
96109,6641,system,I-Condition
96110,6641,disorders,I-Condition
96111,6641,.,O
96112,6642,Severe,O
96113,6642,heart,B-Condition
96114,6642,",",I-Condition
96115,6642,lung,I-Condition
96116,6642,and,I-Condition
96117,6642,central,I-Condition
96118,6642,nervous,I-Condition
96119,6642,system,I-Condition
96120,6642,disorders,I-Condition
96121,6642,.,O
96122,6643,Pregnant,B-Condition
96123,6643,or,O
96124,6643,lactating,B-Condition
96125,6643,women,B-Person
96126,6643,.,O
96127,6644,TBIL(total,O
96128,6644,bilirubin,O
96129,6644,),O
96130,6644,",",O
96131,6644,ALT(alanine,O
96132,6644,"aminotransferase),AST(glutamic",O
96133,6644,-,O
96134,6644,oxalacetic,O
96135,6644,transaminase,O
96136,6644,),O
96137,6644,>,O
96138,6644,2.5×ULN(upper,O
96139,6644,limit,O
96140,6644,of,O
96141,6644,normal,O
96142,6644,),O
96143,6644,;,O
96144,6644,if,O
96145,6644,it,O
96146,6644,were,O
96147,6644,caused,O
96148,6644,by,O
96149,6644,liver,B-Condition
96150,6644,metastases,I-Condition
96151,6644,",",O
96152,6644,TBIL,O
96153,6644,",",O
96154,6644,ALT,O
96155,6644,",",O
96156,6644,AST,O
96157,6644,>,O
96158,6644,5×ULN,O
96159,6644,.,O
96160,6645,Cr(creatinine,O
96161,6645,),O
96162,6645,>,O
96163,6645,1.5×ULN,O
96164,6645,.,O
96165,6646,any,O
96166,6646,medical,B-Condition
96167,6646,condition,I-Condition
96168,6646,that,O
96169,6646,would,O
96170,6646,contraindicate,B-Condition
96171,6646,use,O
96172,6646,of,O
96173,6646,stimulant,B-Drug
96174,6646,medication,I-Drug
96175,6647,any,O
96176,6647,prior,O
96177,6647,adverse,B-Condition
96178,6647,response,I-Condition
96179,6647,to,O
96180,6647,lisdexamfetamine,B-Drug
96181,6647,dimesylate,I-Drug
96182,6647,or,O
96183,6647,other,O
96184,6647,stimulant,B-Drug
96185,6647,medication,I-Drug
96186,6648,use,O
96187,6648,of,O
96188,6648,concurrent,O
96189,6648,",",O
96190,6648,non,B-Drug
96191,6648,-,I-Drug
96192,6648,stimulant,I-Drug
96193,6648,psychoactive,I-Drug
96194,6648,medication,I-Drug
96195,6649,diagnosis,O
96196,6649,of,O
96197,6649,schizophrenia,B-Condition
96198,6649,or,O
96199,6649,presence,O
96200,6649,of,O
96201,6649,thought,B-Condition
96202,6649,disorder,I-Condition
96203,6649,symptoms,B-Mood
96204,6650,autism,B-Condition
96205,6650,spectrum,I-Condition
96206,6650,disorder,I-Condition
96207,6651,diagnosis,O
96208,6651,of,O
96209,6651,ADHD,B-Condition
96210,6652,parental,O
96211,6652,permission,O
96212,6652,and/or,O
96213,6652,teen,O
96214,6652,consent,O
96215,6652,/,O
96216,6652,assent,O
96217,6652,as,O
96218,6652,appropriate,O
96219,6653,between,O
96220,6653,16,O
96221,6653,-,O
96222,6653,25,O
96223,6653,years,O
96224,6653,of,O
96225,6653,age,B-Person
96226,6654,IQ,O
96227,6654,greater,O
96228,6654,than,O
96229,6654,or,O
96230,6654,equal,O
96231,6654,to,O
96232,6654,70,O
96233,6655,permit,B-Observation
96234,6655,or,I-Observation
96235,6655,license,I-Observation
96236,6655,to,I-Observation
96237,6655,drive,I-Observation
96238,6656,ability,B-Observation
96239,6656,to,I-Observation
96240,6656,read,I-Observation
96241,6656,and,I-Observation
96242,6656,understand,I-Observation
96243,6656,English,I-Observation
96244,6657,Emergency,B-Procedure
96245,6657,surgery,I-Procedure
96246,6657,needed,B-Mood
96247,6658,Bowel,B-Condition
96248,6658,obstruction,I-Condition
96249,6659,Colonoscopy,B-Procedure
96250,6659,scheduled,B-Mood
96251,6659,to,O
96252,6659,be,O
96253,6659,undertaken,B-Procedure
96254,6659,peroperatively,O
96255,6660,Other,O
96256,6660,reason,O
96257,6660,indicating,O
96258,6660,mechanical,B-Procedure
96259,6660,preparation,I-Procedure
96260,6660,or,O
96261,6660,contradicting,B-Condition
96262,6660,it,O
96263,6661,Allergy,B-Condition
96264,6661,to,O
96265,6661,used,O
96266,6661,drugs,B-Drug
96267,6661,(,O
96268,6661,PEG,B-Drug
96269,6661,",",O
96270,6661,neomycin,B-Drug
96271,6661,",",O
96272,6661,metronidazole,B-Drug
96273,6661,),O
96274,6662,Patients,O
96275,6662,undergoing,O
96276,6662,colon,B-Condition
96277,6662,resection,I-Condition
96278,6663,Diagnosis,O
96279,6663,as,O
96280,6663,CD,B-Condition
96281,6663,first,O
96282,6663,time,O
96283,6663,or,O
96284,6663,first,O
96285,6663,year,O
96286,6663,.,O
96287,6664,No,O
96288,6664,history,B-Observation
96289,6664,of,O
96290,6664,using,O
96291,6664,5,B-Drug
96292,6664,-,I-Drug
96293,6664,ASA,I-Drug
96294,6664,",",O
96295,6664,biological,O
96296,6664,or,O
96297,6664,immunomodulatory,B-Procedure
96298,6664,therapy,I-Procedure
96299,6665,Moderate,O
96300,6665,to,O
96301,6665,severe,O
96302,6665,CD,B-Condition
96303,6665,define,O
96304,6665,as,O
96305,6665,HBI,O
96306,6665,score,O
96307,6665,>,O
96308,6665,4,O
96309,6665,.,O
96310,6666,Montreal,O
96311,6666,classification,O
96312,6666,:,O
96313,6666,no,O
96314,6666,limitation,O
96315,6666,",",O
96316,6666,except,O
96317,6666,age,O
96318,6666,>,O
96319,6666,6,O
96320,6666,.,O
96321,6667,ED,O
96322,6667,physicians,O
96323,6667,who,O
96324,6667,work,O
96325,6667,casually,O
96326,6667,(,O
96327,6667,less,O
96328,6667,than,O
96329,6667,0.25,O
96330,6667,Full,O
96331,6667,Time,O
96332,6667,Equivalent,O
96333,6667,),O
96334,6668,ED,O
96335,6668,Physicians,O
96336,6668,who,O
96337,6668,are,O
96338,6668,routinely,O
96339,6668,using,O
96340,6668,U,O
96341,6668,/,O
96342,6668,S,O
96343,6668,guided,O
96344,6668,RA,O
96345,6668,for,O
96346,6668,hip,O
96347,6668,fracture,O
96348,6668,patients,O
96349,6668,",",O
96350,6668,or,O
96351,6668,decline,O
96352,6668,participation,O
96353,6668,in,O
96354,6668,the,O
96355,6668,trial,O
96356,6668,.,O
96357,6669,Patients,O
96358,6669,',O
96359,6669,age,B-Person
96360,6669,less,O
96361,6669,than,O
96362,6669,65,O
96363,6669,years,O
96364,6669,;,O
96365,6670,Patients,O
96366,6670,who,O
96367,6670,are,O
96368,6670,delirious,B-Condition
96369,6670,on,O
96370,6670,initial,O
96371,6670,assessment,O
96372,6670,by,O
96373,6670,ED,O
96374,6670,physician,O
96375,6670,or,O
96376,6670,severe,O
96377,6670,dementia,B-Condition
96378,6671,Patients,O
96379,6671,with,O
96380,6671,communication,B-Condition
96381,6671,problems,I-Condition
96382,6671,(,O
96383,6671,critically,B-Condition
96384,6671,ill,I-Condition
96385,6671,",",O
96386,6671,unconscious,B-Condition
96387,6671,",",O
96388,6671,language,B-Condition
96389,6671,barrier,I-Condition
96390,6671,despite,O
96391,6671,use,O
96392,6671,of,O
96393,6671,secure,O
96394,6671,telephone,O
96395,6671,-,O
96396,6671,based,O
96397,6671,translation,O
96398,6671,service,O
96399,6671,),O
96400,6672,Patients,O
96401,6672,with,O
96402,6672,allergies,B-Condition
96403,6672,to,O
96404,6672,narcotics,B-Drug
96405,6672,or,O
96406,6672,local,B-Drug
96407,6672,anesthetic,I-Drug
96408,6672,;,O
96409,6672,or,O
96410,6672,anticoagulant,B-Drug
96411,6672,use,O
96412,6672,(,O
96413,6672,e.g.,O
96414,6672,warfarin,B-Drug
96415,6672,",",O
96416,6672,dabigatran,B-Drug
96417,6672,",",O
96418,6672,rivaroxaban,B-Drug
96419,6672,),O
96420,6672,.,O
96421,6673,Patients,O
96422,6673,with,O
96423,6673,hip,B-Condition
96424,6673,fractures,I-Condition
96425,6673,not,O
96426,6673,requiring,O
96427,6673,surgery,B-Procedure
96428,6673,(,O
96429,6673,e.g.,O
96430,6673,greater,B-Condition
96431,6673,trochanter,I-Condition
96432,6673,avulsion,I-Condition
96433,6673,),O
96434,6673,will,O
96435,6673,also,O
96436,6673,be,O
96437,6673,excluded,O
96438,6673,.,O
96439,6674,At,O
96440,6674,the,O
96441,6674,cluster,O
96442,6674,level,O
96443,6674,",",O
96444,6674,ED,O
96445,6674,physicians,O
96446,6674,practicing,O
96447,6674,at,O
96448,6674,a,O
96449,6674,participating,O
96450,6674,site,O
96451,6674,will,O
96452,6674,be,O
96453,6674,eligible,O
96454,6674,.,O
96455,6675,At,O
96456,6675,the,O
96457,6675,patient,O
96458,6675,level,O
96459,6675,",",O
96460,6675,all,O
96461,6675,hip,B-Condition
96462,6675,fractures,I-Condition
96463,6675,seen,O
96464,6675,by,O
96465,6675,a,O
96466,6675,participating,O
96467,6675,ED,O
96468,6675,physician,O
96469,6675,will,O
96470,6675,be,O
96471,6675,eligible,O
96472,6676,Inmate,B-Person
96473,6676,of,I-Person
96474,6676,a,I-Person
96475,6676,correctional,I-Person
96476,6676,facility,I-Person
96477,6676,(,O
96478,6676,i.e.,O
96479,6676,prisoners,B-Person
96480,6676,),O
96481,6676,.,O
96482,6677,Pregnancy,B-Condition
96483,6678,Documented,O
96484,6678,or,O
96485,6678,suspected,O
96486,6678,family,O
96487,6678,or,O
96488,6678,personal,B-Observation
96489,6678,history,I-Observation
96490,6678,of,O
96491,6678,malignant,B-Condition
96492,6678,hyperthermia,I-Condition
96493,6678,.,O
96494,6679,Patient,O
96495,6679,unable,B-Condition
96496,6679,to,I-Condition
96497,6679,receive,I-Condition
96498,6679,either,O
96499,6679,propofol,B-Drug
96500,6679,or,O
96501,6679,isoflurane,B-Drug
96502,6679,due,O
96503,6679,to,O
96504,6679,allergy,B-Condition
96505,6679,or,O
96506,6679,other,O
96507,6679,specific,O
96508,6679,contraindication,O
96509,6679,.,O
96510,6680,Surgical,O
96511,6680,patients,O
96512,6680,60,O
96513,6680,years,O
96514,6680,of,O
96515,6680,age,B-Person
96516,6680,or,O
96517,6680,older,O
96518,6681,Surgery,B-Procedure
96519,6681,scheduled,O
96520,6681,to,O
96521,6681,last,O
96522,6681,at,O
96523,6681,least,O
96524,6681,2,O
96525,6681,hours,O
96526,6681,(,O
96527,6681,including,O
96528,6681,time,O
96529,6681,for,O
96530,6681,anesthesia,O
96531,6681,induction,O
96532,6681,",",O
96533,6681,etc,O
96534,6681,),O
96535,6682,English,B-Observation
96536,6682,speaking,I-Observation
96537,6682,ability,I-Observation
96538,6682,.,O
96539,6683,Ability,B-Observation
96540,6683,to,I-Observation
96541,6683,give,I-Observation
96542,6683,informed,I-Observation
96543,6683,consent,I-Observation
96544,6684,Emergent,B-Condition
96545,6684,condition,I-Condition
96546,6684,like,O
96547,6684,hematemesis,B-Condition
96548,6684,.,O
96549,6685,Patients,O
96550,6685,with,O
96551,6685,moderate,O
96552,6685,to,O
96553,6685,severe,O
96554,6685,hepatic,B-Condition
96555,6685,encephalopathy,I-Condition
96556,6685,.,O
96557,6686,Patients,O
96558,6686,with,O
96559,6686,hepatopulmonary,B-Condition
96560,6686,syndrome,I-Condition
96561,6686,.,O
96562,6687,Patients,O
96563,6687,with,O
96564,6687,known,B-Mood
96565,6687,or,O
96566,6687,suspected,B-Mood
96567,6687,hypersensitivity,B-Condition
96568,6687,to,O
96569,6687,the,O
96570,6687,used,B-Drug
96571,6687,medication,I-Drug
96572,6687,were,O
96573,6687,also,O
96574,6687,excluded,O
96575,6687,from,O
96576,6687,the,O
96577,6687,study,O
96578,6687,.,O
96579,6688,Patients,O
96580,6688,aged,B-Person
96581,6688,between,O
96582,6688,40,O
96583,6688,and,O
96584,6688,60,O
96585,6688,years,O
96586,6688,old,O
96587,6688,.,O
96588,6689,With,O
96589,6689,Child,O
96590,6689,score,O
96591,6689,B,O
96592,6689,or,O
96593,6689,C,O
96594,6690,Presented,O
96595,6690,for,O
96596,6690,elective,O
96597,6690,gastrointestinal,B-Procedure
96598,6690,endoscopy,I-Procedure
96599,6691,Ongoing,O
96600,6691,acute,B-Condition
96601,6691,kidney,I-Condition
96602,6691,injury,I-Condition
96603,6691,Stage,O
96604,6691,2/3,O
96605,6692,History,B-Observation
96606,6692,of,O
96607,6692,kidney,B-Procedure
96608,6692,transplant,I-Procedure
96609,6693,=,B-Person
96610,6693,18,I-Person
96611,6693,years,I-Person
96612,6694,High,B-Condition
96613,6694,risk,I-Condition
96614,6694,patients,O
96615,6694,:,O
96616,6694,General,O
96617,6694,Surgery,O
96618,6694,AKI,O
96619,6694,Risk,O
96620,6694,Index,O
96621,6694,Class,O
96622,6694,III,O
96623,6694,",",O
96624,6694,IV,O
96625,6694,or,O
96626,6694,V,O
96627,6695,Major,B-Procedure
96628,6695,abdominal,I-Procedure
96629,6695,surgery,I-Procedure
96630,6696,DSM,O
96631,6696,-,O
96632,6696,IV,O
96633,6696,-,O
96634,6696,TR,O
96635,6696,substance,B-Condition
96636,6696,-,I-Condition
96637,6696,related,I-Condition
96638,6696,disorders,I-Condition
96639,6696,(,O
96640,6696,except,O
96641,6696,nicotine,B-Drug
96642,6696,),O
96643,6697,significant,O
96644,6697,medical,O
96645,6697,or,O
96646,6697,neurological,O
96647,6697,conditions,O
96648,6698,mental,B-Condition
96649,6698,retardation,I-Condition
96650,6698,or,O
96651,6698,organic,B-Condition
96652,6698,brain,I-Condition
96653,6698,damage,I-Condition
96654,6699,DSM,O
96655,6699,-,O
96656,6699,IV,O
96657,6699,-,O
96658,6699,TR,O
96659,6699,major,B-Condition
96660,6699,depressive,I-Condition
96661,6699,disorder,I-Condition
96662,6700,aged,B-Person
96663,6700,between,O
96664,6700,20,O
96665,6700,and,O
96666,6700,80,O
96667,6701,durg,B-Drug
96668,6701,-,O
96669,6701,naive,O
96670,6701,or,O
96671,6701,drug,B-Drug
96672,6701,-,O
96673,6701,free,O
96674,6702,Taking,O
96675,6702,other,O
96676,6702,drugs,B-Drug
96677,6702,which,O
96678,6702,can,O
96679,6702,influence,O
96680,6702,the,O
96681,6702,lipid,O
96682,6702,profile,O
96683,6702,(,O
96684,6702,eg,O
96685,6702,.,O
96686,6702,Niacin,B-Drug
96687,6702,",",O
96688,6702,Fibrates,B-Drug
96689,6702,;,O
96690,6703,Serum,O
96691,6703,creatinine,O
96692,6703,level,O
96693,6703,>,O
96694,6703,2.0,O
96695,6703,mg,O
96696,6703,/,O
96697,6703,dL,O
96698,6704,Serum,O
96699,6704,aspartate,O
96700,6704,transaminase,O
96701,6704,>,O
96702,6704,3,O
96703,6704,times,O
96704,6704,upper,O
96705,6704,limit,O
96706,6704,of,O
96707,6704,normal,O
96708,6705,Serum,O
96709,6705,alanine,O
96710,6705,transaminase,O
96711,6705,>,O
96712,6705,3,O
96713,6705,times,O
96714,6705,upper,O
96715,6705,limit,O
96716,6705,of,O
96717,6705,normal,O
96718,6706,Having,O
96719,6706,anaphylactic,B-Condition
96720,6706,reaction,I-Condition
96721,6706,for,O
96722,6706,Rosuvastatin,B-Drug
96723,6706,;,O
96724,6707,Having,O
96725,6707,the,O
96726,6707,other,O
96727,6707,contraindications,B-Condition
96728,6707,for,O
96729,6707,Rosuvastatin,B-Drug
96730,6707,;,O
96731,6708,Having,O
96732,6708,plan,B-Mood
96733,6708,to,O
96734,6708,be,O
96735,6708,pregnant,B-Condition
96736,6708,;,O
96737,6709,Having,O
96738,6709,life,B-Observation
96739,6709,expectancy,I-Observation
96740,6709,less,O
96741,6709,than,O
96742,6709,1,O
96743,6709,year,O
96744,6710,Patients,O
96745,6710,underwent,O
96746,6710,percutaneous,B-Procedure
96747,6710,coronary,I-Procedure
96748,6710,intervention,I-Procedure
96749,6710,with,O
96750,6710,drug,O
96751,6710,-,O
96752,6710,eluting,O
96753,6710,stent,O
96754,6710,;,O
96755,6711,Signs,O
96756,6711,of,O
96757,6711,hemodynamic,B-Condition
96758,6711,instability,I-Condition
96759,6711,(,O
96760,6711,i.e.,O
96761,6711,systolic,O
96762,6711,blood,O
96763,6711,pressure,O
96764,6711,<,O
96765,6711,100,O
96766,6711,mm,O
96767,6711,Hg,O
96768,6711,.,O
96769,6711,St.,O
96770,6711,or,O
96771,6711,episode,O
96772,6711,of,O
96773,6711,systolic,O
96774,6711,blood,O
96775,6711,pressure,O
96776,6711,fall,O
96777,6711,for,O
96778,6711,=,O
96779,6711,40,O
96780,6711,mm,O
96781,6711,Hg,O
96782,6711,.,O
96783,6711,/,O
96784,6711,or,O
96785,6711,heart,O
96786,6711,rate,O
96787,6711,>,O
96788,6711,110,O
96789,6711,lasting,O
96790,6711,more,O
96791,6711,than,O
96792,6711,15,O
96793,6711,min,O
96794,6711,),O
96795,6711,or,O
96796,6711,need,B-Mood
96797,6711,for,I-Mood
96798,6711,ventilatory,B-Procedure
96799,6711,support,I-Procedure
96800,6711,within,O
96801,6711,12,O
96802,6711,hours,O
96803,6711,prior,O
96804,6711,to,O
96805,6711,randomisation,O
96806,6711,.,O
96807,6712,The,O
96808,6712,indication,B-Mood
96809,6712,for,I-Mood
96810,6712,oral,B-Procedure
96811,6712,anticoagulation,I-Procedure
96812,6712,",",O
96813,6712,associated,O
96814,6712,with,O
96815,6712,others,O
96816,6712,disease,O
96817,6712,.,O
96818,6713,malignant,O
96819,6713,neoplasm,B-Condition
96820,6713,of,O
96821,6713,any,O
96822,6713,location,O
96823,6714,Contraindications,B-Condition
96824,6714,to,O
96825,6714,warfarin,B-Drug
96826,6714,or,O
96827,6714,pradaxa,B-Drug
96828,6714,according,O
96829,6714,to,O
96830,6714,Russian,O
96831,6714,Instructions,O
96832,6714,for,O
96833,6714,medical,O
96834,6714,use,O
96835,6714,of,O
96836,6714,these,O
96837,6714,drugs,O
96838,6715,Indications,B-Mood
96839,6715,for,O
96840,6715,concomitant,O
96841,6715,treatment,O
96842,6715,with,O
96843,6715,antiplatelet,B-Drug
96844,6715,agents,I-Drug
96845,6716,Any,O
96846,6716,stroke,B-Condition
96847,6716,within,O
96848,6716,6,O
96849,6716,months,O
96850,6716,before,O
96851,6716,randomization,O
96852,6717,Intracranial,B-Condition
96853,6717,hemorrhage,I-Condition
96854,6717,in,O
96855,6717,anamnesis,B-Procedure
96856,6718,Active,O
96857,6718,bleeding,B-Condition
96858,6718,",",O
96859,6718,bleeding,B-Condition
96860,6718,diathesis,I-Condition
96861,6718,.,O
96862,6719,Clinically,O
96863,6719,significant,O
96864,6719,bleeding,B-Condition
96865,6719,within,O
96866,6719,the,O
96867,6719,last,O
96868,6719,30,O
96869,6719,days,O
96870,6719,.,O
96871,6720,Trauma,B-Condition
96872,6720,or,O
96873,6720,extensive,B-Procedure
96874,6720,surgery,I-Procedure
96875,6720,within,O
96876,6720,1,O
96877,6720,month,O
96878,6720,before,O
96879,6720,randomization,O
96880,6720,or,O
96881,6720,surgery,B-Procedure
96882,6720,planned,B-Mood
96883,6720,in,O
96884,6720,the,O
96885,6720,next,O
96886,6720,6,O
96887,6720,months,O
96888,6720,after,O
96889,6720,randomization,O
96890,6720,.,O
96891,6721,Intracranial,B-Condition
96892,6721,pathology,I-Condition
96893,6721,:,O
96894,6721,tumor,B-Condition
96895,6721,",",O
96896,6721,arteriovenous,B-Condition
96897,6721,fistula,I-Condition
96898,6721,or,O
96899,6721,aneurysm,B-Condition
96900,6721,.,O
96901,6722,Gastrointestinal,B-Condition
96902,6722,bleeding,I-Condition
96903,6722,in,O
96904,6722,the,O
96905,6722,previous,O
96906,6722,3,O
96907,6722,months,O
96908,6722,.,O
96909,6723,Gastric,B-Condition
96910,6723,ulcer,I-Condition
96911,6723,or,O
96912,6723,duodenal,B-Condition
96913,6723,ulcer,I-Condition
96914,6723,with,O
96915,6723,clinical,B-Condition
96916,6723,manifestations,I-Condition
96917,6723,or,O
96918,6723,endoscopically,B-Procedure
96919,6723,identified,O
96920,6723,acute,B-Condition
96921,6723,ulcer,I-Condition
96922,6723,without,O
96923,6723,signs,B-Condition
96924,6723,of,I-Condition
96925,6723,scarring,I-Condition
96926,6723,during,O
96927,6723,previous,O
96928,6723,30,O
96929,6723,days,O
96930,6723,.,O
96931,6724,Uncontrolled,O
96932,6724,hypertension,B-Condition
96933,6724,(,O
96934,6724,systolic,O
96935,6724,blood,O
96936,6724,pressure,O
96937,6724,>,O
96938,6724,180,O
96939,6724,mm,O
96940,6724,Hg,O
96941,6724,.,O
96942,6724,and,O
96943,6724,/,O
96944,6724,or,O
96945,6724,diastolic,O
96946,6724,blood,O
96947,6724,pressure,O
96948,6724,>,O
96949,6724,100,O
96950,6724,mm.hg,O
96951,6724,in,O
96952,6724,patients,O
96953,6724,receiving,O
96954,6724,antihypertensive,B-Drug
96955,6724,drugs,I-Drug
96956,6724,),O
96957,6724,.,O
96958,6725,Pregnancy,B-Condition
96959,6725,",",O
96960,6725,lactation,B-Condition
96961,6725,.,O
96962,6726,Life,B-Observation
96963,6726,expectancy,I-Observation
96964,6726,<,O
96965,6726,6,O
96966,6726,months,O
96967,6726,.,O
96968,6727,Clinically,O
96969,6727,significant,O
96970,6727,liver,B-Condition
96971,6727,disease,I-Condition
96972,6727,.,O
96973,6728,Creatinine,O
96974,6728,clearance,O
96975,6728,(,O
96976,6728,estimated,O
96977,6728,by,O
96978,6728,Cockcroft,O
96979,6728,-,O
96980,6728,Gault,O
96981,6728,),O
96982,6728,<,O
96983,6728,30,O
96984,6728,ml,O
96985,6728,/,O
96986,6728,min,O
96987,6728,.,O
96988,6729,hemoglobin,O
96989,6729,level,O
96990,6729,<,O
96991,6729,90,O
96992,6729,g,O
96993,6729,/,O
96994,6729,l,O
96995,6729,),O
96996,6729,",",O
96997,6729,thrombocytopenia,B-Condition
96998,6729,<,O
96999,6729,100x10,O
97000,6729,^,O
97001,6729,9,O
97002,6729,/,O
97003,6729,L.,O
97004,6730,Patients,O
97005,6730,who,O
97006,6730,",",O
97007,6730,in,O
97008,6730,the,O
97009,6730,opinion,O
97010,6730,of,O
97011,6730,the,O
97012,6730,researcher,O
97013,6730,",",O
97014,6730,are,O
97015,6730,not,O
97016,6730,suitable,O
97017,6730,for,O
97018,6730,inclusion,O
97019,6730,in,O
97020,6730,the,O
97021,6730,study,O
97022,6730,",",O
97023,6730,for,O
97024,6730,example,O
97025,6730,",",O
97026,6730,due,O
97027,6730,to,O
97028,6730,the,O
97029,6730,low,O
97030,6730,likelihood,O
97031,6730,of,O
97032,6730,doctor,O
97033,6730,'s,O
97034,6730,recommendations,O
97035,6730,following,O
97036,6730,.,O
97037,6731,Long,O
97038,6731,-,O
97039,6731,term,O
97040,6731,use,O
97041,6731,of,O
97042,6731,NSAIDs,B-Drug
97043,6732,Current,O
97044,6732,participation,O
97045,6732,in,O
97046,6732,another,O
97047,6732,clinical,O
97048,6732,study,O
97049,6732,.,O
97050,6733,Allergic,B-Condition
97051,6733,to,O
97052,6733,contrast,B-Drug
97053,6733,substance,I-Drug
97054,6733,or,O
97055,6733,radioisotope,B-Drug
97056,6733,drugs,I-Drug
97057,6733,used,O
97058,6733,in,O
97059,6733,procedures,O
97060,6733,to,O
97061,6733,assess,O
97062,6733,endpoints,O
97063,6733,of,O
97064,6733,the,O
97065,6733,study,O
97066,6733,",",O
97067,6733,which,O
97068,6733,according,O
97069,6733,to,O
97070,6733,researchers,O
97071,6733,",",O
97072,6733,may,O
97073,6733,be,O
97074,6733,a,O
97075,6733,contraindication,O
97076,6733,to,O
97077,6733,the,O
97078,6733,implementation,O
97079,6733,of,O
97080,6733,these,O
97081,6733,research,O
97082,6733,methods,O
97083,6733,.,O
97084,6734,Men,B-Person
97085,6734,and,O
97086,6734,women,B-Person
97087,6734,aged,B-Person
97088,6734,>,O
97089,6734,18,O
97090,6734,years,O
97091,6735,Angiographically,B-Procedure
97092,6735,confirmed,O
97093,6735,acute,O
97094,6735,massive,O
97095,6735,pulmonary,B-Condition
97096,6735,embolism,I-Condition
97097,6735,with,O
97098,6735,involvement,B-Condition
97099,6735,of,I-Condition
97100,6735,Central,I-Condition
97101,6735,pulmonary,I-Condition
97102,6735,arteries,I-Condition
97103,6735,.,O
97104,6736,endovascular,B-Condition
97105,6736,mechanical,I-Condition
97106,6736,thrombus,I-Condition
97107,6736,fragmentation,I-Condition
97108,6736,+,O
97109,6736,thrombolytic,B-Procedure
97110,6736,therapy,I-Procedure
97111,6736,(,O
97112,6736,using,O
97113,6736,recombinant,B-Drug
97114,6736,tissue,I-Drug
97115,6736,activator,I-Drug
97116,6736,of,I-Drug
97117,6736,plasminogen,I-Drug
97118,6736,),O
97119,6736,",",O
97120,6736,performed,O
97121,6736,for,O
97122,6736,treatment,B-Procedure
97123,6736,of,O
97124,6736,the,O
97125,6736,above,O
97126,6736,-,O
97127,6736,mentioned,O
97128,6736,pulmonary,B-Condition
97129,6736,embolism,I-Condition
97130,6736,in,O
97131,6736,less,O
97132,6736,than,O
97133,6736,48,O
97134,6736,hours,O
97135,6736,before,O
97136,6736,randomization,O
97137,6736,.,O
97138,6736,The,O
97139,6736,patient,O
97140,6736,should,O
97141,6736,be,O
97142,6736,randomized,O
97143,6736,no,O
97144,6736,earlier,O
97145,6736,than,O
97146,6736,24,O
97147,6736,hours,O
97148,6736,after,O
97149,6736,procedures,O
97150,6736,endovascular,O
97151,6736,mechanical,O
97152,6736,thrombus,O
97153,6736,fragmentation,O
97154,6736,+,O
97155,6736,thrombolytic,O
97156,6736,therapy,O
97157,6737,Written,O
97158,6737,informed,O
97159,6737,consent,O
97160,6737,signed,O
97161,6737,by,O
97162,6737,patient,O
97163,6737,.,O
97164,6738,Coronary,B-Condition
97165,6738,artery,I-Condition
97166,6738,disease,I-Condition
97167,6738,-,O
97168,6738,stent,O
97169,6739,Severe,O
97170,6739,chronic,O
97171,6739,renal,B-Condition
97172,6739,failure,I-Condition
97173,6740,Congenital,O
97174,6740,or,O
97175,6740,acquired,O
97176,6740,thrombophilia,B-Condition
97177,6740,/,O
97178,6740,thrombosis,B-Condition
97179,6740,event,I-Condition
97180,6741,Known,B-Mood
97181,6741,or,O
97182,6741,suspected,B-Mood
97183,6741,allergy,B-Condition
97184,6742,Complex,B-Condition
97185,6742,kidney,I-Condition
97186,6742,stone,I-Condition
97187,6742,(,O
97188,6742,staghorn,B-Condition
97189,6742,calculi,I-Condition
97190,6742,GUYS,O
97191,6742,III,O
97192,6742,and,O
97193,6742,IV,O
97194,6742,),O
97195,6743,Preoperative,O
97196,6743,history,B-Observation
97197,6743,of,O
97198,6743,schizophrenia,B-Condition
97199,6743,",",O
97200,6743,epilepsy,B-Condition
97201,6743,",",O
97202,6743,parkinsonism,B-Condition
97203,6743,or,O
97204,6743,myasthenia,B-Condition
97205,6743,gravis,I-Condition
97206,6743,;,O
97207,6744,Preoperative,O
97208,6744,radio-,O
97209,6744,or,O
97210,6744,chemotherapy,B-Procedure
97211,6744,;,O
97212,6745,Inability,B-Condition
97213,6745,to,I-Condition
97214,6745,communicate,I-Condition
97215,6745,in,O
97216,6745,the,O
97217,6745,preoperative,O
97218,6745,period,O
97219,6745,because,O
97220,6745,of,O
97221,6745,coma,B-Condition
97222,6745,",",O
97223,6745,profound,O
97224,6745,dementia,B-Condition
97225,6745,or,O
97226,6745,language,B-Observation
97227,6745,barrier,I-Observation
97228,6745,;,O
97229,6746,Preoperative,O
97230,6746,obstructive,B-Condition
97231,6746,sleep,I-Condition
97232,6746,apnea,I-Condition
97233,6746,(,O
97234,6746,previously,O
97235,6746,diagnosed,O
97236,6746,as,O
97237,6746,obstructive,B-Condition
97238,6746,sleep,I-Condition
97239,6746,apnea,I-Condition
97240,6746,",",O
97241,6746,or,O
97242,6746,a,O
97243,6746,STOP,O
97244,6746,-,O
97245,6746,Bang,O
97246,6746,score,O
97247,6746,>,O
97248,6746,=,O
97249,6746,3,O
97250,6746,),O
97251,6746,;,O
97252,6747,Brain,B-Condition
97253,6747,trauma,I-Condition
97254,6747,or,O
97255,6747,neurosurgery,B-Procedure
97256,6747,;,O
97257,6748,Preoperative,O
97258,6748,left,O
97259,6748,ventricular,O
97260,6748,ejection,O
97261,6748,fraction,O
97262,6748,<,O
97263,6748,30,O
97264,6748,%,O
97265,6748,",",O
97266,6748,sick,B-Condition
97267,6748,sinus,I-Condition
97268,6748,syndrome,I-Condition
97269,6748,",",O
97270,6748,severe,O
97271,6748,sinus,B-Condition
97272,6748,bradycardia,I-Condition
97273,6748,(,O
97274,6748,<,O
97275,6748,50,O
97276,6748,beats,O
97277,6748,per,O
97278,6748,minute,O
97279,6748,),O
97280,6748,",",O
97281,6748,or,O
97282,6748,second,O
97283,6748,-,O
97284,6748,degree,O
97285,6748,or,O
97286,6748,above,O
97287,6748,atrioventricular,B-Condition
97288,6748,block,I-Condition
97289,6748,without,O
97290,6748,pacemaker,O
97291,6748,;,O
97292,6749,Severe,O
97293,6749,hepatic,B-Condition
97294,6749,dysfunction,I-Condition
97295,6749,(,O
97296,6749,Child,O
97297,6749,-,O
97298,6749,Pugh,O
97299,6749,class,O
97300,6749,C,O
97301,6749,),O
97302,6749,or,O
97303,6749,severe,O
97304,6749,renal,B-Condition
97305,6749,dysfunction,I-Condition
97306,6749,(,O
97307,6749,requirement,O
97308,6749,of,O
97309,6749,renal,B-Procedure
97310,6749,replacement,I-Procedure
97311,6749,therapy,I-Procedure
97312,6749,before,O
97313,6749,surgery,B-Procedure
97314,6749,),O
97315,6749,;,O
97316,6750,ASA,O
97317,6750,classification,O
97318,6750,>,O
97319,6750,=,O
97320,6750,IV,O
97321,6750,.,O
97322,6751,Age,B-Person
97323,6751,>,O
97324,6751,=,O
97325,6751,65,O
97326,6751,years,O
97327,6751,",",O
97328,6751,<,O
97329,6751,90,O
97330,6751,years,O
97331,6751,;,O
97332,6752,Scheduled,B-Mood
97333,6752,to,O
97334,6752,undergo,O
97335,6752,surgery,B-Procedure
97336,6752,for,O
97337,6752,primary,O
97338,6752,solid,B-Condition
97339,6752,organ,I-Condition
97340,6752,cancer,I-Condition
97341,6752,under,O
97342,6752,general,B-Procedure
97343,6752,anesthesia,I-Procedure
97344,6752,",",O
97345,6752,with,O
97346,6752,an,O
97347,6752,expected,O
97348,6752,duration,O
97349,6752,of,O
97350,6752,surgery,O
97351,6752,>,O
97352,6752,=,O
97353,6752,2,O
97354,6752,hours,O
97355,6752,;,O
97356,6753,Planned,O
97357,6753,to,O
97358,6753,use,O
97359,6753,patient,O
97360,6753,-,O
97361,6753,controlled,O
97362,6753,intravenous,B-Procedure
97363,6753,analgesia,I-Procedure
97364,6753,after,O
97365,6753,surgery,B-Procedure
97366,6753,;,O
97367,6754,Provide,O
97368,6754,written,O
97369,6754,informed,O
97370,6754,consent,O
97371,6754,.,O
97372,6755,Earlier,O
97373,6755,operations,O
97374,6755,in,O
97375,6755,the,O
97376,6755,foot,O
97377,6755,and,O
97378,6755,leg,O
97379,6755,",",O
97380,6755,that,O
97381,6755,is,O
97382,6755,judged,O
97383,6755,to,O
97384,6755,complicate,O
97385,6755,training,O
97386,6756,known,O
97387,6756,arthritis,B-Condition
97388,6756,.,O
97389,6757,known,O
97390,6757,diabetes,B-Condition
97391,6758,Leg,B-Condition
97392,6758,ulcerations,I-Condition
97393,6758,or,O
97394,6758,infections,B-Condition
97395,6758,in,I-Condition
97396,6758,the,I-Condition
97397,6758,foot,I-Condition
97398,6758,.,O
97399,6759,Judged,O
97400,6759,unable,O
97401,6759,to,O
97402,6759,comply,O
97403,6759,with,O
97404,6759,the,O
97405,6759,training,O
97406,6759,protocol,O
97407,6759,.,O
97408,6760,Daily,O
97409,6760,use,O
97410,6760,of,O
97411,6760,pain,B-Drug
97412,6760,killers,I-Drug
97413,6761,Glucocorticosteroid,B-Drug
97414,6761,injection,B-Procedure
97415,6761,to,O
97416,6761,the,O
97417,6761,diseased,B-Condition
97418,6761,achilles,I-Condition
97419,6761,tendon,I-Condition
97420,6761,within,O
97421,6761,the,O
97422,6761,last,O
97423,6761,6,O
97424,6761,months,O
97425,6761,.,O
97426,6762,Earlier,O
97427,6762,allergic,B-Condition
97428,6762,reactions,I-Condition
97429,6762,to,O
97430,6762,glucocorticosteroid,B-Drug
97431,6762,or,O
97432,6762,local,B-Drug
97433,6762,anesthetic,I-Drug
97434,6762,.,O
97435,6763,Pregnancy,B-Condition
97436,6763,or,O
97437,6763,planning,B-Mood
97438,6763,to,I-Mood
97439,6763,become,I-Mood
97440,6763,pregnant,B-Condition
97441,6764,BMI,O
97442,6764,above,O
97443,6764,30,O
97444,6764,.,O
97445,6765,Midsubstance,B-Condition
97446,6765,pain,I-Condition
97447,6765,in,O
97448,6765,the,O
97449,6765,achilles,O
97450,6765,tendon,O
97451,6766,Symptoms,B-Condition
97452,6766,for,O
97453,6766,at,O
97454,6766,least,O
97455,6766,3,O
97456,6766,months,O
97457,6767,Ultrasound,B-Procedure
97458,6767,scanning,I-Procedure
97459,6767,at,O
97460,6767,the,O
97461,6767,first,O
97462,6767,visit,O
97463,6767,shows,O
97464,6767,thickness,B-Condition
97465,6767,of,I-Condition
97466,6767,the,I-Condition
97467,6767,achilles,I-Condition
97468,6767,tendon,I-Condition
97469,6767,above,O
97470,6767,7,O
97471,6767,mm,O
97472,6767,or,O
97473,6767,20,O
97474,6767,%,O
97475,6767,thicker,O
97476,6767,than,O
97477,6767,the,O
97478,6767,contralateral,O
97479,6767,.,O
97480,6768,Patient,O
97481,6768,can,O
97482,6768,read,O
97483,6768,and,O
97484,6768,understand,O
97485,6768,danish,O
97486,6769,Patients,O
97487,6769,with,O
97488,6769,a,O
97489,6769,contraindication,B-Condition
97490,6769,to,O
97491,6769,VCE,B-Procedure
97492,6769,(,O
97493,6769,small,B-Condition
97494,6769,bowel,I-Condition
97495,6769,strictures,I-Condition
97496,6769,",",O
97497,6769,oropharyngeal,B-Condition
97498,6769,dysphagia,I-Condition
97499,6769,",",O
97500,6769,pregnancy,B-Condition
97501,6769,",",O
97502,6769,patients,O
97503,6769,who,O
97504,6769,are,O
97505,6769,not,O
97506,6769,surgical,B-Observation
97507,6769,candidates,I-Observation
97508,6769,),O
97509,6770,Endoscopic,B-Procedure
97510,6770,insertion,I-Procedure
97511,6770,of,O
97512,6770,video,O
97513,6770,capsule,O
97514,6770,endoscope,O
97515,6771,Inpatient,B-Procedure
97516,6771,procedures,I-Procedure
97517,6771,for,O
97518,6771,active,O
97519,6771,GI,B-Condition
97520,6771,bleeding,I-Condition
97521,6772,Patients,O
97522,6772,with,O
97523,6772,fluid,B-Observation
97524,6772,restriction,I-Observation
97525,6772,or,O
97526,6772,who,O
97527,6772,are,O
97528,6772,unable,B-Observation
97529,6772,to,I-Observation
97530,6772,drink,I-Observation
97531,6772,up,O
97532,6772,to,O
97533,6772,900,O
97534,6772,ml,O
97535,6772,of,O
97536,6772,fluid,O
97537,6772,within,O
97538,6772,10,O
97539,6772,minutes,O
97540,6772,prior,O
97541,6772,to,O
97542,6772,the,O
97543,6772,VCE,B-Procedure
97544,6773,Patients,O
97545,6773,undergoing,O
97546,6773,small,B-Procedure
97547,6773,bowel,I-Procedure
97548,6773,video,I-Procedure
97549,6773,capsule,I-Procedure
97550,6773,endoscopy,I-Procedure
97551,6774,Has,O
97552,6774,other,O
97553,6774,dermatological,O
97554,6774,conditions,O
97555,6774,that,O
97556,6774,may,O
97557,6774,interfere,O
97558,6774,with,O
97559,6774,clinical,O
97560,6774,assessments,O
97561,6775,Allergy,B-Condition
97562,6775,or,O
97563,6775,sensitivity,B-Condition
97564,6775,to,O
97565,6775,corticosteroids,B-Drug
97566,6775,or,O
97567,6775,any,O
97568,6775,drug,B-Condition
97569,6775,hypersensitivity,I-Condition
97570,6775,or,I-Condition
97571,6775,intolerance,I-Condition
97572,6775,that,O
97573,6775,would,O
97574,6775,compromise,O
97575,6775,patient,O
97576,6775,safety,O
97577,6775,or,O
97578,6775,study,O
97579,6775,results,O
97580,6776,History,O
97581,6776,of,O
97582,6776,an,O
97583,6776,adverse,B-Condition
97584,6776,reaction,I-Condition
97585,6776,to,O
97586,6776,Cortrosyn,B-Drug
97587,6776,™,O
97588,6776,or,O
97589,6776,similar,O
97590,6776,test,B-Procedure
97591,6776,reagents,I-Procedure
97592,6777,Chronic,O
97593,6777,infectious,O
97594,6777,disease,O
97595,6777,",",O
97596,6777,system,O
97597,6777,or,O
97598,6777,organ,O
97599,6777,disorder,O
97600,6777,or,O
97601,6777,other,O
97602,6777,medical,O
97603,6777,condition,O
97604,6777,that,O
97605,6777,would,O
97606,6777,place,O
97607,6777,patient,O
97608,6777,at,O
97609,6777,undue,O
97610,6777,risk,O
97611,6777,by,O
97612,6777,study,O
97613,6777,participation,O
97614,6778,Patients,O
97615,6778,aged,B-Person
97616,6778,7,O
97617,6778,years,O
97618,6778,and,O
97619,6778,older,O
97620,6778,must,O
97621,6778,have,O
97622,6778,provided,O
97623,6778,written,O
97624,6778,assent,O
97625,6778,accompanied,O
97626,6778,by,O
97627,6778,written,O
97628,6778,informed,O
97629,6778,consent,O
97630,6778,from,O
97631,6778,patient,O
97632,6778,'s,O
97633,6778,representative,O
97634,6779,Clinical,O
97635,6779,diagnosis,O
97636,6779,of,O
97637,6779,stable,O
97638,6779,plaque,B-Condition
97639,6779,psoriasis,I-Condition
97640,6779,with,O
97641,6779,involvement,O
97642,6779,of,O
97643,6779,=,O
97644,6779,10,O
97645,6779,%,O
97646,6779,body,O
97647,6779,surface,O
97648,6779,area,O
97649,6779,(,O
97650,6779,excluding,O
97651,6779,face,B-Condition
97652,6779,and,O
97653,6779,scalp,B-Condition
97654,6779,),O
97655,6780,Physicians,O
97656,6780,Global,O
97657,6780,Assessment,O
97658,6780,score,O
97659,6780,of,O
97660,6780,3,O
97661,6780,or,O
97662,6780,4,O
97663,6780,at,O
97664,6780,baseline,O
97665,6781,Prior,O
97666,6781,receipt,O
97667,6781,of,O
97668,6781,investigational,O
97669,6781,anti,B-Drug
97670,6781,-,I-Drug
97671,6781,HIV,I-Drug
97672,6781,vaccine,I-Drug
97673,6782,Ongoing,O
97674,6782,therapy,B-Procedure
97675,6782,with,O
97676,6782,any,O
97677,6782,of,O
97678,6782,the,O
97679,6782,following,O
97680,6782,:,O
97681,6782,Systemic,B-Drug
97682,6782,corticosteroids,I-Drug
97683,6782,.,O
97684,6782,Short,O
97685,6782,course,O
97686,6782,less,O
97687,6782,than,O
97688,6782,or,O
97689,6782,equal,O
97690,6782,to,O
97691,6782,21,O
97692,6782,days,O
97693,6782,of,O
97694,6782,corticosteroids,B-Condition
97695,6782,is,O
97696,6782,allowed,O
97697,6782,;,O
97698,6782,Systemic,B-Drug
97699,6782,chemotherapeutic,I-Drug
97700,6782,agents,I-Drug
97701,6782,;,O
97702,6782,Nephrotoxic,B-Drug
97703,6782,systemic,I-Drug
97704,6782,agents,I-Drug
97705,6782,",",O
97706,6782,including,O
97707,6782,aminoglycosides,B-Drug
97708,6782,",",O
97709,6782,amphotericin,B-Drug
97710,6782,B,I-Drug
97711,6782,",",O
97712,6782,cidofovir,B-Drug
97713,6782,",",O
97714,6782,cisplatin,B-Drug
97715,6782,",",O
97716,6782,foscarnet,B-Drug
97717,6782,",",O
97718,6782,pentamidine,B-Drug
97719,6782,;,O
97720,6782,Immunomodulatory,B-Procedure
97721,6782,treatments,I-Procedure
97722,6782,including,O
97723,6782,Interleukin-2,B-Drug
97724,6782,;,O
97725,6782,Investigational,B-Drug
97726,6782,agents,I-Drug
97727,6783,Known,O
97728,6783,allergy,B-Condition
97729,6783,/,O
97730,6783,sensitivity,B-Condition
97731,6783,or,O
97732,6783,any,O
97733,6783,hypersensitivity,B-Condition
97734,6783,to,O
97735,6783,components,B-Drug
97736,6783,of,I-Drug
97737,6783,study,I-Drug
97738,6783,drugs,I-Drug
97739,6783,(,O
97740,6783,ART,B-Drug
97741,6783,),O
97742,6783,or,B-Drug
97743,6783,their,I-Drug
97744,6783,formulations,I-Drug
97745,6784,Active,O
97746,6784,drug,B-Condition
97747,6784,or,I-Condition
97748,6784,alcohol,I-Condition
97749,6784,use,I-Condition
97750,6784,or,I-Condition
97751,6784,dependence,I-Condition
97752,6784,that,O
97753,6784,would,O
97754,6784,interfere,O
97755,6784,with,O
97756,6784,adherence,O
97757,6784,to,O
97758,6784,study,O
97759,6784,requirements,O
97760,6785,Serious,O
97761,6785,medical,B-Condition
97762,6785,or,I-Condition
97763,6785,psychiatric,I-Condition
97764,6785,illness,I-Condition
97765,6785,that,O
97766,6785,would,O
97767,6785,interfere,O
97768,6785,with,O
97769,6785,the,O
97770,6785,ability,O
97771,6785,to,O
97772,6785,adhere,O
97773,6785,to,O
97774,6785,study,O
97775,6785,requirements,O
97776,6786,Chronic,B-Condition
97777,6786,or,I-Condition
97778,6786,acute,I-Condition
97779,6786,hepatitis,I-Condition
97780,6786,B,I-Condition
97781,6786,infection,I-Condition
97782,6787,Use,O
97783,6787,of,O
97784,6787,female,B-Drug
97785,6787,hormonal,I-Drug
97786,6787,products,I-Drug
97787,6787,based,O
97788,6787,on,O
97789,6787,estrogen,O
97790,6787,or,O
97791,6787,derivatives,O
97792,6788,Adult,B-Person
97793,6788,men,B-Person
97794,6788,who,I-Person
97795,6788,have,I-Person
97796,6788,sex,I-Person
97797,6788,with,I-Person
97798,6788,men,I-Person
97799,6788,",",O
97800,6788,and,O
97801,6788,transgender,B-Person
97802,6788,women,I-Person
97803,6789,Unaware,B-Observation
97804,6789,of,I-Observation
97805,6789,HIV,I-Observation
97806,6789,status,I-Observation
97807,6789,at,O
97808,6789,enrollment,O
97809,6789,in,O
97810,6789,follow,O
97811,6789,-,O
97812,6789,up,O
97813,6789,cohort,O
97814,6790,High,B-Mood
97815,6790,risk,I-Mood
97816,6790,for,I-Mood
97817,6790,HIV,B-Condition
97818,6790,infection,I-Condition
97819,6791,Willing,B-Mood
97820,6791,to,I-Mood
97821,6791,test,B-Condition
97822,6791,for,I-Condition
97823,6791,HIV,I-Condition
97824,6792,No,O
97825,6792,prior,O
97826,6792,ART,B-Procedure
97827,6792,",",O
97828,6792,including,O
97829,6792,prior,O
97830,6792,administration,B-Procedure
97831,6792,of,O
97832,6792,pre-,B-Drug
97833,6792,and,I-Drug
97834,6792,post,I-Drug
97835,6792,-,I-Drug
97836,6792,exposure,I-Drug
97837,6792,prophylaxis,I-Drug
97838,6792,in,O
97839,6792,the,O
97840,6792,last,O
97841,6792,30,O
97842,6792,days,O
97843,6793,Willing,B-Mood
97844,6793,to,I-Mood
97845,6793,provide,I-Mood
97846,6793,informed,B-Observation
97847,6793,consent,I-Observation
97848,6794,Abdominal,O
97849,6794,and,O
97850,6794,complex,O
97851,6794,cervical,B-Procedure
97852,6794,cerclage,I-Procedure
97853,6794,(,O
97854,6794,e.g.,O
97855,6794,bulging,O
97856,6794,bag,O
97857,6794,),O
97858,6795,Contraindication,B-Condition
97859,6795,to,O
97860,6795,neuraxial,B-Procedure
97861,6795,anesthesia,I-Procedure
97862,6796,Known,O
97863,6796,hypersensitivity,B-Condition
97864,6796,to,O
97865,6796,chloroprocaine,B-Drug
97866,6796,(,O
97867,6796,a.k.a,O
97868,6796,.,O
97869,6796,Ester,B-Condition
97870,6796,allergy,I-Condition
97871,6796,),O
97872,6796,",",O
97873,6796,paraaminobenzoic,B-Drug
97874,6796,acid,I-Drug
97875,6796,(,O
97876,6796,PABA,B-Drug
97877,6796,),O
97878,6796,or,O
97879,6796,bupivacaine,B-Drug
97880,6796,(,O
97881,6796,a.k.a,O
97882,6796,.,O
97883,6796,Amide,B-Condition
97884,6796,allergy,I-Condition
97885,6796,),O
97886,6797,Pseudocholinesterase,B-Condition
97887,6797,deficiency,I-Condition
97888,6798,Concomitant,O
97889,6798,use,O
97890,6798,with,O
97891,6798,ergot,B-Drug
97892,6798,-,I-Drug
97893,6798,type,I-Drug
97894,6798,oxytocic,I-Drug
97895,6798,drugs,I-Drug
97896,6799,ASA,O
97897,6799,classification,O
97898,6799,II,O
97899,6799,or,O
97900,6799,III,O
97901,6799,females,B-Person
97902,6800,Age,B-Person
97903,6800,:,O
97904,6800,18,O
97905,6800,-,O
97906,6800,45,O
97907,6800,years,O
97908,6800,old,O
97909,6801,BMI,O
97910,6801,=,O
97911,6801,50,O
97912,6801,kg,O
97913,6801,/,O
97914,6801,m2,O
97915,6802,Singleton,B-Condition
97916,6802,pregnancy,I-Condition
97917,6803,Simple,O
97918,6803,prophylactic,O
97919,6803,cervical,B-Procedure
97920,6803,cerclage,I-Procedure
97921,6804,Planning,B-Mood
97922,6804,neuraxial,B-Procedure
97923,6804,anesthesia,I-Procedure
97924,6805,Operative,B-Condition
97925,6805,findings,I-Condition
97926,6805,not,O
97927,6805,suggestive,B-Mood
97928,6805,of,O
97929,6805,endometriotic,B-Condition
97930,6805,cyst,I-Condition
97931,6806,Contraindications,B-Condition
97932,6806,to,O
97933,6806,progestogens,B-Drug
97934,6806,or,O
97935,6806,oral,B-Drug
97936,6806,contraceptive,I-Drug
97937,6806,pills,I-Drug
97938,6807,Unwillingness,B-Mood
97939,6807,to,I-Mood
97940,6807,tolerate,I-Mood
97941,6807,menstrual,B-Condition
97942,6807,irregularity,I-Condition
97943,6808,Planning,B-Mood
97944,6808,pregnancy,B-Condition
97945,6808,within,O
97946,6808,2,O
97947,6808,years,O
97948,6808,of,O
97949,6808,study,O
97950,6809,Can,O
97951,6809,not,O
97952,6809,understand,O
97953,6809,English,O
97954,6809,",",O
97955,6809,Cantonese,O
97956,6809,or,O
97957,6809,Putonghua,O
97958,6810,Good,B-Condition
97959,6810,general,I-Condition
97960,6810,health,I-Condition
97961,6811,Older,O
97962,6811,than,O
97963,6811,the,O
97964,6811,age,B-Person
97965,6811,of,O
97966,6811,legal,O
97967,6811,consent,O
97968,6811,(,O
97969,6811,i.e.,O
97970,6811,18,O
97971,6811,years,O
97972,6811,old,O
97973,6811,),O
97974,6812,Sonographic,B-Procedure
97975,6812,diagnosis,O
97976,6812,of,O
97977,6812,ovarian,B-Condition
97978,6812,endometrioma,I-Condition
97979,6812,with,O
97980,6812,diameter,O
97981,6812,at,O
97982,6812,least,O
97983,6812,4,O
97984,6812,cm,O
97985,6812,on,O
97986,6812,2,O
97987,6812,separate,O
97988,6812,scans,O
97989,6812,at,O
97990,6812,least,O
97991,6812,6,O
97992,6812,weeks,O
97993,6812,apart,O
97994,6813,No,O
97995,6813,contraindication,B-Condition
97996,6813,to,O
97997,6813,use,O
97998,6813,of,O
97999,6813,progesterone,B-Drug
98000,6813,or,O
98001,6813,combined,B-Drug
98002,6813,oral,I-Drug
98003,6813,contraceptive,I-Drug
98004,6813,pills,I-Drug
98005,6814,Not,O
98006,6814,attempting,B-Mood
98007,6814,to,O
98008,6814,conceive,B-Procedure
98009,6814,either,O
98010,6814,at,O
98011,6814,the,O
98012,6814,time,O
98013,6814,of,O
98014,6814,study,O
98015,6814,entry,O
98016,6814,or,O
98017,6814,for,O
98018,6814,at,O
98019,6814,least,O
98020,6814,2,O
98021,6814,years,O
98022,6814,after,O
98023,6814,surgery,O
98024,6815,Willing,O
98025,6815,and,O
98026,6815,able,O
98027,6815,to,O
98028,6815,participate,O
98029,6815,after,O
98030,6815,the,O
98031,6815,study,O
98032,6815,has,O
98033,6815,been,O
98034,6815,explained,O
98035,6816,Known,O
98036,6816,allergy,B-Condition
98037,6816,or,O
98038,6816,hypersensitive,B-Condition
98039,6816,reaction,O
98040,6816,to,O
98041,6816,dexmedetomidine,B-Drug
98042,6817,Organ,B-Condition
98043,6817,dysfunction,I-Condition
98044,6817,",",O
98045,6817,and,O
98046,6817,significant,O
98047,6817,developmental,B-Condition
98048,6817,delays,I-Condition
98049,6817,or,O
98050,6817,behavior,B-Condition
98051,6817,problems,I-Condition
98052,6818,Cardiac,B-Condition
98053,6818,arrhythmia,I-Condition
98054,6819,Known,O
98055,6819,.,O
98056,6819,acyanotic,B-Condition
98057,6819,congenital,I-Condition
98058,6819,heart,I-Condition
98059,6819,disease,I-Condition
98060,6819,or,O
98061,6819,children,B-Person
98062,6819,after,O
98063,6819,cardiac,B-Procedure
98064,6819,interventional,I-Procedure
98065,6819,procedures,I-Procedure
98066,6819,for,O
98067,6819,follow,B-Procedure
98068,6819,-,I-Procedure
98069,6819,up,I-Procedure
98070,6819,examination,I-Procedure
98071,6819,.,O
98072,6820,Children,B-Person
98073,6820,",",O
98074,6820,aged,B-Person
98075,6820,between,O
98076,6820,one,O
98077,6820,and,O
98078,6820,24,O
98079,6820,months,O
98080,6820,.,O
98081,6820,classified,O
98082,6820,as,O
98083,6820,(,O
98084,6820,American,O
98085,6820,Society,O
98086,6820,of,O
98087,6820,Anesthesiologists,O
98088,6820,),O
98089,6820,ASA,O
98090,6820,physical,O
98091,6820,status,O
98092,6820,I,O
98093,6820,or,O
98094,6820,II,O
98095,6820,",",O
98096,6820,undergoing,O
98097,6820,TEE,B-Procedure
98098,6820,were,O
98099,6820,enrolled,O
98100,6820,in,O
98101,6820,the,O
98102,6820,study,O
98103,6820,.,O
98104,6821,Previous,O
98105,6821,randomization,O
98106,6821,in,O
98107,6821,this,O
98108,6821,study,O
98109,6822,Treatment,O
98110,6822,with,O
98111,6822,IV,B-Drug
98112,6822,antibiotics,I-Drug
98113,6822,in,O
98114,6822,the,O
98115,6822,6,O
98116,6822,weeks,O
98117,6822,prior,O
98118,6822,to,O
98119,6822,Visit,O
98120,6822,1,O
98121,6823,Admission,B-Observation
98122,6823,to,I-Observation
98123,6823,the,I-Observation
98124,6823,intensive,I-Observation
98125,6823,care,I-Observation
98126,6823,unit,I-Observation
98127,6823,for,O
98128,6823,current,O
98129,6823,pulmonary,B-Condition
98130,6823,exacerbation,I-Condition
98131,6823,in,O
98132,6823,the,O
98133,6823,two,O
98134,6823,weeks,O
98135,6823,prior,O
98136,6823,to,O
98137,6823,Visit,O
98138,6823,2,O
98139,6823,",",O
98140,6823,unless,O
98141,6823,admission,O
98142,6823,was,O
98143,6823,due,O
98144,6823,to,O
98145,6823,a,O
98146,6823,desensitization,B-Procedure
98147,6823,protocol,I-Procedure
98148,6824,Pneumothorax,B-Condition
98149,6824,in,O
98150,6824,the,O
98151,6824,two,O
98152,6824,weeks,O
98153,6824,prior,O
98154,6824,to,O
98155,6824,Visit,O
98156,6824,2,O
98157,6825,Primary,B-Condition
98158,6825,diagnosis,I-Condition
98159,6825,for,O
98160,6825,current,B-Observation
98161,6825,hospitalization,I-Observation
98162,6825,is,O
98163,6825,unrelated,O
98164,6825,to,O
98165,6825,worsening,O
98166,6825,lower,B-Condition
98167,6825,respiratory,I-Condition
98168,6825,symptoms,I-Condition
98169,6825,(,O
98170,6825,e.g.,O
98171,6825,",",O
98172,6825,pulmonary,B-Condition
98173,6825,clean,I-Condition
98174,6825,out,I-Condition
98175,6825,",",O
98176,6825,distal,B-Condition
98177,6825,intestinal,I-Condition
98178,6825,obstruction,I-Condition
98179,6825,syndrome,I-Condition
98180,6825,(,O
98181,6825,DIOS,B-Condition
98182,6825,),O
98183,6825,",",O
98184,6825,sinusitis,B-Condition
98185,6825,),O
98186,6826,Massive,O
98187,6826,hemoptysis,B-Condition
98188,6826,defined,O
98189,6826,as,O
98190,6826,>,O
98191,6826,250,O
98192,6826,cc,O
98193,6826,in,O
98194,6826,a,O
98195,6826,24,O
98196,6826,hour,O
98197,6826,period,O
98198,6826,or,O
98199,6826,100,O
98200,6826,cc,O
98201,6826,/,O
98202,6826,day,O
98203,6826,over,O
98204,6826,4,O
98205,6826,consecutive,O
98206,6826,days,O
98207,6826,occurring,O
98208,6826,in,O
98209,6826,the,O
98210,6826,two,O
98211,6826,weeks,O
98212,6826,prior,O
98213,6826,to,O
98214,6826,Visit,O
98215,6826,2,O
98216,6827,Current,O
98217,6827,pulmonary,B-Condition
98218,6827,exacerbation,I-Condition
98219,6827,thought,O
98220,6827,to,O
98221,6827,be,O
98222,6827,due,O
98223,6827,to,O
98224,6827,allergic,B-Condition
98225,6827,bronchopulmonary,I-Condition
98226,6827,aspergillosis,I-Condition
98227,6827,(,O
98228,6827,ABPA,B-Condition
98229,6827,),O
98230,6828,At,O
98231,6828,Visit,O
98232,6828,1,O
98233,6828,",",O
98234,6828,receiving,O
98235,6828,ongoing,O
98236,6828,treatment,O
98237,6828,with,O
98238,6828,a,O
98239,6828,duration,O
98240,6828,of,O
98241,6828,more,O
98242,6828,than,O
98243,6828,2,O
98244,6828,weeks,O
98245,6828,with,O
98246,6828,prednisone,B-Drug
98247,6828,equivalent,O
98248,6828,to,O
98249,6828,>,O
98250,6828,10mg,O
98251,6828,/,O
98252,6828,day,O
98253,6829,History,O
98254,6829,of,O
98255,6829,solid,B-Condition
98256,6829,organ,I-Condition
98257,6829,transplantation,I-Condition
98258,6830,Receiving,O
98259,6830,antimicrobial,B-Drug
98260,6830,therapy,I-Drug
98261,6830,to,O
98262,6830,treat,O
98263,6830,non,O
98264,6830,-,O
98265,6830,tuberculous,O
98266,6830,mycobacterium,O
98267,6830,(,O
98268,6830,e.g.,O
98269,6830,",",O
98270,6830,M.,O
98271,6830,abscessus,O
98272,6830,",",O
98273,6830,M.,O
98274,6830,avium,O
98275,6830,complex,O
98276,6830,),O
98277,6830,in,O
98278,6830,the,O
98279,6830,two,O
98280,6830,weeks,O
98281,6830,prior,O
98282,6830,to,O
98283,6830,Visit,O
98284,6830,2,O
98285,6831,Male,B-Person
98286,6831,or,O
98287,6831,female,B-Person
98288,6831,=,O
98289,6831,18,O
98290,6831,years,O
98291,6831,of,O
98292,6831,age,B-Person
98293,6831,at,O
98294,6831,Visit,O
98295,6831,1,O
98296,6832,Documentation,O
98297,6832,of,O
98298,6832,a,O
98299,6832,CF,B-Condition
98300,6832,diagnosis,O
98301,6833,Enrolled,B-Observation
98302,6833,in,I-Observation
98303,6833,the,I-Observation
98304,6833,Cystic,I-Observation
98305,6833,Fibrosis,I-Observation
98306,6833,Foundation,I-Observation
98307,6833,National,I-Observation
98308,6833,Patient,I-Observation
98309,6833,Registry,I-Observation
98310,6833,(,I-Observation
98311,6833,CFFNPR,I-Observation
98312,6833,),I-Observation
98313,6833,prior,O
98314,6833,to,O
98315,6833,Visit,O
98316,6833,1,O
98317,6833,(,O
98318,6833,US,O
98319,6833,sites,O
98320,6833,only,O
98321,6833,),O
98322,6834,At,O
98323,6834,the,O
98324,6834,time,O
98325,6834,of,O
98326,6834,Visit,O
98327,6834,1,O
98328,6834,",",O
98329,6834,there,O
98330,6834,is,O
98331,6834,a,O
98332,6834,plan,O
98333,6834,to,O
98334,6834,initiate,O
98335,6834,IV,B-Drug
98336,6834,antibiotics,I-Drug
98337,6834,for,O
98338,6834,a,O
98339,6834,pulmonary,B-Condition
98340,6834,exacerbation,I-Condition
98341,6835,Performed,O
98342,6835,spirometry,B-Procedure
98343,6835,at,O
98344,6835,Visit,O
98345,6835,1,O
98346,6835,and,O
98347,6835,Visit,O
98348,6835,2,O
98349,6835,and,O
98350,6835,willing,B-Mood
98351,6835,to,I-Mood
98352,6835,perform,I-Mood
98353,6835,spirometry,B-Procedure
98354,6835,at,O
98355,6835,Visit,O
98356,6835,3,O
98357,6836,Completed,O
98358,6836,the,O
98359,6836,CRISS,B-Procedure
98360,6836,questionnaire,I-Procedure
98361,6836,at,O
98362,6836,Visit,O
98363,6836,1,O
98364,6836,and,O
98365,6836,Visit,O
98366,6836,2,O
98367,6836,and,O
98368,6836,willing,B-Mood
98369,6836,to,I-Mood
98370,6836,complete,I-Mood
98371,6836,the,O
98372,6836,Cystic,B-Procedure
98373,6836,Fibrosis,I-Procedure
98374,6836,Respiratory,I-Procedure
98375,6836,Symptoms,I-Procedure
98376,6836,Diary,I-Procedure
98377,6836,(,I-Procedure
98378,6836,CFRSD,I-Procedure
98379,6836,),I-Procedure
98380,6836,questionnaire,I-Procedure
98381,6836,at,O
98382,6836,Visit,O
98383,6836,3,O
98384,6837,Willing,B-Mood
98385,6837,to,I-Mood
98386,6837,adhere,O
98387,6837,to,O
98388,6837,a,O
98389,6837,specific,O
98390,6837,treatment,O
98391,6837,duration,O
98392,6837,determined,O
98393,6837,by,O
98394,6837,initial,O
98395,6837,response,O
98396,6837,to,O
98397,6837,treatment,O
98398,6837,and,O
98399,6837,subsequent,O
98400,6837,randomization,O
98401,6838,Willing,B-Mood
98402,6838,to,I-Mood
98403,6838,return,O
98404,6838,for,O
98405,6838,follow,B-Procedure
98406,6838,up,I-Procedure
98407,6838,Visit,I-Procedure
98408,6838,3,I-Procedure
98409,6839,Written,B-Observation
98410,6839,informed,I-Observation
98411,6839,consent,I-Observation
98412,6839,obtained,O
98413,6839,from,O
98414,6839,the,O
98415,6839,subject,O
98416,6839,or,O
98417,6839,subject,O
98418,6839,'s,O
98419,6839,legal,O
98420,6839,representative,O
98421,6840,Pregnancy,B-Condition
98422,6841,Known,O
98423,6841,hypersensitivity,B-Condition
98424,6841,to,O
98425,6841,study,B-Drug
98426,6841,drug,I-Drug
98427,6841,(,O
98428,6841,ferric,B-Drug
98429,6841,carboxymaltose,I-Drug
98430,6841,or,O
98431,6841,equivalent,O
98432,6841,),O
98433,6841,or,O
98434,6841,its,O
98435,6841,excipients,O
98436,6842,Known,B-Mood
98437,6842,or,O
98438,6842,suspected,B-Mood
98439,6842,haemoglobinopathy,B-Condition
98440,6842,/,O
98441,6842,thalassaemia,B-Condition
98442,6843,Bone,B-Condition
98443,6843,marrow,I-Condition
98444,6843,disease,I-Condition
98445,6844,Haemochromatosis,B-Condition
98446,6845,Renal,B-Procedure
98447,6845,dialysis,I-Procedure
98448,6846,Erythropoietin,B-Drug
98449,6846,or,O
98450,6846,IV,B-Drug
98451,6846,iron,I-Drug
98452,6846,in,O
98453,6846,the,O
98454,6846,previous,O
98455,6846,4,O
98456,6846,weeks,O
98457,6847,Patients,O
98458,6847,with,O
98459,6847,anaemia,B-Condition
98460,6847,(,O
98461,6847,males,B-Person
98462,6847,Hb,O
98463,6847,<,O
98464,6847,130,O
98465,6847,g,O
98466,6847,/,O
98467,6847,L,O
98468,6847,",",O
98469,6847,females,B-Person
98470,6847,<,O
98471,6847,120,O
98472,6847,g,O
98473,6847,/,O
98474,6847,L,O
98475,6847,),O
98476,6847,undergoing,O
98477,6847,elective,O
98478,6847,cardiac,B-Procedure
98479,6847,surgery,I-Procedure
98480,6847,",",O
98481,6847,and,O
98482,6847,available,B-Mood
98483,6847,to,I-Mood
98484,6847,receive,I-Mood
98485,6847,trial,B-Drug
98486,6847,drug,I-Drug
98487,6847,1-,O
98488,6847,10,O
98489,6847,weeks,O
98490,6847,prior,O
98491,6847,to,O
98492,6847,surgery,B-Procedure
98493,6848,Subjects,O
98494,6848,with,O
98495,6848,poor,O
98496,6848,-,O
98497,6848,controlled,O
98498,6848,arterial,B-Condition
98499,6848,hypertension,I-Condition
98500,6848,(,O
98501,6848,systolic,O
98502,6848,blood,O
98503,6848,pressure,O
98504,6848,>,O
98505,6848,140,O
98506,6848,mmHg,O
98507,6848,and,O
98508,6848,diastolic,O
98509,6848,blood,O
98510,6848,pressure,O
98511,6848,>,O
98512,6848,90,O
98513,6848,mm,O
98514,6848,Hg,O
98515,6848,),O
98516,6848,despite,O
98517,6848,standard,O
98518,6848,medical,O
98519,6848,management,O
98520,6848,;,O
98521,6848,Coronary,B-Condition
98522,6848,heart,I-Condition
98523,6848,disease,I-Condition
98524,6848,greater,O
98525,6848,than,O
98526,6848,ClassII,O
98527,6848,;,O
98528,6848,II,O
98529,6848,-,O
98530,6848,level,O
98531,6848,arrhythmia,B-Condition
98532,6848,(,O
98533,6848,including,O
98534,6848,QT,B-Condition
98535,6848,interval,I-Condition
98536,6848,prolongation,I-Condition
98537,6848,",",O
98538,6848,for,O
98539,6848,man,O
98540,6848,=,O
98541,6848,450,O
98542,6848,ms,O
98543,6848,",",O
98544,6848,for,O
98545,6848,woman,O
98546,6848,=,O
98547,6848,470,O
98548,6848,ms,O
98549,6848,),O
98550,6848,together,O
98551,6848,with,O
98552,6848,Class,O
98553,6848,II,O
98554,6848,cardiac,B-Condition
98555,6848,dysfunction,I-Condition
98556,6848,;,O
98557,6849,Factors,O
98558,6849,that,O
98559,6849,could,O
98560,6849,have,O
98561,6849,an,O
98562,6849,effect,O
98563,6849,on,O
98564,6849,oral,O
98565,6849,medication,O
98566,6849,(,O
98567,6849,such,O
98568,6849,as,O
98569,6849,inability,B-Condition
98570,6849,to,I-Condition
98571,6849,swallow,I-Condition
98572,6849,",",O
98573,6849,chronic,B-Condition
98574,6849,diarrhea,I-Condition
98575,6849,and,O
98576,6849,intestinal,B-Condition
98577,6849,obstruction,I-Condition
98578,6849,),O
98579,6849,;,O
98580,6850,Subjects,O
98581,6850,with,O
98582,6850,high,O
98583,6850,gastrointestinal,B-Observation
98584,6850,bleeding,I-Observation
98585,6850,risk,I-Observation
98586,6850,",",O
98587,6850,including,O
98588,6850,the,O
98589,6850,following,O
98590,6850,conditions,O
98591,6850,:,O
98592,6850,local,O
98593,6850,active,O
98594,6850,ulcer,B-Condition
98595,6850,lesions,I-Condition
98596,6850,with,O
98597,6850,positive,O
98598,6850,fecal,O
98599,6850,occult,O
98600,6850,blood,O
98601,6850,test,O
98602,6850,(,O
98603,6850,+,O
98604,6850,+,O
98605,6850,),O
98606,6850,;,O
98607,6850,history,O
98608,6850,of,O
98609,6850,black,B-Condition
98610,6850,stool,I-Condition
98611,6850,",",O
98612,6850,or,O
98613,6850,vomiting,B-Condition
98614,6850,blood,I-Condition
98615,6850,in,O
98616,6850,the,O
98617,6850,past,O
98618,6850,3,O
98619,6850,months;unresected,O
98620,6850,primary,B-Condition
98621,6850,lesion,I-Condition
98622,6850,in,O
98623,6850,stomach,O
98624,6850,with,O
98625,6850,positive,O
98626,6850,fecal,O
98627,6850,occult,O
98628,6850,blood,O
98629,6850,test,O
98630,6850,(,O
98631,6850,+,O
98632,6850,),O
98633,6850,",",O
98634,6850,ulcerated,B-Condition
98635,6850,gastric,I-Condition
98636,6850,carcinoma,I-Condition
98637,6850,with,O
98638,6850,massive,O
98639,6850,alimentary,O
98640,6850,tract,O
98641,6850,bleeding,B-Observation
98642,6850,risk,I-Observation
98643,6850,judged,O
98644,6850,by,O
98645,6850,PIs,O
98646,6850,based,O
98647,6850,on,O
98648,6850,gastric,O
98649,6850,endoscopy,O
98650,6850,result,O
98651,6850,;,O
98652,6851,Abnormal,B-Condition
98653,6851,Coagulation,I-Condition
98654,6851,(,O
98655,6851,INR>1.5,O
98656,6851,<,O
98657,6851,U+3001,O
98658,6851,>,O
98659,6851,APTT>1.5,O
98660,6851,UNL,O
98661,6851,),O
98662,6851,",",O
98663,6851,with,O
98664,6851,tendency,B-Condition
98665,6851,of,I-Condition
98666,6851,bleed,I-Condition
98667,6851,;,O
98668,6852,Associated,O
98669,6852,with,O
98670,6852,CNS,O
98671,6852,(,O
98672,6852,central,O
98673,6852,nervous,O
98674,6852,system,O
98675,6852,),O
98676,6852,metastases,O
98677,6852,;,O
98678,6853,Pregnant,O
98679,6853,or,O
98680,6853,lactating,O
98681,6853,women,O
98682,6853,;,O
98683,6854,Other,O
98684,6854,conditions,O
98685,6854,regimented,O
98686,6854,at,O
98687,6854,investigators,O
98688,6854,',O
98689,6854,discretion,O
98690,6854,.,O
98691,6855,Age,B-Person
98692,6855,:,O
98693,6855,18,O
98694,6855,to75,O
98695,6855,years,O
98696,6855,old,O
98697,6855,;,O
98698,6856,Pathologically,O
98699,6856,diagnosed,O
98700,6856,with,O
98701,6856,advanced,B-Condition
98702,6856,gastric,I-Condition
98703,6856,cancer,I-Condition
98704,6856,(,O
98705,6856,including,O
98706,6856,adenocarcinoma,B-Condition
98707,6856,of,O
98708,6856,the,O
98709,6856,gastroesophageal,O
98710,6856,junction,O
98711,6856,),O
98712,6856,with,O
98713,6856,measurable,O
98714,6856,metastases,B-Condition
98715,6856,outside,O
98716,6856,the,O
98717,6856,stomach,O
98718,6856,(,O
98719,6856,measuring,O
98720,6856,=,O
98721,6856,10,O
98722,6856,mm,O
98723,6856,on,O
98724,6856,spiral,O
98725,6856,CT,O
98726,6856,scan,O
98727,6856,",",O
98728,6856,satisfying,O
98729,6856,the,O
98730,6856,criteria,O
98731,6856,in,O
98732,6856,RECIST,O
98733,6856,1.1,O
98734,6856,),O
98735,6856,;,O
98736,6857,Failure,O
98737,6857,of,O
98738,6857,prior,O
98739,6857,therapy,O
98740,6857,(,O
98741,6857,during,O
98742,6857,or,O
98743,6857,after,O
98744,6857,treatment,O
98745,6857,),O
98746,6857,in,O
98747,6857,patients,O
98748,6857,who,O
98749,6857,have,O
98750,6857,received,O
98751,6857,at,O
98752,6857,least,O
98753,6857,two,O
98754,6857,prior,O
98755,6857,chemotherapy,B-Procedure
98756,6857,regimens,O
98757,6857,;,O
98758,6858,ECOG,O
98759,6858,PS,O
98760,6858,of,O
98761,6858,0,O
98762,6858,-,O
98763,6858,2,O
98764,6858,;,O
98765,6859,HB,O
98766,6859,=,O
98767,6859,90,O
98768,6859,g,O
98769,6859,/,O
98770,6859,L,O
98771,6860,ANC,O
98772,6860,=,O
98773,6860,1.5,O
98774,6860,×,O
98775,6860,109,O
98776,6860,/,O
98777,6860,L,O
98778,6861,PLT,O
98779,6861,=,O
98780,6861,80,O
98781,6861,×,O
98782,6861,109,O
98783,6861,/,O
98784,6861,L,O
98785,6862,Bilirubin,O
98786,6862,<,O
98787,6862,1.25,O
98788,6862,times,O
98789,6862,the,O
98790,6862,upper,O
98791,6862,limit,O
98792,6862,of,O
98793,6862,normal,O
98794,6862,(,O
98795,6862,ULN,O
98796,6862,),O
98797,6863,ALT,O
98798,6863,and,O
98799,6863,AST,O
98800,6863,<,O
98801,6863,2.5,O
98802,6863,×,O
98803,6863,ULN,O
98804,6863,;,O
98805,6863,liver,B-Condition
98806,6863,metastases,I-Condition
98807,6863,",",O
98808,6863,if,O
98809,6863,any,O
98810,6863,",",O
98811,6863,the,O
98812,6863,ALT,O
98813,6863,and,O
98814,6863,AST<5,O
98815,6863,×,O
98816,6863,ULN,O
98817,6864,Serum,O
98818,6864,Cr,O
98819,6864,=,O
98820,6864,1,O
98821,6864,×,O
98822,6864,ULN,O
98823,6864,endogenous,O
98824,6864,creatinine,O
98825,6864,clearance>50ml,O
98826,6864,/,O
98827,6864,min,O
98828,6864,(,O
98829,6864,Cockcroft,O
98830,6864,-,O
98831,6864,Gault,O
98832,6864,formula,O
98833,6864,),O
98834,6865,An,O
98835,6865,expected,B-Observation
98836,6865,survival,I-Observation
98837,6865,of,O
98838,6865,=,O
98839,6865,3,O
98840,6865,months,O
98841,6865,;,O
98842,6866,Patient,O
98843,6866,received,O
98844,6866,apatinib,B-Drug
98845,6866,treatment,O
98846,6866,regimen,O
98847,6866,at,O
98848,6866,investigators,O
98849,6866,',O
98850,6866,discretion,O
98851,6866,;,O
98852,6867,Patient,O
98853,6867,has,O
98854,6867,to,O
98855,6867,voluntarily,O
98856,6867,join,O
98857,6867,the,O
98858,6867,study,O
98859,6867,and,O
98860,6867,sign,O
98861,6867,the,O
98862,6867,Informed,O
98863,6867,Consent,O
98864,6867,Form,O
98865,6867,for,O
98866,6867,the,O
98867,6867,study,O
98868,6867,;,O
98869,6868,Pregnancy,O
98870,6868,test,O
98871,6868,(,O
98872,6868,serum,O
98873,6868,or,O
98874,6868,urine,O
98875,6868,),O
98876,6868,has,O
98877,6868,to,O
98878,6868,be,O
98879,6868,performed,O
98880,6868,for,O
98881,6868,woman,O
98882,6868,of,O
98883,6868,childbearing,O
98884,6868,age,O
98885,6868,within,O
98886,6868,7,O
98887,6868,days,O
98888,6868,before,O
98889,6868,enrolment,O
98890,6868,and,O
98891,6868,the,O
98892,6868,test,O
98893,6868,result,O
98894,6868,must,O
98895,6868,be,O
98896,6868,negative,O
98897,6868,.,O
98898,6868,They,O
98899,6868,shall,O
98900,6868,take,O
98901,6868,appropriate,O
98902,6868,methods,O
98903,6868,for,O
98904,6868,contraception,O
98905,6868,during,O
98906,6868,the,O
98907,6868,study,O
98908,6868,until,O
98909,6868,the,O
98910,6868,8th,O
98911,6868,week,O
98912,6868,post,O
98913,6868,the,O
98914,6868,last,O
98915,6868,administration,O
98916,6868,of,O
98917,6868,study,O
98918,6868,drug,O
98919,6868,.,O
98920,6868,For,O
98921,6868,men,O
98922,6868,",",O
98923,6868,(,O
98924,6868,previous,O
98925,6868,surgical,O
98926,6868,sterilization,O
98927,6868,accepted,O
98928,6868,),O
98929,6868,",",O
98930,6868,shall,O
98931,6868,agree,O
98932,6868,to,O
98933,6868,take,O
98934,6868,appropriate,O
98935,6868,methods,O
98936,6868,of,O
98937,6868,contraception,O
98938,6868,during,O
98939,6868,the,O
98940,6868,study,O
98941,6868,until,O
98942,6868,the,O
98943,6868,8th,O
98944,6868,week,O
98945,6868,post,O
98946,6868,the,O
98947,6868,last,O
98948,6868,administration,O
98949,6868,of,O
98950,6868,study,O
98951,6868,drug,O
98952,6868,.,O
98953,6869,Children,B-Person
98954,6869,(,O
98955,6869,<,O
98956,6869,18,O
98957,6869,years,O
98958,6869,old,B-Person
98959,6869,),O
98960,6869,.,O
98961,6870,Women,B-Person
98962,6870,who,O
98963,6870,are,O
98964,6870,known,O
98965,6870,to,O
98966,6870,be,O
98967,6870,pregnant,B-Condition
98968,6870,.,O
98969,6871,Any,O
98970,6871,patient,O
98971,6871,who,O
98972,6871,has,O
98973,6871,been,O
98974,6871,previously,O
98975,6871,randomized,B-Procedure
98976,6871,in,O
98977,6871,the,O
98978,6871,EvK,O
98979,6871,Trial,O
98980,6871,.,O
98981,6872,Patients,O
98982,6872,who,O
98983,6872,require,B-Observation
98984,6872,endotracheal,B-Procedure
98985,6872,intubation,I-Procedure
98986,6872,without,O
98987,6872,sedative,B-Drug
98988,6872,medication,I-Drug
98989,6872,.,O
98990,6872,For,O
98991,6872,example,O
98992,6872,",",O
98993,6872,patients,O
98994,6872,in,O
98995,6872,full,B-Condition
98996,6872,cardiac,I-Condition
98997,6872,arrest,I-Condition
98998,6872,.,O
98999,6873,Patients,O
99000,6873,with,O
99001,6873,a,O
99002,6873,known,O
99003,6873,allergy,B-Condition
99004,6873,to,O
99005,6873,ketamine,B-Drug
99006,6873,or,O
99007,6873,etomidate,B-Drug
99008,6873,.,O
99009,6874,Any,B-Condition
99010,6874,individual,I-Condition
99011,6874,wearing,I-Condition
99012,6874,a,I-Condition
99013,6874,MedAlert,I-Condition
99014,6874,bracelet,I-Condition
99015,6874,indicating,I-Condition
99016,6874,that,I-Condition
99017,6874,he,I-Condition
99018,6874,/,I-Condition
99019,6874,she,I-Condition
99020,6874,has,I-Condition
99021,6874,formally,I-Condition
99022,6874,opted,I-Condition
99023,6874,out,I-Condition
99024,6874,of,I-Condition
99025,6874,the,I-Condition
99026,6874,EvK,I-Condition
99027,6874,Trial,I-Condition
99028,6874,.,O
99029,6875,Adult,B-Person
99030,6875,patient,O
99031,6875,(,O
99032,6875,male,B-Person
99033,6875,or,O
99034,6875,female,B-Person
99035,6875,),O
99036,6875,requiring,O
99037,6875,emergency,B-Procedure
99038,6875,endotracheal,I-Procedure
99039,6875,intubation,I-Procedure
99040,6875,.,O
99041,6876,1,O
99042,6876,.,O
99043,6876,Patients,O
99044,6876,with,O
99045,6876,C,O
99046,6876,class,O
99047,6876,by,O
99048,6876,child,O
99049,6876,-,O
99050,6876,pugh,O
99051,6876,score,O
99052,6877,2,O
99053,6877,.,O
99054,6877,Patients,O
99055,6877,in,O
99056,6877,the,O
99057,6877,acute,O
99058,6877,phase,O
99059,6877,of,O
99060,6877,severe,B-Condition
99061,6877,hepatitis,I-Condition
99062,6878,3,O
99063,6878,.,O
99064,6878,Patients,O
99065,6878,have,O
99066,6878,been,O
99067,6878,diagnosed,O
99068,6878,with,O
99069,6878,cancer,B-Condition
99070,6878,of,I-Condition
99071,6878,the,I-Condition
99072,6878,liver,I-Condition
99073,6879,4,O
99074,6879,.,O
99075,6879,Patients,O
99076,6879,with,O
99077,6879,severe,O
99078,6879,cardiopulmonary,B-Condition
99079,6879,cerebral,I-Condition
99080,6879,disease,I-Condition
99081,6879,",",O
99082,6879,and,O
99083,6879,in,O
99084,6879,the,O
99085,6879,failure,O
99086,6879,state,O
99087,6880,5,O
99088,6880,.,O
99089,6880,Patients,O
99090,6880,in,O
99091,6880,Highly,B-Condition
99092,6880,allergic,I-Condition
99093,6880,constitution,I-Condition
99094,6881,6,O
99095,6881,.,O
99096,6881,Patients,O
99097,6881,with,O
99098,6881,moderately,O
99099,6881,severe,O
99100,6881,mental,B-Condition
99101,6881,disease,I-Condition
99102,6882,Patients,O
99103,6882,with,O
99104,6882,hepatocirrhosis,B-Condition
99105,6882,:,O
99106,6882,according,O
99107,6882,to,O
99108,6882,the,O
99109,6882,standard,O
99110,6882,of,O
99111,6882,child-,O
99112,6882,pugh,O
99113,6882,",",O
99114,6882,liver,O
99115,6882,functions,O
99116,6882,to,O
99117,6882,achieve,O
99118,6882,class,O
99119,6882,A,O
99120,6882,or,O
99121,6882,B,O
99122,6882,patients,O
99123,6882,",",O
99124,6882,Including,O
99125,6882,C,O
99126,6882,class,O
99127,6882,patients,O
99128,6882,but,O
99129,6882,can,O
99130,6882,achieve,O
99131,6882,B,O
99132,6882,class,O
99133,6882,after,O
99134,6882,treatment,O
99135,6883,Women,B-Person
99136,6883,with,O
99137,6883,systemic,B-Condition
99138,6883,lupus,I-Condition
99139,6883,erythematosus,I-Condition
99140,6883,(,I-Condition
99141,6883,SLE,I-Condition
99142,6883,),I-Condition
99143,6884,Women,B-Person
99144,6884,with,O
99145,6884,active,O
99146,6884,thromboembolic,B-Condition
99147,6884,disorders,I-Condition
99148,6885,Women,B-Person
99149,6885,with,O
99150,6885,history,B-Observation
99151,6885,of,O
99152,6885,previous,O
99153,6885,thromboembolic,B-Condition
99154,6885,disorders,I-Condition
99155,6886,Pregnant,B-Condition
99156,6886,women,B-Person
99157,6886,with,O
99158,6886,APS,B-Condition
99159,6886,diagnosed,O
99160,6886,according,O
99161,6886,to,O
99162,6886,the,O
99163,6886,revised,O
99164,6886,classification,O
99165,6886,criteria,O
99166,6886,for,O
99167,6886,APS,O
99168,6886,in,O
99169,6886,2006,O
99170,6886,in,O
99171,6886,Sydney,O
99172,6886,",",O
99173,6886,Australia,O
99174,6887,Early,O
99175,6887,pregnancy,O
99176,6887,body,O
99177,6887,weight,O
99178,6887,is,O
99179,6887,50,O
99180,6887,-,O
99181,6887,90,O
99182,6887,Kg,O
99183,6888,Bacterial,B-Condition
99184,6888,infection,I-Condition
99185,6888,origin,O
99186,6888,from,O
99187,6888,another,O
99188,6888,organ,O
99189,6888,(,O
99190,6888,e.g.,O
99191,6888,pneumonia,B-Condition
99192,6888,),O
99193,6889,Severe,B-Condition
99194,6889,sepsis,I-Condition
99195,6889,with,O
99196,6889,multiorgan,B-Condition
99197,6889,failure,I-Condition
99198,6890,Perinephritic,B-Condition
99199,6890,abscess,I-Condition
99200,6891,Pyonephrosis,B-Condition
99201,6891,requiring,B-Mood
99202,6891,drainage,B-Procedure
99203,6892,Allergy,B-Condition
99204,6892,to,O
99205,6892,pivmecillinam,B-Drug
99206,6893,E.coli,B-Condition
99207,6893,isolate,I-Condition
99208,6893,resistant,O
99209,6893,to,O
99210,6893,pivmecillinam,B-Drug
99211,6894,Pregnancy,B-Condition
99212,6894,/,O
99213,6894,breastfeeding,B-Observation
99214,6895,Severe,O
99215,6895,neutropenia,B-Condition
99216,6896,Prostatitis,B-Condition
99217,6897,Severe,O
99218,6897,kidney,B-Condition
99219,6897,failure,I-Condition
99220,6897,(,O
99221,6897,eGFR<15,O
99222,6897,ml,O
99223,6897,/,O
99224,6897,min,O
99225,6897,),O
99226,6898,Using,O
99227,6898,valproate,B-Drug
99228,6899,E.coli,O
99229,6899,in,O
99230,6899,blood,B-Procedure
99231,6899,culture,I-Procedure
99232,6900,AND,O
99233,6900,identical,O
99234,6900,isolate,O
99235,6900,in,O
99236,6900,urine,B-Procedure
99237,6900,sample,I-Procedure
99238,6900,(,O
99239,6900,>,O
99240,6900,=,O
99241,6900,1.000,O
99242,6900,CFU,O
99243,6900,),O
99244,6900,OR,O
99245,6900,relevant,O
99246,6900,clinical,B-Mood
99247,6900,signs,I-Mood
99248,6900,of,O
99249,6900,UTI,B-Condition
99250,6901,1,O
99251,6901,.,O
99252,6901,Diagnosis,O
99253,6901,:,O
99254,6901,Diagnosis,O
99255,6901,of,O
99256,6901,CP,B-Condition
99257,6901,secondary,I-Condition
99258,6901,to,I-Condition
99259,6901,neuronal,I-Condition
99260,6901,migration,I-Condition
99261,6901,.,O
99262,6902,2,O
99263,6902,.,O
99264,6902,Co,O
99265,6902,-,O
99266,6902,morbidities,O
99267,6902,:,O
99268,6902,Medical,O
99269,6902,conditions,O
99270,6902,that,O
99271,6902,may,O
99272,6902,prevent,O
99273,6902,the,O
99274,6902,administration,O
99275,6902,of,O
99276,6902,rehabilitation,O
99277,6902,therapies,O
99278,6902,at,O
99279,6902,the,O
99280,6902,intensity,O
99281,6902,required,O
99282,6902,by,O
99283,6902,the,O
99284,6902,study,O
99285,6902,",",O
99286,6902,or,O
99287,6902,that,O
99288,6902,may,O
99289,6902,compromise,O
99290,6902,the,O
99291,6902,study,O
99292,6902,ability,O
99293,6902,to,O
99294,6902,maintain,O
99295,6902,blindness,O
99296,6902,",",O
99297,6902,or,O
99298,6902,that,O
99299,6902,have,O
99300,6902,a,O
99301,6902,co,O
99302,6902,-,O
99303,6902,morbidity,O
99304,6902,not,O
99305,6902,typically,O
99306,6902,associated,O
99307,6902,with,O
99308,6902,CP,O
99309,6902,(,O
99310,6902,i.e.,O
99311,6902,cancer,O
99312,6902,",",O
99313,6902,cystic,O
99314,6902,fibrosis,O
99315,6902,),O
99316,6902,.,O
99317,6903,3,O
99318,6903,.,O
99319,6903,Co,O
99320,6903,-,O
99321,6903,interventions,O
99322,6903,:,O
99323,6903,Anticipated,O
99324,6903,pharmacological,O
99325,6903,intervention,O
99326,6903,or,O
99327,6903,procedure,O
99328,6903,or,O
99329,6903,participation,O
99330,6903,in,O
99331,6903,other,O
99332,6903,studies,O
99333,6903,that,O
99334,6903,may,O
99335,6903,interfere,O
99336,6903,with,O
99337,6903,this,O
99338,6903,study,O
99339,6903,.,O
99340,6904,1,O
99341,6904,.,O
99342,6904,Age,B-Person
99343,6904,:,O
99344,6904,12,O
99345,6904,to,O
99346,6904,36,O
99347,6904,months,O
99348,6904,of,O
99349,6904,age,O
99350,6904,(,O
99351,6904,The,O
99352,6904,diagnosis,O
99353,6904,of,O
99354,6904,CP,O
99355,6904,is,O
99356,6904,often,O
99357,6904,uncertain,O
99358,6904,under,O
99359,6904,the,O
99360,6904,age,O
99361,6904,of,O
99362,6904,12,O
99363,6904,months,O
99364,6904,.,O
99365,6904,The,O
99366,6904,cutoff,O
99367,6904,at,O
99368,6904,36,O
99369,6904,months,O
99370,6904,is,O
99371,6904,to,O
99372,6904,have,O
99373,6904,a,O
99374,6904,population,O
99375,6904,of,O
99376,6904,young,O
99377,6904,children,O
99378,6904,when,O
99379,6904,the,O
99380,6904,brain,O
99381,6904,is,O
99382,6904,most,O
99383,6904,"""",O
99384,6904,plastic,O
99385,6904,"""",O
99386,6904,and,O
99387,6904,most,O
99388,6904,susceptible,O
99389,6904,to,O
99390,6904,reorganization,O
99391,6904,),O
99392,6904,.,O
99393,6905,2,O
99394,6905,.,O
99395,6905,Diagnosis,O
99396,6905,:,O
99397,6905,Diagnosis,O
99398,6905,of,O
99399,6905,spastic,B-Condition
99400,6905,CP,I-Condition
99401,6905,confirmed,O
99402,6905,by,O
99403,6905,a,O
99404,6905,pediatric,O
99405,6905,neurologist,O
99406,6905,or,O
99407,6905,pediatric,O
99408,6905,rehabilitation,O
99409,6905,specialist,O
99410,6905,.,O
99411,6906,3,O
99412,6906,.,O
99413,6906,Etiology,O
99414,6906,:,O
99415,6906,The,O
99416,6906,insult,O
99417,6906,to,O
99418,6906,the,O
99419,6906,central,O
99420,6906,nervous,O
99421,6906,system,O
99422,6906,that,O
99423,6906,caused,O
99424,6906,the,O
99425,6906,motor,O
99426,6906,dysfunction,O
99427,6906,must,O
99428,6906,have,O
99429,6906,occurred,O
99430,6906,during,O
99431,6906,gestation,O
99432,6906,or,O
99433,6906,within,O
99434,6906,one,O
99435,6906,year,O
99436,6906,after,O
99437,6906,birth,O
99438,6906,independent,O
99439,6906,of,O
99440,6906,gestational,O
99441,6906,age,O
99442,6906,.,O
99443,6907,4,O
99444,6907,.,O
99445,6907,Disease,O
99446,6907,severity,O
99447,6907,level,O
99448,6907,:,O
99449,6907,Gross,O
99450,6907,Motor,O
99451,6907,Function,O
99452,6907,Classification,O
99453,6907,System,O
99454,6907,(,O
99455,6907,GMFCS,O
99456,6907,),O
99457,6907,levels,O
99458,6907,I,O
99459,6907,",",O
99460,6907,II,O
99461,6907,and,O
99462,6907,III,O
99463,6907,.,O
99464,6908,Abnormal,O
99465,6908,resting,B-Procedure
99466,6908,ECG,I-Procedure
99467,6909,Current,O
99468,6909,abnormal,O
99469,6909,blood,B-Procedure
99470,6909,panel,I-Procedure
99471,6909,(,O
99472,6909,assessed,O
99473,6909,by,O
99474,6909,comprehensive,O
99475,6909,metabolic,B-Procedure
99476,6909,panel,I-Procedure
99477,6909,",",O
99478,6909,lipid,B-Procedure
99479,6909,panel,I-Procedure
99480,6909,and,O
99481,6909,complete,B-Procedure
99482,6909,blood,I-Procedure
99483,6909,count,I-Procedure
99484,6909,),O
99485,6909,.,O
99486,6910,Hypertension,B-Condition
99487,6910,(,O
99488,6910,currently,O
99489,6910,taking,O
99490,6910,anti,B-Drug
99491,6910,-,I-Drug
99492,6910,hypertensive,I-Drug
99493,6910,medications,I-Drug
99494,6910,or,O
99495,6910,resting,O
99496,6910,blood,O
99497,6910,pressure,O
99498,6910,>,O
99499,6910,140/90,O
99500,6910,mmHg,O
99501,6910,),O
99502,6911,Medical,O
99503,6911,history,O
99504,6911,of,O
99505,6911,cardiovascular,B-Condition
99506,6911,disease,I-Condition
99507,6911,",",O
99508,6911,malignant,B-Condition
99509,6911,cancer,I-Condition
99510,6911,",",O
99511,6911,diabetes,B-Condition
99512,6911,or,O
99513,6911,kidney,B-Condition
99514,6911,disease,I-Condition
99515,6912,Obesity,B-Condition
99516,6912,(,O
99517,6912,Body,O
99518,6912,Mass,O
99519,6912,Index,O
99520,6912,>,O
99521,6912,30,O
99522,6912,),O
99523,6913,Current,O
99524,6913,pregnancy,B-Condition
99525,6914,Unable,O
99526,6914,to,O
99527,6914,provide,O
99528,6914,consent,O
99529,6915,Habitual,O
99530,6915,dietary,O
99531,6915,sodium,O
99532,6915,intake,O
99533,6915,>,O
99534,6915,3400,O
99535,6915,mg,O
99536,6915,per,O
99537,6915,day,O
99538,6916,Women,B-Person
99539,6916,only,O
99540,6916,:,O
99541,6916,Can,O
99542,6916,not,O
99543,6916,be,O
99544,6916,pregnant,O
99545,6916,or,O
99546,6916,nursing,O
99547,6916,at,O
99548,6916,baseline,O
99549,6916,or,O
99550,6916,plan,O
99551,6916,to,O
99552,6916,become,O
99553,6916,pregnant,O
99554,6916,during,O
99555,6916,the,O
99556,6916,course,O
99557,6916,of,O
99558,6916,the,O
99559,6916,study,O
99560,6917,Body,O
99561,6917,Mass,O
99562,6917,Index,O
99563,6917,(,O
99564,6917,BMI,O
99565,6917,),O
99566,6917,>,O
99567,6917,32,O
99568,6918,Weight,O
99569,6918,>,O
99570,6918,220,O
99571,6918,pounds,O
99572,6919,Allergies,B-Condition
99573,6919,to,O
99574,6919,shell,B-Observation
99575,6919,fish,I-Observation
99576,6919,",",O
99577,6919,seafood,B-Observation
99578,6919,",",O
99579,6919,eggs,B-Observation
99580,6919,or,O
99581,6919,iodine,B-Drug
99582,6920,Heart,B-Condition
99583,6920,disease,I-Condition
99584,6920,",",O
99585,6920,kidney,B-Condition
99586,6920,disease,I-Condition
99587,6920,or,O
99588,6920,diabetes,B-Condition
99589,6921,Diagnosis,O
99590,6921,of,O
99591,6921,asthma,B-Condition
99592,6922,Any,O
99593,6922,metal,O
99594,6922,in,O
99595,6922,or,O
99596,6922,on,O
99597,6922,the,O
99598,6922,body,O
99599,6922,(,O
99600,6922,that,O
99601,6922,can,O
99602,6922,not,O
99603,6922,be,O
99604,6922,removed,O
99605,6922,),O
99606,6922,between,O
99607,6922,the,O
99608,6922,nose,O
99609,6922,and,O
99610,6922,the,O
99611,6922,abdomen,O
99612,6923,Any,O
99613,6923,major,B-Condition
99614,6923,organ,I-Condition
99615,6923,system,I-Condition
99616,6923,disease,I-Condition
99617,6923,(,O
99618,6923,by,O
99619,6923,judgment,O
99620,6923,of,O
99621,6923,the,O
99622,6923,study,O
99623,6923,medical,O
99624,6923,team,O
99625,6923,),O
99626,6924,A,O
99627,6924,glomerular,O
99628,6924,filtration,O
99629,6924,rate,O
99630,6924,of,O
99631,6924,60,O
99632,6924,cc,O
99633,6924,per,O
99634,6924,minute,O
99635,6924,or,O
99636,6924,less,O
99637,6924,.,O
99638,6925,Nitroglycerin,B-Drug
99639,6925,usage,O
99640,6925,or,O
99641,6925,nitrates,B-Drug
99642,6925,and,O
99643,6925,use,O
99644,6925,of,O
99645,6925,phosphodiesterase,B-Drug
99646,6925,5,I-Drug
99647,6925,(,I-Drug
99648,6925,PDE5,I-Drug
99649,6925,),I-Drug
99650,6925,inhibitors,I-Drug
99651,6926,Prior,B-Observation
99652,6926,history,I-Observation
99653,6926,of,O
99654,6926,hypersensitivity,B-Condition
99655,6926,to,O
99656,6926,sildenafil,B-Drug
99657,6927,Currently,O
99658,6927,prescribed,O
99659,6927,a,O
99660,6927,phosphodiesterase,B-Drug
99661,6927,(,I-Drug
99662,6927,PDE,I-Drug
99663,6927,),I-Drug
99664,6927,inhibitors,I-Drug
99665,6927,medication,O
99666,6927,(,O
99667,6927,ex,O
99668,6927,:,O
99669,6927,Viagra,B-Drug
99670,6927,",",O
99671,6927,Cialis,B-Drug
99672,6927,",",O
99673,6927,etc,O
99674,6927,),O
99675,6928,Known,O
99676,6928,Pulmonary,B-Condition
99677,6928,Hypertension,I-Condition
99678,6929,Has,O
99679,6929,used,B-Observation
99680,6929,e,I-Observation
99681,6929,-,I-Observation
99682,6929,cigarettes,I-Observation
99683,6929,and,I-Observation
99684,6929,marijuana,I-Observation
99685,6929,<,O
99686,6929,1,O
99687,6929,years,O
99688,6930,Between,O
99689,6930,the,O
99690,6930,age,B-Person
99691,6930,of,O
99692,6930,25,O
99693,6930,to,O
99694,6930,65,O
99695,6930,at,O
99696,6930,baseline,O
99697,6931,Be,O
99698,6931,willing,B-Mood
99699,6931,to,I-Mood
99700,6931,participate,I-Mood
99701,6931,in,O
99702,6931,a,O
99703,6931,smoking,B-Procedure
99704,6931,cessation,I-Procedure
99705,6931,program,I-Procedure
99706,6932,Be,O
99707,6932,willing,O
99708,6932,to,O
99709,6932,attend,O
99710,6932,all,O
99711,6932,clinic,O
99712,6932,visits,O
99713,6933,Must,O
99714,6933,be,O
99715,6933,currently,O
99716,6933,smoking,B-Observation
99717,6933,at,O
99718,6933,least,O
99719,6933,½,O
99720,6933,pack,O
99721,6933,/,O
99722,6933,day,O
99723,6933,at,O
99724,6933,baseline,O
99725,6933,(,O
99726,6933,confirmed,O
99727,6933,with,O
99728,6933,cotinine,B-Procedure
99729,6933,level,I-Procedure
99730,6933,and,O
99731,6933,CO,B-Procedure
99732,6933,Smokerlyzer,I-Procedure
99733,6934,>,O
99734,6934,5,O
99735,6934,pack,O
99736,6934,-,O
99737,6934,year,O
99738,6934,history,O
99739,6934,of,O
99740,6934,smoking,B-Observation
99741,6935,Global,O
99742,6935,Initiative,O
99743,6935,for,O
99744,6935,Chronic,O
99745,6935,Obstructive,O
99746,6935,Lung,O
99747,6935,Disease,O
99748,6935,(,O
99749,6935,GOLD,O
99750,6935,),O
99751,6935,0,O
99752,6935,:,O
99753,6935,FEV1=0.80,O
99754,6935,and,O
99755,6935,FEV1,O
99756,6935,/,O
99757,6935,FVC>0.70,O
99758,6935,Forced,O
99759,6935,Expiratory,O
99760,6935,Volume,O
99761,6935,in,O
99762,6935,1,O
99763,6935,second,O
99764,6935,(,O
99765,6935,FEV1,O
99766,6935,),O
99767,6935,",",O
99768,6935,Forced,O
99769,6935,Vital,O
99770,6935,Capacity,O
99771,6935,(,O
99772,6935,FVC,O
99773,6935,),O
99774,6936,GOLD,O
99775,6936,1,O
99776,6936,:,O
99777,6936,FEV1=0.80,O
99778,6936,and,O
99779,6936,FEV1,O
99780,6936,/,O
99781,6936,FVC,O
99782,6936,<,O
99783,6936,0.70,O
99784,6937,GOLD,O
99785,6937,2,O
99786,6937,:,O
99787,6937,0.50,O
99788,6937,=,O
99789,6937,FEV1<0.80,O
99790,6937,and,O
99791,6937,FEV1,O
99792,6937,/,O
99793,6937,FVC,O
99794,6937,<,O
99795,6937,0.70,O
99796,6938,Be,O
99797,6938,willing,O
99798,6938,to,O
99799,6938,abstain,O
99800,6938,from,O
99801,6938,using,O
99802,6938,any,O
99803,6938,nicotine,O
99804,6938,patches,O
99805,6938,",",O
99806,6938,e,O
99807,6938,-,O
99808,6938,cigarettes,O
99809,6938,",",O
99810,6938,or,O
99811,6938,marijuana,O
99812,6938,for,O
99813,6938,the,O
99814,6938,duration,O
99815,6938,of,O
99816,6938,the,O
99817,6938,study,O
99818,6938,.,O
99819,6939,incooperative,B-Condition
99820,6939,for,O
99821,6939,glucose,B-Procedure
99822,6939,monitor,I-Procedure
99823,6940,refusal,B-Condition
99824,6940,of,O
99825,6940,insulin,B-Drug
99826,6941,pregnancy,B-Condition
99827,6942,Type,B-Condition
99828,6942,2,I-Condition
99829,6942,diabetic,I-Condition
99830,6942,inpatient,O
99831,6943,Fasting,O
99832,6943,glucose,O
99833,6943,>,O
99834,6943,140,O
99835,6943,mg,O
99836,6943,/,O
99837,6943,dl,O
99838,6943,or,O
99839,6943,random,O
99840,6943,glucose,O
99841,6943,>,O
99842,6943,180,O
99843,6943,mg,O
99844,6943,/,O
99845,6943,dl,O
99846,6944,NA,O
99847,6945,intolerance,B-Condition
99848,6945,of,O
99849,6945,or,O
99850,6945,allergy,B-Condition
99851,6945,to,O
99852,6945,ticagrelor,B-Drug
99853,6945,or,O
99854,6945,prasugrel,B-Drug
99855,6946,history,O
99856,6946,of,O
99857,6946,any,O
99858,6946,stroke,B-Condition
99859,6946,",",O
99860,6946,transient,B-Condition
99861,6946,ischemic,I-Condition
99862,6946,attack,I-Condition
99863,6946,or,O
99864,6946,intracranial,B-Condition
99865,6946,bleeding,I-Condition
99866,6947,known,O
99867,6947,intracranial,B-Condition
99868,6947,neoplasm,I-Condition
99869,6947,",",O
99870,6947,intracranial,B-Condition
99871,6947,arteriovenous,I-Condition
99872,6947,malformation,I-Condition
99873,6947,or,O
99874,6947,intracranial,B-Condition
99875,6947,aneurysm,I-Condition
99876,6948,active,O
99877,6948,bleeding,B-Condition
99878,6948,",",O
99879,6948,clinical,B-Condition
99880,6948,findings,I-Condition
99881,6948,",",I-Condition
99882,6948,that,I-Condition
99883,6948,in,I-Condition
99884,6948,the,I-Condition
99885,6948,judgement,I-Condition
99886,6948,of,I-Condition
99887,6948,the,I-Condition
99888,6948,investigator,I-Condition
99889,6948,are,I-Condition
99890,6948,associated,I-Condition
99891,6948,with,I-Condition
99892,6948,an,I-Condition
99893,6948,increased,I-Condition
99894,6948,risk,I-Condition
99895,6948,of,I-Condition
99896,6948,bleeding,I-Condition
99897,6949,fibrin,O
99898,6949,-,O
99899,6949,specific,O
99900,6949,fibrinolytic,B-Procedure
99901,6949,therapy,I-Procedure
99902,6949,less,O
99903,6949,than,O
99904,6949,24,O
99905,6949,h,O
99906,6949,before,O
99907,6949,randomization,O
99908,6949,",",O
99909,6949,non,O
99910,6949,-,O
99911,6949,fibrin,O
99912,6949,-,O
99913,6949,specific,O
99914,6949,fibrinolytic,B-Procedure
99915,6949,therapy,I-Procedure
99916,6949,less,O
99917,6949,than,O
99918,6949,48,O
99919,6949,h,O
99920,6949,before,O
99921,6949,randomization,O
99922,6950,known,O
99923,6950,platelet,O
99924,6950,count,O
99925,6950,<,O
99926,6950,100.000/µL,O
99927,6950,at,O
99928,6950,the,O
99929,6950,time,O
99930,6950,of,O
99931,6950,screening,O
99932,6951,known,O
99933,6951,anemia,B-Condition
99934,6951,(,O
99935,6951,hemoglobin,O
99936,6951,<,O
99937,6951,10,O
99938,6951,g,O
99939,6951,/,O
99940,6951,dL,O
99941,6951,),O
99942,6951,at,O
99943,6951,the,O
99944,6951,time,O
99945,6951,of,O
99946,6951,screening,O
99947,6952,oral,B-Procedure
99948,6952,anticoagulation,I-Procedure
99949,6952,that,O
99950,6952,can,O
99951,6952,not,O
99952,6952,be,O
99953,6952,safely,O
99954,6952,discontinued,O
99955,6952,for,O
99956,6952,the,O
99957,6952,duration,O
99958,6952,of,O
99959,6952,the,O
99960,6952,study,O
99961,6953,INR,O
99962,6953,known,O
99963,6953,to,O
99964,6953,be,O
99965,6953,greater,O
99966,6953,than,O
99967,6953,1.5,O
99968,6953,at,O
99969,6953,the,O
99970,6953,time,O
99971,6953,of,O
99972,6953,screening,O
99973,6954,chronic,B-Condition
99974,6954,renal,I-Condition
99975,6954,insufficiency,I-Condition
99976,6954,requiring,O
99977,6954,dialysis,B-Procedure
99978,6955,moderate,O
99979,6955,or,O
99980,6955,severe,O
99981,6955,hepatic,B-Condition
99982,6955,dysfunction,I-Condition
99983,6955,(,O
99984,6955,Child,O
99985,6955,Pugh,O
99986,6955,B,O
99987,6955,or,O
99988,6955,C,O
99989,6955,),O
99990,6956,increased,B-Mood
99991,6956,risk,I-Mood
99992,6956,of,O
99993,6956,bradycardia,B-Condition
99994,6956,events,I-Condition
99995,6956,(,O
99996,6956,Sick,B-Condition
99997,6956,Sinus,I-Condition
99998,6956,",",O
99999,6956,AV,B-Condition
100000,6956,block,I-Condition
100001,6956,grade,O
100002,6956,II,O
100003,6956,or,O
100004,6956,III,O
100005,6956,",",O
100006,6956,bradycardia,B-Condition
100007,6956,-,I-Condition
100008,6956,induced,I-Condition
100009,6956,syncope,I-Condition
100010,6956,),O
100011,6957,index,O
100012,6957,event,O
100013,6957,is,O
100014,6957,an,O
100015,6957,acute,O
100016,6957,complication,B-Condition
100017,6957,(,I-Condition
100018,6957,<,I-Condition
100019,6957,30,I-Condition
100020,6957,days,I-Condition
100021,6957,),I-Condition
100022,6957,of,I-Condition
100023,6957,PCI,I-Condition
100024,6958,concomitant,B-Condition
100025,6958,medical,I-Condition
100026,6958,illness,I-Condition
100027,6958,that,O
100028,6958,in,O
100029,6958,the,O
100030,6958,opinion,O
100031,6958,of,O
100032,6958,the,O
100033,6958,investigator,O
100034,6958,is,O
100035,6958,associated,O
100036,6958,with,O
100037,6958,a,O
100038,6958,life,O
100039,6958,expectancy,O
100040,6958,<,O
100041,6958,1,O
100042,6958,year,O
100043,6959,concomitant,O
100044,6959,oral,B-Procedure
100045,6959,or,I-Procedure
100046,6959,i.v,I-Procedure
100047,6959,.,I-Procedure
100048,6959,therapy,I-Procedure
100049,6959,with,O
100050,6959,strong,B-Drug
100051,6959,CYP3A,I-Drug
100052,6959,Inhibitors,I-Drug
100053,6959,(,O
100054,6959,e.g.,O
100055,6959,ketoconazole,B-Drug
100056,6959,",",O
100057,6959,itraconazole,B-Drug
100058,6959,",",O
100059,6959,voriconazole,B-Drug
100060,6959,",",O
100061,6959,telithromycin,B-Drug
100062,6959,",",O
100063,6959,clarithromycin,B-Drug
100064,6959,",",O
100065,6959,nefazodone,B-Drug
100066,6959,",",O
100067,6959,ritonavir,B-Drug
100068,6959,",",O
100069,6959,saquinavir,B-Drug
100070,6959,",",O
100071,6959,nelfinavir,B-Drug
100072,6959,",",O
100073,6959,indinavir,B-Drug
100074,6959,",",O
100075,6959,atazanavir,B-Drug
100076,6959,",",O
100077,6959,grapefruit,B-Drug
100078,6959,juice,I-Drug
100079,6959,>,O
100080,6959,1,O
100081,6959,L,O
100082,6959,/,O
100083,6959,d,O
100084,6959,),O
100085,6959,",",O
100086,6959,CYP3A,B-Drug
100087,6959,substrates,I-Drug
100088,6959,with,I-Drug
100089,6959,narrow,I-Drug
100090,6959,therapeutic,I-Drug
100091,6959,indices,I-Drug
100092,6959,(,O
100093,6959,e.g.,O
100094,6959,cyclosporine,B-Drug
100095,6959,",",O
100096,6959,quinidine,B-Drug
100097,6959,),O
100098,6959,",",O
100099,6959,or,O
100100,6959,strong,B-Drug
100101,6959,CYP3A,I-Drug
100102,6959,inducers,I-Drug
100103,6959,(,O
100104,6959,e.g.,O
100105,6959,rifampin,B-Drug
100106,6959,/,O
100107,6959,rifampicin,B-Drug
100108,6959,",",O
100109,6959,phenytoin,B-Drug
100110,6959,",",O
100111,6959,carbamazepine,B-Drug
100112,6959,",",O
100113,6959,dexamethason,B-Drug
100114,6959,",",O
100115,6959,phenobarbital,B-Drug
100116,6959,),O
100117,6959,that,O
100118,6959,can,O
100119,6959,not,O
100120,6959,be,O
100121,6959,safely,O
100122,6959,discontinued,O
100123,6960,=,O
100124,6960,1,O
100125,6960,doses,O
100126,6960,of,O
100127,6960,ticagrelor,B-Drug
100128,6960,or,O
100129,6960,prasugrel,B-Drug
100130,6960,within,O
100131,6960,5,O
100132,6960,days,O
100133,6960,before,O
100134,6960,randomisation,O
100135,6961,no,O
100136,6961,written,O
100137,6961,informed,O
100138,6961,consent,O
100139,6962,participation,O
100140,6962,in,O
100141,6962,another,O
100142,6962,investigational,O
100143,6962,drug,O
100144,6962,study,O
100145,6963,previous,O
100146,6963,enrolment,O
100147,6963,in,O
100148,6963,this,O
100149,6963,study,O
100150,6964,for,O
100151,6964,women,O
100152,6964,of,O
100153,6964,childbearing,O
100154,6964,potential,O
100155,6964,no,O
100156,6964,negative,O
100157,6964,pregnancy,O
100158,6964,test,O
100159,6964,and,O
100160,6964,no,O
100161,6964,agree,O
100162,6964,to,O
100163,6964,use,O
100164,6964,reliable,O
100165,6964,method,O
100166,6964,of,O
100167,6964,birth,O
100168,6964,control,O
100169,6964,during,O
100170,6964,the,O
100171,6964,study,O
100172,6965,Pregnancy,O
100173,6965,",",O
100174,6965,giving,O
100175,6965,birth,O
100176,6965,within,O
100177,6965,the,O
100178,6965,last,O
100179,6965,90,O
100180,6965,days,O
100181,6965,",",O
100182,6965,or,O
100183,6965,lactation,O
100184,6966,inability,O
100185,6966,to,O
100186,6966,cooperate,O
100187,6966,with,O
100188,6966,protocol,O
100189,6966,requirements,O
100190,6967,Previous,O
100191,6967,treatment,O
100192,6967,with,O
100193,6967,brentuximab,B-Drug
100194,6967,vedotin,O
100195,6967,.,O
100196,6968,Previously,O
100197,6968,received,O
100198,6968,an,O
100199,6968,allogeneic,B-Procedure
100200,6968,transplant,I-Procedure
100201,6968,.,O
100202,6969,Patients,O
100203,6969,with,O
100204,6969,current,O
100205,6969,diagnosis,O
100206,6969,of,O
100207,6969,primary,B-Condition
100208,6969,cutaneous,I-Condition
100209,6969,ALCL,I-Condition
100210,6969,(,O
100211,6969,patients,O
100212,6969,whose,O
100213,6969,ALCL,O
100214,6969,has,O
100215,6969,transformed,O
100216,6969,to,O
100217,6969,sALCL,B-Condition
100218,6969,are,O
100219,6969,eligible,O
100220,6969,),O
100221,6969,.,O
100222,6970,Known,O
100223,6970,cerebral,B-Condition
100224,6970,/,I-Condition
100225,6970,meningeal,I-Condition
100226,6970,disease,I-Condition
100227,6970,including,O
100228,6970,signs,O
100229,6970,or,O
100230,6970,symptoms,O
100231,6970,of,O
100232,6970,progressive,B-Condition
100233,6970,multifocal,I-Condition
100234,6970,leukoencephalopathy,I-Condition
100235,6970,(,O
100236,6970,PML,B-Condition
100237,6970,),O
100238,6971,Female,O
100239,6971,patients,O
100240,6971,who,O
100241,6971,are,O
100242,6971,lactating,O
100243,6971,and,O
100244,6971,breastfeeding,O
100245,6971,or,O
100246,6971,pregnant,O
100247,6972,Known,O
100248,6972,human,O
100249,6972,immunodeficiency,O
100250,6972,virus,O
100251,6972,(,O
100252,6972,HIV,O
100253,6972,),O
100254,6972,positive,O
100255,6973,Known,O
100256,6973,hepatitis,O
100257,6973,B,O
100258,6973,surface,O
100259,6973,antigen,O
100260,6973,-,O
100261,6973,positive,O
100262,6973,",",O
100263,6973,or,O
100264,6973,known,O
100265,6973,or,O
100266,6973,suspected,O
100267,6973,active,O
100268,6973,hepatitis,B-Condition
100269,6973,C,I-Condition
100270,6973,infection,I-Condition
100271,6974,Male,B-Person
100272,6974,or,O
100273,6974,female,B-Person
100274,6974,patients,O
100275,6974,age,B-Person
100276,6974,18,O
100277,6974,years,O
100278,6974,or,O
100279,6974,older,O
100280,6974,",",O
100281,6974,with,O
100282,6974,relapsed,O
100283,6974,or,O
100284,6974,refractory,O
100285,6974,sALCL,B-Condition
100286,6974,who,O
100287,6974,have,O
100288,6974,previously,O
100289,6974,received,O
100290,6974,at,O
100291,6974,least,O
100292,6974,1,O
100293,6974,multiagent,O
100294,6974,chemotherapy,B-Procedure
100295,6975,Bidimensional,O
100296,6975,measurable,O
100297,6975,disease,O
100298,6976,An,O
100299,6976,Eastern,O
100300,6976,Cooperative,O
100301,6976,Oncology,O
100302,6976,Group,O
100303,6976,(,O
100304,6976,ECOG,O
100305,6976,),O
100306,6976,performance,O
100307,6976,status,O
100308,6976,of,O
100309,6976,0,O
100310,6976,or,O
100311,6976,1,O
100312,6977,Female,O
100313,6977,patients,O
100314,6977,who,O
100315,6977,are,O
100316,6977,postmenopausal,O
100317,6977,for,O
100318,6977,at,O
100319,6977,least,O
100320,6977,1,O
100321,6977,year,O
100322,6977,before,O
100323,6977,the,O
100324,6977,screening,O
100325,6977,visit,O
100326,6977,",",O
100327,6977,surgically,O
100328,6977,sterile,O
100329,6977,",",O
100330,6977,or,O
100331,6977,agree,O
100332,6977,to,O
100333,6977,practice,O
100334,6977,2,O
100335,6977,effective,O
100336,6977,methods,O
100337,6977,of,O
100338,6977,contraception,O
100339,6977,",",O
100340,6977,at,O
100341,6977,the,O
100342,6977,same,O
100343,6977,time,O
100344,6977,",",O
100345,6977,from,O
100346,6977,the,O
100347,6977,time,O
100348,6977,of,O
100349,6977,signing,O
100350,6977,the,O
100351,6977,informed,O
100352,6977,consent,O
100353,6977,form,O
100354,6977,through,O
100355,6977,30,O
100356,6977,days,O
100357,6977,after,O
100358,6977,the,O
100359,6977,last,O
100360,6977,dose,O
100361,6977,of,O
100362,6977,study,O
100363,6977,drug,O
100364,6977,",",O
100365,6977,or,O
100366,6977,agree,O
100367,6977,to,O
100368,6977,practice,O
100369,6977,true,O
100370,6977,abstinence,O
100371,6978,Male,O
100372,6978,patients,O
100373,6978,who,O
100374,6978,agree,O
100375,6978,to,O
100376,6978,practice,O
100377,6978,effective,O
100378,6978,barrier,O
100379,6978,contraception,O
100380,6978,during,O
100381,6978,the,O
100382,6978,entire,O
100383,6978,study,O
100384,6978,treatment,O
100385,6978,period,O
100386,6978,through,O
100387,6978,6,O
100388,6978,months,O
100389,6978,after,O
100390,6978,the,O
100391,6978,last,O
100392,6978,dose,O
100393,6978,of,O
100394,6978,study,O
100395,6978,drug,O
100396,6978,or,O
100397,6978,agree,O
100398,6978,to,O
100399,6978,practice,O
100400,6978,true,O
100401,6978,abstinence,O
100402,6979,Clinical,O
100403,6979,laboratory,O
100404,6979,values,O
100405,6979,as,O
100406,6979,specified,O
100407,6979,in,O
100408,6979,the,O
100409,6979,study,O
100410,6979,protocol,O
100411,6980,Uncontrolled,O
100412,6980,hypertension,B-Condition
100413,6980,or,O
100414,6980,metabolic,B-Condition
100415,6980,disease,I-Condition
100416,6981,Neurodegenerative,B-Condition
100417,6981,disorders,I-Condition
100418,6981,(,O
100419,6981,i.e.,O
100420,6981,Parkinson,B-Condition
100421,6981,disease,I-Condition
100422,6981,.,O
100423,6981,LBD,B-Condition
100424,6981,",",O
100425,6981,or,O
100426,6981,FTD,B-Condition
100427,6981,),O
100428,6981,.,O
100429,6982,Dementia,B-Condition
100430,6982,or,O
100431,6982,Mild,B-Condition
100432,6982,cognitive,I-Condition
100433,6982,impairment,I-Condition
100434,6982,at,O
100435,6982,baseline,O
100436,6983,Long,B-Condition
100437,6983,life,I-Condition
100438,6983,major,I-Condition
100439,6983,depression,I-Condition
100440,6983,.,O
100441,6983,Baseline,O
100442,6983,scores,O
100443,6983,=,O
100444,6983,16,O
100445,6983,on,O
100446,6983,the,O
100447,6983,17,O
100448,6983,-,O
100449,6983,item,O
100450,6983,Hamilton,O
100451,6983,Depression,O
100452,6983,Scale,O
100453,6983,at,O
100454,6983,baseline,O
100455,6983,.,O
100456,6984,Long,B-Condition
100457,6984,-,I-Condition
100458,6984,life,I-Condition
100459,6984,DSM,I-Condition
100460,6984,-,I-Condition
100461,6984,IV,I-Condition
100462,6984,axis,I-Condition
100463,6984,1,I-Condition
100464,6984,disorders,I-Condition
100465,6984,.,O
100466,6985,Mental,B-Condition
100467,6985,retardation,I-Condition
100468,6985,.,O
100469,6986,Substance,B-Condition
100470,6986,abuse,I-Condition
100471,6986,.,O
100472,6987,Concurrent,O
100473,6987,medication,B-Drug
100474,6987,limiting,O
100475,6987,validity,O
100476,6987,of,O
100477,6987,neuropsychological,O
100478,6987,tests,O
100479,6987,or,O
100480,6987,imaging,O
100481,6987,.,O
100482,6988,Anti,B-Drug
100483,6988,-,I-Drug
100484,6988,depressants,I-Drug
100485,6988,with,O
100486,6988,anti,B-Drug
100487,6988,-,I-Drug
100488,6988,cholinergic,I-Drug
100489,6988,properties,O
100490,6989,Monoamine,B-Drug
100491,6989,oxidase,I-Drug
100492,6989,inhibitors,I-Drug
100493,6989,(,I-Drug
100494,6989,MAOi,I-Drug
100495,6989,),I-Drug
100496,6990,Regular,O
100497,6990,use,O
100498,6990,of,O
100499,6990,narcotic,B-Drug
100500,6990,analgesics,I-Drug
100501,6990,(,O
100502,6990,>,O
100503,6990,2,O
100504,6990,doses,O
100505,6990,per,O
100506,6990,week,O
100507,6990,),O
100508,6990,.,O
100509,6991,Use,O
100510,6991,of,O
100511,6991,neuroleptics,B-Drug
100512,6992,Use,O
100513,6992,of,O
100514,6992,anti,B-Drug
100515,6992,-,I-Drug
100516,6992,dementia,I-Drug
100517,6992,medications,I-Drug
100518,6992,(,O
100519,6992,Aricept,B-Drug
100520,6992,",",O
100521,6992,Exelon,B-Drug
100522,6992,",",O
100523,6992,Razadyne,B-Drug
100524,6992,),O
100525,6992,and,O
100526,6992,memantine,B-Drug
100527,6992,(,O
100528,6992,Namenda,B-Drug
100529,6992,),O
100530,6992,),O
100531,6992,or,O
100532,6992,anti,B-Drug
100533,6992,-,I-Drug
100534,6992,Parkinsonian,I-Drug
100535,6992,medications,I-Drug
100536,6992,(,O
100537,6992,Sinemet,B-Drug
100538,6992,",",O
100539,6992,amantadine,B-Drug
100540,6992,",",O
100541,6992,bromocriptine,B-Drug
100542,6992,",",O
100543,6992,pergolide,B-Drug
100544,6992,",",O
100545,6992,selegeline,B-Drug
100546,6992,),O
100547,6992,.,O
100548,6993,Individuals,O
100549,6993,taking,O
100550,6993,over,B-Drug
100551,6993,the,I-Drug
100552,6993,counter,I-Drug
100553,6993,memory,I-Drug
100554,6993,enhancing,I-Drug
100555,6993,or,I-Drug
100556,6993,protecting,I-Drug
100557,6993,medications,I-Drug
100558,6993,(,O
100559,6993,e.g.,O
100560,6993,ginkgo,B-Drug
100561,6993,biloba,I-Drug
100562,6993,",",O
100563,6993,vitamins,B-Drug
100564,6993,),O
100565,6993,are,O
100566,6993,not,O
100567,6993,excluded,O
100568,6993,.,O
100569,6994,Implanted,O
100570,6994,medical,O
100571,6994,devices,O
100572,6994,that,O
100573,6994,are,O
100574,6994,incompatible,O
100575,6994,with,O
100576,6994,MRI,B-Procedure
100577,6994,imaging,I-Procedure
100578,6994,.,O
100579,6995,Radiation,O
100580,6995,exposures,O
100581,6995,exceeding,O
100582,6995,annual,O
100583,6995,Rad,O
100584,6995,Worker,O
100585,6995,limits,O
100586,6995,.,O
100587,6996,Heart,B-Condition
100588,6996,failure,I-Condition
100589,6996,stage,O
100590,6996,D,O
100591,6996,as,O
100592,6996,defined,O
100593,6996,by,O
100594,6996,American,O
100595,6996,Heart,O
100596,6996,Association,O
100597,6996,(,O
100598,6996,7,O
100599,6996,),O
100600,6996,.,O
100601,6997,Chronic,B-Condition
100602,6997,kidney,I-Condition
100603,6997,disease,I-Condition
100604,6997,in,O
100605,6997,stages,O
100606,6997,=,O
100607,6997,4,O
100608,6997,",",O
100609,6997,as,O
100610,6997,defined,O
100611,6997,per,O
100612,6997,National,O
100613,6997,Kidney,O
100614,6997,Foundation,O
100615,6997,(,O
100616,6997,8),O
100617,6997,.,O
100618,6998,Brain,B-Condition
100619,6998,tumor,I-Condition
100620,6998,and,O
100621,6998,other,O
100622,6998,neoplastic,B-Condition
100623,6998,disorders,I-Condition
100624,6998,outside,O
100625,6998,the,O
100626,6998,brain,O
100627,6998,where,O
100628,6998,disease,O
100629,6998,itself,O
100630,6998,or,O
100631,6998,its,O
100632,6998,treatment,O
100633,6998,(,O
100634,6998,radiation,B-Procedure
100635,6998,",",O
100636,6998,chemotherapy,B-Procedure
100637,6998,),O
100638,6998,is,O
100639,6998,likely,O
100640,6998,to,O
100641,6998,affect,O
100642,6998,brain,O
100643,6998,structure,O
100644,6998,or,O
100645,6998,function,O
100646,6998,.,O
100647,6999,Stroke,B-Condition
100648,6999,when,O
100649,6999,meeting,O
100650,6999,criteria,O
100651,6999,for,O
100652,6999,total,O
100653,6999,anterior,O
100654,6999,",",O
100655,6999,partial,O
100656,6999,anterior,O
100657,6999,or,O
100658,6999,posterior,O
100659,6999,circulation,B-Condition
100660,6999,infarct,I-Condition
100661,6999,according,O
100662,6999,to,O
100663,6999,the,O
100664,6999,Oxford,O
100665,6999,Community,O
100666,6999,Stroke,O
100667,6999,Project,O
100668,6999,classification,O
100669,6999,.,O
100670,6999,Patients,O
100671,6999,with,O
100672,6999,clinically,O
100673,6999,silent,O
100674,6999,of,O
100675,6999,lacunar,O
100676,6999,strokes,O
100677,6999,and,O
100678,6999,transient,O
100679,6999,ischemic,O
100680,6999,attacks,O
100681,6999,will,O
100682,6999,not,O
100683,6999,be,O
100684,6999,excluded,O
100685,6999,.,O
100686,7000,Significant,O
100687,7000,head,B-Condition
100688,7000,trauma,I-Condition
100689,7000,.,O
100690,7001,Hydrocephalus,B-Condition
100691,7001,.,O
100692,7002,Hostility,B-Observation
100693,7002,or,O
100694,7002,refusal,B-Observation
100695,7002,to,I-Observation
100696,7002,cooperate,I-Observation
100697,7003,Male,B-Person
100698,7003,and,O
100699,7003,female,B-Person
100700,7003,subjects,O
100701,7003,between,O
100702,7003,40,O
100703,7003,-,O
100704,7003,85,O
100705,7003,years,O
100706,7003,old,B-Person
100707,7003,will,O
100708,7003,be,O
100709,7003,enrolled,O
100710,7003,.,O
100711,7003,Younger,O
100712,7003,subjects,O
100713,7003,are,O
100714,7003,not,O
100715,7003,included,O
100716,7003,as,O
100717,7003,the,O
100718,7003,risk,O
100719,7003,for,O
100720,7003,brain,O
100721,7003,amyloid,O
100722,7003,lesions,O
100723,7003,is,O
100724,7003,too,O
100725,7003,low,O
100726,7004,All,O
100727,7004,subjects,O
100728,7004,will,O
100729,7004,speak,B-Observation
100730,7004,English,I-Observation
100731,7004,as,O
100732,7004,their,O
100733,7004,first,O
100734,7004,language,O
100735,7004,or,O
100736,7004,demonstrate,O
100737,7004,proficiency,B-Observation
100738,7004,in,I-Observation
100739,7004,English,I-Observation
100740,7004,(,O
100741,7004,defined,O
100742,7004,as,O
100743,7004,reaching,O
100744,7004,a,O
100745,7004,scaled,O
100746,7004,score,O
100747,7004,of,O
100748,7004,>,O
100749,7004,11,O
100750,7004,on,O
100751,7004,the,O
100752,7004,WAIS,O
100753,7004,vocabulary,O
100754,7004,test,O
100755,7004,),O
100756,7004,.,O
100757,7005,All,O
100758,7005,subjects,O
100759,7005,will,O
100760,7005,have,O
100761,7005,normal,B-Condition
100762,7005,cognition,I-Condition
100763,7005,at,O
100764,7005,baseline,O
100765,7005,:,O
100766,7005,a,O
100767,7005,Clinical,O
100768,7005,Dementia,O
100769,7005,Rating,O
100770,7005,CDR=0,O
100771,7005,",",O
100772,7005,Global,O
100773,7005,Deterioration,O
100774,7005,Scale,O
100775,7005,GDS<2,O
100776,7005,.,O
100777,7006,All,O
100778,7006,subjects,O
100779,7006,will,O
100780,7006,be,O
100781,7006,in,O
100782,7006,good,B-Condition
100783,7006,general,I-Condition
100784,7006,health,I-Condition
100785,7006,and,O
100786,7006,able,B-Observation
100787,7006,to,I-Observation
100788,7006,participate,I-Observation
100789,7006,in,O
100790,7006,the,O
100791,7006,LP,B-Procedure
100792,7006,and,O
100793,7006,imaging,B-Procedure
100794,7006,exams,I-Procedure
100795,7006,.,O
100796,7006,This,O
100797,7006,determination,O
100798,7006,is,O
100799,7006,made,O
100800,7006,by,O
100801,7006,the,O
100802,7006,study,O
100803,7006,neurologist,O
100804,7006,and,O
100805,7006,reviewed,O
100806,7006,at,O
100807,7006,a,O
100808,7006,consensus,O
100809,7006,meeting,O
100810,7006,for,O
100811,7006,each,O
100812,7006,subject,O
100813,7006,.,O
100814,7007,need,O
100815,7007,for,O
100816,7007,major,B-Condition
100817,7007,amputation,I-Condition
100818,7007,known,O
100819,7007,before,O
100820,7007,intervention,O
100821,7008,allergy,B-Condition
100822,7008,to,O
100823,7008,Paclitaxel,B-Drug
100824,7009,contraindication,B-Condition
100825,7009,for,O
100826,7009,combined,B-Procedure
100827,7009,antiplatelet,I-Procedure
100828,7009,treatment,I-Procedure
100829,7010,life,B-Observation
100830,7010,expectancy,I-Observation
100831,7010,<,O
100832,7010,1,O
100833,7010,year,O
100834,7011,hypersensitivity,B-Condition
100835,7011,or,O
100836,7011,contraindication,B-Condition
100837,7011,to,O
100838,7011,one,O
100839,7011,of,O
100840,7011,the,O
100841,7011,study,B-Drug
100842,7011,drugs,I-Drug
100843,7012,lack,O
100844,7012,of,O
100845,7012,consent,O
100846,7013,age>18,B-Person
100847,7013,years,O
100848,7014,critical,O
100849,7014,limb,B-Condition
100850,7014,ischemia,I-Condition
100851,7014,(,O
100852,7014,Rutherford,O
100853,7014,class,O
100854,7014,4,O
100855,7014,-,O
100856,7014,6,O
100857,7014,),O
100858,7015,angiographic,O
100859,7015,stenosis>50,O
100860,7015,%,O
100861,7015,or,O
100862,7015,occlusion,B-Condition
100863,7015,of,O
100864,7015,at,O
100865,7015,least,O
100866,7015,one,O
100867,7015,tibial,O
100868,7015,vessel,O
100869,7015,of,O
100870,7015,at,O
100871,7015,least,O
100872,7015,40,O
100873,7015,mm,O
100874,7015,for,O
100875,7015,which,O
100876,7015,an,O
100877,7015,interventional,B-Procedure
100878,7015,treatment,I-Procedure
100879,7015,is,O
100880,7015,scheduled,B-Mood
100881,7016,Type,B-Condition
100882,7016,1,I-Condition
100883,7016,diabetes,I-Condition
100884,7016,(,O
100885,7016,autoantibody,O
100886,7016,positive,O
100887,7016,),O
100888,7016,.,O
100889,7017,Any,O
100890,7017,history,O
100891,7017,of,O
100892,7017,receiving,O
100893,7017,GLP-1,B-Drug
100894,7017,analogues,I-Drug
100895,7017,or,O
100896,7017,dipeptidyl,B-Drug
100897,7017,peptidase,I-Drug
100898,7017,inhibitors,I-Drug
100899,7017,within,O
100900,7017,6,O
100901,7017,months,O
100902,7018,Known,O
100903,7018,severe,O
100904,7018,heart,B-Condition
100905,7018,failure,I-Condition
100906,7018,",",O
100907,7018,classified,O
100908,7018,as,O
100909,7018,NYHA,O
100910,7018,4,O
100911,7018,.,O
100912,7019,Active,B-Condition
100913,7019,myocarditis,I-Condition
100914,7019,;,O
100915,7019,malfunctioning,O
100916,7019,artificial,O
100917,7019,heart,O
100918,7019,valve,O
100919,7019,.,O
100920,7020,History,O
100921,7020,of,O
100922,7020,ventricular,B-Condition
100923,7020,tachycardia,I-Condition
100924,7020,within,O
100925,7020,3,O
100926,7020,months,O
100927,7020,before,O
100928,7020,study,O
100929,7020,entry,O
100930,7020,;,O
100931,7020,second-,B-Condition
100932,7020,or,I-Condition
100933,7020,third,I-Condition
100934,7020,-,I-Condition
100935,7020,degree,I-Condition
100936,7020,atrioventricular,I-Condition
100937,7020,block,I-Condition
100938,7020,.,O
100939,7021,Supine,O
100940,7021,systolic,O
100941,7021,blood,O
100942,7021,pressure,O
100943,7021,<,O
100944,7021,85,O
100945,7021,mm,O
100946,7021,Hg,O
100947,7021,or,O
100948,7021,>,O
100949,7021,200,O
100950,7021,mm,O
100951,7021,Hg,O
100952,7021,at,O
100953,7021,screening,O
100954,7021,.,O
100955,7022,Primary,B-Condition
100956,7022,renal,I-Condition
100957,7022,impairment,I-Condition
100958,7022,",",O
100959,7022,creatinine,O
100960,7022,clearance,O
100961,7022,<,O
100962,7022,45,O
100963,7022,ml,O
100964,7022,/,O
100965,7022,min,O
100966,7022,if,O
100967,7022,treated,O
100968,7022,with,O
100969,7022,metformin,B-Drug
100970,7022,.,O
100971,7023,Uncorrected,O
100972,7023,hypokalemia,B-Condition
100973,7023,or,O
100974,7023,hyperkalemia,B-Condition
100975,7023,(,O
100976,7023,potassium,O
100977,7023,<,O
100978,7023,3.5,O
100979,7023,mmol,O
100980,7023,/,O
100981,7023,l,O
100982,7023,or,O
100983,7023,>,O
100984,7023,5.5,O
100985,7023,mmol,O
100986,7023,/,O
100987,7023,l,O
100988,7023,),O
100989,7023,.,O
100990,7024,Significant,O
100991,7024,anemia,B-Condition
100992,7024,(,O
100993,7024,Hb,O
100994,7024,<,O
100995,7024,90,O
100996,7024,g,O
100997,7024,/,O
100998,7024,l,O
100999,7024,),O
101000,7025,Severe,O
101001,7025,gastrointestinal,B-Condition
101002,7025,disease,I-Condition
101003,7025,",",O
101004,7025,including,O
101005,7025,gastroparesis,B-Condition
101006,7025,.,O
101007,7025,As,O
101008,7025,judged,O
101009,7025,by,O
101010,7025,the,O
101011,7025,Investigator,O
101012,7025,.,O
101013,7026,Body,O
101014,7026,mass,O
101015,7026,index,O
101016,7026,(,O
101017,7026,BMI,O
101018,7026,),O
101019,7026,>,O
101020,7026,45,O
101021,7026,kg,O
101022,7026,/,O
101023,7026,m2,O
101024,7026,.,O
101025,7027,Malignant,B-Condition
101026,7027,neoplasm,I-Condition
101027,7027,requiring,O
101028,7027,chemotherapy,B-Procedure
101029,7027,",",O
101030,7027,surgery,B-Procedure
101031,7027,",",O
101032,7027,radiation,B-Procedure
101033,7027,or,O
101034,7027,palliative,B-Procedure
101035,7027,therapy,I-Procedure
101036,7027,in,O
101037,7027,the,O
101038,7027,previous,O
101039,7027,5,O
101040,7027,years,O
101041,7027,.,O
101042,7027,Patients,O
101043,7027,with,O
101044,7027,intraepithelial,B-Condition
101045,7027,squamous,I-Condition
101046,7027,cell,I-Condition
101047,7027,carcinoma,I-Condition
101048,7027,of,O
101049,7027,the,O
101050,7027,skin,O
101051,7027,treated,O
101052,7027,with,O
101053,7027,topical,B-Drug
101054,7027,5FU,I-Drug
101055,7027,and,O
101056,7027,subjects,O
101057,7027,with,O
101058,7027,basal,B-Condition
101059,7027,cell,I-Condition
101060,7027,skin,I-Condition
101061,7027,cancer,I-Condition
101062,7027,are,O
101063,7027,allowed,O
101064,7027,to,O
101065,7027,enter,O
101066,7027,the,O
101067,7027,trial,O
101068,7027,.,O
101069,7028,Females,O
101070,7028,of,O
101071,7028,child,O
101072,7028,bearing,O
101073,7028,potential,O
101074,7028,who,O
101075,7028,are,O
101076,7028,pregnant,O
101077,7028,",",O
101078,7028,breast,O
101079,7028,-,O
101080,7028,feeding,O
101081,7028,or,O
101082,7028,intend,O
101083,7028,to,O
101084,7028,become,O
101085,7028,pregnant,O
101086,7028,.,O
101087,7029,Current,O
101088,7029,drug,B-Condition
101089,7029,and,I-Condition
101090,7029,alcohol,I-Condition
101091,7029,abuse,I-Condition
101092,7029,.,O
101093,7030,History,O
101094,7030,of,O
101095,7030,acute,B-Condition
101096,7030,or,I-Condition
101097,7030,chronic,I-Condition
101098,7030,pancreatitis,I-Condition
101099,7031,Subjects,O
101100,7031,considered,O
101101,7031,by,O
101102,7031,the,O
101103,7031,Investigator,O
101104,7031,to,O
101105,7031,be,O
101106,7031,unsuitable,O
101107,7031,for,O
101108,7031,the,O
101109,7031,study,O
101110,7031,.,O
101111,7032,Patients,O
101112,7032,eligible,O
101113,7032,for,O
101114,7032,PCI,B-Procedure
101115,7032,with,O
101116,7032,application,O
101117,7032,of,O
101118,7032,DES,B-Procedure
101119,7032,",",O
101120,7032,due,O
101121,7032,to,O
101122,7032,ACS,B-Condition
101123,7032,.,O
101124,7033,Patients,O
101125,7033,with,O
101126,7033,known,O
101127,7033,or,O
101128,7033,newly,O
101129,7033,diagnosed,O
101130,7033,T2D,B-Condition
101131,7033,(,O
101132,7033,type,O
101133,7033,2,O
101134,7033,diabetes,O
101135,7033,is,O
101136,7033,diagnosed,O
101137,7033,according,O
101138,7033,to,O
101139,7033,current,O
101140,7033,WHO,O
101141,7033,criteria,O
101142,7033,or,O
101143,7033,by,O
101144,7033,the,O
101145,7033,use,O
101146,7033,of,O
101147,7033,anti,O
101148,7033,-,O
101149,7033,diabetic,O
101150,7033,drugs,O
101151,7033,),O
101152,7034,Male,B-Person
101153,7034,and,O
101154,7034,female,B-Person
101155,7034,subjects,O
101156,7034,18,O
101157,7034,-,O
101158,7034,80,O
101159,7034,years,B-Person
101160,7034,.,O
101161,7035,HbA1c,O
101162,7035,(,O
101163,7035,accordingly,O
101164,7035,to,O
101165,7035,IFCC,O
101166,7035,),O
101167,7035,47,O
101168,7035,mmol,O
101169,7035,/,O
101170,7035,mol,O
101171,7035,-,O
101172,7035,110,O
101173,7035,mmol,O
101174,7035,/,O
101175,7035,mol,O
101176,7035,.,O
101177,7036,Signed,O
101178,7036,informed,O
101179,7036,consent,O
101180,7036,form,O
101181,7036,.,O
101182,7037,Evidence,O
101183,7037,of,O
101184,7037,concomitant,B-Condition
101185,7037,infection,I-Condition
101186,7037,on,O
101187,7037,exam,O
101188,7037,or,O
101189,7037,gram,O
101190,7037,stain,O
101191,7037,(,O
101192,7037,i.e.,O
101193,7037,herpes,O
101194,7037,",",O
101195,7037,both,O
101196,7037,bacteria,O
101197,7037,and,O
101198,7037,acanthamoeba,O
101199,7037,on,O
101200,7037,gram,O
101201,7037,stain,O
101202,7037,),O
101203,7038,Impending,O
101204,7038,or,O
101205,7038,frank,O
101206,7038,perforation,B-Condition
101207,7038,at,O
101208,7038,recruitment,O
101209,7039,Involvement,B-Condition
101210,7039,of,I-Condition
101211,7039,sclera,I-Condition
101212,7039,at,O
101213,7039,presentation,O
101214,7040,Non,B-Condition
101215,7040,-,I-Condition
101216,7040,infectious,I-Condition
101217,7040,or,I-Condition
101218,7040,autoimmune,I-Condition
101219,7040,keratitis,I-Condition
101220,7041,History,O
101221,7041,of,O
101222,7041,corneal,B-Procedure
101223,7041,transplantation,I-Procedure
101224,7041,or,O
101225,7041,recent,O
101226,7041,intraocular,B-Procedure
101227,7041,surgery,I-Procedure
101228,7042,No,O
101229,7042,light,B-Condition
101230,7042,perception,I-Condition
101231,7042,in,O
101232,7042,the,O
101233,7042,affected,O
101234,7042,eye,O
101235,7043,Pinhole,O
101236,7043,visual,O
101237,7043,acuity,O
101238,7043,worse,O
101239,7043,than,O
101240,7043,20/200,O
101241,7043,in,O
101242,7043,the,O
101243,7043,unaffected,O
101244,7043,eye,O
101245,7044,Participants,O
101246,7044,who,O
101247,7044,are,O
101248,7044,decisionally,O
101249,7044,and/or,O
101250,7044,cognitively,B-Condition
101251,7044,impaired,I-Condition
101252,7045,Corneal,B-Condition
101253,7045,ulcer,I-Condition
101254,7045,that,O
101255,7045,is,O
101256,7045,smear,O
101257,7045,positive,O
101258,7045,for,O
101259,7045,either,O
101260,7045,bacteria,O
101261,7045,or,O
101262,7045,filamentous,O
101263,7045,fungus,O
101264,7046,Pinhole,O
101265,7046,visual,O
101266,7046,acuity,O
101267,7046,worse,O
101268,7046,than,O
101269,7046,20/70,O
101270,7046,in,O
101271,7046,the,O
101272,7046,affected,O
101273,7046,eye,O
101274,7047,Not,O
101275,7047,treated,O
101276,7047,already,O
101277,7047,with,O
101278,7047,antimicrobial,B-Drug
101279,7047,medications,I-Drug
101280,7047,at,O
101281,7047,presentation,O
101282,7048,Age,B-Person
101283,7048,over,O
101284,7048,18,O
101285,7048,years,O
101286,7049,Basic,O
101287,7049,understanding,O
101288,7049,of,O
101289,7049,the,O
101290,7049,study,O
101291,7049,as,O
101292,7049,determined,O
101293,7049,by,O
101294,7049,the,O
101295,7049,physician,O
101296,7050,Commitment,O
101297,7050,to,O
101298,7050,return,O
101299,7050,for,O
101300,7050,follow,O
101301,7050,up,O
101302,7050,visits,O
101303,7051,Inability,O
101304,7051,to,O
101305,7051,comply,O
101306,7051,with,O
101307,7051,study,O
101308,7051,requirements,O
101309,7051,.,O
101310,7052,Metastatic,O
101311,7052,breast,B-Condition
101312,7052,cancer,I-Condition
101313,7052,.,O
101314,7053,Patients,O
101315,7053,with,O
101316,7053,orthopedic,O
101317,7053,or,O
101318,7053,neuromuscular,B-Condition
101319,7053,disorders,I-Condition
101320,7053,that,O
101321,7053,preclude,O
101322,7053,participation,O
101323,7053,in,O
101324,7053,exercise,O
101325,7053,.,O
101326,7054,Rheumatoid,B-Condition
101327,7054,arthritis,I-Condition
101328,7054,.,O
101329,7055,History,B-Observation
101330,7055,of,O
101331,7055,MI,B-Condition
101332,7055,",",O
101333,7055,angina,B-Condition
101334,7055,or,O
101335,7055,congestive,B-Condition
101336,7055,heart,I-Condition
101337,7055,failure,I-Condition
101338,7055,.,O
101339,7056,Pregnant,B-Condition
101340,7056,or,O
101341,7056,lactating,B-Condition
101342,7056,females,B-Person
101343,7056,.,O
101344,7057,Patients,O
101345,7057,that,O
101346,7057,are,O
101347,7057,high,O
101348,7057,risk,O
101349,7057,for,O
101350,7057,moderate,O
101351,7057,exercise,O
101352,7057,based,O
101353,7057,on,O
101354,7057,ACSM,O
101355,7057,risk,O
101356,7057,classification,O
101357,7057,.,O
101358,7058,Patients,O
101359,7058,who,O
101360,7058,exceed,B-Observation
101361,7058,minimal,I-Observation
101362,7058,physical,I-Observation
101363,7058,activity,I-Observation
101364,7058,recommendations,I-Observation
101365,7058,from,O
101366,7058,the,O
101367,7058,US,O
101368,7058,Surgeon,O
101369,7058,General,O
101370,7058,'s,O
101371,7058,Report,O
101372,7058,:,O
101373,7058,Accumulation,O
101374,7058,of,O
101375,7058,30,O
101376,7058,minutes,O
101377,7058,or,O
101378,7058,more,O
101379,7058,of,O
101380,7058,moderate,O
101381,7058,physical,O
101382,7058,activity,O
101383,7058,on,O
101384,7058,most,O
101385,7058,days,O
101386,7058,of,O
101387,7058,the,O
101388,7058,week,O
101389,7058,.,O
101390,7059,Morbidly,B-Condition
101391,7059,obese,I-Condition
101392,7059,with,O
101393,7059,BMI,O
101394,7059,≥,O
101395,7059,40,O
101396,7060,Post,B-Condition
101397,7060,menopausal,I-Condition
101398,7060,women,B-Person
101399,7060,with,O
101400,7060,a,O
101401,7060,history,B-Observation
101402,7060,of,O
101403,7060,estrogen,O
101404,7060,positive,O
101405,7060,breast,B-Condition
101406,7060,cancer,I-Condition
101407,7060,who,O
101408,7060,are,O
101409,7060,receiving,O
101410,7060,aromatase,B-Drug
101411,7060,inhibitors,I-Drug
101412,7060,for,O
101413,7060,at,O
101414,7060,least,O
101415,7060,one,O
101416,7060,month,O
101417,7060,.,O
101418,7061,Patients,O
101419,7061,must,O
101420,7061,complain,O
101421,7061,of,O
101422,7061,mild,O
101423,7061,to,O
101424,7061,moderate,O
101425,7061,arthralgia,B-Condition
101426,7061,.,O
101427,7062,Ability,O
101428,7062,to,O
101429,7062,understand,O
101430,7062,and,O
101431,7062,sign,O
101432,7062,informed,O
101433,7062,consent,O
101434,7062,.,O
101435,7063,Patients,O
101436,7063,meet,O
101437,7063,criteria,O
101438,7063,for,O
101439,7063,low,O
101440,7063,to,O
101441,7063,moderate,O
101442,7063,risk,O
101443,7063,for,O
101444,7063,moderate,O
101445,7063,exercise,O
101446,7063,based,O
101447,7063,oon,O
101448,7063,the,O
101449,7063,ACSM,O
101450,7063,guidelines,O
101451,7063,.,O
101452,7064,Children,B-Person
101453,7064,will,O
101454,7064,be,O
101455,7064,excluded,O
101456,7064,if,O
101457,7064,they,O
101458,7064,have,O
101459,7064,a,O
101460,7064,history,O
101461,7064,of,O
101462,7064,developmental,B-Condition
101463,7064,delay,I-Condition
101464,7064,or,O
101465,7064,inability,B-Condition
101466,7064,to,I-Condition
101467,7064,communicate,I-Condition
101468,7064,the,I-Condition
101469,7064,effects,I-Condition
101470,7064,of,O
101471,7064,an,O
101472,7064,allergic,B-Condition
101473,7064,reaction,I-Condition
101474,7064,(,O
101475,7064,non,O
101476,7064,-,O
101477,7064,verbal,O
101478,7064,),O
101479,7064,.,O
101480,7065,Any,O
101481,7065,contraindication,B-Condition
101482,7065,to,O
101483,7065,allergy,B-Procedure
101484,7065,testing,I-Procedure
101485,7065,will,O
101486,7065,also,O
101487,7065,result,O
101488,7065,in,O
101489,7065,exclusion,O
101490,7066,(,O
101491,7066,i.e.,O
101492,7066,history,B-Observation
101493,7066,of,O
101494,7066,a,O
101495,7066,severe,B-Condition
101496,7066,allergic,I-Condition
101497,7066,reaction,I-Condition
101498,7066,to,O
101499,7066,skin,B-Procedure
101500,7066,tests,I-Procedure
101501,7066,",",O
101502,7066,",",O
101503,7067,anaphylaxis,B-Condition
101504,7067,in,O
101505,7067,the,O
101506,7067,past,O
101507,7067,six,O
101508,7067,weeks,O
101509,7067,",",O
101510,7068,pregnancy,B-Condition
101511,7068,",",O
101512,7069,child,O
101513,7069,took,O
101514,7069,any,O
101515,7069,antihistamine,B-Drug
101516,7069,in,O
101517,7069,the,O
101518,7069,past,O
101519,7069,three,O
101520,7069,days,O
101521,7069,[,O
101522,7069,including,O
101523,7069,diphenhydramine,B-Drug
101524,7069,(,O
101525,7069,Benadryl,B-Drug
101526,7069,®,O
101527,7069,),O
101528,7069,",",O
101529,7069,cetirizine,B-Drug
101530,7069,(,O
101531,7069,Zyrtec,B-Drug
101532,7069,®,O
101533,7069,),O
101534,7069,",",O
101535,7069,loratadine,B-Drug
101536,7069,(,O
101537,7069,Claritin,B-Drug
101538,7069,®,O
101539,7069,),O
101540,7069,",",O
101541,7069,fexofenadine,B-Drug
101542,7069,(,O
101543,7069,Allegra,B-Drug
101544,7069,®,O
101545,7069,),O
101546,7069,",",O
101547,7069,levocetirizine,B-Drug
101548,7069,(,O
101549,7069,Xyzal,B-Drug
101550,7069,®,O
101551,7069,),O
101552,7069,",",O
101553,7069,and,O
101554,7069,desloratadine,B-Drug
101555,7069,(,O
101556,7069,Clarinex,B-Drug
101557,7069,®,O
101558,7069,),O
101559,7069,],O
101560,7069,or,O
101561,7070,child,O
101562,7070,has,O
101563,7070,a,O
101564,7070,history,O
101565,7070,of,O
101566,7070,a,O
101567,7070,condition,O
101568,7070,that,O
101569,7070,requires,O
101570,7070,a,O
101571,7070,beta,B-Drug
101572,7070,blocker,I-Drug
101573,7070,medicine,I-Drug
101574,7070,for,O
101575,7070,cardiac,B-Condition
101576,7070,conditions,I-Condition
101577,7070,",",O
101578,7070,high,B-Condition
101579,7070,blood,I-Condition
101580,7070,pressure,I-Condition
101581,7070,",",O
101582,7070,migraine,B-Condition
101583,7070,headaches,I-Condition
101584,7070,",",O
101585,7070,or,O
101586,7070,eye,B-Drug
101587,7070,drops,I-Drug
101588,7070,for,O
101589,7070,glaucoma,B-Condition
101590,7070,(,O
101591,7070,e.g.,O
101592,7070,propranolol,B-Drug
101593,7070,",",O
101594,7070,metoprolol,B-Drug
101595,7070,",",O
101596,7070,atenolol,B-Drug
101597,7070,and,O
101598,7070,Timoptic,B-Drug
101599,7070,®,O
101600,7070,",",O
101601,7070,or,O
101602,7070,Betoptic,B-Drug
101603,7070,®,O
101604,7070,eye,B-Drug
101605,7070,drops,I-Drug
101606,7070,),O
101607,7070,.,O
101608,7071,Children,B-Person
101609,7071,who,O
101610,7071,present,O
101611,7071,to,O
101612,7071,the,O
101613,7071,PED,O
101614,7071,with,O
101615,7071,a,O
101616,7071,rash,B-Condition
101617,7071,",",O
101618,7071,vomiting,B-Condition
101619,7071,or,O
101620,7071,current,O
101621,7071,asthma,B-Condition
101622,7071,symptoms,I-Condition
101623,7071,including,O
101624,7071,coughing,B-Condition
101625,7071,",",O
101626,7071,wheezing,B-Condition
101627,7071,or,O
101628,7071,breathing,B-Condition
101629,7071,problems,I-Condition
101630,7071,will,O
101631,7071,also,O
101632,7071,be,O
101633,7071,excluded,O
101634,7071,to,O
101635,7071,ensure,O
101636,7071,these,O
101637,7071,do,O
101638,7071,not,O
101639,7071,mask,O
101640,7071,reactions,O
101641,7071,to,O
101642,7071,an,O
101643,7071,oral,O
101644,7071,challenge,O
101645,7071,.,O
101646,7072,Patients,O
101647,7072,being,O
101648,7072,admitted,O
101649,7072,to,O
101650,7072,the,O
101651,7072,hospital,O
101652,7072,or,O
101653,7072,those,O
101654,7072,who,O
101655,7072,are,O
101656,7072,deemed,O
101657,7072,too,O
101658,7072,acutely,O
101659,7072,ill,O
101660,7072,for,O
101661,7072,participation,O
101662,7072,(,O
101663,7072,triage,O
101664,7072,level,O
101665,7072,1,O
101666,7072,or,O
101667,7072,2,O
101668,7072,or,O
101669,7072,as,O
101670,7072,determined,O
101671,7072,by,O
101672,7072,the,O
101673,7072,ED,O
101674,7072,patient,O
101675,7072,care,O
101676,7072,team,O
101677,7072,),O
101678,7072,will,O
101679,7072,be,O
101680,7072,excluded,O
101681,7072,from,O
101682,7072,the,O
101683,7072,study,O
101684,7072,.,O
101685,7073,During,O
101686,7073,this,O
101687,7073,pilot,O
101688,7073,study,O
101689,7073,",",O
101690,7073,we,O
101691,7073,will,O
101692,7073,exclude,O
101693,7073,non,B-Observation
101694,7073,-,I-Observation
101695,7073,English,I-Observation
101696,7073,speaking,I-Observation
101697,7073,families,O
101698,7073,.,O
101699,7073,However,O
101700,7073,",",O
101701,7073,in,O
101702,7073,subsequent,O
101703,7073,studies,O
101704,7073,we,O
101705,7073,will,O
101706,7073,include,O
101707,7073,the,O
101708,7073,non,O
101709,7073,-,O
101710,7073,English,O
101711,7073,speaking,O
101712,7073,population,O
101713,7073,.,O
101714,7074,Children,O
101715,7074,who,O
101716,7074,are,O
101717,7074,wards,B-Observation
101718,7074,of,I-Observation
101719,7074,the,I-Observation
101720,7074,state,I-Observation
101721,7074,",",O
101722,7074,in,O
101723,7074,foster,B-Observation
101724,7074,care,I-Observation
101725,7074,or,O
101726,7074,police,B-Observation
101727,7074,custody,I-Observation
101728,7074,or,O
101729,7074,detention,B-Observation
101730,7074,will,O
101731,7074,be,O
101732,7074,excluded,O
101733,7074,.,O
101734,7075,Children,O
101735,7075,with,O
101736,7075,any,O
101737,7075,basal,B-Condition
101738,7075,condition,I-Condition
101739,7075,(,O
101740,7075,trauma,B-Condition
101741,7075,",",O
101742,7075,infection,B-Condition
101743,7075,",",O
101744,7075,minor,B-Condition
101745,7075,accidents,I-Condition
101746,7075,",",O
101747,7075,etc,O
101748,7075,..,O
101749,7075,),O
101750,7075,will,O
101751,7075,be,O
101752,7075,able,O
101753,7075,to,O
101754,7075,participate,O
101755,7075,in,O
101756,7075,the,O
101757,7075,study,O
101758,7075,provided,O
101759,7075,they,O
101760,7075,and,O
101761,7075,their,O
101762,7075,family,O
101763,7075,are,O
101764,7075,willing,O
101765,7075,and,O
101766,7075,do,O
101767,7075,not,O
101768,7075,meet,O
101769,7075,the,O
101770,7075,above,O
101771,7075,-,O
101772,7075,mentioned,O
101773,7075,exclusion,O
101774,7075,criteria,O
101775,7075,.,O
101776,7076,Children,B-Person
101777,7076,aged,B-Person
101778,7076,3,O
101779,7076,-,O
101780,7076,16,O
101781,7076,with,O
101782,7076,a,O
101783,7076,parent,O
101784,7076,/,O
101785,7076,guardian,O
101786,7076,(,O
101787,7076,hereafter,O
101788,7076,termed,O
101789,7076,parent,O
101790,7076,),O
101791,7076,reported,O
101792,7076,history,O
101793,7076,of,O
101794,7076,allergy,B-Condition
101795,7076,to,O
101796,7076,a,O
101797,7076,penicillin,B-Drug
101798,7076,antibiotic,I-Drug
101799,7076,in,O
101800,7076,which,O
101801,7076,the,O
101802,7076,reported,O
101803,7076,allergic,B-Condition
101804,7076,reaction,I-Condition
101805,7076,occurred,O
101806,7076,at,O
101807,7076,least,O
101808,7076,six,O
101809,7076,months,O
101810,7076,prior,O
101811,7076,to,O
101812,7076,the,O
101813,7076,current,O
101814,7076,PED,O
101815,7076,visit,O
101816,7076,.,O
101817,7077,Only,O
101818,7077,children,O
101819,7077,well,B-Condition
101820,7077,enough,I-Condition
101821,7077,to,I-Condition
101822,7077,be,I-Condition
101823,7077,discharged,I-Condition
101824,7077,to,I-Condition
101825,7077,home,I-Condition
101826,7077,at,O
101827,7077,the,O
101828,7077,conclusion,O
101829,7077,of,O
101830,7077,the,O
101831,7077,PED,O
101832,7077,visit,O
101833,7077,are,O
101834,7077,eligible,O
101835,7077,.,O
101836,7078,1,O
101837,7078,.,O
101838,7078,Patients,O
101839,7078,with,O
101840,7078,lumbar,B-Condition
101841,7078,common,I-Condition
101842,7078,diseases(e.g,I-Condition
101843,7078,.,O
101844,7078,",",O
101845,7078,Lumbar,B-Condition
101846,7078,disc,I-Condition
101847,7078,",",O
101848,7078,Lumbar,B-Condition
101849,7078,spinal,I-Condition
101850,7078,stenosis,I-Condition
101851,7078,",",O
101852,7078,Lumbar,B-Condition
101853,7078,slippage,I-Condition
101854,7078,",",O
101855,7078,etc,O
101856,7078,),O
101857,7079,2,O
101858,7079,.,O
101859,7079,Researchers,O
101860,7079,think,O
101861,7079,that,O
101862,7079,Patients,O
101863,7079,with,O
101864,7079,disease,O
101865,7079,may,O
101866,7079,be,O
101867,7079,interference,O
101868,7079,results(e.g,O
101869,7079,.,O
101870,7079,",",O
101871,7079,Spinal,B-Condition
101872,7079,deformity,I-Condition
101873,7079,",",O
101874,7079,spine,B-Condition
101875,7079,fracture,I-Condition
101876,7079,",",I-Condition
101877,7079,ankylosing,B-Condition
101878,7079,spondylitis,I-Condition
101879,7079,",",O
101880,7079,spinal,B-Condition
101881,7079,tuberculosis,I-Condition
101882,7079,and,O
101883,7079,spinal,B-Condition
101884,7079,infection,I-Condition
101885,7079,",",O
101886,7079,spinal,B-Condition
101887,7079,tumor,I-Condition
101888,7079,",",O
101889,7079,pelvic,B-Condition
101890,7079,inflammatory,I-Condition
101891,7079,disease,I-Condition
101892,7079,and,O
101893,7079,other,O
101894,7079,disease,O
101895,7079,of,O
101896,7079,department,O
101897,7079,of,O
101898,7079,gynaecology,O
101899,7079,",",O
101900,7079,etc,O
101901,7079,),O
101902,7080,3,O
101903,7080,.,O
101904,7080,Patients,O
101905,7080,with,O
101906,7080,other,O
101907,7080,nervous,B-Condition
101908,7080,system,I-Condition
101909,7080,diseases(e.g,I-Condition
101910,7080,.,O
101911,7080,",",O
101912,7080,cerebral,B-Condition
101913,7080,tumor,I-Condition
101914,7080,",",O
101915,7080,neurinoma,B-Condition
101916,7080,",",O
101917,7080,trigeminal,B-Condition
101918,7080,neuralgia,I-Condition
101919,7080,",",O
101920,7080,etc,O
101921,7080,),O
101922,7081,4,O
101923,7081,.,O
101924,7081,Patients,O
101925,7081,with,O
101926,7081,Magnetic,B-Procedure
101927,7081,resonance,I-Procedure
101928,7081,imaging,I-Procedure
101929,7081,contraindication,B-Condition
101930,7081,",",O
101931,7081,including,O
101932,7081,claustrophobic,B-Condition
101933,7081,syndrome,I-Condition
101934,7081,patients,O
101935,7082,5,O
101936,7082,.,O
101937,7082,Patients,O
101938,7082,with,O
101939,7082,recent,O
101940,7082,(,O
101941,7082,less,O
101942,7082,than,O
101943,7082,3,O
101944,7082,years,O
101945,7082,),O
101946,7082,use,O
101947,7082,chemical,O
101948,7082,drugs,O
101949,7082,or,O
101950,7082,have,O
101951,7082,obvious,O
101952,7082,psychological,O
101953,7082,problems,O
101954,7083,6,O
101955,7083,.,O
101956,7083,In,O
101957,7083,the,O
101958,7083,past,O
101959,7083,2,O
101960,7083,months,O
101961,7083,involved,O
101962,7083,in,O
101963,7083,other,O
101964,7083,drugs,O
101965,7083,or,O
101966,7083,devices,O
101967,7083,clinical,O
101968,7083,trials,O
101969,7084,1,O
101970,7084,.,O
101971,7084,Diagnosed,O
101972,7084,with,O
101973,7084,symptomatic,O
101974,7084,sacral,B-Condition
101975,7084,perineurial,I-Condition
101976,7084,cysts(e.g,I-Condition
101977,7084,.,O
101978,7084,",",O
101979,7084,lumbosacral,B-Condition
101980,7084,or,I-Condition
101981,7084,perineal,I-Condition
101982,7084,pain,I-Condition
101983,7084,",",O
101984,7084,fecal,O
101985,7084,or,O
101986,7084,urinary,B-Condition
101987,7084,functions,I-Condition
101988,7084,change,I-Condition
101989,7084,",",O
101990,7084,sexual,B-Condition
101991,7084,function,I-Condition
101992,7084,change,I-Condition
101993,7084,",",O
101994,7084,lower,B-Condition
101995,7084,limb,I-Condition
101996,7084,radiation,I-Condition
101997,7084,pain,I-Condition
101998,7084,",",O
101999,7084,muscle,B-Condition
102000,7084,abate,I-Condition
102001,7084,",",O
102002,7084,paresthesia,B-Condition
102003,7084,",",O
102004,7084,etc,O
102005,7084,),O
102006,7085,2,O
102007,7085,.,O
102008,7085,Visual,O
102009,7085,analog,O
102010,7085,scale,O
102011,7085,more,O
102012,7085,than,O
102013,7085,or,O
102014,7085,equal,O
102015,7085,to,O
102016,7085,4,O
102017,7086,3,O
102018,7086,.,O
102019,7086,Signed,O
102020,7086,the,O
102021,7086,informed,O
102022,7086,consent,O
102023,7087,4,O
102024,7087,.,O
102025,7087,Years,B-Person
102026,7087,",",O
102027,7087,range,O
102028,7087,18,O
102029,7087,-,O
102030,7087,60,O
102031,7088,5,O
102032,7088,.,O
102033,7088,Self,O
102034,7088,-,O
102035,7088,rating,O
102036,7088,anxiety,O
102037,7088,scale,O
102038,7088,(,O
102039,7088,SAS,O
102040,7088,),O
102041,7088,and,O
102042,7088,self,O
102043,7088,-,O
102044,7088,rating,O
102045,7088,depression,O
102046,7088,scale,O
102047,7088,(,O
102048,7088,SDS,O
102049,7088,),O
102050,7088,scores,O
102051,7088,<,O
102052,7088,50,O
102053,7089,6,O
102054,7089,.,O
102055,7089,No,O
102056,7089,Congenital,B-Condition
102057,7089,",",I-Condition
102058,7089,Mental,I-Condition
102059,7089,and,I-Condition
102060,7089,other,I-Condition
102061,7089,Nervous,I-Condition
102062,7089,system,I-Condition
102063,7089,diseases,I-Condition
102064,7090,7,O
102065,7090,.,O
102066,7090,No,O
102067,7090,Serious,O
102068,7090,Cardiac,B-Condition
102069,7090,",",I-Condition
102070,7090,Pulmonary,I-Condition
102071,7090,",",I-Condition
102072,7090,Hepatic,I-Condition
102073,7090,and,O
102074,7090,Nephritic,B-Condition
102075,7090,disease,I-Condition
102076,7091,8,O
102077,7091,.,O
102078,7091,No,O
102079,7091,history,O
102080,7091,of,O
102081,7091,drug,B-Drug
102082,7091,allergy,B-Condition
102083,7092,9,O
102084,7092,.,O
102085,7092,No,O
102086,7092,pain(including,B-Condition
102087,7092,dysmenorrhea,B-Condition
102088,7092,),O
102089,7092,or,O
102090,7092,drug,B-Drug
102091,7092,use,O
102092,7092,(,O
102093,7092,e.g.,O
102094,7092,",",O
102095,7092,antipyretics,O
102096,7092,",",O
102097,7092,sleeping,O
102098,7092,pills,O
102099,7092,),O
102100,7092,within,O
102101,7092,the,O
102102,7092,last,O
102103,7092,month,O
102104,7093,10,O
102105,7093,.,O
102106,7093,MRI,O
102107,7093,finding,O
102108,7093,of,O
102109,7093,sacral,O
102110,7093,perineurial,O
102111,7093,cysts,O
102112,7093,",",O
102113,7093,but,O
102114,7093,without,O
102115,7093,any,O
102116,7093,clinical,O
102117,7093,symptoms,O
102118,7093,",",O
102119,7093,included,O
102120,7093,in,O
102121,7093,the,O
102122,7093,negative,O
102123,7093,control,O
102124,7093,group,O
102125,7094,11,O
102126,7094,.,O
102127,7094,MRI,O
102128,7094,finding,O
102129,7094,healthy,O
102130,7094,volunteers,O
102131,7094,do,O
102132,7094,n't,O
102133,7094,have,O
102134,7094,sacral,O
102135,7094,perineurial,O
102136,7094,cysts,O
102137,7094,",",O
102138,7094,included,O
102139,7094,in,O
102140,7094,the,O
102141,7094,negative,O
102142,7094,control,O
102143,7094,groupblank,O
102144,7094,control,O
102145,7094,group,O
102146,7095,simultaneous,O
102147,7095,both,O
102148,7095,sided,O
102149,7095,extraction,O
102150,7095,or,O
102151,7095,only,O
102152,7095,upper,O
102153,7095,third,O
102154,7095,molar,B-Procedure
102155,7095,extraction,I-Procedure
102156,7096,general,B-Procedure
102157,7096,anesthesia,I-Procedure
102158,7097,known,O
102159,7097,or,O
102160,7097,presumed,O
102161,7097,abnormal,B-Condition
102162,7097,coagulation,I-Condition
102163,7097,status,I-Condition
102164,7098,known,O
102165,7098,or,O
102166,7098,presumed,O
102167,7098,liver,B-Condition
102168,7098,or,I-Condition
102169,7098,renal,I-Condition
102170,7098,dysfunction,I-Condition
102171,7099,contraindication,B-Condition
102172,7099,against,O
102173,7099,metamizole,B-Drug
102174,7099,known,O
102175,7099,or,O
102176,7099,suspected,O
102177,7099,(,O
102178,7099,known,O
102179,7099,or,O
102180,7099,suspected,O
102181,7099,allergy,B-Condition
102182,7099,against,O
102183,7099,novalgin,B-Drug
102184,7099,or,O
102185,7099,other,O
102186,7099,pyrazolones,B-Drug
102187,7099,",",O
102188,7099,anaphylactic,B-Condition
102189,7099,reaction,I-Condition
102190,7099,against,O
102191,7099,NSAIDS,B-Drug
102192,7099,",",O
102193,7099,decreased,O
102194,7099,bone,O
102195,7099,marrow,O
102196,7099,function,O
102197,7099,or,O
102198,7099,hematopoesis,O
102199,7099,",",O
102200,7099,hepatic,B-Condition
102201,7099,porphyria,I-Condition
102202,7099,",",O
102203,7099,glucose-6,B-Condition
102204,7099,-,I-Condition
102205,7099,phosphate,I-Condition
102206,7099,dehydrogenase,I-Condition
102207,7099,deficiency,I-Condition
102208,7099,",",O
102209,7099,and,O
102210,7099,pregnancy,B-Condition
102211,7099,/,O
102212,7099,breastfeeding,B-Observation
102213,7099,),O
102214,7100,contraindication,B-Condition
102215,7100,against,O
102216,7100,ibuprofen,B-Drug
102217,7100,(,O
102218,7100,known,O
102219,7100,or,O
102220,7100,suspected,O
102221,7100,allergy,B-Condition
102222,7100,against,O
102223,7100,ibuprofen,B-Drug
102224,7100,",",O
102225,7100,anaphylactic,B-Condition
102226,7100,reaction,I-Condition
102227,7100,against,O
102228,7100,Nonsteroidal,B-Drug
102229,7100,anti,I-Drug
102230,7100,-,I-Drug
102231,7100,inflammatory,I-Drug
102232,7100,drugs,I-Drug
102233,7100,(,I-Drug
102234,7100,NSAID,I-Drug
102235,7100,),I-Drug
102236,7100,",",O
102237,7100,active,O
102238,7100,or,O
102239,7100,recurrent,O
102240,7100,stomach,O
102241,7100,or,O
102242,7100,duodenal,O
102243,7100,ulcera,B-Condition
102244,7100,or,O
102245,7100,bleeding,B-Condition
102246,7100,",",O
102247,7100,severe,B-Condition
102248,7100,liver,I-Condition
102249,7100,or,I-Condition
102250,7100,renal,I-Condition
102251,7100,insufficiency,I-Condition
102252,7100,",",O
102253,7100,inflammatory,B-Condition
102254,7100,bowel,I-Condition
102255,7100,syndrome,I-Condition
102256,7100,",",O
102257,7100,and,O
102258,7100,pregnancy,B-Condition
102259,7100,/,O
102260,7100,breastfeeding,B-Observation
102261,7100,),O
102262,7101,pregnancy,B-Condition
102263,7101,and,O
102264,7101,breast,B-Observation
102265,7101,feeding,I-Observation
102266,7101,mothers,O
102267,7102,planned,B-Mood
102268,7102,sequential,O
102269,7102,both,O
102270,7102,-,O
102271,7102,sided,O
102272,7102,lower,B-Procedure
102273,7102,third,I-Procedure
102274,7102,molar,I-Procedure
102275,7102,extraction,I-Procedure
102276,7102,(,O
102277,7102,split,O
102278,7102,-,O
102279,7102,mouth,O
102280,7102,),O
102281,7102,with,O
102282,7102,osteotomy,B-Procedure
102283,7102,(,O
102284,7102,with,O
102285,7102,or,O
102286,7102,without,O
102287,7102,upper,B-Procedure
102288,7102,molar,I-Procedure
102289,7102,extraction,I-Procedure
102290,7102,in,O
102291,7102,local,B-Procedure
102292,7102,anesthesia,I-Procedure
102293,7102,),O
102294,7103,able,B-Observation
102295,7103,to,I-Observation
102296,7103,understand,I-Observation
102297,7103,the,I-Observation
102298,7103,study,I-Observation
102299,7103,and,O
102300,7103,the,O
102301,7103,NRS,O
102302,7103,scale,O
102303,7104,Any,O
102304,7104,condition,O
102305,7104,/,O
102306,7104,illness,B-Condition
102307,7104,that,I-Condition
102308,7104,may,I-Condition
102309,7104,affect,I-Condition
102310,7104,the,I-Condition
102311,7104,study,I-Condition
102312,7104,outcomes,I-Condition
102313,7104,or,I-Condition
102314,7104,would,I-Condition
102315,7104,make,I-Condition
102316,7104,participation,I-Condition
102317,7104,potentially,I-Condition
102318,7104,harmful,I-Condition
102319,7104,such,O
102320,7104,as,O
102321,7104,pregnancy,B-Condition
102322,7104,or,O
102323,7104,breastfeeding,B-Observation
102324,7104,",",O
102325,7104,diabetes,B-Condition
102326,7104,mellitus,I-Condition
102327,7104,",",O
102328,7104,heart,B-Condition
102329,7104,disease,I-Condition
102330,7104,",",O
102331,7104,stroke,B-Condition
102332,7104,",",O
102333,7104,hypertension,B-Condition
102334,7104,",",O
102335,7104,malabsorption,B-Condition
102336,7104,syndromes,I-Condition
102337,7104,",",O
102338,7104,GERD,B-Condition
102339,7104,",",O
102340,7104,a,O
102341,7104,history,B-Observation
102342,7104,of,I-Observation
102343,7104,ulcer,B-Condition
102344,7104,",",O
102345,7104,according,O
102346,7104,to,O
102347,7104,a,O
102348,7104,detailed,O
102349,7104,medical,B-Observation
102350,7104,history,I-Observation
102351,7104,.,O
102352,7105,Abnormal,O
102353,7105,hepatic,O
102354,7105,function,O
102355,7105,(,O
102356,7105,liver,O
102357,7105,function,O
102358,7105,test,O
102359,7105,>,O
102360,7105,twice,O
102361,7105,the,O
102362,7105,normal,O
102363,7105,range,O
102364,7105,),O
102365,7105,",",O
102366,7105,abnormal,O
102367,7105,renal,O
102368,7105,function,O
102369,7105,(,O
102370,7105,creatinine,O
102371,7105,>,O
102372,7105,1.1,O
102373,7105,mg,O
102374,7105,/,O
102375,7105,dl,O
102376,7105,),O
102377,7105,",",O
102378,7105,fasting,O
102379,7105,plasma,O
102380,7105,glucose,O
102381,7105,in,O
102382,7105,the,O
102383,7105,diabetic,O
102384,7105,range,O
102385,7105,(,O
102386,7105,>,O
102387,7105,/=,O
102388,7105,126,O
102389,7105,mg,O
102390,7105,/,O
102391,7105,dl,O
102392,7105,),O
102393,7105,",",O
102394,7105,or,O
102395,7105,blood,O
102396,7105,pressure,O
102397,7105,>,O
102398,7105,140/90,O
102399,7105,mmHg,O
102400,7105,.,O
102401,7106,Present,O
102402,7106,alcoholism,B-Condition
102403,7106,or,O
102404,7106,drug,B-Condition
102405,7106,abuse,I-Condition
102406,7106,or,O
102407,7106,use,O
102408,7106,of,O
102409,7106,medications,B-Drug
102410,7106,that,I-Drug
102411,7106,could,I-Drug
102412,7106,interfere,I-Drug
102413,7106,with,I-Drug
102414,7106,the,I-Drug
102415,7106,treatment,I-Drug
102416,7106,including,O
102417,7106,bronchodilators,B-Drug
102418,7106,",",O
102419,7106,quinolone,B-Drug
102420,7106,antibiotics,I-Drug
102421,7106,",",O
102422,7106,monoamine,B-Drug
102423,7106,oxidase,I-Drug
102424,7106,inhibitors,I-Drug
102425,7106,",",O
102426,7106,anxiolytics,B-Drug
102427,7106,",",O
102428,7106,ranitidine,B-Drug
102429,7106,",",O
102430,7106,corticosteroids,B-Drug
102431,7106,",",O
102432,7106,growth,B-Drug
102433,7106,hormone,I-Drug
102434,7106,",",O
102435,7106,antihypertensives,B-Drug
102436,7106,.,O
102437,7107,Aged,B-Person
102438,7107,at,O
102439,7107,least,O
102440,7107,18,O
102441,7107,years,O
102442,7107,with,O
102443,7107,an,O
102444,7107,ability,B-Observation
102445,7107,and,I-Observation
102446,7107,willingness,I-Observation
102447,7107,to,I-Observation
102448,7107,give,I-Observation
102449,7107,written,I-Observation
102450,7107,informed,I-Observation
102451,7107,consent,I-Observation
102452,7107,.,O
102453,7108,Body,O
102454,7108,mass,O
102455,7108,index,O
102456,7108,25,O
102457,7108,-,O
102458,7108,35,O
102459,7108,kg,O
102460,7108,/,O
102461,7108,m2,O
102462,7109,Users,O
102463,7109,of,O
102464,7109,at,O
102465,7109,least,O
102466,7109,2,O
102467,7109,cups,O
102468,7109,of,O
102469,7109,caffeinated,B-Drug
102470,7109,coffee,I-Drug
102471,7109,per,O
102472,7109,day,O
102473,7109,who,O
102474,7109,are,O
102475,7109,willing,B-Observation
102476,7109,to,I-Observation
102477,7109,be,I-Observation
102478,7109,randomized,I-Observation
102479,7109,to,O
102480,7109,any,O
102481,7109,of,O
102482,7109,the,O
102483,7109,interventions,O
102484,7109,.,O
102485,7110,Non,B-Condition
102486,7110,-,I-Condition
102487,7110,smoking,I-Condition
102488,7111,<,O
102489,7111,37,O
102490,7111,weeks,O
102491,7111,gestation,O
102492,7111,",",O
102493,7111,H,B-Observation
102494,7111,/,I-Observation
102495,7111,o,I-Observation
102496,7111,Cesarean,B-Procedure
102497,7111,Section,I-Procedure
102498,7111,",",O
102499,7111,Multiple,B-Condition
102500,7111,Gestation,I-Condition
102501,7111,",",O
102502,7111,Pre,B-Condition
102503,7111,-,I-Condition
102504,7111,eclampsia,I-Condition
102505,7111,",",O
102506,7111,Narcotics,B-Drug
102507,7111,within,O
102508,7111,3,O
102509,7111,hours,O
102510,7111,prior,O
102511,7111,to,O
102512,7111,labor,B-Procedure
102513,7111,epidural,I-Procedure
102514,7111,placement,I-Procedure
102515,7111,",",O
102516,7111,Chronic,B-Condition
102517,7111,Pain,I-Condition
102518,7111,(,O
102519,7111,as,O
102520,7111,defined,O
102521,7111,by,O
102522,7111,chronic,O
102523,7111,opiate,B-Drug
102524,7111,consumption,O
102525,7111,),O
102526,7111,",",O
102527,7111,Women,O
102528,7111,who,O
102529,7111,are,O
102530,7111,participating,O
102531,7111,in,O
102532,7111,another,O
102533,7111,study,O
102534,7111,that,O
102535,7111,will,O
102536,7111,impact,O
102537,7111,protocol,O
102538,7112,ASA,O
102539,7112,I,O
102540,7112,&,O
102541,7112,II,O
102542,7112,",",O
102543,7112,Nulliparous,B-Condition
102544,7112,and,O
102545,7112,Multiparous,B-Condition
102546,7112,",",O
102547,7112,Spontaneous,B-Condition
102548,7112,/,I-Condition
102549,7112,Induced,I-Condition
102550,7112,/,I-Condition
102551,7112,Augmented,I-Condition
102552,7112,Labor,I-Condition
102553,7112,",",O
102554,7112,Early,B-Condition
102555,7112,active,I-Condition
102556,7112,labor,I-Condition
102557,7112,(,O
102558,7112,cervix,O
102559,7112,<,O
102560,7112,5,O
102561,7112,cm,O
102562,7112,(,O
102563,7112,if,O
102564,7112,known,O
102565,7112,),O
102566,7112,),O
102567,7112,",",O
102568,7112,Pain,O
102569,7112,(,O
102570,7112,VPS,O
102571,7112,),O
102572,7112,>,O
102573,7112,3,O
102574,7112,",",O
102575,7112,18,O
102576,7112,-,O
102577,7112,45,O
102578,7112,years,O
102579,7112,of,O
102580,7112,age,B-Person
102581,7113,previous,O
102582,7113,brain,B-Procedure
102583,7113,surgery,I-Procedure
102584,7113,;,O
102585,7114,cognitive,B-Condition
102586,7114,impairment,I-Condition
102587,7114,(,O
102588,7114,<,O
102589,7114,120,O
102590,7114,points,O
102591,7114,on,O
102592,7114,the,O
102593,7114,Mattis,O
102594,7114,Dementia,O
102595,7114,Rating,O
102596,7114,Scale,O
102597,7114,),O
102598,7115,moderate,O
102599,7115,-,O
102600,7115,to,O
102601,7115,-,O
102602,7115,severe,O
102603,7115,depression,B-Condition
102604,7115,(,O
102605,7115,>,O
102606,7115,25,O
102607,7115,points,O
102608,7115,on,O
102609,7115,the,O
102610,7115,Beck,O
102611,7115,Depression,O
102612,7115,Inventory,O
102613,7115,),O
102614,7116,marked,O
102615,7116,brain,B-Condition
102616,7116,atrophy,I-Condition
102617,7116,as,O
102618,7116,detected,O
102619,7116,by,O
102620,7116,magnetic,B-Procedure
102621,7116,resonance,I-Procedure
102622,7116,imaging,I-Procedure
102623,7117,other,O
102624,7117,medical,O
102625,7117,or,O
102626,7117,psychiatric,O
102627,7117,coexisting,O
102628,7117,disorders,O
102629,7117,that,O
102630,7117,could,O
102631,7117,increase,O
102632,7117,the,O
102633,7117,surgical,O
102634,7117,risk,O
102635,7117,or,O
102636,7117,interfere,O
102637,7117,with,O
102638,7117,completion,O
102639,7117,of,O
102640,7117,the,O
102641,7117,trial,O
102642,7118,ages,B-Person
102643,7118,of,O
102644,7118,7,O
102645,7118,and,O
102646,7118,75,O
102647,7118,years,O
102648,7119,marked,O
102649,7119,disability,B-Condition
102650,7119,owing,O
102651,7119,to,O
102652,7119,primary,O
102653,7119,generalized,O
102654,7119,or,O
102655,7119,segmental,O
102656,7119,dystonia,B-Condition
102657,7119,",",O
102658,7119,despite,O
102659,7119,optimal,O
102660,7119,pharmacologic,B-Procedure
102661,7119,treatment,I-Procedure
102662,7120,disease,O
102663,7120,duration,O
102664,7120,of,O
102665,7120,at,O
102666,7120,least,O
102667,7120,5,O
102668,7120,years,O
102669,7120,.,O
102670,7121,Uncontrolled,O
102671,7121,hypertension,B-Condition
102672,7121,(,O
102673,7121,defined,O
102674,7121,as,O
102675,7121,average,O
102676,7121,SBP,O
102677,7121,=,O
102678,7121,160,O
102679,7121,mmHg,O
102680,7121,[,O
102681,7121,2,O
102682,7121,readings,O
102683,7121,taken,O
102684,7121,at,O
102685,7121,time,O
102686,7121,of,O
102687,7121,screening,O
102688,7121,],O
102689,7121,),O
102690,7121,.,O
102691,7122,End,B-Condition
102692,7122,stage,I-Condition
102693,7122,renal,I-Condition
102694,7122,disease,I-Condition
102695,7122,(,O
102696,7122,CrCl,O
102697,7122,<,O
102698,7122,15,O
102699,7122,ml,O
102700,7122,/,O
102701,7122,min,O
102702,7122,),O
102703,7123,Valvular,B-Condition
102704,7123,Heart,I-Condition
102705,7123,Disease,I-Condition
102706,7123,including,O
102707,7123,those,O
102708,7123,with,O
102709,7123,prosthetic,O
102710,7123,valve,O
102711,7123,",",O
102712,7123,mitral,B-Condition
102713,7123,stenosis,I-Condition
102714,7123,(,O
102715,7123,moderate,O
102716,7123,to,O
102717,7123,severe,O
102718,7123,),O
102719,7123,or,O
102720,7123,valve,B-Procedure
102721,7123,repair,I-Procedure
102722,7123,.,O
102723,7124,Excess,O
102724,7124,alcohol,O
102725,7124,intake,O
102726,7124,(,O
102727,7124,males,B-Person
102728,7124,:,O
102729,7124,=,O
102730,7124,28,O
102731,7124,units,O
102732,7124,/,O
102733,7124,week,O
102734,7124,",",O
102735,7124,females,B-Person
102736,7124,:,O
102737,7124,=,O
102738,7124,21,O
102739,7124,units,O
102740,7124,/,O
102741,7124,week,O
102742,7124,.,O
102743,7124,One,O
102744,7124,unit,O
102745,7124,of,O
102746,7124,alcohol,O
102747,7124,=,O
102748,7124,8,O
102749,7124,oz,O
102750,7124,beer,O
102751,7124,",",O
102752,7124,1,O
102753,7124,oz,O
102754,7124,hard,O
102755,7124,liquor,O
102756,7124,or,O
102757,7124,4,O
102758,7124,oz,O
102759,7124,wine,O
102760,7124,),O
102761,7124,.,O
102762,7125,Intracranial,B-Condition
102763,7125,bleed,I-Condition
102764,7125,at,O
102765,7125,any,O
102766,7125,point,O
102767,7125,.,O
102768,7126,History,B-Observation
102769,7126,of,O
102770,7126,"""",O
102771,7126,Major,B-Condition
102772,7126,Bleeding,I-Condition
102773,7126,"""",O
102774,7126,at,O
102775,7126,any,O
102776,7126,point,O
102777,7126,(,O
102778,7126,defined,O
102779,7126,as,O
102780,7126,overt,B-Condition
102781,7126,bleeding,I-Condition
102782,7126,at,O
102783,7126,a,O
102784,7126,critical,O
102785,7126,site,O
102786,7126,including,O
102787,7126,intracranial,O
102788,7126,",",O
102789,7126,intraspinal,O
102790,7126,",",O
102791,7126,intraocular,O
102792,7126,",",O
102793,7126,pericardial,O
102794,7126,",",O
102795,7126,or,O
102796,7126,retroperitoneal,O
102797,7126,;,O
102798,7126,or,O
102799,7126,bleed,B-Condition
102800,7126,requiring,O
102801,7126,hospitalization,B-Procedure
102802,7126,),O
102803,7126,.,O
102804,7127,Foreshortened,O
102805,7127,life,B-Observation
102806,7127,-,I-Observation
102807,7127,expectancy,I-Observation
102808,7127,or,O
102809,7127,severe,B-Condition
102810,7127,comorbidities,I-Condition
102811,7127,precluding,O
102812,7127,study,O
102813,7127,follow,O
102814,7127,-,O
102815,7127,up,O
102816,7127,period,O
102817,7128,Unable,O
102818,7128,to,O
102819,7128,read,O
102820,7128,/,O
102821,7128,understand,O
102822,7128,English,O
102823,7129,Severe,O
102824,7129,cognitive,B-Condition
102825,7129,impairment,I-Condition
102826,7129,(,O
102827,7129,defined,O
102828,7129,as,O
102829,7129,score,O
102830,7129,=,O
102831,7129,5,O
102832,7129,on,O
102833,7129,the,O
102834,7129,Short,O
102835,7129,Portable,O
102836,7129,Mental,O
102837,7129,Status,O
102838,7129,Questionnaire,O
102839,7129,),O
102840,7130,Age,B-Person
102841,7130,=,O
102842,7130,65,O
102843,7130,years,O
102844,7130,with,O
102845,7130,one,O
102846,7130,additional,O
102847,7130,stroke,B-Condition
102848,7130,risk,B-Condition
102849,7130,factor,I-Condition
102850,7130,(,O
102851,7130,hypertension,B-Condition
102852,7130,",",O
102853,7130,diabetes,B-Condition
102854,7130,",",O
102855,7130,heart,B-Condition
102856,7130,failure,I-Condition
102857,7130,history,B-Observation
102858,7130,of,O
102859,7130,or,O
102860,7130,left,O
102861,7130,ventricular,O
102862,7130,ejection,O
102863,7130,fraction,O
102864,7130,<,O
102865,7130,0.40,O
102866,7130,),O
102867,7130,",",O
102868,7130,previous,O
102869,7130,stroke,B-Condition
102870,7130,or,O
102871,7130,transient,B-Condition
102872,7130,ischemic,I-Condition
102873,7130,attack,I-Condition
102874,7130,),O
102875,7130,.,O
102876,7131,Atrial,B-Condition
102877,7131,fibrillation,I-Condition
102878,7131,and,O
102879,7131,not,O
102880,7131,on,O
102881,7131,oral,B-Procedure
102882,7131,anticoagulation,I-Procedure
102883,7131,(,I-Procedure
102884,7131,OAC,I-Procedure
102885,7131,),I-Procedure
102886,7131,therapy,I-Procedure
102887,7131,but,O
102888,7131,eligible,O
102889,7132,Atrial,B-Condition
102890,7132,fibrillation,I-Condition
102891,7132,on,O
102892,7132,sub,O
102893,7132,-,O
102894,7132,optimal,O
102895,7132,OAC,B-Procedure
102896,7133,Human,B-Condition
102897,7133,immunodeficiency,I-Condition
102898,7133,virus,I-Condition
102899,7133,(,I-Condition
102900,7133,HIV)-infected,I-Condition
102901,7134,Baseline,O
102902,7134,serology,B-Procedure
102903,7134,showed,O
102904,7134,a,O
102905,7134,nonreactive,O
102906,7134,RPR,O
102907,7134,test,O
102908,7135,follow,B-Observation
102909,7135,-,I-Observation
102910,7135,up,I-Observation
102911,7135,is,I-Observation
102912,7135,inadequate,I-Observation
102913,7136,Allergic,B-Condition
102914,7136,to,O
102915,7136,penicillin,B-Drug
102916,7137,Pregnant,B-Condition
102917,7137,woman,B-Person
102918,7138,Early,B-Condition
102919,7138,Syphilis,I-Condition
102920,7138,Cases,O
102921,7138,Determined,O
102922,7138,to,O
102923,7138,Be,O
102924,7138,Serofast,O
102925,7138,at,O
102926,7138,6,O
102927,7138,Months,O
102928,7138,after,O
102929,7138,Initial,O
102930,7138,Treatment,B-Procedure
102931,7139,Child,O
102932,7139,-,O
102933,7139,Pugh,O
102934,7139,score,O
102935,7139,>,O
102936,7139,12,O
102937,7140,Having,O
102938,7140,been,O
102939,7140,diagnosed,O
102940,7140,as,O
102941,7140,HCC,B-Condition
102942,7140,within,O
102943,7140,the,O
102944,7140,past,O
102945,7140,5,O
102946,7140,years,O
102947,7141,Serum,O
102948,7141,creatinine,O
102949,7141,>,O
102950,7141,1.5mg,O
102951,7141,/,O
102952,7141,dl,O
102953,7142,Serum,O
102954,7142,bilirubin,O
102955,7142,>,O
102956,7142,5.0mg,O
102957,7142,/,O
102958,7142,dl,O
102959,7143,Presence,O
102960,7143,of,O
102961,7143,such,O
102962,7143,complications,B-Condition
102963,7143,as,O
102964,7143,SBP,B-Condition
102965,7143,",",O
102966,7143,or,O
102967,7143,hepatic,B-Condition
102968,7143,encephalopathy(West,I-Condition
102969,7143,Haven,O
102970,7143,grade,O
102971,7143,=,O
102972,7143,3,O
102973,7143,),O
102974,7144,Patients,O
102975,7144,who,O
102976,7144,experienced,O
102977,7144,organ,B-Condition
102978,7144,failure,I-Condition
102979,7144,by,O
102980,7144,acute,B-Condition
102981,7144,exacerbation,I-Condition
102982,7144,of,I-Condition
102983,7144,liver,I-Condition
102984,7144,cirrhosis,I-Condition
102985,7144,within,O
102986,7144,the,O
102987,7144,past,O
102988,7144,1,O
102989,7144,month,O
102990,7145,Presence,O
102991,7145,of,O
102992,7145,serious,O
102993,7145,cardiac,B-Condition
102994,7145,or,I-Condition
102995,7145,respiratory,I-Condition
102996,7145,disease,I-Condition
102997,7146,Contraindicated,B-Condition
102998,7146,to,O
102999,7146,either,O
103000,7146,diuretics,B-Drug
103001,7146,or,O
103002,7146,BCAA,B-Drug
103003,7147,Having,O
103004,7147,commenced,O
103005,7147,anti,B-Procedure
103006,7147,-,I-Procedure
103007,7147,viral,I-Procedure
103008,7147,treatment,I-Procedure
103009,7147,against,O
103010,7147,hepatitis,B-Condition
103011,7147,C,I-Condition
103012,7147,",",I-Condition
103013,7147,B,I-Condition
103014,7147,within,O
103015,7147,the,O
103016,7147,past,O
103017,7147,1,O
103018,7147,month,O
103019,7148,Pregnant,O
103020,7148,or,O
103021,7148,lactating,O
103022,7148,women,O
103023,7149,Chronic,O
103024,7149,alcohol,B-Person
103025,7149,taker,I-Person
103026,7150,Woman,O
103027,7150,patients,O
103028,7150,who,O
103029,7150,do,O
103030,7150,not,O
103031,7150,agree,O
103032,7150,to,O
103033,7150,the,O
103034,7150,contraception,O
103035,7150,from,O
103036,7150,baseline,O
103037,7150,to,O
103038,7150,12,O
103039,7150,month,O
103040,7151,Unsuitable,O
103041,7151,patients,O
103042,7151,judged,O
103043,7151,by,O
103044,7151,investigator,O
103045,7152,Patients,O
103046,7152,participating,O
103047,7152,in,O
103048,7152,another,O
103049,7152,clinical,O
103050,7152,trial,O
103051,7152,within,O
103052,7152,1,O
103053,7152,month,O
103054,7153,Age,B-Person
103055,7153,=,O
103056,7153,19,O
103057,7153,and,O
103058,7153,=,O
103059,7153,70,O
103060,7153,years,O
103061,7153,;,O
103062,7154,Presence,O
103063,7154,of,O
103064,7154,liver,B-Condition
103065,7154,cirrhosis,I-Condition
103066,7155,Serum,O
103067,7155,albumin,O
103068,7155,level,O
103069,7155,=,O
103070,7155,3.5g,O
103071,7155,/,O
103072,7155,dl,O
103073,7155,",",O
103074,7155,ultrasound,B-Procedure
103075,7155,or,O
103076,7155,CT,B-Procedure
103077,7155,scan,I-Procedure
103078,7155,confirmed,O
103079,7155,ascites,B-Condition
103080,7155,(=,O
103081,7155,Grade,O
103082,7155,1,O
103083,7155,),O
103084,7156,No,O
103085,7156,administration,O
103086,7156,of,O
103087,7156,diuretics,B-Drug
103088,7156,and,O
103089,7156,BCAA,B-Drug
103090,7156,within,O
103091,7156,the,O
103092,7156,past,O
103093,7156,1,O
103094,7156,week,O
103095,7157,Voluntary,O
103096,7157,consent,O
103097,7157,to,O
103098,7157,take,O
103099,7157,part,O
103100,7157,in,O
103101,7157,this,O
103102,7157,trial,O
103103,7158,uncontrolled,O
103104,7158,hypertension,B-Condition
103105,7159,uncontrolled,O
103106,7159,diabetes,B-Condition
103107,7160,creatinine,O
103108,7160,>,O
103109,7160,"2,5",O
103110,7160,mg,O
103111,7160,/,O
103112,7160,dl,O
103113,7161,potassium,O
103114,7161,>,O
103115,7161,6,O
103116,7161,mg,O
103117,7161,/,O
103118,7161,dl,O
103119,7162,acute,B-Condition
103120,7162,coronary,I-Condition
103121,7162,syndrome,I-Condition
103122,7163,hypertrophic,B-Condition
103123,7163,cardiomyopathy,I-Condition
103124,7164,heart,B-Condition
103125,7164,failure,I-Condition
103126,7164,NYHA,O
103127,7164,II,O
103128,7164,-,O
103129,7164,IV,O
103130,7165,previous,O
103131,7165,treatment,B-Procedure
103132,7165,with,O
103133,7165,diuretics,B-Drug
103134,7166,age>18,B-Person
103135,7166,years,O
103136,7167,Patient,O
103137,7167,included,O
103138,7167,in,O
103139,7167,an,O
103140,7167,interventional,O
103141,7167,study,O
103142,7167,assessing,O
103143,7167,treatment,B-Procedure
103144,7167,for,O
103145,7167,active,B-Condition
103146,7167,proctitis,I-Condition
103147,7167,or,O
103148,7167,distal,B-Condition
103149,7167,proctosigmoiditis,I-Condition
103150,7167,.,O
103151,7168,Patient,O
103152,7168,with,O
103153,7168,left,O
103154,7168,sided,O
103155,7168,",",O
103156,7168,colitis,B-Condition
103157,7168,or,O
103158,7168,pancolitis,B-Condition
103159,7168,.,O
103160,7169,Patient,O
103161,7169,with,O
103162,7169,severe,O
103163,7169,proctitis,B-Condition
103164,7169,(,O
103165,7169,MAYO,O
103166,7169,score,O
103167,7169,≥,O
103168,7169,11,O
103169,7169,at,O
103170,7169,inclusion,O
103171,7169,),O
103172,7169,.,O
103173,7170,Patient,O
103174,7170,previously,O
103175,7170,treated,B-Procedure
103176,7170,with,O
103177,7170,biologics,B-Drug
103178,7170,.,O
103179,7171,Patient,O
103180,7171,treated,O
103181,7171,with,O
103182,7171,immunosuppressive,B-Drug
103183,7171,within,O
103184,7171,1,O
103185,7171,month,O
103186,7171,before,O
103187,7171,study,O
103188,7171,inclusion,O
103189,7171,.,O
103190,7172,Patient,O
103191,7172,treated,O
103192,7172,with,O
103193,7172,corticosteroids,B-Drug
103194,7172,within,O
103195,7172,2,O
103196,7172,weeks,O
103197,7172,before,O
103198,7172,study,O
103199,7172,inclusion,O
103200,7172,.,O
103201,7173,Patient,O
103202,7173,aged,B-Person
103203,7173,18,O
103204,7173,years,O
103205,7173,or,O
103206,7173,older,O
103207,7173,.,O
103208,7174,Patient,O
103209,7174,suffering,O
103210,7174,from,O
103211,7174,mild,O
103212,7174,to,O
103213,7174,moderate,O
103214,7174,active,B-Condition
103215,7174,proctitis,I-Condition
103216,7174,or,O
103217,7174,distal,B-Condition
103218,7174,proctosigmoiditis,I-Condition
103219,7174,(,O
103220,7174,MAYO,O
103221,7174,score,O
103222,7174,≥,O
103223,7174,3,O
103224,7174,and,O
103225,7174,≤,O
103226,7174,10,O
103227,7174,),O
103228,7174,at,O
103229,7174,inclusion,O
103230,7174,based,O
103231,7174,on,O
103232,7174,clinical,O
103233,7174,and,O
103234,7174,endoscopic,O
103235,7174,findings,O
103236,7174,within,O
103237,7174,6,O
103238,7174,months,O
103239,7174,before,O
103240,7174,study,O
103241,7174,inclusion,O
103242,7174,.,O
103243,7175,Patient,O
103244,7175,with,O
103245,7175,evidence,O
103246,7175,of,O
103247,7175,endoscopic,B-Procedure
103248,7175,active,B-Condition
103249,7175,proctitis,I-Condition
103250,7175,or,O
103251,7175,distal,B-Condition
103252,7175,proctosigmoiditis,I-Condition
103253,7175,(,O
103254,7175,Montreal,O
103255,7175,classification,O
103256,7175,E1,O
103257,7175,or,O
103258,7175,E2,O
103259,7175,defined,O
103260,7175,by,O
103261,7175,an,O
103262,7175,involvement,O
103263,7175,not,O
103264,7175,exceeding,O
103265,7175,25,O
103266,7175,cm,O
103267,7175,from,O
103268,7175,the,O
103269,7175,anal,O
103270,7175,margin,O
103271,7175,),O
103272,7175,within,O
103273,7175,6,O
103274,7175,months,O
103275,7175,before,O
103276,7175,study,O
103277,7175,inclusion,O
103278,7175,.,O
103279,7176,Treatment,B-Procedure
103280,7176,of,O
103281,7176,the,O
103282,7176,current,O
103283,7176,flare,B-Condition
103284,7176,with,O
103285,7176,Pentasa,B-Drug
103286,7176,®,O
103287,7176,to,O
103288,7176,induce,O
103289,7176,a,O
103290,7176,remission,O
103291,7176,initiated,O
103292,7176,by,O
103293,7176,the,O
103294,7176,patient,O
103295,7176,",",O
103296,7176,the,O
103297,7176,general,O
103298,7176,practitioner,O
103299,7176,or,O
103300,7176,the,O
103301,7176,gastroenterologist,O
103302,7176,",",O
103303,7176,during,O
103304,7176,the,O
103305,7176,inclusion,O
103306,7176,visit,O
103307,7176,or,O
103308,7176,during,O
103309,7176,the,O
103310,7176,week,O
103311,7176,before,O
103312,7176,the,O
103313,7176,inclusion,O
103314,7176,visit,O
103315,7176,.,O
103316,7177,Patient,O
103317,7177,having,O
103318,7177,received,O
103319,7177,oral,O
103320,7177,and,O
103321,7177,written,O
103322,7177,information,O
103323,7177,on,O
103324,7177,the,O
103325,7177,study,O
103326,7177,",",O
103327,7177,without,O
103328,7177,any,O
103329,7177,objections,O
103330,7177,for,O
103331,7177,the,O
103332,7177,use,O
103333,7177,of,O
103334,7177,his,O
103335,7177,/,O
103336,7177,her,O
103337,7177,personal,O
103338,7177,data,O
103339,7177,",",O
103340,7177,and,O
103341,7177,having,O
103342,7177,signed,O
103343,7177,a,O
103344,7177,written,O
103345,7177,Informed,O
103346,7177,Consent,O
103347,7177,Form,O
103348,7177,.,O
103349,7178,not,O
103350,7178,diabetic,B-Condition
103351,7178,patient,O
103352,7178,;,O
103353,7179,patients,O
103354,7179,in,O
103355,7179,dual,B-Procedure
103356,7179,antiplatelet,I-Procedure
103357,7179,therapy,I-Procedure
103358,7179,;,O
103359,7180,patient,O
103360,7180,with,O
103361,7180,severe,O
103362,7180,renal,B-Condition
103363,7180,failure,I-Condition
103364,7180,;,O
103365,7181,patient,O
103366,7181,poor,B-Condition
103367,7181,responders,I-Condition
103368,7182,diabetic,B-Condition
103369,7182,patient,O
103370,7182,;,O
103371,7183,therapy,O
103372,7183,with,O
103373,7183,aspirin,B-Drug
103374,7183,and,O
103375,7183,insulin,B-Drug
103376,7183,;,O
103377,7184,patient,O
103378,7184,well,B-Condition
103379,7184,responders,I-Condition
103380,7185,age,B-Person
103381,7185,<,O
103382,7185,45,O
103383,7185,or,O
103384,7185,>,O
103385,7185,80,O
103386,7186,allergies,B-Condition
103387,7186,to,O
103388,7186,medications,B-Drug
103389,7186,used,O
103390,7186,in,O
103391,7186,the,O
103392,7186,study,O
103393,7187,history,B-Observation
103394,7187,of,O
103395,7187,renal,B-Condition
103396,7187,diseases,I-Condition
103397,7187,",",O
103398,7187,a,O
103399,7187,coagulation,B-Condition
103400,7187,abnormality,I-Condition
103401,7187,",",O
103402,7187,a,O
103403,7187,hepatic,B-Condition
103404,7187,disease,I-Condition
103405,7187,",",O
103406,7187,or,O
103407,7187,drug,B-Condition
103408,7187,abuse,I-Condition
103409,7188,definite,O
103410,7188,radiographic,B-Mood
103411,7188,evidence,I-Mood
103412,7188,of,O
103413,7188,osteoarthritis,B-Condition
103414,7188,of,O
103415,7188,the,O
103416,7188,glenohumeral,O
103417,7188,joint,O
103418,7189,inflammatory,B-Condition
103419,7189,arthritis,I-Condition
103420,7189,including,O
103421,7189,rheumatoid,B-Condition
103422,7189,arthritis,I-Condition
103423,7190,a,O
103424,7190,history,B-Observation
103425,7190,of,O
103426,7190,acute,B-Condition
103427,7190,trauma,I-Condition
103428,7191,systemic,B-Condition
103429,7191,conditions,I-Condition
103430,7191,associated,O
103431,7191,with,O
103432,7191,chronic,B-Condition
103433,7191,pain,I-Condition
103434,7192,a,O
103435,7192,history,B-Observation
103436,7192,of,O
103437,7192,infection,B-Condition
103438,7193,an,O
103439,7193,inability,B-Observation
103440,7193,to,I-Observation
103441,7193,understand,I-Observation
103442,7193,the,I-Observation
103443,7193,questionnaires,I-Observation
103444,7194,Rotator,B-Condition
103445,7194,cuff,I-Condition
103446,7194,tear,I-Condition
103447,7194,patients,O
103448,7194,undergoing,O
103449,7194,arthroscopic,B-Procedure
103450,7194,rotator,I-Procedure
103451,7194,cuff,I-Procedure
103452,7194,tear,I-Procedure
103453,7195,Participation,O
103454,7195,in,O
103455,7195,other,O
103456,7195,interventional,O
103457,7195,research,O
103458,7195,.,O
103459,7196,History,O
103460,7196,of,O
103461,7196,penetrating,B-Condition
103462,7196,head,I-Condition
103463,7196,injury,I-Condition
103464,7197,History,O
103465,7197,of,O
103466,7197,TBI,B-Condition
103467,7197,more,O
103468,7197,severe,O
103469,7197,than,O
103470,7197,mild,O
103471,7197,by,O
103472,7197,DVBIC,O
103473,7197,criteria,O
103474,7198,Diagnosis,O
103475,7198,of,O
103476,7198,a,O
103477,7198,primary,O
103478,7198,or,O
103479,7198,secondary,O
103480,7198,HA,B-Condition
103481,7198,disorder,I-Condition
103482,7198,other,O
103483,7198,than,O
103484,7198,PTHA,B-Condition
103485,7199,Lifetime,B-Observation
103486,7199,history,I-Observation
103487,7199,of,O
103488,7199,5,O
103489,7199,or,O
103490,7199,more,O
103491,7199,migraine,B-Condition
103492,7199,or,O
103493,7199,probable,O
103494,7199,migraine,B-Condition
103495,7199,headaches,O
103496,7199,pre,O
103497,7199,-,O
103498,7199,dating,O
103499,7199,mTBI,B-Procedure
103500,7200,HAs,B-Condition
103501,7200,of,O
103502,7200,any,O
103503,7200,kind,O
103504,7200,of,O
103505,7200,moderate,O
103506,7200,or,O
103507,7200,severe,O
103508,7200,intensity,O
103509,7200,on,O
103510,7200,an,O
103511,7200,average,O
103512,7200,of,O
103513,7200,more,O
103514,7200,than,O
103515,7200,2,O
103516,7200,days,O
103517,7200,per,O
103518,7200,month,O
103519,7200,preceding,O
103520,7200,the,O
103521,7200,concussive,O
103522,7200,trauma,O
103523,7201,Continuous,O
103524,7201,HAs,B-Condition
103525,7201,of,O
103526,7201,any,O
103527,7201,kind,O
103528,7201,(,O
103529,7201,i.e.,O
103530,7201,",",O
103531,7201,persistent,O
103532,7201,daily,O
103533,7201,HAs,B-Condition
103534,7201,with,O
103535,7201,no,O
103536,7201,HA,O
103537,7201,-,O
103538,7201,free,O
103539,7201,period,O
103540,7201,less,O
103541,7201,than,O
103542,7201,8,O
103543,7201,hours,O
103544,7201,between,O
103545,7201,attacks,O
103546,7201,),O
103547,7202,Acute,O
103548,7202,or,O
103549,7202,serious,O
103550,7202,medical,B-Condition
103551,7202,illness,I-Condition
103552,7202,or,O
103553,7202,unstable,O
103554,7202,chronic,B-Condition
103555,7202,medical,I-Condition
103556,7202,illness,I-Condition
103557,7202,(,O
103558,7202,e.g.,O
103559,7202,",",O
103560,7202,unstable,B-Condition
103561,7202,angina,I-Condition
103562,7202,",",O
103563,7202,myocardial,B-Condition
103564,7202,infarction,I-Condition
103565,7202,within,O
103566,7202,6,O
103567,7202,months,O
103568,7202,",",O
103569,7202,congestive,B-Condition
103570,7202,heart,I-Condition
103571,7202,failure,I-Condition
103572,7202,",",O
103573,7202,clinically,O
103574,7202,significant,O
103575,7202,or,O
103576,7202,concerning,O
103577,7202,cardiac,B-Condition
103578,7202,arrhythmias,I-Condition
103579,7202,;,O
103580,7202,preexisting,O
103581,7202,hypotension,B-Condition
103582,7202,[,O
103583,7202,systolic,O
103584,7202,blood,O
103585,7202,pressure<110,O
103586,7202,],O
103587,7202,or,O
103588,7202,orthostatic,B-Condition
103589,7202,hypotension,I-Condition
103590,7202,[,O
103591,7202,systolic,O
103592,7202,drop,O
103593,7202,>,O
103594,7202,20,O
103595,7202,mm,O
103596,7202,Hg,O
103597,7202,after,O
103598,7202,2,O
103599,7202,min,O
103600,7202,standing,O
103601,7202,accompanied,O
103602,7202,by,O
103603,7202,lightheadedness,B-Condition
103604,7202,],O
103605,7202,",",O
103606,7202,chronic,B-Condition
103607,7202,renal,I-Condition
103608,7202,or,I-Condition
103609,7202,hepatic,I-Condition
103610,7202,failure,I-Condition
103611,7202,",",O
103612,7202,acute,B-Condition
103613,7202,pancreatitis,I-Condition
103614,7202,",",O
103615,7202,Meniere,B-Condition
103616,7202,'s,I-Condition
103617,7202,disease,I-Condition
103618,7202,",",O
103619,7202,or,O
103620,7202,diagnosed,O
103621,7202,but,O
103622,7202,untreated,O
103623,7202,sleep,B-Condition
103624,7202,apnea,I-Condition
103625,7202,),O
103626,7202,.,O
103627,7202,The,O
103628,7202,eligibility,O
103629,7202,of,O
103630,7202,potential,O
103631,7202,participants,O
103632,7202,having,O
103633,7202,acute,O
103634,7202,serious,O
103635,7202,and/or,O
103636,7202,chronic,O
103637,7202,medical,O
103638,7202,illnesses,O
103639,7202,other,O
103640,7202,than,O
103641,7202,those,O
103642,7202,listed,O
103643,7202,will,O
103644,7202,be,O
103645,7202,evaluated,O
103646,7202,on,O
103647,7202,a,O
103648,7202,case,O
103649,7202,-,O
103650,7202,by,O
103651,7202,-,O
103652,7202,case,O
103653,7202,basis,O
103654,7202,by,O
103655,7202,a,O
103656,7202,study,O
103657,7202,physician,O
103658,7202,",",O
103659,7202,PA,O
103660,7202,-,O
103661,7202,C,O
103662,7202,",",O
103663,7202,or,O
103664,7202,ARNP,O
103665,7202,.,O
103666,7203,Use,O
103667,7203,of,O
103668,7203,prazosin,B-Drug
103669,7203,or,O
103670,7203,other,O
103671,7203,alpha-1,B-Drug
103672,7203,antagonist,I-Drug
103673,7203,(,O
103674,7203,including,O
103675,7203,but,O
103676,7203,not,O
103677,7203,limited,O
103678,7203,to,O
103679,7203,alfuzosin,B-Drug
103680,7203,",",O
103681,7203,doxazosin,B-Drug
103682,7203,",",O
103683,7203,silodosin,B-Drug
103684,7203,",",O
103685,7203,tamsulosin,B-Drug
103686,7203,",",O
103687,7203,terazosin,B-Drug
103688,7203,),O
103689,7203,for,O
103690,7203,any,O
103691,7203,purpose,O
103692,7203,in,O
103693,7203,the,O
103694,7203,2,O
103695,7203,weeks,O
103696,7203,prior,O
103697,7203,to,O
103698,7203,initial,O
103699,7203,screen,O
103700,7203,(,O
103701,7203,P1,O
103702,7203,),O
103703,7203,visit,O
103704,7203,and,O
103705,7203,prohibited,O
103706,7203,throughout,O
103707,7203,the,O
103708,7203,study,O
103709,7204,Allergy,B-Condition
103710,7204,or,O
103711,7204,previous,O
103712,7204,adverse,B-Condition
103713,7204,reaction,I-Condition
103714,7204,to,O
103715,7204,prazosin,B-Drug
103716,7204,or,O
103717,7204,other,O
103718,7204,alpha-1,B-Drug
103719,7204,antagonist,I-Drug
103720,7205,Active,O
103721,7205,psychosis,B-Condition
103722,7205,or,O
103723,7205,psychotic,B-Condition
103724,7205,disorder,I-Condition
103725,7205,",",O
103726,7205,severe,B-Condition
103727,7205,depression,I-Condition
103728,7205,(,O
103729,7205,as,O
103730,7205,determined,O
103731,7205,per,O
103732,7205,clinician,O
103733,7205,prescriber,O
103734,7205,judgment,O
103735,7205,),O
103736,7205,",",O
103737,7205,severe,O
103738,7205,psychiatric,B-Condition
103739,7205,instability,I-Condition
103740,7205,or,O
103741,7205,severe,O
103742,7205,situational,B-Condition
103743,7205,life,I-Condition
103744,7205,crisis,I-Condition
103745,7205,(,O
103746,7205,including,O
103747,7205,evidence,O
103748,7205,of,O
103749,7205,being,O
103750,7205,actively,O
103751,7205,suicidal,B-Condition
103752,7205,or,O
103753,7205,homicidal,B-Condition
103754,7205,),O
103755,7205,.,O
103756,7206,Meets,O
103757,7206,Diagnostic,O
103758,7206,and,O
103759,7206,Statistical,O
103760,7206,Manual,O
103761,7206,of,O
103762,7206,Mental,O
103763,7206,Disorders,O
103764,7206,",",O
103765,7206,5th,O
103766,7206,Edition,O
103767,7206,(,O
103768,7206,DSM-5,O
103769,7206,),O
103770,7206,criteria,O
103771,7206,for,O
103772,7206,any,O
103773,7206,Substance,B-Condition
103774,7206,Use,I-Condition
103775,7206,Disorder,I-Condition
103776,7206,except,O
103777,7206,caffeine,B-Condition
103778,7206,-,I-Condition
103779,7206,related,I-Condition
103780,7206,disorders,I-Condition
103781,7206,",",O
103782,7206,or,O
103783,7206,tobacco,B-Condition
103784,7206,-,I-Condition
103785,7206,related,I-Condition
103786,7206,disorders,I-Condition
103787,7206,.,O
103788,7207,History,O
103789,7207,of,O
103790,7207,delirium,B-Condition
103791,7207,within,O
103792,7207,the,O
103793,7207,prior,O
103794,7207,3,O
103795,7207,months,O
103796,7207,",",O
103797,7207,epilepsy,B-Condition
103798,7207,",",O
103799,7207,stroke,B-Condition
103800,7207,",",O
103801,7207,dementia,B-Condition
103802,7207,",",O
103803,7207,psychotic,B-Condition
103804,7207,disorder,I-Condition
103805,7207,",",O
103806,7207,or,O
103807,7207,bipolar,B-Condition
103808,7207,disorder,I-Condition
103809,7208,Structural,B-Condition
103810,7208,brain,I-Condition
103811,7208,abnormalities,I-Condition
103812,7208,on,O
103813,7208,any,O
103814,7208,prior,O
103815,7208,imaging,B-Procedure
103816,7208,with,O
103817,7208,associated,O
103818,7208,clinically,O
103819,7208,evident,O
103820,7208,manifestations,B-Condition
103821,7209,Current,O
103822,7209,participation,O
103823,7209,in,O
103824,7209,transcranial,B-Procedure
103825,7209,magnetic,I-Procedure
103826,7209,stimulation,I-Procedure
103827,7209,studies,I-Procedure
103828,7210,Women,B-Person
103829,7210,of,O
103830,7210,childbearing,B-Condition
103831,7210,potential,I-Condition
103832,7210,must,O
103833,7210,not,O
103834,7210,be,O
103835,7210,pregnant,B-Condition
103836,7210,",",O
103837,7210,planning,B-Mood
103838,7210,to,I-Mood
103839,7210,become,I-Mood
103840,7210,pregnant,B-Condition
103841,7210,during,O
103842,7210,the,O
103843,7210,study,O
103844,7210,period,O
103845,7210,",",O
103846,7210,or,O
103847,7210,nursing,B-Condition
103848,7210,.,O
103849,7211,Participation,B-Procedure
103850,7211,in,I-Procedure
103851,7211,a,I-Procedure
103852,7211,HA,I-Procedure
103853,7211,support,I-Procedure
103854,7211,group,I-Procedure
103855,7211,or,O
103856,7211,other,O
103857,7211,activity,O
103858,7211,such,O
103859,7211,as,O
103860,7211,meditation,B-Procedure
103861,7211,or,O
103862,7211,yoga,B-Procedure
103863,7211,intended,O
103864,7211,to,O
103865,7211,mitigate,O
103866,7211,HA,O
103867,7211,or,O
103868,7211,other,O
103869,7211,chronic,O
103870,7211,pain,O
103871,7211,must,O
103872,7211,be,O
103873,7211,stable,O
103874,7211,at,O
103875,7211,least,O
103876,7211,4,O
103877,7211,weeks,O
103878,7211,prior,O
103879,7211,to,O
103880,7211,beginning,O
103881,7211,the,O
103882,7211,initial,O
103883,7211,screen,O
103884,7211,(,O
103885,7211,P1,O
103886,7211,),O
103887,7211,visit,O
103888,7211,and,O
103889,7211,may,O
103890,7211,not,O
103891,7211,be,O
103892,7211,started,O
103893,7211,during,O
103894,7211,the,O
103895,7211,study,O
103896,7212,Failure,B-Observation
103897,7212,to,I-Observation
103898,7212,record,I-Observation
103899,7212,HA,I-Observation
103900,7212,data,I-Observation
103901,7212,for,O
103902,7212,at,O
103903,7212,least,O
103904,7212,80,O
103905,7212,%,O
103906,7212,of,O
103907,7212,days,O
103908,7212,during,O
103909,7212,the,O
103910,7212,Screening,O
103911,7212,Period,O
103912,7213,Not,O
103913,7213,suitable,O
103914,7213,for,O
103915,7213,study,O
103916,7213,per,O
103917,7213,clinician,O
103918,7213,judgement,O
103919,7213,.,O
103920,7214,The,O
103921,7214,use,O
103922,7214,of,O
103923,7214,HA,O
103924,7214,rescue,O
103925,7214,or,O
103926,7214,symptom,O
103927,7214,-,O
103928,7214,relieving,O
103929,7214,medications,O
103930,7214,will,O
103931,7214,be,O
103932,7214,allowed,O
103933,7214,during,O
103934,7214,the,O
103935,7214,study,O
103936,7214,.,O
103937,7214,This,O
103938,7214,includes,O
103939,7214,triptans,O
103940,7214,",",O
103941,7214,ergotamines,O
103942,7214,",",O
103943,7214,opioids,O
103944,7214,",",O
103945,7214,simple,O
103946,7214,analgesics,O
103947,7214,(,O
103948,7214,e.g.,O
103949,7214,acetaminophen,O
103950,7214,",",O
103951,7214,aspirin,O
103952,7214,",",O
103953,7214,or,O
103954,7214,non,O
103955,7214,-,O
103956,7214,steroidal,O
103957,7214,anti,O
103958,7214,-,O
103959,7214,inflammatories,O
103960,7214,[,O
103961,7214,NSAIDS,O
103962,7214,],O
103963,7214,",",O
103964,7214,and,O
103965,7214,combination,O
103966,7214,analgesics,O
103967,7214,.,O
103968,7214,Their,O
103969,7214,use,O
103970,7214,will,O
103971,7214,be,O
103972,7214,recorded,O
103973,7214,on,O
103974,7214,the,O
103975,7214,concurrent,O
103976,7214,medication,O
103977,7214,CRF,O
103978,7214,during,O
103979,7214,the,O
103980,7214,Preliminary,O
103981,7214,Screening,O
103982,7214,Period,O
103983,7214,(,O
103984,7214,P1,O
103985,7214,),O
103986,7214,and,O
103987,7214,throughout,O
103988,7214,the,O
103989,7214,remainder,O
103990,7214,of,O
103991,7214,the,O
103992,7214,study,O
103993,7214,.,O
103994,7214,Randomization,O
103995,7214,of,O
103996,7214,participants,O
103997,7214,will,O
103998,7214,be,O
103999,7214,stratified,O
104000,7214,based,O
104001,7214,on,O
104002,7214,whether,O
104003,7214,their,O
104004,7214,use,O
104005,7214,of,O
104006,7214,HA,O
104007,7214,medications,O
104008,7214,meets,O
104009,7214,ICHD-3,O
104010,7214,beta,O
104011,7214,criteria,O
104012,7214,for,O
104013,7214,overuse,O
104014,7214,of,O
104015,7214,these,O
104016,7214,medications,O
104017,7214,",",O
104018,7214,as,O
104019,7214,described,O
104020,7214,in,O
104021,7214,section,O
104022,7214,5.5,O
104023,7214,below,O
104024,7214,.,O
104025,7215,Opioid,O
104026,7215,Medications,O
104027,7215,:,O
104028,7215,Use,O
104029,7215,of,O
104030,7215,opioids,O
104031,7215,for,O
104032,7215,treatment,O
104033,7215,of,O
104034,7215,HA,O
104035,7215,or,O
104036,7215,non,O
104037,7215,-,O
104038,7215,HA,O
104039,7215,-,O
104040,7215,related,O
104041,7215,pain,O
104042,7215,or,O
104043,7215,for,O
104044,7215,any,O
104045,7215,other,O
104046,7215,purpose,O
104047,7215,is,O
104048,7215,allowed,O
104049,7215,during,O
104050,7215,the,O
104051,7215,study,O
104052,7215,.,O
104053,7215,Any,O
104054,7215,opioid,O
104055,7215,use,O
104056,7215,would,O
104057,7215,ideally,O
104058,7215,be,O
104059,7215,excluded,O
104060,7215,due,O
104061,7215,to,O
104062,7215,potential,O
104063,7215,confounding,O
104064,7215,effects,O
104065,7215,on,O
104066,7215,interpretation,O
104067,7215,of,O
104068,7215,response,O
104069,7215,to,O
104070,7215,treatment,O
104071,7215,.,O
104072,7215,However,O
104073,7215,",",O
104074,7215,in,O
104075,7215,this,O
104076,7215,population,O
104077,7215,",",O
104078,7215,particularly,O
104079,7215,in,O
104080,7215,Veterans,O
104081,7215,with,O
104082,7215,chronic,O
104083,7215,pain,O
104084,7215,or,O
104085,7215,undergoing,O
104086,7215,minor,O
104087,7215,orthopedic,O
104088,7215,or,O
104089,7215,dental,O
104090,7215,procedures,O
104091,7215,",",O
104092,7215,opioid,O
104093,7215,use,O
104094,7215,is,O
104095,7215,common,O
104096,7215,.,O
104097,7215,Use,O
104098,7215,of,O
104099,7215,opioids,O
104100,7215,",",O
104101,7215,including,O
104102,7215,frequency,O
104103,7215,and,O
104104,7215,dose,O
104105,7215,",",O
104106,7215,will,O
104107,7215,be,O
104108,7215,recorded,O
104109,7215,on,O
104110,7215,the,O
104111,7215,concurrent,O
104112,7215,medication,O
104113,7215,CRF,O
104114,7215,.,O
104115,7216,Other,O
104116,7216,Medications,O
104117,7216,:,O
104118,7216,Participants,O
104119,7216,who,O
104120,7216,are,O
104121,7216,taking,O
104122,7216,other,O
104123,7216,medications,B-Drug
104124,7216,on,O
104125,7216,a,O
104126,7216,routine,O
104127,7216,basis,O
104128,7216,must,O
104129,7216,be,O
104130,7216,on,O
104131,7216,a,O
104132,7216,stable,O
104133,7216,dose,O
104134,7216,for,O
104135,7216,at,O
104136,7216,least,O
104137,7216,4,O
104138,7216,weeks,O
104139,7216,prior,O
104140,7216,to,O
104141,7216,the,O
104142,7216,Preliminary,O
104143,7216,Screening,O
104144,7216,Period,O
104145,7216,(,O
104146,7216,P1,O
104147,7216,),O
104148,7216,",",O
104149,7216,and,O
104150,7216,must,O
104151,7216,intend,O
104152,7216,to,O
104153,7216,continue,O
104154,7216,the,O
104155,7216,medication,O
104156,7216,at,O
104157,7216,the,O
104158,7216,same,O
104159,7216,regimen,O
104160,7216,for,O
104161,7216,the,O
104162,7216,duration,O
104163,7216,of,O
104164,7216,the,O
104165,7216,trial,O
104166,7216,unless,O
104167,7216,lack,O
104168,7216,of,O
104169,7216,efficacy,O
104170,7216,",",O
104171,7216,safety,O
104172,7216,",",O
104173,7216,or,O
104174,7216,tolerability,O
104175,7216,dictates,O
104176,7216,otherwise,O
104177,7216,.,O
104178,7216,The,O
104179,7216,following,O
104180,7216,medications,O
104181,7216,are,O
104182,7216,not,O
104183,7216,excluded,O
104184,7216,:,O
104185,7217,Psychoactive,O
104186,7217,drugs,O
104187,7217,(,O
104188,7217,for,O
104189,7217,example,O
104190,7217,",",O
104191,7217,anticonvulsants,O
104192,7217,",",O
104193,7217,benzodiazepines,O
104194,7217,",",O
104195,7217,antidepressants,O
104196,7217,",",O
104197,7217,sedative,O
104198,7217,/,O
104199,7217,hypnotics,O
104200,7217,),O
104201,7217,",",O
104202,7218,Antihypertensive,O
104203,7218,medications,O
104204,7218,(,O
104205,7218,including,O
104206,7218,beta,O
104207,7218,-,O
104208,7218,blockers,O
104209,7218,",",O
104210,7218,calcium,O
104211,7218,channel,O
104212,7218,blockers,O
104213,7218,",",O
104214,7218,angiotensin,O
104215,7218,converting,O
104216,7218,enzyme,O
104217,7218,[,O
104218,7218,ACE,O
104219,7218,],O
104220,7218,inhibitors,O
104221,7218,",",O
104222,7218,and,O
104223,7218,angiotensin,O
104224,7218,receptor,O
104225,7218,blockers,O
104226,7218,),O
104227,7218,",",O
104228,7219,The,O
104229,7219,use,O
104230,7219,of,O
104231,7219,magnesium,O
104232,7219,in,O
104233,7219,any,O
104234,7219,dose,O
104235,7219,that,O
104236,7219,is,O
104237,7219,prescribed,O
104238,7219,for,O
104239,7219,the,O
104240,7219,purpose,O
104241,7219,of,O
104242,7219,HA,O
104243,7219,prevention,O
104244,7219,or,O
104245,7219,treatment,O
104246,7219,must,O
104247,7219,be,O
104248,7219,stable,O
104249,7219,for,O
104250,7219,at,O
104251,7219,least,O
104252,7219,4,O
104253,7219,weeks,O
104254,7219,.,O
104255,7219,The,O
104256,7219,incidental,O
104257,7219,use,O
104258,7219,of,O
104259,7219,magnesium,O
104260,7219,in,O
104261,7219,multi,O
104262,7219,-,O
104263,7219,vitamins,O
104264,7219,",",O
104265,7219,laxatives,O
104266,7219,",",O
104267,7219,etc,O
104268,7219,.,O
104269,7219,is,O
104270,7219,permissible,O
104271,7219,but,O
104272,7219,must,O
104273,7219,be,O
104274,7219,documented,O
104275,7219,.,O
104276,7220,Hormones,O
104277,7220,(,O
104278,7220,for,O
104279,7220,example,O
104280,7220,",",O
104281,7220,testosterone,O
104282,7220,",",O
104283,7220,estrogen,O
104284,7220,",",O
104285,7220,or,O
104286,7220,progesterone,O
104287,7220,),O
104288,7220,in,O
104289,7220,any,O
104290,7220,form,O
104291,7220,.,O
104292,7221,The,O
104293,7221,"""",O
104294,7221,as,O
104295,7221,-,O
104296,7221,needed,O
104297,7221,"""",O
104298,7221,(,O
104299,7221,prn,O
104300,7221,),O
104301,7221,use,O
104302,7221,of,O
104303,7221,psychoactive,O
104304,7221,and,O
104305,7221,other,O
104306,7221,drugs,O
104307,7221,such,O
104308,7221,as,O
104309,7221,antibiotics,O
104310,7221,is,O
104311,7221,not,O
104312,7221,excluded,O
104313,7221,;,O
104314,7221,however,O
104315,7221,",",O
104316,7221,such,O
104317,7221,use,O
104318,7221,must,O
104319,7221,be,O
104320,7221,discussed,O
104321,7221,with,O
104322,7221,a,O
104323,7221,clinician,O
104324,7221,prescriber,O
104325,7221,and,O
104326,7221,documented,O
104327,7221,.,O
104328,7222,The,O
104329,7222,use,O
104330,7222,of,O
104331,7222,butalbital,B-Drug
104332,7222,in,O
104333,7222,any,O
104334,7222,form,O
104335,7222,within,O
104336,7222,4,O
104337,7222,weeks,O
104338,7222,of,O
104339,7222,beginning,O
104340,7222,the,O
104341,7222,Preliminary,O
104342,7222,Screening,O
104343,7222,Period,O
104344,7222,(,O
104345,7222,P1,O
104346,7222,),O
104347,7222,through,O
104348,7222,the,O
104349,7222,end,O
104350,7222,of,O
104351,7222,the,O
104352,7222,participant,O
104353,7222,'s,O
104354,7222,study,O
104355,7222,involvement,O
104356,7222,is,O
104357,7222,exclusionary,O
104358,7222,.,O
104359,7223,Participants,O
104360,7223,who,O
104361,7223,have,O
104362,7223,been,O
104363,7223,taking,O
104364,7223,trazodone,O
104365,7223,will,O
104366,7223,undergo,O
104367,7223,a,O
104368,7223,2,O
104369,7223,-,O
104370,7223,week,O
104371,7223,washout,O
104372,7223,period,O
104373,7223,before,O
104374,7223,the,O
104375,7223,Preliminary,O
104376,7223,Screening,O
104377,7223,Period,O
104378,7223,(,O
104379,7223,P1,O
104380,7223,visit,O
104381,7223,),O
104382,7223,.,O
104383,7223,Combining,O
104384,7223,prazosin,O
104385,7223,and,O
104386,7223,trazodone,O
104387,7223,may,O
104388,7223,increase,O
104389,7223,the,O
104390,7223,risk,O
104391,7223,of,O
104392,7223,priapism,O
104393,7223,.,O
104394,7223,We,O
104395,7223,have,O
104396,7223,decided,O
104397,7223,to,O
104398,7223,begin,O
104399,7223,the,O
104400,7223,washout,O
104401,7223,period,O
104402,7223,before,O
104403,7223,the,O
104404,7223,Preliminary,O
104405,7223,Screening,O
104406,7223,Period,O
104407,7223,in,O
104408,7223,order,O
104409,7223,to,O
104410,7223,remove,O
104411,7223,any,O
104412,7223,confounding,O
104413,7223,variables,O
104414,7223,while,O
104415,7223,on,O
104416,7223,the,O
104417,7223,headache,O
104418,7223,log,O
104419,7223,and,O
104420,7223,actigraphy,O
104421,7223,.,O
104422,7224,Sildenafil,B-Drug
104423,7224,(,O
104424,7224,Viagra,B-Drug
104425,7224,),O
104426,7224,",",O
104427,7224,tadalafil,B-Drug
104428,7224,(,O
104429,7224,Cialis,B-Drug
104430,7224,),O
104431,7224,",",O
104432,7224,vardenafil,B-Drug
104433,7224,(,O
104434,7224,Levitra,B-Drug
104435,7224,),O
104436,7224,",",O
104437,7224,and,O
104438,7224,avanafil,B-Drug
104439,7224,(,O
104440,7224,Stendra,B-Drug
104441,7224,),O
104442,7224,will,O
104443,7224,not,O
104444,7224,be,O
104445,7224,permitted,O
104446,7224,during,O
104447,7224,the,O
104448,7224,study,O
104449,7224,drug,O
104450,7224,dose,O
104451,7224,Titration,O
104452,7224,Period,O
104453,7224,",",O
104454,7224,because,O
104455,7224,of,O
104456,7224,increased,O
104457,7224,risk,O
104458,7224,of,O
104459,7224,hypotension,O
104460,7224,in,O
104461,7224,combination,O
104462,7224,with,O
104463,7224,alpha-1,O
104464,7224,blockers,O
104465,7224,",",O
104466,7224,but,O
104467,7224,will,O
104468,7224,be,O
104469,7224,allowed,O
104470,7224,at,O
104471,7224,half,O
104472,7224,the,O
104473,7224,usual,O
104474,7224,starting,O
104475,7224,dose,O
104476,7224,following,O
104477,7224,the,O
104478,7224,study,O
104479,7224,drug,O
104480,7224,dose,O
104481,7224,Titration,O
104482,7224,Period,O
104483,7224,",",O
104484,7224,per,O
104485,7224,VA,O
104486,7224,prescribing,O
104487,7224,guidelines,O
104488,7224,.,O
104489,7225,Use,O
104490,7225,of,O
104491,7225,supplements,O
104492,7225,containing,O
104493,7225,nitrates,B-Drug
104494,7225,and,O
104495,7225,supplements,O
104496,7225,containing,O
104497,7225,stimulants,B-Drug
104498,7225,(,O
104499,7225,such,O
104500,7225,as,O
104501,7225,ephedra,B-Drug
104502,7225,),O
104503,7225,are,O
104504,7225,exclusionary,O
104505,7225,in,O
104506,7225,the,O
104507,7225,two,O
104508,7225,weeks,O
104509,7225,prior,O
104510,7225,to,O
104511,7225,initial,O
104512,7225,screen,O
104513,7225,(,O
104514,7225,P1,O
104515,7225,),O
104516,7225,visit,O
104517,7225,and,O
104518,7225,prohibited,O
104519,7225,throughout,O
104520,7225,the,O
104521,7225,study,O
104522,7225,.,O
104523,7225,Participants,O
104524,7225,who,O
104525,7225,take,O
104526,7225,these,O
104527,7225,supplements,O
104528,7225,will,O
104529,7225,be,O
104530,7225,asked,O
104531,7225,to,O
104532,7225,discontinue,O
104533,7225,them,O
104534,7225,for,O
104535,7225,a,O
104536,7225,minimum,O
104537,7225,of,O
104538,7225,two,O
104539,7225,weeks,O
104540,7225,before,O
104541,7225,the,O
104542,7225,Preliminary,O
104543,7225,Screening,O
104544,7225,Period,O
104545,7225,(,O
104546,7225,P1,O
104547,7225,visit,O
104548,7225,),O
104549,7225,..,O
104550,7226,Use,O
104551,7226,of,O
104552,7226,prescribed,B-Drug
104553,7226,stimulants,I-Drug
104554,7226,(,O
104555,7226,such,O
104556,7226,as,O
104557,7226,amphetamine,B-Drug
104558,7226,or,O
104559,7226,dextroamphetamine,B-Drug
104560,7226,containing,O
104561,7226,medications,O
104562,7226,),O
104563,7226,is,O
104564,7226,exclusionary,O
104565,7226,in,O
104566,7226,the,O
104567,7226,2,O
104568,7226,weeks,O
104569,7226,prior,O
104570,7226,to,O
104571,7226,the,O
104572,7226,initial,O
104573,7226,screen,O
104574,7226,(,O
104575,7226,P1,O
104576,7226,),O
104577,7226,visit,O
104578,7226,and,O
104579,7226,prohibited,O
104580,7226,throughout,O
104581,7226,the,O
104582,7226,study,O
104583,7226,.,O
104584,7226,Participants,O
104585,7226,who,O
104586,7226,take,O
104587,7226,these,O
104588,7226,medications,O
104589,7226,will,O
104590,7226,be,O
104591,7226,asked,O
104592,7226,to,O
104593,7226,discontinue,O
104594,7226,them,O
104595,7226,for,O
104596,7226,a,O
104597,7226,minimum,O
104598,7226,of,O
104599,7226,2,O
104600,7226,weeks,O
104601,7226,before,O
104602,7226,the,O
104603,7226,Preliminary,O
104604,7226,Screening,O
104605,7226,Period,O
104606,7226,.,O
104607,7227,Male,B-Person
104608,7227,and,O
104609,7227,female,B-Person
104610,7227,Active,B-Person
104611,7227,-,I-Person
104612,7227,duty,I-Person
104613,7227,SMs,I-Person
104614,7227,or,O
104615,7227,Veterans,B-Person
104616,7227,aged,B-Person
104617,7227,18,O
104618,7227,or,O
104619,7227,older,O
104620,7227,who,O
104621,7227,are,O
104622,7227,in,O
104623,7227,good,B-Condition
104624,7227,general,I-Condition
104625,7227,health,I-Condition
104626,7227,.,O
104627,7228,History,B-Observation
104628,7228,of,I-Observation
104629,7228,blast,B-Observation
104630,7228,and/or,O
104631,7228,impact,B-Condition
104632,7228,head,I-Condition
104633,7228,trauma,I-Condition
104634,7228,mTBI,O
104635,7228,meeting,O
104636,7228,Defense,O
104637,7228,and,O
104638,7228,Veterans,O
104639,7228,Brain,O
104640,7228,Injury,O
104641,7228,Center,O
104642,7228,(,O
104643,7228,DVBIC,O
104644,7228,),O
104645,7228,mTBI,O
104646,7228,criteria,O
104647,7228,",",O
104648,7228,which,O
104649,7228,define,O
104650,7228,mTBI,O
104651,7228,as,O
104652,7228,an,O
104653,7228,injury,O
104654,7228,to,O
104655,7228,the,O
104656,7228,head,O
104657,7228,causing,O
104658,7228,at,O
104659,7228,least,O
104660,7228,one,O
104661,7228,of,O
104662,7228,the,O
104663,7228,following,O
104664,7228,:,O
104665,7228,alteration,B-Condition
104666,7228,in,I-Condition
104667,7228,consciousness,I-Condition
104668,7228,(,O
104669,7228,for,O
104670,7228,up,O
104671,7228,to,O
104672,7228,24,O
104673,7228,hours,O
104674,7228,after,O
104675,7228,the,O
104676,7228,injury,O
104677,7228,),O
104678,7228,",",O
104679,7228,loss,B-Condition
104680,7228,of,I-Condition
104681,7228,consciousness,I-Condition
104682,7228,0,O
104683,7228,-,O
104684,7228,30,O
104685,7228,minutes,O
104686,7228,",",O
104687,7228,and/or,O
104688,7228,post,B-Condition
104689,7228,-,I-Condition
104690,7228,traumatic,I-Condition
104691,7228,amnesia,I-Condition
104692,7228,up,O
104693,7228,to,O
104694,7228,1,O
104695,7228,day,O
104696,7228,post,O
104697,7228,-,O
104698,7228,injury,O
104699,7228,.,O
104700,7228,If,O
104701,7228,available,O
104702,7228,",",O
104703,7228,the,O
104704,7228,Glasgow,O
104705,7228,Coma,O
104706,7228,Scale,O
104707,7228,score,O
104708,7228,must,O
104709,7228,be,O
104710,7228,13,O
104711,7228,-,O
104712,7228,15,O
104713,7228,",",O
104714,7228,and,O
104715,7228,head,B-Procedure
104716,7228,imaging,I-Procedure
104717,7228,findings,B-Condition
104718,7228,(,O
104719,7228,if,O
104720,7228,imaging,O
104721,7228,was,O
104722,7228,performed,O
104723,7228,),O
104724,7228,must,O
104725,7228,be,O
104726,7228,negative,O
104727,7228,.,O
104728,7229,Frequent,O
104729,7229,HAs,B-Condition
104730,7229,that,O
104731,7229,started,O
104732,7229,within,O
104733,7229,3months,O
104734,7229,after,O
104735,7229,a,O
104736,7229,head,O
104737,7229,injury,O
104738,7229,.,O
104739,7229,The,O
104740,7229,HAs,B-Condition
104741,7229,either,O
104742,7229,1,O
104743,7229,),O
104744,7229,must,O
104745,7229,last,O
104746,7229,4,O
104747,7229,or,O
104748,7229,more,O
104749,7229,hours,O
104750,7229,a,O
104751,7229,day,O
104752,7229,and,O
104753,7229,reach,O
104754,7229,a,O
104755,7229,moderate,O
104756,7229,to,O
104757,7229,severe,O
104758,7229,intensity,O
104759,7229,at,O
104760,7229,any,O
104761,7229,point,O
104762,7229,during,O
104763,7229,the,O
104764,7229,headache,O
104765,7229,",",O
104766,7229,or,O
104767,7229,2,O
104768,7229,),O
104769,7229,may,O
104770,7229,be,O
104771,7229,of,O
104772,7229,any,O
104773,7229,severity,O
104774,7229,or,O
104775,7229,duration,O
104776,7229,if,O
104777,7229,the,O
104778,7229,participant,O
104779,7229,takes,O
104780,7229,a,O
104781,7229,triptan,B-Drug
104782,7229,or,O
104783,7229,ergotamine,B-Drug
104784,7229,.,O
104785,7229,HAs,O
104786,7229,meeting,O
104787,7229,these,O
104788,7229,criteria,O
104789,7229,must,O
104790,7229,have,O
104791,7229,been,O
104792,7229,present,O
104793,7229,on,O
104794,7229,average,O
104795,7229,at,O
104796,7229,least,O
104797,7229,8,O
104798,7229,days,O
104799,7229,per,O
104800,7229,4,O
104801,7229,-,O
104802,7229,week,O
104803,7229,period,O
104804,7229,",",O
104805,7229,starting,O
104806,7229,within,O
104807,7229,30,O
104808,7229,days,O
104809,7229,after,O
104810,7229,head,O
104811,7229,injury,O
104812,7229,and,O
104813,7229,occurring,O
104814,7229,by,O
104815,7229,self,O
104816,7229,-,O
104817,7229,report,O
104818,7229,for,O
104819,7229,at,O
104820,7229,least,O
104821,7229,3,O
104822,7229,months,O
104823,7229,prior,O
104824,7229,to,O
104825,7229,the,O
104826,7229,Initial,O
104827,7229,Screening,O
104828,7229,Visit,O
104829,7229,.,O
104830,7229,The,O
104831,7229,4,O
104832,7229,-,O
104833,7229,week,O
104834,7229,HA,O
104835,7229,frequency,O
104836,7229,/,O
104837,7229,severity,O
104838,7229,criteria,O
104839,7229,must,O
104840,7229,be,O
104841,7229,confirmed,O
104842,7229,during,O
104843,7229,the,O
104844,7229,Preliminary,O
104845,7229,Screening,O
104846,7229,Period,O
104847,7229,.,O
104848,7230,Women,O
104849,7230,of,O
104850,7230,childbearing,O
104851,7230,potential,O
104852,7230,must,O
104853,7230,agree,O
104854,7230,to,O
104855,7230,abstain,O
104856,7230,from,O
104857,7230,sexual,O
104858,7230,relations,O
104859,7230,that,O
104860,7230,could,O
104861,7230,result,O
104862,7230,in,O
104863,7230,pregnancy,O
104864,7230,or,O
104865,7230,use,O
104866,7230,an,O
104867,7230,effective,O
104868,7230,method,O
104869,7230,of,O
104870,7230,birth,O
104871,7230,control,O
104872,7230,acceptable,O
104873,7230,to,O
104874,7230,both,O
104875,7230,participant,O
104876,7230,and,O
104877,7230,the,O
104878,7230,clinician,O
104879,7230,prescriber,O
104880,7230,during,O
104881,7230,the,O
104882,7230,study,O
104883,7230,.,O
104884,7230,Men,O
104885,7230,are,O
104886,7230,not,O
104887,7230,required,O
104888,7230,to,O
104889,7230,use,O
104890,7230,contraception,O
104891,7230,during,O
104892,7230,the,O
104893,7230,study,O
104894,7230,.,O
104895,7231,Participants,O
104896,7231,must,O
104897,7231,have,O
104898,7231,English,O
104899,7231,fluency,O
104900,7231,sufficient,O
104901,7231,to,O
104902,7231,complete,O
104903,7231,study,O
104904,7231,measures,O
104905,7231,.,O
104906,7232,adequately,O
104907,7232,controlled,O
104908,7232,with,O
104909,7232,appropriate,O
104910,7232,therapy,O
104911,7232,or,O
104912,7232,would,O
104913,7232,compromise,O
104914,7232,the,O
104915,7232,patient,O
104916,7232,'s,O
104917,7232,ability,O
104918,7232,to,O
104919,7232,tolerate,O
104920,7232,this,O
104921,7232,therapy,O
104922,7232,;,O
104923,7232,2,O
104924,7232,.,O
104925,7232,Treatment,O
104926,7232,with,O
104927,7232,any,O
104928,7232,systemic,B-Procedure
104929,7232,anticancer,I-Procedure
104930,7232,therapy,I-Procedure
104931,7232,≤,O
104932,7232,3,O
104933,7232,weeks,O
104934,7232,prior,O
104935,7232,to,O
104936,7232,cycle,O
104937,7232,1,O
104938,7232,day,O
104939,7232,1,O
104940,7232,3,O
104941,7232,.,O
104942,7232,Uncontrolled,O
104943,7232,active,O
104944,7232,infection,B-Condition
104945,7232,(,O
104946,7232,Hepatitis,B-Condition
104947,7232,B,I-Condition
104948,7232,and,I-Condition
104949,7232,C,I-Condition
104950,7232,infection,I-Condition
104951,7232,are,O
104952,7232,NOT,O
104953,7232,exclusion,O
104954,7232,criteria,O
104955,7232,),O
104956,7232,and/or,O
104957,7232,known,O
104958,7232,HIV,B-Condition
104959,7232,infection,I-Condition
104960,7232,;,O
104961,7232,4,O
104962,7232,.,O
104963,7232,Renal,B-Condition
104964,7232,failure,I-Condition
104965,7232,requiring,O
104966,7232,haemodialysis,B-Procedure
104967,7232,or,O
104968,7232,peritoneal,B-Procedure
104969,7232,dialysis,I-Procedure
104970,7232,;,O
104971,7232,5,O
104972,7232,.,O
104973,7232,Patients,O
104974,7232,who,O
104975,7232,are,O
104976,7232,pregnant,B-Condition
104977,7232,or,O
104978,7232,breast,B-Condition
104979,7232,-,I-Condition
104980,7232,feeding,I-Condition
104981,7232,;,O
104982,7232,6,O
104983,7232,.,O
104984,7232,Patients,O
104985,7232,with,O
104986,7232,significantly,O
104987,7232,diseased,B-Condition
104988,7232,or,I-Condition
104989,7232,obstructed,I-Condition
104990,7232,gastrointestinal,I-Condition
104991,7232,tract,I-Condition
104992,7232,",",O
104993,7232,malabsorption,B-Condition
104994,7232,",",O
104995,7232,uncontrolled,O
104996,7232,vomiting,B-Condition
104997,7232,or,O
104998,7232,diarrhea,B-Condition
104999,7232,resulting,O
105000,7232,in,O
105001,7232,inability,B-Condition
105002,7232,to,I-Condition
105003,7232,swallow,I-Condition
105004,7232,oral,I-Condition
105005,7232,medications,I-Condition
105006,7232,;,O
105007,7232,7,O
105008,7232,.,O
105009,7232,Presence,O
105010,7232,of,O
105011,7232,symptomatic,O
105012,7232,CNS,B-Condition
105013,7232,metastasis,I-Condition
105014,7232,8,O
105015,7232,.,O
105016,7232,Unresolved,B-Condition
105017,7232,toxicity,I-Condition
105018,7232,from,O
105019,7232,previous,O
105020,7232,anti,B-Procedure
105021,7232,-,I-Procedure
105022,7232,cancer,I-Procedure
105023,7232,therapy,I-Procedure
105024,7232,or,O
105025,7232,incomplete,B-Condition
105026,7232,recovery,I-Condition
105027,7232,from,O
105028,7232,surgery,B-Procedure
105029,7232,",",O
105030,7232,in,O
105031,7232,particular,O
105032,7232,oxaliplatin,B-Drug
105033,7232,-,O
105034,7232,induced,O
105035,7232,peripheral,B-Condition
105036,7232,neuropathy,I-Condition
105037,7232,>,O
105038,7232,grade,O
105039,7232,1,O
105040,7232,.,O
105041,7233,9,O
105042,7233,.,O
105043,7233,Any,O
105044,7233,of,O
105045,7233,the,O
105046,7233,following,O
105047,7233,within,O
105048,7233,the,O
105049,7233,12,O
105050,7233,months,O
105051,7233,prior,O
105052,7233,to,O
105053,7233,study,O
105054,7233,drug,O
105055,7233,administration,O
105056,7233,:,O
105057,7233,myocardial,B-Condition
105058,7233,infarction,I-Condition
105059,7233,",",O
105060,7233,severe,B-Condition
105061,7233,/,I-Condition
105062,7233,unstable,I-Condition
105063,7233,angina,I-Condition
105064,7233,",",O
105065,7233,coronary,B-Condition
105066,7233,/,I-Condition
105067,7233,peripheral,I-Condition
105068,7233,artery,I-Condition
105069,7233,bypass,I-Condition
105070,7233,graft,I-Condition
105071,7233,",",O
105072,7233,symptomatic,B-Condition
105073,7233,congestive,I-Condition
105074,7233,heart,I-Condition
105075,7233,failure,I-Condition
105076,7233,",",O
105077,7233,cerebrovascular,B-Condition
105078,7233,accident,I-Condition
105079,7233,or,O
105080,7233,transient,B-Condition
105081,7233,ischemic,I-Condition
105082,7233,attack,I-Condition
105083,7233,",",O
105084,7233,pulmonary,B-Condition
105085,7233,embolism,I-Condition
105086,7233,",",O
105087,7233,deep,B-Condition
105088,7233,vein,I-Condition
105089,7233,thrombosis,I-Condition
105090,7233,",",O
105091,7233,or,O
105092,7233,other,B-Condition
105093,7233,thromboembolic,I-Condition
105094,7233,event,I-Condition
105095,7233,.,O
105096,7234,1,O
105097,7234,.,O
105098,7234,Patients,O
105099,7234,with,O
105100,7234,histologically,B-Procedure
105101,7234,confirmed,O
105102,7234,diagnosis,O
105103,7234,of,O
105104,7234,colorectal,B-Condition
105105,7234,cancer,I-Condition
105106,7234,presenting,O
105107,7234,with,O
105108,7234,unresectable,O
105109,7234,stage,O
105110,7234,IV,O
105111,7234,(,O
105112,7234,UICC,O
105113,7234,),O
105114,7234,disease,B-Condition
105115,7234,(,O
105116,7234,primary,O
105117,7234,tumor,O
105118,7234,may,O
105119,7234,be,O
105120,7234,present,O
105121,7234,),O
105122,7235,2,O
105123,7235,.,O
105124,7235,Patients,O
105125,7235,who,O
105126,7235,are,O
105127,7235,feasible,O
105128,7235,for,O
105129,7235,treatment,O
105130,7235,with,O
105131,7235,FOLFOX,B-Drug
105132,7235,(,O
105133,7235,prior,O
105134,7235,adjuvant,B-Procedure
105135,7235,or,I-Procedure
105136,7235,palliative,I-Procedure
105137,7235,treatment,I-Procedure
105138,7235,is,O
105139,7235,allowed,O
105140,7235,),O
105141,7236,3,O
105142,7236,.,O
105143,7236,ECOG,O
105144,7236,Performance,O
105145,7236,status,O
105146,7236,≤,O
105147,7236,1,O
105148,7237,4,O
105149,7237,.,O
105150,7237,Life,B-Observation
105151,7237,expectancy,I-Observation
105152,7237,>,O
105153,7237,3,O
105154,7237,months,O
105155,7238,5,O
105156,7238,.,O
105157,7238,Age,B-Person
105158,7238,≥18,O
105159,7238,years,O
105160,7239,6,O
105161,7239,.,O
105162,7239,Haematologic,O
105163,7239,function,O
105164,7239,as,O
105165,7239,follows,O
105166,7239,(,O
105167,7239,5,O
105168,7239,%,O
105169,7239,deviation,O
105170,7239,allowed,O
105171,7239,):,O
105172,7240,ANC,O
105173,7240,≥,O
105174,7240,1.5,O
105175,7240,x,O
105176,7240,109,O
105177,7240,/,O
105178,7240,L,O
105179,7241,platelets,O
105180,7241,≥,O
105181,7241,100,O
105182,7241,x109,O
105183,7241,/,O
105184,7241,L,O
105185,7242,hemoglobin,O
105186,7242,≥,O
105187,7242,9,O
105188,7242,g,O
105189,7242,/,O
105190,7242,dl,O
105191,7242,or,O
105192,7242,5.59,O
105193,7242,mmol,O
105194,7242,/,O
105195,7242,l,O
105196,7243,7,O
105197,7243,.,O
105198,7243,Adequate,O
105199,7243,liver,O
105200,7243,function,O
105201,7243,as,O
105202,7243,follows,O
105203,7243,(,O
105204,7243,10,O
105205,7243,%,O
105206,7243,deviation,O
105207,7243,allowed,O
105208,7243,),O
105209,7244,serum,O
105210,7244,alanine,O
105211,7244,transaminase,O
105212,7244,(,O
105213,7244,ALT,O
105214,7244,),O
105215,7244,≤,O
105216,7244,2.5,O
105217,7244,x,O
105218,7244,ULN,O
105219,7244,(,O
105220,7244,in,O
105221,7244,case,O
105222,7244,of,O
105223,7244,liver,B-Condition
105224,7244,metastases,I-Condition
105225,7244,<,O
105226,7244,5,O
105227,7244,x,O
105228,7244,ULN,O
105229,7244,),O
105230,7245,total,O
105231,7245,bilirubin,O
105232,7245,≤,O
105233,7245,1.5,O
105234,7245,x,O
105235,7245,ULN,O
105236,7245,(,O
105237,7245,patients,O
105238,7245,with,O
105239,7245,Gilbert,B-Condition
105240,7245,'s,I-Condition
105241,7245,syndrome,I-Condition
105242,7245,total,O
105243,7245,bilirubin,O
105244,7245,≤2.5,O
105245,7245,x,O
105246,7245,ULN,O
105247,7245,),O
105248,7246,8,O
105249,7246,.,O
105250,7246,Adequate,O
105251,7246,renal,O
105252,7246,function,O
105253,7246,as,O
105254,7246,follows,O
105255,7246,(,O
105256,7246,10,O
105257,7246,%,O
105258,7246,deviation,O
105259,7246,allowed,O
105260,7246,),O
105261,7247,·,O
105262,7247,creatinine,O
105263,7247,≤,O
105264,7247,1.5,O
105265,7247,x,O
105266,7247,ULN,O
105267,7248,9,O
105268,7248,.,O
105269,7248,Signed,O
105270,7248,written,O
105271,7248,informed,O
105272,7248,consent,O
105273,7249,10,O
105274,7249,.,O
105275,7249,Women,B-Person
105276,7249,of,O
105277,7249,child,B-Condition
105278,7249,-,I-Condition
105279,7249,bearing,I-Condition
105280,7249,potential,I-Condition
105281,7249,must,O
105282,7249,have,O
105283,7249,a,O
105284,7249,negative,O
105285,7249,pregnancy,O
105286,7249,test,O
105287,7250,Moderate,O
105288,7250,or,O
105289,7250,severe,O
105290,7250,endometriosis,B-Condition
105291,7250,.,O
105292,7251,Hydrosalpinx,B-Condition
105293,7251,.,O
105294,7252,Uterine,B-Condition
105295,7252,abnormalities,I-Condition
105296,7252,or,O
105297,7252,myoma,B-Condition
105298,7252,.,O
105299,7253,Previous,O
105300,7253,uterine,B-Procedure
105301,7253,surgery,I-Procedure
105302,7253,.,O
105303,7254,Women,B-Person
105304,7254,with,O
105305,7254,PCOS,B-Condition
105306,7254,as,O
105307,7254,defined,O
105308,7254,by,O
105309,7254,the,O
105310,7254,Rotterdam,O
105311,7254,criteria,O
105312,7254,.,O
105313,7255,Presence,O
105314,7255,of,O
105315,7255,at,O
105316,7255,least,O
105317,7255,2,O
105318,7255,cryopreserved,O
105319,7255,good,O
105320,7255,quality,O
105321,7255,cleavage,B-Observation
105322,7255,-,I-Observation
105323,7255,stage,I-Observation
105324,7255,embryo,I-Observation
105325,7255,(,O
105326,7255,good,O
105327,7255,quality,O
105328,7255,cleavage,O
105329,7255,-,O
105330,7255,stage,O
105331,7255,embryos,O
105332,7255,display,O
105333,7255,stage,O
105334,7255,-,O
105335,7255,specific,O
105336,7255,cell,O
105337,7255,division,O
105338,7255,",",O
105339,7255,have,O
105340,7255,blastomeres,O
105341,7255,of,O
105342,7255,fairly,O
105343,7255,equal,O
105344,7255,size,O
105345,7255,with,O
105346,7255,few,O
105347,7255,to,O
105348,7255,no,O
105349,7255,cytoplasmic,O
105350,7255,fragments,O
105351,7255,),O
105352,7255,.,O
105353,7256,asthma,B-Condition
105354,7256,and,O
105355,7256,COPD,B-Condition
105356,7257,asthma,B-Condition
105357,7257,or,O
105358,7257,COPD,B-Condition
105359,7258,Patients,O
105360,7258,with,O
105361,7258,liver,B-Condition
105362,7258,cirrhosis,I-Condition
105363,7258,",",O
105364,7258,Hepatocellular,B-Condition
105365,7258,Carcinoma,I-Condition
105366,7258,or,O
105367,7258,AFP,O
105368,7258,>,O
105369,7258,2,O
105370,7258,ULN,O
105371,7258,or,O
105372,7258,other,O
105373,7258,malignancies,B-Condition
105374,7258,.,O
105375,7259,Patients,O
105376,7259,with,O
105377,7259,other,O
105378,7259,factors,O
105379,7259,causing,O
105380,7259,liver,B-Condition
105381,7259,diseases,I-Condition
105382,7259,.,O
105383,7260,Pregnant,O
105384,7260,and,O
105385,7260,lactating,O
105386,7260,women,O
105387,7260,.,O
105388,7261,Patients,O
105389,7261,with,O
105390,7261,concomitant,O
105391,7261,HIV,B-Condition
105392,7261,infection,I-Condition
105393,7261,or,O
105394,7261,congenital,B-Condition
105395,7261,immune,I-Condition
105396,7261,deficiency,I-Condition
105397,7261,diseases,I-Condition
105398,7261,.,O
105399,7262,Patients,O
105400,7262,with,O
105401,7262,diabetes,B-Condition
105402,7262,",",O
105403,7262,autoimmune,B-Condition
105404,7262,diseases,I-Condition
105405,7262,.,O
105406,7263,Patients,O
105407,7263,with,O
105408,7263,important,O
105409,7263,organ,B-Condition
105410,7263,dysfunctions,I-Condition
105411,7263,.,O
105412,7264,Patients,O
105413,7264,with,O
105414,7264,serious,O
105415,7264,complications,B-Condition
105416,7264,(,O
105417,7264,e.g.,O
105418,7264,",",O
105419,7264,infection,B-Condition
105420,7264,",",O
105421,7264,hepatic,B-Condition
105422,7264,encephalopathy,I-Condition
105423,7264,",",O
105424,7264,hepatorenal,B-Condition
105425,7264,syndrome,I-Condition
105426,7264,",",O
105427,7264,gastrointestinal,B-Condition
105428,7264,bleeding,I-Condition
105429,7264,.,O
105430,7264,),O
105431,7265,Patients,O
105432,7265,who,O
105433,7265,receive,O
105434,7265,antineoplastic,B-Procedure
105435,7265,or,I-Procedure
105436,7265,immunomodulatory,I-Procedure
105437,7265,therapy,I-Procedure
105438,7265,in,O
105439,7265,the,O
105440,7265,past,O
105441,7265,12,O
105442,7265,months,O
105443,7265,.,O
105444,7266,Patients,O
105445,7266,with,O
105446,7266,a,O
105447,7266,previous,O
105448,7266,use,O
105449,7266,of,O
105450,7266,IFN,B-Drug
105451,7266,anti,O
105452,7266,hepatitis,O
105453,7266,B,O
105454,7266,virus,O
105455,7266,treatment,O
105456,7266,or,O
105457,7266,have,O
105458,7266,NAs,B-Drug
105459,7266,drug,I-Drug
105460,7266,resistance,B-Condition
105461,7266,.,O
105462,7267,Patients,O
105463,7267,who,O
105464,7267,ca,O
105465,7267,n't,O
105466,7267,come,O
105467,7267,back,O
105468,7267,to,O
105469,7267,clinic,O
105470,7267,for,O
105471,7267,follow,O
105472,7267,-,O
105473,7267,up,O
105474,7267,on,O
105475,7267,schedule,O
105476,7267,.,O
105477,7268,CHB,B-Condition
105478,7268,patients,O
105479,7268,who,O
105480,7268,had,O
105481,7268,received,O
105482,7268,single,O
105483,7268,NAs,B-Drug
105484,7268,for,O
105485,7268,more,O
105486,7268,than,O
105487,7268,12,O
105488,7268,months,O
105489,7268,.,O
105490,7269,Hepatitis,O
105491,7269,B,O
105492,7269,e,O
105493,7269,antigen,O
105494,7269,(,O
105495,7269,HBeAg)-negative,O
105496,7269,.,O
105497,7270,Hepatitis,O
105498,7270,B,O
105499,7270,surface,O
105500,7270,antigen,O
105501,7270,(,O
105502,7270,HBsAg,O
105503,7270,),O
105504,7270,positive,O
105505,7270,and,O
105506,7270,<,O
105507,7270,1000,O
105508,7270,IU,O
105509,7270,/,O
105510,7270,mL.,O
105511,7271,Hepatitis,O
105512,7271,B,O
105513,7271,virus,O
105514,7271,DNA,O
105515,7271,<,O
105516,7271,100,O
105517,7271,IU,O
105518,7271,/,O
105519,7271,mL.,O
105520,7272,Inadequate,B-Condition
105521,7272,bone,I-Condition
105522,7272,marrow,I-Condition
105523,7272,reserve,I-Condition
105524,7273,history,B-Observation
105525,7273,of,O
105526,7273,poorly,B-Condition
105527,7273,controlled,I-Condition
105528,7273,hypertension,I-Condition
105529,7274,histologically,O
105530,7274,confirmed,O
105531,7274,metastatic,B-Condition
105532,7274,cancer,I-Condition
105533,7274,that,O
105534,7274,is,O
105535,7274,not,O
105536,7274,amenable,O
105537,7274,to,O
105538,7274,surgery,B-Procedure
105539,7274,or,O
105540,7274,radiation,B-Procedure
105541,7274,therapy,I-Procedure
105542,7274,with,O
105543,7274,curative,O
105544,7274,intent,O
105545,7275,measurable,B-Condition
105546,7275,lesion,I-Condition
105547,7275,by,O
105548,7275,CT,B-Procedure
105549,7275,or,O
105550,7275,other,O
105551,7275,techniques,O
105552,7275,according,O
105553,7275,to,O
105554,7275,RECIST,O
105555,7276,1,O
105556,7276,.,O
105557,7276,High,B-Condition
105558,7276,risk,I-Condition
105559,7276,profiles,I-Condition
105560,7276,for,O
105561,7276,ischemic,B-Condition
105562,7276,adverse,I-Condition
105563,7276,events,I-Condition
105564,7276,such,O
105565,7276,as,O
105566,7276,A.,O
105567,7276,ST,B-Condition
105568,7276,-,I-Condition
105569,7276,segment,I-Condition
105570,7276,elevation,I-Condition
105571,7276,myocardial,I-Condition
105572,7276,infarction,I-Condition
105573,7276,(,I-Condition
105574,7276,STEMI,I-Condition
105575,7276,),I-Condition
105576,7276,B.,O
105577,7276,Patients,O
105578,7276,with,O
105579,7276,cardiogenic,B-Condition
105580,7276,shock,I-Condition
105581,7276,or,O
105582,7276,concomitant,O
105583,7276,severe,O
105584,7276,decompensated,O
105585,7276,heart,B-Condition
105586,7276,failure,I-Condition
105587,7276,C.,O
105588,7276,Myocardial,B-Condition
105589,7276,infarction,I-Condition
105590,7276,or,O
105591,7276,stent,B-Condition
105592,7276,thrombosis,I-Condition
105593,7276,in,O
105594,7276,spite,O
105595,7276,of,O
105596,7276,the,O
105597,7276,maintenance,O
105598,7276,of,O
105599,7276,antiplatelet,B-Drug
105600,7276,therapy,I-Drug
105601,7276,D.,O
105602,7276,Restenosis,B-Condition
105603,7276,in,O
105604,7276,stented,O
105605,7276,segments,O
105606,7276,or,O
105607,7276,previous,O
105608,7276,sites,O
105609,7276,of,O
105610,7276,balloon,O
105611,7276,angioplasty,O
105612,7276,2,O
105613,7276,.,O
105614,7276,Patients,O
105615,7276,who,O
105616,7276,can,B-Condition
105617,7276,not,I-Condition
105618,7276,follow,I-Condition
105619,7276,allocated,I-Condition
105620,7276,DAPT,I-Condition
105621,7276,schedule,I-Condition
105622,7276,due,O
105623,7276,to,O
105624,7276,the,O
105625,7276,planned,B-Mood
105626,7276,surgery,B-Procedure
105627,7276,or,O
105628,7276,elective,O
105629,7276,procedure,B-Procedure
105630,7276,within,O
105631,7276,3,O
105632,7276,months,O
105633,7276,after,O
105634,7276,the,O
105635,7276,stenting,O
105636,7276,3,O
105637,7276,.,O
105638,7276,Recent,O
105639,7276,history,O
105640,7276,of,O
105641,7276,major,B-Procedure
105642,7276,surgery,I-Procedure
105643,7276,or,O
105644,7276,evident,O
105645,7276,events,B-Condition
105646,7276,of,I-Condition
105647,7276,gastrointestinal,I-Condition
105648,7276,bleeding,I-Condition
105649,7276,within,O
105650,7276,1,O
105651,7276,month,O
105652,7276,from,O
105653,7276,the,O
105654,7276,procedure,O
105655,7276,4,O
105656,7276,.,O
105657,7276,Patients,O
105658,7276,on,O
105659,7276,anticoagulation,B-Procedure
105660,7276,therapy,I-Procedure
105661,7276,with,O
105662,7276,warfarin,B-Drug
105663,7276,or,O
105664,7276,other,O
105665,7276,anticoagulants,B-Drug
105666,7276,5,O
105667,7276,.,O
105668,7276,Life,B-Observation
105669,7276,expectancy,I-Observation
105670,7276,less,O
105671,7276,than,O
105672,7276,1,O
105673,7276,year,O
105674,7276,(,O
105675,7276,such,O
105676,7276,as,O
105677,7276,malignancies,B-Condition
105678,7276,or,O
105679,7276,other,O
105680,7276,chronic,B-Condition
105681,7276,systemic,I-Condition
105682,7276,diseases,I-Condition
105683,7276,),O
105684,7276,6,O
105685,7276,.,O
105686,7276,Pregnant,B-Condition
105687,7276,women,B-Person
105688,7276,7,O
105689,7276,.,O
105690,7276,Past,O
105691,7276,history,O
105692,7276,of,O
105693,7276,allergy,B-Condition
105694,7276,or,O
105695,7276,other,O
105696,7276,contraindications,B-Condition
105697,7276,for,O
105698,7276,the,O
105699,7276,following,O
105700,7276,medications,O
105701,7276,/,O
105702,7276,materials,O
105703,7276,:,O
105704,7276,aspirin,B-Drug
105705,7276,",",O
105706,7276,clopidogrel,B-Drug
105707,7276,",",O
105708,7276,heparin,B-Drug
105709,7276,",",O
105710,7276,cobalt,B-Drug
105711,7276,chromium,I-Drug
105712,7276,",",O
105713,7276,sirolimus,B-Drug
105714,7277,Patients,O
105715,7277,with,O
105716,7277,de,O
105717,7277,novo,O
105718,7277,stenotic,B-Condition
105719,7277,lesions,I-Condition
105720,7277,who,O
105721,7277,are,O
105722,7277,suitable,B-Mood
105723,7277,for,O
105724,7277,coronary,B-Procedure
105725,7277,stenting,I-Procedure
105726,7277,with,O
105727,7277,drug,O
105728,7277,-,O
105729,7277,eluting,O
105730,7277,stent,O
105731,7278,Significant,O
105732,7278,motor,B-Condition
105733,7278,complication,I-Condition
105734,7278,affecting,O
105735,7278,daily,O
105736,7278,activities,O
105737,7279,Drugs,B-Drug
105738,7279,related,O
105739,7279,to,O
105740,7279,acetylcholine,B-Drug
105741,7279,metabolism,O
105742,7280,Parkinson,B-Condition
105743,7280,disease,I-Condition
105744,7280,diagnosed,O
105745,7280,by,O
105746,7280,United,O
105747,7280,Kingdom,O
105748,7280,Parkinson,O
105749,7280,'s,O
105750,7280,disease,O
105751,7280,Society,O
105752,7280,Brain,O
105753,7280,Bank,O
105754,7280,Criteria,O
105755,7281,Postural,B-Condition
105756,7281,instability,I-Condition
105757,7281,and,O
105758,7281,gait,B-Condition
105759,7281,disturbance,I-Condition
105760,7281,phenotype,O
105761,7282,Hoehn,O
105762,7282,and,O
105763,7282,Yahr,O
105764,7282,stage,O
105765,7282,=,O
105766,7282,3,O
105767,7283,Mini,O
105768,7283,-,O
105769,7283,Mental,O
105770,7283,status,O
105771,7283,examination,O
105772,7283,=,O
105773,7283,24,O
105774,7284,Previous,O
105775,7284,surgical,O
105776,7284,or,O
105777,7284,catheter,B-Procedure
105778,7284,ablation,I-Procedure
105779,7284,for,O
105780,7284,atrial,B-Condition
105781,7284,fibrillation,I-Condition
105782,7285,Previous,O
105783,7285,cardiac,B-Procedure
105784,7285,surgery,I-Procedure
105785,7285,(,O
105786,7285,including,O
105787,7285,CABG,B-Procedure
105788,7285,),O
105789,7285,within,O
105790,7285,the,O
105791,7285,past,O
105792,7285,6,O
105793,7285,months,O
105794,7285,(,O
105795,7285,180,O
105796,7285,days,O
105797,7285,),O
105798,7286,Valvular,B-Procedure
105799,7286,cardiac,I-Procedure
105800,7286,surgical,I-Procedure
105801,7286,/,I-Procedure
105802,7286,percutaneous,I-Procedure
105803,7286,procedure,I-Procedure
105804,7286,(,O
105805,7286,i.e.,O
105806,7286,",",O
105807,7286,ventriculotomy,B-Procedure
105808,7286,",",O
105809,7286,atriotomy,B-Procedure
105810,7286,",",O
105811,7286,and,O
105812,7286,valve,B-Procedure
105813,7286,repair,I-Procedure
105814,7286,or,I-Procedure
105815,7286,replacement,I-Procedure
105816,7286,and,O
105817,7286,presence,O
105818,7286,of,O
105819,7286,a,O
105820,7286,prosthetic,O
105821,7286,valve,O
105822,7286,),O
105823,7287,Any,O
105824,7287,carotid,O
105825,7287,stenting,O
105826,7287,or,O
105827,7287,endarterectomy,B-Procedure
105828,7288,Documented,O
105829,7288,LA,B-Condition
105830,7288,thrombus,I-Condition
105831,7288,on,O
105832,7288,imaging,B-Procedure
105833,7289,LA,O
105834,7289,size,O
105835,7289,>,O
105836,7289,50,O
105837,7289,mm,O
105838,7289,(,O
105839,7289,parasternal,O
105840,7289,long,O
105841,7289,axis,O
105842,7289,view,O
105843,7289,),O
105844,7290,LVEF,O
105845,7290,<,O
105846,7290,40,O
105847,7290,%,O
105848,7291,Contraindication,B-Condition
105849,7291,to,O
105850,7291,anticoagulation,B-Drug
105851,7291,(,O
105852,7291,heparin,B-Drug
105853,7291,or,O
105854,7291,warfarin,B-Drug
105855,7291,),O
105856,7292,History,B-Observation
105857,7292,of,O
105858,7292,blood,B-Condition
105859,7292,clotting,I-Condition
105860,7292,or,O
105861,7292,bleeding,B-Condition
105862,7292,abnormalities,I-Condition
105863,7293,PCI,B-Procedure
105864,7293,/,O
105865,7293,MI,B-Condition
105866,7293,within,O
105867,7293,the,O
105868,7293,past,O
105869,7293,2,O
105870,7293,months,O
105871,7293,(,O
105872,7293,60,O
105873,7293,days,O
105874,7293,),O
105875,7294,Documented,O
105876,7294,thromboembolic,B-Condition
105877,7294,event,I-Condition
105878,7294,(,O
105879,7294,including,O
105880,7294,TIA,B-Condition
105881,7294,),O
105882,7294,within,O
105883,7294,the,O
105884,7294,past,O
105885,7294,12,O
105886,7294,months,O
105887,7294,(,O
105888,7294,365,O
105889,7294,days,O
105890,7294,),O
105891,7295,Rheumatic,B-Condition
105892,7295,Heart,I-Condition
105893,7295,Disease,I-Condition
105894,7296,Uncontrolled,O
105895,7296,heart,B-Condition
105896,7296,failure,I-Condition
105897,7296,or,O
105898,7296,NYHA,O
105899,7296,function,O
105900,7296,class,O
105901,7296,III,O
105902,7296,or,O
105903,7296,IV,O
105904,7297,Severe,O
105905,7297,mitral,B-Condition
105906,7297,regurgitation,I-Condition
105907,7297,(,O
105908,7297,Regurgitant,O
105909,7297,volume,O
105910,7297,=,O
105911,7297,60,O
105912,7297,mL,O
105913,7297,/,O
105914,7297,beat,O
105915,7297,",",O
105916,7297,Regurgitant,O
105917,7297,fraction,O
105918,7297,=,O
105919,7297,50,O
105920,7297,%,O
105921,7297,",",O
105922,7297,and/or,O
105923,7297,Effective,O
105924,7297,regurgitant,O
105925,7297,orifice,O
105926,7297,area,O
105927,7297,=,O
105928,7297,0.40cm2,O
105929,7297,),O
105930,7298,Awaiting,O
105931,7298,cardiac,B-Procedure
105932,7298,transplantation,I-Procedure
105933,7298,or,O
105934,7298,other,O
105935,7298,cardiac,B-Procedure
105936,7298,surgery,I-Procedure
105937,7298,within,O
105938,7298,the,O
105939,7298,next,O
105940,7298,12,O
105941,7298,months,O
105942,7298,(,O
105943,7298,365,O
105944,7298,days,O
105945,7298,),O
105946,7299,Unstable,B-Condition
105947,7299,angina,I-Condition
105948,7300,Acute,B-Condition
105949,7300,illness,I-Condition
105950,7300,or,O
105951,7300,active,O
105952,7300,systemic,B-Condition
105953,7300,infection,I-Condition
105954,7300,or,O
105955,7300,sepsis,B-Condition
105956,7301,AF,B-Condition
105957,7301,secondary,O
105958,7301,to,O
105959,7301,electrolyte,B-Condition
105960,7301,imbalance,I-Condition
105961,7301,",",O
105962,7301,thyroid,B-Condition
105963,7301,disease,I-Condition
105964,7301,",",O
105965,7301,or,O
105966,7301,reversible,O
105967,7301,or,O
105968,7301,non,B-Condition
105969,7301,-,I-Condition
105970,7301,cardiac,I-Condition
105971,7301,cause,I-Condition
105972,7301,.,O
105973,7302,Presence,O
105974,7302,of,O
105975,7302,implanted,O
105976,7302,ICD,O
105977,7302,/,O
105978,7302,CRT,O
105979,7302,-,O
105980,7302,D.,O
105981,7303,Significant,O
105982,7303,pulmonary,B-Condition
105983,7303,disease,I-Condition
105984,7303,",",O
105985,7303,(,O
105986,7303,e.g.,O
105987,7303,",",O
105988,7303,restrictive,B-Condition
105989,7303,pulmonary,I-Condition
105990,7303,disease,I-Condition
105991,7303,",",O
105992,7303,constrictive,B-Condition
105993,7303,or,I-Condition
105994,7303,chronic,I-Condition
105995,7303,obstructive,I-Condition
105996,7303,pulmonary,I-Condition
105997,7303,disease,I-Condition
105998,7303,),O
105999,7303,or,O
106000,7303,any,O
106001,7303,other,O
106002,7303,disease,B-Condition
106003,7303,or,I-Condition
106004,7303,malfunction,I-Condition
106005,7303,of,I-Condition
106006,7303,the,I-Condition
106007,7303,lungs,I-Condition
106008,7303,or,I-Condition
106009,7303,respiratory,I-Condition
106010,7303,system,I-Condition
106011,7303,that,O
106012,7303,produces,O
106013,7303,chronic,B-Condition
106014,7303,symptoms,I-Condition
106015,7303,.,O
106016,7304,Gastroesophageal,B-Condition
106017,7304,Reflux,I-Condition
106018,7304,Disease,I-Condition
106019,7304,(,O
106020,7304,GERD,B-Condition
106021,7304,;,O
106022,7304,active,O
106023,7304,requiring,O
106024,7304,significant,B-Procedure
106025,7304,intervention,I-Procedure
106026,7304,not,O
106027,7304,including,O
106028,7304,OTC,B-Drug
106029,7304,medication,I-Drug
106030,7304,),O
106031,7305,Significant,O
106032,7305,congenital,B-Condition
106033,7305,anomaly,I-Condition
106034,7305,or,O
106035,7305,medical,B-Condition
106036,7305,problem,I-Condition
106037,7305,that,O
106038,7305,in,O
106039,7305,the,O
106040,7305,opinion,O
106041,7305,of,O
106042,7305,the,O
106043,7305,investigator,O
106044,7305,would,O
106045,7305,preclude,O
106046,7305,enrollment,O
106047,7305,in,O
106048,7305,this,O
106049,7305,study,O
106050,7305,.,O
106051,7306,Women,B-Person
106052,7306,who,O
106053,7306,are,O
106054,7306,pregnant,B-Condition
106055,7306,(,O
106056,7306,as,O
106057,7306,evidenced,O
106058,7306,by,O
106059,7306,pregnancy,B-Procedure
106060,7306,test,I-Procedure
106061,7306,if,O
106062,7306,pre,B-Condition
106063,7306,-,I-Condition
106064,7306,menopausal,I-Condition
106065,7306,),O
106066,7307,Concurrent,O
106067,7307,enrollment,O
106068,7307,in,O
106069,7307,an,O
106070,7307,investigational,O
106071,7307,study,O
106072,7307,evaluating,O
106073,7307,another,O
106074,7307,device,O
106075,7307,",",O
106076,7307,biologic,O
106077,7307,",",O
106078,7307,or,O
106079,7307,drug,O
106080,7307,.,O
106081,7308,Presence,O
106082,7308,of,O
106083,7308,intracardiac,B-Condition
106084,7308,thrombus,I-Condition
106085,7308,",",O
106086,7308,myxoma,B-Condition
106087,7308,",",O
106088,7308,tumor,B-Condition
106089,7308,",",O
106090,7308,interatrial,B-Condition
106091,7308,baffle,I-Condition
106092,7308,or,O
106093,7308,patch,O
106094,7308,or,O
106095,7308,other,O
106096,7308,abnormality,B-Condition
106097,7308,that,O
106098,7308,precludes,B-Condition
106099,7308,vascular,B-Procedure
106100,7308,access,I-Procedure
106101,7308,",",O
106102,7308,or,O
106103,7308,manipulation,B-Procedure
106104,7308,of,I-Procedure
106105,7308,the,I-Procedure
106106,7308,catheter,I-Procedure
106107,7308,.,O
106108,7309,Life,B-Observation
106109,7309,expectancy,I-Observation
106110,7309,less,O
106111,7309,than,O
106112,7309,12,O
106113,7309,months,O
106114,7310,Symptomatic,O
106115,7310,paroxysmal,B-Condition
106116,7310,AF,I-Condition
106117,7310,who,O
106118,7310,had,O
106119,7310,at,O
106120,7310,least,O
106121,7310,one,O
106122,7310,AF,B-Condition
106123,7310,episode,I-Condition
106124,7310,electrocardiographically,B-Procedure
106125,7310,documented,O
106126,7310,within,O
106127,7310,one,O
106128,7310,(,O
106129,7310,1,O
106130,7310,),O
106131,7310,year,O
106132,7310,prior,O
106133,7310,to,O
106134,7310,enrollment,O
106135,7310,.,O
106136,7310,Documentation,O
106137,7310,may,O
106138,7310,include,O
106139,7310,electrocardiogram,B-Procedure
106140,7310,(,I-Procedure
106141,7310,ECG,I-Procedure
106142,7310,),I-Procedure
106143,7310,;,O
106144,7310,Transtelephonic,B-Procedure
106145,7310,monitoring,I-Procedure
106146,7310,(,I-Procedure
106147,7310,TTM,I-Procedure
106148,7310,),I-Procedure
106149,7310,",",O
106150,7310,Holter,B-Procedure
106151,7310,monitor,I-Procedure
106152,7310,or,O
106153,7310,telemetry,B-Procedure
106154,7310,strip,I-Procedure
106155,7311,Failed,O
106156,7311,at,O
106157,7311,least,O
106158,7311,one,O
106159,7311,antiarrhythmic,B-Drug
106160,7311,drug,I-Drug
106161,7311,(,I-Drug
106162,7311,AAD,I-Drug
106163,7311,),I-Drug
106164,7311,(,O
106165,7311,Class,B-Drug
106166,7311,I,I-Drug
106167,7311,or,I-Drug
106168,7311,III,I-Drug
106169,7311,antiarrhythmic,I-Drug
106170,7311,drugs,I-Drug
106171,7311,),O
106172,7311,as,O
106173,7311,evidenced,O
106174,7311,by,O
106175,7311,recurrent,B-Condition
106176,7311,symptomatic,I-Condition
106177,7311,AF,I-Condition
106178,7311,",",O
106179,7311,or,O
106180,7311,intolerable,B-Condition
106181,7311,to,O
106182,7311,the,O
106183,7311,AAD,B-Condition
106184,7312,Age,B-Person
106185,7312,18,O
106186,7312,years,O
106187,7312,or,O
106188,7312,older,O
106189,7313,Signed,O
106190,7313,Patient,O
106191,7313,Informed,O
106192,7313,Consent,O
106193,7313,Form,O
106194,7313,(,O
106195,7313,ICF,O
106196,7313,),O
106197,7314,Able,O
106198,7314,and,O
106199,7314,willing,O
106200,7314,to,O
106201,7314,comply,O
106202,7314,with,O
106203,7314,all,O
106204,7314,pre-,O
106205,7314,",",O
106206,7314,post-,O
106207,7314,",",O
106208,7314,and,O
106209,7314,follow,O
106210,7314,-,O
106211,7314,up,O
106212,7314,testing,O
106213,7314,and,O
106214,7314,requirements,O
106215,7315,Visible,O
106216,7315,skin,B-Condition
106217,7315,pathology,I-Condition
106218,7315,",",O
106219,7315,excessive,O
106220,7315,freckles,B-Condition
106221,7315,",",O
106222,7315,or,O
106223,7315,skin,B-Condition
106224,7315,blemishes,I-Condition
106225,7315,in,O
106226,7315,the,O
106227,7315,test,O
106228,7315,area,O
106229,7315,.,O
106230,7316,History,O
106231,7316,of,O
106232,7316,skin,B-Condition
106233,7316,disease,I-Condition
106234,7316,or,O
106235,7316,hypersensitivity,B-Condition
106236,7316,and,O
106237,7316,repeated,O
106238,7316,contact,B-Condition
106239,7316,allergies,I-Condition
106240,7316,.,O
106241,7317,Sarcoma,B-Condition
106242,7317,or,O
106243,7317,squamous,B-Condition
106244,7317,cell,I-Condition
106245,7317,histology,B-Procedure
106246,7317,.,O
106247,7318,Metastatic,B-Condition
106248,7318,disease,I-Condition
106249,7318,to,O
106250,7318,the,O
106251,7318,breast,O
106252,7318,.,O
106253,7319,Current,O
106254,7319,tobacco,B-Observation
106255,7319,use,I-Observation
106256,7319,.,O
106257,7320,Must,O
106258,7320,have,O
106259,7320,pathologically,B-Procedure
106260,7320,confirmed,O
106261,7320,invasive,B-Condition
106262,7320,adenocarcinoma,I-Condition
106263,7320,or,O
106264,7320,ductal,B-Condition
106265,7320,carcinoma,I-Condition
106266,7320,in,I-Condition
106267,7320,situ,I-Condition
106268,7320,of,O
106269,7320,the,O
106270,7320,breast,O
106271,7320,.,O
106272,7321,Patients,O
106273,7321,must,O
106274,7321,have,O
106275,7321,undergone,O
106276,7321,segmental,B-Procedure
106277,7321,mastectomy,I-Procedure
106278,7321,(,O
106279,7321,i.e.,O
106280,7321,",",O
106281,7321,lumpectomy,B-Procedure
106282,7321,),O
106283,7321,.,O
106284,7322,Patients,O
106285,7322,must,O
106286,7322,not,O
106287,7322,have,O
106288,7322,received,O
106289,7322,prior,O
106290,7322,radiation,B-Procedure
106291,7322,therapy,I-Procedure
106292,7322,to,O
106293,7322,the,O
106294,7322,breast,O
106295,7322,.,O
106296,7323,Patients,O
106297,7323,must,O
106298,7323,not,O
106299,7323,have,O
106300,7323,active,O
106301,7323,local,B-Condition
106302,7323,-,I-Condition
106303,7323,regional,I-Condition
106304,7323,disease,I-Condition
106305,7323,prior,O
106306,7323,to,O
106307,7323,registration,O
106308,7323,.,O
106309,7324,Patients,O
106310,7324,must,O
106311,7324,not,O
106312,7324,be,O
106313,7324,pregnant,O
106314,7324,because,O
106315,7324,of,O
106316,7324,the,O
106317,7324,potential,O
106318,7324,for,O
106319,7324,fetal,O
106320,7324,harm,O
106321,7324,as,O
106322,7324,a,O
106323,7324,result,O
106324,7324,of,O
106325,7324,radiation,O
106326,7324,treatment,O
106327,7324,.,O
106328,7324,Women,O
106329,7324,of,O
106330,7324,child,O
106331,7324,-,O
106332,7324,bearing,O
106333,7324,age,O
106334,7324,will,O
106335,7324,be,O
106336,7324,given,O
106337,7324,a,O
106338,7324,serum,O
106339,7324,pregnancy,O
106340,7324,test,O
106341,7324,prior,O
106342,7324,to,O
106343,7324,study,O
106344,7324,entry,O
106345,7324,to,O
106346,7324,ensure,O
106347,7324,they,O
106348,7324,are,O
106349,7324,not,O
106350,7324,pregnant,O
106351,7324,.,O
106352,7324,They,O
106353,7324,will,O
106354,7324,also,O
106355,7324,be,O
106356,7324,counseled,O
106357,7324,on,O
106358,7324,the,O
106359,7324,importance,O
106360,7324,of,O
106361,7324,avoiding,O
106362,7324,pregnancy,O
106363,7324,and,O
106364,7324,hormonal,O
106365,7324,contraception,O
106366,7324,while,O
106367,7324,undergoing,O
106368,7324,radiation,O
106369,7324,therapy,O
106370,7324,.,O
106371,7325,Patients,O
106372,7325,must,O
106373,7325,not,O
106374,7325,have,O
106375,7325,a,O
106376,7325,serious,O
106377,7325,medical,O
106378,7325,or,O
106379,7325,psychiatric,O
106380,7325,illness,O
106381,7325,which,O
106382,7325,prevents,O
106383,7325,informed,O
106384,7325,consent,O
106385,7325,or,O
106386,7325,compliance,O
106387,7325,with,O
106388,7325,treatment,O
106389,7325,.,O
106390,7326,All,O
106391,7326,patients,O
106392,7326,must,O
106393,7326,be,O
106394,7326,informed,O
106395,7326,of,O
106396,7326,the,O
106397,7326,investigational,O
106398,7326,nature,O
106399,7326,of,O
106400,7326,this,O
106401,7326,study,O
106402,7326,and,O
106403,7326,give,O
106404,7326,written,O
106405,7326,informed,O
106406,7326,consent,O
106407,7326,in,O
106408,7326,accordance,O
106409,7326,with,O
106410,7326,institutional,O
106411,7326,and,O
106412,7326,federal,O
106413,7326,guidelines,O
106414,7326,.,O
106415,7327,Serious,O
106416,7327,adverse,B-Condition
106417,7327,reaction,I-Condition
106418,7327,to,O
106419,7327,any,O
106420,7327,vaccination,B-Procedure
106421,7327,",",O
106422,7327,as,O
106423,7327,respiratory,B-Condition
106424,7327,difficulty,I-Condition
106425,7327,",",O
106426,7327,angioedema,B-Condition
106427,7327,and,O
106428,7327,anaphylaxis,B-Condition
106429,7327,;,O
106430,7328,Acute,B-Condition
106431,7328,or,I-Condition
106432,7328,chronic,I-Condition
106433,7328,disease,I-Condition
106434,7328,",",O
106435,7328,as,O
106436,7328,diabetes,B-Condition
106437,7328,",",O
106438,7328,heart,B-Condition
106439,7328,disease,I-Condition
106440,7328,",",O
106441,7328,systemic,B-Condition
106442,7328,arterial,I-Condition
106443,7328,hypertension,I-Condition
106444,7328,;,O
106445,7329,Use,O
106446,7329,of,O
106447,7329,anti,B-Drug
106448,7329,-,I-Drug
106449,7329,allergic,I-Drug
106450,7329,with,O
106451,7329,antigen,B-Procedure
106452,7329,injections,I-Procedure
106453,7329,in,O
106454,7329,a,O
106455,7329,maximum,O
106456,7329,timeline,O
106457,7329,of,O
106458,7329,14,O
106459,7329,days,O
106460,7329,before,O
106461,7329,the,O
106462,7329,vaccination,O
106463,7329,;,O
106464,7330,Use,O
106465,7330,of,O
106466,7330,immunoglobulin,B-Drug
106467,7330,in,O
106468,7330,the,O
106469,7330,past,O
106470,7330,12,O
106471,7330,months,O
106472,7330,before,O
106473,7330,the,O
106474,7330,study,O
106475,7330,vaccination,O
106476,7330,;,O
106477,7331,Use,O
106478,7331,of,O
106479,7331,blood,B-Drug
106480,7331,products,I-Drug
106481,7331,within,O
106482,7331,12,O
106483,7331,months,O
106484,7331,before,O
106485,7331,the,O
106486,7331,vaccination,O
106487,7331,;,O
106488,7332,Use,O
106489,7332,of,O
106490,7332,any,B-Drug
106491,7332,vaccine,I-Drug
106492,7332,type,I-Drug
106493,7332,within,O
106494,7332,30,O
106495,7332,days,O
106496,7332,before,O
106497,7332,the,O
106498,7332,vaccination,O
106499,7332,of,O
106500,7332,the,O
106501,7332,study,O
106502,7332,;,O
106503,7333,Chronic,O
106504,7333,use,O
106505,7333,of,O
106506,7333,any,B-Drug
106507,7333,medication,I-Drug
106508,7333,",",O
106509,7333,except,O
106510,7333,homeopathy,B-Procedure
106511,7333,",",O
106512,7333,and,O
106513,7333,trivial,B-Drug
106514,7333,ones,I-Drug
106515,7333,",",O
106516,7333,as,O
106517,7333,nasal,B-Drug
106518,7333,physiologic,I-Drug
106519,7333,solution,I-Drug
106520,7333,and,O
106521,7333,vitamins,B-Drug
106522,7333,;,O
106523,7334,Previous,O
106524,7334,immunosuppressive,B-Drug
106525,7334,or,I-Drug
106526,7334,cytotoxic,I-Drug
106527,7334,medication,I-Drug
106528,7334,",",O
106529,7334,in,O
106530,7334,the,O
106531,7334,last,O
106532,7334,6,O
106533,7334,months,O
106534,7334,.,O
106535,7334,Individuals,O
106536,7334,who,O
106537,7334,have,O
106538,7334,made,O
106539,7334,use,O
106540,7334,of,O
106541,7334,this,O
106542,7334,kind,O
106543,7334,of,O
106544,7334,medication,O
106545,7334,in,O
106546,7334,non,O
106547,7334,-,O
106548,7334,immunosuppressant,O
106549,7334,doses,O
106550,7334,",",O
106551,7334,as,O
106552,7334,nasal,O
106553,7334,corticosteroid,O
106554,7334,for,O
106555,7334,allergic,O
106556,7334,rhinitis,O
106557,7334,of,O
106558,7334,topic,O
106559,7334,corticosteroid,O
106560,7334,for,O
106561,7334,non,O
106562,7334,-,O
106563,7334,complicated,O
106564,7334,dermatitis,O
106565,7334,",",O
106566,7334,for,O
106567,7334,more,O
106568,7334,than,O
106569,7334,14,O
106570,7334,days,O
106571,7334,",",O
106572,7334,are,O
106573,7334,allowed,O
106574,7334,to,O
106575,7334,be,O
106576,7334,included,O
106577,7334,in,O
106578,7334,the,O
106579,7334,study,O
106580,7334,.,O
106581,7335,Use,O
106582,7335,of,O
106583,7335,any,O
106584,7335,kind,O
106585,7335,of,O
106586,7335,medication,B-Drug
106587,7335,under,I-Drug
106588,7335,investigation,I-Drug
106589,7335,within,O
106590,7335,one,O
106591,7335,year,O
106592,7335,before,O
106593,7335,the,O
106594,7335,vaccination,O
106595,7335,.,O
106596,7336,Unstable,B-Condition
106597,7336,asthma,I-Condition
106598,7336,or,O
106599,7336,which,O
106600,7336,may,O
106601,7336,have,O
106602,7336,required,O
106603,7336,urgent,B-Procedure
106604,7336,care,I-Procedure
106605,7336,",",O
106606,7336,hospitalization,B-Procedure
106607,7336,or,O
106608,7336,intubation,B-Procedure
106609,7336,within,O
106610,7336,the,O
106611,7336,last,O
106612,7336,2,O
106613,7336,years,O
106614,7336,",",O
106615,7336,or,O
106616,7336,which,O
106617,7336,requires,O
106618,7336,use,O
106619,7336,of,O
106620,7336,oral,B-Drug
106621,7336,or,I-Drug
106622,7336,intravenous,I-Drug
106623,7336,corticosteroid,I-Drug
106624,7336,.,O
106625,7337,Coagulopathies,B-Condition
106626,7337,diagnosed,O
106627,7337,by,O
106628,7337,a,O
106629,7337,physician,O
106630,7337,or,O
106631,7337,report,O
106632,7337,of,O
106633,7337,capillary,B-Condition
106634,7337,fragility,I-Condition
106635,7337,(,O
106636,7337,ex,O
106637,7337,:,O
106638,7337,bruises,B-Condition
106639,7337,or,O
106640,7337,bleedings,B-Condition
106641,7337,without,O
106642,7337,justifiable,O
106643,7337,cause,O
106644,7337,;,O
106645,7338,Convulsions,B-Condition
106646,7338,",",O
106647,7338,except,O
106648,7338,the,O
106649,7338,ones,O
106650,7338,caused,O
106651,7338,by,O
106652,7338,fever,B-Condition
106653,7338,",",O
106654,7338,before,O
106655,7338,2,O
106656,7338,years,O
106657,7338,old,O
106658,7338,;,O
106659,7339,Psychiatric,B-Condition
106660,7339,disease,I-Condition
106661,7339,which,O
106662,7339,difficults,O
106663,7339,the,O
106664,7339,adherence,O
106665,7339,to,O
106666,7339,the,O
106667,7339,protocol,O
106668,7339,",",O
106669,7339,such,O
106670,7339,as,O
106671,7339,psychosis,B-Condition
106672,7339,",",O
106673,7339,obsessive,B-Condition
106674,7339,-,I-Condition
106675,7339,compulsive,I-Condition
106676,7339,disorders,I-Condition
106677,7339,",",O
106678,7339,bipolar,B-Condition
106679,7339,disease,I-Condition
106680,7339,under,O
106681,7339,treatment,B-Procedure
106682,7339,",",O
106683,7339,diseases,B-Condition
106684,7339,which,I-Condition
106685,7339,require,I-Condition
106686,7339,treatment,I-Condition
106687,7339,with,I-Condition
106688,7339,lithium,I-Condition
106689,7339,and,O
106690,7339,suicidal,B-Condition
106691,7339,ideas,I-Condition
106692,7339,in,O
106693,7339,the,O
106694,7339,last,O
106695,7339,5,O
106696,7339,years,O
106697,7339,from,O
106698,7339,the,O
106699,7339,inclusion,O
106700,7339,;,O
106701,7340,Active,O
106702,7340,malignant,B-Condition
106703,7340,(,I-Condition
106704,7340,p.e,I-Condition
106705,7340,.,I-Condition
106706,7340,any,I-Condition
106707,7340,kind,I-Condition
106708,7340,of,I-Condition
106709,7340,cancer,I-Condition
106710,7340,),I-Condition
106711,7340,or,I-Condition
106712,7340,treated,I-Condition
106713,7340,disease,I-Condition
106714,7340,",",O
106715,7340,to,O
106716,7340,which,O
106717,7340,the,O
106718,7340,individual,O
106719,7340,may,O
106720,7340,relapse,O
106721,7340,during,O
106722,7340,the,O
106723,7340,study,O
106724,7340,;,O
106725,7341,Asplenia,B-Condition
106726,7341,(,O
106727,7341,absence,O
106728,7341,of,O
106729,7341,spleen,B-Procedure
106730,7341,or,I-Procedure
106731,7341,its,I-Procedure
106732,7341,removal,I-Procedure
106733,7341,),O
106734,7341,;,O
106735,7342,Positive,O
106736,7342,HIV,O
106737,7342,in,O
106738,7342,the,O
106739,7342,screening,O
106740,7342,examination,O
106741,7342,of,O
106742,7342,history,O
106743,7342,of,O
106744,7342,any,O
106745,7342,immunosuppressant,B-Condition
106746,7342,disease,I-Condition
106747,7342,;,O
106748,7343,Positive,O
106749,7343,serology,O
106750,7343,for,O
106751,7343,C,O
106752,7343,hepatitis,O
106753,7343,in,O
106754,7343,the,O
106755,7343,screening,O
106756,7343,evaluation,O
106757,7343,;,O
106758,7344,Positive,O
106759,7344,Antigen,O
106760,7344,HBs,O
106761,7344,in,O
106762,7344,the,O
106763,7344,screening,O
106764,7344,evaluation,O
106765,7344,;,O
106766,7345,Alcoholism,B-Condition
106767,7345,(,O
106768,7345,CAGE,O
106769,7345,criteria,O
106770,7345,),O
106771,7345,",",O
106772,7345,used,O
106773,7345,for,O
106774,7345,detection,O
106775,7345,of,O
106776,7345,abusive,O
106777,7345,drinkers,O
106778,7345,or,O
106779,7345,alcoholic,O
106780,7345,",",O
106781,7345,validated,O
106782,7345,in,O
106783,7345,the,O
106784,7345,Brazilian,O
106785,7345,population,O
106786,7345,with,O
106787,7345,sensibility,O
106788,7345,of,O
106789,7345,88,O
106790,7345,%,O
106791,7345,and,O
106792,7345,specificity,O
106793,7345,of,O
106794,7345,83,O
106795,7345,%,O
106796,7345,",",O
106797,7345,if,O
106798,7345,two,O
106799,7345,or,O
106800,7345,more,O
106801,7345,answers,O
106802,7345,",",O
106803,7345,among,O
106804,7345,four,O
106805,7345,possible,O
106806,7345,",",O
106807,7345,are,O
106808,7345,afirmative(Mansur,O
106809,7345,and,O
106810,7345,Monteiro,O
106811,7345,",",O
106812,7345,1983,O
106813,7345,),O
106814,7345,",",O
106815,7345,or,O
106816,7345,according,O
106817,7345,to,O
106818,7345,medical,O
106819,7345,decision,O
106820,7345,;,O
106821,7346,Abuse,B-Condition
106822,7346,of,I-Condition
106823,7346,illicit,I-Condition
106824,7346,drugs,I-Condition
106825,7346,",",O
106826,7346,according,O
106827,7346,to,O
106828,7346,medical,O
106829,7346,decision,O
106830,7346,;,O
106831,7347,Acquired,B-Condition
106832,7347,or,I-Condition
106833,7347,congenital,I-Condition
106834,7347,immunodeficiency,I-Condition
106835,7347,;,O
106836,7348,Allergy,B-Condition
106837,7348,to,I-Condition
106838,7348,the,I-Condition
106839,7348,vaccine,I-Condition
106840,7348,compounds,I-Condition
106841,7348,",",O
106842,7348,as,O
106843,7348,egg,B-Drug
106844,7348,",",O
106845,7348,neomycin,B-Drug
106846,7348,and,O
106847,7348,gelatin,B-Drug
106848,7348,.,O
106849,7349,Male,B-Person
106850,7350,Age,B-Person
106851,7350,between,O
106852,7350,18,O
106853,7350,and,O
106854,7350,49,O
106855,7350,years,O
106856,7350,old,O
106857,7350,;,O
106858,7351,Willing,O
106859,7351,to,O
106860,7351,provide,O
106861,7351,name,O
106862,7351,",",O
106863,7351,address,O
106864,7351,",",O
106865,7351,telephone,O
106866,7351,and,O
106867,7351,other,O
106868,7351,contact,O
106869,7351,information,O
106870,7351,in,O
106871,7351,order,O
106872,7351,to,O
106873,7351,be,O
106874,7351,contacted,O
106875,7351,",",O
106876,7351,whenever,O
106877,7351,needed,O
106878,7351,(,O
106879,7351,example,O
106880,7351,:,O
106881,7351,in,O
106882,7351,case,O
106883,7351,of,O
106884,7351,missing,O
106885,7351,any,O
106886,7351,scheduled,O
106887,7351,visit,O
106888,7351,",",O
106889,7351,contact,O
106890,7351,for,O
106891,7351,confirmation,O
106892,7351,of,O
106893,7351,scheduling,O
106894,7351,a,O
106895,7351,visit,O
106896,7351,",",O
106897,7351,urgent,O
106898,7351,safety,O
106899,7351,notifications,O
106900,7351,),O
106901,7351,;,O
106902,7352,Willing,O
106903,7352,to,O
106904,7352,strictly,O
106905,7352,follow,O
106906,7352,the,O
106907,7352,study,O
106908,7352,protocol,O
106909,7352,;,O
106910,7353,Capacity,O
106911,7353,for,O
106912,7353,understanding,O
106913,7353,and,O
106914,7353,signing,O
106915,7353,in,O
106916,7353,the,O
106917,7353,Informed,O
106918,7353,Consent,O
106919,7353,Form,O
106920,7353,;,O
106921,7354,To,O
106922,7354,understand,O
106923,7354,the,O
106924,7354,impossibility,O
106925,7354,of,O
106926,7354,participating,O
106927,7354,in,O
106928,7354,another,O
106929,7354,clinical,O
106930,7354,trial,O
106931,7354,during,O
106932,7354,the,O
106933,7354,time,O
106934,7354,of,O
106935,7354,participation,O
106936,7354,in,O
106937,7354,the,O
106938,7354,study,O
106939,7354,",",O
106940,7354,until,O
106941,7354,6,O
106942,7354,months,O
106943,7354,after,O
106944,7354,its,O
106945,7354,conclusion,O
106946,7354,;,O
106947,7355,Intellectual,O
106948,7355,level,O
106949,7355,which,O
106950,7355,allows,O
106951,7355,to,O
106952,7355,filling,O
106953,7355,in,O
106954,7355,the,O
106955,7355,diaries,O
106956,7355,for,O
106957,7355,registering,O
106958,7355,of,O
106959,7355,symptoms,O
106960,7355,at,O
106961,7355,home,O
106962,7355,;,O
106963,7356,Willing,O
106964,7356,to,O
106965,7356,undergo,O
106966,7356,to,O
106967,7356,serological,B-Procedure
106968,7356,testing,I-Procedure
106969,7356,to,I-Procedure
106970,7356,HIV,I-Procedure
106971,7356,",",I-Procedure
106972,7356,HBV,I-Procedure
106973,7356,and,I-Procedure
106974,7356,HCV,I-Procedure
106975,7356,;,O
106976,7357,Being,O
106977,7357,in,O
106978,7357,good,B-Condition
106979,7357,health,I-Condition
106980,7357,",",O
106981,7357,with,O
106982,7357,no,O
106983,7357,significant,O
106984,7357,medical,O
106985,7357,history,O
106986,7357,;,O
106987,7358,Physical,B-Procedure
106988,7358,examination,I-Procedure
106989,7358,at,O
106990,7358,screening,O
106991,7358,period,O
106992,7358,without,O
106993,7358,clinically,O
106994,7358,significant,O
106995,7358,changes,O
106996,7358,;,O
106997,7359,Lab,O
106998,7359,examination,O
106999,7359,at,O
107000,7359,screening,O
107001,7359,period,O
107002,7359,within,O
107003,7359,the,O
107004,7359,normal,O
107005,7359,ranges,O
107006,7359,",",O
107007,7359,determined,O
107008,7359,by,O
107009,7359,the,O
107010,7359,laboratory,O
107011,7359,or,O
107012,7359,abnormal,O
107013,7359,values,O
107014,7359,",",O
107015,7359,grading,O
107016,7359,below,O
107017,7359,1,O
107018,7359,or,O
107019,7359,2,O
107020,7359,",",O
107021,7359,according,O
107022,7359,to,O
107023,7359,medical,O
107024,7359,decision,O
107025,7359,.,O
107026,7360,NA,O
107027,7361,Stage,O
107028,7361,IA,O
107029,7361,or,O
107030,7361,IIA,O
107031,7361,disease,O
107032,7362,Not,O
107033,7362,specified,O
107034,7363,No,O
107035,7363,prior,O
107036,7363,therapy,O
107037,7364,On,O
107038,7364,chronic,O
107039,7364,treatment,B-Procedure
107040,7364,(,O
107041,7364,i.e.,O
107042,7364,",",O
107043,7364,two,O
107044,7364,weeks,O
107045,7364,or,O
107046,7364,more,O
107047,7364,),O
107048,7364,with,O
107049,7364,any,O
107050,7364,medication,O
107051,7364,severely,O
107052,7364,affecting,O
107053,7364,oral,O
107054,7364,status,O
107055,7364,(,O
107056,7364,e.g.,O
107057,7364,participants,O
107058,7364,with,O
107059,7364,gingival,B-Condition
107060,7364,hypertrophy,I-Condition
107061,7364,caused,O
107062,7364,by,O
107063,7364,anti,B-Drug
107064,7364,-,I-Drug
107065,7364,epileptics,I-Drug
107066,7364,",",O
107067,7364,calcium,B-Drug
107068,7364,antagonists,I-Drug
107069,7364,",",O
107070,7364,cyclosporine,B-Drug
107071,7364,and,O
107072,7364,other,O
107073,7364,immunosuppressive,B-Drug
107074,7364,),O
107075,7364,or,O
107076,7364,bone,B-Observation
107077,7364,metabolism,I-Observation
107078,7364,(,O
107079,7364,e.g.,O
107080,7364,anticoagulant,B-Drug
107081,7364,medications,O
107082,7364,",",O
107083,7364,long,O
107084,7364,-,O
107085,7364,standing,O
107086,7364,steroid,B-Drug
107087,7364,medications,O
107088,7364,-i.e,O
107089,7364,.,O
107090,7364,equal,O
107091,7364,or,O
107092,7364,more,O
107093,7364,2.5,O
107094,7364,mg,O
107095,7364,of,O
107096,7364,prednisolone,B-Drug
107097,7364,a,O
107098,7364,day,O
107099,7364,taken,O
107100,7364,for,O
107101,7364,>,O
107102,7364,3,O
107103,7364,months,O
107104,7364,-,O
107105,7364,",",O
107106,7364,anticonvulsants,B-Drug
107107,7364,",",O
107108,7364,immunosuppressants,B-Drug
107109,7364,),O
107110,7364,.,O
107111,7365,Affected,O
107112,7365,by,O
107113,7365,systemic,O
107114,7365,diseases,O
107115,7365,recognized,O
107116,7365,to,O
107117,7365,severely,O
107118,7365,affect,O
107119,7365,bone,O
107120,7365,metabolism,O
107121,7365,(,O
107122,7365,e.g.,O
107123,7365,Cushing,B-Condition
107124,7365,'s,I-Condition
107125,7365,syndrome,I-Condition
107126,7365,",",O
107127,7365,Addison,B-Condition
107128,7365,'s,I-Condition
107129,7365,disease,I-Condition
107130,7365,",",O
107131,7365,diabetes,B-Condition
107132,7365,mellitus,I-Condition
107133,7365,type,I-Condition
107134,7365,1,I-Condition
107135,7365,",",O
107136,7365,leukaemia,B-Condition
107137,7365,",",O
107138,7365,pernicious,B-Condition
107139,7365,anaemia,I-Condition
107140,7365,",",O
107141,7365,malabsorption,B-Condition
107142,7365,syndromes,I-Condition
107143,7365,",",O
107144,7365,chronic,B-Condition
107145,7365,liver,I-Condition
107146,7365,disease,I-Condition
107147,7365,",",O
107148,7365,rheumatoid,B-Condition
107149,7365,arthritis,I-Condition
107150,7365,),O
107151,7365,.,O
107152,7366,Knowingly,O
107153,7366,affected,O
107154,7366,by,O
107155,7366,HIV,B-Condition
107156,7366,or,O
107157,7366,Hepatitis,B-Condition
107158,7366,.,O
107159,7367,History,O
107160,7367,of,O
107161,7367,local,B-Procedure
107162,7367,radiation,I-Procedure
107163,7367,therapy,I-Procedure
107164,7367,in,O
107165,7367,the,O
107166,7367,last,O
107167,7367,five,O
107168,7367,years,O
107169,7367,.,O
107170,7368,Affected,O
107171,7368,by,O
107172,7368,limited,O
107173,7368,mental,O
107174,7368,capacity,O
107175,7368,or,O
107176,7368,language,O
107177,7368,skills,O
107178,7368,such,O
107179,7368,that,O
107180,7368,study,O
107181,7368,information,O
107182,7368,can,O
107183,7368,not,O
107184,7368,be,O
107185,7368,understood,O
107186,7368,",",O
107187,7368,informed,O
107188,7368,consent,O
107189,7368,can,O
107190,7368,not,O
107191,7368,be,O
107192,7368,obtained,O
107193,7368,",",O
107194,7368,or,O
107195,7368,simple,O
107196,7368,instructions,O
107197,7368,can,O
107198,7368,not,O
107199,7368,be,O
107200,7368,followed,O
107201,7368,.,O
107202,7369,Presenting,O
107203,7369,an,O
107204,7369,acute,O
107205,7369,endodontic,O
107206,7369,/,O
107207,7369,periodontal,B-Condition
107208,7369,lesion,I-Condition
107209,7369,in,O
107210,7369,the,O
107211,7369,neighboring,O
107212,7369,areas,O
107213,7369,to,O
107214,7369,the,O
107215,7369,implant,O
107216,7369,site,O
107217,7369,.,O
107218,7370,Completely,O
107219,7370,edentulous,B-Condition
107220,7371,With,O
107221,7371,evident,O
107222,7371,severe,O
107223,7371,atrophy,O
107224,7371,of,O
107225,7371,the,O
107226,7371,alveolar,O
107227,7371,ridge,O
107228,7371,that,O
107229,7371,could,O
107230,7371,preclude,O
107231,7371,an,O
107232,7371,implant,O
107233,7371,placement,O
107234,7371,(,O
107235,7371,e.g.,O
107236,7371,sharp,O
107237,7371,knife,O
107238,7371,edge,O
107239,7371,ridge,O
107240,7371,),O
107241,7372,Severe,O
107242,7372,bruxism,B-Observation
107243,7372,or,O
107244,7372,clenching,B-Observation
107245,7372,habits,I-Observation
107246,7373,Smokers,B-Person
107247,7373,of,O
107248,7373,>,O
107249,7373,5,O
107250,7373,cigarettes,B-Observation
107251,7373,a,O
107252,7373,day,O
107253,7373,.,O
107254,7374,A,O
107255,7374,daily,O
107256,7374,alcohol,B-Observation
107257,7374,intake,O
107258,7374,>,O
107259,7374,2,O
107260,7374,units,O
107261,7374,/,O
107262,7374,day,O
107263,7374,.,O
107264,7375,Other,O
107265,7375,severe,O
107266,7375,acute,O
107267,7375,or,O
107268,7375,chronic,O
107269,7375,medical,O
107270,7375,or,O
107271,7375,psychiatric,O
107272,7375,condition,O
107273,7375,or,O
107274,7375,laboratory,O
107275,7375,abnormality,O
107276,7375,which,O
107277,7375,may,O
107278,7375,increase,O
107279,7375,the,O
107280,7375,risk,O
107281,7375,associated,O
107282,7375,with,O
107283,7375,trial,O
107284,7375,participation,O
107285,7375,or,O
107286,7375,investigational,O
107287,7375,product,O
107288,7375,administration,O
107289,7375,or,O
107290,7375,may,O
107291,7375,interfere,O
107292,7375,with,O
107293,7375,the,O
107294,7375,interpretation,O
107295,7375,of,O
107296,7375,study,O
107297,7375,results,O
107298,7375,and,O
107299,7375,",",O
107300,7375,in,O
107301,7375,the,O
107302,7375,judgment,O
107303,7375,of,O
107304,7375,the,O
107305,7375,investigator,O
107306,7375,",",O
107307,7375,would,O
107308,7375,make,O
107309,7375,the,O
107310,7375,participant,O
107311,7375,inappropriate,O
107312,7375,for,O
107313,7375,entry,O
107314,7375,into,O
107315,7375,this,O
107316,7375,trial,O
107317,7375,.,O
107318,7376,Patients,O
107319,7376,unable,O
107320,7376,or,O
107321,7376,not,O
107322,7376,willing,O
107323,7376,to,O
107324,7376,return,O
107325,7376,for,O
107326,7376,follow,O
107327,7376,-,O
107328,7376,ups,O
107329,7376,.,O
107330,7377,Participants,O
107331,7377,must,O
107332,7377,present,O
107333,7377,a,O
107334,7377,diagnosis,O
107335,7377,of,O
107336,7377,osteoporosis,B-Condition
107337,7377,based,O
107338,7377,on,O
107339,7377,DXA,B-Procedure
107340,7377,measurement,O
107341,7377,of,O
107342,7377,the,O
107343,7377,bone,O
107344,7377,mineral,O
107345,7377,density,O
107346,7377,at,O
107347,7377,the,O
107348,7377,femur,O
107349,7377,neck,O
107350,7377,and/or,O
107351,7377,total,O
107352,7377,hip,O
107353,7377,and/or,O
107354,7377,lumbar,O
107355,7377,spine,O
107356,7377,(,O
107357,7377,T,O
107358,7377,value,O
107359,7377,2.5,O
107360,7377,SD,O
107361,7377,or,O
107362,7377,more,O
107363,7377,below,O
107364,7377,the,O
107365,7377,young,O
107366,7377,female,O
107367,7377,adult,O
107368,7377,mean,O
107369,7377,),O
107370,7377,within,O
107371,7377,the,O
107372,7377,past,O
107373,7377,24,O
107374,7377,months,O
107375,7377,.,O
107376,7378,Not,O
107377,7378,in,O
107378,7378,treatment,O
107379,7378,with,O
107380,7378,anti,B-Drug
107381,7378,-,I-Drug
107382,7378,resorptive,I-Drug
107383,7378,agents,I-Drug
107384,7378,(,O
107385,7378,like,O
107386,7378,bisphosphonates,B-Drug
107387,7378,and,O
107388,7378,denosumab,B-Drug
107389,7378,),O
107390,7378,for,O
107391,7378,more,O
107392,7378,than,O
107393,7378,4,O
107394,7378,consecutive,O
107395,7378,years,O
107396,7378,",",O
107397,7378,in,O
107398,7378,order,O
107399,7378,to,O
107400,7378,reduce,O
107401,7378,the,O
107402,7378,risk,O
107403,7378,of,O
107404,7378,medication,O
107405,7378,-,O
107406,7378,related,O
107407,7378,osteonecrosis,O
107408,7378,of,O
107409,7378,the,O
107410,7378,jaws,O
107411,7378,(,O
107412,7378,Lo,O
107413,7378,et,O
107414,7378,al,O
107415,7378,.,O
107416,7378,",",O
107417,7378,2010,O
107418,7378,),O
107419,7378,.,O
107420,7379,=,O
107421,7379,50,O
107422,7379,years,O
107423,7379,old,B-Person
107424,7379,.,O
107425,7380,In,O
107426,7380,self,O
107427,7380,-,O
107428,7380,reported,O
107429,7380,menopause,B-Condition
107430,7380,",",O
107431,7380,defined,O
107432,7380,as,O
107433,7380,the,O
107434,7380,permanent,O
107435,7380,cessation,B-Condition
107436,7380,of,I-Condition
107437,7380,ovulation,I-Condition
107438,7380,",",O
107439,7380,for,O
107440,7380,at,O
107441,7380,least,O
107442,7380,one,O
107443,7380,year,O
107444,7380,(,O
107445,7380,Soules,O
107446,7380,et,O
107447,7380,al,O
107448,7380,.,O
107449,7380,",",O
107450,7380,2001,O
107451,7380,),O
107452,7380,.,O
107453,7381,Edentulous,O
107454,7381,area,O
107455,7381,involving,O
107456,7381,a,O
107457,7381,maximum,O
107458,7381,of,O
107459,7381,two,O
107460,7381,teeth,O
107461,7381,(,O
107462,7381,wisdom,O
107463,7381,teeth,O
107464,7381,and,O
107465,7381,second,O
107466,7381,molars,O
107467,7381,are,O
107468,7381,excluded,O
107469,7381,),O
107470,7381,and,O
107471,7381,presenting,O
107472,7381,at,O
107473,7381,least,O
107474,7381,one,O
107475,7381,neighbouring,O
107476,7381,tooth,O
107477,7381,(,O
107478,7381,e.g.,O
107479,7381,gap,O
107480,7381,in,O
107481,7381,the,O
107482,7381,area,O
107483,7381,of,O
107484,7381,a,O
107485,7381,second,O
107486,7381,premolar,O
107487,7381,and,O
107488,7381,first,O
107489,7381,molar,O
107490,7381,",",O
107491,7381,with,O
107492,7381,first,O
107493,7381,premolar,O
107494,7381,in,O
107495,7381,place,O
107496,7381,),O
107497,7381,.,O
107498,7382,Residual,O
107499,7382,alveolar,O
107500,7382,width,O
107501,7382,=,O
107502,7382,4,O
107503,7382,mm,O
107504,7382,(,O
107505,7382,Milinkovic,O
107506,7382,and,O
107507,7382,Cordaro,O
107508,7382,",",O
107509,7382,2014,O
107510,7382,),O
107511,7382,",",O
107512,7382,residual,O
107513,7382,alveolar,O
107514,7382,height,O
107515,7382,>,O
107516,7382,8,O
107517,7382,mm,O
107518,7382,",",O
107519,7382,enough,O
107520,7382,inter,O
107521,7382,-,O
107522,7382,arch,O
107523,7382,space,O
107524,7382,for,O
107525,7382,a,O
107526,7382,crown,O
107527,7382,(,O
107528,7382,at,O
107529,7382,least,O
107530,7382,5,O
107531,7382,mm,O
107532,7382,),O
107533,7382,and,O
107534,7382,a,O
107535,7382,minimum,O
107536,7382,distance,O
107537,7382,of,O
107538,7382,7,O
107539,7382,mm,O
107540,7382,from,O
107541,7382,the,O
107542,7382,adjacent,O
107543,7382,teeth,O
107544,7382,(,O
107545,7382,Shah,O
107546,7382,and,O
107547,7382,Lum,O
107548,7382,",",O
107549,7382,2008,O
107550,7382,),O
107551,7382,.,O
107552,7382,The,O
107553,7382,width,O
107554,7382,and,O
107555,7382,height,O
107556,7382,will,O
107557,7382,be,O
107558,7382,confirmed,O
107559,7382,after,O
107560,7382,x,O
107561,7382,-,O
107562,7382,ray,O
107563,7382,examination,O
107564,7382,in,O
107565,7382,Visit,O
107566,7382,2,O
107567,7382,.,O
107568,7383,Possibility,O
107569,7383,to,O
107570,7383,restore,O
107571,7383,a,O
107572,7383,functional,O
107573,7383,occlusion,O
107574,7383,with,O
107575,7383,a,O
107576,7383,minimum,O
107577,7383,of,O
107578,7383,four,O
107579,7383,occlusal,O
107580,7383,units,O
107581,7383,(,O
107582,7383,i.e.,O
107583,7383,pairs,O
107584,7383,of,O
107585,7383,occluding,O
107586,7383,posterior,O
107587,7383,teeth,O
107588,7383,),O
107589,7383,.,O
107590,7384,Willingness,O
107591,7384,to,O
107592,7384,replace,O
107593,7384,the,O
107594,7384,missing,O
107595,7384,tooth,O
107596,7384,/,O
107597,7384,teeth,O
107598,7384,with,O
107599,7384,dental,O
107600,7384,implants,O
107601,7385,Registration,O
107602,7385,with,O
107603,7385,a,O
107604,7385,GDP,O
107605,7386,Current,O
107606,7386,unstable,B-Condition
107607,7386,medical,I-Condition
107608,7386,condition,I-Condition
107609,7386,(,O
107610,7386,e.g.,O
107611,7386,unstable,B-Condition
107612,7386,angina,I-Condition
107613,7386,",",O
107614,7386,myocardial,B-Condition
107615,7386,infarction,I-Condition
107616,7386,or,O
107617,7386,coronary,B-Procedure
107618,7386,revascularization,I-Procedure
107619,7386,in,O
107620,7386,the,O
107621,7386,preceding,O
107622,7386,12,O
107623,7386,months,O
107624,7386,",",O
107625,7386,cardiac,B-Condition
107626,7386,failure,I-Condition
107627,7386,",",O
107628,7386,chronic,B-Condition
107629,7386,renal,I-Condition
107630,7386,failure,I-Condition
107631,7386,",",O
107632,7386,chronic,B-Condition
107633,7386,hepatic,I-Condition
107634,7386,disease,I-Condition
107635,7386,",",O
107636,7386,severe,O
107637,7386,pulmonary,B-Condition
107638,7386,disease,I-Condition
107639,7386,",",O
107640,7386,blood,B-Condition
107641,7386,disorders,I-Condition
107642,7386,",",O
107643,7386,poorly,O
107644,7386,controlled,O
107645,7386,diabetes,B-Condition
107646,7386,",",O
107647,7386,chronic,B-Condition
107648,7386,infection,I-Condition
107649,7386,),O
107650,7387,Able,O
107651,7387,to,O
107652,7387,give,O
107653,7387,fully,O
107654,7387,informed,O
107655,7387,consent,O
107656,7387,in,O
107657,7387,writing,O
107658,7388,Males,B-Person
107659,7388,or,O
107660,7388,females,B-Person
107661,7388,aged,B-Person
107662,7388,>,O
107663,7388,/=,O
107664,7388,50,O
107665,7388,years,O
107666,7389,No,O
107667,7389,significant,O
107668,7389,disease,B-Condition
107669,7389,or,O
107670,7389,drug,B-Condition
107671,7389,use,I-Condition
107672,7390,Absence,O
107673,7390,of,O
107674,7390,any,O
107675,7390,sign,B-Condition
107676,7390,of,I-Condition
107677,7390,dementia,I-Condition
107678,7390,/,I-Condition
107679,7390,cognitive,I-Condition
107680,7390,impairment,I-Condition
107681,7390,in,O
107682,7390,neuropsychological,B-Procedure
107683,7390,examinationsPatients,I-Procedure
107684,7390,for,O
107685,7390,brain,O
107686,7390,imaging,O
107687,7390,:,O
107688,7391,Patient,O
107689,7391,and,O
107690,7391,designee,O
107691,7391,capable,O
107692,7391,of,O
107693,7391,giving,O
107694,7391,fully,O
107695,7391,informed,O
107696,7391,consent,O
107697,7391,in,O
107698,7391,writing,O
107699,7392,Patient,O
107700,7392,fulfils,O
107701,7392,DSM,O
107702,7392,-,O
107703,7392,IV,O
107704,7392,and,O
107705,7392,NINCDS,O
107706,7392,-,O
107707,7392,ADRA,O
107708,7392,criteria,O
107709,7392,for,O
107710,7392,probable,B-Mood
107711,7392,Alzheimers,B-Condition
107712,7392,disease,I-Condition
107713,7393,Contraindications,B-Condition
107714,7393,and/or,O
107715,7393,known,O
107716,7393,hypersensitivity,B-Condition
107717,7393,to,O
107718,7393,the,O
107719,7393,active,O
107720,7393,substance,O
107721,7393,and/or,O
107722,7393,any,O
107723,7393,of,O
107724,7393,the,O
107725,7393,excipients,O
107726,7393,of,O
107727,7393,epoetin,B-Procedure
107728,7393,beta,I-Procedure
107729,7393,treatment,I-Procedure
107730,7394,Poorly,O
107731,7394,controlled,O
107732,7394,hypertension,B-Condition
107733,7394,as,O
107734,7394,assessed,O
107735,7394,by,O
107736,7394,the,O
107737,7394,investigator,O
107738,7395,History,O
107739,7395,of,O
107740,7395,Acute,B-Condition
107741,7395,Myeloid,I-Condition
107742,7395,Leukemia,I-Condition
107743,7395,(,O
107744,7395,AML,B-Condition
107745,7395,),O
107746,7395,or,O
107747,7395,high,O
107748,7395,risk,B-Observation
107749,7395,for,I-Observation
107750,7395,AML,I-Observation
107751,7396,Administration,O
107752,7396,of,O
107753,7396,another,O
107754,7396,investigational,O
107755,7396,drug,O
107756,7396,within,O
107757,7396,1,O
107758,7396,month,O
107759,7396,before,O
107760,7396,screening,O
107761,7396,or,O
107762,7396,planned,O
107763,7396,during,O
107764,7396,the,O
107765,7396,study,O
107766,7396,period,O
107767,7397,Previously,O
107768,7397,documented,O
107769,7397,evidence,O
107770,7397,of,O
107771,7397,Pure,B-Condition
107772,7397,Red,I-Condition
107773,7397,Cell,I-Condition
107774,7397,Aplasia,I-Condition
107775,7397,(,O
107776,7397,PRCA,B-Condition
107777,7397,),O
107778,7398,Adult,B-Person
107779,7398,participants,O
107780,7398,with,O
107781,7398,low,O
107782,7398,or,O
107783,7398,intermediate-1,O
107784,7398,risk,O
107785,7398,MDS,O
107786,7399,No,O
107787,7399,previous,O
107788,7399,treatment,O
107789,7399,with,O
107790,7399,hematopoietic,B-Drug
107791,7399,growth,I-Drug
107792,7399,factors,I-Drug
107793,7399,within,O
107794,7399,3,O
107795,7399,months,O
107796,7399,prior,O
107797,7399,to,O
107798,7399,screening,O
107799,7400,Symptomatic,O
107800,7400,anemia,B-Condition
107801,7400,(,O
107802,7400,hemoglobin,O
107803,7400,<,O
107804,7400,10,O
107805,7400,g,O
107806,7400,/,O
107807,7400,dL,O
107808,7400,),O
107809,7400,as,O
107810,7400,determined,O
107811,7400,by,O
107812,7400,investigator,O
107813,7401,Serum,O
107814,7401,erythropoietin,O
107815,7401,<,O
107816,7401,500,O
107817,7401,milliunits,O
107818,7401,/,O
107819,7401,milliliter,O
107820,7401,(,O
107821,7401,mU,O
107822,7401,/,O
107823,7401,mL,O
107824,7401,),O
107825,7401,within,O
107826,7401,14,O
107827,7401,days,O
107828,7401,prior,O
107829,7401,to,O
107830,7401,the,O
107831,7401,first,O
107832,7401,dose,O
107833,7401,of,O
107834,7401,study,O
107835,7401,treatment,O
107836,7402,Require,O
107837,7402,no,O
107838,7402,red,B-Procedure
107839,7402,blood,I-Procedure
107840,7402,cell,I-Procedure
107841,7402,transfusion,I-Procedure
107842,7402,or,O
107843,7402,dependent,O
107844,7402,on,O
107845,7402,<,O
107846,7402,4,O
107847,7402,units,O
107848,7402,within,O
107849,7402,8,O
107850,7402,weeks,O
107851,7402,prior,O
107852,7402,to,O
107853,7402,screening,O
107854,7403,Clinically,O
107855,7403,stable,B-Condition
107856,7403,for,O
107857,7403,at,O
107858,7403,least,O
107859,7403,1,O
107860,7403,month,O
107861,7403,prior,O
107862,7403,to,O
107863,7403,entry,O
107864,7403,into,O
107865,7403,the,O
107866,7403,study,O
107867,7404,For,O
107868,7404,female,O
107869,7404,participants,O
107870,7404,of,O
107871,7404,childbearing,O
107872,7404,potential,O
107873,7404,and,O
107874,7404,male,O
107875,7404,participants,O
107876,7404,with,O
107877,7404,partners,O
107878,7404,of,O
107879,7404,childbearing,O
107880,7404,potential,O
107881,7404,",",O
107882,7404,agreement,O
107883,7404,(,O
107884,7404,by,O
107885,7404,participants,O
107886,7404,and/or,O
107887,7404,partner,O
107888,7404,),O
107889,7404,to,O
107890,7404,use,O
107891,7404,highly,O
107892,7404,effective,O
107893,7404,form(s,O
107894,7404,),O
107895,7404,of,O
107896,7404,contraception,O
107897,7405,Optune,B-Observation
107898,7405,compliance,I-Observation
107899,7405,<,O
107900,7405,75,O
107901,7405,%,O
107902,7405,;,O
107903,7405,they,O
107904,7405,would,O
107905,7405,be,O
107906,7405,excluded,O
107907,7405,from,O
107908,7405,the,O
107909,7405,final,O
107910,7405,analyses,O
107911,7405,.,O
107912,7406,History,O
107913,7406,of,O
107914,7406,craniectomy,B-Procedure
107915,7406,or,O
107916,7406,significant,O
107917,7406,skull,B-Condition
107918,7406,defect,I-Condition
107919,7406,(,O
107920,7406,contraindication,B-Condition
107921,7406,to,O
107922,7406,Optune,O
107923,7406,),O
107924,7406,.,O
107925,7407,Active,O
107926,7407,implantable,O
107927,7407,medical,O
107928,7407,device,O
107929,7407,(,O
107930,7407,i.e.,O
107931,7407,DBS,O
107932,7407,",",O
107933,7407,spinal,O
107934,7407,cord,O
107935,7407,stimulator,O
107936,7407,",",O
107937,7407,pacemaker,O
107938,7407,",",O
107939,7407,defibrillator,O
107940,7407,",",O
107941,7407,vagus,O
107942,7407,nerve,O
107943,7407,stimulator,O
107944,7407,",",O
107945,7407,programmable,O
107946,7407,shunt,O
107947,7407,),O
107948,7407,.,O
107949,7408,Karnofsky,O
107950,7408,Performance,O
107951,7408,Status,O
107952,7408,(,O
107953,7408,KPS,O
107954,7408,),O
107955,7408,<,O
107956,7408,60,O
107957,7408,.,O
107958,7409,Newly,O
107959,7409,diagnosed,O
107960,7409,glioblastoma,B-Condition
107961,7409,(,O
107962,7409,GBM,B-Condition
107963,7409,),O
107964,7409,",",O
107965,7409,WHO,O
107966,7409,grade,O
107967,7409,IV,O
107968,7409,.,O
107969,7410,NA,O
107970,7411,American,O
107971,7411,Society,O
107972,7411,of,O
107973,7411,Anesthesiologists,O
107974,7411,Classification,O
107975,7411,I,O
107976,7411,-,O
107977,7411,III,O
107978,7412,Normal,O
107979,7412,cognitive,O
107980,7412,function,O
107981,7412,in,O
107982,7412,order,O
107983,7412,to,O
107984,7412,sign,O
107985,7412,written,O
107986,7412,",",O
107987,7412,informed,O
107988,7412,consent,O
107989,7412,and,O
107990,7412,to,O
107991,7412,understand,O
107992,7412,trial,O
107993,7412,protocol,O
107994,7413,Agreement,O
107995,7413,to,O
107996,7413,the,O
107997,7413,trial,O
107998,7413,protocol,O
107999,7413,",",O
108000,7413,including,O
108001,7413,the,O
108002,7413,randomized,O
108003,7413,manner,O
108004,7414,History,B-Observation
108005,7414,of,O
108006,7414,curettage,B-Procedure
108007,7414,or,O
108008,7414,other,O
108009,7414,intrauterine,B-Procedure
108010,7414,surgery,I-Procedure
108011,7415,History,B-Observation
108012,7415,of,O
108013,7415,post,B-Condition
108014,7415,-,I-Condition
108015,7415,abortion,I-Condition
108016,7415,complication,I-Condition
108017,7415,or,I-Condition
108018,7415,infection,I-Condition
108019,7416,Subject,O
108020,7416,has,O
108021,7416,curettage,B-Procedure
108022,7416,for,O
108023,7416,retained,B-Condition
108024,7416,product,I-Condition
108025,7416,after,O
108026,7416,second,O
108027,7416,trimester,O
108028,7416,abortion,B-Procedure
108029,7417,ASA,O
108030,7417,>,O
108031,7417,3,O
108032,7417,;,O
108033,7418,Coagulopathy,B-Condition
108034,7418,;,O
108035,7419,Renal,B-Condition
108036,7419,disease,I-Condition
108037,7419,",",O
108038,7420,Liver,B-Condition
108039,7420,disease,I-Condition
108040,7420,",",O
108041,7421,History,O
108042,7421,of,O
108043,7421,recent,O
108044,7421,gastro,B-Condition
108045,7421,-,I-Condition
108046,7421,intestinal,I-Condition
108047,7421,bleeding,I-Condition
108048,7422,Pregnancy,B-Condition
108049,7422,.,O
108050,7423,Diagnosis,O
108051,7423,of,O
108052,7423,chronic,B-Condition
108053,7423,pain,I-Condition
108054,7423,currently,O
108055,7423,taking,O
108056,7423,opioid,B-Drug
108057,7423,pain,I-Drug
108058,7423,medication,I-Drug
108059,7423,or,O
108060,7423,with,O
108061,7423,a,O
108062,7423,history,B-Observation
108063,7423,of,I-Observation
108064,7423,drug,B-Condition
108065,7423,abuse,I-Condition
108066,7423,.,O
108067,7424,Patients,O
108068,7424,with,O
108069,7424,a,O
108070,7424,self,O
108071,7424,-,O
108072,7424,described,O
108073,7424,allergy,B-Condition
108074,7424,to,O
108075,7424,ASA,B-Drug
108076,7424,",",O
108077,7424,acetaminophen,B-Drug
108078,7424,",",O
108079,7424,NSAIDS,B-Drug
108080,7424,and,O
108081,7424,codeine,B-Drug
108082,7424,.,O
108083,7425,All,O
108084,7425,patients,O
108085,7425,receiving,O
108086,7425,a,O
108087,7425,brachial,B-Procedure
108088,7425,plexus,I-Procedure
108089,7425,block,I-Procedure
108090,7425,for,O
108091,7425,anesthesia,O
108092,7425,and/or,O
108093,7425,analgesia,O
108094,7426,Patients,O
108095,7426,undergoing,O
108096,7426,ambulatory,O
108097,7426,hand,B-Procedure
108098,7426,surgery,I-Procedure
108099,7426,for,O
108100,7426,carpal,B-Condition
108101,7426,tunnel,I-Condition
108102,7426,and,O
108103,7426,trigger,B-Condition
108104,7426,finger,I-Condition
108105,7426,",",O
108106,7426,under,O
108107,7426,local,B-Procedure
108108,7426,anesthesia,I-Procedure
108109,7426,with,O
108110,7426,or,O
108111,7426,without,O
108112,7426,sedation,O
108113,7426,.,O
108114,7427,Patients,O
108115,7427,with,O
108116,7427,prior,O
108117,7427,fistulotomy,B-Procedure
108118,7427,",",O
108119,7427,fistulectomy,B-Procedure
108120,7427,",",O
108121,7427,LIFT,B-Procedure
108122,7427,",",O
108123,7427,cutting,B-Procedure
108124,7427,seton,I-Procedure
108125,7427,or,O
108126,7427,advancement,B-Procedure
108127,7427,flap,I-Procedure
108128,7427,procedure,I-Procedure
108129,7428,Fistula,B-Condition
108130,7428,with,O
108131,7428,multiple,O
108132,7428,tracts,O
108133,7429,Recto,B-Condition
108134,7429,-,I-Condition
108135,7429,vaginal,I-Condition
108136,7429,fistula,I-Condition
108137,7430,Active,O
108138,7430,infection,B-Condition
108139,7430,in,I-Condition
108140,7430,the,I-Condition
108141,7430,anal,I-Condition
108142,7430,fistula,I-Condition
108143,7431,Physical,O
108144,7431,allergies,O
108145,7431,or,O
108146,7431,cultural,O
108147,7431,objections,O
108148,7431,to,O
108149,7431,porcine,O
108150,7431,products,O
108151,7432,Patient,O
108152,7432,is,O
108153,7432,not,O
108154,7432,medically,O
108155,7432,fit,O
108156,7432,to,O
108157,7432,undergo,O
108158,7432,the,O
108159,7432,LIFT,O
108160,7432,procedure,O
108161,7432,as,O
108162,7432,judged,O
108163,7432,by,O
108164,7432,the,O
108165,7432,treating,O
108166,7432,physician,O
108167,7433,Previous,O
108168,7433,diagnosis,O
108169,7433,of,O
108170,7433,collagen,B-Condition
108171,7433,disorder,I-Condition
108172,7434,History,B-Observation
108173,7434,of,O
108174,7434,Crohn,B-Condition
108175,7434,'s,I-Condition
108176,7434,Disease,I-Condition
108177,7434,",",O
108178,7434,Irritable,B-Condition
108179,7434,Bowel,I-Condition
108180,7434,Syndrome,I-Condition
108181,7434,",",O
108182,7434,radiation,B-Procedure
108183,7434,therapy,I-Procedure
108184,7434,in,O
108185,7434,the,O
108186,7434,rectoanal,O
108187,7434,region,O
108188,7435,Persistent,O
108189,7435,primary,O
108190,7435,or,O
108191,7435,recurrent,O
108192,7435,trans,B-Condition
108193,7435,-,I-Condition
108194,7435,sphincteric,I-Condition
108195,7435,anal,I-Condition
108196,7435,fistula,I-Condition
108197,7436,Conversion,O
108198,7436,from,O
108199,7436,laparoscopic,O
108200,7436,to,O
108201,7436,open,O
108202,7436,surgery,O
108203,7437,History,B-Observation
108204,7437,of,O
108205,7437,Chronic,B-Condition
108206,7437,pain,I-Condition
108207,7437,or,O
108208,7437,ongoing,O
108209,7437,treatment,B-Procedure
108210,7437,for,O
108211,7437,chronic,B-Condition
108212,7437,pain,I-Condition
108213,7438,Age,B-Person
108214,7438,less,O
108215,7438,than,O
108216,7438,18,O
108217,7438,yrs,O
108218,7439,Allergy,B-Condition
108219,7439,to,O
108220,7439,local,B-Drug
108221,7439,anesthetics,I-Drug
108222,7440,Age,B-Person
108223,7440,18,O
108224,7440,or,O
108225,7440,older,O
108226,7440,with,O
108227,7440,unilateral,O
108228,7440,or,O
108229,7440,bilateral,O
108230,7440,inguinal,B-Condition
108231,7440,herna,I-Condition
108232,7440,for,O
108233,7440,laparoscopic,B-Procedure
108234,7440,repair,I-Procedure
108235,7441,American,O
108236,7441,Society,O
108237,7441,of,O
108238,7441,Anesthesiology,O
108239,7441,(,O
108240,7441,ASA,O
108241,7441,),O
108242,7441,Class,O
108243,7441,I,O
108244,7441,and,O
108245,7441,II,O
108246,7442,Patients,O
108247,7442,who,O
108248,7442,have,O
108249,7442,coma,B-Condition
108250,7442,",",O
108251,7442,convulsion,B-Condition
108252,7442,or,O
108253,7442,paralysis,B-Condition
108254,7442,due,O
108255,7442,to,O
108256,7442,intracranial,B-Condition
108257,7442,hemorrhage,I-Condition
108258,7442,or,O
108259,7442,central,O
108260,7442,nervous,O
108261,7442,system,O
108262,7442,leukemia,B-Condition
108263,7442,at,O
108264,7442,diagnosis,O
108265,7442,.,O
108266,7443,Patients,O
108267,7443,less,O
108268,7443,than,O
108269,7443,16,O
108270,7443,years,O
108271,7443,old,B-Person
108272,7443,with,O
108273,7443,newly,O
108274,7443,diagnosed,O
108275,7443,PML,O
108276,7443,-,O
108277,7443,RARa,O
108278,7443,positive,O
108279,7443,acute,B-Condition
108280,7443,promyelocytic,I-Condition
108281,7443,leukemia,I-Condition
108282,7443,.,O
108283,7444,having,O
108284,7444,experienced,O
108285,7444,severe,O
108286,7444,allergies,B-Condition
108287,7444,",",O
108288,7444,trauma,B-Condition
108289,7444,history,B-Observation
108290,7444,and/or,O
108291,7444,operation,B-Procedure
108292,7444,history,B-Observation
108293,7444,within,O
108294,7444,3,O
108295,7444,months,O
108296,7444,.,O
108297,7445,with,O
108298,7445,a,O
108299,7445,history,B-Observation
108300,7445,of,O
108301,7445,mental,B-Condition
108302,7445,illness,I-Condition
108303,7445,and/or,O
108304,7445,family,B-Observation
108305,7445,history,I-Observation
108306,7445,of,O
108307,7445,mental,B-Condition
108308,7445,illness,I-Condition
108309,7445,limb,O
108310,7445,disabled,O
108311,7445,.,O
108312,7446,taking,O
108313,7446,medicine,B-Drug
108314,7446,within,O
108315,7446,one,O
108316,7446,month,O
108317,7446,.,O
108318,7447,suffering,O
108319,7447,major,B-Condition
108320,7447,events,I-Condition
108321,7447,or,O
108322,7447,having,O
108323,7447,mood,B-Condition
108324,7447,swings,I-Condition
108325,7447,.,O
108326,7448,having,O
108327,7448,internal,B-Condition
108328,7448,and,I-Condition
108329,7448,surgical,I-Condition
108330,7448,disease(after,I-Condition
108331,7448,having,O
108332,7448,variety,O
108333,7448,of,O
108334,7448,physical,B-Procedure
108335,7448,examination,I-Procedure
108336,7448,such,O
108337,7448,as,O
108338,7448,electrocardiogram,B-Procedure
108339,7448,/,O
108340,7448,hepatic,B-Procedure
108341,7448,and,I-Procedure
108342,7448,renal,I-Procedure
108343,7448,function,I-Procedure
108344,7448,/,O
108345,7448,blood,B-Procedure
108346,7448,routine,I-Procedure
108347,7448,and,O
108348,7448,urine,B-Procedure
108349,7448,routine,I-Procedure
108350,7448,),O
108351,7449,chromosome,B-Condition
108352,7449,aberrations,I-Condition
108353,7449,in,O
108354,7449,anyone,B-Observation
108355,7449,of,I-Observation
108356,7449,the,I-Observation
108357,7449,couple,I-Observation
108358,7449,.,O
108359,7450,patients,O
108360,7450,who,O
108361,7450,have,O
108362,7450,drugs,B-Drug
108363,7450,contraindications,B-Condition
108364,7451,Woman,B-Person
108365,7451,who,O
108366,7451,had,O
108367,7451,2,O
108368,7451,miscarriage,B-Condition
108369,7451,before,O
108370,7451,12(th,O
108371,7451,),O
108372,7451,week,O
108373,7451,of,O
108374,7451,gestation,O
108375,7451,.,O
108376,7451,The,O
108377,7451,patient,O
108378,7451,who,O
108379,7451,is,O
108380,7451,diagnosed,O
108381,7451,as,O
108382,7451,thrombophilia,B-Condition
108383,7451,with,O
108384,7451,recurrent,O
108385,7451,pregnancy,B-Condition
108386,7451,loss,I-Condition
108387,7451,.,O
108388,7451,Signed,O
108389,7451,consent,O
108390,7451,form,O
108391,7451,.,O
108392,7452,Current,O
108393,7452,DVT,B-Procedure
108394,7453,Recurrent,O
108395,7453,varicose,B-Condition
108396,7453,veins,I-Condition
108397,7454,Arterial,B-Condition
108398,7454,disease,I-Condition
108399,7454,(,O
108400,7454,ABPI<0.8,O
108401,7454,),O
108402,7455,Vein,O
108403,7455,diameter,O
108404,7455,<,O
108405,7455,3,O
108406,7455,mm,O
108407,7456,Preference,O
108408,7456,for,O
108409,7456,one,O
108410,7456,of,O
108411,7456,the,O
108412,7456,treatment,O
108413,7456,options,O
108414,7457,Patient,O
108415,7457,who,O
108416,7457,are,O
108417,7457,unwilling,B-Observation
108418,7457,to,I-Observation
108419,7457,participate,I-Observation
108420,7458,Inability,B-Observation
108421,7458,or,I-Observation
108422,7458,unwillingness,I-Observation
108423,7458,to,I-Observation
108424,7458,complete,I-Observation
108425,7458,questionnaires,I-Observation
108426,7459,Inability,B-Observation
108427,7459,to,I-Observation
108428,7459,attend,I-Observation
108429,7459,follow,I-Observation
108430,7459,-,I-Observation
108431,7459,up,I-Observation
108432,7459,appointments,I-Observation
108433,7460,Patient,O
108434,7460,currently,O
108435,7460,included,O
108436,7460,in,O
108437,7460,a,O
108438,7460,study,O
108439,7460,of,O
108440,7460,varicose,O
108441,7460,vein,O
108442,7460,treatment,O
108443,7461,Adults,B-Person
108444,7461,over,O
108445,7461,18,O
108446,7461,years,O
108447,7461,of,O
108448,7461,age,B-Person
108449,7462,Symptomatic,O
108450,7462,GSV,B-Condition
108451,7462,or,I-Condition
108452,7462,SSV,I-Condition
108453,7462,vein,I-Condition
108454,7462,reflux,I-Condition
108455,7462,>,O
108456,7462,0.5,O
108457,7462,seconds,O
108458,7462,on,O
108459,7462,colour,B-Procedure
108460,7462,Duplex,I-Procedure
108461,7463,Varicose,O
108462,7463,vein,O
108463,7463,tributary,O
108464,7463,requiring,B-Mood
108465,7463,treatment,B-Procedure
108466,7464,Patients,O
108467,7464,who,O
108468,7464,were,O
108469,7464,pregnant,B-Condition
108470,7464,",",O
108471,7464,nursing,B-Condition
108472,7464,or,O
108473,7464,not,O
108474,7464,able,B-Observation
108475,7464,to,I-Observation
108476,7464,give,I-Observation
108477,7464,written,I-Observation
108478,7464,informed,I-Observation
108479,7464,consent,I-Observation
108480,7464,were,O
108481,7464,excluded,O
108482,7464,.,O
108483,7465,Patients,O
108484,7465,suspected,B-Mood
108485,7465,to,O
108486,7465,have,O
108487,7465,vitamin,B-Condition
108488,7465,B12,I-Condition
108489,7465,deficiency,I-Condition
108490,7465,defined,O
108491,7465,as,O
108492,7465,a,O
108493,7465,plasma,O
108494,7465,vitamin,O
108495,7465,B12,O
108496,7465,below,O
108497,7465,the,O
108498,7465,reference,O
108499,7465,interval,O
108500,7465,(,O
108501,7465,<,O
108502,7465,200,O
108503,7465,pmol,O
108504,7465,/,O
108505,7465,L,O
108506,7465,),O
108507,7465,.,O
108508,7466,history,O
108509,7466,of,O
108510,7466,major,O
108511,7466,systemic,B-Condition
108512,7466,illness,I-Condition
108513,7466,",",O
108514,7466,including,O
108515,7466,uncontrolled,O
108516,7466,hypertension,B-Condition
108517,7466,",",O
108518,7466,diabetes,B-Condition
108519,7466,",",O
108520,7466,chronic,B-Condition
108521,7466,renal,I-Condition
108522,7466,insufficiency,I-Condition
108523,7466,",",I-Condition
108524,7466,autoimmune,B-Condition
108525,7466,diseases,I-Condition
108526,7466,or,O
108527,7466,malignancies,B-Condition
108528,7467,history,O
108529,7467,of,O
108530,7467,neurological,B-Condition
108531,7467,disorders,I-Condition
108532,7467,which,O
108533,7467,might,O
108534,7467,affect,B-Condition
108535,7467,sensation,I-Condition
108536,7467,such,O
108537,7467,as,O
108538,7467,previous,O
108539,7467,stroke,B-Condition
108540,7467,or,O
108541,7467,peripheral,B-Condition
108542,7467,neuropathy,I-Condition
108543,7468,history,O
108544,7468,of,O
108545,7468,substance,B-Condition
108546,7468,abuse,I-Condition
108547,7468,(,O
108548,7468,except,O
108549,7468,painkillers,B-Drug
108550,7468,),O
108551,7469,heavy,O
108552,7469,smokers,B-Person
108553,7469,(,O
108554,7469,with,O
108555,7469,a,O
108556,7469,daily,O
108557,7469,consumption,O
108558,7469,>,O
108559,7469,20,O
108560,7469,cigarettes,B-Observation
108561,7469,),O
108562,7470,pregnancy,O
108563,7470,or,O
108564,7470,lactation,O
108565,7471,any,O
108566,7471,contraindication,B-Condition
108567,7471,for,O
108568,7471,magnetic,B-Procedure
108569,7471,resonance,I-Procedure
108570,7471,imaging,I-Procedure
108571,7471,(,O
108572,7471,MRI,B-Procedure
108573,7471,),O
108574,7472,and,O
108575,7472,any,O
108576,7472,obvious,O
108577,7472,infection,B-Condition
108578,7472,or,O
108579,7472,inflammation,B-Condition
108580,7472,over,O
108581,7472,a,O
108582,7472,period,O
108583,7472,of,O
108584,7472,at,O
108585,7472,least,O
108586,7472,1,O
108587,7472,month,O
108588,7472,before,O
108589,7472,the,O
108590,7472,study,O
108591,7472,.,O
108592,7473,Control,O
108593,7473,:,O
108594,7473,devoid,O
108595,7473,of,O
108596,7473,any,O
108597,7473,systemic,B-Condition
108598,7473,or,I-Condition
108599,7473,neurological,I-Condition
108600,7473,diseases,I-Condition
108601,7474,Chronic,B-Condition
108602,7474,migraine,I-Condition
108603,7474,:,O
108604,7474,by,O
108605,7474,ICHD,O
108606,7474,-,O
108607,7474,III,O
108608,7474,(,O
108609,7474,International,O
108610,7474,Classification,O
108611,7474,of,O
108612,7474,Headache,O
108613,7474,Disorder,O
108614,7474,),O
108615,7474,criteria,O
108616,7475,Fibromyalgia,B-Condition
108617,7475,:,O
108618,7475,by,O
108619,7475,ACR,O
108620,7475,(,O
108621,7475,American,O
108622,7475,College,O
108623,7475,of,O
108624,7475,Rheumatology,O
108625,7475,),O
108626,7475,2010,O
108627,7475,criteria,O
108628,7476,Age,B-Person
108629,7476,<,O
108630,7476,45,O
108631,7476,or,O
108632,7476,>,O
108633,7476,55,O
108634,7476,years,O
108635,7476,.,O
108636,7477,Blood,B-Condition
108637,7477,disorders,I-Condition
108638,7477,or,O
108639,7477,coagulopathy,B-Condition
108640,7477,.,O
108641,7478,Diagnosed,B-Mood
108642,7478,or,O
108643,7478,suspected,B-Mood
108644,7478,local,B-Condition
108645,7478,gynecologic,I-Condition
108646,7478,lesion,I-Condition
108647,7478,(,O
108648,7478,polyp,B-Condition
108649,7478,",",O
108650,7478,adenomyosis,B-Condition
108651,7478,",",O
108652,7478,myoma,B-Condition
108653,7478,",",O
108654,7478,malignancy,B-Condition
108655,7478,or,O
108656,7478,cervical,B-Condition
108657,7478,pathology,I-Condition
108658,7478,),O
108659,7478,.,O
108660,7479,Use,O
108661,7479,intrauterine,O
108662,7479,contraceptive,O
108663,7479,device,O
108664,7479,.,O
108665,7480,Pregnancy,B-Condition
108666,7480,related,O
108667,7480,conditions,B-Condition
108668,7480,.,O
108669,7481,Perimenopausal,B-Person
108670,7481,women,B-Person
108671,7481,complaining,O
108672,7481,of,O
108673,7481,abnormal,B-Condition
108674,7481,uterine,I-Condition
108675,7481,bleeding,I-Condition
108676,7481,(,O
108677,7481,menorrhagia,B-Condition
108678,7481,",",O
108679,7481,metrorrhagia,B-Condition
108680,7481,",",O
108681,7481,polymenorrhoea,B-Condition
108682,7481,or,O
108683,7481,polymenorrhagia,B-Condition
108684,7481,),O
108685,7481,without,O
108686,7481,local,B-Condition
108687,7481,gynecological,I-Condition
108688,7481,cause,I-Condition
108689,7481,.,O
108690,7482,Failure,B-Observation
108691,7482,of,O
108692,7482,medical,B-Procedure
108693,7482,treatment,I-Procedure
108694,7482,for,O
108695,7482,at,O
108696,7482,least,O
108697,7482,3,O
108698,7482,months,O
108699,7482,.,O
108700,7483,submucosal,B-Condition
108701,7483,leiomyoma,I-Condition
108702,7483,",",O
108703,7484,endometrial,B-Condition
108704,7484,hyperplasia,I-Condition
108705,7484,with,O
108706,7484,atypia,O
108707,7484,",",O
108708,7485,history,B-Observation
108709,7485,of,O
108710,7485,uterine,B-Procedure
108711,7485,surgery,I-Procedure
108712,7486,hypoechoic,O
108713,7486,uterine,B-Condition
108714,7486,leiomyoma,I-Condition
108715,7486,(,O
108716,7486,echogenicity,O
108717,7486,<3,O
108718,7486,),O
108719,7486,",",O
108720,7487,intramural,B-Condition
108721,7487,leiomyomas,I-Condition
108722,7487,with,O
108723,7487,an,O
108724,7487,ultrasonographic,O
108725,7487,size,O
108726,7487,<,O
108727,7487,20,O
108728,7487,cm,O
108729,7487,but,O
108730,7487,>,O
108731,7487,4,O
108732,7487,cm,O
108733,7487,",",O
108734,7488,indication,B-Mood
108735,7488,to,I-Mood
108736,7488,surgery,B-Procedure
108737,7488,(,O
108738,7488,symptoms,O
108739,7488,of,O
108740,7488,menometrorrhagia,B-Condition
108741,7488,",",O
108742,7489,menstrual,B-Condition
108743,7489,disorder,I-Condition
108744,7489,",",O
108745,7490,infertility,B-Condition
108746,7490,",",O
108747,7491,pelvic,B-Condition
108748,7491,pain,I-Condition
108749,7491,or,O
108750,7491,pelvic,B-Condition
108751,7491,pressure,I-Condition
108752,7492,pregnant,B-Condition
108753,7493,30,O
108754,7493,min,O
108755,7493,or,O
108756,7493,more,O
108757,7493,of,O
108758,7493,moderate,B-Observation
108759,7493,to,I-Observation
108760,7493,vigorous,I-Observation
108761,7493,activity,I-Observation
108762,7493,more,O
108763,7493,than,O
108764,7493,3,O
108765,7493,times,O
108766,7493,per,O
108767,7493,week,O
108768,7494,cardiovascular,B-Condition
108769,7494,disease,I-Condition
108770,7495,physical,B-Condition
108771,7495,limitations,I-Condition
108772,7495,that,O
108773,7495,might,O
108774,7495,be,O
108775,7495,aggravated,O
108776,7495,by,O
108777,7495,moderate,O
108778,7495,physical,O
108779,7495,activity,O
108780,7496,planning,B-Observation
108781,7496,to,I-Observation
108782,7496,move,I-Observation
108783,7496,in,O
108784,7496,next,O
108785,7496,12,O
108786,7496,-,O
108787,7496,24,O
108788,7496,months,O
108789,7497,diabetic,B-Condition
108790,7498,Mexican,B-Person
108791,7498,-,I-Person
108792,7498,american,I-Person
108793,7499,Female,B-Person
108794,7500,BMI,O
108795,7500,30,O
108796,7500,-,O
108797,7500,42,O
108798,7501,willingness,O
108799,7501,to,O
108800,7501,complete,O
108801,7501,protocol,O
108802,7502,pre,B-Condition
108803,7502,-,I-Condition
108804,7502,diabetic,I-Condition
108805,7503,English,O
108806,7503,or,O
108807,7503,Spanish,O
108808,7503,literate,O
108809,7504,If,O
108810,7504,smoking,B-Observation
108811,7504,and/or,O
108812,7504,other,O
108813,7504,drug,B-Condition
108814,7504,addiction,I-Condition
108815,7504,is,O
108816,7504,present,O
108817,7505,If,O
108818,7505,local,B-Drug
108819,7505,anesthetic,I-Drug
108820,7505,allergy,B-Condition
108821,7505,is,O
108822,7505,present,O
108823,7506,Patient,O
108824,7506,subjected,O
108825,7506,to,O
108826,7506,chemical,B-Procedure
108827,7506,or,O
108828,7506,radiotherapy,B-Procedure
108829,7507,if,O
108830,7507,Hepatic,B-Condition
108831,7507,disease,I-Condition
108832,7507,is,O
108833,7507,present,O
108834,7508,If,O
108835,7508,immunodepression,B-Condition
108836,7508,is,O
108837,7508,present,O
108838,7509,If,O
108839,7509,Pregnancy,B-Condition
108840,7509,is,O
108841,7509,present,O
108842,7510,If,O
108843,7510,Diabetes,B-Condition
108844,7510,is,O
108845,7510,present,O
108846,7511,If,O
108847,7511,Heart,B-Condition
108848,7511,disease,I-Condition
108849,7511,is,O
108850,7511,present,O
108851,7512,Single,B-Procedure
108852,7512,unit,I-Procedure
108853,7512,implant,I-Procedure
108854,7512,rehabilitation,I-Procedure
108855,7513,Maxilla,O
108856,7513,and,O
108857,7513,mandible,O
108858,7514,Must,O
108859,7514,accept,O
108860,7514,treatment,O
108861,7514,plan,O
108862,7515,Must,O
108863,7515,sign,O
108864,7515,informed,O
108865,7515,consent,O
108866,7516,dental,B-Procedure
108867,7516,extraction,I-Procedure
108868,7516,performed,O
108869,7516,at,O
108870,7516,least,O
108871,7516,3,O
108872,7516,month,O
108873,7516,prior,O
108874,7517,Must,O
108875,7517,have,O
108876,7517,at,O
108877,7517,least,O
108878,7517,6,O
108879,7517,mm,O
108880,7517,of,O
108881,7517,residual,O
108882,7517,bone,O
108883,7518,Absence,O
108884,7518,of,O
108885,7518,oral,B-Condition
108886,7518,lesions,I-Condition
108887,7519,keratinized,B-Condition
108888,7519,tissue,I-Condition
108889,7519,must,I-Condition
108890,7519,be,I-Condition
108891,7519,present,I-Condition
108892,7520,NA,O
108893,7521,Patients,O
108894,7521,who,O
108895,7521,meet,O
108896,7521,1987,O
108897,7521,ACR,O
108898,7521,criteria,O
108899,7521,for,O
108900,7521,SLE,B-Condition
108901,7521,with,O
108902,7521,1996,O
108903,7521,modifications,O
108904,7522,SLEDAI,O
108905,7522,>,O
108906,7522,/=,O
108907,7522,6,O
108908,7522,at,O
108909,7522,screening,O
108910,7522,visit,O
108911,7523,Positive,O
108912,7523,ANA,O
108913,7523,OR,O
108914,7523,anti,O
108915,7523,-,O
108916,7523,dsDNA,O
108917,7523,within,O
108918,7523,one,O
108919,7523,year,O
108920,7523,of,O
108921,7523,screening,O
108922,7524,In,O
108923,7524,the,O
108924,7524,opinion,O
108925,7524,of,O
108926,7524,the,O
108927,7524,investigator,O
108928,7524,there,O
108929,7524,is,O
108930,7524,intent,O
108931,7524,to,O
108932,7524,treat,O
108933,7524,with,O
108934,7524,a,O
108935,7524,biologic,O
108936,7524,(,O
108937,7524,e.g.,O
108938,7524,patient,O
108939,7524,failed,O
108940,7524,standard,O
108941,7524,of,O
108942,7524,care,O
108943,7524,treatment,O
108944,7524,),O
108945,7524,however,O
108946,7524,there,O
108947,7524,is,O
108948,7524,no,O
108949,7524,organ,O
108950,7524,threatening,O
108951,7524,disease,O
108952,7525,Any,O
108953,7525,active,O
108954,7525,respiratory,B-Condition
108955,7525,",",I-Condition
108956,7525,cardiovascular,I-Condition
108957,7525,or,I-Condition
108958,7525,other,I-Condition
108959,7525,disease,I-Condition
108960,7525,requiring,B-Mood
108961,7525,regular,O
108962,7525,treatment,B-Procedure
108963,7525,or,O
108964,7525,being,O
108965,7525,otherwise,O
108966,7525,relevant,O
108967,7525,for,O
108968,7525,tolerance,B-Condition
108969,7525,of,O
108970,7525,hypoxia,B-Condition
108971,7525,or,O
108972,7525,altitude,B-Condition
108973,7525,exposure,I-Condition
108974,7525,.,O
108975,7526,Any,O
108976,7526,condition,O
108977,7526,that,O
108978,7526,may,O
108979,7526,interfere,O
108980,7526,with,O
108981,7526,protocol,O
108982,7526,compliance,O
108983,7526,including,O
108984,7526,current,O
108985,7526,heavy,B-Condition
108986,7526,smoking,I-Condition
108987,7526,(,O
108988,7526,>,O
108989,7526,20,O
108990,7526,cigarettes,O
108991,7526,per,O
108992,7526,day,O
108993,7526,or,O
108994,7526,>,O
108995,7526,20,O
108996,7526,pack,O
108997,7526,-,O
108998,7526,years,O
108999,7526,with,O
109000,7526,active,B-Condition
109001,7526,smoking,I-Condition
109002,7526,during,O
109003,7526,the,O
109004,7526,last,O
109005,7526,10,O
109006,7526,years,O
109007,7526,),O
109008,7526,",",O
109009,7526,regular,B-Condition
109010,7526,use,I-Condition
109011,7526,of,I-Condition
109012,7526,alcohol,I-Condition
109013,7526,.,O
109014,7527,Allergy,B-Condition
109015,7527,to,O
109016,7527,acetazolamide,B-Drug
109017,7527,and,O
109018,7527,other,O
109019,7527,sulfonamides,B-Drug
109020,7527,.,O
109021,7528,Healthy,B-Observation
109022,7528,men,B-Person
109023,7528,and,O
109024,7528,women,B-Person
109025,7528,",",O
109026,7528,age,B-Person
109027,7528,40,O
109028,7528,-,O
109029,7528,75,O
109030,7528,yrs,O
109031,7528,",",O
109032,7528,without,O
109033,7528,any,B-Condition
109034,7528,disease,I-Condition
109035,7528,and,O
109036,7528,need,B-Mood
109037,7528,of,I-Mood
109038,7528,medication,B-Drug
109039,7528,.,O
109040,7529,Born,O
109041,7529,",",O
109042,7529,raised,O
109043,7529,and,O
109044,7529,currently,O
109045,7529,living,B-Observation
109046,7529,at,I-Observation
109047,7529,low,I-Observation
109048,7529,altitude,I-Observation
109049,7529,(,I-Observation
109050,7529,<,I-Observation
109051,7529,800,I-Observation
109052,7529,m,I-Observation
109053,7529,),O
109054,7529,.,O
109055,7530,Written,O
109056,7530,informed,O
109057,7530,consent,O
109058,7530,.,O
109059,7531,Kyrgyz,B-Person
109060,7531,ethnicity,I-Person
109061,7532,recurrent,O
109062,7532,contracture,B-Condition
109063,7532,in,O
109064,7532,the,O
109065,7532,finger,O
109066,7532,to,O
109067,7532,be,O
109068,7532,treated,O
109069,7533,neurologic,B-Condition
109070,7533,condition,I-Condition
109071,7533,causing,O
109072,7533,the,O
109073,7533,loss,B-Condition
109074,7533,of,I-Condition
109075,7533,function,I-Condition
109076,7533,of,O
109077,7533,the,O
109078,7533,finger,O
109079,7533,to,O
109080,7533,be,O
109081,7533,treated,O
109082,7534,contraindication,B-Condition
109083,7534,for,O
109084,7534,collagenase,B-Drug
109085,7534,clostridium,I-Drug
109086,7534,histolyticym,I-Drug
109087,7534,(,O
109088,7534,Xiapex,B-Drug
109089,7534,/,O
109090,7534,Xiaflex,B-Drug
109091,7534,®,O
109092,7534,),O
109093,7535,pregnant,B-Condition
109094,7535,or,O
109095,7535,breast,B-Observation
109096,7535,feeding,I-Observation
109097,7536,TPED,O
109098,7536,>,O
109099,7536,135,O
109100,7536,°,O
109101,7536,(,O
109102,7536,Tubiana,O
109103,7536,stage,O
109104,7536,4,O
109105,7536,),O
109106,7536,in,O
109107,7536,finger,O
109108,7536,to,O
109109,7536,be,O
109110,7536,treated,O
109111,7537,rheumatoid,B-Condition
109112,7537,arthritis,I-Condition
109113,7538,previous,O
109114,7538,fracture,B-Condition
109115,7538,in,O
109116,7538,finger,O
109117,7538,to,O
109118,7538,be,O
109119,7538,treated,O
109120,7538,",",O
109121,7538,which,O
109122,7538,affects,B-Condition
109123,7538,range,I-Condition
109124,7538,of,I-Condition
109125,7538,motion,I-Condition
109126,7538,of,O
109127,7538,MP,O
109128,7538,or,O
109129,7538,PIP,O
109130,7538,joint,O
109131,7539,age,B-Person
109132,7539,>,O
109133,7539,80,O
109134,7539,years,O
109135,7540,patients,O
109136,7540,with,O
109137,7540,=,O
109138,7540,20,O
109139,7540,°,O
109140,7540,passive,B-Condition
109141,7540,extension,I-Condition
109142,7540,deficit,I-Condition
109143,7540,(,I-Condition
109144,7540,PED,I-Condition
109145,7540,),I-Condition
109146,7540,in,O
109147,7540,metacarpophalangeal,O
109148,7540,(,O
109149,7540,MP,O
109150,7540,),O
109151,7540,or,O
109152,7540,proximal,O
109153,7540,interphalangeal,O
109154,7540,(,O
109155,7540,PIP,O
109156,7540,),O
109157,7540,joint,O
109158,7540,",",O
109159,7540,or,O
109160,7540,TPED,B-Condition
109161,7540,of,O
109162,7540,=,O
109163,7540,30,O
109164,7540,°,O
109165,7540,in,O
109166,7540,MP,O
109167,7540,and,O
109168,7540,PIP,O
109169,7540,joints,O
109170,7540,of,O
109171,7540,finger,O
109172,7540,/,O
109173,7540,fingers,O
109174,7540,II,O
109175,7540,-,O
109176,7540,V,O
109177,7541,age,B-Person
109178,7541,>,O
109179,7541,18,O
109180,7541,years,O
109181,7542,palpable,B-Condition
109182,7542,cord,I-Condition
109183,7543,provision,O
109184,7543,of,O
109185,7543,informed,O
109186,7543,consent,O
109187,7544,ability,O
109188,7544,to,O
109189,7544,fill,O
109190,7544,the,O
109191,7544,Finnish,O
109192,7544,versions,O
109193,7544,of,O
109194,7544,questionnaires,O
109195,7544,.,O
109196,7545,1,O
109197,7545,.,O
109198,7545,Absence,O
109199,7545,of,O
109200,7545,objectionable,O
109201,7545,cognitive,B-Condition
109202,7545,impairment,I-Condition
109203,7545,or,O
109204,7545,presence,O
109205,7545,of,O
109206,7545,dementia,B-Condition
109207,7545,of,O
109208,7545,severe,O
109209,7545,degree,O
109210,7545,defined,O
109211,7545,by,O
109212,7545,CDR,O
109213,7545,score,O
109214,7545,>,O
109215,7545,2.0,O
109216,7545,.,O
109217,7546,2,O
109218,7546,.,O
109219,7546,Unavailability,B-Observation
109220,7546,of,O
109221,7546,brain,B-Procedure
109222,7546,MRI,I-Procedure
109223,7546,(,O
109224,7546,in,O
109225,7546,case,O
109226,7546,of,O
109227,7546,absolute,B-Condition
109228,7546,contraindications,I-Condition
109229,7546,",",O
109230,7546,the,O
109231,7546,use,O
109232,7546,of,O
109233,7546,cranial,B-Procedure
109234,7546,CT,I-Procedure
109235,7546,is,O
109236,7546,allowed,O
109237,7546,),O
109238,7546,.,O
109239,7547,3,O
109240,7547,.,O
109241,7547,Expected,O
109242,7547,poor,O
109243,7547,compliance,O
109244,7547,with,O
109245,7547,the,O
109246,7547,study,O
109247,7547,protocol,O
109248,7547,.,O
109249,7548,4,O
109250,7548,.,O
109251,7548,Past,B-Observation
109252,7548,diagnosis,I-Observation
109253,7548,of,O
109254,7548,major,B-Condition
109255,7548,depression,I-Condition
109256,7548,",",O
109257,7548,schizophrenia,B-Condition
109258,7548,",",O
109259,7548,major,B-Condition
109260,7548,anxiety,I-Condition
109261,7548,syndrome,I-Condition
109262,7548,",",O
109263,7548,or,O
109264,7548,manic-,B-Condition
109265,7548,depressive,I-Condition
109266,7548,illness,I-Condition
109267,7548,.,O
109268,7549,5,O
109269,7549,.,O
109270,7549,Diagnosis,O
109271,7549,of,O
109272,7549,degenerative,B-Condition
109273,7549,cognitive,I-Condition
109274,7549,impairment,I-Condition
109275,7549,based,O
109276,7549,on,O
109277,7549,clinical,B-Condition
109278,7549,and/or,I-Condition
109279,7549,neuroradiological,I-Condition
109280,7549,findings,I-Condition
109281,7549,(,O
109282,7549,i.e.,O
109283,7549,",",O
109284,7549,patients,O
109285,7549,with,O
109286,7549,prevailing,O
109287,7549,memory,B-Condition
109288,7549,impairment,I-Condition
109289,7549,",",O
109290,7549,or,O
109291,7549,with,O
109292,7549,medial,B-Condition
109293,7549,temporal,I-Condition
109294,7549,atrophy,I-Condition
109295,7549,on,O
109296,7549,brain,B-Procedure
109297,7549,MRI,I-Procedure
109298,7549,in,O
109299,7549,absence,O
109300,7549,of,O
109301,7549,evident,O
109302,7549,vascular,B-Condition
109303,7549,abnormalities,I-Condition
109304,7549,;,O
109305,7549,i.e.,O
109306,7549,",",O
109307,7549,Alzheimer,B-Condition
109308,7549,disease,I-Condition
109309,7549,as,O
109310,7549,defined,O
109311,7549,using,O
109312,7549,the,O
109313,7549,National,O
109314,7549,Institute,O
109315,7549,of,O
109316,7549,Neurological,O
109317,7549,and,O
109318,7549,Communicative,O
109319,7549,Disorders,O
109320,7549,and,O
109321,7549,Stroke,O
109322,7549,/,O
109323,7549,Alzheimer,O
109324,7549,'s,O
109325,7549,Disease,O
109326,7549,and,O
109327,7549,Related,O
109328,7549,Disorders,O
109329,7549,Association,O
109330,7549,criteria,O
109331,7549,",",O
109332,7549,Parkinson,B-Condition
109333,7549,disease,I-Condition
109334,7549,",",O
109335,7549,Huntington,B-Condition
109336,7549,disease,I-Condition
109337,7549,",",O
109338,7549,frontotemporal,B-Condition
109339,7549,dementia,I-Condition
109340,7549,),O
109341,7549,.,O
109342,7550,6,O
109343,7550,.,O
109344,7550,Diagnosis,O
109345,7550,of,O
109346,7550,cognitive,B-Condition
109347,7550,impairment,I-Condition
109348,7550,from,O
109349,7550,other,O
109350,7550,causes,O
109351,7550,(,O
109352,7550,i.e.,O
109353,7550,",",O
109354,7550,vitamine,B-Condition
109355,7550,B12,I-Condition
109356,7550,and,I-Condition
109357,7550,folic,I-Condition
109358,7550,acid,I-Condition
109359,7550,deficiency,I-Condition
109360,7550,",",O
109361,7550,thyroid,B-Condition
109362,7550,disorders,I-Condition
109363,7550,",",O
109364,7550,metabolic,B-Condition
109365,7550,diseases,I-Condition
109366,7550,",",O
109367,7550,head,B-Condition
109368,7550,trauma,I-Condition
109369,7550,",",O
109370,7550,tumor,B-Condition
109371,7550,or,I-Condition
109372,7550,infections,I-Condition
109373,7550,of,I-Condition
109374,7550,the,I-Condition
109375,7550,central,I-Condition
109376,7550,nervous,I-Condition
109377,7550,system,I-Condition
109378,7550,",",O
109379,7550,normal,B-Condition
109380,7550,pressure,I-Condition
109381,7550,hydrocephalus,I-Condition
109382,7550,),O
109383,7550,.,O
109384,7551,7,O
109385,7551,.,O
109386,7551,Medical,O
109387,7551,conditions,O
109388,7551,expected,O
109389,7551,to,O
109390,7551,progress,O
109391,7551,",",O
109392,7551,recur,O
109393,7551,",",O
109394,7551,or,O
109395,7551,change,O
109396,7551,to,O
109397,7551,such,O
109398,7551,a,O
109399,7551,degree,O
109400,7551,to,O
109401,7551,interfere,O
109402,7551,with,O
109403,7551,the,O
109404,7551,assessment,O
109405,7551,of,O
109406,7551,the,O
109407,7551,clinical,O
109408,7551,and,O
109409,7551,mental,O
109410,7551,status,O
109411,7551,.,O
109412,7552,8,O
109413,7552,.,O
109414,7552,Clinically,O
109415,7552,relevant,O
109416,7552,cardiac,B-Condition
109417,7552,or,I-Condition
109418,7552,pulmonary,I-Condition
109419,7552,insufficiency,I-Condition
109420,7552,.,O
109421,7553,9,O
109422,7553,.,O
109423,7553,Relevant,O
109424,7553,electrocardiograph,B-Procedure
109425,7553,abnormalities,B-Condition
109426,7553,;,O
109427,7553,bradycardia,B-Condition
109428,7553,(,O
109429,7553,50,O
109430,7553,bpm,O
109431,7553,),O
109432,7553,or,O
109433,7553,tachycardia,B-Condition
109434,7553,(,O
109435,7553,120,O
109436,7553,bpm,O
109437,7553,),O
109438,7553,under,O
109439,7553,resting,O
109440,7553,conditions,O
109441,7553,.,O
109442,7554,10,O
109443,7554,.,O
109444,7554,Myocardial,B-Condition
109445,7554,infarction,I-Condition
109446,7554,within,O
109447,7554,the,O
109448,7554,past,O
109449,7554,6,O
109450,7554,months,O
109451,7554,.,O
109452,7555,11,O
109453,7555,.,O
109454,7555,Stroke,B-Condition
109455,7555,still,O
109456,7555,requiring,O
109457,7555,neurological,B-Procedure
109458,7555,rehabilitation,I-Procedure
109459,7555,.,O
109460,7556,12,O
109461,7556,.,O
109462,7556,Severe,O
109463,7556,/,O
109464,7556,untreated,O
109465,7556,blood,O
109466,7556,pressure,O
109467,7556,(,O
109468,7556,systolic,O
109469,7556,180,O
109470,7556,mm,O
109471,7556,Hg,O
109472,7556,",",O
109473,7556,diastolic,O
109474,7556,95,O
109475,7556,mm,O
109476,7556,Hg,O
109477,7556,),O
109478,7556,.,O
109479,7557,13,O
109480,7557,.,O
109481,7557,Clinically,O
109482,7557,relevant,O
109483,7557,liver,B-Condition
109484,7557,function,I-Condition
109485,7557,impairment,I-Condition
109486,7557,.,O
109487,7558,14,O
109488,7558,.,O
109489,7558,Insulin,B-Condition
109490,7558,-,I-Condition
109491,7558,dependent,I-Condition
109492,7558,diabetes,I-Condition
109493,7558,mellitus,I-Condition
109494,7558,.,O
109495,7559,15,O
109496,7559,.,O
109497,7559,Idiopathic,B-Condition
109498,7559,epilepsy,I-Condition
109499,7559,and,O
109500,7559,anti,B-Condition
109501,7559,-,I-Condition
109502,7559,epileptic,I-Condition
109503,7559,treatment,I-Condition
109504,7559,.,O
109505,7560,16,O
109506,7560,.,O
109507,7560,Severe,O
109508,7560,anemia,B-Condition
109509,7560,(,O
109510,7560,Hb,O
109511,7560,<,O
109512,7560,10,O
109513,7560,mg,O
109514,7560,/,O
109515,7560,dL,O
109516,7560,),O
109517,7560,.,O
109518,7561,17,O
109519,7561,.,O
109520,7561,Severe,O
109521,7561,gastrointestinal,B-Condition
109522,7561,disease,I-Condition
109523,7561,.,O
109524,7562,18,O
109525,7562,.,O
109526,7562,Cancer,B-Condition
109527,7562,.,O
109528,7563,19,O
109529,7563,.,O
109530,7563,Known,O
109531,7563,intolerance,B-Condition
109532,7563,to,O
109533,7563,study,B-Drug
109534,7563,drugs,I-Drug
109535,7563,.,O
109536,7564,20,O
109537,7564,.,O
109538,7564,Coexistent,O
109539,7564,serious,O
109540,7564,illnesses,O
109541,7564,that,O
109542,7564,would,O
109543,7564,imply,O
109544,7564,a,O
109545,7564,drop,O
109546,7564,-,O
109547,7564,out,O
109548,7564,before,O
109549,7564,the,O
109550,7564,end,O
109551,7564,of,O
109552,7564,the,O
109553,7564,trial,O
109554,7564,.,O
109555,7565,1,O
109556,7565,.,O
109557,7565,Cognitive,B-Condition
109558,7565,impairment,I-Condition
109559,7565,from,O
109560,7565,mild,O
109561,7565,to,O
109562,7565,moderate,O
109563,7565,degree,O
109564,7565,defined,O
109565,7565,by,O
109566,7565,a,O
109567,7565,Clinical,O
109568,7565,Deterioration,O
109569,7565,Rating,O
109570,7565,(,O
109571,7565,CDR,O
109572,7565,),O
109573,7565,score,O
109574,7565,range,O
109575,7565,between,O
109576,7565,0.5,O
109577,7565,and,O
109578,7565,2.0,O
109579,7565,.,O
109580,7566,2,O
109581,7566,.,O
109582,7566,Evidence,O
109583,7566,on,O
109584,7566,brain,B-Procedure
109585,7566,MRI,I-Procedure
109586,7566,of,O
109587,7566,white,B-Observation
109588,7566,matter,I-Observation
109589,7566,hyperintensities,I-Observation
109590,7566,(,O
109591,7566,leukoaraiosis,B-Condition
109592,7566,of,O
109593,7566,moderate,O
109594,7566,or,O
109595,7566,severe,O
109596,7566,degree,O
109597,7566,according,O
109598,7566,to,O
109599,7566,the,O
109600,7566,modified,O
109601,7566,Fazekas,O
109602,7566,visual,O
109603,7566,scale,O
109604,7566,and/or,O
109605,7566,presence,O
109606,7566,of,O
109607,7566,lacunar,B-Condition
109608,7566,infarcts,I-Condition
109609,7566,),O
109610,7566,.,O
109611,7567,3,O
109612,7567,.,O
109613,7567,Consent,O
109614,7567,to,O
109615,7567,participation,O
109616,7567,in,O
109617,7567,the,O
109618,7567,study,O
109619,7567,.,O
109620,7568,Age,B-Person
109621,7568,<,O
109622,7568,18,O
109623,7569,Pregnancy,B-Condition
109624,7570,Bradycardia,B-Condition
109625,7570,(,O
109626,7570,HR<55bpm,O
109627,7570,),O
109628,7571,Systolic,O
109629,7571,Blood,O
109630,7571,Pressure,O
109631,7571,<,O
109632,7571,80,O
109633,7571,mmHg,O
109634,7571,/,O
109635,7571,Mean,O
109636,7571,arterial,O
109637,7571,pressure,O
109638,7571,<,O
109639,7571,50,O
109640,7571,mmHg,O
109641,7571,on,O
109642,7571,maximal,O
109643,7571,support,B-Procedure
109644,7572,Death,B-Condition
109645,7572,imminent,O
109646,7573,Unlikely,O
109647,7573,to,O
109648,7573,survive,O
109649,7573,90,O
109650,7573,days,O
109651,7574,Acute,B-Condition
109652,7574,liver,I-Condition
109653,7574,failure,I-Condition
109654,7575,Dementia,B-Condition
109655,7576,High,B-Condition
109656,7576,-,I-Condition
109657,7576,grade,I-Condition
109658,7576,block,I-Condition
109659,7576,in,O
109660,7576,the,O
109661,7576,absence,O
109662,7576,of,O
109663,7576,a,O
109664,7576,functioning,O
109665,7576,pacemaker,O
109666,7576,.,O
109667,7577,Septic,B-Condition
109668,7577,shock,I-Condition
109669,7577,patients,O
109670,7577,despite,O
109671,7577,early,B-Procedure
109672,7577,goal,I-Procedure
109673,7577,directed,I-Procedure
109674,7577,therapy,I-Procedure
109675,7578,Agree,O
109676,7578,to,O
109677,7578,participate,O
109678,7578,this,O
109679,7578,study,O
109680,7579,patient,O
109681,7579,not,O
109682,7579,previously,O
109683,7579,scheduled,B-Mood
109684,7579,for,I-Mood
109685,7579,radiofrequency,B-Procedure
109686,7579,ablation,I-Procedure
109687,7579,of,O
109688,7579,the,O
109689,7579,cervical,O
109690,7579,",",O
109691,7579,thoracic,O
109692,7579,",",O
109693,7579,or,O
109694,7579,lumbar,O
109695,7579,facets,O
109696,7579,",",O
109697,7579,or,O
109698,7579,sacroiliac,O
109699,7579,joints,O
109700,7580,on,O
109701,7580,anticoagulation,B-Procedure
109702,7581,have,O
109703,7581,a,O
109704,7581,pacemaker,O
109705,7582,age,B-Person
109706,7582,less,O
109707,7582,than,O
109708,7582,18,O
109709,7582,years,O
109710,7582,old,O
109711,7583,non,O
109712,7583,-,O
109713,7583,English,B-Observation
109714,7583,speaking,I-Observation
109715,7584,patients,O
109716,7584,with,O
109717,7584,a,O
109718,7584,diagnosis,O
109719,7584,of,O
109720,7584,either,O
109721,7584,cervical,B-Condition
109722,7584,",",I-Condition
109723,7584,thoracic,I-Condition
109724,7584,",",I-Condition
109725,7584,or,I-Condition
109726,7584,lumbar,I-Condition
109727,7584,facet,I-Condition
109728,7584,or,I-Condition
109729,7584,sacroiliac,I-Condition
109730,7584,joint,I-Condition
109731,7584,pain,I-Condition
109732,7584,who,O
109733,7584,have,O
109734,7584,responded,B-Observation
109735,7584,to,O
109736,7584,medial,B-Procedure
109737,7584,branch,I-Procedure
109738,7584,blocks,I-Procedure
109739,7584,and,O
109740,7584,are,O
109741,7584,already,O
109742,7584,scheduled,B-Mood
109743,7584,for,I-Mood
109744,7584,bilateral,B-Procedure
109745,7584,radiofrequency,I-Procedure
109746,7584,ablations,I-Procedure
109747,7585,age,B-Person
109748,7585,greater,O
109749,7585,than,O
109750,7585,18,O
109751,7585,years,O
109752,7585,old,O
109753,7586,English,B-Observation
109754,7586,speaking,I-Observation
109755,7587,Pacing,B-Procedure
109756,7587,threshold(s,I-Procedure
109757,7587,),O
109758,7587,(,O
109759,7587,at,O
109760,7587,0.4,O
109761,7587,or,O
109762,7587,0.5,O
109763,7587,ms,O
109764,7587,),O
109765,7587,and/or,O
109766,7587,sensing,B-Procedure
109767,7587,amplitude(s,I-Procedure
109768,7587,),O
109769,7587,and/or,O
109770,7587,impedance(s,B-Procedure
109771,7587,),O
109772,7587,are,O
109773,7587,not,B-Condition
109774,7587,measurable,I-Condition
109775,7588,Meet,O
109776,7588,one,O
109777,7588,or,O
109778,7588,more,O
109779,7588,of,O
109780,7588,the,O
109781,7588,contraindications,B-Condition
109782,7588,for,O
109783,7588,MRI,B-Procedure
109784,7588,including,O
109785,7588,Psychiatric,B-Condition
109786,7588,disorders,I-Condition
109787,7588,",",O
109788,7588,anxiety,B-Condition
109789,7588,",",O
109790,7588,claustrophobia,B-Condition
109791,7588,Cardiac,B-Condition
109792,7588,disorders,I-Condition
109793,7588,that,O
109794,7588,represent,O
109795,7588,a,O
109796,7588,contraindication,B-Condition
109797,7588,to,O
109798,7588,MRI,B-Procedure
109799,7589,Cardiac,B-Procedure
109800,7589,surgery,I-Procedure
109801,7589,already,O
109802,7589,scheduled,B-Mood
109803,7589,in,O
109804,7589,the,O
109805,7589,next,O
109806,7589,three,O
109807,7589,months,O
109808,7590,Have,O
109809,7590,other,O
109810,7590,medical,O
109811,7590,implants,O
109812,7590,that,O
109813,7590,may,O
109814,7590,interact,B-Condition
109815,7590,with,I-Condition
109816,7590,MRI,I-Condition
109817,7590,",",O
109818,7590,e.g.,O
109819,7590,abandoned,O
109820,7590,implantable,O
109821,7590,cardioverter,O
109822,7590,defibrillator,O
109823,7590,(,O
109824,7590,ICD,O
109825,7590,),O
109826,7590,leads,O
109827,7590,or,O
109828,7590,pacemaker,O
109829,7590,leads,O
109830,7590,other,O
109831,7590,than,O
109832,7590,MRI,O
109833,7590,conditional,O
109834,7590,",",O
109835,7590,lead,O
109836,7590,extensions,O
109837,7590,",",O
109838,7590,other,O
109839,7590,active,O
109840,7590,medical,O
109841,7590,devices,O
109842,7590,",",O
109843,7590,non,O
109844,7590,-,O
109845,7590,MRI,O
109846,7590,compatible,O
109847,7590,devices,O
109848,7590,",",O
109849,7590,mechanical,O
109850,7590,valve,O
109851,7591,Have,O
109852,7591,other,O
109853,7591,metallic,O
109854,7591,artifacts,O
109855,7591,/,O
109856,7591,components,O
109857,7591,in,O
109858,7591,body,O
109859,7591,that,O
109860,7591,may,O
109861,7591,interact,B-Condition
109862,7591,with,O
109863,7591,MRI,B-Procedure
109864,7592,Subjects,O
109865,7592,for,O
109866,7592,whom,O
109867,7592,a,O
109868,7592,single,O
109869,7592,dose,O
109870,7592,of,O
109871,7592,1.0,O
109872,7592,milligram,O
109873,7592,(,O
109874,7592,mg,O
109875,7592,),O
109876,7592,dexamethasone,B-Drug
109877,7592,acetate,I-Drug
109878,7592,may,O
109879,7592,be,O
109880,7592,contraindicated,B-Condition
109881,7593,Subjects,O
109882,7593,who,O
109883,7593,require,O
109884,7593,a,O
109885,7593,legally,O
109886,7593,authorized,O
109887,7593,representative,O
109888,7593,to,O
109889,7593,obtain,O
109890,7593,consent,O
109891,7594,Subjects,O
109892,7594,who,O
109893,7594,are,O
109894,7594,immediate,O
109895,7594,candidates,B-Mood
109896,7594,for,I-Mood
109897,7594,an,O
109898,7594,ICD,B-Procedure
109899,7595,Subjects,O
109900,7595,with,O
109901,7595,medical,B-Condition
109902,7595,conditions,I-Condition
109903,7595,that,O
109904,7595,preclude,B-Condition
109905,7595,the,O
109906,7595,testing,B-Procedure
109907,7595,required,I-Procedure
109908,7595,by,I-Procedure
109909,7595,the,I-Procedure
109910,7595,protocol,I-Procedure
109911,7595,or,O
109912,7595,limit,B-Condition
109913,7595,study,I-Condition
109914,7595,participation,I-Condition
109915,7596,Subjects,O
109916,7596,who,O
109917,7596,are,O
109918,7596,enrolled,O
109919,7596,or,O
109920,7596,intend,O
109921,7596,to,O
109922,7596,participate,O
109923,7596,in,O
109924,7596,another,O
109925,7596,clinical,O
109926,7596,trial,O
109927,7596,(,O
109928,7596,of,O
109929,7596,an,O
109930,7596,investigational,O
109931,7596,drug,O
109932,7596,or,O
109933,7596,device,O
109934,7596,",",O
109935,7596,new,O
109936,7596,indication,O
109937,7596,for,O
109938,7596,an,O
109939,7596,approved,O
109940,7596,drug,O
109941,7596,or,O
109942,7596,device,O
109943,7596,",",O
109944,7596,or,O
109945,7596,requirement,O
109946,7596,of,O
109947,7596,additional,O
109948,7596,testing,O
109949,7596,beyond,O
109950,7596,standard,O
109951,7596,clinical,O
109952,7596,practice,O
109953,7596,),O
109954,7596,during,O
109955,7596,this,O
109956,7596,clinical,O
109957,7596,study,O
109958,7597,Being,O
109959,7597,pregnant,B-Condition
109960,7598,Have,O
109961,7598,a,O
109962,7598,life,B-Observation
109963,7598,expectancy,I-Observation
109964,7598,of,O
109965,7598,less,O
109966,7598,than,O
109967,7598,three,O
109968,7598,months,O
109969,7599,Subjects,O
109970,7599,with,O
109971,7599,exclusion,O
109972,7599,criteria,O
109973,7599,required,O
109974,7599,by,O
109975,7599,local,O
109976,7599,law,O
109977,7599,(,O
109978,7599,e.g.,O
109979,7599,age,O
109980,7599,",",O
109981,7599,breastfeeding,O
109982,7599,),O
109983,7600,Approved,O
109984,7600,clinical,B-Condition
109985,7600,indication,I-Condition
109986,7600,for,O
109987,7600,pectoral,B-Procedure
109988,7600,pacemaker,I-Procedure
109989,7600,exchange,I-Procedure
109990,7600,(,O
109991,7600,e.g.,O
109992,7600,elective,B-Condition
109993,7600,replacement,I-Condition
109994,7600,indication,I-Condition
109995,7600,(,I-Condition
109996,7600,ERI,I-Condition
109997,7600,),I-Condition
109998,7600,",",O
109999,7600,end,B-Condition
110000,7600,of,I-Condition
110001,7600,service,I-Condition
110002,7600,(,I-Condition
110003,7600,EOS,I-Condition
110004,7600,),I-Condition
110005,7600,),O
110006,7601,a,O
110007,7601,single,O
110008,7601,or,O
110009,7601,dual,O
110010,7601,chamber,O
110011,7601,MRI,O
110012,7601,conditional,O
110013,7601,pacemaker,O
110014,7601,(,O
110015,7601,BSCI,O
110016,7601,),O
110017,7601,or,O
110018,7602,Any,O
110019,7602,comparable,O
110020,7602,successor,O
110021,7602,IPG,O
110022,7602,(,O
110023,7602,MRI,O
110024,7602,conditional,O
110025,7602,system,O
110026,7602,",",O
110027,7602,BSCI,O
110028,7602,),O
110029,7602,compatible,O
110030,7602,with,O
110031,7603,Implanted,O
110032,7603,Fineline,O
110033,7603,-,O
110034,7603,II,O
110035,7603,-,O
110036,7603,leads,O
110037,7603,(,O
110038,7603,BSCI,O
110039,7603,),O
110040,7603,",",O
110041,7603,MRI,O
110042,7603,conditional,O
110043,7604,The,O
110044,7604,ascertained,O
110045,7604,lead,O
110046,7604,impedance,O
110047,7604,is,O
110048,7604,between,O
110049,7604,200,O
110050,7604,and,O
110051,7604,1500,O
110052,7604,Ohm,O
110053,7604,.,O
110054,7605,All,O
110055,7605,pacing,O
110056,7605,capture,O
110057,7605,thresholds,O
110058,7605,(,O
110059,7605,PCT,O
110060,7605,),O
110061,7605,do,O
110062,7605,not,O
110063,7605,exceed,O
110064,7605,2.0,O
110065,7605,V,O
110066,7605,@0.4,O
110067,7605,or,O
110068,7605,0.5,O
110069,7605,ms,O
110070,7605,in,O
110071,7605,pacemaker,B-Condition
110072,7605,dependent,I-Condition
110073,7605,patients,O
110074,7606,Male,B-Person
110075,7606,or,O
110076,7606,female,B-Person
110077,7606,18,O
110078,7606,years,B-Person
110079,7606,or,I-Person
110080,7606,older,I-Person
110081,7607,Understand,O
110082,7607,the,O
110083,7607,nature,O
110084,7607,of,O
110085,7607,the,O
110086,7607,procedure,O
110087,7608,Give,O
110088,7608,written,O
110089,7608,informed,O
110090,7608,consent,O
110091,7609,Able,O
110092,7609,to,O
110093,7609,complete,O
110094,7609,all,O
110095,7609,testing,O
110096,7609,required,O
110097,7609,by,O
110098,7609,the,O
110099,7609,clinical,O
110100,7609,protocol,O
110101,7610,Ability,O
110102,7610,to,O
110103,7610,measure,O
110104,7610,atrial,O
110105,7610,and/or,O
110106,7610,ventricular,O
110107,7610,pacing,O
110108,7610,threshold(s,O
110109,7610,),O
110110,7610,at,O
110111,7610,0.4,O
110112,7610,or,O
110113,7610,0.5,O
110114,7610,ms,O
110115,7611,Patient,O
110116,7611,body,O
110117,7611,height,O
110118,7611,greater,O
110119,7611,or,O
110120,7611,equal,O
110121,7611,to,O
110122,7611,140,O
110123,7611,cm,O
110124,7612,Pectoral,O
110125,7612,implanted,O
110126,7612,device,O
110127,7613,Subjects,O
110128,7613,who,O
110129,7613,are,O
110130,7613,able,O
110131,7613,and,O
110132,7613,willing,B-Mood
110133,7613,to,I-Mood
110134,7613,undergo,I-Mood
110135,7613,elective,O
110136,7613,cardiac,B-Procedure
110137,7613,magnetic,I-Procedure
110138,7613,resonance,I-Procedure
110139,7613,(,I-Procedure
110140,7613,MR,I-Procedure
110141,7613,),I-Procedure
110142,7613,scanning,I-Procedure
110143,7613,without,O
110144,7613,sedation,O
110145,7613,(,O
110146,7613,MRI,O
110147,7613,-,O
110148,7613,group,O
110149,7613,),O
110150,7614,Subjects,O
110151,7614,who,O
110152,7614,are,O
110153,7614,geographically,B-Person
110154,7614,stable,I-Person
110155,7614,and,O
110156,7614,available,B-Observation
110157,7614,for,I-Observation
110158,7614,follow,I-Observation
110159,7614,-,I-Observation
110160,7614,up,I-Observation
110161,7614,at,O
110162,7614,the,O
110163,7614,study,O
110164,7614,center,O
110165,7614,for,O
110166,7614,the,O
110167,7614,length,O
110168,7614,of,O
110169,7614,the,O
110170,7614,study,O
110171,7615,Documented,O
110172,7615,positive,O
110173,7615,hepatitis,O
110174,7615,B,O
110175,7615,(,O
110176,7615,HBV,O
110177,7615,),O
110178,7615,surface,O
110179,7615,antigen,O
110180,7615,",",O
110181,7615,and/or,O
110182,7615,HBV,O
110183,7615,DNA,O
110184,7615,prior,O
110185,7615,to,O
110186,7615,enrollment,O
110187,7616,Any,O
110188,7616,prior,O
110189,7616,exposure,O
110190,7616,to,O
110191,7616,HCV,B-Procedure
110192,7616,protease,I-Procedure
110193,7616,inhibitor,I-Procedure
110194,7616,therapy,I-Procedure
110195,7617,HIV,B-Condition
110196,7617,co,I-Condition
110197,7617,-,I-Condition
110198,7617,infection,I-Condition
110199,7617,if,O
110200,7617,on,O
110201,7617,a,O
110202,7617,protease,B-Drug
110203,7617,inhibitor,I-Drug
110204,7617,based,O
110205,7617,regimen,O
110206,7618,Increase,O
110207,7618,in,O
110208,7618,creatinine,O
110209,7618,of,O
110210,7618,15,O
110211,7618,%,O
110212,7618,or,O
110213,7618,greater,O
110214,7618,within,O
110215,7618,one,O
110216,7618,month,O
110217,7618,(,O
110218,7618,30,O
110219,7618,days,O
110220,7618,),O
110221,7618,of,O
110222,7618,the,O
110223,7618,screening,O
110224,7618,visit,O
110225,7619,Evidence,O
110226,7619,of,O
110227,7619,hepatocellular,B-Condition
110228,7619,carcinoma,I-Condition
110229,7619,at,O
110230,7619,the,O
110231,7619,time,O
110232,7619,of,O
110233,7619,enrollment,O
110234,7620,Liver,B-Condition
110235,7620,disease,I-Condition
110236,7620,caused,O
110237,7620,by,O
110238,7620,an,O
110239,7620,etiology,O
110240,7620,other,O
110241,7620,than,O
110242,7620,HCV,B-Observation
110243,7621,F4,B-Observation
110244,7621,or,O
110245,7621,decompensated,B-Condition
110246,7621,cirrhotic,I-Condition
110247,7621,patients,O
110248,7622,Child,O
110249,7622,Pugh,O
110250,7622,class,O
110251,7622,B,O
110252,7622,or,O
110253,7622,C,O
110254,7623,AST,O
110255,7623,or,O
110256,7623,ALT,O
110257,7623,>,O
110258,7623,350,O
110259,7623,within,O
110260,7623,6,O
110261,7623,months,O
110262,7623,prior,O
110263,7623,to,O
110264,7623,enrollment,O
110265,7624,Albumin,O
110266,7624,<,O
110267,7624,3g,O
110268,7624,/,O
110269,7624,dL,O
110270,7624,at,O
110271,7624,the,O
110272,7624,time,O
110273,7624,of,O
110274,7624,enrollment,O
110275,7625,Platelet,O
110276,7625,count,O
110277,7625,<,O
110278,7625,75,O
110279,7625,at,O
110280,7625,the,O
110281,7625,time,O
110282,7625,of,O
110283,7625,enrollment,O
110284,7626,History,O
110285,7626,of,O
110286,7626,clinically,O
110287,7626,significant,O
110288,7626,allergy,B-Condition
110289,7626,or,O
110290,7626,adverse,B-Condition
110291,7626,event,I-Condition
110292,7626,with,O
110293,7626,protease,B-Drug
110294,7626,inhibitors,I-Drug
110295,7627,Evidence,O
110296,7627,of,O
110297,7627,the,O
110298,7627,acquisition,B-Condition
110299,7627,of,I-Condition
110300,7627,HCV,I-Condition
110301,7627,at,O
110302,7627,the,O
110303,7627,time,O
110304,7627,of,O
110305,7627,or,O
110306,7627,after,O
110307,7627,transplantation,O
110308,7628,Pregnant,O
110309,7628,or,O
110310,7628,breastfeeding,O
110311,7628,women,O
110312,7629,Cyclosporine,B-Drug
110313,7629,;,O
110314,7629,St.,B-Drug
110315,7629,John,I-Drug
110316,7629,'s,I-Drug
110317,7629,Wort,I-Drug
110318,7629,;,O
110319,7629,Efavirenz,B-Drug
110320,7629,;,O
110321,7629,Phenytoin,B-Drug
110322,7629,;,O
110323,7629,Carbamazepine,B-Drug
110324,7629,;,O
110325,7629,Bosentan,B-Drug
110326,7629,;,O
110327,7629,HIV,B-Drug
110328,7629,protease,I-Drug
110329,7629,inhibitors,I-Drug
110330,7629,;,O
110331,7629,modafinil,B-Drug
110332,7629,;,O
110333,7629,ketoconazole,B-Drug
110334,7629,;,O
110335,7629,or,O
110336,7629,rifampin,B-Drug
110337,7629,use,O
110338,7629,within,O
110339,7629,7,O
110340,7629,days,O
110341,7629,of,O
110342,7629,enrollment,O
110343,7630,Coadministration,O
110344,7630,of,O
110345,7630,more,O
110346,7630,than,O
110347,7630,20,O
110348,7630,mg,O
110349,7630,atorvastatin,B-Drug
110350,7630,;,O
110351,7630,10,O
110352,7630,mg,O
110353,7630,rosuvastatin,B-Drug
110354,7630,;,O
110355,7630,20,O
110356,7630,mg,O
110357,7630,of,O
110358,7630,fluvastatin,B-Drug
110359,7630,",",O
110360,7630,lovastatin,B-Drug
110361,7630,or,O
110362,7630,simvastatin,B-Drug
110363,7631,At,O
110364,7631,least,O
110365,7631,18,O
110366,7631,years,O
110367,7631,of,O
110368,7631,age,B-Person
110369,7631,at,O
110370,7631,the,O
110371,7631,time,O
110372,7631,of,O
110373,7631,screening,O
110374,7632,Have,O
110375,7632,stable,O
110376,7632,renal,O
110377,7632,function,O
110378,7632,for,O
110379,7632,one,O
110380,7632,month,O
110381,7632,(,O
110382,7632,30,O
110383,7632,days,O
110384,7632,),O
110385,7632,prior,O
110386,7632,to,O
110387,7632,enrollment,O
110388,7633,Have,O
110389,7633,Chronic,B-Condition
110390,7633,HCV,I-Condition
110391,7633,infection,I-Condition
110392,7633,prior,O
110393,7633,to,O
110394,7633,transplantation,O
110395,7633,with,O
110396,7633,documented,O
110397,7633,HCV,O
110398,7633,viremia,O
110399,7633,=,O
110400,7633,"1,000",O
110401,7633,IU,O
110402,7633,/,O
110403,7633,ml,O
110404,7633,at,O
110405,7633,screening,O
110406,7633,and,O
110407,7633,either,O
110408,7633,documented,O
110409,7633,HCV,O
110410,7633,Ab,O
110411,7633,positivity,O
110412,7633,or,O
110413,7633,HCV,O
110414,7633,viremia,O
110415,7633,=,O
110416,7633,"1,000",O
110417,7633,IU,O
110418,7633,/,O
110419,7633,ml,O
110420,7633,at,O
110421,7633,least,O
110422,7633,6,O
110423,7633,months,O
110424,7633,prior,O
110425,7633,to,O
110426,7633,enrollment,O
110427,7633,.,O
110428,7634,Documented,O
110429,7634,genotype,O
110430,7634,1,O
110431,7634,HCV,B-Condition
110432,7634,infection,I-Condition
110433,7634,prior,O
110434,7634,to,O
110435,7634,enrollment,O
110436,7634,and,O
110437,7634,after,O
110438,7634,their,O
110439,7634,transplant,O
110440,7634,in,O
110441,7634,the,O
110442,7634,post,O
110443,7634,-,O
110444,7634,transplantation,O
110445,7634,cohort,O
110446,7635,HCV,O
110447,7635,disease,B-Procedure
110448,7635,staging,I-Procedure
110449,7635,within,O
110450,7635,12,O
110451,7635,months,O
110452,7635,prior,O
110453,7635,to,O
110454,7635,enrollment,O
110455,7635,by,O
110456,7635,liver,B-Procedure
110457,7635,biopsy,I-Procedure
110458,7635,",",O
110459,7635,transient,B-Procedure
110460,7635,elastography,I-Procedure
110461,7635,",",O
110462,7635,or,O
110463,7635,biochemical,B-Procedure
110464,7635,testing,I-Procedure
110465,7636,Be,O
110466,7636,able,O
110467,7636,to,O
110468,7636,give,O
110469,7636,informed,O
110470,7636,consent,O
110471,7636,and,O
110472,7636,comply,O
110473,7636,with,O
110474,7636,study,O
110475,7636,guidelines,O
110476,7637,Women,O
110477,7637,of,O
110478,7637,childbearing,O
110479,7637,age,O
110480,7637,will,O
110481,7637,be,O
110482,7637,required,O
110483,7637,to,O
110484,7637,have,O
110485,7637,a,O
110486,7637,negative,O
110487,7637,pregnancy,O
110488,7637,test,O
110489,7637,at,O
110490,7637,enrollment,O
110491,7637,and,O
110492,7637,use,O
110493,7637,birth,O
110494,7637,control,O
110495,7637,throughout,O
110496,7637,the,O
110497,7637,duration,O
110498,7637,of,O
110499,7637,treatment,O
110500,7637,.,O
110501,7638,On,O
110502,7638,the,O
110503,7638,transplant,O
110504,7638,waiting,O
110505,7638,list,O
110506,7638,followed,O
110507,7638,by,O
110508,7638,the,O
110509,7638,University,O
110510,7638,of,O
110511,7638,Maryland,O
110512,7638,'s,O
110513,7638,nephrology,O
110514,7638,clinic,O
110515,7638,or,O
110516,7638,the,O
110517,7638,Baltimore,O
110518,7638,VA,O
110519,7638,'s,O
110520,7638,nephrology,O
110521,7638,clinic,O
110522,7639,On,O
110523,7639,chronic,O
110524,7639,hemodialysis,B-Procedure
110525,7639,not,O
110526,7639,yet,O
110527,7639,on,O
110528,7639,the,O
110529,7639,transplant,O
110530,7639,list,O
110531,7639,and,O
110532,7639,followed,O
110533,7639,in,O
110534,7639,the,O
110535,7639,University,O
110536,7639,'s,O
110537,7639,hemodialysis,O
110538,7639,center,O
110539,7639,or,O
110540,7639,in,O
110541,7639,the,O
110542,7639,University,O
110543,7639,'s,O
110544,7639,nephrology,O
110545,7639,clinic,O
110546,7640,Have,O
110547,7640,chronic,B-Condition
110548,7640,kidney,I-Condition
110549,7640,disease,I-Condition
110550,7640,with,O
110551,7640,GFR,O
110552,7640,<,O
110553,7640,50,O
110554,7641,Participation,O
110555,7641,in,O
110556,7641,another,O
110557,7641,clinical,O
110558,7641,trial,O
110559,7641,at,O
110560,7641,present,O
110561,7641,or,O
110562,7641,within,O
110563,7641,4,O
110564,7641,weeks,O
110565,7641,of,O
110566,7641,study,O
110567,7641,entry,O
110568,7641,.,O
110569,7641,There,O
110570,7641,may,O
110571,7641,be,O
110572,7641,exceptions,O
110573,7641,at,O
110574,7641,the,O
110575,7641,discretion,O
110576,7641,of,O
110577,7641,the,O
110578,7641,Investigator,O
110579,7641,.,O
110580,7642,Has,O
110581,7642,any,O
110582,7642,progressive,O
110583,7642,form,O
110584,7642,of,O
110585,7642,MS,B-Condition
110586,7643,Hypersensitivity,B-Condition
110587,7643,to,O
110588,7643,the,O
110589,7643,active,O
110590,7643,substance,O
110591,7643,",",O
110592,7643,or,O
110593,7643,to,O
110594,7643,any,O
110595,7643,of,O
110596,7643,the,O
110597,7643,excipients,O
110598,7643,of,O
110599,7643,Lemtrada,B-Drug
110600,7643,®,O
110601,7644,Medical,O
110602,7644,",",O
110603,7644,psychiatric,O
110604,7644,",",O
110605,7644,cognitive,O
110606,7644,",",O
110607,7644,or,O
110608,7644,other,O
110609,7644,conditions,O
110610,7644,that,O
110611,7644,",",O
110612,7644,in,O
110613,7644,the,O
110614,7644,Investigator,O
110615,7644,'s,O
110616,7644,opinion,O
110617,7644,",",O
110618,7644,compromise,O
110619,7644,the,O
110620,7644,patient,O
110621,7644,'s,O
110622,7644,ability,O
110623,7644,to,O
110624,7644,understand,O
110625,7644,the,O
110626,7644,patient,O
110627,7644,information,O
110628,7644,",",O
110629,7644,to,O
110630,7644,give,O
110631,7644,informed,O
110632,7644,consent,O
110633,7644,",",O
110634,7644,to,O
110635,7644,comply,O
110636,7644,with,O
110637,7644,the,O
110638,7644,trial,O
110639,7644,protocol,O
110640,7644,",",O
110641,7644,or,O
110642,7644,to,O
110643,7644,complete,O
110644,7644,the,O
110645,7644,study,O
110646,7645,Any,O
110647,7645,disability,O
110648,7645,acquired,O
110649,7645,from,O
110650,7645,trauma,O
110651,7645,or,O
110652,7645,another,O
110653,7645,illness,O
110654,7645,that,O
110655,7645,could,O
110656,7645,interfere,O
110657,7645,with,O
110658,7645,evaluation,O
110659,7645,of,O
110660,7645,disability,O
110661,7645,due,O
110662,7645,to,O
110663,7645,MS,O
110664,7646,Major,O
110665,7646,systemic,O
110666,7646,disease,O
110667,7646,or,O
110668,7646,other,O
110669,7646,illness,O
110670,7646,that,O
110671,7646,would,O
110672,7646,",",O
110673,7646,in,O
110674,7646,the,O
110675,7646,opinion,O
110676,7646,of,O
110677,7646,the,O
110678,7646,Investigator,O
110679,7646,",",O
110680,7646,compromise,O
110681,7646,patient,O
110682,7646,safety,O
110683,7646,or,O
110684,7646,interfere,O
110685,7646,with,O
110686,7646,the,O
110687,7646,interpretation,O
110688,7646,of,O
110689,7646,study,O
110690,7646,results,O
110691,7646,",",O
110692,7646,e.g.,O
110693,7646,",",O
110694,7646,current,O
110695,7646,peptic,O
110696,7646,ulcer,O
110697,7646,disease,O
110698,7646,or,O
110699,7646,other,O
110700,7646,conditions,O
110701,7646,that,O
110702,7646,may,O
110703,7646,predispose,O
110704,7646,to,O
110705,7646,hemorrhage,O
110706,7647,Known,O
110707,7647,bleeding,B-Condition
110708,7647,disorder,I-Condition
110709,7647,(,O
110710,7647,e.g,O
110711,7647,",",O
110712,7647,.,O
110713,7647,dysfibrinogenemia,B-Condition
110714,7647,",",O
110715,7647,factor,B-Condition
110716,7647,IX,I-Condition
110717,7647,deficiency,I-Condition
110718,7647,",",O
110719,7647,hemophilia,B-Condition
110720,7647,",",O
110721,7647,Von,B-Condition
110722,7647,Willebrand,I-Condition
110723,7647,'s,I-Condition
110724,7647,disease,I-Condition
110725,7647,",",O
110726,7647,disseminated,B-Condition
110727,7647,intravascular,I-Condition
110728,7647,coagulation,I-Condition
110729,7647,(,O
110730,7647,DIC,B-Condition
110731,7647,),O
110732,7647,",",O
110733,7647,fibrinogen,B-Condition
110734,7647,deficiency,I-Condition
110735,7647,",",O
110736,7647,or,O
110737,7647,clotting,B-Condition
110738,7647,factor,I-Condition
110739,7647,deficiency,I-Condition
110740,7647,),O
110741,7648,Significant,O
110742,7648,autoimmune,B-Condition
110743,7648,disease,I-Condition
110744,7648,including,O
110745,7648,but,O
110746,7648,not,O
110747,7648,limited,O
110748,7648,to,O
110749,7648,immune,B-Condition
110750,7648,cytopenias,I-Condition
110751,7648,",",I-Condition
110752,7648,rheumatoid,B-Condition
110753,7648,arthritis,I-Condition
110754,7648,",",I-Condition
110755,7648,systemic,B-Condition
110756,7648,lupus,I-Condition
110757,7648,erythematosus,I-Condition
110758,7648,",",O
110759,7648,other,O
110760,7648,connective,B-Condition
110761,7648,tissue,I-Condition
110762,7648,disorders,I-Condition
110763,7648,",",O
110764,7648,vasculitis,B-Condition
110765,7648,",",O
110766,7648,inflammatory,B-Condition
110767,7648,bowel,I-Condition
110768,7648,disease,I-Condition
110769,7648,",",O
110770,7648,severe,O
110771,7648,psoriasis,B-Condition
110772,7649,History,O
110773,7649,of,O
110774,7649,malignancy,B-Condition
110775,7649,",",O
110776,7649,except,O
110777,7649,basal,B-Condition
110778,7649,skin,I-Condition
110779,7649,cell,I-Condition
110780,7649,carcinoma,I-Condition
110781,7650,Major,O
110782,7650,psychiatric,B-Condition
110783,7650,disorder,I-Condition
110784,7650,that,O
110785,7650,is,O
110786,7650,not,O
110787,7650,adequately,O
110788,7650,controlled,O
110789,7650,by,O
110790,7650,treatment,O
110791,7651,Epileptic,B-Condition
110792,7651,seizures,I-Condition
110793,7651,that,O
110794,7651,are,O
110795,7651,not,O
110796,7651,adequately,O
110797,7651,controlled,O
110798,7651,by,O
110799,7651,Treatment,O
110800,7652,Active,O
110801,7652,infection,B-Condition
110802,7652,",",O
110803,7652,e.g.,O
110804,7652,",",O
110805,7652,deep,B-Condition
110806,7652,-,I-Condition
110807,7652,tissue,I-Condition
110808,7652,infection,I-Condition
110809,7652,",",O
110810,7652,that,O
110811,7652,the,O
110812,7652,Investigator,O
110813,7652,considers,O
110814,7652,sufficiently,O
110815,7652,serious,O
110816,7652,to,O
110817,7652,preclude,O
110818,7652,study,O
110819,7652,participation,O
110820,7653,In,O
110821,7653,the,O
110822,7653,Investigator,O
110823,7653,'s,O
110824,7653,opinion,O
110825,7653,",",O
110826,7653,is,O
110827,7653,at,O
110828,7653,high,O
110829,7653,risk,B-Observation
110830,7653,for,I-Observation
110831,7653,infection,I-Observation
110832,7653,(,O
110833,7653,e.g.,O
110834,7653,",",O
110835,7653,indwelling,O
110836,7653,catheter,O
110837,7653,",",O
110838,7653,dysphagia,B-Condition
110839,7653,with,O
110840,7653,aspiration,B-Condition
110841,7653,",",O
110842,7653,decubitus,B-Condition
110843,7653,ulcer,I-Condition
110844,7653,",",O
110845,7653,history,O
110846,7653,of,O
110847,7653,prior,O
110848,7653,aspiration,B-Condition
110849,7653,pneumonia,I-Condition
110850,7653,or,O
110851,7653,recurrent,O
110852,7653,urinary,B-Condition
110853,7653,tract,I-Condition
110854,7653,infection,I-Condition
110855,7653,),O
110856,7654,Seropositivity,O
110857,7654,for,O
110858,7654,human,O
110859,7654,immunodeficiency,O
110860,7654,virus,O
110861,7654,(,O
110862,7654,HIV,O
110863,7654,),O
110864,7655,Infection,B-Condition
110865,7655,with,O
110866,7655,hepatitis,O
110867,7655,C,O
110868,7655,Virus,O
110869,7656,Past,O
110870,7656,or,O
110871,7656,present,O
110872,7656,hepatitis,B-Condition
110873,7656,B,I-Condition
110874,7656,infection,I-Condition
110875,7656,(,O
110876,7656,positive,O
110877,7656,hepatitis,O
110878,7656,B,O
110879,7656,serology,O
110880,7656,),O
110881,7657,Active,O
110882,7657,infection,B-Condition
110883,7657,with,O
110884,7657,human,O
110885,7657,cytomegaly,O
110886,7657,virus,O
110887,7657,(,O
110888,7657,HCMV,O
110889,7657,),O
110890,7657,",",O
110891,7657,Epstein,O
110892,7657,-,O
110893,7657,Barr,O
110894,7657,virus,O
110895,7657,(,O
110896,7657,EBV,O
110897,7657,),O
110898,7657,",",O
110899,7657,varicella,O
110900,7657,-,O
110901,7657,zoster,O
110902,7657,virus,O
110903,7657,(,O
110904,7657,VZV,O
110905,7657,),O
110906,7658,Latent,B-Condition
110907,7658,tuberculosis,I-Condition
110908,7658,unless,O
110909,7658,effective,O
110910,7658,anti,B-Procedure
110911,7658,-,I-Procedure
110912,7658,tuberculosis,I-Procedure
110913,7658,therapy,I-Procedure
110914,7658,has,O
110915,7658,been,O
110916,7658,completed,O
110917,7658,",",O
110918,7658,or,O
110919,7658,active,B-Condition
110920,7658,tuberculosis,I-Condition
110921,7658,.,O
110922,7659,Invasive,O
110923,7659,fungal,B-Condition
110924,7659,infections,I-Condition
110925,7659,in,O
110926,7659,history,O
110927,7659,and,O
110928,7659,at,O
110929,7659,present,O
110930,7660,Cervical,O
110931,7660,cytology,O
110932,7660,other,O
110933,7660,than,O
110934,7660,PAP,O
110935,7660,I,O
110936,7660,or,O
110937,7660,PAP,O
110938,7660,II,O
110939,7660,(,O
110940,7660,Papanicolaou,O
110941,7660,),O
110942,7660,or,O
110943,7660,cervical,O
110944,7660,high,O
110945,7660,risk,O
110946,7660,human,O
110947,7660,papillomavirus,O
110948,7660,(,O
110949,7660,HPV,O
110950,7660,),O
110951,7660,positivity,O
110952,7661,Any,O
110953,7661,other,O
110954,7661,illness,B-Condition
110955,7661,or,O
110956,7661,infection,B-Condition
110957,7661,(,O
110958,7661,latent,O
110959,7661,or,O
110960,7661,active,O
110961,7661,),O
110962,7661,that,O
110963,7661,",",O
110964,7661,in,O
110965,7661,the,O
110966,7661,Investigator,O
110967,7661,'s,O
110968,7661,opinion,O
110969,7661,",",O
110970,7661,could,O
110971,7661,be,O
110972,7661,exacerbated,O
110973,7661,by,O
110974,7661,study,B-Drug
110975,7661,medication,I-Drug
110976,7662,Differential,O
110977,7662,blood,O
110978,7662,count,O
110979,7662,<,O
110980,7662,lower,O
110981,7662,limit,O
110982,7662,of,O
110983,7662,normal,O
110984,7662,(,O
110985,7662,LLN,O
110986,7662,),O
110987,7662,at,O
110988,7662,Screening,O
110989,7663,Confirmed,O
110990,7663,platelet,O
110991,7663,count,O
110992,7663,<,O
110993,7663,the,O
110994,7663,LLN,O
110995,7663,of,O
110996,7663,the,O
110997,7663,evaluating,O
110998,7663,laboratory,O
110999,7663,at,O
111000,7663,Screening,O
111001,7663,or,O
111002,7663,documented,O
111003,7663,at,O
111004,7663,<,O
111005,7663,"100,000/µL",O
111006,7663,within,O
111007,7663,the,O
111008,7663,past,O
111009,7663,year,O
111010,7663,on,O
111011,7663,a,O
111012,7663,sample,O
111013,7663,without,O
111014,7663,platelet,O
111015,7663,clumping,O
111016,7664,Presence,O
111017,7664,(,O
111018,7664,i.e.,O
111019,7664,",",O
111020,7664,above,O
111021,7664,the,O
111022,7664,ULN,O
111023,7664,),O
111024,7664,of,O
111025,7664,anti,O
111026,7664,-,O
111027,7664,thyroid,O
111028,7664,stimulating,O
111029,7664,hormone,O
111030,7664,receptor,O
111031,7664,antibodies,O
111032,7664,(,O
111033,7664,anti,O
111034,7664,-,O
111035,7664,TSHR,O
111036,7664,),O
111037,7664,and,O
111038,7664,anti,O
111039,7664,-,O
111040,7664,thyroid,O
111041,7664,peroxidase,O
111042,7664,antibody,O
111043,7664,(,O
111044,7664,anti,O
111045,7664,-,O
111046,7664,TPO,O
111047,7664,),O
111048,7665,Vaccination,B-Drug
111049,7665,less,O
111050,7665,than,O
111051,7665,6,O
111052,7665,weeks,O
111053,7665,prior,O
111054,7665,to,O
111055,7665,treatment,B-Procedure
111056,7665,with,O
111057,7665,Lemtrada,B-Drug
111058,7665,.,O
111059,7666,Treatment,B-Procedure
111060,7666,with,O
111061,7666,antineoplastic,B-Drug
111062,7666,or,I-Drug
111063,7666,immunosuppressive,I-Drug
111064,7666,drugs,I-Drug
111065,7666,within,O
111066,7666,8,O
111067,7666,weeks,O
111068,7666,prior,O
111069,7666,to,O
111070,7666,study,O
111071,7666,inclusion,O
111072,7667,Intolerance,B-Condition
111073,7667,of,O
111074,7667,pulsed,B-Drug
111075,7667,corticosteroids,I-Drug
111076,7667,",",O
111077,7667,especially,O
111078,7667,a,O
111079,7667,history,B-Observation
111080,7667,of,I-Observation
111081,7667,steroid,B-Condition
111082,7667,psychosis,I-Condition
111083,7668,Inability,B-Condition
111084,7668,to,I-Condition
111085,7668,undergo,I-Condition
111086,7668,MRI,I-Condition
111087,7668,with,O
111088,7668,gadolinium,B-Drug
111089,7668,administration,O
111090,7669,Of,O
111091,7669,childbearing,B-Person
111092,7669,potential,I-Person
111093,7669,with,O
111094,7669,a,O
111095,7669,positive,O
111096,7669,serum,O
111097,7669,pregnancy,O
111098,7669,test,O
111099,7669,",",O
111100,7669,pregnant,B-Condition
111101,7669,or,O
111102,7669,lactating,B-Condition
111103,7670,Female,B-Person
111104,7670,patients,O
111105,7670,of,O
111106,7670,childbearing,B-Person
111107,7670,potential,I-Person
111108,7670,:,O
111109,7670,Unwilling,O
111110,7670,to,O
111111,7670,agree,O
111112,7670,to,O
111113,7670,use,O
111114,7670,a,O
111115,7670,reliable,O
111116,7670,and,O
111117,7670,acceptable,O
111118,7670,contraceptive,O
111119,7670,method,O
111120,7670,(,O
111121,7670,Pearl,O
111122,7670,index,O
111123,7670,<,O
111124,7670,1,O
111125,7670,),O
111126,7670,throughout,O
111127,7670,the,O
111128,7670,study,O
111129,7670,period,O
111130,7670,.,O
111131,7670,These,O
111132,7670,methods,O
111133,7670,include,O
111134,7670,:,O
111135,7670,hormone,O
111136,7670,releasing,O
111137,7670,intrauterine,O
111138,7670,device,O
111139,7670,(,O
111140,7670,IUD,O
111141,7670,),O
111142,7670,",",O
111143,7670,hormonal,O
111144,7670,-,O
111145,7670,based,O
111146,7670,contraception,O
111147,7670,",",O
111148,7670,surgical,O
111149,7670,sterilization,O
111150,7670,",",O
111151,7670,abstinence,O
111152,7670,",",O
111153,7670,or,O
111154,7670,double,O
111155,7670,-,O
111156,7670,barrier,O
111157,7670,contraception,O
111158,7670,(,O
111159,7670,condom,O
111160,7670,and,O
111161,7670,occlusive,O
111162,7670,cap,O
111163,7670,[,O
111164,7670,diaphragm,O
111165,7670,or,O
111166,7670,cervical,O
111167,7670,cap,O
111168,7670,combined,O
111169,7670,with,O
111170,7670,spermicide,O
111171,7670,],O
111172,7670,),O
111173,7670,.,O
111174,7671,Signed,O
111175,7671,informed,O
111176,7671,consent,O
111177,7671,form,O
111178,7671,(,O
111179,7671,ICF,O
111180,7671,),O
111181,7672,Age,B-Person
111182,7672,18,O
111183,7672,to,O
111184,7672,55,O
111185,7672,years,O
111186,7672,old,O
111187,7672,(,O
111188,7672,inclusive,O
111189,7672,),O
111190,7672,as,O
111191,7672,of,O
111192,7672,the,O
111193,7672,date,O
111194,7672,the,O
111195,7672,ICF,O
111196,7672,is,O
111197,7672,signed,O
111198,7673,Diagnosis,O
111199,7673,of,O
111200,7673,MS,B-Condition
111201,7673,according,O
111202,7673,to,O
111203,7673,the,O
111204,7673,McDonald,O
111205,7673,criteria,O
111206,7673,2010,O
111207,7673,and,O
111208,7673,cranial,B-Procedure
111209,7673,MRI,I-Procedure
111210,7673,scan,I-Procedure
111211,7673,demonstrating,O
111212,7673,white,O
111213,7673,matter,O
111214,7673,lesions,O
111215,7673,attributable,O
111216,7673,to,O
111217,7673,MS,O
111218,7673,within,O
111219,7673,10,O
111220,7673,years,O
111221,7673,before,O
111222,7673,Screening,O
111223,7674,Onset,O
111224,7674,of,O
111225,7674,MS,B-Condition
111226,7674,symptoms,I-Condition
111227,7674,(,O
111228,7674,as,O
111229,7674,determined,O
111230,7674,by,O
111231,7674,a,O
111232,7674,neurologist,O
111233,7674,",",O
111234,7674,either,O
111235,7674,at,O
111236,7674,present,O
111237,7674,or,O
111238,7674,retrospectively,O
111239,7674,),O
111240,7674,within,O
111241,7674,10,O
111242,7674,years,O
111243,7674,of,O
111244,7674,the,O
111245,7674,date,O
111246,7674,the,O
111247,7674,ICF,O
111248,7674,is,O
111249,7674,signed,O
111250,7675,EDSS,O
111251,7675,score,O
111252,7675,0.0,O
111253,7675,to,O
111254,7675,5.0,O
111255,7675,(,O
111256,7675,inclusive,O
111257,7675,),O
111258,7675,at,O
111259,7675,Screening,O
111260,7676,Patients,O
111261,7676,with,O
111262,7676,(,O
111263,7676,highly,O
111264,7676,),O
111265,7676,active,O
111266,7676,RRMS,B-Condition
111267,7676,disease,O
111268,7676,course,O
111269,7676,indicated,O
111270,7676,to,O
111271,7676,receive,O
111272,7676,alemtuzumab,B-Drug
111273,7676,according,O
111274,7676,to,O
111275,7676,the,O
111276,7676,following,O
111277,7676,conditions,O
111278,7676,(,O
111279,7676,at,O
111280,7676,least,O
111281,7676,1,O
111282,7676,out,O
111283,7676,of,O
111284,7676,3,O
111285,7676,conditions,O
111286,7676,has,O
111287,7676,to,O
111288,7676,be,O
111289,7676,fulfilled,O
111290,7676,):,O
111291,7676,1,O
111292,7676,.,O
111293,7676,=,O
111294,7676,2,O
111295,7676,MS,B-Condition
111296,7676,relapses,I-Condition
111297,7676,within,O
111298,7676,24,O
111299,7676,months,O
111300,7676,",",O
111301,7676,2,O
111302,7676,.,O
111303,7676,clinical,O
111304,7676,(=,O
111305,7676,1,O
111306,7676,relapse,B-Condition
111307,7676,),O
111308,7676,or,O
111309,7676,MRI,B-Procedure
111310,7676,(,O
111311,7676,new,O
111312,7676,gadolinium,O
111313,7676,enhancing,O
111314,7676,lesions,B-Condition
111315,7676,),O
111316,7676,disease,O
111317,7676,activity,O
111318,7676,under,O
111319,7676,therapy,O
111320,7676,with,O
111321,7676,other,O
111322,7676,diseasemodifying,O
111323,7676,therapies,O
111324,7676,",",O
111325,7676,3,O
111326,7676,.,O
111327,7676,severe,O
111328,7676,relapse,B-Condition
111329,7676,with,O
111330,7676,high,O
111331,7676,disease,O
111332,7676,activity,O
111333,7676,(=,O
111334,7676,9,O
111335,7676,T2,O
111336,7676,hyperintense,O
111337,7676,Lesions,B-Condition
111338,7676,and,O
111339,7676,=,O
111340,7676,1,O
111341,7676,gadolinium,O
111342,7676,enhancing,O
111343,7676,lesion,B-Condition
111344,7676,),O
111345,7676,on,O
111346,7676,MRI,B-Procedure
111347,7676,.,O
111348,7677,Completion,O
111349,7677,of,O
111350,7677,all,O
111351,7677,vaccinations,O
111352,7677,required,O
111353,7677,by,O
111354,7677,the,O
111355,7677,applicable,O
111356,7677,immunization,O
111357,7677,guidelines,O
111358,7677,published,O
111359,7677,by,O
111360,7677,"""",O
111361,7677,ständige,O
111362,7677,Impfkommission,O
111363,7677,"""",O
111364,7677,(,O
111365,7677,STIKO,O
111366,7677,),O
111367,7678,History,O
111368,7678,of,O
111369,7678,chickenpox,B-Condition
111370,7678,or,O
111371,7678,positive,O
111372,7678,test,O
111373,7678,for,O
111374,7678,antibodies,O
111375,7678,against,O
111376,7678,varicella,O
111377,7678,zoster,O
111378,7678,virus,O
111379,7678,(,O
111380,7678,VZV,O
111381,7678,),O
111382,7679,younger,O
111383,7679,than,O
111384,7679,18,O
111385,7679,years,O
111386,7679,old,B-Person
111387,7680,HBsAg,B-Condition
111388,7680,negative,I-Condition
111389,7680,at,O
111390,7680,baseline,O
111391,7681,pregnant,B-Condition
111392,7681,or,O
111393,7681,lactating,B-Condition
111394,7681,women,B-Person
111395,7682,treatment,B-Condition
111396,7682,-,O
111397,7682,naive,O
111398,7682,patients,O
111399,7682,with,O
111400,7682,B,B-Condition
111401,7682,-,I-Condition
111402,7682,cell,I-Condition
111403,7682,lymphoma,I-Condition
111404,7683,HBsAg,B-Condition
111405,7683,positive,I-Condition
111406,7683,at,O
111407,7683,baseline,O
111408,7684,treated,O
111409,7684,with,O
111410,7684,rituximab,B-Drug
111411,7684,-,O
111412,7684,based,O
111413,7684,immunochemotherapy,B-Procedure
111414,7685,life,B-Observation
111415,7685,expectancy,I-Observation
111416,7685,of,O
111417,7685,more,O
111418,7685,than,O
111419,7685,3,O
111420,7685,months,O
111421,7686,-,O
111422,7686,Irregular,B-Condition
111423,7686,menstrual,I-Condition
111424,7686,cycle,I-Condition
111425,7686,demanding,O
111426,7686,preparing,B-Procedure
111427,7686,endometrium,I-Procedure
111428,7686,with,I-Procedure
111429,7686,hormones,I-Procedure
111430,7686,for,I-Procedure
111431,7686,frozen,I-Procedure
111432,7686,-,I-Procedure
111433,7686,thawed,I-Procedure
111434,7686,embryo,I-Procedure
111435,7687,No,O
111436,7687,frozen,B-Observation
111437,7687,embryos,I-Observation
111438,7687,after,O
111439,7687,IVF,B-Procedure
111440,7687,cycle,I-Procedure
111441,7688,Allergy,B-Condition
111442,7688,to,O
111443,7688,Pregnyl,B-Drug
111444,7688,®,O
111445,7688,or,O
111446,7688,some,B-Drug
111447,7688,of,I-Drug
111448,7688,its,I-Drug
111449,7688,ingredients,I-Drug
111450,7688,in,O
111451,7688,the,O
111452,7688,medication,O
111453,7688,or,O
111454,7688,other,O
111455,7688,contraindications,B-Condition
111456,7688,due,O
111457,7688,to,O
111458,7688,Pregnyl,B-Drug
111459,7688,®,O
111460,7689,-,O
111461,7689,Patient,O
111462,7689,with,O
111463,7689,IVF,B-Procedure
111464,7689,cycle,I-Procedure
111465,7689,and,O
111466,7689,therefore,O
111467,7689,having,O
111468,7689,frozen,O
111469,7689,-,O
111470,7689,thawed,O
111471,7689,embryos,O
111472,7690,Regular,B-Condition
111473,7690,menstruation,I-Condition
111474,7690,cycle,I-Condition
111475,7691,Patient,O
111476,7691,'s,O
111477,7691,willingness,O
111478,7691,to,O
111479,7691,participate,O
111480,7691,in,O
111481,7691,the,O
111482,7691,study,O
111483,7692,Contraindication,B-Condition
111484,7692,to,O
111485,7692,Clopidogrel,B-Drug
111486,7693,Smoking,B-Condition
111487,7693,(,O
111488,7693,current,O
111489,7693,smokers,B-Condition
111490,7693,and,O
111491,7693,patients,O
111492,7693,who,O
111493,7693,quit,B-Condition
111494,7693,smoking,I-Condition
111495,7693,less,O
111496,7693,than,O
111497,7693,six,O
111498,7693,months,O
111499,7693,),O
111500,7694,Malignancy(diagnosed,B-Condition
111501,7694,or,O
111502,7694,under,B-Mood
111503,7694,investigation,I-Mood
111504,7694,),O
111505,7695,Haematological,B-Condition
111506,7695,disorders,I-Condition
111507,7695,(,O
111508,7695,Anaemia,B-Condition
111509,7695,",",O
111510,7695,malignancy,B-Condition
111511,7695,",",O
111512,7695,bleeding,B-Condition
111513,7695,disorders,I-Condition
111514,7695,),O
111515,7696,Women,B-Person
111516,7696,of,O
111517,7696,child,B-Condition
111518,7696,-,I-Condition
111519,7696,bearing,I-Condition
111520,7696,potential,I-Condition
111521,7697,Use,O
111522,7697,of,O
111523,7697,corticosteroids,B-Drug
111524,7697,/,O
111525,7697,other,O
111526,7697,antithrombotic,B-Drug
111527,7697,agents(warfarin,I-Drug
111528,7697,),O
111529,7698,Chronic,B-Condition
111530,7698,liver,I-Condition
111531,7698,disease,I-Condition
111532,7698,(,O
111533,7698,Cirrhosis,B-Condition
111534,7698,",",O
111535,7698,malignancy,B-Condition
111536,7698,and,O
111537,7698,patients,O
111538,7698,with,O
111539,7698,more,O
111540,7698,than,O
111541,7698,twice,O
111542,7698,the,O
111543,7698,upper,O
111544,7698,limit,O
111545,7698,of,O
111546,7698,liver,O
111547,7698,function,O
111548,7698,tests,O
111549,7698,),O
111550,7699,Unable,B-Observation
111551,7699,to,I-Observation
111552,7699,consent,I-Observation
111553,7699,.,I-Observation
111554,7700,Use,O
111555,7700,of,O
111556,7700,other,O
111557,7700,investigational,B-Drug
111558,7700,study,I-Drug
111559,7700,drugs,I-Drug
111560,7700,within,O
111561,7700,1,O
111562,7700,year,O
111563,7700,prior,O
111564,7700,to,O
111565,7700,study,O
111566,7700,entry,O
111567,7701,Previous,O
111568,7701,participation,B-Observation
111569,7701,in,I-Observation
111570,7701,this,I-Observation
111571,7701,study,I-Observation
111572,7702,Patients,O
111573,7702,with,O
111574,7702,T2DM,B-Condition
111575,7702,and,O
111576,7702,CAS,B-Condition
111577,7702,as,O
111578,7702,defined,O
111579,7702,below,O
111580,7702,:,O
111581,7703,Clinical,O
111582,7703,definitions,O
111583,7704,T2DM,B-Condition
111584,7704,:,O
111585,7704,Diagnosed,O
111586,7704,according,O
111587,7704,to,O
111588,7704,the,O
111589,7704,WHO,O
111590,7704,criteria,O
111591,7704,[,O
111592,7704,53,O
111593,7704,],O
111594,7704,.,O
111595,7705,CAD,B-Condition
111596,7705,:,O
111597,7705,Presence,O
111598,7705,of,O
111599,7705,any,O
111600,7705,one,O
111601,7705,of,O
111602,7705,the,O
111603,7705,following,O
111604,7705,:,O
111605,7705,Angina,B-Condition
111606,7705,plus,O
111607,7705,positive,O
111608,7705,exercise,O
111609,7705,tolerance,O
111610,7705,test,O
111611,7705,",",O
111612,7705,enzyme,O
111613,7705,and/or,O
111614,7705,Q,O
111615,7705,wave,O
111616,7705,positive,O
111617,7705,myocardial,B-Condition
111618,7705,infarction,I-Condition
111619,7705,",",O
111620,7705,angiographic,B-Condition
111621,7705,evidence,I-Condition
111622,7705,(,O
111623,7705,>,O
111624,7705,50,O
111625,7705,%,O
111626,7705,stenosis,O
111627,7705,of,O
111628,7705,one,O
111629,7705,vessel,O
111630,7705,),O
111631,7705,",",O
111632,7705,percutaneous,O
111633,7705,or,O
111634,7705,surgical,O
111635,7705,coronary,B-Procedure
111636,7705,revascularisation,I-Procedure
111637,7705,.,O
111638,7706,Aged,B-Person
111639,7706,between,O
111640,7706,18,O
111641,7706,and,O
111642,7706,75,O
111643,7707,Provided,O
111644,7707,written,B-Observation
111645,7707,consent,I-Observation
111646,7707,for,I-Observation
111647,7707,participation,I-Observation
111648,7707,in,I-Observation
111649,7707,the,I-Observation
111650,7707,trial,I-Observation
111651,7707,prior,O
111652,7707,to,O
111653,7707,any,O
111654,7707,study,O
111655,7707,-,O
111656,7707,specific,O
111657,7707,procedures,O
111658,7707,or,O
111659,7707,requirements,O
111660,7707,.,O
111661,7708,congenital,O
111662,7708,or,O
111663,7708,valvular,O
111664,7708,cardiomyopathy,B-Condition
111665,7708,;,O
111666,7709,ischemic,B-Condition
111667,7709,heart,I-Condition
111668,7709,disease,I-Condition
111669,7709,;,O
111670,7710,endocrine,B-Condition
111671,7710,diseases,I-Condition
111672,7710,:,O
111673,7710,male,B-Condition
111674,7710,hypogonadism,I-Condition
111675,7710,",",O
111676,7710,hyperthyroidism,B-Condition
111677,7710,",",O
111678,7710,adrenal,B-Condition
111679,7710,diseases,I-Condition
111680,7710,",",O
111681,7710,pituitary,B-Condition
111682,7710,diseases,I-Condition
111683,7711,proliferative,B-Condition
111684,7711,retinopathy,I-Condition
111685,7711,or,O
111686,7711,autonomic,B-Condition
111687,7711,neuropathy,I-Condition
111688,7711,;,O
111689,7712,contraindications,B-Condition
111690,7712,to,O
111691,7712,sildenafil,B-Drug
111692,7712,use,O
111693,7712,or,O
111694,7712,CMR,B-Procedure
111695,7712,imaging,I-Procedure
111696,7712,;,O
111697,7713,age,B-Person
111698,7713,35,O
111699,7713,-,O
111700,7713,75,O
111701,7713,years,O
111702,7713,;,O
111703,7714,Diagnosis,O
111704,7714,of,O
111705,7714,Type,B-Condition
111706,7714,2,I-Condition
111707,7714,Diabetes,I-Condition
111708,7714,from,O
111709,7714,at,O
111710,7714,least,O
111711,7714,3,O
111712,7714,years,O
111713,7714,;,O
111714,7715,HbA1c,O
111715,7715,<,O
111716,7715,10,O
111717,7715,%,O
111718,7715,;,O
111719,7716,normal,B-Condition
111720,7716,blood,I-Condition
111721,7716,pressure,I-Condition
111722,7716,or,O
111723,7716,controlled,B-Condition
111724,7716,hypertension,I-Condition
111725,7716,;,O
111726,7717,BMI,O
111727,7717,<,O
111728,7717,40,O
111729,7717,;,O
111730,7718,Current,O
111731,7718,inpatient,O
111732,7718,hospitalization,B-Procedure
111733,7718,or,O
111734,7718,active,O
111735,7718,suicidal,B-Condition
111736,7718,ideation,I-Condition
111737,7718,requiring,B-Mood
111738,7718,referral,B-Procedure
111739,7718,for,O
111740,7718,inpatient,O
111741,7718,hospitalization,O
111742,7718,for,O
111743,7718,safety,O
111744,7718,.,O
111745,7719,History,B-Observation
111746,7719,of,O
111747,7719,psychotic,B-Condition
111748,7719,disorder,I-Condition
111749,7719,or,O
111750,7719,manic,B-Condition
111751,7719,episode,I-Condition
111752,7719,diagnosed,O
111753,7719,by,O
111754,7719,MINI,B-Procedure
111755,7719,-,I-Procedure
111756,7719,KID,I-Procedure
111757,7720,History,B-Observation
111758,7720,of,O
111759,7720,substance,B-Condition
111760,7720,dependence,I-Condition
111761,7720,diagnosis,O
111762,7720,by,O
111763,7720,MINI,B-Procedure
111764,7720,-,I-Procedure
111765,7720,KID,I-Procedure
111766,7720,(,O
111767,7720,excluding,O
111768,7720,tobacco,B-Drug
111769,7720,),O
111770,7720,or,O
111771,7720,positive,O
111772,7720,urine,O
111773,7720,toxicology,O
111774,7720,.,O
111775,7721,Pregnancy,B-Condition
111776,7721,(,O
111777,7721,urine,B-Procedure
111778,7721,pregnancy,I-Procedure
111779,7721,tests,I-Procedure
111780,7721,on,O
111781,7721,the,O
111782,7721,day,O
111783,7721,of,O
111784,7721,scans,O
111785,7721,for,O
111786,7721,menstruating,B-Person
111787,7721,girls,I-Person
111788,7721,),O
111789,7721,.,O
111790,7722,Inability,O
111791,7722,to,O
111792,7722,provide,O
111793,7722,written,B-Observation
111794,7722,informed,I-Observation
111795,7722,consent,I-Observation
111796,7722,according,O
111797,7722,to,O
111798,7722,the,O
111799,7722,Yale,O
111800,7722,Human,O
111801,7722,Investigation,O
111802,7722,Committee,O
111803,7722,(,O
111804,7722,HIC,O
111805,7722,),O
111806,7722,guidelines,O
111807,7722,in,O
111808,7722,English,O
111809,7722,.,O
111810,7723,MDD,B-Observation
111811,7723,Cohort,I-Observation
111812,7723,:,O
111813,7723,Meet,O
111814,7723,DSM-5,O
111815,7723,criteria,O
111816,7723,for,O
111817,7723,Major,B-Condition
111818,7723,Depressive,I-Condition
111819,7723,Disorder,I-Condition
111820,7723,by,O
111821,7723,structured,B-Procedure
111822,7723,interview,I-Procedure
111823,7723,(,O
111824,7723,MINI,B-Procedure
111825,7723,-,I-Procedure
111826,7723,KID,I-Procedure
111827,7723,),O
111828,7723,;,O
111829,7723,CDRS,O
111830,7723,-,O
111831,7723,R,O
111832,7723,score,O
111833,7723,>,O
111834,7723,40,O
111835,7723,;,O
111836,7723,Failure,O
111837,7723,to,O
111838,7723,achieve,O
111839,7723,remission,B-Condition
111840,7723,with,O
111841,7723,at,O
111842,7723,least,O
111843,7723,1,O
111844,7723,adequate,O
111845,7723,prior,O
111846,7723,antidepressant,B-Procedure
111847,7723,trial,I-Procedure
111848,7723,(,O
111849,7723,e.g.,O
111850,7723,SSRI,B-Drug
111851,7723,",",O
111852,7723,SNRI,B-Drug
111853,7723,",",O
111854,7723,or,O
111855,7723,TCA,B-Drug
111856,7723,),O
111857,7723,",",O
111858,7723,meaning,O
111859,7723,at,O
111860,7723,least,O
111861,7723,8,O
111862,7723,weeks,O
111863,7723,at,O
111864,7723,therapeutic,B-Procedure
111865,7723,dosing,I-Procedure
111866,7723,",",O
111867,7723,including,O
111868,7723,at,O
111869,7723,least,O
111870,7723,4,O
111871,7723,weeks,O
111872,7723,of,O
111873,7723,stable,B-Procedure
111874,7723,dosing,I-Procedure
111875,7723,.,O
111876,7724,Anxiety,B-Observation
111877,7724,Cohort,I-Observation
111878,7724,:,O
111879,7724,Meet,O
111880,7724,DSM-5,O
111881,7724,criteria,O
111882,7724,for,O
111883,7724,any,O
111884,7724,of,O
111885,7724,the,O
111886,7724,following,O
111887,7724,anxiety,B-Condition
111888,7724,disorders,I-Condition
111889,7724,:,O
111890,7724,Social,B-Condition
111891,7724,Anxiety,I-Condition
111892,7724,Disorders,I-Condition
111893,7724,",",O
111894,7724,Generalized,B-Condition
111895,7724,Anxiety,I-Condition
111896,7724,Disorder,I-Condition
111897,7724,",",O
111898,7724,Separation,B-Condition
111899,7724,Anxiety,I-Condition
111900,7724,Disorder,I-Condition
111901,7724,and/or,O
111902,7724,Panic,B-Condition
111903,7724,Disorder,I-Condition
111904,7724,by,O
111905,7724,structured,B-Procedure
111906,7724,interview,I-Procedure
111907,7724,(,O
111908,7724,MINI,B-Procedure
111909,7724,-,I-Procedure
111910,7724,KID,I-Procedure
111911,7724,),O
111912,7724,;,O
111913,7724,ADIS,O
111914,7724,Clinical,O
111915,7724,Severity,O
111916,7724,Rating,O
111917,7724,≥4,O
111918,7724,(,O
111919,7724,moderately,O
111920,7724,severe,O
111921,7724,),O
111922,7724,for,O
111923,7724,any,O
111924,7724,of,O
111925,7724,the,O
111926,7724,4,O
111927,7724,included,O
111928,7724,anxiety,B-Condition
111929,7724,disorders,I-Condition
111930,7724,;,O
111931,7724,Failure,O
111932,7724,to,O
111933,7724,achieve,O
111934,7724,remission,B-Condition
111935,7724,with,O
111936,7724,at,O
111937,7724,least,O
111938,7724,1,O
111939,7724,adequate,O
111940,7724,prior,O
111941,7724,anxiolytic,B-Procedure
111942,7724,medication,I-Procedure
111943,7724,trial,I-Procedure
111944,7724,(,O
111945,7724,e.g.,O
111946,7724,SSRI,B-Drug
111947,7724,",",O
111948,7724,SNRI,B-Drug
111949,7724,",",O
111950,7724,or,O
111951,7724,TCA,B-Drug
111952,7724,),O
111953,7724,",",O
111954,7724,meaning,O
111955,7724,at,O
111956,7724,least,O
111957,7724,8,O
111958,7724,weeks,O
111959,7724,at,O
111960,7724,therapeutic,B-Procedure
111961,7724,dosing,I-Procedure
111962,7724,",",O
111963,7724,including,O
111964,7724,at,O
111965,7724,least,O
111966,7724,4,O
111967,7724,weeks,O
111968,7724,of,O
111969,7724,stable,B-Procedure
111970,7724,dosing,I-Procedure
111971,7724,;,O
111972,7724,Failure,O
111973,7724,to,O
111974,7724,achieve,O
111975,7724,remission,B-Condition
111976,7724,with,O
111977,7724,previous,O
111978,7724,CBT,B-Procedure
111979,7724,or,I-Procedure
111980,7724,subject,I-Procedure
111981,7724,declines,I-Procedure
111982,7724,current,I-Procedure
111983,7724,CBT,I-Procedure
111984,7724,therapy,I-Procedure
111985,7725,Stable,O
111986,7725,psychiatric,B-Drug
111987,7725,medications,I-Drug
111988,7725,and,O
111989,7725,doses,O
111990,7725,for,O
111991,7725,the,O
111992,7725,month,O
111993,7725,prior,O
111994,7725,to,O
111995,7725,enrollment,O
111996,7725,.,O
111997,7725,Subjects,O
111998,7725,may,O
111999,7725,continue,O
112000,7725,to,O
112001,7725,engage,O
112002,7725,in,O
112003,7725,any,O
112004,7725,ongoing,O
112005,7725,psychotherapy,O
112006,7725,.,O
112007,7726,Medically,B-Condition
112008,7726,and,I-Condition
112009,7726,neurologically,I-Condition
112010,7726,healthy,I-Condition
112011,7726,on,O
112012,7726,the,O
112013,7726,basis,O
112014,7726,of,O
112015,7726,physical,B-Procedure
112016,7726,examination,I-Procedure
112017,7726,and,O
112018,7726,medical,B-Observation
112019,7726,history,I-Observation
112020,7726,.,O
112021,7727,Parents,B-Person
112022,7727,able,O
112023,7727,to,O
112024,7727,provide,B-Observation
112025,7727,written,I-Observation
112026,7727,informed,I-Observation
112027,7727,consent,I-Observation
112028,7727,and,O
112029,7727,adolescents,B-Person
112030,7727,must,O
112031,7727,additionally,O
112032,7727,provide,B-Observation
112033,7727,assent,I-Observation
112034,7727,.,O
112035,7728,1,O
112036,7728,.,O
112037,7728,Patients,O
112038,7728,over,O
112039,7728,the,O
112040,7728,age,B-Person
112041,7728,of,O
112042,7728,85,O
112043,7728,years,O
112044,7728,except,O
112045,7728,at,O
112046,7728,the,O
112047,7728,discretion,O
112048,7728,of,O
112049,7728,the,O
112050,7728,Investigator,O
112051,7728,and,O
112052,7728,with,O
112053,7728,agreement,O
112054,7728,of,O
112055,7728,the,O
112056,7728,Sponsor,O
112057,7728,.,O
112058,7729,2,O
112059,7729,.,O
112060,7729,Diagnosis,O
112061,7729,of,O
112062,7729,acute,B-Condition
112063,7729,promyelocytic,I-Condition
112064,7729,leukemia,I-Condition
112065,7730,3,O
112066,7730,.,O
112067,7730,Diagnosis,O
112068,7730,of,O
112069,7730,chronic,B-Condition
112070,7730,myelogenous,I-Condition
112071,7730,leukemia,I-Condition
112072,7730,(,I-Condition
112073,7730,CML,I-Condition
112074,7730,),I-Condition
112075,7730,in,O
112076,7730,blast,B-Condition
112077,7730,crisis,I-Condition
112078,7731,4,O
112079,7731,.,O
112080,7731,AML,B-Condition
112081,7731,in,O
112082,7731,relapse,O
112083,7731,or,O
112084,7731,refractory,O
112085,7731,after,O
112086,7731,3,O
112087,7731,or,O
112088,7731,more,O
112089,7731,previous,O
112090,7731,lines,B-Procedure
112091,7731,of,I-Procedure
112092,7731,chemotherapy,I-Procedure
112093,7731,(,O
112094,7731,and/or,O
112095,7731,HSCT,O
112096,7731,),O
112097,7731,treatment,O
112098,7732,5,O
112099,7732,.,O
112100,7732,AML,B-Condition
112101,7732,or,O
112102,7732,antecedent,O
112103,7732,MDS,B-Condition
112104,7732,secondary,O
112105,7732,to,O
112106,7732,prior,O
112107,7732,chemotherapy,B-Condition
112108,7733,6,O
112109,7733,.,O
112110,7733,Persistent,O
112111,7733,clinically,O
112112,7733,significant,O
112113,7733,non,O
112114,7733,-,O
112115,7733,hematological,O
112116,7733,toxicity,B-Condition
112117,7733,that,O
112118,7733,is,O
112119,7733,Grade,O
112120,7733,>,O
112121,7733,1,O
112122,7733,by,O
112123,7733,NCI,O
112124,7733,CTCAE,O
112125,7733,v4,O
112126,7733,from,O
112127,7733,prior,O
112128,7733,chemotherapy,B-Procedure
112129,7734,7,O
112130,7734,.,O
112131,7734,Patients,O
112132,7734,who,O
112133,7734,have,O
112134,7734,had,O
112135,7734,HSCT,B-Condition
112136,7734,and,O
112137,7734,are,O
112138,7734,within,O
112139,7734,100,O
112140,7734,days,O
112141,7734,of,O
112142,7734,transplant,B-Procedure
112143,7734,and/or,O
112144,7734,are,O
112145,7734,still,O
112146,7734,taking,O
112147,7734,immunosuppressive,B-Drug
112148,7734,drugs,I-Drug
112149,7734,and/or,O
112150,7734,have,O
112151,7734,clinically,O
112152,7734,significant,O
112153,7734,graft,B-Condition
112154,7734,-,I-Condition
112155,7734,versus,I-Condition
112156,7734,-,I-Condition
112157,7734,host,I-Condition
112158,7734,disease,I-Condition
112159,7734,requiring,B-Mood
112160,7734,treatment,B-Procedure
112161,7734,and/or,O
112162,7734,have,O
112163,7734,>,O
112164,7734,Grade,O
112165,7734,1,O
112166,7734,persistent,O
112167,7734,non,O
112168,7734,hematological,O
112169,7734,toxicity,B-Condition
112170,7734,related,O
112171,7734,to,O
112172,7734,the,O
112173,7734,transplant,B-Procedure
112174,7735,8,O
112175,7735,.,O
112176,7735,Clinically,O
112177,7735,active,O
112178,7735,central,B-Condition
112179,7735,nervous,I-Condition
112180,7735,system,I-Condition
112181,7735,(,I-Condition
112182,7735,CNS,I-Condition
112183,7735,),I-Condition
112184,7735,leukemia,I-Condition
112185,7735,.,O
112186,7735,Patients,O
112187,7735,with,O
112188,7735,CNS,O
112189,7735,leukemia,O
112190,7735,",",O
112191,7735,which,O
112192,7735,is,O
112193,7735,controlled,O
112194,7735,",",O
112195,7735,but,O
112196,7735,who,O
112197,7735,are,O
112198,7735,still,O
112199,7735,receiving,O
112200,7735,IT,O
112201,7735,therapy,O
112202,7735,at,O
112203,7735,study,O
112204,7735,entry,O
112205,7735,may,O
112206,7735,be,O
112207,7735,considered,O
112208,7735,eligible,O
112209,7735,and,O
112210,7735,continue,O
112211,7735,receive,O
112212,7735,IT,O
112213,7735,therapy,O
112214,7735,at,O
112215,7735,the,O
112216,7735,discretion,O
112217,7735,of,O
112218,7735,the,O
112219,7735,Investigator,O
112220,7735,and,O
112221,7735,with,O
112222,7735,agreement,O
112223,7735,of,O
112224,7735,the,O
112225,7735,Sponsor,O
112226,7735,.,O
112227,7736,9,O
112228,7736,.,O
112229,7736,Patients,O
112230,7736,who,O
112231,7736,have,O
112232,7736,previously,O
112233,7736,received,O
112234,7736,AC220,B-Drug
112235,7737,10,O
112236,7737,.,O
112237,7737,Disseminated,B-Condition
112238,7737,intravascular,I-Condition
112239,7737,coagulation,I-Condition
112240,7737,(,I-Condition
112241,7737,DIC,I-Condition
112242,7737,),I-Condition
112243,7737,(,O
112244,7737,diagnosis,O
112245,7737,by,O
112246,7737,laboratory,O
112247,7737,or,O
112248,7737,clinical,O
112249,7737,assessment,O
112250,7737,),O
112251,7738,11,O
112252,7738,.,O
112253,7738,Major,B-Procedure
112254,7738,surgery,I-Procedure
112255,7738,within,O
112256,7738,4,O
112257,7738,weeks,O
112258,7738,prior,O
112259,7738,to,O
112260,7738,enrollment,O
112261,7738,in,O
112262,7738,the,O
112263,7738,study,O
112264,7739,12,O
112265,7739,.,O
112266,7739,Radiation,B-Procedure
112267,7739,therapy,I-Procedure
112268,7739,within,O
112269,7739,4,O
112270,7739,weeks,O
112271,7739,prior,O
112272,7739,to,O
112273,7739,",",O
112274,7739,or,O
112275,7739,concurrent,O
112276,7739,with,O
112277,7739,study,O
112278,7740,13,O
112279,7740,.,O
112280,7740,Use,O
112281,7740,of,O
112282,7740,concomitant,O
112283,7740,drugs,B-Drug
112284,7740,that,I-Drug
112285,7740,prolong,I-Drug
112286,7740,QT,I-Drug
112287,7740,/,I-Drug
112288,7740,QTc,I-Drug
112289,7740,interval,I-Drug
112290,7740,and/or,O
112291,7740,are,O
112292,7740,CYP3A4,B-Drug
112293,7740,inhibitors,I-Drug
112294,7740,are,O
112295,7740,prohibited,O
112296,7740,with,O
112297,7740,the,O
112298,7740,exception,O
112299,7740,of,O
112300,7740,antibiotics,B-Drug
112301,7740,",",O
112302,7740,antifungals,B-Drug
112303,7740,",",O
112304,7740,and,O
112305,7740,other,O
112306,7740,antimicrobials,B-Drug
112307,7740,that,O
112308,7740,are,O
112309,7740,used,O
112310,7740,as,O
112311,7740,standard,O
112312,7740,of,O
112313,7740,care,O
112314,7740,to,O
112315,7740,prevent,O
112316,7740,or,O
112317,7740,treat,O
112318,7740,infections,O
112319,7740,and,O
112320,7740,other,O
112321,7740,such,O
112322,7740,drugs,O
112323,7740,that,O
112324,7740,are,O
112325,7740,considered,O
112326,7740,absolutely,O
112327,7740,essential,O
112328,7740,for,O
112329,7740,the,O
112330,7740,care,O
112331,7740,of,O
112332,7740,the,O
112333,7740,patient,O
112334,7740,.,O
112335,7741,14,O
112336,7741,.,O
112337,7741,Uncontrolled,O
112338,7741,or,O
112339,7741,significant,O
112340,7741,cardiovascular,B-Condition
112341,7741,disease,I-Condition
112342,7742,15,O
112343,7742,.,O
112344,7742,Women,O
112345,7742,who,O
112346,7742,are,O
112347,7742,pregnant,B-Condition
112348,7742,",",O
112349,7742,lactating,B-Condition
112350,7742,",",O
112351,7742,or,O
112352,7742,unwilling,B-Mood
112353,7742,to,O
112354,7742,use,O
112355,7742,contraception,B-Condition
112356,7742,if,O
112357,7742,of,O
112358,7742,childbearing,B-Condition
112359,7742,potential,I-Condition
112360,7743,16,O
112361,7743,.,O
112362,7743,Men,B-Person
112363,7743,who,O
112364,7743,are,O
112365,7743,unwilling,B-Mood
112366,7743,to,O
112367,7743,use,O
112368,7743,contraception,B-Drug
112369,7743,if,O
112370,7743,their,B-Observation
112371,7743,partners,I-Observation
112372,7743,are,I-Observation
112373,7743,of,I-Observation
112374,7743,childbearing,I-Observation
112375,7743,potential,I-Observation
112376,7744,17,O
112377,7744,.,O
112378,7744,Active,O
112379,7744,",",O
112380,7744,uncontrolled,O
112381,7744,infection,B-Condition
112382,7745,18,O
112383,7745,.,O
112384,7745,Human,B-Condition
112385,7745,immunodeficiency,I-Condition
112386,7745,virus,I-Condition
112387,7745,positivity,O
112388,7746,19,O
112389,7746,.,O
112390,7746,Active,O
112391,7746,hepatitis,B-Condition
112392,7746,B,I-Condition
112393,7746,or,I-Condition
112394,7746,C,I-Condition
112395,7746,or,O
112396,7746,other,O
112397,7746,active,O
112398,7746,liver,B-Condition
112399,7746,disease,I-Condition
112400,7747,20,O
112401,7747,.,O
112402,7747,History,B-Observation
112403,7747,of,O
112404,7747,cancer,B-Condition
112405,7747,",",O
112406,7747,except,O
112407,7747,Stage,O
112408,7747,1,O
112409,7747,cervix,O
112410,7747,or,O
112411,7747,nonmelanotic,O
112412,7747,skin,B-Condition
112413,7747,cancer,I-Condition
112414,7747,",",O
112415,7747,with,O
112416,7747,the,O
112417,7747,possible,O
112418,7747,exception,O
112419,7747,of,O
112420,7747,patients,O
112421,7747,in,O
112422,7747,complete,O
112423,7747,remission,O
112424,7748,1,O
112425,7748,.,O
112426,7748,Males,B-Person
112427,7748,and,O
112428,7748,females,B-Person
112429,7748,age,B-Person
112430,7748,≥18,O
112431,7748,years,O
112432,7748,in,O
112433,7748,second,O
112434,7748,relapse,B-Condition
112435,7748,or,O
112436,7748,refractory,B-Condition
112437,7748,.,O
112438,7749,2,O
112439,7749,.,O
112440,7749,Males,B-Person
112441,7749,and,O
112442,7749,females,B-Person
112443,7749,age,B-Person
112444,7749,≥60,O
112445,7749,years,O
112446,7749,in,O
112447,7749,first,O
112448,7749,relapse,B-Condition
112449,7749,or,O
112450,7749,refractory,B-Condition
112451,7749,.,O
112452,7750,3,O
112453,7750,.,O
112454,7750,Must,O
112455,7750,have,O
112456,7750,baseline,O
112457,7750,bone,B-Procedure
112458,7750,marrow,I-Procedure
112459,7750,sample,I-Procedure
112460,7750,taken,O
112461,7750,.,O
112462,7751,4,O
112463,7751,.,O
112464,7751,Morphologically,O
112465,7751,documented,O
112466,7751,primary,O
112467,7751,AML,B-Condition
112468,7751,or,O
112469,7751,AML,B-Condition
112470,7751,secondary,O
112471,7751,to,O
112472,7751,myelodysplastic,B-Condition
112473,7751,syndrome,I-Condition
112474,7751,(,O
112475,7751,MDS,B-Condition
112476,7751,with,O
112477,7751,≥20,O
112478,7751,%,O
112479,7751,bone,O
112480,7751,marrow,O
112481,7751,or,O
112482,7751,peripheral,O
112483,7751,blasts,O
112484,7751,),O
112485,7751,",",O
112486,7751,as,O
112487,7751,defined,O
112488,7751,by,O
112489,7751,the,O
112490,7751,World,B-Procedure
112491,7751,Health,I-Procedure
112492,7751,Organization,I-Procedure
112493,7751,(,I-Procedure
112494,7751,WHO,I-Procedure
112495,7751,),I-Procedure
112496,7751,criteria,I-Procedure
112497,7751,",",O
112498,7751,confirmed,O
112499,7751,by,O
112500,7751,pathology,B-Procedure
112501,7751,review,I-Procedure
112502,7751,at,O
112503,7751,treating,O
112504,7751,institution,O
112505,7751,.,O
112506,7752,5,O
112507,7752,.,O
112508,7752,Able,O
112509,7752,to,O
112510,7752,swallow,O
112511,7752,the,O
112512,7752,liquid,O
112513,7752,study,O
112514,7752,drug,O
112515,7752,.,O
112516,7753,6,O
112517,7753,.,O
112518,7753,ECOG,O
112519,7753,performance,O
112520,7753,status,O
112521,7753,of,O
112522,7753,0,O
112523,7753,to,O
112524,7753,2,O
112525,7754,7,O
112526,7754,.,O
112527,7754,In,O
112528,7754,the,O
112529,7754,absence,O
112530,7754,of,O
112531,7754,rapidly,O
112532,7754,progressing,O
112533,7754,disease,O
112534,7754,",",O
112535,7754,the,O
112536,7754,interval,O
112537,7754,from,O
112538,7754,prior,O
112539,7754,treatment,O
112540,7754,to,O
112541,7754,time,O
112542,7754,of,O
112543,7754,AC220,O
112544,7754,administration,O
112545,7754,will,O
112546,7754,be,O
112547,7754,at,O
112548,7754,least,O
112549,7754,2,O
112550,7754,weeks,O
112551,7754,for,O
112552,7754,cytotoxic,O
112553,7754,agents,O
112554,7754,or,O
112555,7754,at,O
112556,7754,least,O
112557,7754,5,O
112558,7754,half,O
112559,7754,-,O
112560,7754,lives,O
112561,7754,for,O
112562,7754,noncytotoxic,O
112563,7754,agents,O
112564,7754,.,O
112565,7754,The,O
112566,7754,use,O
112567,7754,of,O
112568,7754,chemotherapeutic,O
112569,7754,or,O
112570,7754,antileukemic,O
112571,7754,agents,O
112572,7754,other,O
112573,7754,than,O
112574,7754,hydroxyurea,O
112575,7754,is,O
112576,7754,not,O
112577,7754,permitted,O
112578,7754,during,O
112579,7754,the,O
112580,7754,study,O
112581,7754,with,O
112582,7754,the,O
112583,7754,possible,O
112584,7754,exception,O
112585,7754,of,O
112586,7754,intrathecal,O
112587,7754,(,O
112588,7754,IT,O
112589,7754,),O
112590,7754,therapy,O
112591,7754,at,O
112592,7754,the,O
112593,7754,discretion,O
112594,7754,of,O
112595,7754,the,O
112596,7754,Investigator,O
112597,7754,and,O
112598,7754,with,O
112599,7754,the,O
112600,7754,agreement,O
112601,7754,of,O
112602,7754,the,O
112603,7754,Sponsor,O
112604,7754,.,O
112605,7755,8,O
112606,7755,.,O
112607,7755,Persistent,O
112608,7755,chronic,O
112609,7755,clinically,O
112610,7755,significant,O
112611,7755,non,O
112612,7755,-,O
112613,7755,hematological,O
112614,7755,toxicities,B-Condition
112615,7755,from,O
112616,7755,prior,O
112617,7755,treatment,B-Procedure
112618,7755,must,O
112619,7755,be,O
112620,7755,≤Grade,O
112621,7755,1,O
112622,7755,.,O
112623,7756,9,O
112624,7756,.,O
112625,7756,Prior,O
112626,7756,therapy,B-Procedure
112627,7756,with,O
112628,7756,FLT3,B-Drug
112629,7756,inhibitors,I-Drug
112630,7756,is,O
112631,7756,permitted,B-Mood
112632,7756,",",O
112633,7756,except,O
112634,7756,previous,O
112635,7756,treatment,B-Procedure
112636,7756,with,O
112637,7756,AC220,B-Drug
112638,7756,.,O
112639,7757,10,O
112640,7757,.,O
112641,7757,Serum,O
112642,7757,creatinine,O
112643,7757,≤1.5,O
112644,7757,×,O
112645,7757,ULN,O
112646,7757,and,O
112647,7757,glomerular,O
112648,7757,filtration,O
112649,7757,rate,O
112650,7757,(,O
112651,7757,GFR,O
112652,7757,),O
112653,7757,>,O
112654,7757,30,O
112655,7757,mL,O
112656,7757,/,O
112657,7757,min,O
112658,7758,11,O
112659,7758,.,O
112660,7758,Serum,O
112661,7758,potassium,O
112662,7758,",",O
112663,7758,magnesium,O
112664,7758,",",O
112665,7758,and,O
112666,7758,calcium,O
112667,7758,levels,O
112668,7758,should,O
112669,7758,be,O
112670,7758,at,O
112671,7758,least,O
112672,7758,within,O
112673,7758,institutional,O
112674,7758,normal,O
112675,7758,limits,O
112676,7758,.,O
112677,7759,12,O
112678,7759,.,O
112679,7759,Total,O
112680,7759,serum,O
112681,7759,bilirubin,O
112682,7759,≤1.5,O
112683,7759,×,O
112684,7759,ULN,O
112685,7760,13,O
112686,7760,.,O
112687,7760,Serum,O
112688,7760,aspartate,O
112689,7760,transaminase,O
112690,7760,(,O
112691,7760,AST,O
112692,7760,),O
112693,7760,and/or,O
112694,7760,alanine,O
112695,7760,transaminase,O
112696,7760,(,O
112697,7760,ALT,O
112698,7760,),O
112699,7760,≤2.5,O
112700,7760,×,O
112701,7760,ULN,O
112702,7761,14,O
112703,7761,.,O
112704,7761,Females,B-Person
112705,7761,of,O
112706,7761,childbearing,B-Condition
112707,7761,potential,I-Condition
112708,7761,must,O
112709,7761,have,O
112710,7761,a,O
112711,7761,negative,O
112712,7761,pregnancy,O
112713,7761,test,O
112714,7761,(,O
112715,7761,urine,B-Procedure
112716,7761,β,I-Procedure
112717,7761,-,I-Procedure
112718,7761,hCG,I-Procedure
112719,7761,),O
112720,7761,.,O
112721,7762,15,O
112722,7762,.,O
112723,7762,Females,O
112724,7762,of,O
112725,7762,childbearing,O
112726,7762,potential,O
112727,7762,and,O
112728,7762,sexually,O
112729,7762,mature,O
112730,7762,males,O
112731,7762,must,O
112732,7762,agree,O
112733,7762,to,O
112734,7762,use,O
112735,7762,a,O
112736,7762,medically,O
112737,7762,accepted,O
112738,7762,method,O
112739,7762,of,O
112740,7762,contraception,O
112741,7762,throughout,O
112742,7762,the,O
112743,7762,study,O
112744,7762,.,O
112745,7763,16,O
112746,7763,.,O
112747,7763,Written,O
112748,7763,informed,O
112749,7763,consent,O
112750,7763,must,O
112751,7763,be,O
112752,7763,provided,O
112753,7763,.,O
112754,7764,The,O
112755,7764,patient,O
112756,7764,is,O
112757,7764,participating,O
112758,7764,in,O
112759,7764,another,O
112760,7764,study,O
112761,7765,The,O
112762,7765,patient,O
112763,7765,is,O
112764,7765,in,O
112765,7765,an,O
112766,7765,exclusion,O
112767,7765,period,O
112768,7765,determined,O
112769,7765,by,O
112770,7765,a,O
112771,7765,previous,O
112772,7765,study,O
112773,7766,The,O
112774,7766,patient,O
112775,7766,or,O
112776,7766,his,O
112777,7766,/,O
112778,7766,her,O
112779,7766,representative,O
112780,7766,refuses,O
112781,7766,to,O
112782,7766,sign,O
112783,7766,the,O
112784,7766,consent,O
112785,7767,It,O
112786,7767,is,O
112787,7767,impossible,O
112788,7767,to,O
112789,7767,correctly,O
112790,7767,inform,O
112791,7767,the,O
112792,7767,patient,O
112793,7767,or,O
112794,7767,his,O
112795,7767,/,O
112796,7767,her,O
112797,7767,representative,O
112798,7768,The,O
112799,7768,patient,O
112800,7768,is,O
112801,7768,pregnant,O
112802,7768,or,O
112803,7768,breastfeeding,O
112804,7769,The,O
112805,7769,patient,O
112806,7769,has,O
112807,7769,a,O
112808,7769,contraindication,B-Condition
112809,7769,(,O
112810,7769,or,O
112811,7769,an,O
112812,7769,incompatible,O
112813,7769,drug,O
112814,7769,association,O
112815,7769,),O
112816,7769,for,O
112817,7769,a,O
112818,7769,treatment,O
112819,7769,used,O
112820,7769,in,O
112821,7769,this,O
112822,7769,study,O
112823,7770,The,O
112824,7770,patient,O
112825,7770,had,O
112826,7770,a,O
112827,7770,coronary,O
112828,7770,stent,O
112829,7770,for,O
112830,7770,less,O
112831,7770,than,O
112832,7770,12,O
112833,7770,months,O
112834,7771,The,O
112835,7771,patient,O
112836,7771,does,O
112837,7771,not,O
112838,7771,require,B-Mood
112839,7771,treatment,B-Procedure
112840,7771,with,O
112841,7771,aspirin,B-Drug
112842,7771,or,O
112843,7771,any,O
112844,7771,other,O
112845,7771,antiplatelet,B-Drug
112846,7771,agent,I-Drug
112847,7772,The,O
112848,7772,patient,O
112849,7772,has,O
112850,7772,a,O
112851,7772,history,B-Observation
112852,7772,of,I-Observation
112853,7772,aspirin,B-Drug
112854,7772,allergy,B-Condition
112855,7773,High,O
112856,7773,bleeding,B-Observation
112857,7773,risk,I-Observation
112858,7773,;,O
112859,7773,such,O
112860,7773,as,O
112861,7773,platelets,O
112862,7773,<,O
112863,7773,"50,000",O
112864,7773,/,O
112865,7773,mm3,O
112866,7773,during,O
112867,7773,screening,O
112868,7773,",",O
112869,7773,Hb,O
112870,7773,<,O
112871,7773,8.5,O
112872,7773,g,O
112873,7773,/,O
112874,7773,dL,O
112875,7773,",",O
112876,7773,history,O
112877,7773,of,O
112878,7773,intracranial,B-Condition
112879,7773,hemorrhage,I-Condition
112880,7773,or,O
112881,7773,subdural,B-Condition
112882,7773,hematoma,I-Condition
112883,7773,",",O
112884,7773,major,B-Procedure
112885,7773,surgery,I-Procedure
112886,7773,",",I-Procedure
112887,7773,parenchymal,B-Procedure
112888,7773,organ,I-Procedure
112889,7773,biopsy,I-Procedure
112890,7773,or,O
112891,7773,severe,O
112892,7773,trauma,B-Condition
112893,7773,within,O
112894,7773,30,O
112895,7773,days,O
112896,7773,before,O
112897,7773,inclusion,O
112898,7773,",",O
112899,7773,active,O
112900,7773,gastrointestinal,B-Condition
112901,7773,ulcer,I-Condition
112902,7773,in,O
112903,7773,the,O
112904,7773,last,O
112905,7773,3,O
112906,7773,months,O
112907,7773,;,O
112908,7774,History,B-Observation
112909,7774,of,I-Observation
112910,7774,Stroke,B-Condition
112911,7774,in,O
112912,7774,the,O
112913,7774,last,O
112914,7774,3,O
112915,7774,months,O
112916,7774,;,O
112917,7775,Moderate,O
112918,7775,or,O
112919,7775,severe,O
112920,7775,liver,B-Condition
112921,7775,affection,I-Condition
112922,7775,associated,O
112923,7775,with,O
112924,7775,coagulopathy,B-Condition
112925,7776,Active,O
112926,7776,infectious,B-Condition
112927,7776,endocarditis,I-Condition
112928,7777,Active,O
112929,7777,tumor,B-Condition
112930,7777,treated,B-Procedure
112931,7777,at,O
112932,7777,the,O
112933,7777,time,O
112934,7777,of,O
112935,7777,inclusion,O
112936,7777,associated,O
112937,7777,with,O
112938,7777,expected,O
112939,7777,survival,O
112940,7777,less,O
112941,7777,than,O
112942,7777,one,O
112943,7777,year,O
112944,7778,The,O
112945,7778,patient,O
112946,7778,or,O
112947,7778,his,O
112948,7778,/,O
112949,7778,her,O
112950,7778,representative,O
112951,7778,must,O
112952,7778,have,O
112953,7778,given,O
112954,7778,free,O
112955,7778,and,O
112956,7778,informed,O
112957,7778,consent,O
112958,7778,and,O
112959,7778,signed,O
112960,7778,the,O
112961,7778,consent,O
112962,7779,The,O
112963,7779,patient,O
112964,7779,must,O
112965,7779,be,O
112966,7779,insured,O
112967,7779,or,O
112968,7779,beneficiary,O
112969,7779,of,O
112970,7779,a,O
112971,7779,health,O
112972,7779,insurance,O
112973,7779,plan,O
112974,7780,The,O
112975,7780,patient,O
112976,7780,is,O
112977,7780,available,O
112978,7780,for,O
112979,7780,12,O
112980,7780,months,O
112981,7780,of,O
112982,7780,follow,O
112983,7780,-,O
112984,7780,up,O
112985,7781,The,O
112986,7781,patient,O
112987,7781,underwent,O
112988,7781,a,O
112989,7781,successful,O
112990,7781,transcutaneous,B-Procedure
112991,7781,implant,I-Procedure
112992,7781,procedure,I-Procedure
112993,7781,for,O
112994,7781,an,O
112995,7781,aortic,O
112996,7781,valve,O
112997,7781,within,O
112998,7781,the,O
112999,7781,past,O
113000,7781,24,O
113001,7781,hours,O
113002,7782,The,O
113003,7782,patient,O
113004,7782,was,O
113005,7782,receiving,O
113006,7782,anti,B-Drug
113007,7782,-,I-Drug
113008,7782,vitamin,I-Drug
113009,7782,K,I-Drug
113010,7782,(,O
113011,7782,AVK,B-Drug
113012,7782,),O
113013,7782,treatment,O
113014,7782,before,O
113015,7782,percutaneous,O
113016,7782,implantation,O
113017,7782,of,O
113018,7782,the,O
113019,7782,aortic,O
113020,7782,valve,O
113021,7783,Confirmed,O
113022,7783,allergy,B-Condition
113023,7783,to,O
113024,7783,apatinin,B-Drug
113025,7783,and,O
113026,7783,or,O
113027,7783,its,O
113028,7783,excipients,B-Drug
113029,7783,;,O
113030,7784,Hypertension,B-Condition
113031,7784,(,O
113032,7784,high,B-Condition
113033,7784,blood,I-Condition
113034,7784,pressure,I-Condition
113035,7784,),O
113036,7784,that,O
113037,7784,can,O
113038,7784,not,O
113039,7784,be,O
113040,7784,controlled,O
113041,7784,by,O
113042,7784,drugs,B-Drug
113043,7784,;,O
113044,7785,A,O
113045,7785,history,O
113046,7785,of,O
113047,7785,active,O
113048,7785,hemorragge,B-Condition
113049,7785,",",O
113050,7785,ulcer,B-Condition
113051,7785,",",O
113052,7785,intestinal,B-Condition
113053,7785,perforation,I-Condition
113054,7785,",",O
113055,7785,intestinal,B-Condition
113056,7785,obstruction,I-Condition
113057,7785,",",O
113058,7785,or,O
113059,7785,major,B-Condition
113060,7785,surgery,I-Condition
113061,7785,no,O
113062,7785,older,O
113063,7785,than,O
113064,7785,30,O
113065,7785,days,O
113066,7785,;,O
113067,7786,NYHA,O
113068,7786,III,O
113069,7786,-,O
113070,7786,IV,O
113071,7786,heart,B-Condition
113072,7786,function,I-Condition
113073,7786,",",O
113074,7786,or,O
113075,7786,severe,O
113076,7786,hepatic,B-Condition
113077,7786,or,I-Condition
113078,7786,renal,I-Condition
113079,7786,insufficiency,I-Condition
113080,7786,(,O
113081,7786,Grade,O
113082,7786,4,O
113083,7786,),O
113084,7786,;,O
113085,7787,Presence,O
113086,7787,of,O
113087,7787,multiple,O
113088,7787,factors,B-Observation
113089,7787,that,I-Observation
113090,7787,affect,I-Observation
113091,7787,oral,I-Observation
113092,7787,medications,I-Observation
113093,7787,",",O
113094,7787,such,O
113095,7787,as,O
113096,7787,difficulty,B-Condition
113097,7787,swallowing,I-Condition
113098,7787,",",O
113099,7787,nausea,B-Condition
113100,7787,",",O
113101,7787,vomiting,B-Condition
113102,7787,",",O
113103,7787,chronic,B-Condition
113104,7787,diarrhea,I-Condition
113105,7787,and,O
113106,7787,intestinal,B-Condition
113107,7787,obstruction,I-Condition
113108,7787,;,O
113109,7788,Pregnant,O
113110,7788,or,O
113111,7788,lactating,O
113112,7788,women,O
113113,7788,",",O
113114,7788,or,O
113115,7788,women,O
113116,7788,of,O
113117,7788,child,O
113118,7788,-,O
113119,7788,bearing,O
113120,7788,potential,O
113121,7788,who,O
113122,7788,have,O
113123,7788,planned,O
113124,7788,a,O
113125,7788,pregnancy,O
113126,7788,",",O
113127,7788,or,O
113128,7788,male,O
113129,7788,and,O
113130,7788,female,O
113131,7788,patients,O
113132,7788,who,O
113133,7788,do,O
113134,7788,not,O
113135,7788,agree,O
113136,7788,to,O
113137,7788,practice,O
113138,7788,adequate,O
113139,7788,contraception,O
113140,7788,during,O
113141,7788,this,O
113142,7788,study,O
113143,7788,;,O
113144,7789,Patients,O
113145,7789,who,O
113146,7789,have,O
113147,7789,a,O
113148,7789,history,B-Observation
113149,7789,of,O
113150,7789,psychotropics,B-Drug
113151,7789,abuse,B-Condition
113152,7789,and,O
113153,7789,can,O
113154,7789,not,O
113155,7789,quit,O
113156,7789,",",O
113157,7789,or,O
113158,7789,who,O
113159,7789,have,O
113160,7789,mental,B-Condition
113161,7789,disorders,I-Condition
113162,7789,;,O
113163,7790,Participation,O
113164,7790,in,O
113165,7790,other,O
113166,7790,drug,O
113167,7790,clinical,O
113168,7790,trial,O
113169,7790,within,O
113170,7790,the,O
113171,7790,last,O
113172,7790,4,O
113173,7790,weeks,O
113174,7790,;,O
113175,7791,Prior,O
113176,7791,therapy,O
113177,7791,with,O
113178,7791,VEGFR,B-Drug
113179,7791,inhibitors,I-Drug
113180,7791,such,O
113181,7791,as,O
113182,7791,sorafenib,B-Drug
113183,7791,and,O
113184,7791,sunitinib,B-Drug
113185,7791,;,O
113186,7792,Presence,O
113187,7792,of,O
113188,7792,comorbidities,O
113189,7792,that,O
113190,7792,seriously,O
113191,7792,affect,O
113192,7792,the,O
113193,7792,patient,O
113194,7792,'s,O
113195,7792,safety,O
113196,7792,or,O
113197,7792,ability,O
113198,7792,to,O
113199,7792,complete,O
113200,7792,the,O
113201,7792,study,O
113202,7792,",",O
113203,7792,in,O
113204,7792,the,O
113205,7792,investigator,O
113206,7792,'s,O
113207,7792,judgment,O
113208,7792,;,O
113209,7793,Patients,O
113210,7793,who,O
113211,7793,can,O
113212,7793,not,O
113213,7793,tolerate,B-Condition
113214,7793,apatinib,B-Drug
113215,7793,treatment,O
113216,7793,as,O
113217,7793,judged,O
113218,7793,by,O
113219,7793,the,O
113220,7793,investigator,O
113221,7793,depending,O
113222,7793,on,O
113223,7793,the,O
113224,7793,their,O
113225,7793,medical,O
113226,7793,history,O
113227,7793,;,O
113228,7794,Patients,O
113229,7794,that,O
113230,7794,are,O
113231,7794,considered,O
113232,7794,ineligible,O
113233,7794,for,O
113234,7794,this,O
113235,7794,study,O
113236,7794,by,O
113237,7794,the,O
113238,7794,investigator,O
113239,7794,.,O
113240,7795,Age,B-Person
113241,7795,of,O
113242,7795,18,O
113243,7795,and,O
113244,7795,over,O
113245,7795,",",O
113246,7795,male,B-Person
113247,7795,or,O
113248,7795,female,B-Person
113249,7795,;,O
113250,7796,Patients,O
113251,7796,with,O
113252,7796,histologically,B-Procedure
113253,7796,confirmed,O
113254,7796,advanced,O
113255,7796,(,O
113256,7796,stage,O
113257,7796,IV,O
113258,7796,),O
113259,7796,gastric,B-Condition
113260,7796,cancer,I-Condition
113261,7796,",",O
113262,7796,NSCLC,B-Condition
113263,7796,",",O
113264,7796,breast,B-Condition
113265,7796,cancer,I-Condition
113266,7796,or,O
113267,7796,ovarian,B-Condition
113268,7796,cancer,I-Condition
113269,7796,",",O
113270,7796,who,O
113271,7796,choose,O
113272,7796,monotherapy,B-Procedure
113273,7796,of,O
113274,7796,oral,B-Drug
113275,7796,vascular,I-Drug
113276,7796,targeting,I-Drug
113277,7796,drug,I-Drug
113278,7796,(,O
113279,7796,apatinib,B-Drug
113280,7796,),O
113281,7796,due,O
113282,7796,to,O
113283,7796,intolerability,O
113284,7796,or,O
113285,7796,inappropriateness,O
113286,7796,of,O
113287,7796,other,O
113288,7796,therapies,O
113289,7796,;,O
113290,7797,Presence,O
113291,7797,of,O
113292,7797,measurable,B-Condition
113293,7797,lesions,I-Condition
113294,7797,(=,O
113295,7797,10,O
113296,7797,mm,O
113297,7797,on,O
113298,7797,spiral,B-Procedure
113299,7797,CT,I-Procedure
113300,7797,scan,I-Procedure
113301,7797,),O
113302,7797,subject,O
113303,7797,to,O
113304,7797,RECIST,O
113305,7797,1.1,O
113306,7797,;,O
113307,7798,Blood,O
113308,7798,pressured,O
113309,7798,controlled,O
113310,7798,at,O
113311,7798,150/100,O
113312,7798,mHg,O
113313,7798,following,O
113314,7798,drug,O
113315,7798,administration,O
113316,7798,;,O
113317,7799,An,O
113318,7799,ECOG,O
113319,7799,PS,O
113320,7799,score,O
113321,7799,of,O
113322,7799,between,O
113323,7799,0,O
113324,7799,and,O
113325,7799,1,O
113326,7799,;,O
113327,7800,A,O
113328,7800,life,B-Observation
113329,7800,expectancy,I-Observation
113330,7800,of,O
113331,7800,at,O
113332,7800,least,O
113333,7800,3,O
113334,7800,months,O
113335,7800,;,O
113336,7801,Subjects,O
113337,7801,who,O
113338,7801,volunteer,O
113339,7801,to,O
113340,7801,participate,O
113341,7801,in,O
113342,7801,this,O
113343,7801,study,O
113344,7801,and,O
113345,7801,have,O
113346,7801,signed,O
113347,7801,the,O
113348,7801,Informed,O
113349,7801,Consent,O
113350,7801,Form,O
113351,7801,(,O
113352,7801,ICF,O
113353,7801,),O
113354,7801,",",O
113355,7801,with,O
113356,7801,good,O
113357,7801,compliance,O
113358,7801,with,O
113359,7801,treatment,O
113360,7801,and,O
113361,7801,follow,O
113362,7801,-,O
113363,7801,up,O
113364,7801,.,O
113365,7802,Advanced,O
113366,7802,male,B-Condition
113367,7802,factor,I-Condition
113368,7802,infertility,I-Condition
113369,7802,.,O
113370,7803,Polycystic,B-Condition
113371,7803,ovary,I-Condition
113372,7803,syndrome,I-Condition
113373,7803,(,I-Condition
113374,7803,PCOS,I-Condition
113375,7803,),I-Condition
113376,7803,as,O
113377,7803,defined,O
113378,7803,by,O
113379,7803,the,O
113380,7803,Rotterdam,O
113381,7803,criteria,O
113382,7803,.,O
113383,7804,Endometriosis,B-Condition
113384,7804,.,O
113385,7805,Tubal,B-Condition
113386,7805,disease,I-Condition
113387,7805,.,O
113388,7806,Uterine,B-Condition
113389,7806,abnormalities,I-Condition
113390,7806,or,O
113391,7806,myoma,B-Condition
113392,7806,.,O
113393,7807,Previous,O
113394,7807,uterine,B-Procedure
113395,7807,surgery,I-Procedure
113396,7807,.,O
113397,7808,Metabolic,B-Condition
113398,7808,or,I-Condition
113399,7808,hormonal,I-Condition
113400,7808,abnormalities,I-Condition
113401,7808,.,O
113402,7809,Mild,O
113403,7809,male,B-Condition
113404,7809,factor,I-Condition
113405,7809,infertility,I-Condition
113406,7809,or,O
113407,7809,unexplained,B-Condition
113408,7809,infertility,I-Condition
113409,7809,.,O
113410,7810,Cardiac,B-Condition
113411,7810,arrest,I-Condition
113412,7811,Head,B-Condition
113413,7811,trauma,I-Condition
113414,7812,Drowning,B-Condition
113415,7813,Congenital,B-Condition
113416,7813,heart,I-Condition
113417,7813,disease,I-Condition
113418,7814,Inborn,B-Condition
113419,7814,errors,I-Condition
113420,7814,of,I-Condition
113421,7814,metabolism,I-Condition
113422,7815,Electrolyte,B-Condition
113423,7815,imbalance,I-Condition
113424,7815,(,O
113425,7815,hypocalcaemia,B-Condition
113426,7815,",",O
113427,7815,hyponatremia,B-Condition
113428,7815,and,O
113429,7815,hypoglycemia,B-Condition
113430,7815,),O
113431,7816,Hemodynamic,B-Condition
113432,7816,instability,I-Condition
113433,7817,Allergy,B-Condition
113434,7817,to,O
113435,7817,benzodiazepines,B-Drug
113436,7818,Focal,B-Condition
113437,7818,seizures,I-Condition
113438,7818,with,O
113439,7818,preserved,B-Condition
113440,7818,level,I-Condition
113441,7818,of,I-Condition
113442,7818,consciousness,I-Condition
113443,7819,Children,B-Person
113444,7819,6,O
113445,7819,month,O
113446,7819,to,O
113447,7819,14,O
113448,7819,years,B-Person
113449,7819,who,O
113450,7819,will,O
113451,7819,be,O
113452,7819,presented,O
113453,7819,to,O
113454,7819,the,O
113455,7819,pediatric,O
113456,7819,emergency,O
113457,7819,or,O
113458,7819,attended,B-Observation
113459,7819,by,I-Observation
113460,7819,emergency,I-Observation
113461,7819,medical,I-Observation
113462,7819,service,I-Observation
113463,7819,who,O
113464,7819,have,O
113465,7819,active,O
113466,7819,seizure,B-Condition
113467,7819,and,O
113468,7819,had,O
113469,7819,no,O
113470,7819,intravenous,O
113471,7819,access,O
113472,7819,would,O
113473,7819,be,O
113474,7819,eligible,O
113475,7819,for,O
113476,7819,the,O
113477,7819,study,O
113478,7819,.,O
113479,7820,With,O
113480,7820,acute,B-Condition
113481,7820,diseases,I-Condition
113482,7820,",",O
113483,7820,such,O
113484,7820,as,O
113485,7820,acute,O
113486,7820,phase,O
113487,7820,after,O
113488,7820,myocardial,B-Condition
113489,7820,infarction,I-Condition
113490,7820,(,O
113491,7820,within,O
113492,7820,3,O
113493,7820,months,O
113494,7820,),O
113495,7820,",",O
113496,7820,within,O
113497,7820,3,O
113498,7820,months,O
113499,7820,after,O
113500,7820,acute,B-Condition
113501,7820,heart,I-Condition
113502,7820,failure,I-Condition
113503,7820,or,O
113504,7820,new,O
113505,7820,cerebral,B-Condition
113506,7820,infarction,I-Condition
113507,7820,;,O
113508,7821,In,B-Mood
113509,7821,the,I-Mood
113510,7821,list,I-Mood
113511,7821,of,O
113512,7821,heart,B-Procedure
113513,7821,transplantation,I-Procedure
113514,7821,;,O
113515,7822,Expected,B-Observation
113516,7822,survival,I-Observation
113517,7822,less,O
113518,7822,than,O
113519,7822,1,O
113520,7822,year,O
113521,7822,;,O
113522,7823,With,O
113523,7823,other,O
113524,7823,hemorrhagic,B-Condition
113525,7823,diseases,I-Condition
113526,7823,and,O
113527,7823,anticoagulant,B-Procedure
113528,7823,therapy,I-Procedure
113529,7823,is,O
113530,7823,not,B-Condition
113531,7823,allowed,I-Condition
113532,7823,;,O
113533,7824,Thrombosis,B-Condition
113534,7824,in,O
113535,7824,left,O
113536,7824,atrium,O
113537,7824,;,O
113538,7825,Heart,B-Condition
113539,7825,failure,I-Condition
113540,7825,",",O
113541,7825,New,O
113542,7825,York,O
113543,7825,Heart,O
113544,7825,Association(NYHA,O
113545,7825,),O
113546,7825,III,O
113547,7825,/,O
113548,7825,IV,O
113549,7825,or,O
113550,7825,eject,O
113551,7825,fraction(EF)<40,O
113552,7825,%,O
113553,7825,;,O
113554,7826,Patients,O
113555,7826,with,O
113556,7826,uncontrolled,O
113557,7826,cancer,B-Condition
113558,7826,;,O
113559,7827,Significant,O
113560,7827,hepatic,B-Condition
113561,7827,or,I-Condition
113562,7827,renal,I-Condition
113563,7827,impairment,I-Condition
113564,7827,(,O
113565,7827,and/or,O
113566,7827,alanine,O
113567,7827,transaminase(ALT,O
113568,7827,),O
113569,7827,or,O
113570,7827,Aspartate,O
113571,7827,transaminase(AST,O
113572,7827,),O
113573,7827,>,O
113574,7827,2,O
113575,7827,times,O
113576,7827,upper,O
113577,7827,limit,O
113578,7827,of,O
113579,7827,normal,O
113580,7827,",",O
113581,7827,creatinine,O
113582,7827,clearance,O
113583,7827,rate(CCr)<50,O
113584,7827,%,O
113585,7827,),O
113586,7827,;,O
113587,7828,Previous,O
113588,7828,catheter,B-Procedure
113589,7828,radiofrequency,I-Procedure
113590,7828,ablation,I-Procedure
113591,7828,for,O
113592,7828,AF,B-Condition
113593,7828,or,O
113594,7828,cardiac,B-Procedure
113595,7828,surgery,I-Procedure
113596,7828,;,O
113597,7829,Pregnant,O
113598,7829,and,O
113599,7829,lactating,O
113600,7829,women,O
113601,7829,",",O
113602,7829,women,O
113603,7829,who,O
113604,7829,plan,O
113605,7829,to,O
113606,7829,become,O
113607,7829,pregnant,O
113608,7829,",",O
113609,7829,or,O
113610,7829,women,O
113611,7829,of,O
113612,7829,child,O
113613,7829,bearing,O
113614,7829,age,O
113615,7829,not,O
113616,7829,using,O
113617,7829,reliable,O
113618,7829,contraceptive,O
113619,7829,measures,O
113620,7829,.,O
113621,7830,No,O
113622,7830,response,B-Condition
113623,7830,to,O
113624,7830,more,O
113625,7830,than,O
113626,7830,one,O
113627,7830,antiarrhythmic,B-Drug
113628,7830,drug,I-Drug
113629,7830,",",O
113630,7830,or,O
113631,7830,unwilling,O
113632,7830,to,O
113633,7830,receive,O
113634,7830,long,O
113635,7830,-,O
113636,7830,term,O
113637,7830,drug,O
113638,7830,treatment,O
113639,7830,.,O
113640,7831,Can,O
113641,7831,provide,O
113642,7831,informed,O
113643,7831,consent,O
113644,7831,form,O
113645,7831,expressing,O
113646,7831,willingness,O
113647,7831,to,O
113648,7831,participate,O
113649,7831,in,O
113650,7831,the,O
113651,7831,study,O
113652,7831,and,O
113653,7831,comply,O
113654,7831,with,O
113655,7831,follow,O
113656,7831,-,O
113657,7831,up,O
113658,7831,tests,O
113659,7831,and,O
113660,7831,evaluation,O
113661,7831,procedures,O
113662,7831,.,O
113663,7832,Aged,B-Person
113664,7832,18,O
113665,7832,-,O
113666,7832,80,O
113667,7832,years,O
113668,7832,.,O
113669,7833,No,O
113670,7833,Down,B-Condition
113671,7833,syndrome,I-Condition
113672,7834,No,O
113673,7834,other,O
113674,7834,major,B-Condition
113675,7834,disease,I-Condition
113676,7834,that,O
113677,7834,prohibits,O
113678,7834,study,O
113679,7834,treatment,O
113680,7834,(,O
113681,7834,e.g.,O
113682,7834,",",O
113683,7834,severe,O
113684,7834,congenital,B-Condition
113685,7834,heart,I-Condition
113686,7834,disease,I-Condition
113687,7834,),O
113688,7835,Not,O
113689,7835,requiring,O
113690,7835,significant,O
113691,7835,therapy,O
113692,7835,modification,O
113693,7835,owing,O
113694,7835,to,O
113695,7835,study,B-Procedure
113696,7835,therapy,I-Procedure
113697,7835,associated,O
113698,7835,complications,B-Condition
113699,7836,No,O
113700,7836,complications,B-Condition
113701,7836,due,O
113702,7836,to,O
113703,7836,other,O
113704,7836,interventions,B-Procedure
113705,7837,No,O
113706,7837,one,O
113707,7837,with,O
113708,7837,missing,O
113709,7837,data,O
113710,7837,that,O
113711,7837,are,O
113712,7837,needed,O
113713,7837,for,O
113714,7837,the,O
113715,7837,differential,O
113716,7837,diagnosis,O
113717,7837,",",O
113718,7837,or,O
113719,7837,for,O
113720,7837,selection,O
113721,7837,of,O
113722,7837,the,O
113723,7837,proper,O
113724,7837,therapy,O
113725,7837,arm,O
113726,7838,Cytologically,O
113727,7838,proven,O
113728,7838,acute,B-Condition
113729,7838,lymphoblastic,I-Condition
113730,7838,leukemia,I-Condition
113731,7838,(,O
113732,7838,ALL,B-Condition
113733,7838,),O
113734,7839,No,O
113735,7839,relapse,B-Condition
113736,7839,of,O
113737,7839,a,O
113738,7839,previously,O
113739,7839,unrecognized,O
113740,7839,ALL,B-Condition
113741,7840,Patients,O
113742,7840,must,O
113743,7840,meet,O
113744,7840,one,O
113745,7840,of,O
113746,7840,the,O
113747,7840,following,O
113748,7840,risk,O
113749,7840,criteria,O
113750,7840,:,O
113751,7841,Standard,O
113752,7841,-,O
113753,7841,risk,O
113754,7841,(,O
113755,7841,SR,O
113756,7841,),O
113757,7841,group,O
113758,7841,meeting,O
113759,7841,all,O
113760,7841,of,O
113761,7841,the,O
113762,7841,following,O
113763,7841,criteria,O
113764,7841,:,O
113765,7842,Blasts,O
113766,7842,<,O
113767,7842,"1,000/µL",O
113768,7842,in,O
113769,7842,peripheral,O
113770,7842,blood,O
113771,7842,(,O
113772,7842,PB,O
113773,7842,),O
113774,7842,on,O
113775,7842,day,O
113776,7842,8,O
113777,7843,Aged,B-Person
113778,7843,1,O
113779,7843,to,O
113780,7843,<,O
113781,7843,6,O
113782,7843,years,O
113783,7844,Initial,O
113784,7844,WBC,O
113785,7844,<,O
113786,7844,"20,000/µL",O
113787,7845,M1,O
113788,7845,(,O
113789,7845,5,O
113790,7845,%,O
113791,7845,),O
113792,7845,or,O
113793,7845,M2,O
113794,7845,(=,O
113795,7845,5,O
113796,7845,%,O
113797,7845,to,O
113798,7845,<,O
113799,7845,25,O
113800,7845,%,O
113801,7845,),O
113802,7845,blasts,O
113803,7845,in,O
113804,7845,bone,O
113805,7845,marrow,O
113806,7845,on,O
113807,7845,day,O
113808,7845,15,O
113809,7845,;,O
113810,7846,M1,B-Condition
113811,7846,marrow,I-Condition
113812,7846,on,O
113813,7846,day,O
113814,7846,33,O
113815,7846,.,O
113816,7847,Aged,B-Person
113817,7847,<,O
113818,7847,1,O
113819,7847,or,O
113820,7847,=,O
113821,7847,6,O
113822,7847,years,O
113823,7847,and/or,O
113824,7847,WBC,O
113825,7847,=,O
113826,7847,"20,000/µL",O
113827,7848,Blasts,O
113828,7848,<,O
113829,7848,"1,000/µL",O
113830,7848,in,O
113831,7848,PB,B-Condition
113832,7848,on,O
113833,7848,day,O
113834,7848,8,O
113835,7849,M1,B-Condition
113836,7849,or,I-Condition
113837,7849,M2,I-Condition
113838,7849,marrow,I-Condition
113839,7849,on,O
113840,7849,day,O
113841,7849,15,O
113842,7850,M3,B-Condition
113843,7850,(=,I-Condition
113844,7850,25,I-Condition
113845,7850,%,I-Condition
113846,7850,),I-Condition
113847,7850,marrow,I-Condition
113848,7850,on,O
113849,7850,day,O
113850,7850,15,O
113851,7850,OR,O
113852,7850,meets,O
113853,7850,SR,O
113854,7850,criteria,O
113855,7850,but,O
113856,7850,M3,B-Condition
113857,7850,marrow,I-Condition
113858,7850,on,O
113859,7850,day,O
113860,7850,15,O
113861,7850,and,O
113862,7850,*,O
113863,7850,M1,B-Condition
113864,7850,marrow,I-Condition
113865,7850,on,O
113866,7850,day,O
113867,7850,33,O
113868,7850,.,O
113869,7851,Meets,O
113870,7851,IR,O
113871,7851,criteria,O
113872,7851,and,O
113873,7851,M3,B-Condition
113874,7851,marrow,I-Condition
113875,7851,on,O
113876,7851,day,O
113877,7851,15,O
113878,7851,(,O
113879,7851,not,O
113880,7851,SR,O
113881,7851,and,O
113882,7851,M3,B-Condition
113883,7851,on,O
113884,7851,day,O
113885,7851,15,O
113886,7851,),O
113887,7852,Blasts,O
113888,7852,=,O
113889,7852,"1,000/µL",O
113890,7852,in,O
113891,7852,PB,O
113892,7852,on,O
113893,7852,day,O
113894,7852,8,O
113895,7853,M2,B-Condition
113896,7853,or,I-Condition
113897,7853,M3,I-Condition
113898,7853,marrow,I-Condition
113899,7853,on,O
113900,7853,day,O
113901,7853,33,O
113902,7854,Translocation,O
113903,7854,t(9;22,O
113904,7854,),O
113905,7854,[,O
113906,7854,BCR,O
113907,7854,/,O
113908,7854,ABL+,O
113909,7854,],O
113910,7854,(,O
113911,7854,Philadelphia,O
113912,7854,chromosome,O
113913,7854,-,O
113914,7854,positive,O
113915,7854,),O
113916,7854,or,O
113917,7854,t(4;11,O
113918,7854,),O
113919,7854,[,O
113920,7854,MLL,O
113921,7854,/,O
113922,7854,AF4,O
113923,7854,+,O
113924,7854,],O
113925,7854,.,O
113926,7855,Contraindication,B-Condition
113927,7855,to,O
113928,7855,sitagliptin,B-Drug
113929,7855,or,O
113930,7855,metformin,B-Drug
113931,7855,or,O
113932,7855,thiazolidinedione,B-Drug
113933,7856,Pregnant,B-Condition
113934,7856,or,O
113935,7856,breast,B-Condition
113936,7856,feeding,O
113937,7856,women,O
113938,7857,Type,B-Condition
113939,7857,1,I-Condition
113940,7857,diabetes,I-Condition
113941,7857,",",O
113942,7857,gestational,B-Condition
113943,7857,diabetes,I-Condition
113944,7857,",",O
113945,7857,or,O
113946,7857,secondary,B-Condition
113947,7857,forms,I-Condition
113948,7857,of,I-Condition
113949,7857,diabetes,I-Condition
113950,7858,Not,O
113951,7858,appropriate,B-Observation
113952,7858,for,O
113953,7858,oral,B-Drug
113954,7858,antidiabetic,I-Drug
113955,7858,agent,I-Drug
113956,7859,Medication,B-Drug
113957,7859,which,O
113958,7859,affect,B-Observation
113959,7859,glycemic,I-Observation
113960,7859,control,I-Observation
113961,7860,Disease,B-Drug
113962,7860,which,O
113963,7860,affect,O
113964,7860,efficacy,O
113965,7860,and,O
113966,7860,safety,O
113967,7860,of,O
113968,7860,drugs,O
113969,7861,Any,O
113970,7861,major,B-Condition
113971,7861,illness,I-Condition
113972,7861,(,O
113973,7861,Liver,B-Condition
113974,7861,disease,I-Condition
113975,7861,",",O
113976,7861,Renal,B-Condition
113977,7861,failure,I-Condition
113978,7861,",",O
113979,7861,Heart,B-Condition
113980,7861,disease,I-Condition
113981,7861,",",O
113982,7861,Cancer,B-Condition
113983,7861,",",O
113984,7861,etc,O
113985,7861,),O
113986,7862,HbA1c,O
113987,7862,>,O
113988,7862,13.0,O
113989,7862,%,O
113990,7863,No,O
113991,7863,treatment,B-Procedure
113992,7863,with,O
113993,7863,insulin,B-Drug
113994,7863,or,O
113995,7863,oral,B-Drug
113996,7863,agents,I-Drug
113997,7863,for,O
113998,7863,6,O
113999,7863,months,O
114000,7864,20,O
114001,7864,=,O
114002,7864,Age,B-Person
114003,7864,<,O
114004,7864,80,O
114005,7864,years,O
114006,7865,Receiving,O
114007,7865,antibiotic,B-Drug
114008,7865,and/or,O
114009,7865,probiotic,B-Drug
114010,7865,",",O
114011,7865,8,O
114012,7865,weeks,O
114013,7865,before,O
114014,7865,the,O
114015,7865,study,O
114016,7866,Chronic,B-Condition
114017,7866,gastrointestinal,I-Condition
114018,7866,system,I-Condition
114019,7866,disorders,I-Condition
114020,7867,Congenital,B-Condition
114021,7867,anomalies,I-Condition
114022,7868,Chronic,B-Condition
114023,7868,diseases,I-Condition
114024,7869,Chemotherapy,B-Procedure
114025,7869,and,O
114026,7869,radiotherapy,B-Procedure
114027,7870,Pregnancy,B-Condition
114028,7871,Children,B-Person
114029,7871,receiving,O
114030,7871,amoxicilline,B-Drug
114031,7871,-,I-Drug
114032,7871,clavulanic,I-Drug
114033,7871,acid,I-Drug
114034,7871,(,O
114035,7871,50,O
114036,7871,-,O
114037,7871,90,O
114038,7871,mg,O
114039,7871,/,O
114040,7871,kg,O
114041,7871,/,O
114042,7871,day,O
114043,7871,",",O
114044,7871,twice,O
114045,7871,daily,O
114046,7871,),O
114047,7871,due,O
114048,7871,to,O
114049,7871,acute,B-Condition
114050,7871,otitis,I-Condition
114051,7871,media,I-Condition
114052,7871,or,O
114053,7871,acute,B-Condition
114054,7871,sinusitis,I-Condition
114055,7872,Patients,O
114056,7872,with,O
114057,7872,intercurrent,B-Condition
114058,7872,infections,I-Condition
114059,7872,.,O
114060,7873,Patients,O
114061,7873,with,O
114062,7873,sepsis,B-Condition
114063,7873,.,O
114064,7874,Patients,O
114065,7874,receiving,O
114066,7874,drugs,B-Drug
114067,7874,affecting,I-Drug
114068,7874,immune,I-Drug
114069,7874,system,I-Drug
114070,7874,like,O
114071,7874,immunosuppressive,B-Drug
114072,7874,drugs,I-Drug
114073,7874,.,O
114074,7875,Patients,O
114075,7875,on,O
114076,7875,antibiotics,B-Drug
114077,7875,.,O
114078,7876,Patients,O
114079,7876,on,O
114080,7876,regular,B-Procedure
114081,7876,hemodialysis,I-Procedure
114082,7876,3sessions,O
114083,7876,/,O
114084,7876,wk,O
114085,7876,.,O
114086,7877,Recent,O
114087,7877,catheter,B-Procedure
114088,7877,insertion,I-Procedure
114089,7877,at,O
114090,7877,beginning,O
114091,7877,of,O
114092,7877,the,O
114093,7877,study,O
114094,7877,.,O
114095,7878,Both,O
114096,7878,males,B-Person
114097,7878,and,O
114098,7878,females,B-Person
114099,7878,.,O
114100,7879,Age,B-Person
114101,7879,group,I-Person
114102,7879,=,O
114103,7879,18,O
114104,7879,ys,O
114105,7879,.,O
114106,7880,Patients,O
114107,7880,receiving,O
114108,7880,prednisone,B-Drug
114109,7880,=,O
114110,7880,1mg,O
114111,7880,/,O
114112,7880,kg,O
114113,7880,/,O
114114,7880,d,O
114115,7880,for,O
114116,7880,the,O
114117,7880,treatment,O
114118,7880,of,O
114119,7880,acute,B-Condition
114120,7880,GVHD,I-Condition
114121,7880,or,O
114122,7880,mild,O
114123,7880,",",O
114124,7880,severe,O
114125,7880,chronic,O
114126,7880,GVHD,B-Condition
114127,7880,.,O
114128,7881,Recipient,O
114129,7881,<,O
114130,7881,14years,O
114131,7881,of,O
114132,7881,age,B-Person
114133,7882,Donor,O
114134,7882,is,O
114135,7882,sero,B-Condition
114136,7882,-,I-Condition
114137,7882,positive,I-Condition
114138,7882,in,I-Condition
114139,7882,HBV,I-Condition
114140,7882,/,I-Condition
114141,7882,HCV,I-Condition
114142,7882,/,I-Condition
114143,7882,HIV,I-Condition
114144,7882,or,I-Condition
114145,7882,RPR,I-Condition
114146,7882,.,O
114147,7883,Any,O
114148,7883,allogeneic,B-Procedure
114149,7883,stem,I-Procedure
114150,7883,cell,I-Procedure
114151,7883,transplant,I-Procedure
114152,7883,recipient,O
114153,7883,=,O
114154,7883,14,O
114155,7883,years,O
114156,7883,of,O
114157,7883,age,B-Person
114158,7883,and,O
114159,7883,=,O
114160,7883,60,O
114161,7883,years,O
114162,7883,of,O
114163,7883,age,B-Person
114164,7884,Bilirubin/,O
114165,7884,SGOT,O
114166,7884,/,O
114167,7884,SGPT,O
114168,7884,<,O
114169,7884,5,O
114170,7884,×,O
114171,7884,upper,O
114172,7884,normal,O
114173,7884,limits,O
114174,7884,.,O
114175,7885,Creatinine,O
114176,7885,<,O
114177,7885,2,O
114178,7885,×,O
114179,7885,upper,O
114180,7885,normal,O
114181,7885,limits,O
114182,7885,.,O
114183,7886,Ejection,O
114184,7886,fraction,O
114185,7886,=,O
114186,7886,50,O
114187,7886,%,O
114188,7886,",",O
114189,7886,no,O
114190,7886,severe,O
114191,7886,arrhythmia,B-Condition
114192,7886,.,O
114193,7887,Estimated,B-Observation
114194,7887,life,I-Observation
114195,7887,expectancy,I-Observation
114196,7887,=,O
114197,7887,6,O
114198,7887,months,O
114199,7887,.,O
114200,7888,Patients,O
114201,7888,',O
114202,7888,CMV,O
114203,7888,-,O
114204,7888,DNA,O
114205,7888,=,O
114206,7888,1000cp,O
114207,7888,/,O
114208,7888,ml,O
114209,7888,in,O
114210,7888,treatment,B-Person
114211,7888,group,I-Person
114212,7888,and,O
114213,7888,being,O
114214,7888,negative,O
114215,7888,in,O
114216,7888,prophylactic,B-Person
114217,7888,group,I-Person
114218,7888,.,O
114219,7889,Known,O
114220,7889,proved,O
114221,7889,BKV,B-Condition
114222,7889,nephropathy,I-Condition
114223,7890,Hypersensitivity,B-Condition
114224,7890,to,O
114225,7890,everolimus,B-Drug
114226,7890,",",O
114227,7890,sirolimus,B-Drug
114228,7890,or,O
114229,7890,excipient,B-Drug
114230,7891,Concomitant,O
114231,7891,treatment,O
114232,7891,by,O
114233,7891,leflunomide,B-Drug
114234,7891,",",O
114235,7891,cidofovir,B-Drug
114236,7891,",",O
114237,7891,sirolimus,B-Drug
114238,7891,",",O
114239,7891,Millepertuis,B-Drug
114240,7891,(,O
114241,7891,Hypericum,B-Drug
114242,7891,Perforatum,I-Drug
114243,7891,),O
114244,7892,Pregnant,B-Condition
114245,7892,or,O
114246,7892,lactating,B-Condition
114247,7892,women,B-Person
114248,7893,Women,B-Person
114249,7893,of,O
114250,7893,child,B-Condition
114251,7893,bearing,I-Condition
114252,7893,potential,I-Condition
114253,7893,unless,O
114254,7893,they,O
114255,7893,are,O
114256,7893,using,O
114257,7893,a,O
114258,7893,birth,B-Procedure
114259,7893,control,I-Procedure
114260,7893,method,I-Procedure
114261,7894,Adult,B-Person
114262,7894,patients,O
114263,7895,Kidney,B-Procedure
114264,7895,transplant,I-Procedure
114265,7895,recipients,O
114266,7896,Patients,O
114267,7896,treated,O
114268,7896,by,O
114269,7896,a,O
114270,7896,calcineurin,B-Drug
114271,7896,inhibitor,I-Drug
114272,7896,and,O
114273,7896,mycophenolic,B-Drug
114274,7896,acid,I-Drug
114275,7897,Viremia,O
114276,7897,>,O
114277,7897,=,O
114278,7897,3,O
114279,7897,log,O
114280,7897,UI,O
114281,7897,/,O
114282,7897,ml,O
114283,7898,Patients,O
114284,7898,who,O
114285,7898,have,O
114286,7898,given,O
114287,7898,written,O
114288,7898,informed,O
114289,7898,consent,O
114290,7899,Negative,O
114291,7899,pregnancy,O
114292,7899,test,O
114293,7899,(,O
114294,7899,blood,O
114295,7899,ß,O
114296,7899,-,O
114297,7899,HCG,O
114298,7899,dosage,O
114299,7899,),O
114300,7900,Patients,O
114301,7900,who,O
114302,7900,undergo,O
114303,7900,iliac,B-Procedure
114304,7900,crest,I-Procedure
114305,7900,bone,I-Procedure
114306,7900,graft,I-Procedure
114307,7900,harvesting,I-Procedure
114308,7900,as,O
114309,7900,part,O
114310,7900,of,O
114311,7900,their,O
114312,7900,surgery,O
114313,7901,Preexisting,O
114314,7901,neurological,B-Condition
114315,7901,deficits,I-Condition
114316,7901,or,O
114317,7901,peripheral,B-Condition
114318,7901,neuropathy,I-Condition
114319,7901,in,O
114320,7901,the,O
114321,7901,distribution,O
114322,7901,of,O
114323,7901,the,O
114324,7901,sciatic,O
114325,7901,nerve,O
114326,7902,Local,B-Condition
114327,7902,infection,I-Condition
114328,7903,Contraindication,B-Condition
114329,7903,to,O
114330,7903,regional,B-Procedure
114331,7903,anesthesia,I-Procedure
114332,7903,e.g.,O
114333,7903,bleeding,B-Condition
114334,7903,diathesis,I-Condition
114335,7903,",",O
114336,7903,coagulopathy,B-Condition
114337,7904,Chronic,B-Condition
114338,7904,pain,I-Condition
114339,7904,disorders,O
114340,7905,History,O
114341,7905,of,O
114342,7905,use,O
114343,7905,of,O
114344,7905,over,O
114345,7905,30,O
114346,7905,mg,O
114347,7905,oxycodone,B-Drug
114348,7905,or,I-Drug
114349,7905,equivalent,I-Drug
114350,7905,per,O
114351,7905,day,O
114352,7906,Allergy,B-Condition
114353,7906,to,O
114354,7906,local,B-Procedure
114355,7906,anesthetics,I-Procedure
114356,7907,History,O
114357,7907,of,O
114358,7907,significant,O
114359,7907,psychiatric,O
114360,7907,conditions,O
114361,7907,that,O
114362,7907,may,O
114363,7907,affect,O
114364,7907,patient,O
114365,7907,assessment,O
114366,7908,Pregnancy,B-Condition
114367,7909,Inability,O
114368,7909,to,O
114369,7909,provide,O
114370,7909,informed,O
114371,7909,consent,O
114372,7910,Inpatients,O
114373,7910,having,O
114374,7910,major,B-Procedure
114375,7910,foot,I-Procedure
114376,7910,and,I-Procedure
114377,7910,ankle,I-Procedure
114378,7910,surgery,I-Procedure
114379,7910,that,O
114380,7910,will,O
114381,7910,benefit,O
114382,7910,from,O
114383,7910,continuous,O
114384,7910,popliteal,B-Procedure
114385,7910,sciatic,I-Procedure
114386,7910,nerve,I-Procedure
114387,7910,block,I-Procedure
114388,7910,with,O
114389,7910,an,O
114390,7910,indwelling,O
114391,7910,catheter,O
114392,7911,American,O
114393,7911,Society,O
114394,7911,Anesthesiologists,O
114395,7911,(,O
114396,7911,ASA,O
114397,7911,),O
114398,7911,physical,O
114399,7911,status,O
114400,7911,I,O
114401,7911,-,O
114402,7911,III,O
114403,7912,18,O
114404,7912,-,O
114405,7912,85,O
114406,7912,years,O
114407,7912,of,O
114408,7912,age,B-Person
114409,7912,",",O
114410,7912,inclusive,O
114411,7913,40,O
114412,7913,-,O
114413,7913,120,O
114414,7913,kg,B-Person
114415,7913,",",O
114416,7913,inclusive,O
114417,7914,150,O
114418,7914,cm,O
114419,7914,of,O
114420,7914,height,B-Person
114421,7914,or,O
114422,7914,greater,O
114423,7915,severe,O
114424,7915,behavioral,B-Condition
114425,7915,issues,I-Condition
114426,7916,presence,O
114427,7916,of,O
114428,7916,fistula,B-Condition
114429,7916,or,O
114430,7916,abscess,B-Condition
114431,7916,near,O
114432,7916,the,O
114433,7916,selected,O
114434,7916,tooth,O
114435,7917,presence,O
114436,7917,of,O
114437,7917,pulp,B-Condition
114438,7917,exposure,I-Condition
114439,7917,in,O
114440,7917,the,O
114441,7917,selected,O
114442,7917,tooth,O
114443,7918,presence,O
114444,7918,of,O
114445,7918,mobility,B-Condition
114446,7918,in,O
114447,7918,the,O
114448,7918,selected,O
114449,7918,tooth,O
114450,7919,Children,B-Person
114451,7919,aging,B-Person
114452,7919,between,O
114453,7919,3,O
114454,7919,and,O
114455,7919,6,O
114456,7919,years,O
114457,7920,presenting,O
114458,7920,good,B-Condition
114459,7920,health,I-Condition
114460,7920,conditions,I-Condition
114461,7921,whose,O
114462,7921,parents,O
114463,7921,or,O
114464,7921,legal,O
114465,7921,guardians,O
114466,7921,accept,O
114467,7921,and,O
114468,7921,sign,O
114469,7921,the,O
114470,7921,consent,O
114471,7921,form,O
114472,7922,with,O
114473,7922,at,O
114474,7922,least,O
114475,7922,one,O
114476,7922,occlusal,O
114477,7922,or,O
114478,7922,occlusal,O
114479,7922,proximal,O
114480,7922,caries,B-Condition
114481,7922,lesion,I-Condition
114482,7922,in,O
114483,7922,primary,O
114484,7922,molars,O
114485,7923,only,O
114486,7923,occlusal,O
114487,7923,and/or,O
114488,7923,occlusal,O
114489,7923,-,O
114490,7923,proximal,O
114491,7923,surfaces,O
114492,7923,with,O
114493,7923,caries,B-Condition
114494,7923,lesions,I-Condition
114495,7923,with,O
114496,7923,dentin,B-Condition
114497,7923,involvement,I-Condition
114498,7924,Patient,O
114499,7924,refusal,O
114500,7925,Allergy,B-Condition
114501,7925,to,O
114502,7925,local,B-Drug
114503,7925,anaesthesia,I-Drug
114504,7926,Severe,O
114505,7926,coagulopathy,B-Condition
114506,7927,Contralateral,O
114507,7927,phrenic,B-Condition
114508,7927,nerve,I-Condition
114509,7927,palsy,I-Condition
114510,7928,Local,B-Condition
114511,7928,infection,I-Condition
114512,7929,Moderate,O
114513,7929,to,O
114514,7929,severe,O
114515,7929,pulmonary,B-Condition
114516,7929,dysfunction,I-Condition
114517,7929,(,O
114518,7929,GOLD,O
114519,7929,II,O
114520,7929,",",O
114521,7929,II,O
114522,7929,",",O
114523,7929,IV,O
114524,7929,),O
114525,7930,Patients,O
114526,7930,undergoing,O
114527,7930,surgery,B-Procedure
114528,7930,on,O
114529,7930,shoulder,O
114530,7930,",",O
114531,7930,humerus,O
114532,7930,",",O
114533,7930,or,O
114534,7930,clavicle,O
114535,7931,Patients,O
114536,7931,with,O
114537,7931,combined,O
114538,7931,HCV,B-Condition
114539,7931,/,I-Condition
114540,7931,HBV,I-Condition
114541,7931,co,I-Condition
114542,7931,-,I-Condition
114543,7931,infection,I-Condition
114544,7932,hepatocellular,B-Condition
114545,7932,carcinoma,I-Condition
114546,7932,(,I-Condition
114547,7932,HCC,I-Condition
114548,7932,),I-Condition
114549,7933,decompensated,O
114550,7933,liver,B-Condition
114551,7933,cirrhosis,I-Condition
114552,7933,(,O
114553,7933,Child,O
114554,7933,-,O
114555,7933,Pugh,O
114556,7933,score,O
114557,7933,above,O
114558,7933,6,O
114559,7933,),O
114560,7934,non,O
114561,7934,-,O
114562,7934,genotype,B-Condition
114563,7934,4,I-Condition
114564,7935,patients,O
114565,7935,were,O
114566,7935,18,O
114567,7935,years,O
114568,7935,old,B-Person
114569,7935,or,O
114570,7935,more,O
114571,7935,",",O
114572,7936,naive,O
114573,7936,to,O
114574,7936,HCV,B-Procedure
114575,7936,treatment,I-Procedure
114576,7936,",",O
114577,7937,HCV,O
114578,7937,genotype,O
114579,7937,4,O
114580,7937,",",O
114581,7938,compensated,O
114582,7938,liver,B-Condition
114583,7938,disease,I-Condition
114584,7938,.,O
114585,7939,Patients,O
114586,7939,with,O
114587,7939,active,O
114588,7939,GIT,B-Condition
114589,7939,bleeding,I-Condition
114590,7939,.,O
114591,7940,Patients,O
114592,7940,with,O
114593,7940,history,B-Observation
114594,7940,of,O
114595,7940,bowel,B-Condition
114596,7940,obstruction,I-Condition
114597,7940,",",I-Condition
114598,7940,perforation,I-Condition
114599,7940,.,O
114600,7941,Patients,O
114601,7941,with,O
114602,7941,history,B-Observation
114603,7941,of,O
114604,7941,allergy,B-Condition
114605,7941,to,O
114606,7941,PEG,B-Drug
114607,7941,.,O
114608,7942,Treatment,O
114609,7942,with,O
114610,7942,rifaximin,B-Drug
114611,7942,or,O
114612,7942,neomycin,B-Drug
114613,7942,in,O
114614,7942,the,O
114615,7942,previous,O
114616,7942,7,O
114617,7942,days,O
114618,7942,.,O
114619,7943,Patients,O
114620,7943,with,O
114621,7943,major,B-Condition
114622,7943,psychiatric,I-Condition
114623,7943,illness,I-Condition
114624,7943,.,O
114625,7944,Patients,O
114626,7944,receiving,O
114627,7944,benzodiazepines,B-Drug
114628,7944,and,O
114629,7944,narcotics,B-Drug
114630,7944,.,O
114631,7945,Patients,O
114632,7945,with,O
114633,7945,compromised,B-Condition
114634,7945,renal,I-Condition
114635,7945,.,O
114636,7946,Patients,O
114637,7946,receiving,O
114638,7946,medications,B-Drug
114639,7946,highly,I-Drug
114640,7946,bound,I-Drug
114641,7946,to,I-Drug
114642,7946,plasma,I-Drug
114643,7946,proteins,I-Drug
114644,7946,eg,O
114645,7946,.,O
114646,7946,Warfarin,B-Drug
114647,7946,.,O
114648,7947,Pregnant,B-Condition
114649,7947,or,O
114650,7947,lactating,B-Condition
114651,7947,women,B-Person
114652,7947,.,O
114653,7948,Fulminant,O
114654,7948,hepatic,B-Condition
114655,7948,failure,I-Condition
114656,7948,.,O
114657,7949,Adult,B-Person
114658,7949,Patients,O
114659,7949,with,O
114660,7949,Overt,B-Condition
114661,7949,Hepatic,I-Condition
114662,7949,Encephalopathy,I-Condition
114663,7949,.,O
114664,7950,Subjects,O
114665,7950,with,O
114666,7950,a,O
114667,7950,supine,O
114668,7950,BP,O
114669,7950,>,O
114670,7950,140,O
114671,7950,mm,O
114672,7950,Hg,O
114673,7950,systolic,O
114674,7950,or,O
114675,7950,>,O
114676,7950,90,O
114677,7950,mm,O
114678,7950,Hg,O
114679,7950,diastolic,O
114680,7950,or,O
114681,7950,<,O
114682,7950,100,O
114683,7950,mm,O
114684,7950,Hg,O
114685,7950,systolic,O
114686,7950,or,O
114687,7950,<,O
114688,7950,60,O
114689,7950,mm,O
114690,7950,Hg,O
114691,7950,diastolic,O
114692,7950,based,O
114693,7950,on,O
114694,7950,the,O
114695,7950,average,O
114696,7950,of,O
114697,7950,the,O
114698,7950,triplicate,O
114699,7951,Serum,O
114700,7951,potassium,O
114701,7951,>,O
114702,7951,=,O
114703,7951,5.1,O
114704,7951,mmol,O
114705,7951,/,O
114706,7951,L,O
114707,7951,or,O
114708,7951,<,O
114709,7951,3.5,O
114710,7951,mmol,O
114711,7951,/,O
114712,7951,L,O
114713,7951,at,O
114714,7951,screening,O
114715,7951,",",O
114716,7951,confirmed,O
114717,7951,by,O
114718,7951,a,O
114719,7951,single,O
114720,7951,repeat,O
114721,7951,if,O
114722,7951,deemed,O
114723,7951,necessary,O
114724,7951,.,O
114725,7952,Estimated,O
114726,7952,GFR,O
114727,7952,<,O
114728,7952,60,O
114729,7952,mL,O
114730,7952,/,O
114731,7952,min/1.73,O
114732,7952,m2,O
114733,7952,using,O
114734,7952,the,O
114735,7952,Cockcroft,B-Observation
114736,7952,-,I-Observation
114737,7952,Gault,I-Observation
114738,7952,formula,I-Observation
114739,7952,measurement,O
114740,7952,of,O
114741,7952,the,O
114742,7952,individual,O
114743,7952,parameters,O
114744,7952,following,O
114745,7952,at,O
114746,7952,least,O
114747,7952,5,O
114748,7952,minutes,O
114749,7952,of,O
114750,7952,rest,O
114751,7952,at,O
114752,7952,Screening,O
114753,7952,.,O
114754,7953,Male,B-Person
114755,7953,and/or,O
114756,7953,female,B-Person
114757,7953,healthy,B-Condition
114758,7953,volunteers,O
114759,7953,",",O
114760,7953,age,B-Person
114761,7953,18,O
114762,7953,to,O
114763,7953,55,O
114764,7953,years,O
114765,7953,.,O
114766,7953,Females,B-Person
114767,7953,must,O
114768,7953,be,O
114769,7953,of,O
114770,7953,non,O
114771,7953,-,O
114772,7953,childbearing,B-Condition
114773,7953,potential,I-Condition
114774,7953,.,O
114775,7954,Body,O
114776,7954,Mass,O
114777,7954,Index,O
114778,7954,(,O
114779,7954,BMI,O
114780,7954,),O
114781,7954,of,O
114782,7954,17.5,O
114783,7954,to,O
114784,7954,30.5,O
114785,7954,kg,O
114786,7954,/,O
114787,7954,m2,O
114788,7954,;,O
114789,7954,and,O
114790,7954,a,O
114791,7954,total,O
114792,7954,body,O
114793,7954,weight,O
114794,7954,>,O
114795,7954,50,O
114796,7954,kg,O
114797,7954,(,O
114798,7954,110,O
114799,7954,lbs,O
114800,7954,),O
114801,7954,.,O
114802,7955,Subjects,O
114803,7955,who,O
114804,7955,are,O
114805,7955,willing,O
114806,7955,and,O
114807,7955,able,O
114808,7955,to,O
114809,7955,comply,O
114810,7955,with,O
114811,7955,scheduled,O
114812,7955,visits,O
114813,7955,",",O
114814,7955,treatment,O
114815,7955,plan,O
114816,7955,",",O
114817,7955,laboratory,O
114818,7955,tests,O
114819,7955,",",O
114820,7955,diet,O
114821,7955,restrictions,O
114822,7955,and,O
114823,7955,other,O
114824,7955,trial,O
114825,7955,procedures,O
114826,7955,.,O
114827,7956,Fasting,O
114828,7956,plasma,O
114829,7956,glucose,O
114830,7956,>,O
114831,7956,"7,0",O
114832,7956,mM,O
114833,7956,",",O
114834,7956,HbA1c,O
114835,7956,>,O
114836,7956,48,O
114837,7956,mmol,O
114838,7956,/,O
114839,7956,mol,O
114840,7956,3,O
114841,7956,months,O
114842,7956,after,O
114843,7956,RYGB,O
114844,7957,Dysregulated,O
114845,7957,thyroid,B-Condition
114846,7957,diseases,I-Condition
114847,7957,",",O
114848,7957,use,O
114849,7957,of,O
114850,7957,antithyroid,B-Procedure
114851,7957,treatment,I-Procedure
114852,7957,.,O
114853,7958,Late,B-Condition
114854,7958,diabetic,I-Condition
114855,7958,complications,I-Condition
114856,7958,as,O
114857,7958,retinopathy,B-Condition
114858,7958,",",O
114859,7958,renal,B-Condition
114860,7958,insufficiency,I-Condition
114861,7958,",",O
114862,7958,neuropathy,B-Condition
114863,7958,or,O
114864,7958,previous,O
114865,7958,pancreatitis,B-Condition
114866,7958,.,O
114867,7959,Complications,B-Condition
114868,7959,to,O
114869,7959,RYGB,B-Procedure
114870,7959,.,O
114871,7959,Documented,O
114872,7959,reactive,B-Condition
114873,7959,hypoglycaemia,I-Condition
114874,7959,",",O
114875,7959,severe,O
114876,7959,dumping,B-Condition
114877,7959,(,O
114878,7959,vomiting,B-Condition
114879,7959,",",O
114880,7959,diarrhea,B-Condition
114881,7959,",",O
114882,7959,severe,O
114883,7959,abdominal,B-Condition
114884,7959,pain,I-Condition
114885,7959,after,O
114886,7959,food,O
114887,7959,intake,O
114888,7959,),O
114889,7960,Cholecystectomy,B-Procedure
114890,7960,.,O
114891,7961,Uncomplicated,O
114892,7961,RYGB,B-Procedure
114893,7961,performed,O
114894,7961,minimum,O
114895,7961,3,O
114896,7961,months,O
114897,7961,prior,O
114898,7961,to,O
114899,7961,the,O
114900,7961,study,O
114901,7961,.,O
114902,7962,Fasting,O
114903,7962,glucose,O
114904,7962,<,O
114905,7962,"7,0",O
114906,7962,mM,O
114907,7962,",",O
114908,7962,HbA1c,O
114909,7962,<,O
114910,7962,48,O
114911,7962,mmol,O
114912,7962,/,O
114913,7962,mol,O
114914,7962,3,O
114915,7962,months,O
114916,7962,after,O
114917,7962,RYGB,B-Procedure
114918,7963,Prior,O
114919,7963,treatment,B-Procedure
114920,7963,with,O
114921,7963,enzalutamide,B-Drug
114922,7963,or,O
114923,7963,abiraterone,B-Drug
114924,7963,acetate,I-Drug
114925,7963,for,O
114926,7963,>,O
114927,7963,14,O
114928,7963,days,O
114929,7963,prior,O
114930,7963,to,O
114931,7963,enrollment,O
114932,7963,and,O
114933,7963,completion,O
114934,7963,of,O
114935,7963,baseline,O
114936,7963,tests,O
114937,7963,.,O
114938,7964,Receipt,O
114939,7964,of,O
114940,7964,chemotherapy,B-Procedure
114941,7964,for,O
114942,7964,prostate,B-Condition
114943,7964,or,I-Condition
114944,7964,other,I-Condition
114945,7964,cancer,I-Condition
114946,7964,within,O
114947,7964,the,O
114948,7964,past,O
114949,7964,12,O
114950,7964,months,O
114951,7964,with,O
114952,7964,residual,B-Condition
114953,7964,cognitive,I-Condition
114954,7964,deficits,I-Condition
114955,7964,",",O
114956,7964,or,O
114957,7964,receipt,O
114958,7964,of,O
114959,7964,chemotherapy,B-Procedure
114960,7964,for,O
114961,7964,mCRPC,B-Condition
114962,7964,.,O
114963,7964,Patients,O
114964,7964,/,O
114965,7964,physicians,O
114966,7964,planning,O
114967,7964,treatment,O
114968,7964,with,O
114969,7964,chemotherapy,O
114970,7964,during,O
114971,7964,the,O
114972,7964,12,O
114973,7964,month,O
114974,7964,period,O
114975,7964,of,O
114976,7964,the,O
114977,7964,investigation,O
114978,7964,are,O
114979,7964,also,O
114980,7964,ineligible,O
114981,7964,.,O
114982,7965,History,O
114983,7965,of,O
114984,7965,cognitive,B-Condition
114985,7965,impairment,I-Condition
114986,7965,or,I-Condition
114987,7965,dysfunction,I-Condition
114988,7965,",",O
114989,7965,including,O
114990,7965,a,O
114991,7965,history,O
114992,7965,of,O
114993,7965,dementia,B-Condition
114994,7965,",",O
114995,7965,Alzheimer,B-Condition
114996,7965,'s,I-Condition
114997,7965,disease,I-Condition
114998,7965,",",O
114999,7965,stroke,B-Condition
115000,7965,with,O
115001,7965,residual,B-Condition
115002,7965,cognitive,I-Condition
115003,7965,deficits,I-Condition
115004,7965,",",O
115005,7965,cognitive,B-Condition
115006,7965,dysfunction,I-Condition
115007,7965,related,O
115008,7965,to,O
115009,7965,alcohol,B-Condition
115010,7965,or,I-Condition
115011,7965,substance,I-Condition
115012,7965,abuse,I-Condition
115013,7965,",",O
115014,7965,or,O
115015,7965,cognitive,B-Condition
115016,7965,dysfunction,I-Condition
115017,7965,related,O
115018,7965,to,O
115019,7965,prior,O
115020,7965,treatment,B-Procedure
115021,7965,for,O
115022,7965,any,O
115023,7965,cancer,B-Condition
115024,7965,.,O
115025,7966,Patients,O
115026,7966,with,O
115027,7966,a,O
115028,7966,seizure,B-Condition
115029,7966,history,B-Observation
115030,7966,",",O
115031,7966,history,B-Observation
115032,7966,of,I-Observation
115033,7966,recurrent,B-Condition
115034,7966,falls,I-Condition
115035,7966,",",O
115036,7966,or,O
115037,7966,known,O
115038,7966,brain,B-Condition
115039,7966,metastases,I-Condition
115040,7966,are,O
115041,7966,excluded,O
115042,7966,from,O
115043,7966,this,O
115044,7966,clinical,O
115045,7966,trial,O
115046,7966,because,O
115047,7966,of,O
115048,7966,their,O
115049,7966,poor,O
115050,7966,prognosis,O
115051,7966,and,O
115052,7966,because,O
115053,7966,of,O
115054,7966,their,O
115055,7966,heightened,O
115056,7966,risk,O
115057,7966,of,O
115058,7966,seizure,O
115059,7966,or,O
115060,7966,progressive,O
115061,7966,cognitive,O
115062,7966,and/or,O
115063,7966,neurologic,O
115064,7966,dysfunction,O
115065,7966,that,O
115066,7966,would,O
115067,7966,confound,O
115068,7966,the,O
115069,7966,evaluation,O
115070,7966,.,O
115071,7967,Uncontrolled,O
115072,7967,intercurrent,B-Condition
115073,7967,illness,I-Condition
115074,7967,including,O
115075,7967,",",O
115076,7967,but,O
115077,7967,not,O
115078,7967,limited,O
115079,7967,to,O
115080,7967,",",O
115081,7967,uncontrolled,O
115082,7967,diabetes,B-Condition
115083,7967,",",O
115084,7967,ongoing,O
115085,7967,or,O
115086,7967,active,O
115087,7967,infection,B-Condition
115088,7967,",",O
115089,7967,symptomatic,O
115090,7967,congestive,B-Condition
115091,7967,heart,I-Condition
115092,7967,failure,I-Condition
115093,7967,(,O
115094,7967,New,O
115095,7967,York,O
115096,7967,Heart,O
115097,7967,Association,O
115098,7967,Class,O
115099,7967,III,O
115100,7967,and,O
115101,7967,IV,O
115102,7967,heart,B-Condition
115103,7967,failure,I-Condition
115104,7967,),O
115105,7967,",",O
115106,7967,unstable,B-Condition
115107,7967,angina,I-Condition
115108,7967,pectoris,I-Condition
115109,7967,",",O
115110,7967,cardiac,B-Condition
115111,7967,arrhythmia,I-Condition
115112,7967,",",O
115113,7967,or,O
115114,7967,psychiatric,B-Condition
115115,7967,illness,I-Condition
115116,7967,/,O
115117,7967,social,B-Condition
115118,7967,situations,I-Condition
115119,7967,/,O
115120,7967,substance,B-Condition
115121,7967,abuse,I-Condition
115122,7967,that,O
115123,7967,would,O
115124,7967,limit,O
115125,7967,compliance,O
115126,7967,with,O
115127,7967,study,O
115128,7967,requirements,O
115129,7967,.,O
115130,7968,Patients,O
115131,7968,with,O
115132,7968,a,O
115133,7968,"""",O
115134,7968,currently,O
115135,7968,active,O
115136,7968,"""",O
115137,7968,second,O
115138,7968,malignancy,B-Condition
115139,7968,other,O
115140,7968,than,O
115141,7968,non,B-Condition
115142,7968,-,I-Condition
115143,7968,melanoma,I-Condition
115144,7968,skin,I-Condition
115145,7968,cancers,I-Condition
115146,7968,are,O
115147,7968,not,O
115148,7968,eligible,O
115149,7968,.,O
115150,7968,Patients,O
115151,7968,are,O
115152,7968,not,O
115153,7968,considered,O
115154,7968,to,O
115155,7968,have,O
115156,7968,a,O
115157,7968,"""",O
115158,7968,currently,O
115159,7968,active,O
115160,7968,"""",O
115161,7968,malignancy,O
115162,7968,if,O
115163,7968,they,O
115164,7968,have,O
115165,7968,completed,O
115166,7968,all,O
115167,7968,therapy,O
115168,7968,and,O
115169,7968,are,O
115170,7968,now,O
115171,7968,considered,O
115172,7968,without,O
115173,7968,evidence,O
115174,7968,of,O
115175,7968,disease,O
115176,7968,for,O
115177,7968,1,O
115178,7968,year,O
115179,7968,.,O
115180,7968,Patients,O
115181,7968,with,O
115182,7968,cognitive,B-Condition
115183,7968,dysfunction,I-Condition
115184,7968,related,O
115185,7968,to,O
115186,7968,treatment,B-Procedure
115187,7968,of,O
115188,7968,another,O
115189,7968,malignancy,B-Condition
115190,7968,",",O
115191,7968,including,O
115192,7968,a,O
115193,7968,history,O
115194,7968,of,O
115195,7968,"""",O
115196,7968,chemo,O
115197,7968,-,O
115198,7968,brain,O
115199,7968,"""",O
115200,7968,",",O
115201,7968,are,O
115202,7968,ineligible,O
115203,7968,.,O
115204,7969,Patients,O
115205,7969,taking,O
115206,7969,psychotropic,B-Drug
115207,7969,medications,I-Drug
115208,7969,or,O
115209,7969,illicit,B-Drug
115210,7969,drugs,I-Drug
115211,7969,that,O
115212,7969,may,O
115213,7969,alter,B-Condition
115214,7969,cognition,I-Condition
115215,7969,",",I-Condition
115216,7969,concentration,I-Condition
115217,7969,",",I-Condition
115218,7969,or,I-Condition
115219,7969,behavior,I-Condition
115220,7969,.,O
115221,7969,Appropriate,O
115222,7969,treatment,O
115223,7969,by,O
115224,7969,a,O
115225,7969,licensed,O
115226,7969,provider,O
115227,7969,with,O
115228,7969,medications,O
115229,7969,for,O
115230,7969,depression,O
115231,7969,or,O
115232,7969,anxiety,O
115233,7969,",",O
115234,7969,including,O
115235,7969,but,O
115236,7969,not,O
115237,7969,limited,O
115238,7969,to,O
115239,7969,SSRIs,O
115240,7969,",",O
115241,7969,SNRIs,O
115242,7969,",",O
115243,7969,and,O
115244,7969,standard,O
115245,7969,dose,O
115246,7969,benzodiazepines,O
115247,7969,at,O
115248,7969,a,O
115249,7969,stable,O
115250,7969,dose,O
115251,7969,",",O
115252,7969,is,O
115253,7969,permitted,O
115254,7970,Have,O
115255,7970,diagnosis,O
115256,7970,of,O
115257,7970,prostate,B-Condition
115258,7970,cancer,I-Condition
115259,7970,and,O
115260,7970,have,O
115261,7970,received,O
115262,7970,treatment,B-Procedure
115263,7970,with,O
115264,7970,GnRH,B-Drug
115265,7970,agonist,I-Drug
115266,7970,or,I-Drug
115267,7970,antagonist,I-Drug
115268,7970,therapy,O
115269,7970,for,O
115270,7970,at,O
115271,7970,least,O
115272,7970,1,O
115273,7970,month,O
115274,7970,prior,O
115275,7970,to,O
115276,7970,enrollment,O
115277,7970,.,O
115278,7971,Willing,O
115279,7971,and,O
115280,7971,able,O
115281,7971,to,O
115282,7971,complete,O
115283,7971,survey,O
115284,7971,questionnaires,O
115285,7971,in,O
115286,7971,English,O
115287,7971,without,O
115288,7971,assistance,O
115289,7971,through,O
115290,7971,the,O
115291,7971,duration,O
115292,7971,of,O
115293,7971,the,O
115294,7971,study,O
115295,7971,.,O
115296,7971,This,O
115297,7971,stipulation,O
115298,7971,is,O
115299,7971,in,O
115300,7971,place,O
115301,7971,because,O
115302,7971,not,O
115303,7971,all,O
115304,7971,of,O
115305,7971,the,O
115306,7971,proposed,O
115307,7971,quality,O
115308,7971,of,O
115309,7971,life,O
115310,7971,or,O
115311,7971,cognitive,O
115312,7971,tests,O
115313,7971,are,O
115314,7971,available,O
115315,7971,or,O
115316,7971,validated,O
115317,7971,in,O
115318,7971,other,O
115319,7971,languages,O
115320,7971,.,O
115321,7972,Age,B-Person
115322,7972,=,O
115323,7972,18,O
115324,7972,years,O
115325,7972,.,O
115326,7973,Ability,O
115327,7973,to,O
115328,7973,understand,O
115329,7973,and,O
115330,7973,the,O
115331,7973,willingness,O
115332,7973,to,O
115333,7973,sign,O
115334,7973,a,O
115335,7973,written,O
115336,7973,informed,O
115337,7973,consent,O
115338,7973,document,O
115339,7973,written,O
115340,7973,in,O
115341,7973,English,O
115342,7973,that,O
115343,7973,is,O
115344,7973,approved,O
115345,7973,by,O
115346,7973,an,O
115347,7973,institutional,O
115348,7973,review,O
115349,7973,board,O
115350,7973,.,O
115351,7974,Have,O
115352,7974,either,O
115353,7974,newly,O
115354,7974,diagnosed,O
115355,7974,metastatic,O
115356,7974,hormone,O
115357,7974,sensitive,O
115358,7974,prostate,B-Condition
115359,7974,cancer,I-Condition
115360,7974,(,O
115361,7974,mHSPC,B-Condition
115362,7974,),O
115363,7974,or,O
115364,7974,castration,O
115365,7974,-,O
115366,7974,resistant,O
115367,7974,metastatic,O
115368,7974,prostate,B-Condition
115369,7974,cancer,I-Condition
115370,7974,(,O
115371,7974,mCRPC,B-Condition
115372,7974,),O
115373,7974,and,O
115374,7974,eligible,O
115375,7974,to,O
115376,7974,undergo,O
115377,7974,treatment,B-Procedure
115378,7974,with,O
115379,7974,abiraterone,B-Drug
115380,7974,acetate,I-Drug
115381,7974,(,O
115382,7974,mHSPC,B-Condition
115383,7974,or,O
115384,7974,mCRPC,B-Condition
115385,7974,),O
115386,7974,or,O
115387,7974,enzalutamide,B-Drug
115388,7974,(,O
115389,7974,mCRPC,B-Condition
115390,7974,),O
115391,7975,Patients,O
115392,7975,may,O
115393,7975,have,O
115394,7975,received,O
115395,7975,the,O
115396,7975,following,O
115397,7975,prior,O
115398,7975,AR,O
115399,7975,directed,O
115400,7975,therapy,O
115401,7975,prior,O
115402,7975,to,O
115403,7975,enrollment,O
115404,7975,:,O
115405,7975,bicalutamide,O
115406,7975,",",O
115407,7975,ketoconazole,O
115408,7975,.,O
115409,7975,Prior,O
115410,7975,to,O
115411,7975,enrollment,O
115412,7975,",",O
115413,7975,patients,O
115414,7975,may,O
115415,7975,have,O
115416,7975,received,O
115417,7975,treatment,O
115418,7975,with,O
115419,7975,abiraterone,O
115420,7975,acetate,O
115421,7975,or,O
115422,7975,enzalutamide,O
115423,7975,for,O
115424,7975,no,O
115425,7975,more,O
115426,7975,than,O
115427,7975,14,O
115428,7975,days,O
115429,7975,before,O
115430,7975,completing,O
115431,7975,baseline,O
115432,7975,studies,O
115433,7975,.,O
115434,7976,Patients,O
115435,7976,may,O
115436,7976,have,O
115437,7976,received,O
115438,7976,chemotherapy,B-Procedure
115439,7976,for,O
115440,7976,hormone,O
115441,7976,-,O
115442,7976,sensitive,O
115443,7976,metastatic,O
115444,7976,prostate,B-Condition
115445,7976,cancer,I-Condition
115446,7976,only,O
115447,7976,",",O
115448,7976,but,O
115449,7976,it,O
115450,7976,must,O
115451,7976,not,O
115452,7976,have,O
115453,7976,lasted,O
115454,7976,for,O
115455,7976,more,O
115456,7976,than,O
115457,7976,6,O
115458,7976,months,O
115459,7976,.,O
115460,7976,At,O
115461,7976,least,O
115462,7976,12,O
115463,7976,months,O
115464,7976,must,O
115465,7976,have,O
115466,7976,elapsed,O
115467,7976,since,O
115468,7976,completion,O
115469,7976,of,O
115470,7976,chemotherapy,B-Procedure
115471,7976,.,O
115472,7977,Patients,O
115473,7977,may,O
115474,7977,have,O
115475,7977,received,O
115476,7977,prior,O
115477,7977,definitive,O
115478,7977,radiation,B-Procedure
115479,7977,therapy,I-Procedure
115480,7977,or,O
115481,7977,surgery,B-Procedure
115482,7977,.,O
115483,7977,At,O
115484,7977,least,O
115485,7977,60,O
115486,7977,days,O
115487,7977,must,O
115488,7977,have,O
115489,7977,elapsed,O
115490,7977,since,O
115491,7977,completion,O
115492,7977,of,O
115493,7977,definitive,O
115494,7977,radiation,B-Procedure
115495,7977,therapy,I-Procedure
115496,7977,or,O
115497,7977,surgery,B-Procedure
115498,7977,and,O
115499,7977,patient,O
115500,7977,must,O
115501,7977,have,O
115502,7977,only,O
115503,7977,grade,O
115504,7977,2,O
115505,7977,or,O
115506,7977,less,O
115507,7977,adverse,B-Condition
115508,7977,effects,I-Condition
115509,7977,at,O
115510,7977,the,O
115511,7977,time,O
115512,7977,of,O
115513,7977,registration,O
115514,7977,.,O
115515,7977,Enrollment,O
115516,7977,during,O
115517,7977,palliative,O
115518,7977,radiation,O
115519,7977,of,O
115520,7977,=,O
115521,7977,10,O
115522,7977,days,O
115523,7977,",",O
115524,7977,or,O
115525,7977,radiation,O
115526,7977,of,O
115527,7977,=,O
115528,7977,10,O
115529,7977,days,O
115530,7977,during,O
115531,7977,the,O
115532,7977,duration,O
115533,7977,of,O
115534,7977,the,O
115535,7977,study,O
115536,7977,is,O
115537,7977,allowed,O
115538,7977,.,O
115539,7978,Patients,O
115540,7978,must,O
115541,7978,be,O
115542,7978,able,O
115543,7978,to,O
115544,7978,take,O
115545,7978,oral,O
115546,7978,medication,O
115547,7978,.,O
115548,7979,Failure,O
115549,7979,to,O
115550,7979,have,O
115551,7979,fully,B-Condition
115552,7979,recovered,I-Condition
115553,7979,(,O
115554,7979,that,O
115555,7979,is,O
115556,7979,",",O
115557,7979,less,O
115558,7979,than,O
115559,7979,or,O
115560,7979,equal,O
115561,7979,to,O
115562,7979,[,O
115563,7979,<,O
115564,7979,=],O
115565,7979,Grade,O
115566,7979,1,O
115567,7979,toxicity,O
115568,7979,),O
115569,7979,from,O
115570,7979,the,O
115571,7979,reversible,O
115572,7979,effects,O
115573,7979,of,O
115574,7979,prior,O
115575,7979,chemotherapy,B-Procedure
115576,7979,.,O
115577,7980,Major,B-Procedure
115578,7980,surgery,I-Procedure
115579,7980,within,O
115580,7980,14,O
115581,7980,days,O
115582,7980,before,O
115583,7980,enrollment,O
115584,7980,.,O
115585,7981,Radiotherapy,B-Procedure
115586,7981,within,O
115587,7981,14,O
115588,7981,days,O
115589,7981,before,O
115590,7981,enrollment,O
115591,7981,(,O
115592,7981,if,O
115593,7981,the,O
115594,7981,involved,B-Observation
115595,7981,field,I-Observation
115596,7981,is,I-Observation
115597,7981,small,I-Observation
115598,7981,",",O
115599,7981,7,O
115600,7981,days,O
115601,7981,will,O
115602,7981,be,O
115603,7981,considered,O
115604,7981,a,O
115605,7981,sufficient,O
115606,7981,interval,O
115607,7981,between,O
115608,7981,treatment,O
115609,7981,and,O
115610,7981,administration,O
115611,7981,of,O
115612,7981,the,O
115613,7981,ixazomib,O
115614,7981,.,O
115615,7981,),O
115616,7982,Central,B-Condition
115617,7982,nervous,I-Condition
115618,7982,system,I-Condition
115619,7982,involvement,I-Condition
115620,7982,.,O
115621,7983,Infection,B-Condition
115622,7983,requiring,O
115623,7983,systemic,B-Procedure
115624,7983,antibiotic,I-Procedure
115625,7983,therapy,I-Procedure
115626,7983,or,O
115627,7983,other,O
115628,7983,serious,O
115629,7983,infection,B-Condition
115630,7983,within,O
115631,7983,14,O
115632,7983,days,O
115633,7983,before,O
115634,7983,study,O
115635,7983,enrollment,O
115636,7983,.,O
115637,7984,Evidence,O
115638,7984,of,O
115639,7984,current,O
115640,7984,uncontrolled,O
115641,7984,cardiovascular,B-Condition
115642,7984,conditions,I-Condition
115643,7984,",",O
115644,7984,including,O
115645,7984,uncontrolled,O
115646,7984,hypertension,B-Condition
115647,7984,",",O
115648,7984,uncontrolled,O
115649,7984,cardiac,B-Condition
115650,7984,arrhythmias,I-Condition
115651,7984,",",O
115652,7984,symptomatic,O
115653,7984,congestive,B-Condition
115654,7984,heart,I-Condition
115655,7984,failure,I-Condition
115656,7984,",",O
115657,7984,unstable,B-Condition
115658,7984,angina,I-Condition
115659,7984,",",O
115660,7984,or,O
115661,7984,myocardial,B-Condition
115662,7984,infarction,I-Condition
115663,7984,within,O
115664,7984,the,O
115665,7984,past,O
115666,7984,6,O
115667,7984,months,O
115668,7984,.,O
115669,7985,Systemic,B-Procedure
115670,7985,treatment,I-Procedure
115671,7985,",",O
115672,7985,within,O
115673,7985,14,O
115674,7985,days,O
115675,7985,before,O
115676,7985,the,O
115677,7985,first,O
115678,7985,dose,O
115679,7985,of,O
115680,7985,ixazomib,B-Drug
115681,7985,",",O
115682,7985,with,O
115683,7985,strong,B-Drug
115684,7985,cytochrome,I-Drug
115685,7985,P450,I-Drug
115686,7985,3A,I-Drug
115687,7985,(,I-Drug
115688,7985,CYP3A,I-Drug
115689,7985,),I-Drug
115690,7985,inducers,I-Drug
115691,7985,(,O
115692,7985,rifampin,B-Drug
115693,7985,",",O
115694,7985,rifapentine,B-Drug
115695,7985,",",O
115696,7985,rifabutin,B-Drug
115697,7985,",",O
115698,7985,carbamazepine,B-Drug
115699,7985,",",O
115700,7985,phenytoin,B-Drug
115701,7985,",",O
115702,7985,phenobarbital,B-Drug
115703,7985,),O
115704,7985,",",O
115705,7985,or,O
115706,7985,use,O
115707,7985,of,O
115708,7985,Ginkgo,B-Drug
115709,7985,biloba,I-Drug
115710,7985,or,O
115711,7985,St.,B-Drug
115712,7985,John,I-Drug
115713,7985,'s,I-Drug
115714,7985,wort,I-Drug
115715,7985,.,O
115716,7986,Ongoing,O
115717,7986,or,O
115718,7986,active,O
115719,7986,systemic,B-Condition
115720,7986,infection,I-Condition
115721,7986,",",O
115722,7986,active,O
115723,7986,hepatitis,B-Condition
115724,7986,B,I-Condition
115725,7986,or,I-Condition
115726,7986,C,I-Condition
115727,7986,virus,I-Condition
115728,7986,infection,I-Condition
115729,7986,",",O
115730,7986,or,O
115731,7986,known,O
115732,7986,human,O
115733,7986,immunodeficiency,O
115734,7986,virus,O
115735,7986,positive,O
115736,7986,.,O
115737,7987,Diagnosed,O
115738,7987,or,O
115739,7987,treated,O
115740,7987,for,O
115741,7987,another,O
115742,7987,malignancy,B-Condition
115743,7987,within,O
115744,7987,2,O
115745,7987,years,O
115746,7987,before,O
115747,7987,study,O
115748,7987,enrollment,O
115749,7987,or,O
115750,7987,previously,O
115751,7987,diagnosed,O
115752,7987,with,O
115753,7987,another,O
115754,7987,malignancy,B-Condition
115755,7987,and,O
115756,7987,have,O
115757,7987,any,B-Mood
115758,7987,evidence,I-Mood
115759,7987,of,I-Mood
115760,7987,residual,B-Condition
115761,7987,disease,I-Condition
115762,7987,.,O
115763,7987,Participants,O
115764,7987,with,O
115765,7987,non,B-Condition
115766,7987,-,I-Condition
115767,7987,melanoma,I-Condition
115768,7987,skin,I-Condition
115769,7987,cancer,I-Condition
115770,7987,or,O
115771,7987,carcinoma,B-Condition
115772,7987,in,I-Condition
115773,7987,situ,I-Condition
115774,7987,of,O
115775,7987,any,O
115776,7987,type,O
115777,7987,are,O
115778,7987,not,O
115779,7987,excluded,O
115780,7987,if,O
115781,7987,they,O
115782,7987,have,O
115783,7987,undergone,O
115784,7987,complete,B-Procedure
115785,7987,resection,I-Procedure
115786,7987,.,O
115787,7988,Has,O
115788,7988,greater,O
115789,7988,than,O
115790,7988,or,O
115791,7988,equal,O
115792,7988,to,O
115793,7988,(,O
115794,7988,>,O
115795,7988,=),O
115796,7988,Grade,O
115797,7988,2,O
115798,7988,peripheral,B-Condition
115799,7988,neuropathy,I-Condition
115800,7988,",",O
115801,7988,or,O
115802,7988,Grade,O
115803,7988,1,O
115804,7988,with,O
115805,7988,pain,B-Condition
115806,7988,on,O
115807,7988,clinical,O
115808,7988,examination,O
115809,7988,during,O
115810,7988,the,O
115811,7988,screening,O
115812,7988,period,O
115813,7988,.,O
115814,7989,PD,B-Drug
115815,7989,on,O
115816,7989,first,O
115817,7989,-,O
115818,7989,line,O
115819,7989,therapy,O
115820,7989,.,O
115821,7990,Participation,O
115822,7990,in,O
115823,7990,other,O
115824,7990,interventional,O
115825,7990,clinical,O
115826,7990,trials,O
115827,7990,",",O
115828,7990,including,O
115829,7990,those,O
115830,7990,with,O
115831,7990,other,O
115832,7990,investigational,O
115833,7990,agents,O
115834,7990,not,O
115835,7990,included,O
115836,7990,in,O
115837,7990,this,O
115838,7990,trial,O
115839,7990,",",O
115840,7990,within,O
115841,7990,30,O
115842,7990,days,O
115843,7990,of,O
115844,7990,the,O
115845,7990,start,O
115846,7990,of,O
115847,7990,this,O
115848,7990,trial,O
115849,7990,and,O
115850,7990,throughout,O
115851,7990,the,O
115852,7990,duration,O
115853,7990,of,O
115854,7990,this,O
115855,7990,trial,O
115856,7990,.,O
115857,7990,Non,O
115858,7990,-,O
115859,7990,interventional,O
115860,7990,trials,O
115861,7990,(,O
115862,7990,that,O
115863,7990,is,O
115864,7990,",",O
115865,7990,observational,O
115866,7990,trials,O
115867,7990,),O
115868,7990,are,O
115869,7990,permitted,O
115870,7990,at,O
115871,7990,any,O
115872,7990,time,O
115873,7990,point,O
115874,7990,.,O
115875,7991,Participants,O
115876,7991,must,O
115877,7991,have,O
115878,7991,completed,O
115879,7991,3,O
115880,7991,cycles,O
115881,7991,of,O
115882,7991,a,O
115883,7991,bortezomib,B-Drug
115884,7991,-,O
115885,7991,based,O
115886,7991,induction,B-Procedure
115887,7991,regimen,I-Procedure
115888,7991,(,O
115889,7991,as,O
115890,7991,defined,O
115891,7991,by,O
115892,7991,current,O
115893,7991,NCCN,O
115894,7991,guidelines,O
115895,7991,),O
115896,7991,and,O
115897,7991,have,O
115898,7991,no,O
115899,7991,evidence,O
115900,7991,of,O
115901,7991,disease,O
115902,7991,progression,O
115903,7991,as,O
115904,7991,defined,O
115905,7991,by,O
115906,7991,IMWG,O
115907,7991,criteria,O
115908,7991,.,O
115909,7992,Participants,O
115910,7992,with,O
115911,7992,light,B-Condition
115912,7992,chain,I-Condition
115913,7992,and,I-Condition
115914,7992,free,I-Condition
115915,7992,light,I-Condition
115916,7992,chain,I-Condition
115917,7992,(,I-Condition
115918,7992,FLC,I-Condition
115919,7992,),I-Condition
115920,7992,only,O
115921,7992,may,O
115922,7992,be,O
115923,7992,enrolled,O
115924,7992,if,O
115925,7992,they,O
115926,7992,meet,O
115927,7992,all,O
115928,7992,the,O
115929,7992,criteria,O
115930,7992,for,O
115931,7992,a,O
115932,7992,diagnosis,O
115933,7992,of,O
115934,7992,MM,O
115935,7992,.,O
115936,7993,Participants,O
115937,7993,must,O
115938,7993,be,O
115939,7993,considered,O
115940,7993,by,O
115941,7993,their,O
115942,7993,physician,O
115943,7993,eligible,B-Mood
115944,7993,to,I-Mood
115945,7993,receiving,O
115946,7993,the,O
115947,7993,IRD,B-Procedure
115948,7993,regimen,I-Procedure
115949,7993,.,O
115950,7994,Eastern,O
115951,7994,Cooperative,O
115952,7994,Oncology,O
115953,7994,Group,O
115954,7994,(,O
115955,7994,ECOG,O
115956,7994,),O
115957,7994,performance,O
115958,7994,status,O
115959,7994,and/or,O
115960,7994,other,O
115961,7994,performance,O
115962,7994,status,O
115963,7994,0,O
115964,7994,",",O
115965,7994,1,O
115966,7994,",",O
115967,7994,or,O
115968,7994,2,O
115969,7994,at,O
115970,7994,time,O
115971,7994,of,O
115972,7994,enrollment,O
115973,7994,.,O
115974,7995,eGFR,O
115975,7995,<,O
115976,7995,45,O
115977,7996,Type,B-Condition
115978,7996,2,I-Condition
115979,7996,diabetes,I-Condition
115980,7996,(,O
115981,7996,HbA1c>6.5,O
115982,7996,),O
115983,7996,or,O
115984,7996,type,B-Condition
115985,7996,1,I-Condition
115986,7996,diabetes,I-Condition
115987,7997,Any,O
115988,7997,tobacco,B-Observation
115989,7997,or,O
115990,7997,nicotine,B-Observation
115991,7997,product,I-Observation
115992,7997,use,I-Observation
115993,7997,in,O
115994,7997,the,O
115995,7997,past,O
115996,7997,year,O
115997,7998,Low,O
115998,7998,vitamin,O
115999,7998,B12,O
116000,7998,Levels,O
116001,7998,(,O
116002,7998,<,O
116003,7998,300,O
116004,7998,pg,O
116005,7998,/,O
116006,7998,mL,O
116007,7998,),O
116008,7999,Self,O
116009,7999,-,O
116010,7999,reported,O
116011,7999,severe,O
116012,7999,difficulty,O
116013,7999,or,O
116014,7999,inability,O
116015,7999,to,O
116016,7999,walk,O
116017,7999,400,O
116018,7999,m,O
116019,7999,or,O
116020,7999,climb,O
116021,7999,10,O
116022,7999,steps,O
116023,7999,(,O
116024,7999,from,O
116025,7999,Q,O
116026,7999,2,O
116027,7999,and,O
116028,7999,19,O
116029,7999,on,O
116030,7999,PAT,O
116031,7999,-,O
116032,7999,D,O
116033,7999,),O
116034,8000,Self,O
116035,8000,-,O
116036,8000,reported,O
116037,8000,difficulty,O
116038,8000,or,O
116039,8000,inability,O
116040,8000,to,O
116041,8000,perform,O
116042,8000,basic,O
116043,8000,ADL,O
116044,8000,functions,O
116045,8000,(,O
116046,8000,from,O
116047,8000,Q,O
116048,8000,10,O
116049,8000,",",O
116050,8000,13,O
116051,8000,",",O
116052,8000,14,O
116053,8000,",",O
116054,8000,16,O
116055,8000,on,O
116056,8000,PAT,O
116057,8000,-,O
116058,8000,D,O
116059,8000,),O
116060,8001,Excessive,O
116061,8001,alcohol,B-Observation
116062,8001,use,I-Observation
116063,8001,(,O
116064,8001,>,O
116065,8001,14,O
116066,8001,drinks,O
116067,8001,/,O
116068,8001,week,O
116069,8001,),O
116070,8002,Cancer,B-Condition
116071,8002,requiring,O
116072,8002,treatment,B-Procedure
116073,8002,in,O
116074,8002,past,O
116075,8002,year,O
116076,8002,(,O
116077,8002,except,O
116078,8002,skin,O
116079,8002,),O
116080,8003,Dementia,B-Condition
116081,8003,-,O
116082,8003,diagnosed,O
116083,8003,and/or,O
116084,8003,MoCA,O
116085,8003,score,O
116086,8003,<,O
116087,8003,18,O
116088,8004,Parkinson,B-Condition
116089,8004,'s,I-Condition
116090,8004,or,O
116091,8004,other,O
116092,8004,neurological,B-Condition
116093,8004,disease,I-Condition
116094,8005,Chronic,B-Condition
116095,8005,liver,I-Condition
116096,8005,disease,I-Condition
116097,8005,or,O
116098,8005,cirrhosis,B-Condition
116099,8006,End,B-Condition
116100,8006,stage,I-Condition
116101,8006,renal,I-Condition
116102,8006,disease,I-Condition
116103,8006,or,O
116104,8006,on,O
116105,8006,dialysis,B-Procedure
116106,8007,Rheumatic,B-Condition
116107,8007,conditions,I-Condition
116108,8007,(,O
116109,8007,Rheumatoid,B-Condition
116110,8007,arthritis,I-Condition
116111,8007,",",O
116112,8007,lupus,B-Condition
116113,8007,",",O
116114,8007,and,O
116115,8007,any,O
116116,8007,other,O
116117,8007,autoimmune,B-Condition
116118,8007,disease,I-Condition
116119,8007,the,O
116120,8007,-PI,O
116121,8007,deems,O
116122,8007,them,O
116123,8007,to,O
116124,8007,be,O
116125,8007,ineligible,O
116126,8007,for,O
116127,8007,),O
116128,8008,Thyroid,B-Condition
116129,8008,problems,I-Condition
116130,8008,the,O
116131,8008,PI,O
116132,8008,deems,O
116133,8008,them,O
116134,8008,to,O
116135,8008,be,O
116136,8008,ineligible,O
116137,8008,for,O
116138,8009,Gout,B-Condition
116139,8010,Involved,O
116140,8010,in,O
116141,8010,another,O
116142,8010,interventional,O
116143,8010,study,O
116144,8011,Hemoglobin,O
116145,8011,<,O
116146,8011,8,O
116147,8011,or,O
116148,8011,diagnosed,O
116149,8011,with,O
116150,8011,anemia,B-Condition
116151,8012,Recent,O
116152,8012,unintentional,O
116153,8012,weight,O
116154,8012,change,O
116155,8012,(,O
116156,8012,+,O
116157,8012,/-,O
116158,8012,10,O
116159,8012,lbs,O
116160,8012,.,O
116161,8012,in,O
116162,8012,the,O
116163,8012,last,O
116164,8012,12,O
116165,8012,months,O
116166,8012,),O
116167,8013,BMI,O
116168,8013,<,O
116169,8013,18.5,O
116170,8014,Likely,O
116171,8014,to,O
116172,8014,not,O
116173,8014,follow,O
116174,8014,the,O
116175,8014,protocol,O
116176,8015,PI,O
116177,8015,deems,O
116178,8015,unfit,O
116179,8015,to,O
116180,8015,participate,O
116181,8016,Already,O
116182,8016,taking,O
116183,8016,Metformin,B-Drug
116184,8016,or,O
116185,8016,any,O
116186,8016,other,O
116187,8016,drug,B-Drug
116188,8016,intended,O
116189,8016,to,O
116190,8016,treat,O
116191,8016,diabetes,O
116192,8017,Age,B-Person
116193,8017,65,O
116194,8017,-,O
116195,8017,79,O
116196,8018,History,B-Observation
116197,8018,of,O
116198,8018,coronary,B-Condition
116199,8018,artery,I-Condition
116200,8018,disease,I-Condition
116201,8018,(,O
116202,8018,MI,B-Condition
116203,8018,/,O
116204,8018,heart,B-Condition
116205,8018,attack,I-Condition
116206,8018,",",O
116207,8018,stroke,B-Condition
116208,8018,",",O
116209,8018,heart,B-Condition
116210,8018,failure,I-Condition
116211,8018,",",O
116212,8018,or,O
116213,8018,peripheral,B-Condition
116214,8018,artery,I-Condition
116215,8018,disease,I-Condition
116216,8018,),O
116217,8019,Cancer,B-Condition
116218,8019,",",O
116219,8019,with,O
116220,8019,no,O
116221,8019,active,B-Procedure
116222,8019,treatment,I-Procedure
116223,8019,in,O
116224,8019,the,O
116225,8019,last,O
116226,8019,year,O
116227,8020,MCI,B-Condition
116228,8020,(,O
116229,8020,MoCA,O
116230,8020,>,O
116231,8020,18<26,O
116232,8020,-inclusive,O
116233,8020,of,O
116234,8020,1,O
116235,8020,point,O
116236,8020,if,O
116237,8020,<,O
116238,8020,12,O
116239,8020,years,O
116240,8020,of,O
116241,8020,education,O
116242,8020,Group,O
116243,8020,2,O
116244,8021,Decline,B-Condition
116245,8021,physical,I-Condition
116246,8021,function,I-Condition
116247,8021,(,O
116248,8021,walking,O
116249,8021,speed,O
116250,8021,<,O
116251,8021,1,O
116252,8021,m,O
116253,8021,/,O
116254,8021,s,O
116255,8021,),O
116256,8021,Group,O
116257,8021,3,O
116258,8021,(,O
116259,8021,Either,O
116260,8021,or,O
116261,8021,both,O
116262,8021,),O
116263,8022,Abdominal,B-Condition
116264,8022,obesity,I-Condition
116265,8022,(,O
116266,8022,>,O
116267,8022,88,O
116268,8022,cm,O
116269,8022,women,B-Person
116270,8022,",",O
116271,8022,>,O
116272,8022,102,O
116273,8022,cm,O
116274,8022,men,B-Person
116275,8022,),O
116276,8022,AND,O
116277,8022,hypertension,B-Condition
116278,8022,(,O
116279,8022,treated,B-Procedure
116280,8022,or,O
116281,8022,resting,O
116282,8022,blood,O
116283,8022,pressure,O
116284,8022,>,O
116285,8022,140/90,O
116286,8023,Abdominal,B-Condition
116287,8023,obesity,I-Condition
116288,8023,(,O
116289,8023,>,O
116290,8023,88,O
116291,8023,cm,O
116292,8023,women,B-Person
116293,8023,",",O
116294,8023,>,O
116295,8023,102,O
116296,8023,cm,O
116297,8023,men,B-Person
116298,8023,),O
116299,8023,AND,O
116300,8023,hyperlipidemia,B-Condition
116301,8023,(,O
116302,8023,treated,B-Procedure
116303,8023,or,O
116304,8023,fasting,O
116305,8023,total,O
116306,8023,cholesterol,O
116307,8023,>,O
116308,8023,240,O
116309,8023,English,B-Observation
116310,8023,literacy,I-Observation
116311,8023,Willing,B-Mood
116312,8023,to,I-Mood
116313,8023,provide,B-Observation
116314,8023,informed,I-Observation
116315,8023,consent,I-Observation
116316,8024,Suspect,B-Mood
116317,8024,or,O
116318,8024,certainty,B-Mood
116319,8024,of,O
116320,8024,fetal,B-Condition
116321,8024,malformation,I-Condition
116322,8024,",",O
116323,8025,Presence,O
116324,8025,of,O
116325,8025,conditions,O
116326,8025,such,O
116327,8025,as,O
116328,8025,preeclampsia,B-Condition
116329,8025,",",O
116330,8025,multiparity,B-Condition
116331,8025,",",O
116332,8025,preterm,B-Condition
116333,8025,labor,I-Condition
116334,8026,History,O
116335,8026,of,O
116336,8026,adverse,B-Condition
116337,8026,reaction,I-Condition
116338,8026,to,O
116339,8026,a-2,B-Drug
116340,8026,adrenergic,I-Drug
116341,8026,agonists,I-Drug
116342,8027,Nicotine,B-Condition
116343,8027,addiction,I-Condition
116344,8028,Chronic,O
116345,8028,use,O
116346,8028,of,O
116347,8028,opioid,B-Drug
116348,8029,Written,O
116349,8029,maternal,O
116350,8029,informed,O
116351,8029,consent,O
116352,8030,Singleton,B-Condition
116353,8030,pregnancy,I-Condition
116354,8031,Gestational,O
116355,8031,age,O
116356,8031,=,O
116357,8031,37,O
116358,8031,weeks,O
116359,8031,",",O
116360,8032,ASA,O
116361,8032,I,O
116362,8033,BMI,O
116363,8033,<,O
116364,8033,30,O
116365,8034,fetus,O
116366,8034,in,O
116367,8034,cephalic,B-Condition
116368,8034,presentation,I-Condition
116369,8035,Use,O
116370,8035,of,O
116371,8035,any,O
116372,8035,oral,B-Procedure
116373,8035,antidiabetic,I-Procedure
116374,8035,treatment,I-Procedure
116375,8035,except,O
116376,8035,for,O
116377,8035,metformin,B-Drug
116378,8035,(,O
116379,8035,i.e.,O
116380,8035,",",O
116381,8035,sulphonylureas,B-Drug
116382,8035,",",O
116383,8035,DPP,B-Drug
116384,8035,-,I-Drug
116385,8035,IV,I-Drug
116386,8035,inhibitors,I-Drug
116387,8035,",",O
116388,8035,thiazolidinediones,B-Drug
116389,8035,",",O
116390,8035,SGLT-2,B-Drug
116391,8035,inhibitors,I-Drug
116392,8035,(,O
116393,8035,Sodium,O
116394,8035,dependent,O
116395,8035,glucose,O
116396,8035,transporter,O
116397,8035,),O
116398,8035,or,O
116399,8035,GLP-1,B-Drug
116400,8035,analogues,I-Drug
116401,8035,(,O
116402,8035,glucagone,O
116403,8035,like,O
116404,8035,peptide,O
116405,8035,),O
116406,8035,within,O
116407,8035,the,O
116408,8035,last,O
116409,8035,three,O
116410,8035,months,O
116411,8035,prior,O
116412,8035,to,O
116413,8035,Screening,O
116414,8036,Repeated,O
116415,8036,episodes,O
116416,8036,of,O
116417,8036,severe,B-Condition
116418,8036,hypoglycaemia,I-Condition
116419,8036,within,O
116420,8036,the,O
116421,8036,last,O
116422,8036,six,O
116423,8036,months,O
116424,8036,prior,O
116425,8036,to,O
116426,8036,Screening,O
116427,8037,History,B-Observation
116428,8037,of,O
116429,8037,diabetic,B-Condition
116430,8037,ketoacidosis,I-Condition
116431,8037,",",O
116432,8037,precoma,B-Condition
116433,8037,diabetica,I-Condition
116434,8037,",",O
116435,8037,or,O
116436,8037,diabetic,B-Condition
116437,8037,coma,I-Condition
116438,8038,Treatment,B-Procedure
116439,8038,with,O
116440,8038,any,O
116441,8038,other,O
116442,8038,investigational,B-Drug
116443,8038,drug,I-Drug
116444,8038,within,O
116445,8038,the,O
116446,8038,last,O
116447,8038,three,O
116448,8038,months,O
116449,8038,before,O
116450,8038,Screening,O
116451,8039,Acute,B-Condition
116452,8039,infections,I-Condition
116453,8039,within,O
116454,8039,the,O
116455,8039,last,O
116456,8039,four,O
116457,8039,weeks,O
116458,8039,prior,O
116459,8039,to,O
116460,8039,Screening,O
116461,8040,Recurrent,O
116462,8040,urogenital,B-Condition
116463,8040,infections,I-Condition
116464,8041,History,B-Observation
116465,8041,of,O
116466,8041,pancreatitis,B-Condition
116467,8042,Anamnestic,B-Observation
116468,8042,history,I-Observation
116469,8042,of,O
116470,8042,hypersensitivity,B-Condition
116471,8042,to,O
116472,8042,the,O
116473,8042,study,B-Drug
116474,8042,drugs,I-Drug
116475,8042,or,O
116476,8042,to,O
116477,8042,drugs,B-Drug
116478,8042,with,I-Drug
116479,8042,similar,I-Drug
116480,8042,chemical,I-Drug
116481,8042,structures,I-Drug
116482,8043,History,B-Observation
116483,8043,of,O
116484,8043,severe,O
116485,8043,or,O
116486,8043,multiple,O
116487,8043,allergies,B-Condition
116488,8044,Concomitant,O
116489,8044,participation,B-Observation
116490,8044,in,I-Observation
116491,8044,other,I-Observation
116492,8044,clinical,I-Observation
116493,8044,trials,I-Observation
116494,8045,Type,B-Condition
116495,8045,1,I-Condition
116496,8045,diabetes,I-Condition
116497,8046,Cardiovascular,B-Condition
116498,8046,disease,I-Condition
116499,8046,Clinically,O
116500,8046,relevant,O
116501,8046,ventricular,B-Condition
116502,8046,tachycardia,I-Condition
116503,8046,or,O
116504,8046,ventricular,B-Condition
116505,8046,fibrillation,I-Condition
116506,8046,",",O
116507,8046,3rd,B-Condition
116508,8046,degree,I-Condition
116509,8046,AV,I-Condition
116510,8046,block,I-Condition
116511,8046,or,O
116512,8046,Torsades,B-Condition
116513,8046,de,I-Condition
116514,8046,Pointes,I-Condition
116515,8046,or,O
116516,8046,treatment,B-Procedure
116517,8046,with,O
116518,8046,antiarrhythmic,B-Drug
116519,8046,drugs,I-Drug
116520,8046,.,O
116521,8046,Percutaneous,B-Procedure
116522,8046,coronary,I-Procedure
116523,8046,intervention,I-Procedure
116524,8046,within,O
116525,8046,the,O
116526,8046,past,O
116527,8046,6,O
116528,8046,months,O
116529,8046,.,O
116530,8046,Any,O
116531,8046,of,O
116532,8046,the,O
116533,8046,following,O
116534,8046,within,O
116535,8046,the,O
116536,8046,past,O
116537,8046,6,O
116538,8046,months,O
116539,8046,:,O
116540,8046,myocardial,B-Condition
116541,8046,infarction,I-Condition
116542,8046,(,I-Condition
116543,8046,MI,I-Condition
116544,8046,),I-Condition
116545,8046,",",O
116546,8046,coronary,B-Procedure
116547,8046,artery,I-Procedure
116548,8046,bypass,I-Procedure
116549,8046,surgery,I-Procedure
116550,8046,;,O
116551,8046,unstable,B-Condition
116552,8046,angina,I-Condition
116553,8046,;,O
116554,8046,or,O
116555,8046,stroke,B-Condition
116556,8046,.,O
116557,8047,Malignancy,B-Condition
116558,8047,including,O
116559,8047,leukemia,B-Condition
116560,8047,and,O
116561,8047,lymphoma,B-Condition
116562,8047,within,O
116563,8047,the,O
116564,8047,last,O
116565,8047,5y,O
116566,8047,.,O
116567,8048,Liver,B-Condition
116568,8048,disease,I-Condition
116569,8048,such,O
116570,8048,as,O
116571,8048,cirrhosis,B-Condition
116572,8048,or,O
116573,8048,chronic,B-Condition
116574,8048,active,I-Condition
116575,8048,hepatitis,I-Condition
116576,8048,.,O
116577,8049,Significant,O
116578,8049,renal,B-Condition
116579,8049,dysfunction,I-Condition
116580,8049,(,O
116581,8049,see,O
116582,8049,also,O
116583,8049,exclusion,O
116584,8049,criteria,O
116585,8049,laboratory,O
116586,8049,abnormalities,O
116587,8049,),O
116588,8049,.,O
116589,8050,State,B-Condition
116590,8050,after,I-Condition
116591,8050,kidney,I-Condition
116592,8050,transplantation,I-Condition
116593,8051,Endocrine,B-Condition
116594,8051,disease,I-Condition
116595,8051,:,O
116596,8052,Systolic,O
116597,8052,blood,O
116598,8052,pressure,O
116599,8052,outside,O
116600,8052,the,O
116601,8052,range,O
116602,8052,of,O
116603,8052,100,O
116604,8052,-,O
116605,8052,160,O
116606,8052,mmHg,O
116607,8052,or,O
116608,8052,diastolic,O
116609,8052,blood,O
116610,8052,pressure,O
116611,8052,above,O
116612,8052,95,O
116613,8052,mmHg,O
116614,8052,at,O
116615,8052,Screening,O
116616,8053,History,B-Observation
116617,8053,of,O
116618,8053,active,O
116619,8053,substance,B-Condition
116620,8053,abuse,I-Condition
116621,8053,(,O
116622,8053,including,O
116623,8053,alcohol,O
116624,8053,>,O
116625,8053,40g,O
116626,8053,/,O
116627,8053,day,O
116628,8053,),O
116629,8053,within,O
116630,8053,the,O
116631,8053,past,O
116632,8053,2,O
116633,8053,years,O
116634,8053,.,O
116635,8054,Pregnancy,B-Condition
116636,8054,or,O
116637,8054,childbearing,B-Observation
116638,8054,potential,I-Observation
116639,8054,without,O
116640,8054,adequate,O
116641,8054,contraception,B-Procedure
116642,8055,Present,O
116643,8055,therapy,B-Procedure
116644,8055,with,O
116645,8055,systemic,B-Drug
116646,8055,steroids,I-Drug
116647,8056,Presence,O
116648,8056,of,O
116649,8056,psychiatric,B-Condition
116650,8056,disorder,I-Condition
116651,8056,or,O
116652,8056,intake,O
116653,8056,of,O
116654,8056,anti,B-Drug
116655,8056,-,I-Drug
116656,8056,depressive,I-Drug
116657,8056,or,I-Drug
116658,8056,anti,I-Drug
116659,8056,-,I-Drug
116660,8056,psychotic,I-Drug
116661,8056,agents,I-Drug
116662,8056,with,O
116663,8056,the,O
116664,8056,exception,O
116665,8056,of,O
116666,8056,benzodiazepines,B-Drug
116667,8056,and,O
116668,8056,SSRIs,B-Drug
116669,8056,/,O
116670,8056,SNRI,B-Drug
116671,8056,'s,I-Drug
116672,8056,(,O
116673,8056,selective,O
116674,8056,serotonin,O
116675,8056,reuptake,O
116676,8056,inhibitor,O
116677,8056,),O
116678,8057,Potentially,O
116679,8057,unreliable,B-Observation
116680,8057,subjects,I-Observation
116681,8057,",",O
116682,8057,and,O
116683,8057,those,O
116684,8057,judged,O
116685,8057,by,O
116686,8057,the,O
116687,8057,investigator,O
116688,8057,to,O
116689,8057,be,O
116690,8057,unsuitable,B-Observation
116691,8057,for,I-Observation
116692,8057,the,I-Observation
116693,8057,study,I-Observation
116694,8057,.,O
116695,8058,Contraindications,B-Condition
116696,8058,for,O
116697,8058,Magnetic,B-Procedure
116698,8058,resonance,I-Procedure
116699,8058,(,I-Procedure
116700,8058,MR,I-Procedure
116701,8058,),I-Procedure
116702,8058,scanning,I-Procedure
116703,8058,such,O
116704,8058,as,O
116705,8058,persons,O
116706,8058,with,O
116707,8058,cardiac,O
116708,8058,pacemaker,O
116709,8058,and,O
116710,8058,implants,O
116711,8058,out,O
116712,8058,of,O
116713,8058,metal,O
116714,8058,or,O
116715,8058,claustrophobia,B-Condition
116716,8059,Type,B-Condition
116717,8059,2,I-Condition
116718,8059,diabetes,I-Condition
116719,8060,Age,B-Person
116720,8060,18,O
116721,8060,-,O
116722,8060,75,O
116723,8060,years,O
116724,8061,Anti,O
116725,8061,-,O
116726,8061,GAD,O
116727,8061,antibodies,O
116728,8061,negative,O
116729,8061,(,O
116730,8061,Glutamic,O
116731,8061,Acid,O
116732,8061,Decarboxylase,O
116733,8061,),O
116734,8062,C,O
116735,8062,-,O
116736,8062,peptide,O
116737,8062,levels,O
116738,8062,=,O
116739,8062,1.5,O
116740,8062,ng,O
116741,8062,/,O
116742,8062,mL,O
116743,8063,Fasting,O
116744,8063,blood,O
116745,8063,glucose,O
116746,8063,>,O
116747,8063,126,O
116748,8063,mg,O
116749,8063,/,O
116750,8063,dl,O
116751,8064,HbA1c,O
116752,8064,8.0,O
116753,8064,-,O
116754,8064,10.5,O
116755,8064,%,O
116756,8065,BMI,O
116757,8065,25.0,O
116758,8065,-,O
116759,8065,45.0,O
116760,8065,kg,O
116761,8065,/,O
116762,8065,m2,O
116763,8066,Previous,O
116764,8066,therapy,B-Procedure
116765,8066,with,O
116766,8066,BBIT,B-Drug
116767,8066,(,O
116768,8066,basal,B-Drug
116769,8066,insulin,I-Drug
116770,8066,and,I-Drug
116771,8066,at,I-Drug
116772,8066,least,I-Drug
116773,8066,once,I-Drug
116774,8066,daily,I-Drug
116775,8066,bolus,I-Drug
116776,8066,insulin,I-Drug
116777,8066,),O
116778,8067,score,O
116779,8067,level,O
116780,8067,D,O
116781,8067,on,O
116782,8067,the,O
116783,8067,SIGAM,O
116784,8067,mobility,O
116785,8067,grade,O
116786,8068,have,O
116787,8068,experienced,O
116788,8068,1,O
116789,8068,or,O
116790,8068,more,O
116791,8068,falls,B-Observation
116792,8068,in,O
116793,8068,the,O
116794,8068,last,O
116795,8068,month,O
116796,8068,before,O
116797,8068,the,O
116798,8068,study,O
116799,8069,have,O
116800,8069,a,O
116801,8069,residual,O
116802,8069,limb,O
116803,8069,length,O
116804,8069,which,O
116805,8069,does,O
116806,8069,not,O
116807,8069,allow,O
116808,8069,for,O
116809,8069,seven,O
116810,8069,inches,O
116811,8069,clearance,O
116812,8069,of,O
116813,8069,bracket,O
116814,8069,attachment,O
116815,8069,for,O
116816,8069,the,O
116817,8069,PowerFoot,O
116818,8070,the,O
116819,8070,residual,O
116820,8070,limb,O
116821,8070,must,O
116822,8070,be,O
116823,8070,stable,O
116824,8070,in,O
116825,8070,volume,O
116826,8070,(,O
116827,8070,no,O
116828,8070,change,O
116829,8070,in,O
116830,8070,socket,O
116831,8070,or,O
116832,8070,socket,O
116833,8070,padding,O
116834,8070,in,O
116835,8070,last,O
116836,8070,6,O
116837,8070,months,O
116838,8070,),O
116839,8070,and,O
116840,8070,without,O
116841,8070,pain,O
116842,8070,that,O
116843,8070,limits,O
116844,8070,function,O
116845,8071,the,O
116846,8071,sound,O
116847,8071,-,O
116848,8071,side,O
116849,8071,(,O
116850,8071,contralateral,O
116851,8071,),O
116852,8071,lower,B-Observation
116853,8071,extremity,I-Observation
116854,8071,must,O
116855,8071,be,O
116856,8071,free,O
116857,8071,of,O
116858,8071,impediments,B-Condition
116859,8071,that,I-Condition
116860,8071,affect,I-Condition
116861,8071,gait,I-Condition
116862,8071,",",I-Condition
116863,8071,range,I-Condition
116864,8071,of,I-Condition
116865,8071,motion,I-Condition
116866,8071,",",I-Condition
116867,8071,or,I-Condition
116868,8071,limb,I-Condition
116869,8071,muscle,I-Condition
116870,8071,activity,I-Condition
116871,8072,Any,O
116872,8072,diagnosed,O
116873,8072,cardiovascular,B-Condition
116874,8072,",",I-Condition
116875,8072,pulmonary,I-Condition
116876,8072,",",I-Condition
116877,8072,neurological,I-Condition
116878,8072,",",I-Condition
116879,8072,and/,I-Condition
116880,8072,or,I-Condition
116881,8072,orthopedic,I-Condition
116882,8072,conditions,I-Condition
116883,8072,that,O
116884,8072,would,O
116885,8072,interfere,O
116886,8072,with,O
116887,8072,subject,O
116888,8072,participation,O
116889,8073,weigh,O
116890,8073,more,O
116891,8073,than,O
116892,8073,200,O
116893,8073,lbs,O
116894,8074,are,O
116895,8074,high,B-Condition
116896,8074,level,I-Condition
116897,8074,ambulators,I-Condition
116898,8074,corresponding,O
116899,8074,to,O
116900,8074,levels,O
116901,8074,E,O
116902,8074,to,O
116903,8074,F,O
116904,8074,of,O
116905,8074,the,O
116906,8074,Special,O
116907,8074,Interest,O
116908,8074,Group,O
116909,8074,of,O
116910,8074,Amputee,O
116911,8074,Medicine,O
116912,8074,(,O
116913,8074,SIGAM,O
116914,8074,),O
116915,8074,mobility,O
116916,8074,grade,O
116917,8075,have,O
116918,8075,the,O
116919,8075,ability,B-Condition
116920,8075,to,I-Condition
116921,8075,follow,I-Condition
116922,8075,multi,I-Condition
116923,8075,-,I-Condition
116924,8075,step,I-Condition
116925,8075,commands,I-Condition
116926,8075,.,O
116927,8076,Healthy,O
116928,8076,Volunteers,O
116929,8077,Treprostinil,B-Drug
116930,8077,contraindications,B-Condition
116931,8077,:,O
116932,8077,Known,O
116933,8077,hypersensitivity,B-Condition
116934,8077,to,O
116935,8077,treprostinil,B-Drug
116936,8077,or,O
116937,8077,any,B-Drug
116938,8077,of,I-Drug
116939,8077,the,I-Drug
116940,8077,excipients,I-Drug
116941,8077,",",O
116942,8077,Pulmonary,B-Condition
116943,8077,arterial,I-Condition
116944,8077,hypertension,I-Condition
116945,8077,related,O
116946,8077,to,O
116947,8077,veno,B-Condition
116948,8077,-,I-Condition
116949,8077,occlusive,I-Condition
116950,8077,disease,I-Condition
116951,8077,",",O
116952,8077,Congestive,B-Condition
116953,8077,heart,I-Condition
116954,8077,failure,I-Condition
116955,8077,due,O
116956,8077,to,O
116957,8077,severe,O
116958,8077,left,B-Condition
116959,8077,ventricular,I-Condition
116960,8077,dysfunction,I-Condition
116961,8077,",",O
116962,8077,Severe,O
116963,8077,hepatic,B-Condition
116964,8077,insufficiency,I-Condition
116965,8077,(,O
116966,8077,Child,O
116967,8077,-,O
116968,8077,Pugh,O
116969,8077,stage,O
116970,8077,C,O
116971,8077,),O
116972,8077,",",O
116973,8077,Evolving,O
116974,8077,gastrointestinal,B-Condition
116975,8077,ulcer,I-Condition
116976,8077,",",O
116977,8077,intracranial,B-Condition
116978,8077,hemorrhage,I-Condition
116979,8077,",",O
116980,8077,recent,O
116981,8077,trauma,B-Condition
116982,8077,or,O
116983,8077,other,O
116984,8077,clinical,B-Condition
116985,8077,condition,I-Condition
116986,8077,that,I-Condition
116987,8077,may,I-Condition
116988,8077,lead,I-Condition
116989,8077,to,I-Condition
116990,8077,bleeding,I-Condition
116991,8077,",",O
116992,8077,Congenital,B-Condition
116993,8077,or,I-Condition
116994,8077,acquired,I-Condition
116995,8077,valvular,I-Condition
116996,8077,abnormalities,I-Condition
116997,8077,with,O
116998,8077,cardiac,O
116999,8077,repercussions,O
117000,8077,",",O
117001,8077,Severe,O
117002,8077,ischemic,B-Condition
117003,8077,heart,I-Condition
117004,8077,disease,I-Condition
117005,8077,or,O
117006,8077,unstable,B-Condition
117007,8077,angina,I-Condition
117008,8077,;,O
117009,8077,Myocardial,B-Condition
117010,8077,infarction,I-Condition
117011,8077,in,O
117012,8077,the,O
117013,8077,last,O
117014,8077,six,O
117015,8077,months,O
117016,8077,;,O
117017,8077,Decompensated,B-Condition
117018,8077,cardiac,I-Condition
117019,8077,insufficiency,I-Condition
117020,8077,not,O
117021,8077,medically,O
117022,8077,controlled,O
117023,8077,;,O
117024,8077,Severe,O
117025,8077,arrhythmias,B-Condition
117026,8077,;,O
117027,8077,Cerebrovascular,B-Condition
117028,8077,lesions,I-Condition
117029,8077,(,O
117030,8077,such,O
117031,8077,as,O
117032,8077,transient,B-Condition
117033,8077,ischemic,I-Condition
117034,8077,attack,I-Condition
117035,8077,",",O
117036,8077,stroke,B-Condition
117037,8077,),O
117038,8077,that,O
117039,8077,occurred,O
117040,8077,within,O
117041,8077,the,O
117042,8077,last,O
117043,8077,three,O
117044,8077,months,O
117045,8077,.,O
117046,8078,Persons,O
117047,8078,referred,O
117048,8078,to,O
117049,8078,in,O
117050,8078,Articles,O
117051,8078,L1121,O
117052,8078,-,O
117053,8078,5,O
117054,8078,to,O
117055,8078,L1121,O
117056,8078,-,O
117057,8078,8,O
117058,8078,of,O
117059,8078,the,O
117060,8078,French,O
117061,8078,Public,O
117062,8078,health,O
117063,8078,Code,O
117064,8078,:,O
117065,8078,pregnant,B-Condition
117066,8078,woman,B-Person
117067,8078,",",O
117068,8078,parturient,B-Condition
117069,8078,",",O
117070,8078,nursing,B-Condition
117071,8078,mother,O
117072,8078,",",O
117073,8078,person,O
117074,8078,deprived,B-Observation
117075,8078,of,I-Observation
117076,8078,liberty,I-Observation
117077,8078,by,O
117078,8078,judicial,O
117079,8078,or,O
117080,8078,administrative,O
117081,8078,decision,O
117082,8078,",",O
117083,8078,person,O
117084,8078,subject,O
117085,8078,to,O
117086,8078,a,O
117087,8078,legal,O
117088,8078,protection,O
117089,8078,measure,O
117090,8078,",",O
117091,8078,can,O
117092,8078,not,O
117093,8078,Be,O
117094,8078,included,O
117095,8078,in,O
117096,8078,clinical,O
117097,8078,trials,O
117098,8078,.,O
117099,8079,Subject,O
117100,8079,in,O
117101,8079,an,O
117102,8079,exclusion,O
117103,8079,period,O
117104,8079,from,O
117105,8079,another,O
117106,8079,study,O
117107,8079,",",O
117108,8080,Subject,O
117109,8080,who,O
117110,8080,would,O
117111,8080,receive,O
117112,8080,more,O
117113,8080,than,O
117114,8080,4500,O
117115,8080,euros,O
117116,8080,of,O
117117,8080,compensation,O
117118,8080,due,O
117119,8080,to,O
117120,8080,his,O
117121,8080,participation,O
117122,8080,in,O
117123,8080,other,O
117124,8080,biomedical,O
117125,8080,research,O
117126,8080,in,O
117127,8080,the,O
117128,8080,12,O
117129,8080,months,O
117130,8080,preceding,O
117131,8080,this,O
117132,8080,study,O
117133,8081,Systemic,B-Condition
117134,8081,sclerosis,I-Condition
117135,8081,patients,O
117136,8081,:,O
117137,8082,Iloprost,B-Drug
117138,8082,cure,O
117139,8082,carried,O
117140,8082,out,O
117141,8082,in,O
117142,8082,the,O
117143,8082,previous,O
117144,8082,month,O
117145,8082,or,O
117146,8082,planned,B-Observation
117147,8082,in,O
117148,8082,the,O
117149,8082,following,O
117150,8082,month,O
117151,8082,.,O
117152,8083,Initiation,O
117153,8083,or,O
117154,8083,change,O
117155,8083,of,O
117156,8083,dosage,O
117157,8083,of,O
117158,8083,bosentan,B-Drug
117159,8083,",",O
117160,8083,sildenafil,B-Drug
117161,8083,or,O
117162,8083,calcium,B-Drug
117163,8083,channel,I-Drug
117164,8083,blockers,I-Drug
117165,8083,in,O
117166,8083,the,O
117167,8083,previous,O
117168,8083,month,O
117169,8083,or,O
117170,8083,in,O
117171,8083,the,O
117172,8083,following,O
117173,8083,month,O
117174,8084,Digital,B-Procedure
117175,8084,Sympathectomy,I-Procedure
117176,8084,or,O
117177,8084,botulinum,B-Procedure
117178,8084,toxin,I-Procedure
117179,8084,injection,I-Procedure
117180,8084,planned,B-Observation
117181,8084,in,O
117182,8084,the,O
117183,8084,following,O
117184,8084,month,O
117185,8084,.,O
117186,8085,Clinically,O
117187,8085,superinfected,B-Observation
117188,8085,digital,B-Condition
117189,8085,ulcers,I-Condition
117190,8086,Treprostinil,B-Drug
117191,8086,contraindications,B-Condition
117192,8086,:,O
117193,8086,Known,O
117194,8086,hypersensitivity,B-Condition
117195,8086,to,O
117196,8086,treprostinil,B-Drug
117197,8086,or,O
117198,8086,any,B-Drug
117199,8086,of,I-Drug
117200,8086,the,I-Drug
117201,8086,excipients,I-Drug
117202,8086,",",O
117203,8086,Pulmonary,B-Condition
117204,8086,arterial,I-Condition
117205,8086,hypertension,I-Condition
117206,8086,related,O
117207,8086,to,O
117208,8086,veno,B-Condition
117209,8086,-,I-Condition
117210,8086,occlusive,I-Condition
117211,8086,disease,I-Condition
117212,8086,",",O
117213,8086,Congestive,B-Condition
117214,8086,heart,I-Condition
117215,8086,failure,I-Condition
117216,8086,due,O
117217,8086,to,O
117218,8086,severe,O
117219,8086,left,B-Condition
117220,8086,ventricular,I-Condition
117221,8086,dysfunction,I-Condition
117222,8086,",",O
117223,8086,Severe,O
117224,8086,hepatic,B-Condition
117225,8086,insufficiency,I-Condition
117226,8086,(,O
117227,8086,Child,O
117228,8086,-,O
117229,8086,Pugh,O
117230,8086,stage,O
117231,8086,C,O
117232,8086,),O
117233,8086,",",O
117234,8086,Evolving,O
117235,8086,gastrointestinal,B-Condition
117236,8086,ulcer,I-Condition
117237,8086,",",O
117238,8086,intracranial,B-Condition
117239,8086,hemorrhage,I-Condition
117240,8086,",",O
117241,8086,recent,O
117242,8086,trauma,B-Condition
117243,8086,or,O
117244,8086,other,O
117245,8086,clinical,B-Condition
117246,8086,condition,I-Condition
117247,8086,that,I-Condition
117248,8086,may,I-Condition
117249,8086,lead,I-Condition
117250,8086,to,I-Condition
117251,8086,bleeding,I-Condition
117252,8086,",",O
117253,8086,Congenital,B-Condition
117254,8086,or,I-Condition
117255,8086,acquired,I-Condition
117256,8086,valvular,I-Condition
117257,8086,abnormalities,I-Condition
117258,8086,with,O
117259,8086,cardiac,O
117260,8086,repercussions,O
117261,8086,",",O
117262,8086,Severe,O
117263,8086,ischemic,B-Condition
117264,8086,heart,I-Condition
117265,8086,disease,I-Condition
117266,8086,or,O
117267,8086,unstable,B-Condition
117268,8086,angina,I-Condition
117269,8086,;,O
117270,8086,Myocardial,B-Condition
117271,8086,infarction,I-Condition
117272,8086,in,O
117273,8086,the,O
117274,8086,last,O
117275,8086,six,O
117276,8086,months,O
117277,8086,;,O
117278,8086,Decompensated,B-Condition
117279,8086,cardiac,I-Condition
117280,8086,insufficiency,I-Condition
117281,8086,not,O
117282,8086,medically,O
117283,8086,controlled,O
117284,8086,;,O
117285,8086,Severe,O
117286,8086,arrhythmias,B-Condition
117287,8086,;,O
117288,8086,Cerebrovascular,B-Condition
117289,8086,lesions,I-Condition
117290,8086,(,O
117291,8086,such,O
117292,8086,as,O
117293,8086,transient,B-Condition
117294,8086,ischemic,I-Condition
117295,8086,attack,I-Condition
117296,8086,",",O
117297,8086,stroke,B-Condition
117298,8086,),O
117299,8086,that,O
117300,8086,occurred,O
117301,8086,within,O
117302,8086,the,O
117303,8086,last,O
117304,8086,three,O
117305,8086,months,O
117306,8086,.,O
117307,8087,Persons,O
117308,8087,referred,O
117309,8087,to,O
117310,8087,in,O
117311,8087,Articles,O
117312,8087,L1121,O
117313,8087,-,O
117314,8087,5,O
117315,8087,to,O
117316,8087,L1121,O
117317,8087,-,O
117318,8087,8,O
117319,8087,of,O
117320,8087,the,O
117321,8087,French,O
117322,8087,Public,O
117323,8087,health,O
117324,8087,Code,O
117325,8087,:,O
117326,8087,pregnant,B-Condition
117327,8087,woman,B-Person
117328,8087,",",O
117329,8087,parturient,B-Condition
117330,8087,",",O
117331,8087,nursing,B-Condition
117332,8087,mother,O
117333,8087,",",O
117334,8087,person,O
117335,8087,deprived,B-Observation
117336,8087,of,I-Observation
117337,8087,liberty,I-Observation
117338,8087,by,O
117339,8087,judicial,O
117340,8087,or,O
117341,8087,administrative,O
117342,8087,decision,O
117343,8087,",",O
117344,8087,person,O
117345,8087,subject,B-Observation
117346,8087,to,I-Observation
117347,8087,a,I-Observation
117348,8087,legal,I-Observation
117349,8087,protection,I-Observation
117350,8087,measure,O
117351,8087,",",O
117352,8087,can,O
117353,8087,not,O
117354,8087,Be,O
117355,8087,included,O
117356,8087,in,O
117357,8087,clinical,O
117358,8087,trials,O
117359,8087,.,O
117360,8088,Subject,O
117361,8088,in,O
117362,8088,an,O
117363,8088,exclusion,O
117364,8088,period,O
117365,8088,from,O
117366,8088,another,O
117367,8088,study,O
117368,8088,",",O
117369,8089,Subject,O
117370,8089,who,O
117371,8089,would,O
117372,8089,receive,O
117373,8089,more,O
117374,8089,than,O
117375,8089,4500,O
117376,8089,euros,O
117377,8089,of,O
117378,8089,compensation,O
117379,8089,due,O
117380,8089,to,O
117381,8089,his,O
117382,8089,participation,O
117383,8089,in,O
117384,8089,other,O
117385,8089,biomedical,O
117386,8089,research,O
117387,8089,in,O
117388,8089,the,O
117389,8089,12,O
117390,8089,months,O
117391,8089,preceding,O
117392,8089,this,O
117393,8089,study,O
117394,8090,Healthy,O
117395,8090,Volunteers,O
117396,8090,:,O
117397,8091,Age,B-Person
117398,8091,of,O
117399,8091,at,O
117400,8091,least,O
117401,8091,18,O
117402,8091,years,O
117403,8092,Existence,O
117404,8092,of,O
117405,8092,a,O
117406,8092,contraceptive,O
117407,8092,method,O
117408,8092,for,O
117409,8092,women,B-Person
117410,8092,of,O
117411,8092,child,O
117412,8092,-,O
117413,8092,bearing,O
117414,8092,age,B-Person
117415,8093,Person,O
117416,8093,affiliated,O
117417,8093,to,O
117418,8093,social,O
117419,8093,security,O
117420,8093,or,O
117421,8093,beneficiary,O
117422,8093,of,O
117423,8093,such,O
117424,8093,a,O
117425,8093,scheme,O
117426,8094,Signed,O
117427,8094,consent,O
117428,8094,form,O
117429,8095,Systemic,O
117430,8095,sclerosis,O
117431,8095,patients,O
117432,8095,:,O
117433,8096,Systemic,B-Condition
117434,8096,sclerosis,I-Condition
117435,8096,meeting,O
117436,8096,the,O
117437,8096,EULAR,O
117438,8096,criteria,O
117439,8096,.,O
117440,8097,Presence,O
117441,8097,of,O
117442,8097,at,O
117443,8097,least,O
117444,8097,2,O
117445,8097,ischemic,B-Condition
117446,8097,digital,I-Condition
117447,8097,cutaneous,I-Condition
117448,8097,ulcerations,I-Condition
117449,8097,on,O
117450,8097,two,O
117451,8097,different,O
117452,8097,fingers,O
117453,8097,",",O
117454,8097,with,O
117455,8097,digital,B-Condition
117456,8097,ulcers,I-Condition
117457,8097,classified,O
117458,8097,as,O
117459,8097,"""",O
117460,8097,active,O
117461,8097,ulcers,O
117462,8097,"""",O
117463,8097,according,O
117464,8097,to,O
117465,8097,the,O
117466,8097,North,O
117467,8097,American,O
117468,8097,working,O
117469,8097,group,O
117470,8097,definition,O
117471,8097,:,O
117472,8097,epithelial,O
117473,8097,denudation,O
117474,8097,is,O
117475,8097,clearly,O
117476,8097,Visible,O
117477,8097,at,O
117478,8097,one,O
117479,8097,place,O
117480,8097,and,O
117481,8097,the,O
117482,8097,bed,O
117483,8097,of,O
117484,8097,de,O
117485,8097,-,O
117486,8097,epithelialized,O
117487,8097,ulcer,O
117488,8097,can,O
117489,8097,be,O
117490,8097,seen,O
117491,8097,;,O
117492,8097,Ulcerations,O
117493,8097,distal,O
117494,8097,to,O
117495,8097,the,O
117496,8097,proximal,O
117497,8097,interphalangeal,O
117498,8097,joint,O
117499,8097,",",O
117500,8097,not,O
117501,8097,associated,O
117502,8097,with,O
117503,8097,calcinosis,O
117504,8097,or,O
117505,8097,bony,O
117506,8097,relief,O
117507,8097,.,O
117508,8098,Ulcers,B-Condition
117509,8098,whose,O
117510,8098,major,O
117511,8098,axis,O
117512,8098,measured,O
117513,8098,with,O
117514,8098,the,O
117515,8098,electronic,O
117516,8098,caliper,O
117517,8098,is,O
117518,8098,≥,O
117519,8098,2,O
117520,8098,mm,O
117521,8099,Age,B-Person
117522,8099,greater,O
117523,8099,than,O
117524,8099,or,O
117525,8099,equal,O
117526,8099,to,O
117527,8099,18,O
117528,8099,years,O
117529,8100,Existence,O
117530,8100,of,O
117531,8100,a,O
117532,8100,contraceptive,O
117533,8100,method,O
117534,8100,for,O
117535,8100,women,B-Person
117536,8100,of,O
117537,8100,reproductive,O
117538,8100,age,B-Person
117539,8101,A,O
117540,8101,person,O
117541,8101,who,O
117542,8101,is,O
117543,8101,or,O
117544,8101,is,O
117545,8101,a,O
117546,8101,beneficiary,O
117547,8101,of,O
117548,8101,social,O
117549,8101,security,O
117550,8102,Informed,O
117551,8102,and,O
117552,8102,signed,O
117553,8102,consent,O
117554,8102,signed,O
117555,8102,by,O
117556,8102,the,O
117557,8102,patient,O
117558,8102,or,O
117559,8102,his,O
117560,8102,/,O
117561,8102,her,O
117562,8102,legal,O
117563,8102,representative,O
117564,8102,.,O
117565,8103,Previously,O
117566,8103,enrolled,B-Observation
117567,8103,in,I-Observation
117568,8103,this,I-Observation
117569,8103,study,I-Observation
117570,8103,(,O
117571,8103,i.e.,O
117572,8103,patient,O
117573,8103,now,O
117574,8103,at,O
117575,8103,repeat,O
117576,8103,encounter,O
117577,8103,),O
117578,8104,Concomitant,O
117579,8104,surgical,B-Procedure
117580,8104,procedure,I-Procedure
117581,8104,other,O
117582,8104,than,O
117583,8104,CABG,B-Procedure
117584,8105,Anticoagulant,B-Procedure
117585,8105,treatment,I-Procedure
117586,8105,after,O
117587,8105,the,O
117588,8105,operation,B-Procedure
117589,8105,(,O
117590,8105,e.g.,O
117591,8105,warfarin,B-Drug
117592,8105,",",O
117593,8105,direct,B-Drug
117594,8105,thrombin,I-Drug
117595,8105,inhibitors,I-Drug
117596,8105,(,O
117597,8105,dabigatran,B-Drug
117598,8105,),O
117599,8105,",",O
117600,8105,FXa,B-Drug
117601,8105,inhibitors,I-Drug
117602,8105,(,O
117603,8105,rivaroxaban,B-Drug
117604,8105,",",O
117605,8105,apixaban,B-Drug
117606,8105,",",O
117607,8105,heparin,B-Drug
117608,8105,",",O
117609,8105,low,B-Drug
117610,8105,-,I-Drug
117611,8105,molecular,I-Drug
117612,8105,weight,I-Drug
117613,8105,heparin,I-Drug
117614,8105,",",O
117615,8105,fondaparinux,B-Drug
117616,8105,),O
117617,8106,Discharge,B-Observation
117618,8106,from,O
117619,8106,the,O
117620,8106,operating,O
117621,8106,hospital,O
117622,8106,to,O
117623,8106,an,O
117624,8106,ICU,O
117625,8106,at,O
117626,8106,another,O
117627,8106,hospital,O
117628,8107,Pregnancy,B-Condition
117629,8107,or,O
117630,8107,lactation,B-Condition
117631,8108,Known,O
117632,8108,intolerance,B-Condition
117633,8108,or,O
117634,8108,contraindication,B-Condition
117635,8108,to,O
117636,8108,ticagrelor,B-Drug
117637,8108,or,O
117638,8108,ASA,B-Drug
117639,8109,Any,O
117640,8109,disorder,B-Condition
117641,8109,that,O
117642,8109,may,O
117643,8109,interfere,O
117644,8109,with,O
117645,8109,drug,O
117646,8109,absorption,O
117647,8110,Any,O
117648,8110,condition,B-Condition
117649,8110,other,O
117650,8110,than,O
117651,8110,coronary,B-Condition
117652,8110,artery,I-Condition
117653,8110,disease,I-Condition
117654,8110,with,O
117655,8110,a,O
117656,8110,life,B-Observation
117657,8110,expectancy,I-Observation
117658,8110,<,O
117659,8110,12,O
117660,8110,months,O
117661,8111,Known,O
117662,8111,chronic,B-Condition
117663,8111,liver,I-Condition
117664,8111,disease,I-Condition
117665,8111,",",O
117666,8111,renal,B-Condition
117667,8111,disease,I-Condition
117668,8111,requiring,B-Mood
117669,8111,dialysis,B-Procedure
117670,8111,or,O
117671,8111,bleeding,B-Condition
117672,8111,disorder,I-Condition
117673,8112,Atrioventricular,B-Condition
117674,8112,block,I-Condition
117675,8112,II,I-Condition
117676,8112,and,I-Condition
117677,8112,III,I-Condition
117678,8112,in,O
117679,8112,patients,O
117680,8112,without,O
117681,8112,pacemaker,O
117682,8113,Any,O
117683,8113,other,O
117684,8113,indication,B-Condition
117685,8113,for,O
117686,8113,dual,B-Condition
117687,8113,antiplatelet,I-Condition
117688,8113,therapy,I-Condition
117689,8113,",",O
117690,8113,i.e.,O
117691,8113,recent,O
117692,8113,stent,B-Procedure
117693,8113,implantation,I-Procedure
117694,8114,Debilitating,B-Condition
117695,8114,stroke,B-Condition
117696,8114,within,O
117697,8114,90,O
117698,8114,days,O
117699,8114,before,O
117700,8114,inclusion,O
117701,8115,Previous,O
117702,8115,intracranial,B-Procedure
117703,8115,bleeding,I-Procedure
117704,8116,Treatment,O
117705,8116,with,O
117706,8116,immunosuppressants,B-Drug
117707,8116,(,O
117708,8116,e.g.,O
117709,8116,cyclosporine,B-Drug
117710,8116,and,O
117711,8116,tacrolimus,B-Drug
117712,8116,),O
117713,8117,Treatment,O
117714,8117,with,O
117715,8117,strong,B-Drug
117716,8117,CYP3A4,I-Drug
117717,8117,-,I-Drug
117718,8117,inhibitors,I-Drug
117719,8117,(,O
117720,8117,e.g.,O
117721,8117,ketoconazole,B-Drug
117722,8117,",",O
117723,8117,clarithromycin,B-Drug
117724,8117,",",O
117725,8117,nefazodone,B-Drug
117726,8117,",",O
117727,8117,ritonavir,B-Drug
117728,8117,or,O
117729,8117,atazanavir,B-Drug
117730,8117,),O
117731,8118,Any,O
117732,8118,condition,O
117733,8118,that,O
117734,8118,in,O
117735,8118,the,O
117736,8118,opinion,O
117737,8118,of,O
117738,8118,the,O
117739,8118,investigator,O
117740,8118,may,O
117741,8118,interfere,O
117742,8118,with,O
117743,8118,adherence,O
117744,8118,to,O
117745,8118,trial,O
117746,8118,protocol,O
117747,8119,Written,O
117748,8119,informed,O
117749,8119,consent,O
117750,8120,Age,B-Person
117751,8120,=,O
117752,8120,18,O
117753,8120,years,O
117754,8121,Has,O
117755,8121,undergone,O
117756,8121,first,O
117757,8121,time,O
117758,8121,isolated,B-Procedure
117759,8121,CABG,I-Procedure
117760,8121,due,O
117761,8121,to,O
117762,8121,an,O
117763,8121,episode,O
117764,8121,of,O
117765,8121,acute,B-Condition
117766,8121,coronary,I-Condition
117767,8121,syndrome,I-Condition
117768,8121,(,O
117769,8121,STEMI,B-Condition
117770,8121,",",O
117771,8121,NSTEMI,B-Condition
117772,8121,",",O
117773,8121,unstable,B-Condition
117774,8121,angina,I-Condition
117775,8121,),O
117776,8121,within,O
117777,8121,6,O
117778,8121,weeks,O
117779,8121,before,O
117780,8121,surgery,O
117781,8122,Allergy,B-Condition
117782,8122,to,O
117783,8122,ascorbic,B-Drug
117784,8122,acid,I-Drug
117785,8123,Asthma,B-Condition
117786,8124,COPD,B-Condition
117787,8125,Allergy,B-Condition
117788,8125,to,O
117789,8125,opioids,B-Drug
117790,8126,Previous,O
117791,8126,history,B-Observation
117792,8126,of,O
117793,8126,chemical,B-Condition
117794,8126,dependence,I-Condition
117795,8127,Prior,O
117796,8127,cardiac,B-Procedure
117797,8127,surgery,I-Procedure
117798,8128,Known,O
117799,8128,hyperoxaluria,B-Condition
117800,8129,History,B-Observation
117801,8129,of,O
117802,8129,renal,B-Condition
117803,8129,calculi,I-Condition
117804,8130,History,O
117805,8130,of,O
117806,8130,allergic,B-Condition
117807,8130,or,O
117808,8130,hypersensitivity,B-Condition
117809,8130,reaction,O
117810,8130,to,O
117811,8130,ascorbic,B-Drug
117812,8130,acid,I-Drug
117813,8130,products,O
117814,8131,Currently,O
117815,8131,taking,O
117816,8131,1,O
117817,8131,g,O
117818,8131,or,O
117819,8131,more,O
117820,8131,of,O
117821,8131,ascorbic,B-Drug
117822,8131,acid,I-Drug
117823,8131,supplementation,O
117824,8131,daily,O
117825,8132,Elective,O
117826,8132,Cardiac,O
117827,8132,surgery,O
117828,8133,American,O
117829,8133,Society,O
117830,8133,of,O
117831,8133,Anesthesiologists,O
117832,8133,physical,O
117833,8133,status,O
117834,8133,class,O
117835,8133,I,O
117836,8133,-,O
117837,8133,III,O
117838,8134,Fasting,O
117839,8134,blood,O
117840,8134,glucose,O
117841,8134,>,O
117842,8134,126,O
117843,8134,mg,O
117844,8134,/,O
117845,8134,dL,O
117846,8134,at,O
117847,8134,screening,O
117848,8134,.,O
117849,8134,Heterozygous,B-Condition
117850,8134,subjects,O
117851,8134,will,O
117852,8134,be,O
117853,8134,excluded,O
117854,8134,for,O
117855,8134,a,O
117856,8134,fasting,O
117857,8134,blood,O
117858,8134,glucose,O
117859,8134,>,O
117860,8134,140,O
117861,8134,mg,O
117862,8134,/,O
117863,8134,dL.,O
117864,8135,Resting,O
117865,8135,heart,O
117866,8135,rate,O
117867,8135,<,O
117868,8135,45,O
117869,8135,bpm,O
117870,8135,or,O
117871,8135,>,O
117872,8135,90,O
117873,8135,bpm,O
117874,8135,at,O
117875,8135,screening,O
117876,8135,.,O
117877,8136,Abnormal,O
117878,8136,thyroid,O
117879,8136,stimulating,O
117880,8136,hormone,O
117881,8136,(,O
117882,8136,TSH,O
117883,8136,),O
117884,8136,or,O
117885,8136,thyroxine,O
117886,8136,(,O
117887,8136,T4,O
117888,8136,),O
117889,8136,levels,O
117890,8136,on,O
117891,8136,screening,O
117892,8136,.,O
117893,8137,Elevated,O
117894,8137,ALT,O
117895,8137,or,O
117896,8137,serum,O
117897,8137,creatinine,O
117898,8137,on,O
117899,8137,screening,O
117900,8137,or,O
117901,8137,any,O
117902,8137,clinically,O
117903,8137,significant,O
117904,8137,abnormalities,O
117905,8137,on,O
117906,8137,screening,O
117907,8137,laboratory,O
117908,8137,tests,O
117909,8137,as,O
117910,8137,determined,O
117911,8137,by,O
117912,8137,the,O
117913,8137,Investigator,O
117914,8137,.,O
117915,8138,History,B-Observation
117916,8138,of,O
117917,8138,medically,B-Procedure
117918,8138,treated,I-Procedure
117919,8138,diabetes,B-Condition
117920,8138,or,O
117921,8138,of,O
117922,8138,treated,O
117923,8138,or,O
117924,8138,medically,B-Drug
117925,8138,diagnosed,O
117926,8138,hypertension,B-Condition
117927,8138,.,O
117928,8138,Heterozygous,B-Condition
117929,8138,subjects,O
117930,8138,who,O
117931,8138,have,O
117932,8138,diagnosed,O
117933,8138,hypertension,B-Condition
117934,8138,and,O
117935,8138,are,O
117936,8138,well,O
117937,8138,controlled,O
117938,8138,on,O
117939,8138,treatment,B-Procedure
117940,8138,(,O
117941,8138,Refer,O
117942,8138,to,O
117943,8138,Exclusion,O
117944,8138,Criteria,O
117945,8138,20,O
117946,8138,below,O
117947,8138,),O
117948,8138,",",O
117949,8138,are,O
117950,8138,eligible,O
117951,8138,.,O
117952,8138,.,O
117953,8139,Presence,O
117954,8139,of,O
117955,8139,a,O
117956,8139,skin,B-Condition
117957,8139,lesion,I-Condition
117958,8139,suspicious,O
117959,8139,for,O
117960,8139,malignancy,B-Condition
117961,8139,",",O
117962,8139,unless,O
117963,8139,excised,B-Procedure
117964,8139,prior,O
117965,8139,to,O
117966,8139,Day,O
117967,8139,1,O
117968,8139,.,O
117969,8140,History,B-Observation
117970,8140,of,O
117971,8140,malignancy,B-Condition
117972,8140,except,O
117973,8140,for,O
117974,8140,treated,B-Procedure
117975,8140,cervical,B-Condition
117976,8140,carcinoma,I-Condition
117977,8140,in,I-Condition
117978,8140,situ,I-Condition
117979,8140,in,O
117980,8140,the,O
117981,8140,past,O
117982,8140,5,O
117983,8140,years,O
117984,8140,.,O
117985,8141,Active,O
117986,8141,or,O
117987,8141,history,B-Observation
117988,8141,of,O
117989,8141,any,O
117990,8141,clinically,O
117991,8141,significant,O
117992,8141,medical,B-Condition
117993,8141,condition,I-Condition
117994,8141,including,O
117995,8141,renal,O
117996,8141,",",O
117997,8141,hepatic,O
117998,8141,",",O
117999,8141,pulmonary,O
118000,8141,",",O
118001,8141,gastrointestinal,O
118002,8141,",",O
118003,8141,cardiovascular,O
118004,8141,",",O
118005,8141,genitourinary,O
118006,8141,",",O
118007,8141,endocrine,O
118008,8141,",",O
118009,8141,immunologic,O
118010,8141,",",O
118011,8141,metabolic,B-Condition
118012,8141,",",I-Condition
118013,8141,neurologic,I-Condition
118014,8141,",",I-Condition
118015,8141,psychiatric,I-Condition
118016,8141,or,I-Condition
118017,8141,hematological,I-Condition
118018,8141,disease,I-Condition
118019,8141,",",O
118020,8141,based,O
118021,8141,on,O
118022,8141,Investigator,O
118023,8141,judgment,O
118024,8141,.,O
118025,8142,Acute,O
118026,8142,illness,O
118027,8142,or,O
118028,8142,history,O
118029,8142,of,O
118030,8142,illness,O
118031,8142,",",O
118032,8142,which,O
118033,8142,in,O
118034,8142,the,O
118035,8142,opinion,O
118036,8142,of,O
118037,8142,the,O
118038,8142,Investigator,O
118039,8142,",",O
118040,8142,could,O
118041,8142,pose,O
118042,8142,a,O
118043,8142,threat,O
118044,8142,or,O
118045,8142,harm,O
118046,8142,to,O
118047,8142,the,O
118048,8142,subject,O
118049,8142,or,O
118050,8142,obscure,O
118051,8142,interpretation,O
118052,8142,of,O
118053,8142,laboratory,O
118054,8142,test,O
118055,8142,results,O
118056,8142,or,O
118057,8142,interpretation,O
118058,8142,of,O
118059,8142,study,O
118060,8142,data,O
118061,8142,.,O
118062,8143,Positive,O
118063,8143,hepatitis,O
118064,8143,B,O
118065,8143,surface,O
118066,8143,antigen,O
118067,8143,",",O
118068,8143,positive,O
118069,8143,hepatitis,O
118070,8143,C,O
118071,8143,antibody,O
118072,8143,or,O
118073,8143,positive,O
118074,8143,HIV,O
118075,8143,test,O
118076,8143,at,O
118077,8143,screening,O
118078,8143,or,O
118079,8143,a,O
118080,8143,history,B-Observation
118081,8143,of,O
118082,8143,positive,O
118083,8143,testing,B-Procedure
118084,8143,(,O
118085,8143,e.g.,O
118086,8143,liver,B-Procedure
118087,8143,biopsy,I-Procedure
118088,8143,",",O
118089,8143,serology,B-Procedure
118090,8143,),O
118091,8143,suggesting,O
118092,8143,acute,B-Condition
118093,8143,or,I-Condition
118094,8143,chronic,I-Condition
118095,8143,hepatitis,I-Condition
118096,8143,.,O
118097,8144,Abnormal,O
118098,8144,12,B-Procedure
118099,8144,-,I-Procedure
118100,8144,lead,I-Procedure
118101,8144,electrocardiogram,I-Procedure
118102,8144,(,I-Procedure
118103,8144,ECG,I-Procedure
118104,8144,),I-Procedure
118105,8144,at,O
118106,8144,screening,O
118107,8144,or,O
118108,8144,pre,O
118109,8144,-,O
118110,8144,dose,O
118111,8144,(,O
118112,8144,Day,O
118113,8144,-1,O
118114,8144,or,O
118115,8144,Day,O
118116,8144,1,O
118117,8144,),O
118118,8144,",",O
118119,8144,except,O
118120,8144,minor,O
118121,8144,deviations,O
118122,8144,deemed,O
118123,8144,to,O
118124,8144,be,O
118125,8144,of,O
118126,8144,no,O
118127,8144,clinical,O
118128,8144,significance,O
118129,8144,by,O
118130,8144,the,O
118131,8144,Investigator,O
118132,8144,.,O
118133,8145,Received,O
118134,8145,any,O
118135,8145,experimental,B-Drug
118136,8145,drugs,I-Drug
118137,8145,or,O
118138,8145,devices,O
118139,8145,within,O
118140,8145,30,O
118141,8145,days,O
118142,8145,or,O
118143,8145,5,O
118144,8145,half,O
118145,8145,lives,O
118146,8145,",",O
118147,8145,whichever,O
118148,8145,is,O
118149,8145,longer,O
118150,8145,",",O
118151,8145,prior,O
118152,8145,to,O
118153,8145,dosing,O
118154,8145,.,O
118155,8146,Ongoing,O
118156,8146,participation,O
118157,8146,in,O
118158,8146,a,O
118159,8146,prior,O
118160,8146,clinical,O
118161,8146,study,O
118162,8146,at,O
118163,8146,the,O
118164,8146,time,O
118165,8146,of,O
118166,8146,screening,O
118167,8146,.,O
118168,8147,Blood,B-Procedure
118169,8147,donation,I-Procedure
118170,8147,within,O
118171,8147,60,O
118172,8147,days,O
118173,8147,prior,O
118174,8147,to,O
118175,8147,screening,O
118176,8147,or,O
118177,8147,intent,B-Observation
118178,8147,to,I-Observation
118179,8147,donate,I-Observation
118180,8147,within,O
118181,8147,60,O
118182,8147,days,O
118183,8147,after,O
118184,8147,Final,O
118185,8147,Study,O
118186,8147,Visit,O
118187,8147,.,O
118188,8148,Hospitalization,B-Procedure
118189,8148,for,O
118190,8148,major,O
118191,8148,surgery,B-Procedure
118192,8148,including,O
118193,8148,but,O
118194,8148,not,O
118195,8148,limited,O
118196,8148,to,O
118197,8148,abdominal,B-Procedure
118198,8148,",",I-Procedure
118199,8148,thoracic,I-Procedure
118200,8148,",",I-Procedure
118201,8148,or,I-Procedure
118202,8148,cardiovascular,I-Procedure
118203,8148,surgery,I-Procedure
118204,8148,within,O
118205,8148,the,O
118206,8148,past,O
118207,8148,3,O
118208,8148,months,O
118209,8148,prior,O
118210,8148,to,O
118211,8148,screening,O
118212,8148,",",O
118213,8148,or,O
118214,8148,for,O
118215,8148,a,O
118216,8148,clinically,O
118217,8148,significant,O
118218,8148,non,B-Condition
118219,8148,-,I-Condition
118220,8148,surgical,I-Condition
118221,8148,illness,I-Condition
118222,8148,",",O
118223,8148,based,O
118224,8148,on,O
118225,8148,Investigator,O
118226,8148,judgment,O
118227,8148,",",O
118228,8148,within,O
118229,8148,the,O
118230,8148,past,O
118231,8148,3,O
118232,8148,months,O
118233,8148,.,O
118234,8149,Planned,B-Observation
118235,8149,elective,B-Procedure
118236,8149,surgery,I-Procedure
118237,8149,within,O
118238,8149,30,O
118239,8149,days,O
118240,8149,of,O
118241,8149,the,O
118242,8149,Final,O
118243,8149,Study,O
118244,8149,Visit,O
118245,8149,.,O
118246,8150,Poor,B-Condition
118247,8150,venous,I-Condition
118248,8150,access,I-Condition
118249,8150,or,O
118250,8150,inability,B-Condition
118251,8150,to,I-Condition
118252,8150,tolerate,I-Condition
118253,8150,venipuncture,I-Condition
118254,8150,.,O
118255,8151,History,B-Observation
118256,8151,of,O
118257,8151,significant,O
118258,8151,drug,B-Condition
118259,8151,hypersensitivity,I-Condition
118260,8151,or,I-Condition
118261,8151,anaphylaxis,I-Condition
118262,8151,.,O
118263,8152,History,B-Observation
118264,8152,of,O
118265,8152,hypersensitivity,B-Condition
118266,8152,to,I-Condition
118267,8152,proteins,I-Condition
118268,8152,(,I-Condition
118269,8152,e.g.,I-Condition
118270,8152,",",I-Condition
118271,8152,allergy,I-Condition
118272,8152,shots,I-Condition
118273,8152,),O
118274,8152,.,O
118275,8153,Use,O
118276,8153,of,O
118277,8153,prescription,B-Drug
118278,8153,medications,I-Drug
118279,8153,on,O
118280,8153,a,O
118281,8153,regular,O
118282,8153,basis,O
118283,8153,.,O
118284,8153,The,O
118285,8153,last,O
118286,8153,use,O
118287,8153,of,O
118288,8153,any,B-Drug
118289,8153,prescription,I-Drug
118290,8153,medication,I-Drug
118291,8153,must,O
118292,8153,have,O
118293,8153,been,O
118294,8153,greater,O
118295,8153,than,O
118296,8153,5,O
118297,8153,half,O
118298,8153,-,O
118299,8153,lives,O
118300,8153,for,O
118301,8153,the,O
118302,8153,specific,O
118303,8153,medication,O
118304,8153,or,O
118305,8153,at,O
118306,8153,least,O
118307,8153,14,O
118308,8153,days,O
118309,8153,prior,O
118310,8153,to,O
118311,8153,admission,O
118312,8153,(,O
118313,8153,Day,O
118314,8153,-1,O
118315,8153,),O
118316,8153,",",O
118317,8153,whichever,O
118318,8153,is,O
118319,8153,longer,O
118320,8153,.,O
118321,8153,Hormonal,B-Procedure
118322,8153,contraception,I-Procedure
118323,8153,is,O
118324,8153,allowed,O
118325,8153,for,O
118326,8153,female,B-Person
118327,8153,subjects,O
118328,8153,.,O
118329,8154,Heterozygous,O
118330,8154,cohorts,O
118331,8154,:,O
118332,8154,Use,O
118333,8154,of,O
118334,8154,prescription,O
118335,8154,medications,O
118336,8154,on,O
118337,8154,a,O
118338,8154,regular,O
118339,8154,basis,O
118340,8154,is,O
118341,8154,not,O
118342,8154,allowed,O
118343,8154,with,O
118344,8154,the,O
118345,8154,following,O
118346,8154,exceptions,O
118347,8154,:,O
118348,8155,Antihypertensives,B-Drug
118349,8155,(,O
118350,8155,<3,O
118351,8155,medications,O
118352,8155,on,O
118353,8155,a,O
118354,8155,stable,O
118355,8155,dose,O
118356,8155,for,O
118357,8155,≥,O
118358,8155,30,O
118359,8155,days,O
118360,8155,),O
118361,8155,;,O
118362,8156,Statins,B-Drug
118363,8156,(,O
118364,8156,dose,O
118365,8156,must,O
118366,8156,be,O
118367,8156,≤,O
118368,8156,half,O
118369,8156,the,O
118370,8156,maximum,O
118371,8156,dose,O
118372,8156,;,O
118373,8156,must,O
118374,8156,be,O
118375,8156,on,O
118376,8156,a,O
118377,8156,stable,O
118378,8156,dose,O
118379,8156,≥3,O
118380,8156,months,O
118381,8156,),O
118382,8156,;,O
118383,8157,Fibrates,B-Drug
118384,8157,(,O
118385,8157,must,O
118386,8157,be,O
118387,8157,on,O
118388,8157,stable,O
118389,8157,dose,O
118390,8157,for,O
118391,8157,≥3,O
118392,8157,months,O
118393,8157,),O
118394,8157,;,O
118395,8158,Niacin,B-Drug
118396,8158,(,O
118397,8158,must,O
118398,8158,be,O
118399,8158,on,O
118400,8158,stable,O
118401,8158,dose,O
118402,8158,for,O
118403,8158,≥3,O
118404,8158,months,O
118405,8158,),O
118406,8158,;,O
118407,8159,Thyroxin,B-Drug
118408,8159,(,O
118409,8159,stable,O
118410,8159,dose,O
118411,8159,for,O
118412,8159,≥,O
118413,8159,30,O
118414,8159,days,O
118415,8159,),O
118416,8159,;,O
118417,8159,The,O
118418,8159,last,O
118419,8159,use,O
118420,8159,of,O
118421,8159,any,O
118422,8159,other,O
118423,8159,prescription,O
118424,8159,medication,O
118425,8159,will,O
118426,8159,need,O
118427,8159,follow,O
118428,8159,the,O
118429,8159,criteria,O
118430,8159,for,O
118431,8159,all,O
118432,8159,other,O
118433,8159,cohorts,O
118434,8159,",",O
118435,8159,as,O
118436,8159,outlined,O
118437,8159,above,O
118438,8159,.,O
118439,8160,Use,O
118440,8160,of,O
118441,8160,prescription,B-Drug
118442,8160,medications,I-Drug
118443,8160,not,O
118444,8160,listed,O
118445,8160,above,O
118446,8160,may,O
118447,8160,be,O
118448,8160,allowed,O
118449,8160,at,O
118450,8160,the,O
118451,8160,discretion,O
118452,8160,of,O
118453,8160,the,O
118454,8160,Investigator,O
118455,8160,upon,O
118456,8160,consultation,O
118457,8160,with,O
118458,8160,Rhythm,O
118459,8160,.,O
118460,8161,Use,O
118461,8161,of,O
118462,8161,a,O
118463,8161,non,B-Drug
118464,8161,-,I-Drug
118465,8161,prescription,I-Drug
118466,8161,drug,I-Drug
118467,8161,and,O
118468,8161,herbal,B-Drug
118469,8161,substances,I-Drug
118470,8161,during,O
118471,8161,the,O
118472,8161,study,O
118473,8161,(,O
118474,8161,through,O
118475,8161,the,O
118476,8161,Final,O
118477,8161,Study,O
118478,8161,Visit,O
118479,8161,),O
118480,8161,.,O
118481,8161,The,O
118482,8161,last,O
118483,8161,dose,O
118484,8161,of,O
118485,8161,any,B-Drug
118486,8161,non,I-Drug
118487,8161,-,I-Drug
118488,8161,prescription,I-Drug
118489,8161,drug,I-Drug
118490,8161,must,O
118491,8161,have,O
118492,8161,been,O
118493,8161,taken,O
118494,8161,greater,O
118495,8161,than,O
118496,8161,5,O
118497,8161,half,O
118498,8161,-,O
118499,8161,lives,O
118500,8161,for,O
118501,8161,that,O
118502,8161,drug,O
118503,8161,before,O
118504,8161,receiving,O
118505,8161,study,O
118506,8161,drug,O
118507,8161,.,O
118508,8162,Inability,O
118509,8162,to,O
118510,8162,attend,O
118511,8162,all,O
118512,8162,study,O
118513,8162,visits,O
118514,8162,or,O
118515,8162,to,O
118516,8162,comply,O
118517,8162,with,O
118518,8162,protocol,O
118519,8162,requirements,O
118520,8162,including,O
118521,8162,fasting,O
118522,8162,and,O
118523,8162,restrictions,O
118524,8162,on,O
118525,8162,alcohol,O
118526,8162,",",O
118527,8162,caffeine,O
118528,8162,",",O
118529,8162,nicotine,O
118530,8162,and,O
118531,8162,concomitant,O
118532,8162,medication,O
118533,8162,intake,O
118534,8162,.,O
118535,8163,A,O
118536,8163,significant,O
118537,8163,history,B-Observation
118538,8163,of,O
118539,8163,drug,B-Condition
118540,8163,/,I-Condition
118541,8163,solvent,I-Condition
118542,8163,abuse,I-Condition
118543,8163,within,O
118544,8163,5,O
118545,8163,years,O
118546,8163,of,O
118547,8163,screening,O
118548,8163,or,O
118549,8163,a,O
118550,8163,positive,O
118551,8163,test,O
118552,8163,for,O
118553,8163,drugs,O
118554,8163,of,O
118555,8163,abuse,O
118556,8163,test,O
118557,8163,at,O
118558,8163,screening,O
118559,8163,or,O
118560,8163,on,O
118561,8163,Day,O
118562,8163,-1,O
118563,8163,.,O
118564,8164,Positive,O
118565,8164,alcohol,O
118566,8164,(,O
118567,8164,breath,O
118568,8164,test,O
118569,8164,),O
118570,8164,or,O
118571,8164,nicotine,O
118572,8164,screen,O
118573,8164,at,O
118574,8164,Screening,O
118575,8164,Visit,O
118576,8164,or,O
118577,8164,Day,O
118578,8164,1,O
118579,8164,(,O
118580,8164,positive,O
118581,8164,nicotine,O
118582,8164,screen,O
118583,8164,does,O
118584,8164,not,O
118585,8164,apply,O
118586,8164,to,O
118587,8164,heterozygous,O
118588,8164,cohort,O
118589,8164,),O
118590,8164,.,O
118591,8165,History,B-Observation
118592,8165,of,O
118593,8165,alcohol,B-Condition
118594,8165,abuse,I-Condition
118595,8165,(,O
118596,8165,defined,O
118597,8165,as,O
118598,8165,average,O
118599,8165,intake,O
118600,8165,of,O
118601,8165,three,O
118602,8165,or,O
118603,8165,more,O
118604,8165,units,O
118605,8165,of,O
118606,8165,alcohol,B-Drug
118607,8165,per,O
118608,8165,day,O
118609,8165,),O
118610,8165,within,O
118611,8165,5,O
118612,8165,years,O
118613,8165,of,O
118614,8165,the,O
118615,8165,Screening,O
118616,8165,Visit,O
118617,8165,.,O
118618,8166,History,B-Observation
118619,8166,of,O
118620,8166,tobacco,B-Condition
118621,8166,or,I-Condition
118622,8166,tobacco,I-Condition
118623,8166,product,I-Condition
118624,8166,use,I-Condition
118625,8166,unless,O
118626,8166,abstinent,B-Condition
118627,8166,for,O
118628,8166,at,O
118629,8166,least,O
118630,8166,one,O
118631,8166,year,O
118632,8166,prior,O
118633,8166,to,O
118634,8166,the,O
118635,8166,Screening,O
118636,8166,Visit,O
118637,8166,.,O
118638,8166,This,O
118639,8166,criterion,O
118640,8166,does,O
118641,8166,not,O
118642,8166,apply,O
118643,8166,to,O
118644,8166,heterozygous,O
118645,8166,subjects,O
118646,8166,.,O
118647,8167,Previously,O
118648,8167,randomized,O
118649,8167,and,O
118650,8167,dosed,O
118651,8167,in,O
118652,8167,this,O
118653,8167,study,O
118654,8167,.,O
118655,8167,This,O
118656,8167,criterion,O
118657,8167,does,O
118658,8167,not,O
118659,8167,apply,O
118660,8167,to,O
118661,8167,heterozygous,O
118662,8167,subjects,O
118663,8167,.,O
118664,8168,Any,O
118665,8168,other,O
118666,8168,reason,O
118667,8168,",",O
118668,8168,which,O
118669,8168,in,O
118670,8168,the,O
118671,8168,opinion,O
118672,8168,of,O
118673,8168,the,O
118674,8168,Investigator,O
118675,8168,would,O
118676,8168,confound,O
118677,8168,proper,O
118678,8168,evaluation,O
118679,8168,of,O
118680,8168,the,O
118681,8168,study,O
118682,8168,.,O
118683,8169,Able,O
118684,8169,to,O
118685,8169,provide,O
118686,8169,voluntary,O
118687,8169,",",O
118688,8169,written,O
118689,8169,informed,O
118690,8169,consent,O
118691,8169,with,O
118692,8169,comprehension,O
118693,8169,of,O
118694,8169,all,O
118695,8169,aspects,O
118696,8169,of,O
118697,8169,the,O
118698,8169,protocol,O
118699,8169,",",O
118700,8169,prior,O
118701,8169,to,O
118702,8169,any,O
118703,8169,study,O
118704,8169,procedures,O
118705,8169,.,O
118706,8170,Healthy,B-Condition
118707,8170,obese,B-Condition
118708,8170,male,B-Person
118709,8170,and,O
118710,8170,female,B-Person
118711,8170,volunteers,O
118712,8170,aged,B-Person
118713,8170,18,O
118714,8170,to,O
118715,8170,55,O
118716,8170,years,O
118717,8170,",",O
118718,8170,inclusive,O
118719,8170,.,O
118720,8170,Heterozygous,B-Condition
118721,8170,subjects,O
118722,8170,may,O
118723,8170,be,O
118724,8170,18,O
118725,8170,to,O
118726,8170,65,O
118727,8170,years,O
118728,8170,inclusive,O
118729,8170,.,O
118730,8171,In,O
118731,8171,good,B-Condition
118732,8171,general,I-Condition
118733,8171,health,I-Condition
118734,8171,",",O
118735,8171,without,O
118736,8171,significant,O
118737,8171,medical,O
118738,8171,history,O
118739,8171,",",O
118740,8171,physical,O
118741,8171,examination,O
118742,8171,findings,O
118743,8171,",",O
118744,8171,or,O
118745,8171,clinical,O
118746,8171,laboratory,O
118747,8171,abnormalities,O
118748,8171,.,O
118749,8172,Body,O
118750,8172,Mass,O
118751,8172,Index,O
118752,8172,of,O
118753,8172,30,O
118754,8172,-,O
118755,8172,40,O
118756,8172,kg,O
118757,8172,/,O
118758,8172,m2,O
118759,8172,",",O
118760,8172,inclusive,O
118761,8172,.,O
118762,8172,Heterozygous,B-Condition
118763,8172,subjects,O
118764,8172,may,O
118765,8172,have,O
118766,8172,a,O
118767,8172,broader,O
118768,8172,BMI,O
118769,8172,range,O
118770,8172,;,O
118771,8172,to,O
118772,8172,be,O
118773,8172,eligible,O
118774,8172,heterozygous,B-Condition
118775,8172,subjects,O
118776,8172,may,O
118777,8172,have,O
118778,8172,a,O
118779,8172,BMI,O
118780,8172,27,O
118781,8172,-55,O
118782,8172,kg/,O
118783,8172,m2,O
118784,8172,",",O
118785,8172,inclusive,O
118786,8172,.,O
118787,8173,Stable,O
118788,8173,body,O
118789,8173,weight,O
118790,8173,during,O
118791,8173,the,O
118792,8173,previous,O
118793,8173,6,O
118794,8173,months,O
118795,8173,",",O
118796,8173,based,O
118797,8173,on,O
118798,8173,Investigator,O
118799,8173,judgment,O
118800,8173,.,O
118801,8174,Blood,O
118802,8174,pressure,O
118803,8174,<,O
118804,8174,140/90,O
118805,8174,mmHg,O
118806,8174,at,O
118807,8174,Screening,O
118808,8174,and,O
118809,8174,D-1,O
118810,8174,.,O
118811,8174,Measurement,O
118812,8174,may,O
118813,8174,be,O
118814,8174,repeated,O
118815,8174,within,O
118816,8174,24,O
118817,8174,hours,O
118818,8174,",",O
118819,8174,based,O
118820,8174,on,O
118821,8174,Investigator,O
118822,8174,judgment,O
118823,8174,.,O
118824,8175,Females,B-Person
118825,8175,must,O
118826,8175,not,O
118827,8175,be,O
118828,8175,pregnant,B-Condition
118829,8175,and,O
118830,8175,must,O
118831,8175,have,O
118832,8175,a,O
118833,8175,negative,O
118834,8175,serum,O
118835,8175,pregnancy,O
118836,8175,test,O
118837,8175,result,O
118838,8175,at,O
118839,8175,the,O
118840,8175,Screening,O
118841,8175,Visit,O
118842,8175,and,O
118843,8175,Day,O
118844,8175,-1,O
118845,8175,.,O
118846,8176,Females,O
118847,8176,of,O
118848,8176,childbearing,B-Condition
118849,8176,potential,I-Condition
118850,8176,must,O
118851,8176,agree,O
118852,8176,to,O
118853,8176,be,O
118854,8176,abstinent,O
118855,8176,or,O
118856,8176,else,O
118857,8176,use,O
118858,8176,any,O
118859,8176,two,O
118860,8176,of,O
118861,8176,the,O
118862,8176,following,O
118863,8176,medically,O
118864,8176,acceptable,O
118865,8176,forms,O
118866,8176,of,O
118867,8176,contraception,O
118868,8176,from,O
118869,8176,the,O
118870,8176,Screening,O
118871,8176,Period,O
118872,8176,through,O
118873,8176,the,O
118874,8176,Final,O
118875,8176,Study,O
118876,8176,Visit,O
118877,8176,:,O
118878,8176,hormonal,O
118879,8176,",",O
118880,8176,condom,O
118881,8176,with,O
118882,8176,spermicidal,O
118883,8176,jelly,O
118884,8176,",",O
118885,8176,diaphragm,O
118886,8176,or,O
118887,8176,cervical,O
118888,8176,cap,O
118889,8176,with,O
118890,8176,spermicidal,O
118891,8176,jelly,O
118892,8176,",",O
118893,8176,or,O
118894,8176,IUD,O
118895,8176,.,O
118896,8176,Hormonal,B-Procedure
118897,8176,contraception,I-Procedure
118898,8176,must,O
118899,8176,have,O
118900,8176,started,O
118901,8176,at,O
118902,8176,least,O
118903,8176,3,O
118904,8176,months,O
118905,8176,prior,O
118906,8176,to,O
118907,8176,screening,O
118908,8176,.,O
118909,8176,A,O
118910,8176,female,O
118911,8176,whose,O
118912,8176,male,O
118913,8176,partner,O
118914,8176,has,O
118915,8176,had,O
118916,8176,a,O
118917,8176,vasectomy,O
118918,8176,must,O
118919,8176,agree,O
118920,8176,to,O
118921,8176,use,O
118922,8176,one,O
118923,8176,additional,O
118924,8176,form,O
118925,8176,of,O
118926,8176,medically,O
118927,8176,acceptable,O
118928,8176,contraception,O
118929,8176,.,O
118930,8176,Subjects,O
118931,8176,must,O
118932,8176,agree,O
118933,8176,to,O
118934,8176,practice,O
118935,8176,the,O
118936,8176,above,O
118937,8176,birth,O
118938,8176,control,O
118939,8176,methods,O
118940,8176,for,O
118941,8176,30,O
118942,8176,days,O
118943,8176,from,O
118944,8176,the,O
118945,8176,final,O
118946,8176,visit,O
118947,8176,as,O
118948,8176,a,O
118949,8176,safety,O
118950,8176,precaution,O
118951,8176,.,O
118952,8177,Females,O
118953,8177,of,O
118954,8177,non,O
118955,8177,-,O
118956,8177,childbearing,O
118957,8177,potential,O
118958,8177,",",O
118959,8177,defined,O
118960,8177,as,O
118961,8177,surgically,O
118962,8177,sterile,O
118963,8177,(,O
118964,8177,status,O
118965,8177,post,O
118966,8177,hysterectomy,O
118967,8177,",",O
118968,8177,bilateral,O
118969,8177,oophorectomy,O
118970,8177,",",O
118971,8177,or,O
118972,8177,bilateral,O
118973,8177,tubal,O
118974,8177,ligation,O
118975,8177,),O
118976,8177,or,O
118977,8177,post,O
118978,8177,-,O
118979,8177,menopausal,O
118980,8177,for,O
118981,8177,at,O
118982,8177,least,O
118983,8177,12,O
118984,8177,months,O
118985,8177,(,O
118986,8177,and,O
118987,8177,confirmed,O
118988,8177,with,O
118989,8177,a,O
118990,8177,screening,O
118991,8177,FSH,O
118992,8177,level,O
118993,8177,in,O
118994,8177,the,O
118995,8177,post,O
118996,8177,-,O
118997,8177,menopausal,O
118998,8177,range,O
118999,8177,),O
119000,8177,",",O
119001,8177,do,O
119002,8177,not,O
119003,8177,require,O
119004,8177,contraception,O
119005,8177,during,O
119006,8177,the,O
119007,8177,study,O
119008,8177,.,O
119009,8178,Males,O
119010,8178,with,O
119011,8178,female,O
119012,8178,partners,O
119013,8178,of,O
119014,8178,childbearing,O
119015,8178,potential,O
119016,8178,must,O
119017,8178,agree,O
119018,8178,to,O
119019,8178,use,O
119020,8178,two,O
119021,8178,medically,O
119022,8178,acceptable,O
119023,8178,forms,O
119024,8178,of,O
119025,8178,contraception,O
119026,8178,as,O
119027,8178,described,O
119028,8178,above,O
119029,8178,",",O
119030,8178,with,O
119031,8178,one,O
119032,8178,of,O
119033,8178,the,O
119034,8178,two,O
119035,8178,forms,O
119036,8178,being,O
119037,8178,condom,O
119038,8178,with,O
119039,8178,spermicide,O
119040,8178,",",O
119041,8178,from,O
119042,8178,the,O
119043,8178,Screening,O
119044,8178,Period,O
119045,8178,through,O
119046,8178,the,O
119047,8178,Final,O
119048,8178,Study,O
119049,8178,Visit,O
119050,8178,.,O
119051,8178,Males,O
119052,8178,with,O
119053,8178,female,O
119054,8178,partners,O
119055,8178,of,O
119056,8178,childbearing,O
119057,8178,potential,O
119058,8178,who,O
119059,8178,themselves,O
119060,8178,are,O
119061,8178,surgically,O
119062,8178,sterile,O
119063,8178,(,O
119064,8178,status,O
119065,8178,post,O
119066,8178,vasectomy,O
119067,8178,),O
119068,8178,must,O
119069,8178,agree,O
119070,8178,to,O
119071,8178,use,O
119072,8178,condoms,O
119073,8178,with,O
119074,8178,spermicide,O
119075,8178,over,O
119076,8178,the,O
119077,8178,same,O
119078,8178,period,O
119079,8178,of,O
119080,8178,time,O
119081,8178,.,O
119082,8178,Male,O
119083,8178,subjects,O
119084,8178,must,O
119085,8178,agree,O
119086,8178,to,O
119087,8178,practice,O
119088,8178,the,O
119089,8178,above,O
119090,8178,birth,O
119091,8178,control,O
119092,8178,methods,O
119093,8178,for,O
119094,8178,30,O
119095,8178,days,O
119096,8178,from,O
119097,8178,the,O
119098,8178,final,O
119099,8178,visit,O
119100,8178,as,O
119101,8178,a,O
119102,8178,safety,O
119103,8178,precaution,O
119104,8178,.,O
119105,8179,Pregnant,B-Condition
119106,8179,or,O
119107,8179,lactating,B-Condition
119108,8179,women,B-Person
119109,8180,Patients,O
119110,8180,with,O
119111,8180,severe,O
119112,8180,organ,B-Condition
119113,8180,dysfunction,I-Condition
119114,8180,or,I-Condition
119115,8180,failure,I-Condition
119116,8181,With,O
119117,8181,severe,O
119118,8181,cardiovascular,B-Condition
119119,8181,disease,I-Condition
119120,8181,",",O
119121,8181,or,O
119122,8181,mental,O
119123,8182,Extraliver,B-Condition
119124,8182,metastases,I-Condition
119125,8183,Histologically,B-Procedure
119126,8183,confirmed,O
119127,8183,colorectal,B-Condition
119128,8183,adenocarcinoma,I-Condition
119129,8184,Disease,B-Observation
119130,8184,limited,I-Observation
119131,8184,to,I-Observation
119132,8184,the,I-Observation
119133,8184,liver,I-Observation
119134,8184,Unresectable,B-Condition
119135,8184,disease,I-Condition
119136,8184,by,O
119137,8184,surgery,B-Procedure
119138,8184,or,O
119139,8184,other,O
119140,8184,local,B-Procedure
119141,8184,therapies,I-Procedure
119142,8185,Age,B-Person
119143,8185,>,O
119144,8185,18,O
119145,8185,years,O
119146,8186,ECOG,O
119147,8186,performance,O
119148,8186,status,O
119149,8186,0,O
119150,8186,-,O
119151,8186,"2,Child",O
119152,8186,pugh,O
119153,8186,A,O
119154,8186,or,O
119155,8186,B,O
119156,8187,Expected,B-Observation
119157,8187,survival,I-Observation
119158,8187,=,O
119159,8187,3,O
119160,8187,months,O
119161,8188,Adequate,O
119162,8188,hematological,O
119163,8188,",",O
119164,8188,hepatic,O
119165,8188,",",O
119166,8188,and,O
119167,8188,renal,O
119168,8188,function,O
119169,8189,Ovarian,B-Condition
119170,8189,cancer,I-Condition
119171,8189,",",O
119172,8189,adrenal,B-Condition
119173,8189,gland,I-Condition
119174,8189,tumor,I-Condition
119175,8189,",",O
119176,8189,endometrial,B-Condition
119177,8189,cancer,I-Condition
119178,8189,",",O
119179,8189,cervical,B-Condition
119180,8189,cancer,I-Condition
119181,8189,",",O
119182,8189,breast,B-Condition
119183,8189,cancer,I-Condition
119184,8190,Congenital,B-Condition
119185,8190,adrenal,I-Condition
119186,8190,hyperplasia,I-Condition
119187,8190,(,O
119188,8190,17,O
119189,8190,-,O
119190,8190,OH,O
119191,8190,-,O
119192,8190,progesterone,O
119193,8190,>,O
119194,8190,2.5,O
119195,8190,ng,O
119196,8190,/,O
119197,8190,mL,O
119198,8190,),O
119199,8191,Clinically,O
119200,8191,diagnosed,O
119201,8191,Cushing,B-Condition
119202,8191,'s,I-Condition
119203,8191,disease,I-Condition
119204,8191,",",O
119205,8191,acromegaly,B-Condition
119206,8191,",",O
119207,8191,gigantism,B-Condition
119208,8192,Type,B-Condition
119209,8192,I,I-Condition
119210,8192,or,I-Condition
119211,8192,II,I-Condition
119212,8192,diabetes,I-Condition
119213,8193,Unexplained,B-Condition
119214,8193,bleeding,I-Condition
119215,8193,from,O
119216,8193,the,O
119217,8193,genital,O
119218,8193,tract,O
119219,8194,Hormone,B-Procedure
119220,8194,treatment,I-Procedure
119221,8194,within,O
119222,8194,the,O
119223,8194,last,O
119224,8194,2,O
119225,8194,months,O
119226,8195,Written,O
119227,8195,consent,O
119228,8195,for,O
119229,8195,participation,O
119230,8195,in,O
119231,8195,the,O
119232,8195,clinical,O
119233,8195,trial,O
119234,8196,Age,B-Person
119235,8196,18,O
119236,8196,to,O
119237,8196,45,O
119238,8196,years,O
119239,8196,Irregular,B-Condition
119240,8196,menstruation,I-Condition
119241,8196,(,O
119242,8196,>,O
119243,8196,35,O
119244,8196,days,O
119245,8196,),O
119246,8196,or,O
119247,8196,secondary,B-Condition
119248,8196,amenorrhea,I-Condition
119249,8196,>,O
119250,8196,3,O
119251,8196,months,O
119252,8197,pregnant,B-Condition
119253,8197,or,O
119254,8197,breastfeeding,B-Observation
119255,8198,known,O
119256,8198,thromboembolic,B-Condition
119257,8198,disease,I-Condition
119258,8198,or,O
119259,8198,with,O
119260,8198,high,B-Mood
119261,8198,risk,I-Mood
119262,8198,of,I-Mood
119263,8198,thromboembolism,B-Condition
119264,8198,",",O
119265,8198,warranting,O
119266,8198,extra,B-Procedure
119267,8198,anticoagulation,I-Procedure
119268,8198,in,O
119269,8198,connection,O
119270,8198,with,O
119271,8198,the,O
119272,8198,procedure,O
119273,8199,known,O
119274,8199,allergy,B-Condition
119275,8199,to,O
119276,8199,tranexamic,B-Drug
119277,8199,acid,I-Drug
119278,8199,/,O
119279,8199,Cyklokapron,B-Drug
119280,8199,®,O
119281,8200,breast,B-Condition
119282,8200,cancer,I-Condition
119283,8201,undergoing,O
119284,8201,unilateral,O
119285,8201,mastectomy,O
119286,8201,with,O
119287,8201,or,O
119288,8201,without,O
119289,8201,axillary,B-Procedure
119290,8201,node,I-Procedure
119291,8201,dissection,I-Procedure
119292,8202,received,O
119293,8202,adequate,O
119294,8202,oral,O
119295,8202,and,O
119296,8202,written,O
119297,8202,information,O
119298,8202,about,O
119299,8202,the,O
119300,8202,study,O
119301,8202,and,O
119302,8202,signed,O
119303,8202,an,O
119304,8202,informed,O
119305,8202,-,O
119306,8202,consent,O
119307,8202,form,O
119308,8203,Non,B-Condition
119309,8203,-,I-Condition
119310,8203,compliance,I-Condition
119311,8203,with,O
119312,8203,DOTPlus,B-Procedure
119313,8203,.,O
119314,8203,Alternatively,O
119315,8203,DOT,O
119316,8203,can,O
119317,8203,be,O
119318,8203,done,O
119319,8203,by,O
119320,8203,telephoning,O
119321,8203,patient,O
119322,8203,on,O
119323,8203,a,O
119324,8203,daily,O
119325,8203,basis,O
119326,8203,5,O
119327,8203,times,O
119328,8203,a,O
119329,8203,week,O
119330,8203,and,O
119331,8203,having,O
119332,8203,patient,O
119333,8203,annotate,O
119334,8203,taking,O
119335,8203,drug,O
119336,8203,in,O
119337,8203,a,O
119338,8203,log,O
119339,8203,which,O
119340,8203,would,O
119341,8203,be,O
119342,8203,reviewed,O
119343,8203,by,O
119344,8203,clinic,O
119345,8203,staff,O
119346,8204,History,O
119347,8204,of,O
119348,8204,being,O
119349,8204,treated,B-Procedure
119350,8204,for,O
119351,8204,tuberculosis,B-Condition
119352,8204,in,O
119353,8204,the,O
119354,8204,prior,O
119355,8204,2,O
119356,8204,years,O
119357,8204,unless,O
119358,8204,there,O
119359,8204,is,O
119360,8204,DST,B-Condition
119361,8204,",",O
119362,8204,including,O
119363,8204,PCR,B-Procedure
119364,8204,testing,I-Procedure
119365,8204,",",O
119366,8204,showing,O
119367,8204,sensitivity,B-Condition
119368,8204,to,O
119369,8204,rifamycin,B-Drug
119370,8204,.,O
119371,8205,Known,O
119372,8205,hypersensitivity,B-Condition
119373,8205,to,O
119374,8205,rifampin,B-Drug
119375,8205,or,O
119376,8205,rifabutin,B-Drug
119377,8205,.,O
119378,8206,Liver,O
119379,8206,enzymes,O
119380,8206,greater,O
119381,8206,than,O
119382,8206,2,O
119383,8206,times,O
119384,8206,ULN,O
119385,8206,.,O
119386,8207,Bilirubin,O
119387,8207,greater,O
119388,8207,than,O
119389,8207,2,O
119390,8207,times,O
119391,8207,ULN,O
119392,8207,.,O
119393,8208,Serum,O
119394,8208,creatinine,O
119395,8208,greater,O
119396,8208,than,O
119397,8208,3,O
119398,8208,times,O
119399,8208,ULN,O
119400,8208,.,O
119401,8209,Hemoglobin,O
119402,8209,less,O
119403,8209,than,O
119404,8209,7.0,O
119405,8209,gms,O
119406,8209,even,O
119407,8209,if,O
119408,8209,receiving,O
119409,8209,erythropoietin,O
119410,8209,.,O
119411,8210,Absolute,O
119412,8210,neutrophil,O
119413,8210,count,O
119414,8210,less,O
119415,8210,than,O
119416,8210,750,O
119417,8210,cells,O
119418,8210,/,O
119419,8210,mm3,O
119420,8210,even,O
119421,8210,if,O
119422,8210,receiving,O
119423,8210,G,O
119424,8210,-,O
119425,8210,CSF,O
119426,8210,.,O
119427,8211,Fasting,O
119428,8211,triglycerides,O
119429,8211,greater,O
119430,8211,than,O
119431,8211,400,O
119432,8211,mg,O
119433,8211,/,O
119434,8211,dL.,O
119435,8212,Fasting,O
119436,8212,cholesterol,O
119437,8212,>,O
119438,8212,1.6,O
119439,8212,upper,O
119440,8212,limits,O
119441,8212,of,O
119442,8212,normal,O
119443,8212,.,O
119444,8213,GI,B-Condition
119445,8213,intolerance,I-Condition
119446,8213,of,O
119447,8213,tuberculosis,B-Drug
119448,8213,medications,I-Drug
119449,8213,requiring,O
119450,8213,discontinuation,B-Procedure
119451,8213,of,O
119452,8213,tuberculosis,B-Drug
119453,8213,medications,I-Drug
119454,8213,.,O
119455,8214,Fasting,O
119456,8214,glucose,O
119457,8214,greater,O
119458,8214,150,O
119459,8214,mg,O
119460,8214,/,O
119461,8214,dL.,O
119462,8215,Pregnant,B-Condition
119463,8215,women,B-Person
119464,8215,.,O
119465,8216,Use,O
119466,8216,of,O
119467,8216,one,O
119468,8216,of,O
119469,8216,the,O
119470,8216,prohibited,O
119471,8216,medications,O
119472,8217,Any,O
119473,8217,condition,O
119474,8217,that,O
119475,8217,the,O
119476,8217,investigators,O
119477,8217,feel,O
119478,8217,could,O
119479,8217,compromise,O
119480,8217,the,O
119481,8217,use,O
119482,8217,of,O
119483,8217,the,O
119484,8217,current,O
119485,8217,medication,O
119486,8217,.,O
119487,8218,Have,O
119488,8218,a,O
119489,8218,CD4,O
119490,8218,cell,O
119491,8218,count,O
119492,8218,of,O
119493,8218,50,O
119494,8218,cells,O
119495,8218,/,O
119496,8218,mm3or,O
119497,8218,less,O
119498,8219,Hepatitis,B-Condition
119499,8219,B,I-Condition
119500,8219,or,I-Condition
119501,8219,C,I-Condition
119502,8219,infection,O
119503,8220,Alcohol,B-Observation
119504,8220,or,I-Observation
119505,8220,illicit,I-Observation
119506,8220,drug,I-Observation
119507,8220,use,I-Observation
119508,8220,",",O
119509,8220,which,O
119510,8220,in,O
119511,8220,the,O
119512,8220,investigators,O
119513,8220,opinion,O
119514,8220,may,O
119515,8220,affect,O
119516,8220,participation,O
119517,8220,in,O
119518,8220,study,O
119519,8220,.,O
119520,8221,Antiretroviral,B-Drug
119521,8221,naive,B-Condition
119522,8222,Taking,O
119523,8222,Kaletra,B-Drug
119524,8222,containing,O
119525,8222,regimen,B-Procedure
119526,8222,with,O
119527,8222,suppressed,O
119528,8222,viral,O
119529,8222,load,O
119530,8222,.,O
119531,8223,Taking,O
119532,8223,an,O
119533,8223,NNRTI,B-Drug
119534,8223,or,O
119535,8223,integrase,B-Drug
119536,8223,containing,O
119537,8223,regimen,B-Procedure
119538,8223,without,O
119539,8223,prior,O
119540,8223,history,O
119541,8223,of,O
119542,8223,use,O
119543,8223,of,O
119544,8223,PI,B-Drug
119545,8223,for,O
119546,8223,more,O
119547,8223,than,O
119548,8223,2,O
119549,8223,weeks,O
119550,8224,Taking,O
119551,8224,an,O
119552,8224,NNRTI,B-Drug
119553,8224,or,O
119554,8224,integrase,B-Drug
119555,8224,containing,O
119556,8224,regimen,B-Procedure
119557,8224,with,O
119558,8224,prior,O
119559,8224,exposure,O
119560,8224,to,O
119561,8224,PI,B-Drug
119562,8224,greater,O
119563,8224,than,O
119564,8224,2,O
119565,8224,weeks,O
119566,8224,.,O
119567,8224,It,O
119568,8224,must,O
119569,8224,be,O
119570,8224,clearly,O
119571,8224,stated,O
119572,8224,in,O
119573,8224,the,O
119574,8224,source,O
119575,8224,document,O
119576,8224,that,O
119577,8224,PI,O
119578,8224,was,O
119579,8224,switched,O
119580,8224,to,O
119581,8224,another,O
119582,8224,agent,O
119583,8224,for,O
119584,8224,convenience,O
119585,8224,.,O
119586,8225,Taking,O
119587,8225,another,O
119588,8225,PI,B-Drug
119589,8225,containing,O
119590,8225,regimens,B-Procedure
119591,8225,with,O
119592,8225,suppressed,O
119593,8225,viral,O
119594,8225,load,O
119595,8225,.,O
119596,8225,It,O
119597,8225,must,O
119598,8225,be,O
119599,8225,clearly,O
119600,8225,stated,O
119601,8225,in,O
119602,8225,source,O
119603,8225,document,O
119604,8225,that,O
119605,8225,if,O
119606,8225,another,O
119607,8225,PI,O
119608,8225,was,O
119609,8225,used,O
119610,8225,for,O
119611,8225,greater,O
119612,8225,than,O
119613,8225,2,O
119614,8225,weeks,O
119615,8225,the,O
119616,8225,regimen,O
119617,8225,was,O
119618,8225,switched,O
119619,8225,to,O
119620,8225,another,O
119621,8225,agent,O
119622,8225,for,O
119623,8225,convenience,O
119624,8225,.,O
119625,8225,Subjects,O
119626,8225,with,O
119627,8225,prior,O
119628,8225,history,O
119629,8225,of,O
119630,8225,PI,O
119631,8225,use,O
119632,8225,may,O
119633,8225,be,O
119634,8225,enrolled,O
119635,8225,",",O
119636,8225,if,O
119637,8225,there,O
119638,8225,is,O
119639,8225,a,O
119640,8225,genotype,O
119641,8225,showing,O
119642,8225,no,O
119643,8225,resistance,O
119644,8225,to,O
119645,8225,Kaletra,O
119646,8225,Other,O
119647,8225,Inclusion,O
119648,8225,criteria,O
119649,8226,Be,O
119650,8226,at,O
119651,8226,least,O
119652,8226,18,O
119653,8226,years,O
119654,8226,of,O
119655,8226,age,B-Person
119656,8226,and,O
119657,8226,able,O
119658,8226,to,O
119659,8226,give,O
119660,8226,informed,O
119661,8226,consent,O
119662,8226,.,O
119663,8227,Diagnosed,O
119664,8227,with,O
119665,8227,TB,B-Condition
119666,8227,by,O
119667,8227,criteria,O
119668,8227,per,O
119669,8227,Brazilian,O
119670,8227,Ministry,O
119671,8227,of,O
119672,8227,Health,O
119673,8228,Have,O
119674,8228,a,O
119675,8228,good,B-Condition
119676,8228,clinical,I-Condition
119677,8228,response,I-Condition
119678,8228,to,O
119679,8228,TB,B-Condition
119680,8228,.,O
119681,8229,Tolerating,O
119682,8229,tuberculosis,B-Procedure
119683,8229,therapy,I-Procedure
119684,8229,containing,O
119685,8229,rifampin,B-Drug
119686,8229,for,O
119687,8229,the,O
119688,8229,2,O
119689,8229,weeks,O
119690,8229,prior,O
119691,8229,to,O
119692,8229,screening,O
119693,8229,",",O
119694,8229,except,O
119695,8229,for,O
119696,8229,persons,O
119697,8229,taking,O
119698,8229,protease,B-Drug
119699,8229,inhibitors,I-Drug
119700,8229,at,O
119701,8229,time,O
119702,8229,of,O
119703,8229,diagnosis,O
119704,8229,of,O
119705,8229,TB,O
119706,8229,.,O
119707,8229,",",O
119708,8229,.,O
119709,8229,Subjects,O
119710,8229,taking,O
119711,8229,protease,O
119712,8229,inhibitors,O
119713,8229,will,O
119714,8229,be,O
119715,8229,screened,O
119716,8229,and,O
119717,8229,initiate,O
119718,8229,visit,O
119719,8229,1,O
119720,8229,within,O
119721,8229,3,O
119722,8229,days,O
119723,8229,of,O
119724,8229,starting,O
119725,8229,TB,O
119726,8229,medication,O
119727,8230,HIV,B-Condition
119728,8230,positive,I-Condition
119729,8230,with,O
119730,8230,documentation,O
119731,8230,present,O
119732,8230,in,O
119733,8230,source,O
119734,8230,document,O
119735,8230,.,O
119736,8231,Have,O
119737,8231,a,O
119738,8231,CD4,O
119739,8231,cell,O
119740,8231,count,O
119741,8231,greater,O
119742,8231,than,O
119743,8231,50,O
119744,8231,cells,O
119745,8231,/,O
119746,8231,mm3if,O
119747,8231,not,O
119748,8231,taking,O
119749,8231,ART,B-Procedure
119750,8231,.,O
119751,8231,Persons,O
119752,8231,with,O
119753,8231,cd4,O
119754,8231,<,O
119755,8231,50,O
119756,8231,may,O
119757,8231,be,O
119758,8231,enrolled,O
119759,8231,",",O
119760,8231,if,O
119761,8231,it,O
119762,8231,is,O
119763,8231,felt,O
119764,8231,that,O
119765,8231,in,O
119766,8231,the,O
119767,8231,best,O
119768,8231,interest,O
119769,8231,of,O
119770,8231,the,O
119771,8231,patient,O
119772,8231,",",O
119773,8231,that,O
119774,8231,enrollment,O
119775,8231,in,O
119776,8231,the,O
119777,8231,study,O
119778,8231,will,O
119779,8231,allow,O
119780,8231,for,O
119781,8231,quicker,O
119782,8231,initiation,O
119783,8231,of,O
119784,8231,antiretroviral,O
119785,8231,therapy,O
119786,8231,than,O
119787,8231,referral,O
119788,8231,to,O
119789,8231,another,O
119790,8231,treatment,O
119791,8231,center,O
119792,8231,.,O
119793,8232,Active,O
119794,8232,bleeding,B-Condition
119795,8232,without,O
119796,8232,control,O
119797,8232,;,O
119798,8233,Receiving,O
119799,8233,nasal,B-Procedure
119800,8233,or,I-Procedure
119801,8233,facial,I-Procedure
119802,8233,surgery,I-Procedure
119803,8233,recently,O
119804,8233,;,O
119805,8234,With,O
119806,8234,severe,O
119807,8234,cardio,B-Condition
119808,8234,-,I-Condition
119809,8234,pulmonary,I-Condition
119810,8234,dysfunction,I-Condition
119811,8234,",",O
119812,8234,such,O
119813,8234,as,O
119814,8234,left,B-Condition
119815,8234,heart,I-Condition
119816,8234,failure,I-Condition
119817,8234,",",O
119818,8234,unstable,O
119819,8234,arrhythmia,B-Condition
119820,8234,",",O
119821,8234,etc,O
119822,8234,.,O
119823,8235,With,O
119824,8235,other,O
119825,8235,respiratory,B-Condition
119826,8235,diseases,I-Condition
119827,8235,:,O
119828,8235,such,O
119829,8235,as,O
119830,8235,active,O
119831,8235,pulmonary,B-Condition
119832,8235,tuberculosis,I-Condition
119833,8235,",",O
119834,8235,non,B-Condition
119835,8235,-,I-Condition
119836,8235,tuberculosis,I-Condition
119837,8235,mycobacteria,I-Condition
119838,8235,(,I-Condition
119839,8235,NTM,I-Condition
119840,8235,),I-Condition
119841,8235,pulmonary,I-Condition
119842,8235,disease,I-Condition
119843,8235,",",O
119844,8235,pulmonary,B-Condition
119845,8235,aspergillosis,I-Condition
119846,8235,",",O
119847,8235,etc,O
119848,8235,.,O
119849,8236,Be,O
119850,8236,allergic,B-Condition
119851,8236,to,O
119852,8236,amikacin,B-Drug
119853,8237,Age=18,B-Person
119854,8237,years,O
119855,8237,and,O
119856,8237,=,O
119857,8237,80,O
119858,8237,years,O
119859,8237,;,O
119860,8238,Patients,O
119861,8238,with,O
119862,8238,non,B-Condition
119863,8238,-,I-Condition
119864,8238,cystic,I-Condition
119865,8238,fibrosis,I-Condition
119866,8238,bronchiectasis,I-Condition
119867,8238,diagnosed,O
119868,8238,by,O
119869,8238,high,B-Procedure
119870,8238,-,I-Procedure
119871,8238,resolution,I-Procedure
119872,8238,CT,I-Procedure
119873,8238,;,O
119874,8239,Are,O
119875,8239,sensitive,B-Condition
119876,8239,to,O
119877,8239,amikacin,B-Drug
119878,8239,;,O
119879,8240,Acute,B-Condition
119880,8240,exacerbation,I-Condition
119881,8240,of,I-Condition
119882,8240,bronchiectasis,I-Condition
119883,8240,;,O
119884,8241,Capable,O
119885,8241,of,O
119886,8241,the,O
119887,8241,completion,O
119888,8241,of,O
119889,8241,bronchoscopy,O
119890,8241,",",O
119891,8241,alveolar,O
119892,8241,lavage,O
119893,8241,",",O
119894,8241,pulmonary,O
119895,8241,function,O
119896,8241,testing,O
119897,8241,etc,O
119898,8241,;,O
119899,8242,Willing,O
119900,8242,to,O
119901,8242,join,O
119902,8242,in,O
119903,8242,and,O
119904,8242,sign,O
119905,8242,the,O
119906,8242,informed,O
119907,8242,consent,O
119908,8242,form,O
119909,8242,.,O
119910,8243,Hospitalization,B-Observation
119911,8243,for,O
119912,8243,acute,B-Condition
119913,8243,decompensated,I-Condition
119914,8243,HF,I-Condition
119915,8243,within,O
119916,8243,previous,O
119917,8243,30,O
119918,8243,days,O
119919,8244,Hospitalization,B-Observation
119920,8244,for,O
119921,8244,myocardial,B-Condition
119922,8244,infarction,I-Condition
119923,8244,or,O
119924,8244,cardiac,B-Procedure
119925,8244,surgery,I-Procedure
119926,8244,within,O
119927,8244,previous,O
119928,8244,90,O
119929,8244,days,O
119930,8245,Presence,O
119931,8245,of,O
119932,8245,a,O
119933,8245,left,O
119934,8245,ventricular,O
119935,8245,assist,O
119936,8245,device,O
119937,8246,History,O
119938,8246,of,O
119939,8246,heart,B-Procedure
119940,8246,transplantation,I-Procedure
119941,8247,Poorly,O
119942,8247,controlled,O
119943,8247,hypertension,B-Condition
119944,8247,(,O
119945,8247,>,O
119946,8247,170/>110,O
119947,8247,),O
119948,8248,Poorly,O
119949,8248,controlled,O
119950,8248,diabetes,B-Condition
119951,8248,(,O
119952,8248,HbA1c,O
119953,8248,>,O
119954,8248,9.0,O
119955,8248,),O
119956,8249,Severe,O
119957,8249,renal,B-Condition
119958,8249,failure,I-Condition
119959,8249,with,O
119960,8249,estimated,O
119961,8249,glomerular,O
119962,8249,filtration,O
119963,8249,rate,O
119964,8249,<,O
119965,8249,30,O
119966,8249,ml,O
119967,8249,/,O
119968,8249,min,O
119969,8250,Prior,O
119970,8250,stroke,B-Condition
119971,8250,with,O
119972,8250,functional,B-Condition
119973,8250,impairment,I-Condition
119974,8250,or,O
119975,8250,other,O
119976,8250,severe,O
119977,8250,",",O
119978,8250,uncontrolled,O
119979,8250,medical,O
119980,8250,problems,O
119981,8250,that,O
119982,8250,may,O
119983,8250,impair,O
119984,8250,ability,O
119985,8250,to,O
119986,8250,participate,O
119987,8250,in,O
119988,8250,the,O
119989,8250,study,O
119990,8250,exams,O
119991,8250,",",O
119992,8250,based,O
119993,8250,on,O
119994,8250,medical,O
119995,8250,history,O
119996,8250,and,O
119997,8250,review,O
119998,8250,of,O
119999,8250,medical,O
120000,8250,records,O
120001,8251,Severe,O
120002,8251,chronic,B-Condition
120003,8251,insomnia,I-Condition
120004,8251,",",O
120005,8251,with,O
120006,8251,reported,O
120007,8251,usual,O
120008,8251,sleep,B-Observation
120009,8251,duration,I-Observation
120010,8251,<,O
120011,8251,4,O
120012,8251,hours,O
120013,8252,Severe,O
120014,8252,daytime,B-Condition
120015,8252,sleepiness,I-Condition
120016,8252,",",O
120017,8252,defined,O
120018,8252,as,O
120019,8252,Epworth,O
120020,8252,Sleepiness,O
120021,8252,Scale,O
120022,8252,score,O
120023,8252,18,O
120024,8252,or,O
120025,8252,higher,O
120026,8252,or,O
120027,8252,a,O
120028,8252,report,O
120029,8252,of,O
120030,8252,falling,O
120031,8252,asleep,O
120032,8252,driving,O
120033,8252,during,O
120034,8252,the,O
120035,8252,previous,O
120036,8252,year,O
120037,8252,",",O
120038,8252,and,O
120039,8252,deemed,O
120040,8252,a,O
120041,8252,safety,O
120042,8252,risk,O
120043,8252,by,O
120044,8252,study,O
120045,8252,physician,O
120046,8253,Awake,O
120047,8253,resting,O
120048,8253,oxyhemoglobin,O
120049,8253,saturation,O
120050,8253,<,O
120051,8253,89,O
120052,8253,%,O
120053,8254,Pregnancy,B-Condition
120054,8255,Smoking,O
120055,8255,by,O
120056,8255,subject,O
120057,8255,or,O
120058,8255,other,O
120059,8255,person,O
120060,8255,in,O
120061,8255,the,O
120062,8255,subject,O
120063,8255,'s,O
120064,8255,bedroom,O
120065,8255,",",O
120066,8255,or,O
120067,8255,other,O
120068,8255,open,O
120069,8255,flame,O
120070,8255,in,O
120071,8255,bedroom,O
120072,8256,Current,O
120073,8256,use,O
120074,8256,of,O
120075,8256,a,O
120076,8256,positive,O
120077,8256,airway,O
120078,8256,pressure,O
120079,8256,device,O
120080,8256,(,O
120081,8256,including,O
120082,8256,continuous,O
120083,8256,or,O
120084,8256,bi,O
120085,8256,-,O
120086,8256,level,O
120087,8256,positive,O
120088,8256,airway,O
120089,8256,pressure,O
120090,8256,or,O
120091,8256,adaptive,O
120092,8256,servo,O
120093,8256,-,O
120094,8256,ventilation,O
120095,8256,),O
120096,8256,or,O
120097,8256,supplemental,B-Procedure
120098,8256,oxygen,I-Procedure
120099,8256,therapy,I-Procedure
120100,8257,Veteran,B-Person
120101,8257,receiving,O
120102,8257,care,O
120103,8257,within,O
120104,8257,the,O
120105,8257,Veterans,O
120106,8257,Health,O
120107,8257,Administration,O
120108,8257,healthcare,O
120109,8257,system,O
120110,8258,Age,B-Person
120111,8258,18,O
120112,8258,years,O
120113,8259,Physician,O
120114,8259,diagnosis,O
120115,8259,of,O
120116,8259,chronic,B-Condition
120117,8259,heart,I-Condition
120118,8259,failure,I-Condition
120119,8259,",",O
120120,8259,American,O
120121,8259,Heart,O
120122,8259,Association,O
120123,8259,Stage,O
120124,8259,C,O
120125,8259,-,O
120126,8259,D,O
120127,8260,LVEF,O
120128,8260,<,O
120129,8260,45,O
120130,8260,%,O
120131,8261,No,O
120132,8261,change,O
120133,8261,in,O
120134,8261,active,O
120135,8261,cardiac,B-Drug
120136,8261,medications,I-Drug
120137,8261,for,O
120138,8261,4,O
120139,8261,weeks,O
120140,8261,prior,O
120141,8261,to,O
120142,8261,randomization,O
120143,8262,Ability,O
120144,8262,to,O
120145,8262,provide,O
120146,8262,informed,O
120147,8262,consent,O
120148,8263,Moderate,O
120149,8263,to,O
120150,8263,severe,O
120151,8263,central,B-Condition
120152,8263,or,I-Condition
120153,8263,mixed,I-Condition
120154,8263,central,I-Condition
120155,8263,and,I-Condition
120156,8263,obstructive,I-Condition
120157,8263,sleep,I-Condition
120158,8263,apnea,I-Condition
120159,8263,",",O
120160,8263,defined,O
120161,8263,as,O
120162,8263,an,O
120163,8263,apnea,O
120164,8263,-,O
120165,8263,hypopnea,O
120166,8263,index,O
120167,8263,(,O
120168,8263,AHI,O
120169,8263,),O
120170,8263,15,O
120171,8263,events,O
120172,8263,per,O
120173,8263,hour,O
120174,8263,",",O
120175,8263,with,O
120176,8263,a,O
120177,8263,central,O
120178,8263,AHI,O
120179,8263,>,O
120180,8263,5,O
120181,8263,events,O
120182,8263,/,O
120183,8263,hour,O
120184,8264,Renal,B-Condition
120185,8264,impairment,I-Condition
120186,8265,Evidence,O
120187,8265,or,O
120188,8265,history,O
120189,8265,of,O
120190,8265,clinically,O
120191,8265,significant,O
120192,8265,allergic,B-Condition
120193,8265,reactions,O
120194,8265,to,O
120195,8265,varenicline,B-Drug
120196,8266,A,O
120197,8266,cardiovascular,B-Condition
120198,8266,event,I-Condition
120199,8266,in,O
120200,8266,the,O
120201,8266,past,O
120202,8266,month,O
120203,8267,History,O
120204,8267,of,O
120205,8267,alcohol,B-Condition
120206,8267,or,I-Condition
120207,8267,drug,I-Condition
120208,8267,dependence,I-Condition
120209,8267,in,O
120210,8267,the,O
120211,8267,past,O
120212,8267,year,O
120213,8268,Major,B-Condition
120214,8268,depressive,I-Condition
120215,8268,disorder,I-Condition
120216,8268,in,O
120217,8268,the,O
120218,8268,last,O
120219,8268,year,O
120220,8268,requiring,O
120221,8268,treatment,B-Procedure
120222,8269,History,O
120223,8269,of,O
120224,8269,panic,B-Condition
120225,8269,disorder,I-Condition
120226,8269,",",O
120227,8269,psychosis,B-Condition
120228,8269,",",O
120229,8269,bipolar,B-Condition
120230,8269,disorder,I-Condition
120231,8269,",",O
120232,8269,or,O
120233,8269,eating,B-Condition
120234,8269,disorders,I-Condition
120235,8270,Use,B-Observation
120236,8270,of,I-Observation
120237,8270,tobacco,I-Observation
120238,8270,products,O
120239,8270,other,O
120240,8270,than,O
120241,8270,cigarettes,B-Observation
120242,8270,in,O
120243,8270,past,O
120244,8270,30,O
120245,8270,days,O
120246,8271,Use,O
120247,8271,of,O
120248,8271,pharmacotherapy,B-Procedure
120249,8271,in,O
120250,8271,the,O
120251,8271,month,O
120252,8271,prior,O
120253,8271,to,O
120254,8271,enrollment,O
120255,8271,",",O
120256,8271,including,O
120257,8271,prior,O
120258,8271,use,O
120259,8271,of,O
120260,8271,varenicline,O
120261,8272,Pregnant,O
120262,8272,",",O
120263,8272,contemplating,O
120264,8272,getting,O
120265,8272,pregnant,O
120266,8272,",",O
120267,8272,or,O
120268,8272,breastfeeding,O
120269,8273,Plans,O
120270,8273,to,O
120271,8273,move,O
120272,8273,from,O
120273,8273,Kansas,O
120274,8273,City,O
120275,8273,during,O
120276,8273,the,O
120277,8273,treatment,O
120278,8273,and,O
120279,8273,follow,O
120280,8273,-,O
120281,8273,up,O
120282,8273,phase,O
120283,8274,Another,O
120284,8274,household,O
120285,8274,member,O
120286,8274,enrolled,O
120287,8274,in,O
120288,8274,the,O
120289,8274,study,O
120290,8275,Evidence,O
120291,8275,of,O
120292,8275,current,O
120293,8275,severe,O
120294,8275,major,B-Condition
120295,8275,depressive,I-Condition
120296,8275,disorder,I-Condition
120297,8275,or,O
120298,8275,suicidal,B-Condition
120299,8275,ideation,I-Condition
120300,8276,Self,O
120301,8276,-,O
120302,8276,identified,O
120303,8276,African,B-Person
120304,8276,American,I-Person
120305,8277,Smokes,B-Observation
120306,8277,=,O
120307,8277,1,O
120308,8277,cigarette,O
120309,8277,per,O
120310,8277,day,O
120311,8277,(,O
120312,8277,cpd,O
120313,8277,),O
120314,8278,Smoke,B-Observation
120315,8278,on,O
120316,8278,=,O
120317,8278,25,O
120318,8278,days,O
120319,8278,of,O
120320,8278,the,O
120321,8278,past,O
120322,8278,30,O
120323,8278,days,O
120324,8279,Functioning,O
120325,8279,telephone,O
120326,8280,Interested,B-Mood
120327,8280,in,O
120328,8280,quitting,B-Observation
120329,8280,smoking,I-Observation
120330,8281,Interested,O
120331,8281,in,O
120332,8281,taking,O
120333,8281,3,O
120334,8281,months,O
120335,8281,of,O
120336,8281,varenicline,O
120337,8282,Willing,O
120338,8282,to,O
120339,8282,complete,O
120340,8282,all,O
120341,8282,study,O
120342,8282,visits,O
120343,8283,Subjects,O
120344,8283,with,O
120345,8283,any,O
120346,8283,condition,O
120347,8283,that,O
120348,8283,as,O
120349,8283,judged,O
120350,8283,by,O
120351,8283,the,O
120352,8283,Investigator,O
120353,8283,would,O
120354,8283,place,O
120355,8283,the,O
120356,8283,subject,O
120357,8283,at,O
120358,8283,increased,O
120359,8283,risk,O
120360,8283,of,O
120361,8283,harm,O
120362,8283,if,O
120363,8283,he,O
120364,8283,/,O
120365,8283,she,O
120366,8283,participated,O
120367,8283,in,O
120368,8283,the,O
120369,8283,study,O
120370,8283,.,O
120371,8284,Pregnancy,O
120372,8284,or,O
120373,8284,lactation,O
120374,8285,Known,O
120375,8285,allergic,B-Condition
120376,8285,reaction,O
120377,8285,to,O
120378,8285,tranexamic,B-Drug
120379,8285,acid,I-Drug
120380,8286,Patients,O
120381,8286,scheduled,B-Mood
120382,8286,for,I-Mood
120383,8286,dental,B-Procedure
120384,8286,extraction,I-Procedure
120385,8286,and,O
120386,8286,treated,O
120387,8286,with,O
120388,8286,edoxaban,B-Drug
120389,8286,",",O
120390,8286,apixaban,B-Drug
120391,8286,",",O
120392,8286,rivaroxaban,B-Drug
120393,8286,or,O
120394,8286,dabigatran,B-Drug
120395,8287,Not,O
120396,8287,having,O
120397,8287,taken,O
120398,8287,the,O
120399,8287,direct,O
120400,8287,oral,O
120401,8287,anticoagulant,B-Drug
120402,8287,on,O
120403,8287,the,O
120404,8287,day,O
120405,8287,of,O
120406,8287,the,O
120407,8287,extraction,O
120408,8288,Provision,O
120409,8288,of,O
120410,8288,signed,O
120411,8288,and,O
120412,8288,dated,O
120413,8288,informed,O
120414,8288,consent,O
120415,8288,form,O
120416,8289,Stated,O
120417,8289,willingness,O
120418,8289,to,O
120419,8289,comply,O
120420,8289,with,O
120421,8289,all,O
120422,8289,study,O
120423,8289,procedures,O
120424,8289,and,O
120425,8289,availability,O
120426,8289,for,O
120427,8289,the,O
120428,8289,duration,O
120429,8289,of,O
120430,8289,the,O
120431,8289,study,O
120432,8290,Clinically,O
120433,8290,significant,O
120434,8290,systemic,B-Condition
120435,8290,disease,I-Condition
120436,8290,(,O
120437,8290,such,O
120438,8290,as,O
120439,8290,diabetes,B-Condition
120440,8290,",",O
120441,8290,metabolic,B-Condition
120442,8290,syndrome,I-Condition
120443,8290,",",O
120444,8290,immunological,B-Condition
120445,8290,diseases,I-Condition
120446,8290,",",O
120447,8290,diagnosed,B-Condition
120448,8290,thrombophilia,I-Condition
120449,8290,",",O
120450,8290,porphyria,B-Condition
120451,8290,",",O
120452,8290,or,O
120453,8290,any,O
120454,8290,other,O
120455,8290,medical,B-Condition
120456,8290,condition,I-Condition
120457,8290,requiring,O
120458,8290,the,O
120459,8290,use,O
120460,8290,of,O
120461,8290,low,B-Drug
120462,8290,-,I-Drug
120463,8290,molecular,I-Drug
120464,8290,weight,I-Drug
120465,8290,heparin,I-Drug
120466,8290,therapy,O
120467,8290,),O
120468,8291,Polycystic,B-Condition
120469,8291,ovary,I-Condition
120470,8291,syndrome,I-Condition
120471,8291,(,I-Condition
120472,8291,PCOS,I-Condition
120473,8291,),I-Condition
120474,8291,according,O
120475,8291,to,O
120476,8291,Rotterdam,O
120477,8291,Consensus,O
120478,8291,Criteria,O
120479,8291,(,O
120480,8291,European,O
120481,8291,Society,O
120482,8291,of,O
120483,8291,Human,O
120484,8291,Reproduction,O
120485,8291,and,O
120486,8291,Embryology,O
120487,8291,[,O
120488,8291,ESHRE]/American,O
120489,8291,Society,O
120490,8291,for,O
120491,8291,Reproductive,O
120492,8291,Medicine,O
120493,8291,[,O
120494,8291,ASRM,O
120495,8291,],O
120496,8291,",",O
120497,8291,2003,O
120498,8291,),O
120499,8292,Poor,B-Condition
120500,8292,ovarian,I-Condition
120501,8292,response,I-Condition
120502,8292,(,I-Condition
120503,8292,POR,I-Condition
120504,8292,),I-Condition
120505,8292,according,O
120506,8292,to,O
120507,8292,the,O
120508,8292,European,O
120509,8292,Society,O
120510,8292,of,O
120511,8292,Human,O
120512,8292,Reproduction,O
120513,8292,and,O
120514,8292,Embryology,O
120515,8292,(,O
120516,8292,ESHRE,O
120517,8292,),O
120518,8292,Criteria,O
120519,8293,RIF,B-Condition
120520,8293,(,I-Condition
120521,8293,repeated,I-Condition
120522,8293,implantation,I-Condition
120523,8293,failure,I-Condition
120524,8293,),I-Condition
120525,8293,",",O
120526,8293,defined,O
120527,8293,as,O
120528,8293,greater,O
120529,8293,than,O
120530,8293,or,O
120531,8293,equals,O
120532,8293,to,O
120533,8293,(,O
120534,8293,>,O
120535,8293,=),O
120536,8293,2,O
120537,8293,previous,O
120538,8293,failed,O
120539,8293,embryo,O
120540,8293,transfers,O
120541,8294,Endometriosis,B-Condition
120542,8294,III,O
120543,8294,-,O
120544,8294,IV,O
120545,8294,stage,O
120546,8294,or,O
120547,8294,adenomyosis,B-Condition
120548,8295,Clinically,O
120549,8295,significant,O
120550,8295,findings,B-Observation
120551,8295,on,O
120552,8295,exam,B-Procedure
120553,8295,or,O
120554,8295,ultrasound,B-Procedure
120555,8295,",",O
120556,8295,such,O
120557,8295,as,O
120558,8295,salpingitis,B-Condition
120559,8295,",",O
120560,8295,hydrosalpynx,B-Condition
120561,8295,or,O
120562,8295,evidence,B-Mood
120563,8295,of,O
120564,8295,ovarian,B-Condition
120565,8295,cysts,I-Condition
120566,8296,Known,O
120567,8296,hypersensitivity,B-Condition
120568,8296,to,O
120569,8296,any,O
120570,8296,of,O
120571,8296,the,O
120572,8296,components,B-Drug
120573,8296,of,I-Drug
120574,8296,the,I-Drug
120575,8296,solution,I-Drug
120576,8297,Known,O
120577,8297,hypersensitivity,B-Condition
120578,8297,to,O
120579,8297,vaginal,B-Drug
120580,8297,progesterone,I-Drug
120581,8297,or,O
120582,8297,its,O
120583,8297,excipients,B-Drug
120584,8298,Other,O
120585,8298,protocol,O
120586,8298,defined,O
120587,8298,exclusion,O
120588,8298,criteria,O
120589,8298,could,O
120590,8298,apply,O
120591,8299,All,O
120592,8299,infertile,B-Condition
120593,8299,women,B-Person
120594,8299,treated,O
120595,8299,with,O
120596,8299,intracytoplasmic,B-Procedure
120597,8299,sperm,I-Procedure
120598,8299,injection,I-Procedure
120599,8299,(,I-Procedure
120600,8299,ICSI)/Fertilization,I-Procedure
120601,8299,in,I-Procedure
120602,8299,Vitro,I-Procedure
120603,8299,and,I-Procedure
120604,8299,Embryo,I-Procedure
120605,8299,Transfer,I-Procedure
120606,8299,(,I-Procedure
120607,8299,FIVET,I-Procedure
120608,8299,),I-Procedure
120609,8300,Less,O
120610,8300,than,O
120611,8300,or,O
120612,8300,equal,O
120613,8300,to,O
120614,8300,(,O
120615,8300,<,O
120616,8300,=),O
120617,8300,1,O
120618,8300,previous,O
120619,8300,failed,O
120620,8300,embryo,O
120621,8300,transfer,O
120622,8301,Eumenorrheic,B-Condition
120623,8301,normo,B-Condition
120624,8301,-,I-Condition
120625,8301,gonadotropic,I-Condition
120626,8301,women,B-Person
120627,8302,Basal,O
120628,8302,follicle,O
120629,8302,-,O
120630,8302,stimulating,O
120631,8302,hormone,O
120632,8302,(,O
120633,8302,FSH,O
120634,8302,),O
120635,8302,<,O
120636,8302,=,O
120637,8302,12,O
120638,8302,International,O
120639,8302,unit,O
120640,8302,per,O
120641,8302,liter,O
120642,8302,(,O
120643,8302,IU,O
120644,8302,/,O
120645,8302,L,O
120646,8302,),O
120647,8303,Anti,O
120648,8303,-,O
120649,8303,mullerian,O
120650,8303,hormone,O
120651,8303,(,O
120652,8303,AMH,O
120653,8303,),O
120654,8303,greater,O
120655,8303,than,O
120656,8303,(,O
120657,8303,>,O
120658,8303,),O
120659,8303,1.1,O
120660,8303,nanogram,O
120661,8303,per,O
120662,8303,milliliter,O
120663,8303,(,O
120664,8303,ng,O
120665,8303,/,O
120666,8303,mL,O
120667,8303,),O
120668,8304,Ovarian,O
120669,8304,Reserve,O
120670,8304,:,O
120671,8304,number,O
120672,8304,of,O
120673,8304,antral,O
120674,8304,follicles,O
120675,8304,2,O
120676,8304,millimeter,O
120677,8304,(,O
120678,8304,mm,O
120679,8304,),O
120680,8304,between,O
120681,8304,6,O
120682,8304,<,O
120683,8304,=,O
120684,8304,antral,O
120685,8304,follicle,O
120686,8304,count,O
120687,8304,(,O
120688,8304,AFC,O
120689,8304,),O
120690,8304,<,O
120691,8304,=,O
120692,8304,16,O
120693,8305,Follicles,O
120694,8305,>,O
120695,8305,16,O
120696,8305,mm,O
120697,8305,at,O
120698,8305,the,O
120699,8305,triggering,O
120700,8305,day,O
120701,8305,between,O
120702,8305,5,O
120703,8305,-,O
120704,8305,14,O
120705,8306,Body,O
120706,8306,Mass,O
120707,8306,Index,O
120708,8306,(,O
120709,8306,BMI,O
120710,8306,),O
120711,8306,between,O
120712,8306,18,O
120713,8306,<,O
120714,8306,=,O
120715,8306,BMI,O
120716,8306,<,O
120717,8306,=,O
120718,8306,27,O
120719,8306,kilogram,O
120720,8306,per,O
120721,8306,meter,O
120722,8306,square,O
120723,8306,(,O
120724,8306,kg,O
120725,8306,/,O
120726,8306,m^2,O
120727,8306,),O
120728,8307,Indication,B-Mood
120729,8307,for,I-Mood
120730,8307,Fresh,B-Procedure
120731,8307,Embryo,I-Procedure
120732,8307,transfer,I-Procedure
120733,8308,Normal,B-Observation
120734,8308,uterine,I-Observation
120735,8308,cavity,I-Observation
120736,8308,on,O
120737,8308,ultrasound,B-Procedure
120738,8308,exam,I-Procedure
120739,8308,(,O
120740,8308,e.g.,O
120741,8308,",",O
120742,8308,no,O
120743,8308,presence,O
120744,8308,of,O
120745,8308,hydrosalpinx,B-Condition
120746,8308,),O
120747,8309,Undergoing,O
120748,8309,Assisted,B-Procedure
120749,8309,Reproductive,I-Procedure
120750,8309,Technique,I-Procedure
120751,8309,(,I-Procedure
120752,8309,ART,I-Procedure
120753,8309,),I-Procedure
120754,8309,and,O
120755,8309,oocyte,B-Procedure
120756,8309,maturation,I-Procedure
120757,8309,by,O
120758,8309,human,B-Procedure
120759,8309,chorionic,I-Procedure
120760,8309,gonadotropin,I-Procedure
120761,8309,(,I-Procedure
120762,8309,HCG,I-Procedure
120763,8309,),I-Procedure
120764,8309,triggering,I-Procedure
120765,8310,Progesterone,O
120766,8310,(,O
120767,8310,P4,O
120768,8310,),O
120769,8310,serum,O
120770,8310,level,O
120771,8310,at,O
120772,8310,the,O
120773,8310,HCG,O
120774,8310,triggering,O
120775,8310,day,O
120776,8310,<,O
120777,8310,=,O
120778,8310,1.5,O
120779,8310,ng,O
120780,8310,/,O
120781,8310,mL,O
120782,8310,(,O
120783,8310,Day,O
120784,8310,O,O
120785,8310,/,O
120786,8310,Randomization,O
120787,8310,),O
120788,8311,Estradiol,O
120789,8311,(,O
120790,8311,E2,O
120791,8311,),O
120792,8311,<,O
120793,8311,=,O
120794,8311,3000,O
120795,8311,picogram,O
120796,8311,/,O
120797,8311,milliliter,O
120798,8311,(,O
120799,8311,pg,O
120800,8311,/,O
120801,8311,mL,O
120802,8311,),O
120803,8311,at,O
120804,8311,the,O
120805,8311,human,O
120806,8311,chorionic,O
120807,8311,gonadotropin,O
120808,8311,(,O
120809,8311,HCG,O
120810,8311,),O
120811,8311,triggering,O
120812,8311,day,O
120813,8311,(,O
120814,8311,Day,O
120815,8311,0,O
120816,8311,/,O
120817,8311,Randomization,O
120818,8311,),O
120819,8312,Subjects,O
120820,8312,must,O
120821,8312,have,O
120822,8312,read,O
120823,8312,and,O
120824,8312,signed,O
120825,8312,the,O
120826,8312,Informed,O
120827,8312,Consent,O
120828,8312,Form,O
120829,8312,prior,O
120830,8312,to,O
120831,8312,study,O
120832,8312,-,O
120833,8312,specific,O
120834,8312,-,O
120835,8312,procedures,O
120836,8312,not,O
120837,8312,part,O
120838,8312,of,O
120839,8312,standard,O
120840,8312,of,O
120841,8312,care,O
120842,8313,Other,O
120843,8313,protocol,O
120844,8313,defined,O
120845,8313,inclusion,O
120846,8313,criteria,O
120847,8313,could,O
120848,8313,apply,O
120849,8314,previous,O
120850,8314,use,O
120851,8314,of,O
120852,8314,insulin,O
120853,8314,pump,O
120854,8315,pregnancy,B-Condition
120855,8315,or,O
120856,8315,planning,B-Mood
120857,8315,to,I-Mood
120858,8315,become,I-Mood
120859,8315,pregnant,B-Condition
120860,8315,in,O
120861,8315,the,O
120862,8315,next,O
120863,8315,2,O
120864,8315,years,O
120865,8315,",",O
120866,8316,lack,O
120867,8316,of,O
120868,8316,ability,B-Observation
120869,8316,to,I-Observation
120870,8316,use,I-Observation
120871,8316,the,I-Observation
120872,8316,study,I-Observation
120873,8316,devices,I-Observation
120874,8317,history,B-Observation
120875,8317,of,O
120876,8317,severe,O
120877,8317,chronic,B-Condition
120878,8317,diseases,I-Condition
120879,8318,recent,O
120880,8318,or,O
120881,8318,concomitant,O
120882,8318,use,O
120883,8318,of,O
120884,8318,corticosteroids,B-Drug
120885,8319,drug,B-Drug
120886,8319,or,I-Drug
120887,8319,alcohol,I-Drug
120888,8319,abuse,I-Drug
120889,8320,psychiatric,B-Condition
120890,8320,complaints,I-Condition
120891,8320,that,O
120892,8320,interfere,B-Mood
120893,8320,with,I-Mood
120894,8320,the,O
120895,8320,correct,B-Observation
120896,8320,use,I-Observation
120897,8320,of,I-Observation
120898,8320,the,I-Observation
120899,8320,devices,I-Observation
120900,8321,T1DM,B-Condition
120901,8321,for,O
120902,8321,at,O
120903,8321,least,O
120904,8321,12,O
120905,8321,months,O
120906,8322,persistent,O
120907,8322,HbA1c,O
120908,8322,levels,O
120909,8322,=,O
120910,8322,7.5,O
120911,8322,%,O
120912,8322,(,O
120913,8322,58,O
120914,8322,mmol,O
120915,8322,/,O
120916,8322,mol,O
120917,8322,),O
120918,8322,despite,O
120919,8322,optimized,B-Procedure
120920,8322,education,I-Procedure
120921,8322,therapy,I-Procedure
120922,8322,",",O
120923,8323,recurrent,O
120924,8323,severe,O
120925,8323,hypoglycemic,B-Condition
120926,8323,episodes,I-Condition
120927,8323,or,O
120928,8323,high,B-Condition
120929,8323,glucose,I-Condition
120930,8323,variability,I-Condition
120931,8324,willingness,B-Mood
120932,8324,to,O
120933,8324,wear,B-Procedure
120934,8324,the,I-Procedure
120935,8324,insulin,I-Procedure
120936,8324,pump,I-Procedure
120937,8325,patient,O
120938,8325,'s,O
120939,8325,refusal,O
120940,8326,contraindications,B-Condition
120941,8326,to,O
120942,8326,dexmedetomidine,B-Drug
120943,8327,diseases,B-Condition
120944,8327,/,O
120945,8327,drugs,B-Drug
120946,8327,that,O
120947,8327,influence,O
120948,8327,on,O
120949,8327,autonomic,O
120950,8327,nervous,O
120951,8327,system,O
120952,8327,activity,O
120953,8328,patients,O
120954,8328,classified,O
120955,8328,with,O
120956,8328,American,O
120957,8328,Society,O
120958,8328,of,O
120959,8328,Anesthesiologists,O
120960,8328,Physical,O
120961,8328,Status,O
120962,8328,Classification,O
120963,8328,System,O
120964,8328,as,O
120965,8328,1,O
120966,8328,or,O
120967,8328,2,O
120968,8328,status,O
120969,8329,planned,B-Mood
120970,8329,eye,B-Procedure
120971,8329,surgery,I-Procedure
120972,8329,under,O
120973,8329,sedation,B-Procedure
120974,8330,Pre,O
120975,8330,-,O
120976,8330,existing,O
120977,8330,hemoptysis,B-Condition
120978,8330,of,O
120979,8330,a,O
120980,8330,severity,O
120981,8330,>,O
120982,8330,grade,O
120983,8330,3,O
120984,8330,by,O
120985,8330,NCI,O
120986,8330,CTCAE,O
120987,8330,criteria,O
120988,8330,within,O
120989,8330,4,O
120990,8330,weeks,O
120991,8330,prior,O
120992,8330,to,O
120993,8330,study,O
120994,8330,entry,O
120995,8331,Uncontrolled,O
120996,8331,hypertension,B-Condition
120997,8332,CHF,B-Condition
120998,8332,",",O
120999,8332,angina,B-Condition
121000,8332,or,O
121001,8332,arrhythmias,B-Condition
121002,8333,LVEF,O
121003,8333,<,O
121004,8333,1,O
121005,8333,UNL,O
121006,8334,Existing,O
121007,8334,a,O
121008,8334,second,B-Condition
121009,8334,malignancy,I-Condition
121010,8334,within,O
121011,8334,5,O
121012,8334,years,O
121013,8335,Infected,O
121014,8335,with,O
121015,8335,HIV,B-Condition
121016,8336,Histologic,B-Procedure
121017,8336,or,O
121018,8336,cytologic,B-Procedure
121019,8336,diagnosis,O
121020,8336,of,O
121021,8336,stage,O
121022,8336,IIIB,O
121023,8336,/,O
121024,8336,IV,O
121025,8336,NSCLC,B-Condition
121026,8337,ECOG,O
121027,8337,PS,O
121028,8337,:,O
121029,8337,"0,1",O
121030,8338,Unidimensional,O
121031,8338,or,O
121032,8338,bi,O
121033,8338,-,O
121034,8338,dimensional,O
121035,8338,measurable,O
121036,8338,disease,O
121037,8339,Receive,O
121038,8339,prior,O
121039,8339,treatment,B-Procedure
121040,8339,including,O
121041,8339,first,O
121042,8339,-,O
121043,8339,line,O
121044,8339,platinum,B-Procedure
121045,8339,-,I-Procedure
121046,8339,based,I-Procedure
121047,8339,chemotherapy,I-Procedure
121048,8339,",",O
121049,8339,standard,O
121050,8339,second,B-Procedure
121051,8339,-,I-Procedure
121052,8339,line,I-Procedure
121053,8339,chemotherapy,I-Procedure
121054,8339,and,O
121055,8339,1,B-Drug
121056,8339,EGF,I-Drug
121057,8339,/,I-Drug
121058,8339,EGFR,I-Drug
121059,8339,inhibitor,I-Drug
121060,8340,Evidence,B-Observation
121061,8340,of,O
121062,8340,disease,B-Condition
121063,8340,progression,I-Condition
121064,8341,Life,B-Observation
121065,8341,expectancy,I-Observation
121066,8341,>,O
121067,8341,12,O
121068,8341,weeks,O
121069,8342,Neutrophils,O
121070,8342,>,O
121071,8342,1.5,O
121072,8342,109,O
121073,8342,/,O
121074,8342,l,O
121075,8342,",",O
121076,8342,Platelets,O
121077,8342,>,O
121078,8342,100,O
121079,8342,109,O
121080,8342,/,O
121081,8342,l,O
121082,8342,",",O
121083,8342,Hemoglobin,O
121084,8342,>,O
121085,8342,9g,O
121086,8342,/,O
121087,8342,dl,O
121088,8342,",",O
121089,8342,Total,O
121090,8342,bilirubin,O
121091,8342,<,O
121092,8342,1.5,O
121093,8342,UNL,O
121094,8342,",",O
121095,8342,AST,O
121096,8342,(,O
121097,8342,SGOT,O
121098,8342,),O
121099,8342,and,O
121100,8342,ALT,O
121101,8342,(,O
121102,8342,SGPT,O
121103,8342,),O
121104,8342,<,O
121105,8342,2.5,O
121106,8342,UNL,O
121107,8342,",",O
121108,8342,Alkaline,O
121109,8342,phosphatases,O
121110,8342,<,O
121111,8342,5,O
121112,8342,UNL,O
121113,8342,",",O
121114,8342,Creatinine,O
121115,8342,<,O
121116,8342,1,O
121117,8342,UNL,O
121118,8343,neurological,B-Condition
121119,8343,diseases,I-Condition
121120,8344,previous,O
121121,8344,pelvic,B-Procedure
121122,8344,surgeries,I-Procedure
121123,8345,diabetes,B-Condition
121124,8346,cognitive,B-Condition
121125,8346,difficulties,I-Condition
121126,8347,vaginal,O
121127,8347,and,O
121128,8347,urinary,B-Condition
121129,8347,infection,I-Condition
121130,8348,presence,O
121131,8348,of,O
121132,8348,stress,B-Condition
121133,8348,urinary,I-Condition
121134,8348,or,I-Condition
121135,8348,urgency,I-Condition
121136,8348,incontinence,I-Condition
121137,8349,Previous,O
121138,8349,treated,B-Procedure
121139,8349,with,O
121140,8349,anti,B-Drug
121141,8349,-,I-Drug
121142,8349,diabetic,I-Drug
121143,8349,medication,I-Drug
121144,8350,Pregnant,B-Condition
121145,8350,or,O
121146,8350,nursing,B-Condition
121147,8350,women,B-Person
121148,8350,.,O
121149,8351,Impaired,B-Condition
121150,8351,liver,I-Condition
121151,8351,function,I-Condition
121152,8351,(,O
121153,8351,ALT,O
121154,8351,>,O
121155,8351,120,O
121156,8351,U,O
121157,8351,/,O
121158,8351,L,O
121159,8351,),O
121160,8352,Impaired,B-Condition
121161,8352,renal,I-Condition
121162,8352,function,I-Condition
121163,8352,(,O
121164,8352,Serum,O
121165,8352,creatinine,O
121166,8352,>,O
121167,8352,1.5,O
121168,8352,mg,O
121169,8352,/,O
121170,8352,dL,O
121171,8352,in,O
121172,8352,male,B-Person
121173,8352,",",O
121174,8352,>,O
121175,8352,1.4,O
121176,8352,mg,O
121177,8352,/,O
121178,8352,dL,O
121179,8352,in,O
121180,8352,female,B-Person
121181,8352,),O
121182,8353,Recently,O
121183,8353,suffered,O
121184,8353,from,O
121185,8353,MI,B-Condition
121186,8353,or,O
121187,8353,CVA,B-Condition
121188,8353,.,O
121189,8354,Patients,O
121190,8354,are,O
121191,8354,acute,B-Condition
121192,8354,intercurrent,I-Condition
121193,8354,illness,I-Condition
121194,8354,.,O
121195,8355,2,O
121196,8355,-,O
121197,8355,hour,O
121198,8355,C,O
121199,8355,-,O
121200,8355,peptide,O
121201,8355,level,O
121202,8355,<,O
121203,8355,1.8,O
121204,8355,ng,O
121205,8355,/,O
121206,8355,mL.,O
121207,8356,Recently,O
121208,8356,diagnosed,O
121209,8356,type,B-Condition
121210,8356,2,I-Condition
121211,8356,diabetic,I-Condition
121212,8356,patients,O
121213,8356,.,O
121214,8357,Fasting,O
121215,8357,plasma,O
121216,8357,glucose,O
121217,8357,between,O
121218,8357,200,O
121219,8357,-,O
121220,8357,300,O
121221,8357,mg,O
121222,8357,/,O
121223,8357,dl,O
121224,8357,(,O
121225,8357,A1C,O
121226,8357,level,O
121227,8357,between,O
121228,8357,7,O
121229,8357,%,O
121230,8357,and,O
121231,8357,10,O
121232,8357,%,O
121233,8357,),O
121234,8357,.,O
121235,8358,Those,O
121236,8358,who,O
121237,8358,age,B-Person
121238,8358,between,O
121239,8358,30,O
121240,8358,and,O
121241,8358,80,O
121242,8358,years,O
121243,8358,old,O
121244,8358,and,O
121245,8358,can,B-Observation
121246,8358,inject,B-Procedure
121247,8358,insulin,I-Procedure
121248,8358,by,O
121249,8358,themselves,O
121250,8358,.,O
121251,8359,Patients,O
121252,8359,that,O
121253,8359,do,O
121254,8359,not,O
121255,8359,have,B-Observation
121256,8359,a,I-Observation
121257,8359,valid,I-Observation
121258,8359,Ontario,I-Observation
121259,8359,Health,I-Observation
121260,8359,Insurance,I-Observation
121261,8359,Plan,I-Observation
121262,8359,(,I-Observation
121263,8359,OHIP,I-Observation
121264,8359,),I-Observation
121265,8359,number,I-Observation
121266,8359,at,O
121267,8359,time,O
121268,8359,of,O
121269,8359,first,O
121270,8359,transfusion,B-Procedure
121271,8360,Patients,O
121272,8360,that,O
121273,8360,require,B-Mood
121274,8360,emergent,O
121275,8360,release,O
121276,8360,of,O
121277,8360,a,O
121278,8360,RBC,B-Procedure
121279,8360,transfusion,I-Procedure
121280,8360,and,O
121281,8360,in,O
121282,8360,whom,O
121283,8360,emergency,B-Procedure
121284,8360,randomization,I-Procedure
121285,8360,could,O
121286,8360,not,O
121287,8360,be,O
121288,8360,completed,O
121289,8361,Patients,O
121290,8361,with,O
121291,8361,complex,B-Condition
121292,8361,antibody,I-Condition
121293,8361,profile,I-Condition
121294,8361,in,O
121295,8361,which,O
121296,8361,it,O
121297,8361,is,O
121298,8361,impossible,B-Observation
121299,8361,to,I-Observation
121300,8361,match,I-Observation
121301,8361,RBC,I-Observation
121302,8361,units,I-Observation
121303,8362,All,O
121304,8362,patients,O
121305,8362,(,O
121306,8362,excluding,O
121307,8362,neonates,B-Person
121308,8362,),O
121309,8362,requiring,B-Mood
121310,8362,one,O
121311,8362,or,O
121312,8362,more,O
121313,8362,allogeneic,O
121314,8362,RBC,B-Procedure
121315,8362,transfusions,I-Procedure
121316,8362,for,O
121317,8362,the,O
121318,8362,treatment,B-Procedure
121319,8362,of,O
121320,8362,anemia,B-Condition
121321,8362,will,O
121322,8362,be,O
121323,8362,included,O
121324,8362,.,O
121325,8363,coagulopathy,B-Condition
121326,8364,allergy,B-Condition
121327,8364,to,O
121328,8364,to,O
121329,8364,local,B-Drug
121330,8364,anesthetics,I-Drug
121331,8365,depression,B-Condition
121332,8365,",",O
121333,8365,antidepressant,B-Drug
121334,8365,drugs,I-Drug
121335,8365,treatment,O
121336,8366,epilepsy,B-Condition
121337,8367,usage,O
121338,8367,of,O
121339,8367,painkiller,B-Drug
121340,8367,before,O
121341,8367,surgery,O
121342,8368,addiction,B-Condition
121343,8368,to,I-Condition
121344,8368,alcohol,I-Condition
121345,8368,or,I-Condition
121346,8368,recreational,I-Condition
121347,8368,drugs,I-Condition
121348,8369,obtained,O
121349,8369,consent,O
121350,8370,singleton,O
121351,8370,pregnancy,B-Condition
121352,8371,subarachnoid,B-Procedure
121353,8371,anaesthesia,I-Procedure
121354,8372,Malignancy,B-Condition
121355,8372,and,O
121356,8372,other,O
121357,8372,significant,O
121358,8372,medical,B-Condition
121359,8372,conditions,I-Condition
121360,8372,that,O
121361,8372,will,O
121362,8372,impact,O
121363,8372,follow,O
121364,8372,up,O
121365,8372,within,O
121366,8372,this,O
121367,8372,program,O
121368,8372,.,O
121369,8373,Those,O
121370,8373,less,O
121371,8373,than,O
121372,8373,18,O
121373,8373,years,O
121374,8373,of,O
121375,8373,age,B-Person
121376,8373,.,O
121377,8374,Concomitant,O
121378,8374,interstitial,B-Condition
121379,8374,lung,I-Condition
121380,8374,disease,I-Condition
121381,8374,",",O
121382,8374,sarcoidosis,B-Condition
121383,8374,",",O
121384,8374,other,O
121385,8374,significant,O
121386,8374,lung,B-Condition
121387,8374,disease,I-Condition
121388,8374,.,O
121389,8375,Those,O
121390,8375,who,O
121391,8375,have,O
121392,8375,had,O
121393,8375,a,O
121394,8375,transplant,B-Procedure
121395,8375,.,O
121396,8376,Significant,O
121397,8376,travel,O
121398,8376,with,O
121399,8376,work,O
121400,8376,.,O
121401,8377,Unable,O
121402,8377,to,O
121403,8377,make,O
121404,8377,appointments,O
121405,8377,(,O
121406,8377,every,O
121407,8377,three,O
121408,8377,to,O
121409,8377,six,O
121410,8377,months,O
121411,8377,over,O
121412,8377,2,O
121413,8377,years,O
121414,8377,),O
121415,8377,.,O
121416,8378,Those,O
121417,8378,residing,O
121418,8378,in,O
121419,8378,another,O
121420,8378,country,O
121421,8378,or,O
121422,8378,planned,O
121423,8378,absence,O
121424,8378,for,O
121425,8378,more,O
121426,8378,than,O
121427,8378,one,O
121428,8378,month,O
121429,8378,.,O
121430,8379,Adults,B-Person
121431,8379,(,O
121432,8379,18,B-Person
121433,8379,and,I-Person
121434,8379,older,I-Person
121435,8379,),O
121436,8379,with,O
121437,8379,physiologically,O
121438,8379,confirmed,O
121439,8379,SA,B-Condition
121440,8379,or,O
121441,8379,mild,O
121442,8379,-,O
121443,8379,moderate,O
121444,8379,asthma,B-Condition
121445,8379,and,O
121446,8379,followed,B-Observation
121447,8379,by,I-Observation
121448,8379,an,I-Observation
121449,8379,asthma,I-Observation
121450,8379,specialist,I-Observation
121451,8379,for,O
121452,8379,at,O
121453,8379,least,O
121454,8379,6,O
121455,8379,months,O
121456,8379,.,O
121457,8380,Must,O
121458,8380,agree,O
121459,8380,to,O
121460,8380,have,O
121461,8380,regular,O
121462,8380,clinic,O
121463,8380,visits,O
121464,8380,(,O
121465,8380,minimum,O
121466,8380,3,O
121467,8380,-,O
121468,8380,4,O
121469,8380,per,O
121470,8380,year,O
121471,8380,for,O
121472,8380,SA,O
121473,8380,",",O
121474,8380,1,O
121475,8380,-,O
121476,8380,2,O
121477,8380,for,O
121478,8380,mild,O
121479,8380,-,O
121480,8380,moderate,O
121481,8380,asthma,O
121482,8380,),O
121483,8380,.,O
121484,8381,Must,O
121485,8381,have,O
121486,8381,good,B-Condition
121487,8381,compliance,I-Condition
121488,8381,with,O
121489,8381,medications,B-Drug
121490,8381,Patients,O
121491,8381,with,O
121492,8381,asthma,B-Condition
121493,8381,and,O
121494,8381,COPD,B-Condition
121495,8381,.,O
121496,8382,Patients,O
121497,8382,having,O
121498,8382,had,O
121499,8382,an,O
121500,8382,ophthalmic,B-Procedure
121501,8382,surgical,I-Procedure
121502,8382,procedure,I-Procedure
121503,8382,within,O
121504,8382,6,O
121505,8382,months,O
121506,8382,of,O
121507,8382,the,O
121508,8382,beginning,O
121509,8382,of,O
121510,8382,the,O
121511,8382,study,O
121512,8382,.,O
121513,8383,Patients,O
121514,8383,with,O
121515,8383,a,O
121516,8383,diagnosis,O
121517,8383,of,O
121518,8383,glaucoma,B-Condition
121519,8384,Any,O
121520,8384,abnormality,B-Condition
121521,8384,of,O
121522,8384,the,O
121523,8384,cornea,O
121524,8384,which,O
121525,8384,may,O
121526,8384,prevent,O
121527,8384,reliable,O
121528,8384,applanation,O
121529,8384,tonometry,O
121530,8385,Known,O
121531,8385,allergy/,B-Condition
121532,8385,hypersensitivity,B-Condition
121533,8385,reaction,O
121534,8385,to,O
121535,8385,Brimonidine,B-Drug
121536,8386,Contra,B-Condition
121537,8386,-,I-Condition
121538,8386,indication,I-Condition
121539,8386,to,O
121540,8386,Brimonidine,B-Drug
121541,8386,including,O
121542,8386,patients,O
121543,8386,on,O
121544,8386,monoamine,B-Drug
121545,8386,oxidase,I-Drug
121546,8386,inhibitors,I-Drug
121547,8386,(,O
121548,8386,MOA,B-Drug
121549,8386,),O
121550,8387,Patients,O
121551,8387,unwilling,O
121552,8387,or,O
121553,8387,unable,O
121554,8387,to,O
121555,8387,provide,O
121556,8387,informed,O
121557,8387,consent,O
121558,8388,Patients,O
121559,8388,with,O
121560,8388,anticipated,O
121561,8388,difficult,B-Observation
121562,8388,airway,I-Observation
121563,8388,management,I-Observation
121564,8388,(,O
121565,8388,as,O
121566,8388,this,O
121567,8388,may,O
121568,8388,require,O
121569,8388,medications,O
121570,8388,and/or,O
121571,8388,airway,O
121572,8388,manipulations,O
121573,8388,resulting,O
121574,8388,in,O
121575,8388,increased,O
121576,8388,IOP,O
121577,8388,),O
121578,8389,Males,B-Person
121579,8389,aged,B-Person
121580,8389,18,O
121581,8389,years,O
121582,8389,and,O
121583,8389,above,O
121584,8390,Patients,O
121585,8390,with,O
121586,8390,a,O
121587,8390,diagnosis,O
121588,8390,of,O
121589,8390,prostatic,B-Condition
121590,8390,carcinoma,I-Condition
121591,8390,requiring,O
121592,8390,prostate,B-Procedure
121593,8390,surgery,I-Procedure
121594,8391,Vaccination,B-Procedure
121595,8391,against,O
121596,8391,pneumococcal,B-Condition
121597,8391,infection,I-Condition
121598,8391,in,O
121599,8391,anamnesis,O
121600,8391,;,O
121601,8392,Application,O
121602,8392,of,O
121603,8392,preparations,B-Drug
121604,8392,of,I-Drug
121605,8392,immune,I-Drug
121606,8392,globulin,I-Drug
121607,8392,or,O
121608,8392,blood,B-Procedure
121609,8392,transfusion,I-Procedure
121610,8392,within,O
121611,8392,last,O
121612,8392,three,O
121613,8392,months,O
121614,8392,prior,O
121615,8392,to,O
121616,8392,clinical,O
121617,8392,studies,O
121618,8392,;,O
121619,8393,Prolonged,O
121620,8393,use,O
121621,8393,(,O
121622,8393,more,O
121623,8393,than,O
121624,8393,14,O
121625,8393,days,O
121626,8393,),O
121627,8393,immunosuppressants,B-Drug
121628,8393,or,O
121629,8393,other,O
121630,8393,immunosuppressive,B-Drug
121631,8393,drugs,I-Drug
121632,8393,within,O
121633,8393,6,O
121634,8393,months,O
121635,8393,prior,O
121636,8393,to,O
121637,8393,the,O
121638,8393,start,O
121639,8393,of,O
121640,8393,the,O
121641,8393,study,O
121642,8393,;,O
121643,8394,Any,O
121644,8394,confirmed,O
121645,8394,or,O
121646,8394,suspected,O
121647,8394,immunosuppressive,B-Condition
121648,8394,or,I-Condition
121649,8394,immunodeficient,I-Condition
121650,8394,condition,I-Condition
121651,8394,",",O
121652,8394,including,O
121653,8394,HIV,B-Condition
121654,8394,infection,I-Condition
121655,8394,;,O
121656,8395,A,O
121657,8395,history,O
121658,8395,or,O
121659,8395,currently,O
121660,8395,hematologic,O
121661,8395,and,O
121662,8395,other,O
121663,8395,cancers,O
121664,8395,;,O
121665,8396,A,O
121666,8396,positive,O
121667,8396,reaction,O
121668,8396,for,O
121669,8396,HIV,O
121670,8396,infection,O
121671,8396,",",O
121672,8396,viral,O
121673,8396,hepatitis,O
121674,8396,B,O
121675,8396,and,O
121676,8396,hepatitis,O
121677,8396,C,O
121678,8396,;,O
121679,8397,The,O
121680,8397,presence,O
121681,8397,of,O
121682,8397,respiratory,B-Condition
121683,8397,",",I-Condition
121684,8397,cardio,I-Condition
121685,8397,-,I-Condition
121686,8397,vascular,I-Condition
121687,8397,insufficiency,I-Condition
121688,8397,",",O
121689,8397,impaired,B-Condition
121690,8397,liver,I-Condition
121691,8397,and,I-Condition
121692,8397,kidney,I-Condition
121693,8397,function,I-Condition
121694,8397,",",O
121695,8397,established,O
121696,8397,during,O
121697,8397,a,O
121698,8397,physical,O
121699,8397,examination,O
121700,8397,at,O
121701,8397,visit,O
121702,8397,number,O
121703,8397,1,O
121704,8397,;,O
121705,8398,Pronounced,O
121706,8398,congenital,B-Condition
121707,8398,defects,I-Condition
121708,8398,or,O
121709,8398,serious,O
121710,8398,chronic,B-Condition
121711,8398,diseases,I-Condition
121712,8398,in,O
121713,8398,the,O
121714,8398,acute,O
121715,8398,stage,O
121716,8398,",",O
121717,8398,including,O
121718,8398,any,O
121719,8398,clinically,O
121720,8398,important,O
121721,8398,exacerbation,B-Condition
121722,8398,of,O
121723,8398,chronic,O
121724,8398,diseases,B-Condition
121725,8398,of,I-Condition
121726,8398,the,I-Condition
121727,8398,liver,I-Condition
121728,8398,",",I-Condition
121729,8398,kidney,I-Condition
121730,8398,",",I-Condition
121731,8398,cardiovascular,I-Condition
121732,8398,",",I-Condition
121733,8398,nervous,I-Condition
121734,8398,system,I-Condition
121735,8398,",",O
121736,8398,mental,B-Condition
121737,8398,diseases,I-Condition
121738,8398,or,O
121739,8398,metabolic,B-Condition
121740,8398,disorders,I-Condition
121741,8398,",",O
121742,8398,confirmed,O
121743,8398,by,O
121744,8398,the,O
121745,8398,history,O
121746,8398,or,O
121747,8398,objective,O
121748,8398,examination,O
121749,8398,(,O
121750,8398,pulmonary,O
121751,8398,:,O
121752,8398,cystic,B-Condition
121753,8398,fibrosis,I-Condition
121754,8398,",",O
121755,8398,lung,B-Condition
121756,8398,abscess,I-Condition
121757,8398,",",O
121758,8398,empyema,B-Condition
121759,8398,",",O
121760,8398,active,O
121761,8398,tuberculosis,B-Condition
121762,8398,;,O
121763,8398,extra,O
121764,8398,-,O
121765,8398,pulmonary,O
121766,8398,:,O
121767,8398,congestive,B-Condition
121768,8398,heart,I-Condition
121769,8398,failure,I-Condition
121770,8398,",",O
121771,8398,malabsorption,B-Condition
121772,8398,",",O
121773,8398,chronic,O
121774,8398,renal,B-Condition
121775,8398,and,I-Condition
121776,8398,hepatic,I-Condition
121777,8398,failure,I-Condition
121778,8398,",",O
121779,8398,cirrhosis,B-Condition
121780,8398,",",O
121781,8398,malignancy,B-Condition
121782,8398,",",O
121783,8398,immunodeficiency,B-Condition
121784,8398,",",O
121785,8398,cirrhosis,B-Condition
121786,8398,of,I-Condition
121787,8398,the,I-Condition
121788,8398,liver,I-Condition
121789,8398,),O
121790,8398,;,O
121791,8399,Severe,O
121792,8399,allergic,B-Condition
121793,8399,reactions,I-Condition
121794,8399,in,O
121795,8399,anamnesis,O
121796,8399,of,O
121797,8399,autoimmune,O
121798,8399,disease,O
121799,8399,;,O
121800,8400,The,O
121801,8400,presence,O
121802,8400,of,O
121803,8400,acute,O
121804,8400,infectious,B-Condition
121805,8400,and/or,I-Condition
121806,8400,communicable,I-Condition
121807,8400,illnesses,I-Condition
121808,8400,within,O
121809,8400,1,O
121810,8400,month,O
121811,8400,prior,O
121812,8400,to,O
121813,8400,study,O
121814,8400,;,O
121815,8401,History,O
121816,8401,of,O
121817,8401,chronic,O
121818,8401,alcohol,B-Condition
121819,8401,abuse,I-Condition
121820,8401,and/or,O
121821,8401,drug,B-Condition
121822,8401,use,I-Condition
121823,8401,;,O
121824,8402,Exacerbation,B-Condition
121825,8402,of,O
121826,8402,chronic,B-Condition
121827,8402,diseases,I-Condition
121828,8402,;,O
121829,8403,Breastfeeding,B-Observation
121830,8403,;,O
121831,8404,Pregnancy,B-Condition
121832,8404,;,O
121833,8405,Participation,B-Observation
121834,8405,in,I-Observation
121835,8405,any,I-Observation
121836,8405,other,I-Observation
121837,8405,clinical,I-Observation
121838,8405,study,I-Observation
121839,8405,within,O
121840,8405,the,O
121841,8405,last,O
121842,8405,3,O
121843,8405,months,O
121844,8405,.,O
121845,8406,Individuals,O
121846,8406,of,O
121847,8406,both,B-Person
121848,8406,sexes,I-Person
121849,8406,from,B-Person
121850,8406,18,I-Person
121851,8406,years,I-Person
121852,8406,with,O
121853,8406,a,O
121854,8406,diagnosis,O
121855,8406,of,O
121856,8406,community,B-Condition
121857,8406,-,I-Condition
121858,8406,acquired,I-Condition
121859,8406,pneumonia,I-Condition
121860,8406,",",O
121861,8406,COPD,B-Condition
121862,8406,or,O
121863,8406,Bronchial,B-Condition
121864,8406,Asthma,I-Condition
121865,8406,;,O
121866,8407,The,O
121867,8407,presence,O
121868,8407,of,O
121869,8407,signed,O
121870,8407,and,O
121871,8407,dated,O
121872,8407,informed,O
121873,8407,consent,O
121874,8407,to,O
121875,8407,participate,O
121876,8407,in,O
121877,8407,a,O
121878,8407,clinical,O
121879,8407,study,O
121880,8407,;,O
121881,8408,The,O
121882,8408,ability,O
121883,8408,to,O
121884,8408,perform,O
121885,8408,the,O
121886,8408,requirements,O
121887,8408,of,O
121888,8408,the,O
121889,8408,Protocol,O
121890,8408,;,O
121891,8409,For,O
121892,8409,women,O
121893,8409,of,O
121894,8409,childbearing,O
121895,8409,age,O
121896,8409,is,O
121897,8409,a,O
121898,8409,negative,O
121899,8409,result,O
121900,8409,of,O
121901,8409,a,O
121902,8409,pregnancy,O
121903,8409,test,O
121904,8409,before,O
121905,8409,vaccination,O
121906,8409,.,O
121907,8410,community,B-Condition
121908,8410,-,I-Condition
121909,8410,acquired,I-Condition
121910,8410,pneumonia,I-Condition
121911,8410,:,O
121912,8410,the,O
121913,8410,presence,O
121914,8410,of,O
121915,8410,radiologically,B-Procedure
121916,8410,confirmed,O
121917,8410,infiltration,B-Condition
121918,8410,of,I-Condition
121919,8410,the,I-Condition
121920,8410,lung,I-Condition
121921,8410,tissue,I-Condition
121922,8410,;,O
121923,8410,the,O
121924,8410,presence,O
121925,8410,of,O
121926,8410,at,O
121927,8410,least,O
121928,8410,two,O
121929,8410,of,O
121930,8410,the,O
121931,8410,following,O
121932,8410,clinical,O
121933,8410,signs,O
121934,8410,:,O
121935,8410,acute,B-Condition
121936,8410,fever,I-Condition
121937,8410,early,O
121938,8410,in,O
121939,8410,the,O
121940,8410,disease,O
121941,8410,(,O
121942,8410,temperature,O
121943,8410,>,O
121944,8410,38.0,O
121945,8410,°,O
121946,8410,C,O
121947,8410,),O
121948,8410,",",O
121949,8410,cough,B-Condition
121950,8410,with,I-Condition
121951,8410,sputum,I-Condition
121952,8410,",",O
121953,8410,the,O
121954,8410,physical,B-Condition
121955,8410,signs,I-Condition
121956,8410,of,O
121957,8410,pneumonia,B-Condition
121958,8410,(,O
121959,8410,focus,O
121960,8410,of,O
121961,8410,crepitate,B-Condition
121962,8410,and/or,I-Condition
121963,8410,fine,I-Condition
121964,8410,bubble,I-Condition
121965,8410,rales,I-Condition
121966,8410,",",O
121967,8410,bronchial,B-Condition
121968,8410,breathing,I-Condition
121969,8410,hard,I-Condition
121970,8410,",",O
121971,8410,shortening,B-Condition
121972,8410,of,I-Condition
121973,8410,percussion,I-Condition
121974,8410,sounds,I-Condition
121975,8410,),O
121976,8410,",",O
121977,8410,leukocytosis,O
121978,8410,>,O
121979,8410,10,O
121980,8410,*,O
121981,8410,10,O
121982,8410,9,O
121983,8410,/l,O
121984,8410,and/or,O
121985,8410,stab,O
121986,8410,shift,O
121987,8410,>,O
121988,8410,10,O
121989,8410,%,O
121990,8410,;,O
121991,8410,the,O
121992,8410,occurrence,O
121993,8410,of,O
121994,8410,the,O
121995,8410,disease,O
121996,8410,outside,O
121997,8410,the,O
121998,8410,hospital,O
121999,8410,and,O
122000,8410,the,O
122001,8410,organized,O
122002,8410,groups,O
122003,8410,(,O
122004,8410,such,O
122005,8410,as,O
122006,8410,nursing,O
122007,8410,homes,O
122008,8410,",",O
122009,8410,sanatoriums,O
122010,8410,",",O
122011,8410,etc,O
122012,8410,.,O
122013,8410,),O
122014,8410,.,O
122015,8411,COPD,B-Condition
122016,8411,:,O
122017,8411,dyspnea,B-Condition
122018,8411,:,O
122019,8411,progressive,O
122020,8411,(,O
122021,8411,worsens,O
122022,8411,over,O
122023,8411,time,O
122024,8411,),O
122025,8411,",",O
122026,8411,increases,O
122027,8411,with,O
122028,8411,exertion,O
122029,8411,",",O
122030,8411,persistent,O
122031,8411,;,O
122032,8411,chronic,B-Condition
122033,8411,cough,I-Condition
122034,8411,(,O
122035,8411,may,O
122036,8411,appear,O
122037,8411,sporadically,O
122038,8411,and,O
122039,8411,may,O
122040,8411,be,O
122041,8411,unproductive,O
122042,8411,),O
122043,8411,;,O
122044,8411,chronic,B-Condition
122045,8411,expectoration,I-Condition
122046,8411,;,O
122047,8411,the,O
122048,8411,impact,O
122049,8411,of,O
122050,8411,risk,B-Condition
122051,8411,factors,I-Condition
122052,8411,in,O
122053,8411,the,O
122054,8411,medical,O
122055,8411,history,O
122056,8411,(,O
122057,8411,Smoking,B-Condition
122058,8411,",",O
122059,8411,occupational,B-Condition
122060,8411,dust,I-Condition
122061,8411,pollutants,I-Condition
122062,8411,and,I-Condition
122063,8411,chemicals,I-Condition
122064,8411,),O
122065,8411,;,O
122066,8411,widespread,O
122067,8411,wheeze,B-Condition
122068,8411,on,I-Condition
122069,8411,auscultation,I-Condition
122070,8411,of,I-Condition
122071,8411,the,I-Condition
122072,8411,chest,I-Condition
122073,8411,and/or,O
122074,8411,distant,B-Condition
122075,8411,wheezing,I-Condition
122076,8411,in,I-Condition
122077,8411,the,I-Condition
122078,8411,chest,I-Condition
122079,8411,;,O
122080,8411,family,B-Observation
122081,8411,history,I-Observation
122082,8411,of,O
122083,8411,COPD,B-Condition
122084,8411,;,O
122085,8411,spirometric,B-Procedure
122086,8411,data,O
122087,8411,confirming,O
122088,8411,the,O
122089,8411,presence,O
122090,8411,of,O
122091,8411,fixed,B-Condition
122092,8411,bronchial,I-Condition
122093,8411,obstruction,I-Condition
122094,8411,.,O
122095,8412,Inability,O
122096,8412,to,O
122097,8412,obtain,O
122098,8412,consent,O
122099,8413,Subjects,O
122100,8413,under,O
122101,8413,18,O
122102,8413,years,O
122103,8413,of,O
122104,8413,age,B-Person
122105,8414,Non,O
122106,8414,-,O
122107,8414,English,O
122108,8414,speaking,O
122109,8414,subjects,O
122110,8415,Subjects,O
122111,8415,that,O
122112,8415,are,O
122113,8415,unable,B-Condition
122114,8415,to,I-Condition
122115,8415,lay,I-Condition
122116,8415,flat,I-Condition
122117,8415,due,O
122118,8415,to,O
122119,8415,pulmonary,B-Condition
122120,8415,complications,I-Condition
122121,8415,",",O
122122,8415,increased,B-Condition
122123,8415,intracranial,I-Condition
122124,8415,pressure,I-Condition
122125,8415,(,I-Condition
122126,8415,ICP,I-Condition
122127,8415,),I-Condition
122128,8415,",",O
122129,8415,or,O
122130,8415,unstable,O
122131,8415,spinal,B-Condition
122132,8415,cord,I-Condition
122133,8415,injuries,I-Condition
122134,8416,Subjects,O
122135,8416,with,O
122136,8416,known,O
122137,8416,cardiac,B-Condition
122138,8416,abnormalities,I-Condition
122139,8416,(,O
122140,8416,atrial,B-Condition
122141,8416,septal,I-Condition
122142,8416,defects,I-Condition
122143,8416,or,O
122144,8416,ventricular,B-Condition
122145,8416,septal,I-Condition
122146,8416,defects,I-Condition
122147,8416,",",O
122148,8416,severe,O
122149,8416,tricuspid,B-Condition
122150,8416,valve,I-Condition
122151,8416,disease,I-Condition
122152,8416,",",O
122153,8416,severe,O
122154,8416,pulmonary,B-Condition
122155,8416,hypertension,I-Condition
122156,8416,",",O
122157,8416,Ejection,O
122158,8416,fraction,O
122159,8416,<,O
122160,8416,15,O
122161,8416,%,O
122162,8416,),O
122163,8417,Prisoners,B-Person
122164,8418,Subjects,O
122165,8418,with,O
122166,8418,known,O
122167,8418,upper,B-Condition
122168,8418,extremity,I-Condition
122169,8418,deep,I-Condition
122170,8418,vein,I-Condition
122171,8418,thromboses,I-Condition
122172,8418,(,O
122173,8418,subclavian,O
122174,8418,or,O
122175,8418,distal,O
122176,8418,),O
122177,8419,Subjects,O
122178,8419,with,O
122179,8419,non,O
122180,8419,-,O
122181,8419,functional,O
122182,8419,CICC,O
122183,8419,or,O
122184,8419,PICC,O
122185,8419,distal,O
122186,8419,ports,O
122187,8420,Subjects,O
122188,8420,with,O
122189,8420,femoral,O
122190,8420,CICCs,O
122191,8421,Pregnant,B-Condition
122192,8421,women,B-Person
122193,8422,Subject,O
122194,8422,'s,O
122195,8422,ability,B-Observation
122196,8422,to,I-Observation
122197,8422,lay,I-Observation
122198,8422,in,I-Observation
122199,8422,a,I-Observation
122200,8422,supine,I-Observation
122201,8422,position,I-Observation
122202,8422,with,I-Observation
122203,8422,their,I-Observation
122204,8422,hands,I-Observation
122205,8422,at,I-Observation
122206,8422,their,I-Observation
122207,8422,sides,I-Observation
122208,8422,during,O
122209,8422,CVP,B-Procedure
122210,8422,measurements,I-Procedure
122211,8423,A,O
122212,8423,consent,O
122213,8423,form,O
122214,8423,signed,O
122215,8423,by,O
122216,8423,the,O
122217,8423,patient,O
122218,8423,or,O
122219,8423,patient,O
122220,8423,'s,O
122221,8423,representative,O
122222,8424,Subjects,O
122223,8424,that,O
122224,8424,are,O
122225,8424,age,B-Person
122226,8424,18,O
122227,8424,-,O
122228,8424,90,O
122229,8425,Subjects,O
122230,8425,that,O
122231,8425,have,O
122232,8425,an,O
122233,8425,indwelling,O
122234,8425,CICC,O
122235,8425,and,O
122236,8425,are,O
122237,8425,transitioning,B-Observation
122238,8425,to,I-Observation
122239,8425,a,I-Observation
122240,8425,PICC,I-Observation
122241,8425,for,O
122242,8425,long,O
122243,8425,-,O
122244,8425,term,O
122245,8425,IV,O
122246,8425,access,O
122247,8426,CICC,O
122248,8426,placed,O
122249,8426,in,O
122250,8426,the,O
122251,8426,internal,O
122252,8426,jugular,O
122253,8426,vein,O
122254,8426,or,O
122255,8426,subclavian,O
122256,8426,vein,O
122257,8426,position,O
122258,8427,Research,B-Observation
122259,8427,exemption,I-Observation
122260,8427,requested,I-Observation
122261,8428,History,B-Observation
122262,8428,of,O
122263,8428,PCV-13,B-Procedure
122264,8428,vaccination,I-Procedure
122265,8429,History,B-Observation
122266,8429,of,O
122267,8429,cochlear,O
122268,8429,implant,O
122269,8430,Cerebrospinal,B-Condition
122270,8430,Fluid,I-Condition
122271,8430,(,I-Condition
122272,8430,CSF,I-Condition
122273,8430,),I-Condition
122274,8430,leak,I-Condition
122275,8431,Congestive,B-Condition
122276,8431,Heart,I-Condition
122277,8431,Failure,I-Condition
122278,8431,(,I-Condition
122279,8431,CHF,I-Condition
122280,8431,),I-Condition
122281,8432,Diabetes,B-Condition
122282,8432,Mellitus,I-Condition
122283,8432,(,I-Condition
122284,8432,DM,I-Condition
122285,8432,),I-Condition
122286,8433,Chronic,B-Condition
122287,8433,Kidney,I-Condition
122288,8433,Disease,I-Condition
122289,8433,(,I-Condition
122290,8433,CKD,I-Condition
122291,8433,),I-Condition
122292,8434,Human,B-Condition
122293,8434,Immunodeficiency,I-Condition
122294,8434,Virus,I-Condition
122295,8434,(,I-Condition
122296,8434,HIV,I-Condition
122297,8434,),I-Condition
122298,8435,Common,B-Condition
122299,8435,Variable,I-Condition
122300,8435,Immune,I-Condition
122301,8435,Deficiency,I-Condition
122302,8435,(,I-Condition
122303,8435,CVID,I-Condition
122304,8435,),I-Condition
122305,8436,Patients,O
122306,8436,who,O
122307,8436,have,O
122308,8436,received,O
122309,8436,the,O
122310,8436,PPSV23,B-Drug
122311,8436,vaccine,I-Drug
122312,8436,in,O
122313,8436,the,O
122314,8436,last,O
122315,8436,5,O
122316,8436,years,O
122317,8437,Women,B-Person
122318,8437,who,O
122319,8437,are,O
122320,8437,pregnant,B-Condition
122321,8437,will,O
122322,8437,also,O
122323,8437,be,O
122324,8437,excluded,O
122325,8437,from,O
122326,8437,the,O
122327,8437,study,O
122328,8437,by,O
122329,8437,performing,O
122330,8437,2,O
122331,8437,point,B-Procedure
122332,8437,of,I-Procedure
122333,8437,care,I-Procedure
122334,8437,urine,I-Procedure
122335,8437,pregnancy,I-Procedure
122336,8437,tests,I-Procedure
122337,8437,(,O
122338,8437,prior,O
122339,8437,to,O
122340,8437,vaccinations,B-Procedure
122341,8437,),O
122342,8438,Diagnosis,O
122343,8438,of,O
122344,8438,asthma,B-Condition
122345,8439,Autoimmune,B-Condition
122346,8439,hepatitis,I-Condition
122347,8440,Primary,B-Condition
122348,8440,sclerosing,I-Condition
122349,8440,cholangitis,I-Condition
122350,8441,Patients,O
122351,8441,diagnosed,O
122352,8441,with,O
122353,8441,primary,B-Condition
122354,8441,biliary,I-Condition
122355,8441,cholangitis,I-Condition
122356,8442,Treated,O
122357,8442,with,O
122358,8442,Ursodeoxycholic,B-Drug
122359,8442,Acid,I-Drug
122360,8442,in,O
122361,8442,West,O
122362,8442,China,O
122363,8442,Hospital,O
122364,8442,for,O
122365,8442,at,O
122366,8442,least,O
122367,8442,6,O
122368,8442,month,O
122369,8442,and,O
122370,8442,suboptimal,B-Condition
122371,8442,response,I-Condition
122372,8442,to,O
122373,8442,Ursodeoxycholic,B-Drug
122374,8442,Acid,I-Drug
122375,8443,Fasting,O
122376,8443,plasma,O
122377,8443,glucose,O
122378,8443,>,O
122379,8443,"7,0",O
122380,8443,mM,O
122381,8443,",",O
122382,8443,HbA1c,O
122383,8443,>,O
122384,8443,48,O
122385,8443,mmol,O
122386,8443,/,O
122387,8443,mol,O
122388,8443,3,O
122389,8443,months,O
122390,8443,after,O
122391,8443,RYGB,B-Procedure
122392,8443,.,O
122393,8444,Dysregulated,O
122394,8444,thyroid,B-Condition
122395,8444,diseases,I-Condition
122396,8444,",",O
122397,8444,use,O
122398,8444,of,O
122399,8444,antithyroid,B-Procedure
122400,8444,treatment,I-Procedure
122401,8444,.,O
122402,8445,Late,B-Condition
122403,8445,diabetic,I-Condition
122404,8445,complications,I-Condition
122405,8445,as,O
122406,8445,retinopathy,B-Condition
122407,8445,",",O
122408,8445,renal,B-Condition
122409,8445,insufficiency,I-Condition
122410,8445,",",O
122411,8445,neuropathy,B-Condition
122412,8445,or,O
122413,8445,previous,O
122414,8445,pancreatitis,B-Condition
122415,8445,.,O
122416,8446,Complications,B-Condition
122417,8446,to,O
122418,8446,RYGB,B-Procedure
122419,8446,.,O
122420,8446,Documented,O
122421,8446,reactive,B-Condition
122422,8446,hypoglycaemia,I-Condition
122423,8446,",",O
122424,8446,severe,O
122425,8446,dumping,B-Condition
122426,8446,(,O
122427,8446,vomiting,B-Condition
122428,8446,",",O
122429,8446,diarrhea,B-Condition
122430,8446,",",O
122431,8446,severe,O
122432,8446,abdominal,B-Condition
122433,8446,pain,I-Condition
122434,8446,after,O
122435,8446,food,O
122436,8446,intake,O
122437,8446,),O
122438,8446,.,O
122439,8447,Cholecystectomy,B-Procedure
122440,8448,Uncomplicated,O
122441,8448,RYGB,B-Procedure
122442,8448,performed,O
122443,8448,minimum,O
122444,8448,3,O
122445,8448,months,O
122446,8448,prior,O
122447,8448,to,O
122448,8448,the,O
122449,8448,study,O
122450,8448,.,O
122451,8449,Fasting,O
122452,8449,plasma,O
122453,8449,glucose,O
122454,8449,<,O
122455,8449,"7,0",O
122456,8449,mM,O
122457,8449,",",O
122458,8449,HbA1c,O
122459,8449,<,O
122460,8449,48,O
122461,8449,mmol,O
122462,8449,/,O
122463,8449,mol,O
122464,8449,3,O
122465,8449,months,O
122466,8449,after,O
122467,8449,RYGB,B-Procedure
122468,8450,Rest,B-Condition
122469,8450,pain,I-Condition
122470,8450,or,O
122471,8450,tissue,B-Condition
122472,8450,loss,I-Condition
122473,8450,due,O
122474,8450,to,O
122475,8450,PAD,B-Condition
122476,8450,(,O
122477,8450,Fontaine,O
122478,8450,stage,O
122479,8450,III,O
122480,8450,and,O
122481,8450,IV,O
122482,8450,),O
122483,8450,",",O
122484,8451,acute,O
122485,8451,lower,O
122486,8451,extremity,O
122487,8451,ischemic,B-Condition
122488,8451,event,I-Condition
122489,8451,secondary,O
122490,8451,to,O
122491,8451,thromboembolic,B-Condition
122492,8451,disease,I-Condition
122493,8451,or,O
122494,8451,acute,B-Condition
122495,8451,trauma,I-Condition
122496,8451,",",O
122497,8452,Walking,O
122498,8452,capacity,O
122499,8452,significantly,O
122500,8452,limited,O
122501,8452,by,O
122502,8452,conditions,B-Condition
122503,8452,other,I-Condition
122504,8452,than,I-Condition
122505,8452,claudication,I-Condition
122506,8452,including,O
122507,8452,leg,B-Condition
122508,8452,(,I-Condition
122509,8452,joint,I-Condition
122510,8452,/,I-Condition
122511,8452,musculoskeletal,I-Condition
122512,8452,",",I-Condition
122513,8452,neurologic,I-Condition
122514,8452,),I-Condition
122515,8452,and,I-Condition
122516,8452,systemic,I-Condition
122517,8452,(,I-Condition
122518,8452,heart,I-Condition
122519,8452,",",I-Condition
122520,8452,lung,I-Condition
122521,8452,disease,I-Condition
122522,8452,),I-Condition
122523,8452,pathology,I-Condition
122524,8452,",",O
122525,8453,Current,O
122526,8453,use,O
122527,8453,of,O
122528,8453,either,O
122529,8453,ACE,B-Drug
122530,8453,inhibitors,I-Drug
122531,8453,or,O
122532,8453,angiotensin,B-Drug
122533,8453,II,I-Drug
122534,8453,receptor,I-Drug
122535,8453,blockers,I-Drug
122536,8453,",",O
122537,8454,Chronic,B-Condition
122538,8454,kidney,I-Condition
122539,8454,disease,I-Condition
122540,8454,with,O
122541,8454,estimated,O
122542,8454,Glomerular,O
122543,8454,Filtration,O
122544,8454,Rate,O
122545,8454,<,O
122546,8454,30,O
122547,8454,ml,O
122548,8454,/,O
122549,8454,min/1.73,O
122550,8454,m2,O
122551,8454,",",O
122552,8455,History,B-Observation
122553,8455,of,O
122554,8455,bilateral,O
122555,8455,severe,O
122556,8455,renal,B-Condition
122557,8455,artery,I-Condition
122558,8455,stenosis,I-Condition
122559,8455,and,O
122560,8455,7,O
122561,8455,),O
122562,8455,History,B-Observation
122563,8455,of,O
122564,8455,angioedema,B-Condition
122565,8455,related,O
122566,8455,to,O
122567,8455,previous,O
122568,8455,ACE,B-Procedure
122569,8455,-,I-Procedure
122570,8455,inhibitor,I-Procedure
122571,8455,treatment,I-Procedure
122572,8455,or,O
122573,8455,known,O
122574,8455,hypersensitivity,B-Condition
122575,8455,to,O
122576,8455,ramipril,B-Drug
122577,8455,or,O
122578,8455,other,O
122579,8455,ACE,B-Drug
122580,8455,inhibitors,I-Drug
122581,8455,.,O
122582,8456,A,O
122583,8456,positive,B-Observation
122584,8456,history,I-Observation
122585,8456,of,O
122586,8456,chronic,B-Condition
122587,8456,claudication,I-Condition
122588,8456,",",O
122589,8457,Exercise,B-Condition
122590,8457,-,I-Condition
122591,8457,limiting,I-Condition
122592,8457,claudication,I-Condition
122593,8457,established,O
122594,8457,by,O
122595,8457,history,B-Observation
122596,8457,and,O
122597,8457,direct,B-Procedure
122598,8457,observation,I-Procedure
122599,8457,during,O
122600,8457,a,O
122601,8457,screening,B-Procedure
122602,8457,walking,I-Procedure
122603,8457,test,I-Procedure
122604,8457,administered,O
122605,8457,by,O
122606,8457,the,O
122607,8457,evaluating,O
122608,8457,vascular,O
122609,8457,surgeon,O
122610,8457,",",O
122611,8458,Arterial,B-Condition
122612,8458,occlusive,I-Condition
122613,8458,disease,I-Condition
122614,8458,per,O
122615,8458,ankle,B-Procedure
122616,8458,Brachial,I-Procedure
122617,8458,index,I-Procedure
122618,8458,measurements,I-Procedure
122619,8458,and/or,O
122620,8458,other,O
122621,8458,imaging,B-Procedure
122622,8458,modalities,I-Procedure
122623,8458,",",O
122624,8459,Stable,O
122625,8459,blood,B-Procedure
122626,8459,pressure,I-Procedure
122627,8459,regimen,I-Procedure
122628,8459,",",O
122629,8459,stable,O
122630,8459,lipid,B-Procedure
122631,8459,regimen,I-Procedure
122632,8459,",",O
122633,8459,stable,O
122634,8459,diabetes,B-Procedure
122635,8459,regimen,I-Procedure
122636,8459,and,O
122637,8459,risk,B-Procedure
122638,8459,factor,I-Procedure
122639,8459,control,I-Procedure
122640,8459,for,O
122641,8459,6,O
122642,8459,weeks,O
122643,8459,.,O
122644,8460,Contra,B-Condition
122645,8460,-,I-Condition
122646,8460,indication,I-Condition
122647,8460,for,O
122648,8460,multiorgan,B-Procedure
122649,8460,procurement,I-Procedure
122650,8460,(,O
122651,8460,infections,B-Condition
122652,8460,",",O
122653,8460,cancer,B-Condition
122654,8460,",",O
122655,8460,etc,O
122656,8460,),O
122657,8461,Preexistent,O
122658,8461,chronic,B-Condition
122659,8461,renal,I-Condition
122660,8461,failure,I-Condition
122661,8461,.,O
122662,8462,Refusal,B-Observation
122663,8462,for,I-Observation
122664,8462,organ,I-Observation
122665,8462,procurement,I-Observation
122666,8462,by,I-Observation
122667,8462,the,I-Observation
122668,8462,donor,I-Observation
122669,8462,(,O
122670,8462,confirmed,O
122671,8462,by,O
122672,8462,the,O
122673,8462,French,O
122674,8462,national,O
122675,8462,register,O
122676,8462,or,O
122677,8462,reported,O
122678,8462,by,O
122679,8462,the,O
122680,8462,next,O
122681,8462,-,O
122682,8462,of,O
122683,8462,-,O
122684,8462,kin,O
122685,8462,),O
122686,8462,.,O
122687,8463,Need,B-Mood
122688,8463,for,I-Mood
122689,8463,a,O
122690,8463,double,B-Procedure
122691,8463,kidney,I-Procedure
122692,8463,transplantation,I-Procedure
122693,8463,.,O
122694,8464,Need,B-Mood
122695,8464,for,I-Mood
122696,8464,a,O
122697,8464,multiorgan,B-Procedure
122698,8464,transplantation,I-Procedure
122699,8465,Male,B-Person
122700,8465,and,O
122701,8465,females,B-Person
122702,8465,aged,B-Person
122703,8465,18,O
122704,8465,to,O
122705,8465,70,O
122706,8465,years,O
122707,8466,Brain,B-Condition
122708,8466,death,I-Condition
122709,8467,Male,B-Person
122710,8467,and,O
122711,8467,females,B-Person
122712,8467,aged,B-Person
122713,8467,18,O
122714,8467,to,O
122715,8467,70,O
122716,8467,years,O
122717,8468,Indication,B-Mood
122718,8468,of,O
122719,8468,kidney,B-Procedure
122720,8468,transplantation,I-Procedure
122721,8469,Informed,O
122722,8469,consent,O
122723,8470,Patients,O
122724,8470,with,O
122725,8470,coagulopathy,B-Condition
122726,8470,or,O
122727,8470,under,O
122728,8470,anti,B-Procedure
122729,8470,-,I-Procedure
122730,8470,coagulation,I-Procedure
122731,8470,therapy,I-Procedure
122732,8470,.,O
122733,8471,Gastrointestinal,B-Condition
122734,8471,disease,I-Condition
122735,8471,",",O
122736,8472,motion,B-Condition
122737,8472,sickness,I-Condition
122738,8472,.,O
122739,8473,diabetes,B-Condition
122740,8473,mellitus,I-Condition
122741,8473,.,O
122742,8474,Patients,O
122743,8474,with,O
122744,8474,preeclampsia,B-Condition
122745,8474,",",O
122746,8475,adult,B-Person
122747,8475,female,B-Observation
122748,8475,partner,I-Observation
122749,8476,aged,B-Person
122750,8476,18,O
122751,8476,to,O
122752,8476,40,O
122753,8476,years,O
122754,8476,.,O
122755,8477,scheduled,B-Mood
122756,8477,for,I-Mood
122757,8477,elective,O
122758,8477,cesarean,B-Procedure
122759,8477,section,I-Procedure
122760,8477,.,O
122761,8478,Contraindication,B-Condition
122762,8478,of,I-Condition
122763,8478,CT,I-Condition
122764,8478,Known,B-Condition
122765,8478,allergy,I-Condition
122766,8478,to,O
122767,8478,iodinated,B-Drug
122768,8478,contrast,I-Drug
122769,8478,media,I-Drug
122770,8478,or,O
122771,8478,history,O
122772,8478,of,O
122773,8478,contrast,B-Condition
122774,8478,-,I-Condition
122775,8478,induced,I-Condition
122776,8478,nephropathy,I-Condition
122777,8478,Decreased,O
122778,8478,renal,O
122779,8478,function,O
122780,8478,:,O
122781,8478,elevated,O
122782,8478,serum,O
122783,8478,creatinine(>1.5mg,O
122784,8478,/,O
122785,8478,dl,O
122786,8478,),O
122787,8478,Contraindication,B-Condition
122788,8478,to,O
122789,8478,beta,B-Drug
122790,8478,-,I-Drug
122791,8478,blockers,I-Drug
122792,8478,Severe,O
122793,8478,arrhythmia,B-Condition
122794,8478,:,O
122795,8478,arterial,B-Condition
122796,8478,fibrillation,I-Condition
122797,8478,or,O
122798,8478,uncontrolled,B-Condition
122799,8478,tachyarrhythmia,I-Condition
122800,8478,",",O
122801,8478,or,O
122802,8478,advanced,B-Condition
122803,8478,atrioventricular,I-Condition
122804,8478,block,I-Condition
122805,8478,(,O
122806,8478,second,B-Condition
122807,8478,or,I-Condition
122808,8478,third,I-Condition
122809,8478,degree,I-Condition
122810,8478,heart,I-Condition
122811,8478,block,I-Condition
122812,8478,),O
122813,8479,Contraindication,B-Condition
122814,8479,of,O
122815,8479,MRI,B-Procedure
122816,8479,Claustrophobia,B-Condition
122817,8479,Metallic,B-Condition
122818,8479,hazards,I-Condition
122819,8479,Pacemaker,O
122820,8479,implant,O
122821,8479,eGFR<30,O
122822,8479,ml,O
122823,8479,/,O
122824,8479,min,O
122825,8480,Unstable,B-Condition
122826,8480,or,I-Condition
122827,8480,uncooperative,I-Condition
122828,8480,patients,I-Condition
122829,8481,Limited,O
122830,8481,life,B-Person
122831,8481,expectancy,I-Person
122832,8481,due,O
122833,8481,to,O
122834,8481,cancer,B-Condition
122835,8481,or,O
122836,8481,end,B-Condition
122837,8481,-,I-Condition
122838,8481,stage,I-Condition
122839,8481,renal,I-Condition
122840,8481,or,I-Condition
122841,8481,liver,I-Condition
122842,8481,disease,I-Condition
122843,8482,Evidence,O
122844,8482,of,O
122845,8482,severe,O
122846,8482,symptomatic,O
122847,8482,heart,B-Condition
122848,8482,failure,I-Condition
122849,8482,(,O
122850,8482,NYHA,O
122851,8482,Class,O
122852,8482,III,O
122853,8482,or,O
122854,8482,IV,O
122855,8482,),O
122856,8483,Previous,O
122857,8483,myocardial,B-Condition
122858,8483,infarction,I-Condition
122859,8483,",",O
122860,8483,coronary,B-Procedure
122861,8483,artery,I-Procedure
122862,8483,intervention,I-Procedure
122863,8483,",",O
122864,8483,coronary,B-Procedure
122865,8483,artery,I-Procedure
122866,8483,bypass,I-Procedure
122867,8483,surgery,I-Procedure
122868,8483,",",O
122869,8483,or,O
122870,8483,other,B-Procedure
122871,8483,cardiac,I-Procedure
122872,8483,surgery,I-Procedure
122873,8484,Men,B-Person
122874,8484,and,O
122875,8484,women,B-Person
122876,8484,patients,O
122877,8484,",",O
122878,8484,with,O
122879,8484,age,B-Person
122880,8484,ranging,O
122881,8484,40,O
122882,8484,-,O
122883,8484,80,O
122884,8484,.,O
122885,8485,Suspected,B-Mood
122886,8485,coronary,B-Condition
122887,8485,artery,I-Condition
122888,8485,disease,I-Condition
122889,8485,who,O
122890,8485,are,O
122891,8485,supposed,B-Mood
122892,8485,to,I-Mood
122893,8485,undergo,I-Mood
122894,8485,invasive,B-Procedure
122895,8485,coronary,I-Procedure
122896,8485,angiography,I-Procedure
122897,8485,with,O
122898,8485,appropriate,O
122899,8485,clinical,O
122900,8485,indications,O
122901,8486,Patients,O
122902,8486,who,O
122903,8486,are,O
122904,8486,willing,O
122905,8486,to,O
122906,8486,sign,O
122907,8486,the,O
122908,8486,informed,O
122909,8486,consent,O
122910,8486,form,O
122911,8487,Patient,B-Observation
122912,8487,refusal,I-Observation
122913,8487,for,O
122914,8487,supraclavicular,B-Procedure
122915,8487,block,I-Procedure
122916,8488,Inability,B-Observation
122917,8488,to,I-Observation
122918,8488,give,I-Observation
122919,8488,informed,I-Observation
122920,8488,consent,I-Observation
122921,8489,Allergy,B-Condition
122922,8489,to,O
122923,8489,local,B-Drug
122924,8489,anesthetics,I-Drug
122925,8490,Hemidiaphragmatic,B-Condition
122926,8490,dysfunction,I-Condition
122927,8490,",",O
122928,8490,suspected,O
122929,8490,or,O
122930,8490,known,O
122931,8490,PNP,B-Condition
122932,8491,Neuromuscular,B-Condition
122933,8491,disease,I-Condition
122934,8492,Obstructive,B-Condition
122935,8492,or,I-Condition
122936,8492,restrictive,I-Condition
122937,8492,pulmonary,I-Condition
122938,8492,disease,I-Condition
122939,8493,Medical,O
122940,8493,or,O
122941,8493,anatomic,O
122942,8493,contraindication,B-Condition
122943,8493,to,O
122944,8493,supraclavicular,B-Procedure
122945,8493,blockade,I-Procedure
122946,8493,as,O
122947,8493,judged,O
122948,8493,by,O
122949,8493,clinician,O
122950,8494,Pregnancy,B-Condition
122951,8495,Undergoing,O
122952,8495,right,B-Procedure
122953,8495,upper,I-Procedure
122954,8495,extremity,I-Procedure
122955,8495,surgery,I-Procedure
122956,8495,with,O
122957,8495,supraclavicular,B-Procedure
122958,8495,block,I-Procedure
122959,8495,as,O
122960,8495,the,O
122961,8495,primary,O
122962,8495,anesthetic,O
122963,8496,Age,B-Person
122964,8496,greater,O
122965,8496,than,O
122966,8496,or,O
122967,8496,equal,O
122968,8496,to,O
122969,8496,18,O
122970,8496,years,O
122971,8496,of,O
122972,8496,age,O
122973,8497,American,O
122974,8497,Society,O
122975,8497,of,O
122976,8497,Anesthesiologists,O
122977,8497,(,O
122978,8497,ASA,O
122979,8497,),O
122980,8497,physical,O
122981,8497,status,O
122982,8497,1,O
122983,8497,to,O
122984,8497,3,O
122985,8498,Able,B-Observation
122986,8498,to,I-Observation
122987,8498,give,I-Observation
122988,8498,informed,I-Observation
122989,8498,consent,I-Observation
122990,8499,Immunocompromised,B-Condition
122991,8499,patients,O
122992,8499,:,O
122993,8500,Patients,O
122994,8500,with,O
122995,8500,a,O
122996,8500,known,O
122997,8500,congenital,O
122998,8500,or,O
122999,8500,acquired,O
123000,8500,immunodeficiency,B-Condition
123001,8500,.,O
123002,8501,Patients,O
123003,8501,who,O
123004,8501,received,O
123005,8501,chemotherapy,B-Procedure
123006,8501,less,O
123007,8501,than,O
123008,8501,6,O
123009,8501,weeks,O
123010,8501,ago,O
123011,8501,.,O
123012,8502,Patients,O
123013,8502,who,O
123014,8502,received,O
123015,8502,corticosteroids,B-Drug
123016,8502,in,O
123017,8502,the,O
123018,8502,last,O
123019,8502,6,O
123020,8502,weeks,O
123021,8502,.,O
123022,8503,Patients,O
123023,8503,who,O
123024,8503,received,O
123025,8503,immunosuppressive,B-Procedure
123026,8503,medication,I-Procedure
123027,8503,in,O
123028,8503,the,O
123029,8503,last,O
123030,8503,6,O
123031,8503,weeks,O
123032,8503,(,O
123033,8503,e.g.,O
123034,8503,cyclosporin,B-Drug
123035,8503,",",O
123036,8503,cyclophosphamide,B-Drug
123037,8503,",",O
123038,8503,azathioprine,B-Drug
123039,8503,),O
123040,8503,.,O
123041,8504,Patients,O
123042,8504,with,O
123043,8504,chronic,B-Condition
123044,8504,obstructive,I-Condition
123045,8504,pulmonary,I-Condition
123046,8504,disease,I-Condition
123047,8504,who,O
123048,8504,are,O
123049,8504,on,O
123050,8504,systemic,B-Drug
123051,8504,corticosteroids,I-Drug
123052,8504,.,O
123053,8505,Patients,O
123054,8505,who,O
123055,8505,require,O
123056,8505,intensive,O
123057,8505,care,O
123058,8505,unit,O
123059,8505,treatment,O
123060,8505,.,O
123061,8506,Patients,O
123062,8506,with,O
123063,8506,tropical,B-Condition
123064,8506,worm,I-Condition
123065,8506,infection,I-Condition
123066,8506,.,O
123067,8507,Patients,O
123068,8507,with,O
123069,8507,dexamethasone,B-Drug
123070,8507,intolerance,B-Condition
123071,8507,.,O
123072,8508,Pregnant,O
123073,8508,and,O
123074,8508,breastfeeding,O
123075,8508,women,O
123076,8508,.,O
123077,8509,18,O
123078,8509,years,B-Person
123079,8509,or,O
123080,8509,older,O
123081,8510,Chest,B-Procedure
123082,8510,radiograph,I-Procedure
123083,8510,showing,O
123084,8510,new,O
123085,8510,opacities,B-Condition
123086,8510,.,O
123087,8511,Cough,B-Condition
123088,8512,Production,O
123089,8512,of,O
123090,8512,sputum,B-Condition
123091,8513,Temp,O
123092,8513,>,O
123093,8513,"38,0",O
123094,8513,°,O
123095,8513,C,O
123096,8513,or,O
123097,8513,<,O
123098,8513,"36,0",O
123099,8513,°,O
123100,8513,C,O
123101,8514,Audible,B-Observation
123102,8514,abnormalities,I-Observation
123103,8514,by,O
123104,8514,chest,B-Procedure
123105,8514,examination,I-Procedure
123106,8514,compatible,O
123107,8514,with,O
123108,8514,pneumonia,B-Condition
123109,8515,Leukocytosis,B-Condition
123110,8515,(,O
123111,8515,>,O
123112,8515,10.000,O
123113,8515,cells,O
123114,8515,/,O
123115,8515,mm3,O
123116,8515,),O
123117,8515,",",O
123118,8515,leftward,O
123119,8515,shift,O
123120,8515,(,O
123121,8515,>,O
123122,8515,10,O
123123,8515,%,O
123124,8515,),O
123125,8515,or,O
123126,8515,leucopenia,B-Condition
123127,8515,(,O
123128,8515,<,O
123129,8515,4000,O
123130,8515,cells,O
123131,8515,/,O
123132,8515,mm3,O
123133,8515,),O
123134,8516,C,O
123135,8516,-,O
123136,8516,reactive,O
123137,8516,protein,O
123138,8516,>,O
123139,8516,15,O
123140,8516,mg,O
123141,8516,/,O
123142,8516,l,O
123143,8516,(,O
123144,8516,three,O
123145,8516,fold,O
123146,8516,higher,O
123147,8516,than,O
123148,8516,the,O
123149,8516,upper,O
123150,8516,limit,O
123151,8516,of,O
123152,8516,normal,O
123153,8516,),O
123154,8517,Pregnant,B-Condition
123155,8517,woman,B-Person
123156,8517,or,O
123157,8517,breastfeeding,B-Observation
123158,8518,immunosuppression,B-Condition
123159,8518,including,O
123160,8518,AIDS,B-Condition
123161,8518,",",O
123162,8518,corticosteroids,B-Drug
123163,8518,over,O
123164,8518,60mg,O
123165,8518,/,O
123166,8518,day,O
123167,8519,ongoing,O
123168,8519,antibiotic,B-Drug
123169,8519,treatment,B-Procedure
123170,8519,at,O
123171,8519,the,O
123172,8519,day,O
123173,8519,of,O
123174,8519,inclusion,O
123175,8520,impossibility,B-Condition
123176,8520,to,I-Condition
123177,8520,obtain,I-Condition
123178,8520,a,O
123179,8520,signed,B-Observation
123180,8520,consent,I-Observation
123181,8520,form,I-Observation
123182,8520,.,O
123183,8521,Patient,O
123184,8521,harboring,O
123185,8521,a,O
123186,8521,GRE,B-Condition
123187,8521,or,I-Condition
123188,8521,CRE,I-Condition
123189,8521,bacteria,I-Condition
123190,8522,Colonization,B-Condition
123191,8522,confirmed,O
123192,8522,by,O
123193,8522,our,O
123194,8522,microbiology,O
123195,8522,department,O
123196,8522,",",O
123197,8522,including,O
123198,8522,at,O
123199,8522,least,O
123200,8522,3,O
123201,8522,positives,O
123202,8522,swabs,B-Procedure
123203,8522,in,O
123204,8522,the,O
123205,8522,last,O
123206,8522,month,O
123207,8523,Known,O
123208,8523,or,O
123209,8523,suspected,O
123210,8523,alcohol,B-Condition
123211,8523,or,I-Condition
123212,8523,substance,I-Condition
123213,8523,abuse,I-Condition
123214,8523,in,O
123215,8523,the,O
123216,8523,preceding,O
123217,8523,12,O
123218,8523,months,O
123219,8523,.,O
123220,8524,Women,O
123221,8524,who,O
123222,8524,are,O
123223,8524,pregnant,O
123224,8524,or,O
123225,8524,breastfeeding,O
123226,8524,.,O
123227,8525,Women,O
123228,8525,of,O
123229,8525,childbearing,O
123230,8525,potential,O
123231,8525,(,O
123232,8525,WOCP,O
123233,8525,),O
123234,8525,who,O
123235,8525,are,O
123236,8525,not,O
123237,8525,using,O
123238,8525,at,O
123239,8525,least,O
123240,8525,one,O
123241,8525,method,O
123242,8525,of,O
123243,8525,contraception,O
123244,8525,.,O
123245,8526,Patients,O
123246,8526,with,O
123247,8526,severe,O
123248,8526,renal,B-Condition
123249,8526,impairment,I-Condition
123250,8526,(,O
123251,8526,CLcr,O
123252,8526,=,O
123253,8526,29,O
123254,8526,mL,O
123255,8526,/,O
123256,8526,min,O
123257,8526,",",O
123258,8526,or,O
123259,8526,eGFR,O
123260,8526,=,O
123261,8526,29,O
123262,8526,mL,O
123263,8526,/,O
123264,8526,min/1.73,O
123265,8526,m2,O
123266,8526,),O
123267,8526,",",O
123268,8526,or,O
123269,8526,moderate,O
123270,8526,or,O
123271,8526,severe,O
123272,8526,hepatic,B-Condition
123273,8526,impairment,I-Condition
123274,8526,(,O
123275,8526,Child,O
123276,8526,-,O
123277,8526,Pugh,O
123278,8526,classes,O
123279,8526,B,O
123280,8526,or,O
123281,8526,C,O
123282,8526,),O
123283,8526,.,O
123284,8527,Patients,O
123285,8527,with,O
123286,8527,bladder,B-Condition
123287,8527,outlet,I-Condition
123288,8527,obstruction,I-Condition
123289,8527,(,O
123290,8527,BOO,B-Condition
123291,8527,),O
123292,8527,that,O
123293,8527,",",O
123294,8527,in,O
123295,8527,the,O
123296,8527,opinion,O
123297,8527,of,O
123298,8527,the,O
123299,8527,study,O
123300,8527,urologist,O
123301,8527,",",O
123302,8527,would,O
123303,8527,expose,O
123304,8527,them,O
123305,8527,to,O
123306,8527,risk,B-Observation
123307,8527,of,I-Observation
123308,8527,urinary,I-Observation
123309,8527,retention,I-Observation
123310,8527,during,O
123311,8527,treatment,O
123312,8527,with,O
123313,8527,mirabegron,B-Drug
123314,8527,.,O
123315,8528,Patients,O
123316,8528,treated,O
123317,8528,with,O
123318,8528,drugs,O
123319,8528,metabolized,O
123320,8528,by,O
123321,8528,the,O
123322,8528,CYP2D6,O
123323,8528,pathway,O
123324,8528,.,O
123325,8529,Patients,O
123326,8529,with,O
123327,8529,supine,O
123328,8529,systolic,O
123329,8529,blood,O
123330,8529,pressure,O
123331,8529,(,O
123332,8529,SBP,O
123333,8529,),O
123334,8529,=,O
123335,8529,180,O
123336,8529,mm,O
123337,8529,Hg,O
123338,8529,",",O
123339,8529,or,O
123340,8529,diastolic,O
123341,8529,blood,O
123342,8529,pressure,O
123343,8529,(,O
123344,8529,DBP,O
123345,8529,),O
123346,8529,=,O
123347,8529,110,O
123348,8529,mm,O
123349,8529,Hg,O
123350,8529,.,O
123351,8530,Clinically,O
123352,8530,significant,O
123353,8530,",",O
123354,8530,uncontrolled,O
123355,8530,cardiac,B-Condition
123356,8530,arrhythmia,I-Condition
123357,8530,",",O
123358,8530,unstable,B-Condition
123359,8530,angina,I-Condition
123360,8530,",",O
123361,8530,congestive,B-Condition
123362,8530,heart,I-Condition
123363,8530,failure,I-Condition
123364,8530,(,O
123365,8530,NYHA,O
123366,8530,Class,O
123367,8530,3,O
123368,8530,or,O
123369,8530,4,O
123370,8530,),O
123371,8530,",",O
123372,8530,or,O
123373,8530,history,O
123374,8530,of,O
123375,8530,myocardial,B-Condition
123376,8530,infarction,I-Condition
123377,8530,in,O
123378,8530,the,O
123379,8530,preceding,O
123380,8530,2,O
123381,8530,years,O
123382,8530,.,O
123383,8531,History,O
123384,8531,of,O
123385,8531,cancer,B-Condition
123386,8531,in,O
123387,8531,the,O
123388,8531,preceding,O
123389,8531,2,O
123390,8531,years,O
123391,8531,other,O
123392,8531,than,O
123393,8531,successfully,O
123394,8531,treated,O
123395,8531,",",O
123396,8531,non,O
123397,8531,-,O
123398,8531,metastatic,O
123399,8531,",",O
123400,8531,squamous,O
123401,8531,cell,O
123402,8531,or,O
123403,8531,basal,B-Condition
123404,8531,cell,I-Condition
123405,8531,carcinoma,I-Condition
123406,8531,",",O
123407,8531,or,O
123408,8531,cervical,B-Condition
123409,8531,cancer,I-Condition
123410,8531,in,I-Condition
123411,8531,situ,I-Condition
123412,8531,.,O
123413,8532,Any,O
123414,8532,major,B-Procedure
123415,8532,urological,I-Procedure
123416,8532,procedure,I-Procedure
123417,8532,in,O
123418,8532,the,O
123419,8532,preceding,O
123420,8532,90,O
123421,8532,days,O
123422,8532,.,O
123423,8533,Any,O
123424,8533,major,B-Procedure
123425,8533,surgical,I-Procedure
123426,8533,procedure,I-Procedure
123427,8533,in,O
123428,8533,the,O
123429,8533,preceding,O
123430,8533,30,O
123431,8533,days,O
123432,8533,.,O
123433,8534,Previously,O
123434,8534,treated,O
123435,8534,with,O
123436,8534,mirabegron,B-Drug
123437,8534,within,O
123438,8534,60,O
123439,8534,days,O
123440,8534,prior,O
123441,8534,to,O
123442,8534,the,O
123443,8534,baseline,O
123444,8534,visit,O
123445,8534,(,O
123446,8534,Visit,O
123447,8534,2,O
123448,8534,),O
123449,8534,",",O
123450,8534,or,O
123451,8534,previously,O
123452,8534,having,O
123453,8534,failed,O
123454,8534,treatment,O
123455,8534,with,O
123456,8534,mirabegron,O
123457,8534,regardless,O
123458,8534,of,O
123459,8534,duration,O
123460,8534,and,O
123461,8534,timing,O
123462,8534,of,O
123463,8534,treatment,O
123464,8534,.,O
123465,8535,Current,O
123466,8535,or,O
123467,8535,previous,O
123468,8535,",",O
123469,8535,within,O
123470,8535,the,O
123471,8535,60,O
123472,8535,days,O
123473,8535,preceding,O
123474,8535,the,O
123475,8535,baseline,O
123476,8535,visit,O
123477,8535,(,O
123478,8535,Visit,O
123479,8535,2,O
123480,8535,),O
123481,8535,",",O
123482,8535,treatment,O
123483,8535,with,O
123484,8535,antimuscarinic,B-Drug
123485,8535,agents,I-Drug
123486,8535,for,O
123487,8535,OAB,B-Condition
123488,8535,symptoms,I-Condition
123489,8535,;,O
123490,8535,and,O
123491,8535,",",O
123492,8535,willingness,O
123493,8535,to,O
123494,8535,not,O
123495,8535,use,O
123496,8535,antimuscarinic,O
123497,8535,agents,O
123498,8535,for,O
123499,8535,the,O
123500,8535,duration,O
123501,8535,of,O
123502,8535,the,O
123503,8535,study,O
123504,8535,.,O
123505,8536,Currently,O
123506,8536,receiving,O
123507,8536,any,O
123508,8536,other,O
123509,8536,investigational,O
123510,8536,drug,O
123511,8536,or,O
123512,8536,having,O
123513,8536,received,O
123514,8536,an,O
123515,8536,investigational,O
123516,8536,drug,O
123517,8536,within,O
123518,8536,the,O
123519,8536,60,O
123520,8536,days,O
123521,8536,preceding,O
123522,8536,the,O
123523,8536,baseline,O
123524,8536,visit,O
123525,8536,(,O
123526,8536,Visit,O
123527,8536,2,O
123528,8536,),O
123529,8536,.,O
123530,8537,Any,O
123531,8537,condition,O
123532,8537,or,O
123533,8537,laboratory,O
123534,8537,test,O
123535,8537,result,O
123536,8537,",",O
123537,8537,which,O
123538,8537,",",O
123539,8537,in,O
123540,8537,the,O
123541,8537,opinion,O
123542,8537,of,O
123543,8537,the,O
123544,8537,Investigator,O
123545,8537,or,O
123546,8537,the,O
123547,8537,Study,O
123548,8537,Urologist,O
123549,8537,",",O
123550,8537,might,O
123551,8537,result,O
123552,8537,in,O
123553,8537,an,O
123554,8537,increased,O
123555,8537,risk,O
123556,8537,to,O
123557,8537,the,O
123558,8537,patient,O
123559,8537,",",O
123560,8537,or,O
123561,8537,would,O
123562,8537,affect,O
123563,8537,their,O
123564,8537,participation,O
123565,8537,in,O
123566,8537,the,O
123567,8537,study,O
123568,8537,.,O
123569,8538,Any,O
123570,8538,patient,O
123571,8538,who,O
123572,8538,",",O
123573,8538,in,O
123574,8538,the,O
123575,8538,opinion,O
123576,8538,of,O
123577,8538,the,O
123578,8538,Investigator,O
123579,8538,",",O
123580,8538,is,O
123581,8538,not,O
123582,8538,a,O
123583,8538,good,O
123584,8538,candidate,O
123585,8538,for,O
123586,8538,the,O
123587,8538,study,O
123588,8538,or,O
123589,8538,will,O
123590,8538,not,O
123591,8538,be,O
123592,8538,able,O
123593,8538,to,O
123594,8538,follow,O
123595,8538,study,O
123596,8538,procedures,O
123597,8538,.,O
123598,8539,Aged,B-Person
123599,8539,25,O
123600,8539,-,O
123601,8539,80,O
123602,8539,at,O
123603,8539,screening,O
123604,8539,.,O
123605,8539,Subjects,O
123606,8539,older,O
123607,8539,than,O
123608,8539,80,O
123609,8539,will,O
123610,8539,be,O
123611,8539,allowed,O
123612,8539,at,O
123613,8539,the,O
123614,8539,discretion,O
123615,8539,of,O
123616,8539,the,O
123617,8539,PI,O
123618,8539,.,O
123619,8540,Ambulatory,B-Person
123620,8540,(,O
123621,8540,defined,O
123622,8540,as,O
123623,8540,able,O
123624,8540,to,O
123625,8540,ambulate,O
123626,8540,at,O
123627,8540,least,O
123628,8540,10,O
123629,8540,meters,O
123630,8540,",",O
123631,8540,with,O
123632,8540,or,O
123633,8540,without,O
123634,8540,assistance,O
123635,8540,),O
123636,8540,.,O
123637,8541,Clinical,O
123638,8541,Diagnosis,O
123639,8541,of,O
123640,8541,PD,B-Condition
123641,8541,based,O
123642,8541,on,O
123643,8541,the,O
123644,8541,United,O
123645,8541,Kingdom,O
123646,8541,Brain,O
123647,8541,Bank,O
123648,8541,diagnostic,O
123649,8541,criteria,O
123650,8541,for,O
123651,8541,PD,O
123652,8541,.,O
123653,8542,At,O
123654,8542,least,O
123655,8542,8,O
123656,8542,micturitions,B-Condition
123657,8542,per,O
123658,8542,24,O
123659,8542,hours,O
123660,8542,and,O
123661,8543,At,O
123662,8543,least,O
123663,8543,3,O
123664,8543,urgency,B-Condition
123665,8543,episodes,I-Condition
123666,8543,per,O
123667,8543,3,O
123668,8543,-,O
123669,8543,day,O
123670,8543,diary,O
123671,8543,.,O
123672,8544,A,O
123673,8544,MoCA,O
123674,8544,score,O
123675,8544,between,O
123676,8544,19,O
123677,8544,and,O
123678,8544,28,O
123679,8544,(,O
123680,8544,inclusive,O
123681,8544,),O
123682,8544,at,O
123683,8544,screening,O
123684,8544,.,O
123685,8544,For,O
123686,8544,those,O
123687,8544,on,O
123688,8544,cognitive,B-Procedure
123689,8544,enhancers,I-Procedure
123690,8544,(,O
123691,8544,donepezil,B-Drug
123692,8544,",",O
123693,8544,rivastigmine,B-Drug
123694,8544,",",O
123695,8544,memantine,B-Drug
123696,8544,",",O
123697,8544,galantamine,B-Drug
123698,8544,),O
123699,8544,a,O
123700,8544,MoCA,O
123701,8544,score,O
123702,8544,between,O
123703,8544,19,O
123704,8544,and,O
123705,8544,29,O
123706,8544,(,O
123707,8544,inclusive,O
123708,8544,),O
123709,8544,at,O
123710,8544,screening,O
123711,8544,.,O
123712,8545,Provide,O
123713,8545,informed,O
123714,8545,consent,O
123715,8545,to,O
123716,8545,participate,O
123717,8545,in,O
123718,8545,the,O
123719,8545,study,O
123720,8545,and,O
123721,8545,understand,O
123722,8545,that,O
123723,8545,they,O
123724,8545,may,O
123725,8545,withdraw,O
123726,8545,their,O
123727,8545,consent,O
123728,8545,at,O
123729,8545,any,O
123730,8545,time,O
123731,8545,without,O
123732,8545,prejudice,O
123733,8545,to,O
123734,8545,their,O
123735,8545,future,O
123736,8545,medical,O
123737,8545,care,O
123738,8545,.,O
123739,8546,Be,O
123740,8546,cognitively,O
123741,8546,capable,O
123742,8546,",",O
123743,8546,in,O
123744,8546,the,O
123745,8546,opinion,O
123746,8546,of,O
123747,8546,investigator,O
123748,8546,",",O
123749,8546,to,O
123750,8546,understand,O
123751,8546,and,O
123752,8546,provide,O
123753,8546,such,O
123754,8546,informed,O
123755,8546,consent,O
123756,8546,.,O
123757,8547,Be,O
123758,8547,cognitively,O
123759,8547,capable,O
123760,8547,to,O
123761,8547,complete,O
123762,8547,the,O
123763,8547,required,O
123764,8547,questionnaires,O
123765,8547,and,O
123766,8547,assessments,O
123767,8547,",",O
123768,8547,OR,O
123769,8547,have,O
123770,8547,a,O
123771,8547,care,O
123772,8547,partner,O
123773,8547,who,O
123774,8547,is,O
123775,8547,willing,O
123776,8547,and,O
123777,8547,capable,O
123778,8547,to,O
123779,8547,assist,O
123780,8547,them,O
123781,8547,in,O
123782,8547,the,O
123783,8547,completion,O
123784,8547,of,O
123785,8547,these,O
123786,8547,tasks,O
123787,8547,.,O
123788,8548,Be,O
123789,8548,on,O
123790,8548,a,O
123791,8548,stable,O
123792,8548,regimen,O
123793,8548,of,O
123794,8548,antiparkinson,B-Drug
123795,8548,'s,I-Drug
123796,8548,medications,I-Drug
123797,8548,at,O
123798,8548,least,O
123799,8548,30,O
123800,8548,days,O
123801,8548,prior,O
123802,8548,to,O
123803,8548,screening,O
123804,8548,",",O
123805,8548,and,O
123806,8548,be,O
123807,8548,expected,O
123808,8548,to,O
123809,8548,remain,O
123810,8548,on,O
123811,8548,a,O
123812,8548,stable,O
123813,8548,dose,O
123814,8548,for,O
123815,8548,the,O
123816,8548,duration,O
123817,8548,of,O
123818,8548,the,O
123819,8548,study,O
123820,8548,.,O
123821,8549,If,O
123822,8549,taking,O
123823,8549,cognitive,B-Procedure
123824,8549,enhancers,I-Procedure
123825,8549,(,O
123826,8549,donepezil,B-Drug
123827,8549,",",O
123828,8549,rivastigmine,B-Drug
123829,8549,",",O
123830,8549,memantine,B-Drug
123831,8549,",",O
123832,8549,galantamine,B-Drug
123833,8549,),O
123834,8549,",",O
123835,8549,must,O
123836,8549,be,O
123837,8549,on,O
123838,8549,stable,O
123839,8549,dose,O
123840,8549,at,O
123841,8549,least,O
123842,8549,30,O
123843,8549,days,O
123844,8549,prior,O
123845,8549,to,O
123846,8549,screening,O
123847,8549,",",O
123848,8549,and,O
123849,8549,be,O
123850,8549,expected,O
123851,8549,to,O
123852,8549,remain,O
123853,8549,on,O
123854,8549,a,O
123855,8549,stable,O
123856,8549,dose,O
123857,8549,for,O
123858,8549,the,O
123859,8549,duration,O
123860,8549,of,O
123861,8549,the,O
123862,8549,study,O
123863,8549,.,O
123864,8550,vulnerable,B-Condition
123865,8550,study,O
123866,8550,subjects,O
123867,8550,such,O
123868,8550,as,O
123869,8550,described,O
123870,8550,in,O
123871,8550,Finnish,O
123872,8550,law,O
123873,8550,concerning,O
123874,8550,clinical,O
123875,8550,studies,O
123876,8550,(,O
123877,8550,disabled,B-Condition
123878,8550,",",O
123879,8550,children,B-Person
123880,8550,",",O
123881,8550,pregnant,B-Condition
123882,8550,or,O
123883,8550,breast,B-Condition
123884,8550,-,I-Condition
123885,8550,feeding,I-Condition
123886,8550,women,B-Person
123887,8550,",",O
123888,8550,prisoners,B-Observation
123889,8550,),O
123890,8550,will,O
123891,8550,not,O
123892,8550,be,O
123893,8550,included,O
123894,8550,.,O
123895,8551,suspicion,B-Mood
123896,8551,of,O
123897,8551,nonfunctional,B-Condition
123898,8551,P,I-Condition
123899,8551,-,I-Condition
123900,8551,NET,I-Condition
123901,8551,on,O
123902,8551,primary,B-Procedure
123903,8551,CT,I-Procedure
123904,8551,(,O
123905,8551,i.e,O
123906,8551,hypervascularity,B-Condition
123907,8551,),O
123908,8551,or,O
123909,8551,MRI,B-Procedure
123910,8552,signed,O
123911,8552,informed,O
123912,8552,consent,O
123913,8553,Active,O
123914,8553,consumption,B-Condition
123915,8553,of,I-Condition
123916,8553,alcohol,I-Condition
123917,8553,and/or,O
123918,8553,drugs,O
123919,8554,Co,O
123920,8554,-,O
123921,8554,infection,O
123922,8554,with,O
123923,8554,human,B-Condition
123924,8554,immunodeficiency,I-Condition
123925,8554,virus,I-Condition
123926,8554,",",O
123927,8554,hepatitis,B-Condition
123928,8554,C,I-Condition
123929,8554,virus,I-Condition
123930,8554,",",O
123931,8554,or,O
123932,8554,hepatitis,B-Condition
123933,8554,D,I-Condition
123934,8554,virus,I-Condition
123935,8555,History,B-Observation
123936,8555,of,O
123937,8555,autoimmune,B-Condition
123938,8555,hepatitis,I-Condition
123939,8556,Psychiatric,B-Condition
123940,8556,disease,I-Condition
123941,8557,Evidence,B-Mood
123942,8557,of,I-Mood
123943,8557,neoplastic,B-Condition
123944,8557,diseases,I-Condition
123945,8557,of,O
123946,8557,the,O
123947,8557,liver,O
123948,8558,HBsAg,B-Condition
123949,8558,and,I-Condition
123950,8558,HBeAg,I-Condition
123951,8558,positive,I-Condition
123952,8558,for,O
123953,8558,more,O
123954,8558,than,O
123955,8558,6,O
123956,8558,months,O
123957,8558,",",O
123958,8558,HBV,B-Condition
123959,8558,DNA,I-Condition
123960,8558,detectable,I-Condition
123961,8558,with,O
123962,8558,ALT,O
123963,8558,level,O
123964,8558,abnormal,O
123965,8558,lasted,O
123966,8558,for,O
123967,8558,three,O
123968,8558,months,O
123969,8558,and,O
123970,8558,at,O
123971,8558,least,O
123972,8558,time190,O
123973,8558,IU,O
123974,8558,/,O
123975,8558,L,O
123976,8558,or,O
123977,8558,liver,B-Procedure
123978,8558,puncture,I-Procedure
123979,8558,biopsy,I-Procedure
123980,8558,demonstrated,O
123981,8558,apparent,O
123982,8558,inflammation,B-Condition
123983,8558,",",O
123984,8558,never,O
123985,8558,treated,B-Procedure
123986,8558,before,O
123987,8558,enrolled,O
123988,8558,.,O
123989,8559,Had,O
123990,8559,dose,O
123991,8559,increase,O
123992,8559,of,O
123993,8559,anti,B-Drug
123994,8559,-,I-Drug
123995,8559,TNF,I-Drug
123996,8559,agent,I-Drug
123997,8559,or,O
123998,8559,DMARD,B-Drug
123999,8559,in,O
124000,8559,the,O
124001,8559,last,O
124002,8559,6,O
124003,8559,months,O
124004,8560,Had,O
124005,8560,change,B-Procedure
124006,8560,of,O
124007,8560,anti,B-Drug
124008,8560,-,I-Drug
124009,8560,TNF,I-Drug
124010,8560,agent,I-Drug
124011,8560,or,O
124012,8560,DMARD,B-Drug
124013,8560,in,O
124014,8560,the,O
124015,8560,last,O
124016,8560,6,O
124017,8560,months,O
124018,8561,Treated,O
124019,8561,currently,O
124020,8561,with,O
124021,8561,golimumab,B-Drug
124022,8561,or,O
124023,8561,certolizumab,B-Drug
124024,8562,Treated,O
124025,8562,with,O
124026,8562,greater,O
124027,8562,than,O
124028,8562,10,O
124029,8562,mg,O
124030,8562,of,O
124031,8562,prednisone,B-Drug
124032,8562,(,O
124033,8562,or,O
124034,8562,equivalent,O
124035,8562,),O
124036,8562,daily,O
124037,8562,in,O
124038,8562,the,O
124039,8562,last,O
124040,8562,6,O
124041,8562,months,O
124042,8563,Treated,O
124043,8563,with,O
124044,8563,greater,O
124045,8563,than,O
124046,8563,5,O
124047,8563,mg,O
124048,8563,of,O
124049,8563,prednisone,B-Drug
124050,8563,(,O
124051,8563,or,O
124052,8563,equivalent,O
124053,8563,),O
124054,8563,daily,O
124055,8563,in,O
124056,8563,the,O
124057,8563,last,O
124058,8563,3,O
124059,8563,months,O
124060,8564,Treated,O
124061,8564,with,O
124062,8564,intramuscular,O
124063,8564,or,O
124064,8564,intravenous,O
124065,8564,corticosteroids,B-Drug
124066,8564,in,O
124067,8564,the,O
124068,8564,last,O
124069,8564,6,O
124070,8564,months,O
124071,8564,for,O
124072,8564,RA,B-Condition
124073,8564,activity,O
124074,8565,Treated,O
124075,8565,with,O
124076,8565,anakinra,B-Drug
124077,8565,",",O
124078,8565,abatacept,B-Drug
124079,8565,",",O
124080,8565,or,O
124081,8565,tocilizumab,B-Drug
124082,8565,in,O
124083,8565,the,O
124084,8565,last,O
124085,8565,6,O
124086,8565,months,O
124087,8566,Treated,O
124088,8566,with,O
124089,8566,rituximab,B-Drug
124090,8566,in,O
124091,8566,the,O
124092,8566,last,O
124093,8566,12,O
124094,8566,months,O
124095,8567,Treated,O
124096,8567,with,O
124097,8567,an,O
124098,8567,investigational,O
124099,8567,RA,B-Drug
124100,8567,drug,I-Drug
124101,8567,in,O
124102,8567,the,O
124103,8567,last,O
124104,8567,6,O
124105,8567,months,O
124106,8568,Pregnant,B-Condition
124107,8568,(,O
124108,8568,or,O
124109,8568,anticipate,B-Mood
124110,8568,pregnancy,I-Mood
124111,8568,during,I-Mood
124112,8568,the,I-Mood
124113,8568,study,I-Mood
124114,8568,period,I-Mood
124115,8568,),O
124116,8568,or,O
124117,8568,lactating,B-Condition
124118,8568,women,B-Person
124119,8569,Absence,O
124120,8569,of,O
124121,8569,documentation,O
124122,8569,in,O
124123,8569,the,O
124124,8569,medical,O
124125,8569,record,O
124126,8569,of,O
124127,8569,clinical,B-Condition
124128,8569,remission,I-Condition
124129,8569,for,O
124130,8569,the,O
124131,8569,last,O
124132,8569,6,O
124133,8569,months,O
124134,8570,Unwilling,B-Mood
124135,8570,to,O
124136,8570,discontinue,B-Procedure
124137,8570,anti,B-Drug
124138,8570,-,I-Drug
124139,8570,TNF,I-Drug
124140,8570,agent,I-Drug
124141,8571,Absence,O
124142,8571,of,O
124143,8571,documentation,O
124144,8571,of,O
124145,8571,negative,O
124146,8571,tuberculin,B-Procedure
124147,8571,skin,I-Procedure
124148,8571,test,I-Procedure
124149,8571,",",O
124150,8571,negative,O
124151,8571,QuantiFERON,O
124152,8571,-,O
124153,8571,TB,O
124154,8571,Gold,O
124155,8571,test,O
124156,8571,",",O
124157,8571,or,O
124158,8571,treatment,B-Procedure
124159,8571,for,O
124160,8571,latent,O
124161,8571,tuberculosis,B-Condition
124162,8571,prior,O
124163,8571,to,O
124164,8571,starting,O
124165,8571,treatment,B-Procedure
124166,8571,with,I-Procedure
124167,8571,the,I-Procedure
124168,8571,anti,I-Procedure
124169,8571,-,I-Procedure
124170,8571,TNF,I-Procedure
124171,8571,agent,I-Procedure
124172,8572,Treatment,O
124173,8572,of,O
124174,8572,solid,B-Condition
124175,8572,malignancy,I-Condition
124176,8572,or,O
124177,8572,non,B-Condition
124178,8572,-,I-Condition
124179,8572,melanoma,I-Condition
124180,8572,skin,I-Condition
124181,8572,cancer,I-Condition
124182,8572,within,O
124183,8572,the,O
124184,8572,past,O
124185,8572,5,O
124186,8572,years,O
124187,8572,",",O
124188,8572,or,O
124189,8572,any,O
124190,8572,history,O
124191,8572,of,O
124192,8572,melanoma,B-Condition
124193,8572,or,O
124194,8572,hematologic,B-Condition
124195,8572,or,O
124196,8572,lymphoproliferative,B-Condition
124197,8572,malignancy,I-Condition
124198,8573,Absence,O
124199,8573,of,O
124200,8573,documentation,O
124201,8573,of,O
124202,8573,age,O
124203,8573,-,O
124204,8573,appropriate,O
124205,8573,cancer,B-Procedure
124206,8573,screening,I-Procedure
124207,8573,at,O
124208,8573,the,O
124209,8573,time,O
124210,8573,of,O
124211,8573,randomization,O
124212,8574,Absence,O
124213,8574,of,O
124214,8574,documentation,O
124215,8574,of,O
124216,8574,negative,O
124217,8574,hepatitis,O
124218,8574,B,O
124219,8574,serologies,O
124220,8574,",",O
124221,8574,absence,O
124222,8574,of,O
124223,8574,completion,O
124224,8574,of,O
124225,8574,treatment,B-Procedure
124226,8574,for,O
124227,8574,chronic,B-Condition
124228,8574,hepatitis,I-Condition
124229,8574,B,I-Condition
124230,8574,",",O
124231,8574,or,O
124232,8574,absence,O
124233,8574,of,O
124234,8574,suppressive,B-Procedure
124235,8574,antiviral,I-Procedure
124236,8574,treatment,I-Procedure
124237,8575,Unable,O
124238,8575,to,O
124239,8575,provide,O
124240,8575,informed,O
124241,8575,consent,O
124242,8576,Anticipate,O
124243,8576,not,O
124244,8576,being,O
124245,8576,available,O
124246,8576,or,O
124247,8576,able,O
124248,8576,to,O
124249,8576,comply,O
124250,8576,with,O
124251,8576,the,O
124252,8576,schedule,O
124253,8576,of,O
124254,8576,study,O
124255,8576,visits,O
124256,8577,Age,B-Person
124257,8577,greater,O
124258,8577,than,O
124259,8577,or,O
124260,8577,equal,O
124261,8577,to,O
124262,8577,18,O
124263,8577,years,O
124264,8578,Have,O
124265,8578,RA,B-Condition
124266,8578,",",O
124267,8578,as,O
124268,8578,defined,O
124269,8578,by,O
124270,8578,the,O
124271,8578,1987,O
124272,8578,revised,O
124273,8578,American,O
124274,8578,College,O
124275,8578,of,O
124276,8578,Rheumatology,O
124277,8578,criteria,O
124278,8579,In,O
124279,8579,sustained,B-Condition
124280,8579,clinical,I-Condition
124281,8579,remission,I-Condition
124282,8579,for,O
124283,8579,the,O
124284,8579,last,O
124285,8579,6,O
124286,8579,months,O
124287,8579,while,O
124288,8579,receiving,O
124289,8579,treatment,O
124290,8579,with,O
124291,8579,either,O
124292,8579,etanercept,B-Drug
124293,8579,",",O
124294,8579,infliximab,B-Drug
124295,8579,",",O
124296,8579,or,O
124297,8579,adalimumab,B-Drug
124298,8579,",",O
124299,8579,and,O
124300,8579,greater,O
124301,8579,than,O
124302,8579,or,O
124303,8579,equal,O
124304,8579,to,O
124305,8579,1,O
124306,8579,DMARD,B-Drug
124307,8579,(,O
124308,8579,methotrexate,B-Drug
124309,8579,",",O
124310,8579,hydroxychloroquine,B-Drug
124311,8579,",",O
124312,8579,sulfasalazine,B-Drug
124313,8579,",",O
124314,8579,leflunomide,B-Drug
124315,8579,",",O
124316,8579,minocycline,B-Drug
124317,8579,",",O
124318,8579,cyclosporine,B-Drug
124319,8579,",",O
124320,8579,azathioprine,B-Drug
124321,8579,",",O
124322,8579,gold,B-Drug
124323,8579,",",O
124324,8579,penicillamine,B-Drug
124325,8579,),O
124326,8579,.,O
124327,8579,DAS28,O
124328,8579,should,O
124329,8579,be,O
124330,8579,less,O
124331,8579,than,O
124332,8579,2.6,O
124333,8579,on,O
124334,8579,each,O
124335,8579,visit,B-Procedure
124336,8579,over,O
124337,8579,the,O
124338,8579,preceding,O
124339,8579,6,O
124340,8579,months,O
124341,8579,",",O
124342,8579,with,O
124343,8579,at,O
124344,8579,least,O
124345,8579,one,O
124346,8579,visit,B-Procedure
124347,8579,2,O
124348,8579,-,O
124349,8579,4,O
124350,8579,months,O
124351,8579,before,O
124352,8579,enrollment,O
124353,8579,.,O
124354,8579,If,O
124355,8579,there,O
124356,8579,is,O
124357,8579,no,O
124358,8579,visit,O
124359,8579,6,O
124360,8579,months,O
124361,8579,before,O
124362,8579,enrollment,O
124363,8579,",",O
124364,8579,the,O
124365,8579,nearest,O
124366,8579,visit,O
124367,8579,in,O
124368,8579,the,O
124369,8579,6,O
124370,8579,-,O
124371,8579,12,O
124372,8579,month,O
124373,8579,period,O
124374,8579,before,O
124375,8579,enrollment,O
124376,8579,should,O
124377,8579,be,O
124378,8579,considered,O
124379,8579,and,O
124380,8579,have,O
124381,8579,a,O
124382,8579,DAS28,O
124383,8579,less,O
124384,8579,than,O
124385,8579,2.6,O
124386,8579,.,O
124387,8580,1,O
124388,8580,.,O
124389,8580,Patient,O
124390,8580,with,O
124391,8580,equivocal,O
124392,8580,diagnosis,O
124393,8580,of,O
124394,8580,rupture,B-Condition
124395,8580,of,I-Condition
124396,8580,membranes,I-Condition
124397,8581,2,O
124398,8581,.,O
124399,8581,advanced,B-Condition
124400,8581,labor,I-Condition
124401,8582,3,O
124402,8582,.,O
124403,8582,intrauterine,B-Condition
124404,8582,infection,I-Condition
124405,8583,4,O
124406,8583,.,O
124407,8583,vaginal,B-Condition
124408,8583,bleeding,I-Condition
124409,8583,or,O
124410,8584,5,O
124411,8584,.,O
124412,8584,non,O
124413,8584,reassuring,O
124414,8584,fetal,O
124415,8584,heart,O
124416,8584,rate,O
124417,8584,.,O
124418,8585,1,O
124419,8585,.,O
124420,8585,PPROM,B-Condition
124421,8585,with,O
124422,8585,gestational,O
124423,8585,age,O
124424,8585,between,O
124425,8585,27,O
124426,8585,to,O
124427,8585,34,O
124428,8585,weeks,O
124429,8586,2,O
124430,8586,.,O
124431,8586,Cephalic,B-Condition
124432,8586,presentation,I-Condition
124433,8587,3,O
124434,8587,.,O
124435,8587,Clear,B-Observation
124436,8587,amniotic,I-Observation
124437,8587,fluid,I-Observation
124438,8588,4,O
124439,8588,.,O
124440,8588,Oral,O
124441,8588,temperature,O
124442,8588,>,O
124443,8588,38,O
124444,8588,C,O
124445,8589,5,O
124446,8589,.,O
124447,8589,Near,O
124448,8589,distance,O
124449,8589,from,O
124450,8589,the,O
124451,8589,hospital,O
124452,8589,(,O
124453,8589,the,O
124454,8589,patient,O
124455,8589,can,O
124456,8589,reach,O
124457,8589,hospital,O
124458,8589,within,O
124459,8589,one,O
124460,8589,hour,O
124461,8589,),O
124462,8590,6,O
124463,8590,.,O
124464,8590,Home,O
124465,8590,environment,O
124466,8590,safe,O
124467,8590,and,O
124468,8590,amenable,O
124469,8590,to,O
124470,8590,rest,O
124471,8590,",",O
124472,8590,availability,O
124473,8590,of,O
124474,8590,family,O
124475,8590,support,O
124476,8590,such,O
124477,8590,as,O
124478,8590,a,O
124479,8590,sister,O
124480,8590,or,O
124481,8590,mother,O
124482,8590,who,O
124483,8590,will,O
124484,8590,help,O
124485,8590,the,O
124486,8590,patient,O
124487,8590,at,O
124488,8590,home,O
124489,8590,.,O
124490,8591,7,O
124491,8591,.,O
124492,8591,Maternal,B-Condition
124493,8591,and,I-Condition
124494,8591,fetal,I-Condition
124495,8591,condition,I-Condition
124496,8591,remain,O
124497,8591,stable,O
124498,8591,after,O
124499,8591,hospitalization,O
124500,8591,for,O
124501,8591,72,O
124502,8591,hours,O
124503,8592,contraindications,B-Condition
124504,8592,from,O
124505,8592,manufacturer,O
124506,8592,for,O
124507,8592,medications,O
124508,8592,including,O
124509,8592,currently,O
124510,8592,taking,O
124511,8592,haloperidol,B-Drug
124512,8592,",",O
124513,8592,artane,B-Drug
124514,8592,",",O
124515,8592,Phenergan,B-Drug
124516,8592,(,O
124517,8592,Promethazine,B-Drug
124518,8592,),O
124519,8592,",",O
124520,8592,chlorpromazine,B-Drug
124521,8592,",",O
124522,8592,erythromycin,B-Drug
124523,8592,",",O
124524,8592,Azithromycin,B-Drug
124525,8592,",",O
124526,8592,clarithromycin,B-Drug
124527,8592,",",O
124528,8592,Ketoconazole,B-Drug
124529,8592,",",O
124530,8592,fluconazole,B-Drug
124531,8592,",",O
124532,8592,mefloquine,B-Drug
124533,8592,(,O
124534,8592,as,O
124535,8592,prophylaxis,O
124536,8592,),O
124537,8592,",",O
124538,8592,lumefantrine,B-Drug
124539,8592,(,O
124540,8592,in,O
124541,8592,Coartem,B-Drug
124542,8592,),O
124543,8592,",",O
124544,8592,quinine,B-Drug
124545,8592,",",O
124546,8592,Septrin,B-Drug
124547,8593,anyone,O
124548,8593,seriously,B-Condition
124549,8593,ill,I-Condition
124550,8594,currently,O
124551,8594,taking,O
124552,8594,antimalarial,B-Drug
124553,8594,medicines,I-Drug
124554,8595,allergy,B-Condition
124555,8595,to,O
124556,8595,artemisinin,B-Drug
124557,8595,drugs,I-Drug
124558,8596,pregnant,B-Condition
124559,8596,women,B-Person
124560,8596,in,O
124561,8596,first,B-Condition
124562,8596,trimester,I-Condition
124563,8597,children,B-Person
124564,8597,under,O
124565,8597,3,O
124566,8597,months,O
124567,8597,of,O
124568,8597,age,B-Person
124569,8598,reported,O
124570,8598,heart,B-Condition
124571,8598,condition,I-Condition
124572,8599,anyone,O
124573,8599,not,O
124574,8599,excluded,O
124575,8599,and,O
124576,8599,consenting,O
124577,8600,NA,O
124578,8601,Patient,O
124579,8601,>,O
124580,8601,18,O
124581,8601,years,O
124582,8601,of,O
124583,8601,age,B-Person
124584,8602,Patient,O
124585,8602,presents,O
124586,8602,with,O
124587,8602,acute,B-Condition
124588,8602,coronary,I-Condition
124589,8602,syndrome,I-Condition
124590,8602,(,O
124591,8602,ACS,B-Condition
124592,8602,),O
124593,8602,or,O
124594,8602,stable,O
124595,8602,coronary,B-Condition
124596,8602,artery,I-Condition
124597,8602,disease,I-Condition
124598,8602,(,O
124599,8602,CAD,B-Condition
124600,8602,),O
124601,8603,Patient,O
124602,8603,is,O
124603,8603,eligible,B-Mood
124604,8603,for,O
124605,8603,PCI,B-Procedure
124606,8604,Patient,O
124607,8604,is,O
124608,8604,willing,O
124609,8604,and,O
124610,8604,able,O
124611,8604,to,O
124612,8604,provide,O
124613,8604,informed,O
124614,8604,written,O
124615,8604,consent,O
124616,8605,Patient,O
124617,8605,not,O
124618,8605,able,B-Condition
124619,8605,to,I-Condition
124620,8605,receive,I-Condition
124621,8605,12,O
124622,8605,months,O
124623,8605,of,O
124624,8605,dual,B-Procedure
124625,8605,anti,I-Procedure
124626,8605,-,I-Procedure
124627,8605,platelet,I-Procedure
124628,8605,therapy,I-Procedure
124629,8606,Failure,B-Observation
124630,8606,of,O
124631,8606,index,O
124632,8606,PCI,B-Procedure
124633,8607,Patient,O
124634,8607,or,O
124635,8607,physician,O
124636,8607,refusal,O
124637,8607,to,O
124638,8607,enroll,O
124639,8607,in,O
124640,8607,the,O
124641,8607,study,O
124642,8608,Patient,O
124643,8608,with,O
124644,8608,known,O
124645,8608,CYP2C19,B-Condition
124646,8608,genotype,I-Condition
124647,8608,prior,O
124648,8608,to,O
124649,8608,randomization,O
124650,8609,Planned,B-Mood
124651,8609,revascularization,B-Procedure
124652,8609,of,O
124653,8609,any,O
124654,8609,vessel,O
124655,8609,within,O
124656,8609,30,O
124657,8609,days,O
124658,8609,post,O
124659,8609,-,O
124660,8609,index,O
124661,8609,procedure,O
124662,8609,and/or,O
124663,8609,of,O
124664,8609,the,O
124665,8609,target,O
124666,8609,vessel(s,O
124667,8609,),O
124668,8609,within,O
124669,8609,12,O
124670,8609,months,O
124671,8609,post,O
124672,8609,-,O
124673,8609,procedure,O
124674,8610,Anticipated,O
124675,8610,discontinuation,O
124676,8610,of,O
124677,8610,clopidogrel,B-Drug
124678,8610,or,O
124679,8610,ticagrelor,B-Drug
124680,8610,within,O
124681,8610,the,O
124682,8610,12,O
124683,8610,month,O
124684,8610,follow,O
124685,8610,up,O
124686,8610,period,O
124687,8610,",",O
124688,8610,example,B-Mood
124689,8610,for,I-Mood
124690,8610,elective,B-Procedure
124691,8610,surgery,I-Procedure
124692,8611,Serum,O
124693,8611,creatinine,O
124694,8611,>,O
124695,8611,2.5,O
124696,8611,mg,O
124697,8611,/,O
124698,8611,dL,O
124699,8611,within,O
124700,8611,7,O
124701,8611,days,O
124702,8611,of,O
124703,8611,index,O
124704,8611,procedure,O
124705,8612,Platelet,O
124706,8612,count,O
124707,8612,<,O
124708,8612,"80,000",O
124709,8612,or,O
124710,8612,>,O
124711,8612,"700,000",O
124712,8612,cells,O
124713,8612,/,O
124714,8612,mm3,O
124715,8612,",",O
124716,8612,or,O
124717,8612,white,O
124718,8612,blood,O
124719,8612,cell,O
124720,8612,count,O
124721,8612,<,O
124722,8612,"3,000",O
124723,8612,cells,O
124724,8612,/,O
124725,8612,mm3,O
124726,8612,if,O
124727,8612,persistent,O
124728,8612,(,O
124729,8612,at,O
124730,8612,least,O
124731,8612,2,O
124732,8612,abnormal,O
124733,8612,values,O
124734,8612,),O
124735,8612,within,O
124736,8612,7,O
124737,8612,days,O
124738,8612,prior,O
124739,8612,to,O
124740,8612,index,O
124741,8612,procedure,O
124742,8612,.,O
124743,8613,History,O
124744,8613,of,O
124745,8613,intracranial,B-Condition
124746,8613,hemorrhage,I-Condition
124747,8614,Known,O
124748,8614,hypersensitivity,B-Condition
124749,8614,to,O
124750,8614,clopidogrel,B-Drug
124751,8614,or,O
124752,8614,ticagrelor,B-Drug
124753,8614,or,O
124754,8614,any,B-Drug
124755,8614,of,I-Drug
124756,8614,its,I-Drug
124757,8614,components,I-Drug
124758,8615,Patient,O
124759,8615,is,O
124760,8615,participating,O
124761,8615,in,O
124762,8615,an,O
124763,8615,investigational,O
124764,8615,drug,O
124765,8615,or,O
124766,8615,device,O
124767,8615,clinical,O
124768,8615,trial,O
124769,8615,that,O
124770,8615,has,O
124771,8615,not,O
124772,8615,reached,O
124773,8615,its,O
124774,8615,primary,O
124775,8615,endpoint,O
124776,8616,Patient,O
124777,8616,previously,O
124778,8616,enrolled,O
124779,8616,in,O
124780,8616,this,O
124781,8616,study,O
124782,8617,Patient,O
124783,8617,is,O
124784,8617,pregnant,B-Condition
124785,8617,",",O
124786,8617,lactating,B-Condition
124787,8617,",",O
124788,8617,or,O
124789,8617,planning,B-Mood
124790,8617,to,I-Mood
124791,8617,become,I-Mood
124792,8617,pregnant,B-Condition
124793,8617,within,O
124794,8617,12,O
124795,8617,months,O
124796,8618,Patient,O
124797,8618,has,O
124798,8618,received,O
124799,8618,an,O
124800,8618,organ,B-Procedure
124801,8618,transplant,I-Procedure
124802,8618,or,O
124803,8618,is,B-Mood
124804,8618,on,I-Mood
124805,8618,a,I-Mood
124806,8618,waiting,I-Mood
124807,8618,list,I-Mood
124808,8618,for,O
124809,8618,an,O
124810,8618,organ,B-Procedure
124811,8618,transplant,I-Procedure
124812,8619,Patient,O
124813,8619,is,B-Mood
124814,8619,receiving,I-Mood
124815,8619,or,O
124816,8619,scheduled,B-Mood
124817,8619,to,I-Mood
124818,8619,receive,I-Mood
124819,8619,chemotherapy,B-Procedure
124820,8619,within,O
124821,8619,30,O
124822,8619,days,O
124823,8619,before,O
124824,8619,or,O
124825,8619,after,O
124826,8619,the,O
124827,8619,procedure,O
124828,8620,Patient,O
124829,8620,is,O
124830,8620,receiving,O
124831,8620,immunosuppressive,B-Procedure
124832,8620,therapy,I-Procedure
124833,8620,or,O
124834,8620,has,O
124835,8620,known,O
124836,8620,immunosuppressive,B-Condition
124837,8620,or,I-Condition
124838,8620,autoimmune,I-Condition
124839,8620,disease,I-Condition
124840,8620,(,O
124841,8620,e.g.,O
124842,8620,",",O
124843,8620,human,B-Condition
124844,8620,immunodeficiency,I-Condition
124845,8620,virus,I-Condition
124846,8620,",",O
124847,8620,systemic,B-Condition
124848,8620,lupus,I-Condition
124849,8620,erythematous,I-Condition
124850,8620,",",O
124851,8620,etc,O
124852,8620,.,O
124853,8620,),O
124854,8621,Patient,O
124855,8621,is,O
124856,8621,receiving,O
124857,8621,chronic,O
124858,8621,oral,B-Procedure
124859,8621,anticoagulation,I-Procedure
124860,8621,therapy,I-Procedure
124861,8621,(,O
124862,8621,i.e.,O
124863,8621,",",O
124864,8621,vitamin,B-Drug
124865,8621,K,I-Drug
124866,8621,antagonist,I-Drug
124867,8621,",",O
124868,8621,direct,B-Drug
124869,8621,thrombin,I-Drug
124870,8621,inhibitor,I-Drug
124871,8621,",",O
124872,8621,Factor,B-Drug
124873,8621,Xa,I-Drug
124874,8621,inhibitor,I-Drug
124875,8621,),O
124876,8622,Concomitant,O
124877,8622,use,O
124878,8622,of,O
124879,8622,simvastatin,B-Drug
124880,8622,/,O
124881,8622,lovastatin,B-Drug
124882,8622,>,O
124883,8622,40,O
124884,8622,mg,O
124885,8622,qd,O
124886,8623,Concomitant,O
124887,8623,use,O
124888,8623,of,O
124889,8623,potent,B-Drug
124890,8623,CYP3A4,I-Drug
124891,8623,inhibitors,I-Drug
124892,8623,(,I-Drug
124893,8623,atazanavir,I-Drug
124894,8623,",",I-Drug
124895,8623,clarithromycin,I-Drug
124896,8623,",",I-Drug
124897,8623,indinavir,I-Drug
124898,8623,",",I-Drug
124899,8623,itraconazole,I-Drug
124900,8623,",",I-Drug
124901,8623,ketoconazole,I-Drug
124902,8623,",",I-Drug
124903,8623,nefazodone,I-Drug
124904,8623,",",I-Drug
124905,8623,nelfinavir,I-Drug
124906,8623,",",I-Drug
124907,8623,ritonavir,I-Drug
124908,8623,",",I-Drug
124909,8623,saquinavir,I-Drug
124910,8623,",",I-Drug
124911,8623,telithromycin,I-Drug
124912,8623,and,I-Drug
124913,8623,voriconazole,I-Drug
124914,8623,),I-Drug
124915,8623,or,I-Drug
124916,8623,inducers,I-Drug
124917,8623,(,O
124918,8623,carbamazepine,B-Drug
124919,8623,",",O
124920,8623,dexamethasone,B-Drug
124921,8623,",",O
124922,8623,phenobarbital,B-Drug
124923,8623,",",O
124924,8623,phenytoin,B-Drug
124925,8623,",",O
124926,8623,rifampin,B-Drug
124927,8623,",",O
124928,8623,and,O
124929,8623,rifapentine,B-Drug
124930,8623,),O
124931,8624,Non,B-Condition
124932,8624,-,I-Condition
124933,8624,cardiac,I-Condition
124934,8624,condition,I-Condition
124935,8624,limiting,O
124936,8624,life,B-Observation
124937,8624,expectancy,I-Observation
124938,8624,to,O
124939,8624,less,O
124940,8624,than,O
124941,8624,one,O
124942,8624,year,O
124943,8624,",",O
124944,8624,per,O
124945,8624,physician,O
124946,8624,judgment,O
124947,8624,(,O
124948,8624,e.g.,O
124949,8624,cancer,O
124950,8624,),O
124951,8625,Known,O
124952,8625,history,O
124953,8625,of,O
124954,8625,severe,O
124955,8625,hepatic,B-Condition
124956,8625,impairment,I-Condition
124957,8626,Patient,O
124958,8626,has,O
124959,8626,a,O
124960,8626,history,O
124961,8626,of,O
124962,8626,bleeding,B-Condition
124963,8626,diathesis,I-Condition
124964,8626,or,O
124965,8626,coagulopathy,B-Condition
124966,8626,or,O
124967,8626,will,B-Mood
124968,8626,refuse,I-Mood
124969,8626,blood,B-Procedure
124970,8626,transfusions,I-Procedure
124971,8627,Patient,O
124972,8627,has,O
124973,8627,an,O
124974,8627,active,O
124975,8627,pathological,B-Condition
124976,8627,bleeding,I-Condition
124977,8627,",",O
124978,8627,such,O
124979,8627,as,O
124980,8627,active,O
124981,8627,gastrointestinal,B-Condition
124982,8627,(,I-Condition
124983,8627,GI,I-Condition
124984,8627,),I-Condition
124985,8627,bleeding,I-Condition
124986,8628,Inability,B-Condition
124987,8628,to,I-Condition
124988,8628,take,I-Condition
124989,8628,aspirin,B-Drug
124990,8628,at,O
124991,8628,a,O
124992,8628,dosage,O
124993,8628,of,O
124994,8628,100,O
124995,8628,mg,O
124996,8628,or,O
124997,8628,less,O
124998,8629,Current,O
124999,8629,substance,B-Condition
125000,8629,abuse,I-Condition
125001,8629,(,O
125002,8629,e.g.,O
125003,8629,",",O
125004,8629,alcohol,O
125005,8629,",",O
125006,8629,cocaine,O
125007,8629,",",O
125008,8629,heroin,O
125009,8629,",",O
125010,8629,etc,O
125011,8629,.,O
125012,8629,),O
125013,8630,Secondary,B-Condition
125014,8630,hypertension,I-Condition
125015,8630,or,O
125016,8630,malignant,B-Condition
125017,8630,hypertension,I-Condition
125018,8631,Diabetes,B-Condition
125019,8631,mellitus,I-Condition
125020,8632,History,B-Observation
125021,8632,or,O
125022,8632,evidence,B-Mood
125023,8632,of,O
125024,8632,a,O
125025,8632,stroke,B-Condition
125026,8633,Hepatic,B-Condition
125027,8633,or,I-Condition
125028,8633,hematologic,I-Condition
125029,8633,abnormality,I-Condition
125030,8634,Mild,B-Condition
125031,8634,Cognitive,I-Condition
125032,8634,Impairment,I-Condition
125033,8634,or,O
125034,8634,Dementia,B-Condition
125035,8635,Serum,O
125036,8635,potassium,O
125037,8635,level,O
125038,8635,=,O
125039,8635,5.5,O
125040,8635,mEq,O
125041,8635,/,O
125042,8635,L,O
125043,8636,Serum,O
125044,8636,creatinine,O
125045,8636,level,O
125046,8636,=,O
125047,8636,3.0,O
125048,8636,mg,O
125049,8636,/,O
125050,8636,dL,O
125051,8637,Acute,B-Condition
125052,8637,or,I-Condition
125053,8637,chronic,I-Condition
125054,8637,disease,I-Condition
125055,8638,Allergy,B-Condition
125056,8638,to,O
125057,8638,any,B-Drug
125058,8638,drugs,I-Drug
125059,8639,Pregnancy,B-Condition
125060,8640,Written,O
125061,8640,informed,O
125062,8640,consent,O
125063,8640,obtained,O
125064,8641,Male,B-Person
125065,8641,and,O
125066,8641,female,B-Person
125067,8641,subjects,O
125068,8641,aged,B-Person
125069,8641,20,O
125070,8641,years,O
125071,8641,or,O
125072,8641,older,O
125073,8641,at,O
125074,8641,informed,O
125075,8641,consent,O
125076,8642,Essential,B-Condition
125077,8642,hypertension,I-Condition
125078,8642,who,O
125079,8642,had,O
125080,8642,never,O
125081,8642,received,O
125082,8642,angiotensin,B-Drug
125083,8642,II,I-Drug
125084,8642,receptor,I-Drug
125085,8642,antagonists,I-Drug
125086,8642,and,O
125087,8642,calcium,B-Drug
125088,8642,channel,I-Drug
125089,8642,blockers,I-Drug
125090,8643,Not,O
125091,8643,pregnant,B-Condition
125092,8644,Not,O
125093,8644,seeking,O
125094,8644,medication,B-Procedure
125095,8644,abortion,I-Procedure
125096,8645,Under,O
125097,8645,the,O
125098,8645,age,B-Person
125099,8645,of,O
125100,8645,15,O
125101,8646,Contraindications,B-Condition
125102,8646,for,O
125103,8646,medication,B-Procedure
125104,8646,abortion,I-Procedure
125105,8647,Women,B-Person
125106,8647,seeking,O
125107,8647,medication,B-Procedure
125108,8647,abortion,I-Procedure
125109,8647,through,O
125110,8647,70,O
125111,8647,days,O
125112,8647,gestation,O
125113,8648,Eligible,B-Mood
125114,8648,for,I-Mood
125115,8648,Mifeprex(r,B-Drug
125116,8648,),I-Drug
125117,8648,at,O
125118,8648,a,O
125119,8648,study,O
125120,8648,clinical,O
125121,8648,site,O
125122,8649,English,B-Observation
125123,8649,or,I-Observation
125124,8649,Spanish,I-Observation
125125,8649,speaking,I-Observation
125126,8650,Willing,B-Observation
125127,8650,and,I-Observation
125128,8650,able,I-Observation
125129,8650,to,I-Observation
125130,8650,participate,I-Observation
125131,8650,in,I-Observation
125132,8650,the,I-Observation
125133,8650,study,I-Observation
125134,8650,",",O
125135,8650,including,O
125136,8650,willing,B-Observation
125137,8650,to,I-Observation
125138,8650,go,I-Observation
125139,8650,to,I-Observation
125140,8650,the,I-Observation
125141,8650,study,I-Observation
125142,8650,pharmacy,I-Observation
125143,8650,to,B-Mood
125144,8650,obtain,I-Mood
125145,8650,mifepristone,B-Drug
125146,8651,Inability,B-Condition
125147,8651,to,I-Condition
125148,8651,perform,I-Condition
125149,8651,exercise,B-Procedure
125150,8651,tests,I-Procedure
125151,8652,Diagnosed,O
125152,8652,psychiatric,B-Condition
125153,8652,or,I-Condition
125154,8652,cognitive,I-Condition
125155,8652,disorders,I-Condition
125156,8653,Progressive,O
125157,8653,neurological,O
125158,8653,or,O
125159,8653,neuromuscular,O
125160,8653,disorders,O
125161,8653,having,O
125162,8653,a,O
125163,8653,major,O
125164,8653,impact,B-Condition
125165,8653,on,I-Condition
125166,8653,exercise,I-Condition
125167,8653,capacity,I-Condition
125168,8654,Previous,O
125169,8654,diagnoses,O
125170,8654,of,O
125171,8654,COPD,B-Condition
125172,8654,and,O
125173,8654,HF,B-Condition
125174,8654,under,O
125175,8654,optimized,O
125176,8654,clinical,B-Procedure
125177,8654,treatment,I-Procedure
125178,8654,as,O
125179,8654,judged,O
125180,8654,by,O
125181,8654,the,O
125182,8654,accompanying,O
125183,8654,physician,O
125184,8655,Reduced,O
125185,8655,left,O
125186,8655,ventricular,O
125187,8655,ejection,O
125188,8655,fraction,O
125189,8655,(,O
125190,8655,<,O
125191,8655,50,O
125192,8655,%,O
125193,8655,),O
125194,8656,Non,O
125195,8656,-,O
125196,8656,reversible,O
125197,8656,airway,B-Condition
125198,8656,obstruction,I-Condition
125199,8656,(,O
125200,8656,post,O
125201,8656,-,O
125202,8656,bronchodilator,O
125203,8656,FEV1,O
125204,8656,/,O
125205,8656,FVC,O
125206,8656,<,O
125207,8656,0.7,O
125208,8656,and,O
125209,8656,FEV1,O
125210,8656,<,O
125211,8656,80,O
125212,8656,%,O
125213,8656,),O
125214,8657,Respiratory,B-Condition
125215,8657,muscle,I-Condition
125216,8657,weakness,I-Condition
125217,8657,(,O
125218,8657,Pi,O
125219,8657,",",O
125220,8657,max,O
125221,8657,<,O
125222,8657,70cmH2O,O
125223,8657,),O
125224,8658,Persistent,O
125225,8658,dyspnea,B-Condition
125226,8658,on,I-Condition
125227,8658,daily,I-Condition
125228,8658,life,I-Condition
125229,8658,(,O
125230,8658,Baseline,O
125231,8658,Dyspnea,O
125232,8658,Index,O
125233,8658,focal,O
125234,8658,score,O
125235,8658,<,O
125236,8658,or=,O
125237,8658,8),O
125238,8658,.,O
125239,8659,All,O
125240,8659,adult,B-Person
125241,8659,patients,O
125242,8659,with,O
125243,8659,chronic,B-Condition
125244,8659,myeloid,I-Condition
125245,8659,leukaemia,I-Condition
125246,8659,in,O
125247,8659,any,O
125248,8659,phase,O
125249,8659,(,O
125250,8659,chronic,O
125251,8659,",",O
125252,8659,accelerated,O
125253,8659,or,O
125254,8659,blastic,O
125255,8659,),O
125256,8659,who,O
125257,8659,undergo,O
125258,8659,allogeneic,B-Procedure
125259,8659,stem,I-Procedure
125260,8659,cell,I-Procedure
125261,8659,transplantation,I-Procedure
125262,8659,between,O
125263,8659,01/01/2010,O
125264,8659,and,O
125265,8659,30/09/2013,O
125266,8659,and,O
125267,8659,have,O
125268,8659,been,O
125269,8659,previously,O
125270,8659,treated,O
125271,8659,with,O
125272,8659,Nilotinib,B-Drug
125273,8659,or,O
125274,8659,Dasatinib,B-Drug
125275,8659,",",O
125276,8659,regardless,O
125277,8659,of,O
125278,8659,their,O
125279,8659,response,O
125280,8659,to,O
125281,8659,these,O
125282,8659,drugs,O
125283,8659,.,O
125284,8660,any,O
125285,8660,condition,O
125286,8660,that,O
125287,8660,would,O
125288,8660,contra,O
125289,8660,-,O
125290,8660,indicate,O
125291,8660,Magnetic,O
125292,8660,Resonance,O
125293,8660,Imaging,O
125294,8660,or,O
125295,8660,administration,O
125296,8660,of,O
125297,8660,contrast,O
125298,8660,agent,O
125299,8661,male,B-Person
125300,8661,and,O
125301,8661,female,B-Person
125302,8661,patients,O
125303,8661,over,O
125304,8661,the,O
125305,8661,age,B-Person
125306,8661,of,O
125307,8661,18,O
125308,8661,years,O
125309,8661,.,O
125310,8662,written,O
125311,8662,informed,O
125312,8662,consent,O
125313,8662,(,O
125314,8662,approved,O
125315,8662,by,O
125316,8662,the,O
125317,8662,Institutional,O
125318,8662,Review,O
125319,8662,Board,O
125320,8662,[,O
125321,8662,IRB]/Independent,O
125322,8662,Ethics,O
125323,8662,Committee,O
125324,8662,[,O
125325,8662,IEC,O
125326,8662,],O
125327,8662,),O
125328,8662,obtained,O
125329,8662,prior,O
125330,8662,to,O
125331,8662,any,O
125332,8662,study,O
125333,8662,specific,O
125334,8662,procedures,O
125335,8662,.,O
125336,8663,patient,O
125337,8663,with,O
125338,8663,mild,O
125339,8663,to,O
125340,8663,severe,O
125341,8663,carotid,B-Condition
125342,8663,artery,I-Condition
125343,8663,disease,I-Condition
125344,8664,no,O
125345,8664,consent,O
125346,8665,known,O
125347,8665,allergy,B-Condition
125348,8665,to,O
125349,8665,administered,O
125350,8665,opioid,B-Drug
125351,8666,contraindications,B-Condition
125352,8666,to,O
125353,8666,epidural,B-Procedure
125354,8666,analgesia,I-Procedure
125355,8667,coagulopathies,B-Condition
125356,8667,including,O
125357,8667,platelet,O
125358,8667,count,O
125359,8667,of,O
125360,8667,less,O
125361,8667,than,O
125362,8667,"100,000",O
125363,8668,spine,B-Procedure
125364,8668,surgery,I-Procedure
125365,8668,in,O
125366,8668,past,O
125367,8669,parturient,B-Person
125368,8669,in,O
125369,8669,labour,B-Procedure
125370,8669,without,O
125371,8669,cervical,B-Procedure
125372,8669,dilation,I-Procedure
125373,8669,and,O
125374,8669,regular,B-Condition
125375,8669,uterine,I-Condition
125376,8669,contractions,I-Condition
125377,8670,Primary,B-Observation
125378,8670,groups,I-Observation
125379,8670,:,O
125380,8670,Vaccination,B-Procedure
125381,8670,against,I-Procedure
125382,8670,typhoid,I-Procedure
125383,8670,fever,I-Procedure
125384,8670,within,O
125385,8670,5,O
125386,8670,years,O
125387,8670,before,O
125388,8670,dosing,O
125389,8670,.,O
125390,8671,History,B-Observation
125391,8671,of,O
125392,8671,clinical,B-Condition
125393,8671,typhoid,I-Condition
125394,8671,fever,I-Condition
125395,8671,",",O
125396,8671,clinical,B-Condition
125397,8671,paratyphoid,I-Condition
125398,8671,A,I-Condition
125399,8671,or,I-Condition
125400,8671,B,I-Condition
125401,8671,fever,I-Condition
125402,8671,.,O
125403,8672,Immunization,B-Procedure
125404,8672,with,I-Procedure
125405,8672,any,I-Procedure
125406,8672,other,I-Procedure
125407,8672,vaccine,I-Procedure
125408,8672,(,O
125409,8672,oral,O
125410,8672,or,O
125411,8672,parenteral,O
125412,8672,),O
125413,8672,within,O
125414,8672,4,O
125415,8672,weeks,O
125416,8672,prior,O
125417,8672,to,O
125418,8672,study,O
125419,8672,start,O
125420,8672,or,O
125421,8672,planned,B-Mood
125422,8672,vaccination,B-Procedure
125423,8672,during,O
125424,8672,the,O
125425,8672,study,O
125426,8673,Current,O
125427,8673,intake,O
125428,8673,of,O
125429,8673,antibiotics,B-Drug
125430,8673,or,O
125431,8673,end,O
125432,8673,of,O
125433,8673,antibiotic,B-Procedure
125434,8673,therapy,I-Procedure
125435,8673,<,O
125436,8673,8,O
125437,8673,days,O
125438,8673,before,O
125439,8673,first,O
125440,8673,IMP,O
125441,8673,administration,O
125442,8674,Chronic,O
125443,8674,(,O
125444,8674,longer,O
125445,8674,than,O
125446,8674,14,O
125447,8674,days,O
125448,8674,),O
125449,8674,administration,O
125450,8674,of,O
125451,8674,immunosuppressants,B-Drug
125452,8674,or,O
125453,8674,other,O
125454,8674,immune,B-Drug
125455,8674,-,I-Drug
125456,8674,modifying,I-Drug
125457,8674,drugs,I-Drug
125458,8674,within,O
125459,8674,6,O
125460,8674,months,O
125461,8674,before,O
125462,8674,the,O
125463,8674,first,O
125464,8674,dose,O
125465,8674,of,O
125466,8674,investigational,B-Drug
125467,8674,vaccine,I-Drug
125468,8674,;,O
125469,8674,oral,B-Drug
125470,8674,corticosteroids,I-Drug
125471,8674,in,O
125472,8674,dosages,O
125473,8674,of,O
125474,8674,=,O
125475,8674,0.5,O
125476,8674,mg,O
125477,8674,/,O
125478,8674,kg,O
125479,8674,/,O
125480,8674,d,O
125481,8674,prednisolone,O
125482,8674,or,O
125483,8674,equivalent,O
125484,8674,are,O
125485,8674,excluded,O
125486,8674,;,O
125487,8674,inhaled,O
125488,8674,or,O
125489,8674,topical,O
125490,8674,steroids,O
125491,8674,are,O
125492,8674,allowed,O
125493,8675,Acute,O
125494,8675,or,O
125495,8675,chronic,O
125496,8675,clinically,O
125497,8675,significant,O
125498,8675,gastrointestinal,B-Condition
125499,8675,disease,I-Condition
125500,8676,Male,B-Person
125501,8676,or,O
125502,8676,female,B-Person
125503,8676,subjects,O
125504,8676,aged,B-Person
125505,8676,=,O
125506,8676,18,O
125507,8676,to,O
125508,8676,=,O
125509,8676,65,O
125510,8676,years,O
125511,8677,General,B-Condition
125512,8677,good,I-Condition
125513,8677,health,I-Condition
125514,8677,as,O
125515,8677,established,O
125516,8677,by,O
125517,8677,medical,O
125518,8677,history,O
125519,8677,and,O
125520,8677,physical,B-Procedure
125521,8677,examination,I-Procedure
125522,8678,Written,B-Observation
125523,8678,informed,I-Observation
125524,8678,consent,I-Observation
125525,8679,Females,B-Person
125526,8679,of,O
125527,8679,childbearing,B-Observation
125528,8679,potential,I-Observation
125529,8679,must,O
125530,8679,agree,B-Mood
125531,8679,to,I-Mood
125532,8679,use,I-Mood
125533,8679,an,O
125534,8679,efficacious,O
125535,8679,hormonal,O
125536,8679,or,O
125537,8679,barrier,O
125538,8679,method,O
125539,8679,of,O
125540,8679,birth,B-Procedure
125541,8679,control,I-Procedure
125542,8679,during,O
125543,8679,the,O
125544,8679,study,O
125545,8679,.,O
125546,8679,Abstinence,B-Observation
125547,8679,is,O
125548,8679,acceptable,O
125549,8679,.,O
125550,8680,Available,B-Observation
125551,8680,for,I-Observation
125552,8680,all,I-Observation
125553,8680,visits,I-Observation
125554,8680,scheduled,O
125555,8680,in,O
125556,8680,this,O
125557,8680,study,O
125558,8680,.,O
125559,8681,Congestive,B-Condition
125560,8681,heart,I-Condition
125561,8681,failure,I-Condition
125562,8681,or,O
125563,8681,coronary,B-Condition
125564,8681,artery,I-Condition
125565,8681,disease,I-Condition
125566,8682,Blood,O
125567,8682,pressure,O
125568,8682,averaging,O
125569,8682,>,O
125570,8682,159/99,O
125571,8682,mmHg,O
125572,8683,Serum,O
125573,8683,creatinine,O
125574,8683,>,O
125575,8683,1.5,O
125576,8683,mg,O
125577,8683,/,O
125578,8683,dL,O
125579,8684,Diabetes,B-Condition
125580,8684,mellitus,I-Condition
125581,8684,or,O
125582,8684,other,O
125583,8684,systemic,B-Condition
125584,8684,illness,I-Condition
125585,8685,Left,B-Condition
125586,8685,ventricular,I-Condition
125587,8685,hypertrophy,I-Condition
125588,8685,by,O
125589,8685,echocardiography,B-Procedure
125590,8685,or,O
125591,8685,ECG,B-Procedure
125592,8686,Pregnancy,B-Condition
125593,8687,Hypersensitivity,B-Condition
125594,8687,to,O
125595,8687,spironolactone,B-Drug
125596,8687,",",O
125597,8687,chlorthalidone,B-Drug
125598,8687,",",O
125599,8687,amlodipine,B-Drug
125600,8687,",",O
125601,8687,human,B-Drug
125602,8687,recombinant,I-Drug
125603,8687,insulin,I-Drug
125604,8687,or,O
125605,8687,Definity,O
125606,8688,Any,O
125607,8688,history,O
125608,8688,of,O
125609,8688,substance,B-Condition
125610,8688,abuse,I-Condition
125611,8688,(,O
125612,8688,other,O
125613,8688,than,O
125614,8688,tobacco,B-Observation
125615,8688,),O
125616,8689,History,O
125617,8689,of,O
125618,8689,gouty,B-Condition
125619,8689,arthritis,I-Condition
125620,8690,Patients,O
125621,8690,with,O
125622,8690,right,O
125623,8690,-,O
125624,8690,to,O
125625,8690,-,O
125626,8690,left,O
125627,8690,",",O
125628,8690,bi,O
125629,8690,-,O
125630,8690,directional,O
125631,8690,",",O
125632,8690,or,O
125633,8690,transient,O
125634,8690,right,O
125635,8690,-,O
125636,8690,to,O
125637,8690,-,O
125638,8690,left,O
125639,8690,cardiac,B-Condition
125640,8690,shunts,I-Condition
125641,8691,Hypersensitivity,B-Condition
125642,8691,to,O
125643,8691,perflutren,B-Drug
125644,8691,",",O
125645,8691,blood,B-Procedure
125646,8691,",",O
125647,8691,blood,B-Procedure
125648,8691,products,I-Procedure
125649,8691,or,O
125650,8691,albumin,B-Drug
125651,8692,Normotensive,O
125652,8692,controls,B-Procedure
125653,8693,Stage,O
125654,8693,I,O
125655,8693,(,O
125656,8693,140,O
125657,8693,-,O
125658,8693,159/90,O
125659,8693,-,O
125660,8693,99,O
125661,8693,mmHg,O
125662,8693,),O
125663,8693,untreated,O
125664,8693,subjects,O
125665,8693,with,O
125666,8693,essential,B-Condition
125667,8693,hypertension,I-Condition
125668,8694,Patients,O
125669,8694,with,O
125670,8694,PA,B-Condition
125671,8694,and,O
125672,8694,stage,O
125673,8694,I,O
125674,8694,(,O
125675,8694,140,O
125676,8694,-,O
125677,8694,159/90,O
125678,8694,-,O
125679,8694,99,O
125680,8694,mmHg,O
125681,8694,),O
125682,8694,hypertension,B-Condition
125683,8695,an,O
125684,8695,underlying,O
125685,8695,infectious,B-Condition
125686,8695,disease,I-Condition
125687,8696,chromosomal,B-Condition
125688,8696,abnormality,I-Condition
125689,8697,metabolic,B-Condition
125690,8697,disorder,I-Condition
125691,8698,specific,O
125692,8698,brain,O
125693,8698,related,O
125694,8698,disorder,B-Condition
125695,8698,(,O
125696,8698,such,O
125697,8698,as,O
125698,8698,tuberous,B-Condition
125699,8698,sclerosis,I-Condition
125700,8698,),O
125701,8699,history,O
125702,8699,of,O
125703,8699,fetal,O
125704,8699,cytomegalovirus,B-Condition
125705,8699,infection,I-Condition
125706,8700,birth,B-Condition
125707,8700,asphyxia,I-Condition
125708,8701,a,O
125709,8701,history,O
125710,8701,of,O
125711,8701,major,B-Condition
125712,8701,head,I-Condition
125713,8701,injury,I-Condition
125714,8702,a,O
125715,8702,chronic,B-Condition
125716,8702,use,I-Condition
125717,8702,of,O
125718,8702,non,B-Drug
125719,8702,-,I-Drug
125720,8702,steroidal,I-Drug
125721,8702,anti,I-Drug
125722,8702,-,I-Drug
125723,8702,inflammatory,I-Drug
125724,8702,drugs,I-Drug
125725,8702,",",O
125726,8702,(,O
125727,8702,NSAID,B-Drug
125728,8702,),O
125729,8703,known,O
125730,8703,brain,B-Condition
125731,8703,damage,I-Condition
125732,8704,Epilepsy,B-Condition
125733,8705,Abnormal,O
125734,8705,Electro,O
125735,8705,-,O
125736,8705,cardiogram,O
125737,8705,(,O
125738,8705,ECG,O
125739,8705,),O
125740,8706,Epileptiform,O
125741,8706,EEG,O
125742,8707,Use,O
125743,8707,of,O
125744,8707,psychostimulants,B-Drug
125745,8707,",",O
125746,8707,anti,B-Drug
125747,8707,-,I-Drug
125748,8707,depressants,I-Drug
125749,8707,",",O
125750,8707,neuroleptics,B-Drug
125751,8707,or,O
125752,8707,anti,B-Drug
125753,8707,-,I-Drug
125754,8707,convulsive,I-Drug
125755,8707,agents,I-Drug
125756,8707,within,O
125757,8707,the,O
125758,8707,past,O
125759,8707,month,O
125760,8707,.,O
125761,8708,Lack,O
125762,8708,of,O
125763,8708,cooperation,O
125764,8708,in,O
125765,8708,the,O
125766,8708,screening,O
125767,8708,phase,O
125768,8709,A,O
125769,8709,formal,O
125770,8709,diagnosis,O
125771,8709,of,O
125772,8709,Autism,B-Condition
125773,8709,or,O
125774,8709,Pervasive,B-Condition
125775,8709,Developmental,I-Condition
125776,8709,Disorder,I-Condition
125777,8709,not,I-Condition
125778,8709,otherwise,I-Condition
125779,8709,specified,I-Condition
125780,8709,(,O
125781,8709,PDD,B-Condition
125782,8709,-,I-Condition
125783,8709,NOS,I-Condition
125784,8709,),O
125785,8709,",",O
125786,8709,given,O
125787,8709,by,O
125788,8709,a,O
125789,8709,child,O
125790,8709,neurologist,O
125791,8709,.,O
125792,8710,Age,B-Person
125793,8710,:,O
125794,8710,10,O
125795,8710,-,O
125796,8710,18,O
125797,8710,years,O
125798,8710,.,O
125799,8711,A,O
125800,8711,signed,O
125801,8711,parental,O
125802,8711,consent,O
125803,8711,form,O
125804,8711,.,O
125805,8712,Have,O
125806,8712,not,O
125807,8712,received,O
125808,8712,influenza,B-Procedure
125809,8712,vaccination,I-Procedure
125810,8712,in,O
125811,8712,the,O
125812,8712,past,O
125813,8712,or,O
125814,8712,can,O
125815,8712,not,O
125816,8712,be,O
125817,8712,vaccinated,O
125818,8712,due,O
125819,8712,to,O
125820,8712,previous,O
125821,8712,severe,O
125822,8712,reaction,O
125823,8712,to,O
125824,8712,influenza,O
125825,8712,vaccine,O
125826,8712,",",O
125827,8712,egg,O
125828,8712,",",O
125829,8712,latex,O
125830,8712,",",O
125831,8712,or,O
125832,8712,thimerosol,O
125833,8712,allergies,O
125834,8712,",",O
125835,8712,or,O
125836,8712,refusal,O
125837,8712,of,O
125838,8712,vaccination,O
125839,8713,Participant,O
125840,8713,has,O
125841,8713,received,O
125842,8713,a,O
125843,8713,community,O
125844,8713,available,O
125845,8713,influenza,B-Procedure
125846,8713,vaccine,I-Procedure
125847,8713,within,O
125848,8713,<,O
125849,8713,6,O
125850,8713,months,O
125851,8714,History,O
125852,8714,of,O
125853,8714,Guillain,B-Condition
125854,8714,-,I-Condition
125855,8714,Barré,I-Condition
125856,8714,syndrome,I-Condition
125857,8715,Immunosuppressive,B-Drug
125858,8715,disorders,I-Drug
125859,8715,or,I-Drug
125860,8715,medications,I-Drug
125861,8715,(,O
125862,8715,including,O
125863,8715,oral,B-Drug
125864,8715,prednisone,I-Drug
125865,8715,>,O
125866,8715,10,O
125867,8715,mg,O
125868,8715,daily,O
125869,8715,",",O
125870,8715,recent,O
125871,8715,chemotherapy,B-Procedure
125872,8715,treatment,O
125873,8715,),O
125874,8716,Emergency,O
125875,8716,cases,O
125876,8716,as,O
125877,8716,determined,O
125878,8716,by,O
125879,8716,the,O
125880,8716,investigator,O
125881,8716,or,O
125882,8716,physician,O
125883,8717,Subjects,O
125884,8717,who,O
125885,8717,the,O
125886,8717,investigator,O
125887,8717,believes,O
125888,8717,can,O
125889,8717,and,O
125890,8717,will,O
125891,8717,comply,O
125892,8717,with,O
125893,8717,the,O
125894,8717,requirements,O
125895,8717,of,O
125896,8717,the,O
125897,8717,protocol,O
125898,8717,(,O
125899,8717,i.e.,O
125900,8717,return,O
125901,8717,for,O
125902,8717,follow,O
125903,8717,-,O
125904,8717,up,O
125905,8717,visits,O
125906,8717,",",O
125907,8717,and,O
125908,8717,able,O
125909,8717,to,O
125910,8717,converse,O
125911,8717,with,O
125912,8717,study,O
125913,8717,personnel,O
125914,8717,),O
125915,8718,Age,B-Person
125916,8718,18,O
125917,8718,years,O
125918,8718,or,O
125919,8718,older,O
125920,8719,Undergoing,O
125921,8719,major,B-Procedure
125922,8719,cardiac,I-Procedure
125923,8719,surgery,I-Procedure
125924,8719,using,O
125925,8719,cardiopulmonary,B-Procedure
125926,8719,bypass,I-Procedure
125927,8720,known,O
125928,8720,allergy,B-Condition
125929,8720,to,O
125930,8720,any,O
125931,8720,of,O
125932,8720,drugs,B-Drug
125933,8720,used,I-Drug
125934,8721,coagulopathy,B-Condition
125935,8722,any,O
125936,8722,wound,B-Condition
125937,8722,or,O
125938,8722,infection,B-Condition
125939,8722,related,O
125940,8722,to,O
125941,8722,puncture,O
125942,8722,site,O
125943,8723,major,O
125944,8723,illness,B-Condition
125945,8724,failure,O
125946,8724,to,O
125947,8724,gain,O
125948,8724,consent,B-Observation
125949,8724,of,I-Observation
125950,8724,parents,I-Observation
125951,8724,.,O
125952,8725,American,O
125953,8725,society,O
125954,8725,of,O
125955,8725,anesthesiologist,O
125956,8725,(,O
125957,8725,ASA,O
125958,8725,),O
125959,8725,physical,O
125960,8725,status,O
125961,8725,I,O
125962,8725,or,O
125963,8725,II,O
125964,8726,Systemic,B-Procedure
125965,8726,therapy,I-Procedure
125966,8726,or,O
125967,8726,radiotherapy,B-Procedure
125968,8726,within,O
125969,8726,4,O
125970,8726,weeks,O
125971,8726,prior,O
125972,8726,to,O
125973,8726,Day,O
125974,8726,1,O
125975,8727,Prior,O
125976,8727,therapy,B-Procedure
125977,8727,with,O
125978,8727,agents,B-Drug
125979,8727,targeting,I-Drug
125980,8727,the,I-Drug
125981,8727,DR5,I-Drug
125982,8727,apoptosis,I-Drug
125983,8727,pathway,I-Drug
125984,8728,Major,O
125985,8728,surgical,B-Procedure
125986,8728,procedure,I-Procedure
125987,8728,",",O
125988,8728,open,B-Procedure
125989,8728,biopsy,I-Procedure
125990,8728,",",O
125991,8728,or,O
125992,8728,significant,O
125993,8728,traumatic,B-Condition
125994,8728,injury,I-Condition
125995,8728,within,O
125996,8728,4,O
125997,8728,weeks,O
125998,8728,prior,O
125999,8728,to,O
126000,8728,Day,O
126001,8728,1,O
126002,8728,",",O
126003,8728,or,O
126004,8728,anticipation,B-Mood
126005,8728,of,I-Mood
126006,8728,need,I-Mood
126007,8728,for,O
126008,8728,major,O
126009,8728,surgical,B-Procedure
126010,8728,procedure,I-Procedure
126011,8728,during,O
126012,8728,the,O
126013,8728,course,O
126014,8728,of,O
126015,8728,the,O
126016,8728,study,O
126017,8729,Other,O
126018,8729,invasive,B-Condition
126019,8729,malignancies,I-Condition
126020,8729,within,O
126021,8729,5,O
126022,8729,years,O
126023,8729,prior,O
126024,8729,to,O
126025,8729,Day,O
126026,8729,1,O
126027,8730,Known,O
126028,8730,active,O
126029,8730,brain,B-Condition
126030,8730,metastases,I-Condition
126031,8731,Uncontrolled,O
126032,8731,intercurrent,B-Condition
126033,8731,illness,I-Condition
126034,8731,",",O
126035,8731,including,O
126036,8731,but,O
126037,8731,not,O
126038,8731,limited,O
126039,8731,to,O
126040,8731,ongoing,O
126041,8731,or,O
126042,8731,active,O
126043,8731,infection,B-Condition
126044,8731,requiring,O
126045,8731,parenteral,B-Drug
126046,8731,antibiotics,I-Drug
126047,8731,at,O
126048,8731,enrollment,O
126049,8732,Clinically,O
126050,8732,significant,O
126051,8732,",",O
126052,8732,symptomatic,O
126053,8732,cardiovascular,B-Condition
126054,8732,disease,I-Condition
126055,8732,",",O
126056,8732,New,O
126057,8732,York,O
126058,8732,Heart,O
126059,8732,Association,O
126060,8732,(,O
126061,8732,NYHA,O
126062,8732,),O
126063,8732,Grade,O
126064,8732,II,O
126065,8732,or,O
126066,8732,greater,O
126067,8732,congestive,B-Condition
126068,8732,heart,I-Condition
126069,8732,failure,I-Condition
126070,8732,",",O
126071,8732,serious,O
126072,8732,cardiac,B-Condition
126073,8732,arrhythmia,I-Condition
126074,8732,",",O
126075,8732,Grade,O
126076,8732,II,O
126077,8732,or,O
126078,8732,greater,O
126079,8732,peripheral,B-Condition
126080,8732,vascular,I-Condition
126081,8732,disease,I-Condition
126082,8732,",",O
126083,8732,or,O
126084,8732,history,B-Observation
126085,8732,of,I-Observation
126086,8732,major,O
126087,8732,heart,B-Procedure
126088,8732,surgery,I-Procedure
126089,8732,within,O
126090,8732,6,O
126091,8732,months,O
126092,8732,of,O
126093,8732,Day,O
126094,8732,1,O
126095,8732,",",O
126096,8732,or,O
126097,8732,any,O
126098,8732,situation,O
126099,8732,that,O
126100,8732,would,O
126101,8732,likely,O
126102,8732,limit,B-Observation
126103,8732,compliance,I-Observation
126104,8732,with,O
126105,8732,study,O
126106,8732,requirements,O
126107,8733,Known,O
126108,8733,to,O
126109,8733,be,O
126110,8733,positive,O
126111,8733,for,O
126112,8733,hepatitis,O
126113,8733,C,O
126114,8733,or,O
126115,8733,hepatitis,O
126116,8733,B,O
126117,8733,surface,O
126118,8733,antigen,O
126119,8734,History,B-Observation
126120,8734,of,O
126121,8734,other,O
126122,8734,disease,B-Condition
126123,8734,",",O
126124,8734,metabolic,B-Condition
126125,8734,dysfunction,I-Condition
126126,8734,",",O
126127,8734,physical,B-Condition
126128,8734,examination,I-Condition
126129,8734,finding,I-Condition
126130,8734,",",O
126131,8734,or,O
126132,8734,clinical,B-Condition
126133,8734,laboratory,I-Condition
126134,8734,finding,I-Condition
126135,8734,giving,O
126136,8734,reasonable,O
126137,8734,suspicion,B-Mood
126138,8734,of,I-Mood
126139,8734,a,O
126140,8734,disease,B-Condition
126141,8734,or,O
126142,8734,condition,B-Condition
126143,8734,that,O
126144,8734,contraindicates,B-Condition
126145,8734,use,O
126146,8734,of,O
126147,8734,an,O
126148,8734,investigational,B-Drug
126149,8734,drug,I-Drug
126150,8734,or,O
126151,8734,that,O
126152,8734,might,O
126153,8734,affect,B-Observation
126154,8734,interpretation,I-Observation
126155,8734,of,I-Observation
126156,8734,the,I-Observation
126157,8734,results,I-Observation
126158,8734,of,O
126159,8734,the,O
126160,8734,study,O
126161,8734,or,O
126162,8734,render,B-Observation
126163,8734,the,I-Observation
126164,8734,patient,I-Observation
126165,8734,at,I-Observation
126166,8734,high,I-Observation
126167,8734,risk,I-Observation
126168,8734,for,O
126169,8734,treatment,B-Condition
126170,8734,complications,I-Condition
126171,8735,Use,O
126172,8735,of,O
126173,8735,anticoagulation,B-Procedure
126174,8735,therapy,I-Procedure
126175,8736,Participation,B-Observation
126176,8736,in,I-Observation
126177,8736,clinical,I-Observation
126178,8736,trials,I-Observation
126179,8736,or,O
126180,8736,undergoing,B-Observation
126181,8736,other,I-Observation
126182,8736,investigational,I-Observation
126183,8736,procedures,I-Observation
126184,8736,within,O
126185,8736,30,O
126186,8736,days,O
126187,8736,prior,O
126188,8736,to,O
126189,8736,Day,O
126190,8736,1,O
126191,8737,Pregnancy,B-Condition
126192,8737,or,O
126193,8737,breast,B-Observation
126194,8737,feeding,I-Observation
126195,8738,Known,O
126196,8738,sensitivity,B-Condition
126197,8738,to,O
126198,8738,any,B-Drug
126199,8738,of,I-Drug
126200,8738,the,I-Drug
126201,8738,products,I-Drug
126202,8738,administered,I-Drug
126203,8738,during,I-Drug
126204,8738,the,I-Drug
126205,8738,study,I-Drug
126206,8739,Any,O
126207,8739,disorder,B-Condition
126208,8739,that,O
126209,8739,compromises,O
126210,8739,the,O
126211,8739,ability,O
126212,8739,of,O
126213,8739,the,O
126214,8739,patient,O
126215,8739,to,O
126216,8739,give,O
126217,8739,written,O
126218,8739,informed,O
126219,8739,consent,O
126220,8739,and/or,O
126221,8739,comply,B-Procedure
126222,8739,with,I-Procedure
126223,8739,study,I-Procedure
126224,8739,procedures,I-Procedure
126225,8740,Ability,O
126226,8740,to,O
126227,8740,understand,O
126228,8740,and,O
126229,8740,willingness,O
126230,8740,to,O
126231,8740,sign,O
126232,8740,a,O
126233,8740,written,O
126234,8740,informed,O
126235,8740,consent,O
126236,8740,document,O
126237,8741,Age,B-Person
126238,8741,≥,O
126239,8741,18,O
126240,8741,years,O
126241,8742,Histologic,O
126242,8742,diagnosis,O
126243,8742,of,O
126244,8742,chondrosarcoma,B-Condition
126245,8742,",",O
126246,8742,verifiable,O
126247,8742,after,O
126248,8742,enrollment,O
126249,8743,Measurable,O
126250,8743,disease,O
126251,8744,Previously,O
126252,8744,treated,O
126253,8744,or,O
126254,8744,incurable,O
126255,8744,disease,O
126256,8744,without,O
126257,8744,options,O
126258,8744,for,O
126259,8744,standard,O
126260,8744,of,O
126261,8744,care,O
126262,8744,therapy,O
126263,8745,ECOG,O
126264,8745,performance,O
126265,8745,status,O
126266,8745,of,O
126267,8745,0,O
126268,8745,-,O
126269,8745,2,O
126270,8746,Life,B-Observation
126271,8746,expectancy,I-Observation
126272,8746,of,O
126273,8746,>,O
126274,8746,3,O
126275,8746,months,O
126276,8747,For,O
126277,8747,patients,O
126278,8747,of,O
126279,8747,reproductive,B-Condition
126280,8747,potential,I-Condition
126281,8747,(,O
126282,8747,males,O
126283,8747,and,O
126284,8747,females,O
126285,8747,),O
126286,8747,",",O
126287,8747,use,O
126288,8747,of,O
126289,8747,reliable,O
126290,8747,means,O
126291,8747,for,O
126292,8747,contraception,B-Procedure
126293,8747,(,O
126294,8747,e.g.,O
126295,8747,",",O
126296,8747,contraceptive,B-Drug
126297,8747,pill,I-Drug
126298,8747,",",O
126299,8747,intrauterine,O
126300,8747,device,O
126301,8747,[,O
126302,8747,IUD,O
126303,8747,],O
126304,8747,",",O
126305,8747,physical,O
126306,8747,barrier,O
126307,8747,),O
126308,8747,throughout,O
126309,8747,the,O
126310,8747,trial,O
126311,8747,and,O
126312,8747,for,O
126313,8747,1,O
126314,8747,year,O
126315,8747,following,O
126316,8747,their,O
126317,8747,final,O
126318,8747,exposure,O
126319,8747,to,O
126320,8747,study,O
126321,8747,treatment,O
126322,8748,Patients,O
126323,8748,ASA,O
126324,8748,III,O
126325,8748,y,O
126326,8748,IV,O
126327,8749,Chronic,B-Condition
126328,8749,pain,I-Condition
126329,8749,history,O
126330,8750,Drug,B-Condition
126331,8750,and,I-Condition
126332,8750,alcohol,I-Condition
126333,8750,abuse,I-Condition
126334,8751,Chronic,O
126335,8751,use,O
126336,8751,of,O
126337,8751,opioid,B-Drug
126338,8751,and,O
126339,8751,sedatives,B-Drug
126340,8752,Neuropsychiatric,B-Condition
126341,8752,illness,I-Condition
126342,8753,NSAID,B-Drug
126343,8753,and,O
126344,8753,other,O
126345,8753,analgesics,B-Drug
126346,8753,used,O
126347,8753,the,O
126348,8753,48,O
126349,8753,hours,O
126350,8753,previous,O
126351,8753,to,O
126352,8753,the,O
126353,8753,surgery,O
126354,8754,CMI,O
126355,8754,>,O
126356,8754,30,O
126357,8755,Patients,O
126358,8755,scheduled,B-Mood
126359,8755,for,I-Mood
126360,8755,thyroidectomy,B-Procedure
126361,8755,with,O
126362,8755,general,B-Procedure
126363,8755,anesthesia,I-Procedure
126364,8755,in,O
126365,8755,the,O
126366,8755,University,O
126367,8755,of,O
126368,8755,Chile,O
126369,8755,Clinical,O
126370,8755,Hospital,O
126371,8756,PGD,B-Procedure
126372,8756,patients,O
126373,8757,More,O
126374,8757,than,O
126375,8757,4,O
126376,8757,previous,O
126377,8757,embryo,B-Procedure
126378,8757,transfers,I-Procedure
126379,8758,20,O
126380,8758,-,O
126381,8758,40,O
126382,8758,years,O
126383,8758,old,B-Person
126384,8758,women,B-Person
126385,8759,Spontaneously,B-Condition
126386,8759,ovulating,I-Condition
126387,8759,women,B-Person
126388,8760,Treated,O
126389,8760,in,O
126390,8760,our,O
126391,8760,IVF,O
126392,8760,unit,O
126393,8760,for,O
126394,8760,frozen,B-Procedure
126395,8760,-,I-Procedure
126396,8760,thawed,I-Procedure
126397,8760,embryo,I-Procedure
126398,8760,transfer,I-Procedure
126399,8761,At,O
126400,8761,least,O
126401,8761,one,O
126402,8761,top,O
126403,8761,quality,O
126404,8761,embryo,O
126405,8762,Diabetic,B-Condition
126406,8762,patients,O
126407,8763,Patients,O
126408,8763,with,O
126409,8763,any,O
126410,8763,macular,B-Condition
126411,8763,changes,I-Condition
126412,8763,prior,O
126413,8763,to,O
126414,8763,the,O
126415,8763,surgery,B-Procedure
126416,8763,(,O
126417,8763,epiretinal,B-Condition
126418,8763,membranes,I-Condition
126419,8763,",",O
126420,8763,age,B-Condition
126421,8763,macular,I-Condition
126422,8763,disease,I-Condition
126423,8763,",",O
126424,8763,macular,B-Condition
126425,8763,edema,I-Condition
126426,8763,...,O
126427,8763,),O
126428,8764,Patients,O
126429,8764,who,O
126430,8764,had,O
126431,8764,any,O
126432,8764,complication,B-Condition
126433,8764,during,O
126434,8764,phacoemulsification,B-Procedure
126435,8764,surgery,I-Procedure
126436,8765,Any,O
126437,8765,patients,O
126438,8765,that,O
126439,8765,will,B-Mood
126440,8765,be,I-Mood
126441,8765,submitted,I-Mood
126442,8765,to,I-Mood
126443,8765,phacoemulsification,B-Procedure
126444,8765,surgery,I-Procedure
126445,8765,in,O
126446,8765,the,O
126447,8765,Hospital,O
126448,8765,de,O
126449,8765,Clinicas,O
126450,8765,of,O
126451,8765,State,O
126452,8765,University,O
126453,8765,of,O
126454,8765,Campinas,O
126455,8765,(,O
126456,8765,BRAZIL,O
126457,8765,),O
126458,8766,Patients,O
126459,8766,over,O
126460,8766,18,O
126461,8766,years,O
126462,8766,old,B-Person
126463,8767,Patients,O
126464,8767,who,O
126465,8767,are,O
126466,8767,able,B-Mood
126467,8767,to,I-Mood
126468,8767,perform,I-Mood
126469,8767,SD,B-Procedure
126470,8767,-,I-Procedure
126471,8767,OCT,I-Procedure
126472,8768,Patients,O
126473,8768,who,O
126474,8768,sign,O
126475,8768,the,O
126476,8768,consent,O
126477,8768,form,O
126478,8769,Contraindication,B-Condition
126479,8769,to,O
126480,8769,Filgrastim,B-Drug
126481,8770,Histologically,B-Procedure
126482,8770,confirmed,O
126483,8770,primary,B-Condition
126484,8770,breast,I-Condition
126485,8770,cancer,I-Condition
126486,8771,Planned,B-Mood
126487,8771,to,I-Mood
126488,8771,start,I-Mood
126489,8771,docetaxel,B-Drug
126490,8771,component,O
126491,8771,of,O
126492,8771,FEC,B-Procedure
126493,8771,-,I-Procedure
126494,8771,D,I-Procedure
126495,8771,or,O
126496,8771,AC,B-Procedure
126497,8771,-,I-Procedure
126498,8771,D,I-Procedure
126499,8771,",",O
126500,8771,or,O
126501,8771,first,O
126502,8771,cycle,O
126503,8771,of,O
126504,8771,;,O
126505,8771,dose,B-Procedure
126506,8771,-,I-Procedure
126507,8771,dense,I-Procedure
126508,8771,AC,I-Procedure
126509,8771,-,I-Procedure
126510,8771,T,I-Procedure
126511,8771,",",O
126512,8771,TC,B-Procedure
126513,8771,",",O
126514,8771,FEC,B-Procedure
126515,8771,-,I-Procedure
126516,8771,D,I-Procedure
126517,8771,or,O
126518,8771,TAC,B-Procedure
126519,8771,chemotherapy,I-Procedure
126520,8772,=,O
126521,8772,19,O
126522,8772,years,O
126523,8772,of,O
126524,8772,age,B-Person
126525,8773,Able,O
126526,8773,to,O
126527,8773,provide,O
126528,8773,verbal,O
126529,8773,consent,O
126530,8774,NA,O
126531,8775,Healthy,O
126532,8776,Male,B-Person
126533,8777,>,O
126534,8777,7,O
126535,8777,Metabolic,O
126536,8777,Equivalents,O
126537,8778,Written,O
126538,8778,informed,O
126539,8778,consent,O
126540,8779,Chronic,B-Condition
126541,8779,pain,I-Condition
126542,8779,syndrome,I-Condition
126543,8780,Drug,B-Condition
126544,8780,abuse,I-Condition
126545,8781,Alcohol,B-Condition
126546,8781,abuse,I-Condition
126547,8782,Suspicion,B-Mood
126548,8782,of,O
126549,8782,neurologic,B-Condition
126550,8782,dysfunction,I-Condition
126551,8782,at,O
126552,8782,tested,O
126553,8782,sites,O
126554,8783,Ongoing,O
126555,8783,treatment,B-Procedure
126556,8783,with,O
126557,8783,antidepressants,B-Drug
126558,8784,Ongoing,O
126559,8784,treatment,B-Procedure
126560,8784,with,O
126561,8784,analgesics,B-Drug
126562,8785,Pretreatment,B-Procedure
126563,8785,with,O
126564,8785,any,O
126565,8785,CYP3A,B-Drug
126566,8785,inducers,I-Drug
126567,8785,or,I-Drug
126568,8785,inhibitors,I-Drug
126569,8786,Known,O
126570,8786,allergy,B-Condition
126571,8786,to,O
126572,8786,tested,B-Drug
126573,8786,drugs,I-Drug
126574,8787,Elevated,B-Condition
126575,8787,eye,I-Condition
126576,8787,pressure,I-Condition
126577,8788,Obstructive,B-Condition
126578,8788,uropathy,I-Condition
126579,8789,Heart,B-Condition
126580,8789,disease,I-Condition
126581,8790,Pulmonary,B-Condition
126582,8790,disease,I-Condition
126583,8791,Neurological,B-Condition
126584,8791,disease,I-Condition
126585,8792,Psychiatric,B-Condition
126586,8792,illness,I-Condition
126587,8793,contra,B-Condition
126588,8793,-,I-Condition
126589,8793,indications,I-Condition
126590,8793,for,O
126591,8793,regular,B-Procedure
126592,8793,dental,I-Procedure
126593,8793,treatment,I-Procedure
126594,8794,medical,B-Observation
126595,8794,history,I-Observation
126596,8794,that,O
126597,8794,contraindicates,B-Condition
126598,8794,the,O
126599,8794,use,O
126600,8794,of,O
126601,8794,epinephrine,B-Drug
126602,8795,participant,O
126603,8795,taken,O
126604,8795,an,O
126605,8795,opioid,B-Drug
126606,8795,or,O
126607,8795,an,O
126608,8795,opioid,B-Drug
126609,8795,like,I-Drug
126610,8795,analgesic,I-Drug
126611,8795,within,O
126612,8795,24,O
126613,8795,hours,O
126614,8796,pregnant,B-Condition
126615,8797,18,O
126616,8797,years,O
126617,8797,of,O
126618,8797,age,B-Person
126619,8797,or,O
126620,8797,older,O
126621,8798,capable,O
126622,8798,of,O
126623,8798,providing,O
126624,8798,informed,O
126625,8798,consent,O
126626,8799,Any,O
126627,8799,active,O
126628,8799,respiratory,B-Condition
126629,8799,",",I-Condition
126630,8799,cardiovascular,I-Condition
126631,8799,or,I-Condition
126632,8799,other,I-Condition
126633,8799,disease,I-Condition
126634,8799,requiring,O
126635,8799,regular,O
126636,8799,treatment,B-Procedure
126637,8799,or,O
126638,8799,being,O
126639,8799,otherwise,O
126640,8799,relevant,B-Mood
126641,8799,for,I-Mood
126642,8799,tolerance,B-Condition
126643,8799,of,O
126644,8799,hypoxia,B-Condition
126645,8799,or,O
126646,8799,altitude,B-Observation
126647,8799,exposure,I-Observation
126648,8799,.,O
126649,8800,Any,O
126650,8800,condition,O
126651,8800,that,O
126652,8800,may,O
126653,8800,interfere,O
126654,8800,with,O
126655,8800,protocol,O
126656,8800,compliance,O
126657,8800,including,O
126658,8800,current,O
126659,8800,heavy,O
126660,8800,smoking,O
126661,8800,(,O
126662,8800,>,O
126663,8800,20,O
126664,8800,cigarettes,O
126665,8800,per,O
126666,8800,day,O
126667,8800,or,O
126668,8800,>,O
126669,8800,20,O
126670,8800,pack,O
126671,8800,-,O
126672,8800,years,O
126673,8800,with,O
126674,8800,active,O
126675,8800,smoking,O
126676,8800,during,O
126677,8800,the,O
126678,8800,last,O
126679,8800,10,O
126680,8800,years,O
126681,8800,),O
126682,8800,",",O
126683,8800,regular,O
126684,8800,use,O
126685,8800,of,O
126686,8800,alcohol,O
126687,8800,.,O
126688,8801,Allergy,B-Condition
126689,8801,to,O
126690,8801,acetazolamide,B-Drug
126691,8801,and,O
126692,8801,other,O
126693,8801,sulfonamides,B-Drug
126694,8801,.,O
126695,8802,Healthy,O
126696,8802,men,B-Person
126697,8802,and,O
126698,8802,women,B-Person
126699,8802,",",O
126700,8802,age,B-Person
126701,8802,40,O
126702,8802,-,O
126703,8802,75,O
126704,8802,yrs,O
126705,8802,",",O
126706,8802,without,O
126707,8802,any,O
126708,8802,disease,B-Condition
126709,8802,and,O
126710,8802,need,O
126711,8802,of,O
126712,8802,medication,B-Procedure
126713,8802,.,O
126714,8803,Born,O
126715,8803,",",O
126716,8803,raised,O
126717,8803,and,O
126718,8803,currently,O
126719,8803,living,O
126720,8803,at,O
126721,8803,low,O
126722,8803,altitude,O
126723,8803,(,O
126724,8803,<,O
126725,8803,800,O
126726,8803,m,O
126727,8803,),O
126728,8803,.,O
126729,8804,Written,O
126730,8804,informed,O
126731,8804,consent,O
126732,8804,.,O
126733,8805,Kyrgyz,O
126734,8805,ethnicity,O
126735,8806,Cardiac,B-Condition
126736,8806,morbidities,I-Condition
126737,8807,Hypertensive,B-Condition
126738,8807,disorders,I-Condition
126739,8807,of,I-Condition
126740,8807,pregnancy,I-Condition
126741,8807,",",O
126742,8808,Peripartum,B-Condition
126743,8808,bleeding,I-Condition
126744,8809,Baseline,O
126745,8809,systolic,O
126746,8809,blood,O
126747,8809,pressure,O
126748,8809,(,O
126749,8809,SBP,O
126750,8809,),O
126751,8809,<,O
126752,8809,100,O
126753,8809,mmHg,O
126754,8810,Body,O
126755,8810,mass,O
126756,8810,index,O
126757,8810,>,O
126758,8810,35,O
126759,8811,full,O
126760,8811,term,O
126761,8811,singleton,O
126762,8811,pregnant,B-Condition
126763,8811,women,B-Person
126764,8812,Scheduled,B-Mood
126765,8812,for,I-Mood
126766,8812,elective,O
126767,8812,Cesarean,B-Procedure
126768,8812,Delivery,I-Procedure
126769,8813,Aged,B-Person
126770,8813,between,O
126771,8813,18,O
126772,8813,and,O
126773,8813,40,O
126774,8813,years,O
126775,8814,Subjects,O
126776,8814,with,O
126777,8814,a,O
126778,8814,known,O
126779,8814,or,O
126780,8814,suspected,O
126781,8814,alcohol,O
126782,8814,or,O
126783,8814,drug,O
126784,8814,abuse,O
126785,8814,which,O
126786,8814,in,O
126787,8814,the,O
126788,8814,opinion,O
126789,8814,of,O
126790,8814,the,O
126791,8814,investigator,O
126792,8814,could,O
126793,8814,interfere,O
126794,8814,with,O
126795,8814,the,O
126796,8814,subject,O
126797,8814,'s,O
126798,8814,proper,O
126799,8814,completion,O
126800,8814,of,O
126801,8814,the,O
126802,8814,protocol,O
126803,8814,requirement,O
126804,8814,.,O
126805,8815,History,O
126806,8815,of,O
126807,8815,life,O
126808,8815,threatening,O
126809,8815,asthma,B-Condition
126810,8815,:,O
126811,8815,Defined,O
126812,8815,as,O
126813,8815,an,O
126814,8815,asthma,B-Condition
126815,8815,episode,I-Condition
126816,8815,that,O
126817,8815,required,O
126818,8815,intubation,B-Procedure
126819,8815,and/or,O
126820,8815,was,O
126821,8815,associated,O
126822,8815,with,O
126823,8815,hypercapnea,B-Condition
126824,8815,",",O
126825,8815,respiratory,B-Condition
126826,8815,arrest,I-Condition
126827,8815,or,O
126828,8815,hypoxic,B-Condition
126829,8815,seizures,I-Condition
126830,8815,within,O
126831,8815,the,O
126832,8815,last,O
126833,8815,6,O
126834,8815,months,O
126835,8815,.,O
126836,8816,A,O
126837,8816,lower,B-Condition
126838,8816,respiratory,I-Condition
126839,8816,tract,I-Condition
126840,8816,infection,I-Condition
126841,8816,within,O
126842,8816,7,O
126843,8816,days,O
126844,8816,of,O
126845,8816,the,O
126846,8816,screening,O
126847,8816,visit,O
126848,8816,.,O
126849,8817,Concurrent,O
126850,8817,diagnosis,O
126851,8817,of,O
126852,8817,chronic,B-Condition
126853,8817,obstructive,I-Condition
126854,8817,pulmonary,I-Condition
126855,8817,disease,I-Condition
126856,8817,(,I-Condition
126857,8817,COPD,I-Condition
126858,8817,),I-Condition
126859,8817,or,O
126860,8817,other,O
126861,8817,respiratory,B-Condition
126862,8817,disorders,I-Condition
126863,8817,including,O
126864,8817,active,O
126865,8817,tuberculosis,B-Condition
126866,8817,",",O
126867,8817,lung,B-Condition
126868,8817,cancer,I-Condition
126869,8817,",",O
126870,8817,bronchiectasis,B-Condition
126871,8817,",",O
126872,8817,sarcoidosis,B-Condition
126873,8817,",",O
126874,8817,lung,B-Condition
126875,8817,fibrosis,I-Condition
126876,8817,",",O
126877,8817,pulmonary,B-Condition
126878,8817,hypertension,I-Condition
126879,8817,",",O
126880,8817,interstitial,B-Condition
126881,8817,lung,I-Condition
126882,8817,diseases,I-Condition
126883,8817,or,O
126884,8817,other,O
126885,8817,active,O
126886,8817,pulmonary,B-Condition
126887,8817,diseases,I-Condition
126888,8817,.,O
126889,8818,History,O
126890,8818,of,O
126891,8818,hypersensitivity,B-Condition
126892,8818,/,O
126893,8818,intolerance,B-Condition
126894,8818,to,O
126895,8818,any,O
126896,8818,components,B-Drug
126897,8818,of,I-Drug
126898,8818,the,I-Drug
126899,8818,study,I-Drug
126900,8818,inhalers,I-Drug
126901,8818,(,O
126902,8818,example,O
126903,8818,",",O
126904,8818,lactose,B-Drug
126905,8818,",",O
126906,8818,magnesium,B-Drug
126907,8818,stearate,I-Drug
126908,8818,),O
126909,8818,.,O
126910,8818,In,O
126911,8818,addition,O
126912,8818,",",O
126913,8818,subjects,O
126914,8818,with,O
126915,8818,a,O
126916,8818,history,B-Observation
126917,8818,of,O
126918,8818,severe,O
126919,8818,milk,B-Drug
126920,8818,protein,I-Drug
126921,8818,allergy,B-Condition
126922,8818,that,O
126923,8818,",",O
126924,8818,in,O
126925,8818,the,O
126926,8818,opinion,O
126927,8818,of,O
126928,8818,the,O
126929,8818,study,O
126930,8818,physician,O
126931,8818,",",O
126932,8818,contraindicates,B-Condition
126933,8818,participation,I-Condition
126934,8818,will,O
126935,8818,also,O
126936,8818,be,O
126937,8818,excluded,O
126938,8818,.,O
126939,8819,Historical,B-Observation
126940,8819,or,O
126941,8819,current,O
126942,8819,evidence,O
126943,8819,of,O
126944,8819,clinically,O
126945,8819,significant,O
126946,8819,or,O
126947,8819,rapidly,O
126948,8819,progressing,O
126949,8819,or,O
126950,8819,unstable,O
126951,8819,cardiovascular,B-Condition
126952,8819,",",I-Condition
126953,8819,neurological,I-Condition
126954,8819,",",I-Condition
126955,8819,cardiovascular,I-Condition
126956,8819,",",I-Condition
126957,8819,neurological,I-Condition
126958,8819,",",I-Condition
126959,8819,renal,I-Condition
126960,8819,",",I-Condition
126961,8819,hepatic,I-Condition
126962,8819,",",I-Condition
126963,8819,immunological,I-Condition
126964,8819,",",I-Condition
126965,8819,endocrine,I-Condition
126966,8819,(,I-Condition
126967,8819,including,I-Condition
126968,8819,uncontrolled,I-Condition
126969,8819,diabetes,I-Condition
126970,8819,or,I-Condition
126971,8819,thyroid,I-Condition
126972,8819,disease,I-Condition
126973,8819,),I-Condition
126974,8819,or,I-Condition
126975,8819,hematological,I-Condition
126976,8819,abnormalities,I-Condition
126977,8819,that,O
126978,8819,are,O
126979,8819,uncontrolled,O
126980,8819,.,O
126981,8819,Significant,O
126982,8819,is,O
126983,8819,defined,O
126984,8819,as,O
126985,8819,any,O
126986,8819,disease,O
126987,8819,that,O
126988,8819,",",O
126989,8819,in,O
126990,8819,the,O
126991,8819,opinion,O
126992,8819,of,O
126993,8819,the,O
126994,8819,investigator,O
126995,8819,",",O
126996,8819,would,O
126997,8819,put,O
126998,8819,the,O
126999,8819,safety,O
127000,8819,of,O
127001,8819,the,O
127002,8819,subject,O
127003,8819,at,O
127004,8819,risk,O
127005,8819,through,O
127006,8819,participation,O
127007,8819,",",O
127008,8819,or,O
127009,8819,which,O
127010,8819,would,O
127011,8819,affect,O
127012,8819,the,O
127013,8819,analysis,O
127014,8819,if,O
127015,8819,the,O
127016,8819,disease,O
127017,8819,/,O
127018,8819,condition,O
127019,8819,exacerbated,O
127020,8819,during,O
127021,8819,the,O
127022,8819,study,O
127023,8819,.,O
127024,8820,Subjects,O
127025,8820,who,O
127026,8820,have,O
127027,8820,ever,O
127028,8820,received,O
127029,8820,treatment,B-Procedure
127030,8820,with,O
127031,8820,biological,O
127032,8820,based,O
127033,8820,therapy,O
127034,8820,example,O
127035,8820,",",O
127036,8820,omalizumab,B-Drug
127037,8820,",",O
127038,8820,mepolizumab,B-Drug
127039,8820,",",O
127040,8820,for,O
127041,8820,asthma,B-Drug
127042,8820,.,O
127043,8821,Subjects,O
127044,8821,who,O
127045,8821,have,O
127046,8821,received,O
127047,8821,an,O
127048,8821,investigational,O
127049,8821,drug,O
127050,8821,and/or,O
127051,8821,medical,O
127052,8821,device,O
127053,8821,within,O
127054,8821,30,O
127055,8821,days,O
127056,8821,of,O
127057,8821,entry,O
127058,8821,into,O
127059,8821,this,O
127060,8821,study,O
127061,8821,(,O
127062,8821,Screening,O
127063,8821,),O
127064,8821,",",O
127065,8821,or,O
127066,8821,within,O
127067,8821,five,O
127068,8821,drug,O
127069,8821,half,O
127070,8821,-,O
127071,8821,lives,O
127072,8821,of,O
127073,8821,the,O
127074,8821,investigational,O
127075,8821,drug,O
127076,8821,",",O
127077,8821,whichever,O
127078,8821,is,O
127079,8821,longer,O
127080,8821,.,O
127081,8822,A,O
127082,8822,subject,O
127083,8822,will,O
127084,8822,not,O
127085,8822,be,O
127086,8822,eligible,O
127087,8822,for,O
127088,8822,this,O
127089,8822,study,O
127090,8822,if,O
127091,8822,he,O
127092,8822,/,O
127093,8822,she,O
127094,8822,is,O
127095,8822,an,O
127096,8822,immediate,O
127097,8822,family,O
127098,8822,member,O
127099,8822,of,O
127100,8822,the,O
127101,8822,participating,O
127102,8822,investigator,O
127103,8822,",",O
127104,8822,sub,O
127105,8822,-,O
127106,8822,investigator,O
127107,8822,",",O
127108,8822,study,O
127109,8822,coordinator,O
127110,8822,",",O
127111,8822,employee,O
127112,8822,of,O
127113,8822,the,O
127114,8822,participating,O
127115,8822,investigator,O
127116,8822,",",O
127117,8822,or,O
127118,8822,any,O
127119,8822,family,O
127120,8822,member,O
127121,8822,of,O
127122,8822,a,O
127123,8822,Propeller,O
127124,8822,Health,O
127125,8822,employee,O
127126,8822,.,O
127127,8823,Subjects,O
127128,8823,aged,B-Person
127129,8823,18,O
127130,8823,years,O
127131,8823,or,O
127132,8823,older,O
127133,8823,",",O
127134,8823,at,O
127135,8823,the,O
127136,8823,time,O
127137,8823,of,O
127138,8823,signing,O
127139,8823,the,O
127140,8823,informed,O
127141,8823,consent,O
127142,8823,.,O
127143,8824,Subjects,O
127144,8824,with,O
127145,8824,documented,O
127146,8824,physician,O
127147,8824,diagnosis,O
127148,8824,of,O
127149,8824,asthma,B-Condition
127150,8824,as,O
127151,8824,their,O
127152,8824,primary,O
127153,8824,respiratory,O
127154,8824,disease,O
127155,8824,.,O
127156,8825,ACT,O
127157,8825,score,O
127158,8825,<,O
127159,8825,20,O
127160,8825,at,O
127161,8825,screening,O
127162,8825,visit,O
127163,8825,.,O
127164,8826,Non,B-Observation
127165,8826,-,I-Observation
127166,8826,smokers,I-Observation
127167,8826,(,O
127168,8826,never,B-Observation
127169,8826,smoked,I-Observation
127170,8826,or,O
127171,8826,not,B-Observation
127172,8826,smoking,I-Observation
127173,8826,for,O
127174,8826,>,O
127175,8826,6,O
127176,8826,months,O
127177,8826,with,O
127178,8826,<,O
127179,8826,10,O
127180,8826,pack,O
127181,8826,years,O
127182,8826,history,O
127183,8826,(,O
127184,8826,Pack,O
127185,8826,years,O
127186,8826,=,O
127187,8826,[,O
127188,8826,cigarettes,O
127189,8826,per,O
127190,8826,day,O
127191,8826,smoked/20,O
127192,8826,],O
127193,8826,multiplied,O
127194,8826,by,O
127195,8826,number,O
127196,8826,of,O
127197,8826,years,O
127198,8826,smoked,O
127199,8826,),O
127200,8826,.,O
127201,8827,Male,B-Person
127202,8827,or,O
127203,8827,female,B-Person
127204,8827,subjects,O
127205,8827,will,O
127206,8827,be,O
127207,8827,included,O
127208,8827,.,O
127209,8827,A,O
127210,8827,female,O
127211,8827,subject,O
127212,8827,is,O
127213,8827,eligible,O
127214,8827,to,O
127215,8827,participate,O
127216,8827,if,O
127217,8827,she,O
127218,8827,is,O
127219,8827,not,O
127220,8827,pregnant,O
127221,8827,",",O
127222,8827,not,O
127223,8827,breastfeeding,O
127224,8827,",",O
127225,8827,and,O
127226,8827,at,O
127227,8827,least,O
127228,8827,one,O
127229,8827,of,O
127230,8827,the,O
127231,8827,following,O
127232,8827,conditions,O
127233,8827,applies,O
127234,8827,:,O
127235,8827,(,O
127236,8827,i,O
127237,8827,),O
127238,8827,Not,O
127239,8827,a,O
127240,8827,woman,O
127241,8827,of,O
127242,8827,childbearing,O
127243,8827,potential,O
127244,8827,(,O
127245,8827,WOCBP,O
127246,8827,),O
127247,8827,.,O
127248,8827,(,O
127249,8827,ii,O
127250,8827,),O
127251,8827,A,O
127252,8827,WOCBP,O
127253,8827,who,O
127254,8827,agrees,O
127255,8827,to,O
127256,8827,follow,O
127257,8827,the,O
127258,8827,contraceptive,O
127259,8827,guidance,O
127260,8827,during,O
127261,8827,the,O
127262,8827,treatment,O
127263,8827,period,O
127264,8827,and,O
127265,8827,for,O
127266,8827,at,O
127267,8827,least,O
127268,8827,5,O
127269,8827,days,O
127270,8827,],O
127271,8827,after,O
127272,8827,the,O
127273,8827,last,O
127274,8827,dose,O
127275,8827,of,O
127276,8827,study,O
127277,8827,treatment,O
127278,8827,.,O
127279,8828,Capable,O
127280,8828,of,O
127281,8828,giving,O
127282,8828,signed,O
127283,8828,informed,O
127284,8828,consent,O
127285,8828,which,O
127286,8828,includes,O
127287,8828,compliance,O
127288,8828,with,O
127289,8828,the,O
127290,8828,requirements,O
127291,8828,and,O
127292,8828,restrictions,O
127293,8828,listed,O
127294,8828,in,O
127295,8828,the,O
127296,8828,consent,O
127297,8828,form,O
127298,8828,and,O
127299,8828,protocol,O
127300,8828,.,O
127301,8829,Subject,O
127302,8829,understands,O
127303,8829,and,O
127304,8829,is,O
127305,8829,willing,O
127306,8829,",",O
127307,8829,able,O
127308,8829,",",O
127309,8829,and,O
127310,8829,likely,O
127311,8829,to,O
127312,8829,comply,O
127313,8829,with,O
127314,8829,study,O
127315,8829,procedures,O
127316,8829,and,O
127317,8829,restrictions,O
127318,8829,.,O
127319,8830,Subject,O
127320,8830,must,O
127321,8830,be,O
127322,8830,able,O
127323,8830,to,O
127324,8830,read,O
127325,8830,in,O
127326,8830,a,O
127327,8830,language,O
127328,8830,supported,O
127329,8830,by,O
127330,8830,the,O
127331,8830,smart,O
127332,8830,phone,O
127333,8830,app,O
127334,8830,in,O
127335,8830,their,O
127336,8830,region,O
127337,8830,.,O
127338,8831,Subject,O
127339,8831,must,O
127340,8831,have,O
127341,8831,been,O
127342,8831,on,O
127343,8831,maintenance,B-Procedure
127344,8831,therapy,I-Procedure
127345,8831,(,O
127346,8831,Fixed,O
127347,8831,dose,O
127348,8831,combination,B-Drug
127349,8831,ICS,I-Drug
127350,8831,/,I-Drug
127351,8831,LABA,I-Drug
127352,8831,),O
127353,8831,for,O
127354,8831,3,O
127355,8831,months,O
127356,8831,",",O
127357,8831,can,O
127358,8831,not,O
127359,8831,have,O
127360,8831,changed,O
127361,8831,dose,O
127362,8831,in,O
127363,8831,the,O
127364,8831,month,O
127365,8831,prior,O
127366,8831,to,O
127367,8831,screening,O
127368,8831,and,O
127369,8831,be,O
127370,8831,able,O
127371,8831,to,O
127372,8831,change,O
127373,8831,to,O
127374,8831,an,O
127375,8831,equivalent,O
127376,8831,dose,O
127377,8831,of,O
127378,8831,RELVAR,O
127379,8831,/,O
127380,8831,BREO,O
127381,8831,for,O
127382,8831,the,O
127383,8831,duration,O
127384,8831,of,O
127385,8831,the,O
127386,8831,study,O
127387,8831,.,O
127388,8831,Other,O
127389,8831,background,O
127390,8831,asthma,O
127391,8831,medication,O
127392,8831,such,O
127393,8831,as,O
127394,8831,anti,O
127395,8831,-,O
127396,8831,leukotrienes,O
127397,8831,and,O
127398,8831,oral,O
127399,8831,corticosteroids,O
127400,8831,are,O
127401,8831,permitted,O
127402,8831,provided,O
127403,8831,the,O
127404,8831,dose,O
127405,8831,has,O
127406,8831,been,O
127407,8831,stable,O
127408,8831,for,O
127409,8831,1,O
127410,8831,month,O
127411,8831,prior,O
127412,8831,to,O
127413,8831,screening,O
127414,8831,.,O
127415,8832,Subject,O
127416,8832,must,O
127417,8832,be,O
127418,8832,able,B-Mood
127419,8832,to,I-Mood
127420,8832,change,B-Procedure
127421,8832,to,O
127422,8832,Salbutamol,B-Drug
127423,8832,/,O
127424,8832,Albuterol,B-Drug
127425,8832,MDI,B-Procedure
127426,8832,rescue,I-Procedure
127427,8832,for,O
127428,8832,the,O
127429,8832,duration,O
127430,8832,of,O
127431,8832,the,O
127432,8832,study,O
127433,8832,and,O
127434,8832,judged,O
127435,8832,capable,B-Condition
127436,8832,of,I-Condition
127437,8832,withholding,I-Condition
127438,8832,albuterol,B-Drug
127439,8832,/,O
127440,8832,salbutamol,B-Drug
127441,8832,for,O
127442,8832,at,O
127443,8832,least,O
127444,8832,6,O
127445,8832,hours,O
127446,8832,prior,O
127447,8832,to,O
127448,8832,study,O
127449,8832,visits,O
127450,8832,.,O
127451,8833,Subject,O
127452,8833,must,O
127453,8833,have,O
127454,8833,their,O
127455,8833,own,O
127456,8833,Android,O
127457,8833,or,O
127458,8833,iPhone,O
127459,8833,operating,O
127460,8833,system,O
127461,8833,(,O
127462,8833,IOS,O
127463,8833,),O
127464,8833,smart,O
127465,8833,phone,O
127466,8833,and,O
127467,8833,a,O
127468,8833,data,O
127469,8833,package,O
127470,8833,suitable,O
127471,8833,for,O
127472,8833,the,O
127473,8833,installation,O
127474,8833,and,O
127475,8833,running,O
127476,8833,of,O
127477,8833,the,O
127478,8833,app,O
127479,8833,and,O
127480,8833,sending,O
127481,8833,and,O
127482,8833,receiving,O
127483,8833,data,O
127484,8833,.,O
127485,8833,Data,O
127486,8833,used,O
127487,8833,by,O
127488,8833,the,O
127489,8833,CIS,O
127490,8833,is,O
127491,8833,approximately,O
127492,8833,1,O
127493,8833,megabyte,O
127494,8833,(,O
127495,8833,MB,O
127496,8833,),O
127497,8833,per,O
127498,8833,month,O
127499,8833,as,O
127500,8833,a,O
127501,8833,maximum,O
127502,8833,;,O
127503,8833,this,O
127504,8833,is,O
127505,8833,less,O
127506,8833,data,O
127507,8833,than,O
127508,8833,a,O
127509,8833,1,O
127510,8833,minute,O
127511,8833,video,O
127512,8833,streamed,O
127513,8833,from,O
127514,8833,YouTube,O
127515,8833,(,O
127516,8833,2,O
127517,8833,MB,O
127518,8833,),O
127519,8833,.,O
127520,8834,Subjects,O
127521,8834,must,O
127522,8834,be,O
127523,8834,willing,O
127524,8834,and,O
127525,8834,able,O
127526,8834,to,O
127527,8834,download,O
127528,8834,the,O
127529,8834,app,O
127530,8834,on,O
127531,8834,their,O
127532,8834,personal,O
127533,8834,smart,O
127534,8834,phone,O
127535,8834,and,O
127536,8834,keep,O
127537,8834,it,O
127538,8834,turned,O
127539,8834,on,O
127540,8834,for,O
127541,8834,the,O
127542,8834,duration,O
127543,8834,of,O
127544,8834,the,O
127545,8834,study,O
127546,8834,.,O
127547,8834,This,O
127548,8834,will,O
127549,8834,also,O
127550,8834,require,O
127551,8834,Bluetooth,O
127552,8834,to,O
127553,8834,be,O
127554,8834,turned,O
127555,8834,on,O
127556,8834,for,O
127557,8834,duration,O
127558,8834,of,O
127559,8834,the,O
127560,8834,study,O
127561,8834,.,O
127562,8834,Subjects,O
127563,8834,will,O
127564,8834,also,O
127565,8834,have,O
127566,8834,to,O
127567,8834,turn,O
127568,8834,on,O
127569,8834,mobile,O
127570,8834,data,O
127571,8834,for,O
127572,8834,the,O
127573,8834,app,O
127574,8834,for,O
127575,8834,the,O
127576,8834,duration,O
127577,8834,of,O
127578,8834,study,O
127579,8834,;,O
127580,8834,unless,O
127581,8834,travelling,O
127582,8834,and,O
127583,8834,when,O
127584,8834,extra,O
127585,8834,data,O
127586,8834,roaming,O
127587,8834,costs,O
127588,8834,could,O
127589,8834,be,O
127590,8834,incurred,O
127591,8834,.,O
127592,8835,ACT,O
127593,8835,score,O
127594,8835,<,O
127595,8835,20,O
127596,8835,at,O
127597,8835,randomization,O
127598,8835,visit,O
127599,8835,(,O
127600,8835,visit,O
127601,8835,2,O
127602,8835,),O
127603,8835,.,O
127604,8836,Exclusion,O
127605,8836,criteria,O
127606,8836,includes,O
127607,8836,ICUs,O
127608,8836,with,O
127609,8836,an,O
127610,8836,average,O
127611,8836,length,O
127612,8836,of,O
127613,8836,stay,O
127614,8836,of,O
127615,8836,less,O
127616,8836,than,O
127617,8836,2,O
127618,8836,days,O
127619,8836,;,O
127620,8837,HCA,O
127621,8837,hospitals,O
127622,8837,that,O
127623,8837,are,O
127624,8837,not,O
127625,8837,able,O
127626,8837,to,O
127627,8837,transfer,O
127628,8837,or,O
127629,8837,merge,O
127630,8837,data,O
127631,8837,into,O
127632,8837,the,O
127633,8837,centralized,O
127634,8837,data,O
127635,8837,warehouse,O
127636,8837,for,O
127637,8837,the,O
127638,8837,baseline,O
127639,8837,and,O
127640,8837,intervention,O
127641,8837,periods,O
127642,8837,of,O
127643,8837,the,O
127644,8837,study,O
127645,8837,are,O
127646,8837,also,O
127647,8837,excluded,O
127648,8837,.,O
127649,8838,Inclusion,O
127650,8838,criteria,O
127651,8838,includes,O
127652,8838,all,O
127653,8838,U.S.,O
127654,8838,HCA,O
127655,8838,hospitals,O
127656,8838,with,O
127657,8838,an,O
127658,8838,adult,B-Person
127659,8838,ICU,O
127660,8838,;,O
127661,8839,Note,O
127662,8839,:,O
127663,8839,Unit,O
127664,8839,of,O
127665,8839,randomization,O
127666,8839,is,O
127667,8839,the,O
127668,8839,hospital,O
127669,8839,",",O
127670,8839,but,O
127671,8839,the,O
127672,8839,participants,O
127673,8839,are,O
127674,8839,hospital,O
127675,8839,adult,O
127676,8839,ICUs,O
127677,8840,All,O
127678,8840,patients,O
127679,8840,within,O
127680,8840,adult,B-Person
127681,8840,ICUs,O
127682,8840,are,O
127683,8840,included,O
127684,8840,",",O
127685,8840,including,O
127686,8840,rare,B-Person
127687,8840,patients,I-Person
127688,8840,<,O
127689,8840,18,O
127690,8840,years,B-Person
127691,8840,and,O
127692,8840,>,O
127693,8840,=,O
127694,8840,12,O
127695,8840,years,O
127696,8840,.,O
127697,8841,Had,O
127698,8841,/,O
127699,8841,have,O
127700,8841,the,O
127701,8841,following,O
127702,8841,prior,O
127703,8841,/,O
127704,8841,concurrent,O
127705,8841,therapy,O
127706,8841,:,O
127707,8842,Systemic,B-Drug
127708,8842,corticosteroids,I-Drug
127709,8842,(,O
127710,8842,oral,O
127711,8842,or,O
127712,8842,injectable,O
127713,8842,),O
127714,8842,within,O
127715,8842,7,O
127716,8842,days,O
127717,8842,of,O
127718,8842,first,O
127719,8842,dose,O
127720,8842,of,O
127721,8842,852A,B-Drug
127722,8842,(,O
127723,8842,topical,B-Drug
127724,8842,or,I-Drug
127725,8842,inhaled,I-Drug
127726,8842,steroids,I-Drug
127727,8842,are,O
127728,8842,allowed,O
127729,8842,),O
127730,8843,Investigational,B-Drug
127731,8843,drugs,I-Drug
127732,8843,/,I-Drug
127733,8843,agents,I-Drug
127734,8843,within,O
127735,8843,14,O
127736,8843,days,O
127737,8843,of,O
127738,8843,first,O
127739,8843,dose,O
127740,8843,of,O
127741,8843,852A,B-Drug
127742,8844,Immunosuppressive,B-Procedure
127743,8844,therapy,I-Procedure
127744,8844,",",O
127745,8844,including,O
127746,8844,cytotoxic,B-Drug
127747,8844,agents,I-Drug
127748,8844,within,O
127749,8844,14,O
127750,8844,days,O
127751,8844,of,O
127752,8844,first,O
127753,8844,dose,O
127754,8844,of,O
127755,8844,852A,B-Drug
127756,8844,(,O
127757,8844,nitrosoureas,B-Drug
127758,8844,within,O
127759,8844,30,O
127760,8844,days,O
127761,8844,of,O
127762,8844,first,O
127763,8844,dose,O
127764,8844,),O
127765,8845,Drugs,B-Drug
127766,8845,known,I-Drug
127767,8845,to,I-Drug
127768,8845,induce,I-Drug
127769,8845,QT,I-Drug
127770,8845,interval,I-Drug
127771,8845,prolongation,I-Drug
127772,8845,and/or,I-Drug
127773,8845,induce,I-Drug
127774,8845,Torsades,I-Drug
127775,8845,de,I-Drug
127776,8845,pointes,I-Drug
127777,8845,unless,O
127778,8845,best,O
127779,8845,available,O
127780,8845,drug,O
127781,8845,required,O
127782,8845,to,O
127783,8845,treat,O
127784,8845,life,O
127785,8845,-,O
127786,8845,threatening,O
127787,8845,conditions,O
127788,8846,Radiotherapy,B-Procedure
127789,8846,within,O
127790,8846,3,O
127791,8846,weeks,O
127792,8846,of,O
127793,8846,the,O
127794,8846,first,O
127795,8846,dose,O
127796,8846,of,O
127797,8846,852A,B-Drug
127798,8847,Hematopoietic,B-Procedure
127799,8847,cell,I-Procedure
127800,8847,transplantation,I-Procedure
127801,8847,within,O
127802,8847,4,O
127803,8847,weeks,O
127804,8847,of,O
127805,8847,first,O
127806,8847,dose,O
127807,8847,of,O
127808,8847,852A,B-Drug
127809,8848,Evidence,B-Observation
127810,8848,of,O
127811,8848,active,B-Condition
127812,8848,infection,I-Condition
127813,8848,within,O
127814,8848,3,O
127815,8848,days,O
127816,8848,of,O
127817,8848,first,O
127818,8848,dose,O
127819,8848,of,O
127820,8848,852A,B-Drug
127821,8849,Active,O
127822,8849,fungal,B-Condition
127823,8849,infection,I-Condition
127824,8849,or,O
127825,8849,pulmonary,B-Condition
127826,8849,infiltrates,I-Condition
127827,8849,(,O
127828,8849,prior,B-Condition
127829,8849,treated,I-Condition
127830,8849,disease,I-Condition
127831,8849,stable,O
127832,8849,for,O
127833,8849,2,O
127834,8849,weeks,O
127835,8849,is,O
127836,8849,allowable,O
127837,8849,),O
127838,8850,Cardiac,B-Condition
127839,8850,ischemia,I-Condition
127840,8850,",",O
127841,8850,cardiac,B-Condition
127842,8850,arrhythmias,I-Condition
127843,8850,or,O
127844,8850,congestive,B-Condition
127845,8850,heart,I-Condition
127846,8850,failure,I-Condition
127847,8850,uncontrolled,O
127848,8850,by,O
127849,8850,medication,O
127850,8851,History,B-Observation
127851,8851,of,O
127852,8851,",",O
127853,8851,or,O
127854,8851,clinical,B-Observation
127855,8851,evidence,I-Observation
127856,8851,of,O
127857,8851,",",O
127858,8851,a,O
127859,8851,condition,O
127860,8851,which,O
127861,8851,",",O
127862,8851,in,O
127863,8851,the,O
127864,8851,opinion,O
127865,8851,of,O
127866,8851,the,O
127867,8851,investigator,O
127868,8851,",",O
127869,8851,could,O
127870,8851,confound,O
127871,8851,the,O
127872,8851,results,O
127873,8851,of,O
127874,8851,the,O
127875,8851,study,O
127876,8851,or,O
127877,8851,put,O
127878,8851,the,O
127879,8851,subject,O
127880,8851,at,O
127881,8851,undue,O
127882,8851,risk,O
127883,8852,Uncontrolled,O
127884,8852,intercurrent,B-Condition
127885,8852,or,I-Condition
127886,8852,chronic,I-Condition
127887,8852,illness,I-Condition
127888,8853,Active,O
127889,8853,autoimmune,B-Condition
127890,8853,disease,I-Condition
127891,8853,requiring,O
127892,8853,immunosuppressive,B-Procedure
127893,8853,therapy,I-Procedure
127894,8853,within,O
127895,8853,30,O
127896,8853,days,O
127897,8854,Active,O
127898,8854,coagulation,B-Condition
127899,8854,disorder,I-Condition
127900,8854,not,O
127901,8854,controlled,O
127902,8854,with,O
127903,8854,medication,O
127904,8855,Pregnant,B-Condition
127905,8855,or,O
127906,8855,lactating,B-Condition
127907,8856,Concurrent,O
127908,8856,malignancy,B-Condition
127909,8856,(,O
127910,8856,if,O
127911,8856,in,O
127912,8856,remission,O
127913,8856,",",O
127914,8856,at,O
127915,8856,least,O
127916,8856,5,O
127917,8856,years,O
127918,8856,disease,O
127919,8856,free,O
127920,8856,),O
127921,8856,except,O
127922,8856,for,O
127923,8856,localized,B-Condition
127924,8856,(,I-Condition
127925,8856,in,I-Condition
127926,8856,-,I-Condition
127927,8856,situ,I-Condition
127928,8856,),I-Condition
127929,8856,disease,I-Condition
127930,8856,",",O
127931,8856,basal,B-Condition
127932,8856,carcinomas,I-Condition
127933,8856,and,O
127934,8856,cutaneous,B-Condition
127935,8856,squamous,I-Condition
127936,8856,cell,I-Condition
127937,8856,carcinomas,I-Condition
127938,8856,that,O
127939,8856,have,O
127940,8856,been,O
127941,8856,adequately,O
127942,8856,treated,O
127943,8857,Any,O
127944,8857,history,B-Observation
127945,8857,of,I-Observation
127946,8857,brain,B-Condition
127947,8857,metastases,I-Condition
127948,8857,or,O
127949,8857,any,B-Condition
127950,8857,other,I-Condition
127951,8857,active,I-Condition
127952,8857,central,I-Condition
127953,8857,nervous,I-Condition
127954,8857,system,I-Condition
127955,8857,(,I-Condition
127956,8857,CNS,I-Condition
127957,8857,),I-Condition
127958,8857,disease,I-Condition
127959,8858,Adequate,O
127960,8858,performance,O
127961,8858,status,O
127962,8858,:,O
127963,8859,Breast,O
127964,8859,-,O
127965,8859,Karnofsky,O
127966,8859,score,O
127967,8859,>,O
127968,8859,50,O
127969,8859,;,O
127970,8860,Ovarian,O
127971,8860,",",O
127972,8860,endometrial,O
127973,8860,or,O
127974,8860,cervical,O
127975,8860,-,O
127976,8860,Gynecologic,O
127977,8860,Oncology,O
127978,8860,Group,O
127979,8860,(,O
127980,8860,GOG,O
127981,8860,),O
127982,8860,performance,O
127983,8860,score,O
127984,8860,≤2,O
127985,8861,If,O
127986,8861,female,B-Person
127987,8861,and,O
127988,8861,of,O
127989,8861,childbearing,B-Condition
127990,8861,potential,I-Condition
127991,8861,",",O
127992,8861,are,O
127993,8861,willing,B-Observation
127994,8861,to,I-Observation
127995,8861,use,O
127996,8861,adequate,O
127997,8861,contraception,B-Procedure
127998,8861,(,O
127999,8861,hormonal,B-Drug
128000,8861,",",O
128001,8861,barrier,B-Procedure
128002,8861,method,I-Procedure
128003,8861,",",O
128004,8861,abstinence,B-Procedure
128005,8861,),O
128006,8861,prior,O
128007,8861,to,O
128008,8861,study,O
128009,8861,entry,O
128010,8861,and,O
128011,8861,for,O
128012,8861,the,O
128013,8861,duration,O
128014,8861,of,O
128015,8861,study,O
128016,8861,participation,O
128017,8861,.,O
128018,8862,Normal,B-Condition
128019,8862,organ,I-Condition
128020,8862,function,I-Condition
128021,8862,within,O
128022,8862,14,O
128023,8862,days,O
128024,8862,of,O
128025,8862,study,O
128026,8862,entry,O
128027,8863,Diagnosis,O
128028,8863,of,O
128029,8863,one,O
128030,8863,of,O
128031,8863,the,O
128032,8863,following,O
128033,8863,malignancies,O
128034,8863,:,O
128035,8864,Metastatic,B-Condition
128036,8864,breast,I-Condition
128037,8864,cancer,I-Condition
128038,8864,(,O
128039,8864,BR,O
128040,8864,),O
128041,8865,Metastatic,B-Condition
128042,8865,ovarian,I-Condition
128043,8865,cancer,I-Condition
128044,8865,(,O
128045,8865,OV,O
128046,8865,),O
128047,8866,Metastatic,B-Condition
128048,8866,endometrial,I-Condition
128049,8866,cancer,I-Condition
128050,8866,(,O
128051,8866,EM,O
128052,8866,),O
128053,8867,Metastatic,B-Condition
128054,8867,cervical,I-Condition
128055,8867,cancer,I-Condition
128056,8867,(,O
128057,8867,CX,O
128058,8867,),O
128059,8868,Measurable,O
128060,8868,metastatic,B-Condition
128061,8868,disease,I-Condition
128062,8868,(,O
128063,8868,>,O
128064,8868,1,O
128065,8868,cm,O
128066,8868,),O
128067,8868,in,O
128068,8868,at,O
128069,8868,least,O
128070,8868,one,O
128071,8868,site,O
128072,8868,other,O
128073,8868,than,O
128074,8868,bone,O
128075,8868,-,O
128076,8868,only,O
128077,8869,Progression,B-Observation
128078,8869,on,I-Observation
128079,8869,or,O
128080,8869,failure,B-Observation
128081,8869,to,I-Observation
128082,8869,respond,I-Observation
128083,8869,to,O
128084,8869,at,O
128085,8869,least,O
128086,8869,one,O
128087,8869,previous,O
128088,8869,chemotherapy,B-Procedure
128089,8869,regimen,I-Procedure
128090,8869,for,O
128091,8869,metastatic,B-Condition
128092,8869,disease,I-Condition
128093,8870,Progression,B-Observation
128094,8870,on,I-Observation
128095,8870,prior,O
128096,8870,therapy,B-Procedure
128097,8870,with,I-Procedure
128098,8870,a,I-Procedure
128099,8870,hormonal,I-Procedure
128100,8870,agent,I-Procedure
128101,8870,if,I-Procedure
128102,8870,estrogen,I-Procedure
128103,8870,receptor,I-Procedure
128104,8870,or,I-Procedure
128105,8870,progesterone,I-Procedure
128106,8870,receptor,I-Procedure
128107,8870,positive,I-Procedure
128108,8870,",",I-Procedure
128109,8870,and/or,I-Procedure
128110,8870,with,I-Procedure
128111,8870,trastuzumab,I-Procedure
128112,8870,if,O
128113,8870,HER2,B-Condition
128114,8870,-,I-Condition
128115,8870,neu,I-Condition
128116,8870,positive,I-Condition
128117,8870,.,O
128118,8870,If,O
128119,8870,patient,O
128120,8870,has,O
128121,8870,progressed,B-Observation
128122,8870,through,I-Observation
128123,8870,hormone,B-Procedure
128124,8870,or,I-Procedure
128125,8870,trastuzumab,I-Procedure
128126,8870,therapy,I-Procedure
128127,8870,only,O
128128,8870,",",O
128129,8870,must,O
128130,8870,have,O
128131,8870,received,O
128132,8870,one,O
128133,8870,chemotherapy,B-Procedure
128134,8870,regimen,I-Procedure
128135,8870,.,O
128136,8871,Measurable,O
128137,8871,metastatic,B-Condition
128138,8871,disease,I-Condition
128139,8871,as,O
128140,8871,defined,O
128141,8871,by,O
128142,8871,Response,O
128143,8871,Evaluation,O
128144,8871,Criteria,O
128145,8871,in,O
128146,8871,Solid,O
128147,8871,Tumors,O
128148,8871,(,O
128149,8871,RECIST,O
128150,8871,),O
128151,8872,Primary,O
128152,8872,tumor,O
128153,8872,must,O
128154,8872,have,O
128155,8872,been,O
128156,8872,diagnosed,O
128157,8872,histologically,B-Procedure
128158,8872,as,O
128159,8872,either,O
128160,8872,epithelial,B-Condition
128161,8872,ovarian,I-Condition
128162,8872,cancer,I-Condition
128163,8872,",",O
128164,8872,fallopian,B-Condition
128165,8872,tube,I-Condition
128166,8872,cancer,I-Condition
128167,8872,",",O
128168,8872,or,O
128169,8872,primary,B-Condition
128170,8872,peritoneal,I-Condition
128171,8872,cancer,I-Condition
128172,8872,(,O
128173,8872,not,O
128174,8872,borderline,O
128175,8872,or,O
128176,8872,low,O
128177,8872,malignant,O
128178,8872,potential,O
128179,8872,epithelial,B-Condition
128180,8872,carcinoma,I-Condition
128181,8872,),O
128182,8872,.,O
128183,8873,Subjects,O
128184,8873,must,O
128185,8873,have,O
128186,8873,failed,B-Observation
128187,8873,at,O
128188,8873,least,O
128189,8873,two,O
128190,8873,previous,O
128191,8873,chemotherapy,B-Procedure
128192,8873,regimens,I-Procedure
128193,8873,.,O
128194,8873,Paclitaxel,B-Drug
128195,8873,must,O
128196,8873,have,O
128197,8873,been,O
128198,8873,a,O
128199,8873,component,O
128200,8873,of,O
128201,8873,one,O
128202,8873,or,O
128203,8873,both,O
128204,8873,regimens,O
128205,8873,and,O
128206,8873,cisplatin,B-Drug
128207,8873,or,O
128208,8873,carboplatin,B-Drug
128209,8873,must,O
128210,8873,have,O
128211,8873,been,O
128212,8873,a,O
128213,8873,component,O
128214,8873,of,O
128215,8873,one,O
128216,8873,or,O
128217,8873,both,O
128218,8873,regimens,O
128219,8873,.,O
128220,8874,Measurable,O
128221,8874,metastatic,B-Condition
128222,8874,disease,I-Condition
128223,8875,Histologically,O
128224,8875,proven,O
128225,8875,recurrent,O
128226,8875,or,O
128227,8875,persistent,O
128228,8875,endometrial,B-Condition
128229,8875,cancer,I-Condition
128230,8875,that,O
128231,8875,is,O
128232,8875,not,O
128233,8875,amenable,O
128234,8875,to,O
128235,8875,curative,O
128236,8875,treatment,O
128237,8875,with,O
128238,8875,surgery,B-Procedure
128239,8875,and/or,O
128240,8875,radiation,B-Procedure
128241,8875,therapy,I-Procedure
128242,8875,AND,O
128243,8875,has,O
128244,8875,failed,B-Observation
128245,8875,2,O
128246,8875,previous,O
128247,8875,treatment,B-Procedure
128248,8875,regimens,I-Procedure
128249,8876,Measurable,O
128250,8876,metastatic,B-Condition
128251,8876,disease,I-Condition
128252,8877,Histologically,O
128253,8877,proven,O
128254,8877,recurrent,O
128255,8877,or,O
128256,8877,persistent,O
128257,8877,squamous,B-Condition
128258,8877,cell,I-Condition
128259,8877,carcinoma,I-Condition
128260,8877,",",O
128261,8877,adenosquamous,B-Condition
128262,8877,carcinoma,I-Condition
128263,8877,",",O
128264,8877,or,O
128265,8877,adenocarcinoma,B-Condition
128266,8877,of,I-Condition
128267,8877,the,I-Condition
128268,8877,cervix,I-Condition
128269,8877,that,O
128270,8877,is,O
128271,8877,not,O
128272,8877,amenable,O
128273,8877,to,O
128274,8877,curative,O
128275,8877,treatment,O
128276,8877,with,O
128277,8877,surgery,B-Procedure
128278,8877,and/or,O
128279,8877,radiation,B-Procedure
128280,8877,therapy,I-Procedure
128281,8877,AND,O
128282,8877,has,O
128283,8877,failed,O
128284,8877,2,O
128285,8877,previous,O
128286,8877,treatment,B-Procedure
128287,8877,regimens,I-Procedure
128288,8877,.,O
128289,8878,History,O
128290,8878,of,O
128291,8878,neuropathy,B-Condition
128292,8879,Regularly,O
128293,8879,taking,O
128294,8879,prescribed,O
128295,8879,analgesia,B-Drug
128296,8880,History,O
128297,8880,of,O
128298,8880,a,O
128299,8880,chronic,B-Condition
128300,8880,pain,I-Condition
128301,8880,condition,O
128302,8881,History,O
128303,8881,of,O
128304,8881,severe,O
128305,8881,mental,B-Condition
128306,8881,illness,I-Condition
128307,8881,(,O
128308,8881,as,O
128309,8881,their,O
128310,8881,experience,O
128311,8881,of,O
128312,8881,symptoms,O
128313,8881,may,O
128314,8881,already,O
128315,8881,be,O
128316,8881,altered,O
128317,8881,),O
128318,8882,Current,O
128319,8882,use,O
128320,8882,of,O
128321,8882,fibrates,B-Drug
128322,8882,(,O
128323,8882,because,O
128324,8882,of,O
128325,8882,the,O
128326,8882,risk,O
128327,8882,of,O
128328,8882,interaction,O
128329,8882,with,O
128330,8882,statins,O
128331,8882,but,O
128332,8882,will,O
128333,8882,not,O
128334,8882,exclude,O
128335,8882,participants,O
128336,8882,taking,O
128337,8882,ezetimibe,O
128338,8882,),O
128339,8882,.,O
128340,8883,Severe,O
128341,8883,previous,O
128342,8883,reaction,O
128343,8883,or,O
128344,8883,reaction,O
128345,8883,considered,O
128346,8883,immunological,O
128347,8883,",",O
128348,8883,such,O
128349,8883,as,O
128350,8883,anaphylaxis,B-Condition
128351,8883,",",O
128352,8883,facial,B-Condition
128353,8883,swelling,I-Condition
128354,8883,",",I-Condition
128355,8883,severe,B-Condition
128356,8883,rash,I-Condition
128357,8883,",",O
128358,8883,muscle,B-Condition
128359,8883,ache,I-Condition
128360,8883,with,O
128361,8883,rise,O
128362,8883,in,O
128363,8883,serum,O
128364,8883,creatine,O
128365,8883,kinase,O
128366,8883,",",O
128367,8883,inflammatory,B-Condition
128368,8883,myopathy,I-Condition
128369,8883,",",O
128370,8883,rhabdomyolysis,B-Condition
128371,8883,or,O
128372,8883,liver,B-Condition
128373,8883,function,I-Condition
128374,8883,abnormalities,I-Condition
128375,8883,(,O
128376,8883,aspartate,O
128377,8883,transaminase,O
128378,8883,(,O
128379,8883,AST,O
128380,8883,),O
128381,8883,or,O
128382,8883,alanine,O
128383,8883,transaminase,O
128384,8883,(,O
128385,8883,ALT,O
128386,8883,),O
128387,8883,greater,O
128388,8883,than,O
128389,8883,3,O
128390,8883,times,O
128391,8883,upper,O
128392,8883,limit,O
128393,8883,or,O
128394,8883,normal,O
128395,8883,),O
128396,8883,.,O
128397,8884,Side,O
128398,8884,-,O
128399,8884,effects,O
128400,8884,taking,O
128401,8884,longer,O
128402,8884,than,O
128403,8884,2,O
128404,8884,weeks,O
128405,8884,to,O
128406,8884,develop,O
128407,8884,(,O
128408,8884,because,O
128409,8884,in,O
128410,8884,such,O
128411,8884,participants,O
128412,8884,much,O
128413,8884,longer,O
128414,8884,blocks,O
128415,8884,of,O
128416,8884,treatment,O
128417,8884,would,O
128418,8884,be,O
128419,8884,required,O
128420,8884,",",O
128421,8884,if,O
128422,8884,the,O
128423,8884,present,O
128424,8884,study,O
128425,8884,is,O
128426,8884,positive,O
128427,8884,such,O
128428,8884,studies,O
128429,8884,will,O
128430,8884,be,O
128431,8884,planned,O
128432,8884,for,O
128433,8884,the,O
128434,8884,future,O
128435,8884,),O
128436,8884,*,O
128437,8884,.,O
128438,8885,History,O
128439,8885,of,O
128440,8885,statin,B-Drug
128441,8885,intolerance,B-Condition
128442,8885,with,O
128443,8885,drug,O
128444,8885,interaction,O
128445,8885,to,O
128446,8885,antiretroviral,B-Drug
128447,8885,drugs,I-Drug
128448,8885,.,O
128449,8886,History,O
128450,8886,of,O
128451,8886,statin,B-Drug
128452,8886,intolerance,B-Condition
128453,8886,to,O
128454,8886,any,O
128455,8886,other,O
128456,8886,drug,O
128457,8886,.,O
128458,8887,Pregnant,O
128459,8887,or,O
128460,8887,breast,O
128461,8887,feeding,O
128462,8887,.,O
128463,8888,Side,O
128464,8888,effects,O
128465,8888,taking,O
128466,8888,longer,O
128467,8888,than,O
128468,8888,2,O
128469,8888,weeks,O
128470,8888,to,O
128471,8888,present,O
128472,8888,.,O
128473,8889,In,O
128474,8889,clinical,O
128475,8889,judgement,O
128476,8889,of,O
128477,8889,study,O
128478,8889,doctor,O
128479,8889,",",O
128480,8889,participant,O
128481,8889,should,O
128482,8889,not,O
128483,8889,participate,O
128484,8889,.,O
128485,8890,Aged,B-Person
128486,8890,18,O
128487,8890,years,O
128488,8890,or,O
128489,8890,older,O
128490,8891,Previously,O
128491,8891,taken,O
128492,8891,one,O
128493,8891,or,O
128494,8891,more,O
128495,8891,statins,B-Drug
128496,8892,Withdrawn,O
128497,8892,from,O
128498,8892,statins,O
128499,8892,because,O
128500,8892,of,O
128501,8892,perceived,O
128502,8892,side,O
128503,8892,effects,O
128504,8893,Developed,O
128505,8893,side,B-Condition
128506,8893,effects,I-Condition
128507,8893,within,O
128508,8893,2,O
128509,8893,weeks,O
128510,8893,of,O
128511,8893,initiation,O
128512,8894,Clinical,O
128513,8894,indication,B-Condition
128514,8894,for,O
128515,8894,statins,B-Drug
128516,8894,for,O
128517,8894,primary,O
128518,8894,or,O
128519,8894,secondary,O
128520,8894,prevention,B-Observation
128521,8894,of,I-Observation
128522,8894,cardiovascular,I-Observation
128523,8894,disease,I-Observation
128524,8894,or,O
128525,8894,dyslipidaemia,B-Condition
128526,8894,",",O
128527,8894,on,O
128528,8894,either,O
128529,8894,no,O
128530,8894,medication,O
128531,8894,or,O
128532,8894,non,O
128533,8894,-,O
128534,8894,statin,O
128535,8894,lipid,O
128536,8894,lowering,O
128537,8894,therapy,O
128538,8894,(,O
128539,8894,e.g,O
128540,8894,",",O
128541,8894,ezetimibe,O
128542,8894,),O
128543,8895,Preoperative,O
128544,8895,Hemoglobin,O
128545,8895,<,O
128546,8895,U+2266>11,O
128547,8895,g,O
128548,8895,/,O
128549,8895,dl,O
128550,8896,History,B-Observation
128551,8896,of,O
128552,8896,infection,B-Condition
128553,8896,or,O
128554,8896,intraarticular,B-Condition
128555,8896,fracture,I-Condition
128556,8896,of,O
128557,8896,the,O
128558,8896,affective,O
128559,8896,hip,O
128560,8897,Renal,B-Condition
128561,8897,function,I-Condition
128562,8897,deficiency,I-Condition
128563,8897,(,O
128564,8897,GFR,O
128565,8897,<,O
128566,8897,30,O
128567,8897,ml,O
128568,8897,/,O
128569,8897,min/1.73m2,O
128570,8897,),O
128571,8898,Elevated,O
128572,8898,liver,O
128573,8898,enzyme,O
128574,8898,(,O
128575,8898,aspartate,O
128576,8898,transaminase,O
128577,8898,(,O
128578,8898,AST)/,O
128579,8898,alanine,O
128580,8898,transaminase(ALT,O
128581,8898,),O
128582,8898,level,O
128583,8898,are,O
128584,8898,more,O
128585,8898,than,O
128586,8898,twice,O
128587,8898,normal,O
128588,8898,range,O
128589,8898,),O
128590,8898,",",O
128591,8898,history,B-Observation
128592,8898,of,O
128593,8898,liver,B-Condition
128594,8898,cirrhosis,I-Condition
128595,8898,",",O
128596,8898,impaired,B-Condition
128597,8898,liver,I-Condition
128598,8898,function(elevated,I-Condition
128599,8898,total,O
128600,8898,bilirubin,O
128601,8898,level,O
128602,8898,),O
128603,8898,and,O
128604,8898,coagulopathy,B-Condition
128605,8898,(,O
128606,8898,including,O
128607,8898,long,O
128608,8898,-,O
128609,8898,term,O
128610,8898,use,O
128611,8898,anticoagulant,B-Drug
128612,8898,),O
128613,8899,History,O
128614,8899,of,O
128615,8899,deep,B-Condition
128616,8899,vein,I-Condition
128617,8899,thrombosis,I-Condition
128618,8899,",",O
128619,8899,ischemic,B-Condition
128620,8899,heart,I-Condition
128621,8899,disease,I-Condition
128622,8899,or,O
128623,8899,stroke,B-Condition
128624,8900,Contraindications,B-Condition
128625,8900,of,O
128626,8900,tranexamic,B-Drug
128627,8900,acid,I-Drug
128628,8900,",",O
128629,8900,floseal,B-Drug
128630,8900,",",O
128631,8900,or,O
128632,8900,rivaroxaban,B-Drug
128633,8901,Allergy,B-Condition
128634,8901,to,O
128635,8901,tranexamic,B-Drug
128636,8901,acid,I-Drug
128637,8901,",",O
128638,8901,floseal,B-Drug
128639,8901,",",O
128640,8901,rivaroxaban,B-Drug
128641,8901,",",O
128642,8901,or,O
128643,8901,the,O
128644,8901,excipients,B-Drug
128645,8902,History,B-Observation
128646,8902,of,O
128647,8902,heparin,B-Condition
128648,8902,-,I-Condition
128649,8902,induced,I-Condition
128650,8902,thrombocytopenia,I-Condition
128651,8902,(,I-Condition
128652,8902,HIT,I-Condition
128653,8902,),I-Condition
128654,8903,Coagulopathy,B-Condition
128655,8903,or,O
128656,8903,bleeding,B-Condition
128657,8903,tendency,I-Condition
128658,8903,caused,O
128659,8903,by,O
128660,8903,organ,B-Condition
128661,8903,dysfunction,I-Condition
128662,8903,",",O
128663,8903,such,O
128664,8903,as,O
128665,8903,cirrhosis,B-Condition
128666,8903,",",O
128667,8903,bone,B-Condition
128668,8903,marrow,I-Condition
128669,8903,suppression,I-Condition
128670,8903,etc,O
128671,8903,.,O
128672,8904,Patient,O
128673,8904,who,O
128674,8904,have,O
128675,8904,active,O
128676,8904,bleeding,B-Condition
128677,8904,disorder,I-Condition
128678,8904,",",O
128679,8904,such,O
128680,8904,as,O
128681,8904,intracranial,B-Condition
128682,8904,hemorrhage,I-Condition
128683,8904,",",O
128684,8904,upper,B-Condition
128685,8904,gastrointestinal,I-Condition
128686,8904,bleeding,I-Condition
128687,8904,",",O
128688,8904,hematuria,B-Condition
128689,8904,.,O
128690,8905,Patients,O
128691,8905,with,O
128692,8905,known,O
128693,8905,allergies,B-Condition
128694,8905,to,O
128695,8905,materials,B-Drug
128696,8905,of,I-Drug
128697,8905,bovine,I-Drug
128698,8905,origin,I-Drug
128699,8905,.,O
128700,8906,Patients,O
128701,8906,with,O
128702,8906,osteoarthritis,B-Condition
128703,8906,of,O
128704,8906,the,O
128705,8906,hip,O
128706,8906,secondary,O
128707,8906,to,O
128708,8906,degeneration,B-Condition
128709,8906,",",O
128710,8906,inflammatory,B-Condition
128711,8906,arthritis,I-Condition
128712,8906,",",O
128713,8906,gouty,B-Condition
128714,8906,arthritis,I-Condition
128715,8906,",",O
128716,8906,acetabular,B-Condition
128717,8906,dysplasia,I-Condition
128718,8906,or,O
128719,8906,osteonecrosis,B-Condition
128720,8906,of,O
128721,8906,the,O
128722,8906,femoral,O
128723,8906,head,O
128724,8906,",",O
128725,8906,and,O
128726,8906,undergoing,O
128727,8906,primary,O
128728,8906,unilateral,O
128729,8906,minimally,B-Procedure
128730,8906,invasive,I-Procedure
128731,8906,THA,I-Procedure
128732,8907,Age,B-Person
128733,8907,>,O
128734,8907,18,O
128735,8907,years,O
128736,8907,and,O
128737,8907,<,O
128738,8907,90,O
128739,8907,years,O
128740,8908,Failure,O
128741,8908,of,O
128742,8908,medical,B-Procedure
128743,8908,treatment,I-Procedure
128744,8908,or,O
128745,8908,rehabilitation,B-Procedure
128746,8908,.,O
128747,8909,Hemoglobin,O
128748,8909,>,O
128749,8909,11g,O
128750,8909,/,O
128751,8909,dl,O
128752,8909,",",O
128753,8910,No,O
128754,8910,use,O
128755,8910,of,O
128756,8910,non,B-Drug
128757,8910,-,I-Drug
128758,8910,steroid,I-Drug
128759,8910,anti,I-Drug
128760,8910,-,I-Drug
128761,8910,inflammatory,I-Drug
128762,8910,agent,I-Drug
128763,8910,one,O
128764,8910,week,O
128765,8910,before,O
128766,8910,operation,O
128767,8911,use,O
128768,8911,more,O
128769,8911,than,O
128770,8911,2,O
128771,8911,g,O
128772,8911,a,O
128773,8911,day,O
128774,8911,;,O
128775,8911,5,O
128776,8911,times,O
128777,8911,a,O
128778,8911,week,O
128779,8911,to,O
128780,8911,everyday,O
128781,8912,Subjects,O
128782,8912,who,O
128783,8912,are,O
128784,8912,diagnosed,O
128785,8912,as,O
128786,8912,suffering,O
128787,8912,from,O
128788,8912,psychotic,B-Condition
128789,8912,illness,I-Condition
128790,8912,according,O
128791,8912,to,O
128792,8912,DSM,O
128793,8912,-,O
128794,8912,IV,O
128795,8912,(,O
128796,8912,Axis,O
128797,8912,1)22,O
128798,8912,",",O
128799,8912,or,O
128800,8912,with,O
128801,8912,a,O
128802,8912,history,B-Observation
128803,8912,of,O
128804,8912,CNS,B-Condition
128805,8912,disease,I-Condition
128806,8912,",",O
128807,8912,a,O
128808,8912,history,B-Observation
128809,8912,of,O
128810,8912,infection,B-Condition
128811,8912,that,O
128812,8912,might,O
128813,8912,affect,O
128814,8912,CNS,O
128815,8912,(,O
128816,8912,HIV,B-Condition
128817,8912,",",O
128818,8912,syphilis,B-Condition
128819,8912,",",O
128820,8912,cytomegalovirus,B-Condition
128821,8912,",",O
128822,8912,herpes,B-Condition
128823,8912,),O
128824,8912,",",O
128825,8912,or,O
128826,8912,a,O
128827,8912,history,B-Observation
128828,8912,of,O
128829,8912,head,B-Condition
128830,8912,injury,I-Condition
128831,8912,with,O
128832,8912,loss,B-Condition
128833,8912,of,I-Condition
128834,8912,consciousness,I-Condition
128835,8912,",",O
128836,8912,pregnant,B-Condition
128837,8912,women,O
128838,8912,.,O
128839,8913,Methadone,B-Drug
128840,8913,-,O
128841,8913,maintained,O
128842,8913,cocaine,B-Condition
128843,8913,-,I-Condition
128844,8913,dependent,I-Condition
128845,8913,patients,O
128846,8913,use,O
128847,8913,between,O
128848,8913,1,O
128849,8913,g,O
128850,8913,to,O
128851,8913,2,O
128852,8913,g,O
128853,8913,a,O
128854,8913,day,O
128855,8913,;,O
128856,8913,1,O
128857,8913,to,O
128858,8913,3,O
128859,8913,times,O
128860,8913,a,O
128861,8913,week,O
128862,8914,Unable,B-Observation
128863,8914,to,I-Observation
128864,8914,read,I-Observation
128865,8914,and,I-Observation
128866,8914,understand,I-Observation
128867,8914,the,I-Observation
128868,8914,Danish,I-Observation
128869,8914,language,I-Observation
128870,8914,or,I-Observation
128871,8914,to,I-Observation
128872,8914,give,I-Observation
128873,8914,informed,I-Observation
128874,8914,consent,I-Observation
128875,8915,Cervical,O
128876,8915,dilatation,O
128877,8915,>,O
128878,8915,4,O
128879,8915,cm,O
128880,8916,Non,B-Condition
128881,8916,-,I-Condition
128882,8916,cephalic,I-Condition
128883,8916,presentation,I-Condition
128884,8917,Multiple,B-Condition
128885,8917,gestation,I-Condition
128886,8918,Pathological,B-Condition
128887,8918,fetal,I-Condition
128888,8918,heart,I-Condition
128889,8918,rate,I-Condition
128890,8918,pattern,I-Condition
128891,8918,(,O
128892,8918,cardiotocogram,B-Procedure
128893,8918,",",O
128894,8918,CTG,B-Procedure
128895,8918,),O
128896,8918,before,O
128897,8918,Syntocinon,B-Drug
128898,8918,®,I-Drug
128899,8918,initiation,O
128900,8919,Fetal,O
128901,8919,weight,O
128902,8919,estimation,O
128903,8919,>,O
128904,8919,4500,O
128905,8919,g,O
128906,8919,(,O
128907,8919,clinical,O
128908,8919,or,O
128909,8919,ultrasonic,B-Procedure
128910,8919,),O
128911,8920,Subject,O
128912,8920,declines,O
128913,8920,participation,O
128914,8921,Gestational,O
128915,8921,age,O
128916,8921,less,O
128917,8921,than,O
128918,8921,37,O
128919,8921,completed,O
128920,8921,weeks,O
128921,8922,Women,B-Person
128922,8922,stimulated,O
128923,8922,with,O
128924,8922,Syntocinon,B-Procedure
128925,8922,®,I-Procedure
128926,8922,infusion,I-Procedure
128927,8922,for,O
128928,8922,induction,B-Procedure
128929,8922,of,I-Procedure
128930,8922,labour,I-Procedure
128931,8922,(,O
128932,8922,with,O
128933,8922,or,O
128934,8922,without,O
128935,8922,cervical,B-Procedure
128936,8922,priming,I-Procedure
128937,8922,by,O
128938,8922,prostaglandin,B-Drug
128939,8922,),O
128940,8923,History,B-Observation
128941,8923,or,O
128942,8923,presence,O
128943,8923,of,O
128944,8923,any,O
128945,8923,clinically,B-Condition
128946,8923,significant,I-Condition
128947,8923,disease,I-Condition
128948,8923,or,I-Condition
128949,8923,disorder,I-Condition
128950,8924,Any,O
128951,8924,condition,O
128952,8924,or,O
128953,8924,disease,O
128954,8924,that,O
128955,8924,would,O
128956,8924,render,O
128957,8924,the,O
128958,8924,subject,O
128959,8924,unsuitable,O
128960,8924,for,O
128961,8924,the,O
128962,8924,study,O
128963,8924,",",O
128964,8924,place,O
128965,8924,the,O
128966,8924,subject,O
128967,8924,at,O
128968,8924,undue,O
128969,8924,risk,O
128970,8924,or,O
128971,8924,interfere,O
128972,8924,with,O
128973,8924,the,O
128974,8924,ability,O
128975,8924,of,O
128976,8924,the,O
128977,8924,subject,O
128978,8924,to,O
128979,8924,complete,O
128980,8924,the,O
128981,8924,study,O
128982,8924,in,O
128983,8924,the,O
128984,8924,opinion,O
128985,8924,of,O
128986,8924,the,O
128987,8924,investigator,O
128988,8925,History,O
128989,8925,of,O
128990,8925,clinically,O
128991,8925,significant,O
128992,8925,hypersensitivity,B-Condition
128993,8925,or,O
128994,8925,allergic,B-Condition
128995,8925,drug,I-Condition
128996,8925,reactions,I-Condition
128997,8926,Any,O
128998,8926,suspicion,B-Observation
128999,8926,or,O
129000,8926,history,B-Observation
129001,8926,of,O
129002,8926,alcohol,B-Condition
129003,8926,abuse,I-Condition
129004,8926,and/or,O
129005,8926,consumption,B-Condition
129006,8926,of,I-Condition
129007,8926,other,I-Condition
129008,8926,drugs,I-Condition
129009,8926,of,I-Condition
129010,8926,abuse,I-Condition
129011,8927,Regular,B-Condition
129012,8927,smoker,I-Condition
129013,8927,(,O
129014,8927,>,O
129015,8927,5,O
129016,8927,cigarettes,B-Observation
129017,8927,",",O
129018,8927,>,O
129019,8927,1,O
129020,8927,pipeful,B-Observation
129021,8927,or,O
129022,8927,>,O
129023,8927,1,O
129024,8927,cigar,B-Observation
129025,8927,per,O
129026,8927,day,O
129027,8927,),O
129028,8928,Positive,O
129029,8928,for,O
129030,8928,hepatitis,O
129031,8928,B,O
129032,8928,",",O
129033,8928,hepatitis,O
129034,8928,C,O
129035,8928,or,O
129036,8928,HIV,B-Condition
129037,8928,infection,I-Condition
129038,8929,Dietary,B-Condition
129039,8929,restrictions,I-Condition
129040,8929,that,O
129041,8929,would,O
129042,8929,prohibit,O
129043,8929,the,O
129044,8929,consumption,O
129045,8929,of,O
129046,8929,standardized,O
129047,8929,meals,O
129048,8930,Participation,O
129049,8930,in,O
129050,8930,an,O
129051,8930,investigational,O
129052,8930,drug,O
129053,8930,or,O
129054,8930,device,O
129055,8930,study,O
129056,8930,within,O
129057,8930,90,O
129058,8930,days,O
129059,8930,prior,O
129060,8930,to,O
129061,8930,screening,O
129062,8930,",",O
129063,8930,as,O
129064,8930,calculated,O
129065,8930,from,O
129066,8930,the,O
129067,8930,follow,O
129068,8930,-,O
129069,8930,up,O
129070,8930,from,O
129071,8930,the,O
129072,8930,previous,O
129073,8930,study,O
129074,8931,Healthy,B-Condition
129075,8931,male,B-Person
129076,8931,volunteers,O
129077,8931,",",O
129078,8931,18,O
129079,8931,to,O
129080,8931,45,O
129081,8931,years,O
129082,8931,of,O
129083,8931,age,B-Person
129084,8931,",",O
129085,8931,inclusive,O
129086,8931,.,O
129087,8931,Healthy,O
129088,8931,status,O
129089,8931,is,O
129090,8931,defined,O
129091,8931,by,O
129092,8931,absence,O
129093,8931,of,O
129094,8931,evidence,B-Observation
129095,8931,of,I-Observation
129096,8931,any,I-Observation
129097,8931,active,I-Observation
129098,8931,or,I-Observation
129099,8931,chronic,I-Observation
129100,8931,disease,I-Observation
129101,8931,following,O
129102,8931,a,O
129103,8931,detailed,O
129104,8931,medical,B-Observation
129105,8931,and,I-Observation
129106,8931,surgical,I-Observation
129107,8931,history,I-Observation
129108,8931,",",O
129109,8931,a,O
129110,8931,complete,O
129111,8931,physical,B-Procedure
129112,8931,examination,I-Procedure
129113,8931,including,O
129114,8931,vital,B-Procedure
129115,8931,signs,I-Procedure
129116,8931,",",O
129117,8931,12,B-Procedure
129118,8931,-,I-Procedure
129119,8931,lead,I-Procedure
129120,8931,ECG,I-Procedure
129121,8931,",",O
129122,8931,hematology,B-Procedure
129123,8931,",",O
129124,8931,blood,B-Procedure
129125,8931,chemistry,I-Procedure
129126,8931,",",O
129127,8931,serology,B-Procedure
129128,8931,and,O
129129,8931,urinalysis,B-Procedure
129130,8932,Body,O
129131,8932,mass,O
129132,8932,index,O
129133,8932,(,O
129134,8932,BMI,O
129135,8932,),O
129136,8932,18,O
129137,8932,to,O
129138,8932,30,O
129139,8932,kg,O
129140,8932,/,O
129141,8932,m2,O
129142,8932,inclusive,O
129143,8933,Male,B-Person
129144,8933,subjects,O
129145,8933,(,O
129146,8933,whether,O
129147,8933,surgically,B-Condition
129148,8933,sterilized,I-Condition
129149,8933,or,O
129150,8933,not,O
129151,8933,),O
129152,8933,with,O
129153,8933,female,B-Person
129154,8933,partners,O
129155,8933,of,O
129156,8933,child,B-Condition
129157,8933,-,I-Condition
129158,8933,bearing,I-Condition
129159,8933,potential,I-Condition
129160,8933,must,O
129161,8933,use,O
129162,8933,two,O
129163,8933,forms,O
129164,8933,of,O
129165,8933,contraception,O
129166,8933,",",O
129167,8933,one,O
129168,8933,of,O
129169,8933,which,O
129170,8933,must,O
129171,8933,be,O
129172,8933,a,O
129173,8933,barrier,O
129174,8933,method,O
129175,8933,",",O
129176,8933,for,O
129177,8933,the,O
129178,8933,duration,O
129179,8933,of,O
129180,8933,the,O
129181,8933,study,O
129182,8933,and,O
129183,8933,for,O
129184,8933,77,O
129185,8933,days,O
129186,8933,after,O
129187,8933,the,O
129188,8933,last,O
129189,8933,dose,O
129190,8934,Pregnant,B-Condition
129191,8934,and/or,O
129192,8934,nursing,B-Condition
129193,8934,mothers,O
129194,8934,.,O
129195,8935,Allergy,B-Condition
129196,8935,to,O
129197,8935,bupivacaine,B-Drug
129198,8935,.,O
129199,8936,History,B-Observation
129200,8936,of,O
129201,8936,drug,B-Condition
129202,8936,/,I-Condition
129203,8936,alcohol,I-Condition
129204,8936,abuse,I-Condition
129205,8936,.,O
129206,8937,Severe,O
129207,8937,cardiovascular,O
129208,8937,",",O
129209,8937,hepatic,B-Condition
129210,8937,",",I-Condition
129211,8937,renal,I-Condition
129212,8937,disease,I-Condition
129213,8937,or,O
129214,8937,neurological,B-Condition
129215,8937,impairment,I-Condition
129216,8937,.,O
129217,8938,Patients,O
129218,8938,undergoing,O
129219,8938,urologic,B-Procedure
129220,8938,surgery,I-Procedure
129221,8938,.,O
129222,8939,Use,O
129223,8939,of,O
129224,8939,antihistamine,B-Drug
129225,8939,within,O
129226,8939,the,O
129227,8939,past,O
129228,8939,72,O
129229,8939,hours,O
129230,8940,Chronic,B-Condition
129231,8940,Pulmonary,I-Condition
129232,8940,Condition,I-Condition
129233,8940,other,O
129234,8940,than,O
129235,8940,asthma,B-Condition
129236,8941,Other,O
129237,8941,contraindication,B-Condition
129238,8941,to,O
129239,8941,cetirizine,B-Drug
129240,8942,Severe,O
129241,8942,asthma,B-Condition
129242,8942,exacerbation,I-Condition
129243,8942,requiring,O
129244,8942,resuscitation,B-Procedure
129245,8943,History,O
129246,8943,of,O
129247,8943,allergic,B-Condition
129248,8943,rhinitis,I-Condition
129249,8944,Wheezing,B-Condition
129250,8945,Immunosuppresant,B-Condition
129251,8945,host,I-Condition
129252,8946,Chronic,O
129253,8946,cardiovascular,B-Condition
129254,8946,/,I-Condition
129255,8946,pulmonary,I-Condition
129256,8946,disease,I-Condition
129257,8947,Hospital,B-Condition
129258,8947,acquired,I-Condition
129259,8947,infection,I-Condition
129260,8948,Evidence,O
129261,8948,of,O
129262,8948,Mycoplasma,B-Condition
129263,8948,pneumoniae,I-Condition
129264,8948,infection,I-Condition
129265,8949,Lobar,B-Condition
129266,8949,pneumonia,I-Condition
129267,8949,or,O
129268,8949,pneumoniae,B-Condition
129269,8949,with,O
129270,8949,pleural,B-Condition
129271,8949,effusion,I-Condition
129272,8950,Respiratory,B-Condition
129273,8950,exacerbation,I-Condition
129274,8950,within,O
129275,8950,the,O
129276,8950,2,O
129277,8950,months,O
129278,8950,preceding,O
129279,8950,the,O
129280,8950,study,O
129281,8951,Current,O
129282,8951,diagnostic,B-Condition
129283,8951,of,I-Condition
129284,8951,asthma,I-Condition
129285,8952,Significant,O
129286,8952,O2,B-Condition
129287,8952,desaturation,I-Condition
129288,8952,(,O
129289,8952,SpO2,O
129290,8952,<,O
129291,8952,85,O
129292,8952,%,O
129293,8952,),O
129294,8952,at,O
129295,8952,rest,O
129296,8952,or,O
129297,8952,during,O
129298,8952,exercise,O
129299,8953,Presence,O
129300,8953,of,O
129301,8953,another,O
129302,8953,pathology,B-Condition
129303,8953,that,O
129304,8953,could,O
129305,8953,influence,O
129306,8953,exercise,O
129307,8953,tolerance,O
129308,8954,Use,O
129309,8954,of,O
129310,8954,home,B-Procedure
129311,8954,oxygen,I-Procedure
129312,8955,Age,B-Person
129313,8955,>,O
129314,8955,50,O
129315,8955,years,O
129316,8956,Smoking,O
129317,8956,history,O
129318,8956,>,O
129319,8956,10,O
129320,8956,packs,O
129321,8956,/,O
129322,8956,year,O
129323,8957,FEV1,O
129324,8957,30,O
129325,8957,-,O
129326,8957,79,O
129327,8957,%,O
129328,8957,of,O
129329,8957,predicted,O
129330,8957,and,O
129331,8957,FEV1,O
129332,8957,/,O
129333,8957,FVC,O
129334,8957,<,O
129335,8957,70,O
129336,8957,%,O
129337,8957,(,O
129338,8957,GOLD,O
129339,8957,2,O
129340,8957,-,O
129341,8957,3,O
129342,8957,),O
129343,8958,FRC,O
129344,8958,>,O
129345,8958,120,O
129346,8958,%,O
129347,8958,predicted,O
129348,8959,Borg,O
129349,8959,dyspnea,O
129350,8959,score,O
129351,8959,>,O
129352,8959,3,O
129353,8959,during,O
129354,8959,the,O
129355,8959,3,O
129356,8959,-,O
129357,8959,min,O
129358,8959,constant,O
129359,8959,rate,O
129360,8959,shuttle,O
129361,8959,walking,O
129362,8959,test,O
129363,8959,at,O
129364,8959,V3,O
129365,8960,Women,O
129366,8960,did,O
129367,8960,not,O
129368,8960,have,O
129369,8960,breast,B-Condition
129370,8960,cancer,I-Condition
129371,8961,do,O
129372,8961,not,O
129373,8961,use,O
129374,8961,tamoxifen,B-Drug
129375,8961,or,O
129376,8961,aromatase,B-Drug
129377,8961,inhibitor,I-Drug
129378,8962,not,O
129379,8962,in,O
129380,8962,menopause,B-Condition
129381,8962,and,O
129382,8962,not,O
129383,8962,have,O
129384,8962,hot,B-Condition
129385,8962,flashes,I-Condition
129386,8963,Menopausal,B-Condition
129387,8963,women,B-Person
129388,8963,with,O
129389,8963,breast,B-Condition
129390,8963,cancer,I-Condition
129391,8963,treated,B-Procedure
129392,8963,and,O
129393,8963,using,O
129394,8963,tamoxifen,B-Drug
129395,8963,or,O
129396,8963,aromatase,B-Drug
129397,8963,inhibitor,I-Drug
129398,8963,.,O
129399,8964,With,O
129400,8964,hot,B-Condition
129401,8964,flashes,I-Condition
129402,8964,and,O
129403,8964,with,B-Observation
129404,8964,or,I-Observation
129405,8964,without,I-Observation
129406,8964,active,I-Observation
129407,8964,sexual,I-Observation
129408,8964,life,I-Observation
129409,8964,.,O
129410,8965,Any,O
129411,8965,significant,O
129412,8965,acute,O
129413,8965,or,O
129414,8965,chronic,O
129415,8965,medical,B-Condition
129416,8965,illness,I-Condition
129417,8965,or,O
129418,8965,problem,O
129419,8965,",",O
129420,8965,including,O
129421,8965,",",O
129422,8965,but,O
129423,8965,not,O
129424,8965,limited,O
129425,8965,to,O
129426,8965,",",O
129427,8965,diabetes,B-Condition
129428,8965,",",O
129429,8965,hypertension,B-Condition
129430,8965,",",O
129431,8965,cardiac,B-Condition
129432,8965,disease,I-Condition
129433,8965,",",O
129434,8965,asthma,B-Condition
129435,8965,",",O
129436,8965,chronic,B-Condition
129437,8965,obstructive,I-Condition
129438,8965,lung,I-Condition
129439,8965,disease,I-Condition
129440,8966,Current,O
129441,8966,or,O
129442,8966,recent,O
129443,8966,(,O
129444,8966,last,O
129445,8966,60,O
129446,8966,days,O
129447,8966,),O
129448,8966,tobacco,B-Observation
129449,8966,or,I-Observation
129450,8966,nicotine,I-Observation
129451,8966,use,I-Observation
129452,8967,History,O
129453,8967,of,O
129454,8967,sickle,B-Condition
129455,8967,cell,I-Condition
129456,8967,trait,I-Condition
129457,8967,or,I-Condition
129458,8967,disease,I-Condition
129459,8967,or,O
129460,8967,any,O
129461,8967,other,O
129462,8967,acquired,B-Condition
129463,8967,or,I-Condition
129464,8967,hereditary,I-Condition
129465,8967,hematological,I-Condition
129466,8967,abnormality,I-Condition
129467,8968,History,O
129468,8968,of,O
129469,8968,fainting,B-Condition
129470,8968,or,O
129471,8968,other,O
129472,8968,significant,O
129473,8968,adverse,B-Condition
129474,8968,reaction,I-Condition
129475,8968,during,O
129476,8968,phlebotomy,B-Procedure
129477,8968,or,O
129478,8968,donation,B-Observation
129479,8968,of,I-Observation
129480,8968,blood,I-Observation
129481,8969,Known,O
129482,8969,prolonged,O
129483,8969,QTc,O
129484,8969,(,O
129485,8969,or,O
129486,8969,evidence,O
129487,8969,of,O
129488,8969,such,O
129489,8969,at,O
129490,8969,screening,O
129491,8969,),O
129492,8969,on,O
129493,8969,electrocardiogram,B-Procedure
129494,8969,defined,O
129495,8969,as,O
129496,8969,>,O
129497,8969,470,O
129498,8969,ms,O
129499,8970,Known,O
129500,8970,or,O
129501,8970,suspected,O
129502,8970,illicit,B-Condition
129503,8970,drug,I-Condition
129504,8970,or,I-Condition
129505,8970,alcohol,I-Condition
129506,8970,abuse,I-Condition
129507,8971,Known,O
129508,8971,or,O
129509,8971,suspected,O
129510,8971,HIV,B-Condition
129511,8971,",",I-Condition
129512,8971,Hepatitis,I-Condition
129513,8971,B,I-Condition
129514,8971,",",I-Condition
129515,8971,or,I-Condition
129516,8971,Hepatitis,I-Condition
129517,8971,C,I-Condition
129518,8971,infection,I-Condition
129519,8972,History,O
129520,8972,of,O
129521,8972,thrombophilia,B-Condition
129522,8972,or,O
129523,8972,anticoagulant,B-Drug
129524,8972,therapy,I-Drug
129525,8973,Pregnancy,B-Condition
129526,8974,Obesity,B-Condition
129527,8974,defined,O
129528,8974,as,O
129529,8974,BMI>30,O
129530,8975,Recent,O
129531,8975,history,O
129532,8975,of,O
129533,8975,blood,B-Observation
129534,8975,donation,I-Observation
129535,8975,:,O
129536,8975,a,O
129537,8975,),O
129538,8975,Single,O
129539,8975,whole,O
129540,8975,blood,O
129541,8975,unit,O
129542,8975,donation,O
129543,8975,within,O
129544,8975,the,O
129545,8975,past,O
129546,8975,8,O
129547,8975,weeks,O
129548,8975,;,O
129549,8975,b,O
129550,8975,),O
129551,8975,Double,O
129552,8975,RBC,O
129553,8975,donation,O
129554,8975,by,O
129555,8975,apheresis,O
129556,8975,within,O
129557,8975,the,O
129558,8975,past,O
129559,8975,16,O
129560,8975,weeks,O
129561,8975,;,O
129562,8975,or,O
129563,8975,c,O
129564,8975,),O
129565,8975,Plasma,O
129566,8975,donation,O
129567,8975,by,O
129568,8975,apheresis,O
129569,8975,within,O
129570,8975,the,O
129571,8975,past,O
129572,8975,4,O
129573,8975,weeks,O
129574,8976,Inadequate,O
129575,8976,RBC,B-Observation
129576,8976,mass,I-Observation
129577,8976,based,O
129578,8976,on,O
129579,8976,TBV,O
129580,8976,<,O
129581,8976,4500,O
129582,8976,ml,O
129583,8976,(,O
129584,8976,above,O
129585,8976,),O
129586,8976,or,O
129587,8976,screening,O
129588,8976,Hb,O
129589,8976,<,O
129590,8976,14,O
129591,8976,g,O
129592,8976,/,O
129593,8976,dL,O
129594,8977,Habitual,O
129595,8977,exerciser,O
129596,8977,defined,O
129597,8977,as,O
129598,8977,=,O
129599,8977,30,O
129600,8977,minutes,O
129601,8977,of,O
129602,8977,at,O
129603,8977,least,O
129604,8977,moderate,O
129605,8977,or,O
129606,8977,high,O
129607,8977,intensity,O
129608,8977,exercise,O
129609,8977,=,O
129610,8977,3,O
129611,8977,times,O
129612,8977,per,O
129613,8977,week,O
129614,8977,.,O
129615,8977,After,O
129616,8977,consent,O
129617,8977,",",O
129618,8977,and,O
129619,8977,at,O
129620,8977,the,O
129621,8977,subsequent,O
129622,8977,screening,O
129623,8977,visit,O
129624,8977,",",O
129625,8977,a,O
129626,8977,VO2,O
129627,8977,max,O
129628,8977,test,O
129629,8977,will,O
129630,8977,be,O
129631,8977,performed,O
129632,8977,",",O
129633,8977,and,O
129634,8977,subjects,O
129635,8977,with,O
129636,8977,a,O
129637,8977,low,O
129638,8977,value,O
129639,8977,(,O
129640,8977,<,O
129641,8977,35,O
129642,8977,mL,O
129643,8977,/,O
129644,8977,kg,O
129645,8977,/,O
129646,8977,min,O
129647,8977,),O
129648,8977,will,O
129649,8977,be,O
129650,8977,excluded,O
129651,8977,(,O
129652,8977,screen,O
129653,8977,failure,O
129654,8977,),O
129655,8977,.,O
129656,8977,Based,O
129657,8977,on,O
129658,8977,our,O
129659,8977,previous,O
129660,8977,experience,O
129661,8977,",",O
129662,8977,we,O
129663,8977,anticipate,O
129664,8977,that,O
129665,8977,<,O
129666,8977,10,O
129667,8977,%,O
129668,8977,of,O
129669,8977,the,O
129670,8977,subjects,O
129671,8977,will,O
129672,8977,fall,O
129673,8977,into,O
129674,8977,this,O
129675,8977,category,O
129676,8978,Men,B-Person
129677,8978,:,O
129678,8978,(,O
129679,8978,0.006012,O
129680,8978,x,O
129681,8978,H3,O
129682,8978,),O
129683,8978,+,O
129684,8978,(,O
129685,8978,14.6,O
129686,8978,x,O
129687,8978,W,O
129688,8978,),O
129689,8978,+,O
129690,8978,604,O
129691,8978,=,O
129692,8978,TBV,O
129693,8979,Women,B-Person
129694,8979,:,O
129695,8979,(,O
129696,8979,0.005835,O
129697,8979,x,O
129698,8979,H3,O
129699,8979,),O
129700,8979,+,O
129701,8979,(,O
129702,8979,15,O
129703,8979,x,O
129704,8979,W,O
129705,8979,),O
129706,8979,+,O
129707,8979,183,O
129708,8979,=,O
129709,8979,TBV,O
129710,8979,[,O
129711,8979,H,O
129712,8979,=,O
129713,8979,height,O
129714,8979,in,O
129715,8979,inches,O
129716,8979,;,O
129717,8979,W,O
129718,8979,=,O
129719,8979,weight,O
129720,8979,in,O
129721,8979,pounds,O
129722,8979,],O
129723,8980,Has,O
129724,8980,access,O
129725,8980,to,O
129726,8980,transportation,O
129727,8980,to,O
129728,8980,visit,O
129729,8980,the,O
129730,8980,blood,O
129731,8980,collection,O
129732,8980,facility,O
129733,8980,and,O
129734,8980,to,O
129735,8980,return,O
129736,8980,to,O
129737,8980,Stony,O
129738,8980,Brook,O
129739,8980,for,O
129740,8980,all,O
129741,8980,study,O
129742,8980,visits,O
129743,8980,.,O
129744,8981,Patients,O
129745,8981,not,O
129746,8981,capable,O
129747,8981,or,O
129748,8981,willing,O
129749,8981,to,O
129750,8981,provide,O
129751,8981,informed,O
129752,8981,consent,O
129753,8982,Patients,O
129754,8982,starting,O
129755,8982,Adalimumab,B-Drug
129756,8982,less,O
129757,8982,than,O
129758,8982,five,O
129759,8982,half,O
129760,8982,-,O
129761,8982,lives,O
129762,8982,after,O
129763,8982,the,O
129764,8982,interruption,O
129765,8982,of,O
129766,8982,a,O
129767,8982,previous,O
129768,8982,anti,B-Procedure
129769,8982,-,I-Procedure
129770,8982,TNF,I-Procedure
129771,8982,therapy,I-Procedure
129772,8982,.,O
129773,8983,Patients,O
129774,8983,aged,B-Person
129775,8983,of,O
129776,8983,18,O
129777,8983,and,O
129778,8983,over,O
129779,8983,",",O
129780,8984,Satisfying,O
129781,8984,the,O
129782,8984,1987,O
129783,8984,American,O
129784,8984,College,O
129785,8984,of,O
129786,8984,Rheumatology,O
129787,8984,(,O
129788,8984,ACR,O
129789,8984,),O
129790,8984,criteria,O
129791,8984,for,O
129792,8984,RA,B-Condition
129793,8985,Receiving,O
129794,8985,a,O
129795,8985,prescription,O
129796,8985,of,O
129797,8985,Adalimumab,B-Drug
129798,8985,40,O
129799,8985,mg,O
129800,8985,subcutaneous,O
129801,8985,every,O
129802,8985,two,O
129803,8985,weeks,O
129804,8985,.,O
129805,8986,Cardio,B-Condition
129806,8986,-,I-Condition
129807,8986,vascular,I-Condition
129808,8986,pathologies,I-Condition
129809,8986,",",O
129810,8986,evoluting,O
129811,8986,and,O
129812,8986,uncontrolled,O
129813,8986,",",O
129814,8986,(,O
129815,8986,severe,O
129816,8986,HTA,B-Condition
129817,8986,),O
129818,8986,",",O
129819,8986,cardiac,B-Condition
129820,8986,deficiency,I-Condition
129821,8986,",",O
129822,8986,severe,O
129823,8986,angor,B-Condition
129824,8986,",",O
129825,8986,severe,O
129826,8986,arrhythmia,B-Condition
129827,8986,.,O
129828,8987,Infectious,B-Condition
129829,8987,pathologies,I-Condition
129830,8987,evoluting,O
129831,8987,and,O
129832,8987,requiring,O
129833,8987,antibiotherapy,B-Drug
129834,8987,.,O
129835,8988,Patients,O
129836,8988,HIV+,B-Condition
129837,8988,.,O
129838,8989,Transplanted,B-Procedure
129839,8989,patients,O
129840,8989,or,O
129841,8989,patients,O
129842,8989,suffering,O
129843,8989,from,O
129844,8989,severe,B-Condition
129845,8989,auto,I-Condition
129846,8989,-,I-Condition
129847,8989,immune,I-Condition
129848,8989,disease,I-Condition
129849,8989,.,O
129850,8990,Psychiatric,B-Condition
129851,8990,troubles,I-Condition
129852,8990,that,O
129853,8990,do,O
129854,8990,not,O
129855,8990,allow,O
129856,8990,the,O
129857,8990,protocol,O
129858,8990,follow,O
129859,8990,-,O
129860,8990,up,O
129861,8990,.,O
129862,8991,Pregnant,B-Condition
129863,8991,or,O
129864,8991,breast,B-Condition
129865,8991,-,I-Condition
129866,8991,feeding,I-Condition
129867,8991,women,B-Person
129868,8991,.,O
129869,8992,No,O
129870,8992,contraception,B-Procedure
129871,8992,.,O
129872,8993,HLA,O
129873,8993,-,O
129874,8993,A2,O
129875,8993,melanoma,B-Condition
129876,8993,patients,O
129877,8993,with,O
129878,8993,:,O
129879,8994,either,O
129880,8994,loco,B-Condition
129881,8994,-,I-Condition
129882,8994,regional,I-Condition
129883,8994,or,I-Condition
129884,8994,lymph,I-Condition
129885,8994,node,I-Condition
129886,8994,metastasis,I-Condition
129887,8995,transit,B-Condition
129888,8995,nodules,I-Condition
129889,8995,not,O
129890,8995,surgically,B-Procedure
129891,8995,resectable,O
129892,8996,measurable,O
129893,8996,cutaneous,B-Condition
129894,8996,or,I-Condition
129895,8996,visceral,I-Condition
129896,8996,metastasis,I-Condition
129897,8997,Patients,O
129898,8997,',O
129899,8997,tumor,O
129900,8997,express,O
129901,8997,Melan,B-Observation
129902,8997,-,I-Observation
129903,8997,A,I-Observation
129904,8997,/,I-Observation
129905,8997,MART-1,I-Observation
129906,8997,antigen,I-Observation
129907,8997,.,O
129908,8998,No,O
129909,8998,chemotherapy,B-Procedure
129910,8998,treatment,O
129911,8998,(,O
129912,8998,except,O
129913,8998,for,O
129914,8998,Deticene,B-Drug
129915,8998,used,O
129916,8998,before,O
129917,8998,the,O
129918,8998,first,O
129919,8998,T,O
129920,8998,cell,O
129921,8998,clones,O
129922,8998,infusion,O
129923,8998,),O
129924,8998,or,O
129925,8998,radiotherapy,B-Procedure
129926,8998,or,O
129927,8998,immunotherapy,B-Procedure
129928,8998,in,O
129929,8998,the,O
129930,8998,last,O
129931,8998,4,O
129932,8998,weeks,O
129933,8998,before,O
129934,8998,infusion,O
129935,8998,.,O
129936,8999,No,O
129937,8999,other,O
129938,8999,melanoma,B-Condition
129939,8999,treatment,B-Procedure
129940,8999,during,O
129941,8999,the,O
129942,8999,protocol,O
129943,8999,.,O
129944,9000,Life,B-Observation
129945,9000,expectancy,I-Observation
129946,9000,should,O
129947,9000,be,O
129948,9000,greater,O
129949,9000,than,O
129950,9000,6,O
129951,9000,months,O
129952,9000,.,O
129953,9001,General,O
129954,9001,state,O
129955,9001,with,O
129956,9001,Karnowsky,O
129957,9001,greater,O
129958,9001,than,O
129959,9001,80,O
129960,9001,",",O
129961,9001,ECOG,O
129962,9001,=,O
129963,9001,0,O
129964,9001,",",O
129965,9001,1,O
129966,9001,or,O
129967,9001,2,O
129968,9001,.,O
129969,9002,Patient,O
129970,9002,should,O
129971,9002,be,O
129972,9002,negative,O
129973,9002,for,O
129974,9002,HIV,O
129975,9002,and,O
129976,9002,B,O
129977,9002,and,O
129978,9002,C,O
129979,9002,hepatitis,O
129980,9002,.,O
129981,9003,Biological,O
129982,9003,parameters,O
129983,9003,at,O
129984,9003,the,O
129985,9003,beginning,O
129986,9003,of,O
129987,9003,the,O
129988,9003,study,O
129989,9003,:,O
129990,9003,leucocytes,O
129991,9003,³,O
129992,9003,2000,O
129993,9003,elements,O
129994,9003,per,O
129995,9003,mm3,O
129996,9003,",",O
129997,9003,hemoglobin,O
129998,9003,³,O
129999,9003,10.5g,O
130000,9003,/,O
130001,9003,dl,O
130002,9003,",",O
130003,9003,platelets,O
130004,9003,³,O
130005,9003,100,O
130006,9003,000,O
130007,9003,per,O
130008,9003,mm3,O
130009,9003,",",O
130010,9003,phosphatases,O
130011,9003,alcalines,O
130012,9003,transaminases,O
130013,9003,£,O
130014,9003,1,O
130015,9003,time,O
130016,9003,1/2,O
130017,9003,compared,O
130018,9003,to,O
130019,9003,the,O
130020,9003,normal,O
130021,9003,.,O
130022,9004,Signed,B-Observation
130023,9004,informed,I-Observation
130024,9004,consent,I-Observation
130025,9005,Pregnant,B-Condition
130026,9005,or,O
130027,9005,lactating,B-Condition
130028,9005,women,B-Person
130029,9005,.,O
130030,9006,Evolutive,B-Condition
130031,9006,skin,I-Condition
130032,9006,disease,I-Condition
130033,9006,on,O
130034,9006,the,O
130035,9006,testing,O
130036,9006,zone,O
130037,9006,(,O
130038,9006,lower,O
130039,9006,back,O
130040,9006,),O
130041,9006,.,O
130042,9007,Patients,O
130043,9007,with,O
130044,9007,a,O
130045,9007,clinically,O
130046,9007,significant,O
130047,9007,disease,B-Condition
130048,9007,(,O
130049,9007,chronic,O
130050,9007,",",O
130051,9007,recurrent,O
130052,9007,or,O
130053,9007,active,O
130054,9007,),O
130055,9007,.,O
130056,9008,Systemic,B-Procedure
130057,9008,corticotherapy,I-Procedure
130058,9008,or,O
130059,9008,immunosuppressive,B-Procedure
130060,9008,treatment,I-Procedure
130061,9008,during,O
130062,9008,the,O
130063,9008,previous,O
130064,9008,month,O
130065,9008,",",O
130066,9008,or,O
130067,9008,local,B-Procedure
130068,9008,corticoid,I-Procedure
130069,9008,treatment,I-Procedure
130070,9008,the,O
130071,9008,week,O
130072,9008,before,O
130073,9008,the,O
130074,9008,patch,O
130075,9008,testing,O
130076,9008,.,O
130077,9009,Local,O
130078,9009,or,O
130079,9009,systemic,O
130080,9009,drug,B-Drug
130081,9009,use,O
130082,9009,which,O
130083,9009,interacts,O
130084,9009,with,O
130085,9009,the,O
130086,9009,outcome,O
130087,9009,measures,O
130088,9009,.,O
130089,9010,Exposure,B-Condition
130090,9010,to,I-Condition
130091,9010,sun,I-Condition
130092,9010,or,I-Condition
130093,9010,UV,I-Condition
130094,9010,radiations,I-Condition
130095,9010,",",O
130096,9010,15,O
130097,9010,days,O
130098,9010,before,O
130099,9010,the,O
130100,9010,patch,O
130101,9010,testing,O
130102,9010,.,O
130103,9011,Patients,O
130104,9011,deprived,B-Condition
130105,9011,of,I-Condition
130106,9011,their,I-Condition
130107,9011,civic,I-Condition
130108,9011,rights,I-Condition
130109,9011,",",O
130110,9011,in,B-Condition
130111,9011,custody,I-Condition
130112,9011,",",O
130113,9011,or,O
130114,9011,subject,B-Condition
130115,9011,to,I-Condition
130116,9011,a,I-Condition
130117,9011,tutorial,I-Condition
130118,9011,",",I-Condition
130119,9011,judiciary,I-Condition
130120,9011,or,I-Condition
130121,9011,administrative,I-Condition
130122,9011,decision,I-Condition
130123,9011,.,O
130124,9012,Patients,O
130125,9012,subject,B-Condition
130126,9012,to,I-Condition
130127,9012,a,I-Condition
130128,9012,protection,I-Condition
130129,9012,measure,I-Condition
130130,9012,.,O
130131,9013,Patients,O
130132,9013,in,O
130133,9013,a,O
130134,9013,critical,B-Condition
130135,9013,medical,I-Condition
130136,9013,situation,I-Condition
130137,9013,.,O
130138,9014,Patients,O
130139,9014,with,O
130140,9014,a,O
130141,9014,personal,B-Observation
130142,9014,situation,I-Observation
130143,9014,judged,O
130144,9014,by,O
130145,9014,the,O
130146,9014,investigator,O
130147,9014,as,O
130148,9014,unlikely,O
130149,9014,to,O
130150,9014,be,O
130151,9014,compatible,O
130152,9014,with,O
130153,9014,optimal,O
130154,9014,participation,O
130155,9014,in,O
130156,9014,the,O
130157,9014,study,O
130158,9014,",",O
130159,9014,or,O
130160,9014,which,O
130161,9014,could,O
130162,9014,constitute,O
130163,9014,a,O
130164,9014,risk,O
130165,9014,for,O
130166,9014,the,O
130167,9014,patient,O
130168,9014,.,O
130169,9015,Linguistic,B-Observation
130170,9015,barrier,I-Observation
130171,9015,or,O
130172,9015,psychological,B-Condition
130173,9015,profile,I-Condition
130174,9015,preventing,O
130175,9015,the,O
130176,9015,patient,O
130177,9015,from,O
130178,9015,signing,O
130179,9015,the,O
130180,9015,consent,O
130181,9015,form,O
130182,9015,.,O
130183,9016,Patient,O
130184,9016,still,O
130185,9016,in,O
130186,9016,an,O
130187,9016,exclusion,O
130188,9016,period,O
130189,9016,following,O
130190,9016,the,O
130191,9016,participation,O
130192,9016,in,O
130193,9016,another,O
130194,9016,clinical,O
130195,9016,trial,O
130196,9016,.,O
130197,9017,Patients,O
130198,9017,having,O
130199,9017,earned,B-Observation
130200,9017,more,I-Observation
130201,9017,than,I-Observation
130202,9017,4500,I-Observation
130203,9017,€,I-Observation
130204,9017,in,I-Observation
130205,9017,indemnities,I-Observation
130206,9017,for,O
130207,9017,participation,O
130208,9017,in,O
130209,9017,clinical,O
130210,9017,trials,O
130211,9017,during,O
130212,9017,the,O
130213,9017,previous,O
130214,9017,12,O
130215,9017,months,O
130216,9017,",",O
130217,9017,including,O
130218,9017,this,O
130219,9017,study,O
130220,9017,.,O
130221,9018,For,O
130222,9018,both,O
130223,9018,groups,O
130224,9018,:,O
130225,9019,Patients,O
130226,9019,aged,B-Person
130227,9019,from,O
130228,9019,18,O
130229,9019,to,O
130230,9019,65,O
130231,9019,years,O
130232,9019,old,O
130233,9019,.,O
130234,9020,Both,B-Person
130235,9020,genders,I-Person
130236,9020,eligible,O
130237,9020,for,O
130238,9020,study,O
130239,9020,.,O
130240,9021,Female,B-Person
130241,9021,participants,O
130242,9021,must,O
130243,9021,use,O
130244,9021,a,O
130245,9021,contraceptive,B-Procedure
130246,9021,method,I-Procedure
130247,9021,.,O
130248,9022,Feasibility,B-Mood
130249,9022,of,I-Mood
130250,9022,patch,O
130251,9022,testing,O
130252,9022,.,O
130253,9023,Participants,O
130254,9023,must,O
130255,9023,be,B-Mood
130256,9023,able,I-Mood
130257,9023,to,I-Mood
130258,9023,understand,O
130259,9023,and,O
130260,9023,sign,O
130261,9023,the,O
130262,9023,Informed,O
130263,9023,Consent,O
130264,9023,",",O
130265,9023,and,O
130266,9023,comply,O
130267,9023,with,O
130268,9023,all,O
130269,9023,aspects,O
130270,9023,of,O
130271,9023,the,O
130272,9023,protocol,O
130273,9023,.,O
130274,9024,Patients,O
130275,9024,must,O
130276,9024,be,O
130277,9024,registered,B-Observation
130278,9024,in,I-Observation
130279,9024,a,I-Observation
130280,9024,social,I-Observation
130281,9024,security,I-Observation
130282,9024,system,I-Observation
130283,9024,or,O
130284,9024,with,O
130285,9024,a,O
130286,9024,health,B-Observation
130287,9024,insurance,I-Observation
130288,9024,coverage,I-Observation
130289,9025,,O
130290,9025,First,O
130291,9025,group,O
130292,9025,:,O
130293,9025,allergic,B-Condition
130294,9025,patients,O
130295,9026,Patients,O
130296,9026,with,O
130297,9026,allergic,B-Condition
130298,9026,contact,I-Condition
130299,9026,dermatitis,I-Condition
130300,9026,to,O
130301,9026,para,B-Drug
130302,9026,-,I-Drug
130303,9026,phenylenediamine,I-Drug
130304,9026,(,I-Drug
130305,9026,PPD,I-Drug
130306,9026,),I-Drug
130307,9026,based,O
130308,9026,on,O
130309,9026,a,O
130310,9026,history,O
130311,9026,of,O
130312,9026,PPD,B-Drug
130313,9026,contact,B-Condition
130314,9026,dermatitis,I-Condition
130315,9026,and,O
130316,9026,positive,O
130317,9026,PPD,O
130318,9026,patch,O
130319,9026,tests,O
130320,9026,.,O
130321,9027,,O
130322,9027,Second,O
130323,9027,group,O
130324,9027,:,O
130325,9027,healthy,B-Observation
130326,9027,volunteers,O
130327,9028,No,O
130328,9028,history,O
130329,9028,of,O
130330,9028,PPD,B-Drug
130331,9028,allergic,B-Condition
130332,9028,contact,I-Condition
130333,9028,dermatitis,I-Condition
130334,9028,",",O
130335,9028,with,O
130336,9028,a,O
130337,9028,negative,O
130338,9028,PPD,O
130339,9028,patch,O
130340,9028,test,O
130341,9028,.,O
130342,9029,Subjects,O
130343,9029,with,O
130344,9029,a,O
130345,9029,history,B-Observation
130346,9029,of,O
130347,9029,hypercoagulopathy,B-Condition
130348,9029,",",O
130349,9029,deep,B-Condition
130350,9029,vein,I-Condition
130351,9029,thrombosis,I-Condition
130352,9029,(,O
130353,9029,DVT,B-Condition
130354,9029,),O
130355,9029,",",O
130356,9029,pulmonary,B-Condition
130357,9029,embolism,I-Condition
130358,9030,Renal,B-Condition
130359,9030,impairment,I-Condition
130360,9031,Subjects,O
130361,9031,with,O
130362,9031,known,O
130363,9031,hypersensitivity,B-Condition
130364,9031,to,O
130365,9031,tranexamic,B-Drug
130366,9031,acid,I-Drug
130367,9032,Consecutive,O
130368,9032,fibrinolytic,B-Condition
130369,9032,states,I-Condition
130370,9032,to,O
130371,9032,coagulopathy,B-Condition
130372,9033,History,B-Observation
130373,9033,of,O
130374,9033,convulsions,B-Condition
130375,9034,Subjects,O
130376,9034,undergoing,O
130377,9034,burn,B-Procedure
130378,9034,excision,I-Procedure
130379,9034,surgery,I-Procedure
130380,9034,for,O
130381,9034,standard,O
130382,9034,of,O
130383,9034,care,O
130384,9034,purposes,O
130385,9035,Male,B-Person
130386,9035,or,O
130387,9035,female,B-Person
130388,9035,>,O
130389,9035,=,O
130390,9035,18,O
130391,9035,years,O
130392,9035,of,O
130393,9035,age,B-Person
130394,9036,Subject,O
130395,9036,or,O
130396,9036,subject,O
130397,9036,'s,O
130398,9036,medical,O
130399,9036,decision,O
130400,9036,maker,O
130401,9036,agrees,O
130402,9036,to,O
130403,9036,participate,O
130404,9036,in,O
130405,9036,this,O
130406,9036,study,O
130407,9036,and,O
130408,9036,provides,O
130409,9036,informed,O
130410,9036,consent,O
130411,9037,Subjects,O
130412,9037,under,O
130413,9037,the,O
130414,9037,age,B-Person
130415,9037,of,O
130416,9037,21,O
130417,9037,.,O
130418,9038,Subjects,O
130419,9038,with,O
130420,9038,excessively,B-Condition
130421,9038,thin,I-Condition
130422,9038,corneas,I-Condition
130423,9038,.,O
130424,9039,Subjects,O
130425,9039,with,O
130426,9039,topographic,B-Condition
130427,9039,evidence,I-Condition
130428,9039,of,O
130429,9039,keratoconus,B-Condition
130430,9039,.,O
130431,9040,Subjects,O
130432,9040,with,O
130433,9040,ectatic,B-Condition
130434,9040,eye,I-Condition
130435,9040,disorders,I-Condition
130436,9040,.,O
130437,9041,Subjects,O
130438,9041,with,O
130439,9041,autoimmune,B-Condition
130440,9041,diseases,I-Condition
130441,9041,.,O
130442,9042,Subjects,O
130443,9042,who,O
130444,9042,are,O
130445,9042,pregnant,B-Condition
130446,9042,or,O
130447,9042,nursing,B-Condition
130448,9042,.,O
130449,9043,Subjects,O
130450,9043,age,B-Person
130451,9043,21,O
130452,9043,and,O
130453,9043,older,O
130454,9044,Subjects,O
130455,9044,with,O
130456,9044,healthy,B-Condition
130457,9044,eyes,I-Condition
130458,9045,Subjects,O
130459,9045,who,O
130460,9045,have,O
130461,9045,previously,O
130462,9045,undergone,O
130463,9045,LASIK,B-Procedure
130464,9045,surgery,I-Procedure
130465,9046,Subjects,O
130466,9046,with,O
130467,9046,residual,B-Condition
130468,9046,refractive,I-Condition
130469,9046,error,I-Condition
130470,9046,.,O
130471,9047,Richter,B-Condition
130472,9047,'s,I-Condition
130473,9047,syndrome,I-Condition
130474,9047,",",O
130475,9047,Burkitt,B-Condition
130476,9047,'s,I-Condition
130477,9047,lymphoma,I-Condition
130478,9047,",",O
130479,9047,or,O
130480,9047,Burkitt,B-Condition
130481,9047,-,I-Condition
130482,9047,like,I-Condition
130483,9047,Lymphoma,I-Condition
130484,9047,(,O
130485,9047,transformed,O
130486,9047,DLBCL,B-Condition
130487,9047,from,O
130488,9047,Follicular,B-Condition
130489,9047,NHL,I-Condition
130490,9047,are,O
130491,9047,eligible,O
130492,9047,),O
130493,9047,.,O
130494,9048,Prior,O
130495,9048,transplant,B-Procedure
130496,9048,with,O
130497,9048,stem,B-Procedure
130498,9048,cell,I-Procedure
130499,9048,infusion,I-Procedure
130500,9048,90,O
130501,9048,days,O
130502,9048,or,O
130503,9048,active,O
130504,9048,graft,B-Procedure
130505,9048,-,I-Procedure
130506,9048,versus,I-Procedure
130507,9048,-,I-Procedure
130508,9048,host,I-Procedure
130509,9048,treatment,I-Procedure
130510,9048,within,O
130511,9048,8,O
130512,9048,weeks,O
130513,9048,of,O
130514,9048,Day,O
130515,9048,1,O
130516,9048,.,O
130517,9049,Prior,O
130518,9049,therapy,B-Procedure
130519,9049,with,O
130520,9049,SYK,B-Drug
130521,9049,inhibitors,I-Drug
130522,9049,.,O
130523,9050,Chronic,O
130524,9050,treatment,O
130525,9050,with,O
130526,9050,strong,B-Drug
130527,9050,CYP3A4,I-Drug
130528,9050,inhibitor/,I-Drug
130529,9050,inducer,I-Drug
130530,9050,",",O
130531,9050,acid,B-Drug
130532,9050,reducing,I-Drug
130533,9050,agent,I-Drug
130534,9050,",",O
130535,9050,Proton,B-Drug
130536,9050,pump,I-Drug
130537,9050,inhibitors,I-Drug
130538,9051,Known,O
130539,9051,lymphomatous,B-Condition
130540,9051,involvement,I-Condition
130541,9051,of,I-Condition
130542,9051,the,I-Condition
130543,9051,CNS,I-Condition
130544,9051,.,O
130545,9052,Persistent,O
130546,9052,",",O
130547,9052,unresolved,O
130548,9052,NCI,O
130549,9052,CTCAE,O
130550,9052,v4.0,O
130551,9052,≥,O
130552,9052,Grade,O
130553,9052,2,O
130554,9052,",",O
130555,9052,previous,O
130556,9052,drug,B-Condition
130557,9052,-,I-Condition
130558,9052,related,I-Condition
130559,9052,toxicity,I-Condition
130560,9052,(,O
130561,9052,except,O
130562,9052,alopecia,B-Condition
130563,9052,",",O
130564,9052,erectile,B-Condition
130565,9052,impotence,I-Condition
130566,9052,",",O
130567,9052,hot,B-Condition
130568,9052,flashes,I-Condition
130569,9052,",",O
130570,9052,libido,B-Condition
130571,9052,",",O
130572,9052,neuropathy,B-Condition
130573,9052,),O
130574,9052,.,O
130575,9053,Prior,O
130576,9053,monoclonal,B-Drug
130577,9053,antibody,I-Drug
130578,9053,",",O
130579,9053,radioimmunoconjugate,B-Drug
130580,9053,",",O
130581,9053,antibody,B-Drug
130582,9053,drug,I-Drug
130583,9053,conjugate,I-Drug
130584,9053,",",O
130585,9053,phototherapy,B-Procedure
130586,9053,",",O
130587,9053,radiotherapy,B-Procedure
130588,9053,",",O
130589,9053,chemotherapy,B-Procedure
130590,9053,",",O
130591,9053,immunotherapy,B-Procedure
130592,9053,",",O
130593,9053,immunosuppressive,B-Procedure
130594,9053,therapy,I-Procedure
130595,9053,",",O
130596,9053,or,O
130597,9053,any,O
130598,9053,test,O
130599,9053,agent,O
130600,9053,within,O
130601,9053,3,O
130602,9053,weeks,O
130603,9053,or,O
130604,9053,for,O
130605,9053,alemtuzumab,B-Drug
130606,9053,8,O
130607,9053,weeks,O
130608,9053,of,O
130609,9053,Day,O
130610,9053,1,O
130611,9053,.,O
130612,9054,For,O
130613,9054,CTCL,B-Condition
130614,9054,:,O
130615,9054,(,O
130616,9054,TSEBT,B-Procedure
130617,9054,),O
130618,9054,within,O
130619,9054,12,O
130620,9054,weeks,O
130621,9054,",",O
130622,9054,or,O
130623,9054,initiation,B-Observation
130624,9054,of,O
130625,9054,topical,B-Drug
130626,9054,steroid,I-Drug
130627,9054,",",O
130628,9054,nitrogen,B-Drug
130629,9054,mustard,I-Drug
130630,9054,",",O
130631,9054,or,O
130632,9054,topical,B-Drug
130633,9054,retinoid,I-Drug
130634,9054,within,O
130635,9054,2,O
130636,9054,weeks,O
130637,9054,.,O
130638,9054,(,O
130639,9054,Stable,O
130640,9054,topical,O
130641,9054,≥,O
130642,9054,4,O
130643,9054,weeks,O
130644,9054,prior,O
130645,9054,to,O
130646,9054,Day,O
130647,9054,1,O
130648,9054,allowed,O
130649,9054,),O
130650,9054,.,O
130651,9055,Known,O
130652,9055,carrier,O
130653,9055,or,O
130654,9055,infection,B-Condition
130655,9055,for,I-Condition
130656,9055,HIV,I-Condition
130657,9055,/,O
130658,9055,Hep,O
130659,9055,B,O
130660,9055,or,O
130661,9055,C.,O
130662,9055,HCV,B-Condition
130663,9055,ab+,I-Condition
130664,9055,must,O
130665,9055,be,O
130666,9055,PCR-,O
130667,9055,.,O
130668,9055,HBV,B-Condition
130669,9055,ab+,I-Condition
130670,9055,must,O
130671,9055,be,O
130672,9055,HBsAg-,O
130673,9055,or,O
130674,9055,undetectable,B-Condition
130675,9055,DNA,I-Condition
130676,9056,Active,O
130677,9056,infection,B-Condition
130678,9056,requiring,O
130679,9056,systemic,B-Procedure
130680,9056,treatment,I-Procedure
130681,9056,",",O
130682,9057,Significant,O
130683,9057,GI,B-Condition
130684,9057,disease,I-Condition
130685,9057,",",O
130686,9057,previous,O
130687,9057,major,O
130688,9057,gastric,B-Procedure
130689,9057,/,I-Procedure
130690,9057,bowel,I-Procedure
130691,9057,surgery,I-Procedure
130692,9057,",",O
130693,9057,difficulty,B-Condition
130694,9057,swallowing,I-Condition
130695,9057,or,O
130696,9057,malabsorption,B-Condition
130697,9057,syndrome,I-Condition
130698,9057,.,O
130699,9058,Major,O
130700,9058,surgery,B-Procedure
130701,9058,within,O
130702,9058,4,O
130703,9058,weeks,O
130704,9059,Previous,O
130705,9059,malignancies,B-Condition
130706,9059,within,O
130707,9059,2,O
130708,9059,yrs,O
130709,9059,.,O
130710,9059,unless,O
130711,9059,relapse,O
130712,9059,risk,O
130713,9059,is,O
130714,9059,small,O
130715,9059,(,O
130716,9059,<,O
130717,9059,5,O
130718,9059,%,O
130719,9059,),O
130720,9059,.,O
130721,9060,Current,O
130722,9060,use,O
130723,9060,of,O
130724,9060,systemic,B-Drug
130725,9060,steroids,I-Drug
130726,9060,>,O
130727,9060,20,O
130728,9060,mg,O
130729,9060,QD,O
130730,9060,prednisone,B-Drug
130731,9060,(,O
130732,9060,or,O
130733,9060,equivalent,O
130734,9060,),O
130735,9061,Breastfeeding,B-Observation
130736,9061,or,O
130737,9061,pregnant,B-Condition
130738,9061,(,O
130739,9061,intention,O
130740,9061,to,O
130741,9061,become,O
130742,9061,),O
130743,9061,females,B-Person
130744,9061,or,O
130745,9061,participation,O
130746,9061,in,O
130747,9061,other,O
130748,9061,clinical,O
130749,9061,trials,O
130750,9062,Phase,O
130751,9062,1,O
130752,9062,Specific,O
130753,9062,Patient,O
130754,9062,at,O
130755,9062,least,O
130756,9062,18yrs,O
130757,9062,of,O
130758,9062,age,B-Person
130759,9062,with,O
130760,9062,histologically,B-Procedure
130761,9062,confirmed,O
130762,9062,CLL,B-Condition
130763,9062,/,O
130764,9062,SLL,B-Condition
130765,9062,or,O
130766,9062,B,B-Condition
130767,9062,-,I-Condition
130768,9062,cell,I-Condition
130769,9062,Non,I-Condition
130770,9062,-,I-Condition
130771,9062,Hodgkin,I-Condition
130772,9062,lymphoma,I-Condition
130773,9062,(,O
130774,9062,DLBCL,B-Condition
130775,9062,",",O
130776,9062,FL,B-Condition
130777,9062,",",O
130778,9062,MCL,B-Condition
130779,9062,",",O
130780,9062,MZL,B-Condition
130781,9062,",",O
130782,9062,lymphoplasmacytic,B-Condition
130783,9062,lymphoma,I-Condition
130784,9062,),O
130785,9062,.,O
130786,9063,Phase,O
130787,9063,2a,O
130788,9063,Inclusion,O
130789,9064,Histological,B-Procedure
130790,9064,evidence,O
130791,9064,:,O
130792,9064,FL,B-Condition
130793,9064,Grade,O
130794,9064,1,O
130795,9064,-,O
130796,9064,3A,O
130797,9064,/,O
130798,9064,iNHL,B-Condition
130799,9064,",",O
130800,9064,with,O
130801,9064,relapsed,B-Condition
130802,9064,or,I-Condition
130803,9064,refractory,I-Condition
130804,9064,disease,I-Condition
130805,9064,(,O
130806,9064,iNHL,B-Condition
130807,9064,includes,O
130808,9064,LPL,B-Condition
130809,9064,/,O
130810,9064,WM,B-Condition
130811,9064,",",O
130812,9064,MZL,B-Condition
130813,9064,),O
130814,9064,;,O
130815,9064,aNHL,B-Condition
130816,9064,",",O
130817,9064,defined,O
130818,9064,as,O
130819,9064,DLBCL,B-Condition
130820,9064,",",O
130821,9064,FL,B-Condition
130822,9064,Grade,O
130823,9064,3B,O
130824,9064,",",O
130825,9064,MCL,B-Condition
130826,9064,",",O
130827,9064,and,O
130828,9064,transformed,B-Condition
130829,9064,NHL,I-Condition
130830,9064,with,O
130831,9064,relapsed,B-Condition
130832,9064,disease,I-Condition
130833,9064,;,O
130834,9064,CLL,B-Condition
130835,9064,/,O
130836,9064,SLL,B-Condition
130837,9064,",",O
130838,9064,PTCL,B-Condition
130839,9064,",",O
130840,9064,or,O
130841,9064,CTCL,B-Condition
130842,9064,(,O
130843,9064,with,O
130844,9064,MF,B-Condition
130845,9064,/,O
130846,9064,SS,B-Condition
130847,9064,),O
130848,9064,with,O
130849,9064,relapsed,O
130850,9064,or,O
130851,9064,refractory,O
130852,9064,.,O
130853,9065,Received,O
130854,9065,BCR,B-Drug
130855,9065,and/or,I-Drug
130856,9065,BCL2,I-Drug
130857,9065,inhibitors,I-Drug
130858,9065,were,O
130859,9065,intolerant,B-Condition
130860,9065,or,O
130861,9065,had,O
130862,9065,relapsed,B-Condition
130863,9065,/,O
130864,9065,refractory,B-Condition
130865,9065,disease,I-Condition
130866,9065,afterwards,O
130867,9065,.,O
130868,9066,Prior,O
130869,9066,treatment,B-Procedure
130870,9066,for,O
130871,9066,lymphoid,B-Condition
130872,9066,malignancy,I-Condition
130873,9066,for,O
130874,9066,progressive,B-Condition
130875,9066,/refractory,I-Condition
130876,9066,disease,I-Condition
130877,9067,≥,O
130878,9067,1,O
130879,9067,prior,O
130880,9067,regimen,O
130881,9067,(,O
130882,9067,min,O
130883,9067,2,O
130884,9067,cycles,O
130885,9067,),O
130886,9067,with,O
130887,9067,antibody,B-Drug
130888,9067,conjugate,I-Drug
130889,9067,",",O
130890,9067,cytotoxic,B-Procedure
130891,9067,chemotherapy,I-Procedure
130892,9067,",",O
130893,9067,or,O
130894,9067,TKI,B-Drug
130895,9067,alone,O
130896,9067,or,O
130897,9067,in,O
130898,9067,combination,O
130899,9067,.,O
130900,9068,Measureable,B-Condition
130901,9068,disease,I-Condition
130902,9068,defined,O
130903,9068,as,O
130904,9068,:,O
130905,9068,≥,O
130906,9068,1,O
130907,9068,lesion,O
130908,9068,≥,O
130909,9068,1.5,O
130910,9068,cm,O
130911,9068,single,O
130912,9068,dimension,O
130913,9068,via,O
130914,9068,CT,B-Procedure
130915,9068,",",O
130916,9068,CT,B-Procedure
130917,9068,/,I-Procedure
130918,9068,PET,I-Procedure
130919,9068,with,O
130920,9068,nodal,B-Condition
130921,9068,or,I-Condition
130922,9068,mass,I-Condition
130923,9068,lesions,I-Condition
130924,9068,;,O
130925,9068,Quantifiable,O
130926,9068,circulating,B-Condition
130927,9068,tumor,I-Condition
130928,9068,cells,I-Condition
130929,9068,;,O
130930,9068,or,O
130931,9068,for,O
130932,9068,Waldenström,B-Condition
130933,9068,'s,I-Condition
130934,9068,macroglobulinemia,I-Condition
130935,9068,presence,O
130936,9068,of,O
130937,9068,IgM,O
130938,9068,l,O
130939,9068,>,O
130940,9068,2X,O
130941,9068,ULN,O
130942,9068,;,O
130943,9068,For,O
130944,9068,CTCL,B-Condition
130945,9068,:,O
130946,9068,mSWAT,O
130947,9068,>,O
130948,9068,0,O
130949,9069,Ability,O
130950,9069,to,O
130951,9069,provide,O
130952,9069,diagnostic,O
130953,9069,reports,O
130954,9070,General,O
130955,9070,Inclusion,O
130956,9071,ECOG,O
130957,9071,Score,O
130958,9071,of,O
130959,9071,0,O
130960,9071,or,O
130961,9071,1,O
130962,9071,.,O
130963,9072,Hematologic,O
130964,9072,ANC,O
130965,9072,>,O
130966,9072,1000,O
130967,9072,/,O
130968,9072,uL,O
130969,9072,and,O
130970,9072,platelet,O
130971,9072,>,O
130972,9072,"75,000",O
130973,9072,/,O
130974,9072,uL,O
130975,9072,",",O
130976,9073,Serum,O
130977,9073,creatinine,O
130978,9073,of,O
130979,9073,<,O
130980,9073,1.5,O
130981,9073,ULN,O
130982,9073,or,O
130983,9073,calculated,O
130984,9073,CrCl,O
130985,9073,of,O
130986,9073,>,O
130987,9073,50,O
130988,9073,mL,O
130989,9073,/,O
130990,9073,min,O
130991,9074,Bilirubin,O
130992,9074,<,O
130993,9074,20.0mg,O
130994,9074,/,O
130995,9074,dL,O
130996,9074,(,O
130997,9074,if,O
130998,9074,Gilberts,B-Condition
130999,9074,then,O
131000,9074,<,O
131001,9074,2.5,O
131002,9074,mg,O
131003,9074,/,O
131004,9074,dL,O
131005,9074,),O
131006,9074,and,O
131007,9074,AST,O
131008,9074,/,O
131009,9074,AST,O
131010,9074,<,O
131011,9074,2.5,O
131012,9074,ULN,O
131013,9075,Patients,O
131014,9075,requiring,O
131015,9075,emergent,B-Procedure
131016,9075,cesarean,I-Procedure
131017,9075,birth,I-Procedure
131018,9076,Patients,O
131019,9076,allergic,B-Condition
131020,9076,to,O
131021,9076,lidocaine,B-Drug
131022,9076,or,O
131023,9076,adhesive,B-Drug
131024,9077,Patients,O
131025,9077,who,O
131026,9077,have,O
131027,9077,already,O
131028,9077,received,O
131029,9077,an,O
131030,9077,epidural,B-Procedure
131031,9077,during,O
131032,9077,this,O
131033,9077,admission,O
131034,9077,or,O
131035,9077,requiring,B-Mood
131036,9077,general,B-Procedure
131037,9077,anesthesia,I-Procedure
131038,9077,for,O
131039,9077,cesarean,B-Procedure
131040,9077,birth,I-Procedure
131041,9078,Patients,O
131042,9078,using,O
131043,9078,chronic,B-Drug
131044,9078,oral,I-Drug
131045,9078,neuromodulators,I-Drug
131046,9079,Patients,O
131047,9079,with,O
131048,9079,cardiac,B-Condition
131049,9079,disease,I-Condition
131050,9079,or,O
131051,9079,using,O
131052,9079,anti,B-Drug
131053,9079,-,I-Drug
131054,9079,arrhythmic,I-Drug
131055,9079,agents,I-Drug
131056,9080,Patients,O
131057,9080,with,O
131058,9080,fibromyalgia,B-Condition
131059,9080,or,O
131060,9080,chronic,B-Condition
131061,9080,pain,I-Condition
131062,9080,syndromes,I-Condition
131063,9080,such,O
131064,9080,as,O
131065,9080,rheumatoid,B-Condition
131066,9080,arthritis,I-Condition
131067,9080,",",O
131068,9080,osteoarthritis,B-Condition
131069,9080,",",O
131070,9080,or,O
131071,9080,lupus,B-Condition
131072,9080,.,O
131073,9081,Daily,O
131074,9081,narcotic,B-Drug
131075,9081,or,O
131076,9081,opiate,B-Drug
131077,9081,use,O
131078,9081,for,O
131079,9081,greater,O
131080,9081,than,O
131081,9081,the,O
131082,9081,2,O
131083,9081,months,O
131084,9081,prior,O
131085,9081,to,O
131086,9081,enrollment,O
131087,9081,in,O
131088,9081,the,O
131089,9081,study,O
131090,9081,.,O
131091,9082,Pregnant,B-Condition
131092,9082,patients,O
131093,9082,who,O
131094,9082,require,O
131095,9082,a,O
131096,9082,scheduled,O
131097,9082,or,O
131098,9082,non,O
131099,9082,-,O
131100,9082,urgent,O
131101,9082,cesarean,B-Procedure
131102,9082,birth,I-Procedure
131103,9083,Patient,O
131104,9083,able,B-Mood
131105,9083,to,I-Mood
131106,9083,receive,I-Mood
131107,9083,neuraxial,B-Procedure
131108,9083,analgesia,I-Procedure
131109,9084,Patient,O
131110,9084,able,O
131111,9084,to,O
131112,9084,give,O
131113,9084,verbal,O
131114,9084,and,O
131115,9084,written,O
131116,9084,consent,O
131117,9084,for,O
131118,9084,both,O
131119,9084,cesarean,O
131120,9084,birth,O
131121,9084,and,O
131122,9084,study,O
131123,9085,women,B-Person
131124,9085,undergoing,O
131125,9085,caesarean,B-Procedure
131126,9085,section,I-Procedure
131127,9085,at,O
131128,9085,less,O
131129,9085,than,O
131130,9085,37,O
131131,9085,weeks,O
131132,9085,of,O
131133,9085,gestation,O
131134,9085,.,O
131135,9086,Hypertension,B-Condition
131136,9086,with,O
131137,9086,pregnancy,B-Condition
131138,9086,.,O
131139,9087,Cardiac,B-Condition
131140,9087,and,I-Condition
131141,9087,coronary,I-Condition
131142,9087,diseases,I-Condition
131143,9087,with,O
131144,9087,pregnancy,B-Condition
131145,9088,Women,O
131146,9088,with,O
131147,9088,a,O
131148,9088,singleton,B-Condition
131149,9088,pregnancy,I-Condition
131150,9088,undergoing,O
131151,9088,cesarean,B-Procedure
131152,9088,section,I-Procedure
131153,9088,after,O
131154,9088,37,O
131155,9088,weeks,O
131156,9088,of,O
131157,9088,gestation,O
131158,9088,.,O
131159,9089,Prior,O
131160,9089,treatment,B-Procedure
131161,9089,with,O
131162,9089,Acthar,B-Drug
131163,9089,in,O
131164,9089,the,O
131165,9089,past,O
131166,9089,2mos,O
131167,9090,Meet,O
131168,9090,one,O
131169,9090,of,O
131170,9090,the,O
131171,9090,above,O
131172,9090,RA,B-Condition
131173,9090,flare,I-Condition
131174,9090,requirements,I-Condition
131175,9091,Subjects,O
131176,9091,who,O
131177,9091,have,O
131178,9091,received,O
131179,9091,live,B-Drug
131180,9091,or,I-Drug
131181,9091,live,I-Drug
131182,9091,attenuated,I-Drug
131183,9091,vaccines,I-Drug
131184,9091,within,O
131185,9091,6,O
131186,9091,weeks,O
131187,9091,prior,O
131188,9091,to,O
131189,9091,the,O
131190,9091,first,O
131191,9091,dose,O
131192,9091,of,O
131193,9091,study,B-Drug
131194,9091,drug,I-Drug
131195,9091,(,O
131196,9091,or,O
131197,9091,the,O
131198,9091,zoster,B-Drug
131199,9091,vaccine,I-Drug
131200,9091,),O
131201,9092,Patient,O
131202,9092,must,O
131203,9092,meet,O
131204,9092,1987,B-Condition
131205,9092,ACR,I-Condition
131206,9092,criteria,I-Condition
131207,9093,Age,B-Person
131208,9093,>,O
131209,9093,18,O
131210,9093,years,O
131211,9093,of,O
131212,9093,age,O
131213,9094,Baseline,O
131214,9094,DAS28,O
131215,9094,/,O
131216,9094,Erythrocyte,O
131217,9094,Sedimentation,O
131218,9094,Rate,O
131219,9094,(,O
131220,9094,ESR,O
131221,9094,),O
131222,9094,>,O
131223,9094,=,O
131224,9094,3.2,O
131225,9095,Stable,O
131226,9095,concomitant,O
131227,9095,Disease,B-Drug
131228,9095,Modifying,I-Drug
131229,9095,Anti,I-Drug
131230,9095,-,I-Drug
131231,9095,Rheumatic,I-Drug
131232,9095,Drugs,I-Drug
131233,9095,(,I-Drug
131234,9095,DMARDs,I-Drug
131235,9095,),I-Drug
131236,9096,Stable,O
131237,9096,prednisone,B-Drug
131238,9096,<,O
131239,9096,10,O
131240,9096,mg,O
131241,9096,or,O
131242,9096,equivalent,O
131243,9097,Power,O
131244,9097,Doppler,O
131245,9097,score,O
131246,9097,of,O
131247,9097,>,O
131248,9097,=,O
131249,9097,10,O
131250,9098,Concomitant,O
131251,9098,use,O
131252,9098,with,O
131253,9098,oral,B-Drug
131254,9098,anticoagulant,I-Drug
131255,9098,drugs,I-Drug
131256,9099,Acquired,B-Condition
131257,9099,deficiency,I-Condition
131258,9099,of,I-Condition
131259,9099,coagulation,I-Condition
131260,9099,factors,I-Condition
131261,9099,whose,O
131262,9099,treatment,O
131263,9099,is,O
131264,9099,established,O
131265,9100,Hypersensitivity,B-Condition
131266,9100,to,O
131267,9100,a,O
131268,9100,PCC,B-Drug
131269,9101,History,O
131270,9101,of,O
131271,9101,thrombocytopenia,B-Condition
131272,9101,induced,O
131273,9101,by,O
131274,9101,heparin,B-Drug
131275,9102,Disseminated,B-Condition
131276,9102,intravascular,I-Condition
131277,9102,coagulation,I-Condition
131278,9103,Extracranial,B-Condition
131279,9103,active,I-Condition
131280,9103,bleeding,I-Condition
131281,9104,Hypersensitivity,B-Condition
131282,9104,to,O
131283,9104,vitamin,B-Drug
131284,9104,K,I-Drug
131285,9105,Patient,O
131286,9105,with,O
131287,9105,spontaneous,B-Condition
131288,9105,intracranial,I-Condition
131289,9105,hemorrhage,I-Condition
131290,9105,or,O
131291,9105,traumatic,B-Condition
131292,9105,intracranial,I-Condition
131293,9105,hemorrhage,I-Condition
131294,9105,or,O
131295,9105,patient,O
131296,9105,requiring,B-Mood
131297,9105,neurological,B-Procedure
131298,9105,surgery,I-Procedure
131299,9106,Coagulation,B-Condition
131300,9106,disorder,I-Condition
131301,9106,defined,O
131302,9106,by,O
131303,9106,PT,O
131304,9106,less,O
131305,9106,than,O
131306,9106,60,O
131307,9106,%,O
131308,9107,the,O
131309,9107,history,B-Observation
131310,9107,or,O
131311,9107,family,B-Observation
131312,9107,history,I-Observation
131313,9107,of,O
131314,9107,anaphylaxis,B-Condition
131315,9107,",",O
131316,9107,convulsion,B-Condition
131317,9107,",",O
131318,9107,epilepsy,B-Condition
131319,9107,",",O
131320,9107,encephalopathy,B-Condition
131321,9107,and,O
131322,9107,psychosis,B-Condition
131323,9108,the,O
131324,9108,history,B-Observation
131325,9108,of,O
131326,9108,severe,O
131327,9108,inoculation,B-Condition
131328,9108,allergies,I-Condition
131329,9109,patients,O
131330,9109,with,O
131331,9109,immunodeficiency,B-Condition
131332,9109,and,O
131333,9109,malignant,B-Condition
131334,9109,tumors,I-Condition
131335,9109,during,O
131336,9109,the,O
131337,9109,treatment,O
131338,9109,period,O
131339,9109,",",O
131340,9109,receiving,O
131341,9109,immunosuppressive,B-Procedure
131342,9109,therapy,I-Procedure
131343,9109,(,O
131344,9109,oral,B-Drug
131345,9109,steroid,I-Drug
131346,9109,),O
131347,9109,or,O
131348,9109,HIV,B-Condition
131349,9109,due,O
131350,9109,to,O
131351,9109,low,O
131352,9109,immunity,O
131353,9109,",",O
131354,9109,or,O
131355,9109,family,B-Observation
131356,9109,members,I-Observation
131357,9109,have,O
131358,9109,congenital,B-Condition
131359,9109,immune,I-Condition
131360,9109,disease,I-Condition
131361,9110,Nonspecific,B-Drug
131362,9110,immunoglobulin,I-Drug
131363,9110,was,O
131364,9110,injected,O
131365,9110,within,O
131366,9110,one,O
131367,9110,month,O
131368,9111,temperature=37.1,O
131369,9111,<,O
131370,9111,U+2103,O
131371,9111,>,O
131372,9111,and,O
131373,9111,infectious,B-Condition
131374,9111,diseases,I-Condition
131375,9112,the,O
131376,9112,history,B-Observation
131377,9112,of,O
131378,9112,thrombocytopenia,B-Condition
131379,9112,or,O
131380,9112,other,O
131381,9112,thrombocytopenia,B-Condition
131382,9112,with,O
131383,9112,a,O
131384,9112,definite,O
131385,9112,diagnosis,O
131386,9113,respiratory,B-Condition
131387,9113,disease,I-Condition
131388,9113,",",O
131389,9113,acute,B-Condition
131390,9113,infection,I-Condition
131391,9113,or,O
131392,9113,chronic,B-Condition
131393,9113,disease,I-Condition
131394,9113,activity,I-Condition
131395,9113,period,I-Condition
131396,9114,severe,O
131397,9114,cardiovascular,B-Condition
131398,9114,disease,I-Condition
131399,9114,",",O
131400,9114,liver,B-Condition
131401,9114,and,I-Condition
131402,9114,kidney,I-Condition
131403,9114,disease,I-Condition
131404,9114,",",O
131405,9114,and,O
131406,9114,complications,B-Condition
131407,9114,of,O
131408,9114,diabetes,B-Condition
131409,9115,infectious,B-Condition
131410,9115,",",I-Condition
131411,9115,suppurative,I-Condition
131412,9115,and,I-Condition
131413,9115,allergic,I-Condition
131414,9115,dermatosis,I-Condition
131415,9116,other,O
131416,9116,conditions,O
131417,9116,that,O
131418,9116,may,O
131419,9116,affect,O
131420,9116,the,O
131421,9116,evaluation,O
131422,9116,of,O
131423,9116,the,O
131424,9116,trail,O
131425,9117,any,O
131426,9117,serious,O
131427,9117,adverse,B-Condition
131428,9117,events,I-Condition
131429,9117,that,O
131430,9117,have,O
131431,9117,a,O
131432,9117,causal,O
131433,9117,relationship,O
131434,9117,with,O
131435,9117,the,O
131436,9117,inoculation,B-Procedure
131437,9117,of,I-Procedure
131438,9117,the,I-Procedure
131439,9117,upper,I-Procedure
131440,9117,dose,I-Procedure
131441,9117,of,I-Procedure
131442,9117,the,I-Procedure
131443,9117,vaccine,I-Procedure
131444,9118,the,O
131445,9118,abnormality,O
131446,9118,of,O
131447,9118,4,O
131448,9118,levels,O
131449,9118,(,O
131450,9118,local,O
131451,9118,",",O
131452,9118,systemic,O
131453,9118,adverse,O
131454,9118,reactions,O
131455,9118,and,O
131456,9118,vital,O
131457,9118,signs,O
131458,9118,),O
131459,9118,was,O
131460,9118,judged,O
131461,9118,to,O
131462,9118,be,O
131463,9118,related,O
131464,9118,to,O
131465,9118,vaccination,O
131466,9119,other,O
131467,9119,new,O
131468,9119,standards,O
131469,9119,of,O
131470,9119,exclusion,O
131471,9119,criteria,O
131472,9119,for,O
131473,9119,first,O
131474,9119,needle,O
131475,9120,other,O
131476,9120,conditions,O
131477,9120,that,O
131478,9120,may,O
131479,9120,affect,O
131480,9120,the,O
131481,9120,evaluation,O
131482,9120,of,O
131483,9120,the,O
131484,9120,trail,O
131485,9121,aged,B-Person
131486,9121,=,O
131487,9121,6,O
131488,9121,months,O
131489,9122,sign,O
131490,9122,the,O
131491,9122,informed,O
131492,9122,consent,O
131493,9122,form,O
131494,9123,the,O
131495,9123,legal,O
131496,9123,guardians,O
131497,9123,participate,O
131498,9123,in,O
131499,9123,all,O
131500,9123,the,O
131501,9123,planned,O
131502,9123,follow,O
131503,9123,-,O
131504,9123,up,O
131505,9123,and,O
131506,9123,be,O
131507,9123,able,O
131508,9123,to,O
131509,9123,comply,O
131510,9123,with,O
131511,9123,all,O
131512,9123,research,O
131513,9123,procedures,O
131514,9124,the,O
131515,9124,subjects,O
131516,9124,have,O
131517,9124,completed,O
131518,9124,the,O
131519,9124,basic,O
131520,9124,immunization,O
131521,9124,of,O
131522,9124,2,O
131523,9124,needle,B-Drug
131524,9124,recombinant,I-Drug
131525,9124,hepatitis,I-Drug
131526,9124,B,I-Drug
131527,9124,vaccine,I-Drug
131528,9124,",",O
131529,9124,there,O
131530,9124,is,O
131531,9124,no,O
131532,9124,inoculation,B-Procedure
131533,9124,history,B-Observation
131534,9124,of,O
131535,9124,EV71,B-Drug
131536,9124,vaccine,I-Drug
131537,9124,",",O
131538,9124,and,O
131539,9124,no,O
131540,9124,history,B-Observation
131541,9124,of,O
131542,9124,EV71,B-Condition
131543,9124,infection,I-Condition
131544,9125,the,O
131545,9125,last,B-Observation
131546,9125,vaccination,I-Observation
131547,9125,intervals,I-Observation
131548,9125,=,O
131549,9125,14,O
131550,9125,days,O
131551,9126,temperature,O
131552,9126,=,O
131553,9126,37,O
131554,9126,<,O
131555,9126,U+2103,O
131556,9126,>,O
131557,9127,aged,B-Person
131558,9127,=,O
131559,9127,6,O
131560,9127,months,O
131561,9128,sign,O
131562,9128,the,O
131563,9128,informed,O
131564,9128,consent,O
131565,9128,form,O
131566,9129,the,O
131567,9129,legal,O
131568,9129,guardians,O
131569,9129,participate,O
131570,9129,in,O
131571,9129,all,O
131572,9129,the,O
131573,9129,planned,O
131574,9129,follow,O
131575,9129,-,O
131576,9129,up,O
131577,9129,and,O
131578,9129,be,O
131579,9129,able,O
131580,9129,to,O
131581,9129,comply,O
131582,9129,with,O
131583,9129,all,O
131584,9129,research,O
131585,9129,procedures,O
131586,9130,there,O
131587,9130,is,O
131588,9130,no,O
131589,9130,inoculation,B-Procedure
131590,9130,history,B-Observation
131591,9130,of,O
131592,9130,EV71,B-Drug
131593,9130,vaccine,I-Drug
131594,9130,",",O
131595,9130,and,O
131596,9130,there,O
131597,9130,is,O
131598,9130,no,O
131599,9130,history,B-Observation
131600,9130,of,O
131601,9130,EV71,B-Condition
131602,9130,infection,I-Condition
131603,9131,the,O
131604,9131,last,B-Observation
131605,9131,vaccination,I-Observation
131606,9131,intervals,I-Observation
131607,9131,=,O
131608,9131,14,O
131609,9131,days,O
131610,9132,temperature,O
131611,9132,=,O
131612,9132,37,O
131613,9132,<,O
131614,9132,U+2103,O
131615,9132,>,O
131616,9133,aged,B-Person
131617,9133,=,O
131618,9133,8,O
131619,9133,months,O
131620,9134,sign,O
131621,9134,the,O
131622,9134,informed,O
131623,9134,consent,O
131624,9134,form,O
131625,9135,the,O
131626,9135,legal,O
131627,9135,guardians,O
131628,9135,participate,O
131629,9135,in,O
131630,9135,all,O
131631,9135,the,O
131632,9135,planned,O
131633,9135,follow,O
131634,9135,-,O
131635,9135,up,O
131636,9135,and,O
131637,9135,be,O
131638,9135,able,O
131639,9135,to,O
131640,9135,comply,O
131641,9135,with,O
131642,9135,all,O
131643,9135,research,O
131644,9135,procedures,O
131645,9136,there,O
131646,9136,is,O
131647,9136,no,O
131648,9136,inoculation,B-Procedure
131649,9136,history,B-Observation
131650,9136,of,O
131651,9136,EV71,B-Drug
131652,9136,vaccine,I-Drug
131653,9136,",",O
131654,9136,and,O
131655,9136,there,O
131656,9136,is,O
131657,9136,no,O
131658,9136,history,B-Observation
131659,9136,of,O
131660,9136,EV71,B-Condition
131661,9136,infection,I-Condition
131662,9137,the,O
131663,9137,last,B-Observation
131664,9137,vaccination,I-Observation
131665,9137,intervals,I-Observation
131666,9137,=,O
131667,9137,14,O
131668,9137,days,O
131669,9137,and,O
131670,9137,the,O
131671,9137,last,B-Observation
131672,9137,attenuated,I-Observation
131673,9137,live,I-Observation
131674,9137,vaccine,I-Observation
131675,9137,intervals=28days,I-Observation
131676,9138,temperature,O
131677,9138,=,O
131678,9138,37,O
131679,9138,<,O
131680,9138,U+2103,O
131681,9138,>,O
131682,9139,aged,B-Person
131683,9139,=,O
131684,9139,8,O
131685,9139,months,O
131686,9140,sign,O
131687,9140,the,O
131688,9140,informed,O
131689,9140,consent,O
131690,9140,form,O
131691,9141,the,O
131692,9141,legal,O
131693,9141,guardians,O
131694,9141,participate,O
131695,9141,in,O
131696,9141,all,O
131697,9141,the,O
131698,9141,planned,O
131699,9141,follow,O
131700,9141,-,O
131701,9141,up,O
131702,9141,and,O
131703,9141,be,O
131704,9141,able,O
131705,9141,to,O
131706,9141,comply,O
131707,9141,with,O
131708,9141,all,O
131709,9141,research,O
131710,9141,procedures,O
131711,9142,there,O
131712,9142,is,O
131713,9142,no,O
131714,9142,inoculation,B-Procedure
131715,9142,history,B-Observation
131716,9142,of,O
131717,9142,EV71,B-Drug
131718,9142,vaccine,I-Drug
131719,9142,",",O
131720,9142,and,O
131721,9142,there,O
131722,9142,is,O
131723,9142,no,O
131724,9142,history,B-Observation
131725,9142,of,O
131726,9142,EV71,B-Condition
131727,9142,infection,I-Condition
131728,9143,the,O
131729,9143,last,B-Observation
131730,9143,vaccination,I-Observation
131731,9143,intervals,I-Observation
131732,9143,=,O
131733,9143,14,O
131734,9143,days,O
131735,9143,and,O
131736,9143,the,O
131737,9143,last,B-Observation
131738,9143,attenuated,I-Observation
131739,9143,live,I-Observation
131740,9143,vaccine,I-Observation
131741,9143,intervals,I-Observation
131742,9143,=,O
131743,9143,28,O
131744,9143,days,O
131745,9144,temperature,O
131746,9144,=,O
131747,9144,37,O
131748,9144,<,O
131749,9144,U+2103,O
131750,9144,>,O
131751,9145,Anticoagulation,B-Procedure
131752,9145,therapy,I-Procedure
131753,9146,Prior,O
131754,9146,CABG,B-Procedure
131755,9146,.,O
131756,9147,Active,O
131757,9147,bleeding,B-Condition
131758,9147,or,O
131759,9147,at,O
131760,9147,high,O
131761,9147,risk,O
131762,9147,of,O
131763,9147,bleeding,B-Condition
131764,9148,Severe,O
131765,9148,liver,O
131766,9148,or,O
131767,9148,renal,B-Condition
131768,9148,disease,I-Condition
131769,9148,.,O
131770,9149,Hypersensitivity,B-Condition
131771,9149,to,O
131772,9149,ticagrelor,B-Drug
131773,9150,History,B-Observation
131774,9150,of,O
131775,9150,intracranial,B-Condition
131776,9150,hemorrhage,I-Condition
131777,9151,Accepted,B-Mood
131778,9151,for,I-Mood
131779,9151,CABG,B-Procedure
131780,9151,surgery,I-Procedure
131781,9152,Treatment,B-Procedure
131782,9152,with,O
131783,9152,Ticagrelor,B-Drug
131784,9152,within,O
131785,9152,48,O
131786,9152,hours,O
131787,9153,Documented,O
131788,9153,renal,B-Condition
131789,9153,failure,I-Condition
131790,9154,documented,O
131791,9154,allergy,B-Condition
131792,9154,to,O
131793,9154,iodine,B-Drug
131794,9154,or,O
131795,9154,shellfish,B-Drug
131796,9155,previous,O
131797,9155,spine,B-Procedure
131798,9155,fusion,I-Procedure
131799,9155,surgery,I-Procedure
131800,9156,undergoing,O
131801,9156,elective,O
131802,9156,posterior,O
131803,9156,spine,O
131804,9156,single,B-Procedure
131805,9156,-,I-Procedure
131806,9156,level,I-Procedure
131807,9156,instrumentation,I-Procedure
131808,9156,surgery,I-Procedure
131809,9157,undergoing,O
131810,9157,anterior,O
131811,9157,spine,O
131812,9157,multi,B-Procedure
131813,9157,-,I-Procedure
131814,9157,level,I-Procedure
131815,9157,instrumentation,I-Procedure
131816,9157,surgery,I-Procedure
131817,9158,current,O
131818,9158,antibiotic,B-Drug
131819,9158,use,I-Drug
131820,9158,.,O
131821,9159,Age,B-Person
131822,9159,3,O
131823,9159,to,O
131824,9159,18,O
131825,9159,years,O
131826,9159,on,O
131827,9159,day,O
131828,9159,of,O
131829,9159,surgery,O
131830,9160,diagnosis,O
131831,9160,of,O
131832,9160,spinal,B-Condition
131833,9160,deformity,I-Condition
131834,9161,undergoing,O
131835,9161,elective,O
131836,9161,posterior,O
131837,9161,spine,O
131838,9161,multi,B-Procedure
131839,9161,-,I-Procedure
131840,9161,level,I-Procedure
131841,9161,instrumentation,I-Procedure
131842,9161,surgery,I-Procedure
131843,9162,Contraindication,B-Condition
131844,9162,for,I-Condition
131845,9162,hepatectomy,I-Condition
131846,9162,",",O
131847,9162,including,O
131848,9162,gastrointestinal,B-Condition
131849,9162,hemorrhage,I-Condition
131850,9162,",",O
131851,9162,severe,O
131852,9162,hemorrhagic,B-Condition
131853,9162,disorders,I-Condition
131854,9162,",",O
131855,9162,explicit,O
131856,9162,acute,O
131857,9162,nonspecific,O
131858,9162,infectious,B-Condition
131859,9162,lesion,I-Condition
131860,9162,",",O
131861,9162,overt,O
131862,9162,ascites,B-Condition
131863,9162,",",O
131864,9162,Child,O
131865,9162,-,O
131866,9162,Pugh,O
131867,9162,Score,O
131868,9162,C,O
131869,9162,",",O
131870,9162,indocyanine,O
131871,9162,green,O
131872,9162,retention,O
131873,9162,rate,O
131874,9162,at,O
131875,9162,15min,O
131876,9162,(,O
131877,9162,ICGR15)＞30%(12,O
131878,9162,),O
131879,9162,",",O
131880,9162,serum,O
131881,9162,hepatitis,O
131882,9162,B,O
131883,9162,virus,O
131884,9162,(,O
131885,9162,HBV)-DNA＞126,O
131886,9162,copies,O
131887,9162,/,O
131888,9162,ml,O
131889,9162,and,O
131890,9162,serum,O
131891,9162,alanine,O
131892,9162,aminotransferase,O
131893,9162,(,O
131894,9162,ALT,O
131895,9162,),O
131896,9162,＞,O
131897,9162,2×ULN,O
131898,9162,",",O
131899,9162,serum,O
131900,9162,triglycerides＞2.0,O
131901,9162,mmol,O
131902,9162,/,O
131903,9162,L,O
131904,9162,",",O
131905,9162,circulatory,B-Condition
131906,9162,shock,I-Condition
131907,9162,",",O
131908,9162,stroke,B-Condition
131909,9162,",",O
131910,9162,acute,B-Condition
131911,9162,myocardial,I-Condition
131912,9162,infarction,I-Condition
131913,9162,",",O
131914,9162,renal,B-Condition
131915,9162,failure,I-Condition
131916,9162,",",O
131917,9162,coma,B-Condition
131918,9162,of,O
131919,9162,unknown,O
131920,9162,cause,O
131921,9163,Pregnancy,B-Condition
131922,9164,Age,B-Person
131923,9164,of＜18y,O
131924,9164,or＞75y,O
131925,9165,Performed,O
131926,9165,intraoperative,B-Procedure
131927,9165,ablation,I-Procedure
131928,9166,Unresectable,B-Condition
131929,9166,tumor,I-Condition
131930,9166,during,O
131931,9166,operation,O
131932,9167,Allergic,B-Condition
131933,9167,reactions,I-Condition
131934,9167,against,O
131935,9167,fish,B-Drug
131936,9167,or,I-Drug
131937,9167,egg,I-Drug
131938,9167,proteins,I-Drug
131939,9168,The,O
131940,9168,cirrhotic,B-Condition
131941,9168,malnourished,B-Condition
131942,9168,patients,O
131943,9168,who,O
131944,9168,were,O
131945,9168,diagnosed,O
131946,9168,as,O
131947,9168,liver,B-Condition
131948,9168,cancer,I-Condition
131949,9168,preoperatively,O
131950,9168,and,O
131951,9168,underwent,O
131952,9168,hepatectomy,B-Procedure
131953,9168,were,O
131954,9168,consecutively,O
131955,9168,enrolled,O
131956,9168,.,O
131957,9169,The,O
131958,9169,diagnosis,O
131959,9169,of,O
131960,9169,developmental,B-Condition
131961,9169,delay,I-Condition
131962,9169,",",O
131963,9169,attention,B-Condition
131964,9169,deficit,I-Condition
131965,9169,disorder,I-Condition
131966,9169,",",O
131967,9169,chronic,B-Condition
131968,9169,pain,I-Condition
131969,9169,",",O
131970,9169,psychiatric,B-Condition
131971,9169,illness,I-Condition
131972,9169,",",O
131973,9169,previous,O
131974,9169,open,B-Procedure
131975,9169,abdominal,I-Procedure
131976,9169,surgery,I-Procedure
131977,9169,",",O
131978,9169,the,O
131979,9169,presence,O
131980,9169,of,O
131981,9169,a,O
131982,9169,gastrostomy,O
131983,9169,",",O
131984,9169,ventricular,O
131985,9169,-,O
131986,9169,peritoneal,O
131987,9169,shunt,O
131988,9169,or,O
131989,9169,other,O
131990,9169,abdominal,O
131991,9169,prosthesis,O
131992,9169,",",O
131993,9169,immunosuppression,B-Condition
131994,9169,",",O
131995,9169,and,O
131996,9169,those,O
131997,9169,allergic,B-Condition
131998,9169,to,O
131999,9169,any,B-Drug
132000,9169,of,I-Drug
132001,9169,the,I-Drug
132002,9169,medications,I-Drug
132003,9169,.,O
132004,9170,Patients,O
132005,9170,are,O
132006,9170,of,O
132007,9170,American,O
132008,9170,Society,O
132009,9170,of,O
132010,9170,Anesthesiologists,O
132011,9170,(,O
132012,9170,ASA,O
132013,9170,),O
132014,9170,physical,O
132015,9170,status,O
132016,9170,I,O
132017,9170,and,O
132018,9170,II,O
132019,9170,",",O
132020,9170,aged,B-Person
132021,9170,8,O
132022,9170,-,O
132023,9170,14,O
132024,9170,years,O
132025,9170,old,O
132026,9170,",",O
132027,9170,of,O
132028,9170,both,B-Person
132029,9170,gender,I-Person
132030,9170,",",O
132031,9170,with,O
132032,9170,suspected,B-Mood
132033,9170,acute,B-Condition
132034,9170,appendicitis,I-Condition
132035,9170,scheduled,B-Mood
132036,9170,for,I-Mood
132037,9170,laparoscopic,B-Procedure
132038,9170,appendicectomy,I-Procedure
132039,9170,.,O
132040,9171,Known,B-Mood
132041,9171,or,I-Mood
132042,9171,suspected,I-Mood
132043,9171,serious,O
132044,9171,spinal,B-Condition
132045,9171,pathology,I-Condition
132046,9171,and,O
132047,9171,spinal,O
132048,9171,implants,O
132049,9172,Lumbar,B-Procedure
132050,9172,spinal,I-Procedure
132051,9172,surgery,I-Procedure
132052,9172,within,O
132053,9172,the,O
132054,9172,preceding,O
132055,9172,six,O
132056,9172,months,O
132057,9173,Serious,O
132058,9173,comorbidities,B-Condition
132059,9173,preventing,B-Condition
132060,9173,prescription,O
132061,9173,of,O
132062,9173,paracetamol,B-Drug
132063,9174,Alternative,O
132064,9174,treatment,B-Procedure
132065,9174,for,O
132066,9174,low,B-Condition
132067,9174,back,I-Condition
132068,9174,pain,I-Condition
132069,9174,in,O
132070,9174,previous,O
132071,9174,two,O
132072,9174,weeks,O
132073,9175,Chronic,B-Condition
132074,9175,neurological,I-Condition
132075,9175,lesion,I-Condition
132076,9176,Chronic,B-Condition
132077,9176,musculoskeletal,I-Condition
132078,9176,lesion,I-Condition
132079,9177,Active,O
132080,9177,cancer,B-Condition
132081,9178,Pregnancy,B-Condition
132082,9179,Use,O
132083,9179,of,O
132084,9179,pain,B-Drug
132085,9179,medication,I-Drug
132086,9179,(,O
132087,9179,except,O
132088,9179,paracetamol,B-Drug
132089,9179,),O
132090,9179,within,O
132091,9179,3,O
132092,9179,days,O
132093,9180,Treatment,O
132094,9180,site,O
132095,9180,has,O
132096,9180,active,O
132097,9180,skin,B-Condition
132098,9180,lesion,I-Condition
132099,9180,or,O
132100,9180,inflammation,B-Condition
132101,9181,Known,O
132102,9181,allergy,B-Condition
132103,9181,to,O
132104,9181,skin,O
132105,9181,patch,O
132106,9182,All,O
132107,9182,subjects,O
132108,9182,underwent,O
132109,9182,a,O
132110,9182,detailed,O
132111,9182,history,O
132112,9182,and,O
132113,9182,systemic,O
132114,9182,physical,O
132115,9182,examination,O
132116,9182,including,O
132117,9182,neurologic,O
132118,9182,and,O
132119,9182,musculoskeletal,O
132120,9182,evaluations,O
132121,9182,.,O
132122,9182,To,O
132123,9182,rule,O
132124,9182,out,O
132125,9182,any,O
132126,9182,confounding,O
132127,9182,etiologies,O
132128,9182,",",O
132129,9182,basic,O
132130,9182,diagnostic,B-Procedure
132131,9182,laboratory,I-Procedure
132132,9182,tests,I-Procedure
132133,9182,including,O
132134,9182,complete,B-Procedure
132135,9182,blood,I-Procedure
132136,9182,count,I-Procedure
132137,9182,and,O
132138,9182,acute,B-Procedure
132139,9182,phase,I-Procedure
132140,9182,reactants,I-Procedure
132141,9182,(,O
132142,9182,erythrocyte,B-Procedure
132143,9182,sedimentation,I-Procedure
132144,9182,rate,I-Procedure
132145,9182,and,O
132146,9182,C,B-Procedure
132147,9182,-,I-Procedure
132148,9182,reactive,I-Procedure
132149,9182,protein,I-Procedure
132150,9182,),O
132151,9182,were,O
132152,9182,performed,O
132153,9182,.,O
132154,9182,The,O
132155,9182,patients,O
132156,9182,diagnosed,O
132157,9182,as,O
132158,9182,having,O
132159,9182,acute,O
132160,9182,non,B-Condition
132161,9182,-,I-Condition
132162,9182,specific,I-Condition
132163,9182,low,I-Condition
132164,9182,back,I-Condition
132165,9182,pain,I-Condition
132166,9182,according,O
132167,9182,to,O
132168,9182,history,B-Observation
132169,9182,and,O
132170,9182,physical,B-Procedure
132171,9182,examinations,I-Procedure
132172,9182,were,O
132173,9182,invited,O
132174,9182,to,O
132175,9182,participate,O
132176,9182,and,O
132177,9182,will,O
132178,9182,be,O
132179,9182,informed,O
132180,9182,about,O
132181,9182,the,O
132182,9182,purpose,O
132183,9182,and,O
132184,9182,course,O
132185,9182,of,O
132186,9182,the,O
132187,9182,study,O
132188,9182,.,O
132189,9183,A,O
132190,9183,primary,O
132191,9183,complaint,O
132192,9183,of,O
132193,9183,pain,B-Condition
132194,9183,in,O
132195,9183,the,O
132196,9183,area,O
132197,9183,between,O
132198,9183,the,O
132199,9183,12th,O
132200,9183,rib,O
132201,9183,and,O
132202,9183,buttock,O
132203,9183,crease,O
132204,9183,without,O
132205,9183,leg,B-Condition
132206,9183,pain,I-Condition
132207,9184,Female,B-Person
132208,9184,or,O
132209,9184,male,B-Person
132210,9184,",",O
132211,9184,20,O
132212,9184,-,O
132213,9184,80,O
132214,9184,years,O
132215,9184,of,O
132216,9184,age,B-Person
132217,9185,Low,B-Condition
132218,9185,back,I-Condition
132219,9185,pain,I-Condition
132220,9185,of,O
132221,9185,less,O
132222,9185,than,O
132223,9185,six,O
132224,9185,weeks,O
132225,9185,',O
132226,9185,duration,O
132227,9185,;,O
132228,9185,and,O
132229,9185,at,O
132230,9185,least,O
132231,9185,moderate,O
132232,9185,pain,O
132233,9185,intensity,O
132234,9185,(,O
132235,9185,NRS,O
132236,9185,<,O
132237,9185,U+2267>4,O
132238,9185,),O
132239,9186,Pregnancy,B-Condition
132240,9187,Hemodynamic,B-Condition
132241,9187,instability,I-Condition
132242,9188,Body,O
132243,9188,mass,O
132244,9188,index,O
132245,9188,greater,O
132246,9188,than,O
132247,9188,40,O
132248,9188,kg,O
132249,9188,/,O
132250,9188,m2,O
132251,9189,Use,O
132252,9189,of,O
132253,9189,intravenous,O
132254,9189,amiodarone,B-Drug
132255,9189,or,O
132256,9189,lidocaine,B-Drug
132257,9189,in,O
132258,9189,the,O
132259,9189,last,O
132260,9189,24,O
132261,9189,hours,O
132262,9190,Acute,B-Condition
132263,9190,coronary,I-Condition
132264,9190,syndrome,I-Condition
132265,9191,Presence,O
132266,9191,of,O
132267,9191,tachycardia,B-Condition
132268,9191,with,O
132269,9191,irregular,B-Condition
132270,9191,or,I-Condition
132271,9191,supraventricular,I-Condition
132272,9191,RR,I-Condition
132273,9192,Contraindications,B-Condition
132274,9192,to,O
132275,9192,study,B-Drug
132276,9192,drugs,I-Drug
132277,9193,Adult,B-Person
132278,9193,men,B-Person
132279,9193,and,O
132280,9193,women,B-Person
132281,9193,>,O
132282,9193,18,O
132283,9193,years,O
132284,9193,old,B-Person
132285,9194,Presence,O
132286,9194,of,O
132287,9194,sustained,O
132288,9194,ventricular,B-Condition
132289,9194,tachycardia,I-Condition
132290,9194,with,O
132291,9194,HR,O
132292,9194,>,O
132293,9194,120,O
132294,9194,bpm,O
132295,9195,Systolic,O
132296,9195,blood,O
132297,9195,pressure,O
132298,9195,>,O
132299,9195,90,O
132300,9195,mmHg,O
132301,9196,No,O
132302,9196,signs,B-Mood
132303,9196,of,I-Mood
132304,9196,poor,B-Condition
132305,9196,peripheral,I-Condition
132306,9196,perfusion,I-Condition
132307,9197,Absence,O
132308,9197,of,O
132309,9197,dyspnea,B-Condition
132310,9198,Absence,O
132311,9198,of,O
132312,9198,severe,O
132313,9198,angina,B-Condition
132314,9199,Signed,O
132315,9199,consent,O
132316,9199,form,O
132317,9200,Pregnant,O
132318,9200,women,O
132319,9200,and,O
132320,9200,nursing,O
132321,9200,mothers,O
132322,9200,are,O
132323,9200,ineligible,O
132324,9200,due,O
132325,9200,to,O
132326,9200,the,O
132327,9200,possible,O
132328,9200,risk,O
132329,9200,of,O
132330,9200,adverse,O
132331,9200,effects,O
132332,9200,in,O
132333,9200,the,O
132334,9200,newborn,O
132335,9200,.,O
132336,9200,Eligible,O
132337,9200,patients,O
132338,9200,of,O
132339,9200,reproductive,O
132340,9200,potential,O
132341,9200,should,O
132342,9200,use,O
132343,9200,adequate,O
132344,9200,contraception,O
132345,9200,if,O
132346,9200,sexually,O
132347,9200,active,O
132348,9200,.,O
132349,9201,Serious,O
132350,9201,concurrent,O
132351,9201,medical,O
132352,9201,illness,O
132353,9201,which,O
132354,9201,would,O
132355,9201,jeopardize,O
132356,9201,the,O
132357,9201,ability,O
132358,9201,of,O
132359,9201,the,O
132360,9201,subject,O
132361,9201,to,O
132362,9201,receive,O
132363,9201,the,O
132364,9201,therapy,O
132365,9201,as,O
132366,9201,outlined,O
132367,9201,in,O
132368,9201,this,O
132369,9201,protocol,O
132370,9201,with,O
132371,9201,reasonable,O
132372,9201,safety,O
132373,9201,.,O
132374,9202,Malignancy,B-Condition
132375,9202,diagnosed,O
132376,9202,or,O
132377,9202,treated,O
132378,9202,within,O
132379,9202,5,O
132380,9202,years,O
132381,9202,(,O
132382,9202,recent,O
132383,9202,localized,O
132384,9202,treatment,B-Procedure
132385,9202,of,O
132386,9202,squamous,B-Condition
132387,9202,or,I-Condition
132388,9202,non,I-Condition
132389,9202,-,I-Condition
132390,9202,invasive,I-Condition
132391,9202,basal,I-Condition
132392,9202,cell,I-Condition
132393,9202,skin,I-Condition
132394,9202,cancers,I-Condition
132395,9202,is,O
132396,9202,permitted,O
132397,9202,;,O
132398,9202,cervical,B-Condition
132399,9202,carcinoma,I-Condition
132400,9202,in,I-Condition
132401,9202,situ,I-Condition
132402,9202,is,O
132403,9202,allowed,O
132404,9202,if,O
132405,9202,appropriately,O
132406,9202,treated,B-Procedure
132407,9202,prior,O
132408,9202,to,O
132409,9202,screening,O
132410,9202,),O
132411,9202,;,O
132412,9202,subjects,O
132413,9202,under,O
132414,9202,evaluation,O
132415,9202,for,O
132416,9202,a,O
132417,9202,malignancy,O
132418,9202,are,O
132419,9202,not,O
132420,9202,eligible,O
132421,9202,.,O
132422,9203,Infection,O
132423,9203,with,O
132424,9203,hepatitis,B-Condition
132425,9203,B,I-Condition
132426,9203,virus,I-Condition
132427,9203,(,I-Condition
132428,9203,HBV,I-Condition
132429,9203,),I-Condition
132430,9203,or,O
132431,9203,human,B-Condition
132432,9203,immunodeficiency,I-Condition
132433,9203,virus,I-Condition
132434,9203,(,I-Condition
132435,9203,HIV,I-Condition
132436,9203,),I-Condition
132437,9204,Use,O
132438,9204,of,O
132439,9204,any,O
132440,9204,prohibited,O
132441,9204,concomitant,O
132442,9204,medications,O
132443,9204,within,O
132444,9204,30,O
132445,9204,days,O
132446,9204,of,O
132447,9204,the,O
132448,9204,Baseline,O
132449,9204,/,O
132450,9204,Day,O
132451,9204,1,O
132452,9204,visit,O
132453,9204,.,O
132454,9205,Known,O
132455,9205,hypersensitivity,B-Condition
132456,9205,to,O
132457,9205,LDV,B-Drug
132458,9205,/,O
132459,9205,SOF,B-Drug
132460,9206,The,O
132461,9206,subject,O
132462,9206,must,O
132463,9206,be,O
132464,9206,willingly,O
132465,9206,and,O
132466,9206,able,O
132467,9206,to,O
132468,9206,provide,O
132469,9206,written,O
132470,9206,informed,O
132471,9206,consent,O
132472,9207,Age,B-Person
132473,9207,19,O
132474,9207,years,O
132475,9207,of,O
132476,9207,age,O
132477,9207,or,O
132478,9207,older,O
132479,9207,(,O
132480,9207,The,O
132481,9207,age,O
132482,9207,of,O
132483,9207,consent,O
132484,9207,in,O
132485,9207,Nebraska,O
132486,9207,),O
132487,9208,HCV,B-Condition
132488,9208,treatment,B-Procedure
132489,9208,-,O
132490,9208,naïve,O
132491,9208,",",O
132492,9208,as,O
132493,9208,defined,O
132494,9208,as,O
132495,9208,no,O
132496,9208,prior,O
132497,9208,exposure,O
132498,9208,to,O
132499,9208,any,O
132500,9208,Interferon,B-Drug
132501,9208,(,I-Drug
132502,9208,IFN,I-Drug
132503,9208,),I-Drug
132504,9208,",",O
132505,9208,RBV,B-Drug
132506,9208,",",O
132507,9208,or,O
132508,9208,other,O
132509,9208,FDA,O
132510,9208,approved,O
132511,9208,or,O
132512,9208,experimental,O
132513,9208,HCV,O
132514,9208,-,O
132515,9208,specific,O
132516,9208,direct,O
132517,9208,-,O
132518,9208,acting,O
132519,9208,antiviral,O
132520,9208,agent,O
132521,9209,HCV,O
132522,9209,RNA,O
132523,9209,level,O
132524,9209,at,O
132525,9209,most,O
132526,9209,6,O
132527,9209,months,O
132528,9209,prior,O
132529,9209,to,O
132530,9209,the,O
132531,9209,Baseline,O
132532,9209,/,O
132533,9209,Day,O
132534,9209,1,O
132535,9209,visit,O
132536,9209,.,O
132537,9210,HCV,O
132538,9210,genotyping,O
132539,9210,1a,O
132540,9210,",",O
132541,9210,1b,O
132542,9210,",",O
132543,9210,or,O
132544,9210,mixed,O
132545,9210,1a,O
132546,9210,/,O
132547,9210,ab,O
132548,9210,.,O
132549,9210,Any,O
132550,9210,non,O
132551,9210,-,O
132552,9210,definitive,O
132553,9210,results,O
132554,9210,will,O
132555,9210,exclude,O
132556,9210,the,O
132557,9210,subject,O
132558,9210,from,O
132559,9210,study,O
132560,9210,participation,O
132561,9210,.,O
132562,9211,Alcohol,B-Condition
132563,9211,misuse,I-Condition
132564,9211,as,O
132565,9211,defined,O
132566,9211,by,O
132567,9211,the,O
132568,9211,Alcohol,O
132569,9211,Use,O
132570,9211,Disorders,O
132571,9211,Identification,O
132572,9211,Test,O
132573,9211,(,O
132574,9211,AUDIT,O
132575,9211,),O
132576,9211,score,O
132577,9211,subjects,O
132578,9211,must,O
132579,9211,score,O
132580,9211,>,O
132581,9211,8,O
132582,9211,(,O
132583,9211,associated,O
132584,9211,with,O
132585,9211,harmful,O
132586,9211,or,O
132587,9211,hazardous,O
132588,9211,drinking,O
132589,9211,),O
132590,9212,History,O
132591,9212,of,O
132592,9212,a,O
132593,9212,liver,B-Procedure
132594,9212,biopsy,I-Procedure
132595,9212,showing,O
132596,9212,cirrhosis,B-Condition
132597,9212,(,O
132598,9212,e.g.,O
132599,9212,Metavir,O
132600,9212,score,O
132601,9212,=,O
132602,9212,4,O
132603,9212,or,O
132604,9212,Ishak,O
132605,9212,score,O
132606,9212,>,O
132607,9212,5,O
132608,9212,),O
132609,9213,Fibroscan,B-Procedure
132610,9213,showing,O
132611,9213,cirrhosis,B-Condition
132612,9213,or,O
132613,9213,results,O
132614,9213,>,O
132615,9213,12.5,O
132616,9213,kPa,O
132617,9214,FIBRO,O
132618,9214,Spect,O
132619,9214,II,O
132620,9214,index,O
132621,9214,consistent,O
132622,9214,with,O
132623,9214,F3,O
132624,9214,or,O
132625,9214,F4,O
132626,9214,AND,O
132627,9214,an,O
132628,9214,AST,O
132629,9214,:,O
132630,9214,platelet,O
132631,9214,ration,O
132632,9214,index,O
132633,9214,(,O
132634,9214,APRI,O
132635,9214,),O
132636,9214,of,O
132637,9214,>,O
132638,9214,2,O
132639,9214,during,O
132640,9214,Screening,O
132641,9215,Liver,B-Procedure
132642,9215,biopsy,I-Procedure
132643,9215,within,O
132644,9215,2,O
132645,9215,years,O
132646,9215,of,O
132647,9215,Screening,O
132648,9215,showing,O
132649,9215,absence,O
132650,9215,of,O
132651,9215,cirrhosis,B-Condition
132652,9216,Fibroscan,B-Procedure
132653,9216,within,O
132654,9216,6,O
132655,9216,months,O
132656,9216,of,O
132657,9216,Baseline,O
132658,9216,/,O
132659,9216,Day1,O
132660,9216,with,O
132661,9216,a,O
132662,9216,result,O
132663,9216,of,O
132664,9216,=,O
132665,9216,12.5,O
132666,9216,kPa,O
132667,9217,FIBRO,O
132668,9217,Spect,O
132669,9217,II,O
132670,9217,Index,O
132671,9217,consistent,O
132672,9217,with,O
132673,9217,F0-,O
132674,9217,F2,O
132675,9217,AND,O
132676,9217,APRI,O
132677,9217,of,O
132678,9217,=,O
132679,9217,1,O
132680,9217,during,O
132681,9217,Screening,O
132682,9218,Liver,B-Procedure
132683,9218,imaging,I-Procedure
132684,9218,within,O
132685,9218,6,O
132686,9218,months,O
132687,9218,of,O
132688,9218,Baseline,O
132689,9218,/,O
132690,9218,Day,O
132691,9218,1,O
132692,9218,to,O
132693,9218,exclude,O
132694,9218,hepatocellular,B-Condition
132695,9218,carcinoma,I-Condition
132696,9218,HCC,I-Condition
132697,9218,),I-Condition
132698,9218,is,O
132699,9218,required,O
132700,9219,ALT,O
132701,9219,<,O
132702,9219,10,O
132703,9219,x,O
132704,9219,the,O
132705,9219,upper,O
132706,9219,limit,O
132707,9219,of,O
132708,9219,normal,O
132709,9219,(,O
132710,9219,ULN,O
132711,9219,),O
132712,9220,AST,O
132713,9220,<,O
132714,9220,10,O
132715,9220,x,O
132716,9220,ULN,O
132717,9221,Direct,O
132718,9221,bilirubin,O
132719,9221,<,O
132720,9221,2.0,O
132721,9221,x,O
132722,9221,ULN,O
132723,9222,Platelets,O
132724,9222,>,O
132725,9222,"50,000",O
132726,9223,HbA1c,O
132727,9223,<,O
132728,9223,8.5,O
132729,9223,%,O
132730,9224,Creatinine,O
132731,9224,clearance,O
132732,9224,(,O
132733,9224,CLcr,O
132734,9224,),O
132735,9224,=,O
132736,9224,60,O
132737,9224,mL,O
132738,9224,/min,O
132739,9224,",",O
132740,9224,as,O
132741,9224,calculated,O
132742,9224,by,O
132743,9224,the,O
132744,9224,Cockcroft,O
132745,9224,-,O
132746,9224,Gault,O
132747,9224,equation,O
132748,9225,Hemoglobin,O
132749,9225,=,O
132750,9225,11,O
132751,9225,g,O
132752,9225,/,O
132753,9225,dL,O
132754,9225,for,O
132755,9225,female,B-Person
132756,9225,subjects,O
132757,9225,;,O
132758,9225,=,O
132759,9225,12,O
132760,9225,g,O
132761,9225,/,O
132762,9225,dL,O
132763,9225,for,O
132764,9225,male,B-Person
132765,9225,subjects,O
132766,9225,.,O
132767,9226,Albumin,O
132768,9226,=,O
132769,9226,2.5,O
132770,9226,g,O
132771,9226,/,O
132772,9226,dL,O
132773,9227,INR,O
132774,9227,=,O
132775,9227,1.5,O
132776,9227,x,O
132777,9227,ULN,O
132778,9227,unless,O
132779,9227,subject,O
132780,9227,has,O
132781,9227,known,O
132782,9227,hemophilia,B-Condition
132783,9227,or,O
132784,9227,is,O
132785,9227,stable,B-Condition
132786,9227,on,I-Condition
132787,9227,an,I-Condition
132788,9227,anticoagulant,I-Condition
132789,9227,regimen,I-Condition
132790,9227,affecting,I-Condition
132791,9227,INR,I-Condition
132792,9227,.,O
132793,9228,Subject,O
132794,9228,has,O
132795,9228,not,O
132796,9228,been,O
132797,9228,treated,O
132798,9228,with,O
132799,9228,any,O
132800,9228,investigational,O
132801,9228,drug,O
132802,9228,or,O
132803,9228,device,O
132804,9228,within,O
132805,9228,30,O
132806,9228,days,O
132807,9228,of,O
132808,9228,the,O
132809,9228,screening,O
132810,9228,visit,O
132811,9228,.,O
132812,9229,Coagulopathies,B-Condition
132813,9229,(,O
132814,9229,with,O
132815,9229,prothrombin,O
132816,9229,concentration,O
132817,9229,less,O
132818,9229,than,O
132819,9229,60,O
132820,9229,%,O
132821,9229,or,O
132822,9229,INR,O
132823,9229,more,O
132824,9229,than,O
132825,9229,1.5,O
132826,9229,),O
132827,9230,In,B-Mood
132828,9230,-,I-Mood
132829,9230,ability,I-Mood
132830,9230,to,I-Mood
132831,9230,postpone,I-Mood
132832,9230,anti,B-Drug
132833,9230,-,I-Drug
132834,9230,coagulation,I-Drug
132835,9230,medications,I-Drug
132836,9230,.,O
132837,9231,Infection,B-Condition
132838,9231,or,O
132839,9231,injury,B-Condition
132840,9231,or,O
132841,9231,a,O
132842,9231,lesion,B-Condition
132843,9231,at,O
132844,9231,the,O
132845,9231,block,O
132846,9231,site,O
132847,9231,.,O
132848,9232,Suspected,B-Mood
132849,9232,cervical,B-Condition
132850,9232,vertebral,I-Condition
132851,9232,column,I-Condition
132852,9232,injury,I-Condition
132853,9232,necessitating,O
132854,9232,using,O
132855,9232,a,O
132856,9232,neck,O
132857,9232,collar,O
132858,9232,.,O
132859,9233,A,O
132860,9233,compromised,B-Condition
132861,9233,lung,I-Condition
132862,9233,on,O
132863,9233,the,O
132864,9233,contralateral,O
132865,9233,side,O
132866,9233,of,O
132867,9233,the,O
132868,9233,block,O
132869,9233,(,O
132870,9233,Pneumothorax,B-Condition
132871,9233,",",O
132872,9233,hemothorax,B-Condition
132873,9233,or,O
132874,9233,Pneumonectomy,B-Condition
132875,9233,),O
132876,9233,.,O
132877,9234,Traumatic,B-Condition
132878,9234,vascular,I-Condition
132879,9234,injuries,I-Condition
132880,9234,or,O
132881,9234,operative,B-Procedure
132882,9234,interventions,I-Procedure
132883,9234,(,O
132884,9234,Surgical,B-Procedure
132885,9234,harvesting,I-Procedure
132886,9234,),O
132887,9234,involving,O
132888,9234,arteries,O
132889,9234,of,O
132890,9234,the,O
132891,9234,upper,O
132892,9234,limb,O
132893,9234,on,O
132894,9234,the,O
132895,9234,operative,O
132896,9234,side,O
132897,9234,.,O
132898,9235,Patients,O
132899,9235,with,O
132900,9235,communication,B-Condition
132901,9235,difficulties,I-Condition
132902,9235,.,O
132903,9236,Hypersensitivity,B-Condition
132904,9236,to,O
132905,9236,local,B-Drug
132906,9236,anesthetics,I-Drug
132907,9236,and/or,O
132908,9236,Dexamethasone,B-Drug
132909,9236,.,O
132910,9237,Patients,O
132911,9237,on,O
132912,9237,perioperative,O
132913,9237,intravenous,B-Drug
132914,9237,(,I-Drug
132915,9237,IV,I-Drug
132916,9237,),I-Drug
132917,9237,steroids,I-Drug
132918,9237,.,O
132919,9238,Patients,O
132920,9238,undergoing,O
132921,9238,surgeries,B-Procedure
132922,9238,in,O
132923,9238,the,O
132924,9238,upper,O
132925,9238,limb,O
132926,9238,(,O
132927,9238,arm,O
132928,9238,",",O
132929,9238,forearm,O
132930,9238,or,O
132931,9238,hand,O
132932,9238,),O
132933,9239,Cardiopulmonary,B-Condition
132934,9239,arrest,I-Condition
132935,9240,Pregnancy,B-Condition
132936,9241,Severe,O
132937,9241,right,B-Condition
132938,9241,heart,I-Condition
132939,9241,failure,I-Condition
132940,9242,Age,B-Person
132941,9242,greater,O
132942,9242,than,O
132943,9242,or,O
132944,9242,equal,O
132945,9242,to,O
132946,9242,18,O
132947,9242,years,O
132948,9242,old,O
132949,9243,Requirement,O
132950,9243,for,O
132951,9243,vasoactive,B-Drug
132952,9243,drugs,I-Drug
132953,9243,via,O
132954,9243,a,O
132955,9243,central,O
132956,9243,venous,O
132957,9243,catheter,O
132958,9243,for,O
132959,9243,the,O
132960,9243,treatment,O
132961,9243,of,O
132962,9243,shock,B-Condition
132963,9243,.,O
132964,9243,Shock,O
132965,9243,will,O
132966,9243,be,O
132967,9243,defined,O
132968,9243,as,O
132969,9243,mean,O
132970,9243,arterial,O
132971,9243,pressure,O
132972,9243,less,O
132973,9243,than,O
132974,9243,70,O
132975,9243,mmHg,O
132976,9243,or,O
132977,9243,systolic,O
132978,9243,blood,O
132979,9243,pressure,O
132980,9243,less,O
132981,9243,than,O
132982,9243,100,O
132983,9243,mmHg,O
132984,9243,despite,O
132985,9243,administration,O
132986,9243,of,O
132987,9243,at,O
132988,9243,least,O
132989,9243,1000,O
132990,9243,mL,O
132991,9243,of,O
132992,9243,crystalloid,O
132993,9243,or,O
132994,9243,500,O
132995,9243,mL,O
132996,9243,of,O
132997,9243,colloid,O
132998,9243,",",O
132999,9243,unless,O
133000,9243,there,O
133001,9243,is,O
133002,9243,an,O
133003,9243,elevation,O
133004,9243,in,O
133005,9243,the,O
133006,9243,central,O
133007,9243,venous,O
133008,9243,pressure,O
133009,9243,to,O
133010,9243,>,O
133011,9243,12,O
133012,9243,mmHg,O
133013,9243,or,O
133014,9243,in,O
133015,9243,the,O
133016,9243,pulmonary,O
133017,9243,artery,O
133018,9243,occlusion,O
133019,9243,pressure,O
133020,9243,to,O
133021,9243,>,O
133022,9243,14,O
133023,9243,mmHg,O
133024,9243,coupled,O
133025,9243,with,O
133026,9243,signs,O
133027,9243,of,O
133028,9243,tissue,O
133029,9243,hypoperfusion,O
133030,9243,(,O
133031,9243,e.g.,O
133032,9243,altered,O
133033,9243,mental,O
133034,9243,state,O
133035,9243,",",O
133036,9243,mottled,O
133037,9243,skin,O
133038,9243,",",O
133039,9243,urine,O
133040,9243,output,O
133041,9243,<,O
133042,9243,0.5,O
133043,9243,mL,O
133044,9243,/,O
133045,9243,kg,O
133046,9243,body,O
133047,9243,weight,O
133048,9243,for,O
133049,9243,one,O
133050,9243,hour,O
133051,9243,",",O
133052,9243,or,O
133053,9243,a,O
133054,9243,serum,O
133055,9243,lactate,O
133056,9243,level,O
133057,9243,of,O
133058,9243,>,O
133059,9243,2,O
133060,9243,mmol,O
133061,9243,per,O
133062,9243,liter,O
133063,9243,),O
133064,9243,.,O
133065,9244,Severe,B-Condition
133066,9244,Hypertension,I-Condition
133067,9244,Grade,O
133068,9244,3,O
133069,9244,WHO,O
133070,9244,classification,O
133071,9244,(,O
133072,9244,Mean,O
133073,9244,Sitting,O
133074,9244,Diastolic,O
133075,9244,Blood,O
133076,9244,Pressure,O
133077,9244,(,O
133078,9244,MSDBP,O
133079,9244,),O
133080,9244,110,O
133081,9244,mmHg,O
133082,9244,and/or,O
133083,9244,Mean,O
133084,9244,Sitting,O
133085,9244,Systolic,O
133086,9244,Blood,O
133087,9244,Pressure,O
133088,9244,MSSBP,O
133089,9244,180,O
133090,9244,mmHg,O
133091,9244,),O
133092,9245,Acetylsalicyclic,B-Procedure
133093,9245,acid,I-Procedure
133094,9245,(,I-Procedure
133095,9245,ASA,I-Procedure
133096,9245,),I-Procedure
133097,9245,treatment,I-Procedure
133098,9245,>,O
133099,9245,1g,O
133100,9245,/,O
133101,9245,day,O
133102,9245,or,O
133103,9245,regular,O
133104,9245,use,O
133105,9245,of,O
133106,9245,Non,B-Drug
133107,9245,steroidal,I-Drug
133108,9245,anti,I-Drug
133109,9245,-,I-Drug
133110,9245,inflammatory,I-Drug
133111,9245,drug,I-Drug
133112,9245,(,I-Drug
133113,9245,NSAIDs,I-Drug
133114,9245,),I-Drug
133115,9246,Kidney,B-Condition
133116,9246,disease,I-Condition
133117,9246,not,O
133118,9246,caused,O
133119,9246,by,O
133120,9246,diabetes,B-Condition
133121,9246,or,O
133122,9246,hypertension,B-Condition
133123,9247,Serum,O
133124,9247,potassium,O
133125,9247,<,O
133126,9247,3.5,O
133127,9247,or,O
133128,9247,>,O
133129,9247,5.1,O
133130,9247,mEq,O
133131,9247,/,O
133132,9247,L,O
133133,9248,GFR,O
133134,9248,<,O
133135,9248,40,O
133136,9248,ml,O
133137,9248,/,O
133138,9248,min/1.73m2,O
133139,9248,as,O
133140,9248,measured,O
133141,9248,by,O
133142,9248,the,O
133143,9248,MDRD,O
133144,9248,formula,O
133145,9249,Serum,O
133146,9249,albumin,O
133147,9249,<,O
133148,9249,2.0mg,O
133149,9249,/,O
133150,9249,dL,O
133151,9250,History,B-Observation
133152,9250,of,O
133153,9250,hypertensive,B-Condition
133154,9250,encephalopathy,I-Condition
133155,9250,or,O
133156,9250,cerebrovascular,B-Condition
133157,9250,accident,I-Condition
133158,9250,at,O
133159,9250,any,O
133160,9250,time,O
133161,9250,prior,O
133162,9250,to,O
133163,9250,Visit1,O
133164,9250,.,O
133165,9251,Current,O
133166,9251,diagnosis,O
133167,9251,of,O
133168,9251,heart,B-Condition
133169,9251,failure,I-Condition
133170,9251,(,O
133171,9251,New,O
133172,9251,York,O
133173,9251,Heart,O
133174,9251,Association,O
133175,9251,(,O
133176,9251,NYHA,O
133177,9251,),O
133178,9251,Class,O
133179,9251,II,O
133180,9251,-,O
133181,9251,IV,O
133182,9251,),O
133183,9252,History,B-Observation
133184,9252,of,O
133185,9252,myocardial,B-Condition
133186,9252,infarction,I-Condition
133187,9252,",",O
133188,9252,unstable,B-Condition
133189,9252,angina,I-Condition
133190,9252,pectoris,I-Condition
133191,9252,",",O
133192,9252,coronary,B-Condition
133193,9252,bypass,I-Condition
133194,9252,surgery,I-Condition
133195,9252,",",O
133196,9252,or,O
133197,9252,any,O
133198,9252,percutaneous,B-Condition
133199,9252,coronary,I-Condition
133200,9252,intervention,I-Condition
133201,9252,(,I-Condition
133202,9252,PCI,I-Condition
133203,9252,),I-Condition
133204,9252,during,O
133205,9252,the,O
133206,9252,6,O
133207,9252,months,O
133208,9252,prior,O
133209,9252,to,O
133210,9252,Visit,O
133211,9252,1,O
133212,9253,Second,B-Condition
133213,9253,or,I-Condition
133214,9253,third,I-Condition
133215,9253,degree,I-Condition
133216,9253,heart,I-Condition
133217,9253,block,I-Condition
133218,9253,without,O
133219,9253,a,O
133220,9253,pacemaker,O
133221,9254,Concurrent,O
133222,9254,potentially,O
133223,9254,life,O
133224,9254,threatening,O
133225,9254,arrhythmia,B-Condition
133226,9254,or,O
133227,9254,symptomatic,O
133228,9254,arrhythmia,B-Condition
133229,9255,Clinically,O
133230,9255,significant,O
133231,9255,valvular,B-Condition
133232,9255,heart,I-Condition
133233,9255,disease,I-Condition
133234,9256,Type,B-Condition
133235,9256,1,I-Condition
133236,9256,diabetes,I-Condition
133237,9256,mellitus,I-Condition
133238,9257,Uncontrolled,O
133239,9257,Type,B-Condition
133240,9257,II,I-Condition
133241,9257,diabetes,I-Condition
133242,9257,mellitus,I-Condition
133243,9257,(,O
133244,9257,Hemaglobin,O
133245,9257,subtype,O
133246,9257,A1C,O
133247,9257,(,O
133248,9257,HbA1C,O
133249,9257,),O
133250,9257,>,O
133251,9257,11,O
133252,9257,%,O
133253,9257,),O
133254,9258,History,O
133255,9258,of,O
133256,9258,malignancy,B-Condition
133257,9258,including,O
133258,9258,leukemia,B-Condition
133259,9258,and,O
133260,9258,lymphoma,B-Condition
133261,9258,(,O
133262,9258,but,O
133263,9258,not,O
133264,9258,basal,B-Condition
133265,9258,cell,I-Condition
133266,9258,skin,I-Condition
133267,9258,carcinoma,I-Condition
133268,9258,),O
133269,9258,within,O
133270,9258,the,O
133271,9258,past,O
133272,9258,five,O
133273,9258,years,O
133274,9259,Participation,O
133275,9259,in,O
133276,9259,any,O
133277,9259,clinical,O
133278,9259,investigation,O
133279,9259,within,O
133280,9259,4,O
133281,9259,weeks,O
133282,9259,prior,O
133283,9259,to,O
133284,9259,dosing,O
133285,9259,or,O
133286,9259,longer,O
133287,9259,if,O
133288,9259,required,O
133289,9259,by,O
133290,9259,local,O
133291,9259,regulation,O
133292,9259,.,O
133293,9260,Donation,B-Procedure
133294,9260,or,I-Procedure
133295,9260,loss,I-Procedure
133296,9260,of,I-Procedure
133297,9260,400,I-Procedure
133298,9260,mL,I-Procedure
133299,9260,or,I-Procedure
133300,9260,more,I-Procedure
133301,9260,of,I-Procedure
133302,9260,blood,I-Procedure
133303,9260,within,O
133304,9260,8,O
133305,9260,weeks,O
133306,9260,prior,O
133307,9260,to,O
133308,9260,dosing,O
133309,9260,.,O
133310,9261,Significant,B-Condition
133311,9261,illness,I-Condition
133312,9261,within,O
133313,9261,the,O
133314,9261,two,O
133315,9261,weeks,O
133316,9261,prior,O
133317,9261,to,O
133318,9261,dosing,O
133319,9261,.,O
133320,9262,Any,O
133321,9262,surgical,B-Condition
133322,9262,or,I-Condition
133323,9262,medical,I-Condition
133324,9262,condition,I-Condition
133325,9262,which,O
133326,9262,might,O
133327,9262,significantly,O
133328,9262,alter,O
133329,9262,the,O
133330,9262,absorption,O
133331,9262,",",O
133332,9262,distribution,O
133333,9262,",",O
133334,9262,metabolism,O
133335,9262,",",O
133336,9262,or,O
133337,9262,excretion,O
133338,9262,of,O
133339,9262,study,O
133340,9262,drugs,O
133341,9262,including,O
133342,9262,",",O
133343,9262,but,O
133344,9262,not,O
133345,9262,limited,O
133346,9262,to,O
133347,9262,",",O
133348,9262,any,O
133349,9262,of,O
133350,9262,the,O
133351,9262,following,O
133352,9262,:,O
133353,9263,History,B-Observation
133354,9263,of,O
133355,9263,major,B-Condition
133356,9263,gastrointestinal,I-Condition
133357,9263,tract,I-Condition
133358,9263,surgery,I-Condition
133359,9263,such,O
133360,9263,as,O
133361,9263,gastrectomy,B-Procedure
133362,9263,",",O
133363,9263,gastroenterostomy,B-Procedure
133364,9263,",",O
133365,9263,or,O
133366,9263,bowel,B-Procedure
133367,9263,resection,I-Procedure
133368,9264,-Currently,O
133369,9264,active,O
133370,9264,or,O
133371,9264,previously,O
133372,9264,active,O
133373,9264,inflammatory,B-Condition
133374,9264,bowel,I-Condition
133375,9264,disease,I-Condition
133376,9264,during,O
133377,9264,the,O
133378,9264,12,O
133379,9264,months,O
133380,9264,prior,O
133381,9264,to,O
133382,9264,Visit,O
133383,9264,1,O
133384,9264,Currently,O
133385,9264,active,O
133386,9264,gastritis,B-Condition
133387,9264,",",O
133388,9264,duodenal,B-Condition
133389,9264,or,O
133390,9264,gastric,B-Condition
133391,9264,ulcers,I-Condition
133392,9264,",",O
133393,9264,or,O
133394,9264,gastrointestinal,B-Condition
133395,9264,/,I-Condition
133396,9264,rectal,I-Condition
133397,9264,bleeding,I-Condition
133398,9264,during,O
133399,9264,the,O
133400,9264,3,O
133401,9264,months,O
133402,9264,prior,O
133403,9264,to,O
133404,9264,Visit,O
133405,9264,1,O
133406,9264,.,O
133407,9265,Any,O
133408,9265,history,B-Observation
133409,9265,of,O
133410,9265,pancreatic,B-Condition
133411,9265,injury,I-Condition
133412,9265,",",O
133413,9265,pancreatitis,B-Condition
133414,9265,or,O
133415,9265,evidence,O
133416,9265,of,O
133417,9265,impaired,O
133418,9265,pancreatic,B-Condition
133419,9265,function,I-Condition
133420,9265,/,I-Condition
133421,9265,injury,I-Condition
133422,9265,as,O
133423,9265,indicated,O
133424,9265,by,O
133425,9265,abnormal,O
133426,9265,lipase,O
133427,9265,or,O
133428,9265,amylase,O
133429,9265,Evidence,O
133430,9265,of,O
133431,9265,hepatic,B-Condition
133432,9265,disease,I-Condition
133433,9265,",",O
133434,9265,a,O
133435,9265,history,B-Observation
133436,9265,of,O
133437,9265,hepatic,B-Condition
133438,9265,encephalopathy,I-Condition
133439,9265,",",O
133440,9265,a,O
133441,9265,history,B-Observation
133442,9265,of,O
133443,9265,esophageal,B-Condition
133444,9265,varices,I-Condition
133445,9265,",",O
133446,9265,or,O
133447,9265,a,O
133448,9265,history,B-Observation
133449,9265,of,O
133450,9265,portocaval,B-Condition
133451,9265,shunt,I-Condition
133452,9266,Current,O
133453,9266,treatment,O
133454,9266,with,O
133455,9266,cholestyramine,B-Drug
133456,9266,or,O
133457,9266,cholestipol,B-Drug
133458,9266,resins,I-Drug
133459,9267,History,B-Observation
133460,9267,of,O
133461,9267,immunocompromise,B-Condition
133462,9267,",",O
133463,9267,including,O
133464,9267,a,O
133465,9267,positive,O
133466,9267,HIV,O
133467,9267,test,O
133468,9267,result,O
133469,9267,.,O
133470,9268,History,B-Observation
133471,9268,of,O
133472,9268,a,O
133473,9268,positive,O
133474,9268,Hepatitis,O
133475,9268,B,O
133476,9268,surface,O
133477,9268,antigen,O
133478,9268,(,O
133479,9268,HBsAg,O
133480,9268,),O
133481,9268,or,O
133482,9268,Hepatitis,O
133483,9268,C,O
133484,9268,test,O
133485,9268,result,O
133486,9268,.,O
133487,9269,History,B-Observation
133488,9269,of,O
133489,9269,drug,B-Condition
133490,9269,or,I-Condition
133491,9269,alcohol,I-Condition
133492,9269,abuse,I-Condition
133493,9269,within,O
133494,9269,the,O
133495,9269,12,O
133496,9269,months,O
133497,9269,prior,O
133498,9269,to,O
133499,9269,dosing,O
133500,9269,.,O
133501,9270,Persons,O
133502,9270,directly,O
133503,9270,involved,O
133504,9270,in,O
133505,9270,the,O
133506,9270,execution,O
133507,9270,of,O
133508,9270,this,O
133509,9270,protocol,O
133510,9270,.,O
133511,9271,Any,O
133512,9271,condition,B-Condition
133513,9271,that,O
133514,9271,in,O
133515,9271,the,O
133516,9271,opinion,O
133517,9271,of,O
133518,9271,the,O
133519,9271,investigator,O
133520,9271,or,O
133521,9271,the,O
133522,9271,Novartis,O
133523,9271,medical,O
133524,9271,monitor,O
133525,9271,would,O
133526,9271,jeopardize,O
133527,9271,the,O
133528,9271,evaluation,O
133529,9271,of,O
133530,9271,efficacy,O
133531,9271,or,O
133532,9271,safety,O
133533,9272,History,B-Observation
133534,9272,of,I-Observation
133535,9272,noncompliance,B-Observation
133536,9272,to,I-Observation
133537,9272,medical,I-Observation
133538,9272,regimens,I-Observation
133539,9272,or,O
133540,9272,unwillingness,B-Mood
133541,9272,to,I-Mood
133542,9272,comply,O
133543,9272,with,O
133544,9272,the,O
133545,9272,study,O
133546,9272,protocol,O
133547,9273,Known,O
133548,9273,or,O
133549,9273,suspected,O
133550,9273,contraindications,B-Condition
133551,9273,to,O
133552,9273,the,O
133553,9273,study,B-Drug
133554,9273,medications,I-Drug
133555,9273,",",O
133556,9273,including,O
133557,9273,history,B-Observation
133558,9273,of,I-Observation
133559,9273,allergy,B-Condition
133560,9273,to,O
133561,9273,Angiotensin,B-Drug
133562,9273,converting,I-Drug
133563,9273,enzyme,I-Drug
133564,9273,(,I-Drug
133565,9273,ACE,I-Drug
133566,9273,),I-Drug
133567,9273,inhibitors,I-Drug
133568,9273,and/or,O
133569,9273,to,O
133570,9273,thiazide,B-Drug
133571,9273,diuretics,I-Drug
133572,9273,or,O
133573,9273,other,O
133574,9273,sulfonamide,B-Drug
133575,9273,derived,I-Drug
133576,9273,drug,I-Drug
133577,9274,Any,O
133578,9274,surgical,B-Condition
133579,9274,or,I-Condition
133580,9274,medical,I-Condition
133581,9274,condition,I-Condition
133582,9274,",",O
133583,9274,which,O
133584,9274,in,O
133585,9274,the,O
133586,9274,opinion,O
133587,9274,of,O
133588,9274,the,O
133589,9274,investigator,O
133590,9274,",",O
133591,9274,may,O
133592,9274,place,O
133593,9274,the,O
133594,9274,patient,O
133595,9274,at,O
133596,9274,higher,O
133597,9274,risk,O
133598,9274,from,O
133599,9274,his,O
133600,9274,/,O
133601,9274,her,O
133602,9274,participation,O
133603,9274,in,O
133604,9274,the,O
133605,9274,study,O
133606,9274,",",O
133607,9274,or,O
133608,9274,is,O
133609,9274,likely,B-Mood
133610,9274,to,I-Mood
133611,9274,prevent,I-Mood
133612,9274,the,I-Mood
133613,9274,patient,I-Mood
133614,9274,from,I-Mood
133615,9274,complying,O
133616,9274,with,O
133617,9274,the,O
133618,9274,requirements,O
133619,9274,of,O
133620,9274,the,O
133621,9274,study,O
133622,9274,or,O
133623,9274,completing,O
133624,9274,the,O
133625,9274,study,O
133626,9275,Use,O
133627,9275,of,O
133628,9275,any,O
133629,9275,prescription,B-Drug
133630,9275,drug,I-Drug
133631,9275,or,O
133632,9275,over,B-Drug
133633,9275,-,I-Drug
133634,9275,the,I-Drug
133635,9275,-,I-Drug
133636,9275,counter,I-Drug
133637,9275,(,I-Drug
133638,9275,OTC,I-Drug
133639,9275,),I-Drug
133640,9275,medication,I-Drug
133641,9275,which,O
133642,9275,is,O
133643,9275,prohibited,O
133644,9275,by,O
133645,9275,the,O
133646,9275,protocol,O
133647,9275,.,O
133648,9276,Patients,O
133649,9276,who,O
133650,9276,previously,O
133651,9276,participated,O
133652,9276,in,O
133653,9276,any,O
133654,9276,Aliskiren,B-Drug
133655,9276,study,O
133656,9276,.,O
133657,9277,Pregnant,B-Condition
133658,9277,or,O
133659,9277,nursing,B-Condition
133660,9277,woman,B-Person
133661,9277,.,O
133662,9278,Other,O
133663,9278,protocol,O
133664,9278,-,O
133665,9278,defined,O
133666,9278,inclusion,O
133667,9278,/,O
133668,9278,exclusion,O
133669,9278,criteria,O
133670,9278,may,O
133671,9278,apply,O
133672,9279,Male,O
133673,9279,and/or,O
133674,9279,female,O
133675,9279,patients,O
133676,9279,from,O
133677,9279,30,O
133678,9279,-,O
133679,9279,80,O
133680,9279,years,O
133681,9279,of,B-Person
133682,9279,age,I-Person
133683,9279,with,O
133684,9279,a,O
133685,9279,diagnosis,O
133686,9279,of,O
133687,9279,Type,B-Condition
133688,9279,2,I-Condition
133689,9279,diabetes,I-Condition
133690,9279,(,O
133691,9279,WHO,O
133692,9279,criteria,O
133693,9279,),O
133694,9279,.,O
133695,9280,Incipient,O
133696,9280,and,O
133697,9280,established,O
133698,9280,diabetic,B-Condition
133699,9280,nephropathy,I-Condition
133700,9280,(,O
133701,9280,urinary,O
133702,9280,albumin,O
133703,9280,excretion,O
133704,9280,≥,O
133705,9280,100,O
133706,9280,mg,O
133707,9280,/,O
133708,9280,day,O
133709,9280,but,O
133710,9280,≤,O
133711,9280,2000,O
133712,9280,mg,O
133713,9280,/,O
133714,9280,day,O
133715,9280,),O
133716,9280,.,O
133717,9281,Glomerular,O
133718,9281,filtration,O
133719,9281,rate,O
133720,9281,(,O
133721,9281,GFR,O
133722,9281,),O
133723,9281,≥,O
133724,9281,40,O
133725,9281,ml,O
133726,9281,/,O
133727,9281,min,O
133728,9281,(,O
133729,9281,estimated,O
133730,9281,using,O
133731,9281,Modification,O
133732,9281,of,O
133733,9281,Diet,O
133734,9281,in,O
133735,9281,Renal,O
133736,9281,Disease,O
133737,9281,(,O
133738,9281,MDRD,O
133739,9281,),O
133740,9281,formula,O
133741,9281,),O
133742,9281,in,O
133743,9281,the,O
133744,9281,last,O
133745,9281,4,O
133746,9281,months,O
133747,9281,.,O
133748,9282,Female,B-Person
133749,9282,patients,O
133750,9282,must,O
133751,9282,be,O
133752,9282,postmenopausal,B-Condition
133753,9282,or,O
133754,9282,must,O
133755,9282,have,O
133756,9282,had,O
133757,9282,a,O
133758,9282,bilateral,B-Procedure
133759,9282,oophorectomy,I-Procedure
133760,9282,or,O
133761,9282,must,O
133762,9282,have,O
133763,9282,been,O
133764,9282,surgically,B-Procedure
133765,9282,sterilized,I-Procedure
133766,9282,or,O
133767,9282,hysterectomized,B-Procedure
133768,9282,at,O
133769,9282,least,O
133770,9282,6,O
133771,9282,months,O
133772,9282,prior,O
133773,9282,to,O
133774,9282,screening,O
133775,9282,.,O
133776,9283,To,O
133777,9283,be,O
133778,9283,eligible,O
133779,9283,patients,O
133780,9283,must,O
133781,9283,fulfill,O
133782,9283,the,O
133783,9283,following,O
133784,9283,criteria,O
133785,9283,:,O
133786,9283,Patients,O
133787,9283,on,O
133788,9283,ongoing,O
133789,9283,hypertensive,B-Procedure
133790,9283,therapy,I-Procedure
133791,9283,must,O
133792,9283,have,O
133793,9283,a,O
133794,9283,blood,O
133795,9283,pressure,O
133796,9283,≥,O
133797,9283,135/85,O
133798,9283,mm,O
133799,9283,Hg,O
133800,9283,but,O
133801,9283,lower,O
133802,9283,than,O
133803,9283,170/105,O
133804,9283,mm,O
133805,9283,Hg,O
133806,9283,at,O
133807,9283,baseline,O
133808,9283,(,O
133809,9283,Day,O
133810,9283,-1,O
133811,9283,),O
133812,9283,AND,O
133813,9283,patients,O
133814,9283,must,O
133815,9283,be,O
133816,9283,on,O
133817,9283,stable,O
133818,9283,antihypertensive,B-Drug
133819,9283,medications,I-Drug
133820,9283,for,O
133821,9283,at,O
133822,9283,least,O
133823,9283,8,O
133824,9283,weeks,O
133825,9283,prior,O
133826,9283,to,O
133827,9283,baseline,O
133828,9283,(,O
133829,9283,Day,O
133830,9283,-1,O
133831,9283,),O
133832,9283,.,O
133833,9283,;,O
133834,9283,Newly,O
133835,9283,diagnosed,O
133836,9283,hypertensive,B-Condition
133837,9283,patients,I-Condition
133838,9283,must,O
133839,9283,have,O
133840,9283,a,O
133841,9283,blood,O
133842,9283,pressure,O
133843,9283,≥,O
133844,9283,135/85,O
133845,9283,mm,O
133846,9283,Hg,O
133847,9283,but,O
133848,9283,lower,O
133849,9283,than,O
133850,9283,170/105,O
133851,9283,mm,O
133852,9283,Hg,O
133853,9283,at,O
133854,9283,baseline,O
133855,9283,(,O
133856,9283,Day,O
133857,9283,-1,O
133858,9283,),O
133859,9283,.,O
133860,9284,Patients,O
133861,9284,must,O
133862,9284,be,O
133863,9284,on,O
133864,9284,stable,O
133865,9284,hypoglycemic,B-Drug
133866,9284,medications,I-Drug
133867,9284,for,O
133868,9284,at,O
133869,9284,least,O
133870,9284,8,O
133871,9284,weeks,O
133872,9284,prior,O
133873,9284,to,O
133874,9284,Visit,O
133875,9284,2,O
133876,9284,(,O
133877,9284,Day,O
133878,9284,-1,O
133879,9284,),O
133880,9284,.,O
133881,9285,Patients,O
133882,9285,must,O
133883,9285,be,O
133884,9285,willing,O
133885,9285,and,O
133886,9285,medically,O
133887,9285,able,O
133888,9285,to,O
133889,9285,discontinue,O
133890,9285,all,O
133891,9285,Angiotensin,O
133892,9285,-,O
133893,9285,converting,O
133894,9285,enzyme,O
133895,9285,inhibitor,O
133896,9285,(,O
133897,9285,ACEI,O
133898,9285,),O
133899,9285,",",O
133900,9285,Angiotensin,O
133901,9285,receptor,O
133902,9285,blocker,O
133903,9285,(,O
133904,9285,ARB,O
133905,9285,),O
133906,9285,",",O
133907,9285,aldosterone,O
133908,9285,receptor,O
133909,9285,antagonist,O
133910,9285,and,O
133911,9285,potassium,O
133912,9285,sparing,O
133913,9285,diuretic,O
133914,9285,medications,O
133915,9285,for,O
133916,9285,the,O
133917,9285,duration,O
133918,9285,of,O
133919,9285,the,O
133920,9285,study,O
133921,9285,.,O
133922,9286,Oral,O
133923,9286,body,O
133924,9286,temperature,O
133925,9286,within,O
133926,9286,the,O
133927,9286,range,O
133928,9286,35.0,O
133929,9286,-,O
133930,9286,37.5,O
133931,9286,°,O
133932,9286,C,O
133933,9287,Able,O
133934,9287,to,O
133935,9287,provide,O
133936,9287,written,B-Observation
133937,9287,informed,I-Observation
133938,9287,consent,I-Observation
133939,9287,prior,O
133940,9287,to,O
133941,9287,study,O
133942,9287,participation,O
133943,9287,.,O
133944,9287,.,O
133945,9288,Able,B-Observation
133946,9288,to,I-Observation
133947,9288,communicate,I-Observation
133948,9288,well,I-Observation
133949,9288,with,O
133950,9288,the,O
133951,9288,investigator,O
133952,9288,and,O
133953,9288,comply,B-Observation
133954,9288,with,I-Observation
133955,9288,the,I-Observation
133956,9288,requirements,I-Observation
133957,9288,of,I-Observation
133958,9288,the,I-Observation
133959,9288,study,I-Observation
133960,9288,.,O
133961,9289,amide,B-Drug
133962,9289,and/or,I-Drug
133963,9289,esther,I-Drug
133964,9289,local,I-Drug
133965,9289,anaesthetic,I-Drug
133966,9289,allergy,B-Condition
133967,9290,paraben,B-Drug
133968,9290,allergy,B-Condition
133969,9291,Child,O
133970,9291,-,O
133971,9291,Pugh,O
133972,9291,grade,O
133973,9291,B,O
133974,9291,/,O
133975,9291,C,O
133976,9291,liver,B-Condition
133977,9291,failure,I-Condition
133978,9292,renal,B-Condition
133979,9292,insufficiency,I-Condition
133980,9292,(,O
133981,9292,calculated,O
133982,9292,glomerular,O
133983,9292,filtration,O
133984,9292,rate,O
133985,9292,under,O
133986,9292,60,O
133987,9292,ml,O
133988,9292,/,O
133989,9292,min/1.73,O
133990,9292,m2,O
133991,9292,according,O
133992,9292,to,O
133993,9292,Cockcroft,O
133994,9292,-,O
133995,9292,Gault,O
133996,9292,scale,O
133997,9292,),O
133998,9293,dementia,B-Condition
133999,9294,those,O
134000,9294,presenting,O
134001,9294,with,O
134002,9294,swallowing,B-Condition
134003,9294,problem,I-Condition
134004,9295,chronic,B-Condition
134005,9295,pain,I-Condition
134006,9295,condition,I-Condition
134007,9296,chronic,O
134008,9296,use,O
134009,9296,of,O
134010,9296,pain,B-Drug
134011,9296,medication,I-Drug
134012,9297,pregnancy,B-Condition
134013,9298,lactation,B-Condition
134014,9299,elective,B-Procedure
134015,9299,procedure,I-Procedure
134016,9300,weight,O
134017,9300,over,O
134018,9300,40,O
134019,9300,kg,O
134020,9301,American,O
134021,9301,Society,O
134022,9301,of,O
134023,9301,Anesthesiology,O
134024,9301,class,O
134025,9301,I,O
134026,9301,-,O
134027,9301,III,O
134028,9302,first,O
134029,9302,upper,O
134030,9302,GI,O
134031,9302,endoscopy,B-Procedure
134032,9302,procedure,I-Procedure
134033,9303,finnish,B-Observation
134034,9303,or,I-Observation
134035,9303,/,I-Observation
134036,9303,and,I-Observation
134037,9303,swedish,I-Observation
134038,9303,speaking,I-Observation
134039,9304,Patients,O
134040,9304,will,O
134041,9304,not,O
134042,9304,be,O
134043,9304,included,O
134044,9304,if,O
134045,9304,they,O
134046,9304,have,O
134047,9304,reached,O
134048,9304,a,O
134049,9304,stable,O
134050,9304,dose,O
134051,9304,of,O
134052,9304,warfarin,B-Drug
134053,9304,",",O
134054,9304,liver,B-Condition
134055,9304,dysfunction,I-Condition
134056,9304,",",O
134057,9304,alcoholism,B-Condition
134058,9304,",",O
134059,9304,use,O
134060,9304,of,O
134061,9304,another,O
134062,9304,anticoagulant,B-Drug
134063,9304,",",O
134064,9304,use,O
134065,9304,of,O
134066,9304,chemotherapy,B-Procedure
134067,9304,",",O
134068,9304,or,O
134069,9304,if,O
134070,9304,they,O
134071,9304,do,O
134072,9304,not,O
134073,9304,meet,O
134074,9304,the,O
134075,9304,inclusion,O
134076,9304,criteria,O
134077,9305,Only,O
134078,9305,patients,O
134079,9305,with,O
134080,9305,atrial,B-Condition
134081,9305,fibrillation,I-Condition
134082,9305,",",O
134083,9305,above,O
134084,9305,18,O
134085,9305,years,B-Person
134086,9305,",",O
134087,9305,and,O
134088,9305,with,O
134089,9305,TTR,O
134090,9305,<,O
134091,9305,50,O
134092,9305,%,O
134093,9305,based,O
134094,9305,on,O
134095,9305,the,O
134096,9305,last,O
134097,9305,three,O
134098,9305,values,O
134099,9305,of,O
134100,9305,INR,O
134101,9305,will,O
134102,9305,be,O
134103,9305,included,O
134104,9305,in,O
134105,9305,this,O
134106,9305,study,O
134107,9305,.,O
134108,9306,adjuvant,B-Procedure
134109,9306,radiotherapy,I-Procedure
134110,9307,evident,O
134111,9307,intra,B-Condition
134112,9307,-,I-Condition
134113,9307,abdominal,I-Condition
134114,9307,inflammation,I-Condition
134115,9307,(,O
134116,9307,diagnosed,O
134117,9307,by,O
134118,9307,imaging,B-Procedure
134119,9307,and/or,O
134120,9307,laboratory,B-Procedure
134121,9307,results,O
134122,9307,",",O
134123,9307,including,O
134124,9307,an,O
134125,9307,abscess,B-Condition
134126,9307,or,O
134127,9307,cholecystitis,B-Condition
134128,9307,),O
134129,9308,chronic,B-Condition
134130,9308,pancreatitis,I-Condition
134131,9309,pancreatic,B-Condition
134132,9309,polypeptide,I-Condition
134133,9309,producing,I-Condition
134134,9309,endocrine,I-Condition
134135,9309,tumor,I-Condition
134136,9310,American,O
134137,9310,Society,O
134138,9310,of,O
134139,9310,Anesthesiologists,O
134140,9310,physical,O
134141,9310,-,O
134142,9310,health,O
134143,9310,status,O
134144,9310,classification,O
134145,9310,(,O
134146,9310,ASA,O
134147,9310,-,O
134148,9310,PS)>3,O
134149,9311,Poorly,O
134150,9311,regulated,O
134151,9311,diabetes,B-Condition
134152,9311,(,O
134153,9311,>,O
134154,9311,200,O
134155,9311,mg,O
134156,9311,/,O
134157,9311,dl,O
134158,9311,(=,O
134159,9311,11,O
134160,9311,mmol,O
134161,9311,/,O
134162,9311,l,O
134163,9311,),O
134164,9311,),O
134165,9312,patients,O
134166,9312,undergoing,O
134167,9312,partial,B-Procedure
134168,9312,or,I-Procedure
134169,9312,full,I-Procedure
134170,9312,resection,I-Procedure
134171,9312,of,I-Procedure
134172,9312,the,I-Procedure
134173,9312,pancreas,I-Procedure
134174,9312,due,O
134175,9312,to,O
134176,9312,a,O
134177,9312,benign,B-Condition
134178,9312,or,I-Condition
134179,9312,malignant,I-Condition
134180,9312,tumor,I-Condition
134181,9313,planned,O
134182,9313,surgical,O
134183,9313,duration,O
134184,9313,more,O
134185,9313,than,O
134186,9313,3,O
134187,9313,hours,O
134188,9314,contraindication,B-Condition
134189,9314,to,O
134190,9314,spinal,B-Procedure
134191,9314,anaesthesia,I-Procedure
134192,9315,severe,O
134193,9315,respiratory,B-Condition
134194,9315,disease,I-Condition
134195,9316,patient,O
134196,9316,known,O
134197,9316,and,O
134198,9316,treated,B-Procedure
134199,9316,for,O
134200,9316,sleep,B-Condition
134201,9316,apnea,I-Condition
134202,9316,syndrome,I-Condition
134203,9317,physical,O
134204,9317,status,O
134205,9317,I,O
134206,9317,-,O
134207,9317,III,O
134208,9318,patients,O
134209,9318,scheduled,B-Mood
134210,9318,to,I-Mood
134211,9318,undergo,I-Mood
134212,9318,hip,B-Procedure
134213,9318,arthroplasty,I-Procedure
134214,9319,The,O
134215,9319,difference,O
134216,9319,in,O
134217,9319,blood,O
134218,9319,pressure,O
134219,9319,between,O
134220,9319,the,O
134221,9319,selected,O
134222,9319,arm,O
134223,9319,versus,O
134224,9319,non,O
134225,9319,-,O
134226,9319,selected,O
134227,9319,arm,O
134228,9319,is,O
134229,9319,=,O
134230,9319,20,O
134231,9319,mmHg,O
134232,9319,for,O
134233,9319,siSBP,O
134234,9319,and,O
134235,9319,=,O
134236,9319,10,O
134237,9319,mmHg,O
134238,9319,for,O
134239,9319,siDBP,O
134240,9319,at,O
134241,9319,Visit,O
134242,9319,1,O
134243,9319,(,O
134244,9319,screening,O
134245,9319,),O
134246,9319,.,O
134247,9320,Blood,O
134248,9320,pressure,O
134249,9320,taken,O
134250,9320,at,O
134251,9320,screening,O
134252,9320,and,O
134253,9320,randomization,O
134254,9320,is,O
134255,9320,=,O
134256,9320,180,O
134257,9320,mmHg,O
134258,9320,for,O
134259,9320,siSBP,O
134260,9320,or,O
134261,9320,=,O
134262,9320,110,O
134263,9320,mmHg,O
134264,9320,for,O
134265,9320,siDBP,O
134266,9320,.,O
134267,9321,Diagnosed,O
134268,9321,with,O
134269,9321,secondary,O
134270,9321,hypertension,B-Condition
134271,9321,or,O
134272,9321,suspected,B-Mood
134273,9321,of,O
134274,9321,secondary,O
134275,9321,hypertension,B-Condition
134276,9321,[,O
134277,9321,e.g.,O
134278,9321,",",O
134279,9321,renovascular,B-Condition
134280,9321,disease,I-Condition
134281,9321,",",O
134282,9321,adrenal,B-Condition
134283,9321,medullary,I-Condition
134284,9321,and,I-Condition
134285,9321,cortical,I-Condition
134286,9321,hyperfunction,I-Condition
134287,9321,",",O
134288,9321,coarctation,B-Condition
134289,9321,of,I-Condition
134290,9321,the,I-Condition
134291,9321,aorta,I-Condition
134292,9321,",",O
134293,9321,hyperaldosteronism,B-Condition
134294,9321,",",O
134295,9321,unilateral,O
134296,9321,or,O
134297,9321,bilateral,O
134298,9321,renal,B-Condition
134299,9321,artery,I-Condition
134300,9321,stenosis,I-Condition
134301,9321,",",O
134302,9321,Cushing,B-Condition
134303,9321,'s,I-Condition
134304,9321,syndrome,I-Condition
134305,9321,",",O
134306,9321,pheochromocytoma,B-Condition
134307,9321,",",O
134308,9321,polycystic,B-Condition
134309,9321,kidney,I-Condition
134310,9321,disease,I-Condition
134311,9321,",",O
134312,9321,etc,O
134313,9321,.,O
134314,9321,],O
134315,9322,Patients,O
134316,9322,with,O
134317,9322,symptomatic,O
134318,9322,orthostatic,B-Condition
134319,9322,hypertension,I-Condition
134320,9322,(,O
134321,9322,the,O
134322,9322,difference,O
134323,9322,in,O
134324,9322,the,O
134325,9322,blood,O
134326,9322,pressures,O
134327,9322,between,O
134328,9322,measured,O
134329,9322,at,O
134330,9322,supine,O
134331,9322,position,O
134332,9322,and,O
134333,9322,measured,O
134334,9322,at,O
134335,9322,standing,O
134336,9322,position,O
134337,9322,is,O
134338,9322,=,O
134339,9322,20,O
134340,9322,mmHg,O
134341,9322,for,O
134342,9322,siSBP,O
134343,9322,and,O
134344,9322,=,O
134345,9322,10,O
134346,9322,mmHg,O
134347,9322,for,O
134348,9322,siDBP,O
134349,9322,),O
134350,9323,Diagnosis,O
134351,9323,of,O
134352,9323,type,B-Condition
134353,9323,1,I-Condition
134354,9323,diabetes,I-Condition
134355,9323,mellitus,I-Condition
134356,9323,(,I-Condition
134357,9323,DM,I-Condition
134358,9323,),I-Condition
134359,9323,or,O
134360,9323,uncontrolled,O
134361,9323,DM,B-Condition
134362,9323,(,O
134363,9323,patients,O
134364,9323,on,O
134365,9323,insulin,B-Procedure
134366,9323,therapy,I-Procedure
134367,9323,or,O
134368,9323,with,O
134369,9323,HbA1c,O
134370,9323,>,O
134371,9323,9,O
134372,9323,%,O
134373,9323,),O
134374,9324,Patients,O
134375,9324,with,O
134376,9324,severe,O
134377,9324,cardiac,B-Condition
134378,9324,conditions,I-Condition
134379,9324,:,O
134380,9324,heart,B-Condition
134381,9324,failure,I-Condition
134382,9324,(,O
134383,9324,NYHA,O
134384,9324,Class,O
134385,9324,3,O
134386,9324,or,O
134387,9324,4,O
134388,9324,),O
134389,9324,",",O
134390,9324,history,B-Observation
134391,9324,of,O
134392,9324,ischemic,B-Condition
134393,9324,cardiac,I-Condition
134394,9324,disease,I-Condition
134395,9324,(,O
134396,9324,unstable,B-Condition
134397,9324,angina,I-Condition
134398,9324,",",O
134399,9324,myocardial,B-Condition
134400,9324,infarction,I-Condition
134401,9324,),O
134402,9324,",",O
134403,9324,peripheral,B-Condition
134404,9324,vascular,I-Condition
134405,9324,diseases,I-Condition
134406,9324,",",O
134407,9324,percutaneous,B-Procedure
134408,9324,transluminal,I-Procedure
134409,9324,angioplasty,I-Procedure
134410,9324,or,O
134411,9324,coronary,B-Procedure
134412,9324,artery,I-Procedure
134413,9324,bypass,I-Procedure
134414,9324,graft,I-Procedure
134415,9324,within,O
134416,9324,recent,O
134417,9324,6,O
134418,9324,months,O
134419,9324,.,O
134420,9325,Patients,O
134421,9325,with,O
134422,9325,clinically,O
134423,9325,significant,O
134424,9325,ventricular,B-Condition
134425,9325,tachycardia,I-Condition
134426,9325,",",O
134427,9325,atrial,B-Condition
134428,9325,fibrillation,I-Condition
134429,9325,",",O
134430,9325,atrial,B-Condition
134431,9325,flutter,I-Condition
134432,9325,or,O
134433,9325,other,O
134434,9325,clinically,O
134435,9325,significant,O
134436,9325,arrhythmia,B-Condition
134437,9325,at,O
134438,9325,the,O
134439,9325,discretion,O
134440,9325,of,O
134441,9325,the,O
134442,9325,investigator,O
134443,9326,Patients,O
134444,9326,with,O
134445,9326,hypertrophic,B-Condition
134446,9326,occlusive,I-Condition
134447,9326,myocardiopathy,I-Condition
134448,9326,",",O
134449,9326,severe,O
134450,9326,occlusive,B-Condition
134451,9326,coronary,I-Condition
134452,9326,artery,I-Condition
134453,9326,disease,I-Condition
134454,9326,",",O
134455,9326,aortic,B-Condition
134456,9326,stenosis,I-Condition
134457,9326,",",O
134458,9326,hemodynamically,O
134459,9326,significant,O
134460,9326,aortic,B-Condition
134461,9326,valve,I-Condition
134462,9326,or,I-Condition
134463,9326,mitral,I-Condition
134464,9326,valve,I-Condition
134465,9326,stenosis,I-Condition
134466,9327,History,B-Observation
134467,9327,of,O
134468,9327,cardiogenic,B-Condition
134469,9327,shock,I-Condition
134470,9328,Presence,O
134471,9328,of,O
134472,9328,severe,O
134473,9328,cerebrovascular,B-Condition
134474,9328,disorders,I-Condition
134475,9328,(,O
134476,9328,diagnosis,O
134477,9328,of,O
134478,9328,stroke,B-Condition
134479,9328,",",O
134480,9328,cerebral,B-Condition
134481,9328,infarction,I-Condition
134482,9328,or,O
134483,9328,cerebral,B-Condition
134484,9328,hemorrhage,I-Condition
134485,9328,within,O
134486,9328,recent,O
134487,9328,6,O
134488,9328,months,O
134489,9328,),O
134490,9329,History,B-Observation
134491,9329,or,O
134492,9329,current,O
134493,9329,evidence,O
134494,9329,of,O
134495,9329,wasting,B-Observation
134496,9329,",",O
134497,9329,autoimmune,B-Condition
134498,9329,(,I-Condition
134499,9329,such,I-Condition
134500,9329,as,I-Condition
134501,9329,rheumatoid,I-Condition
134502,9329,arthritis,I-Condition
134503,9329,and,I-Condition
134504,9329,systemic,I-Condition
134505,9329,lupus,I-Condition
134506,9329,erythematosus,I-Condition
134507,9329,),I-Condition
134508,9329,or,I-Condition
134509,9329,connective,I-Condition
134510,9329,tissue,I-Condition
134511,9329,diseases,I-Condition
134512,9330,Known,O
134513,9330,diagnosis,O
134514,9330,of,O
134515,9330,moderate,O
134516,9330,or,O
134517,9330,malignant,O
134518,9330,retinopathy,B-Condition
134519,9330,(,O
134520,9330,including,O
134521,9330,retinal,B-Condition
134522,9330,hemorrhage,I-Condition
134523,9330,",",O
134524,9330,visual,B-Condition
134525,9330,disturbance,I-Condition
134526,9330,and,O
134527,9330,retinal,B-Condition
134528,9330,microaneurysm,I-Condition
134529,9330,within,O
134530,9330,6,O
134531,9330,months,O
134532,9330,),O
134533,9331,Patients,O
134534,9331,with,O
134535,9331,surgical,O
134536,9331,or,O
134537,9331,medical,O
134538,9331,intestinal,B-Condition
134539,9331,diseases,I-Condition
134540,9331,or,O
134541,9331,having,O
134542,9331,received,O
134543,9331,surgeries,B-Procedure
134544,9331,that,O
134545,9331,could,O
134546,9331,interfere,O
134547,9331,with,O
134548,9331,drug,O
134549,9331,absorption,O
134550,9331,distribution,O
134551,9331,",",O
134552,9331,metabolism,O
134553,9331,and,O
134554,9331,elimination,O
134555,9332,History,B-Observation
134556,9332,of,I-Observation
134557,9332,malignancy,B-Condition
134558,9332,including,O
134559,9332,leukemia,B-Condition
134560,9332,and,O
134561,9332,lymphoma,B-Condition
134562,9332,within,O
134563,9332,recent,O
134564,9332,5,O
134565,9332,years,O
134566,9332,except,O
134567,9332,for,O
134568,9332,localized,B-Condition
134569,9332,basal,I-Condition
134570,9332,cell,I-Condition
134571,9332,carcinoma,I-Condition
134572,9332,of,I-Condition
134573,9332,the,I-Condition
134574,9332,skin,I-Condition
134575,9332,),O
134576,9333,Patients,O
134577,9333,with,O
134578,9333,any,O
134579,9333,inflammatory,B-Condition
134580,9333,diseases,I-Condition
134581,9333,requiring,O
134582,9333,chronic,O
134583,9333,anti,B-Procedure
134584,9333,-,I-Procedure
134585,9333,inflammatory,I-Procedure
134586,9333,therapy,I-Procedure
134587,9334,Renal,B-Condition
134588,9334,failure,I-Condition
134589,9334,on,O
134590,9334,dialysis,B-Procedure
134591,9335,AST,O
134592,9335,or,O
134593,9335,ALT,O
134594,9335,>,O
134595,9335,2,O
134596,9335,x,O
134597,9335,upper,O
134598,9335,limit,O
134599,9335,of,O
134600,9335,normal,O
134601,9335,(,O
134602,9335,ULN,O
134603,9335,),O
134604,9336,Serum,O
134605,9336,creatinine,O
134606,9336,>,O
134607,9336,1.5,O
134608,9336,x,O
134609,9336,ULN,O
134610,9337,Serum,O
134611,9337,potassium,O
134612,9337,<,O
134613,9337,3.5,O
134614,9337,mmol,O
134615,9337,/,O
134616,9337,L,O
134617,9337,or,O
134618,9337,>,O
134619,9337,5.5,O
134620,9337,mmol,O
134621,9337,/,O
134622,9337,L,O
134623,9338,Needs,O
134624,9338,for,O
134625,9338,co,O
134626,9338,-,O
134627,9338,administration,O
134628,9338,of,O
134629,9338,non,O
134630,9338,-,O
134631,9338,study,O
134632,9338,antihypertensive,B-Drug
134633,9338,agents,I-Drug
134634,9338,or,O
134635,9338,contraindicated,B-Drug
134636,9338,medications,I-Drug
134637,9338,during,O
134638,9338,the,O
134639,9338,study,O
134640,9339,History,B-Observation
134641,9339,of,I-Observation
134642,9339,hypersensitivity,B-Condition
134643,9339,to,O
134644,9339,ARBs,B-Drug
134645,9339,or,O
134646,9339,dihydropyridines,B-Drug
134647,9340,History,B-Observation
134648,9340,of,I-Observation
134649,9340,angioedema,B-Condition
134650,9340,to,O
134651,9340,treatment,B-Procedure
134652,9340,with,O
134653,9340,ACE,B-Drug
134654,9340,inhibitors,I-Drug
134655,9340,or,O
134656,9340,ARBs,B-Drug
134657,9341,Pregnant,B-Condition
134658,9341,or,O
134659,9341,lactating,B-Condition
134660,9341,women,B-Person
134661,9341,and,O
134662,9341,female,B-Person
134663,9341,volunteers,O
134664,9341,of,O
134665,9341,childbearing,B-Observation
134666,9341,potential,I-Observation
134667,9341,(,O
134668,9341,except,O
134669,9341,for,O
134670,9341,women,O
134671,9341,who,O
134672,9341,are,O
134673,9341,surgically,O
134674,9341,sterile,O
134675,9341,),O
134676,9341,who,O
134677,9341,are,O
134678,9341,not,O
134679,9341,willing,B-Mood
134680,9341,to,I-Mood
134681,9341,use,O
134682,9341,an,O
134683,9341,adequate,B-Procedure
134684,9341,method,I-Procedure
134685,9341,of,I-Procedure
134686,9341,contraception,I-Procedure
134687,9341,(,O
134688,9341,oral,O
134689,9341,contraceptives,O
134690,9341,",",O
134691,9341,intrauterine,O
134692,9341,device,O
134693,9341,",",O
134694,9341,condom,O
134695,9341,",",O
134696,9341,etc,O
134697,9341,.,O
134698,9341,),O
134699,9341,during,O
134700,9341,the,O
134701,9341,study,O
134702,9341,.,O
134703,9341,Women,O
134704,9341,of,O
134705,9341,childbearing,O
134706,9341,potential,O
134707,9341,who,O
134708,9341,are,O
134709,9341,not,O
134710,9341,surgically,O
134711,9341,sterile,O
134712,9341,will,O
134713,9341,be,O
134714,9341,allowed,O
134715,9341,to,O
134716,9341,participate,O
134717,9341,in,O
134718,9341,the,O
134719,9341,study,O
134720,9341,only,O
134721,9341,if,O
134722,9341,they,O
134723,9341,have,O
134724,9341,negative,O
134725,9341,pregnancy,O
134726,9341,test,O
134727,9341,at,O
134728,9341,Visit,O
134729,9341,1,O
134730,9341,(,O
134731,9341,screening,O
134732,9341,),O
134733,9341,and,O
134734,9341,should,O
134735,9341,continue,O
134736,9341,to,O
134737,9341,use,O
134738,9341,medically,O
134739,9341,acceptable,O
134740,9341,method,O
134741,9341,of,O
134742,9341,contraception,O
134743,9341,(,O
134744,9341,basic,O
134745,9341,body,O
134746,9341,temperature,O
134747,9341,method,O
134748,9341,and,O
134749,9341,rhythm,O
134750,9341,method,O
134751,9341,will,O
134752,9341,not,O
134753,9341,be,O
134754,9341,allowed,O
134755,9341,),O
134756,9341,.,O
134757,9341,Women,O
134758,9341,with,O
134759,9341,no,O
134760,9341,menses,O
134761,9341,for,O
134762,9341,=,O
134763,9341,12,O
134764,9341,months,O
134765,9341,will,O
134766,9341,be,O
134767,9341,considered,O
134768,9341,as,O
134769,9341,postmenopausal,O
134770,9341,state,O
134771,9341,and,O
134772,9341,method,O
134773,9341,of,O
134774,9341,contraception,O
134775,9341,using,O
134776,9341,hormonal,O
134777,9341,contraception,O
134778,9341,such,O
134779,9341,as,O
134780,9341,oral,O
134781,9341,contraceptive,O
134782,9341,should,O
134783,9341,be,O
134784,9341,initiated,O
134785,9341,from,O
134786,9341,or,O
134787,9341,prior,O
134788,9341,to,O
134789,9341,the,O
134790,9341,screening,O
134791,9341,.,O
134792,9342,History,B-Observation
134793,9342,of,O
134794,9342,drug,B-Condition
134795,9342,or,I-Condition
134796,9342,alcohol,I-Condition
134797,9342,abuse,I-Condition
134798,9342,within,O
134799,9342,recent,O
134800,9342,1,O
134801,9342,year,O
134802,9343,Patients,O
134803,9343,having,O
134804,9343,received,O
134805,9343,any,O
134806,9343,other,B-Drug
134807,9343,investigational,I-Drug
134808,9343,product,I-Drug
134809,9343,within,O
134810,9343,recent,O
134811,9343,12,O
134812,9343,weeks,O
134813,9344,Conditions,O
134814,9344,which,O
134815,9344,render,O
134816,9344,a,O
134817,9344,subject,O
134818,9344,ineligible,O
134819,9344,for,O
134820,9344,the,O
134821,9344,study,O
134822,9344,at,O
134823,9344,the,O
134824,9344,discretion,O
134825,9344,of,O
134826,9344,the,O
134827,9344,investigator,O
134828,9345,Adult,O
134829,9345,male,B-Person
134830,9345,and,O
134831,9345,female,B-Person
134832,9345,aged,B-Person
134833,9345,19,O
134834,9345,to,O
134835,9345,75,O
134836,9345,years,O
134837,9346,Voluntarily,O
134838,9346,consented,O
134839,9346,to,O
134840,9346,participate,O
134841,9346,in,O
134842,9346,the,O
134843,9346,study,O
134844,9346,and,O
134845,9346,signed,O
134846,9346,the,O
134847,9346,informed,O
134848,9346,consent,O
134849,9346,form,O
134850,9346,after,O
134851,9346,receiving,O
134852,9346,the,O
134853,9346,explanation,O
134854,9346,of,O
134855,9346,the,O
134856,9346,objectives,O
134857,9346,",",O
134858,9346,methods,O
134859,9346,and,O
134860,9346,effects,O
134861,9346,of,O
134862,9346,the,O
134863,9346,study,O
134864,9346,.,O
134865,9347,Unstable,B-Condition
134866,9347,medical,I-Condition
134867,9347,disease,I-Condition
134868,9347,of,O
134869,9347,comorbid,B-Condition
134870,9347,psychiatric,I-Condition
134871,9347,disease,I-Condition
134872,9348,Dementia,B-Condition
134873,9349,Subjects,O
134874,9349,with,O
134875,9349,less,O
134876,9349,than,O
134877,9349,one,O
134878,9349,year,O
134879,9349,duration,O
134880,9349,of,O
134881,9349,Parkinson,B-Condition
134882,9349,'s,I-Condition
134883,9350,Current,O
134884,9350,treatment,O
134885,9350,with,O
134886,9350,a,O
134887,9350,dopamine,B-Drug
134888,9350,agonist,I-Drug
134889,9351,Diagnosis,O
134890,9351,of,O
134891,9351,DSM,B-Condition
134892,9351,5,I-Condition
134893,9351,Anxiety,I-Condition
134894,9351,Disorder,I-Condition
134895,9352,Stable,B-Condition
134896,9352,medical,I-Condition
134897,9352,history,I-Condition
134898,9352,and,I-Condition
134899,9352,general,I-Condition
134900,9352,health,I-Condition
134901,9353,On,O
134902,9353,stable,O
134903,9353,anti,B-Procedure
134904,9353,-,I-Procedure
134905,9353,parkinsonian,I-Procedure
134906,9353,therapy,I-Procedure
134907,9353,for,O
134908,9353,2,O
134909,9353,weeks,O
134910,9353,before,O
134911,9353,enrollment,O
134912,9354,age,B-Person
134913,9354,less,O
134914,9354,than,O
134915,9354,18,O
134916,9354,years,O
134917,9355,allergy,B-Condition
134918,9355,to,O
134919,9355,study,B-Drug
134920,9355,drugs,I-Drug
134921,9356,substance,B-Condition
134922,9356,misuse,I-Condition
134923,9356,other,O
134924,9356,contraindication,B-Condition
134925,9356,to,O
134926,9356,used,O
134927,9356,study,B-Drug
134928,9356,drugs,I-Drug
134929,9356,no,O
134930,9356,informed,O
134931,9356,consent,O
134932,9357,normal,O
134933,9357,full,O
134934,9357,term,O
134935,9357,single,O
134936,9357,pregnancy,B-Condition
134937,9358,age,B-Person
134938,9358,18,O
134939,9358,years,O
134940,9358,or,O
134941,9358,more,O
134942,9359,BMI,O
134943,9359,20,O
134944,9359,-,O
134945,9359,35,O
134946,9359,kg,O
134947,9359,/,O
134948,9359,m2,O
134949,9360,written,O
134950,9360,informed,O
134951,9360,consent,O
134952,9360,obtained,O
134953,9361,taken,O
134954,9361,adenosine,B-Drug
134955,9361,diphosphate,I-Drug
134956,9361,(,I-Drug
134957,9361,ADP,I-Drug
134958,9361,),I-Drug
134959,9361,receptor,I-Drug
134960,9361,antagonists,I-Drug
134961,9361,within,O
134962,9361,2,O
134963,9361,weeks,O
134964,9362,Platelet,O
134965,9362,count,O
134966,9362,<,O
134967,9362,100g,O
134968,9362,/,O
134969,9362,L,O
134970,9362,;,O
134971,9363,A,O
134972,9363,history,B-Observation
134973,9363,of,O
134974,9363,bleeding,B-Condition
134975,9363,tendency,I-Condition
134976,9363,;,O
134977,9364,Aspirin,B-Drug
134978,9364,",",O
134979,9364,ticagrelor,B-Drug
134980,9364,or,O
134981,9364,clopidogrel,B-Drug
134982,9364,allergies,B-Condition
134983,9364,;,O
134984,9365,Severe,O
134985,9365,liver,B-Condition
134986,9365,injury,I-Condition
134987,9365,.,O
134988,9366,After,O
134989,9366,half,O
134990,9366,-,O
134991,9366,dose,O
134992,9366,ticagrelor,B-Drug
134993,9366,(,O
134994,9366,loading,O
134995,9366,dose,O
134996,9366,90,O
134997,9366,mg,O
134998,9366,",",O
134999,9366,and,O
135000,9366,then,O
135001,9366,45,O
135002,9366,mg,O
135003,9366,bidpo,O
135004,9366,.,O
135005,9366,),O
135006,9366,treatment,O
135007,9366,for,O
135008,9366,3,O
135009,9366,days,O
135010,9366,",",O
135011,9366,the,O
135012,9366,platelet,O
135013,9366,aggregation,O
135014,9366,is,O
135015,9366,effectively,O
135016,9366,inhibited,O
135017,9366,by,O
135018,9366,light,B-Procedure
135019,9366,transmission,I-Procedure
135020,9366,aggregometry,I-Procedure
135021,9366,method,O
135022,9366,and,O
135023,9366,thromboela,B-Procedure
135024,9366,-,I-Procedure
135025,9366,stogram,I-Procedure
135026,9366,.,O
135027,9367,planned,B-Mood
135028,9367,to,I-Mood
135029,9367,undergo,I-Mood
135030,9367,PCI,B-Procedure
135031,9367,recently,O
135032,9368,planned,B-Mood
135033,9368,to,I-Mood
135034,9368,DAPT,B-Procedure
135035,9368,for,O
135036,9368,1,O
135037,9368,year,O
135038,9368,after,O
135039,9368,PCI,B-Procedure
135040,9369,Patients,O
135041,9369,who,O
135042,9369,have,O
135043,9369,taken,O
135044,9369,either,O
135045,9369,morphine,B-Drug
135046,9369,with,O
135047,9369,daily,O
135048,9369,dose,O
135049,9369,more,O
135050,9369,than,O
135051,9369,120,O
135052,9369,mg,O
135053,9369,or,O
135054,9369,Fentanyl,B-Drug
135055,9369,with,O
135056,9369,daily,O
135057,9369,dose,O
135058,9369,more,O
135059,9369,than,O
135060,9369,50ug,O
135061,9369,/,O
135062,9369,hr,O
135063,9370,Patients,O
135064,9370,with,O
135065,9370,significant,O
135066,9370,abnormalities,B-Condition
135067,9370,in,I-Condition
135068,9370,hepatic,I-Condition
135069,9370,or,I-Condition
135070,9370,renal,I-Condition
135071,9370,function,I-Condition
135072,9370,which,O
135073,9370,would,O
135074,9370,",",O
135075,9370,in,O
135076,9370,the,O
135077,9370,opinion,O
135078,9370,of,O
135079,9370,the,O
135080,9370,investigator,O
135081,9370,",",O
135082,9370,prevent,O
135083,9370,the,O
135084,9370,patients,O
135085,9370,involvement,O
135086,9370,in,O
135087,9370,the,O
135088,9370,study,O
135089,9371,Patients,O
135090,9371,with,O
135091,9371,significant,O
135092,9371,clinical,O
135093,9371,abnormalities,B-Condition
135094,9371,in,I-Condition
135095,9371,CNS,I-Condition
135096,9371,",",I-Condition
135097,9371,respiratory,I-Condition
135098,9371,or,I-Condition
135099,9371,cardiovascular,I-Condition
135100,9371,function,I-Condition
135101,9371,",",O
135102,9371,which,O
135103,9371,in,O
135104,9371,the,O
135105,9371,investigators,O
135106,9371,judgement,O
135107,9371,prevents,O
135108,9371,participation,O
135109,9371,in,O
135110,9371,the,O
135111,9371,study,O
135112,9372,Patients,O
135113,9372,who,O
135114,9372,have,O
135115,9372,taken,O
135116,9372,antidepressants,B-Drug
135117,9372,or,O
135118,9372,anti,B-Drug
135119,9372,-,I-Drug
135120,9372,epileptic,I-Drug
135121,9372,drugs,I-Drug
135122,9372,",",O
135123,9372,sedative,B-Drug
135124,9372,hypnotics,I-Drug
135125,9372,",",O
135126,9372,selective,B-Drug
135127,9372,serotonin,I-Drug
135128,9372,reuptake,I-Drug
135129,9372,inhibitor,I-Drug
135130,9372,",",O
135131,9372,short,B-Drug
135132,9372,-,I-Drug
135133,9372,acting,I-Drug
135134,9372,analgesics,I-Drug
135135,9372,",",O
135136,9372,topical,B-Drug
135137,9372,medications,I-Drug
135138,9372,and,O
135139,9372,anesthetics,B-Drug
135140,9372,and/or,O
135141,9372,muscle,B-Drug
135142,9372,relaxants,I-Drug
135143,9372,when,O
135144,9372,taking,O
135145,9372,Tramadol,B-Drug
135146,9372,/,O
135147,9372,Acetaminophen,B-Drug
135148,9373,Patients,O
135149,9373,with,O
135150,9373,a,O
135151,9373,histologically,B-Procedure
135152,9373,",",O
135153,9373,radiologically,B-Procedure
135154,9373,or,O
135155,9373,haematologically,B-Procedure
135156,9373,confirmed,O
135157,9373,malignancy,B-Condition
135158,9373,whose,O
135159,9373,pain,B-Condition
135160,9373,is,O
135161,9373,judged,O
135162,9373,by,O
135163,9373,the,O
135164,9373,investigator,O
135165,9373,to,O
135166,9373,be,O
135167,9373,caused,O
135168,9373,by,O
135169,9373,the,O
135170,9373,malignancy,O
135171,9374,Patients,O
135172,9374,must,O
135173,9374,have,O
135174,9374,been,O
135175,9374,on,O
135176,9374,a,O
135177,9374,stable,O
135178,9374,daily,O
135179,9374,dose,O
135180,9374,of,O
135181,9374,weak,B-Drug
135182,9374,opioids,I-Drug
135183,9374,or,O
135184,9374,strong,B-Drug
135185,9374,opioids,I-Drug
135186,9374,for,O
135187,9374,at,O
135188,9374,least,O
135189,9374,72,O
135190,9374,hours,O
135191,9374,prior,O
135192,9374,to,O
135193,9374,the,O
135194,9374,start,O
135195,9374,the,O
135196,9374,study,O
135197,9374,and,O
135198,9374,must,O
135199,9374,remain,O
135200,9374,at,O
135201,9374,the,O
135202,9374,same,O
135203,9374,dosage,O
135204,9374,for,O
135205,9374,the,O
135206,9374,duration,O
135207,9374,of,O
135208,9374,the,O
135209,9374,study,O
135210,9375,Patients,O
135211,9375,must,O
135212,9375,have,O
135213,9375,a,O
135214,9375,VAS,O
135215,9375,(,O
135216,9375,Visual,O
135217,9375,analog,O
135218,9375,scale,O
135219,9375,),O
135220,9375,>,O
135221,9375,=,O
135222,9375,40,O
135223,9375,mm,O
135224,9376,pregnancy,B-Condition
135225,9377,known,O
135226,9377,allergies,B-Condition
135227,9377,for,O
135228,9377,tranexamic,B-Drug
135229,9377,acid,I-Drug
135230,9377,or,O
135231,9377,any,O
135232,9377,other,O
135233,9377,substance,O
135234,9377,in,O
135235,9377,Exacyl,B-Drug
135236,9378,deep,B-Condition
135237,9378,vein,I-Condition
135238,9378,thrombosis,I-Condition
135239,9379,Hormone,B-Procedure
135240,9379,Replacement,I-Procedure
135241,9379,Therapy,I-Procedure
135242,9379,or,O
135243,9379,oral,B-Drug
135244,9379,contraceptive,I-Drug
135245,9379,usage,O
135246,9380,anticoagulants,B-Drug
135247,9380,usage,O
135248,9381,obesity,B-Condition
135249,9381,-,O
135250,9381,BMI,O
135251,9381,(,O
135252,9381,body,O
135253,9381,mass,O
135254,9381,index,O
135255,9381,),O
135256,9381,>,O
135257,9381,30,O
135258,9381,kg,O
135259,9381,/,O
135260,9381,m2,O
135261,9382,renal,B-Condition
135262,9382,disease,I-Condition
135263,9382,",",O
135264,9382,as,O
135265,9382,glomerular,O
135266,9382,filtration,O
135267,9382,rate,O
135268,9382,(,O
135269,9382,GFR,O
135270,9382,),O
135271,9382,<,O
135272,9382,60,O
135273,9382,ml,O
135274,9382,/,O
135275,9382,"min/1,73",O
135276,9382,m*m,O
135277,9383,seizures,O
135278,9383,or,O
135279,9383,epilepsy,O
135280,9383,in,O
135281,9383,the,O
135282,9383,past,O
135283,9384,age,B-Person
135284,9384,>,O
135285,9384,18,O
135286,9384,y.o,O
135287,9384,.,O
135288,9385,American,O
135289,9385,Society,O
135290,9385,of,O
135291,9385,Anesthesiologists,O
135292,9385,Physical,O
135293,9385,Status,O
135294,9385,Classification,O
135295,9385,(,O
135296,9385,ASA,O
135297,9385,),O
135298,9385,1,O
135299,9385,-,O
135300,9385,2,O
135301,9386,signed,O
135302,9386,informed,O
135303,9386,consent,O
135304,9386,form,O
135305,9386,after,O
135306,9386,reading,O
135307,9386,the,O
135308,9386,information,O
135309,9386,about,O
135310,9386,the,O
135311,9386,study,O
135312,9386,and,O
135313,9386,talking,O
135314,9386,with,O
135315,9386,one,O
135316,9386,of,O
135317,9386,the,O
135318,9386,investigators,O
135319,9387,Patients,O
135320,9387,with,O
135321,9387,Non,B-Condition
135322,9387,-,I-Condition
135323,9387,androgenetic,I-Condition
135324,9387,causes,I-Condition
135325,9387,of,I-Condition
135326,9387,hair,I-Condition
135327,9387,loss,I-Condition
135328,9387,.,O
135329,9388,Female,B-Person
135330,9388,patients,O
135331,9388,with,O
135332,9388,androgenetic,B-Condition
135333,9388,alopecia,I-Condition
135334,9388,.,O
135335,9389,Patients,O
135336,9389,who,O
135337,9389,received,O
135338,9389,anti,B-Procedure
135339,9389,-,I-Procedure
135340,9389,hair,I-Procedure
135341,9389,loss,I-Procedure
135342,9389,treatment,I-Procedure
135343,9389,within,O
135344,9389,the,O
135345,9389,past,O
135346,9389,six,O
135347,9389,months,O
135348,9389,.,O
135349,9390,Patients,O
135350,9390,with,O
135351,9390,history,B-Observation
135352,9390,of,O
135353,9390,bleeding,B-Condition
135354,9390,disorders,I-Condition
135355,9390,or,O
135356,9390,on,O
135357,9390,anticoagulant,B-Procedure
135358,9390,therapy,I-Procedure
135359,9390,.,O
135360,9391,Patients,O
135361,9391,with,O
135362,9391,history,B-Observation
135363,9391,of,O
135364,9391,chronic,B-Condition
135365,9391,liver,I-Condition
135366,9391,disease,I-Condition
135367,9391,",",O
135368,9391,cancer,B-Condition
135369,9391,or,O
135370,9391,connective,B-Condition
135371,9391,tissue,I-Condition
135372,9391,disorders,I-Condition
135373,9391,.,O
135374,9392,Patients,O
135375,9392,with,O
135376,9392,current,O
135377,9392,scalp,B-Condition
135378,9392,infection,I-Condition
135379,9392,.,O
135380,9393,male,B-Person
135381,9393,patients,O
135382,9393,with,O
135383,9393,androgenetic,B-Condition
135384,9393,alopecia,I-Condition
135385,9393,between,O
135386,9393,18,O
135387,9393,years,O
135388,9393,and,O
135389,9393,60,O
135390,9393,years,B-Person
135391,9394,Significant,O
135392,9394,illness,B-Condition
135393,9394,",",O
135394,9394,trauma,B-Condition
135395,9394,or,O
135396,9394,surgical,B-Procedure
135397,9394,procedures,I-Procedure
135398,9394,.,O
135399,9395,Clinically,O
135400,9395,significant,O
135401,9395,laboratory,B-Condition
135402,9395,abnormalities,I-Condition
135403,9395,.,O
135404,9396,Clinically,O
135405,9396,significant,O
135406,9396,medical,B-Observation
135407,9396,history,I-Observation
135408,9397,body,O
135409,9397,mass,O
135410,9397,index,O
135411,9397,(,O
135412,9397,BMI,O
135413,9397,),O
135414,9397,between,O
135415,9397,19,O
135416,9397,to,O
135417,9397,30,O
135418,9397,kg,O
135419,9397,/,O
135420,9397,m2,O
135421,9397,and,O
135422,9397,body,O
135423,9397,weight,O
135424,9397,between,O
135425,9397,50,O
135426,9397,to,O
135427,9397,100,O
135428,9397,kg,O
135429,9397,inclusive,O
135430,9398,Currently,O
135431,9398,pregnant,B-Condition
135432,9398,or,O
135433,9398,breastfeeding,B-Observation
135434,9399,Severe,O
135435,9399,pelvic,B-Condition
135436,9399,organ,I-Condition
135437,9399,prolapse,I-Condition
135438,9399,or,O
135439,9399,prolapse,B-Condition
135440,9399,to,O
135441,9399,any,O
135442,9399,degree,O
135443,9399,that,O
135444,9399,may,O
135445,9399,prevent,O
135446,9399,retention,O
135447,9399,of,O
135448,9399,the,O
135449,9399,vaginal,O
135450,9399,ring,O
135451,9399,after,O
135452,9399,insertion,O
135453,9400,Use,O
135454,9400,of,O
135455,9400,oral,B-Drug
135456,9400,contraceptive,I-Drug
135457,9400,pills,I-Drug
135458,9400,",",O
135459,9400,patches,O
135460,9400,",",O
135461,9400,implants,O
135462,9400,or,O
135463,9400,hormonal,B-Procedure
135464,9400,intrauterine,I-Procedure
135465,9400,contraception,I-Procedure
135466,9400,in,O
135467,9400,the,O
135468,9400,month,O
135469,9400,prior,O
135470,9400,to,O
135471,9400,screening,O
135472,9401,Use,O
135473,9401,of,O
135474,9401,depo,B-Drug
135475,9401,medroxyprogesterone,I-Drug
135476,9401,within,O
135477,9401,6,O
135478,9401,months,O
135479,9401,of,O
135480,9401,screening,O
135481,9402,Use,O
135482,9402,of,O
135483,9402,medications,B-Drug
135484,9402,that,O
135485,9402,interact,B-Observation
135486,9402,with,I-Observation
135487,9402,contraceptive,B-Drug
135488,9402,steroid,I-Drug
135489,9402,hormones,I-Drug
135490,9402,:,O
135491,9402,anti,B-Drug
135492,9402,-,I-Drug
135493,9402,epileptic,I-Drug
135494,9402,medications,I-Drug
135495,9402,",",O
135496,9402,rifampin,B-Drug
135497,9402,",",O
135498,9402,rifabutin,B-Drug
135499,9402,",",O
135500,9402,fosamprenavir,B-Drug
135501,9402,",",O
135502,9402,etc,O
135503,9403,Medical,B-Condition
135504,9403,condition,I-Condition
135505,9403,with,O
135506,9403,safety,O
135507,9403,deemed,O
135508,9403,to,O
135509,9403,be,O
135510,9403,category,O
135511,9403,3,O
135512,9403,or,O
135513,9403,4,O
135514,9403,when,O
135515,9403,using,O
135516,9403,a,O
135517,9403,combined,B-Drug
135518,9403,hormonal,I-Drug
135519,9403,contraceptive,I-Drug
135520,9403,",",O
135521,9403,as,O
135522,9403,determined,O
135523,9403,by,O
135524,9403,the,O
135525,9403,Center,O
135526,9403,for,O
135527,9403,Disease,O
135528,9403,Control,O
135529,9403,Medical,O
135530,9403,Eligibility,O
135531,9403,Criteria,O
135532,9403,:,O
135533,9403,current,O
135534,9403,or,O
135535,9403,past,O
135536,9403,history,B-Observation
135537,9403,of,O
135538,9403,breast,B-Condition
135539,9403,cancer,I-Condition
135540,9403,",",O
135541,9403,severe,O
135542,9403,decompensated,O
135543,9403,cirrhosis,B-Condition
135544,9403,",",O
135545,9403,history,B-Observation
135546,9403,of,O
135547,9403,deep,B-Condition
135548,9403,vein,I-Condition
135549,9403,thrombosis,I-Condition
135550,9403,or,O
135551,9403,pulmonary,B-Condition
135552,9403,embolus,I-Condition
135553,9403,",",O
135554,9403,diabetes,B-Condition
135555,9403,with,O
135556,9403,nephropathy,B-Condition
135557,9403,/,O
135558,9403,retinopathy,B-Condition
135559,9403,/,O
135560,9403,neuropathy,B-Condition
135561,9403,or,O
135562,9403,other,O
135563,9403,vascular,B-Condition
135564,9403,disease,I-Condition
135565,9403,diagnosed,O
135566,9403,more,O
135567,9403,than,O
135568,9403,20,O
135569,9403,years,O
135570,9403,ago,O
135571,9403,",",O
135572,9403,current,O
135573,9403,symptomatic,O
135574,9403,gallbladder,B-Condition
135575,9403,disease,I-Condition
135576,9403,",",O
135577,9403,hypertension,B-Condition
135578,9403,",",O
135579,9403,ischemic,B-Condition
135580,9403,heart,I-Condition
135581,9403,disease,I-Condition
135582,9403,",",O
135583,9403,known,O
135584,9403,thrombogenic,B-Condition
135585,9403,mutations,I-Condition
135586,9403,",",O
135587,9403,hepatocellular,B-Condition
135588,9403,adenoma,I-Condition
135589,9403,",",O
135590,9403,malignant,B-Condition
135591,9403,hepatoma,I-Condition
135592,9403,",",O
135593,9403,multiple,O
135594,9403,risk,B-Mood
135595,9403,factors,I-Mood
135596,9403,for,O
135597,9403,atherosclerotic,B-Condition
135598,9403,cardiovascular,I-Condition
135599,9403,disease,I-Condition
135600,9403,",",O
135601,9403,multiple,B-Condition
135602,9403,sclerosis,I-Condition
135603,9403,with,O
135604,9403,prolonged,B-Condition
135605,9403,immobility,I-Condition
135606,9403,",",O
135607,9403,history,B-Observation
135608,9403,of,O
135609,9403,peripartum,B-Condition
135610,9403,cardiomyopathy,I-Condition
135611,9403,",",O
135612,9403,cigarette,B-Observation
135613,9403,smoking,I-Observation
135614,9403,and,O
135615,9403,=,O
135616,9403,35yo,O
135617,9403,",",O
135618,9403,history,B-Observation
135619,9403,of,O
135620,9403,complicated,B-Procedure
135621,9403,solid,I-Procedure
135622,9403,organ,I-Procedure
135623,9403,transplant,I-Procedure
135624,9403,",",O
135625,9403,history,B-Observation
135626,9403,of,O
135627,9403,stroke,B-Condition
135628,9403,",",O
135629,9403,history,B-Observation
135630,9403,of,O
135631,9403,superficial,B-Condition
135632,9403,venous,I-Condition
135633,9403,thrombosis,I-Condition
135634,9403,not,O
135635,9403,associated,O
135636,9403,with,O
135637,9403,catheter,O
135638,9403,",",O
135639,9403,systemic,B-Condition
135640,9403,lupus,I-Condition
135641,9403,erythematosus,I-Condition
135642,9403,with,O
135643,9403,positive,O
135644,9403,antiphospholipid,O
135645,9403,antibodies,O
135646,9403,",",O
135647,9403,valvular,B-Condition
135648,9403,heart,I-Condition
135649,9403,disease,I-Condition
135650,9403,complicated,O
135651,9403,by,O
135652,9403,pulmonary,B-Condition
135653,9403,hypertension,I-Condition
135654,9403,or,O
135655,9403,atrial,B-Condition
135656,9403,fibrillation,I-Condition
135657,9403,or,O
135658,9403,bacterial,B-Condition
135659,9403,endocarditis,I-Condition
135660,9403,",",O
135661,9403,and,O
135662,9403,acute,B-Condition
135663,9403,viral,I-Condition
135664,9403,hepatitis,I-Condition
135665,9404,Healthy,B-Condition
135666,9404,",",O
135667,9404,women,B-Person
135668,9404,ages,B-Person
135669,9404,18,O
135670,9404,to,O
135671,9404,39yo,O
135672,9404,with,O
135673,9404,BMI,O
135674,9404,<,O
135675,9404,30,O
135676,9405,Regular,B-Condition
135677,9405,menstrual,I-Condition
135678,9405,cycles,I-Condition
135679,9405,with,O
135680,9405,duration,O
135681,9405,between,O
135682,9405,24,O
135683,9405,-,O
135684,9405,35,O
135685,9405,days,O
135686,9406,Completion,O
135687,9406,of,O
135688,9406,screening,O
135689,9406,visit,O
135690,9406,where,O
135691,9406,ovulation,O
135692,9406,will,O
135693,9406,be,O
135694,9406,assessed,O
135695,9406,with,O
135696,9406,blood,O
135697,9406,draw,O
135698,9406,for,O
135699,9406,progesterone,O
135700,9406,level,O
135701,9406,(,O
135702,9406,must,O
135703,9406,be,O
135704,9406,5ng,O
135705,9406,/,O
135706,9406,mL,O
135707,9406,or,O
135708,9406,greater,O
135709,9406,),O
135710,9407,Not,O
135711,9407,seeking,O
135712,9407,pregnancy,O
135713,9407,during,O
135714,9407,the,O
135715,9407,study,O
135716,9407,period,O
135717,9408,Use,O
135718,9408,of,O
135719,9408,a,O
135720,9408,non,B-Procedure
135721,9408,-,I-Procedure
135722,9408,hormonal,I-Procedure
135723,9408,form,I-Procedure
135724,9408,of,I-Procedure
135725,9408,contraception,I-Procedure
135726,9408,",",O
135727,9408,such,O
135728,9408,as,O
135729,9408,:,O
135730,9408,sterilization,B-Procedure
135731,9408,(,O
135732,9408,tubal,B-Procedure
135733,9408,ligation,I-Procedure
135734,9408,",",O
135735,9408,Essure,B-Procedure
135736,9408,),O
135737,9408,",",O
135738,9408,copper,B-Procedure
135739,9408,IUD,I-Procedure
135740,9408,(,O
135741,9408,intrauterine,B-Procedure
135742,9408,device,I-Procedure
135743,9408,),O
135744,9408,",",O
135745,9408,barrier,B-Procedure
135746,9408,methods,I-Procedure
135747,9408,or,O
135748,9408,abstinence,B-Observation
135749,9409,Must,O
135750,9409,speak,O
135751,9409,English,O
135752,9409,or,O
135753,9409,Spanish,O
135754,9410,History,O
135755,9410,of,O
135756,9410,hypersensitivity,B-Condition
135757,9410,or,O
135758,9410,allergy,B-Condition
135759,9410,to,O
135760,9410,any,O
135761,9410,of,O
135762,9410,the,O
135763,9410,study,B-Drug
135764,9410,drugs,I-Drug
135765,9410,",",O
135766,9410,drugs,O
135767,9410,of,O
135768,9410,similar,O
135769,9410,chemical,O
135770,9410,classes,O
135771,9410,",",O
135772,9410,ACE,B-Drug
135773,9410,inhibitors,I-Drug
135774,9410,(,I-Drug
135775,9410,ACEIs,I-Drug
135776,9410,),I-Drug
135777,9410,",",O
135778,9410,angiotensin,B-Drug
135779,9410,II,I-Drug
135780,9410,receptor,I-Drug
135781,9410,blockers,I-Drug
135782,9410,(,I-Drug
135783,9410,ARBs,I-Drug
135784,9410,),I-Drug
135785,9410,",",O
135786,9410,or,O
135787,9410,neprilysin,B-Drug
135788,9410,inhibitors,I-Drug
135789,9410,",",O
135790,9410,as,O
135791,9410,well,O
135792,9410,as,O
135793,9410,known,B-Mood
135794,9410,or,O
135795,9410,suspected,B-Mood
135796,9410,contraindications,B-Condition
135797,9410,to,O
135798,9410,the,O
135799,9410,study,B-Drug
135800,9410,drugs,I-Drug
135801,9410,.,O
135802,9411,Previous,O
135803,9411,history,B-Observation
135804,9411,of,O
135805,9411,intolerance,B-Condition
135806,9411,to,O
135807,9411,recommended,O
135808,9411,target,O
135809,9411,doses,O
135810,9411,of,O
135811,9411,ACEIs,B-Drug
135812,9411,or,O
135813,9411,ARBs,B-Drug
135814,9411,.,O
135815,9412,Known,O
135816,9412,history,B-Observation
135817,9412,of,O
135818,9412,angioedema,B-Condition
135819,9412,.,O
135820,9413,Requirement,B-Mood
135821,9413,for,I-Mood
135822,9413,treatment,B-Procedure
135823,9413,with,O
135824,9413,both,O
135825,9413,ACEIs,B-Drug
135826,9413,and,O
135827,9413,ARBs,B-Drug
135828,9413,.,O
135829,9414,Current,O
135830,9414,acute,O
135831,9414,decompensated,O
135832,9414,heart,B-Condition
135833,9414,failure,I-Condition
135834,9414,(,O
135835,9414,exacerbation,B-Condition
135836,9414,of,O
135837,9414,chronic,B-Condition
135838,9414,heart,I-Condition
135839,9414,failure,I-Condition
135840,9414,manifested,O
135841,9414,by,O
135842,9414,signs,B-Condition
135843,9414,and,O
135844,9414,symptoms,B-Condition
135845,9414,that,O
135846,9414,may,O
135847,9414,require,O
135848,9414,intravenous,B-Procedure
135849,9414,therapy,I-Procedure
135850,9414,),O
135851,9414,.,O
135852,9415,Symptomatic,O
135853,9415,hypotension,B-Condition
135854,9415,.,O
135855,9416,Estimated,O
135856,9416,glomerular,O
135857,9416,filtration,O
135858,9416,rate,O
135859,9416,(,O
135860,9416,eGFR,O
135861,9416,),O
135862,9416,<,O
135863,9416,30,O
135864,9416,%,O
135865,9416,.,O
135866,9417,Serum,O
135867,9417,potassium,O
135868,9417,>,O
135869,9417,5.4,O
135870,9417,mmol,O
135871,9417,/,O
135872,9417,L.,O
135873,9418,Acute,B-Condition
135874,9418,coronary,I-Condition
135875,9418,syndrome,I-Condition
135876,9418,",",O
135877,9418,stroke,B-Condition
135878,9418,",",O
135879,9418,transient,B-Condition
135880,9418,ischaemic,I-Condition
135881,9418,attack,I-Condition
135882,9418,",",O
135883,9418,cardiac,B-Condition
135884,9418,",",O
135885,9418,carotid,B-Condition
135886,9418,",",O
135887,9418,or,O
135888,9418,other,O
135889,9418,major,B-Procedure
135890,9418,cardiovascular,I-Procedure
135891,9418,surgery,I-Procedure
135892,9418,",",O
135893,9418,percutaneous,B-Procedure
135894,9418,coronary,I-Procedure
135895,9418,intervention,I-Procedure
135896,9418,",",O
135897,9418,or,O
135898,9418,carotid,B-Procedure
135899,9418,angioplasty,I-Procedure
135900,9418,within,O
135901,9418,the,O
135902,9418,3,O
135903,9418,months,O
135904,9418,.,O
135905,9419,Coronary,B-Condition
135906,9419,or,I-Condition
135907,9419,carotid,I-Condition
135908,9419,artery,I-Condition
135909,9419,disease,I-Condition
135910,9419,likely,B-Mood
135911,9419,to,O
135912,9419,require,O
135913,9419,surgical,B-Procedure
135914,9419,or,I-Procedure
135915,9419,percutaneous,I-Procedure
135916,9419,intervention,I-Procedure
135917,9419,within,O
135918,9419,the,O
135919,9419,6,O
135920,9419,months,O
135921,9419,.,O
135922,9420,Implantation,B-Procedure
135923,9420,of,O
135924,9420,a,O
135925,9420,cardiac,O
135926,9420,resynchronization,O
135927,9420,therapy,O
135928,9420,(,O
135929,9420,CRT,O
135930,9420,),O
135931,9420,device,O
135932,9420,within,O
135933,9420,3,O
135934,9420,months,O
135935,9420,or,O
135936,9420,intent,B-Mood
135937,9420,to,O
135938,9420,implant,B-Procedure
135939,9420,a,O
135940,9420,CRT,O
135941,9420,.,O
135942,9421,History,B-Observation
135943,9421,of,O
135944,9421,heart,B-Procedure
135945,9421,transplant,I-Procedure
135946,9421,or,O
135947,9421,on,B-Observation
135948,9421,a,I-Observation
135949,9421,transplant,I-Observation
135950,9421,list,I-Observation
135951,9421,or,O
135952,9421,with,O
135953,9421,left,O
135954,9421,ventricular,O
135955,9421,(,O
135956,9421,LV,O
135957,9421,),O
135958,9421,assistance,O
135959,9421,device,O
135960,9421,.,O
135961,9422,History,B-Observation
135962,9422,of,O
135963,9422,severe,B-Condition
135964,9422,pulmonary,I-Condition
135965,9422,disease,I-Condition
135966,9422,.,O
135967,9423,Diagnosis,O
135968,9423,of,O
135969,9423,peripartum-,B-Condition
135970,9423,or,O
135971,9423,chemotherapy,B-Procedure
135972,9423,-,O
135973,9423,induced,O
135974,9423,cardiomyopathy,B-Condition
135975,9423,within,O
135976,9423,the,O
135977,9423,12,O
135978,9423,months,O
135979,9423,.,O
135980,9424,Documented,O
135981,9424,untreated,O
135982,9424,ventricular,B-Condition
135983,9424,arrhythmia,I-Condition
135984,9424,with,O
135985,9424,syncopal,B-Condition
135986,9424,episodes,I-Condition
135987,9424,within,O
135988,9424,the,O
135989,9424,3,O
135990,9424,months,O
135991,9424,.,O
135992,9425,Symptomatic,O
135993,9425,bradycardia,B-Condition
135994,9425,or,O
135995,9425,second-,O
135996,9425,or,O
135997,9425,third,O
135998,9425,-,O
135999,9425,degree,O
136000,9425,atrioventricular,B-Condition
136001,9425,block,I-Condition
136002,9425,without,O
136003,9425,a,O
136004,9425,pacemaker,O
136005,9425,.,O
136006,9426,Presence,O
136007,9426,of,O
136008,9426,haemodynamically,O
136009,9426,significant,O
136010,9426,mitral,B-Condition
136011,9426,and/or,I-Condition
136012,9426,aortic,I-Condition
136013,9426,valve,I-Condition
136014,9426,disease,I-Condition
136015,9426,",",O
136016,9426,except,O
136017,9426,mitral,B-Condition
136018,9426,regurgitation,I-Condition
136019,9426,secondary,O
136020,9426,to,O
136021,9426,LV,B-Condition
136022,9426,dilatation,I-Condition
136023,9426,.,O
136024,9427,Presence,O
136025,9427,of,O
136026,9427,other,O
136027,9427,haemodynamically,O
136028,9427,significant,O
136029,9427,obstructive,B-Condition
136030,9427,lesions,I-Condition
136031,9427,of,O
136032,9427,the,O
136033,9427,LV,O
136034,9427,outflow,O
136035,9427,tract,O
136036,9427,",",O
136037,9427,including,O
136038,9427,aortic,B-Condition
136039,9427,and,I-Condition
136040,9427,subaortic,I-Condition
136041,9427,stenosis,I-Condition
136042,9427,.,O
136043,9428,Any,O
136044,9428,surgical,B-Condition
136045,9428,or,I-Condition
136046,9428,medical,I-Condition
136047,9428,condition,I-Condition
136048,9428,which,O
136049,9428,might,O
136050,9428,significantly,O
136051,9428,alter,B-Condition
136052,9428,the,I-Condition
136053,9428,absorption,I-Condition
136054,9428,",",I-Condition
136055,9428,distribution,I-Condition
136056,9428,",",I-Condition
136057,9428,metabolism,I-Condition
136058,9428,",",I-Condition
136059,9428,or,I-Condition
136060,9428,excretion,I-Condition
136061,9428,of,O
136062,9428,study,B-Drug
136063,9428,drugs,I-Drug
136064,9428,",",O
136065,9428,including,O
136066,9428,",",O
136067,9428,but,O
136068,9428,not,O
136069,9428,limited,O
136070,9428,to,O
136071,9428,",",O
136072,9428,any,O
136073,9428,of,O
136074,9428,the,O
136075,9428,following,O
136076,9428,:,O
136077,9428,History,O
136078,9428,of,O
136079,9428,active,O
136080,9428,inflammatory,B-Condition
136081,9428,bowel,I-Condition
136082,9428,disease,I-Condition
136083,9428,during,O
136084,9428,the,O
136085,9428,12,O
136086,9428,months,O
136087,9428,.,O
136088,9428,Active,O
136089,9428,duodenal,B-Condition
136090,9428,or,I-Condition
136091,9428,gastric,I-Condition
136092,9428,ulcers,I-Condition
136093,9428,during,O
136094,9428,the,O
136095,9428,3,O
136096,9428,months,O
136097,9428,.,O
136098,9428,Evidence,B-Mood
136099,9428,of,O
136100,9428,hepatic,B-Condition
136101,9428,disease,I-Condition
136102,9428,as,O
136103,9428,determined,O
136104,9428,by,O
136105,9428,any,O
136106,9428,one,O
136107,9428,of,O
136108,9428,the,O
136109,9428,following,O
136110,9428,:,O
136111,9428,aspartate,O
136112,9428,aminotransferase,O
136113,9428,or,O
136114,9428,alanine,O
136115,9428,aminotransferase,O
136116,9428,values,O
136117,9428,exceeding,O
136118,9428,2x,O
136119,9428,upper,O
136120,9428,limit,O
136121,9428,of,O
136122,9428,normal,O
136123,9428,",",O
136124,9428,history,B-Observation
136125,9428,of,O
136126,9428,hepatic,B-Condition
136127,9428,encephalopathy,I-Condition
136128,9428,",",O
136129,9428,history,B-Observation
136130,9428,of,O
136131,9428,oesophageal,B-Condition
136132,9428,varices,I-Condition
136133,9428,",",O
136134,9428,or,O
136135,9428,history,B-Observation
136136,9428,of,O
136137,9428,porto,B-Condition
136138,9428,-,I-Condition
136139,9428,caval,I-Condition
136140,9428,shunt,I-Condition
136141,9428,.,O
136142,9428,Current,O
136143,9428,treatment,B-Procedure
136144,9428,with,O
136145,9428,cholestyramine,B-Drug
136146,9428,or,I-Drug
136147,9428,colestipol,I-Drug
136148,9428,resins,I-Drug
136149,9428,.,O
136150,9429,Presence,O
136151,9429,of,O
136152,9429,any,O
136153,9429,other,O
136154,9429,disease,B-Condition
136155,9429,with,O
136156,9429,a,O
136157,9429,life,B-Observation
136158,9429,expectancy,I-Observation
136159,9429,of,O
136160,9429,<,O
136161,9429,5,O
136162,9429,years,O
136163,9429,.,O
136164,9430,Symptomatic,B-Condition
136165,9430,patients,O
136166,9430,with,O
136167,9430,heart,B-Condition
136168,9430,failure,I-Condition
136169,9430,(,O
136170,9430,men,B-Person
136171,9430,and,O
136172,9430,women,B-Person
136173,9430,),O
136174,9430,aged,B-Person
136175,9430,>,O
136176,9430,18,O
136177,9430,years,O
136178,9430,",",O
136179,9431,Functional,O
136180,9431,class,O
136181,9431,II,O
136182,9431,",",O
136183,9431,III,O
136184,9431,or,O
136185,9431,IV,O
136186,9431,by,O
136187,9431,the,O
136188,9431,New,O
136189,9431,York,O
136190,9431,Heart,O
136191,9431,Association,O
136192,9431,(,O
136193,9431,NYHA,O
136194,9431,),O
136195,9432,Left,O
136196,9432,ventricular,O
136197,9432,ejection,O
136198,9432,fraction,O
136199,9432,<,O
136200,9432,35,O
136201,9432,%,O
136202,9433,Ischemic,B-Condition
136203,9433,and,I-Condition
136204,9433,nonischemic,I-Condition
136205,9433,etiology,I-Condition
136206,9434,Type,O
136207,9434,B,O
136208,9434,natriuretic,O
136209,9434,peptide,O
136210,9434,(,O
136211,9434,BNP,O
136212,9434,),O
136213,9434,>,O
136214,9434,150,O
136215,9434,pg,O
136216,9434,/,O
136217,9434,ml,O
136218,9434,(,O
136219,9434,or,O
136220,9434,pro,O
136221,9434,-,O
136222,9434,BNP,O
136223,9434,[,O
136224,9434,N,O
136225,9434,-,O
136226,9434,terminal,O
136227,9434,-,O
136228,9434,proBNP,O
136229,9434,],O
136230,9434,=,O
136231,9434,600,O
136232,9434,pg,O
136233,9434,/,O
136234,9434,ml,O
136235,9434,),O
136236,9434,or,O
136237,9434,if,O
136238,9434,the,O
136239,9434,patient,O
136240,9434,was,O
136241,9434,hospitalized,B-Procedure
136242,9434,for,O
136243,9434,cardiac,B-Condition
136244,9434,decompensation,I-Condition
136245,9434,within,O
136246,9434,the,O
136247,9434,preceding,O
136248,9434,12,O
136249,9434,months,O
136250,9434,",",O
136251,9434,BNP,O
136252,9434,>,O
136253,9434,100,O
136254,9434,pg,O
136255,9434,/,O
136256,9434,ml,O
136257,9434,(,O
136258,9434,or,O
136259,9434,N,O
136260,9434,-,O
136261,9434,terminal,O
136262,9434,-,O
136263,9434,proBNP,O
136264,9434,=,O
136265,9434,400,O
136266,9434,pg,O
136267,9434,/,O
136268,9434,ml,O
136269,9434,),O
136270,9435,1,O
136271,9435,.,O
136272,9435,bilateral,B-Condition
136273,9435,AT,I-Condition
136274,9436,2,O
136275,9436,.,O
136276,9436,insertional,B-Condition
136277,9436,AT,I-Condition
136278,9437,3,O
136279,9437,.,O
136280,9437,local,B-Procedure
136281,9437,steroid,I-Procedure
136282,9437,injection,I-Procedure
136283,9437,within,O
136284,9437,6,O
136285,9437,weeks,O
136286,9437,or,O
136287,9437,physical,B-Procedure
136288,9437,therapy,I-Procedure
136289,9437,within,O
136290,9437,4,O
136291,9437,weeks,O
136292,9438,4,O
136293,9438,.,O
136294,9438,inability,O
136295,9438,to,O
136296,9438,comply,O
136297,9438,with,O
136298,9438,follow,O
136299,9438,-,O
136300,9438,up,O
136301,9438,criteria,O
136302,9439,5,O
136303,9439,.,O
136304,9439,history,B-Observation
136305,9439,of,O
136306,9439,surgery,B-Procedure
136307,9439,on,I-Procedure
136308,9439,the,I-Procedure
136309,9439,Achilles,I-Procedure
136310,9439,tendon,I-Procedure
136311,9439,or,O
136312,9439,systemic,B-Condition
136313,9439,diseases,I-Condition
136314,9439,(,O
136315,9439,general,B-Condition
136316,9439,inflammatory,I-Condition
136317,9439,diseases,I-Condition
136318,9439,such,O
136319,9439,as,O
136320,9439,rheumatologic,B-Condition
136321,9439,disorders,I-Condition
136322,9439,and,O
136323,9439,diabetes,B-Condition
136324,9439,),O
136325,9440,6,O
136326,9440,.,O
136327,9440,daily,O
136328,9440,use,O
136329,9440,of,O
136330,9440,opioids,B-Drug
136331,9440,for,O
136332,9440,pain,B-Condition
136333,9441,7,O
136334,9441,.,O
136335,9441,anticoagulation,B-Procedure
136336,9441,or,I-Procedure
136337,9441,immunosuppressive,I-Procedure
136338,9441,therapy,I-Procedure
136339,9442,8,O
136340,9442,.,O
136341,9442,intent,O
136342,9442,to,O
136343,9442,use,O
136344,9442,NSAIDs,B-Drug
136345,9442,or,O
136346,9442,steroids,B-Drug
136347,9443,9,O
136348,9443,.,O
136349,9443,self,O
136350,9443,-,O
136351,9443,reported,O
136352,9443,pregnancy,B-Condition
136353,9444,1,O
136354,9444,.,O
136355,9444,age,B-Person
136356,9444,18,O
136357,9444,-,O
136358,9444,65,O
136359,9444,years,O
136360,9444,",",O
136361,9444,inclusive,O
136362,9445,2,O
136363,9445,.,O
136364,9445,diagnosis,O
136365,9445,of,O
136366,9445,moderate,O
136367,9445,to,O
136368,9445,severe,O
136369,9445,AT,B-Condition
136370,9445,",",O
136371,9445,confirmed,O
136372,9445,by,O
136373,9445,Dr.,O
136374,9445,Wilson,O
136375,9445,using,O
136376,9445,clinical,O
136377,9445,symptoms,O
136378,9445,and,O
136379,9445,exam,O
136380,9445,findings,O
136381,9445,consistent,O
136382,9445,with,O
136383,9445,chronic,B-Condition
136384,9445,AT,I-Condition
136385,9445,(,O
136386,9445,>,O
136387,9445,6,O
136388,9445,month,O
136389,9445,duration,O
136390,9445,),O
136391,9445,-,O
136392,9445,which,O
136393,9445,includes,O
136394,9445,pain,B-Condition
136395,9445,while,I-Condition
136396,9445,palpating,I-Condition
136397,9445,the,I-Condition
136398,9445,intratendinous,I-Condition
136399,9445,swelling,I-Condition
136400,9445,part,I-Condition
136401,9445,of,I-Condition
136402,9445,the,I-Condition
136403,9445,Achilles,I-Condition
136404,9445,tendon,I-Condition
136405,9445,and,O
136406,9445,relief,B-Condition
136407,9445,of,I-Condition
136408,9445,pain,I-Condition
136409,9445,when,I-Condition
136410,9445,tendon,I-Condition
136411,9445,placed,I-Condition
136412,9445,under,I-Condition
136413,9445,tension,I-Condition
136414,9445,-,O
136415,9445,and,O
136416,9445,pre,O
136417,9445,-,O
136418,9445,procedure,O
136419,9445,US,O
136420,9446,3,O
136421,9446,.,O
136422,9446,self,B-Observation
136423,9446,-,I-Observation
136424,9446,reported,I-Observation
136425,9446,AT,B-Condition
136426,9446,-,I-Condition
136427,9446,related,I-Condition
136428,9446,pain,I-Condition
136429,9446,for,O
136430,9446,at,O
136431,9446,least,O
136432,9446,6,O
136433,9446,months,O
136434,9446,and,O
136435,9446,VAS,O
136436,9446,(,O
136437,9446,Visual,O
136438,9446,Analog,O
136439,9446,Scale,O
136440,9446,),O
136441,9446,pain,O
136442,9446,>,O
136443,9446,5,O
136444,9446,(,O
136445,9446,0,O
136446,9446,-,O
136447,9446,10,O
136448,9446,scale,O
136449,9446,),O
136450,9447,4,O
136451,9447,.,O
136452,9447,self,B-Observation
136453,9447,-,I-Observation
136454,9447,reported,I-Observation
136455,9447,failure,B-Condition
136456,9447,of,I-Condition
136457,9447,eccentric,I-Condition
136458,9447,exercise,I-Condition
136459,9447,protocol,I-Condition
136460,9447,(,O
136461,9447,at,O
136462,9447,least,O
136463,9447,75,O
136464,9447,%,O
136465,9447,completion,O
136466,9447,),O
136467,9448,5,O
136468,9448,.,O
136469,9448,self,B-Observation
136470,9448,-,I-Observation
136471,9448,reported,I-Observation
136472,9448,failure,B-Condition
136473,9448,of,I-Condition
136474,9448,at,I-Condition
136475,9448,least,I-Condition
136476,9448,2,I-Condition
136477,9448,of,I-Condition
136478,9448,the,I-Condition
136479,9448,3,I-Condition
136480,9448,most,I-Condition
136481,9448,common,I-Condition
136482,9448,treatments,I-Condition
136483,9448,for,I-Condition
136484,9448,AT,I-Condition
136485,9448,(,O
136486,9448,NSAIDS,B-Drug
136487,9448,",",O
136488,9448,rest,B-Procedure
136489,9448,/,O
136490,9448,ice,B-Drug
136491,9448,or,O
136492,9448,taping,B-Procedure
136493,9448,),O
136494,9449,6,O
136495,9449,.,O
136496,9449,patient,O
136497,9449,considered,O
136498,9449,surgery,B-Procedure
136499,9449,but,O
136500,9449,decided,O
136501,9449,to,O
136502,9449,wait,O
136503,9449,and/or,O
136504,9449,refused,O
136505,9449,surgery,O
136506,9449,-,O
136507,9450,1,O
136508,9450,.,O
136509,9450,Institutionalized,O
136510,9450,subjects,O
136511,9450,will,O
136512,9450,not,O
136513,9450,be,O
136514,9450,used,O
136515,9450,.,O
136516,9450,2,O
136517,9450,Social,O
136518,9450,Habits,O
136519,9450,:,O
136520,9451,1,O
136521,9451,.,O
136522,9451,Use,O
136523,9451,of,O
136524,9451,any,O
136525,9451,tobacco,B-Drug
136526,9451,products,I-Drug
136527,9451,.,O
136528,9452,2,O
136529,9452,.,O
136530,9452,Ingestion,O
136531,9452,of,O
136532,9452,any,O
136533,9452,alcoholic,O
136534,9452,",",O
136535,9452,caffeine-,O
136536,9452,or,O
136537,9452,xanthine,O
136538,9452,-,O
136539,9452,containing,O
136540,9452,food,O
136541,9452,or,O
136542,9452,beverage,O
136543,9452,within,O
136544,9452,the,O
136545,9452,48,O
136546,9452,hours,O
136547,9452,prior,O
136548,9452,to,O
136549,9452,the,O
136550,9452,initial,O
136551,9452,dose,O
136552,9452,of,O
136553,9452,study,O
136554,9452,medication,O
136555,9452,.,O
136556,9453,3,O
136557,9453,.,O
136558,9453,Ingestion,O
136559,9453,of,O
136560,9453,any,O
136561,9453,vitamins,O
136562,9453,or,O
136563,9453,herbal,O
136564,9453,products,O
136565,9453,within,O
136566,9453,the,O
136567,9453,48,O
136568,9453,hours,O
136569,9453,prior,O
136570,9453,to,O
136571,9453,the,O
136572,9453,initial,O
136573,9453,dose,O
136574,9453,of,O
136575,9453,the,O
136576,9453,study,O
136577,9453,medication,O
136578,9453,.,O
136579,9454,4,O
136580,9454,.,O
136581,9454,Any,O
136582,9454,recent,O
136583,9454,",",O
136584,9454,significant,O
136585,9454,change,O
136586,9454,in,O
136587,9454,dietary,O
136588,9454,or,O
136589,9454,exercise,O
136590,9454,habits,O
136591,9454,.,O
136592,9455,5,O
136593,9455,.,O
136594,9455,Positive,O
136595,9455,test,O
136596,9455,for,O
136597,9455,any,O
136598,9455,drug,O
136599,9455,included,O
136600,9455,in,O
136601,9455,the,O
136602,9455,urine,O
136603,9455,drug,O
136604,9455,screen,O
136605,9455,.,O
136606,9456,3,O
136607,9456,.,O
136608,9456,Medications,O
136609,9456,:,O
136610,9457,1,O
136611,9457,.,O
136612,9457,Use,O
136613,9457,of,O
136614,9457,any,O
136615,9457,medication,B-Drug
136616,9457,within,O
136617,9457,the,O
136618,9457,14,O
136619,9457,days,O
136620,9457,prior,O
136621,9457,to,O
136622,9457,the,O
136623,9457,initial,O
136624,9457,dose,O
136625,9457,of,O
136626,9457,study,O
136627,9457,medication,O
136628,9457,.,O
136629,9458,2,O
136630,9458,.,O
136631,9458,Use,O
136632,9458,of,O
136633,9458,any,O
136634,9458,medication,B-Drug
136635,9458,known,I-Drug
136636,9458,to,I-Drug
136637,9458,alter,I-Drug
136638,9458,hepatic,I-Drug
136639,9458,enzyme,I-Drug
136640,9458,activity,I-Drug
136641,9458,within,O
136642,9458,28,O
136643,9458,days,O
136644,9458,prior,O
136645,9458,to,O
136646,9458,the,O
136647,9458,initial,O
136648,9458,dose,O
136649,9458,of,O
136650,9458,study,O
136651,9458,medication,O
136652,9458,.,O
136653,9459,3,O
136654,9459,.,O
136655,9459,Use,O
136656,9459,of,O
136657,9459,hormonal,B-Drug
136658,9459,contraceptives,I-Drug
136659,9459,and,O
136660,9459,hormonal,B-Drug
136661,9459,replacement,I-Drug
136662,9459,therapy,I-Drug
136663,9459,within,O
136664,9459,three,O
136665,9459,months,O
136666,9459,prior,O
136667,9459,to,O
136668,9459,the,O
136669,9459,initial,O
136670,9459,dose,O
136671,9459,of,O
136672,9459,study,O
136673,9459,medication,O
136674,9459,.,O
136675,9460,4,O
136676,9460,.,O
136677,9460,Diseases,O
136678,9460,:,O
136679,9461,a.,O
136680,9461,History,B-Observation
136681,9461,of,O
136682,9461,any,O
136683,9461,significant,O
136684,9461,chronic,B-Condition
136685,9461,disease,I-Condition
136686,9461,and/or,O
136687,9461,hepatitis,B-Condition
136688,9461,.,O
136689,9461,b.,O
136690,9461,History,B-Observation
136691,9461,of,O
136692,9461,drug,B-Condition
136693,9461,and/or,I-Condition
136694,9461,alcohol,I-Condition
136695,9461,abuse,I-Condition
136696,9461,.,O
136697,9461,c.,O
136698,9461,Acute,O
136699,9461,illness,O
136700,9461,at,O
136701,9461,the,O
136702,9461,time,O
136703,9461,of,O
136704,9461,either,O
136705,9461,the,O
136706,9461,prestudy,O
136707,9461,medical,O
136708,9461,evaluation,O
136709,9461,or,O
136710,9461,dosing,O
136711,9461,.,O
136712,9462,d.,O
136713,9462,Positive,O
136714,9462,HIV,O
136715,9462,",",O
136716,9462,Hepatitis,O
136717,9462,B,O
136718,9462,",",O
136719,9462,or,O
136720,9462,Hepatitis,O
136721,9462,C,O
136722,9462,test,O
136723,9462,.,O
136724,9462,e.,O
136725,9462,Renal,B-Condition
136726,9462,disease,I-Condition
136727,9462,or,O
136728,9462,renal,B-Condition
136729,9462,dysfunction,I-Condition
136730,9462,(,O
136731,9462,as,O
136732,9462,suggested,O
136733,9462,by,O
136734,9462,serum,O
136735,9462,creatinine,O
136736,9462,levels,O
136737,9462,greater,O
136738,9462,than,O
136739,9462,or,O
136740,9462,equal,O
136741,9462,to,O
136742,9462,1.5,O
136743,9462,mg,O
136744,9462,/,O
136745,9462,dL,O
136746,9462,(,O
136747,9462,for,O
136748,9462,males,B-Person
136749,9462,),O
136750,9462,and,O
136751,9462,greater,O
136752,9462,than,O
136753,9462,or,O
136754,9462,equal,O
136755,9462,to,O
136756,9462,1.4,O
136757,9462,mg,O
136758,9462,/,O
136759,9462,dL,O
136760,9462,(,O
136761,9462,for,O
136762,9462,females,B-Person
136763,9462,),O
136764,9462,or,O
136765,9462,abnormal,B-Condition
136766,9462,creatinine,I-Condition
136767,9462,clearance,I-Condition
136768,9462,),O
136769,9462,.,O
136770,9463,5,O
136771,9463,.,O
136772,9463,Abnormal,O
136773,9463,and,O
136774,9463,clinically,O
136775,9463,significant,O
136776,9463,laboratory,O
136777,9463,test,O
136778,9463,results,O
136779,9463,:,O
136780,9464,1,O
136781,9464,.,O
136782,9464,Clinically,O
136783,9464,significant,O
136784,9464,deviation,O
136785,9464,from,O
136786,9464,the,O
136787,9464,Guide,O
136788,9464,for,O
136789,9464,Clinically,O
136790,9464,Relevant,O
136791,9464,Abnormalities,O
136792,9464,(,O
136793,9464,see,O
136794,9464,Part,O
136795,9464,II,O
136796,9464,ADMINISTRATIVE,O
136797,9464,ASPECTS,O
136798,9464,OF,O
136799,9464,BIOEQUIVALENCE,O
136800,9464,PROTOCOLS,O
136801,9464,),O
136802,9464,.,O
136803,9465,2,O
136804,9465,.,O
136805,9465,Abnormal,B-Condition
136806,9465,and,I-Condition
136807,9465,clinically,I-Condition
136808,9465,relevant,I-Condition
136809,9465,ECG,I-Condition
136810,9465,tracing,I-Condition
136811,9465,.,O
136812,9465,6,O
136813,9465,.,O
136814,9465,Donation,O
136815,9465,or,O
136816,9465,loss,O
136817,9465,of,O
136818,9465,a,O
136819,9465,significant,O
136820,9465,volume,O
136821,9465,of,O
136822,9465,blood,O
136823,9465,or,O
136824,9465,plasma,O
136825,9465,(,O
136826,9465,>,O
136827,9465,450,O
136828,9465,mL,O
136829,9465,),O
136830,9465,within,O
136831,9465,28,O
136832,9465,days,O
136833,9465,prior,O
136834,9465,to,O
136835,9465,the,O
136836,9465,initial,O
136837,9465,dose,O
136838,9465,of,O
136839,9465,study,O
136840,9465,medication,O
136841,9465,.,O
136842,9466,7,O
136843,9466,.,O
136844,9466,Subjects,O
136845,9466,who,O
136846,9466,have,O
136847,9466,received,O
136848,9466,an,O
136849,9466,investigational,O
136850,9466,drug,O
136851,9466,within,O
136852,9466,30,O
136853,9466,days,O
136854,9466,prior,O
136855,9466,to,O
136856,9466,the,O
136857,9466,initial,O
136858,9466,dose,O
136859,9466,of,O
136860,9466,study,O
136861,9466,medication,O
136862,9466,.,O
136863,9467,8,O
136864,9467,.,O
136865,9467,Allergy,B-Condition
136866,9467,or,O
136867,9467,hypersensitivity,B-Condition
136868,9467,to,O
136869,9467,metformin,B-Drug
136870,9467,hydrochloride,I-Drug
136871,9467,.,O
136872,9467,9,O
136873,9467,.,O
136874,9467,History,B-Observation
136875,9467,of,O
136876,9467,difficulty,B-Condition
136877,9467,in,I-Condition
136878,9467,swallowing,I-Condition
136879,9467,medication,I-Condition
136880,9467,",",O
136881,9467,or,O
136882,9467,any,O
136883,9467,gastrointestinal,B-Condition
136884,9467,disorder,I-Condition
136885,9467,which,O
136886,9467,could,O
136887,9467,affect,O
136888,9467,the,O
136889,9467,drug,O
136890,9467,absorption,O
136891,9467,.,O
136892,9468,1,O
136893,9468,.,O
136894,9468,Age,B-Person
136895,9468,:,O
136896,9468,18,O
136897,9468,years,O
136898,9468,and,O
136899,9468,older,O
136900,9468,.,O
136901,9469,2,O
136902,9469,.,O
136903,9469,Sex,O
136904,9469,:,O
136905,9469,Male,B-Person
136906,9469,and,O
136907,9469,non,O
136908,9469,-,O
136909,9469,pregnant,B-Condition
136910,9469,",",O
136911,9469,non,O
136912,9469,-,O
136913,9469,lactating,B-Condition
136914,9469,female,B-Person
136915,9470,1,O
136916,9470,.,O
136917,9470,Women,B-Person
136918,9470,of,O
136919,9470,childbearing,B-Condition
136920,9470,potential,I-Condition
136921,9470,must,O
136922,9470,have,O
136923,9470,negative,O
136924,9470,serum,B-Procedure
136925,9470,(,I-Procedure
136926,9470,Beta,I-Procedure
136927,9470,HCG,I-Procedure
136928,9470,),I-Procedure
136929,9470,pregnancy,I-Procedure
136930,9470,tests,I-Procedure
136931,9470,performed,O
136932,9470,within,O
136933,9470,14,O
136934,9470,days,O
136935,9470,prior,O
136936,9470,to,O
136937,9470,the,O
136938,9470,start,O
136939,9470,of,O
136940,9470,the,O
136941,9470,study,O
136942,9470,and,O
136943,9470,on,O
136944,9470,the,O
136945,9470,evening,O
136946,9470,prior,O
136947,9470,to,O
136948,9470,each,O
136949,9470,dose,O
136950,9470,administration,O
136951,9470,.,O
136952,9470,If,O
136953,9470,dosing,O
136954,9470,is,O
136955,9470,scheduled,O
136956,9470,on,O
136957,9470,Sunday,O
136958,9470,or,O
136959,9470,Monday,O
136960,9470,",",O
136961,9470,the,O
136962,9470,HCG,O
136963,9470,pregnancy,O
136964,9470,test,O
136965,9470,should,O
136966,9470,be,O
136967,9470,given,O
136968,9470,within,O
136969,9470,48,O
136970,9470,hours,O
136971,9470,prior,O
136972,9470,to,O
136973,9470,dosing,O
136974,9470,of,O
136975,9470,each,O
136976,9470,study,O
136977,9470,period,O
136978,9470,.,O
136979,9470,An,O
136980,9470,additional,O
136981,9470,serum,O
136982,9470,(,O
136983,9470,Beta,O
136984,9470,HCG,O
136985,9470,),O
136986,9470,pregnancy,O
136987,9470,test,O
136988,9470,will,O
136989,9470,be,O
136990,9470,performed,O
136991,9470,upon,O
136992,9470,completion,O
136993,9470,of,O
136994,9470,the,O
136995,9470,study,O
136996,9470,.,O
136997,9471,2,O
136998,9471,.,O
136999,9471,Women,B-Person
137000,9471,of,O
137001,9471,childbearing,B-Condition
137002,9471,potential,I-Condition
137003,9471,must,O
137004,9471,practice,O
137005,9471,abstinence,B-Procedure
137006,9471,or,O
137007,9471,be,O
137008,9471,using,O
137009,9471,an,O
137010,9471,acceptable,O
137011,9471,form,O
137012,9471,of,O
137013,9471,contraception,B-Procedure
137014,9471,throughout,O
137015,9471,the,O
137016,9471,duration,O
137017,9471,of,O
137018,9471,the,O
137019,9471,study,O
137020,9471,.,O
137021,9471,Acceptable,O
137022,9471,forms,O
137023,9471,of,O
137024,9471,contraception,O
137025,9471,include,O
137026,9471,the,O
137027,9471,following,O
137028,9471,:,O
137029,9472,(,O
137030,9472,1,O
137031,9472,),O
137032,9472,intrauterine,O
137033,9472,device,O
137034,9472,in,O
137035,9472,place,O
137036,9472,for,O
137037,9472,at,O
137038,9472,least,O
137039,9472,3,O
137040,9472,months,O
137041,9472,prior,O
137042,9472,to,O
137043,9472,the,O
137044,9472,start,O
137045,9472,of,O
137046,9472,the,O
137047,9472,study,O
137048,9472,and,O
137049,9472,remaining,O
137050,9472,in,O
137051,9472,place,O
137052,9472,during,O
137053,9472,the,O
137054,9472,study,O
137055,9472,period,O
137056,9472,",",O
137057,9472,or,O
137058,9472,(,O
137059,9472,2,O
137060,9472,),O
137061,9472,barrier,B-Procedure
137062,9472,methods,I-Procedure
137063,9472,containing,O
137064,9472,or,O
137065,9472,used,O
137066,9472,in,O
137067,9472,conjunction,O
137068,9472,with,O
137069,9472,a,O
137070,9472,spermicidal,B-Drug
137071,9472,agent,I-Drug
137072,9472,",",O
137073,9472,or,O
137074,9472,(,O
137075,9472,3,O
137076,9472,),O
137077,9472,postmenopausal,B-Condition
137078,9472,accompanied,O
137079,9472,with,O
137080,9472,a,O
137081,9472,documented,O
137082,9472,postmenopausal,O
137083,9472,course,O
137084,9472,of,O
137085,9472,at,O
137086,9472,least,O
137087,9472,one,O
137088,9472,year,O
137089,9472,or,O
137090,9472,surgical,B-Condition
137091,9472,sterility,I-Condition
137092,9472,(,O
137093,9472,tubal,B-Procedure
137094,9472,ligation,I-Procedure
137095,9472,",",O
137096,9472,oophorectomy,B-Procedure
137097,9472,or,O
137098,9472,hysterectomy,B-Procedure
137099,9472,),O
137100,9472,.,O
137101,9473,3,O
137102,9473,.,O
137103,9473,During,O
137104,9473,the,O
137105,9473,course,O
137106,9473,of,O
137107,9473,the,O
137108,9473,study,O
137109,9473,",",O
137110,9473,from,O
137111,9473,study,O
137112,9473,screen,O
137113,9473,until,O
137114,9473,study,O
137115,9473,exit,O
137116,9473,-,O
137117,9473,including,O
137118,9473,the,O
137119,9473,washout,O
137120,9473,period,O
137121,9473,",",O
137122,9473,women,B-Person
137123,9473,of,O
137124,9473,childbearing,B-Condition
137125,9473,potential,I-Condition
137126,9473,must,O
137127,9473,use,O
137128,9473,a,O
137129,9473,spermicide,B-Procedure
137130,9473,containing,I-Procedure
137131,9473,barrier,I-Procedure
137132,9473,method,I-Procedure
137133,9473,of,I-Procedure
137134,9473,contraception,I-Procedure
137135,9473,in,O
137136,9473,addition,O
137137,9473,to,O
137138,9473,their,O
137139,9473,current,O
137140,9473,contraceptive,O
137141,9473,device,O
137142,9473,.,O
137143,9473,This,O
137144,9473,advice,O
137145,9473,should,O
137146,9473,be,O
137147,9473,documented,O
137148,9473,in,O
137149,9473,the,O
137150,9473,informed,O
137151,9473,consent,O
137152,9473,form,O
137153,9473,.,O
137154,9474,3,O
137155,9474,.,O
137156,9474,Weight,O
137157,9474,:,O
137158,9474,At,O
137159,9474,least,O
137160,9474,60,O
137161,9474,kg,O
137162,9474,(,O
137163,9474,132,O
137164,9474,lbs,O
137165,9474,),O
137166,9474,for,O
137167,9474,man,B-Person
137168,9474,and,O
137169,9474,48,O
137170,9474,kg,O
137171,9474,(,O
137172,9474,106,O
137173,9474,lbs,O
137174,9474,),O
137175,9474,for,O
137176,9474,women,B-Person
137177,9474,and,O
137178,9474,within,O
137179,9474,15,O
137180,9474,%,O
137181,9474,of,O
137182,9474,Ideal,O
137183,9474,Body,O
137184,9474,Weight,O
137185,9474,(,O
137186,9474,IBW,O
137187,9474,),O
137188,9474,",",O
137189,9474,as,O
137190,9474,referenced,O
137191,9474,by,O
137192,9474,the,O
137193,9474,Table,O
137194,9474,of,O
137195,9474,"""",O
137196,9474,"""",O
137197,9474,Desirable,O
137198,9474,Weights,O
137199,9474,of,O
137200,9474,Adults,O
137201,9474,"""",O
137202,9474,"""",O
137203,9474,Metropolitan,O
137204,9474,Life,O
137205,9474,Insurance,O
137206,9474,Company,O
137207,9474,",",O
137208,9474,1999,O
137209,9474,(,O
137210,9474,See,O
137211,9474,Part,O
137212,9474,II,O
137213,9474,ADMINISTRATIVE,O
137214,9474,ASPECTS,O
137215,9474,OF,O
137216,9474,BIOEQUIVALENCE,O
137217,9474,PROTOCOLS,O
137218,9474,),O
137219,9474,.,O
137220,9475,4,O
137221,9475,.,O
137222,9475,All,O
137223,9475,subjects,O
137224,9475,should,O
137225,9475,be,O
137226,9475,judged,O
137227,9475,normal,B-Condition
137228,9475,and,O
137229,9475,healthy,B-Condition
137230,9475,during,O
137231,9475,a,O
137232,9475,pre,B-Procedure
137233,9475,-,I-Procedure
137234,9475,study,I-Procedure
137235,9475,medical,I-Procedure
137236,9475,evaluation,I-Procedure
137237,9475,(,O
137238,9475,physical,B-Procedure
137239,9475,examination,I-Procedure
137240,9475,",",O
137241,9475,laboratory,B-Procedure
137242,9475,evaluation,I-Procedure
137243,9475,",",O
137244,9475,12,B-Procedure
137245,9475,-,I-Procedure
137246,9475,lead,I-Procedure
137247,9475,ECG,I-Procedure
137248,9475,",",O
137249,9475,hepatitis,B-Procedure
137250,9475,B,I-Procedure
137251,9475,and,I-Procedure
137252,9475,hepatitis,I-Procedure
137253,9475,C,I-Procedure
137254,9475,tests,I-Procedure
137255,9475,",",O
137256,9475,HIV,B-Procedure
137257,9475,test,I-Procedure
137258,9475,",",O
137259,9475,and,O
137260,9475,urine,B-Procedure
137261,9475,drug,I-Procedure
137262,9475,screen,I-Procedure
137263,9475,including,O
137264,9475,amphetamine,O
137265,9475,",",O
137266,9475,barbiturates,O
137267,9475,",",O
137268,9475,benzodiazepine,O
137269,9475,",",O
137270,9475,cannabinoid,O
137271,9475,",",O
137272,9475,cocaine,O
137273,9475,",",O
137274,9475,opiates,O
137275,9475,",",O
137276,9475,phencyclidine,O
137277,9475,",",O
137278,9475,and,O
137279,9475,methadone,O
137280,9475,),O
137281,9475,performed,O
137282,9475,within,O
137283,9475,14,O
137284,9475,days,O
137285,9475,of,O
137286,9475,the,O
137287,9475,initial,O
137288,9475,dose,O
137289,9475,of,O
137290,9475,study,O
137291,9475,medication,O
137292,9475,.,O
137293,9476,Partial,B-Condition
137294,9476,mole,I-Condition
137295,9477,History,O
137296,9477,of,O
137297,9477,treatment,B-Procedure
137298,9477,for,O
137299,9477,molar,B-Condition
137300,9477,pregnancy,I-Condition
137301,9477,like,O
137302,9477,prior,O
137303,9477,evacuation,B-Procedure
137304,9477,or,O
137305,9477,chemotherapy,B-Procedure
137306,9478,Women,B-Person
137307,9478,requiring,O
137308,9478,hysterectomy,B-Procedure
137309,9478,for,O
137310,9478,treatment,O
137311,9478,of,O
137312,9478,H,B-Condition
137313,9478,Mole,I-Condition
137314,9479,Ultrasound,B-Procedure
137315,9479,confirmed,O
137316,9479,complete,B-Condition
137317,9479,mole,I-Condition
137318,9480,Unable,O
137319,9480,or,O
137320,9480,unwilling,O
137321,9480,to,O
137322,9480,provide,O
137323,9480,informed,O
137324,9480,consent,O
137325,9480,.,O
137326,9481,Active,O
137327,9481,ischemia,B-Condition
137328,9481,(,O
137329,9481,acute,B-Condition
137330,9481,thrombus,I-Condition
137331,9481,diagnosed,O
137332,9481,by,O
137333,9481,coronary,B-Procedure
137334,9481,angiography,I-Procedure
137335,9481,",",O
137336,9481,or,O
137337,9481,dynamic,O
137338,9481,ST,B-Condition
137339,9481,segment,I-Condition
137340,9481,changes,I-Condition
137341,9481,demonstrated,O
137342,9481,on,O
137343,9481,ECG,B-Procedure
137344,9481,),O
137345,9481,or,O
137346,9481,another,O
137347,9481,reversible,O
137348,9481,cause,O
137349,9481,of,O
137350,9481,VT,B-Condition
137351,9481,(,O
137352,9481,e.g.,O
137353,9481,drug,B-Condition
137354,9481,-,I-Condition
137355,9481,induced,I-Condition
137356,9481,arrhythmia,I-Condition
137357,9481,),O
137358,9481,",",O
137359,9481,had,O
137360,9481,recent,O
137361,9481,acute,B-Condition
137362,9481,coronary,I-Condition
137363,9481,syndrome,I-Condition
137364,9481,within,O
137365,9481,30,O
137366,9481,days,O
137367,9481,",",O
137368,9481,coronary,B-Procedure
137369,9481,revascularization,I-Procedure
137370,9481,(,O
137371,9481,<,O
137372,9481,90,O
137373,9481,days,O
137374,9481,bypass,B-Procedure
137375,9481,surgery,I-Procedure
137376,9481,",",O
137377,9481,<,O
137378,9481,30,O
137379,9481,days,O
137380,9481,percutaneous,B-Procedure
137381,9481,coronary,I-Procedure
137382,9481,intervention,I-Procedure
137383,9481,),O
137384,9481,",",O
137385,9481,or,O
137386,9481,have,O
137387,9481,CCS,O
137388,9481,functional,O
137389,9481,class,O
137390,9481,IV,O
137391,9481,angina,B-Condition
137392,9481,.,O
137393,9481,Note,O
137394,9481,that,O
137395,9481,biomarker,O
137396,9481,level,O
137397,9481,elevation,O
137398,9481,alone,O
137399,9481,after,O
137400,9481,ventricular,O
137401,9481,arrhythmias,O
137402,9481,does,O
137403,9481,not,O
137404,9481,denote,O
137405,9481,acute,O
137406,9481,coronary,O
137407,9481,syndrome,O
137408,9481,or,O
137409,9481,active,O
137410,9481,ischemia,O
137411,9481,.,O
137412,9482,Are,O
137413,9482,ineligible,O
137414,9482,to,O
137415,9482,take,O
137416,9482,the,O
137417,9482,antiarrhythmic,B-Drug
137418,9482,drug,I-Drug
137419,9482,to,O
137420,9482,which,O
137421,9482,they,O
137422,9482,would,O
137423,9482,be,O
137424,9482,assigned,O
137425,9482,due,O
137426,9482,to,O
137427,9482,allergy,B-Condition
137428,9482,",",O
137429,9482,intolerance,B-Condition
137430,9482,or,O
137431,9482,contraindication,B-Condition
137432,9483,Are,O
137433,9483,known,O
137434,9483,to,O
137435,9483,have,O
137436,9483,protruding,O
137437,9483,left,B-Condition
137438,9483,ventricular,I-Condition
137439,9483,thrombus,I-Condition
137440,9483,or,O
137441,9483,mechanical,O
137442,9483,aortic,O
137443,9483,and,O
137444,9483,mitral,O
137445,9483,valves,O
137446,9484,Have,O
137447,9484,had,O
137448,9484,a,O
137449,9484,prior,O
137450,9484,catheter,B-Procedure
137451,9484,ablation,I-Procedure
137452,9484,procedure,I-Procedure
137453,9484,for,O
137454,9484,VT,B-Condition
137455,9485,Are,O
137456,9485,in,O
137457,9485,renal,B-Condition
137458,9485,failure,I-Condition
137459,9485,(,O
137460,9485,Creatinine,O
137461,9485,clearance,O
137462,9485,<,O
137463,9485,15,O
137464,9485,mL,O
137465,9485,/,O
137466,9485,min,O
137467,9485,),O
137468,9485,",",O
137469,9485,have,O
137470,9485,NYHA,O
137471,9485,Functional,O
137472,9485,class,O
137473,9485,IV,O
137474,9485,heart,B-Condition
137475,9485,failure,I-Condition
137476,9485,",",O
137477,9485,or,O
137478,9485,a,O
137479,9485,systemic,B-Condition
137480,9485,illness,I-Condition
137481,9485,likely,O
137482,9485,to,O
137483,9485,limit,O
137484,9485,survival,B-Observation
137485,9485,to,O
137486,9485,<,O
137487,9485,1,O
137488,9485,year,O
137489,9486,Have,O
137490,9486,had,O
137491,9486,recent,O
137492,9486,ST,B-Condition
137493,9486,elevation,I-Condition
137494,9486,myocardial,I-Condition
137495,9486,infarction,I-Condition
137496,9486,or,O
137497,9486,non,B-Condition
137498,9486,-,I-Condition
137499,9486,ST,I-Condition
137500,9486,elevation,I-Condition
137501,9486,MI,I-Condition
137502,9486,(,O
137503,9486,<,O
137504,9486,30,O
137505,9486,days,O
137506,9486,),O
137507,9486,;,O
137508,9486,note,O
137509,9486,that,O
137510,9486,biomarker,O
137511,9486,elevation,O
137512,9486,alone,O
137513,9486,after,O
137514,9486,ventricular,O
137515,9486,arrhythmias,O
137516,9486,does,O
137517,9486,not,O
137518,9486,denote,O
137519,9486,MI,O
137520,9486,.,O
137521,9487,Are,O
137522,9487,pregnant,B-Condition
137523,9487,.,O
137524,9488,Prior,O
137525,9488,Myocardial,B-Condition
137526,9488,Infarction,I-Condition
137527,9488,and,O
137528,9489,Sustained,O
137529,9489,monomorphic,B-Condition
137530,9489,VT,I-Condition
137531,9489,documented,O
137532,9489,on,O
137533,9489,12,B-Procedure
137534,9489,-,I-Procedure
137535,9489,lead,I-Procedure
137536,9489,ECG,I-Procedure
137537,9489,or,O
137538,9489,rhythm,B-Procedure
137539,9489,strip,I-Procedure
137540,9489,terminated,O
137541,9489,by,O
137542,9489,pharmacologic,B-Procedure
137543,9489,means,I-Procedure
137544,9489,or,O
137545,9489,DC,B-Procedure
137546,9489,cardioversion,I-Procedure
137547,9490,=3,O
137548,9490,episodes,O
137549,9490,of,O
137550,9490,VT,B-Condition
137551,9490,treated,O
137552,9490,with,O
137553,9490,antitachycardia,B-Procedure
137554,9490,pacing,I-Procedure
137555,9490,(,O
137556,9490,ATP,B-Procedure
137557,9490,),O
137558,9490,",",O
137559,9490,at,O
137560,9490,least,O
137561,9490,one,O
137562,9490,of,O
137563,9490,which,O
137564,9490,was,O
137565,9490,symptomatic,O
137566,9491,=,O
137567,9491,5,O
137568,9491,episodes,O
137569,9491,of,O
137570,9491,VT,B-Condition
137571,9491,treated,O
137572,9491,with,O
137573,9491,antitachycardia,B-Procedure
137574,9491,pacing,I-Procedure
137575,9491,(,O
137576,9491,ATP,B-Procedure
137577,9491,),O
137578,9491,regardless,O
137579,9491,of,O
137580,9491,symptoms,O
137581,9492,=,O
137582,9492,1,O
137583,9492,appropriate,O
137584,9492,ICD,B-Procedure
137585,9492,shocks,I-Procedure
137586,9492,",",O
137587,9493,=3,O
137588,9493,VT,B-Condition
137589,9493,episodes,O
137590,9493,within,O
137591,9493,24,O
137592,9493,hours,O
137593,9494,Moderate,O
137594,9494,or,O
137595,9494,severe,O
137596,9494,endometriosis,B-Condition
137597,9494,.,O
137598,9495,Hydrosalpinx,B-Condition
137599,9495,.,O
137600,9496,Uterine,B-Condition
137601,9496,abnormalities,I-Condition
137602,9496,.,O
137603,9497,Myoma,B-Condition
137604,9497,.,O
137605,9498,Previous,O
137606,9498,uterine,B-Procedure
137607,9498,surgery,I-Procedure
137608,9498,.,O
137609,9499,Women,B-Person
137610,9499,subjected,O
137611,9499,to,O
137612,9499,ICSI,B-Procedure
137613,9499,through,O
137614,9499,controlled,O
137615,9499,ovarian,B-Procedure
137616,9499,hyperstimulation,I-Procedure
137617,9499,(,O
137618,9499,COH,B-Procedure
137619,9499,),O
137620,9499,with,O
137621,9499,pituitary,B-Procedure
137622,9499,downregulation,I-Procedure
137623,9499,by,O
137624,9499,GnRH,B-Procedure
137625,9499,antagonist,I-Procedure
137626,9499,.,O
137627,9500,Traumatic,O
137628,9500,pulmonary,B-Condition
137629,9500,contusion,I-Condition
137630,9500,or,O
137631,9500,laceration,B-Condition
137632,9501,Lung,B-Procedure
137633,9501,reduction,I-Procedure
137634,9501,surgery,I-Procedure
137635,9502,Planned,B-Mood
137636,9502,removal,B-Procedure
137637,9502,of,O
137638,9502,more,O
137639,9502,than,O
137640,9502,10,O
137641,9502,lung,B-Condition
137642,9502,lesions,I-Condition
137643,9503,Pneumonectomy,B-Procedure
137644,9504,Known,O
137645,9504,hypersensitivity,B-Condition
137646,9504,to,O
137647,9504,bovine,B-Drug
137648,9504,protein,I-Drug
137649,9505,Known,O
137650,9505,hypersensitivity,B-Condition
137651,9505,to,O
137652,9505,Brilliant,B-Drug
137653,9505,Blue,I-Drug
137654,9505,FCF,I-Drug
137655,9505,(,I-Drug
137656,9505,E133,I-Drug
137657,9505,),I-Drug
137658,9506,Presence,O
137659,9506,of,O
137660,9506,active,B-Condition
137661,9506,infection,I-Condition
137662,9507,Patients,O
137663,9507,over,B-Person
137664,9507,the,I-Person
137665,9507,age,I-Person
137666,9507,of,I-Person
137667,9507,18,I-Person
137668,9507,years,I-Person
137669,9507,who,O
137670,9507,are,O
137671,9507,able,B-Observation
137672,9507,to,I-Observation
137673,9507,give,I-Observation
137674,9507,their,I-Observation
137675,9507,informed,I-Observation
137676,9507,consent,I-Observation
137677,9508,Lobar,B-Procedure
137678,9508,and,I-Procedure
137679,9508,sublobar,I-Procedure
137680,9508,resections,I-Procedure
137681,9509,Open,O
137682,9509,",",O
137683,9509,video,O
137684,9509,-,O
137685,9509,assisted,O
137686,9509,thoracoscopic,B-Procedure
137687,9509,or,I-Procedure
137688,9509,robotic,I-Procedure
137689,9509,surgeries,I-Procedure
137690,9510,Diagnostic,B-Procedure
137691,9510,or,I-Procedure
137692,9510,therapeutic,I-Procedure
137693,9510,procedures,I-Procedure
137694,9511,Legally,B-Observation
137695,9511,incompetent,I-Observation
137696,9511,or,O
137697,9511,mentally,B-Condition
137698,9511,impaired,I-Condition
137699,9511,(,O
137700,9511,e.g.,O
137701,9511,",",O
137702,9511,minors,B-Person
137703,9511,",",O
137704,9511,Alzheimer,B-Condition
137705,9511,'s,I-Condition
137706,9511,subjects,O
137707,9511,",",O
137708,9511,dementia,B-Condition
137709,9511,",",O
137710,9511,etc,O
137711,9511,.,O
137712,9511,),O
137713,9512,Younger,O
137714,9512,than,O
137715,9512,18,O
137716,9512,years,O
137717,9512,of,O
137718,9512,age,B-Person
137719,9513,Any,O
137720,9513,patient,O
137721,9513,considered,O
137722,9513,a,O
137723,9513,vulnerable,B-Observation
137724,9513,subject,I-Observation
137725,9514,Have,O
137726,9514,bleeding,B-Condition
137727,9514,or,I-Condition
137728,9514,clotting,I-Condition
137729,9514,disorder,I-Condition
137730,9515,Preoperative,O
137731,9515,anticoagulation,B-Procedure
137732,9515,therapy,I-Procedure
137733,9516,Abnormal,B-Condition
137734,9516,coagulation,I-Condition
137735,9516,profile,I-Condition
137736,9517,Renal,B-Condition
137737,9517,disorder,I-Condition
137738,9517,or,I-Condition
137739,9517,insufficiency,I-Condition
137740,9518,Sickle,B-Condition
137741,9518,cell,I-Condition
137742,9518,disease,I-Condition
137743,9519,Patients,O
137744,9519,undergoing,O
137745,9519,a,O
137746,9519,high,B-Procedure
137747,9519,tibial,I-Procedure
137748,9519,osteotomy,I-Procedure
137749,9519,(,I-Procedure
137750,9519,HTO,I-Procedure
137751,9519,),I-Procedure
137752,9520,Patients,O
137753,9520,undergoing,O
137754,9520,tibial,B-Procedure
137755,9520,tubercle,I-Procedure
137756,9520,osteotomy,I-Procedure
137757,9520,(,I-Procedure
137758,9520,TTO,I-Procedure
137759,9520,),I-Procedure
137760,9520,with,O
137761,9520,or,O
137762,9520,without,O
137763,9520,medial,B-Procedure
137764,9520,patello,I-Procedure
137765,9520,-,I-Procedure
137766,9520,femoral,I-Procedure
137767,9520,ligament,I-Procedure
137768,9520,(,I-Procedure
137769,9520,MPFL,I-Procedure
137770,9520,),I-Procedure
137771,9520,reconstruction,I-Procedure
137772,9521,Blood,B-Procedure
137773,9521,donation,I-Procedure
137774,9521,of,O
137775,9521,more,O
137776,9521,than,O
137777,9521,450ml,O
137778,9521,in,O
137779,9521,the,O
137780,9521,previous,O
137781,9521,three,O
137782,9521,months,O
137783,9521,.,O
137784,9522,Subject,O
137785,9522,with,O
137786,9522,an,O
137787,9522,abnormal,B-Condition
137788,9522,karyotype,I-Condition
137789,9522,in,O
137790,9522,favor,O
137791,9522,of,O
137792,9522,Turner,B-Condition
137793,9522,syndrome,I-Condition
137794,9522,or,O
137795,9522,having,O
137796,9522,a,O
137797,9522,premutation,B-Condition
137798,9522,of,I-Condition
137799,9522,the,I-Condition
137800,9522,FMR1,I-Condition
137801,9522,gene,I-Condition
137802,9522,or,O
137803,9522,a,O
137804,9522,syndromic,B-Condition
137805,9522,form,I-Condition
137806,9523,Subject,O
137807,9523,exclusion,O
137808,9523,period,O
137809,9523,in,O
137810,9523,another,O
137811,9523,study,O
137812,9523,without,O
137813,9523,direct,O
137814,9523,individual,O
137815,9523,benefit,O
137816,9524,Subject,O
137817,9524,refusing,O
137818,9524,to,O
137819,9524,sign,O
137820,9524,the,O
137821,9524,consent,O
137822,9524,form,O
137823,9525,Patients,O
137824,9525,of,O
137825,9525,familial,O
137826,9525,cases,O
137827,9525,of,O
137828,9525,POF,O
137829,9525,:,O
137830,9526,Female,B-Person
137831,9526,subjects,O
137832,9526,between,O
137833,9526,16,O
137834,9526,and,O
137835,9526,40,O
137836,9526,years,B-Person
137837,9526,or,O
137838,9526,women,B-Person
137839,9526,older,O
137840,9526,than,O
137841,9526,40,O
137842,9526,years,O
137843,9526,with,O
137844,9526,a,O
137845,9526,cessation,B-Condition
137846,9526,of,I-Condition
137847,9526,ovarian,I-Condition
137848,9526,function,I-Condition
137849,9526,before,O
137850,9526,the,O
137851,9526,age,B-Person
137852,9526,of,O
137853,9526,40,O
137854,9526,years,O
137855,9526,with,O
137856,9526,increased,O
137857,9526,levels,O
137858,9526,of,O
137859,9526,FSH,O
137860,9527,Primary,O
137861,9527,or,O
137862,9527,secondary,O
137863,9527,amenorrhea,B-Condition
137864,9527,for,O
137865,9527,more,O
137866,9527,than,O
137867,9527,three,O
137868,9527,months,O
137869,9527,with,O
137870,9527,LH,O
137871,9527,and,O
137872,9527,FSH,O
137873,9527,>,O
137874,9527,30mUI,O
137875,9527,/,O
137876,9527,ml,O
137877,9528,No,O
137878,9528,cases,O
137879,9528,of,O
137880,9528,fragile,B-Condition
137881,9528,X,I-Condition
137882,9528,syndrome,I-Condition
137883,9528,in,B-Observation
137884,9528,the,I-Observation
137885,9528,family,I-Observation
137886,9528,or,O
137887,9528,blepharophimosis,B-Condition
137888,9528,syndrome,I-Condition
137889,9529,At,O
137890,9529,least,O
137891,9529,two,O
137892,9529,cases,O
137893,9529,in,O
137894,9529,the,O
137895,9529,family,O
137896,9530,Origin,O
137897,9530,Caucasian,B-Condition
137898,9531,Patient,O
137899,9531,signing,O
137900,9531,the,O
137901,9531,consent,O
137902,9531,form,O
137903,9531,for,O
137904,9531,at,O
137905,9531,least,O
137906,9531,the,O
137907,9531,blood,O
137908,9531,sample,O
137909,9532,Patient,O
137910,9532,with,O
137911,9532,Social,O
137912,9532,Security,O
137913,9533,Population,O
137914,9533,Index,O
137915,9533,related,O
137916,9533,topics,O
137917,9533,:,O
137918,9534,The,O
137919,9534,presence,B-Condition
137920,9534,of,I-Condition
137921,9534,cycles,I-Condition
137922,9534,until,O
137923,9534,the,O
137924,9534,age,B-Person
137925,9534,of,O
137926,9534,40,O
137927,9534,years,O
137928,9534,with,O
137929,9534,proven,O
137930,9534,fertility,O
137931,9534,",",O
137932,9534,at,O
137933,9534,least,O
137934,9534,one,O
137935,9534,child,O
137936,9535,Amenorrhea,B-Condition
137937,9535,and,O
137938,9535,FSH,O
137939,9535,>,O
137940,9535,30mUI,O
137941,9535,/,O
137942,9535,ml,O
137943,9535,according,O
137944,9535,to,O
137945,9535,the,O
137946,9535,criteria,O
137947,9535,of,O
137948,9535,the,O
137949,9535,index,O
137950,9535,subject,O
137951,9536,Men,O
137952,9536,of,O
137953,9536,the,O
137954,9536,family,O
137955,9536,of,O
137956,9536,index,O
137957,9536,case,O
137958,9537,Population,O
137959,9537,control,O
137960,9537,:,O
137961,9538,Women,B-Person
137962,9538,of,O
137963,9538,Caucasian,B-Condition
137964,9538,origin,I-Condition
137965,9539,Women,B-Person
137966,9539,who,B-Condition
137967,9539,had,I-Condition
137968,9539,regular,I-Condition
137969,9539,cycles,I-Condition
137970,9539,until,I-Condition
137971,9539,at,I-Condition
137972,9539,least,I-Condition
137973,9539,age,I-Condition
137974,9539,40,I-Condition
137975,9539,and,O
137976,9539,at,O
137977,9539,least,O
137978,9539,one,O
137979,9539,child,O
137980,9540,Lack,O
137981,9540,of,O
137982,9540,land,O
137983,9540,autoimmune,B-Condition
137984,9540,(,O
137985,9540,no,O
137986,9540,history,B-Observation
137987,9540,of,O
137988,9540,thyroid,B-Condition
137989,9540,disease,I-Condition
137990,9540,or,O
137991,9540,diabetes,B-Condition
137992,9540,type,I-Condition
137993,9540,1,I-Condition
137994,9540,),O
137995,9541,Woman,O
137996,9541,signing,O
137997,9541,the,O
137998,9541,consent,O
137999,9541,form,O
138000,9541,for,O
138001,9541,at,O
138002,9541,least,O
138003,9541,the,O
138004,9541,blood,O
138005,9541,sample,O
138006,9542,Current,O
138007,9542,viral,O
138008,9542,or,O
138009,9542,bacterial,B-Condition
138010,9542,infection,I-Condition
138011,9542,.,O
138012,9543,Positive,O
138013,9543,serology,O
138014,9543,for,O
138015,9543,HIV,O
138016,9543,",",O
138017,9543,HCV,O
138018,9543,",",O
138019,9543,HBV,O
138020,9543,.,O
138021,9544,Age,B-Person
138022,9544,:,O
138023,9544,>,O
138024,9544,or,O
138025,9544,=,O
138026,9544,16,O
138027,9544,years,O
138028,9545,Weight,O
138029,9545,:,O
138030,9545,more,O
138031,9545,than,O
138032,9545,40,O
138033,9545,Kg,O
138034,9546,Autoimmune,B-Condition
138035,9546,Hemolytic,I-Condition
138036,9546,anemia,I-Condition
138037,9546,with,O
138038,9546,clinical,O
138039,9546,and,O
138040,9546,biochemical,B-Mood
138041,9546,evidence,I-Mood
138042,9546,of,O
138043,9546,hemolysis,B-Condition
138044,9546,refractory,O
138045,9546,to,O
138046,9546,treatment,B-Procedure
138047,9546,",",O
138048,9546,in,O
138049,9546,relapse,O
138050,9546,or,O
138051,9546,steroids,B-Drug
138052,9546,dependant,O
138053,9547,Idiopathic,B-Condition
138054,9547,thrombocytopenic,I-Condition
138055,9547,purpura,I-Condition
138056,9547,with,O
138057,9547,platelet,O
138058,9547,counts,O
138059,9547,<,O
138060,9547,"50,000",O
138061,9547,",",O
138062,9547,refractory,O
138063,9547,to,O
138064,9547,treatment,B-Drug
138065,9547,",",O
138066,9547,in,O
138067,9547,relapse,O
138068,9547,or,O
138069,9547,steroids,B-Drug
138070,9547,dependant,O
138071,9548,Affected,O
138072,9548,by,O
138073,9548,alcohol,B-Observation
138074,9548,or,O
138075,9548,drugs,B-Observation
138076,9548,during,O
138077,9548,the,O
138078,9548,last,O
138079,9548,month,O
138080,9548,.,O
138081,9549,Untreated,O
138082,9549,severe,O
138083,9549,comorbid,O
138084,9549,psychiatric,O
138085,9549,or,O
138086,9549,somatic,B-Condition
138087,9549,illness,I-Condition
138088,9549,.,O
138089,9550,Bloodpressure,O
138090,9550,150/95,O
138091,9550,or,O
138092,9550,higher,O
138093,9550,.,O
138094,9551,Irregular,O
138095,9551,pulse,O
138096,9551,",",O
138097,9551,or,O
138098,9551,pulse,O
138099,9551,100,O
138100,9551,or,O
138101,9551,higher,O
138102,9551,.,O
138103,9552,No,O
138104,9552,counter,O
138105,9552,indications,O
138106,9552,according,O
138107,9552,to,O
138108,9552,the,O
138109,9552,Medikinet,O
138110,9552,pill,O
138111,9552,.,O
138112,9553,Concurrent,O
138113,9553,clinical,O
138114,9553,diagnosis,O
138115,9553,that,O
138116,9553,significantly,O
138117,9553,could,O
138118,9553,affect,O
138119,9553,test,O
138120,9553,performance,O
138121,9553,.,O
138122,9554,Concurrent,O
138123,9554,prescription,O
138124,9554,of,O
138125,9554,medicines,B-Drug
138126,9554,for,O
138127,9554,ADHD,B-Condition
138128,9554,or,O
138129,9554,medicines,O
138130,9554,that,O
138131,9554,significantly,O
138132,9554,could,O
138133,9554,affect,O
138134,9554,test,O
138135,9554,performance,O
138136,9554,.,O
138137,9555,18,O
138138,9555,years,O
138139,9555,old,B-Person
138140,9555,or,O
138141,9555,older,O
138142,9555,.,O
138143,9556,ADHD,B-Condition
138144,9556,is,O
138145,9556,diagnosed,O
138146,9556,according,O
138147,9556,to,O
138148,9556,Diagnostic,O
138149,9556,and,O
138150,9556,Statistical,O
138151,9556,Manual,O
138152,9556,of,O
138153,9556,Mental,O
138154,9556,Disorders,O
138155,9556,",",O
138156,9556,fifth,O
138157,9556,edition,O
138158,9556,(,O
138159,9556,DSM-5,O
138160,9556,criteria,O
138161,9556,),O
138162,9556,.,O
138163,9557,Substance,B-Condition
138164,9557,Use,I-Condition
138165,9557,Disorder,I-Condition
138166,9557,is,O
138167,9557,diagnosed,O
138168,9557,according,O
138169,9557,to,O
138170,9557,DSM-5,O
138171,9557,criteria,O
138172,9557,.,O
138173,9558,Qb,O
138174,9558,-,O
138175,9558,score,O
138176,9558,1.3,O
138177,9558,or,O
138178,9558,higher,O
138179,9558,on,O
138180,9558,at,O
138181,9558,least,O
138182,9558,one,O
138183,9558,of,O
138184,9558,the,O
138185,9558,weighted,O
138186,9558,summary,O
138187,9558,parameters,O
138188,9558,QbActivity,O
138189,9558,",",O
138190,9558,QbInattention,O
138191,9558,or,O
138192,9558,QbImpulsivity,O
138193,9558,on,O
138194,9558,the,O
138195,9558,QbTest,O
138196,9558,.,O
138197,9559,Participants,O
138198,9559,are,O
138199,9559,given,O
138200,9559,their,O
138201,9559,written,O
138202,9559,informed,O
138203,9559,consent,O
138204,9559,to,O
138205,9559,participate,O
138206,9559,in,O
138207,9559,the,O
138208,9559,study,O
138209,9559,.,O
138210,9560,1,O
138211,9560,.,O
138212,9560,Atrial,B-Condition
138213,9560,fibrillation,I-Condition
138214,9560,;,O
138215,9561,2,O
138216,9561,.,O
138217,9561,Subject,O
138218,9561,underwent,O
138219,9561,cardiac,B-Procedure
138220,9561,pacemaker,I-Procedure
138221,9561,treatment,I-Procedure
138222,9561,;,O
138223,9562,3,O
138224,9562,.,O
138225,9562,Subject,O
138226,9562,underwent,O
138227,9562,metal,B-Procedure
138228,9562,graft,I-Procedure
138229,9562,treatment,I-Procedure
138230,9562,;,O
138231,9563,4,O
138232,9563,.,O
138233,9563,Claustrophobia,B-Condition
138234,9563,;,O
138235,9564,5,O
138236,9564,.,O
138237,9564,Acute,B-Condition
138238,9564,myocardial,I-Condition
138239,9564,infarction,I-Condition
138240,9564,",",O
138241,9564,cardiac,B-Condition
138242,9564,ischemia,I-Condition
138243,9564,indicated,O
138244,9564,by,O
138245,9564,6,B-Procedure
138246,9564,-,I-Procedure
138247,9564,minute,I-Procedure
138248,9564,walk,I-Procedure
138249,9564,test,I-Procedure
138250,9564,",",O
138251,9564,hypertrophic,B-Condition
138252,9564,cardiomyopathy,I-Condition
138253,9564,",",O
138254,9564,constrictive,B-Condition
138255,9564,pericarditis,I-Condition
138256,9564,",",O
138257,9564,significant,O
138258,9564,valve,B-Condition
138259,9564,disease,I-Condition
138260,9564,or,O
138261,9564,congenital,B-Condition
138262,9564,heart,I-Condition
138263,9564,disease,I-Condition
138264,9564,",",O
138265,9564,severe,B-Condition
138266,9564,pulmonary,I-Condition
138267,9564,hypertension,I-Condition
138268,9564,;,O
138269,9565,6,O
138270,9565,.,O
138271,9565,Ischemic,B-Condition
138272,9565,heart,I-Condition
138273,9565,failure,I-Condition
138274,9565,without,O
138275,9565,the,O
138276,9565,revascularization,B-Procedure
138277,9565,or,O
138278,9565,undergone,O
138279,9565,the,O
138280,9565,revascularization,B-Procedure
138281,9565,within,O
138282,9565,last,O
138283,9565,6,O
138284,9565,months,O
138285,9565,;,O
138286,9566,7,O
138287,9566,.,O
138288,9566,Subject,O
138289,9566,underwent,O
138290,9566,cardiac,B-Procedure
138291,9566,surgery,I-Procedure
138292,9566,or,O
138293,9566,cerebrovascular,B-Condition
138294,9566,events,I-Condition
138295,9566,within,O
138296,9566,the,O
138297,9566,previous,O
138298,9566,six,O
138299,9566,months,O
138300,9566,;,O
138301,9567,8,O
138302,9567,.,O
138303,9567,Subjects,O
138304,9567,who,O
138305,9567,plan,B-Observation
138306,9567,to,O
138307,9567,have,O
138308,9567,cardiac,B-Procedure
138309,9567,transplantation,I-Procedure
138310,9567,;,O
138311,9568,9,O
138312,9568,.,O
138313,9568,Severe,O
138314,9568,hepatic,B-Condition
138315,9568,and,I-Condition
138316,9568,renal,I-Condition
138317,9568,insufficiency,I-Condition
138318,9568,(,O
138319,9568,serum,O
138320,9568,creatinine>2.0,O
138321,9568,mg,O
138322,9568,/dl,O
138323,9568,",",O
138324,9568,AST,O
138325,9568,or,O
138326,9568,ALT,O
138327,9568,is,O
138328,9568,five,O
138329,9568,times,O
138330,9568,higher,O
138331,9568,than,O
138332,9568,the,O
138333,9568,upper,O
138334,9568,limit,O
138335,9568,of,O
138336,9568,normal,O
138337,9568,range,O
138338,9568,),O
138339,9568,;,O
138340,9569,10,O
138341,9569,.,O
138342,9569,Subject,O
138343,9569,needs,O
138344,9569,mechanical,B-Procedure
138345,9569,ventilation,I-Procedure
138346,9569,;,O
138347,9570,11,O
138348,9570,.,O
138349,9570,Systolic,O
138350,9570,blood,O
138351,9570,pressure,O
138352,9570,<,O
138353,9570,90mmHg,O
138354,9570,",",O
138355,9570,or,O
138356,9570,>,O
138357,9570,160mmHg,O
138358,9570,;,O
138359,9571,12,O
138360,9571,.,O
138361,9571,Chronic,B-Condition
138362,9571,heart,I-Condition
138363,9571,failure,I-Condition
138364,9571,complicated,O
138365,9571,with,O
138366,9571,acute,B-Condition
138367,9571,hemodynamic,I-Condition
138368,9571,disturbance,I-Condition
138369,9571,or,O
138370,9571,acute,B-Condition
138371,9571,decompensation,I-Condition
138372,9571,within,O
138373,9571,last,O
138374,9571,1,O
138375,9571,month,O
138376,9571,;,O
138377,9572,13,O
138378,9572,.,O
138379,9572,Mobitz,O
138380,9572,Type,O
138381,9572,II,O
138382,9572,or,O
138383,9572,III,O
138384,9572,°,O
138385,9572,atrial,B-Condition
138386,9572,ventricular,I-Condition
138387,9572,block，severe,I-Condition
138388,9572,ventricular,B-Condition
138389,9572,arrhythmia,I-Condition
138390,9572,(,O
138391,9572,polymorphic,O
138392,9572,and,O
138393,9572,frequent,O
138394,9572,premature,B-Observation
138395,9572,ventricular,I-Observation
138396,9572,beats,I-Observation
138397,9572,",",O
138398,9572,frequent,O
138399,9572,non,O
138400,9572,-,O
138401,9572,sustained,O
138402,9572,ventricular,B-Condition
138403,9572,tachycardia,I-Condition
138404,9572,),O
138405,9572,;,O
138406,9573,14,O
138407,9573,.,O
138408,9573,Serum,O
138409,9573,potassium<3.2mmol,O
138410,9573,/,O
138411,9573,L,O
138412,9573,",",O
138413,9573,or>5.5mmol,O
138414,9573,/,O
138415,9573,L,O
138416,9573,;,O
138417,9574,15,O
138418,9574,.,O
138419,9574,Female,B-Person
138420,9574,subject,O
138421,9574,is,O
138422,9574,pregnant,B-Condition
138423,9574,or,O
138424,9574,plan,B-Observation
138425,9574,to,O
138426,9574,become,O
138427,9574,pregnant,B-Condition
138428,9575,16,O
138429,9575,.,O
138430,9575,Childbearing,O
138431,9575,-,O
138432,9575,aged,O
138433,9575,female,B-Person
138434,9575,subject,O
138435,9575,who,O
138436,9575,is,O
138437,9575,unmarried,B-Observation
138438,9575,or,O
138439,9575,dose,O
138440,9575,not,O
138441,9575,bear,B-Observation
138442,9575,child,I-Observation
138443,9575,;,O
138444,9576,17,O
138445,9576,.,O
138446,9576,Subject,O
138447,9576,with,O
138448,9576,life,B-Observation
138449,9576,expectancy,I-Observation
138450,9576,less,O
138451,9576,than,O
138452,9576,6,O
138453,9576,months,O
138454,9576,as,O
138455,9576,assessed,O
138456,9576,by,O
138457,9576,investigators,O
138458,9576,;,O
138459,9577,18,O
138460,9577,.,O
138461,9577,Subject,O
138462,9577,participated,O
138463,9577,in,O
138464,9577,any,O
138465,9577,other,O
138466,9577,clinical,O
138467,9577,trial,O
138468,9577,within,O
138469,9577,the,O
138470,9577,previous,O
138471,9577,three,O
138472,9577,months,O
138473,9577,;,O
138474,9578,19,O
138475,9578,.,O
138476,9578,Subject,O
138477,9578,with,O
138478,9578,previous,B-Observation
138479,9578,history,I-Observation
138480,9578,of,O
138481,9578,tumor,B-Condition
138482,9578,",",O
138483,9578,or,O
138484,9578,current,O
138485,9578,tumor,B-Condition
138486,9578,patient,O
138487,9578,",",O
138488,9578,or,O
138489,9578,subject,O
138490,9578,with,O
138491,9578,pre,B-Condition
138492,9578,-,I-Condition
138493,9578,cancerous,I-Condition
138494,9578,disease,I-Condition
138495,9578,manifested,O
138496,9578,by,O
138497,9578,pathological,B-Procedure
138498,9578,examination,I-Procedure
138499,9578,(,O
138500,9578,such,O
138501,9578,as,O
138502,9578,ductal,B-Condition
138503,9578,carcinoma,I-Condition
138504,9578,in,I-Condition
138505,9578,situ,I-Condition
138506,9578,or,O
138507,9578,cervical,B-Condition
138508,9578,epithelial,I-Condition
138509,9578,dysplasia,I-Condition
138510,9578,),O
138511,9579,20,O
138512,9579,.,O
138513,9579,Examinations,B-Procedure
138514,9579,(,O
138515,9579,physical,B-Procedure
138516,9579,examination,I-Procedure
138517,9579,",",O
138518,9579,X,B-Procedure
138519,9579,-,I-Procedure
138520,9579,ray,I-Procedure
138521,9579,examination,I-Procedure
138522,9579,",",O
138523,9579,type,B-Procedure
138524,9579,-,I-Procedure
138525,9579,B,I-Procedure
138526,9579,ultrasonic,I-Procedure
138527,9579,detection,I-Procedure
138528,9579,or,O
138529,9579,other,B-Procedure
138530,9579,methods,I-Procedure
138531,9579,),O
138532,9579,reveal,O
138533,9579,that,O
138534,9579,the,O
138535,9579,subject,O
138536,9579,has,O
138537,9579,malignant,B-Condition
138538,9579,mass,I-Condition
138539,9579,",",O
138540,9579,gland,B-Condition
138541,9579,hyperplasia,I-Condition
138542,9579,or,O
138543,9579,adenoma,B-Condition
138544,9579,with,O
138545,9579,endocrine,B-Condition
138546,9579,activity,I-Condition
138547,9579,",",O
138548,9579,or,O
138549,9579,impact,B-Condition
138550,9579,on,I-Condition
138551,9579,heart,I-Condition
138552,9579,",",I-Condition
138553,9579,or,I-Condition
138554,9579,endocrine,I-Condition
138555,9579,function,I-Condition
138556,9579,(,O
138557,9579,such,O
138558,9579,as,O
138559,9579,pheochromocytoma,B-Condition
138560,9579,",",O
138561,9579,thyroid,B-Condition
138562,9579,enlargement,I-Condition
138563,9579,),O
138564,9579,;,O
138565,9580,21,O
138566,9580,.,O
138567,9580,The,O
138568,9580,Investigator,O
138569,9580,deemed,O
138570,9580,for,O
138571,9580,whatever,O
138572,9580,reason,O
138573,9580,that,O
138574,9580,the,O
138575,9580,subject,O
138576,9580,is,O
138577,9580,not,O
138578,9580,likely,O
138579,9580,to,O
138580,9580,complete,O
138581,9580,the,O
138582,9580,study,O
138583,9580,or,O
138584,9580,comply,O
138585,9580,with,O
138586,9580,the,O
138587,9580,study,O
138588,9580,procedures,O
138589,9580,(,O
138590,9580,due,O
138591,9580,to,O
138592,9580,administration,O
138593,9580,or,O
138594,9580,any,O
138595,9580,other,O
138596,9580,reason,O
138597,9580,),O
138598,9580,.,O
138599,9581,1,O
138600,9581,.,O
138601,9581,Age,B-Person
138602,9581,:,O
138603,9581,18,O
138604,9581,-,O
138605,9581,75,O
138606,9581,years,O
138607,9581,old,O
138608,9581,",",O
138609,9581,no,O
138610,9581,limitation,O
138611,9581,in,O
138612,9581,gender,O
138613,9581,;,O
138614,9582,2,O
138615,9582,.,O
138616,9582,Left,O
138617,9582,ventricular,O
138618,9582,ejection,O
138619,9582,fraction,O
138620,9582,(,O
138621,9582,LVEF,O
138622,9582,),O
138623,9582,≤,O
138624,9582,40,O
138625,9582,%,O
138626,9582,(,O
138627,9582,ECHO,B-Procedure
138628,9582,),O
138629,9582,;,O
138630,9583,3,O
138631,9583,.,O
138632,9583,Patients,O
138633,9583,with,O
138634,9583,chronic,B-Condition
138635,9583,heart,I-Condition
138636,9583,failure,I-Condition
138637,9583,(,O
138638,9583,NYHA,O
138639,9583,class,O
138640,9583,II,O
138641,9583,or,O
138642,9583,III,O
138643,9583,),O
138644,9583,;,O
138645,9584,4,O
138646,9584,.,O
138647,9584,In,O
138648,9584,the,O
138649,9584,past,O
138650,9584,one,O
138651,9584,month,O
138652,9584,",",O
138653,9584,the,O
138654,9584,clinical,O
138655,9584,condition,O
138656,9584,(,O
138657,9584,including,O
138658,9584,history,B-Observation
138659,9584,",",O
138660,9584,clinical,B-Condition
138661,9584,symptoms,I-Condition
138662,9584,and,I-Condition
138663,9584,signs,I-Condition
138664,9584,),O
138665,9584,was,O
138666,9584,relatively,O
138667,9584,stable,O
138668,9584,;,O
138669,9585,5,O
138670,9585,.,O
138671,9585,Patients,O
138672,9585,on,O
138673,9585,standard,O
138674,9585,treatment,B-Procedure
138675,9585,of,I-Procedure
138676,9585,chronic,I-Procedure
138677,9585,heart,I-Procedure
138678,9585,failure,I-Procedure
138679,9585,at,O
138680,9585,the,O
138681,9585,target,B-Observation
138682,9585,dose,I-Observation
138683,9585,or,O
138684,9585,maximum,B-Observation
138685,9585,tolerance,I-Observation
138686,9585,dose,I-Observation
138687,9585,for,O
138688,9585,over,O
138689,9585,1,O
138690,9585,month,O
138691,9585,",",O
138692,9585,or,O
138693,9585,unchanged,B-Observation
138694,9585,dose,I-Observation
138695,9585,in,O
138696,9585,last,O
138697,9585,1,O
138698,9585,month,O
138699,9585,;,O
138700,9586,6,O
138701,9586,.,O
138702,9586,Understand,O
138703,9586,and,O
138704,9586,sign,O
138705,9586,the,O
138706,9586,informed,O
138707,9586,consent,O
138708,9586,form,O
138709,9586,;,O
138710,9587,Non,B-Condition
138711,9587,diabetic,I-Condition
138712,9587,nephropathy,I-Condition
138713,9587,(,O
138714,9587,confirmed,O
138715,9587,by,O
138716,9587,biopsy,B-Procedure
138717,9587,),O
138718,9587,.,O
138719,9588,Dialysis,B-Procedure
138720,9588,for,O
138721,9588,acute,B-Condition
138722,9588,renal,I-Condition
138723,9588,failure,I-Condition
138724,9588,within,O
138725,9588,the,O
138726,9588,6,O
138727,9588,previous,O
138728,9588,months,O
138729,9588,.,O
138730,9589,Evidence,O
138731,9589,in,O
138732,9589,the,O
138733,9589,clinic,O
138734,9589,history,O
138735,9589,of,O
138736,9589,relevant,O
138737,9589,bilateral,O
138738,9589,stenosis,B-Condition
138739,9589,of,I-Condition
138740,9589,renal,I-Condition
138741,9589,artery,I-Condition
138742,9589,(,O
138743,9589,>,O
138744,9589,75,O
138745,9589,%,O
138746,9589,),O
138747,9590,Urinary,O
138748,9590,albumin,O
138749,9590,/,O
138750,9590,creatinine,O
138751,9590,ratio,O
138752,9590,higher,O
138753,9590,than,O
138754,9590,3000,O
138755,9590,mg,O
138756,9590,/,O
138757,9590,g,O
138758,9590,",",O
138759,9590,at,O
138760,9590,the,O
138761,9590,baseline,O
138762,9590,visit,O
138763,9590,.,O
138764,9591,Systolic,O
138765,9591,blood,O
138766,9591,pressure,O
138767,9591,=,O
138768,9591,180,O
138769,9591,mmHg,O
138770,9591,or,O
138771,9591,diastolic,O
138772,9591,blood,O
138773,9591,pressure,O
138774,9591,=,O
138775,9591,110,O
138776,9591,mm,O
138777,9591,Hg,O
138778,9591,at,O
138779,9591,the,O
138780,9591,baseline,O
138781,9591,visit,O
138782,9591,.,O
138783,9592,Stroke,B-Condition
138784,9592,",",O
138785,9592,transient,B-Condition
138786,9592,ischemic,I-Condition
138787,9592,attack,I-Condition
138788,9592,",",O
138789,9592,acute,B-Condition
138790,9592,coronary,I-Condition
138791,9592,syndrome,I-Condition
138792,9592,",",O
138793,9592,or,O
138794,9592,hospitalization,B-Procedure
138795,9592,for,O
138796,9592,heart,B-Condition
138797,9592,failure,I-Condition
138798,9592,worsening,O
138799,9592,",",O
138800,9592,within,O
138801,9592,the,O
138802,9592,previous,O
138803,9592,30,O
138804,9592,days,O
138805,9592,.,O
138806,9593,Professional,B-Person
138807,9593,drivers,I-Person
138808,9593,",",O
138809,9593,risk,B-Person
138810,9593,profession,I-Person
138811,9593,or,O
138812,9593,respiratory,B-Condition
138813,9593,failure,I-Condition
138814,9593,.,O
138815,9594,Severe,O
138816,9594,daytime,B-Condition
138817,9594,sleepiness,I-Condition
138818,9594,(,O
138819,9594,Epworth,O
138820,9594,sleepiness,O
138821,9594,scale,O
138822,9594,>,O
138823,9594,18,O
138824,9594,),O
138825,9595,Concomitant,O
138826,9595,treatment,B-Procedure
138827,9595,with,O
138828,9595,high,O
138829,9595,doses,O
138830,9595,of,O
138831,9595,acetylsalicylic,B-Drug
138832,9595,acid,I-Drug
138833,9595,(,O
138834,9595,>,O
138835,9595,500,O
138836,9595,mg,O
138837,9595,/,O
138838,9595,day,O
138839,9595,),O
138840,9595,or,O
138841,9595,continuous,O
138842,9595,treatment,B-Procedure
138843,9595,with,O
138844,9595,non,B-Drug
138845,9595,-,I-Drug
138846,9595,steroidal,I-Drug
138847,9595,anti,I-Drug
138848,9595,-,I-Drug
138849,9595,inflammatory,I-Drug
138850,9595,drugs,I-Drug
138851,9596,Previous,O
138852,9596,treatment,B-Procedure
138853,9596,with,O
138854,9596,CPAP,O
138855,9597,Participation,O
138856,9597,in,O
138857,9597,another,O
138858,9597,clinical,O
138859,9597,trial,O
138860,9597,within,O
138861,9597,the,O
138862,9597,30,O
138863,9597,days,O
138864,9597,prior,O
138865,9597,to,O
138866,9597,randomization,O
138867,9597,.,O
138868,9598,Subjects,O
138869,9598,aged,B-Person
138870,9598,18,O
138871,9598,to,O
138872,9598,80,O
138873,9598,years,O
138874,9598,old,O
138875,9599,Overweight,B-Condition
138876,9599,or,O
138877,9599,obesity,B-Condition
138878,9599,(,O
138879,9599,BMI,O
138880,9599,=,O
138881,9599,25,O
138882,9599,kg,O
138883,9599,/,O
138884,9599,m2,O
138885,9599,),O
138886,9600,Previous,O
138887,9600,diagnosis,O
138888,9600,of,O
138889,9600,type,B-Condition
138890,9600,2,I-Condition
138891,9600,diabetes,I-Condition
138892,9600,",",O
138893,9600,fulfilling,O
138894,9600,at,O
138895,9600,least,O
138896,9600,one,O
138897,9600,of,O
138898,9600,the,O
138899,9600,following,O
138900,9600,criteria,O
138901,9600,:,O
138902,9600,1,O
138903,9600,),O
138904,9600,current,O
138905,9600,treatment,O
138906,9600,with,O
138907,9600,oral,B-Drug
138908,9600,antidiabetic,I-Drug
138909,9600,drugs,I-Drug
138910,9600,and/or,O
138911,9600,insulin,B-Drug
138912,9600,;,O
138913,9600,2,O
138914,9600,),O
138915,9600,a,O
138916,9600,fasting,O
138917,9600,glucose,O
138918,9600,value,O
138919,9600,above,O
138920,9600,126,O
138921,9600,mg,O
138922,9600,/,O
138923,9600,dl,O
138924,9600,on,O
138925,9600,at,O
138926,9600,least,O
138927,9600,2,O
138928,9600,occasions,O
138929,9600,;,O
138930,9600,3,O
138931,9600,),O
138932,9600,blood,O
138933,9600,glucose,O
138934,9600,level,O
138935,9600,at,O
138936,9600,2,O
138937,9600,hours,O
138938,9600,after,O
138939,9600,an,O
138940,9600,oral,B-Procedure
138941,9600,glucose,I-Procedure
138942,9600,tolerance,I-Procedure
138943,9600,test,I-Procedure
138944,9600,is,O
138945,9600,equal,O
138946,9600,to,O
138947,9600,or,O
138948,9600,more,O
138949,9600,than,O
138950,9600,200,O
138951,9600,mg,O
138952,9600,/,O
138953,9600,dl,O
138954,9600,;,O
138955,9600,or,O
138956,9600,4,O
138957,9600,),O
138958,9600,a,O
138959,9600,glycated,O
138960,9600,hemoglobin,O
138961,9600,(,O
138962,9600,HbA1c,O
138963,9600,),O
138964,9600,level,O
138965,9600,>,O
138966,9600,6.5,O
138967,9600,%,O
138968,9601,Clinical,O
138969,9601,diagnosis,O
138970,9601,of,O
138971,9601,diabetic,B-Condition
138972,9601,nephropathy,I-Condition
138973,9601,",",O
138974,9601,with,O
138975,9601,a,O
138976,9601,urinary,O
138977,9601,albumin,O
138978,9601,/,O
138979,9601,creatinine,O
138980,9601,ratio,O
138981,9601,>,O
138982,9601,30,O
138983,9601,mg,O
138984,9601,/,O
138985,9601,g,O
138986,9601,and,O
138987,9601,an,O
138988,9601,estimated,O
138989,9601,glomerular,O
138990,9601,filtration,O
138991,9601,rate,O
138992,9601,more,O
138993,9601,than,O
138994,9601,20,O
138995,9601,ml,O
138996,9601,/,O
138997,9601,min,O
138998,9601,per,O
138999,9601,1.73,O
139000,9601,m2,O
139001,9601,.,O
139002,9602,Treatment,O
139003,9602,with,O
139004,9602,stable,O
139005,9602,doses,O
139006,9602,of,O
139007,9602,angiotensin,B-Drug
139008,9602,-,I-Drug
139009,9602,converting,I-Drug
139010,9602,enzyme,I-Drug
139011,9602,inhibitors,I-Drug
139012,9602,",",O
139013,9602,angiotensin,B-Drug
139014,9602,II,I-Drug
139015,9602,receptor,I-Drug
139016,9602,blockers,I-Drug
139017,9602,or,O
139018,9602,anti,B-Drug
139019,9602,-,I-Drug
139020,9602,aldosterone,I-Drug
139021,9602,agents,I-Drug
139022,9602,in,O
139023,9602,the,O
139024,9602,last,O
139025,9602,four,O
139026,9602,weeks,O
139027,9602,.,O
139028,9603,the,O
139029,9603,child,B-Person
139030,9603,has,O
139031,9603,temperature,O
139032,9603,>,O
139033,9603,39.0,O
139034,9603,◦,O
139035,9603,C,O
139036,9603,or,O
139037,9603,a,O
139038,9603,severe,O
139039,9603,acute,B-Condition
139040,9603,illness,I-Condition
139041,9603,as,O
139042,9603,defined,O
139043,9603,by,O
139044,9603,the,O
139045,9603,examining,O
139046,9603,nurse,O
139047,9604,the,O
139048,9604,child,B-Person
139049,9604,has,O
139050,9604,as,O
139051,9604,a,O
139052,9604,mid,O
139053,9604,upper,O
139054,9604,arm,O
139055,9604,circumference,O
139056,9604,<,O
139057,9604,110,O
139058,9604,mm,O
139059,9604,and,O
139060,9604,is,O
139061,9604,older,B-Person
139062,9604,than,O
139063,9604,6,O
139064,9604,months,O
139065,9604,(,O
139066,9604,most,O
139067,9604,feasible,O
139068,9604,local,O
139069,9604,indicator,O
139070,9604,of,O
139071,9604,AIDS,O
139072,9604,and,O
139073,9604,chronic,O
139074,9604,immunosuppressive,O
139075,9604,disease,O
139076,9604,),O
139077,9605,the,O
139078,9605,child,B-Person
139079,9605,has,O
139080,9605,experienced,O
139081,9605,a,O
139082,9605,severe,B-Condition
139083,9605,allergic,I-Condition
139084,9605,reaction,I-Condition
139085,9605,after,O
139086,9605,previous,O
139087,9605,vaccination,B-Procedure
139088,9605,",",O
139089,9605,drug,B-Procedure
139090,9605,or,O
139091,9605,food,B-Procedure
139092,9605,.,O
139093,9606,the,O
139094,9606,child,O
139095,9606,is,O
139096,9606,enrolled,O
139097,9606,in,O
139098,9606,an,O
139099,9606,ongoing,O
139100,9606,study,O
139101,9606,of,O
139102,9606,Bacillus,O
139103,9606,Calmette,O
139104,9606,Guerin,O
139105,9606,vaccine,O
139106,9606,and,O
139107,9606,is,O
139108,9606,<,O
139109,9606,2,O
139110,9606,months,O
139111,9606,old,O
139112,9607,For,O
139113,9607,the,O
139114,9607,RECAMP,B-Observation
139115,9607,-,I-Observation
139116,9607,MV,I-Observation
139117,9607,trial,I-Observation
139118,9607,:,O
139119,9607,the,O
139120,9607,child,O
139121,9607,is,O
139122,9607,enrolled,B-Observation
139123,9607,in,I-Observation
139124,9607,RECAMP,I-Observation
139125,9607,-,I-Observation
139126,9607,OPV,I-Observation
139127,9608,Children,B-Person
139128,9608,aged,B-Person
139129,9608,0,O
139130,9608,-,O
139131,9608,59,O
139132,9608,months,O
139133,9608,living,B-Observation
139134,9608,with,I-Observation
139135,9608,families,I-Observation
139136,9608,registered,I-Observation
139137,9608,in,I-Observation
139138,9608,the,I-Observation
139139,9608,rural,I-Observation
139140,9608,Bandim,I-Observation
139141,9608,Health,I-Observation
139142,9608,Project,I-Observation
139143,9608,Health,I-Observation
139144,9608,and,O
139145,9608,Demographic,O
139146,9608,Surveillance,O
139147,9608,Site,O
139148,9608,are,O
139149,9608,included,O
139150,9608,",",O
139151,9608,provided,O
139152,9608,a,O
139153,9608,parent,O
139154,9608,/,O
139155,9608,guardian,O
139156,9608,consent,O
139157,9608,.,O
139158,9609,patients,O
139159,9609,',O
139160,9609,refusal,O
139161,9610,contraindication,B-Condition
139162,9610,to,O
139163,9610,regional,B-Procedure
139164,9610,anaesthesia,I-Procedure
139165,9610,(,I-Procedure
139166,9610,coagulopathies,I-Procedure
139167,9610,",",O
139168,9610,concurrent,O
139169,9610,anticoagulant,B-Drug
139170,9610,therapy,I-Drug
139171,9610,",",O
139172,9610,allergy,B-Condition
139173,9610,to,O
139174,9610,local,B-Procedure
139175,9610,anaesthetics,I-Procedure
139176,9610,",",O
139177,9610,infection,B-Condition
139178,9610,at,O
139179,9610,puncture,O
139180,9610,site,O
139181,9610,),O
139182,9611,adult,B-Person
139183,9611,patients,O
139184,9612,ASA,O
139185,9612,class,O
139186,9612,1,O
139187,9612,to,O
139188,9612,3,O
139189,9612,patients,O
139190,9613,patients,O
139191,9613,scheduled,O
139192,9613,for,O
139193,9613,elective,O
139194,9613,breast,B-Procedure
139195,9613,mastectomy,I-Procedure
139196,9613,or,I-Procedure
139197,9613,quadrantectomy,I-Procedure
139198,9614,age,B-Person
139199,9614,under,O
139200,9614,18y,O
139201,9614,or,O
139202,9614,over,O
139203,9614,85y,O
139204,9615,diabetes,B-Condition
139205,9615,type,I-Condition
139206,9615,1,I-Condition
139207,9615,with,O
139208,9615,complications,B-Condition
139209,9616,no,O
139210,9616,co,B-Observation
139211,9616,-,I-Observation
139212,9616,operation,I-Observation
139213,9616,or,O
139214,9616,inadequate,B-Observation
139215,9616,finnish,I-Observation
139216,9616,language,I-Observation
139217,9616,skills,I-Observation
139218,9617,persistent,B-Condition
139219,9617,pain,I-Condition
139220,9617,for,O
139221,9617,other,O
139222,9617,reason,O
139223,9618,severe,O
139224,9618,hepatic,B-Condition
139225,9618,insufficiency,I-Condition
139226,9618,or,O
139227,9618,paracetamol,B-Drug
139228,9618,(,O
139229,9618,acetaminophen,B-Drug
139230,9618,),O
139231,9618,is,O
139232,9618,contraindicated,B-Condition
139233,9618,for,O
139234,9618,other,O
139235,9618,reason,O
139236,9619,any,O
139237,9619,type,O
139238,9619,of,O
139239,9619,steroid,B-Drug
139240,9619,in,O
139241,9619,regular,O
139242,9619,use,O
139243,9620,oxycodone,B-Drug
139244,9620,contraindicated,B-Condition
139245,9621,medications,O
139246,9621,changing,O
139247,9621,notably,O
139248,9621,paracetamol,B-Drug
139249,9621,(,O
139250,9621,acetaminophen,B-Drug
139251,9621,),O
139252,9621,and/or,O
139253,9621,ropivacaine,B-Drug
139254,9621,metabolism,O
139255,9621,in,O
139256,9621,regular,O
139257,9621,use,O
139258,9622,patients,O
139259,9622,with,O
139260,9622,renal,B-Condition
139261,9622,cancer,I-Condition
139262,9622,coming,O
139263,9622,to,O
139264,9622,the,O
139265,9622,laparoscopic,O
139266,9622,radical,B-Procedure
139267,9622,nephrectomy,I-Procedure
139268,9623,Therapy,O
139269,9623,area,O
139270,9623,located,O
139271,9623,outside,O
139272,9623,of,O
139273,9623,head,O
139274,9623,and,O
139275,9623,neck,O
139276,9623,;,O
139277,9624,Other,O
139278,9624,skin,B-Condition
139279,9624,diseases,I-Condition
139280,9624,that,O
139281,9624,might,O
139282,9624,interfere,O
139283,9624,with,O
139284,9624,the,O
139285,9624,efficacy,O
139286,9624,evaluation,O
139287,9624,;,O
139288,9625,Therapy,O
139289,9625,area,O
139290,9625,was,O
139291,9625,previously,O
139292,9625,received,O
139293,9625,isotope,B-Drug
139294,9625,or,O
139295,9625,PDT,B-Drug
139296,9625,or,O
139297,9625,other,O
139298,9625,treatment,B-Procedure
139299,9625,which,O
139300,9625,might,O
139301,9625,interfere,O
139302,9625,with,O
139303,9625,the,O
139304,9625,efficacy,O
139305,9625,evaluation,O
139306,9625,;,O
139307,9626,Allergy,B-Condition
139308,9626,to,O
139309,9626,porphyrins,B-Drug
139310,9626,and,O
139311,9626,analogues,B-Drug
139312,9626,;,O
139313,9626,Photosensitivity,B-Condition
139314,9626,;,O
139315,9626,Porphyria,B-Condition
139316,9626,;,O
139317,9626,Allergic,B-Condition
139318,9626,constitution,I-Condition
139319,9626,;,O
139320,9627,Scar,B-Condition
139321,9627,diathesis,I-Condition
139322,9627,;,O
139323,9628,Immunocompromised,B-Condition
139324,9628,conditions,I-Condition
139325,9628,;,O
139326,9629,Electrocardiographic,B-Condition
139327,9629,abnormalities,I-Condition
139328,9629,or,O
139329,9629,organic,O
139330,9629,heart,B-Condition
139331,9629,diseases,I-Condition
139332,9629,;,O
139333,9630,Coagulation,B-Condition
139334,9630,disorders,I-Condition
139335,9630,;,O
139336,9631,Hepatic,O
139337,9631,or,O
139338,9631,renal,O
139339,9631,functions,O
139340,9631,abnormal,O
139341,9631,(,O
139342,9631,alanine,O
139343,9631,aminotransferase,O
139344,9631,or,O
139345,9631,aspartate,O
139346,9631,transaminase,O
139347,9631,or,O
139348,9631,total,O
139349,9631,bilirubin,O
139350,9631,>,O
139351,9631,1.5,O
139352,9631,upper,O
139353,9631,limit,O
139354,9631,of,O
139355,9631,normal,O
139356,9631,[,O
139357,9631,ULN,O
139358,9631,],O
139359,9631,",",O
139360,9631,or,O
139361,9631,serum,O
139362,9631,creatinine,O
139363,9631,or,O
139364,9631,blood,O
139365,9631,urea,O
139366,9631,nitrogen,O
139367,9631,>,O
139368,9631,1.5,O
139369,9631,ULN,O
139370,9631,),O
139371,9631,;,O
139372,9632,Psychiatric,B-Condition
139373,9632,diseases,I-Condition
139374,9632,;,O
139375,9632,Severe,O
139376,9632,endocrinopathies,B-Condition
139377,9632,;,O
139378,9633,Previous,O
139379,9633,therapy,B-Procedure
139380,9633,of,O
139381,9633,PWS,B-Condition
139382,9633,within,O
139383,9633,the,O
139384,9633,last,O
139385,9633,4,O
139386,9633,weeks,O
139387,9633,;,O
139388,9634,Participation,B-Observation
139389,9634,in,I-Observation
139390,9634,any,I-Observation
139391,9634,clinical,I-Observation
139392,9634,studies,I-Observation
139393,9634,within,O
139394,9634,the,O
139395,9634,last,O
139396,9634,4,O
139397,9634,weeks,O
139398,9634,;,O
139399,9635,Be,O
139400,9635,judged,O
139401,9635,not,O
139402,9635,suitable,O
139403,9635,to,O
139404,9635,participate,O
139405,9635,the,O
139406,9635,study,O
139407,9635,by,O
139408,9635,the,O
139409,9635,investigators,O
139410,9636,Children,B-Person
139411,9636,with,O
139412,9636,clinical,O
139413,9636,diagnosis,O
139414,9636,of,O
139415,9636,PWS,B-Condition
139416,9636,;,O
139417,9637,Age,B-Person
139418,9637,range,O
139419,9637,:,O
139420,9637,7,O
139421,9637,to,O
139422,9637,14,O
139423,9637,years,O
139424,9637,-,O
139425,9637,old,O
139426,9637,;,O
139427,9638,Voluntarily,B-Observation
139428,9638,participated,I-Observation
139429,9638,and,O
139430,9638,Written,B-Observation
139431,9638,informed,I-Observation
139432,9638,consent,I-Observation
139433,9638,signed,I-Observation
139434,9639,cauda,O
139435,9639,equina,O
139436,9639,or,O
139437,9639,conus,O
139438,9639,lesion,B-Condition
139439,9640,currently,O
139440,9640,use,O
139441,9640,ventilator,B-Procedure
139442,9641,colostomy,B-Procedure
139443,9641,",",O
139444,9641,or,O
139445,9641,do,O
139446,9641,not,O
139447,9641,perform,O
139448,9641,regular,B-Procedure
139449,9641,bowel,I-Procedure
139450,9641,care,I-Procedure
139451,9641,for,O
139452,9641,any,O
139453,9641,reason,O
139454,9642,any,O
139455,9642,skin,B-Condition
139456,9642,breakdown,I-Condition
139457,9642,(,O
139458,9642,pressure,B-Condition
139459,9642,sores,I-Condition
139460,9642,),O
139461,9643,do,O
139462,9643,not,O
139463,9643,speak,B-Observation
139464,9643,English,I-Observation
139465,9644,are,O
139466,9644,under,O
139467,9644,19,O
139468,9644,years,O
139469,9644,old,B-Person
139470,9645,are,O
139471,9645,pregnant,B-Condition
139472,9645,or,O
139473,9645,think,B-Mood
139474,9645,you,I-Mood
139475,9645,might,I-Mood
139476,9645,be,I-Mood
139477,9645,pregnant,B-Condition
139478,9646,medical,B-Condition
139479,9646,/,I-Condition
139480,9646,psychiatric,I-Condition
139481,9646,condition,I-Condition
139482,9646,or,O
139483,9646,substance,B-Condition
139484,9646,abuse,I-Condition
139485,9646,that,O
139486,9646,is,O
139487,9646,likely,O
139488,9646,to,O
139489,9646,affect,O
139490,9646,your,O
139491,9646,ability,O
139492,9646,to,O
139493,9646,complete,O
139494,9646,this,O
139495,9646,study,O
139496,9647,currently,O
139497,9647,using,O
139498,9647,medications,B-Drug
139499,9647,containing,I-Drug
139500,9647,lidocaine,I-Drug
139501,9648,allergy,B-Condition
139502,9648,to,O
139503,9648,lidocaine,B-Drug
139504,9649,traumatic,B-Condition
139505,9649,spinal,I-Condition
139506,9649,cord,I-Condition
139507,9649,injury,I-Condition
139508,9649,at,O
139509,9649,least,O
139510,9649,one,O
139511,9649,year,O
139512,9649,ago,O
139513,9650,regular,B-Observation
139514,9650,bowel,I-Observation
139515,9650,care,I-Observation
139516,9650,routine,I-Observation
139517,9650,(,O
139518,9650,at,O
139519,9650,least,O
139520,9650,four,O
139521,9650,weeks,O
139522,9650,),O
139523,9651,Multiple,B-Condition
139524,9651,pregnancy,I-Condition
139525,9652,Prior,O
139526,9652,spontaneous,B-Condition
139527,9652,preterm,I-Condition
139528,9652,birth,I-Condition
139529,9652,or,O
139530,9652,second,O
139531,9652,trimester,O
139532,9652,losses,B-Condition
139533,9652,between,O
139534,9652,16(0,O
139535,9652,),O
139536,9652,and,O
139537,9652,36(6,O
139538,9652,),O
139539,9652,weeks,O
139540,9653,Cerclage,B-Condition
139541,9653,in,I-Condition
139542,9653,situ,I-Condition
139543,9654,Painful,B-Condition
139544,9654,regular,I-Condition
139545,9654,uterine,I-Condition
139546,9654,contraction,I-Condition
139547,9654,and/or,O
139548,9654,preterm,B-Condition
139549,9654,labor,I-Condition
139550,9655,Ruptured,B-Condition
139551,9655,membranes,I-Condition
139552,9656,Major,B-Condition
139553,9656,fetal,I-Condition
139554,9656,defects,I-Condition
139555,9657,Active,B-Condition
139556,9657,vaginal,I-Condition
139557,9657,bleeding,I-Condition
139558,9658,Placenda,B-Condition
139559,9658,previa,I-Condition
139560,9658,and/or,O
139561,9658,accreta,B-Condition
139562,9659,Cervical,O
139563,9659,dilation,O
139564,9659,>,O
139565,9659,1.5,O
139566,9659,cm,O
139567,9659,and/or,O
139568,9659,visible,B-Condition
139569,9659,membranes,I-Condition
139570,9659,by,O
139571,9659,pelvic,B-Procedure
139572,9659,exam,I-Procedure
139573,9660,Suspicion,B-Mood
139574,9660,of,I-Mood
139575,9660,chorioamnionitis,B-Condition
139576,9661,18,O
139577,9661,-,O
139578,9661,50,O
139579,9661,ages,B-Person
139580,9662,Singleton,B-Condition
139581,9662,pregnancy,I-Condition
139582,9663,Cervical,O
139583,9663,length,O
139584,9663,<,O
139585,9663,=,O
139586,9663,25,O
139587,9663,mm,O
139588,9663,between,O
139589,9663,18(0,O
139590,9663,),O
139591,9663,and,O
139592,9663,23(6,O
139593,9663,),O
139594,9663,weeks,O
139595,9664,Hemoglobin,O
139596,9664,>,O
139597,9664,12g,O
139598,9664,/,O
139599,9664,dL,O
139600,9665,Hematochrit,O
139601,9665,>,O
139602,9665,36,O
139603,9665,%,O
139604,9666,Thrombocytosis,O
139605,9666,>,O
139606,9666,750,O
139607,9666,K,O
139608,9667,AST,O
139609,9667,or,O
139610,9667,ALT,O
139611,9667,>,O
139612,9667,120,O
139613,9668,HIV,B-Condition
139614,9668,(,I-Condition
139615,9668,+,I-Condition
139616,9668,),I-Condition
139617,9669,Allergic,B-Condition
139618,9669,reaction,O
139619,9669,upon,O
139620,9669,erythropoietin,B-Drug
139621,9670,Uncontrolled,B-Condition
139622,9670,hypertension,I-Condition
139623,9671,mRS,O
139624,9671,before,O
139625,9671,the,O
139626,9671,autoimmune,B-Condition
139627,9671,encephalitis,I-Condition
139628,9671,>,O
139629,9671,3,O
139630,9672,Breast,B-Observation
139631,9672,feeding,I-Observation
139632,9672,or,O
139633,9672,pregnancy,B-Condition
139634,9673,History,B-Observation
139635,9673,of,O
139636,9673,ischemic,B-Condition
139637,9673,stroke,I-Condition
139638,9673,or,O
139639,9673,pulmonary,B-Condition
139640,9673,thrombosis,I-Condition
139641,9674,Refuse,B-Observation
139642,9674,to,I-Observation
139643,9674,be,I-Observation
139644,9674,enrolled,I-Observation
139645,9675,Clinically,O
139646,9675,diagnosed,O
139647,9675,autoimmune,B-Condition
139648,9675,encephalitis,I-Condition
139649,9676,Ineffective,O
139650,9676,1st,B-Procedure
139651,9676,line,I-Procedure
139652,9676,treatment,I-Procedure
139653,9676,(,O
139654,9676,e.g.,O
139655,9676,steroid,B-Drug
139656,9676,IV,I-Drug
139657,9676,",",O
139658,9676,IVIg,B-Drug
139659,9676,),O
139660,9676,and,O
139661,9676,2nd,B-Procedure
139662,9676,line,I-Procedure
139663,9676,treatment,I-Procedure
139664,9676,(,O
139665,9676,e.g.,O
139666,9676,Rituximab,B-Drug
139667,9676,or,O
139668,9676,cyclophosphamide,B-Drug
139669,9676,),O
139670,9677,Baseline,O
139671,9677,cognitive,O
139672,9677,deficits,O
139673,9677,sufficient,O
139674,9677,to,O
139675,9677,make,O
139676,9677,objective,O
139677,9677,pain,O
139678,9677,self,O
139679,9677,-,O
139680,9677,assessments,O
139681,9677,unreliable,O
139682,9677,in,O
139683,9677,the,O
139684,9677,estimation,O
139685,9677,of,O
139686,9677,the,O
139687,9677,Study,O
139688,9677,Investigators,O
139689,9677,.,O
139690,9678,Immunocompromised,B-Condition
139691,9678,subject,O
139692,9679,Coagulopathy,B-Condition
139693,9680,Severe,O
139694,9680,liver,B-Condition
139695,9680,and,I-Condition
139696,9680,renal,I-Condition
139697,9680,dysfunction,I-Condition
139698,9681,Preoperative,O
139699,9681,neurological,B-Condition
139700,9681,deficits,I-Condition
139701,9682,The,O
139702,9682,dura,B-Observation
139703,9682,damage,I-Observation
139704,9682,during,O
139705,9682,surgery,B-Procedure
139706,9683,Inability,O
139707,9683,to,O
139708,9683,follow,O
139709,9683,directions,O
139710,9683,or,O
139711,9683,comprehend,O
139712,9683,the,O
139713,9683,English,O
139714,9683,language,O
139715,9683,.,O
139716,9684,Females,O
139717,9684,who,O
139718,9684,are,O
139719,9684,pregnant,O
139720,9684,as,O
139721,9684,determined,O
139722,9684,by,O
139723,9684,positive,O
139724,9684,pregnancy,O
139725,9684,test,O
139726,9684,on,O
139727,9684,or,O
139728,9684,before,O
139729,9684,the,O
139730,9684,day,O
139731,9684,of,O
139732,9684,surgery,O
139733,9684,.,O
139734,9685,Prisoners,B-Person
139735,9685,.,O
139736,9686,Patient,O
139737,9686,refusal,O
139738,9686,to,O
139739,9686,provide,O
139740,9686,informed,O
139741,9686,consent,O
139742,9686,.,O
139743,9687,Allergy,B-Condition
139744,9687,to,O
139745,9687,amide,B-Drug
139746,9687,local,I-Drug
139747,9687,anesthetics,I-Drug
139748,9687,(,O
139749,9687,lidocaine,B-Drug
139750,9687,",",O
139751,9687,bupivacaine,B-Drug
139752,9687,",",O
139753,9687,ropivacaine,B-Drug
139754,9687,),O
139755,9687,or,O
139756,9687,opioid,B-Drug
139757,9687,(,O
139758,9687,fentanyl,B-Drug
139759,9687,),O
139760,9687,.,O
139761,9688,Adult,B-Person
139762,9688,subjects,O
139763,9688,aged,B-Person
139764,9688,18,O
139765,9688,years,O
139766,9688,or,O
139767,9688,older,O
139768,9689,Scheduled,B-Mood
139769,9689,for,I-Mood
139770,9689,elective,O
139771,9689,posterior,B-Procedure
139772,9689,lumbar,I-Procedure
139773,9689,spinal,I-Procedure
139774,9689,fusion,I-Procedure
139775,9689,surgery,I-Procedure
139776,9689,between,O
139777,9689,1,O
139778,9689,and,O
139779,9689,3,O
139780,9689,levels,O
139781,9690,Unable,O
139782,9690,to,O
139783,9690,consent,O
139784,9691,Chronic,O
139785,9691,opioid,B-Condition
139786,9691,consumption,I-Condition
139787,9692,Allergy,B-Condition
139788,9692,to,O
139789,9692,study,B-Drug
139790,9692,medication,I-Drug
139791,9693,Lower,B-Procedure
139792,9693,limb,I-Procedure
139793,9693,surgery,I-Procedure
139794,9693,preceding,O
139795,9693,year,O
139796,9694,Unable,O
139797,9694,to,O
139798,9694,complete,O
139799,9694,baseline,O
139800,9694,testing,O
139801,9694,",",O
139802,9694,pre,O
139803,9694,-,O
139804,9694,existing,O
139805,9694,neurological,B-Condition
139806,9694,deficit,I-Condition
139807,9695,Contraindication,B-Condition
139808,9695,to,O
139809,9695,spinal,B-Procedure
139810,9695,anaesthesia,I-Procedure
139811,9696,Patients,O
139812,9696,undergoing,O
139813,9696,total,B-Procedure
139814,9696,knee,I-Procedure
139815,9696,arthroplasty,I-Procedure
139816,9696,under,O
139817,9696,spinal,B-Procedure
139818,9696,anaesthesia,I-Procedure
139819,9697,45y,O
139820,9697,or,O
139821,9697,older,O
139822,9698,ASA,O
139823,9698,1,O
139824,9698,-,O
139825,9698,3,O
139826,9699,BMI,O
139827,9699,18,O
139828,9699,-,O
139829,9699,35,O
139830,9700,Patient,O
139831,9700,has,O
139832,9700,history,B-Observation
139833,9700,of,I-Observation
139834,9700,loose,B-Condition
139835,9700,or,I-Condition
139836,9700,watery,I-Condition
139837,9700,stools,I-Condition
139838,9701,Patient,O
139839,9701,has,O
139840,9701,both,O
139841,9701,clinically,B-Condition
139842,9701,significant,I-Condition
139843,9701,findings,I-Condition
139844,9701,and,O
139845,9701,unexplained,O
139846,9701,clinically,B-Condition
139847,9701,significant,I-Condition
139848,9701,alarm,I-Condition
139849,9701,symptoms,I-Condition
139850,9702,Patient,O
139851,9702,has,O
139852,9702,symptoms,O
139853,9702,of,O
139854,9702,or,O
139855,9702,been,O
139856,9702,diagnosed,O
139857,9702,with,O
139858,9702,a,O
139859,9702,medical,B-Condition
139860,9702,condition,I-Condition
139861,9702,that,O
139862,9702,may,O
139863,9702,contribute,O
139864,9702,to,O
139865,9702,abdominal,B-Condition
139866,9702,pain,I-Condition
139867,9703,Patient,O
139868,9703,has,O
139869,9703,any,O
139870,9703,protocol,O
139871,9703,-,O
139872,9703,excluded,O
139873,9703,or,O
139874,9703,clinically,O
139875,9703,significant,O
139876,9703,medical,B-Observation
139877,9703,or,I-Observation
139878,9703,surgical,I-Observation
139879,9703,history,I-Observation
139880,9703,that,O
139881,9703,could,O
139882,9703,confound,O
139883,9703,the,O
139884,9703,study,O
139885,9703,assessments,O
139886,9704,Patient,O
139887,9704,meets,O
139888,9704,protocol,O
139889,9704,criteria,O
139890,9704,for,O
139891,9704,diagnosis,O
139892,9704,of,O
139893,9704,IBS,B-Condition
139894,9704,-,I-Condition
139895,9704,C,I-Condition
139896,9704,",",O
139897,9704,abdominal,B-Condition
139898,9704,pain,I-Condition
139899,9704,",",O
139900,9704,abdominal,B-Condition
139901,9704,bloating,I-Condition
139902,9704,and,O
139903,9704,abdominal,B-Condition
139904,9704,girth,I-Condition
139905,9705,(,O
139906,9705,1,O
139907,9705,),O
139908,9705,Uterine,B-Condition
139909,9705,abnormalities,I-Condition
139910,9705,(,O
139911,9705,e.g.,O
139912,9705,septate,B-Condition
139913,9705,",",I-Condition
139914,9705,bicornuate,I-Condition
139915,9705,and,I-Condition
139916,9705,fibroid,I-Condition
139917,9705,uterus,I-Condition
139918,9705,",",O
139919,9705,Asherman,B-Condition
139920,9705,Syndrome,I-Condition
139921,9705,),O
139922,9705,.,O
139923,9706,Concurrent,O
139924,9706,use,O
139925,9706,of,O
139926,9706,organic,B-Drug
139927,9706,nitrites,I-Drug
139928,9706,and,O
139929,9706,nitrates,B-Drug
139930,9706,.,O
139931,9707,Severe,O
139932,9707,hepatic,B-Condition
139933,9707,impairment,I-Condition
139934,9707,.,O
139935,9708,Severe,O
139936,9708,renal,B-Condition
139937,9708,impairment,I-Condition
139938,9708,.,O
139939,9709,Hypotension,B-Condition
139940,9709,.,O
139941,9710,Recent,O
139942,9710,stroke,B-Condition
139943,9710,or,O
139944,9710,heart,B-Condition
139945,9710,attack,I-Condition
139946,9710,.,O
139947,9711,(,O
139948,9711,1,O
139949,9711,),O
139950,9711,cases,O
139951,9711,of,O
139952,9711,infertility,B-Condition
139953,9711,",",O
139954,9711,older,O
139955,9711,than,O
139956,9711,20,O
139957,9711,years,O
139958,9711,of,O
139959,9711,age,B-Person
139960,9711,and,O
139961,9711,not,O
139962,9711,older,O
139963,9711,than,O
139964,9711,40,O
139965,9711,years,O
139966,9711,.,O
139967,9712,(,O
139968,9712,2,O
139969,9712,),O
139970,9712,Body,O
139971,9712,mass,O
139972,9712,index,O
139973,9712,(,O
139974,9712,BMI):20,O
139975,9712,-,O
139976,9712,29,O
139977,9712,.,O
139978,9713,(,O
139979,9713,3,O
139980,9713,),O
139981,9713,women,B-Person
139982,9713,have,O
139983,9713,experienced,O
139984,9713,two,O
139985,9713,or,O
139986,9713,more,O
139987,9713,implantation,B-Procedure
139988,9713,failure,O
139989,9713,attributed,B-Mood
139990,9713,to,I-Mood
139991,9713,inadequate,B-Condition
139992,9713,endometrial,I-Condition
139993,9713,development,I-Condition
139994,9713,.,O
139995,9714,Any,O
139996,9714,intraocular,B-Condition
139997,9714,inflammation,I-Condition
139998,9714,in,O
139999,9714,the,O
140000,9714,study,O
140001,9714,eye,O
140002,9714,present,O
140003,9714,during,O
140004,9714,the,O
140005,9714,screening,O
140006,9714,slit,B-Procedure
140007,9714,lamp,I-Procedure
140008,9714,examination,I-Procedure
140009,9715,Score,O
140010,9715,greater,O
140011,9715,than,O
140012,9715,"""",O
140013,9715,0,O
140014,9715,"""",O
140015,9715,on,O
140016,9715,the,O
140017,9715,Ocular,O
140018,9715,Pain,O
140019,9715,Assessment,O
140020,9715,in,O
140021,9715,the,O
140022,9715,study,O
140023,9715,eye,O
140024,9715,at,O
140025,9715,Screening,O
140026,9716,Any,O
140027,9716,intraocular,B-Condition
140028,9716,inflammation,I-Condition
140029,9716,in,O
140030,9716,the,O
140031,9716,study,O
140032,9716,eye,O
140033,9716,present,O
140034,9716,during,O
140035,9716,the,O
140036,9716,screening,O
140037,9716,slit,B-Procedure
140038,9716,lamp,I-Procedure
140039,9716,examination,I-Procedure
140040,9717,Has,O
140041,9717,a,O
140042,9717,cataract,B-Condition
140043,9717,and,O
140044,9717,is,O
140045,9717,expected,O
140046,9717,to,O
140047,9717,undergo,O
140048,9717,clear,B-Procedure
140049,9717,corneal,I-Procedure
140050,9717,cataract,I-Procedure
140051,9717,surgery,I-Procedure
140052,9717,with,O
140053,9717,phacoemulsification,O
140054,9717,and,O
140055,9717,implantation,O
140056,9717,of,O
140057,9717,a,O
140058,9717,posterior,O
140059,9717,chamber,O
140060,9717,intraocular,O
140061,9717,lens,O
140062,9718,Has,O
140063,9718,a,O
140064,9718,potential,O
140065,9718,post,O
140066,9718,-,O
140067,9718,operative,O
140068,9718,pinhole,O
140069,9718,corrected,O
140070,9718,Snellen,O
140071,9718,VA,O
140072,9718,of,O
140073,9718,at,O
140074,9718,least,O
140075,9718,20/200,O
140076,9718,or,O
140077,9718,better,O
140078,9718,in,O
140079,9718,both,O
140080,9718,eyes,O
140081,9719,Inability,O
140082,9719,to,O
140083,9719,obtain,O
140084,9719,consent,O
140085,9719,from,O
140086,9719,patient,O
140087,9719,or,O
140088,9719,patients,O
140089,9719,kin,O
140090,9720,Pregnant,O
140091,9720,women,O
140092,9721,less,O
140093,9721,than,O
140094,9721,18,O
140095,9721,years,O
140096,9721,of,O
140097,9721,age,B-Person
140098,9721,of,O
140099,9721,more,O
140100,9721,than,O
140101,9721,80,O
140102,9721,years,O
140103,9721,of,O
140104,9721,age,B-Person
140105,9722,Hunt,O
140106,9722,Hess,O
140107,9722,Grade,O
140108,9722,5,O
140109,9722,SAH,B-Condition
140110,9723,Adult,B-Person
140111,9723,patient,O
140112,9723,",",O
140113,9723,age,B-Person
140114,9723,18,O
140115,9723,-,O
140116,9723,80,O
140117,9723,years,O
140118,9723,old,O
140119,9723,",",O
140120,9723,with,O
140121,9723,ruptured,B-Condition
140122,9723,aneurysm(s,I-Condition
140123,9723,),O
140124,9723,who,O
140125,9723,experience,O
140126,9723,cerebral,B-Condition
140127,9723,vasospasm,I-Condition
140128,9723,post,O
140129,9723,operatively,O
140130,9723,within,O
140131,9723,3,O
140132,9723,-,O
140133,9723,21,O
140134,9723,days,O
140135,9723,.,O
140136,9724,ileus,B-Condition
140137,9725,known,B-Mood
140138,9725,or,O
140139,9725,suspected,B-Mood
140140,9725,bowel,B-Condition
140141,9725,obstruction,I-Condition
140142,9726,active,O
140143,9726,bowel,B-Condition
140144,9726,inflammation,I-Condition
140145,9727,pregnancy,B-Condition
140146,9728,any,O
140147,9728,presence,O
140148,9728,of,O
140149,9728,serious,B-Condition
140150,9728,medical,I-Condition
140151,9728,conditions,I-Condition
140152,9728,(,O
140153,9728,esp,O
140154,9728,.,O
140155,9728,cardiac,B-Condition
140156,9728,",",I-Condition
140157,9728,renal,I-Condition
140158,9728,",",I-Condition
140159,9728,liver,I-Condition
140160,9728,diseases,I-Condition
140161,9728,),O
140162,9729,history,B-Observation
140163,9729,of,I-Observation
140164,9729,prior,O
140165,9729,colonic,B-Procedure
140166,9729,or,I-Procedure
140167,9729,rectal,I-Procedure
140168,9729,surgery,I-Procedure
140169,9730,inability,O
140170,9730,to,O
140171,9730,obtain,O
140172,9730,valid,O
140173,9730,data,O
140174,9730,from,O
140175,9731,Subjects,O
140176,9731,referred,O
140177,9731,to,O
140178,9731,diagnostic,B-Observation
140179,9731,or,O
140180,9731,therapeutic,B-Observation
140181,9731,colonoscopy,B-Procedure
140182,9731,.,O
140183,9732,cardiac,B-Condition
140184,9732,or,I-Condition
140185,9732,non,I-Condition
140186,9732,-,I-Condition
140187,9732,cardiac,I-Condition
140188,9732,illness,I-Condition
140189,9732,with,O
140190,9732,life,B-Observation
140191,9732,expectancy,I-Observation
140192,9732,of,O
140193,9732,less,O
140194,9732,than,O
140195,9732,two,O
140196,9732,years,O
140197,9732,;,O
140198,9733,failure,O
140199,9733,to,O
140200,9733,advance,B-Procedure
140201,9733,the,I-Procedure
140202,9733,IVUS,I-Procedure
140203,9733,catheter,I-Procedure
140204,9733,through,O
140205,9733,the,O
140206,9733,culprit,O
140207,9733,lesion,O
140208,9733,;,O
140209,9734,acute,B-Condition
140210,9734,coronary,I-Condition
140211,9734,syndrome,I-Condition
140212,9735,congestive,B-Condition
140213,9735,heart,I-Condition
140214,9735,failure,I-Condition
140215,9735,NYHA,O
140216,9735,III,O
140217,9735,-,O
140218,9735,IV,O
140219,9736,diabetes,B-Condition
140220,9736,mellitus,I-Condition
140221,9737,chronic,B-Condition
140222,9737,kidney,I-Condition
140223,9737,disease,I-Condition
140224,9738,previous,O
140225,9738,PCI,B-Procedure
140226,9738,in,O
140227,9738,the,O
140228,9738,target,O
140229,9738,vessel,O
140230,9739,heavily,B-Condition
140231,9739,calcified,I-Condition
140232,9739,vessels,I-Condition
140233,9740,allergy,B-Condition
140234,9740,to,O
140235,9740,metformin,B-Drug
140236,9741,age,B-Person
140237,9741,=,O
140238,9741,18,O
140239,9741,and,O
140240,9741,<,O
140241,9741,75,O
140242,9741,years,O
140243,9741,;,O
140244,9742,patients,O
140245,9742,with,O
140246,9742,stable,O
140247,9742,coronary,B-Condition
140248,9742,artery,I-Condition
140249,9742,disease,I-Condition
140250,9742,referred,B-Mood
140251,9742,to,I-Mood
140252,9742,PCI,B-Procedure
140253,9742,in,O
140254,9742,an,O
140255,9742,artery,O
140256,9742,suitable,O
140257,9742,for,O
140258,9742,IVUS,O
140259,9742,pullback,O
140260,9742,;,O
140261,9743,signed,O
140262,9743,informed,O
140263,9743,consent,O
140264,9743,before,O
140265,9743,PCI,O
140266,9743,.,O
140267,9744,Patients,O
140268,9744,with,O
140269,9744,known,B-Mood
140270,9744,or,O
140271,9744,suspected,B-Mood
140272,9744,heparin,B-Drug
140273,9744,induced,O
140274,9744,thrombocytopenia,B-Condition
140275,9744,prior,O
140276,9744,to,O
140277,9744,consent,O
140278,9745,Patients,O
140279,9745,with,O
140280,9745,hepatic,B-Condition
140281,9745,failure,I-Condition
140282,9745,defined,O
140283,9745,as,O
140284,9745,coagulopathy,B-Condition
140285,9745,with,O
140286,9745,elevated,O
140287,9745,transaminases,O
140288,9745,more,O
140289,9745,than,O
140290,9745,three,O
140291,9745,times,O
140292,9745,normal,O
140293,9745,values,O
140294,9746,Patients,O
140295,9746,with,O
140296,9746,plan,O
140297,9746,to,O
140298,9746,decannulate,B-Procedure
140299,9746,from,I-Procedure
140300,9746,ECMO,I-Procedure
140301,9746,within,O
140302,9746,48,O
140303,9746,hours,O
140304,9747,Known,B-Mood
140305,9747,or,O
140306,9747,suspected,B-Mood
140307,9747,pregnant,B-Condition
140308,9747,women,B-Person
140309,9748,Previous,O
140310,9748,enrollment,O
140311,9748,in,O
140312,9748,this,O
140313,9748,study,O
140314,9749,Primary,O
140315,9749,language,O
140316,9749,spoken,O
140317,9749,that,O
140318,9749,is,O
140319,9749,not,O
140320,9749,English,O
140321,9749,or,O
140322,9749,Spanish,O
140323,9750,Age,B-Person
140324,9750,1,O
140325,9750,day,O
140326,9750,to,O
140327,9750,less,O
140328,9750,than,O
140329,9750,18,O
140330,9750,years,O
140331,9751,Cared,O
140332,9751,for,O
140333,9751,in,O
140334,9751,the,O
140335,9751,pediatric,O
140336,9751,intensive,O
140337,9751,care,O
140338,9751,unit,O
140339,9751,or,O
140340,9751,pediatric,O
140341,9751,cardiac,O
140342,9751,intensive,O
140343,9751,care,O
140344,9751,unit,O
140345,9752,receiving,O
140346,9752,venovenous,B-Procedure
140347,9752,or,I-Procedure
140348,9752,venoarterial,I-Procedure
140349,9752,ECMO,I-Procedure
140350,9753,History,B-Observation
140351,9753,of,O
140352,9753,significant,O
140353,9753,head,B-Condition
140354,9753,trauma,I-Condition
140355,9753,",",O
140356,9753,seizure,B-Condition
140357,9753,disorder,I-Condition
140358,9753,",",O
140359,9753,or,O
140360,9753,mental,B-Condition
140361,9753,retardation,I-Condition
140362,9754,History,B-Observation
140363,9754,of,O
140364,9754,alcohol,O
140365,9754,or,O
140366,9754,drug,B-Condition
140367,9754,abuse,I-Condition
140368,9754,or,O
140369,9754,dependence,O
140370,9754,within,O
140371,9754,1,O
140372,9754,month,O
140373,9754,prior,O
140374,9754,to,O
140375,9754,study,O
140376,9754,entry,O
140377,9755,History,B-Observation
140378,9755,of,O
140379,9755,violence,B-Observation
140380,9755,within,O
140381,9755,6,O
140382,9755,months,O
140383,9755,prior,O
140384,9755,to,O
140385,9755,study,O
140386,9755,entry,O
140387,9756,Diagnosis,O
140388,9756,of,O
140389,9756,schizophrenia,B-Condition
140390,9756,or,O
140391,9756,schizoaffective,B-Condition
140392,9756,disorder,I-Condition
140393,9757,If,O
140394,9757,entering,O
140395,9757,the,O
140396,9757,study,O
140397,9757,as,O
140398,9757,an,O
140399,9757,inpatient,O
140400,9757,",",O
140401,9757,hospitalization,O
140402,9757,was,O
140403,9757,recent,O
140404,9758,Currently,O
140405,9758,receiving,O
140406,9758,treatment,B-Procedure
140407,9758,with,O
140408,9758,an,O
140409,9758,atypical,B-Drug
140410,9758,antipsychotic,I-Drug
140411,9758,and,O
140412,9758,continuation,B-Procedure
140413,9758,on,I-Procedure
140414,9758,the,I-Procedure
140415,9758,medication,I-Procedure
140416,9758,has,O
140417,9758,been,O
140418,9758,recommended,B-Mood
140419,9759,Assumes,O
140420,9759,primary,O
140421,9759,responsibility,O
140422,9759,for,O
140423,9759,taking,O
140424,9759,medication,O
140425,9760,Currently,O
140426,9760,living,B-Observation
140427,9760,in,I-Observation
140428,9760,a,I-Observation
140429,9760,stable,I-Observation
140430,9760,environment,I-Observation
140431,9761,Purulent,B-Condition
140432,9761,infection,I-Condition
140433,9762,Refusal,O
140434,9762,to,O
140435,9762,participate,O
140436,9763,Allergy,B-Condition
140437,9763,to,O
140438,9763,tested,B-Drug
140439,9763,material,I-Drug
140440,9764,Patients,O
140441,9764,after,O
140442,9764,throat,B-Procedure
140443,9764,surgeries,I-Procedure
140444,9764,:,O
140445,9764,tonsillectomy,B-Procedure
140446,9764,",",O
140447,9764,adenotonsillectomy,B-Procedure
140448,9764,",",O
140449,9764,uvulopalatoplasty,B-Procedure
140450,9764,",",O
140451,9764,uvulopalatopharyngoplasty,B-Procedure
140452,9765,Patients,O
140453,9765,with,O
140454,9765,acute,B-Condition
140455,9765,throat,I-Condition
140456,9765,diseases,I-Condition
140457,9765,:,O
140458,9765,pharyngitis,B-Condition
140459,9765,",",O
140460,9765,tonsillitis,B-Condition
140461,9765,",",O
140462,9765,pharyngotonsillitis,B-Condition
140463,9766,NA,O
140464,9767,children,B-Person
140465,9767,and,O
140466,9767,teenagers,B-Person
140467,9767,aged,B-Person
140468,9767,less,O
140469,9767,than,O
140470,9767,20,O
140471,9767,years,O
140472,9767,",",O
140473,9768,history,B-Observation
140474,9768,of,O
140475,9768,gastrectomy,B-Procedure
140476,9768,",",O
140477,9769,gastric,B-Condition
140478,9769,malignancy,I-Condition
140479,9769,",",O
140480,9769,including,O
140481,9769,adenocarcinoma,B-Condition
140482,9769,and,O
140483,9769,lymphoma,B-Condition
140484,9769,",",O
140485,9770,previous,O
140486,9770,allergic,B-Condition
140487,9770,reaction,I-Condition
140488,9770,to,O
140489,9770,antibiotics,B-Drug
140490,9770,(,O
140491,9770,bismuth,B-Drug
140492,9770,",",O
140493,9770,amoxicillin,B-Drug
140494,9770,",",O
140495,9770,metronidazole,B-Drug
140496,9770,",",O
140497,9770,clarithromycin,B-Drug
140498,9770,",",O
140499,9770,tetracycline,B-Drug
140500,9770,),O
140501,9770,and,O
140502,9770,PPI,B-Drug
140503,9770,(,O
140504,9770,esomeprazole,B-Drug
140505,9770,),O
140506,9770,",",O
140507,9771,contraindication,B-Condition
140508,9771,to,O
140509,9771,treatment,B-Drug
140510,9771,drugs,I-Drug
140511,9771,",",O
140512,9772,pregnant,B-Condition
140513,9772,or,O
140514,9772,lactating,B-Condition
140515,9772,women,B-Person
140516,9772,",",O
140517,9773,severe,O
140518,9773,concurrent,O
140519,9773,disease,B-Condition
140520,9773,",",O
140521,9774,concomitant,O
140522,9774,use,O
140523,9774,of,O
140524,9774,clopidogrel,B-Drug
140525,9774,",",O
140526,9774,or,O
140527,9774,(,O
140528,9774,9,O
140529,9774,),O
140530,9774,Unwilling,O
140531,9774,to,O
140532,9774,accept,O
140533,9774,random,O
140534,9774,assignment,O
140535,9774,of,O
140536,9774,subjects,O
140537,9775,Any,O
140538,9775,other,O
140539,9775,primary,O
140540,9775,DSM,O
140541,9775,-,O
140542,9775,IV,O
140543,9775,diagnosis,B-Condition
140544,9775,;,O
140545,9775,DSM,O
140546,9775,-,O
140547,9775,IV,O
140548,9775,criteria,O
140549,9775,for,O
140550,9775,body,B-Condition
140551,9775,dysmorphic,I-Condition
140552,9775,disorder,I-Condition
140553,9775,",",O
140554,9775,bipolar,B-Condition
140555,9775,affective,I-Condition
140556,9775,disorder,I-Condition
140557,9775,",",O
140558,9775,schizophrenia,B-Condition
140559,9775,",",O
140560,9775,psychotic,B-Condition
140561,9775,disorder,I-Condition
140562,9775,",",I-Condition
140563,9775,current,O
140564,9775,alcohol,B-Condition
140565,9775,/,I-Condition
140566,9775,substance,I-Condition
140567,9775,abuse,I-Condition
140568,9775,.,O
140569,9776,A,O
140570,9776,previous,O
140571,9776,adequate,O
140572,9776,trial,O
140573,9776,of,O
140574,9776,topiramate,B-Drug
140575,9777,Comorbid,O
140576,9777,major,B-Condition
140577,9777,depressive,I-Condition
140578,9777,disorder,I-Condition
140579,9777,diagnosis,O
140580,9777,which,O
140581,9777,predates,O
140582,9777,OCD,O
140583,9777,diagnosis,O
140584,9778,Cognitive,B-Procedure
140585,9778,behavioural,I-Procedure
140586,9778,therapy,I-Procedure
140587,9778,or,O
140588,9778,additional,O
140589,9778,psychotherapy,B-Procedure
140590,9778,in,O
140591,9778,past,O
140592,9778,four,O
140593,9778,months,O
140594,9779,Allergy,B-Condition
140595,9779,or,O
140596,9779,hypersensitivity,B-Condition
140597,9779,to,O
140598,9779,topiramate,B-Drug
140599,9780,BMI,O
140600,9780,<,O
140601,9780,20,O
140602,9781,History,B-Observation
140603,9781,of,I-Observation
140604,9781,kidney,B-Condition
140605,9781,stones,I-Condition
140606,9782,Outpatient,O
140607,9782,with,O
140608,9782,primary,O
140609,9782,DSM-,O
140610,9782,IV,O
140611,9782,OCD,B-Condition
140612,9783,Completion,O
140613,9783,of,O
140614,9783,a,O
140615,9783,14,O
140616,9783,-,O
140617,9783,week,O
140618,9783,open,O
140619,9783,label,O
140620,9783,trial,O
140621,9783,of,O
140622,9783,one,O
140623,9783,the,O
140624,9783,following,O
140625,9783,SRI,O
140626,9783,'s,O
140627,9783,:,O
140628,9783,fluoxetine,B-Drug
140629,9783,80,O
140630,9783,mg,O
140631,9783,/,O
140632,9783,day,O
140633,9783,",",O
140634,9783,paroxetine,B-Drug
140635,9783,60,O
140636,9783,mg,O
140637,9783,/,O
140638,9783,day,O
140639,9783,",",O
140640,9783,fluvoxamine,B-Drug
140641,9783,300,O
140642,9783,mg,O
140643,9783,/,O
140644,9783,day,O
140645,9783,",",O
140646,9783,clomipramine,B-Drug
140647,9783,250,O
140648,9783,mg,O
140649,9783,/,O
140650,9783,day,O
140651,9783,",",O
140652,9783,sertraline,B-Drug
140653,9783,200,O
140654,9783,mg,O
140655,9783,/,O
140656,9783,day,O
140657,9783,",",O
140658,9783,citalopram,B-Drug
140659,9783,60,O
140660,9783,mg,O
140661,9783,/,O
140662,9783,day,O
140663,9783,",",O
140664,9783,escitalopram,B-Drug
140665,9783,30,O
140666,9783,mg,O
140667,9783,/,O
140668,9783,day,O
140669,9783,and,O
140670,9783,demonstrating,O
140671,9783,a,O
140672,9783,non,O
140673,9783,or,O
140674,9783,partial,O
140675,9783,responses,B-Condition
140676,9783,to,I-Condition
140677,9783,SRI,B-Procedure
140678,9783,treatment,I-Procedure
140679,9783,(,O
140680,9783,CGI,O
140681,9783,-,O
140682,9783,I,O
140683,9783,of,O
140684,9783,3,O
140685,9783,or,O
140686,9783,4,O
140687,9783,",",O
140688,9783,Y,O
140689,9783,-,O
140690,9783,BOCS,O
140691,9783,reduction,O
140692,9783,of,O
140693,9783,<,O
140694,9783,35,O
140695,9783,%,O
140696,9783,),O
140697,9784,Stable,O
140698,9784,(,O
140699,9784,8,O
140700,9784,wks,O
140701,9784,or,O
140702,9784,longer,O
140703,9784,),O
140704,9784,concurrent,O
140705,9784,medications,B-Drug
140706,9784,including,O
140707,9784,benzodiazepines,B-Drug
140708,9784,",",O
140709,9784,sedative,B-Drug
140710,9784,hypnotics,I-Drug
140711,9784,",",O
140712,9784,antipsychotics,B-Drug
140713,9784,",",O
140714,9784,and,O
140715,9784,antidepressants,B-Drug
140716,9784,.,O
140717,9785,Type,B-Condition
140718,9785,1,I-Condition
140719,9785,diabetes,I-Condition
140720,9786,uncontrolled,O
140721,9786,diabetes,B-Condition
140722,9786,mellitus,I-Condition
140723,9786,type,I-Condition
140724,9786,2,I-Condition
140725,9786,with,O
140726,9786,fasting,O
140727,9786,glucose,O
140728,9786,>,O
140729,9786,13.3,O
140730,9786,mmol,O
140731,9786,/,O
140732,9786,l,O
140733,9786,confirmed,O
140734,9786,on,O
140735,9786,a,O
140736,9786,second,O
140737,9786,day,O
140738,9787,known,O
140739,9787,or,O
140740,9787,suspected,O
140741,9787,hypersensitivity,B-Condition
140742,9787,to,O
140743,9787,empagliflozin,B-Drug
140744,9787,",",O
140745,9787,glimepiride,B-Drug
140746,9787,",",O
140747,9787,or,O
140748,9787,any,O
140749,9787,excipients,O
140750,9787,;,O
140751,9787,and,O
140752,9787,/,O
140753,9787,or,O
140754,9787,known,O
140755,9787,or,O
140756,9787,suspected,O
140757,9787,hypersensitivity,B-Condition
140758,9787,to,O
140759,9787,sulfonylureas,B-Drug
140760,9787,",",O
140761,9787,sulfonamides,B-Drug
140762,9787,or,O
140763,9787,SGLT2,B-Drug
140764,9787,inhibitors,I-Drug
140765,9787,in,O
140766,9787,general,O
140767,9788,history,O
140768,9788,of,O
140769,9788,multiple,O
140770,9788,severe,O
140771,9788,hypoglycemic,B-Condition
140772,9788,episodes,I-Condition
140773,9788,within,O
140774,9788,the,O
140775,9788,last,O
140776,9788,two,O
140777,9788,years,O
140778,9789,use,O
140779,9789,of,O
140780,9789,Insulin,B-Drug
140781,9789,",",O
140782,9789,SGLT2,B-Drug
140783,9789,-,I-Drug
140784,9789,inhibitor,I-Drug
140785,9789,",",O
140786,9789,sulfonylurea,B-Drug
140787,9789,derivate,I-Drug
140788,9789,or,O
140789,9789,a,O
140790,9789,glinide,B-Drug
140791,9789,within,O
140792,9789,past,O
140793,9789,3,O
140794,9789,months,O
140795,9790,clinical,O
140796,9790,significant,O
140797,9790,macular,B-Condition
140798,9790,edema,I-Condition
140799,9790,in,O
140800,9790,both,O
140801,9790,eyes,O
140802,9790,and,O
140803,9790,indication,O
140804,9790,for,O
140805,9790,intravitreal,B-Procedure
140806,9790,anti,I-Procedure
140807,9790,-,I-Procedure
140808,9790,VEGF,I-Procedure
140809,9790,treatment,I-Procedure
140810,9790,for,O
140811,9790,both,O
140812,9790,eyes,O
140813,9790,at,O
140814,9790,screening,O
140815,9790,or,O
140816,9790,baseline,O
140817,9790,visit,O
140818,9790,.,O
140819,9790,Eyes,O
140820,9790,with,O
140821,9790,a,O
140822,9790,small,O
140823,9790,amount,O
140824,9790,of,O
140825,9790,intraretinal,O
140826,9790,or,O
140827,9790,subretinal,O
140828,9790,fluid,O
140829,9790,(,O
140830,9790,seen,O
140831,9790,in,O
140832,9790,OCT,O
140833,9790,),O
140834,9790,but,O
140835,9790,no,O
140836,9790,need,O
140837,9790,for,O
140838,9790,intravitreal,O
140839,9790,treatment,O
140840,9790,as,O
140841,9790,judged,O
140842,9790,by,O
140843,9790,the,O
140844,9790,investigator,O
140845,9790,(,O
140846,9790,according,O
140847,9790,to,O
140848,9790,current,O
140849,9790,practice,O
140850,9790,patterns,O
140851,9790,),O
140852,9790,may,O
140853,9790,be,O
140854,9790,included,O
140855,9790,.,O
140856,9790,Eyes,O
140857,9790,with,O
140858,9790,a,O
140859,9790,history,O
140860,9790,of,O
140861,9790,intravitreal,O
140862,9790,treatment,O
140863,9790,of,O
140864,9790,macular,O
140865,9790,edema,O
140866,9790,which,O
140867,9790,do,O
140868,9790,not,O
140869,9790,need,O
140870,9790,ongoing,O
140871,9790,intravitreal,O
140872,9790,treatment,O
140873,9790,at,O
140874,9790,the,O
140875,9790,time,O
140876,9790,of,O
140877,9790,screening,O
140878,9790,may,O
140879,9790,be,O
140880,9790,included,O
140881,9790,.,O
140882,9791,eye,O
140883,9791,diseases,O
140884,9791,or,O
140885,9791,pathologies,O
140886,9791,that,O
140887,9791,prevent,O
140888,9791,clear,O
140889,9791,ophthalmoscopy,B-Procedure
140890,9791,and,O
140891,9791,evaluation,O
140892,9791,of,O
140893,9791,study,O
140894,9791,parameters,O
140895,9791,",",O
140896,9791,thus,O
140897,9791,not,O
140898,9791,allowing,O
140899,9791,study,O
140900,9791,participation,O
140901,9791,according,O
140902,9791,to,O
140903,9791,the,O
140904,9791,investigator´s,O
140905,9791,judgment,O
140906,9791,",",O
140907,9791,such,O
140908,9791,as,O
140909,9791,(,O
140910,9791,but,O
140911,9791,not,O
140912,9791,only,O
140913,9791,),O
140914,9791,vitreous,B-Condition
140915,9791,hemorrhage,I-Condition
140916,9791,",",O
140917,9791,mature,B-Condition
140918,9791,cataract,I-Condition
140919,9791,",",O
140920,9791,macular,B-Condition
140921,9791,pathologies,I-Condition
140922,9791,other,O
140923,9791,than,O
140924,9791,diabetic,B-Condition
140925,9791,maculopathy,I-Condition
140926,9792,history,O
140927,9792,of,O
140928,9792,ketoacidosis,B-Condition
140929,9792,or,O
140930,9792,metabolic,B-Condition
140931,9792,acidosis,I-Condition
140932,9793,use,O
140933,9793,of,O
140934,9793,loop,B-Drug
140935,9793,diuretics,I-Drug
140936,9794,history,O
140937,9794,of,O
140938,9794,>,O
140939,9794,1,O
140940,9794,urogenital,B-Condition
140941,9794,infection,I-Condition
140942,9794,/,O
140943,9794,year,O
140944,9795,any,O
140945,9795,history,O
140946,9795,of,O
140947,9795,stroke,B-Condition
140948,9795,",",O
140949,9795,transient,B-Condition
140950,9795,ischemic,I-Condition
140951,9795,attack,I-Condition
140952,9795,(,O
140953,9795,TIA,B-Condition
140954,9795,),O
140955,9795,",",O
140956,9795,instable,O
140957,9795,angina,B-Condition
140958,9795,pectoris,I-Condition
140959,9795,or,O
140960,9795,myocardial,B-Condition
140961,9795,infarction,I-Condition
140962,9795,within,O
140963,9795,last,O
140964,9795,3,O
140965,9795,months,O
140966,9795,prior,O
140967,9795,to,O
140968,9795,baseline,O
140969,9795,visit,O
140970,9796,congestive,B-Condition
140971,9796,heart,I-Condition
140972,9796,failure,I-Condition
140973,9796,New,O
140974,9796,York,O
140975,9796,Heart,O
140976,9796,Association,O
140977,9796,(,O
140978,9796,NYHA,O
140979,9796,),O
140980,9796,III,O
140981,9796,and,O
140982,9796,IV,O
140983,9797,severe,O
140984,9797,valvular,B-Condition
140985,9797,or,I-Condition
140986,9797,left,I-Condition
140987,9797,ventricular,I-Condition
140988,9797,outflow,I-Condition
140989,9797,obstruction,I-Condition
140990,9797,disease,I-Condition
140991,9797,needing,O
140992,9797,intervention,B-Procedure
140993,9797,;,O
140994,9798,atrial,B-Condition
140995,9798,fibrillation,I-Condition
140996,9798,/,I-Condition
140997,9798,flutter,I-Condition
140998,9798,with,O
140999,9798,a,O
141000,9798,mean,O
141001,9798,ventricular,O
141002,9798,response,O
141003,9798,rate,O
141004,9798,at,O
141005,9798,rest,O
141006,9798,>,O
141007,9798,100,O
141008,9798,beats,O
141009,9798,per,O
141010,9798,minute,O
141011,9799,chronic,O
141012,9799,lower,B-Condition
141013,9799,urinary,I-Condition
141014,9799,tract,I-Condition
141015,9799,infections,I-Condition
141016,9799,(,O
141017,9799,but,O
141018,9799,not,O
141019,9799,simple,O
141020,9799,asymptomatic,B-Condition
141021,9799,bacteriuria,I-Condition
141022,9799,),O
141023,9800,eGFR,O
141024,9800,<,O
141025,9800,60,O
141026,9800,ml,O
141027,9800,/,O
141028,9800,"min/1,73",O
141029,9800,m2,O
141030,9800,(,O
141031,9800,MDRD,O
141032,9800,-,O
141033,9800,formula,O
141034,9800,",",O
141035,9800,confirmed,O
141036,9800,on,O
141037,9800,a,O
141038,9800,second,O
141039,9800,day,O
141040,9800,),O
141041,9801,chronic,B-Condition
141042,9801,diarrhea,I-Condition
141043,9801,",",O
141044,9801,any,O
141045,9801,clinical,O
141046,9801,signs,O
141047,9801,of,O
141048,9801,volume,B-Condition
141049,9801,depletion,I-Condition
141050,9801,or,O
141051,9801,a,O
141052,9801,hematocrit,O
141053,9801,>,O
141054,9801,48,O
141055,9801,%,O
141056,9801,(,O
141057,9801,women,B-Person
141058,9801,),O
141059,9801,and,O
141060,9801,>,O
141061,9801,53,O
141062,9801,%,O
141063,9801,(,O
141064,9801,men,B-Person
141065,9801,),O
141066,9802,elevated,O
141067,9802,risk,B-Observation
141068,9802,for,I-Observation
141069,9802,volume,I-Observation
141070,9802,depletion,I-Observation
141071,9802,",",I-Observation
141072,9802,e.g.,O
141073,9802,history,O
141074,9802,of,O
141075,9802,severe,O
141076,9802,volume,O
141077,9802,depletion,O
141078,9802,that,O
141079,9802,required,O
141080,9802,medical,O
141081,9802,therapy,O
141082,9803,chronic,B-Condition
141083,9803,liver,I-Condition
141084,9803,disease,I-Condition
141085,9803,(,O
141086,9803,including,O
141087,9803,known,O
141088,9803,active,B-Condition
141089,9803,hepatitis,I-Condition
141090,9803,),O
141091,9803,and/or,O
141092,9803,screening,O
141093,9803,alanine,O
141094,9803,transaminase,O
141095,9803,(,O
141096,9803,ALT,O
141097,9803,),O
141098,9803,or,O
141099,9803,aspartate,O
141100,9803,transaminase,O
141101,9803,(,O
141102,9803,AST,O
141103,9803,),O
141104,9803,>,O
141105,9803,3,O
141106,9803,x,O
141107,9803,upper,O
141108,9803,limit,O
141109,9803,of,O
141110,9803,normal,O
141111,9803,(,O
141112,9803,ULN,O
141113,9803,),O
141114,9803,(,O
141115,9803,confirmed,O
141116,9803,on,O
141117,9803,a,O
141118,9803,second,O
141119,9803,day,O
141120,9803,),O
141121,9804,Subjects,O
141122,9804,with,O
141123,9804,known,O
141124,9804,seropositivity,O
141125,9804,to,O
141126,9804,human,O
141127,9804,immunodeficiency,O
141128,9804,virus,O
141129,9804,.,O
141130,9805,acute,O
141131,9805,illness,O
141132,9805,at,O
141133,9805,screening,O
141134,9805,or,O
141135,9805,randomization,O
141136,9805,according,O
141137,9805,to,O
141138,9805,judgement,O
141139,9805,by,O
141140,9805,the,O
141141,9805,investigator,O
141142,9805,or,O
141143,9805,patient,O
141144,9806,drug,B-Condition
141145,9806,or,I-Condition
141146,9806,alcohol,I-Condition
141147,9806,abuse,I-Condition
141148,9807,psychosomatic,B-Condition
141149,9807,or,I-Condition
141150,9807,psychiatric,I-Condition
141151,9807,diseases,I-Condition
141152,9807,requiring,O
141153,9807,hospitalization,O
141154,9807,during,O
141155,9807,the,O
141156,9807,last,O
141157,9807,12,O
141158,9807,months,O
141159,9808,clinical,O
141160,9808,evidence,O
141161,9808,of,O
141162,9808,current,O
141163,9808,malignancy,B-Condition
141164,9808,with,O
141165,9808,exception,O
141166,9808,of,O
141167,9808,basal,B-Condition
141168,9808,cell,I-Condition
141169,9808,or,I-Condition
141170,9808,squamous,I-Condition
141171,9808,cell,I-Condition
141172,9808,carcinoma,I-Condition
141173,9808,of,I-Condition
141174,9808,the,I-Condition
141175,9808,skin,I-Condition
141176,9808,",",O
141177,9808,and,O
141178,9808,cervical,B-Condition
141179,9808,intraepithelial,I-Condition
141180,9808,neoplasia,I-Condition
141181,9808,(,O
141182,9808,5,O
141183,9808,years,O
141184,9808,prior,O
141185,9808,to,O
141186,9808,randomization,O
141187,9808,),O
141188,9809,any,O
141189,9809,medical,O
141190,9809,or,O
141191,9809,surgical,O
141192,9809,intervention,O
141193,9809,planned,O
141194,9809,for,O
141195,9809,the,O
141196,9809,next,O
141197,9809,13,O
141198,9809,months,O
141199,9809,after,O
141200,9809,randomization,O
141201,9809,not,O
141202,9809,allowing,O
141203,9809,study,O
141204,9809,participation,O
141205,9809,according,O
141206,9809,to,O
141207,9809,the,O
141208,9809,investigator´s,O
141209,9809,judgment,O
141210,9810,current,O
141211,9810,participation,O
141212,9810,in,O
141213,9810,any,O
141214,9810,other,O
141215,9810,clinical,O
141216,9810,trial,O
141217,9810,or,O
141218,9810,participation,O
141219,9810,in,O
141220,9810,another,O
141221,9810,clinical,O
141222,9810,trial,O
141223,9810,within,O
141224,9810,30,O
141225,9810,days,O
141226,9810,before,O
141227,9810,screening,O
141228,9811,women,B-Person
141229,9811,and,O
141230,9811,men,B-Person
141231,9811,between,O
141232,9811,18,O
141233,9811,-,O
141234,9811,80,O
141235,9811,years,O
141236,9811,of,O
141237,9811,age,B-Person
141238,9812,type,B-Condition
141239,9812,2,I-Condition
141240,9812,diabetes,I-Condition
141241,9812,mellitus,I-Condition
141242,9813,early,O
141243,9813,to,O
141244,9813,moderate,O
141245,9813,stage,O
141246,9813,diabetic,B-Condition
141247,9813,retinopathy,I-Condition
141248,9813,(,O
141249,9813,ETDRS,O
141250,9813,:,O
141251,9813,20,O
141252,9813,(,O
141253,9813,microaneurysms,O
141254,9813,only,O
141255,9813,),O
141256,9813,to,O
141257,9813,35,O
141258,9813,(,O
141259,9813,microaneurysms/,O
141260,9813,hemorrhages,O
141261,9813,and/or,O
141262,9813,hard,O
141263,9813,exsudates,O
141264,9813,),O
141265,9813,),O
141266,9813,in,O
141267,9813,one,O
141268,9813,or,O
141269,9813,both,O
141270,9813,eyes,O
141271,9814,stable,O
141272,9814,HbA1c,O
141273,9814,(,O
141274,9814,±,O
141275,9814,0.5,O
141276,9814,%,O
141277,9814,),O
141278,9814,for,O
141279,9814,at,O
141280,9814,least,O
141281,9814,12,O
141282,9814,weeks,O
141283,9815,antidiabetic,B-Procedure
141284,9815,treatment,I-Procedure
141285,9815,with,O
141286,9815,either,O
141287,9815,diet,B-Observation
141288,9815,",",O
141289,9815,metformin,B-Drug
141290,9815,",",O
141291,9815,DPP4,B-Drug
141292,9815,",",O
141293,9815,GLP1,B-Drug
141294,9815,",",O
141295,9815,pioglitazone,B-Drug
141296,9815,",",O
141297,9815,acarbose,B-Drug
141298,9815,",",O
141299,9815,or,O
141300,9815,respective,O
141301,9815,combinations,O
141302,9816,HbA1c,O
141303,9816,=,O
141304,9816,6.5,O
141305,9816,and,O
141306,9816,=,O
141307,9816,10.0,O
141308,9816,%,O
141309,9817,body,B-Person
141310,9817,mass,I-Person
141311,9817,index,I-Person
141312,9817,<,O
141313,9817,46,O
141314,9817,kg,O
141315,9817,/,O
141316,9817,m2,O
141317,9818,office,O
141318,9818,blood,O
141319,9818,pressure,O
141320,9818,=,O
141321,9818,150/95,O
141322,9818,mmHg,O
141323,9818,(,O
141324,9818,confirmed,O
141325,9818,on,O
141326,9818,a,O
141327,9818,second,O
141328,9818,day,O
141329,9818,;,O
141330,9818,24h,O
141331,9818,ambulatory,O
141332,9818,blood,O
141333,9818,pressure,O
141334,9818,measurement,O
141335,9818,(,O
141336,9818,ABPM,O
141337,9818,),O
141338,9818,is,O
141339,9818,allowed,O
141340,9818,to,O
141341,9818,check,O
141342,9818,accuracy,O
141343,9818,of,O
141344,9818,office,O
141345,9818,values,O
141346,9818,;,O
141347,9818,inclusion,O
141348,9818,with,O
141349,9818,24h,O
141350,9818,mean,O
141351,9818,blood,O
141352,9818,pressure,O
141353,9818,=,O
141354,9818,145/90,O
141355,9818,mm,O
141356,9818,Hg,O
141357,9818,is,O
141358,9818,possible,O
141359,9818,),O
141360,9818,;,O
141361,9818,patients,O
141362,9818,with,O
141363,9818,hypertension,O
141364,9818,should,O
141365,9818,be,O
141366,9818,treated,O
141367,9818,according,O
141368,9818,to,O
141369,9818,current,O
141370,9818,treatment,O
141371,9818,guidelines,O
141372,9819,at,O
141373,9819,least,O
141374,9819,6,O
141375,9819,weeks,O
141376,9819,after,O
141377,9819,surgical,B-Procedure
141378,9819,sterilization,I-Procedure
141379,9819,by,O
141380,9819,bilateral,B-Procedure
141381,9819,tubal,I-Procedure
141382,9819,ligation,I-Procedure
141383,9819,or,O
141384,9819,bilateral,B-Procedure
141385,9819,oophorectomy,I-Procedure
141386,9820,hysterectomy,B-Procedure
141387,9821,=,O
141388,9821,50,O
141389,9821,years,B-Person
141390,9821,and,O
141391,9821,in,O
141392,9821,postmenopausal,B-Observation
141393,9821,state,I-Observation
141394,9821,>,O
141395,9821,1,O
141396,9821,year,O
141397,9822,<,O
141398,9822,50,O
141399,9822,years,O
141400,9822,and,O
141401,9822,in,O
141402,9822,postmenopausal,O
141403,9822,state,O
141404,9822,>,O
141405,9822,1,O
141406,9822,year,O
141407,9822,with,O
141408,9822,serum,O
141409,9822,follicle,O
141410,9822,stimulating,O
141411,9822,hormone,O
141412,9822,(,O
141413,9822,FSH,O
141414,9822,),O
141415,9822,>,O
141416,9822,40,O
141417,9822,IU,O
141418,9822,/,O
141419,9822,l,O
141420,9822,and,O
141421,9822,serum,O
141422,9822,estrogen,O
141423,9822,<,O
141424,9822,30,O
141425,9822,ng,O
141426,9822,/,O
141427,9822,l,O
141428,9822,or,O
141429,9822,a,O
141430,9822,negative,O
141431,9822,estrogen,O
141432,9822,test,O
141433,9822,",",O
141434,9822,both,O
141435,9822,at,O
141436,9822,screening,O
141437,9822,or,O
141438,9822,women,O
141439,9822,of,O
141440,9822,childbearing,O
141441,9822,potential,O
141442,9822,with,O
141443,9822,a,O
141444,9822,negative,O
141445,9822,serum,O
141446,9822,beta,O
141447,9822,human,O
141448,9822,chorionic,O
141449,9822,gonadotropin,O
141450,9822,(,O
141451,9822,ß,O
141452,9822,-,O
141453,9822,hCG,O
141454,9822,),O
141455,9822,pregnancy,O
141456,9822,test,O
141457,9822,at,O
141458,9822,screening,O
141459,9822,who,O
141460,9822,agree,O
141461,9822,to,O
141462,9822,meet,O
141463,9822,one,O
141464,9822,of,O
141465,9822,the,O
141466,9822,following,O
141467,9822,criteria,O
141468,9822,from,O
141469,9822,the,O
141470,9822,time,O
141471,9822,of,O
141472,9822,screening,O
141473,9822,",",O
141474,9822,during,O
141475,9822,the,O
141476,9822,study,O
141477,9822,and,O
141478,9822,for,O
141479,9822,a,O
141480,9822,period,O
141481,9822,of,O
141482,9822,4,O
141483,9822,days,O
141484,9822,following,O
141485,9822,the,O
141486,9822,last,O
141487,9822,administration,O
141488,9822,of,O
141489,9822,study,O
141490,9822,medication,O
141491,9822,:,O
141492,9823,correct,O
141493,9823,use,O
141494,9823,of,O
141495,9823,one,O
141496,9823,of,O
141497,9823,the,O
141498,9823,following,O
141499,9823,accepted,O
141500,9823,contraception,O
141501,9823,methods,O
141502,9823,:,O
141503,9823,hormonal,O
141504,9823,contraceptives,O
141505,9823,(,O
141506,9823,combined,O
141507,9823,oral,O
141508,9823,contraceptives,O
141509,9823,",",O
141510,9823,implants,O
141511,9823,",",O
141512,9823,transdermal,O
141513,9823,patches,O
141514,9823,",",O
141515,9823,hormonal,O
141516,9823,vaginal,O
141517,9823,devices,O
141518,9823,or,O
141519,9823,injections,O
141520,9823,with,O
141521,9823,prolonged,O
141522,9823,release,O
141523,9823,),O
141524,9823,",",O
141525,9823,intrauterine,O
141526,9823,device,O
141527,9823,(,O
141528,9823,IUD,O
141529,9823,/,O
141530,9823,IUS,O
141531,9823,),O
141532,9823,or,O
141533,9823,a,O
141534,9823,double,O
141535,9823,barrier,O
141536,9823,method,O
141537,9823,",",O
141538,9823,e.g.,O
141539,9823,condom,O
141540,9823,and,O
141541,9823,occlusive,O
141542,9823,cap,O
141543,9823,(,O
141544,9823,diaphragm,O
141545,9823,or,O
141546,9823,cervical,O
141547,9823,/,O
141548,9823,vault,O
141549,9823,caps,O
141550,9823,),O
141551,9823,with,O
141552,9823,spermicide,O
141553,9823,(,O
141554,9823,foam,O
141555,9823,",",O
141556,9823,gel,O
141557,9823,",",O
141558,9823,film,O
141559,9823,",",O
141560,9823,cream,O
141561,9823,or,O
141562,9823,suppository,O
141563,9823,),O
141564,9824,true,O
141565,9824,abstinence,O
141566,9824,(,O
141567,9824,periodic,O
141568,9824,abstinence,O
141569,9824,and,O
141570,9824,withdrawal,O
141571,9824,are,O
141572,9824,not,O
141573,9824,acceptable,O
141574,9824,methods,O
141575,9824,of,O
141576,9824,contraception,O
141577,9824,),O
141578,9825,sexual,O
141579,9825,relationship,O
141580,9825,only,O
141581,9825,with,O
141582,9825,female,O
141583,9825,partners,O
141584,9826,sterile,O
141585,9826,male,O
141586,9826,partners,O
141587,9827,signed,O
141588,9827,written,O
141589,9827,informed,O
141590,9827,consent,O
141591,9827,and,O
141592,9827,willingness,O
141593,9827,to,O
141594,9827,comply,O
141595,9827,with,O
141596,9827,treatment,O
141597,9827,and,O
141598,9827,follow,O
141599,9827,-,O
141600,9827,up,O
141601,9827,procedures,O
141602,9828,capability,O
141603,9828,of,O
141604,9828,understanding,O
141605,9828,the,O
141606,9828,investigational,O
141607,9828,nature,O
141608,9828,",",O
141609,9828,potential,O
141610,9828,risks,O
141611,9828,and,O
141612,9828,benefits,O
141613,9828,of,O
141614,9828,the,O
141615,9828,clinical,O
141616,9828,trial,O
141617,9829,HPN,O
141618,9829,<,O
141619,9829,12,O
141620,9829,months,O
141621,9830,metabolically,B-Condition
141622,9830,unstable,I-Condition
141623,9831,cancer,B-Condition
141624,9831,as,O
141625,9831,the,O
141626,9831,reason,O
141627,9831,for,O
141628,9831,intestinal,B-Condition
141629,9831,failure,I-Condition
141630,9832,patients,O
141631,9832,receiving,O
141632,9832,home,O
141633,9832,parenteral,O
141634,9832,nutrition,O
141635,9832,(,O
141636,9832,HPN,O
141637,9832,),O
141638,9832,because,O
141639,9832,of,O
141640,9832,short,B-Condition
141641,9832,bowel,I-Condition
141642,9832,syndrome,I-Condition
141643,9832,for,O
141644,9832,at,O
141645,9832,least,O
141646,9832,12,O
141647,9832,months,O
141648,9833,stable,O
141649,9833,metabolic,O
141650,9833,status,O
141651,9834,benign,B-Condition
141652,9834,disease,I-Condition
141653,9835,Patient,O
141654,9835,not,O
141655,9835,expected,O
141656,9835,to,O
141657,9835,survive,B-Observation
141658,9835,more,O
141659,9835,than,O
141660,9835,4,O
141661,9835,days,O
141662,9836,Patient,O
141663,9836,allergic,B-Condition
141664,9836,to,O
141665,9836,a,O
141666,9836,penicillin,B-Drug
141667,9836,or,O
141668,9836,a,O
141669,9836,carbapenem,B-Drug
141670,9837,Patient,O
141671,9837,with,O
141672,9837,significant,O
141673,9837,polymicrobial,O
141674,9837,bacteraemia,B-Condition
141675,9837,(,O
141676,9837,that,O
141677,9837,is,O
141678,9837,",",O
141679,9837,a,O
141680,9837,Gram,O
141681,9837,positive,O
141682,9837,skin,O
141683,9837,contaminant,O
141684,9837,in,O
141685,9837,one,O
141686,9837,set,O
141687,9837,of,O
141688,9837,blood,O
141689,9837,cultures,O
141690,9837,is,O
141691,9837,not,O
141692,9837,regarded,O
141693,9837,as,O
141694,9837,significant,O
141695,9837,polymicrobial,O
141696,9837,bacteraemia,O
141697,9837,),O
141698,9837,.,O
141699,9838,Treatment,O
141700,9838,is,O
141701,9838,not,O
141702,9838,with,O
141703,9838,the,O
141704,9838,intent,O
141705,9838,to,O
141706,9838,cure,O
141707,9838,the,O
141708,9838,infection,O
141709,9838,(,O
141710,9838,that,O
141711,9838,is,O
141712,9838,",",O
141713,9838,palliative,O
141714,9838,care,O
141715,9838,is,O
141716,9838,an,O
141717,9838,exclusion,O
141718,9838,),O
141719,9838,.,O
141720,9839,Pregnancy,O
141721,9839,or,O
141722,9839,breast,O
141723,9839,-,O
141724,9839,feeding,O
141725,9839,.,O
141726,9840,Use,O
141727,9840,of,O
141728,9840,concomitant,O
141729,9840,antimicrobials,B-Drug
141730,9840,in,O
141731,9840,the,O
141732,9840,first,O
141733,9840,4,O
141734,9840,days,O
141735,9840,after,O
141736,9840,enrolment,O
141737,9840,with,O
141738,9840,known,O
141739,9840,activity,O
141740,9840,against,O
141741,9840,Gram,B-Observation
141742,9840,-,I-Observation
141743,9840,negative,I-Observation
141744,9840,bacilli,I-Observation
141745,9840,(,O
141746,9840,except,O
141747,9840,trimethoprim,O
141748,9840,/,I-Drug
141749,9840,sulphamethoxazole,I-Drug
141750,9840,may,O
141751,9840,be,O
141752,9840,continued,O
141753,9840,as,O
141754,9840,Pneumocystis,O
141755,9840,prophylaxis,O
141756,9840,),O
141757,9840,.,O
141758,9841,Severe,O
141759,9841,acute,O
141760,9841,illness,O
141761,9841,as,O
141762,9841,defined,O
141763,9841,by,O
141764,9841,Pitt,O
141765,9841,bacteraemia,O
141766,9841,score,O
141767,9841,of,O
141768,9841,>,O
141769,9841,4,O
141770,9842,Likely,O
141771,9842,source,O
141772,9842,to,O
141773,9842,be,O
141774,9842,from,O
141775,9842,(,O
141776,9842,proven,O
141777,9842,or,O
141778,9842,suspected,O
141779,9842,at,O
141780,9842,the,O
141781,9842,time,O
141782,9842,of,O
141783,9842,randomisation,O
141784,9842,),O
141785,9842,the,O
141786,9842,central,O
141787,9842,nervous,O
141788,9842,system,O
141789,9842,",",O
141790,9842,e.g.,O
141791,9842,brain,B-Condition
141792,9842,abscess,I-Condition
141793,9842,",",O
141794,9842,post,O
141795,9842,-,O
141796,9842,surgical,O
141797,9842,meningitis,B-Condition
141798,9842,",",O
141799,9842,shunt,B-Condition
141800,9842,infection,I-Condition
141801,9842,(,O
141802,9842,due,O
141803,9842,to,O
141804,9842,concerns,O
141805,9842,over,O
141806,9842,CNS,O
141807,9842,penetration,O
141808,9842,of,O
141809,9842,piperacillin,O
141810,9842,/,O
141811,9842,tazobactam,O
141812,9842,),O
141813,9843,Bloodstream,B-Condition
141814,9843,infection,I-Condition
141815,9843,with,O
141816,9843,Enterobacter,O
141817,9843,spp,O
141818,9843,.,O
141819,9843,",",O
141820,9843,Serratia,O
141821,9843,marcescens,O
141822,9843,",",O
141823,9843,Providencia,O
141824,9843,spp,O
141825,9843,.,O
141826,9843,",",O
141827,9843,Morganella,O
141828,9843,morganii,O
141829,9843,or,O
141830,9843,Citrobacter,O
141831,9843,freundii,O
141832,9843,(,O
141833,9843,i.e.,O
141834,9843,likely,O
141835,9843,AmpC,O
141836,9843,-,O
141837,9843,producer,O
141838,9843,),O
141839,9843,",",O
141840,9843,and,O
141841,9843,susceptibility,O
141842,9843,to,O
141843,9843,3rd,B-Drug
141844,9843,generation,I-Drug
141845,9843,cephalosporins,I-Drug
141846,9843,(,I-Drug
141847,9843,i.e.,O
141848,9843,ceftriaxone,B-Drug
141849,9843,",",O
141850,9843,cefotaxime,B-Drug
141851,9843,or,O
141852,9843,ceftazidime,B-Drug
141853,9843,),O
141854,9843,",",O
141855,9843,meropenem,B-Drug
141856,9843,and,O
141857,9843,piperacillin,B-Drug
141858,9843,-,I-Drug
141859,9843,tazobactam,I-Drug
141860,9843,from,O
141861,9843,at,O
141862,9843,least,O
141863,9843,one,O
141864,9843,blood,O
141865,9843,culture,O
141866,9843,draw,O
141867,9843,.,O
141868,9843,This,O
141869,9843,will,O
141870,9843,be,O
141871,9843,determined,O
141872,9843,in,O
141873,9843,accordance,O
141874,9843,with,O
141875,9843,laboratory,O
141876,9843,methods,O
141877,9843,and,O
141878,9843,susceptibility,O
141879,9843,breakpoints,O
141880,9843,defined,O
141881,9843,by,O
141882,9843,protocols,O
141883,9843,used,O
141884,9843,in,O
141885,9843,the,O
141886,9843,recruiting,O
141887,9843,site,O
141888,9843,laboratories,O
141889,9843,..,O
141890,9844,No,O
141891,9844,more,O
141892,9844,than,O
141893,9844,72,O
141894,9844,hours,O
141895,9844,has,O
141896,9844,elapsed,O
141897,9844,since,O
141898,9844,the,O
141899,9844,first,O
141900,9844,positive,O
141901,9844,blood,O
141902,9844,culture,O
141903,9844,collection,O
141904,9844,.,O
141905,9845,Patient,O
141906,9845,is,O
141907,9845,aged,B-Person
141908,9845,18,O
141909,9845,years,O
141910,9845,and,O
141911,9845,over,O
141912,9845,(,O
141913,9845,>,O
141914,9845,=,O
141915,9845,21y,O
141916,9845,in,O
141917,9845,Singapore,B-Person
141918,9845,),O
141919,9845,.,O
141920,9846,Patients,O
141921,9846,minors,B-Person
141922,9847,Patients,O
141923,9847,on,O
141924,9847,a,O
141925,9847,legal,B-Person
141926,9847,protection,I-Person
141927,9847,regime,I-Person
141928,9847,type,I-Person
141929,9847,guardianship,I-Person
141930,9848,Respiratory,B-Condition
141931,9848,pathologies,I-Condition
141932,9848,",",O
141933,9848,cardiovascular,B-Condition
141934,9848,",",O
141935,9848,renal,B-Condition
141936,9848,",",O
141937,9848,diabetes,B-Condition
141938,9849,Claustrophobia,B-Condition
141939,9850,Contraindications,B-Condition
141940,9850,to,O
141941,9850,exposure,O
141942,9850,to,O
141943,9850,a,O
141944,9850,magnetic,O
141945,9850,field,O
141946,9851,Contraindications,B-Condition
141947,9851,to,O
141948,9851,injecting,O
141949,9851,Dotarem,B-Drug
141950,9851,®,O
141951,9852,Major,O
141952,9852,subjects,O
141953,9852,of,O
141954,9852,over,O
141955,9852,40,O
141956,9852,years,B-Person
141957,9852,(,O
141958,9852,mean,O
141959,9852,age,O
141960,9852,of,O
141961,9852,Meniere,O
141962,9852,'s,O
141963,9852,disease,O
141964,9852,40,O
141965,9852,to,O
141966,9852,50,O
141967,9852,years,O
141968,9852,),O
141969,9853,Informed,O
141970,9853,consent,O
141971,9853,signed,O
141972,9854,Medical,B-Procedure
141973,9854,examination,I-Procedure
141974,9854,performed,O
141975,9854,prior,O
141976,9854,to,O
141977,9854,participation,O
141978,9854,in,O
141979,9854,research,O
141980,9855,Patients,O
141981,9855,without,O
141982,9855,history,B-Observation
141983,9855,of,O
141984,9855,inner,B-Condition
141985,9855,ear,I-Condition
141986,9855,disease,I-Condition
141987,9856,Recipient,O
141988,9856,of,O
141989,9856,a,O
141990,9856,French,O
141991,9856,social,O
141992,9856,security,O
141993,9856,scheme,O
141994,9857,Age,B-Person
141995,9857,less,O
141996,9857,than,O
141997,9857,one,O
141998,9857,year,O
141999,9857,or,O
142000,9857,age,B-Person
142001,9857,greater,O
142002,9857,than,O
142003,9857,/,O
142004,9857,equals,O
142005,9857,to,O
142006,9857,18,O
142007,9857,years,O
142008,9858,Previous,O
142009,9858,treatment,B-Procedure
142010,9858,with,O
142011,9858,cytotoxic,B-Drug
142012,9858,agents,I-Drug
142013,9858,or,O
142014,9858,high,B-Drug
142015,9858,-,I-Drug
142016,9858,dose,I-Drug
142017,9858,steroids,I-Drug
142018,9859,Mixed,B-Condition
142019,9859,phenotype,I-Condition
142020,9859,acute,I-Condition
142021,9859,leukemia,I-Condition
142022,9859,(,O
142023,9859,MPAL,B-Condition
142024,9859,),O
142025,9860,ALL,B-Condition
142026,9860,as,O
142027,9860,secondary,O
142028,9860,malignancy,B-Condition
142029,9861,Abnormal,B-Condition
142030,9861,renal,I-Condition
142031,9861,or,I-Condition
142032,9861,liver,I-Condition
142033,9861,function,I-Condition
142034,9862,Doubtful,B-Observation
142035,9862,compliance,I-Observation
142036,9862,or,O
142037,9862,unable,B-Observation
142038,9862,to,I-Observation
142039,9862,afford,I-Observation
142040,9862,full,I-Observation
142041,9862,course,I-Observation
142042,9862,of,I-Observation
142043,9862,therapy,I-Observation
142044,9863,Confirmed,O
142045,9863,diagnosis,O
142046,9863,of,O
142047,9863,non,B-Condition
142048,9863,-,I-Condition
142049,9863,Burkitt,I-Condition
142050,9863,B,I-Condition
142051,9863,-,I-Condition
142052,9863,lineage,I-Condition
142053,9863,ALL,I-Condition
142054,9864,1,O
142055,9864,to,O
142056,9864,17,O
142057,9864,years,O
142058,9864,of,O
142059,9864,age,B-Person
142060,9864,(,O
142061,9864,before,O
142062,9864,18th,O
142063,9864,birthday,O
142064,9864,),O
142065,9865,Renal,O
142066,9865,function,O
142067,9865,within,O
142068,9865,normal,O
142069,9865,range,O
142070,9865,for,O
142071,9865,age,O
142072,9866,Liver,O
142073,9866,function,O
142074,9866,within,O
142075,9866,normal,O
142076,9866,range,O
142077,9866,for,O
142078,9866,age,O
142079,9867,Able,B-Observation
142080,9867,to,I-Observation
142081,9867,participate,I-Observation
142082,9867,in,O
142083,9867,the,O
142084,9867,full,O
142085,9867,2,O
142086,9867,years,O
142087,9867,of,O
142088,9867,treatment,B-Procedure
142089,9868,Invasively,O
142090,9868,mechanically,B-Procedure
142091,9868,ventilated,I-Procedure
142092,9868,>,O
142093,9868,72,O
142094,9868,hours,O
142095,9868,at,O
142096,9868,the,O
142097,9868,time,O
142098,9868,of,O
142099,9868,screening,O
142100,9868,;,O
142101,9869,Patients,O
142102,9869,at,O
142103,9869,potential,O
142104,9869,increased,O
142105,9869,risk,B-Observation
142106,9869,of,I-Observation
142107,9869,iatrogenic,I-Observation
142108,9869,probiotic,I-Observation
142109,9869,infection,I-Observation
142110,9869,(,O
142111,9869,see,O
142112,9869,Section,O
142113,9869,2.6,O
142114,9869,for,O
142115,9869,detailed,O
142116,9869,explanation,O
142117,9869,),O
142118,9869,including,O
142119,9869,specific,O
142120,9869,immunocompromised,B-Condition
142121,9869,populations,O
142122,9869,(,O
142123,9869,HIV,B-Condition
142124,9869,<,O
142125,9869,200,O
142126,9869,CD4,O
142127,9869,cells/µL,O
142128,9869,",",O
142129,9869,those,O
142130,9869,receiving,O
142131,9869,chronic,O
142132,9869,immunosuppressive,B-Procedure
142133,9869,medications,I-Procedure
142134,9869,(,O
142135,9869,e.g.,O
142136,9869,",",O
142137,9869,azathioprine,B-Drug
142138,9869,",",O
142139,9869,cyclosporine,B-Drug
142140,9869,",",O
142141,9869,cyclophosphamide,B-Drug
142142,9869,",",O
142143,9869,tacrolimus,B-Drug
142144,9869,",",O
142145,9869,methotrexate,B-Drug
142146,9869,",",O
142147,9869,mycofenolate,B-Drug
142148,9869,",",O
142149,9869,Anti,B-Drug
142150,9869,-,I-Drug
142151,9869,IL2,I-Drug
142152,9869,),O
142153,9869,",",O
142154,9869,previous,O
142155,9869,transplantation,B-Procedure
142156,9869,(,O
142157,9869,including,O
142158,9869,stem,O
142159,9869,cell,O
142160,9869,),O
142161,9869,at,O
142162,9869,any,O
142163,9869,time,O
142164,9869,",",O
142165,9869,malignancy,O
142166,9869,requiring,O
142167,9869,chemotherapy,B-Procedure
142168,9869,in,O
142169,9869,the,O
142170,9869,last,O
142171,9869,3,O
142172,9869,months,O
142173,9869,",",O
142174,9869,neutropenia,B-Condition
142175,9869,[,O
142176,9869,absolute,O
142177,9869,neutrophil,O
142178,9869,count,O
142179,9869,<,O
142180,9869,500,O
142181,9869,],O
142182,9869,),O
142183,9869,.,O
142184,9869,However,O
142185,9869,",",O
142186,9869,patients,O
142187,9869,receiving,O
142188,9869,corticosteroids,O
142189,9869,previously,O
142190,9869,or,O
142191,9869,presently,O
142192,9869,or,O
142193,9869,projected,O
142194,9869,to,O
142195,9869,receive,O
142196,9869,corticosteroids,O
142197,9869,are,O
142198,9869,not,O
142199,9869,excluded,O
142200,9869,;,O
142201,9870,Patients,O
142202,9870,at,O
142203,9870,risk,B-Observation
142204,9870,for,I-Observation
142205,9870,endovascular,I-Observation
142206,9870,infection,I-Observation
142207,9870,(,O
142208,9870,previously,O
142209,9870,documented,O
142210,9870,rheumatic,B-Condition
142211,9870,heart,I-Condition
142212,9870,disease,I-Condition
142213,9870,",",O
142214,9870,congenital,B-Condition
142215,9870,valve,I-Condition
142216,9870,disease,I-Condition
142217,9870,",",O
142218,9870,surgically,O
142219,9870,repaired,O
142220,9870,congenital,B-Condition
142221,9870,heart,I-Condition
142222,9870,disease,I-Condition
142223,9870,",",O
142224,9870,unrepaired,O
142225,9870,cyanotic,B-Condition
142226,9870,congenital,I-Condition
142227,9870,heart,I-Condition
142228,9870,disease,I-Condition
142229,9870,",",O
142230,9870,any,O
142231,9870,intracardiac,B-Procedure
142232,9870,repair,I-Procedure
142233,9870,with,O
142234,9870,prosthetic,O
142235,9870,material,O
142236,9870,[,O
142237,9870,mechanical,O
142238,9870,or,O
142239,9870,bio,O
142240,9870,-,O
142241,9870,prosthetic,O
142242,9870,cardiac,O
142243,9870,valves,O
142244,9870,],O
142245,9870,",",O
142246,9870,previous,O
142247,9870,or,O
142248,9870,current,O
142249,9870,endocarditis,B-Condition
142250,9870,",",O
142251,9870,permanent,O
142252,9870,endovascular,O
142253,9870,devices,O
142254,9870,(,O
142255,9870,e.g.,O
142256,9870,",",O
142257,9870,endovascular,O
142258,9870,grafts,O
142259,9870,[,O
142260,9870,e.g.,O
142261,9870,",",O
142262,9870,aortic,B-Procedure
142263,9870,aneurysm,I-Procedure
142264,9870,repair,I-Procedure
142265,9870,",",O
142266,9870,stents,O
142267,9870,involving,O
142268,9870,large,O
142269,9870,arteries,O
142270,9870,such,O
142271,9870,as,O
142272,9870,aorta,O
142273,9870,",",O
142274,9870,femorals,O
142275,9870,and,O
142276,9870,carotids,O
142277,9870,],O
142278,9870,",",O
142279,9870,inferior,O
142280,9870,vena,O
142281,9870,cava,O
142282,9870,filters,O
142283,9870,",",O
142284,9870,dialysis,O
142285,9870,vascular,O
142286,9870,grafts,O
142287,9870,),O
142288,9870,",",O
142289,9870,tunnelled,O
142290,9870,(,O
142291,9870,not,O
142292,9870,short,O
142293,9870,-,O
142294,9870,term,O
142295,9870,),O
142296,9870,hemodialysis,O
142297,9870,catheters,O
142298,9870,",",O
142299,9870,pacemakers,O
142300,9870,or,O
142301,9870,defibrillators,O
142302,9870,.,O
142303,9870,Patients,O
142304,9870,with,O
142305,9870,temporary,O
142306,9870,central,O
142307,9870,venous,O
142308,9870,catheters,O
142309,9870,",",O
142310,9870,central,O
142311,9870,venous,O
142312,9870,dialysis,O
142313,9870,catheters,O
142314,9870,or,O
142315,9870,peripherally,O
142316,9870,inserted,O
142317,9870,central,O
142318,9870,catheters,O
142319,9870,(,O
142320,9870,PICCs,O
142321,9870,),O
142322,9870,are,O
142323,9870,not,O
142324,9870,excluded,O
142325,9870,and,O
142326,9870,patients,O
142327,9870,with,O
142328,9870,coronary,O
142329,9870,artery,O
142330,9870,stents,O
142331,9870,",",O
142332,9870,coronary,O
142333,9870,artery,O
142334,9870,bypass,O
142335,9870,grafts,O
142336,9870,(,O
142337,9870,CABG,O
142338,9870,),O
142339,9870,or,O
142340,9870,neurovascular,O
142341,9870,coils,O
142342,9870,are,O
142343,9870,not,O
142344,9870,excluded,O
142345,9870,;,O
142346,9870,patients,O
142347,9870,with,O
142348,9870,mitral,B-Condition
142349,9870,valve,I-Condition
142350,9870,prolapse,I-Condition
142351,9870,or,O
142352,9870,bicuspid,B-Condition
142353,9870,aortic,I-Condition
142354,9870,valve,I-Condition
142355,9870,are,O
142356,9870,not,O
142357,9870,excluded,O
142358,9870,providing,O
142359,9870,they,O
142360,9870,have,O
142361,9870,no,O
142362,9870,other,O
142363,9870,exclusion,O
142364,9870,criteria,O
142365,9870,;,O
142366,9871,Patients,O
142367,9871,with,O
142368,9871,a,O
142369,9871,primary,O
142370,9871,diagnosis,O
142371,9871,of,O
142372,9871,severe,O
142373,9871,acute,B-Condition
142374,9871,pancreatitis,I-Condition
142375,9871,",",O
142376,9871,without,O
142377,9871,reference,O
142378,9871,to,O
142379,9871,a,O
142380,9871,Ranson,O
142381,9871,score,O
142382,9871,[,O
142383,9871,Ranson,O
142384,9871,1974,O
142385,9871,],O
142386,9871,),O
142387,9871,.,O
142388,9871,However,O
142389,9871,",",O
142390,9871,patients,O
142391,9871,with,O
142392,9871,mild,O
142393,9871,or,O
142394,9871,moderate,O
142395,9871,pancreatitis,B-Condition
142396,9871,are,O
142397,9871,not,O
142398,9871,excluded,O
142399,9871,;,O
142400,9872,Patients,O
142401,9872,with,O
142402,9872,percutaneous,O
142403,9872,gastric,O
142404,9872,or,O
142405,9872,jejunal,O
142406,9872,feeding,O
142407,9872,tubes,O
142408,9872,already,O
142409,9872,in,O
142410,9872,situ,O
142411,9872,as,O
142412,9872,per,O
142413,9872,Health,O
142414,9872,Canada,O
142415,9872,guidance,O
142416,9872,;,O
142417,9873,Strict,O
142418,9873,contraindication,B-Condition
142419,9873,or,O
142420,9873,inability,O
142421,9873,to,O
142422,9873,receive,O
142423,9873,enteral,B-Procedure
142424,9873,medications,I-Procedure
142425,9873,;,O
142426,9874,Intent,O
142427,9874,to,O
142428,9874,withdraw,O
142429,9874,advanced,O
142430,9874,life,O
142431,9874,support,O
142432,9874,as,O
142433,9874,per,O
142434,9874,the,O
142435,9874,ICU,O
142436,9874,physician,O
142437,9874,;,O
142438,9875,Previous,O
142439,9875,enrolment,O
142440,9875,in,O
142441,9875,this,O
142442,9875,or,O
142443,9875,current,O
142444,9875,enrolment,O
142445,9875,in,O
142446,9875,a,O
142447,9875,potentially,O
142448,9875,confounding,O
142449,9875,tria,O
142450,9876,Adults,B-Person
142451,9876,=,O
142452,9876,18,O
142453,9876,years,O
142454,9876,of,O
142455,9876,age,B-Person
142456,9877,Admitted,O
142457,9877,to,O
142458,9877,any,O
142459,9877,ICU,O
142460,9877,and,O
142461,9877,receiving,O
142462,9877,invasive,O
142463,9877,mechanical,B-Procedure
142464,9877,ventilation,I-Procedure
142465,9878,Anticipated,B-Mood
142466,9878,ventilation,B-Procedure
142467,9878,of,O
142468,9878,=,O
142469,9878,72,O
142470,9878,hours,O
142471,9878,at,O
142472,9878,the,O
142473,9878,time,O
142474,9878,of,O
142475,9878,screening,O
142476,9878,",",O
142477,9878,as,O
142478,9878,per,O
142479,9878,the,O
142480,9878,ICU,O
142481,9878,physician,O
142482,9878,.,O
142483,9879,Relative,B-Condition
142484,9879,contraindications,I-Condition
142485,9879,to,O
142486,9879,ECT,B-Procedure
142487,9879,therapy,I-Procedure
142488,9879,(,O
142489,9879,recent,O
142490,9879,MI,B-Condition
142491,9879,or,O
142492,9879,CVA,B-Condition
142493,9879,",",O
142494,9879,increased,O
142495,9879,intracranial,O
142496,9879,pressure,O
142497,9879,",",O
142498,9879,intracranial,B-Condition
142499,9879,mass,I-Condition
142500,9879,lesion,I-Condition
142501,9879,",",O
142502,9879,intracranial,B-Condition
142503,9879,aneurysm,I-Condition
142504,9879,",",O
142505,9879,epilepsy,B-Condition
142506,9879,",",O
142507,9879,known,O
142508,9879,cardiac,B-Condition
142509,9879,arrhythmia,I-Condition
142510,9879,",",O
142511,9879,pheochromocytoma,B-Condition
142512,9879,",",O
142513,9879,pregnancy,B-Condition
142514,9879,),O
142515,9880,Contraindications,B-Condition
142516,9880,to,O
142517,9880,etomidate,B-Drug
142518,9880,(,O
142519,9880,sepsis,B-Condition
142520,9880,",",O
142521,9880,primary,O
142522,9880,or,O
142523,9880,secondary,O
142524,9880,adrenal,B-Condition
142525,9880,insufficiency,I-Condition
142526,9880,",",O
142527,9880,porphyria,B-Condition
142528,9880,),O
142529,9881,DSM,O
142530,9881,-,O
142531,9881,V,O
142532,9881,diagnosis,O
142533,9881,of,O
142534,9881,a,O
142535,9881,lifetime,B-Observation
142536,9881,history,I-Observation
142537,9881,of,O
142538,9881,psychotic,B-Condition
142539,9881,spectrum,I-Condition
142540,9881,disorder,I-Condition
142541,9882,Drug,B-Condition
142542,9882,or,I-Condition
142543,9882,alcohol,I-Condition
142544,9882,dependence,I-Condition
142545,9882,",",I-Condition
142546,9882,or,I-Condition
142547,9882,abuse,I-Condition
142548,9882,within,O
142549,9882,the,O
142550,9882,past,O
142551,9882,3,O
142552,9882,months,O
142553,9882,",",O
142554,9882,soy,B-Condition
142555,9882,-,I-Condition
142556,9882,bean,I-Condition
142557,9882,oil,I-Condition
142558,9882,allergy,I-Condition
142559,9883,Adults,B-Person
142560,9883,patients,O
142561,9883,aged,B-Person
142562,9883,18,O
142563,9883,to,O
142564,9883,85,O
142565,9883,years,O
142566,9884,Diagnosed,O
142567,9884,with,O
142568,9884,Major,B-Condition
142569,9884,Depressive,I-Condition
142570,9884,Disorder,I-Condition
142571,9884,",",O
142572,9884,unipolar,B-Condition
142573,9884,or,I-Condition
142574,9884,bipolar,I-Condition
142575,9884,depression,I-Condition
142576,9885,Undergoing,O
142577,9885,ECT,B-Procedure
142578,9885,for,O
142579,9885,treatment,O
142580,9885,of,O
142581,9885,their,O
142582,9885,symptoms,O
142583,9886,Currently,B-Observation
142584,9886,residing,I-Observation
142585,9886,in,O
142586,9886,Manitoba,O
